PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Cao, SB; Ma, TF; Ungerleider, N; Roberts, C; Kobelski, M; Jin, LJ; Concha, M; Wang, X; Baddoo, M; Nguyen, HM; Corey, E; Fazli, L; Ledet, E; Zhang, RB; Silberstein, JL; Zhang, WS; Zhang, K; Sartor, O; Dong, XS; Flemington, EK; Dong, Y				Cao, Subing; Ma, Tianfang; Ungerleider, Nathan; Roberts, Claire; Kobelski, Margaret; Jin, Lianjin; Concha, Monica; Wang, Xia; Baddoo, Melody; Nguyen, Holly M.; Corey, Eva; Fazli, Ladan; Ledet, Elisa; Zhang, Rubin; Silberstein, Jonathan L.; Zhang, Wensheng; Zhang, Kun; Sartor, Oliver; Dong, Xuesen; Flemington, Erik K.; Dong, Yan			Circular RNAs add diversity to androgen receptor isoform repertoire in castration-resistant prostate cancer	ONCOGENE			English	Article							TRANSLATION; EXPRESSION; PROGRESSION; LANDSCAPE	Deregulated expression of circular RNAs (circRNAs) is associated with various human diseases, including many types of cancer. Despite their growing links to cancer, there has been limited characterization of circRNAs in metastatic castration-resistant prostate cancer, the major cause of prostate cancer mortality. Here, through the analysis of an exome-capture RNA-seq dataset from 47 metastatic castration-resistant prostate cancer samples and ribodepletion and RNase R RNA-sequencing of patient-derived xenografts (PDXs) and cell models, we identified 13 circRNAs generated from the key prostate cancer driver gene-androgen receptor (AR). We validated and characterized the top four most abundant, clinically relevant AR circRNAs. Expression of these AR circRNAs was upregulated during castration-resistant progression of PDXs. The upregulation was not due to global increase of circRNA formation in these tumors. Instead, the levels of AR circRNAs correlated strongly with that of the linear AR transcripts (both AR and AR variants) in clinical samples and PDXs, indicating a transcriptional mechanism of regulation. In cultured cells, androgen suppressed the expression of these AR circRNAs and the linear AR transcripts, and the suppression was attenuated by an antiandrogen. Using nuclear/cytoplasmic fractionation and RNA in-situ hybridization assays, we demonstrated predominant cytoplasmic localization of these AR circRNAs, indicating likely cytoplasmic functions. Overall, this is the first comprehensive characterization of circRNAs arising from the AR gene. With greater resistance to exoribonuclease compared to the linear AR transcripts and detectability of AR circRNAs in patient plasma, these AR circRNAs may serve as surrogate circulating markers for AR/AR-variant expression and castration-resistant prostate cancer progression.	[Cao, Subing; Ma, Tianfang; Kobelski, Margaret; Jin, Lianjin; Dong, Yan] Tulane Univ, Sch Med, Dept Struct & Cellular Biol, Tulane Canc Ctr, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Ungerleider, Nathan; Roberts, Claire; Concha, Monica; Wang, Xia; Baddoo, Melody; Flemington, Erik K.] Tulane Univ, Sch Med, Dept Pathol, Tulane Canc Ctr, New Orleans, LA 70112 USA; [Nguyen, Holly M.; Corey, Eva] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Fazli, Ladan; Dong, Xuesen] Univ British Columbia, Vancouver Prostate Ctr, Dept Urol Sci, Vancouver, BC, Canada; [Ledet, Elisa; Zhang, Rubin; Silberstein, Jonathan L.; Sartor, Oliver] Tulane Univ, Sch Med, Dept Med, Tulane Canc Ctr, New Orleans, LA 70112 USA; [Zhang, Wensheng; Zhang, Kun] Xavier Univ Louisiana, Dept Comp Sci, Bioinformat Facil, Xavier RCMI Ctr Canc Res, New Orleans, LA USA	Tulane University; Tulane University; University of Washington; University of Washington Seattle; University of British Columbia; Tulane University; Xavier University of Louisiana	Dong, Y (corresponding author), Tulane Univ, Sch Med, Dept Struct & Cellular Biol, Tulane Canc Ctr, 1430 Tulane Ave, New Orleans, LA 70112 USA.; Flemington, EK (corresponding author), Tulane Univ, Sch Med, Dept Pathol, Tulane Canc Ctr, New Orleans, LA 70112 USA.	erik@tulane.edu; ydong@tulane.edu	Dong, Xuesen/AGF-9228-2022	Dong, Yan/0000-0003-1622-5354; Ma, Tianfang/0000-0003-4161-882X; Kobelski, Margaret/0000-0002-8829-4562	National Institutes of Health [R01CA188609, R01AI101046, R01AI106676, P01CA214091]; PNW Prostate Cancer SPORE [P50CA097186, P01CA163227, RCMI 2U54MD007595, 5P20GM103424-17]; Department of Defense [W81XWH-15-10439, W81XWH-16-1-0317, W81XWH-16-1-0318]; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA243793, R21CA236549, P01CA214091, P01CA163227, R01CA188609, P50CA097186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106676, R01AI101046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103424] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PNW Prostate Cancer SPORE; Department of Defense(United States Department of Defense); Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by the following grants: the National Institutes of Health grants R01CA188609, R01AI101046, R01AI106676, P01CA214091, PNW Prostate Cancer SPORE P50CA097186, P01CA163227, RCMI 2U54MD007595, and 5P20GM103424-17; Department of Defense grants W81XWH-15-10439, W81XWH-16-1-0317, and W81XWH-16-1-0318; The Prostate Cancer Foundation. The Richard M. Lucas Foundation supported the development of the LuCaP models. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.	Abdelmohsen K, 2017, RNA BIOL, V14, P361, DOI 10.1080/15476286.2017.1279788; Abe N, 2015, SCI REP-UK, V5, DOI 10.1038/srep16435; Abe N, 2013, ANGEW CHEM INT EDIT, V52, P7004, DOI 10.1002/anie.201302044; Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Bach DH, 2019, MOL THER-NUCL ACIDS, V16, P118, DOI 10.1016/j.omtn.2019.02.005; Burd CE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001233; Burnstein KL, 2005, J CELL BIOCHEM, V95, P657, DOI 10.1002/jcb.20460; Cai CM, 2011, CANCER CELL, V20, P457, DOI 10.1016/j.ccr.2011.09.001; Cao SB, 2016, ENDOCR-RELAT CANCER, V23, pT199, DOI 10.1530/ERC-16-0298; Chen S, 2019, CANCER CELL, V176, pe822; Dai YQ, 2018, MED SCI MONITOR, V24, P3462, DOI 10.12659/MSM.908009; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dong Y, 2004, CANCER RES, V64, P19, DOI 10.1158/0008-5472.CAN-03-2789; Egan A, 2014, CANCER TREAT REV, V40, P426, DOI 10.1016/j.ctrv.2013.09.011; Hamilton MP, 2016, NEOPLASIA, V18, P356, DOI 10.1016/j.neo.2016.04.008; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Holdt LM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12429; Huang H, 2002, CRIT REV EUKAR GENE, V12, P193, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i3.30; Jie ST, 2019, INT J BIOL MACROMOL, V122, P1235, DOI 10.1016/j.ijbiomac.2018.09.076; Kahn B, 2014, INT J BIOL SCI, V10, P588, DOI 10.7150/ijbs.8671; Kong Z, 2017, BIOCHEM BIOPH RES CO, V493, P1217, DOI 10.1016/j.bbrc.2017.07.162; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Kristensen LS, 2018, ONCOGENE, V37, P555, DOI 10.1038/onc.2017.361; Legnini I, 2017, MOL CELL, V66, P22, DOI 10.1016/j.molcel.2017.02.017; Li SL, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0629-7; Li Y, 2012, ONCOGENE, V31, P4759, DOI 10.1038/onc.2011.637; Li Y, 2015, CELL RES, V25, P981, DOI 10.1038/cr.2015.82; Li ZY, 2015, NAT STRUCT MOL BIOL, V22, P256, DOI 10.1038/nsmb.2959; Liang DM, 2014, GENE DEV, V28, P2233, DOI 10.1101/gad.251926.114; Markowski MC, 2017, JCO PRECIS ONCOL, V1; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Nyquist MD, 2013, P NATL ACAD SCI USA, V110, P17492, DOI 10.1073/pnas.1308587110; Pamudurti NR, 2017, MOL CELL, V66, P9, DOI 10.1016/j.molcel.2017.02.021; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Shand RL, 2006, CURR OPIN UROL, V16, P123, DOI 10.1097/01.mou.0000193384.39351.64; Ungerleider N, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2865-7; Ungerleider N, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007206; Ungerleider NA, 2019, J VIROL, V93, DOI 10.1128/JVI.01952-18; Vo JN, 2019, CELL, V176, P869, DOI 10.1016/j.cell.2018.12.021; Xia QL, 2018, CELL PHYSIOL BIOCHEM, V50, P1903, DOI 10.1159/000494870; Xu HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep12453; Yang Y, 2017, CELL RES, V27, P626, DOI 10.1038/cr.2017.31; Yuan X, 2014, ONCOGENE, V33, P2815, DOI 10.1038/onc.2013.235; Zhang Y, 2013, MOL CELL, V51, P792, DOI 10.1016/j.molcel.2013.08.017; Zheng QP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11215	45	23	24	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 7	2019	38	45					7060	7072		10.1038/s41388-019-0947-7	http://dx.doi.org/10.1038/s41388-019-0947-7			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JL9XI	31409897	Green Accepted			2022-12-26	WOS:000495878400003
J	Khan, NS; Lukason, DP; Feliu, M; Ward, RA; Lord, AK; Reedy, JL; Ramirez-Ortiz, ZG; Tam, JM; Kasperkovitz, PV; Negoro, PE; Vyas, TD; Xu, SY; Brinkmann, MM; Acharaya, M; Artavanis-Tsakonas, K; Frickel, EM; Becker, CE; Dagher, Z; Kim, YM; Latz, E; Ploegh, HL; Mansour, MK; Miranti, CK; Levitz, SM; Vyas, JM				Khan, Nida S.; Lukason, Daniel P.; Feliu, Marianela; Ward, Rebecca A.; Lord, Allison K.; Reedy, Jennifer L.; Ramirez-Ortiz, Zaida G.; Tam, Jenny M.; Kasperkovitz, Pia V.; Negoro, Paige E.; Vyas, Tammy D.; Xu, Shuying; Brinkmann, Melanie M.; Acharaya, Mridu; Artavanis-Tsakonas, Katerina; Frickel, Eva-Maria; Becker, Christine E.; Dagher, Zeina; Kim, You-Me; Latz, Eicke; Ploegh, Hidde L.; Mansour, Michael K.; Miranti, Cindy K.; Levitz, Stuart M.; Vyas, Jatin M.			CD82 controls CpG-dependent TLR9 signaling	FASEB JOURNAL			English	Article						tetraspanins; TLRs; myddosome; macrophages	RECEPTOR 9; PROTEOLYTIC CLEAVAGE; ANTIGEN PRESENTATION; INNATE IMMUNITY; DECTIN-1; ACTIVATION; PROTEIN; TRAFFICKING; INDUCTION; PATHWAY	The tetraspanin CD82 is a potent suppressor of tumor metastasis and regulates several processes including signal transduction, cell adhesion, motility, and aggregation. However, the mechanisms by which CD82 participates in innate immunity are unknown. We report that CD82 is a key regulator of TLR9 trafficking and signaling. TLR9 recognizes unmethylated cytosine-phosphate-guanine (CpG) motifs present in viral, bacterial, and fungal DNA. We demonstrate that TLR9 and CD82 associate in macrophages, which occurs in the endoplasmic reticulum (ER) and post-ER. Moreover, CD82 is essential for TLR9-dependent myddosome formation in response to CpG stimulation. Finally, CD82 modulates TLR9-dependent NF-kappa B nuclear translocation, which is critical for inflammatory cytokine production. To our knowledge, this is the first time a tetraspanin has been implicated as a key regulator of TLR signaling. Collectively, our study demonstrates that CD82 is a specific regulator of TLR9 signaling, which may be critical in cancer immunotherapy approaches and coordinating the innate immune response to pathogens.	[Khan, Nida S.; Lukason, Daniel P.; Feliu, Marianela; Ward, Rebecca A.; Lord, Allison K.; Reedy, Jennifer L.; Tam, Jenny M.; Negoro, Paige E.; Vyas, Tammy D.; Xu, Shuying; Dagher, Zeina; Mansour, Michael K.; Vyas, Jatin M.] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA; [Khan, Nida S.] Univ Massachusetts Med Sch, Biomed Engn & Biotechnol, Boston, MA USA; [Latz, Eicke; Levitz, Stuart M.] Univ Massachusetts Med Sch, Dept Med, Boston, MA USA; [Lukason, Daniel P.] Univ Massachusetts, Biomed Engn & Biotechnol, Lowell, MA USA; [Khan, Nida S.; Reedy, Jennifer L.; Ramirez-Ortiz, Zaida G.; Mansour, Michael K.; Vyas, Jatin M.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Boston, MA 02115 USA; [Ramirez-Ortiz, Zaida G.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02115 USA; [Ramirez-Ortiz, Zaida G.] Harvard Med Sch, Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Becker, Christine E.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02115 USA; [Kasperkovitz, Pia V.] F Hoffmann La Roche Innovat Ctr Basel, Basel, Switzerland; [Brinkmann, Melanie M.] Helmholtz Ctr Infect Res, Viral Immune Modulat Res Grp, Braunschweig, Germany; [Brinkmann, Melanie M.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Genet, Braunschweig, Germany; [Acharaya, Mridu] Benaroya Res Inst, Seattle, WA USA; [Acharaya, Mridu] Seattle Childrens Res Inst, Ctr Immun & Immunotherapy, Seattle, WA USA; [Artavanis-Tsakonas, Katerina] Univ Cambridge, Dept Pathol, Cambridge, England; [Frickel, Eva-Maria] Francis Crick Inst, Host Toxoplasma Interact Lab, London, England; [Kim, You-Me] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea; [Latz, Eicke] Univ Bonn, Univ Hosp Bonn, Inst Innate Immun, Bonn, Germany; [Latz, Eicke] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Ploegh, Hidde L.] Boston Childrens Hosp, Boston, MA USA; [Miranti, Cindy K.] Van Andel Res Inst, Lab Integrin Signaling & Tumorigenesis, Grand Rapids, MI USA; [Miranti, Cindy K.] Univ Arizona, Canc Ctr, Dept Cellular & Mol Med, Tucson, AZ USA	Harvard University; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Lowell; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Helmholtz Association; Helmholtz-Center for Infection Research; Braunschweig University of Technology; Benaroya Research Institute; Seattle Children's Hospital; University of Cambridge; Francis Crick Institute; Korea Advanced Institute of Science & Technology (KAIST); University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Harvard University; Boston Children's Hospital; Van Andel Institute; University of Arizona	Vyas, JM (corresponding author), Massachusetts Gen Hosp, Dept Infect Dis, 55 Fruit St, Boston, MA 02114 USA.	jvyas@mgh.harvard.edu	Vyas, Jatin/Q-1627-2016; Miranti, Cindy/AAJ-3783-2020; Kim, You-Me/I-5553-2013; Latz, Eicke/H-3951-2014	Vyas, Jatin/0000-0002-9985-9565; Kim, You-Me/0000-0001-8780-704X; Lukason, Daniel/0000-0003-1829-5735; Latz, Eicke/0000-0003-1488-5666; Ramirez Ortiz, Zaida/0000-0002-0253-0473; Xu, Shuying/0000-0003-4572-8663	U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases [R01 AI092084, R01 AI097519, R01 AI025780, R01 AI139615]; Francis Crick Institute - Cancer Research UK [FC001076]; UK Medical Research Council [FC001076]; Wellcome Trust [FC001076]; MRC [MC_UP_1202/12] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI136529, R01AI025780, R01AI097519, R01AI139615] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Francis Crick Institute - Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Nicole Wolf for the artwork displayed in the graphical abstract (Fig. 7), Shizuo Akira (Osaka University, Osaka, Japan) for the TLR9 knockout (TLR9KO) mice, and Douglas Golenbock (University of Massachusetts Medical Center, Worcester, MA, USA) for the TLR9KO macrophage cell line. The authors also thank Kensuyke Miyake and Ryutaro Fukui (University of Tokyo, Tokyo, Japan) for the TLR9 monoclonal and polyclonal antibodies (41), and Gregory Barton and Bo Liu (University of California-Berkeley, Berkeley, CA, USA) for the TLR7-FLAG construct. This work was supported by U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases Grants R01 AI092084 and R01 AI097519 (to J.M.V.) and R01 AI025780 and R01 AI139615 (to S.M.L.). This work was also supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001076), the UK Medical Research Council (FC001076), and the Wellcome Trust (FC001076). The authors declare no conflicts of interest.	Artavanis-Tsakonas K, 2011, INFECT IMMUN, V79, P1098, DOI 10.1128/IAI.01135-10; Avalos AM, 2013, J IMMUNOL, V190, P695, DOI 10.4049/jimmunol.1202342; Babdor J, 2017, NAT IMMUNOL, V18, P509, DOI 10.1038/ni.3711; Bandyopadhyay S, 2006, NAT MED, V12, P933, DOI 10.1038/nm1444; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Blanque R, 1998, GEN PHARMACOL, V31, P301, DOI 10.1016/S0306-3623(97)00434-5; Bonham KS, 2014, CELL, V156, P705, DOI 10.1016/j.cell.2014.01.019; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Danglot L, 2010, J CELL SCI, V123, P723, DOI 10.1242/jcs.062497; Delos Santos RC, 2015, CELL SIGNAL, V27, P1963, DOI 10.1016/j.cellsig.2015.07.004; den Brok MHMGM, 2006, CANCER RES, V66, P7285, DOI 10.1158/0008-5472.CAN-06-0206; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Fukui R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01491; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hammond C, 1998, J IMMUNOL, V161, P3282; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Hemler ME, 2014, NAT REV CANCER, V14, P49, DOI 10.1038/nrc3640; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Herbst S, 2015, EMBO MOL MED, V7, P240, DOI 10.15252/emmm.201404556; Hur J, 2016, CELL STEM CELL, V18, P508, DOI 10.1016/j.stem.2016.01.013; Inoue M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003873; Jahrsdorfer Bernd, 2008, Update Cancer Ther, V3, P27, DOI 10.1016/j.uct.2007.11.003; Jones EL, 2016, J IMMUNOL, V196, P978, DOI 10.4049/jimmunol.1500357; Kagan JC, 2014, NAT REV IMMUNOL, V14, P821, DOI 10.1038/nri3757; Kasperkovitz PV, 2010, J IMMUNOL, V185, P7614, DOI 10.4049/jimmunol.1002760; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Khan NS, 2016, J IMMUNOL, V196, P2249, DOI 10.4049/jimmunol.1401545; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Koh HJ, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0091-4; Kropshofer H, 2002, NAT IMMUNOL, V3, P61, DOI 10.1038/ni750; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; LEBELBINAY S, 1995, J LEUKOCYTE BIOL, V57, P956, DOI 10.1002/jlb.57.6.956; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Ligeon LA, 2014, AUTOPHAGY, V10, P1588, DOI 10.4161/auto.29411; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Liu WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051797; Marjon KD, 2016, ONCOGENE, V35, P4132, DOI 10.1038/onc.2015.449; Meyer-Wentrup F, 2007, J IMMUNOL, V178, P154, DOI 10.4049/jimmunol.178.1.154; Mollinedo F, 1997, CLIN DIAGN LAB IMMUN, V4, P229, DOI 10.1128/CDLI.4.2.229-231.1997; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; Murakami Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep44042; Newman ZR, 2016, P NATL ACAD SCI USA, V113, pE1362, DOI 10.1073/pnas.1518976113; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Rocha-Perugini V, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00653; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; Sepulveda FE, 2009, IMMUNITY, V31, P737, DOI 10.1016/j.immuni.2009.09.013; Shirota H, 2001, J IMMUNOL, V167, P66, DOI 10.4049/jimmunol.167.1.66; Sparwasser T, 1997, EUR J IMMUNOL, V27, P1671, DOI 10.1002/eji.1830270712; Suzuki M, 2009, J IMMUNOL, V182, P6485, DOI 10.4049/jimmunol.0802797; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Tam JM, 2019, J IMMUNOL, V202, P3256, DOI 10.4049/jimmunol.1801384; Tan YH, 2019, CELL, V177, P384, DOI 10.1016/j.cell.2019.01.039; Tonoli H, 2005, TRENDS MOL MED, V11, P563, DOI 10.1016/j.molmed.2005.10.002; Tsai YC, 2011, FEBS LETT, V585, P3166, DOI 10.1016/j.febslet.2011.08.031; Uchtmann K, 2015, EXP CELL RES, V339, P261, DOI 10.1016/j.yexcr.2015.11.006; van den Hoorn T, 2012, J CELL SCI, V125, P328, DOI 10.1242/jcs.088047; van Spriel AB, 2010, MICROBES INFECT, V12, P106, DOI 10.1016/j.micinf.2009.11.001; van Zelm MC, 2010, J CLIN INVEST, V120, P1265, DOI 10.1172/JCI39748; Vyas JM, 2007, J IMMUNOL, V178, P7199, DOI 10.4049/jimmunol.178.11.7199; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yi AK, 2006, J BIOL CHEM, V281, P15001, DOI 10.1074/jbc.M601337200; Yoshizaki M, 2009, BLOOD, V114, P1518, DOI 10.1182/blood-2008-12-192344; Zhou YF, 2017, J NEUROL SCI, V373, P95, DOI 10.1016/j.jns.2016.12.027	69	13	15	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12500	12514		10.1096/fj.201901547R	http://dx.doi.org/10.1096/fj.201901547R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31408613	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000507461600070
J	Bradshaw, WJ; Bruxelle, JF; Kovacs-Simon, A; Harmer, NJ; Janoir, C; Pechine, S; Acharya, KR; Michell, SL				Bradshaw, William J.; Bruxelle, Jean-Francois; Kovacs-Simon, Andrea; Harmer, Nicholas J.; Janoir, Claire; Pechine, Severine; Acharya, K. Ravi; Michell, Stephen L.			Molecular features of lipoprotein CD0873: A potential vaccine against the human pathogen Clostridioides difficile	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein structure; ABC transporter; vaccine; crystallography; microbiology; Clostridioides difficile; tyrosine metabolism	CRYSTAL-STRUCTURE; ADHESIN; PROTEIN; INFECTION; BACTERIA; REVEALS; MODEL	Clostridioides difficile is the primary cause of antibiotic-associated diarrhea and colitis, a healthcare-associated intestinal disease resulting in a significant fatality rate. Colonization of the gut is critical for C. difficile pathogenesis. The bacterial molecules essential for efficient colonization therefore offer great potential as vaccine candidates. Here we present findings demonstrating that the C. difficile immunogenic lipoprotein CD0873 plays a critical role in pathogen success in vivo. We found that in a dixenic colonization model, a CD0873-positive strain of C. difficile significantly outcompeted a CD0873-negative strain. Immunization of mice with recombinant CD0873 prevented long-term gut colonization and was correlated with a strong secretory IgA immune response. We further present high-resolution crystal structures of CD0873, at 1.35?2.50 ? resolutions, offering a first view of the ligand-binding pocket of CD0873 and provide evidence that this lipoprotein adhesin is part of a tyrosine import system, an amino acid key in C. difficile infection. These findings suggest that CD0873 could serve as an effective component in a vaccine against C. difficile.	[Bradshaw, William J.; Acharya, K. Ravi] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Bruxelle, Jean-Francois; Janoir, Claire; Pechine, Severine] Univ Paris Saclay, Univ Paris Sud, EA4043 Unite Bacteries Pathogenes & Sante UBaPS, Chatenay Malabry, France; [Kovacs-Simon, Andrea; Harmer, Nicholas J.; Michell, Stephen L.] Univ Exeter, Coll Life & Environm Sci, Geoffrey Pope Bldg,Stocker Rd, Exeter EX4 4QD, Devon, England; [Harmer, Nicholas J.] Univ Exeter, Living Syst Inst, Exeter EX4 4QD, Devon, England; [Bradshaw, William J.] Univ Oxford, Struct Genom Consortium, ORCRB, Roosevelt Dr, Oxford OX3 7DQ, England; [Bruxelle, Jean-Francois] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada	University of Bath; UDICE-French Research Universities; Universite Paris Saclay; University of Exeter; University of Exeter; University of Oxford; Simon Fraser University	Acharya, KR (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.; Michell, SL (corresponding author), Univ Exeter, Coll Life & Environm Sci, Geoffrey Pope Bldg,Stocker Rd, Exeter EX4 4QD, Devon, England.	K.R.Acharya@bath.ac.uk; S.L.Michell@exeter.ac.uk	PÉCHINÉ, SÉVERINE/ABD-1960-2021; Harmer, Nicholas/AAJ-2596-2020	Harmer, Nicholas/0000-0002-4073-0505; Bradshaw, William/0000-0002-7985-9752; Bruxelle, Jean-Francois/0000-0001-7180-8611; Acharya, K. Ravi/0000-0002-3009-4058				Barkin JA, 2017, DIGEST DIS SCI, V62, P1035, DOI 10.1007/s10620-017-4462-9; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Bruxelle JF, 2018, ADV EXP MED BIOL, V1050, P197, DOI 10.1007/978-3-319-72799-8_12; Bruxelle JF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187212; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen XH, 2008, GASTROENTEROLOGY, V135, P1984, DOI 10.1053/j.gastro.2008.09.002; Dawson LF, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-86; ELSDEN SR, 1976, ARCH MICROBIOL, V107, P283, DOI 10.1007/BF00425340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Entwisle C, 2017, VACCINE, V35, P7181, DOI 10.1016/j.vaccine.2017.10.076; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fukami-Kobayashi K, 1999, J MOL BIOL, V286, P279, DOI 10.1006/jmbi.1998.2454; Ghose C, 2015, INFECT DIS CLIN N AM, V29, P145, DOI 10.1016/j.idc.2014.11.013; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hussain HA, 2005, J MED MICROBIOL, V54, P137, DOI 10.1099/jmm.0.45790-0; Janoir C, 2016, ANAEROBE, V37, P13, DOI 10.1016/j.anaerobe.2015.10.009; Janvilisri T, 2010, J INFECT DIS, V202, P282, DOI 10.1086/653484; Kirk JA, 2017, MICROB BIOTECHNOL, V10, P76, DOI 10.1111/1751-7915.12372; Kovacs-Simon A, 2014, J INFECT DIS, V210, P274, DOI 10.1093/infdis/jiu070; Lawrence MC, 1998, STRUCTURE, V6, P1553, DOI 10.1016/S0969-2126(98)00153-1; Lee BY, 2010, VACCINE, V28, P5245, DOI 10.1016/j.vaccine.2010.05.062; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Lithgow KV, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14273; Malito E, 2014, P NATL ACAD SCI USA, V111, P17128, DOI 10.1073/pnas.1419686111; Mascioni A, 2010, BBA-BIOMEMBRANES, V1798, P87, DOI 10.1016/j.bbamem.2009.09.021; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muller A, 2007, J MOL BIOL, V372, P160, DOI 10.1016/j.jmb.2007.06.041; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Ong E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01382; Ong GKB, 2017, AM J SURG, V213, P565, DOI 10.1016/j.amjsurg.2016.10.035; Passmore IJ, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007191; Pechine S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01009; Rangarajan ES, 2007, PROTEIN SCI, V16, P990, DOI 10.1110/ps.062737507; Solanki V, 2018, INT J BIOL MACROMOL, V112, P54, DOI 10.1016/j.ijbiomac.2018.01.151; Steere AC, 1998, NEW ENGL J MED, V339, P209, DOI 10.1056/NEJM199807233390401; Steglich M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00901; Stevenson E, 2015, TRENDS MICROBIOL, V23, P275, DOI 10.1016/j.tim.2015.01.004; Tanaka KJ, 2018, BBA-BIOMEMBRANES, V1860, P868, DOI 10.1016/j.bbamem.2017.08.011; Teichmann L, 2017, MOL MICROBIOL, V104, P761, DOI 10.1111/mmi.13660; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Vivoli M, 2014, JOVE-J VIS EXP, DOI 10.3791/51809; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Watanabe M, 2010, J APPL MICROBIOL, V109, P927, DOI 10.1111/j.1365-2672.2010.04719.x; Winter G, 2018, ACTA CRYSTALLOGR D, V74, P85, DOI 10.1107/S2059798317017235; Wright A, 2008, J MED MICROBIOL, V57, P750, DOI 10.1099/jmm.0.47532-0	46	10	10	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2019	294	43					15850	15861		10.1074/jbc.RA119.010120	http://dx.doi.org/10.1074/jbc.RA119.010120			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9JD	31420448	Green Published, hybrid			2022-12-26	WOS:000499253000025
J	Wang, ZQ; Hutcherson, SM; Yang, C; Jattani, RP; Tritapoe, JM; Yang, YK; Pomerantz, J				Wang, Zhaoquan; Hutcherson, Shelby M.; Yang, Chao; Jattani, Rakhi P.; Tritapoe, Julia M.; Yang, Yong-Kang; Pomerantz, Joel			Coordinated regulation of scaffold opening and enzymatic activity during CARD11 signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						NF-kappa B (NF-?B); immunology; signal transduction; scaffold protein; ubiquitylation (ubiquitination); antigen receptor; Bcl10; CARD11; LUBAC; MALT1	NF-KAPPA-B; T-CELL-RECEPTOR; MALT1 CLEAVES; DOMAIN; MUTATIONS; PHOSPHORYLATION; BCL10; IMMUNODEFICIENCY; LYMPHOCYTOSIS; ACTIVATION	The activation of key signaling pathways downstream of antigen receptor engagement is critically required for normal lymphocyte activation during the adaptive immune response. CARD11 is a multidomain signaling scaffold protein required for antigen receptor signaling to NF-kappa B, c-Jun N-terminal kinase, and mTOR. Germline mutations in the CARD11 gene result in at least four types of primary immunodeficiency, and somatic CARD11 gain-of-function mutations drive constitutive NF-kappa B activity in diffuse large B cell lymphoma and other lymphoid cancers. In response to antigen receptor triggering, CARD11 transitions from a closed, inactive state to an open, active scaffold that recruits multiple signaling partners into a complex to relay downstream signaling. However, how this signal-induced CARD11 conversion occurs remains poorly understood. Here we investigate the role of Inducible Element 1 (IE1), a short regulatory element in the CARD11 Inhibitory Domain, in the CARD11 signaling cycle. We find that IE1 controls the signal-dependent Opening Step that makes CARD11 accessible to the binding of cofactors, including Bcl10, MALT1, and the HOIP catalytic subunit of the linear ubiquitin chain assembly complex. Surprisingly, we find that IE1 is also required at an independent step for the maximal activation of HOIP and MALT1 enzymatic activity after cofactor recruitment to CARD11. This role of IE1 reveals that there is an Enzymatic Activation Step in the CARD11 signaling cycle that is distinct from the Cofactor Association Step. Our results indicate that CARD11 has evolved to actively coordinate scaffold opening and the induction of enzymatic activity among recruited cofactors during antigen receptor signaling.	[Wang, Zhaoquan; Hutcherson, Shelby M.; Yang, Chao; Jattani, Rakhi P.; Tritapoe, Julia M.; Yang, Yong-Kang; Pomerantz, Joel] Johns Hopkins Univ, Sch Med, Dept Biol Chemist, Baltimore, MD 21205 USA; [Wang, Zhaoquan; Hutcherson, Shelby M.; Yang, Chao; Jattani, Rakhi P.; Tritapoe, Julia M.; Yang, Yong-Kang; Pomerantz, Joel] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Pomerantz, J (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Dept Biol Chem, Miller Res Bldg,Rm 623,733 N Broadway, Baltimore, MD 21205 USA.	joel.pomerantz@jhmi.edu	YANG, YONGKANG/AEP-2772-2022	YANG, YONGKANG/0000-0002-0333-7712; Hutcherson, Shelby/0000-0001-8380-5012; Pomerantz, Joel L./0000-0002-5030-1018	National Institutes of Health [RO1CA177600]; Johns Hopkins University Institute for Cell Engineering; NATIONAL CANCER INSTITUTE [T32CA009110, R01CA177600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University Institute for Cell Engineering; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant RO1CA177600 and funds from The Johns Hopkins University Institute for Cell Engineering. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arjunaraja S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00198; Arjunaraja S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00913; Bedsaul JR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02105; Blonska M, 2009, IMMUNOL REV, V228, P199, DOI 10.1111/j.1600-065X.2008.00749.x; Brohl AS, 2015, J CLIN IMMUNOL, V35, P32, DOI 10.1007/s10875-014-0106-4; Buchbinder D, 2015, J ALLERGY CLIN IMMUN, V136, P819, DOI 10.1016/j.jaci.2015.03.008; Chan WP, 2013, MOL CELL BIOL, V33, P429, DOI 10.1128/MCB.00850-12; Dadi H, 2018, J ALLERGY CLIN IMMUN, V141, P1818, DOI 10.1016/j.jaci.2017.06.047; Dorjbal B, 2019, J ALLERGY CLIN IMMUN, V143, P1482, DOI 10.1016/j.jaci.2018.08.013; Douanne T, 2016, J CELL SCI, V129, P1775, DOI 10.1242/jcs.185025; Elton L, 2016, FEBS J, V283, P403, DOI 10.1111/febs.13597; Greil J, 2013, J ALLERGY CLIN IMMUN, V131, P1376, DOI 10.1016/j.jaci.2013.02.012; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Jattani RP, 2016, J BIOL CHEM, V291, P8338, DOI 10.1074/jbc.M116.717322; Jattani RP, 2016, J BIOL CHEM, V291, P8324, DOI 10.1074/jbc.M115.683714; Juilland M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01927; Juilland M, 2016, CURR OPIN HEMATOL, V23, P402, DOI 10.1097/MOH.0000000000000257; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Klein T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9777; Lamason RL, 2010, MOL CELL, V40, P798, DOI 10.1016/j.molcel.2010.11.007; Lamason RL, 2010, BIOCHEMISTRY-US, V49, P8240, DOI 10.1021/bi101052d; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Lork M, 2019, CELL IMMUNOL, V340, DOI 10.1016/j.cellimm.2018.11.001; Lu HY, 2019, J ALLERGY CLIN IMMUN, V143, P1661, DOI 10.1016/j.jaci.2019.03.009; Ma CA, 2017, NAT GENET, V49, P1192, DOI 10.1038/ng.3898; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; McCully RR, 2008, MOL CELL BIOL, V28, P5668, DOI 10.1128/MCB.00418-08; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Paul S, 2013, TRENDS IMMUNOL, V34, P269, DOI 10.1016/j.it.2013.02.002; Pedersen SM, 2016, MOL CELL BIOL, V36, P794, DOI 10.1128/MCB.00876-15; Shinohara H, 2007, J EXP MED, V204, P3285, DOI 10.1084/jem.20070379; Snow AL, 2012, J EXP MED, V209, P2247, DOI 10.1084/jem.20120831; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Stepensky P, 2013, J ALLERGY CLIN IMMUN, V131, P477, DOI 10.1016/j.jaci.2012.11.050; Thys A, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00498; Yang YK, 2016, J BIOL CHEM, V291, P25921, DOI 10.1074/jbc.M116.754028; Zhang SL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00176; Zotti T, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02167	38	11	12	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2019	294	40					14648	14660		10.1074/jbc.RA119.009551	http://dx.doi.org/10.1074/jbc.RA119.009551			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JP0II	31391255	hybrid, Green Published			2022-12-26	WOS:000497955000012
J	Zhang, YJ; Yan, LB; Zeng, J; Zhou, H; Liu, HR; Yu, G; Yao, WM; Chen, K; Ye, ZQ; Xu, H				Zhang, Yangjun; Yan, Libin; Zeng, Jin; Zhou, Hui; Liu, Haoran; Yu, Gan; Yao, Weimin; Chen, Ke; Ye, Zhangqun; Xu, Hua			Pan-cancer analysis of clinical relevance of alternative splicing events in 31 human cancers	ONCOGENE			English	Article							MESSENGER-RNA DECAY; FUNCTIONAL CONSEQUENCES; PROSTATE-CANCER; GENE; PROTEIN; TRANSCRIPTOME; REGULATOR; IMPACT; EXONS; PBRM1	Alternative splicing represents a critical posttranscriptional regulation of gene expression, which contributes to the protein complexity and mRNA processing. Defects of alternative splicing including genetic alteration and/or altered expression of both pre-mRNA and trans-acting factors give rise to many cancers. By integrally analyzing clinical data and splicing data from TCGA and SpliceSeq databases, a number of splicing events were found clinically relevant in tumor samples. Alternative splicing of KLK2 (KLK2_51239) was found as a potential inducement of nonsense-mediated mRNA decay and associated with poor survival in prostate cancer. Consensus K-means clustering analysis indicated that alternative splicing events could be potentially used for molecular subtype classification of cancers. By random forest survival algorithm, prognostic prediction signatures with well performances were constructed for 31 cancers by using survival-associated alternative splicing events. Furthermore, an online tool for visualization of Kaplan-Meier plots of splicing events in 31 cancers was explored. Briefly, alternative splicing was found of significant clinical relevance with cancers.	[Zhang, Yangjun; Yan, Libin; Zeng, Jin; Zhou, Hui; Liu, Haoran; Yu, Gan; Yao, Weimin; Chen, Ke; Ye, Zhangqun; Xu, Hua] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Urol, Wuhan 430030, Hubei, Peoples R China; [Zhang, Yangjun; Yan, Libin; Zeng, Jin; Zhou, Hui; Liu, Haoran; Yu, Gan; Yao, Weimin; Chen, Ke; Ye, Zhangqun; Xu, Hua] Inst Urol Hubei Prov, Wuhan 430030, Hubei, Peoples R China	Huazhong University of Science & Technology	Xu, H (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Urol, Wuhan 430030, Hubei, Peoples R China.; Xu, H (corresponding author), Inst Urol Hubei Prov, Wuhan 430030, Hubei, Peoples R China.	xuhuawhu@163.com	Zhou, Hui/AAV-2680-2020		National Natural Science Foundation of China [81702522, 81602236]; National Major Scientific and Technological Special Project for Significant New Drugs Development [2017ZX09304022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Scientific and Technological Special Project for Significant New Drugs Development	The authors would like to thank Xudong Zhang of Genek Company for helpful advices of data processing. This work was funded by the National Natural Science Foundation of China (81702522, 81602236) and National Major Scientific and Technological Special Project for Significant New Drugs Development (2017ZX09304022).	Arzalluz-Luque A, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1496-z; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Baralle FE, 2017, NAT REV MOL CELL BIO, V18, P437, DOI 10.1038/nrm.2017.27; Bates DO, 2017, PHARMACOL REV, V69, P63, DOI 10.1124/pr.115.011239; Bauman JA, 2010, NUCLEIC ACIDS RES, V38, P8348, DOI 10.1093/nar/gkq731; Blencowe BJ, 2017, TRENDS BIOCHEM SCI, V42, P407, DOI 10.1016/j.tibs.2017.04.001; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chen FJ, 2018, CLIN CANCER RES, V24, P2182, DOI 10.1158/1078-0432.CCR-17-3378; Climente-Gonzalez H, 2017, CELL REP, V20, P2215, DOI 10.1016/j.celrep.2017.08.012; da Costa PJ, 2017, INT J BIOCHEM CELL B, V91, P168, DOI 10.1016/j.biocel.2017.07.013; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Eilertsen IA, 2019, INT J CANCER, V144, P841, DOI 10.1002/ijc.31809; Fu XD, 2014, NAT REV GENET, V15, P689, DOI 10.1038/nrg3778; Gao WH, 2017, P NATL ACAD SCI USA, V114, P1027, DOI 10.1073/pnas.1619726114; Ge Y, 2014, BIOESSAYS, V36, P236, DOI 10.1002/bies.201300156; Gerstberger S, 2014, NAT REV GENET, V15, P829, DOI 10.1038/nrg3813; Green RE, 2003, BIOINFORMATICS, V19, pi118, DOI 10.1093/bioinformatics/btg1015; Guo ZQ, 2016, CANCER CELL, V30, P474, DOI 10.1016/j.ccell.2016.08.003; Han L, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.013; Han T, 2017, SCIENCE, V356, DOI 10.1126/science.aal3755; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Hogner A, 2018, UROL ONCOL, V36, pe1, DOI DOI 10.1016/J.UR0L0NC.2017.10.027; Hong SK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/526341; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jayasinghe RG, 2018, CELL REP, V23, P270, DOI 10.1016/j.celrep.2018.03.052; Kahles A, 2018, CANCER CELL, V34, P211, DOI 10.1016/j.ccell.2018.07.001; Kahles A, 2016, BIOINFORMATICS, V32, P1840, DOI 10.1093/bioinformatics/btw076; Karpinski P, 2017, EPIGENOMICS-UK, V9, P1341, DOI 10.2217/epi-2017-0070; Kelemen O, 2013, GENE, V514, P1, DOI 10.1016/j.gene.2012.07.083; Kim JY, 2015, J UROLOGY, V194, DOI 10.1016/j.juro.2015.04.114; Ladomery MR, 2007, CANCER LETT, V249, P133, DOI 10.1016/j.canlet.2006.08.015; Li H, 2018, MODERN PATHOL, V31, P198, DOI 10.1038/modpathol.2017.74; Li Y, 2017, CANCER LETT, V393, P40, DOI 10.1016/j.canlet.2017.02.016; Lindeboom RGH, 2016, NAT GENET, V48, P1112, DOI 10.1038/ng.3664; Lu JW, 2016, J CLIN INVEST, V126, P3058, DOI 10.1172/JCI86508; Miller MB, 2017, J NEUROCHEM, V140, P889, DOI 10.1111/jnc.13749; Nam RK, 2006, CLIN CANCER RES, V12, P6452, DOI 10.1158/1078-0432.CCR-06-1485; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Popp MWL, 2013, ANNU REV GENET, V47, P139, DOI 10.1146/annurev-genet-111212-133424; Prinos P, 2011, NAT STRUCT MOL BIOL, V18, P673, DOI 10.1038/nsmb.2040; Ryan MC, 2012, BIOINFORMATICS, V28, P2385, DOI 10.1093/bioinformatics/bts452; Schafer Sebastian, 2015, Curr Protoc Hum Genet, V87, DOI 10.1002/0471142905.hg1116s87; Sebestyen E, 2016, GENOME RES, V26, P732, DOI 10.1101/gr.199935.115; Shum EY, 2016, CELL, V165, P382, DOI 10.1016/j.cell.2016.02.046; Stros M, 2007, CELL MOL LIFE SCI, V64, P2590, DOI 10.1007/s00018-007-7162-3; Tabrez SS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00370-5; Taliaferro JM, 2016, MOL CELL, V61, P821, DOI 10.1016/j.molcel.2016.01.020; Tian JB, 2019, NUCLEIC ACIDS RES, V47, pD909, DOI 10.1093/nar/gky954; Tien JF, 2017, NUCLEIC ACIDS RES, V45, P6698, DOI 10.1093/nar/gkx187; Tilgner H, 2018, GENOME RES, V28, P231, DOI 10.1101/gr.230516.117; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Traunmuller L, 2016, SCIENCE, V352, P982, DOI 10.1126/science.aaf2397; Ushijima T, 2017, CELL, V171, P1316, DOI 10.1016/j.cell.2017.10.018; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Vuong CK, 2016, NAT REV NEUROSCI, V17, P265, DOI 10.1038/nrn.2016.27; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1; Yan QH, 2015, P NATL ACAD SCI USA, V112, P3445, DOI 10.1073/pnas.1502849112; Ylitalo EB, 2017, EUR UROL, V72, pE147, DOI 10.1016/j.eururo.2017.07.043; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	60	34	35	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 3	2019	38	40					6678	6695		10.1038/s41388-019-0910-7	http://dx.doi.org/10.1038/s41388-019-0910-7			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JC0EY	31391553				2022-12-26	WOS:000488953500003
J	Verhaart, IEC; Putker, K; van de Vijver, D; Tanganyika-de Winter, CL; Currency, SPV; Plomp, JJ; Aartsma-Rus, AM; van Putten, M				Verhaart, Ingrid E. C.; Putker, Kayleigh; van de Vijver, Davy; Tanganyika-de Winter, Christa L.; Currency, Svetlana Pasteuning-Vuhman; Plomp, Jaap J.; Aartsma-Rus, Annemieke M.; van Putten, Maaike			Cross-sectional study into age-related pathology of mouse models for limb girdle muscular dystrophy types 2D and 2F	PLOS ONE			English	Article							MUSCLE; CARDIOMYOPATHY; INVOLVEMENT; MICRORNAS; MECHANISM; COMPLEX	Limb girdle muscular dystrophy (LGMD) types 2D and 2F are caused by mutations in the genes encoding for alpha- and delta-sarcoglycan, respectively, leading to progressive muscle weakness. Mouse models exist for LGMD2D (Sgca(-/-)) and 2F (Sgcd(-/-)). In a previous natural history study, we described the pathology in these mice at 34 weeks of age. However, the development of muscle pathology at younger ages has not been fully characterised yet. We therefore performed a study into age-related changes in muscle function and pathology by examining mice at different ages. From 4 weeks of age onwards, male mice were subjected to functional tests and sacrificed at respectively 8, 16 or 24 weeks of age. Muscle histopathology and expression of genes involved in muscle pathology were analysed for several skeletal muscles, while miRNA levels were assessed in serum. In addition, for Sgcd(-/-) mice heart pathology was assessed. Muscle function showed a gradual decline in both Sgca(-/-) and Sgcd(-/-) mice. Respiratory function was also impaired at all examined timepoints. Already at 8 weeks of age, muscle pathology was prominent, and fibrotic, inflammatory and regenerative markers were elevated, which remained relatively constant with age. In addition, Sgcd(-/-) mice showed signs of cardiomyopathy from 16 weeks of age onwards. These results indicate that Sgca(-/-) and Sgcd(-/-) are relevant disease models for LGMD2D and 2F.	[Verhaart, Ingrid E. C.; Putker, Kayleigh; van de Vijver, Davy; Tanganyika-de Winter, Christa L.; Currency, Svetlana Pasteuning-Vuhman; Aartsma-Rus, Annemieke M.; van Putten, Maaike] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Plomp, Jaap J.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [Currency, Svetlana Pasteuning-Vuhman] Univ Med Ctr, Dept Translat Neurosci, Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center	Aartsma-Rus, AM (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands.	a.m.rus@lumc.nl	Verhaart, Ingrid/Y-2588-2018	Verhaart, Ingrid/0000-0001-7348-7989; Plomp, Jaap/0000-0002-8427-9090; van Putten, Maaike/0000-0002-0683-8897; van de Vijver, David/0000-0001-5877-8526	AFM Telethon [20251]; NeurOmics [2012-305121]	AFM Telethon(Association Francaise contre les Myopathies); NeurOmics	This work was supported by: AFM Telethon (http://www.afm-telethon.com), grant number 20251 to MvP; and by NeurOmics (https://rd-neuromics.eu/), FP7, grant agreement 2012-305121) to AR. The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2014, JOVE-J VIS EXP, DOI 10.3791/51303; Aguennouz M, 2016, CELL BIOCHEM FUNCT, V34, P414, DOI 10.1002/cbf.3202; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blain AM, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-13; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; Bushby Kate, 2009, Pract Neurol, V9, P314, DOI 10.1136/jnnp.2009.193938; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T; Coley WD, 2016, HUM MOL GENET, V25, P130, DOI 10.1093/hmg/ddv460; Coral-Vazquez R, 1999, CELL, V98, P465, DOI 10.1016/S0092-8674(00)81975-3; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Eisenberg I, 2009, J CELL MOL MED, V13, P2, DOI 10.1111/j.1582-4934.2008.00524.x; Fayssoil A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153095; Frank KF, 2003, CARDIOVASC RES, V57, P20, DOI 10.1016/S0008-6363(02)00694-6; Giovannelli G, 2018, MUSCLE NERVE; Goehringer C, 2009, CARDIOVASC RES, V82, P404, DOI 10.1093/cvr/cvp061; Goonasekera SA, 2011, J CLIN INVEST, V121, P1044, DOI 10.1172/JCI43844; Grounds MD, 2008, NEUROBIOL DIS, V31, P1, DOI 10.1016/j.nbd.2008.03.008; Guess MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118229; Hack AA, 2000, J CELL SCI, V113, P2535; Jakubiec-Puka A, 2005, ACTA BIOCHIM POL, V52, P453; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Klagsbrun Michael, 1996, Cytokine and Growth Factor Reviews, V7, P259, DOI 10.1016/S1359-6101(96)00027-5; Koutsoulidou A, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-34; Li XH, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.29; Mendell JR, 2009, ANN NEUROL, V66, P290, DOI 10.1002/ana.21732; Murphy Alexander Peter, 2015, J Neuromuscul Dis, V2, pS7; Nigro Vincenzo, 2014, Acta Myol, V33, P1; Norwood F, 2007, EUR J NEUROL, V14, P1305, DOI 10.1111/j.1468-1331.2007.01979.x; Pardo PS, 2017, AGING-US, V9, P1012, DOI 10.18632/aging.101207; Pasteuning-Vuhman S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182704; Politano L, 2001, NEUROMUSCULAR DISORD, V11, P178, DOI 10.1016/S0960-8966(00)00174-7; Potter Lincoln R., 2009, V191, P341, DOI 10.1007/978-3-540-68964-5_15; Radley-Crabb HG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089277; RStudio Team, 2016, RSTUDIO INT DEV R; Straub V, 1997, CURR OPIN NEUROL, V10, P168, DOI 10.1097/00019052-199704000-00016; Straub V, 2016, NEUROMUSCULAR DISORD, V26, P111, DOI 10.1016/j.nmd.2015.11.012; Thompson R, 2016, NAT REV NEUROL, V12, P294, DOI 10.1038/nrneurol.2016.35; Turk R, 2005, FASEB J, V19, P127, DOI 10.1096/fj.05-4678fje; van der Pijl EM, 2016, EUR J NEUROSCI, V43, P1623, DOI 10.1111/ejn.13249; van Putten M, 2012, NEUROMUSCULAR DISORD, V22, P406, DOI 10.1016/j.nmd.2011.10.011; van Putten M, 2010, NEUROMUSCULAR DISORD, V20, P273, DOI 10.1016/j.nmd.2010.02.004; van Westrum SMS, 2014, MUSCLE NERVE, V50, P909, DOI 10.1002/mus.24233; vanPutten M, 2019, FASEB J OFFICIAL PUB; Vignier N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055281; Willmann R, 2009, NEUROMUSCULAR DISORD, V19, P241, DOI 10.1016/j.nmd.2008.11.015; Zaharieva IT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080263; Zhang J, 2012, J BIOL CHEM, V287, P21093, DOI 10.1074/jbc.M111.330381	52	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0220665	10.1371/journal.pone.0220665	http://dx.doi.org/10.1371/journal.pone.0220665			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430305	Green Submitted, Green Published, gold			2022-12-26	WOS:000485026800011
J	Savin, KW; Zawadzki, J; Auldist, MJ; Wang, JH; Ram, D; Rochfort, S; Cocks, BG				Savin, Keith W.; Zawadzki, Jody; Auldist, Martin J.; Wang, Jianghui; Ram, Doris; Rochfort, Simone; Cocks, Benjamin G.			Faecalibacterium diversity in dairy cow milk	PLOS ONE			English	Article							RAW-MILK; FUSOBACTERIUM-PRAUSNITZII; UP-REGULATION; MICROBIOTA; SEQUENCE; BACTERIA; PHYLOGENIES; INSIGHTS; MUSCLE	The bacterial species, Faecalibacterium prausnitzii, beneficial to humans and animals and found in mammalian and avian gut, is also occasionally found in dairy cow milk. It is one of the butyrate-producing bacteria of the colon, has anti-inflammatory properties and its abundance in the gut is negatively correlated with obesity in humans. Several strains differing in their functional capability, have been identified. It is important therefore, milk being a potential source of F. prausnitzii as a novel probiotic, to investigate the diversity of this species in bovine milk. Using 16s rRNA gene amplicons we find 292 different dereplicated Faecalibacterium-related amplicons in a herd of 21 dairy cows. The distribution of the 20 most abundant amplicons with >97% identity to a Greengenes OTU varies from cow to cow. Clustering of the 292 pooled sequences from all cows at 99.6% identity finds 4 likely Faecalibacterium phylotypes with >98.5% identity to an F. prausnitzii reference sequence. Sequence alignment and phylogenetic analysis shows these phylotypes are distinct from 34 other species from the Ruminococcaceae family and displaying the sequence clusters as a network illustrates how each cluster is composed of sequences from multiple cows. We conclude there are several phylotypes of Faecalibacterium prausnitzii (the only species so far defined for the genus) in this dairy herd with cows being inoculated with a mixture of several strains from a common source. We conclude that not only can Faecalibacterium be detected in dairy cow milk (as noted by others) but that there exist multiple different strains in the milk of a dairy herd. Therefore milk, as an alternative to faeces, offers the opportunity of discovering new strains with potential probiotic application.	[Savin, Keith W.; Zawadzki, Jody; Wang, Jianghui; Ram, Doris; Rochfort, Simone; Cocks, Benjamin G.] Agr Victoria Res, AgriBio Ctr, Bundoora, Vic, Australia; [Auldist, Martin J.] Agr Victoria Res, Ellinbank, Vic, Australia		Savin, KW (corresponding author), Agr Victoria Res, AgriBio Ctr, Bundoora, Vic, Australia.	keith.savin@agriculture.vic.gov.au		Savin, Keith/0000-0001-8347-0320	Agribio Milk Systems Biology project from internal Agriculture Victoria general research fund; Department of Jobs, Precincts and Regions, Victoria, Australia	Agribio Milk Systems Biology project from internal Agriculture Victoria general research fund; Department of Jobs, Precincts and Regions, Victoria, Australia	The project was funded as part of the Agribio Milk Systems Biology project from internal Agriculture Victoria general research funding (contact = Benjamin G. Cocks), Department of Jobs, Precincts and Regions, Victoria, Australia, http://agriculture.vic.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abudabos AM, 2017, APPL MICROBIOL BIOT, V101, P7017, DOI 10.1007/s00253-017-8448-5; Addis MF, 2016, MOL BIOSYST, V12, P2359, DOI 10.1039/c6mb00217j; Andrews S, FASTQC QUALITY CONTR; Balamurugan R, 2010, BRIT J NUTR, V103, P335, DOI 10.1017/S0007114509992182; Benevides L, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01790; Bhatt VD, 2012, J APPL MICROBIOL, V112, P639, DOI 10.1111/j.1365-2672.2012.05244.x; Bishop KS, 2017, GENET EPIGENETICS, V9, DOI 10.1177/1179237X17729900; Bjerrum L, 2006, POULTRY SCI, V85, P1151, DOI 10.1093/ps/85.7.1151; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonsaglia ECR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08790-5; Breyner NM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00114; CANDIDO EPM, 1978, CELL, V14, P105, DOI 10.1016/0092-8674(78)90305-7; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chriett S, 2017, MOL CELL ENDOCRINOL, V439, P224, DOI 10.1016/j.mce.2016.09.006; Correa RO, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12720; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Donovan SM, 2012, ADV NUTR, V3, p450S, DOI 10.3945/an.112.001859; Doyle CJ, 2017, INT J FOOD MICROBIOL, V255, P1, DOI 10.1016/j.ijfoodmicro.2017.05.019; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI [10.1099/ijs.0.02241-0, 10.1099/00207713-52-6-2141]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feng J, 2014, ARCH MICROBIOL, V196, P73, DOI 10.1007/s00203-013-0942-2; Fitzgerald CB, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5313-6; Foditsch C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145485; Foditsch C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116465; Ganda EK, 2016, SCI REP-UK, V6, DOI 10.1038/srep37565; Gotteland M, 2014, J MED FOOD, V17, P487, DOI 10.1089/jmf.2013.0030; Hantsis-Zacharov E, 2007, APPL ENVIRON MICROB, V73, P7162, DOI 10.1128/AEM.00866-07; Hu SE, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0450-x; Jia YM, 2017, EXP PHYSIOL, V102, P273, DOI 10.1113/EP086114; Jimenez E, 2015, J HUM LACT, V31, P406, DOI 10.1177/0890334415585078; Jost T, 2013, BRIT J NUTR, V110, P1253, DOI 10.1017/S0007114513000597; Jovel J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00459; Kuehn JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061959; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lasitschka F, 2017, IMMUN INFLAMM DIS, V5, P480, DOI 10.1002/iid3.184; Lee KC, 2017, J MICROBIOL, V55, P939, DOI 10.1007/s12275-017-7202-0; Liu ZQ, 2017, J AGR FOOD CHEM, V65, P1307, DOI 10.1021/acs.jafc.6b04098; Lopez-Siles M, 2017, ISME J, V11, P841, DOI 10.1038/ismej.2016.176; Lopez-Siles M, 2012, APPL ENVIRON MICROB, V78, P420, DOI 10.1128/AEM.06858-11; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Mahe F, 2015, PEERJ, V3, DOI 10.7717/peerj.1420; Malmuthuge N, 2014, APPL ENVIRON MICROB, V80, P2021, DOI 10.1128/AEM.03864-13; Martin R, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01226; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Murphy MA, 2002, J DAIRY RES, V69, P645, DOI 10.1017/S0022029902005848; Myer PR, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1201-6; Oikonomou G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085904; Oikonomou G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063157; Oikonomou G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047671; Patel SH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08451-7; Perez PF, 2007, PEDIATRICS, V119, pE724, DOI 10.1542/peds.2006-1649; Quevrain E, 2016, GUT, V65, P415, DOI 10.1136/gutjnl-2014-307649; Quigley L, 2013, FEMS MICROBIOL REV, V37, P664, DOI 10.1111/1574-6976.12030; Quigley L, 2011, INT J FOOD MICROBIOL, V150, P81, DOI 10.1016/j.ijfoodmicro.2011.08.001; Remely M, 2014, GENE, V537, P85, DOI 10.1016/j.gene.2013.11.081; Rodriguez JM, 2014, ADV NUTR, V5, P779, DOI 10.3945/an.114.007229; Rossi O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123013; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shreiner AB, 2015, CURR OPIN GASTROEN, V31, P69, DOI 10.1097/MOG.0000000000000139; Singh KM, 2012, MOL BIOL REP, V39, P10595, DOI 10.1007/s11033-012-1947-7; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Sze MA, 2016, MBIO, V7, DOI 10.1128/mBio.01018-16; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Urbaniak C, 2016, MICROBIOME, V4, DOI 10.1186/s40168-015-0145-y; Urbaniak C, 2014, APPL ENVIRON MICROB, V80, P3007, DOI 10.1128/AEM.00242-14; Vermeire S, 2016, J CROHNS COLITIS, V10, P387, DOI 10.1093/ecco-jcc/jjv203; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Wang RF, 1996, INT J SYST BACTERIOL, V46, P341, DOI 10.1099/00207713-46-1-341; Ward TL, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-116; Wong K, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00500; Wu SR, 2019, POULTRY SCI, V98, P828, DOI 10.3382/ps/pey393; Young W, 2015, PEERJ, V3, DOI 10.7717/peerj.888; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zimmerman MA, 2012, AM J PHYSIOL-GASTR L, V302, pG1405, DOI 10.1152/ajpgi.00543.2011	76	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2019	14	8							e0221055	10.1371/journal.pone.0221055	http://dx.doi.org/10.1371/journal.pone.0221055			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5LL	31419254	Green Published, gold			2022-12-26	WOS:000485019900026
J	Alvarado-Facundo, E; Audet, S; Moss, WJ; Beeler, JA				Alvarado-Facundo, Esmeralda; Audet, Susette; Moss, William J.; Beeler, Judy A.			Development of a high-throughput assay to measure measles neutralizing antibodies	PLOS ONE			English	Article							VIRUS	Measles virus is highly infectious and remains a leading cause of vaccine preventable deaths in children. Neutralizing antibody responses elicited by measles virus infection or immunization are a serological correlate of protection. We describe a high-throughput neutralization assay to improve surveillance for measles immunity. Measles virus-antibody mixtures were incubated on Vero cell monolayers and 24 hours later cell-lysates harvested and subjected to one-step SYBR green RT-qPCR to amplify a target sequence within the measles virus nucleoprotein gene. Neutralization endpoint titers were interpolated to determine the dilution that inhibited the relative amplicon copy number by at least 90% compared to the mean signal obtained in virus control wells in the absence of serum. Anti-measles virus and anti-measles hemagglutinin antisera specifically neutralized measles virus in the micro-neutralization RT-qPCR assay while pre-immune sera and sera raised against other viruses did not. The microneutralization RT-qPCR assay obeyed the Percentage Law for measles virus inputs ranging from 100-5000 TCID50/well. The linear range of the assay corresponds to measles antibody concentrations of 30 to 3000 mIU/mL. Bland-Altman analysis and twoway analysis of variance demonstrated that results obtained using the microneutralization RT-qPCR assay were comparable to those obtained using a plaque reduction neutralization test and correctly identified human serum samples that were seropositive (95% and 100%, sensitivity and specificity, respectively). Furthermore, these comparisons suggest that a concentration of 300 mIU/mL may be a conservative cut-point to use to identify individuals likely to be protected against severe measles disease when the endpoint is based on 90% inhibition of virus replication. Measles virus microneutralization RT-qPCR is a rapid, sensitive, specific, and robust assay for detecting measles neutralizing antibodies that may help to improve immunization strategies nationally and achieve measles elimination globally.	[Alvarado-Facundo, Esmeralda; Audet, Susette; Beeler, Judy A.] US FDA, Div Viral Prod, Off Vaccines Res & Review, Ctr Biol Evaluat Res, Silver Spring, MD 20993 USA; [Moss, William J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Baltimore, MD USA	US Food & Drug Administration (FDA); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Beeler, JA (corresponding author), US FDA, Div Viral Prod, Off Vaccines Res & Review, Ctr Biol Evaluat Res, Silver Spring, MD 20993 USA.	judy.beeler@fda.hhs.gov		Audet, Susette/0000-0001-6064-2943	CRADA [2017-0028-CRD]; Johns Hopkins Bloomberg School of Public Health from Bill and Melinda Gates Foundation, Seattle, WA [OPP1094816]	CRADA; Johns Hopkins Bloomberg School of Public Health from Bill and Melinda Gates Foundation, Seattle, WA	This work was supported by a CRADA (#2017-0028-CRD to JB) with Johns Hopkins Bloomberg School of Public Health under a grant from Bill and Melinda Gates Foundation, Seattle, WA (grant #OPP1094816 to WJM, https://www.gatesfoundation.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT P, 1981, J VIROL METHODS, V3, P251, DOI 10.1016/0166-0934(81)90062-8; Andrewes CH, 1933, BRIT J EXP PATHOL, V14, P367; [Anonymous], 2008, VACCINES-BASEL, DOI DOI 10.1016/B978-1-4160-3611-1.50022-2; CHEN RT, 1990, J INFECT DIS, V162, P1036, DOI 10.1093/infdis/162.5.1036; Cohen BJ, 2007, VACCINE, V26, P59, DOI 10.1016/j.vaccine.2007.10.046; Dabbagh A, 2018, MMWR-MORBID MORTAL W, V67, P1323, DOI 10.15585/mmwr.mm6747a6; Fujino M, 2007, J VIROL METHODS, V142, P15, DOI 10.1016/j.jviromet.2007.01.001; Haralambieva IH, 2008, CLIN VACCINE IMMUNOL, V15, P1054, DOI 10.1128/CVI.00008-08; Hosken N, 2017, VACCINE, V35, P3082, DOI 10.1016/j.vaccine.2017.04.053; Hummel KB, 2006, J VIROL METHODS, V132, P166, DOI 10.1016/j.jviromet.2005.10.006; Klasse PJ, 2002, J GEN VIROL, V83, P2091, DOI 10.1099/0022-1317-83-9-2091; NAKAYAMA T, 1995, VIRUS RES, V35, P1; Plumet S, 2005, J VIROL METHODS, V128, P79, DOI 10.1016/j.jviromet.2005.03.020; Shatzkes K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04659; Sowers SB, 2016, CLIN VACCINE IMMUNOL, V23, P707, DOI 10.1128/CVI.00268-16; Varada JC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-195	16	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220780	10.1371/journal.pone.0220780	http://dx.doi.org/10.1371/journal.pone.0220780			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415584	Green Submitted, Green Published, gold			2022-12-26	WOS:000485017200031
J	Chen, AC; Shyu, LY; Lin, YC; Chen, KM; Lai, SC				Chen, An-Chih; Shyu, Ling-Yuh; Lin, Yi-Chieh; Chen, Ke-Min; Lai, Shih-Chan			Proteasome serves as pivotal regulator in Angiostrongylus cantonensis-induced eosinophilic meningoencephalitis	PLOS ONE			English	Article							NF-KAPPA-B; BALB/C MICE; MENINGITIS; MATRIX-METALLOPROTEINASE-9; INDUCTION; ASSOCIATION; LEADS; 20S	Proteasome primarily degrades the unneeded or damaged proteins by proteolysis. Disruption of the brain barrier and its resulting meningoencephalitis caused by Angiostrongylus cantonensis are important pathological events in non-permissive hosts. In this study, the results showed upregulated proteasome during A. cantonensis infection. Occludin degradation and matrix metalloproteinase-9 (MMP-9) activity were significantly increased in infected mice than in uninfected mice. Moreover, confocal immunoflourescence microscopy showed that occludin was co-localized with MMP-9. The infected-mice were treated with proteasomal activity inhibitor MG132 by 1.5 and 3.0 mg/kg/day, which resulted in significantly reduced protein levels of phosphorylated I kappa B alpha (P<0.05) compared with the untreated control. The phosphorylated nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) showed similar result. In addition, MMP-9 activity and occludin degradation were reduced because of MG132 treatment. These results suggested that the proteasome in A. cantonensis infection degraded phosphorylated I kappa B alpha, modulated phosphorylated NF-kappa B, and then regulated the activation of MMP-9 and occludin degradation. Proteasome alterations were presented in eosinophilic meningitis of BALB/c mice and may contribute to the pathophysiology of eosinophilic meningitis by increasing occludin degradation. This molecule would serve as pivotal regulator in A. cantonensis-induced eosinophilic meningoencephalitis.	[Chen, An-Chih] Chung Shan Med Univ Hosp, Dept Neurol, Taichung, Taiwan; [Shyu, Ling-Yuh; Lin, Yi-Chieh; Chen, Ke-Min; Lai, Shih-Chan] Chung Shan Med Univ, Dept Parasitol, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University	Lai, SC (corresponding author), Chung Shan Med Univ, Dept Parasitol, Taichung, Taiwan.	shih@csmu.edu.tw						Bard JAM, 2018, ANNU REV BIOCHEM, V87, P697, DOI 10.1146/annurev-biochem-062917-011931; Baud V, 2011, CURR TOP MICROBIOL, V349, P97, DOI 10.1007/82_2010_101; Chang CY, 2015, GLIA, V63, P1915, DOI 10.1002/glia.22857; Chen AC, 2017, ACTA TROP, V173, P76, DOI 10.1016/j.actatropica.2017.05.023; Chen KM, 2004, INT J PARASITOL, V34, P1147, DOI 10.1016/j.ijpara.2004.07.004; Chiu PS, 2014, ACTA TROP, V140, P141, DOI 10.1016/j.actatropica.2014.08.015; Chiu PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053370; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; GARDINER CH, 1990, AM J TROP MED HYG, V42, P70, DOI 10.4269/ajtmh.1990.42.70; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hou RF, 2004, INT J PARASITOL, V34, P1355, DOI 10.1016/j.ijpara.2004.08.010; HSU WY, 1990, PEDIATR INFECT DIS J, V9, P443, DOI 10.1097/00006454-199006000-00016; Hubert-Buron A, 2006, J NUTR, V136, P1461, DOI 10.1093/jn/136.6.1461; Jobin C, 2000, AM J PHYSIOL-CELL PH, V278, pC451, DOI 10.1152/ajpcell.2000.278.3.C451; Lai SC, 2004, ANN TROP MED PARASIT, V98, P715, DOI 10.1179/000349804225021479; Lee HH, 2000, EXP PARASITOL, V95, P202, DOI 10.1006/expr.2000.4530; Lee HH, 2004, PARASITOL RES, V94, P321, DOI 10.1007/s00436-004-1196-3; MACKERRAS MJ, 1954, NATURE, V173, P956, DOI 10.1038/173956a0; Mueller O, 2012, J MOL NEUROSCI, V46, P509, DOI 10.1007/s12031-011-9631-2; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; PARSONS JC, 1990, J PARASITOL, V76, P53, DOI 10.2307/3282627; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Qureshi N, 2012, BBA-MOL CELL RES, V1823, P2087, DOI 10.1016/j.bbamcr.2012.06.016; Ravindran J, 2011, TOXICOLOGY, V280, P44, DOI 10.1016/j.tox.2010.11.006; Traweger A, 2002, J BIOL CHEM, V277, P10201, DOI 10.1074/jbc.M111384200; Wei PC, 2011, INT J PARASITOL, V41, P1175, DOI 10.1016/j.ijpara.2011.07.002; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350; Zheng C, 2011, CELL RES, V21, P183, DOI 10.1038/cr.2010.171	29	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220503	10.1371/journal.pone.0220503	http://dx.doi.org/10.1371/journal.pone.0220503			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415587	Green Published, Green Submitted, gold			2022-12-26	WOS:000485017200018
J	Yonow, T; Ramirez-Villegas, J; Abadie, C; Darnell, RE; Ota, N; Kriticos, DJ				Yonow, Tania; Ramirez-Villegas, Julian; Abadie, Catherine; Darnell, Ross E.; Ota, Noboru; Kriticos, Darren J.			Black Sigatoka in bananas: Ecoclimatic suitability and disease pressure assessments	PLOS ONE			English	Article							POTENTIAL GLOBAL DISTRIBUTION; LEAF STREAK DISEASE; MYCOSPHAERELLA-FIJIENSIS; CLIMATE-CHANGE; SPOT DISEASE; TEMPERATURE; PATHOGEN; RISK; DISTRIBUTIONS; IRRIGATION	Black leaf streak disease, or black Sigatoka, is caused by the fungus Pseudocercospora fijiensis, and has been identified as a major constraint to global production of banana and plantain. We fitted a climatic niche model (CLIMEX) for P. fijiensis to gain an understanding of the patterns of climate suitability, and hence hazard from this disease. We then calibrated the climate suitability patterns against the results of an expert elicitation of disease pressure patterns. We found a moderately strong non-linear relationship between modelled climate suitability for P. degrees fijiensis and the expert ratings for disease pressure. The strength of the relationship provides a cross-validation between the CLIMEX model and the expert elicitation process. The bulk of global banana production experiences high potential threat from P. fijiensis, and the higher yielding areas for banana and plantain production are at greatest threat. By explicitly considering the role of irrigation we have been able to identify how strategic irrigation could be used to support banana production in areas that are at low risk from P. fijiensis.	[Yonow, Tania; Kriticos, Darren J.] Univ Minnesota, InSTePP, HarvestChoice, St Paul, MN 55108 USA; [Yonow, Tania; Ota, Noboru; Kriticos, Darren J.] CSIRO, Canberra, ACT, Australia; [Ramirez-Villegas, Julian] Int Ctr Trop Agr CIAT, Cali, Colombia; [Ramirez-Villegas, Julian] Agr & Food Secur CCAFS, CGIAR Res Program Climate Change, Cali, Colombia; [Ramirez-Villegas, Julian] Univ Leeds, Sch Earth & Environm, Leeds, W Yorkshire, England; [Abadie, Catherine] Univ Montpellier, CIRAD, INRA, BGPI,Montpellier SupAgro, Montpellier, France; [Abadie, Catherine] CIRAD, UMR BGPI, F-97130 Capesterre Belle Eau, Guadeloupe, France; [Darnell, Ross E.] CSIRO, Brisbane, Qld, Australia; [Kriticos, Darren J.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia	University of Minnesota System; University of Minnesota Twin Cities; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Alliance; International Center for Tropical Agriculture - CIAT; CGIAR; University of Leeds; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier; CIRAD; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland	Kriticos, DJ (corresponding author), Univ Minnesota, InSTePP, HarvestChoice, St Paul, MN 55108 USA.; Kriticos, DJ (corresponding author), CSIRO, Canberra, ACT, Australia.; Kriticos, DJ (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.	Darren.Kriticos@csiro.au	DARNELL, ROSS E/B-3823-2009; ABADIE, Catherine/AAL-5362-2020; Ramirez-Villegas, Julian/AAY-8073-2020	DARNELL, ROSS E/0000-0002-7973-6322; ABADIE, Catherine/0000-0002-5075-6338; Ramirez-Villegas, Julian/0000-0002-8044-583X	Bill and Melinda Gates Foundation [OPPGD1450]; CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS)	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS)	Work by TY was funded by the Bill and Melinda Gates Foundation (https/Amy/gatesfoundation org/), Grant No. OPPGD1450. Project Title: HarvestChoice Phase II: Supporting Strategic Investment Choices in Agriculture. JR-V is supported by the CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, INT STANDARDS PHYTOS; [Anonymous], 2008, BIOL MUSA L BANANA; Beddow JM, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.132, 10.1038/nplants.2015.132]; Biosecurity, 2008, FIN IMP RISK AN REP; Blomme G, 2013, ANN APPL BIOL, V162, P4, DOI 10.1111/aab.12002; Bo Meteorology, 1975, CLIM AV AUSTR; Brasier C. M., 1994, Bulletin OEPP, V24, P221, DOI 10.1111/j.1365-2338.1994.tb01063.x; CABI, 2016, MIC FIJ BLACK SIG DA; Carlier J, 2000, PHYTOPATHOLOGY, V90, P884, DOI 10.1094/PHYTO.2000.90.8.884; Carlier J, 2000, DISEASES OF BANANA A; Castro M. E. A., 2005, Fitopatologia Brasileira, V30, P668, DOI 10.1590/S0100-41582005000600018; CHUANG TY, 1987, PHYTOPATHOLOGY, V77, P1542, DOI 10.1094/Phyto-77-1542; Churchill ACL, 2011, MOL PLANT PATHOL, V12, P307, DOI 10.1111/j.1364-3703.2010.00672.x; Cook D, 2012, 40024 MT COOP RES CT; CRAENEN K, 1998, BLACK SIGATOKA DIS B; Crous PW, 2002, SYDOWIA, V54, P35; de Bellaire LD, 2010, FRUITS, V65, P327, DOI 10.1051/fruits/2010034; de Jesus WC, 2008, SCI AGR, V65, P40, DOI 10.1590/S0103-90162008000700008; de Villiers M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181397; Devi P. G., 2014, Indian Phytopathology, V67, P388; Diczbalis Y, 2016, IRRIGATION MANAGEMEN, P1; Dita MA, 2013, ACTA HORTIC, V986, P365; EPPO, 2016, MYC FIJ; Eyre D., 2012, Bulletin OEPP, V42, P48, DOI [10.1111/epp.2549, 10.1111/j.1365-2338.2012.02549.x]; FROSSARD P, 1980, FRUITS, V35, P519; Gauhl F., 1994, EPIDEMIOLOGY ECOLOGY; GOENAGA R, 1995, J AGR U PUERTO RICO, V79, P13; Guirkinger C, 2008, WORLD DEV, V36, P1436, DOI 10.1016/j.worlddev.2007.07.002; Hamelin FM, 2016, B MATH BIOL, V78, P695, DOI 10.1007/s11538-016-0157-1; Henderson J, 2006, AUSTRALAS PLANT PATH, V35, P181, DOI 10.1071/AP06017; Hwang SC, 2004, PLANT DIS, V88, P580, DOI 10.1094/PDIS.2004.88.6.580; Ioos R, 2011, PLANT DIS, V95, P359, DOI 10.1094/PDIS-11-10-0850; JACOME LH, 1992, PHYTOPATHOLOGY, V82, P515, DOI 10.1094/Phyto-82-515; JACOME LH, 1991, PHYTOPATHOLOGY, V81, P1480, DOI 10.1094/Phyto-81-1480; JACOME LH, 1993, TROP AGR, V70, P51; Jones D.R., 1990, MUSARAMA, V3, P2; Jones DR, 1999, DIS BANANA; KRISHNAMOORTHY V, 2004, INFOMUSA, V13, P25; Kriticos D. J., 2015, CLIMEX VERSION 4 EXP; Kriticos DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132807; Kriticos DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064479; Kriticos DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054861; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Kriticos DJ, 2005, WEED RES, V45, P246, DOI 10.1111/j.1365-3180.2005.00458.x; Kriticos DJ, 2003, J APPL ECOL, V40, P111, DOI 10.1046/j.1365-2664.2003.00777.x; Linbing X, 2004, P 3 BAPNET STEER COM; LONG PG, 1979, T BRIT MYCOL SOC, V72, P299, DOI 10.1016/S0007-1536(79)80046-7; Marin DH, 2003, PLANT DIS, V87, P208, DOI 10.1094/PDIS.2003.87.3.208; MouliomPefoura A, 1996, PLANT DIS, V80, P950, DOI 10.1094/PD-80-0950; Mourichon X, 2003, ANAL RISQUE PHYTOSAN, P1; Pardey PG, 2013, SCIENCE, V340, P147, DOI 10.1126/science.122970; PEREGRINE W T H, 1989, FAO (Food and Agriculture Organization of the United Nations) Plant Protection Bulletin, V37, P130; Perez Ponce J, 1994, P 1 GLOB C INT MUS T; Perez-Vicente L, 2006, 17 INT ACORBAT M 15; Perez-Vicente L, 2012, HOLISTIC INTEGRATED, P30; Pinkard EA, 2010, ECOL MODEL, V221, P2828, DOI 10.1016/j.ecolmodel.2010.08.017; Ploetz R., 2000, Pesticide Outlook, V11, P19, DOI 10.1039/b006308h; Porras A., 1997, Infomusa, V6, P27; Puno N, 2014, PROT CRIT INFRASTRUC, V2, P161, DOI 10.1007/978-3-319-01092-2_8; Ravigne V, 2017, B MATH BIOL, V79, P430, DOI 10.1007/s11538-016-0240-7; Rieux A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103225; Robert S, 2012, MOL ECOL, V21, P1098, DOI 10.1111/j.1365-294X.2011.05432.x; Robert S, 2015, REV ECOL-TERRE VIE, V70, P127; Rodda GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014670; Sathiamoorthy S, 1994, P 1 GLOB C INT MUS T; Selvarajan R, 2001, ADV BANANA PLANTAIN, V10; SHELFORD VE, 1963, ECOLOGY N AM; Siebert S., 2013, GLOBAL MAP IRRIGATIO; STOVER RH, 1983, FRUITS, V38, P625; STOVER RH, 1986, ANNU REV PHYTOPATHOL, V24, P83; STOVER RH, 1978, TROP AGR, V55, P65; Sutherst RW, 2009, BIOL INVASIONS, V11, P1231, DOI 10.1007/s10530-008-9335-x; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; Tang C, 1994, P 1 GLOB C INT MUS T; Venette RC, 2006, FOREST ECOL MANAG, V231, P18, DOI 10.1016/j.foreco.2006.04.036; Wardlaw CW, 1972, BANANA DIS INCLUDING; Watt MS, 2011, GLOBAL CHANGE BIOL, V17, P3608, DOI 10.1111/j.1365-2486.2011.02486.x; Watt MS, 2011, CAN J FOREST RES, V41, P412, DOI 10.1139/X10-204; Watt MS, 2010, BIOL INVASIONS, V12, P3711, DOI 10.1007/s10530-010-9764-1; Webber BL, 2011, DIVERS DISTRIB, V17, P978, DOI 10.1111/j.1472-4642.2011.00811.x; Wielemaker F., 1990, P INT WORKSH HELD SA, P107; Yonow T, 2004, PHYTOPATHOLOGY, V94, P805, DOI 10.1094/PHYTO.2004.94.8.805; Yonow T, 2018, J PEST SCI, V91, P523, DOI 10.1007/s10340-017-0938-9; Yonow T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173265; Yonow T, 2017, J PEST SCI, V90, P459, DOI 10.1007/s10340-016-0801-4; Yonow T, 2013, CROP PROT, V44, P18, DOI 10.1016/j.cropro.2012.10.006; You L, 2014, SPATIAL PRODUCTION A	87	12	12	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0220601	10.1371/journal.pone.0220601	http://dx.doi.org/10.1371/journal.pone.0220601			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412052	Green Published, Green Submitted, gold			2022-12-26	WOS:000485012600033
J	Mathys, A; Semal, P; Brecko, J; Van den Spiegel, D				Mathys, Aurore; Semal, Patrick; Brecko, Jonathan; Van den Spiegel, Didier			Improving 3D photogrammetry models through spectral imaging: Tooth enamel as a case study	PLOS ONE			English	Article								Reflective or translucent materials are a challenge to digitize in 3D. Results are better with a matt coating although objects from museum collections are often too fragile or too valuable to be treated in this way. It is therefore essential that alternative solutions are found. This study analyzed spectral photogrammetry as a possible solution. Spectral photogrammetry is an emerging technique which uses images at different wavelengths to create 3D models. Tooth enamel is a challenging material to digitize. Six sets of teeth were photographed at different wavelengths. The results showed that the quality of the models enamels parts improved when taken with ultraviolet wavelengths whilst models were less accurate when photogrammetry was performed with the red and infrared spectrum. This can be explained by the optical properties of enamel. This study demonstrates that knowing the optical properties of a material beforehand could help future photogrammetric digitization of challenging materials.	[Mathys, Aurore; Brecko, Jonathan; Van den Spiegel, Didier] Royal Museum Cent Africa, Biol Collect & Data Management, Tervuren, Belgium; [Mathys, Aurore; Semal, Patrick; Brecko, Jonathan] Royal Belgian Inst Nat Sci, Sci Heritage Serv, Brussels, Belgium	Royal Museum for Central Africa; Royal Belgian Institute of Natural Sciences	Mathys, A (corresponding author), Royal Museum Cent Africa, Biol Collect & Data Management, Tervuren, Belgium.; Mathys, A (corresponding author), Royal Belgian Inst Nat Sci, Sci Heritage Serv, Brussels, Belgium.	aurore.mathys@africamuseum.be	Mathys, Aurore/AAA-3835-2022	Mathys, Aurore/0000-0002-3884-4853; Semal, Patrick/0000-0002-4048-7728	Belgian Scientific Policy [BR/175/PI/3DSPECTRAL]	Belgian Scientific Policy	The study is part of the research project BR/175/PI/3DSPECTRAL funded by the Belgian Scientific Policy (http://belspo.be/).Project leader is DV.	Aggarwal Charu C., 2016, OUTLIER ANAL; Arbace L, 2013, J CULT HERIT, V14, P332, DOI 10.1016/j.culher.2012.06.008; Bade R, 2006, PROC 17 SIMULATION V, V6, P289; Bertacchini E, 2013, INT J ARTS MANAG, V15, P60; Betts MW, 2011, J ARCHAEOL SCI, V38, P755, DOI 10.1016/j.jas.2010.06.021; BRODBELT RHW, 1981, J DENT RES, V60, P1749, DOI 10.1177/00220345810600100401; Brusco N, 2006, MACH VISION APPL, V17, P373, DOI 10.1007/s00138-006-0026-2; Bucking TM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178540; Busby J., 2016, 3D SCANNING REFLECTI; Callieri M, 2004, IEEE COMPUT GRAPH, V24, P16, DOI 10.1109/MCG.2004.1274056; Chane CS, 2013, IMAGE VISION COMPUT, V31, P91, DOI 10.1016/j.imavis.2012.10.006; Chen HF, 2014, ADVANCED CERAMICS FOR DENTISTRY, P5, DOI 10.1016/B978-0-12-394619-5.00002-X; Chieruzzi M, 2016, NANOMATERIALS-BASEL, V6, DOI 10.3390/nano6070134; Curson MEJ, 2003, ENCY FOOD SCI NUTR, P1743; Davies A, 2018, APPL SCI PHOTOGR, P1; Delcourt J, 2010, THESIS; Delvaux L, 2017, CONSERVATION IR UV 3, DOI [10.13140/RG.2.2.10989.28649, DOI 10.13140/RG.2.2.10989.28649]; Evin A, 2016, J ARCHAEOL SCI-REP, V9, P87, DOI 10.1016/j.jasrep.2016.06.028; Gonizzi Barsanti S, 2013, ISPRS ANN PHOTOGRAMM, P151; Granero-Montagud L, 2013, PROC SPIE, V8790, DOI 10.1117/12.2020333; Hassett BR, 2017, ARCHAEOMETRY, V59, P191, DOI 10.1111/arcm.12229; Hess M, 2015, STUD CONSERV, V60, pS126, DOI 10.1179/0039363015Z.000000000217; Horak R., 2008, WEBSTERS NEW WORLD T; Kim MH, 2012, ACM T GRAPHIC, V31, DOI 10.1145/2185520.2185534; Liang HD, 2014, ISPRS J PHOTOGRAMM, V95, P13, DOI 10.1016/j.isprsjprs.2014.05.011; Lopez-Martinez T, 2018, J CULT HERIT, V30, P117, DOI 10.1016/j.culher.2017.09.019; Mallison H., 2014, J PALEONTOL TECHN, V12, P1; Mathys A, 2015, 2015 DIGITAL HERITAGE INTERNATIONAL CONGRESS, VOL 1: DIGITIZATION & ACQUISITION, COMPUTER GRAPHICS & INTERACTION, P19, DOI 10.1109/DigitalHeritage.2015.7413827; Mathys Aurore, 2013, 2013 Digital Heritage International Congress (DigitalHeritage). Federating the 19th Int'I VSMM, 10th Eurographics GCH, & 2nd UNESCO Memory of the World Conferences, plus special sessions from CAA, Arqueologico 2.0, Space2Place, ICOMOS ICIP & CIPA, EU projects, et al. Proceedings, P201; Mathys A, 2014, EUROMED 2014 DIGITAL, P17; Mitchell H. L., 2008, INT ARCH PHOTOGRAMME, VXXXVII, P779; de Almeida VM, 2017, COL DEVEL CULT HERIT, P3; Munoz-Munoz F, 2016, J ZOOL SYST EVOL RES, V54, P318, DOI 10.1111/jzs.12137; Nikonenko NA, 2015, OPTICAL PROPERTIES S; Nocerino E., 2018, INT ARCH PHOTOGRAMME, V42, P773, DOI [10.5194/isprs, DOI 10.5194/ISPRS]; Orban R, 2006, B ARCHEOLOGIQUE PROV, V2006, P79; Pamart A, 2017, INT ARCH PHOTOGRAMM, V42-2, P559, DOI 10.5194/isprs-archives-XLII-2-W3-559-2017; Porter S., 2016, COMPUTER APPL QUANTI; Rougier H, 2012, SPY CAVE 125 YEARS M, V1, P123; Salgado C.M., 2016, SECONDARY ANAL ELECT, P163, DOI [10.1007/978-3-319-43742-2_14.2, DOI 10.1007/978-3-319-43742-2_14.2, DOI 10.1007/978-3-319-43742-2_14]; Tsiafaki D, 2016, VIRTUAL ARCHAEOL REV, V7, P67, DOI 10.4995/var.2016.5910; Tucci G, 2011, INT ARCH PHOTOGRAMM, V38-5, P413; VALINASAB B., 2015, J KOREAN SOC MANUF T, V24, P23, DOI [DOI 10.7735/KSMTE.2015.24.1.023, 10.7735/ksmte.2015.24.1.023]; Vautherin J, 2016, ISPRS ANN PHOTO REM, V3, P139, DOI 10.5194/isprsannals-III-3-139-2016; Wachowiak MJ, 2009, J AM INST CONSERV, V48, P141, DOI 10.1179/019713609804516992; Webb EK, 2017, J AM INST CONSERV, V56, P211, DOI 10.1080/01971360.2017.1359463; Weyrich T, 2004, SPBG 04 S POINT BAS, P85, DOI [10.2312/SPBG/SPBG04/085-094, DOI 10.2312/SPBG/SPBG04/085-094]; Zijp J.R., 2001, OPTICAL PROPERTIES D	48	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220949	10.1371/journal.pone.0220949	http://dx.doi.org/10.1371/journal.pone.0220949			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408481	Green Submitted, Green Published, gold			2022-12-26	WOS:000485009500028
J	Buunk, AM; Spikman, JM; Metzemaekers, JDM; van Dijk, JMC; Groen, RJM				Buunk, Anne M.; Spikman, Jacoba M.; Metzemaekers, Jan D. M.; van Dijk, J. Marc C.; Groen, Rob J. M.			Return to work after subarachnoid hemorrhage: The influence of cognitive deficits	PLOS ONE			English	Article							MENTAL-STATE-EXAMINATION; TRAUMATIC BRAIN-INJURY; LONG-TERM OUTCOMES; QUALITY-OF-LIFE; REINTEGRATION; SATISFACTION; IMPAIRMENTS; DEPRESSION	Introduction Cognitive deficits are frequently found after subarachnoid hemorrhage (SAH), but their influence on return to work is largely unknown. To improve identification of those patients at-risk for long-term return to work problems, we aimed to examine the value of cognitive deficits in the prediction of long-term return to work after subarachnoid hemorrhage. Methods SAH patients (N = 71) who were employed before SAH and were able to undergo neuropsychological assessment, were included. Demographic characteristics and acute SAH-related variables (SAH-type and external cerebrospinal fluid drainage) were taken into account. Neuropsychological tests for memory, speed, attention, executive function, and emotion recognition and a questionnaire for executive functions were used. Return to work was assessed using the Role Resumption List. Results Results showed that patients with incomplete return to work had significantly lower scores on neuropsychological measures for complex attention and executive functions (p < 0.05) compared to patients with complete return to work. Return to work could not be significantly predicted using only demographic characteristics and acute SAH-related variables, but adding measures of complex attention and executive functions resulted in a prognostic model that could reliably distinguish between complete and incomplete return to work. Statistically significant predictors in the final model were cerebrospinal fluid drainage and scores on a questionnaire for executive functions: patients with cerebrospinal fluid drainage and higher scores on the a questionnaire for executive functions were less likely to return to work. Discussion Together, these findings show that neuropsychological measures, especially for complex attention and executive functions, have added value to acute SAH-related and demographic variables in the prediction of long-term return to work after SAH.	[Buunk, Anne M.; Spikman, Jacoba M.] Univ Groningen, Subdept Neuropsychol, Dept Neurol, Univ Med Ctr Groningen, Groningen, Netherlands; [Metzemaekers, Jan D. M.; van Dijk, J. Marc C.; Groen, Rob J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosurg, Groningen, Netherlands	University of Groningen; University of Groningen	Buunk, AM (corresponding author), Univ Groningen, Subdept Neuropsychol, Dept Neurol, Univ Med Ctr Groningen, Groningen, Netherlands.	a.m.buunk@umcg.nl	van Dijk, J. Marc C./C-1078-2013	van Dijk, J. Marc C./0000-0002-0814-5680; Spikman, Jacoba/0000-0002-6477-0763; Groen, Rob J.M./0000-0003-3067-763X	charitable foundation Catharina Heerdt	charitable foundation Catharina Heerdt	This study was funded by the charitable foundation Catharina Heerdt to JMS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Alfieri A, 2011, J CLIN NEUROSCI, V18, P1478, DOI 10.1016/j.jocn.2011.02.036; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Blonder LX, 2012, J CLIN EXP NEUROPSYC, V34, P634, DOI 10.1080/13803395.2012.667069; Boerboom W, 2014, J REHABIL MED, V46, P28, DOI 10.2340/16501977-1236; Buunk AM, 2016, NEUROPSYCHOLOGY; Buunk AM, 2017, NEUROPSYCHOLOGIA, V103, P131, DOI 10.1016/j.neuropsychologia.2017.07.015; CANHAO P, 1995, ACTA NEUROCHIR, V132, P14, DOI 10.1007/BF01404842; Carter BS, 2000, NEUROSURGERY, V46, P1326, DOI 10.1097/00006123-200006000-00008; Deelman B.G., 1980, NEUROPSYCHOLOGIE NED; Degos V, 2012, ANESTHESIOLOGY, V117, P1289, DOI 10.1097/ALN.0b013e318267395b; Doerfler S, 2018, WORLD NEUROSURG, V114, pE483, DOI 10.1016/j.wneu.2018.02.195; Dupont S, 2013, NEUROL RES, V35, P107, DOI 10.1179/1743132812Y.0000000122; Edwards JD, 2018, INT J STROKE, V13, P243, DOI 10.1177/1747493017743059; Godefroy O, 2011, STROKE, V42, P1712, DOI 10.1161/STROKEAHA.110.606277; Golden C.J., 1978, STROOP COLOR WORD TE; Hedlund M, 2011, BRIT J NEUROSURG, V25, P693, DOI 10.3109/02688697.2011.578769; HUTTER BO, 1993, NEUROSURGERY, V33, P999; HUTTER BO, 1994, ACTA NEUROCHIR, V127, P129, DOI 10.1007/BF01808755; HUTTER BO, 1995, J CLIN EXP NEUROPSYC, V17, P499, DOI 10.1080/01688639508405141; Kauranen T, 2013, J NEUROL NEUROSUR PS, V84, P316, DOI 10.1136/jnnp-2012-302629; Kollegger H, 1989, Int Disabil Stud, V11, P57; Konczalla J, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-140; Lago A, 2016, NEUROL RES, V38, P692, DOI 10.1080/01616412.2016.1200306; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Mani K, 2017, WORK, V58, P51, DOI 10.3233/WOR-172597; Morris PG, 2004, NEUROSURGERY, V54, P47, DOI 10.1227/01.NEU.0000097198.94828.E1; Passier PECA, 2011, J STROKE CEREBROVASC, V20, P324, DOI 10.1016/j.jstrokecerebrovasdis.2010.02.001; Powell J, 2004, J NEUROL NEUROSUR PS, V75, P1119, DOI 10.1136/jnnp.2002.000414; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rinkel GJE, 2011, LANCET NEUROL, V10, P349, DOI 10.1016/S1474-4422(11)70017-5; Schweizer TA, 2012, J NEUROL SCI, V316, P137, DOI 10.1016/j.jns.2012.01.003; Simblett SK, 2011, NEUROPSYCHOL REHABIL, V21, P1, DOI [10.1080/09602011.2010.531216, 10.1080/09602011.2011.592099]; Sonesson B, 2018, J NEUROSURG, V128, P785, DOI 10.3171/2016.11.JNS16805; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Spikman JM, 2010, J NEUROTRAUM, V27, P1195, DOI 10.1089/neu.2010.1277; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Stienen MN, 2014, WORLD NEUROSURG; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Taufique Z, 2016, NEUROSURGERY, V78, P256, DOI 10.1227/NEU.0000000000001042; TEASDALE GM, 1988, J NEUROL NEUROSUR PS, V51, P1457, DOI 10.1136/jnnp.51.11.1457; van der Kemp J, 2019, NEUROPSYCHOL REHABIL, V29, P638, DOI 10.1080/09602011.2017.1313746; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Verhage F., 1964, INTELLIGENTIE LEEFTI; Vilkki JS, 2004, NEUROSURGERY, V55, P790, DOI 10.1227/01.NEU.0000137629.17424.6D; Vilkki J, 2012, ACTA NEUROCHIR, V154, P1437, DOI 10.1007/s00701-012-1417-y; Wallmark S, 2016, ACTA NEUROCHIR, V158, P233, DOI 10.1007/s00701-015-2665-4; Wilson B.A., 1996, BEHAV ASSESSMENT DYS; Young AW, 2002, FACIAL EXPRESSIONS E	49	22	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220972	10.1371/journal.pone.0220972	http://dx.doi.org/10.1371/journal.pone.0220972			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398223	Green Published, gold, Green Submitted			2022-12-26	WOS:000485004000033
J	Li, J; Zhu, XD; Wang, HS; Lee, CP; Chen, SJ; Qian, YY; Han, M; Bunney, R; Beiser, DG; Hoek, TLV				Li, Jing; Zhu, Xiangdong; Wang, Huashan; Lee, Chunpei; Chen, Sy-Jou; Qian, Yuanyu; Han, Mei; Bunney, Ryan; Beiser, David G.; Hoek, Terry L. Vanden			Akt1-mediated CPR cooling protection targets regulators of metabolism, inflammation and contractile function in mouse cardiac arrest	PLOS ONE			English	Article							FACTOR-KAPPA-B; THERAPEUTIC HYPOTHERMIA CARDIOPROTECTION; PYRUVATE-DEHYDROGENASE COMPLEX; MILD HYPOTHERMIA; AKT; RESUSCITATION; ACTIVATION; INHIBITION; HEART; PHOSPHOLAMBAN	Therapeutic hypothermia initiated during cardiopulmonary resuscitation (CPR) in pre-clinical studies appears to be highly protective against sudden cardiac arrest injury. Given the challenges to implementing CPR cooling clinically, insights into its critical mechanisms of protection could guide development of new CPR drugs that mimic hypothermia effects without the need for physical cooling. Here, we used Akt1-deficient mice that lose CPR hypothermia protection to identify hypothermia targets. Adult female C57BL/6 mice (Akt1(+/+) and Akt1(+/-)) underwent 8 min of KCl-induced asystolic arrest and were randomized to receive hypothermia (30 +/- 0.5 degrees C) or normothermia. Hypothermia was initiated during CPR and extended for 1 h after resuscitation. Neurologically scored survival was measured at 72 h. Other outcomes included mean arterial pressure and target measures in heart and brain related to contractile function, glucose utilization and inflammation. Compared to northothermia, hypothermia improved both 2h mean arterial pressure and 72h neurologically intact survival in Akt1(+/+) mice but not in Akt1(+/-) mice. In Akt1(+/+) mice, hypothermia increased Akt and GSK3 beta phosphorylation, pyruvate dehydrogenase activation, and NAD(+) and ATP production while decreasing I kappa B alpha degradation and NF-kappa B activity in both heart and brain at 30 min after CPR. It also increased phospholamban phosphorylation in heart tissue. Further, hypothermia reduced metabolic and inflammatory blood markers lactate and Pre-B cell Colony Enhancing Factor. Despite hypothermia treatment, all these effects were reversed in Akt1(+/-) mice. Taken together, drugs that target Akt1 and its effectors may have the potential to mimic hypothermia-like protection to improve sudden cardiac arrest survival when administered during CPR.	[Li, Jing; Zhu, Xiangdong; Wang, Huashan; Lee, Chunpei; Chen, Sy-Jou; Qian, Yuanyu; Bunney, Ryan; Hoek, Terry L. Vanden] Univ Illinois Hosp & Hlth Sci Syst, Ctr Adv Resuscitat Med, Ctr Cardiovasc Res, Chicago, IL 60612 USA; [Li, Jing; Zhu, Xiangdong; Wang, Huashan; Lee, Chunpei; Chen, Sy-Jou; Qian, Yuanyu; Bunney, Ryan; Hoek, Terry L. Vanden] Univ Illinois Hosp & Hlth Sci Syst, Dept Emergency Med, Chicago, IL 60612 USA; [Chen, Sy-Jou] Triserv Gen Hosp, Dept Emergency Med, Natl Def Med Ctr, Taipei, Taiwan; [Qian, Yuanyu] Chinese Peoples Liberat Army Gen Hosp, Emergency Dept, Beijing, Peoples R China; [Han, Mei; Beiser, David G.] Univ Chicago, Dept Med, Sect Emergency Med, 5841 S Maryland Ave, Chicago, IL 60637 USA	National Defense Medical Center; Tri-Service General Hospital; Chinese People's Liberation Army General Hospital; University of Chicago	Hoek, TLV (corresponding author), Univ Illinois Hosp & Hlth Sci Syst, Ctr Adv Resuscitat Med, Ctr Cardiovasc Res, Chicago, IL 60612 USA.; Hoek, TLV (corresponding author), Univ Illinois Hosp & Hlth Sci Syst, Dept Emergency Med, Chicago, IL 60612 USA.	tvh@uic.edu		wang, huashan/0000-0002-3662-1576; Beiser, David/0000-0001-9676-087X	National Institute of General Medical Sciences [1R01 GM120485]; National Heart, Lung, and Blood Institute [K08-HL-091184, 1R01HL147031-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL147031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120485] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences, http://dx.doi.org/10.13039/100000057, 1R01 GM120485, to Dr Terry L. Vanden Hoek; National Heart, Lung, and Blood Institute, http://dx.doi.org/10.13039/100000050, K08-HL-091184, to Dr. David G. Beiser; and National Heart, Lung and Blood Institute, 1R01HL147031-01, to Dr Terry L. Vanden Hoek. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella BS, 2004, CIRCULATION, V109, P2786, DOI 10.1161/01.CIR.0000131940.19833.85; Adrie C, 2002, CIRCULATION, V106, P562, DOI 10.1161/01.CIR.0000023891.80661.AD; ALOIA RC, 1989, BIOCHIM BIOPHYS ACTA, V988, P123, DOI 10.1016/0304-4157(89)90007-5; Anthonsen MW, 2001, J BIOL CHEM, V276, P35344, DOI 10.1074/jbc.M105264200; Beeson CC, 2012, J VASC RES, V49, P89, DOI 10.1159/000332326; Beiser DG, 2011, RESUSCITATION, V82, P115, DOI 10.1016/j.resuscitation.2010.08.038; Beiser DG, 2010, AM J PHYSIOL-HEART C, V298, pH1761, DOI 10.1152/ajpheart.00187.2010; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Cai LP, 2016, J NEUROSCI RES, V94, P749, DOI 10.1002/jnr.23740; Calera MR, 1998, J BIOL CHEM, V273, P7201, DOI 10.1074/jbc.273.13.7201; Catalucci D, 2009, J BIOL CHEM, V284, P28180, DOI 10.1074/jbc.M109.036566; Chae YC, 2016, CANCER CELL, V30, P257, DOI 10.1016/j.ccell.2016.07.004; Diestel A, 2008, CRYOBIOLOGY, V57, P216, DOI 10.1016/j.cryobiol.2008.08.005; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Han HS, 2003, J CEREBR BLOOD F MET, V23, P589, DOI 10.1097/01.WCB.0000059566.39780.8D; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; HENDRICKX HHL, 1984, RESUSCITATION, V12, P117, DOI 10.1016/0300-9572(84)90063-7; Hoshi M, 1996, P NATL ACAD SCI USA, V93, P2719, DOI 10.1073/pnas.93.7.2719; Jones AE, 2004, SHOCK, V22, P410, DOI 10.1097/01.shk.0000142186.95718.82; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Karmazyn M., 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P323, DOI 10.2174/1568006054553417; Katome T, 2003, J BIOL CHEM, V278, P28312, DOI 10.1074/jbc.M302094200; Ketzer LA, 2009, AM J PHYSIOL-HEART C, V297, pH556, DOI 10.1152/ajpheart.00302.2009; Kilgannon JH, 2008, RESUSCITATION, V79, P410, DOI 10.1016/j.resuscitation.2008.07.019; Kloner RA, 2001, CIRCULATION, V104, P2981, DOI 10.1161/hc4801.100038; KUSUOKA H, 1991, AM J PHYSIOL, V261, pH1005, DOI 10.1152/ajpheart.1991.261.4.H1005; Laver S, 2004, INTENS CARE MED, V30, P2126, DOI 10.1007/s00134-004-2425-z; LEWANDOWSKI ED, 1995, CIRCULATION, V91, P2071, DOI 10.1161/01.CIR.91.7.2071; Li J, 2015, AM J PHYSIOL-HEART C, V308, pH1414, DOI 10.1152/ajpheart.00748.2014; Li J, 2014, CRIT CARE MED, V42, pE734, DOI 10.1097/CCM.0000000000000656; Li J, 2011, J TRAUMA, V71, P1262, DOI 10.1097/TA.0b013e31821280c5; Li J, 2011, J NEUROTRAUM, V28, P1281, DOI 10.1089/neu.2011.1751; Lim CM, 2004, INTENS CARE MED, V30, P1638, DOI 10.1007/s00134-004-2336-z; Luthra P, 2008, J VIROL, V82, P10887, DOI 10.1128/JVI.00806-08; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Ning XH, 1998, AM J PHYSIOL-HEART C, V274, pH786, DOI 10.1152/ajpheart.1998.274.3.H786; NISHIJIMA MK, 1989, AM J PHYSIOL, V257, pH1860, DOI 10.1152/ajpheart.1989.257.6.H1860; Nishimura Yoshiharu, 2005, Interact Cardiovasc Thorac Surg, V4, P101, DOI 10.1510/icvts.2004.097188; Piao L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185046; Post H, 2010, ACTA PHYSIOL, V199, P43, DOI 10.1111/j.1748-1716.2010.02083.x; Randle P J, 1981, Curr Top Cell Regul, V18, P107; Ridder DA, 2009, NEUROSCIENCE, V158, P995, DOI 10.1016/j.neuroscience.2008.07.007; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Schleicher M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000343; Shao ZH, 2010, AM J PHYSIOL-HEART C, V298, pH2164, DOI 10.1152/ajpheart.00994.2009; Sharp WW, 2014, FASEB J, V28, P316, DOI 10.1096/fj.12-226225; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Stowe DF, 1999, AM J PHYSIOL-HEART C, V277, pH2321, DOI 10.1152/ajpheart.1999.277.6.H2321; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; TANI M, 1989, CIRC RES, V65, P1045, DOI 10.1161/01.RES.65.4.1045; Van der Heiden K, 2010, CLIN SCI, V118, P593, DOI 10.1042/CS20090557; Webster CM, 2009, NEUROBIOL DIS, V33, P301, DOI 10.1016/j.nbd.2008.11.001; Yannopoulos D, 2009, CIRCULATION, V120, P1426, DOI 10.1161/CIRCULATIONAHA.109.848424; YATVIN MB, 1980, INT J RADIAT BIOL, V37, P513, DOI 10.1080/09553008014550641; Zhao TC, 2001, CIRC RES, V89, P915, DOI 10.1161/hh2201.099452; Zhu XD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095622	56	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220604	10.1371/journal.pone.0220604	http://dx.doi.org/10.1371/journal.pone.0220604			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398213	Green Published, gold, Green Submitted			2022-12-26	WOS:000485004000011
J	Ogawa, Y; Takahashi, N; Takemoto, T; Nishiume, T; Suzuki, M; Ishiguro, N; Kojima, T				Ogawa, Yoshikazu; Takahashi, Nobunori; Takemoto, Toki; Nishiume, Tsuyoshi; Suzuki, Mochihito; Ishiguro, Naoki; Kojima, Toshihisa			Hyaluronan promotes TRPV4-induced chondrogenesis in ATDC5 cells	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; NF-KAPPA-B; DOWN-REGULATION; ACID INCREASES; TRPV4; CHONDROCYTES; EXPRESSION; ACTIVATION; RECEPTOR; KINASE	Hyaluronan (HA) is an extracellular matrix glycosaminoglycan essential for the homeostasis of cartilage-related tissues. Intracellular adhesion molecule-1 (ICAM-1) and CD44 have been identified as receptors for HA. Recently, transient receptor potential vanilloid 4 (TRPV4) has emerged as a potential research target in several areas of physiology. TRPV4 is a Ca2+-permeable, non-selective cation channel that appears to have mechanosensory or osmosensory roles in several musculoskeletal tissues. HA and TRPV4 play key roles in chondrogenesis; however, it has remained unclear whether they have interactive effects on chondrogenesis and, if so, how do they interact with each other? This study investigated the relationship between HA, its receptors ICAM-1 and CD44, and TRPV4 in the chondrogenic pathway using the ATDC5 cell line. It was found that the presence of HA is required for TRPV4-induced chondrogenesis. Loss of HA suppressed TRPV4-induced expression of the chondrogenic markers, SOX9 and Aggrecan. Moreover, HA affects TRPV4-induced chondrogenic development via each of ICAM-1 and CD44 partially. In conclusion, for the first time, the existence of an interaction between HA, its receptor ICAM-1 and CD44, and TRPV4-activity in chondrogenesis in the ATDC5 cell line was reported. TRPV4 is known to function as a mechanosensory channel in several musculoskeletal tissues. Therefore, findings of this study may suggest the existence of a molecular mechanism that underlies the interactive effects of HA and mechanical loading on joint chondrogenesis.	[Ogawa, Yoshikazu; Takahashi, Nobunori; Takemoto, Toki; Nishiume, Tsuyoshi; Suzuki, Mochihito; Ishiguro, Naoki; Kojima, Toshihisa] Nagoya Univ, Grad Sch Med, Dept Orthopaed Surg, Showa Ku, Nagoya, Aichi, Japan	Nagoya University	Takahashi, N (corresponding author), Nagoya Univ, Grad Sch Med, Dept Orthopaed Surg, Showa Ku, Nagoya, Aichi, Japan.	nobunori@med.nagoya-u.ac.jp			JSPS KAKENHI [16K10897]; Seikagaku Corporation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Seikagaku Corporation	This work was supported by JSPS KAKENHI Grant Number 16K10897. Seikagaku Corporation has provided research funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adapala RK, 2016, ONCOGENE, V35, P314, DOI 10.1038/onc.2015.83; Addison MP, 2016, PHARMACOL REP, V68, P620, DOI 10.1016/j.pharep.2016.01.003; Ariyoshi W, 2014, OSTEOARTHR CARTILAGE, V22, P111, DOI 10.1016/j.joca.2013.10.013; Bourguignon LYW, 2010, J BIOL CHEM, V285, P36721, DOI 10.1074/jbc.M110.162305; Caron MMJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033467; Chan DD, 2015, OSTEOARTHR CARTILAGE, V23, P1879, DOI 10.1016/j.joca.2015.06.021; DAVIES ME, 1991, CONNECT TISSUE RES, V26, P207, DOI 10.3109/03008209109152439; Fukui T, 2014, J MATER SCI-MATER M, V25, P1173, DOI 10.1007/s10856-013-5139-3; Guilak F, 2010, ANN NY ACAD SCI, V1192, P404, DOI 10.1111/j.1749-6632.2010.05389.x; Hirabara S, 2013, BIOCHEM BIOPH RES CO, V430, P519, DOI 10.1016/j.bbrc.2012.12.003; Hiramitsu T, 2006, RHEUMATOLOGY, V45, P824, DOI 10.1093/rheumatology/kel026; JIAO Q, 2015, BIOMARKERS, P1, DOI DOI 10.3109/1354750X.2015.1118547.PMID:26634947; Jin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016713; Lessey-Morillon EC, 2014, J IMMUNOL, V192, P3390, DOI 10.4049/jimmunol.1302525; LEV R, 1964, J HISTOCHEM CYTOCHEM, V12, P309, DOI 10.1177/12.4.309; Lisignoli G, 2001, ARTHRITIS RHEUM-US, V44, P1800, DOI 10.1002/1529-0131(200108)44:8<1800::AID-ART317>3.0.CO;2-1; Lo WC, 2013, BIOMATERIALS, V34, P4739, DOI 10.1016/j.biomaterials.2013.03.016; Lu XW, 2015, GLYCOCONJUGATE J, V32, P549, DOI 10.1007/s10719-015-9597-3; MCCOURT PAG, 1994, J BIOL CHEM, V269, P30081; Misra S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00201; Mongkhon JM, 2014, INFLAMM RES, V63, P691, DOI 10.1007/s00011-014-0742-4; Muramatsu S, 2007, J BIOL CHEM, V282, P32158, DOI 10.1074/jbc.M706158200; O'Conor CJ, 2014, P NATL ACAD SCI USA, V111, P1316, DOI 10.1073/pnas.1319569111; Onodera Y, 2015, FEBS OPEN BIO, V5, P476, DOI 10.1016/j.fob.2015.05.007; Phan MN, 2009, ARTHRITIS RHEUM-US, V60, P3028, DOI 10.1002/art.24799; Sanchez JC, 2014, CELL CALCIUM, V56, P493, DOI 10.1016/j.ceca.2014.10.006; Sato E, 2014, J ORTHOP RES, V32, P1619, DOI 10.1002/jor.22691; Scheraga RG, 2016, J IMMUNOL, V196, P428, DOI 10.4049/jimmunol.1501688; Takahashi N, 2015, RHEUMATOL INT, V35, P1707, DOI 10.1007/s00296-015-3283-4; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Xu T, 2012, INT J MOL MED, V30, P1119, DOI 10.3892/ijmm.2012.1107; Yasuda T, 2007, INFLAMM RES, V56, P246, DOI 10.1007/s00011-007-6168-5; Yasuda T, 2012, J PHARMACOL SCI, V118, P25, DOI 10.1254/jphs.11044FP; Yasuda T, 2010, CLIN RHEUMATOL, V29, P1259, DOI 10.1007/s10067-010-1512-5; Yatabe T, 2009, ANN RHEUM DIS, V68, P1051, DOI 10.1136/ard.2007.086884; Zhang LP, 2015, NEUROSCIENCE, V311, P166, DOI 10.1016/j.neuroscience.2015.10.028	37	6	8	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0219492	10.1371/journal.pone.0219492	http://dx.doi.org/10.1371/journal.pone.0219492			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393869	Green Submitted, Green Published, gold			2022-12-26	WOS:000485002500011
J	Vaccani, AC; Freret-Meurer, NV; Bertoncini, AA; Santos, LN				Vaccani, Amanda C.; Freret-Meurer, Natalie V.; Bertoncini, Athila A.; Santos, Luciano N.			Shining in the dark: First record of biofluorescence in the seahorse Hippocampus reidi	PLOS ONE			English	Article							FLUORESCENCE	Marine environments are visual domains restricted regarding light characteristics. Overall, blue monochromatic spectrum prevails in offshore areas especially below 15m depth, since long wavelengths are quickly attenuated. Light intensity is even more constrained in coastal waters, particularly those of tropical estuaries and bays, because further scattering through dissolved and suspended materials. Biofluorescence, which is the ability of organisms to absorb light and reflect it in a different wavelength, has been reported for many marine fish. In this paper, biofluorescence was recorded for the first time for the longsnout seahorse Hippocampus reidi, under natural conditions at Ilha Grande bay, Brazil, and both adult, juvenile and fry individuals kept in captivity. Although displaying the same colour emissions, sea-horses differed in relation to body lighting, colour patterns, and age wherein fluorescence occurs. Newborn seahorses exhibit green biofluorescence only in the eyes and stomach. Further experiments are necessary to address whether H. reidi can change the patterns of biofluorescence emission for sensorial and social purposes.	[Vaccani, Amanda C.; Bertoncini, Athila A.; Santos, Luciano N.] Univ Fed Estado Rio de Janeiro, Dept Ecol & Recursos Marinhos, Rio De Janeiro, RJ, Brazil; [Vaccani, Amanda C.; Freret-Meurer, Natalie V.] Univ Santa Ursula, Inst Biol, Rio De Janeiro, RJ, Brazil; [Vaccani, Amanda C.; Freret-Meurer, Natalie V.] Univ Santa Ursula, Lab Comportamento Anim & Conservacao, Rio De Janeiro, RJ, Brazil; [Bertoncini, Athila A.; Santos, Luciano N.] Univ Fed Estado Rio de Janeiro, Lab Ictiol Teor & Aplicada, Rio De Janeiro, RJ, Brazil	Universidade Federal do Estado do Rio de Janeiro; Universidade Federal do Estado do Rio de Janeiro	Santos, LN (corresponding author), Univ Fed Estado Rio de Janeiro, Dept Ecol & Recursos Marinhos, Rio De Janeiro, RJ, Brazil.; Santos, LN (corresponding author), Univ Fed Estado Rio de Janeiro, Lab Ictiol Teor & Aplicada, Rio De Janeiro, RJ, Brazil.	luciano.santos@unirio.br	Santos, Luciano/M-4377-2015; Bertoncini, Athila/B-3640-2013	Santos, Luciano/0000-0002-5279-5672; Vaccani, Amanda/0000-0001-7900-575X; Bertoncini, Athila/0000-0002-6310-0127	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [E-26/202.840/2015, E-26/202.755/2018]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [314379/2018-5]; CAPES - Coordenacao de aperfeicoamento de pessoal de nivel superior	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES - Coordenacao de aperfeicoamento de pessoal de nivel superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (Research Grant to LNS, E-26/202.840/2015; E-26/202.755/2018) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Research Grant to LNS, ref. 314379/2018-5). This work was also supported by CAPES - Coordenacao de aperfeicoamento de pessoal de nivel superior (https://www.capes.gov.br/) to AV. The funder had no role in study design,data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, LIST THREATENED SPEC; Anthes N, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00126; Arnold KE, 2002, SCIENCE, V295, P92, DOI 10.1126/science.295.5552.92; De Brauwer M, 2018, CONSERV BIOL, V32, P706, DOI 10.1111/cobi.13033; Gerlach T, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0145-1; Gruber DF, 2016, SCI REPORTS, V6, P1, DOI [10.1038/s41598-016-0001-8, DOI 10.1038/S41598-016-0001-8]; Haddock SHD, 2005, SCI BLUE WATER DIVIN; Haddock SHD, 2010, P ROY SOC B-BIOL SCI, V277, P1155, DOI 10.1098/rspb.2009.1774; IUCN, 2010, RED LIST THREATENED; Kalb N, 2015, ETHOLOGY, V121, P566, DOI 10.1111/eth.12367; Kirk J.T.O., 2011, LIGHT PHOTOSYNTHESIS; Lourie S. A., 1999, SEAHORSES IDENTIFICA; Lourie SA, 2016, ZOOTAXA, V4146, P1, DOI 10.11646/zootaxa.4146.1.1; Mazel CH, 2004, SCIENCE, V303, P51, DOI 10.1126/science.1089803; Meadows MG, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1211; Michiels Nico K., 2008, BMC Ecology, V8, P16, DOI 10.1186/1472-6785-8-16; Sparks JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083259; Wucherer MF, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-1; Wucherer MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037913; Zhang YH, 2016, ZOOTAXA, V4170, P384, DOI 10.11646/zootaxa.4170.2.11	20	3	3	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220561	10.1371/journal.pone.0220561	http://dx.doi.org/10.1371/journal.pone.0220561			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393893	Green Submitted, Green Published, gold			2022-12-26	WOS:000485002500040
J	Buffiere, A; Uzan, B; Aucagne, R; Hermetet, F; Mas, M; Nassurdine, S; Aznague, A; Carmignac, V; Tournier, B; Bouchot, O; Ballerini, P; Barata, JT; Bastie, JN; Delva, L; Pflumio, F; Quere, R				Buffiere, Anne; Uzan, Benjamin; Aucagne, Romain; Hermetet, Francois; Mas, Manon; Nassurdine, Sandra; Aznague, Aziza; Carmignac, Virginie; Tournier, Benjamin; Bouchot, Olivier; Ballerini, Paola; Barata, Joao T.; Bastie, Jean-Noel; Delva, Laurent; Pflumio, Francoise; Quere, Ronan			T-cell acute lymphoblastic leukemia displays autocrine production of Interleukin-7	ONCOGENE			English	Article							OF-FUNCTION MUTATIONS; IL-7; PROGRESSION; ACTIVATION; SURVIVAL; ISLANDS; GROWTH; IL7R	T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy characterized by an accumulation of immature T cells. Although patient outcomes have improved, novel targeted therapies are needed to reduce the intensity of chemotherapy and improve the prognosis of high-risk patients. Interleukin-7 (IL-7) modulates the survival and proliferation of normal and malignant T cells. Targeting the IL-7 signaling pathway is thus a potentially effective therapeutic strategy. To achieve such aim, it is essential to first understand how the IL-7 signaling pathway is activated. Although IL-7 production has been observed from multiple stromal tissues, T-ALL autocrine IL-7 secretion has not yet been described. Interestingly, using T-ALL cell lines, primary and patient-derived xenotransplanted (PDX) T-ALL cells, we demonstrate that T-ALL cells produce IL-7 whereas normal T cells do not. Finally, using knock down of IL7 gene in T-ALL cells, we describe to what extent IL-7 autocrine secretion is involved in the T-ALL cells propagation in bone marrow and how it affects the number of leukemia-initiating cells in PDX mice. Together, these results demonstrate how the autocrine production of the IL-7 cytokine mediated by T-ALL cells can be involved in the oncogenic development of T-ALL and offer novel insights into T-ALL spreading.	[Buffiere, Anne; Aucagne, Romain; Hermetet, Francois; Mas, Manon; Nassurdine, Sandra; Aznague, Aziza; Carmignac, Virginie; Bastie, Jean-Noel; Delva, Laurent; Quere, Ronan] Univ Bourgogne Franche Comte, Inserm, UMR1231, Dijon, France; [Buffiere, Anne; Aucagne, Romain; Hermetet, Francois; Aznague, Aziza; Bastie, Jean-Noel; Delva, Laurent; Quere, Ronan] LipSTIC Lab, Dijon, France; [Uzan, Benjamin; Pflumio, Francoise] Univ Paris 11, Univ Paris 7, CEA, Inserm,UMR967, Fontenay Aux Roses, France; [Uzan, Benjamin; Pflumio, Francoise] CEA, IRCM, LSHL, Fontenay Aux Roses, France; [Tournier, Benjamin] Hop Univ Francois Mitterrand, Serv Genet Canc, Dijon, France; [Bouchot, Olivier] Hop Univ Francois Mitterrand, Chirurg Cardiovasc, Dijon, France; [Ballerini, Paola] Hop Trousseau, AP HP, Lab Hematol, Paris, France; [Barata, Joao T.] Univ Lisbon, Fac Med, Inst Med Mol, Lisbon, Portugal; [Bastie, Jean-Noel] Hop Univ Francois Mitterrand, Serv Hematol Clin, Dijon, France; [Bastie, Jean-Noel] Hop Univ Francois Mitterrand, CRB Ferdinand Cabanne, BB 0033-00044, Dijon, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CHU Dijon Bourgogne; CHU Dijon Bourgogne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Universidade de Lisboa; CHU Dijon Bourgogne; CHU Dijon Bourgogne	Quere, R (corresponding author), Univ Bourgogne Franche Comte, Inserm, UMR1231, Dijon, France.; Quere, R (corresponding author), LipSTIC Lab, Dijon, France.	ronan.quere@inserm.fr	Hermetet, François/GPF-8614-2022; Quere, Ronan/C-6178-2017	Pflumio, Francoise/0000-0001-8995-596X; Aucagne, Romain/0000-0002-5644-3287; DELVA, Laurent/0000-0002-1086-3964; Quere, Ronan/0000-0002-1615-6769; Hermetet, Francois/0000-0001-5549-1992; Tournier, Benjamin/0000-0001-6609-8096	Association Laurette Fugain; Conference de Coordination Interregionale du Grand Est - Bourgogne Franche-Comte (CCIRGE-BFC) de la Ligue contre le Cancer; National Research Agency under the program "Investissements d'Avenir" [ANR-11-LABX-0021]; (LipSTIC Labex); Conseil Regional de Bourgogne through the plan d'action regional pour l'innovation (PARI); European Union through the PO FEDER-FSE Bourgogne; French Ministere de la Recherche et de l'Enseignement Superieur (MRES); Ligue contre le Cancer; INSERM; Universite Paris Diderot	Association Laurette Fugain; Conference de Coordination Interregionale du Grand Est - Bourgogne Franche-Comte (CCIRGE-BFC) de la Ligue contre le Cancer; National Research Agency under the program "Investissements d'Avenir"(French National Research Agency (ANR)); (LipSTIC Labex); Conseil Regional de Bourgogne through the plan d'action regional pour l'innovation (PARI); European Union through the PO FEDER-FSE Bourgogne; French Ministere de la Recherche et de l'Enseignement Superieur (MRES); Ligue contre le Cancer(Ligue nationale contre le cancer); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris Diderot	The authors express their gratitude to the animal housing facility and cytometry platform staff at the University of Burgundy (Dijon, France), especially Valerie Saint-Giorgio, David Lheraud, Sebastien Lapipe, Anabelle Sequeira, and Serge Monier, for their excellent suggestions and valuable technical support. The authors also thank Julien Guy for providing information on T-ALL immune data that helped in the EGIL characterization, as well as Antonio Vitobello for providing insight about DNA methylation. The authors are also grateful to Suzanne Rankin (CHU Dijon) for editing and proofreading this paper. This study was supported by grants from the Association Laurette Fugain (RQ), the Conference de Coordination Interregionale du Grand Est - Bourgogne Franche-Comte (CCIRGE-BFC) de la Ligue contre le Cancer (RQ), by the National Research Agency under the program "Investissements d'Avenir" (reference ANR-11-LABX-0021, LipSTIC Labex), by the Conseil Regional de Bourgogne through the plan d'action regional pour l'innovation (PARI), and the European Union through the PO FEDER-FSE Bourgogne 2014/2020 programs. AB was supported by fellowships from the French Ministere de la Recherche et de l'Enseignement Superieur (MRES) and the Ligue contre le Cancer. FP and BU have grants from LNCC, INSERM, CEA, and Universite Paris Diderot.	Alves NL, 2009, P NATL ACAD SCI USA, V106, P1512, DOI 10.1073/pnas.0809559106; Barata JT, 2006, EXP HEMATOL, V34, P1133, DOI 10.1016/j.exphem.2006.05.001; Barata JT, 2004, J EXP MED, V200, P659, DOI 10.1084/jem.20040789; Barata JT, 2001, BLOOD, V98, P1524, DOI 10.1182/blood.V98.5.1524; Black KL, 2018, NUCLEIC ACIDS RES, V46, P11357, DOI 10.1093/nar/gky946; Buffiere A, 2018, LEUKEMIA, V32, P2062, DOI 10.1038/s41375-018-0081-5; Cai YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058647; Cramer SD, 2016, BLOOD, V128, P473, DOI 10.1182/blood-2016-03-679209; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Freyer DR, 2011, BLOOD, V117, P3010, DOI 10.1182/blood-2010-07-294678; Fry TJ, 2002, BLOOD, V99, P3892, DOI 10.1182/blood.V99.11.3892; FUNK PE, 1995, BLOOD, V86, P2661; Girardi T, 2017, BLOOD, V129, P1113, DOI 10.1182/blood-2016-10-706465; Hunger SP, 2015, NEW ENGL J MED, V373, P1541, DOI 10.1056/NEJMra1400972; Jacobs SR, 2010, J IMMUNOL, V184, P3461, DOI 10.4049/jimmunol.0902593; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Karawajew L, 2000, BLOOD, V96, P297, DOI 10.1182/blood.V96.1.297.013k24_297_306; Laouar Y, 2004, BLOOD, V103, P1985, DOI 10.1182/blood-2003-06-2126; Liu Y, 2017, NAT GENET, V49, P1211, DOI 10.1038/ng.3909; Marks DI, 2009, BLOOD, V114, P5136, DOI 10.1182/blood-2009-08-231217; Oosterwegel MA, 1997, IMMUNITY, V6, P351, DOI 10.1016/S1074-7613(00)80337-4; Oshima S, 2004, MOL CELL BIOL, V24, P6298, DOI 10.1128/MCB.24.14.6298-6310.2004; Poglio S, 2015, LEUKEMIA, V29, P977, DOI 10.1038/leu.2014.317; RICH BE, 1993, J EXP MED, V177, P305, DOI 10.1084/jem.177.2.305; Richter-Pechanska P, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201809443; Scupoli MT, 2007, HAEMATOLOGICA, V92, P264, DOI 10.3324/haematol.10356; Scupoli MT, 2003, HAEMATOLOGICA, V88, P1229; Shochat C, 2011, J EXP MED, V208, P901, DOI 10.1084/jem.20110580; Silva A, 2011, CANCER RES, V71, P4780, DOI 10.1158/0008-5472.CAN-10-3606; Thomas X, 2004, J CLIN ONCOL, V22, P4075, DOI 10.1200/JCO.2004.10.050; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Zenatti PP, 2011, NAT GENET, V43, P932, DOI 10.1038/ng.924	32	7	7	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 28	2019	38	48					7357	7365		10.1038/s41388-019-0921-4	http://dx.doi.org/10.1038/s41388-019-0921-4			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JR4XX	31417180				2022-12-26	WOS:000499631000006
J	Koh, XY; Koh, XH; Hwang, LA; Ferrer, FJ; Rahmat, SAB; Lama, D; Lane, DP				Koh, Xin Yu; Koh, Xiao Hui; Hwang, Le-ann; Ferrer, Fernando Jose; Rahmat, Siti Aishah Binte; Lama, Dilraj; Lane, David P.			Therapeutic anti-cancer activity of antibodies targeting sulfhydryl bond constrained epitopes on unglycosylated RON receptor tyrosine kinase	ONCOGENE			English	Article							MACROPHAGE-STIMULATING PROTEIN; N-LINKED GLYCOSYLATION; C-MET; MONOCLONAL-ANTIBODY; CANCER-CELLS; GROWTH; PATHOGENESIS; ACTIVATION; PHENOTYPES; HALLMARKS	Recepteur d'origine nantais (RON) receptor tyrosine kinase (RTK) and its ligand, serum macrophage-stimulating protein (MSP), are well-established oncogenic drivers for tumorigenesis and metastasis. RON is often found to be alternatively spliced resulting in various isoforms that are constitutively active. RON is therefore an attractive target for cancer therapeutics, including small molecular inhibitors and monoclonal antibodies. While small molecule inhibitors of RON may inhibit other protein kinases including the highly similar MET kinase, monoclonal antibodies targeting RON are more specific, potentially inducing fewer side effects. Although anti-RON monoclonal antibody therapies have been developed and tested in clinical trials, they were met with limited success. Cancer cells have been associated with aberrant glycosylation mechanisms. Notably for RON, the loss of N-bisected glycosylation is a direct cause for tumorigenesis and poorer prognosis in cancer patients. Particularly in gastric cancer, aberrant RON glycosylation augments RON activation. Here, we present a novel panel of monoclonal antibodies which potentially widens the specific targeting of not only the glycosylated RON, but also unglycosylated and aberrantly glycosylated RON. Our antibodies can bind strongly to deglycosylated RON from tunicamycin treated cells, recognise RON in IHC/IF and possess superior therapeutic efficacy in RON expressing xenograft tumours. Our most potent antibody in xenograft assays, is directed to the RON alpha chain and targets a sulfhydryl bond constrained epitope that appears to be cryptic in the crystal structure. This establishes the paradigm that such constrained and cryptic epitopes represent good targets for therapeutic antibodies.	[Koh, Xin Yu; Koh, Xiao Hui; Hwang, Le-ann; Ferrer, Fernando Jose; Rahmat, Siti Aishah Binte; Lane, David P.] ASTAR, P53 Lab, Singapore, Singapore; [Lama, Dilraj] ASTAR, Bioinformat Inst, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII)	Lane, DP (corresponding author), ASTAR, P53 Lab, Singapore, Singapore.	dplane@p53Lab.a-star.edu.sg	Lama, Dilraj/ABG-9950-2020	Lama, Dilraj/0000-0001-8603-9368; Lane, David/0000-0003-0551-3545	A*STAR	A*STAR(Agency for Science Technology & Research (A*STAR))	This work was supported by A*STAR.	Andrade K, 2017, SCI TRANSL MED, V9, P1, DOI 10.1126/scitranslmed.aai9338; Angeloni D, 2004, J BIOL CHEM, V279, P3726, DOI 10.1074/jbc.M309342200; Beers SA, 2016, BLOOD, V127, P1097, DOI 10.1182/blood-2015-09-625343; Benham AM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012872; Benz I, 2002, MOL MICROBIOL, V45, P267, DOI 10.1046/j.1365-2958.2002.03030.x; Case VB DA, 2014, AMBER 14; Catenacci DVT, 2011, CANCER BIOL THER, V12, P9, DOI 10.4161/cbt.12.1.15747; Cazet A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2577; Chakedis J, 2016, ONCOTARGET, V7, P45959, DOI 10.18632/oncotarget.10009; Chang K, 2015, ONCOTARGET, V6, P3507, DOI 10.18632/oncotarget.3420; Chao KLL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041912; Chen JF, 2017, ONCOL REP, V37, P721, DOI 10.3892/or.2017.5356; de-Freitas JCM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091921; Dussault I, 2009, ANTI-CANCER AGENT ME, V9, P221, DOI 10.2174/187152009787313792; Ellis CR, 2012, J AM CHEM SOC, V134, P8184, DOI 10.1021/ja301005f; Ferreira IG, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020580; Gomes C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066737; Gorlatova N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027269; Greenbaum A, 2016, HELIYON, V2, DOI 10.1016/j.heliyon.2016.e00153; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haynes PA, 1998, GLYCOBIOLOGY, V8, P1, DOI 10.1093/glycob/8.1.1; Ho WL, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0334-6; Itkonen HM, 2015, METHODS MOL BIOL, V1233, P103, DOI 10.1007/978-1-4939-1789-1_10; Johns TG, 2004, J BIOL CHEM, V279, P30375, DOI 10.1074/jbc.M401218200; Kang JG, 2011, BMB REP, V44, P765, DOI 10.5483/BMBRep.2011.44.12.765; Kaszuba K, 2015, P NATL ACAD SCI USA, V112, P4334, DOI 10.1073/pnas.1503262112; Krishnaswamy S, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3747-x; Lama D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03451; Ling Y, 2017, ONCOTARGET, V8, P39101, DOI 10.18632/oncotarget.16603; LoRusso PM, 2017, INVEST NEW DRUG, V35, P442, DOI 10.1007/s10637-016-0413-0; Mereiter S, 2016, BBA-GEN SUBJECTS, V1860, P1795, DOI 10.1016/j.bbagen.2015.12.016; Meyer SE, 2009, DEV BIOL, V333, P173, DOI 10.1016/j.ydbio.2009.06.028; Morrison AC, 2004, J IMMUNOL, V172, P1825, DOI 10.4049/jimmunol.172.3.1825; Munkley J, 2016, ONCOTARGET, V7, P35478, DOI 10.18632/oncotarget.8155; Phuc Vinh Nguyen Lam, 2013, Genomics Proteomics & Bioinformatics, V11, P96, DOI 10.1016/j.gpb.2012.11.003; RONSIN C, 1993, ONCOGENE, V8, P1195; Sarabipour S, 2013, BIOPHYS J, V105, P165, DOI 10.1016/j.bpj.2013.05.053; Very N, 2018, ONCOTARGET, V9, P1380, DOI 10.18632/oncotarget.22377; Wagh PK, 2008, ADV CANCER RES, V100, P1, DOI 10.1016/S0065-230X(08)00001-8; Wang MH, 2007, J PATHOL, V213, P402, DOI 10.1002/path.2245; Wang MH, 2013, J BIOMED RES, V27, P345, DOI 10.7555/JBR.27.20130038; Wong CH, 2005, J ORG CHEM, V70, P4219, DOI 10.1021/jo050278f; Wong JS, 2013, ONCOTARGET, V4, P1019, DOI 10.18632/oncotarget.1075; Yao HP, 2013, NAT REV CANCER, V13, P466, DOI 10.1038/nrc3545; Yao HP, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-82; Yao HP, 2006, CANCER BIOL THER, V5, P1179, DOI 10.4161/cbt.5.9.3073; Zhang K, 2010, INT J ONCOL, V36, P255, DOI 10.3892/ijo_00000496; Zou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069992	48	9	11	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 28	2019	38	48					7342	7356		10.1038/s41388-019-0946-8	http://dx.doi.org/10.1038/s41388-019-0946-8			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JR4XX	31417186	hybrid			2022-12-26	WOS:000499631000005
J	Liu, Y; Liu, QL; Chen, SM; Liu, YJ; Huang, YM; Chen, P; Li, XY; Gao, G; Xu, KQ; Fan, SQ; Zeng, ZY; Xiong, W; Tan, M; Li, GY; Zhang, WL				Liu, Yi; Liu, Qingluan; Chen, Shumin; Liu, Yijun; Huang, Yumei; Chen, Pan; Li, Xiayu; Gao, Ge; Xu, Keqian; Fan, Songqing; Zeng, Zhaoyang; Xiong, Wei; Tan, Ming; Li, Guiyuan; Zhang, Wenling			APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling	FASEB JOURNAL			English	Article						all-trans-RA; prognosis; proliferation; metastasis	TRANS-RETINOIC ACID; GELATINASE-ASSOCIATED LIPOCALIN; ACUTE PROMYELOCYTIC LEUKEMIA; APELIN; EXPRESSION; RECEPTOR; CANCER; METASTASIS; PROMOTES; TISSUE	The apelin receptor (APLNR) is a GPCR involved in many pathophysiological processes; however, the correlation between APLNR expression and nasopharyngeal carcinoma (NPC) has not been reported. In this study, we used cDNA microarray data to determine APLNR expression levels in NPC tissues. We found that APLNR expression was reduced in NPC tissues compared with noncancerous nasopharyngeal epithelial tissues. Subsequently, a large-scale sample of 1015 tissues was used to validate this discovery and explore the relationship between APLNR expression and prognosis of NPC. Expression levels of APLNR in NPC tissues were indeed down-regulated. Furthermore, positive expression of APLNR in NPC predicted a better prognosis (disease-free survival: P = 0.001; overall survival: P < 0.001). Moreover, ingenuity pathway analysis revealed that an indirect interaction existed between APLNR and retinoic acid (RA) in the cancer regulatory network. Consistently, after treatment with all-trans-RA (ATRA), we found that APLNR was significantly up-regulated in NPC cell lines (5-8F and HNE1), and proliferation of NPC cells was inhibited. Cell cycle arrest occurred in the G(0)/G(1) phase. In contrast, knockdown of APLNR diminished ATRA-induced growth inhibition of NPC cells. In addition, we surprisingly found that APLNR also played an important role in migration and invasion of NPC. Wound-healing and Transwell assays revealed that APLNR overexpression led to reduced migratory and invasive properties in 2 NPC cell lines. Western blot results revealed that hallmarks of epithelial-mesenchymal transition (EMT) were altered as well, suggesting that APLNR was capable of inhibiting EMT in NPC cells. Our study further demonstrated that low expression of APLNR promoted EMT in NPC cells by activating the PI3K-protein kinase B-mammalian target of rapamycin signaling pathway. Taken together, our data suggest that APLNR could potentially predict prognosis for patients with NPC and inhibit proliferation, migration, invasion, and EMT in nasopharyngeal cancer cells.	[Liu, Yi; Liu, Qingluan; Liu, Yijun; Huang, Yumei; Gao, Ge; Xu, Keqian; Zhang, Wenling] Cent South Univ, Xiangya Hosp 3, Dept Med Lab Sci, Tongzipo Rd 172, Changsha 410013, Hunan, Peoples R China; [Chen, Pan] Cent South Univ, Affiliated Canc Hosp Xiangya, Sch Med, Hunan Canc Hosp, Changsha, Peoples R China; [Li, Xiayu; Zeng, Zhaoyang; Xiong, Wei; Tan, Ming; Li, Guiyuan] Cent South Univ, Chinese Minist Educ, Canc Res Inst, Key Lab Carcinogenesis & Canc Invas, Changsha, Peoples R China; [Fan, Songqing] Cent South Univ, Xiangya Hosp 2, Dept Pathol, Changsha, Peoples R China; [Chen, Shumin] Peking Univ, Peoples Hosp, Dept Hematol, Beijing, Peoples R China; [Tan, Ming] Univ S Alabama, USA Hlth, Mitchell Canc Inst, Mobile, AL 36688 USA	Central South University; Central South University; Central South University; Central South University; Peking University; University of South Alabama	Zhang, WL (corresponding author), Cent South Univ, Xiangya Hosp 3, Dept Med Lab Sci, Tongzipo Rd 172, Changsha 410013, Hunan, Peoples R China.	zhangwenling73@126.com	Tan, Ming/ABD-5847-2021; li, xia/HHZ-7468-2022	Tan, Ming/0000-0003-2007-9898; 	National Natural Science Foundation of China [81672688, 81372907, 81472531, 81472595, 81672683, 81772928]; Central South University Innovation Foundation for Postgraduates [2018zzts881]; Natural Science Foundation of Hunan Province [2019JJ50359]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Central South University Innovation Foundation for Postgraduates; Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province)	This study was supported by grants from the National Natural Science Foundation of China (81672688, 81372907, 81472531, 81472595, 81672683, and 81772928), the Central South University Innovation Foundation for Postgraduates (2018zzts881), and the Natural Science Foundation of Hunan Province (Grant 2019JJ50359). The authors declare no conflicts of interest.	Akcilar R, 2015, INT J CLIN EXP MED, V8, P18793; Berta J, 2014, ONCOTARGET, V5, P4426, DOI 10.18632/oncotarget.2032; Brabletz T, 2012, CANCER CELL, V22, P699, DOI 10.1016/j.ccr.2012.11.009; Bulbul M, 2016, AM J PHYSIOL-GASTR L, V310, pG249, DOI 10.1152/ajpgi.00145.2015; Cai LM, 2015, ONCOGENE, V34, P2156, DOI 10.1038/onc.2014.341; Chapman NA, 2014, BIOCHEM CELL BIOL, V92, P431, DOI 10.1139/bcb-2014-0072; Chaves-Almagro C, 2015, EUR J PHARMACOL, V763, P149, DOI 10.1016/j.ejphar.2015.05.017; Chiang KC, 2016, SCI REP-UK, V6, DOI 10.1038/srep36138; Chng SC, 2013, DEV CELL, V27, P672, DOI 10.1016/j.devcel.2013.11.002; Chua MLK, 2016, LANCET, V387, P1012, DOI 10.1016/S0140-6736(15)00055-0; Cudnoch-Jedrzejewska A, 2015, CLIN EXP PHARMACOL P, V42, P52, DOI 10.1111/1440-1681.12324; Dey Biswajit, 2015, Middle East J Dig Dis, V7, P220; Fan SQ, 2006, HUM PATHOL, V37, P593, DOI 10.1016/j.humpath.2006.01.010; Hall C, 2017, CANCER LETT, V386, P179, DOI 10.1016/j.canlet.2016.11.025; Han MY, 2018, CELL PHYSIOL BIOCHEM, V50, P694, DOI 10.1159/000494236; Hwangbo C, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aad4000; Kalin RE, 2007, DEV BIOL, V305, P599, DOI 10.1016/j.ydbio.2007.03.004; Kong H, 2016, ONCOL REP, V35, P1868, DOI 10.3892/or.2015.4535; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28906-9; Lim R, 2007, INT J CANCER, V120, P2426, DOI 10.1002/ijc.22352; Lin YZ, 2018, CANCER MANAG RES, V10, P4191, DOI 10.2147/CMAR.S178219; Liu F, 2018, GENE, V676, P269, DOI 10.1016/j.gene.2018.08.060; Liu L, 2018, EXP CELL RES, V362, P532, DOI 10.1016/j.yexcr.2017.12.019; Liu WH, 2018, BIOMED PHARMACOTHER, V104, P94, DOI 10.1016/j.biopha.2018.05.015; Liu WJ, 2016, MOL MED REP, V13, P4221, DOI 10.3892/mmr.2016.5086; Lv XR, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00221; Martin N, 2014, TRENDS MOL MED, V20, P667, DOI 10.1016/j.molmed.2014.09.008; Martinez-Cuadron D, 2018, LEUKEMIA, V32, P21, DOI 10.1038/leu.2017.178; Masri Bernard, 2015, Med Sci (Paris), V31, P275, DOI 10.1051/medsci/20153103013; Murata K, 2016, J BIOL CHEM, V291, P11241, DOI 10.1074/jbc.M115.699009; Muto J, 2014, ANTICANCER RES, V34, P5313; Narayanan S, 2016, BIOORGAN MED CHEM, V24, P3758, DOI 10.1016/j.bmc.2016.06.018; Nellessen CM, 2018, ARCH GYNECOL OBSTET, V297, P281, DOI 10.1007/s00404-017-4583-6; Patrad E, 2018, CYTOTECHNOLOGY, V70, P865, DOI 10.1007/s10616-018-0199-3; Peng R, 2018, CANCER MED-US, V7, P796, DOI 10.1002/cam4.1313; Picault FX, 2014, EUR J CANCER, V50, P663, DOI 10.1016/j.ejca.2013.11.017; Salk JJ, 2010, ANNU REV PATHOL-MECH, V5, P51, DOI 10.1146/annurev-pathol-121808-102113; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Tong ZM, 2008, CANCER RES, V68, P6100, DOI 10.1158/0008-5472.CAN-08-0540; Wang JH, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-2; Watanabe M, 2009, J VET MED SCI, V71, P1413, DOI 10.1292/jvms.001413; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Xiao WW, 2011, CANCER-AM CANCER SOC, V117, P1874, DOI 10.1002/cncr.25754; Yang H, 2015, INT J SPORTS MED, V36, P535, DOI 10.1055/s-0034-1398653; Yang L, 2014, ACTA BIOCH BIOPH SIN, V46, P100, DOI 10.1093/abbs/gmt140; Yeh HW, 2018, NAT CELL BIOL, V20, P479, DOI 10.1038/s41556-018-0062-y; Zeng Z, 2016, CLIN TRANSL ONCOL, V18, P206, DOI 10.1007/s12094-015-1354-3; Zeng ZY, 2007, HUM PATHOL, V38, P120, DOI 10.1016/j.humpath.2006.06.023; Zeng ZY, 2007, J CANCER RES CLIN, V133, P71, DOI 10.1007/s00432-006-0136-2; Zhang HY, 2014, J CELL MOL MED, V18, P542, DOI 10.1111/jcmm.12208; Zhang WL, 2014, FEBS J, V281, P4815, DOI 10.1111/febs.13020; Zhang WL, 2013, J MOL HISTOL, V44, P545, DOI 10.1007/s10735-013-9503-x; Zhang WL, 2012, J MOL HISTOL, V43, P297, DOI 10.1007/s10735-012-9392-4; Zhang Y, 2012, CANCER EPIDEMIOL, V36, pE294, DOI 10.1016/j.canep.2012.05.012; Zhong JC, 2005, CARDIOVASC RES, V65, P743, DOI 10.1016/j.cardiores.2004.10.020; Zong JF, 2016, CHIN CLIN ONCOL, V5, DOI 10.21037/cco.2016.03.04	57	19	19	1	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11959	11972		10.1096/fj.201802416RR	http://dx.doi.org/10.1096/fj.201802416RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31408612				2022-12-26	WOS:000507461600029
J	Dutta, P; Islam, S; Choppara, S; Sengupta, P; Kumar, A; Kumar, A; Wani, MR; Chatterjee, S; Santra, MK				Dutta, Parul; Islam, Sehbanul; Choppara, Srinadh; Sengupta, Pallabi; Kumar, Anil; Kumar, Avinash; Wani, Mohan R.; Chatterjee, Subhrangsu; Santra, Manas Kumar			The tumor suppressor FBXO31 preserves genomic integrity by regulating DNA replication and segregation through precise control of cyclin A levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein degradation; cell cycle; DNA replication; genomic instability; tumor suppressor gene; anaphase-promoting complex; F-box protein 31 (FBXO31); LOH; MCM complex; SCF complex	MINICHROMOSOME MAINTENANCE PROTEINS; CELL-CYCLE; S-PHASE; DEGRADATION; RECOGNITION; PROTEOLYSIS; COMPLEX; STRESS; ORIGIN; ARREST	F-box protein 31 (FBXO31) is a reported putative tumor suppressor, and its inactivation due to loss of heterozygosity is associated with cancers of different origins. An emerging body of literature has documented FBXO31's role in preserving genome integrity following DNA damage and in the cell cycle. However, knowledge regarding the role of FBXO31 during normal cell-cycle progression is restricted to its functions during the G(2)/M phase. Interestingly, FBXO31 levels remain high even during the early G(1) phase, a crucial stage for preparing the cells for DNA replication. Therefore, we sought to investigate the functions of FBXO31 during the G(1) phase of the cell cycle. Here, using flow cytometric, biochemical, and immunofluorescence techniques, we show that FBXO31 is essential for maintaining optimum expression of the cell-cycle protein cyclin A for efficient cell-cycle progression. Stable FBXO31 knockdown led to atypical accumulation of cyclin A during the G(1) phase, driving premature DNA replication and compromised loading of the minichromosome maintenance complex, resulting in replication from fewer origins and DNA double-strand breaks. Because of these inherent defects in replication, FBXO31-knockdown cells were hypersensitive to replication stress-inducing agents and displayed pronounced genomic instability. Upon entering mitosis, the cells defective in DNA replication exhibited a delay in the prometaphase?to?metaphase transition and anaphase defects such as lagging and bridging chromosomes. In conclusion, our findings establish that FBXO31 plays a pivotal role in preserving genomic integrity by maintaining low cyclin A levels during the G(1) phase for faithful genome duplication and segregation.	[Dutta, Parul; Islam, Sehbanul; Choppara, Srinadh; Kumar, Anil; Kumar, Avinash; Wani, Mohan R.; Santra, Manas Kumar] Natl Ctr Cell Sci, NCCS Complex,Ganeshkhind Rd, Pune 411007, Maharashtra, India; [Dutta, Parul; Islam, Sehbanul; Choppara, Srinadh; Kumar, Anil] Savitribai Phule Pune Univ, Dept Biotechnol, Ganeshkhind Rd, Pune 411007, Maharashtra, India; [Sengupta, Pallabi; Chatterjee, Subhrangsu] Bose Inst, Dept Biophys, Kolkata 700054, India; [Kumar, Avinash] Long Isl Univ, Arnold & Marie Schwartz Coll Pharm & Hlth Sci, Brooklyn, NY 11201 USA	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Savitribai Phule Pune University; Department of Science & Technology (India); Bose Institute; Long Island University-Brooklyn Campus	Santra, MK (corresponding author), Natl Ctr Cell Sci, NCCS Complex,Ganeshkhind Rd, Pune 411007, Maharashtra, India.	manas@nccs.res.in	Kumar, Anil/AAC-9216-2022; Wani, Mohan/AAK-8516-2020; Kumar, Avinash/AAQ-9784-2021; Kumar, Anil/ABE-8362-2021	Kumar, Anil/0000-0003-2287-5388; Kumar, Avinash/0000-0001-8132-5939; Islam, Sehbanul/0000-0003-2686-2787; Dutta, Parul/0000-0003-1082-2617	University Grants Commission; DBT; CSIR; National Centre for Cell Science and Department of Biotechnology, Government of India [BT/PR6690/GBD/27/475/2012]	University Grants Commission(University Grants Commission, India); DBT(Department of Biotechnology (DBT) India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); National Centre for Cell Science and Department of Biotechnology, Government of India	This work was supported by the University Grants Commission fellowship (to P. D.), DBT fellowship (to S. I.), CSIR fellowship (to S. Ch., P. S., and A. K.), and in part by National Centre for Cell Science and Department of Biotechnology, Government of India, Grant BT/PR6690/GBD/27/475/2012. The authors declare that they have no conflicts of interest with the contents of this article.	Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Boehm EM, 2016, ENZYMES, V39, P231, DOI 10.1016/bs.enz.2016.03.003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chibazakura T, 2011, MOL CELL BIOL, V31, P248, DOI 10.1128/MCB.00630-10; Choppara S, 2018, J BIOL CHEM, V293, P16291, DOI 10.1074/jbc.RA118.005354; Choppara S, 2018, P NATL ACAD SCI USA, V115, P998, DOI 10.1073/pnas.1705954115; Coverley D, 2002, NAT CELL BIOL, V4, P523, DOI 10.1038/ncb813; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Essers J, 2005, MOL CELL BIOL, V25, P9350, DOI 10.1128/MCB.25.21.9350-9359.2005; Fung TK, 2005, CELL CYCLE, V4, P1411, DOI 10.4161/cc.4.10.2046; Furuno N, 1999, J CELL BIOL, V147, P295, DOI 10.1083/jcb.147.2.295; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Greil C, 2016, ONCOGENE, V35, P3062, DOI 10.1038/onc.2015.367; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Jeffery JM, 2017, ONCOGENE, V36, P1012, DOI 10.1038/onc.2016.268; Johansson P, 2014, J BIOL CHEM, V289, P18514, DOI 10.1074/jbc.M114.559930; Kabeche L, 2013, NATURE, V502, P110, DOI 10.1038/nature12507; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Kumar R, 2005, CANCER RES, V65, P11304, DOI 10.1158/0008-5472.CAN-05-0936; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Lambert S, 2013, CHROMOSOMA, V122, P33, DOI 10.1007/s00412-013-0398-9; Laoukili J, 2008, MOL CELL BIOL, V28, P3076, DOI 10.1128/MCB.01710-07; Li YF, 2018, P NATL ACAD SCI USA, V115, P319, DOI 10.1073/pnas.1708677115; Malonia SK, 2015, P NATL ACAD SCI USA, V112, P8632, DOI 10.1073/pnas.1510929112; Mankouri HW, 2013, EMBO J, V32, P2661, DOI 10.1038/emboj.2013.211; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Nishitani H, 2002, GENES CELLS, V7, P523, DOI 10.1046/j.1365-2443.2002.00544.x; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Podhorecka M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/920161; RESNITZKY D, 1995, MOL CELL BIOL, V15, P4347; ROSENBERG AR, 1995, ONCOGENE, V10, P1501; ROSENBLUM ML, 1975, IN VITRO CELL DEV B, V11, P264; Santra MK, 2009, NATURE, V459, P722, DOI 10.1038/nature08011; Schonenberger F, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0618-9; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Symeonidou IE, 2013, J BIOL CHEM, V288, P35852, DOI 10.1074/jbc.M113.474825; Tan YY, 2018, ONCOL LETT, V15, P4047, DOI 10.3892/ol.2018.7816; Uzbekov RE, 2004, BIOCHEMISTRY-MOSCOW+, V69, P485, DOI 10.1023/B:BIRY.0000029845.11184.30; Wheeler LW, 2008, CELL CYCLE, V7, P2179, DOI 10.4161/cc.7.14.6270; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106	43	5	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2019	294	41					14879	14895		10.1074/jbc.RA118.007055	http://dx.doi.org/10.1074/jbc.RA118.007055			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9JH	31413110	Green Published, hybrid			2022-12-26	WOS:000499253400005
J	Lang, DE; Morris, JS; Rowley, M; Torres, MA; Maksimovich, VA; Facchini, PJ; Ng, KKS				Lang, Dean E.; Morris, Jeremy S.; Rowley, Michael; Torres, Miguel A.; Maksimovich, Vook A.; Facchini, Peter J.; Ng, Kenneth K. S.			Structure-function studies of tetrahydroprotoberberine N-methyltransferase reveal the molecular basis of stereoselective substrate recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						X-ray crystallography; biosynthesis; secondary metabolism; enzyme mechanism; enzyme structure; substrate specificity; stereoselectivity; benzylisoquinoline alkaloids; morphine; N-methyltransferase; structure?function relationship	ISOQUINOLINE ALKALOIDS; CULTURED-CELLS; BIOSYNTHESIS; MECHANISM; ENZYMES; SANGUINARINE; LOCALIZATION; PAPAVERACEAE; PROTEINS; INSIGHTS	Benzylisoquinoline alkaloids (BIAs) are a structurally diverse class of plant-specialized metabolites that have been particularly well-studied in the order Ranunculales. The N-methyltransferases (NMTs) in BIA biosynthesis can be divided into three groups according to substrate specificity and amino acid sequence. Here, we report the first crystal structures of enzyme complexes from the tetrahydroprotoberberine NMT (TNMT) subclass, specifically for GfTNMT from the yellow horned poppy (Glaucium flavum). GfTNMT was co-crystallized with the cofactor S-adenosyl-L-methionine (d(min) = 1.6 angstrom), the product S-adenosyl-L-homocysteine (d(min) = 1.8 angstrom), or in complex with S-adenosyl-L-homocysteine and (S)-cis-N-methylstylopine (d(min) = 1.8 angstrom). These structures reveal for the first time how a mostly hydrophobic L-shaped substrate recognition pocket selects for the (S)-cis configuration of the two central six-membered rings in protoberberine BIA compounds. Mutagenesis studies confirm and functionally define the roles of several highly-conserved residues within and near the GfTNMT-active site. The substrate specificity of TNMT enzymes appears to arise from the arrangement of subgroup-specific stereospecific recognition elements relative to catalytic elements that are more widely-conserved among all BIA NMTs. The binding mode of protoberberine compounds to GfTNMT appears to be similar to coclaurine NMT, with the isoquinoline rings buried deepest in the binding pocket. This binding mode differs from that of pavine NMT, in which the benzyl ring is bound more deeply than the isoquinoline rings. The insights into substrate recognition and catalysis provided here form a sound basis for the rational engineering of NMT enzymes for chemoenzymatic synthesis and metabolic engineering.	[Lang, Dean E.; Morris, Jeremy S.; Rowley, Michael; Torres, Miguel A.; Maksimovich, Vook A.; Facchini, Peter J.; Ng, Kenneth K. S.] Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada; [Torres, Miguel A.] Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA	University of Calgary; Stanford University	Ng, KKS (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	ngk@ucalgary.ca		Lang, Dean/0000-0002-0272-1296; Torres, Megan/0000-0001-6126-709X; Ng, Kenneth K.S./0000-0001-7280-8445	Natural Sciences and Engineering Research Council of Canada (NSERC); National Research Council of Canada; Canadian Institutes of Health Research; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; DOE Office of Biological and Environmental Research; National Institutes of Health NIGMS Grant [P41GM103393]; National Institutes of Health NCRR Grant [P41RR001209]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health NIGMS Grant; National Institutes of Health NCRR Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Some of the X-ray diffraction data were measured at beamlines 08B-1 of the Canadian Light Source (CLS), which is supported by the Natural Sciences and Engineering Research Council of Canada (NSERC), the National Research Council of Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan. Some of the diffraction data were also measured at beamlines 12-2 and 14-1 at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the United States Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by National Institutes of Health NIGMS Grant P41GM103393 and NCRR Grant P41RR001209.	AMANN M, 1986, PLANTA, V167, P310, DOI 10.1007/BF00391333; Beaudoin GAW, 2014, PLANTA, V240, P19, DOI 10.1007/s00425-014-2056-8; Beng G. T., 2011, MALAYSIAN J ANAL SCI, V15, P54; Bennett MR, 2018, ANGEW CHEM INT EDIT, V57, P10600, DOI 10.1002/anie.201805060; Choi KB, 2002, J BIOL CHEM, V277, P830, DOI 10.1074/jbc.M106405200; Dastmalchi M, 2018, PHYTOCHEM REV, V17, P249, DOI 10.1007/s11101-017-9519-z; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Desgagne-Penix I, 2012, PLANT J, V72, P331, DOI 10.1111/j.1365-313X.2012.05084.x; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gana R, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-6; Grobe N, 2011, ARCH BIOCHEM BIOPHYS, V506, P42, DOI 10.1016/j.abb.2010.11.010; Hagel JM, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0596-0; Hagel JM, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0594-2; Hagel JM, 2013, PLANT CELL PHYSIOL, V54, P647, DOI 10.1093/pcp/pct020; Hagel JM, 2012, IN VITRO CELL DEV-PL, V48, P233, DOI 10.1007/s11627-012-9426-3; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Iwasa K, 1996, EUR J MED CHEM, V31, P469, DOI 10.1016/0223-5234(96)85167-1; Iwasa K, 1995, ALKALOIDS, V46, P273; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kamigauchi M, 2003, B CHEM SOC JPN, V76, P587, DOI 10.1246/bcsj.76.587; KAMIGAUCHI M, 1995, HELV CHIM ACTA, V78, P80, DOI 10.1002/hlca.19950780108; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kulp M, 2011, J CHROMATOGR A, V1218, P5298, DOI 10.1016/j.chroma.2011.06.016; Lee SG, 2012, J BIOL CHEM, V287, P1426, DOI 10.1074/jbc.M111.315267; Lehn, 1970, DYNAMIC STEREOCHEMIS, V15, P311, DOI DOI 10.1007/BFB0050820; Li YR, 2018, P NATL ACAD SCI USA, V115, pE3922, DOI 10.1073/pnas.1721469115; Liscombe DK, 2007, J BIOL CHEM, V282, P14741, DOI 10.1074/jbc.M611908200; Liscombe DK, 2012, NAT PROD REP, V29, P1238, DOI 10.1039/c2np20029e; Liscombe DK, 2009, PLANT J, V60, P729, DOI 10.1111/j.1365-313X.2009.03980.x; Ma ZZ, 2008, MOLECULES, V13, P2303, DOI 10.3390/molecules13092303; Marek R, 2002, MAGN RESON CHEM, V40, P687, DOI 10.1002/mrc.1084; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morris JS, 2018, J BIOL CHEM, V293, P13364, DOI 10.1074/jbc.RA118.004067; Morris JS, 2016, J BIOL CHEM, V291, P23416, DOI 10.1074/jbc.M116.750893; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Narcross L, 2016, ACS SYNTH BIOL, V5, P1505, DOI 10.1021/acssynbio.6b00119; Narcross L, 2016, TRENDS BIOTECHNOL, V34, P228, DOI 10.1016/j.tibtech.2015.12.005; Reed MC, 2010, BIOESSAYS, V32, P422, DOI 10.1002/bies.200900167; Robin AY, 2016, PLANT J, V87, P641, DOI 10.1111/tpj.13225; RUEFFER M, 1990, PHYTOCHEMISTRY, V29, P3727, DOI 10.1016/0031-9422(90)85321-6; RUEFFER M, 1986, TETRAHEDRON LETT, V27, P5603, DOI 10.1016/S0040-4039(00)85276-4; Saen-oon S, 2014, J BIOL CHEM, V289, P33815, DOI 10.1074/jbc.M114.611319; Schlager S, 2016, CURR OPIN BIOTECH, V37, P155, DOI 10.1016/j.copbio.2015.12.003; Schrodinger L.L.C.,, 2015, PYMOL MOL GRAPHICS S; Shriver J., 2009, AM J UNDERGRAD RES, V8, P2, DOI [10.33697/ajur.2009.013, DOI 10.33697/ajur.2009.013]; Shulgin A. T., 2002, SILENT WARFARE UNDER, P1; SLAVIK J, 1990, COLLECT CZECH CHEM C, V55, P1812, DOI 10.1135/cccc19901812; Slavik J, 1996, COLLECT CZECH CHEM C, V61, P1047, DOI 10.1135/cccc19961047; SLAVIK J, 1985, COLLECT CZECH CHEM C, V50, P1216, DOI 10.1135/cccc19851216; Stratton CF, 2017, ACS CHEM BIOL, V12, P342, DOI 10.1021/acschembio.6b00922; Swiderek K, 2018, J AM CHEM SOC, V140, P4327, DOI 10.1021/jacs.7b13655; TAKAO N, 1983, HELV CHIM ACTA, V66, P473, DOI 10.1002/hlca.19830660208; Takata Y, 2003, BIOCHEMISTRY-US, V42, P8394, DOI 10.1021/bi034245a; Torres MA, 2016, J BIOL CHEM, V291, P23403, DOI 10.1074/jbc.M116.747261; Wilkins MR, 1999, METH MOL B, V112, P531; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winzer T, 2012, SCIENCE, V336, P1704, DOI 10.1126/science.1220757; Zhang JY, 2016, J AM CHEM SOC, V138, P9158, DOI 10.1021/jacs.6b03462; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	60	10	10	4	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2019	294	40					14482	14498		10.1074/jbc.RA119.009214	http://dx.doi.org/10.1074/jbc.RA119.009214			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JP0II	31395658	hybrid, Green Published			2022-12-26	WOS:000497955000001
J	Lee, M; Morgan, CA; Hong, M				Lee, Myungwoon; Morgan, Chloe A.; Hong, Mei			Fully hydrophobic HIV gp41 adopts a hemifusion-like conformation in phospholipid bilayers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						solid state NMR; virus entry; fusion protein; membrane fusion; membrane structure; structural biology	SOLID-STATE NMR; MEMBRANE-PROTEIN STRUCTURE; FUSION PEPTIDE; PARAMYXOVIRUS PIV5; STRUCTURAL BASIS; SPIN-DIFFUSION; DYNAMICS; ECTODOMAIN; DOMAIN; SPECTROSCOPY	The HIV envelope glycoprotein mediates virus entry into target cells by fusing the virus lipid envelope with the cell membrane. This process requires large-scale conformational changes of the fusion protein gp41. Current understanding of the mechanisms with which gp41 induces membrane merger is limited by the fact that the hydrophobic N-terminal fusion peptide (FP) and C-terminal transmembrane domain (TMD) of the protein are challenging to characterize structurally in the lipid bilayer. Here we have expressed a gp41 construct that contains both termini, including the FP, the fusion peptide-proximal region (FPPR), the membrane-proximal external region (MPER), and the TMD. These hydrophobic domains are linked together by a shortened water-soluble ectodomain. We reconstituted this "short NC" gp41 into a virus-mimetic lipid membrane and conducted solid-state NMR experiments to probe the membrane-bound conformation and topology of the protein. C-13 chemical shifts indicate that the C-terminal MPER-TMD is predominantly alpha-helical, whereas the N-terminal FP-FPPR exhibits beta-sheet character. Water and lipid H-1 polarization transfer to the protein revealed that the TMD is well-inserted into the lipid bilayer, whereas the FPPR and MPER are exposed to the membrane surface. Importantly, correlation signals between the FP-FPPR and the MPER are observed, providing evidence that the ectodomain is sufficiently collapsed to bring the N- and C-terminal hydrophobic domains into close proximity. These results support a hemifusion-like model of the short NC gp41 in which the ectodomain forms a partially folded hairpin that places the FPPR and MPER on the opposing surfaces of two lipid membranes.	[Lee, Myungwoon; Morgan, Chloe A.; Hong, Mei] MIT, Dept Chem, 170 Albany St, Cambridge, MA 02139 USA; [Lee, Myungwoon] NIDDK, Lab Chem Phys, NIH, Bethesda, MD 20892 USA	Massachusetts Institute of Technology (MIT); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hong, M (corresponding author), MIT, Dept Chem, 170 Albany St, Cambridge, MA 02139 USA.	meihong@mit.edu		Hong, Mei/0000-0001-5255-5858	National Institutes of Health [GM066976]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066976] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM066976 (to M. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ader C, 2009, J AM CHEM SOC, V131, P170, DOI 10.1021/ja806306e; Apellaniz B, 2015, J BIOL CHEM, V290, P12999, DOI 10.1074/jbc.M115.644351; BIELECKI A, 1989, CHEM PHYS LETT, V155, P341, DOI 10.1016/0009-2614(89)87166-0; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chiliveri SC, 2018, J AM CHEM SOC, V140, P34, DOI 10.1021/jacs.7b10245; Chipot C, 2018, CHEM REV, V118, P3559, DOI 10.1021/acs.chemrev.7b00570; Dai Z, 2015, BIOCHEMISTRY-US, V54, P1589, DOI 10.1021/bi501376f; Dev J, 2016, SCIENCE, V353, P172, DOI 10.1126/science.aaf7066; Doherty T, 2009, J MAGN RESON, V196, P39, DOI 10.1016/j.jmr.2008.10.001; Donald JE, 2011, P NATL ACAD SCI USA, V108, P3958, DOI 10.1073/pnas.1019668108; FENNIE C, 1989, J VIROL, V63, P639, DOI 10.1128/JVI.63.2.639-646.1989; Gabrys CM, 2013, J PHYS CHEM A, V117, P9848, DOI 10.1021/jp312845w; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hong M, 1999, J MAGN RESON, V139, P389, DOI 10.1006/jmre.1999.1805; Hong M, 1999, J BIOMOL NMR, V14, P71, DOI 10.1023/A:1008334930603; Hong M, 1997, J MAGN RESON, V129, P85, DOI 10.1006/jmre.1997.1242; Hou GJ, 2013, J MAGN RESON, V232, P18, DOI 10.1016/j.jmr.2013.04.009; Huster D, 2002, J AM CHEM SOC, V124, P874, DOI 10.1021/ja017001r; Huster D, 2001, BIOCHEMISTRY-US, V40, P7662, DOI 10.1021/bi0027231; Kumashiro KK, 1998, J AM CHEM SOC, V120, P5043, DOI 10.1021/ja972655e; Kwon B, 2018, J AM CHEM SOC, V140, P8246, DOI 10.1021/jacs.8b04010; Lai AL, 2012, J MOL BIOL, V418, P3, DOI 10.1016/j.jmb.2012.02.010; Lakomek NA, 2014, STRUCTURE, V22, P1311, DOI 10.1016/j.str.2014.06.016; Lakomek NA, 2013, ANGEW CHEM INT EDIT, V52, P3911, DOI 10.1002/anie.201207266; Lamb RA, 2007, CURR OPIN STRUC BIOL, V17, P427, DOI 10.1016/j.sbi.2007.08.016; Li YL, 2007, BIOPHYS J, V93, P876, DOI 10.1529/biophysj.106.102335; Moulard M, 2000, BBA-REV BIOMEMBRANES, V1469, P121, DOI 10.1016/S0304-4157(00)00014-9; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Qiang W, 2008, J AM CHEM SOC, V130, P5459, DOI 10.1021/ja077302m; Qiang W, 2009, P NATL ACAD SCI USA, V106, P15314, DOI 10.1073/pnas.0907360106; Qiang W, 2009, BIOCHEMISTRY-US, V48, P289, DOI 10.1021/bi8015668; Ratnayake PU, 2015, BBA-BIOMEMBRANES, V1848, P289, DOI 10.1016/j.bbamem.2014.07.022; Reuven EM, 2012, BIOCHEMISTRY-US, V51, P2867, DOI 10.1021/bi201721r; Roche J, 2015, J BIOMOL NMR, V61, P235, DOI 10.1007/s10858-015-9900-4; Roche J, 2014, P NATL ACAD SCI USA, V111, P3425, DOI 10.1073/pnas.1401397111; Roos M, 2018, J PHYS CHEM B, V122, P9302, DOI 10.1021/acs.jpcb.8b06878; Roos M, 2018, J PHYS CHEM B, V122, P2900, DOI 10.1021/acs.jpcb.8b00310; Sackett K, 2014, J MOL BIOL, V426, P1077, DOI 10.1016/j.jmb.2013.11.010; Sackett K, 2011, EUR BIOPHYS J BIOPHY, V40, P489, DOI 10.1007/s00249-010-0662-3; Shcherbakov AA, 2019, J PHYS CHEM B, V123, P4387, DOI 10.1021/acs.jpcb.9b03812; Shcherbakov AA, 2018, J BIOMOL NMR, V71, P31, DOI 10.1007/s10858-018-0187-0; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Wang T, 2017, J AM CHEM SOC, V139, P6242, DOI 10.1021/jacs.7b02089; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Williams JK, 2014, J MAGN RESON, V247, P118, DOI 10.1016/j.jmr.2014.08.007; Yang Y, 2015, J PHYS CHEM B, V119, P4993, DOI 10.1021/acs.jpcb.5b01001; Yao HW, 2015, P NATL ACAD SCI USA, V112, P10926, DOI 10.1073/pnas.1501430112; Yao HW, 2014, J AM CHEM SOC, V136, P2611, DOI 10.1021/ja4121956; Yao HW, 2013, J MOL BIOL, V425, P563, DOI 10.1016/j.jmb.2012.11.027	49	7	7	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2019	294	40					14732	14744		10.1074/jbc.RA119.009542	http://dx.doi.org/10.1074/jbc.RA119.009542			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JP0II	31409642	Green Published, hybrid			2022-12-26	WOS:000497955000018
J	Ogura, T				Ogura, Toshihiko			Direct observation of unstained biological samples in water using newly developed impedance scanning electron microscopy	PLOS ONE			English	Article							CELLS; FREQUENCY; SPECIMENS; GROWTH; LIGHT	Nanometre-scale observation of specimens in water is indispensable in several scientific fields, such as biology, chemistry, materials science and nanotechnology. Scanning electron microscopy (SEM) obtains high-resolution images of biological samples under high vacuum conditions but requires specific sample-preparation protocols. Observations of unstained biological samples in water require more convenient and less invasive methods. Herein, we have developed a new type of impedance microscopy, namely impedance SEM (IP-SEM), which allows the imaging and sub-micrometer scale examination of various specimens in water. By varying the frequency of the input signal, the proposed system can detect the impedance properties of the sample's composition at sub-micrometer scale resolution. Besides examining various unstained biological specimens and material samples in water. Furthermore, the proposed system can be used for diverse liquid samples across a broad range of scientific fields, such as nanoparticles, nanotubes and organic and catalytic materials.	[Ogura, Toshihiko] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Cent 6, Higashi Ku, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Ogura, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Cent 6, Higashi Ku, Tsukuba, Ibaraki, Japan.	t-ogura@aist.go.jp		Ogura, Toshihiko/0000-0001-8953-6562	MEXT of Japan [17H05829]; JSPS KAKENHI [19H03230]; Japan Science and Technology Agency [18071327]	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This study was supported by a Grant-inaid for scientific research on innovative areas from the MEXT of Japan (17H05829), and JSPS KAKENHI (19H03230) and for CREST specific issues survey from the Japan Science and Technology Agency (18071327). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boverman G, 2017, IEEE T BIO-MED ENG, V64, P795, DOI 10.1109/TBME.2016.2578646; Boverman G, 2009, IEEE T BIO-MED ENG, V56, P2762, DOI 10.1109/TBME.2009.2027129; DAVEY CL, 1988, BIOELECTROCH BIOENER, V20, P83, DOI 10.1016/S0302-4598(98)80007-X; de Smit E, 2008, NATURE, V456, P222, DOI 10.1038/nature07516; Drouin D, 2007, SCANNING, V29, P92, DOI 10.1002/sca.20000; DUCKETT JG, 1995, ANN BOT-LONDON, V76, P405, DOI 10.1006/anbo.1995.1114; Fabrizi L, 2009, PHYSIOL MEAS, V30, pS103, DOI 10.1088/0967-3334/30/6/S07; Gallier S, 2010, J AGR FOOD CHEM, V58, P4250, DOI 10.1021/jf9032409; Kuang W, 1998, T ASAE, V41, P173, DOI 10.13031/2013.17142; Kulkarni R, 2009, PHYSIOL MEAS, V30, pS19, DOI 10.1088/0967-3334/30/6/S02; McMahon DJ, 2008, J DAIRY SCI, V91, P1709, DOI 10.3168/jds.2007-0819; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368; MOTTA PM, 1994, ARCH HISTOL CYTOL, V57, P369, DOI 10.1679/aohc.57.369; NAGATA F, 1972, JPN J APPL PHYS, V11, P1239, DOI 10.1143/JJAP.11.1239; Ogura T, 2017, BIOCHEM BIOPH RES CO, V491, P1021, DOI 10.1016/j.bbrc.2017.08.004; Ogura T, 2015, BIOCHEM BIOPH RES CO, V459, P521, DOI 10.1016/j.bbrc.2015.02.140; Ogura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092780; Okada T, 2016, SCI REP-UK, V6, DOI 10.1038/srep29169; PARSONS DF, 1974, SCIENCE, V186, P407, DOI 10.1126/science.186.4162.407; Quan HT, 2012, TELECOMMUN SYST, V49, P35, DOI 10.1007/s11235-010-9351-x; Sali A, 2003, NATURE, V422, P216, DOI 10.1038/nature01513; Sartori A, 2007, J STRUCT BIOL, V160, P135, DOI 10.1016/j.jsb.2007.07.011; Wang SX, 2012, HISTOCHEM CELL BIOL, V137, P703, DOI 10.1007/s00418-012-0948-x; Yuk JM, 2012, SCIENCE, V336, P61, DOI 10.1126/science.1217654	25	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0221296	10.1371/journal.pone.0221296	http://dx.doi.org/10.1371/journal.pone.0221296			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430321	Green Published, gold, Green Submitted			2022-12-26	WOS:000485026800041
J	Chen, HC; Tan, ECH; Liao, CH; Lin, ZZ; Yang, MC				Chen, Hsi-Chieh; Tan, Elise Chia-Hui; Liao, Chih-Hsien; Lin, Zhong-Zhe; Yang, Ming-Chin			Development and validation of nomograms for predicting survival probability of patients with advanced adenocarcinoma in different EGFR mutation status	PLOS ONE			English	Article							CELL-LUNG-CANCER; PROGNOSTIC MODEL; CHEMOTHERAPY; ERLOTINIB; OUTCOMES; GEFITINIB; MORTALITY; NUMBER	Introduction Molecular markers are important variables in the selection of treatment for cancer patients and highly associated with their survival. Therefore, a nomogram that can predict survival probability by incorporating epidermal growth factor receptor mutation status and treatments for patients with advanced adenocarcinoma would be highly valuable. The aim of the study is to develop and validate a novel nomogram, incorporating epidermal growth factor receptor mutation status and treatments, for predicting 1-year and 2-year survival probability of patients with advanced adenocarcinoma. Material and methods Data on 13,043 patients between June 1, 2011, and December 31, 2014 were collected. Seventy percent of them were randomly assigned to the training cohort for nomogram development, and the remaining 30% assigned to the validation cohort. The most important factors for constructing the nomogram were identified using multivariable Cox regression analysis. The discriminative ability and calibration of the nomograms were tested using C-statistics, calibration plots, and Kaplan-Meier curves. Results In the training cohort, 1-year and 2-year OS were 52.8% and 28.5% in EGFR(-) patients, and 73.9% and 44.1% in EGFR(+) patients, respectively. In EGFR(+) group, factors selected were age, gender, congestive heart failure, renal disease, number of lymph node examined, tumor stage, surgical intervention, radiotherapy, first-line chemotherapy, ECOG performance status, malignant pleural effusion, and smoking. In EGFR(-) group, factors selected were age, gender, myocardial infarction, cerebrovascular disease, chronic pulmonary disease, number of lymph node examined, tumor stage, surgical intervention, radiotherapy, ECOG performance status, malignant pleural effusion, and a history of smoking. Two nomograms show good accuracy in predicting OS, with a concordance index of 0.83 in EGFR(+) and of 0.88 in EGFR(-). Conclusions The survival prediction models can be used to make individualized predictions with different EGFR mutation status and a useful tool for selecting regimens for treating advanced adenocarcinoma.	[Chen, Hsi-Chieh; Yang, Ming-Chin] Natl Taiwan Univ, Inst Hlth Policy & Management, Coll Publ Hlth, Taipei, Taiwan; [Tan, Elise Chia-Hui] Minist Hlth & Welf, Natl Res Inst Chinese Med, Taipei, Taiwan; [Tan, Elise Chia-Hui] Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Taipei, Taiwan; [Liao, Chih-Hsien] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Lin, Zhong-Zhe] Natl Taiwan Univ, Natl Canc, Dept Oncol, Taipei, Taiwan; [Lin, Zhong-Zhe] Natl Taiwan Univ, Dept Internal Med, Coll Med, Taipei, Taiwan	National Taiwan University; National Research Institute of Chinese Medicine; National Yang Ming Chiao Tung University; Taipei Medical University; National Taiwan University; National Taiwan University	Yang, MC (corresponding author), Natl Taiwan Univ, Inst Hlth Policy & Management, Coll Publ Hlth, Taipei, Taiwan.	mcyang637@ntu.edu.tw		YANG, MING-CHIN/0000-0001-7326-8671; Tan, Elise (Chia-Hui)/0000-0002-8115-3011	Taiwan Ministry of Science and Technology [MOST 105-2410-H-002-215]	Taiwan Ministry of Science and Technology	This study was supported by the Taiwan Ministry of Science and Technology (Grant No: MOST 105-2410-H-002-215 to M-CY). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P. D., 1995, SURVIVAL ANAL USING; American Cancer Society, WHAT IS NONSM CELL L; American Cancer Society, 2016, CANC FACTS FIG; Bilimoria KY, 2008, CANCER, V113, P3130, DOI 10.1002/cncr.23886; Carbone DP, 2011, CLIN LUNG CANCER, V12, P261, DOI 10.1016/j.cllc.2011.06.002; Chiang CJ, 2019, J FORMOS MED ASSOC, V118, P856, DOI 10.1016/j.jfma.2019.01.012; Dehing-Oberije C, 2011, INT J RADIAT ONCOL, V81, P360, DOI 10.1016/j.ijrobp.2010.06.011; Dehing-Oberije C, 2009, INT J RADIAT ONCOL, V74, P355, DOI 10.1016/j.ijrobp.2008.08.052; Ettinger DS, 2010, J NATL COMPR CANC NE, V8, P740, DOI 10.6004/jnccn.2010.0056; Florescu M, 2008, J THORAC ONCOL, V3, P590, DOI 10.1097/JTO.0b013e3181729299; Gajra A, 2003, J CLIN ONCOL, V21, P1029, DOI 10.1200/JCO.2003.07.010; Giaccone G, 2005, J CLIN ONCOL, V23, P3235, DOI 10.1200/JCO.2005.08.409; Girard N, 2012, EUR RESPIR J, V39, P366, DOI 10.1183/09031936.00010111; Goldstraw P, 2011, LANCET, V378, P1727, DOI 10.1016/S0140-6736(10)62101-0; Gore EM, 2011, J CLIN ONCOL, V29, P272, DOI 10.1200/JCO.2010.29.1609; Harrell FE, 2001, REGRESSION MODELING; Hoang T, 2005, J CLIN ONCOL, V23, P175, DOI 10.1200/JCO.2005.04.177; Iasonos A, 2008, J CLIN ONCOL, V26, P1364, DOI 10.1200/JCO.2007.12.9791; Janne PA, 2004, LUNG CANCER-J IASLC, V44, P221, DOI 10.1016/j.lungcan.2003.12.014; Keam B, 2014, CANCER RES TREAT, V46, P323, DOI 10.4143/crt.2013.120; Kim S, 2010, J THORAC ONCOL, V5, pS400; Li CT, 2011, J CANCER, V2, P52, DOI 10.7150/jca.2.52; Liang WH, 2015, J CLIN ONCOL, V33, P861, DOI 10.1200/JCO.2014.56.6661; Lilenbaum R, 2008, J CLIN ONCOL, V26, P863, DOI 10.1200/JCO.2007.13.2720; Lin J, 2015, J THORAC ONCOL, V10, P1694, DOI 10.1097/JTO.0000000000000691; Lughezzani G, 2010, EUR J CANCER, V46, P713, DOI 10.1016/j.ejca.2009.12.007; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mo HN, 2016, CANCER MED-US, V5, P1116, DOI 10.1002/cam4.689; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Oberije C, 2015, INT J RADIAT ONCOL, V92, P935, DOI 10.1016/j.ijrobp.2015.02.048; Osarogiagbon RU, 2014, ANN THORAC SURG, V97, P385, DOI 10.1016/j.athoracsur.2013.09.058; Park MJ, 2009, CANCER-AM CANCER SOC, V115, P1518, DOI 10.1002/cncr.24151; Putila J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100994; Radosavljevic DZ, 2011, J CLIN ONCOL, V29; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Smith Tyler, 2003, SURVIVAL ANAL USING, P254; Sobin LHGM., 2009, TNM CLASSIFICATION M, V7th; Hoang T, 2012, J THORAC ONCOL, V7, P1361, DOI 10.1097/JTO.0b013e318260e106; Yang JCH, 2012, LANCET ONCOL, V13, P539, DOI 10.1016/S1470-2045(12)70086-4; Yang P, 2005, CHEST, V128, P452, DOI 10.1378/chest.128.1.452; Zhang JJ, 2015, J THORAC ONCOL, V10, P682, DOI 10.1097/JTO.0000000000000456; Zhang J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1398-3; Zhang KJ, 2015, INT J CANCER, V136, P382, DOI 10.1002/ijc.28995; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	44	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2019	14	8							e0220730	10.1371/journal.pone.0220730	http://dx.doi.org/10.1371/journal.pone.0220730			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5LL	31419239	Green Published, Green Submitted, gold			2022-12-26	WOS:000485019900015
J	Bi, CJ; Yang, JM; Sun, J; Song, Y; Wu, XY; Zhang, F				Bi, Cunjian; Yang, Junmin; Sun, Jian; Song, Yi; Wu, Xiaoyan; Zhang, Feng			Benefits of normal body mass index on physical fitness: A cross-sectional study among children and adolescents in Xinjiang Uyghur Autonomous Region, China	PLOS ONE			English	Article							ETHNICALLY DIVERSE SAMPLE; CARDIORESPIRATORY FITNESS; BMI; PREVALENCE; ENDURANCE; OBESITY; YOUTH	Objective To assess the association between body mass index (BMI) and physical fitness index (PFI) among children and adolescents in Xinjiang Uyghur Autonomous Region, China. Methods In total, 17,618 children and adolescents aged 7-18 years from the selected region were enrolled in this cross-sectional study (8,800 boys and 8,818 girls). Participants were stratified by age and sex and divided into five groups by BMI percentiles: very low (BMI < 5th percentile); low, (5th <= BMI < 15th percentile); normal (15th <= BMI < 85th percentile); high (85th <= BMI < 95th percentile); and very high (BMI >= 95th percentile). PFI was assessed by height, weight, and five health-related fitness indicators (grip strength, standing long jump, sit and reach, 50 m dash, and endurance run). Results BMI was significantly associated with PFI during adolescence (13-18 years) in boys and pre-adolescence (7-12 years) in girls. Between the ages of 13 and 18 years, an increase in BMI had a greater impact on PFI in boys than girls. PFI showed a parabolic curvilinear relationship with BMI. Conclusion Children and adolescents in China's Xinjiang Uyghur Autonomous Region with a normal BMI demonstrated good physical fitness. A BMI below or above the normal range may contribute to poor physical fitness. The relationship between BMI and PFI shows an inverted U-shaped curve.	[Bi, Cunjian; Zhang, Feng] East China Normal Univ, Sch Phys Educ & Hlth, Shanghai, Peoples R China; [Yang, Junmin] Xihua Univ, Sch Phys Educ, Chengdu, Sichuan, Peoples R China; [Sun, Jian] Xinjiang Normal Univ, Inst Phys Educ, Urumqi, Peoples R China; [Song, Yi] Peking Univ, Inst Child & Adolescent Hlth, Beijing, Peoples R China; [Song, Yi] Peking Univ, Sch Publ Hlth, Beijing, Peoples R China; [Wu, Xiaoyan] Anhui Med Univ, Sch Publ Hlth, Dept Maternal Child & Adolescent Hlth, Hefei, Anhui, Peoples R China	East China Normal University; Xihua University; Xinjiang Normal University; Peking University; Peking University; Anhui Medical University	Zhang, F (corresponding author), East China Normal Univ, Sch Phys Educ & Hlth, Shanghai, Peoples R China.	zhangfengjiemei@163.com		Zhang, Feng/0000-0001-7566-1477	National Social Science Fund of China [18BTY107]	National Social Science Fund of China	This work was supported by the National Social Science Fund of China, grant number 18BTY107. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MD, 2017, COGENT PSYCHOL, V4, DOI 10.1080/23311908.2017.1331602; Association CNSSCH, 2016, REP 2014 NAT SURV ST; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Beets MW, 2005, RES Q EXERCISE SPORT, V76, P389; Beets MW, 2004, MED SCI SPORT EXER, V36, P1796, DOI 10.1249/01.MSS.0000142309.29139.22; Burns RD, 2017, AM J HEALTH EDUC, V48, P32, DOI 10.1080/19325037.2016.1250689; Carnethon MR, 2005, JAMA-J AM MED ASSOC, V294, P2981, DOI 10.1001/jama.294.23.2981; Chaddock L, 2012, MED SCI SPORT EXER, V44, P749, DOI 10.1249/MSS.0b013e31823a90cb; Cochrane T, 2015, PREV MED, V81, P433, DOI 10.1016/j.ypmed.2015.10.013; Cohen J, 1988, PERCEPT MOTOR SKILL, V67, P1007; Cottrell LA, 2007, OBESITY, V15, P3170, DOI 10.1038/oby.2007.377; Donnelly JE, 2016, MED SCI SPORT EXER, V48, P1223, DOI 10.1249/MSS.0000000000000966; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Fang Q, 2012, J HYGIENE RES, V41, P4; Frey GC, 2006, INT J OBESITY, V30, P861, DOI 10.1038/sj.ijo.0803196; Graff M, 2013, CIRCULATION, V127; Huang YC, 2007, MED SCI SPORT EXER, V39, P701, DOI 10.1249/mss.0b013e31802f0512; Kwiecinski J, 2018, ANN HUM BIOL, V45, P406, DOI 10.1080/03014460.2018.1494306; LaVigne T, 2016, J CLIN SPORT PSYCHOL, V10, P32, DOI 10.1123/jcsp.2014-0053; Li M, 2017, CHINESE J SCH HLTH, V38, P4; Li YP, 2008, ASIA PAC J CLIN NUTR, V17, P131; Liu Y, 2016, J PHYS ACT HEALTH, V13, pS124, DOI 10.1123/jpah.2016-0362; Lu YJ, 2014, INT J CLIN EXP MED, V7, P3630; Mak KK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-88; Malina RM, 1998, MED SPORT SCI, V43, P13; Mota J, 2006, AM J HUM BIOL, V18, P335, DOI 10.1002/ajhb.20513; Niederer I, 2012, RES Q EXERCISE SPORT, V83, P12, DOI 10.1080/02701367.2012.10599820; Qi LT, 2006, CHINESE J REHABILITA, V12, P1106; Ribeiro JC, 2003, J HUM MOVEMENT STUD, V45, P257; Sanz B, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00627; Sekulic D, 2005, COLLEGIUM ANTROPOL, V29, P723; Shang XW, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/515414; Shenzhen Statistics Bureau, 2021, SHENZH 7 NAT POP CEN; Xie LL, 2014, ZHEJIANG SPORT SCI, V36; Xu SH, 2008, AM J HUM GENET, V82, P883, DOI 10.1016/j.ajhg.2008.01.017	35	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220863	10.1371/journal.pone.0220863	http://dx.doi.org/10.1371/journal.pone.0220863			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415603	Green Published, gold, Green Submitted			2022-12-26	WOS:000485017200041
J	Coulon, M; Schurr, F; Martel, AC; Cougoule, N; Begaud, A; Mangoni, P; Di Prisco, G; Dalmon, A; Alaux, C; Ribiere-Chabert, M; Le Conte, Y; Thiery, R; Dubois, E				Coulon, Marianne; Schurr, Frank; Martel, Anne-Claire; Cougoule, Nicolas; Begaud, Adrien; Mangoni, Patrick; Di Prisco, Gennaro; Dalmon, Anne; Alaux, Cedric; Ribiere-Chabert, Magali; Le Conte, Yves; Thiery, Richard; Dubois, Eric			Influence of chronic exposure to thiamethoxam and chronic bee paralysis virus on winter honey bees	PLOS ONE			English	Article							APIS-MELLIFERA L.; NEONICOTINOID INSECTICIDES; PESTICIDE-RESIDUES; CBPV GENOME; DETOXIFICATION; CLOTHIANIDIN; HYMENOPTERA; TOXICITY; APIARIES; PATHOGEN	Co-exposure to pesticides and viruses is likely to occur in honey bee colonies. Pesticides can be present in pollen, nectar, and persist in stored food (honey and bee bread), and viruses can be highly prevalent in honey bee colonies. Therefore, the present study describes the influence of chronic co-exposure to thiamethoxam and Chronic bee paralysis virus (CBPV) on bee survival, virus loads, expression level of immune and detoxication genes, and pesticide metabolism Experiments were performed on honey bees collected from a winter apiary with reduced viral contaminations. No synergistic effect of co-exposure was observed on bee survival, nor on the ability of bees to metabolise the pesticide into clothianidin. However, we found that co-exposure caused an increase in CBPV loads that reached the viral levels usually found in overt infections. The effect of co-exposure on CBPV replication was associated with down-regulation of vitellogenin and dorsal-1a gene transcription. Nevertheless, the observed effects might be different to those occurring in spring or summer bees, which are more likelyco-exposed to thiamethoxam and CBPV and exhibit a different physiology.	[Coulon, Marianne; Schurr, Frank; Martel, Anne-Claire; Cougoule, Nicolas; Begaud, Adrien; Mangoni, Patrick; Ribiere-Chabert, Magali; Thiery, Richard; Dubois, Eric] ANSES Sophia Antipolis, Unit Honey Bee Pathol, Sophia Antipolis, France; [Coulon, Marianne; Dalmon, Anne; Alaux, Cedric; Le Conte, Yves] INRA, PACA, UR Abeilles & Environm 406, Avignon, France; [Di Prisco, Gennaro] Univ Napoli Federico II, Dept Agr, Naples, Italy; [Di Prisco, Gennaro] Council Agr Res & Econ, CREA, Res Ctr Agr & Environm, Bologna, Italy	INRAE; University of Naples Federico II; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA)	Dubois, E (corresponding author), ANSES Sophia Antipolis, Unit Honey Bee Pathol, Sophia Antipolis, France.	eric.dubois@anses.fr	Di Prisco, Gennaro/AGY-3511-2022; Le Conte, Yves/AAP-2379-2021; Le Conte, Yves/M-4442-2018; Alaux, Cedric/B-4667-2013; DALMON, Anne BONJOUR/K-1386-2019; Thiery, Richard/GRR-1496-2022	Le Conte, Yves/0000-0002-8466-5370; Le Conte, Yves/0000-0002-8466-5370; Alaux, Cedric/0000-0002-3045-2599; DALMON, Anne BONJOUR/0000-0001-5044-4724; Thiery, Richard/0000-0003-2049-918X; Dubois, Eric/0000-0003-1035-2782	ANSES; INRA/ANSES scholarship	ANSES; INRA/ANSES scholarship	This project was funded and supported by ANSES via the tax on sales of plant protection products. The proceeds of this tax are assigned to ANSES to finance the establishment of the system for monitoring the adverse effects of plant protection products, called `phytopharmacovigilance' (PPV), established by the French Act on the future of agriculture of 13 October 2014. MC was co-funded by an INRA/ANSES scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike T, 2001, REV MED VIROL, V11, P87, DOI 10.1002/rmv.303; Alaux Cedric, 2010, Biol Lett, V6, P562, DOI 10.1098/rsbl.2009.0986; Aliouane Y, 2009, ENVIRON TOXICOL CHEM, V28, P113, DOI 10.1897/08-110.1; Amdam G V., 2004, ALTERED PHYSL WORKER, DOI [10.1603/0022-0493(2004)097, DOI 10.1603/0022-0493(2004)097]; Amdam GV, 2004, EXP GERONTOL, V39, P767, DOI 10.1016/j.exger.2004.02.010; Amdam GV, 2002, J THEOR BIOL, V216, P209, DOI 10.1006/jtbi.2002.2545; Aubert M, 2008, VIROLOGY AND THE HON; Aufauvre J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00326; BAILEY L, 1963, VIROLOGY, V21, P390, DOI 10.1016/0042-6822(63)90200-9; Bailey L, 2013, J APICULT RES, V52, DOI [10.3896/IBRA.1.52.1.13, DOI 10.3896/IBRA.1.52.1.13]; Barganska Z, 2013, FOOD CONTROL, V31, P196, DOI 10.1016/j.foodcont.2012.09.049; Behrends A, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00015; Berenbaum MR, 2015, CURR OPIN INSECT SCI, V10, P51, DOI 10.1016/j.cois.2015.03.005; Berenyi O, 2006, APPL ENVIRON MICROB, V72, P2414, DOI 10.1128/AEM.72.4.2414-2420.2006; Blanchard P, 2007, J VIROL METHODS, V141, P7, DOI 10.1016/j.jviromet.2006.11.021; Bland JM, 2004, BRIT MED J, V328, P1073, DOI 10.1136/bmj.328.7447.1073; Boncristiani H, 2012, J INSECT PHYSIOL, V58, P613, DOI 10.1016/j.jinsphys.2011.12.011; Boncristiani HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073429; Bordier C, 2017, J INSECT PHYSIOL, V98, P47, DOI 10.1016/j.jinsphys.2016.11.013; Botias C, 2015, ENVIRON SCI TECHNOL, V49, P12731, DOI 10.1021/acs.est.5b03459; Brandt A, 2016, J INSECT PHYSIOL, V86, P40, DOI 10.1016/j.jinsphys.2016.01.001; Brutscher LM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005757; Brutscher LM, 2015, CURR OPIN INSECT SCI, V10, P71, DOI 10.1016/j.cois.2015.04.016; Bull JC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003083; CALABRESE EJ, 1989, PHARMACOL THERAPEUT, V44, P297, DOI 10.1016/0163-7258(89)90069-7; Catae AF, 2014, MICROSC RES TECHNIQ, V77, P274, DOI 10.1002/jemt.22339; Celle O, 2008, VIRUS RES, V133, P280, DOI 10.1016/j.virusres.2007.12.011; Chauzat MP, 2016, APIDOLOGIE, V47, P348, DOI 10.1007/s13592-016-0440-z; Chauzat MP, 2011, ENVIRON TOXICOL CHEM, V30, P103, DOI 10.1002/etc.361; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Chen YP, 2007, ADV VIRUS RES, V70, P33, DOI 10.1016/S0065-3527(07)70002-7; Chen YP, 2006, J INVERTEBR PATHOL, V92, P152, DOI 10.1016/j.jip.2006.03.010; Chevin A, 2012, VIRUS RES, V167, P173, DOI 10.1016/j.virusres.2012.04.012; Cohen J, 1992, CURRENT DIRECTIONS P, V1, P98, DOI DOI 10.1111/1467-8721.EP10768783; Coulon M, 2018, PESTIC BIOCHEM PHYS, V144, P10, DOI 10.1016/j.pestbp.2017.10.009; Cutler GC, 2015, PEST MANAG SCI, V71, P1368, DOI 10.1002/ps.4042; Dainat B, 2012, APPL ENVIRON MICROB, V78, P981, DOI 10.1128/AEM.06537-11; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; Decourtye A, 2003, PEST MANAG SCI, V59, P269, DOI 10.1002/ps.631; Di Prisco G, 2016, P NATL ACAD SCI USA, V113, P3203, DOI 10.1073/pnas.1523515113; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; Doublet V, 2015, ENVIRON MICROBIOL, V17, P969, DOI 10.1111/1462-2920.12426; du Rand EE, 2017, J INSECT PHYSIOL, V98, P14, DOI 10.1016/j.jinsphys.2016.10.017; Efron B., 1988, LOGISTIC REGRESSION; Erban T, 2013, APIDOLOGIE, V44, P404, DOI 10.1007/s13592-012-0190-5; Evans JD, 2010, J INVERTEBR PATHOL, V103, pS62, DOI 10.1016/j.jip.2009.06.019; Forgach P, 2008, J INVERTEBR PATHOL, V98, P235, DOI 10.1016/j.jip.2007.11.002; Fries I, 2001, APIDOLOGIE, V32, P199, DOI 10.1051/apido:2001122; Garrido-Bailon E, 2010, SPAN J AGRIC RES, V8, P658, DOI 10.5424/sjar/2010083-1262; Genersch E, 2010, VET RES, V41, DOI 10.1051/vetres/2010027; Gisder S, 2015, VIRUSES-BASEL, V7, P5603, DOI 10.3390/v7102885; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Highfield AC, 2009, APPL ENVIRON MICROB, V75, P7212, DOI 10.1128/AEM.02227-09; Jefferson JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054097; JOHANSEN CA, 1977, ANNU REV ENTOMOL, V22, P177, DOI 10.1146/annurev.en.22.010177.001141; Kessler SC, 2015, NATURE, V521, P74, DOI 10.1038/nature14414; Koywiwattrakul P, 2005, APIS MELLIFERA, V5, P1, DOI DOI 10.1673/1536-2442; Laurent M, 2015, EPILOBEE A PAN EUROP; Laurino D, 2013, B INSECTOL, V66, P119; Laurino D, 2011, B INSECTOL, V64, P107; Makela P, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3129; Manjon C, 2018, CURR BIOL, V28, P1137, DOI 10.1016/j.cub.2018.02.045; Mao WF, 2011, P NATL ACAD SCI USA, V108, P12657, DOI 10.1073/pnas.1109535108; Martel AC, 2011, INT J ENVIRON AN CH, V91, P978, DOI 10.1080/03067310903524822; MCVAY JR, 1977, J INVERTEBR PATHOL, V29, P367, DOI 10.1016/S0022-2011(77)80045-1; Mullin CA, 2010, ABSTR PAP AM CHEM S, P239; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Nauen R, 2003, PESTIC BIOCHEM PHYS, V76, P55, DOI 10.1016/S0048-3575(03)00065-8; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Oliveira RA, 2014, ENVIRON TOXICOL, V29, P1122, DOI 10.1002/tox.21842; Olivier V, 2008, J VIROL METHODS, V153, P232, DOI 10.1016/j.jviromet.2008.06.027; PAIN JANINE, 1966, ANN ABEILLE [PARIS], V9, P71, DOI 10.1051/apido:19660106; PEPE MS, 1989, BIOMETRICS, V45, P497, DOI 10.2307/2531492; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; RAND EE, 2015, SCI REP, V5, P11779, DOI DOI 10.1038/SREP11779; Reim T, 2015, SUITABILITY 3 COMMON, DOI [10.1007/s13592-012-0184-3, DOI 10.1007/S13592-012-0184-3]; Ribiere M, 2010, J INVERTEBR PATHOL, V103, pS120, DOI 10.1016/j.jip.2009.06.013; Rinkevich FD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139841; Sanchez-Bayo F, 2016, ENVIRON INT, V89-90, P7, DOI 10.1016/j.envint.2016.01.009; Schurr F, 2019, J VIROL METHODS, V270, P70, DOI 10.1016/j.jviromet.2019.04.020; Schurr F, 2017, J VIROL METHODS, V248, P217, DOI 10.1016/j.jviromet.2017.07.013; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Simon-Delso N, 2015, ENVIRON SCI POLLUT R, V22, P5, DOI 10.1007/s11356-014-3470-y; Simon-Delso N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103073; Simone M, 2016, RESIN COLLECTION SOC, V63, P3016, DOI [10.1111/j.l558-5646.2009.00772.x, DOI 10.1111/J.L558-5646.2009.00772.X]; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; SMIRLE MJ, 1987, J ECON ENTOMOL, V80, P5, DOI 10.1093/jee/80.1.5; Suchail S, 2001, ENVIRON TOXICOL CHEM, V20, P2482, DOI [10.1002/etc.5620201113, 10.1897/1551-5028(2001)020&lt;2482:DBAACT&gt;2.0.CO;2]; Tentcheva D, 2004, APPL ENVIRON MICROB, V70, P7185, DOI 10.1128/AEM.70.12.7185-7191.2004; van der Sluijs JP, 2013, CURR OPIN ENV SUST, V5, P293, DOI 10.1016/j.cosust.2013.05.007; WAHL O, 1983, OECOLOGIA, V59, P106, DOI 10.1007/BF00388082; Youssef I, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/423493	93	15	15	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220703	10.1371/journal.pone.0220703	http://dx.doi.org/10.1371/journal.pone.0220703			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415597	Green Published, gold, Green Submitted			2022-12-26	WOS:000485017200025
J	Cukor, J; Vacek, Z; Linda, R; Sharma, RP; Vacek, S				Cukor, Jan; Vacek, Zdenek; Linda, Rostislav; Sharma, Ram Prasad; Vacek, Stanislav			Afforested farmland vs. forestland: Effects of bark stripping by Cervus elaphus and climate on production potential and structure of Picea abies forests	PLOS ONE			English	Article							FORMER AGRICULTURAL LAND; NORTH TEMPERATE FORESTS; SITKA SPRUCE FOREST; NORWAY SPRUCE; RED DEER; L. KARST.; ARABLE LAND; STEREUM-SANGUINOLENTUM; SPECIES COMPOSITION; WESTERN SCOTLAND	The aim of this study was to evaluate (1) effects of bark stripping and climatic factors on radial growth of Picea abies /L./ Karst., (2) production and structural differences between stands established on the forestland and abandoned farmland (afforested farmland-hence-forth, farmland), and (3) interaction among the losses caused by ungulate damages, production, diversity, and soil types. Data acquired from four permanent research plots (PRPs) located on the forestland and eight PRPs on the farmland were used. A number of tree- and stand-level models, stand structural indices, tree-rings, and climate characteristics were analysed to evaluate the hypotheses. The results show significantly higher means of DBH, tree height and basal area on the forestland compared to those on the farmland. There was a larger mean standing stem volume on the forestland (466 m(3) ha(-1)) compared to farmland (770 m(3) ha(-1)). Significant difference was observed between the mean DBH and mean stem volume of healthy trees compared to those of the trees with substantial damage (girth damage > 1/3 of stem circumference). A greater extent of the girth damage was found on 86% trees on the farmland, while 54% damage on the forestland. About 62% bark-strip damage was further deteriorated by rot infection on the farmland, while on the forestland such an infection was only for 39% trees. The precipitation significantly positively affected the radial growth of trees that were largely affected by ungulate damages on the farmland.	[Cukor, Jan; Vacek, Zdenek; Linda, Rostislav; Sharma, Ram Prasad; Vacek, Stanislav] Czech Univ Life Sci Prague, Fac Forestry & Wood Sci, Prague, Czech Republic; [Cukor, Jan] Forestry & Game Management Res Inst, Stmady, Jiloviste, Czech Republic	Czech University of Life Sciences Prague; Forestry & Game Management Research Institute	Linda, R (corresponding author), Czech Univ Life Sci Prague, Fac Forestry & Wood Sci, Prague, Czech Republic.	lindar@fld.czu.cz	Vacek, Zdeněk/AAC-9576-2021; Sharma, Ram P./E-5776-2019; Cukor, Jan/ABC-5008-2021; Cukor, Jan/AAB-1311-2019	Vacek, Zdeněk/0000-0002-7269-4174; Sharma, Ram P./0000-0002-8623-6211; Cukor, Jan/0000-0002-0003-3174; Vacek, Stanislav/0000-0002-5234-1881	Czech University of Life Sciences Prague, Faculty of Forestry and Wood Sciences [B_19_05]; Ministry of Agriculture of the Czech Republic [NAZV QK1910232]	Czech University of Life Sciences Prague, Faculty of Forestry and Wood Sciences; Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	This study was funded by the Czech University of Life Sciences Prague, Faculty of Forestry and Wood Sciences (Excellent Output 2019 and IGA no. B_19_05) and Ministry of Agriculture of the Czech Republic (NAZV QK1910232).	Ahlen I., 1965, Viltrevy, V3, P89; Allikmae E, 2017, FORESTS, V8, DOI 10.3390/f8070223; ALRIKSSON A, 1995, PLANT SOIL, V168, P103, DOI 10.1007/BF00029319; Andreassen K, 2006, FOREST ECOL MANAG, V222, P211, DOI 10.1016/j.foreco.2005.10.029; Armolaitis K, 2007, BALT FOR, V13, P169; Baltzinger M, 2016, BASIC APPL ECOL, V17, P552, DOI 10.1016/j.baae.2016.04.005; Bazil J., 2003, EUROPEAN COMMISSION; Biasi R, 2017, AGROFOREST SYST, V91, P1199, DOI 10.1007/s10457-016-0006-0; Bila Karolina, 2016, European Journal of Environmental Sciences, V6, P108; Biondi F, 2004, COMPUT GEOSCI-UK, V30, P303, DOI 10.1016/j.cageo.2003.11.004; Books P. C. E, 1948, BELL SYST TECH J, V27, P1119; Bosela M, 2016, AGR FOREST METEOROL, V222, P21, DOI 10.1016/j.agrformet.2016.03.005; Brazdil R, 2018, AGR FOREST METEOROL, V250, P47, DOI 10.1016/j.agrformet.2017.11.036; Cadenasso ML, 2000, J ECOL, V88, P31, DOI 10.1046/j.1365-2745.2000.00423.x; Cermak P., 2007, Journal of Forest Science (Prague), V53, P567, DOI 10.17221/2164-JFS; Cermak P., 2004, Acta Universitatis Agriculturae et Silviculturae Mendelianae Brunensis, V52, P165; Cermak P, 2011, FOLIA BOHEM, V20, P80; Cermak P, 2003, LOUPANI A NASLEDNE H, P24; Cermak P, 2005, ROT CAUSED BY STEREU, P2; Cerny A., 1995, SKODY ZPUSOBENE NA S, P99; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; Coulson T, 1997, ECOLOGY, V78, P852, DOI 10.1890/0012-9658(1997)078[0852:PSLDAC]2.0.CO;2; Cukor J, 2017, ZPRAVY LESN VYZKUMU, V2017, P288; Cukor Jan, 2017, Journal of Forest Science (Prague), V63, P1, DOI [10.17221/27/2016-jfs, 10.17221/27/2016-JFS]; Deer R, 2008, SILVA FENNICA, V42, P125; Ding H, 2017, PLANT BIOLOGY, V19, P709, DOI 10.1111/plb.12596; Domanski S., 1996, FOLIA FOR POLLONICA, V12, P157; Dusek D, 2009, REP FOR RES, V54, P12; Dvorak Z, 2016, ZPRAVY LESN VYZKUMU, V61, P298; Eckmullner O, 1985, AUSTRIAN J FOR SCI, V102, P190; Eidmann F. E., 1952, Forstarchiv, V23, P65; ELATTA HA, 1987, FORESTRY, V60, P101, DOI 10.1093/forestry/60.1.101; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; European Commission, 2013, COM 2013 659 FINAL; Fabrika M, 2003, LESN CASOPIS FOR J, V49; Falkengren-Grerup U, 2006, FOREST ECOL MANAG, V225, P74, DOI 10.1016/j.foreco.2005.12.027; Fanta B, 1983, POSKOZENI LESNICH PO, P55; FAO, 2008, FIGHTING FOOD INFLAT, P49; Forest Europe, 2015, STATE OF EUROPES FOR, DOI [10.1007/s00424-012-1133-8, DOI 10.1007/S00424-012-1133-8]; Forest Europe, 2011, STATE OF EUROPES FOR, DOI [10.1016/j.beproc.2012.10.011, DOI 10.1016/J.BEPROC.2012.10.011]; Fuchs R, 2015, APPL GEOGR, V59, P43, DOI 10.1016/j.apgeog.2015.02.013; Fuldner K., 1995, Forstarchiv, V66, P235; Gill R, 2000, THE ECONOMIC IMPLICA; GILL RMA, 1992, FORESTRY, V65, P145, DOI 10.1093/forestry/65.2.145; GILL RMA, 1992, FORESTRY, V65, P363, DOI 10.1093/forestry/65.4.363-a; Gobiet A, 2014, SCI TOTAL ENVIRON, V493, P1138, DOI 10.1016/j.scitotenv.2013.07.050; Goldewijk KK, 2001, GLOBAL BIOGEOCHEM CY, V15, P417, DOI 10.1029/1999GB001232; GrissinoMayer HD, 1997, HOLOCENE, V7, P235, DOI 10.1177/095968369700700212; Hagen R, 2014, SCI TOTAL ENVIRON, V468, P140, DOI 10.1016/j.scitotenv.2013.08.022; Hagen-Thorn A, 2004, FOREST ECOL MANAG, V195, P373, DOI 10.1016/j.foreco.2004.02.036; Haglof Sweden AB, VERTEX LASER II OPER; HATLAPATKOVA L., 2006, ZALESNOVANI ZEMEDELS, P185; Hauck M, 2012, ENVIRON POLLUT, V164, P132, DOI 10.1016/j.envpol.2012.01.026; Havranek F, 2018, MODELOVANI VLIVU ZVE; Heinze E, 2011, FOREST ECOL MANAG, V261, P288, DOI 10.1016/j.foreco.2010.10.022; Henzlik V., 1995, SKODY ZVERI JEJICH R, P25; Holusa J, 2018, FOREST ECOL MANAG, V427, P434, DOI 10.1016/j.foreco.2018.01.031; Houet T, 2017, REG ENVIRON CHANGE, V17, P2293, DOI 10.1007/s10113-017-1171-z; Houet T, 2015, J MT SCI-ENGL, V12, P1095, DOI 10.1007/s11629-014-3404-7; Hytonen J, 2008, SILVA FENN, V42, P355, DOI 10.14214/sf.242; Hytonen J, 2017, SILVA FENN, V51, DOI 10.14214/sf.1734; Irbe I, 2015, BALT FOR, V21, P114; Jaehne S, 1997, FORSTWISS CENTRALBL, V116, P333, DOI 10.1007/BF02766909; Jarnemo A, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00106.1; Jarsky V, 2013, LAND USE POLICY, V35, P237, DOI 10.1016/j.landusepol.2013.05.020; Johansson T, 2014, FORESTS, V5, P2037, DOI 10.3390/f5082037; Kacalek D., 2009, Journal of Forest Science (Prague), V55, P9, DOI 10.17221/74/2008-JFS; Kacalek D, 2011, FOREST SYST, V20, P437, DOI 10.5424/fs/20112003-11042; Kaplan JO, 2009, QUATERNARY SCI REV, V28, P3016, DOI 10.1016/j.quascirev.2009.09.028; KESSL J., 1957, OCHRANA PROTI SKODAM; Knibbe B., 2007, PERSONAL ANALYSIS SY, P1; Kolecka N, 2017, APPL GEOGR, V88, P62, DOI 10.1016/j.apgeog.2017.09.002; Koltzenburg C., 1985, Forst- und Holzwirt, V40, P471; Koppen W, 1936, HANDBUCH DER KLIMATO; Korpela I, 2008, SILVA FENN, V42, P753, DOI 10.14214/sf.466; Kort J, 1998, BIOMASS BIOENERG, V14, P351, DOI 10.1016/S0961-9534(97)10071-X; Kotecky V, 2015, LAND USE POLICY, V47, P112, DOI 10.1016/j.landusepol.2015.03.014; Kozak J, 2007, J LAND USE SCI, V2, P127, DOI 10.1080/17474230701218244; Kral J, 2015, CENT EURO FOR J, V61, P175, DOI 10.1515/forj-2015-0026; Kralicek I, 2017, DENDROBIOLOGY, V77, P119, DOI 10.12657/denbio.077.010; Lanz B, 2018, ECOL ECON, V144, P260, DOI 10.1016/j.ecolecon.2017.07.018; Lindner M, 2014, J ENVIRON MANAGE, V146, P69, DOI 10.1016/j.jenvman.2014.07.030; Makinen H, 2002, FOREST ECOL MANAG, V171, P243, DOI 10.1016/S0378-1127(01)00786-1; Makinen H, 2001, TREES-STRUCT FUNCT, V15, P177, DOI 10.1007/s004680100089; Malik V., 2007, Journal of Forest Science (Prague), V53, P406, DOI 10.17221/2143-JFS; Mansson J, 2013, SCAND J FOREST RES, V28, P117, DOI 10.1080/02827581.2012.701323; Marconi V., 2016, LIVING PLANET REPORT; Matuszkiewicz JM, 2013, FOREST ECOL MANAG, V310, P567, DOI 10.1016/j.foreco.2013.08.060; McIntyre E. B., 1972, Scottish Forestry, V26, P43; MENHINICK EF, 1964, ECOLOGY, V45, P859, DOI 10.2307/1934933; Meyer FD, 2001, ECOSCIENCE, V8, P105, DOI 10.1080/11956860.2001.11682636; Mikeska M., 2012, PECE O LESNI EKOSYST; Mikeska M., 1999, OBLASTNI PLAN ROZVOJ; Ministry of Agriculture, 2017, ZPRAVA O STAVU LESA; MOUNTFORD MD, 1961, J ECOL, V49, P271, DOI 10.2307/2257261; Naslund M, 1937, SKOGSFORSOKSANSTALTE; PETRAS R, 1991, FORESTRY J, V37, P49; PIELOU EC, 1959, J ECOL, V47, P607, DOI 10.2307/2257293; Pielou EC., 1975, ECOLOGICAL DIVERSITY, DOI [10.1016/0006-3207(92)90776-J, DOI 10.1016/0006-3207(92)90776-J]; Plante M, 2004, ECOL MODEL, V174, P387, DOI 10.1016/j.ecolmodel.2003.09.035; Podrazsky V., 2011, Zpravy Lesnickeho Vyzkumu, V56, P27; Podrazsky V., 2008, Zpravy Lesnickeho Vyzkumu, V53, P258; Pretzsch H., 2006, AFZ/Der Wald, Allgemeine Forst Zeitschrift fur Waldwirtschaft und Umweltvorsorge, V61, P1158; Pretzsch H., 2012, RESISTANCE OF EUROPE, P483; Pretzsch H, 2018, FOR ECOSYST, V5, DOI 10.1186/s40663-018-0139-x; Pulpan J, 2001, ZPRAVY LESN VYZKUMU, V46, P135; Quitt E, 1971, KLIMATICKE OBLASTI; R Core Team, 2018, R A LANGUAGE AND ENV; Reimoser Friedrich, 2003, Journal for Nature Conservation (Jena), V10, P243, DOI 10.1078/1617-1381-00024; ROLLHANSEN F, 1980, EUR J FOREST PATHOL, V10, P396; Ronnberg J, 2013, FOREST ECOL MANAG, V289, P409, DOI 10.1016/j.foreco.2012.10.013; Schweingruber F. H., 1990, Dendrochronologia, V8, P9; Scott D., 1998, Scottish Forestry, V52, P8; Siegel S., 2009, NONPARAMETRIC STAT B, V2nd; Sierota Z., 2013, Scientific Research and Essays, V8, P2298; Simon J., 2001, Journal of Forest Science (Prague), V47, P402; SMIRNOV K A, 1981, Lesovedenie, P56; Spiecker H, 2003, J ENVIRON MANAGE, V67, P55, DOI 10.1016/S0301-4797(02)00188-3; Spulak O, 2011, REP FOR RES, V56, P49; Thulin CG, 2015, EUR J WILDLIFE RES, V61, P649, DOI 10.1007/s10344-015-0945-1; UHUL, 2017, INVENTARIZACE SKOD Z; Vacek S., 2010, Journal of Forest Science (Prague), V56, P505, DOI 10.17221/127/2010-JFS; VACEK S, 1987, FOREST ECOL MANAG, V22, P291, DOI 10.1016/0378-1127(87)90113-7; Vacek S, 2009, ZAKLADANI A STABILIZ; Vacek S, 2018, DENDROBIOLOGY, V79, P61, DOI 10.12657/denbio.079.006; Vacek Z, 2017, CENT EURO FOR J, V63, P23, DOI 10.1515/forj-2017-0006; Vacek Z, 2016, DENDROBIOLOGY, V75, P31, DOI 10.12657/denbio.075.004; Vacek Z, 2014, FORESTS, V5, P2929, DOI 10.3390/f5112929; Vala Z., 2011, Journal of Forest Science (Prague), V57, P59, DOI 10.17221/57/2010-JFS; Valtinat K, 2008, SCAND J FOREST RES, V23, P513, DOI 10.1080/02827580802545572; Vasiliauskas R, 1996, EUR J FOREST PATHOL, V26, P285; Verheyden H, 2006, MAMMAL REV, V36, P217, DOI 10.1111/j.1365-2907.2006.00085.x; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Vlad R., 2013, Revista Padurilor, V128, P27; Vlad R., 2014, P BIENN INT S FOR SU, P381; von Oheimb G, 2008, FOREST ECOL MANAG, V255, P1984, DOI 10.1016/j.foreco.2007.12.021; Vopravil Jan, 2014, Ekologia (Bratislava), V33, P67, DOI 10.2478/eko-2014-0008; Vospernik S, 2006, SILVA FENN, V40, P589, DOI 10.14214/sf.316; Wall A, 2005, PLANT SOIL, V275, P247, DOI 10.1007/s11104-005-1869-4; Wall A, 2009, FOREST ECOL MANAG, V257, P1751, DOI 10.1016/j.foreco.2009.01.029; WELCH D, 1988, FORESTRY, V61, P245, DOI 10.1093/forestry/61.3.245; Welch D, 1997, FORESTRY, V70, P113, DOI 10.1093/forestry/70.2.113-a; Williams M, 2000, J HIST GEOGR, V26, P28, DOI 10.1006/jhge.1999.0189; Wysocka-Fijorek E, 2017, SYLWAN, V161, P460; YAMAGUCHI DK, 1991, CAN J FOREST RES, V21, P414, DOI 10.1139/x91-053	145	24	24	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0221082	10.1371/journal.pone.0221082	http://dx.doi.org/10.1371/journal.pone.0221082			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5KK	31415638	Green Submitted, gold, Green Published			2022-12-26	WOS:000485017200071
J	Cheung-Flynn, J; Alvis, BD; Hocking, KM; Guth, CM; Luo, WF; McCallister, R; Chadalavada, K; Polcz, M; Komalavilas, P; Brophy, CM				Cheung-Flynn, Joyce; Alvis, Bret D.; Hocking, Kyle M.; Guth, Christy M.; Luo, Weifeng; McCallister, Reid; Chadalavada, Kalyan; Polcz, Monica; Komalavilas, Padmini; Brophy, Colleen M.			Normal Saline solutions cause endothelial dysfunction through loss of membrane integrity, ATP release, and inflammatory responses mediated by P2X7R/p38 MAPK/MK2 signaling pathways	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; P2X7 RECEPTOR; UP-REGULATION; INJURY; PHOSPHORYLATION; HEMORRHAGE; TRISTETRAPROLIN; INHIBITION; ANTAGONISM; APOPTOSIS	Resuscitation with 0.9% Normal Saline (NS), a non-buffered acidic solution, leads to increased morbidity and mortality in the critically ill. The goal of this study was to determine the molecular mechanisms of endothelial injury after exposure to NS. The hypothesis of this investigation is that exposure of endothelium to NS would lead to loss of cell membrane integrity, resulting in release of ATP, activation of the purinergic receptor (P2X7R), and subsequent activation of stress activated signaling pathways and inflammation. Human saphenous vein endothelial cells (HSVEC) incubated in NS, but not buffered electrolyte solution (Plasma-Lyte, PL), exhibited abnormal morphology and increased release of lactate dehydrogenase (LDH), adenosine triphosphate (ATP), and decreased transendothelial resistance (TEER), suggesting loss of membrane integrity. Incubation of intact rat aorta (RA) or human saphenous vein in NS but not PL led to impaired endothelial-dependent relaxation which was ameliorated by apyrase (hydrolyzes ATP) or SB203580 (p38 MAPK inhibitor). Exposure of HSVEC to NS but not PL led to activation of p38 MAPK and its downstream substrate, MAPKAP kinase 2 (MK2). Treatment of HSVEC with exogenous ATP led to interleukin 113 (IL-1 beta) release and increased vascular cell adhesion molecule (VCAM) expression. Treatment of RA with IL-1 beta led to impaired endothelial relaxation. IL-1 beta treatment of HSVEC led to increases in p38 MAPK and MK2 phosphorylation, and increased levels of arginase II. Incubation of porcine saphenous vein (PSV) in PL with pH adjusted to 6.0 or less also led to impaired endothelial function, suggesting that the acidic nature of NS is what contributes to endothelial dysfunction. Volume overload resuscitation in a porcine model after hemorrhage with NS, but not PL, led to acidosis and impaired endothelial function. These data suggest that endothelial dysfunction caused by exposure to acidic, non-buffered NS is associated with loss of membrane integrity, release of ATP, and is modulated by P2X7R-mediated inflammatory responses.	[Cheung-Flynn, Joyce; Hocking, Kyle M.; Guth, Christy M.; Luo, Weifeng; McCallister, Reid; Chadalavada, Kalyan; Polcz, Monica; Komalavilas, Padmini; Brophy, Colleen M.] Vanderbilt Univ, Dept Surg, Med Ctr, Nashville, TN 37240 USA; [Alvis, Bret D.] Vanderbilt Univ, Dept Anesthesiol, Med Ctr, Nashville, TN USA; [Komalavilas, Padmini; Brophy, Colleen M.] VA Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Komalavilas, P (corresponding author), Vanderbilt Univ, Dept Surg, Med Ctr, Nashville, TN 37240 USA.; Komalavilas, P (corresponding author), VA Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA.	padmini.komalavilas@vumc.org			National Institute of Health [R01HL70715, R01HL105731-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070715] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This material is based upon work supported by National Institute of Health grants R01HL70715 to CMB and R01HL105731-01 to JCF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayee MAA, 2017, BIOPHYS J, V112, P325, DOI 10.1016/j.bpj.2016.12.002; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen S, 2013, CRIT CARE MED, V41, pE466, DOI 10.1097/CCM.0b013e31829a8246; CHESTER AH, 1993, EUR J CARDIO-THORAC, V7, P399, DOI 10.1016/1010-7940(93)90002-S; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Crimi E, 2012, J CRIT CARE, V27, P108, DOI 10.1016/j.jcrc.2011.06.001; Davies M G, 1994, Ann Vasc Surg, V8, P150, DOI 10.1007/BF02018863; de Vries MR, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00003; Donnelly-Roberts DL, 2004, J PHARMACOL EXP THER, V308, P1053, DOI 10.1124/jpet.103.059600; Dubyak GR, 2002, AM J PHYSIOL-CELL PH, V282, pC242, DOI 10.1152/ajpcell.00522.2001; Feng L, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0409-2; Ferrari D, 1997, J IMMUNOL, V159, P1451; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Gorska MM, 2007, J EXP MED, V204, P1637, DOI 10.1084/jem.20062621; Harskamp RE, 2014, JAMA SURG, V149, P798, DOI 10.1001/jamasurg.2014.87; Heming N, 2018, ANESTHESIOLOGY, V129, P1149, DOI 10.1097/ALN.0000000000002413; Hocking KM, 2016, SHOCK, V46, P447, DOI 10.1097/SHK.0000000000000615; Honore P, 2006, J PHARMACOL EXP THER, V319, P1376, DOI 10.1124/jpet.106.111559; Huang CS, 2014, MOL MED REP, V9, P57, DOI 10.3892/mmr.2013.1807; Jespersen Brian, 2015, J Vis Exp, P52324, DOI 10.3791/52324; Komalavilas P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188069; Kyriakis JM, 1996, BIOESSAYS, V18, P567, DOI 10.1002/bies.950180708; Liang LH, 2005, AM J PHYSIOL-CELL PH, V289, pC388, DOI 10.1152/ajpcell.00491.2004; Luo WF, 2017, PURINERG SIGNAL, V13, P579, DOI 10.1007/s11302-017-9585-0; Michel AD, 2001, BRIT J PHARMACOL, V132, P1501, DOI 10.1038/sj.bjp.0703968; Papp L, 2007, BIOCHEM BIOPH RES CO, V355, P568, DOI 10.1016/j.bbrc.2007.02.014; Pernow J, 2015, BRIT J PHARMACOL, V172, P4684, DOI 10.1111/bph.13242; Reddi BAJ, 2013, INT J MED SCI, V10, P747, DOI 10.7150/ijms.5868; Ronkina N, 2010, BIOCHEM PHARMACOL, V80, P1915, DOI 10.1016/j.bcp.2010.06.021; Rousseau S, 2002, EMBO J, V21, P6505, DOI 10.1093/emboj/cdf639; Santos HAF, 2015, J CHEM THEORY COMPUT, V11, P5973, DOI 10.1021/acs.jctc.5b00956; Semler MW, 2018, NEW ENGL J MED, V378, P829, DOI 10.1056/NEJMoa1711584; Shatanawi A, 2015, EUR J PHARMACOL, V746, P106, DOI 10.1016/j.ejphar.2014.10.042; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Wilbring M, 2011, EUR J CARDIO-THORAC, V40, P811, DOI 10.1016/j.ejcts.2011.01.024; Wise ES, 2015, SURGERY, V158, P537, DOI 10.1016/j.surg.2015.03.036; Yan YL, 2015, AM J PHYSIOL-CELL PH, V308, pC463, DOI 10.1152/ajpcell.00245.2014; Yu Y, 2009, NEUROREPORT, V20, P393, DOI 10.1097/WNR.0b013e328324ede7; Zamaraeva MV, 2005, CELL DEATH DIFFER, V12, P1390, DOI 10.1038/sj.cdd.4401661; Zeiser R, 2011, J MOL MED, V89, P833, DOI 10.1007/s00109-011-0767-x	41	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0220893	10.1371/journal.pone.0220893	http://dx.doi.org/10.1371/journal.pone.0220893			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412063	Green Published, Green Submitted, gold			2022-12-26	WOS:000485012600040
J	Hirsch, P; Koch, I; Karbach, J				Hirsch, Patricia; Koch, Iring; Karbach, Julia			Putting a stereotype to the test: The case of gender differences in multitasking costs in task-switching and dual-task situations	PLOS ONE			English	Article							AGE-DIFFERENCES; WORKING-MEMORY; PERFORMANCE; ROTATIONS; TIME	According to a popular stereotype, women are better at multitasking than men, but empirical evidence for gender differences in multitasking performance is mixed. Previous work has focused on specific aspects of multitasking or has not considered gender differences in abilities contributing to multitasking performance. We therefore tested gender differences (N = 96, 50% female) in sequential (i.e., task switching) and concurrent (i.e., dual tasking) multitasking, while controlling for possible gender differences in working memory, processing speed, spatial abilities, and fluid intelligence. Applying two standard experimental paradigms allowed us to test multitasking abilities across five different empirical indices (i.e., performance costs) for both reaction time (RT) and accuracy measures, respectively. Multitasking resulted in substantial performance costs across all experimental conditions without a single significant gender difference in any of these ten measures, even when controlling for gender differences in underlying cognitive abilities. Thus, our results do not confirm the widespread stereotype that women are better at multitasking than men at least in the popular sequential and concurrent multitasking settings used in the present study.	[Hirsch, Patricia; Koch, Iring] Rhein Westfal TH Aachen, Inst Psychol, Aachen, Germany; [Karbach, Julia] Univ Koblenz Landau, Dept Psychol, Landau, Germany	RWTH Aachen University; University of Koblenz & Landau	Hirsch, P (corresponding author), Rhein Westfal TH Aachen, Inst Psychol, Aachen, Germany.	patricia.hirsch@psych.rwth-aachen.de	Koch, Iring/AAT-3126-2021	Koch, Iring/0000-0001-9664-8220	DFG [KO 2045/19-1]	DFG(German Research Foundation (DFG))	This research was funded by DFG grant KO 2045/19-1 (www.dfg.de) in the context of the DFG Priority Program 1772 (Human performance under multiple cognitive task requirements: From basic mechanisms to optimized task scheduling; awarded to Iring Koch). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Buschkuehl M, 2008, BRAINTWISTER AUFGABE; Etz A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149794; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Halvorson KM, 2013, J EXP PSYCHOL HUMAN, V39, P413, DOI 10.1037/a0029475; Hirnstein M, 2019, PSYCHOL RES-PSYCH FO, V83, P286, DOI 10.1007/s00426-018-1045-0; Hirsch P, 2018, ADV COGN PSYCHOL, V14, P62, DOI 10.5709/acp-0239-y; Karbach J, 2009, DEVELOPMENTAL SCI, V12, P978, DOI 10.1111/j.1467-7687.2009.00846.x; Kiesel A, 2010, PSYCHOL BULL, V136, P849, DOI 10.1037/a0019842; Koch I, 2018, PSYCHOL BULL, V144, P557, DOI 10.1037/bul0000144; Konig CJ, 2005, HUM PERFORM, V18, P243, DOI 10.1207/s15327043hup1803_3; Kray J, 2000, PSYCHOL AGING, V15, P126, DOI 10.1037//0882-7974.15.1.126; Kunzell S, 2018, PSYCHOL RES-PSYCH FO, V82, P4, DOI 10.1007/s00426-017-0942-y; Kuptsova S. V., 2015, Human Physiology, V41, P611, DOI 10.1134/S0362119715050084; Lague-Beauvais M, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-368; Maeda Y, 2013, EDUC PSYCHOL REV, V25, P69, DOI 10.1007/s10648-012-9215-x; Mantyla T, 2017, COGN PROCESS, V18, P229, DOI 10.1007/s10339-017-0799-4; Mantyla T, 2013, PSYCHOL SCI, V24, P514, DOI 10.1177/0956797612459660; Mayr U, 2001, PSYCHOL AGING, V16, P96, DOI 10.1037/0882-7974.16.1.96; Meiran N, 2011, PSYCHIAT RES, V185, P149, DOI 10.1016/j.psychres.2010.04.044; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Morey RD, 2011, PSYCHOL METHODS, V16, P406, DOI 10.1037/a0024377; Paridon HM, 2010, EUR J PSYCHOL, V6, P110; Pashler H, 1994, PSYCHOL BULL, V116, P358; Roivainen E, 2011, LEARN INDIVID DIFFER, V21, P145, DOI 10.1016/j.lindif.2010.11.021; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Salvucci DD, 2005, COGNITIVE SCI, V29, P457, DOI 10.1207/s15516709cog0000_19; Schuch S, 2015, PSYCHOL RES-PSYCH FO, V79, P759, DOI 10.1007/s00426-014-0602-4; Silverman I, 1992, ADAPTED MIND EVOLUTI, P487; Stoet G., 2013, BMC PSYCHOL, V1, DOI [10.1186/2050-7283-1-18, DOI 10.1186/2050-7283-1-18]; Strayer DL, 2013, PSYCHOL SCI, V24, P809, DOI 10.1177/0956797612465199; Strobach T, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01922; Szameitat AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140371; Tschernegg M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181554; VANDENBERG SG, 1978, PERCEPT MOTOR SKILL, V47, P599, DOI 10.2466/pms.1978.47.2.599; Wechsler W., 2013, WECHSLER ADULT INTEL; Wechsler W., 1982, HAMBURG WECHSLER INT; Wetzels R, 2011, PERSPECT PSYCHOL SCI, V6, P291, DOI 10.1177/1745691611406923	37	10	11	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0220150	10.1371/journal.pone.0220150	http://dx.doi.org/10.1371/journal.pone.0220150			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5IT	31412048	gold, Green Published, Green Submitted			2022-12-26	WOS:000485012600020
J	McAvoy, KM; Soit, HR; Marsh, G; Peterson, M; Reynolds, TL; Gagnon, J; Geisler, S; Leach, P; Roberts, C; Cahir-McFarland, E; Ransohoff, RM; Crotti, A				McAvoy, Kathleen M.; Soit, Hameetha Rajamohamed; Marsh, Galina; Peterson, Michael; Reynolds, Taylor L.; Gagnon, Jake; Geisler, Sarah; Leach, Prescott; Roberts, Chris; Cahir-McFarland, Ellen; Ransohoff, Richard M.; Crotti, Andrea			Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; CANCER SUPPRESSION; PROTEIN EXPRESSION; C-FOS; ACTIVATION; BRAIN; GENE; BAR; NEURODEGENERATION; IDENTIFICATION	BIN1 is the most important risk locus for Late Onset Alzheimer's Disease (LOAD), after ApoE. BIN1 AD-associated SNPs correlate with Tau deposition as well as with brain atrophy. Furthermore, the level of neuronal-specific BIN1 isoform 1 protein is decreased in sporadic AD cases in parallel with neuronal loss, despite an overall increase in BIN1 total mRNA. To address the relationship between reduction of BIN1 and neuronal cell loss in the context of Tau pathology, we knocked-down endogenous murine Bin1 via stereotaxic injection of AAV-Bin1 shRNA in the hippocampus of mice expressing Tau P301S (PS19). We observed a statistically significant reduction in the number of neurons in the hippocampus of mice injected with AAV-Bin1 shRNA in comparison with mice injected with AAV control. To investigate whether neuronal loss is due to deletion of Bin1 selectively in neurons in presence Tau P301S, we bred Bin1(flox/flox) with Thy1-Cre and subsequently with PS19 mice. Mice lacking neuronal Bin1 and expressing Tau P301S showed increased mortality, without increased neuropathology, when compared to neuronal Bin1 and Tau P301S-expressing mice. The loss of Bin1 isoform 1 resulted in reduced excitability in primary neurons in vitro, reduced neuronal c-fos expression as well as in altered microglia transcriptome in vivo. Taken together, our data suggest that the contribution of genetic variation in BIN1 locus to AD risk could result from a cell-autonomous reduction of neuronal excitability due to Bin1 decrease, exacerbated by the presence of aggregated Tau, coupled with a non-cell autonomous microglia activation.	[McAvoy, Kathleen M.; Soit, Hameetha Rajamohamed; Marsh, Galina; Peterson, Michael; Reynolds, Taylor L.; Gagnon, Jake; Geisler, Sarah; Leach, Prescott; Roberts, Chris; Cahir-McFarland, Ellen; Crotti, Andrea] Biogen, Cambridge, MA 02142 USA; [Ransohoff, Richard M.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Crotti, Andrea] Astellas Innovat Management, Cambridge, MA 02138 USA	Biogen; Harvard University; Harvard Medical School	Crotti, A (corresponding author), Biogen, Cambridge, MA 02142 USA.; Crotti, A (corresponding author), Astellas Innovat Management, Cambridge, MA 02138 USA.	andrea.crotti@astellas.com			Biogen	Biogen(Biogen)	Funding for this work had been provided by Biogen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SL, 2016, J NEUROPATH EXP NEUR, V75, P779, DOI 10.1093/jnen/nlw056; Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; [Anonymous], [No title captured]; Biffi A, 2010, ARCH NEUROL-CHICAGO, V67, P677, DOI 10.1001/archneurol.2010.108; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buccafusco JJ, 2009, FRONT NEUROSCI, P1; Bungenberg J, 2016, NEUROBIOL DIS, V86, P121, DOI 10.1016/j.nbd.2015.11.011; Butler MH, 1997, J CELL BIOL, V137, P1355, DOI 10.1083/jcb.137.6.1355; Chapuis J, 2013, MOL PSYCHIATR, V18, P1225, DOI 10.1038/mp.2013.1; Cruz FC, 2015, BRAIN RES, V1628, P157, DOI 10.1016/j.brainres.2014.11.005; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Cruz JC, 2006, J NEUROSCI, V26, P10536, DOI 10.1523/JNEUROSCI.3133-06.2006; De Rossi P, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0124-1; Dewachter I, 2002, J NEUROSCI, V22, P3445; Di Paolo G, 2002, NEURON, V33, P789, DOI 10.1016/S0896-6273(02)00601-3; Drager NM, 2017, EMBO REP, V18, P2051, DOI 10.15252/embr.201744137; Fugier C, 2011, NAT MED, V17, P720, DOI 10.1038/nm.2374; Glennon EBC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078806; Hargis KE, 2017, BEHAV BRAIN RES, V322, P311, DOI 10.1016/j.bbr.2016.05.007; Holler CJ, 2014, J ALZHEIMERS DIS, V42, P1221, DOI 10.3233/JAD-132450; Holtmaat A, 2016, NAT NEUROSCI, V19, P1553, DOI 10.1038/nn.4418; Hong TT, 2017, PHYSIOL REV, V97, P227, DOI 10.1152/physrev.00037.2015; Huser S, 2013, BIOCHEM J, V450, P73, DOI 10.1042/BJ20121373; Jasnow AM, 2013, J NEUROSCI, V33, P10396, DOI 10.1523/JNEUROSCI.5539-12.2013; Joo JY, 2016, NAT NEUROSCI, V19, P75, DOI 10.1038/nn.4170; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Leprince C, 1997, J BIOL CHEM, V272, P15101, DOI 10.1074/jbc.272.24.15101; Mandhane SN, 2007, SEIZURE-EUR J EPILEP, V16, P636, DOI 10.1016/j.seizure.2007.05.005; Mathys H, 2017, CELL REP, V21, P366, DOI 10.1016/j.celrep.2017.09.039; McCullough KM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13149; Montaguti E, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00441; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Munoz W, 2014, CELL REP, V9, P2304, DOI 10.1016/j.celrep.2014.11.042; Palop JJ, 2016, NAT REV NEUROSCI, V17, P777, DOI 10.1038/nrn.2016.141; Pant S, 2009, NAT CELL BIOL, V11, P1399, DOI 10.1038/ncb1986; Prendergast GC, 2009, BBA-REV CANCER, V1795, P25, DOI 10.1016/j.bbcan.2008.09.001; Ramalingam A, 2007, CELL CYCLE, V6, P1914, DOI 10.4161/cc.6.15.4514; Ramjaun AR, 1997, J BIOL CHEM, V272, P16700, DOI 10.1074/jbc.272.26.16700; Ramjaun AR, 1998, J NEUROCHEM, V70, P2369; Ren G, 2006, MICROBIOL MOL BIOL R, V70, P37, DOI 10.1128/MMBR.70.1.37-120.2006; REPRESA A, 1995, J NEUROBIOL, V26, P413, DOI 10.1002/neu.480260313; Scharfman HE, 2012, FUTUR NEUROL, V7, P177, DOI 10.2217/FNL.12.8; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Sottejeau Y, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0237-8; Vossel KA, 2017, LANCET NEUROL, V16, P311, DOI 10.1016/S1474-4422(17)30044-3; Wang HF, 2016, J ALZHEIMERS DIS, V52, P179, DOI 10.3233/JAD-150972; WechslerReya R, 1997, J BIOL CHEM, V272, P31453, DOI 10.1074/jbc.272.50.31453; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; Wiltgen BJ, 2006, J NEUROSCI, V26, P5484, DOI 10.1523/JNEUROSCI.2685-05.2006; Woerman AL, 2017, JAMA NEUROL, V74, P1464, DOI 10.1001/jamaneurol.2017.2822; Ye H, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0399-8; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhang XL, 2015, NEUROPSYCHOPHARMACOL, V40, P1794, DOI 10.1038/npp.2015.30; Zhou Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099665	57	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220125	10.1371/journal.pone.0220125	http://dx.doi.org/10.1371/journal.pone.0220125			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408457	Green Published, gold, Green Submitted			2022-12-26	WOS:000485009500008
J	Adam, AC; Lie, KK; Whatmore, P; Jakt, LM; Moren, M; Skjaerven, KH				Adam, Anne-Catrin; Lie, Kai Kristoffer; Whatmore, Paul; Jakt, Lars Martin; Moren, Mari; Skjaerven, Kaja Helvik			Profiling DNA methylation patterns of zebrafish liver associated with parental high dietary arachidonic acid	PLOS ONE			English	Article							GENE BODY METHYLATION; DEVELOPMENTAL PLASTICITY; EPIGENETIC MODIFICATION; PROTEIN RESTRICTION; PREGNANT RATS; EXPRESSION; METABOLISM; NUTRITION; DISEASE; CONSEQUENCES	Diet has been shown to influence epigenetic key players, such as DNA methylation, which can regulate the gene expression potential in both parents and offspring. Diets enriched in omega-6 and deficient in omega-3 PUFAs (low dietary omega-3/omega-6 PUFA ratio), have been associated with the promotion of pathogenesis of diseases in humans and other mammals. In this study, we investigated the impact of increased dietary intake of arachidonic acid (ARA), a physiologically important omega-6 PUFA, on 2 generations of zebrafish. Parental fish were fed either a low or a high ARA diet, while the progeny of both groups were fed the low ARA diet. We screened for DNA methylation on single base-pair resolution using reduced representation bisulfite sequencing (RRBS). The DNA methylation profiling revealed significant differences between the dietary groups in both parents and offspring. The majority of differentially methylated loci associated with high dietary ARA were found in introns and intergenic regions for both generations. Common loci between the identified differentially methylated loci in F-0 and F-1 livers were reported. We described overlapping gene annotations of identified methylation changes with differential expression, but based on a small number of overlaps. The present study describes the diet-associated methylation profiles across genomic regions, and it demonstrates that parental high dietary ARA modulates DNA methylation patterns in zebrafish liver.	[Adam, Anne-Catrin; Lie, Kai Kristoffer; Whatmore, Paul; Moren, Mari; Skjaerven, Kaja Helvik] Inst Marine Res, Bergen, Norway; [Jakt, Lars Martin] Nord Univ, Fac Biosci & Aquaculture, Bodo, Norway; [Moren, Mari] Nofima AS, Bergen, Norway	Institute of Marine Research - Norway; Nord University; Nofima	Adam, AC (corresponding author), Inst Marine Res, Bergen, Norway.	aad@hi.no	Lie, Kai Kristoffer/AAM-8809-2020	Jakt, Lars Martin/0000-0002-3787-8138; Skjaerven, Kaja Helvik/0000-0003-4185-390X; Adam, Anne-Catrin/0000-0001-9713-4512	Research Council of Norway [EpiSip 228877, EpiFeedFish 225250/E40]	Research Council of Norway(Research Council of Norway)	This research was financed through The Research Council of Norway (www.forskningsradet.no): EpiSip 228877 (KHS) and EpiFeedFish 225250/E40 (KHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam AC, 2017, BR J NUTR, V09, P1; Adam AC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201278; Akalin A, 2015, BIOINFORMATICS, V31, P1127, DOI 10.1093/bioinformatics/btu775; Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r87, 10.1186/gb-2012-13-10-R87]; Alswat KA, 2013, SAUDI J GASTROENTERO, V19, P144, DOI 10.4103/1319-3767.114505; Amarasinghe HE, 2015, PEERJ, V3, DOI 10.7717/peerj.1079; Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; Andrews S., 2017, FASTQC QUALITY CONTR; [Anonymous], 2013, R LANG ENV STAT COMP; Asil SM, 2017, AQUACULTURE, V476, P8, DOI 10.1016/j.aquaculture.2017.03.048; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Bogdanovic O, 2017, CURR OPIN GENET DEV, V46, P9, DOI 10.1016/j.gde.2017.06.007; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Burdge GC, 2007, BRIT J NUTR, V97, P435, DOI 10.1017/S0007114507352392; Burdge GC, 2010, ANNU REV NUTR, V30, P315, DOI 10.1146/annurev.nutr.012809.104751; Cannon MV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090335; Ciano M, 2016, BIOCHEM BIOPH RES CO, V479, P325, DOI 10.1016/j.bbrc.2016.09.071; Clermont PL, 2016, FRONT BIOSCI-LANDMRK, V21, P430, DOI 10.2741/4399; Curradi M, 2002, MOL CELL BIOL, V22, P3157, DOI 10.1128/MCB.22.9.3157-3173.2002; de Vrieze E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089347; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Gluckman PD, 2011, BIRTH DEFECTS RES C, V93, P12, DOI 10.1002/bdrc.20198; Godfrey KM, 2011, DIABETES, V60, P1528, DOI 10.2337/db10-0979; Goodman RH, 2000, GENE DEV, V14, P1553; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Hoile SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021668; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Hore TA, 2017, EPIGENOMICS-UK, V9, P863, DOI 10.2217/epi-2017-0021; Huang K, 2010, REGEN MED, V5, P531, DOI [10.2217/rme.10.35, 10.2217/RME.10.35]; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jjingo D, 2012, ONCOTARGET, V3, P462, DOI 10.18632/oncotarget.497; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Klughammer J, 2015, CELL REP, V13, P2621, DOI 10.1016/j.celrep.2015.11.024; Lands B, 2012, NUTRIENTS, V4, P1338, DOI 10.3390/nu4091338; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lee HJ, 2014, CELL STEM CELL, V14, P710, DOI 10.1016/j.stem.2014.05.008; Levo M, 2014, NAT REV GENET, V15, P453, DOI 10.1038/nrg3684; Li E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019133; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lie KK, 2016, COMP BIOCHEM PHYS A, V191, P80, DOI 10.1016/j.cbpa.2015.10.011; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Lou SK, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0408-0; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McGaughey DM, 2014, G3-GENES GENOM GENET, V4, P861, DOI 10.1534/g3.113.009514; McGregor K, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0935-y; McRae AF, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r73; Moody L, 2017, EPIGENOMICS-UK, V9, P1387, DOI 10.2217/epi-2017-0066; Newman T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166394; Norberg B, 2017, GEN COMP ENDOCR, V250, P21, DOI 10.1016/j.ygcen.2017.05.020; NRC (National Research Council), 2011, NUTR REQ FISH SHRIMP; Park LK, 2012, P NUTR SOC, V71, P75, DOI 10.1017/S0029665111003302; Patterson E, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/539426; Polak M, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1492; Sabet JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154979; Schneider E, 2010, NUCLEIC ACIDS RES, V38, P3880, DOI 10.1093/nar/gkq126; Schubeler D, 2015, NATURE, V517, P321, DOI 10.1038/nature14192; Seiliez I, 2017, AQUACULTURE, V471, P80, DOI 10.1016/j.aquaculture.2017.01.010; Sharma U, 2017, CELL METAB, V25, P544, DOI 10.1016/j.cmet.2017.02.003; Sheffield NC, 2017, NAT MED, V23, P386, DOI 10.1038/nm.4273; Silva-Martinez GA, 2016, EPIGENETICS-US, V11, P321, DOI 10.1080/15592294.2016.1161873; Simopoulos AP, 2006, BIOMED PHARMACOTHER, V60, P502, DOI 10.1016/j.biopha.2006.07.080; Skjaerven KH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21211-5; Skjaerven KH, 2016, SCI REP-UK, V6, DOI 10.1038/srep34535; Szyf M, 2007, TOXICOL SCI, V100, P7, DOI 10.1093/toxsci/kfm177; Thomas MH, 2016, BIOCHIMIE; Triggs AM, 2012, FUNCT ECOL, V26, P1409, DOI 10.1111/j.1365-2435.2012.02051.x; Veron V, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5048-4; Voisin S, 2015, EUR J HUM GENET, V23, P654, DOI 10.1038/ejhg.2014.139; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; Waterland RA, 2009, HORM RES, V71, P13, DOI 10.1159/000178030; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Xue SS, 2015, BBA-MOL CELL BIOL L, V1851, P1317, DOI 10.1016/j.bbalip.2015.07.001; Yang XJ, 2014, CANCER CELL, V26, P577, DOI 10.1016/j.ccr.2014.07.028; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu HL, 2015, BRIT J NUTR, V113, P1032, DOI 10.1017/S0007114515000252; Yuan T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004996; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zenk F, 2017, SCIENCE, V357, P212, DOI 10.1126/science.aam5339; Zhang CS, 2016, FORESTS, V7, DOI 10.3390/f7100222; Zhang NF, 2018, ANIM NUTR, V4, P11, DOI 10.1016/j.aninu.2017.08.009; Zhang Y, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00505; Zilberman D, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1230-2	89	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220934	10.1371/journal.pone.0220934	http://dx.doi.org/10.1371/journal.pone.0220934			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398226	Green Published, Green Submitted, gold			2022-12-26	WOS:000485004000028
J	Liang, YR; Song, XJ; Li, YM; Su, P; Han, DW; Ma, TT; Guo, RB; Chen, B; Zhao, WJ; Sang, YT; Zhang, N; Li, XY; Zhang, HW; Liu, Y; Duan, Y; Wang, LJ; Yang, QF				Liang, Yiran; Song, Xiaojin; Li, Yaming; Su, Peng; Han, Dianwen; Ma, Tingting; Guo, Renbo; Chen, Bing; Zhao, Wenjing; Sang, Yuting; Zhang, Ning; Li, Xiaoyan; Zhang, Hanwen; Liu, Ying; Duan, Yi; Wang, Lijuan; Yang, Qifeng			circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer	ONCOGENE			English	Article							OSTEOSARCOMA CELLS; WNT/BETA-CATENIN; RNA; CHEMORESISTANCE; METASTASIS; EXPRESSION; CIRCHIPK3; CIRCPVT1; ABUNDANT; MARKER	Increasing evidence has indicated that circular RNAs (circRNAs) play a critical role in cancer development. However, only a small number of circRNAs have been experimentally validated and functionally annotated. In this study, using a high-throughput microarray assay, we identified a novel circRNA, circKDM4C, which was downregulated in breast cancer tissues with metastasis. Furthermore, we analyzed a cohort of breast cancer patients and found that circKDM4C expression was decreased in breast cancer tissues, and lower circKDM4C expression was associated with poor prognosis and metastasis in breast cancer. Functionally, we demonstrated that circKDM4C significantly repressed breast cancer proliferation, metastasis, and doxorubicin resistance in vitro and in vivo. Mechanistically, using a dual-luciferase activity assay and AGO2 RNA immunoprecipitation, circKDM4C was identified as a miR-548p sponge. We also found that PBLD was a direct target of miR-548p, which functioned as a tumor suppressor in breast cancer. Moreover, miR-548p overexpression was able to reverse the circKDM4C-induced attenuation of malignant phenotypes and elevated expression of PBLD in breast cancer cells. Taken together, our data indicate that circKDM4C might have considerable potential as a prognostic biomarker in breast cancer, and support the notion that therapeutic targeting of circKDM4C/miR-548p/PBLD axis may be a promising treatment approach for breast cancer patients.	[Liang, Yiran; Song, Xiaojin; Li, Yaming; Han, Dianwen; Ma, Tingting; Sang, Yuting; Zhang, Ning; Li, Xiaoyan; Zhang, Hanwen; Liu, Ying; Duan, Yi; Yang, Qifeng] Shandong Univ, Qilu Hosp, Dept Breast Surg, Jinan 250012, Shandong, Peoples R China; [Su, Peng] Shandong Univ, Qilu Hosp, Dept Pathol, Jinan 250012, Shandong, Peoples R China; [Guo, Renbo] Shandong Univ, Shandong Canc Hosp, Dept Urol, Jinan 250117, Shandong, Peoples R China; [Chen, Bing; Zhao, Wenjing; Wang, Lijuan; Yang, Qifeng] Shandong Univ, Qilu Hosp, Pathol Tissue Bank, Jinan 250012, Shandong, Peoples R China	Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University	Yang, QF (corresponding author), Shandong Univ, Qilu Hosp, Dept Breast Surg, Jinan 250012, Shandong, Peoples R China.; Yang, QF (corresponding author), Shandong Univ, Qilu Hosp, Pathol Tissue Bank, Jinan 250012, Shandong, Peoples R China.	qifengy_sdu@163.com	yang, qiang/GYJ-0971-2022; Zhang, Ning/GOJ-8058-2022; Zhang, Ning/GNP-1966-2022; Zhang, Hanwen/CAG-1998-2022	Zhang, Ning/0000-0002-6430-4236; Yang, Qifeng/0000-0003-0576-8513	National Natural Science Foundation of China [81272903, 81672613, 81502285, 81602329]; China Postdoctoral Science Foundation [2018M630787]; Key Research and Development Program of Shandong Province [2015GSF118093, 2016GSF201119]; Natural Science Foundation of Shandong Province [ZR2014HQ078]; Shandong Science and Technology Development Plan [2016CYJS01A02]; Special Support Plan for National High Level Talents ("Ten Thousand Talents Program")	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Key Research and Development Program of Shandong Province; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Shandong Science and Technology Development Plan; Special Support Plan for National High Level Talents ("Ten Thousand Talents Program")	This work was supported by the National Natural Science Foundation of China (No. 81272903; No. 81672613; No. 81502285; No. 81602329), China Postdoctoral Science Foundation to NZ (2018M630787), the Key Research and Development Program of Shandong Province (No. 2015GSF118093, No. 2016GSF201119), the Natural Science Foundation of Shandong Province (ZR2014HQ078), the Shandong Science and Technology Development Plan (2016CYJS01A02), and the Special Support Plan for National High Level Talents ("Ten Thousand Talents Program") to QY.	Barrett SP, 2015, ELIFE, V4, DOI 10.7554/eLife.07540; Bray F, 2018, CA CANC J CLIN; Cai JC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15870; Chen GW, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0204-3; Chen J, 2017, CANCER LETT, V388, P208, DOI 10.1016/j.canlet.2016.12.006; Chen LL, 2015, RNA BIOL, V12, P381, DOI 10.1080/15476286.2015.1020271; COCQUERELLE C, 1993, FASEB J, V7, P155, DOI 10.1096/fasebj.7.1.7678559; Du WW, 2016, NUCLEIC ACIDS RES, V44, P2846, DOI 10.1093/nar/gkw027; Gao DF, 2017, EPIGENOMICS-UK, V9, P1175, DOI 10.2217/epi-2017-0055; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Huang GL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131225; Huang SL, 2019, CIRCULATION, V139, P2857, DOI 10.1161/CIRCULATIONAHA.118.038361; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Jones SE, 2008, CLIN BREAST CANCER, V8, P224, DOI 10.3816/CBC.2008.n.025; Ke ZY, 2019, J CELL PHYSIOL, V234, P1699, DOI 10.1002/jcp.27041; Kim C, 2018, CELL, V173, P879, DOI 10.1016/j.cell.2018.03.041; Li AM, 2016, ONCOTARGET, V7, P524, DOI 10.18632/oncotarget.6358; Li DM, 2013, WORLD J GASTROENTERO, V19, P2781, DOI 10.3748/wjg.v19.i18.2781; Li DM, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1637-7; Li F, 2015, ONCOTARGET, V6, P6001, DOI 10.18632/oncotarget.3469; Li RC, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0852-y; Li YW, 2017, EMBO REP, V18, P1646, DOI 10.15252/embr.201643581; Long JA, 2010, HEPATOB PANCREAT DIS, V9, P296; Maishman T, 2017, ANN SURG, V266, P165, DOI 10.1097/SLA.0000000000001930; O'Reilly EA, 2015, BBA CLIN, V3, P257, DOI 10.1016/j.bbacli.2015.03.003; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Sang MX, 2018, CANCER LETT, V426, P37, DOI 10.1016/j.canlet.2018.03.049; Shi L, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.556; Shi ZM, 2017, FEBS J, V284, P1096, DOI 10.1111/febs.14045; Tan SY, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0887-9; Wan L, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/1579490; Wang KF, 2017, CANCER LETT, V394, P1, DOI 10.1016/j.canlet.2016.12.036; Wang L., 2018, JOULE, V2, P1, DOI DOI 10.1016/j.mtnano.2018.04.007; Wang Y, 2016, CANCER LETT, V382, P137, DOI 10.1016/j.canlet.2016.08.024; Wei XF, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.541; Xie F., 2018, AXIS, V17, P144, DOI DOI 10.1186/S12943-018-0892-Z; Xiong W, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8421614; Xu H, 2018, CANCER LETT, V412, P69, DOI 10.1016/j.canlet.2017.09.030; Zeng KX, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0454-8; Zhang J, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0719-3; Zhang J, 2007, J PROTEOME RES, V6, P4423, DOI 10.1021/pr0703425; Zheng QP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11215; Zhong ZY, 2016, SCI REP-UK, V6, DOI 10.1038/srep30919; Zhu KP, 2018, INT J BIOL SCI, V14, P321, DOI 10.7150/ijbs.24360	44	93	95	3	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 17	2019	38	42					6850	6866		10.1038/s41388-019-0926-z	http://dx.doi.org/10.1038/s41388-019-0926-z			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JE5UU	31406252				2022-12-26	WOS:000490758200004
J	Mann, E; Kelly, SD; Al-Abdul-Wahid, MS; Clarke, BR; Ovchinnikova, OG; Liu, B; Whitfield, C				Mann, Evan; Kelly, Steven D.; Al-Abdul-Wahid, M. Sameer; Clarke, Bradley R.; Ovchinnikova, Olga G.; Liu, Bin; Whitfield, Chris			Substrate recognition by a carbohydrate-binding module in the prototypical ABC transporter for lipopolysaccharide O-antigen from Escherichia coli O9a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipopolysaccharide (LPS); glycolipid; ABC transporter; membrane transport; glycobiology; bacterial outer membrane; carbohydrate-binding module (CBM); glycan export; O-antigen polysaccharide	TRANSFER-DIFFERENCE NMR; S-LAYER GLYCOPROTEIN; CHAIN-LENGTH; KLEBSIELLA-PNEUMONIAE; SERUM RESISTANCE; OUTER-MEMBRANE; LIGAND-BINDING; POLYSACCHARIDE; BIOSYNTHESIS; PROTEIN	Escherichia coli serotype O9a provides a model for export of lipopolysaccharide (LPS) O-antigen polysaccharide (O-PS) via ABC transporters. In O9a biosynthesis, a chain-terminator enzyme, WbdD, caps the nonreducing end of the glycan with a methylphosphate moiety and thereby establishes chain-length distribution. A carbohydrate-binding module (CBM) in the ABC transporter recognizes terminated glycans, ensuring that only mature O-PS is exported and incorporated into LPS. Here, we addressed two questions arising from this model. Are both residues in the binary terminator necessary for termination and export? And is a terminal methylphosphate moiety sufficient for export of heterologous glycans? To answer the first question, we uncoupled WbdD kinase and methyltransferase activities. WbdD mutants revealed that although the kinase activity is solely responsible for chain-length regulation, both activities are essential for CBM recognition and export. Consistent with this observation, a saturation transfer difference NMR experiment revealed a direct interaction between the CBM and the terminal methyl group. To determine whether methylphosphate is the sole determinant of substrate recognition by the CBM, we exploited Klebsiella pneumoniae O7, whose O-PS repeat-unit structure differs from O9a, but, as shown here, offers the second confirmed example of a terminal methylphosphate serving in substrate recognition. In vitro and in vivo experiments indicated that each CBM can bind the O-PS only with the native repeat unit, revealing that methylphosphate is essential but not sufficient for substrate recognition and export. Our findings provide important new insight into the structural determinants in a prototypical quality control system for glycan assembly and export.	[Mann, Evan; Kelly, Steven D.; Clarke, Bradley R.; Ovchinnikova, Olga G.; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada; [Al-Abdul-Wahid, M. Sameer] Univ Guelph, Adv Anal Ctr, Guelph, ON N1G 2W1, Canada; [Liu, Bin] Nankai Univ, TEDA Inst Biol Sci & Biotechnol, 3 Hongda St TEDA, Tianjin 300457, Peoples R China	University of Guelph; University of Guelph; Nankai University	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca		Kelly, Steven/0000-0003-1250-7055; Whitfield, Chris/0000-0002-5267-7027; Al-Abdul-Wahid, Mohamed Sameer/0000-0001-7925-5863	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported by funding from the Natural Sciences and Engineering Research Council of Canada (to C. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Bi YC, 2018, NATURE, V553, P361, DOI 10.1038/nature25190; BOCK K, 1983, ADV CARBOHYD CHEM BI, V41, P27, DOI 10.1016/S0065-2318(08)60055-4; Burns SM, 1998, INFECT IMMUN, V66, P4244; Claasen B, 2005, J AM CHEM SOC, V127, P916, DOI 10.1021/ja044434w; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; Clarke BR, 2011, J BIOL CHEM, V286, P41391, DOI 10.1074/jbc.M111.295857; Clarke BR, 2009, J BIOL CHEM, V284, P30662, DOI 10.1074/jbc.M109.052878; Cuthbertson L, 2005, J BIOL CHEM, V280, P30310, DOI 10.1074/jbc.M504371200; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Cuthbertson L, 2010, MICROBIOL MOL BIOL R, V74, P341, DOI 10.1128/MMBR.00009-10; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fedonenko YP, 2002, CARBOHYD RES, V337, P869, DOI 10.1016/S0008-6215(02)00061-7; Greenfield LK, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412577; Greenfield LK, 2012, J BIOL CHEM, V287, P35078, DOI 10.1074/jbc.M112.401000; Greenfield LK, 2012, CARBOHYD RES, V356, P12, DOI 10.1016/j.carres.2012.02.027; GROSSMAN N, 1987, J BACTERIOL, V169, P856, DOI 10.1128/jb.169.2.856-863.1987; Guachalla LM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06682-2; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hagelueken G, 2015, NAT STRUCT MOL BIOL, V22, P50, DOI 10.1038/nsmb.2935; Hagelueken G, 2012, MOL MICROBIOL, V86, P730, DOI 10.1111/mmi.12014; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; JANSSON PE, 1989, CARBOHYD RES, V188, P169, DOI 10.1016/0008-6215(89)84069-8; Kahlig H, 2005, J BIOL CHEM, V280, P20292, DOI 10.1074/jbc.M501724200; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; King JD, 2014, P NATL ACAD SCI USA, V111, P6407, DOI 10.1073/pnas.1400814111; Kooistra O, 2002, EUR J BIOCHEM, V269, P573, DOI 10.1046/j.0014-2956.2001.02684.x; Kos V, 2009, J BIOL CHEM, V284, P2947, DOI 10.1074/jbc.M807213200; Kubler-Kielb J, 2012, CARBOHYD RES, V347, P186, DOI 10.1016/j.carres.2011.11.019; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lerouge I, 2002, FEMS MICROBIOL REV, V26, P17, DOI 10.1111/j.1574-6976.2002.tb00597.x; LINDBERG B, 1973, ACTA CHEM SCAND, V27, P3787, DOI 10.3891/acta.chem.scand.27-3787; Liston SD, 2017, BBA-MOL CELL BIOL L, V1862, P1394, DOI 10.1016/j.bbalip.2016.10.008; Liston SD, 2015, J BIOL CHEM, V290, P1075, DOI 10.1074/jbc.M114.622480; Mann E, 2016, J BIOL CHEM, V291, P9748, DOI 10.1074/jbc.M116.719344; Mann E, 2015, J BIOL CHEM, V290, P25561, DOI 10.1074/jbc.M115.660803; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Mostowy RJ, 2018, TRENDS MICROBIOL, V26, P1008, DOI 10.1016/j.tim.2018.06.006; Okuda S, 2016, NAT REV MICROBIOL, V14, P337, DOI 10.1038/nrmicro.2016.25; Ovchinnikova OG, 2016, P NATL ACAD SCI USA, V113, pE3120, DOI 10.1073/pnas.1603146113; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Schaffer C, 1999, GLYCOBIOLOGY, V9, P407, DOI 10.1093/glycob/9.4.407; Schaffer C, 2002, J BIOL CHEM, V277, P6230, DOI 10.1074/jbc.M108873200; Sperandeo P, 2017, J BIOL CHEM, V292, P17981, DOI 10.1074/jbc.R117.802512; Steiner K, 2008, J BIOL CHEM, V283, P21120, DOI 10.1074/jbc.M801833200; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; van de Weerd R, 2015, CHEMBIOCHEM, V16, P977, DOI 10.1002/cbic.201402713; Vinogradov E, 2002, J BIOL CHEM, V277, P25070, DOI 10.1074/jbc.M202683200; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; WHITFIELD C, 1989, J GEN MICROBIOL, V135, P2589; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Williams DM, 2017, P NATL ACAD SCI USA, V114, pE1215, DOI 10.1073/pnas.1613609114; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	54	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2019	294	41					14978	14990		10.1074/jbc.RA119.010323	http://dx.doi.org/10.1074/jbc.RA119.010323			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9JH	31416837	hybrid, Green Published			2022-12-26	WOS:000499253400012
J	Thakur, VS; Aguila, B; Brett-Morris, A; Creighton, CJ; Welford, SM				Thakur, Vijay S.; Aguila, Brittany; Brett-Morris, Adina; Creighton, Chad J.; Welford, Scott M.			Spermidine/spermine N1-acetyltransferase 1 is a gene-specific transcriptional regulator that drives brain tumor aggressiveness	ONCOGENE			English	Article							CELL-MIGRATION; PROLIFERATION; GLIOBLASTOMA; EXPRESSION; BINDING; GROWTH	Spermidine/spermine N1-acetyltransferase 1 (SAT1), the rate-limiting enzyme in polyamine catabolism, has broad regulatory roles due to near ubiquitous polyamine binding. We describe a novel function of SAT1 as a gene-specific transcriptional regulator through local polyamine acetylation. SAT1 expression is elevated in aggressive brain tumors and promotes resistance to radiotherapy. Expression profiling in glioma cells identified SAT1 target genes that distinguish high-and low-grade tumors, in support of the prognostic utility of SAT1 expression. We further discovered mechanisms of SAT1-driven tumor aggressiveness through promotion of expression of both DNA damage response pathways as well as cell cycle regulatory genes. Mechanistically, SAT1 associates specifically with the promoter of the MELK gene, which functionally controls other SAT1 targets, and leads biologically to maintenance of neurosphere stemness in conjunction with FOXM1 and EZH2. CRISPR knockin mutants demonstrate the essentiality of the polyamine acetyltransferase activity of SAT1 for its function as a transcriptional regulator. Together, the data demonstrate that gene-specific polyamine removal is a major transcriptional regulatory mechanism active in high-grade gliomas that drives poor outcomes.	[Thakur, Vijay S.; Welford, Scott M.] Univ Miami, Miller Sch Med, Dept Radiat Oncol, Miami, FL 33136 USA; [Aguila, Brittany] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Brett-Morris, Adina] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Creighton, Chad J.] Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA; [Creighton, Chad J.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Welford, Scott M.] Univ Miami, Sylvester Comprehens Canc Ctr, Miller Sch Med, Miami, FL 33136 USA	University of Miami; Case Western Reserve University; Case Western Reserve University; Baylor College of Medicine; Baylor College of Medicine; University of Miami	Welford, SM (corresponding author), Univ Miami, Miller Sch Med, Dept Radiat Oncol, Miami, FL 33136 USA.; Welford, SM (corresponding author), Univ Miami, Sylvester Comprehens Canc Ctr, Miller Sch Med, Miami, FL 33136 USA.	scott.welford@med.miami.edu			 [P30CA125123];  [R01CA187053]; NATIONAL CANCER INSTITUTE [R01CA187053, P30CA125123] Funding Source: NIH RePORTER	; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by P30CA125123 (CJC); and R01CA187053 (SMW).	Baek JH, 2007, J BIOL CHEM, V282, P33358, DOI 10.1074/jbc.M705627200; Brett-Morris A, 2014, CANCER RES, V74, P6925, DOI 10.1158/0008-5472.CAN-14-1249; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Chen X, 2013, MOL CELL BIOL, V33, P227, DOI 10.1128/MCB.00881-12; Coleman CS, 1996, BIOCHEM J, V316, P697, DOI 10.1042/bj3160697; Dehart GW, 2008, P NATL ACAD SCI USA, V105, P7188, DOI 10.1073/pnas.0708044105; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Holst CM, 2008, CELL BIOL INT, V32, P39, DOI 10.1016/j.cellbi.2007.08.008; Huang L, 2017, BIOCHEM BIOPH RES CO, V490, P707, DOI 10.1016/j.bbrc.2017.06.105; Joshi K, 2013, STEM CELLS, V31, P1051, DOI 10.1002/stem.1358; Kim SH, 2015, STEM CELL REP, V4, P226, DOI 10.1016/j.stemcr.2014.12.006; Krieg AJ, 2006, MOL CELL BIOL, V26, P7030, DOI 10.1128/MCB.00322-06; Lee SB, 2011, BIOCHEM J, V433, P205, DOI 10.1042/BJ20101322; Pegg AE, 2008, AM J PHYSIOL-ENDOC M, V294, pE995, DOI 10.1152/ajpendo.90217.2008; Pegg AE, 2011, METHODS MOL BIOL, V720, P3, DOI 10.1007/978-1-61779-034-8_1; Santos JS, 2010, DEV DYNAM, V239, P1010, DOI 10.1002/dvdy.22228; Sharma V, 2017, CARCINOGENESIS, V38, P152, DOI 10.1093/carcin/bgw126; Takeuchi H, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006441; Uemura T, 2008, J BIOL CHEM, V283, P26428, DOI 10.1074/jbc.M804714200; Veeravalli KK, 2012, CELL SIGNAL, V24, P272, DOI 10.1016/j.cellsig.2011.09.011; Wang J, 2017, J CLIN INVEST, V127, P3075, DOI 10.1172/JCI89092; Yoo J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11045	22	16	16	3	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 10	2019	38	41					6794	6800		10.1038/s41388-019-0917-0	http://dx.doi.org/10.1038/s41388-019-0917-0			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JC8UZ	31399646	Green Accepted			2022-12-26	WOS:000489552900007
J	Hoop, CL; Kemraj, AP; Wang, BF; Gahlawat, S; Godesky, M; Zhu, J; Warren, HR; Case, DA; Shreiber, DI; Baum, J				Hoop, Cody L.; Kemraj, Allysa P.; Wang, Baifan; Gahlawat, Sonal; Godesky, Madison; Zhu, Jie; Warren, Haley R.; Case, David A.; Shreiber, David, I; Baum, Jean			Molecular underpinnings of integrin binding to collagen-mimetic peptides containing vascular Ehlers?Danlos syndrome?associated substitutions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen; integrin; protein-protein interaction; cell surface receptor; extracellular matrix protein; cell spreading; collagen mutations; connective tissue disorder; triple helix; vascular Ehlers-Danlos syndrome	OSTEOGENESIS IMPERFECTA MUTATIONS; EPITHELIUM-DERIVED FACTOR; PARTICLE MESH EWALD; TRIPLE-HELIX; I COLLAGEN; MODEL PEPTIDES; DANLOS-SYNDROME; NATURAL INTERRUPTION; SEQUENCE DEPENDENCE; PLATELET-ADHESION	Collagens carry out critical extracellular matrix (ECM) functions by interacting with numerous cell receptors and ECM components. Single glycine substitutions in collagen III, which predominates in vascular walls, result in vascular Ehlers?Danlos syndrome (vEDS), leading to arterial, uterine, and intestinal rupture and an average life expectancy of <50 years. Collagen interactions with integrin ?(2)?(1) are vital for platelet adhesion and activation; however, how these interactions are impacted by vEDS-associated mutations and by specific amino acid substitutions is unclear. Here, we designed collagen-mimetic peptides (CMPs) with previously reported Gly ? Xaa (Xaa = Ala, Arg, or Val) vEDS substitutions within a high-affinity integrin ?(2)?(1)-binding motif, GROGER. We used these peptides to investigate, at atomic-level resolution, how these amino acid substitutions affect the collagen III?integrin ?(2)?(1) interaction. Using a multitiered approach combining biological adhesion assays, CD, NMR, and molecular dynamics (MD) simulations, we found that these substitutions differentially impede human mesenchymal stem cell spreading and integrin ?(2)?inserted (?I-2) domain binding to the CMPs and were associated with triple-helix destabilization. Although an Ala substitution locally destabilized hydrogen bonding and enhanced mobility, it did not significantly reduce the CMP?integrin interactions. MD simulations suggested that bulkier Gly ? Xaa substitutions differentially disrupt the CMP??I-2 interaction. The Gly ? Arg substitution destabilized CMP??I-2 side-chain interactions, and the Gly ? Val change broke the essential Mg2+ coordination. The relationship between the loss of functional binding and the type of vEDS substitution provides a foundation for developing potential therapies for managing collagen disorders.	[Hoop, Cody L.; Kemraj, Allysa P.; Wang, Baifan; Zhu, Jie; Case, David A.; Baum, Jean] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Gahlawat, Sonal; Godesky, Madison; Warren, Haley R.; Shreiber, David, I] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Baum, J (corresponding author), Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA.	jean.baum@rutgers.edu	Shreiber, David/ABE-8254-2021	Gahlawat, Sonal/0000-0002-0780-6651; Kemraj, Allysa/0000-0002-3722-9074; Shreiber, David/0000-0001-8248-419X; Hoop, Cody/0000-0003-4441-8321	Rutgers; State of New Jersey; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045302] Funding Source: NIH RePORTER	Rutgers; State of New Jersey; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research used resources from the Rutgers Discovery Informatics Institute, which is supported by Rutgers and the State of New Jersey.	Andriotis OG, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0701; Arseni L, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051407; BACHINGER HP, 1980, EUR J BIOCHEM, V106, P619, DOI 10.1111/j.1432-1033.1980.tb04610.x; BAHOU WF, 1994, BLOOD, V84, P3734, DOI 10.1182/blood.V84.11.3734.bloodjournal84113734; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Barrow AD, 2011, J CLIN INVEST, V121, P3505, DOI 10.1172/JCI45913; Baxter NJ, 1997, J BIOMOL NMR, V9, P359, DOI 10.1023/A:1018334207887; Beck K, 2000, P NATL ACAD SCI USA, V97, P4273, DOI 10.1073/pnas.070050097; Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; Bhate M, 2002, BIOCHEMISTRY-US, V41, P6539, DOI 10.1021/bi020070d; Bodian DL, 2008, BIOCHEMISTRY-US, V47, P5424, DOI 10.1021/bi800026k; Bodian DL, 2009, HUM MUTAT, V30, P946, DOI 10.1002/humu.20978; BONADIO J, 1985, NATURE, V316, P363, DOI 10.1038/316363a0; Brodsky B, 2008, NATURE, V453, P998, DOI 10.1038/453998a; Broos K, 2012, THROMB RES, V129, P245, DOI 10.1016/j.thromres.2011.11.002; Bryan MA, 2011, BIOPOLYMERS, V96, P4, DOI 10.1002/bip.21432; Buevich AV, 2004, J BIOL CHEM, V279, P46890, DOI 10.1074/jbc.M407061200; Case D. A., 2018, AMBER 2019; Chhum P, 2016, J BIOL CHEM, V291, P27073, DOI 10.1074/jbc.M116.753566; Dalgleish R, 1998, NUCLEIC ACIDS RES, V26, P253, DOI 10.1093/nar/26.1.253; Dalgleish R, 1997, NUCLEIC ACIDS RES, V25, P181, DOI 10.1093/nar/25.1.181; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Des Parkin J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175582; DIAMOND MS, 1993, J CELL BIOL, V120, P1031, DOI 10.1083/jcb.120.4.1031; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Farndale RW, 2008, BIOCHEM SOC T, V36, P241, DOI 10.1042/BST0360241; Forlino A, 2007, MATRIX BIOL, V26, P604, DOI 10.1016/j.matbio.2007.06.005; Gautieri A, 2009, PROTEIN SCI, V18, P161, DOI 10.1002/pro.21; Giudici C, 2008, J BIOL CHEM, V283, P19551, DOI 10.1074/jbc.M710001200; Goddard TD, 2008, SPARKY 3 115; Gopalakrishnan R, 2015, PHYS CHEM CHEM PHYS, V17, P5172, DOI 10.1039/c4cp04969a; Hayashi Y, 1998, BIOORGAN MED CHEM, V6, P355, DOI 10.1016/S0968-0896(97)10050-5; Heino J, 2007, BIOESSAYS, V29, P1001, DOI 10.1002/bies.20636; Humtsoe JO, 2005, J BIOL CHEM, V280, P13848, DOI 10.1074/jbc.M410605200; Hyde TJ, 2006, J BIOL CHEM, V281, P36937, DOI 10.1074/jbc.M605135200; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jarvis GE, 2008, BLOOD, V111, P4986, DOI 10.1182/blood-2007-08-108472; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; KAMATA T, 1994, J BIOL CHEM, V269, P26006; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kim JK, 2005, J BIOL CHEM, V280, P32512, DOI 10.1074/jbc.M502431200; Knight CG, 1999, CARDIOVASC RES, V41, P450, DOI 10.1016/S0008-6363(98)00306-X; Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287; Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200; Kuivaniemi H, 1997, HUM MUTAT, V9, P300, DOI 10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9; Lebbink RJ, 2008, J IMMUNOL, V180, P1662, DOI 10.4049/jimmunol.180.3.1662; Lebbink RJ, 2006, J EXP MED, V203, P1419, DOI 10.1084/jem.20052554; Leo JC, 2010, INFECT IMMUN, V78, P3226, DOI 10.1128/IAI.01057-09; Li YJ, 2009, J BIOL CHEM, V284, P20660, DOI 10.1074/jbc.M109.018077; Lisman T, 2006, BLOOD, V108, P3753, DOI 10.1182/blood-2006-03-011965; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Makareeva E, 2011, TRENDS CELL BIOL, V21, P168, DOI 10.1016/j.tcb.2010.11.007; Maurice P, 2004, FASEB J, V18, P1339, DOI 10.1096/fj.03-1151com; Meyer C, 2002, J BIOL CHEM, V277, P45400, DOI 10.1074/jbc.M208339200; MILLER EJ, 1976, ARCH BIOCHEM BIOPHYS, V173, P631, DOI 10.1016/0003-9861(76)90300-3; Moroi Masaaki, 1998, Frontiers in Bioscience, V3, pD719; MORTON LF, 1994, BIOCHEM J, V299, P791, DOI 10.1042/bj2990791; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Orgel JPRO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007028; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Pepin M, 2000, NEW ENGL J MED, V342, P673, DOI 10.1056/NEJM200003093421001; Pepin MG, 2014, GENET MED, V16, P881, DOI 10.1038/gim.2014.72; Persikov AV, 2004, HUM MUTAT, V24, P330, DOI 10.1002/humu.20091; Persikov AV, 2000, BIOPOLYMERS, V55, P436, DOI 10.1002/1097-0282(2000)55:6<436::AID-BIP1019>3.0.CO;2-D; Popov C, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.71; Qiu YM, 2018, J STRUCT BIOL, V203, P255, DOI 10.1016/j.jsb.2018.05.003; Rainey JK, 2004, BIOINFORMATICS, V20, P2458, DOI 10.1093/bioinformatics/bth247; RAMACHANDRAN GN, 1955, NATURE, V176, P593, DOI 10.1038/176593a0; Rauch F, 2010, EUR J HUM GENET, V18, P642, DOI 10.1038/ejhg.2009.242; RICH A, 1955, NATURE, V176, P915, DOI 10.1038/176915a0; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SANANTONIO JD, 1994, J CELL BIOL, V125, P1179, DOI 10.1083/jcb.125.5.1179; Savage B, 1999, BLOOD, V94, P2704, DOI 10.1182/blood.V94.8.2704.420k41_2704_2715; Sekiya A, 2011, J BIOL CHEM, V286, P26364, DOI 10.1074/jbc.M111.252684; Semon JA, 2010, CELL TISSUE RES, V341, P147, DOI 10.1007/s00441-010-0994-4; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200; Slatter DA, 2012, PEPTIDES, V36, P86, DOI 10.1016/j.peptides.2012.04.013; Springer TA, 1997, P NATL ACAD SCI USA, V94, P65, DOI 10.1073/pnas.94.1.65; Sun XX, 2019, J MATER CHEM B, V7, P3201, DOI 10.1039/c9tb00086k; Sun XX, 2016, PROTEIN SCI, V25, P383, DOI 10.1002/pro.2828; Sun XX, 2015, BIOCHEMISTRY-US, V54, P6106, DOI 10.1021/acs.biochem.5b00747; Sweeney SM, 2008, J BIOL CHEM, V283, P21187, DOI 10.1074/jbc.M709319200; Sweeney SM, 1998, P NATL ACAD SCI USA, V95, P7275, DOI 10.1073/pnas.95.13.7275; TUCKWELL D, 1995, J CELL SCI, V108, P1629; Tulla M, 2001, J BIOL CHEM, V276, P48206, DOI 10.1074/jbc.M104058200; UITTO J, 1976, J INVEST DERMATOL, V66, P59, DOI 10.1111/1523-1747.ep12481404; Wallace JM, 2011, J STRUCT BIOL, V173, P146, DOI 10.1016/j.jsb.2010.08.003; Xiao JX, 2015, J STRUCT BIOL, V192, P127, DOI 10.1016/j.jsb.2015.05.002; Xiao JX, 2011, BIOCHEMISTRY-US, V50, P10771, DOI 10.1021/bi201476a; Xiao JX, 2011, BIOPHYS J, V101, P449, DOI 10.1016/j.bpj.2011.06.017; Xu K, 2008, J BIOL CHEM, V283, P34337, DOI 10.1074/jbc.M805485200; Yigit S, 2016, J BIOL CHEM, V291, P19196, DOI 10.1074/jbc.M116.726182	98	1	2	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2019	294	39					14442	14453		10.1074/jbc.RA119.009685	http://dx.doi.org/10.1074/jbc.RA119.009685			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HH	31406019	Green Published, hybrid			2022-12-26	WOS:000499248200023
J	Noveski, P; Terzic, M; Vujovic, M; Kuzmanovska, M; Stefanovska, ES; Plaseska-Karanfilska, D				Noveski, Predrag; Terzic, Marija; Vujovic, Marija; Kuzmanovska, Maja; Stefanovska, Emilija Sukarova; Plaseska-Karanfilska, Dijana			Multilevel regression modeling for aneuploidy classification and physical separation of maternal cell contamination facilitates the QF-PCR based analysis of common fetal aneuploidies	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; RAPID PRENATAL-DIAGNOSIS; CHROMOSOME ANEUPLOIDIES; MOSAIC LOSS; DNA; SAMPLES; BLOOD; RISK	Background The quantitative fluorescent polymerase chain reaction (QF-PCR) has proven to be a reliable method for detection of common fetal chromosomal aneuploidies. However, there are some technical shortcomings, such as uncertainty of aneuploidy determination when the short tandem repeats (STR) height ratio is unusual due to a large size difference between alleles or failure due to the presence of maternal cell contamination (MCC). The aim of our study is to facilitate the implementation of the QF-PCR as a rapid diagnostic test for common fetal aneuploidies. Methods Here, we describe an in-house one-tube multiplex QF-PCR method including 20 PCR markers (15 STR markers and 5 fixed size) for rapid prenatal diagnosis of chromosome 13, 18, 21, X and Y aneuploidies. In order to improve the aneuploidy classification of a given diallelic STR marker, we have employed a multilevel logistic regression analysis using "height-ratio" and "allele-size-difference" as fixed effects and "marker" as a random effect. We employed two regression models, one for the 2:1 height ratio (n = 48 genotypes) and another for the 1:2 height ratio (n = 41 genotypes) of the trisomic diallelic markers while using the same 9015 genotypes with normal 1:1 height ratio in both models. Furthermore, we have described a simple procedure for the treatment of the MCC, prior DNA isolation and QF-PCR analysis. Results For both models, we have achieved 100% specificity for the marker aneuploidy classification as compared to 98.60% (2:1 ratio) and 98.04% (1:2 ratio) specificity when using only the height ratio for classification. Treatment of the MCC enables a successful diagnosis rate of 76% among truly contaminated amniotic fluids. Conclusions Adjustment for the allele size difference and marker type improves the STR aneuploidy classification, which, complemented with appropriate treatment of contaminated amniotic fluids, eliminates sample re-testing and reinforces the robustness of the QF-PCR method for prenatal testing.	[Noveski, Predrag; Terzic, Marija; Vujovic, Marija; Kuzmanovska, Maja; Stefanovska, Emilija Sukarova; Plaseska-Karanfilska, Dijana] Macedonian Acad Sci & Arts, Res Ctr Genet Engn & Biotechnol Georgi D Efremov, Skopje, North Macedonia; [Kuzmanovska, Maja] Inst Publ Hlth, Lab Virol & Mol Diagnost, Skopje, North Macedonia		Plaseska-Karanfilska, D (corresponding author), Macedonian Acad Sci & Arts, Res Ctr Genet Engn & Biotechnol Georgi D Efremov, Skopje, North Macedonia.	dijana@manu.edu.mk	Plaseska-Karanfilska, Dijana/P-6096-2018	Plaseska-Karanfilska, Dijana/0000-0001-8877-2416; Noveski, Predrag/0000-0002-3882-9821				Aho K, 2014, ECOLOGY, V95, P631, DOI 10.1890/13-1452.1; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Badenas C, 2010, J MOL DIAGN, V12, P828, DOI 10.2353/jmoldx.2010.090224; Carlson LM, 2017, OBSTET GYN CLIN N AM, V44, P245, DOI 10.1016/j.ogc.2017.02.004; Cirigliano V, 2004, MOL HUM REPROD, V10, P839, DOI 10.1093/molehr/gah108; Cirigliano V, 2001, MOL HUM REPROD, V7, P1001, DOI 10.1093/molehr/7.10.1001; Cirigliano V, 2009, PRENATAL DIAG, V29, P40, DOI 10.1002/pd.2192; Dey M, 2013, N AM J MED SCI, V5, P41, DOI [10.4103/1947-2714.109180, 10.4103/1947-2714.106198]; Dumanski JP, 2016, AM J HUM GENET, V98, P1208, DOI 10.1016/j.ajhg.2016.05.014; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Forsberg LA, 2014, NAT GENET, V46, P624, DOI 10.1038/ng.2966; Gujarati D., 2003, BASIC ECONOMETRICS, P363; Hahn S, 2010, GENOME MED, V2, DOI 10.1186/gm171; Haitjema S, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.116.001544; Hastings R, 2012, ECA NEWSLETTER, V30, P11; Hulten MA, 2003, REPRODUCTION, V126, P279, DOI 10.1530/reprod/126.3.279; Kim Young Joo, 2013, Obstet Gynecol Sci, V56, P160, DOI 10.5468/ogs.2013.56.3.160; Kimura A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190667; Kozlowski P, 2006, FETAL DIAGN THER, V21, P217, DOI 10.1159/000089306; Langlois S, 2011, J OBSTET GYNAECOL CA, V33, P955, DOI 10.1016/S1701-2163(16)35022-8; Lapaire O, 2007, PRENATAL DIAG, V27, P616, DOI 10.1002/pd.1752; Madjunkova S, 2014, PRENATAL DIAG, V34, P970, DOI 10.1002/pd.4405; Mann K, 2012, PRENATAL DIAG, V32, P1197, DOI 10.1002/pd.3986; MANSFIELD ES, 1993, HUM MOL GENET, V2, P43, DOI 10.1093/hmg/2.1.43; Nagan N, 2011, J MOL DIAGN, V13, P7, DOI 10.1016/j.jmoldx.2010.11.013; Nicolini U, 2004, HUM REPROD UPDATE, V10, P541, DOI 10.1093/humupd/dmh046; Noveski P, QUANTITATIVE FLUORES, DOI [10.17504/protocols.io.2v9ge96, DOI 10.17504/PROTOCOLS.IO.2V9GE96]; Noveski P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146264; Pan M, 2013, PRENATAL DIAG, V33, P598, DOI 10.1002/pd.4069; Pertl B, 1997, AM J OBSTET GYNECOL, V177, P899, DOI 10.1016/S0002-9378(97)70292-8; PERTL B, 1994, LANCET, V343, P1197, DOI 10.1016/S0140-6736(94)92404-X; Plaseska-Karanfilska D, 2011, HUMAN GENETIC DIS; Plaseski T, 2008, GENET TEST, V12, P595, DOI 10.1089/gte.2008.0068; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sachs MC, 2017, J STAT SOFTW, V79, DOI 10.18637/jss.v079.c02; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Shaffer LG, 2007, AM J MED GENET C, V145C, P87, DOI 10.1002/ajmg.c.30114; Sherlock J, 1998, ANN HUM GENET, V62, P9; Shmueli G, 2010, STAT SCI, V25, P289, DOI 10.1214/10-STS330; Speevak MD, 2011, PRENATAL DIAG, V31, P454, DOI 10.1002/pd.2716; Stojilkovic-Mikic T, 2005, PRENATAL DIAG, V25, P79, DOI 10.1002/pd.1089; Van Opstal D, 2016, EXPERT REV MOL DIAGN, V16, P513, DOI 10.1586/14737159.2016.1152890; Vaughan TS, 2005, J STAT EDUC, V13, DOI 10.1080/10691898.2005.11910640; Wickham H., 2017, TIDYVERSE EASILY INS, V1; Winsor EJT, 1996, PRENATAL DIAG, V16, P49, DOI 10.1002/(SICI)1097-0223(199601)16:1<49::AID-PD808>3.3.CO;2-L; Wolfe D, 2013, BIODATA MIN, V6, DOI 10.1186/1756-0381-6-18	46	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0221227	10.1371/journal.pone.0221227	http://dx.doi.org/10.1371/journal.pone.0221227			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430300	Green Published, gold, Green Submitted			2022-12-26	WOS:000485026800035
J	Ntampaka, P; Nyaga, PN; Niragire, F; Gathumbi, JK; Tukei, M				Ntampaka, P.; Nyaga, P. N.; Niragire, F.; Gathumbi, J. K.; Tukei, M.			Knowledge, attitudes and practices regarding rabies and its control among dog owners in Kigali city, Rwanda	PLOS ONE			English	Article							LOGISTIC-REGRESSION; AWARENESS; COMMUNITY	Background Rabies is a zoonotic viral disease that can occur in all warm-blooded animals, including humans. Vaccinating dogs can protect people from contracting rabies. Rabies is a public health threat in Rwanda, but the country does not have information on the epidemiology of rabies. The present study aimed to understand the knowledge, attitudes and practices (KAP) of rabies and its control among dog owners in Kigali city of Rwanda. Methods We conducted a cross-sectional survey using a structured questionnaire among 137 dog owners selected from nine administrative study sites. A two-stage random sampling procedure was used to select the participants. Frequency distributions analysis and a series of chi-square tests of associations as well as binary logistic regressions were performed to determine the important factors associated with the response variables. Results The results showed that 99.5% of respondents knew at least a host susceptible to rabies. Only 22.4% and 21.3% knew that dogs and people can develop rabies, respectively. Nearly 73.6% knew that human rabies can be transmitted through dog-bites and 99% could identify at least a clinical sign of canine rabies. Overall, 81.8% knew that regular vaccination of dogs helps to prevent dog-transmitted human rabies and 43.1% and 26.3% were aware that rabies in humans and in dogs are fatal once clinical symptoms have shown, respectively. Only 69% would observe a dog for 10 days after it bites a man or an animal. Approximately 20.4% were familiar with appropriate cleaning of dog-bites wounds, and 20.6% knew that puppies could receive rabies vaccination before they are three months old. Of those who owned vaccinated dogs, 78% were happy about the cost (US $ <= 34) of rabies vaccination. Of all the respondents, 58% had their dogs vaccinated at home by veterinarians while 86% indicated their veterinarians kept rabies vaccines on ice in a cool box. Overall, 53% of the dog owners had sufficient knowledge of rabies, whilst 66% and 17% adopted adequate practices and positive attitudes towards rabies, respectively. Multivariable logistic regression analyses indicated that none of the respondents' sex, educational level, and the length of dog ownership were statistically associated with their knowledge, attitudes and practices of rabies. Conclusions This study showed that majority of the dog owners had sufficient knowledge and adopted appropriate practices of rabies. However there exist some knowledge gaps among the dog owners particularly on treatment, transmission and control methods. Therefore, rabies awareness campaign is required to upgrade rabies knowledge of the dog owners on rabies prevention and control in Rwanda.	[Ntampaka, P.; Tukei, M.] Univ Rwanda, Dept Vet Med, Nyagatare, Rwanda; [Nyaga, P. N.; Gathumbi, J. K.] Univ Nairobi, Dept Vet Pathol Microbiol & Parasitol, Nairobi, Kenya; [Niragire, F.] Univ Rwanda, Dept Appl Stat, Kigali, Rwanda	University of Rwanda; University of Nairobi; University of Rwanda	Ntampaka, P (corresponding author), Univ Rwanda, Dept Vet Med, Nyagatare, Rwanda.	piusynt@gmail.com	Ntampaka, Pie/AAF-1714-2019; Niragire, François/GMX-0394-2022	Ntampaka, Pie/0000-0001-5605-1091; Niragire, François/0000-0003-0473-387X	Borlaug Higher Education for Agricultural Research and Development (BHEARD); United States Agency for International Development, Feed the Future Initiative, under the CGIAR Fund [BFS-G-11-00002]; predecessor fund the Food Security and Crisis Mitigation II grant [EEM-G-00-04-00013]	Borlaug Higher Education for Agricultural Research and Development (BHEARD); United States Agency for International Development, Feed the Future Initiative, under the CGIAR Fund(United States Agency for International Development (USAID)); predecessor fund the Food Security and Crisis Mitigation II grant	This work was supported by Borlaug Higher Education for Agricultural Research and Development (BHEARD) (https://www.canr.msu.edu/bheard). BHEARD is a project funded by the United States Agency for International Development, as part of the Feed the Future Initiative, under the CGIAR Fund, award number BFS-G-11-00002, and the predecessor fund the Food Security and Crisis Mitigation II grant, award number EEM-G-00-04-00013. Mr Pie Ntampaka acquired funding and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Subaihi AA, 2003, SAUDI MED J, V24, P323; Ameh Veronica O, 2014, Glob J Health Sci, V6, P226, DOI 10.5539/gjhs.v6n5p226; [Anonymous], 2018, WHO EXP CONS RAB 3 R; [Anonymous], 2017, THE NEW TIMES; Bartlett EJ, 2001, INFORM TECHNOLOGY LE, V19; Castillo-Neyra R, 2017, PLOS NEGLECT TROP D, V11, P1, DOI [10.1371nournalpntd.0005460, DOI 10.1371NOURNALPNTD.0005460]; CBS (central office of statistics), 2019, OPL; da Costa LJC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004474; Dabuma T, 2017, J MED MICROB DIAGN, V6, DOI 10.4172/2161-0703.1000263; Dhiman A.K., 2017, INT J COMMUNITY MED, V3, P2064; Fenelon N, 2017, EPIDEMIOL INFECT, V145, P1624, DOI 10.1017/S0950268816003125; Ghosh S, 2016, VET MED SCI, V2, P161, DOI 10.1002/vms3.30; Global Alliance for Rabies Control, 2017, SARE REC; Global Alliance for Rabies Control, 2017, 1 M DIR RAB CONTR PR; Global Alliance for Rabies Control, 2016, STEPW APPR RAB EL PL; Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI [10.1371/journal.pntd.0003709, 10.1371/journal.pntd.0003786]; Jemberu WT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002216; Matibag Gino C., 2007, Environmental Health and Preventive Medicine, V12, P84, DOI 10.1007/BF02898154; Mitmoonpitak C, 1997, J VET MED SCI, V59, P457, DOI 10.1292/jvms.59.457; Mitmoonpitak C, 1998, EPIDEMIOL INFECT, V120, P165, DOI 10.1017/S0950268897008601; Mucheru GM, 2014, PAN AFR MED J, V19, P1, DOI [10.11604/pamj.2014.19.1.5025, DOI 10.11604/PAMJ.2014.19.1.5025]; Niragire F, 2017, J EDUC WORK, V30, P235, DOI 10.1080/13639080.2016.1165343; Preparedness & Response (one health in action), 2017, RWANDA PRIORITIZES Z; Rupprecht C., 2017, F1000 RES, V6, P184, DOI [DOI 10.12688/F1000RESEARCH.10416.1, 10.12688/f1000research.10416.1]; Sambo M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003310; Singh A. S., 2014, INT J EC COMMERCE MA, V2, P1; Southern and Eastern African Rabies Group, 2011, 10 SEARG M MAP MOZ; Stoltzfus JC, 2011, ACAD EMERG MED, V18, P1099, DOI 10.1111/j.1553-2712.2011.01185.x; Tadesse Guadu, 2014, Global Veterinaria, V13, P348; Tenzin, 2012, INT HEALTH, V4, P210, DOI 10.1016/j.inhe.2012.03.005; Tepsumethanon V, 2004, CLIN INFECT DIS, V39, P278, DOI 10.1086/421556; Tiwari HK, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007120; Tschopp R, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004471; Widdowson MA, 2002, EMERG INFECT DIS, V8, P458, DOI 10.3201/eid0805.010302; World Health Organisation, 2013, WHO EXP CONS RAB, V982; World Health Organization, 2013, FREQ ASK QUEST RAB; World Organisation for Animal Health, 2016, TERR AN HLTH COD GEN, V1; World Organisation for Animal Health, 2011, 19 C OIE REG COMM AF; World Organisation for Animal Health, 2011, RAB GEN DIS INF SHEE	39	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0210044	10.1371/journal.pone.0210044	http://dx.doi.org/10.1371/journal.pone.0210044			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430285	Green Published, Green Submitted, gold			2022-12-26	WOS:000485026800001
J	Vegter, RJK; Mason, BS; Sporrel, B; Stone, B; van der Woude, LHV; Goosey-Tolfrey, VL				Vegter, Riemer J. K.; Mason, Barry S.; Sporrel, Bastiaan; Stone, Benjamin; van der Woude, Lucas H. V.; Goosey-Tolfrey, Vicky L.			Crank fore-aft position alters the distribution of work over the push and pull phase during synchronous recumbent handcycling of able-bodied participants	PLOS ONE			English	Article							HANDRIM WHEELCHAIR PROPULSION; MECHANICAL EFFICIENCY; SHOULDER LOAD; PERFORMANCE; ERGOMETRY; RESPONSES; VELOCITY; CADENCE; STRAIN; LENGTH	Objective The objective of the current study was to investigate the effect of four different crank fore-aft positions on elbow flexion and shoulder protraction, the consequent propulsion kinetics and the physiological responses during handcycling. Methods Twelve able-bodied male participants volunteered in this study. Crank fore-aft positions were standardised at 94%, 97%, 100% and 103% of the participants' arm length. Two sub maximal 3 min trials were performed at a fixed cadence (70 rpm), in a recumbent handcyle attached to an ergometer at two fixed power outputs (30W and 60W). Elbow flexion, shoulder protraction, propulsion kinetics and physiological responses of the participants were continuously measured. Results As crank fore-aft distance increased, a decrease in elbow flexion (42 +/- 4, 37 +/- 3, 33 +/- 3, 29 +/- 3) and an increase shoulder protraction was observed (29 +/- 5, 31 +/- 5, 34 +/- 5, 36 +/- 5). The percentage of work done in the pull phase increased as well (62 +/- 7, 65 +/- 7, 67 +/- 6, 69 +/- 8%, at 60W), which was in line with an increased peak torque during the pull phase (8.8 +/- 1.6, 9.0 +/- 1.4, 9.4 +/- 1.5, 9.7 +/- 1.4Nm, at 60W) and reduced peak torque during the push phase (6.0 +/- 0.9, 5.6 +/- 0.9, 5.6 +/- 0.9, 5.4 +/- 1.0Nm, in 60W condition). Despite these changes in work distribution, there were no significant changes in gross mechanical efficiency (15.7 +/- 0.8, 16.2 +/- 1.1, 15.8 +/- 0.9, 15.6 +/- 1.0%, at 60W). The same patterns were observed in the 30W condition. Conclusions From a biomechanical perspective the crank position closest to the trunk (94%) seems to be advantageous, because it evens the load over the push and pull phase, which reduces speed fluctuations, without causing an increase in whole body energy expenditure and hence a decrease of gross mechanical efficiency. These findings may help handcyclists to optimize their recumbent handcycle configuration.	[Vegter, Riemer J. K.; Sporrel, Bastiaan; van der Woude, Lucas H. V.] Univ Groningen, Univ Med Ctr Groningen, Dept Human Movement Sci, Groningen, Netherlands; [Vegter, Riemer J. K.; Mason, Barry S.; Stone, Benjamin; Goosey-Tolfrey, Vicky L.] Loughborough Univ, Sch Sport Exercise & Hlth Sci, Peter Harrison Ctr Disabil Sport, Loughborough, Leics, England; [van der Woude, Lucas H. V.] Univ Groningen, Univ Med Ctr Groningen, Ctr Rehabil, Groningen, Netherlands	University of Groningen; Loughborough University; University of Groningen	Vegter, RJK (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Human Movement Sci, Groningen, Netherlands.; Vegter, RJK (corresponding author), Loughborough Univ, Sch Sport Exercise & Hlth Sci, Peter Harrison Ctr Disabil Sport, Loughborough, Leics, England.	r.j.k.vegter@umcg.nl	Sporrel, Bastiaan/ABE-9464-2020; JK, Vegter Riemer/N-3385-2013; van der Woude, Lucas/E-7986-2018	JK, Vegter Riemer/0000-0002-4294-6086; van der Woude, Lucas/0000-0002-8472-334X				Abel T, 2006, SPINAL CORD, V44, P211, DOI 10.1038/sj.sc.3101845; Abel T, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00331; Arnet U, 2014, SCAND J MED SCI SPOR, V24, P386, DOI 10.1111/j.1600-0838.2012.01524.x; Arnet U, 2013, J APPL BIOMECH, V29, P687, DOI 10.1123/jab.29.6.687; Arnet U, 2012, J REHABIL MED, V44, P222, DOI 10.2340/16501977-0929; Arnet U, 2012, CLIN BIOMECH, V27, P1, DOI 10.1016/j.clinbiomech.2011.07.002; Azizpour G, 2018, J APPL BIOMECH, V34, P175, DOI 10.1123/jab.2017-0136; Bobbert MF, 2016, MED SCI SPORT EXER, V48, P869, DOI 10.1249/MSS.0000000000000845; Dallmeijer AJ, 2004, SPINAL CORD, V42, P91, DOI 10.1038/sj.sc.3101566; Ehrig RM, 2007, J BIOMECH, V40, P2150, DOI 10.1016/j.jbiomech.2006.10.026; Faupin A, 2008, J REHABIL RES DEV, V45, P109, DOI 10.1682/JRRD.2006.10.0139; GARBY L, 1987, ACTA PHYSIOL SCAND, V129, P443, DOI 10.1111/j.1365-201X.1987.tb10613.x; Goosey-Tolfrey VL, 2008, EUR J APPL PHYSIOL, V102, P189, DOI 10.1007/s00421-007-0576-7; Hansen EA, 2003, J BIOMECH, V36, P1713, DOI 10.1016/S0021-9290(03)00167-2; Hill H, 2009, SCAND J MED SCI SPOR, V19, P585, DOI 10.1111/j.1600-0838.2008.00819.x; Jacquier-Bret J, 2013, J APPL BIOMECH, V29, P798, DOI 10.1123/jab.29.6.798; Kouwijzer I, 2020, DISABIL REHABIL, V42, P400, DOI 10.1080/09638288.2018.1501097; Kraaijenbrink C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183502; Kramer C, 2009, EUR J APPL PHYSIOL, V106, P749, DOI 10.1007/s00421-009-1062-1; Litzenberger S, 2015, PROCEDIA ENGINEER, V112, P355, DOI 10.1016/j.proeng.2015.07.262; Nesser TW, 2008, J STRENGTH COND RES, V22, P1750, DOI 10.1519/JSC.0b013e3181874564; Powers SK, 2017, J APPL PHYSIOL, V56, P495; Price MJ, 2007, APPL PHYSIOL NUTR ME, V32, P686, DOI 10.1139/H07-052; Quittmann OJ, 2018, SPORTS ENG, V21, P283, DOI 10.1007/s12283-018-0269-y; Stone B, 2019, ERGONOMICS, V62, P449, DOI 10.1080/00140139.2018.1531149; van der Woude L H, 1989, J Rehabil Res Dev, V26, P31; van der Woude LHV, 2009, J REHABIL MED, V41, P143, DOI 10.2340/16501977-0296; van Drongelen S., 2009, Journal of Medical Engineering & Technology, V33, P151, DOI 10.1080/13561820802565676; VEEGER HEJ, 1991, J ELECTROMYOGR KINES, V1, P270, DOI 10.1016/1050-6411(91)90014-V; Vegter RJK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089729; Verellen J, 2012, EUR J APPL PHYSIOL, V112, P983, DOI 10.1007/s00421-011-2051-8; Verellen J, 2008, J REHABIL RES DEV, V45, P1295, DOI 10.1682/JRRD.2007.12.0205; Warner MB, 2015, JOVE-J VIS EXP, DOI 10.3791/51717; Woude LHV, 1988, MED SCI SPORT EXERC, V20; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042	35	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0220943	10.1371/journal.pone.0220943	http://dx.doi.org/10.1371/journal.pone.0220943			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5MK	31425557	Green Published, gold, Green Submitted			2022-12-26	WOS:000485022400021
J	Xie, E; Zheng, L; Li, XY; Wang, YY; Dou, JF; Ding, AZ; Zhang, DY				Xie, En; Zheng, Lei; Li, Xinyang; Wang, Yingying; Dou, Junfeng; Ding, Aizhong; Zhang, Dayi			One-step synthesis of magnetic-TiO2-nanocomposites with high iron oxide composing ratio for photocatalysis of rhodamine 6G	PLOS ONE			English	Article							MAGNETIC TIO2 PHOTOCATALYST; CORE-SHELL NANOCOMPOSITES; DEGRADATION; SEPARATION; FE; PHOTODEGRADATION; NANOPARTICLES; PERFORMANCE; 4-NITROPHENOL; PURIFICATION	In the study, a facile one-step method for synthesizing magnetic-TiO2-nanophotocatalysts was developed. With the same composing ratio of 0.5 and 0.35 (Fe:Ti, mole:mole), we prepared two types of magnetic-TiO2-nanocomposites as one-step synthesized FexOy-composed TiO2 (FexOy/TiO2-0.5 and FexOy/TiO2-0.35) and two-step synthesized core-shell FexOy@TiO2 (FexOy@TiO2-0.5 and FexOy@TiO2-0.35), and tested their performance in rhodamine 6G (R6G) photodegradation. X-ray diffraction (XRD) analysis showed that FexOy@TiO2-0.5 has the smallest crystallite size (16.8 nm), followed by FexOy@TiO2-0.5 (18.4 nm), FexOy@TiO2-0.35 (21.0 nm) and FexOy@TiO2-0.5 (19.0 nm), and X-ray photoelectron spectroscopy (XPS) suggested the decreasing percentage of Fe3O4 from 52.1% to 36.7%-47.2% after Ti-deposition treatment. The saturated magnetisms followed the order: FexOy@TiO2-0.5 > FexOy@TiO2-0.35 > FexOy@TiO2-0.5 > FexOy@TiO2-0.35. R6G photodegradation followed the first order kinetics and was slightly influenced by pH but significantly affected by initial photocatalyst concentration. FexOy@TiO2-0.35 achieved the highest removal efficiency for R6G (92.5%), followed by FexOy@TiO2-0.35 (88.97%), FexOy@TiO2-0.5 (60.49%) and FexOy@TiO2-0.5 (48.06%). Additionally, all these magnetic-TiO2-nanocomposites had satisfied magnetic recoverability and exhibited laudable reusability after 5-times reuse, even achieving higher R6G removal efficiencies from 97.30% to 98.47%. Our one-step method took only 75 min for nanocomposite synthesis, 90 min less than conventional two-step method, showing its feasibility as a practical method for magnetic-TiO2-nanocomposite synthesis in industrial application.	[Xie, En] China Agr Univ, Coll Water Resources & Civil Engn, Beijing, Peoples R China; [Xie, En; Zheng, Lei; Wang, Yingying; Dou, Junfeng; Ding, Aizhong] Beijing Normal Univ, Coll Water Sci, Beijing, Peoples R China; [Xie, En; Li, Xinyang; Zhang, Dayi] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England; [Li, Xinyang] Beijing Jiaotong Univ, Sch Civil Engn, Beijing, Peoples R China; [Zhang, Dayi] Tsinghua Univ, Sch Environm, Beijing, Peoples R China	China Agricultural University; Beijing Normal University; Lancaster University; Beijing Jiaotong University; Tsinghua University	Ding, AZ (corresponding author), Beijing Normal Univ, Coll Water Sci, Beijing, Peoples R China.; Zhang, DY (corresponding author), Univ Lancaster, Lancaster Environm Ctr, Lancaster, England.; Zhang, DY (corresponding author), Tsinghua Univ, Sch Environm, Beijing, Peoples R China.	zhangdayi@tsinghua.org.cn; ading@bnu.edu.cn	wang, yan/GSE-6489-2022; wang, yingying/GRS-3058-2022; Ding, A/ABG-5659-2021; Zhang, Dayi/Y-2956-2019; ZHANG, DAYI/F-7858-2010; Zhang, Dayi/AAN-1472-2020	ZHANG, DAYI/0000-0002-4175-5982; Zhang, Dayi/0000-0002-4175-5982; Zhang, Dayi/0000-0002-1647-0408; Li, Xinyang/0000-0002-9722-1234	National Natural Science Foundation of China [51509003]; Chinese Government's Thousand Talents Plan for Young Professionals	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Government's Thousand Talents Plan for Young Professionals	This project was funded by the National Natural Science Foundation of China (No. 51509003). DZ also acknowledges the support of Chinese Government's Thousand Talents Plan for Young Professionals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adan C, 2007, CATAL TODAY, V129, P79, DOI 10.1016/j.cattod.2007.06.051; Ai LH, 2010, CHEM ENG J, V156, P243, DOI 10.1016/j.cej.2009.08.028; Ali T, 2017, MATER RES EXPRESS, V4, DOI 10.1088/2053-1591/aa576d; Ambrus Z, 2008, APPL CATAL B-ENVIRON, V81, P27, DOI 10.1016/j.apcatb.2007.11.041; Andreozzi R, 1999, CATAL TODAY, V53, P51, DOI 10.1016/S0920-5861(99)00102-9; Asiri AM, 2011, J SAUDI CHEM SOC, V15, P121, DOI 10.1016/j.jscs.2010.06.005; Bhowmick S, 2014, CHEM ENG J, V243, P14, DOI 10.1016/j.cej.2013.12.049; Huy BT, 2017, CHEMOSPHERE, V184, P849, DOI 10.1016/j.chemosphere.2017.06.069; Chakhari W, 2017, J ALLOY COMPD, V708, P862, DOI 10.1016/j.jallcom.2016.12.181; Chen CC, 2017, J PHOTOCH PHOTOBIO A, V334, P74, DOI 10.1016/j.jphotochem.2016.11.005; Chen DW, 1998, WATER RES, V32, P3223, DOI 10.1016/S0043-1354(98)00118-3; Chen SY, 2013, APPL SURF SCI, V283, P422, DOI 10.1016/j.apsusc.2013.06.125; Chen Y, 2017, POWDER TECHNOL, V313, P44, DOI 10.1016/j.powtec.2017.03.005; Chen Z, 2017, J ALLOY COMPD, V700, P113, DOI 10.1016/j.jallcom.2017.01.045; Chiou CH, 2008, CHEM ENG J, V139, P322, DOI 10.1016/j.cej.2007.08.002; CHOI WY, 1994, J PHYS CHEM-US, V98, P13669, DOI 10.1021/j100102a038; Cui B, 2013, SEP PURIF TECHNOL, V103, P251, DOI 10.1016/j.seppur.2012.10.008; Devi LG, 2009, CHEMOSPHERE, V76, P1163, DOI 10.1016/j.chemosphere.2009.04.005; Ganesh I, 2012, PROCESS APPL CERAM, V6, P21, DOI DOI 10.2298/PAC1201021G; Gao YW, 2016, APPL CATAL B-ENVIRON, V185, P22, DOI 10.1016/j.apcatb.2015.12.002; Gondal MA, 2010, CHEM ENG J, V165, P250, DOI 10.1016/j.cej.2010.09.025; Gu HW, 2006, CHEM COMMUN, P941, DOI 10.1039/b514130c; Guo J, 2006, APPL CATAL A-GEN, V299, P175, DOI 10.1016/j.apcata.2005.10.039; Habibi-Yangjeh A, 2016, SEP PURIF TECHNOL, V166, P63, DOI 10.1016/j.seppur.2016.04.022; He ZQ, 2012, SEP PURIF TECHNOL, V96, P50, DOI 10.1016/j.seppur.2012.05.005; HOFFMANN MR, 1995, CHEM REV, V95, P69, DOI 10.1021/cr00033a004; Iram M, 2010, J HAZARD MATER, V181, P1039, DOI 10.1016/j.jhazmat.2010.05.119; Iranmanesh M, 2017, CHEM SOC REV, V46, P5925, DOI 10.1039/c7cs00230k; Jeng MJ, 2013, INT J PHOTOENERGY, V2013, P10510; Jing Y, 2007, BIOTECHNOL BIOENG, V96, P1139, DOI 10.1002/bit.21202; Khalyavka TA, 2009, THEOR EXP CHEM, V45, P234, DOI 10.1007/s11237-009-9087-4; Khojasteh H, 2016, RSC ADV, V6, P78043, DOI 10.1039/c6ra13613c; Kong L, 2014, ACS APPL MATER INTER, V3, P35; Thao LTS, 2017, MATERIALS, V10, DOI 10.3390/ma10020122; Lee SW, 2006, MATER CHEM PHYS, V96, P483, DOI 10.1016/j.matchemphys.2005.07.039; Li D, 2015, J ALLOY COMPD, V646, P978, DOI 10.1016/j.jallcom.2015.06.075; Li SK, 2011, J MATER CHEM, V21, P7459, DOI 10.1039/c0jm04569a; Lin Z, 2015, BIORESOURCE TECHNOL, V190, P82, DOI 10.1016/j.biortech.2015.04.068; Marien CBD, 2016, APPL CATAL B-ENVIRON, V194, P1, DOI 10.1016/j.apcatb.2016.04.040; Mayorov AS, 2011, NANO LETT, V11, P2396, DOI 10.1021/nl200758b; Muthukumaran T, 2012, J NANOFLUIDS, V1, P85, DOI 10.1166/jon.2012.1006; Pal NK, 2016, CHEMOSPHERE, V144, P1655, DOI 10.1016/j.chemosphere.2015.10.060; Pandey SK, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/27/276005; Raileanu M, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1548-7; Rajoriya S, 2017, ULTRASON SONOCHEM, V34, P183, DOI 10.1016/j.ultsonch.2016.05.028; Salaeh S, 2017, J PHOTOCH PHOTOBIO A, V333, P117, DOI 10.1016/j.jphotochem.2016.10.015; Saliu OD, 2017, E-POLYMERS, V17, P295, DOI 10.1515/epoly-2016-0289; Seaton A, 2010, J R SOC INTERFACE, V7, pS119, DOI 10.1098/rsif.2009.0252.focus; Shan AY, 2010, APPL CATAL A-GEN, V389, P1, DOI 10.1016/j.apcata.2010.08.053; Sui JH, 2012, MATER CHEM PHYS, V134, P229, DOI 10.1016/j.matchemphys.2012.02.057; Thompson TL, 2006, CHEM REV, V106, P4428, DOI 10.1021/cr050172k; Wang Q, 2017, CHEM ENG J, V319, P39, DOI 10.1016/j.cej.2017.02.145; Wang XZ, 2016, RES MICROBIOL, V167, P731, DOI 10.1016/j.resmic.2016.07.004; Xie TP, 2013, APPL SURF SCI, V273, P684, DOI 10.1016/j.apsusc.2013.02.113; Xin TJ, 2014, APPL SURF SCI, V288, P51, DOI 10.1016/j.apsusc.2013.09.108; Xu MW, 2005, MATER LETT, V59, P2194, DOI 10.1016/j.matlet.2005.02.065; Yamashita T, 2008, APPL SURF SCI, V254, P2441, DOI 10.1016/j.apsusc.2007.09.063; Yang SY, 2007, J ENVIRON SCI-CHINA, V19, P86, DOI 10.1016/S1001-0742(07)60014-X; Yao HB, 2015, J MATER CHEM A, V3, P17511, DOI 10.1039/c5ta03215f; Yavuz CT, 2006, SCIENCE, V314, P964, DOI 10.1126/science.1131475; Yeganeh M, 2017, PHYSICA B, V511, P89, DOI 10.1016/j.physb.2017.02.010; Yu JG, 2009, APPL CATAL B-ENVIRON, V90, P595, DOI 10.1016/j.apcatb.2009.04.021; Zhang DY, 2015, ISME J, V9, P603, DOI 10.1038/ismej.2014.161; Zhang DY, 2011, MICROB BIOTECHNOL, V4, P89, DOI 10.1111/j.1751-7915.2010.00228.x; Zhang L, 2016, SOLID STATE SCI, V52, P42, DOI 10.1016/j.solidstatesciences.2015.12.006; Zhang P, 2014, IND ENG CHEM RES, V53, P8057, DOI 10.1021/ie5001696; Zhao BX, 2010, J HAZARD MATER, V176, P569, DOI 10.1016/j.jhazmat.2009.11.066; Zhao XH, 2016, MATER LETT, V163, P154, DOI 10.1016/j.matlet.2015.10.061; Zielinska-Jurek A, 2017, J ENVIRON MANAGE, V195, P157, DOI 10.1016/j.jenvman.2016.06.056	69	1	1	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0221221	10.1371/journal.pone.0221221	http://dx.doi.org/10.1371/journal.pone.0221221			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5MK	31425521	gold, Green Submitted, Green Published			2022-12-26	WOS:000485022400030
J	Marefiaw, TA; Yenesew, MA; Mihirete, KM				Marefiaw, Tefera Alemu; Yenesew, Muluken Azage; Mihirete, Kebadnew Mulatu			Age-appropriate vaccination coverage and its associated factors for pentavalent 1-3 and measles vaccine doses, in northeast Ethiopia: A community-based cross-sectional study	PLOS ONE			English	Article							IMMUNIZATION; RISK	Background In Ethiopia, there are limited studies on age-appropriate vaccinations that children received at the recommended specific ages. Therefore, we assessed age-appropriate vaccinations coverage and its associated factors among children 12 to 23 months of age in Menz Lalo district, northeast Ethiopia. Methods A community-based cross-sectional study was conducted in Menz Lalo district from March to April/2018 among 417 mothers/caregivers with children 12 to 23 months of age using simple random sampling technique. Data were collected using a pretested structured questionnaire. Information about children's vaccination status was collected from vaccination cards. Age-appropriate vaccination coverage was measured using World Health Organization vaccination schedule recommendation. Data was entered into Epi-Info(7) software and exported to SPSS-20 for analysis. Four consecutive logistic regression models were performed to identify factors associated with age-inappropriate vaccinations. A P-value of <= 0.05 was considered to state statistically significant associations. Results Age-appropriate vaccination coverage was 39.1% (95% CI: 34.3 to 44) for pentavalent 1, 36.3% (95% CI: 31.6 to 41.5) for pentavalent 2, 30.3% (95% CI: 25.6 to 35) for pentavalent 3 and 26.4% (95% CI: 21.7 to 31) for measles vaccine doses. Age-inappropriate pentavalent 1-3 vaccinations was associated with being male sex (AOR: 0.47, 95% CI: 0.29-0.74), lack of telephone (AOR: 2.2, 95% CI: 1.4-3.6), lack of usual caretaker (AOR: 2.6, 95% CI: 1.3-5.2), unplanned pregnancy (AOR: 1.9, 95% CI: 1.1-3.5), missing pregnant women's conference (AOR: 2.7, 95% CI: 1.3-5.7), decreasing birth order (AOR: 0.34, 95% CI: 0.17-0.68) and insufficient knowledge (AOR: 2.7, 95% CI: 1.6-4.4). Conclusion The proportions of age-appropriate vaccination coverage were low in the study area. Modifiable factors were associated with age-inappropriate vaccinations. Vaccination interventions should consider identified modifiable factors to improve age-appropriate vaccinations coverage.	[Marefiaw, Tefera Alemu] Publ Hlth Emergency Management Directorate, Amhara Publ Hlth Inst, Dessie, Ethiopia; [Yenesew, Muluken Azage] Bahir Dar Univ, Dept Environm Hlth, Sch Publ Hlth, Coll Med & Hlth Sci, Bahir Dar, Ethiopia; [Mihirete, Kebadnew Mulatu] Bahir Dar Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Coll Med & Hlth Sci, Bahir Dar, Ethiopia	Bahir Dar University; Bahir Dar University	Marefiaw, TA (corresponding author), Publ Hlth Emergency Management Directorate, Amhara Publ Hlth Inst, Dessie, Ethiopia.	teferaalemu2@gmail.com	Mihretie, Kebadnew Mulatu/AAB-6838-2021; Azage, Muluken/AAF-6515-2020	Azage, Muluken/0000-0003-3222-0158; Mulatu, kebadnew/0000-0002-1057-1267	Bahir Dar University, College of Medicine and Health Sciences to cover data enumerator expenses	Bahir Dar University, College of Medicine and Health Sciences to cover data enumerator expenses	Funding was received from Bahir Dar University, College of Medicine and Health Sciences to cover data enumerator expenses.	Adamo G, 2017, ANN IG MED PREV COMU, V29, P1, DOI 10.7416/ai.2017.2128; Aregawi HG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185533; Asrat Meleko, 2017, ASSESSMENT CHILD IMM; Awofeso N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-358; Breiman RF, 2004, LANCET, V364, P2204, DOI 10.1016/S0140-6736(04)17593-4; CDC, GEN BEST PRACT GUID, P11; CDC, 2011, GEN REC IMM REC ADV, P9; Central Statistical Authority, 2012, NATL ANAL REP, V1st, P1; Delrieu I, 2015, VACCINE, V33, P7290, DOI 10.1016/j.vaccine.2015.10.107; Dombkowski KJ, 2004, PUBLIC HEALTH REP, V119, P144, DOI 10.1177/003335490411900207; Ethiopian Ministry of Health, 2015, HLTH SECT TRANSF PLA; Fadnes LT, 2011, VACCINE, V29, P3564, DOI 10.1016/j.vaccine.2011.02.093; Federal Ministry of Health, 2016, ETH NAT EXP PROGR IM; Gibson DG, 2015, VACCINE, V33, P6778, DOI 10.1016/j.vaccine.2015.10.021; Giovanna Adamo, 2018, REGIONAL REPORTS SUB, P1; Grant CC, 2003, BRIT MED J, V326, P852, DOI 10.1136/bmj.326.7394.852; Gualu T., 2017, ADV PUBLIC HLTH, V2017, DOI [DOI 10.1155/2017/5352847, 10.1155/2017/5352847]; Higgins JPT, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5170; Hu Y, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14091086; Hu Y, 2014, HUM VACC IMMUNOTHER, V10, P1408, DOI 10.4161/hv.28054; Kapil Yadav, 2018, SIGNIFICANT VACCINAT, V58, P133, DOI [10.1093/tropej/fmr059, DOI 10.1093/TROPEJ/FMR059]; Kassahun Melkamu Beyene, 2015, BMC Res Notes, V8, P239, DOI 10.1186/s13104-015-1192-y; Legesse E, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0345-4; Luman ET, 2002, PEDIATRICS, V110, P935, DOI 10.1542/peds.110.5.935; Mvula H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154997; Odutola A, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1015-9; Ouedraogo N, 2013, INT J TROP DIS HLTH, V3, P45; Park YJ, 2013, JPN J INFECT DIS, V66, P6, DOI 10.7883/yoken.66.6; Sadoh AE, 2013, TANZANIA J HLTH RES, V15, P1, DOI DOI 10.4314/thrb.v15i3.6; Sheikh S, 2018, VACCINE, V36, P4979, DOI 10.1016/j.vaccine.2018.06.044; Simon Sheather, 2009, MODERN APPROACH REGR; Sood RK, 2015, WJV, V05, P69, DOI DOI 10.4236/WJV.2015.52009; Stein-Zamir C, 2017, HUM VACC IMMUNOTHER, V13, P2102, DOI 10.1080/21645515.2017.1341028; Worku Animaw, 2014, EXPANDED PROGRAM IMM; World Health Organization, WHO REC ROUT IMM US; World Health Organization, 2017, TRACK UN HLTH COV 20, P1; Yihunie Lakew, 2015, BMC PUBLIC HEALTH, P1; Yu HP, 2019, MULTIMED TOOLS APPL, V78, P11779, DOI 10.1007/s11042-018-6735-5	38	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2019	14	8							e0218470	10.1371/journal.pone.0218470	http://dx.doi.org/10.1371/journal.pone.0218470			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5LL	31419230	Green Published, Green Submitted, gold			2022-12-26	WOS:000485019900008
J	Goshain, O; Ahmed, B				Goshain, Omprakash; Ahmed, Bahar			Antihypertensive activity, toxicity and molecular docking study of newly synthesized xanthon derivatives (xanthonoxypropanolamine)	PLOS ONE			English	Article							CHOLESTEROL; PLASMA; STRESS	Context Xanthone derivatives have been reported to possess a wide range of biological properties. In effort to search new effective antihypertensive compounds, we have synthesizednovel xanthone derivatives (xanthonoxypropanolamines) and got patent for these compounds (The Patent Office, Government of India, S. No.: 011-016308, Patent No.: 250538). Objective In the present work, we attempted to establish the antihypertensive activity, toxicity and molecular docking study forthese newly synthesized compounds (1a, 1b and 2). Materials and method The preliminary antihypertensive screening was performed by administering synthesized compounds and standard drugs intraperitonially and orally into wistar rats. The change in systolic, diastolic and the mean blood pressure before and after the treatment of the drugs was measured on a Digital LE-S100 Blood Pressure Meter by Tail-cuff method non-invasively. Toxicity studies were carried out after oral administration of synthesized compounds to rats at doses of 25, 50, and 100mg/kg. The serum samples were tested for different toxicity parameters such as liver function test, kidney function test etc. The docking simulations of all the compounds were performed using Maestro, version 9.4 implemented from Schrodinger software suite. Results and discussion The result showed that the compound 1a, 1b and 2 have greater antihypertensive activity with almost equal or less toxicity profile in comparison to standard drug Propranolol and Atenolol. The docking score for the compound 1b was found -9.1 while for compound 1a and 2 were found -8.7 and -8.6 respectively. Conclusion These novel compounds i.e. 1a, 1b, and 2 have greater antihypertensive activity in comparison to standard drugs Propranolol and Atenolol. All these compounds do not have any toxicity.	[Goshain, Omprakash; Ahmed, Bahar] Jamia Hamdard, Fac Pharm, Dept Pharmaceut Chem, New Delhi, India	Jamia Hamdard University	Ahmed, B (corresponding author), Jamia Hamdard, Fac Pharm, Dept Pharmaceut Chem, New Delhi, India.	bahaarahmad40@gmail.com			University Grants Commission, Bhadurshah Zafar Marg, New Delhi, India [F.40-276/2011 (SR)]	University Grants Commission, Bhadurshah Zafar Marg, New Delhi, India(University Grants Commission, India)	This research work was funded by University Grants Commission, Bhadurshah Zafar Marg, New Delhi, India, Grant no: F.40-276/2011 (SR).	Ahmed B., 2012, Indian Patent, Patent No. 250538; [Anonymous], 1965, PRACTICAL CLIN ENZYM; Arakawa H, 1997, J PHARMACOL EXP THER, V280, P1296; Asdaq SMB, 2009, IRAN J PHARM RES, V8, P201; Ashwood E. R., 1994, TIETZ TXB CLIN CHEM; Avula PR, 2014, INDIAN J PHARMACOL, V46, P94, DOI 10.4103/0253-7613.125185; Blanco-Ayala T, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-262; Buduneli E, 2005, J PERIODONTOL, V76, P1927, DOI 10.1902/jop.2005.76.11.1927; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Feldman E., 2004, ANIM MODELS DIABET C, P1; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Ghosh MU, 1994, FUNDAMENTALS EXPT PH; GOYAL BR, 2011, INT J DIAB METAB, V19, P11; GROVER PK, 1955, J CHEM SOC, P3982, DOI 10.1039/jr9550003982; Gutierrez-Orozco F, 2013, NUTRIENTS, V5, P3163, DOI 10.3390/nu5083163; Hay AE, 2004, LIFE SCI, V75, P3077, DOI 10.1016/j.lfs.2004.07.009; JORGENSEN WL, 1991, SCIENCE, V254, P954, DOI 10.1126/science.1719636; Khan S.A., 2003, CHEM RAJKOT INDIA, V1, P47; KUNIHARA M, 1983, J LIPID RES, V24, P639; Liu Y, 2006, BIOORGAN MED CHEM, V14, P5683, DOI 10.1016/j.bmc.2006.04.014; Mak IT, 2006, J PHARMACOL EXP THER, V317, P522, DOI 10.1124/jpet.105.097709; Marona H, 2008, ACTA POL PHARM, V65, P383; Marona H, 2008, BIOORGAN MED CHEM, V16, P7234, DOI 10.1016/j.bmc.2008.06.039; Na Y, 2009, J PHARM PHARMACOL, V61, P707, DOI [10.1211/jpp/61.06.0002, 10.1211/jpp.61.06.0002]; Padi SSV, 2002, NEPHRON, V92, P685, DOI 10.1159/000064095; Pires MJ, 2010, PORT J NEPHROL HYPER, V24, P33; Prajapati AR, 2012, IJPRB, V1, P396; Teitz NW., 1976, CLIN GUIDE LAB TESTS; Trinder P., 1969, ANN CLIN BIOCHEM, V6, p24?27, DOI DOI 10.1177/000456326900600108; Wang LW, 2002, BIOORGAN MED CHEM, V10, P567, DOI 10.1016/S0968-0896(01)00315-7; WARNICK GR, 1985, CLIN CHEM, V31, P217; WYBENGA DR, 1970, CLIN CHEM, V16, P980	32	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220920	10.1371/journal.pone.0220920	http://dx.doi.org/10.1371/journal.pone.0220920			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415607	Green Published, gold, Green Submitted			2022-12-26	WOS:000485017200046
J	Jang, SY; Chae, MK; Lee, JH; Lee, EJ; Yoon, JS				Jang, Sun Young; Chae, Min Kyung; Lee, Joon H.; Lee, Eun Jig; Yoon, Jin Sook			MicroRNA-27 inhibits adipogenic differentiation in orbital fibroblasts from patients with Graves' orbitopathy	PLOS ONE			English	Article							PPAR-GAMMA; ADIPOCYTE DIFFERENTIATION; FAT DECOMPRESSION; DISEASE; PATHOGENESIS; INFLAMMATION; QUERCETIN; DIPLOPIA; MODEL; RISK	Background To investigate the role of microRNA (miR)-27a and miR-27b in adipogenesis in an in vitro model of Graves' orbitopathy (GO). Methods Orbital fat tissues were harvested from GO and non-GO participants for primary orbital fibro-blast cultures. The expression levels of miR-27a and miR-27b between GO and non-GO orbital fat tissues were compared. During adipogenesis of GO orbital fibroblasts, the expression levels of miR-27a and miR-27b were determined, and the effects of mimics of miR-27a and miR-27b transfection on adipogenesis of GO orbital fibroblast were investigated. Results Real time-polymerase chain reaction showed significantly more decreases in miR-27a and miR-27b levels in orbital fat tissues in GO participants than in non-GO participants (p < 0.05). The expression of both miR-27a and miR-27b was highest in orbital fibroblasts at day 0 and declined gradually after the induction of adipogenic differentiation. The expression levels of PPAR gamma, CCAAT/enhancer binding protein (C/EBP)alpha and C/EBP beta were decreased and Oil Red O-stained lipid droplets were lower in GO orbital fibroblasts transfected with miR-27a and miR-27b mimics than in negative controls. Conclusions Our results indicated that miR-27a and miR-27b inhibited adipogenesis in orbital fibroblasts from GO patients. Further studies are required to examine the potential of miR-27a and miR-27b as targets for therapeutic strategies.	[Jang, Sun Young] Soonchunhyang Univ, Coll Med, Bucheon Hosp, Dept Ophthalmol, Bucheon, South Korea; [Chae, Min Kyung; Yoon, Jin Sook] Yonsei Univ, Coll Med, Severance Hosp, Dept Ophthalmol,Inst Vis Res, Seoul, South Korea; [Lee, Joon H.] Konyang Univ, Coll Med, Myung Gok Eye Res Inst, Seoul, South Korea; [Lee, Eun Jig] Yonsei Univ, Coll Med, Inst Endocrine Res, Dept Endocrinol,Severance Hosp, Seoul, South Korea	Soonchunhyang University; Yonsei University; Yonsei University Health System; Konyang University; Konyang University Hospital; Yonsei University; Yonsei University Health System	Yoon, JS (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Ophthalmol,Inst Vis Res, Seoul, South Korea.	yoonjs@yuhs.ac		Yoon, Jin Sook/0000-0002-8751-9467; Lee, Eun Jig/0000-0002-9876-8370	National Research Foundation of Korea [NRF-2017R1A2B4009565, NRF-2017R1A1A1A05001051]	National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by a grant from the National Research Foundation of Korea (NRF-2017R1A2B4009565 to JSY) and a grant from NRF-2017R1A1A1A05001051 to SYJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahn RS, 2010, NEW ENGL J MED, V362, P726, DOI 10.1056/NEJMra0905750; Chang M, 2013, GRAEF ARCH CLIN EXP, V251, P935, DOI 10.1007/s00417-012-2195-1; Couzin J, 2008, SCIENCE, V319, P1782, DOI 10.1126/science.319.5871.1782; Douglas RS, 2011, CURR OPIN OPHTHALMOL, V22, P385, DOI 10.1097/ICU.0b013e3283499446; Ediriwickrema Lilangi S, 2018, Ophthalmic Plast Reconstr Surg, V34, pS90, DOI 10.1097/IOP.0000000000001119; Eing F, 2012, OPHTHAL PLAST RECONS, V28, P204, DOI 10.1097/IOP.0b013e31824dd8a0; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Fernandez-Hernando C, 2011, CURR OPIN LIPIDOL, V22, P86, DOI 10.1097/MOL.0b013e3283428d9d; Iyer S, 2012, BEST PRACT RES CL EN, V26, P281, DOI 10.1016/j.beem.2011.10.003; Jang SY, 2018, BRIT J OPHTHALMOL, V102, P407, DOI 10.1136/bjophthalmol-2017-310723; Jang SY, 2016, INVEST OPHTH VIS SCI, V57, P4027, DOI 10.1167/iovs.16-19213; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; Kim SY, 2010, BIOCHEM BIOPH RES CO, V392, P323, DOI 10.1016/j.bbrc.2010.01.012; Lin Q, 2009, FEBS J, V276, P2348, DOI 10.1111/j.1742-4658.2009.06967.x; McGregor RA, 2011, CURR MOL MED, V11, P304; Moshkelgosha S, 2013, ENDOCRINOLOGY, V154, P3008, DOI 10.1210/en.2013-1576; Mu WJ, 2015, CELL RES, V25, P477, DOI 10.1038/cr.2015.23; PEYSTER RG, 1986, AM J ROENTGENOL, V146, P459, DOI 10.2214/ajr.146.3.459; Prabhakar BS, 2003, ENDOCR REV, V24, P802, DOI 10.1210/er.2002-0020; Qin LM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-320; Rocchi R, 2012, THYROID, V22, P1170, DOI 10.1089/thy.2012.0272; Rootman DB, 2018, SURV OPHTHALMOL, V63, P86, DOI 10.1016/j.survophthal.2017.03.007; Siersbaek R, 2010, FEBS LETT, V584, P3242, DOI 10.1016/j.febslet.2010.06.010; Spiegelman BM, 1997, BIOCHIMIE, V79, P111, DOI 10.1016/S0300-9084(97)81500-3; Wang Y, 2014, INVEST OPHTH VIS SCI, V55, P1735, DOI 10.1167/iovs.14-14002; Wu WC, 2015, AM J OPHTHALMOL, V159, P277, DOI 10.1016/j.ajo.2014.10.029; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Yoon JS, 2013, J ENDOCRINOL, V216, P145, DOI 10.1530/JOE-12-0257; Yoon JS, 2012, INVEST OPHTH VIS SCI, V53, P5921, DOI 10.1167/iovs.12-9646; Yoon JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026261	30	20	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0221077	10.1371/journal.pone.0221077	http://dx.doi.org/10.1371/journal.pone.0221077			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415657	Green Published, gold, Green Submitted			2022-12-26	WOS:000485017200068
J	Kalinovich, AA; Komissarova, MV; Sazonov, SV; Zakharova, IG				Kalinovich, Aleksey A.; Komissarova, Maria V.; Sazonov, Sergey V.; Zakharova, Irina G.			Trapping of two-component light bullets in a gradient waveguide with normal group dispersion	PLOS ONE			English	Article							SPATIOTEMPORAL SOLITONS; SOLVERS	In this paper we consider the process of the second harmonic generation in a gradient waveguide, taking into account diffraction and relatively weak temporal dispersion. Using the slowly varying envelope approximation and neglecting the dispersion of the nonlinear part of the response of the medium we obtain the system of parabolic equations for the envelopes of both harmonics. We also derive integrals of motion of this system. To solve it numerically we construct a nonlinear finite-difference scheme based on the Crank-Nicolson method preserving the integrals. Primarily, we focus our investigations on the processes of a two-component light bullets generation. We demonstrate that the generation of a coupled pair is possible in a planar waveguide even at normal group velocity dispersion.	[Kalinovich, Aleksey A.; Komissarova, Maria V.; Zakharova, Irina G.] Lomonosov Moscow State Univ, Fac Phys, Moscow, Russia; [Sazonov, Sergey V.] Kurchatov Ist, Natl Res Ctr, Moscow, Russia	Lomonosov Moscow State University	Kalinovich, AA (corresponding author), Lomonosov Moscow State Univ, Fac Phys, Moscow, Russia.	kalinovich@gmail.com	Zakharova, Irina/ABF-5771-2020; Kalinovich, Aleksey/AAE-8173-2019; Sazonov, Sergey Vladimirovich/J-3420-2012	Kalinovich, Aleksey/0000-0003-3398-298X	Russian Science Foundation [17-11-01157]	Russian Science Foundation(Russian Science Foundation (RSF))	The investigation was made using support of the Russian Science Foundation (http://www.rscf.ru/en/) (Grant No 17-11-01157) to AAK, MVK, SVS, and IGZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal G. P., 2012, NONLINEAR FIBER OPTI; Antoine X, 2003, J COMPUT PHYS, V188, P157, DOI 10.1016/S0021-9991(03)00159-1; Boyd R. W., 2003, NONLINEAR OPTICS; Ciegis R, 2013, COMPUT METH APPL MAT, V13, P237, DOI 10.1515/cmam-2013-0004; DRUMMOND PD, 1983, COMPUT PHYS COMMUN, V29, P211, DOI 10.1016/0010-4655(83)90001-2; Gaspar FJ, 2014, INT J NUMER ANAL MOD, V11, P131; KANASHOV AA, 1981, PHYSICA D, V4, P122, DOI 10.1016/0167-2789(81)90009-9; Karamzin YN, 1974, EKSP ZH TEOR FIZ, V20, P734; Karamzin YN, 1974, USSR COMP MATH MATH, V14, P236, DOI [10.1016/0041-5553(74)90093-7, DOI 10.1016/0041-5553(74)90093-7]; Kivshar Y. S., 2003, OPTICAL SOLITONS FIB; Malomed BA, 1997, PHYS REV E, V56, P4725, DOI 10.1103/PhysRevE.56.4725; MANASSAH JT, 1992, OPT LETT, V17, P1259, DOI 10.1364/OL.17.001259; MENYUK CR, 1994, J OPT SOC AM B, V11, P2434, DOI 10.1364/JOSAB.11.002434; Raghavan S, 2000, OPT COMMUN, V180, P377, DOI 10.1016/S0030-4018(00)00727-6; Samarskii A.A., 2001, THEORY DIFFERENCE SC; Sazonov SV, 2017, PHYS WAVE PHENOM, V25, P83, DOI 10.3103/S1541308X17020017; Sazonov S, 2017, EPJ WEB CONF, V161, DOI 10.1051/epjconf/201716102009; Sazonov SV, 2017, PHYS REV E, V96, DOI 10.1103/PhysRevE.96.022208; Sazonov SV, 2018, P SOC PHOTO-OPT INS, V10684; Shizgal B, 2015, SCI COMPUT, P1, DOI 10.1007/978-94-017-9454-1; Skryabin DV, 1998, OPT COMMUN, V148, P79, DOI 10.1016/S0030-4018(97)00660-3; Trofimov V.A., 2015, WIT T MODELLING SIMU, V59, P85, DOI DOI 10.2495/CMEM150081; Trofimov VA, 2005, J COMPUTATIONAL MATH, V5, P2185; Trofimov VA, 2014, PROC SPIE, V9127, DOI 10.1117/12.2049401; YU SS, 1995, OPT COMMUN, V119, P167, DOI 10.1016/0030-4018(95)00377-K	25	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220840	10.1371/journal.pone.0220840	http://dx.doi.org/10.1371/journal.pone.0220840			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415604	Green Published, Green Submitted, gold			2022-12-26	WOS:000485017200039
J	Ortega-Martorell, S; Candiota, AP; Thomson, R; Riley, P; Julia-Sape, M; Olier, I				Ortega-Martorell, Sandra; Candiota, Ana Paula; Thomson, Ryan; Riley, Patrick; Julia-Sape, Margarida; Olier, Ivan			Embedding MRI information into MRSI data source extraction improves brain tumour delineation in animal models	PLOS ONE			English	Article							MATRIX FACTORIZATION; CLASSIFICATION; SEGMENTATION; HETEROGENEITY; TEMOZOLOMIDE; CONCOMITANT; CRITERIA; GLIOMAS; IMAGES	Glioblastoma is the most frequent malignant intra-cranial tumour. Magnetic resonance imaging is the modality of choice in diagnosis, aggressiveness assessment, and follow-up. However, there are examples where it lacks diagnostic accuracy. Magnetic resonance spectroscopy enables the identification of molecules present in the tissue, providing a precise metabolomic signature. Previous research shows that combining imaging and spectroscopy information results in more accurate outcomes and superior diagnostic value. This study proposes a method to combine them, which builds upon a previous methodology whose main objective is to guide the extraction of sources. To this aim, prior knowledge about class-specific information is integrated into the methodology by setting the metric of a latent variable space where Non-negative Matrix Factorisation is performed. The former methodology, which only used spectroscopy and involved combining spectra from different subjects, was adapted to use selected areas of interest that arise from segmenting the T2-weighted image. Results showed that embedding imaging information into the source extraction (the proposed semi-supervised analysis) improved the quality of the tumour delineation, as compared to those obtained without this information (unsupervised analysis). Both approaches were applied to pre-clinical data, involving thirteen brain tumour-bearing mice, and tested against histopathological data. On results of twenty-eight images, the proposed Semi-Supervised Source Extraction (SSSE) method greatly outperformed the unsupervised one, as well as an alternative semi-supervised approach from the literature, with differences being statistically significant. SSSE has proven successful in the delineation of the tumour, while bringing benefits such as 1) not constricting the metabolomic-based prediction to the image-segmented area, 2) ability to deal with signal-to-noise issues, 3) opportunity to answer specific questions by allowing researchers/radiologists define areas of interest that guide the source extraction, 4) creation of an intra-subject model and avoiding contamination from inter-subject overlaps, and 5) extraction of meaningful, good-quality sources that adds interpretability, conferring validation and better understanding of each case.	[Ortega-Martorell, Sandra; Thomson, Ryan; Riley, Patrick; Olier, Ivan] Liverpool John Moores Univ, Dept Appl Math, Liverpool, Merseyside, England; [Ortega-Martorell, Sandra; Candiota, Ana Paula; Julia-Sape, Margarida] CIBER BBN, Cerdanyola Del Valles, Spain; [Candiota, Ana Paula; Julia-Sape, Margarida] Univ Autonoma Barcelona, Unitat Biociencies, Dept Bioquim & Biol Mol, Cerdanyola Del Valles, Spain; [Candiota, Ana Paula; Julia-Sape, Margarida] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Cerdanyola Del Valles, Spain	Liverpool John Moores University; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Autonomous University of Barcelona; Autonomous University of Barcelona	Ortega-Martorell, S (corresponding author), Liverpool John Moores Univ, Dept Appl Math, Liverpool, Merseyside, England.; Ortega-Martorell, S (corresponding author), CIBER BBN, Cerdanyola Del Valles, Spain.	s.ortegamartorell@ljmu.ac.uk	Candiota, Ana Paula/A-4531-2009; Candiota, Ana Paula/AAY-6090-2020; Julià-Sapé, Margarida/AIC-9348-2022; Julià-Sapé, Margarida/A-4003-2009	Julià-Sapé, Margarida/0000-0002-3316-9027; Julià-Sapé, Margarida/0000-0002-3316-9027; Ortega-Martorell, Sandra/0000-0001-9927-3209; Riley, Patrick/0000-0002-4917-5827; Olier, Ivan/0000-0002-5679-7501; Candiota, Ana Paula/0000-0002-1523-6505	Ministerio de Economia y Competitividad in Spain [SAF2014-52332-R]; CIBER-BBN - Instituto de Salud Carlos III; European Regional Development Fund	Ministerio de Economia y Competitividad in Spain(Spanish Government); CIBER-BBN - Instituto de Salud Carlos III(Instituto de Salud Carlos III); European Regional Development Fund(European Commission)	APC and MJS acknowledge project MOLIMAGLIO (SAF2014-52332-R) from Ministerio de Economia y Competitividad in Spain. This work was also partially funded by CIBER-BBN which is financed by the Instituto de Salud Carlos III with assistance from the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandes AA, 2008, NEURO-ONCOLOGY, V10, P361, DOI 10.1215/15228517-2008-008; Cha S, 2003, MAGNET RESON MED, V49, P848, DOI 10.1002/mrm.10446; De Edeleny FS, 2000, NAT MED, V6, P1287, DOI 10.1038/81401; De Vos M, 2007, J MAGN RESON, V184, P292, DOI 10.1016/j.jmr.2006.10.017; Delgado-Goni T, 2016, NMR BIOMED, V29, P732, DOI 10.1002/nbm.3521; Delgado-Goni T, 2014, NMR BIOMED, V27, P1333, DOI 10.1002/nbm.3194; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Ding C, 2010, IEEE T PATTERN ANAL, V32, P45, DOI 10.1109/TPAMI.2008.277; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Garcia-Gomez JM, 2009, MAGN RESON MATER PHY, V22, P5, DOI 10.1007/s10334-008-0146-y; Garcia-Gomez JM, 2008, NMR BIOMED, V21, P1112, DOI 10.1002/nbm.1288; Julia-Sape M, 2006, J NEUROSURG, V105, P6, DOI 10.3171/jns.2006.105.1.6; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Li YQ, 2017, COMPUT BIOL MED, V81, P121, DOI 10.1016/j.compbiomed.2016.12.017; Luts J, 2009, NMR BIOMED, V22, P374, DOI 10.1002/nbm.1347; Mocioiu V, 2016, LECT N BIOINFORMAT, V9656, P719, DOI 10.1007/978-3-319-31744-1_62; Ortega-Martorell S, 2016, EMAGRES, V5, P945, DOI 10.1002/9780470034590.emrstm1484; Ortega-Martorell S, 2014, 2014 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE AND DATA MINING (CIDM), P93, DOI 10.1109/CIDM.2014.7008653; Ortega-Martorell S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083773; Ortega-Martorell S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047824; Ortega-Martorell S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-38; Ortega-Martorell S, 2011, 2011 INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORKS (IJCNN), P3279, DOI 10.1109/IJCNN.2011.6033656; Ortega-Martorell S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-106; OSTERTAG CB, 1987, ACTA NEUROCHIR, V89, P117, DOI 10.1007/BF01560376; PAATERO P, 1994, ENVIRONMETRICS, V5, P111, DOI 10.1002/env.3170050203; Postma GJ, 2011, COMPUT BIOL MED, V41, P87, DOI 10.1016/j.compbiomed.2010.12.003; Ruiz H., 2011, EUR S ART NEUR NETW, P381; Safar MH, 2003, MULTIMED SYST APPL, V23, P9, DOI [10.1007/978-1-4615-0349-1_2, DOI 10.1007/978-1-4615-0349-1_2]; Sauwen N, 2016, NEUROIMAGE-CLIN, V12, P753, DOI 10.1016/j.nicl.2016.09.021; Sauwen N, 2017, BMC MED IMAGING, V17, DOI 10.1186/s12880-017-0198-4; Sauwen N, 2015, NMR BIOMED, V28, P1599, DOI 10.1002/nbm.3413; SEGEBARTH CM, 1990, MAGN RESON MED, V13, P62, DOI 10.1002/mrm.1910130108; Simoes RV, 2010, NMR BIOMED, V23, P23, DOI 10.1002/nbm.1421; Simonetti AW, 2003, ANAL CHEM, V75, P5352, DOI 10.1021/ac034541t; Sorber L, 2015, IEEE J-STSP, V9, P586, DOI 10.1109/JSTSP.2015.2400415; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Wang TC, 2015, MOL MED REP, V12, P6435, DOI 10.3892/mmr.2015.4228; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Widhalm G, 2012, NEUROSURG REV, V35, P381, DOI 10.1007/s10143-012-0374-5; ZIJDENBOS AP, 1994, IEEE T MED IMAGING, V13, P716, DOI 10.1109/42.363096; Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8	42	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220809	10.1371/journal.pone.0220809	http://dx.doi.org/10.1371/journal.pone.0220809			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415601	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000485017200035
J	Aquilani, R; Maestri, R; Boselli, M; Achilli, MP; Arrigoni, N; Bruni, M; Dossena, M; Verri, M; Buonocore, D; Pasini, E; Barbieri, A; Boschi, F				Aquilani, Roberto; Maestri, Roberto; Boselli, Mirella; Achilli, Maria Pia; Arrigoni, Nadia; Bruni, Mariella; Dossena, Maurizia; Verri, Manuela; Buonocore, Daniela; Pasini, Evasio; Barbieri, Annalisa; Boschi, Federica			The relationship between plasma amino acids and circulating albumin and haemoglobin in postabsorptive stroke patients	PLOS ONE			English	Article							MARKED NEUROPROTECTIVE EFFICACY; CEREBRAL-ARTERY OCCLUSION; PERFUSED-RAT-LIVER; SHORT-TERM FAST; PROTEIN-SYNTHESIS; SKELETAL-MUSCLE; SERUM-ALBUMIN; ISCHEMIC-STROKE; GLUTAMINE; DISEASE	Background This retrospective study had two main aims: (1) to document possible correlations between plasma Amino Acids (AAs) and circulating Albumin (Alb) and Haemoglobin (Hb); and (2) to identify which AAs were predictors of Alb and Hb. Methods The study considered 125 stroke subjects (ST) (61.6% males; 65.6 +/-14.9 years) who met the eligibility criteria (absence of co morbidities associated with altered plasma AAs and presence of plasma AAs determined after overnight fasting). Fifteen matched healthy subjects with measured plasma AAs served as controls. Results The best correlations of Alb were with tryptophan (Trp) and histidine (His) (r = + 0.53; p < 0.0001), and those of Hb were with histidine (r = +0.47) and Essential AAs (r = +0.47) (both p<0.0001). In multivariate analysis, Trp (p< 0.0001) and His (p = 0.01) were shown to be the best positive predictors of Alb, whereas glutamine (p = 0.006) was the best positive predictor of Hb. Conclusions The study shows that the majority of plasma AAs were positively correlated with Alb and Hb. The best predictors of circulating Alb and Hb were the levels of tryptophan and glutamine, respectively.	[Aquilani, Roberto; Dossena, Maurizia; Verri, Manuela; Buonocore, Daniela] Univ Pavia, Dipartimento Biol & Biotecnol, Pavia, Italy; [Maestri, Roberto] Ist Clin Sci Maugeri IRCCS, Ist Montescano, Serv Bioingn, Pavia, Italy; [Boselli, Mirella; Achilli, Maria Pia; Arrigoni, Nadia] Ist Clin Sci Maugeri IRCCS, Ist Montescano, Unita Riabilitaz Neuromotoria, Unita Gravi Cerebroles Acquisite, Pavia, Italy; [Bruni, Mariella] Ist Clin Sci Maugeri IRCCS, Serv Patol Clin, Ist Pavia, Pavia, Italy; [Pasini, Evasio] IRCCS, Ist Clin Sci Maugeri, Div Riabilitaz Cardiol, Ist Lumezzane, Bergamo, Italy; [Barbieri, Annalisa; Boschi, Federica] Univ Pavia, Dipartimento Sci Farmaco, Pavia, Italy	University of Pavia; Istituti Clinici Scientifici Maugeri IRCCS; University of Pavia	Boschi, F (corresponding author), Univ Pavia, Dipartimento Sci Farmaco, Pavia, Italy.	federica.boschi@unipv.it	Maestri, Roberto/AAA-7585-2019; Barbieri, Annalisa/ABE-6328-2021; Pasini, Evasio/AAC-1798-2020; Maestri, Roberto/J-8168-2016; Achilli, Maria Pia/AAE-1142-2021	Maestri, Roberto/0000-0002-2873-0430; Barbieri, Annalisa/0000-0003-2947-0084; Pasini, Evasio/0000-0003-2836-4490; Maestri, Roberto/0000-0002-2873-0430; Achilli, Maria Pia/0000-0003-1918-2388; Verri, Manuela/0000-0003-3734-9540				ABBOTT RD, 1987, JAMA-J AM MED ASSOC, V257, P949, DOI 10.1001/jama.257.7.949; Alabi OJ, 2015, J ANIM PHYSIOL AN N, V99, P436, DOI 10.1111/jpn.12277; ANAGNOSTOU A, 1977, BLOOD, V50, P1093; ANDRULIS IL, 1987, MOL CELL BIOL, V7, P2435, DOI 10.1128/MCB.7.7.2435; [Anonymous], [No title captured]; Aquilani R, 1999, EUR HEART J, V20, P1020, DOI 10.1053/euhj.1999.1402; Aquilani R., 1999, EUR MEDICOPHYS, V35, P75; Aquilani R, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060637; Aquilani R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/964365; Aquilani R, 2014, BRAIN INJURY, V28, P161, DOI 10.3109/02699052.2013.860470; Aquilani R, 2010, NUTR NEUROSCI, V13, P129, DOI 10.1179/147683010X12611460764002; Aquilani R, 2009, NUTR NEUROSCI, V12, P219, DOI 10.1179/147683009X423445; Aquilani R, 2008, CLIN REHABIL, V22, P1042, DOI 10.1177/0269215508094244; AUSTIN SA, 1980, FEBS LETT, V110, P1, DOI 10.1016/0014-5793(80)80009-3; Bacchetta J, 2014, J AM SOC NEPHROL, V25, P564, DOI 10.1681/ASN.2013040355; Baumgartner RN, 1996, AM J CLIN NUTR, V64, P552, DOI 10.1093/ajcn/64.4.552; Belayev L, 1998, STROKE, V29, P2587, DOI 10.1161/01.STR.29.12.2587; Belayev L, 2001, STROKE, V32, P553, DOI 10.1161/01.STR.32.2.553; Belayev L, 1997, J NEUROSURG, V87, P595, DOI 10.3171/jns.1997.87.4.0595; Benjamini Y, 2001, ANN STAT, V29, P1165; Boselli M, 2012, NUTR CLIN PRACT, V27, P99, DOI 10.1177/0884533611431068; BRUNS GP, 1965, BIOCHEM BIOPH RES CO, V18, P236, DOI 10.1016/0006-291X(65)90746-1; CARNEVALE E, 1989, TABELLE COMPOSIZIONE; Carubelli V, 2015, HEART FAIL REV, V20, P39, DOI 10.1007/s10741-014-9436-9; Caso G, 2007, AM J CLIN NUTR, V85, P446, DOI 10.1093/ajcn/85.2.446; CHANDRAN K, 1951, BIOCHEM J, V49, P393, DOI 10.1042/bj0490393; CHUMLEA WC, 1985, J AM GERIATR SOC, V33, P116, DOI 10.1111/j.1532-5415.1985.tb02276.x; Curi R, 2005, J CELL PHYSIOL, V204, P392, DOI 10.1002/jcp.20339; CURZON G, 1973, NATURE, V242, P198, DOI 10.1038/242198a0; DEFEO P, 1992, AM J PHYSIOL, V263, pE794, DOI 10.1152/ajpendo.1992.263.4.E794; DEODHAR SD, 1989, CLEV CLIN J MED, V56, P126; Ferrando AA, 1999, J CLIN ENDOCR METAB, V84, P3515, DOI 10.1210/jc.84.10.3515; FLAIM KE, 1982, J BIOL CHEM, V257, P2939; FLAIM KE, 1982, J BIOL CHEM, V257, P2932; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Ginsberg MD, 2001, J NEUROSURG, V94, P499, DOI 10.3171/jns.2001.94.3.0499; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; GRAYZEL AI, 1966, P NATL ACAD SCI USA, V55, P650, DOI 10.1073/pnas.55.3.650; GRIMBLE RF, 1992, J NUTR, V122, P2066, DOI 10.1093/jn/122.11.2066; Gundogdu RH, 2017, JPEN-PARENTER ENTER, V41, P1045, DOI 10.1177/0148607115625221; Hankard RG, 1996, AM J PHYSIOL-ENDOC M, V271, pE748, DOI 10.1152/ajpendo.1996.271.4.E748; Hata R, 2000, J CEREBR BLOOD F MET, V20, P306, DOI 10.1097/00004647-200002000-00012; HENNIG B, 1988, J NUTR, V118, P1586, DOI 10.1093/jn/118.12.1586; HUNTER KA, 1995, CLIN SCI, V88, P235, DOI 10.1042/cs0880235; Ioannou A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188095; JOHN DW, 1969, J BIOL CHEM, V244, P6134; KELMAN L, 1972, BIOCHEM J, V129, P805, DOI 10.1042/bj1290805; KIRSCH R, 1968, NATURE, V217, P578, DOI 10.1038/217578a0; KIRSCH RE, 1969, AM J CLIN NUTR, V22, P1559; Kitagawa M, 2017, NUTR CLIN PRACT, V32, P645, DOI 10.1177/0884533617724742; KOPPLE JD, 1975, J CLIN INVEST, V55, P881, DOI 10.1172/JCI108016; Kriengsinyos W, 2002, J NUTR, V132, P3340, DOI 10.1093/jn/132.11.3340; Lee JM, 2002, NEUROSCIENCE, V115, P871, DOI 10.1016/S0306-4522(02)00513-4; Li HT, 2016, FREE RADICAL BIO MED, V92, P126, DOI 10.1016/j.freeradbiomed.2016.01.007; Mathers CD, 2000, MED J AUSTRALIA, V172, P592, DOI 10.5694/j.1326-5377.2000.tb124125.x; MEANS RT, 1995, STEM CELLS, V13, P32, DOI 10.1002/stem.5530130105; Mendez Christian M, 2005, Nutr Clin Pract, V20, P314, DOI 10.1177/0115426505020003314; Mogos T., 1993, Revue Roumaine de Medecine Interne, V31, P223; Morris CR, 2008, BLOOD, V111, P402, DOI 10.1182/blood-2007-04-081703; NASSET ES, 1954, J NUTR, V53, P163; Niihara Y., 2014, CLIN PHARM BIOPHARM, V3, P1; Norberg A, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1283-8; NORTON JA, 1985, CANCER, V56, P1181, DOI 10.1002/1097-0142(19850901)56:5<1181::AID-CNCR2820560535>3.0.CO;2-8; Ohtani M, 2001, BIOSCI BIOTECH BIOCH, V65, P1970, DOI 10.1271/bbb.65.1970; Perry L, 2004, CLIN NUTR, V23, P1333, DOI 10.1016/j.clnu.2004.04.009; Reimer WJMSO, 1998, STROKE, V29, P1605, DOI 10.1161/01.STR.29.8.1605; Roth E, 2007, CLIN NUTR, V26, P535, DOI 10.1016/j.clnu.2007.05.007; ROTHSCHILD MA, 1988, HEPATOLOGY, V8, P385, DOI 10.1002/hep.1840080234; ROTHSCHILD MA, 1979, NEW ENGL J MED, V301, P497, DOI 10.1056/NEJM197908303010909; ROTHSCHILD MA, 1969, J NUTR, V98, P395, DOI 10.1093/jn/98.4.395; ROTHSCHILD MA, 1968, J CLIN INVEST, V47, P2591, DOI 10.1172/JCI105941; SHENG YB, 1977, J NUTR, V107, P621, DOI 10.1093/jn/107.4.621; Soeters PB, 2009, CURR OPIN CLIN NUTR, V12, P258, DOI 10.1097/MCO.0b013e32832a3e1a; Visser M, 2005, AM J CLIN NUTR, V82, P531; Volpi E, 1996, DIABETES, V45, P1245, DOI 10.2337/diabetes.45.9.1245; Wilmore DW, 2017, JPEN-PARENTER ENTER, V41, P912, DOI 10.1177/0148607117727271; Wischmeyer PE, 2008, CURR OPIN GASTROEN, V24, P190, DOI 10.1097/MOG.0b013e3282f4db94; YAMASAKI Y, 1995, STROKE, V26, P676, DOI 10.1161/01.STR.26.4.676; Yang RJ, 2007, JPEN-PARENTER ENTER, V31, P32, DOI 10.1177/014860710703100132; YAP SH, 1978, J BIOL CHEM, V253, P4944; YOUNG VR, 1990, AM J CLIN NUTR, V51, P270, DOI 10.1093/ajcn/51.2.270; Zoico E, 2002, NUTR REV, V60, P39, DOI 10.1301/00296640260085949; Zughaier SM, 2014, J CLIN TRANSL ENDOCR, V1, pE19, DOI 10.1016/j.jcte.2014.01.003	83	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0219756	10.1371/journal.pone.0219756	http://dx.doi.org/10.1371/journal.pone.0219756			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412042	Green Submitted, Green Published, gold			2022-12-26	WOS:000485012600015
J	Ganz, M; Vogel, C; Czada, C; Jorke, V; Gwosch, EC; Kleiner, R; Pierzynska-Mach, A; Zanacchi, FC; Diaspro, A; Kappes, F; Burkle, A; Ferrando-May, E				Ganz, Magdalena; Vogel, Christopher; Czada, Christina; Joerke, Vera; Gwosch, Eva Christina; Kleiner, Rebecca; Pierzynska-Mach, Agnieszka; Zanacchi, Francesca Cella; Diaspro, Alberto; Kappes, Ferdinand; Buerkle, Alexander; Ferrando-May, Elisa			The oncoprotein DEK affects the outcome of PARP1/2 inhibition during mild replication stress	PLOS ONE			English	Article							DNA-DAMAGE; TERMINAL DOMAIN; PROTEIN DEK; POLY(ADP-RIBOSE); CHROMATIN; FORKS; PROTOONCOGENE; BINDING; OVEREXPRESSION; PROLIFERATION	DNA replication stress is a major source of genomic instability and is closely linked to tumor formation and progression. Poly(ADP-ribose) polymerases1/2 (PARP1/2) enzymes are activated in response to replication stress resulting in poly(ADP-ribose) (PAR) synthesis. PARy-lation plays an important role in the remodelling and repair of impaired replication forks, providing a rationale for targeting highly replicative cancer cells with PARP1/2 inhibitors. The human oncoprotein DEK is a unique, non-histone chromatin architectural protein whose deregulated expression is associated with the development of a wide variety of human cancers. Recently, we showed that DEK is a high-affinity target of PARylation and that it promotes the progression of impaired replication forks. Here, we investigated a potential functional link between PAR and DEK in the context of replication stress. Under conditions of mild replication stress induced either by topoisomerase1 inhibition with camptothecin or nucleotide depletion by hydroxyurea, we found that the effect of acute PARP1/2 inhibition on replication fork progression is dependent on DEK expression. Reducing DEK protein levels also overcomes the restart impairment of stalled forks provoked by blocking PARylation. Non-covalent DEK-PAR interaction via the central PAR-binding domain of DEK is crucial for counteracting PARP1/2 inhibition as shown for the formation of RPA positive foci in hydroxyurea treated cells. Finally, we show by iPOND and super resolved microscopy that DEK is not directly associated with the replisome since it binds to DNA at the stage of chromatin formation. Our report sheds new light on the still enigmatic molecular functions of DEK and suggests that DEK expression levels may influence the sensitivity of cancer cells to PARP1/2 inhibitors.	[Ganz, Magdalena; Vogel, Christopher; Czada, Christina; Joerke, Vera; Gwosch, Eva Christina; Kleiner, Rebecca; Ferrando-May, Elisa] Univ Konstanz, Bioimaging Ctr, Dept Biol, Constance, Germany; [Pierzynska-Mach, Agnieszka; Zanacchi, Francesca Cella; Diaspro, Alberto] Ist Italiano Tecnol, Nanoscopy & NIC IIT, Genoa, Italy; [Pierzynska-Mach, Agnieszka] European Inst Oncol, Dept Expt Oncol, Milan, Italy; [Zanacchi, Francesca Cella] Natl Res Council CNR, Biophys Inst IBF, Genoa, Italy; [Diaspro, Alberto] Univ Genoa, Dept Phys, DIFILAB, Genoa, Italy; [Kappes, Ferdinand] Xian Jiaotong Liverpool Univ, Dushu Lake Higher Educ Town, Suzhou, Peoples R China; [Buerkle, Alexander] Univ Konstanz, Dept Biol, Mol Toxicol Grp, Constance, Germany	University of Konstanz; Istituto Italiano di Tecnologia - IIT; IRCCS European Institute of Oncology (IEO); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Genoa; Xi'an Jiaotong-Liverpool University; University of Konstanz	Ferrando-May, E (corresponding author), Univ Konstanz, Bioimaging Ctr, Dept Biol, Constance, Germany.	elisa.may@uni-konstanz.de	Ferdinand, Kappes/H-4445-2014; Zanacchi, Francesca Cella/ABI-1651-2020; Diaspro, Alberto/E-7833-2010	Ferdinand, Kappes/0000-0002-0369-0065; Pierzynska-Mach, Agnieszka/0000-0002-4094-6189; Diaspro, Alberto/0000-0002-4916-5928	German Research Foundation (DFG), Research Training Group 1331 [RTG1331]; German Research Foundation (DFG), Collaborative Research Center 969 [CRC969]; Excellence Initiative of the German Federal Government through funds of the Konstanz Research School Chemical Biology; Excellence Initiative of the German State Government through funds of the Konstanz Research School Chemical Biology	German Research Foundation (DFG), Research Training Group 1331(German Research Foundation (DFG)); German Research Foundation (DFG), Collaborative Research Center 969(German Research Foundation (DFG)); Excellence Initiative of the German Federal Government through funds of the Konstanz Research School Chemical Biology; Excellence Initiative of the German State Government through funds of the Konstanz Research School Chemical Biology	This work was supported by funds of the German Research Foundation (DFG), Research Training Group 1331 (RTG1331, to EFM), and of the Collaborative Research Center 969 (CRC969, project B04, to EFM and AB), and by the Excellence Initiative of the German Federal and State Governments through funds of the Konstanz Research School Chemical Biology (to CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiadis V, 2000, GENE DEV, V14, P1308; Bai P, 2015, MOL CELL, V58, P947, DOI 10.1016/j.molcel.2015.01.034; Ball G, 2015, SCI REP-UK, V5, DOI 10.1038/srep15915; Berti M, 2013, NAT STRUCT MOL BIOL, V20, P347, DOI 10.1038/nsmb.2501; Bhat KP, 2018, NAT STRUCT MOL BIOL, V25, P446, DOI 10.1038/s41594-018-0075-z; Bonfiglio JJ, 2017, NUCLEIC ACIDS RES, V45, P6259, DOI 10.1093/nar/gkx446; Brazda V, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-33; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bryant HE, 2009, EMBO J, V28, P2601, DOI 10.1038/emboj.2009.206; Chaudhuri AR, 2012, NAT STRUCT MOL BIOL, V19, P417, DOI 10.1038/nsmb.2258; Cleary J, 2005, J BIOL CHEM, V280, P31760, DOI 10.1074/jbc.M500884200; Dantzer F, 2013, FEBS J, V280, P3508, DOI 10.1111/febs.12368; Datta A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-234; DEMURCIA G, 1983, EMBO J, V2, P543, DOI 10.1002/j.1460-2075.1983.tb01460.x; Deutzmann A, 2015, ONCOGENE, V34, P4270, DOI 10.1038/onc.2014.346; Devany M, 2008, PROTEIN SCI, V17, P205, DOI 10.1110/ps.073244108; Dungrawala H, 2015, MOL CELL, V59, P998, DOI 10.1016/j.molcel.2015.07.030; Fahrer J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm944; Fahrer J, 2010, BIOCHEMISTRY-US, V49, P7119, DOI 10.1021/bi1004365; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fischbach A, 2018, NUCLEIC ACIDS RES, V46, P804, DOI 10.1093/nar/gkx1205; Gamble MJ, 2007, NAT STRUCT MOL BIOL, V14, P548, DOI 10.1038/nsmb1248; Gill SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140988; Grasemann C, 2005, ONCOGENE, V24, P6441, DOI 10.1038/sj.onc.1208792; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Hacker KE, 2018, NEOPLASIA, V20, P1209, DOI 10.1016/j.neo.2018.10.005; Han SY, 2009, PATHOL INT, V59, P443, DOI 10.1111/j.1440-1827.2009.02392.x; Hanzlikova H, 2018, MOL CELL, V71, P319, DOI 10.1016/j.molcel.2018.06.004; Illuzzi G, 2014, NUCLEIC ACIDS RES, V42, P7776, DOI 10.1093/nar/gku505; Kappes F, 2008, MOL CELL BIOL, V28, P3245, DOI 10.1128/MCB.01921-07; Kappes F, 2004, MOL CELL BIOL, V24, P6011, DOI 10.1128/MCB.24.13.6011-6020.2004; Kappes F, 2004, MOL CELL BIOL, V24, P6000, DOI 10.1128/MCB.24.13.6000-6010.2004; Kappes F, 2011, GENE DEV, V25, P673, DOI 10.1101/gad.2036411; Kappes F, 2011, HUM PATHOL, V42, P932, DOI 10.1016/j.humpath.2010.10.022; Kavanaugh GM, 2011, NUCLEIC ACIDS RES, V39, P7465, DOI 10.1093/nar/gkr454; Khodadoust MS, 2009, CANCER RES, V69, P6405, DOI 10.1158/0008-5472.CAN-09-1063; Kurnit KC, 2018, CURR TREAT OPTION ON, V19, DOI 10.1007/s11864-018-0572-7; Lin LJ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-366; Lopez-Contreras AJ, 2013, CELL REP, V3, P1105, DOI 10.1016/j.celrep.2013.03.009; Lossaint G, 2013, MOL CELL, V51, P678, DOI 10.1016/j.molcel.2013.07.023; Marechal A, 2015, CELL RES, V25, P9, DOI 10.1038/cr.2014.147; Martello R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12917; Maya-Mendoza A, 2018, NATURE, V559, P279, DOI 10.1038/s41586-018-0261-5; Soares LMM, 2006, SCIENCE, V312, P1961, DOI 10.1126/science.1128659; Merrick CJ, 2004, J BIOL CHEM, V279, P20067, DOI 10.1074/jbc.M400022200; MIWA M, 1971, J BIOL CHEM, V246, P6362; Mor-Vaknin N, 2011, ARTHRITIS RHEUM-US, V63, P556, DOI 10.1002/art.30138; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Nozaki T, 2017, MOL CELL, V67, P282, DOI 10.1016/j.molcel.2017.06.018; Palazzo L, 2018, BIOCHEM SOC T, V46, P1681, DOI 10.1042/BST20180418; Ribeyre C, 2016, CELL REP, V15, P300, DOI 10.1016/j.celrep.2016.03.027; Riveiro-Falkenbach E, 2017, PIGM CELL MELANOMA R, V30, P194, DOI 10.1111/pcmr.12563; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Saha AK, 2013, P NATL ACAD SCI USA, V110, P6847, DOI 10.1073/pnas.1220751110; Salvati E, 2010, ONCOGENE, V29, P6280, DOI 10.1038/onc.2010.344; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; Smith EA, 2018, PROTEINS, V86, P88, DOI 10.1002/prot.25411; Smith EA, 2017, SCI REP-UK, V7, DOI 10.1038/srep44662; Toledo LI, 2013, CELL, V155, P1088, DOI 10.1016/j.cell.2013.10.043; Velic D, 2015, BIOMOLECULES, V5, P3204, DOI 10.3390/biom5043204; Vinnedge LMP, 2011, ONCOGENE, V30, P2741, DOI 10.1038/onc.2011.2; Vinnedge LMP, 2013, CELL CYCLE, V12, P51, DOI 10.4161/cc.23121; Waldmann T, 2004, GENE, V343, P1, DOI 10.1016/j.gene.2004.08.029; Waldmann T, 2003, NUCLEIC ACIDS RES, V31, P7003, DOI 10.1093/nar/gkg864; Waldmann T, 2002, J BIOL CHEM, V277, P24988, DOI 10.1074/jbc.M204045200; Wise-Draper TM, 2005, J VIROL, V79, P14309, DOI 10.1128/JVI.79.22.14309-14317.2005; Wise-Draper TM, 2006, MOL CELL BIOL, V26, P7506, DOI 10.1128/MCB.00430-06; Ying SM, 2016, CANCER RES, V76, P1078, DOI 10.1158/0008-5472.CAN-15-0608; Ying SM, 2012, CANCER RES, V72, P2814, DOI 10.1158/0008-5472.CAN-11-3417; Zhang YJ, 2013, NAT METHODS, V10, P981, DOI 10.1038/nmeth.2603; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zhou QC, 2018, ONCOL LETT, V15, P8573, DOI 10.3892/ol.2018.8436	73	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0213130	10.1371/journal.pone.0213130	http://dx.doi.org/10.1371/journal.pone.0213130			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408463	Green Submitted, gold, Green Published			2022-12-26	WOS:000485009500001
J	Schroer, AB; Mohamed, JS; Willard, MD; Setola, V; Oestreich, E; Siderovski, DP				Schroer, Adam B.; Mohamed, Junaith S.; Willard, Melinda D.; Setola, Vincent; Oestreich, Emily; Siderovski, David P.			A role for Regulator of G protein Signaling-12 (RGS12) in the balance between myoblast proliferation and differentiation	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; SKELETAL-MUSCLE; SATELLITE CELL; RHABDOMYOSARCOMA CELL; SCAFFOLD PROTEINS; GENE-EXPRESSION; H-RAS; KINASE; BINDING; PAX7	Regulators of G Protein Signaling (RGS proteins) inhibit G protein-coupled receptor (GPCR) signaling by accelerating the GTP hydrolysis rate of activated Ga subunits. Some RGS proteins exert additional signal modulatory functions, and RGS12 is one such protein, with five additional, functional domains: a PDZ domain, a phosphotyrosine-binding domain, two Ras-binding domains, and a Ga. GDP-binding GoLoco motif. RGS12 expression is temporospatially regulated in developing mouse embryos, with notable expression in somites and developing skeletal muscle. We therefore examined whether RGS12 is involved in the skeletal muscle myogenic program. In the adult mouse, RGS12 is expressed in the tibialis anterior (TA) muscle, and its expression is increased early after cardiotoxin-induced injury, suggesting a role in muscle regeneration. Consistent with a potential role in coordinating myogenic signals, RGS12 is also expressed in primary myoblasts; as these cells undergo differentiation and fusion into myotubes, RGS12 protein abundance is reduced. Myoblasts isolated from mice lacking Rgs12 expression have an impaired ability to differentiate into myotubes ex vivo, suggesting that RGS12 may play a role as a modulator/switch for differentiation. We also assessed the muscle regenerative capacity of mice conditionally deficient in skeletal muscle Rgs12 expression (via Pax7-driven Cre recombinase expression), following cardiotoxin-induced damage to the TA muscle. Eight days post-damage, mice lacking RGS12 in skeletal muscle had attenuated repair of muscle fibers. However, when mice lacking skeletal muscle expression of Rgs12 were cross-bred with mdx mice (a model of human Duchenne muscular dystrophy), no increase in muscle degeneration was observed over time. These data support the hypothesis that RGS12 plays a role in coordinating signals during the myogenic program in select circumstances, but loss of the protein may be compensated for within model syndromes of prolonged bouts of muscle damage and repair.	[Schroer, Adam B.; Siderovski, David P.] West Virginia Univ, Dept Physiol & Pharmacol, WVU Sch Med, Morgantown, WV 26506 USA; [Mohamed, Junaith S.] West Virginia Univ, Div Exercise Physiol, Morgantown, WV 26506 USA; [Willard, Melinda D.; Oestreich, Emily] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA; [Setola, Vincent] West Virginia Univ, Dept Neurosci, Morgantown, WV 26506 USA; [Mohamed, Junaith S.] Univ Tennessee, Dept Clin Lab Sci, Hlth Sci Ctr, Memphis, TN USA; [Willard, Melinda D.] Eli Lilly & Co, Lilly Res Labs, Oncol Early Phase, Indianapolis, IN 46285 USA; [Oestreich, Emily] Pacific Northwest Univ Hlth Sci, Coll Osteopath Med, Dept Biomed Sci, Yakima, WA 98901 USA	West Virginia University; West Virginia University; University of North Carolina; University of North Carolina Chapel Hill; West Virginia University; University of Tennessee System; University of Tennessee Health Science Center; Eli Lilly	Siderovski, DP (corresponding author), West Virginia Univ, Dept Physiol & Pharmacol, WVU Sch Med, Morgantown, WV 26506 USA.; Oestreich, E (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA.; Oestreich, E (corresponding author), Pacific Northwest Univ Hlth Sci, Coll Osteopath Med, Dept Biomed Sci, Yakima, WA 98901 USA.	eoestreich@pnwu.edu; dpsiderovski@hsc.wvu.edu	Mohamed, Junaith/AAC-4050-2020; Siderovski, David Peter/AAA-9603-2019	Siderovski, David Peter/0000-0002-0688-8210; Setola, Vincent/0000-0002-9791-2270	Pharmaceutical Research and Manufacturers of America Foundation predoctoral fellowship; National Institute of Arthritis and Musculoskeletal and Skin Diseases postdoctoral fellowship [F32 AR057644]; NIDA [R01 DA048153]; WVU E.J. Van Liere Endowed Medicine Professorship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104942] Funding Source: NIH RePORTER	Pharmaceutical Research and Manufacturers of America Foundation predoctoral fellowship; National Institute of Arthritis and Musculoskeletal and Skin Diseases postdoctoral fellowship; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); WVU E.J. Van Liere Endowed Medicine Professorship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided from a Pharmaceutical Research and Manufacturers of America Foundation predoctoral fellowship (to M.D.W.), a National Institute of Arthritis and Musculoskeletal and Skin Diseases postdoctoral fellowship (F32 AR057644 to E.A.O.), and and in part from NIDA (R01 DA048153), and from the WVU E.J. Van Liere Endowed Medicine Professorship (to D.P.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Bennett AM, 1997, SCIENCE, V278, P1288, DOI 10.1126/science.278.5341.1288; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Bosnakovski D, 2008, STEM CELLS, V26, P3194, DOI 10.1634/stemcells.2007-1017; Bray D, 1997, P NATL ACAD SCI USA, V94, P13493, DOI 10.1073/pnas.94.25.13493; Brinegar AE, 2017, ELIFE, V6, DOI 10.7554/eLife.27192; Brooks MJ, 2018, J APPL PHYSIOL, V124, P1616, DOI 10.1152/japplphysiol.00451.2017; CHARDIN P, 1985, INT J CANCER, V35, P647, DOI 10.1002/ijc.2910350513; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chatterjee TK, 2002, MOL CELL BIOL, V22, P4334, DOI 10.1128/MCB.22.12.4334-4345.2002; CHOI KY, 1994, CELL, V78, P499; Corvera S, 2001, TRAFFIC, V2, P859, DOI 10.1034/j.1600-0854.2001.21201.x; Dagher R, 1999, Oncologist, V4, P34; DALBIS A, 1988, EUR J BIOCHEM, V174, P103, DOI 10.1111/j.1432-1033.1988.tb14068.x; DALBIS A, 1989, DEV BIOL, V135, P320, DOI 10.1016/0012-1606(89)90182-6; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Deconinck AE, 1997, J CELL BIOL, V136, P883, DOI 10.1083/jcb.136.4.883; Diggins NL, 2017, BIOCHEM SOC T, V45, P771, DOI 10.1042/BST20160191; Ganley IG, 2004, MOL BIOL CELL, V15, P5420, DOI 10.1091/mbc.E04-08-0747; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Gerber KJ, 2016, MOL PHARMACOL, V89, P273, DOI 10.1124/mol.115.102210; Girardi F, 2018, PROG MOL BIOL TRANSL, V153, P157, DOI 10.1016/bs.pmbts.2017.11.026; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Gross JD, 2018, J PSYCHOPHARMACOL, V32, P191, DOI 10.1177/0269881117742100; Hamoud N, 2014, P NATL ACAD SCI USA, V111, P3745, DOI 10.1073/pnas.1313886111; Haramizu S, 2017, J NUTR BIOCHEM, V50, P103, DOI 10.1016/j.jnutbio.2017.08.008; Hobbs GA, 2016, J CELL SCI, V129, P1287, DOI 10.1242/jcs.182873; Huang JA, 2014, AM J PHYSIOL-GASTR L, V306, pG802, DOI 10.1152/ajpgi.00440.2013; Hutsell SQ, 2010, METHODS MOL BIOL, V627, P75, DOI 10.1007/978-1-60761-670-2_4; Jones NC, 2001, J CELL PHYSIOL, V186, P104, DOI 10.1002/1097-4652(200101)186:1<104::AID-JCP1015>3.0.CO;2-0; JOSTES B, 1990, MECH DEVELOP, V33, P27, DOI 10.1016/0925-4773(90)90132-6; Kaplow ME, 2008, GENETICS, V178, P2003, DOI 10.1534/genetics.107.086397; Karasarides M, 2006, CELL BIOL INT, V30, P308, DOI 10.1016/j.cellbi.2005.12.003; Keller C, 2004, GENE DEV, V18, P2608, DOI 10.1101/gad.1243904; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; KONG YF, 1995, MOL CELL BIOL, V15, P5205; Lambert NA, 2010, P NATL ACAD SCI USA, V107, P7066, DOI 10.1073/pnas.0912934107; LASSAR AB, 1989, CELL, V58, P659, DOI 10.1016/0092-8674(89)90101-3; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Li WQ, 2007, FASEB J, V21, P3606, DOI 10.1096/fj.07-8159com; Li Z, 2018, J BONE MINER RES; Lin DC, 2006, MOL CELL BIOL, V26, P8928, DOI 10.1128/MCB.00228-06; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu AP, 2014, HUM MOL GENET, V23, P4786, DOI 10.1093/hmg/ddu194; Marampon F, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-31; Martin-McCaffrey L, 2005, DEV DYNAM, V234, P438, DOI 10.1002/dvdy.20555; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; MCALLISTER RM, 1969, CANCER-AM CANCER SOC, V24, P520, DOI 10.1002/1097-0142(196909)24:3<520::AID-CNCR2820240313>3.0.CO;2-M; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; PAYNE PA, 1987, P NATL ACAD SCI USA, V84, P8956, DOI 10.1073/pnas.84.24.8956; Ponting CP, 1999, J MOL MED, V77, P695, DOI 10.1007/s001099900054; Price FD, 2014, NAT MED, V20, P1174, DOI 10.1038/nm.3655; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Sambi BS, 2006, CELL SIGNAL, V18, P971, DOI 10.1016/j.cellsig.2005.08.003; SARTORE S, 1982, NATURE, V298, P294, DOI 10.1038/298294a0; Schaaf G, 2010, CANCER RES, V70, P762, DOI 10.1158/0008-5472.CAN-09-2532; Scholz ME, 2009, AM J PHYSIOL-CELL PH, V297, pC1012, DOI 10.1152/ajpcell.00567.2008; Schroer AB, 2018, CHEM SENSES, V43, P367, DOI 10.1093/chemse/bjy024; SCHULTZ E, 1978, J EXP ZOOL, V206, P451, DOI 10.1002/jez.1402060314; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Sethakorn N, 2010, CELL SIGNAL, V22, P1274, DOI 10.1016/j.cellsig.2010.03.016; Smith FD, 2002, CURR BIOL, V12, pR32, DOI 10.1016/S0960-9822(01)00646-7; Snow BE, 1998, J BIOL CHEM, V273, P17749, DOI 10.1074/jbc.273.28.17749; SPIZZ G, 1986, J BIOL CHEM, V261, P9483; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; Suzuki J, 2000, ONCOGENE, V19, P1138, DOI 10.1038/sj.onc.1203402; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; VAIDYA TB, 1989, MOL CELL BIOL, V9, P3576, DOI 10.1128/MCB.9.8.3576; Vellano CP, 2013, J BIOL CHEM, V288, P3620, DOI 10.1074/jbc.M112.440057; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; Wang Y, 2013, CELL TISSUE RES, V351, P183, DOI 10.1007/s00441-012-1515-4; Wang Y, 2011, J CELL SCI, V124, P3835, DOI 10.1242/jcs.086686; Wang YQ, 2017, CANCER RES, V77, P4247, DOI 10.1158/0008-5472.CAN-17-0669; Weston CR, 2002, SCIENCE, V296, P2345, DOI 10.1126/science.1073344; Willard FS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004884; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Willard MD, 2007, EMBO J, V26, P2029, DOI 10.1038/sj.emboj.7601659; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Yang SY, 2007, J BONE MINER RES, V22, P45, DOI 10.1359/JBMR.061007; Yoo J, 1999, CANCER, V86, P58, DOI 10.1002/(SICI)1097-0142(19990701)86:1<58::AID-CNCR10>3.3.CO;2-J; Yoon MS, 2008, J CELL SCI, V121, P282, DOI 10.1242/jcs.022566; Ziman MR, 1997, INT J BIOCHEM CELL B, V29, P1029, DOI 10.1016/S1357-2725(97)00023-X	86	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0216167	10.1371/journal.pone.0216167	http://dx.doi.org/10.1371/journal.pone.0216167			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408461	gold, Green Published, Green Submitted			2022-12-26	WOS:000485009500002
J	Tourigny, DS; Karim, MKA; Echeveste, R; Kotter, MRN; O'Neill, JS				Tourigny, David S.; Karim, Muhammad Kaiser Abdul; Echeveste, Rodrigo; Kotter, Mark R. N.; O'Neill, John S.			Energetic substrate availability regulates synchronous activity in an excitatory neural network	PLOS ONE			English	Article							GLUTAMATE UPTAKE; SYNAPTIC-TRANSMISSION; GLYCOLYTIC-ENZYMES; NEURONAL-ACTIVITY; GRANULE CELLS; GLUCOSE; LACTATE; ATP; METABOLISM; BRAIN	Neural networks are required to meet significant metabolic demands associated with performing sophisticated computational tasks in the brain. The necessity for efficient transmission of information imposes stringent constraints on the metabolic pathways that can be used for energy generation at the synapse, and thus low availability of energetic substrates can reduce the efficacy of synaptic function. Here we study the effects of energetic substrate availability on global neural network behavior and find that glucose alone can sustain excitatory neurotransmission required to generate high-frequency synchronous bursting that emerges in culture. In contrast, obligatory oxidative energetic substrates such as lactate and pyruvate are unable to substitute for glucose, indicating that processes involving glucose metabolism form the primary energy-generating pathways supporting coordinated network activity. Our experimental results are discussed in the context of the role that metabolism plays in supporting the performance of individual synapses, including the relative contributions from postsynaptic responses, astrocytes, and presynaptic vesicle cycling. We propose a simple computational model for our excitatory cultures that accurately captures the inability of metabolically compromised synapses to sustain synchronous bursting when extracellular glucose is depleted.	[Tourigny, David S.; O'Neill, John S.] MRC, Lab Mol Biol, Cambridge Biomed Campus, Cambridge, England; [Tourigny, David S.] Columbia Univ, Irving Med Ctr, New York, NY 10032 USA; [Karim, Muhammad Kaiser Abdul; Kotter, Mark R. N.] Univ Cambridge, MRC Cambridge Stem Cell Inst, Dept Clin Neu Rosci & Wellcome Trust, Cambridge Biomed Campus, Cambridge, England; [Echeveste, Rodrigo] Univ Cambridge, Dept Engn, Computat & Biol Learning Lab, Cambridge, England	MRC Laboratory Molecular Biology; Columbia University; NewYork-Presbyterian Hospital; University of Cambridge; University of Cambridge	Tourigny, DS; O'Neill, JS (corresponding author), MRC, Lab Mol Biol, Cambridge Biomed Campus, Cambridge, England.; Tourigny, DS (corresponding author), Columbia Univ, Irving Med Ctr, New York, NY 10032 USA.; Kotter, MRN (corresponding author), Univ Cambridge, MRC Cambridge Stem Cell Inst, Dept Clin Neu Rosci & Wellcome Trust, Cambridge Biomed Campus, Cambridge, England.	dst2156@cumc.columbia.edu; mrk25@cam.ac.uk; oneillj@mrc-lmb.cam.ac.uk		Abdul Karim, Muhammad Kaiser Bin/0000-0003-1715-0390	UK Multiple Sclerosis Society; Wellcome Trust; Medical Research Council; National Institute for Health Research Clinician Scientist Award [CS-2015-15-023]; Medical Research Council [MC_UP_120/4]; DayaDiri Cambridge Scholarship	UK Multiple Sclerosis Society; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Clinician Scientist Award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DayaDiri Cambridge Scholarship	Research in MRNK's laboratory is funded by the UK Multiple Sclerosis Society and supported by a core support grant from the Wellcome Trust and Medical Research Council to the Wellcome Trust-MRC Cambridge Stem Cell Institute. MRNK holds a National Institute for Health Research Clinician Scientist Award CS-2015-15-023. (Disclaimer: This report is independent research arising from Clinician Scientist Award, CS-2015-15-023, supported by the National Institute for Health Research. The views expressed in this publication are those of the authors and not necessarily those of the National Health Service, National Institute for Health Research or the Department of Health.) JSO is supported by the Medical Research Council (MC_UP_120/4).; We thank past and present members of the O'Neill and Kotter labs for assistance and comments, and also the anonymous referees whose comments helped to improve the quality of the paper. We are grateful to Simon Laughlin for inspiring discussions and suggestions. DST is a Simons Foundation Fellow of the Life Sciences Research Foundation. MKAK is supported by a DayaDiri Cambridge Scholarship.	Alabi AA, 2013, ANNU REV PHYSIOL, V75, P393, DOI 10.1146/annurev-physiol-020911-153305; Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; Amrhein V, 2019, NATURE, V567, P305, DOI 10.1038/d41586-019-00857-9; Ashrafi G, 2017, CURR OPIN NEUROBIOL, V45, P156, DOI 10.1016/j.conb.2017.03.007; Ashrafi G, 2017, NEURON, V93, P606, DOI 10.1016/j.neuron.2016.12.020; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bak LK, 2006, J CEREBR BLOOD F MET, V26, P1285, DOI 10.1038/sj.jcbfm.9600281; Barros LF, 2018, J PHYSIOL-LONDON, V596, P347, DOI 10.1113/JP274944; Bertram R, 2004, BIOPHYS J, V87, P3074, DOI 10.1529/biophysj.104.049262; BLAKE JF, 1988, NEUROSCI LETT, V89, P182, DOI 10.1016/0304-3940(88)90378-3; Chavan V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125185; Chih CP, 2003, J CEREBR BLOOD F MET, V23, P1263, DOI 10.1097/01.WCB.0000081369.51727.6F; Chih CP, 2001, TRENDS NEUROSCI, V24, P573, DOI 10.1016/S0166-2236(00)01920-2; COX DWG, 1982, BRAIN RES, V239, P527, DOI 10.1016/0006-8993(82)90527-3; COX DWG, 1983, BIOCHEM J, V212, P365, DOI 10.1042/bj2120365; Devine MJ, 2018, NAT REV NEUROSCI, V19, P63, DOI 10.1038/nrn.2017.170; Diaz-Garcia CM, 2017, CELL METAB, V26, P361, DOI 10.1016/j.cmet.2017.06.021; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; FLECK MW, 1993, J NEUROSCI, V13, P3944; FOX PT, 1988, SCIENCE, V241, P462, DOI 10.1126/science.3260686; Frega M, 2017, JOVE-J VIS EXP, DOI 10.3791/54900; Ghasemi A, 2012, INT J ENDOCRINOL MET, V10, P486, DOI 10.5812/ijem.3505; Guerrier C, 2015, P NATL ACAD SCI USA, V112, P9728, DOI 10.1073/pnas.1421997112; Haller M, 2001, J PHYSIOL-LONDON, V537, P69, DOI 10.1111/j.1469-7793.2001.0069k.x; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; Heidelberger R, 2002, J NEUROPHYSIOL, V88, P98, DOI 10.1152/jn.2002.88.1.98; Hildebrand B, 1997, NEUROSCIENCE, V78, P957, DOI 10.1016/S0306-4522(96)00676-8; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; Ikemoto A, 2003, J BIOL CHEM, V278, P5929, DOI 10.1074/jbc.M211617200; Ishida A, 2009, NEUROCHEM RES, V34, P807, DOI 10.1007/s11064-008-9833-3; Izumi Y, 1997, J NEUROSCI, V17, P9448; Jang S, 2016, NEURON, V90, P278, DOI 10.1016/j.neuron.2016.03.011; KANATANI T, 1995, EXPERIENTIA, V51, P213, DOI 10.1007/BF01931098; KNULL HR, 1980, J BIOL CHEM, V255, P6439; Kojima I, 2017, DIABETES OBES METAB, V19, P54, DOI 10.1111/dom.13013; Lam RS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169506; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Levy WB, 1996, NEURAL COMPUT, V8, P531, DOI 10.1162/neco.1996.8.3.531; Levy WB, 2002, J NEUROSCI, V22, P4746, DOI 10.1523/JNEUROSCI.22-11-04746.2002; Lucas SJ, 2018, J PHYSIOL-LONDON, V596, P1699, DOI 10.1113/JP275107; Lujan B, 2016, J NEUROPHYSIOL, V116, P2523, DOI 10.1152/jn.00629.2016; Lundgaard I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7807; Lutas A, 2013, TRENDS NEUROSCI, V36, P32, DOI 10.1016/j.tins.2012.11.005; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Magistretti PJ, 2018, NAT REV NEUROSCI, V19, P235, DOI 10.1038/nrn.2018.19; Mamczur P, 2015, GLIA, V63, P328, DOI 10.1002/glia.22753; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MINK JW, 1981, AM J PHYSIOL, V241, pR203, DOI 10.1152/ajpregu.1981.241.3.R203; NAITO S, 1985, J NEUROCHEM, V44, P99, DOI 10.1111/j.1471-4159.1985.tb07118.x; Neher Erwin, 2010, Front Synaptic Neurosci, V2, P144, DOI 10.3389/fnsyn.2010.00144; Nortley R, 2017, CURR OPIN NEUROBIOL, V47, P80, DOI 10.1016/j.conb.2017.09.012; Paavilainen T, 2018, STEM CELL RES, V27, P151, DOI 10.1016/j.scr.2018.01.018; Pasquale V, 2008, NEUROSCIENCE, V153, P1354, DOI 10.1016/j.neuroscience.2008.03.050; Patel AB, 2014, P NATL ACAD SCI USA, V111, P5385, DOI 10.1073/pnas.1403576111; Pathak D, 2015, J BIOL CHEM, V290, P22325, DOI 10.1074/jbc.M115.656405; Pawlowski M, 2017, STEM CELL REP, V8, P803, DOI 10.1016/j.stemcr.2017.02.016; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Perge JA, 2009, J NEUROSCI, V29, P7917, DOI 10.1523/JNEUROSCI.5200-08.2009; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Rangaraju V, 2014, CELL, V156, P825, DOI 10.1016/j.cell.2013.12.042; SCHURR A, 1988, SCIENCE, V240, P1326, DOI 10.1126/science.3375817; Shao Li-Rong, 2018, Epilepsia Open, V3, P191, DOI 10.1002/epi4.12251; Shao LR, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00168; Shao LR, 2017, J NEUROPHYSIOL, V118, P103, DOI 10.1152/jn.00100.2017; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Sobieski C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195520; Sobieski C, 2017, J NEUROSCI, V37, P1888, DOI 10.1523/JNEUROSCI.2712-16.2017; Stafstrom CE, 2009, ANN NEUROL, V65, P435, DOI 10.1002/ana.21603; Stryer L, 2002, BIOCHEMISTRY; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sunwoldt J, 2017, FRONT MOL NEUROSCI, V10, P1, DOI 10.1523/JNEUROSCI.5951-10.2011; Syed YA, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E4; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tanner GR, 2011, J NEUROSCI, V31, P8689, DOI 10.1523/JNEUROSCI.5951-10.2011; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Xu JH, 2008, NAT NEUROSCI, V11, P45, DOI 10.1038/nn2021; Yellen G, 2018, J CELL BIOL, V217, P2235, DOI 10.1083/jcb.201803152; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029; Zheng X, 2016, ELIFE, V5, DOI [10.7554/eLife.18638, 10.7554/eLife.13374]; Zilberter Y, 2010, TRENDS PHARMACOL SCI, V31, P394, DOI 10.1016/j.tips.2010.06.005	83	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220937	10.1371/journal.pone.0220937	http://dx.doi.org/10.1371/journal.pone.0220937			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408504	gold, Green Published, Green Submitted			2022-12-26	WOS:000485009500026
J	Chen, WQ; Zhao, L; Li, H; Dong, YL; Xu, H; Guan, Y; Rong, SH; Gao, XL; Chen, RJ; Li, LH; Xu, ZJ				Chen, Wenqian; Zhao, Lu; Li, Hui; Dong, Yilun; Xu, Hong; Guan, Ying; Rong, Songhao; Gao, Xiaoling; Chen, Rongjun; Li, Lihua; Xu, Zhengjun			The isolation of the antagonistic strain Bacillus australimaris CQ07 and the exploration of the pathogenic inhibition mechanism of Magnaporthe oryzae	PLOS ONE			English	Article							RICE BLAST; ANTIFUNGAL ACTIVITY; BIOLOGICAL-CONTROL; BIOCONTROL AGENT; IN-VITRO	Biological control as a promising method to combat plant disease has gained public attention in recent years. In the present study, we isolated 12 strains resistant to Magnaporthe oryzae from western Sichuan subalpine soil. Among them, CQ07 exhibited remarkable activity against M. oryzae. The result of 16S rRNA sequence analysis revealed that CQ07 is approximately 99% similar to Bacillus australimaris. The sterilized culture filtrate of CQ07 inhibited the growth of M. oryzae, which motivated us to deduce the influence of CQ07 on the pathogenicity of M. oryzae. As shown by experimentation, sterilized culture filtrate (10 mu l/ml) of CQ07 can delay and even suppress the germination of conidia and prevent the formation of appressorium in vitro and in vivo. In addition, by simulative field tests, the spraying of conidia suspension diluted with sterilized culture filtrate of CQ07 reduced infection of rice blast. To better control rice blasts, understanding the infection mechanism of M. oryzae and inhibiting the mechanism of the antagonistic strain is of great importance.	[Chen, Wenqian; Zhao, Lu; Li, Hui; Dong, Yilun; Xu, Hong; Guan, Ying; Rong, Songhao; Gao, Xiaoling; Chen, Rongjun; Li, Lihua; Xu, Zhengjun] Sichuan Agr Univ, Crop Ecophysiol & Cultivat Key Lab Sichuan Prov, Rice Res Inst, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University	Li, LH; Xu, ZJ (corresponding author), Sichuan Agr Univ, Crop Ecophysiol & Cultivat Key Lab Sichuan Prov, Rice Res Inst, Chengdu, Sichuan, Peoples R China.	lilihua1976@tom.com; mywildrice@aliyun.com	Gao, xiao ling/GQI-2790-2022; Guan, Ying/AAN-5109-2020	Guan, Ying/0000-0002-1207-2656	International Cooperation Project of Sichuan Provincial Science And Technology Department.u Grant [2017HH0031]	International Cooperation Project of Sichuan Provincial Science And Technology Department.u Grant	This work was supported by the International Cooperation Project of Sichuan Provincial Science And Technology Department.u Grant number 2017HH0031. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calvo H, 2017, FOOD MICROBIOL, V63, P101, DOI 10.1016/j.fm.2016.11.004; Chaves JQ, 2011, INT J FOOD MICROBIOL, V147, P12, DOI 10.1016/j.ijfoodmicro.2011.02.029; Ebbole DJ, 2007, ANNU REV PHYTOPATHOL, V45, P437, DOI 10.1146/annurev.phyto.45.062806.094346; Gao MY, 2008, BIOL CONTROL, V44, P380, DOI 10.1016/j.biocontrol.2007.11.011; Geraldine M, 2010, MOL MICROBIOL, V46, P305; Han T, 2016, BIOCONTROL, V61, P195, DOI 10.1007/s10526-015-9705-0; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Hyakumachi M, 2014, J GEN PLANT PATHOL, V80, P287, DOI 10.1007/s10327-014-0524-4; Karthikeyan V, 2008, CROP PROT, V27, P263, DOI 10.1016/j.cropro.2007.05.013; Kato Hajime, 2000, Journal of General Plant Pathology, V66, P30, DOI 10.1007/PL00012919; Li QL, 2011, BIOL CONTROL, V58, P139, DOI 10.1016/j.biocontrol.2011.04.013; Mu C, 2007, ACTA PHYTOPHYLACICA, P123; Ohtaka N, 2008, J GEN PLANT PATHOL, V74, P101, DOI 10.1007/s10327-007-0063-3; Park CH, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005529; Raaijmakers JM, 2002, ANTON LEEUW INT J G, V81, P537, DOI 10.1023/A:1020501420831; Sellem I, 2017, J BASIC MICROB, V57, P393, DOI 10.1002/jobm.201600604; Sevgi E, 2010, TURK J BIOL, V34, P423, DOI 10.3906/biy-0901-23; Sha YX, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2858-1; Shan HY, 2013, CROP PROT, V44, P29, DOI 10.1016/j.cropro.2012.10.012; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; Vidhyasekaran P, 2010, PLANT PATHOL, V46, P291; Wang JM, 2013, MOL PLANT PATHOL, V14, P470, DOI 10.1111/mpp.12020; Xiao X, 2011, PHYS CHEM EARTH, V36, P424, DOI 10.1016/j.pce.2010.03.028; Xiong ZQ, 2013, BIOTECHNOL LETT, V35, P1475, DOI 10.1007/s10529-013-1229-z; Yilmaz M, 2006, MICROBIOL RES, V161, P127, DOI 10.1016/j.micres.2005.07.001; Yoshida K, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2690-6; Zhang HF, 2009, FEMS MICROBIOL LETT, V293, P160, DOI 10.1111/j.1574-6968.2009.01524.x; Zhang HL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5518; Zhang YL, 2013, J AGR FOOD CHEM, V61, P1521, DOI 10.1021/jf305210u; Zhao ZZ, 2010, BIORESOURCE TECHNOL, V101, P292, DOI 10.1016/j.biortech.2009.07.071	30	3	3	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220410	10.1371/journal.pone.0220410	http://dx.doi.org/10.1371/journal.pone.0220410			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404061	Green Submitted, Green Published, gold			2022-12-26	WOS:000485006800013
J	Jeon, JM; Kwon, OK; Na, AY; Sung, EJ; Cho, IJ; Kim, M; Yea, SS; Chun, SY; Lee, JH; Ha, YS; Kwon, TG; Lee, S				Jeon, Ju Mi; Kwon, Oh Kwang; Na, Ann-Yae; Sung, Eun Ji; Cho, Il Je; Kim, Mirae; Yea, Sung Su; Chun, So Young; Lee, Jun Hyung; Ha, Yun-Sok; Kwon, Tae Gyun; Lee, Sangkyu			Secretome profiling of PC3/nKR cells, a novel highly migrating prostate cancer subline derived from PC3 cells	PLOS ONE			English	Article							LEUKOCYTE PROTEASE INHIBITOR; MATRIX METALLOPROTEINASES; EXPRESSION; IDENTIFICATION; CARCINOMAS; NETWORKS; INVASION	Prostate cancer (PCa) is the most common cancer among men worldwide. Most PCa cases are not fatal; however, the outlook is poor when PCa spreads to another organ. Bone is the target organ in about 80% of patients who experience metastasis from a primary PCa tumor. In the present study, we characterized the secretome of PC3/nKR cells, which are a new subline of PC3 cells that were originally isolated from nude mice that were implanted with PC3 cells without anti-natural killer (NK) cell treatment. Wound healing and Transwell assays revealed that PC3/nKR cells had increased migratory and invasive activities in addition to a higher resistance to NK cells-induced cytotoxicity as compared to PC3 cells. We quantitatively profiled the secreted proteins of PC3/nKR and PC3 cells by liquid chromatography-tandem mass spectrometry analysis coupled with 2-plex tandem mass tag labeling. In total, 598 secretory proteins were identified, and 561 proteins were quantified, among which 45 proteins were secreted more and 40 proteins were secreted less by PC3/nKR cells than by PC3 cells. For validation, the adapter molecule crk, serpin B3, and cystatin-M were analyzed by western blotting. PC3/nKR cells showed the selective secretion of NKG2D ligand 2, HLA-A, and IL-6, which may contribute to their NK cell-mediated cytotoxicity resistance, and had a high secretion of crk protein, which may contribute to their high migration and invasion properties. Based on our secretome analysis, we propose that PC3/nKR cells represent a new cell system for studying the metastasis and progression of PCa.	[Jeon, Ju Mi; Kwon, Oh Kwang; Na, Ann-Yae; Sung, Eun Ji; Lee, Sangkyu] Kyungpook Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, BK21 Plus KNU Multiom Based Creat Drug Res Team, Daegu, South Korea; [Cho, Il Je] Daegu Haany Univ, Coll Korean Med, Gyongsan, Gyeongsangbuk D, South Korea; [Kim, Mirae; Yea, Sung Su] Inje Univ, Coll Med, Dept Biochem, Busan, South Korea; [Chun, So Young] Kyungpook Natl Univ Hosp, Joint Inst Regenerat Med, Daegu, South Korea; [Lee, Jun Hyung; Ha, Yun-Sok; Kwon, Tae Gyun] Kyungpook Natl Univ, Sch Med, Dept Urol, Daegu, South Korea; [Lee, Jun Hyung; Ha, Yun-Sok; Kwon, Tae Gyun] Kyungpook Natl Univ Hosp, Dept Urol, Daegu, South Korea	Kyungpook National University; Daegu Haany University; Inje University; Kyungpook National University; Kyungpook National University Hospital; Kyungpook National University; Kyungpook National University; Kyungpook National University Hospital	Lee, S (corresponding author), Kyungpook Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, BK21 Plus KNU Multiom Based Creat Drug Res Team, Daegu, South Korea.; Kwon, TG (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Urol, Daegu, South Korea.; Kwon, TG (corresponding author), Kyungpook Natl Univ Hosp, Dept Urol, Daegu, South Korea.	tgkwon@knu.ac.kr; sangkyu@knu.ac.kr			National Research Foundation of Korea (NRF) - Korea government (MSIP) [2014M3A9D3034164, 2015R1A2A2A01004286, 2016R1C1B1011180, 2019R1A2C1004046, 2019R1F1A1062343]; Korea Basic Science Institute (KBSI) National Research Facilities & Equipment Center (NFEC) [2019R1A6C1010001]	National Research Foundation of Korea (NRF) - Korea government (MSIP)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea); Korea Basic Science Institute (KBSI) National Research Facilities & Equipment Center (NFEC)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (grant number 2014M3A9D3034164 for TG, 2015R1A2A2A01004286 for SK, 2016R1C1B1011180 for YS, 2019R1A2C1004046 for SY, and 2019R1F1A1062343 for SS).; This work was carried out using the mass spectrometers belonging to the Mass Analysis Support Center supported by the Korea Basic Science Institute (KBSI) National Research Facilities & Equipment Center (NFEC) (2019R1A6C1010001).	Bell Emily S, 2012, Genes Cancer, V3, P341, DOI 10.1177/1947601912459951; Carretero R, 2014, ACTAS UROL ESP, V38, P192, DOI 10.1016/j.acuro.2013.06.006; Cathcart J, 2015, GENES DIS, V2, P26, DOI 10.1016/j.gendis.2014.12.002; Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054; Chou RH, 2012, ONCOL REP, V27, P238, DOI 10.3892/or.2011.1497; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dai YQ, 2011, CELL BIOCHEM FUNCT, V29, P625, DOI 10.1002/cbf.1797; Devoogdt N, 2009, CANCER SCI, V100, P434, DOI 10.1111/j.1349-7006.2009.01076.x; Dhupkar Pooja, 2016, Biochem Biophys Rep, V8, P382, DOI 10.1016/j.bbrep.2016.10.009; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Farooqi AA, 2012, ARCH IMMUNOL THER EX, V60, P191, DOI 10.1007/s00005-012-0169-y; Fathers KE, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3183; FISCHER A, 1946, NATURE, V157, P442, DOI 10.1038/157442c0; Gandaglia G, 2015, EUR UROL, V68, P325, DOI 10.1016/j.eururo.2014.07.020; Garrido F, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5010007; Hodson R, 2015, NATURE, V528, pS137, DOI 10.1038/528S137a; Jin FY, 1998, INFECT IMMUN, V66, P2447, DOI 10.1128/IAI.66.6.2447-2452.1998; KAIGHN ME, 1979, INVEST UROL, V17, P16; Karagiannis GS, 2010, MOL ONCOL, V4, P496, DOI 10.1016/j.molonc.2010.09.001; KIM U, 1986, J SURG ONCOL, V33, P151, DOI 10.1002/jso.2930330303; Kwon OK, 2018, CANCER GENOM PROTEOM, V15, P279, DOI 10.21873/cgp.20086; Lee YC, 2015, MOL CELL PROTEOMICS, V14, P471, DOI 10.1074/mcp.M114.039909; Lima AR, 2016, TRANSL ONCOL, V9, P357, DOI 10.1016/j.tranon.2016.05.004; Lin QF, 2013, BBA-PROTEINS PROTEOM, V1834, P2360, DOI 10.1016/j.bbapap.2013.01.030; Liu G, 2013, J CLIN INVEST, V123, P4410, DOI 10.1172/JCI69369; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Lundholm M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108925; Malmberg KJ, 2017, SEMIN IMMUNOL, V31, P20, DOI 10.1016/j.smim.2017.08.002; Manca P, 2017, CRIT REV ONCOL HEMAT, V112, P59, DOI 10.1016/j.critrevonc.2017.02.013; Molfetta R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081677; Nanjappa V, 2014, NUCLEIC ACIDS RES, V42, pD959, DOI 10.1093/nar/gkt1251; OHNUKI Y, 1980, CANCER RES, V40, P524; Paltridge JL, 2013, BBA-PROTEINS PROTEOM, V1834, P2233, DOI 10.1016/j.bbapap.2013.03.014; Pettaway CA, 1996, CLIN CANCER RES, V2, P1627; Pulukuri SM, 2009, ONCOGENE, V28, P2829, DOI 10.1038/onc.2009.134; Roden MM, 1999, J IMMUNOL METHODS, V226, P29, DOI 10.1016/S0022-1759(99)00039-3; ROEB E, 1994, FEBS LETT, V349, P45, DOI 10.1016/0014-5793(94)00636-9; Savage N, 2015, NATURE, V528, pS128, DOI 10.1038/528S128a; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sung E, 2017, ELECTROPHORESIS, V38, P2638, DOI 10.1002/elps.201700052; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Tjalsma H, 2000, MICROBIOL MOL BIOL R, V64, P515, DOI 10.1128/MMBR.64.3.515-547.2000; Tsuda Masumi, 2012, Genes Cancer, V3, P334, DOI 10.1177/1947601912458687; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wei HF, 2012, GYNECOL ONCOL, V125, P727, DOI 10.1016/j.ygyno.2012.03.018; Xu LJ, 2018, MOL ONCOL, V12, P269, DOI 10.1002/1878-0261.12135; Yea SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099486; Zeeuwen PLJM, 2009, J INVEST DERMATOL, V129, P1327, DOI 10.1038/jid.2009.40	50	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220807	10.1371/journal.pone.0220807	http://dx.doi.org/10.1371/journal.pone.0220807			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404090	Green Published, gold, Green Submitted			2022-12-26	WOS:000485006800034
J	Secker, KA; Keppeler, H; Duerr-Stoerzer, S; Schmid, H; Schneidawind, D; Hentrich, T; Schulze-Hentrich, JM; Mankel, B; Fend, F; Schneidawind, C				Secker, Kathy-Ann; Keppeler, Hildegard; Duerr-Stoerzer, Silke; Schmid, Hannes; Schneidawind, Dominik; Hentrich, Thomas; Schulze-Hentrich, Julia M.; Mankel, Barbara; Fend, Falko; Schneidawind, Corina			Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9	ONCOGENE			English	Article							HEMATOPOIETIC PROGENITOR CELLS; GENE-EXPRESSION PROFILE; ACUTE MYELOID-LEUKEMIA; STEM-CELLS; ARGININE METHYLATION; PROTEIN; TRANSLOCATIONS; MURINE; IDENTIFICATION; MAINTENANCE	MLL rearrangements play a crucial role in leukemogenesis and comprise a poor prognosis. Therefore, new treatment strategies are urgently needed. We used the CRISPR/Cas9 system to generate an innovative leukemia model based on 100% pure MLL-AF4 or -AF9 rearranged cells derived from umbilical cord blood with indefinite growth in cell culture systems. Our model shared phenotypical, morphological and molecular features of patient cells faithfully mimicking the nature of the disease. Thus, it serves as a fundamental basis for pharmacological studies: inhibition of histone methyltransferase disruptor of telomeric silencing 1-like (DOT1L) is one specific therapeutic approach currently tested in clinical trials. However, success was limited by restricted response warranting further investigation of drug combinations. Recently, it has been shown that the inhibition of protein arginine methyltransferase 5 (PRMT5) exhibits anti-tumoral activity against human cell lines and in MLL mouse models. Here, we used DOT1L and PRMT5 inhibitors in our human MLL-rearranged model demonstrating dose-dependent reduced proliferation, impairment of cell cycle, increasing differentiation, apoptosis, downregulation of target genes and sensitization to chemotherapy. Strikingly, the combination of both compounds led to synergistic anti-tumoral effects. Our study provides a strong rationale for novel targeted combination therapies to improve the outcome of MLL-rearranged leukemias.	[Secker, Kathy-Ann; Keppeler, Hildegard; Duerr-Stoerzer, Silke; Schmid, Hannes; Schneidawind, Dominik; Schneidawind, Corina] Univ Hosp Tuebingen, Dept Hematol & Oncol, Tubingen, Germany; [Hentrich, Thomas; Schulze-Hentrich, Julia M.] Univ Tubingen, Inst Med Genet & Appl Genom, Tubingen, Germany; [Mankel, Barbara; Fend, Falko] Univ Tubingen, Inst Pathol & Neuropathol, Tubingen, Germany; [Mankel, Barbara; Fend, Falko] Univ Hosp Tuebingen, Ctr Comprehens Canc, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Schneidawind, C (corresponding author), Univ Hosp Tuebingen, Dept Hematol & Oncol, Tubingen, Germany.	corina.schneidawind@med.uni-tuebingen.de	Schulze-Hentrich, Julia M./C-1830-2017; Schneidawind, Dominik/AAR-4509-2020; Hentrich, Thomas/N-9336-2019	Schulze-Hentrich, Julia M./0000-0002-9242-2096; Hentrich, Thomas/0000-0002-1488-9096; Fend, Falko/0000-0002-5496-293X	Junior Research Group Grant of the Interdisciplinary Centre for Clinical Research (IZKF) [2383-0-0, 2386-0-0, 2316-0-0]; Wuerttembergischer Krebspreis; Clinician Scientist Program of the Faculty of Medicine Tuebingen; Max Eder Junior Research Group Grant from the Deutsche Krebshilfe; American Society for Blood and Marrow Transplantation (ASBMT); Margarete-von-Wrangell fellowship through the Ministry of Science, Research and the Arts Baden-Wuerttemberg; decipherPD transnational consortium on Epigenomics of Complex Diseases (BMBF) [01KU1503]	Junior Research Group Grant of the Interdisciplinary Centre for Clinical Research (IZKF); Wuerttembergischer Krebspreis; Clinician Scientist Program of the Faculty of Medicine Tuebingen; Max Eder Junior Research Group Grant from the Deutsche Krebshilfe; American Society for Blood and Marrow Transplantation (ASBMT); Margarete-von-Wrangell fellowship through the Ministry of Science, Research and the Arts Baden-Wuerttemberg; decipherPD transnational consortium on Epigenomics of Complex Diseases (BMBF)(Federal Ministry of Education & Research (BMBF))	We thank the Flow Cytometry Core Facility Berg of the University Hospital Tuebingen for their excellent technical support. Likewise, we would like to thank the Department of Obstetrics and Gynecology of the University Hospital Tuebingen for providing human cord blood, and the core facility c.ATG of the University Hospital Tuebingen for preparing the RNA-seq libraries, sequencing the samples and data quality control. Furthermore, we thank Dr. Johan Jeong for his technical support in the analysis of the RNA-seq data. CS was supported by a Junior Research Group Grant of the Interdisciplinary Centre for Clinical Research (IZKF, 2383-0-0), the Wuerttembergischer Krebspreis and the Clinician Scientist Program of the Faculty of Medicine Tuebingen. DS was supported by a Max Eder Junior Research Group Grant from the Deutsche Krebshilfe, a New Investigator Award of the American Society for Blood and Marrow Transplantation (ASBMT), a Junior Research Group Grant of the Interdisciplinary Centre for Clinical Research (IZKF, 2316-0-0) and the Clinician Scientist Program of the Faculty of Medicine Tuebingen. JMSH was supported by a Margarete-von-Wrangell fellowship through the Ministry of Science, Research and the Arts Baden-Wuerttemberg, a Junior Research Group Grant of the Interdisciplinary Centre for Clinical Research (IZKF, 2386-0-0) and, together with TH, received funding from the decipherPD transnational consortium on Epigenomics of Complex Diseases (BMBF grant number 01KU1503).	Andersson AK, 2015, NAT GENET, V47, P330, DOI 10.1038/ng.3230; Andrews S., 2010, FASTQC QUALITY CONTR; Aoki Y, 2015, BLOOD, V125, P967, DOI 10.1182/blood-2014-03-563304; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Baer MR, 1998, LEUKEMIA, V12, P317, DOI 10.1038/sj.leu.2400933; Barabe F, 2007, SCIENCE, V316, P600, DOI 10.1126/science.1139851; Bouchlaka MN, 2013, J EXP MED, V210, P2223, DOI 10.1084/jem.20131219; Breese EH, 2013, BLOOD, V122, P3722; Breese EH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136644; Brinkmann KO, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13938; Buechele C, 2015, BLOOD, V126, P1683, DOI 10.1182/blood-2015-05-646398; Bueno C, 2012, CELL RES, V22, P986, DOI 10.1038/cr.2012.4; Bursen A, 2010, BLOOD, V115, P3570, DOI 10.1182/blood-2009-06-229542; Chen W, 2008, CANCER CELL, V13, P432, DOI 10.1016/j.ccr.2008.03.005; Chen W, 2011, BLOOD, V117, P3474, DOI 10.1182/blood-2010-11-317529; Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Daigle SR, 2013, BLOOD, V122, P1017, DOI 10.1182/blood-2013-04-497644; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Gundry MC, 2016, CELL REP, V17, P1453, DOI 10.1016/j.celrep.2016.09.092; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Kaushik S, 2018, LEUKEMIA, V32, P499, DOI 10.1038/leu.2017.206; Kerbel RS, 2003, CANCER BIOL THER, V2, pS134; Krivtsov AV, 2008, CANCER CELL, V14, P355, DOI 10.1016/j.ccr.2008.10.001; Langer T, 2003, GENE CHROMOSOME CANC, V36, P393, DOI 10.1002/gcc.10167; Lavallee VP, 2015, NAT GENET, V47, P1030, DOI 10.1038/ng.3371; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin S, 2016, CANCER CELL, V30, P737, DOI 10.1016/j.ccell.2016.10.008; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Meyer C, 2018, LEUKEMIA, V32, P273, DOI 10.1038/leu.2017.213; Meyer C, 2013, LEUKEMIA, V27, P2165, DOI 10.1038/leu.2013.135; Mongiardi MP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15494; Montes R, 2011, BLOOD, V117, P4746, DOI 10.1182/blood-2010-12-322230; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Moriya K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037892; Mullighan CG, 2007, LEUKEMIA, V21, P2000, DOI 10.1038/sj.leu.2404808; Muntean AG, 2012, ANNU REV PATHOL-MECH, V7, P283, DOI 10.1146/annurev-pathol-011811-132434; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Piganeau M, 2013, GENOME RES, V23, P1182, DOI 10.1101/gr.147314.112; Reichel M, 2001, ONCOGENE, V20, P2900, DOI 10.1038/sj.onc.1204401; Reimer J, 2017, HAEMATOLOGICA, V102, P1558, DOI 10.3324/haematol.2017.164046; Schneidawind C, 2018, BLOOD ADV, V2, P832, DOI 10.1182/bloodadvances.2017013748; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Serio J, 2018, ONCOGENE, V37, P450, DOI 10.1038/onc.2017.337; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Slany RK, 2009, HAEMATOL-HEMATOL J, V94, P984, DOI 10.3324/haematol.2008.002436; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Srinivasan K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11295; Stam RW, 2010, BLOOD, V115, P2835, DOI 10.1182/blood-2009-07-233049; Stein EM, 2018, BLOOD, V131, P2661, DOI 10.1182/blood-2017-12-818948; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Torres R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4964; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Zhang BL, 2015, ONCOTARGET, V6, P22799, DOI 10.18632/oncotarget.4332	59	15	17	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 14	2019	38	46					7181	7195		10.1038/s41388-019-0937-9	http://dx.doi.org/10.1038/s41388-019-0937-9			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JN5HX	31417187				2022-12-26	WOS:000496930500005
J	Ge, Y; Dansokho, SC; Liao, XP				Ge, Yi; Dansokho, Selma Chipenda; Liao, Xiang-Peng			Advanced neonatal medicine in China: Is newborn ward capacity associated with inpatient antibiotic usage?	PLOS ONE			English	Article							CARE; PRESCRIPTION; INFECTIONS; GUIDELINES; PATTERNS	Previous surveys of neonatal medicine in China have not collected comprehensive information on antibiotic use in newborns. The goal of the present study was to assess the trends in antibiotic use in inpatient newborns from advanced hospitals in mainland China and to evaluate the contributing factors. We extracted retrospective data on newborn clinical units from a database containing key clinical subspecialty area indicators from provincial or ministerial (Class A level III) hospitals over three consecutive years (2008-2010) and in 25 of 31 provincial districts of mainland China. Fifty-five newborn units were included in the study. The results showed that two thirds (65.7% +/- 23.1%) of inpatient new-borns were prescribed antibiotic products. Antibiotic use rates were significantly different by newborn ward bed capacity (p = 0.023; 60.6% for d capacity (ficant65.7% +/- 23-100 beds group, and 77.1% for (ficant65.7% +/- 23.1%) of inpatient newb significantly different by type of hospital, geographic area, admission to physician or nurse ratio, or physician or nurse academic degree. Factors contributing significantly to antibiotic use included ward bed capacity, physician to nurse ratio, average hospital stay, and pneumonia to preterm infant ratio. Our data suggested that the use of antibiotics among inpatient newborns in advanced hospitals in mainland China was prevalent and should be subject to rigorous monitoring, and highlighted the need to explore how newborn ward bed capacity potentially impacts antibiotic use.	[Ge, Yi; Liao, Xiang-Peng] Second Mil Med Univ, Gongli Hosp, Dept Pediat, Shanghai, Peoples R China; [Dansokho, Selma Chipenda] Laval Univ, Fac Med, Off Educ & Continuing Profess Dev, Quebec City, PQ, Canada	Naval Medical University; Laval University	Liao, XP (corresponding author), Second Mil Med Univ, Gongli Hosp, Dept Pediat, Shanghai, Peoples R China.	lxp4848@aliyun.com	Liao, Xiangpeng/GNP-2312-2022	/0000-0002-4588-8803	Canadian Institutes of Health Research - Quebec Training Network in Perinatal Research Program	Canadian Institutes of Health Research - Quebec Training Network in Perinatal Research Program(Canadian Institutes of Health Research (CIHR))	This study was supported by a scholarship from the Canadian Institutes of Health Research - Quebec Training Network in Perinatal Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; This study was supported by a scholarship from the Canadian Institutes of Health Research-Quebec Training Network in Perinatal Research Program. We are extremely thankful to the government agencies for the open access to the data, and to the physicians, nurses, information engineers, and other staffs to collect data from the participating hospitals.	Baggs J, 2016, JAMA INTERN MED, V176, P1639, DOI 10.1001/jamainternmed.2016.5651; Ballinger GA, 2004, ORGAN RES METHODS, V7, P127, DOI 10.1177/1094428104263672; Bert F, 2017, EUR J PUBLIC HEALTH, V27, P506, DOI 10.1093/eurpub/ckw209; Bianco A, 2018, INFECT DRUG RESIST, V11, P2199, DOI 10.2147/IDR.S170349; Boyle J, 2014, IEEE J BIOMED HEALTH, V18, P15, DOI 10.1109/JBHI.2013.2262053; Cantey JB, 2016, LANCET INFECT DIS, V16, P1178, DOI 10.1016/S1473-3099(16)30205-5; Cox LM, 2015, NAT REV ENDOCRINOL, V11, P182, DOI 10.1038/nrendo.2014.210; Currie J, 2011, ADV APPL MATH, V47, P116, DOI 10.1016/j.aam.2010.05.001; Ding H, 2008, ACTA PAEDIATR, V97, P100, DOI 10.1111/j.1651-2227.2007.00580.x; Dong LF, 2008, J ANTIMICROB CHEMOTH, V62, P410, DOI 10.1093/jac/dkn153; Driscoll A, 2018, EUR J CARDIOVASC NUR, V17, P6, DOI 10.1177/1474515117721561; Hauge C, 2017, ACTA PAEDIATR, V106, P1674, DOI 10.1111/apa.13935; Hecker MT, 2003, ARCH INTERN MED, V163, P972, DOI 10.1001/archinte.163.8.972; Lapin B, 2014, J ALLERGY CLIN IMMUN, V134, P728, DOI 10.1016/j.jaci.2014.05.006; Leroux S, 2015, ARCH DIS CHILD, V100, P394, DOI 10.1136/archdischild-2014-306873; Liang XY, 2014, FAM PRACT, V31, P311, DOI 10.1093/fampra/cmu001; Liao XP, 2018, J MATERN-FETAL NEO M, V31, P843, DOI 10.1080/14767058.2017.1299127; Liao XP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169970; Mendelson M, 2015, SAMJ S AFR MED J, V105, P325, DOI [10.7196/SAMJ.9644, 10.7196/samj.9644]; Napolitano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084177; National action plan for combating antibiotic-resistant bacteria  2015, 2015, NAT ACT PLAN COMB AN; National Bureau of Statistics of China, 2014, CHIN POP EMPL STAT Y; National Health and Family Planning Commission of the People's Republic of China (NHFPC), 2010, PIL PROJ EV DEV NAT; Needleman J, 2002, NEW ENGL J MED, V346, P1715, DOI 10.1056/NEJMsa012247; Organisation for Economic Co-operation Development Staff, 2005, HLTH AT A GLANC; Poulsen MN, 2017, OBESITY, V25, P438, DOI 10.1002/oby.21719; Schulman J, 2015, PEDIATRICS, V135, P826, DOI 10.1542/peds.2014-3409; Shah PS, 2015, J PERINATOL, V35, P522, DOI 10.1038/jp.2015.4; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Sun Q, 2008, HEALTH AFFAIR, V27, P1042, DOI 10.1377/hlthaff.27.4.1042; Tarnow-Mordi WO, 2000, LANCET, V356, P185, DOI 10.1016/S0140-6736(00)02478-8; United Nations Development Programme, 2013, HUM DEV IND 2010; USA Centers for Disease Control and Prevention, 2017, ANT US US 2017 PROGR; Wang J, 2014, JAMA INTERN MED, V174, P1914, DOI 10.1001/jamainternmed.2014.5214; World Health Organization, 2004, PRACTICAL GUIDELINES; World Health Organization, 1993, SEL DRUG US IND EDM; World Health Organization, 2014, ANT RES GLOB REP SUR; Xiao YH, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001556; Yin XX, 2013, J ANTIMICROB CHEMOTH, V68, P2445, DOI 10.1093/jac/dkt223; Zhang WS, 2008, EUR J CLIN PHARMACOL, V64, P821, DOI 10.1007/s00228-008-0489-3; 吴安华, 2002, [中华医院感染学杂志, Chinese Journal of Nosocomiology], V12, P881	41	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0219630	10.1371/journal.pone.0219630	http://dx.doi.org/10.1371/journal.pone.0219630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408462	Green Submitted, Green Published, gold			2022-12-26	WOS:000485009500005
J	Toriz, CG; Melo, AI; Solano-Agama, C; Gomez-Dominguez, EG; Martinez-Munoz, MD; Castaneda-Obeso, J; Vera-Aguilar, E; Aguirre-Benitez, EL; Romero-Aguilar, L; Gonzalez-del Pliego, M; Jimenez-Estrada, I; Luna, M; Pardo, JP; Camacho, J; Mendoza-Garrido, ME				Toriz, Cesar G.; Melo, Angel, I; Solano-Agama, Carmen; Gomez-Dominguez, Edgar Giovanhi; de los Angeles Martinez-Munoz, Ma; Castaneda-Obeso, Jorge; Vera-Aguilar, Eunice; Liliana Aguirre-Benitez, Elsa; Romero-Aguilar, Lucero; Gonzalez-del Pliego, Margarita; Jimenez-Estrada, Ismael; Luna, Maricela; Pablo Pardo, Juan; Camacho, Javier; Eugenia Mendoza-Garrido, Maria			Physiological changes of growth hormone during lactation in pup rats artificially reared	PLOS ONE			English	Article							NEONATAL-RAT; DEVELOPMENTAL-CHANGES; SOMATOSTATIN ANALOGS; MATERNAL-DEPRIVATION; FACTOR-I; SECRETION; PITUITARY; GHRELIN; RELEASE; STIMULATION	During the lactation period, rat pups are fed by the dam, and the patterns of mother-pup interaction change during this period. Additionally, there are changes in feeding; first, mother's milk is the only food needed for sustenance, and later, it is combined with solid food and water. GH serum concentrations depend on both maternal-pup interaction and energy metabolism. In the artificial rearing (AR) procedure, pups are deprived of mother-pup interaction, and the feeding pattern is controlled. This rearing paradigm has been used in rats to analyze the effects of maternal deprivation on social behavior. In the present study, we analyzed the variation in GH, acylated ghrelin and IGF-1 serum concentrations throughout the lactation period in AR pups. At pnd7, the maternal rearing (MR) pups responded to a 4 h fast with a drop in GH serum concentration, which is a well-known response to maternal deprivation. GH serum levels in the AR pups did not change, suggesting an adaptation phenomenon. A dopamine inhibitory effect of GH secretion was observed in pnd7 cultured somatotropes, suggesting dopamine regulation of GH secretion at this age. Acylated ghrelin serum levels in the AR pups showed an inverted pattern compared to that in the MR pups, which was related to the artificial feeding pattern. IGF-1 serum levels were lower in the AR pups than in MR pups, which was associated with hepatic GH resistance and with low Igf1 mRNA expression at pnd7. Interestingly, at pnd14, both pup groups showed high hepatic Igf1 mRNA expression but low IGF-1 serum levels, and this was inverted at pnd21. However, serum glucose levels were lower in the AR pups at pnd14 but reached the same levels as the MR pups at pnd21. Moreover, hepatomegaly and higher hepatic GH-receptor levels were observed in the AR pups at pnd21, which was in agreement with an absence of a solid food meal. During AR, the pups lost the maternal interaction-stimulated GH secretion, which correlated with lower IGF-1 serum levels during the first week of postnatal development.	[Toriz, Cesar G.; Solano-Agama, Carmen; Gomez-Dominguez, Edgar Giovanhi; Castaneda-Obeso, Jorge; Jimenez-Estrada, Ismael; Eugenia Mendoza-Garrido, Maria] Inst Politecn Nacl, CINVESTAV, Ctr Invest & Estudios Avanzados, Dept Fisiol Biofis & Neurociencias, Mexico City, DF, Mexico; [Melo, Angel, I; de los Angeles Martinez-Munoz, Ma] Univ Autonoma Tlaxcala, IPN, CINVESTAV, Ctr Invest Reprod & Anim, Ixtacuixtla, Tlaxcala, Mexico; [Vera-Aguilar, Eunice; Camacho, Javier] IPN, CINVESTAV, Dept Farmacol, Mexico City, DF, Mexico; [Liliana Aguirre-Benitez, Elsa; Gonzalez-del Pliego, Margarita] Univ Nacl Autonoma Mexico, Fac Med, Dept Embriol, Mexico City, DF, Mexico; [Romero-Aguilar, Lucero; Pablo Pardo, Juan] Univ Nacl Autonoma Mexico, Dept Bioquim, Fac Med, Mexico City, DF, Mexico; [Luna, Maricela] UNAM, Neurobiol Celular & Mol, Inst Neurobiol, Juriquilla, Queretaro, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Mendoza-Garrido, ME (corresponding author), Inst Politecn Nacl, CINVESTAV, Ctr Invest & Estudios Avanzados, Dept Fisiol Biofis & Neurociencias, Mexico City, DF, Mexico.	mmendoza@fisio.cinvestav.mx	, Javier/AAS-1379-2021; Melo, Angel I./AAZ-7094-2021	Melo, Angel I./0000-0003-4842-7217; Toriz Gonzalez, Cesar Gabriel/0000-0002-9691-8435	National Council of Sciences and Technology of Mexico (CONACyT) [181334, 45270]	National Council of Sciences and Technology of Mexico (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work and CG Toriz were supported by the National Council of Sciences and Technology of Mexico (CONACyT) with grant number: 181334 and fellowship number 45270, respectively.	Aguayo-Mazzucato C, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000035; Aguirre-Benitez EL, 2017, DEV NEUROBIOL, V77, P1413, DOI 10.1002/dneu.22548; Al Ain S, 2017, SOC NEUROSCI-UK, V12, P32, DOI 10.1080/17470919.2016.1159605; Arellanes-Licea EC, 2018, ENDOCR CONNECT, V7, P258, DOI 10.1530/EC-17-0380; Bello-Pineda J, 1999, J ENDOCRINOL, V160, P333, DOI 10.1677/joe.0.1600333; Bergan-Roller HE, 2018, GEN COMP ENDOCR, V258, P119, DOI 10.1016/j.ygcen.2017.07.028; BLASS EM, 1980, SCIENCE, V210, P15, DOI 10.1126/science.6997992; Bonnefont X, 2005, P NATL ACAD SCI USA, V102, P16880, DOI 10.1073/pnas.0508202102; Chanoine JP, 2006, HORM RES, V66, P81, DOI 10.1159/000093585; Dvorak B, 2010, J PEDIATR-US, V156, pS31, DOI 10.1016/j.jpeds.2009.11.018; EDEN S, 1979, ENDOCRINOLOGY, V105, P555, DOI 10.1210/endo-105-2-555; Fak F, 2007, J ENDOCRINOL, V192, P345, DOI [10.1677/joe.1.07077, 10.1677/JOE.1.07077]; Gavalda-Navarro A, 2015, SCI REP-UK, V5, DOI 10.1038/srep13717; GROSVENOR CE, 1993, ENDOCR REV, V14, P710, DOI 10.1210/edrv-14-6-710; Gruszka A, 2012, MOL CELL ENDOCRINOL, V362, P104, DOI 10.1016/j.mce.2012.05.020; GULYAS M, 1993, HISTOCHEMISTRY, V100, P503, DOI 10.1007/BF00267832; HALL WG, 1975, SCIENCE, V190, P1313, DOI 10.1126/science.1198116; HENNING SJ, 1981, AM J PHYSIOL, V241, pG199, DOI 10.1152/ajpgi.1981.241.3.G199; INIGUEZ C, 1995, NEUROENDOCRINOLOGY, V62, P308, DOI 10.1159/000127018; Jouihan H, 2012, BIO-PROTOCOL, V2, P223, DOI [10.21769/BioProtoc.223, DOI 10.21769/BIOPROTOC.223, DOI 10.21769/BioProtoc.223]; KACSOH B, 1989, ENDOCRINOLOGY, V125, P1326, DOI 10.1210/endo-125-3-1326; KACSOH B, 1990, J ENDOCRINOL, V124, P233, DOI 10.1677/joe.0.1240233; KACSOH B, 1991, J NEUROENDOCRINOL, V3, P529, DOI 10.1111/j.1365-2826.1991.tb00314.x; KEEN CL, 1981, J NUTR, V111, P226, DOI 10.1093/jn/111.2.226; KHORRAM O, 1983, ENDOCRINOLOGY, V113, P720, DOI 10.1210/endo-113-2-720; Kim YD, 2012, J BIOL CHEM, V287, P37098, DOI 10.1074/jbc.M112.339887; KUHN CM, 1978, SCIENCE, V201, P1034, DOI 10.1126/science.684424; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; Le Roith D, 2001, TRENDS ENDOCRIN MET, V12, P48; Levy F, 2003, DEV PSYCHOBIOL, V43, P177, DOI 10.1002/dev.10131; Lomanowska AM, 2016, HORM BEHAV, V77, P224, DOI 10.1016/j.yhbeh.2015.05.017; LOPEZ F, 1986, ACTA ENDOCRINOL-COP, V113, P317, DOI 10.1530/acta.0.1130317; Mani BK, 2017, TRENDS ENDOCRIN MET, V28, P843, DOI 10.1016/j.tem.2017.10.001; Melo AI, 2006, DEV PSYCHOBIOL, V48, P209, DOI 10.1002/dev.20130; MESSER M, 1969, J NUTR, V98, P404, DOI 10.1093/jn/98.4.404; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; Murray PG, 2015, J ENDOCRINOL, V226, pT123, DOI 10.1530/JOE-15-0120; Newman-Tancredi A, 2002, J PHARMACOL EXP THER, V303, P815, DOI 10.1124/jpet.102.039883; Ohlsson C, 2009, ENDOCR REV, V30, P494, DOI 10.1210/er.2009-0010; Pacha J, 2000, PHYSIOL REV, V80, P1633, DOI 10.1152/physrev.2000.80.4.1633; Papageorgiou A, 2007, ENDOCRINOLOGY, V148, P4509, DOI 10.1210/en.2007-0034; Raineki C, 2010, BRAZ J MED BIOL RES, V43, P914, DOI 10.1590/S0100-879X2010001000001; RENIER G, 1991, NEUROENDOCRINOLOGY, V54, P521, DOI 10.1159/000125947; RIEUTORT M, 1981, J ENDOCRINOL, V89, P355, DOI 10.1677/joe.0.0890355; Sakata I, 2012, AM J PHYSIOL-ENDOC M, V302, pE1300, DOI 10.1152/ajpendo.00041.2012; SCHANBERG SM, 1984, P SOC EXP BIOL MED, V175, P135; Shumate ML, 2005, AM J PHYSIOL-GASTR L, V289, pG227, DOI 10.1152/ajpgi.00424.2004; Sjogren K, 2002, J BONE MINER RES, V17, P1977, DOI 10.1359/jbmr.2002.17.11.1977; SMART JL, 1983, BRIT J NUTR, V49, P497, DOI 10.1079/BJN19830058; Sperling MA, 2016, GROWTH HORM IGF RES, V28, P69, DOI 10.1016/j.ghir.2015.06.005; Steculorum SM, 2015, J CLIN INVEST, V125, P846, DOI 10.1172/JCI73688; Steculorum SM, 2011, PEPTIDES, V32, P2362, DOI 10.1016/j.peptides.2011.06.021; Taniguchi Y, 2002, ANAT EMBRYOL, V206, P1, DOI 10.1007/s00429-002-0271-8; Vijayakumar A, 2010, GROWTH HORM IGF RES, V20, P1, DOI 10.1016/j.ghir.2009.09.002; WALKER P, 1977, ENDOCRINOLOGY, V101, P782, DOI 10.1210/endo-101-3-782; Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325; Yakar S, 2002, J CLIN INVEST, V110, P771, DOI 10.1172/JCI200215463; Zatelli C, 2005, J MOL ENDOCRINOL, V35, P333, DOI 10.1677/jme.1.01876; Zempoalteca R, 2018, DEV NEUROBIOL, V78, P351, DOI 10.1002/dneu.22561; Zhang P., 2012, BIO-PROTOCOL, V2, pe186	60	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220853	10.1371/journal.pone.0220853	http://dx.doi.org/10.1371/journal.pone.0220853			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408482	gold, Green Published, Green Submitted			2022-12-26	WOS:000485009500022
J	Pstras, L; Debowska, M; Wojcik-Zaluska, A; Zaluska, W; Waniewski, J				Pstras, Leszek; Debowska, Malgorzata; Wojcik-Zaluska, Alicja; Zaluska, Wojciech; Waniewski, Jacek			Hemodialysis-induced changes in hematocrit, hemoglobin and total protein: Implications for relative blood volume monitoring	PLOS ONE			English	Article							PHOSPHATE KINETICS; PLASMA-VOLUME; SESSIONS	Background Relative blood volume (RBV) changes during hemodialysis (HD) are typically estimated based on online measurements of hematocrit, hemoglobin or total blood protein. The aim of this study was to assess changes in the above parameters during HD in order to compare the potential differences in the RBV changes estimated by individual methods. Methods 25 anuric maintenance HD patients were monitored during a 1-week conventional HD treatment. Blood samples were collected from the arterial dialysis blood line at the beginning and at the end of each HD session. The analysis of blood samples was performed using the hematology analyzer Advia 2120 and clinical chemistry analyzer Advia 1800 (Siemens Healthcare). Results During the analyzed 30 HD sessions with ultrafiltration in the range 0.7-4.0 L (2.5 +/- 0.8 L) hematocrit (HCT) increased by 9.1 +/- 7.0% (mean +/- SD), hemoglobin (HGB) increased by 10.6 +/- 6.3%, total plasma protein (TPP) increased by 15.6 +/- 9.5%, total blood protein (TBP) increased by 10.4 +/- 5.8%, red blood cell count (RBC) increased by 10.8 +/- 7.1%, while mean corpuscular red cell volume (MCV) decreased by 1.5 +/- 1.1% (all changes statistically significant, p < 0.001). HGB increased on average by 1.5% more than HCT (p < 0.001). The difference between HGB and TBP increase was insignificant (p = 0.16). Conclusions Tracking HGB or TBP can be treated as equivalent for the purpose of estimating RBV changes during HD. Due to the reduction of MCV, the HCT-based estimate of RBV changes may underestimate the actual blood volume changes.	[Pstras, Leszek; Debowska, Malgorzata; Waniewski, Jacek] Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland; [Wojcik-Zaluska, Alicja] Med Univ Lublin, Dept Phys Therapy & Rehabil, Lublin, Poland; [Zaluska, Wojciech] Med Univ Lublin, Dept Nephrol, Lublin, Poland	Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences; Medical University of Lublin; Medical University of Lublin	Pstras, L (corresponding author), Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland.	leszek.pstras@ibib.waw.pl	Debowska, Malgorzata/F-3035-2015	Debowska, Malgorzata/0000-0001-8741-7930; Zaluska, Wojciech/0000-0001-6043-3236; Pstras, Leszek/0000-0001-5705-6142; Jacek, Waniewski/0000-0002-2705-504X; Wojcik-Zaluska, Alicja/0000-0001-7971-0141	National Science Centre (Poland) [N N518 289840]	National Science Centre (Poland)	The clinical data presented in this article were originally collected within the study "Evaluation of disturbances of calcium-phosphate management in patients on dialysis" funded by the National Science Centre (Poland), grant no N N518 289840 to MD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTELS PC, 1990, J CLIN CHEM CLIN BIO, V28, P113; CHAPLIN H, 1953, J CLIN INVEST, V32, P1309, DOI 10.1172/JCI102859; Dasselaar JJ, 2005, NEPHROL DIAL TRANSPL, V20, P2043, DOI 10.1093/ndt/gfi056; Dasselaar Judith J, 2007, Hemodial Int, V11, P448, DOI 10.1111/j.1542-4758.2007.00216.x; Dasselaar JJ, 2007, CLIN J AM SOC NEPHRO, V2, P669, DOI 10.2215/CJN.00880207; Dasselaar JJ, 2012, BLOOD PURIFICAT, V33, P177, DOI 10.1159/000334142; Debowska M, 2015, ARTIF ORGANS, V39, P1005, DOI 10.1111/aor.12489; Debowska M, 2015, NEPHROL DIAL TRANSPL, V30, P129, DOI 10.1093/ndt/gfu266; FAIRBANKS VF, 1996, BLOOD CELL MOL DIS, V22, P169, DOI DOI 10.1006/BCMD.1996.0024; FLEMING SJ, 1988, CLIN NEPHROL, V29, P63; Gellert R., 1989, DEV NEPHROLOGY, V24; HSU CH, 1984, NEPHRON, V38, P202, DOI 10.1159/000183308; Johnson DW, 1996, KIDNEY INT, V49, P255, DOI 10.1038/ki.1996.36; Keane DF, 2018, ASAIO J, V64, P812, DOI 10.1097/MAT.0000000000000795; KIRSCHBAUM B, 1989, INT J ARTIF ORGANS, V12, P307; Krepel HP, 2000, NEPHROL DIAL TRANSPL, V15, P673, DOI 10.1093/ndt/15.5.673; Kron J, 2014, BLOOD PURIFICAT, V38, P180, DOI 10.1159/000368157; LEYPOLDT JK, 1995, J AM SOC NEPHROL, V6, P214; Linne J., 1999, CLIN LAB SCI BASICS; Longanbach S., 2007, HEMATOLOGY CLIN PRIN; MALIN MJ, 1989, AM J CLIN PATHOL, V92, P286, DOI 10.1093/ajcp/92.3.286; Mitra S, 2004, J AM SOC NEPHROL, V15, P463, DOI 10.1097/01.ASN.0000108970.48370.33; Pietribiasi M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209553; Pietribiasi M, 2018, INT J ARTIF ORGANS, V41, P706, DOI 10.1177/0391398818803439; Pietribiasi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159748; Pietribiasi M, 2015, ASAIO J, V61, P350, DOI 10.1097/MAT.0000000000000206; Polaschegg H. D., 2004, REPLACEMENT RENAL FU; Poleszczuk J, 2016, BLOOD PURIFICAT, V42, P177, DOI 10.1159/000445934; RASMUSSEN KC, 1993, SCAND J CLIN LAB INV, V53, P211, DOI 10.3109/00365519309088411; Samandari H, 2018, ASAIO J, V64, P77, DOI 10.1097/MAT.0000000000000608; SCHALLENBERG U, 1987, LIFE SUPPORT SYST, V5, P293; Schneditz D, 1996, J AM SOC NEPHROL, V7, P1241; SCHNEDITZ D, 1992, KIDNEY INT, V42, P1425, DOI 10.1038/ki.1992.437; Schneditz D, 2018, ASAIO J, V64, P697, DOI 10.1097/MAT.0000000000000885; Schneditz D, 2016, HEMODIAL INT, V20, P120, DOI 10.1111/hdi.12338; Schneditz D, 2014, ASAIO J, V60, P436, DOI 10.1097/MAT.0000000000000086; Siemens Healthcare Diagnostics Inc, 2010, ADVIA 2120 2120I HEM; STOTT RAW, 1995, CLIN CHEM, V41, P306; SWARTZ RD, 1982, AM J NEPHROL, V2, P189, DOI 10.1159/000166644; Thijssen S, 2013, BLOOD PURIFICAT, V35, P63, DOI 10.1159/000345484; Waniewski J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153285; Yu AW, 1997, KIDNEY INT, V51, P1986, DOI 10.1038/ki.1997.270	42	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220764	10.1371/journal.pone.0220764	http://dx.doi.org/10.1371/journal.pone.0220764			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404089	Green Published, Green Submitted, gold			2022-12-26	WOS:000485006800030
J	Tan, CJ; Zhang, JH; Chen, WL; Feng, FF; Yu, C; Lu, XD; Lin, RH; Li, ZF; Huang, YM; Zheng, LP; Huang, MY; Wu, GW				Tan, Chunjiang; Zhang, Jiahui; Chen, Wenlie; Feng, Fangfang; Yu, Chao; Lu, Xiaodong; Lin, Ruhui; Li, Zuanfang; Huang, Yunmei; Zheng, Liangpu; Huang, Meiya; Wu, Guangwen			Inflammatory cytokines via up-regulation of aquaporins deteriorated the pathogenesis of early osteoarthritis	PLOS ONE			English	Article							TOUGU XIAOTONG CAPSULE; ARTICULAR-CARTILAGE; RAT MODEL; CHONDROCYTE APOPTOSIS; KNEE OSTEOARTHRITIS; IN-VIVO; ALPHA; EXPRESSION; DEGRADATION; INHIBITION	Background Inflammatory cytokines enhanced the progress of the pathogenesis of osteoarthritis, however the mechanisms remain unclear. The objective is to determine aquaporins (AQPs) in the pathogenesis of osteoarthritis. Methods and findings Primary rat articular chondrocytes were treated with IL-1 beta to mimic the early stage of osteoarthritis in vitro. Early osteoarthritis animal model was established by intra-articular injection of 4% papain. Micro- or ultra-structure histopathologic changes, cell viability, apoptosis cells and cell membrane permeability, locations and expressions of AQP1 and AQP3 and matrix were detected in the cartilage or in the chondrocytes of knee. IL-1 beta could reduce the chondrocytes viability, increase the apoptosis cells, and also impair the cell membrane and organelles. IL-1 beta significantly induced the up-regulation of AQP1 and AQP3 in the chondrocytes. In the chondrocytes, AQPs were mainly clustered in both membrane and perinuclear region of cytoplasm, while higher AQPs were detected in the superficial and middle layers of the cartilage. With the up-regulation of AQPs, the cartilage matrix was considerably decreased in both the chondrocytes and in the osteoarthritis cartilage. In the early osteoarthritis rat model, serum and synovial fluid confirmed that higher IL-1 beta could increase the expressions of AQPs, and decrease the cartilage matrix in both the chondrocytes and the cartilage. Conclusions Inflammatory cytokine IL-1 beta via up-regulation of AQPs caused the abnormal metabolism of water transport and loss of the cartilage matrix in the chondrocytes, and ultimately exacerbated the pathogenesis of early osteoarthritis. Therefore, AQPs may be a candidate therapeutic target for prevention and treatment of osteoarthritis.	[Tan, Chunjiang; Zhang, Jiahui; Chen, Wenlie; Feng, Fangfang; Yu, Chao; Lu, Xiaodong; Lin, Ruhui; Li, Zuanfang; Huang, Yunmei; Zheng, Liangpu; Huang, Meiya; Wu, Guangwen] Fujian Univ Tradit Chinese Med, Fuzhou, Fujian, Peoples R China; [Tan, Chunjiang; Chen, Wenlie; Lin, Ruhui; Li, Zuanfang; Huang, Yunmei; Zheng, Liangpu; Huang, Meiya] Fujian Acad Integrat Med, Fuzhou, Fujian, Peoples R China; [Tan, Chunjiang; Chen, Wenlie; Li, Zuanfang; Zheng, Liangpu; Wu, Guangwen] Fujian Key Lab Integrat Med Geriatr, Fuzhou, Fujian, Peoples R China; [Zhang, Jiahui] First Hosp Fuzhou, Fuzhou, Fujian, Peoples R China; [Chen, Wenlie; Lin, Ruhui; Huang, Yunmei; Huang, Meiya; Wu, Guangwen] Natl Lab Tradit Chinese Med Pharmacol Cell Struct, Fuzhou, Fujian, Peoples R China	Fujian University of Traditional Chinese Medicine	Tan, CJ; Chen, WL (corresponding author), Fujian Univ Tradit Chinese Med, Fuzhou, Fujian, Peoples R China.; Tan, CJ; Chen, WL (corresponding author), Fujian Acad Integrat Med, Fuzhou, Fujian, Peoples R China.; Tan, CJ; Chen, WL (corresponding author), Fujian Key Lab Integrat Med Geriatr, Fuzhou, Fujian, Peoples R China.; Chen, WL (corresponding author), Natl Lab Tradit Chinese Med Pharmacol Cell Struct, Fuzhou, Fujian, Peoples R China.	tchunj@126.com; chen.wl@163.com			National Natural Science Foundation of China [81573801]; Natural Science Foundation of Fujian Province [2017J06018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province)	This work was supported by the National Natural Science Foundation of China No. 81573801 and the Natural Science Foundation of Fujian Province No. 2017J06018 to WC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton Nicola J, 2007, J Inflamm (Lond), V4, P13, DOI 10.1186/1476-9255-4-13; BRADLEY JD, 1992, J RHEUMATOL, V19, P1950; Cai L, 2018, IMMUNOPHARM IMMUNOT, V40, P117, DOI 10.1080/08923973.2017.1417998; Chen QZ, 2012, FOLIA HISTOCHEM CYTO, V50, P137, DOI [10.2478/18709, 10.5603/FHC.2012.0020]; Chowdhury TT, 2001, BIOCHEM BIOPH RES CO, V285, P1168, DOI 10.1006/bbrc.2001.5311; Cohen NP, 1998, J ORTHOP SPORT PHYS, V28, P203, DOI 10.2519/jospt.1998.28.4.203; DIJKGRAAF LC, 1995, J ORAL MAXIL SURG, V53, P1182, DOI 10.1016/0278-2391(95)90632-0; Gao HF, 2016, INT J MOL MED, V38, P1752, DOI 10.3892/ijmm.2016.2785; Gao H, 2011, SURG INNOV, V18, P279, DOI 10.1177/1553350611399587; Geyer M, 2009, OSTEOARTHR CARTILAGE, V17, P328, DOI 10.1016/j.joca.2008.07.010; Hagiwara K, 2013, MED MOL MORPHOL, V46, P104, DOI 10.1007/s00795-013-0014-3; Honorati MC, 2004, OSTEOARTHR CARTILAGE, V12, P683, DOI 10.1016/j.joca.2004.05.009; Huang GL, 2018, EXP THER MED, V15, P3096, DOI 10.3892/etm.2018.5794; Kraus VB, 2015, OSTEOARTHR CARTILAGE, V23, P1233, DOI 10.1016/j.joca.2015.03.036; Laurent D, 2003, MAGNET RESON MED, V50, P541, DOI 10.1002/mrm.10566; Li HT, 2013, INT J MOL MED, V32, P1329, DOI 10.3892/ijmm.2013.1527; Li XH, 2013, INT J MOL MED, V31, P1349, DOI 10.3892/ijmm.2013.1341; Liao NS, 2015, EXP THER MED, V10, P1908, DOI 10.3892/etm.2015.2739; Liess C, 2002, OSTEOARTHR CARTILAGE, V10, P907, DOI 10.1053/joca.2002.0847; Meng JH, 2007, CHINESE MED J-PEKING, V120, P2191, DOI 10.1097/00029330-200712020-00006; Minguzzi M, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/3075293; Murat Nergis, 2007, Acta Orthop Traumatol Turc, V41, P233; Musumeci G, 2013, TISSUE CELL, V45, P145, DOI 10.1016/j.tice.2012.10.004; Permuy M, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0458-x; Raman S, 2018, FRONT BIOENG BIOTECH, V6, DOI 10.3389/fbioe.2018.00022; SAKLATVALA J, 1986, NATURE, V322, P547, DOI 10.1038/322547a0; Shakibaei M, 2005, ANN ANAT, V187, P487, DOI 10.1016/j.aanat.2005.06.007; Shakibaei M, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/509383; Taruc-Uy RL, 2013, PRIMARY CARE, V40, P821, DOI 10.1016/j.pop.2013.08.003; Trujillo E, 2004, HISTOL HISTOPATHOL, V19, P435, DOI 10.14670/HH-19.435; Verkman Alan S, 2009, Handb Exp Pharmacol, P359, DOI 10.1007/978-3-540-79885-9_18; Wang SN, 2015, INT IMMUNOPHARMACOL, V24, P408, DOI 10.1016/j.intimp.2014.12.029; Yang Y, 2016, INFLAMMATION, V39, P1, DOI [10.1007/s10753-015-0215-0, DOI 10.1007/S10753-015-0215-0]; Zhang XH, 2015, CHIN J NAT MEDICINES, V13, P283, DOI 10.1016/S1875-5364(15)30015-7; Zhao HH, 2014, J CELL MOL MED, V18, P283, DOI 10.1111/jcmm.12186; Zhou PH, 2008, J ORTHOP RES, V26, P1643, DOI 10.1002/jor.20683	36	10	11	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220846	10.1371/journal.pone.0220846	http://dx.doi.org/10.1371/journal.pone.0220846			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404098	Green Published, Green Submitted, gold			2022-12-26	WOS:000485006800037
J	Badgujar, NV; Tarapara, BV; Shah, FD				Badgujar, Nutan V.; Tarapara, Bhoomi V.; Shah, Franky D.			Computational analysis of high-risk SNPs in human CHK2 gene responsible for hereditary breast cancer: A functional and structural impact	PLOS ONE			English	Article							PROTEIN STABILITY CHANGES; DNA-DAMAGE; CHEK2 GENE; DELETERIOUS NSSNPS; MISSENSE MUTATIONS; KINASE; SEQUENCE; VARIANTS; RECOGNITION; PREDICTION	Nowadays CHK2 mutation is studied frequently in hereditary breast and ovarian cancer patients in addition to BRCA1/BRCA2. CHK2 is a tumor suppressor gene that encodes a serine/threonine kinase, also involved in pathways such as DNA repair, cell cycle regulation and apoptosis in response to DNA damage. CHK2 is a well-studied moderate penetrance gene that correlates with third high risk susceptibility gene with an increased risk for breast cancer. Hence before planning large population study, it is better to scrutinize putative functional SNPs of CHK2 using different computational tools. In this study, we have used various computational approaches to identify nsSNPs which are deleterious to the structure and/or function of CHK2 protein that might be causing this disease. Computational analysis was performed by different in silico tools including SIFT, Align GVGD, SNAP-2, PROVEAN, Poly-Phen-2, PANTHER, PhD-SNP, MUpro, iPTREE-STAB, Consurf, InterPro, NCBI Conserved Domain Search tool, ModPred, SPARKS-X, RAMPAGE, Verify-3D, FT Site, COACH and PyMol. Out of 78 nsSNP of human CHK2 gene, seven nsSNPs were predicted functionally most significant SNPs. Among these seven nsSNP, p.Arg160Gly, p.Gly210Arg and p.Ser415Phe are highly conserved residues with conservation score of 9 and three nsSNP were predicted to be involved in post translational modification. The p.Arg160Gly and p.Gly210Arg may interfere in phosphopeptide binding site on FHA conserved domain. The p.Ser415Phe may interfere in formation of activation loop of protein-kinase domain and might interfere in interactions of CHK2 with ligand. The study concludes that mutation of serine to phenylalanine at position 415 is a major mutation in native CHK2 protein which might contribute to its malfunction, ultimately causing disease. This is the first comprehensive study, where CHK2 gene variants are analyzed using in silico tools hence it will be of great help while considering large scale studies and also in developing precision medicines related to these polymorphisms in the era of personalized medicine.	[Badgujar, Nutan V.; Tarapara, Bhoomi V.; Shah, Franky D.] Gujarat Canc Res Inst, Dept Canc Biol, Stem Cell Biol Lab, Ahmadabad, Gujarat, India	The Gujarat Cancer & Research Institute	Shah, FD (corresponding author), Gujarat Canc Res Inst, Dept Canc Biol, Stem Cell Biol Lab, Ahmadabad, Gujarat, India.	franky.shah@gcriindia.org		Tarapara, Bhoomi/0000-0001-9262-925X; Shah, Franky/0000-0002-7265-2839				Abdelraheem N.E., 2016, AM J BIOINFORMATICS, V6, P56; Abdelraheem NE., 2016, AM J BIOINFORM RES, V6, P32, DOI [10.5923/j.bioinformatics.20160602.02, DOI 10.5923/J.BIOINFORMATICS.20160602.02]; Alanazi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025876; Apostolou P, 2017, BREAST CANCER-TARGET, V9, P331, DOI 10.2147/BCTT.S111394; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baloch Abdul Hameed, 2016, Asian Pac J Cancer Prev, V17, P1089; Baloch AH, 2014, MOL BIOL REP, V41, P1103, DOI 10.1007/s11033-013-2956-x; Bartek J, 2001, NAT REV MOL CELL BIO, V2, P877, DOI 10.1038/35103059; Baysal BE, 2004, GYNECOL ONCOL, V95, P62, DOI 10.1016/j.ygyno.2004.07.015; Bell DW, 2007, INT J CANCER, V121, P2661, DOI 10.1002/ijc.23026; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Bhagwat M., 2010, CURRENT PROTOCOLS BI, V32; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Delimitsou A, 2019, HUMAN MUTATION; Desai M, 2018, COMPUT BIOL CHEM, V74, P20, DOI 10.1016/j.compbiolchem.2018.02.022; Desai M, 2017, COMPUT BIOL CHEM, V70, P7, DOI 10.1016/j.compbiolchem.2017.07.001; Desai M, 2016, META GENE, V10, P1, DOI 10.1016/j.mgene.2016.09.004; Doniger SW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000183; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Gassoum A, 2016, OPEN ACCESS LIB J, V3, P1; Hicks S, 2011, HUM MUTAT, V32, P661, DOI 10.1002/humu.21490; Hines SL, 2019, MOL OMICS, V15, P59, DOI 10.1039/c8mo00137e; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Huang LT, 2007, BIOINFORMATICS, V23, P1292, DOI 10.1093/bioinformatics/btm100; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jalilvand Manizheh, 2017, Comp Clin Path, V26, P837, DOI 10.1007/s00580-017-2455-x; Karczewski KJ, 2017, NUCLEIC ACIDS RES, V45, pD840, DOI 10.1093/nar/gkw971; Kilpivaara O, 2004, INT J CANCER, V111, P543, DOI 10.1002/ijc.20299; Lovell SC, 2003, PROTEIN-STRUCT FUNCT, DOI [10.1093/bioinformatics/btt447, DOI 10.1093/BIOINFORMATICS/BTT447]; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Meijers-Heijboer H, 2003, AM J HUM GENET, V72, P1308, DOI 10.1086/375121; Miller MP, 2001, HUM MOL GENET, V10, P2319, DOI 10.1093/hmg/10.21.2319; Nachman MW, 2001, TRENDS GENET, V17, P481, DOI 10.1016/S0168-9525(01)02409-X; Nevanlinna H, 2006, ONCOGENE, V25, P5912, DOI 10.1038/sj.onc.1209877; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ngan CH, 2012, BIOINFORMATICS, V28, P286, DOI 10.1093/bioinformatics/btr651; Oliver AW, 2006, EMBO J, V25, P3179, DOI 10.1038/sj.emboj.7601209; Pejaver V, 2014, PROTEIN SCI, V23, P1077, DOI 10.1002/pro.2494; Pritzlaff M, 2017, BREAST CANCER RES TR, V161, P575, DOI 10.1007/s10549-016-4085-4; Rahner N, 2008, DTSCH ARZTEBL INT, V105, P706, DOI 10.3238/arztebl.2008.0706; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Roeb W, 2012, HUM MOL GENET, V21, P2738, DOI 10.1093/hmg/dds101; Ruijs MWG, 2009, HERED CANCER CLIN PR, V7, DOI 10.1186/1897-4287-7-4; Schmidt MK, 2016, J CLIN ONCOL, V34, P2750, DOI 10.1200/JCO.2016.66.5844; Schwarz JK, 2003, MOL CANCER RES, V1, P598; Shaag A, 2005, HUM MOL GENET, V14, P555, DOI 10.1093/hmg/ddi052; Sodha N, 2006, CANCER RES, V66, P8966, DOI 10.1158/0008-5472.CAN-06-1990; Staalesen V, 2004, ONCOGENE, V23, P8535, DOI 10.1038/sj.onc.1207928; Tang HM, 2016, BIOINFORMATICS, V32, P2230, DOI 10.1093/bioinformatics/btw222; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; Toss A, 2015, BIOMED RES INT; Vahteristo P, 2002, AM J HUM GENET, V71, P432, DOI 10.1086/341943; Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024; Yachdav G, 2014, F1000RESEARCH, P3; Yang JY, 2013, BIOINFORMATICS, V29, P2588, DOI 10.1093/bioinformatics/btt447; Yang YD, 2011, BIOINFORMATICS, V27, P2076, DOI 10.1093/bioinformatics/btr350	61	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220711	10.1371/journal.pone.0220711	http://dx.doi.org/10.1371/journal.pone.0220711			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398194	Green Submitted, Green Published, gold			2022-12-26	WOS:000485004000015
J	Carleton, RE; Graham, JH; Lee, A; Taylor, ZP; Carleton, JF				Carleton, Renee E.; Graham, John H.; Lee, Adel; Taylor, Zachary P.; Carleton, Jon F.			Reproductive success of Eastern Bluebirds (Sialia sialis) varies with the timing and severity of drought	PLOS ONE			English	Article							CLUTCH SIZE; CLIMATE-CHANGE; GRASSLAND BIRDS; EGG VIABILITY; SNAIL KITE; NORTH; CONSERVATION; DENSITY; TEMPERATURE; CONSTRAINT	Drought affects avian communities in complex ways. We used our own and citizen science-generated reproductive data acquired through The Cornell Lab of Ornithology's NestWatch Program, combined with drought and vegetation indices obtained from governmental agencies, to determine drought effects on Eastern Bluebird (Sialia sialis L.) reproduction across their North American breeding range for the years 2006-2013. Our results demonstrate that some aspects of bluebird reproductive success vary with the timing and severity of drought. Clutch size was unaffected by any level of drought at the time of clutch initiation or during the 30 to 60 days prior to clutch initiation. Hatching and fledging rates decreased as drought severity increased. Drought conditions occurring at least 30 days prior to the date eggs should have hatched and 60 days prior to the date offspring should have fledged negatively affected reproduction. We also demonstrate the value of datasets generated by citizen scientists in combination with climate data for examining biotic responses at large temporal and spatial scales.	[Carleton, Renee E.; Graham, John H.] Berry Coll, Dept Biol, Mt Berry, GA 30149 USA; [Lee, Adel] Etosha Business & Res Consulting LLC, Rome, GA USA; [Taylor, Zachary P.] Berry Coll, Dept Environm Sci, Mt Berry, GA USA; [Carleton, Jon F.] MIServ Consulting, Taylorsville, GA USA		Carleton, RE (corresponding author), Berry Coll, Dept Biol, Mt Berry, GA 30149 USA.	rcarleton@berry.edu		Taylor, Zachary/0000-0003-0736-570X	Berry College Bluebird Fund 2017	Berry College Bluebird Fund 2017	The study was funded by Berry College Bluebird Fund 2017 granted to REC. AL received a stipend to perform the statistical analysis from Etosha Business and Research Consulting, LLC (https://opencorporates.com/companies/us_ga/15093793).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Albright TP, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00057.1; Albright TP, 2010, GLOBAL CHANGE BIOL, V16, P2158, DOI 10.1111/j.1365-2486.2009.02120.x; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Beissinger SR, 2005, ECOLOGY, V86, P2164, DOI 10.1890/04-1624; Bolger DT, 2005, OECOLOGIA, V142, P398, DOI 10.1007/s00442-004-1734-9; BOYCE MS, 1987, ECOLOGY, V68, P142, DOI 10.2307/1938814; BRENNER FJ, 1966, AM MIDL NAT, V76, P201, DOI 10.2307/2423243; Carleton Renee E., 2011, Oriole, V76, P57; Conway CJ, 2000, BEHAV ECOL, V11, P178, DOI 10.1093/beheco/11.2.178; Cooper CB, 2006, IBIS, V148, P221, DOI 10.1111/j.1474-919x.2006.00500.x; Cooper CB, 2005, ECOLOGY, V86, P2018, DOI 10.1890/03-8028; Crick HQP, GUIDELINES USE WILD, V146, P48; Dai AG, 2011, WIRES CLIM CHANGE, V2, P45, DOI 10.1002/wcc.81; Dhondt AA, 2002, IBIS, V144, P646, DOI 10.1046/j.1474-919X.2002.00103.x; Dunn PO, 1999, P ROY SOC B-BIOL SCI, V266, P2487, DOI 10.1098/rspb.1999.0950; Fair J., 2010, ORNITHOLOGICAL COUNC; FOX J, 1992, J AM STAT ASSOC, V87, P178, DOI 10.2307/2290467; GEORGE TL, 1992, ECOL APPL, V2, P275, DOI 10.2307/1941861; Gowaty P. A., 2015, BIRDS N AM ONLINE, DOI 10.2173/bna.381; Heim RR, 2002, B AM METEOROL SOC, V83, P1149, DOI 10.1175/1520-0477-83.8.1149; Hochachka WM, 2012, TRENDS ECOL EVOL, V27, P130, DOI 10.1016/j.tree.2011.11.006; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Karnieli A, 2010, J CLIMATE, V23, P618, DOI 10.1175/2009JCLI2900.1; Kerr JT, 2003, TRENDS ECOL EVOL, V18, P299, DOI 10.1016/S0169-5347(03)00071-5; KOENIG WD, 1982, AUK, V99, P526; Lack D., 1968, pvii; LACK D, 1947, IBIS, V89, P302, DOI 10.1111/j.1474-919X.1947.tb04155.x; Langham GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135350; Langin KM, 2009, P 7 CAL ISL S, P293; Lehikoinen A, 2016, GLOBAL CHANGE BIOL, V22, P1121, DOI 10.1111/gcb.13150; McKinley DC, 2017, BIOL CONSERV, V208, P15, DOI 10.1016/j.biocon.2016.05.015; Mooij WM, 2002, ECOL MODEL, V149, P25, DOI 10.1016/S0304-3800(01)00512-9; Niemuth ND, 2008, CONDOR, V110, P211, DOI 10.1525/cond.2008.8514; Olsen B, 2008, OECOLOGIA, V158, P421, DOI 10.1007/s00442-008-1148-1; Phillips T, 2009, P 4 INT PARTN FLIGHT, P633; PINKOWSKI BC, 1977, CONDOR, V79, P289, DOI 10.2307/1368006; RICKLEFS RE, 1980, AUK, V97, P38; Sarhadi A, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau3487; Seager R, 2009, J CLIMATE, V22, P5021, DOI 10.1175/2009JCLI2683.1; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Slagsvold T, 2007, ANIM BEHAV, V73, P691, DOI 10.1016/j.anbehav.2006.05.021; SMITH KG, 1982, ECOLOGY, V63, P952, DOI 10.2307/1937235; Stahle DW, 2007, CLIMATIC CHANGE, V83, P133, DOI 10.1007/s10584-006-9171-x; Stoleson SH, 1999, J ANIM ECOL, V68, P951, DOI 10.1046/j.1365-2656.1999.00342.x; Sullivan BL, 2017, BIOL CONSERV, V208, P5, DOI 10.1016/j.biocon.2016.04.031; TAKEKAWA JE, 1989, CONSERV BIOL, V3, P302, DOI 10.1111/j.1523-1739.1989.tb00090.x; Thacker JI, 1997, J APPL ENTOMOL, V121, P137, DOI 10.1111/j.1439-0418.1997.tb01383.x; Visser ME, 2004, ADV ECOL RES, V35, P89, DOI 10.1016/S0065-2504(04)35005-1; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	49	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0214266	10.1371/journal.pone.0214266	http://dx.doi.org/10.1371/journal.pone.0214266			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398191	Green Submitted, gold, Green Published			2022-12-26	WOS:000485004000001
J	Cunningham, SA; Chandrasekar, EK; Cartwright, K; Yount, KM				Cunningham, Solveig A.; Chandrasekar, Eeshwar K.; Cartwright, Kate; Yount, Kathryn M.			Protecting children's health in a calorie-surplus context: Household structure and child growth in the United States	PLOS ONE			English	Article							BODY-MASS INDEX; FAMILY-STRUCTURE; PHYSICAL-ACTIVITY; US CHILDREN; RISK-FACTORS; WEIGHT-GAIN; OBESITY; OVERWEIGHT; ADOLESCENTS; FOOD	Studies from the social and health sciences have tended to view the household as the locus of access to and distribution of care, resources, monitoring and modeling for children's wellbeing. Obesity may present a special case for the study of investments in children, being a component of health for which more of certain inputs may not lead to better outcomes. We expanded on common measures of household structure in the child health literature by considering co-residence and relatedness of parents, grandparents, other relatives, and other children. Data were from a longitudinal sample of 6,700 children participating in the Early Childhood Longitudinal Study Kindergarten Class of 1998-99 (ECLS-K), the largest U.S. national dataset with measures of child anthropometrics and household structure at seven time-points over nine years. We used lagged survey-adjusted regressions to estimate associations between household structure and subsequent changes in children's weight between ages 5 and 14 years in terms of BMI gain and incident obesity. Adjusting for household structure more thoroughly, children living in households with two parents rather than one parent did not experience advantages in terms of less excess weight gain or lower incidence of obesity during elementary and middle school. Children living with a grandmother gained more weight than children not living with a grandmother. Living with siblings and with non-related adults was associated with less weight gain. These findings corroborate a scenario in which, for health problems associated with caloric surplus, classic household factors have more complex associations with child wellbeing.	[Cunningham, Solveig A.; Yount, Kathryn M.] Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Cunningham, Solveig A.; Yount, Kathryn M.] Emory Univ, Dept Sociol, Atlanta, GA 30322 USA; [Chandrasekar, Eeshwar K.] Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA; [Chandrasekar, Eeshwar K.] Emory Univ, Sch Med, Atlanta, GA USA; [Cartwright, Kate] Univ New Mexico, Sch Publ Adm, Albuquerque, NM 87131 USA	Emory University; Emory University; Emory University; Emory University; University of New Mexico	Cunningham, SA (corresponding author), Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.; Cunningham, SA (corresponding author), Emory Univ, Dept Sociol, Atlanta, GA 30322 USA.	sargese@emory.edu	Cunningham, Solveig A/K-6760-2012; Yount, Kathryn M/K-1239-2012; Cunningham, Solveig/W-2672-2019	Cunningham, Solveig A/0000-0002-2354-1526; 	Eunice Kennedy Shriver National Institute of Child Health and Human Development [R03HD060602]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK115937]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK115937] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant R03HD060602 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and grant R01DK115937 from the National Institute of Diabetes and Digestive and Kidney Diseases to SAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this article are those of the authors and do not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development or the National Institutes of Health.	Adam EK, 2002, DEV PSYCHOL, V38, P792, DOI 10.1037//0012-1649.38.5.792; Adkins S, 2004, OBES RES, V12, p38S, DOI 10.1038/oby.2004.267; Agras WS, 2004, J PEDIATR-US, V145, P20, DOI 10.1016/j.jpeds.2004.03.023; Anderson PM, 2003, J HEALTH ECON, V22, P477, DOI 10.1016/S0167-6296(03)00022-5; Argeseanu S., 2004, African Population Studies, V19, P13; Arkes J, 2012, OBESITY, V20, P1696, DOI 10.1038/oby.2012.84; Augustine JM, 2017, J FAM ISSUES, V38, P2277, DOI 10.1177/0192513X15621344; Augustine JM, 2013, J APPL RES CHILDREN, V4; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Bates CR, 2018, OBES REV, V19, P716, DOI 10.1111/obr.12662; Beise J., 2005, GRANDMOTHERHOOD EVOL, P215; Birch LL, 2001, PEDIATR CLIN N AM, V48, P893, DOI 10.1016/S0031-3955(05)70347-3; Bogaert N, 2003, EUR J CLIN NUTR, V57, P1242, DOI 10.1038/sj.ejcn.1601677; Brunner EJ, 2007, AM J EPIDEMIOL, V165, P828, DOI 10.1093/aje/kwk058; Bruss MB, 2003, J AM DIET ASSOC, V103, P1042, DOI 10.1016/S0002-8223(03)00472-3; Burdette AM, 2008, SOC SCI MED, V67, P38, DOI 10.1016/j.socscimed.2008.03.029; Byrne LK, 2011, INT J PEDIATR OBES, V6, P415, DOI 10.3109/17477166.2011.598938; Case A, 2001, J HEALTH ECON, V20, P301, DOI 10.1016/S0167-6296(00)00088-6; Case A, 1999, AM EC REV, V89; Chaparro MP, 2014, SOC SCI MED, V120, P199, DOI 10.1016/j.socscimed.2014.09.024; Chen AY, 2010, PREV CHRONIC DIS, V7; Chen AY, 2014, MATERN CHILD HLTH J, V18, P1772, DOI 10.1007/s10995-013-1422-7; Cheung PC, 2016, CHILD OBES, V12, P1, DOI 10.1089/chi.2015.0055; Cole T, 2005, EUROPEAN J CLIN NUTR, V59; Costa-Font J, 2013, SOC SCI MED, V93, P29, DOI 10.1016/j.socscimed.2013.05.035; Cunningham SA, 2014, NEW ENGL J MED, V370, P403, DOI [10.1056/NEJMoa1309753, 10.1056/NEJMc1402397]; Cunningham SA, 2010, POP STUD-J DEMOG, V64, P229, DOI 10.1080/00324728.2010.510201; Daly M., 1998, TRUTH CINDERELLA DAR; Datar A, 2004, OBES RES, V12, P58, DOI 10.1038/oby.2004.9; Datar A, 2014, SOC SCI MED, V107, P196, DOI 10.1016/j.socscimed.2013.12.022; Dattilo AM, 2012, J OBES, V2012, DOI 10.1155/2012/123023; DAWSON DA, 1991, J MARRIAGE FAM, V53, P573, DOI 10.2307/352734; DeLeire T, 2002, DEMOGRAPHY, V39, P393, DOI 10.1353/dem.2002.0016; Downey DB, 2001, AM PSYCHOL, V56, P497, DOI 10.1037//0003-066X.56.6-7.497; Duflo E, 2003, WORLD BANK ECON REV, V17, P1, DOI 10.1093/wber/lhg013; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Entwisle DR, 1996, J MARRIAGE FAM, V58, P341, DOI 10.2307/353500; Fertig A, 2009, REV ECON HOUSEHOLD, V7, P227, DOI 10.1007/s11150-009-9052-y; Fiese BH, 2012, ADV CHILD DEV BEHAV, V42, P307; Formisano A, 2014, PUBLIC HEALTH NUTR, V17, P2307, DOI 10.1017/S1368980013002474; Frankish H, 2001, LANCET, V358, P564, DOI 10.1016/S0140-6736(01)05750-6; Freeman E, 2012, INT J OBESITY, V36, P12, DOI 10.1038/ijo.2011.198; Gabel S, 2004, FAMILY PROCESSES, V31, P303; Ganong L ColemanM, 2017, EFFECTS STEPFAMILY L; Gennetian L, 2005, J POPUL ECON, V18, P415, DOI 10.1007/s00148-004-0215-0; Gerards SMPL, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-267; Geronimus AT, 1997, POLIT SCI QUART, V112, P405, DOI 10.2307/2657564; Ginther DK, 2004, DEMOGRAPHY, V41, P671, DOI 10.1353/dem.2004.0031; Goodman E, 2003, OBES RES, V11, P1018, DOI 10.1038/oby.2003.140; Gruber KJ, 2009, PREV CHRONIC DIS, V6; Halpern-Meekin S, 2008, J MARRIAGE FAM, V70, P435, DOI 10.1111/j.1741-3737.2008.00492.x; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Hofferth SL, 2005, J POLICY ANAL MANAG, V24, P703, DOI 10.1002/pam.20134; Hofferth SL, 2003, J MARRIAGE FAM, V65, P213, DOI 10.1111/j.1741-3737.2003.00213.x; Hunsberger M, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.28; Jackson SL, 2017, PREV MED, V100, P229, DOI 10.1016/j.ypmed.2017.04.026; Jiang JX, 2007, APPETITE, V48, P377, DOI 10.1016/j.appet.2006.10.004; Johnson-Taylor WL, 2006, OBESITY, V14, P929, DOI 10.1038/oby.2006.109; Kamo Y, 2000, SOCIOL PERSPECT, V43, P211, DOI 10.2307/1389794; Kimbro RT, 2013, SOC SCI MED, V95, P97, DOI 10.1016/j.socscimed.2012.09.032; Kreider R, 2005, LIVING ARRANGEMENTS; Kreider R.M., 2011, LIVING ARRANGEMENTS; Krueger PM, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0038-0; Landry-Meyer L, 1999, FAM RELAT, V48, P381, DOI 10.2307/585245; Leonetti D., 2005, GRANDMOTHERHOOD EVOL, P194; Li J, 2010, J SCHOOL HEALTH, V80, P96, DOI 10.1111/j.1746-1561.2009.00471.x; Lindsay AC, 2006, FUTURE CHILD, V16, P169, DOI 10.1353/foc.2006.0006; Matheson FI, 2008, SOC SCI MED, V66, P675, DOI 10.1016/j.socscimed.2007.10.008; McConley RL, 2011, OBESITY, V19, P345, DOI 10.1038/oby.2010.177; McLanahan S., 1994, GROWING SINGLE PAREN; Muller MJ, 2005, P NUTR SOC, V64, P249, DOI 10.1079/PNS2005424; Ogden CL, 2008, JAMA-J AM MED ASSOC, V299, P2401, DOI 10.1001/jama.299.20.2401; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Ong KK, 2006, ACTA PAEDIATR, V95, P904, DOI 10.1080/08035250600719754; Parikka S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1548-1; Patrick H, 2005, J AM COLL NUTR, V24, P83, DOI 10.1080/07315724.2005.10719448; Phipps SA, 2006, OBES REV, V7, P5, DOI 10.1111/j.1467-789X.2006.00217.x; Price J, 2012, ECON HUM BIOL, V2012, P1026, DOI [10.1038/oby.2003.140, DOI 10.1038/OBY.2003.140]; Ritchie LD, 2006, J AM DIET ASSOC, V106, P925, DOI 10.1016/j.jada.2006.03.001; Salmon J, 2005, OBES RES, V13, P1939, DOI 10.1038/oby.2005.239; Sear R, 2000, P ROY SOC B-BIOL SCI, V267, P1641, DOI 10.1098/rspb.2000.1190; Sear R, 2008, EVOL HUM BEHAV, V29, P1, DOI 10.1016/j.evolhumbehav.2007.10.001; Singh GK, 2010, ARCH PEDIAT ADOL MED, V164, P598, DOI 10.1001/archpediatrics.2010.84; Singh GK, 2010, ANN EPIDEMIOL, V20, P40, DOI 10.1016/j.annepidem.2009.09.008; Strauss RS, 2001, JAMA-J AM MED ASSOC, V286, P2845, DOI 10.1001/jama.286.22.2845; Timperio A, 2008, INT J PEDIATR OBES, V3, P160, DOI 10.1080/17477160801970385; Tourangeau K., 2009, 2009004 NCES; Tourangeau Karen, 2006, 2006032 NCES; U. S. Department of Education- National Center for Education Statistics, 2004, 2001029 NCES US DEP; Voland E, 2002, MAX PLANCK I DEMOGRA; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Wu Fei-Ling, 2003, J Nurs Res, V11, P19; Yelick A, 2017, CHILD ADOLESC SOC WO, V34, P381, DOI 10.1007/s10560-016-0468-y; Zvoch K, 1999, EVOL HUM BEHAV, V20, P453, DOI 10.1016/S1090-5138(99)00024-0	94	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220802	10.1371/journal.pone.0220802	http://dx.doi.org/10.1371/journal.pone.0220802			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5EW	31393933	Green Submitted, Green Published, gold			2022-12-26	WOS:000485002500064
J	Chen, XF; Chen, ZY; Huang, WJ; Fu, HH; Wang, QX; Wang, YF; Cao, JG				Chen, Xuefei; Chen, Zhiyi; Huang, Wujie; Fu, Huanhuan; Wang, Quanxi; Wang, Youfang; Cao, Jianguo			Proteomic analysis of gametophytic sex expression in the fern Ceratopteris thalictroides	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONES; BETA-OXIDATION; CENTRIN; ANTHERIDIOGEN; TOLERANCE; EQUISETUM; DENSITY	Ceratopteris thalictroides, a model fern, has two kinds of gametophytes with different sex expression: male and hermaphrodite. Hermaphroditic gametophytes have one or several archegonia beneath the growing point and a few antheridia at the base or margin. Male gametophytes show a spoon-like shape with much longer than the width and produce many antheridia at the margin and surface. The results of chlorophyll fluorescence detection showed that the photochemical efficiency of hermaphrodites was higher than that of males. By using two-dimensional electrophoresis and mass spectrometry, the differentially abundant proteins in hermaphroditic and male gametophytes were identified. A total of 1136 +/- 55 protein spots were detected in Coomassie-stained gels of proteins from hermaphroditic gametophytes, and 1130 65 spots were detected in gels of proteins from male gametophytes. After annotation, 33 spots representing differentially abundant proteins were identified. Among these, proteins involved in photosynthesis and chaperone proteins were over-represented in hermaphrodites, whereas several proteins involved in metabolism were increased in male gametophytes in order to maintain their development under relatively nutritionally deficient conditions. Furthermore, the differentially abundant cytoskeletal proteins detected in this study, such as centrin and actin, may be involved in the formation of sexual organs and are directly related to sex expression. These differentially abundant proteins are important for maintaining the development of gametophytes of different sexes in C. thalictroides.	[Chen, Xuefei; Wang, Youfang] East China Normal Univ, Coll Life Sci, Shanghai, Peoples R China; [Chen, Xuefei; Chen, Zhiyi; Huang, Wujie; Fu, Huanhuan; Wang, Quanxi; Cao, Jianguo] Shanghai Normal Univ, Coll Life Sci, Shanghai, Peoples R China	East China Normal University; Shanghai Normal University	Wang, YF (corresponding author), East China Normal Univ, Coll Life Sci, Shanghai, Peoples R China.; Cao, JG (corresponding author), Shanghai Normal Univ, Coll Life Sci, Shanghai, Peoples R China.	yfwang@bio.ecnu.cn; cao101@shnu.edu.cn			Natural Science Foundation of Shanghai [13ZR1429700]; Science and Engineering Research Project of Shanghai Normal University [DYL201702]	Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Science and Engineering Research Project of Shanghai Normal University	This research was supported by the Natural Science Foundation of Shanghai (13ZR1429700, J.C), and the Science and Engineering Research Project of Shanghai Normal University (DYL201702, J.C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afitlhile MM, 2005, PLANT PHYSIOL BIOCH, V43, P603, DOI 10.1016/j.plaphy.2005.03.016; Anjum NA, 2014, PROTOPLASMA, V251, P1265, DOI 10.1007/s00709-014-0636-x; Atallah NM, 2018, G3-GENES GENOM GENET, V8, P2205, DOI 10.1534/g3.118.200292; Atallah NM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00100; BANKS JA, 1994, DEVELOPMENT, V120, P1949; Banks JA, 1999, ANNU REV PLANT PHYS, V50, P163, DOI 10.1146/annurev.arplant.50.1.163; BARON AT, 1992, BIOL CELL, V76, P383, DOI 10.1016/0248-4900(92)90442-4; Castillo MC, 2008, J EXP BOT, V59, P2171, DOI 10.1093/jxb/ern079; Castillo MC, 2004, PLANT PHYSIOL, V135, P85, DOI 10.1104/pp.104.039925; Cavalcanti JHF, 2018, J EXP BOT, V69, P5489, DOI 10.1093/jxb/ery325; Cheruiyot Dorothy J., 2007, BIOS, V78, P58, DOI 10.1893/0005-3155(2007)78[58:COMGTH]2.0.CO;2; DeSoto L, 2008, J ECOL, V96, P1319, DOI 10.1111/j.1365-2745.2008.01425.x; Domzalska L, 2017, PLANT SCI, V258, P61, DOI 10.1016/j.plantsci.2017.01.017; Edvardsson A, 2003, FEBS LETT, V542, P137, DOI 10.1016/S0014-5793(03)00366-1; Elhiti M, 2013, IN VITRO CELL DEV-PL, V49, P631, DOI 10.1007/s11627-013-9547-3; Cea MG, 2014, CR BIOL, V337, P235, DOI 10.1016/j.crvi.2014.02.002; Golenberg EM, 2013, AM J BOT, V100, P1022, DOI 10.3732/ajb.1200544; Gollan PJ, 2011, PHYSIOL PLANTARUM, V143, P385, DOI 10.1111/j.1399-3054.2011.01503.x; Guillon JM, 2003, J ECOL, V91, P49, DOI 10.1046/j.1365-2745.2003.00744.x; Guillon JM, 2002, INT J PLANT SCI, V163, P825, DOI 10.1086/341229; Hasanuzzaman M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010200; Hauser T, 2015, NAT PLANTS, V1, P1, DOI [10.1038/NPLANTS.2015.65, 10.1038/nplants.2015.65]; Heide H, 2004, J PLANT PHYSIOL, V161, P139, DOI 10.1078/0176-1617-01033; HEMMINGSEN SM, 1986, PLANT PHYSIOL, V80, P269, DOI 10.1104/pp.80.1.269; Huang YM, 2004, ANN BOT-LONDON, V94, P229, DOI 10.1093/aob/mch142; Klink VP, 2001, MOL BIOL CELL, V12, P761, DOI 10.1091/mbc.12.3.761; Korpelainen H, 1998, BIOL REV, V73, P157, DOI 10.1017/S0006323197005148; Krishna P, 2001, CELL STRESS CHAPERON, V6, P238, DOI 10.1379/1466-1268(2001)006<0238:THFOPI>2.0.CO;2; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Levy YY, 1996, CELL MOTIL CYTOSKEL, V33, P298; Libik-Konieczny M, 2012, ACTA PHYSIOL PLANT, V34, P1471, DOI 10.1007/s11738-012-0945-7; Mattoo RUH, 2014, CELL MOL LIFE SCI, V71, P3311, DOI 10.1007/s00018-014-1627-y; Moreno JC, 2018, PLANT PHYSIOL, V176, P1485, DOI 10.1104/pp.17.01635; Pannell JR, 2017, CURR BIOL, V27, pR191, DOI 10.1016/j.cub.2017.01.052; Park CJ, 2015, PLANT PATHOLOGY J, V31, P323, DOI 10.5423/PPJ.RW.08.2015.0150; Porter K, 2016, J INTEGR PLANT BIOL, V58, P299, DOI 10.1111/jipb.12445; Quintanilla LG, 2007, AM J BOT, V94, P986, DOI 10.3732/ajb.94.6.986; SALISBURY JL, 1995, CURR OPIN CELL BIOL, V7, P39; Schroda M, 2001, BIOCHEM SOC T, V29, P413, DOI 10.1042/BST0290413; Shirasu K, 2009, ANNU REV PLANT BIOL, V60, P139, DOI 10.1146/annurev.arplant.59.032607.092906; Slate ML, 2017, ANN BOT-LONDON, V120, P845, DOI 10.1093/aob/mcx071; Swindell WR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-125; Tanurdzic M, 2004, PLANT CELL, V16, pS61, DOI 10.1105/tpc.016667; Valledor L, 2014, PROTEOMICS, V14, P2061, DOI 10.1002/pmic.201300166; Varga S, 2016, AM J BOT, V103, P1928, DOI 10.3732/ajb.1600158; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wang YF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-344; WARNE TR, 1991, BOT GAZ, V152, P148, DOI 10.1086/337874; WARNE TR, 1989, PLANT PHYSIOL, V89, P535, DOI 10.1104/pp.89.2.535; Winter G, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00534; YABE N, 1994, PLANT CELL PHYSIOL, V35, P1207, DOI 10.1093/oxfordjournals.pcp.a078715; Zhao Q, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00441	52	4	4	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0221470	10.1371/journal.pone.0221470	http://dx.doi.org/10.1371/journal.pone.0221470			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5MK	31425560	Green Submitted, gold, Green Published			2022-12-26	WOS:000485022400046
J	Florescu, A; Branisteanu, D; Bilha, S; Scripcariu, D; Florescu, I; Scripcariu, V; Dimofte, G; Grigoras, I				Florescu, Alexandru; Branisteanu, Dumitru; Bilha, Stefana; Scripcariu, Dragos; Florescu, Ioana; Scripcariu, Viorel; Dimofte, Gabriel; Grigoras, Ioana			Leptin and adiponectin dynamics at patients with rectal neoplasm - Gender differences	PLOS ONE			English	Article							OBESITY-RELATED ADIPOKINES; COLORECTAL-CANCER; SERUM LEPTIN; ABDOMINAL-SURGERY; FAT DISTRIBUTION; COLON-CANCER; WEIGHT-LOSS; RISK; INFLAMMATION; ASSOCIATION	Background Numerous studies associate adipokines with colorectal malignancy, but few data deal with patients suffering exclusively of rectal carcinoma (RC). Aims We evaluated leptin and adiponectin levels in RC patients compared to healthy population and their dynamics after surgery. Material and methods Serum leptin and adiponectin were evaluated before surgery in 59 RC consecutive patients (38 males and 21 females), and in age and weight matched healthy controls. Measurements were repeated at 24, 72 hours and 7 days after surgery. Results Adipokine levels were higher in women. Controls had higher leptin (32.+/- 4.34 vs 9.51 +/- 1.73 ng/ml in women and 11 +/- 2.66 vs 2.54 +/- 0.39 ng/ml in men, p = 0.00048 and 0.0032) and lower adiponectin (9 +/- 0.64 vs 11.85 +/- 1.02 mu g/ml in women and 7.39 +/- 0.51 vs 8.5 +/- 0.62 mu g/ml in men, p = 0.017 and 0.019) than RC patients. Surgery caused an increase of leptin from 5.11 +/- 0.8 to 18.7 +/- 2.42 ng/ml, p = 6.85 x 10(-8), and a decrease of adiponectin from 9.71 +/- 0.58 to 7.87 +/- 0.47 mu g/ml, p = 1.4 x 10(-10) for all RC patients and returned thereafter to the initial range at 7 days. Adipokines were correlated with body weight (BW). The significance of correlation persisted after surgery only in males, but disappeared in females. Adipokines were not modified by tumor position, presurgical chemoradiotherapy or surgical technique. Women with RC experiencing weight loss had higher adiponectin than women without weight modifications (p<0.05 at all time points). Conclusions Adipokine levels of patients with RC differ from the healthy population, possibly reflecting an adaptation to disease. Adipokine modifications after surgery may be related to acute surgical stress. Whether leptin and adiponectin directly interact is not clear. Women have higher adipokine levels, more so after significant weight loss, but the strength of their correlation with BW decreases after surgery. These data suggest gender differences in the adipokine profile of RC patients which may find clinical applications.	[Florescu, Alexandru; Branisteanu, Dumitru; Bilha, Stefana] Grigore T Popa Univ Med & Pharm, Dept Endocrinol, Iasi, Romania; [Scripcariu, Dragos; Scripcariu, Viorel; Dimofte, Gabriel] Grigore T Popa Univ Med & Pharm, Dept Surg, Iasi, Romania; [Florescu, Ioana; Grigoras, Ioana] Grigore T Popa Univ Med & Pharm, Dept Intens Care, Iasi, Romania	Grigore T Popa University of Medicine & Pharmacy; Grigore T Popa University of Medicine & Pharmacy; Grigore T Popa University of Medicine & Pharmacy	Branisteanu, D (corresponding author), Grigore T Popa Univ Med & Pharm, Dept Endocrinol, Iasi, Romania.	branisteanu_dumitru@yahoo.com	Dimofte, Mihail Gabriel/GXG-4768-2022; Grigoras, Ioana/A-5355-2015; Scripcariu, Viorel/AAN-5821-2020	Grigoras, Ioana/0000-0001-9412-9574; Branisteanu, Dumitru/0000-0001-8610-1416	European Social Fund through SOP HRD 2007-2013, Priority I "Education and training to support growth and development of knowledge based society" Area of Intervention 1.5 "Doctoral and post-doctoral research support" CERO -CAREER PROFILE: ROMANIAN RESEARCHE [POSDRU/159/1.5/S/135760]	European Social Fund through SOP HRD 2007-2013, Priority I "Education and training to support growth and development of knowledge based society" Area of Intervention 1.5 "Doctoral and post-doctoral research support" CERO -CAREER PROFILE: ROMANIAN RESEARCHE	AF received financial support from the European Social Fund through SOP HRD 2007-2013, Priority I "Education and training to support growth and development of knowledge based society" Area of Intervention 1.5 "Doctoral and post-doctoral research support" CERO -CAREER PROFILE: ROMANIAN RESEARCHER, Contract financing: POSDRU/159/1.5/S/135760. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adya R, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/648239; Aleksandrova K, 2017, AM J EPIDEMIOL, V185, P751, DOI 10.1093/aje/kww194; Aleksandrova K, 2014, INT J CANCER, V134, P612, DOI 10.1002/ijc.28368; Aleksandrova K, 2012, CANCER RES, V72, P5328, DOI 10.1158/0008-5472.CAN-12-0465; Arpaci F, 2002, TUMORI, V88, P147, DOI 10.1177/030089160208800213; Berger NA, 2014, ANN NY ACAD SCI, V1311, P57, DOI 10.1111/nyas.12416; Bilir BE, 2016, ENDOKRYNOL POL, V67, P277, DOI 10.5603/EP.a2016.0023; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Bultman SJ, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201500902; Byeon JS, 2010, INT J CANCER, V127, P2758, DOI 10.1002/ijc.25301; Chachkhiani I, 2005, PHYSIOL RES, V54, P279, DOI 10.33549/physiolres.930592; Chelazzi Cosimo, 2017, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V16, P168, DOI 10.2174/1871523016666171114164219; Christen T, 2018, PEPTIDES, V107, P25, DOI 10.1016/j.peptides.2018.07.008; Erkasap N, 2013, BRAZ J MED BIOL RES, V46, P306, DOI 10.1590/1414-431X20122559; Fasshauer M, 2015, TRENDS PHARMACOL SCI, V36, P461, DOI 10.1016/j.tips.2015.04.014; Fenton JI, 2008, INT J CANCER, V122, P2437, DOI 10.1002/ijc.23436; Florescu A, 2016, MED-SURG J, V120, P252; Grassmann S, 2017, OBESITY, V25, P1776, DOI 10.1002/oby.21945; Grigoras I, 2014, CHIRURGIA-BUCHAREST, V109, P66; Guadagni F, 2009, ANTICANCER RES, V29, P3321; Hillenbrand A, 2012, BMC CANCER, DOI [10.1186/s12885-018-4019-0, DOI 10.1186/S12885-018-4019-0]; Ho GYF, 2012, CANCER RES, V72, P3029, DOI 10.1158/0008-5472.CAN-11-2771; Joshi RK, 2014, WORLD J GASTROENTERO, V20, P7941, DOI 10.3748/wjg.v20.i24.7941; Joshi RK, 2014, ASIAN PAC J CANCER P, V15, P397, DOI 10.7314/APJCP.2014.15.1.397; Kumor A, 2009, INT J COLORECTAL DIS, V24, P275, DOI 10.1007/s00384-008-0605-y; Li Y, 2016, INT J BIOL SCI, V12, P1022, DOI 10.7150/ijbs.15438; Liu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060777; Ma WJ, 2018, CANCER PREV RES, V11, P535, DOI 10.1158/1940-6207.CAPR-18-0159; Musil F, 2015, PHYSIOL RES, V64, P221, DOI 10.33549/physiolres.932723; Nimptsch K, 2017, EUR J EPIDEMIOL, V32, P419, DOI 10.1007/s10654-017-0262-y; Otake S, 2010, WORLD J GASTROENTERO, V16, P1252, DOI 10.3748/wjg.v16.i10.1252; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pietrzyk Lukasz, 2015, Asian Pac J Cancer Prev, V16, P4161; Preda C, 2016, ENVIRON ENG MANAG J, V15, P913; Ramel A, 2010, ANN NUTR METAB, V56, P190, DOI 10.1159/000281833; Reinehr T, 2004, J CLIN ENDOCR METAB, V89, P3790, DOI 10.1210/jc.2003-031925; Riondino S, 2014, WORLD J GASTROENTERO, V20, P5177, DOI 10.3748/wjg.v20.i18.5177; Salageanu Aurora, 2010, J Med Life, V3, P416; Selthofer-Relatic K, 2018, DIABETES VASC DIS RE, V15, P260, DOI 10.1177/1479164117752491; Slomian G, 2017, POSTEP HIG MED DOSW, V71, P281; Smith F, 2018, EUR J CANCER CARE, V27, DOI 10.1111/ecc.12829; Staiger H, 2003, OBES RES, V11, P368, DOI 10.1038/oby.2003.48; Stattin P, 2004, INT J CANCER, V109, P149, DOI 10.1002/ijc.11668; Teplan V, 2015, BIOMED PAP, V159, P489, DOI 10.5507/bp.2014.012; Touvier M, 2012, WORLD J GASTROENTERO, V18, P2805, DOI 10.3748/wjg.v18.i22.2805; Uddin S, 2014, TUMOR BIOL, V35, P871, DOI 10.1007/s13277-013-1166-4; van der Sijp MPL, 2016, INT J COLORECTAL DIS, V31, P1683, DOI 10.1007/s00384-016-2633-3; Vasiliu I, 2015, MED-SURG J, V119, P1037; Wang XH, 2017, IUBMB LIFE, V69, P776, DOI 10.1002/iub.1674; Wei EK, 2005, JNCI-J NATL CANCER I, V97, P1688, DOI 10.1093/jnci/dji376; Yadav A, 2013, CLIN CHIM ACTA, V417, P80, DOI 10.1016/j.cca.2012.12.007; Yamamoto H, 2016, ANN SURG ONCOL, V23, P540, DOI 10.1245/s10434-016-5386-x; Zhang Z, 2014, J MOL ENDOCRINOL, V53, P145, DOI 10.1530/JME-14-0027; Zhou WQ, 2014, EXPERT OPIN THER TAR, V18, P961, DOI 10.1517/14728222.2014.926889	54	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0212471	10.1371/journal.pone.0212471	http://dx.doi.org/10.1371/journal.pone.0212471			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5MK	31425509	gold, Green Published, Green Submitted			2022-12-26	WOS:000485022400002
J	Binson, G; Grignon, C; Le Moal, G; Lazaro, P; Lelong, J; Roblot, F; Venisse, N; Dupuis, A				Binson, Guillaume; Grignon, Claire; Le Moal, Gwenael; Lazaro, Pauline; Lelong, Jeremy; Roblot, France; Venisse, Nicolas; Dupuis, Antoine			Overcoming stability challenges during continuous intravenous administration of high-dose amoxicillin using portable elastomeric pumps	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; ANTIMICROBIAL THERAPY; ANTIBIOTIC AMOXICILLIN; MAJOR METABOLITES; INFUSION; MANAGEMENT; COMPATIBILITY; PRINCIPLES; RATIONALE; DIAGNOSIS	While treatment of serious infectious diseases may require high-dose amoxicillin, continuous infusion may be limited by lack of knowledge regarding the chemical stability of the drug. Therefore, we have performed a comprehensive study so as to determine the chemical stability of high-dose amoxicillin solutions conducive to safe and effective continuous intravenous administration using portable elastomeric pumps. First, amoxicillin solubility in water was assessed within the range of 25 to 300 mg/mL. Then, amoxicillin solutions were prepared at different concentrations (25, 50, 125, 250 mg/mL) and stored in different conditions (5 +/- 2 degrees C, 25 +/- 1 degrees C, 30 +/- 1 degrees C and 37 +/- 1 degrees C) to investigate the influence of concentration and temperature on the chemical stability of amoxicillin. Finally, its stability was assessed under optimized conditions using a fully validated HPLC-UV stability-indicating method. Degradation products of amoxicillin were investigated by accurate mass determination using high-resolution mass spectrometry. Amoxicillin displayed limited water solubility requiring reconstitution at concentrations below or equal to 150 mg/mL. Amoxicillin degradation were time, temperature as well as concentration-dependent, resulting in short-term stability, in particular at high concentrations. Four degradation products of amoxicillin have been identified. Among them, amoxicilloic acid and diketopiperazine amoxicillin are at risk of allergic reaction and may accumulate in the patient. Optimized conditions allowing for continuous infusion of high-dose amoxicillin has been determined: amoxicillin should be reconstituted at 25 mg/mL and stored up to 12 hours at room temperature (22 +/- 4 degrees C) or up to 24 hours between 4 and 8 degrees C.	[Binson, Guillaume; Grignon, Claire; Lazaro, Pauline; Dupuis, Antoine] Univ Hosp Poitiers, Dept Pharm, Poitiers, France; [Binson, Guillaume; Venisse, Nicolas; Dupuis, Antoine] INSERM, CIC, Poitiers, France; [Le Moal, Gwenael; Roblot, France] Univ Hosp Poitiers, Dept Infect Dis, Poitiers, France; [Lelong, Jeremy; Venisse, Nicolas] Univ Hosp Poitiers, Dept Pharmacokinet, Poitiers, France	CHU Poitiers; Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; CHU Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers	Dupuis, A (corresponding author), Univ Hosp Poitiers, Dept Pharm, Poitiers, France.; Dupuis, A (corresponding author), INSERM, CIC, Poitiers, France.	antoine.dupuis@univ-poitiers.fr	Binson, Guillaume/AAQ-3038-2020	DUPUIS, Antoine/0000-0003-2471-5679; Roblot, France/0000-0003-4325-023X				Abdul-Aziz MH, 2015, SEMIN RESP CRIT CARE, V36, P136, DOI 10.1055/s-0034-1398490; Abraham J, 2009, HANDBOOK OF TRANSNATIONAL ECONOMIC GOVERNANCE REGIMES, P1041; Arensdorff L, 2017, J ANTIMICROB CHEMOTH, V72, P2613, DOI 10.1093/jac/dkx178; Arlicot N, 2011, PHARMAZIE, V66, P631, DOI 10.1691/ph.2011.1023; Baddour LM, 2015, CIRCULATION, V132, P1435, DOI 10.1161/CIR.0000000000000296; Bernard L, 2012, ANN FR ANESTH, V31, P47, DOI 10.1016/j.annfar.2011.08.019; Chant C, 2013, CRIT CARE, V17, DOI 10.1186/cc13134; Charmillon A, 2016, CLIN MICROBIOL INFEC, V22, P625, DOI 10.1016/j.cmi.2016.04.019; COOK B, 1982, J CLIN HOSP PHARM, V7, P245, DOI 10.1111/j.1365-2710.1982.tb01029.x; Craig WA, 1998, CLIN INFECT DIS, V26, P1, DOI 10.1086/516284; Durojaiye OC, 2018, INT J ANTIMICROB AG, V51, P26, DOI 10.1016/j.ijantimicag.2017.03.016; Everts RJ, 2004, ANZ J SURG, V74, P210, DOI 10.1111/j.1445-2197.2004.02942.x; Habib G, 2015, EUR HEART J, V36, P3075, DOI [10.1093/eurheartj/ehv319, 10.5603/KP.2015.0227]; Hirte K, 2016, WATER RES, V88, P880, DOI 10.1016/j.watres.2015.11.028; Jenkins A, 2017, J ANTIMICROB CHEMOTH, V72, P1217, DOI 10.1093/jac/dkw556; Lehr HA, 2002, AM J RESP CRIT CARE, V165, P514, DOI 10.1164/ajrccm.165.4.2108033; Longuet P, 2016, MED MALADIES INFECT, V46, P242, DOI 10.1016/j.medmal.2016.01.010; MacKenzie M, 2014, INT J ANTIMICROB AG, V43, P7, DOI 10.1016/j.ijantimicag.2013.09.006; MacVane SH, 2014, INT J ANTIMICROB AG, V43, P105, DOI 10.1016/j.ijantimicag.2013.10.021; Maffulli N, 2016, SURG-J R COLL SURG E, V14, P345, DOI 10.1016/j.surge.2015.12.005; McNearney T, 2003, DIGEST DIS SCI, V48, P1352, DOI 10.1023/A:1024119512162; Muldoon EG, 2015, INFECT DIS-NOR, V47, P39, DOI 10.3109/00365548.2014.967290; Nagele E, 2005, J AM SOC MASS SPECTR, V16, P1670, DOI 10.1016/j.jasms.2005.06.002; Norris AH, 2019, CLIN INFECT DIS, V68, P1, DOI 10.1093/cid/ciy867; PUNTIS JWL, 1992, ARCH DIS CHILD, V67, P1475, DOI 10.1136/adc.67.12.1475; Reyns T, 2008, J CHROMATOGR B, V861, P108, DOI 10.1016/j.jchromb.2007.11.007; Reyns T, 2008, J AGR FOOD CHEM, V56, P448, DOI 10.1021/jf072398p; Rico AG, 1986, DRUG RESIDUES ANIMAL; Seaton RA, 2013, EUR J INTERN MED, V24, P617, DOI 10.1016/j.ejim.2013.03.014; Skryabina EA, 2006, AM J HEALTH-SYST PH, V63, P1260, DOI 10.2146/ajhp050408; Steffens E, 2019, INFECTION, V47, P169, DOI 10.1007/s15010-018-1250-1; Teo J, 2014, INT J ANTIMICROB AG, V43, P403, DOI 10.1016/j.ijantimicag.2014.01.027; Torres MJ, 2010, ALLERGY, V65, P590, DOI 10.1111/j.1398-9995.2009.02245.x; TRISSEL LA, 1983, AM J HOSP PHARM, V40, P1159, DOI 10.1093/ajhp/40.7.1159; United States Pharmacopeial Convention, 2017, US PHARM 2018 USP 41; Verdier MC, 2011, J CHEMOTHERAPY, V23, P277, DOI 10.1179/joc.2011.23.5.277; Voumard R, 2017, J ANTIMICROB CHEMOTH, V72, P1462, DOI 10.1093/jac/dkw582; Williams DN, 2015, INT J ANTIMICROB AG, V46, P307, DOI 10.1016/j.ijantimicag.2015.07.001	38	8	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2019	14	8							e0221391	10.1371/journal.pone.0221391	http://dx.doi.org/10.1371/journal.pone.0221391			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5LL	31419268	Green Submitted, Green Published, gold			2022-12-26	WOS:000485019900042
J	Chirila, C; Botea, M; Iuga, A; Tomulescu, AG; Balescu, L; Galca, AC; Boni, AG; Leonat, L; Pintilie, I; Pintilie, L				Chirila, C.; Botea, M.; Iuga, A.; Tomulescu, A. G.; Balescu, L.; Galca, A. C.; Boni, A. G.; Leonat, L.; Pintilie, I.; Pintilie, L.			Carbon-based sprayed electrodes for pyroelectric applications	PLOS ONE			English	Article							ENERGY-CONVERSION; BLACK COATINGS; GRAPHENE; TITANATE; DEVICES	A carbon-based layer was deposited by spraying on top of a ferroelectric layer grown by sol-gel on Si (001) substrate and its properties as electrode and absorber for pyroelectric detection were tested. It was found that the electric properties of the ferroelectric capacitor with top carbon-based sprayed electrode (CBSE) are comparable with those of the capacitors with standard top SrRuO3 (SRO)/Au electrode. Pyroelectric measurements show that the pyroelectric signal recorded on ferroelectric capacitors with top CBSE electrode is 2.5 times greater than for top SRO/Au electrode for low frequency range. The value of the pyroelectric coefficient was estimated to 9.73.10(-4) C/m(2)K for CBSE electrodes and 3.36.10(-4) C/m(2)K for SRO/Au respectively. The fabrication process of CBSE is of low cost, easy to implement and with high throughput making it attractive for manufacturing various devices like pyroelectric detector, thermal imaging, solar cells, etc.	[Chirila, C.; Botea, M.; Iuga, A.; Tomulescu, A. G.; Balescu, L.; Galca, A. C.; Boni, A. G.; Leonat, L.; Pintilie, I.; Pintilie, L.] Natl Inst Mat Phys, Magurele Ilfov, Romania	National Institute of Materials Physics - Romania	Chirila, C (corresponding author), Natl Inst Mat Phys, Magurele Ilfov, Romania.	dragoi@infim.ro	Chirila, Cristina/AAA-5295-2019; boni, andra georgia/AAT-5477-2021; Botea, Mihaela G/O-9011-2016; boni, andra georgia C/A-9393-2014; Trinca, Liliana Marinela/E-7100-2014; Pintilie, Ioana/C-4545-2011; Galca, Aurelian-Catalin/C-7386-2009; Galca, Aurelian Catalin/A-5344-2008; Leonat, Lucia/N-6868-2016; Tomulescu, Andrei Gabriel C/B-8700-2019; Chirila, Cristina/A-2413-2012; Chirila, Cristina/AAO-6218-2021; Pintilie, Lucian/D-9475-2011	Chirila, Cristina/0000-0002-3323-8336; boni, andra georgia/0000-0002-8355-6826; Botea, Mihaela G/0000-0003-1017-8796; boni, andra georgia C/0000-0002-8355-6826; Trinca, Liliana Marinela/0000-0001-5962-4836; Pintilie, Ioana/0000-0002-3857-8524; Galca, Aurelian-Catalin/0000-0002-1914-4210; Galca, Aurelian Catalin/0000-0002-1914-4210; Leonat, Lucia/0000-0002-7120-3644; Tomulescu, Andrei Gabriel C/0000-0002-3025-6854; Chirila, Cristina/0000-0002-3323-8336; Pintilie, Lucian/0000-0002-4934-2912	Romanian Ministry of Education Executive Unit for Funding High Education, Research, Development and Innovation (MEN-UEFISCDI) [PN18110101]; IFA-CEA [C503/2016]	Romanian Ministry of Education Executive Unit for Funding High Education, Research, Development and Innovation (MEN-UEFISCDI); IFA-CEA	The authors acknowledge the financial support of the Romanian Ministry of Education Executive Unit for Funding High Education, Research, Development and Innovation (MEN-UEFISCDI) through the Core Program PN18110101, the IFA-CEA (Contract No. C503/2016).	Aggarwal M, 2010, PYROELECTRIC MAT UNC; Arduini F, 2010, ANAL LETT, V43, P1688, DOI 10.1080/00032711003653932; Battista L, 2014, APPL ENERG, V136, P357, DOI 10.1016/j.apenergy.2014.09.035; Botea M, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4838035; Bowen CR, 2014, ENERG ENVIRON SCI, V7, P3836, DOI 10.1039/c4ee01759e; Brownson DAC, 2011, J POWER SOURCES, V196, P4873, DOI 10.1016/j.jpowsour.2011.02.022; Chen F, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.094105; CHILDRESS JD, 1962, J APPL PHYS, V33, P1793, DOI 10.1063/1.1728833; Chirila C, 2015, J MATER SCI, V50, P3883, DOI 10.1007/s10853-015-8907-2; CLAYBOURN M, 1991, APPL SPECTROSC, V45, P279, DOI 10.1366/0003702914337669; CLINGMAN WH, 1961, J APPL PHYS, V32, P675, DOI 10.1063/1.1736069; Evlashin S, 2014, CARBON, V70, P111, DOI 10.1016/j.carbon.2013.12.079; Fan W, 2013, ACS APPL MATER INTER, V5, P3382, DOI 10.1021/am4003827; Howe JY, 2003, POWDER DIFFR, V18, P150, DOI 10.1154/1.1536926; Hrib LM, 2013, J APPL PHYS, V113, DOI 10.1063/1.4808464; Krivchenko VA, 2013, SCI REP-UK, V3, DOI 10.1038/srep03328; Lehman J, 2003, MEAS SCI TECHNOL, V14, P916, DOI 10.1088/0957-0233/14/7/304; Lehman JH, 2007, OPT LETT, V32, P772, DOI 10.1364/OL.32.000772; Mellouki I, 2004, INFRARED PHYS TECHN, V45, P273, DOI 10.1016/j.infrared.2003.11.010; Muller MT, 2017, MATERIALS, V10, DOI 10.3390/ma10050545; Niu G, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.054105; Niu G, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3193548; Robertson J, 1999, APPL PHYS LETT, V74, P1168, DOI 10.1063/1.123476; Sharma M, 2018, ENERGY TECHNOL-GER, V6, P950, DOI 10.1002/ente.201700972; Theocharous E, 2008, APPL OPTICS, V47, P3999, DOI 10.1364/AO.47.003999; VANDERZI.A, 1974, J APPL PHYS, V45, P4128, DOI 10.1063/1.1663926; WHATMORE RW, 1986, REP PROG PHYS, V49, P1335, DOI 10.1088/0034-4885/49/12/002; Xie JD, 2017, COATINGS, V7, DOI 10.3390/coatings7090138; Yang Y, 2012, NANO LETT, V12, P2833, DOI 10.1021/nl3003039; Yang YS, 2000, APPL PHYS LETT, V76, P774, DOI 10.1063/1.125891; Yang ZP, 2008, NANO LETT, V8, P446, DOI 10.1021/nl072369t; Yu T, 2015, SENSOR ACTUAT A-PHYS, V223, P159, DOI 10.1016/j.sna.2015.01.008; Zabek D, 2017, ACS APPL MATER INTER, V9, P9161, DOI 10.1021/acsami.6b16477; Zhao L, 2013, SENSOR ACTUAT A-PHYS, V196, P16, DOI 10.1016/j.sna.2013.03.030	34	2	2	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0221108	10.1371/journal.pone.0221108	http://dx.doi.org/10.1371/journal.pone.0221108			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415643	Green Published, Green Submitted, gold			2022-12-26	WOS:000485017200075
J	Moura, MT; Silva, RLO; Nascimento, PS; Ferreira-Silva, JC; Cantanhede, LF; Kido, EA; Benko-Iseppon, AM; Oliveira, MAL				Moura, Marcelo T.; Silva, Roberta L. O.; Nascimento, Pabola S.; Ferreira-Silva, Jose C.; Cantanhede, Ludymila F.; Kido, Ederson A.; Benko-Iseppon, Ana M.; Oliveira, Marcos A. L.			Inter-genus gene expression analysis in livestock fibroblasts using reference gene validation based upon a multi-species primer set	PLOS ONE			English	Article							REAL-TIME PCR; QUANTITATIVE PCR; MESSENGER-RNA; TRANSCRIPTION FACTORS; NUCLEAR TRANSFER; SELF-RENEWAL; RT-QPCR; QUANTIFICATION; IDENTIFICATION; NORMALIZATION	Quantitative reverse transcription PCR (RT-qPCR) remains as an accurate approach for gene expression analysis but requires labor-intensive validation of reference genes using species-specific primers. To ease such demand, the aim was to design and test a multi-species primer set to validate reference genes for inter-genus RT-qPCR gene expression analysis. Primers were designed for ten housekeeping genes using transcript sequences of various livestock species. All ten gene transcripts were detected by RT-PCR in Bos taurus (cattle), Bubalus bubalis (buffaloes), Capra hircus (goats), and Ovis aries (sheep) cDNA. Primer efficiency was attained for eight reference genes using B. taurus-O. aries fibroblast cDNA (95.54-98.39%). The RT-qPCR data normalization was carried out for B. taurus vs. O. aries relative gene expression using Bestkeeper, GeNorm, Norm-finder, Delta CT method, and RefFinder algorithms. Validation of inter-genus RT-qPCR showed up-regulation of TLR4 and ZFXgene transcripts in B. taurus fibroblasts, irrespectively of normalization conditions (two, three, or four reference genes). In silico search in mammalian transcriptomes showed that the multi-species primer set is expected to amplify transcripts of at least two distinct loci in 114 species, and 79 species would be covered by six or more primers. Hence, a multi-species primer set allows for inter-genus gene expression analysis between O. aries and B. taurus fibroblasts and further reveals species-specific gene transcript abundance of key transcription factors.	[Moura, Marcelo T.; Nascimento, Pabola S.; Ferreira-Silva, Jose C.; Cantanhede, Ludymila F.; Oliveira, Marcos A. L.] Univ Fed Rural Pernambuco, Dept Med Vet, Recife, PE, Brazil; [Silva, Roberta L. O.; Kido, Ederson A.; Benko-Iseppon, Ana M.] Univ Fed Rural Pernambuco, Dept Genet, Recife, PE, Brazil	Universidade Federal Rural de Pernambuco (UFRPE); Universidade Federal Rural de Pernambuco (UFRPE)	Moura, MT (corresponding author), Univ Fed Rural Pernambuco, Dept Med Vet, Recife, PE, Brazil.	marcelotmoura@gmail.com	AKIO KIDO, EDERSON/P-9932-2019; Ferreira-Silva, José Carlos/F-2137-2018; Silva, Roberta Lane de Oliveira/B-5866-2014; Moura, M. T./G-8561-2014; Kido, Ederson A/E-2489-2016; Oliveira, Marcos Antonio Lemos/AAK-9669-2021	AKIO KIDO, EDERSON/0000-0001-5484-993X; Ferreira-Silva, José Carlos/0000-0003-3544-3859; Silva, Roberta Lane de Oliveira/0000-0003-1876-0094; Moura, M. T./0000-0003-3808-6607; Kido, Ederson A/0000-0001-5484-993X; Oliveira, Marcos Antonio Lemos/0000-0002-2360-8313	Fundagao de Amparo a Ciencia e Tecnologia de Pernambuco -FACEPE [APQ-1101-5.05/15]; CNPq (National Council for Scientific and Technological Development); CAPES (Coordination of Higher Level Personnel)	Fundagao de Amparo a Ciencia e Tecnologia de Pernambuco -FACEPE; CNPq (National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordination of Higher Level Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The research was financially supported by Fundagao de Amparo a Ciencia e Tecnologia de Pernambuco -FACEPE (Grant APQ-1101-5.05/15), ['tip//wwvi facepe brt, CNPq (National Council for Scientific and Technological Development); and CAPES (Coordination of Higher Level Personnel). These funding agencies had no contribution to the study design, data collection or analysis, preparation of the manuscript, or decision where to publish.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Ariasi AM, 2011, CURR OPIN CELL BIOL, V23, P650, DOI 10.1016/j.ceb.2011.09.007; Armond JW, 2014, SCI REP-UK, V4, DOI 10.1038/srep03692; Beyhan Z, 2007, CELL STEM CELL, V1, P502, DOI 10.1016/j.stem.2007.10.009; Bonnet M, 2013, ANIMAL, V7, P1344, DOI 10.1017/S1751731113000475; Burga A, 2013, CURR OPIN BIOTECH, V24, P803, DOI 10.1016/j.copbio.2013.03.004; Bustin S, 2017, EUR J CLIN INVEST, V47, P756, DOI 10.1111/eci.12801; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Chopra-Dewasthaly R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170015; Silva RLD, 2014, SCI WORLD J, DOI 10.1155/2014/357052; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Dhanasekaran S, 2010, VET OPHTHALMOL, V13, P270, DOI 10.1111/j.1463-5224.2010.00783.x; Edmunds Richard C, 2014, J Biomol Tech, V25, P54, DOI 10.7171/jbt.14-2502-003; Everaert C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01617-3; Fang MY, 1997, MICROBIOL IMMUNOL, V41, P209, DOI 10.1111/j.1348-0421.1997.tb01192.x; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Gerrard G, 2012, AM J HEMATOL, V87, P717, DOI 10.1002/ajh.23212; Gonzales KAU, 2015, COLD SH Q B, V80, P189, DOI 10.1101/sqb.2015.80.027326; Gu YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098956; Harel S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042302; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Hung Jui-Hung, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.prot093096; Jacob F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059180; Jean A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172358; Kaur R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191558; Kleine M, 2008, XENOTRANSPLANTATION, V15, P208, DOI 10.1111/j.1399-3089.2008.00478.x; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Latos PA, 2015, GENE DEV, V29, P2435, DOI 10.1101/gad.268821.115; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luoh SW, 1997, DEVELOPMENT, V124, P2275; Ma LB, 2008, MOL REPROD DEV, V75, P33, DOI 10.1002/mrd.20736; Macabelli CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093287; Martinez-Giner M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066023; Melo EO, 2017, ANIM GENET, V48, P19, DOI 10.1111/age.12496; Menzies M, 2006, VET IMMUNOL IMMUNOP, V109, P23, DOI 10.1016/j.vetimm.2005.06.014; Montgomery SB, 2009, HUM MOL GENET, V18, pR211, DOI 10.1093/hmg/ddp400; Moura MT, 2018, LIVEST SCI, V212, P52, DOI 10.1016/j.livsci.2018.03.018; Moura MT, 2008, ANIM REPROD SCI, V109, P40, DOI 10.1016/j.anireprosci.2007.10.013; Muraoka N, 2015, CIRC RES, V116, P216, DOI 10.1161/CIRCRESAHA.114.305696; Narbonne P, 2012, CURR OPIN GENET DEV, V22, P450, DOI 10.1016/j.gde.2012.09.002; Park SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060758; Pei DS, 2007, THERIOGENOLOGY, V68, P1282, DOI 10.1016/j.theriogenology.2007.08.027; Pei DS, 2007, ANAL BIOCHEM, V363, P291, DOI 10.1016/j.ab.2006.12.005; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pineau P, 2005, MOL BIOL EVOL, V22, P582, DOI 10.1093/molbev/msi053; Poloumienko A, 2004, GENOME, V47, P74, DOI [10.1139/g03-099, 10.1139/G03-099]; Puech C, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0382-0; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Silva PGC, 2018, ZYGOTE, V26, P270, DOI 10.1017/S0967199418000175; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Tan GW, 2015, SCI REP-UK, V5, DOI 10.1038/srep09430; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Taylor SC, 2014, J MOL MICROB BIOTECH, V24, P46, DOI 10.1159/000356189; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Wang YK, 2017, REPROD DOMEST ANIM, V52, P722, DOI 10.1111/rda.12972; Wittkopp PJ, 2007, J EXP BIOL, V210, P1567, DOI 10.1242/jeb.002592; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Yathish HM, 2017, ANIM REPROD SCI, V177, P25, DOI 10.1016/j.anireprosci.2016.12.003; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhu WZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121280	63	5	6	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0221170	10.1371/journal.pone.0221170	http://dx.doi.org/10.1371/journal.pone.0221170			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412093	Green Submitted, Green Published, gold			2022-12-26	WOS:000485012600049
J	van de Vossenberg, BTLH; Warbroek, T; Ingerson-Mahar, J; Waalwijk, C; van der Gouw, LP; Eichinger, B; Loomans, AJM				van de Vossenberg, Bail T. L. H.; Warbroek, Tim; Ingerson-Mahar, Joseph; Waalwijk, Cees; van der Gouw, Lucas P.; Eichinger, Bernadette; Loomans, Antoon J. M.			Tracking outbreak populations of the pepper weevil Anthonomus eugenii (CoIeoptera; Curculionidae) using complete mitochondrial genomes	PLOS ONE			English	Article							COLEOPTERA; ORTHOPTERA; PHYLOGENY; CANO	The pepper weevil, Anthonomus eugenii, is a major pest on Capsicum species. Apart from natural spread, there is a risk of spread via international pepper trade. In the Netherlands, a pepper weevil outbreak occurred in 2012 and affected six greenhouses producing different sweet pepper varieties. The following year, a pepper weevil outbreak occurred in Italy. To trace the origin of the Dutch outbreak and to establish if the Dutch and Italian outbreaks were linked, we determined the mitogenomes of A. eugeniispecimens collected at outbreak locations, and compared these with specimens from the native area, and other areas where the pest was introduced either by natural dispersal or via trade. The circular 17,257 bp A. eugenii mitogenome comprises thirteen mitochondrial genes typically found in insect species. Intra-species variation of these mitochondrial genes revealed four main mitochondrial lineages encompassing 41 haplotypes. The highest diversity was observed for specimens from its presumed native area (i.e. Mexico). The Dutch outbreak specimens represented three highly similar haplotypes, suggesting a single introduction of the pest. The major Dutch haplotype was also found in two specimens from New Jersey. As the Netherlands does not have pepper trade with New Jersey, it is likely that the specimens sampled in New Jersey and those sampled in the Netherlands originate from a shared source that was not included in this study. In addition, our analysis shows that the Italian and Dutch outbreaks were not linked. The mitochondrial genome is a useful tool to trace outbreak populations and the methodology presented in this paper could prove valuable for other invasive pest species, such as the African fruit moth Thaumatotibia leucotreta and emerald ash borer Agrilus planipennis.	[van de Vossenberg, Bail T. L. H.; Warbroek, Tim; van der Gouw, Lucas P.; Loomans, Antoon J. M.] Dutch Natl Plant Protect Org, Natl Reference Ctr Plant Hlth, Wageningen, Netherlands; [Ingerson-Mahar, Joseph; Eichinger, Bernadette] Rutgers State Univ, Dept Entomol, New Brunswick, NJ USA; [Waalwijk, Cees] Wageningen Univ & Res, Biointeract & Plant Hlth, Wageningen, Gelderland, Netherlands	Rutgers State University New Brunswick; Wageningen University & Research	van de Vossenberg, BTLH (corresponding author), Dutch Natl Plant Protect Org, Natl Reference Ctr Plant Hlth, Wageningen, Netherlands.	b.t.l.h.vandevossenberg@nvwa.nl		van de Vossenberg, Bart T.L.H./0000-0003-1205-6119	Netherlands Food and Consumer Product Safety Authority [OS_20141027]	Netherlands Food and Consumer Product Safety Authority	This work was supported by the Netherlands Food and Consumer Product Safety Authority grant OS_20141027 to Mr Bart T.L.H. van de Vossenberg and Mr. Cees Waalwijk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABREU E, 1985, J AGR U PUERTO RICO, V69, P223; [Anonymous], 2018, RELAZIONE SULLINFEST; Battaglia V, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00208; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Blacket MJ, 2017, ECOL EVOL, V7, P2604, DOI 10.1002/ece3.2783; Brankovics B, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004753; Campbell RE, 1924, J ECON ENTOMOL, V17, P645, DOI 10.1093/jee/17.6.645; CFIA, 2011, RMD1028 CFIA; Clark WE, 1996, SOUTHWEST ENTOMOL, P1; Costello R.A., 1993, Bulletin SROP, V16, P31; DeGoffau L. J. W, 2000, VERSLAGEN MEDEDELING, P56; Elmore J. C., 1934, USDA TECHNICAL B; EU, INTERCEPTIONS OF HAR; Fenn JD, 2008, MOL PHYLOGENET EVOL, V49, P59, DOI 10.1016/j.ympev.2008.07.004; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Gillett CPDT, 2014, MOL BIOL EVOL, V31, P2223, DOI 10.1093/molbev/msu154; Goff C. C., 1937, FLORIDA AGR EXPT STA, P1; Hammes C., 1986, CATALOGUE INSECTES A, P260; Hua JM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-134; Ingerson-Mahar J., 2015, J INTEGR PEST MANAG, V6, P23; JONES D, 1979, ENVIRON ENTOMOL, V8, P874, DOI 10.1093/ee/8.5.874; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Mao SL, 2018, ZOOKEYS, P57, DOI 10.3897/zookeys.773.24156; NPPO-NL, 2014, EPPO REPORTING SERVI, P2; NPPO-NL, 2012, EPPO REPORTING SERVI, P10; Oepp B., 2016, EPPO B, DOI [DOI 10.1111/EPP.12344, 10.1111/epp.12344]; OEPP/ EPPO, 2019, EPPO GLOB DAT; PATROCK RJ, 1992, TROP PEST MANAGE, V38, P65; RILEY DG, 1994, ENTOMOL TRENDS AGR S, V2, P109; Serra C. A, 2011, IMPACTS RECENTLY EME; Smith DR, 2016, BRIEF FUNCT GENOMICS, V15, P47, DOI 10.1093/bfgp/elv027; SMITH IM, 1996, QUARANTINE PESTS EUR; Speranza S, 2014, FLA ENTOMOL, V97, P844, DOI 10.1653/024.097.0275; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; van der Gaag D. J, 2013, PEST RISK ANAL ANTHO, P64; Walker C. M, 1905, USDA BUR ENTOMOL B, P43; Wang Y, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030680	39	4	4	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0221182	10.1371/journal.pone.0221182	http://dx.doi.org/10.1371/journal.pone.0221182			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412079	Green Published, gold, Green Submitted			2022-12-26	WOS:000485012600052
J	Choi, JG; Huh, E; Kim, N; Kim, DH; Oh, MS				Choi, Jin Gyu; Huh, Eugene; Kim, Namkwon; Kim, Dong-Hyun; Oh, Myung Sook			High-throughput 16S rRNA gene sequencing reveals that 6-hydroxydopamine affects gut microbial environment	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PARKINSONS-DISEASE; NONMOTOR SYMPTOMS; BRAIN AXIS; SYMPATHETIC INNERVATION; PROBIOTIC MIXTURE; MODEL; DYSFUNCTION; DISORDERS; DIAGNOSIS	Recently, there has been a rapid increase in studies on the relationship between brain diseases and gut microbiota, and clinical evidence on gut microbial changes in Parkinson's disease (PD) has accumulated. 6-Hydroxydopamine (6-OHDA) is a widely used neurotoxin that leads to PD pathogenesis, but whether 6-OHDA affects gut microbial environment has not been investigated. Here we performed the 16S rRNA gene sequencing to analyze the gut microbial community of mice. We found that there were no significant changes in species richness and its diversity in the 6-OHDA-lesioned mice. The relative abundance of Lactobacillus gasseri and L. reuteri probiotic species in feces of 6-OHDA-lesioned mice was significantly decreased compared with those of sham-operated mice, while the commensal bacterium Bacteroides acidifaciens in 6-OHDA-treated mice was remarkably higher than sham-operated mice. These results provide a baseline for understanding the microbial communities of 6-OHDA-induced PD model to investigate the role of gut microbiota in the pathogenesis of PD.	[Choi, Jin Gyu; Huh, Eugene; Oh, Myung Sook] Kyung Hee Univ, Coll Pharm, Dept Oriental Pharmaceut Sci, Seoul, South Korea; [Choi, Jin Gyu; Huh, Eugene; Oh, Myung Sook] Kyung Hee Univ, Kyung Hee East West Pharmaceut Res Inst, Seoul, South Korea; [Huh, Eugene] Kyung Hee Univ, Grad Sch, Dept Med Sci Meridian, Seoul, South Korea; [Kim, Namkwon; Kim, Dong-Hyun; Oh, Myung Sook] Kyung Hee Univ, Grad Sch, Dept Life & Nanopharmaceut Sci, Seoul, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University	Oh, MS (corresponding author), Kyung Hee Univ, Coll Pharm, Dept Oriental Pharmaceut Sci, Seoul, South Korea.; Oh, MS (corresponding author), Kyung Hee Univ, Kyung Hee East West Pharmaceut Res Inst, Seoul, South Korea.; Oh, MS (corresponding author), Kyung Hee Univ, Grad Sch, Dept Life & Nanopharmaceut Sci, Seoul, South Korea.	msohok@khu.ac.kr	Oh, Myung Sook/AAH-9948-2020	Oh, Myung Sook/0000-0001-8189-4066	National Research Foundation of Korea (NRF) - Korea government (MEST) [NRF2015R1A2A2A01004341]; Medical Research Center Program through the NRF - Ministry of Science and ICT [NRF2017R1A5A2014768]	National Research Foundation of Korea (NRF) - Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); Medical Research Center Program through the NRF - Ministry of Science and ICT	This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (NRF2015R1A2A2A01004341), to MSO; Medical Research Center Program through the NRF funded by the Ministry of Science and ICT (NRF2017R1A5A2014768), to MSO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; .	Alrafas HR, 2019, J LEUKOCYTE BIOL, V106, P467, DOI 10.1002/JLB.3A1218-476RR; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antonini A, 2012, J NEUROL, V259, P2621, DOI 10.1007/s00415-012-6557-8; Bailey MT, 2011, BRAIN BEHAV IMMUN, V25, P397, DOI 10.1016/j.bbi.2010.10.023; Bailey MT, 2004, J PEDIATR GASTR NUTR, V38, P414, DOI 10.1097/00005176-200404000-00009; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonfili L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02587-2; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Bundzikova-Osacka J, 2015, STRESS, V18, P221, DOI 10.3109/10253890.2015.1013531; Carabotti M, 2015, ANN GASTROENTEROL, V28, P203; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Delang C.O., 2013, ECOLOGICAL SUCCESSIO, VVolume 978, P39; Devos D, 2013, NEUROBIOL DIS, V50, P42, DOI 10.1016/j.nbd.2012.09.007; Dinan TG, 2012, PSYCHONEUROENDOCRINO, V37, P1369, DOI 10.1016/j.psyneuen.2012.03.007; Donaldson GP, 2018, SCIENCE, V360, P795, DOI 10.1126/science.aaq0926; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Galley JD, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-189; Georgescu D, 2016, CLIN INTERV AGING, V11, P1601, DOI 10.2147/CIA.S106284; Gerhardt S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060708; Gonzalez-Ariki S, 2000, DEV COMP IMMUNOL, V24, P61, DOI 10.1016/S0145-305X(99)00056-7; Hasegawa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142164; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hopfner F, 2017, BRAIN RES, V1667, P41, DOI 10.1016/j.brainres.2017.04.019; Houlden A, 2016, BRAIN BEHAV IMMUN, V57, P10, DOI 10.1016/j.bbi.2016.04.003; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Kato LM, 2014, IMMUNOL CELL BIOL, V92, P49, DOI 10.1038/icb.2013.54; Keshavarzian A, 2015, MOVEMENT DISORD, V30, P1351, DOI 10.1002/mds.26307; Kwon HK, 2013, CLIN IMMUNOL, V146, P217, DOI 10.1016/j.clim.2013.01.001; Lavasani S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009009; Lo BC, 2019, J IMMUNOL, V202, P956, DOI 10.4049/jimmunol.1801308; Malinen E, 2005, AM J GASTROENTEROL, V100, P373, DOI 10.1111/j.1572-0241.2005.40312.x; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Miyake S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137429; Mukherjee A, 2016, WORLD J GASTROENTERO, V22, P5742, DOI 10.3748/wjg.v22.i25.5742; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Ojetti V, 2014, J GASTROINTEST LIVER, V23, P387, DOI 10.15403/jgld.2014.1121.234.elr; Olanow CW, 2014, MOVEMENT DISORD, V29, P963, DOI 10.1002/mds.25966; Park AJ, 2013, NEUROGASTROENT MOTIL, V25, P733, DOI 10.1111/nmo.12153; Paxinos G, 2012, PAXINOS FRANKLINS MO; Petra AI, 2015, CLIN THER, V37, P984, DOI 10.1016/j.clinthera.2015.04.002; Petrov VA, 2017, B EXP BIOL MED+, V162, P734, DOI 10.1007/s10517-017-3700-7; Pistollato F, 2016, NUTR REV, V74, P624, DOI 10.1093/nutrit/nuw023; Ribiere C, 2016, SCI REP-UK, V6, DOI 10.1038/srep31027; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Scheperjans F, 2015, MOVEMENT DISORD, V30, P350, DOI 10.1002/mds.26069; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shultz Jeanette M, 2016, J Alzheimers Dis Parkinsonism, V6, DOI 10.4172/2161-0460.1000279; Simola N, 2007, NEUROTOX RES, V11, P151, DOI 10.1007/BF03033565; Soderholm JD, 2002, AM J PHYSIOL-GASTR L, V283, pG1257, DOI 10.1152/ajpgi.00314.2002; Thiele SL, 2012, JOVE-J VIS EXP, DOI 10.3791/3234; Unger MM, 2016, PARKINSONISM RELAT D, V32, P66, DOI 10.1016/j.parkreldis.2016.08.019; Varghese AK, 2006, GASTROENTEROLOGY, V130, P1743, DOI 10.1053/j.gastro.2006.02.007; Wang SQ, 2019, NEUROSCI LETT, V696, P93, DOI 10.1016/j.neulet.2018.12.021; WILLIAMS JM, 1981, BRAIN RES BULL, V6, P83, DOI 10.1016/S0361-9230(81)80072-X; Yanagibashi T, 2013, IMMUNOBIOLOGY, V218, P645, DOI 10.1016/j.imbio.2012.07.033; YODLOWSKI ML, 1984, J NEUROSCI, V4, P1535; Yoon SH, 2017, INT J SYST EVOL MICR, V67, P1613, DOI 10.1099/ijsem.0.001755; Zheng LF, 2014, ACTA PHYSIOL, V211, P434, DOI 10.1111/apha.12229; Zhu XQ, 2017, ONCOTARGET, V8, P53829, DOI 10.18632/oncotarget.17754	65	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0217194	10.1371/journal.pone.0217194	http://dx.doi.org/10.1371/journal.pone.0217194			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404072	gold, Green Published, Green Submitted			2022-12-26	WOS:000485006800003
J	Kanai, Y; Ishiki, H; Maeda, I; Iwase, S				Kanai, Yoshiaki; Ishiki, Hiroto; Maeda, Isseki; Iwase, Satoru			A survey of practice in management of malignancy-related ascites in Japan	PLOS ONE			English	Article							REINFUSION THERAPY CART; CANCER-PATIENTS; DEXAMETHASONE; HYDRATION	Although ascites is a distressing complication observed commonly in the course of advanced cancer, there is no effective treatment established for malignancy-related ascites. We conducted a nationwide survey of cancer physicians in Japan who treat malignancy related ascites in order to determine what kind of therapeutic approach is thought to be significant and what kind of diuretic prescriptions are thought to be standard for malignancy related ascites. From 2017 to 2018, we sent a one-page memo to oncologists in Japan asking them to participate in a questionnaire-style survey that they could complete online. The significance of each of the nine representative interventions was measured on a 5-stage Likert scale. At the same time, participants were asked about what type and dosage of diuretics they thought to be standard as a treatment for malignancy-related ascites. Ultimately, 187 oncologists responded to our invitation. The interventions that were particularly significant were reducing hydration volume, paracentesis, and symptom management with analgesics. The respondents indicated that the importance of diuretics was significantly lower than that of these three interventions. Furthermore, 86.2% of the respondents in Japan regarded the use of loop diuretics aldosterone antagonists as the standard of diuretic therapy for malignancy-related ascites, and the most common regimen was 20 mg of oral furosemide 25 mg of spironolactone daily at the start, and 30-40 mg 50 mg daily at the time of initial escalation. Although our study revealed that the attitude of oncologists in Japan toward therapeutic options for malignancy-related ascites was nearly consistent with that of previous reports from other countries, it was newly found that they seemed to commonly be concerned with preventing overhydration of terminally ill cancer patients and that analgesics were also thought to be a significant form of intervention.	[Kanai, Yoshiaki] TMG Asaka Med Ctr, Palliat Care Ctr, Saitama, Japan; [Kanai, Yoshiaki] Univ Tokyo Hosp, Div Palliat Med, Tokyo, Japan; [Ishiki, Hiroto] Natl Canc Ctr, Dept Palliat Med, Tokyo, Japan; [Maeda, Isseki] Gratia Hosp, Gratia Hospice, Osaka, Japan; [Iwase, Satoru] Saitama Med Univ, Dept Palliat Med, Saitama, Japan	University of Tokyo; National Cancer Center - Japan; Saitama Medical University	Kanai, Y (corresponding author), TMG Asaka Med Ctr, Palliat Care Ctr, Saitama, Japan.; Kanai, Y (corresponding author), Univ Tokyo Hosp, Div Palliat Med, Tokyo, Japan.	kanai-hongou@umin.ac.jp	Hiroto, Ishiki/AHC-0321-2022	Maeda, Isseki/0000-0002-0018-3359	Japanese society of palliative medicine	Japanese society of palliative medicine	This work was supported by the Japanese society of palliative medicine (https://www.jspm.ne.jp/) to YK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker G, 2006, EUR J CANCER, V42, P589, DOI 10.1016/j.ejca.2005.11.018; Bruera E, 2004, J PAIN SYMPTOM MANAG, V28, P381, DOI 10.1016/j.jpainsymman.2004.01.009; Bruera E, 2013, J CLIN ONCOL, V31, P111, DOI 10.1200/JCO.2012.44.6518; GOUGH IR, 1993, CANCER, V71, P2377, DOI 10.1002/1097-0142(19930401)71:7<2377::AID-CNCR2820710732>3.0.CO;2-H; Hardy JR, 2001, PALLIATIVE MED, V15, P3, DOI 10.1191/026921601673324846; Jehn CF, 2015, SUPPORT CARE CANCER, V23, P2073, DOI 10.1007/s00520-014-2557-9; Lee CW, 1998, J PAIN SYMPTOM MANAG, V16, P96, DOI 10.1016/S0885-3924(98)00037-2; Morita T, 2005, ANN ONCOL, V16, P640, DOI 10.1093/annonc/mdi121; Newman G, 2006, CLIN ONCOL-UK, V18, P154, DOI 10.1016/j.clon.2005.11.016; POCKROS PJ, 1992, GASTROENTEROLOGY, V103, P1302, DOI 10.1016/0016-5085(92)91520-E; Riedel AN, 2018, WORLD J GASTROENTERO, V24, P1650, DOI 10.3748/wjg.v24.i15.1650; RUNYON BA, 1988, HEPATOLOGY, V8, P1104, DOI 10.1002/hep.1840080521; Runyon Bruce A., AM ASS STUDY LIVER D, P66; Teunissen SCCM, 2007, J PAIN SYMPTOM MANAG, V34, P94, DOI 10.1016/j.jpainsymman.2006.10.015; Togami S, 2014, EUR J GYNAECOL ONCOL, V35, P301; Yamaguchi H, 2015, EJSO-EUR J SURG ONC, V41, P875, DOI 10.1016/j.ejso.2015.04.013	16	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220869	10.1371/journal.pone.0220869	http://dx.doi.org/10.1371/journal.pone.0220869			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398238	gold, Green Published, Green Submitted			2022-12-26	WOS:000485004000024
J	Kulkarni, G				Kulkarni, Gourihar			Ice nucleation ability of loess from the northwestern United States	PLOS ONE			English	Article							MINERAL DUST PARTICLES; SURFACE SITE DENSITY; ADSORPTION; AEROSOL; NUCLEI; WATER	The heterogeneous nucleation of ice processes involving loess particles that influences the formation of mixed-phase clouds are poorly understood. Here, the ice nucleating ability of wind-blown dust or loess accumulated from the past glaciated area was investigated at three temperatures:-26,-30, and -34 degrees C and at below and above saturation with respect to liquid water conditions. Total six loess samples from different regions across Columbia Basin province, WA, USA were collected, dry dispersed, size-selected at mobility diameter 200 nm, and investigated for their ice nucleation efficiency. To understand the effect of atmospheric processing during long-range transport on their ice nucleating ability, similar experiments were also performed on acid-treated loess samples. Additionally, the ice nucleating properties of Arizona Test Dust (ATD) were investigated as a surrogate for natural mineral dust particles to test the experimental approach. Results show that treated particles have lower ice nucleation efficiency compared to untreated particles at all temperature and saturation with respect to liquid water conditions. Comparison based on ice-active site density (N-s) metric indicate that loess particles at saturation with respect to liquid water conditions are marginally more efficient than the mineral and soil dust values reported in the literature, but they have lower efficiencies than the predicted N-s efficiency of K-feldspar particles at supercooled temperatures greater than -38 degrees C.	[Kulkarni, Gourihar] Pacific Northwest Natl Lab, Atmospher Sci & Global Change Div, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	Kulkarni, G (corresponding author), Pacific Northwest Natl Lab, Atmospher Sci & Global Change Div, Richland, WA 99352 USA.	Gourihar.Kulkarni@pnnl.gov			US DOE	US DOE(United States Department of Energy (DOE))	This work was supported by the US DOE to GK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson JD, 2013, NATURE, V498, P355, DOI 10.1038/nature12278; Baron PAaW, 2001, MEASUREMENT PRINCIPL; Chernoff DI, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014254; China S, 2017, J GEOPHYS RES-ATMOS, V122, P3065, DOI 10.1002/2016JD025817; Connolly PJ, 2009, ATMOS CHEM PHYS, V9, P2805, DOI 10.5194/acp-9-2805-2009; Crouvi O, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2008JF001083; DeMott PJ, 2018, ATMOS MEAS TECH, V11, P6231, DOI 10.5194/amt-11-6231-2018; Friedman B, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD015999; Gaylord DR, 2003, QUATERNARY GEOLOGY U, P438; Hiranuma N, 2015, ATMOS CHEM PHYS, V15, P2489, DOI 10.5194/acp-15-2489-2015; Hiranuma N, 2019, ATMOS CHEM PHYS, V19, P4823, DOI 10.5194/acp-19-4823-2019; Knopf DA, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006894; Kulkarni G, 2012, ATMOS CHEM PHYS, V12, P7295, DOI 10.5194/acp-12-7295-2012; Kulkarni G, 2018, ATMOSPHERE-BASEL, V9, DOI 10.3390/atmos9020055; Kulkarni G, 2014, J GEOPHYS RES-ATMOS, V119, P9993, DOI 10.1002/2014JD021567; Marcolli C, 2014, ATMOS CHEM PHYS, V14, P2071, DOI 10.5194/acp-14-2071-2014; Mason RH, 2016, ATMOS CHEM PHYS, V16, P1637, DOI 10.5194/acp-16-1637-2016; Muhs DR, 2013, AEOLIAN RES, V9, P3, DOI 10.1016/j.aeolia.2012.08.001; Muhs DR., 2014, GLOBAL CHANGES, V22, P84, DOI [10.22498/pages.22.2, DOI 10.22498/PAGES.22.2]; Muhs DR, 2013, LOESS ITS GEOMORPHIC; Murphy DM, 2005, Q J ROY METEOR SOC, V131, P1539, DOI 10.1256/qj.04.94; Murray BJ, 2012, CHEM SOC REV, V41, P6519, DOI 10.1039/c2cs35200a; Niedermeier D, 2011, ATMOS CHEM PHYS, V11, P11131, DOI 10.5194/acp-11-11131-2011; Niedermeier D, 2015, J GEOPHYS RES-ATMOS, V120, P5036, DOI 10.1002/2014JD022814; Niemand M, 2012, J ATMOS SCI, V69, P3077, DOI 10.1175/JAS-D-11-0249.1; Panda AK, 2010, COLLOID SURFACE A, V363, P98, DOI 10.1016/j.colsurfa.2010.04.022; Paramonov M, 2018, ATMOS CHEM PHYS, V18, P16515, DOI 10.5194/acp-18-16515-2018; Pye K, 1995, QUATERNARY SCI REV, V14, P653, DOI 10.1016/0277-3791(95)00047-X; Reitz P, 2011, ATMOS CHEM PHYS, V11, P7839, DOI 10.5194/acp-11-7839-2011; Sihvonen SK, 2014, J PHYS CHEM A, V118, P8787, DOI 10.1021/jp504846g; Steinke I, 2015, ATMOS CHEM PHYS, V15, P3703, DOI 10.5194/acp-15-3703-2015; Sullivan RC, 2010, ATMOS CHEM PHYS, V10, P11471, DOI 10.5194/acp-10-11471-2010; Sullivan RC, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045540; Suski KJ, 2018, ATMOS CHEM PHYS, V18, P13755, DOI 10.5194/acp-18-13755-2018; Sweeney MR, 2004, GEOLOGY, V32, P705, DOI 10.1130/G20584.1; Tang MJ, 2016, CHEM REV, V116, P4205, DOI 10.1021/acs.chemrev.5b00529; Tobo Y, 2014, ATMOS CHEM PHYS, V14, P8521, DOI 10.5194/acp-14-8521-2014; Tobo Y, 2019, NAT GEOSCI, V12, P253, DOI 10.1038/s41561-019-0314-x; Tobo Y, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053007; Vali G, 2015, ATMOS CHEM PHYS, V15, P10263, DOI 10.5194/acp-15-10263-2015; Veghte DP, 2014, AEROSOL SCI TECH, V48, P715, DOI 10.1080/02786826.2014.920484; Volzone C, 2011, J ENVIRON MANAGE, V92, P2590, DOI 10.1016/j.jenvman.2011.05.031; Wex H, 2014, ATMOS CHEM PHYS, V14, P5529, DOI 10.5194/acp-14-5529-2014; Woodward X, 2015, AEROSOL SCI TECH, V49, P229, DOI 10.1080/02786826.2015.1017550	45	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220991	10.1371/journal.pone.0220991	http://dx.doi.org/10.1371/journal.pone.0220991			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398218	Green Published, Green Submitted, gold			2022-12-26	WOS:000485004000038
J	Barone, M; Turroni, S; Rampelli, S; Soverini, M; D'Amico, F; Biagi, E; Brigidi, P; Troiani, E; Candela, M				Barone, Monica; Turroni, Silvia; Rampelli, Simone; Soverini, Matteo; D'Amico, Federica; Biagi, Elena; Brigidi, Patrizia; Troiani, Emidio; Candela, Marco			Gut microbiome response to a modern Paleolithic diet in a Western lifestyle context	PLOS ONE			English	Article							INFLAMMATION; IMPACT	The modern Paleolithic diet (MPD), featured by the consumption of vegetables, fruit, nuts, seeds, eggs, fish and lean meat, while excluding grains, dairy products, salt and refined sugar, has gained substantial public attention in recent years because of its potential multiple health benefits. However, to date little is known about the actual impact of this dietary pattern on the gut microbiome (GM) and its implications for human health. In the current scenario where Western diets, low in fiber while rich in industrialized and processed foods, are considered one of the leading causes of maladaptive GM changes along human evolution, likely contributing to the increasing incidence of chronic non-communicable diseases, we hypothesize that the MPD could modulate the Western GM towards a more "ancestral" configuration. In an attempt to shed light on this, here we profiled the GM structure of urban Italian subjects adhering to the MPD, and compared data with other urban Italians following a Mediterranean Diet (MD), as well as worldwide traditional hunter-gatherer populations from previous publications. Notwithstanding a strong geography effect on the GM structure, our results show an unexpectedly high degree of biodiversity in MPD subjects, which well approximates that of traditional populations. The GM of MPD individuals also shows some peculiarities, including a high relative abundance of bile-tolerant and fat-loving microorganisms. The consumption of plant-based foods-albeit with the exclusion of grains and pulses-along with the minimization of the intake of processed foods, both hallmarks of the MPD, could therefore contribute to partially rewild the GM but caution should be taken in adhering to this dietary pattern in the long term.	[Barone, Monica; Turroni, Silvia; Rampelli, Simone; Soverini, Matteo; D'Amico, Federica; Biagi, Elena; Brigidi, Patrizia; Candela, Marco] Univ Bologna, Dept Pharm & Biotechnol, Unit Microbial Ecol Hlth, Bologna, Italy; [Troiani, Emidio] Social Secur Inst, Primary Care Unit, Cailungo, San Marino; [Troiani, Emidio] Social Secur Inst, Terr Hlth, Cailungo, San Marino	University of Bologna	Turroni, S (corresponding author), Univ Bologna, Dept Pharm & Biotechnol, Unit Microbial Ecol Hlth, Bologna, Italy.	silvia.turroni@unibo.it	Rampelli, Simone/K-5675-2016; Barone, Monica/AAA-3514-2019; Turroni, Silvia/J-7195-2016; D'Amico, Federica/AAA-7556-2019; TROIANI, EMIDIO/AHC-2826-2022	Rampelli, Simone/0000-0002-5655-6695; Turroni, Silvia/0000-0003-2345-9482; D'Amico, Federica/0000-0002-2136-9558; TROIANI, EMIDIO/0000-0002-5173-8174; Soverini, Matteo/0000-0002-3026-9460; Barone, Monica/0000-0001-5229-570X				Ayeni FA, 2018, CELL REP, V23, P3056, DOI 10.1016/j.celrep.2018.05.018; Biagi E, 2016, CURR BIOL, V26, P1480, DOI 10.1016/j.cub.2016.04.016; Blaser MJ, 2017, NAT REV IMMUNOL, V17, P461, DOI 10.1038/nri.2017.77; Caesar R, 2015, CELL METAB, V22, P658, DOI 10.1016/j.cmet.2015.07.026; Cani PD, 2018, NAT REV GASTRO HEPAT, V15, P671, DOI 10.1038/s41575-018-0025-6; Cani PD, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01765; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Coyte KZ, 2015, SCIENCE, V350, P663, DOI 10.1126/science.aad2602; Dall'Asta C, 2012, MOL NUTR FOOD RES, V56, P632, DOI 10.1002/mnfr.201100515; Danchin A, 2018, ENVIRON MICROBIOL, V20, P1966, DOI 10.1111/1462-2920.14255; Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778; Davenport ER, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0454-7; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Filippis F, 2016, GUT, V65, P1812, DOI 10.1136/gutjnl-2015-309957; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Deschasaux M, 2018, NAT MED, V24, P1526, DOI 10.1038/s41591-018-0160-1; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Genoni A, 2016, NUTRIENTS, V8; Genoni A, 2019, BRIT J NUTR, V121, P322, DOI 10.1017/S000711451800329X; Girard C, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00297-16; Gorvitovskaia A, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0160-7; Groves HT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00182; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; He Y, 2018, NAT MED, V24, P1532, DOI 10.1038/s41591-018-0164-x; Johnson KVA, 2016, GUT MICROBES, V7, P455, DOI 10.1080/19490976.2016.1241933; Jonsson T, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-35; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Lahti L, 2013, PEERJ, V1, DOI 10.7717/peerj.32; Lindeberg S, 2007, DIABETOLOGIA, V50, P1795, DOI 10.1007/s00125-007-0716-y; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Martin G, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01153; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Mellberg C, 2014, EUR J CLIN NUTR, V68, P350, DOI 10.1038/ejcn.2013.290; Moeller AH, 2014, P NATL ACAD SCI USA, V111, P16431, DOI 10.1073/pnas.1419136111; Mosca A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00455; Obregon-Tito AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7505; Otten J, 2018, DIABETOLOGIA, V61, P1548, DOI 10.1007/s00125-018-4618-y; Otten J, 2017, DIABETES-METAB RES, V33, DOI 10.1002/dmrr.2828; Rajilic-Stojanovic M, 2014, FEMS MICROBIOL REV, V38, P996, DOI 10.1111/1574-6976.12075; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; Smits SA, 2017, SCIENCE, V357, P802, DOI 10.1126/science.aan4834; Sonnenburg ED, 2014, CELL METAB, V20, P779, DOI 10.1016/j.cmet.2014.07.003; Whalen KA, 2016, J NUTR, V146, P1217, DOI 10.3945/jn.115.224048; Wirbel J, 2019, NAT MED, V25, P679, DOI 10.1038/s41591-019-0406-6; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zuo T, 2018, NAT REV GASTRO HEPAT, V15, P440, DOI 10.1038/s41575-018-0003-z	48	34	37	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220619	10.1371/journal.pone.0220619	http://dx.doi.org/10.1371/journal.pone.0220619			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393934	gold, Green Published, Green Submitted			2022-12-26	WOS:000485002500048
J	Han, Y; Kim, B; Cho, U; Park, IS; Kim, SI; Dhanasekaran, DN; Tsang, BK; Song, YS				Han, Youngjin; Kim, Boyun; Cho, Untack; Park, In Sil; Kim, Se Ik; Dhanasekaran, Danny N.; Tsang, Benjamin K.; Song, Yong Sang			Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells	ONCOGENE			English	Article							INDUCED MIGRATION; DYNAMICS; DRP1; PHOSPHORYLATION; METASTASIS; SURVIVAL; P53; TRAFFICKING; STRESS; FUSION	Mitochondria undergo fission and fusion continually for survival through the course of cellular adaption processes in response to changes in the surrounding environment. Dysregulated mitochondria' dynamics has been reported in various diseases including cancer. Under hypoxic conditions (<1% O-2), the relationship between mitochondrial dynamics and sensitivity to cisplatin (CDDP) was examined in ovarian cancer cells. We found that hypoxia promoted mitochondria' fission and CDDP resistance in ovarian cancer cells. Hypoxia-induced reactive oxygen species (ROS) caused an increase in mitochondrial fission, a response abolished by free radical scavenging with N-acetylcysteine (NAC) and Trolox. Also, treatment of hydrogen peroxide (H2O2) decreased inhibitory p-Drp1 (Ser637) content and increased mitochondrial fission. Suppression of mitochondrial fission enhanced the CDDP sensitivity of hypoxic ovarian cancer cells. Lastly, in tumor spheroids from malignant ascites or tissues of patients with advanced-stage ovarian cancer, pretreatment with Mdivi-1 increased the CDDP sensitivity. Taken together, our results implicate that hypoxia-induced ROS trigger mitochondrial fission and CDDP resistance through downregulation of p-Drpl (Ser637) and Mfn1 in ovarian cancer cells. Inhibition of Drp1 by Mdivi-1 treatment or si-Drpl transfection increased CDDP sensitivity of ovarian cancer cells under hypoxia. Therefore, mitochondrial dynamics of cancer cells adapting to the hypoxic tumor microenvironment could be a potential target for anticancer therapy.	[Han, Youngjin; Song, Yong Sang] Seoul Natl Univ, Dept Agr Biotechnol, WCU Biomodulat, Seoul 08826, South Korea; [Han, Youngjin; Kim, Boyun; Cho, Untack; Park, In Sil; Song, Yong Sang] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul 03080, South Korea; [Kim, Boyun] Univ Texas Hlth Sci Ctr Houston, Dept Anesthesiol, McGovern Med Sch, Houston, TX 77030 USA; [Cho, Untack; Song, Yong Sang] Seoul Natl Univ, Interdisciplinary Program Canc Biol, Seoul 03080, South Korea; [Park, In Sil] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 08826, South Korea; [Kim, Se Ik; Song, Yong Sang] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul 03080, South Korea; [Dhanasekaran, Danny N.] Univ Oklahoma, Hlth Sci Ctr, Stephenson Canc Ctr, Oklahoma City, OK 73012 USA; [Tsang, Benjamin K.] Univ Ottawa, Dept Obstet & Gynecol, Ottawa, ON K1H 8L6, Canada; [Tsang, Benjamin K.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8L6, Canada; [Tsang, Benjamin K.] Ottawa Hosp Res Inst, Chron Dis Program, Ottawa, ON K1H 8L6, Canada; [Tsang, Benjamin K.] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau Inst Appl Res Med & Hlth, Macau, Peoples R China	Seoul National University (SNU); Seoul National University (SNU); University of Texas System; University of Texas Health Science Center Houston; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; Macau University of Science & Technology	Song, YS (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, WCU Biomodulat, Seoul 08826, South Korea.; Song, YS (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul 03080, South Korea.; Song, YS (corresponding author), Seoul Natl Univ, Interdisciplinary Program Canc Biol, Seoul 03080, South Korea.; Song, YS (corresponding author), Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul 03080, South Korea.	yssong@snu.ac.kr		SONG, YONGSANG/0000-0001-7115-4021; Han, Youngjin/0000-0002-3778-2056; Kim, Se Ik/0000-0002-9790-6735	BK21 Plus Program of the Department of Agricultural Biotechnology, Seoul National University (Seoul, Korea); Korea Health Technology R&D Project through the Korea Health Industry Development R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI16C2037]; Seoul National University Hospital (SNUH) research fund [04-2017-0530]; Canadian Institutes of Health Research [MOP-126144]	BK21 Plus Program of the Department of Agricultural Biotechnology, Seoul National University (Seoul, Korea); Korea Health Technology R&D Project through the Korea Health Industry Development R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; Seoul National University Hospital (SNUH) research fund; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by the BK21 Plus Program of the Department of Agricultural Biotechnology, Seoul National University (Seoul, Korea), a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea [grant number HI16C2037], and Seoul National University Hospital (SNUH) research fund [grant number 04-2017-0530], as well as a grant from the Canadian Institutes of Health Research [grant number MOP-126144]. Also, we would like to thank Prof. Woo Ho Kim (Seoul National University, Republic of Korea) and his lab members for technical assistance in this study.	Akbarzadeh M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16940-y; Altieri DC, 2017, BRIT J CANCER, V117, P301, DOI 10.1038/bjc.2017.201; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Braicu EI, 2014, ONCOTARGETS THER, V7, P1563, DOI 10.2147/OTT.S65373; Caino MC, 2015, P NATL ACAD SCI USA, V112, P8638, DOI 10.1073/pnas.1500722112; Capriglione S, 2017, MED ONCOL, V34, DOI 10.1007/s12032-017-1026-y; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Casciello F, 2017, P NATL ACAD SCI USA, V114, P7077, DOI 10.1073/pnas.1618706114; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Chen Y, 2012, INT J MOL SCI, V13, P13264, DOI 10.3390/ijms131013264; Cheng CT, 2016, CANCER RES, V76, P5006, DOI 10.1158/0008-5472.CAN-15-2921; Cho U, 2018, MOL CARCINOGEN, V57, P235, DOI 10.1002/mc.22750; Coburn SB, 2017, INT J CANCER, V140, P2451, DOI 10.1002/ijc.30676; Cocola C, 2017, J CELL BIOCHEM, V118, P570, DOI 10.1002/jcb.25737; Eales KL, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.50; Farrand L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074008; Ferree A, 2012, ADV EXP MED BIOL, V748, P13, DOI 10.1007/978-1-4614-3573-0_2; Ferreira-da-Silva A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122308; Girda E, 2017, INT J GYNECOL CANCER, V27, P1701, DOI 10.1097/IGC.0000000000001061; Gjorevski N, 2016, NATURE, V539, P359, DOI 10.1038/nature20168; Han XJ, 2015, INT J ONCOL, V46, P691, DOI 10.3892/ijo.2014.2781; Han Y, 2018, FREE RADICAL RES, V52, P1271, DOI 10.1080/10715762.2018.1459594; Hong YH, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00167; Humpton TJ, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026146; Itoh K, 2013, TRENDS CELL BIOL, V23, P64, DOI 10.1016/j.tcb.2012.10.006; Jabs J, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20177697; Kang J, 2018, CANCER RES, V78, P1184, DOI 10.1158/0008-5472.CAN-17-2506; Kim B, 2013, AM J PHYSIOL-REG I, V305, pR927, DOI 10.1152/ajpregu.00502.2012; Kim B, 2017, ONCOTARGET, V8, P60299, DOI 10.18632/oncotarget.19140; Kim B, 2017, CANCER RES TREAT, V49, P338, DOI 10.4143/crt.2016.175; Kim S, 2018, NPJ PRECIS ONCOL, V2, DOI 10.1038/s41698-018-0063-0; Kim S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31097-y; Kong B, 2015, ANN NY ACAD SCI, V1350, P1, DOI 10.1111/nyas.12883; Lee JH, 2012, J BIOL CHEM, V287, P20898, DOI 10.1074/jbc.M111.336875; Lee JY, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1077-4; Li PY, 2016, SCI REP-UK, V6, DOI 10.1038/srep22831; Matz M, 2017, GYNECOL ONCOL, V144, P396, DOI 10.1016/j.ygyno.2016.11.019; Oettinghaus B, 2016, BBA-BIOENERGETICS, V1857, P1267, DOI 10.1016/j.bbabio.2016.03.016; Otera H, 2016, J CELL BIOL, V212, P531, DOI 10.1083/jcb.201508099; Panieri E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.105; Park HK, 2017, CANCER EPIDEM BIOMAR, V26, P1511, DOI 10.1158/1055-9965.EPI-17-0290; Parone PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003257; Pletjushkina OY, 2006, BBA-BIOENERGETICS, V1757, P518, DOI 10.1016/j.bbabio.2006.03.018; Ren YA, 2016, CANCER RES, V76, P2206, DOI 10.1158/0008-5472.CAN-15-1046; Seo JA, 2016, CANCER LETT, V371, P30, DOI 10.1016/j.canlet.2015.11.021; Shen YL, 2018, INT J MOL MED, V41, P2317, DOI 10.3892/ijmm.2018.3385; Soragni A, 2016, CANCER CELL, V29, P90, DOI 10.1016/j.ccell.2015.12.002; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Turco MY, 2017, NAT CELL BIOL, V19, P568, DOI 10.1038/ncb3516; Wan YY, 2014, ONCOL REP, V32, P619, DOI 10.3892/or.2014.3235; Xie Q, 2015, NAT NEUROSCI, V18, P501, DOI 10.1038/nn.3960; Xu SC, 2016, J PINEAL RES, V60, P291, DOI 10.1111/jpi.12310; Zhang D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197266	53	77	78	3	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 7	2019	38	45					7089	7105		10.1038/s41388-019-0949-5	http://dx.doi.org/10.1038/s41388-019-0949-5			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JL9XI	31409904				2022-12-26	WOS:000495878400005
J	Preston, KJ; Rom, I; Vrakas, C; Landesberg, G; Etwebi, Z; Muraoka, S; Autieri, M; Eguchi, S; Scalia, R				Preston, Kyle J.; Rom, Inna; Vrakas, Christine; Landesberg, Gavin; Etwebi, Zienab; Muraoka, Sanae; Autieri, Michael; Eguchi, Satoru; Scalia, Rosario			Postprandial activation of leukocyte-endothelium interaction by fatty acids in the visceral adipose tissue microcirculation	FASEB JOURNAL			English	Article						free fatty acids; inflammation; insulin resistance; adipocyte	NECROSIS-FACTOR-ALPHA; INDUCED INSULIN-RESISTANCE; P-SELECTIN EXPRESSION; ALIMENTARY LIPEMIA; METABOLIC SYNDROME; CONVERTING-ENZYME; HUMAN OBESITY; INFLAMMATION; MYELOPEROXIDASE; ADIPONECTIN	High-fat diet (HFD)-induced obesity is associated with accumulation of inflammatory cells predominantly in visceral adipose depots [visceral adipose tissue (VAT)] rather than in subcutaneous ones [subcutaneous adipose tissue (SAT)]. The cellular and molecular mechanisms responsible for this phenotypic difference remain poorly understood. Controversy also exists on the overall impact that adipose tissue inflammation has on metabolic health in diet-induced obesity. The endothelium of the microcirculation regulates both the transport of lipids and the trafficking of leukocytes into organ tissue. We hypothesized that the VAT and SAT microcirculations respond differently to postprandial processing of dietary fat. We also tested whether inhibition of endothelial postprandial responses to high-fat meals (HFMs) preserves metabolic health in chronic obesity. We demonstrate that administration of a single HFM or ad libitum access to a HFD for 24 h quickly induces a transient P-selectin- dependent inflammatory phenotype in the VAT but not the SAT microcirculation of lean wild-type mice. Studies in P-selectin-deficient mice confirmed a mechanistic role for P-selectin in the initiation of leukocyte trafficking, myeloperoxidase accumulation, and acute reduction in adiponectin mRNA expression by HFMs. Despite reduced VAT inflammation in response to HFMs, P-selectin-deficient mice still developed glucose intolerance and insulin resistance when chronically fed an HFD. Our data uncover a novel nutrient-sensing role of the vascular endothelium that instigates postprandial VAT inflammation. They also demonstrate that inhibition of this transient postprandial inflammatory response fails to correct metabolic dysfunction in diet-induced obesity.	[Preston, Kyle J.; Rom, Inna; Vrakas, Christine; Landesberg, Gavin; Etwebi, Zienab; Muraoka, Sanae] Temple Univ, Cardiovasc Res Ctr, Philadelphia, PA 19122 USA; [Autieri, Michael; Eguchi, Satoru; Scalia, Rosario] Temple Univ, Dept Physiol, Lewis Katz Sch Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Scalia, R (corresponding author), Temple Univ, Dept Physiol, 3500 N Broad St,MERB Room 1049, Philadelphia, PA 19140 USA.	rscalia@temple.edu			U.S. National Institutes of Health (NIH) [DK59637]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [DK096521, DK111042]; NIH National Heart, Lung, and Blood Institute [HL133248]; American Diabetes Association (ADA) [1-12-BS-180]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL133248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096521, R01DK111042] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Diabetes Association (ADA)(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Serum TNF-alpha analysis and plasma insulin levels were performed by ELISA at Case Western University Mouse Metabolic Phenotyping Center (Cleveland, OH, USA). Free fatty acid (FFA) analysis was performed at the Vanderbilt University Mouse Metabolic Phenotyping Center (Nashville, TN, USA), which is supported by U.S. National Institutes of Health (NIH) Grant DK59637. This study was supported by NIH National Institute of Diabetes and Digestive and Kidney Diseases Grants DK096521 (to R.S.), DK111042 (to R.S. and S.E.), NIH National Heart, Lung, and Blood Institute Grant HL133248 (to S.E.), and American Diabetes Association (ADA) Grant 1-12-BS-180 (to R.S.). The authors declare no conflicts of interest.	Arnoldussen IAC, 2016, J NUTR BIOCHEM, V30, P177, DOI 10.1016/j.jnutbio.2015.12.011; Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Aye MM, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000706; BLAAK EE, 1995, METABOLISM, V44, P183, DOI 10.1016/0026-0495(95)90262-7; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Broijersen A, 1998, ATHEROSCLEROSIS, V137, P107, DOI 10.1016/S0021-9150(97)00260-8; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Davies BSJ, 2010, CELL METAB, V12, P42, DOI 10.1016/j.cmet.2010.04.016; De Pergola G, 2008, NUTR METAB CARDIOVAS, V18, P227, DOI 10.1016/j.numecd.2006.09.010; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Fiorentino L, 2010, HEPATOLOGY, V51, P103, DOI 10.1002/hep.23250; Fu XY, 2003, J BIOL CHEM, V278, P28403, DOI 10.1074/jbc.M304739200; Gallistl S, 2000, BLOOD COAGUL FIBRIN, V11, P755, DOI 10.1097/00001721-200012000-00009; Garcia AG, 2015, DIABETES METAB J, V39, P59, DOI 10.4093/dmj.2015.39.1.59; Graf D, 2014, EUR J NUTR, V53, P211, DOI 10.1007/s00394-013-0518-6; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; He YD, 2016, ENDOCRINE, V51, P456, DOI 10.1007/s12020-015-0741-4; Hirata T, 2000, J EXP MED, V192, P1669, DOI 10.1084/jem.192.11.1669; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Ichimura H, 2003, J CLIN INVEST, V111, P691, DOI 10.1172/JCI200317271; JOHNSON RC, 1995, BLOOD, V86, P1106; JOHNSTON GI, 1989, CELL, V56, P1033, DOI 10.1016/0092-8674(89)90636-3; Junyent M, 2010, NUTR METAB CARDIOVAS, V20, P698, DOI 10.1016/j.numecd.2009.06.011; Kabon B, 2004, ANESTHESIOLOGY, V100, P274, DOI 10.1097/00000542-200402000-00015; Kalsch T, 2007, THROMB RES, V120, P703, DOI 10.1016/j.thromres.2006.12.022; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; Kato H, 2006, ARTERIOSCL THROM VAS, V26, P224, DOI 10.1161/01.ATV.0000194076.84568.81; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Koutsari C, 2011, DIABETES, V60, P2032, DOI 10.2337/db11-0154; Kranendonk MEG, 2015, ATHEROSCLEROSIS, V239, P419, DOI 10.1016/j.atherosclerosis.2015.01.035; Kuo A, 2017, CIRC RES, V120, P1289, DOI 10.1161/CIRCRESAHA.116.310498; Kwon EY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-450; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; Lau D, 2006, PHARMACOL THERAPEUT, V111, P16, DOI 10.1016/j.pharmthera.2005.06.023; Lee MJ, 2013, MOL ASPECTS MED, V34, P1, DOI 10.1016/j.mam.2012.10.001; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Liu ML, 2014, BEST PRACT RES CL EN, V28, P25, DOI 10.1016/j.beem.2013.06.003; LORANT DE, 1995, J CLIN INVEST, V96, P171, DOI 10.1172/JCI118018; LORANT DE, 1993, J CLIN INVEST, V92, P559, DOI 10.1172/JCI116623; Mansuy-Aubert V, 2013, CELL METAB, V17, P534, DOI 10.1016/j.cmet.2013.03.005; MULLANE KM, 1985, J PHARMACOL METHOD, V14, P157, DOI 10.1016/0160-5402(85)90029-4; Nappo F, 2002, J AM COLL CARDIOL, V39, P1145, DOI 10.1016/S0735-1097(02)01741-2; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; Noyan H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130658; Ohtsu H, 2006, ARTERIOSCL THROM VAS, V26, pE133, DOI 10.1161/01.ATV.0000236203.90331.d0; Oike Hideaki, 2014, Curr Nutr Rep, V3, P204; Olza J, 2012, DIABETES CARE, V35, P2373, DOI 10.2337/dc12-0614; Ozeke O, 2011, MED HYPOTHESES, V76, P61, DOI 10.1016/j.mehy.2010.08.030; Pasarica M, 2010, J CLIN ENDOCR METAB, V95, P4052, DOI 10.1210/jc.2009-2377; Pasarica M, 2009, J CLIN ENDOCR METAB, V94, P5155, DOI 10.1210/jc.2009-0947; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Patel MS, 2017, TRANSL RES, V183, P1, DOI [10.1016/j.trs1.2016.11.007, 10.1016/j.trsl.2016.11.007]; Perez-Martinez P, 2014, EUR J CLIN INVEST, V44, P1053, DOI 10.1111/eci.12339; Pruefer D, 1999, GEN PHARMACOL, V33, P487, DOI 10.1016/S0306-3623(99)00045-2; Rao RM, 2007, CIRC RES, V101, P234, DOI 10.1161/CIRCRESAHA.107.151860b; Russo HM, 2010, CIRC RES, V107, P388, DOI 10.1161/CIRCRESAHA.110.218651; SAKO D, 1995, CELL, V83, P323, DOI 10.1016/0092-8674(95)90173-6; Sato C, 2011, DIABETES, V60, P189, DOI 10.2337/db09-1894; Scalia R, 1997, P NATL ACAD SCI USA, V94, P9967, DOI 10.1073/pnas.94.18.9967; Scalia R, 2013, REV ENDOCR METAB DIS, V14, P69, DOI 10.1007/s11154-013-9236-x; Scalia R, 2011, CIRC RES, V108, P1102, DOI 10.1161/CIRCRESAHA.110.229393; Schneider DJ, 2009, DIABETES CARE, V32, P944, DOI 10.2337/dc08-1308; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Sell H, 2012, NAT REV ENDOCRINOL, V8, P709, DOI 10.1038/nrendo.2012.114; Serino M, 2007, DIABETES, V56, P2541, DOI 10.2337/db07-0360; Shore SA, 2006, J ALLERGY CLIN IMMUN, V118, P389, DOI 10.1016/j.jaci.2006.04.021; Stadtmann A, 2013, J EXP MED, V210, P2171, DOI 10.1084/jem.20130664; Stalker TJ, 2005, DIABETES, V54, P1132, DOI 10.2337/diabetes.54.4.1132; Strzepa A, 2017, CELL IMMUNOL, V317, P1, DOI 10.1016/j.cellimm.2017.05.002; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Takano M, 2002, AM J PHYSIOL-HEART C, V283, pH2054, DOI 10.1152/ajpheart.01001.2001; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; van Oostrom AJHHM, 2003, J LIPID RES, V44, P576, DOI 10.1194/jlr.M200419-JLR200; Wang LM, 2009, J LIPID RES, V50, P204, DOI 10.1194/jlr.M700505-JLR200; Wang QL, 2014, DIABETES, V63, P4172, DOI 10.2337/db14-0026; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu F, 2012, ENDOCRINOLOGY, V153, P1706, DOI 10.1210/en.2011-1667; Xu HY, 2002, DIABETES, V51, P1876, DOI 10.2337/diabetes.51.6.1876; Yamauchi T, 2008, INT J OBESITY, V32, pS13, DOI 10.1038/ijo.2008.233; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Zheng YF, 2002, J BIOL CHEM, V277, P42463, DOI 10.1074/jbc.M207459200	87	7	7	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11993	12007		10.1096/fj.201802637RR	http://dx.doi.org/10.1096/fj.201802637RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31393790	Green Published			2022-12-26	WOS:000507461600031
J	Hu, X; Xiang, DX; Xie, Y; Tao, LW; Zhang, Y; Jin, Y; Pinello, L; Wan, YZ; Yuan, GC; Li, Z				Hu, Xin; Xiang, Dongxi; Xie, Ying; Tao, Luwei; Zhang, Yu; Jin, Yue; Pinello, Luca; Wan, Youzhong; Yuan, Guo-Cheng; Li, Zhe			LSD1 suppresses invasion, migration and metastasis of luminal breast cancer cells via activation of GATA3 and repression of TRIM37 expression	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MOLECULAR PORTRAITS; MAMMARY-GLAND; DIFFERENTIATION; DEMETHYLATION; INHIBITION; PROGRAMS; TARGETS; GENOME; EMT	LSD1 (KDM1A) is a histone demethylase that plays both oncogenic and tumor suppressor roles in breast cancer. However, the exact contexts under which it plays these opposite functions remain largely elusive. By characterizing its role in luminal breast epithelial cells, here we show that inhibition of LSD1 by both genetic and pharmacological approaches increases their invasion and migration, whereas its inhibition by genetic approach, but not by pharmacological approach, impairs their proliferation/survival. Induced loss of LSD1 in luminal cells in a mouse model of luminal breast cancer, MMTV-PyMT, leads to a profound increase in lung metastasis. Mechanistically, LSD1 interacts with GATA3, a key luminal-specific transcription factor (TF), and their common target genes are highly related to breast cancer. LSD1 positively regulates GATA3 expression. It also represses expression of TRIM37, a breast epithelial oncogene encoding a histone H2A ubiquitin ligase, and ELF5, a key TF gene for luminal progenitors and alveolar luminal cells. LSD1-loss also leads to reduced expression of several cell-cell adhesion genes (e.g., CDH1, VCL, CTNNA1), possibly via TRIM37-upregulation and subsequently TRIM37-mediated repression. Collectively, our data suggest LSD1 largely plays a tumor suppressor role in luminal breast cancer and the oncogenic program associated with LSD1-inhibition may be suppressed via TRIM37-inhibition.	[Hu, Xin; Zhang, Yu; Jin, Yue; Wan, Youzhong] Jilin Univ, Sch Life Sci, Changchun, Jilin, Peoples R China; [Hu, Xin; Xiang, Dongxi; Xie, Ying; Tao, Luwei; Li, Zhe] Harvard Med Sch, Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Hu, Xin; Xiang, Dongxi; Xie, Ying; Tao, Luwei; Li, Zhe] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Pinello, Luca; Yuan, Guo-Cheng] Harvard Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostatist & Computat Biol, Boston, MA 02115 USA	Jilin University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health	Li, Z (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA.; Li, Z (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.	zli4@rics.bwh.harvard.edu		HU, XIN/0000-0002-5105-8929; Li, Zhe/0000-0002-3434-0885	U.S. Department of Defense [W81XWH-15-1-0100]; NCI/NIH [SG-0062-10, CA126980, CA222560]; Harvard Stem Cell Institute [DP-0137-13-00]; Brigham and Women's Hospital; National Natural Science Foundation of China [NSFC31471356]; Jilin Province Science and Technology Development Project [20180101240JC, 20190701005GH]; NATIONAL CANCER INSTITUTE [R01CA222560] Funding Source: NIH RePORTER	U.S. Department of Defense(United States Department of Defense); NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Harvard Stem Cell Institute; Brigham and Women's Hospital; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin Province Science and Technology Development Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Stuart Orkin for the Lsd1<SUP>L/L</SUP> conditional knockout mouse line, and Drs. Alan Cantor, Hui Huang, and Andrew Woo (Boston Children's Hospital) for help with gel filtration chromatography. This research was supported by Breakthrough Award from U.S. Department of Defense (W81XWH-15-1-0100), Pathway-to-Independence K99/R00 grant (CA126980) and R01 grant (CA222560) from NCI/NIH, Seed Grant (SG-0062-10) and Cancer Program Pilot Grant (DP-0137-13-00) from Harvard Stem Cell Institute, and Start-up Fund from Brigham and Women's Hospital to ZL. This work was also supported by National Natural Science Foundation of China (NSFC31471356) and Jilin Province Science and Technology Development Project (20180101240JC, 20190701005GH) to XH.	Ahuja N, 2014, J CLIN INVEST, V124, P56, DOI 10.1172/JCI69736; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Asselin-Labat ML, 2011, MOL CELL BIOL, V31, P4609, DOI 10.1128/MCB.05766-11; Benner C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003906; Bhatnagar S, 2014, NATURE, V516, P116, DOI 10.1038/nature13955; Choi HJ, 2015, EMBO REP, V16, P1288, DOI 10.15252/embr.201540244; Choi YS, 2009, DEV BIOL, V329, P227, DOI 10.1016/j.ydbio.2009.02.032; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Feng JX, 2016, BREAST CANCER RES TR, V159, P443, DOI 10.1007/s10549-016-3959-9; Gallego-Ortega D, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002330; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Hu X, 2009, P NATL ACAD SCI USA, V106, P10141, DOI 10.1073/pnas.0900437106; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang Y, 2012, BREAST CANCER RES TR, V131, P777, DOI 10.1007/s10549-011-1480-8; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee JY, 2014, ONCOGENE, V33, P1325, DOI 10.1038/onc.2013.53; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Li Q, 2011, CANCER RES, V71, P6899, DOI 10.1158/0008-5472.CAN-11-1523; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Lin YW, 2010, EMBO J, V29, P1803, DOI 10.1038/emboj.2010.63; Lynch JT, 2012, EXPERT OPIN THER TAR, V16, P1239, DOI 10.1517/14728222.2012.722206; Maes T, 2018, CANCER CELL, V33, P495, DOI 10.1016/j.ccell.2018.02.002; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Mould DP, 2015, MED RES REV, V35, P586, DOI 10.1002/med.21334; Oakes SR, 2008, GENE DEV, V22, P581, DOI 10.1101/gad.1614608; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Serce N, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-13; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Si WZ, 2015, CANCER CELL, V27, P822, DOI 10.1016/j.ccell.2015.04.011; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tao LW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14431; Tao LW, 2015, STEM CELL REP, V5, P60, DOI 10.1016/j.stemcr.2015.05.014; Tao LW, 2014, STEM CELL REP, V2, P770, DOI 10.1016/j.stemcr.2014.04.004; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Woo AJ, 2008, MOL CELL BIOL, V28, P2675, DOI 10.1128/MCB.01945-07; Wu YD, 2013, CELL REP, V5, P224, DOI 10.1016/j.celrep.2013.08.030; Wu ZQ, 2012, P NATL ACAD SCI USA, V109, P16654, DOI 10.1073/pnas.1205822109; Yan W, 2010, J BIOL CHEM, V285, P14042, DOI 10.1074/jbc.M110.105262; Zhang XM, 2013, CELL REP, V5, P445, DOI 10.1016/j.celrep.2013.09.018; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	53	35	35	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 31	2019	38	44					7017	7034		10.1038/s41388-019-0923-2	http://dx.doi.org/10.1038/s41388-019-0923-2			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JJ1AO	31409898	Green Accepted			2022-12-26	WOS:000493892900005
J	Siddiqui, S; Brooks, MB; Malik, AA; Fuad, J; Nazish, A; Bano, S; Becerra, MC; Hussain, H				Siddiqui, Sara; Brooks, Meredith B.; Malik, Amyn A.; Fuad, Junaid; Nazish, Ahsana; Bano, Safia; Becerra, Mercedes C.; Hussain, Hamidah			Evaluation of GenoType MTBDRp/us for the detection of drug-resistant Mycobacterium tuberculosis on isolates from Karachi, Pakistan	PLOS ONE			English	Article							ETHIONAMIDE; MUTATIONS; RIFAMPIN; ASSAY; KATG	Objective To compare the diagnostic performance of the GenoType MRBDRplus assay with the gold standard phenotypic drug susceptibility testing in the detection of drug resistance among culture isolates obtained from patients in Karachi, Pakistan. Design Mycobacterium tuberculosis isolates were obtained from 96 consecutive tuberculosis patients found to have resistance to isoniazid from two health centers in Karachi (January-November 2017). Isolates were tested for drug resistance against rifampin and isoniazid using the MTBDRplus assay. Results were compared with conventional drug-susceptibility testing and the frequency of specific mutations were reported. Results The MTBDRplus assay had a sensitivity for rifampin resistance of 98.8% (95% CI: 93.4-100) and for isoniazid resistance of 90.6% (95% CI: 83.0-95.6). The MTBDRplus assay showed mutations in rpoB in 81 of the 96 (84.4%) isolates. Of the 87 isolates showing resistance to isoniazid via the MTBDRplus assay, 71 (74.0%) isolates had mutations in the katG gene only, 15 (15.6%) isolates had mutations in the inhA promoter region, and 1 (1.0%) showed mutations in both genes. Conclusion The GenoType MTBDRplus assay in Pakistan can identify subgroups at high-risk of having isolates with mutations in the katG and/or inhA genes. Understanding the local burden of these mutations have implications for local diagnostic and treatment guidelines.	[Siddiqui, Sara; Malik, Amyn A.; Fuad, Junaid; Nazish, Ahsana] Global Hlth Directorate, Indus Hlth Network, Karachi, Sindh, Pakistan; [Brooks, Meredith B.; Becerra, Mercedes C.] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Malik, Amyn A.; Hussain, Hamidah] Interact Res & Dev, Karachi, Sindh, Pakistan; [Malik, Amyn A.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Bano, Safia] Indus Hosp, Indus Hlth Network, TB Lab, Karachi, Sindh, Pakistan	Harvard University; Harvard Medical School; Emory University; Rollins School Public Health	Siddiqui, S (corresponding author), Global Hlth Directorate, Indus Hlth Network, Karachi, Sindh, Pakistan.	Sara.Siddiqui@ghd.ihn.org.pk	Malik, Amyn A./AAF-4883-2021	Malik, Amyn A./0000-0003-4875-9916; Hussain, Hamidah/0000-0002-6585-9815; Brooks, Meredith/0000-0001-8431-5517	Harvard Medical School Center for Global Health Delivery Dubai	Harvard Medical School Center for Global Health Delivery Dubai	This work was funded by the Harvard Medical School Center for Global Health Delivery Dubai (to MCB and HH), https://ghd-dubai.hms.harvard.edu/.The funder did not play a role in the study design, data collection, analysis, or decision to publish this manuscript. The funder organized a Scientific Manuscript Writing Workshop in April 2018, at which the manuscript was drafted and prepared.	Akinci P, 2016, J CLIN MICROBIOL, V44, P2338; Ali A, 2011, ANTIMICROB AGENTS CH, V55, P5654, DOI 10.1128/AAC.05101-11; [Anonymous], STAND OP PROC SOP SP; [Anonymous], 2011, BBL MGIT MYC GROWTH; Bollela VR, 2016, INT J TUBERC LUNG D, V20, P1099, DOI 10.5588/ijtld.15.0864; Bwanga F, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-67; Gupta A, 2013, J CLIN LAB ANAL, V27, P31, DOI 10.1002/jcla.21558; Hain Lifescience GmbH, 2012, GENOTYPE MTBDRPLUS V; Hillemann D, 2007, J CLIN MICROBIOL, V45, P2635, DOI 10.1128/JCM.00521-07; Javed H, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02265; Katiyar SK, 2008, INT J TUBERC LUNG D, V12, P139; Machado D, 2013, J ANTIMICROB CHEMOTH, V68, P1728, DOI 10.1093/jac/dkt090; Madhuri K, 2015, J GLOB INFECT DIS, V7, P60, DOI 10.4103/0974-777X.157237; Piersimoni C, 2006, J CLIN MICROBIOL, V44, P20, DOI 10.1128/JCM.44.1.20-28.2006; Schaaf HS, 2007, EUR J CLIN MICROBIOL, V26, P203, DOI 10.1007/s10096-007-0257-9; Telenti A, 1997, J CLIN MICROBIOL, V35, P719, DOI 10.1128/JCM.35.3.719-723.1997; Unissa AN, 2016, INFECT GENET EVOL, V45, P474, DOI 10.1016/j.meegid.2016.09.004; Vadwai V, 2013, INT J TUBERC LUNG D, V17, P129, DOI 10.5588/ijtld.12.0511; Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807	20	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0221485	10.1371/journal.pone.0221485	http://dx.doi.org/10.1371/journal.pone.0221485			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5MK	31425565	Green Published, gold, Green Submitted			2022-12-26	WOS:000485022400047
J	Akpa, CA; Kleo, K; Lenze, D; Oker, E; Dimitrova, L; Hummel, M				Akpa, Chidimma Agatha; Kleo, Karsten; Lenze, Dido; Oker, Elisabeth; Dimitrova, Lora; Hummel, Michael			DZNep-mediated apoptosis in B-cell lymphoma is independent of the lymphoma type, EZH2 mutation status and MYC, BCL2 or BCL6 translocations	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE EZH2; COMBINED EPIGENETIC THERAPY; OF-FUNCTION MUTATION; INHIBITOR 3-DEAZANEPLANOCIN; SOMATIC MUTATIONS; DRUG-RESISTANCE; TARGETING EZH2; LYSINE 27; CANCER; GENES	Enhancer of zeste homolog 2 (EZH2) tri-methylates histone 3 at position lysine 27 (H3K27me3). Overexpression and gain-of-function mutations in EZH2 are regarded as oncogenic drivers in lymphoma and other malignancies due to the silencing of tumor suppressors and differentiation genes. EZH2 inhibition is sought to represent a good strategy for tumor therapy. In this study, we treated Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) cell lines with 3-deazaneplanocin-A (DZNep), an indirect EZH2 inhibitor which possesses anticancer properties both in-vitro and in-vivo. We aimed to address the impact of the lymphoma type, EZH2 mutation status, as well as MYC, BCL2 and BCL6 translocations on the sensitivity of the lymphoma cell lines to DZNep-mediated apoptosis. We show that DZNep inhibits proliferation and induces apoptosis of these cell lines independent of the type of lymphoma, the EZH2 mutation status and the MYC, BCL2 and BCL6 rearrangement status. Furthermore, DZNep induced a much stronger apoptosis in majority of these cell lines at a lower concentration, and within a shorter period when compared with EPZ-6438, a direct EZH2 inhibitor currently in phase II clinical trials. Apoptosis induction by DZNep was both concentration-dependent and time-dependent, and was associated with the inhibition of EZH2 and subsequent downregulation of H3K27me3 in DZNep-sensitive cell lines. Although EZH2, MYC, BCL2 and BCL6 are important prognostic biomarkers for lymphomas, our study shows that they poorly influence the sensitivity of lymphoma cell lines to DZNep-mediated apoptosis.	[Akpa, Chidimma Agatha; Kleo, Karsten; Lenze, Dido; Oker, Elisabeth; Dimitrova, Lora; Hummel, Michael] Charite, Inst Pathol, Dept Expt Hematopathol, Berlin, Germany; [Akpa, Chidimma Agatha] Charite, Berlin Sch Integrat Oncol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Akpa, CA (corresponding author), Charite, Inst Pathol, Dept Expt Hematopathol, Berlin, Germany.; Akpa, CA (corresponding author), Charite, Berlin Sch Integrat Oncol, Berlin, Germany.	chidimma.akpa@charite.de		Hummel, Michael/0000-0001-6717-605X	Berlin School of Integrative Onclology, Berlin, Germany	Berlin School of Integrative Onclology, Berlin, Germany	CAA was funded by the Berlin School of Integrative Onclology, Berlin, Germany. URL: https://www.bsio-cancerschool.de/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; Bodor C, 2013, BLOOD, V122, P3165, DOI 10.1182/blood-2013-04-496893; Brach D, 2017, MOL CANCER THER, V16, P2586, DOI 10.1158/1535-7163.MCT-16-0840; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Bradley WD, 2014, CHEM BIOL, V21, P1463, DOI 10.1016/j.chembiol.2014.09.017; Chang CJ, 2012, BRIT J CANCER, V106, P243, DOI 10.1038/bjc.2011.551; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Crea F, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-40; Deb G, 2014, MOL CANCER RES, V12, P639, DOI 10.1158/1541-7786.MCR-13-0546; Drexler HG, 2016, LEUKEMIA LYMPHOMA, V57, P1015, DOI 10.3109/10428194.2015.1108414; Fiskus W, 2012, CLIN CANCER RES, V18, P6227, DOI 10.1158/1078-0432.CCR-12-0873; Fiskus W, 2009, BLOOD, V114, P2733, DOI 10.1182/blood-2009-03-213496; Gao SB, 2014, MOL CANCER RES, V12, P1388, DOI 10.1158/1541-7786.MCR-14-0034; Garraway LA, 2012, CANCER DISCOV, V2, P214, DOI 10.1158/2159-8290.CD-12-0012; GIRARD N, 2014, PLOS ONE, V9, P2, DOI DOI 10.1182/BLOOD-2016-02-636316; Gonda Amber, 2019, MOL CANCER RES, V17, P337, DOI [10.1158/1541-7786.MCR-18-0891, DOI 10.1158/1541-7786.MCR-18-0891, 10.1158/1541-7786.MCR-16-0141, DOI 10.1158/1541-7786.MCR-13-0546]; Herviou L, 2016, ONCOTARGET, V7, P2284, DOI 10.18632/oncotarget.6198; Horn H, 2015, LEUKEMIA, V29, P1564, DOI 10.1038/leu.2015.43; Horn H, 2013, BLOOD, V121, P2253, DOI 10.1182/blood-2012-06-435842; Housman G, 2014, CANCERS, V6, P1769, DOI 10.3390/cancers6031769; HTTPS, MCR, DOI DOI 10.1158/1541-7786.MCR-13-0546; HTTPS, MCR, DOI DOI 10.1158/1541-7786.MCR-13-0546; HTTPS, MCR, DOI DOI 10.1158/1541-7786.MCR-13-0546; HTTPS, MCR, DOI DOI 10.1158/1541-7786.MCR-13-0546; HTTPS, MCR, DOI DOI 10.1158/1541-7786.MCR-13-0546; HTTPS, MCR, DOI DOI 10.1158/1541-7786.MCR-13-0546; Kikuchi J, 2012, LUNG CANCER, V78, P138, DOI 10.1016/j.lungcan.2012.08.003; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Knutson SK, 2014, MOL CANCER THER, V13, P842, DOI 10.1158/1535-7163.MCT-13-0773; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Konze KD, 2013, ACS CHEM BIOL, V8, P1324, DOI [10.1021/cb400133J, 10.1021/cb400133j]; Li CH, 2015, CURR PROTEIN PEPT SC, V16, P559, DOI 10.2174/1389203716666150409100233; Liu Y, 2017, HUM PATHOL, V64, P213, DOI 10.1016/j.humpath.2017.04.011; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Madhavan Subha, 2009, MOL CANCER RES, V7, P157, DOI [10.1158/1541-7786.MCR-08-0435, DOI 10.1158/1541-7786.MCR-08-0435]; Madhavan Subha, 2009, MOL CANCER RES, V7, P157, DOI [10.1158/1541-7786.MCR-08-0435, DOI 10.1158/1541-7786.MCR-08-0435, DOI 10.1158/1541-7786.MCR-13-0546]; Majer CR, 2012, FEBS LETT, V586, P3448, DOI 10.1016/j.febslet.2012.07.066; Marchesi I, 2016, WORLD J CLIN ONCOL, V7, P135, DOI 10.5306/wjco.v7.i2.135; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; McCabe MT, 2012, P NATL ACAD SCI USA, V109, P2989, DOI 10.1073/pnas.1116418109; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Nakagawa S, 2014, ONCOL REP, V31, P983, DOI 10.3892/or.2013.2922; O'Meara MM, 2012, CHROMOSOMA, V121, P221, DOI 10.1007/s00412-012-0361-1; OFFIT K, 1994, NEW ENGL J MED, V331, P74, DOI 10.1056/NEJM199407143310202; Pagel J, 2018, CL LYMPH MYELOM LEUK, V18, pS278, DOI 10.1016/j.clml.2018.07.208; Quentmeier H, 2013, LEUKEMIA, V27, P1155, DOI 10.1038/leu.2012.358; RYAN RJH, 2011, PLOS ONE, V6, DOI DOI 10.1371/J0URNAL.P0NE.0028585; Salaverria I, 2014, BLOOD, V123, P1187, DOI 10.1182/blood-2013-06-507996; Sesques P, 2017, BLOOD, V129, P280, DOI 10.1182/blood-2016-02-636316; Sha MQ, 2015, ACTA PHARM SIN B, V5, P188, DOI 10.1016/j.apsb.2015.01.011; Shen C, 2015, CURR OPIN ONCOL, V27, P57, DOI 10.1097/CCO.0000000000000151; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Sun F, 2015, EUR J PHARM SCI, V77, P290, DOI 10.1016/j.ejps.2015.06.021; Sun RF, 2016, MODERN PATHOL, V29, P1118, DOI 10.1038/modpathol.2016.92; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; To Kenneth K.W., 2008, MOL CANCER RES, V6, P151, DOI [10.1158/1541-7786.MCR-07-0175, DOI 10.1158/1541-7786.MCR-07-0175, DOI 10.1158/1541-7786.MCR-13-0546]; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Wang GG, 2015, BLOOD, V125, P1217, DOI 10.1182/blood-2014-10-606822; Yamaguchi H, 2014, CANCER RES TREAT, V46, P209, DOI 10.4143/crt.2014.46.3.209; Yan JL, 2013, BLOOD, V121, P4512, DOI 10.1182/blood-2012-08-450494; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; Zhou JB, 2011, BLOOD, V118, P2830, DOI 10.1182/blood-2010-07-294827	67	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2019	14	8							e0220681	10.1371/journal.pone.0220681	http://dx.doi.org/10.1371/journal.pone.0220681			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5LL	31419226	Green Published, Green Submitted, gold			2022-12-26	WOS:000485019900014
J	Gele, AA; Musse, FK; Qureshi, S				Gele, Abdi A.; Musse, Fathia K.; Qureshi, Samera			Unmet needs for contraception: A comparative study among Somali immigrant women in Oslo and their original population in Mogadishu, Somalia	PLOS ONE			English	Article							INDUCED-ABORTION; NATIVE WOMEN; ATTITUDES; PERCEPTIONS	Introduction Unmet need for contraception is defined as the proportion of fertile individuals who do not use contraceptives despite wanting to space or limit their childbearing. Studies show that immigrant women in Europe, have higher rates of unintended pregnancies and abortion than native born women. Somali women, have the highest fertility rate in Norway which is much higher than the total fertility rate in Norway (4.0 vs. 1.7). This study investigates the unmet need for contraception among Somali immigrant women in Oslo, Norway, compared to their original population in Mogadishu, Somalia. Methods A community based, cross sectional study was carried out among Somali women in Oslo (N = 228) and Mogadishu (N = 229) from May to December 2018. Pre-structured questionnaires were given to women who were recruited through snow-ball sampling. Data was analyzed using SPSS version 25. We performed a chi-square test for the analyses of categorical variables, a t-test for continuous variables and multivariate logistic analysis to determine the association between exposure and outcome variable. Results The unmet needs for contraception among Somali women in Oslo was 20.2%, which is similar to unmet needs for contraception of women in many sub-Saharan African countries. The unmet needs for Somali immigrant women in Oslo (20.2) is two times lower than that of their original population in Somalia (48.5). The odds of having unmet needs for contraception was nearly, three times higher among Somali women in Mogadishu compared to those in Oslo (OR: 2.6, CI: 2.56-7.68). The mean intended fertility was 4 among the women in Oslo and 10.8 in Mogadishu. About 13.4% of study participants in Oslo and 86.6% of those in Mogadishu consider modern contraception irrelevant for women's health. Nearly 50% of women in both places had unintended childbirth on one or more occasion. Conclusion The study results show the prevalence of unmet needs for contraception among Somali immigrant women Oslo, is 4 fold higher than that of Norway (20.2 vs 5.5). Information Education Communication to both men and women, may reduce the high unmet need for contraception and also improve partner communication on family planning among Somali immigrants in Oslo. Training primary health providers for provision of tailored information about the modern contraception to immigrant women, which includes an individualized counselling may improve partners' knowledge, demand and uptake of modern contraception.	[Gele, Abdi A.] Norwegian Inst Publ Hlth, Dept Hlth Serv Res, Oslo, Norway; [Musse, Fathia K.] Oslo Municipal, Dept Family Counselling, Oslo, Norway; [Qureshi, Samera] Norwegian Inst Publ Hlth, Dept Hlth Serv Res, Oslo, Norway; [Qureshi, Samera] Nydalen, Oslo, Norway	Norwegian Institute of Public Health (NIPH); Norwegian Institute of Public Health (NIPH)	Gele, AA (corresponding author), Norwegian Inst Publ Hlth, Dept Hlth Serv Res, Oslo, Norway.	abdi.gele@fhi.no		Gele, Abdi A./0000-0002-3616-6411	Norwegian Extrastiftelsen [45523]	Norwegian Extrastiftelsen	This work was supported by Norwegian Extrastiftelsen (45523 to AG). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraha TH, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0632-2; Alkema L, 2013, LANCET, V381, P1642, DOI 10.1016/S0140-6736(12)62204-1; Alvarez-Nieto C, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0071-2; Bruckner TA, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1397-2; Cates W, 2010, CONTRACEPTION, V81, P460, DOI 10.1016/j.contraception.2010.01.002; Comerasamy Huguette, 2003, J Obstet Gynaecol, V23, P412, DOI 10.1080/01443610310001209342; Cox CM, 2019, PERSPECT SEX REPRO H, V51, P63, DOI 10.1363/psrh.12100; Degni F, 2006, EUR J CONTRACEP REPR, V11, P190, DOI 10.1080/13625180600557605; Egeh AA, 2019, SEX REPROD HEALTHC, V20, P27, DOI 10.1016/j.srhc.2019.02.003; Eskild Anne, 2002, Tidsskr Nor Laegeforen, V122, P1355; Fisher William, 2004, J Obstet Gynaecol Can, V26, P580; Gele A, 2019, ONLINE JOURNAL OF CO; Gele AA, 2012, INT J WOMENS HEALTH, V4, P7, DOI 10.2147/IJWH.S27577; Goth UGS, 2011, EUR J GEN PRACT, V17, P28, DOI 10.3109/13814788.2010.525632; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gure F, 2016, STUD FAMILY PLANN, V47, P69, DOI 10.1111/j.1728-4465.2016.00047.x; Helstrom L, 2003, SCAND J PUBLIC HEALT, V31, P405, DOI 10.1080/14034940210165181; Kingori C, 2018, ETHNIC HEALTH, V23, P339, DOI 10.1080/13557858.2016.1263285; Kiura Annet Wanjira, 2014, CONSTRAINED AGENCY O, V18; Koch E, 2014, PUBLIC HEALTH, V128, P384, DOI 10.1016/j.puhe.2014.01.008; Leeners B, 2017, EUR J CONTRACEP REPR, V22, P38, DOI 10.1080/13625187.2016.1258053; Link CF, 2011, STUD FAMILY PLANN, V42, P83, DOI 10.1111/j.1728-4465.2011.00268.x; Nketiah-Amponsah Edward, 2012, Afr J Reprod Health, V16, P155; Nyarko SH, 2019, J PREGNANCY, V2019, DOI 10.1155/2019/2920491; Omland G, 2014, BJOG-INT J OBSTET GY, V121, P1221, DOI 10.1111/1471-0528.12906; Ontiri S, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16091543; Prata N, 2017, AFR J REPROD HEALTH, V21, P35, DOI 10.29063/ajrh2017/v21i2.5; Raben LAD, 2018, FAM PRACT, V35, P468, DOI 10.1093/fampra/cmx133; Rasch V, 2008, EUR J PUBLIC HEALTH, V18, P144, DOI 10.1093/eurpub/ckm112; Rasch V, 2007, HUM REPROD, V22, P1320, DOI 10.1093/humrep/dem012; Sedgh G, 2014, STUD FAMILY PLANN, V45, P301, DOI 10.1111/j.1728-4465.2014.00393.x; Statistics Norway, 2000, SAMLET FRUKTBARHETST; The WHO's original source is Guttmacher Institute, 2017, ADDING IT UP THE COS; The World Bank, 2019, FERTILITY RATE TOTAL; Vangen S, AN INTERNATIONAL JOU, V115; Wiebe E, 2013, CAN FAM PHYSICIAN, V59, pE451; Wiebe ER, 2006, CONTRACEPTION, V73, P623, DOI 10.1016/j.contraception.2006.02.001; World Health Organization, 2018, UNMET NEED FOR FAMIL; World Health Organization, 2016, ACTION PLAN FOR SEXU	39	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220783	10.1371/journal.pone.0220783	http://dx.doi.org/10.1371/journal.pone.0220783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5KK	31415575	Green Published, Green Submitted, gold			2022-12-26	WOS:000485017200032
J	Salobrar-Garcia, E; de Hoz, R; Ramirez, AI; Lopez-Cuenca, I; Rojas, P; Vazirani, R; Amarante, C; Yubero, R; Gil, P; Pinazo-Duran, MD; Salazar, JJ; Ramirez, JM				Salobrar-Garcia, Elena; de Hoz, Rosa; Ramirez, Ana I.; Lopez-Cuenca, Ines; Rojas, Pilar; Vazirani, Ravi; Amarante, Carla; Yubero, Raquel; Gil, Pedro; Pinazo-Duran, Maria D.; Salazar, Juan J.; Ramirez, Jose M.			Changes in visual function and retinal structure in the progression of Alzheimer's disease	PLOS ONE			English	Article							NERVE-FIBER LAYER; MILD COGNITIVE IMPAIRMENT; OPTICAL COHERENCE TOMOGRAPHY; CONTRAST SENSITIVITY; COLOR DISCRIMINATION; NEURITIC PLAQUES; THICKNESS; DYSFUNCTION; DEMENTIA; ABNORMALITIES	Background Alzheimer's Disease (AD) can cause degeneration in the retina and optic nerve either directly, as a result of amyloid beta deposits, or secondarily, as a result of the degradation of the visual cortex. These effects raise the possibility that tracking ophthalmologic changes in the retina can be used to assess neurodegeneration in AD. This study aimed to detect retinal changes and associated functional changes in three groups of patients consisting of AD patients with mild disease, AD patients with moderate disease and healthy controls by using non-invasive psychophysical ophthalmological tests and optical coherence tomography (OCT). Methods We included 39 patients with mild AD, 21 patients with moderate AD and 40 age-matched healthy controls. Both patients and controls were ophthalmologically healthy. Visual acuity, contrast sensitivity, colour perception, visual integration, and choroidal thicknesses were measured. In addition, OCT and OCT angiography (OCTA) were applied. Findings Visual acuity, contrast sensitivity, colour perception, and visual integration were significantly lower in AD patients than in healthy controls. Compared to healthy controls, macular thinning in the central region was significant in the mild AD patients, while macular thickening in the central region was found in the moderate AD group. The analysis of macular layers revealed significant thinning of the retinal nerve fibre layer, the ganglion cell layer and the outer plexiform layer in AD patients relative to controls. Conversely, significant thickening was observed in the outer nuclear layer of the patients. However, mild AD was associated with significant thinning of the subfovea and the nasal and inferior sectors of the choroid. Significant superonasal and inferotemporal peripapillary thinning was observed in patients with moderate disease. Conclusions The first changes in the mild AD patients appear in the psychophysical tests and in the central macula with a decrease in the central retinal thickness. When there was a disease progression to moderate AD, psychophysical tests remained stable with respect to the decrease in mild AD, but significant thinning in the peripapillary retina and thickening in the central retina appeared. The presence of AD is best indicated based on contrast sensitivity.	[Salobrar-Garcia, Elena; de Hoz, Rosa; Ramirez, Ana I.; Lopez-Cuenca, Ines; Rojas, Pilar; Vazirani, Ravi; Amarante, Carla; Salazar, Juan J.; Ramirez, Jose M.] Univ Complutense Madrid, Fac Med, Inst Invest Oftalmol Ramon Castroviejo, Madrid, Spain; [Salobrar-Garcia, Elena; Lopez-Cuenca, Ines; Ramirez, Jose M.] Univ Complutense Madrid, Fac Med, Dept Inmunol Oftalmol & ORL, Madrid, Spain; [de Hoz, Rosa; Ramirez, Ana I.; Salazar, Juan J.] Univ Complutense Madrid, Fac Opt & Optometria, Dept Inmunol Oftalmol & ORL, Madrid, Spain; [Rojas, Pilar] Hosp Univ Gregorio Maranon, Serv Oftalmol, Madrid, Spain; [Yubero, Raquel; Gil, Pedro] Hosp Clin San Carlos, Serv Geriatr, Unidad Memoria, Madrid, Spain; [Pinazo-Duran, Maria D.] Unidad Invest Oftalmol Santiago Grisolia FISABIO, Valencia, Spain; [Pinazo-Duran, Maria D.] Univ Valencia, Fac Med & Odontol, Grp Oftalmobiol Celular & Mol, Valencia, Spain	Complutense University of Madrid; Complutense University of Madrid; Complutense University of Madrid; General University Gregorio Maranon Hospital; Hospital Clinico San Carlos; University of Valencia	Salazar, JJ; Ramirez, JM (corresponding author), Univ Complutense Madrid, Fac Med, Inst Invest Oftalmol Ramon Castroviejo, Madrid, Spain.; Ramirez, JM (corresponding author), Univ Complutense Madrid, Fac Med, Dept Inmunol Oftalmol & ORL, Madrid, Spain.; Salazar, JJ (corresponding author), Univ Complutense Madrid, Fac Opt & Optometria, Dept Inmunol Oftalmol & ORL, Madrid, Spain.	jjsalaza@ucm.es; ramirezs@med.ucm.es	Ramírez, Ana I/ABF-4789-2021; Salobrar-Garcia, Elena/I-6908-2019; Salazar, Juan J/L-6887-2014; De Hoz, Rosa/ABF-9295-2020; LOZANO, MARIA PILAR ROJAS/AAD-9011-2021	Ramírez, Ana I/0000-0002-2656-4723; Salobrar-Garcia, Elena/0000-0001-5939-5551; Salazar, Juan J/0000-0001-5480-5902; De Hoz, Rosa/0000-0002-1581-087X; LOZANO, MARIA PILAR ROJAS/0000-0001-9137-2261; Amarante Cuadrado, Carla/0000-0002-0884-5716; VAZIRANI BALLESTEROS, RAVI/0000-0002-7337-0593; Pinazo-Duran, Maria Dolores/0000-0002-0823-8836	Ophthalmological Network OFTARED of the Institute of Health of Carlos III of the Spanish Ministry of Economy [RD16/0008/0005, RD16/0008/0022]; Spanish Ministry of Education, Culture and Sport	Ophthalmological Network OFTARED of the Institute of Health of Carlos III of the Spanish Ministry of Economy(Spanish Government); Spanish Ministry of Education, Culture and Sport(Spanish Government)	This work are supported by the Ophthalmological Network OFTARED of the Institute of Health of Carlos III of the Spanish Ministry of Economy (grant RD16/0008/0005 to ES-G, RdH, AIR, JJS, and JMR; and grant RD16/0008/0022 to MDP-D; Enfermedades oculares: "Prevencion, deteccion precoz, tratamiento y rehabilitacion de las patologias oculares"). ES-G was supported by a Predoctoral Fellowship (FPU) from the Spanish Ministry of Education, Culture and Sport. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberca Serrano R, 2010, MADRID; Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; Baker D R, 1997, J Am Optom Assoc, V68, P483; BARM A, 2003, J COGNITIVE NEUROSCI, V15, P600; BASSI CJ, 1993, OPTOMETRY VISION SCI, V70, P809, DOI 10.1097/00006324-199310000-00005; Bayhan HA, 2015, CLIN EXP OPHTHALMOL, V43, P145, DOI 10.1111/ceo.12386; Berisha F, 2007, INVEST OPHTH VIS SCI, V48, P2285, DOI 10.1167/iovs.06-1029; Bernardin F, 2017, NEUROPSYCHOLOGIA, V99, P128, DOI 10.1016/j.neuropsychologia.2017.03.002; Berry SM, 2017, A COMPARISON BETWEEN; BOWEN DM, 1982, J NEUROL SCI, V57, P191, DOI 10.1016/0022-510X(82)90026-0; BREWER AA, CHANGES IN VISUAL CO, P46079, DOI DOI 10.1167/IOVS.17-23240; Bruban J, 2009, AGING CELL, V8, P162, DOI 10.1111/j.1474-9726.2009.00456.x; Calabrese V, 2001, NEUROCHEM RES, V26, P739, DOI 10.1023/A:1010955807739; Chan D, 2001, J NEUROL NEUROSUR PS, V71, P515, DOI 10.1136/jnnp.71.4.515; Chi Ying, 2010, Zhonghua Yan Ke Za Zhi, V46, P134; CHOI SH, 2016, VISION, V11, P8262; Cormack FK, 2000, INT J GERIATR PSYCH, V15, P614, DOI 10.1002/1099-1166(200007)15:7<614::AID-GPS153>3.0.CO;2-0; Cronin-Golomb A, 2007, CORTEX, V43, P952, DOI 10.1016/S0010-9452(08)70693-2; CRONINGOLOMB A, 1995, OPTOMETRY VISION SCI, V72, P168, DOI 10.1097/00006324-199503000-00004; CRONINGOLOMB A, 1991, ANN NEUROL, V29, P41, DOI 10.1002/ana.410290110; CRONINGOLOMB A, 1993, NEUROBIOL AGING, V14, P471, DOI 10.1016/0197-4580(93)90105-K; Crow RW, 2003, INVEST OPHTH VIS SCI, V44, P875, DOI 10.1167/iovs.01-1101; CUNHA LP, 2016, PLOS ONE PUBLIC LIBR, V11, P4962, DOI DOI 10.1167/IOVS.13-12046; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Ferrari L, 2017, J ALZHEIMERS DIS, V56, P1101, DOI 10.3233/JAD-160886; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gao LY, 2015, ARCH GERONTOL GERIAT, V60, P162, DOI 10.1016/j.archger.2014.10.011; Garcia-Martin ES, 2014, OPHTHALMOLOGY, V121, P1149, DOI 10.1016/j.ophtha.2013.12.023; Ghiso JA, 2013, J GLAUCOMA S5, V22, pS36; GILMORE GC, 1995, OPTOMETRY VISION SCI, V72, P83, DOI 10.1097/00006324-199502000-00007; GIME P, 2016, REV NEUROL, V63, P5; Grimaldi A, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0740-5; Hart NJ, 2016, ACTA NEUROPATHOL, V132, P767, DOI 10.1007/s00401-016-1613-6; He XF, 2012, INT J OPHTHALMOL-CHI, V5, P401, DOI 10.3980/j.issn.2222-3959.2012.03.30; HUTTON JT, 1993, NEUROLOGY, V43, P2328, DOI 10.1212/WNL.43.11.2328; Iseri PK, 2006, J NEURO-OPHTHALMOL, V26, P18, DOI 10.1097/01.wno.0000204645.56873.26; JIANG H, 2017, BRAIN, P46079, DOI DOI 10.1093/CERCOR/1.1.103; Kesler A, 2011, CLIN NEUROL NEUROSUR, V113, P523, DOI 10.1016/j.clineuro.2011.02.014; Kim M, 2011, INVEST OPHTH VIS SCI, V52, P6882, DOI 10.1167/iovs.11-7276; Kirbas S, 2013, J NEURO-OPHTHALMOL, V33, P58, DOI 10.1097/WNO.0b013e318267fd5f; Ko F, 2018, JAMA NEUROL, V75, P1198, DOI 10.1001/jamaneurol.2018.1578; KROMER R, 2014, FRONT PSYCHIATRY, V5, P1; KURYLO DD, 1994, NEUROBIOL AGING, V15, P305, DOI 10.1016/0197-4580(94)90025-6; LAD EM, 2018, PLOS ONE, V13, P642, DOI DOI 10.1016/J.OPHTHA.2013.12.023; Lakshminarayanan V, 1996, NEUROL RES, V18, P9, DOI 10.1080/01616412.1996.11740369; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Leroi I, 2003, AM J GERIAT PSYCHIAT, V11, P83, DOI 10.1176/appi.ajgp.11.1.83; LEUBA G, 1995, NEUROPATH APPL NEURO, V21, P410, DOI 10.1111/j.1365-2990.1995.tb01078.x; Leuba G, 2001, DEMENT GERIATR COGN, V12, P146, DOI 10.1159/000051249; LEVINE DN, 1993, NEUROLOGY, V43, P305, DOI 10.1212/WNL.43.2.305; Lin DJ, 2013, J RADIOL CASE REP, V7, P1, DOI 10.3941/jrcr.v7i5.1319; Liu DC, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0268-6; Lu Y, 2010, NEUROSCI LETT, V480, P69, DOI 10.1016/j.neulet.2010.06.006; Marchiafava PL, 1999, J PINEAL RES, V26, P184, DOI 10.1111/j.1600-079X.1999.tb00582.x; MARMOR MF, 1986, BRIT J OPHTHALMOL, V70, P553, DOI 10.1136/bjo.70.7.553; Martin PR, 1997, EUR J NEUROSCI, V9, P1536, DOI 10.1111/j.1460-9568.1997.tb01509.x; Martinelli V, 1996, DEMENTIA, V7, P63, DOI 10.1159/000106855; Martinez-Lazcano J, 2010, MENSAJE BIOQUIMICO, VXXXIV, P43; Marziani E, 2013, INVEST OPHTH VIS SCI, V54, P5953, DOI 10.1167/iovs.13-12046; MASLAND RH, 1979, J CELL BIOL, V83, P159, DOI 10.1083/jcb.83.1.159; MASSEY SC, 1979, J NEUROCHEM, V32, P1327, DOI 10.1111/j.1471-4159.1979.tb11062.x; Massoud F, 2002, ALZ DIS ASSOC DIS, V16, P31, DOI 10.1097/00002093-200201000-00005; MENDEZ MF, 1990, J CLIN NEURO-OPHTHAL, V10, P62; Moreno-Ramos T, 2013, J ALZHEIMERS DIS, V34, P659, DOI 10.3233/JAD-121975; Moschos MM, 2012, CURR ALZHEIMER RES, V9, P782; MUTLU U, 2017, INC, V197, P296; Neargarder SA, 2003, J GERONTOL B-PSYCHOL, V58, pP54, DOI 10.1093/geronb/58.1.P54; Ohno-Matsui K, 2011, PROG RETIN EYE RES, V30, P217, DOI 10.1016/j.preteyeres.2011.02.004; OKTEM EO, 2015, SPRINGER, P1; Paquet C, 2007, NEUROSCI LETT, V420, P97, DOI 10.1016/j.neulet.2007.02.090; Parisi V, 2001, CLIN NEUROPHYSIOL, V112, P1860, DOI 10.1016/S1388-2457(01)00620-4; Patton N, 2005, J ANAT, V206, P319, DOI 10.1111/j.1469-7580.2005.00395.x; Pelak VS, 2010, CURR NEUROL NEUROSCI, V10, P440, DOI 10.1007/s11910-010-0137-z; Polo V, 2017, EYE, V31, P1034, DOI 10.1038/eye.2017.23; Rami L, 2007, NEUROLOGIA, V22, P342; RIZZO JF, 1992, ARCH NEUROL-CHICAGO, V49, P93, DOI 10.1001/archneur.1992.00530250097023; Rizzo M, 1998, BRAIN, V121, P2259, DOI 10.1093/brain/121.12.2259; Roth A, 1966, TEST 28 HUE DE ROTH; SADUN AA, 1987, AM J OPHTHALMOL, V104, P113, DOI 10.1016/0002-9394(87)90001-8; SADUN AA, 1990, OPHTHALMOLOGY, V97, P9; Salamone G, 2009, DEMENT GERIATR COGN, V27, P501, DOI 10.1159/000218366; Salobrar-Garcia E, 2015, ARTICLE, V2015, DOI 10.1155/2015/736949; Santos C. Y., 2018, SPRINGER, V10, P196, DOI 10.1016/j.dadm.2018.01.003; Santos Claudia Y, 2018, Alzheimers Dement (Amst), V10, P196, DOI 10.1016/j.dadm.2018.01.003; Saumier D, 2005, BRAIN COGNITION, V59, P299, DOI 10.1016/j.bandc.2004.02.060; Savaskan E, 2002, J HISTOCHEM CYTOCHEM, V50, P519, DOI 10.1177/002215540205000408; SCHLOTTERER G, 1984, BRAIN, V107, P309, DOI 10.1093/brain/107.1.309; SENSITIVITY F, PRESS, P46079; SENSITIVITY F, PRESS, P11; SENSITIVITY F, PRESS, P46079, DOI DOI 10.1038/S41419-018-0740-5; SENSITIVITY F, 1987, PRESS, V110, P107; Syed AB, 2005, FOLIA NEUROPATHOL, V43, P1; Thote Abhishek M., 2017, Molecular & Cellular Biomechanics, V14, P1; Tiraboschi P, 2004, NEUROLOGY, V62, P1984, DOI 10.1212/01.WNL.0000129697.01779.0A; Trebbastoni A, 2016, NEUROSCI LETT, V629, P165, DOI 10.1016/j.neulet.2016.07.006; TRICK GL, 1989, ANN NEUROL, V26, P226, DOI 10.1002/ana.410260208; Uchida A, 2018, INVEST OPHTH VIS SCI, V59, P2768, DOI 10.1167/iovs.17-23240; Valenti DA, 2007, NEUROLOGY, V69, P1060, DOI 10.1212/01.wnl.0000280584.64363.83; Ward ME, 2018, ANN NEUROL, V83, P730, DOI 10.1002/ana.25196; Webster Michael A, 2012, F1000 Biol Rep, V4, P21, DOI 10.3410/B4-21; Wijk H, 1999, INT J GERIATR PSYCH, V14, P1000; Wood S, 1997, ARCH CLIN NEUROPSYCH, V12, P483; WRIGHT CE, PATHOLOGY, P46079; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010	104	36	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220535	10.1371/journal.pone.0220535	http://dx.doi.org/10.1371/journal.pone.0220535			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5KK	31415594	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000485017200019
J	Baraldo, G; Etemad, S; Weiss, AKH; Jansen-Durr, P; Mack, HID				Baraldo, Giorgia; Etemad, Solmaz; Weiss, Alexander K. H.; Jansen-Duerr, Pidder; Mack, Hildegard I. D.			Modulation of serotonin signaling by the putative oxaloacetate decarboxylase FAHD-1 in Caenorhabditis elegans	PLOS ONE			English	Article							CONTAINING PROTEIN-1 FAHD1; IDENTIFICATION	Human fumarylacetoacetate hydrolase (FAH) domain containing protein 1 (FAHD1) is a mitochondrial oxalocatate decarboxylase, the first of its kind identified in eukaryotes. The physiological role of FAHD1 in other eukaryotes is still poorly understood. In C. elegans loss of the FAHD1 ortholog FAHD-1 was reported to impair mitochondrial function, locomotion and egg-laying behavior, yet the underlying mechanisms remained unclear. Using tissue specific rescue of fand-1 (-) worms, we find that these phenotypic abnormalities are at least in part due to fand-l's function in neurons. Moreover, we show that egg-laying defects in fand-1(-) worms can be fully rescued by external dopamine administration and that depletion of fand-1 expression induces expression of several enzymes involved in serotonin biosynthesis. Together, our results support a role for fand-1 in modulating serotonin levels and suggest this protein as a novel link between metabolism and neurotransmitter signaling in the nervous system. Finally, we propose a model to explain how a metabolic defect could ultimately lead to marked changes in neuronal signaling.	[Baraldo, Giorgia; Etemad, Solmaz; Weiss, Alexander K. H.; Jansen-Duerr, Pidder] Univ Innsbruck, Res Inst Biomed Ageing Res, Dept Mol & Cell Biol, Innsbruck, Austria; [Baraldo, Giorgia; Etemad, Solmaz; Weiss, Alexander K. H.; Jansen-Duerr, Pidder] Univ Innsbruck, CMBI, Innsbruck, Austria; [Mack, Hildegard I. D.] Univ Innsbruck, Res Inst Biomed Aging Res, Dept Biochem & Genet Aging, Innsbruck, Austria	University of Innsbruck; University of Innsbruck; University of Innsbruck	Jansen-Durr, P (corresponding author), Univ Innsbruck, Res Inst Biomed Ageing Res, Dept Mol & Cell Biol, Innsbruck, Austria.; Jansen-Durr, P (corresponding author), Univ Innsbruck, CMBI, Innsbruck, Austria.; Mack, HID (corresponding author), Univ Innsbruck, Res Inst Biomed Aging Res, Dept Biochem & Genet Aging, Innsbruck, Austria.	Pidder.Jansen-Duerr@uibk.ac.at; Hildegard.Mack@uibk.ac.at	Jansen-Dürr, Pidder/ABG-2466-2020	Jansen-Dürr, Pidder/0000-0001-7771-3429; Mack, Hildegard/0000-0001-7559-1851; Etemad, Solmaz/0000-0001-5789-1922	Austrian Science Fund FWF [P-315820]; Tiroler Wissenschaftsfonds [ZAP746008, ZAP746009]; Office of the Vice Rector for Research of the University of Innsbruck	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Tiroler Wissenschaftsfonds; Office of the Vice Rector for Research of the University of Innsbruck	PJD recieved funding by: Austrian Science Fund FWF (P-315820); GB recieved funding by: Tiroler Wissenschaftsfonds (ZAP746009); GB recieved funding (fellowship) by: Office of the Vice Rector for Research of the University of Innsbruck; HIDM recieved funding by: Tiroler Wissenschaftsfonds (ZAP746008).	Bany IA, 2003, J NEUROSCI, V23, P8060; BRENNER S, 1974, GENETICS, V77, P71; Brouns SJJ, 2008, J MOL BIOL, V379, P357, DOI 10.1016/j.jmb.2008.03.064; Chase D.L., 2007, BIOGENIC AMINE NEURO; Dempsey CM, 2005, GENETICS, V169, P1425, DOI 10.1534/genetics.104.032540; Etemad S, 2019, MECH AGEING DEV, V177, P22, DOI 10.1016/j.mad.2018.07.007; Hapiak VM, 2009, GENETICS, V181, P153, DOI 10.1534/genetics.108.096891; LOER CM, 1993, J NEUROSCI, V13, P5407, DOI 10.1523/JNEUROSCI.13-12-05407.1993; Martinez-Pastor B, 2013, CANCER DISCOV, V3, P497, DOI 10.1158/2159-8290.CD-13-0059; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Pircher H, 2015, J BIOL CHEM, V290, P6755, DOI 10.1074/jbc.M114.609305; Pircher H, 2011, J BIOL CHEM, V286, P36500, DOI 10.1074/jbc.M111.264770; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Shi L, 2015, CURR OPIN CELL BIOL, V33, P125, DOI 10.1016/j.ceb.2015.02.003; Srinivasan S, 2008, CELL METAB, V7, P533, DOI 10.1016/j.cmet.2008.04.012; Sugden MC, 2011, ISLETS, V3, P302, DOI 10.4161/isl.3.6.17806; Taferner A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134161	17	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0220434	10.1371/journal.pone.0220434	http://dx.doi.org/10.1371/journal.pone.0220434			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412049	Green Submitted, Green Published, gold			2022-12-26	WOS:000485012600029
J	Veyron, JH; Friocourt, P; Jeanjean, O; Luquel, L; Bonifas, N; Denis, F; Belmin, J				Veyron, Jacques-Henri; Friocourt, Patrick; Jeanjean, Olivier; Luquel, Laurence; Bonifas, Nicolas; Denis, Fabrice; Belmin, Joel			Home care aides' observations and machine learning algorithms for the prediction of visits to emergency departments by older community-dwelling individuals receiving home care assistance: A proof of concept study	PLOS ONE			English	Article							TRENDS; MODEL; RISK	Background Older individuals receiving home assistance are at high risk for emergency visits and unplanned hospitalization. Anticipating their health difficulties could prevent these events. This study investigated the effectiveness of an at-home monitoring method using social workers' observations to predict risk for 7- and 14-day emergency department (ED) visits. Methods This was a prospective cohort study of persons. 75 years, living at home and receiving assistance from home care aides (HCA) at 6 French facilities. After each home visit, HCAs reported on participants' functional status using a smartphone application that recorded 27 functional items about each participant (e.g., ability to stand, move, eat, mood, loneliness). We recorded ED visits. Finally, we used machine learning techniques (i.e., leveraging random forest predictors) to develop a 7-and 14-day predictive algorithm for the risk of ED visit. Results The study included 301 participants, and the HCA made 9,987 observations. Over the mean 10-month follow-up, 97 participants (32%) had at least one ED visit. Modeling techniques identified 9 contributory factors from the longitudinal records of the HCA and developed a predictive algorithm for the risk of ED visit. The predictive performance (i.e., the area under the ROC curve) was 0.70 at 7 days and 0.67 at 14 days. Interpretation For frail elders receiving in-home care, information on functional status collected by HCA helps predict the risk of ED visits 7 to 14 days in advance. A survey system for real-time identification of risks could be developed using this exploratory work.	[Veyron, Jacques-Henri] ANAP, Paris, France; [Friocourt, Patrick] Hop Simone Veil, Serv Med Interne Geriatr, Blois, France; [Jeanjean, Olivier] Grp Hosp Nord Essonne, Soins Palliatifs, Pole Geriatrie, SSR, Longjumeau, France; [Luquel, Laurence] Hop Prive Geriatr Magnolias, Ballainvilliers, France; [Bonifas, Nicolas] Ecole Polytech, Palaiseau, France; [Denis, Fabrice] Inst Interreg Cancerol Jean Bernard, Le Mans, France; [Belmin, Joel] Hop Charles Foix, AP HP, Ivry, France; [Belmin, Joel] Sorbonne Univ, Paris, France	Institut Polytechnique de Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Charles-Foix - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Veyron, JH (corresponding author), ANAP, Paris, France.	Jacques-Henri.veyron@anap.fr	Belmin, Joel/V-9995-2019; Belmin, Joël/Q-3914-2017	Belmin, Joel/0000-0003-1630-9582; Belmin, Joël/0000-0003-1630-9582				Adams JG, 2013, JAMA-J AM MED ASSOC, V309, P1173, DOI 10.1001/jama.2013.2476; Basch E, 2017, JAMA-J AM MED ASSOC, V318, P197, DOI 10.1001/jama.2017.7156; Belmin J, 2007, AGE AGEING, V36, P298, DOI 10.1093/ageing/afm026; Crane SJ, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-338; de Gelder J, 2018, J AM GERIATR SOC, V66, P735, DOI 10.1111/jgs.15301; Denis F, 2019, JAMA-J AM MED ASSOC, V321, P306, DOI 10.1001/jama.2018.18085; Duong HV, 2018, PREHOSP EMERG CARE, V22, P7, DOI 10.1080/10903127.2017.1347223; Gasperini B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189925; Hao SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112944; Hartig MT, 1997, J GERONTOL A-BIOL, V52, pM142, DOI 10.1093/gerona/52A.3.M142; Horng S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174708; Hu ZK, 2015, INTERACT J MED RES, V4, P39, DOI 10.2196/ijmr.4022; Hwang U, 2007, J AM GERIATR SOC, V55, P1873, DOI 10.1111/j.1532-5415.2007.01400.x; Jin B, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0074-5; Jones A, 2018, CAN MED ASSOC J, V190, pE525, DOI 10.1503/cmaj.170892; Kahn JH, 2016, EMERG MED CLIN N AM, V34, P435, DOI 10.1016/j.emc.2016.04.014; Nair NP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165757; Pishgoo B, 2011, J RES MED SCI, V16, P262; Shelton P, 2000, AM J MANAG CARE, V6, P925; Takahashi PY, 2016, AM J MANAG CARE, V22, P475; Tang N, 2010, JAMA-J AM MED ASSOC, V304, P664, DOI 10.1001/jama.2010.1112; Thome B, 2003, J CLIN NURS, V12, P860, DOI 10.1046/j.1365-2702.2003.00803.x; Uscher-Pines L, 2013, AM J MANAG CARE, V19, P47; Wolinsky FD, 2008, J GERONTOL A-BIOL, V63, P204, DOI 10.1093/gerona/63.2.204; Wong A, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.1018	25	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220002	10.1371/journal.pone.0220002	http://dx.doi.org/10.1371/journal.pone.0220002			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5HO	31408458	gold, Green Published, Green Submitted			2022-12-26	WOS:000485009500006
J	Wande, DP; Sangeda, RZ; Tibalinda, P; Mutta, IK; Mkumbwa, S; Bitegeko, A; Kaale, E				Wande, Dickson Pius; Sangeda, Raphael Zozimus; Tibalinda, Prosper; Mutta, Innocent Kairuki; Mkumbwa, Sonia; Bitegeko, Adonis; Kaale, Eliangiringa			Pharmaceuticals imports in Tanzania: Overview of private sector market size, share, growth and projected trends to 2021	PLOS ONE			English	Article								Background To assess the extent to which foreign pharmaceutical imports vary from year to year and identifying leading generic and branded formulations, key countries and key importers of pharmaceuticals in private sector supply chain. Methodology A systematic analysis of data for pharmaceutical imports from the Ministry of Health. Data from 2013 to 2016 fiscal years and relevant documents were accessed from the Tanzania Food and Drugs Authority (TFDA). Data cleaning was carried out to remove duplicate entries and to exclude pharmaceutical imports for individual uses, promotion purpose, donations, raw material, medical devices, government institutions and veterinary products. Results A total of 397 different suppliers imported pharmaceutical in Tanzania mainland from 2013 to 2016 fiscal years. In the 2013-2014 fiscal year, the private sector suppliers imported pharmaceutical worth 216 U.S million dollars. India ranked as the first country for exporting highest value of pharmaceutical into the country. It displays a 54% cumulative market share of total imports from 2013-2016, followed by Egypt (11.7%), Switzerland and the USA hold 4.1% of cumulative market share. By 2020-2021 fiscal years, we forecast for imported pharmaceuticals to reach a total value of 906 U.S million dollars for the private sector supply chain. All analysis in this study and the forecasted figures are limited to private sector pharmaceutical supply chain only and does not include data for government pharmaceutical supply chain. Conclusions Our result shows that the vast majority of pharmaceutical imports in the private sector supply chain are dominated by imports from India. India is competing with other countries such as Egypt, Switzerland, USA and South Africa among the top importing countries. There was almost an equal distribution of pharmaceutical for both communicable and non-communicable diseases. Data presented shows a growing trend for the market segment for medicines required for the management of non-communicable diseases. Generally, the private sector pharmaceutical market is keeping on rising at a rapid pace. By the year 2021, the growth is forecasted to increase by 28% compared to the current market value. The projected growth rate could be good news for foreign pharmaceutical companies seeking new sources of growth in international pharmaceutical trading. It is also good news to the poor patients if the availability of drugs previously unavailable in the country is significantly increased.	[Wande, Dickson Pius] Muhimbili Univ Hlth & Allied Sci, Sch Pharm, Dept Pharmaceut & Pharm Practice, Dar Es Salaam, Tanzania; [Sangeda, Raphael Zozimus] Muhimbili Univ Hlth & Allied Sci, Sch Pharm, Dept Pharmaceut Microbiol, Dar Es Salaam, Tanzania; [Tibalinda, Prosper; Kaale, Eliangiringa] Muhimbili Univ Hlth & Allied Sci, Sch Pharm, Pharmaceut R&D Lab, Dar Es Salaam, Tanzania; [Mutta, Innocent Kairuki] Hubert Kairuki Mem Univ, Dar Es Salaam, Tanzania; [Mkumbwa, Sonia; Bitegeko, Adonis] Minist Hlth, Tanzania Food & Drugs Author, Dar Es Salaam, Tanzania; [Kaale, Eliangiringa] Muhimbili Univ Hlth & Allied Sci, Sch Pharm, Dept Med Chem, Dar Es Salaam, Tanzania	Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences	Kaale, E (corresponding author), Muhimbili Univ Hlth & Allied Sci, Sch Pharm, Pharmaceut R&D Lab, Dar Es Salaam, Tanzania.; Kaale, E (corresponding author), Muhimbili Univ Hlth & Allied Sci, Sch Pharm, Dept Med Chem, Dar Es Salaam, Tanzania.	elia.kaale@gmail.com	Kaale, Eliangiringa/AAC-8561-2019; Sangeda, Raphael Zozimus/V-6624-2018	Kaale, Eliangiringa/0000-0001-6008-3539; Sangeda, Raphael Zozimus/0000-0002-6574-5308; Wande, Dickson Pius/0000-0002-1788-3650				Alba S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-163; BOT, 2018, IND FOR EXCH MARK RA; Business Monitor International Ltd, 2016, TANZ PHARM HLTH REP, VQ3; CDC, GLOB HLTH TANZ; EAC, 2014, 2 E AFRIC COMM EAC R; Embrey M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164332; Ewen M, 2017, J Pharm Policy Pract, V10, P7, DOI 10.1186/s40545-016-0095-1; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Kaale E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165785; Kagashe LF G A, 2004, TANZANIA MED J, V19; Kengne AP, 2017, INT J EPIDEMIOL, V46, P1421, DOI 10.1093/ije/dyx078; Lee B., 2018, ANAL GOVT TANZANIAS; Losse K., 2007, VIABILITY LOCAL PHAR; Marty Francisco, 2002, Expert Opin Pharmacother, V3, P91; Mhamba RM, 2010, PHARM IND ACCESS ESS; MoHSW, 2006, NATL MED POLICY NMP; Mushi MF, 2017, TANZAN J HLTH RES, V19, P1; Mziray S, 2017, PHARM REGUL AFF, V6, P1, DOI 10.4172/2167-7689.1000191; NANRA RS, 1980, MED J AUSTRALIA, V1, P486, DOI 10.5694/j.1326-5377.1980.tb135047.x; Ogbera AO, 2014, WORLD J DIABETES, V5, P905, DOI 10.4239/wjd.v5.i6.905; Opiyo N, 2016, COCHRANE DATABASE SY; Ozioko Calistus, 2017, SOLID DOSAGE FORMS T; Rehman HA-U, 2011, PHARM DEV WORLD INDI; Sabot OJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006857; Samarasekera U, 2008, LANCET, V371, P1403, DOI 10.1016/S0140-6736(08)60611-X; Sikika, 2018, HLTH SECT BUDG AN FI; Simba Daudi, 2012, Tanzan J Health Res, V14, P89; Spyros G, 1998, FORECASTING METHODS; Stanifer JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122638; STEWART JH, 1976, AUST NZ J MED, V6, P498, DOI 10.1111/j.1445-5994.1976.tb03045.x; Tibandebage P., 2016, MAKING MED AFRICA PO, P45; UNAIDS, 2016, HIV AIDS TANZ; UNDP, 2016, LOC PROD PHARM CAN P; WHO, 2006, NAT GUID DIAGN TREAT, P105; WHO, 1990, AN THER CHEM CLASS S; WHO, 2015, UNIT REP TANZ WHO ST; Wilson R, 2012, SHAKESPEARE, V8, P1, DOI 10.1080/17450918.2012.660280; World Health Organization, 2010, GLOBAL STATUS REPORT, P176; Ziraba AK, 2009, BMC HEALTH SERV RES, V9, DOI [10.1186/1471-2458-9-465, 10.1186/1472-6963-9-46]	39	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220701	10.1371/journal.pone.0220701	http://dx.doi.org/10.1371/journal.pone.0220701			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404109	Green Published, Green Submitted, gold			2022-12-26	WOS:000485006800025
J	Yatsuoka, W; Ueno, T; Miyano, K; Uezono, Y; Enomoto, A; Kaneko, M; Ota, S; Soga, T; Sugimoto, M; Ushijima, T				Yatsuoka, Wakako; Ueno, Takao; Miyano, Kanako; Uezono, Yasuhito; Enomoto, Ayame; Kaneko, Miku; Ota, Sana; Soga, Tomoyoshi; Sugimoto, Masahiro; Ushijima, Toshikazu			Metabolomic profiling reveals salivary hypotaurine as a potential early detection marker for medication-related osteonecrosis of the jaw	PLOS ONE			English	Article							BISPHOSPHONATE-RELATED OSTEONECROSIS; SURGEONS POSITION PAPER; AMERICAN ASSOCIATION; RISK-FACTORS; MANAGEMENT; PROPOSAL; TAURINE	Medication-related osteonecrosis of the jaw (MRONJ) is a rare but serious adverse event of bone-modifying agents used to prevent bone complications in cancer patients with bone metastasis. Currently, early treatment is the only way to prevent further progression, as the pathogenesis of MRONJ has not yet been elucidated, and a standard treatment has not been established. The aim of this study was to identify a marker for early detection marker of MRONJ by exploring substances in saliva specific to MRONJ at an early stage. We collected salivary samples from 17 patients with MRONJ and conducted metabolomic analyses using capillary electrophoresis mass spectrometry for non-targeted analysis of hydrophilic metabolites. In the screening cohort, we compared the saliva of patients with stage >= 1 advanced MRONJ (n = 9) with that of controls without MRONJ before chemotherapy (n = 9). The top 5 most elevated salivary metabolites were histamine, 3-(4-hydroxyphenyl)propionate, malonate, carnosine, and hypotaurine. In the validation cohort, we analyzed additional patients with stage >= 1 advanced MRONJ (n = 8) and controls without MRONJ after chemotherapy (n = 9), confirming a significant 2.28-fold elevation in the salivary concentration of hypotaurine. These results revealed elevated salivary hypotaurine concentration as a potential marker for the early detection of MRONJ.	[Yatsuoka, Wakako; Ueno, Takao] Natl Canc Ctr Hosp, Dent Div, Chuo Ku, Tsukiji, Japan; [Yatsuoka, Wakako; Ushijima, Toshikazu] Juntendo Univ, Grad Sch Med, Course Adv Clin Res Canc, Bunkyo Ku, Tokyo, Japan; [Miyano, Kanako; Uezono, Yasuhito] Natl Canc Ctr, Div Canc Pathophysiol, Res Inst, Chuo Ku, Tsukiji, Japan; [Uezono, Yasuhito] Natl Canc Ctr, Div Support Care Res, Exploratory Oncol Res & Clin Trial Ctr, Chuo Ku, Tsukiji, Japan; [Uezono, Yasuhito] Natl Canc Ctr Hosp, Innovat Ctr Support Palliat & Psychosocial Care, Chuo Ku, Tsukiji, Japan; [Enomoto, Ayame; Kaneko, Miku; Ota, Sana; Soga, Tomoyoshi; Sugimoto, Masahiro] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Sugimoto, Masahiro] Tokyo Med Univ, Res & Dev Ctr Minimally Invas Therapies Hlth Prom, Shinjuku Ku, Tokyo, Japan; [Ushijima, Toshikazu] Natl Canc Ctr, Div Epigen, Res Inst, Chuo Ku, Tsukiji, Japan	National Cancer Center - Japan; Juntendo University; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Keio University; Tokyo Medical University; National Cancer Center - Japan	Yatsuoka, W (corresponding author), Natl Canc Ctr Hosp, Dent Div, Chuo Ku, Tsukiji, Japan.; Yatsuoka, W (corresponding author), Juntendo Univ, Grad Sch Med, Course Adv Clin Res Canc, Bunkyo Ku, Tokyo, Japan.	wyatsuok@ncc.go.jp	Ushijima, Toshikazu/AAP-5742-2021	Ushijima, Toshikazu/0000-0003-3405-7817; Miyano, Kanako/0000-0003-1673-6074; Sugimoto, Masahiro/0000-0003-3316-2543	JSPS KAKENHI, Japanese Society for Palliative Medicine [JP17K11867]; Yamagata Prefectural Government	JSPS KAKENHI, Japanese Society for Palliative Medicine; Yamagata Prefectural Government	This work was supported by the JSPS KAKENHI Grant Number JP17K11867, Grant for Research Advancement on Palliative Medicine, Japanese Society for Palliative Medicine. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the research funds from Yamagata Prefectural Government and Tsuruoka City, Japan, JSPS KAKENHI Grant Number JP17K11867, Grant for Research Advancement on Palliative Medicine, Japanese Society for Palliative Medicine.	Aghaloo TL, 2011, J BONE MINER RES, V26, P1871, DOI 10.1002/jbmr.379; ARUOMA OI, 1988, BIOCHEM J, V256, P251, DOI 10.1042/bj2560251; Bedogni A, 2012, ORAL DIS, V18, P621, DOI 10.1111/j.1601-0825.2012.01903.x; Boldyrev AA, 2013, PHYSIOL REV, V93, P1803, DOI 10.1152/physrev.00039.2012; Falus A, 2003, ACTA BIOL HUNG, V54, P27, DOI 10.1556/ABiol.54.2003.1.3; Fedele S, 2010, AM J MED, V123, P1060, DOI 10.1016/j.amjmed.2010.04.033; Ficarra G, 2005, J CLIN PERIODONTOL, V32, P1123, DOI 10.1111/j.1600-051X.2005.00842.x; Fleisher KE, 2010, ORAL SURG ORAL MED O, V110, P509, DOI 10.1016/j.tripleo.2010.04.023; Fliefel R, 2015, INT J ORAL MAX SURG, V44, P568, DOI 10.1016/j.ijom.2015.01.026; Fu X, 2016, FEBS LETT, V590, P22, DOI 10.1002/1873-3468.12049; GREEN TR, 1991, BIOCHIM BIOPHYS ACTA, V1073, P91, DOI 10.1016/0304-4165(91)90187-L; Hoff AO, 2008, J BONE MINER RES, V23, P826, DOI [10.1359/jbmr.080205, 10.1359/JBMR.080205]; Hosseini E, 2011, NUTR REV, V69, P245, DOI 10.1111/j.1753-4887.2011.00388.x; Ishikawa S, 2017, AMINO ACIDS, V49, P761, DOI 10.1007/s00726-017-2378-5; Ishikawa S, 2016, SCI REP-UK, V6, DOI 10.1038/srep31520; Kageyama G, 2015, CLIN EXP IMMUNOL, V182, P149, DOI 10.1111/cei.12683; Kawanishi N, 2019, CLIN CHIM ACTA, V489, P41, DOI 10.1016/j.cca.2018.11.030; Kitajima S, 2018, INTERNAL MED, V57, P3341, DOI 10.2169/internalmedicine.0643-17; Lalla RV, 2014, CANCER-AM CANCER SOC, V120, P1453, DOI 10.1002/cncr.28592; Li Y, 2004, CLIN CANCER RES, V10, P8442, DOI 10.1158/1078-0432.CCR-04-1167; Marx RE, 2005, J ORAL MAXIL SURG, V63, P1567, DOI 10.1016/j.joms.2005.07.010; Marx RE, 2003, J ORAL MAXIL SURG, V61, P1115, DOI 10.1016/S0278-2391(03)00720-1; Nishimura T, 2015, PLACENTA, V36, P693, DOI 10.1016/j.placenta.2015.02.014; O'Ryan FS, 2009, J ORAL MAXIL SURG, V67, P1363, DOI 10.1016/j.joms.2009.03.005; Ohshima M, 2017, ONCOL REP, V37, P2727, DOI 10.3892/or.2017.5561; Otto S, 2015, J BONE MINER RES, V30, P1113, DOI 10.1002/jbmr.2525; Ozeki Miho, 2016, Mass Spectrom (Tokyo), V5, pA0047, DOI 10.5702/massspectrometry.A0047; Ra SG, 2014, APPL PHYSIOL NUTR ME, V39, P1120, DOI 10.1139/apnm-2013-0546; Ruggiero SL, 2014, J ORAL MAXIL SURG, V72, P1938, DOI 10.1016/j.joms.2014.04.031; Ruggiero SL, 2009, J ORAL MAXIL SURG, V67, P2, DOI 10.1016/j.joms.2009.01.009; Ruggiero SL, 2004, J ORAL MAXIL SURG, V62, P527, DOI 10.1016/j.joms.2004.02.004; Schiodt M, 2014, OR SURG OR MED OR PA, V117, P204, DOI 10.1016/j.oooo.2013.10.010; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Sugimoto M, 2013, METABOLOMICS, V9, P454, DOI 10.1007/s11306-012-0464-y; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; Tomita A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30482-x; Yamamoto Y, 2018, J NUCL MED, V59	37	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220712	10.1371/journal.pone.0220712	http://dx.doi.org/10.1371/journal.pone.0220712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404085	Green Submitted, gold, Green Published			2022-12-26	WOS:000485006800026
J	Essayagh, T; Essayagh, M; El Rhaffouli, A; Khouchoua, M; Kazadi, GB; Khattabi, A; Essayagh, S				Essayagh, Touria; Essayagh, Meriem; El Rhaffouli, Abderrahmane; Khouchoua, Mohammed; Kazadi, Germain Bukassa; Khattabi, Asmae; Essayagh, Sanah			Prevalence of uncontrolled blood pressure in Meknes, Morocco, and its associated risk factors in 2017	PLOS ONE			English	Article							HYPERTENSIVE PATIENTS; MANAGEMENT; ALGERIA; BURDEN; ADULTS	Background Uncontrolled high blood pressure (UBP) can lead to various cardiovascular complications causing an estimated nine million deaths per year worldwide. In Meknes, epidemiologic data on UBP are scarce, depriving programs from evidence-based information that would allow a better management of hypertension. Hence, we aimed to assess UBP prevalence in hypertensive patients treated in Meknes and identify UBP-associated risk factors. Methods Between November and December 2017, we conducted a cross-sectional study enrolling 922 hypertensive patients managed at Meknes's primary health care facilities using the multistage sampling method. We interviewed patients face to face to collect their socio-demographic-characteristics, lifestyle behaviours, clinical parameters and the triad care system patient -physician. Another questionnaire was self-administered by physicians to characterize therapeutic inertia. A multivariate logistic regression analysis highlighted the risk factors associated with UBP. Results UBP prevalence was 73% with a mean age of 61 +/- 11 years (mean +/- standard deviation) and a male/female ratio of 1/3. Risk factors associated with UBP were: therapeutic inertia (adjusted odds ratio to other variables (AOR) = 18.2, 95% CI [8.35-39.84]), drug non-adherence (AOR = 1.8, 95% CI [1.07-3.04]), obesity/overweight (AOR = 1.6, 95% CI [1.0-32.58]), unemployment (AOR = 1.9, 95% CI [1.09-3.01]), low income (AOR = 2.6, 95% CI [1.01-6.86]), family history of hypertension (AOR = 1.5, 95% CI [1.07-2.08]) and male sex (AOR = 1.6, 95% CI [1.04-2.58]). Conclusion UBP prevalence is high in Meknes. Prevention should firstly focus on raised awareness of hypertensive patients' self-care management. Secondly, health professionals should better comply to the guidelines of anti-hypertensive treatments. Lastly, health professionals should frequently be reminded to reach therapeutic goals to overcome therapeutic inertia.	[Essayagh, Touria] Univ Hassan 1er, Lab Sci & Technol Sante, Inst Super Sci Sante, Settat, Morocco; [Essayagh, Touria; Khattabi, Asmae] Ecole Natl Sante Publ, Rabat, Morocco; [Essayagh, Meriem] Univ Mohammed 5, Fac Med & Pharm, Rabat, Morocco; [El Rhaffouli, Abderrahmane; Khouchoua, Mohammed] Delegat Sante, Meknes, Morocco; [Kazadi, Germain Bukassa] First Nations & Inuit Hlth, Dept Indigenous Serv Canada, Hlth Surveillance & Assessment Unit, Govt Canada, Regina, SK, Canada; [Essayagh, Sanah] Univ Hassan 1er, Lab Agroalimentaire & Sante, Fac Sci & Tech, Settat, Morocco	Hassan First University of Settat; Mohammed First University of Oujda; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Moulay Ismail University of Meknes; Hassan First University of Settat	Essayagh, T (corresponding author), Univ Hassan 1er, Lab Sci & Technol Sante, Inst Super Sci Sante, Settat, Morocco.; Essayagh, T (corresponding author), Ecole Natl Sante Publ, Rabat, Morocco.	essayagh.toula@gmail.com	khattabi, asmae/X-8687-2019	khattabi, asmae/0000-0001-5194-996X				[Anonymous], 2000, INSERM COLLECTIVE EX; Asgedom SW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166432; Bachir Cherif A, 2017, Ann Cardiol Angeiol (Paris), V66, P123, DOI 10.1016/j.ancard.2017.04.009; Bencherif S., 2010, ADAPTATION TRAITEMEN, V5; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Cheong A T, 2015, Malays Fam Physician, V10, P19; Cortez-Dias N, 2013, J HYPERTENS, V31, P1991, DOI 10.1097/HJH.0b013e32836342f7; de Campos CL, 2017, EINSTEIN-SAO PAULO, V15, P45, DOI [10.1590/S1679-45082017AO3862, 10.1590/s1679-45082017ao3862]; Dong GH, 2008, INDIAN J MED RES, V128, P122; Doulougou B., 2014, HYPERTENSION ARTE RI; Dzudie A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001217; Geronooz I, 2000, Rev Med Liege, V55, P921; Girerd X, 2016, Ann Cardiol Angeiol (Paris), V65, P219, DOI 10.1016/j.ancard.2016.04.019; Giroux E, 2011, REV HIST SCI, V64, P297, DOI 10.3917/rhs.642.0297; Goverwa Tafadzwa Priscilla, 2014, BMC Res Notes, V7, P703, DOI 10.1186/1756-0500-7-703; Gudina EK, 2013, INTEGR BLOOD PRESS C, V6, P111, DOI 10.2147/IBPC.S47298; Hamida F, 2013, ANN CARDIOL ANGEIOL, V62, P172, DOI 10.1016/j.ancard.2013.04.008; Ikama M S, 2015, Ann Cardiol Angeiol (Paris), V64, P76, DOI 10.1016/j.ancard.2015.01.007; Jarab A., 2017, PALESTINIAN MED PHAR; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Le directeur et comite de redaction, 2012, CADR PANC PREV CONTR; Maginga J, 2016, J CLIN HYPERTENS, V18, P207, DOI 10.1111/jch.12646; Mainous AG, 2004, ANN FAM MED, V2, P563, DOI 10.1370/afm.119; Majernick TG, 2004, AM J HYPERTENS, V17, P915, DOI 10.1016/j.amjhyper.2004.05.016; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Menanga A, 2016, CARDIOVASC DIAGN THE, V6, P439, DOI 10.21037/cdt.2016.04.03; Mertens IL, 2000, OBES RES, V8, P270, DOI 10.1038/oby.2000.32; Mesli M F, 2015, Ann Cardiol Angeiol (Paris), V64, P32, DOI 10.1016/j.ancard.2014.04.009; Nejjari C, 2013, J HYPERTENS, V31, P49, DOI 10.1097/HJH.0b013e32835a6611; Omar SM, 2018, BMC CARDIOVASC DISOR, V18, DOI 10.1186/s12872-018-0769-5; Organisation Mondiale de la Sante, 2017, MAL CARD; Perrine A. L., 2018, Bulletin Epidemiologique Hebdomadaire, P170; Phillips LS, 2001, ANN INTERN MED, V135, P825, DOI 10.7326/0003-4819-135-9-200111060-00012; Plouin P. F. CG, 1986, STRATEGIE EXPLORATIO; Sabbahi A, 2018, HYPERTENSION, V71, P229, DOI 10.1161/HYPERTENSIONAHA.117.10116; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; [Service des maladies cardiovasculaires Ministere de la Sante Maroc], 2017, PROGR PREV CONTR HYP; Steichen O, 2014, REV MED INTERNE, V35, P235, DOI 10.1016/j.revmed.2013.06.013; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Tazi MA, 2003, J HYPERTENS, V21, P897, DOI 10.1097/00004872-200305000-00013; Williams EA, 2013, DIABETES METAB SYND, V7, P123, DOI 10.1016/j.dsx.2013.06.015; Yameogo NV, 2013, ANN CARDIOL ANGEIOL, V62, P38, DOI 10.1016/j.ancard.2012.05.001; Zhang M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-301	43	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220710	10.1371/journal.pone.0220710	http://dx.doi.org/10.1371/journal.pone.0220710			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398197	Green Published, gold, Green Submitted			2022-12-26	WOS:000485004000014
J	Kang, MS; Kim, HS				Kang, Michael Seungcheol; Kim, Han-Soo			Characteristics and trends of traumatic injuries in children visiting emergency departments in South Korea: A retrospective serial cross-sectional study using both nationwide-sample and single-institutional data	PLOS ONE			English	Article							TRAMPOLINE-RELATED INJURIES; PHYSICAL-ACTIVITY; UNINTENTIONAL INJURIES; FRACTURES	We investigated the incidences and characteristics of pediatric traumatic injuries requiring emergency department visits, through a complementary approach using both nationwide sample and single-institutional data. Data for children (aged <15 years) identified with traumatic injuries during a 10-year period from the Korean National Health Insurance Sharing Service (n = 35,064 among 10,114,909 randomly sampled cases from the claim records of the National Health Insurance) and the authors' institute (n = 39,228) were retrospectively reviewed. The incidences and characteristics of the injuries were investigated using both datasets; additionally, detailed information regarding the injury environments was investigated using the single-institutional data. The findings were similar across both datasets. The incidence of injuries increased during the study period; the head was most commonly injured, whereas the trunk or proximal extremities were rarely injured; low-energy head injuries accounted for >50% of the cases in children aged <5 years, although the incidences of lower extremity injuries and fractures increased in older children. Single-institutional data demonstrated that the proportion of indoor playground and trampoline-related injuries increased rapidly during the study period, and outdoor injuries and seasonal variation (with peak incidences in May and June) were more prominent in older children. Based on similarities between both datasets, the detailed results regarding pediatric traumatic injuries obtained from the single institutional data could be generalized nationally with adequate external validity. To prevent traumatic injuries, it may be more effective to wear protective equipment covering the head and distal extremities rather than the trunk or proximal extremities; simple clothing, such as caps, could prevent many injuries in preschoolers. Among older children, safety guidelines for outdoor sports/leisure activities are needed. The increase in pediatric traumatic injuries may be partially explained by the increased availability of indoor playgrounds and installation of trampolines. Stricter adherence to the preventive guidelines is needed.	[Kang, Michael Seungcheol] Asan Med Ctr Childrens Hosp, Dept Orthopaed Surg, Seoul, South Korea; [Kim, Han-Soo] Seoul Natl Univ Hosp, Dept Orthopaed Surg, Seoul, South Korea	University of Ulsan; Asan Medical Center; Seoul National University (SNU); Seoul National University Hospital	Kang, MS (corresponding author), Asan Med Ctr Childrens Hosp, Dept Orthopaed Surg, Seoul, South Korea.	kang@amc.seoul.kr		Kang, Michael Seungcheol/0000-0002-0172-2721	Asan Medical Center Children's Hospital, Seoul, Korea [2017-0384]	Asan Medical Center Children's Hospital, Seoul, Korea	This study was supported by a grant (2017-0384) from Asan Medical Center Children's Hospital, Seoul, Korea.	Alonge O, 2016, PEDIATR CLIN N AM, V63, P167, DOI 10.1016/j.pcl.2015.08.009; Ashby K, 2015, AUST NZ J PUBL HEAL, V39, P491, DOI 10.1111/1753-6405.12404; Booth VM, 2015, J SCI MED SPORT, V18, P418, DOI 10.1016/j.jsams.2014.06.002; Briskin S, 2012, PEDIATRICS, V130, P774, DOI 10.1542/peds.2012-2082; Cheung MY, 2016, HONG KONG MED J, V22, P81, DOI 10.12809/hkmj144411; Choi ES, 2018, INJURY, V49, P443, DOI 10.1016/j.injury.2017.12.017; Dronina Yuliya, 2016, J Lifestyle Med, V6, P16, DOI 10.15280/jlm.2016.6.1.16; Eiosdottir SP, 2008, EUR J PUBLIC HEALTH, V18, P289, DOI 10.1093/eurpub/ckn004; Felfe C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151729; Gong HS, 2009, J BONE JOINT SURG AM, V91A, P2376, DOI 10.2106/JBJS.H.01871; Hashikawa AN, 2015, J CHILD HEALTH CARE, V19, P93, DOI 10.1177/1367493513501020; Houshian S, 2001, J Orthop Sci, V6, P312, DOI 10.1007/s007760100024; Jack A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h3403; Johnston BD, 2013, ACAD PEDIATR, V13, P499, DOI 10.1016/j.acap.2013.04.016; JONGSCHAAP H C N, 1990, Health Bulletin (Edinburgh), V48, P58; Kang HY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-230; Kang S, 2015, J ORTHOP TRAUMA, V29, pE253, DOI 10.1097/BOT.0000000000000322; Khoshbin A, 2014, INJURY, V45, P701, DOI 10.1016/j.injury.2013.10.004; Konigshausen M, 2014, SPORTVERLETZ SPORTSC, V28, P69, DOI 10.1055/s-0034-1366544; Landry BW, 2012, PM&R, V4, P826, DOI 10.1016/j.pmrj.2012.09.585; McDonald NC, 2011, AM J PREV MED, V41, P146, DOI 10.1016/j.amepre.2011.04.006; Palmu SA, 2014, ACTA ORTHOP, V85, P513, DOI 10.3109/17453674.2014.916489; Park SG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055378, 10.1371/journal.pone.0057138]; Pearson M, 2012, INJURY PREV, V18, P113, DOI 10.1136/injuryprev-2011-040043; Salmon J, 2005, AUST NZ J PUBL HEAL, V29, P337, DOI 10.1111/j.1467-842X.2005.tb00204.x; Shin J, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004880; Shin SY, 2013, HEALTHC INFORM RES, V19, P102, DOI 10.4258/hir.2013.19.2.102; Shin Y, 2015, STUD HEALTH TECHNOL, V216, P924, DOI 10.3233/978-1-61499-564-7-924; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Su AW, 2015, FOOT ANKLE CLIN, V20, P705, DOI 10.1016/j.fcl.2015.07.004; Welch R, 2017, CLIN PEDIATR, V56, P707, DOI 10.1177/0009922816672451; 2007, MMWR MORB MORTAL WKL, V56, P52	32	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220798	10.1371/journal.pone.0220798	http://dx.doi.org/10.1371/journal.pone.0220798			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5FL	31398222	Green Published, Green Submitted, gold			2022-12-26	WOS:000485004000022
J	Yeh, ML; Huang, CF; Huang, CI; Dai, CY; Lin, IH; Liang, PC; Hsieh, MH; Lin, ZY; Chen, SC; Huang, JF; Chen, JJ; Yu, ML; Chuang, WL				Yeh, Ming-Lun; Huang, Chung-Feng; Huang, Ching-I; Dai, Chia-Yen; Lin, I-Hung; Liang, Po-Cheng; Hsieh, Meng-Hsuan; Lin, Zu-Yau; Chen, Shinn-Chern; Huang, Jee-Fu; Chen, Jyh-Jou; Yu, Ming-Lung; Chuang, Wan-Long			Wisteria floribunda agglutinin-positive Mac-2-binding protein in the prediction of disease severity in chronic hepatitis B patients	PLOS ONE			English	Article							MAC-2 BINDING-PROTEIN; SIMPLE NONINVASIVE INDEX; HEPATOCELLULAR-CARCINOMA; LIVER FIBROSIS; SERUM WFA(+)-M2BP; VIRUS INFECTION; BIOPSY; GUIDELINES; ENTECAVIR; CIRRHOSIS	Background Wisteria floribunda agglutinin-positive Mac-2-binding protein (WFA(+)-M2BP) was a novel marker of liver fibrosis. We aimed to investigate WFA(+)-M2BP level in assessing liver fibrosis in patients with chronic hepatitis B (CHB) infection. Methods A total of 160 CHB patients, who received a liver biopsy, were consecutively recruited. Serum WFA(+)-M2BP level was quantified at the time point of biopsy. The results were compared with histopathological manifestations and clinical characteristics of the patients. Results The median WFA(+)-M2BP level, aspartate aminotransferase-to-platelet ratio (APRI) and Fibrosis-4 (FIB-4) index were 1.20 COI, 1.19, and 1.63, respectively. Fifty-one (31.9%) patients had advanced fibrosis. There was a significant increase of WFA(+)-M2BP levels in parallel to necroinflammation/fibrosis stages. The areas under the receiver operating characteristic curve (AUROC) of WFA(+)-M2BP level for predicting fibrosis stages were 0.780 of F2, 0.785 of F3, and 0.769 of F4, respectively (all p < 0.001). The multivariate analysis identified age (Odds ratio [OR] 1.05, 95% confidence interval [CI]: 1.010-1.092, p = 0.014), platelet (OR: 0.99, 95% CI: 0.980-0.998, p = 0.013), and WFA(+)-M2BP level (OR: 1.97, 95% CI: 1.299-2.984, p = 0.001) as independent factors associated with advanced fibrosis. Combination of age, platelet and WFA(+)-M2BP level achieved a better diagnostic performance for advanced fibrosis (AUROC: 0.732, accuracy: 81.3%) than APRI (AUROC: 0.577, accuracy: 63.8%) or FIB-4 index (AUROC: 0.691, accuracy: 75.6%). Conclusion WFA(+)-M2BP had a good performance indistinguishing liver fibrosis in CHB patients. The combination of age, platelet, and WFA(+)-M2BPaddressed more accuracy in identifying patients with advanced fibrosis.	[Yeh, Ming-Lun; Huang, Chung-Feng; Huang, Ching-I; Dai, Chia-Yen; Lin, I-Hung; Liang, Po-Cheng; Hsieh, Meng-Hsuan; Lin, Zu-Yau; Chen, Shinn-Chern; Huang, Jee-Fu; Yu, Ming-Lung; Chuang, Wan-Long] Kaohsiung Med Univ Hosp, Hepatitis Ctr, Kaohsiung, Taiwan; [Yeh, Ming-Lun; Huang, Chung-Feng; Huang, Ching-I; Dai, Chia-Yen; Lin, I-Hung; Liang, Po-Cheng; Hsieh, Meng-Hsuan; Lin, Zu-Yau; Chen, Shinn-Chern; Huang, Jee-Fu; Yu, Ming-Lung; Chuang, Wan-Long] Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan; [Yeh, Ming-Lun; Huang, Chung-Feng; Dai, Chia-Yen; Hsieh, Meng-Hsuan; Lin, Zu-Yau; Huang, Jee-Fu; Yu, Ming-Lung; Chuang, Wan-Long] Kaohsiung Med Univ, Fac Internal Med, Coll Med, Kaohsiung, Taiwan; [Dai, Chia-Yen; Hsieh, Meng-Hsuan] Kaohsiung Med Univ Hosp, Hlth Management Ctr, Kaohsiung, Taiwan; [Chen, Jyh-Jou] Chi Mei Med Ctr, Div Gastroenterol & Hepatol, Liouying, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Chi Mei Hospital	Huang, JF (corresponding author), Kaohsiung Med Univ Hosp, Hepatitis Ctr, Kaohsiung, Taiwan.; Huang, JF (corresponding author), Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan.; Huang, JF (corresponding author), Kaohsiung Med Univ, Fac Internal Med, Coll Med, Kaohsiung, Taiwan.; Chen, JJ (corresponding author), Chi Mei Med Ctr, Div Gastroenterol & Hepatol, Liouying, Taiwan.	jf71218@gmail.com; jjchen@mail.chimei.org.tw	Hsieh, Meng Hsuan/AAY-7973-2021; Chuang, Wan-Long/ABF-7427-2021; Yu, Ming-Lung/AAZ-4306-2020; Huang, Jee-Fu/AAX-4622-2020	Chuang, Wan-Long/0000-0002-2376-421X; Yu, Ming-Lung/0000-0001-8145-1900; Huang, Jee-Fu/0000-0002-2752-7051; Hsieh, Meng-Hsuen/0000-0001-9739-3901; Yeh, Ming-Lun/0000-0003-3728-7618	Kaohsiung Medical University Hospital [KMUH102-2R05, KMUH105-5R04, 105CM-KMU-09, KMUH104-4T02, KMUH105-5R03]	Kaohsiung Medical University Hospital	This study was supported partly by grants from Kaohsiung Medical University Hospital - grant number KMUH102-2R05, KMUH105-5R04, 105CM-KMU-09 for the author Jee-Fu Huang and KMUH104-4T02, KMUH105-5R03 for the author Ming-Lun Yeh. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2015, J GASTROENTEROL, V50, P776, DOI 10.1007/s00535-014-1007-2; Akay S, 2007, DIGEST DIS SCI, V52, P579, DOI 10.1007/s10620-006-9493-6; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Castera L, 2015, DIGEST DIS, V33, P498, DOI 10.1159/000374097; Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Germani G, 2011, SEMIN LIVER DIS, V31, P82, DOI 10.1055/s-0031-1272836; Hasegawa K, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091500; Heo JY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003328; Hosaka T, 2013, HEPATOLOGY, V58, P98, DOI 10.1002/hep.26180; Huang JF, 2007, GUT, V56, P736, DOI 10.1136/gut.2006.115410; Jekarl DW, 2018, ANN LAB MED, V38, P348, DOI 10.3343/alm.2018.38.4.348; Kuno A, 2013, PROTEOM CLIN APPL, V7, P642, DOI 10.1002/prca.201300010; Kuno A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01065; Liaw YF, 2009, LIVER INT, V29, P100, DOI 10.1111/j.1478-3231.2008.01941.x; Lin D, 2016, ALIMENT PHARM THER, V44, P846, DOI 10.1111/apt.13774; LIN TM, 1991, ANTICANCER RES, V11, P2063; Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105; Myers RP, 2008, LIVER INT, V28, P705, DOI 10.1111/j.1478-3231.2008.01691.x; Nishikawa H, 2017, HEPATOL RES, V47, pE74, DOI 10.1111/hepr.12724; Nishikawa H, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004679; Sarin SK, 2016, HEPATOL INT, V10, P1, DOI 10.1007/s12072-015-9675-4; Sasaki R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129053; Sato S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122143; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Terrault NA, 2016, HEPATOLOGY, V63, P261, DOI 10.1002/hep.28156; Toyoda H, 2016, LIVER INT, V36, P293, DOI 10.1111/liv.12907; Ura K, 2016, ALIMENT PHARM THER, V43, P114, DOI 10.1111/apt.13431; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Xiao GQ, 2015, HEPATOLOGY, V61, P292, DOI 10.1002/hep.27382; Xu HQ, 2017, BMC GASTROENTEROL, V17, DOI 10.1186/s12876-017-0618-5; Yamasaki K, 2014, HEPATOLOGY, V60, P1563, DOI 10.1002/hep.27305; Zou X, 2017, LIVER INT, V37, P35, DOI 10.1111/liv.13188	35	9	9	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220663	10.1371/journal.pone.0220663	http://dx.doi.org/10.1371/journal.pone.0220663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393964	gold, Green Submitted, Green Published			2022-12-26	WOS:000485002500049
J	Wang, PY; Li, SJ; Zhao, YC; Zhang, BH; Li, YF; Liu, SD; Du, HQ; Cao, LL; Ou, ML; Ye, XH; Li, P; Gao, X; Wang, PH; Jing, CX; Shao, F; Yang, G; You, FP				Wang, Peiyan; Li, Siji; Zhao, Yingchi; Zhang, Baohuan; Li, Yunfei; Liu, Shengde; Du, Hongqiang; Cao, Lili; Ou, Meiling; Ye, Xiaohong; Li, Peng; Gao, Xiang; Wang, Penghua; Jing, Chunxia; Shao, Feng; Yang, Guang; You, Fuping			The GRA15 protein from Toxoplasma gondii enhances host defense responses by activating the interferon stimulator STING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Toxoplasma gondii; TNF receptor-associated factor (TRAF); interferon; innate immunity; signal transduction; cyclic GMP-AMP synthase (cGAS); protozoan parasite; stimulator of interferon genes protein (STING); type I IFNs	CYTOSOLIC DNA SENSOR; I INTERFERON; INNATE IMMUNITY; BETA-INTERFERON; RECOGNITION; RESISTANCE; INFLAMMASOME; MACROPHAGES; PATHWAY	Toxoplasma gondii is an important neurotropic pathogen that establishes latent infections in humans that can cause toxoplasmosis in immunocompromised individuals. It replicates inside host cells and has developed several strategies to manipulate host immune responses. However, the cytoplasmic pathogen-sensing pathway that detects T. gondii is not well-characterized. Here, we found that cyclic GMP-AMP synthase (cGAS), a sensor of foreign dsDNA, is required for activation of anti-T. gondii immune signaling in a mouse model. We also found that mice deficient in STING (Sting(gt/gt) mice) are much more susceptible to T. gondii infection than WT mice. Of note, the induction of inflammatory cytokines, type I IFNs, and interferon-stimulated genes in the spleen from Sting(gt/gt) mice was significantly impaired. Sting(gt/gt) mice exhibited more severe symptoms than cGAS-deficient mice after T. gondii infection. Interestingly, we found that the dense granule protein GRA15 from T. gondii is secreted into the host cell cytoplasm and then localizes to the endoplasmic reticulum, mediated by the second transmembrane motif in GRA15, which is essential for activating STING and innate immune responses. Mechanistically, GRA15 promoted STING polyubiquitination at Lys-337 and STING oligomerization in a TRAF protein-dependent manner. Accordingly, GRA15-deficient T. gondii failed to elicit robust innate immune responses compared with WT T. gondii. Consequently, GRA15(?/?) T. gondii was more virulent and caused higher mortality of WT mice but not Sting(gt/gt) mice upon infection. Together, T. gondii infection triggers cGAS/STING signaling, which is enhanced by GRA15 in a STING- and TRAF-dependent manner.	[Wang, Peiyan; Li, Siji; Zhao, Yingchi; Li, Yunfei; Liu, Shengde; Du, Hongqiang; Cao, Lili; You, Fuping] Peking Univ, Sch Basic Med Sci, Beijing Key Lab Tumor Syst Biol, Dept Immunol,Inst Syst Biomed,Hlth Sci Ctr, Beijing 100191, Peoples R China; [Zhang, Baohuan; Ou, Meiling; Ye, Xiaohong; Yang, Guang] Jinan Univ, Sch Med, Dept Parasitol, 601 Huangpu Ave West, Guangzhou 510632, Guangdong, Peoples R China; [Zhang, Baohuan; Ou, Meiling; Ye, Xiaohong; Yang, Guang] Jinan Univ, Sch Med, Dept Publ Hlth & Prevent Med, 601 Huangpu Ave West, Guangzhou 510632, Guangdong, Peoples R China; [Wang, Penghua] Univ Connecticut, Dept Immunol, Sch Med, Farmington, CT 06030 USA; [Li, Peng; Shao, Feng] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Gao, Xiang] Shandong Univ, Sch Life Sci, Microbial Technol Inst, State Key Lab Microbial Technol, 72 Binhai Rd, Qingdao 266237, Shandong, Peoples R China; [Jing, Chunxia] Jinan Univ, Sch Med, Dept Epidemiol, Guangzhou 510632, Guangdong, Peoples R China	Peking University; Jinan University; Jinan University; University of Connecticut; National Institute of Biological Sciences, Beijing; Shandong University; Jinan University	You, FP (corresponding author), Peking Univ, Sch Basic Med Sci, Beijing Key Lab Tumor Syst Biol, Dept Immunol,Inst Syst Biomed,Hlth Sci Ctr, Beijing 100191, Peoples R China.; Yang, G (corresponding author), Peking Univ, Dept Immunol, Hlth Sci Ctr, Beijing, Peoples R China.; Yang, G (corresponding author), Peking Univ, Beijing Key Lab Tumor Syst Biol, Hlth Sci Ctr, Beijing, Peoples R China.	tyangguang@email.jnu.edu.cn; fupingyou@hsc.pku.edu.cn	wang, Penghua/AAL-4011-2020	gao, xiang/0000-0001-6397-5639	National Natural Science Foundation of China [31570891, 31872736]; National Key Research and Development Program of China [2016YFA0500302]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work was supported by National Natural Science Foundation of China Grants 31570891 and 31872736 and National Key Research and Development Program of China Grant 2016YFA0500302. The authors declare that they have no conflicts of interest with the contents of this article.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Andrade WA, 2013, CELL HOST MICROBE, V13, P42, DOI 10.1016/j.chom.2012.12.003; Belting DP, 2014, TRENDS PARASITOL, V30, P491, DOI 10.1016/j.pt.2014.07.007; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Debierre-Grockiego F, 2007, J IMMUNOL, V179, P1129, DOI 10.4049/jimmunol.179.2.1129; Delbridge LM, 2007, CURR OPIN IMMUNOL, V19, P10, DOI 10.1016/j.coi.2006.11.005; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Ewald SE, 2014, INFECT IMMUN, V82, P460, DOI 10.1128/IAI.01170-13; Gissot M, 2008, EUKARYOT CELL, V7, P537, DOI 10.1128/EC.00448-07; Gov L, 2013, MBIO, V4, DOI 10.1128/mBio.00255-13; Hakimi MA, 2015, CURR OPIN MICROBIOL, V26, P24, DOI 10.1016/j.mib.2015.04.003; Han SJ, 2014, IMMUNOL CELL BIOL, V92, P872, DOI 10.1038/icb.2014.70; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hiszczynska-Sawicka E, 2011, VET PARASITOL, V177, P281, DOI 10.1016/j.vetpar.2010.11.047; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hsiao CHC, 2013, TRAFFIC, V14, P519, DOI 10.1111/tra.12049; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hunter CA, 2012, NAT REV MICROBIOL, V10, P766, DOI 10.1038/nrmicro2858; Jiang ZF, 2004, P NATL ACAD SCI USA, V101, P3533, DOI 10.1073/pnas.0308496101; Koblansky AA, 2013, IMMUNITY, V38, P119, DOI 10.1016/j.immuni.2012.09.016; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lee EJ, 2008, KOREAN J PARASITOL, V46, P145, DOI 10.3347/kjp.2008.46.3.145; Leng J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007589; Liu Q, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0902-6; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Liu SQ, 2013, ELIFE, V2, DOI 10.7554/eLife.00785; Majumdar T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004779; Melo MB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003779; Melo MB, 2011, TRENDS PARASITOL, V27, P487, DOI 10.1016/j.pt.2011.08.001; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Mun HS, 2005, INFECT IMMUN, V73, P4634, DOI 10.1128/IAI.73.8.4634-4642.2005; Nam HW, 2009, KOREAN J PARASITOL, V47, pS29, DOI 10.3347/kjp.2009.47.S.S29; Neyen C, 2016, CURR OPIN IMMUNOL, V38, P8, DOI 10.1016/j.coi.2015.10.007; ORELLANA MA, 1991, INFECT IMMUN, V59, P3287, DOI 10.1128/IAI.59.9.3287-3290.1991; Peng D, 2015, MICROB GENOMICS, V1, DOI 10.1099/mgen.0.000033; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Qin Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004358; Robert-Gangneux F, 2012, CLIN MICROBIOL REV, V25, P264, DOI 10.1128/CMR.05013-11; Rommereim LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159306; Rosowski EE, 2011, J EXP MED, V208, P195, DOI 10.1084/jem.20100717; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; SCHMITZ JL, 1989, INFECT IMMUN, V57, P3254, DOI 10.1128/IAI.57.10.3254-3256.1989; Silva-Barrios S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00014; Sugi T, 2016, PARASITOL INT, V65, P558, DOI 10.1016/j.parint.2016.05.002; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wang Q, 2014, IMMUNITY, V41, P919, DOI 10.1016/j.immuni.2014.11.011; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; Witola WH, 2011, INFECT IMMUN, V79, P756, DOI 10.1128/IAI.00898-10; Yarovinsky F, 2014, NAT REV IMMUNOL, V14, P109, DOI 10.1038/nri3598; You FP, 2013, NAT IMMUNOL, V14, P1237, DOI 10.1038/ni.2756; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008	59	20	21	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16494	16508		10.1074/jbc.RA119.009172	http://dx.doi.org/10.1074/jbc.RA119.009172			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31416833	Green Published, hybrid			2022-12-26	WOS:000501801900002
J	Hale, BJ; Fernandez, RF; Kim, SQ; Diaz, VD; Jackson, SN; Liu, L; Brenna, JT; Hermann, BP; Geyer, CB; Ellis, JM				Hale, Benjamin J.; Fernandez, Regina F.; Kim, Sora Q.; Diaz, Victoria D.; Jackson, Shelley N.; Liu, Lei; Brenna, J. Thomas; Hermann, Brian P.; Geyer, Christopher B.; Ellis, Jessica M.			Acyl-CoA synthetase 6 enriches seminiferous tubules with the ?-3 fatty acid docosahexaenoic acid and is required for male fertility in the mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fatty acid metabolism; polyunsaturated fatty acid (PUFA); spermatogenesis; phospholipid metabolism; testis; acyl-CoA synthetase; docosahexaenoic acid; male infertility	BINDING PROTEIN MSY2; MESSENGER-RNA; GERM-CELLS; SPERMATOGENESIS; IDENTIFICATION; MANCHETTE; MEDIATORS; ABSENCE; TESTES; LEADS	Docosahexaenoic acid (DHA) is an ?-3 dietary-derived polyunsaturated fatty acid of marine origin enriched in testes and necessary for normal fertility, yet the mechanisms regulating the enrichment of DHA in the testes remain unclear. Long-chain ACSL6 (acyl-CoA synthetase isoform 6) activates fatty acids for cellular anabolic and catabolic metabolism by ligating a CoA to a fatty acid, is highly expressed in testes, and has high preference for DHA. Here, we investigated the role of ACSL6 for DHA enrichment in the testes and its requirement for male fertility. Acsl6(?/?) males were severely subfertile with smaller testes, reduced cauda epididymal sperm counts, germ cell loss, and disorganization of the seminiferous epithelium. Total fatty acid profiling of Acsl6(?/?) testes revealed reduced DHA and increased ?-6 arachidonic acid, a fatty acid profile also reflected in phospholipid composition. Strikingly, lipid imaging demonstrated spatial redistribution of phospholipids in Acsl6(?/?) testes. Arachidonic acid?containing phospholipids were predominantly interstitial in control testes but diffusely localized across Acsl6(?/?) testes. In control testes, DHA-containing phospholipids were predominantly within seminiferous tubules, which contain Sertoli cells and spermatogenic cells but relocalized to the interstitium in Acsl6(?/?) testes. Taken together, these data demonstrate that ACSL6 is an initial driving force for germ cell DHA enrichment and is required for normal spermatogenesis and male fertility.	[Hale, Benjamin J.; Geyer, Christopher B.] East Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, Greenville, NC 27834 USA; [Fernandez, Regina F.; Ellis, Jessica M.] East Carolina Univ, Brody Sch Med, Dept Physiol, Greenville, NC 27834 USA; [Geyer, Christopher B.; Ellis, Jessica M.] East Carolina Univ, East Carolina Diabet & Obes Inst, Greenville, NC 27834 USA; [Kim, Sora Q.] Purdue Univ, Dept Nutr Sci, W Lafayette, IN 47907 USA; [Diaz, Victoria D.; Hermann, Brian P.] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA; [Jackson, Shelley N.] NIDA, Intramural Res Program, Struct Biol Core, Baltimore, MD 21224 USA; [Liu, Lei; Brenna, J. Thomas] Univ Texas Austin, Dell Pediat Res Inst, Dept Pediat, Austin, TX 78723 USA; [Liu, Lei; Brenna, J. Thomas] Univ Texas Austin, Dell Pediat Res Inst, Dept Chem, Austin, TX 78723 USA; [Liu, Lei; Brenna, J. Thomas] Univ Texas Austin, Dell Pediat Res Inst, Dept Nutr, Austin, TX 78723 USA; [Liu, Lei] Hunan Agr Univ, Dept Vet Sci, Changsha 410128, Hunan, Peoples R China	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Texas System; University of Texas at San Antonio (UTSA); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Hunan Agricultural University	Geyer, CB; Ellis, JM (corresponding author), East Carolina Univ, 115 Heart Dr,ECHI Mail Stop 743, Greenville, NC 27834 USA.	geyerc@ecu.edu; ellisje18@ecu.edu	Hermann, Brian P/E-7853-2011	Hermann, Brian P/0000-0002-0503-3616; Brenna, James Thomas/0000-0001-9494-4245; Kim, Sora/0000-0003-3151-0970	NICHD, National Institutes of Health [R01-HD090083, R01-HD090007]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD090083, R01HD090007] Funding Source: NIH RePORTER	NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by NICHD, National Institutes of Health Grant R01-HD090083 (to C. B. G.) and R01-HD090007 (to B. P. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This article contains Table S1 and Figs. S1-S4.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ahmed EA, 2009, METHODS MOL BIOL, V558, P263, DOI 10.1007/978-1-60761-103-5_16; Battista N, 2012, MOL CELL ENDOCRINOL, V355, P1, DOI 10.1016/j.mce.2012.01.014; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brenna JT, 2013, CURR OPIN CLIN NUTR, V16, P548, DOI 10.1097/MCO.0b013e328363bc0a; Bryant JM, 2013, JOVE-J VIS EXP, DOI 10.3791/50648; Calder PC, 2016, ANN NUTR METAB, V69, P8, DOI 10.1159/000448262; Castellano CA, 2011, THERIOGENOLOGY, V76, P1134, DOI 10.1016/j.theriogenology.2011.05.022; Chouinard-Watkins R, 2018, P NATL ACAD SCI USA, V115, P12343, DOI 10.1073/pnas.1817557115; CLERMONT Y, 1955, AM J ANAT, V96, P229, DOI 10.1002/aja.1000960203; Coleman RA, 2019, J LIPID RES, V60, P490, DOI 10.1194/jlr.S091843; CRAWFORD MA, 1976, COMP BIOCHEM PHYS B, V54, P395, DOI 10.1016/0305-0491(76)90264-9; Crawford MA, 2013, PROSTAG LEUKOTR ESS, V88, P5, DOI 10.1016/j.plefa.2012.08.005; Ellis JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116587; Ellis JM, 2010, CURR OPIN LIPIDOL, V21, P212, DOI 10.1097/MOL.0b013e32833884bb; Endo T, 2017, P NATL ACAD SCI USA, V114, pE10132, DOI 10.1073/pnas.1710837114; Esmaeili V, 2015, ANDROLOGY-US, V3, P450, DOI 10.1111/andr.12024; Fernandez RF, 2018, P NATL ACAD SCI USA, V115, P12525, DOI 10.1073/pnas.1807958115; Geyer CB, 2008, GENE, V423, P194, DOI 10.1016/j.gene.2008.06.031; Green CD, 2018, DEV CELL, V46, P651, DOI 10.1016/j.devcel.2018.07.025; Grimaldi P, 2009, P NATL ACAD SCI USA, V106, P11131, DOI 10.1073/pnas.0812789106; Griswold MD, 2016, PHYSIOL REV, V96, P1, DOI 10.1152/physrev.00013.2015; Grive KJ, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007810; Hermann BP, 2018, CELL REP, V25, P1650, DOI 10.1016/j.celrep.2018.10.026; Iizuka-Hishikawa Y, 2017, J BIOL CHEM, V292, P12065, DOI [10.1074/jbc.M117.791277, 10.1074/jbc.m117.791277]; Kierszenbaum AL, 2001, MOL REPROD DEV, V59, P347, DOI 10.1002/mrd.1040; Klett EL, 2017, J LIPID RES, V58, P884, DOI 10.1194/jlr.M072512; Lehti MS, 2016, REPRODUCTION, V151, pR43, DOI 10.1530/REP-15-0310; Lorenzetti Aldo, 2012, Acta Biomed, V83, P108; Meistrich Marvin L, 2013, Methods Mol Biol, V927, P299; Miller MR, 2016, SCIENCE, V352, P555, DOI 10.1126/science.aad6887; Muciaccia B, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111682; Niedenberger BA, 2018, STEM CELL RES, V27, P162, DOI 10.1016/j.scr.2018.01.031; Niedenberger BA, 2015, REPRODUCTION, V149, P329, DOI 10.1530/REP-14-0653; Papanikolaou Y, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-64; Piscitelli F, 2017, ADV PHARMACOL, V80, P1, DOI 10.1016/bs.apha.2017.04.003; Roqueta-Rivera M, 2010, J LIPID RES, V51, P360, DOI 10.1194/jlr.M001180; SAKAI Y, 1989, ANAT REC, V223, P43, DOI 10.1002/ar.1092230107; Serhan CN, 2017, FASEB J, V31, P1273, DOI [10.1096/fj.201601222R, 10.1096/fj.201601222r]; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Simopoulos AP, 2006, BIOMED PHARMACOTHER, V60, P502, DOI 10.1016/j.biopha.2006.07.080; Sohni A, 2019, CELL REP, V26, P1501, DOI 10.1016/j.celrep.2019.01.045; Stroud CK, 2009, J LIPID RES, V50, P1870, DOI 10.1194/jlr.M900039-JLR200; Suh M, 2011, BRIT J NUTR, V106, P1005, DOI 10.1017/S0007114511001292; Teletin M, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.170225; Toguri JT, 2018, PROSTAG OTH LIPID M, V139, P54, DOI 10.1016/j.prostaglandins.2018.09.004; Van Horn CG, 2005, BIOCHEMISTRY-US, V44, P1635, DOI 10.1021/bi047721l; Wang DD, 2018, J FOOD SCI, V83, P481, DOI 10.1111/1750-3841.14017; Watkins PA, 2007, J LIPID RES, V48, P2736, DOI 10.1194/jlr.M700378-JLR200; Xu MG, 2007, BIOL REPROD, V76, P1025, DOI 10.1095/biolreprod.107.060079; Xu MG, 2011, BIOL REPROD, V84, P435, DOI 10.1095/biolreprod.110.087114; Yang JX, 2007, BIOL REPROD, V76, P48, DOI 10.1095/biolreprod.106.055095; Yang JX, 2005, P NATL ACAD SCI USA, V102, P1513, DOI 10.1073/pnas.0404685102; Yang JX, 2005, P NATL ACAD SCI USA, V102, P5755, DOI 10.1073/pnas.0408718102; Yang SC, 2004, FEBS LETT, V576, P221, DOI 10.1016/j.febslet.2004.08.082; Zadravec D, 2011, J LIPID RES, V52, P245, DOI 10.1194/jlr.M011346; Zalata AA, 1998, MOL HUM REPROD, V4, P111, DOI 10.1093/molehr/4.2.111; Zhou YH, 2008, LIPIDS, V43, P525, DOI 10.1007/s11745-008-3186-1	58	19	19	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2019	294	39					14394	14405		10.1074/jbc.RA119.009972	http://dx.doi.org/10.1074/jbc.RA119.009972			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HH	31399511	hybrid, Green Published			2022-12-26	WOS:000499248200020
J	Gergs, U; Jahn, T; Werner, F; Kohler, C; Kopp, F; Grossmann, C; Neumann, J				Gergs, Ulrich; Jahn, Tina; Werner, Franziska; Koehler, Carolin; Koepp, Friedrich; Grossmann, Claudia; Neumann, Joachim			Overexpression of protein phosphatase 5 in the mouse heart: Reduced contractility but increased stress tolerance - Two sides of the same coin?	PLOS ONE			English	Article							INTERNATIONAL CONSENSUS DEFINITIONS; KAPPA-B ACTIVATION; GENE-EXPRESSION; SEPTIC SHOCK; SIGNAL-TRANSDUCTION; S100 PROTEINS; DYSFUNCTION; MICE; PHOSPHORYLATION; SEPSIS	The pathophysiological mechanisms of sepsis-induced cardiac dysfunction are largely unknown. The Toll-like receptor 4 (TLR4) is expressed in cardiac myocytes and is involved in bacterial endotoxin-mediated inflammatory disorders. TLR4 signaling leads to activation of the nuclear factor kappa B followed by increased expression of cytokines. Several protein phosphatases including PP2C beta, PP2A or PP1 are known to act as regulators of this signaling pathway. Here, we examined the role of PP5 for the inflammatory response to the bacterial endotoxin lipopolysaccharide in the heart using a transgenic mouse model with cardiac myocyte directed overexpression of PP5. In these transgenic mice, basal cardiac contractility was reduced, in vivo as well as in vitro, but LPS-induced cardiac dysfunction was less pronounced compared to wild type mice. Quantitative RT-PCR suggested an attenuated NF-kappa B signaling in the heart and cardiac expression of heat shock protein 25 (HSP25) was increased in PP5 transgenic mice. From our data we assume that PP5 increases stress tolerance of cardiac myocytes by downregulation of NF-kappa B signaling and upregulation of HSP25 expression.	[Gergs, Ulrich; Jahn, Tina; Werner, Franziska; Koehler, Carolin; Koepp, Friedrich; Neumann, Joachim] Martin Luther Univ Halle Wittenberg, Med Fak, Inst Pharmakol & Toxikol, Halle, Saale, Germany; [Grossmann, Claudia] Martin Luther Univ Halle Wittenberg, Julius Bernstein Inst Physiol, Med Fak, Halle, Saale, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Gergs, U (corresponding author), Martin Luther Univ Halle Wittenberg, Med Fak, Inst Pharmakol & Toxikol, Halle, Saale, Germany.	ulrich.gergs@medizin.uni-halle.de		Gergs, Ulrich/0000-0001-6986-485X	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	The authors received financial support within the funding program Open Access Publishing by the German Research Foundation (DFG) for the article processing charge of this manuscript.	Bas S, 2004, J IMMUNOL, V172, P4470, DOI 10.4049/jimmunol.172.7.4470; Boyd JH, 2006, CARDIOVASC RES, V72, P384, DOI 10.1016/j.cardiores.2006.09.011; Chen YL, 2006, BIOCHEM BIOPH RES CO, V346, P160, DOI 10.1016/j.bbrc.2006.05.093; Chiang CW, 2011, BIOCHEM J, V433, P187, DOI 10.1042/BJ20100247; Chinkers M, 2001, TRENDS ENDOCRIN MET, V12, P28, DOI 10.1016/S1043-2760(00)00335-0; Conde R, 2005, J BIOL CHEM, V280, P28989, DOI 10.1074/jbc.M503594200; Fallach R, 2010, J MOL CELL CARDIOL, V48, P1236, DOI 10.1016/j.yjmcc.2010.02.020; Furlow JD, 2013, PHYSIOL GENOMICS, V45, P1168, DOI 10.1152/physiolgenomics.00022.2013; Gergs U, 2017, ACTA PHYSIOL, V219, P669, DOI 10.1111/apha.12766; Gergs U, 2004, J BIOL CHEM, V279, P40827, DOI 10.1074/jbc.M405770200; Gergs U, 2009, N-S ARCH PHARMACOL, V379, P55; Gergs U, 2012, INT J CARDIOL, V154, P116, DOI 10.1016/j.ijcard.2010.09.009; Hajjar AM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002963; Hattori Y, 2017, PHARMACOL THERAPEUT, V177, P56, DOI 10.1016/j.pharmthera.2017.02.040; Heijman J, 2013, J MOL CELL CARDIOL, V64, P90, DOI 10.1016/j.yjmcc.2013.09.006; Hinds TD, 2008, INT J BIOCHEM CELL B, V40, P2358, DOI 10.1016/j.biocel.2007.08.010; Imbalzano E, 2016, HEART FAIL REV, V21, P463, DOI 10.1007/s10741-016-9529-8; Jahn T, 2014, N-S ARCH PHARMACOL, V387, pS52; Joulin O, 2009, CRIT CARE, V13, DOI 10.1186/cc7712; Kohler C, 2014, N-S ARCH PHARMACOL, V387, pS58; Kopp F, 2018, N-S ARCH PHARMACOL, V391, pS29; Krankel N, 2003, MOL GENET METAB, V80, P262, DOI 10.1016/S1096-7192(03)00132-X; Krysiak J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02483-3; Kuzmich NN, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5040034; Layland J, 2005, FASEB J, V19, P1137, DOI 10.1096/fj.04-2519fje; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marshall M, 2009, CARDIOVASC RES, V82, P67, DOI 10.1093/cvr/cvp037; Matkovich SJ, 2017, CRIT CARE MED, V45, P407, DOI 10.1097/CCM.0000000000002207; Morrison AL, 2006, AM J PHYSIOL-CELL PH, V290, pC1625, DOI 10.1152/ajpcell.00635.2005; National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A, V8th, DOI [10.1258/la.2010.010031, DOI 10.1258/LA.2010.010031]; Neumann J, 1997, J MOL CELL CARDIOL, V29, P265, DOI 10.1006/jmcc.1996.0271; Perner A, 2017, INTENS CARE MED, V43, P1294, DOI 10.1007/s00134-017-4821-1; Sanchez-Ortiz E, 2009, J NEUROCHEM, V111, P391, DOI 10.1111/j.1471-4159.2009.06337.x; Shankar-Hari M, 2016, JAMA-J AM MED ASSOC, V315, P775, DOI 10.1001/jama.2016.0289; Shih CK, 2010, FOOD CHEM TOXICOL, V48, P1913, DOI 10.1016/j.fct.2010.04.033; Shuvaev VV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077002; Silverstein AM, 1997, J BIOL CHEM, V272, P16224, DOI 10.1074/jbc.272.26.16224; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Swingle MR, 2004, J BIOL CHEM, V279, P33992, DOI 10.1074/jbc.M402855200; Tsuchiya Y, 2017, FEBS LETT, V591, P4083, DOI 10.1002/1873-3468.12912; Valen G, 2001, J AM COLL CARDIOL, V38, P307, DOI 10.1016/S0735-1097(01)01377-8; Wu LL, 2001, AM J PHYSIOL-REG I, V281, pR408, DOI 10.1152/ajpregu.2001.281.2.R408; Wu TH, 2002, INVEST OPHTH VIS SCI, V43, P2834; Yamaguchi F, 2012, J BIOL CHEM, V287, P13787, DOI 10.1074/jbc.M111.329771; Yamamoto H, 2009, J NEUROSCI RES, V87, P1832, DOI 10.1002/jnr.22018; Yang Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.140; Yokoyama T, 1999, J MOL CELL CARDIOL, V31, P261, DOI 10.1006/jmcc.1998.0863; Yu JK, 2015, J PHARM PHARMACOL, V67, P1240, DOI 10.1111/jphp.12415	48	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0221289	10.1371/journal.pone.0221289	http://dx.doi.org/10.1371/journal.pone.0221289			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5MK	31425567	gold, Green Published, Green Submitted			2022-12-26	WOS:000485022400036
J	Foley, L; Dumuid, D; Atkin, AJ; Wijndaele, K; Ogilvie, D; Olds, T				Foley, Louise; Dumuid, Dorothea; Atkin, Andrew J.; Wijndaele, Katrien; Ogilvie, David; Olds, Timothy			Cross-sectional and longitudinal associations between active commuting and patterns of movement behaviour during discretionary time: A compositional data analysis	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE RISK; PHYSICAL-ACTIVITY; SEDENTARY BEHAVIORS; MORTALITY; METAANALYSIS; EXPENDITURE; MARKERS; OBESITY; ENERGY; ADULTS	Background Active living approaches seek to promote physical activity and reduce sedentary time across different domains, including through active travel. However, there is little information on how movement behaviours in different domains relate to each other. We used compositional data analysis to explore associations between active commuting and patterns of movement behaviour during discretionary time. Methods and findings We analysed cross-sectional and longitudinal data from the UK Biobank study. At baseline (2006-2010) and follow up (2009-2013) participants reported their mode of travel to work, dichotomised as active (walking, cycling or public transport) or inactive (car). Participants also reported activities performed during discretionary time, categorised as (i) screen time; (ii) walking for pleasure; and (iii) sport and do-it-yourself (DIY) activities, summed to produce a total. We applied compositional data analysis to test for associations between active commuting and the composition and total amount of discretionary time, using linear regression models adjusted for covariates. Adverse events were not investigated in this observational analysis. The survey response rate was 5.5%. In the cross-sectional analysis (n = 182,406; mean age = 52 years; 51% female), active commuters engaged in relatively less screen time than those who used inactive modes (coefficient -0.12, 95% confidence interval [CI] -0.13 to -0.11), equating to approximately 60 minutes less screen time per week. Similarly, in the longitudinal analysis (n = 4,323; mean age = 51 years; 49% female) there were relative reductions in screen time in those who used active modes at both time points compared with those who used inactive modes at both time points (coefficient -0.15, 95% confidence interval [CI] -0.24 to -0.06), equating to a difference between these commute groups of approximately 30 minutes per week at follow up. However, as exposures and outcomes were measured concurrently, reverse causation is possible. Conclusions Active commuting was associated with a more favourable pattern of movement behaviour during discretionary time. Active commuters accumulated 30-60 minutes less screen time per week than those using inactive modes. Though modest, this could have a cumulative effect on health over time.	[Foley, Louise; Wijndaele, Katrien; Ogilvie, David] Univ Cambridge, MRC Epidemiol Unit, Sch Clin Med, Cambridge, England; [Foley, Louise; Ogilvie, David] Univ Cambridge, UKCRC Ctr Diet & Activ Res CEDAR, Sch Clin Med, Cambridge, England; [Dumuid, Dorothea; Olds, Timothy] Univ South Australia, Sch Hlth Sci, Adelaide, SA, Australia; [Atkin, Andrew J.] Univ East Anglia, Fac Med & Hlth Sci, Sch Hlth Sci, Norwich, Norfolk, England	University of Cambridge; University of Cambridge; University of South Australia; University of East Anglia	Foley, L (corresponding author), Univ Cambridge, MRC Epidemiol Unit, Sch Clin Med, Cambridge, England.; Foley, L (corresponding author), Univ Cambridge, UKCRC Ctr Diet & Activ Res CEDAR, Sch Clin Med, Cambridge, England.	lf354@medschl.cam.ac.uk	Olds, Tim/A-1223-2008; Dumuid, Dorothea/AAC-7383-2019; Dumuid, Dot/HCI-5863-2022; Wijndaele, Katrien/H-5465-2013	Olds, Tim/0000-0001-6894-5519; Dumuid, Dorothea/0000-0003-3057-0963; Wijndaele, Katrien/0000-0003-2199-7981; Atkin, Andrew/0000-0002-3819-3448; Ogilvie, David/0000-0002-0270-4672	Centre for Diet and Activity Research (CEDAR); UKCRC Public Health Research Centre of Excellence; British Heart Foundation; Cancer Research UK; Economic and Social Research Council, Medical Research Council; National Institute for Health Research; Wellcome Trust; UK Clinical Research Collaboration [087636/Z/08/Z, ES/G007462/1, MR/K023187/1, MC_UU_12015/6, MC_UU_12015/3]; Medical Research Council; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MC_UU_12015/3, MR/K023187/1, MC_UU_12015/6] Funding Source: UKRI	Centre for Diet and Activity Research (CEDAR); UKCRC Public Health Research Centre of Excellence; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council, Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Economic & Social Research Council (ESRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); UK Clinical Research Collaboration; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was conducted using the UK Biobank resource (application No 20684). LF was funded by the Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence. Funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the National Institute for Health Research, and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged (087636/Z/08/Z, ES/G007462/1, MR/K023187/1). DO (MC_UU_12015/6) and KW (MC_UU_12015/3) were supported by the Medical Research Council. We acknowledge Craig Knott for his assistance with data cleaning and variable derivation. The funders played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the paper; or in the decision to submit the paper for publication.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Aitchison J, 2003, CONCISE GUIDE COMPOS; Allen N, 2012, HEALTH POLICY TECHN, V1, P123, DOI 10.1016/j.hlpt.2012.07.003; Biobank UK, 2017, ACCESS MATTER REPRES; Biobank UK, 2013, REPEAT ASSESSMENT DA; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Buman MP, 2014, AM J EPIDEMIOL, V179, P323, DOI 10.1093/aje/kwt292; Celis-Morales CA, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1456; Chastin SFM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139984; Costa S, 2015, PREV MED, V81, P339, DOI 10.1016/j.ypmed.2015.09.022; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Department for Transport, 2017, CYCL WALK INV STRAT; Dumuid D, 2018, STAT METHODS MED RES, V27, P3726, DOI 10.1177/0962280217710835; Ekelund U, 2016, LANCET, V388, P1302, DOI 10.1016/S0140-6736(16)30370-1; Ferrer-Rosell B, 2016, TOURISM ECON, V22, P269, DOI 10.5367/te.2016.0548; Flint E, 2016, LANCET PUBLIC HEALTH, V1, pE46, DOI 10.1016/S2468-2667(16)30006-8; Foley L, 2018, INT J BEHAV NUTR PHY, V15, DOI 10.1186/s12966-018-0662-8; Foley L, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0323-0; Gomersall SR, 2015, J SCI MED SPORT, V18, P43, DOI 10.1016/j.jsams.2014.01.004; Hamer M, 2014, MED SCI SPORT EXER, V46, P1946, DOI 10.1249/MSS.0000000000000317; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Jakes RW, 2003, EUR J CLIN NUTR, V57, P1089, DOI 10.1038/sj.ejcn.1601648; Kelly P, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0132-x; Knott CS, 2018, PREV MED, V112, P61, DOI 10.1016/j.ypmed.2018.03.018; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Palarea-Albaladejo J, 2015, CHEMOMETR INTELL LAB, V143, P85, DOI 10.1016/j.chemolab.2015.02.019; Panter J, 2018, HEART, V104, P1749, DOI 10.1136/heartjnl-2017-312699; Patterson R, 2018, EUR J EPIDEMIOL, V33, P811, DOI 10.1007/s10654-018-0380-1; Pawlowsky-Glahn V, 2011, AUST J STAT, V40, P103; PawlowskyGlahn V, 2011, COMPOSITIONAL DATA ANALYSIS: THEORY AND APPLICATIONS, P1, DOI 10.1002/9781119976462; Pedis Z., 2017, KINESIOLOGY, V49; Public Health England, 2017, EVERYBODY ACTIVE EVE; Sahlqvist S, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-28; Sallis JF, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0188-2; Samitz G, 2011, INT J EPIDEMIOL, V40, P1382, DOI 10.1093/ije/dyr112; Stamatakis E, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0280-7; Sugiyama T, 2016, PREV MED, V83, P26, DOI 10.1016/j.ypmed.2015.11.029; Templ M, 2011, COMPOSITIONAL DATA ANALYSIS: THEORY AND APPLICATIONS, P341; UK Biobank, 2011, TOUCH SCREEN QUEST; UK Biobank, 2007, UK BIOBANK PROTOCOL; van den Boogaart KG, 2008, COMPUT GEOSCI-UK, V34, P320, DOI 10.1016/j.cageo.2006.11.017; Van Der Berg JD, 2017, MED SCI SPORT EXER, V49, P1347, DOI 10.1249/MSS.0000000000001248; Wijndaele K, 2017, MED SCI SPORT EXER, V49, P1111, DOI 10.1249/MSS.0000000000001206; Woodcock J, 2007, LANCET, V370, P1078, DOI 10.1016/S0140-6736(07)61254-9	45	5	5	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2019	14	8							e0216650	10.1371/journal.pone.0216650	http://dx.doi.org/10.1371/journal.pone.0216650			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5LL	31419234	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000485019900004
J	Giran, G; Pare, A; Croise, B; Koudougou, C; Mercier, JM; Laure, B; Corre, P; Bertin, H				Giran, Guillaume; Pare, Arnaud; Croise, Benjamin; Koudougou, Carine; Mercier, Jacques Marie; Laure, Boris; Corre, Pierre; Bertin, Helios			Radiographic evaluation of percutaneous transfacial wiring versus open internal fixation for surgical treatment of unstable zygomatic bone fractures	PLOS ONE			English	Article							ZYGOMATICOMAXILLARY COMPLEX FRACTURES; MAXILLOFACIAL TRAUMA; COMPUTED-TOMOGRAPHY; OPEN REDUCTION; WIRE FIXATION; OSTEOSYNTHESIS; MULTICENTER; MANAGEMENT; SURGERY	Introduction The fixation of unstable zygomaticomaxillary complex (ZMC) fractures can be achieved by open reduction with rigid internal fixation (ORIF) and/or by closed reduction with percutaneous transfacial Kirschner wire fixation (CRWF). The aim of this study was to tomographically assess the symmetry and the protrusion of the cheekbone with unstable ZMC fractures that had been treated by ORIF vs. CRWF. Materials and methods Sixty patients exhibiting a surgically unstable tetrapodal ZMC fracture were included in this multicenter retrospective study. The coordinates of 5 landmarks representing the zygomatic protrusion were comparatively studied on the healthy and on the broken side using preoperative and postoperative tridimensional computed tomography (CT) scans or cone beam CT. Results No significant difference was found in the zygomatic protrusion irrespective of the surgical technique that was used. The zygomatico-maxillary ansa was found to be the most complicated area to reduce, particularly in the frontal plane with both the CRWF and the ORIF technique (p(1) = 0.001 and p(2) = 0.0009, respectively). There was no difference in terms of the level of complications, while the mean duration of the surgery was significantly less for the CRWF group. Conclusion With good postoperative radiographic outcomes, the CRWF can be proposed as an alternative or in association with the ORIF technique for fixation of tetrapodal fractures of the ZMC.	[Giran, Guillaume; Koudougou, Carine; Mercier, Jacques Marie; Corre, Pierre; Bertin, Helios] CHU Nantes, Serv Chirurg Maxillofaciale & Stomatol, Nantes, France; [Pare, Arnaud; Croise, Benjamin; Laure, Boris] CHU Tours, Serv Chirurg Maxillofaciale & Plast, Chambray Les Tours, France; [Pare, Arnaud; Corre, Pierre] Fac Chirurg Dentaire, Lab Med Regenerat & Squelette RMeS, Nantes, France; [Bertin, Helios] Fac Med, Lab Sarcomes Osseux & Remodelage Tissus Calcif Ph, Nantes, France	Nantes Universite; CHU de Nantes; CHU Tours	Bertin, H (corresponding author), CHU Nantes, Serv Chirurg Maxillofaciale & Stomatol, Nantes, France.; Bertin, H (corresponding author), Fac Med, Lab Sarcomes Osseux & Remodelage Tissus Calcif Ph, Nantes, France.	helios.bertin@chu-nantes.fr	CORRE, Pierre/P-1307-2014; Bertin, Hélios/AAY-8733-2020; Pare, Arnaud/AHC-9509-2022	CORRE, Pierre/0000-0003-4587-2163; Bertin, Hélios/0000-0002-0546-079X; 				Aksu F, 2009, CLIN ANAT, V22, P559, DOI 10.1002/ca.20805; Boffano P, 2015, OR SURG OR MED OR PA, V119, P385, DOI 10.1016/j.oooo.2014.12.004; Boffano P, 2015, J CRANIO MAXILL SURG, V43, P62, DOI 10.1016/j.jcms.2014.10.011; Caple J, 2016, INT J LEGAL MED, V130, P863, DOI 10.1007/s00414-015-1292-1; DAHLBERG G., 1940, Statistical Methods for Medical and Biological Students.; DELAIRE J, 1981, ORAL SURG ORAL MED O, V52, P226, DOI 10.1016/0030-4220(81)90252-8; El-Anwar MW, 2017, ORAL MAXILLOFAC SURG, V21, P187, DOI 10.1007/s10006-017-0617-2; Ellis E, 1996, J ORAL MAXIL SURG, V54, P386, DOI 10.1016/S0278-2391(96)90107-X; Evans Brogan G A, 2008, Plast Reconstr Surg, V121, P1, DOI 10.1097/01.prs.0000294655.16607.ea; FARKAS LG, 1981, ANGLE ORTHOD, V51, P70; FRYER MP, 1969, PLAST RECONSTR SURG, V44, P576, DOI 10.1097/00006534-196912000-00008; Furst IM, 2001, J ORAL MAXIL SURG, V59, P647, DOI 10.1053/joms.2001.23394; Gandi LN, 2012, HEAD FACE MED, V8, DOI 10.1186/1746-160X-8-7; Gassner R, 2003, J CRANIO MAXILL SURG, V31, P51, DOI 10.1016/S1010-5182(02)00168-3; LARSEN OD, 1978, SCAND J PLAST RECONS, V12, P59, DOI 10.3109/02844317809010481; Li P, 2016, INT J ORAL MAX SURG, V45, P1665, DOI 10.1016/j.ijom.2016.06.021; Makowski GJ, 1995, ORAL SURG ORAL MED O, V80, P624; Manson PN, 1996, J ORAL MAXIL SURG, V54, P400, DOI 10.1016/S0278-2391(96)90108-1; Mehrotra S, 2017, ANN PLAS SURG, V78, P668, DOI 10.1097/SAP.0000000000000985; Nimeskern N, 2002, Rev Stomatol Chir Maxillofac, V103, P327; O'Connell J, 2009, INT J ORAL MAX SURG, V38, P731, DOI 10.1016/j.ijom.2009.02.016; Pan Z, 2014, EUR J TRAUMA EMERG S, V40, P587, DOI 10.1007/s00068-013-0348-5; Raoul G, 2009, J CRANIOFAC SURG, V20, P1231, DOI 10.1097/SCS.0b013e3181acde63; Rohner D, 2002, PLAST RECONSTR SURG, V110, P1463, DOI 10.1097/01.PRS.0000029360.61857.AE; ROHRICH RJ, 1995, PLAST RECONSTR SURG, V96, P570, DOI 10.1097/00006534-199509000-00008; Salentijn EG, 2014, J CRANIO MAXILL SURG, V42, P1717, DOI 10.1016/j.jcms.2014.06.005; Shintaku WH, 2009, DENT TRAUMATOL, V25, P358, DOI 10.1111/j.1600-9657.2009.00795.x; Singh M K, 2012, Ann R Coll Surg Engl, V94, pe157, DOI 10.1308/003588412X13171221590494; Soejima K, 2009, J PLAST RECONSTR AES, V62, P499, DOI 10.1016/j.bjps.2007.11.007; van Hout WMMT, 2013, BRIT J ORAL MAX SURG, V51, P416, DOI 10.1016/j.bjoms.2012.11.002; Zhang QB, 2006, J CRANIO MAXILL SURG, V34, P182, DOI 10.1016/j.jcms.2005.09.004; Zhang QB, 2011, J CRANIOFAC SURG, V22, P1460, DOI 10.1097/SCS.0b013e31821d1832; ZINGG M, 1992, J ORAL MAXIL SURG, V50, P778, DOI 10.1016/0278-2391(92)90266-3	33	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220913	10.1371/journal.pone.0220913	http://dx.doi.org/10.1371/journal.pone.0220913			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415600	Green Published, gold, Green Submitted			2022-12-26	WOS:000485017200044
J	Abuelizz, HA; Anouar, E; Ahmad, R; Azman, NIIN; Marzouk, M; Al-Salahi, R				Abuelizz, Hatem A.; Anouar, El Hassane; Ahmad, Rohaya; Azman, Nor Izzati Iwana Nor; Marzouk, Mohamed; Al-Salahi, Rashad			Triazoloquinazolines as a new class of potent alpha-glucosidase inhibitors: in vitro evaluation and docking study	PLOS ONE			English	Article							BIOLOGICAL EVALUATION; MOLECULAR DOCKING; DERIVATIVES	Previously, we synthesized triazoloquinazolines 1-14 and characterized their structure. In this study, we aimed to evaluate the in vitro activity of the targets 1-14 as a-glucosidase inhibitors using a-glucosidase enzyme from Saccharomyces cerevisiae type 1. Among the tested compounds, triazoloquinazolines 14, 8, 4, 5, and 3 showed the highest inhibitory activity (IC50 = 12.70 +/- 1.87, 28.54 +/- 1.22, 45.65 +/- 4.28, 72.28 +/- 4.67, and 83.87 +/- 5.12 mu M, respectively) in relation to that of acarbose (IC50 = 143.54 +/- 2.08 mu M) as a reference drug. Triazoloquinazolines were identified herein as a new class of potent a-glucosidase inhibitors. Molecular docking results envisaged the plausible binding interaction between the target triazoloquinazolines and alpha-glucosidase enzyme and indicated considerable interaction with the active site residues.	[Abuelizz, Hatem A.; Al-Salahi, Rashad] King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh, Saudi Arabia; [Anouar, El Hassane] Prince Sattam Bin Abdulaziz Univ, Coll Sci & Humanities, Dept Chem, Al Kharj, Saudi Arabia; [Ahmad, Rohaya; Azman, Nor Izzati Iwana Nor] Univ Teknol MARA, Fac Appl Sci, Shah Alam, Selangor Darul, Malaysia; [Marzouk, Mohamed] Natl Res Ctr, Ctr Excellence Adv Sci, Chem Nat Prod Grp, Cairo, Egypt	King Saud University; Prince Sattam Bin Abdulaziz University; Universiti Teknologi MARA; Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	Al-Salahi, R (corresponding author), King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh, Saudi Arabia.	ralsalahi@ksu.edu.sa	Anouar, El Hassane/AAG-8489-2019; Al-salahi, Rashad/AAY-5539-2020; Al-Salahi, Rashad/AAY-2240-2020; Bari, Ahmed/ABB-4134-2020; Anouar, El Hassane/H-5088-2017; Abuelizz, Hatem/E-5871-2017	Anouar, El Hassane/0000-0001-9240-7163; Al-Salahi, Rashad/0000-0003-1747-2736; Abuelizz, Hatem/0000-0002-7092-7544; , mohamed/0000-0002-1344-0617	Deanship of Scientific Research at King Saud University [RG-1435-068]	Deanship of Scientific Research at King Saud University(King Saud University)	The authors extend their appreciation to the Deanship of Scientific Research at King Saud University for funding this study through research group no. RG-1435-068.	Abuelizz HA, 2019, BMC CHEM, V13, DOI 10.1186/s13065-019-0560-4; Abuelizz HA, 2017, MOLECULES, V22, DOI 10.3390/molecules22071094; Adib M, 2018, EUR J MED CHEM, V155, P353, DOI 10.1016/j.ejmech.2018.05.046; Ahmad R., 2011, Research Journal of Medicinal Plant, V5, P587, DOI 10.3923/rjmp.2011.587.595; Al Salahi R., 2013, LIFE SCI J, V10, P2018; Al-Salahi R. A., 2013, J PHARM PHARMACOL, V64, P1678; Al-Salahi R, 2018, FUTURE MED CHEM, V10, P1889, DOI 10.4155/fmc-2018-0141; Al-Salahi R, 2014, CHEM CENT J, V8, DOI 10.1186/1752-153X-8-3; Al-Salahi R, 2011, SYNTHETIC COMMUN, V41, P3512, DOI 10.1080/00397911.2010.518780; Al-Salahi RA, 2010, MOLECULES, V15, P7016, DOI 10.3390/molecules15107016; Chiasson JL, 2003, JAMA-J AM MED ASSOC, V290, P486, DOI 10.1001/jama.290.4.486; Ding SM, 2018, BIOORGAN MED CHEM, V26, P3370, DOI 10.1016/j.bmc.2018.05.008; Garlapati R, 2013, ORG BIOMOL CHEM, V11, P4778, DOI 10.1039/c3ob40636a; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Gurram V, 2015, MED CHEM RES, V24, P2227, DOI 10.1007/s00044-014-1293-5; Hati S, 2015, EUR J MED CHEM, V100, P188, DOI 10.1016/j.ejmech.2015.04.059; Imran S, 2015, EUR J MED CHEM, V105, P156, DOI 10.1016/j.ejmech.2015.10.017; International Diabetes Federation, 2014, IDF DIABETES ATLAS, V6th; Iqbal S, 2017, BIOORG CHEM, V74, P72, DOI 10.1016/j.bioorg.2017.07.006; Kalita H, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00102; Kalra S, 2014, J PAK MED ASSOC, V64, P474; Liu ZY, 2017, CHEMMEDCHEM, V12, P819, DOI 10.1002/cmdc.201700216; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Salar U, 2016, EUR J MED CHEM, V122, P196, DOI 10.1016/j.ejmech.2016.06.037; Spasov AA, 2017, CHEM BIOL DRUG DES, V90, P1184, DOI 10.1111/cbdd.13038; Tundis R, 2010, MINI-REV MED CHEM, V10, P315, DOI 10.2174/138955710791331007; Wang GC, 2017, MEDCHEMCOMM, V8, P1477, DOI 10.1039/c7md00173h; Wang GC, 2017, EUR J MED CHEM, V125, P423, DOI 10.1016/j.ejmech.2016.09.067; Wang GC, 2016, BIOORG MED CHEM LETT, V26, P2806, DOI 10.1016/j.bmcl.2016.04.071; Wang QQ, 2014, BIOORGAN MED CHEM, V22, P1515, DOI 10.1016/j.bmc.2014.01.038; Wei MK, 2017, BIOORGAN MED CHEM, V25, P1303, DOI 10.1016/j.bmc.2016.09.042; Zhang AJ, 2017, J NUTR BIOCHEM, V47, P86, DOI 10.1016/j.jnutbio.2017.05.008; Zhang YL, 2017, BIOORG MED CHEM LETT, V27, P4309, DOI 10.1016/j.bmcl.2017.08.035; Zhen J, 2017, BIOORGAN MED CHEM, V25, P5355, DOI 10.1016/j.bmc.2017.07.055	34	21	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0220379	10.1371/journal.pone.0220379	http://dx.doi.org/10.1371/journal.pone.0220379			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412050	gold, Green Published, Green Submitted			2022-12-26	WOS:000485012600028
J	Zhang, XY; Li, XT; Li, RH; Zhang, YB; Li, YP; Li, SF				Zhang, Xiaoyuan; Li, Xintian; Li, Ronghong; Zhang, Yunbin; Li, Yiping; Li, Shifeng			Transcriptomic profile of early zebrafish PGCs by single cell sequencing	PLOS ONE			English	Article							PRIMORDIAL GERM-CELLS; GENE-EXPRESSION; RNA-SEQ; DEAD-END; MIGRATION; VASA; PROTEIN; NANOG; PLURIPOTENCY; COMPONENT	Single cell RNA-seq is a powerful and sensitive way to capture the genome-wide gene expression. Here, single cell RNA-seq was utilized to study the transcriptomic profile of early zebrafish PGCs (primordial germ cells) at three different developmental stages. The three stages were 6, 11 and 24 hpf (hours post fertilization). For each developmental stage, three zebrafish PGCs from one embryo were collected, and 9 samples in total were used in this experiment. Single cell RNA-seq results showed that 5099-7376 genes were detected among the 9 samples, and the number of expressed genes decreased as development progressed. Based on the gene expression pattern, samples from 6 and 11 hpf clustered closely, while samples from 24 hpf were more dispersed. By WGCNA (weighted gene co-expression network analysis), the two biggest modules that had inverse gene expression patterns were found to be related to PGC formation or migration. Functional enrichment analysis for these two modules showed that PGCs mainly conducted migration and cell division in early development (6/11 hpf) and translation activity became active in late development (24 hpf). Differentially expressed gene analyses showed that more genes were downregulated than upregulated between two adjacent stages, and genes related to PGC formation or migration reported by previous studies decreased significantly from 11 to 24 hpf. Our results provide base knowledge about zebrafish PGC development at the single cell level and can be further studied by other researchers interested in biological development.	[Zhang, Xiaoyuan; Li, Xintian; Li, Ronghong; Zhang, Yunbin; Li, Yiping; Li, Shifeng] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai, Peoples R China; [Zhang, Xiaoyuan; Li, Xintian; Li, Ronghong; Zhang, Yunbin; Li, Yiping; Li, Shifeng] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, Shanghai Key Lab Mol Androl, Shanghai, Peoples R China; [Zhang, Xiaoyuan; Li, Xintian; Li, Ronghong; Zhang, Yunbin; Li, Yiping; Li, Shifeng] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, Ctr Excellence Mol Cell Sci, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS	Li, SF (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai, Peoples R China.; Li, SF (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, Shanghai Key Lab Mol Androl, Shanghai, Peoples R China.; Li, SF (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, Ctr Excellence Mol Cell Sci, Shanghai, Peoples R China.	sfli01@sibcb.ac.cn	Li, Xintian/HGA-0346-2022	Zhang, Xiaoyuan/0000-0001-5130-9495	National Basic Research Program of China (973 Program) [2014CB943102]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by National Basic Research Program of China (973 Program), Grant number: 2014CB943102, to Shifeng Li. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; Blaser H, 2005, J CELL SCI, V118, P4027, DOI 10.1242/jcs.02522; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Braat AK, 2000, MECH DEVELOP, V95, P271, DOI 10.1016/S0925-4773(00)00344-0; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chen J, 2017, NAT PROTOC, V12, P566, DOI 10.1038/nprot.2017.003; Feitsma H, 2008, MOL CANCER RES, V6, P685, DOI 10.1158/1541-7786.MCR-07-2167; Gross-Thebing T, 2017, DEV CELL, V43, P704, DOI 10.1016/j.devcel.2017.11.019; Guo F, 2015, CELL, V161, P1437, DOI 10.1016/j.cell.2015.05.015; Hartung O, 2014, MOL REPROD DEV, V81, P946, DOI 10.1002/mrd.22414; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Hsu CW, 2018, GEN COMP ENDOCR, V265, P154, DOI 10.1016/j.ygcen.2018.01.026; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knaut H, 2000, J CELL BIOL, V149, P875, DOI 10.1083/jcb.149.4.875; Knaut H, 2003, NATURE, V421, P279, DOI 10.1038/nature01338; Ko MSH, 2001, TRENDS BIOTECHNOL, V19, P511, DOI 10.1016/S0167-7799(01)01806-6; Koprunner M, 2001, GENE DEV, V15, P2877; Kudoh T, 2001, GENOME RES, V11, P1979, DOI 10.1101/gr.209601; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee MT, 2013, NATURE, V503, P360, DOI 10.1038/nature12632; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Muller K, 2002, MECH DEVELOP, V117, P253, DOI 10.1016/S0925-4773(02)00174-0; Olsen LC, 1997, MECH DEVELOP, V66, P95, DOI 10.1016/S0925-4773(97)00099-3; Onichtchouk D, 2012, GENESIS, V50, P75, DOI 10.1002/dvg.20800; Otten ABC, 2016, CELL REP, V16, P622, DOI 10.1016/j.celrep.2016.06.023; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; R CT, 2017, R A LANGUAGE AND ENV; Raz E, 2003, NAT REV GENET, V4, P690, DOI 10.1038/nrg1154; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saito T, 2006, INT J DEV BIOL, V50, P691, DOI 10.1387/ijdb.062143ts; Strasser U, 2008, NAT HAZARD EARTH SYS, V8, P1, DOI 10.5194/nhess-8-1-2008; Strome S, 2015, NAT REV MOL CELL BIO, V16, P406, DOI 10.1038/nrm4009; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Tong SK, 2010, DEV BIOL, V344, P849, DOI 10.1016/j.ydbio.2010.05.515; Tzung KW, 2015, STEM CELL REP, V4, P61, DOI 10.1016/j.stemcr.2014.10.011; Veldman MB, 2008, PEDIATR RES, V64, P470, DOI 10.1203/PDR.0b013e318186e609; Vesterlund L, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-30; Walser CB, 2011, CURR OPIN GENET DEV, V21, P431, DOI 10.1016/j.gde.2011.03.003; Wang HN, 2016, DEV GROWTH DIFFER, V58, P355, DOI 10.1111/dgd.12279; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weidinger G, 2003, CURR BIOL, V13, P1429, DOI 10.1016/S0960-9822(03)00537-2; Weidinger G, 2002, DEVELOPMENT, V129, P25; Weidinger G, 1999, DEVELOPMENT, V126, P5295; Westerfield M., 2000, THE ZEBRAFISH BOOK A; White RJ, 2017, ELIFE, V6, DOI [10.7554/eLife.30860.001, 10.7554/eLife.30860]; Wibrand K, 2002, MECH DEVELOP, V117, P249, DOI 10.1016/S0925-4773(02)00173-9; Yamaji M, 2017, NATURE, V543, P568, DOI 10.1038/nature21690; Yang HX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064799, 10.1371/journal.pone.0064058]; Yoon C, 1997, DEVELOPMENT, V124, P3157; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang J, 2017, DYN GAMES APPL, V7, P112, DOI 10.1007/s13235-015-0165-z; Zhao SY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05105-8	57	5	7	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0220364	10.1371/journal.pone.0220364	http://dx.doi.org/10.1371/journal.pone.0220364			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412047	gold, Green Published, Green Submitted			2022-12-26	WOS:000485012600027
J	Sui, J; Luan, S; Yang, GL; Xia, ZL; Luo, K; Tang, QY; Lu, X; Meng, XH; Kong, J				Sui, Juan; Luan, Sheng; Yang, Guoliang; Xia, Zhenglong; Luo, Kun; Tang, Qiongying; Lu, Xia; Meng, Xianhong; Kong, Jie			Genetic parameters and selection response for the harvest body weight of the giant freshwater prawn (Macrobrachium rosenbergii) in a breeding program in China	PLOS ONE			English	Article							OPTIMUM CONTRIBUTION SELECTION; LINEAR UNBIASED PREDICTION; MORPHOTYPIC DIFFERENTIATION; SIBSHIP INFERENCE; GROWTH TRAITS; DE-MAN; PARENTAGE; HERITABILITY; POPULATIONS; FISH	A multi-trait selective breeding program of Macrobrachium rosenbergii was initiated in China in 2015. In this program, the M. rosenbergii resources were widely collected from four countries, the origin of the founders was verified with 16 microsatellites and the pedigree was reconstructed, and the optimum contribution selection was used to make the mating design. In this study, we evaluated the genetic parameters and selection response for the harvest body weight (HBW) of M. rosenbergii after being communally reared for 95-109 days. The data were collected from two generations that comprised 25,212 progenies from 150 sires and 198 dams. The residual maximum-likelihood methodology was employed to evaluate the variance components, by fitting an animal model. The accuracy of estimated breeding values increased by 0.38% after pedigree reconstruction using microsatellite markers. The estimated heritability (h(2)) for HBW was moderate (0.212 +/- 0.049) and the common environmental coefficient (c(2)) was low (0.063 +/- 0.017) when all the data were used for the analysis. Within generations, h(2) was moderate to high (0.198 +/- 0.080 to 0.338 +/- 0.049). c(2) could only be estimated in G(1), which was 0.055 +/- 0.030. The average HBW of males was significantly larger than that of females (P < 0.01). h(2) estimated for female HBWs were higher than that for males within generations, while h(2) estimated for female HBWs were lower than that for males across generations. But they were not significantly different (P > 0.05). The genetic correlations between sexes were moderate to high within each generation (0.529 to 0.763). Two methods were used to estimate the realized response. One method was calculated from the differences between the least squares means of the selected population HBW and that of control population HBW, which was 14.01%. The other method was calculated from the differences between the EBVs of the selected population HBW and that of control population HBW, which was 11.52%. The predicted responses derived from two sets of genetic parameters acquired from within- and across-generation datasets were 11.68% and 10.67%, respectively. The present study provides valuable information for breeding programs of M. rosenbergii.	[Sui, Juan; Luan, Sheng; Luo, Kun; Lu, Xia; Meng, Xianhong; Kong, Jie] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Utilizat Marine Fisheries Res, Minist Agr, Qingdao, Shandong, Peoples R China; [Sui, Juan; Luan, Sheng; Luo, Kun; Lu, Xia; Meng, Xianhong; Kong, Jie] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Shandong, Peoples R China; [Yang, Guoliang; Tang, Qiongying] Huzhou Univ, Huzhou, Peoples R China; [Xia, Zhenglong] Jiangsu Shufeng Prawn Breeding Co LTD, Gaoyou, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Qingdao National Laboratory for Marine Science & Technology; Huzhou University	Kong, J (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Utilizat Marine Fisheries Res, Minist Agr, Qingdao, Shandong, Peoples R China.; Kong, J (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Shandong, Peoples R China.	kongjie@ysfri.ac.cn			China Agriculture Research System [CARS-48]; Projects of International Exchange and Cooperation in Agriculture, Ministry of Agriculture and Rural Affairs of China-Science; Technology and Innovation Cooperation in Aquaculture with Tropical Countries; Taishan scholar program for seed industry; Special funds for major science and technology of breeding new agriculture (aquatic) varieties in Zhejiang province [2016C02055-2-1]	China Agriculture Research System; Projects of International Exchange and Cooperation in Agriculture, Ministry of Agriculture and Rural Affairs of China-Science; Technology and Innovation Cooperation in Aquaculture with Tropical Countries; Taishan scholar program for seed industry; Special funds for major science and technology of breeding new agriculture (aquatic) varieties in Zhejiang province	This study was supported by China Agriculture Research System (CARS-48); Projects of International Exchange and Cooperation in Agriculture, Ministry of Agriculture and Rural Affairs of China-Science; Technology and Innovation Cooperation in Aquaculture with Tropical Countries; The Taishan scholar program for seed industry; Special funds for major science and technology of breeding new agriculture (aquatic) varieties in Zhejiang province (2016C02055-2-1). The funder provided support in the form of research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The commercial company: Jiangsu Shufeng Prawn Breeding Co. LTD did not provided financial support but did play a role in this study. The specific roles of all the authors are articulated in the ` author contributions' section.	Avendano S, 2004, GENET RES, V83, P55, DOI 10.1017/S0016672303006566; Avendano S, 2003, J ANIM SCI, V81, P2964; Bijma P, 1999, GENETICS, V151, P1197; Charoentawee K, 2006, MOL ECOL NOTES, V6, P823, DOI 10.1111/j.1471-8286.2006.01358.x; Dai XL, BIOTECHNOLOGY B, V32, P192; Hung D, 2013, AQUACULTURE, V412, P70, DOI 10.1016/j.aquaculture.2013.07.015; Hung D, 2013, AQUACULTURE, V404, P122, DOI 10.1016/j.aquaculture.2013.04.027; Gheyas AA, 2009, AQUACULTURE, V294, P187, DOI 10.1016/j.aquaculture.2009.06.013; Gilmour A. R., 2015, ASREML USER GUIDE RE; Gitterle T, 2005, AQUACULTURE, V243, P83, DOI 10.1016/j.aquaculture.2004.10.015; Gjedrem T, 2000, AQUAC RES, V31, P25, DOI 10.1046/j.1365-2109.2000.00389.x; Gjedrem T, 2012, AQUACULTURE, V344, P12, DOI 10.1016/j.aquaculture.2012.03.003; Gopal C, 2010, AQUACULTURE, V300, P237, DOI 10.1016/j.aquaculture.2010.01.007; Grundy B, 1998, GENET RES, V72, P159, DOI 10.1017/S0016672398003474; HANSFORD SW, 1994, AQUACULTURE, V125, P147, DOI 10.1016/0044-8486(94)90291-7; Howard DM, 2018, GENET SEL EVOL, V50, DOI 10.1186/s12711-018-0392-z; HULATA G, 1990, Journal of the World Aquaculture Society, V21, P295, DOI 10.1111/j.1749-7345.1990.tb00542.x; Dinh H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090142; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Karplus I, 2005, AQUAC RES, V36, P238, DOI 10.1111/j.1365-2109.2005.01239.x; Kause A, 2005, AQUACULTURE, V247, P177, DOI 10.1016/j.aquaculture.2005.02.023; Kearney JF, 2004, J DAIRY SCI, V87, P3503, DOI 10.3168/jds.S0022-0302(04)73485-2; Kinghorn BP., 2000, ANIMAL BREEDING USE, P291; Kitcharoen N, 2012, AQUAC RES, V43, P19, DOI 10.1111/j.1365-2109.2011.02796.x; KURIS AM, 1987, J CRUSTACEAN BIOL, V7, P219, DOI 10.2307/1548603; Luan S, 2012, AQUACULTURE, V362, P88, DOI 10.1016/j.aquaculture.2012.05.011; Meuwissen THE, 1997, J ANIM SCI, V75, P934; Mohanty P, 2013, CONSERV GENET RESOUR, V5, P133, DOI 10.1007/s12686-012-9751-1; New M.B., 2010, FRESHWATER PRAWNS BI, Vfirst; Nguyen NH, 2007, AQUACULTURE, V272, pS38, DOI 10.1016/j.aquaculture.2007.08.013; Nguyen TTT, 2011, J ANIM BREED GENET, V128, P482, DOI 10.1111/j.1439-0388.2011.00948.x; Nielsen HM, 2011, J ANIM SCI, V89, P630, DOI 10.2527/jas.2009-2731; Pillai BR, 2017, AQUAC RES, V48, P5741, DOI 10.1111/are.13397; Pillai BR, 2015, AQUAC RES, V46, P2644, DOI 10.1111/are.12419; Ponzoni RW, 2005, AQUACULTURE, V247, P203, DOI 10.1016/j.aquaculture.2005.02.020; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; SAGI A, 1988, J CRUSTACEAN BIOL, V8, P43, DOI 10.2307/1548428; Sambrook J., 2001, MOL CLONING LAB MANU; Skaarud A, 2011, AQUACULTURE, V311, P110, DOI 10.1016/j.aquaculture.2010.11.023; Sonesson AK, 2005, GENET SEL EVOL, V37, P587, DOI 10.1051/gse:2005020; Sonesson AK, 2005, AQUACULTURE, V243, P61, DOI 10.1016/j.aquaculture.2004.09.024; Sorensen AC, 2005, GENET SEL EVOL, V37, P57, DOI 10.1051/gse:2004036; Sorensen MK, 2008, LIVEST SCI, V118, P212, DOI 10.1016/j.livsci.2008.01.027; Sui J, 2016, AQUACULTURE, V452, P134, DOI 10.1016/j.aquaculture.2015.08.011; Thanh NM, 2010, AQUACULTURE, V299, P30, DOI 10.1016/j.aquaculture.2009.12.011; Vandeputte M, 2004, AQUACULTURE, V235, P223, DOI 10.1016/j.aquaculture.2003.12.019; Wang J, 2009, GENETICS, V181, P1579, DOI 10.1534/genetics.108.100214; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Woolliams JA, 2015, J ANIM BREED GENET, V132, P89, DOI 10.1111/jbg.12148; Woolliams JA, 1999, GENETICS, V153, P1009; Zhong DD, 2015, AGR SCI GUANGDONG, V5, P140	52	8	8	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0218379	10.1371/journal.pone.0218379	http://dx.doi.org/10.1371/journal.pone.0218379			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404067	Green Published, Green Submitted, gold			2022-12-26	WOS:000485006800005
J	Saha, UR; Chattapadhayay, A; Richardus, JH				Saha, Unnati Rani; Chattapadhayay, Aparajita; Richardus, Jan Hendrik			Trends, prevalence and determinants of childhood chronic undernutrition in regional divisions of Bangladesh: Evidence from demographic health surveys, 2011 and 2014	PLOS ONE			English	Article							FERTILITY DECLINE; CHILDREN; MALNUTRITION; NUTRITION; WOMEN; URBAN	Background Undernutrition, an important indicator for monitoring progress of development goals, is a matter of concern in many developing countries, including Bangladesh. Despite regional differences in chronic undernutrition in Bangladesh, regional determinants among children under the age of five were not extensively explored. Data and methods Using combined repeated cross-sectional nationwide Bangladesh Demographic and Health Surveys (BDHS 2011 and 2014) and employing bivariate and logistic regression analyses, we estimated prevalence, changes and variations in regional determinants of stunting among children aged 6-59 months over two time periods 2011 and 2014. Results Our benchmark results suggested that the children from Rajshahi, Khulna, Rangpur, Chittagong and Dhaka tend to be significantly less stunted by 51% (p = 0.000; CI = [0.38, 0.63]), 44% (p = 0.000; CI = [0.44, 0.71]), 26% (p = 0.012; CI = [0.58, 0.93]), 23% (p = 0.012; CI = [0.62, 0.95]) and 22% (p = 0.033; [0.63, 0.97]) respectively, against Sylhet in 2011. With the exception of Dhaka, no region showed significant differences in the odds of stunting over two time periods 2011 and 2014, i. e. only Dhaka revealed significant difference by 30% reductions in the odds of stunting in 2014. Also, rural children were less likely to be stunted (by 19%) of the urban counterparts. Regional covariates of stunting differ. However, children's age, household wealth, mother's height, and parental education were important determinants of stunting in Bangladesh. Conclusion Dhaka made an impressive improvement in child nutrition, thus contributed largely to the reduction of stunting levels in Bangladesh for 2014 over 2011. Sylhet and Barisal require strong push to improve nutritional status of children. Further decline is possible through region-specific multipronged interventions that can address area-specific covariates to break the cycle of undernutrition like strengthening economic and educational status, emphasizing the role of father to augment their knowledge in varying aspects like family planning, reduction of fertility and by improving mother's health.	[Saha, Unnati Rani; Richardus, Jan Hendrik] Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands; [Chattapadhayay, Aparajita] IIPS, Mumbai, Maharashtra, India	Erasmus University Rotterdam; Erasmus MC; International Institute for Population Sciences	Saha, UR (corresponding author), Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands.	u.saha@erasmusmc.nl	Richardus, Jan Hendrik/AAE-1278-2021	Richardus, Jan Hendrik/0000-0003-0564-6313; Saha, Unnati Rani/0000-0002-4019-9697				Ahmed T, 2012, J HEALTH POPUL NUTR, V30, P1; Amin S, 2002, POPUL RES POLICY REV, V21, P275, DOI 10.1023/A:1020030616075; Basu AM, 2000, POPUL DEV REV, V26, P761, DOI 10.1111/j.1728-4457.2000.00761.x; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; Chattopadhyay A., 2005, DEMOGRAPHY INDIA, V34, P299; Chattopadhyay A, 2007, J BIOSOC SCI, V39, P267, DOI 10.1017/S002193200600126X; Das S., 2009, Asia-Pacific Population Journal, V24, P51; FANTA, SCAL NUTR INT BANGL; Government of India Ministry of Health and Family Welfare, 2017, NATL FAMILY HLTH SUR; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Hanchett S., 2016, CLTS KNOWLEDGE HUB L; Hasan MM, 2018, INDIAN J PUBLIC HLTH, V62, P82, DOI 10.4103/ijph.IJPH_153_17; Hasan MT, 2015, PUBLIC HEALTH NUTR, V18, P1728, DOI 10.1017/S1368980014003279; Hoddinott J, 2013, MATERN CHILD NUTR, V9, P69, DOI 10.1111/mcn.12080; Hong Rathavuth, 2006, Int J Equity Health, V5, P15, DOI 10.1186/1475-9276-5-15; Kent JL, 2014, J PLAN LIT, V29, P239, DOI 10.1177/0885412214520712; Ministry of Planning, 2007, STAT POCK BOOK BANGL; National Encyclopedia of Bangladesh, BANGL SOIL; National Institute of Population Research and Training (NIPORT) Mitra and Associates and ICF International, 2016, BANGL DEM HLTH SURV; NIPORT Mitra and Associates and ICF International, 2013, BANGL DEM HLTH SURV; Nisbett N, 2017, GLOB FOOD SECUR-AGR, V13, P21, DOI 10.1016/j.gfs.2017.01.005; Quddus MA, 2004, J AGR ECON, V2, P57; Rahman AM, 2018, J HLTH RES, V5; Rahman A, 2009, ASIA-PAC J PUBLIC HE, V21, P294, DOI 10.1177/1010539509335399; Rahman MS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157814; Rajia S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211875; Saha KK, 2009, PUBLIC HEALTH NUTR, V12, P1556, DOI 10.1017/S1368980009004765; Shetty P, 2003, WHO TECHN REP SER, V916; Siddhanta A., 2017, ROLE WOMENS EMPOWERM, V3, P38; Smith LC, 2005, WORLD DEV, V33, P1285, DOI 10.1016/j.worlddev.2005.03.002; Srinivasan CS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-581; Tanwi TS, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-019-0725-2; Unicef and World Health Organization, 2015, PROGR SAN DRINK WAT; United Nations, 2001, SECR GEN REP GEN ASS; United Nations, 2015, 2030 AG SUST DEV; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; World Health Organization, 2016, CHILDR RED MORT; Zahangir MS, 2017, NUTR DIABETES, V7, DOI 10.1038/nutd.2017.2	39	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220062	10.1371/journal.pone.0220062	http://dx.doi.org/10.1371/journal.pone.0220062			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5FL	31398208	gold, Green Published, Green Submitted			2022-12-26	WOS:000485004000009
J	Tang, YK; Wu, YS; Liu, K; Li, JL; Li, HX; Wang, Q; Yu, JH; Xu, P				Tang, Yongkai; Wu, Yunsheng; Liu, Kai; Li, Jianlin; Li, Hongxia; Wang, Qin; Yu, Juhua; Xu, Pao			Investigating the distribution of the Yangtze finless porpoise in the Yangtze River using environmental DNA	PLOS ONE			English	Article							BIODIVERSITY; EDNA	Determining the distribution of the Yangtze finless porpoise (Neophocaena asiaeorientalis asiaeorientalis, YFP) in the Yangtze River has to date relied on traditional visual and counting methods, but such field surveys are time-consuming and expensive. Analyses using environmental DNA (eDNA) to investigate the presence and range of endangered aquatic species have proven to be more economical and effective detection methods, and are a non-invasive approach to sampling. A challenge of relying on eDNA for YFP monitoring is that the Yangtze River is characterized by high turbidity and a strong current. Here, we used an eDNA-based approach to estimate the presence of YFP at 18 sites in the Yangtze River in August 2017 and at an additional 11 sites in January 2018. At each sampling site, we filtered six 1 L water samples with 5 pm pore size filter paper and quantified the amount of YFP eDNA in each water sample using quantitative real-time polymerase chain reaction (qPCR). In addition, YFP eDNA was successfully detected in locations where we visually observed YFP, as well as in locations where YFP were not observed directly. We found that our eDNA-based method had higher detection rates than traditional field survey methods. Although YFP was visually observed in the Yangtze River in winter, water samples collected during the summer contained significantly higher YFP eDNA than winter water samples. Our results demonstrate the potential effectiveness of eDNA detection methods in determining the distribution of YFP in the Yangtze River.	[Tang, Yongkai; Liu, Kai; Li, Jianlin; Li, Hongxia; Yu, Juhua; Xu, Pao] Chinese Acad Fishery Sci, Key Lab Freshwater Fisheries & Germplasm Resource, Minist Agr, Freshwater Fisheries Res Ctr, Wuxi, Jiangsu, Peoples R China; [Tang, Yongkai; Wu, Yunsheng; Liu, Kai; Wang, Qin; Yu, Juhua; Xu, Pao] Nanjing Agr Univ, Wuxi Fisheries Coll, Wuxi, Jiangsu, Peoples R China	Chinese Academy of Fishery Sciences; Freshwater Fisheries Research Center, CAFS; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Yu, JH; Xu, P (corresponding author), Chinese Acad Fishery Sci, Key Lab Freshwater Fisheries & Germplasm Resource, Minist Agr, Freshwater Fisheries Res Ctr, Wuxi, Jiangsu, Peoples R China.; Yu, JH; Xu, P (corresponding author), Nanjing Agr Univ, Wuxi Fisheries Coll, Wuxi, Jiangsu, Peoples R China.	yujh@ffrc.cn; xup@ffrc.cn		tang, yongkai/0000-0002-5643-2844	Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of fishery Science [2017HY-XKQ0201]; Project on rehabilitation of fishery resources in the Xiangjiaba reservoir and protection of rare and endemic species of the Yangtze River (F02 Yangtze finless porpoises migration and domestication in Xijiang reserve); Jiangsu Province Yangtze finless porpoises Breeding project [2016-36]	Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of fishery Science; Project on rehabilitation of fishery resources in the Xiangjiaba reservoir and protection of rare and endemic species of the Yangtze River (F02 Yangtze finless porpoises migration and domestication in Xijiang reserve); Jiangsu Province Yangtze finless porpoises Breeding project	Funding for this study was provided by the Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of fishery Science (2017HY-XKQ0201), Project on rehabilitation of fishery resources in the Xiangjiaba reservoir and protection of rare and endemic species of the Yangtze River (F02 Yangtze finless porpoises migration and domestication in Xijiang reserve), Jiangsu Province Yangtze finless porpoises Breeding project (2016-36). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Dai L.L., 2011, J HYDROECOL, V32, P30, DOI [10.15928/j.1674-3075.2011.05.001, DOI 10.15928/J.1674-3075.2011.05.001]; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Ding W., 2019, CHINESE SCI BULL, V54, P3473; Doi H, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170568; Dong LJ, 2015, MAR MAMMAL SCI, V31, P612, DOI 10.1111/mms.12181; Geerts AN, 2018, ECOL INDIC, V84, P564, DOI 10.1016/j.ecolind.2017.08.068; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Jane SF, 2015, MOL ECOL RESOUR, V15, P216, DOI 10.1111/1755-0998.12285; Jerde CL, 2013, CAN J FISH AQUAT SCI, V70, P522, DOI 10.1139/cjfas-2012-0478; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; LI MZ, 2017, SCI FISH FARM, V8, P19621, DOI DOI 10.3389/FPHAR.2017.00142; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; Minamoto T, 2016, LIMNOLOGY, V17, P23, DOI 10.1007/s10201-015-0457-4; Parajuli N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048590; Shaw JLA, 2016, BIOL CONSERV, V197, P131, DOI 10.1016/j.biocon.2016.03.010; Stewart K, 2017, CONSERV BIOL, V183, P410; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; Williams KE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179282; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997; Yamanaka H, 2016, ECOL INDIC, V62, P147, DOI 10.1016/j.ecolind.2015.11.022	24	3	4	9	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0221120	10.1371/journal.pone.0221120	http://dx.doi.org/10.1371/journal.pone.0221120			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398225	Green Published, Green Submitted, gold			2022-12-26	WOS:000485004000046
J	Kim, KJ; Kim, KH; Kim, WH; Sohn, DW				Kim, Kyung-Jin; Kim, Kyung-Hwan; Kim, Woong-Han; Sohn, Dae-Won			Postoperative persistent diastolic dyssynchronous expansion in patients with Ebstein's anomaly	PLOS ONE			English	Article							TRICUSPID-VALVE; TASK-FORCE; ECHOCARDIOGRAPHY; COMMITTEE; FEATURES; FETUS	In Ebstein's anomaly, maximal expansion in the atrialized right ventricle (RV) occurs during early diastole, whereas that of the functional RV occurs in late diastole, resulting in diastolic dyssynchronous expansion (DSE). We quantitatively assessed DSE and identified preoperative factors correlated with persistent DSE after surgery. Seventeen patients diagnosed with Ebstein's anomaly in whom transthoracic echocardiography (TTE) and cardiac magnetic resonance (CMR) images available were retrospectively analyzed for quantitative DSE assessment and 10 patients who underwent surgery and postoperative TTE available were additionally analyzed for postoperative DSE. Severity of DSE was assessed by the time difference of maximal expansion between the atrialized and functional RV divided by the cardiac cycle length x 100 ("DSE index"). Relations between DSE and, clinical, electrophysiologic parameters and the severity of tricuspid valve (TV) tethering (the RV length / tethering height during diastole: "Tethering index") were assessed. In total patients, median DSE index and tethering index were 30.3 and 2.1 respectively, and the DSE index was correlated with tethering index (r(s) = 0.664, P = 0.004). In 10 patients who underwent surgery, this association remained after surgery and at 2-year follow up. Tethering index >= 2.5 separated patients with and without persistent DSE. In conclusion, DSE exists in Ebstein's anomaly. DSE index is related to the tethering index and DSE persists postoperatively if tethering index >= 2.5. As the persistent DSE might possibly impede the optimal recovery of RV function after surgery, severity of TV tethering should take into account in considering surgery.	[Kim, Kyung-Jin] Ewha Womans Univ, Med Ctr, Sch Med, Dept Internal Med,Div Cardiol, Seoul, South Korea; [Kim, Kyung-Hwan; Kim, Woong-Han] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea; [Sohn, Dae-Won] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Cardiovasc Ctr,Dept Internal Med, Seoul, South Korea	Ewha Womans University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Sohn, DW (corresponding author), Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Cardiovasc Ctr,Dept Internal Med, Seoul, South Korea.	dwsohn@snu.ac.kr		Sohn, Dae-Won/0000-0002-1092-3285; Kim, Kyung-Hwan Kim/0000-0002-2718-8758				Attie F, 2000, MEDICINE, V79, P27, DOI 10.1097/00005792-200001000-00003; Badiu CC, 2010, EUR J CARDIO-THORAC, V37, P186, DOI 10.1016/j.ejcts.2009.06.052; BENSON LN, 1987, CIRCULATION, V75, P353, DOI 10.1161/01.CIR.75.2.353; CARPENTIER A, 1988, J THORAC CARDIOV SUR, V96, P92; CELERMAJER DS, 1992, J AM COLL CARDIOL, V19, P1041, DOI 10.1016/0735-1097(92)90291-T; CELERMAJER DS, 1994, J AM COLL CARDIOL, V23, P170, DOI 10.1016/0735-1097(94)90516-9; Cheitlin MD, 1997, CIRCULATION, V95, P1686; Daliento L, 1997, AM J CARDIOL, V80, P1051, DOI 10.1016/S0002-9149(97)00602-4; Dearani JA, 2015, EXPERT REV CARDIOVAS, V13, P1101, DOI 10.1586/14779072.2015.1087849; Ebstein W., 1866, UEBER SEHR SELTENEN; Fabian C E, 1966, Invest Radiol, V1, P63, DOI 10.1097/00004424-196601000-00030; Fratz S, 2013, INT J CARDIOL, V167, P258, DOI 10.1016/j.ijcard.2011.12.081; Frescura C, 2000, THORAC CARDIOV SURG, V48, P203, DOI 10.1055/s-2000-6893; Hosch O, 2014, CIRC-CARDIOVASC IMAG, V7, P601, DOI 10.1161/CIRCIMAGING.113.001467; Jost CHA, 2007, CIRCULATION, V115, P277, DOI 10.1161/CIRCULATIONAHA.106.619338; Park JB, 2016, RADIOLOGY, V280, P723, DOI 10.1148/radiol.2016151556; Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202; ROBERSON DA, 1989, J AM COLL CARDIOL, V14, P1300, DOI 10.1016/0735-1097(89)90432-4; SHIINA A, 1983, CIRCULATION, V68, P534, DOI 10.1161/01.CIR.68.3.534; Silva José Pedro da, 2004, Arq. Bras. Cardiol., V82, P212, DOI 10.1590/S0066-782X2004000300002; Tobler D, 2013, INT J CARDIOL, V165, P146, DOI 10.1016/j.ijcard.2011.08.004; Warnes CA, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; WATSON H, 1974, BRIT HEART J, V36, P417; Yalonetsky S, 2011, AM J CARDIOL, V107, P767, DOI 10.1016/j.amjcard.2010.10.058; YIM BJB, 1958, CIRCULATION, V17, P543, DOI 10.1161/01.CIR.17.4.543	25	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220890	10.1371/journal.pone.0220890	http://dx.doi.org/10.1371/journal.pone.0220890			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393951	Green Published, Green Submitted, gold			2022-12-26	WOS:000485002500079
J	Richter, J; Tryfonos, C; Christodoulou, C				Richter, Jan; Tryfonos, Christina; Christodoulou, Christina			Molecular epidemiology of enteroviruses in Cyprus 2008-2017	PLOS ONE			English	Article							NON-POLIO ENTEROVIRUSES; MOUTH-DISEASE; ECHOVIRUS 30; COXSACKIEVIRUS A6; VIRAL MENINGITIS; HAND; FOOT; OUTBREAK; INFECTIONS; SURVEILLANCE	Enteroviruses (EVs) are associated with a broad spectrum of disease manifestations, including aseptic meningitis, encephalitis, hand, foot and mouth disease, acute flaccid paralysis and acute flaccid myelitis with outbreaks being reported frequently world-wide. The aim of this study was the molecular characterization of all enteroviruses detected in Cyprus in the ten-year period from January 2008 and December 2017 as well as a description of the circulation patterns associated with the most frequently encountered genotypes. For this purpose, serum, cerebrospinal fluid, nasal swab, skin swab and/or stool samples from 2666 patients with a suspected EV infection were analysed between January 2008 and December 2017. Enteroviruses were detected in 295 (11.1%) patients, which were then investigated further for epidemiological analysis by VP1 genotyping. Overall, 24 different enterovirus types belonging to three different species were identified. The predominant species was EV-B (209/295, 71%), followed by species EV-A (77/295, 26.1%). Only one virus belonged to species EV-D, whereas EV-C enteroviruses were not identified at all. The most frequent genotypes identified were echovirus 30 (26.1%), echovirus 6 (14.2%) and coxsackievirus A6 (10.9%). While Echovirus 30 and echovirus 6 frequency was significantly higher in patients older than 3 years of age, the opposite was observed for CV-A16 and EV-A71, which dominated in young children less than 3 years. Importantly, for the current study period a significant increase of previously only sporadically observed EV-A types, such as EV-A71 and CV-A16 was noted. A phylogenetic analysis of EV-A71 showed that the majority of the EV-A71 strains from Cyprus belonged to sub-genogroup C1 and C2, with the exception of one C4 strain that was observed in 2011. The data presented provide a comprehensive picture of enteroviruses circulating in Cyprus over the last decade and will be helpful to clinicians and researchers involved in the treatment, prevention and control of enteroviral infections by helping interpret trends in enteroviral diseases by associating them with circulating serotypes, for studying the association of enteroviruses with clinical manifestations and develop strategies for designing future EV vaccines.	[Richter, Jan; Tryfonos, Christina; Christodoulou, Christina] Cyprus Inst Neurol & Genet, Dept Mol Virol, Nicosia, Cyprus		Richter, J (corresponding author), Cyprus Inst Neurol & Genet, Dept Mol Virol, Nicosia, Cyprus.	richter@cing.ac.cy						Abedi GR, 2015, MMWR-MORBID MORTAL W, V64, P940, DOI 10.15585/mmwr.mm6434a3; Akhmadishina LV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097404; Bailly JL, 2011, INFECT GENET EVOL, V11, P276, DOI 10.1016/j.meegid.2010.06.019; Bailly JL, 2009, INFECT GENET EVOL, V9, P699, DOI 10.1016/j.meegid.2008.04.009; Benschop KS, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.39.30351; Bian LL, 2015, EXPERT REV ANTI-INFE, V13, P1061, DOI 10.1586/14787210.2015.1058156; Blomqvist S, 2010, J CLIN VIROL, V48, P49, DOI 10.1016/j.jcv.2010.02.002; Broberg EK, 2018, EUROSURVEILLANCE, V23, P2, DOI 10.2807/1560-7917.ES.2018.23.44.1800537; Cabrerizo M, 2014, CLIN MICROBIOL INFEC, V20, pO150, DOI 10.1111/1469-0691.12361; Cabrerizo M, 2014, J MED VIROL, V86, P857, DOI 10.1002/jmv.23741; Christian Kira A, 2013, Emerg Health Threats J, V6, P20632, DOI 10.3402/ehtj.v6i0.20632; Cordey S, 2017, J CLIN VIROL, V89, P22, DOI 10.1016/j.jcv.2017.01.008; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Fischer TK, 2014, EUROSURVEILLANCE, V19, P5, DOI 10.2807/1560-7917.ES2014.19.38.20911; Gonzalez-Sanz R, 2016, EUROSURVEILLANCE, V24, DOI [10.2807/1560-7917.ES.2019.24.7, DOI 10.2807/1560-7917.ES.2019.24.7]; Guerra JA, 2017, J MED VIROL, V89, P1550, DOI 10.1002/jmv.24765; He YQ, 2013, J CLIN MICROBIOL, V51, P3560, DOI 10.1128/JCM.01231-13; Henquell C, 2013, J VIROL, V87, P12249, DOI 10.1128/JVI.02075-13; Holm-Hansen CC, 2016, LANCET INFECT DIS, V16, pE64, DOI 10.1016/S1473-3099(15)00543-5; Holmes CW, 2016, J CLIN VIROL, V81, P90, DOI 10.1016/j.jcv.2016.06.007; Jubelt B, 2014, HAND CLINIC, V123, P379, DOI 10.1016/B978-0-444-53488-0.00018-3; Khetsuriani N., 2006, ENTEROVIRUS SURVEILL; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lang M, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.44.20952; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leitch ECM, 2009, J VIROL, V83, P2109, DOI 10.1128/JVI.02109-08; Li H, 2017, ADV BIO SCI RES, V4, P113; Lu YQ, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/210490; Mantadakis E, 2013, PEDIATR INFECT DIS J, V32, P914, DOI 10.1097/INF.0b013e31828f875c; Milia MG, 2013, J CLIN VIROL, V58, P579, DOI 10.1016/j.jcv.2013.08.023; Mirand A, 2012, CLIN MICROBIOL INFEC, V18, pE110, DOI 10.1111/j.1469-0691.2012.03789.x; Oermann CM, 2015, ANN AM THORAC SOC, V12, P775, DOI 10.1513/AnnalsATS.201412-592FR; Osterback R, 2015, J CLIN VIROL, V69, P7, DOI 10.1016/j.jcv.2015.05.012; Papa A, 2009, EUR J CLIN MICROBIOL, V28, P683, DOI 10.1007/s10096-008-0685-1; Perez-Velez CM, 2007, CLIN INFECT DIS, V45, P950, DOI 10.1086/521895; Poelman R, 2015, J CLIN VIROL, V71, P1, DOI 10.1016/j.jcv.2015.07.296; Pons-Salort M, 2015, CURR OPIN INFECT DIS, V28, P479, DOI 10.1097/QCO.0000000000000187; Rabenau HF, 2010, MED MICROBIOL IMMUN, V199, P45, DOI 10.1007/s00430-009-0133-6; Richter J, 2011, J APPL MICROBIOL, V111, P491, DOI 10.1111/j.1365-2672.2011.05061.x; Richter J, 2006, J MED MICROBIOL, V55, P1035, DOI 10.1099/jmm.0.46447-0; Rudolph H, 2017, EUR J CLIN MICROBIOL, V36, P1651, DOI 10.1007/s10096-017-2979-7; Savolainen C, 2001, ARCH VIROL, V146, P521, DOI 10.1007/s007050170160; Savolainen-Kopra C, 2011, VIRUS GENES, V42, P28, DOI 10.1007/s11262-010-0536-x; Schuffenecker I, 2014, EMERG INFECT DIS, V20, P1343, DOI 10.3201/eid2008.131858; Schuffenecker I, 2011, J CLIN VIROL, V50, P50, DOI 10.1016/j.jcv.2010.09.019; Smura T, 2013, INFECT GENET EVOL, V16, P234, DOI 10.1016/j.meegid.2013.02.011; Tan XJ, 2015, ARCH VIROL, V160, P1097, DOI 10.1007/s00705-015-2340-3; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Tao ZX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089766; Tao ZX, 2012, APPL ENVIRON MICROB, V78, P6946, DOI 10.1128/AEM.01861-12; Tapparel C, 2013, INFECT GENET EVOL, V14, P282, DOI 10.1016/j.meegid.2012.10.016; Trallero G, 2010, J CLIN VIROL, V47, P170, DOI 10.1016/j.jcv.2009.11.013; Tryfonos C, 2011, J MED MICROBIOL, V60, P1433, DOI 10.1099/jmm.0.029892-0; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Yarmolskaya MS, 2015, INFECT GENET EVOL, V30, P244, DOI 10.1016/j.meegid.2014.12.033; Zell R, 2017, J GEN VIROL, V98, P2421, DOI 10.1099/jgv.0.000911; Zhang Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059086, 10.1371/journal.pone.0056341]; Zhuang ZC, 2015, VIRUSES-BASEL, V7, P6400, DOI 10.3390/v7122947	59	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220938	10.1371/journal.pone.0220938	http://dx.doi.org/10.1371/journal.pone.0220938			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393960	Green Published, gold, Green Submitted			2022-12-26	WOS:000485002500084
J	Stolerman, LM; Maia, PD; Kutz, JN				Stolerman, Lucas M.; Maia, Pedro D.; Kutz, J. Nathan			Forecasting dengue fever in Brazil: An assessment of climate conditions	PLOS ONE			English	Article							RIO-DE-JANEIRO; AEDES-AEGYPTI; TEMPERATURE; VECTOR; TRANSMISSION; VIRUS; CULICIDAE; EPIDEMICS; DIPTERA; MODEL	Local climate conditions play a major role in the biology of the Aedes aegypti mosquito, the main vector responsible for transmitting dengue, zika, chikungunya and yellow fever in urban centers. For this reason, a detailed assessment of periods in which changes in climate conditions affect the number of human cases may improve the timing of vector-control efforts. In this work, we develop new machine-learning algorithms to analyze climate time series and their connection to the occurrence of dengue epidemic years for seven Brazilian state capitals. Our method explores the impact of two key variables-frequency of precipitation and average temperature-during a wide range of time windows in the annual cycle. Our results indicate that each Brazilian state capital considered has its own climate signatures that correlate with the overall number of human dengue-cases. However, for most of the studied cities, the winter preceding an epidemic year shows a strong predictive power. Understanding such climate contributions to the vector's biology could lead to more accurate prediction models and early warning systems.	[Stolerman, Lucas M.] Fiocruz MS, Programa Comp Cient PROCC, Rio De Janeiro, RJ, Brazil; [Stolerman, Lucas M.] IMPA, Rio De Janeiro, RJ, Brazil; [Maia, Pedro D.; Kutz, J. Nathan] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA	Fundacao Oswaldo Cruz; Instituto Nacional de Matematica Pura e Aplicada (IMPA); University of Washington; University of Washington Seattle	Stolerman, LM (corresponding author), Fiocruz MS, Programa Comp Cient PROCC, Rio De Janeiro, RJ, Brazil.; Stolerman, LM (corresponding author), IMPA, Rio De Janeiro, RJ, Brazil.	lstolerman@eng.ucsd.edu	Batista, Ewerthon/AAY-5409-2020	D. Maia, Pedro/0000-0002-3335-4257; Stolerman, Lucas/0000-0001-6313-0126				Adams B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006763; Adde A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004681; Alto BW, 2013, AM J TROP MED HYG, V88, P497, DOI 10.4269/ajtmh.12-0421; Bakar A.A., 2011, EL ENG INF ICEEI 201, P1; Banu S, 2015, SCI REPORT, P5; Baquero OS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195065; Barmak DH, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.011901; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bishop C.M., 2006, MACH LEARN, V128; Brazilian Ministry of Health, PROM NAT MOB EFF AED; Brazilian National Institute of Meteorology (INMET), TEMP PREC TIM SER; Buczak AL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002771; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Cazelles B, 2005, PLOS MED, V2, P313, DOI 10.1371/journal.pmed.0020106; Choi Y, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2923-2; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cummings DAT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000139; Dibo MR, 2008, MEM I OSWALDO CRUZ, V103, P554, DOI 10.1590/S0074-02762008000600008; Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873; FOCKS DA, 1993, J MED ENTOMOL, V30, P1018, DOI 10.1093/jmedent/30.6.1018; Gambhir S., 2019, PRESCREENING SYSTEMS, P69; Guo P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005973; Honorio NA, 2009, J MED ENTOMOL, V46, P1001, DOI 10.1603/033.046.0505; Hopp MJ, 2001, CLIMATIC CHANGE, V48, P441, DOI 10.1023/A:1010717502442; Pena-Garcia VH, 2017, ANN GLOB HEALTH, V83, P509, DOI 10.1016/j.aogh.2017.10.011; Johansson MA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000382; Kesorn K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125049; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; Lana RM, 2014, ACTA TROP, V129, P25, DOI 10.1016/j.actatropica.2013.07.025; Lana RM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190673; Li C F, 1985, Southeast Asian J Trop Med Public Health, V16, P560; Liao CM, 2015, STOCH ENV RES RISK A, V29, P947, DOI 10.1007/s00477-014-0948-6; Lowe R, 2013, STAT MED, V32, P864, DOI 10.1002/sim.5549; Lowe R, 2011, COMPUT GEOSCI-UK, V37, P371, DOI 10.1016/j.cageo.2010.01.008; Luiz T.M.F., 2003, DENGUE B, V27, P25; Luz PM, 2008, AM J TROP MED HYG, V79, P933, DOI 10.4269/ajtmh.2008.79.933; Pessanha JEMP, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/760951; Ministry of Health, 2008, EP REP DENG FEV; Mondini A, 2008, SCI TOTAL ENVIRON, V393, P241, DOI 10.1016/j.scitotenv.2008.01.010; Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568; Ong J, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006587; Rabaa MA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002581; Racloz V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001648; Raghwani J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002064; Rahman D, 2016, IEEE ENER CONV; Silva FD, 2016, CIENC SAUDE COLETIVA, V21, P641, DOI 10.1590/1413-81232015212.09592015; Stolerman LM, 2015, SIAM J APPL MATH, V75, P2581, DOI 10.1137/140996148; Teng Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0165085; Tsuda Y, 2001, ENVIRON ENTOMOL, V30, P855, DOI 10.1603/0046-225X-30.5.855; Valdez L. D., 2017, ARXIV171107164; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Wesolowski A, 2015, P NATL ACAD SCI USA, V112, P11887, DOI 10.1073/pnas.1504964112; Xu L, 2017, P NATL ACAD SCI USA, V114, P113, DOI 10.1073/pnas.1618558114	54	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220106	10.1371/journal.pone.0220106	http://dx.doi.org/10.1371/journal.pone.0220106			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393908	Green Published, Green Submitted, gold			2022-12-26	WOS:000485002500021
J	Schloer, S; Hubel, N; Masemann, D; Pajonczyk, D; Brunotte, L; Ehrhardt, C; Brandenburg, LO; Ludwig, S; Gerke, V; Rescher, U				Schloer, Sebastian; Huebel, Nicole; Masemann, Doerthe; Pajonczyk, Denise; Brunotte, Linda; Ehrhardt, Christina; Brandenburg, Lars-Ove; Ludwig, Stephan; Gerke, Volker; Rescher, Ursula			The annexin A1/FPR2 signaling axis expands alveolar macrophages, limits viral replication, and attenuates pathogenesis in the murine influenza A virus infection model	FASEB JOURNAL			English	Article						pattern recognition receptors; innate immune system; mucosal immunity	FORMYL PEPTIDE RECEPTOR; COLONY-STIMULATING FACTORS; GM-CSF; DENDRITIC CELLS; INNATE IMMUNITY; DEFICIENT MICE; LUNG INJURY; TISSUE; ACTIVATION; MONOCYTES	Pattern recognition receptors (PRRs) are key elements in the innate immune response. Formyl peptide receptor (FPR) 2 is a PRR that, in addition to proinflammatory, pathogen-derived compounds, also recognizes the anti-inflammatory endogenous ligand annexin A1 (ArixA1). Because the contribution of this signaling axis in viral infections is undefined, we investigated AnxA1-mediated FPR2 activation on influenza A virus (IAV) infection in the murine model. AnxA1-treated mice displayed significantly attenuated pathology upon a subsequent IAV infection with significantly improved survival, impaired viral replication in the respiratory tract, and less severe lung damage. The AnxA1-mediated protection against IAV infection was not caused by priming of the type I LEN response but was associated with an increase in the number of alveolar macrophages (AMs) and enhanced pulmonary expression of the AM-regulating cytokine granulocyte-M-CSF (GM-CSF). Both AnxA1-mediated increase in AM levels and GM-CSF production were abrogated when mouse (m)FPR2 signaling was antagonized but remained up-regulated in mice genetically deleted for mFPR1, an mFPR2 isoform also serving as AnxA1 receptor. Our results indicate a novel protective function of the AnxA1-FPR2 signaling axis in IAV pathology via GM-CSF-associated maintenance of AMs, expanding knowledge on the potential use of proresolving mediators in host defense against pathogens.	[Schloer, Sebastian; Huebel, Nicole; Pajonczyk, Denise; Gerke, Volker; Rescher, Ursula] Univ Munster, Inst Virol, Inst Med Biochem, Ctr Mol Biol Inflammat, Munster, Germany; [Schloer, Sebastian; Huebel, Nicole; Masemann, Doerthe; Pajonczyk, Denise; Brunotte, Linda; Ehrhardt, Christina; Ludwig, Stephan; Gerke, Volker; Rescher, Ursula] Univ Munster, Cells In Mot Cluster Excellence, Munster, Germany; [Masemann, Doerthe; Brunotte, Linda; Ehrhardt, Christina; Ludwig, Stephan] Univ Munster, Ctr Mol Biol Inflammat, Munster, Germany; [Ehrhardt, Christina] Jena Univ Hosp, Inst Med Microbiol, Sect Expt Virol, Jena, Germany; [Brandenburg, Lars-Ove] Rhein Westfal TH Aachen, Dept Anat & Cell Biol, Aachen, Germany; [Brandenburg, Lars-Ove] Rostock Univ, Med Ctr, Inst Anat, Rostock, Germany	University of Munster; University of Munster; University of Munster; Friedrich Schiller University of Jena; RWTH Aachen University; University of Rostock	Rescher, U (corresponding author), Univ Munster, Inst Med Biochem, Ctr Mol Biol Inflammat, Von Esmarch Str 56, D-48149 Munster, Germany.	rescher@uni-muenster.de	Schloer, Sebastian/AAQ-4008-2021	Ludwig, Stephan/0000-0003-4490-3052	German Research Foundation (DFG) [SFB1009/A06, SFB1009/B02, Lu477/23-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	The authors are grateful to Andreas Wilbers (Institute of Medical Biochemistry, University of Muenster) for technical assistance. This work was supported by funding from the German Research Foundation (DFG; SFB1009/A06 and B02, Lu477/23-1 to C.E., S.L., V.G., and U.R.). C.E., S.L., V.G., and U.R. are members of the Pathogen Host Interplay (PHI) Club of the Muenster Alliance for Infection Research. The authors declare no conflicts of interest.	Alessi MC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01719; Allard B, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01777; Areschoug Thomas, 2008, V15, P45, DOI 10.1159/000135685; Bae YS, 2004, J IMMUNOL, V173, P607, DOI 10.4049/jimmunol.173.1.607; Berclaz PY, 2002, J IMMUNOL, V169, P6332, DOI 10.4049/jimmunol.169.11.6332; Cardani A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006140; Chen KQ, 2018, J BIOL CHEM, V293, P13452, DOI 10.1074/jbc.RA118.002683; Chen KQ, 2010, J IMMUNOL, V184, P3331, DOI 10.4049/jimmunol.0903022; Cline TD, 2017, J GEN VIROL, V98, P2401, DOI 10.1099/jgv.0.000922; Courtin N, 2017, ANTIVIR RES, V143, P252, DOI 10.1016/j.antiviral.2017.05.001; CRANDALL BF, 1986, PRENATAL DIAG, V6, P237, DOI 10.1002/pd.1970060402; D'Amico M, 2000, FASEB J, V14, P1867; Dalli J, 2015, NAT MED, V21, P1071, DOI 10.1038/nm.3911; Damazo AS, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-59; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Duvigneau S, 2016, SCI REP-UK, V6, DOI 10.1038/srep37045; Ernst S, 2004, CELL MOL LIFE SCI, V61, P1684, DOI 10.1007/s00018-004-4116-x; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gavins FNE, 2007, FASEB J, V21, P1751, DOI 10.1096/fj.06-7842com; Gavins FNE, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00354; Ghoneim HE, 2013, J IMMUNOL, V191, P1250, DOI 10.4049/jimmunol.1300014; Goebeler V, 2006, FEBS LETT, V580, P2430, DOI 10.1016/j.febslet.2006.03.076; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Halstead ES, 2018, RESP RES, V19, DOI 10.1186/s12931-017-0708-5; Halstead ES, 2015, EXPERT REV ANTI-INFE, V13, P1425, DOI 10.1586/14787210.2015.1094375; Halstead E, 2015, J IMMUNOL, V194; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hamilton JA, 2013, TRENDS IMMUNOL, V34, P81, DOI 10.1016/j.it.2012.08.006; Happle C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009750; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; He HQ, 2017, MOLECULES, V22, DOI 10.3390/molecules22030455; He HQ, 2014, J BIOL CHEM, V289, P2295, DOI 10.1074/jbc.M113.509216; He HQ, 2013, MOL PHARMACOL, V83, P389, DOI 10.1124/mol.112.081315; Heitzig N, 2018, BBA-MOL CELL BIOL L, V1863, P349, DOI 10.1016/j.bbalip.2018.01.001; Helft J, 2012, J CLIN INVEST, V122, P4037, DOI 10.1172/JCI60659; Holt PG, 2008, NAT REV IMMUNOL, V8, P142, DOI 10.1038/nri2236; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Kaufmann SHE, 2018, NAT REV DRUG DISCOV, V17, P35, DOI 10.1038/nrd.2017.162; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Kretschmer D, 2010, CELL HOST MICROBE, V7, P463, DOI 10.1016/j.chom.2010.05.012; Kuiken T, 2008, VACCINE, V26, pD59, DOI 10.1016/j.vaccine.2008.07.025; Lee SH, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-017-0557-5; LeVine AM, 1999, J CLIN INVEST, V103, P563, DOI 10.1172/JCI5212; Maddox JF, 1997, J BIOL CHEM, V272, P6972, DOI 10.1074/jbc.272.11.6972; Maderna P, 2005, J IMMUNOL, V174, P3727, DOI 10.4049/jimmunol.174.6.3727; Manicassamy B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000745; Martin Thomas R, 2005, Proc Am Thorac Soc, V2, P403, DOI 10.1513/pats.200508-090JS; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027; Musiol A, 2013, MBIO, V4, DOI 10.1128/mBio.00608-13; Nadkarni S, 2011, ARTERIOSCL THROM VAS, V31, P2749, DOI 10.1161/ATVBAHA.111.235176; NISHINAKAMURA R, 1995, IMMUNITY, V2, P211, DOI 10.1016/1074-7613(95)90046-2; Paine R, 2001, AM J PHYSIOL-LUNG C, V281, pL1210, DOI 10.1152/ajplung.2001.281.5.L1210; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Pupjalis D, 2011, EMBO MOL MED, V3, P102, DOI 10.1002/emmm.201000113; Rahman F, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051400; Rescher U, 2002, J IMMUNOL, V169, P1500, DOI 10.4049/jimmunol.169.3.1500; Rigaux P, 2012, VIROLOGY, V422, P338, DOI 10.1016/j.virol.2011.10.031; Rong BX, 2017, INT J BIOL MARKER, V32, pE132, DOI 10.5301/jbm.5000243; Rosler Barbara, 2016, Mol Cell Pediatr, V3, P29, DOI 10.1186/s40348-016-0055-5; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Schattgen SA, 2016, J IMMUNOL, V196, P29, DOI 10.4049/jimmunol.1501048; Schloer S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061781; Schneider C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004053; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Shaw ML, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000085; Shibata Y, 2001, IMMUNITY, V15, P557, DOI 10.1016/S1074-7613(01)00218-7; Shoemaker JE, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004856; Short KR, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00653; Smith HK, 2015, FASEB J, V29, P2161, DOI 10.1096/fj.14-263160; Subramaniam R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124593; Takabayshi K, 2006, IMMUNITY, V24, P475, DOI 10.1016/j.immuni.2006.02.008; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Tavares LP, 2016, AM J RESP CELL MOL, V55, P24, DOI 10.1165/rcmb.2015-0083OC; Tcherniuk S, 2016, J INFECT DIS, V214, P237, DOI 10.1093/infdis/jiw127; Trapnell BC, 2002, ANNU REV PHYSIOL, V64, P775, DOI 10.1146/annurev.physiol.64.090601.113847; Trentin PG, 2015, BRIT J PHARMACOL, V172, P3058, DOI 10.1111/bph.13109; Tzelepis F, 2015, J CLIN INVEST, V125, P752, DOI 10.1172/JCI77014; Vazquez AI, 2018, AM J RESP CRIT CARE, V197; Villarroya-Beltri C, 2017, J CELL SCI, V130, P2961, DOI 10.1242/jcs.205468; Vong L, 2007, J BIOL CHEM, V282, P29998, DOI 10.1074/jbc.M702876200; Yona S, 2006, BRIT J PHARMACOL, V148, P469, DOI 10.1038/sj.bjp.0706730; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhang HB, 2017, J IMMUNOL, V198, P4383, DOI 10.4049/jimmunol.1600714	86	30	30	2	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12188	12199		10.1096/fj.201901265R	http://dx.doi.org/10.1096/fj.201901265R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31398292	Green Published, hybrid			2022-12-26	WOS:000507461600046
J	Guadall, A; Cochet, S; Renaud, O; Colin, Y; Le Van Kim, C; de Brevern, AG; El Nemer, W				Guadall, Anna; Cochet, Sylvie; Renaud, Olivier; Colin, Yves; Le Van Kim, Caroline; de Brevern, Alexandre G.; El Nemer, Wassim			Dimerization and phosphorylation of Lutheran/basal cell adhesion molecule are critical for its function in cell migration on laminin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dimerization; protein phosphorylation; cell migration; laminin; epithelial cell; adhesion; Lutheran; basal cell adhesion molecule (Lu; BCAM); extracellular matrix (ECM); transmembrane protein; metastasis	BLOOD-GROUP GLYCOPROTEIN; POLYCYTHEMIA-VERA; B-CAM; EXPRESSION; LU/BCAM; PROTEIN; PREDICTION; TOPOLOGY; GENE; WEB	Tumor cell migration depends on the interactions of adhesion proteins with the extracellular matrix. Lutheran/basal cell adhesion molecule (Lu/BCAM) promotes tumor cell migration by binding to laminin ?5 chain, a subunit of laminins 511 and 521. Lu/BCAM is a type I transmembrane protein with a cytoplasmic domain of 59 (Lu) or 19 (Lu(v13)) amino acids. Here, using an array of techniques, including site-directed mutagenesis, immunoblotting, FRET, and proximity-ligation assays, we show that both Lu and Lu(v13) form homodimers at the cell surface of epithelial cancer cells. We mapped two small-XXX-small motifs in the transmembrane domain as potential sites for monomers docking and identified three cysteines in the cytoplasmic domain as being critical for covalently stabilizing dimers. We further found that Lu dimerization and phosphorylation of its cytoplasmic domain were concomitantly needed to promote cell migration. We conclude that Lu is the critical isoform supporting tumor cell migration on laminin 521 and that the Lu:Lu(v13) ratio at the cell surface may control the balance between cellular firm adhesion and migration.	[Guadall, Anna; Cochet, Sylvie; Colin, Yves; Le Van Kim, Caroline; de Brevern, Alexandre G.; El Nemer, Wassim] Univ Paris, UMR S1134, BIGR, INSERM, F-75015 Paris, France; [Guadall, Anna; Cochet, Sylvie; Colin, Yves; Le Van Kim, Caroline; de Brevern, Alexandre G.; El Nemer, Wassim] Inst Natl Transfus Sanguine, F-75015 Paris, France; [Guadall, Anna; Cochet, Sylvie; Colin, Yves; Le Van Kim, Caroline; de Brevern, Alexandre G.; El Nemer, Wassim] Lab Excellence GR Ex, F-75015 Paris, France; [Renaud, Olivier] Paris Sci & Lettres Res Univ, Inst Curie, F-75005 Paris, France; [Renaud, Olivier] Inst Natl Sante & Rech Med, U934, F-75005 Paris, France; [Renaud, Olivier] CNRS, UMR3215, F-75005 Paris, France; [Renaud, Olivier] Inst Curie, Cell & Tissue Imaging Facil PICT IBiSA, F-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	El Nemer, W (corresponding author), Univ Paris, UMR S1134, BIGR, INSERM, F-75015 Paris, France.; El Nemer, W (corresponding author), Inst Natl Transfus Sanguine, F-75015 Paris, France.; El Nemer, W (corresponding author), Lab Excellence GR Ex, F-75015 Paris, France.	wassim.el-nemer@inserm.fr	de Brevern, Alexandre G./B-4788-2009; Guadall, Anna/AAG-1691-2019; Guadall, Anna/I-1709-2014; le van kim, caroline/O-7030-2017	de Brevern, Alexandre G./0000-0001-7112-5626; Guadall, Anna/0000-0002-7821-8582; Guadall, Anna/0000-0002-7821-8582; Renaud, Olivier/0000-0003-0187-6680; El Nemer, Wassim/0000-0001-8184-427X; le van kim, caroline/0000-0002-3251-1310	Indo-French Centre for the Promotion of Advanced Research/CEFIPRA for Collaborative Grant [5302-2]; Agence Nationale de la Recherche (SCADHESION 2007); Region Ile-de-France (SESAME 2007) [F-08-1104/R]; Institut National de la Transfusion Sanguine	Indo-French Centre for the Promotion of Advanced Research/CEFIPRA for Collaborative Grant(French National Research Agency (ANR)); Agence Nationale de la Recherche (SCADHESION 2007)(French National Research Agency (ANR)); Region Ile-de-France (SESAME 2007); Institut National de la Transfusion Sanguine	We acknowledge the Indo-French Centre for the Promotion of Advanced Research/CEFIPRA for Collaborative Grant 5302-2. This work was supported by institutional funding to the Inserm unit 1134, Institut National de la Transfusion Sanguine, Agence Nationale de la Recherche (SCADHESION 2007), and Region Ile-de-France (SESAME 2007 no. F-08-1104/R).	Adamian L, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-13; Akiyama H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078716; Alais S, 2001, J CELL SCI, V114, P1847; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andre M, 2006, PROTEOMICS, V6, P1437, DOI 10.1002/pmic.200500180; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Bartolini A, 2016, CLIN CANCER RES, V22, P4923, DOI 10.1158/1078-0432.CCR-15-2664; Bartolucci P, 2010, BLOOD, V116, P2152, DOI 10.1182/blood-2009-12-257444; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bernemann TM, 2000, J CUTAN PATHOL, V27, P108, DOI 10.1034/j.1600-0560.2000.027003108.x; Boado RJ, 2000, J CEREBR BLOOD F MET, V20, P1096, DOI 10.1097/00004647-200007000-00009; Bony V, 1999, BRIT J HAEMATOL, V107, P263, DOI 10.1046/j.1365-2141.1999.01721.x; Chaar V, 2014, J BIOL CHEM, V289, P11512, DOI 10.1074/jbc.M113.506121; Chaar V, 2010, HAEMATOL-HEMATOL J, V95, P1841, DOI 10.3324/haematol.2010.026294; Chang HY, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0360-x; De Grandis M, 2013, BLOOD, V121, P658, DOI 10.1182/blood-2012-07-440487; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; El Nemer W, 2008, TRANSFUS CLIN BIOL, V15, P29, DOI 10.1016/j.tracli.2008.05.002; El Nemer W, 1998, J BIOL CHEM, V273, P16686; El Nemer W, 2010, TRANSFUS CLIN BIOL, V17, P143, DOI 10.1016/j.tracli.2010.06.002; El Nemer W, 2001, J BIOL CHEM, V276, P23757, DOI 10.1074/jbc.M102978200; El Nemer W, 1999, J BIOL CHEM, V274, P31903, DOI 10.1074/jbc.274.45.31903; ElNemer W, 1997, BLOOD, V89, P4608, DOI 10.1182/blood.V89.12.4608; Enomoto-Okawa Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167860; Franco M, 2013, BLOOD, V121, P546, DOI 10.1182/blood-2012-07-442467; GARINCHESA P, 1994, INT J ONCOL, V5, P1261; Gauthier E, 2005, J BIOL CHEM, V280, P30055, DOI 10.1074/jbc.M503293200; Gauthier E, 2010, BRIT J HAEMATOL, V148, P456, DOI 10.1111/j.1365-2141.2009.07973.x; Jun CD, 2001, J BIOL CHEM, V276, P29019, DOI 10.1074/jbc.M103394200; Kikkawa Y, 2008, EXP CELL RES, V314, P2579, DOI 10.1016/j.yexcr.2008.05.021; Kikkawa Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24961-4; Kikkawa Y, 2013, J BIOL CHEM, V288, P30990, DOI 10.1074/jbc.M113.486456; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Mankelow T, 2007, BLOOD, V110, P3398, DOI 10.1182/blood-2007-06-094748; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Miura Y, 2018, ELIFE, V7, DOI 10.7554/eLife.36572; Latini FRM, 2013, BLOOD CELL MOL DIS, V50, P161, DOI 10.1016/j.bcmd.2012.10.009; Novitzky-Basso I, 2018, INT J LAB HEMATOL, V40, P473, DOI 10.1111/ijlh.12838; PARSONS SF, 1995, P NATL ACAD SCI USA, V92, P5496, DOI 10.1073/pnas.92.12.5496; Parsons SF, 2001, BLOOD, V97, P312, DOI 10.1182/blood.V97.1.312; Picot J, 2014, AM J HEMATOL, V89, P115, DOI 10.1002/ajh.23597; Polyansky AA, 2014, BIOINFORMATICS, V30, P889, DOI 10.1093/bioinformatics/btt645; R Core Team, 2018, R LANG ENV STAT COMP; R Studio Team, 2016, RSTUDIO INT DEV ENV; Rahuel C, 1996, BLOOD, V88, P1865; RETTIG WJ, 1988, P NATL ACAD SCI USA, V85, P3110, DOI 10.1073/pnas.85.9.3110; Richard M, 2006, TRANSFUSION, V46, P1011, DOI 10.1111/j.1537-2995.2006.00836.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schon M, 2000, J INVEST DERMATOL, V115, P1047, DOI 10.1046/j.1523-1747.2000.00189.x; Severson EA, 2008, MOL BIOL CELL, V19, P1862, DOI 10.1091/mbc.E07-09-0869; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Udani M, 1998, J CLIN INVEST, V101, P2550, DOI 10.1172/JCI1204; Wautier MP, 2007, BLOOD, V110, P894, DOI 10.1182/blood-2006-10-048298; Zheng CG, 2009, INT J BIOCHEM CELL B, V41, P2163, DOI 10.1016/j.biocel.2009.03.014	57	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2019	294	41					14911	14921		10.1074/jbc.RA119.007521	http://dx.doi.org/10.1074/jbc.RA119.007521			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9JH	31413112	Green Published, hybrid			2022-12-26	WOS:000499253400007
J	Menendez, P; Losada, IJ; Torres-Ortega, SPL; Toimil, A; Beck, MW				Menendez, Pelayo; Losada, Inigo J.; Torres-Ortega, Sau Prime L.; Toimil, Alexandra; Beck, Michael W.			Assessing the effects of using high-quality data and high-resolution models in valuing flood protection services of mangroves	PLOS ONE			English	Article							CLIMATE	The rate of change on coastlines is accelerating from climate change and coastal development. Coastal flooding is a particularly pressing and increasing problem, which affects hundreds of millions of people and damages trillions of US$ in property. Scientists, practitioners and managers must be able to quickly assess flood risk and identify appropriate adaptation and risk reduction measures often with limited data and tools, particularly in developing countries. To inform these decision-making processes, we identify how sensitive flood risk and adaptation analyses are to changes in the resolution of data and models. We further do these comparisons in the context of assess the benefits of an ecosystem-based approach for risk reduction. There is growing interest in these ecosystem-based approaches as cost effective measures for adaptation and risk reduction. We assess flood risks from tropical cyclones and the flood risk reduction benefits provided by mangroves in Pagbilao (the Philippines). Then, we also compare risks and risk reduction (benefits) using different quality data and models, to identify where to invest in in new modeling and data acquisition to improve decision-making. We find that coastal flood risk valuation improves by using high resolution topography and long time series of data on tropical cyclones, while flood reduction benefits of mangroves are better valued by using consistent databases and models along the whole process rather than investing in single measures.	[Menendez, Pelayo; Losada, Inigo J.; Torres-Ortega, Sau Prime L.; Toimil, Alexandra] Univ Cantabria Avda, Environm Hydraul Inst IHCantabria, Parque Cient & Tecnol Cantabria, Santander, Spain; [Beck, Michael W.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA	Universidad de Cantabria; University of California System; University of California Santa Cruz	Menendez, P (corresponding author), Univ Cantabria Avda, Environm Hydraul Inst IHCantabria, Parque Cient & Tecnol Cantabria, Santander, Spain.	menendezfp@unican.es	Beck, Michael W./AAB-2844-2019; Losada, Iñigo J/F-9001-2012; Toimil, Alexandra/AAS-9897-2020; Bujan, Pablo Menendez/W-3736-2017; Torres-Ortega, Saúl/J-4947-2019	Beck, Michael W./0000-0002-5107-9973; Losada, Iñigo J/0000-0002-9651-9709; Bujan, Pablo Menendez/0000-0001-9372-1007; Torres-Ortega, Saúl/0000-0003-0619-2608; Menendez Fernandez, Pelayo/0000-0003-4761-3069	World Bank WAVES Program (Wealthn Accounting and the Valuation of Ecosystem Services); Ministry of Science, Innovation and Universities within ECOPROOF project [BIA2014-59718-R]; Ministry of Science, Innovation and Universities within RISKOADAPT project [BIA2017-89401-R]; Ministry of Science, Innovation and Universities within FPI grant [BES-2015-074343]	World Bank WAVES Program (Wealthn Accounting and the Valuation of Ecosystem Services); Ministry of Science, Innovation and Universities within ECOPROOF project; Ministry of Science, Innovation and Universities within RISKOADAPT project; Ministry of Science, Innovation and Universities within FPI grant	This work was supported in part by the World Bank WAVES Program (Wealthn Accounting and the Valuation of Ecosystem Services) and by the Spanish Ministry of Economy and Innovation (currently named as Ministry of Science, Innovation and Universities), within ECOPROOF project (BIA2014-59718-R), RISKOADAPT project (BIA2017-89401-R) and the FPI grant (BES-2015-074343).; We gratefully acknowledge support from the World Bank WAVES Program (Wealth Accounting and the Valuation of Ecosystem Services) and by the Spanish Ministry of Economy and Innovation (currently named as Ministry of Science, Innovation and Universities), within ECOPROOF project (BIA2014-59718-R), RISKOADAPT project (BIA2017-89401-R) and the FPI grant (BES-2015-074343). Authors are grateful to the useful contributions provided by Sheila Abad and Javier Garcia Alba (IHCantabria).	Beck MW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04568-z; Bravo DR, 1996, P EC 4 EC MAN MANGR, P190; Camus P, 2011, COAST ENG, V58, P851, DOI 10.1016/j.coastaleng.2011.05.007; Camus P, 2011, COAST ENG, V58, P453, DOI 10.1016/j.coastaleng.2011.02.003; de Moel H, 2015, MITIG ADAPT STRAT GL, V20, P865, DOI 10.1007/s11027-015-9654-z; Elsner JB, 2008, NATURE, V455, P92, DOI 10.1038/nature07234; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Flores P., 2006, NAT HAZARDS REV, V7, P72, DOI [10.1061/(ASCE)1527-6988(2006)7:2(72), DOI 10.1061/(ASCE)1527-6988(2006)7:2(72)]; Hinkel J, 2014, P NATL ACAD SCI USA, V111, P3292, DOI 10.1073/pnas.1222469111; Jamero ML, 2017, NAT CLIM CHANGE, V7, P581, DOI [10.1038/nclimate3344, 10.1038/NCLIMATE3344]; Jamieson SR, 2012, COMPREHENSIVE FLOOD, P121; Knapp KR, 2010, B AM METEOROL SOC, V91, P363, DOI 10.1175/2009BAMS2755.1; Le Cozannet G, 2015, ENVIRON MODELL SOFTW, V73, P44, DOI 10.1016/j.envsoft.2015.07.021; Leon JX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108727; Li X, ACCURACY AIRBORNE IF; Long JB, 2011, SENSORS-BASEL, V11, P2972, DOI 10.3390/s110302972; Losada IJ, 2018, TECHNICAL REPORT, DOI [10.7291/V9DV1H2S, DOI 10.7291/V9DV1H2S]; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; Menendez P, 2018, ECOSYST SERV, V34, P24, DOI 10.1016/j.ecoser.2018.09.005; Mondal P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048191; Nakajo S, 2014, J APPL METEOROL CLIM, V53, P1547, DOI 10.1175/JAMC-D-13-08.1; Narayan S, 2016, PLOS UNPUB; Polidoro BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010095; Primavera J. H., 2008, Wetlands Ecology and Management, V16, P345, DOI 10.1007/s11273-008-9101-y; Rahmstorf S, 2017, P NATL ACAD SCI USA, V114, P11806, DOI 10.1073/pnas.1715895114; Reguero BG, 2018, COMP COST EFFECTIVEN, P1; Reguero BG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133409; Robinson J.A., 2000, P 6 INT C REM SENS M, V2, P473; Ron J, 1999, ENVIRON RESOUR ECON, V14, P297, DOI 10.1023/A:1008344128527; Spalding M., 2010, WETLANDS, V31, P1003, DOI 10.1007/s13157-011-0224-1; Spalding MD, 2014, CONSERV LETT, V7, P293, DOI 10.1111/conl.12074; Sutton-Grier AE, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10020523; UNISDR, 2015, GLOB ASS REP DIS RIS; Weatherall P, 2015, EARTH SPACE SCI, V2, P331, DOI 10.1002/2015EA000107; Wessel P, 1996, J GEOPHYS RES-SOL EA, V101, P8741, DOI 10.1029/96JB00104; Yamazaki D, 2017, GEOPHYS RES LETT, V44, P5844, DOI 10.1002/2017GL072874	36	7	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0220941	10.1371/journal.pone.0220941	http://dx.doi.org/10.1371/journal.pone.0220941			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430317	Green Submitted, Green Published, gold			2022-12-26	WOS:000485026800018
J	Meyer, S; Thiel, V; Joergensen, RG; Sundrum, A				Meyer, Stephanie; Thiel, Volker; Joergensen, Rainer Georg; Sundrum, Albert			Relationships between feeding and microbial faeces indices in dairy cows at different milk yield levels	PLOS ONE			English	Article							FUMIGATION-EXTRACTION METHOD; CATTLE MANURE DECOMPOSITION; HOME-FIELD ADVANTAGE; AMINO-SUGARS; FATTY-ACIDS; APPARENT DIGESTIBILITY; CHLOROFORM FUMIGATION; BIOMASS CALIBRATION; COMMUNITY STRUCTURE; BACTERIAL NITROGEN	A study was carried out to gain quantitative information on the diet-dependent faecal microbial biomass of dairy cows, especially on the biomass fractions of fungi, Gram-positive (G+) and Gram-negative (G-) bacteria. Groups of high-yield, low-yield and non-lactating cows were investigated at four different farms. A mean faecal microbial biomass C (MBC) concentration of 33.5 mg g(-1) DM was obtained by the chloroform fumigation extraction method. This is similar to a mean microbial C concentration of 31.8 mg g(-1) DM, which is the sum of bacterial C and fungal C, estimated by cell-wall derived muramic acid (MurN) and fungal glucosamine (GlcN), respectively. However, the response of these two approaches to the feeding regime was contradictory, due to feeding effects on the conversion values. The higher neutral detergent fibre (NDF) and acid detergent fibre (ADF) concentrations in the non-lactating group led to higher (P < 0.05) concentrations of cellulose and lignin in their faeces in comparison with the lactating cows. This change in faecal chemical composition in the non-lactating group was accompanied by usually higher ratios of G+/G-phospholipid fatty acids (PLFA), ergosterol/MBC and fungal C/bacterial C. Although bacteria dominate the faecal microbial biomass, fungi contribute a considerable mean percentage of roughly 20% to the faecal microbiome, according to PLFA and amino sugar data, which requires more attention in the future. Near-infra red spectroscopic estimates of organic N and C fractions of cow faeces were able to model microbial biomarkers successfully, which might be useful in the future to predict its N2O emission potential and fertilizer value.	[Meyer, Stephanie; Sundrum, Albert] Univ Kassel, Anim Nutr & Anim Hlth, Witzenhausen, Germany; [Meyer, Stephanie; Joergensen, Rainer Georg] Univ Kassel, Soil Biol & Plant Nutr, Witzenhausen, Germany; [Thiel, Volker] Univ Gottingen, Geobiol Grp, Geosci Ctr, Gottingen, Germany	Universitat Kassel; Universitat Kassel; University of Gottingen	Joergensen, RG (corresponding author), Univ Kassel, Soil Biol & Plant Nutr, Witzenhausen, Germany.	joerge@uni-kassel.de		Thiel, Volker/0000-0003-4758-2784; Joergensen, Rainer Georg/0000-0002-3142-221X	Research Training Group 1397 "Regulation of soil organic matter and nutrient turnover in organic agriculture" of the German Research Foundation (DFG)	Research Training Group 1397 "Regulation of soil organic matter and nutrient turnover in organic agriculture" of the German Research Foundation (DFG)(German Research Foundation (DFG))	This project was supported by the Research Training Group 1397 "Regulation of soil organic matter and nutrient turnover in organic agriculture" of the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera F, 2006, INT J FOOD MICROBIOL, V110, P34, DOI 10.1016/j.ijfoodmicro.2006.02.002; Ahmad A, 2010, MICROB PATHOGENESIS, V48, P35, DOI 10.1016/j.micpath.2009.10.001; Al-Kindi A, 2016, BIOL AGRIC HORTIC, V32, P159, DOI 10.1080/01448765.2015.1108869; Althaus B, 2013, ANIM FEED SCI TECH, V185, P53, DOI 10.1016/j.anifeedsci.2013.07.003; Appuhn A, 2004, J PLANT NUTR SOIL SC, V167, P17, DOI 10.1002/jpln.200321302; Appuhn A, 2006, SOIL BIOL BIOCHEM, V38, P1040, DOI 10.1016/j.soilbio.2005.09.002; Ayres E, 2009, SOIL BIOL BIOCHEM, V41, P606, DOI 10.1016/j.soilbio.2008.12.022; Baath E, 2003, SOIL BIOL BIOCHEM, V35, P955, DOI 10.1016/S0038-0717(03)00154-8; Berndmeyer C, 2014, BIOGEOSCIENCES, V11, P7009, DOI 10.5194/bg-11-7009-2014; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; CABOTAJE LM, 1994, APPL ENVIRON MICROB, V60, P1302, DOI 10.1128/AEM.60.4.1302-1307.1994; CORFIELD AP, 1992, INFECT IMMUN, V60, P3971, DOI 10.1128/IAI.60.10.3971-3978.1992; Dippold MA, 2016, GEOCHIM COSMOCHIM AC, V174, P211, DOI 10.1016/j.gca.2015.10.032; Eberhardt U, 1996, SOIL BIOL BIOCHEM, V28, P677, DOI 10.1016/0038-0717(96)00006-5; Engelking B, 2007, SOIL BIOL BIOCHEM, V39, P2111, DOI 10.1016/j.soilbio.2007.03.020; Frey JC, 2010, J APPL MICROBIOL, V108, P1982, DOI 10.1111/j.1365-2672.2009.04602.x; Frostegard A, 1997, APPL ENVIRON MICROB, V63, P2224; Frostegard A, 2011, SOIL BIOL BIOCHEM, V43, P1621, DOI 10.1016/j.soilbio.2010.11.021; Gattinger A, 2007, ENVIRON MICROBIOL, V9, P612, DOI 10.1111/j.1462-2920.2006.01181.x; Geisseler D, 2014, SOIL BIOL BIOCHEM, V74, P100, DOI 10.1016/j.soilbio.2014.02.024; Gill FL, 2011, ANIM FEED SCI TECH, V166-67, P87, DOI 10.1016/j.anifeedsci.2011.04.006; Gors S, 2016, J DAIRY SCI, V99, P9313, DOI 10.3168/jds.2016-11447; GREENFIELD LG, 1995, SOIL BIOL BIOCHEM, V27, P1235, DOI 10.1016/0038-0717(95)00023-8; Gressley TF, 2011, J ANIM SCI, V89, P1120, DOI 10.2527/jas.2010-3460; Griffith GW, 2009, FUNGAL ECOL, V2, P87, DOI 10.1016/j.funeco.2009.01.005; Guerrero C, 2007, BIORESOURCE TECHNOL, V98, P3259, DOI 10.1016/j.biortech.2006.07.015; Hartman WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057127; Hartmann MA, 1998, TRENDS PLANT SCI, V3, P170, DOI 10.1016/S1360-1385(98)01233-3; Heinze S, 2010, PLANT SOIL, V328, P203, DOI 10.1007/s11104-009-0102-2; Henderson G, 2015, SCI REP-UK, V5, DOI 10.1038/srep14567; Indorf C, 2011, BIOL FERT SOILS, V47, P387, DOI 10.1007/s00374-011-0545-5; Iqbal J, 2003, J BIOL CHEM, V278, P31610, DOI 10.1074/jbc.M301177200; IRELANDPERRY RL, 1993, J DAIRY SCI, V76, P1074, DOI 10.3168/jds.S0022-0302(93)77436-6; JENKINS TC, 1993, J DAIRY SCI, V76, P3851, DOI 10.3168/jds.S0022-0302(93)77727-9; Jenkinson D. S., 1988, Advances in nitrogen cycling in agricultural ecosystems, P368; Joergensen RG, 2006, J PLANT NUTR SOIL SC, V169, P295, DOI 10.1002/jpln.200521941; Joergensen RG, 2018, BIOL FERT SOILS, V54, P559, DOI 10.1007/s00374-018-1288-3; Joergensen RG, 2018, SOIL BIOL BIOCHEM, V116, P419, DOI 10.1016/j.soilbio.2017.10.022; Joergensen RG, 2011, SOIL BIOL BIOCHEM, V43, P873, DOI 10.1016/j.soilbio.2010.09.024; Joergensen RG, 2008, SOIL BIOL BIOCHEM, V40, P2977, DOI 10.1016/j.soilbio.2008.08.017; Joergensen RG, 2005, SOIL BIOL BIOCHEM, V37, P1249, DOI 10.1016/j.soilbio.2004.11.021; Joergensen RG, 1996, SOIL BIOL BIOCHEM, V28, P25, DOI 10.1016/0038-0717(95)00102-6; Joergensen RG, 1996, SOIL BIOL BIOCHEM, V28, P33, DOI 10.1016/0038-0717(95)00101-8; Jose VL, 2017, AMB EXPRESS, V7, DOI 10.1186/s13568-016-0310-0; Jost DI, 2013, ARCH ANIM NUTR, V67, P104, DOI 10.1080/1745039X.2013.776326; Jost DI, 2013, BIOL FERT SOILS, V49, P61, DOI 10.1007/s00374-012-0697-y; Jost DI, 2011, SOIL BIOL BIOCHEM, V43, P1237, DOI 10.1016/j.soilbio.2011.02.013; Kagami M, 2007, P R SOC B, V274, P1561, DOI 10.1098/rspb.2007.0425; Kala A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172051; Kellermann MY, 2016, ORG GEOCHEM, V95, P13, DOI 10.1016/j.orggeochem.2016.02.004; Khan KS, 2016, GEODERMA, V271, P115, DOI 10.1016/j.geoderma.2016.02.019; Klamer M, 2004, SOIL BIOL BIOCHEM, V36, P57, DOI 10.1016/j.soilbio.2003.08.019; KRAUS RJ, 1990, J CHROMATOGR, V513, P71, DOI 10.1016/S0021-9673(01)89426-7; Kurasawa S, 2000, J AM COLL NUTR, V19, P426, DOI 10.1080/07315724.2000.10718942; Kyvsgaard P, 2000, NUTR CYCL AGROECOSYS, V57, P207, DOI 10.1023/A:1009874500769; Larsen M, 2001, J ANIM PHYSIOL AN N, V85, P9, DOI 10.1046/j.1439-0396.2001.00297.x; Lim KLH, 2012, ARCHAEA, V2012, DOI 10.1155/2012/896727; Macfarlane S, 2005, APPL ENVIRON MICROB, V71, P7483, DOI 10.1128/AEM.71.11.7483-7492.2005; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; MAKI LR, 1965, J BACTERIOL, V89, P1244, DOI 10.1128/JB.89.5.1244-1249.1965; McCartney CA, 2014, LIVEST SCI, V164, P39, DOI 10.1016/j.livsci.2014.02.020; McCartney CA, 2013, J DAIRY SCI, V96, P1211, DOI 10.3168/jds.2012-6042; McGovern E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13013-y; Moore-Kucera J, 2008, MICROB ECOL, V55, P500, DOI 10.1007/s00248-007-9295-1; Neher DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079512; Niemetz R, 1997, EUR J BIOCHEM, V249, P905, DOI 10.1111/j.1432-1033.1997.00905.x; Pancost RD, 2011, ORG GEOCHEM, V42, P1279, DOI 10.1016/j.orggeochem.2011.07.003; Partanen K, 2007, ANIMAL, V1, P389, DOI 10.1017/S1751731107657838; PETERS J, 1995, J MOL BIOL, V245, P385, DOI 10.1006/jmbi.1994.0032; Pitta DW, 2016, ANAEROBE, V38, P50, DOI 10.1016/j.anaerobe.2015.12.003; Powell JM, 2006, SOIL SCI SOC AM J, V70, P786, DOI 10.2136/sssaj2005.0286; Quideau S. A., 2016, JOVE-J VIS EXP, P1; Ramakrishnan V, 1997, J BACTERIOL, V179, P1505, DOI 10.1128/jb.179.5.1505-1512.1997; Rashid MI, 2017, APPL SOIL ECOL, V113, P107, DOI 10.1016/j.apsoil.2017.02.009; Rashid MI, 2013, SOIL BIOL BIOCHEM, V57, P320, DOI 10.1016/j.soilbio.2012.10.005; Schoenhusen U, 2008, VET MED-CZECH, V53, P184, DOI 10.17221/1922-VETMED; Schwarm A, 2015, ARCH ANIM NUTR, V69, P159, DOI 10.1080/1745039X.2015.1043211; SORENSEN P, 1995, PLANT SOIL, V173, P283, DOI 10.1007/BF00011466; Spohn M, 2016, BASIC APPL ECOL, V17, P471, DOI 10.1016/j.baae.2016.05.003; Taniwaki MH, 2009, INT J FOOD MICROBIOL, V132, P100, DOI 10.1016/j.ijfoodmicro.2009.04.005; Thomas M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12481-6; TURCK D, 1993, PEDIATR RES, V33, P564, DOI 10.1203/00006450-199306000-00005; van Vliet PCJ, 2007, J DAIRY SCI, V90, P5146, DOI 10.3168/jds.2007-0065; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; VESTAL JR, 1989, BIOSCIENCE, V39, P535, DOI 10.2307/1310976; Wachendorf C, 2011, BIOL FERT SOILS, V47, P147, DOI 10.1007/s00374-010-0516-2; WEETE JD, 1989, EXP MYCOL, V13, P183, DOI 10.1016/0147-5975(89)90023-6; Weete JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010899; Weiss WP, 2009, J DAIRY SCI, V92, P5607, DOI 10.3168/jds.2009-2248; Wentzel S, 2016, ENG LIFE SCI, V16, P231, DOI 10.1002/elsc.201400229; WU J, 1990, SOIL BIOL BIOCHEM, V22, P1167, DOI 10.1016/0038-0717(90)90046-3; Xu R, 2004, J AM CHEM SOC, V126, P15654, DOI 10.1021/ja044711z; Yamamoto N, 2011, APPL MICROBIOL BIOT, V90, P1501, DOI 10.1007/s00253-011-3153-2; ZELLES L, 1993, SOIL BIOL BIOCHEM, V25, P495, DOI 10.1016/0038-0717(93)90075-M; Zelles L, 1999, BIOL FERT SOILS, V29, P111, DOI 10.1007/s003740050533; Zhong XZ, 2018, BIORESOURCE TECHNOL, V247, P443, DOI 10.1016/j.biortech.2017.09.116; ZINN RA, 1986, CAN J ANIM SCI, V66, P157, DOI 10.4141/cjas86-017	97	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0221266	10.1371/journal.pone.0221266	http://dx.doi.org/10.1371/journal.pone.0221266			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430322	Green Published, Green Submitted, gold			2022-12-26	WOS:000485026800038
J	Kuringe, E; Materu, J; Nyato, D; Majani, E; Ngeni, F; Shao, A; Mjungu, D; Mtenga, B; Nnko, S; Kipingili, T; Mongi, A; Nyanda, P; Changalucha, J; Wambura, M				Kuringe, Evodius; Materu, Jacqueline; Nyato, Daniel; Majani, Esther; Ngeni, Flaviana; Shao, Amani; Mjungu, Deusdedit; Mtenga, Baltazar; Nnko, Soori; Kipingili, Thomas; Mongi, Aminiel; Nyanda, Peter; Changalucha, John; Wambura, Mwita			Prevalence and correlates of depression and anxiety symptoms among out-of-school adolescent girls and young women in Tanzania: A cross-sectional study	PLOS ONE			English	Article							GLOBAL MENTAL-HEALTH; INTIMATE PARTNER VIOLENCE; CAPE-TOWN; SCREENING SCALE; SOCIAL SUPPORT; RISK BEHAVIOR; SEX WORKERS; LOW-INCOME; HIV; DISORDERS	Background In sub-Saharan Africa, adolescent girls and young women (AGYW) who are out of school are at higher risk of depressive and anxiety disorders compared to their school attending peers. However, little is known about the prevalence and risk factors for these conditions among out-of-school AGYW. This study examines the prevalence of depression and anxiety and associated factors in a community sample of out-of-school AGYW in Tanzania. Methods A cross-sectional analysis of baseline data from an on-going cluster randomized controlled trial in North-West Tanzania was conducted. A total of 3013 out-of-school AGYW aged 15 to 23 years from 30 clusters were included. Anxiety and depression were assessed using the Patient Health Questionnaire (PHQ-4), a tool comprising of PHQ-2 and Generalized Anxiety Disorders (GAD-2) screeners. Data were collected using Audio Computer-Assisted Self-Interview (ACASI). A random-effects logistic regression was fitted for binary outcomes and an ordinal logistic regression model with robust variance was used to adjust for clustering at the village level. Logistic regression and ordinal logistic regression were used to explore the associations between mental disorders symptoms and other factors. Results The prevalence of depressive (PHQ-2 >= 3) and anxiety (GAD-2 >= 3) symptoms among out-of-school AGYW were 36% (95% CI 33.8%-37.3%) and 31% (95% CI 29.0%-32.3%) respectively. Further, using the PHQ-4 tool, 33% (95% CI 30.8%-34.2%) had mild, 20% (95% CI 18.3%-21.1%) moderate and 6% (95% CI 5.5%-7.2%) had severe symptoms of anxiety and depression. After adjusting for other covariates, two factors most strongly associated with having anxiety symptoms were violence experience from sexual partners (AOR = 1.63, 95% CI: 1.36-1.96) and HIV positive status (AOR = 1.54, 95% CI: 1.03-2.31). Likewise, living alone, with younger siblings or others (AOR = 2.51, 95% CI: 1.47-4.29) and violence experience from sexual partners (AOR = 1.90, 95% CI: 1.59-2.27) were strongly associated with depression symptoms. Having savings (AOR = 0.81, 95% CI: 0.70-0.95) and emotional support (AOR = 0.82, 95% CI: 0.67-0.99) were protective against depression and anxiety, respectively. Conclusion Depressive and anxiety symptoms are prevalent among out-of-school AGYW in Tanzania. The findings emphasize the need to strengthen preventive interventions and scale-up mental health disorder screening, referral for diagnosis and management.	[Kuringe, Evodius; Materu, Jacqueline; Nyato, Daniel; Shao, Amani; Mtenga, Baltazar; Nnko, Soori; Changalucha, John; Wambura, Mwita] Natl Inst Med Res, Dept Sexual & Reprod Hlth, Mwanza, Tanzania; [Majani, Esther; Ngeni, Flaviana; Mjungu, Deusdedit; Mongi, Aminiel; Nyanda, Peter] Jhpiego Tanzania, Sauti Project, Dar Es Salaam, Tanzania; [Kipingili, Thomas] Pact Tanzania, Dar Es Salaam, Tanzania	National Institute of Medical Research; Jhpiego	Kuringe, E (corresponding author), Natl Inst Med Res, Dept Sexual & Reprod Hlth, Mwanza, Tanzania.	evokur@yahoo.co.uk	Nyato, Daniel/J-1682-2019	Nyato, Daniel/0000-0002-2397-1390; Materu, Jacqueline/0000-0002-5678-8285; Shao, Amani/0000-0003-1995-3031; Shao, Anwen/0000-0001-9986-6290	United States Agency for International Development (USAID) [AID-621-A15-00003]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	The cluster randomized controlled trial (CARE study), from which the current study draws the data, is funded by a grant from the United States Agency for International Development (USAID) under Cooperative Agreement AID-621-A15-00003. The funders had no role in current study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2002, CATEGORICAL DATA ANA, P710, DOI [10.1002/0471249688, DOI 10.1002/0471249688]; [Anonymous], 2016, DEATHS CAUS AG SEX C; Audet CM, 2018, J AFFECT DISORDERS, V227, P48, DOI 10.1016/j.jad.2017.10.022; Bitew T, 2014, ETHIOP J HEALTH SCI, V24, P162, DOI 10.4314/ejhs.v24i2.9; Bottomley C, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0127-1; Brawner BM, 2012, AIDS CARE, V24, P618, DOI 10.1080/09540121.2011.630344; Bui QTT, 2018, J CHILD ADOLESC MENT, V30, P51, DOI 10.2989/17280583.2018.1478299; Carter RM, 2001, DEPRESS ANXIETY, V13, P78, DOI 10.1002/da.1020; Casale M, 2015, J BEHAV MED, V38, P17, DOI 10.1007/s10865-014-9556-7; Cheng Y, 2014, J ADOLESCENT HEALTH, V55, pS31, DOI 10.1016/j.jadohealth.2014.08.020; Chiyaka T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194301; Davis EC, 2017, AIDS BEHAV, V21, pS174, DOI 10.1007/s10461-017-1927-y; de Lijster JM, 2018, J AFFECT DISORDERS, V230, P108, DOI 10.1016/j.jad.2018.01.008; Dhungel S, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0441-8; Estes LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009149; Familiar I, 2016, AIDS CARE, V28, P1541, DOI 10.1080/09540121.2016.1191609; Gameroff M., 2005, 30 ANN SAS USERS GRO, P1; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Geert Molenberghs, 2005, MODELS DISCRETE LONG, DOI [10.1007/0-387-28980-1, DOI 10.1007/0-387-28980-1]; Gibbs A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194885; Hammarstrom A, 2002, J EPIDEMIOL COMMUN H, V56, P624, DOI 10.1136/jech.56.8.624; Hendriks SM, 2015, J AFFECT DISORDERS, V178, P121, DOI 10.1016/j.jad.2015.03.004; Himle JA, 2009, J ANXIETY DISORD, V23, P578, DOI 10.1016/j.janxdis.2009.01.002; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2017, END AIDS PROGR 90 90; Kakuma R, 2011, LANCET, V378, P1654, DOI 10.1016/S0140-6736(11)61093-3; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Kessler RC, 2007, CURR OPIN PSYCHIATR, V20, P359, DOI 10.1097/YCO.0b013e32816ebc8c; Khubchandani J, 2016, ARCH PSYCHIAT NURS, V30, P457, DOI 10.1016/j.apnu.2016.01.014; Kidman R, 2018, JAIDS-J ACQ IMM DEF, V77, P64, DOI 10.1097/QAI.0000000000001569; Kieling C, 2011, LANCET, V378, P1515, DOI 10.1016/S0140-6736(11)60827-1; Kimbui E, 2018, ANN GEN PSYCHIATR, V17, DOI 10.1186/s12991-018-0222-2; Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613; Lance CE, 2006, ORGAN RES METHODS, V9, P202, DOI 10.1177/1094428105284919; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lowe B, 2010, J AFFECT DISORDERS, V122, P86, DOI 10.1016/j.jad.2009.06.019; Lowe B, 2005, J PSYCHOSOM RES, V58, P163, DOI 10.1016/j.jpsychores.2004.09.006; Lund C, 2011, LANCET, V378, P1502, DOI 10.1016/S0140-6736(11)60754-X; Lundberg P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-125; Lwidiko A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193145; MacLachlan E, 2009, AIDS CARE, V21, P355, DOI 10.1080/09540120802184121; Mahenge B, 2015, INT J GYNECOL OBSTET, V130, P261, DOI 10.1016/j.ijgo.2015.04.032; Mashalla Y.J.S., 2009, GUIDELINES ETHICS HL; Mathur S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203929; Mo PKH, 2018, AIDS CARE, V30, P1031, DOI 10.1080/09540121.2018.1435847; Mokitimi S, 2018, INT J MENT HEALTH SY, V12, DOI 10.1186/s13033-018-0213-3; Morrison-Beedy D, 2006, AIDS BEHAV, V10, P541, DOI 10.1007/s10461-006-9081-y; Muhwezi WW, 2008, INT J SOC PSYCHIATR, V54, P144, DOI 10.1177/0020764007083878; Myer L, 2008, SOC SCI MED, V66, P1828, DOI 10.1016/j.socscimed.2008.01.025; Myers B, 2016, INT J DRUG POLICY, V30, P52, DOI 10.1016/j.drugpo.2015.12.019; Nduna M, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-44; Ng LC, 2015, BRIT J PSYCHIAT, V207, P262, DOI 10.1192/bjp.bp.114.154591; Nunnally JC., 1978, PSYCHOMETRIC THEORY; Ojagbemi A, 2017, BEHAV NEUROL, V2017, DOI 10.1155/2017/4160259; Okafor CN, 2021, J INTERPERS VIOLENCE, V36, pNP5060, DOI 10.1177/0886260518796522; Osok J, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1706-y; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Pantelic M, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21771; Patel V, 2007, LANCET, V369, P1302, DOI 10.1016/S0140-6736(07)60368-7; Patel V, 2018, LANCET, V392, P1553, DOI 10.1016/S0140-6736(18)31612-X; Petersen I, 2016, INT J MENT HEALTH SY, V10, DOI 10.1186/s13033-016-0060-z; Phillips AE, 2010, INT J EPIDEMIOL, V39, P1541, DOI 10.1093/ije/dyq114; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Ratinthorn A, 2009, HEALTH CARE WOMEN IN, V30, P249, DOI 10.1080/07399330902733281; Rock A, 2016, SOC SCI MED, V170, P55, DOI 10.1016/j.socscimed.2016.10.005; Rwakarema M, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0225-y; Saraceno B, 2007, LANCET, V370, P1164, DOI 10.1016/S0140-6736(07)61263-X; Seabrook JA, 2012, CAN REV SOCIOL, V49, P50, DOI 10.1111/j.1755-618X.2011.01280.x; Seedat S, 2004, BRIT J PSYCHIAT, V184, P169, DOI 10.1192/bjp.184.2.169; Shatkin Jess P, 2004, Child Adolesc Ment Health, V9, P104, DOI 10.1111/j.1475-3588.2004.00090.x; Sprague C, 2016, CULT HEALTH SEX, V18, P567, DOI 10.1080/13691058.2015.1096420; Tanzania Ministry of Health and social Welfare, 2013, NAT COMPR GUID HIV T; Tanzania Ministry of Health Community Development Gender Elderly and Children; National AIDS Control Programme (NACP), 2017, TANZ NAT GUID COMPR; Tol WA, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1626-x; Wang X, 2018, J AFFECT DISORDERS, V227, P810, DOI 10.1016/j.jad.2017.11.006; WHO, 2017, GLOB ACC ACT HLTH AD; Willis N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190423; Wong M, 2017, ARCH WOMEN MENT HLTH, V20, P149, DOI 10.1007/s00737-016-0688-3; World Health Organization, 2014, POL BRIEF CONS GUID; World Health Organization (WHO), 2017, WORLD MENT HLTH DAY	79	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2019	14	8							e0221053	10.1371/journal.pone.0221053	http://dx.doi.org/10.1371/journal.pone.0221053			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5LL	31419238	Green Published, Green Submitted, gold			2022-12-26	WOS:000485019900025
J	Trinkaus, E; Samsel, M; Villotte, S				Trinkaus, Erik; Samsel, Mathilde; Villotte, Sebastien			External auditory exostoses among western Eurasian late Middle and Late Pleistocene humans	PLOS ONE			English	Article							MARINE MOLLUSK EXPLOITATION; STABLE-ISOTOPE EVIDENCE; CANAL EXOSTOSES; COLD-WATER; CAVE; SURFERS; REMAINS; COASTAL; FISH; EAR	External auditory exostoses (EAE) have been noted among the Neandertals and a few other Pleistocene humans, but until recently they have been discussed primary as minor pathological lesions with possible auditory consequences. An assessment of available western Eurasian late Middle and Late Pleistocene human temporal bones with sufficiently preserved auditory canals (n = 77) provides modest levels of EAE among late Middle Pleistocene archaic humans (approximate to 20%) and early modern humans (Middle Paleolithic: approximate to 25%; Early/Mid Upper Paleolithic: 20.8%; Late Upper Paleolithic: 9.5%). The Neandertals, however, exhibit an exceptionally high level of EAE (56.5%; 47.8% if two anomalous cases are considered normal). The levels of EAE for the early modern humans are well within recent human ranges of variation, frequencies which are low for equatorial inland and high latitude samples but occasionally higher elsewhere. The Early/Mid Upper Paleolithic frequency is nonetheless high for a high latitude sample under interpleniglacial conditions. Given the strong etiological and environmental associations of EAE development with exposure to cold water and/or damp wind chill, the high frequency of EAE among the Neandertals implies frequent aquatic resource exploitation, more frequent than the archeological and stable isotopic evidence for Middle Paleolithic/Neandertal littoral and freshwater resource foraging implies. As such, the Neandertal data parallel a similar pattern evident in eastern Eurasian archaic humans. Yet, factors in addition to cold water/wind exposure may well have contributed to their high EAE frequencies.	[Trinkaus, Erik] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA; [Samsel, Mathilde] Univ Bordeaux, PACEA UMR5199, Batiment B8,Allee Geoff Roy St Hilaire, Pessac, France; [Villotte, Sebastien] CNRS, PACEA UMR5199, Batiment B8,Allee Geoffroy St Hilaire, Pessac, France	Washington University (WUSTL); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux	Trinkaus, E (corresponding author), Washington Univ, Dept Anthropol, St Louis, MO 63130 USA.	trinkaus@wustl.edu		Villotte, Sebastien/0000-0002-2958-8034; Trinkaus, Erik/0000-0002-5175-1651	Universite de Bordeaux, Washington University in Saint Louis; Agence Nationale de la Recherche [ANR-15-CE33-0004]	Universite de Bordeaux, Washington University in Saint Louis; Agence Nationale de la Recherche(French National Research Agency (ANR))	Portions of the data collection have been funded by the Universite de Bordeaux, Washington University in Saint Louis, and the Agence Nationale de la Recherche (grant number ANR-15-CE33-0004). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adan GE, 2009, J ARCHAEOL SCI, V36, P895, DOI 10.1016/j.jas.2008.11.017; Allen JRM, 2010, QUATERNARY SCI REV, V29, P2604, DOI 10.1016/j.quascirev.2010.05.031; Altuna Mariezkurrena X, 2004, Acta Otorrinolaringol Esp, V55, P364; Alvarez-Fernandez E, 2015, PALETHNOLOGIE, V7, DOI [10.4000/palethnologie, DOI 10.4000/PALETHNOLOGIE]; [Anonymous], 2018, NCSS 11 0 19; Arnay-de-la-Rosa M, 2001, ANN OTO RHINOL LARYN, V110, P1080, DOI 10.1177/000348940111001117; Aymard I., ETUDE PALEOPATHOLOGI; BERRY AC, 1967, J ANAT, V101, P361; BIETTI A, 1990, J WORLD PREHIST, V4, P95, DOI 10.1007/BF00974820; Blanc A., 1940, NAT HIST, V45, P280; Boule M, 1911, ANN PALEONTOL, V6, P1; Boule M., 1911, ANTHROPOLOGIE, V22, P1; Boule M, 1911, ANN PALEONTOL, V6, P111; Boule M., 1911, ANN PALEONTOL, V7, P21; Colonese AC, 2011, QUATERN INT, V239, P86, DOI 10.1016/j.quaint.2010.09.001; Condemi S, 2001, NEANDERTALIENS CHAIS; Cooper A, 2010, BRIT J SPORT MED, V44, P144, DOI 10.1136/bjsm.2008.048157; Crowe F, 2010, AM J PHYS ANTHROPOL, V142, P355, DOI 10.1002/ajpa.21229; DUTOUR O, 1991, CR ACAD SCI III-VIE, V313, P125; Fa DA, 2016, QUATERN INT, V407, P16, DOI 10.1016/j.quaint.2015.11.148; FILIPO R, 1982, J SPORT MED PHYS FIT, V22, P329; Fleitmann D, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040050; Fletcher WJ, 2010, QUATERNARY SCI REV, V29, P2839, DOI 10.1016/j.quascirev.2009.11.015; Formicola V, 2005, J ARCHAEOL SCI, V32, P1598, DOI 10.1016/j.jas.2005.04.013; FRAYER DW, 1988, CURR ANTHROPOL, V29, P346, DOI 10.1086/203645; GRAHAM MD, 1979, ANN OTO RHINOL LARYN, V88, P566, DOI 10.1177/000348947908800422; Guest JF, 2004, QJM-INT J MED, V97, P477, DOI 10.1093/qjmed/hch082; Gutierrez-Zugasti I, 2018, QUATERN INT, V474, P44, DOI 10.1016/j.quaint.2017.06.059; Haeusler M, 2019, P NATL ACAD SCI USA, V116, P4923, DOI 10.1073/pnas.1820745116; Hanihara T, 2001, J ANAT, V199, P251, DOI 10.1046/j.1469-7580.2001.19930251.x; Hardy BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023768; HARRISON D F, 1962, Ann R Coll Surg Engl, V31, P187; HARRISON D F N, 1951, J Laryngol Otol, V65, P704, DOI 10.1017/S0022215100010641; Hauser G., 1989, EPIGENETIC VARIANTS; Henry AG, 2011, P NATL ACAD SCI USA, V108, P486, DOI 10.1073/pnas.1016868108; Holt BM, 2008, YEARB PHYS ANTHROPOL, V51, P70, DOI 10.1002/ajpa.20950; Hrdlicka A, 1935, SMITHSON MISC COLLEC, V93, P1; Hurst W, 2004, J LARYNGOL OTOL, V118, P348, DOI 10.1258/002221504323086525; Ito M, 1998, UNDERSEA HYPERBAR M, V25, P59; Jackson G., 1909, BMJ-BRIT MED J, V2, P1137; Jaouen K, 2019, P NATL ACAD SCI USA, V116, P4928, DOI 10.1073/pnas.1814087116; JELINEK AJ, 1982, SCIENCE, V216, P1369, DOI 10.1126/science.216.4553.1369; KAREGEANNES JC, 1995, UNDERSEA HYPERBAR M, V22, P301; KENNEDY GE, 1986, AM J PHYS ANTHROPOL, V71, P401, DOI 10.1002/ajpa.1330710403; King JF, 2010, OTOL NEUROTOL, V31, P345, DOI 10.1097/MAO.0b013e3181be6b2d; Koruyucu MM, 2018, INT J OSTEOARCHAEOL, V28, P615, DOI 10.1002/oa.2674; Kroon DF, 2002, OTOLARYNG HEAD NECK, V126, P499, DOI 10.1067/mhn.2002.124474; Kuzminsky SC, 2016, INT J OSTEOARCHAEOL, V26, P1014, DOI 10.1002/oa.2512; LEGALL O, 1992, ANTHROPOLOGIE, V96, P121; Leonetti JP, 2015, CLINICAL OTOLOGY, 4TH EDITION, P181; Mannino MA, 2011, J ARCHAEOL SCI, V38, P3094, DOI 10.1016/j.jas.2011.07.009; MANZI G, 1991, AM J PHYS ANTHROPOL, V85, P253, DOI 10.1002/ajpa.1330850303; Mazza B, 2016, INT J OSTEOARCHAEOL, V26, P420, DOI 10.1002/oa.2432; Mehta C, 1999, STATXACT 4 WINDOWS; Munoz M, 1997, J QUATERNARY SCI, V12, P111, DOI 10.1002/(SICI)1099-1417(199703/04)12:2<111::AID-JQS294>3.0.CO;2-P; Nadel D, 2002, OHALO II 23 000 YEAR; Nakanishi H, 2011, OTOLARYNG HEAD NECK, V145, P80, DOI 10.1177/0194599811402041; Ogawa T., 1970, AMUD MAN HIS CAVE SI, P411; Okumura MMM, 2007, AM J PHYS ANTHROPOL, V132, P558, DOI 10.1002/ajpa.20544; Perez PJ, 1997, J HUM EVOL, V33, P409, DOI 10.1006/jhev.1997.0139; Ponce P, 2008, BAR INT SERIES, V1743, P101; Rabach LA, 2015, CLINICAL OTOLOGY, 4TH EDITION, P139; Richards MP, 2009, VERTEBR PALEOBIOL PA, P251, DOI 10.1007/978-1-4020-9699-0_20; Richards MP, 2001, P NATL ACAD SCI USA, V98, P6528, DOI 10.1073/pnas.111155298; ROCHE AF, 1964, ANN OTO RHINOL LARYN, V73, P82, DOI 10.1177/000348946407300109; Rosello Izquierdo E., 1992, Estudios Geologicos (Madrid), V48, P79; Sefoakova A, 2011, ACTA MUSEI NATL PR B, V67B, DOI [10.1016/j.crpv.2016.09.004, DOI 10.1016/J.CRPV.2016.09.004]; Snow CE., 1948, U KENTUCKY REPORTS A, V4, P371; Soper D, 2019, BINOMIAL PROBABILITY; Standen VG, 1997, AM J PHYS ANTHROPOL, V103, P119, DOI 10.1002/(SICI)1096-8644(199705)103:1<119::AID-AJPA8>3.0.CO;2-R; Stiner M. C., 2009, FARMING, V2009, P1, DOI DOI 10.3828/BFARM.2009.3.3; Straus LG., 1992, IBERIA IBERIANS; Stringer CB, 2008, P NATL ACAD SCI USA, V105, P14319, DOI 10.1073/pnas.0805474105; Suzuki H, 1982, B U MUSEUM, V19, P7; Timofeev I, 2004, CLIN OTOLARYNGOL, V29, P588, DOI 10.1111/j.1365-2273.2004.00865.x; TOMMASEO PONZETTA M., 1997, INT J ANTHR, V12, P29; Trinkaus, 2014, SHANIDAR NEANDERTALS; Trinkaus E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189390; Trinkaus E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186684; Trinkaus E, 2011, P NATL ACAD SCI USA, V108, P1267, DOI 10.1073/pnas.1018700108; Van Gilse PHG, 1938, ACTA OTO-LARYNGOL, V26, P343, DOI DOI 10.3109/00016483809118459; Villotte S, 2016, J ARCHAEOL SCI-REP, V6, P633, DOI 10.1016/j.jasrep.2015.05.013; Villotte S, 2017, CR PALEVOL, V16, P462, DOI 10.1016/j.crpv.2016.09.004; Villotte S, 2014, ANTHROPOL-INT J HUM, V52, P73; Weidenreich F., 1943, Palaeontologia Sinica, VD 10, P1; Welcker H, 1864, ARCH OHRENHEILKUNDE, V1, P163; White RD, 2012, CLIN RADIOL, V67, P172, DOI 10.1016/j.crad.2011.08.019; Wissing C, 2016, QUATERN INT, V411, P327, DOI 10.1016/j.quaint.2015.09.091; WOLPOFF MH, 1979, AM J PHYS ANTHROPOL, V50, P67, DOI 10.1002/ajpa.1330500110; Wong BJF, 1999, ARCH OTOLARYNGOL, V125, P969, DOI 10.1001/archotol.125.9.969; Zilhao J., 2012, BIODIVERSIDAD HUMANA, P68	91	11	11	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0220464	10.1371/journal.pone.0220464	http://dx.doi.org/10.1371/journal.pone.0220464			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5IT	31412053	Green Published, gold, Green Submitted			2022-12-26	WOS:000485012600031
J	Mandelbrot, L; Ceccaldi, PF; Duro, D; Le, M; Pencole, L; Peytavin, G				Mandelbrot, Laurent; Ceccaldi, Pierre-Francois; Duro, Dominique; Le, Minh; Pencole, Lucile; Peytavin, Gilles			Placental transfer and tissue accumulation of dolutegravir in the ex vivo human cotyledon perfusion model	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; PHARMACOKINETICS; PREGNANCY; ANTIPYRINE; EXPOSURE; WOMEN	Objective To determine the transplacental pharmacokinetics of the HIV integrase inhibitor dolutegravir. Study design Maternal-to-fetal transfer across the term human placenta was investigated with the ex-vivo dually perfused cotyledon model, in 5 closed-circuit, recirculating experiments. Dolutegravir was added to a maternal perfusate containing antipyrine, a marker to validate the cotyledon's viability, and 2 g/liter of human albumin. Results After 3h of recirculating perfusion, the mean (+/- SD) DTG concentrations in the maternal and in the fetal compartments were respectively 2450 +/- 286 ng/mL and 715 +/- 369 ng/mL, with a fetal-to-maternal ratio of 34% +/- 18% and a clearance index (in comparison with antipyrine transfer) of 79% +/- 23%. The mean cotyledon accumulation index was 153% +/- 25%. Conclusion Fetal transplacental exposure to dolutegravir was considerable as well as accumulation in placental tissue. Whether this may lead to risks for the exposed fetus requires more investigation.	[Mandelbrot, Laurent; Duro, Dominique; Pencole, Lucile] Hop Univ Paris Nord Val Seine, Serv Gynecol Obstet, Hop Louis Mourier, AP HP, Colombes, France; [Mandelbrot, Laurent; Ceccaldi, Pierre-Francois; Pencole, Lucile] Univ Paris Diderot, Univ Sorbonne Paris Cite, Paris, France; [Mandelbrot, Laurent; Ceccaldi, Pierre-Francois] Dept Hosp Univ Risques & Grossesse, Paris, France; [Mandelbrot, Laurent; Le, Minh; Pencole, Lucile; Peytavin, Gilles] INSERM, IAME, UMR 1137, Paris, France; [Ceccaldi, Pierre-Francois] Hop Univ Paris Nord Val Seine, Hop Beaujon, AP HP, Serv Gynecol Obstet, Clichy, France; [Duro, Dominique] Agence Natl Rech Sida & Hepatites Virales Inserm, Paris, France; [Le, Minh; Peytavin, Gilles] Hop Univ Paris Nord Val Seine, Hop Bichat Claude Bernard, AP HP, Pharmacotoxicol Dept, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Mandelbrot, L (corresponding author), Hop Univ Paris Nord Val Seine, Serv Gynecol Obstet, Hop Louis Mourier, AP HP, Colombes, France.; Mandelbrot, L (corresponding author), Univ Paris Diderot, Univ Sorbonne Paris Cite, Paris, France.; Mandelbrot, L (corresponding author), Dept Hosp Univ Risques & Grossesse, Paris, France.; Mandelbrot, L (corresponding author), INSERM, IAME, UMR 1137, Paris, France.	laurent.mandelbrot@lmr.aphp.fr	Ceccaldi, Pierre-Francois/B-7966-2008; Mandelbrot, Laurent/AAD-3554-2019	Ceccaldi, Pierre-Francois/0000-0003-4716-9199; Mandelbrot, Laurent/0000-0002-5883-7597	Agence Nationale de Recherches sur le Sida et Hepatites Virales (Inserm-ANRS)	Agence Nationale de Recherches sur le Sida et Hepatites Virales (Inserm-ANRS)	The salary of Dominique Duro was funded by the Agence Nationale de Recherches sur le Sida et Hepatites Virales (Inserm-ANRS). The Agence Nationale de Recherches sur le Sida et Hepatites Virales (Inserm-ANRS) also also provided funding to purchase equipment and for publication costs. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bapat P, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.06.065; Berveiller P, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.10.007; Berveiller P, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.07.023; Ceccaldi PF, 2009, OBSTET GYNECOL INT, V2009, DOI 10.1155/2009/726593; Ceccaldi PF, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.802; CHALLIER JC, 1983, REPROD NUTR DEV, V23, P41, DOI 10.1051/rnd:19830104; Cottrell ML, 2013, CLIN PHARMACOKINET, V52, P981, DOI 10.1007/s40262-013-0093-2; De Sousa Mendes M, 2016, CLINICAL PHARMACOKIN; Fauchet F, 2015, ANTIMICROB AGENTS CH, V59, P5727, DOI 10.1128/AAC.00863-15; Faure-Bardon V, 2018, AIDS, V32, P321, DOI 10.1097/QAD.0000000000001681; Gavard L, 2006, AM J OBSTET GYNECOL, V195, P296, DOI 10.1016/j.ajog.2006.01.017; Gavard L, 2009, EUR J OBSTET GYN R B, V147, P157, DOI 10.1016/j.ejogrb.2009.08.007; Jung BH, 2007, BIOMED CHROMATOGR, V21, P1095, DOI 10.1002/bmc.865; Lewis JM, 2016, AIDS, V30, P1313, DOI 10.1097/QAD.0000000000001055; Mandelbrot L, 2015, CROI 2015; Mandelbrot L, 2015, CLIN INFECT DIS, V61, P1715, DOI 10.1093/cid/civ578; Mandelbrot L, 2015, ANTIMICROB AGENTS CH, V59, P2901, DOI 10.1128/AAC.00075-15; Mandelbrot L, 2014, ANTIMICROB AGENTS CH, V58, P5617, DOI 10.1128/AAC.03184-14; Mofenson LM, 2018, LANCET GLOB HEALTH, V6, pE716, DOI 10.1016/S2214-109X(18)30272-9; Mofenson LM, 2016, J INFECT DIS, V213, P1051, DOI 10.1093/infdis/jiv390; Mulligan N BB, 2016, DOLUTEGRAVIR PHARMAC; Pain JB, 2015, ANTIMICROB AGENTS CH, V59, P3660, DOI 10.1128/AAC.00173-15; Rimawi BH, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02213-16, 10.1128/aac.02213-16]; Schalkwijk S, 2016, J ANTIMICROB CHEMOTH, V71, P480, DOI 10.1093/jac/dkv358; SCHNEIDE.H, 1972, AM J OBSTET GYNECOL, V114, P822, DOI 10.1016/0002-9378(72)90909-X; Schomaker M, 2018, LANCET GLOB HEALTH, V6, pE958, DOI 10.1016/S2214-109X(18)30326-7; Sibiude J, 2015, EXPERT OPIN DRUG SAF, V14, P643, DOI 10.1517/14740338.2015.1019462; Slogrove AL, 2017, CURR OPIN HIV AIDS, V12, P359, DOI 10.1097/COH.0000000000000386; Smith JA, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.12.013; Vinot C, 2013, ANTIMICROB AGENTS CH, V57, P1415, DOI 10.1128/AAC.01821-12; Vinot C, 2016, ANTIMICROB AGENTS CH, V60, P3112, DOI 10.1128/AAC.00007-16; Zash R, 2018, LANCET GLOB HEALTH, V6, pE804, DOI 10.1016/S2214-109X(18)30218-3; Zhang JP, 2015, BRIT J CLIN PHARMACO, V80, P502, DOI 10.1111/bcp.12639; 2018, LANCET, V391, P2296	34	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220323	10.1371/journal.pone.0220323	http://dx.doi.org/10.1371/journal.pone.0220323			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408460	Green Published, Green Submitted, gold			2022-12-26	WOS:000485009500013
J	Das, G; Patra, JK; Debnath, T; Ansari, A; Shin, HS				Das, Gitishree; Patra, Jayanta Kumar; Debnath, Trishna; Ansari, Abuzar; Shin, Han-Seung			Investigation of antioxidant, antibacterial, antidiabetic, and cytotoxicity potential of silver nanoparticles synthesized using the outer peel extract of Ananas comosus (L.)	PLOS ONE			English	Article							GREEN SYNTHESIS; LEAF EXTRACT; GOLD NANOPARTICLES; ESSENTIAL OIL; SEED EXTRACT; PINEAPPLE; WASTE; BIOSYNTHESIS; OXIDE	Currently, green nanotechnology-based approaches using waste materials from food have been accepted as an environmentally friendly and cost-effective approach with various biomedical applications. In the current study, AgNPs were synthesized using the outer peel extract of the fruit Ananas comosus (AC), which is a food waste material. Characterization was done using UV-visible spectroscopy, X-ray diffraction (XRD), Fourier transform infrared (FT-IR) spectroscopy, scanning electronic microscopy (SEM) and energy-dispersive X-ray spectroscopy (EDX) analyses. The formation of AgNPs has confirmed through UV-visible spectroscopy (at 485 nm) by the change of color owing to surface Plasmon resonance. Based on the XRD pattern, the crystalline property of AgNPs was established. The functional group existing in AC outer peel extract accountable for the reduction of Ag+ ion and the stabilization of AC-AgNPs was investigated through FT-IR. The morphological structures and elemental composition was determined by SEM and EDX analysis. With the growing application of AgNPs in biomedical perspectives, the biosynthesized AC-AgNPs were evaluated for their antioxidative, antidiabetic, and cytotoxic potential against HepG(2) cells along with their antibacterial potential. The results showed that AC-AgNPs are extremely effective with high antidiabetic potential at a very low concentration as well as it exhibited higher cytotoxic activity against the HepG(2) cancer cells in a dose-dependent manner. It also exhibited potential antioxidant activity and moderate antibacterial activity against the four tested foodborne pathogenic bacteria. Overall, the results highlight the effectiveness and potential applications of AC-AgNPs in biomedical fields such as in the treatment of acute illnesses as well as in drug formulation for treating various diseases such as cancer and diabetes. Further, it has applications in wound dressing or in treating bacterial related diseases.	[Das, Gitishree; Patra, Jayanta Kumar] Dongguk Univ Seoul, Res Inst Biotechnol & Med Converged Sci, Seoul, Gyeonggi Do, South Korea; [Debnath, Trishna; Shin, Han-Seung] Dongguk Univ Seoul, Dept Food Sci & Biotechnol, Seoul, Gyeonggi Do, South Korea; [Ansari, Abuzar] Ewha Womans Univ, Ewha Med Res Inst, Dept Obstet & Gynecol, Med Sch, Seoul, South Korea	Dongguk University; Dongguk University; Ewha Womans University	Shin, HS (corresponding author), Dongguk Univ Seoul, Dept Food Sci & Biotechnol, Seoul, Gyeonggi Do, South Korea.	spartan@dongguk.edu	PATRA, JAYANTA KUMAR/AEM-6689-2022; ANSARI, ABUZAR/AAZ-2578-2020	Das, Gitishree/0000-0002-5676-0768; PATRA, JAYANTA KUMAR/0000-0003-4118-4355	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) through High Value-added Food Technology Development Program - Ministry of Agriculture, Food and Rural Affairs (MAFRA) [118056-2]; Korea Environmental Industry & Technology Institute [A117-00197-0703-0]	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) through High Value-added Food Technology Development Program - Ministry of Agriculture, Food and Rural Affairs (MAFRA); Korea Environmental Industry & Technology Institute	This work was supported by the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) through High Value-added Food Technology Development Program funded by Ministry of Agriculture, Food and Rural Affairs (MAFRA) (118056-2) and funded by Korea Environmental Industry & Technology Institute (A117-00197-0703-0) to H-SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adedapo AA, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-54; Ahmed S, 2016, J ADV RES, V7, P17, DOI 10.1016/j.jare.2015.02.007; Anand MAV, 2019, MICROB PATHOGENESIS, V135, DOI 10.1016/j.micpath.2019.103609; Annu, 2018, J APPL BIOMED, V16, P221, DOI 10.1016/j.jab.2018.02.002; [Anonymous], 2014, J PHARMACOGNOSY PHYT; Ashraf JM, 2016, SCI REP-UK, V6, DOI 10.1038/srep20414; Balan K, 2016, RSC ADV, V6, P40162, DOI 10.1039/c5ra24391b; Baruwa Olayinka Isiaka, 2013, Journal of Horticultural Research, V21, P59, DOI 10.2478/johr-2013-0022; Basavegowda N, 2017, CATAL LETT, V147, P2630, DOI 10.1007/s10562-017-2168-4; Butala MA, 2018, STARCH-STARKE, V70, DOI 10.1002/star.201700182; Cao YW, 2001, J AM CHEM SOC, V123, P7961, DOI 10.1021/ja011342n; Chaloupka K, 2010, TRENDS BIOTECHNOL, V28, P580, DOI 10.1016/j.tibtech.2010.07.006; Cheng R, 2010, ADV MOLEC TOXICOL, V4, P157, DOI 10.1016/S1872-0854(10)04005-1; Choi SM, 2011, SYNTHETIC MET, V161, P2405, DOI 10.1016/j.synthmet.2011.09.008; Coates J., 2000, INTERPRETATION OF IN; Diao WR, 2013, J AGR FOOD CHEM, V61, P6044, DOI 10.1021/jf4007856; Faedmaleki F, 2014, IRAN J PHARM RES, V13, P235; Femi-Adepoju A, 2019, GREEN SYNTHESIS SILV; Gangula A, 2011, LANGMUIR, V27, P15268, DOI 10.1021/la2034559; Govindappa M, 2018, RESULTS PHYS, V9, P400, DOI 10.1016/j.rinp.2018.02.049; He D, 2013, ENVIRON SCI TECHNOL, V47, P9148, DOI 10.1021/es400391a; He YQ, 2018, NEW J CHEM, V42, P2882, DOI 10.1039/c7nj04224h; He YQ, 2017, RSC ADV, V7, P39842, DOI 10.1039/c7ra05286c; IALENTI A, 1993, BRIT J PHARMACOL, V110, P701, DOI 10.1111/j.1476-5381.1993.tb13868.x; Iravani S, 2014, RES PHARM SCI, V9, P385; Jagtap UB, 2013, IND CROP PROD, V46, P132, DOI 10.1016/j.indcrop.2013.01.019; Jain PK, 2008, ACCOUNTS CHEM RES, V41, P1578, DOI 10.1021/ar7002804; Kalaiyarasu T., 2016, ASIAN J PHARM CLIN R, V9, P1; Kalpana M. B., 2014, Der Pharmacia Lettre, V6, P22; Kargutkar S, 2016, PHARM BIOL, V54, P2616, DOI 10.3109/13880209.2016.1173066; Kumar B, 2017, SAUDI J BIOL SCI, V24, P45, DOI 10.1016/j.sjbs.2015.09.006; Li T, 2014, INT J FOOD PROP, V17, P1805, DOI 10.1080/10942912.2012.732168; Mittal AK, 2013, BIOTECHNOL ADV, V31, P346, DOI 10.1016/j.biotechadv.2013.01.003; Mousavi Bita, 2018, Artif Cells Nanomed Biotechnol, V46, P499, DOI 10.1080/21691401.2018.1430697; Naganathan K, 2017, IOP C SERIES MAT SCI; de Barros CHN, 2018, NANOTECHNOL SCI APPL, V11, P1, DOI 10.2147/NSA.S156115; Naz S, 2017, IET NANOBIOTECHNOL, V11, P1040, DOI 10.1049/iet-nbt.2017.0082; Nguyen NHA, 2018, NANOSCALE RES LETT, V13, DOI 10.1186/s11671-018-2575-5; Omran BA, 2018, ENERG SOURCE PART A, V40, P227, DOI 10.1080/15567036.2017.1410597; Oves M, 2018, MAT SCI ENG C-MATER, V89, P429, DOI 10.1016/j.msec.2018.03.035; P Patil Shriniwas, 2017, Biochem Biophys Rep, V10, P76, DOI 10.1016/j.bbrep.2017.03.002; Parveen M, 2016, APPL NANOSCI, V6, P267, DOI 10.1007/s13204-015-0433-7; Patil S, 2017, 3 BIOTECH, V7, DOI 10.1007/s13205-016-0589-1; Patra J. K., 2017, MICROBIOL, V8, P167, DOI [10.3389/fmicb.2017.00167, DOI 10.3389/FMICB.2017.00167]; Patra JK, 2018, J PHOTOCH PHOTOBIO B, V188, P116, DOI 10.1016/j.jphotobiol.2018.08.004; Patra JK, 2016, IET NANOBIOTECHNOL, V10, P326, DOI 10.1049/iet-nbt.2015.0102; Patra JK, 2015, INT J NANOMED, V10, P7253, DOI 10.2147/IJN.S95483; Patra JK, 2015, J FOOD BIOCHEM, V39, P80, DOI 10.1111/jfbc.12110; Pirtarighat S, 2019, J NANOSTRUCTURE CHEM, V9, P1, DOI 10.1007/s40097-018-0291-4; Poadang S, 2017, SYNTHESIS CHARACTERI; Poadang Sarinya, 2017, Chiang Mai University Journal of Natural Sciences, V16, P123, DOI 10.12982/cmujns.2017.0010; Prakash P, 2013, COLLOID SURFACE B, V108, P255, DOI 10.1016/j.colsurfb.2013.03.017; Prasannaraj Govindaraj, 2017, Advances in Natural Sciences: Nanoscience & Nanotechnology, V8, DOI 10.1088/2043-6254/aa6d2c; Punbusayakul N., 2018, P INN FUNCT FOODS AS; Putri D A, 2018, MAL J FUND APPL SCI, V14, P307; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Rajeshkumar S., 2014, BIOINORGANIC CHEM AP, V2014; Rajkumar T, 2019, J PHOTOCH PHOTOBIO B, V193, P1, DOI 10.1016/j.jphotobiol.2019.01.008; Ramesh PS, 2015, SPECTROCHIM ACTA A, V142, P339, DOI 10.1016/j.saa.2015.01.062; Rashad M M, 2015, INT J TOXICOL PHARM, V7, P287; Reenaa M., 2017, INT J CURRENT MICROB, V6, P2358, DOI DOI 10.20546/IJCMAS.2017.607.337; Rehan M, 2018, ACS SUSTAIN CHEM ENG, V6, P5911, DOI 10.1021/acssuschemeng.7b04302; Riya MP, 2014, J SCI FOOD AGR, V94, P943, DOI 10.1002/jsfa.6340; Romelle FD., 2016, EURO J FOOD SCI TECH, V4, P12, DOI DOI 10.2527/JAS2012-5761.; Sah BNP, 2016, J FOOD SCI TECH MYS, V53, P1698, DOI 10.1007/s13197-015-2100-0; Santiso R, 2012, MUTAT RES-FUND MOL M, V734, P41, DOI 10.1016/j.mrfmmm.2012.03.006; Saraswaty V, 2017, IOP C SERIES EARTH E; Shafiya Rafiq, 2018, Journal of the Saudi Society of Agricultural Sciences, V17, P351; Sharma D., 2015, ARABIAN J CHEM; Shen WN, 2011, CHEM ENG J, V175, P592, DOI 10.1016/j.cej.2011.09.121; Sivaranjani K., 2013, INT RES J PHARM, V4, P225; Soto KM, 2019, LWT-FOOD SCI TECHNOL, V103, P293, DOI 10.1016/j.lwt.2019.01.023; Sre PRR, 2015, SPECTROCHIM ACTA A, V135, P1137, DOI 10.1016/j.saa.2014.08.019; Tashi T., 2016, J CHEM PHARM RES, V8, P526; Vanaja M, 2013, APPL NANOSCI, V3, P217, DOI 10.1007/s13204-012-0121-9; Wypij M, 2018, WORLD J MICROB BIOT, V34, DOI 10.1007/s11274-017-2406-3; Zhou Y, 2001, CHEM COMMUN, P613, DOI 10.1039/b100636n; Zhou Y, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-19	78	80	81	6	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220950	10.1371/journal.pone.0220950	http://dx.doi.org/10.1371/journal.pone.0220950			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404086	Green Submitted, Green Published, gold			2022-12-26	WOS:000485006800045
J	Weise, LD; ten Tusscher, KHWJ				Weise, Louis D.; ten Tusscher, Kirsten H. W. J.			Discrete mechanical growth model for plant tissue	PLOS ONE			English	Article							BIOLOGICAL-MATERIALS; AUXIN; STRESS; ORIENTATION; ELONGATION; EPIDERMIS; NETWORK; CELLS; SHAPE	We present a discrete mechanical model to study plant development. The method is built up of mass points, springs and hinges mimicking the plant cell wall's microstructure. To model plastic growth the resting lengths of springs are adjusted; when springs exceed a threshold length, new mass points, springs and hinges, are added. We formulate a stiffness tensor for the springs and hinges as a function of the fourth rank tensor of elasticity and the geometry of the mesh. This allows us to approximate the material law as a generalized orthotropic Hooke's law, and control material properties during growth. The material properties of the model are illustrated in numerical simulations for finite strain and plastic growth. To solve the equations of motion of mass points we assume elastostatics and use Verlet integration. The method is demonstrated in simulations when anisotropic growth causes emergent residual strain fields in cell walls and a bending of tissue. The method can be used in multilevel models to study plant development, for example by coupling it to models for cytoskeletal, hormonal and gene regulatory processes.	[Weise, Louis D.; ten Tusscher, Kirsten H. W. J.] Univ Utrecht, Theoret Biol & Bioinformat, Utrecht, Netherlands	Utrecht University	Weise, LD (corresponding author), Univ Utrecht, Theoret Biol & Bioinformat, Utrecht, Netherlands.	Louis.Daniel.Weise@gmail.com			Netherlands Organization for Scientific Research NWO-VIDI [864.14.003]	Netherlands Organization for Scientific Research NWO-VIDI(Netherlands Organization for Scientific Research (NWO))	This research is funded by the Netherlands Organization for Scientific Research (www.nwo.nl) NWO-VIDI to Kirsten H.W.J. ten Tusscher (Grant No. 864.14.003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali O, 2014, ANNU REV CELL DEV BI, V30, P59, DOI 10.1146/annurev-cellbio-101512-122410; Armezzani A, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.162255; Barbez E, 2017, P NATL ACAD SCI USA, V114, pE4884, DOI 10.1073/pnas.1613499114; Baskin TI, 2013, J EXP BOT, V64, P4697, DOI 10.1093/jxb/ert176; Bidhendi AJ, 2018, PLANT PHYSIOL, V176, P41, DOI 10.1104/pp.17.01684; Biot MA, 1939, PHILOS MAG, V27, P468; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Bonilla MR, 2015, SOFT MATTER, V11, P1281, DOI 10.1039/c4sm02440k; Boudon F, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1003950; Bozorg B, 2016, PHYS BIOL, V13, DOI 10.1088/1478-3975/13/6/065002; Bozorg B, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003410; Braden B., 1986, COLL MATH J, V17, P326, DOI [10.2307/2686282, DOI 10.1080/07468342.1986.11972974]; Chanliaud E, 2002, PLANTA, V215, P989, DOI 10.1007/s00425-002-0783-8; Choi DS, 2003, PLANT CELL, V15, P1386, DOI 10.1105/tpc.011965; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Ditengou FA, 2008, P NATL ACAD SCI USA, V105, P18818, DOI 10.1073/pnas.0807814105; Eringen AC, 1980, MECH CONTINUA; Feynman RP, 1969, FEYNMAN LECT PHYS MA; Fozard JA, 2016, INTERFACE FOCUS, V6, DOI 10.1098/rsfs.2016.0043; Fozard JA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00233; Geitmann A, 2013, CELL BIOL, P1; Gibson LJ, 2012, J R SOC INTERFACE, V9, P2749, DOI 10.1098/rsif.2012.0341; Gray WM, 2004, PLOS BIOL, V2, P1270, DOI 10.1371/journal.pbio.0020311; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Grieneisen VA, 2009, CURR OPIN PLANT BIOL, V12, P606, DOI 10.1016/j.pbi.2009.07.008; Hamant O, 2008, SCIENCE, V322, P1650, DOI 10.1126/science.1165594; Hamant O, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0403-5; Hamant O, 2010, NEW PHYTOL, V185, P369, DOI 10.1111/j.1469-8137.2009.03100.x; Hejnowicz Z, 2000, J PLANT GROWTH REGUL, V19, P31, DOI 10.1007/s003440000005; Hogeweg P, 2009, LECT NOTES COMPUT SC, V5391, P29; Jensen OE, 2015, PHYSIOLOGY, V30, P159, DOI 10.1152/physiol.00030.2014; Kierzkowski D, 2012, SCIENCE, V335, P1096, DOI 10.1126/science.1213100; Kumpf RP, 2013, P NATL ACAD SCI USA, V110, P5235, DOI 10.1073/pnas.1210835110; Kutschera U, 2007, J PLANT PHYSIOL, V164, P1395, DOI 10.1016/j.jplph.2007.08.002; Landau L. D., 1975, COURSE THEORETICAL P, V7; Laskowski M, 2008, PLOS BIOL, V6, P2721, DOI 10.1371/journal.pbio.0060307; Louveaux M, 2016, P NATL ACAD SCI USA, V113, pE4294, DOI 10.1073/pnas.1600677113; Mahonen AP, 2014, NATURE, V515, P125, DOI 10.1038/nature13663; Merks RMH, 2011, PLANT PHYSIOL, V155, P656, DOI 10.1104/pp.110.167619; Meyers MA, 2009, MECHANICAL BEHAVIOR OF MATERIALS, 2ND EDITION, P1; Mullen JL, 1998, PLANTA, V206, P598, DOI 10.1007/s004250050437; Niklas KJ, 1997, AM J BOT, V84, P735, DOI 10.2307/2445809; Oliveri H, 2019, J MATH BIOL, V78, P625, DOI 10.1007/s00285-018-1286-y; Radotic K, 2012, BIOPHYS J, V103, P386, DOI 10.1016/j.bpj.2012.06.046; Rebocho AB, 2017, CURR BIOL, V27, P2610, DOI 10.1016/j.cub.2017.07.064; Ryden P, 2003, PLANT PHYSIOL, V132, P1033, DOI 10.1104/pp.103.021873; Sampathkumar A, 2014, CURR BIOL, V24, pR475, DOI 10.1016/j.cub.2014.03.014; Saxe F, 2014, PLANT METHODS, V10, DOI 10.1186/1746-4811-10-25; Seth B, 1964, 2 ORDER EFFECTS ELAS, P162; Shabala SN, 2002, PLANT PHYSIOL, V129, P290, DOI 10.1104/pp.020005; Thimann KV, 1935, J BIOL CHEM, V109, P279; Valero C, 2016, J MECH BEHAV BIOMED, V62, P222, DOI 10.1016/j.jmbbm.2016.05.006; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; VERLET L, 1967, PHYS REV, V159, P98, DOI 10.1103/PhysRev.159.98; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Weise LD, 2015, MS A MOD SIMUL, V14, P29, DOI 10.1007/978-3-319-05230-4_2; Weise LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059317; Weise LD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021934; Yavari A, 2010, J NONLINEAR SCI, V20, P781, DOI 10.1007/s00332-010-9073-y	59	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0221059	10.1371/journal.pone.0221059	http://dx.doi.org/10.1371/journal.pone.0221059			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404094	Green Published, gold, Green Submitted			2022-12-26	WOS:000485006800050
J	Alene, KA; Clements, ACA				Alene, Kefyalew Addis; Clements, Archie C. A.			Spatial clustering of notified tuberculosis in Ethiopia: A nationwide study	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; RISK-FACTORS; URBAN; PREVALENCE; INFECTION; BURDEN	Background Tuberculosis (TB) remains a major health problem worldwide and in Ethiopia. This study aimed to investigate the spatial distributions of notified TB over the whole territory of Ethiopia and to quantify the role of health care access, environmental, socio-demographic, and behavioural factors associated with the clustering of TB. Methods A spatial analysis was conducted using national TB data reported between June 2016 and June 2017 in Ethiopia. Spatial clustering of TB was explored using Moran's I statistic and the local indicator of spatial autocorrelation (LISA). A multivariate Poisson regression model was developed with a conditional autoregressive (CAR) prior structure and with posterior parameters estimated using Bayesian Markov chain Monte Carlo (MCMC) simulation with Gibbs sampling to investigate the drivers of the clustering. Result A total of 120,149 TB cases were reported from 745 districts in Ethiopia during the study period; 41,343 (34%) were bacteriologically confirmed new pulmonary TB and 33,997 (28%) were clinically diagnosed, new, smear-negative pulmonary TB patients. The nationwide annual incidence rate of notified TB was 112 per 100,000 population. The highest incidence was observed in three city administrative regions, namely Dire Dewa (348 cases per 100,000 population), Addis Ababa (262 per 100,000 population) and Harari (206 per 100,000 population), and the lowest incidence was observed in Somali region (51 per 100,000 population). High-high spatial clustering of notified TB was detected at Humera, Gog, and Surima district, and low-low clustering was detected in some districts located in the Somali region. Poor health care access (IRR = 0.78; 95%Cl: 0.66, 0.90) and good knowledge about TB (IRR = 0.84; 95%CI: 0.73, 0.96) were negatively associated with the incidence of notified TB. Conclusion Substantial spatial clustering of notified TB was detected at region, zone and district level in Ethiopia. Health care access and knowledge about TB was associated with incidence of TB. This study may provide policy makers target hotspot areas, where national control programs could be implemented more efficiently for the prevention and control of TB, and to address potential under-reporting in poor access areas.	[Alene, Kefyalew Addis; Clements, Archie C. A.] Curtin Univ, Fac Hlth Sci, Perth, WA, Australia; [Alene, Kefyalew Addis; Clements, Archie C. A.] Telethon Kids Inst, Wesfarmers Ctr Vaccines & Infect Dis, Perth, WA, Australia; [Alene, Kefyalew Addis] Univ Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia	Curtin University; Telethon Kids Institute; Wesfarmers Limited; University of Gondar	Alene, KA (corresponding author), Curtin Univ, Fac Hlth Sci, Perth, WA, Australia.; Alene, KA (corresponding author), Telethon Kids Inst, Wesfarmers Ctr Vaccines & Infect Dis, Perth, WA, Australia.; Alene, KA (corresponding author), Univ Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia.	kefyalew.alene@telethonkids.org.au	Alene, Dr Kefyalew Addis/V-8240-2018; Clements, Archie/ABD-1615-2020	Alene, Dr Kefyalew Addis/0000-0002-1904-4682; 				Abebe Y, 2003, AIDS, V17, P1835, DOI 10.1097/00002030-200308150-00013; Alene KA, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4099-8; Alene KA, 2019, TRANSBOUND EMERG DIS, V66, P1611, DOI 10.1111/tbed.13188; Alene KA, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-022948; Alene KA, 2017, GEOSPATIAL HEALTH, V12, P342, DOI 10.4081/gh.2017.575; Alene KA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171800; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Coker R, 2006, BRIT MED J, V332, P85, DOI 10.1136/bmj.38684.687940.80; Couceiro L, 2011, INT J TUBERC LUNG D, V15, P1445, DOI 10.5588/ijtld.10.0302; CSA I, 2012, ETHIOPIA DEMOGRAPHIC; Datiko DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005443; Getnet F, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0551-y; Golub JE, 2005, INT J TUBERC LUNG D, V9, P992; Hussen Awol, 2012, BMC Res Notes, V5, P320, DOI 10.1186/1756-0500-5-320; Kyu HH, 2018, LANCET INFECT DIS, V18, P1329, DOI 10.1016/S1473-3099(18)30625-X; Lakew Y, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008669; Marais B, 2018, LANCET CHILD ADOLESC, V2, P7, DOI 10.1016/S2352-4642(17)30150-5; Mesfin MM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-53; MNYIKA KS, 1994, AIDS, V8, P1477, DOI 10.1097/00002030-199410000-00016; MOH, 2015, ANN TUB B; NPC, 2016, FED DEM REP ETH GROW; Reves R, 2016, ETHIOPIA MOVES TUBER; Shen XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039256; United Nations, 2017, WORLD POPULATION PRO; World Health Organization, 2015, US HIGH BURD COUNTR; World Health Organization, 2018, GLOBAL TUBERCULOSIS; World Health Organization, 2015, GEAR END TB INTR END; World Health Organization, 2008, COMMUNITY INVOLVEMEN, P1	28	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0221027	10.1371/journal.pone.0221027	http://dx.doi.org/10.1371/journal.pone.0221027			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398220	gold, Green Published, Green Submitted			2022-12-26	WOS:000485004000044
J	Ameyaw, EK; Budu, E; Sambah, F; Baatiema, L; Appiah, F; Seidu, AA; Ahinkorah, BO				Ameyaw, Edward Kwabena; Budu, Eugene; Sambah, Francis; Baatiema, Linus; Appiah, Francis; Seidu, Abdul-Aziz; Ahinkorah, Bright Opoku			Prevalence and determinants of unintended pregnancy in sub-Saharan Africa: A multi-country analysis of demographic and health surveys	PLOS ONE			English	Article							UNPLANNED PREGNANCY; CONTRACEPTIVE USE; TRENDS; CHILDBEARING; ABORTION; LUANDA	Introduction Approximately 14 million unintended pregnancies are recorded annually in sub-Saharan Africa (SSA). We sought to investigate the prevalence and determinants of unintended pregnancies among women in sub-Saharan Africa. Materials and methods The study pooled data from current Demographic and Health Surveys (DHS) conducted from January 1, 2010 to December 31, 2016 from 29 countries in SSA. Logistic regression analysis was used to examine the factors that influence unintended pregnancies in SSA. Results were presented using odds ratios (OR). Results We found overall unintended pregnancy prevalence rate of 29%, ranging from 10.8% in Nigeria to 54.5% in Namibia. As compared to women aged 15-19 years, women of all other age categories had higher odds of unintended pregnancies. Married women were 6 times more probable to report unintended pregnancy as compared to women who had never married (OR = 6.29, CI = 5.65-7.01). The phenomenon had higher odds among rural residents as compared to urban residents (OR = 1.08, CI = 1.01-1.16). Women with primary (OR = 0.74, CI = 0.69-0.80) and secondary (OR = 0.71, CI = 0.65-0.77) levels of education had less chances of unintended pregnancies, compared to those with no education. Again, women in all other wealth categories had less probability of unintended pregnancy, as compared to women with poorest wealth status. Conclusion Our study contributes substantially towards the discourse of maternal wellbeing by unveiling the prevalence and determinants of unintended pregnancy across the SSA region. There is the need for SSA countries with high prevalence of unintended pregnancies to consider past and present successful interventions of other countries within the region such as health education, counselling, skills-building, comprehensive sex education and access to contraception. Much of these efforts rest with the governments of SSA countries.	[Ameyaw, Edward Kwabena; Ahinkorah, Bright Opoku] Univ Technol Sydney, Fac Hlth, Australian Ctr Publ & Populat Hlth Res, Sydney, NSW, Australia; [Budu, Eugene; Baatiema, Linus; Appiah, Francis; Seidu, Abdul-Aziz] Univ Cape Coast, Dept Populat & Hlth, Coll Humanities & Legal Studies, Cape Coast, Ghana; [Appiah, Francis] Univ Cape Coast, Dept Hlth Phys Educ & Recreat, Cape Coast, Ghana	University of Technology Sydney; University of Cape Coast; University of Cape Coast	Seidu, AA (corresponding author), Univ Cape Coast, Dept Populat & Hlth, Coll Humanities & Legal Studies, Cape Coast, Ghana.	abdul-aziz.seidu@stu.ucc.edu.gh	Ameyaw, Edward/AAF-2526-2020; Seidu, Abdul-Aziz/S-2521-2019	Ameyaw, Edward/0000-0002-6617-237X; Seidu, Abdul-Aziz/0000-0001-9734-9054				Abayu H., 2015, J PREG CHILD HLTH, V2, P1, DOI DOI 10.4172/2376-127X.1000137; Abraha TH, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0632-2; Adeniyi OV, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-2942-z; Ajayi AI, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2328-7; Aliaga A., 2006, OPTIMAL SAMPLE SIZES; Ameyaw Edward Kwabena, 2018, Matern Health Neonatol Perinatol, V4, P17, DOI 10.1186/s40748-018-0085-1; Amin SF, 2009, EUR J SCI RES, V26, P108; [Anonymous], 2001, NAT POL REPR HLTH; Baschieri A, 2017, MATERN CHILD HLTH J, V21, P467, DOI 10.1007/s10995-016-2124-8; Bearak J, 2018, LANCET GLOB HEALTH, V6, pE380, DOI 10.1016/S2214-109X(18)30029-9; BRONFENBRENNER U, 1977, AM PSYCHOL, V32, P513, DOI 10.1037/0003-066x.32.7.513; Calvert C, 2013, J FAM PLAN REPROD H, V39, P1, DOI 10.1136/jfprhc-2012-100389; Centers for Disease Control and Prevention, 2015, UN PREGN PREV; Central Statistical Agency [Ethiopia] ORC Macro, 2006, ORC MACR; Chanda MM, 2017, CONTRACEPTION, V96, P196, DOI 10.1016/j.contraception.2017.07.003; Chol C, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-023128; Christofides NJ, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23719; Claridge AM, 2013, WOMEN HEALTH, V53, P777, DOI 10.1080/03630242.2013.831018; Darroch JE, 2013, LANCET, V381, P1756, DOI 10.1016/S0140-6736(13)60597-8; Darteh EKM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209985; Decker Martha, 2011, Afr J Reprod Health, V15, P68; Eugene KY, 2018, SCIENCE, V6, P6, DOI DOI 10.11648/J.SJPH.20180601.12; Federal Government of Nigeria, 2014, NIG FAM PLANN BLUEPR; Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575; Fishbein M., 1979, NEBRASKA S MOTIVATIO, V27, P65; Getu MK, 2016, OBSTET GYNECOLOGY IN; Habte D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082987; Haffejee F, 2018, S AFR FAM PRACT, V60, P79, DOI 10.1080/20786190.2017.1396790; Hubacher D, 2008, CONTRACEPTION, V78, P73, DOI 10.1016/j.contraception.2008.03.002; Hulton L, 2000, FRAMEWORK EVALUATION; Ikamari L, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-69; Jayaweera RT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191412; Kebede E, 2019, P NATL ACAD SCI; Lamina M A, 2015, Ghana Med J, V49, P187, DOI 10.4314/gmj.v49i3.10; Little P, 2001, FAM PRACT, V18, P449, DOI 10.1093/fampra/18.4.449; Maxwell L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118234; McGowan PJ, 2003, J MOD AFR STUD, V41, P339, DOI 10.1017/S0022278X0300435X; Mejia-Guevara I, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002757; Messer LC, 2005, MATERN CHILD HLTH J, V9, P403, DOI 10.1007/s10995-005-0021-7; Miller E, 2010, CONTRACEPTION, V81, P316, DOI 10.1016/j.contraception.2009.12.004; Ministry of Health and Social Services, 2010, NAT HLTH POL FRAM 20; Mkandawire P, 2019, MIDWIFERY, V68, P30, DOI 10.1016/j.midw.2018.08.017; Morris N, 2018, OPEN ACCESS J CONTR, V9, P45, DOI 10.2147/OAJC.S164736; Muanda MF, 2017, CULT HEALTH SEX, V19, P1011, DOI 10.1080/13691058.2017.1286690; Mueni E., 2016, CHANGING NARRATIVE F; Nieto-Andrade B, 2017, GLOB HEALTH-SCI PRAC, V5, P75, DOI 10.9745/GHSP-D-16-00304; Noor FR, 2012, INT Q COMMUNITY HEAL, V32, P101, DOI 10.2190/IQ.32.2.b; Nyarko SH, 2019, J PREGNANCY, V2019, DOI 10.1155/2019/2920491; Polis CB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173639; Powell J, 2016, STUD COMP INT DEV, V51, P482, DOI 10.1007/s12116-015-9210-6; Rottenstreich M, 2018, ISR J HEALTH POLICY, V7, DOI 10.1186/s13584-018-0239-7; Rowe H, 2016, AUST NZ J PUBL HEAL, V40, P104, DOI 10.1111/1753-6405.12461; Roy TK, 2003, INT FAM PLAN PERSPEC, V29, P25, DOI 10.2307/3180998; Shah PS, 2011, MATERN CHILD HLTH J, V15, P205, DOI 10.1007/s10995-009-0546-2; Singh S, 2010, STUD FAMILY PLANN, V41, P241, DOI 10.1111/j.1728-4465.2010.00250.x; Sutton A, 2017, POP ASS AM C; Tsegaye AT, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0649-6; Wellings K, 2013, LANCET, V382, P1807, DOI 10.1016/S0140-6736(13)62071-1; Wong LP, 2014, BMC PUBLIC HEALTH, V14, P1; Yaya S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209801; Zahr C. A., 2004, MATERNAL MORTALITY 2	61	62	62	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220970	10.1371/journal.pone.0220970	http://dx.doi.org/10.1371/journal.pone.0220970			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5FL	31398240	gold, Green Submitted, Green Published			2022-12-26	WOS:000485004000032
J	Corder, RM; Paula, GA; Pincelli, A; Ferreira, MU				Corder, Rodrigo M.; Paula, Gilberto A.; Pincelli, Anaclara; Ferreira, Marcelo U.			Statistical modeling of surveillance data to identify correlates of urban malaria risk: A population-based study in the Amazon Basin	PLOS ONE			English	Article							CENTRAL-AFRICA; TRANSMISSION; URBANIZATION; EPIDEMIOLOGY; BRAZZAVILLE; PREVALENCE; DIVERSITY; CHILDREN; EXAMPLE; REGION	Despite the recent malaria burden reduction in the Americas, focal transmission persists across the Amazon Basin. Timely analysis of surveillance data is crucial to characterize high-risk individuals and households for better targeting of regional elimination efforts. Here we analyzed 5,480 records of laboratory-confirmed clinical malaria episodes combined with demographic and socioeconomic information to identify risk factors for elevated malaria incidence in Mancio Lima, the main urban transmission hotspot of Brazil. Overdispersed malaria count data clustered into households were fitted with random-effects zero-inflated negative binomial regression models. Random-effect predictors were used to characterize the spatial heterogeneity in malaria risk at the household level. Adult males were identified as the population stratum at greatest risk, likely due to increased occupational exposure away of the town. However, poor housing and residence in the less urbanized periphery of the town were also found to be key predictors of malaria risk, consistent with a substantial local transmission. Two thirds of the 8,878 urban residents remained uninfected after 23,975 person-years of follow-up. Importantly, we estimated that nearly 14% of them, mostly children and older adults living in the central urban hub, were free of malaria risk, being either unexposed, naturally unsusceptible, or immune to infection. We conclude that statistical modeling of routinely collected, but often neglected, malaria surveillance data can be explored to characterize drivers of transmission heterogeneity at the community level and provide evidence for the rational deployment of control interventions.	[Corder, Rodrigo M.; Pincelli, Anaclara; Ferreira, Marcelo U.] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil; [Paula, Gilberto A.] Univ Sao Paulo, Inst Math & Stat, Dept Stat, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Corder, RM; Ferreira, MU (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil.	rodrigo.corder@usp.br; muferrei@usp.br	Corder, Rodrigo M./K-6132-2017; Paula, Gilberto/D-2924-2012; Ferreira, Marcelo U/G-8289-2011	Corder, Rodrigo M./0000-0002-8929-2200; Paula, Gilberto/0000-0002-9906-9942; Ferreira, Marcelo U/0000-0002-5293-9090; Pincelli Cintra, Anaclara/0000-0002-2071-1139	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil [2016/18740-9]; National Institute of Allergy and Infectious Diseases, National Institutes of Health, United States of America [U19 AI089681]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); FAPESP [2018/18557-5]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089681] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Institute of Allergy and Infectious Diseases, National Institutes of Health, United States of America; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; http://www.fapesp.br/en/), Brazil (grant 2016/18740-9), and by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, (https://www.niaid.nih.gov/), United States of America (grant U19 AI089681). RMC receives a doctoral fellowship from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; http://cnpq.br/), which also provides senior research scholarships to GAP and MUF. FAPESP (2018/18557-5) provides a doctoral fellowship to AP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-173; Barbosa S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003109; Bejon P, 2014, ELIFE, V3, DOI 10.7554/eLife.02130; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Cairns ME, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-355; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; Clark TD, 2008, J INFECT DIS, V198, P393, DOI 10.1086/589778; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; dos Reis IC, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0947-1; dos Reis IC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137521; Ferreira MU, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1335-1; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Saraiva MDG, 2009, REV SOC BRAS MED TRO, V42, P515, DOI 10.1590/S0037-86822009000500008; GOMEZ KM, 2017, PLOS NEGLECT TROP D, V11, pNIL_1337, DOI DOI 10.1371/journal.pntd.0005780; Greenwood B.M., 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene, V83, P25, DOI 10.1016/0035-9203(89)90599-3; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Hiwat H, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-177; Kang Su Yun, 2018, Gates Open Res, V2, P32, DOI 10.12688/gatesopenres.12838.2; Keiser J, 2004, AM J TROP MED HYG, V71, P118, DOI 10.4269/ajtmh.2004.71.118; Killeen GF, 2019, LANCET PLANET HEALTH, V3, pE132, DOI 10.1016/S2542-5196(19)30035-X; Lana RM, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2045-z; Maheu-Giroux M, 2010, ACTA TROP, V115, P112, DOI 10.1016/j.actatropica.2010.02.011; Martins LMO, 2018, J VECTOR ECOL, V43, P235, DOI 10.1111/jvec.12307; Mathanga DP, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1623-9; Ministry of Health of Brazil, 2015, MAL EP STAT BRAZ 201; Ministry of Health of Brazil, 2010, PRACT GUID MAL THER; Ministry of Health of Brazil, 2017, LIST MUN BEL RISK MA; Ministry of Health of Brazil, MAL CAS MON BRAZ 201; Mwangi TW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002196; Ndungu FM, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0422-4; Osorio L, 2007, TROP MED INT HEALTH, V12, P331, DOI 10.1111/j.1365-3156.2006.01791.x; Padilla JC, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0956-0; Pan JX, 2014, STAT COMPUT, V24, P725, DOI 10.1007/s11222-013-9398-0; Qi QY, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-403; Reis IC, 2018, NEOTROP ENTOMOL, V47, P412, DOI 10.1007/s13744-018-0595-6; Rek JC, 2018, LANCET PLANET HEALTH, V2, pE83, DOI 10.1016/S2542-5196(18)30010-X; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; Robert V, 2003, AM J TROP MED HYG, V68, P169, DOI 10.4269/ajtmh.2003.68.169; Rosas-Aguirre A, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0670-y; Stasinopoulos MD., 2020, FLEXIBLE REGRESSION, V1st ed, P571, DOI [DOI 10.1201/B21973, 10.1201/b21973]; Tada MS, 2007, MEM I OSWALDO CRUZ, V102, P263, DOI 10.1590/S0074-02762007005000012; TRAPE JF, 1987, T ROY SOC TROP MED H, V81, P10, DOI 10.1016/0035-9203(87)90472-X; TRAPE JF, 1987, T ROY SOC TROP MED H, V81, P26, DOI 10.1016/0035-9203(87)90474-3; Tusting LS, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002234; van Buuren S, 2001, STAT MED, V20, P1259, DOI 10.1002/sim.746; WHO, 2018, WORLD MAL REP 2018; Wilson ML, 2015, AM J TROP MED HYG, V93, P110, DOI 10.4269/ajtmh.14-0834; Yau KKW, 2003, BIOMETRICAL J, V45, P437, DOI 10.1002/bimj.200390024	48	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220980	10.1371/journal.pone.0220980	http://dx.doi.org/10.1371/journal.pone.0220980			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398228	Green Submitted, Green Published, gold			2022-12-26	WOS:000485004000035
J	Chiku, C; Zolfo, M; Senkoro, M; Mabhala, M; Tweya, H; Musasa, P; Shukusho, FD; Mazarura, E; Mushavi, A; Mangwanya, D				Chiku, Charles; Zolfo, Maria; Senkoro, Mbazi; Mabhala, Mzwandile; Tweya, Hannock; Musasa, Patience; Shukusho, Fungai D.; Mazarura, Exervia; Mushavi, Angela; Mangwanya, Douglas			Common causes of EID sample rejection in Zimbabwe and how to mitigate them	PLOS ONE			English	Article							HIV	Early infant diagnosis (EID) of HIV provides an opportunity for early HIV detection and access to appropriate Antiretroviral treatment (ART). Dried Blood Spot (DBS) samples are used for EID of exposed infants, born to HIV-positive mothers. However, DBS rejection rates in Zimbabwe have been exceeding the target of less than 2% per month set by the National Microbiology Reference Laboratory (NMRL), in Harare. The aim of this study was to determine the DBS sample rejection rate, the reasons for rejection and the possible associations between rejection and level of health facility where the samples were collected. This is an analytical cross-sectional study using routine DBS sample data from the NMRL in Harare, Zimbabwe, between January and December 2017. A total of 34 950 DBS samples were received at the NMRL. Of these, 1291(4%) were rejected. Reasons for rejection were insufficient specimen volume (72%), missing request form (11%), missing sample (6%), cross-contamination (6%), mismatch of information (4%) and clotted sample (1%). Samples collected from clinics/rural health facilities were five times more likely to be rejected compared to those from a central hospital. Rejection rates were above the set target of <2%. The reasons for rejection were 'pre-analytical' errors including labelling errors, missing or inconsistent data, and insufficient blood collected. Samples collected at primary healthcare facilities had higher rejection rates.	[Chiku, Charles; Musasa, Patience; Shukusho, Fungai D.; Mazarura, Exervia] Natl Microbiol Reference Lab, Harare, Zimbabwe; [Zolfo, Maria] Inst Trop Med, Antwerp, Belgium; [Senkoro, Mbazi] Natl Inst Med Res, Muhimbili, Tanzania; [Mabhala, Mzwandile] Univ Chester, Chester, Cheshire, England; [Tweya, Hannock] Lighthouse Trust, Lilongwe, Malawi; [Mushavi, Angela] Prevent Mother Child Transmiss HIV, Harare, Zimbabwe; [Mangwanya, Douglas] Directorate Lab Serv, Harare, Zimbabwe	Institute of Tropical Medicine (ITM); University of Chester	Chiku, C (corresponding author), Natl Microbiol Reference Lab, Harare, Zimbabwe.	charleschiku@gmail.com	; zolfo, maria/B-9787-2015	Chiku, Charles/0000-0003-3455-598X; zolfo, maria/0000-0001-9756-9380	United Kingdom's Department for International Development (DFID); La Fondation Veuve Emile Metz-Tesch	United Kingdom's Department for International Development (DFID); La Fondation Veuve Emile Metz-Tesch	The programme was funded by: the United Kingdom's Department for International Development (DFID); La Fondation Veuve Emile Metz-Tesch supported open access publications costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was conducted through the Structured Operational Research and Training Initiative (SORT IT), a global partnership led by the Special Programme for Research and Training in Tropical Diseases at the World Health Organization (WHO/TDR). The training model is based on a course developed jointly by the International Union Against Tuberculosis and Lung Disease (The Union) and Medecins sans Frontieres (MSF). The specific SORT IT programme which resulted in this publication was implemented by: Medecins Sans Frontieres, Brussels Operational Centre, Luxembourg and the Centre for Operational Research, The Union, Paris, France. Mentorship and coordination/facilitation of the SORT IT workshops were provided through the Centre for Operational Research, The Union, Paris, France; the Operational Research Unit (LuxOR); AMPATH, Eldoret, Kenya; The Institute of Tropical Medicine, Antwerp, Belgium; The Centre for International Health, University of Bergen, Norway; University of Washington, USA; The Luxembourg Institute of Health, Luxembourg; The Institute of Medicine, University of Chester, UK; The National Institute for Medical Research, Muhimbili Medical Research Centre, Dar es Salaam, Tanzania.	Agarwal R, 2012, INDIAN J CLIN BIOCHE, V27, P61, DOI 10.1007/s12291-011-0182-7; [Anonymous], 2018, GLOB TUB REP; Gill MM, 2017, AIDS RES TREAT, V2017, DOI 10.1155/2017/2572594; Govender K, 2016, AFR J LAB MED, V5, DOI 10.4102/ajlm.v5i1.349; Inalegwu Auchi, 2016, World J Virol, V5, P73, DOI 10.5501/wjv.v5.i2.73; Lippi G, 2011, CLIN CHEM LAB MED, V49, P1113, DOI 10.1515/CCLM.2011.600; Mazanderani AH, 2017, PLOS ONE, V585, P2010; Mugauri H, 2018, AIDS RES TREAT, V2018, DOI 10.1155/2018/4234256; Nkengasong JN, 2010, AM J CLIN PATHOL, V134, P368, DOI 10.1309/AJCPMPSINQ9BRMU6; Smit PW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086461; Thomson KA, 2011, T ROY SOC TROP MED H, V105, P320, DOI 10.1016/j.trstmh.2011.02.011; UNAIDS, 2014, GAP REP; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; World Health Organization, 2017, INT NEGL TROP DIS GL, V4, P1	14	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0210136	10.1371/journal.pone.0210136	http://dx.doi.org/10.1371/journal.pone.0210136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393883	gold, Green Published, Green Submitted			2022-12-26	WOS:000485002500002
J	Liu, YY; Li, XY; Zhang, YP; Wang, HX; Rong, XM; Peng, JL; He, L; Peng, Y				Liu, Yunyun; Li, Xiaoyu; Zhang, Yuanpei; Wang, Hongxuan; Rong, Xiongming; Peng, Jialing; He, Lei; Peng, Ying			An miR-340-5p-macrophage feedback loop modulates the progression and tumor microenvironment of glioblastoma multiforme	ONCOGENE			English	Article							CANCER STEM-CELLS; MACROPHAGE POLARIZATION; TGF-BETA; GROWTH; REGULATORS; PREDICTS; AGGRESSIVENESS; PROLIFERATION; INFILTRATION; SUPPRESSES	MicroRNAs (miRNAs) have been shown to be involved in the progression and tumor microenvironment of glioblastoma multiforme (GBM). Our previous research has indicated that miR-340-5p has an antitumor effect in vitro. However, the role of miR-340-5p in GBM has not been fully elucidated. Here, we show that downregulation of miR-340-5p in GBM is correlated with tumor size, recurrence, and poor survival. Moreover, we found that miR-340-5p levels are correlated with the density of tumor-associated macrophages (TAMs) and M2-polarized TAMs in GBM. Biofunctional investigations revealed that downregulation of miR-340-5p promoted TAM recruitment and M2-TAMs polarization in vitro and in vivo. In addition, we found that upregulation of miR-340-5p inhibited tumor growth and was associated with good prognosis in vivo. Through gene expression profiles and bioinformatics analysis, we showed that miR-340-5p directly targets POSTN, which recruited TAMs through integrin alpha v beta 3. Downregulation of miR-340-5p in GBM did not induce the differentiation of TAMs into polarized M2 cells but was able to promote the M2 polarization of TAMs through directly targeting LTBP-1. Furthermore, we found that M2-TAMs promoted tumorigenesis and were associated with a poor prognosis in vivo. In an in vitro study, we demonstrated that M2-TAMs inhibited miR-340-5p expression in GBM cells by upregulation of TGF beta-1, which increased HMGA-2 expression in GBM. A ChIP assay confirmed that HMGA-2 transcriptionally suppressed miR-340-5p expression. Patients with low-miR-340-5p expression, high CD163, high POSTN, high LIBP1 levels, and high HMGA-2 had a poor prognosis with shorter overall survival, confirming data from the TCGA database. These findings suggest that an miR-340-5p-macrophage feedback loop modulates the progression and tumor microenvironment of GBM and may represent a prognostic biomarker and therapeutic strategy for GBM.	[Liu, Yunyun; Li, Xiaoyu; Zhang, Yuanpei; Wang, Hongxuan; Rong, Xiongming; Peng, Jialing; He, Lei; Peng, Ying] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Neurol, Guangzhou 510120, Guangdong, Peoples R China; [Liu, Yunyun; Li, Xiaoyu; Zhang, Yuanpei; Wang, Hongxuan; Rong, Xiongming; Peng, Jialing; He, Lei; Peng, Ying] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou 510120, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Peng, Y (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Neurol, Guangzhou 510120, Guangdong, Peoples R China.; Peng, Y (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou 510120, Guangdong, Peoples R China.	docpengy123@163.com			National Natural Science Foundation of China [81572481, 81502167, 81502552]; key point program of Science & Technique plan for production, study, and research of Guangzhou city [201508020058]; Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes, Sun Yat-sen University [KLB09001]; Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology [[2013]163]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); key point program of Science & Technique plan for production, study, and research of Guangzhou city; Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes, Sun Yat-sen University; Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology	We thank and acknowledge the patients for tumor tissue donation. We also thank SWQ and BH for their scientific support in some experiments. This work was supported by the National Natural Science Foundation of China (No. 81572481 to YP, 81502167 to XMR and 81502552 to LH), the key point program of Science & Technique plan for production, study, and research of Guangzhou city (201508020058). Grant KLB09001 from the Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes, Sun Yat-sen University and Grant [2013]163 from Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology.	Baer C, 2016, NAT CELL BIOL, V18, P790, DOI 10.1038/ncb3371; Chen DG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03225-9; Chen H, 2017, ONCOGENE, V36, P4415, DOI 10.1038/onc.2017.73; Chen XW, 2017, ONCOGENE, V36, P5045, DOI 10.1038/onc.2017.118; Chi JQ, 2015, VIROLOGY, V476, P72, DOI 10.1016/j.virol.2014.11.027; Chiou GY, 2013, MOL CELL, V52, P693, DOI 10.1016/j.molcel.2013.11.009; Cui TT, 2019, ONCOGENE, V38, P2923, DOI 10.1038/s41388-018-0601-9; Da FA, 2013, CLIN DEV IMMUNOL, V2013; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; Fernandez S, 2015, ONCOGENE, V34, P3240, DOI 10.1038/onc.2014.267; Fiore D, 2016, ONCOTARGET, V7, P19531, DOI 10.18632/oncotarget.6968; Forstreuter F, 2002, J NEUROIMMUNOL, V132, P93, DOI 10.1016/S0165-5728(02)00315-6; Gargiulo G, 2013, CANCER CELL, V23, P660, DOI 10.1016/j.ccr.2013.03.030; Garris C, 2013, NAT MED, V19, P1207, DOI 10.1038/nm.3355; Gordon SR, 2017, NATURE, V545, P495, DOI 10.1038/nature22396; Hambardzumyan D, 2016, NAT NEUROSCI, V19, P20, DOI 10.1038/nn.4185; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Held-Feindt J, 2010, EXP CELL RES, V316, P1553, DOI 10.1016/j.yexcr.2010.02.018; Heusinkveld M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-216; Huang DQ, 2015, ONCOTARGET, V6, P9257, DOI 10.18632/oncotarget.3288; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Lathia JD, 2011, CELL STEM CELL, V8, P482, DOI 10.1016/j.stem.2011.04.013; Lee J, 2015, NEURO-ONCOLOGY, V17, P685, DOI 10.1093/neuonc/nou302; Li H, 2006, CELL RES, V16, P169, DOI 10.1038/sj.cr.7310023; Liu B, 2014, HUM PATHOL, V45, P1752, DOI 10.1016/j.humpath.2014.02.028; Luo H, 2015, BRAIN, V138, P3654, DOI 10.1093/brain/awv287; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Mikheev AM, 2015, NEURO-ONCOLOGY, V17, P372, DOI 10.1093/neuonc/nou161; Ngambenjawong C, 2017, ADV DRUG DELIVER REV, V114, P206, DOI 10.1016/j.addr.2017.04.010; Okada M, 2009, INT J ONCOL, V34, P1621, DOI 10.3892/ijo_00000292; Platten M, 2003, ANN NEUROL, V54, P388, DOI 10.1002/ana.10679; Ponomarev ED, 2013, GLIA, V61, P91, DOI 10.1002/glia.22363; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Qian Y, 2017, ACS NANO, V11, P9536, DOI 10.1021/acsnano.7b05465; Rape A, 2014, ADV DRUG DELIVER REV, V79-80, P172, DOI 10.1016/j.addr.2014.08.012; Rong XM, 2016, ONCOTARGET, V7, P83976, DOI 10.18632/oncotarget.6930; Roth P, 2013, BRAIN, V136, P564, DOI 10.1093/brain/aws351; Saha D, 2017, CANCER CELL, V32, P253, DOI 10.1016/j.ccell.2017.07.006; Schwarm FP, 2016, INT J ONCOL, V48, P1485, DOI 10.3892/ijo.2016.3397; Shi Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15080; Simon T, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0878-x; Squadrito ML, 2013, TRENDS IMMUNOL, V34, P350, DOI 10.1016/j.it.2013.02.003; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Wang SC, 2012, LAB INVEST, V92, P151, DOI 10.1038/labinvest.2011.128; Wu A, 2010, NEURO-ONCOLOGY, V12, P1113, DOI 10.1093/neuonc/noq082; Wu ZS, 2011, CANCER-AM CANCER SOC, V117, P2842, DOI 10.1002/cncr.25860; Xiong QS, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0144-8; Yamashita D, 2015, CANCER RES, V75, P1123, DOI 10.1158/0008-5472.CAN-14-0938; Zheng F, 2012, GUT, V61, P278, DOI 10.1136/gut.2011.239145; Zhou WC, 2015, NAT CELL BIOL, V17, P170, DOI 10.1038/ncb3090; Zhuang XQ, 2017, NAT CELL BIOL, V19, P1274, DOI 10.1038/ncb3613	53	35	35	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 5	2019	38	49					7399	7415		10.1038/s41388-019-0952-x	http://dx.doi.org/10.1038/s41388-019-0952-x			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JT4BN	31427735				2022-12-26	WOS:000500936600003
J	Zheng, J; Zhang, H; Ma, RR; Liu, HT; Gao, P				Zheng, Jie; Zhang, Hui; Ma, Ranran; Liu, Haiting; Gao, Peng			Long non-coding RNA KRT19P3 suppresses proliferation and metastasis through COPS7A-mediated NF-kappa B pathway in gastric cancer	ONCOGENE			English	Article							COP9 SIGNALOSOME; BREAST-CANCER; EXPRESSION; DEGRADATION; HOMOLOG; P53	Long non-coding RNAs (lncRNAs) have emerged as critical regulators in gastric cancer (GC). LncRNA expression microarray data indicate that KRT19P3 (Keratin 19 Pseudogene 3) is downregulated in GC samples. However, the expression pattern and molecular mechanism of KRT19P3 in GC have not been characterized. The present study confirmed the downregulation of KRT19P3 in GC tissues and cells. Decreased expression of KRT19P3 was correlated with larger tumor size, advanced TNM stage, Lauren's classification, positive lymph node metastasis, and poor prognosis. Enforced expression of KRT19P3 significantly inhibited cell proliferation, migration, and invasion in vitro, as well as tumorigenesis and metastasis in vivo. Conversely, KRT19P3 knockdown had opposite effects. Mechanistically, RNA pull-down and RNA immunoprecipitation assay revealed that KRT19P3 could directly bind COPS7A. KRT19P3 enhanced COPS7A protein stability in GC cells, and KRT19P3 suppressed GC cell proliferation and metastasis partly through regulation of COPS7A expression. COPS7A could promote deubiquitinylation of I kappa B alpha, which was executed by CSN-associated deubiquitinylase USP15, and then KRT19P3 inactivated nuclear factor kappa-B (NF-kappa B) signaling pathway in a COPS7A-dependent manner. For the first time, we revealed that KRT19P3 could suppress tumor growth and metastasis through COPS7A-mediated NF-kappa B pathway, which may serve as potential targets for treatment of GC in the future.	[Zheng, Jie; Zhang, Hui; Ma, Ranran; Liu, Haiting; Gao, Peng] Shandong Univ, Minist Educ, Key Lab Expt Teratol, Jinan, Shandong, Peoples R China; [Zheng, Jie; Zhang, Hui; Ma, Ranran; Liu, Haiting; Gao, Peng] Shandong Univ, Sch Med, Dept Pathol, Jinan, Shandong, Peoples R China; [Zheng, Jie] Weifang Med Univ, Dept Pathol, Weifang, Shandong, Peoples R China; [Zhang, Hui; Ma, Ranran; Liu, Haiting; Gao, Peng] Shandong Univ, Qilu Hosp, Dept Pathol, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Weifang Medical University; Shandong University	Gao, P (corresponding author), Shandong Univ, Minist Educ, Key Lab Expt Teratol, Jinan, Shandong, Peoples R China.; Gao, P (corresponding author), Shandong Univ, Sch Med, Dept Pathol, Jinan, Shandong, Peoples R China.; Gao, P (corresponding author), Shandong Univ, Qilu Hosp, Dept Pathol, Jinan, Shandong, Peoples R China.	gaopeng@sdu.edu.cn			National Science Foundation of China [81672842, 81802474]; Taishan Scholars Program of Shandong Province [ts201511096]; Natural Scientific Foundation of Shandong Province [ZR2015HL091]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholars Program of Shandong Province; Natural Scientific Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This study was supported by the National Science Foundation of China (Grant No. 81672842 and 81802474), the Taishan Scholars Program of Shandong Province (Grant No. ts201511096), the Natural Scientific Foundation of Shandong Province (ZR2015HL091).	Alves KH, 2002, FEBS LETT, V527, P15, DOI 10.1016/S0014-5793(02)03147-2; Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; Chen RB, 2017, NUCLEIC ACIDS RES, V45, P9947, DOI 10.1093/nar/gkx600; de Groen FLM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132495; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hou J, 2017, ONCOGENE, V36, P1134, DOI 10.1038/onc.2016.280; Hsu MC, 2008, MODERN PATHOL, V21, P609, DOI [10.1038/modpathol.2008.23, 10.1038/mpath.2008.23]; Hu Y, 2014, CANCER RES, V74, P6890, DOI 10.1158/0008-5472.CAN-14-0686; Kouvaraki MA, 2003, CANCER RES, V63, P2977; Liu TY, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0873-2; Lu MH, 2016, ONCOGENE, V35, P3524, DOI 10.1038/onc.2015.413; Mao LX, 2019, EXP CELL RES, V374, P274, DOI 10.1016/j.yexcr.2018.10.012; Qi FZ, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0420-4; Sasaki N, 2001, CLIN CANCER RES, V7, P4136; Schweitzer K, 2007, EMBO J, V26, P1532, DOI 10.1038/sj.emboj.7601600; Shackleford TJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2902; Shi XF, 2013, CANCER LETT, V339, P159, DOI 10.1016/j.canlet.2013.06.013; Sokolova O, 2017, TOXINS, V9, DOI 10.3390/toxins9040119; Uhle S, 2003, EMBO J, V22, P1302, DOI 10.1093/emboj/cdg127; Wang H, 2018, THERANOSTICS, V8, P2814, DOI 10.7150/thno.23012; Wang YL, 2002, BIOCHEM J, V366, P79, DOI 10.1042/bj20020211; Wicker CA, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3313-y; Yang F, 2011, HEPATOLOGY, V54, P1679, DOI 10.1002/hep.24563; Zhao RY, 2011, J CLIN INVEST, V121, P851, DOI 10.1172/JCI44111; Zhu YP, 2014, ONCOL LETT, V7, P1197, DOI 10.3892/ol.2014.1843	28	38	41	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 7	2019	38	45					7073	7088		10.1038/s41388-019-0934-z	http://dx.doi.org/10.1038/s41388-019-0934-z			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JL9XI	31409899				2022-12-26	WOS:000495878400004
J	Benrimoh, D; Parr, T; Adams, RA; Friston, K				Benrimoh, David; Parr, Thomas; Adams, Rick A.; Friston, Karl			Hallucinations both in and out of context: An active inference account	PLOS ONE			English	Article							AUDITORY HALLUCINATIONS; SCHIZOPHRENIA; SYMPTOMS; PREDICTION; PERCEPTION; THOUGHTS; SPEECH; MODELS	Hallucinations, including auditory verbal hallucinations (AVH), occur in both the healthy population and in psychotic conditions such as schizophrenia (often developing after a prodromal period). In addition, hallucinations can be in-context (they can be consistent with the environment, such as when one hallucinates the end of a sentence that has been repeated many times), or out-of-context (such as the bizarre hallucinations associated with schizophrenia). In previous work, we introduced a model of hallucinations as false (positive) inferences based on a (Markov decision process) formulation of active inference. In this work, we extend this model to include content-to disclose the computational mechanisms behind in-and out-of-context hallucinations. In active inference, sensory information is used to disambiguate alternative hypotheses about the causes of sensations. Sensory information is balanced against prior beliefs, and when this balance is tipped in the favor of prior beliefs, hallucinations can occur. We show that in-context hallucinations arise when (simulated) subjects cannot use sensory information to correct prior beliefs about hearing a voice, but beliefs about content (i.e. the sequential order of a sentence) remain accurate. When hallucinating subjects also have inaccurate beliefs about state transitions, out-of-context hallucinations occur; i.e. their hallucinated speech content is disordered. Note that out-of-context hallucinations in this setting does not refer to inference about context, but rather to false perceptual inference that emerges when the confidence in-or precision of-sensory evidence is reduced. Furthermore, subjects with inaccurate beliefs about state transitions but an intact ability to use sensory information do not hallucinate and are reminiscent of prodromal patients. This work demonstrates the different computational mechanisms that may underlie the spectrum of hallucinatory experience-from the healthy population to psychotic states.	[Benrimoh, David; Parr, Thomas; Friston, Karl] UCL, Inst Neurol, Wellcome Ctr Human Neuroimaging, London, England; [Benrimoh, David] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Adams, Rick A.] UCL, Div Psychiat, London, England; [Adams, Rick A.] UCL, Inst Cognit Neurosci, London, England	University of London; University College London; McGill University; University of London; University College London; University of London; University College London	Benrimoh, D (corresponding author), UCL, Inst Neurol, Wellcome Ctr Human Neuroimaging, London, England.; Benrimoh, D (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.	david.benrimoh@mail.mcgill.ca	Benrimoh, David/Y-4331-2019; Adams, Rick/M-7640-2015; Friston, Karl/D-9230-2011	Adams, Rick/0000-0002-7661-8881; Friston, Karl/0000-0001-7984-8909; Benrimoh, David/0000-0002-1452-4791; Parr, Thomas/0000-0001-5108-5743	Richard and Edith Strauss Fellowship (McGill University); Fonds de Recherche du Quebec-Sante (FRQS); Rosetrees Trust [173346]; MRC Skills Development Fellow [MR/S007806/1]; Wellcome Principal Research Fellow [088130/Z/09/Z]; MRC [MR/S007806/1] Funding Source: UKRI	Richard and Edith Strauss Fellowship (McGill University); Fonds de Recherche du Quebec-Sante (FRQS); Rosetrees Trust(Rosetrees Trust); MRC Skills Development Fellow; Wellcome Principal Research Fellow; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	DB is supported by a Richard and Edith Strauss Fellowship (McGill University) and the Fonds de Recherche du Quebec-Sante (FRQS). TP is supported by the Rosetrees Trust (Award Number 173346). RAA was supported by an NIHR University College London Hospitals Biomedical Research Centre Postgraduate Fellowship and is now an MRC Skills Development Fellow (MR/S007806/1). KJF is a Wellcome Principal Research Fellow (Ref: 088130/Z/09/Z).	Adams Rick A, 2013, Front Psychiatry, V4, P47, DOI 10.3389/fpsyt.2013.00047; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; ANDREASEN NC, 1986, SCHIZOPHRENIA BULL, V12, P473, DOI 10.1093/schbul/12.3.473; ARNDT S, 1991, BRIT J PSYCHIAT, V158, P317, DOI 10.1192/bjp.158.3.317; Benrimoh David, 2018, Comput Psychiatr, V2, P183, DOI 10.1162/cpsy_a_00022; BENTALL RP, 1991, BRIT J CLIN PSYCHOL, V30, P213, DOI 10.1111/j.2044-8260.1991.tb00939.x; Blakemore SJ, 2000, NEUROREPORT, V11, pR11, DOI 10.1097/00001756-200008030-00002; Botvinick M, 2012, TRENDS COGN SCI, V16, P485, DOI 10.1016/j.tics.2012.08.006; Cassidy CM, 2018, CURR BIOL, V28, P503, DOI 10.1016/j.cub.2017.12.059; Demirdjian D, 2005, 10 IEEE INT C COMP V, V1; Dietrich E, 2003, MIND LANG, V18, P95, DOI 10.1111/1468-0017.00216; FEINBERG I, 1978, SCHIZOPHRENIA BULL, V4, P636, DOI 10.1093/schbul/4.4.636; Feldman H, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00215; Fletcher PC, 2009, NAT REV NEUROSCI, V10, P48, DOI 10.1038/nrn2536; Ford JM, 2007, AM J PSYCHIAT, V164, P458, DOI 10.1176/appi.ajp.164.3.458; Ford JM, 2015, SCHIZOPHRENIA BULL, V41, P223, DOI 10.1093/schbul/sbu031; Friston K, 2016, TRENDS COGN SCI; Friston K, 2016, SCHIZOPHR RES, V176, P83, DOI 10.1016/j.schres.2016.07.014; Friston KJ, 2006, J PHYSIOL-PARIS, V100, P70, DOI 10.1016/j.jphysparis.2006.10.001; Friston KJ, 2012, INT J PSYCHOPHYSIOL, V83, P248, DOI 10.1016/j.ijpsycho.2011.11.014; FRITH CD, 1989, PSYCHOL MED, V19, P359, DOI 10.1017/S003329170001240X; Goodfellow Ian J., 2016, DEEP LEARNING, P184; Handest P, 2016, REV PHILOS PSYCHOL, V7, P595, DOI 10.1007/s13164-015-0286-8; Hoffman RE, 2006, PHARMACOPSYCHIATRY, V39, pS54, DOI 10.1055/s-2006-931496; HOLZMAN PS, 1972, PSYCHOPHARMACOLOGIA, V24, P29, DOI 10.1007/BF00402904; Jardri R, 2013, BRAIN, V136, P3227, DOI 10.1093/brain/awt257; KLOSTERKOTTER J, 1992, NEUROL PSYCHIAT BR, V1, P30; Lawrie SM, 2003, ANN NY ACAD SCI, V985, P445; Limanowski J, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00643; Mathys C, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00039; McCarthy-Jones S, 2014, SCHIZOPHRENIA BULL, V40, P225, DOI 10.1093/schbul/sbs156; McCarthy-Jones S, 2011, CONSCIOUS COGN, V20, P1586, DOI 10.1016/j.concog.2011.08.005; Mirza MB, 2016, FRONT COMPUT NEUROSC, V10, DOI 10.3389/fncom.2016.00056; Parr T, 2018, FRONT INTEGR NEUROSC, V12, DOI 10.3389/fnint.2018.00039; Parr T, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0376; Pettersson-Yeo W, 2011, NEUROSCI BIOBEHAV R, V35, P1110, DOI 10.1016/j.neubiorev.2010.11.004; Powers AR, 2017, SCIENCE, V357, P596, DOI 10.1126/science.aan3458; Rolls ET, 2008, NAT REV NEUROSCI, V9, P696, DOI 10.1038/nrn2462; Sass LA, 2003, SCHIZOPHRENIA BULL, V29, P427, DOI 10.1093/oxfordjournals.schbul.a007017; Schwartenbeck P, 2015, CEREB CORTEX, V25, P3434, DOI 10.1093/cercor/bhu159; Shergill SS, 2003, SCIENCE, V301, P187, DOI 10.1126/science.1085327; Shergill SS, 2005, AM J PSYCHIAT, V162, P2384, DOI 10.1176/appi.ajp.162.12.2384; Sterzer P, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00502; Teufel C, 2015, P NATL ACAD SCI USA, V112, P13401, DOI 10.1073/pnas.1503916112; Vercammen A, 2010, SCHIZOPHRENIA BULL, V36, P151, DOI 10.1093/schbul/sbn063; Wang J, 2014, NEUROIMAGE, V91, P91, DOI 10.1016/j.neuroimage.2014.01.003	46	17	17	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0212379	10.1371/journal.pone.0212379	http://dx.doi.org/10.1371/journal.pone.0212379			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5OC	31430277	Green Submitted, Green Published, gold			2022-12-26	WOS:000485026800003
J	Fujikawa, A; Noda, Y; Yamamoto, H; Tanga, N; Sakaguchi, G; Hattori, S; Song, WJ; Sora, I; Nabeshima, T; Katsuura, G; Noda, M				Fujikawa, Akihiro; Noda, Yukihiro; Yamamoto, Hideko; Tanga, Naomi; Sakaguchi, Gaku; Hattori, Satoko; Song, Wen-Jie; Sora, Ichiro; Nabeshima, Toshitaka; Katsuura, Goro; Noda, Masaharu			Mice deficient in protein tyrosine phosphatase receptor type Z (PTPRZ) show reduced responsivity to methamphetamine despite an enhanced response to novelty	PLOS ONE			English	Article							INDUCED NEUROTOXICITY; DOPAMINE; RATS; PHOSPHORYLATION; IDENTIFICATION; HIPPOCAMPUS; KINASES; NEURONS; BRAIN; MODEL	Methamphetamine (METH), a commonly abused drug, elevates extracellular dopamine (DA) levels by inducing DA efflux through the DA transporter (DAT). Emerging evidence in rodent models suggests that locomotor responses to a novel inescapable open field may predict behavioral responses to abused drugs; METH produces more potent stimulant effects in high responders to novelty than in low responders. We herein found that mice deficient in protein tyrosine phosphatase receptor type Z (Ptprz-KO) exhibited an enhanced behavioral response to novelty; however, METH-induced hyperlocomotion was significantly lower in Ptprz-KO than in wild-type mice when METH was administered at a non-toxic dose of 1 mg per kg body weight (bdw). Single-cell RT-PCR revealed that the majority of midbrain DA neurons expressed PTPRZ. No histological alterations were observed in the mesolimbic or nigrostriatal dopaminergic pathways in Ptprz-KO brains; however, a significant decrease was noted in brain DA turnover, suggesting functional alterations. In vivo microdialysis experiments revealed that METH-evoked DA release in the nucleus accumbens was significantly lower in Ptprz-KO mice than in wild-type mice. Consistent with this result, Ptprz-KO mice showed significantly fewer cell surface DAT as well as weaker DA uptake activity in striatal synaptosomes prepared 1 hr after the administration of METH than wild-type mice, while no significant differences were observed in the two groups treated with saline. These results indicate that the high response phenotype of Ptprz-KO mice to novelty may not be simply attributed to hyper-dopaminergic activity, and that deficits in PTPRZ reduce the effects of METH by reducing DAT activity.	[Fujikawa, Akihiro; Tanga, Naomi; Noda, Masaharu] Natl Inst Basic Biol, Div Mol Neurobiol, Higashiyama Ku, Myodaiji Cho, Okazaki, Aichi, Japan; [Noda, Yukihiro] Meijo Univ, Div Clin Sci & Neuropsychopharmacol, Fac Pharm, Tempaku Ku, Nagoya, Aichi, Japan; [Yamamoto, Hideko] Tokyo Metropolitan Inst Med Sci, Dept Psychiat & Behav Sci, Setagaya Ku, Tokyo, Japan; [Tanga, Naomi; Noda, Masaharu] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Higashiyama Ku, Myodaiji Cho, Okazaki, Aichi, Japan; [Sakaguchi, Gaku] SHIONOGI & CO LTD, Biomarker R&D Dept, Futaba Cho, Toyonaka, Osaka, Japan; [Hattori, Satoko] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Syst Med Sci, Kutsukake Cho, Toyoake, Aichi, Japan; [Song, Wen-Jie] Kumamoto Univ, Grad Sch Med Sci, Dept Sensory & Cognit Physiol, Chuo Ku, Kumamoto, Japan; [Sora, Ichiro] Kobe Univ, Grad Sch Med, Dept Psychiat, Chuo Ku, Kusunoki Cho, Kobe, Hyogo, Japan; [Nabeshima, Toshitaka] Fujita Hlth Univ, Adv Diagnost Syst Res Lab, Grad Sch Hlth Sci, Kutsukake Cho, Toyoake, Aichi, Japan; [Katsuura, Goro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Psychosomat Internal Med, Kagoshima, Japan; [Katsuura, Goro] Univ Hosp, Kagoshima, Japan; [Noda, Masaharu] Tokyo Inst Technol, Inst Innovat Res, Cell Biol Ctr, Midori Ku, Nagatsuta Cho, Yokohama, Kanagawa, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Meijo University; Tokyo Metropolitan Institute of Medical Science; Graduate University for Advanced Studies - Japan; Shionogi & Company Limited; Fujita Health University; Kumamoto University; Kobe University; Fujita Health University; Kagoshima University; Tokyo Institute of Technology	Noda, M (corresponding author), Natl Inst Basic Biol, Div Mol Neurobiol, Higashiyama Ku, Myodaiji Cho, Okazaki, Aichi, Japan.; Noda, M (corresponding author), Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Higashiyama Ku, Myodaiji Cho, Okazaki, Aichi, Japan.; Noda, M (corresponding author), Tokyo Inst Technol, Inst Innovat Res, Cell Biol Ctr, Midori Ku, Nagatsuta Cho, Yokohama, Kanagawa, Japan.	noda.m.ae@m.titech.ac.jp	Hattori, Satoko/AAE-6873-2022	Hattori, Satoko/0000-0002-1047-6454	JSPS KAKENHI [21700416, 24500390, 17K07069, 16209008, 08458187]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The analyses were supported by JSPS KAKENHI Grant Numbers 21700416, 24500390, and 17K07069 for AF, and 16209008 and 08458187 for MN. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. SHIONOGI & CO. LTD provided support in the form of salary for author GS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Bardo MT, 1996, BEHAV BRAIN RES, V77, P23, DOI 10.1016/0166-4328(95)00203-0; Bevins RA, 2004, PHARMACOL BIOCHEM BE, V79, P65, DOI 10.1016/j.pbb.2004.06.002; Chen R, 2007, PHARMACOL BIOCHEM BE, V87, P158, DOI 10.1016/j.pbb.2007.04.012; Chow JPH, 2008, J BIOL CHEM, V283, P30879, DOI 10.1074/jbc.M802976200; Chow JPH, 2008, NEUROSCI LETT, V442, P208, DOI 10.1016/j.neulet.2008.07.028; Dabrowski A, 2011, J BIOCHEM, V149, P641, DOI 10.1093/jb/mvr047; Fleckenstein AE, 1997, J PHARMACOL EXP THER, V282, P834; Foster JD, 2006, HANDB EXP PHARM, V175, P197; Fujikawa A, 2003, NAT GENET, V33, P375, DOI 10.1038/ng1112; Fujikawa A, 2001, NEUR M PLANN SAN DIE; Fujikawa A, 2007, J BIOCHEM, V142, P343, DOI 10.1093/jb/mvm140; Fujikawa A, 2017, J BIOCHEM, V162, P381, DOI 10.1093/jb/mvx042; Fujikawa A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119361; Fujikawa A, 2011, J BIOL CHEM, V286, P37137, DOI 10.1074/jbc.M111.270140; Fukada M, 2005, METHODS, V35, P54, DOI 10.1016/j.ymeth.2004.07.008; Fukumura M, 1998, BRAIN RES, V806, P1, DOI 10.1016/S0006-8993(98)00656-8; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; Harroch S, 2000, MOL CELL BIOL, V20, P7706, DOI 10.1128/MCB.20.20.7706-7715.2000; Kawachi H, 2001, P NATL ACAD SCI USA, V98, P6593, DOI 10.1073/pnas.041608698; Kita T, 1998, NEUROPHARMACOLOGY, V37, P1177, DOI 10.1016/S0028-3908(98)00106-3; KRUEGER NX, 1992, P NATL ACAD SCI USA, V89, P7417, DOI 10.1073/pnas.89.16.7417; Kuboyama K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048797; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Lisman JE, 2001, HIPPOCAMPUS, V11, P551; MAEDA N, 1994, FEBS LETT, V354, P67, DOI 10.1016/0014-5793(94)01093-5; MYHRER T, 1988, PHYSIOL BEHAV, V42, P371, DOI 10.1016/0031-9384(88)90279-X; Niisato K, 2005, J NEUROSCI, V25, P1081, DOI 10.1523/JNEUROSCI.2565.04.2005; Niwa M, 2007, BIOL PSYCHIAT, V61, P890, DOI 10.1016/j.biopsych.2006.06.016; Ohnishi H, 2011, TRENDS NEUROSCI, V34, P629, DOI 10.1016/j.tins.2011.09.005; Ohyama K, 1998, DEV BRAIN RES, V107, P219, DOI 10.1016/S0165-3806(97)00220-4; PETTIT HO, 1984, PSYCHOPHARMACOLOGY, V84, P167, DOI 10.1007/BF00427441; PIAZZA PV, 1989, SCIENCE, V245, P1511, DOI 10.1126/science.2781295; Shintani T, 1998, NEUROSCI LETT, V247, P135, DOI 10.1016/S0304-3940(98)00295-X; Shintani T, 1997, BIOCHEM BIOPH RES CO, V230, P419, DOI 10.1006/bbrc.1996.5973; Shintani T, 2009, J NEUROSCI, V29, P11628, DOI 10.1523/JNEUROSCI.2394-09.2009; Simon JR, 1997, NEUROSCI LETT, V224, P201, DOI 10.1016/S0304-3940(97)13479-6; Sora I, 2010, ANN NY ACAD SCI, V1187, P218, DOI 10.1111/j.1749-6632.2009.05276.x; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Tamura H, 2006, NEUROSCI LETT, V399, P33, DOI 10.1016/j.neulet.2006.01.045; Tanga N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217880; Tanga N, 2019, GLIA, V67, P967, DOI 10.1002/glia.23583; Volz TJ, 2007, J NEUROCHEM, V101, P883, DOI 10.1111/j.1471-4159.2006.04419.x; Zhu SY, 2015, NAT NEUROSCI, V18, P1084, DOI 10.1038/nn.4060; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	44	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0221205	10.1371/journal.pone.0221205	http://dx.doi.org/10.1371/journal.pone.0221205			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430310	Green Published, Green Submitted, gold			2022-12-26	WOS:000485026800032
J	Stavnsbo, M; Skrede, T; Aadland, E; Aadland, KN; Chinapaw, M; Anderssen, SA; Andersen, LB; Resaland, GK				Stavnsbo, Mette; Skrede, Turid; Aadland, Eivind; Aadland, Katrine N.; Chinapaw, Mai; Anderssen, Sigmund A.; Andersen, Lars B.; Resaland, Geir K.			Cardiometabolic risk factor levels in Norwegian children compared to international reference values: The ASK study	PLOS ONE			English	Article							BODY-MASS INDEX; BLOOD-PRESSURE-MEASUREMENT; CARDIOVASCULAR RISK; METABOLIC SYNDROME; CARDIORESPIRATORY FITNESS; PHYSICAL-ACTIVITY; INSULIN SENSITIVITY; WAIST CIRCUMFERENCE; ADOLESCENTS; DISEASE	Objective To investigate cardiometabolic risk factor levels in a group of Norwegian 10-year-old children compared to international values and examine the association between cardiorespiratory fitness (CRF) and the reference-standardized clustered risk score. Methods 913 children (49% girls) were included from the Active Smarter Kids (ASK) study. Body mass index (BMI), waist circumference (WC), systolic blood pressure (SBP), diastolic blood pressure (DBP), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), total cholesterol (TC) to HDL-C ratio, triglyceride (TG), glucose, insulin, homeostatic model assessment (HOMA) score and CRF, were standardized according to international age-and sex-specific reference values. Results The Norwegian children had significantly more favorable WC, DBP, glucose, HDL-C and CRF levels compared to the international reference values, but similar or less favorable levels of other cardiometabolic risk factors. CRF was the variable that differed the most from the international values (mean (95% CI) 1.20 (1.16 to 1.24) SD). The clustered risk score (excluding CRF) was higher in the Norwegian children, but decreased to below international levels when including CRF (mean (95% CI) - 0.08 (- 0.12 to 0.05) SD). CRF had a significant inverse association with the clustered risk score (excluding CRF) (beta - 0.37 SD, 95% CI -0.43 to 0.31). Conclusions Norwegian children have substantially higher CRF levels than international standards, and including CRF in clustered risk scores reduces overall risk in Norwegian children below that of international levels. CRF is associated with improved cardiometabolic health in children.	[Stavnsbo, Mette; Skrede, Turid; Aadland, Eivind; Aadland, Katrine N.; Anderssen, Sigmund A.; Andersen, Lars B.] Western Norway Univ Appl Sci, Dept Sport Food & Nat Sci, Sogndal, Norway; [Stavnsbo, Mette; Skrede, Turid; Anderssen, Sigmund A.; Andersen, Lars B.] Norwegian Sch Sport Sci, Dept Sports Med, Oslo, Norway; [Chinapaw, Mai] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Amsterdam Univ Med Ctr, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Resaland, Geir K.] Western Norway Univ Appl Sci, Fac Educ Arts & Sports, Ctr Phys Act Learning, Sogndal, Norway	Western Norway University of Applied Sciences; Norwegian School of Sport Sciences; Vrije Universiteit Amsterdam; Western Norway University of Applied Sciences	Stavnsbo, M (corresponding author), Western Norway Univ Appl Sci, Dept Sport Food & Nat Sci, Sogndal, Norway.; Stavnsbo, M (corresponding author), Norwegian Sch Sport Sci, Dept Sports Med, Oslo, Norway.	Mette.Stavnsbo@hvl.no	Stavnsbo, Mette/AAV-3655-2021; Paw, Mai Chin A/N-1665-2019	Paw, Mai Chin A/0000-0001-6259-2441; Stavnsbo, Mette/0000-0002-0920-964X; Andersen, Lars Bo/0000-0002-9800-029X	Research Council of Norway [221047/F40]; Western Norway University of Applied Science; Gjensidige Foundation [1042294]	Research Council of Norway(Research Council of Norway); Western Norway University of Applied Science; Gjensidige Foundation	This work received support from the Research Council of Norway (grant number 221047/F40), Western Norway University of Applied Science, the Norwegian School of Sports Science and the Gjensidige Foundation (grant number 1042294).	Aadland E, 2018, SCAND J MED SCI SPOR, V28, P862, DOI 10.1111/sms.12985; Aadland Eivind, 2017, Prev Med Rep, V7, P74, DOI 10.1016/j.pmedr.2017.05.001; Aadland E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110492; Aksglaede L, 2009, PEDIATRICS, V123, pE932, DOI 10.1542/peds.2008-2491; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Andersen LB, 2008, J SPORT MED PHYS FIT, V48, P434; Andersen LB, 2011, INT J PEDIATR OBES, V6, P29, DOI 10.3109/17477166.2011.606816; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Andersen LB, 2006, PREV MED, V42, P73, DOI 10.1016/j.ypmed.2005.10.009; ANDERSEN LB, 1989, J INTERN MED, V225, P157, DOI 10.1111/j.1365-2796.1989.tb00057.x; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Assmann G, 2004, CIRCULATION, V109, P8, DOI 10.1161/01.CIR.0000131512.50667.46; Bailey DP, 2012, EUR J PEDIATR, V171, P1317, DOI 10.1007/s00431-012-1719-3; Beevers G, 2001, BRIT MED J, V322, P981, DOI 10.1136/bmj.322.7292.981; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Bertrais S, 2000, ANN EPIDEMIOL, V10, P316, DOI 10.1016/S1047-2797(00)00056-9; Blair SN, 2009, BRIT J SPORT MED, V43, P1; Carel JC, 2008, NEW ENGL J MED, V358, P2366, DOI 10.1056/NEJMcp0800459; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; Cook S, 2003, ARCH PEDIAT ADOL MED, V157, P821, DOI 10.1001/archpedi.157.8.821; Dron JS, 2017, CURR ATHEROSCLER REP, V19, DOI 10.1007/s11883-017-0667-9; Duncombe SL, 2017, J HYPERTENS, V35, P213, DOI 10.1097/HJH.0000000000001178; Ekelund U, 2007, DIABETOLOGIA, V50, P1832, DOI 10.1007/s00125-007-0762-5; El Assaad MA, 2002, BLOOD PRESS MONIT, V7, P237, DOI 10.1097/00126097-200208000-00006; Elhakeem A, 2015, INT J BEHAV NUTR PHY, V12, DOI [10.1186/s12966-015-0250-0, 10.1186/s12966-015-0274-5]; Farsani SF, 2013, DIABETOLOGIA, V56, P1471, DOI 10.1007/s00125-013-2915-z; Franks PW, 2007, DIABETES, V56, P2964, DOI 10.2337/db06-1639; Funtikova AN, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0107-z; Garnett SP, 2007, AM J CLIN NUTR, V86, P549, DOI 10.1093/ajcn/86.3.549; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Gungor N, 2004, J PEDIATR-US, V144, P47, DOI 10.1016/j.jpeds.2003.09.045; Huxley R, 2010, EUR J CLIN NUTR, V64, P16, DOI 10.1038/ejcn.2009.68; Jolliffe CJ, 2007, J AM COLL CARDIOL, V49, P891, DOI 10.1016/j.jacc.2006.08.065; Jones DW, 2003, JAMA-J AM MED ASSOC, V289, P1027, DOI 10.1001/jama.289.8.1027; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Kollias A, 2014, J HYPERTENS, V32, P2315, DOI 10.1097/HJH.0000000000000384; Kwiterovich PO, 2003, JAMA-J AM MED ASSOC, V290, P912, DOI 10.1001/jama.290.7.912; Magnussen CG, 2013, CURR OPIN CARDIOL, V28, P561, DOI 10.1097/HCO.0b013e32836428f4; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mourad JJ, 2008, VASC HEALTH RISK MAN, V4, P1315, DOI 10.2147/VHRM.S4073; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Myers J, 2015, PROG CARDIOVASC DIS, V57, P306, DOI 10.1016/j.pcad.2014.09.011; Nicklas TA, 2002, INT J SPORTS MED, V23, pS39; Resaland GK, 2010, SCAND J MED SCI SPOR, V20, pE112, DOI 10.1111/j.1600-0838.2009.00921.x; Resaland GK, 2009, ACTA PAEDIATR, V98, P687, DOI 10.1111/j.1651-2227.2008.01181.x; Resaland GK, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2049-y; Ross R, 2016, CIRCULATION, V134, pE653, DOI 10.1161/CIR.0000000000000461; Skinner AC, 2018, PEDIATRICS, V142, DOI [10.1542/peds.2018-1916, 10.1542/peds.2017-3459, 10.1542/peds.2018-0725]; Sorensen K, 2012, HORM RES PAEDIAT, V77, P137, DOI 10.1159/000336325; Stavnsbo M, 2018, ATHEROSCLEROSIS, V278, P299, DOI 10.1016/j.atherosclerosis.2018.10.003; Steene-Johannessen J, 2009, SCAND J CLIN LAB INV, V69, P380, DOI 10.1080/00365510802691771; Titmuss AT, 2016, J PAEDIATR CHILD H, V52, P928, DOI 10.1111/jpc.13190; Tolonen H, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0020-3; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; White WB, 2001, BLOOD PRESS MONIT, V6, P107, DOI 10.1097/00126097-200104000-00007; World Health Organization, 2017, AD OB REL BEH TRENDS; World Medical Association Declaration of Helsinki (WMA), 1964, ETH PRINC MED RES IN; WYNDER EL, 1981, PREV MED, V10, P121, DOI 10.1016/0091-7435(81)90068-2; Zhou B, 2017, LANCET, V389, P37, DOI 10.1016/S0140-6736(16)31919-5; Zimmet P, 2007, LANCET, V369, P2059, DOI 10.1016/S0140-6736(07)60958-1	61	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0220239	10.1371/journal.pone.0220239	http://dx.doi.org/10.1371/journal.pone.0220239			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5MK	31425532	gold, Green Submitted, Green Published			2022-12-26	WOS:000485022400012
J	Gao, ZH; Deng, WH; Zhu, F				Gao, Zhenghui; Deng, Wenhui; Zhu, Fen			Reference gene selection for quantitative gene expression analysis in black soldier fly (Hermetia illucens)	PLOS ONE			English	Article							HOUSEKEEPING GENES; PCR; STRATIOMYIDAE; CADMIUM; DIPTERA; LARVAE; QPCR	Hermetia illucens is an important resource insect for the conversion of organic waste. Quantitative PCR (qPCR) is the primary tool of gene expression analysis and a core technology of molecular biology research. Reference genes are essential for qPCR analysis; however, a stability analysis of H. illucens reference genes has not yet been carried out. To find suitable reference genes for normalizing gene expression data, the stability of eight housekeeping genes (including ATP6V1A, RPL8, EF1, Tubulin, TBP, GAPDH, Actin and RP49) was investigated under both biotic (developmental stages, tissues and sex) and abiotic (heavy metals, food, antibiotics) conditions. Gene expression data were analysed by geNorm, NormFinder, BestKeeper, and Delta Ct programs. A set of specific reference genes was recommended for each experimental condition using the results of RefFinder synthesis analysis. This study offers a solid foundation for further studies of the molecular biology of H. illucens.	[Gao, Zhenghui; Deng, Wenhui] Huazhong Agr Univ, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Hubei, Peoples R China; [Zhu, Fen] Huazhong Agr Univ, Hubei Int Sci & Technol Cooperat Base Waste Conve, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Zhu, F (corresponding author), Huazhong Agr Univ, Hubei Int Sci & Technol Cooperat Base Waste Conve, Wuhan, Hubei, Peoples R China.	zhufen@mail.hzau.edu.cn			National Natural Science Foundation of China [31872306]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partly supported by National Natural Science Foundation of China (Grant numbers: 31872306). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Borrelli L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16560-6; Bulak P, 2018, SCI TOTAL ENVIRON, V633, P912, DOI 10.1016/j.scitotenv.2018.03.252; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Cai MM, 2018, ENVIRON MICROBIOL, V20, P4051, DOI 10.1111/1462-2920.14450; Cai MM, 2018, ENVIRON POLLUT, V242, P634, DOI 10.1016/j.envpol.2018.06.105; Chia SY, 2018, PEERJ, V6, DOI 10.7717/peerj.5885; Dai TM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173821; Dobermann D, 2019, J CLEAN PROD, V211, P303, DOI 10.1016/j.jclepro.2018.11.176; Gao X, 2017, ALGAL RES, V24, P1, DOI 10.1016/j.algal.2017.03.009; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Huggett JF, 2013, CLIN CHEM, V59, P892, DOI 10.1373/clinchem.2013.206375; Jiang XY, 2016, BIOL TRACE ELEM RES, V169, P374, DOI 10.1007/s12011-015-0402-8; Lalander C, 2013, SCI TOTAL ENVIRON, V458, P312, DOI 10.1016/j.scitotenv.2013.04.033; Lee CM, 2018, J BIOTECHNOL, V279, P47, DOI 10.1016/j.jbiotec.2018.05.003; Lee YS, 2016, INT J BIOL MACROMOL, V82, P514, DOI 10.1016/j.ijbiomac.2015.10.067; Li LL, 2016, J ASIA-PAC ENTOMOL, V19, P233, DOI 10.1016/j.aspen.2016.01.006; Li SL, 2017, AQUACULTURE, V477, P62, DOI 10.1016/j.aquaculture.2017.04.015; Luo J, 2018, J INTEGR AGR, V17, P2745, DOI [10.1016/S2095-3119(18)61926-4, 10.1016/s2095-3119(18)61926-4]; Macabelli CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093287; Moniruzzaman M, 2017, J TOXICOL SCI, V42, P731, DOI 10.2131/jts.42.731; Muller A, 2017, Z NATURFORSCHUNG C, V72; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Oliveira Fernanda, 2015, Journal of Entomology and Zoology Studies, V3, P147; Park SI, 2017, ENTOMOL RES, V47, P115, DOI 10.1111/1748-5967.12226; Peng R, 2011, ADV MATER RES-SWITZ, V175-176, P67, DOI 10.4028/www.scientific.net/AMR.175-176.67; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Pujol-Luz JR, 2008, J FORENSIC SCI, V53, P476, DOI 10.1111/j.1556-4029.2008.00659.x; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Rehman KU, 2017, J ENVIRON MANAGE, V196, P458, DOI 10.1016/j.jenvman.2017.03.047; Salomone R, 2017, J CLEAN PROD, V140, P890, DOI 10.1016/j.jclepro.2016.06.154; Shinkai Y, 2017, TOXICOL SCI, V156, P412, DOI 10.1093/toxsci/kfw268; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Spranghers T, 2017, J SCI FOOD AGR, V97, P2594, DOI 10.1002/jsfa.8081; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tomberlin JK, 2009, ENVIRON ENTOMOL, V38, P930, DOI 10.1603/022.038.0347; Tomberlin JK, 2002, ANN ENTOMOL SOC AM, V95, P379, DOI 10.1603/0013-8746(2002)095[0379:SLHTOB]2.0.CO;2; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Veazey KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027592; Wang XY, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1175-9; Wang YS, 2017, FOODS, V6, DOI 10.3390/foods6100091; Wasko A, 2016, INT J BIOL MACROMOL, V92, P316, DOI 10.1016/j.ijbiomac.2016.07.038; Xu J, 2017, J ECON ENTOMOL; Yang XW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20612-w; Yu YC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205182	48	13	15	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2019	14	8							e0221420	10.1371/journal.pone.0221420	http://dx.doi.org/10.1371/journal.pone.0221420			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5LL	31419256	Green Published, Green Submitted, gold			2022-12-26	WOS:000485019900043
J	Kim, B; Kim, J; Jo, YH; Lee, JH; Hwang, JE				Kim, Byunghyun; Kim, Joonghee; Jo, You Hwan; Lee, Jae Hyuk; Hwang, Ji Eun			The change in age distribution of CAP population in Korea with an estimation of clinical implications of increasing age threshold of current CURB65 and CRB65 scoring system	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; CURB-65; PERFORMANCE; PROGNOSIS; SEVERITY; BURDEN; ADULTS	Background CURB65 and CRB65 score are simple and popular methods to estimate the mortality in patients with community-acquired pneumonia (CAP). Although there has been a global increase in life expectancy and population ageing, we are still using the same age threshold derived from patients in late 1990s to calculate the scores. We sought to assess the implication of using higher age threshold using Korean population data and a single center hospital records. Methods Using Korean National Health Insurance Service-National Sample Cohort (NHIS-NSC), we analyzed annual age distribution of CAP patients in Korea from 2005 to 2013 and report how patients aged >65 years increased over time. We also assessed annual change in test characteristics of various age threshold in Korean CAP population. Using a single center hospital registry of CAP patients (2008-2017), we analyzed test characteristics of CURB65 and CRB65 scores with various age thresholds. Results 116,481 CAP cases were identified from NHIS-NSC dataset. The proportion of patients aged >65 increased by 1.01% (95% CI, 0.70%-1.33%, P<0.001) every year. In the sample Korean population dataset, age threshold showed its peak AUROC (0.829) at 70. In the hospital dataset, 7,197 cases were included for analysis. The AUROC of both CRB65 and CURB65 was maximized at 71. When CRB71 was applied instead of CRB65 for hospital referral using score <1 to define a low-risk case, the potential hospital referral was significantly decreased (72.9% to 64.6%, P<0.001) without any significant increase in 1-month mortality in the low risk group (0.6% to 0.7%, P = 0.690). Conclusion There was a significant age shift in CAP population in Korea. Increasing the current age threshold of CURB65 (or CRB65) could be a viable option to reduce ever-increasing hospital referrals and admissions of CAP patients.	[Kim, Byunghyun; Kim, Joonghee; Jo, You Hwan; Lee, Jae Hyuk; Hwang, Ji Eun] Seoul Natl Univ, Bundang Hosp, Dept Emergency Med, Seongnam Si, Gyeonggi Do, South Korea	Seoul National University (SNU)	Kim, J (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Emergency Med, Seongnam Si, Gyeonggi Do, South Korea.	joonghee@snubh.org	Kim, Joonghee/C-9811-2014	Kim, Joonghee/0000-0001-5080-7097				Dwyer R, 2013, BMJ OPEN RESPIR RES, V1, DOI 10.1136/bmjresp-2014-000038; Fine MJ, 1996, JAMA-J AM MED ASSOC, V275, P134, DOI 10.1001/jama.275.2.134; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Jeon S-H, 2016, AN EXPLORATORY STUDY; Kim B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200620; Kim B, 2018, AM J EMERG MED, V36, P758, DOI 10.1016/j.ajem.2017.10.005; Lee J, 2014, AM J EMERG MED, V32, P700, DOI 10.1016/j.ajem.2014.04.010; Lee YS, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/8160838; Lim WS, 2009, THORAX, V64, P1, DOI 10.1136/thx.2009.121434; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Liu JL, 2016, SCI REP-UK, V6, DOI 10.1038/srep22911; Ma HM, 2015, INTERN MED J, V45, P300, DOI 10.1111/imj.12676; Morimoto K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122247; Moskowitz CS, 2006, CLIN TRIALS, V3, P272, DOI 10.1191/1740774506cn147oa; Myint PK, 2009, INT J CLIN PRACT, V63, P1345, DOI 10.1111/j.1742-1241.2009.02147.x; Myint PK, 2007, THORAX, V62, P1015; Ouslander JG, 2010, J AM GERIATR SOC, V58, P627, DOI 10.1111/j.1532-5415.2010.02768.x; Ramirez JA, 2017, CLIN INFECT DIS, V65, P1806, DOI 10.1093/cid/cix647; Restrepo MI, 2013, CURR OPIN INFECT DIS, V26, P151, DOI 10.1097/QCO.0b013e32835ebc6d; Shimizu H, 2016, 2016 23RD INTERNATIONAL CONFERENCE ON TELECOMMUNICATIONS (ICT), DOI 10.1109/ICT.2016.7500419; United Nations, 2015, STESASERA390 UN; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502; Wroe PC, 2012, J INFECT DIS, V205, P1589, DOI 10.1093/infdis/jis240	23	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0219367	10.1371/journal.pone.0219367	http://dx.doi.org/10.1371/journal.pone.0219367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415581	gold, Green Submitted, Green Published			2022-12-26	WOS:000485017200005
J	Sugimoto, M; Kondo, M; Kamimoto, Y; Ikeda, T; Cutler, A; Mariya, A; Anand-Apte, B				Sugimoto, Masahiko; Kondo, Mineo; Kamimoto, Yuki; Ikeda, Tomoaki; Cutler, Alecia; Mariya, Ali; Anand-Apte, Bela			Changes in VEGF-related factors are associated with presence of inflammatory factors in carbohydrate metabolism disorders during pregnancy	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MATERNAL PLASMA-LEVELS; DIABETIC-RETINOPATHY; FACTOR RECEPTOR-1; ANGIOGENESIS; ACTIVATION; EXPRESSION; MARKERS; FLT-1; RISK	The aim of this study was to determine the action of molecules in carbohydrate metabolism disorders during pregnancy. The concentration of different types of cytokines and vascular endothelial growth factor (VEGF) in the plasma were measured in 4 groups of women: Group I, normal pregnancy (n = 10); Group II, patients with gestational DM (n = 12); Group III, pregnant patients with preexisting DM (n = 16); and Group IV, diabetic non-pregnant women (n = 22). The plasma VEGF concentration was significantly higher in the women in Group IV than in other groups (P < 0.01). The concentration of the soluble form of the VEGF receptor-1 (sVEGFR-1) was significantly higher in Group I than in other groups (P < 0.01). The concentration of soluble form of the VEGF receptor-2 (sVEGFR-2) was significantly lower in Groups I than in other groups (P < 0.05). The concentrations of monocyte chemotactic protein-1 (MCP-1) and eotaxin were significantly lower in Group I than in Groups III and IV. The levels of interleukin (IL)-8, IL-6, and tumor necrosis factor-alpha (TNF-alpha) were significantly higher in Group I than in Group IV. Both the VEGF-related molecules and the Inflammatory cytokines are altered in pregnant women with the carbohydrate metabolism disorders.	[Sugimoto, Masahiko; Kondo, Mineo] Mie Univ, Grad Sch Med, Dept Ophthalmol, Tsu, Mie, Japan; [Kamimoto, Yuki; Ikeda, Tomoaki] Mie Univ, Grad Sch Med, Dept Obstet & Gynecol, Tsu, Mie, Japan; [Cutler, Alecia; Mariya, Ali; Anand-Apte, Bela] Cleveland Clin Fdn, Cole Eye Inst, Dept Ophthalm Res, 9500 Euclid Ave, Cleveland, OH 44195 USA	Mie University; Mie University; Cleveland Clinic Foundation	Sugimoto, M (corresponding author), Mie Univ, Grad Sch Med, Dept Ophthalmol, Tsu, Mie, Japan.	sugimochi@clin.medic.mie-u.ac.jp			Kanzawa Medical Research Foundation, Japan	Kanzawa Medical Research Foundation, Japan	This research was funded by the Kanzawa Medical Research Foundation, Japan (2013). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamis AP, 2002, BRIT J OPHTHALMOL, V86, P363, DOI 10.1136/bjo.86.4.363; Agostini HT, 2005, CURR EYE RES, V30, P249, DOI 10.1080/02713680590923249; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Beharier O, 2017, ARCH GYNECOL OBSTET, V295, P1477, DOI 10.1007/s00404-017-4362-4; Bo S, 2007, ATHEROSCLEROSIS, V194, pE72, DOI 10.1016/j.atherosclerosis.2006.09.017; Bosio PM, 2001, AM J OBSTET GYNECOL, V184, P146, DOI 10.1067/mob.2001.108342; Clauss M, 1996, J BIOL CHEM, V271, P17629, DOI 10.1074/jbc.271.30.17629; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Funatsu H, 2012, BRIT J OPHTHALMOL, V96, P302, DOI 10.1136/bjo.2010.181222; Funk M, 2010, RETINA-J RET VIT DIS, V30, P1412, DOI 10.1097/IAE.0b013e3181e095c0; Gille H, 2001, J BIOL CHEM, V276, P3222, DOI 10.1074/jbc.M002016200; Gobl CS, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0138-3; Hagmann H, 2012, CLIN CHEM, V58, P837, DOI 10.1373/clinchem.2011.169094; Jo N, 2003, INVEST OPHTH VIS SCI, V44, P4054, DOI 10.1167/iovs.02-1308; Joussen AM, 2002, FASEB J, V8, P1450; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Kendall RL, 1996, BIOCHEM BIOPH RES CO, V226, P324, DOI 10.1006/bbrc.1996.1355; Kernt M, 2012, GROWTH FACTORS, V30, P49, DOI 10.3109/08977194.2011.639300; Kinsley B, 2007, CLIN THER, V29, pS153, DOI 10.1016/j.clinthera.2007.12.015; Kitzmiller JL, 2008, DIABETES CARE, V31, P1060, DOI 10.2337/dc08-9020; Kupferminc MJ, 1997, AM J REPROD IMMUNOL, V38, P302; Kwee BJ, 2015, ANN BIOMED ENG, V43, P628, DOI 10.1007/s10439-014-1145-y; Lee CT, 2010, ARTIF ORGANS, V34, pE222, DOI 10.1111/j.1525-1594.2010.01000.x; Li Aihua, 2005, Angiogenesis, V8, P63, DOI 10.1007/s10456-005-5208-4; Lygnos MC, 2006, IN VIVO, V20, P157; Metzger BE, 1998, DIABETES CARE, V21, pB161; Murakami M, 2006, BLOOD, V108, P1849, DOI 10.1182/blood-2006-04-016030; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; OPPENHEIM JJ, 1991, ANNU REV IMMUNOL, V9, P617, DOI 10.1146/annurev.iy.09.040191.003153; Paradisi G, 2002, DIABETES CARE, V25, P560, DOI 10.2337/diacare.25.3.560; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Poulaki V, 2002, J CLIN INVEST, V109, P805, DOI 10.1172/JCI200213776; Qiu Y, 2009, BIOCHEM SOC T, V37, P1207, DOI 10.1042/BST0371207; Renault KM, 2017, INT J OBESITY, V41, P598, DOI 10.1038/ijo.2017.9; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Salcedo R, 2001, J IMMUNOL, V166, P7571, DOI 10.4049/jimmunol.166.12.7571; Sharkey AM, 1996, EUR J CLIN INVEST, V26, P1182, DOI 10.1046/j.1365-2362.1996.830605.x; Sheth BP, 2008, CURR DIABETES REP, V8, P270, DOI 10.1007/s11892-008-0048-4; Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469; Sugiyama T, 2014, DIABETES RES CLIN PR, V103, P412, DOI 10.1016/j.diabres.2013.12.017; Szlosarek P, 2006, EUR J CANCER, V42, P745, DOI 10.1016/j.ejca.2006.01.012; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Toda J, 2016, JPN J OPHTHALMOL, V60, P454, DOI 10.1007/s10384-016-0464-y; Viedt C, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015609.31253.7F; Wang X, 2013, DIABETES CARE, V36, P166, DOI 10.2337/dc12-0702; Wong TY, 2018, OPHTHALMOLOGY, V125, P1608, DOI 10.1016/j.ophtha.2018.04.007; 1996, AM J OBSTET GYNECOL, V174, P1343, DOI DOI 10.1016/S0002-9378(96)70683-X; 2000, DIABETES CARE, V23, P1084, DOI [DOI 10.2337/DIACARE.23.8.1084, 10.2337/diacare.23.8.1084]	50	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220650	10.1371/journal.pone.0220650	http://dx.doi.org/10.1371/journal.pone.0220650			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415573	gold, Green Submitted, Green Published			2022-12-26	WOS:000485017200023
J	Huang, CC; Huang, CC; Lin, SY; Chang, CYY; Lin, WC; Chung, CH; Lin, FH; Tsao, CH; Lo, CM; Chien, WC				Huang, Chun-Chung; Huang, Chien-Chu; Lin, Shao-Yi; Chang, Cherry Yin-Yi; Lin, Wu-Chou; Chung, Chi-Hsiang; Lin, Fu-Huang; Tsao, Chang-Huei; Lo, Chun-Min; Chien, Wu-Chien			Association of pelvic inflammatory disease (PID) with ectopic pregnancy and preterm labor in Taiwan: A nationwide population-based retrospective cohort study	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS; BACTERIAL VAGINOSIS; SEXUAL-BEHAVIOR; SEQUELAE; INFECTION; DIAGNOSIS; EPIDEMIOLOGY; ENDOMETRITIS; SALPINGITIS; PREVALENCE	Background Pelvic inflammatory disease (PID) is an infectious disease that causes tubal occlusion and other pelvic and abdominal adhesions. The incidence of pelvic inflammatory disease (PID) has increased due to the sexually active status of the young population. This leads to a more serious problem and a larger effect than previously observed. However, there have been few studies on this topic in Asian populations. Aim We aimed to evaluate the risk of preterm labor and/or ectopic pregnancy in Taiwanese women following PID. Design Using the Taiwan National Health Insurance Database, we designed a retrospective cohort study that included 12-to 55-year-old pregnant women between 2000 and 2010. We selected a 1: 3 age-matched control group of non-PID women. The endpoint was any episode of preterm labor or ectopic pregnancy; otherwise, the patients were tracked until 31 December 2010. Methods The risk factors for preterm labor or ectopic pregnancy were explored. For cases included from the index date until the end of 2010, we analyzed the risk of incident preterm labor or ectopic pregnancy. With the use of a multivariate Cox proportional hazard regression analysis, we calculated the hazard ratio (HR) with a 95% CI and compared it with that of the control group. Results This study examined 30,450 patients with PID and 91,350 controls. During the follow-up period, patients in the PID group were more likely to develop preterm labor or ectopic pregnancy than patients in the control group. The cumulative incidence rates for developing preterm labor were 1.84% (561/30,450 individuals) in patients with PID and 1.63% (1492/91,350 individuals) in patients without PID. On the other hand, the cumulative incidence rate for developing ectopic pregnancy in patients with PID was 0.05% (14/30,450 individuals) but was only 0.04% (33/91,350 individuals) in patients without PID. Compared with those without PID, the patients with PID had a 1.864 times (P< 0.001) higher risk of developing preterm labor and a 2.121 times (P = 0.003) higher risk of developing ectopic pregnancy. Conclusion Our study provided evidence of an increased risk of preterm labor or ectopic pregnancy in PID patients.	[Huang, Chun-Chung; Lo, Chun-Min] Natl Yang Ming Univ, Dept Biomed Engn, Taipei, Taiwan; [Huang, Chien-Chu; Chang, Cherry Yin-Yi; Lin, Wu-Chou] China Med Univ Hosp, Dept Obstet & Gynecol, Taichung, Taiwan; [Huang, Chien-Chu] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Lin, Shao-Yi] Natl Formosa Univ, Dept Mech & Comp Aided Engn, Huwei Township, Yunlin, Taiwan; [Chang, Cherry Yin-Yi; Lin, Wu-Chou] China Med Univ, Dept Med, Taichung, Taiwan; [Chung, Chi-Hsiang; Lin, Fu-Huang; Chien, Wu-Chien] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Tsao, Chang-Huei; Chien, Wu-Chien] Triserv Gen Hosp, Dept Med Res, Taipei, Taiwan; [Tsao, Chang-Huei] Natl Def Med Ctr, Dept Microbiol & Immunol, Taipei, Taiwan; [Chien, Wu-Chien] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan	National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Formosa University; China Medical University Taiwan; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center	Lo, CM (corresponding author), Natl Yang Ming Univ, Dept Biomed Engn, Taipei, Taiwan.; Chien, WC (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.; Chien, WC (corresponding author), Triserv Gen Hosp, Dept Med Res, Taipei, Taiwan.; Chien, WC (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	cmlo@ym.edu.tw; chienwu@ndmctsgh.edu.tw	Chung, Chi-Hsiang/AAY-3386-2021	Huang, Chun Chung/0000-0002-3285-0523; Lo, Chun-Min/0000-0003-4382-4512; Huang, Chien Chu/0000-0003-1782-5722	Tri-Service General Hospital Research Foundation [TSGH-C107-004, TSGH-C108-003]	Tri-Service General Hospital Research Foundation	This study was funded by Tri-Service General Hospital Research Foundation (TSGH-C107-004 and TSGH-C108-003). The funder has no role in the design, concept, data collection and interpretation, analysis, drafting or other process in this paper.	Adinkra P, 2000, HOSP MED, V61, P475, DOI 10.12968/hosp.2000.61.7.1377; Andrews WW, 2005, AM J OBSTET GYNECOL, V193, P739, DOI 10.1016/j.ajog.2005.02.128; Banikarim C, 2005, PELVIC INFLAMMATORY, P175; Bjartling C, 2000, ACTA OBSTET GYN SCAN, V79, P123, DOI 10.1034/j.1600-0412.2000.079002123.x; Brunham RC, 2015, NEW ENGL J MED, V372, P2039, DOI 10.1056/NEJMra1411426; Bugg Charles Walter, 2016, Emerg Med Pract, V18, P1; Cheng TM, 2009, 6 COUNTRIES 6 REFORM, P171, DOI [10.1142/9789814261593_000710, 1142/9789814261593_0007, DOI 10.1142/9789814261593_0007]; CUMMING DC, 1988, INT J FERTIL, V33, P324; DUBUISSON J B, 1987, Journal de Gynecologie Obstetrique et biologie de la Reproduction, V16, P27; ESCHENBACH DA, 1980, OBSTET GYNECOL, V55, pS142, DOI 10.1097/00006250-198003001-00037; Espinoza J, 2006, AM J OBSTET GYNECOL, V194, P630, DOI 10.1016/j.ajog.2005.11.050; Goller JL, 2018, SEX TRANSM INFECT, V94, P534, DOI 10.1136/sextrans-2017-053423; Haggerty CL, 2003, AM J OBSTET GYNECOL, V188, P141, DOI 10.1067/mob.2003.87; HILLIS SD, 1993, AM J OBSTET GYNECOL, V168, P1503, DOI 10.1016/S0002-9378(11)90790-X; Houck CD, 2014, PEDIATRICS, V133, pE276, DOI 10.1542/peds.2013-1157; ISMAIL MA, 1992, AM J PERINAT, V9, P368, DOI 10.1055/s-2007-999266; Jennings LK, 2018, PELVIC INFLAMMATORY; JOESOEF MR, 1991, AM J OBSTET GYNECOL, V165, P46, DOI 10.1016/0002-9378(91)90221-C; Jurstrand M, 2007, SEX TRANSM INFECT, V83, DOI 10.1136/sti.2007.024752; KIMBALL MW, 1970, NEW ENGL J MED, V282, P1082, DOI 10.1056/NEJM197005072821908; Knudtson EJ, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.11.004; Kotchick BA, 2001, CLIN PSYCHOL REV, V21, P493, DOI 10.1016/S0272-7358(99)00070-7; Koumans EH, 2001, SEX TRANSM DIS, V28, P292, DOI 10.1097/00007435-200105000-00011; Lenz JD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02710; Li C, 2015, PHARMACOEPIDEM DR S, V24, P548, DOI 10.1002/pds.3775; Locksmith G, 2001, SEMIN PERINATOL, V25, P295, DOI 10.1053/sper.2001.27163; Ma JS, 2016, J REPROD MED, V61, P139; Mindjah YAA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207699; Mitchell C, 2013, INFECT DIS CLIN N AM, V27, P793, DOI 10.1016/j.idc.2013.08.004; Morris M, 2001, BRIT J OBSTET GYNAEC, V108, P439; Ngui R, 2014, J CLIN MICROBIOL, V52, P3468, DOI 10.1128/JCM.01191-14; Peter NG, 2004, CLEV CLIN J MED, V71, P233, DOI 10.3949/ccjm.71.3.233; Pitegoff J G, 1986, Semin Adolesc Med, V2, P215; Reddy UM, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.06.064; Rein DB, 2000, OBSTET GYNECOL, V95, P397, DOI 10.1016/S0029-7844(99)00551-7; Rekart ML, 2013, J INFECT DIS, V207, P30, DOI 10.1093/infdis/jis644; Romero R, 2004, FERTIL STERIL, V82, P799, DOI 10.1016/j.fertnstert.2004.05.076; ROSEN Y, 1974, OBSTET GYNECOL, V43, P413; Rutgers JKL, 2014, INT J GYNECOL PATHOL, V33, P385, DOI 10.1097/PGP.0000000000000143; SAFRIN S, 1992, AM J OBSTET GYNECOL, V166, P1300, DOI 10.1016/S0002-9378(11)90626-7; Savel'eva G M, 1995, Akush Ginekol (Mosk), P36; Shaaban OM, 2013, BMC WOMENS HEALTH, V13, DOI 10.1186/1472-6874-13-23; Thinkhamrop J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002250.pub2; Tita A, 2007, AM J OBSTET GYNECOL, V197, pS37, DOI 10.1016/j.ajog.2007.10.096; TOTH M, 1988, OBSTET GYNECOL, V71, P723; Toth M, 1993, Infect Dis Obstet Gynecol, V1, P12, DOI 10.1155/S1064744993000043; Twenge JM, 2015, ARCH SEX BEHAV, V44, P2273, DOI 10.1007/s10508-015-0540-2; WANG SP, 1980, AM J OBSTET GYNECOL, V138, P1034, DOI 10.1016/0002-9378(80)91103-5; WESTROM L, 1995, VENEREOLOGY, V8, P219; WESTROM L, 1980, AM J OBSTET GYNECOL, V138, P880, DOI 10.1016/0002-9378(80)91077-7; WESTROM L, 1975, AM J OBSTET GYNECOL, V121, P707, DOI 10.1016/0002-9378(75)90477-9; Wiesenfeld HC, 2012, OBSTET GYNECOL, V120, P37, DOI 10.1097/AOG.0b013e31825a6bc9; Wiesenfeld HC, 2005, SEX TRANSM DIS, V32, P400, DOI 10.1097/01.olq.0000154508.26532.6a; Workowski KA., 2015, REPROD ENDOCRINOL, V24, P51	54	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0219351	10.1371/journal.pone.0219351	http://dx.doi.org/10.1371/journal.pone.0219351			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5HO	31408465	gold, Green Published, Green Submitted			2022-12-26	WOS:000485009500003
J	Velazquez-Lizarraga, AE; Juarez-Morales, JL; Racotta, IS; Villarreal-Colmenares, H; Valdes-Lopez, O; Luna-Gonzalez, A; Rodriguez-Jaramillo, C; Estrada, N; Ascencio, F				Velazquez-Lizarraga, Adrian E.; Luis Juarez-Morales, Jose; Racotta, Ilie S.; Villarreal-Colmenares, Humberto; Valdes-Lopez, Oswaldo; Luna-Gonzalez, Antonio; Rodriguez-Jaramillo, Carmen; Estrada, Norma; Ascencio, Felipe			Transcriptomic analysis of Pacific white shrimp (Litopenaeus vannamei, Boone 1931) in response to acute hepatopancreatic necrosis disease caused by Vibrio parahaemolyticus	PLOS ONE			English	Article							REAL-TIME PCR; RNA-SEQ DATA; MOLECULAR-CLONING; CAUSATIVE AGENT; EXPRESSED TRANSCRIPTS; HYPERCAPNIC HYPOXIA; MINIMUM INFORMATION; PENAEUS-MONODON; CHINESE SHRIMP; AHPND	Acute hepatopancreatic necrosis disease (AHPND), caused by marine bacteria Vibrio Parahaemolyticus, is a huge problem in shrimp farms. The V. parahaemolyticus infecting material is contained in a plasmid which encodes for the lethal toxins PirAB(Vp), whose primary target tissue is the hepatopancreas, causing sloughing of epithelial cells, necrosis, and massive hemocyte infiltration. To get a better understanding of the hepatopancreas response during AHPND, juvenile shrimp Litopenaeus vannamei were infected by immersion with V. parahaemolyticus. We performed transcriptomic mRNA sequencing of infected shrimp hepatopancreas, at 24 hours post-infection, to identify novel differentially expressed genes a total of 174,098 transcripts were examined of which 915 transcripts were found differentially expressed after comparative transcriptomic analysis: 442 up-regulated and 473 down-regulated transcripts. Gene Ontology term enrichment analysis for up-regulated transcripts includes metabolic process, regulation of programmed cell death, carbohydrate metabolic process, and biological adhesion, whereas for down-regulated transcripts include, microtubule-based process, cell activation, and chitin metabolic process. The analysis of protein-protein network between up and down-regulated genes indicates that the first gene interactions are connected to oxidation-processes and sarcomere organization. Additionally, protein-protein networks analysis identified 20-top highly connected hub nodes. Based on their immunological or metabolic function, ten candidate transcripts were selected to measure their mRNA relative expression levels in AHPND infected shrimp hepatopancreas by RT-qPCR. Our results indicate a close connection between the immune and metabolism systems during AHPND infection. Our RNA-Seq and RT-qPCR data provide the possible immunological and physiological scenario as well as the molecular pathways that take place in the shrimp hepatopancreas in response to an infectious disease.	[Velazquez-Lizarraga, Adrian E.; Ascencio, Felipe] Ctr Invest Biol Noroeste SC CIBNOR, Lab Patogenesis Microbiana, La Paz, Baja California, Mexico; [Luis Juarez-Morales, Jose; Estrada, Norma] Ctr Invest Biol Noroeste SC CIBNOR, Programa Catedras CONACyT, La Paz, Baja California, Mexico; [Racotta, Ilie S.] Ctr Invest Biol Noroeste SC CIBNOR, Lab Metab Energet, La Paz, Baja California, Mexico; [Villarreal-Colmenares, Humberto] Ctr Invest Biol Noroeste SC CIBNOR, Parque Innovac Tecnol, La Paz, Baja California, Mexico; [Valdes-Lopez, Oswaldo] Univ Autonoma Mexico, Dept Bioquim, Fac Estudios Super, Tlalnepantla De Baz, Estado De Mexic, Mexico; [Luna-Gonzalez, Antonio] Inst Politecn Nacl, Ctr Interdisciplinario Invest Desarrollo Integral, Unidad Sinaloa IPN CIIDIR Sinaloa, Dept Acuacultura, Guasave, Sinaloa, Mexico; [Rodriguez-Jaramillo, Carmen] Ctr Invest Biol Noroeste SC CIBNOR, Lab Histol, La Paz, Baja California, Mexico	CIBNOR - Centro de Investigaciones Biologicas del Noroeste; CIBNOR - Centro de Investigaciones Biologicas del Noroeste; CIBNOR - Centro de Investigaciones Biologicas del Noroeste; CIBNOR - Centro de Investigaciones Biologicas del Noroeste; Universidad Nacional Autonoma de Mexico; Instituto Politecnico Nacional - Mexico; CIBNOR - Centro de Investigaciones Biologicas del Noroeste	Ascencio, F (corresponding author), Ctr Invest Biol Noroeste SC CIBNOR, Lab Patogenesis Microbiana, La Paz, Baja California, Mexico.; Estrada, N (corresponding author), Ctr Invest Biol Noroeste SC CIBNOR, Programa Catedras CONACyT, La Paz, Baja California, Mexico.	nestrada@cibnor.mx; ascencio@cibnor.mx	Valdés-López, Oswaldo/K-8695-2019	Valdés-López, Oswaldo/0000-0002-4760-048X; Rodriguez-Jaramillo, Maria del Carmen/0000-0003-3926-9560; JUAREZ-MORALES, JOSE-LUIS/0000-0001-6356-3415; Ascencio, Felipe/0000-0003-3515-8708; Velazquez-Lizarraga, Adrian Esteban/0000-0001-7049-7209	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [247567]; CIBNOR (PAC); CONACyT [466639]; Consejo Nacional de Ciencia y Tecnologia (CONACyT) Problemas Nacionales [247567]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CIBNOR (PAC); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Nacional de Ciencia y Tecnologia (CONACyT) Problemas Nacionales(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research was supported by grants of Consejo Nacional de Ciencia y Tecnologia (CONACyT) No. 247567 to NE and from CIBNOR (PAC) To FA. AEVL have a scholarship from CONACyT No. 466639. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.; This research was supported by grants of Consejo Nacional de Ciencia y Tecnologia (CONACyT) Problemas Nacionales 247567 to NE and from CIBNOR (PAC) To FA. AEVL have a scholarship from CONACyT No. 466639. Mayra de Fatima Vargas Mendieta and Jesus Antonio Aguilar Villavicencio for technical support in organism maintenance. Eulalia Meza Chavez of Histology Laboratory in CIBNOR. Dr. Ricardo Vazquez-Juarez of bioinformatics laboratory. Rosa Maria Morelos-Castro for technical support for gene expression analysis.	Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], INT J INFORM TECHNOL; [Anonymous], 2014, NEW IMPROVED PCR MET; Aranda PS, 2012, ELECTROPHORESIS, V33, P366, DOI 10.1002/elps.201100335; Armstrong LC, 2003, MATRIX BIOL, V22, P63, DOI 10.1016/S0945-053X(03)00005-2; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bell TA, 1988, HDB NORMAL PENAEID S; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boonchuen P, 2018, DEV COMP IMMUNOL, V84, P371, DOI 10.1016/j.dci.2018.03.010; Brinkmann U, 1996, BIOCHEMISTRY-US, V35, P6891, DOI 10.1021/bi952829+; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chaikeeratisak V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047384; Coates CJ, 2014, DEV COMP IMMUNOL, V45, P43, DOI 10.1016/j.dci.2014.01.021; Cesar JRD, 2006, AQUACULTURE, V261, P688, DOI 10.1016/j.aquaculture.2006.08.003; De Schryver P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003919; De Wit P, 2012, MOL ECOL RESOUR, V12, P1058, DOI 10.1111/1755-0998.12003; Duan YF, 2013, MOL BIOL REP, V40, P6569, DOI 10.1007/s11033-013-2702-4; ELLERTON HD, 1983, PROG BIOPHYS MOL BIO, V41, P143, DOI 10.1016/0079-6107(83)90028-7; Evans DL, 2000, FISH SHELLFISH IMMUN, V10, P419, DOI 10.1006/fsim.1999.0250; Fagutao FF, 2009, FEBS J, V276, P5298, DOI 10.1111/j.1742-4658.2009.07225.x; FAO, 2018, M SUSTAINABLE DEV GO; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; FINNEY D J, 1971, P333; Flegel TW, 2012, J INVERTEBR PATHOL, V110, P166, DOI 10.1016/j.jip.2012.03.004; Galindo-Torres P, 2018, MAR GENOM, V37, P161, DOI 10.1016/j.margen.2017.11.004; Ge QQ, 2017, FISH SHELLFISH IMMUN, V67, P620, DOI 10.1016/j.fsi.2017.06.047; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Han JE, 2015, DIS AQUAT ORGAN, V113, P33, DOI 10.3354/dao02830; Hardy KM, 2013, AM J PHYSIOL-REG I, V305, pR1356, DOI 10.1152/ajpregu.00519.2012; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hu KJ, 2007, COMP BIOCHEM PHYS B, V146, P69, DOI 10.1016/j.cbpb.2006.09.010; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Indo HP, 2007, MITOCHONDRION, V7, P106, DOI 10.1016/j.mito.2006.11.026; Ji PF, 2011, DIS AQUAT ORGAN, V96, P9, DOI 10.3354/dao02373; Joshi J, 2014, AQUACULTURE, V428, P297, DOI 10.1016/j.aquaculture.2014.03.030; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Khimmakthong U, 2017, MICROB PATHOGENESIS, V113, P107, DOI 10.1016/j.micpath.2017.10.028; Koiwai K, 2016, J FISH DIS, V39, P603, DOI 10.1111/jfd.12387; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuwabara K, 1996, J BIOL CHEM, V271, P5025; Lai HC, 2015, FISH SHELLFISH IMMUN, V47, P1006, DOI 10.1016/j.fsi.2015.11.008; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LAYCOCK MV, 1991, FEBS LETT, V292, P115, DOI 10.1016/0014-5793(91)80847-V; Leano E.M., 2012, GLOB AQUACULT, P38; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liao C, 2011, CHINESE J INORG CHEM, V27, P1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livingstone DR, 2001, MAR POLLUT BULL, V42, P656, DOI 10.1016/S0025-326X(01)00060-1; Tran L, 2013, DIS AQUAT ORGAN, V105, P45, DOI 10.3354/dao02621; Lopez-Leon P, 2016, LAT AM J AQUAT RES, V44, P470, DOI 10.3856/vol44-issue3-fulltext-5; Maralit BA, 2018, FISH SHELLFISH IMMUN, V81, P284, DOI 10.1016/j.fsi.2018.06.054; Meng QG, 2014, FISH SHELLFISH IMMUN, V40, P182, DOI 10.1016/j.fsi.2014.06.029; Mikulski CM, 2000, J SHELLFISH RES, V19, P301; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Morris JH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-436; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Nunan L, 2014, DIS AQUAT ORGAN, V111, P81, DOI 10.3354/dao02776; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pongsomboon S, 2008, FISH SHELLFISH IMMUN, V25, P485, DOI 10.1016/j.fsi.2008.07.010; Powell S, 2014, NUCLEIC ACIDS RES, V42, pD231, DOI 10.1093/nar/gkt1253; Radyuk SN, 2001, FREE RADICAL BIO MED, V31, P1090, DOI 10.1016/S0891-5849(01)00692-X; Rao M. Sreenivasa, 2008, Biotechnology, V7, P153; Rao R, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0052-6; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Reyes-Ramos CA, 2018, COMP BIOCHEM PHYS B, V226, P1, DOI 10.1016/j.cbpb.2018.08.001; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rosas C, 2001, J EXP MAR BIOL ECOL, V259, P1, DOI 10.1016/S0022-0981(01)00222-2; Ross J, 2003, GENE, V304, P117, DOI 10.1016/S0378-1119(02)01187-3; Roszer T, 2014, CELL TISSUE RES, V358, P685, DOI 10.1007/s00441-014-1985-7; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi XZ, 2008, FISH SHELLFISH IMMUN, V25, P589, DOI 10.1016/j.fsi.2008.07.011; Soonthornchai W, 2016, DEV COMP IMMUNOL, V65, P53, DOI 10.1016/j.dci.2016.06.013; Soto-Rodriguez SA, 2015, APPL ENVIRON MICROB, V81, P1689, DOI 10.1128/AEM.03610-14; Su G, 2010, BIOINFORMATICS, V26, P3135, DOI 10.1093/bioinformatics/btq596; Sun YD, 2006, MOL IMMUNOL, V43, P1202, DOI 10.1016/j.molimm.2005.07.014; Tassanakajon A, 2013, FISH SHELLFISH IMMUN, V34, P954, DOI 10.1016/j.fsi.2012.09.021; Tyagi A, 2009, INT J FOOD MICROBIOL, V129, P124, DOI 10.1016/j.ijfoodmicro.2008.11.006; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wen R, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092635; Xiao JZ, 2017, SCI REP-UK, V7, DOI 10.1038/srep42177; Yilmaz P, 2011, NAT BIOTECHNOL, V29, P415, DOI 10.1038/nbt.1823; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139; Zheng ZH, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4728-4; Zheng ZH, 2018, FISH SHELLFISH IMMUN, V74, P10, DOI 10.1016/j.fsi.2017.12.032; ZIMMERMANN J, 1988, FEBS LETT, V233, P432, DOI 10.1016/0014-5793(88)80477-0; Zorriehzahra M.J., 2015, ADV ANIMAL VET SCI, V3, P64, DOI [DOI 10.14737/J0URNAL.AAVS/2015/3.2S.64.72, DOI 10.14737/JOURNAL.AAVS/2015/3.2S.64.72]	91	20	20	7	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220993	10.1371/journal.pone.0220993	http://dx.doi.org/10.1371/journal.pone.0220993			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408485	Green Submitted, gold, Green Published			2022-12-26	WOS:000485009500032
J	Malinska, H; Huttl, M; Oliyarnyk, O; Markova, I; Poruba, M; Racova, Z; Kazdova, L; Vecera, R				Malinska, Hana; Huttl, Martina; Oliyarnyk, Olena; Markova, Irena; Poruba, Martin; Racova, Zuzana; Kazdova, Ludmila; Vecera, Rostislav			Beneficial effects of troxerutin on metabolic disorders in non-obese model of metabolic syndrome	PLOS ONE			English	Article							OXIDATIVE STRESS; INSULIN-RESISTANCE; HEPATIC EXPRESSION; HIGH-FAT; PROTECTS; MUSCLE; CYTOCHROME-P450; CELLS; HEART; RAT	Background Troxerutin (TRX) has a beneficial effect on blood viscosity and platelet aggregation, and is currently used for the treatment of chronic varicosity. Recently, TRX can improve lipid abnormalities, glucose intolerance and oxidative stress in high-fat diet-induced metabolic disorders. In this study, we tested the effect of TRX on metabolic syndrome-associated disorders using a non-obese model of metabolic syndrome-the Hereditary Hypertriglyceridaemic rats (HHTg). Methods Adult male HHTg rats were fed standard diet without or with TRX (150 mg/kg bwt/day for 4 weeks). Results Compared to untreated rats, TRX supplementation in HHTg rats decreased serum glucose (p<0.05) and insulin (p<0.05). Although blood lipids were not affected, TRX decreased hepatic cholesterol concentrations (p<0.01) and reduced gene expression of HMGCR, SREBP2 and SCD1 (p<0.01), involved in cholesterol synthesis and lipid homeostasis. TRX-treated rats exhibited decreased lipoperoxidation and increased activity of antioxidant enzymes SOD and GPx (p<0.05) in the liver. In addition, TRX supplementation increased insulin sensitivity in muscles and epididymal adipose tissue (p<0.05). Elevated serum adiponectin (p<0.05) and decreased muscle triglyceride (p<0.05) helped improve insulin sensitivity. Among the beneficial effects of TRX were changes to cytochrome P450 family enzymes. Hepatic gene expression of CYP4A1, CYP4A3 and CYP5A1 (p<0.01) decreased, while there was a marked elevation in gene expression of CYP1A1 (p<0.01). Conclusion Our results indicate that TRX improves hepatic lipid metabolism and insulin sensitivity in peripheral tissues. As well as ameliorating oxidative stress, TRX can reduce ectopic lipid deposition, affect genes involved in lipid metabolism, and influence the activity of CYP family enzymes.	[Malinska, Hana; Huttl, Martina; Oliyarnyk, Olena; Markova, Irena] Inst Clin & Expt Med, Ctr Expt Med, Prague, Czech Republic; [Poruba, Martin; Racova, Zuzana; Kazdova, Ludmila; Vecera, Rostislav] Palacky Univ, Fac Med & Dent, Dept Pharmacol, Olomouc, Czech Republic	Institute for Clinical & Experimental Medicine (IKEM); Palacky University Olomouc	Malinska, H (corresponding author), Inst Clin & Expt Med, Ctr Expt Med, Prague, Czech Republic.	hana.malinska@ikem.cz	Stefanadis, Christodoulos/ABH-2232-2020; Oliyarnyk, Olena/Q-6380-2019	Stefanadis, Christodoulos/0000-0001-5974-6454; Oliyarnyk, Olena/0000-0002-4912-6187; Markova, Irena/0000-0002-4331-7636; Racova, Zuzana/0000-0001-9478-9513; Poruba, Martin/0000-0003-1252-4971	Czech Science Foundation [17-08888S]	Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by grant of Czech Science Foundation, project number 17-08888S. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz Z, 2015, J CLIN PHARM THER, V40, P177, DOI 10.1111/jcpt.12247; Belcaro G, 2017, INT J ANGIOL, V26, P170, DOI 10.1055/s-0036-1597756; Chatuphonprasert W, 2010, BIOL PHARM BULL, V33, P1698, DOI 10.1248/bpb.33.1698; Chiva-Blanch G, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5812401; Cowart LA, 2002, J BIOL CHEM, V277, P35105, DOI 10.1074/jbc.M201575200; Das A, 2014, CHEMBIOCHEM, V15, P892, DOI 10.1002/cbic.201300646; Divisova J, 2002, ANN NY ACAD SCI, V967, P440; Endo T, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-018-0090-1; Geetha R, 2017, CHEM-BIOL INTERACT, V278, P74, DOI 10.1016/j.cbi.2017.09.012; Geetha R, 2014, MOL CELL BIOCHEM, V387, P123, DOI 10.1007/s11010-013-1877-2; Gomes WF, 2017, FOOD CHEM, V218, P261, DOI 10.1016/j.foodchem.2016.08.132; Karakurt S, 2016, ACTA PHARMACEUT, V66, P491, DOI 10.1515/acph-2016-0046; Karnieli E, 2008, AM J PHYSIOL-ENDOC M, V295, pE38, DOI 10.1152/ajpendo.90306.2008; Lu J, 2011, BRAIN, V134, P783, DOI 10.1093/brain/awq376; Malinska H, 2018, PHYSIOL RES, V67, P181, DOI 10.33549/physiolres.933606; Malinska H, 2015, NUTRITION, V31, P1045, DOI 10.1016/j.nut.2015.03.011; Mar-Heyming R, 2008, ARTERIOSCL THROM VAS, V28, P1193, DOI 10.1161/ATVBAHA.107.160150; Murillo AG, 2017, CURR PHARM DESIGN, V23, P2444, DOI 10.2174/1381612823666170329144307; Oh SJ, 2012, CHEM-BIOL INTERACT, V195, P173, DOI 10.1016/j.cbi.2011.12.010; Panat NA, 2016, FOOD CHEM, V194, P32, DOI 10.1016/j.foodchem.2015.07.078; Park SY, 2016, FOOD CHEM TOXICOL, V96, P244, DOI 10.1016/j.fct.2016.08.010; Qi NN, 2002, J BIOL CHEM, V277, P48501, DOI 10.1074/jbc.M206655200; Rajagopalan G, 2017, CLIN EXP PHARMACOL P, V44, P103, DOI 10.1111/1440-1681.12671; Sampath S, 2014, MOL CELL BIOCHEM, V395, P11, DOI 10.1007/s11010-014-2107-2; Szendroedi J, 2014, P NATL ACAD SCI USA, V111, P9597, DOI 10.1073/pnas.1409229111; Uno T, 2018, BIOPHARM DRUG DISPOS, V39, P371, DOI 10.1002/bdd.2153; Vinayagam R, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0057-7; Voulgari C, 2011, J AM COLL CARDIOL, V58, P1343, DOI 10.1016/j.jacc.2011.04.047; VRANA A, 1990, TRANSPLANT P, V22, P2579; Yang HJ, 2016, NUTRITION, V32, P129, DOI 10.1016/j.nut.2015.07.012; Zhang ZF, 2009, J AGR FOOD CHEM, V57, P7731, DOI 10.1021/jf9012357; Zhang ZF, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010031; Zicha J, 2006, PHYSIOL RES, V55, pS49, DOI 10.33549/physiolres.930000.55.S1.49	33	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220377	10.1371/journal.pone.0220377	http://dx.doi.org/10.1371/journal.pone.0220377			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404079	Green Submitted, Green Published, gold			2022-12-26	WOS:000485006800012
J	Ohira, T; Kojima, H; Kuroda, Y; Aoki, S; Inaoka, D; Osaki, M; Wanibuchi, H; Okada, F; Oshimura, M; Kugoh, H				Ohira, Takahito; Kojima, Hirotada; Kuroda, Yuko; Aoki, Sayaka; Inaoka, Daigo; Osaki, Mitsuhiko; Wanibuchi, Hideki; Okada, Futoshi; Oshimura, Mitsuo; Kugoh, Hiroyuki			PITX1 protein interacts with ZCCHC10 to regulate hTERT mRNA transcription	PLOS ONE			English	Article							TELOMERASE REVERSE-TRANSCRIPTASE; HOMEOBOX GENE-EXPRESSION; MUTANT TERT PROMOTER; CANCER; GROWTH; CELLS; ACTIVATION; REPRESSION; COMPONENTS; MUTATIONS	Telomerase is a ribonucleoprotein ribonucleic enzyme that is essential for cellular immortalization via elongation of telomere repeat sequences at the end of chromosomes. Human telomerase reverse transcriptase (hTERT), the catalytic subunit of telomerase holoenzyme, is a key regulator of telomerase activity. Telomerase activity, which has been detected in the majority of cancer cells, is accompanied by hTERT expression, suggesting that this enzyme activity contributes to an unlimited replication potential of cancer cells via regulation of telomere length. Thus, hTERT is an attractive target for cancer-specific treatments. We previously reported that pared-like homeodomain 1 (PITX1) is a negative regulator of hTERT through direct binding to the hTERT promoter. However, the mechanism by which the function of PITX1 contributes to transcriptional silencing of the hTERT gene remains to be clarified. Here, we show that PITX1 and zinc finger CCHC-type containing 10 (ZCCHC10) proteins cooperate to facilitate the transcriptional regulation of the hTERT gene by functional studies via FLAG pull-down assay. Co-expression of PITX1 and ZCCHC10 resulted in inhibition of hTERT transcription, in melanoma cell lines, whereas mutate-deletion of homeodomain in PITX1 that interact with ZCCHC10 did not induce similar phenotypes. In addition, ZCCHC10 expression levels showed marked decrease in the majority of melanoma cell lines and tissues. Taken together, these results suggest that ZCCHC10-PITX1 complex is the functional unit that suppresses hTERT transcription, and may play a crucial role as a novel tumor suppressor complex.	[Ohira, Takahito; Kuroda, Yuko; Aoki, Sayaka; Inaoka, Daigo; Kugoh, Hiroyuki] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Dept Biomed Sci, Yonago, Tottori, Japan; [Ohira, Takahito; Osaki, Mitsuhiko; Okada, Futoshi; Oshimura, Mitsuo; Kugoh, Hiroyuki] Tottori Univ, Chromosome Engn Res Ctr, Yonago, Tottori, Japan; [Kojima, Hirotada] Osaka City Univ, Grad Sch Med, Dept Immunol, Abeno Ku, Osaka, Japan; [Osaki, Mitsuhiko; Okada, Futoshi] Tottori Univ, Fac Med, Sch Life Sci, Div Pathol Biochem, Yonago, Tottori, Japan; [Wanibuchi, Hideki] Osaka City Univ, Grad Sch Med, Dept Mol Pathol, Abeno Ku, Osaka, Japan	Tottori University; Tottori University; Osaka Metropolitan University; Tottori University; Osaka Metropolitan University	Kugoh, H (corresponding author), Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Dept Biomed Sci, Yonago, Tottori, Japan.; Kugoh, H (corresponding author), Tottori Univ, Chromosome Engn Res Ctr, Yonago, Tottori, Japan.	kugoh@tottori-u.ac.jp		Okada, Futoshi/0000-0003-4733-1037	Japan Society for the Promotion of Science (JSPS) [15H06414, 18K16030, 15K08304]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science (JSPS), a Grant-in-Aid for Young Scientists (Start-up) Grant Number 15H06414, Early-Career Scientists Grant Number 18K16030, and Grant-in-Aid for Scientific Research (C) Grant Number 15K08304. This research was partly performed at the Tottori Bio Frontier managed by Tottori prefecture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was partly performed at the Tottori Bio Frontier managed by Tottori prefecture. We would like to thank Dr. Teruhiko Suzuki for assisting with our FLAG-Pull down examination.	Akincilar SC, 2016, CANCER DISCOV, V6, P1276, DOI 10.1158/2159-8290.CD-16-0177; Akincilar SC, 2015, FEBS LETT, V589, P974, DOI 10.1016/j.febslet.2015.02.035; Allan LA, 1999, ONCOGENE, V18, P5403, DOI 10.1038/sj.onc.1202931; Amendt BA, 1998, J BIOL CHEM, V273, P20066, DOI 10.1074/jbc.273.32.20066; Arndt GM, 2016, NAT REV CANCER, V16, P508, DOI 10.1038/nrc.2016.55; de Jesus BB, 2013, TRENDS GENET, V29, P513, DOI 10.1016/j.tig.2013.06.007; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Cantor AB, 2005, SEMIN CELL DEV BIOL, V16, P117, DOI 10.1016/j.semcdb.2004.10.006; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chen YN, 2008, WORLD J GASTROENTERO, V14, P292, DOI 10.3748/wjg.14.292; Chen Y, 2007, LUNG CANCER, V55, P287, DOI 10.1016/j.lungcan.2006.11.001; Chiba K, 2017, SCIENCE, V357, P1416, DOI 10.1126/science.aao0535; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Daniel M, 2012, GENE, V498, P135, DOI 10.1016/j.gene.2012.01.095; Ebert BL, 2010, BEST PRACT RES CL HA, V23, P457, DOI 10.1016/j.beha.2010.09.006; Eisenmann KM, 2009, ONCOGENE, V28, P3429, DOI 10.1038/onc.2009.207; Furukawa T, 1997, P NATL ACAD SCI USA, V94, P3088, DOI 10.1073/pnas.94.7.3088; Geuens T, 2016, HUM GENET, V135, P851, DOI 10.1007/s00439-016-1683-5; Ghosh A, 2012, NAT CELL BIOL, V14, P1270, DOI 10.1038/ncb2621; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Island ML, 2002, MOL CELL BIOL, V22, P7120, DOI 10.1128/MCB.22.20.7120-7133.2002; Izutsu T, 2006, ACTA OBSTET GYN SCAN, V85, P3, DOI 10.1080/00016340500317096; Ji ZY, 2012, J INVEST DERMATOL, V132, P356, DOI 10.1038/jid.2011.313; Khattar E, 2016, J CLIN INVEST, V126, P4045, DOI 10.1172/JCI86042; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; Kugoh H, 2003, GENE CHROMOSOME CANC, V36, P37, DOI 10.1002/gcc.10135; Kugoh H, 2016, CANCERS, V8, DOI 10.3390/cancers8010004; Lamonerie T, 1996, GENE DEV, V10, P1284, DOI 10.1101/gad.10.10.1284; Lee KM, 2004, CYTOTECHNOLOGY, V45, P33, DOI 10.1007/s10616-004-5123-3; Li M, 2015, MOL MED REP, V11, P4645, DOI 10.3892/mmr.2015.3287; Li YH, 2016, P NATL ACAD SCI USA, V113, P14402, DOI 10.1073/pnas.1611106113; Liu DX, 2007, CELL DEATH DIFFER, V14, P1893, DOI 10.1038/sj.cdd.4402209; Liu X, 2014, ENVIRON MOL MUTAGEN, V55, P223, DOI 10.1002/em.21827; Lord RVN, 2005, SURGERY, V138, P924, DOI 10.1016/j.surg.2005.05.007; Lu WJ, 2011, CELL DEATH DIFFER, V18, P1046, DOI 10.1038/cdd.2010.177; Marcil A, 2003, DEVELOPMENT, V130, P45, DOI 10.1242/dev.00192; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; Nakabayashi M, 2014, ONCOL LETT, V7, P750, DOI 10.3892/ol.2013.1775; Ohira T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08201; Osaki M, 2013, EUR J DERMATOL, V23, P344, DOI 10.1684/ejd.2013.2021; Qi DL, 2011, MOL CELL BIOL, V31, P1624, DOI 10.1128/MCB.00470-10; Qi DL, 2010, BIOCHEM BIOPH RES CO, V398, P695, DOI 10.1016/j.bbrc.2010.07.003; Ramlee MK, 2016, GENES-BASEL, V7, DOI 10.3390/genes7080050; Schubert SW, 2004, J BIOL CHEM, V279, P50358, DOI 10.1074/jbc.M404587200; Shats I, 2004, J BIOL CHEM, V279, P50976, DOI 10.1074/jbc.M402502200; Wei GF, 2015, ONCOTARGET, V6, P17065, DOI 10.18632/oncotarget.4185; Wright WE, 1996, DEV GENET, V18, P173; Xi LH, 2014, NUCLEIC ACIDS RES, V42, P8565, DOI 10.1093/nar/gku560; Yamaguchi T, 2010, APOPTOSIS, V15, P927, DOI 10.1007/s10495-010-0488-6; Yan TD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02601-1; Yin SJ, 2018, INT J BIOL MACROMOL, V106, P1052, DOI 10.1016/j.ijbiomac.2017.08.109	53	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0217605	10.1371/journal.pone.0217605	http://dx.doi.org/10.1371/journal.pone.0217605			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404068	Green Published, Green Submitted, gold			2022-12-26	WOS:000485006800004
J	Park, MR; Wong, MS; Arauzo-Bravo, MJ; Lee, H; Nam, D; Park, SY; Seo, HD; Lee, SM; Zeilhofer, HF; Zaehres, H; Scholer, HR; Kim, JB				Park, Myung Rae; Wong, Man Sze; Arauzo-Bravo, Marcos J.; Lee, Hyunah; Nam, Donggyu; Park, Soo Yong; Seo, Hong Dae; Lee, Sang Min; Zeilhofer, Hans Florian; Zaehres, Holm; Schoeler, Hans R.; Kim, Jeong Beom			Oct4 and Hnf4 alpha-induced hepatic stem cells ameliorate chronic liver injury in liver fibrosis model	PLOS ONE			English	Article							HEPATOCYTE-LIKE CELLS; PROGENITOR CELLS; HUMAN FIBROBLASTS; FUNCTIONAL HEPATOCYTES; DIRECT CONVERSION; DIFFERENTIATION; TRANSPLANTATION; PROLIFERATION; GENERATION; FAILURE	Direct conversion from fibroblasts to generate hepatocyte like-cells (iHeps) bypassing the pluripotent state has been described in previous reports as an attractive method acquiring hepatocytes for cell-based therapy. The limited proliferation of iHeps, however, has hampered it uses in cell-based therapy. Since hepatic stem cells (HepSCs) possess self-renewal and bipotency with the capacity to differentiate into both hepatocytes and cholangiocytes, they have therapeutic potential for treating liver disease. Here, we investigated the therapeutic effects of induced HepSCs (iHepSCs) on a carbon tetrachloride (CCl4)-induced liver fibrosis model. We demonstrate that Oct4 and Hnf4a are sufficient to convert fibroblasts into expandable iHepSCs. Hepatocyte-like cells derived from iHepSCs (iHepSC-HEPs) exhibit the typical morphology of hepatocytes and hepatic functions, including glycogen storage, low-density lipoprotein (LDL) uptake, Indocyanine green (ICG) detoxification, drug metabolism, urea production, and albumin secretion. iHepSCs-derived cholangiocyte-like cells (iHepSC-CLCs) expressed cholangiocyte-specific markers and formed cysts and tubule-like structures with apical-basal polarity and secretory function in three-dimensional culture condition. Furthermore, iHepSCs showed anti-inflammatory and anti-fibrotic effects in CCl4-induced liver fibrosis. This study demonstrates that Oct4 and Hnf4 alpha-induced HepSCs show typical hepatic and biliary functionality in vitro. It also presents the therapeutic effect of iHepSCs in liver fibrosis. Therefore, directly converting iHepSCs from somatic cells may facilitate the development of patient-specific cell-based therapy for chronic liver damage.	[Park, Myung Rae; Wong, Man Sze; Lee, Hyunah; Nam, Donggyu; Park, Soo Yong; Seo, Hong Dae; Lee, Sang Min; Kim, Jeong Beom] UNIST, Sch Life Sci, HSSCRC, Ulsan, South Korea; [Arauzo-Bravo, Marcos J.] Biodonostia Hlth Res Inst, Grp Computat Biol & Bioinformat, San Sebastian, Spain; [Arauzo-Bravo, Marcos J.] Ikerbasque, Basque Fdn Sci, Bilbao, Spain; [Zeilhofer, Hans Florian] Univ Hosp Basel, Dept Craniomaxillofacial Surg, Basel, Switzerland; [Zaehres, Holm; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Munster, Germany	Ulsan National Institute of Science & Technology (UNIST); Instituto de Investigacion Sanitaria Biodonostia; Basque Foundation for Science; University of Basel; Max Planck Society	Kim, JB (corresponding author), UNIST, Sch Life Sci, HSSCRC, Ulsan, South Korea.	jbkim@unist.ac.kr		Seo, Hongdae/0000-0002-4907-8445; Nam, Donggyu/0000-0003-4571-5547; Kim, Jeong Beom/0000-0001-6230-8826; Scholer, Hans/0000-0003-2643-5136; Wong, Man Sze/0000-0002-1323-7299	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science ICT [2016M3A9B4919719, 2017M3A9C6033875]; Tech Incubator Program for Startup (TIPS) - Ministry of SMEs and Startups [S2566811]	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science ICT; Tech Incubator Program for Startup (TIPS) - Ministry of SMEs and Startups	JBK received funding for this work by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science & ICT (Grant No. 2016M3A9B4919719 and Grant No. 2017M3A9C6033875) and Tech Incubator Program for Startup (TIPS) funded by the Ministry of SMEs and Startups (S2566811). The funders (www.nrf.re.kr) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy I, 2013, STEM CELLS, V31, P2632, DOI 10.1002/stem.1522; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bhave VS, 2011, HEPATOLOGY, V54, P1360, DOI 10.1002/hep.24507; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Chang HM, 2012, INT J MOL SCI, V13, P3598, DOI 10.3390/ijms13033598; Chen C, 2018, BIOTECHNOL BIOENG, V115, P2807, DOI 10.1002/bit.26784; Chiba T, 2010, HEPATOLOGY, V52, P1111, DOI 10.1002/hep.23793; DeLaForest A, 2011, DEVELOPMENT, V138, P4143, DOI 10.1242/dev.062547; Du YY, 2014, CELL STEM CELL, V14, P394, DOI 10.1016/j.stem.2014.01.008; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Espanol-Suner R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024; Fujii T, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-79; Huang PY, 2014, CELL STEM CELL, V14, P370, DOI 10.1016/j.stem.2014.01.003; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kim JB, 2015, EMBO J, V34, P2971, DOI 10.15252/embj.201592652; Kim JB, 2009, NAT PROTOC, V4, P1464, DOI 10.1038/nprot.2009.173; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Li FM, 2010, GASTROENTEROLOGY, V139, P2158, DOI 10.1053/j.gastro.2010.08.042; Li JX, 2000, GENE DEV, V14, P464; Li WL, 2006, STEM CELLS, V24, P322, DOI 10.1634/stemcells.2005-0108; Lim KT, 2016, CELL REP, V15, P814, DOI 10.1016/j.celrep.2016.03.071; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; Mitchell C, 2009, AM J PATHOL, V174, P1766, DOI 10.2353/ajpath.2009.080632; Mitchell R, 2014, STEM CELLS, V32, P2178, DOI 10.1002/stem.1721; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Nussler A, 2006, J HEPATOL, V45, P144, DOI 10.1016/j.jhep.2006.04.002; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Pournasr B, 2015, EUR J CELL BIOL, V94, P603, DOI 10.1016/j.ejcb.2015.10.003; Sakaida I, 2004, HEPATOLOGY, V40, P1304, DOI 10.1002/hep.20452; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Shen L, 2012, JOVE-J VIS EXP, DOI 10.3791/3917; Song GQ, 2016, CELL STEM CELL, V18, P797, DOI 10.1016/j.stem.2016.01.010; Soto-Gutierrez A, 2006, NAT BIOTECHNOL, V24, P1412, DOI 10.1038/nbt1257; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Tabibian JH, 2013, COMPR PHYSIOL, V3, P541, DOI 10.1002/cphy.c120019; Takayama K, 2012, MOL THER, V20, P127, DOI 10.1038/mt.2011.234; Tanaka M, 2009, MECH DEVELOP, V126, P665, DOI 10.1016/j.mod.2009.06.939; Tarlow BD, 2014, HEPATOLOGY, V60, P278, DOI 10.1002/hep.27084; Walesky C, 2015, GENE EXPRESSION, V16, P101, DOI 10.3727/105221615X14181438356292; Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100; Warlich E, 2011, MOL THER, V19, P782, DOI 10.1038/mt.2010.314; Woo DH, 2012, GASTROENTEROLOGY, V142, P602, DOI 10.1053/j.gastro.2011.11.030; Yanger K, 2014, CELL STEM CELL, V15, P340, DOI 10.1016/j.stem.2014.06.003; Yu B, 2013, CELL STEM CELL, V13, P328, DOI 10.1016/j.stem.2013.06.017; Zhang RR, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-017-0747-3; Zhao R, 2014, P NATL ACAD SCI USA, V111, P15768, DOI 10.1073/pnas.1417518111; Zhu SY, 2014, NATURE, V508, P93, DOI 10.1038/nature13020	50	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0221085	10.1371/journal.pone.0221085	http://dx.doi.org/10.1371/journal.pone.0221085			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404112	Green Submitted, Green Published, gold			2022-12-26	WOS:000485006800054
J	Dobia, A; Ryan, K; Abutaleb, M; Edwards, A				Dobia, Ali; Ryan, Kath; Abutaleb, Mohammed; Edwards, Alexander			Perceptions of physicians in Saudi Arabia on the use of international clinical guidelines for managing primary insomnia	PLOS ONE			English	Article							SLEEP MEDICINE; GPS ATTITUDES; IMPLEMENTATION; GUIDANCE	Introduction While there are no national clinical guidelines for managing primary insomnia in Saudi Arabia, there are also no published studies of physicians' perceptions of and attitudes towards using international guidelines. The objective of this study was to explore the knowledge, perceptions, and attitudes of physicians practising in Saudi Arabia about using international guidelines for managing insomnia. Methods A qualitative study using in-depth, face-to-face, and semi-structured interviews with 15 physicians held in July 2017 at a tertiary care hospital in Jazan, the distal south-western province in Saudi Arabia. Interviews were audio-recorded, transcribed verbatim, coded using the qualitative software NVivo11 and analysed thematically. Data saturation was assumed as no new understandings of the broad thematic issues were produced by the last three interviews. Results Themes identified were: Knowledge, Resistance, Barriers and Facilitators. Participants acknowledged their lack of awareness of available guidelines and their lack of training and education about Cognitive Behavioural Therapy for Insomnia (CBT-I). They highlighted a lack of education for patients about insomnia and its treatment. Beliefs about dependence on hypnotics and the inappropriateness of international guidelines for Saudi Arabia inclined many to resist using them. Inability to document diagnosis and consultations due to limited time and lack of suitable electronic systems, lack of suitably trained practitioners for referral for CBT-I, and lack of accountability for practice were identified as key barriers to following international guidelines. Development of national guidelines was the most important facilitator suggested by participants. Conclusions The health authorities in the government of the Kingdom of Saudi Arabia (KSA) should improve general public awareness about sleep disorders and provide focused training for specialists and technologists. Above all, KSA needs its own nationwide guidelines for treating sleep-disorders based on evidence-based clinical trials, consistent with its history, culture, socioeconomic conditions and traditions.	[Dobia, Ali; Ryan, Kath; Edwards, Alexander] Univ Reading, Reading Sch Pharm, Reading, Berks, England; [Dobia, Ali] Gen Directorate Med Serv, Riyadh, Saudi Arabia; [Abutaleb, Mohammed] Minist Hlth, Jazan Hlth Affairs, Jazan, Saudi Arabia	University of Reading; Ministry of Health - Saudi Arabia	Dobia, A (corresponding author), Univ Reading, Reading Sch Pharm, Reading, Berks, England.; Dobia, A (corresponding author), Gen Directorate Med Serv, Riyadh, Saudi Arabia.	a.m.a.dobia@pgr.reading.ac.uk	Edwards, Alexander/F-7440-2010; Edwards, Alexander Daniel/AAX-8524-2021; Abutaleb, Mohammed/I-2595-2013	Edwards, Alexander/0000-0003-2369-989X; Edwards, Alexander Daniel/0000-0003-2369-989X; Abutaleb, Mohammed/0000-0002-5300-5900; Dobia, Ali/0000-0001-5579-5056	Saudi Arabian Cultural Bureau in London	Saudi Arabian Cultural Bureau in London	The first author AD is supported by a full time scholarship provided by the Saudi Arabian Cultural Bureau in London. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AE, 2017, ETHNIC HEALTH, V22, P285, DOI 10.1080/13557858.2016.1244624; Alahmari T, 2019, MOJ ADDICTION MED TH, V6; Albejaidi F., 2010, J ALTERN PERSPECT SO, V2, P794; Almeneessier AS, 2017, J CLIN SLEEP MED, V13, P641, DOI 10.5664/jcsm.6566; Alnaim L, 2017, INDIAN J PHARM SCI, V79, P923, DOI 10.4172/pharmaceutical-sciences.1000309; Altokhais TI, 2017, J EVAL CLIN PRACT, V23, P156, DOI 10.1111/jep.12658; Amer YS, 2019, J EVAL CLIN PRACT, V25, P543, DOI 10.1111/jep.12923; Bahammam AS, 2014, ANN THORAC MED, V9, P45, DOI 10.4103/1817-1737.124444; BaHammam AS, 2000, SAUDI MED J, V21, P1164; Baynouna Al Ketbi Latifa Mohammad, 2018, Asia Pac Fam Med, V17, P5, DOI 10.1186/s12930-018-0041-2; Birrenbach Tanja, 2016, Adv Med Educ Pract, V7, P673, DOI 10.2147/AMEP.S115149; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Campbell N, 2003, AM J HYPERTENS, V16, P698, DOI 10.1016/S0895-7061(03)00055-4; Carlsen B, 2007, BRIT J GEN PRACT, V57, P971, DOI 10.3399/096016407782604820; Cook JM, 2007, J GEN INTERN MED, V22, P303, DOI 10.1007/s11606-006-0021-3; Dobia A, 2019, PHARMACY, V7, DOI 10.3390/pharmacy7010015; Farquhar CM, 2002, MED J AUSTRALIA, V177, P502, DOI 10.5694/j.1326-5377.2002.tb04920.x; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Grol R, 2001, MED CARE, V39, pII46; Grol R, 1997, BRIT MED J, V315, P418, DOI 10.1136/bmj.315.7105.418; Gundersen L, 2000, ANN INTERN MED, V133, P317, DOI 10.7326/0003-4819-133-4-200008150-00102; Hasanain R, 2014, HLTH INFORM INT J, V3, DOI [10.5121/HIIJ.2014.3201, DOI 10.5121/HIIJ.2014.3201]; Hennink MM, 2017, QUAL HEALTH RES, V27, P591, DOI 10.1177/1049732316665344; Heselmans A, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-64; Layard R, 2006, BRIT MED J, V332, P1030, DOI 10.1136/bmj.332.7548.1030; Lugtenberg M, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-54; Morriss R, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0464-7; Pagliari H, 1999, J CLIN NURSES, V13, P731, DOI [10.1111/J.1365-2702.2004.00941.X, DOI 10.1111/J.1365-2702.2004.00941.X]; Robbie F, 2001, BR J CLIN GOV, V6, P166, DOI [DOI 10.1108/EUM0000000005680, 10.1108/EUM0000000005680]; Rycroft-Malone J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-80; Sheldon TA, 2004, BRIT MED J, V329, P999, DOI 10.1136/bmj.329.7473.999; Siriwardena AN, 2006, BRIT J GEN PRACT, V56, P964; Sola I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086065; Storm-Versloot MN, 2012, J EVAL CLIN PRACT, V18, P841, DOI 10.1111/j.1365-2753.2011.01687.x; Taba P, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-455; van Dulmen SA, 2014, PHYS THER, V94, P1396, DOI 10.2522/ptj.20130286; Wahabi HA, 2011, J EVAL CLIN PRACT, V17, P763, DOI 10.1111/j.1365-2753.2011.01694.x; World Health Organization, 2014, MENT HLTH ATL COUNTR	39	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220960	10.1371/journal.pone.0220960	http://dx.doi.org/10.1371/journal.pone.0220960			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398230	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000485004000031
J	Xu, PP; Dong, N; Wong, SC; Huang, HL				Xu, Pengpeng; Dong, Ni; Wong, S. C.; Huang, Helai			Cyclists injured in traffic crashes in Hong Kong: A call for action	PLOS ONE			English	Article							SIGNALIZED INTERSECTIONS; SAFETY; RISK; EXPOSURE; PEDESTRIANS; SEVERITY; NUMBERS; MODELS; RATES	Background Perceived as a minor transportation mode mainly for recreation, cycling and its related safety issues have not been treated as a citywide concern in Hong Kong and have thus received inadequate research efforts. Our study aimed to illuminate the safety challenges faced by cyclists in Hong Kong. Methods We examined the police crash records from 1998 to 2017 and developed a Bayesian Poisson state space model to evaluate the longitudinal change in traffic injuries to cyclists. We then used quasi-induced exposure to measure the annual relative risk of crash involvement for cycling. Based on an officially published travel characteristics survey, we further measured the risk of injury for cycling per minutes cycled. Results Between 1998 and 2017, Hong Kong witnessed a more than twofold increase in the number of cyclist injuries, with an average annual increase rate of 5.18% (95% CI: 0.53%-12.77%). By 2017, cyclists were 2.21 (1.82-2.69) times more likely to be involved in traffic crashes than in 1998. Per 10 million minutes, the injury rates for cycling were 28.64 (27.43-29.70) and 42.54 (41.07-44.02) on weekdays during 2001-2003 and 2010-2012. After adjusting for sex and age groups, cyclists were 1.95 (1.43-2.61) times more likely to be injured in 2010-2012 than in 2001-2003. Per minutes traveled, cyclists also sustained significantly higher risks of fatality and injury than pedestrians, private car drivers and passengers, taxi passengers, public bus passengers, and minibus passengers. A comparison of Hong Kong with other regions suggests that Hong Kong is among the most dangerous areas for cycling in terms of fatality rate per minutes cycled. Conclusions Cyclist injuries have become a substantial public health burden in Hong Kong. A range of countermeasures with proven effectiveness should be promptly implemented to improve the safety of these vulnerable road users.	[Xu, Pengpeng; Wong, S. C.] Univ Hong Kong, Dept Civil Engn, Hong Kong, Peoples R China; [Dong, Ni] Southwest Jiaotong Univ, Sch Transportat & Logist, Chengdu, Sichuan, Peoples R China; [Huang, Helai] Cent South Univ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China	University of Hong Kong; Southwest Jiaotong University; Central South University	Wong, SC (corresponding author), Univ Hong Kong, Dept Civil Engn, Hong Kong, Peoples R China.	hhecwsc@hku.hk	Xu, Pengpeng/W-7868-2019; Dong, Ni/AAP-5112-2020; Wong, S.C./A-7258-2008	Wong, S.C./0000-0003-1169-7045; Xu, Pengpeng/0000-0001-9826-4212	Joint Research Scheme of National Nature Science Foundation of China/Research Grants Council of Hong Kong [71561167001, N_HKU707/15]; Natural Science Foundation of China [71601163, 71671100]; University of Hong Kong	Joint Research Scheme of National Nature Science Foundation of China/Research Grants Council of Hong Kong; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of Hong Kong(University of Hong Kong)	This work was supported by grants from the Joint Research Scheme of National Nature Science Foundation of China/Research Grants Council of Hong Kong (Project Nos. 71561167001 and N_HKU707/15) and the Natural Science Foundation of China (Project No. 71601163; 71671100). SCW and PX were respectively supported by the Francis S Y Bong Professorship in Engineering and a Research Postgraduate Studentship from the University of Hong Kong. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, HONG KONG TRANSP DEP; Bergel R, 2012, TRANSPORT REV, V32, P653, DOI 10.1080/01441647.2012.695407; Blaizot S, 2013, ACCIDENT ANAL PREV, V58, P35, DOI 10.1016/j.aap.2013.04.018; Bouaoun L, 2015, ACCIDENT ANAL PREV, V75, P217, DOI 10.1016/j.aap.2014.10.025; Brown V, 2017, J TRANSP HEALTH, V7, P23, DOI 10.1016/j.jth.2017.02.011; Chandraratna S, 2009, ACCIDENT ANAL PREV, V41, P308, DOI 10.1016/j.aap.2008.12.005; Cheng W, 2018, ACCIDENT ANAL PREV, V112, P84, DOI 10.1016/j.aap.2017.12.020; Chieng M, 2017, J TRANSP HEALTH, V6, P23, DOI 10.1016/j.jth.2017.02.008; Chin HC, 2018, ACCIDENT ANAL PREV, V112, P50, DOI 10.1016/j.aap.2017.12.024; Commandeur JJF, 2013, ACCIDENT ANAL PREV, V60, P424, DOI 10.1016/j.aap.2012.11.006; Congdon P., 2014, APPL BAYESIAN MODELL; Constant A, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000228; de Hartog JJ, 2010, ENVIRON HEALTH PERSP, V118, P1109, DOI 10.1289/ehp.0901747; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Gotschi T, 2016, TRANSPORT REV, V36, P45, DOI 10.1080/01441647.2015.1057877; Guo Q, 2017, ACCIDENT ANAL PREV, V99, P114, DOI 10.1016/j.aap.2016.11.002; Hong Kong Transport Department, 2014, TRAV CHAR SURV 2011; Hong Kong Transport Department, 2017, ROAD TRAFF ACC STAT; Jiang XG, 2010, ACCIDENT ANAL PREV, V42, P1352, DOI 10.1016/j.aap.2010.02.016; Keall M, 2009, TRAFFIC INJ PREV, V10, P30, DOI 10.1080/15389580802383117; Kim JH, 2016, INT J EPIDEMIOL, V45, P1668, DOI 10.1093/ije/dyw172; Loo BPY, 2007, INJURY PREV, V13, P186, DOI 10.1136/ip.2006.013458; Loo BPY, 2010, ACCIDENT ANAL PREV, V42, P1902, DOI 10.1016/j.aap.2010.05.011; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Lusk AC, 2011, INJURY PREV, V17, P131, DOI 10.1136/ip.2010.028696; Ma XX, 2017, ANAL METHODS ACCID R, V15, P29, DOI 10.1016/j.amar.2017.06.001; Maibach E, 2009, PREV MED, V49, P326, DOI 10.1016/j.ypmed.2009.06.028; Mandic S, 2018, J TRANSP HEALTH, V8, P271, DOI 10.1016/j.jth.2017.12.010; McAndrews C., 2001, INJURY PREV, V17, P204; McAndrews C, 2013, ACCIDENT ANAL PREV, V60, P103, DOI 10.1016/j.aap.2013.08.005; Mindell JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050606; Olivier J, 2017, INT J EPIDEMIOL, V46, P278, DOI [10.1093/ije/dyw360, 10.1093/ije/dyw153]; Pedroso FE, 2016, AM J PUBLIC HEALTH, V106, P2171, DOI 10.2105/AJPH.2016.303454; Prati G, 2017, TRANSPORT RES F-TRAF, V47, P34, DOI 10.1016/j.trf.2017.04.008; Pucher J, 2008, TRANSPORT REV, V28, P495, DOI 10.1080/01441640701806612; Pulugurtha SS, 2015, ACCIDENT ANAL PREV, V76, P34, DOI 10.1016/j.aap.2014.12.020; Rojas-Rueda D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4521; Santamarina-Rubio E, 2014, ACCIDENT ANAL PREV, V65, P1, DOI 10.1016/j.aap.2013.11.015; Schneider RJ, 2017, ACCIDENT ANAL PREV, V106, P82, DOI 10.1016/j.aap.2017.04.018; Short J, 2014, TRANSPORT POLICY, V33, P154, DOI 10.1016/j.tranpol.2014.03.003; Sze NN, 2019, ACCIDENT ANAL PREV, V128, P17, DOI 10.1016/j.aap.2019.03.017; Sze NN, 2011, HONG KONG J EMERG ME, V18, P136, DOI 10.1177/102490791101800302; Thornley SJ, 2008, INJURY PREV, V14, P11, DOI 10.1136/ip.2007.016675; Tin ST, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-655; To DKB, 2005, TRANSPORTMETRICA, V1, P247, DOI 10.1080/18128600508685650; Vanparijs J, 2015, ACCIDENT ANAL PREV, V84, P9, DOI 10.1016/j.aap.2015.08.007; Xie SQ, 2018, ACCIDENT ANAL PREV, V121, P285, DOI 10.1016/j.aap.2018.09.030; Xu PP, 2019, INJURY PREV, V25, P20, DOI 10.1136/injuryprev-2017-042469; Xu PP, 2017, ACCIDENT ANAL PREV, V98, P330, DOI 10.1016/j.aap.2016.10.015; Xu XC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181544; Xu XC, 2016, J ADV TRANSPORT, V50, P2015, DOI 10.1002/atr.1442; Yao S, 2016, INJURY PREV, V22, P379, DOI 10.1136/injuryprev-2016-041964; Yeung JHH, 2009, INJURY, V40, P555, DOI 10.1016/j.injury.2008.08.015	53	11	11	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220785	10.1371/journal.pone.0220785	http://dx.doi.org/10.1371/journal.pone.0220785			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5FL	31398211	Green Submitted, Green Published, gold			2022-12-26	WOS:000485004000020
J	Haider, M; Dambuza, IM; Asamaphan, P; Stappers, M; Reid, D; Yamasaki, S; Brown, GD; Gow, NAR; Erwig, LP				Haider, Mohammed; Dambuza, Ivy M.; Asamaphan, Patawee; Stappers, Mark; Reid, Delyth; Yamasaki, Sho; Brown, Gordon D.; Gow, Neil A. R.; Erwig, Lars P.			The pattern recognition receptors dectin-2, mincle, and FcR gamma impact the dynamics of phagocytosis of Candida, Saccharomyces, Malassezia, and Mucor species	PLOS ONE			English	Article							C-TYPE LECTIN; HOST-DEFENSE; PATHOGEN INTERACTIONS; ACTIVATING RECEPTOR; ALBICANS; MATURATION; PHAGOSOMES; RESPONSES; INSIGHTS; FAMILY	Phagocytosis is a receptor-mediated process critical to innate immune clearance of pathogens. It proceeds in a regulated sequence of stages: (a) migration of phagocytes towards pathogens, (b) recognition of PAMPs and binding through PRRs, (c) engulfment and internalisation into phagosomes, (d) phagosome maturation, and (e) killing of pathogen or host cells. However, little is known about the role that individual receptors play in these discrete stages in the recognition of fungal cells. In a previous study, we found that dectin-2 deficiency impacted some but not all stages of macrophage-mediated phagocytosis of Candida glabrata. Because the C-type lectin receptor dectin-2 critically requires coupling to the FcR gamma chain for signalling, we hypothesised that this coupling may be important for regulating phagocytosis of fungal cargo. We therefore examined how deficiency in FcR gamma itself or two receptors to which it couples (dectin-2 and mincle) impacts phagocytosis of six fungal organisms representing three different fungal taxa. Our data show that deficiency in these proteins impairs murine bone marrow-derived macrophage migration, engulfment, and phagosome maturation, but not macrophage survival. Therefore, FcR gamma engagement with selective C-type lectin receptors (CLRs) critically affects the spatio-temporal dynamics of fungal phagocytosis.	[Haider, Mohammed; Dambuza, Ivy M.; Asamaphan, Patawee; Stappers, Mark; Reid, Delyth; Brown, Gordon D.; Gow, Neil A. R.; Erwig, Lars P.] Univ Aberdeen, Ctr Med Mycol, Inst Med Sci, Med Res Council,Aberdeen Fungal Grp, Aberdeen, Scotland; [Yamasaki, Sho] Kyushu Univ, Med Inst Bioregulat, Div Mol Immunol, Fukuoka, Fukuoka, Japan; [Yamasaki, Sho] Chiba Univ, Med Mycol Res Ctr, Dept Mol Immunol, Chiba, Japan; [Haider, Mohammed] Kuwait Univ, Fac Sci, Dept Biol Sci, Microbiol Programme, Kuwait, Kuwait; [Asamaphan, Patawee] Univ Glasgow, Ctr Virus Res, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Stappers, Mark; Gow, Neil A. R.] Univ Exeter, Sch Biosci, Geoffrey Pope Bldg, Exeter, Devon, England; [Reid, Delyth] Osaka Univ, Res Inst Microbial Dis, Osaka, Japan; [Erwig, Lars P.] Galvani Bioelect, Gunnels Wood Rd, Stevenage, Herts, England	University of Aberdeen; Kyushu University; Chiba University; Kuwait University; University of Glasgow; University of Exeter; Osaka University	Gow, NAR; Erwig, LP (corresponding author), Univ Aberdeen, Ctr Med Mycol, Inst Med Sci, Med Res Council,Aberdeen Fungal Grp, Aberdeen, Scotland.; Gow, NAR (corresponding author), Univ Exeter, Sch Biosci, Geoffrey Pope Bldg, Exeter, Devon, England.; Erwig, LP (corresponding author), Galvani Bioelect, Gunnels Wood Rd, Stevenage, Herts, England.	n.gow@exeter.ac.uk; lars.x.erwig@galvani.bio	GOW, Neil/AAS-5323-2021; Haider, Mohammed/AAZ-7803-2020	GOW, Neil/0000-0002-2776-5850; Haider, Mohammed/0000-0002-4660-338X; Stappers, Mark/0000-0003-4154-7160	MRC Centre for Medical Mycology [MR/N006364/1]; Wellcome Trust [080088, 086827, 075470, 099215, 097377, 101873/Z/13/Z, 200208/A/15/Z]; MRC [MR/N006364/1, MR/N006364/2] Funding Source: UKRI	MRC Centre for Medical Mycology(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the MRC Centre for Medical Mycology (MR/N006364/1). NARG thanks The Wellcome Trust (080088, 086827, 075470, 099215, 097377, 101873/Z/13/Z, and 200208/A/15/Z) for support. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Microscopy and Histology core facility at the University of Aberdeen. In particular, we extend our thanks to Mr Kevin MacKenzie and Ms Lucinda Wight for their helpful support and advice on imaging. We are also grateful to Prof. Sho Yamasaki (Kyushu University, Japan) for the generous gift of bone marrow cells from FcR gamma<SUP>-/-</SUP> mice. This work was supported by the MRC Centre for Medical Mycology (MR/N006364/1). NARG thanks The Wellcome Trust (080088, 086827, 075470, 099215, 097377, 101873/Z/13/Z, and 200208/A/15/Z) for support.	Alvarez M, 2006, CURR BIOL, V16, P2161, DOI 10.1016/j.cub.2006.09.061; Bain J, 2015, SEMIN IMMUNOPATHOL, V37, P131, DOI 10.1007/s00281-014-0463-3; Bain JM, 2014, MBIO, V5, DOI 10.1128/mBio.01874-14; Bain JM, 2012, FUNGAL GENET BIOL, V49, P677, DOI 10.1016/j.fgb.2012.01.008; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; Brown GD, 2011, ANNU REV IMMUNOL, V29, P1, DOI 10.1146/annurev-immunol-030409-101229; Dantas AD, 2010, MOL CELL BIOL, V30, P4550, DOI 10.1128/MCB.00313-10; Danhof HA, 2015, INFECT IMMUN, V83, P4416, DOI 10.1128/IAI.00984-15; Drummond RA, 2011, EUR J IMMUNOL, V41, P276, DOI 10.1002/eji.201041252; Hardison SE, 2012, NAT IMMUNOL, V13, P817, DOI 10.1038/ni.2369; Ifrim DC, 2016, J INTERF CYTOK RES, V36, P267, DOI 10.1089/jir.2015.0040; Ifrim DC, 2014, INFECT IMMUN, V82, P1064, DOI 10.1128/IAI.01189-13; Kano R, 1999, MICROBIOL IMMUNOL, V43, P813, DOI 10.1111/j.1348-0421.1999.tb02475.x; Kerscher B, 2013, INT IMMUNOL, V25, P271, DOI 10.1093/intimm/dxt006; Kimura Y, 2016, P NATL ACAD SCI USA, V113, P14097, DOI 10.1073/pnas.1617903113; Lee SC, 2015, MOL MICROBIOL, V97, P844, DOI 10.1111/mmi.13071; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Levin R, 2016, IMMUNOL REV, V273, P156, DOI 10.1111/imr.12439; Lewis LE, 2013, JOVE-J VIS EXP, DOI 10.3791/50196; Lewis LE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002578; Li CH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002086; Lim J, 2018, J IMMUNOL, V200, P3539, DOI 10.4049/jimmunol.1700790; Ma HS, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-15; McKenzie CGJ, 2010, INFECT IMMUN, V78, P1650, DOI 10.1128/IAI.00001-10; McPhillips KA, 2009, METHODS MOL BIOL, V559, P247, DOI 10.1007/978-1-60327-017-5_17; Moretti J, 2014, CURR OPIN IMMUNOL, V26, P100, DOI 10.1016/j.coi.2013.11.003; MORTIMER RK, 1986, GENETICS, V113, P35; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Okai B, 2015, INFECT IMMUN, V83, P1523, DOI 10.1128/IAI.02917-14; Patterson MJ, 2013, ANTIOXID REDOX SIGN, V19, P2244, DOI 10.1089/ars.2013.5199; Rudkin FM, 2013, MBIO, V4, DOI 10.1128/mBio.00810-13; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Satoh K, 2009, MICROBIOL IMMUNOL, V53, P41, DOI 10.1111/j.1348-0421.2008.00083.x; Sharma A, 2014, J INFECT DIS, V209, P1837, DOI 10.1093/infdis/jit820; Slesiona S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031223; Strasser JE, 1999, J IMMUNOL, V162, P6148; Sugita T, 2002, J CLIN MICROBIOL, V40, P1363, DOI 10.1128/JCM.40.4.1363-1367.2002; Uwamahoro N, 2014, MBIO, V5, DOI 10.1128/mBio.00003-14; Vijayan D, 2012, IMMUNOL CELL BIOL, V90, P889, DOI 10.1038/icb.2012.24; Vylkova S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003995; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zhuang LH, 2012, J IMMUNOL METHODS, V385, P1, DOI 10.1016/j.jim.2012.06.008	47	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220867	10.1371/journal.pone.0220867	http://dx.doi.org/10.1371/journal.pone.0220867			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393930	Green Published, gold, Green Submitted			2022-12-26	WOS:000485002500074
J	Liao, RR; Lv, YH; Zhu, LH; Lin, YX				Liao, Rongrong; Lv, Yuhua; Zhu, Lihui; Lin, Yuexia			Altered expression of miRNAs and mRNAs reveals the potential regulatory role of miRNAs in the developmental process of early weaned goats	PLOS ONE			English	Article							MUSCLE-CELL PROLIFERATION; SKELETAL-MUSCLE; MAINTENANCE; MICRORNAS; GROWTH	MicroRNAs (miRNAs) play pivotal roles in growth, development, and stress responses. However, the regulatory function of miRNAs in early weaned goats remains unclear. Deep sequencing comparison of mRNA and miRNA expression profiles showed that 18 miRNAs and 373 genes were differentially expressed in pre- and post-weaning Chongming white goats. Bioinformatics analysis indicated that these differentially expressed genes are involved in cellular processes, developmental processes, and growth in terms of biological process analysis. KEGG analysis showed that downregulated genes were enriched in salivary secretion, bile secretion, vascular smooth muscle contraction, and calcium signaling pathways. Additionally, a miRNA-mRNA co-expression network of the 18 dysregulated miRNAs and their 107 target mRNAs was constructed using a combination of Pearson's correlation analysis and prediction by miRanda software. Among the downregulated miRNAs, two (chi-miR-206 and chi-miR-133a/b) were muscle development-related and the others were cell proliferation associated. Further RT-qPCR analysis confirmed that downregulated miRNAs (chi-miR-99b-3p, chi-miR-224, and chi-miR-10b-5p) were highly expressed in muscle tissues (heart, spleen, or kidney) of the rapid growth period (7-month old) in Chongming white goats. The results of the present study suggested that weaning induced cell proliferation repression in post-weaning goats, providing new insight into the mechanism of muscle development of goats, although additional details remain to be elucidated in the future.	[Liao, Rongrong; Lv, Yuhua; Zhu, Lihui; Lin, Yuexia] Shanghai Acad Agr Sci, Inst Anim Husb & Vet Sci, Shanghai, Peoples R China	Shanghai Academy of Agricultural Sciences	Zhu, LH; Lin, YX (corresponding author), Shanghai Acad Agr Sci, Inst Anim Husb & Vet Sci, Shanghai, Peoples R China.	zhulihui@saas.sh.cn; linyuexia@saas.sh.cn		Zhu, Lihui/0000-0002-2931-6207	Youth Talent Development Plan of Shanghai Municipal Agricultural System [20170116]; Shanghai Agriculture Applied Technology Development Program [Z20170303]; Young Scientist Plan of Shanghai Academy of Agricultural Sciences [ZP173]	Youth Talent Development Plan of Shanghai Municipal Agricultural System; Shanghai Agriculture Applied Technology Development Program; Young Scientist Plan of Shanghai Academy of Agricultural Sciences	This work was financially supported by the Youth Talent Development Plan of Shanghai Municipal Agricultural System (Grant No. 20170116) to RL, Shanghai Agriculture Applied Technology Development Program (Grant No. Z20170303) to Y. Lin, and the Young Scientist Plan of Shanghai Academy of Agricultural Sciences (Grant No. ZP173) to RL.	Bai L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173912; Boettger T, 2014, SKELET MUSCLE, V4, DOI 10.1186/s13395-014-0023-5; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Davis-Dusenbery BN, 2010, J BIOCHEM, V148, P381, DOI 10.1093/jb/mvq096; Do DN, 2018, GENOMICS; Do DN, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7090134; Esumi M, 2015, HEPATOLOGY, V61, P437, DOI 10.1002/hep.27426; Gheinani AH, 2015, J BIOL CHEM, V290, P7067, DOI 10.1074/jbc.M114.618694; Greenwood PL, 2007, ANIMAL, V1, P1283, DOI 10.1017/S175173110700050X; Hao Y, 2016, ANIM GENET, V47, P365, DOI 10.1111/age.12419; He K, 2015, INT J ONCOL, V47, P1528, DOI 10.3892/ijo.2015.3135; He M, 2017, CELL PHYSIOL BIOCHEM, V42, P2078, DOI 10.1159/000479903; Kelly D, 2000, LIVEST PROD SCI, V66, P161, DOI 10.1016/S0301-6226(00)00223-2; Ling YH, 2015, J ANIM PLANT SCI, V25, P146; Liu C, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010994; Ma GD, 2015, INT J BIOL SCI, V11, P345, DOI 10.7150/ijbs.10921; Mavrommatis E, 2013, J INTERF CYTOK RES, V33, P206, DOI 10.1089/jir.2012.0133; Miao XY, 2015, GENE, V562, P188, DOI 10.1016/j.gene.2015.02.070; Mu YH, 2016, EMBO REP, V17, P94, DOI 10.15252/embr.201540964; Nakasa T, 2010, J CELL MOL MED, V14, P2495, DOI 10.1111/j.1582-4934.2009.00898.x; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Ren FH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135544; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tao X, 2017, BIOL DIRECT, V12, DOI 10.1186/s13062-017-0199-9; Tao X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162776; Tao X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079343; Teke B, 2012, SMALL RUMINANT RES, V103, P176, DOI 10.1016/j.smallrumres.2011.08.012; Turcatel G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031032; Wang C, 2019, J CELL PHYSIOL, V234, P9467, DOI 10.1002/jcp.27632; Wang L, 2017, EUR REV MED PHARMACO, V21, P3223; Wang Z, 2018, SCI REP, V8; Wei CH, 2018, CELL PHYSIOL BIOCHEM, V49, P447, DOI 10.1159/000492979; Xu JC, 2018, GENE, V679, P266, DOI 10.1016/j.gene.2018.09.010; Yates C, 2017, FRONT BIOSCI-LANDMRK, V22, P212, DOI 10.2741/4482; Yu X, 2015, CURR VASC PHARMACOL, V13, P679, DOI 10.2174/1570161113666150123112751; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Yue YX, 2018, CARDIOVASC PATHOL, V37, P15, DOI 10.1016/j.carpath.2018.08.003; Zhang WR, 2017, IN VITRO CELL DEV-AN, V53, P265, DOI 10.1007/s11626-016-0109-y; Zhen L, 2017, J THERM BIOL, V66, P114, DOI 10.1016/j.jtherbio.2017.03.005; Zhou JZ, 2017, INT J MED SCI, V14, P937, DOI 10.7150/ijms.19565; Zhu LH, 2016, SCI REP-UK, V6, DOI 10.1038/srep25885; Zuo JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124873	45	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220907	10.1371/journal.pone.0220907	http://dx.doi.org/10.1371/journal.pone.0220907			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393969	Green Submitted, gold, Green Published			2022-12-26	WOS:000485002500081
J	Zaren, P; Alson, S; Henic, E; Bungum, M; Giwercman, A				Zaren, Peter; Alson, Sara; Henic, Emir; Bungum, Mona; Giwercman, Aleksander			Interaction between serum levels of Anti-Mullerian Hormone and the degree of sperm DNA fragmentation measured by sperm chromatin structure assay can be a predictor for the outcome of standard in vitro fertilization	PLOS ONE			English	Article							ANTIMULLERIAN HORMONE; ASSISTED CONCEPTION; METAANALYSIS; PREGNANCY; UTILITY; DAMAGE; IVF; AMH	Serum levels of Anti-Mullerian Hormone (AMH) have been shown to be biomarker for prediction of the quantitative aspects of ovarian reserve. On the male side, sperm chromatin structure assay (SCSA) DNA fragmentation index (DFI) has been demonstrated to be an important predictor of outcomes in standard IVF procedures but to less degree in intracytoplasmic sperm injection procedures (ICSI). The purpose of this study was to investigate whether the combination of female AMH serum levels and sperm DFI adds to prediction of the outcome of assisted reproduction. A total of 352 couples was included (ICSI-148: IVF-204) A venous blood sample was drawn for AMH analysis before IVF/ICSI treatment. DFI was measured in the ejaculate used for assisted reproduction. Regression models for the following odds ratio calculations were constructed: for obtaining at least one Good Quality Embryo; for live birth in all procedures; for pregnancy in procedures where embryo transfer was performed; for miscarriage. For DFI increase by 10 percentage points (not increased DFI as reference) odds ratio for Good Quality Embryo was statistically significantly lower when AMH was at lower quartile (AMH < 12 pmol/L; OR = 0.29, 95% CI: 0.14-0.59,) but not when AMH was at upper quartile (AMH >= 36 pmol/L; OR = 0.95, 95% CI: 0.43-2.13,). The marginal effect of an increase in DFI by 10 percentage points was statistically significant only when AMH < 25.2 pmol/L. Similar results were obtained as considers live birth following standard IVF. No interactions were seen for standard IVF in relation to the risk of miscarriage and for any of the outcomes when ICSI was used as method of treatment. We conclude that the impact of high DFI on the outcome of standard IVF is most pronounced if the female partner has relatively low AMH levels. This finding may help in defining the role of sperm DNA integrity testing in management of infertile couples. It may also explain some of the heterogeneity in results of studies focusing on predictive value of DFI measurements in assisted reproduction.	[Zaren, Peter; Giwercman, Aleksander] Lund Univ, Dept Translat Med, Malmo, Sweden; [Alson, Sara] Skane Univ Hosp, Dept Obstet & Gynaecol, Malmo, Sweden; [Henic, Emir; Bungum, Mona; Giwercman, Aleksander] Skane Univ Hosp, Reprod Med Ctr, Malmo, Sweden	Lund University; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Giwercman, A (corresponding author), Lund Univ, Dept Translat Med, Malmo, Sweden.; Giwercman, A (corresponding author), Skane Univ Hosp, Reprod Med Ctr, Malmo, Sweden.	aleksander.giwercman@med.lu.se		Giwercman, Giwercman/0000-0001-5816-0785	Merck-Serono; ReproUnion (Interreg V EU Regional Fund)	Merck-Serono(Merck & Company); ReproUnion (Interreg V EU Regional Fund)	The study was supported by an unrestricted research grant from Merck-Serono and grants from ReproUnion (Interreg V EU Regional Fund) to AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Broer SL, 2009, FERTIL STERIL, V91, P705, DOI 10.1016/j.fertnstert.2007.12.013; Bungum M, 2006, HUM REPROD, V21, P518, DOI 10.1093/humrep/dei350; Bungum M, 2004, HUM REPROD, V19, P1401, DOI 10.1093/humrep/deh280; Centers for Disease Control and Prevention, 2017, 2015 ASS REPR TECHN; Chi HJ, 2017, CLIN EXP REPROD MED, V44, P132, DOI 10.5653/cerm.2017.44.3.132; Comhaire F., 1987, INT J ANDROL S, V7, P1; De Geyter C, 2018, HUM REPROD, V33, P1586, DOI 10.1093/humrep/dey242; de Marcillac FD, 2017, J GYNECOL OBSTET HUM, V46, P629, DOI 10.1016/j.jogoh.2017.08.001; Evenson Donald, 2000, Methods in Cell Science, V22, P169, DOI 10.1023/A:1009844109023; Evenson DP, 1999, HUM REPROD, V14, P1039, DOI 10.1093/humrep/14.4.1039; Gardner DK, 1999, TOWARDS REPRODUCTIVE CERTAINTY, P378; Harrell F.E., 2017, HMISC HARRELL MISCEL; Harrell FE., 2017, BIOS, V330, P14; Henkel Ralf, 2005, Reprod Med Biol, V4, P7, DOI 10.1111/j.1447-0578.2005.00087.x; Iliodromiti S, 2015, HUM REPROD UPDATE, V21, P698, DOI 10.1093/humupd/dmu062; Iliodromiti S, 2014, HUM REPROD UPDATE, V20, P560, DOI 10.1093/humupd/dmu003; La Marca A, 2010, HUM REPROD UPDATE, V16, P113, DOI 10.1093/humupd/dmp036; La Marca A, 2009, HUM REPROD, V24, P2264, DOI 10.1093/humrep/dep210; Lee TH, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-100; Nelson SM, 2015, FERTIL STERIL, V104, P325, DOI 10.1016/j.fertnstert.2015.04.032; Oleszczuk K, 2016, ANDROLOGY-US, V4, P290, DOI 10.1111/andr.12153; Pfeifer S, 2013, FERTIL STERIL, V99, P673, DOI 10.1016/j.fertnstert.2012.12.049; Simon L, 2017, ASIAN J ANDROL, V19, P80, DOI 10.4103/1008-682X.182822; Spano M, 2000, FERTIL STERIL, V73, P43, DOI 10.1016/S0015-0282(99)00462-8; Tal R, 2015, FERTIL STERIL, V103, P119, DOI 10.1016/j.fertnstert.2014.09.041; van Rooij IAJ, 2002, HUM REPROD, V17, P3065, DOI 10.1093/humrep/17.12.3065; van Rooij IAJ, 2006, REPROD BIOMED ONLINE, V12, P182, DOI 10.1016/S1472-6483(10)60859-0; Verhaak CM, 2005, HUM REPROD, V20, P2253, DOI 10.1093/humrep/dei015; Weenen C, 2004, MOL HUM REPROD, V10, P77, DOI 10.1093/molehr/gah015; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th	31	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220909	10.1371/journal.pone.0220909	http://dx.doi.org/10.1371/journal.pone.0220909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393936	gold, Green Submitted, Green Published			2022-12-26	WOS:000485002500082
J	Ali, A; Anthony, RV; Bouma, GJ; Winger, QA				Ali, Asghar; Anthony, Russell V.; Bouma, Gerrit J.; Winger, Quinton A.			LIN28-let-7 axis regulates genes in immortalized human trophoblast cells by targeting the ARID3B-complex	FASEB JOURNAL			English	Article						intrauterine growth restriction; placenta; gene regulation	INTRAUTERINE GROWTH RESTRICTION; MICRORNA BIOGENESIS; C-MYC; ARID3B; DIFFERENTIATION; PREECLAMPSIA; INHIBITION; MATURATION; PLACENTA; LIN-28	Abnormal placental development is one of the main etiological factors for intrauterine growth restriction (IUGR). Here, we show that LIN28A and LIN28B are significantly lower and lethal-7 (let-7) microRNAs (miRNAs) significantly higher in term human IUGR vs. normal placentas. We hypothesize that let-7 miRNAs regulate genes with known importance for human placental development [high-mobility group AT-hook 1 (HMGA1), transcriptional regulator Myc-like (c-myc), vascular endothelial growth factor A (VEGF-A), and Wnt family member 1 (WNT1)] by targeting the AT-rich interacting domain (ARID)-3B complex. ACH-3P cells with LIN28A and LIN28B knockout (DKOs) significantly increased let-7 miRNAs, leading to significantly decreased ARID3A, ARID3B, and lysine demethylase 4C (KDM4C). Similarly, Sw.71 cells overexpressing LIN28A and LIN28B (DKIs) significantly decreased let-7 miRNAs, leading to significantly increased ARID3A, ARID3B, and KDM4C. In ACH-3P cells, ARID3A, ARID3B, and KDM4C make a triprotein complex [triprotein complex comprising ARID3A, ARID3B, and KDM4C (ARID3B-complex)] that binds the promoter regions of HMGA1, c-MYC, VEGF-A, and WNT1. ARID3B knockout in ACH-3P cells disrupted the ARID3B-complex, leading to a significant decrease in HMGA1, c-MYC, VEGF-A, and WNT1. DKOs had a significant reduction, whereas DKIs had a significant increase in HMGA1, c-MYC, VEGF-A, and WNT1, potentially due to regulation by the ARID3B-complex. This is the first study showing regulation of let-7 targets in immortalized human trophoblast cells by the ARID3B-complex.	[Ali, Asghar; Anthony, Russell V.; Bouma, Gerrit J.; Winger, Quinton A.] Colorado State Univ, Dept Biomed Sci, Anim Reprod & Biotechnol Lab, 1683 Campus Delivery, Ft Collins, CO 80523 USA	Colorado State University	Winger, QA (corresponding author), Colorado State Univ, Dept Biomed Sci, Anim Reprod & Biotechnol Lab, 1683 Campus Delivery, Ft Collins, CO 80523 USA.	quinton.winger@colostate.edu	Bouma, Gerrit/AAT-4644-2020	Bouma, Gerrit/0000-0003-2433-5086; Ali, Asghar/0000-0002-5137-2547	Agriculture and Food Research Initiative Competitive Grant from the U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture [2017-67015-26460]; Institute of International Education (IIE); United States Education Foundation in Pakistan (USEFP)	Agriculture and Food Research Initiative Competitive Grant from the U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture; Institute of International Education (IIE); United States Education Foundation in Pakistan (USEFP)	The authors thank Dr. Marcin Jozwik (University of Warmia and Mazury, Olsztyn, Poland) and Dr. Maciej Jozwik (Medical University of Bialystok, Bialystok, Poland) for providing the human placental tissue samples (53). This project was supported by Agriculture and Food Research Initiative Competitive Grant 2017-67015-26460 from the U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture. The authors thank the Institute of International Education (IIE) and United States Education Foundation in Pakistan (USEFP) for funding the doctoral studies of A.A. at Colorado State University through the Foreign Fulbright Scholarship Program. The authors declare no conflicts of interest.	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Barker DJP, 1999, ANN MED, V31, P3, DOI 10.1080/07853890.1999.11904392; Beune IM, 2018, J PEDIATR-US, V196, P71, DOI 10.1016/j.jpeds.2017.12.059; Bobbs A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131961; Canfield J, 2019, FASEB J, V33, P2759, DOI 10.1096/fj.201801163R; Casanova JC, 2011, DEVELOPMENT, V138, P1195, DOI 10.1242/dev.057570; DEVOR EJ, 2014, OBSTET GYNECOLOGY IN, V2014, P1, DOI DOI 10.1155/2014/678984; Djakovic A, 2007, Z Geburtshilfe Neonatol, V211, P169, DOI 10.1055/s-2007-981219; Feng C, 2012, CELL CYCLE, V11, P2486, DOI 10.4161/cc.20893; Habir K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01387; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Heinonen S, 2001, PLACENTA, V22, P399, DOI 10.1053/plac.2001.0630; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Hiden U, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-137; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Jin B, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2904-y; Jozwik M, 2009, PLACENTA, V30, P607, DOI 10.1016/j.placenta.2009.05.005; Kim D, 2007, J BIOL CHEM, V282, P15768, DOI 10.1074/jbc.M700397200; Kobayashi K, 2006, CANCER RES, V66, P8331, DOI 10.1158/0008-5472.CAN-06-0756; Kortschak RD, 2000, TRENDS BIOCHEM SCI, V25, P294, DOI 10.1016/S0968-0004(00)01597-8; Kumar P, 2013, MOL CELL BIOL, V33, P1782, DOI 10.1128/MCB.01228-12; Lala N, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.097881; Li Y, 2015, ENDOCRINOLOGY, V156, P4257, DOI 10.1210/en.2015-1228; Liao TT, 2016, CELL REP, V14, P520, DOI 10.1016/j.celrep.2015.12.064; Liu FL, 2018, MOL MED REP, V17, P5627, DOI 10.3892/mmr.2018.8558; Lyons P., 2006, OBSTET FAMILY MED PR; Ma W, 2013, CELL CYCLE, V12, P88, DOI 10.4161/cc.23028; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Norwitz Errol R, 2007, Reprod Biomed Online, V14 Spec No 1, P101, DOI 10.1016/S1472-6483(10)61464-2; Pang V, 2017, CLIN SCI, V131, P2763, DOI 10.1042/CS20171252; Park J, 2015, BIOINFORMATICS, V31, P4014, DOI 10.1093/bioinformatics/btv537; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Rahman MM, 2009, BRIT J CANCER, V100, P501, DOI 10.1038/sj.bjc.6604883; Raney BJ, 2011, NUCLEIC ACIDS RES, V39, pD871, DOI 10.1093/nar/gkq1017; Ratliff ML, 2016, J IMMUNOL, V196, P614, DOI 10.4049/jimmunol.1500355; Rhee C, 2017, DEV BIOL, V422, P83, DOI 10.1016/j.ydbio.2016.12.003; Roy L, 2014, ONCOTARGET, V5, P8355, DOI 10.18632/oncotarget.2247; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Scifres CM, 2009, J PHYSIOL-LONDON, V587, P3453, DOI 10.1113/jphysiol.2009.173252; Seabrook JL, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109868; Sharma D, 2016, J MATERN-FETAL NEO M, V29, P3977, DOI 10.3109/14767058.2016.1152249; Sonderegger S, 2007, PLACENTA, V28, pS97, DOI 10.1016/j.placenta.2006.11.003; Straszewski-Chavez SL, 2009, PLACENTA, V30, P939, DOI 10.1016/j.placenta.2009.08.007; Takebe A, 2006, DEV BIOL, V293, P25, DOI 10.1016/j.ydbio.2005.12.016; Uchikura Y., 2015, PREGNANCY HYPERTENS, V5, P243; Uchikura Y, 2017, REPROD SCI, V24, P1630, DOI 10.1177/1933719117697254; Wagner S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/376326; Wang XF, 2018, J MOL HISTOL, V49, P317, DOI 10.1007/s10735-018-9770-7; Webb CF, 2011, MOL CELL BIOL, V31, P1041, DOI 10.1128/MCB.01448-10; West RC, 2019, BIOL REPROD, V100, P227, DOI 10.1093/biolre/ioy183; Wilkins-Haug L, 2006, PRENATAL DIAG, V26, P428, DOI 10.1002/pd.1430; Wilsker D, 2005, GENOMICS, V86, P242, DOI 10.1016/j.ygeno.2005.03.013; Wood JJ, 2016, J VIROL, V90, P9543, DOI 10.1128/JVI.03262-15; Wu KJ, 2019, REPROD FERT DEVELOP, V31, P377, DOI 10.1071/RD18118; Yang XJ, 2015, ONCOL REP, V33, P1723, DOI 10.3892/or.2015.3757; Yu KM, 1992, ZHONGHUA FU CHAN KE, V27, P250	57	11	12	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12348	12363		10.1096/fj.201900718RR	http://dx.doi.org/10.1096/fj.201900718RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31415216	Bronze, Green Published			2022-12-26	WOS:000507461600059
J	Zeng, YT; Liu, XF; Yang, WT; Zheng, PS				Zeng, Yu-Ting; Liu, Xiao-Fang; Yang, Wen-Ting; Zheng, Peng-Sheng			REX1 promotes EMT-induced cell metastasis by activating the JAK2/STAT3-signaling pathway by targeting SOCS1 in cervical cancer	ONCOGENE			English	Article							SIGNAL TRANSDUCER; DNA METHYLATION; GENE-EXPRESSION; YY1; PROTEIN; MARKER; CLASSIFICATION; ASSOCIATION; SUPPRESSOR; CARCINOMA	ZFP42 zinc finger protein (REX1), a pluripotency marker in mouse pluripotent stem cells, has been identified as a tumor suppressor in several human cancers. However, the function of REX1 in cervical cancer remains unknown. Both IHC and western blot assays demonstrated that the expression of REX1 protein in cervical cancer tissue was much higher than that in normal cervical tissue. A xenograft assay showed that REX1 overexpression in SiHa and HeLa cells facilitated distant metastasis but did not significantly affect tumor formation in vivo. In addition, in vitro cell migration and invasion capabilities were also promoted by REX1. Mechanistically, REX1 overexpression induced epithelial-to-mesenchymal transition (EMT) by upregulating VIMENTIN and downregulating E-CADHERIN. Furthermore, the JAK2/STAT3-signaling pathway was activated in REX1-overexpressing cells, which also exhibited increased levels of p-STAT3 and p-JAK2, as well as downregulated expression of SOCS1, which is an inhibitor of the JAK2/STAT3-signaling pathway, at both the transcriptional and translational levels. A dual-luciferase reporter assay and qChIP assays confirmed that REX1 trans-suppressed the expression of SOCS1 by binding to two specific regions of the SOCS1 promoter. Therefore, all our data suggest that REX1 overexpression could play a crucial role in the metastasis and invasion of cervical cancer by upregulating the activity of the JAK2/STAT3 pathway by trans-suppressing SOCS1 expression.	[Zeng, Yu-Ting; Yang, Wen-Ting; Zheng, Peng-Sheng] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Reprod Med, Xian 710061, Shaanxi, Peoples R China; [Liu, Xiao-Fang; Zheng, Peng-Sheng] Minist Educ Peoples Republ China, Key Lab Environm & Genes Related Dis, Sect Canc Stem Cell Res, Xian 710061, Shaanxi, Peoples R China	Xi'an Jiaotong University; Ministry of Education, China	Yang, WT; Zheng, PS (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Reprod Med, Xian 710061, Shaanxi, Peoples R China.; Zheng, PS (corresponding author), Minist Educ Peoples Republ China, Key Lab Environm & Genes Related Dis, Sect Canc Stem Cell Res, Xian 710061, Shaanxi, Peoples R China.	04203031@stu.xjtu.edu.cn; zpsheng@mail.xjtu.edu.cn			National Natural Science Foundation of China [81802946, 81472728, 81672910]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a to grant Dr XiaoFang Liu from the National Natural Science Foundation of China (No. 81802946) and Prof. Peng-Sheng Zheng from the National Natural Science Foundation of China (Nos. 81472728 and 81672910).	Anzai E, 2017, BIOL PHARM BULL, V40, P1483, DOI 10.1248/bpb.b17-00307; Aoyama T, 2010, J BIOL CHEM, V285, P29842, DOI 10.1074/jbc.M110.116319; Arai E, 2012, CARCINOGENESIS, V33, P1487, DOI 10.1093/carcin/bgs177; Astudillo H, 2004, J CLIN ONCOL, V22, p466S; Berkopec A, 2007, J DISCRET ALGORITHMS, V5, P341, DOI 10.1016/j.jda.2006.01.001; Boxberg M, 2019, AM J SURG PATHOL, V43, P303, DOI 10.1097/PAS.0000000000001178; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brivanlou AH, 2003, SCIENCE, V300, P913, DOI 10.1126/science.1082940; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chen Q, 2016, ONCOTARGET, V7, P36115, DOI 10.18632/oncotarget.8741; Cui N, 2016, ONCOTARGET, V7, P26152, DOI 10.18632/oncotarget.8434; Cui Y, 2016, ONCOL REP, V36, P108, DOI 10.3892/or.2016.4822; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Do Kim J, 2009, NUCLEIC ACIDS RES, V37, P5656, DOI 10.1093/nar/gkp613; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Garcia-Tunon I, 2011, STEM CELL RES, V7, P1, DOI 10.1016/j.scr.2011.02.005; Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329; Huang SY, 2007, CLIN CANCER RES, V13, P1362, DOI 10.1158/1078-0432.CCR-06-2313; Kamizono S, 2001, J BIOL CHEM, V276, P12530, DOI 10.1074/jbc.M010074200; Karpathiou G, 2019, HEAD NECK-J SCI SPEC, V41, P1918, DOI 10.1002/hed.25629; Kim BS, 2011, HUM GENE THER, V22, P1551, DOI 10.1089/hum.2011.096; Kim MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123133; Kumar L, 2007, BIOINFORMATION, V2, P5, DOI 10.6026/97320630002005; Lee MY, 2010, J CELL PHYSIOL, V224, P17, DOI 10.1002/jcp.22071; Liu XF, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0359-6; Mongan NP, 2006, MOL CARCINOGEN, V45, P887, DOI 10.1002/mc.20186; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Oka D, 2009, CANCER-AM CANCER SOC, V115, P3412, DOI 10.1002/cncr.24394; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Palko L, 2004, J CELL SCI, V117, P465, DOI 10.1242/jcs.00870; Qin HW, 2012, P NATL ACAD SCI USA, V109, P5004, DOI 10.1073/pnas.1117218109; Qureshi R, 2015, CANCER LETT, V356, P321, DOI 10.1016/j.canlet.2014.09.021; Raman JD, 2006, CARCINOGENESIS, V27, P499, DOI 10.1093/carcin/bgi299; Rizvi MMA, 2011, J CANCER RES CLIN, V137, P1255, DOI 10.1007/s00432-011-0994-0; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sobti RC, 2011, CELL ONCOL, V34, P533, DOI 10.1007/s13402-011-0056-2; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takemoto S, 2009, BRIT J CANCER, V101, P967, DOI 10.1038/sj.bjc.6605212; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Tewari KS, 2014, NEW ENGL J MED, V370, P734, DOI 10.1056/NEJMoa1309748; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang HY, 2015, ONCOTARGET, V6, P20711, DOI 10.18632/oncotarget.4133; Wu YZ, 2004, ONCOGENE, V23, P168, DOI 10.1038/sj.onc.1207003; Yang WT, 2012, CANCER-AM CANCER SOC, V118, P3691, DOI 10.1002/cncr.26698; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Zhang JJ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-130; Zhao GW, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0177-y; Zhou XC, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0911-3	52	36	38	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 24	2019	38	43					6940	6957		10.1038/s41388-019-0906-3	http://dx.doi.org/10.1038/s41388-019-0906-3			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JH4GX	31409905	hybrid			2022-12-26	WOS:000492728000005
J	Khoder-Agha, F; Harrus, D; Brysbaert, G; Lensink, MF; Harduin-Lepers, A; Glumoff, T; Kellokumpu, S				Khoder-Agha, Fawzi; Harrus, Deborah; Brysbaert, Guillaume; Lensink, Marc F.; Harduin-Lepers, Anne; Glumoff, Tuomo; Kellokumpu, Sakari			Assembly of B4GALT1/ST6GAL1 heteromers in the Golgi membranes involves lateral interactions via highly charged surface domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycosyltransferase; galactosyltransferase; ?-galactoside ?-2; 6-sialyltransferase 1 (ST6GAL1); protein complex; protein?protein interaction; molecular interplay	N-GLYCOSYLTRANSFERASES; WEB SERVER; COMPLEX; PH; ALPHA-2,6-SIALYLTRANSFERASE; FORM; ORGANIZATION; EXPRESSION; FEATURES; REVEALS	?-1,4-Galactosyltransferase 1 (B4GALT1) and ST6 ?-galactoside ?-2,6-sialyltransferase 1 (ST6GAL1) catalyze the successive addition of terminal ?-1,4?linked galactose and ?-2,6?linked sialic acid to N-glycans. Their exclusive interaction in the Golgi compartment is a prerequisite for their full catalytic activity, whereas a lack of this interaction is associated with cancers and hypoxia. To date, no structural information exists that shows how glycosyltransferases functionally assemble with each other. Using molecular docking simulations to predict interaction surfaces, along with mutagenesis screens and high-throughput FRET analyses in live cells to validate these predictions, we show here that B4GALT1 and ST6GAL1 interact via highly charged noncatalytic surfaces, leaving the active sites exposed and accessible for donor and acceptor substrate binding. Moreover, we found that the assembly of ST6GAL1 homomers in the endoplasmic reticulum before ST6GAL1 activation in the Golgi utilizes the same noncatalytic surface, whereas B4GALT1 uses its active-site surface for assembly, which silences its catalytic activity. Last, we show that the homomeric and heteromeric B4GALT1/ST6GAL1 complexes can assemble laterally in the Golgi membranes without forming cross-cisternal contacts between enzyme molecules residing in the opposite membranes of each Golgi cisterna. Our results provide detailed mechanistic insights into the regulation of glycosyltransferase interactions, the transitions between B4GALT1 and ST6GAL1 homo- and heteromers in the Golgi, and cooperative B4GALT1/ST6GAL1 function in N-glycan synthesis.	[Khoder-Agha, Fawzi; Harrus, Deborah; Glumoff, Tuomo; Kellokumpu, Sakari] Univ Oulu, Fac Biochem & Mol Med, Aapistie 7A, SF-90220 Oulu, Finland; [Brysbaert, Guillaume; Lensink, Marc F.; Harduin-Lepers, Anne] Univ Lille, CNRS, UMR 8576, UGSF, F-59000 Lille, France	University of Oulu; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Kellokumpu, S (corresponding author), Univ Oulu, Fac Biochem & Mol Med, Aapistie 7A, SF-90220 Oulu, Finland.	sakari.kellokumpu@oulu.fi	Khoder-Agha, Fawzi/G-5735-2019; Lensink, Marc F/A-1678-2008; Harduin-Lepers, Anne/O-7503-2017	Khoder-Agha, Fawzi/0000-0003-0784-4997; Lensink, Marc F/0000-0003-3957-9470; Brysbaert, Guillaume/0000-0002-6807-6621; Harrus, Deborah/0000-0002-7651-672X; Harduin-Lepers, Anne/0000-0002-1233-3799	Academy of Finland [285232]; CNRS	Academy of Finland(Academy of Finland); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by Academy of Finland Grant 285232 and CNRS. The authors declare that they have no conflicts of interest with the contents of this article.	Brauer P, 2019, SCIENCE, V363, P1103, DOI 10.1126/science.aaw2859; Datta AK, 2001, J BIOL CHEM, V276, P15200, DOI 10.1074/jbc.M010542200; Datta AK, 2009, CURR DRUG TARGETS, V10, P483, DOI 10.2174/138945009788488422; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engel BD, 2015, P NATL ACAD SCI USA, V112, P11264, DOI 10.1073/pnas.1515337112; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Harduin-Lepers A, 2000, BIOCHEM J, V352, P37, DOI 10.1042/0264-6021:3520037; Harduin-Lepers A., 2013, SIALOBIOLOGY STRUCTU, P85; Harrus D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205571; Harrus D, 2018, CELL MOL LIFE SCI, V75, P833, DOI 10.1007/s00018-017-2659-x; Hassinen A, 2019, REDOX BIOL, V24, DOI 10.1016/j.redox.2019.101182; Hassinen A, 2014, J BIOL CHEM, V289, P26937, DOI 10.1074/jbc.M114.595058; Hassinen A, 2011, J BIOL CHEM, V286, P38329, DOI 10.1074/jbc.M111.277681; Hassinen A, 2010, J BIOL CHEM, V285, P17771, DOI 10.1074/jbc.M110.103184; Kellokumpu S, 2016, CELL MOL LIFE SCI, V73, P305, DOI 10.1007/s00018-015-2066-0; Khoder-Agha F, 2019, CELL MOL LIFE SCI, V76, P1821, DOI 10.1007/s00018-019-03032-5; Kim SH, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124114; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Kuhn B, 2013, ACTA CRYSTALLOGR D, V69, P1826, DOI 10.1107/S0907444913015412; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135; Lee JH, 2001, J BIOL CHEM, V276, P13924, DOI 10.1074/jbc.M010046200; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; Meng L, 2013, J BIOL CHEM, V288, P34680, DOI 10.1074/jbc.M113.519041; Ramakrishnan B, 2004, BIOCHEMISTRY-US, V43, P12513, DOI 10.1021/bi049007+; Rivinoja A, 2006, J CELL PHYSIOL, V208, P167, DOI 10.1002/jcp.20653; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schneidman-Duhovny D, 2005, PROTEINS, V60, P224, DOI 10.1002/prot.20562; Soonthornsit J, 2014, EXP CELL RES, V328, P325, DOI 10.1016/j.yexcr.2014.09.009; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Varki A., 2017, ESSENTIALS GLYCOBIOL	30	16	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2019	294	39					14383	14393		10.1074/jbc.RA119.009539	http://dx.doi.org/10.1074/jbc.RA119.009539			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HH	31395657	Green Published, hybrid			2022-12-26	WOS:000499248200019
J	Perrier, A; Bonnin, A; Desmarets, L; Danneels, A; Goffard, A; Rouille, Y; Dubuisson, J; Belouzard, S				Perrier, Anabelle; Bonnin, Ariane; Desmarets, Lowiese; Danneels, Adeline; Goffard, Anne; Rouille, Yves; Dubuisson, Jean; Belouzard, Sandrine			The C-terminal domain of the MERS coronavirus M protein contains a trans-Golgi network localization signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						viral protein; protein motif; protein sorting; intracellular trafficking; endoplasmic reticulum (ER); coronavirus; MERS-CoV; Middle East respiratory syndrome; trans-Golgi network localization; plasma membrane	RESPIRATORY SYNDROME CORONAVIRUS; AVIAN CORONAVIRUS; CYTOPLASMIC TAIL; ENVELOPE PROTEIN; E1 GLYCOPROTEIN; RETENTION; ER; REPLICATION; TRAFFICKING; MATURATION	Coronavirus M proteins represent the major protein component of the viral envelope. They play an essential role during viral assembly by interacting with all of the other structural proteins. Coronaviruses bud into the endoplasmic reticulum (ER)?Golgi intermediate compartment (ERGIC), but the mechanisms by which M proteins are transported from their site of synthesis, the ER, to the budding site remain poorly understood. Here, we investigated the intracellular trafficking of the Middle East respiratory syndrome coronavirus (MERS-CoV) M protein. Subcellular localization analyses revealed that the MERS-CoV M protein is retained intracellularly in the trans-Golgi network (TGN), and we identified two motifs in the distal part of the C-terminal domain as being important for this specific localization. We identified the first motif as a functional diacidic DxE ER export signal, because substituting Asp-211 and Glu-213 with alanine induced retention of the MERS-CoV M in the ER. The second motif, (199)KxGxYR(204), was responsible for retaining the M protein in the TGN. Substitution of this motif resulted in MERS-CoV M leakage toward the plasma membrane. We further confirmed the role of (199)KxGxYR(204) as a TGN retention signal by using chimeras between MERS-CoV M and the M protein of infectious bronchitis virus (IBV). Our results indicated that the C-terminal domains of both proteins determine their specific localization, namely TGN and ERGIC/cis-Golgi for MERS-M and IBV-M, respectively. Our findings indicate that MERS-CoV M protein localizes to the TGN because of the combined presence of an ER export signal and a TGN retention motif.	[Perrier, Anabelle; Bonnin, Ariane; Desmarets, Lowiese; Danneels, Adeline; Goffard, Anne; Rouille, Yves; Dubuisson, Jean; Belouzard, Sandrine] Univ Lille, CHU Lille, Inst Pasteur Lille, CNRS,INSERM,Ctr Infect & Immun Lille,U1019 UMR 82, F-59000 Lille, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille	Belouzard, S (corresponding author), Univ Lille, CHU Lille, Inst Pasteur Lille, CNRS,INSERM,Ctr Infect & Immun Lille,U1019 UMR 82, F-59000 Lille, France.	sandrine.belouzard@ibl.cnrs.fr	Belouzard, Sandrine/O-8527-2016; Belouzard, Sandrine/AAX-1584-2021; GOFFARD, Anne/GXG-6242-2022; Dubuisson, Jean/E-6813-2016; Goffard, Anne/G-5488-2016	Belouzard, Sandrine/0000-0002-9972-4054; Belouzard, Sandrine/0000-0002-9972-4054; Dubuisson, Jean/0000-0003-1626-7693; Desmarets, Lowiese/0000-0001-5077-3333; Rouille, Yves/0000-0003-0788-9271; Goffard, Anne/0000-0002-6521-9711	Visionn-AIRR grant from Region Hauts-de-France; University of Lille; Region Hauts-de-France	Visionn-AIRR grant from Region Hauts-de-France; University of Lille; Region Hauts-de-France(Region Hauts-de-France)	This work was supported by a Visionn-AIRR grant from Region Hauts-de-France. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a fellowship from the University of Lille and the Region Hauts-de-France.; Supported by a fellowship from the Region Hauts-de-France.	ARMSTRONG J, 1991, J CELL SCI, V98, P567; Arndt AL, 2010, J VIROL, V84, P11418, DOI 10.1128/JVI.01131-10; Baudoux P, 1998, J VIROL, V72, P8636, DOI 10.1128/JVI.72.11.8636-8643.1998; Belouzard S, 2012, VIRUSES-BASEL, V4, P1011, DOI 10.3390/v4061011; BOS K, 1993, EMBO J, V12, P2219, DOI 10.1002/j.1460-2075.1993.tb05870.x; Corman VM, 2018, ADV VIRUS RES, V100, P163, DOI 10.1016/bs.aivir.2018.01.001; de Haan CAM, 2000, J VIROL, V74, P4967, DOI 10.1128/JVI.74.11.4967-4978.2000; de Haan CAM, 1998, J VIROL, V72, P6838, DOI 10.1128/JVI.72.8.6838-6850.1998; de Haan CAM, 2005, ADV VIRUS RES, V64, P165, DOI 10.1016/S0065-3527(05)64006-7; de Haan CAM, 1999, J VIROL, V73, P7441, DOI 10.1128/JVI.73.9.7441-7452.1999; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Geva Y, 2014, CURR BIOL, V24, pR130, DOI 10.1016/j.cub.2013.12.008; Heald-Sargent T, 2012, VIRUSES-BASEL, V4, P557, DOI 10.3390/v4040557; Heffernan LF, 2014, BIOCHEM SOC T, V42, P1453, DOI 10.1042/BST20140178; KLUMPERMAN J, 1994, J VIROL, V68, P6523, DOI 10.1128/JVI.68.10.6523-6534.1994; Lim KP, 2001, J BIOL CHEM, V276, P17515, DOI 10.1074/jbc.M009731200; LOCKER JK, 1995, J BIOL CHEM, V270, P8815, DOI 10.1074/jbc.270.15.8815; LOCKER JK, 1992, J BIOL CHEM, V267, P14094; LOCKER JK, 1994, J BIOL CHEM, V269, P28263; MACHAMER CE, 1987, J CELL BIOL, V105, P1205, DOI 10.1083/jcb.105.3.1205; MACHAMER CE, 1993, MOL BIOL CELL, V4, P695, DOI 10.1091/mbc.4.7.695; MACHAMER CE, 1990, P NATL ACAD SCI USA, V87, P6944, DOI 10.1073/pnas.87.18.6944; Masters PS, 2006, ADV VIRUS RES, V66, P193, DOI 10.1016/S0065-3527(06)66005-3; McBride CE, 2010, J VIROL, V84, P1891, DOI 10.1128/JVI.02458-09; Nal B, 2005, J GEN VIROL, V86, P1423, DOI 10.1099/vir.0.80671-0; Nieto-Torres JL, 2015, VIRUSES-BASEL, V7, P3552, DOI 10.3390/v7072786; OPSTELTEN DJE, 1995, J CELL BIOL, V131, P339, DOI 10.1083/jcb.131.2.339; Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147; PONNAMBALAM S, 1994, J CELL BIOL, V125, P253, DOI 10.1083/jcb.125.2.253; Puthenveedu MA, 2005, CURR OPIN CELL BIOL, V17, P369, DOI 10.1016/j.ceb.2005.06.006; Ruch TR, 2012, VIRUSES-BASEL, V4, P363, DOI 10.3390/v4030363; Salanueva IJ, 1999, J VIROL, V73, P7952, DOI 10.1128/JVI.73.10.7952-7964.1999; Siu YL, 2008, J VIROL, V82, P11318, DOI 10.1128/JVI.01052-08; Tseng YT, 2010, J BIOL CHEM, V285, P12862, DOI 10.1074/jbc.M109.030270; Tu LN, 2010, CELL MOL LIFE SCI, V67, P29, DOI 10.1007/s00018-009-0126-z; Venditti R, 2014, TRENDS CELL BIOL, V24, P9, DOI 10.1016/j.tcb.2013.08.005; Vennema H, 1996, EMBO J, V15, P2020, DOI 10.1002/j.1460-2075.1996.tb00553.x; Votsmeier C, 2001, EMBO J, V20, P6742, DOI 10.1093/emboj/20.23.6742; Waguri S, 2003, MOL BIOL CELL, V14, P142, DOI 10.1091/mbc.E02-06-0338; Westerbeck JW, 2019, J VIROL, V93, DOI [10.1128/JVI.00015-19, 10.1128/jvi.00015-19]; Westerbeck JW, 2015, J VIROL, V89, P9313, DOI 10.1128/JVI.01237-15; Yang YA, 2013, PROTEIN CELL, V4, P331, DOI 10.1007/s13238-013-2093-2	42	56	61	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2019	294	39					14406	14421		10.1074/jbc.RA119.008964	http://dx.doi.org/10.1074/jbc.RA119.008964			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HH	31399512	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000499248200021
J	Jin, L; Ouyang, N; Huang, Y; Liu, CL; Ruan, Y				Jin, Lu; Ouyang, Ning; Huang, Yong; Liu, Chunlin; Ruan, Ying			Genome-wide analysis of sulfotransferase genes and their responses to abiotic stresses in Chinese cabbage (Brassica rapa L.)	PLOS ONE			English	Article							TYROSYLPROTEIN SULFOTRANSFERASE; ARABIDOPSIS; IDENTIFICATION; PROTEIN; SULFATION; ACID; RESISTANCE; PAPS; RNA	Sulfotransferases (SOTs; EC 2.8.2.-), which are widespread from prokaryotes to eukaryotes, constitute a multi-protein family that plays crucial roles in plant growth, development and stress adaptation. However, this family has not been systemically investigated in Brassica rapa. Here, a genome-wide systemic analysis of SOT genes in B. rapa subsp. pekinensis, a globally cultivated vegetable, were conducted. We identified 56 SOT genes from the whole B. rapa genome using Arabidopsis SOT sequences as queries and classified them into nine groups, rather than the eight groups of previous research. 56 B. rapa SOT genes (BraSOTs) were distributed on all 10 chromosomes except for chromosome 5. Of these, 27 BraSOTs were distributed in seven clusters on five chromosomes (ChrA01, ChrA02, Chr03, ChrA07, and Chr09). Among the BraSOT proteins, 48 had only one SOT_1 domain and 6 had two, while 2 had one SOT_3 domain. Additionally, 47 BraSOT proteins contained only known SOT domains. The remaining nine proteins, five in group-VW and two in group-IX, contained additional transmembrane domains. Specific motif regions I and IV for 3'-phosphoadenosine 5'-phosphosulfate binding were found in 41 BraSOT proteins. Introns were present in only 18 BraSOT genes, and all seven BraSOT genes in groups VIII and IX had more than three introns. To identify crucial SOTs mediating the response to abiotic stress in B. rapa, expression changes in 56 BraSOT genes were determined by quantitative RT-PCR after drought, salinity, and ABA treatments, and some BraSOT genes were associated with NaCl, drought and ABA stress, e.g. Bra017370, Bra009300, Bra027880.	[Jin, Lu; Ouyang, Ning; Huang, Yong; Ruan, Ying] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Hunan, Peoples R China; [Jin, Lu; Ouyang, Ning; Huang, Yong; Ruan, Ying] Key Lab Crop Epigenet Regulat & Dev Hunan Prov, Changsha, Hunan, Peoples R China; [Jin, Lu; Ouyang, Ning; Huang, Yong; Ruan, Ying] Educ Dept Hunan Prov, Key Lab Plant Genet & Mol Biol, Changsha, Hunan, Peoples R China; [Liu, Chunlin] Hunan Agr Univ, Agr Coll, Changsha, Hunan, Peoples R China	Hunan Agricultural University; Hunan Agricultural University	Ruan, Y (corresponding author), Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Hunan, Peoples R China.; Ruan, Y (corresponding author), Key Lab Crop Epigenet Regulat & Dev Hunan Prov, Changsha, Hunan, Peoples R China.; Ruan, Y (corresponding author), Educ Dept Hunan Prov, Key Lab Plant Genet & Mol Biol, Changsha, Hunan, Peoples R China.	yingruan@hotmail.com	, 江上鸥飞/AHA-6713-2022	, 江上鸥飞/0000-0002-3163-1716; ning, ouyang/0000-0001-6459-4686	National Key R&D Program of China [2016YFD0100202-8]; Hunan Provincial Education Department Project [17K045, 16K041]; Hunan Provincial Innovation Foundation for Postgraduate [CX2017B362]	National Key R&D Program of China; Hunan Provincial Education Department Project; Hunan Provincial Innovation Foundation for Postgraduate	National Key R&D Program of China (2016YFD0100202-8) and Hunan Provincial Education Department Project (17K045, 16K041) funded all reagent used in the research and paid the salaries. Lu J has received funding from Hunan Provincial Innovation Foundation for Postgraduate (CX2017B362). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert VA, 2013, SCIENCE, V342, P1467, DOI 10.1126/science.1241089; Aoki K, 1997, FEBS LETT, V401, P109, DOI 10.1016/S0014-5793(96)01444-5; Baek D, 2010, PLANT CELL ENVIRON, V33, P1383, DOI 10.1111/j.1365-3040.2010.02156.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Chen JH, 2015, PLANT CELL ENVIRON, V38, P1673, DOI 10.1111/pce.12525; Chen RJ, 2012, GENES GENOM, V34, P549, DOI 10.1007/s13258-012-0053-5; Cheng XY, 2014, TIANJIN AGR SCI, V20, P109; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gidda SK, 2006, PLANT PHYSIOL BIOCH, V44, P628, DOI 10.1016/j.plaphy.2006.10.004; Hanai H, 2000, FEBS LETT, V470, P97, DOI 10.1016/S0014-5793(00)01299-0; Hashiguchi T, 2014, J BIOCHEM, V155, P91, DOI 10.1093/jb/mvt102; Hashiguchi T, 2013, BIOCHEM BIOPH RES CO, V434, P829, DOI 10.1016/j.bbrc.2013.04.022; Hirschmann F, 2015, PLANT PHYSIOL BIOCH, V91, P10, DOI 10.1016/j.plaphy.2015.03.009; Hirschmann F, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00556; Holub EB, 2001, NAT REV GENET, V2, P516, DOI 10.1038/35080508; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; James MO, 2014, METHODS MOL BIOL, V1113, P187, DOI 10.1007/978-1-62703-758-7_10; Kauffman Frederick C, 1994, CONJUGATION DECONJUG, P45, DOI [10.1007/978-3-642-78429-3, DOI 10.1007/978-3-642-78429-3]; Klaassen CD, 1997, FASEB J, V11, P404, DOI 10.1096/fasebj.11.6.9194521; Klein M, 2004, J EXP BOT, V55, P1809, DOI 10.1093/jxb/erh183; Klein Marion, 2008, P149, DOI 10.1007/978-3-540-76326-0_7; Komori R, 2009, P NATL ACAD SCI USA, V106, P15067, DOI 10.1073/pnas.0902801106; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Lacomme C, 1996, PLANT MOL BIOL, V30, P995, DOI 10.1007/BF00020810; Lee SC, 2012, PLANT CELL ENVIRON, V35, P53, DOI 10.1111/j.1365-3040.2011.02426.x; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MANTHEY GM, 1995, EMBO J, V14, P4031, DOI 10.1002/j.1460-2075.1995.tb00074.x; Marsolais F, 1995, J BIOL CHEM, V270, P30458, DOI 10.1074/jbc.270.51.30458; Marsolais F, 2007, PLANTA, V225, P1233, DOI 10.1007/s00425-006-0413-y; NIEHRS C, 1994, CHEM-BIOL INTERACT, V92, P257, DOI 10.1016/0009-2797(94)90068-X; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Osakabe Y, 2014, NEW PHYTOL, V202, P35, DOI 10.1111/nph.12613; Qin F, 2011, PLANT CELL PHYSIOL, V52, P1569, DOI 10.1093/pcp/pcr106; Sebastia Varin L, 2008, SULFOTRANSFERASES PL, DOI [10.1007/978-1-4020-6863-8_6, DOI 10.1007/978-1-4020-6863-8_6]; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Varin L, 1997, PLANT J, V12, P831, DOI 10.1046/j.1365-313X.1997.12040831.x; Wang Q, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5768; Weinshilboum RM, 1997, FASEB J, V11, P3, DOI 10.1096/fasebj.11.1.9034160; Zang YX, 2009, FEBS J, V276, P3559, DOI 10.1111/j.1742-4658.2009.07076.x; Zhao LM, 2013, CURR GENOMICS, V14, P214, DOI 10.2174/1389202911314030007	41	4	5	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0221422	10.1371/journal.pone.0221422	http://dx.doi.org/10.1371/journal.pone.0221422			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5MK	31425555	Green Published, gold, Green Submitted			2022-12-26	WOS:000485022400043
J	Beargie, SM; Higgins, CR; Evans, DR; Laing, SK; Erim, D; Ozawa, S				Beargie, Sarah M.; Higgins, Colleen R.; Evans, Daniel R.; Laing, Sarah K.; Erim, Daniel; Ozawa, Sachiko			The economic impact of substandard and falsified antimalarial medications in Nigeria	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; SULFADOXINE-PYRIMETHAMINE; ARTEMETHER-LUMEFANTRINE; ARTESUNATE-AMODIAQUINE; AFRICAN CHILDREN; EFFICACY; QUALITY; CHLOROQUINE; LIMITATIONS; QUININE	Introduction Substandard and falsified medications pose significant risks to global health. Nearly one in five antimalarials circulating in low- and middle-income countries are substandard or falsified. We assessed the health and economic impact of substandard and falsified antimalarials on children under five in Nigeria, where malaria is endemic and poor-quality medications are commonplace. Methods We developed a dynamic agent-based SAFARI (Substandard and Falsified Antimalarial Research Impact) model to capture the impact of antimalarial use in Nigeria. The model simulated children with background characteristics, malaria infections, patient care-seeking, disease progression, treatment outcomes, and incurred costs. Using scenario analyses, we simulated the impact of substandard and falsified medicines, antimalarial resistance, as well as possible interventions to improve the quality of treatment, reduce stock-outs, and educate caregivers about antimalarial quality. Results We estimated that poor quality antimalarials are responsible for 12,300 deaths and $892 million ($890-$893 million) in costs annually in Nigeria. If antimalarial resistance develops, we simulated that current costs of malaria could increase by $839 million (11% increase, $837-$841 million). The northern regions of Nigeria have a greater burden as compared to the southern regions, with 9,700 deaths and $698 million ($697-$700 million) in total economic losses annually due to substandard and falsified antimalarials. Furthermore, our scenario analyses demonstrated that possible interventions-such as removing stock-outs in all facilities ($1.11 billion), having only ACTs available for treatment ($594 million), and 20% more patients seeking care ($469 million)-can save hundreds of millions in costs annually in Nigeria. Conclusions The results highlight the significant health and economic burden of poor quality antimalarials in Nigeria, and the impact of potential interventions to counter them. In order to reduce the burden of malaria and prevent antimalarials from developing resistance, policymakers and donors must understand the problem and implement interventions to reduce the impact of ineffective and harmful antimalarials.	[Beargie, Sarah M.; Higgins, Colleen R.; Laing, Sarah K.; Ozawa, Sachiko] Univ N Carolina, Div Practice Adv & Clin Educ, UNC Eshelman Sch Pharm, Chapel Hill, NC 27515 USA; [Evans, Daniel R.] Duke Univ, Sch Med, Durham, NC USA; [Erim, Daniel] RTI Int, Qual Measurement & Hlth Policy Grp, Res Triangle Pk, NC USA; [Ozawa, Sachiko] Univ N Carolina, Dept Maternal & Child Hlth, UNC Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; Duke University; Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill	Ozawa, S (corresponding author), Univ N Carolina, Div Practice Adv & Clin Educ, UNC Eshelman Sch Pharm, Chapel Hill, NC 27515 USA.; Ozawa, S (corresponding author), Univ N Carolina, Dept Maternal & Child Hlth, UNC Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA.	ozawa@unc.edu	; Ozawa, Sachiko/D-4399-2014	Evans, Daniel/0000-0002-9818-5001; Ozawa, Sachiko/0000-0001-7608-9038				ACTwatch Group SFH, 2015, ACTWATCH STUD REF DO; Adjuik M, 2002, LANCET, V359, P1365, DOI 10.1016/S0140-6736(02)08348-4; Affum AO, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-220; Aina BA, 2008, J INFECT DEV COUNTR, V2, P68, DOI 10.3855/jidc.325; ATTARAN A, 2012, BMJ-BRIT MED J, V345, DOI DOI 10.1136/BMJ.E7381; Atwine D, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001119; Bate R, 2010, RES REP TROP MED, V1, P19, DOI 10.2147/RRTM.S13242; Blackstone EA, 2014, AM HEALTH DRUG BENEF, V7, P216; Bruxvoort K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134275; Bruxvoort K, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0602-x; Buckley G.J., 2013, COUNTERING PROBLEM F, DOI 10.17226/18272; Camponovo F, 2017, MALARIA J, V16, DOI 10.1186/s12936-016-1650-6; Central Bank of Nigeria, 2018, MONTHL AV EXCH RAT N; Dapel Z., 2018, POVERTY NIGERIA UNDE; Davis B, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-135; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Erhun WO., 2001, J HLTH POPULATION DE, V4, P23; Evans DR, 2019, HLTH POLICY PLANNING; Ezeoke OP, 2012, AM J TROP MED HYG, V86, P52, DOI 10.4269/ajtmh.2012.11-0090; Falade C, 2005, T ROY SOC TROP MED H, V99, P459, DOI 10.1016/j.trstmh.2004.09.013; Falade CO, 2014, MED PRIN PRACT, V23, P204, DOI 10.1159/000360578; Farrar J, 2014, MANSONS TROPICAL INF, pxi, DOI [10.1016/b978-0-7020-5101-2.00094-7, DOI 10.1016/B978-0-7020-5101-2.00094-7]; Fatokun O, 2016, LANCET, V388, P2603, DOI 10.1016/S0140-6736(16)32121-3; Faucher JF, 2009, J INFECT DIS, V200, P57, DOI 10.1086/599378; Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85; Garuba HA, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-14; Gomez-Ramirez J, 2013, PROG BIOPHYS MOL BIO, V113, P80, DOI 10.1016/j.pbiomolbio.2013.03.008; Grandesso F, 2006, T ROY SOC TROP MED H, V100, P419, DOI 10.1016/j.trstmh.2005.07.017; Idowu O A, 2006, Tanzan Health Res Bull, V8, P45; Ioset JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007270; Kaur H, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1096-x; Kaur H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125577; Lubell Y, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-452; Lubell Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017439; Nahum A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-37; National Malaria Elimination Programme-NMEP/ Nigeria National Population Commission-NPC/ Nigeria National Bureau of Statistics-NBS/ Nigeria ICF International, 2016, NIG MAL IND SURV 201; National Population Commission (NPC) [Nigeria] and ICF International, 2014, NIG DEM HLTH SURV 20; Nyarko Samuel Harrenson, 2014, Malar Res Treat, V2014, P304361, DOI 10.1155/2014/304361; Obieche OA, 2016, MWJ, V7; Ochekpe NA, 2010, INT J DRUG DEV RES, V2, P211; Onwujekwe O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078362; Onwujekwe O, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-22; Ozawa S, 2019, AM J TROP MED HYG, V100, P1149, DOI 10.4269/ajtmh.18-0334; Ozawa S, 2019, MALARIA J, V18, DOI 10.1186/s12936-018-2628-3; Ozawa S, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.1662; President's Malaria Initiative, 2019, NIG MAL OP PLAN FY 2; Ramharter M, 2005, CLIN INFECT DIS, V40, P1777, DOI 10.1086/430309; Renschler JP, 2015, AM J TROP MED HYG, V92, P119, DOI 10.4269/ajtmh.14-0725; Sabartova J, 2011, SURVEY QUALITY SELEC; Salihu O, 2013, J EC SUSTAINABLE DEV, V4; Taylor RB, 2001, LANCET, V357, P1933, DOI 10.1016/S0140-6736(00)05065-0; UNICEF, 2019, CHILD MORT EST NEW Y; Verret WJ, 2011, ANTIMICROB AGENTS CH, V55, P2629, DOI 10.1128/AAC.01727-10; White NJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-253; WHO, 2018, MAL CHILDR 5; WHO, 2018, WORLD MAL REP 2018; World Health Organization, 2017, WHO PARTN TAK MAL TO; World Health Organization, 2017, DEPRESSION; World Health Organization (WHO), 2017, 1 10 MED PROD DEV CO; Xie Y, 2011, RES SOC STRAT MOBIL, V29, P343, DOI 10.1016/j.rssm.2011.04.001; Yeka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053772; Zongo I, 2005, AM J TROP MED HYG, V73, P826, DOI 10.4269/ajtmh.2005.73.826	62	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0217910	10.1371/journal.pone.0217910	http://dx.doi.org/10.1371/journal.pone.0217910			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415560	gold, Green Published, Green Submitted			2022-12-26	WOS:000485017200002
J	Khajehnejad, M				Khajehnejad, Moein			SimNet: Similarity-based network embeddings with mean commute time	PLOS ONE			English	Article							COMPUTATION; GRAPH	In this paper, we propose a new approach for learning node embeddings for weighted undirected networks. We perform a random walk on the network to extract the latent structural information and perform node embedding learning under a similarity-based framework. Unlike previous works, we apply a different criterion to capture the proximity information between nodes in a network, and use it for improved modeling of similarities between nodes. We show that the mean commute time (MCT) between two nodes, defined as the average time a random walker takes to reach a target node and return to the source, plays a crucial role in quantifying the actual degree of proximity between two nodes of the network. We then introduce a novel definition of a similarity matrix that is based on the pair-wise mean commute time captured, which enables us to adequately represent the connection of similar nodes. We utilize pseudoinverse of the Laplacian matrix of the graph for calculating such a proximity measure, capturing rich structural information out of the graph for learning more adequate node representations of a network. The results of different experiments on three real-world networks demonstrate that our proposed method outperforms existing related efforts in classification, clustering, visualization as well as link prediction tasks.	[Khajehnejad, Moein] Max Planck Inst Software Syst MPI SWS, Saarbrucken, Germany	Max Planck Society	Khajehnejad, M (corresponding author), Max Planck Inst Software Syst MPI SWS, Saarbrucken, Germany.	mkhajehn@mpi-sws.org		Khajehnejad, Moein/0000-0002-2185-4596	MOE Tier 1 Grant [SUTDT12015008]	MOE Tier 1 Grant(Ministry of Education, Singapore)	This work was supported by MOE Tier 1 Grant SUTDT12015008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldous David J., 1995, REVERSIBLE MARKOV CH; [Anonymous], 2000, WORKSH ART INT WEB S; Burda Z, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.160602; Cao S, 2016, 13 AAAI C ART INT; Chen K., 2013, ADV NEURAL INF PROCE, V26, P3111, DOI DOI 10.5555/2999792.2999959; Cheng X, 2011, ACM SIGCOMM COMP COM, V41, P39, DOI 10.1145/1971162.1971168; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fouss F, 2006, IEEE DATA MINING, P863; Fouss F, 2007, IEEE T KNOWL DATA EN, V19, P355, DOI 10.1109/TKDE.2007.46; Grinstead C.M., 2012, INTRO PROBABILITY; Grover A, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P855, DOI 10.1145/2939672.2939754; Katz L., 1953, PSYCHOMETRIKA, V18, P39, DOI [DOI 10.1007/BF02289026, 10.1007/BF02289026]; Kemeny J. G., 1960, FINITE MARKOV CHAINS; KLEMA VC, 1980, IEEE T AUTOMAT CONTR, V25, P164, DOI 10.1109/TAC.1980.1102314; Levy O., 2015, T ASS COMPUT LINGUIS, V3, P211, DOI [10.1162/tacl_a_00134, DOI 10.1162/TACL_A_00134]; Levy O, 2014, ADV NEUR IN, V27; Liang B, 2015, INT CONF SOFTW ENG, P894, DOI 10.1109/ICSESS.2015.7339198; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Page Lawrence, 1999, 199966 STANF INFOLAB; Pennington J, 2014, EMNLP, V14, P1532, DOI DOI 10.3115/V1/D14-1162; Perozzi Bryan, 2014, KDD, P701, DOI DOI 10.1145/2623330.2623732; Salton G, 1983, INTRO MODERN INFORM; Sen P, 2008, AI MAG, V29, P93, DOI 10.1609/aimag.v29i3.2157; Shi J., 2000, DEP PAPERS CIS, P107; Skardal PS, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.144101; Tang J, 2015, PROCEEDINGS OF THE 24TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW 2015), P1067, DOI 10.1145/2736277.2741093; Tian F., 2014, 28 AAAI C ART INT; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wang Hongwei, 2018, 32 AAAI C ART INT; Wang HJ, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022801; Wu Z., 2019, 190100596 ARXIV; Yang ZM, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.056106; Yen L., 2005, P 13 S ART NEUR NETW, P317; Yen L., 2008, P 14 SIGKDD INT C KN, P785, DOI DOI 10.1145/1401890.1401984; Yen L, 2007, LECT NOTES COMPUT SC, V4426, P1037; Zhang ZZ, 2011, EUR PHYS J B, V84, P691, DOI 10.1140/epjb/e2011-20834-1; Zhou CS, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.034101; Zhu X., 2007, HLT NAACL, P97	40	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0221172	10.1371/journal.pone.0221172	http://dx.doi.org/10.1371/journal.pone.0221172			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415635	Green Published, gold, Green Submitted			2022-12-26	WOS:000485017200087
J	Konigstein, K; Infanger, D; Bertelsen, RJ; Johannessen, A; Waje-Andreassen, U; Schmidt-Trucksass, A; Svanes, C; Dratva, J				Konigstein, Karsten; Infanger, Denis; Bertelsen, Randi Jacobsen; Johannessen, Ane; Waje-Andreassen, Ulrike; Schmidt-Trucksass, Arno; Svanes, Cecilie; Dratva, Julia			Is atopic sensitization associated with indicators of early vascular ageing in adolescents?	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; C-REACTIVE PROTEIN; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; YOUNG-ADULTS; RISK-FACTORS; FOAM CELLS; CHILDREN; ASTHMA; LDL	Background Chronic systemic inflammation accelerates early vascular ageing. Atopic sensitization and allergic diseases may involve increased inflammatory activity. This study aimed to assess whether atopic sensitization and allergic diseases were associated with altered vascular biomarkers in Norwegian adolescents. Methods Distensibility coefficient of the common carotid arteries, carotid intima-media thickness and atopic sensitization (serum total and specific IgEs) were assessed in 95 Norwegian adolescents, who participated in the RHINESSA generation study. Symptoms of allergic disease were assessed by an interviewer-led questionnaire. Results Atopic sensitization was found in 33 (34.7%) of the adolescents. Symptomatic allergic disease was found in 11 (33.3%) of those with atopic sensitization. Distensibility coefficient of the common carotid arteries appeared to be lower in participants with atopic sensitization than in those without (46.99 +/- 8.07*10(-3)/kPa versus 51.50 +/- 11.46* 10-3 /kPa; p>0.05), while carotid intima-media thickness did not differ between these groups (0.50 +/- 0.04mm versus 0.50 +/- 0.04mm; p>0.05). Crude, as well as age-and sex-adjusted multiple regression, revealed no significant association, neither of atopic sensitization nor of allergic disease, with distensibility coefficient of the common carotid arteries and carotid intima-media thickness. Conclusions Our results do not support the assumption of an adverse impact of atopic sensitization and/or allergic disease on distensibility coefficient of the common carotid arteries and carotid intima-media thickness in Norwegian adolescents. Further research is necessary to study whether the clinical severity of allergic diseases might be more important than the status of allergic disease or atopic sensitization.	[Konigstein, Karsten; Infanger, Denis; Schmidt-Trucksass, Arno] Univ Basel, Div Sports & Exercise Med, Dept Sport Exercise & Hlth, Basel, Switzerland; [Bertelsen, Randi Jacobsen] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Bertelsen, Randi Jacobsen; Johannessen, Ane; Svanes, Cecilie] Haukeland Hosp, Dept Occupat Med, Bergen, Norway; [Johannessen, Ane; Svanes, Cecilie] Univ Bergen, Dept Global Publ Hlth & Primary Care, Ctr Int Hlth, Bergen, Norway; [Waje-Andreassen, Ulrike] Haukeland Hosp, Dept Neurol, Bergen, Norway; [Dratva, Julia] Univ Basel, Med Fac, Basel, Switzerland; [Dratva, Julia] ZHAW, Sch Hlth Profess, Winterthur, Switzerland	University of Basel; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Basel; Zurich University of Applied Sciences	Konigstein, K (corresponding author), Univ Basel, Div Sports & Exercise Med, Dept Sport Exercise & Hlth, Basel, Switzerland.	k.koenigstein@unibas.ch	Schmidt-Trucksäss, Arno/I-7673-2015; Svanes, Cecilie/N-7556-2017	Schmidt-Trucksäss, Arno/0000-0002-4662-3911; Svanes, Cecilie/0000-0001-8512-5192; Infanger, Denis/0000-0001-9028-7110; Johannessen, Ane/0000-0003-3269-8354; Konigstein, Karsten/0000-0002-2994-8570				Barnard J, 1999, BIOMETRIKA, V86, P948, DOI 10.1093/biomet/86.4.948; Berenson GS, 2002, AM J CARDIOL, V90, p3L, DOI 10.1016/S0002-9149(02)02953-3; Cakmak A, 2010, ASIAN PAC J ALLERGY, V28, P256; Celermajer DS, 1996, NEW ENGL J MED, V334, P150, DOI 10.1056/NEJM199601183340303; Chang MK, 2002, P NATL ACAD SCI USA, V99, P13043, DOI 10.1073/pnas.192399699; Dalla Pozza R, 2007, J CLIN ENDOCR METAB, V92, P2053, DOI 10.1210/jc.2006-2868; Dalla Pozza R, 2015, ATHEROSCLEROSIS, V238, P380, DOI 10.1016/j.atherosclerosis.2014.12.029; Doyon A, 2013, HYPERTENSION, V62, P550, DOI 10.1161/HYPERTENSIONAHA.113.01297; Dratva J, 2015, ATHEROSCLEROSIS, V243, P609, DOI 10.1016/j.atherosclerosis.2015.10.021; Dwyer JH, 2004, NEW ENGL J MED, V350, P29, DOI 10.1056/NEJMoa025079; Elkiran O, 2013, INT J CARDIOL, V165, P528, DOI 10.1016/j.ijcard.2011.09.080; Endes S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163844; Evelein AMV, 2015, EUR J PREV CARDIOL, V22, P1480, DOI 10.1177/2047487314554863; Fernberg U, 2017, EUR J PREV CARDIOL, V24, P1809, DOI 10.1177/2047487317720796; Ferreira I, 2012, HYPERTENSION, V59, P54, DOI 10.1161/HYPERTENSIONAHA.110.156109; Goksor E, 2007, ACTA PAEDIATR, V96, P1030, DOI 10.1111/j.1651-2227.2007.00296.x; Horta BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074301; Juliusson PB, 2013, ANN HUM BIOL, V40, P220, DOI 10.3109/03014460.2012.759276; Kallio K, 2010, CIRC-CARDIOVASC QUAL, V3, P196, DOI 10.1161/CIRCOUTCOMES.109.857771; Knoflach M, 2005, ARCH INTERN MED, V165, P2521, DOI 10.1001/archinte.165.21.2521; Kovanen PT, 2007, IMMUNOL REV, V217, P105, DOI 10.1111/j.1600-065X.2007.00515.x; Lamotte C, 2011, EUR J PEDIATR, V170, P719, DOI 10.1007/s00431-010-1328-y; Levitan I, 2010, ANTIOXID REDOX SIGN, V13, P39, DOI 10.1089/ars.2009.2733; Liuba P, 2005, ACTA PAEDIATR, V94, P643, DOI 10.1080/08035250510026319; Liuba P, 2003, EUR HEART J, V24, P517, DOI 10.1016/S0195-668X(02)00750-9; Ma H, 2000, ARTERIOSCL THROM VAS, V20, pE134, DOI 10.1161/01.ATV.20.12.e134; MA H, 1995, ARTERIOSCL THROM VAS, V15, P811, DOI 10.1161/01.ATV.15.6.811; Marciniak-Sroka J, 2011, POL ARCH MED WEWN, V121, P109, DOI 10.20452/pamw.1036; Matsuura E, 2008, AUTOIMMUN REV, V7, P558, DOI 10.1016/j.autrev.2008.04.018; Potaczek DP, 2014, INT J CARDIOL, V170, P278, DOI 10.1016/j.ijcard.2013.11.029; Rasmussen F, 2000, EUR RESPIR J, V16, P866, DOI 10.1183/09031936.00.16586600; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Rosenfeld ME, 2011, THROMB HAEMOSTASIS, V106, P858, DOI 10.1160/TH11-06-0392; Sicherer SH, 2012, PEDIATRICS, V129, P193, DOI 10.1542/peds.2011-2382; Skilton MR, 2011, ARTERIOSCL THROM VAS, V31, P2975, DOI 10.1161/ATVBAHA.111.234757; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Tabuchi M, 2007, J LIPID RES, V48, P768, DOI 10.1194/jlr.M600414-JLR200; Teynor A, 2012, ULTRASOUND MED BIOL, V38, P1440, DOI 10.1016/j.ultrasmedbio.2012.03.015; Togias Alkis, 2004, Journal of Allergy and Clinical Immunology, V113, pS8, DOI 10.1016/j.jaci.2003.09.051; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; TOUBOUL PJ, 1992, J HYPERTENS, V10, pS37, DOI 10.1097/00004872-199207005-00006; van Buuren S., 2018, FLEXIBLE IMPUTATION, V2nd, DOI DOI 10.1201/9780429492259; van Buuren S, 2011, J STAT SOFTW, V45, P1; Wang J, 2011, J CLIN INVEST, V121, P3564, DOI 10.1172/JCI46028; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wick G, 2004, ANNU REV IMMUNOL, V22, P361, DOI 10.1146/annurev.immunol.22.012703.104644; Zeyrek D, 2009, PEDIATR ALLERGY IMMU, V20, P370, DOI 10.1111/j.1399-3038.2008.00780.x	47	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220198	10.1371/journal.pone.0220198	http://dx.doi.org/10.1371/journal.pone.0220198			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415591	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000485017200013
J	LaFollette, MR; Cloutier, S; Brady, C; Gaskill, BN; O'Haire, ME				LaFollette, Megan R.; Cloutier, Sylvie; Brady, Colleen; Gaskill, Brianna N.; O'Haire, Marguerite E.			Laboratory animal welfare and human attitudes: A cross-sectional survey on heterospecific play or "rat tickling"	PLOS ONE			English	Article							BEHAVIOR; PIGS	Introduction Laboratory rat welfare is critically influenced by laboratory animal personnel through their implementation, or lack of implementation, of various enrichment techniques. One such promising technique is heterospecific play, or "rat tickling", which mimics aspects of rat rough-and-tumble play and can contribute to improving welfare, but may be infrequently implemented. The theory of planned behavior can be used to study implementation by measuring intentions and beliefs about rat tickling, including behavioral attitudes (whether it is good or bad), subjective norms (whether there is social/professional pressure to provide it), and control beliefs (whether they feel in control of providing it). Therefore, the objective of this study was to identify current rat tickling prevalence and predictors among laboratory animal personnel in the United States and Canada. Our hypothesis was that rat tickling prevalence would be low and associated with beliefs about the practice, enrichment, and laboratory animals in general. Methods Laboratory animal personnel were recruited from widespread online promotion. A total of 794 personnel (mean = 40 +/- 11 years, 80% white, 80% female) completed at least 50% of the mixed methods online survey and met inclusion criteria of currently working with laboratory rats in the USA or Canada. The survey included questions about demographics, enrichment practices and beliefs, attitudes towards rats, general positive behaviors (e.g. talking to laboratory animals), and both practices and beliefs about rat tickling. Qualitative data were coded using thematic analysis. Quantitative data were analyzed using general linear models. Results Laboratory personnel reported low levels of rat tickling implementation, with 89% of participants reporting using it never or rarely. Laboratory personnel reported 2 key benefits (handling: 61%, welfare: 55%) and 3 key barriers (time: 59%, personnel: 22%, and research: 22%) to rat tickling using qualitative analysis. Current and planned rat tickling were positively associated with more positive beliefs (social/professional pressure p<0.0001, control of providing tickling p<0.0001) and familiarity with tickling (p<0.0001). Current rat tickling was also positively associated with more positive general behaviors towards laboratory animals, such as naming animals (p<0.0001). Future rat tickling was positively associated with more positive attitudes about it (p<0.0001) and a desire to implement more enrichment (p<0.01). Conclusion Our findings show that even though rat tickling implementation is currently low, it is positively associated with personnel beliefs, familiarity, general attitudes, and a desire for more enrichment. That is, laboratory animal personnel were more likely to provide rat tickling if they were more familiar with it, thought providing it was both good and under their control, and felt subject to social/professional pressure, as well as if they wanted to provide more enrichment and generally had more positive behaviors towards laboratory animals. There is potential to increase rat tickling by increasing personnel familiarity with the procedure through training, decreasing the time required, and changing personnel beliefs thereby improving rat welfare.	[LaFollette, Megan R.; Gaskill, Brianna N.] Purdue Univ, Dept Anim Sci, Coll Agr, W Lafayette, IN 47907 USA; [Brady, Colleen] Purdue Univ, Coll Agr, Dept Agr Sci Educ & Commun, W Lafayette, IN 47907 USA; [O'Haire, Marguerite E.] Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, Ctr Human Anim Bond, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	LaFollette, MR (corresponding author), Purdue Univ, Dept Anim Sci, Coll Agr, W Lafayette, IN 47907 USA.	meglafollette@gmail.com	LaFollette, Megan/AAF-1034-2019	LaFollette, Megan/0000-0003-0643-2210; O'Haire, Marguerite/0000-0003-4910-3126; Brady, Colleen/0000-0002-3828-9917	Animal Welfare Institute	Animal Welfare Institute	This work was made possible with support by the Animal Welfare Institute, https//anonline org (MRL; BG; SC; MEO). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Balcombe JP, 2004, CONTEMP TOP LAB ANIM, V43, P42; Barker DJ, 2018, HBK BEHAV NEUROSCI, V25, P253, DOI 10.1016/B978-0-12-809600-0.00024-X; Bayne Kathryn, 2002, ILAR J, V43, P4; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; BRUDZYNSKI SM, 1992, PHYSIOL BEHAV, V52, P655, DOI 10.1016/0031-9384(92)90393-G; Burgdorf J, 2001, PHYSIOL BEHAV, V72, P167, DOI 10.1016/S0031-9384(00)00411-X; Cloutier S, 2008, APPL ANIM BEHAV SCI, V112, P158, DOI 10.1016/j.applanim.2007.07.003; Cloutier S, 2018, JOVE-J VIS EXP, DOI 10.3791/57190; Coleman GJ, 1998, APPL ANIM BEHAV SCI, V58, P63, DOI 10.1016/S0168-1591(96)01168-9; Coleman GJ, 2000, APPL ANIM BEHAV SCI, V66, P11, DOI 10.1016/S0168-1591(99)00073-8; Dillman D. R., 2007, MAIL INTERNET SURVEY; Francis J., 2004, CONSTRUCTING QUESTIO, V5th ed.; GARTNER K, 1980, LAB ANIM, V14, P267, DOI 10.1258/002367780780937454; Goodman LA, 2011, SOCIOL METHODOL, V41, P347, DOI 10.1111/j.1467-9531.2011.01242.x; Hemsworth PH, 2011, HUMAN-LIVESTOCK INTERACTIONS, 2ND EDITION: THE STOCKPERSON AND THE PRODUCTIVITY AND WELFARE OF INTENSIVELY FARMED ANIMALS, P103, DOI 10.1079/9781845936730.0103; LaFollette MR, 2018, APPL ANIM BEHAV SCI, V208, P82, DOI 10.1016/j.applanim.2018.08.005; LaFollette MR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175320; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Morgan KN, 2007, APPL ANIM BEHAV SCI, V102, P262, DOI 10.1016/j.applanim.2006.05.032; Shepherdson David J., 1998, P1; Wurbel H., 2007, NC3RS, V9, P1, DOI DOI 10.1016/S1353-8020(08)70759-4	22	10	10	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0220580	10.1371/journal.pone.0220580	http://dx.doi.org/10.1371/journal.pone.0220580			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412066	gold, Green Published, Green Submitted			2022-12-26	WOS:000485012600032
J	Chiaw, PK; Hantouche, C; Wong, MJH; Matthes, E; Robert, R; Hanrahan, JW; Shrier, A; Young, JC				Chiaw, Patrick Kim; Hantouche, Christine; Wong, Michael J. H.; Matthes, Elizabeth; Robert, Renaud; Hanrahan, John W.; Shrier, Alvin; Young, Jason C.			Hsp70 and DNAJA2 limit CFTR levels through degradation	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; SMALL-MOLECULE INHIBITOR; PROTEIN-QUALITY CONTROL; HEAT-SHOCK-PROTEIN; ENDOPLASMIC-RETICULUM; DELTA-F508-CFTR TRAFFICKING; CO-CHAPERONE; IN-VITRO; APOPTOSIS; MKT-077	Cystic Fibrosis is caused by mutations in the CFTR anion channel, many of which cause its misfolding and degradation. CFTR folding depends on the Hsc70 and Hsp70 chaperones and their co-chaperone DNAJA1, but Hsc70/Hsp70 is also involved in CFTR degradation. Here, we address how these opposing functions are balanced. DNAJA2 and DNAJA1 were both important for CFTR folding, however overexpressing DNAJA2 but not DNAJA1 enhanced CFTR degradation at the endoplasmic reticulum by Hsc70/Hsp70 and the E3 ubiquitin ligase CHIP. Excess Hsp70 also promoted CFTR degradation, but this occurred through the lysosomal pathway and required CHIP but not complex formation with HOP and Hsp90. Notably, the Hsp70 inhibitor MKT077 enhanced levels of mature CFTR and the most common disease variant Delta F508-CFTR, by slowing turnover and allowing delayed maturation, respectively. MKT077 also boosted the channel activity of Delta F508-CFTR when combined with the corrector compound VX809. Thus, the Hsp70 system is the major determinant of CFTR degradation, and its modulation can partially relieve the misfolding phenotype.	[Chiaw, Patrick Kim; Wong, Michael J. H.; Young, Jason C.] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Chiaw, Patrick Kim; Hantouche, Christine; Wong, Michael J. H.; Matthes, Elizabeth; Robert, Renaud; Hanrahan, John W.; Shrier, Alvin; Young, Jason C.] McGill Univ, Grp Rech Axe Struct Prot, Montreal, PQ, Canada; [Hantouche, Christine; Matthes, Elizabeth; Robert, Renaud; Hanrahan, John W.; Shrier, Alvin] McGill Univ, Dept Physiol, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Young, JC (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.; Young, JC (corresponding author), McGill Univ, Grp Rech Axe Struct Prot, Montreal, PQ, Canada.	jason.young2@mcgill.ca	Hanrahan, John/AGG-1926-2022	Hanrahan, John/0000-0001-9080-2039	Canadian Institutes of Health Research [CIHR MOP-130332, CIHR PJT-159666, CFC 2634, CIHR MOP-133451]; Cystic Fibrosis Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada	This work was supported by: JCY, CIHR MOP-130332, CIHR PJT-159666, CFC 2634, Canadian Institutes of Health Research, http://www.cihr-irsc.gc.ca/e/193.html, Cystic Fibrosis Canada, https://www.cysticfibrosis.ca/; AS, CIHR MOP-133451, Canadian Institutes of Health Research, http://www.cihr-irsc.gc.ca/e/193.html.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral MD, 2005, PEDIATR PULM, V39, P479, DOI 10.1002/ppul.20168; Baaklini I, 2012, J BIOL CHEM, V287, P41939, DOI 10.1074/jbc.M112.413278; Bagdany M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00444-4; Bell SC, 2015, PHARMACOL THERAPEUT, V145, P19, DOI 10.1016/j.pharmthera.2014.06.005; Bhangoo MK, 2007, MOL BIOL CELL, V18, P3414, DOI 10.1091/mbc.E07-01-0088; Coppinger JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037682; Dalal S, 2004, MOL BIOL CELL, V15, P637, DOI 10.1091/mbc.E03-02-0097; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Du K, 2009, MOL BIOL CELL, V20, P1903, DOI 10.1091/mbc.E08-09-0950; Farinha CA, 2005, MOL CELL BIOL, V25, P5242, DOI 10.1128/MCB.25.12.5242-5252.2005; Farinha CM, 2002, BIOCHEM J, V366, P797, DOI 10.1042/BJ20011717; Finka A, 2013, CELL STRESS CHAPERON, V18, P591, DOI 10.1007/s12192-013-0413-3; Gee HY, 2011, CELL, V146, P746, DOI 10.1016/j.cell.2011.07.021; Grove DE, 2011, MOL BIOL CELL, V22, P301, DOI 10.1091/mbc.E10-09-0760; Hageman J, 2009, CELL STRESS CHAPERON, V14, P1, DOI 10.1007/s12192-008-0060-2; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kim SJ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00201; Ko SK, 2015, CHEM BIOL, V22, P391, DOI 10.1016/j.chembiol.2015.02.004; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Leu JIJ, 2014, ACS CHEM BIOL, V9, P2508, DOI 10.1021/cb500236y; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Li XK, 2013, ACS MED CHEM LETT, V4, P1042, DOI 10.1021/ml400204n; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Mall MA, 2015, J CYST FIBROS, V14, P561, DOI 10.1016/j.jcf.2015.06.002; Massey AJ, 2010, CANCER CHEMOTH PHARM, V66, P535, DOI 10.1007/s00280-009-1194-3; Matsumura Y, 2013, J BIOL CHEM, V288, P31069, DOI 10.1074/jbc.M113.479345; Matsumura Y, 2011, MOL BIOL CELL, V22, P2797, DOI 10.1091/mbc.E11-02-0137; Matthes E, 2016, BRIT J PHARMACOL, V173, P459, DOI 10.1111/bph.13365; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Narayan V, 2015, MOL CELL PROTEOMICS, V14, P2973, DOI 10.1074/mcp.M115.051169; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Orthwein A, 2012, EMBO J, V31, P679, DOI 10.1038/emboj.2011.417; Perez-Sala D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008117; Rab A, 2007, AM J PHYSIOL-CELL PH, V292, pC756, DOI 10.1152/ajpcell.00391.2006; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Ren HY, 2013, MOL BIOL CELL, V24, P3016, DOI 10.1091/mbc.E13-05-0240; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rodina A, 2013, CHEM BIOL, V20, P1469, DOI 10.1016/j.chembiol.2013.10.008; Rosales-Hernandez A, 2009, CELL STRESS CHAPERON, V14, P71, DOI 10.1007/s12192-008-0056-y; Rousaki A, 2011, J MOL BIOL, V411, P614, DOI 10.1016/j.jmb.2011.06.003; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schmidt BZ, 2009, J BIOL CHEM, V284, P4168, DOI 10.1074/jbc.M806485200; Sheppard David N., 1999, Physiological Reviews, V79, pS23; Taddei A, 2004, FEBS LETT, V558, P52, DOI 10.1016/S0014-5793(04)00011-0; Taldone T, 2014, TRENDS PHARMACOL SCI, V35, P48, DOI 10.1016/j.tips.2014.09.001; Terada K, 2005, EMBO J, V24, P611, DOI 10.1038/sj.emboj.7600549; Tzankov S, 2008, J BIOL CHEM, V283, P27100, DOI 10.1074/jbc.M803923200; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Varga K, 2008, BIOCHEM J, V410, P555, DOI 10.1042/BJ20071420; Wadhwa R, 2000, CANCER RES, V60, P6818; Wainwright CE, 2015, NEW ENGL J MED, V373, P220, DOI 10.1056/NEJMoa1409547; Walker VE, 2010, J BIOL CHEM, V285, P3319, DOI 10.1074/jbc.M109.024000; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; WARD CL, 1994, J BIOL CHEM, V269, P25710; Williams DR, 2008, ANGEW CHEM INT EDIT, V47, P7466, DOI 10.1002/anie.200802801; Williamson DS, 2009, J MED CHEM, V52, P1510, DOI 10.1021/jm801627a; Yamamoto Y, 2010, CELL STRUCT FUNCT, V35, P107, DOI 10.1247/csf.10023; Young JC, 2014, DIS MODEL MECH, V7, P319, DOI 10.1242/dmm.014001; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065; Zhang HQ, 2015, STRUCTURE, V23, P472, DOI 10.1016/j.str.2015.01.003	71	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220984	10.1371/journal.pone.0220984	http://dx.doi.org/10.1371/journal.pone.0220984			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408507	Green Published, gold, Green Submitted			2022-12-26	WOS:000485009500031
J	Zhang, KR; Hassan, M				Zhang, Kairan; Hassan, Mohamed			Crash severity analysis of nighttime and daytime highway work zone crashes	PLOS ONE			English	Article							INJURY SEVERITY; FATAL CRASHES; ACCIDENTS; VEHICLE; DRIVERS; MULTIPLE; IMPACTS; MODELS; LEVEL; AGE	Introduction Egypt's National Road Project is a large infrastructure project which presently aims to upgrade 2500 kilometers of road networks as well as construct 4000 kilometers of new roads to meet today's need. This leads to an increase in the number of work zones on highways and therefore a rise in hazardous traffic conditions. This is why highways agencies are shifting towards night construction in order to reduce the adverse traffic impacts on the public. Although many studies have investigated work zone crashes, only a few studies provide comparative analysis of the difference between nighttime and daytime work zone crashes. Methods Data from Egyptian long-term highway work zone projects between 2010 and 2016 are studied with respect to the difference in injury severity between nighttime and daytime crashes by using separate mixed logit models. Results The results indicate that significant differences exist between factors contributing to injury severity. Four variables are found significant only in the nighttime model and four other variables significant in the daytime model. The results show that older and male drivers, the number of lane closures, sidewise crashes, and rainy weather have opposite effects on injury severity in nighttime and daytime crashes. The findings presented in this paper could serve as an aid for transportation agencies in development of efficient measures to improve safety in work zones.	[Zhang, Kairan] Southwest Jiaotong Univ, Natl Engn Lab Integrated Transportat Big Data App, Chengdu, Sichuan, Peoples R China; [Hassan, Mohamed] Southwest Jiaotong Univ, Natl United Engn Lab Integrated & Intelligent Tra, Chengdu, Sichuan, Peoples R China	Southwest Jiaotong University; Southwest Jiaotong University	Hassan, M (corresponding author), Southwest Jiaotong Univ, Natl United Engn Lab Integrated & Intelligent Tra, Chengdu, Sichuan, Peoples R China.	abo_heseny@yahoo.com		Hassan, Mohamed/0000-0002-7805-7635				Abdel-Aty M, 2003, J SAFETY RES, V34, P597, DOI 10.1016/j.jsr.2003.05.009; Abdel-Aty MA, 2003, TRANSPORT RES REC, P140, DOI 10.3141/1840-16; Abdel-Aty MA, 1998, ACCIDENT ANAL PREV, V30, P851, DOI 10.1016/S0001-4575(98)00038-4; Akepati S., 2011, INTEGR TRANSP DEV BE, P472; Anarkooli AJ, 2016, J SAFETY RES, V56, P57, DOI 10.1016/j.jsr.2015.12.003; [Anonymous], 2015, DAILYNEWSEGYPT; Arditi D, 2004, J TRANSP ENG, V130, P725, DOI 10.1061/(ASCE)0733-947X(2004)130:6(725); Arditi D, 2007, J SAFETY RES, V38, P399, DOI 10.1016/j.jsr.2007.04.001; Bai Y, 2006, KTRANKU051 KANS DEP, P168; Borowsky A, 2010, ACCIDENT ANAL PREV, V42, P1240, DOI 10.1016/j.aap.2010.02.001; Bryden J. E., 2002, PROCEDURE ASSESSING; Cantin V, 2009, ACCIDENT ANAL PREV, V41, P763, DOI 10.1016/j.aap.2009.03.019; Chen F, 2011, ACCIDENT ANAL PREV, V43, P1677, DOI 10.1016/j.aap.2011.03.026; Daniel J, 2000, TRANSPORT RES REC, P18, DOI 10.3141/1715-03; Dias I., 2016, COMPARISON FACTORS A; Dias I. M., 2015, WORK ZONE CRASH ANAL; Dissanayake S, 2009, MIDC TRANSP RES S; Dong CJ, 2015, INT J INJ CONTROL SA, V22, P116, DOI 10.1080/17457300.2013.844713; Elshamly Ahmed Fathalla, 2017, MATEC Web of Conferences, V124, DOI 10.1051/matecconf/201712404009; Garber N.J., 2002, 02R12 VTRC; Geedipally SR, 2011, TRANSPORT RES REC, P62, DOI 10.3141/2265-07; Gkritza K, 2010, ACCIDENT ANAL PREV, V42, P1392, DOI 10.1016/j.aap.2010.03.003; Gray RC, 2008, J SAFETY RES, V39, P483, DOI 10.1016/j.jsr.2008.07.003; Guo Y, 2019, TRANSP RES REC; Guo YY, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11072071; Guo YY, 2019, ACCIDENT ANAL PREV, V128, P164, DOI 10.1016/j.aap.2019.04.013; Guo YY, 2019, IEEE ACCESS, V7, P11809, DOI 10.1109/ACCESS.2019.2892135; Guo YY, 2018, TRANSPORT RES F-TRAF, V59, P212, DOI 10.1016/j.trf.2018.09.008; Gupta S, 2016, INJURY PREV, V22, pA53, DOI 10.1136/injuryprev-2016-042156.143; Harb R, 2008, J TRANSP ENG, V134, P203, DOI 10.1061/(ASCE)0733-947X(2008)134:5(203); Hosseinpour M, 2018, ACCIDENT ANAL PREV, V118, P277, DOI 10.1016/j.aap.2018.05.003; Hu W, 2011, J SAFETY RES, V42, P375, DOI 10.1016/j.jsr.2011.07.004; Johansson O, 2009, ACCIDENT ANAL PREV, V41, P809, DOI 10.1016/j.aap.2009.04.003; Katta V., 2013, DEV CRASH SEVERITY M; Kim JK, 2008, ACCIDENT ANAL PREV, V40, P1695, DOI 10.1016/j.aap.2008.06.005; Lee C, 2014, ACCIDENT ANAL PREV, V71, P286, DOI 10.1016/j.aap.2014.06.008; Li YF, 2009, J TRANSP ENG, V135, P694, DOI 10.1061/(ASCE)TE.1943-5436.0000055; Li ZB, 2012, ACCIDENT ANAL PREV, V45, P478, DOI 10.1016/j.aap.2011.08.016; Manner H, 2013, ACCIDENT ANAL PREV, V57, P40, DOI 10.1016/j.aap.2013.03.022; Meng Q, 2010, ACCIDENT ANAL PREV, V42, P1866, DOI 10.1016/j.aap.2010.05.007; Mosa AI, 2013, TRANSP LETT, V5, P201, DOI 10.1179/1942787513Y.0000000006; Osman M, 2018, ACCIDENT ANAL PREV, V111, P161, DOI 10.1016/j.aap.2017.11.026; Osman M, 2016, ACCIDENT ANAL PREV, V97, P261, DOI 10.1016/j.aap.2016.10.020; Ozturk F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-113; PIGMAN JG, 1990, TRANSPORT RES REC, V1270, P12; Rifaat SM, 2009, TRANSPORT RES REC, P61, DOI 10.3141/2102-08; Savolainen PT, 2011, ACCIDENT ANAL PREV, V43, P1666, DOI 10.1016/j.aap.2011.03.025; Schrock SD, 2004, FHWATX0504028; Sisiopiku V. P., 2015, 2015 ROAD SAF SIM IN, P40; Sullivan JM, 2002, ACCIDENT ANAL PREV, V34, P487, DOI 10.1016/S0001-4575(01)00046-X; Sze N. N., 2019, International Journal of Sustainable Transportation, V13, P148, DOI 10.1080/15568318.2018.1452083; Tang JJ, 2019, ACCIDENT ANAL PREV, V122, P226, DOI 10.1016/j.aap.2018.10.016; Ulfarsson GF, 2004, ACCIDENT ANAL PREV, V36, P135, DOI 10.1016/S0001-4575(02)00135-5; Van Ristell J, 2013, TRANSPORTATION, V40, P69, DOI 10.1007/s11116-012-9410-0; Wang Q., 2009, STUDY CRASH CHARACTE; Wei XX, 2017, J ADV TRANSPORT, DOI 10.1155/2017/5783696; Weng JX, 2016, P I CIVIL ENG-TRANSP, V169, P97, DOI 10.1680/jtran.14.00019; World Health Organisation, 2018, NONC DIS COUNTR PROF; Wu Biao, 2009, International Conference on transportation engineering 2009, Volumes 1-5. Proceedings of the Second International Conference, Southwest Jiatong University, Chengdu, China, 25-27 July, 2009, P2183; Wu Q, 2016, ACCIDENT ANAL PREV, V94, P28, DOI 10.1016/j.aap.2016.04.005; Wu Q, 2014, ACCIDENT ANAL PREV, V72, P105, DOI 10.1016/j.aap.2014.06.014; Yang X, 2013, APPL SOFT COMPUT, V13, P1, DOI 10.1016/j.asoc.2012.07.002; Ye X, 2013, ACCIDENT ANAL PREV, V57, P140, DOI 10.1016/j.aap.2013.03.025; Zhang KR, 2018, J ADV TRANSPORT, DOI 10.1155/2018/8570207; Zhang L, 2019, COMPLEXITY, DOI 10.1155/2019/1671340	65	19	19	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0221128	10.1371/journal.pone.0221128	http://dx.doi.org/10.1371/journal.pone.0221128			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5HO	31408489	Green Published, gold, Green Submitted			2022-12-26	WOS:000485009500044
J	Lai, CC; Weng, TC; Tseng, YF; Chiang, JR; Lee, MS; Hu, AYC				Lai, Chia-Chun; Weng, Tsai-Chuan; Tseng, Yu-Fen; Chiang, Jen-Ron; Lee, Min-Shi; Hu, Alan Yung-Chih			Evaluation of novel disposable bioreactors on pandemic influenza virus production	PLOS ONE			English	Article							CELL CULTURE; A VIRUS; FUTURE	Since 1997, the highly pathogenic influenza H5N1 virus has spread from Hong Kong. According to the WHO bulletin report, the H5N1 virus is a zoonotic disease threat that has infected more than 850 humans, causing over 450 deaths. In addition, an outbreak of another new and highly pathogenic influenza virus (H7N9) occurred in 2013 in China. These highly pathogenic influenza viruses could potentially cause a worldwide pandemic. it is crucial to develop a rapid production platform to meet this surge demand against any possible influenza pandemic. A potential solution for this problem is the use of cell-based bioreactors for rapid vaccine production. These novel bioreactors, used for cell-based vaccine production, possess various advantages. For example, they enable a short production time, allow for the handling highly pathogenic influenza in closed environments, and can be easily scaled up. In this study, two novel disposable cell-based bioreactors, BelloCell and TideCell, were used to produce H5N1 clade II and H7N9 candidate vaccine viruses (CVVs). Madin-Darby canine kidney (MDCK) cells were used for the production of these influenza CVVs. A novel bench-scale bioreactor named BelloCell bioreactor was used in the study. All culturing conditions were tested and scaled to 10 L industrial-scale bioreactor known as TideCell002. The performances of between BelloCell and TideCell were similar in cell growth, the average MDCK cell doubling time was slightly decreased to 25 hours. The systems yielded approximately 39.2 and 18.0 mu g/ml of HA protein with the 10-liter TideCell002 from the H5N1 clade II and H7N9 CVVs, respectively. The results of this study not only highlight the overall effectiveness of these bioreactors but also illustrate the potential of maintaining the same outcome when scaled up to industrial production, which has many implications for faster vaccine production. Although additional studies are required for process optimization, the results of this study are promising and show that oscillating bioreactors may be a suitable platform for pandemic influenza virus production.	[Lai, Chia-Chun; Weng, Tsai-Chuan; Tseng, Yu-Fen; Lee, Min-Shi; Hu, Alan Yung-Chih] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Taiwan; [Lai, Chia-Chun] Natl Tsing Hua Univ, Coll Life Sci Biol, Hsinchu, Taiwan; [Chiang, Jen-Ron] Ctr Dis Control, Vaccine Ctr, Taipei, Taiwan	National Health Research Institutes - Taiwan; National Tsing Hua University; Centers For Disease Control - Taiwan	Hu, AYC (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Taiwan.	alanhu@nhri.edu.tw		Hu, Alan Yung-Chih/0000-0003-4501-8645	Ministry of Science and Technology (R.O.C.) [102-2622-B-400-001-CC2, 103-2622-B-400-001-CC2]	Ministry of Science and Technology (R.O.C.)	The authors would like to thank Mr. Anthony Chang for English editing, and the US CDC for supplying the egg-derived vaccine strains. The authors would also like to thank the funding support from the Ministry of Science and Technology (R.O.C. 102-2622-B-400-001-CC2; 103-2622-B-400-001-CC2). Mr. Chia-Chun Lai is currently pursuing his Ph.D. studies under the Graduate Program of Biotechnology in Medicine, National Tsing Hua University and the National Health Research Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Mr. Anthony Chang for English editing, and the US CDC for supplying the egg-derived vaccine strains. The authors would also like to thank the funding support from the Ministry of Science and Technology (R.O.C. 102-2622-B-400-001-CC2; 103-2622-B-400-001-CC2). Chia-Chun Lai carried out his PhD study under the auspices of the Graduate Program of Biotechnology in Medicine, National Tsing Hua University and National Health Research Institutes.	Bock A, 2011, BIOTECHNOL PROGR, V27, P241, DOI 10.1002/btpr.539; Chen A, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-81; Chen YH, 2005, J BIOTECHNOL, V118, P135, DOI 10.1016/j.jbiotec.2005.02.018; Eisfeld AJ, 2014, NAT PROTOC, V9, P2663, DOI 10.1038/nprot.2014.180; Genzel Y, 2014, VACCINE, V32, P2770, DOI 10.1016/j.vaccine.2014.02.016; Genzel Y, 2013, APPL MICROBIOL BIOT, V97, P111, DOI 10.1007/s00253-012-4238-2; Genzel Y, 2010, APPL MICROBIOL BIOT, V88, P461, DOI 10.1007/s00253-010-2742-9; Hamamoto I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059892; Hu AZ, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-91; Hu YC, 2003, CYTOTECHNOLOGY, V42, P145, DOI 10.1023/B:CYTO.0000015841.98225.27; Huang D, 2015, MATH PROBL ENG, V2015, P11; Huang KS, 2007, HUM GENE THER, V18, P1161, DOI 10.1089/hum.2007.107; Kamen A, 2004, J GENE MED, V6, pS184, DOI 10.1002/jgm.503; Lee MS, 2012, TRENDS MICROBIOL, V20, P103, DOI 10.1016/j.tim.2011.12.002; Lu JT, 2005, BIOTECHNOL LETT, V27, P1059, DOI 10.1007/s10529-005-8450-3; Manini I, 2015, EXPERT REV VACCINES, V14, P789, DOI 10.1586/14760584.2015.1039520; Merten OW, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0040; Milian E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/504831; Perdue ML, 2011, EXPERT REV VACCINES, V10, P1183, DOI [10.1586/erv.11.82, 10.1586/ERV.11.82]; Rao G, 2009, BIOTECHNOL BIOENG, V102, P348, DOI 10.1002/bit.22192; Rourou S, 2009, APPL MICROBIOL BIOT, V85, P53, DOI 10.1007/s00253-009-2064-y; Shin D, 2015, VIRUS RES, V204, P40, DOI 10.1016/j.virusres.2015.04.005; Shukla AA, 2013, TRENDS BIOTECHNOL, V31, P147, DOI 10.1016/j.tibtech.2012.10.004; Souza MCO, 2009, VACCINE, V27, P6420, DOI 10.1016/j.vaccine.2009.06.023; Tapia F, 2014, VACCINE, V32, P1003, DOI 10.1016/j.vaccine.2013.11.044; To KKW, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.24; Toriniwa H, 2007, BIOLOGICALS, V35, P221, DOI 10.1016/j.biologicals.2007.02.002; Tseng YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024057; Wang Yu-Chi, 2003, NOVEL DISPOSABLE BIO; WHO, 2017, CUM NUMB CONF HUM CA; World Health Organization, 2002, WHO MAN AN INFL DIAG; World Health Organization, 2017, ANT GEN CHAR ZOON IN; Wu WL, 2008, J VIROL, V82, P1798, DOI 10.1128/JVI.02256-07	33	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220803	10.1371/journal.pone.0220803	http://dx.doi.org/10.1371/journal.pone.0220803			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404117	Green Published, gold, Green Submitted			2022-12-26	WOS:000485006800033
J	Alelign, A; Petros, B; Ameni, G				Alelign, Amir; Petros, Beyene; Ameni, Gobena			Smear positive tuberculosis and genetic diversity of M. tuberculosis isolates in individuals visiting health facilities in South Gondar Zone, northwest Ethiopia	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; EXTRAPULMONARY TUBERCULOSIS; MOLECULAR EPIDEMIOLOGY; PREVALENCE; LINEAGES; STRAINS; BURDEN; CATTLE	Background Tuberculosis (TB), a bacterial infectious disease, continues to be a public health concern in many developing countries. However, lack of data concerning the public health burden and potential risk factors for the disease hampers control programs in target areas. Therefore, the aims of present study were to determine the prevalence of TB and genetic diversity of M. tuberculosis isolates from individuals visiting health facilities in South Gondar Zone, north-west Ethiopia. Methods A cross-sectonal study was conducted between March 2015 and April 2017. Bacteriological examination, region of difference (RD) 9 based polymerase chain reaction (PCR) and spoligotyping were used. Results The overall prevalence of all smear positive TB was 6.3% (186/2953). Extra pulmonary TB (EPTB) was clinically characterized in about 62.4% (116/186) TB-positive cases. Some demographic characteristics, such as patients' origin (districts where patients were recruited) [patients' origin (chi-square (chi(2)) value; 62.8, p<0.001) were found to be significantly associated risk factors for the occurrence of TB in the study area. All the mycobacterial isolates were found to be M. tuberculosis. Among the 35 different spoligotype patterns identified, 22 patterns were shared types. The three dominantly identified families were T, CAS and Manu, each consisting of 46.9%, 24.0% and 10.4% of the isolates, respectively. Conclusion The present study revealed that TB continues to be a public health problem in South Gondar Zone which suggests a need of implementing effective disease control strategies.	[Alelign, Amir; Ameni, Gobena] Addis Ababa Univ, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Alelign, Amir; Petros, Beyene] Addis Ababa Univ, Coll Nat Sci, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia; [Alelign, Amir] Debrebrhan Univ, Coll Nat & Computat Sci, Dept Biol, Debrebrhan, Ethiopia	Addis Ababa University; Addis Ababa University	Alelign, A (corresponding author), Addis Ababa Univ, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia.; Alelign, A (corresponding author), Addis Ababa Univ, Coll Nat Sci, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia.; Alelign, A (corresponding author), Debrebrhan Univ, Coll Nat & Computat Sci, Dept Biol, Debrebrhan, Ethiopia.	aleamiro2009@gmail.com	Ameni, Gobena/AAR-4201-2020; Alelign, Amir/P-4524-2018	Ameni, Gobena/0000-0003-3987-0671; Alelign, Amir/0000-0003-2750-7904	Addis Ababa University [0162230106072100101]; National Institute of Health (NIH, USA), H3Africa Consortium Program [U01HG007472-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007472] Funding Source: NIH RePORTER	Addis Ababa University; National Institute of Health (NIH, USA), H3Africa Consortium Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The study was funded by Addis Ababa University (Grant Ref. No. 0162230106072100101) and the National Institute of Health (NIH, USA), H3Africa Consortium Program (Grant Ref. No. U01HG007472-01).	Addis Z, 2015, ASIAN PAC J TROP MED, V8, P127, DOI 10.1016/S1995-7645(14)60302-3; Ahmed Esmael, 2014, Journal of Microbial and Biochemical Technology, V6, P075; Alemayehu M, 2017, AM J INFECT DIS MICR, V5, P61; Ali H, 2012, ETHIOP J HEALTH SCI, V22, P70; Amare H, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-6; [Anonymous], 2000, INT UNION TUBERCULOS; Anwar Nuru, 2015, Ethiopian Veterinary Journal, V19, P27, DOI 10.4314/evj.v19i2.3; Belay M, BIOMEDICAL RES INT, DOI [10.1155/2014/, DOI 10.1155/2014/]; Berg S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005068; Centers for Disease Control and Prevention (CDC), 2002, PUBLIC MED, V28, P250; Central Statistical Agency, 2011, ETH DEM HLTH SURV; Central Statistics Agency Addis Ababa Ethiopia, 2007, SUMM STAT REP THE200; Converse P. J., 2000, RISK PREVENTIVE BE 1, V7, P147; Debebe T, 2014, J MICROBIOL IMMUNOL, V47, P333, DOI 10.1016/j.jmii.2013.03.012; Desikan P, 2016, INDIAN J MED RES, V143, P481, DOI 10.4103/0971-5916.184287; Diriba B, 2013, INT J TUBERC LUNG D, V17, P246, DOI 10.5588/ijtld.12.0195; Disassa H, 2015, BR MICROBIOL RES J, V10, P1, DOI DOI 10.9734/BMRJ/2015/20032; Eliso E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1411-4; Federal Ministry of Health, 2008, TUB LEPR TB HIV PREV, V4th; Firdessa R, 2013, EMERG INFECT DIS, V19, P460, DOI 10.3201/eid1903.120256; Forssbohm M, 2008, EUR RESPIR J, V31, P99, DOI 10.1183/09031936.00020607; Garcia de Viedma D, 2005, J INFECT DIS, V192, P2059, DOI 10.1086/498245; Garedew L, 2013, INT J TUBERC LUNG D, V17, P1076, DOI 10.5588/ijtld.12.0854; Gebrecherkos T, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3761-y; Gele AA, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-5; Getahun Asebe, 2016, African Journal of Microbiology Research, V10, P1086, DOI 10.5897/AJMR2015.7415; Gumi B, 2012, ECOHEALTH, V9, P139, DOI 10.1007/s10393-012-0754-x; Hesseling AC, 2009, CLIN INFECT DIS, V48, P108, DOI 10.1086/595012; Iliyasu Z, 2009, J EPIDEMIOL, V19, P81, DOI 10.2188/jea.JE20080026; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kapata Nathan, 2016, PLoS One, V11, pe0146392, DOI 10.1371/journal.pone.0146392; Korma W, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1177-4; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Maru M., 2015, TUBERC RES TREAT, V2015, DOI 10.1155/2015/215015; Mathema B, 2015, ANN AM THORAC SOC, V12, P12, DOI 10.1513/AnnalsATS.201404-150OC; Mesfin M. M., 2005, Ethiopian Journal of Health Development, V19, P13; Mihret A, 2012, AFR HEALTH SCI, V12, P339, DOI 10.4314/ahs.v12i3.15; Moges B, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-352; Mozafari M, 2013, IRAN J MICROBIOL, V5, P366; Mumpe-Mwanja D, 2015, AFR HEALTH SCI, V15, P851, DOI 10.4314/ahs.v15i3.20; Ngowi BJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-341; Nuru Anwar, 2017, BMC Res Notes, V10, P31, DOI 10.1186/s13104-016-2349-z; Oelemann MC, 2007, J CLIN MICROBIOL, V45, P691, DOI 10.1128/JCM.01393-06; Pareek M, 2012, THORAX J; Parsons LM, 2002, J CLIN MICROBIOL, V40, P2339, DOI 10.1128/JCM.40.7.2339-2345.2002; Tesgaye F, 2014, PUBLIC HEALTH ACTION, V4, pS25, DOI 10.5588/pha.14.0052; Tessema B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-371; TIBEBU M, 2014, J MYCOBACT DIS, V4, P139; Tulu Begna, 2014, BMC Res Notes, V7, P285, DOI 10.1186/1756-0500-7-285; WHO, 2017, GLOB TUB REP; Wondimeneh Yitayih, 2012, BMC Res Notes, V5, P331, DOI 10.1186/1756-0500-5-331; Wood R, 2010, INT J TUBERC LUNG D, V14, P406; World Health Organization, 1998, LAB SERV TUB CONTR 3; World Health Organization, 2018, GLOB TUB REP 2018; Zenebe Yohannes, 2013, BMC Res Notes, V6, P21, DOI 10.1186/1756-0500-6-21	56	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0216437	10.1371/journal.pone.0216437	http://dx.doi.org/10.1371/journal.pone.0216437			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393882	Green Submitted, gold, Green Published			2022-12-26	WOS:000485002500004
J	Dinstag, G; Amar, D; Ingelsson, E; Ashley, E; Shamir, R				Dinstag, Gal; Amar, David; Ingelsson, Erik; Ashley, Euan; Shamir, Ron			Personalized prediction of adverse heart and kidney events using baseline and longitudinal data from SPRINT and ACCORD	PLOS ONE			English	Article							REGULARIZATION PATHS; MODELS	Background The 2017 guidelines of the American College of Cardiology and the American Heart Association propose substantial changes to hypertension management. The guidelines lower the blood pressure threshold defining hypertension and promote more aggressive treatments. Thus, more individuals are now classified as hypertensive and as a result, medication usage may become more extensive. An inevitable byproduct of greater medication use is higher incidence of adverse effects. Here, we examined these issues by developing models that predict both cardiovascular events and other adverse events based on the treatment chosen and other patient's data. Methods and results We used data from the SPRINT trial to produce patient-specific predictions of the risks for adverse cardiovascular or kidney outcomes. Unlike prior models, we used both the baseline characteristics collected upon recruitment and the longitudinal data during the follow-up. Importantly, our cardiovascular predictor outperformed extant models on SPRINT participants, achieving AUC = 0.765, and was validated with good performance in an independent cohort of the ACCORD trial. Conclusions Our study illustrates the importance of including longitudinal data for assessing personalized risk and provides means for recommending personalized treatment decisions.	[Dinstag, Gal; Shamir, Ron] Tel Aviv Univ, Blavatnik Sch Comp Sci, Tel Aviv, Israel; [Amar, David; Ingelsson, Erik; Ashley, Euan] Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA USA; [Ingelsson, Erik] Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA	Tel Aviv University; Stanford University; Stanford University	Shamir, R (corresponding author), Tel Aviv Univ, Blavatnik Sch Comp Sci, Tel Aviv, Israel.	rshamir@tau.ac.il	Shamir, Ron/E-6514-2011	Shamir, Ron/0000-0003-1889-9870; Ingelsson, Erik/0000-0003-2256-6972	Israel Science Foundation (ISF) as part of the ISF-NSFC joint program [2193/15]; ISF [1339/18]; Blavatnik Family foundation; Edmond J. Safra Center for Bioinformatics at Tel Aviv University	Israel Science Foundation (ISF) as part of the ISF-NSFC joint program; ISF(Israel Science Foundation); Blavatnik Family foundation; Edmond J. Safra Center for Bioinformatics at Tel Aviv University	Study supported in part by the Israel Science Foundation (ISF) as part of the ISF-NSFC joint program (grant 2193/15), by ISF grant 1339/18, and by Len Blavatnik and the Blavatnik Family foundation (to RS) and a fellowship from the Edmond J. Safra Center for Bioinformatics at Tel Aviv University (to GD).	Basu S, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002410; Burns NS, 2017, NEW ENGL J MED, V376, P2205, DOI 10.1056/NEJMp1705323; Chandrasekhar A, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap8674; COX DR, 1972, J R STAT SOC B, V34, P187; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Huang CX, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.007509; Huesch MD, 2017, DRUGS R&D, V17, P623, DOI 10.1007/s40268-017-0213-9; Ioannidis JPA, 2018, JAMA-J AM MED ASSOC, V319, P115, DOI 10.1001/jama.2017.19672; Mezue K, 2018, AM J HYPERTENS, V31, P48, DOI 10.1093/ajh/hpx128; Patel KK, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.117.003624; Pearl J, 2009, CAUSALITY, DOI 10.1017/CBO9780511803161; Pool LR, 2018, JAMA CARDIOL, V3, P1096, DOI 10.1001/jamacardio.2018.2763; Simon N, 2011, J STAT SOFTW, V39, P1; SPRINT, 2016, NEW ENGL J MED, V36, P140, DOI [10.1097/HCR.0000000000000175, DOI 10.1097/HCR.0000000000000175]; Steyerberg E.W., 2019, CLIN PREDICTION MODE, DOI [10.1007/978-3-030-16399-0, DOI 10.1007/978-3-030-16399-0]; Whelton P.K., 2017, J AM COLL CARDIOL, V71, P85	17	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0219728	10.1371/journal.pone.0219728	http://dx.doi.org/10.1371/journal.pone.0219728			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393900	gold, Green Published, Green Submitted			2022-12-26	WOS:000485002500016
J	Kokkoris, V; Hamel, C; Hart, MM				Kokkoris, Vasilis; Hamel, Chantal; Hart, Miranda M.			Mycorrhizal response in crop versus wild plants	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZA; GENETIC-VARIABILITY; RHIZOPHAGUS-IRREGULARIS; GLOMUS-INTRARADICES; PHOTON IRRADIANCE; FIELD TRIALS; FUNGI; GROWTH; COLONIZATION; POPULATION	We proposed a theoretical framework predicting mutualistic outcomes for the arbuscular mycorrhizal (AM) symbiosis based on host provenance (crop versus wild). To test the framework, we grew two isolates of Rhizoglomus irregulare (commercial versus an isolate locally isolated), with five crop plants and five wild plants endemic to the region that co-occur with the locally sourced fungus. While inoculation with either isolate had no effect on plant biomass, it decreased leaf P content, particularly for wild plants. All plants associating with the commercial fungus had lower leaf P. Overall, our data shows that wild plants may be more sensitive to differences in mutualistic quality among fungal isolates.	[Kokkoris, Vasilis; Hart, Miranda M.] Univ British Columbia, Dept Biol, Okanagan Campus, Kelowna, BC, Canada; [Hamel, Chantal] Agr & Agri Food Canada, Quebec Res & Dev Ctr, Quebec City, PQ, Canada	University of British Columbia; Agriculture & Agri Food Canada	Kokkoris, V (corresponding author), Univ British Columbia, Dept Biol, Okanagan Campus, Kelowna, BC, Canada.	bill.kokkoris@ubc.ca	Hart, Miranda m/D-1562-2011; Kokkoris, Vasilis/V-5228-2019	Kokkoris, Vasilis/0000-0002-1667-0493				Al-Karaki G, 2004, MYCORRHIZA, V14, P263, DOI 10.1007/s00572-003-0265-2; Alejandro-Cordova A, RESPONSES ARBUSCULAR, DOI [10.1007/s11270-017-3247-2, DOI 10.1007/S11270-017-3247-2]; Antunes PM, 2011, NEW PHYTOL, V189, P507, DOI 10.1111/j.1469-8137.2010.03480.x; BALTRUSCHAT H, 1987, Z PFLANZENK PFLANZEN, V94, P419; BAON JB, 1993, PLANT SOIL, V157, P97, DOI 10.1007/BF02390231; Bates D, 2015, PARSIMONIOUS MIXED M, DOI DOI 10.1177/0146167220913363; Bethlenfalvay GJ, 1983, PLANT PHYSL; Borstler B, 2008, NEW PHYTOL, V180, P452, DOI 10.1111/j.1469-8137.2008.02574.x; Buysens C, 2016, APPL SOIL ECOL, V105, P137, DOI 10.1016/j.apsoil.2016.04.011; Calvet C, 2013, HORTSCIENCE; Campagnac E, 2014, MYCORRHIZA, V24, P121, DOI 10.1007/s00572-013-0517-8; Ceballos I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070633; Cely MVT, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00720; CHABOT S, 1992, MYCOLOGIA, V84, P315, DOI 10.2307/3760183; Christophersen HM, 2009, NEW PHYTOL, V184, P962, DOI 10.1111/j.1469-8137.2009.03009.x; Croll D, 2008, NEW PHYTOL, V180, P564, DOI 10.1111/j.1469-8137.2008.02602.x; DAFT MJ, 1978, NEW PHYTOL, V80, P365, DOI 10.1111/j.1469-8137.1978.tb01570.x; Delavaux CS, 2017, ECOLOGY, V98, P2111, DOI 10.1002/ecy.1892; Druille M, 2013, APPL SOIL ECOL, V72, P143, DOI 10.1016/j.apsoil.2013.06.011; Ehinger M, 2009, NEW PHYTOL, V184, P412, DOI 10.1111/j.1469-8137.2009.02983.x; Emam T, 2016, RESTOR ECOL, V24, P35, DOI 10.1111/rec.12287; Engelmoer DJP, 2014, MOL ECOL, V23, P1584, DOI 10.1111/mec.12451; Facelli E, 2010, NEW PHYTOL, V185, P1050, DOI 10.1111/j.1469-8137.2009.03162.x; FITTER AH, 1991, EXPERIENTIA, V47, P350, DOI 10.1007/BF01972076; Fortin JA, 2002, CAN J BOT, V80, P1, DOI 10.1139/b01-139; FRANSON RL, 1989, SOIL SCI SOC AM J, V53, P754, DOI 10.2136/sssaj1989.03615995005300030020x; Gianinazzi S, 2004, CAN J BOT, V82, P1264, DOI [10.1139/b04-072, 10.1139/B04-072]; Grace EJ, 2009, NEW PHYTOL, V181, P938, DOI 10.1111/j.1469-8137.2008.02720.x; Hamel C, 1996, AGR ECOSYST ENVIRON, V60, P197, DOI 10.1016/S0167-8809(96)01071-7; HAMEL C, 1991, SOIL BIOL BIOCHEM, V23, P661, DOI 10.1016/0038-0717(91)90080-4; Hart MM, 2018, FUNCT ECOL, V32, P126, DOI 10.1111/1365-2435.12976; Hart MM, 2002, NEW PHYTOL, V153, P335, DOI 10.1046/j.0028-646X.2001.00312.x; HETRICK BAD, 1993, CAN J BOT, V71, P512, DOI 10.1139/b93-056; Hijri M, 2016, MYCORRHIZA, V26, P209, DOI 10.1007/s00572-015-0661-4; Jackson LE, 2002, SCI HORTIC-AMSTERDAM, V94, P205, DOI 10.1016/S0304-4238(01)00341-7; JAKOBSEN I, 1992, NEW PHYTOL, V120, P371, DOI 10.1111/j.1469-8137.1992.tb01077.x; Johnson NC, 2010, P NATL ACAD SCI USA, V107, P2093, DOI 10.1073/pnas.0906710107; Johnson NC, 2003, ECOLOGY, V84, P1895, DOI 10.1890/0012-9658(2003)084[1895:NEAMAA]2.0.CO;2; Keymer A, 2017, ELIFE, V6, DOI [10.7554/eLife.29107, 10.7554/eLife.29107.001]; Kiers ET, 2011, SCIENCE, V333, P880, DOI 10.1126/science.1208473; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; Koch AM, 2017, NEW PHYTOL, V214, P1330, DOI 10.1111/nph.14465; Koch AM, 2006, ECOL LETT, V9, P103, DOI 10.1111/j.1461-0248.2005.00853.x; Koch AM, 2004, P NATL ACAD SCI USA, V101, P2369, DOI 10.1073/pnas.0306441101; KOSKE RE, 1989, MYCOL RES, V92, P486, DOI 10.1016/S0953-7562(89)80195-9; Lee EH, 2015, MYCOBIOLOGY, V43, P444, DOI 10.5941/MYCO.2015.43.4.444; Lekberg Y, 2005, NEW PHYTOL, V168, P189, DOI 10.1111/j.1469-8137.2005.01490.x; Li HY, 2008, NEW PHYTOL, V178, P852, DOI 10.1111/j.1469-8137.2008.02410.x; Luginbuehl LH, 2017, SCIENCE, V356, P1175, DOI 10.1126/science.aan0081; McGonigle TP, 1988, FUNCT ECOL, V2, P473, DOI 10.2307/2389390; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; MENGE JA, 1983, CAN J BOT, V61, P1015, DOI 10.1139/b83-109; Middleton EL, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00152.1; MILLER RM, 1995, OECOLOGIA, V103, P17, DOI 10.1007/BF00328420; Munkvold L, 2004, NEW PHYTOL, V164, P357, DOI 10.1111/j.1469-8137.2004.01169.x; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Oksanen J., 2011, MULTIVARIATE ANAL EC; Pellegrino E, 2015, SOIL BIOL BIOCHEM, V84, P210, DOI 10.1016/j.soilbio.2015.02.020; Perner H, 2007, MYCORRHIZA, V17, P469, DOI 10.1007/s00572-007-0116-7; Poulsen KH, 2005, NEW PHYTOL, V168, P445, DOI 10.1111/j.1469-8137.2005.01523.x; RAVNSKOV S, 1995, NEW PHYTOL, V129, P611, DOI 10.1111/j.1469-8137.1995.tb03029.x; Rodriguez A, 2015, ISME J, V9, P1053, DOI 10.1038/ismej.2014.207; Rowe HI, 2007, RESTOR ECOL, V15, P44, DOI 10.1111/j.1526-100X.2006.00188.x; Rua MA, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0698-9; Ryan MH, 2002, PLANT SOIL, V244, P263, DOI 10.1023/A:1020207631893; Shukla A, PHOSPHORUS THRESHOLD, DOI [10.1007/s00374-011-0576-y, DOI 10.1007/S00374-011-0576-Y]; Sieverding E, 2014, MYCOTAXON, V129, P373, DOI 10.5248/129.373; Smith FA, 2009, NEW PHYTOL, V182, P347, DOI 10.1111/j.1469-8137.2008.02753.x; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; SON CL, 1988, NEW PHYTOL, V108, P305, DOI 10.1111/j.1469-8137.1988.tb04167.x; STAHL PD, 1991, MYCOL RES, V95, P300, DOI 10.1016/S0953-7562(09)81238-0; Stockinger H, 2009, NEW PHYTOL, V183, P1176, DOI 10.1111/j.1469-8137.2009.02874.x; Tarbell TJ, 2007, MYCORRHIZA, V18, P51, DOI 10.1007/s00572-007-0152-3; TESTER M, 1986, NEW PHYTOL, V103, P375, DOI 10.1111/j.1469-8137.1986.tb00623.x; Vosatka M, 2012, SYMBIOSIS, V58, P29, DOI 10.1007/s13199-012-0208-9; Wilson GWT, 1998, AM J BOT, V85, P1732, DOI 10.2307/2446507; Wright DP, 2005, NEW PHYTOL, V167, P881, DOI 10.1111/j.1469-8137.2005.01472.x; Xing XK, 2012, P ROY SOC B-BIOL SCI, V279, P1122, DOI 10.1098/rspb.2011.1550; Zhu YG, 2001, PLANT SOIL, V237, P249, DOI 10.1023/A:1013343811110	79	8	8	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0221037	10.1371/journal.pone.0221037	http://dx.doi.org/10.1371/journal.pone.0221037			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393956	Green Submitted, gold, Green Published			2022-12-26	WOS:000485002500092
J	Schmedt, N; Schiffner-Rohe, J; Sprenger, R; Walker, J; von Eiff, C; Hackl, D				Schmedt, Niklas; Schiffner-Rohe, Julia; Sprenger, Ralf; Walker, Jochen; von Eiff, Christof; Haeckl, Dennis			Pneumococcal vaccination rates in immunocompromised patients-A cohort study based on claims data from more than 200,000 patients in Germany	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; RHEUMATOID-ARTHRITIS; RESPIRATORY SOCIETY; POSITION PAPER; ADULTS; PREVENTION; COVERAGE; CHILDREN; BURDEN	Background The German Committee on Vaccination recommends pneumococcal vaccination for infants, seniors 60+ years and patients at risk with defined underlying diseases. Aim of this study was to assess the pneumococcal vaccination rate (pnc-VR) in patients with certain incident inherited or acquired immunodeficiency or immunosuppression and to understand who vaccinates these patients who are particularly at high risk to develop a pneumococcal infection. Methods We conducted a cohort study in patients aged 2 years or older, with a first episode of a "high-risk" condition between January 2013 and December 2014 based on a representative sample of German claims data. Pnc-VR was calculated as the proportion of patients receiving any pneumococcal vaccine within two years after first episode of "high-risk" condition. Further analyses cover pnc-VR stratified by high risk conditions and region, time to vaccination, and physician specialty administering the pneumococcal vaccination. Results The study population comprised 204,088 incident "high-risk" patients (56% female). The overall pnc-VR within two years was 4.4% (95%-confidence interval: 4.3%-4.5%). Within specific high-risk conditions, we found the highest vaccination rate of 11.5% (10.1%-13.0%) among patients starting immunosuppressants with underlying rheumatoid arthritis followed by 9.9% (7.8%-12.4%) in HIV patients. Stratification by region revealed a slightly higher vaccination rate in Eastern (6.5%: 6.0%-6.9%) compared to Western Germany (4.2%: 4.1-4.3%). Median time to vaccination within the first two years in vaccinated patients was 332.5 days (Q1 142 days, Q3 528 days). The majority of patients (92.6%) got vaccinated by a general practitioner. Conclusion Although these vulnerable patients need protection most, our study suggests that the overall pnc-VR after a first episode of a high-risk condition for pneumococcal disease is very low and vaccination is far too late. To prevent pneumococcal disease in patients at high risk, further efforts are needed to increase awareness and improve the timeliness of pneumococcal vaccination.	[Schmedt, Niklas; Walker, Jochen] InGef Inst Appl Hlth Res Berlin, Berlin, Germany; [Schiffner-Rohe, Julia] Pfizer Deutschland GmbH, Berlin, Germany; [Sprenger, Ralf; von Eiff, Christof] Pfizer Pharma GmbH, Berlin, Germany; [Haeckl, Dennis] WIG2 Sci Inst Hlth Econ & Hlth Syst Res, Leipzig, Germany	Pfizer; Pfizer	Schmedt, N (corresponding author), InGef Inst Appl Hlth Res Berlin, Berlin, Germany.	niklas.schmedt@ingef.de			Pfizer Deutschland GmbH	Pfizer Deutschland GmbH	This study was supported by an unrestricted research grant from Pfizer Deutschland GmbH. The funder provided support in the form of salaries for authors [JSR, RS, CvE], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Andersohn F, 2016, PHARMACOEPIDEM DR S, V25, P106, DOI 10.1002/pds.3895; Braeter U., 2016, INFOBLATT PNEUMOKOKK; European Centre for Disease Prevention and Control (ECDC), 2018, VACC SCHED PNEUM DIS; Ewig S, 2016, PNEUMOLOGIE, V70, P151, DOI 10.1055/s-0042-101873; Ewig S, 2017, KRITIK STIKO EMPFEHL, V114; Fatkenheuer G, 2014, Z GERONTOL GERIATR, V47, P302, DOI 10.1007/s00391-014-0650-9; Falkenhorst G, 2017, PLADOYER STIKO EMPFE, V114; Falkenhorst G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169368; Hocker B, 2018, PEDIATR NEPHROL, V33, P341, DOI 10.1007/s00467-017-3776-3; Institute for Quality Assurance and Transparency in Healthcare (IQTiQ), QUAL REP 2017; Klett-Tammen CJ, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0502-3; Krasselt M, 2017, RHEUMATOL INT, V37, P229, DOI 10.1007/s00296-016-3608-y; Pelton SI, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1162-y; Pletz MW, 2015, PNEUMOLOGIE, V69, P633, DOI 10.1055/s-0034-1393413; Pletz M W, 2012, Pneumologie, V66, P470; Poethko-Muller C, 2013, BUNDESGESUNDHEITSBLA, V56, P845, DOI 10.1007/s00103-013-1693-6; Ramos AL, 2016, RHEUMATOL INT, V36, P1255, DOI 10.1007/s00296-016-3516-1; Robert Koch- Institut (RKI), 2017, EMPF STAND IMPFK STI; Robert Koch-Institut (RKI), 2016, WISS BEGR AKT EMPF I; Robert Koch- Institut (RKI), 2016, EMPF STAND IMPFK STI; Robert Koch-Institut (RKI), 2016, WISS BEGR AKT PNEUM; Schiffner-Rohe J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146338; Theidel U, 2013, DTSCH ARZTEBL INT, V110, P743, DOI 10.3238/arztebl.2013.0743; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502	24	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220848	10.1371/journal.pone.0220848	http://dx.doi.org/10.1371/journal.pone.0220848			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393931	Green Published, gold, Green Submitted			2022-12-26	WOS:000485002500069
J	Yang, R; Liu, N; Chen, L; Jiang, YQ; Shi, Y; Mao, C; Liu, YT; Wang, M; Lai, WW; Tang, HS; Gao, MH; Xiao, DS; Wang, X; Zhou, H; Tang, CE; Liu, WL; Yu, FL; Cao, Y; Yan, Q; Liu, S; Tao, YG				Yang, Rui; Liu, Na; Chen, Ling; Jiang, Yiqun; Shi, Ying; Mao, Chao; Liu, Yating; Wang, Min; Lai, Weiwei; Tang, Haosheng; Gao, Menghui; Xiao, Desheng; Wang, Xiang; Zhou, Hu; Tang, Can-e; Liu, Wenliang; Yu, Fenglei; Cao, Ya; Yan, Qin; Liu, Shuang; Tao, Yongguang			GIAT4RA functions as a tumor suppressor in non-small cell lung cancer by counteracting Uchl3-mediated deubiquitination of LSH	ONCOGENE			English	Article							LONG NONCODING RNA; LYMPHOID-SPECIFIC HELICASE; GENE-EXPRESSION; METHYLATION PATTERNS; DNA METHYLATION; BINDING-SITE; GINS COMPLEX; AXIS; PHOSPHORYLATION; PROLIFERATION	Elucidating mechanisms in tumor suppressors and epigenetic modifiers are needed to gain insights into the etiology and treatment of cancer, the interplay between long intergenic non-coding RNAs (lncRNAs) and chromatin remodeling remains unclear. Here, we showed that GIAT4RA, a poorly characterized lncRNA LOC102723729, was significantly decreased in lung cancer cells and tissues; while no association was observed with clinical risk factors, expression was linked with clinical stage and lymphatic metastasis. Higher expression of GIAT4RA was linked with overall survival in NSCLC. GIAT4RA inhibited many characteristics of tumorigenesis including cell growth, clonal formation, migration and invasion, epithelial-mesenchymal transition, tumor sphere and tumor growth in vivo. Mechanistically, GIAT4RA was essential for the degradation of chromatin modifier lymphoid-specific helicase (LSH) by counteracting the deubiquintination in proteasome pathway by binding to 227-589 AA of LSH. GIAT4RA interfered with ubiquitin hydrolase Uchl3-mediated interaction and stabilization of LSH. LSH knockdown rescued GIAT4RA-promoted features, and LSH overexpression prevented GIAT4RA-induced phenotypes. Taken together, lncRNA GIAT4RA plays a critical role in NSCLC adenocarcinoma as a ubiquitination regulator and tumor suppressor.	[Yang, Rui; Liu, Na; Chen, Ling; Jiang, Yiqun; Shi, Ying; Mao, Chao; Liu, Yating; Wang, Min; Lai, Weiwei; Tang, Haosheng; Gao, Menghui; Cao, Ya; Tao, Yongguang] Cent S Univ, Xiangya Hosp, Dept Pathol, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Changsha 410078, Hunan, Peoples R China; [Yang, Rui; Liu, Na; Chen, Ling; Jiang, Yiqun; Shi, Ying; Mao, Chao; Liu, Yating; Wang, Min; Lai, Weiwei; Tang, Haosheng; Gao, Menghui; Cao, Ya; Tao, Yongguang] Cent S Univ, Sch Basic Med, Canc Res Inst, Key Lab Carcinogenesis,Minist Hlth, Changsha 410078, Hunan, Peoples R China; [Jiang, Yiqun; Xiao, Desheng] Cent S Univ, Xiangya Hosp, Dept Pathol, Changsha 410008, Hunan, Peoples R China; [Wang, Xiang; Liu, Wenliang; Yu, Fenglei; Tao, Yongguang] Cent S Univ, Xiangya Hosp 2, Dept Thorac Surg, Hunan Key Lab Tumor Models & Individualized Med, Changsha, Hunan, Peoples R China; [Zhou, Hu] Chinese Acad Sci, Shanghai Inst Mat Med, 555 Zu Chongzhi Rd,Zhangjiang Hitech Pk, Shanghai 201203, Peoples R China; [Tang, Can-e; Liu, Shuang] Cent S Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Dept Oncol,Inst Med Sci, Changsha 410008, Hunan, Peoples R China; [Yan, Qin] Yale Sch Med, Dept Pathol, New Haven, CT 06520 USA	Central South University; Central South University; Central South University; Central South University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Central South University; Yale University	Tao, YG (corresponding author), Cent S Univ, Xiangya Hosp, Dept Pathol, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Changsha 410078, Hunan, Peoples R China.; Tao, YG (corresponding author), Cent S Univ, Sch Basic Med, Canc Res Inst, Key Lab Carcinogenesis,Minist Hlth, Changsha 410078, Hunan, Peoples R China.; Tao, YG (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Thorac Surg, Hunan Key Lab Tumor Models & Individualized Med, Changsha, Hunan, Peoples R China.; Liu, S (corresponding author), Cent S Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Dept Oncol,Inst Med Sci, Changsha 410008, Hunan, Peoples R China.	shuangliu2016@csu.edu.cn; taoyong@csu.edu.cn	Mao, Chao/AAM-6358-2020	Jiang, Yiqun/0000-0003-3262-9498; , chao/0000-0002-8685-8539	National Natural Science Foundation of China [81672787, 81672991, 81874139, 81728014, 81672308]; National Basic Research Program of China [2015CB553903]; Fundamental Research Funds for the Central Universities [2017zzts828, 2017zzts206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (81672787 [YT], 81672991 and 81874139 [SL], 81728014 [QY], 81672308 [XW]), the National Basic Research Program of China (2015CB553903 [YT]), and the Fundamental Research Funds for the Central Universities (2017zzts828 [RY] and 2017zzts206 [NL]).	Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Bhan A, 2017, CANCER RES, V77, P3965, DOI 10.1158/0008-5472.CAN-16-2634; Brunner AL, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r75; Burrage J, 2012, J CELL SCI, V125, P5524, DOI 10.1242/jcs.111252; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Fan T, 2003, CANCER RES, V63, P4677; Feinberg AP, 2016, NAT REV GENET, V17, P284, DOI 10.1038/nrg.2016.13; Forde PM, 2014, CLIN CANCER RES, V20, P2244, DOI 10.1158/1078-0432.CCR-13-2088; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; He XZ, 2016, CANCER RES, V76, P5743, DOI 10.1158/0008-5472.CAN-16-0268; Huarte M, 2015, NAT MED, V21, P1253, DOI 10.1038/nm.3981; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Jia JT, 2017, THERANOSTICS, V7, P3920, DOI 10.7150/thno.21389; Jiang Y, 2015, ONCOGENE, V34, P6079, DOI 10.1038/onc.2015.53; Jiang YQ, 2017, THERANOSTICS, V7, P3293, DOI 10.7150/thno.19988; Kamada K, 2007, NAT STRUCT MOL BIOL, V14, P388, DOI 10.1038/nsmb1231; Keren I, 2017, EPIGENETICS-US, V12, P584, DOI 10.1080/15592294.2017.1348446; Keyes WM, 2011, CELL STEM CELL, V8, P164, DOI 10.1016/j.stem.2010.12.009; Kim JY, 2011, FEBS LETT, V585, P1121, DOI 10.1016/j.febslet.2011.03.053; Kong LY, 2006, BIOCHEM BIOPH RES CO, V339, P1204, DOI 10.1016/j.bbrc.2005.11.136; Labib K, 2007, TRENDS CELL BIOL, V17, P271, DOI 10.1016/j.tcb.2007.04.002; Leveille N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7520; Liao CY, 2018, CELL REP, V23, P3352, DOI 10.1016/j.celrep.2018.05.033; Liu S, 2016, CHIN J CANCER, V35, DOI 10.1186/s40880-016-0138-7; Luo KT, 2016, GENE DEV, V30, P2581, DOI 10.1101/gad.289439.116; Mao C, 2018, CANCER RES, V78, P3484, DOI 10.1158/0008-5472.CAN-17-3454; Materne P, 2016, ELIFE, V5, DOI 10.7554/eLife.13500; Myant K, 2011, GENOME RES, V21, P83, DOI 10.1101/gr.108498.110; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Ren JK, 2015, NUCLEIC ACIDS RES, V43, P1444, DOI 10.1093/nar/gku1371; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Shi Y, 2012, CARCINOGENESIS, V33, P1468, DOI 10.1093/carcin/bgs171; Shi Y, 2018, CANCER LETT, V422, P81, DOI 10.1016/j.canlet.2018.02.028; Taniue K, 2016, P NATL ACAD SCI USA, V113, P1273, DOI 10.1073/pnas.1500992113; Tao YG, 2011, NUCLEIC ACIDS RES, V39, P9508, DOI 10.1093/nar/gkr611; Tao YG, 2011, P NATL ACAD SCI USA, V108, P5626, DOI 10.1073/pnas.1017000108; Tao YG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009163; von Eyss B, 2012, EMBO J, V31, P972, DOI 10.1038/emboj.2011.451; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Xiao DS, 2017, THERANOSTICS, V7, P132, DOI 10.7150/thno.17032; Yan B, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0542-9; Yoon JH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3939; Yu WS, 2014, GENOME RES, V24, P1613, DOI 10.1101/gr.172015.114; Yu WS, 2014, P NATL ACAD SCI USA, V111, P5890, DOI 10.1073/pnas.1320945111; Zemach A, 2013, CELL, V153, P193, DOI 10.1016/j.cell.2013.02.033; Zhang H, 2015, CANCER RES, V75, P2363, DOI 10.1158/0008-5472.CAN-14-2928; Zhang KC, 2017, THERANOSTICS, V7, P213, DOI 10.7150/thno.16044; Zhang PF, 2016, EMBO REP, V17, P1204, DOI 10.15252/embr.201642067; Zhao D, 2017, NATURE, V542, P484, DOI 10.1038/nature21357; Zheng J, 2016, NAT GENET, V48, P747, DOI 10.1038/ng.3568	51	32	34	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 14	2019	38	46					7133	7145		10.1038/s41388-019-0909-0	http://dx.doi.org/10.1038/s41388-019-0909-0			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JN5HX	31417184				2022-12-26	WOS:000496930500002
J	Pique, L; de Paz, AM; Pineyro, D; Martinez-Cardus, A; de Moura, MC; Llinas-Arias, P; Setien, F; Gomez-Miragaya, J; Gonzalez-Suarez, E; Sigurdsson, S; Jonasson, JG; Villanueva, A; Vidal, A; Davalos, V; Esteller, M				Pique, Laia; Martinez de Paz, Alexia; Pineyro, David; Martinez-Cardus, Anna; Castro de Moura, Manuel; Llinas-Arias, Pere; Setien, Fernando; Gomez-Miragaya, Jorge; Gonzalez-Suarez, Eva; Sigurdsson, Stefan; Jonasson, Jon G.; Villanueva, Alberto; Vidal, August; Davalos, Veronica; Esteller, Manel			Epigenetic inactivation of the splicing RNA-binding protein CELF2 in human breast cancer	ONCOGENE			English	Article							TUMOR; IDENTIFICATION; ACTIVATION	Human tumors show altered patterns of protein isoforms that can be related to the dysregulation of messenger RNA alternative splicing also observed in transformed cells. Although somatic mutations in core spliceosome components and their associated factors have been described in some cases, almost nothing is known about the contribution of distorted epigenetic patterns to aberrant splicing. Herein, we show that the splicing RNA-binding protein CELF2 is targeted by promoter hypermethylation-associated transcriptional silencing in human cancer. Focusing on the context of breast cancer, we also demonstrate that CELF2 restoration has growth-inhibitory effects and that its epigenetic loss induces an aberrant downstream pattern of alternative splicing, affecting key genes in breast cancer biology such as the autophagy factor ULK1 and the apoptotic protein CARD10. Furthermore, the presence of CELF2 hypermethylation in the clinical setting is associated with shorter overall survival of the breast cancer patients carrying this epigenetic lesion.	[Pique, Laia; Martinez de Paz, Alexia; Pineyro, David; Martinez-Cardus, Anna; Castro de Moura, Manuel; Llinas-Arias, Pere; Setien, Fernando; Gomez-Miragaya, Jorge; Gonzalez-Suarez, Eva; Davalos, Veronica; Esteller, Manel] Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, Lhospitalet Barcelona, Catalonia, Spain; [Sigurdsson, Stefan] Biomed Ctr, Dept Biochem & Mol Biol, Vatnsmyrarvegur 16, IS-101 Reykjavik, Iceland; [Jonasson, Jon G.] Univ Iceland, Fac Med, Sturlugata 8, IS-101 Reykjavik, Iceland; [Jonasson, Jon G.] Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland; [Villanueva, Alberto] IDIBELL Inst Catala Oncol, Translat Res Lab, Barcelona, Catalonia, Spain; [Vidal, August] Bellvitge Univ Hosp, Dept Pathol, Barcelona, Catalonia, Spain; [Esteller, Manel] Ctr Invest Biomed Red Canc CIBERONC, Madrid 28029, Spain; [Esteller, Manel] ICREA, Barcelona, Catalonia, Spain; [Esteller, Manel] UB, Sch Med & Hlth Sci, Physiol Sci Dept, Barcelona, Catalonia, Spain; [Esteller, Manel] Josep Carreras Leukaemia Res Inst IJC, Barcelona, Catalonia, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Iceland; Landspitali National University Hospital; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; ICREA; University of Barcelona; Institut de Recerca Contra la Leucemia Josep Carreras (IJC)	Esteller, M (corresponding author), Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, Lhospitalet Barcelona, Catalonia, Spain.; Esteller, M (corresponding author), Ctr Invest Biomed Red Canc CIBERONC, Madrid 28029, Spain.; Esteller, M (corresponding author), ICREA, Barcelona, Catalonia, Spain.; Esteller, M (corresponding author), UB, Sch Med & Hlth Sci, Physiol Sci Dept, Barcelona, Catalonia, Spain.; Esteller, M (corresponding author), Josep Carreras Leukaemia Res Inst IJC, Barcelona, Catalonia, Spain.	mesteller@carrerasresearch.org	Davalos, Veronica/AAR-8547-2020; Llinàs-Arias, Pere/AAB-8254-2022; Llinàs-Arias, Pere/M-4501-2014; Gonzalez-Suarez, Eva/L-6298-2014; Martinez, Anna/AAA-4939-2020; Esteller, Manel/L-5956-2014; Sigurdsson, Stefan/L-9820-2015; Castro de Moura, Manuel/L-4259-2017; Davalos, Veronica/S-1668-2016	Llinàs-Arias, Pere/0000-0002-3666-0532; Gonzalez-Suarez, Eva/0000-0003-0858-8171; Esteller, Manel/0000-0003-4490-6093; Sigurdsson, Stefan/0000-0002-5284-0058; Jonasson, Jon G./0000-0002-2635-5032; Martinez Cardus, Anna/0000-0002-3937-8794; Pineyro, David/0000-0001-5633-3339; Castro de Moura, Manuel/0000-0002-8488-5306; Martinez de Paz, Alexia/0000-0003-0808-1389; Davalos, Veronica/0000-0003-4077-5137	Health Department PERIS-project of the Catalan Government (Generalitat de Catalunya) [SLT/002/16/00374]; AGAUR of the Catalan Government (Generalitat de Catalunya) [2017SGR1080, 2014SGR633, 2009SGR1315]; Spanish Institute of Health Carlos III (ISCIII) [DTS16/00153]; Ministerio de Economia y Competitividad (MINECO) [SAF2014-55000-R]; European Development Regional Fund, "A way to achieve Europe" ERDF; Cellex Foundation; "la Caixa" Banking Foundation [LCF/PR/PR15/11100003]	Health Department PERIS-project of the Catalan Government (Generalitat de Catalunya); AGAUR of the Catalan Government (Generalitat de Catalunya); Spanish Institute of Health Carlos III (ISCIII)(Instituto de Salud Carlos III); Ministerio de Economia y Competitividad (MINECO); European Development Regional Fund, "A way to achieve Europe" ERDF; Cellex Foundation(Foundation CELLEX); "la Caixa" Banking Foundation(La Caixa Foundation)	We thank CERCA Program/Generalitat de Catalunya for institutional support. This work was supported by the Health Department PERIS-project no. SLT/002/16/00374 and AGAUR-projects nos. 2017SGR1080, 2014SGR633, and 2009SGR1315 of the Catalan Government (Generalitat de Catalunya); the Spanish Institute of Health Carlos III (ISCIII) project no. DTS16/00153 and Ministerio de Economia y Competitividad (MINECO) project no. SAF2014-55000-R, co-financed by the European Development Regional Fund, "A way to achieve Europe" ERDF; the Cellex Foundation; and "la Caixa" Banking Foundation (LCF/PR/PR15/11100003).	Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Carey KT, 2018, TRENDS GENET, V34, P279, DOI 10.1016/j.tig.2017.12.012; Dasgupta T, 2012, WIRES RNA, V3, P104, DOI 10.1002/wrna.107; Dvinge H, 2016, NAT REV CANCER, V16, P413, DOI 10.1038/nrc.2016.51; Dvinge H, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0168-9; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feinberg AP, 2018, NEW ENGL J MED, V378, P1323, DOI [10.1056/nejmra1402513, 10.1056/NEJMra1402513]; Gomez-Miragaya J, 2017, STEM CELL REP, V8, P1392, DOI 10.1016/j.stemcr.2017.03.026; Han J, 2005, NUCLEIC ACIDS RES, V33, P2769, DOI 10.1093/nar/gki561; Hosur V, 2014, P NATL ACAD SCI USA, V111, pE2200, DOI 10.1073/pnas.1323908111; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; Johnson KC, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0094-0; Jung- H, 2015, NAT GENET, V47, P1242, DOI 10.1038/ng.3414; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Kuchay S, 2017, NATURE, V546, P554, DOI 10.1038/nature22965; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Pan D, 2016, MOL CANCER RES, V14, P93, DOI 10.1158/1541-7786.MCR-15-0229-T; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Papasaikas P, 2016, TRENDS BIOCHEM SCI, V41, P33, DOI 10.1016/j.tibs.2015.11.003; Rodriguez-Pinto D, 2009, CANCER IMMUNOL IMMUN, V58, P221, DOI 10.1007/s00262-008-0543-0; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Sveen A, 2016, ONCOGENE, V35, P2413, DOI 10.1038/onc.2015.318; Vlasova IA, 2008, RNA BIOL, V5, P201, DOI 10.4161/rna.7056; Zhang L, 2018, J MED CHEM, V61, P6491, DOI 10.1021/acs.jmedchem.7b01684	24	34	34	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 7	2019	38	45					7106	7112		10.1038/s41388-019-0936-x	http://dx.doi.org/10.1038/s41388-019-0936-x			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JL9XI	31409895	hybrid, Green Published			2022-12-26	WOS:000495878400006
J	Ritchey, L; Ha, T; Otsuka, A; Kabashima, K; Wang, DR; Wang, YY; Lowy, DR; Tosato, G				Ritchey, Lisa; Ha, Taekyu; Otsuka, Atsushi; Kabashima, Kenji; Wang, Dunrui; Wang, Yuyi; Lowy, Douglas R.; Tosato, Giovanna			DLC1 deficiency and YAP signaling drive endothelial cell contact inhibition of growth and tumorigenesis	ONCOGENE			English	Article							FOCAL ADHESION KINASE; GTPASE-ACTIVATING PROTEIN; ORGAN SIZE CONTROL; HIPPO PATHWAY; TUMOR-SUPPRESSOR; RHO; ANGIOGENESIS; THERAPY; COMPLEX; SRC	Deleted in Liver Cancer 1 (DLC1) is a tumor suppressor gene deleted in many cancers, including angiosarcoma, an aggressive malignancy of endothelial cell derivation. DLC1-deficiency in primary endothelial cells causes the loss of cell contact inhibition of growth through incompletely defined mechanisms. We report that DLC1 is a regulator of YAP, a transcriptional coactivator of proliferation-promoting and tumor-promoting genes; when confluent, active/nuclear YAP was significantly more abundant in DLC1-deficient endothelial cells compared with control cells. We also found that YAP is a required effector of the loss of cell contact inhibition of growth manifested by DLC1-deficient endothelial cells, as the silencing of YAP prevents this loss. Consistently, human angiosarcomas specimens contained a significantly greater proportion of DLC1(-) tumor cells with nuclear YAP compared with the DLC1(+) normal cells in the adjacent tissue. Verteporfin, an inhibitor of YAP, significantly reduced angiosarcoma growth in mice. These results identify YAP as a previously unrecognized effector of DLC1 deficiency-associated loss of cell contact growth inhibition in endothelial cells and a potential therapeutic target in angiosarcoma.	[Ritchey, Lisa; Ha, Taekyu; Wang, Dunrui; Wang, Yuyi; Lowy, Douglas R.; Tosato, Giovanna] NCI, Lab Cellular Oncol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Otsuka, Atsushi; Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Kyoto University	Tosato, G (corresponding author), NCI, Lab Cellular Oncol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	tosatog@mail.nih.gov		Otsuka, Atsushi/0000-0001-7365-947X; Tosato, Giovanna/0000-0003-1663-3227	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; Japan Society for the Promotion of Science KAKENHI [15H05790]; NATIONAL CANCER INSTITUTE [ZIASC010355] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Michael Kruhlak, Langston Lim, and Andy Tran for helping with confocal imaging and images quantification; Ms. Luowei Li, M. DiPrima, Drs. R. Yarchoan, D. Sanchez-Martin, H. Ohnuki, M. Potente, H. Gerhard and Jing-xin Feng; and members of the Laboratory of Cellular Oncology for contributing in various aspects of this work. This work was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research (DSM, XQ, DRL, GT) and by the Japan Society for the Promotion of Science KAKENHI, Grants-in-Aid for Scientific Research 15H05790 (AO, KK).	Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Behjati S, 2014, NAT GENET, V46, P376, DOI 10.1038/ng.2921; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; Braun AC, 2015, CELL SIGNAL, V27, P1643, DOI 10.1016/j.cellsig.2015.04.003; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chalmers ZR, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0424-2; Choi HJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7943; Coxon A, 2010, MOL CANCER THER, V9, P2641, DOI 10.1158/1535-7163.MCT-10-0213; da Costa A, 2017, CLIN EXP DERMATOL, V42, P645, DOI 10.1111/ced.13149; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; EAGLE H, 1967, NATURE, V213, P1102, DOI 10.1038/2131102a0; Edwards DN, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aan4667; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Gao YJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5629; Golubovskaya VM, 2008, J MED CHEM, V51, P7405, DOI 10.1021/jm800483v; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huggett MT, 2014, BRIT J CANCER, V110, P1698, DOI 10.1038/bjc.2014.95; Ishida Y, 2018, CURR OPIN ONCOL, V30, P107, DOI 10.1097/CCO.0000000000000427; Jiao S, 2014, CANCER CELL, V25, P166, DOI 10.1016/j.ccr.2014.01.010; Khan JA, 2018, J CLIN ONCOL, V36, P194, DOI 10.1200/JCO.2017.74.9812; Kim TY, 2007, BIOCHEM BIOPH RES CO, V355, P72, DOI 10.1016/j.bbrc.2007.01.121; Li GR, 2011, P NATL ACAD SCI USA, V108, P17129, DOI 10.1073/pnas.1112122108; Liao YC, 2008, INT J BIOCHEM CELL B, V40, P843, DOI 10.1016/j.biocel.2007.04.008; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Masuzawa M, 1998, J DERMATOL SCI, V16, P91, DOI 10.1016/S0923-1811(97)00032-7; Mohseni M, 2014, NAT CELL BIOL, V16, P108, DOI 10.1038/ncb2884; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Murga M, 2004, STEM CELLS, V22, P385, DOI 10.1634/stemcells.22-3-385; Neto F, 2018, ELIFE, V7, DOI 10.7554/eLife.31037; Nguyen LT, 2015, CANCER CELL, V27, P797, DOI 10.1016/j.ccell.2015.05.005; OBESO J, 1990, LAB INVEST, V63, P259; Pang A, 2016, JAMA ONCOL, V2, P941, DOI 10.1001/jamaoncol.2016.0241; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Qian XL, 2009, CANCER CELL, V16, P246, DOI 10.1016/j.ccr.2009.07.031; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Salvucci O, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7576; Sanchez-Martin D, 2018, JNCI-J NATL CANCER I, V110, P390, DOI 10.1093/jnci/djx219; Shih YP, 2010, CANCER RES, V70, P8270, DOI 10.1158/0008-5472.CAN-10-1174; Shimozono N, 2015, CANCER RES, V75, P4458, DOI 10.1158/0008-5472.CAN-15-0418; Song SM, 2014, CANCER RES, V74, P4170, DOI 10.1158/0008-5472.CAN-13-3569; Sorrentino G, 2014, NAT CELL BIOL, V16, P357, DOI 10.1038/ncb2936; Stein C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005465; STOKER MGP, 1973, NATURE, V246, P200, DOI 10.1038/246200a0; Taniguchi K, 2015, NATURE, V519, P57, DOI 10.1038/nature14228; Thomas JW, 1998, J BIOL CHEM, V273, P577, DOI 10.1074/jbc.273.1.577; Totaro A, 2018, NAT CELL BIOL, V20, P888, DOI 10.1038/s41556-018-0142-z; Tripathi BK, 2019, J CELL BIOL, V218, P3060, DOI 10.1083/jcb.201810098; Tsuneki M, 2017, CANCER SCI, V108, P2295, DOI 10.1111/cas.13379; Wu L, 1999, Curr Opin Ophthalmol, V10, P217, DOI 10.1097/00055735-199906000-00011; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Yu FX, 2014, CANCER CELL, V25, P822, DOI 10.1016/j.ccr.2014.04.017; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zhang HB, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aac5418; Zhang H, 2014, J BIOL CHEM, V289, P18681, DOI 10.1074/jbc.M114.554584; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Ziemssen F, 2012, EXPERT OPIN DRUG MET, V8, P1023, DOI 10.1517/17425255.2012.701617	60	7	8	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 7	2019	38	45					7046	7059		10.1038/s41388-019-0944-x	http://dx.doi.org/10.1038/s41388-019-0944-x			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JL9XI	31409902	Green Accepted			2022-12-26	WOS:000495878400002
J	Burton-Smith, RN; Watanabe, A; Tokutse, R; Song, CH; Murata, K; Minagawa, J				Burton-Smith, Raymond N.; Watanabe, Akimasa; Tokutse, Ryutaro; Song, Chihong; Murata, Kazuyoshi; Minagawa, Jun			Structural determination of the large photosystem II?light-harvesting complex II supercomplex of Chlamydomonas reinhardtii using nonionic amphipol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						photosynthesis; algae; cryo-electron microscopy; single-particle analysis; light-harvesting complex (antenna complex); Chlamydomonas reinhardtii	SUPRAMOLECULAR ORGANIZATION; STATE TRANSITIONS; LIGHT; LHCII; IDENTIFICATION; ASSOCIATION; PROTEOMICS; RESOLUTION; PROTEINS; ANTENNA	In photosynthetic organisms, photosystem II (PSII) is a large membrane protein complex, consisting of a pair of core complexes surrounded by an array of variable numbers of light-harvesting complex (LHC) II proteins. Previously reported structures of the PSII?LHCII supercomplex of the green alga Chlamydomonas reinhardtii exhibit significant structural heterogeneity, but recently improved purification methods employing ionic amphipol A8-35 have enhanced supercomplex stability, providing opportunities for determining a more intact structure. Herein, we present a 5.8 ? cryo-EM map of the C. reinhardtii PSII?LHCII supercomplex containing six LHCII trimers (C2S2M2L2). Utilizing a newly developed nonionic amphipol?based purification and stabilizing method, we purified the largest photosynthetic supercomplex to the highest percentage of the intact configuration reported to date. We found that the interprotein distances within the light-harvesting complex array in the green algal photosystem are larger than those previously observed in higher plants, indicating that the potential route of energy transfer in the PSII?LHCII supercomplex in green algae may be altered. Interestingly, we also observed an asymmetric PSII?LHCII supercomplex structure comprising C2S2M1L1 in the same sample. Moreover, we found a new density adjacent to the PSII core complex, attributable to a single-transmembrane helix. It was previously unreported in the cryo-EM maps of PSII?LHCII supercomplexes from land plants.	[Burton-Smith, Raymond N.; Watanabe, Akimasa; Tokutse, Ryutaro; Minagawa, Jun] Natl Inst Basic Biol, Div Environm Photobiol, Okazaki, Aichi 4448585, Japan; [Burton-Smith, Raymond N.; Watanabe, Akimasa; Tokutse, Ryutaro; Minagawa, Jun] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama 3320012, Japan; [Watanabe, Akimasa; Tokutse, Ryutaro; Minagawa, Jun] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi 4448585, Japan; [Murata, Kazuyoshi] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Dept Physiol Sci, Okazaki, Aichi 4448585, Japan; [Song, Chihong; Murata, Kazuyoshi] Natl Inst Physiol Sci, Okazaki, Aichi 4448585, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Japan Science & Technology Agency (JST); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Minagawa, J (corresponding author), Natl Inst Basic Biol, Div Environm Photobiol, Okazaki, Aichi 4448585, Japan.; Murata, K (corresponding author), Natl Inst Physiol Sci, Okazaki, Aichi 4448585, Japan.	kazum@nips.ac.jp; minagawa@nibb.ac.jp	Tokutsu, Ryutaro/GRF-0208-2022; Tokutsu, Ryutaro/V-7596-2019	Tokutsu, Ryutaro/0000-0003-2037-255X; Watanabe, Akimasa/0000-0001-6068-1328; Minagawa, Jun/0000-0002-3028-3203; Murata, Kazuyoshi/0000-0001-9446-3652	Japan Society for the Promotion of Science KAKENHI [16H06553]; National Institute for Physiological Sciences	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Institute for Physiological Sciences(National Institutes of Natural Sciences (NINS) - JapanNational Institute for Physiological Sciences (NIPS))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant-in-Aid 16H06553 (to R. T. and J. M.) and by funds from the collaborative study program of the National Institute for Physiological Sciences (to J. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Albanese P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10700-8; Albanese P, 2016, PHOTOSYNTH RES, V130, P19, DOI 10.1007/s11120-016-0216-3; Barber J, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.41; Bartesaghi A, 2015, SCIENCE, V348, P1147, DOI 10.1126/science.aab1576; Bazzacco P, 2009, BIOMACROMOLECULES, V10, P3317, DOI 10.1021/bm900938w; Boekema EJ, 1999, BIOCHEMISTRY-US, V38, P2233, DOI 10.1021/bi9827161; Bricker TM, 2012, BBA-BIOENERGETICS, V1817, P121, DOI 10.1016/j.bbabio.2011.07.006; CRAMER WA, 1977, ANNU REV PLANT PHYS, V28, P133, DOI 10.1146/annurev.pp.28.060177.001025; Drop B, 2014, BBA-BIOENERGETICS, V1837, P63, DOI 10.1016/j.bbabio.2013.07.012; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Frank J, 2017, NAT PROTOC, V12, P209, DOI 10.1038/nprot.2017.004; Garcia-Cerdan JG, 2011, PLANT J, V65, P368, DOI 10.1111/j.1365-313X.2010.04429.x; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Grant T, 2018, ELIFE, V7, DOI 10.7554/eLife.35383; Inoue-Kashino N, 2011, J PHOTOCH PHOTOBIO B, V104, P220, DOI 10.1016/j.jphotobiol.2011.01.024; Inoue-Kashino N, 2008, PHOTOSYNTH RES, V98, P323, DOI 10.1007/s11120-008-9340-z; Iwai M, 2008, PLANT CELL, V20, P2177, DOI 10.1105/tpc.108.059352; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim E, 2018, J PHYS CHEM B, V122, P1627, DOI 10.1021/acs.jpcb.7b12417; Kubota-Kawai H, 2019, J BIOL CHEM, V294, P4304, DOI 10.1074/jbc.RA118.006536; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/NMETH.2727, 10.1038/nmeth.2727]; Mazor Y, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.14; Minagawa J, 2004, PHOTOSYNTH RES, V82, P241, DOI 10.1007/s11120-004-2079-2; Murata K, 2018, BBA-GEN SUBJECTS, V1862, P324, DOI 10.1016/j.bbagen.2017.07.020; Nakane T, 2018, ELIFE, V7, DOI [10.7554/elife.36861, 10.7554/eLife.36861]; Nield J, 2000, J BIOL CHEM, V275, P27940; Pan XW, 2018, SCIENCE, V360, P1109, DOI 10.1126/science.aat1156; Popot JL, 2018, BIOL MED PHYS BIOMED, P237, DOI 10.1007/978-3-319-73148-3_5; Rosenthal PB, 2015, CURR OPIN STRUC BIOL, V34, P135, DOI 10.1016/j.sbi.2015.07.002; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Stauber EJ, 2003, EUKARYOT CELL, V2, P978, DOI 10.1128/EC.2.5.978-994.2003; Su XD, 2019, NAT PLANTS, V5, P273, DOI 10.1038/s41477-019-0380-5; Su XD, 2017, SCIENCE, V357, P816, DOI 10.1126/science.aan0327; Takahashi H, 2006, P NATL ACAD SCI USA, V103, P477, DOI 10.1073/pnas.0509952103; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Teramoto H, 2001, PLANT CELL PHYSIOL, V42, P849, DOI 10.1093/pcp/pce115; Tokutsu R, 2013, P NATL ACAD SCI USA, V110, P10016, DOI 10.1073/pnas.1222606110; Tokutsu R, 2012, J BIOL CHEM, V287, P31574, DOI 10.1074/jbc.M111.331991; Torabi S, 2014, PLANT CELL, V26, P1183, DOI 10.1105/tpc.113.120444; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; van Bezouwen LS, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.80; Watanabe A, 2019, FEBS LETT, V593, P1072, DOI 10.1002/1873-3468.13394; Wei XP, 2016, NATURE, V534, P69, DOI 10.1038/nature18020; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	48	14	14	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2019	294	41					15003	15013		10.1074/jbc.RA119.009341	http://dx.doi.org/10.1074/jbc.RA119.009341			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9JH	31420447	hybrid, Green Published			2022-12-26	WOS:000499253400014
J	Peterson, E; Shippee, E; Brinton, MA; Kaur, P				Peterson, Elizabeth; Shippee, Emma; Brinton, Margo A.; Kaur, Parjit			Biochemical characterization of the mouse ABCF3 protein, a partner of the flavivirus-resistance protein OAS1B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; fluorescence; flavivirus; sphingolipid; ATPase; ABCF3; ATP hydrolysis; OAS1B; sphingolipids; West Nile virus	GLYCOPROTEIN MULTIDRUG TRANSPORTER; RAT NEUROTENSIN RECEPTOR; BINDING CASSETTE PROTEIN; 2',5'-OLIGOADENYLATE SYNTHETASE; P-GLYCOPROTEIN; BACTERIAL EXPRESSION; VIRUS-REPLICATION; ABC50 INTERACTS; INDUCED DISEASE; ATP HYDROLYSIS	Mammalian ATP-binding cassette (ABC) subfamily F member 3 (ABCF3) is a class 2 ABC protein that has previously been identified as a partner of the mouse flavivirus resistance protein 2?,5?-oligoadenylate synthetase 1B (OAS1B). The functions and natural substrates of ABCF3 are not known. In this study, analysis of purified ABCF3 showed that it is an active ATPase, and binding analyses with a fluorescent ATP analog suggested unequal contributions by the two nucleotide-binding domains. We further showed that ABCF3 activity is increased by lipids, including sphingosine, sphingomyelin, platelet-activating factor, and lysophosphatidylcholine. However, cholesterol inhibited ABCF3 activity, whereas alkyl ether lipids either inhibited or resulted in a biphasic response, suggesting small changes in lipid structure differentially affect ABCF3 activity. Point mutations in the two nucleotide-binding domains of ABCF3 affected sphingosine-stimulated ATPase activity differently, further supporting different roles for the two catalytic pockets. We propose a model in which pocket 1 is the site of basal catalysis, whereas pocket 2 engages in ligand-stimulated ATP hydrolysis. Co-localization of the ABCF3?OAS1B complex to the virus-remodeled endoplasmic reticulum membrane has been shown before. We also noted that co-expression of ABCF3 and OAS1B in bacteria alleviated growth inhibition caused by expression of OAS1B alone, and ABCF3 significantly enhanced OAS1B levels, indirectly showing interaction between these two proteins in bacterial cells. As viral RNA synthesis requires large amounts of ATP, we conclude that lipid-stimulated ATP hydrolysis may contribute to the reduction in viral RNA production characteristic of the flavivirus resistance phenotype.	[Peterson, Elizabeth; Shippee, Emma; Brinton, Margo A.; Kaur, Parjit] Georgia State Univ, Dept Biol, POB 4010, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Kaur, P (corresponding author), Georgia State Univ, Dept Biol, POB 4010, Atlanta, GA 30303 USA.	pkaur@gsu.edu		Peterson, Elizabeth/0000-0002-1615-1992	USPHS National Institutes of Health Grant from NIAID [5R01AI045135-12]; Georgia State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045135] Funding Source: NIH RePORTER	USPHS National Institutes of Health Grant from NIAID; Georgia State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by USPHS National Institutes of Health Grant 5R01AI045135-12 from NIAID (to M. A. B. and P. K.) and by a graduate fellowship from Georgia State University (to E. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akiyama Y, 1996, J BIOL CHEM, V271, P31196, DOI 10.1074/jbc.271.49.31196; Akiyama Y, 2009, J BIOCHEM, V146, P449, DOI 10.1093/jb/mvp071; Ambrose KD, 2005, ANTIMICROB AGENTS CH, V49, P4203, DOI 10.1128/AAC.49.10.4203-4209.2005; AMBUDKAR SV, 1992, P NATL ACAD SCI USA, V89, P8472, DOI 10.1073/pnas.89.18.8472; Andersen CBF, 2006, NATURE, V443, P663, DOI 10.1038/nature05126; Ando-Akatsuka Y, 2012, J CELL PHYSIOL, V227, P3498, DOI 10.1002/jcp.24050; Boel G, 2014, NAT STRUCT MOL BIOL, V21, P143, DOI 10.1038/nsmb.2740; Brinton M. A., 1996, VIRAL PATHOGENESIS, P303; Chen B, 2014, NAT STRUCT MOL BIOL, V21, P152, DOI 10.1038/nsmb.2741; Chotiwan N, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006853; Chuang CK, 2017, CELL HOST MICROBE, V22, P639, DOI 10.1016/j.chom.2017.10.004; Clay AT, 2015, BIOCHEMISTRY-US, V54, P6586, DOI 10.1021/acs.biochem.5b00904; Courtney SC, 2012, J VIROL, V86, P7953, DOI 10.1128/JVI.00333-12; Daniel J, 2018, BIOCHEM BIOPH RES CO, V495, P35, DOI 10.1016/j.bbrc.2017.10.168; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; DEALDANA CRV, 1995, EMBO J, V14, P3184, DOI 10.1002/j.1460-2075.1995.tb07321.x; Dong JS, 2005, MOL CELL BIOL, V25, P9859, DOI 10.1128/MCB.25.22.9859-9873.2005; Eckford PDW, 2008, J BIOL CHEM, V283, P12840, DOI 10.1074/jbc.M708274200; Eckford PDW, 2006, BIOCHEM CELL BIOL, V84, P1022, DOI 10.1139/O06-196; Elbahesh H, 2011, VIROLOGY, V409, P262, DOI 10.1016/j.virol.2010.10.016; Elkhateeb E, 2016, INFECT GENET EVOL, V45, P393, DOI 10.1016/j.meegid.2016.09.018; Osuna-Ramos JF, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00388; Gebhard LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036244; Gorynia S, 2008, ACTA CRYSTALLOGR F, V64, P840, DOI 10.1107/S174430910802558X; GRISSHAMMER R, 1993, BIOCHEM J, V295, P571, DOI 10.1042/bj2950571; GRISSHAMMER R, 1994, RECEPTOR CHANNEL, V2, P295; Gubellini F, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007930; Guo FY, 2015, MOL BIOL CELL, V26, P2311, DOI 10.1091/mbc.E14-09-1343; Holland I. B., 2003, ABC PROTEINS BACTERI, P14; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Jacquemyn J, 2017, EMBO REP, V18, P1905, DOI 10.15252/embr.201643426; Jacquet E, 2008, J BIOL CHEM, V283, P25332, DOI 10.1074/jbc.M800418200; Jaffres PA, 2016, PHARMACOL THERAPEUT, V165, P114, DOI 10.1016/j.pharmthera.2016.06.003; Kajaste-Rudnitski A, 2006, J BIOL CHEM, V281, P4624, DOI 10.1074/jbc.M508649200; Kakuta S, 2002, J INTERF CYTOK RES, V22, P981, DOI 10.1089/10799900260286696; Khow Orawan, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P159, DOI 10.1016/S2221-1691(11)60213-X; Kiefer H, 2000, RECEPTOR CHANNEL, V7, P109; Kiefer H, 1996, BIOCHEMISTRY-US, V35, P16077, DOI 10.1021/bi9612069; Kurata S, 2010, P NATL ACAD SCI USA, V107, P10854, DOI 10.1073/pnas.1006247107; Laage R, 2001, TRAFFIC, V2, P99, DOI 10.1034/j.1600-0854.2001.020204.x; Lee MN, 2013, NAT IMMUNOL, V14, P179, DOI 10.1038/ni.2509; Lenart J, 2015, ANTIMICROB AGENTS CH, V59, P1360, DOI 10.1128/AAC.04468-14; Li W, 2014, J BIOL CHEM, V289, P12633, DOI 10.1074/jbc.M113.536136; Li W, 2013, J BIOL CHEM, V288, P11854, DOI 10.1074/jbc.M112.441915; Liu RH, 1996, BIOCHEMISTRY-US, V35, P11865, DOI 10.1021/bi960823u; Liu RH, 2000, BIOCHEMISTRY-US, V39, P14927, DOI 10.1021/bi0018786; Martin-Acebes MA, 2016, PROG LIPID RES, V64, P123, DOI 10.1016/j.plipres.2016.09.005; MARTINEZ E, 1988, GENE, V68, P159, DOI 10.1016/0378-1119(88)90608-7; Marton MJ, 1997, MOL CELL BIOL, V17, P4474, DOI 10.1128/MCB.17.8.4474; Mashimo T, 2002, P NATL ACAD SCI USA, V99, P11311, DOI 10.1073/pnas.172195399; Monne M, 2005, PROTEIN SCI, V14, P3048, DOI 10.1110/ps.051689905; Murat D, 2006, J BIOL CHEM, V281, P6850, DOI 10.1074/jbc.M509926200; Murina V, 2018, NUCLEIC ACIDS RES, V46, P3753, DOI 10.1093/nar/gky050; Murinat V, 2019, J MOL BIOL, V431, P3568, DOI 10.1016/j.jmb.2018.12.013; Nunez-Samudio V, 2013, RES MICROBIOL, V164, P226, DOI 10.1016/j.resmic.2012.12.003; Patoli BB, 2017, MICROBIOL-SGM, V163, P1802, DOI 10.1099/mic.0.000562; Paul D, 2015, ANNU REV VIROL, V2, P289, DOI 10.1146/annurev-virology-100114-055007; Paytubi S, 2008, BIOCHEM J, V409, P223, DOI 10.1042/BJ20070811; Perelygin AA, 2002, P NATL ACAD SCI USA, V99, P9322, DOI 10.1073/pnas.142287799; Perelygin AA, 2006, J MOL EVOL, V63, P562, DOI 10.1007/s00239-006-0073-3; Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584; Plesniak L, 2002, BIOCHEMISTRY-US, V41, P13876, DOI 10.1021/bi020331j; Putman M, 1999, BIOCHEMISTRY-US, V38, P13900, DOI 10.1021/bi991262k; Qu L, 2018, STRUCTURE, V26, P1259, DOI 10.1016/j.str.2018.05.019; Quazi F, 2013, J BIOL CHEM, V288, P34414, DOI 10.1074/jbc.M113.508812; Rahman SJ, 2018, ARCH BIOCHEM BIOPHYS, V658, P31, DOI 10.1016/j.abb.2018.09.017; Scherbik SV, 2007, VIROLOGY, V368, P232, DOI 10.1016/j.virol.2007.08.017; Sharkey LKR, 2016, MBIO, V7, DOI 10.1128/mBio.01975-15; Silverman RH, 2007, J VIROL, V81, P12720, DOI 10.1128/JVI.01471-07; SKOGERSON L, 1976, P NATL ACAD SCI USA, V73, P73, DOI 10.1073/pnas.73.1.73; Stewart RC, 1998, BIOCHEMISTRY-US, V37, P12269, DOI 10.1021/bi980970n; TAURA T, 1993, J BACTERIOL, V175, P7771, DOI 10.1128/JB.175.24.7771-7775.1993; Telbisz A, 2014, DRUG METAB DISPOS, V42, P575, DOI 10.1124/dmd.113.055731; ter Beek J, 2014, J GEN PHYSIOL, V143, P419, DOI 10.1085/jgp.201411164; Thakur KG, 2010, PROTEIN EXPRES PURIF, V74, P223, DOI 10.1016/j.pep.2010.06.018; TRIANAALONSO FJ, 1995, J BIOL CHEM, V270, P20473, DOI 10.1074/jbc.270.35.20473; Tucker J, 1996, BIOCHEM J, V317, P891, DOI 10.1042/bj3170891; Tyzack JK, 2000, J BIOL CHEM, V275, P34131, DOI 10.1074/jbc.M002868200; URBATSCH IL, 1995, ARCH BIOCHEM BIOPHYS, V316, P135, DOI 10.1006/abbi.1995.1020; Vihervaara T, 2011, CELL MOL LIFE SCI, V68, P537, DOI 10.1007/s00018-010-0470-z; Villaverde A, 2015, NANOMEDICINE-UK, V10, P2881, DOI 10.2217/nnm.15.125; Wagner S, 2007, MOL CELL PROTEOMICS, V6, P1527, DOI 10.1074/mcp.M600431-MCP200; Wagner S, 2006, TRENDS BIOTECHNOL, V24, P364, DOI 10.1016/j.tibtech.2006.06.008; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Wilson DN, 2016, MBIO, V7, DOI 10.1128/mBio.00598-16; Yao HB, 2006, ARCH BIOCHEM BIOPHYS, V451, P175, DOI 10.1016/j.abb.2006.04.011; Zhang H, 2015, BIOCHEM BIOPH RES CO, V459, P148, DOI 10.1016/j.bbrc.2015.02.086; Zhou J, 2013, MOL BIOL REP, V40, P5759, DOI 10.1007/s11033-013-2679-z	88	3	3	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2019	294	41					14937	14952		10.1074/jbc.RA119.008477	http://dx.doi.org/10.1074/jbc.RA119.008477			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9JH	31413116	hybrid, Green Published			2022-12-26	WOS:000499253400009
J	Gregory, PA				Gregory, Philip A.			The miR-200-Quaking axis functions in tumour angiogenesis	ONCOGENE			English	Editorial Material							RNA-BINDING PROTEINS; MIR-200 FAMILY; QUAKING; METASTASIS; PROMOTES; CANCER; ZEB1; REPRESSION; INVASION; EMT		[Gregory, Philip A.] Univ South Australia, Ctr Canc Biol, Adelaide, SA 5000, Australia; [Gregory, Philip A.] SA Pathol, Adelaide, SA 5000, Australia; [Gregory, Philip A.] Univ Adelaide, Discipline Med, Adelaide, SA 5005, Australia	Centre for Cancer Biology; University of South Australia; SA Pathology; University of Adelaide	Gregory, PA (corresponding author), Univ South Australia, Ctr Canc Biol, Adelaide, SA 5000, Australia.; Gregory, PA (corresponding author), SA Pathol, Adelaide, SA 5000, Australia.; Gregory, PA (corresponding author), Univ Adelaide, Discipline Med, Adelaide, SA 5005, Australia.	philip.gregory@unisa.edu.au			Cancer Council's Beat Cancer Project; State Government through the Department of Health	Cancer Council's Beat Cancer Project; State Government through the Department of Health	This work was undertaken with the financial support of Cancer Council's Beat Cancer Project on behalf of its donors and the State Government through the Department of Health.	Azam SH, 2019, ONCOGENE, V38, P5191, DOI 10.1038/s41388-019-0786-6; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Bracken CP, 2014, EMBO J, V33, P2040, DOI 10.15252/embj.201488641; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Chan YC, 2012, ARTERIOSCL THROM VAS, V32, P1372, DOI 10.1161/ATVBAHA.112.248583; Chan YC, 2011, J BIOL CHEM, V286, P2047, DOI 10.1074/jbc.M110.158790; Chen AJ, 2012, GENE DEV, V26, P1459, DOI 10.1101/gad.189001.112; Cochrane A, 2017, STEM CELLS, V35, P952, DOI 10.1002/stem.2594; Conn SJ, 2015, CELL, V160, P1125, DOI 10.1016/j.cell.2015.02.014; Darbelli L, 2016, WIRES RNA, V7, P399, DOI 10.1002/wrna.1344; de Bruin RG, 2016, SCI REP-UK, V6, DOI 10.1038/srep21643; Ding YZ, 2017, LIFE SCI, V191, P245, DOI 10.1016/j.lfs.2017.09.001; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Gill JG, 2012, STEM CELLS DEV, V21, P167, DOI 10.1089/scd.2011.0194; Goel S, 2018, TRENDS CELL BIOL, V28, P911, DOI 10.1016/j.tcb.2018.07.002; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Harrison EB, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00307; Hoefert JE, 2018, J CELL BIOL, V217, P2185, DOI 10.1083/jcb.201708173; Kim EJ, 2019, INT J CANCER, V145, P1585, DOI 10.1002/ijc.32372; Larocque D, 2005, NAT NEUROSCI, V8, P27, DOI 10.1038/nn1359; Liu TZ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13923; Lupo G, 2017, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00519; Magenta A, 2011, CELL DEATH DIFFER, V18, P1628, DOI 10.1038/cdd.2011.42; Noveroske JK, 2002, GENESIS, V32, P218, DOI 10.1002/gene.10060; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pecot CV, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3427; Pillman KA, 2018, EMBO J, V37, DOI 10.15252/embj.201899016; Schettini F, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00608; van Mil A, 2012, CARDIOVASC RES, V93, P655, DOI 10.1093/cvr/cvs003; Zhou X, 2017, ONCOTARGET, V8, P82174, DOI 10.18632/oncotarget.19066; Zong FY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004289	33	2	2	2	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 10	2019	38	41					6767	6769		10.1038/s41388-019-0916-1	http://dx.doi.org/10.1038/s41388-019-0916-1			3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JC8UZ	31406253				2022-12-26	WOS:000489552900004
J	Mkuu, RS; Gilreath, TD; Wekullo, C; Reyes, GA; Harvey, IS				Mkuu, Rahma S.; Gilreath, Tamika D.; Wekullo, Caroline; Reyes, Gabriela A.; Harvey, Idethia S.			Social determinants of hypertension and type-2 diabetes in Kenya: A latent class analysis of a nationally representative sample	PLOS ONE			English	Article							COMPARATIVE RISK-ASSESSMENT; BLOOD-PRESSURE; GLOBAL BURDEN; CARDIOVASCULAR-DISEASE; SYSTEMATIC ANALYSIS; PREVALENCE; OBESITY; AWARENESS; CLUSTERS; DIETARY	Introduction Cardiovascular disease is among the leading causes of death in Kenya and type II diabetes (T2D) is a growing chronic health concern in the country. However, a gap exists in examining how demographic and social characteristics coalesce to identify individuals at high risk for hypertension and/or T2D in Kenya. The current study examined demographic typologies associated with self-report diagnoses. Methods Nationally representative cross-sectional study using 43,898 individuals from the Kenya Demographic and Health Survey 2014. Main Outcome Measures were self-reported Hypertension and Type 2 Diabetes diagnosis. Descriptive analyses were conducted using STATA 14. Latent class analysis (LCA) was conducted using Mplus 7.4. Results Approximately 5% reported hypertension and 1% reported T2D. Latent class analysis suggested a 4-class solution. The class with the highest likelihood to report previous diagnosis of hypertension (10.4%), consisted of high proportion of married adult women. The second highest prevalence of previous diagnosis of hypertension (4.4%) consisted of a high proportion of married middle aged men with high probability of being smokers. The results suggest that Kenyan women over 30 years may be at increased risk of hypertension compared to men. Future studies should include additional socio-demographic and behavioral characteristics to better understand gender differences in correlates for hypertension to be used for targeted and tailored health promotion-interventions.	[Mkuu, Rahma S.; Gilreath, Tamika D.; Harvey, Idethia S.] Texas A&M Univ, Transdisciplinary Ctr Hlth Equ Res, Dept Hlth & Kinesiol, College Stn, TX 77843 USA; [Wekullo, Caroline] Masinde Muliro Univ Sci & Technol, Post Grad Studies, Kakamega, Kenya; [Reyes, Gabriela A.] Colorado Univ, Colorado Sch Publ Hlth, Denver Anschutz Med Campus, Denver, CO USA	Texas A&M University System; Texas A&M University College Station; Colorado School of Public Health; University of Colorado System; University of Colorado Denver	Mkuu, RS (corresponding author), Texas A&M Univ, Transdisciplinary Ctr Hlth Equ Res, Dept Hlth & Kinesiol, College Stn, TX 77843 USA.	rsmkuu@tamu.edu	Harvey, Idethia/AAI-3459-2020	Gilreath, Tamika/0000-0001-9545-9153; Mkuu, Rahma/0000-0002-4541-2821; Harvey, Idethia Shevon/0000-0002-6535-3910				Asparouhov T., 2010, MPLUSTECHNICAL APPEN; Ayah R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-371; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; Centre for Sport and Human Rights, 2019, MAPP ACC REM MECH SP; Chin JH, 2017, ETHNIC DIS, V27, P15, DOI 10.18865/ed.27.1.15; Christensen DL, 2016, ANN HUM BIOL, V43, P42, DOI 10.3109/03014460.2015.1013987; Cisse-Egbuonye N, 2017, MATERN CHILD HLTH J, V21, P1408, DOI 10.1007/s10995-016-2248-x; Donnison CP, 1929, LANCET, V1, P6; Forouzanfar MH, 2017, JAMA-J AM MED ASSOC, V317, P165, DOI 10.1001/jama.2016.19043; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Hagenaars J., 2002, APPL LATENT CLASS AN, DOI DOI 10.1017/CBO9780511499531; Irazola VE, 2016, GLOB HEART, V11, P47, DOI 10.1016/j.gheart.2015.12.008; Joshi MD, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1177; Kenya National Bureau of Statistics Ministry of Health National AIDS Control Council Kenya Medical Research Institute, 2015, KEN DEM HLTH SURV 20; Kimani-Murage EW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129943; Kiraka G, 2014, AJDM, V22; Kotchen TA, 2010, AM J HYPERTENS, V23, P1170, DOI 10.1038/ajh.2010.172; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; MANN GV, 1964, J ATHEROSCLER RES, V4, P289, DOI 10.1016/S0368-1319(64)80041-7; Muthuri SK, 2017, HEALTH CARE WOMEN IN, V38, P38, DOI 10.1080/07399332.2016.1245306; Olack B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2610-8; Oti SO, 2013, TROP MED INT HEALTH, V18, P1520, DOI 10.1111/tmi.12200; Pawelec G, 2014, CURR OPIN IMMUNOL, V29, P23, DOI 10.1016/j.coi.2014.03.007; Ploubidis GB, 2013, INT J PUBLIC HEALTH, V58, P133, DOI 10.1007/s00038-012-0389-2; Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289; Sobngwi E, 2002, INT J OBESITY, V26, P1009, DOI 10.1038/sj.ijo.0802008; Steyn NP, 2011, SCAND J PUBLIC HEALT, V39, P88, DOI 10.1177/1403494810384426; van de Vijver SJM, 2013, J HYPERTENS, V31, P1018, DOI 10.1097/HJH.0b013e32835e3a56; WHO, GLOB REP DIAB; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890	32	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0221257	10.1371/journal.pone.0221257	http://dx.doi.org/10.1371/journal.pone.0221257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5MK	31425539	Green Published, gold, Green Submitted			2022-12-26	WOS:000485022400031
J	Gilbertie, JM; Schnabel, LV; Hickok, NJ; Jacob, ME; Conlon, BP; Shapiro, IM; Parvizi, J; Schaer, TP				Gilbertie, Jessica M.; Schnabel, Lauren V.; Hickok, Noreen J.; Jacob, Megan E.; Conlon, Brian P.; Shapiro, Irving M.; Parvizi, Javad; Schaer, Thomas P.			Equine or porcine synovial fluid as a novel ex vivo model for the study of bacterial free-floating biofilms that form in human joint infections	PLOS ONE			English	Article							STAPHYLOCOCCUS-EPIDERMIDIS; SEPTIC ARTHRITIS; AMIKACIN SULFATE; HORSES; AGGREGATION; PHARMACOKINETICS/PHARMACODYNAMICS; COMBINATION; MECHANISMS; PERFUSION; IMIPENEM	Bacterial invasion of synovial joints, as in infectious or septic arthritis, can be difficult to treat in both veterinary and human clinical practice. Biofilms, in the form of free-floating clumps or aggregates, are involved with the pathogenesis of infectious arthritis and periprosthetic joint infection (PJI). Infection of a joint containing an orthopedic implant can additionally complicate these infections due to the presence of adherent biofilms. Because of these biofilm phenotypes, bacteria within these infected joints show increased antimicrobial tolerance even at high antibiotic concentrations. To date, animal models of PJI or infectious arthritis have been limited to small animals such as rodents or rabbits. Small animal models, however, yield limited quantities of synovial fluid making them impractical for in vitro research. Herein, we describe the use of ex vivo equine and porcine models for the study of synovial fluid induced biofilm aggregate formation and antimicrobial tolerance. We observed Staphylococcus aureus and other bacterial pathogens adapt the same biofilm aggregate phenotype with significant antimicrobial tolerance in both equine and porcine synovial fluid, analogous to human synovial fluid. We also demonstrate that enzymatic dispersal of synovial fluid aggregates restores the activity of antimicrobials. Future studies investigating the interaction of bacterial cell surface proteins with host synovial fluid proteins can be readily carried out in equine or porcine ex vivo models to identify novel drug targets for treatment of prevention of these difficult to treat infectious diseases.	[Gilbertie, Jessica M.; Schnabel, Lauren V.] North Carolina State Univ, Dept Clin Sci, Coll Vet Med, Raleigh, NC 27695 USA; [Gilbertie, Jessica M.; Schnabel, Lauren V.; Jacob, Megan E.] North Carolina State Univ, Comparat Med Inst, Raleigh, NC 27695 USA; [Gilbertie, Jessica M.; Schaer, Thomas P.] Univ Penn, Sch Vet Med, Dept Clin Studies, New Bolton Ctr, Kennett Sq, PA 19348 USA; [Hickok, Noreen J.; Shapiro, Irving M.; Parvizi, Javad] Thomas Jefferson Univ, Dept Orthoped Surg, Philadelphia, PA 19107 USA; [Jacob, Megan E.] North Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA; [Conlon, Brian P.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of Pennsylvania; Jefferson University; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill	Schnabel, LV (corresponding author), North Carolina State Univ, Dept Clin Sci, Coll Vet Med, Raleigh, NC 27695 USA.; Schnabel, LV (corresponding author), North Carolina State Univ, Comparat Med Inst, Raleigh, NC 27695 USA.; Schaer, TP (corresponding author), Univ Penn, Sch Vet Med, Dept Clin Studies, New Bolton Ctr, Kennett Sq, PA 19348 USA.	lvschnab@ncsu.edu; tpschaer@vet.upenn.edu	Schaer, Thomas/F-4519-2010	Schaer, Thomas/0000-0002-4340-8212; Conlon, Brian/0000-0002-2155-8375; Gilbertie, Jessica/0000-0002-4953-6717	Raymond Firestone Trust, University of Pennsylvania Internal Grant; National Institutes of Health (NIH) [R01 AR072513]; Fund for Orthopedic Research in honor of Gus and Equine athletes (F.O.R.G.E), private foundation through The Schnabel Laboratory at North Carolina State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI137273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR072513] Funding Source: NIH RePORTER	Raymond Firestone Trust, University of Pennsylvania Internal Grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fund for Orthopedic Research in honor of Gus and Equine athletes (F.O.R.G.E), private foundation through The Schnabel Laboratory at North Carolina State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by: (1) Raymond Firestone Trust (JMG and TPS), University of Pennsylvania Internal Grant; NO URL; (2) National Institutes of Health (NIH) under award number R01 AR072513 (NJH, IMS and TPS), https://www.niams.nih.gov/; (3) The Fund for Orthopedic Research in honor of Gus and Equine athletes (F. O. R. G. E; LVS), private foundation through The Schnabel Laboratory at North Carolina State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner T, 2010, OSTEOARTHR CARTILAGE, V18, pS2, DOI 10.1016/j.joca.2010.07.013; Alhede M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027943; Arciola CR, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00007; Barton Nicola J, 2007, J Inflamm (Lond), V4, P13, DOI 10.1186/1476-9255-4-13; Bay L, 2018, ADV WOUND CARE, V7, P105, DOI 10.1089/wound.2017.0770; Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Belfield K, 2015, INT J PEDIATR OTORHI, V79, P296, DOI 10.1016/j.ijporl.2015.01.003; Bjarnsholt T, 2013, TRENDS MICROBIOL, V21, P466, DOI 10.1016/j.tim.2013.06.002; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Bolt DM, 2008, AM J VET RES, V69, P861, DOI 10.2460/ajvr.69.7.861; Borg H, 2013, VET SURG, V42, P262, DOI 10.1111/j.1532-950X.2013.01106.x; Burmolle M, 2010, FEMS IMMUNOL MED MIC, V59, P324, DOI 10.1111/j.1574-695X.2010.00714.x; Ceri H, 1999, J CLIN MICROBIOL, V37, P1771, DOI 10.1128/JCM.37.6.1771-1776.1999; Corrado A, 2016, SCI REP-UK, V6, DOI 10.1038/srep38043; Crosby HA, 2016, ADV APPL MICROBIOL, V96, P1, DOI 10.1016/bs.aambs.2016.07.018; Dastgheyb S, 2015, J INFECT DIS, V211, P641, DOI 10.1093/infdis/jiu514; Dastgheyb SS, 2015, INFECT IMMUN, V83, P2966, DOI 10.1128/IAI.00394-15; Dastgheyb SS, 2015, ANTIMICROB AGENTS CH, V59, P2122, DOI 10.1128/AAC.04579-14; Fleming D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29121-2; GATELL JM, 1983, ANTIMICROB AGENTS CH, V23, P897, DOI 10.1128/AAC.23.6.897; Gawande PV, 2014, CURR MICROBIOL, V68, P635, DOI 10.1007/s00284-014-0519-6; Gilbertie JM, 2019, EQUINE VET J, V51, P537, DOI 10.1111/evj.13048; Gilbertie JM, 2018, VET MICROBIOL, V226, P64, DOI 10.1016/j.vetmic.2018.10.009; Gries CM, 2017, J AM ACAD ORTHOP SUR, V25, pS20, DOI 10.5435/JAAOS-D-16-00636; Haley CL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-181; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Hanke ML, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00062; Horohov DW, 2015, MOL IMMUNOL, V66, P89, DOI 10.1016/j.molimm.2014.09.020; Hurtig MB, 2011, CARTILAGE, V2, P137, DOI 10.1177/1947603511401905; Ibberson CB, 2016, INFECT IMMUN, V84, P1917, DOI 10.1128/IAI.01418-15; Jarvis Gavin E, 2004, Methods Mol Biol, V272, P65; Jensen LK, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01889-18; Josefsson E, 2001, J INFECT DIS, V184, P1572, DOI 10.1086/324430; KANAZAWA Y, 1984, NIPPON KAGAKU KAISHI, P434, DOI 10.1246/nikkashi.1984.434; Kirchner S, 2012, JOVE-J VIS EXP, DOI 10.3791/3857; Kragh KN, 2016, MBIO, V7, DOI 10.1128/mBio.00237-16; Kuyinu EL, 2016, J ORTHOP SURG RES, V11, DOI 10.1186/s13018-016-0346-5; Lan Z, 2005, AM J CLIN PATHOL, V123, P172, DOI 10.1309/Y9EC63RW3XG1V313; Landry RM, 2006, MOL MICROBIOL, V59, P142, DOI 10.1111/j.1365-2958.2005.04941.x; Lora-Tamayo J, 2013, CLIN INFECT DIS, V56, P182, DOI 10.1093/cid/cis746; Lorian V, 1982, J CLIN MICROBIOLOGY; Mage RG, 2019, DEV COMP IMMUNOL, V92, P99, DOI 10.1016/j.dci.2018.10.003; Mair KH, 2014, DEV COMP IMMUNOL, V45, P321, DOI 10.1016/j.dci.2014.03.022; Mathews CJ, 2010, LANCET, V375, P846, DOI 10.1016/S0140-6736(09)61595-6; Matsuzaka S, 2002, CLIN EXP RHEUMATOL, V20, P531; McConoughey SJ, 2014, FUTURE MICROBIOL, V9, P987, DOI [10.2217/fmb.14.64, 10.2217/FMB.14.64]; McCoy AM, 2015, VET PATHOL, V52, P803, DOI 10.1177/0300985815588611; McIlwraith CW, 2012, BONE JOINT RES, V1, P297, DOI 10.1302/2046-3758.111.2000132; McIlwraith CW, 2011, CARTILAGE, V2, P317, DOI 10.1177/1947603511406531; Moran Conor J, 2016, J Exp Orthop, V3, P1, DOI 10.1186/s40634-015-0037-x; Morton AJ, 2005, VET CLIN N AM-EQUINE, V21, P627, DOI 10.1016/j.cveq.2005.08.001; Mottola C, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0737-0; Murphey ED, 1999, J VET PHARMACOL THER, V22, P68, DOI 10.1046/j.1365-2885.1999.00180.x; Nieto JE, 2016, CAN J VET RES, V80, P230; O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Paharik AE, 2016, VIRULENCE MECHANISMS OF BACTERIAL PATHOGENS, 5 EDITION, P529, DOI 10.1128/microbiolspec.VMBF-0022-2015; Perez K, 2015, J INFECT DIS, V212, P335, DOI 10.1093/infdis/jiv096; Pinto N, 2010, PHARMACOKINETICS AMI, DOI [10.1111/j.2042-3306.2010.00144.x, DOI 10.1111/J.2042-3306.2010.00144.X]; Post JC, 2001, LARYNGOSCOPE, V111, P2083, DOI 10.1097/00005537-200112000-00001; Pulido L, 2008, CLIN ORTHOP RELAT R, V466, P1710, DOI 10.1007/s11999-008-0209-4; Secor PR, 2018, P NATL ACAD SCI USA, V115, P10780, DOI 10.1073/pnas.1806005115; Seifer DR, 2008, OSTEOARTHR CARTILAGE, V16, P1532, DOI 10.1016/j.joca.2008.04.013; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shirtliff ME, 2002, CLIN MICROBIOL REV, V15, P527, DOI 10.1128/CMR.15.4.527-544.2002; Sonderholm M, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00113-17; Stewart PS, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0010-2014; Swindle MM, 2012, VET PATHOL, V49, P344, DOI 10.1177/0300985811402846; Taintor J, 2006, EQUINE VET J, V38, P189, DOI 10.2746/042516406776563233; Tande AJ, 2014, CLIN MICROBIOL REV, V27, P302, DOI 10.1128/CMR.00111-13; Taylor AH, 2010, EQUINE VET J, V42, P213, DOI 10.2746/042516409X480403; Tong SYC, 2015, CLIN MICROBIOL REV, V28, P603, DOI 10.1128/CMR.00134-14; Tremblay YDN, 2017, MICROB BIOTECHNOL, V10, P756, DOI 10.1111/1751-7915.12432; VANPELT RW, 1967, CAN J COMPARAT MED, V31, P342; Walmsley EA, 2011, AUST VET J, V89, P226, DOI 10.1111/j.1751-0813.2011.00720.x; Wang HZ, 2012, ANTIMICROB AGENTS CH, V56, P2683, DOI 10.1128/AAC.06486-11; Wang HZ, 2011, ANTIMICROB AGENTS CH, V55, P4469, DOI 10.1128/AAC.00126-11; Wang Y, 2017, P NATL ACAD SCI USA, V114, pE5094, DOI 10.1073/pnas.1703427114; Wu H, 2015, INT J ORAL SCI, V7, P1, DOI 10.1038/ijos.2014.65; Zimmerli W, 2017, APMIS, V125, P353, DOI 10.1111/apm.12687; Zimmerli W, 2012, FEMS IMMUNOL MED MIC, V65, P158, DOI 10.1111/j.1574-695X.2012.00938.x	81	29	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0221012	10.1371/journal.pone.0221012	http://dx.doi.org/10.1371/journal.pone.0221012			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415623	Green Published, Green Submitted, gold			2022-12-26	WOS:000485017200058
J	Meierhofer, D				Meierhofer, David			Acylcarnitine profiling by low-resolution LC-MS	PLOS ONE			English	Article							COMPREHENSIVE ANALYSIS; PLASMA; LIPIDS; METABOLOME; CARNITINE; ACIDS	Acylcarnitines are fatty acyl esters of L-carnitine and facilitate the entry of long-chain fatty acids into mitochondria via the carnitine shuttle, where they are metabolized via beta-oxidation. Alterations of acylcarnitine species can be diagnostic for fatty acid oxidation disorders and organic aciduria and are thus frequently used to screen newborns. Only a subfraction of all known acylcarnitines is thereby monitored and quantified. Therefore, a method for the simultaneous fast and robust detection of all known acylcarnitines was developed using a single concise liquid chromatography mass spectrometry (LC-MS) approach. Derivatization by 3-nitrophenylhydrazine increased the signal intensity of the acylcarnitines and a linear elution from a reversed phase column was observed that was dependent on the length of the carbon chain. This allowed a precise prediction of the exact elution time for each acylcarnitine class, which depended solely on the chemical nature of the carbon chain. This method can be further used to screen for yet unknown acylcarnitine species and adds a layer of confidence for their correct identification. Altogether 123 acylcarnitines species were used to establish a targeted low-resolution LC-MS method. The method was applied to acylcarnitine profiling in several mouse tissues and fluids, in order to identify large differences in the quantity and composition of acylcarnitines.	[Meierhofer, David] Max Planck Inst Mol Genet, Mass Spectrometry Facil, Berlin, Germany	Max Planck Society	Meierhofer, D (corresponding author), Max Planck Inst Mol Genet, Mass Spectrometry Facil, Berlin, Germany.	Meierhof@molgen.mpg.de	Meierhofer, David/V-4711-2019	Meierhofer, David/0000-0002-0170-868X				Batchuluun B, 2018, DIABETES, V67, P885, DOI 10.2337/db17-1150; BUCHI G, 1954, J AM CHEM SOC, V76, P4327, DOI 10.1021/ja01646a024; Gielisch I, 2015, J PROTEOME RES, V14, P224, DOI 10.1021/pr500894v; Han J, 2018, ANAL CHIM ACTA, V1037, P177, DOI 10.1016/j.aca.2018.01.045; Han J, 2015, ANAL CHIM ACTA, V854, P86, DOI 10.1016/j.aca.2014.11.015; Ma XX, 2014, ANGEW CHEM INT EDIT, V53, P2592, DOI 10.1002/anie.201310699; Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Ovcacikova M, 2016, J CHROMATOGR A, V1450, P76, DOI 10.1016/j.chroma.2016.04.082; Paterno E., 1909, GAZZ CHIM ITAL, V39, P341; Peng MZ, 2013, J CHROMATOGR B, V932, P12, DOI 10.1016/j.jchromb.2013.05.028; Ramsay RR, 2001, BBA-PROTEIN STRUCT M, V1546, P21, DOI 10.1016/S0167-4838(01)00147-9; Rinaldo P, 2008, GENET MED, V10, P151, DOI 10.1097/GIM.0b013e3181614289; Sandra K, 2010, J CHROMATOGR A, V1217, P4087, DOI 10.1016/j.chroma.2010.02.039; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089; Xiang L, 2017, ANAL CHEM, V89, P10368, DOI 10.1021/acs.analchem.7b02283; Xu G, 2016, J CLIN ENDOCR METAB, V101, P5044, DOI 10.1210/jc.2016-1859; Yoon Hye-Ran, 2015, Ann Pediatr Endocrinol Metab, V20, P119, DOI 10.6065/apem.2015.20.3.119; Yu D, 2018, ANAL CHEM, V90, P5712, DOI 10.1021/acs.analchem.7b05471; Zuniga A, 2011, ANAL CHIM ACTA, V689, P77, DOI 10.1016/j.aca.2011.01.018	22	10	10	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0221342	10.1371/journal.pone.0221342	http://dx.doi.org/10.1371/journal.pone.0221342			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415665	Green Published, Green Submitted, gold			2022-12-26	WOS:000485017200099
J	Gruber, DF; Phillips, BT; O'Brien, R; Boominathan, V; Veeraraghavan, A; Vasan, G; O'Brien, P; Pieribone, VA; Sparks, JS				Gruber, David F.; Phillips, Brennan T.; O'Brien, Rory; Boominathan, Vivek; Veeraraghavan, Ashok; Vasan, Ganesh; O'Brien, Peter; Pieribone, Vincent A.; Sparks, John S.			Bioluminescent flashes drive nighttime schooling behavior and synchronized swimming dynamics in flashlight fish	PLOS ONE			English	Article							LATERAL-LINE; LIGHT; BERYCIFORMES; ORGAN; MECHANISMS; THRESHOLD; TELEOSTEI; EVOLUTION	Schooling fishes, like flocking birds and swarming insects, display remarkable behavioral coordination. While over 25% of fish species exhibit schooling behavior, nighttime schooling has rarely been observed or reported. This is due to vision being the primary modality for schooling, which is corroborated by the fact that most fish schools disperse at critically low light levels. Here we report on a large aggregation of the bioluminescent flashlight fish Anomalops katoptron that exhibited nighttime schooling behavior during multiple moon phases, including the new moon. Data were recorded with a suite of low-light imaging devices, including a high-speed, high-resolution scientific complementary metal-oxide-semiconductor (sCMOS) camera. Image analysis revealed nighttime schooling using synchronized bioluminescent flashing displays, and demonstrated that school motion synchrony exhibits correlation with relative swim speed. A computer model of flashlight fish schooling behavior shows that only a small percentage of individuals need to exhibit bioluminescence in order for school cohesion to be maintained. Flashlight fish schooling is unique among fishes, in that bioluminescence enables schooling in conditions of no ambient light. In addition, some members can still partake in the school while not actively exhibiting their bioluminescence. Image analysis of our field data and model demonstrate that if a small percentage of fish become motivated to change direction, the rest of the school follows. The use of bioluminescence by flashlight fish to enable schooling in shallow water adds an additional ecological application to bioluminescence and suggests that schooling behavior in mesopelagic bioluminescent fishes may be also mediated by luminescent displays.	[Gruber, David F.] CUNY, Baruch Coll, Dept Nat Sci, New York, NY 10021 USA; [Gruber, David F.] CUNY, Grad Ctr, PhD Program Biol, New York, NY 10016 USA; [Gruber, David F.; Sparks, John S.] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Phillips, Brennan T.] Univ Rhode Isl, Dept Ocean Engn, Narragansett, RI USA; [O'Brien, Rory; Vasan, Ganesh; O'Brien, Peter; Pieribone, Vincent A.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, John B Pierce Lab, New Haven, CT 06510 USA; [Boominathan, Vivek; Veeraraghavan, Ashok] Rice Univ, Dept Elect & Comp Engn, POB 1892, Houston, TX 77251 USA; [Sparks, John S.] Amer Museum Nat Hist, Dept Ichthyol, Div Vertebrate Zool, New York, NY 10024 USA	City University of New York (CUNY) System; Baruch College (CUNY); City University of New York (CUNY) System; American Museum of Natural History (AMNH); University of Rhode Island; Yale University; The John B Pierce Laboratory, Inc; Rice University; American Museum of Natural History (AMNH)	Gruber, DF (corresponding author), CUNY, Baruch Coll, Dept Nat Sci, New York, NY 10021 USA.; Gruber, DF (corresponding author), CUNY, Grad Ctr, PhD Program Biol, New York, NY 10016 USA.; Gruber, DF (corresponding author), Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA.	David.Gruber@Baruch.cuny.au		Vasan, Ganesh/0000-0002-6612-7739; O'Brien, Ciara/0000-0002-3139-4298; Phillips, Brennan/0000-0003-4361-6529	NOAA OER grant [NA160AR0110198]; National Geographic Expedition Council [EC0780-16]; NSF [DBI-1556213, DEB -1257555]; The Ray and Barbara Dalio Family Foundation Explore21 AMNH expedition grant	NOAA OER grant; National Geographic Expedition Council; NSF(National Science Foundation (NSF)); The Ray and Barbara Dalio Family Foundation Explore21 AMNH expedition grant	This study was funded by NOAA OER grant #NA160AR0110198 to DFG, BP, JSS and VAP, National Geographic Expedition Council #EC0780-16 to BP, NSF grants #DBI-1556213 to DFG and #DEB -1257555 to JSS, and The Ray and Barbara Dalio Family Foundation Explore21 AMNH expedition grant to JSS, DFG, and VAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T., 1951, Japanese Journal of Ichthyology, V1, P304; BASSOT J-M, 1968, Bulletin de la Societe Zoologique de France, V93, P569; Bleeker P., 1856, ACTA SOC REGIAE SCI, V1, P1; Boddaert P., 1781, NEUE NORD BEITR PALL, P55; BREDER C. M., 1959, BULL AMER MUS NAT HIST, V117, P393; Burkenroad MD, 1943, J MAR RES, V5, P161; Butler JM, 2016, J EXP BIOL, V219, P2781, DOI 10.1242/jeb.133801; Chakrabarty P, 2011, MOL ECOL, V20, P2818, DOI 10.1111/j.1365-294X.2011.05112.x; CLARK E, 1978, NATL GEOGR, V154, P719; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Davis MP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155154; Davis MP, 2014, MAR BIOL, V161, P1139, DOI 10.1007/s00227-014-2406-x; Delcourt J, 2012, REV FISH BIOL FISHER, V22, P595, DOI 10.1007/s11160-012-9260-z; DIJKGRAAF S, 1963, BIOL REV, V38, P51, DOI 10.1111/j.1469-185X.1963.tb00654.x; Gibbons J. D., 2011, NONPARAMETRIC STAT I; Gonzalez R. C., 2008, DIGITAL IMAGE PROCES; Haddock SHD, 2010, ANNU REV MAR SCI, V2, P443, DOI 10.1146/annurev-marine-120308-081028; HARRIS GG, 1962, J ACOUST SOC AM, V34, P733, DOI 10.1121/1.1937263; Hellinger J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170489; Hemelrijk CK, 2008, ETHOLOGY, V114, P245, DOI 10.1111/j.1439-0310.2007.01459.x; HEMMINGS CC, 1966, J EXP BIOL, V45, P449; Hendry TA, 2016, GENOME BIOL EVOL, V8, P2203, DOI 10.1093/gbe/evw161; Hendry TA, 2011, MOL PHYLOGENET EVOL, V61, P834, DOI 10.1016/j.ympev.2011.08.006; Herskin J, 1998, J FISH BIOL, V53, P366, DOI 10.1006/jfbi.1998.0708; Higgs DM, 1996, J FISH BIOL, V48, P979, DOI 10.1006/jfbi.1996.0096; HUNTER J, 1985, FISH B-NOAA, V83, P235; HUNTER JR, 1968, J FISH RES BOARD CAN, V25, P393, DOI 10.1139/f68-031; Johnsen S., 2012, THE OPTICS OF LIFE A; JOHNSON GD, 1988, ZOOL J LINN SOC-LOND, V94, P65, DOI 10.1111/j.1096-3642.1988.tb00882.x; JONES FRH, 1956, J EXP BIOL, V33, P271; KESSEL M, 1977, CYTOBIOLOGIE, V15, P145; Kowalko JE, 2013, CURR BIOL, V23, P1874, DOI 10.1016/j.cub.2013.07.056; Krause J, 2000, BIOL REV, V75, P477; Krause J, 2002, LIVING GROUPS; Lee Z, 2015, APPL OPTICS, V54, P546, DOI 10.1364/AO.54.000546; MAGURRAN AE, 1990, ANN ZOOL FENN, V27, P51; MCCOSKER JE, 1987, JPN J ICHTHYOL, V34, P157, DOI 10.1007/BF02912410; MILTON AF, 1985, OPT ENG, V24, P855, DOI 10.1117/12.7973588; Miyazaki T, 2000, MAR ECOL PROG SER, V192, P267, DOI 10.3354/meps192267; MORIN JG, 1975, SCIENCE, V190, P74, DOI 10.1126/science.190.4209.74; Myers RF, 1999, MICRONESIAN REEF FIS, V3rd; Parr AE, 1931, AM NAT, V65, P173, DOI 10.1086/280359; Pavlov D.S., 2000, J ICHTHYOL+, V40, pS163; Phillips BT, 2016, DEEP-SEA RES PT I, V111, P102, DOI 10.1016/j.dsr.2016.02.012; PITCHER TJ, 1983, ANIM BEHAV, V31, P611, DOI 10.1016/S0003-3472(83)80087-6; PITCHER TJ, 1976, SCIENCE, V194, P963, DOI 10.1126/science.982056; RYER CH, 1992, ANIM BEHAV, V44, P69, DOI 10.1016/S0003-3472(05)80756-0; SHAW E, 1978, AM SCI, V66, P166; Shaw E., 1961, Bulletin de l'Institut Oceanographique Monaco, VNo. 1213, P1; Soltan K, 2018, OCEANS 2018 MTS IEEE, P1; Torisawa S, 2007, J FISH BIOL, V71, P411, DOI 10.1111/j.1095-8649.2007.01498.x; TURNER GF, 1986, AM NAT, V128, P228, DOI 10.1086/284556; Watson M, 1978, P ROY SOC LOND B BIO, P202	54	9	9	8	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0219852	10.1371/journal.pone.0219852	http://dx.doi.org/10.1371/journal.pone.0219852			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412054	Green Published, Green Submitted, gold			2022-12-26	WOS:000485012600016
J	Hassaan, PS; Dief, AE; Zeitoun, TM; Baraka, AM; Deacon, RMJ; Elshorbagy, A				Hassaan, Passainte S.; Dief, Abeer E.; Zeitoun, Teshreen M.; Baraka, Azza M.; Deacon, Robert M. J.; Elshorbagy, Amany			Cortical tau burden and behavioural dysfunctions in mice exposed to monosodium glutamate in early life	PLOS ONE			English	Article							SPECIES-TYPICAL BEHAVIORS; ALZHEIMERS-DISEASE; NEONATAL EXPOSURE; PHOSPHORYLATION; NEUROTOXICITY; HIPPOCAMPUS; PATHOLOGY; LESIONS; SITES; MODEL	Although monosodium glutamate (MSG)-induced neurotoxicity has been recognized for decades, the potential similarities of the MSG model to Alzheimer's disease (AD)-type neuropathology have only recently been investigated. MSG-treated mice were examined behaviourally and histologically in relation to some features of AD. Four-week old mice received 5 subcutaneous MSG (2 g/kg) injections on alternate days, or saline. At age 10-12 weeks, they were given a battery of behavioural tests for species-typical behaviours and working memory. The mice were killed at 12 weeks and the brains excised. Accumulation of hyperphosphorylated tau protein was assessed in cortical and hippocampal neurons by immunohistochemistry, and in cerebral cortical homogenates. A 78% increase in cortical concentrations of phosphorylated tau protein was observed in the MSG mice. Intracellular hyperphosphorylated tau immunostaining was observed diffusely in the cortex and hippo campus, together with cortical atrophic neurons, extensive vacuolation and dysmorphic neuropil suggestive of spongiform neurodegeneration. Nest-building was significantly impaired, and spontaneous T-maze alternation was reduced, suggesting defective short-term working memory. Subcutaneous MSG treatment also induced a 56% reduction in exploratory head dips in a holeboard (P = 0.009), and a non-significant tendency for decreased burrowing behaviour (P = 0.085). These effects occurred in the absence of MSG-induced obesity or gross locomotor deficits. The findings point to subcutaneous MSG administration in early life as a cause of tau pathology and compromised species-typical behaviour in rodents. Determining whether MSG can be useful in modelling AD requires further studies of longer duration and full behavioural characterization.	[Hassaan, Passainte S.; Dief, Abeer E.; Elshorbagy, Amany] Univ Alexandria, Fac Med, Dept Med Physiol, Alexandria, Egypt; [Zeitoun, Teshreen M.] Univ Alexandria, Fac Med, Dept Med Histol & Cell Biol, Alexandria, Egypt; [Baraka, Azza M.] Univ Alexandria, Fac Med, Dept Clin Pharmacol, Alexandria, Egypt; [Deacon, Robert M. J.] Univ Alexandria, Fac Med, Basic Sci Div, Alexandria, Egypt	Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Alexandria University	Dief, AE (corresponding author), Univ Alexandria, Fac Med, Dept Med Physiol, Alexandria, Egypt.	abeer.dief@alexmed.edu.eg		Elshorbagy, Amany/0000-0002-8624-860X				Ali MM, 2000, NEUROSCI LETT, V284, P57, DOI 10.1016/S0304-3940(00)00958-7; Andersen Christian K, 2004, Health Qual Life Outcomes, V2, P52, DOI 10.1186/1477-7525-2-52; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Beas-Zarate C, 2002, BRAIN RES, V952, P275, DOI 10.1016/S0006-8993(02)03252-3; Buerger K, 2002, NEUROLOGY, V59, P627, DOI 10.1212/WNL.59.4.627; Buerger K, 2006, BRAIN, V129, P3035, DOI 10.1093/brain/awl269; BURDE RM, 1971, NATURE, V233, P58, DOI 10.1038/233058a0; Cohen RM, 2013, J NEUROSCI, V33, P6245, DOI 10.1523/JNEUROSCI.3672-12.2013; Deacon RMJ, 2005, BEHAV BRAIN RES, V156, P241, DOI 10.1016/j.bbr.2004.05.027; Deacon RMJ, 2002, BEHAV BRAIN RES, V132, P203, DOI 10.1016/S0166-4328(01)00401-6; Deacon RMJ, 2014, J ALZHEIMERS DIS PAR, V4, P142, DOI [10.4172/2161-0460.1000142, DOI 10.4172/2161-0460.1000142]; Deacon R, 2012, JOVE-J VIS EXP, DOI 10.3791/2607; Dief AE, 2014, NEUROTOXICOLOGY, V42, P76, DOI 10.1016/j.neuro.2014.04.003; Doonan F, 2008, METHODS, V44, P200, DOI 10.1016/j.ymeth.2007.11.006; Dronse J, 2017, J ALZHEIMERS DIS, V55, P465, DOI 10.3233/JAD-160316; Filipcik P, 2012, NEUROBIOL AGING, V33, P1448, DOI 10.1016/j.neurobiolaging.2010.10.015; Henry-Unaeze Helen Nonye, 2017, Pathophysiology, V24, P243, DOI 10.1016/j.pathophys.2017.08.001; Jekel K, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0099-0; Jerneren F, 2015, AM J CLIN NUTR, V102, P215, DOI 10.3945/ajcn.114.103283; Jin L, 2018, NEUROSCI LETT, V682, P39, DOI 10.1016/j.neulet.2018.06.008; Lopez-Perez SJ, 2010, BRAIN RES, V1317, P246, DOI 10.1016/j.brainres.2009.12.054; Kidemet-Piskac S, 2018, CNS NEUROSCI THER, V24, P734, DOI 10.1111/cns.12814; Kiss P, 2005, NEUROTOX RES, V8, P235, DOI 10.1007/BF03033977; Kumar A, 2007, PHARMACOL REP, V59, P274; Latham N, 2004, APPL ANIM BEHAV SCI, V86, P261, DOI 10.1016/j.applanim.2004.02.006; Lester-Coll N, 2006, J ALZHEIMERS DIS, V9, P13; Maletinska L, 2006, REGUL PEPTIDES, V136, P58, DOI 10.1016/j.regpep.2006.04.020; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; Olvera-Cortes E, 2005, PHARMACOL BIOCHEM BE, V82, P247, DOI 10.1016/j.pbb.2005.08.007; Ossenkoppele R, 2016, BRAIN, V139, P1551, DOI 10.1093/brain/aww027; Puzzo D, 2015, EXPERT OPIN DRUG DIS, V10, P703, DOI 10.1517/17460441.2015.1041913; Reisberg B, 2001, INT PSYCHOGERIATR, V13, P163, DOI 10.1017/S1041610201007566; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Salkovic-Petrisic M, WHAT HAVE WE LEARNED, DOI [10.1007/s00702-012-0877-9, DOI 10.1007/S00702-012-0877-9]; SMITH TW, 1987, ARCH NEUROL-CHICAGO, V44, P1225, DOI 10.1001/archneur.1987.00520240007003; Spolcova A, 2015, J ALZHEIMERS DIS, V45, P823, DOI 10.3233/JAD-143150; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; Wang JZ, 2013, J ALZHEIMERS DIS, V33, pS123, DOI 10.3233/JAD-2012-129031	40	5	5	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0220720	10.1371/journal.pone.0220720	http://dx.doi.org/10.1371/journal.pone.0220720			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412065	Green Submitted, Green Published, gold			2022-12-26	WOS:000485012600035
J	Palaniappan, M; Nguyen, L; Grimm, SL; Xi, YX; Xia, Z; Li, W; Coartam, C				Palaniappan, Murugesan; Loc Nguyen; Grimm, Sandra L.; Xi, Yuanxin; Xia, Zheng; Li, Wei; Coartam, Cristian			The genomic landscape of estrogen receptor alpha binding sites in mouse mammary gland	PLOS ONE			English	Article							BREAST-CANCER; ER-ALPHA; MOLECULAR PORTRAITS; SIGNALING PATHWAYS; WIDE ANALYSIS; TARGET GENE; CHIP-SEQ; MORPHOGENESIS; EXPRESSION; GATA3	Estrogen receptor alpha (ER alpha) is the major driving transcription factor in the mammary gland development as well as breast cancer initiation and progression. However, the genomic landscape of ER alpha binding sites in the normal mouse mammary gland has not been completely elucidated. Here, we mapped genome-wide ER alpha binding events by chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq) in the mouse mammary gland in response to estradiol. We identified 6237 high confidence ER alpha binding sites in two biological replicates and showed that many of these were located at distal enhancer regions. Furthermore, we discovered 3686 unique genes in the mouse genome that recruit ER in response to estradiol. Interrogation of ER-DNA binding sites in ER-positive luminal epithelial cells showed that the ERE, PAX2, SF1, and AP1 motifs were highly enriched at distal enhancer regions. In addition, comprehensive transcriptome analysis by RNA-seq revealed that 493 genes are differentially regulated by acute treatment with estradiol in the mouse mammary gland in vivo. Through integration of RNA-seq and ER alpha ChIP-seq data, we uncovered a novel ER alpha targetome in mouse mammary epithelial cells. Taken together, our study has identified the genomic landscape of ER alpha binding events in mouse mammary epithelial cells. Furthermore, our study also highlights the cis-regulatory elements and cofactors that are involved in estrogen signaling and may contribute to ductal elongation in the normal mouse mammary gland.	[Palaniappan, Murugesan; Loc Nguyen; Grimm, Sandra L.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Xi, Yuanxin; Xia, Zheng; Li, Wei] Baylor Coll Med, Div Biostat, Duncan L Canc Ctr, Houston, TX 77030 USA; [Coartam, Cristian] Baylor Coll Med, Duncan L Canc Ctr, Houston, TX 77030 USA; [Coartam, Cristian] Baylor Coll Med, Adv Technol Core, Houston, TX 77030 USA; [Palaniappan, Murugesan] Baylor Coll Med, Dept Pathol & Immunol, One Baylor Plaza, Houston, TX 77030 USA; [Palaniappan, Murugesan] Baylor Coll Med, Ctr Drug Discovery, One Baylor Plaza, Houston, TX 77030 USA; [Xi, Yuanxin] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Xia, Zheng] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Oregon Health & Science University	Palaniappan, M (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.; Palaniappan, M (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, One Baylor Plaza, Houston, TX 77030 USA.; Palaniappan, M (corresponding author), Baylor Coll Med, Ctr Drug Discovery, One Baylor Plaza, Houston, TX 77030 USA.	palaniap@bcm.edu	Xia, Zheng/AAC-5360-2022	Xia, Zheng/0000-0003-3364-8324; PALANIAPPAN, MURUGESAN/0000-0003-4916-6565	CPRIT grant [RP110471-P3]	CPRIT grant	This work was supported by funding from CPRIT grant RP110471-P3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold JM, 2010, BREAST CANCER RES TR, V119, P491, DOI 10.1007/s10549-008-0269-x; Asch-Kendrick R, 2016, HUM PATHOL, V48, P37, DOI 10.1016/j.humpath.2015.09.035; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Bernardo GM, 2010, DEVELOPMENT, V137, P2045, DOI 10.1242/dev.043299; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bocchinfuso WP, 2000, ENDOCRINOLOGY, V141, P2982, DOI 10.1210/en.141.8.2982; Brisken C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003178; Caizzi L, 2014, P NATL ACAD SCI USA, V111, P4892, DOI 10.1073/pnas.1315445111; Cakir A, 2017, PATHOL RES PRACT, V213, P227, DOI 10.1016/j.prp.2016.12.010; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; Carroll JS, 2017, NAT REV CANCER, V17, P54, DOI 10.1038/nrc.2016.116; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chanock SJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1637; Chung D, 2015, MOL CELL ENDOCRINOL, V400, P48, DOI 10.1016/j.mce.2014.11.002; Ciarloni L, 2007, P NATL ACAD SCI USA, V104, P5455, DOI 10.1073/pnas.0611647104; Conneely O M, 2007, Ernst Schering Found Symp Proc, P45; Dall GV, 2018, J ENDOCRINOL, V237, P323, DOI 10.1530/JOE-17-0582; Dennis G, 2003, GENOME BIOL, V4; Deschenes J, 2007, J BIOL CHEM, V282, P17335, DOI 10.1074/jbc.C700030200; Dupont S, 2000, DEVELOPMENT, V127, P4277; Durchdewald M, 2008, CANCER RES, V68, P6877, DOI 10.1158/0008-5472.CAN-08-0299; Echeverria PC, 2010, BBA-MOL CELL RES, V1803, P641, DOI 10.1016/j.bbamcr.2009.11.012; Feng Y, 2007, P NATL ACAD SCI USA, V104, P14718, DOI 10.1073/pnas.0706933104; Franco HL, 2015, MOL CELL, V58, P21, DOI 10.1016/j.molcel.2015.02.001; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Garcia-Closas M, 2007, CANCER EPIDEM BIOMAR, V16, P2269, DOI 10.1158/1055-9965.EPI-07-0449; Ghosh MG, 2000, CANCER RES, V60, P6367; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Grober OMV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-36; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Hewitt SC, 2012, MOL ENDOCRINOL, V26, P887, DOI 10.1210/me.2011-1311; Hurtado A, 2008, NATURE, V456, P663, DOI 10.1038/nature07483; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Korach KS, 1996, RECENT PROG HORM RES, V51, P159; Korach KS, 1996, RECENT PROG HORM RES, V51, P86; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Kouros-Mehr H, 2006, DEV DYNAM, V235, P3404, DOI 10.1002/dvdy.20978; Lain AR, 2013, MOL ENDOCRINOL, V27, P1743, DOI 10.1210/me.2013-1144; Lanz RB, 1999, CELL, V97, P17, DOI 10.1016/S0092-8674(00)80711-4; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Macias H, 2012, WIRES DEV BIOL, V1, P533, DOI 10.1002/wdev.35; Magnani L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002368; Mallepell S, 2006, P NATL ACAD SCI USA, V103, P2196, DOI 10.1073/pnas.0510974103; Marinov GK, 2014, G3-GENES GENOM GENET, V4, P209, DOI 10.1534/g3.113.008680; Miyamoto-Sato E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009289; Mueller SO, 2002, ENDOCRINOLOGY, V143, P2357, DOI 10.1210/en.143.6.2357; Mulac-Jericevic B, 2000, SCIENCE, V289, P1751, DOI 10.1126/science.289.5485.1751; Mulac-Jericevic B, 2003, P NATL ACAD SCI USA, V100, P9744, DOI 10.1073/pnas.1732707100; Murakami S, 2017, GENE DEV, V31, P1535, DOI 10.1101/gad.302182.117; Nautiyal J, 2013, DEVELOPMENT, V140, P1079, DOI 10.1242/dev.085720; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Palaniappan M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194913; Panigrahi AK, 2018, MOL CELL, V70, P679, DOI 10.1016/j.molcel.2018.04.014; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rae JM, 2005, BREAST CANCER RES TR, V92, P141, DOI 10.1007/s10549-005-1483-4; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Ross-Innes CS, 2010, GENE DEV, V24, P171, DOI 10.1101/gad.552910; Shan L, 2014, ONCOGENE, V33, P3205, DOI 10.1038/onc.2013.270; Siersbaek R, 2018, GENE DEV, V32, P1141, DOI 10.1101/gad.316646.118; Sisto M, 2017, ARCH IMMUNOL THER EX, V65, P477, DOI 10.1007/s00005-017-0478-2; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Stender JD, 2010, MOL CELL BIOL, V30, P3943, DOI 10.1128/MCB.00118-10; Stingl John, 2011, Hormones & Cancer, V2, P85, DOI 10.1007/s12672-010-0055-1; Sun J, 2007, MOL ENDOCRINOL, V21, P2651, DOI 10.1210/me.2007-0082; Theodorou V, 2013, GENOME RES, V23, P12, DOI 10.1101/gr.139469.112; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Yi P, 2017, MOL CELL, V67, P733, DOI 10.1016/j.molcel.2017.07.026; Zhao GQ, 1998, DEVELOPMENT, V125, P1103	80	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220311	10.1371/journal.pone.0220311	http://dx.doi.org/10.1371/journal.pone.0220311			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408468	Green Published, gold, Green Submitted			2022-12-26	WOS:000485009500011
J	Xie, SZ; Cai, BH; Rasidi, E; Yen, CC; Hsu, CD; Chow, WT; De Busscher, V; Hsu, L				Xie, Shangzhe; Cai, Bohong; Rasidi, Ellen; Yen, Ching-Chivan; Hsu, Chia-da; Chow, Wai Tung; De Busscher, Virginie; Hsu, Li Chieh			The use of a 3D-printed prosthesis in a Great Hornbill (Buceros bicornis) with squamous cell carcinoma of the casque	PLOS ONE			English	Article							SURGICAL GUIDES; 3D; SURGERY	The advent of new technologies in medical imaging and 3D printing in recent years has made customization of surgical tools and implants more accessible, revolutionizing many surgical fields. In many human diseases, these implants have led to superior surgical outcomes and greatly improved patients' quality of life. Thus, it is of great interest to apply these technologies to the treatment of animal diseases. In this study, we report the use of computed tomography (CT) and 3D printing for the treatment of a Great Hornbill at Jurong Bird Park that was diagnosed with squamous cell carcinoma of the casque. A 3D printed prosthesis that perfectly fitted the subject was implanted to replace its resected casque. The subject exhibited natural eating behaviour with no post-operative complications. Using this case as an example, the positive outcomes suggest a great potential in applying these technologies to the treatment of other wildlife diseases.	[Xie, Shangzhe; Rasidi, Ellen; Hsu, Chia-da] Wildlife Reserves Singapore, Singapore, Singapore; [Cai, Bohong; Yen, Ching-Chivan; Chow, Wai Tung] Natl Univ Singapore, Keio NUS CUTE Ctr, Smart Syst Inst, Singapore, Singapore; [Yen, Ching-Chivan] Natl Univ Singapore, Sch Design & Environm, Div Ind Design, Singapore, Singapore; [De Busscher, Virginie] Vet Emergency & Specialty Hosp, Singapore, Singapore; [Hsu, Li Chieh] Anim Clin, Singapore, Singapore	National University of Singapore; National University of Singapore	Xie, SZ (corresponding author), Wildlife Reserves Singapore, Singapore, Singapore.	shangzhe.xie@wrs.com.sg	Xie, Shangzhe/AAQ-4480-2021; Rasidi, Ellen/CAJ-0581-2022; Yen, Ching Chiuan/C-5029-2017	Xie, Shangzhe/0000-0001-7880-5261; Cai, Bohong/0000-0001-8441-2747; Yen, Ching Chiuan/0000-0003-4325-1689	National Research Foundation, Prime Minister's Office, Singapore under its International Research Centres in Singapore Funding Initiative	National Research Foundation, Prime Minister's Office, Singapore under its International Research Centres in Singapore Funding Initiative	The 3D printing related design and research is supported by the National Research Foundation, Prime Minister's Office, Singapore under its International Research Centres in Singapore Funding Initiative. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The 3D printing related design and research is supported by the National Research Foundation, Prime Minister's Office, Singapore under its International Research Centres in Singapore Funding Initiative. We would also like to thank all the members of the Wildlife Reserves Singapore/Jurong Bird Park Avian Department and veterinary team who were involved in the care of the patient.	Bauer A, 2011, BRIT J DERMATOL, V165, P612, DOI 10.1111/j.1365-2133.2011.10425.x; Chen X, 2017, J NEUROSCI METH, V286, P38, DOI 10.1016/j.jneumeth.2017.05.013; Dahake SW, 2017, RAPID PROTOTYPING J, V23, P602, DOI 10.1108/RPJ-09-2015-0129; Gamble K. C, 2012, FOWLERS ZOO WILD ANI, DOI [10.1016/b978-1-4377-1986-4.00037-8, DOI 10.1016/B978-1-4377-1986-4.00037-8]; Gamble KC, 2007, J AVIAN MED SURG, V21, P38, DOI 10.1647/1082-6742(2007)21[38:IAOTHC]2.0.CO;2; Jung SY, 2016, BIOFABRICATION, V8, DOI 10.1088/1758-5090/8/4/045015; Lin HH, 2018, J FORMOS MED ASSOC, V117, P547, DOI 10.1016/j.jfma.2018.01.008; Louvrier A, 2017, J STOMATOL ORAL MAXI, V118, P206, DOI 10.1016/j.jormas.2017.07.002; Manucy TK, 1998, J AVIAN MED SURG, V12, P158; MILLER RE, 1985, J ZOO WILDLIFE MED, V16, P131, DOI 10.2307/20094768; OBENDORF DL, 1983, AUST VET J, V60, P62, DOI 10.1111/j.1751-0813.1983.tb05867.x; Popescu D, 2018, RAPID PROTOTYPING J, V24, P901, DOI 10.1108/RPJ-05-2017-0099; Shilo D, 2018, RAMBAM MAIMONIDES ME, V9, DOI 10.5041/RMMJ.10343; Sun W, 2002, COMPUT METH PROG BIO, V67, P85, DOI 10.1016/S0169-2607(01)00116-X; Wang FP, 2017, ONCOL LETT, V14, P4581, DOI 10.3892/ol.2017.6749; Zehnder AM, 2018, JAVMA-J AM VET MED A, V252, P309, DOI 10.2460/javma.252.3.309	16	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220922	10.1371/journal.pone.0220922	http://dx.doi.org/10.1371/journal.pone.0220922			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408483	gold, Green Published, Green Submitted			2022-12-26	WOS:000485009500025
J	Hurtado, MO; Wolbert, J; Fisher, J; Flutter, B; Stafford, S; Barton, J; Jain, N; Barone, G; Majani, Y; Anderson, J				Hurtado, Marina Olle; Wolbert, Jolien; Fisher, Jonathan; Flutter, Barry; Stafford, Sian; Barton, Jack; Jain, Neha; Barone, Giuseppe; Majani, Yvonne; Anderson, John			Tumor infiltrating lymphocytes expanded from pediatric neuroblastoma display heterogeneity of phenotype and function	PLOS ONE			English	Article							ADOPTIVE CELL TRANSFER; MHC CLASS-I; T-CELLS; METASTATIC MELANOMA; NKT CELLS; EXPRESSION; THERAPY; TARGET; COMBINATION; GENERATION	Adoptive transfer of ex vivo expanded tumor infiltrating lymphocytes (TILs) has led to clinical benefit in some patients with melanoma but has not demonstrated convincing efficacy in other solid cancers. Whilst the presence of TILs in many types of cancer is often associated with better clinical prognosis, their function has not been systematically evaluated across cancer types. Responses to immunological checkpoint inhibitors in a wide range of cancers, including those for which adoptive transfer of expanded TILs has not shown clinical benefit, has clearly delineated a number of tumor type associated with tumor-reactive lymphocytes capable of effecting tumor remissions. Neuroblastoma is an aggressive childhood solid cancer in which immunotherapy with GD2-directed antibodies confers a proven survival advantage through incompletely understood mechanisms. We therefore evaluated the feasibility of ex vivo expansion of TILs from freshly resected neuroblastoma tumors and the potential therapeutic utility of TIL expansions. TILs were successfully expanded from both tumor biopsies or resections. Significant numbers of NKT and gamma delta T cells were identified alongside the mixed population of cytotoxic (CD8(+)) and helper (CD4(+)) T cells of both effector and central memory phenotypes. Isolated TILs were broadly non-reactive against autologous tumor and neuroblastoma cell lines, so enhancement of neuroblastoma killing was attained by transducing TILs with a second-generation chimeric antigen receptor (CAR) targeting GD2. CAR-TILs demonstrated antigen-specific cytotoxicity against tumor cell lines. This study is the first to show reproducible expansion of TILs from pediatric neuroblastoma, the high proportion of innate-like lymphocytes, and the feasibility to use CAR-TILs therapeutically.	[Hurtado, Marina Olle; Wolbert, Jolien; Fisher, Jonathan; Flutter, Barry; Stafford, Sian; Barton, Jack; Majani, Yvonne; Anderson, John] UCL Great Ormond St Inst Child Hlth, Dev Biol & Canc Programme, Canc Sect, London, England; [Jain, Neha; Barone, Giuseppe; Anderson, John] Great Ormond St Hosp Sick Children, Dept Oncol, London, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Anderson, J (corresponding author), UCL Great Ormond St Inst Child Hlth, Dev Biol & Canc Programme, Canc Sect, London, England.; Anderson, J (corresponding author), Great Ormond St Hosp Sick Children, Dept Oncol, London, England.	j.anderson@ucl.ac.uk		Jain, Neha/0000-0002-8499-3366; Wolbert, Jolien/0000-0003-2684-5098; Fisher, Jonathan/0000-0003-3302-2241; Anderson, William/0000-0001-7509-3203; Flutter, Barry/0000-0002-8084-6369	Olivia Hodson Cancer Fund via GOSHCC; GOSHCC infrastructure award; Action Medical Research [GN2400]; NIHR GOSH Biomedical Research Centre; GOSHCC leadership grant; Wellcome Trust; Research in Childhood Cancer (RICC); Great Ormond Street Hospital Charity [W1134, VS0118, W1029, W1076]	Olivia Hodson Cancer Fund via GOSHCC; GOSHCC infrastructure award; Action Medical Research; NIHR GOSH Biomedical Research Centre; GOSHCC leadership grant; Wellcome Trust(Wellcome TrustEuropean Commission); Research in Childhood Cancer (RICC); Great Ormond Street Hospital Charity	This work was funded by awards from Olivia Hodson Cancer Fund via GOSHCC (MH and JW), GOSHCC infrastructure award (JB, BF), Action Medical Research (GN2400 to BF), NIHR GOSH Biomedical Research Centre (JA), GOSHCC leadership grant (JA), Wellcome Trust fellowship (JF), Research in Childhood Cancer (RICC) (JA), Great Ormond Street Hospital Charity (JA leadership award and grants W1134, VS0118, W1029 and W1076). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algarra I, 2004, CANCER IMMUNOL IMMUN, V53, P904, DOI 10.1007/s00262-004-0517-9; Anderson J, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26548; Baldan V, 2015, BRIT J CANCER, V112, P1510, DOI 10.1038/bjc.2015.96; Barrett DM, 2014, ANNU REV MED, V65, P333, DOI 10.1146/annurev-med-060512-150254; Bollard CM, 2002, BLOOD, V99, P3179, DOI 10.1182/blood.V99.9.3179; Bouet-Toussaint F, 2000, EUR CYTOKINE NETW, V11, P217; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Cabrera T, 2003, CANCER IMMUNOL IMMUN, V52, P1, DOI 10.1007/s00262-002-0332-0; Carlson LM, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23618; Eaton D, 2002, GENE THER, V9, P527, DOI 10.1038/sj.gt.3301685; Fisher J, 2015, ONCOIMMUNOLOGY, V4, P1; Fisher J, 2017, MOL THER, V25, P1234, DOI 10.1016/j.ymthe.2017.03.002; Gattinoni L, 2012, NAT REV CANCER, V12, P671, DOI 10.1038/nrc3322; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Grobner SN, 2018, NATURE, V555, P321, DOI 10.1038/nature25480; Hall M, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0164-7; Harao M, 2017, CANCER IMMUNOL RES, V5, P439, DOI 10.1158/2326-6066.CIR-16-0364; HELLSTROM IE, 1968, P NATL ACAD SCI USA, V60, P1231, DOI 10.1073/pnas.60.4.1231; Jensen JB, 2006, MOL NEUROBIOL, V34, P153, DOI 10.1385/MN:34:3:153; Jiang SS, 2015, ONCOTARGET, V6, P41339, DOI 10.18632/oncotarget.5463; Kabelitz D, 2007, CANCER RES, V67, P5, DOI 10.1158/0008-5472.CAN-06-3069; Khalil DN, 2016, NAT REV CLIN ONCOL, V13, P273, DOI 10.1038/nrclinonc.2016.25; Kodumudi KN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153053; Kroesen M, 2014, INT J CANCER, V134, P1335, DOI 10.1002/ijc.28463; Kunkele A, 2017, CLIN CANCER RES, V23, P466, DOI 10.1158/1078-0432.CCR-16-0354; Ladenstein R, 2017, LANCET ONCOL, V18, P500, DOI 10.1016/S1470-2045(17)30070-0; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; London WB, 2017, CANCER-AM CANCER SOC, V123, P4914, DOI 10.1002/cncr.30934; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Metelitsa LS, 2004, J EXP MED, V199, P1213, DOI 10.1084/jem.20031462; Mina M., 2015, ONCOIMMUNOLOGY, V4, P1; Mullinax JE, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00044; Newick K, 2016, MOL THER-ONCOLYTICS, V3, DOI 10.1038/mto.2016.6; Philip B, 2014, BLOOD, V124, P1277, DOI 10.1182/blood-2014-01-545020; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Radvanyi LG, 2012, CLIN CANCER RES, V18, P6758, DOI 10.1158/1078-0432.CCR-12-1177; Raffaghello L, 2005, ONCOGENE, V24, P4634, DOI 10.1038/sj.onc.1208594; RIVIERE I, 1995, P NATL ACAD SCI USA, V92, P6733, DOI 10.1073/pnas.92.15.6733; ROSENBERG SA, 1994, J NATL CANCER I, V86, P1159, DOI 10.1093/jnci/86.15.1159; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Schilbach KE, 2000, J IMMUNOTHER, V23, P536, DOI 10.1097/00002371-200009000-00004; Song L, 2007, J CLIN INVEST, V117, P2702, DOI 10.1172/JCI30751; Suzuki M, 2015, EXPERT OPIN THER TAR, V19, P349, DOI 10.1517/14728222.2014.986459; Thomas S, 2016, PLOS ONE, V11; Turcotte S, 2013, J IMMUNOL, V191, P2217, DOI 10.4049/jimmunol.1300538; Turtle CJ, 2016, J CLIN INVEST, V1, P1; Wesolowski R, 2014, J CARCINOG MUTAGEN, V5, DOI [10.4172/2157-2518.1000199, DOI 10.4172/2157-2518.1000199]; Wolfl M, 2005, CANCER IMMUNOL IMMUN, V54, P400, DOI 10.1007/s00262-004-0603-z; Wu R, 2012, CANCER J, V18, P160, DOI 10.1097/PPO.0b013e31824d4465; Yang SC, 2013, CANCER IMMUNOL IMMUN, V62, P727, DOI 10.1007/s00262-012-1378-2; Yannelli JR, 1996, INT J CANCER, V65, P413, DOI 10.1002/(SICI)1097-0215(19960208)65:4<413::AID-IJC3>3.0.CO;2-#; Yu SN, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0444-9	55	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0216373	10.1371/journal.pone.0216373	http://dx.doi.org/10.1371/journal.pone.0216373			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398192	Green Published, Green Submitted, gold			2022-12-26	WOS:000485004000002
J	Jiang, J; Tang, MZ; Chen, JF; Yang, YW				Jiang, Jie; Tang, Meizhen; Chen, Junfeng; Yang, Yuewei			Identification and degradation characteristics of Bacillus cereus strain WD-2 isolated from prochloraz-manganese-contaminated soils	PLOS ONE			English	Article							BACTERIAL CONSORTIUM; BIODEGRADATION; PESTICIDES; CHLORPYRIFOS; MANGO; WATER	The bacterial strain WD-2, which was capable of efficiently degrading prochloraz-manganese, was isolated from soil contaminated with prochloraz-manganese, selected through enrichment culturing and identified as Bacillus cereus. Test results indicated that the optimal temperature and pH for bacterial growth were 35-40 degrees C and 7.0-8.0, respectively. The highest degradation rate was above 88-90% when the pH was 7.0 similar to 8.0 and reached a maximum value (90.7%) at approximately 8.0. In addition, the bacterium showed the greatest growth ability with an OD600 of 0.805 and the highest degradation rate (68.2%) when glucose was chosen as the carbon source, while the difference in nitrogen source had no obvious influence on bacterial growth. The degradation rate exceeded 80% when the NaCI concentration was 0 similar to 2% and the rate reached 89.2% at 1%. When the concentration was higher than 7%, the growth of WD-2 and the degradation of prochloraz-manganese were found to be inhibited, and the degradation rate was merely 8.5%. The results indicated that strain WD-2 was able to effectively degrade prochloraz-manganese and might contribute to the bioremediation of contaminated soils.	[Jiang, Jie; Tang, Meizhen; Chen, Junfeng; Yang, Yuewei] Qufu Normal Univ, Key Lab Nasihu Lake Wetland Ecosystem & Environm, Qufu, Shandong, Peoples R China	Qufu Normal University	Tang, MZ (corresponding author), Qufu Normal Univ, Key Lab Nasihu Lake Wetland Ecosystem & Environm, Qufu, Shandong, Peoples R China.	tmzh0816@163.com		Jiang, Jie/0000-0002-1095-3839	National Natural Science Fund of China [31700433, 31672314]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Fund of China (no. 31700433 and no. 31672314). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2012, ANN MICROBIOL, V62, P233, DOI 10.1007/s13213-011-0251-4; Asemoloye MD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183373; Aziz A, 2018, ENVIRON TECHNOL, V39, P527, DOI 10.1080/09593330.2017.1305455; Belal ESB, 2018, ENVIRON ENG SCI, V35, P1194, DOI 10.1089/ees.2018.0111; Chen S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048747, 10.1371/journal.pone.0046703, 10.1371/journal.pone.0029579, 10.1371/journal.pone.0050850]; COOKE BK, 1979, PESTIC SCI, V10, P467, DOI 10.1002/ps.2780100605; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gea FJ, 2010, CROP PROT, V29, P1021, DOI 10.1016/j.cropro.2010.06.006; Itoh K., 2015, JAPANESE J PESTIC SC, V39, P115, DOI [10.1584/jpestics.w14-05, DOI 10.1584/JPESTICS.W14-05]; Journal B., 2009, BRAZ J MICROBIOL, P893; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kurt S, 2003, CROP PROT, V22, P51, DOI 10.1016/S0261-2194(02)00097-2; Liu MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084769; Mehrparvar M, 2013, J AGR SCI TECH-IRAN, V15, P389; Pino N, 2011, INT BIODETER BIODEGR, V65, P827, DOI 10.1016/j.ibiod.2011.06.001; Prusky D, 2006, POSTHARVEST BIOL TEC, V42, P134, DOI 10.1016/j.postharvbio.2006.06.001; Prusky D, 1999, POSTHARVEST BIOL TEC, V15, P165, DOI 10.1016/S0925-5214(98)00082-9; RAINER B, 2006, FUNGICIDAL MIXTURES; Rutters H, 1999, J AGR FOOD CHEM, V47, P1242, DOI 10.1021/jf980429y; Singh DP, 2011, ENVIRON SCI POLLUT R, V18, P1351, DOI 10.1007/s11356-011-0472-x; Taha MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144071; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang MQ, 2012, MICROBIOL RES, V167, P299, DOI 10.1016/j.micres.2011.10.004; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Yadav IC, 2015, SCI TOTAL ENVIRON, V511, P123, DOI 10.1016/j.scitotenv.2014.12.041; Zhang H, 2016, INT BIODETER BIODEGR, V106, P53, DOI 10.1016/j.ibiod.2015.10.005; Zhao RB, 2010, AGR SCI CHINA, V9, P695, DOI 10.1016/S1671-2927(09)60145-0	27	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220975	10.1371/journal.pone.0220975	http://dx.doi.org/10.1371/journal.pone.0220975			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398235	Green Published, Green Submitted, gold			2022-12-26	WOS:000485004000034
J	Nagappa, LK; Balasubramanian, S; Balaram, H				Nagappa, Lakshmeesha Kempaiah; Balasubramanian, Sundaram; Balaram, Hemalatha			How a purine salvage enzyme singles out the right base	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							TRANSITION-STATE; CRYSTAL-STRUCTURE; PHOSPHORIBOSYLTRANSFERASE	Two phosphoribosyltransferases in the purine salvage pathway exhibit exquisite substrate specificity despite the chemical similarity of their distinct substrates, but the basis for this discrimination was not fully understood. Ozeir et al. now employ a complementary biochemical, structural, and computational approach to deduce the chemical constraints governing binding and propose a distinct mechanism for catalysis in one of these enzymes, adenine phosphoribosyltransferase. These insights, built on data from an unexpected finding, finally provide direct answers to key questions regarding these enzymes and substrate recognition more generally.	[Nagappa, Lakshmeesha Kempaiah; Balaram, Hemalatha] Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India; [Balasubramanian, Sundaram] Jawaharlal Nehru Ctr Adv Sci Res, Chem & Phys Mat Unit, Bangalore 560064, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Balaram, H (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India.	hb@jncasr.ac.in	BALASUBRAMANIAN, SUNDARAM/AAC-1774-2019	BALASUBRAMANIAN, SUNDARAM/0000-0002-3355-6764; KN, Lakshmeesha/0000-0002-7034-2378; Balaram, Hemalatha/0000-0002-8821-1288	Department of Biotechnology, Department of Science and Technology, Science and Engineering Research Board, Council of Scientific and Industrial Research; Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR)	Department of Biotechnology, Department of Science and Technology, Science and Engineering Research Board, Council of Scientific and Industrial Research; Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR)(Department of Science & Technology (India))	This work was supported by the Department of Biotechnology, Department of Science and Technology, Science and Engineering Research Board, Council of Scientific and Industrial Research, and institutional funding from the Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR). The authors declare that they have no conflicts of interest with the contents of this article.	Focia PJ, 1998, BIOCHEMISTRY-US, V37, P17120, DOI 10.1021/bi9821465; GOITEIN RK, 1978, J BIOL CHEM, V253, P2963; Heroux A, 1999, BIOCHEMISTRY-US, V38, P14495, DOI 10.1021/bi990508i; Moggre GJ, 2017, ACS CHEM BIOL, V12, P2662, DOI 10.1021/acschembio.7b00484; Munagala NR, 1998, BIOCHEMISTRY-US, V37, P16612, DOI 10.1021/bi9818974; Ozeir NM, 2019, J BIOL CHEM, V294, P11980, DOI 10.1074/jbc.RA119.009087; Shi WX, 1999, NAT STRUCT BIOL, V6, P588; Shi WX, 1999, BIOCHEMISTRY-US, V38, P9872, DOI 10.1021/bi990664p; Tao W, 1996, BIOCHEMISTRY-US, V35, P14, DOI 10.1021/bi951898l; Thomas A, 2006, J AM CHEM SOC, V128, P10096, DOI 10.1021/ja060823+	10	0	0	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					11992	11993		10.1074/jbc.H119.010025	http://dx.doi.org/10.1074/jbc.H119.010025			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31399535	hybrid, Green Published			2022-12-26	WOS:000484284500005
J	Brinks, MV; Redd, T; Lambert, WE; Zaback, T; Randall, J; Field, T; Wilson, D				Brinks, Mitchell V.; Redd, Travis; Lambert, William E.; Zaback, Tosha; Randall, Joan; Field, Teresa; Wilson, David			Using registry data to characterize the incidence and causes of blindness in Oregon	PLOS ONE			English	Article							VISUAL IMPAIRMENT; TIME TRENDS	In the United States, there is no reliable data to describe the prevalence of eye diseases leading to visual impairment and little active surveillance to address this knowledge gap. Data that is readily available from many state blind registries may provide helpful information on trends and causes of blindness. We analyzed new registrations with the Oregon Commission for the Blind (OCB) and Oregon State Department of Administrative Services (DAS) from 1961 to 2016 for causes of and trends in blindness. Persons with blindness self-refer into the OCB registry and the Oregon State Department of Administrative Services (DAS) includes those receiving social security disability financial support and other state services. Data for 9,273 blind persons registered were analyzed. The most frequent causes of blindness were age related macular degeneration (AMD) 3,308 (38%), followed by diabetic retinopathy (DR) 729 (8%), congenital conditions 697 (8%), optic nerve atrophy 611 (7%), glaucoma 549 (6%), retinitis pigmentosa 546 (6%), retinopathy of prematurity192 (2%), cataract 180 (2%), and trauma 174 (2%). The mean age of onset of blindness was younger for Blacks (31 years) and Hispanics (33 years) than for Whites (44 years). Analysis of state-based registries can provide useful and locally relevant vision and eye health data where little information is otherwise available.	[Brinks, Mitchell V.; Redd, Travis; Zaback, Tosha; Randall, Joan; Wilson, David] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA; [Lambert, William E.] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97201 USA; [Field, Teresa] Oregon Commiss Blind, Portland, OR USA	Oregon Health & Science University; Oregon Health & Science University	Brinks, MV (corresponding author), Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA.	brinks@ohsu.edu		Zaback, Tosha/0000-0003-2028-9684	Research to Prevent Blindness (New York, NY)	Research to Prevent Blindness (New York, NY)(Research to Prevent Blindness (RPB))	This study was supported by unrestricted departmental funding from Research to Prevent Blindness (New York, NY). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen N, 2016, CLIN EPIDEMIOL, V8, P613, DOI 10.2147/CLEP.S99507; [Anonymous], 2017, LEADING INDICATORS C; Belkin M, 2013, AM J OPHTHALMOL, V155, P404, DOI 10.1016/j.ajo.2012.09.017; Bressler NM, 2011, ARCH OPHTHALMOL-CHIC, V129, P709, DOI 10.1001/archophthalmol.2011.140; Bureau UC, 2016, OR QUICK FACTS OR QU; CDC, 2017, LONG TERM TRENDS DIA; Cruickshanks KJ, 2017, JAMA OPHTHALMOL, V135, P1417, DOI 10.1001/jamaophthalmol.2017.5001; EDERER F, 1986, AM J PUBLIC HEALTH, V76, P160, DOI 10.2105/AJPH.76.2.160; Foran S, 2003, OPHTHALMIC EPIDEMIOL, V10, P215, DOI 10.1076/opep.10.4.215.15906; Hyman L, 2001, OPHTHALMOLOGY, V108, P1751, DOI 10.1016/S0161-6420(01)00590-5; Moorhead HB, 1973, STAT BLINDNESS MODEL; Skaat A, 2012, AM J OPHTHALMOL, V153, P214, DOI 10.1016/j.ajo.2011.08.035; U. S. Bureau of the Census, 1963, CHAR POP 39, VI; U. S. Census Bureau, 2012, CPH139 US CENS BUR; Varma R, 2010, AM J OPHTHALMOL, V149, P713, DOI 10.1016/j.ajo.2009.12.011; Warne D, 2014, AM J PUBLIC HEALTH, V104, pS263, DOI 10.2105/AJPH.2013.301682; Welp A., 2016, MAKING EYE HLTH POPU; William Kandel JC, 2012, USDA EC RES SERVICE; Xu L, 2006, OPHTHALMOLOGY, V113, P1134, DOI 10.1016/j.ophtha.2006.01.035; Zhang X, 2012, AM J OPHTHALMOL S, V154, pe1, DOI DOI 10.1016/J.AJ0.2011.08.045	20	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220983	10.1371/journal.pone.0220983	http://dx.doi.org/10.1371/journal.pone.0220983			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393957	Green Published, gold, Green Submitted			2022-12-26	WOS:000485002500090
J	Ganesan, C; Thomas, IC; Song, S; Sun, AJ; Sohlberg, EM; Tamura, MK; Chertow, GM; Liao, JC; Conti, S; Elliott, CS; Leppert, JT; Pao, AC				Ganesan, Calyani; Thomas, I-Chun; Song, Shen; Sun, Andrew J.; Sohlberg, Ericka M.; Tamura, Manjula Kurella; Chertow, Glenn M.; Liao, Joseph C.; Conti, Simon; Elliott, Christopher S.; Leppert, John T.; Pao, Alan C.			Prevalence of twenty-four hour urine testing in Veterans with urinary stone disease	PLOS ONE			English	Article							QUALITY	Objective The American Urological Association guidelines recommend 24-hour urine testing in patients with urinary stone disease to decrease the risk of stone recurrence; however, national practice patterns for 24-hour urine testing are not well characterized. Our objective is to determine the prevalence of 24-hour urine testing in patients with urinary stone disease in the Veterans Health Administration and examine patient-specific and facility-level factors associated with 24-hour urine testing. Identifying variations in clinical practice can inform future quality improvement efforts in the management of urinary stone disease in integrated healthcare systems. Materials and methods We accessed national Veterans Health Administration data through the Corporate Data Warehouse (CDW), hosted by the Veterans Affairs Informatics and Computing Infrastructure (VINCI), to identify patients with urinary stone disease. We defined stone formers as Veterans with one inpatient ICD-9 code for kidney or ureteral stones, two or more outpatient ICD-9 codes for kidney or ureteral stones, or one or more CPT codes for kidney or ureteral stone procedures from 2007 through 2013. We defined a 24-hour urine test as a 24-hour collection for calcium, oxalate, citrate or sulfate. We used multivariable regression to assess demographic, geographic, and selected clinical factors associated with 24-hour urine testing. Results We identified 130,489 Veterans with urinary stone disease; 19,288 (14.8%) underwent 24-hour urine testing. Patients who completed 24-hour urine testing were younger, had fewer comorbidities, and were more likely to be White. Utilization of 24-hour urine testing varied widely by geography and facility, the latter ranging from 1 to 40%. Conclusions Fewer than one in six patients with urinary stone disease complete 24-hour urine testing in the Veterans Health Administration. In addition, utilization of 24-hour urine testing varies widely by facility identifying a target area for improvement in the care of patients with urinary stone disease. Future efforts to increase utilization of 24-hour urine testing and improve clinician awareness of targeted approaches to stone prevention may be warranted to reduce the morbidity and cost of urinary stone disease.	[Ganesan, Calyani; Song, Shen; Tamura, Manjula Kurella; Chertow, Glenn M.; Leppert, John T.; Pao, Alan C.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Thomas, I-Chun; Liao, Joseph C.; Conti, Simon; Leppert, John T.] Vet Affairs Palo Alto Hlth Care Syst, Dept Urol, Palo Alto, CA USA; [Thomas, I-Chun; Tamura, Manjula Kurella] Vet Affairs Palo Alto Hlth Care Syst, Geriatr Res & Educ Clin Ctr, Palo Alto, CA USA; [Sun, Andrew J.; Sohlberg, Ericka M.; Liao, Joseph C.; Conti, Simon; Elliott, Christopher S.; Leppert, John T.; Pao, Alan C.] Stanford Univ, Dept Urol, Sch Med, Stanford, CA USA; [Chertow, Glenn M.] Stanford Univ, Dept Hlth Res & Policy, Sch Med, Stanford, CA USA; [Elliott, Christopher S.] Santa Clara Valley Med Ctr, Div Urol, San Jose, CA 95128 USA; [Pao, Alan C.] Vet Affairs Palo Alto Hlth Care Syst, Dept Med, Palo Alto, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; Santa Clara Valley Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Ganesan, C (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.	calyani@stanford.edu	; Kurella Tamura, Manjula/C-8284-2014	Chertow, Glenn/0000-0002-7599-0534; Ganesan, Calyani/0000-0002-4050-9587; Liao, Joseph/0000-0003-2448-5463; Kurella Tamura, Manjula/0000-0001-5227-2479	ASN Ben J. Lipps Research Fellowship Award; NIH T32 Ruth L. Kirschstein Institutional National Research Service Award [DK 7357-34]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007357, F32DK118801] Funding Source: NIH RePORTER	ASN Ben J. Lipps Research Fellowship Award; NIH T32 Ruth L. Kirschstein Institutional National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work received funding through the ASN Ben J. Lipps Research Fellowship Award and the NIH T32 Ruth L. Kirschstein Institutional National Research Service Award DK 7357-34 to CG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha Z, 2000, ARCH INTERN MED, V160, P3252, DOI 10.1001/archinte.160.21.3252; Alruwaily AF, 2015, UROLOGY, V86, P454, DOI 10.1016/j.urology.2015.05.022; Dauw CA, 2015, J UROLOGY, V193, P885, DOI 10.1016/j.juro.2014.09.111; Ghiraldi EM, 2017, J ENDOUROL, V31, pS64, DOI 10.1089/end.2016.0594; Hsi RS, 2017, J UROLOGY, V197, P1084, DOI 10.1016/j.juro.2016.10.052; Milose JC, 2014, J UROLOGY, V191, P376, DOI 10.1016/j.juro.2013.08.080; Pearle MS, 2014, J UROLOGY, V192, P316, DOI 10.1016/j.juro.2014.05.006; Semins MJ, 2010, J UROLOGY, V184, P190, DOI 10.1016/j.juro.2010.03.011	8	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220768	10.1371/journal.pone.0220768	http://dx.doi.org/10.1371/journal.pone.0220768			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393935	Green Published, Green Submitted, gold			2022-12-26	WOS:000485002500060
J	Ingrosso, A; Abbott, LF				Ingrosso, Alessandro; Abbott, L. F.			Training dynamically balanced excitatory-inhibitory networks	PLOS ONE			English	Article							STATE; MECHANISM; PATTERNS; CHAOS; MODEL	The construction of biologically plausible models of neural circuits is crucial for understanding the computational properties of the nervous system. Constructing functional networks composed of separate excitatory and inhibitory neurons obeying Dale's law presents a number of challenges. We show how a target-based approach, when combined with a fast online constrained optimization technique, is capable of building functional models of rate and spiking recurrent neural networks in which excitation and inhibition are balanced. Balanced networks can be trained to produce complicated temporal patterns and to solve input-output tasks while retaining biologically desirable features such as Dale's law and response variability.	[Ingrosso, Alessandro; Abbott, L. F.] Columbia Univ, Brain Behav Inst, Zuckerman Mind, New York, NY 10027 USA	Columbia University	Ingrosso, A (corresponding author), Columbia Univ, Brain Behav Inst, Zuckerman Mind, New York, NY 10027 USA.	ai2367@columbia.edu		Ingrosso, Alessandro/0000-0001-5430-7559	NSF NeuroNex Award [DBI-1707398]; Gatsby Charitable Foundation [GAT3419]; Simons Collaboration for the Global Brain [542939SPI]; Swartz Foundation	NSF NeuroNex Award; Gatsby Charitable Foundation; Simons Collaboration for the Global Brain; Swartz Foundation	Funding is provided by NSF NeuroNex Award (LFA, DBI-1707398, https://nsf.gov/), the Gatsby Charitable Foundation (LFA, GAT3419, http://www.gatsby.org.uk/), the Simons Collaboration for the Global Brain (LFA, 542939SPI, https://www.simonsfoundation.org/collaborations/global-brain/) and the Swartz Foundation (LFA, AI, http://www.theswartzfoundation.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2016, NAT NEUROSCI, V19, P350, DOI 10.1038/nn.4241; Alemi A, 2017, ARXIV170508026; [Anonymous], 2003, NEURAL ENG COMPUTATI; Boerlin M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001080; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; del Molino LCG, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042824; Deneve S, 2017, NEURON, V94, P969, DOI 10.1016/j.neuron.2017.05.016; DePasquale B., 2016, ARXIV160107620; DePasquale B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191527; Hansel D, 2012, J NEUROSCI, V32, P4049, DOI 10.1523/JNEUROSCI.6284-11.2012; Harish O, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004266; Hennequin G, 2017, ANNU REV NEUROSCI, V40, P557, DOI 10.1146/annurev-neuro-072116-031005; Hennequin G, 2014, NEURON, V82, P1394, DOI 10.1016/j.neuron.2014.04.045; Huh D., 2018, ADV NEURAL INFORM PR, V31, P1440; Jaeger H., 2002, 159 GMD GERM NAT RES; Jazayeri M, 2010, NAT NEUROSCI, V13, P1020, DOI 10.1038/nn.2590; Kadmon J, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.041030; Kim CM, 2018, ELIFE, V7, DOI 10.7554/eLife.37124; Kingma DP., 2014, ADAM METHOD STOCHAST; Laje R, 2013, NAT NEUROSCI, V16, P925, DOI 10.1038/nn.3405; Lee D., 2014, ABS14127525 CORR; Lee JH, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00508; Mastrogiuseppe F, 2018, NEURON, V99, P609, DOI 10.1016/j.neuron.2018.07.003; Mastrogiuseppe F, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005498; Murphy BK, 2009, NEURON, V61, P635, DOI 10.1016/j.neuron.2009.02.005; Nicola W, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01827-3; Pehlevan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089992; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Rubin R, 2017, P NATL ACAD SCI USA, V114, pE9366, DOI 10.1073/pnas.1705841114; Song H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005411; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Tetzlaff T, 2012, PLOS COMPUTATIONAL B, V8, P1, DOI [10.1371/journal.pcbi, DOI 10.1371/JOURNAL.PCBI]; TSODYKS MV, 1995, NETWORK-COMP NEURAL, V6, P111, DOI 10.1088/0954-898X/6/2/001; van Vreeswijk C, 1998, NEURAL COMPUT, V10, P1321, DOI 10.1162/089976698300017214; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Vincent-Lamarre P, 2016, J COMPUT NEUROSCI, V41, P305, DOI 10.1007/s10827-016-0619-3; Wright SJ, 2015, MATH PROGRAM, V151, P3, DOI 10.1007/s10107-015-0892-3; Zenke F, 2018, NEURAL COMPUT, V30, P1514, DOI 10.1162/neco_a_01086	38	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220547	10.1371/journal.pone.0220547	http://dx.doi.org/10.1371/journal.pone.0220547			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393909	Green Published, gold, Green Submitted			2022-12-26	WOS:000485002500037
J	Kou, HW; Yeh, CH; Tsai, HI; Hsu, CC; Hsieh, YC; Chen, WT; Cheng, HT; Yu, MC; Lee, CW				Kou, Hao-Wei; Yeh, Chih-Hua; Tsai, Hsin-I; Hsu, Chih-Chieh; Hsieh, Yi-Chung; Chen, Wei-Ting; Cheng, Hao-Tsai; Yu, Ming-Chin; Lee, Chao-Wei			Sarcopenia is an effective predictor of difficult-to-wean and mortality among critically ill surgical patients	PLOS ONE			English	Article							MECHANICAL VENTILATION; DEFINITION; SURVIVAL; IMPACT	Background Critically-ill surgical patients are at higher risk for sarcopenia, which is associated with worse survival. Sarcopenia may impair the respiratory musculature, which can subsequently influence the outcome of ventilator weaning. Although there are a variety of weaning parameters predictive of weaning outcomes, none have tried to incorporate "muscle strength" or "sarcopenia". The aim of the current study was to explore the association between sarcopenia and difficult-to-wean (DtW) in critically-ill surgical patients. The influence of sarcopenia on ICU mortality was also analyzed. Methods Ninety-six patients undergoing mechanical ventilation in the surgical intensive care unit (ICU) were enrolled. Demographic data and weaning parameters were recorded from the prospectively collected database, and the total psoas muscle area (TPA) was determined at the level of the 3 rd lumbar vertebra by computed tomography. Sarcopenia was defined by previously established cut-off points and its influence on clinical outcomes was examined. Receiver operating characteristic (ROC) curve analysis was conducted to investigate the predictive capability of TPA and weaning parameters for predicting weaning outcomes. Results The median age of the studied patients was 73 years. Thirty patients (31.3%) were sarcopenic and 30 (31.3%) were defined as DtW. Eighteen patients (18.8%) had ICU mortality. Multivariate logistic regression analyses revealed that sarcopenia was an independent risk factor for DtW and ICU mortality. The area under the ROC curve (AUC) of TPA for predicting successful weaning was 0.727 and 0.720 in female and male patients, respectively. After combining TPA and conventional weaning parameters, the AUC for DtW increased from 0.836 to 0.911 and from 0.835 to 0.922 in female and male patients, respectively. Conclusion Sarcopenia is an independent risk factor for DtW and ICU mortality. TPA has predictive value when assessing weaning outcomes and can be used as an effective adjunct predictor along with conventional weaning parameters.	[Kou, Hao-Wei; Hsu, Chih-Chieh; Yu, Ming-Chin; Lee, Chao-Wei] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Surg, Div Gen Surg, Taoyuan, Taiwan; [Yeh, Chih-Hua] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Med Imaging & Intervent, Taoyuan, Taiwan; [Yeh, Chih-Hua; Tsai, Hsin-I; Cheng, Hao-Tsai; Yu, Ming-Chin; Lee, Chao-Wei] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Tsai, Hsin-I] Chang Gung Mem Hosp, Dept Anesthesiol, Linkou Med Ctr, Taoyuan, Taiwan; [Tsai, Hsin-I; Cheng, Hao-Tsai; Yu, Ming-Chin; Lee, Chao-Wei] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Hsieh, Yi-Chung; Chen, Wei-Ting; Cheng, Hao-Tsai] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Hepatogastroenterol, Taoyuan, Taiwan; [Yu, Ming-Chin] Xiamen Chang Gung Hosp, Dept Surg, Xiamen, Fujian, Peoples R China	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Lee, CW (corresponding author), Chang Gung Mem Hosp, Linkou Med Ctr, Dept Surg, Div Gen Surg, Taoyuan, Taiwan.; Lee, CW (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.; Lee, CW (corresponding author), Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan.	alanchaoweilee@hotmail.com	Yeh, Chih-Hua/N-5165-2018	Yeh, Chih-Hua/0000-0001-6988-8739; Lee, Chao-Wei/0000-0002-6853-4557	Chang Gung Memorial Hospital [CMRPG3I0301, CMRPG3F0122]; Ministry of Science and Technology, Taiwan, R.O.C. [MOST 107-2314-B-182A-119-/NMRPG3H0291]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Ministry of Science and Technology, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This study was supported by Chang Gung Memorial Hospital (www.cgmh.org.tw) (Grant number: CMRPG3I0301 (CW Lee) and CMRPG3F0122 (MC Yu)) and Ministry of Science and Technology, Taiwan, R.O.C. (www.most.gov.tw)(Grant number: MOST 107-2314-B-182A-119-/NMRPG3H0291 (CW Lee)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baptistella AR, 2018, J CRIT CARE, V48, P56, DOI 10.1016/j.jcrc.2018.08.023; Beduneau G, 2017, AM J RESP CRIT CARE, V195, P772, DOI 10.1164/rccm.201602-0320OC; Boles JM, 2007, EUR RESPIR J, V29, P1033, DOI 10.1183/09031936.00010206; Burton LA, 2010, CLIN INTERV AGING, V5, P217; CAPDEVILA XJ, 1995, CHEST, V108, P482, DOI 10.1378/chest.108.2.482; Coplin WM, 2000, AM J RESP CRIT CARE, V161, P1530, DOI 10.1164/ajrccm.161.5.9905102; Croce MA, 2003, J TRAUMA, V54, P724, DOI 10.1097/01.TA.0000054643.54218.C5; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Damuth E, 2015, LANCET RESP MED, V3, P544, DOI 10.1016/S2213-2600(15)00150-2; Elliott JE, 2016, RESP PHYSIOL NEUROBI, V226, P137, DOI 10.1016/j.resp.2015.10.001; Friedman J, 2015, NUTR CLIN PRACT, V30, P175, DOI 10.1177/0884533615569888; Fuggle N, 2017, BEST PRACT RES CL RH, V31, P218, DOI 10.1016/j.berh.2017.11.007; Funk GC, 2010, EUR RESPIR J, V35, P88, DOI 10.1183/09031936.00056909; Heard RSM, 2017, SURG-J R COLL SURG E, V15, P366, DOI 10.1016/j.surge.2017.06.001; Heunks LM, 2010, CRIT CARE, V14, DOI 10.1186/cc9296; Izawa KP, 2016, AGING CLIN EXP RES, V28, P1143, DOI 10.1007/s40520-016-0534-5; Jeong BH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122810; Joglekar S, 2015, J SURG ONCOL, V112, P503, DOI 10.1002/jso.24025; Jones KI, 2015, COLORECTAL DIS, V17, pO20, DOI 10.1111/codi.12805; Jones K, 2017, WORLD J SURG, V41, P2266, DOI 10.1007/s00268-017-3999-2; Kim J, 2009, ARCH GERONTOL GERIAT, V48, P361, DOI 10.1016/j.archger.2008.03.006; Kizilarslanoglu MC, 2016, J ANESTH, V30, P884, DOI 10.1007/s00540-016-2211-4; Leeper CM, 2016, J TRAUMA ACUTE CARE, V80, P805, DOI 10.1097/TA.0000000000000989; Magalhaes PAF, 2018, RESP MED, V134, P54, DOI 10.1016/j.rmed.2017.11.023; Mccusker A, 2018, AM J SURG; Mirkin KA, 2017, J GASTROINTEST ONCOL, V8, P589, DOI 10.21037/jgo.2017.03.02; Moisey LL, 2013, CRIT CARE, V17, DOI 10.1186/cc12901; Nemer SN, 2009, CRIT CARE, V13, DOI 10.1186/cc8051; Pu L, 2015, J CRIT CARE, V30, DOI 10.1016/j.jcrc.2015.04.001; Rangel EL, 2017, J TRAUMA ACUTE CARE, V83, P1179, DOI 10.1097/TA.0000000000001657; Shibahashi K, 2017, J INTENSIVE CARE, V5, DOI 10.1186/s40560-016-0205-9; Simonsen C, 2018, ANN SURG, V268, P58, DOI 10.1097/SLA.0000000000002679; Sturmer T, 2006, J CLIN EPIDEMIOL, V59, P437, DOI 10.1016/j.jclinepi.2005.07.004; Toptas M, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/5263208; Weijs PJM, 2014, CRIT CARE, V18, DOI 10.1186/cc13189; YANG KL, 1991, NEW ENGL J MED, V324, P1445, DOI 10.1056/NEJM199105233242101	36	37	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220699	10.1371/journal.pone.0220699	http://dx.doi.org/10.1371/journal.pone.0220699			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393937	Green Published, Green Submitted, gold			2022-12-26	WOS:000485002500052
J	Meierhofer, MB; Johnson, JS; Leivers, SJ; Pierce, BL; Evans, JE; Morrison, ML				Meierhofer, Melissa B.; Johnson, Joseph S.; Leivers, Samantha J.; Pierce, Brian L.; Evans, Jonah E.; Morrison, Michael L.			Winter habitats of bats in Texas	PLOS ONE			English	Article							WHITE-NOSE SYNDROME; EASTERN PIPISTRELLE; ENERGY AVAILABILITY; RELATIVE-HUMIDITY; HIBERNATING BATS; METABOLIC-RATE; HOT BATS; SELECTION; TORPOR; TEMPERATURE	Few studies have described winter microclimate selection by bats in the southern United States. This is of particular importance as the cold-adapted fungus, Pseudogymnoascus destructans, which causes the fatal bat disease white-nose syndrome (WNS), continues to spread into southern United States. To better understand the suitability of winter bat habitats for the growth of P. destructans in this region, we collected roost temperature and vapor pressure deficit from 97 hibernacula in six ecoregions in Texas during winter 2016-17 and 2017-18. We also measured skin temperature of Rafinesque's big-eared bats (Corynorhinus townsendii), Townsend's big-eared bats (C. townsendii), big-brown bats (Eptesicus fuscus), southeastern myotis (Myotis austroriparius), cave myotis (M. velifer), tri-colored bats (Perimyotis subflavus), and Mexican free-tailed bats (Tadarida brasiliensis) during hibernation to study their use of torpor in these habitats. We found that temperatures within hibernacula were strongly correlated with external air temperatures and were often within the optimal range of temperatures for P. destructans growth. Hibernacula and skin temperatures differed among species, with Rafinesque's big-eared bats, southeastern myotis, and Mexican free-tailed bats occupying warmer microclimates and having higher torpid skin temperatures. For species that were broadly distributed throughout Texas, hibernacula and skin temperatures differed within species by ecoregion; Tri-colored bats and cave myotis in colder, northern regions occupied colder microclimates within hibernacula and exhibited colder skin temperatures, than individuals of the same species in warmer, southern regions. These data illustrate the variability in microclimates used as hibernacula by bats in Texas and suggest similar variation in susceptibility to WNS in the state. Thus, monitoring microclimates at winter roosts may help predict where WNS may develop, and where management efforts would be most effective.	[Meierhofer, Melissa B.; Morrison, Michael L.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Meierhofer, Melissa B.; Leivers, Samantha J.; Pierce, Brian L.] Texas A&M Univ, Nat Resources Inst, College Stn, TX 77843 USA; [Johnson, Joseph S.] Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA; [Evans, Jonah E.] Texas Parks & Wildlife Dept, Wildlife Div Program, Boerne, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University System of Ohio; Ohio University	Meierhofer, MB (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA.; Meierhofer, MB (corresponding author), Texas A&M Univ, Nat Resources Inst, College Stn, TX 77843 USA.	melissa.meierhofer@ag.tamu.edu	Meierhofer, Melissa/AAS-3473-2021	Meierhofer, Melissa/0000-0003-2384-1999; Leivers, Samantha/0000-0003-3635-3863	U.S. Fish and Wildlife Service's State Wildlife Grant Program (CFDA) [15.611]; U.S. Fish and Wildlife Service (CFDA) [15.657]; Fightwns 'Micro Grants for Microbats'; Texas Ecolab research grants; National Speleological Society WNS Rapid Response Grant	U.S. Fish and Wildlife Service's State Wildlife Grant Program (CFDA); U.S. Fish and Wildlife Service (CFDA); Fightwns 'Micro Grants for Microbats'; Texas Ecolab research grants; National Speleological Society WNS Rapid Response Grant	This work was funded by the U.S. Fish and Wildlife Service's State Wildlife Grant Program (CFDA#15.611) as administered by Texas Parks and Wildlife Department, https://tpwd.texas.gov/and the U.S. Fish and Wildlife Service (CFDA#15.657), https://www.fws.gov/(MLM, BLP). Additional funding support was provided by the Fightwns ` Micro Grants for Microbats', https://www.fightwns.org/, Texas Ecolab research grants, https://texasecolab.org/, and National Speleological Society WNS Rapid Response Grant, https://caves.org/WNS/Rapid_ Response. shtml (BLP, MBM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammerman LK, 2012, BATS TEXAS; Anderson DB, 1936, ECOLOGY, V17, P277, DOI 10.2307/1931468; Avila-Flores R, 2004, J MAMMAL, V85, P675, DOI 10.1644/BOS-127; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Bondarenco A, 2014, NATURWISSENSCHAFTEN, V101, P679, DOI 10.1007/s00114-014-1202-2; Boyles JG, 2007, J EXP BIOL, V210, P4345, DOI 10.1242/jeb.007294; Boyles JG, 2010, ECOL MODEL, V221, P1644, DOI 10.1016/j.ecolmodel.2010.03.018; Briggler JT, 2003, AM MIDL NAT, V149, P406, DOI 10.1674/0003-0031(2003)149[0406:SUASOC]2.0.CO;2; Buck CL, 2000, AM J PHYSIOL-REG I, V279, pR255, DOI 10.1152/ajpregu.2000.279.1.R255; Cryan PM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-135; Czenze ZJ, 2017, CAN J ZOOL, V95, P909, DOI 10.1139/cjz-2016-0318; Dausmann KH, 2004, NATURE, V429, P825, DOI 10.1038/429825a; DAVIS RB, 1962, ECOL MONOGR, V32, P311, DOI 10.2307/1942378; Dunbar MB, 2010, J COMP PHYSIOL B, V180, P885, DOI 10.1007/s00360-010-0457-y; FRENCH AR, 1982, J APPL PHYSIOL, V52, P216, DOI 10.1152/jappl.1982.52.1.216; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Geiser F, 2013, CURR BIOL, V23, pR188, DOI 10.1016/j.cub.2013.01.062; Geiser F, 2011, INTEGR COMP BIOL, V51, P337, DOI 10.1093/icb/icr042; Griffith G., 2007, ECOREGIONS TEXAS; Herreid II C. F., 1963, Journal of Mammalogy, V44, P560, DOI 10.2307/1377140; Humphrey SR, RARE AND ENDANGERED, V1, P335; Humphries MM, 2003, PHYSIOL BIOCHEM ZOOL, V76, P165, DOI 10.1086/367950; Humphries MM, 2002, NATURE, V418, P313, DOI 10.1038/nature00828; Johnson J.S., 2016, CONSERV ECOL, P181; Johnson JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049754; Johnson JI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106014; Jonasson KA, 2012, J EXP BIOL, V90, P891; Kasper Stephen, 2018, Texas Journal of Science, V70, P57, DOI 10.32011/txjsci_70_1_Article4; Kobbe S, 2009, NATURWISSENSCHAFTEN, V96, P1221, DOI 10.1007/s00114-009-0580-3; Kurta A, 2014, NORTHEAST NAT, V21, P587, DOI 10.1656/045.021.0407; Kurta A, 2014, ACTA CHIROPTEROL, V16, P249, DOI 10.3161/150811014X683444; Langwig KE, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0456; Langwig KE, 2012, ECOL LETT, V15, P1050, DOI 10.1111/j.1461-0248.2012.01829.x; Lilley TM, 2018, FUNCT ECOL, V32, P2483, DOI 10.1111/1365-2435.13183; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; MCNAB BK, 1974, ECOLOGY, V55, P943, DOI 10.2307/1940347; Meierhofer MB, 2019, J MAMMAL, V100, P1274, DOI 10.1093/jmammal/gyz099; Moore MS, 2018, J COMP PHYSIOL B, V188, P163, DOI 10.1007/s00360-017-1109-2; Park KJ, 2000, FUNCT ECOL, V14, P580, DOI 10.1046/j.1365-2435.2000.00460.x; Perry RW, 2013, ENVIRON REV, V21, P28, DOI 10.1139/er-2012-0042; R Core Team, 2021, R LANGUAGE ENV STAT; RAESLY RL, 1987, AM MIDL NAT, V118, P15, DOI 10.2307/2425624; Reeder DeeAnn M., 2013, P413; Reeder DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038920; RICE DALE W., 1957, JOUR MAMMAL, V38, P15, DOI 10.2307/1376471; Sandel JK, 2001, J MAMMAL, V82, P173, DOI 10.1644/1545-1542(2001)082<0173:UASOWH>2.0.CO;2; SCHMIDLY D.J., 2016, MAMMALS TEXAS; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Sikes RS, 2016, J MAMMAL, V97, P663, DOI 10.1093/jmammal/gyw078; Stawski C, 2010, J EXP BIOL, V213, P393, DOI 10.1242/jeb.038224; Stevens DL, 2004, J AM STAT ASSOC, V99, P262, DOI 10.1198/016214504000000250; Texas Parks and Wildlife Department, 2017, FUNG CAUS WHIT NOS S; Texas Parks and Wildlife Department, 2019, FUNG CAUS WHIT NOS S; Texas Parks and Wildlife Department, 2018, FUNGUS CAUSING WHITE; Tinkle D. W., 1965, Journal of Mammalogy, V46, P612, DOI 10.2307/1377932; Turner Gregory G., 2009, Bat Research News, V50, P47; Tuttle MD, 1977, NAT CAV MAN S P ALB, P108; Verant ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046280; Vincent Elizabeth A., 2007, Proceedings of the Indiana Academy of Science, V116, P58; Walker CW, 1996, TEX J SCI, V48, P166; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; Webb PI, 1996, CAN J ZOOL, V74, P761, DOI 10.1139/z96-087; Willis CKR, 2011, INTEGR COMP BIOL, V51, P364, DOI 10.1093/icb/icr076	63	19	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220839	10.1371/journal.pone.0220839	http://dx.doi.org/10.1371/journal.pone.0220839			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393965	Green Published, Green Submitted, gold			2022-12-26	WOS:000485002500068
J	Nachar, W; Merlet, N; Maafi, F; Shi, YF; Mihalache-Avram, T; Mecteau, M; Ferron, M; Rheaume, E; Tardif, JC				Nachar, Walid; Merlet, Nolwenn; Maafi, Foued; Shi, Yanfen; Mihalache-Avram, Teodora; Mecteau, Melanie; Ferron, Marine; Rheaume, Eric; Tardif, Jean-Claude			Cardiac inflammation and diastolic dysfunction in hypercholesterolemic rabbits	PLOS ONE			English	Article							HEART-FAILURE; MODEL; UPDATE	Background Left ventricular diastolic dysfunction (LVDD) is present in more than 50% of patients suffering from heart failure. LVDD animal models are limited and its underlying mechanisms remain largely unknown. Aortic valve stenosis (AVS) may cause LVDD, and we recently reported LVDD in an AVS rabbit model. Here we aimed to develop a rabbit model of LVDD without AVS. Methods Rabbits were fed with a 0.5% cholesterol-enriched diet (n = 9) or normal diet (n = 8) until they developed LVDD defined by a value of the echocardiographic parameter E/Em ratio higher than the mean at baseline +2SD. Rabbits were then fed a 0.2% cholesterol-enriched diet for 4 weeks (average total diet duration: 20 weeks). Detailed cardiac structure and function measurements were assessed by echocardiography at baseline, weeks 8, 12 and 14 to 20, when applicable. Histological analyses and RT-qPCR were performed on LV samples. Results The hypercholesterolemic diet induced LVDD without systolic dysfunction or AVS, as shown by multiple echocardiographic parameters, including early filling mitral peak velocity and deceleration rate, Em/Am ratio and E/Em ratio (all p<0.05), and by increased cardiac mRNA expression of brain natriuretic peptide (Bnp). Cardiac expression of mRNA for Nox2, Vcam1, Mmp12, Mmp12/Timp1, Il1b and Col1/Col3 ratios was also higher in these rabbits (p<0.05). In contrast, cardiac Sod2 mRNA expression was reduced in hypercholesterolemic rabbits compared to controls. Conclusion Rabbits fed with a cholesterol-enriched diet develop LVDD with preserved systolic function and evidence of cardiac inflammation and oxidative stress. This rabbit model may be used in future studies to test treatment strategies against LVDD.	[Nachar, Walid; Merlet, Nolwenn; Maafi, Foued; Shi, Yanfen; Mihalache-Avram, Teodora; Mecteau, Melanie; Ferron, Marine; Rheaume, Eric; Tardif, Jean-Claude] Montreal Heart Inst, Montreal, PQ, Canada; [Nachar, Walid; Maafi, Foued; Rheaume, Eric; Tardif, Jean-Claude] Univ Montreal, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Tardif, JC (corresponding author), Montreal Heart Inst, Montreal, PQ, Canada.; Tardif, JC (corresponding author), Univ Montreal, Montreal, PQ, Canada.	jean-claude.tardif@icm-mhi.org	Rheaume, Eric/ABA-4918-2021	Merlet, Nolwenn/0000-0002-0092-2326; Tardif, Jean-Claude/0000-0002-8200-8983				Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; Busseuil D, 2008, BRIT J PHARMACOL, V154, P765, DOI 10.1038/bjp.2008.122; Dubi S, 2010, CARDIOVASC PATHOL, V19, P147, DOI 10.1016/j.carpath.2008.12.008; Franssen C, 2016, JACC-HEART FAIL, V4, P312, DOI 10.1016/j.jchf.2015.10.007; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Horgan S, 2014, J Card Fail, V20, P984, DOI 10.1016/j.cardfail.2014.09.001; Huang Y, 2004, CIRCULATION, V109, P97, DOI 10.1161/01.CIR.0000109213.10461.F6; Kai H, 2005, HYPERTENS RES, V28, P483, DOI 10.1291/hypres.28.483; Khatibzadeh S, 2013, INT J CARDIOL, V168, P1186, DOI 10.1016/j.ijcard.2012.11.065; Merlet N, 2016, INT J CARDIOL, V215, P364, DOI 10.1016/j.ijcard.2016.04.029; Moller S, 2016, HEART FAIL REV, V21, P599, DOI 10.1007/s10741-016-9552-9; Murase T, 2012, HYPERTENS RES, V35, P186, DOI 10.1038/hr.2011.157; Nachar W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089331; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092; Periasamy Muthu, 2008, Heart Fail Clin, V4, P13, DOI 10.1016/j.hfc.2007.10.007; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pober JS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016345; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Silberman GA, 2010, CIRCULATION, V121, P519, DOI 10.1161/CIRCULATIONAHA.109.883777; Sorop O, 2018, CARDIOVASC RES, V114, P954, DOI 10.1093/cvr/cvy038; Takatsu M, 2013, HYPERTENSION, V62, P957, DOI 10.1161/HYPERTENSIONAHA.113.02093; Van Linthout Sophie, 2017, Curr Heart Fail Rep, V14, P251, DOI 10.1007/s11897-017-0337-9; Westermann D, 2011, CIRC-HEART FAIL, V4, P44, DOI 10.1161/CIRCHEARTFAILURE.109.931451	24	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220707	10.1371/journal.pone.0220707	http://dx.doi.org/10.1371/journal.pone.0220707			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393963	Green Submitted, Green Published, gold			2022-12-26	WOS:000485002500054
J	Rashidi, A; Ebadi, M; Shields-Cutler, RR; Kruziki, K; Manias, DA; Barnes, AMT; DeFor, TE; Ferrieri, P; Young, JAH; Knights, D; Blazar, BR; Weisdorf, DJ; Dunny, GM				Rashidi, Armin; Ebadi, Maryam; Shields-Cutler, Robin R.; Kruziki, Kathryn; Manias, Dawn A.; Barnes, Aaron M. T.; DeFor, Todd E.; Ferrieri, Patricia; Young, Jo-Anne H.; Knights, Dan; Blazar, Bruce R.; Weisdorf, Daniel J.; Dunny, Gary M.			Early E. casseliflavus gut colonization and outcomes of allogeneic hematopoietic cell transplantation	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; INTESTINAL MICROBIOTA; ENTEROCOCCI; SUSCEPTIBILITY; RESISTANT; INDOLE; INFECTIONS; BACTEREMIA; DOMINATION; GALLINARUM	Gut dysbiosis has been associated with worse allogeneic hematopoietic cell transplantation (allo-HCT) outcomes. We reported an association between intrinsically vancomycin-resistant enterococci (iVRE: E. gallinarum and E. casseliflavus) gut colonization and lower posttransplant mortality. In this study, using an expanded cohort, we evaluated whether our previously observed association is species-specific. We included allo-HCT recipients with >= 1 positive rectal swab or stool culture for iVRE between days-14 and +14 of transplant. To investigate whether iVRE modulate the gut microbiota, we performed agar diffusion assays. To investigate whether iVRE differ in their ability to activate the aryl hydrocarbon receptor, we analyzed iVRE genomes for enzymes in the shikimate and tryptophan pathways. Sixty six (23 E. casseliflavus and 43 E. gallinarum) of the 908 allograft recipients (2011-2017) met our inclusion criteria. Overall survival was significantly higher in patients with E. casseliflavus (91% vs. 62% at 3 years, P = 0.04). In multivariable analysis, E. casseliflavus gut colonization was significantly associated with reduced all-cause mortality (hazard ratio 0.20, 95% confidence interval 0.04-0.91, P = 0.04). While agar assays were largely unremarkable, genome mining predicted that E. casseliflavus encodes a larger number of enzymes in the tryptophan metabolism pathway. In conclusion, E. casseliflavus gut colonization is associated with reduced post-HCT morality. Further research is needed to understand the mechanisms for this association.	[Rashidi, Armin; Weisdorf, Daniel J.] Univ Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Box 736 UMHC, Minneapolis, MN 55455 USA; [Ebadi, Maryam] Univ Minnesota, Dept Pediat, Div Pediat Hematol Oncol, Minneapolis, MN 55455 USA; [Shields-Cutler, Robin R.; Knights, Dan] Univ Minnesota, Coll Biol Sci, Biotechnol Inst, Minneapolis, MN USA; [Shields-Cutler, Robin R.] Macalester Coll, Dept Biol, St Paul, MN 55105 USA; [Kruziki, Kathryn; Manias, Dawn A.; Barnes, Aaron M. T.; Dunny, Gary M.] Univ Minnesota, Dept Microbiol & Immunol, Minneapolis, MN USA; [Barnes, Aaron M. T.; Ferrieri, Patricia] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [DeFor, Todd E.] Univ Minnesota, Masonic Canc Ctr, Biostat Core, Minneapolis, MN USA; [Young, Jo-Anne H.] Univ Minnesota, Dept Med, Div Infect Dis & Int Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Blazar, Bruce R.] Univ Minnesota, Dept Pediat, Div Blood & Marrow Transplantat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Macalester College; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Rashidi, A (corresponding author), Univ Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Box 736 UMHC, Minneapolis, MN 55455 USA.	arashidi@umn.edu	Young, Jo-Anne/G-2617-2013; Barnes, Aaron/B-7009-2012	Young, Jo-Anne/0000-0003-4182-341X; Barnes, Aaron/0000-0002-7014-7556; Rashidi, Armin/0000-0002-9384-272X	National Institutes of Health [P30 CA77598]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000114]; NATIONAL CANCER INSTITUTE [P01CA111412, P30CA077598] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the National Institutes of Health [grant number P30 CA77598] utilizing the Biostatistics and Bioinformatics Core shared resource of the Masonic Cancer Center, University of Minnesota and the National Center for Advancing Translational Sciences of the National Institutes of Health [grant number UL1TR000114]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors have no conflicts of interest to declare.	ALEXEEV EE, REGULATION, DOI DOI 10.1016/J.AJPATH.2018.01.01; Andermann TM, 2018, BIOL BLOOD MARROW TR, V24, P1322, DOI 10.1016/j.bbmt.2018.02.009; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Darkoh C, 2015, APPL ENVIRON MICROB, V81, P8093, DOI 10.1128/AEM.02787-15; DUNNY GM, 1975, J BACTERIOL, V124, P784, DOI 10.1128/JB.124.2.784-790.1975; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; GORDON S, 1992, J CLIN MICROBIOL, V30, P2373, DOI 10.1128/JCM.30.9.2373-2378.1992; JASPERSON LK, 2008, BLOOD, V111, P3, DOI DOI 10.1038/S41385-018-0019-2; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kelly CJ, 2015, CELL HOST MICROBE, V17, P662, DOI 10.1016/j.chom.2015.03.005; Koch LK, 2009, BLOOD, V114, P5062, DOI 10.1182/blood-2009-06-227587; Kommineni S, 2015, NATURE, V526, P719, DOI 10.1038/nature15524; Lamas B, 2018, MUCOSAL IMMUNOL, V11, P1024, DOI 10.1038/s41385-018-0019-2; LECLERCQ R, 1992, ANTIMICROB AGENTS CH, V36, P2005, DOI 10.1128/AAC.36.9.2005; Li G, 2013, MICROBIOL-SGM, V159, P402, DOI 10.1099/mic.0.064139-0; Mathewson ND, 2016, NAT IMMUNOL, V17, P505, DOI 10.1038/ni.3400; Moura-Alves P, 2014, NATURE, V512, P387, DOI 10.1038/nature13684; Palmer KL, 2012, MBIO, V3, DOI 10.1128/mBio.00318-11; PATTERSON JE, 1995, MEDICINE, V74, P191, DOI 10.1097/00005792-199507000-00003; Peled JU, 2017, J CLIN ONCOL, V35, P1650, DOI 10.1200/JCO.2016.70.3348; Peng LY, 2009, J NUTR, V139, P1619, DOI 10.3945/jn.109.104638; Rashidi A, 2018, BIOL BLOOD MARROW TR, V24, P1260, DOI 10.1016/j.bbmt.2018.01.025; RECEPTOR AMJ, AM J PATHOL, DOI DOI 10.1016/J.AJPATH.2018.01; RECEPTOR AMJ, AM J PATHOL, DOI DOI 10.1016/J.AJPATH.2018.01; RECEPTOR AMJ, AM J PATHOL, DOI DOI 10.1016/J.AJPATH.2018.01; RECEPTOR AMJ, 2018, AM J PATHOL, V188, P1183, DOI DOI 10.1016/J.AJPATH.2018.01; Reid KC, 2001, CLIN INFECT DIS, V32, P1540, DOI 10.1086/320542; RUOFF KL, 1990, J CLIN MICROBIOL, V28, P435, DOI 10.1128/JCM.28.3.435-437.1990; Schiering C, 2017, NATURE, V542, P242, DOI 10.1038/nature21080; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Swimm A, 2018, BLOOD, V132, P2506, DOI 10.1182/blood-2018-03-838193; Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580; Toye B, 1997, J CLIN MICROBIOL, V35, P3166, DOI 10.1128/JCM.35.12.3166-3170.1997; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; VINCENT S, 1991, J CLIN MICROBIOL, V29, P2335, DOI 10.1128/JCM.29.10.2335-2337.1991; Whitfield-Cargile CM, 2016, GUT MICROBES, V7, P246, DOI 10.1080/19490976.2016.1156827; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003	39	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220850	10.1371/journal.pone.0220850	http://dx.doi.org/10.1371/journal.pone.0220850			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393924	Green Submitted, Green Published, gold			2022-12-26	WOS:000485002500071
J	Berggren, KL; Cruz, SR; Hixon, MD; Cowan, AT; Keysar, SB; Craig, S; James, J; Barry, M; Ozbun, MA; Jimeno, A; McCance, DJ; Beswick, EJ; Gan, GN				Berggren, Kiersten L.; Cruz, Sebastian Restrepo; Hixon, Michael D.; Cowan, Andrew T.; Keysar, Stephen B.; Craig, Stephanie; James, Jacqueline; Barry, Marc; Ozbun, Michelle A.; Jimeno, Antonio; McCance, Dennis J.; Beswick, Ellen J.; Gan, Gregory N.			MAPKAPK2 (MK2) inhibition mediates radiation-induced inflammatory cytokine production and tumor growth in head and neck squamous cell carcinoma	ONCOGENE			English	Article							HUMAN-PAPILLOMAVIRUS; ENDOTHELIAL-CELLS; NECROSIS-FACTOR; KINASE 2; CANCER; SMOKING; FIBROBLASTS; EXPRESSION; HSP27; IL-6	Radiation therapy (RT) is a cornerstone of treatment in the management of head and neck squamous cell carcinomas (HNSCC), yet treatment failure and disease recurrence are common. The p38/MK2 pathway is activated in response to cellular stressors, including radiation, and promotes tumor inflammation in a variety of cancers. We investigated MK2 pathway activation in HNSCC and the interaction of MK2 and RT in vitro and in vivo. We used a combination of an oropharyngeal SCC tissue microarray, HNSCC cell lines, and patient-derived xenograft (PDX) tumor models to study the effect of RT on MK2 pathway activation and to determine how inhibition of MK2 by pharmacologic (PF-3644022) and genetic (siRNA) methods impacts tumor growth. We show that high phosphorylated MK2 (p-MK2) levels are associated with worsened disease-specific survival in p16-negative HNSCC patients. RT increased p-MK2 in both p16-positive, HPV-positive and p16-negative, HPV-negative HNSCC cell lines. Pharmacologic inhibition or gene silencing of MK2 in vitro abrogated RT-induced increases in p-MK2; inflammatory cytokine expression and expression of the downstream MK2 target, heat shock protein 27 (HSP27); and markers of epithelial-to-mesenchymal transition. Mouse PDX models treated with a combination of RT and MK2 inhibitor experienced decreased tumor growth and increased survival. Our results suggest that MK2 is a potential prognostic biomarker for head and neck cancer and that MK2 pathway activation can mediate radiation resistance in HNSCC.	[Berggren, Kiersten L.; Cruz, Sebastian Restrepo; Hixon, Michael D.] Univ New Mexico, Dept Internal Med, Sect Radiat Oncol, Albuquerque, NM 87131 USA; [Berggren, Kiersten L.; Cruz, Sebastian Restrepo; Hixon, Michael D.] Univ New Mexico, Ctr Comprehens Canc, Canc Therapeut Program, Albuquerque, NM 87131 USA; [Cowan, Andrew T.] Univ New Mexico, Dept Surg, Div Otolaryngol, Albuquerque, NM 87131 USA; [Cowan, Andrew T.; Ozbun, Michelle A.] Univ New Mexico, Ctr Comprehens Canc, Canc Biol & Signaling Program, Albuquerque, NM 87131 USA; [Keysar, Stephen B.; Jimeno, Antonio] Univ Colorado Denver, Dept Med, Div Med Oncol, Aurora, CO USA; [Craig, Stephanie; James, Jacqueline] Queens Univ, Ctr Canc Res & Cell Biol, Belfast BT9 7BL, Antrim, North Ireland; [Barry, Marc; McCance, Dennis J.] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA; [Ozbun, Michelle A.] Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; [Beswick, Ellen J.] Univ Utah, Dept Internal Med, Div Gastroenterol Hepataol & Nutr, Salt Lake City, UT 84112 USA; [Gan, Gregory N.] Univ Kansas, Med Ctr, Dept Radiat Oncol, Kansas City, KS 66103 USA	University of New Mexico; University of New Mexico; University of New Mexico; University of New Mexico; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Queens University Belfast; University of New Mexico; University of New Mexico; Utah System of Higher Education; University of Utah; University of Kansas; University of Kansas Medical Center	Gan, GN (corresponding author), Univ Kansas, Med Ctr, Dept Radiat Oncol, Kansas City, KS 66103 USA.	greg.gan@gmail.com	Ozbun, Michelle/AAN-2922-2021; Craig, Stephanie/AAX-2060-2020	Ozbun, Michelle/0000-0001-8551-4606; Craig, Stephanie/0000-0002-5476-751X; Gan, Gregory/0000-0001-5090-0064	RSNA Foundation Research Scholar Grant; ACS-IRG [IRG-14-187-19]; University of New Mexico School of Medicine; STI CRC [U19 AI 113187]; NIH P30 Grant NCI [P30CA118100]; Department of Pathology; University of New Mexico Comprehensive Cancer Center [NCI P30CA118100]; NCI [2P30 CA118100]; University of New Mexico Cancer Center Animal Shared Resource - NCI [2P30 CA118100]; NATIONAL CANCER INSTITUTE [R01CA207051, P30CA118100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI113187] Funding Source: NIH RePORTER	RSNA Foundation Research Scholar Grant; ACS-IRG(American Cancer Society); University of New Mexico School of Medicine; STI CRC; NIH P30 Grant NCI; Department of Pathology; University of New Mexico Comprehensive Cancer Center; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of New Mexico Cancer Center Animal Shared Resource - NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work supported in part by RSNA Foundation Research Scholar Grant, ACS-IRG (IRG-14-187-19), Dedicated Health Research Fund from the University of New Mexico School of Medicine (UNM RAC 2018), STI CRC (U19 AI 113187), and the NIH P30 Grant NCI P30CA118100. The research in this paper was supported by the Human Tissue Repository and Tissue Analysis Shared Resource, funded by the Department of Pathology and The University of New Mexico Comprehensive Cancer Center and NCI P30CA118100. Many of the images in this paper were generated in the University of New Mexico Cancer Center Fluorescence Microscopy Shared Resource with current funding from NCI 2P30 CA118100. Initial support with PDX generation was performed with the assistance from the University of New Mexico Cancer Center Animal Shared Resource funded by NCI 2P30 CA118100. We also wish to acknowledge UNM Cancer Center Biostatistics Core Facility for their statistical assistance.	An SS, 2005, AM J PHYSIOL-CELL PH, V289, pC521, DOI 10.1152/ajpcell.00429.2004; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Argiris A, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00072; Bae JY, 2014, NEOPLASIA, V16, P928, DOI 10.1016/j.neo.2014.09.003; Cheng JCH, 2014, ANN SURG ONCOL, V21, P2361, DOI 10.1245/s10434-014-3611-z; Duffy SA, 2008, CANCER-AM CANCER SOC, V113, P750, DOI 10.1002/cncr.23615; Gan GN, 2014, CANCER RES, V74, P7024, DOI 10.1158/0008-5472.CAN-14-1346; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Gorska MM, 2007, J EXP MED, V204, P1637, DOI 10.1084/jem.20062621; Gurgis FMS, 2015, ONCOGENE, V34, P2934, DOI 10.1038/onc.2014.225; Guttmann DM, 2013, INT J RADIAT ONCOL, V87, P168, DOI 10.1016/j.ijrobp.2013.05.028; Haigentz M, 2018, ADV THER, V35, P255, DOI 10.1007/s12325-018-0682-4; Jank BJ, 2019, EUR ARCH OTO-RHINO-L, V276, P1487, DOI 10.1007/s00405-019-05381-0; Jomrich G, 2018, J CANCER, V9, P460, DOI 10.7150/jca.22310; Keysar SB, 2013, MOL ONCOL, V7, P776, DOI 10.1016/j.molonc.2013.03.004; Keysar SB, 2013, CANCER RES, V73, P3381, DOI 10.1158/0008-5472.CAN-12-4047; Kim JY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22635-9; Klussmann JP, 2003, AM J PATHOL, V162, P747, DOI 10.1016/S0002-9440(10)63871-0; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kumar B, 2017, ONCOTARGET, V8, P14847, DOI 10.18632/oncotarget.14682; Leon X, 2015, ONCOTARGET, V6, P37407, DOI 10.18632/oncotarget.6054; Liskamp CP, 2016, HEAD NECK-J SCI SPEC, V38, P1780, DOI 10.1002/hed.24516; Liu TG, 2007, AM J RESP CELL MOL, V37, P507, DOI 10.1165/rcmb.2007-0077OC; Mirghani H, 2018, ORAL ONCOL, V82, P131, DOI 10.1016/j.oraloncology.2018.05.007; Morandell S, 2013, CELL REP, V5, P868, DOI 10.1016/j.celrep.2013.10.025; Munshi Anupama, 2013, Genes Cancer, V4, P401, DOI 10.1177/1947601913485414; Muschter D, 2018, CLIN ORAL INVEST, V22, P2251, DOI 10.1007/s00784-017-2323-8; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Park KJ, 2003, J BIOL CHEM, V278, P35272, DOI 10.1074/jbc.M305095200; Pavan S, 2014, INT J CANCER, V134, P1289, DOI 10.1002/ijc.28464; Powrozek T, 2018, J CANCER RES CLIN, V144, P1423, DOI 10.1007/s00432-018-2679-4; Qin X, 2018, THERANOSTICS, V8, P921, DOI 10.7150/thno.22182; Ray AL, 2018, INT J CANCER, V142, P1702, DOI 10.1002/ijc.31191; Ray AL, 2016, INT J CANCER, V138, P770, DOI 10.1002/ijc.29716; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Schernberg A, 2019, HEAD NECK-J SCI SPEC, V41, P1441, DOI 10.1002/hed.25598; Seiwert TY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102112; Sharma RA, 2016, NAT REV CLIN ONCOL, V13, P627, DOI 10.1038/nrclinonc.2016.79; Shen BR, 2017, SCI REP-UK, V7, DOI 10.1038/srep46231; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Singh MK, 2017, J THERM BIOL, V69, P149, DOI 10.1016/j.jtherbio.2017.06.004; Singh RK, 2017, PHARMACOL REP, V69, P746, DOI 10.1016/j.pharep.2017.03.023; Stein AP, 2015, CANCER MED-US, V4, P699, DOI 10.1002/cam4.387; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; Sumner WA, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1268-7; Thuraisingam T, 2010, J INVEST DERMATOL, V130, P278, DOI 10.1038/jid.2009.209; Tribius S, 2012, ORAL ONCOL, V48, P1178, DOI 10.1016/j.oraloncology.2012.05.022; Xu L, 2014, J MOL CELL CARDIOL, V77, P86, DOI 10.1016/j.yjmcc.2014.09.011; Yadav A, 2017, ONCOTARGET, V8, P66912, DOI 10.18632/oncotarget.11464; Yeung YT, 2012, J NEURO-ONCOL, V109, P35, DOI 10.1007/s11060-012-0875-7; Zheng GP, 2018, CLIN CANCER RES, V24, P1163, DOI 10.1158/1078-0432.CCR-17-2619	51	7	7	0	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 28	2019	38	48					7329	7341		10.1038/s41388-019-0945-9	http://dx.doi.org/10.1038/s41388-019-0945-9			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JR4XX	31417185	Green Accepted			2022-12-26	WOS:000499631000004
J	Xu, CL; Wang, XR; Zhou, Y; Chen, FX; Wang, HW; Li, KN; Fan, HY; Tang, XM; Jiang, GJ; Zhang, J				Xu, Congling; Wang, Xinrui; Zhou, Yu; Chen, Fei Xavier; Wang, Haiwei; Li, Kening; Fan, Huiyong; Tang, Xiaomei; Jiang, Guojuan; Zhang, Ji			Synergy between arsenic trioxide and JQ1 on autophagy in pancreatic cancer	ONCOGENE			English	Article							CELL-DEATH; MEDIATED APOPTOSIS; UP-REGULATION; TUMOR-GROWTH; NRF2; P53; INHIBITION; ACTIVATION; SURVIVAL; BIOLOGY	Pancreatic cancer is a deadliest type of malignancy and lacks effective intervention. We here report a potential strategy for treatment of this malignancy by the combination of arsenic trioxide (ATO) and BET bromodomain inhibitor JQ1. These two agents synergistically modulate multistages of autophagy and thus induce apoptosis effectively in pancreatic cancer cells. Our genomic and biochemical data have demonstrated that crosstalks between ER stress and autophagy play crucial roles during ATO-induced apoptosis, in which NRF2 may stand at the crossroad between cell death and survival. This has been further strengthened by our finding that NRF2 depletion renders insensitive cells into sensitive ones in regard to ATO treatment-caused cell death. The knockdown of NRF2 and the addition of JQ1 result in similar molecular/cellular effects in promoting effective ATO-induced apoptosis in cells that are insensitive to ATO treatment alone. Thus, the combination of ATO and JQ1 may represent a new treatment strategy for pancreatic cancer.	[Xu, Congling; Wang, Xinrui; Li, Kening; Fan, Huiyong; Tang, Xiaomei; Jiang, Guojuan; Zhang, Ji] Shanghai Jiao Tong Univ, Rui Jin Hosp, Shanghai Inst Hematol, State Key Lab Med Genom,Sch Med, Shanghai, Peoples R China; [Xu, Congling; Chen, Fei Xavier] Fudan Univ, Sch Basic Med Sci, Dept Syst Biol Med, Key Lab Mol Med,Shanghai Med Coll,Minist Educ, Shanghai 200032, Peoples R China; [Zhou, Yu] Civil Aviat Hosp Shanghai, Dept Orthoped, Shanghai, Peoples R China; [Wang, Haiwei] Fujian Med Univ, Fujian Prov Matern & Childrens Hosp, Fujian Key Lab Prenatal Diag & Birth Defect, Affiliated Hosp, Fuzhou 350001, Fujian, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Fudan University; Fujian Medical University	Zhang, J (corresponding author), Shanghai Jiao Tong Univ, Rui Jin Hosp, Shanghai Inst Hematol, State Key Lab Med Genom,Sch Med, Shanghai, Peoples R China.	Zj11222@rjh.com.cn	Wang, Xinrui/AAW-5405-2021	Wang, Xinrui/0000-0002-7383-9128; CHEN, FEI/0000-0002-7827-7988	National Natural Science Foundation [81370655]; Shanghai Jiao Tong University School of Medicine, Shanghai Jiao Tong University	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Jiao Tong University School of Medicine, Shanghai Jiao Tong University	This study is supported in part by the National Natural Science Foundation (no. 81370655), and by Distinguished Professorship (JZ) from Shanghai Jiao Tong University School of Medicine, Shanghai Jiao Tong University.	Allemani C, 2018, LANCET, V391, P1023, DOI 10.1016/S0140-6736(17)33326-3; Antonucci L, 2015, P NATL ACAD SCI USA, V112, pE6166, DOI 10.1073/pnas.1519384112; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; Cho HY, 2006, ANTIOXID REDOX SIGN, V8, P76, DOI 10.1089/ars.2006.8.76; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Du YZ, 2006, BLOOD, V107, P1582, DOI 10.1182/blood-2005-06-2318; Dunne RF, 2015, HEMATOL ONCOL CLIN N, V29, P595, DOI 10.1016/j.hoc.2015.04.003; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Garcia PL, 2016, ONCOGENE, V35, P833, DOI 10.1038/onc.2015.126; Gewirtz DA, 2014, CANCER RES, V74, P647, DOI 10.1158/0008-5472.CAN-13-2966; Ghaneh P, 2007, GUT, V56, P1134, DOI 10.1136/gut.2006.103333; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Hussong M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.157; Iacobuzio-Donahue CA, 2014, NEW ENGL J MED, V370, P1352, DOI 10.1056/NEJMcibr1400189; Kanzawa T, 2005, ONCOGENE, V24, P980, DOI 10.1038/sj.onc.1208095; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kim J, 2013, CANCER CELL, V23, P23, DOI 10.1016/j.ccr.2012.11.017; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Ktistakis NT, 2016, TRENDS CELL BIOL, V26, P624, DOI 10.1016/j.tcb.2016.03.006; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Langdon CG, 2017, MOL CANCER THER, V16, P1041, DOI 10.1158/1535-7163.MCT-16-0794; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Martina JA, 2016, EMBO J, V35, P479, DOI 10.15252/embj.201593428; Martina JA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004754; Mazur PK, 2015, NAT MED, V21, P1163, DOI 10.1038/nm.3952; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Newman RA, 2007, INTEGR CANCER THER, V6, P354, DOI 10.1177/1534735407309623; Pietrocola F, 2013, SEMIN CANCER BIOL, V23, P310, DOI 10.1016/j.semcancer.2013.05.008; Piya S, 2017, AUTOPHAGY, V13, P214, DOI 10.1080/15548627.2016.1245263; Qian WB, 2007, LEUKEMIA RES, V31, P329, DOI 10.1016/j.leukres.2006.06.021; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Sakamaki JI, 2017, MOL CELL, V66, P517, DOI 10.1016/j.molcel.2017.04.027; Shah P, 2017, MOLECULES, V22, DOI 10.3390/molecules22020194; Sun H. D., 1992, CHIN J INTEGRAT CHIN, V12, P170; Sun XF, 2016, HEPATOLOGY, V63, P173, DOI 10.1002/hep.28251; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wakabayashi N, 2010, ANTIOXID REDOX SIGN, V13, P1649, DOI 10.1089/ars.2010.3216; Wang KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007538; Wen X, 2017, AUTOPHAGY, V13, P1801, DOI 10.1080/15548627.2017.1364334; Xia Y, 2013, EXP BIOL MED, V238, P932, DOI 10.1177/1535370213492689; Yang A, 2014, CANCER DISCOV, V4, P905, DOI 10.1158/2159-8290.CD-14-0362; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Zhang T. D., 1973, HEILONGJIANG MED J, P66; Zhang YX, 2011, ANTIOXID REDOX SIGN, V15, P2867, DOI 10.1089/ars.2010.3685	53	14	15	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 21	2019	38	47					7249	7265		10.1038/s41388-019-0930-3	http://dx.doi.org/10.1038/s41388-019-0930-3			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JP0UL	31420604				2022-12-26	WOS:000497989400005
J	Nakagawa, M; Nakatani, F; Matsunaga, H; Seki, T; Endo, M; Ogawara, Y; Machida, Y; Katsumoto, T; Yamagata, K; Hattori, A; Fujita, S; Aikawa, Y; Ishikawa, T; Soga, T; Kawai, A; Chuman, H; Yokoyama, N; Fukushima, S; Yahiro, K; Kimura, A; Shimada, E; Hirose, T; Fujiwara, T; Setsu, N; Matsumoto, Y; Iwamoto, Y; Nakashima, Y; Kitabayashi, I				Nakagawa, Makoto; Nakatani, Fumihiko; Matsunaga, Hironori; Seki, Takahiko; Endo, Makoto; Ogawara, Yoko; Machida, Yukino; Katsumoto, Takuo; Yamagata, Kazutsune; Hattori, Ayuna; Fujita, Shuhei; Aikawa, Yukiko; Ishikawa, Takamasa; Soga, Tomoyoshi; Kawai, Akira; Chuman, Hirokazu; Yokoyama, Nobuhiko; Fukushima, Suguru; Yahiro, Kenichiro; Kimura, Atsushi; Shimada, Eijiro; Hirose, Takeshi; Fujiwara, Toshifumi; Setsu, Nokitaka; Matsumoto, Yoshihiro; Iwamoto, Yukihide; Nakashima, Yasuharu; Kitabayashi, Issay			Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma	ONCOGENE			English	Article							SOFT-TISSUE SARCOMA; OPEN-LABEL; ONCOMETABOLITE 2-HYDROXYGLUTARATE; OLLIER DISEASE; MUTATIONS; DIFFERENTIATION; CHEMOTHERAPY; SUFFICIENT; EXPRESSION; ENASIDENIB	Chondrosarcoma is the second most common malignant bone tumor. It is characterized by low vascularity and an abundant extracellular matrix, which confer these tumors resistance to chemotherapy and radiotherapy. There are currently no effective treatment options for relapsed or dedifferentiated chondrosarcoma, and new targeted therapies need to be identified. Isocitrate dehydrogenase (IDH) mutations, which are detected in similar to 50% of chondrosarcoma patients, contribute to malignant transformation by catalyzing the production of 2-hydroxyglutarate (2-HG), a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases. Mutant IDH inhibitors are therefore potential novel anticancer drugs in IDH mutant tumors. Here, we examined the efficacy of the inhibition of mutant IDH1 as an antitumor approach in chondrosarcoma cells in vitro and in vivo, and investigated the association between the IDH mutation and chondrosarcoma cells. DS-1001b, a novel, orally bioavailable, selective mutant IDH1 inhibitor, impaired the proliferation of chondrosarcoma cells with IDH1 mutations in vitro and in vivo, and decreased 2-HG levels. RNA-seq analysis showed that inhibition of mutant IDH1 promoted chondrocyte differentiation in the conventional chondrosarcoma L835 cell line and caused cell cycle arrest in the dedifferentiated JJ012 cell line. Mutant IDH1-mediated modulation of SOX9 and CDKN1C expression regulated chondrosarcoma tumor progression, and DS-1001b upregulated the expression of these genes via a common mechanism involving the demethylation of H3K9me3. DS-1001b treatment reversed the epigenetic changes caused by aberrant histone modifications. The present data strongly suggest that inhibition of mutant IDH1 is a promising therapeutic approach in chondrosarcoma, particularly for the treatment of relapsed or dedifferentiated chondrosarcoma.	[Nakagawa, Makoto; Ogawara, Yoko; Machida, Yukino; Katsumoto, Takuo; Yamagata, Kazutsune; Hattori, Ayuna; Fujita, Shuhei; Aikawa, Yukiko; Kitabayashi, Issay] Natl Canc Ctr, Div Hematol Malignancy, Tokyo, Japan; [Nakagawa, Makoto; Endo, Makoto; Yokoyama, Nobuhiko; Fukushima, Suguru; Yahiro, Kenichiro; Kimura, Atsushi; Shimada, Eijiro; Hirose, Takeshi; Fujiwara, Toshifumi; Setsu, Nokitaka; Matsumoto, Yoshihiro; Nakashima, Yasuharu] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Fukuoka, Fukuoka, Japan; [Nakagawa, Makoto; Nakatani, Fumihiko; Kawai, Akira] Natl Canc Ctr, Div Musculoskeletal Oncol, Tokyo, Japan; [Matsunaga, Hironori; Seki, Takahiko] Daiichi Sankyo Co Ltd, Oncol Labs, Tokyo, Japan; [Ishikawa, Takamasa; Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, Yamagata, Japan; [Chuman, Hirokazu] Katai Orthopaed Internal Med Hosp, Div Orthopaed Surg, Fukuoka, Fukuoka, Japan; [Iwamoto, Yukihide] Kyushu Rosai Hosp, Div Orthopaed Surg, Fukuoka, Fukuoka, Japan	National Cancer Center - Japan; Kyushu University; National Cancer Center - Japan; Daiichi Sankyo Company Limited; Keio University	Kitabayashi, I (corresponding author), Natl Canc Ctr, Div Hematol Malignancy, Tokyo, Japan.	ikitabay@ncc.go.jp	Endo, Makoto/K-2896-2012	Endo, Makoto/0000-0002-7956-2190; Nakagawa, Makoto/0000-0001-8243-7705; Hirose, Takeshi/0000-0003-1588-9757; Kitabayashi, Issay/0000-0002-8409-0407	Foundation for Promotion of Cancer Research (FPCR); Acceleration Transformative Research for Medical Innovation from the Japan Agency for Medical Research and Development; National Cancer Center Research and Development Fund	Foundation for Promotion of Cancer Research (FPCR); Acceleration Transformative Research for Medical Innovation from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); National Cancer Center Research and Development Fund(National Cancer Center - Japan)	We wish to thank Dr Joel A. Block, Dr Judith V.M. G. Bovee, and Dr A. Ogose for providing important cell lines. We thank Yutaka Shima, Yuki Kagiyama, and Emi Takamatsu-Ichihara for expert advice and technical support. This work was supported by a Grant from Foundation for Promotion of Cancer Research (FPCR) (F.N.). IK was funded by Acceleration Transformative Research for Medical Innovation from the Japan Agency for Medical Research and Development and by the National Cancer Center Research and Development Fund.	Amary MF, 2011, NAT GENET, V43, P1262, DOI 10.1038/ng.994; Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Amatangelo MD, 2017, BLOOD, V130, P732, DOI 10.1182/blood-2017-04-779447; Andreou D, 2011, ACTA ORTHOP, V82, P749, DOI 10.3109/17453674.2011.636668; Borger DR, 2012, ONCOLOGIST, V17, P72, DOI 10.1634/theoncologist.2011-0386; Cairns RA, 2012, BLOOD, V119, P1901, DOI 10.1182/blood-2011-11-391748; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Clark JCM, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-20; Endo M, 2015, MODERN PATHOL, V28, P587, DOI 10.1038/modpathol.2014.155; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Ghert MA, 2001, ONCOLOGY-BASEL, V61, P306, DOI 10.1159/000055338; Giuffrida AY, 2009, J BONE JOINT SURG AM, V91A, P1063, DOI 10.2106/JBJS.H.00416; Hirata M, 2015, P NATL ACAD SCI USA, V112, P2829, DOI 10.1073/pnas.1424400112; Hogendoorn P, 2013, WHO CLASSIFICATION T, V4, P264; Italiano A, 2013, ANN ONCOL, V24, P2916, DOI 10.1093/annonc/mdt374; Jin Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126956; Kawai A, 2015, LANCET ONCOL, V16, P406, DOI 10.1016/S1470-2045(15)70098-7; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Kudo N, 2007, VIRCHOWS ARCH, V451, P691, DOI 10.1007/s00428-007-0426-3; Li L., 2015, J OCEAN WIND ENERGY, V2, P1, DOI DOI 10.1371/J0URNAL.P0NE.0133813; Losman JA, 2013, SCIENCE, V339, P1621, DOI 10.1126/science.1231677; Lu C, 2013, GENE DEV, V27, P1986, DOI 10.1101/gad.226753.113; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Mitchell AD, 2000, J BONE JOINT SURG BR, V82B, P55, DOI 10.1302/0301-620X.82B1.9020; Ogawara Y, 2015, CANCER RES, V75, P2005, DOI 10.1158/0008-5472.CAN-14-2200; Pansuriya TC, 2011, NAT GENET, V43, P1256, DOI 10.1038/ng.1004; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Perut F, 2018, J ORTHOP RES, V36, P2305, DOI 10.1002/jor.23880; Pollack SM, 2018, J CLIN ONCOL, V36, P125, DOI 10.1200/JCO.2017.75.1610; Pollack SM, 2017, J IMMUNOTHER, V40, P302, DOI 10.1097/CJI.0000000000000183; Polychronidou G, 2017, FUTURE ONCOL, V13, P637, DOI 10.2217/fon-2016-0226; Pusch S, 2017, ACTA NEUROPATHOL, V133, P629, DOI 10.1007/s00401-017-1677-y; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Sasaki M, 2012, GENE DEV, V26, P2038, DOI 10.1101/gad.198200.112; Schoffski P, 2016, LANCET, V387, P1629, DOI 10.1016/S0140-6736(15)01283-0; Stein EM, 2017, BLOOD, V130, P722, DOI 10.1182/blood-2017-04-779405; Streitbuerger A, 2012, J BONE JOINT SURG BR, V94B, P122, DOI 10.1302/0301-620X.94B1.26876; Suijker J, 2015, ONCOTARGET, V6, P12505, DOI 10.18632/oncotarget.3723; Tap WD, 2016, LANCET, V388, P488, DOI 10.1016/S0140-6736(16)30587-6; Tawbi HA, 2017, LANCET ONCOL, V18, P1493, DOI 10.1016/S1470-2045(17)30624-1; van der Graaf WTA, 2012, LANCET, V379, P1879, DOI 10.1016/S0140-6736(12)60651-5; van Oosterwijk JG, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-375; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yen K, 2017, CANCER DISCOV, V7, P478, DOI 10.1158/2159-8290.CD-16-1034; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	47	31	32	1	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 17	2019	38	42					6835	6849		10.1038/s41388-019-0929-9	http://dx.doi.org/10.1038/s41388-019-0929-9			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JE5UU	31406254	hybrid			2022-12-26	WOS:000490758200003
J	Wang, X; Yu, YX; Ge, JJ; Xie, BY; Zhu, SF; Cheng, XY				Wang, Xu; Yu, Yanxue; Ge, Jianjun; Xie, Bingyan; Zhu, Shuifang; Cheng, Xinyue			Effects of alpha-pinene on the pinewood nematode (Bursaphelenchus xylophilus) and its symbiotic bacteria	PLOS ONE			English	Article							WOOD NEMATODE; NEMATOCIDAL ACTIVITY; DEGRADATION; ACID	The pinewood nematode (PWN), Bursaphelenchus xylophilus, is an important plant-parasitic nematode that can cause severe mortality of pine trees. This PWN-induced harm to plants may be closely related to the abundance and diversity of the symbiotic microorganisms of the parasitic nematode. In this study, nematodes were divided into untreated and antibiotic-treated groups. Nematodes were treated by fumigation with different amounts of alpha-pinene, and the resultant mortality rates were analyzed statistically. Concentrations of symbiotic bacteria were calculated as colony-forming units per nematode. High-throughput sequencing was used to investigate the bacterial community structure. The results showed that the mortality of nematodes increased slightly with an increasing concentration of alpha-pinene, and nematodes untreated with antibiotics were more sensitive to a-pinene than those treated with antibiotics. The highest abundance of symbiotic bacteria was obtained via medium and low levels of alpha-pinene, but for which community diversity was the lowest (Shannon and Simpson indexes). The proportion of Pseudomonas spp. in the symbiotic bacteria of nematodes without antibiotics was relatively high (more than 70%), while that of Stenotrophomonas spp. was low (6%-20%). However, the proportion of Stenotrophomonas spp. was larger than that of Pseudomonas spp in the symbiotic bacteria associated with the antibiotic-treated nematodes. Pseudomonas sp. increased after pinene treatment, whereas Stenotrophomonas spp. decreased. These results indicate that although alpha-pinene has low toxicity to PWNs over a short time period, alpha-pinene ultimately influences the abundance and community diversity of the symbiotic bacteria of these nematodes; this influence may potentially disturb the development and reproduction of nematodes in the process of infecting pine trees.	[Wang, Xu; Cheng, Xinyue] Beijing Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Wang, Xu; Yu, Yanxue; Ge, Jianjun; Zhu, Shuifang] Chinese Acad Inspect & Quarantine, Beijing, Peoples R China; [Xie, Bingyan] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing, Peoples R China	Beijing Normal University; Chinese Academy of Inspection & Quarantine; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS	Cheng, XY (corresponding author), Beijing Normal Univ, Coll Life Sci, Beijing, Peoples R China.	chengxy@bnu.edu.cn		Wang, Xu/0000-0003-1475-026X	National Natural Science Foundation of China [31370501, 31300309]; National Key Research and Development Program [2018YFC0809102]; National Nature Science Foundation of China [31370501, 31300309]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (31370501, 31300309) and the National Key Research and Development Program (2018YFC0809102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Dr. W. J. Zhao for his helpful suggestions regarding our research. We also thank Ms. X. M. Hou and Ms. X. Zhang for their assistance during the experimental process. This research was supported by the National Nature Science Foundation of China (31370501, 31300309) and the National Key Research and Development Program (2018YFC0809102).	Abdel-Rahman FH, 2013, J ENVIRON SCI HEAL B, V48, P16, DOI 10.1080/03601234.2012.716686; Ajayi O.E., 2014, J INSECTS, V2014, P917212, DOI [10.1155/2014/917212, DOI 10.1155/2014/917212]; [Anonymous], 2008, PINE WILT DISEASE; [Anonymous], 2014, THESIS; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cheng XY, 2013, SCI REP-UK, V3, DOI 10.1038/srep01869; Choi IH, 2007, RUSS J NEMATOL, V15, P35; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; FUKUDA K, 1994, EUR J FOREST PATHOL, V24, P193; Garrity GM, 2007, TAXONOMIC OUTLINE BA, V7, P1; GIBBON GH, 1971, FEBS LETT, V18, P103, DOI 10.1016/0014-5793(71)80418-0; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Kong JO, 2007, J NEMATOL, V39, P237; KURODA K, 1989, Annals of the Phytopathological Society of Japan, V55, P170, DOI 10.3186/jjphytopath.55.170; KURODA K, 1991, EUR J FOREST PATHOL, V21, P82; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; LEWINSOHN E, 1993, PHYTOCHEM ANALYSIS, V4, P220, DOI 10.1002/pca.2800040506; Linares D, 2009, FOOD RES INT, V42, P461, DOI 10.1016/j.foodres.2008.12.001; Matsuda F, 2013, ANAL CHEM, V85, P8291, DOI 10.1021/ac401564v; Ning Tiao, 2006, Acta Entomologica Sinica, V49, P179; OKU H, 1988, J NEMATOL, V20, P245; Proenca DN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105190; Proenca DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015191; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Takeuchi Y, 2006, NEMATOLOGY, V8, P869, DOI 10.1163/156854106779799295; TUDROSZEN NJ, 1977, BIOCHEM J, V168, P315, DOI 10.1042/bj1680315; Vicente CSL, 2011, ANTON LEEUW INT J G, V100, P477, DOI 10.1007/s10482-011-9602-1; VIGLIERCHIO DR, 1983, J NEMATOL, V15, P438; Wu XQ, 2013, INT J BIOL SCI, V9, P34, DOI 10.7150/ijbs.5071; Xiang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137386; Yan X, 2012, GENE, V505, P81, DOI 10.1016/j.gene.2012.05.041; Yoo SK, 2001, PROCESS BIOCHEM, V36, P925, DOI 10.1016/S0032-9592(00)00248-X; Zhang H, 1997, Z NATURFORSCH C, V52, P329; Zhao BG, 2003, NEMATOLOGY, V5, P899, DOI 10.1163/156854103773040817; Zorn H, 2004, J BIOTECHNOL, V107, P255, DOI 10.1016/j.jbiotec.2003.10.002; Zulak KG, 2010, J INTEGR PLANT BIOL, V52, P86, DOI 10.1111/j.1744-7909.2010.00910.x	36	8	9	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0221099	10.1371/journal.pone.0221099	http://dx.doi.org/10.1371/journal.pone.0221099			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5MK	31425544	Green Published, Green Submitted, gold			2022-12-26	WOS:000485022400025
J	Wei, SQ; Zhang, HJ; Li, B; Ji, JF; Shao, XW				Wei, Shuqin; Zhang, Huijuan; Li, Bo; Ji, Jianfen; Shao, Xiwen			Insecticidal effect of aconitine on the rice brown planthoppers	PLOS ONE			English	Article							LUGENS STAL HOMOPTERA; NILAPARVATA-LUGENS; IMIDACLOPRID RESISTANCE; MOLECULAR-MECHANISMS; CARBAMATE RESISTANCE; ORGANOPHOSPHORUS; SUSCEPTIBILITY	The brown planthopper, Nilaparvata lugens (Stal), severely damages rice production and develops high level resistance to several classes of insecticides. To find potential insecticidal resources is always important. As an environmentally friendly compound, aconitine exhibits potential pesticide features. In the present study, the pesticide and knockdown effects of aconitine were first tested on the brown planthopper. The results showed that the knockdown rates for an aconitine concentration of 200 ppm was 83.6%. The insecticidal LD50 was 22.68 ng/pest (95% CI, 17.75-28.99). The molecular mechanisms responding to aconitine application were analyzed through transcriptional sequencing. Compared to that of the knockdown nymphs of the brown planthoppers, the enzymes CYP3A4, UDP-glucuronosyltransferase (UGT), GST, carboxylesterase (EC3.1.1.1), and GABAergic synapse were up-regulated. We inferred that aconitine might be neurotoxic to the brown planthoppers, and the conscious nymphs resist the drug neurotoxicity through the upregulation of CYP3A4, UGT, and GABA receptor mutation. Although aconitine is not safe for mammals, it may be a leading compound to develop novel insecticides.	[Wei, Shuqin; Shao, Xiwen] Jilin Agr Univ, Coll Agron, Changchun, Jilin, Peoples R China; [Wei, Shuqin] Jilin Coll Agr Sci & Technol, Coll Agron, Jilin, Jilin, Peoples R China; [Zhang, Huijuan; Li, Bo; Ji, Jianfen] Jilin Coll Agr Sci & Technol, Coll Biol & Pharmaceut Engn, Jilin, Jilin, Peoples R China	Jilin Agricultural University	Shao, XW (corresponding author), Jilin Agr Univ, Coll Agron, Changchun, Jilin, Peoples R China.	jilinwsq@163.com			China National Science Project [2016YFC0501204, 2016YFD0300104]; China Jilin Provincial Science Technology Project [20160204011NY]; Chinese Medicine Key advantages of the provincial subjects of Jilin Agricultural Science and Technology College in Jilin province screening [JNYHZ 2015-X034]	China National Science Project; China Jilin Provincial Science Technology Project; Chinese Medicine Key advantages of the provincial subjects of Jilin Agricultural Science and Technology College in Jilin province screening	The study is funded by China National Science Project (Grant no. 2016YFC0501204; 2016YFD0300104), http://www.nsfc.gov.cn/; China Jilin Provincial Science Technology Project (grant no. 20160204011NY), http://kjt.jl.gov.cn/; Chinese Medicine Key advantages of the provincial subjects of Jilin Agricultural Science and Technology College in Jilin province screening (JNYHZ 2015-X034), http://kjt.jl.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogacz Anna, 2014, Ginekol Pol, V85, P348; Chan TYK, 2012, FORENSIC SCI INT, V222, P1, DOI 10.1016/j.forsciint.2012.02.026; Chan TYK, 2011, HUM EXP TOXICOL, V30, P2023, DOI 10.1177/0960327111407224; Dermauw W, 2013, P NATL ACAD SCI USA, V110, pE113, DOI 10.1073/pnas.1213214110; Ding ZP, 2013, INSECT BIOCHEM MOLEC, V43, P1021, DOI 10.1016/j.ibmb.2013.08.005; Ge LQ, 2011, J PROTEOME RES, V10, P4597, DOI 10.1021/pr200414g; Gorman K, 2008, PEST MANAG SCI, V64, P1122, DOI 10.1002/ps.1635; HAMA H, 1983, APPL ENTOMOL ZOOL, V18, P475, DOI 10.1303/aez.18.475; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Khush GS, 1999, GENOME, V42, P646, DOI 10.1139/gen-42-4-646; KILIN D, 1981, APPL ENTOMOL ZOOL, V16, P1; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liu ZW, 2003, PEST MANAG SCI, V59, P1355, DOI 10.1002/ps.768; Preap V., 2006, J AGR, V7, P17; Preap V, 2001, ASIA PAC ENTOMOL, V4, P75; Puinean AM, 2010, PESTIC BIOCHEM PHYS, V97, P129, DOI 10.1016/j.pestbp.2009.06.008; Qin GH, 2014, PESTIC BIOCHEM PHYS, V109, P1, DOI 10.1016/j.pestbp.2013.12.008; Riaz MA, 2013, AQUAT TOXICOL, V126, P326, DOI 10.1016/j.aquatox.2012.09.010; Riga M, 2014, INSECT BIOCHEM MOLEC, V46, P43, DOI 10.1016/j.ibmb.2014.01.006; Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7; Small GJ, 2000, INSECT MOL BIOL, V9, P647, DOI 10.1046/j.1365-2583.2000.00229.x; Visarto P., 2001, Journal of Asia-Pacific Entomology, V4, P75, DOI 10.1016/S1226-8615(08)60107-7; Wang YH, 2008, PEST MANAG SCI, V64, P1278, DOI 10.1002/ps.1629; Wei DD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080046; Wu JC, 2001, ENTOMOL EXP APPL, V100, P119, DOI 10.1023/A:1019284703260; Xu JH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-874	26	8	8	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0221090	10.1371/journal.pone.0221090	http://dx.doi.org/10.1371/journal.pone.0221090			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5MK	31426056	Green Published, Green Submitted, gold			2022-12-26	WOS:000485022400023
J	Lee, J; Kim, S; Kim, HM; Kim, HJ; Yu, FH				Lee, Jisoo; Kim, Shinae; Kim, Hye-mi; Kim, Hyun Jeong; Yu, Frank H.			Na(V)1.6 and Na(V)1.7 channels are major endogenous voltage-gated sodium channels in ND7/23 cells	PLOS ONE			English	Article							HETEROLOGOUS EXPRESSION; FUNCTIONAL MODULATION; SNS	ND7/23 cells are gaining traction as a host model to express peripheral sodium channels such as Na(V)1.8 and Na(V)1.9 that have been difficult to express in widely utilized heterologous cells, like CHO and HEK293. Use of ND7/23 as a model cell to characterize the properties of sodium channels requires clear understanding of the endogenous ion channels. To define the nature of the background sodium currents in ND7/23 cells, we aimed to comprehensively profile the voltage-gated sodium channel subunits by endpoint and quantitative reverse transcription-PCR and by whole-cell patch clamp electrophysiology. We found that untransfected ND7/23 cells express endogenous peak sodium currents that average - 2.12nA (n = 15) and with kinetics typical of fast sodium currents having activation and inactivation completed within few milliseconds. Furthermore, sodium currents were reduced to virtually nil upon exposure to 100nM tetrodotoxin, indicating that ND7/23 cells have essentially null background for tetrodotoxin-resistant (TTX-R) currents. qRT-PCR profiling indicated a major expression of TTX-sensitive (TTX-S) Na(V)1.6 and Na(V)1.7 at similar levels and very low expression of TTX-R Na(V)1.9 transcripts. There was no expression of TTX-R Na(V)1.8 in ND7/23 cells. There was low expression of Na(V)1.1, Na(V)1.2, Na(V)1.3 and no expression of cardiac or skeletal muscle sodium channels. As for the sodium channel auxiliary subunits, beta 1 and beta 3 subunits were expressed, but not the beta 2 and beta 4 subunits that covalently associate with the alpha-subunits. In addition, our results also showed that only the mouse forms of Na(V)1.6, Na(V)1.7 and Na(V)1.9 sodium channels were expressed in ND7/23 cells that was originally generated as a hybridoma of rat embryonic DRG and mouse neuroblastoma cell-line. By molecular profiling of auxiliary beta- and principal alpha-subunits of the voltage gated sodium channel complex, our results define the background sodium channels expressed in ND7/23 cells, and confirm their utility for detailed functional studies of emerging pain channelopathies ascribed to mutations of the TTX-R sodium channels of sensory neurons.	[Lee, Jisoo; Kim, Shinae; Kim, Hye-mi; Yu, Frank H.] Seoul Natl Univ, Dent Res Inst, Dept Pharmacol & Dent Therapeut, Program Neurobiol,Sch Dent, Seoul, South Korea; [Kim, Hyun Jeong] Seoul Natl Univ, Dent Res Inst, Dept Dent Anesthesiol, Program Neurobiol,Sch Dent, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Yu, FH (corresponding author), Seoul Natl Univ, Dent Res Inst, Dept Pharmacol & Dent Therapeut, Program Neurobiol,Sch Dent, Seoul, South Korea.	frankyu@snu.ac.kr		Yu, Frank/0000-0001-9306-1731; Kim, Hyun Jeong/0000-0002-9265-7549	National Research Foundation of Korea [20110013782]; Korean government	National Research Foundation of Korea(National Research Foundation of Korea); Korean government(Korean Government)	This work is supported by the National Research Foundation of Korea Grant 20110013782 (F.H.Y), funded by the Korean government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Dib-Hajj S, 2002, TRENDS NEUROSCI, V25, P253, DOI 10.1016/S0166-2236(02)02150-1; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; England S, 2010, FUTURE MED CHEM, V2, P775, DOI [10.4155/fmc.10.26, 10.4155/FMC.10.26]; Fitzgerald EM, 1999, J PHYSIOL-LONDON, V516, P433, DOI 10.1111/j.1469-7793.1999.0433v.x; Fryatt AG, 2009, MOL CELL NEUROSCI, V42, P399, DOI 10.1016/j.mcn.2009.09.001; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; Goral RO, 2015, PFLUG ARCH EUR J PHY, V467, P2423, DOI 10.1007/s00424-015-1709-1; Herold KF, 2009, ANESTHESIOLOGY, V111, P591, DOI 10.1097/ALN.0b013e3181af64d4; Isom LL, 2001, NEUROSCIENTIST, V7, P42, DOI 10.1177/107385840100700108; John VH, 2004, NEUROPHARMACOLOGY, V46, P425, DOI 10.1016/j.neuropharm.2003.09.018; Kennedy PGE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051570; Leffler A, 2010, EUR J PHARMACOL, V630, P19, DOI 10.1016/j.ejphar.2009.12.027; LI M, 1992, NEURON, V8, P1151, DOI 10.1016/0896-6273(92)90135-Z; Lin ZX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161450; NUMANN R, 1991, SCIENCE, V254, P115, DOI 10.1126/science.1656525; Okuse K, 2002, NATURE, V417, P653, DOI 10.1038/nature00781; Priest BT, 2005, P NATL ACAD SCI USA, V102, P9382, DOI 10.1073/pnas.0501549102; Rogers M, 2016, ASSAY DRUG DEV TECHN, V14, P109, DOI 10.1089/adt.2016.704; Schmalhofer WA, 2008, MOL PHARMACOL, V74, P1476, DOI 10.1124/mol.108.047670; Soltysinska E, 2009, PFLUG ARCH EUR J PHY, V459, P11, DOI 10.1007/s00424-009-0718-3; Stahlberg A, 2004, CLIN CHEM, V50, P509, DOI 10.1373/clinchem.2003.026161; Vanoye CG, 2013, J GEN PHYSIOL, V141, P193, DOI 10.1085/jgp.201210919; WOOD JN, 1990, P ROY SOC B-BIOL SCI, V241, P187, DOI 10.1098/rspb.1990.0084; Yu FH, 2003, J NEUROSCI, V23, P7577; Zacharias DA, 1999, BBA-GEN SUBJECTS, V1428, P397, DOI 10.1016/S0304-4165(99)00058-6; Zhou XP, 2003, J PHARMACOL EXP THER, V306, P498, DOI 10.1124/jpet.103.051086	30	5	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2019	14	8							e0221156	10.1371/journal.pone.0221156	http://dx.doi.org/10.1371/journal.pone.0221156			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5LL	31419255	Green Published, Green Submitted, gold			2022-12-26	WOS:000485019900030
J	Harper, T; Rougier, GW				Harper, Tony; Rougier, Guillermo W.			Petrosal morphology and cochlear function in Mesozoic stem therians	PLOS ONE			English	Article							INNER-EAR STRUCTURES; MIDDLE-EAR; SOUND LOCALIZATION; COMPARATIVE ANATOMY; MAMMALIAN COCHLEA; PRIMITIVE MAMMALS; BASILAR-MEMBRANE; EVOLUTION; MECHANISMS; MARSUPIALS	Here we describe the bony anatomy of the inner ear and surrounding structures seen in three plesiomorphic crown mammalian petrosal specimens. Our study sample includes the triconodont Priacodon fruitaensis from the Upper Jurassic of North America, and two isolated stem therian petrosal specimens colloquially known as the Hoovor petrosals, recovered from Aptian-Albian sediments in Mongolia. The second Hoovor petrosal is here described at length for the first time. All three of these petrosals and a comparative sample of extant mammalian taxa have been imaged using micro-CT, allowing for detailed anatomical descriptions of the osteological correlates of functionally significant neurovascular features, especially along the abneural wall of the cochlear canal. The high resolution imaging provided here clarifies several hypotheses regarding the mosaic evolution of features of the cochlear endocast in early mammals. In particular, these images demonstrate that the membranous cochlear duct adhered to the bony cochlear canal abneurally to a secondary bony lamina before the appearance of an opposing primary bony lamina or tractus foraminosus. Additionally, while corroborating the general trend of reduction of venous sinuses and plexuses within the pars cochlearis seen in crownward mammaliaforms generally, the Hoovor petrosals show the localized enlargement of a portion of the intrapetrosal venous plexus. This new vascular feature is here interpreted as the bony accommodation for the vein of cochlear aqueduct, a structure that is solely, or predominantly, responsible for the venous drainage of the cochlear apparatus in extant therians. Given that our fossil stem therian inner ear specimens appear to have very limited high-frequency capabilities, the development of these modern vascular features of the cochlear endocast suggest that neither the initiation or enlargement of the stria vascularis (a unique mammalian organ) was originally associated with the capacity for high-frequency hearing or precise sound-source localization.	[Harper, Tony] Johns Hopkins Univ, Ctr Funct Anat & Evolut, Baltimore, MD 21218 USA; [Rougier, Guillermo W.] Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA	Johns Hopkins University; University of Louisville	Rougier, GW (corresponding author), Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA.	grougier@louisville.edu		Harper, Tony/0000-0002-9561-1562; Rougier, Guillermo W./0000-0003-3051-1373	CONICET-Agencia de Promocion Cientifica y Tecnica, Argentina [PICT-2016-3682, PICT 2014-0564]; NSF [DEB 0946430, DEB 1068089]; Department of Anatomical Sciences, University of Louisville; National Science Foundation as part of the National Nanotechnology Coordinated Infrastructure (NNCI) [ECCS-1542015]	CONICET-Agencia de Promocion Cientifica y Tecnica, Argentina; NSF(National Science Foundation (NSF)); Department of Anatomical Sciences, University of Louisville; National Science Foundation as part of the National Nanotechnology Coordinated Infrastructure (NNCI)(National Science Foundation (NSF)NSF - Office of the Director (OD))	Specimen collecting and data analysis was funded in part by PICT-2016-3682 from CONICET-Agencia de Promocion Cientifica y Tecnica, Argentina; and NSF grants DEB 0946430, and DEB 1068089 to GWR and the Department of Anatomical Sciences, University of Louisville.; This work was performed in part at the Duke University Shared Materials Instrumentation Facility (SMIF), a member of the North Carolina Research Triangle Nanotechnology Network (RTNN), which is supported by the National Science Foundation (Grant ECCS-1542015) as part of the National Nanotechnology Coordinated Infrastructure (NNCI). The CT lab, Austin Texas produced images of some specimens and provided technical and instructional support to GWR. Specimen collecting and data analysis was funded in part by PICT 2014-0564, PICT-2016-3682 from CONICET-Agencia de Promocion Cientifica y Tecnica, Argentina; and NSF grants DEB 0946430, and DEB 1068089 to GWR and the Department of Anatomical Sciences and Neurobiology, University of Louisville. Finally, we would like to thank Jin Meng, Eric Ekdale, and Alistair Evans for their attention and insightful comments during the review of this manuscript.	AITKIN L, 1995, HEARING RES, V82, P257, DOI 10.1016/0378-5955(94)00182-P; Allin E.F., 1986, P283; ALLIN EF, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P587; [Anonymous], 1885, INTRO OSTEOLOGY MAMM; Arch VS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005413; ARCHER M, 1976, ZOOL J LINN SOC-LOND, V59, P217, DOI 10.1111/j.1096-3642.1976.tb01016.x; Asher Robert J., 2003, Journal of Mammalian Evolution, V10, P131, DOI 10.1023/A:1025504124129; Ashwell Ken W.S., 2013, P219; Augee M, 2006, AUSTRAL NAT HIST SER, P1; Averianov AO, 2002, ACTA PALAEONTOL POL, V47, P705; AXELSSON A, 1988, AM J OTOLARYNG, V9, P278, DOI 10.1016/S0196-0709(88)80036-X; Basch ML, 2016, J ANAT, V228, P233, DOI 10.1111/joa.12314; Bast T. H., 1954, ANN OTO RHINOL LARYN, V62, P1083; BAST TH, 1946, ANN OTO RHINOL LARYN, V55, P278, DOI 10.1177/000348944605500204; Belyaeva E.I., 1974, T SOVMESTNOI SOV MON, V1, P19; Benton MJ, 2000, AGE DINOSAURS RUSSIA, pxvi; Bi SD, 2018, NATURE, V558, P390, DOI 10.1038/s41586-018-0210-3; Bok JW, 2007, INT J DEV BIOL, V51, P521, DOI 10.1387/ijdb.072381jb; Brown J, 2005, LANDFALL, P124; Butler A.B., 2005, COMP VERTEBRATE NEUR, Vsecond; Callison G., 1987, PALEONTOLOGY GEOLOGY, P91; Cantos R, 2000, P NATL ACAD SCI USA, V97, P11707, DOI 10.1073/pnas.97.22.11707; Chan DK, 2005, NAT NEUROSCI, V8, P149, DOI 10.1038/nn1385; Christensen-Dalsgaard J, 2005, J EXP BIOL, V208, P1209, DOI 10.1242/jeb.01511; Christensen-Dalsgaard J, 2008, JARO-J ASSOC RES OTO, V9, P407, DOI 10.1007/s10162-008-0130-2; Christensen-Dalsgaard J, 2011, HEARING RES, V273, P37, DOI 10.1016/j.heares.2010.08.007; Close RA, 2015, CURR BIOL, V25, P2137, DOI 10.1016/j.cub.2015.06.047; CROMPTON AW, 1993, MAMMAL PHYLOGENY, P30; Crompton AW, 1971, ZOOLOGICAL J LINN S1, P65; DASHZEVEG D, 1979, Acta Palaeontologica Polonica, V24, P199; DASHZEVEG D, 1975, NATURE, V256, P402, DOI 10.1038/256402a0; de Beer G., 1937, DEV VERTEBRATE SKULL; de Beer GR, 1929, PHILOS T R SOC LON B, V217, P411, DOI 10.1098/rstb.1929.0009; Diogo R, 2008, J ANAT, V213, P391, DOI 10.1111/j.1469-7580.2008.00953.x; Drexl M, 2003, JARO-J ASSOC RES OTO, V4, P555, DOI 10.1007/s10162-002-3043-5; Ekdale EG, 2016, SPRINGER HANDB AUDIT, V59, P175, DOI 10.1007/978-3-319-46661-3_7; Ekdale EG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066624; Engelmann George F., 1998, Modern Geology, V23, P343; Evans H.E., 2013, MILLERS ANATOMY DOG; Fettiplace R, 1999, ANNU REV PHYSIOL, V61, P809, DOI 10.1146/annurev.physiol.61.1.809; Fettiplace R, 2017, COMPR PHYSIOL, V7, P1197, DOI 10.1002/cphy.c160049; Forasiepi AM, 2009, J ZOOL SYST EVOL RES, V47, P391, DOI 10.1111/j.1439-0469.2008.00519.x; FORSMAN KA, 1988, J ZOOL, V216, P655, DOI 10.1111/j.1469-7998.1988.tb02463.x; Fox RC, 1997, ZOOL J LINN SOC-LOND, V121, P249; Fritzsch B, 2013, EVOL DEV, V15, P63, DOI 10.1111/ede.12015; Gaetano LC, 2011, J VERTEBR PALEONTOL, V31, P829, DOI 10.1080/02724634.2011.589877; Gao CL, 2009, P R SOC B; GATES GR, 1974, J ACOUST SOC AM, V56, P152, DOI 10.1121/1.1903246; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; GRAYBEAL A, 1989, ZOOL J LINN SOC-LOND, V96, P107, DOI 10.1111/j.1096-3642.1989.tb01823.x; Grossnickle DM, 2016, P R SOC B, V283, P1; Grossnickle DM, 2017, SWISS JOURNAL OF GEO, V7, P1; Grothe B, 2000, PROG NEUROBIOL, V61, P581, DOI 10.1016/S0301-0082(99)00068-4; Grothe B, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00116; Grothe B, 2010, PHYSIOL REV, V90, P983, DOI 10.1152/physrev.00026.2009; Gu JJ, 2012, P NATL ACAD SCI USA, V109, P3868, DOI 10.1073/pnas.1118372109; Han G, 2017, NATURE, V551, P451, DOI 10.1038/nature24483; HEFFNER HE, 1969, J AUD RES, V9, P12; Heffner HE., 2016, ACOUST TODAY, V12, P2027, DOI DOI 10.1063/1.5038516; HENSON MM, 1988, HEARING RES, V35, P237, DOI 10.1016/0378-5955(88)90121-9; Hossler FE, 2002, HEARING RES, V164, P155, DOI 10.1016/S0378-5955(01)00427-0; Hu YM, 1997, NATURE, V390, P137, DOI 10.1038/36505; Hughes EM, 2015, ANN CARNEGIE MUS, V83, P1; Janfaza P., 2011, SURG ANATOMY HEAD NE; Ji Q, 2009, SCIENCE, V326, P278, DOI 10.1126/science.1178501; Kemp TS, 2016, SPRINGER HANDB AUDIT, V59, P107, DOI 10.1007/978-3-319-46661-3_5; KERMACK KA, 1963, PHILOS T ROY SOC B, V246, P87; KERMACK KA, 1981, ZOOL J LINN SOC-LOND, V71, P1, DOI 10.1111/j.1096-3642.1981.tb01127.x; Kielan-Jaworowska Z., 2005, MAMMALS AGE DINOSAUR; KIELANJAWOROWSKA Z, 1986, PHILOS T R SOC B, V313, P525, DOI 10.1098/rstb.1986.0055; Kikuchi K, 1966, Acta Otolaryngol, V62, P277, DOI 10.3109/00016486609119573; Koppl C, 2018, BRAIN BEHAV EVOLUT, V92, P1, DOI 10.1159/000494050; Koppl C, 2019, CSH PERSPECT MED, V9, DOI 10.1101/cshperspect.a033241; Koppl C, 2009, CURR BIOL, V19, pR635, DOI 10.1016/j.cub.2009.05.035; Koppl C, 1997, J NEUROSCI, V17, P3312; Ladeveze S, 2008, J ANAT, V213, P686, DOI 10.1111/j.1469-7580.2008.00985.x; Ladhams A, 1996, J COMP NEUROL, V366, P335, DOI 10.1002/(SICI)1096-9861(19960304)366:2<335::AID-CNE11>3.0.CO;2-O; LEMPERT J, 1952, AMA ARCH OTOLARYNGOL, V55, P134; Liu Z, 2012, MOL BIOL EVOL, V29, P2187, DOI 10.1093/molbev/mss087; Lopatin A V, 2018, Dokl Biol Sci, V478, P8, DOI 10.1134/S0012496618010027; Lopatin AV, 2017, PALEONTOL J+, V51, P1293, DOI 10.1134/S0031030117120048; Lopatin A, 2007, ACTA PALAEONTOL POL, V52, P441; Luo ZX, 2016, SPRINGER HANDB AUDIT, V59, P139, DOI 10.1007/978-3-319-46661-3_6; Luo ZX, 2012, ZOOL J LINN SOC-LOND, V166, P433, DOI 10.1111/j.1096-3642.2012.00852.x; Luo ZX, 2011, ANNU REV ECOL EVOL S, V42, P355, DOI 10.1146/annurev-ecolsys-032511-142302; Luo ZX, 2011, NATURE, V476, P442, DOI 10.1038/nature10291; Luo ZX, 2011, P ROY SOC B-BIOL SCI, V278, P28, DOI 10.1098/rspb.2010.1148; LUO ZX, 1995, J VERTEBR PALEONTOL, V15, P113, DOI 10.1080/02724634.1995.10011211; MacIntyre GT, 1966, EVOLUTION, V21, P834; MacIntyre GT., 1972, EVOLUTIONARY BIOL, P275, DOI [10.1007/978-1-4684-9063-3_9, DOI 10.1007/978-1-4684-9063-3_9]; Maclean P.D., 1986, P1; MacPhee RD, 1981, AUDITORY REIGIONS PR; Maier W, 2016, J ANAT, V228, P270, DOI 10.1111/joa.12379; Manley GA, 1998, CURR OPIN NEUROBIOL, V8, P468, DOI 10.1016/S0959-4388(98)80033-0; MANLEY GA, 1972, EVOLUTION, V26, P608, DOI 10.1111/j.1558-5646.1972.tb01968.x; MANLEY GA, 1991, HEARING RES, V56, P211, DOI 10.1016/0378-5955(91)90172-6; Manley GA, 2001, J NEUROPHYSIOL, V86, P541, DOI 10.1152/jn.2001.86.2.541; Manley GA, 2000, P NATL ACAD SCI USA, V97, P11736, DOI 10.1073/pnas.97.22.11736; Manley GA, 2016, J MAMM EVOL, V25, P155; Manley GA, 2017, SPRINGER HANDB AUDIT, V62, P17, DOI 10.1007/978-3-319-52073-5_2; Manley GA, 2017, HEARING RES, V352, P23, DOI 10.1016/j.heares.2016.12.007; Manley GA, 2017, JARO-J ASSOC RES OTO, V18, P1, DOI 10.1007/s10162-016-0579-3; Manley GA, 2012, JARO-J ASSOC RES OTO, V13, P733, DOI 10.1007/s10162-012-0349-9; Manley GA, 2011, HEARING RES, V273, P1, DOI 10.1016/j.heares.2011.01.005; Manoussaki D, 2008, P NATL ACAD SCI USA, V105, P6162, DOI 10.1073/pnas.0710037105; Martin T, 2015, NATURE, V526, P380, DOI 10.1038/nature14905; Mason MJ, 2016, BIOL CYBERN, V110, P345, DOI 10.1007/s00422-015-0675-1; Mason MJ, 2016, J ANAT, V228, P300, DOI 10.1111/joa.12316; Mason MJ, 2016, J ANAT, V228, P284, DOI 10.1111/joa.12313; MCDOWELL SAMUEL BOOKER, 1958, BULL AMER MUS NAT HIST, V115, P113; McKenna M. C., 1975, PHYLOGENY PRIMATES, P21, DOI DOI 10.1007/978-1-4684-2166-8_2; McKenna MC, 2000, ACTA PALAEONTOL POL, V45, P1; MENG J, 1995, ZOOL J LINN SOC-LOND, V115, P47, DOI 10.1006/zjls.1995.0033; MENG J, 1995, J VERTEBR PALEONTOL, V15, P122, DOI 10.1080/02724634.1995.10011212; Mills DM, 2001, JARO-J ASSOC RES OTO, V2, P130, DOI 10.1007/s101620010059; Moore W.J., 1981, MAMMALIAN SKULL; MULLER M, 1993, HEARING RES, V67, P198, DOI 10.1016/0378-5955(93)90247-X; Nin F, 2016, PFLUG ARCH EUR J PHY, V468, P1637, DOI 10.1007/s00424-016-1871-0; Nomura Yasuya, 2014, MORPHOLOGICAL ASPECT; Nothwang HG, 2016, PROG NEUROBIOL, V141, P1, DOI 10.1016/j.pneurobio.2016.02.003; Novacek Michael J., 1993, P438; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Olson Everett C., 1944, GEOL SOC AMER SPEC PAPERS, V55, P1; Orliac MJ, 2016, J MAMM EVOL, V23, P337, DOI 10.1007/s10914-016-9327-z; Paez-Arango N, 2008, THESIS; Panciroli E, 2018, PAPERS PALEONTOL; Patuzzi R., 1996, COCHLEA, P186; Payan P, 2002, J EXP BIOL, V205, P2687; Peng AW, 2011, HEARING RES, V273, P109, DOI 10.1016/j.heares.2010.03.094; PERLMAN HB, 1952, ANN OTO RHINOL LARYN, V61, P33, DOI 10.1177/000348945206100103; Polley DB, 2013, COMPREHENSIVE DEVELOPMENTAL NEUROSCIENCE: NEURAL CIRCUIT DEVELOPMENT AND FUNCTION IN THE HEALTHY AND DISEASED BRAIN, P21, DOI 10.1016/B978-0-12-397267-5.00136-9; PRESTON RE, 1975, ACTA OTO-LARYNGOL, V80, P269, DOI 10.3109/00016487509121327; Pritchard U., 1881, Philosophical Transactions, Vclxxii, P267; Prothero D. R., 1981, B AM MUS NAT HIST, V167, P281; PROTHERO DR, 1983, J PALEONTOL, V57, P1040; Ramanathan K, 1999, SCIENCE, V283, P215, DOI 10.1126/science.283.5399.215; RASMUSSEN TE, 1981, J PALEONTOL, V55, P628; Ravicz ME, 2010, HEARING RES, V263, P16, DOI 10.1016/j.heares.2009.11.014; RAVIZZA RJ, 1969, J AUD RES, V9, P1; RICE JJ, 1992, HEARING RES, V58, P132, DOI 10.1016/0378-5955(92)90123-5; Rich TH, 2005, SCIENCE, V307, P910, DOI 10.1126/science.1105717; Rodrigues PG, 2013, J MAMM EVOL, V20, P291, DOI 10.1007/s10914-012-9221-2; ROSOWSKI JJ, 1991, ZOOL J LINN SOC-LOND, V101, P131, DOI 10.1111/j.1096-3642.1991.tb00890.x; Rougier G.W., 1992, Journal of Vertebrate Paleontology, V12, P188; Rougier Guillermo W., 1996, American Museum Novitates, V3183, P1; Rougier Guillermo W., 2006, P269; Rougier Guillermo W., 2016, PALAEONTOLOGIA POLONICA, P197, DOI 10.4202/pp.2016.67_197; Rougier GW, 2011, NATURE, V479, P98, DOI 10.1038/nature10591; Rougier GW, 2009, ACTA PALAEONTOL POL, V54, P195, DOI 10.4202/app.2006.0026; Rougier GW, 2003, ACTA GEOL SIN-ENGL, V77, P7; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; Rowe T.B., 2017, EVOLUTION NERVOUS SY, P1; Ruf I, 2013, J VERTEBR PALEONTOL, V33, P382, DOI 10.1080/02724634.2013.722575; Ruf I, 2009, J ANAT, V214, P679, DOI 10.1111/j.1469-7580.2009.01059.x; Ruggero M A, 1992, Curr Opin Neurobiol, V2, P449, DOI 10.1016/0959-4388(92)90179-O; SALT AN, 1987, LARYNGOSCOPE, V97, P984; SALT AN, 1989, AM J OTOLARYNG, V10, P371, DOI 10.1016/0196-0709(89)90030-6; SCHMIDT RS, 1962, J CELL COMPAR PHYSL, V59, P311, DOI 10.1002/jcp.1030590311; Schultz JA, 2017, J MORPHOL, V278, P236, DOI 10.1002/jmor.20632; Schultz JA, 2014, NATURWISSENSCHAFTEN, V101, P771, DOI 10.1007/s00114-014-1214-y; SEGALL W, 1970, Fieldiana Zoology, V51, P169; SELLICK PM, 1982, J ACOUST SOC AM, V72, P131, DOI 10.1121/1.387996; Shahid R, 2018, FASEB J S, V32, P780, DOI [10.1096/fasebj.2018.32.1_supplement.780.9, DOI 10.1096/FASEBJ.2018.32.1_SUPPLEMENT.780.9]; Shodo R, 2017, BIOMED RES-TOKYO, V38, P239, DOI 10.2220/biomedres.38.239; SPOOR F, 1995, J ANAT, V186, P271; Tan XD, 2011, J NEUROPHYSIOL, V105, P36, DOI 10.1152/jn.00234.2010; Thomas JA, 2004, ECHOLOCATION BATS DO, P547; Trofimov BA, 1997, ACTA PALAEONTOL POL, V42, P496; Turkewitsch BG, 1935, AM J ANAT, V57, P503, DOI 10.1002/aja.1000570305; Urban DJ, 2017, P R SOC B, V284, P1; Vater M, 2004, SPR HDB AUD, V22, P256; Vater M, 2011, HEARING RES, V273, P89, DOI 10.1016/j.heares.2010.05.018; Wang YQ, 2001, SCIENCE, V294, P357, DOI 10.1126/science.1063830; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; Wangemann P, 2006, J PHYSIOL-LONDON, V576, P11, DOI 10.1113/jphysiol.2006.112888; WATANABE Y, 1988, ARCH OTO-RHINO-LARYN, V245, P340, DOI 10.1007/BF00457990; Wever E.., 1978, REPTILE EAR ITS STRU; Wible J.R., 1990, Journal of Vertebrate Paleontology, V10, P183; Wible J.R., 1986, Journal of Vertebrate Paleontology, V6, P313; Wible JR, 2017, ANN CARNEGIE MUS, V84, P183, DOI 10.2992/007.084.0302; Wible JR, 2010, ANN CARNEGIE MUS, V79, P1, DOI 10.2992/007.079.0101; Wible John R., 2001, American Museum Novitates, V3322, P1, DOI 10.1206/0003-0082(2001)322<0001:EEERAP>2.0.CO;2; Wible John R., 1995, American Museum Novitates, V3149, P1; WIBLE JR, 1993, MAMMAL PHYLOGENY, P45; WIBLE JR, 1987, ZOOL J LINN SOC-LOND, V91, P107, DOI 10.1111/j.1096-3642.1987.tb01725.x; WIBLE JR, 1995, J VERTEBR PALEONTOL, V15, P331, DOI 10.1080/02724634.1995.10011233; Wilms V, 2016, SCI REP, V6, P1; Wilson GP, 2013, PALEOBIOLOGY, V39, P429, DOI 10.1666/12041; ZELLER U, 1985, FORTS ZOOL, V30, P153; ZELLER U, 1993, MAMMAL PHYLOGENY, P95; Zeller U., 1985, Gegenbaurs Morphologisches Jahrbuch, V131, P179	191	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0209457	10.1371/journal.pone.0209457	http://dx.doi.org/10.1371/journal.pone.0209457			62	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412094	Green Submitted, gold, Green Published			2022-12-26	WOS:000485012600002
J	Kitten, AK; Kamath, M; Ryan, L; Reveles, KR				Kitten, Amanda K.; Kamath, Meghan; Ryan, Laurajo; Reveles, Kelly R.			National ambulatory care non-insulin antidiabetic medication prescribing trends in the United States from 2009 to 2015	PLOS ONE			English	Article							CARDIOVASCULAR OUTCOMES; TYPE-2; RISK; SULFONYLUREAS; MORTALITY; EVENTS; HYPOGLYCEMIA; PREVENTION	Objective Despite their efficacy in lowering hemoglobin A1c, recent data suggest that sulfonylureas are associated with cardiovascular risk and hypoglycemia. The objective of this study was to determine whether prescribers decreased sulfonylurea use in favor of newer medications in the United States over seven years. Research design and methods This cross-sectional study utilized data from the Centers for Disease Control and Prevention's National Ambulatory Medical Care Survey. Patient visits between 2009 and 2015 were included for patients who were at least 18 years old, had a documented prescription for a non-insulin antidiabetic medication, and a diagnosis of type 2 diabetes. Sample survey data were extrapolated to national estimates using data weights. Prescribing rates were calculated as the number of visits with a documented medication class divided by the total number of visits with a prescription for any diabetes medication class, times 100%. Results A total of 303 million patient visits were included in this study. The median (IQR) patient age was 64 (55-73) years old and 49.8% were male. Sulfonylurea prescribing rates decreased from 43% in 2009 to 36.5% in 2015. Prescribing of GLP-1 receptor agonists increased from 2009 to 2014 (3.95% to 5.30%), but then decreased to 4.19% in 2015. SGLT-2 inhibitor prescribing began in 2013 and increased to 7.3% by 2015. Metformin prescribing remained relatively stable over the study period (range 70% to 72%). Conclusions National ambulatory sulfonylurea prescribing decreased from 2009 to 2015 with a corresponding increase in newer non-insulin antidiabetic agent prescribing.	[Kitten, Amanda K.; Kamath, Meghan; Ryan, Laurajo; Reveles, Kelly R.] Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA; [Kitten, Amanda K.; Kamath, Meghan; Ryan, Laurajo; Reveles, Kelly R.] Univ Texas Hlth San Antonio, Pharmacotherapy Educ & Res Ctr, San Antonio, TX 78229 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Health San Antonio	Kitten, AK (corresponding author), Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA.; Kitten, AK (corresponding author), Univ Texas Hlth San Antonio, Pharmacotherapy Educ & Res Ctr, San Antonio, TX 78229 USA.	akitten191@utexas.edu	Reveles, Kelly/AAI-1575-2021					Ahren B, 2013, VASC HEALTH RISK MAN, V9, P155, DOI 10.2147/VHRM.S33934; Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS73, DOI 10.2337/dc18-S008; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; American Diabetes Association, 2010, Diabetes Care, V33 Suppl 1, pS11, DOI 10.2337/dc10-S011; [Anonymous], 2019, DIABETES CARE, V42, pS4, DOI 10.2337/dc19-Srev01; [Anonymous], 2015, DIABETES CARE, V38, pS41, DOI 10.2337/dc15-S010; [Anonymous], 2018, EXENATIDE; Ashman Jill J, 2017, NCHS Data Brief, P1; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Basile JN, 2013, J DIABETES COMPLICAT, V27, P280, DOI 10.1016/j.jdiacomp.2012.12.004; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Centers for Disease Control and Prevention, 2022, NAT DIAB STAT REP WE; Centers for Disease Control and Prevention, AMB HLTH CAR DAT 201; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Evans JMM, 2006, DIABETOLOGIA, V49, P930, DOI 10.1007/s00125-006-0176-9; Forst T, 2013, DIABETES VASC DIS RE, V10, P302, DOI 10.1177/1479164112465442; Lapane KL, 2013, DRUG AGING, V30, P527, DOI 10.1007/s40266-013-0081-0; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; Middleton TL, 2017, DIABETES CARE, V40, P663, DOI 10.2337/dc16-1972; Neal B, 2017, NEW ENGL J MED, V377, P644, DOI 10.1056/NEJMoa1611925; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Palmer SC, 2016, JAMA-J AM MED ASSOC, V316, P313, DOI 10.1001/jama.2016.9400; Regier Emily E, 2016, Clin Diabetes, V34, P173; ROBINSON LE, 2013, BMJ OPEN, V3, DOI DOI 10.1016/J.JDIACOMP.2012.12.004; Rowley WR, 2017, POPUL HEALTH MANAG, V20, P6, DOI 10.1089/pop.2015.0181; Schopman JE, 2014, DIABETES-METAB RES, V30, P11, DOI 10.1002/dmrr.2470; Schwartz SS, 2016, DIABETES CARE, V39, P179, DOI 10.2337/dc15-1585; Talwalkar Anjali, 2016, NCHS Data Brief, P1; White J, 2014, INT J CHILD YOUTH FA, V5, P1; Wright A, 2002, DIABETES CARE, V25, P330, DOI 10.2337/diacare.25.2.330; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720; 2016, SOD GLUC COTR 2 SGLT, DOI DOI 10.1056/NEJMOA1603827; 2018, PIOGLITAZONE	36	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0221174	10.1371/journal.pone.0221174	http://dx.doi.org/10.1371/journal.pone.0221174			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412090	Green Published, gold, Green Submitted			2022-12-26	WOS:000485012600051
J	Westrich, JA; Vermeer, DW; Silva, A; Bonney, S; Berger, JN; Cicchini, L; Greer, RO; Song, JI; Raben, D; Slansky, JE; Lee, JH; Spanos, WC; Pyeon, D				Westrich, Joseph A.; Vermeer, Daniel W.; Silva, Alexa; Bonney, Stephanie; Berger, Jennifer N.; Cicchini, Louis; Greer, Robert O.; Song, John I.; Raben, David; Slansky, Jill E.; Lee, John H.; Spanos, William C.; Pyeon, Dohun			CXCL14 suppresses human papillomavirus-associated head and neck cancer through antigen-specific CD8(+) T-cell responses by upregulating MHC-I expression	ONCOGENE			English	Article							COMPLEX CLASS-I; CERVICAL INTRAEPITHELIAL NEOPLASIA; IMMUNE; SURVIVAL; TISSUE; INFILTRATION; NEUTROPHILS; CARCINOMA; DEPLETION; PROTECTS	Evasion of the host immune responses is critical for both persistent human papillomavirus (HPV) infection and associated cancer progression. We have previously shown that expression of the homeostatic chemokine CXCL14 is significantly downregulated by the HPV oncoprotein E7 during cancer progression. Restoration of CXCL14 expression in HPV-positive head and neck cancer (HNC) cells dramatically suppresses tumor growth and increases survival through an immune-dependent mechanism in mice. Although CXCL14 recruits natural killer (NK) and T cells to the tumor microenvironment, the mechanism by which CXCL14 mediates tumor suppression through NK and/or T cells remained undefined. Here we report that CD8(+) T cells are required for CXCL14-mediated tumor suppression. Using a CD8(+) T-cell receptor transgenic model, we show that the CXCL14-mediated antitumor CD8 + T-cell responses require antigen specificity. Interestingly, CXCL14 expression restores major histocompatibility complex class I (MHC-I) expression on HPV-positive HNC cells downregulated by HPV, and knockdown of MHC-I expression in HNC cells results in loss of tumor suppression even with CXCL14 expression. These results suggest that CXCL14 enacts antitumor immunity through restoration of MHC-I expression on tumor cells and promoting antigen-specific CD8(+) T-cell responses to suppress HPV-positive HNC.	[Westrich, Joseph A.; Silva, Alexa; Berger, Jennifer N.; Cicchini, Louis; Slansky, Jill E.; Pyeon, Dohun] Univ Colorado, Sch Med, Dept Immunol & Microbiol, Aurora, CO 80045 USA; [Vermeer, Daniel W.; Spanos, William C.] Sanford Res, Canc Biol Res Ctr, Sioux Falls, SD 57104 USA; [Bonney, Stephanie] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Greer, Robert O.] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO 80045 USA; [Greer, Robert O.] Univ Colorado, Sch Med, Dept Dermatol, Aurora, CO 80045 USA; [Greer, Robert O.] Univ Colorado, Sch Dent Med, Div Oral & Maxillofacial Pathol, Aurora, CO 80045 USA; [Song, John I.] Univ Colorado, Sch Med, Dept Otolaryngol, Aurora, CO 80045 USA; [Raben, David] Univ Colorado, Sch Med, Dept Radiat Oncol, Aurora, CO 80045 USA; [Lee, John H.] Chan Soon Shiong Inst Med, El Segundo, CA 90245 USA; [Pyeon, Dohun] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Westrich, Joseph A.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Sanford Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Michigan State University; Colorado State University	Pyeon, D (corresponding author), Univ Colorado, Sch Med, Dept Immunol & Microbiol, Aurora, CO 80045 USA.; Pyeon, D (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	dpyeon@msu.edu		Slansky, Jill/0000-0003-3820-1724; Pyeon, Dohun/0000-0003-1970-844X; Vermeer, Daniel/0000-0002-1501-0418	NIH [R01 DE026125, T32 AI052066]; Immunology and Microbiology Pilot Award; University of Colorado Cancer Center; Colorado Clinical and Translational Sciences Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI052066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE026125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008730] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Immunology and Microbiology Pilot Award; University of Colorado Cancer Center; Colorado Clinical and Translational Sciences Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Ross Kedl, Linda van Dyk, Eric Clambey, Paul Ahlquist, Paul Lambert, Xiao-Jing Wang, and members of the Pyeon laboratory for useful comments and suggestions. This work was supported in part by NIH R01 DE026125 (DP and WCS), NIH T32 AI052066 (JAW), Immunology and Microbiology Pilot Award (DP and JES), grants from the University of Colorado Cancer Center (DP), Colorado Clinical and Translational Sciences Institute (DP, JIS, and ROG), and a generous gift from the Marsico Fund (DR).	Augsten M, 2009, P NATL ACAD SCI USA, V106, P3414, DOI 10.1073/pnas.0813144106; BAL V, 1990, EUR J IMMUNOL, V20, P1893, DOI 10.1002/eji.1830200904; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Cao XT, 2000, J IMMUNOL, V165, P2588, DOI 10.4049/jimmunol.165.5.2588; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Chen LM, 2010, J IMMUNOL, V184, P4455, DOI 10.4049/jimmunol.0900525; Cicchini L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03295-7; Cicchini L, 2016, MBIO, V7, DOI 10.1128/mBio.00270-16; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; Cuburu N, 2012, J CLIN INVEST, V122, P4606, DOI 10.1172/JCI63287; Da Silva DM, 2015, PAPILLOMAVIRUS RES, V1, P12, DOI 10.1016/j.pvr.2015.05.001; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; de Oliveira LC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118225; DiMaio D, 2013, VIROLOGY, V445, P99, DOI 10.1016/j.virol.2013.05.006; Farkona S, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0623-5; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; Ferris RL, 2016, NEW ENGL J MED, V375, P1856, DOI 10.1056/NEJMoa1602252; Garcia-Lora A, 2003, J CELL PHYSIOL, V195, P346, DOI 10.1002/jcp.10290; Glasner A, 2017, J VIROL, V91, P22; Handisurya A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004314; Hata RI, 2015, SCI REP-UK, V5, DOI 10.1038/srep09083; Herzer K, 2003, J VIROL, V77, P8299, DOI 10.1128/JVI.77.15.8299-8309.2003; Hibma Merilyn H, 2012, Open Virol J, V6, P241, DOI 10.2174/1874357901206010241; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hu CY, 2013, INT J ONCOL, V43, P1487, DOI 10.3892/ijo.2013.2078; Johnston RJ, 2014, CANCER CELL, V26, P923, DOI 10.1016/j.ccell.2014.10.018; Kansy BA, 2017, CANCER RES, V77, P6353, DOI 10.1158/0008-5472.CAN-16-3167; Kim DH, 2011, BIOCHEM BIOPH RES CO, V409, P792, DOI 10.1016/j.bbrc.2011.05.090; Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x; Kurth I, 2001, J EXP MED, V194, P855, DOI 10.1084/jem.194.6.855; Kuss-Duerkop SK, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020082; Lee HT, 2017, THERANOSTICS, V7, P855, DOI 10.7150/thno.17558; Liu CQ, 2017, MOL MED REP, V15, P1063, DOI 10.3892/mmr.2017.6102; Lu JC, 2015, J CLIN INVEST, V125, P1839, DOI 10.1172/JCI78437; Lu J, 2016, J INFLAMM-LOND, V13, DOI 10.1186/s12950-015-0109-9; Lyu XJ, 2015, ONCOTARGET, V6, P6656, DOI 10.18632/oncotarget.3169; Maldonado L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007323; Miyamoto C, 2014, BIOMED RES-TOKYO, V35, P381, DOI 10.2220/biomedres.35.381; Moses K, 2016, J LEUKOCYTE BIOL, V99, P811, DOI 10.1189/jlb.1HI0715-289R; Nasman A, 2013, INT J CANCER, V132, P72, DOI 10.1002/ijc.27635; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Pasero C, 2015, ONCOTARGET, V6, P14360, DOI 10.18632/oncotarget.3965; Podolin PL, 2013, AM J PHYSIOL-LUNG C, V304, pL312, DOI 10.1152/ajplung.00152.2012; Ran XW, 2017, DRUG DES DEV THER, V11, P2007, DOI 10.2147/DDDT.S140687; Ribas A, 2017, CELL, V170, P1109, DOI 10.1016/j.cell.2017.08.027; Shurin GV, 2005, J IMMUNOL, V174, P5490, DOI 10.4049/jimmunol.174.9.5490; Smola Sigrun, 2017, Ther Adv Vaccines, V5, P69, DOI 10.1177/2051013617717914; Su RC, 2001, J IMMUNOL, V167, P4869, DOI 10.4049/jimmunol.167.9.4869; Tardif KD, 2003, J VIROL, V77, P11644, DOI 10.1128/JVI.77.21.11644-11650.2003; Tarek N, 2014, ADV EXP MED BIOL, V804, P341, DOI 10.1007/978-3-319-04843-7_19; Tindle RW, 2002, NAT REV CANCER, V2, P59, DOI 10.1038/nrc700; Trimble CL, 2010, J IMMUNOL, V185, P7107, DOI 10.4049/jimmunol.1002756; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Van Audenaerde JRM, 2018, PHARMACOL THERAPEUT, V189, P31, DOI 10.1016/j.pharmthera.2018.04.003; van der Burg SH, 2002, VIRUS RES, V89, P275, DOI 10.1016/S0168-1702(02)00196-X; Welters MJP, 2018, CLIN CANCER RES, V24, P634, DOI 10.1158/1078-0432.CCR-17-2140; Wente MN, 2008, CANCER LETT, V259, P209, DOI 10.1016/j.canlet.2007.10.021; Westrich JA, 2017, VIRUS RES, V231, P21, DOI 10.1016/j.virusres.2016.11.023; Woo YL, 2008, BJOG-INT J OBSTET GY, V115, P1616, DOI 10.1111/j.1471-0528.2008.01936.x; Woo Y. L., 2008, BJOG, V115, P1621	60	21	24	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 14	2019	38	46					7166	7180		10.1038/s41388-019-0911-6	http://dx.doi.org/10.1038/s41388-019-0911-6			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JN5HX	31417179	Green Accepted, hybrid			2022-12-26	WOS:000496930500004
J	Huertas, JR; Ruiz-Ojeda, FJ; Plaza-Diaz, J; Nordsborg, NB; Martin-Albo, J; Rueda-Robles, A; Casuso, RA				Huertas, Jesus R.; Javier Ruiz-Ojeda, Francisco; Plaza-Diaz, Julio; Nordsborg, Nikolai B.; Martin-Albo, Jesus; Rueda-Robles, Ascension; Casuso, Rafael A.			Human muscular mitochondrial fusion in athletes during exercise	FASEB JOURNAL			English	Article						physical activity; mitochondrial fission; skeletal muscle; mitofusin 2	HUMAN SKELETAL-MUSCLE; MEMBRANE INTERACTIONS; FISSION; PROTEIN; RETICULUM; ADAPTATIONS; ACTIVATION; FIS1	The main objective of this work was to investigate whether mitochondrial fusion occurs in the skeletal muscle of well-trained athletes in response to high-intensity exercise. Well-trained swimmers (n = 9) performed a duration-matched sprint interval training (SIT) and high-intensity high-volume training (HIHVT) session on separate days. Muscle samples from triceps brachii were taken before, immediately after, and 3 h after the training sessions. Transmission electron microscopy (TEM) was applied to assess mitochondrial morphology. Moreover, expression of genes coding for regulators of mitochondrial fusion and fission were assessed by real-time quantitative PCR. In addition, mitofusin (MFN)2 and optic atrophy 1 (OPA1) were quantified by Western blot analysis. TEM analyses showed that mitochondrial morphology remained altered for 3 h after HIHVT, whereas SIT-induced changes were only evident immediately after exercise. Only SIT increased MFN1 and MFN2 mRNA expression, whereas SIT and HIHVT both increased MFN2 protein content 3 h after exercise. Notably, only HIHVT increased OPA1 protein content. Mitochondrial morphologic changes that suggest fusion occurs in well-adapted athletes during exercise. However, HIHVT appears as a more robust inducer of mitochondrial fusion events than SIT. Indeed, SIT induces a rapid and transient change in mitochondrial morphology.	[Huertas, Jesus R.; Casuso, Rafael A.] Univ Granada, Sch Pharm, Dept Physiol, Granada, Spain; [Huertas, Jesus R.; Plaza-Diaz, Julio; Martin-Albo, Jesus; Rueda-Robles, Ascension; Casuso, Rafael A.] Univ Granada, Biomed Res Ctr, Jose Mataix Inst Nutr & Food Technol, Lab 116,Ave Conocimiento S-N, Granada 18100, Spain; [Javier Ruiz-Ojeda, Francisco; Plaza-Diaz, Julio] Univ Granada, Sch Pharm, Dept Biochem & Mol Biol 2, Granada, Spain; [Javier Ruiz-Ojeda, Francisco; Plaza-Diaz, Julio] Complejo Hosp Univ Granada, Inst Invest Biosanitaria Granada IBS GRANADA, Granada, Spain; [Javier Ruiz-Ojeda, Francisco] Helmholtz Ctr Munich, Helmholtz Diabet Ctr, Inst Diabet & Obes, Adipocytes & Metab Unit, Munich, Germany; [Nordsborg, Nikolai B.] Univ Copenhagen, Sect Integrat Physiol, Dept Nutr Exercise & Sports NEXS, Copenhagen, Denmark	University of Granada; University of Granada; University of Granada; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Copenhagen	Huertas, JR; Casuso, RA (corresponding author), Univ Granada, Biomed Res Ctr, Jose Mataix Inst Nutr & Food Technol, Lab 116,Ave Conocimiento S-N, Granada 18100, Spain.	jhuertas@ugr.es; casusopt@gmail.es	Rueda, Ascensión/AAB-7765-2021; Huertas, Jesus Francisco Rodriguez/G-8188-2015; Plaza-Diaz, Julio/C-8094-2016; Casuso, Rafael/E-9617-2016; Nordsborg, Nikolai/O-6173-2014	Rueda, Ascensión/0000-0003-1048-2448; Huertas, Jesus Francisco Rodriguez/0000-0002-7446-0857; Plaza-Diaz, Julio/0000-0002-5171-9408; Casuso, Rafael/0000-0002-4482-3186; Nordsborg, Nikolai/0000-0001-7077-9265	Ministerio de Economia y Competitividad [SAF2015-65786-R]; Fundacion General Empresa-Universidad de Granada [3650]; CTS-454 investigation group, "Impacto Fisiologico del estres Oxidativo, Deporte, Actividad Fisica y Salud"	Ministerio de Economia y Competitividad(Spanish Government); Fundacion General Empresa-Universidad de Granada; CTS-454 investigation group, "Impacto Fisiologico del estres Oxidativo, Deporte, Actividad Fisica y Salud"	The authors thank Daniel Camiletti Moiron (University of Cadiz, Cadiz, Spain) and Jeronimo Aragon-Vela (University of Granada) for technical assistance, and Mohamed Tassi Mzanzi (University of Granada) for helpful comments on transmission electron microscopy analysis. F.J.R.-O. and J.P.-D. are part of the University of Granada Plan Propio de Investigacion 2016. This study was partially supported by Grant SAF2015-65786-R from the Ministerio de Economia y Competitividad, Grant 3650 managed by Fundacion General Empresa-Universidad de Granada, and the CTS-454 investigation group, "Impacto Fisiologico del estres Oxidativo, Deporte, Actividad Fisica y Salud." The authors declare no conflicts of interest.	Axelrod CL, 2019, ACTA PHYSIOL, V225, DOI 10.1111/apha.13216; Boushel R, 2011, MITOCHONDRION, V11, P303, DOI 10.1016/j.mito.2010.12.006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cartoni R, 2005, J PHYSIOL-LONDON, V567, P349, DOI 10.1113/jphysiol.2005.092031; Casuso RA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185494; Casuso RA, 2014, J SPORT SCI MED, V13, P958; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Del Dotto V, 2017, CELL REP, V19, P2557, DOI 10.1016/j.celrep.2017.05.073; Drake JC, 2016, FASEB J, V30, P13, DOI 10.1096/fj.15-276337; Eisner V, 2014, J CELL BIOL, V205, P179, DOI 10.1083/jcb.201312066; Fealy CE, 2014, J APPL PHYSIOL, V117, P239, DOI 10.1152/japplphysiol.01064.2013; Feng Q, 2018, J CELL SCI, V131, DOI 10.1242/jcs.218479; Fiorenza M, 2018, J PHYSIOL-LONDON, V596, P2823, DOI 10.1113/JP275972; Franco A, 2016, NATURE, V540, P74, DOI 10.1038/nature20156; GAITANOS GC, 1993, J APPL PHYSIOL, V75, P712, DOI 10.1152/jappl.1993.75.2.712; GALE JB, 1974, MED SCI SPORT EXER, V6, P182; Gibala MJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE235; Glancy B, 2015, NATURE, V523, P617, DOI 10.1038/nature14614; GOLLNICK PD, 1969, AM J PHYSIOL, V216, P1502, DOI 10.1152/ajplegacy.1969.216.6.1502; Gomes LC, 2008, BBA-BIOENERGETICS, V1777, P860, DOI 10.1016/j.bbabio.2008.05.442; Granata C, 2018, SPORTS MED, V48, P1809, DOI 10.1007/s40279-018-0936-y; Granata C, 2017, SCI REP-UK, V7, DOI 10.1038/srep44227; Granata C, 2016, FASEB J, V30, P959, DOI 10.1096/fj.15-276907; Greggio C, 2017, CELL METAB, V25, P301, DOI 10.1016/j.cmet.2016.11.004; Helle SCJ, 2017, ELIFE, V6, DOI 10.7554/eLife.30292; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; HOPPELER H, 1986, INT J SPORTS MED, V7, P187, DOI 10.1055/s-2008-1025758; Huertas JR, 2017, REDOX BIOL, V13, P477, DOI 10.1016/j.redox.2017.07.009; Huertas JR, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/7058350; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Koyano F, 2019, J BIOL CHEM, V294, P10300, DOI 10.1074/jbc.RA118.006302; Larsen FJ, 2016, FASEB J, V30, P417, DOI 10.1096/fj.15-276857; Lundby AKM, 2018, ACTA PHYSIOL, V222, DOI 10.1111/apha.12905; MacInnis MJ, 2017, J PHYSIOL-LONDON, V595, P2915, DOI 10.1113/JP273196; Mathai AS, 2008, J APPL PHYSIOL, V105, P1098, DOI 10.1152/japplphysiol.00847.2007; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Nielsen J, 2011, J PHYSIOL-LONDON, V589, P2871, DOI 10.1113/jphysiol.2010.204487; Niklas P, 2010, EUR J APPL PHYSIOL, V110, P597, DOI 10.1007/s00421-010-1544-1; Ortenblad N, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01031; Ortenblad N, 2011, J PHYSIOL-LONDON, V589, P711, DOI 10.1113/jphysiol.2010.195982; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011; Picard M, 2013, J APPL PHYSIOL, V115, P1562, DOI 10.1152/japplphysiol.00819.2013; Picard M, 2013, J APPL PHYSIOL, V114, P161, DOI 10.1152/japplphysiol.01096.2012; Schwalm C, 2017, MED SCI SPORT EXER, V49, P1552, DOI 10.1249/MSS.0000000000001256; Sebastian D, 2018, CURR OPIN PHYSIOL, V3, P34, DOI 10.1016/j.cophys.2018.02.006; Shen QF, 2014, MOL BIOL CELL, V25, P145, DOI 10.1091/mbc.E13-09-0525; Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7; TERJUNG RL, 1972, AM J PHYSIOL, V223, P549, DOI 10.1152/ajplegacy.1972.223.3.549; Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138; West Mark J, 2012, Cold Spring Harb Protoc, V2012, P1129, DOI 10.1101/pdb.top071787; Zinner C, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00426	53	14	15	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12087	12098		10.1096/fj.201900365RR	http://dx.doi.org/10.1096/fj.201900365RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31398297	Bronze			2022-12-26	WOS:000507461600038
J	Mao, SS; Zhang, SS; Zhou, SS; Huang, T; Feng, W; Gu, XS; Yu, B				Mao, Susu; Zhang, Shanshan; Zhou, Shuoshuo; Huang, Tao; Feng, Wei; Gu, Xiaosong; Yu, Bin			A Schwann cell-enriched circular RNA circ-Ankib1 regulates Schwann cell proliferation following peripheral nerve injury	FASEB JOURNAL			English	Article						Cyp26b1; competing endogenous RNA; sciatic nerve injury; axon regeneration	MIGRATION; BINDING; REGENERATION; BIOGENESIS; INDUCTION; ABUNDANT; ROLES	Schwann cells (SCs) play an essential role in nerve injury repair. A striking feature of the cellular response to peripheral nerve injury is the proliferation of SCs. Circular (circ)RNAs are enriched in the nervous system and are involved in physiologic and pathologic processes. However, the potential role of circRNAs in SC proliferation post nerve injury remains largely unknown. Using a sciatic nerve crush model, we obtained an expression profiling of circRNAs in injured sciatic nerves in rats by RNA sequencing and bioinformatics analysis, and we further identified a circRNA [circ-ankyrin repeat and in-between Ring finger (IBR) domain containing 1 (Ankib1)] involved in SC proliferation by the transfection of specific small interfering RNAs. Overexpression of circ-Ankib1, which was specifically and highly enriched in SCs, impaired SC proliferation and axon regeneration following sciatic nerve injury. Mechanistically, increased expression of DEx/H-box helicase 9 (DHX9) postinjury might contribute to the down-regulation of circ-Ankib1, which further suppressed cytochrome P450, family 26, subfamily B, polypeptide 1 expression by sponging miR-423-5p, miR-485-5p, and miR-666-3p, leading to the induction of SC proliferation and nerve regeneration. Taken together, our results reveal a crucial role for circRNAs in regulating proliferation of SCs involved in sciatic nerve regeneration; as such, circRNAs may serve as a potential therapeutic avenue for nerve injury repair.	[Mao, Susu; Zhang, Shanshan; Zhou, Shuoshuo; Huang, Tao; Feng, Wei; Gu, Xiaosong; Yu, Bin] Nantong Univ, Affiliated Hosp, Key Lab Neuroregenerat Jiangsu, Nantong, Peoples R China; [Mao, Susu; Zhang, Shanshan; Zhou, Shuoshuo; Huang, Tao; Feng, Wei; Gu, Xiaosong; Yu, Bin] Nantong Univ, Affiliated Hosp, Minist Educ, Coinnovat Ctr Neuroregenerat, Nantong, Peoples R China; [Gu, Xiaosong; Yu, Bin] Nantong Univ, Affiliated Hosp, Jiangsu Clin Med Ctr Tissue Engn & Nerve Injury R, Nantong, Peoples R China	Nantong University; Nantong University; Nantong University	Yu, B (corresponding author), Nantong Univ, Key Lab Neuroregenerat Jiangsu, Bldg 7,19 Qixiu Rd, Nantong 226001, Peoples R China.; Yu, B (corresponding author), Nantong Univ, Minist Educ, Coinnovat Ctr Neuroregenerat, Bldg 7,19 Qixiu Rd, Nantong 226001, Peoples R China.	yubin@ntu.edu.cn			National Major Project of Research and Development [2017YFA0104701]; National Natural Science Foundation of China [31730031, 81771326, 31700925]; Jiangsu Provincial Natural Science Foundation [BK20170442]; Jiangsu Government Scholarship for Overseas Studies [JS2018-189]; Jiangsu Provincial Key Medical Center of Jiangsu Higher Education Institution; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institution	National Major Project of Research and Development; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Jiangsu Government Scholarship for Overseas Studies; Jiangsu Provincial Key Medical Center of Jiangsu Higher Education Institution; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institution	This work was supported by the National Major Project of Research and Development (2017YFA0104701 to B.Y.), the National Natural Science Foundation of China (31730031 to X.G., 81771326 to B.Y., and 31700925 to S.M.), the Jiangsu Provincial Natural Science Foundation (BK20170442 to S.M.), a Jiangsu Government Scholarship for Overseas Studies (JS2018-189 to S.M.), and the Jiangsu Provincial Key Medical Center and Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions. The authors declare no conflicts of interest.	Aktas T, 2017, NATURE, V544, P115, DOI 10.1038/nature21715; Allodi I, 2014, GLIA, V62, P1736, DOI 10.1002/glia.22712; Arthur-Farraj PJ, 2017, CELL REP, V20, P2719, DOI 10.1016/j.celrep.2017.08.064; Chang HM, 2014, J PINEAL RES, V56, P322, DOI 10.1111/jpi.12125; Chen LL, 2016, NAT REV MOL CELL BIO, V17, P205, DOI 10.1038/nrm.2015.32; Conn SJ, 2015, CELL, V160, P1125, DOI 10.1016/j.cell.2015.02.014; Doyle KL, 2008, J NEUROCHEM, V105, P641, DOI 10.1111/j.1471-4159.2007.05188.x; Engedal N, 2006, J IMMUNOL, V177, P2851, DOI 10.4049/jimmunol.177.5.2851; Gao Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0571-3; Guertin AD, 2005, J NEUROSCI, V25, P3478, DOI 10.1523/JNEUROSCI.3766-04.2005; Gupta SK, 2018, CIRC RES, V122, P246, DOI 10.1161/CIRCRESAHA.117.311335; Hall S, 2005, J BONE JOINT SURG BR, V87B, P1309, DOI 10.1302/0301-620X.87B10.16700; Haque S, 2017, GENES-BASEL, V8, DOI 10.3390/genes8120353; Hu X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.424; Hua WF, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.252; Ivanov A, 2015, CELL REP, V10, P170, DOI 10.1016/j.celrep.2014.12.019; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Jessen KR, 2016, J PHYSIOL-LONDON, V594, P3521, DOI 10.1113/JP270874; Kipp JL, 2011, ENDOCRINOLOGY, V152, P303, DOI 10.1210/en.2010-0749; Kleaveland B, 2018, CELL, V174, P350, DOI 10.1016/j.cell.2018.05.022; Koeppen AH, 2004, J NEUROL SCI, V220, P115, DOI 10.1016/j.jns.2004.03.008; KOMIYAMA A, 1991, J NEUROSCI RES, V29, P308, DOI 10.1002/jnr.490290306; Kramer MC, 2015, GENE DEV, V29, P2168, DOI 10.1101/gad.270421.115; Latasa MJ, 2016, BBA-MOL CELL RES, V1863, P1510, DOI 10.1016/j.bbamcr.2016.04.009; Latasa MJ, 2010, GLIA, V58, P1451, DOI 10.1002/glia.21020; Legnini I, 2017, MOL CELL, V66, P22, DOI 10.1016/j.molcel.2017.02.017; Li ZY, 2015, NAT STRUCT MOL BIOL, V22, P256, DOI 10.1038/nsmb.2959; Mantuano E, 2008, J NEUROSCI, V28, P11571, DOI 10.1523/JNEUROSCI.3053-08.2008; Mao SS, 2018, EXP NEUROL, V308, P80, DOI 10.1016/j.expneurol.2018.07.003; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Miller SLH, 2004, J BIOL CHEM, V279, P33528, DOI 10.1074/jbc.M313097200; Mishra S, 2018, STEM CELL REP, V10, P1705, DOI 10.1016/j.stemcr.2018.04.024; Muscarella LA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/854737; Noe L, 2005, NUCLEIC ACIDS RES, V33, pW540, DOI 10.1093/nar/gki478; Qu SB, 2018, CANCER LETT, V414, P301, DOI 10.1016/j.canlet.2017.11.022; Ross AC, 2011, ANNU REV NUTR, V31, P65, DOI 10.1146/annurev-nutr-072610-145127; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Scheib J, 2013, NAT REV NEUROL, V9, P668, DOI 10.1038/nrneurol.2013.227; Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Triolo D, 2006, J CELL SCI, V119, P3981, DOI 10.1242/jcs.03168; Vaidyanathan G, 2004, ONCOGENE, V23, P5858, DOI 10.1038/sj.onc.1207774; Verrier JD, 2010, J NEUROSCI RES, V88, P2558, DOI 10.1002/jnr.22418; Viader A, 2011, J NEUROSCI, V31, P17358, DOI 10.1523/JNEUROSCI.3931-11.2011; Xie LL, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00354; Xu JY, 2019, FASEB J, V33, P2659, DOI 10.1096/fj.201800243RRR; Yao C, 2018, J NEUROSCI, V38, P6574, DOI 10.1523/JNEUROSCI.3790-16.2018; You XT, 2015, NAT NEUROSCI, V18, P603, DOI 10.1038/nn.3975; Yu B, 2012, NUCLEIC ACIDS RES, V40, P10356, DOI 10.1093/nar/gks750; Yu B, 2012, J CELL SCI, V125, P2675, DOI 10.1242/jcs.098996; Yu J, 2018, J HEPATOL, V68, P1214, DOI 10.1016/j.jhep.2018.01.012; Zhang XO, 2014, CELL, V159, P134, DOI 10.1016/j.cell.2014.09.001; Zhang Y, 2013, MOL CELL, V51, P792, DOI 10.1016/j.molcel.2013.08.017; Zhelyaznik N, 2003, EUR J NEUROSCI, V18, P1033, DOI 10.1046/j.1460-9568.2003.02834.x; Zhou SL, 2014, J CELL SCI, V127, P967, DOI 10.1242/jcs.131672; Zhou ZB, 2018, MOL THER-NUCL ACIDS, V12, P718, DOI 10.1016/j.omtn.2018.07.011; Zochodne DW, 2012, J PERIPHER NERV SYST, V17, P1, DOI 10.1111/j.1529-8027.2012.00378.x	59	15	17	5	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12409	12424		10.1096/fj.201900965R	http://dx.doi.org/10.1096/fj.201900965R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31415184	Green Published, Bronze			2022-12-26	WOS:000507461600063
J	Sessions, GA; Copp, ME; Liu, JY; Sinkler, MA; D'Costa, S; Diekman, BO				Sessions, Garrett A.; Copp, Michaela E.; Liu, Jie-Yu; Sinkler, Margaret A.; D'Costa, Susan; Diekman, Brian O.			Controlled induction and targeted elimination of p16(INK4a)-expressing chondrocytes in cartilage explant culture	FASEB JOURNAL			English	Article						osteoarthritis; aging; senolytic; ABT-263; senescence	SENESCENT CELLS; IN-VIVO; CELLULAR SENESCENCE; OSTEOARTHRITIS; P16(INK4A); EXPRESSION; CLEARANCE; BIOMARKER; DISEASE; MICE	Cellular senescence is a phenotypic state that contributes to age-related diseases through the secretion of matrix-degrading and inflammatory molecules. An emerging therapeutic strategy for osteoarthritis (OA) is to selectively eliminate senescent cells by initiating apoptosis. This study establishes a cartilage explant model of senescence induction and senolytic clearance using p16(Ink4a) expression as a biomarker of senescence. Growth-factor stimulation of explants increased the expression of p16(Ink4a) at both the mRNA and protein levels. Applying this culture system to cartilage from p16tdTom reporter mice (a knockin allele with tdTomato fluorescent protein regulated by the endogenous p16Ink4a promoter) demonstrated the emergence of a p16-high population that was quantified using flow cytometry for tdTomato. Cell sorting was used to separate chondrocytes based on tdTomato fluorescence and p16-high cells showed higher senescence-associated beta-galactosidase activity and increased gene expression of the senescence-associated secretory phenotype as compared with p16-low cells. The potential for effective senolysis within the cartilage extracellular matrix was assessed using navitoclax (ABT-263). Navitoclax treatment reduced the percentage of p16-high cells from 17.9 to 6.1% (mean of 13 matched pairs; P < 0.001) and increased cleaved caspase-3 confirmed apoptotic activity. Together, these findings establish a physiologically relevant cartilage explant model for testing the induction and elimination of senescent chondrocytes, which will support investigations of senolytic therapy for OA.	[Sessions, Garrett A.; Sinkler, Margaret A.; D'Costa, Susan; Diekman, Brian O.] Univ N Carolina, Thurston Arthrit Res Ctr, Chapel Hill, NC 27515 USA; [Liu, Jie-Yu; Diekman, Brian O.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Copp, Michaela E.; Diekman, Brian O.] North Carolina North Carolina State Univ, Univ North Carolina Chapel Hill, Joint Dept Biomed Engn, Raleigh, NC USA; [Sinkler, Margaret A.] Augusta Univ, Med Coll Georgia, Augusta, GA USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University System of Georgia; Augusta University	Diekman, BO (corresponding author), Univ N Carolina, Sch Med, Thurston Arthrit Res Ctr, 104 Manning Dr,3300 Thurston Bldg,Campus Box 7280, Chapel Hill, NC 27599 USA.	bdiekman@email.unc.edu	, Pathology Services Core/CEZ-2246-2022; , UNC Flow Cytometry Core/AGU-9839-2022	Sessions, Garrett/0000-0003-2853-0612; Diekman, Brian/0000-0001-9055-4282	U.S. National Institutes of Health (NIH) National Institute on Aging [F32 AG050399]; Arthritis National Research Foundation (ANRF); American Federation for Aging Research; ANRF; NIH National Institute on Aging [NIA 2T35-AG038047-08]; Cancer Center Core Support Grant [P30 CA016086]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T35AG038047, F32AG050399] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute on Aging; Arthritis National Research Foundation (ANRF); American Federation for Aging Research; ANRF; NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Cancer Center Core Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank the members of Dr. Richard Loeser's laboratory [University of North Carolina (UNC) at Chapel Hill] for valuable feedback, and the UNC Animal Histopathology and UNC Flow Cytometry Cores. This work was supported by the U.S. National Institutes of Health (NIH) National Institute on Aging (Grant F32 AG050399 to B.O.D.), and was conducted while B.O. D. was an Arthritis and Aging Research Grant recipient from the Arthritis National Research Foundation (ANRF) and the American Federation for Aging Research, as well as second-year funding from the ANRF. Support from the NIH National Institute on Aging was provided to M.A.S. for the UNC Summer Research in Aging for Medical Students (NIA 2T35-AG038047-08). The UNC Flow Cytometry Core Facility is supported, in part, by the P30 CA016086 Cancer Center Core Support Grant to the UNC Lineberger Comprehensive Cancer Center. The authors declare no conflicts of interest.	Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Bijlsma JWJ, 2011, LANCET, V377, P2115, DOI 10.1016/S0140-6736(11)60243-2; Blagosklonny MV, 2014, CELL CYCLE, V13, P3628, DOI 10.4161/15384101.2014.985507; Boehme KA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082282; Burd CE, 2013, CELL, V152, P340, DOI 10.1016/j.cell.2012.12.010; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Cao X, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1193-1; Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010; Childs BG, 2016, SCIENCE, V354, P472, DOI 10.1126/science.aaf6659; Chong KW, 2013, ARTHRITIS RHEUM-US, V65, P2346, DOI 10.1002/art.38039; Chonghaile TN, 2008, ONCOGENE, V27, pS149, DOI 10.1038/onc.2009.52; Colins JA, 2018, CURR OPIN RHEUMATOL, V30, P101, DOI 10.1097/BOR.0000000000000456; Coppe JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009188; Dai CY, 2000, ONCOGENE, V19, P1613, DOI 10.1038/sj.onc.1203438; Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012; Diekman BO, 2018, J AM ACAD ORTHOP SUR, V26, pE455, DOI 10.5435/JAAOS-D-18-00394; Diekman BO, 2018, AGING CELL, V17, DOI 10.1111/acel.12771; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Fuhrmann-Stroissnigg H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00314-z; He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015; Henry SP, 2009, GENESIS, V47, P805, DOI 10.1002/dvg.20564; Jeck WR, 2012, AGING CELL, V11, P727, DOI 10.1111/j.1474-9726.2012.00871.x; Jeon OH, 2018, J CLIN INVEST, V128, P1229, DOI 10.1172/JCI95147; Jeon OH, 2017, NAT MED, V23, P775, DOI 10.1038/nm.4324; Kirkland JL, 2017, J AM GERIATR SOC, V65, P2297, DOI 10.1111/jgs.14969; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Li W, 2019, AGING-US, V11, P771, DOI 10.18632/aging.101787; Liu JY, 2019, P NATL ACAD SCI USA, V116, P2603, DOI 10.1073/pnas.1818313116; Loeser RF, 2016, NAT REV RHEUMATOL, V12, P412, DOI 10.1038/nrrheum.2016.65; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Martin JA, 2001, J GERONTOL A-BIOL, V56, pB172, DOI 10.1093/gerona/56.4.B172; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Novais EJ, 2019, MATRIX BIOL, V82, P54, DOI 10.1016/j.matbio.2019.02.004; Ovadya Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07825-3; Ozsvari B, 2018, AGING-US, V10, P3294, DOI 10.18632/aging.101633; Pan J, 2017, INT J RADIAT ONCOL, V99, P353, DOI 10.1016/j.ijrobp.2017.02.216; Philipot D, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4494; Potter DS, 2016, COLD SH Q B, V81, P131, DOI 10.1101/sqb.2016.81.030841; Price JS, 2002, AGING CELL, V1, P57, DOI 10.1046/j.1474-9728.2002.00008.x; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960; Stanton H, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.179; Tang XD, 2018, ANN RHEUM DIS, V77, P1372, DOI 10.1136/annrheumdis-2018-212964; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Wang YY, 2016, AGING-US, V8, P2915, DOI 10.18632/aging.101100; Wood WA, 2016, EBIOMEDICINE, V11, P227, DOI 10.1016/j.ebiom.2016.08.029; Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9; Xu M, 2017, J GERONTOL A-BIOL, V72, P780, DOI 10.1093/gerona/glw154; Yamakoshi K, 2009, J CELL BIOL, V186, P393, DOI 10.1083/jcb.200904105; Yousefzadeh MJ, 2018, EBIOMEDICINE, V36, P18, DOI 10.1016/j.ebiom.2018.09.015; Zhou HW, 2004, RHEUMATOLOGY, V43, P555, DOI 10.1093/rheumatology/keh127; Zhu Y, 2017, AGING-US, V9, P955, DOI 10.18632/aging.101202; Zhu Y, 2016, AGING CELL, V15, P428, DOI 10.1111/acel.12445; Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344	59	22	23	2	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12364	12373		10.1096/fj.201900815RR	http://dx.doi.org/10.1096/fj.201900815RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31408372	Green Published			2022-12-26	WOS:000507461600060
J	Ghosh, JC; Seo, JH; Agarwal, E; Wang, Y; Kossenkov, AV; Tang, HY; Speicher, DW; Altieri, DC				Ghosh, Jagadish C.; Seo, Jae Ho; Agarwal, Ekta; Wang, Yuan; Kossenkov, Andrew V.; Tang, Hsin-Yao; Speicher, David W.; Altieri, Dario C.			Akt phosphorylation of mitochondrial Lonp1 protease enables oxidative metabolism and advanced tumor traits	ONCOGENE			English	Article							STRESS; PROTEOSTASIS; CANCER; CLPP; DEGRADATION; DYNAMICS; DISEASE; ROS	Tumor mitochondria have heightened protein folding quality control, but the regulators of this process and how they impact cancer traits are not completely understood. Here we show that the ATP-directed mitochondrial protease, LonP1 is upregulated by stress conditions, including hypoxia, in tumor, but not normal cells. In mitochondria, LonP1 is phosphorylated by Akt on Ser173 and Ser181, enhancing its protease activity. Interference with this pathway induces accumulation of misfolded subunits of electron transport chain complex II and complex V, resulting in impaired oxidative bioenergetics and heightened ROS production. Functionally, this suppresses mitochondrial trafficking to the cortical cytoskeleton, shuts off tumor cell migration and invasion, and inhibits primary and metastatic tumor growth, in vivo. These data identify LonP1 as a key effector of mitochondrial reprogramming in cancer and potential therapeutic target.	[Ghosh, Jagadish C.; Seo, Jae Ho; Agarwal, Ekta; Wang, Yuan; Speicher, David W.; Altieri, Dario C.] Prostate Canc Discovery & Dev Program, Philadelphia, PA 19107 USA; [Ghosh, Jagadish C.; Seo, Jae Ho; Agarwal, Ekta; Wang, Yuan; Altieri, Dario C.] Wistar Inst Anat & Biol, Immunol Microenvironm & Metastasis Program, 3601 Spruce St, Philadelphia, PA 19104 USA; [Kossenkov, Andrew V.; Tang, Hsin-Yao; Speicher, David W.] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, 3601 Spruce St, Philadelphia, PA 19104 USA; [Speicher, David W.] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, 3601 Spruce St, Philadelphia, PA 19104 USA	The Wistar Institute; The Wistar Institute; The Wistar Institute	Altieri, DC (corresponding author), Prostate Canc Discovery & Dev Program, Philadelphia, PA 19107 USA.; Altieri, DC (corresponding author), Wistar Inst Anat & Biol, Immunol Microenvironm & Metastasis Program, 3601 Spruce St, Philadelphia, PA 19104 USA.	daltieri@wistar.org		Tang, Hsin-Yao/0000-0003-1838-018X; Agarwal, Ekta/0000-0002-5992-3358	National Institutes of Health (NIH) [P01 CA140043, R35 CA220446, R50 CA221838, R50 CA211199]; Cancer Center Support Grant (CCSG) [CA010815]; NATIONAL CANCER INSTITUTE [P30CA010815, P01CA140043, R35CA220446] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant (CCSG); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank James Hayden and Frederick Keeney for assistance with time-lapse videomicroscopy and Sandra Harper for performing the HPLC gel filtration experiments. This work was supported by the National Institutes of Health (NIH) grants P01 CA140043 (DCA and DWS), R35 CA220446 (D.C.A.) R50 CA221838 (H-YT), and R50 CA211199 (AVK). and Support for Core Facilities utilized in this study was provided by Cancer Center Support Grant (CCSG) CA010815 to The Wistar Institute.	Altieri DC, 2013, CELL MOL LIFE SCI, V70, P2463, DOI 10.1007/s00018-012-1177-0; Anderson RG, 2018, BBA-REV CANCER, V1870, P96, DOI 10.1016/j.bbcan.2018.05.005; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bezawork-Geleta A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17397; Bota DA, 2016, FREE RADICAL BIO MED, V100, P188, DOI 10.1016/j.freeradbiomed.2016.06.031; Caino MC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13730; Caino MC, 2015, P NATL ACAD SCI USA, V112, P8638, DOI 10.1073/pnas.1500722112; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Cha SS, 2010, EMBO J, V29, P3520, DOI 10.1038/emboj.2010.226; Chae YC, 2016, CANCER CELL, V30, P257, DOI 10.1016/j.ccell.2016.07.004; Chae YC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3139; Chevet E, 2015, CANCER DISCOV, V5, P586, DOI 10.1158/2159-8290.CD-14-1490; Ciechanover A, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.117; Cole A, 2015, CANCER CELL, V27, P864, DOI 10.1016/j.ccell.2015.05.004; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Desai SP, 2013, BIOPHYS J, V104, P2077, DOI 10.1016/j.bpj.2013.03.025; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Ghosh JC, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju502; Gibellini L, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00254; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Granot Z, 2007, MOL ENDOCRINOL, V21, P2164, DOI 10.1210/me.2005-0458; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Hetz C, 2015, NAT CELL BIOL, V17, P829, DOI 10.1038/ncb3184; Janku F, 2018, NAT REV CLIN ONCOL, V15, P273, DOI 10.1038/nrclinonc.2018.28; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Kao TY, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.9; Liu KY, 2014, CRIT REV BIOCHEM MOL, V49, P400, DOI 10.3109/10409238.2014.925421; Lu B, 2017, ADV EXP MED BIOL, V1038, P173, DOI 10.1007/978-981-10-6674-0_12; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Marchi S, 2019, EMBO J, V38, DOI 10.15252/embj.201899435; Pinti M, 2016, BBA-BIOENERGETICS, V1857, P1300, DOI 10.1016/j.bbabio.2016.03.025; Pinti M, 2015, CELL MOL LIFE SCI, V72, P4807, DOI 10.1007/s00018-015-2039-3; Piskounova E, 2015, NATURE, V527, P186, DOI 10.1038/nature15726; Potter M, 2016, BIOCHEM SOC T, V44, P1499, DOI 10.1042/BST20160094; Pryde KR, 2016, CELL REP, V17, P2522, DOI 10.1016/j.celrep.2016.11.027; Quiros PM, 2014, CELL REP, V8, P541, DOI 10.1016/j.celrep.2014.06.018; Rotanova TV, 2006, PROTEIN SCI, V15, P1815, DOI 10.1110/ps.052069306; Sabharwal SS, 2014, NAT REV CANCER, V14, P709, DOI 10.1038/nrc3803; Sanchez-Alvarez M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16662-1; Santi SA, 2010, AM J PHYSIOL-CELL PH, V298, pC580, DOI 10.1152/ajpcell.00375.2009; Senft D, 2016, CURR OPIN CELL BIOL, V39, P43, DOI 10.1016/j.ceb.2016.02.001; Seo JH, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002507; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; van Oosten-Hawle P, 2014, GENE DEV, V28, P1533, DOI 10.1101/gad.241125.114; Vieux EF, 2013, P NATL ACAD SCI USA, V110, pE2002, DOI 10.1073/pnas.1307066110; Vyas S, 2016, CELL, V166, P555, DOI 10.1016/j.cell.2016.07.002; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Zhao J, 2013, ONCOGENE, V32, P4814, DOI 10.1038/onc.2012.494	49	22	22	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 24	2019	38	43					6926	6939		10.1038/s41388-019-0939-7	http://dx.doi.org/10.1038/s41388-019-0939-7			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JH4GX	31406245	Green Accepted			2022-12-26	WOS:000492728000004
J	Martins, AM; Latham, JA; Martel, PJ; Barr, I; Iavarone, AT; Klinman, JP				Martins, Ana M.; Latham, John A.; Martel, Paulo J.; Barr, Ian; Iavarone, Anthony T.; Klinman, Judith P.			A two-component protease in Methylorubrum extorquens with high activity toward the peptide precursor of the redox cofactor pyrroloquinoline quinone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protease; zinc; serine; enzyme catalysis; peptides; heterodimer; M16B protease; PQQ	GLUCOSE-DEHYDROGENASE; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; MAMMALIAN ENZYME; PQQ; METHYLOBACTERIUM; BIOSYNTHESIS; BIOGENESIS; SITE; OXIDATION	Pyrroloquinoline quinone is a prominent redox cofactor in many prokaryotes, produced from a ribosomally synthesized and post-translationally modified peptide PqqA via a pathway comprising four conserved proteins PqqB?E. These four proteins are now fairly well-characterized and span radical SAM activity (PqqE), aided by a peptide chaperone (PqqD), a dual hydroxylase (PqqB), and an eight-electron, eight-proton oxidase (PqqC). A full description of this pathway has been hampered by a lack of information regarding a protease/peptidase required for the excision of an early, cross-linked di-amino acid precursor to pyrroloquinoline quinone. Herein, we isolated and characterized a two-component heterodimer protein from the ?-proteobacterium Methylobacterium (Methylorubrum) extorquens that can rapidly catalyze cleavage of PqqA into smaller peptides. Using pulldown assays, surface plasmon resonance, and isothermal calorimetry, we demonstrated the formation of a complex PqqF/PqqG, with a K-D of 300 nm. We created a molecular model of the heterodimer by comparison with the Sphingomonas sp. A1 M16B Sph2681/Sph2682 protease. Analysis of time-dependent patterns for the appearance of proteolysis products indicates high specificity of PqqF/PqqG for serine side chains. We hypothesize that PqqF/PqqG initially cleaves between the PqqE/PqqD-generated cross-linked form of PqqA, with nonspecific cellular proteases completing the release of a suitable substrate for the downstream enzyme PqqB. The finding of a protease that specifically targets serine side chains is rare, and we propose that this activity may be useful in proteomic analyses of the large family of proteins that have undergone post-translational phosphorylation at serine.	[Martins, Ana M.; Barr, Ian; Iavarone, Anthony T.; Klinman, Judith P.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, 608C Stanley Hall, Berkeley, CA 94720 USA; [Barr, Ian; Iavarone, Anthony T.; Klinman, Judith P.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Klinman, Judith P.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Latham, John A.] Univ Denver, Dept Chem & Biochem, Denver, CO USA; [Martel, Paulo J.] Univ Algarve, Fac Sci & Technol, Ctr Biomed Res, P-8005139 Faro, Portugal; [Iavarone, Anthony T.] Dominican Univ Calif, Dept Nat Sci & Math, San Rafael, CA 94901 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Denver; Universidade do Algarve	Klinman, JP (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci, 608C Stanley Hall, Berkeley, CA 94720 USA.	klinman@berkeley.edu	Martel, Paulo J/AFV-2568-2022; Martons, Ana Margarida/AAP-4337-2021; Martins, Samir/P-6251-2014	Martel, Paulo J/0000-0001-8237-1267; Martons, Ana Margarida/0000-0003-4822-3249; Martins, Samir/0000-0003-1702-8504; Latham, John/0000-0002-3034-1768; Barr, Ian/0000-0003-1805-1415	National Institutes of Health [GM118117, GM124002, 1S10OD020062-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM124002, R35GM118117] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM118117 (to J. P. K.) and GM124002 (to J. A. L.) and the QB3/Chemistry Mass Spectrometry Facility Grant 1S10OD020062-01. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Akagawa M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26723; Akagawa M, 2016, BIOSCI BIOTECH BIOCH, V80, P13, DOI 10.1080/09168451.2015.1062715; Asplund-Samuelsson J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049888; Barr I, 2016, J BIOL CHEM, V291, P8877, DOI 10.1074/jbc.C115.699918; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; BLAKE CCF, 1994, NAT STRUCT BIOL, V1, P102, DOI 10.1038/nsb0294-102; Bonnot F, 2013, BIOCHEMISTRY-US, V52, P4667, DOI 10.1021/bi4003315; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Duncan EA, 1997, J BIOL CHEM, V272, P12778, DOI 10.1074/jbc.272.19.12778; Felton LM, 2005, NATURE, V433, pE10, DOI 10.1038/nature03322; Ghilarov D, 2017, STRUCTURE, V25, P1549, DOI 10.1016/j.str.2017.08.006; Gliese N, 2010, ARCH MICROBIOL, V192, P1, DOI 10.1007/s00203-009-0523-6; Goodwin PM, 1998, ADV MICROB PHYSIOL, V40, P1, DOI 10.1016/S0065-2911(08)60129-0; GOOSEN N, 1992, J BACTERIOL, V174, P1426, DOI 10.1128/jb.174.4.1426-1427.1992; GOOSEN N, 1987, J BACTERIOL, V169, P303, DOI 10.1128/jb.169.1.303-307.1987; Green PN, 2018, INT J SYST EVOL MICR, V68, P2727, DOI 10.1099/ijsem.0.002856; HARRIS ED, 1992, NUTR REV, V50, P263, DOI 10.1111/j.1753-4887.1992.tb01343.x; HAUGE JG, 1964, J BIOL CHEM, V239, P3630; HOUCK DR, 1989, A VAN LEEUW J MICROB, V56, P93, DOI 10.1007/BF00822589; Jongejan J. A., 1989, PQQ QUINOPROTEINS; Kasahara T, 2003, NATURE, V422, P832, DOI 10.1038/422832a; Klemencic M, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00293; Klinman JP, 2014, CHEM REV, V114, P4343, DOI 10.1021/cr400475g; Koehn EM, 2019, J AM CHEM SOC, V141, P4398, DOI 10.1021/jacs.8b13453; KUMAZAWA T, 1992, BIOCHIM BIOPHYS ACTA, V1156, P62, DOI 10.1016/0304-4165(92)90096-D; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Latham JA, 2015, J BIOL CHEM, V290, P12908, DOI 10.1074/jbc.M115.646521; Liddington RC, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P1450, DOI 10.1016/B978-0-12-382219-2.00326-4; Lin SX, 2017, SCIENCE, V355, P597, DOI 10.1126/science.aal3316; LOBENSTEINVERBEEK CL, 1984, FEBS LETT, V170, P305, DOI 10.1016/0014-5793(84)81333-2; Louche A, 2017, METHODS MOL BIOL, V1615, P247, DOI 10.1007/978-1-4939-7033-9_20; Maghrabi AHA, 2017, NUCLEIC ACIDS RES, V45, pW416, DOI 10.1093/nar/gkx332; Magnusson OT, 2007, BIOCHEMISTRY-US, V46, P7174, DOI 10.1021/bi700162n; Magnusson OT, 2004, P NATL ACAD SCI USA, V101, P7913, DOI 10.1073/pnas.0402640101; Magnusson OT, 2004, J AM CHEM SOC, V126, P5342, DOI 10.1021/ja0493852; Maruyama Y, 2011, J MOL BIOL, V407, P180, DOI 10.1016/j.jmb.2011.01.038; Matsushita K, 1997, MICROBIOL-UK, V143, P3149, DOI 10.1099/00221287-143-10-3149; MEULENBERG JJM, 1992, MOL GEN GENET, V232, P284, DOI 10.1007/BF00280008; Misra HS, 2012, J BIOSCIENCES, V37, P313, DOI 10.1007/s12038-012-9195-5; MORRIS CJ, 1994, J BACTERIOL, V176, P1746, DOI 10.1128/jb.176.6.1746-1755.1994; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Offenbacher AR, 2017, ACS CENTRAL SCI, V3, P570, DOI 10.1021/acscentsci.7b00142; Oubrie A, 1999, EMBO J, V18, P5187, DOI 10.1093/emboj/18.19.5187; Ozbabacan SEA, 2011, PROTEIN ENG DES SEL, V24, P635, DOI 10.1093/protein/gzr025; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Rawlings ND, 2018, NUCLEIC ACIDS RES, V46, pD624, DOI 10.1093/nar/gkx1134; Rawlings ND, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P325, DOI 10.1016/B978-0-12-382219-2.00077-6; RoseFigura J. M., 2010, THESIS; Rucker R, 2005, NATURE, V433, pE10, DOI 10.1038/nature03323; Saihara K, 2017, BIOCHEMISTRY-US, V56, P6615, DOI 10.1021/acs.biochem.7b01185; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Seaman JE, 2016, CELL DEATH DIFFER, V23, P1717, DOI 10.1038/cdd.2016.62; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shen YQ, 2012, BIOCHEMISTRY-US, V51, P2265, DOI 10.1021/bi201763d; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sode K, 1996, J BIOTECHNOL, V49, P239, DOI 10.1016/0168-1656(96)01540-4; Springer AL, 1996, J BACTERIOL, V178, P2154, DOI 10.1128/jb.178.7.2154-2157.1996; Steinberg F, 2003, EXP BIOL MED, V228, P160, DOI 10.1177/153537020322800205; STEINBERG FM, 1994, J NUTR, V124, P744, DOI 10.1093/jn/124.5.744; VANKLEEF MAG, 1988, FEBS LETT, V237, P91, DOI 10.1016/0014-5793(88)80178-9; VANKLEEF MAG, 1989, APPL ENVIRON MICROB, V55, P1209, DOI 10.1128/AEM.55.5.1209-1213.1989; Vuilleumier S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005584; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wecksler SR, 2009, BIOCHEMISTRY-US, V48, P10151, DOI 10.1021/bi900918b; Wei QE, 2016, J BIOL CHEM, V291, P15575, DOI 10.1074/jbc.M115.711226; Zhang M, 2003, MICROBIOL-SGM, V149, P1033, DOI 10.1099/mic.0.26105-0	69	11	12	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2019	294	41					15025	15036		10.1074/jbc.RA119.009684	http://dx.doi.org/10.1074/jbc.RA119.009684			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9JH	31427437	Green Published, hybrid			2022-12-26	WOS:000499253400016
J	Schmuck, B; Gudmundsson, M; Hard, T; Sandgren, M				Schmuck, Benjamin; Gudmundsson, Mikael; Hard, Torleif; Sandgren, Mats			Coupled chemistry kinetics demonstrate the utility of functionalized Sup35 amyloid nanofibrils in biocatalytic cascades	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; enzyme kinetics; fusion protein; protein aggregation; protein chimera; protein engineering; aldose sugar dehydrogenase; beta-xylosidase; protein nanofibrils; xylan; xylanase	BETA-XYLOSIDASE; ENZYME CASCADE; IMMOBILIZATION; ACID; DEGRADATION; SENSITIVITY; HYDROLYSIS; EXPRESSION; STRATEGIES; XYLANASES	Concerns over the environment are a central driver for designing cell-free enzymatic cascade reactions that synthesize non?petrol-based commodity compounds. An often-suggested strategy that would demonstrate the economic competitiveness of this technology is recycling of valuable enzymes through their immobilization. For this purpose, amyloid nanofibrils are an ideal scaffold to realize chemistry-free covalent enzyme immobilization on a material that offers a large surface area. However, in most instances, only single enzyme?functionalized amyloid fibrils have so far been studied. To embark on the next stage, here we displayed xylanase A, ?-xylosidase, and an aldose sugar dehydrogenase on Sup35(1?61) nanofibrils to convert beechwood xylan to xylonolactone. We characterized this enzymatic cascade by measuring the time-dependent accumulation of xylose, xylooligomers, and xylonolactone. Furthermore, we studied the effects of relative enzyme concentrations, pH, temperature, and agitation on product formation. Our investigations revealed that a modular cascade with a mixture of xylanase and ?-xylosidase, followed by product removal and separate oxidation of xylose with the aldose sugar dehydrogenase, is more productive than an enzyme mix containing all of these enzymes together. Moreover, we found that the nanofibril-coupled enzymes do not lose activity compared with their native state. These findings provide proof of concept of the feasibility of functionalized Sup35(1?61) fibrils as a molecular scaffold for biocatalytic cascades consisting of reusable enzymes that can be used in biotechnology.	[Schmuck, Benjamin; Gudmundsson, Mikael; Hard, Torleif; Sandgren, Mats] Swedish Univ Agr Sci, Dept Mol Sci, Box 7015, S-75007 Uppsala, Sweden	Swedish University of Agricultural Sciences	Sandgren, M (corresponding author), Swedish Univ Agr Sci, Dept Mol Sci, Box 7015, S-75007 Uppsala, Sweden.	mats.sandgren@slu.se		Sandgren, Mats/0000-0002-2358-4534; Schmuck, Benjamin/0000-0003-4021-6458; Hard, Torleif/0000-0001-9813-9913; Gudmundsson, Mikael/0000-0002-8095-4423	Swedish Research Council Formas [942-2015-945]	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	This work was supported by Swedish Research Council Formas Grant 942-2015-945 (to M. S. and T. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Artzi L, 2017, NAT REV MICROBIOL, V15, P83, DOI 10.1038/nrmicro.2016.164; Bajpai P, 2014, XYLANOLYTIC ENZYMES, P9; Banka AL, 2014, APPL BIOCHEM BIOTECH, V174, P2702, DOI 10.1007/s12010-014-1219-1; Bardsley W. G., 1993, MODERN TRENDS BIOTHE; Baxa U, 2003, J BIOL CHEM, V278, P43717, DOI 10.1074/jbc.M306004200; Baxa U, 2002, P NATL ACAD SCI USA, V99, P5253, DOI 10.1073/pnas.082097899; Biely P, 2016, BIOTECHNOL ADV, V34, P1260, DOI 10.1016/j.biotechadv.2016.09.001; Bourgois TM, 2007, J BIOTECHNOL, V130, P95, DOI 10.1016/j.jbiotec.2007.02.011; Cao YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067305; Chen AH, 2012, TRENDS CELL BIOL, V22, P662, DOI 10.1016/j.tcb.2012.07.002; Correa JM, 2012, APPL BIOCHEM BIOTECH, V168, P2218, DOI 10.1007/s12010-012-9931-1; DiCosimo R, 2013, CHEM SOC REV, V42, P6437, DOI 10.1039/c3cs35506c; Dou TY, 2019, ARCH MICROBIOL, V201, P163, DOI 10.1007/s00203-018-1606-z; Dudley QM, 2015, BIOTECHNOL J, V10, P69, DOI 10.1002/biot.201400330; Eckhard U, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00599-0; Fu JL, 2012, J AM CHEM SOC, V134, P5516, DOI 10.1021/ja300897h; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Hilpmann G, 2016, CATAL TODAY, V259, P376, DOI 10.1016/j.cattod.2015.04.044; Hodgman CE, 2012, METAB ENG, V14, P261, DOI 10.1016/j.ymben.2011.09.002; Jia F, 2014, BIOTECHNOL BIOENG, V111, P209, DOI 10.1002/bit.25136; Jiang ZQ, 2006, J BIOTECHNOL, V126, P304, DOI 10.1016/j.jbiotec.2006.05.006; Juturu V, 2012, BIOTECHNOL ADV, V30, P1219, DOI 10.1016/j.biotechadv.2011.11.006; Knowles TPJ, 2011, NAT NANOTECHNOL, V6, P469, DOI [10.1038/nnano.2011.102, 10.1038/NNANO.2011.102]; Korman TP, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15526; Kumar R, 2008, J IND MICROBIOL BIOT, V35, P377, DOI 10.1007/s10295-008-0327-8; Lee CC, 2017, J MICROBIOL BIOTECHN, V27, P77, DOI 10.4014/jmb.1606.06041; Liang H, 2016, NANOSCALE, V8, P6071, DOI 10.1039/c5nr08734a; Linares-Pasten JA, 2018, CURR PROTEIN PEPT SC, V19, P48, DOI 10.2174/1389203717666160923155209; Malgas S, 2017, ENZYME MICROB TECH, V103, P1, DOI 10.1016/j.enzmictec.2017.04.007; McCleary BV, 2015, APPL BIOCHEM BIOTECH, V177, P1152, DOI 10.1007/s12010-015-1803-z; McClendon SD, 2012, APPL BIOCHEM BIOTECH, V167, P395, DOI 10.1007/s12010-012-9680-1; McKenna SM, 2015, GREEN CHEM, V17, P3271, DOI 10.1039/c5gc00707k; Men D, 2009, NANO LETT, V9, P2246, DOI 10.1021/nl9003464; Mohite BV, 2016, NEW AND FUTURE DEVELOPMENTS IN MICROBIAL BIOTECHNOLOGY AND BIOENGINEERING: MICROBIAL CELLULASE SYSTEM PROPERTIES AND APPLICATIONS, P31, DOI 10.1016/B978-0-444-63507-5.00004-6; Nussbaumer MG, 2017, CHEMCATCHEM, V9, P4328, DOI 10.1002/cctc.201701221; POUTANEN K, 1988, APPL MICROBIOL BIOT, V28, P425, DOI 10.1007/BF00268208; Qing Q, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-18; Raynes JK, 2011, BIOTECHNOL PROGR, V27, P360, DOI 10.1002/btpr.518; Schmuck B, 2018, ACS NANO, V12, P9363, DOI 10.1021/acsnano.8b04450; Schmuck B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196250; Schmuck B, 2017, BIOTECHNOL J, V12, DOI 10.1002/biot.201600672; Scism RA, 2010, CHEMBIOCHEM, V11, P67, DOI 10.1002/cbic.200900620; Singh RK, 2013, INT J MOL SCI, V14, P1232, DOI 10.3390/ijms14011232; Sirisha VL, 2016, ADV FOOD NUTR RES, V79, P179, DOI 10.1016/bs.afnr.2016.07.004; Southall SM, 2006, J BIOL CHEM, V281, P30650, DOI 10.1074/jbc.M601783200; Tiwari R, 2018, CRIT REV MICROBIOL, V44, P244, DOI [10.1080/1040841x.2017.1337713, 10.1080/1040841X.2017.1337713]; Toivari MH, 2012, APPL MICROBIOL BIOT, V96, P1, DOI 10.1007/s00253-012-4288-5; van Dongen SFM, 2009, CHEM-EUR J, V15, P1107, DOI 10.1002/chem.200802114; Wang YY, 2018, J MOL BIOL, V430, P3720, DOI 10.1016/j.jmb.2018.04.012; Yang XZ, 2014, FOOD CHEM, V148, P381, DOI 10.1016/j.foodchem.2013.10.062; Yu Y, 2011, BIOCHEM J, V434, P143, DOI 10.1042/BJ20101895; Zamora F, 2000, MACROMOLECULES, V33, P2030, DOI 10.1021/ma9916436; Zhou XM, 2015, ACS NANO, V9, P5772, DOI 10.1021/acsnano.5b00061; Zhou XM, 2014, CHEMCATCHEM, V6, P1961, DOI 10.1002/cctc.201402125	54	0	1	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2019	294	41					14966	14977		10.1074/jbc.RA119.008455	http://dx.doi.org/10.1074/jbc.RA119.008455			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9JH	31416835	Green Published, hybrid			2022-12-26	WOS:000499253400011
J	Wang, J; Li, N; Huang, ZB; Fu, S; Yu, SM; Fu, YM; Zhou, PC; Chen, RC; Zhou, RR; Huang, Y; Hu, XW; Fan, XG				Wang, Juan; Li, Ning; Huang, Ze-Bing; Fu, Sha; Yu, Song-Man; Fu, Yong-Ming; Zhou, Peng-Cheng; Chen, Ruo-Chan; Zhou, Rong-Rong; Huang, Yan; Hu, Xing-Wang; Fan, Xue-Gong			HBx regulates transcription factor PAX8 stabilization to promote the progression of hepatocellular carcinoma	ONCOGENE			English	Article							VIRUS X PROTEIN; AURORA KINASE; UBIQUITIN; DEGRADATION; SKP2; MYC; PHOSPHORYLATION; INHIBITION; EXPRESSION; STABILITY	Transcription factor PAX8 expression is upregulated in several types of cancers. However, little is known about the function of PAX8 in the progression of hepatoma and its regulatory mechanisms. Here, we show that PAX8 silencing inhibits the proliferation and clonogenicity of hepatoma cells and its growth in vivo. The HBV X protein (HBx) does not directly interacts, but stabilizes PAX8 by inhibiting proteasome-dependent ubiquitination and degradation. Furthermore, the E3 ubiquitin ligase complex component Skp2 through its LRR domain directly interacts with the Prd domain of PAX8 and targets PAX8 by recognizing its lysine 275 for ubiquitination and degradation in hepatoma cells. In addition, HBx directly interacts and is colocalized with Skp2 to inhibit its recognition and subsequent ubiquitination and degradation of PAX8 in hepatoma cells. Moreover, HBx upregulates the expression and phosphorylation of Aurora A, a serine-threonine kinase, which interacts with and phosphorylates PAX8 at S209 and T277, compromising the Skp2-recognized PAX8 ubiquitination and destabilization. Thus, HBx stabilizes PAX8 protein by inhibiting the Skp2 targeted PAX8 ubiquitination and enhancing the Aurora A-mediated its phosphorylation, contributing to the progression of hepatoma. Our findings suggest that PAX8 may a new target for design of therapies and uncover new insights into the pathogenesis of hepatoma.	[Wang, Juan; Huang, Ze-Bing; Fu, Sha; Yu, Song-Man; Fu, Yong-Ming; Zhou, Peng-Cheng; Chen, Ruo-Chan; Zhou, Rong-Rong; Huang, Yan; Hu, Xing-Wang; Fan, Xue-Gong] Cent S Univ, Xiangya Hosp, Dept Infect Dis, Changsha, Hunan, Peoples R China; [Wang, Juan; Huang, Ze-Bing; Fu, Sha; Yu, Song-Man; Fu, Yong-Ming; Zhou, Peng-Cheng; Chen, Ruo-Chan; Zhou, Rong-Rong; Huang, Yan; Hu, Xing-Wang; Fan, Xue-Gong] Key Lab Viral Hepatitis, Changsha, Hunan, Peoples R China; [Li, Ning] Cent S Univ, Xiangya Hosp, Dept Blood Transfus, Changsha, Hunan, Peoples R China	Central South University; Central South University	Hu, XW; Fan, XG (corresponding author), Cent S Univ, Xiangya Hosp, Dept Infect Dis, Changsha, Hunan, Peoples R China.; Hu, XW; Fan, XG (corresponding author), Key Lab Viral Hepatitis, Changsha, Hunan, Peoples R China.	lebithu@csu.edu.cn; xgfan@hotmail.com	Hu, Xingwang/ABG-6400-2021	Fu, Sha/0000-0001-7465-4929	International Scientific and Technology Cooperation Program of China [2015DFA31490]; National Natural Sciences Foundation of China [81700561, 81873574, 81402623]; National Science and Technology Major Project of China [2017YFC0908104, 2018ZX10732202]; Independent Exploration and Innovation Project of Graduate Student of Central South University [2016zzts519]	International Scientific and Technology Cooperation Program of China; National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of China; Independent Exploration and Innovation Project of Graduate Student of Central South University	This work was supported by grant from International Scientific and Technology Cooperation Program of China (2015DFA31490), grant from National Natural Sciences Foundation of China (No. 81700561, No. 81873574, No. 81402623), the National Science and Technology Major Project of China (2017YFC0908104, 2018ZX10732202) and Independent Exploration and Innovation Project of Graduate Student of Central South University (No. 2016zzts519).	Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brockmann M, 2016, CANCER CELL, V30, P357, DOI 10.1016/j.ccell.2016.07.002; Campagnolo M, 2007, J BIOMOL STRUCT DYN, V24, P429, DOI 10.1080/07391102.2007.10507131; Chai HJ, 2017, ONCOL LETT, V14, P5871, DOI 10.3892/ol.2017.6949; Chen L, 2014, KAOHSIUNG J MED SCI, V30, P181, DOI 10.1016/j.kjms.2013.07.002; Chen RC, 2017, WORLD J GASTROENTERO, V23, P1787, DOI 10.3748/wjg.v23.i10.1787; de Cristofaro T, 2009, J MOL ENDOCRINOL, V42, P35, DOI 10.1677/JME-08-0100; Decorsiere A, 2016, NATURE, V531, P386, DOI 10.1038/nature17170; Delogu S, 2015, ONCOTARGET, V6, P2222, DOI 10.18632/oncotarget.2945; Di Palma T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.262; Ding FB, 2014, FRONT BIOSCI-LANDMRK, V19, P886, DOI 10.2741/4254; Gao Y, 2017, HEPATOLOGY, V66, P1413, DOI 10.1002/hep.29316; Ghannam-Shahbari D, 2018, ONCOGENE, V37, P2213, DOI 10.1038/s41388-017-0040-z; Gong J, 2018, ONCOL LETT, V15, P8891, DOI 10.3892/ol.2018.8500; Hoeck JD, 2010, NAT NEUROSCI, V13, P1365, DOI 10.1038/nn.2644; Hou DS, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0823-3; Hung N, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-159; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Jacobsen A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24982-z; Jamal A, 2015, CELL CYCLE, V14, P2688, DOI 10.1080/15384101.2015.1056946; Kalra N, 2006, FEBS LETT, V580, P431, DOI 10.1016/j.febslet.2005.12.034; Katayama H, 2004, NAT GENET, V36, P55, DOI 10.1038/ng1279; Kivinummi K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18210-3; Lee S, 2016, ONCOGENE, V35, P1857, DOI 10.1038/onc.2015.251; Levrero M, 2016, J HEPATOL, V64, pS84, DOI 10.1016/j.jhep.2016.02.021; Li CG, 2011, ONCOGENE, V30, P4824, DOI 10.1038/onc.2011.190; Li J, 2017, ONCOTARGET, V8, P96027, DOI 10.18632/oncotarget.21630; Lin GY, 1998, VIROLOGY, V249, P189, DOI 10.1006/viro.1998.9317; Liu XJ, 2015, BIOCHEM BIOPH RES CO, V459, P214, DOI 10.1016/j.bbrc.2015.02.060; Liu ZG, 2017, EUR J CELL BIOL, V96, P695, DOI 10.1016/j.ejcb.2017.07.004; Llovet JM, 2018, NAT REV CLIN ONCOL, V15, P599, DOI 10.1038/s41571-018-0073-4; Lu LF, 2015, MOL CARCINOGEN, V54, P1467, DOI 10.1002/mc.22223; Ma SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173700; Mattiroli F, 2014, NAT STRUCT MOL BIOL, V21, P308, DOI 10.1038/nsmb.2792; Minor MM, 2014, VIRUSES-BASEL, V6, P4683, DOI 10.3390/v6114683; Murphy CM, 2016, CELL REP, V16, P2846, DOI 10.1016/j.celrep.2016.08.026; Nandi D, 2006, J BIOSCIENCES, V31, P137, DOI 10.1007/BF02705243; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; POLEEV A, 1992, DEVELOPMENT, V116, P611; Suzuki A, 2015, ENDOCR J, V62, P991, DOI 10.1507/endocrj.EJ15-0226; Varshavsky A, 2017, ANNU REV BIOCHEM, V86, P123, DOI 10.1146/annurev-biochem-061516-044859; VerPlank JJS, 2017, BIOCHEM J, V474, P3355, DOI 10.1042/BCJ20160809; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wang J, 2016, GASTROENT RES PRACT, V2016, DOI 10.1155/2016/8780695; Wang LY, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0830-3; Wang ZW, 2012, BBA-REV CANCER, V1825, P11, DOI 10.1016/j.bbcan.2011.09.002; Xu QD, 2019, ONCOL RES, V27, P509, DOI 10.3727/096504018X15278771272963; ZANNINI M, 1992, MOL CELL BIOL, V12, P4230, DOI 10.1128/MCB.12.9.4230; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	49	10	11	2	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 3	2019	38	40					6696	6710		10.1038/s41388-019-0907-2	http://dx.doi.org/10.1038/s41388-019-0907-2			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JC0EY	31391550	hybrid			2022-12-26	WOS:000488953500004
J	Nikonorova, IA; Zhu, QQ; Signore, CC; Mirek, ET; Jonsson, WO; Kong, B; Guo, GL; Belden, WJ; Anthony, TG				Nikonorova, Inna A.; Zhu, Qiaoqiao; Signore, Christina C.; Mirek, Emily T.; Jonsson, William O.; Kong, Bo; Guo, Grace L.; Belden, William J.; Anthony, Tracy G.			Age modulates liver responses to asparaginase-induced amino acid stress in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						eukaryotic initiation factor 2 (eIF2); amino acid; triglyceride; mRNA; development; age-dependent response; asparaginase; hepatic metabolism; integrated stress response; integrated stress response (ISR)	TRANSCRIPTIONAL ACTIVATION; GENE-EXPRESSION; KINASE GCN2; ATF4; DEPRIVATION; METABOLISM; TOXICITY; CHILDREN; TRB3	Asparaginase is an amino acid-depleting agent used to treat blood cancers. Metabolic complications due to asparaginase affect liver function in humans. To examine how the liver response to asparaginase changes during maturity to adulthood, here we treated juvenile (2-week), young adult (8-week), and mature adult (16-week) mice with drug or excipient for 1 week and conducted RNA-Seq and functional analyses. Asparaginase reduced body growth and liver mass in juveniles but not in the adult animals. Unbiased exploration of the effect of asparaginase on the liver transcriptome revealed that the integrated stress response (ISR) was the only molecular signature shared across the ages, corroborating similar eukaryotic initiation factor 2 phosphorylation responses to asparaginase at all ages. Juvenile livers exhibited steatosis and iron accumulation following asparaginase exposure along with a hepatic gene signature indicating that asparaginase uniquely affects lipid, cholesterol, and iron metabolism in juvenile mice. In contrast, asparaginase-treated adult mice displayed greater variability in liver function, which correlated with an acute-phase inflammatory response gene signature. Asparaginase-exposed adults also had a serine/glycine/one-carbon metabolism gene signature in liver that corresponded with reduced circulating glycine and serine levels. These results establish the ISR as a conserved response to asparaginase-mediated amino acid deprivation and provide new insights into the relationship between the liver transcriptome and hepatic function upon asparaginase exposure.	[Nikonorova, Inna A.; Signore, Christina C.; Mirek, Emily T.; Jonsson, William O.; Anthony, Tracy G.] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA; [Zhu, Qiaoqiao; Belden, William J.] Rutgers State Univ, Dept Anim Sci, New Brunswick, NJ 08901 USA; [Kong, Bo; Guo, Grace L.] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmacol & Toxicol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Anthony, TG (corresponding author), Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA.	tracy.anthony@rutgers.edu	; Anthony, Tracy/K-7951-2017	Belden, William/0000-0003-2400-5028; Jonsson, William/0000-0002-3921-8301; Nikonorova, Inna/0000-0001-8498-848X; Mirek, Emily/0000-0002-9683-8216; Anthony, Tracy/0000-0002-8586-5884	National Institutes of Health [HD070487, DK109714, K12GM093854, R21ES028258]; China Scholarship Council [201406270118]; National Institute of Food and Agriculture [NE1439];  [VA-BX002741]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK109714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM093854] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002741] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grants HD070487 (to T. G. A.), DK109714 (to T. G. A.), K12GM093854 (to I. A. N.), R21ES028258 (to G. L. G.), China Scholarship Council grant 201406270118 (Q. Z.), VA-BX002741 (to G. L. G.) and National Institute of Food and Agriculture Grant NE1439 (to W. J. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Baghdadi RJT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01041-7; Averous J, 2011, BIOCHEM BIOPH RES CO, V413, P24, DOI 10.1016/j.bbrc.2011.08.028; Ben Tanfous M, 2015, CLIN CANCER RES, V21, P329, DOI 10.1158/1078-0432.CCR-14-0508; Ben-Sahra I, 2016, SCIENCE, V351, P728, DOI 10.1126/science.aad0489; Boissel N, 2015, J ADOLESC YOUNG ADUL, V4, P118, DOI 10.1089/jayao.2015.0014; BOLLA RI, 1980, MECH AGEING DEV, V12, P107, DOI 10.1016/0047-6374(80)90087-1; Braoudaki M, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-52; Bunpo P, 2010, J NUTR, V140, P2020, DOI 10.3945/jn.110.129197; Bunpo P, 2009, J BIOL CHEM, V284, P32742, DOI 10.1074/jbc.M109.047910; Caballero-Molada M, 2018, BIOCHEM J, V475, P1523, DOI 10.1042/BCJ20170871; Carraro V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015716; Christ TN, 2018, J ONCOL PHARM PRACT, V24, P299, DOI 10.1177/1078155217701291; Conesa A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0881-8; Dreesen O, 2013, NUCLEUS-AUSTIN, V4, P283, DOI 10.4161/nucl.25808; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Evstafieva AG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191107; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; Fu ZD, 2012, DRUG METAB DISPOS, V40, P1216, DOI 10.1124/dmd.111.044461; Hedayati M, 2018, INT J HYPERTHER, V34, P373, DOI 10.1080/02656736.2017.1354403; Hijiya N, 2016, LEUKEMIA LYMPHOMA, V57, P748, DOI 10.3109/10428194.2015.1101098; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jin HO, 2009, IUBMB LIFE, V61, P1153, DOI 10.1002/iub.271; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; Kim BT, 2001, P NATL ACAD SCI USA, V98, P7176, DOI 10.1073/pnas.131188498; KIMBALL SR, 1992, BIOCHEM J, V286, P263, DOI 10.1042/bj2860263; Kobayashi M, 2017, HAEMATOLOGICA, V102, P454, DOI 10.3324/haematol.2016.151043; Koufaris C, 2018, CANCER METAB, V6, DOI 10.1186/s40170-018-0185-4; Kwekel JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-675; Liu ZM, 2014, MOL CELL BIOL, V34, P2533, DOI 10.1128/MCB.00231-14; Lomelino CL, 2017, J BIOL CHEM, V292, P19952, DOI 10.1074/jbc.R117.819060; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maida A, 2016, J CLIN INVEST, V126, P3263, DOI 10.1172/JCI85946; Nikonorova IA, 2018, J BIOL CHEM, V293, P5005, DOI 10.1074/jbc.RA117.001625; Nikonorova IA, 2017, J BIOL CHEM, V292, P6786, DOI [10.1074/jbc.m116.768408, 10.1074/jbc.M116.768408]; Ord D, 2003, EXP CELL RES, V286, P308, DOI 10.1016/S0014-4827(03)00070-3; Orgel E, 2014, J CLIN ONCOL, V32, P1331, DOI 10.1200/JCO.2013.52.6962; Pedley AM, 2017, TRENDS BIOCHEM SCI, V42, P141, DOI 10.1016/j.tibs.2016.09.009; Phillipson-Weiner L, 2016, AM J PHYSIOL-GASTR L, V310, pG1061, DOI 10.1152/ajpgi.00052.2016; Reinert RB, 2006, J BIOL CHEM, V281, P31222, DOI 10.1074/jbc.M604511200; SCHIELE F, 1983, CLIN CHEM, V29, P634; Schmidt PJ, 2015, J BIOL CHEM, V290, P18975, DOI 10.1074/jbc.R115.650150; Sikalidis AK, 2011, AMINO ACIDS, V41, P159, DOI 10.1007/s00726-010-0571-x; Somel M, 2006, CURR BIOL, V16, pR359, DOI 10.1016/j.cub.2006.04.024; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; White RR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2061-8; Wilson GJ, 2015, AM J PHYSIOL-ENDOC M, V308, pE283, DOI 10.1152/ajpendo.00361.2014; Wilson GJ, 2013, AM J PHYSIOL-ENDOC M, V305, pE1124, DOI 10.1152/ajpendo.00080.2013; Xu JZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002865; Yu Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4230; Zughaier SM, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/140728	50	3	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2019	294	38					13864	13875		10.1074/jbc.RA119.009864	http://dx.doi.org/10.1074/jbc.RA119.009864			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JE5JX	31413113	Green Published, hybrid			2022-12-26	WOS:000490729800002
J	de Castilho, ARF; Rosalen, PL; Araujo, IJD; Kitagawa, IL; Costa, CAGD; Janal, MN; Alves, MC; Duarte, S; Lisboa, PN; Stipp, RN; Puppin-Rontani, RM				Freire de Castilho, Aline Rogeria; Rosalen, Pedro Luiz; de Souza Araujo, Isaac Jordao; Kitagawa, Igor Lebedenco; Goncalves de Araujo Costa, Cecilia Atem; Janal, Malvin N.; Alves, Marcelo Correa; Duarte, Simone; Lisboa Filho, Paulo Noronha; Stipp, Rafael Nobrega; Puppin-Rontani, Regina Maria			Trans, trans-farnesol, an antimicrobial natural compound, improves glass ionomer cement properties	PLOS ONE			English	Article							STREPTOCOCCUS-MUTANS; IN-VITRO; PROPOLIS; VIRULENCE	A series of experiments were conducted to characterize a novel restorative material. We explored the effect on biological, physical and chemical properties of glass ionomer cement (GIC) adding-the naturally occurring tt-farnesol (900 mM). Two groups were accomplished for all assays: GIC+tt-farnesol and GIC (control). Biological assays: 1) agar diffusion against some cariogenic bacteria; 2) S. mutans biofilm formation and confocal laser scanning microscopy-CLSM. 3) gtfB, gtfC, gtfD, gbpB, vicR, and covR expression; 4) MTT and microscopic morphology. Physical properties assays: 1) roughness; 2) hardness; 3) compressive strength and 4) diametral tensile strength. Chemical assay: Raman spectroscopy. The adding of tt-farnesol to GIC led to larger zones of inhibition (p<0.05), biofilms with a short-term reduction in bacterial viability but similar biomass (p>0.05). Polysaccharides levels increased over time, similarly over groups (p>0.05). Viable and non-viable S. mutans were seen on the specimens' surface by CLSM but their virulence was not modulated by tt-farnesol. The tt-farnesol increased the HaCaT cell viability without impact on compressive and diametral tensile strength and roughness although the hardness was positively affected (p<0.05). Raman confirmed the presence of tt-farnesol. The incorporation of tt-farnesol into GIC inhibited the growth of cariogenic bacteria but had a little effect on the composition, structure and physiology of the biofilm matrices. Also, the tt-farnesol increased the hardness and the biocompatibility of the GIC, not influencing negatively other physical properties of the restorative material.	[Freire de Castilho, Aline Rogeria; Puppin-Rontani, Regina Maria] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Pediat Dent, Piracicaba, SP, Brazil; [Rosalen, Pedro Luiz] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Physiol Sci, Piracicaba, SP, Brazil; [de Souza Araujo, Isaac Jordao; Puppin-Rontani, Regina Maria] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Restorat Dent, Piracicaba, SP, Brazil; [Kitagawa, Igor Lebedenco; Lisboa Filho, Paulo Noronha] State Univ Sao Paulo, Sch Sci, Dept Phys, Bauru, SP, Brazil; [Goncalves de Araujo Costa, Cecilia Atem] Univ Fed Ceara, Dept Restorat Dent, Fortaleza, Ceara, Brazil; [Janal, Malvin N.] NYU, Coll Dent, Dept Epidemiol & Hlth Promot, New York, NY USA; [Alves, Marcelo Correa] Univ Sao Paulo, Super Sch Agr Luiz De Queiroz, Tech Sect Informat Technol, Piracicaba, SP, Brazil; [Duarte, Simone] Purdue Univ Indianapolis, Indiana Univ, Sch Dent, Dept Cariol Operat Dent & Dent Publ Hlth, Indianapolis, IN USA; [Stipp, Rafael Nobrega] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Oral Diag, Piracicaba, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual Paulista; Universidade Federal do Ceara; New York University; Universidade de Sao Paulo; Indiana University System; Indiana University-Purdue University Indianapolis; Purdue University System; Purdue University; Universidade Estadual de Campinas	Puppin-Rontani, RM (corresponding author), Univ Estadual Campinas, Piracicaba Dent Sch, Dept Pediat Dent, Piracicaba, SP, Brazil.; Puppin-Rontani, RM (corresponding author), Univ Estadual Campinas, Piracicaba Dent Sch, Dept Restorat Dent, Piracicaba, SP, Brazil.	rmpuppin@unicamp.br	Kitagawa, Igor Lebedenco/ABC-4249-2021; Castilho, Aline/H-4676-2012; Stipp, Rafael Nobrega/D-4518-2011; PUPPIN-RONTANI, REGINA/GVS-2045-2022; Janal, Malvin/AAA-2036-2020; PUPPIN-RONTANI, regina/AAM-9962-2020; PUPPIN-RONTANI, regina/C-3994-2012; de Souza Araújo, Isaac Jordao/P-6068-2017; Duarte, Simone/Y-2496-2019; Alves, Marcelo/A-5270-2019	Castilho, Aline/0000-0003-4704-6973; Stipp, Rafael Nobrega/0000-0001-5305-1299; PUPPIN-RONTANI, regina/0000-0002-1218-5159; PUPPIN-RONTANI, regina/0000-0002-1218-5159; de Souza Araújo, Isaac Jordao/0000-0002-1795-8640; Duarte, Simone/0000-0002-4744-4026; Alves, Marcelo/0000-0002-3463-2642	Sao Paulo Research Foundation-FAPESP [2014/01723-9, 2015/08871-6]; National Council for Scientific and Technological Development-CNPq [443036/2014-4, 310522/2015-3, 312868/2017-0]	Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by two scholarships from Sao Paulo Research Foundation-FAPESP (2014/01723-9 and 2015/08871-6; https://bv.fapesp.br/en/pesquisador/62128/aline-rogeria-freire-de-castilho/) to the first author (ARFdC) and grants from the National Council for Scientific and Technological Development-CNPq (443036/2014-4 to ARFdC; 310522/2015-3 to PLR; 312868/2017-0 to RMPR; http://www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi AJ, 2018, ETHIOP J HEALTH SCI, V28, P505, DOI 10.4314/ejhs.v28i4.16; Abou Neel EA, 2016, INT J NANOMED, V11, P4743, DOI 10.2147/IJN.S107624; American Academy of Pediatric Dentistry, 2016, REFERENCE MANUAL, V40, P18; Andre CB, 2017, DENT MATER, V33, P1084, DOI [10.1016/j.dental.7017.07.006, 10.1016/j.dental.2017.07.006]; Bayrak GD, 2017, J ESTHET RESTOR DENT, V29, P424, DOI 10.1111/jerd.12313; Bowen WH, 2018, TRENDS MICROBIOL, V26, P229, DOI 10.1016/j.tim.2017.09.008; Ca L, 2017, J BIOMED RES, V31, P333, DOI 10.7555/JBR.31.20150151; Pedraza MCC, 2017, BIOFOULING, V33, P722, DOI 10.1080/08927014.2017.1361412; Dainezi VB, 2017, J APPL ORAL SCI, V25, P101, DOI 10.1590/1678-77572016-0053; de Castilho ARF, 2012, ARCH ORAL BIOL, V57, P131, DOI 10.1016/j.archoralbio.2011.08.009; de Sousa DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131941; Araujo IJD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195244; Duque C, 2017, J APPL ORAL SCI, V25, P541, DOI 10.1590/1678-7757-2016-0195; Faustova Mariia O, 2018, Wiad Lek, V71, P378; de Castilho ARF, 2018, J APPL ORAL SCI, V26, DOI 10.1590/1678-7757-2017-0116; de Castilho ARF, 2013, J DENT, V41, P155, DOI 10.1016/j.jdent.2012.10.014; Freires IA, 2016, PHARM RES-DORDR, V33, P1311, DOI 10.1007/s11095-016-1905-5; Hu JQ, 2013, J DENT, V41, P927, DOI 10.1016/j.jdent.2013.07.014; Jeon JG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-228; Koo H, 2008, Adv Dent Res, V20, P17; Krzysciak W, 2014, EUR J CLIN MICROBIOL, V33, P499, DOI 10.1007/s10096-013-1993-7; Lagerweij M D, 2015, Curr Oral Health Rep, V2, P212; Liberio SA, 2009, J ETHNOPHARMACOL, V125, P1, DOI 10.1016/j.jep.2009.04.047; Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055; Troca VBPB, 2011, J APPL ORAL SCI, V19, P100, DOI 10.1590/S1678-77572011000200004; Pitts NB, 2017, NAT REV DIS PRIMERS, V3, P1, DOI 10.1038/nrdp.2017.30; Rocha GR, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2132-x; Sidhu SK, 2016, J FUNCT BIOMATER, V7, DOI 10.3390/jfb7030016; Stipp RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058271; Takahashi N, 2011, J DENT RES, V90, P294, DOI 10.1177/0022034510379602; Wang SP, 2016, INT J ORAL SCI, V8, P76, DOI 10.1038/ijos.2015.55; Weber K, 2014, FEMS MICROBIOL LETT, V350, P175, DOI 10.1111/1574-6968.12334	32	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0220718	10.1371/journal.pone.0220718	http://dx.doi.org/10.1371/journal.pone.0220718			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430298	Green Published, gold, Green Submitted			2022-12-26	WOS:000485026800012
J	Corral, A; Serra, I				Corral, Alvaro; Serra, Isabel			Time window to constrain the corner value of the global seismic-moment distribution	PLOS ONE			English	Article							POWER-LAW; SIZE DISTRIBUTION; EARTHQUAKE; CONVERGENCE; RELEASE; FORM	It is well accepted that, at the global scale, the Gutenberg-Richter (GR) law describing the distribution of earthquake magnitude or seismic moment has to be modified at the tail to properly account for the most extreme events. It is debated, though, how much additional time of earthquake recording will be necessary to properly constrain this tail. Using the global CMT catalog, we study how three modifications of the GR law that incorporate a corner-value parameter are compatible with the size of the largest observed earthquake in a given time window. Current data lead to a rather large range of parameter values (e.g., corner magnitude from 8.6 to 10.2 for the so-called tapered GR distribution). Updating this estimation in the future will strongly depend on the maximum magnitude observed, but, under reasonable assumptions, the range will be substantially reduced by the end of this century, contrary to claims in previous literature.	[Corral, Alvaro; Serra, Isabel] Ctr Recerca Matemat, Edifici C,Campus Bellaterra, Barcelona, Spain; [Corral, Alvaro] Univ Autonoma Barcelona, Dept Matemat, Fac Ciencies, Barcelona, Spain; [Corral, Alvaro] Barcelona Grad Sch Math, Edifici C,Campus Bellaterra, Barcelona, Spain; [Corral, Alvaro] Complex Sci Hub Vienna, Josefstadter Str 39, Vienna, Austria	Centre de Recerca Matematica (CRM); Autonomous University of Barcelona	Corral, A (corresponding author), Ctr Recerca Matemat, Edifici C,Campus Bellaterra, Barcelona, Spain.; Corral, A (corresponding author), Univ Autonoma Barcelona, Dept Matemat, Fac Ciencies, Barcelona, Spain.; Corral, A (corresponding author), Barcelona Grad Sch Math, Edifici C,Campus Bellaterra, Barcelona, Spain.; Corral, A (corresponding author), Complex Sci Hub Vienna, Josefstadter Str 39, Vienna, Austria.	alvaro.corral@uab.es	serra, isabel/AAE-1146-2022; Serra, Isabel/AAE-1120-2022; Corral, Alvaro/I-5590-2015	Serra, Isabel/0000-0002-2465-8574; Corral, Alvaro/0000-0002-5280-2692	"La Caixa" Foundation [FIS2015-71851-P, FIS-PGC2018-099629B-I00, MAT2015-69777-REDT, MDM-2014-0445]; Spanish Ministry of Economy and Competitiveness (MINECO, Spain) [FIS2015-71851-P, FIS-PGC2018-099629B-I00, MAT2015-69777-REDT, MDM-2014-0445]	"La Caixa" Foundation(La Caixa Foundation); Spanish Ministry of Economy and Competitiveness (MINECO, Spain)	This work was supported by "La Caixa" Foundation and the Spanish Ministry of Economy and Competitiveness (MINECO, Spain), through Grants FIS2015-71851-P, FIS-PGC2018-099629B-I00, "Proyecto Redes de Excelencia" Grant No. MAT2015-69777-REDT and the "Maria de Maeztu" Programme for Units of Excellence in R&D (Grant No. MDM-2014-0445). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell AF, 2013, GEOPHYS RES LETT, V40, P2585, DOI 10.1002/grl.50416; Ben-Zion Y, 2008, REV GEOPHYS, V46, DOI 10.1029/2008RG000260; Broderick T, 2007, 07122437 ARXIV; Coles S., 2001, INTRO STAT MODELING; Corless RM, 1996, ADV COMPUT MATH, V5, P329, DOI 10.1007/BF02124750; Corral A, 2006, LECT NOTES PHYS, V705, P191, DOI 10.1007/3-540-35375-5_8; Corral A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.108501; Corral A., 2013, SELF ORG CRITICALITY, P183; Corral A, 2015, CHAOS SOLITON FRACT, V74, P99, DOI 10.1016/j.chaos.2015.01.011; Deluca A, 2013, ACTA GEOPHYS, V61, P1351, DOI 10.2478/s11600-013-0154-9; DZIEWONSKI AM, 1981, J GEOPHYS RES, V86, P2825, DOI 10.1029/JB086iB04p02825; Ekstrom G, 2005, PHYS EARTH PLANET IN, V148, P327, DOI 10.1016/j.pepi.2004.09.006; Geist EL, 2014, NAT HAZARDS, V72, P565, DOI 10.1007/s11069-013-1024-0; Godano C, 2000, GEOPHYS J INT, V142, P193, DOI 10.1046/j.1365-246x.2000.00149.x; Kagan Y., 2014, EARTHQUAKES MODELS S; Kagan YY, 1999, PURE APPL GEOPHYS, V155, P537, DOI 10.1007/s000240050277; Kagan YY, 2002, GEOPHYS J INT, V148, P520, DOI 10.1046/j.1365-246x.2002.01594.x; Kagan YY, EARTHQUAKE SIZE DIST, V490, P103, DOI [10.1016/j.tecto.2010.04.034, DOI 10.1016/J.TECTO.2010.04.034]; Kanamori H, 2004, REP PROG PHYS, V67, P1429, DOI 10.1088/0034-4885/67/8/R03; KANAMORI H, 1977, J GEOPHYS RES, V82, P2981, DOI 10.1029/JB082i020p02981; LOMNITZADLER J, 1979, B SEISMOL SOC AM, V69, P1209; Main IG, 2008, NAT GEOSCI, V1, P142, DOI 10.1038/ngeo141; Morina D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38918-8; Mulargia F, 2003, EARTHQUAKE SCI SEISM; Mulargia F, 2017, PHYS EARTH PLANET IN, V264, P63, DOI 10.1016/j.pepi.2016.12.002; Ross S. M., 2010, 1 COURSE PROBABILITY; Satake K, 2007, ANNU REV EARTH PL SC, V35, P349, DOI 10.1146/annurev.earth.35.031306.140302; Serra I, 2017, SCI REP-UK, V7, DOI 10.1038/srep40045; Tsai VC, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023813; Utsu T, 1999, PURE APPL GEOPHYS, V155, P509, DOI 10.1007/s000240050276; Vere-Jones D, 2001, GEOPHYS J INT, V144, P517, DOI 10.1046/j.1365-246x.2001.01348.x; Zoller G, 2013, GEOPHYS RES LETT, V40, P3873, DOI 10.1002/grl.50779	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0220237	10.1371/journal.pone.0220237	http://dx.doi.org/10.1371/journal.pone.0220237			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5MK	31425542	Green Published, Green Submitted, gold			2022-12-26	WOS:000485022400011
J	Haug, I; Setaro, S; Suarez, JP				Haug, Ingeborg; Setaro, Sabrina; Pablo Suarez, Juan			Species composition of arbuscular mycorrhizal communities changes with elevation in the Andes of South Ecuador	PLOS ONE			English	Article							TROPICAL MONTANE FORESTS; MOLECULAR DIVERSITY; FUNGAL COMMUNITIES; PHOSPHORUS ADDITIONS; ATLANTIC FOREST; PLANT; GRADIENT; ABUNDANCE; NITROGEN; SOIL	Arbuscular mycorrhizal fungi (AMF) are the most prominent mycobionts of plants in the tropics, yet little is known about their diversity, species compositions and factors driving AMF distribution patterns. To investigate whether elevation and associated vegetation type affect species composition, we sampled 646 mycorrhizal samples in locations between 1000 and 4000 m above sea level (masl) in the South of Ecuador. We estimated diversity, distribution and species compositions of AMF by cloning and Sanger sequencing the 18S rDNA (the section between AML1 and AML2) and subsequent derivation of fungal OTUs based on 99% sequence similarity. In addition, we analyzed the phylogenetic structure of the sites by computing the mean pairwise distance (MPD) and the mean nearest taxon difference (MNTD) for each elevation level. It revealed that AMF species compositions at 1000 and 2000 masl differ from 3000 and 4000 masl. Lower elevations (1000 and 2000 masl) were dominated by members of Glomeraceae, whereas Acaulosporaceae were more abundant in higher elevations (3000 and 4000 masl). Ordination of OTUs with respect to study sites revealed a correlation to elevation with a continuous turnover of species from lower to higher elevations. Most of the abundant OTUs are not endemic to South Ecuador. We also found a high proportion of rare OTUs at all elevations: 79-85% of OTUs occurred in less than 5% of the samples. Phylogenetic community analysis indicated clustering and evenness for most elevation levels indicating that both, stochastic processes and habitat filtering are driving factors of AMF community compositions.	[Haug, Ingeborg] Eberhard Karls Univ Tubingen, Evolutionary Ecol Plants, Tubingen, Germany; [Setaro, Sabrina] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; [Pablo Suarez, Juan] Univ Tecn Particular Loja, Dept Ciencias Biol, Loja, Ecuador	Eberhard Karls University of Tubingen; Wake Forest University; Universidad Tecnica Particular de Loja	Haug, I (corresponding author), Eberhard Karls Univ Tubingen, Evolutionary Ecol Plants, Tubingen, Germany.	ingeborg.haug@uni-tuebingen.de	Suárez, Juan Pablo/AHB-9751-2022; Suárez, Juan Pablo/D-1839-2009	Suárez, Juan Pablo/0000-0002-9453-5545; Suárez, Juan Pablo/0000-0002-9453-5545	Deutsche Forschungsgemeinschaft [402, 816, PAK825]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was funded by the Deutsche Forschungsgemeinschaft (http://www.dfg.de) within the Research Units 402 and 816 and PAK825 to IH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	da Silva DKA, 2015, BIODIVERS CONSERV, V24, P2213, DOI 10.1007/s10531-015-0968-7; Arellano G, 2014, PLANT ECOL, V215, P39, DOI 10.1007/s11258-013-0277-8; Bachelot B, 2015, OECOLOGIA, V179, P853, DOI 10.1007/s00442-015-3402-7; Bonfim JA, 2016, MICROB ECOL, V71, P164, DOI 10.1007/s00248-015-0661-0; Camenzind T, 2016, SOIL BIOL BIOCHEM, V94, P37, DOI 10.1016/j.soilbio.2015.11.011; Camenzind T, 2014, GLOBAL CHANGE BIOL, V20, P3646, DOI 10.1111/gcb.12618; Colwell R.K., 2016, ESTIMATES STAT ESTIM; Crespo PJ, 2011, J HYDROL, V407, P164, DOI 10.1016/j.jhydrol.2011.07.021; De Beenhouwer M, 2015, AGRON SUSTAIN DEV, V35, P241, DOI 10.1007/s13593-014-0231-8; Dumbrell AJ, 2010, J ECOL, V98, P419, DOI 10.1111/j.1365-2745.2009.01622.x; Egan CP, 2017, MYCORRHIZA, V27, P273, DOI 10.1007/s00572-016-0752-x; Encinas-Viso F, 2016, OIKOS, V125, P457, DOI 10.1111/oik.02667; Gai JP, 2006, MYCORRHIZA, V16, P229, DOI 10.1007/s00572-005-0023-8; Gai JP, 2012, PEDOBIOLOGIA, V55, P145, DOI 10.1016/j.pedobi.2011.12.004; Gaston KJ, 2012, NATURE, V487, P46, DOI 10.1038/487046a; Geml J, 2014, MOL ECOL, V23, P2452, DOI 10.1111/mec.12765; Geoffroy A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01426; Goker M, 2010, EVOL BIOINFORM, V6, P97; Haug I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063524; Haug I, 2010, TROP ECOL, V51, P125; Homeier J., 2008, V198, P87; HOMEIER J, 2013, ECOSYSTEM SERVICES B, P315, DOI DOI 10.1007/978-3-642-38137-9_23; Homeier J., 2013, ECOL STUD, V221, P93, DOI DOI 10.1007/978-3-642-38137-9; Horn S, 2014, ISME J, V8, P2231, DOI 10.1038/ismej.2014.72; Husband R, 2002, MOL ECOL, V11, P2669, DOI 10.1046/j.1365-294X.2002.01647.x; Husband R, 2002, FEMS MICROBIOL ECOL, V42, P131, DOI 10.1111/j.1574-6941.2002.tb01002.x; Janos DP, 1996, FUNGI ENV CHANGE, P129, DOI DOI 10.1017/CBO9780511753190.011; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kiers ET, 2011, SCIENCE, V333, P880, DOI 10.1126/science.1208473; Kotilinek M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06938-x; Kottke I, 2004, J TROP ECOL, V20, P125, DOI 10.1017/S0266467403001020; Kottke I, 2008, BASIC APPL ECOL, V9, P13, DOI 10.1016/j.baae.2007.03.007; Leal PL, 2013, APPL SOIL ECOL, V71, P72, DOI 10.1016/j.apsoil.2013.05.010; Lee J, 2008, FEMS MICROBIOL ECOL, V65, P339, DOI 10.1111/j.1574-6941.2008.00531.x; Lekberg Y, 2016, FUNGAL ECOL, V24, P135, DOI 10.1016/j.funeco.2016.05.012; Lerat S, 2003, CAN J BOT, V81, P886, DOI [10.1139/b03-070, 10.1139/B03-070]; Lerat S, 2003, NEW PHYTOL, V157, P589, DOI 10.1046/j.1469-8137.2003.00691.x; Li XL, 2018, MYCORRHIZA, V28, P605, DOI 10.1007/s00572-018-0850-z; Li XL, 2015, ENVIRON MICROBIOL, V17, P2841, DOI 10.1111/1462-2920.12792; Li XL, 2014, MYCORRHIZA, V24, P95, DOI 10.1007/s00572-013-0518-7; Liu L, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv078; Looby CI, 2016, ECOL EVOL, V6, P1996, DOI 10.1002/ece3.2025; Lugo MA, 2008, MICROB ECOL, V55, P705, DOI 10.1007/s00248-007-9313-3; Maherali H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036695; Martinson GO, 2013, BIOGEOCHEMISTRY, V112, P625, DOI 10.1007/s10533-012-9753-9; Mi XC, 2012, AM NAT, V180, pE17, DOI 10.1086/665999; Moser G, 2007, ECOSYSTEMS, V10, P924, DOI 10.1007/s10021-007-9063-6; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Oliveras I, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/11/115011; Opik M, 2010, NEW PHYTOL, V188, P223, DOI 10.1111/j.1469-8137.2010.03334.x; Opik M, 2006, J ECOL, V94, P778, DOI 10.1111/j.1365-2745.2006.01136.x; Pigot AL, 2015, ECOL LETT, V18, P153, DOI 10.1111/ele.12395; Pinos J, 2017, MT RES DEV, V37, P87, DOI 10.1659/MRD-JOURNAL-D-16-00004.1; Prada CM, 2016, BIOTROPICA, V48, P568, DOI 10.1111/btp.12331; Rodriguez-Echeverria S, 2017, NEW PHYTOL, V214, P487, DOI 10.1111/nph.14467; Rosendahl S, 2008, NEW PHYTOL, V178, P253, DOI 10.1111/j.1469-8137.2008.02378.x; Senes-Guerrero C, 2016, FUNGAL DIVERS, V77, P317, DOI 10.1007/s13225-015-0328-7; Staats M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028448; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Torres-Arias Y, 2017, BRAZ J MICROBIOL, V48, P87, DOI 10.1016/j.bjm.2016.10.012; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Yang W, 2016, SCI REP-UK, V6, DOI 10.1038/srep36606; Zobel M, 2014, J VEG SCI, V25, P1133, DOI 10.1111/jvs.12191	67	6	6	6	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2019	14	8							e0221091	10.1371/journal.pone.0221091	http://dx.doi.org/10.1371/journal.pone.0221091			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5LL	31419262	Green Published, gold, Green Submitted			2022-12-26	WOS:000485019900028
J	Masuda, H; Sato, A; Shizuno, T; Yokoyama, K; Suzuki, Y; Tokunaga, M; Asahara, T				Masuda, Haruchika; Sato, Atsuko; Shizuno, Tomoko; Yokoyama, Keiko; Suzuki, Yusuke; Tokunaga, Masayoshi; Asahara, Takayuki			Batroxobin accelerated tissue repair via neutrophil extracellular trap regulation and defibrinogenation in a murine ischemic hindlimb model	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR; IN-VITRO; FIBRINOGEN; ANGIOGENESIS; INHIBITION; PLASMA; ARTERIOGENESIS; INFLAMMATION; FIBRINOLYSIS	Batroxobin, isolated from Bothrops moojeni, is a defibrinogenating agent used as a throm-bin-like serine protease against fibrinogen for improving microcirculation. Here, we investigated whether, and if so, how batroxobin restores ischemic tissue injury in terms of anti-inflammatory effects. In an in vitro flow cytometry assay for human neutrophil extracellular traps (NETs), batroxobin (DF-521; Defibrase) inhibited human NETs induced by tumor necrosis factor-alpha (TNF-alpha) in the presence of human fibrinogen. Next, the effect of batroxobin was investigated by immunohistochemistry of the anterior tibial muscle (ATM) in an ischemic hindlimb model using C57BL/6J mice intraperitoneally injected with DF-521 versus the saline control. NETs and fibrinogen deposition in the ischemic ATM decreased in DF-521-treated mice on day 2 after ischemia. Meanwhile, reverse transcription-quantitative PCR assay of the ischemic ATM unveiled continuous downregulation in the expression of the genes; Tnf-alpha and nitric oxide synthase2 (Nos2) with hypoxia-inducible factor-1 alpha (Hif-1 alpha) and vascular endothelial growth factor-a (Vegf-a) from day 3 to day 7, but the upregulation of arginase-1 (Arg-1) and placental growth factor (Plgf) with myogenin (Myog) on day 7. Daily intraperitoneal DF-521 injection for the initial 7 days into mice with ischemic hindlimbs promoted angiogenesis and arteriogenesis on day 14. Moreover, DF-521 injection accelerated myofiber maturation after day 14. Laser doppler imaging analysis revealed that blood perfusion in DF-521-injected mice significantly improved on day 14 versus the saline control. Thus, DF-521 improves microcirculation by protecting NETs with tissue defibrinogenation, thereby protecting against severe ischemic tissue injury and accelerating vascular and skeletal muscular regeneration. To our knowledge, batroxobin might be the first clinically applicable NET inhibitor against ischemic diseases.	[Masuda, Haruchika; Sato, Atsuko] Tokai Univ, Sch Med, Dept Physiol, Isehara, Kanagawa, Japan; [Shizuno, Tomoko; Asahara, Takayuki] Tokai Univ, Sch Med, Dept Regenerat Med Sci, Isehara, Kanagawa, Japan; [Yokoyama, Keiko; Suzuki, Yusuke; Tokunaga, Masayoshi] Tokai Univ, Sch Med, Dept Res, Isehara, Kanagawa, Japan; [Yokoyama, Keiko; Suzuki, Yusuke; Tokunaga, Masayoshi] Tokai Univ, Sch Med, Educ Support Ctr, Isehara, Kanagawa, Japan	Tokai University; Tokai University; Tokai University; Tokai University	Masuda, H (corresponding author), Tokai Univ, Sch Med, Dept Physiol, Isehara, Kanagawa, Japan.	masu3510@is.icc.u-tokai.ac.jp			AMED [JP19lm0203004]; Tokai University School of Medicine Research Aid; Ministry of Education, Culture, Sports, Science and Technology (Academic Frontier Promotion Program) [25461091]; Tobishi Pharmaceutical Co., Ltd. [17A006000]	AMED; Tokai University School of Medicine Research Aid; Ministry of Education, Culture, Sports, Science and Technology (Academic Frontier Promotion Program); Tobishi Pharmaceutical Co., Ltd.	Batroxobin (DF-521; Defibrase (R)) was supplied by Tobishi Pharmaceutical Co., Ltd. This study was financially supported by AMED under Grant Number JP19lm0203004 (HM), Tokai University School of Medicine Research Aid (HM), the Ministry of Education, Culture, Sports, Science and Technology (Academic Frontier PromotionProgram and Basic Research Grant 25461091), and Tobishi Pharmaceutical Co., Ltd., under Grant Number 17A006000 (HM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrikopoulou E, 2011, CURR MOL MED, V11, P218, DOI 10.2174/156652411795243414; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Bruno NE, 2008, THROMB HAEMOSTASIS, V100, P90, DOI 10.1160/TH08-02-0092; Camous L, 2011, BLOOD, V117, P1340, DOI 10.1182/blood-2010-05-283564; Campbell L, 2013, J INVEST DERMATOL, V133, P2461, DOI 10.1038/jid.2013.164; De Falco S, 2012, EXP MOL MED, V44, P1, DOI 10.3858/emm.2012.44.1.025; Fan H, 2013, NEUROSCI BULL, V29, P501, DOI 10.1007/s12264-013-1354-7; Fouda AY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1051-6; Gould TJ, 2015, ARTERIOSCL THROM VAS, V35, P2544, DOI 10.1161/ATVBAHA.115.306035; Grosskreutz CL, 1999, MICROVASC RES, V58, P128, DOI 10.1006/mvre.1999.2171; Hao ZL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000091.pub2; Healy LD, 2016, J IMMUNOL METHODS, V435, P77, DOI 10.1016/j.jim.2016.06.002; HIRSCHELMANN R, 1989, PHARMAZIE, V44, P505; HIRSCHELMANN R, 1990, AGENTS ACTIONS, V30, P412, DOI 10.1007/BF01966306; Ishida A, 2001, J CELL PHYSIOL, V188, P359, DOI 10.1002/jcp.1121; Izumi Y, 1996, STROKE, V27, P1328, DOI 10.1161/01.STR.27.8.1328; Jeffery U, 2018, VET PATHOL, V55, P116, DOI 10.1177/0300985817699860; Jetten N, 2014, ANGIOGENESIS, V17, P109, DOI 10.1007/s10456-013-9381-6; Jin Wei, 2016, Biochem Biophys Rep, V6, P209, DOI 10.1016/j.bbrep.2016.04.009; Jorch SK, 2017, NAT MED, V23, P279, DOI 10.1038/nm.4294; Kambas K, 2014, ANN RHEUM DIS, V73, P1854, DOI 10.1136/annrheumdis-2013-203430; Kapoor S, 2018, THROMB RES, V170, P87, DOI 10.1016/j.thromres.2018.08.005; KAWAKAMI M, 1992, ACTA OTO-LARYNGOL, V112, P991, DOI 10.3109/00016489209137500; Kottlors M, 2010, CELL TISSUE RES, V340, P541, DOI 10.1007/s00441-010-0976-6; KUBO T, 1988, ARCH OTOLARYNGOL, V114, P649; Laridan E, 2017, ANN NEUROL, V82, P223, DOI 10.1002/ana.24993; Lasch M, 2016, LAB INVEST, V96, P830, DOI 10.1038/labinvest.2016.62; Le DSNT, 2008, DIABETES RES CLIN PR, V82, P317, DOI 10.1016/j.diabres.2008.08.019; LOCHNIT G, 1995, EUR J BIOCHEM, V228, P805, DOI 10.1111/j.1432-1033.1995.tb20326.x; Marucco A, 2016, NANOTOXICOLOGY, V10, P1, DOI 10.3109/17435390.2014.978405; Massberg S, 1999, BLOOD, V94, P3829, DOI 10.1182/blood.V94.11.3829.423k35_3829_3838; Masuda S, 2017, CYTOM PART A, V91A, P822, DOI 10.1002/cyto.a.23169; Michaud SE, 2003, FASEB J, V17, P1150, DOI 10.1096/fj.02-0172fje; Nagy JA, 2003, TRENDS CARDIOVAS MED, V13, P169, DOI 10.1016/S1050-1738(03)00056-2; NASU Y, 1986, SCAND J WORK ENV HEA, V12, P272, DOI 10.5271/sjweh.2147; Ong LT, 2017, J IMMUNOL, V198, P883, DOI 10.4049/jimmunol.1601447; Oya R, 2016, ACTA OTO-LARYNGOL, V136, P271, DOI 10.3109/00016489.2015.1104723; Parmar JH, 2009, ANN VASC SURG, V23, P569, DOI 10.1016/j.avsg.2009.02.004; Pipp F, 2003, CIRC RES, V92, P378, DOI 10.1161/01.RES.0000057997.77714.72; Qiao F, 2010, AM J PATHOL, V177, P3061, DOI 10.2353/ajpath.2010.100158; Rath M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00532; RAZAAHMAD A, 1994, BIOTECH HISTOCHEM, V69, P268, DOI 10.3109/10520299409106300; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Salmeri M, 2013, CELL MICROBIOL, V15, P1367, DOI 10.1111/cmi.12121; Sheu JJ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-164; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Stocker K., 1976, Methods Enzymol, V45, P214; SUGAI K-I, 1986, Journal of Toxicological Sciences, V11, P135; Takeda Y, 2009, CIRC J, V73, P1674, DOI 10.1253/circj.CJ-08-1067; Thalin C, 2016, THROMB RES, V139, P56, DOI 10.1016/j.thromres.2016.01.009; Tsukada S, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt168; Valles J, 2017, THROMB HAEMOSTASIS, V117, P1919, DOI 10.1160/TH17-02-0130; Wang DS, 2001, ATHEROSCLEROSIS, V156, P73, DOI 10.1016/S0021-9150(00)00628-6; Wang JR, 2017, WORLD J GASTROENTERO, V23, P4701, DOI 10.3748/wjg.v23.i26.4701; Wang T, 2014, BRAZ J MED BIOL RES, V47, P738, DOI 10.1590/1414-431X20142910; Wu G, 2005, ACT NEUR S, V95, P381; Xu GL, 2007, BLOOD COAGUL FIBRIN, V18, P193, DOI 10.1097/MBC.0b013e328040c0f2; Yang Y, 2011, CELL MOL NEUROBIOL, V31, P437, DOI 10.1007/s10571-010-9637-2; Yin W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175499; YOSHIKAWA T, 1983, THROMB RES, V31, P729, DOI 10.1016/0049-3848(83)90103-2; Yuen J, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00137; Zarrouk-Mahjoub S, 2016, INT J CARDIOL, V221, P632, DOI 10.1016/j.ijcard.2016.07.073	63	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2019	14	8							e0220898	10.1371/journal.pone.0220898	http://dx.doi.org/10.1371/journal.pone.0220898			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5LL	31419236	Green Published, gold, Green Submitted			2022-12-26	WOS:000485019900019
J	de Water, E; Papazaharias, DM; Ambrosi, C; Mascaro, L; Iannilli, E; Gasparotti, R; Lucchini, RG; Austin, C; Arora, M; Tang, CY; Smith, DR; Wright, RO; Horton, MK				de Water, Erik; Papazaharias, Demetrios M.; Ambrosi, Claudia; Mascaro, Lorella; Iannilli, Emilia; Gasparotti, Roberto; Lucchini, Roberto G.; Austin, Christine; Arora, Manish; Tang, Cheuk Y.; Smith, Donald R.; Wright, Robert O.; Horton, Megan K.			Early-life dentine manganese concentrations and intrinsic functional brain connectivity in adolescents: A pilot study	PLOS ONE			English	Article							SEX-DIFFERENCES; EXPOSURE; CHILDREN; MOTOR; ROBUST; TEETH; TIME; OPTIMIZATION; REGISTRATION; INTELLIGENCE	Maturational processes in the developing brain are disrupted by exposure to environmental toxicants, setting the stage for deviant developmental trajectories. Manganese (Mn) is an essential nutrient that is neurotoxic at high levels of exposure, particularly affecting the basal ganglia and prefrontal cortex. Both the intensity and timing of exposure matter; deciduous teeth can be used to retrospectively and objectively determine early-life windows of vulnerability. The aim of this pilot study was to examine associations between prenatal, early postnatal and childhood dentine Mn concentrations and intrinsic functional connectivity (iFC) of adolescents' brains. 14 adolescents (12-18 years; 6 girls) from northern Italian regions with either current, historic or no Mn contamination, completed a 10-minute resting state functional Magnetic Resonance Imaging (MRI) scan in an 1.5T MRI scanner. We estimated prenatal, early postnatal and childhood Mn concentrations in deciduous teeth using laser ablation-inductively coupled plasma-mass spectrometry. We performed seed-based correlation analyses, focusing on six subcortical seeds (left and right caudate, putamen, pallidum) and one cortical seed (bilateral middle frontal gyrus) from Harvard-Oxford atlases. We examined linear and quadratic correlations between log-transformed Mn concentrations and seed-based iFC (Bonferroni-corrected p<0.0023), controlling for either socio-economic status, sex or age. Dentine Mn concentrations (Mn:Calcium ratio) were highest during the prenatal period (median = 0.48) and significantly declined during the early postnatal (median = 0.14) and childhood periods (median = 0.006). Postnatal Mn concentrations were associated with: 1) increased iFC between the middle frontal gyrus and medial prefrontal cortex; 2) decreased iFC between the right putamen and pre- and postcentral gyrus. Together, these findings suggest that early postnatal Mn concentrations are associated with increased iFC within cognitive control brain areas, but decreased iFC between motor areas in adolescents. Future studies should replicate these findings in larger samples, and link brain connectivity measures to cognitive and motor outcomes.	[de Water, Erik; Papazaharias, Demetrios M.; Lucchini, Roberto G.; Austin, Christine; Arora, Manish; Tang, Cheuk Y.; Wright, Robert O.; Horton, Megan K.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Ambrosi, Claudia; Mascaro, Lorella] ASST Spedali Civili Hosp, Brescia, Italy; [Iannilli, Emilia] Tech Univ Dresden, Dresden, Germany; [Gasparotti, Roberto; Lucchini, Roberto G.] Univ Brescia, Brescia, Italy; [Smith, Donald R.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA	Icahn School of Medicine at Mount Sinai; Technische Universitat Dresden; University of Brescia; University of California System; University of California Santa Cruz	de Water, E (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.	erik.dewater@mssm.edu	Iannilli, Emilia/H-6776-2019	Iannilli, Emilia/0000-0001-6871-3769; Wright, Robert/0000-0003-1180-6459; de Water, Erik/0000-0002-6844-2759	National Institute of Environmental Health Sciences (NIEHS) [R01 ES019222, R01 ES013744, R01 ES026033, DP2 ES025453, P30 ES023515]; European Union [FOODCT-2006-016253]; Rubicon grant from the Netherlands Organization for Scientific Research (NWO); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013744, R01ES026033, R01ES019222, P30ES023515, DP2ES025453] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); European Union(European Commission); Rubicon grant from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The study was supported by National Institute of Environmental Health Sciences (NIEHS; https:ftww.niehs.niti.gov) grants R01 ES019222 awarded to RGL, DRS, and ROW; R01 ES013744 awarded to ROW; R01 ES026033 awarded to MA and ROW; DP2 ES025453 awarded to MA; P30 ES023515 awarded to ROW; funding from the European Union (https://ec.europa.eu/info/research-and-innevation_en) through its Sixth Framework Program for RTD (contract no FOODCT-2006-016253) awarded to RGL, and a Rubicon grant from the Netherlands Organization for Scientific Research (NWO; https://www.nwo.nl/en) awarded to EDW. The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J., 2007, SD; Andersson J.L.R., 2007, TR07JA1 FMRIB, DOI DOI 10.1093/CERCOR/8.4.372; Arora M, 2013, CURR OPIN PEDIATR, V25, P261, DOI 10.1097/MOP.0b013e32835e9084; Arora M, 2012, ENVIRON SCI TECHNOL, V46, P5118, DOI 10.1021/es203569f; Arora M, 2011, SCI TOTAL ENVIRON, V409, P1315, DOI 10.1016/j.scitotenv.2010.12.018; Aschner Judy L., 2005, Molecular Aspects of Medicine, V26, P353, DOI 10.1016/j.mam.2005.07.003; Aschner JL, 2015, AM J CLIN NUTR, V102, P1482, DOI 10.3945/ajcn.115.116285; Aschner M, 2000, ENVIRON HEALTH PERSP, V108, P429, DOI 10.2307/3454532; Austin C, 2017, ENVIRON RES, V155, P373, DOI 10.1016/j.envres.2017.03.004; Bauer JA, 2017, ENVIRON INT, V108, P299, DOI 10.1016/j.envint.2017.08.013; Berman BD, 2012, NEUROIMAGE, V59, P917, DOI 10.1016/j.neuroimage.2011.07.035; Bouchard MF, 2011, ENVIRON HEALTH PERSP, V119, P138, DOI 10.1289/ehp.1002321; Butler L, 2019, J EXPO SCI ENV EPID, V29, P674, DOI 10.1038/s41370-018-0081-6; Cecil KM, 2008, PLOS MED, V5, P741, DOI 10.1371/journal.pmed.0050112; Cesana G C, 1995, Med Lav, V86, P16; Chiu YHM, 2017, ENVIRON RES, V159, P458, DOI 10.1016/j.envres.2017.08.035; de Water E, 2018, NEUROTOXICOLOGY, V64, P85, DOI 10.1016/j.neuro.2017.06.006; Dion LA, 2016, NEUROTOXICOLOGY, V53, P124, DOI 10.1016/j.neuro.2016.01.004; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Grandjean P, 2006, LANCET, V368, P2167, DOI 10.1016/S0140-6736(06)69665-7; Grandjean P, 2014, LANCET NEUROL, V13, P330, DOI 10.1016/S1474-4422(13)70278-3; Gunier RB, 2014, ENVIRON SCI TECHNOL, V48, P14695, DOI 10.1021/es503866a; Hackman DA, 2009, TRENDS COGN SCI, V13, P65, DOI 10.1016/j.tics.2008.11.003; Henn BC, 2018, ENVIRON RES, V161, P588, DOI 10.1016/j.envres.2017.12.003; Horton MK, 2018, ENVIRON INT, V121, P148, DOI 10.1016/j.envint.2018.08.045; Horton MK, 2014, CURR OPIN PEDIATR, V26, P230, DOI 10.1097/MOP.0000000000000074; Iannilli E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144783; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jolles DD, 2013, HUM BRAIN MAPP, V34, P396, DOI 10.1002/hbm.21444; Jolles DD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00076; Jolles DD, 2011, CEREB CORTEX, V21, P385, DOI 10.1093/cercor/bhq104; Keller JB, 2015, CORTEX, V64, P271, DOI 10.1016/j.cortex.2014.12.001; Kelly C, 2014, NEUROPSYCHOL REV, V24, P63, DOI 10.1007/s11065-014-9252-y; Kennedy DN, 1998, CEREB CORTEX, V8, P372, DOI 10.1093/cercor/8.4.372; Kim Y, 2009, NEUROTOXICOLOGY, V30, P564, DOI 10.1016/j.neuro.2009.03.012; Lao Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep41804; Ljung K, 2007, ENVIRON HEALTH PERSP, V115, P1533, DOI 10.1289/ehp.10316; Lucas EL, 2015, ENVIRON RES, V138, P279, DOI 10.1016/j.envres.2015.01.019; Lucchini RG, 2012, NEUROTOXICOLOGY, V33, P687, DOI 10.1016/j.neuro.2012.01.005; McLeod KR, 2014, NEUROIMAGE-CLIN, V4, P566, DOI 10.1016/j.nicl.2014.03.010; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mora AM, 2015, ENVIRON INT, V84, P39, DOI 10.1016/j.envint.2015.07.009; Normandin L, MANGANESE NEUROTOXIC; Pavilonis BT, 2015, J EXPO SCI ENV EPID, V25, P443, DOI 10.1038/jes.2014.70; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Roth JA, HOMEOSTATIC TOXIC ME; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; van Duijvenvoorde ACK, 2016, NEUROIMAGE, V124, P409, DOI 10.1016/j.neuroimage.2015.04.069; Woolger C, 2001, PERSP INDIV, P219; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Worsley K.J., 2001, FUNCTIONAL MRI AN IN, P251, DOI [10.1093/acprof:oso/ 9780192630711.003.0014, DOI 10.1093/ACPROF:OSO/9780192630711.003.0014]; Wright RO, METALS NEUROTOXICOLO; Zuo XN, 2010, J NEUROSCI, V30, P15034, DOI 10.1523/JNEUROSCI.2612-10.2010	56	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0220790	10.1371/journal.pone.0220790	http://dx.doi.org/10.1371/journal.pone.0220790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412061	Green Published, gold, Green Submitted			2022-12-26	WOS:000485012600037
J	Matos, SRD; Cunha, MLR; Podgaec, S; Weltman, E; Centrone, AFY; Mafra, ACCN				de Lima Matos, Sabrina Rosa; Rocha Cunha, Mariana Lucas; Podgaec, Sergio; Weltman, Eduardo; Yamazaki Centrone, Ana Fernanda; Cintra Nunes Mafra, Ana Carolina			Consensus for vaginal stenosis prevention in patients submitted to pelvic radiotherapy	PLOS ONE			English	Article							SEXUAL REHABILITATION; DILATOR USE; INTERVENTION; RADIATION	Objective To propose a consensus for prevention of vaginal stenosis in patients submitted to pelvic radiotherapy. Method In this methodological study, Delphi technique was applied for content validation on vaginal stenosis prevention. Data regarding content validation were collected from 32 specialists practicing in the oncology profession. The content validity index of items in the consensus was calculated based on the evaluations by the specialists. Results In the first round, of the 38 items evaluated, 29 items reached a Content Validity Index (CVI-I) greater than 80%, and 9 items had a CVI lower than 80%. Of the items that did not obtain agreement, 2 items were excluded, and 7 were reformulated and included in the second round. In the second round, all 7 items obtained a CVI-I greater than 80%. The final instrument consisted of 29 items validated in the first round, plus 7 items reformulated and consolidated in the second round. The judges agreed that it is the responsibility of the health professionals to consult the patients undergoing radiation therapy in the area of sexuality to patients. The radiation oncologist should be the first professional to address this issue and the nurse oncologist in the follow-up consultation should pass the guidelines to the patients as comprehensively as possible. Patients should be informed about vaginal dilation, regardless of whether they are sexually active or have a partner. They should also be informed of when they can resume sexual activity. The procedure of vaginal dilation should be individualized. The prescribed vaginal dilators should be used with a lubricant for a duration of at least 5-10 minutes, 2-3 times a week, as per the need of each patient (sexual activity and/or clinical follow-up) for an indefinite time. Patients should seek medical help in case they experience pain, discomfort, or bleeding during dilation. Conclusion The Brazilian version of the consensus for vaginal stenosis prevention in patients submitted to pelvic radiotherapy was validated with 36 items in 7 categories related to Responsibility; Target population; Rationale; Vaginal dilator; Content instructions; Information provision; and Patient support. In Brazil, the educational practices on vaginal dilation for patients submitted to radiotherapy partly revealed similar difficulties as identified in other studies as well as countries with reference to specific guidelines for the start and duration of vaginal dilation. The final consensus developed in this study could strengthen the guidelines for education of patients in Brazil and provide a future scope to establish a single and safe guideline.	[de Lima Matos, Sabrina Rosa; Weltman, Eduardo] Hosp Israelita Albert Einstein, Radiat Oncol Dept, Sao Paulo, SP, Brazil; [Rocha Cunha, Mariana Lucas] Fac Israelita Ciencias Saude Albert Einstein, Nursing Sch, Sao Paulo, SP, Brazil; [Podgaec, Sergio] Hosp Israelita Albert Einstein, Womens Hlth Dept, Sao Paulo, SP, Brazil; [Yamazaki Centrone, Ana Fernanda] Hosp Israelita Albert Einstein, Oncol Ctr, Sao Paulo, SP, Brazil; [Cintra Nunes Mafra, Ana Carolina] Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil	Hospital Israelita Albert Einstein; Hospital Israelita Albert Einstein; Hospital Israelita Albert Einstein; Hospital Israelita Albert Einstein	Matos, SRD (corresponding author), Hosp Israelita Albert Einstein, Radiat Oncol Dept, Sao Paulo, SP, Brazil.	sabrina.rlmatos@gmail.com	Mafra, Ana Carolina CN/H-1030-2015	Mafra, Ana Carolina CN/0000-0001-9004-7176; Rosa de Lima Matos, Sabrina/0000-0001-8452-8491; Weltman, Eduardo/0000-0002-7964-2051; Podgaec, Sergio/0000-0002-9760-6003				Baiocchi Neto G, 2013, ONCOLOGIA GRADUACAO, P464; Bakker RM, 2017, SUPPORT CARE CANCER, V25, P729, DOI 10.1007/s00520-016-3453-2; Bakker RM, 2014, INT J GYNECOL CANCER, V24, P1499, DOI 10.1097/IGC.0000000000000253; BEATON D, 2002, RECOMMENDATIONS CROS; Bonner C, 2012, SUPPORT CARE CANCER, V20, P2305, DOI 10.1007/s00520-011-1337-z; Brand AH, 2012, INT J GYNECOL CANCER, V22, P897, DOI 10.1097/IGC.0b013e31824d7243; Brasil. Ministerio da Saude. Instituto Nacional de Cancer, 2017, EST 2018 INC CANC BR, P25; Brasil. Ministerio da Saude. Instituto Nacional de Cancer, 2017, EST 2018 INC CANC BR, P38; BRUNER DW, 1993, INT J RADIAT ONCOL, V27, P825, DOI 10.1016/0360-3016(93)90455-5; Carvalho HA, 2013, RADIOTERAPIA ONCOLOG, P939; Ferreira SMD, 2015, REV LAT-AM ENFERM, V23, P82, DOI 10.1590/0104-1169.3602.2528; Gwet K. L., 2014, HDB INTERRATER RELIA; International Clinical Guideline Group, 2012, INT GUID VAG DIL PEL; Jeffries SA, 2006, INT J RADIAT ONCOL, V65, P404, DOI 10.1016/j.ijrobp.2005.12.009; Lancaster Letitia, 2004, Eur J Oncol Nurs, V8, P30, DOI 10.1016/S1462-3889(03)00059-0; Martins J, 2017, ARCH GYNECOL OBSTET, V296, P1125, DOI 10.1007/s00404-017-4553-z; Miles T, 2014, COCHRANE DB SYST REV, V12, P1; Mirabeau-Beale K, 2015, PRACT RADIAT ONCOL, V5, pE113, DOI 10.1016/j.prro.2014.09.003; Novaes PE, 2011, RADIOTERAPIA BASEADA, P273; Polit DF, 2006, RES NURS HEALTH, V29, P489, DOI 10.1002/nur.20147; R Core Team, 2013, R LANG ENV STAT COMP; Santos SD, 2011, FISIOTERAPIA SER, V6, P25; Scarparo AF, 2012, REV RENE, V13, P242, DOI DOI 10.15253/REVRENE.V13I1.3803; Vinuto J., 2014, TEMATICAS CAMPINAS S, V44, P203, DOI [10.20396/tematicas.v22i44.10977, DOI 10.20396/TEMATICAS.V22I44.10977]; White ID, 2006, INT J GYNECOL CANCER, V16, P1140, DOI 10.1111/j.1525-1438.2006.00452.x	25	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0221054	10.1371/journal.pone.0221054	http://dx.doi.org/10.1371/journal.pone.0221054			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398239	Green Published, gold, Green Submitted			2022-12-26	WOS:000485004000045
J	Santini, CD; Imakawa, TD; Duarte, G; Quintana, SM; Moises, ECD				Santini, Cibele de Oliveira; Imakawa, Thiago dos Santos; Duarte, Geraldo; Quintana, Silvana Maria; Dantas Moises, Elaine Christine			Do the body mass index and the diagnosis of gestational diabetes mellitus influence the level of physical activity during pregnancy and postpartum?	PLOS ONE			English	Article							EXERCISE; RISK; INACTIVITY; BEHAVIORS; PATTERNS; WOMEN; COMPENDIUM; BENEFITS; BARRIERS; BELIEFS	Obesity and lack of physical exercise are associated with the increase of diabetes mellitus in women of reproductive age and during the gestational period. The objective of the present study was to evaluate physical activity levels during the pregnancy and postpartum periods and the influence of body mass index (BMI) in women with gestational diabetes mellitus (GDM) or low risk pregnancy. The Pregnancy Physical Activity Questionnaire (PPAQ), translated and validated for Portuguese, was used for the evaluation of physical activity (PA) level. The sample was stratified according to preconception BMI and the presence or absence of diagnosis of GDM, resulting in four groups with 66 participants each: low risk pregnancy (LRP) with normal weight (BMI >= 18.5 and <= 24 kg/m(2)), LRP and overweight/obese (BMI >= 25 kg/m(2)), GDM with normal weight and GDM with overweight/obese. The level of PA of each participant was measured as Metabolic Equivalent of Task (MET) during the preconceptional period (T0), in the third trimester of gestation (T1), and three months after delivery (T2). The comparison of the MET values showed that the values found in the evaluation three months after delivery (T2) were higher than 1.00 (1.10 MET for the LRP-normal weight, 1.06 MET for LRP-overweight/obese, 1.02 MET for the GDM-normal weight, 1.07 MET for the GDM-overweight/obese). On the pre-gestational (T0) and third trimester (T1) analyzes, the values were less than 1.00 MET. The analysis between groups in relation to BMI and diagnosis of GDM showed no difference.	[Santini, Cibele de Oliveira; Duarte, Geraldo; Quintana, Silvana Maria; Dantas Moises, Elaine Christine] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Gynecol & Obstet, Sao Paulo, Brazil; [Imakawa, Thiago dos Santos] Univ Sao Paulo, Fac Med Ribeirao Preto, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Moises, ECD (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Gynecol & Obstet, Sao Paulo, Brazil.	elainemoises@fmrp.usp.br	Moisés, Elaine C/A-5708-2015	Moisés, Elaine C/0000-0001-9099-4544; Santini de Oliveira Imakawa, Cibele/0000-0003-3244-2930	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [1538886/2015-2017]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), wich provided a master scholarship to CSO (1538886/2015-2017). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; [Anonymous], 2015, DIABETES CARE, V38, pS1, DOI 10.2337/dc15-S001; Aune D, 2014, EPIDEMIOLOGY, V25, P331, DOI 10.1097/EDE.0000000000000036; Bloom D.E, 2011, GLOBAL EC BURDEN NON; Borodulin Katja, 2009, BMC Womens Health, V9, P32, DOI 10.1186/1472-6874-9-32; Borodulin KM, 2008, MED SCI SPORT EXER, V40, P1901, DOI 10.1249/MSS.0b013e31817f1957; Brown W, 2002, J SCI MED SPORT, V5, P37, DOI 10.1016/S1440-2440(02)80296-1; Bueno DR, 2016, CIENC SAUDE COLETIVA, V21, P1001, DOI 10.1590/1413-81232015214.09082015; Byrne NM, 2005, J APPL PHYSIOL, V99, P1112, DOI 10.1152/japplphysiol.00023.2004; Cerin E, 2008, SOC SCI MED, V66, P2596, DOI 10.1016/j.socscimed.2008.02.012; Chasan-Taber L, 2004, MED SCI SPORT EXER, V36, P1750, DOI 10.1249/01.MSS.0000142303.49306.0D; Chasan-Taber L, 2008, J WOMENS HEALTH, V17, P999, DOI 10.1089/jwh.2007.0560; Colberg SR, 2016, DIABETES CARE, V39, P2065, DOI 10.2337/dc16-1728; Colberg SR, 2013, WORLD J DIABETES, V4, P256, DOI 10.4239/wjd.v4.i6.256; Comm Obstet Practice, 2015, OBSTET GYNECOL, V126, pe135, DOI 10.1097/AOG.0000000000001214; Di Mascio D, 2016, AM J OBSTET GYNECOL, V215, P561, DOI 10.1016/j.ajog.2016.06.014; Dias-da-Costa Juvenal Soares, 2005, Cad. Saúde Pública, V21, P275, DOI 10.1590/S0102-311X2005000100030; Ding D, 2016, LANCET, V388, P1311, DOI 10.1016/S0140-6736(16)30383-X; do Nascimento SL, 2012, REV BRAS GINECOL OBS, V36, P423; Downs DS, 2004, J MIDWIFERY WOM HEAL, V49, P138, DOI 10.1016/j.jmwh.2003.11.009; Eaton SB, 2017, RES Q EXERCISE SPORT, V88, P1, DOI 10.1080/02701367.2016.1268519; Ehrlich SF, 2017, DIABETES METAB, V43, P416, DOI 10.1016/j.diabet.2017.01.006; Eime RM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1796-0; Evenson KR, 2009, J WOMENS HEALTH, V18, P1925, DOI 10.1089/jwh.2008.1309; Evenson KR, 2009, MATERN CHILD HLTH J, V13, P364, DOI 10.1007/s10995-008-0359-8; Fazzi C, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0485-z; Feghali MN, 2018, DIABETES RES CLIN PR, V138, P177, DOI 10.1016/j.diabres.2018.02.004; Gaston A, 2011, J SCI MED SPORT, V14, P299, DOI 10.1016/j.jsams.2011.02.006; Gavard JA, 2008, CLIN OBSTET GYNECOL, V51, P467, DOI 10.1097/GRF.0b013e31816feb1d; Hallal Pedro C., 2005, Cad. Saúde Pública, V21, P573, DOI 10.1590/S0102-311X2005000200024; Harrison Cheryce L, 2016, Semin Reprod Med, V34, pe28, DOI 10.1055/s-0036-1583530; Hayman M, 2016, J SCI MED SPORT, V19, P664, DOI 10.1016/j.jsams.2015.09.004; Instituto Brasileiro de Geografia e Estatistica, 2014, SINT IND POP BRAS; King AC, 2000, HEALTH PSYCHOL, V19, P354, DOI 10.1037//0278-6133.19.4.354; Knuth AG, 2010, J EPIDEMIOL COMMUN H, V64, P591, DOI 10.1136/jech.2009.088526; Lynch KE, 2012, AM J PREV MED, V43, P434, DOI 10.1016/j.amepre.2012.06.020; Magro-Malosso ER, 2017, ACTA OBSTET GYN SCAN, V96, P921, DOI 10.1111/aogs.13151; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Negrato CA, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-41; Coll CDN, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4036-y; Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024; Padmapriya N, 2015, MATERN CHILD HLTH J, V19, P2523, DOI 10.1007/s10995-015-1773-3; Perales M, 2017, JAMA-J AM MED ASSOC, V317, P1113, DOI 10.1001/jama.2017.0593; Prather H, 2012, PM&R, V4, P845, DOI 10.1016/j.pmrj.2012.07.012; Russo LM, 2015, OBSTET GYNECOL, V125, P576, DOI 10.1097/AOG.0000000000000691; Salles-Costa Rosana, 2003, Cad. Saúde Pública, V19, P1095, DOI 10.1590/S0102-311X2003000400031; Shepherd E, 2017, COCHRANE DATABASE SY; Silva F T, 2015, Ceska Gynekol, V80, P290; Sklempe Kokic I, 2018, SCAND J MED SCI SPOR; Teh WT, 2011, AUST NZ J OBSTET GYN, V51, P26, DOI 10.1111/j.1479-828X.2011.01292.x; Tobias DK, 2011, DIABETES CARE, V34, P223, DOI 10.2337/dc10-1368; 2002, OBSTET GYNECOL, V99, P869	53	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220947	10.1371/journal.pone.0220947	http://dx.doi.org/10.1371/journal.pone.0220947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5FL	31398219	Green Published, Green Submitted, gold			2022-12-26	WOS:000485004000030
J	Andaleon, A; Mogil, LS; Wheeler, HE				Andaleon, Angela; Mogil, Lauren S.; Wheeler, Heather E.			Genetically regulated gene expression underlies lipid traits in Hispanic cohorts	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; ANCESTRY; POPULATION; CETP; ATHEROSCLEROSIS; INFERENCE; RISK; STATISTICS; DIVERSITY	Plasma lipid levels are risk factors for cardiovascular disease, a leading cause of death worldwide. While many studies have been conducted in genetic variation underlying lipid levels, they mainly comprise individuals of European ancestry and thus their transferability to non-European populations is unclear. We performed genome-wide (GWAS) and imputed transcriptome-wide association studies of four lipid traits in the Hispanic Community Health Study/Study of Latinos cohort (HCHS/SoL, n = 11,103), replicated top hits in the Multi-Ethnic Study of Atherosclerosis (MESA, n = 3,855), and compared the results to the larger, predominantly European ancestry meta-analysis by the Global Lipids Genetics Consortium (GLGC, n = 196,475). In our GWAS, we found significant SNP associations in regions within or near known lipid genes, but in our admixture mapping analysis, we did not find significant associations between local ancestry and lipid phenotypes. In the imputed transcriptomewide association study in multiple tissues and in different ethnicities, we found 59 significant gene-tissue-phenotype associations (P < 3.61x10(-8)) with 14 unique significant genes, many of which occurred across multiple phenotypes, tissues, and ethnicities and replicated in MESA (45/59) and in GLGC (44/59). These include well-studied lipid genes such as SORT1, CETP, and PSRC1, as well as genes that have been implicated in cardiovascular phenotypes, such as CCL22 and ICAM1. The majority (40/59) of significant associations colocalized with expression quantitative trait loci (eQTLs), indicating a possible mechanism of gene regulation in lipid level variation. To fully characterize the genetic architecture of lipid traits in diverse populations, larger studies in non-European ancestry populations are needed.	[Andaleon, Angela; Mogil, Lauren S.; Wheeler, Heather E.] Loyola Univ, Dept Biol, Chicago, IL 60626 USA; [Andaleon, Angela; Wheeler, Heather E.] Loyola Univ, Program Bioinformat, Chicago, IL 60611 USA; [Wheeler, Heather E.] Loyola Univ, Dept Comp Sci, Chicago, IL 60611 USA; [Wheeler, Heather E.] Loyola Univ Chicago, Stritch Sch Med, Dept Publ Hlth Sci, Maywood, IL 60153 USA	Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago	Wheeler, HE (corresponding author), Loyola Univ, Dept Biol, Chicago, IL 60626 USA.; Wheeler, HE (corresponding author), Loyola Univ, Program Bioinformat, Chicago, IL 60611 USA.; Wheeler, HE (corresponding author), Loyola Univ, Dept Comp Sci, Chicago, IL 60611 USA.; Wheeler, HE (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Publ Hlth Sci, Maywood, IL 60153 USA.	hwheeler1@luc.edu	; Wheeler, Heather/I-9279-2019	Andaleon, Angela/0000-0003-4459-6398; Wheeler, Heather/0000-0003-1365-9667	NIH National Human Genome Research Institute Academic Research Enhancement Award [R15 HG009569]; Loyola University Chicago; Loyola Carbon Undergraduate Research Fellowship; Loyola MS Bioinformatics Research Assistant Fellowship; National Heart, Lung, and Blood Institute (NHLBI) [N01HC65233, N01-HC65234, N01HC65235, N01HC65236, N01HC65237]; National Center on Minority Health and Health Disparities; National Institute of Deafness and Other Communications Disorders; National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Neurological Disorders and Stroke; Office of Dietary Supplements; National Heart, Lung, and Blood Institute (NHLBI); NHLBI [N02HL-64278];  [N01-HC95159];  [N01-HC-95160];  [N01-HC95161];  [N01-HC-95162];  [N01-HC-95163];  [N01-HC95164];  [N01-HC-95165];  [N01-HC95166];  [N01-HC95167];  [N01-HC-95168];  [N01-HC-95169];  [UL1-RR025005];  [UL1-TR-000040]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R15HG009569] Funding Source: NIH RePORTER	NIH National Human Genome Research Institute Academic Research Enhancement Award; Loyola University Chicago; Loyola Carbon Undergraduate Research Fellowship; Loyola MS Bioinformatics Research Assistant Fellowship; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute of Deafness and Other Communications Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; ; ; ; ; ; ; ; ; ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work is supported by the NIH National Human Genome Research Institute Academic Research Enhancement Award R15 HG009569 (HEW), start-up funds from Loyola University Chicago (HEW), the Loyola Carbon Undergraduate Research Fellowship (AA), and the Loyola MS Bioinformatics Research Assistant Fellowship (AA). The Hispanic Community Health Study/Study of Latinos is supported by contracts from the National Heart, Lung, and Blood Institute (NHLBI) to the University of North Carolina (N01HC65233), University of Miami (N01-HC65234), Albert Einstein College of Medicine (N01HC65235), Northwestern University (N01HC65236), and San Diego State University (N01HC65237). The following Institutes/Centers/Offices contribute to the HCHS/SOL through a transfer of funds to the NHLBI: National Center on Minority Health and Health Disparities, the National Institute of Deafness and Other Communications Disorders, the National Institute of Dental and Craniofacial Research, the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Neurological Disorders and Stroke, and the Office of Dietary Supplements. The authors thank the staff and participants of the HCHS/SOL study for their important contributions. MESA and the MESA SHARe project are conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with MESA investigators. Support for MESA is provided by contracts N01-HC95159, N01-HC-95160, N01-HC95161, N01-HC-95162, N01-HC-95163, N01-HC95164, N01-HC-95165, N01-HC95166, N01-HC95167, N01-HC-95168, N01-HC-95169, UL1-RR025005, and UL1-TR-000040. Funding for SHARe genotyping was provided by NHLBI Contract N02HL-64278. Genotyping was performed at Affymetrix (Santa Clara, California, USA) and the Broad Institute of Harvard and MIT (Boston, Massachusetts, USA) using the Affymetrix Genome-Wide Human SNP Array 6.0. The authors thank the other investigators, the staff, and the participants of the MESA study for their valuable contributions. A full list of participating MESA investigators and institutions can be found at mesa-nhlbi. org. The following datasets were downloaded from dbGaP: phs000810. v1.p1 and phs000209. v13.p3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Andaleon A, 2018, PEERJ, V6, DOI 10.7717/peerj.4314; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Arvind P, 2014, J CARDIOL, V64, P339, DOI 10.1016/j.jjcc.2014.02.012; Barbeira AN, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007889; Barbeira AN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03621-1; Barter PJ, 2003, ARTERIOSCL THROM VAS, V23, P160, DOI 10.1161/01.ATV.0000054658.91146.64; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Belbin GM, 2018, CURR OPIN GENET DEV, V53, P98, DOI 10.1016/j.gde.2018.07.006; Below JE, 2016, SCI REP-UK, V6, DOI 10.1038/srep19429; Bhatti JS, 2018, ANN HUM GENET, V82, P448, DOI 10.1111/ahg.12274; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Brown LA, 2017, J AM SOC NEPHROL, V28, P2211, DOI 10.1681/ASN.2016091010; Browning SR, 2016, G3-GENES GENOM GENET, V6, P1525, DOI 10.1534/g3.116.028779; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Conomos MP, 2016, AM J HUM GENET, V98, P165, DOI 10.1016/j.ajhg.2015.12.001; Conomos MP, 2015, GENET EPIDEMIOL, V39, P276, DOI 10.1002/gepi.21896; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Daviglus ML, 2012, JAMA-J AM MED ASSOC, V308, P1775, DOI 10.1001/jama.2012.14517; de Grooth GJ, 2004, J LIPID RES, V45, P1967, DOI 10.1194/jlr.R400007-JLR200; Feingold KR, 2000, INTRO LIPIDS LIPOPRO; Fotis L, 2012, IN VIVO, V26, P243; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Graff M, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0591-6; Guo K, 2018, J MOL CELL CARDIOL, V116, P69, DOI 10.1016/j.yjmcc.2018.01.013; Keys K.L, 2019, CROSS POPULATION GEN, DOI [10.1101/552042, DOI 10.1101/552042]; Kimura S, 2015, J ATHEROSCLER THROMB, V22, P599, DOI 10.5551/jat.27417; Kimura S, 2012, PATHOL INT, V62, P675, DOI 10.1111/j.1440-1827.2012.02854.x; Klarin D, 2018, NAT GENET, V50, P1514, DOI 10.1038/s41588-018-0222-9; Kosmas CE, 2016, CLIN MED INSIGHTS-CA, V10, P37, DOI 10.4137/CMC.S32667; Kramer HJ, 2017, J AM SOC NEPHROL, V28, P915, DOI 10.1681/ASN.2016030357; Langefeld CD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16021; Lavange LM, 2010, ANN EPIDEMIOL, V20, P642, DOI 10.1016/j.annepidem.2010.05.006; Liu BX, 2019, NAT GENET, V51, P768, DOI 10.1038/s41588-019-0404-0; Luna A, 2007, BIOINFORMATICS, V23, P774, DOI 10.1093/bioinformatics/btl657; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Maples BK, 2013, AM J HUM GENET, V93, P278, DOI 10.1016/j.ajhg.2013.06.020; Martin AR, 2019, NAT GENET, V51, P584, DOI 10.1038/s41588-019-0379-x; Mikhaylova AV, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00261; Mogil LS, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007586; Moreno-Estrada A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003925; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nielsen JL, 2011, CAN J FISH AQUAT SCI, V68, P1, DOI 10.1139/F10-124; Paththinige CS, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0488-4; Petty LE, 2019, HUM MOL GENET, V28, P1212, DOI 10.1093/hmg/ddy435; Popejoy AB, 2016, NATURE, V538, P161, DOI 10.1038/538161a; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rodrigues DA, 2017, GENET MOL RES, V16, DOI 10.4238/gmr16019101; Rodriguez CJ, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001867; Rosenson RS, 2016, NAT REV CARDIOL, V13, P48, DOI 10.1038/nrcardio.2015.124; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Sofer T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188400; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Strong A, 2014, CURR OPIN LIPIDOL, V25, P350, DOI 10.1097/MOL.0000000000000110; Surakka I, 2015, NAT GENET, V47, P589, DOI 10.1038/ng.3300; Tabet F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4292; Tall AR, 2018, CIRC RES, V122, P106, DOI 10.1161/CIRCRESAHA.117.311978; Thompson JF, 2003, ATHEROSCLEROSIS, V167, P195, DOI 10.1016/S0021-9150(03)00005-4; Vijai J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6751; Wainberg M, 2019, NATURE GENETICS, V51; Weissglas-Volkov D, 2013, J MED GENET, V50, P298, DOI 10.1136/jmedgenet-2012-101461; Wheeler HE, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006423; Wiliams AL, 2012, AM J HUM GENET, V91, P238, DOI 10.1016/j.ajhg.2012.06.013; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wu Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003379; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zhong YZ, 2019, AM J HUM GENET, V104, P1097, DOI 10.1016/j.ajhg.2019.04.009; Zhou L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082420; Zhou X, 2017, ANN APPL STAT, V11, P2027, DOI 10.1214/17-AOAS1052; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	77	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220827	10.1371/journal.pone.0220827	http://dx.doi.org/10.1371/journal.pone.0220827			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393916	Green Published, Green Submitted, gold			2022-12-26	WOS:000485002500066
J	Falcon, A; Montano, U; Tavira, M; Dominguez-Gallegos, O				Falcon, Alberto; Montano, Ulianov; Tavira, Mariel; Dominguez-Gallegos, Osmara			Haptic sound-symbolism in young Spanish-speaking children	PLOS ONE			English	Article							CROSSMODAL CORRESPONDENCES; ASSOCIATIONS; ODORS; SHAPE; INTEGRATION; BOUBA; TOUCH; KIKI	Haptic sound symbolism has been found in adults, between ideophones and various textures, between words and shape, and between written words and texture. However, associations between the sound of nonwords and features other than shape and in early stages of development have been less explored. The present study investigates the haptic manifestation of sound symbolism in an early developmental stage. We examined associations between nonwords and the rough-smooth tactile dimension in 3.5-to-4.5-year-old children. Two experiments were conducted: a pointing selection task and a naming task. Sound symbolic associations were found in the naming task, but not in the pointing task. On the other hand an unexpected bias towards smoothness was found in the pointing task. We explain these results by suggesting that the articulation of nonwords may facilitate or intensify sound symbolism, and that hedonic biases are manifested in the pointing task.	[Falcon, Alberto; Montano, Ulianov; Tavira, Mariel; Dominguez-Gallegos, Osmara] Univ Autonoma Estado Morelos, Lab Comunicac Humana & Cognic, Fac Comunicac Humana, Cuernavaca, Morelos, Mexico	Universidad Autonoma del Estado de Morelos	Falcon, A (corresponding author), Univ Autonoma Estado Morelos, Lab Comunicac Humana & Cognic, Fac Comunicac Humana, Cuernavaca, Morelos, Mexico.	falcon@uaem.mx		FALCON, ALBERTO/0000-0003-4884-6518				[Anonymous], P ANN M PHONOLOGY; Aoki H., 1994, SOUND SYMBOLISM, P15; Asano M, 2015, CORTEX, V63, P196, DOI 10.1016/j.cortex.2014.08.025; Bremner AJ, 2013, COGNITION, V126, P165, DOI 10.1016/j.cognition.2012.09.007; Crisinel AS, 2012, CHEMOSENS PERCEPT, V5, P266, DOI 10.1007/s12078-012-9133-9; Crisinel AS, 2012, CHEM SENSES, V37, P151, DOI 10.1093/chemse/bjr085; DAVIS R, 1961, BRIT J PSYCHOL, V52, P259, DOI 10.1111/j.2044-8295.1961.tb00788.x; Dingemanse M, 2015, TRENDS COGN SCI, V19, P603, DOI 10.1016/j.tics.2015.07.013; Dominguez-Gallegos, 2014, THESIS; Eitan Z, 2011, PSYCHOL MUSIC, V39, P449, DOI 10.1177/0305735610377592; Etzi R, 2016, MULTISENS RES, V29, P133, DOI 10.1163/22134808-00002497; Evans KK, 2010, J VISION, V10, DOI 10.1167/10.1.6; Fort M., 2013, P 12 INT C AUD VIS S, P71; Fryer L, 2014, COGNITION, V132, P164, DOI 10.1016/j.cognition.2014.03.015; Gallace A, 2006, PERCEPT PSYCHOPHYS, V68, P1191, DOI 10.3758/BF03193720; Gallace A, 2011, SOC SEMIOT, V21, P569, DOI 10.1080/10350330.2011.591998; Gick B, 2009, NATURE, V462, P502, DOI 10.1038/nature08572; Hanson-Vaux G, 2013, CHEM SENSES, V38, P161, DOI 10.1093/chemse/bjs087; Hinton L., 1994, SOUND SYMBOLISM, P40; Hubbard TL, 1996, AM J PSYCHOL, V109, P219, DOI 10.2307/1423274; Hunter-Smith S., 2007, UNDERSTANDING BABBLE; Imai M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0298; Imai M, 2008, COGNITION, V109, P54, DOI 10.1016/j.cognition.2008.07.015; Kantartzis K, 2011, COGNITIVE SCI, V35, P575, DOI 10.1111/j.1551-6709.2010.01169.x; Kohler W., 1929, GESTALT PSYCHOL; Langdon M., 1994, SOUND SYMBOLISM, P94; LEDERMAN SJ, 1993, ACTA PSYCHOL, V84, P29, DOI 10.1016/0001-6918(93)90070-8; Lockwood G, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00933; Ludwig VU, 2013, CORTEX, V49, P1089, DOI 10.1016/j.cortex.2012.04.004; Martino G, 2000, PERCEPTION, V29, P745, DOI 10.1068/p2984; Masuda K., 2007, INSISTENT IMAGES, V5, P57; Maurer D, 2006, DEVELOPMENTAL SCI, V9, P316, DOI 10.1111/j.1467-7687.2006.00495.x; Ngo MK, 2011, FOOD QUAL PREFER, V22, P567, DOI 10.1016/j.foodqual.2011.03.009; Nielsen A, 2012, LANG COGN, V4, P115, DOI 10.1515/langcog-2012-0007; Oda Hiromi, 2000, EMBODIED SEMANTIC ME; Ohala JJ, 2006, SOUND SYMBOLISM, P325; Ohala John J., 1983, PRODUCTION SPEECH, P189, DOI DOI 10.1007/978-1-4613-8202-7_9; Ozturk O, 2013, J EXP CHILD PSYCHOL, V114, P173, DOI 10.1016/j.jecp.2012.05.004; Parise CV, 2012, EXP BRAIN RES, V220, P319, DOI 10.1007/s00221-012-3140-6; Pena M, 2011, PSYCHOL SCI, V22, P1419, DOI 10.1177/0956797611421791; Perry LK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137147; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; Sakamoto M, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00295; Sapir E, 1929, J EXP PSYCHOL, V12, P225, DOI 10.1037/h0070931; Seo HS, 2010, NEUROSCI LETT, V478, P175, DOI 10.1016/j.neulet.2010.05.011; Tzeng CY, 2017, J EXP CHILD PSYCHOL, V160, P107, DOI 10.1016/j.jecp.2017.03.004; von Humboldt WF, 1836, KONIGL AKAD WISS; Watanbe J, 2012, P ANN M COGN SCI SOC	48	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220618	10.1371/journal.pone.0220618	http://dx.doi.org/10.1371/journal.pone.0220618			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5EW	31393921	gold, Green Published, Green Submitted			2022-12-26	WOS:000485002500047
J	Sanchez-Quinto, A; Falcon, LI				Sanchez-Quinto, Andres; Falcon, Luisa I.			Metagenome of Acropora palmata coral rubble: Potential metabolic pathways and diversity in the reef ecosystem	PLOS ONE			English	Article							FRINGING-REEF; MARINE FUNGI; NITROGEN; METAMORPHOSIS; ECOLOGY; GENOME; DMSP	Over the past 30 years, the stony coral Acropora palmata has experienced an excessive loss of individuals showing few signs of recovery throughout the Mexican Caribbean, resulting in long stretches of coral rubble structures. When the coral dies, the skeleton begins to be colonized by algae, sponges, virus, bacteria and other microorganisms, forming a new community. Here we analyze, using a metagenomic approach, the diversity and biogeochemical cycles associated to coral rubble in La Bocana (Puerto Morelos, QRoo, Mexico). This study provides the first broad characterization of coral rubble associated communities and their role in biogeochemical cycling, suggesting a potential view of a world where coral reefs are no longer dominated by corals.	[Sanchez-Quinto, Andres] Univ Nacl Autonoma Mexico, Posgrad Ciencias Mar & Limnol, Mexico City, DF, Mexico; [Sanchez-Quinto, Andres; Falcon, Luisa I.] Univ Nacl Autonoma Mexico, Inst Ecol, Lab Ecol Bacteriana, Mexico City, DF, Mexico; [Falcon, Luisa I.] UNAM, Parque Cient & Tecnol Yucatan, Sierra Papacal, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Falcon, LI (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Lab Ecol Bacteriana, Mexico City, DF, Mexico.; Falcon, LI (corresponding author), UNAM, Parque Cient & Tecnol Yucatan, Sierra Papacal, Mexico.	falcon@ecologia.unam.mx		Falcon, Luisa I/0000-0002-7210-6483	SEP-CONACyT (La Secretaria de Educacion Publica-Consejo Nacional de Ciencia y Tecnologia) [254962]; PAPIIT-UNAM [IN 202016-3]	SEP-CONACyT (La Secretaria de Educacion Publica-Consejo Nacional de Ciencia y Tecnologia); PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico)	Funding for this project was granted through SEP-CONACyT (https://www.conacyt.gob.mx/) (La Secretaria de Educacion Publica-Consejo Nacional de Ciencia y Tecnologia) No. 254962 (L.I.F.) and PAPIIT-UNAM No. IN 202016-3 (https://www.gob.mx/sep) (L.I. F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2010, TRENDS ECOL EVOL, V25, P233, DOI 10.1016/j.tree.2009.11.001; Aloisi G, 2006, GEOLOGY, V34, P1017, DOI 10.1130/G22986A.1; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Amend AS, 2012, ISME J, V6, P1291, DOI 10.1038/ismej.2011.193; Anandan R, 2016, ACTINOBACTERIA BASIC, V2, P1; Andrews S, 2010, FASTQC QUALITY CONTR; Arp G, 2001, SCIENCE, V292, P1701, DOI 10.1126/science.1057204; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Baker DM, 2013, CORAL REEFS, V32, P691, DOI 10.1007/s00338-013-1040-2; Beltran Y, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiv162; Blanchon P, 1997, J SEDIMENT RES, V67, P1; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bourne DG, 2012, PROKARYOTES PROKARYO, P163; Broadbent AD, 2004, MAR FRESHWATER RES, V55, P849, DOI 10.1071/MF04114; Capone D.G., 1993, HDB METHODS AQUATIC, P621, DOI 10.1201/9780203752746-74; Coronado C, 2007, CORAL REEFS, V26, P149, DOI 10.1007/s00338-006-0175-9; Eric Jordan-Dahlgren, 2003, LATIN AM CORAL REEFS, V508; Falcon LI, 2007, MICROB ECOL, V54, P363, DOI 10.1007/s00248-007-9240-3; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Grasshoff K, 1999, METHODS SEAWATER ANA; Grober-Dunsmore R, 2006, MAR ECOL PROG SER, V321, P123, DOI 10.3354/meps321123; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hassan R., 2005, ECOSYSTEMS HUMAN WEL, P331; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Instituto Nacional de Ecologia, 2000, PROGR MAN PARQ NAC A, P224; Ivarez-Filip L, 2014, DIAGNOSTICO ESTADO C; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Jordan-Dahlgren E., 1993, REV SOC MEXICANA HIS, V44, P157; Kanehisa M, 2016, J MOL BIOL, V428, P726, DOI 10.1016/j.jmb.2015.11.006; Keegan KP, 2016, METHODS MOL BIOL, V1399, P207, DOI 10.1007/978-1-4939-3369-3_13; Kimes NE, 2010, ENVIRON MICROBIOL, V12, P541, DOI 10.1111/j.1462-2920.2009.02113.x; Kirkwood D.S, 1994, SEAWATER ANAL; KURSAR TA, 1983, PLANT PHYSIOL, V72, P409, DOI 10.1104/pp.72.2.409; Li DH, 2015, BIOINFORMATICS, V31, P1674, DOI 10.1093/bioinformatics/btv033; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Mukherjee S, 2015, STAND GENOMIC SCI, V10; Mulhall M, 2009, DUKE ENV LAW POLICY, V19, P321; Muyzer G, 2008, NAT REV MICROBIOL, V6, P441, DOI 10.1038/nrmicro1892; Negri AP, 2001, MAR ECOL PROG SER, V223, P121, DOI 10.3354/meps223121; Nurk S, 2017, GENOME RES, V27, P824, DOI 10.1101/gr.213959.116; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Perry CT, 2008, EARTH-SCI REV, V86, P106, DOI 10.1016/j.earscirev.2007.08.006; Pester M, 2011, CURR OPIN MICROBIOL, V14, P300, DOI 10.1016/j.mib.2011.04.007; Raina JB, 2010, TRENDS MICROBIOL, V18, P101, DOI 10.1016/j.tim.2009.12.002; Rasser MW, 2002, CORAL REEFS, V21, P57, DOI 10.1007/s00338-001-0206-5; Richards TA, 2012, ANNU REV MAR SCI, V4, P495, DOI 10.1146/annurev-marine-120710-100802; Riding R., 1991, CALCAREOUS ALGAE STR, DOI DOI 10.1007/978-3-642-52335-9_2; Riding R., 2000, MICROBIAL SEDIMENTS; Riding Robert, 2011, P911; Rodriguez-Martinez RE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096140; SEBENS KP, 1994, AM ZOOL, V34, P115; Sumich JL, 2004, INTRO BIOL MARINE LI, V8, P1; Thompson A, 2011, REP AIMS ACT CORAL R, V128; Turchyn A V., 2005, OXYGEN ISOTOPES MARI, P1; VALDERRAMA JC, 1981, MAR CHEM, V10, P109, DOI 10.1016/0304-4203(81)90027-X; Webster NS, 2004, APPL ENVIRON MICROB, V70, P1213, DOI 10.1128/AEM.70.2.1213-1221.2004; Witzany G., 2017, BIOCOMMUNICATION ARC, P1; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103; Young CN, 2012, B MAR SCI, V88, P1075, DOI 10.5343/bms.2011.1143; Zhu TT, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00004	61	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220117	10.1371/journal.pone.0220117	http://dx.doi.org/10.1371/journal.pone.0220117			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31394568	Green Published, Green Submitted, gold			2022-12-26	WOS:000485002500022
J	Yamashita, H; Katai, H; Kawaguchi, L; Nagano, AJ; Nakamura, Y; Morita, A; Ikka, T				Yamashita, Hiroto; Katai, Hideyuki; Kawaguchi, Lina; Nagano, Atsushi J.; Nakamura, Yoriyuki; Morita, Akio; Ikka, Takashi			Analyses of single nucleotide polymorphisms identified by ddRAD-seq reveal genetic structure of tea germplasm and Japanese landraces for tea breeding	PLOS ONE			English	Article							POPULATION-STRUCTURE; QUANTITATIVE-EVALUATION; SHAPE; DIFFERENTIATION; DIVERSITY; CULTIVARS; INFERENCE	To obtain genetic information about the germplasm of tea (Camellia sinensis L.) in Japan, 167 accessions including 138 var. sinensis (96 Japanese var. sinensis and 42 exotic var. sinensis) and 29 Assam hybrids were analyzed using single nucleotide polymorphisms (SNPs) markers identified by double-digest restriction-site-associated DNA sequencing (ddRAD-seq) analysis. Approximately 10,000 SNPs were identified by ddRAD-seq and were mapped across the whole genome. The 167 tea accessions were classified into three genetic subgroups: (1) Japanese var. sinensis; (2) Japanese and exotic var. sinensis; (3) Assam hybrids and exotic var. sinensis. Leaf morphology varied widely within each genetic subgroups. The 96 Japanese var. sinensis were classified into four genetic subgroups as follows; two subgroups of Shizuoka (the largest tea production region) landraces, Uji (most ancient tea production region) landraces, and the pedigree of 'Yabukita', the leading green tea cultivar in Japan. These results indicated that the SNP markers obtained from ddRAD-seq are a useful tool to investigate the geographical background and breeding history of Japanese tea. This genetic information revealed the ancestral admixture situation of the 'Yabukita' pedigree, and showed that the genome structure of 'Yabukita' is clearly different from those of other Japanese accessions.	[Yamashita, Hiroto; Morita, Akio; Ikka, Takashi] Shizuoka Univ, Fac Agr, Shizuoka, Japan; [Yamashita, Hiroto] Gifu Univ, United Grad Sch Agr Sci, Gifu, Japan; [Katai, Hideyuki] Shizuoka Prefectural Res Inst Agr & Forestry, Tea Res Ctr, Shizuoka, Japan; [Kawaguchi, Lina; Nagano, Atsushi J.] Ryukoku Univ, Fac Agr, Otsu, Shiga, Japan; [Nakamura, Yoriyuki] Univ Shizuoka, Sch Food & Nutr Sci, Yada, Shizuoka, Japan	Shizuoka University; Gifu University; Ryukoku University; University of Shizuoka	Ikka, T (corresponding author), Shizuoka Univ, Fac Agr, Shizuoka, Japan.	ikka.takashi@shizuoka.ac.jp	Nagano, Atsushi J./A-2957-2019	Nagano, Atsushi J./0000-0001-7891-5049; Ikka, Takashi/0000-0002-1845-5658	ICHIMURA Foundation For New Technology	ICHIMURA Foundation For New Technology	This work partly supported by The 27th and the 28th Botanical Research Grant of ICHIMURA Foundation For New Technology (http://www.sgkz.or.jp/project/plant/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Freeman H., 1974, Computing Surveys, V6, P57, DOI 10.1145/356625.356627; FURUTA N, 1995, BREEDING SCI, V45, P315; Gunasekare MTK, 2012, TEA PLANT CAMELLIA S, P125; HASHIMOTO M., 1971, Japanese Journal of Tropical Agriculture, V15, P158; HASIMOTO M, 1978, JPN J TROP AGR, V21, P93; Iwata H, 2002, J HERED, V93, P384, DOI 10.1093/jhered/93.5.384; Kubo N, 2019, GENET RESOUR CROP EV, V66, P441, DOI 10.1007/s10722-018-0722-6; Lin C, 2018, INT J STROKE, V13, P8; MATSUMOTO S, 1994, THEOR APPL GENET, V89, P671, DOI 10.1007/BF00223703; Matsumoto S, 2002, THEOR APPL GENET, V104, P998, DOI 10.1007/s00122-001-0806-z; Namita P., 2012, GLOBAL J PHARM, V6, P52; Penjor T, 2016, BREEDING SCI, V66, P797, DOI 10.1270/jsbbs.16059; Peterson BK, 2012, DOUBLE DIGEST RADSEQ, V7, DOI [10.1371/JOURNAL.PONE.0037135, DOI 10.1371/JOURNAL.PONE.0037135]; Pritchard JK, 2000, GENETICS, V155, P945; Raina SN, 2012, GENET RESOUR CROP EV, V59, P1527, DOI 10.1007/s10722-011-9782-6; ROHLF FJ, 1984, SYST ZOOL, V33, P302, DOI 10.2307/2413076; Sakaguchi S, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0944-0; Sealy JR, 1958, REVISION GENUS CAMEL, P111; Shirasawa K, 2017, SCI REP-UK, V7, DOI 10.1038/srep44207; Shirasawa K, 2016, DNA RES, V23, P145, DOI 10.1093/dnares/dsw004; Stekhoven DJ, 2012, BIOINFORMATICS, V28, P112, DOI 10.1093/bioinformatics/btr597; Tamaki I, 2016, GENET RESOUR CROP EV, V63, P823, DOI 10.1007/s10722-015-0286-7; Tanaka Y, 2012, INTED PROC, P227; Taniguchi F, 2014, TREE GENET GENOMES, V10, P1555, DOI 10.1007/s11295-014-0779-0; Toyao T, 1999, TEA RES J, V87, P39; Vigouroux Y, 2008, AM J BOT, V95, P1240, DOI 10.3732/ajb.0800097; Wachira F, 2001, J HORTIC SCI BIOTECH, V76, P557; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wei CL, 2018, P NATL ACAD SCI USA, V115, pE4151, DOI 10.1073/pnas.1719622115; Yang HW, 2016, SOC MEDIA SOC, V2, DOI 10.1177/2056305115623802	35	9	9	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220981	10.1371/journal.pone.0220981	http://dx.doi.org/10.1371/journal.pone.0220981			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393947	Green Submitted, Green Published, gold			2022-12-26	WOS:000485002500089
J	Leon, LM; Gautier, M; Allan, R; Ilie, M; Nottet, N; Pons, N; Paquet, A; Lebrigand, K; Truchi, M; Fassy, J; Magnone, V; Kinnebrew, G; Radovich, M; Cheok, MHC; Barbry, P; Vassaux, G; Marquette, CH; Ponzio, G; Ivan, M; Pottier, N; Hofman, P; Mari, B; Rezzonico, R				Leon, Laura Moreno; Gautier, Marine; Allan, Richard; Ilie, Marius; Nottet, Nicolas; Pons, Nicolas; Paquet, Agnes; Lebrigand, Kevin; Truchi, Marin; Fassy, Julien; Magnone, Virginie; Kinnebrew, Garrett; Radovich, Milan; Cheok, Meyling Hua-Chen; Barbry, Pascal; Vassaux, Georges; Marquette, Charles-Hugo; Ponzio, Gilles; Ivan, Mircea; Pottier, Nicolas; Hofman, Paul; Mari, Bernard; Rezzonico, Roger			The nuclear hypoxia-regulated NLUCAT1 long non-coding RNA contributes to an aggressive phenotype in lung adenocarcinoma through regulation of oxidative stress	ONCOGENE			English	Article							NF-KAPPA-B; CIGARETTE-SMOKE; GENE-EXPRESSION; CELL-PROLIFERATION; EPITHELIAL-CELLS; DRUG-RESISTANCE; POOR-PROGNOSIS; CANCER; TRANSCRIPTION; ANNOTATION	Lung cancer is the leading cause of cancer death worldwide, with poor prognosis and a high rate of recurrence despite early surgical removal. Hypoxic regions within tumors represent sources of aggressiveness and resistance to therapy. Although long non-coding RNAs (lncRNAs) are increasingly recognized as major gene expression regulators, their regulation and function following hypoxic stress are still largely unexplored. Combining profiling studies on early-stage lung adenocarcinoma (LUAD) biopsies and on A549 LUAD cell lines cultured in normoxic or hypoxic conditions, we identified a subset of lncRNAs that are both correlated with the hypoxic status of tumors and regulated by hypoxia in vitro. We focused on a new transcript, NLUCAT1, which is strongly upregulated by hypoxia in vitro and correlated with hypoxic markers and poor prognosis in LUADs. Full molecular characterization showed that NLUCAT1 is a large nuclear transcript composed of six exons and mainly regulated by NF-kappa B and NRF2 transcription factors. CRISPR-Cas9-mediated invalidation of NLUCAT1 revealed a decrease in proliferative and invasive properties, an increase in oxidative stress and a higher sensitivity to cisplatin-induced apoptosis. Transcriptome analysis of NLUCAT1-deficient cells showed repressed genes within the antioxidant and/or cisplatin-response networks. We demonstrated that the concomitant knockdown of four of these genes products, GPX2, GLRX, ALDH3A1, and PDK4, significantly increased ROS-dependent caspase activation, thus partially mimicking the consequences of NLUCAT1 inactivation in LUAD cells. Overall, we demonstrate that NLUCAT1 contributes to an aggressive phenotype in early-stage hypoxic tumors, suggesting it may represent a new potential therapeutic target in LUADs.	[Leon, Laura Moreno; Gautier, Marine; Allan, Richard; Nottet, Nicolas; Pons, Nicolas; Paquet, Agnes; Lebrigand, Kevin; Truchi, Marin; Fassy, Julien; Magnone, Virginie; Barbry, Pascal; Ponzio, Gilles; Mari, Bernard] Univ Cote Azur, CNRS, UMR7275, IPMC, Valbonne, France; [Leon, Laura Moreno; Gautier, Marine; Allan, Richard; Ilie, Marius; Nottet, Nicolas; Pons, Nicolas; Paquet, Agnes; Lebrigand, Kevin; Truchi, Marin; Fassy, Julien; Magnone, Virginie; Barbry, Pascal; Vassaux, Georges; Marquette, Charles-Hugo; Ponzio, Gilles; Hofman, Paul; Mari, Bernard; Rezzonico, Roger] FHU OncoAge, Nice, France; [Ilie, Marius; Marquette, Charles-Hugo; Hofman, Paul] Univ Cote Azur, CNRS, INSERM, IRCAN, Nice, France; [Ilie, Marius; Hofman, Paul] Pasteur Hosp, Hosp Related Biobank BB 0033 00025, Nice, France; [Kinnebrew, Garrett; Radovich, Milan] Indiana Univ Sch Med, Dept Surg Med & Mol Genet, Indianapolis, IN 46202 USA; [Cheok, Meyling Hua-Chen] Inst Canc Res Lille, Factors Leukemia Cell Persistence, INSERM, UMR S1172, Lille, France; [Vassaux, Georges; Rezzonico, Roger] Univ Cote Azur, INSERM, CNRS, UMR7275,IPMC, Valbonne, France; [Marquette, Charles-Hugo] CHU Nice, Dept Pneumol, Nice, France; [Ivan, Mircea] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Ivan, Mircea] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Pottier, Nicolas] Fac Med Lille, Pole Rech, EA4483, Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; Indiana University System; Indiana University Bloomington; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Universite de Lille - ISITE; Universite de Lille	Mari, B (corresponding author), Univ Cote Azur, CNRS, UMR7275, IPMC, Valbonne, France.; Mari, B; Rezzonico, R (corresponding author), FHU OncoAge, Nice, France.; Rezzonico, R (corresponding author), Univ Cote Azur, INSERM, CNRS, UMR7275,IPMC, Valbonne, France.	mari@unice.fr; rezzonico@ipmc.cnrs.fr	Moreno Leon, Laura/AGP-7137-2022; Mari, Bernard/Q-5832-2019; Cheok, Meyling h/C-3822-2014; Cheok, Meyling/AFS-4025-2022; Hofman, Paul/P-7654-2018; Vassaux, Georges/N-9724-2016; REZZONICO, Roger/N-9626-2016; Mari, Bernard P/GVS-3100-2022; Barbry, Pascal/O-5021-2016	Moreno Leon, Laura/0000-0002-5560-1765; Mari, Bernard/0000-0002-0422-9182; Cheok, Meyling h/0000-0002-7820-8026; Cheok, Meyling/0000-0002-7820-8026; Hofman, Paul/0000-0003-0431-9353; Vassaux, Georges/0000-0002-1149-7716; REZZONICO, Roger/0000-0002-8460-1641; Mari, Bernard P/0000-0002-0422-9182; GAUTIER-ISOLA, Marine/0000-0003-3768-8809; Kinnebrew, Garrett/0000-0001-7384-6582; Nottet, Nicolas/0000-0002-8699-6747; Barbry, Pascal/0000-0001-9632-6483	Plan Cancer 2018 "ARN non-codants en cancerologie: du fondamental au translationnel" [18CN045]; Canceropole PACA; Fondation ARC pour la Recherche sur le Cancer; Fondation Unice (AIR project); Ligue contre le cancer (comite departemental du Nord); French Government (Agence Nationale de Recherche, ANR) through the Investments for the Future LABEX SIGNALIFE [ANR-11-LABX-0028-01]; French Government (Agence Nationale de Recherche, ANR) through the FRANCE GENOMIQUE [ANR-10-INBS-09-03, ANR-10-INBS-09-02]; Fondation pour la Recherche Medicale	Plan Cancer 2018 "ARN non-codants en cancerologie: du fondamental au translationnel"; Canceropole PACA(Region Grand-Est); Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Fondation Unice (AIR project); Ligue contre le cancer (comite departemental du Nord); French Government (Agence Nationale de Recherche, ANR) through the Investments for the Future LABEX SIGNALIFE(French National Research Agency (ANR)); French Government (Agence Nationale de Recherche, ANR) through the FRANCE GENOMIQUE(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	We gratefully acknowledge the outstanding technical support of the UCA GenomiX platform and MICA imaging facility of the University Cote d'Azur, and the staff from the CHU Nice Biobank. This work was supported by Plan Cancer 2018 "ARN non-codants en cancerologie: du fondamental au translationnel" (number 18CN045), Canceropole PACA, Fondation ARC pour la Recherche sur le Cancer, Fondation Unice (AIR project), Ligue contre le cancer (comite departemental du Nord), and the French Government (Agence Nationale de Recherche, ANR) through the Investments for the Future LABEX SIGNALIFE (ANR-11-LABX-0028-01) and FRANCE GENOMIQUE (ANR-10-INBS-09-03 and ANR-10-INBS-09-02). LML was a recipient of the Fondation pour la Recherche Medicale.	Akagi I, 2013, CANCER RES, V73, P3821, DOI 10.1158/0008-5472.CAN-13-0031; Ashouri A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13197; Bertero T, 2013, CELL DEATH DIFFER, V20, P800, DOI 10.1038/cdd.2013.5; Bertero T, 2017, INT REV CEL MOL BIO, V333, P91, DOI 10.1016/bs.ircmb.2017.03.006; Blanco MR, 2017, EMBO J, V36, P964, DOI 10.15252/embj.201796796; Buelna-Chontal M, 2013, CELL SIGNAL, V25, P2548, DOI 10.1016/j.cellsig.2013.08.007; Buffa FM, 2010, BRIT J CANCER, V102, P428, DOI 10.1038/sj.bjc.6605450; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chang MY, 2007, J THORAC CARDIOV SUR, V134, P850, DOI 10.1016/j.jtcvs.2007.03.044; Chang YN, 2016, GENE, V575, P1, DOI 10.1016/j.gene.2015.08.049; Choi YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135083; Clark MB, 2012, GENOME RES, V22, P885, DOI 10.1101/gr.131037.111; Davidovich C, 2013, NAT STRUCT MOL BIOL, V20, P1250, DOI 10.1038/nsmb.2679; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dong J, 2016, TUMOR BIOL, V37, P1379, DOI 10.1007/s13277-015-4457-0; Du Z, 2013, NAT STRUCT MOL BIOL, V20, P908, DOI 10.1038/nsmb.2591; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Fang JH, 2014, FREE RADICAL BIO MED, V68, P80, DOI 10.1016/j.freeradbiomed.2013.11.028; Fang SS, 2018, NUCLEIC ACIDS RES, V46, pD308, DOI 10.1093/nar/gkx1107; Ferdin J, 2013, CELL DEATH DIFFER, V20, P1675, DOI 10.1038/cdd.2013.119; Fitzpatrick SF, 2011, J IMMUNOL, V186, P1091, DOI 10.4049/jimmunol.1002256; Galluzzi L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.428; Gastaldi C, 2014, CARCINOGENESIS, V35, P1110, DOI 10.1093/carcin/bgt490; Gee HE, 2014, ANTIOXID REDOX SIGN, V21, P1220, DOI 10.1089/ars.2013.5639; Gorlach Agnes, 2008, Biochem J, V412, pe17, DOI 10.1042/BJ20080920; Grosso S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.71; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Hangauer MJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003569; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Heery R, 2017, CANCERS, V9, DOI 10.3390/cancers9040038; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Duong HQ, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6030052; Hu Y, 2018, ONCOTARGETS THER, V11, P3185, DOI 10.2147/OTT.S158104; Ilie M, 2010, BRIT J CANCER, V102, P1627, DOI 10.1038/sj.bjc.6605690; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Lassen N, 2006, FREE RADICAL BIO MED, V41, P1459, DOI 10.1016/j.freeradbiomed.2006.08.009; Leclerc D, 2017, BRIT J CANCER, V116, P930, DOI 10.1038/bjc.2017.38; Li WB, 2016, NAT REV GENET, V17, P207, DOI 10.1038/nrg.2016.4; Lin AF, 2016, NAT CELL BIOL, V18, P213, DOI 10.1038/ncb3295; Lin CX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003231; Liu XB, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111835; Liu XB, 2015, INVEST OPHTH VIS SCI, V56, P2821, DOI 10.1167/iovs.14-15876; Loewen G, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0090-4; Lugthart S, 2005, CANCER CELL, V7, P375, DOI 10.1016/j.ccr.2005.03.002; Marullo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081162; Muzio G, 2012, FREE RADICAL BIO MED, V52, P735, DOI 10.1016/j.freeradbiomed.2011.11.033; Naiki T, 2014, CARCINOGENESIS, V35, P1962, DOI 10.1093/carcin/bgu048; Nakajima S, 2013, FREE RADICAL BIO MED, V65, P162, DOI 10.1016/j.freeradbiomed.2013.06.020; Oliver KM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2575; Ou SHI, 2007, CANCER-AM CANCER SOC, V110, P1532, DOI 10.1002/cncr.22938; Patten DA, 2010, MOL BIOL CELL, V21, P3247, DOI 10.1091/mbc.E10-01-0025; Portoso M, 2017, EMBO J, V36, P981, DOI 10.15252/embj.201695335; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Puissegur MP, 2011, CELL DEATH DIFFER, V18, P465, DOI 10.1038/cdd.2010.119; Quinn JJ, 2016, NAT REV GENET, V17, P47, DOI 10.1038/nrg.2015.10; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Schmidt LH, 2011, J THORAC ONCOL, V6, P1984, DOI 10.1097/JTO.0b013e3182307eac; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Shelton P, 2013, FASEB J, V27, P414, DOI 10.1096/fj.12-217257; Singh A, 2006, AM J RESP CELL MOL, V35, P639, DOI 10.1165/rcmb.2005-0325OC; Sun Y, 2017, ONCOTARGET, V8, P28297, DOI 10.18632/oncotarget.16044; Tafani M, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3907147; Tani H, 2012, GENOME RES, V22, P947, DOI 10.1101/gr.130559.111; Thai P, 2013, AM J RESP CELL MOL, V49, P204, DOI 10.1165/rcmb.2013-0159RC; Toth RK, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6020027; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Volders PJ, 2015, NUCLEIC ACIDS RES, V43, P4363, DOI 10.1093/nar/gkv295; Volders PJ, 2013, NUCLEIC ACIDS RES, V41, pD246, DOI 10.1093/nar/gks915; Wang YM, 2006, METHODS, V39, P356, DOI 10.1016/j.ymeth.2006.06.010; White NM, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0429-8; Woolbright BL, 2018, MOL CANCER THER, V17, P2004, DOI 10.1158/1535-7163.MCT-18-0063; Wu X, 2018, ANTIOXID REDOX SIGN, V29, P922, DOI 10.1089/ars.2017.7293; Yan WS, 2006, J BIOL CHEM, V281, P7856, DOI 10.1074/jbc.M512655200; Yang F, 2014, MOL CELL, V53, P88, DOI 10.1016/j.molcel.2013.11.004; Yang F, 2013, MOL CELL, V49, P1083, DOI 10.1016/j.molcel.2013.01.010; Zhang Y, 2016, J BIOL CHEM, V291, P17405, DOI 10.1074/jbc.M116.713735; Zheng ZG, 2016, SCI REP-UK, V6, DOI 10.1038/srep26093	81	42	42	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 14	2019	38	46					7146	7165		10.1038/s41388-019-0935-y	http://dx.doi.org/10.1038/s41388-019-0935-y			20	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JN5HX	31417181				2022-12-26	WOS:000496930500003
J	Yang, CX; Cao, ML; Liu, YW; He, YQ; Du, Y; Zhang, GL; Gao, F				Yang, Cuixia; Cao, Manlin; Liu, Yiwen; He, Yiqing; Du, Yan; Zhang, Guoliang; Gao, Feng			Inducible formation of leader cells driven by CD44 switching gives rise to collective invasion and metastases in luminal breast carcinomas	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CANCER STEM-CELLS; DYNAMIC EQUILIBRIUM; TUMOR-CELLS; MIGRATION; HETEROGENEITY; DISSEMINATION; PLASTICITY; IDENTIFICATION; CONTRIBUTES	Collective invasion into adjacent tissue is a hallmark of luminal breast cancer, and similar to 20% of these cases eventually undergo metastasis. How less aggressive luminal-like breast cancer transitions to invasive cancer remains unclear. Our study revealed that CD44(hi) cancer cells are the leading subpopulation in collectively invading luminal cancer cells and efficiently promote the collective invasion of CD44(lo)/follower cells. The CD44(hi)/leader subpopulation showed a specific gene signature of various hybrid epithelial/mesenchymal genes and key functional coregulators of collective invasion, which was distinct from that of CD44(lo)/follower cells. However, the CD44(hi)/leader cells, which showed a partial epithelial-mesenchymal transition (EMT) phenotype, readily switched to the CD44(lo) phenotype along with collective migration and vice versa; this phenomenon was spontaneous and sensitive to the tumor microenvironment. The CD44(lo)-to-CD44(hi) conversion was accompanied by a shift in CD44s to CD44v but not a conversion of non-cancer stem cells to cancer stem cells (CSCs). Therefore, the CD44(hi) leader cells, as currently identified, are not a stable subpopulation in breast tumors. This plasticity and ability to generate CD44(hi) carcinoma cells with enhanced migratory and invasive behavior might be responsible for the transition from in situ to invasive behavior of luminal-type breast cancer.	[Yang, Cuixia; Liu, Yiwen; He, Yiqing; Du, Yan; Zhang, Guoliang; Gao, Feng] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Mol Biol Lab, Shanghai, Peoples R China; [Yang, Cuixia; Gao, Feng] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Clin Lab, Shanghai, Peoples R China; [Cao, Manlin] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Rehabil Med, Shanghai 200233, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Gao, F (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Mol Biol Lab, Shanghai, Peoples R China.; Gao, F (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Clin Lab, Shanghai, Peoples R China.	gao3507@126.com	liu, yi/GXE-9662-2022		National Natural Science Foundation of China [81672843, 81572821, 81502490, 81502491, 81402419, 81702852, 81872357]; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support [20171924]; Shanghai Training and Support Program for Medical Technologist; Natural Science Foundation of Shanghai Municipality [14YF1412200]; Shanghai Shen-Kang Hospital Development Center [SHDC22014004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support; Shanghai Training and Support Program for Medical Technologist; Natural Science Foundation of Shanghai Municipality(Natural Science Foundation of Shanghai); Shanghai Shen-Kang Hospital Development Center	This work was supported by the National Natural Science Foundation of China (81672843, 81572821, 81502490, 81502491, 81402419, 81702852, 81872357), the Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support (20171924), the Shanghai Training and Support Program for Medical Technologist (2017), the Natural Science Foundation of Shanghai Municipality (14YF1412200), and the Shanghai Shen-Kang Hospital Development Center (SHDC22014004).	Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Ahmed M, 2016, CANCER CELL, V30, P432, DOI 10.1016/j.ccell.2016.08.002; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Almendro V, 2013, ANNU REV PATHOL-MECH, V8, P277, DOI 10.1146/annurev-pathol-020712-163923; Banky B, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-83; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Chapnick DA, 2014, MOL BIOL CELL, V25, P1586, DOI 10.1091/mbc.E14-01-0697; Cheung KJ, 2016, P NATL ACAD SCI USA, V113, pE854, DOI 10.1073/pnas.1508541113; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Chiasson-MacKenzie C, 2015, J CELL BIOL, V211, P391, DOI 10.1083/jcb.201503081; Corsa CAS, 2016, CELL REP, V15, P2510, DOI 10.1016/j.celrep.2016.05.033; Dang TT, 2011, CANCER RES, V71, P6857, DOI 10.1158/0008-5472.CAN-11-1818; Das T, 2015, NAT CELL BIOL, V17, P276, DOI 10.1038/ncb3115; Donatello S, 2012, AM J PATHOL, V181, P2172, DOI 10.1016/j.ajpath.2012.08.025; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Fortier AM, 2013, J BIOL CHEM, V288, P11555, DOI 10.1074/jbc.M112.428920; Freeman SA, 2018, CELL, V172, P305, DOI 10.1016/j.cell.2017.12.023; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; Guo W, 2014, ONCOGENE, V33, P537, DOI 10.1038/onc.2013.260; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Ito T, 2015, CLIN BREAST CANCER, V15, pE93, DOI 10.1016/j.clbc.2014.11.002; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Nguyen-Ngoc KV, 2012, P NATL ACAD SCI USA, V109, pE2595, DOI 10.1073/pnas.1212834109; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Liu LY, 2013, P NATL ACAD SCI USA, V110, P1686, DOI 10.1073/pnas.1221147110; Matak A, 2018, HEPATOLOGY, V68, P933, DOI 10.1002/hep.29679; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; Morath I, 2018, ONCOGENE, V37, P1472, DOI 10.1038/s41388-017-0030-1; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Pinto Mauricio P, 2011, Front Endocrinol (Lausanne), V2, P15, DOI 10.3389/fendo.2011.00015; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Preca BT, 2015, INT J CANCER, V137, P2566, DOI 10.1002/ijc.29642; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Reffay M, 2014, NAT CELL BIOL, V16, P217, DOI 10.1038/ncb2917; Ribeiro AS, 2015, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00371; Roswall P, 2018, NAT MED, V24, P463, DOI 10.1038/nm.4494; Shamir ER, 2014, J CELL BIOL, V204, P839, DOI 10.1083/jcb.201306088; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Yadav A, 2011, MOL CANCER RES, V9, P1658, DOI 10.1158/1541-7786.MCR-11-0271; Yae T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1892; Yang CX, 2015, ONCOTARGET, V6, P15283, DOI 10.18632/oncotarget.3681; Yang CX, 2012, J BIOL CHEM, V287, P43094, DOI 10.1074/jbc.M112.349209; Yang G, 2012, BRIT J CANCER, V106, P1512, DOI 10.1038/bjc.2012.126; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zajac O, 2018, NAT CELL BIOL, V20, P296, DOI 10.1038/s41556-017-0027-6; Zhang GL, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1172154; Zhao S, 2016, CLIN CANCER RES, V22, P5592, DOI 10.1158/1078-0432.CCR-15-3115; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	62	34	34	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 14	2019	38	46					7113	7132		10.1038/s41388-019-0899-y	http://dx.doi.org/10.1038/s41388-019-0899-y			20	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JN5HX	31417182				2022-12-26	WOS:000496930500001
J	Collodet, C; Foretz, M; Deak, M; Bultot, L; Metairon, S; Viollet, B; Lefebvre, G; Raymond, F; Parisi, A; Civiletto, G; Gut, P; Descombes, P; Sakamoto, K				Collodet, Caterina; Foretz, Marc; Deak, Maria; Bultot, Laurent; Metairon, Sylviane; Viollet, Benoit; Lefebvre, Gregory; Raymond, Frederic; Parisi, Alice; Civiletto, Gabriele; Gut, Philipp; Descombes, Patrick; Sakamoto, Kei			AMPK promotes induction of the tumor suppressor FLCN through activation of TFEB independently of mTOR	FASEB JOURNAL			English	Article						AICAR; 991; folliculin; folliculin interacting protein; Birt-Hogg-Dube syndrome	PROTEIN-KINASE ACTIVATOR; GLUCOSE-UPTAKE; TRANSCRIPTION FACTORS; LYSOSOMAL BIOGENESIS; THERAPEUTIC TARGET; LIPID-METABOLISM; STRUCTURAL BASIS; IMMUNE-RESPONSE; AICA RIBOSIDE; ENERGY SENSOR	AMPK is a central regulator of energy homeostasis. AMPK not only elicits acute metabolic responses but also promotes metabolic reprogramming and adaptations in the long-term through regulation of specific transcription factors and coactivators. We performed a whole-genome transcriptome profiling in wild-type (WT) and AMPK-deficient mouse embryonic fibroblasts (MEFs) and primary hepatocytes that had been treated with 2 distinct classes of small-molecule AMPK activators. We identified unique compound-dependent gene expression signatures and several AMPK-regulated genes, including folliculin (Flcn), which encodes the tumor suppressor FLCN. Bioinformatics analysis highlighted the lysosomal pathway and the associated transcription factor EB (TFEB) as a key transcriptional mediator responsible for AMPK responses. AMPK-induced Flcn expression was abolished in MEFs lacking TFEB and transcription factor E3, 2 transcription factors with partially redundant function; additionally, the promoter activity of Flcn was profoundly reduced when its putative TFEB-binding site was mutated. The AMPK-TFEB-FLCN axis is conserved across species; swimming exercise in WT zebrafish induced Flcn expression in muscle, which was significantly reduced in AMPK-deficient zebrafish. Mechanistically, we have found that AMPK promotes dephosphorylation and nuclear localization of TFEB independently of mammalian target of rapamycin activity. Collectively, we identified the novel AMPK-TFEB-FLCN axis, which may function as a key cascade for cellular and metabolic adaptations.	[Collodet, Caterina; Deak, Maria; Bultot, Laurent; Metairon, Sylviane; Lefebvre, Gregory; Raymond, Frederic; Parisi, Alice; Civiletto, Gabriele; Gut, Philipp; Descombes, Patrick; Sakamoto, Kei] Ecole Polytech, Nestle Res, Lausanne, Switzerland; [Collodet, Caterina; Descombes, Patrick; Sakamoto, Kei] Ecole Polytech Fed Lausanne, Sch Life Sci, Innovat Pk, Lausanne, Switzerland; [Foretz, Marc; Viollet, Benoit] Inst Cochin, INSERM, Unit e 1016, Paris, France; [Foretz, Marc; Viollet, Benoit] CNRS, UMR 8104, Paris, France; [Foretz, Marc; Viollet, Benoit] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Bultot, Laurent] Catholic Univ Louvain, Inst Rech Expt & Clin, Pole Rech Cardiovasc, Brussels, Belgium	Nestle SA; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite Catholique Louvain	Sakamoto, K (corresponding author), Ecole Polytech Fed Lausanne, Nestle Res, Innovat Pk,B atiment H, CH-1015 Lausanne, Switzerland.	kei.sakamoto@rd.nestle.com	Viollet, Benoit/N-2397-2019; FORETZ, Marc/O-7334-2017; Viollet, Benoit/O-6927-2017; Sakamoto, Kei/C-8806-2019	Viollet, Benoit/0000-0002-0121-0224; FORETZ, Marc/0000-0001-7017-9032; Viollet, Benoit/0000-0002-0121-0224; Sakamoto, Kei/0000-0001-8839-5980; Lefebvre, Greg/0000-0001-7519-2316; Raymond, Frederic/0000-0002-6148-6898; Collodet, Caterina/0000-0002-2332-4599; Gut, Philipp/0000-0002-0689-9518				Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Banko MR, 2011, MOL CELL, V44, P878, DOI 10.1016/j.molcel.2011.11.005; Barnes BR, 2004, J BIOL CHEM, V279, P38441, DOI 10.1074/jbc.M405533200; Benziane B, 2009, AM J PHYSIOL-CELL PH, V297, pC1554, DOI 10.1152/ajpcell.00010.2009; Brady OA, 2018, AUTOPHAGY, V14, P181, DOI 10.1080/15548627.2017.1313943; Bultot L, 2016, AM J PHYSIOL-ENDOC M, V311, pE706, DOI 10.1152/ajpendo.00237.2016; Cokorinos EC, 2017, CELL METAB, V25, P1147, DOI 10.1016/j.cmet.2017.04.010; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Coughlan KA, 2014, DIABET METAB SYND OB, V7, P241, DOI 10.2147/DMSO.S43731; Day EA, 2017, TRENDS ENDOCRIN MET, V28, P545, DOI 10.1016/j.tem.2017.05.004; Ducommun S, 2019, CELL SIGNAL, V57, P45, DOI 10.1016/j.cellsig.2019.02.001; Ducommun S, 2015, CELL SIGNAL, V27, P978, DOI 10.1016/j.cellsig.2015.02.008; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032; Gilbert MJH, 2014, EXP GERONTOL, V50, P106, DOI 10.1016/j.exger.2013.11.013; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Gowans GJ, 2013, CELL METAB, V18, P556, DOI 10.1016/j.cmet.2013.08.019; Green GH, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1302; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Guigas B, 2009, IUBMB LIFE, V61, P18, DOI 10.1002/iub.135; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Hellemans J, 2014, METHODS MOL BIOL, V1160, P19, DOI 10.1007/978-1-4939-0733-5_3; Hoffman NJ, 2015, CELL METAB, V22, P922, DOI 10.1016/j.cmet.2015.09.001; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hunter RW, 2018, NAT MED, V24, P1395, DOI 10.1038/s41591-018-0159-7; Hunter RW, 2014, CHEM BIOL, V21, P866, DOI 10.1016/j.chembiol.2014.05.014; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Lai YC, 2014, BIOCHEM J, V460, P363, DOI 10.1042/BJ20131673; Langendorf CG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10912; Li XJ, 2017, MOL CELL, V66, P684, DOI 10.1016/j.molcel.2017.04.026; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Mansueto G, 2017, CELL METAB, V25, P182, DOI 10.1016/j.cmet.2016.11.003; Martina JA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004754; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Moreno D, 2008, FEBS LETT, V582, P2650, DOI 10.1016/j.febslet.2008.06.044; Myers RW, 2017, SCIENCE, V357, P507, DOI 10.1126/science.aah5582; Napolitano G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05862-6; Napolitano G, 2016, J CELL SCI, V129, P2475, DOI 10.1242/jcs.146365; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Pastore N, 2017, EMBO MOL MED, V9, P605, DOI 10.15252/emmm.201607204; Possik E, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005520; Raben N, 2016, ANNU REV CELL DEV BI, V32, P255, DOI 10.1146/annurev-cellbio-111315-125407; Salatto CT, 2017, J PHARMACOL EXP THER, V361, P303, DOI 10.1124/jpet.116.237925; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schaffer BE, 2015, CELL METAB, V22, P907, DOI 10.1016/j.cmet.2015.09.009; Scott JW, 2008, CHEM BIOL, V15, P1220, DOI 10.1016/j.chembiol.2008.10.005; Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Thomson DM, 2008, J APPL PHYSIOL, V104, P429, DOI 10.1152/japplphysiol.00900.2007; Treebak JT, 2009, AM J PHYSIOL-CELL PH, V297, pC1041, DOI 10.1152/ajpcell.00051.2009; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vincent MF, 1996, DIABETOLOGIA, V39, P1148, DOI 10.1007/BF02658500; Wada S, 2016, GENE DEV, V30, P2551, DOI 10.1101/gad.287953.116; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Wu J, 2013, J BIOL CHEM, V288, P35904, DOI 10.1074/jbc.M113.508747; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xiao B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4017; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Yan M, 2016, GENE DEV, V30, P1034, DOI 10.1101/gad.281410.116; Yan M, 2014, J CLIN INVEST, V124, P2640, DOI 10.1172/JCI71749; Young NP, 2016, GENE DEV, V30, P535, DOI 10.1101/gad.274142.115; Zibrova D, 2017, BIOCHEM J, V474, P983, DOI 10.1042/BCJ20160980	80	35	37	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12374	12391		10.1096/fj.201900841R	http://dx.doi.org/10.1096/fj.201900841R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31404503	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000507461600061
J	Logun, MT; Wynens, KE; Simchick, G; Zhao, WJ; Mao, LD; Zhao, Q; Mukherjee, S; Brat, DJ; Karumbaiah, L				Logun, Meghan T.; Wynens, Kallie E.; Simchick, Gregory; Zhao, Wujun; Mao, Leidong; Zhao, Qun; Mukherjee, Subhas; Brat, Daniel J.; Karumbaiah, Lohitash			Surfen-mediated blockade of extratumoral chondroitin sulfate glycosaminoglycans inhibits glioblastoma invasion	FASEB JOURNAL			English	Article						tumor microenvironment; glioma; extracellular matrix	BINDING GROWTH-FACTORS; EXTRACELLULAR-MATRIX; STEM-CELLS; GLIOMA INVASION; ANTITUMOR-ACTIVITY; CD133 PROTEIN; RECEPTOR; BRAIN; MIGRATION; EXPRESSION	Invasive spread of glioblastoma (GBM) is linked to changes in chondroitin sulfate (CS) proteoglycan (CSPG)-associated sulfated glycosaminoglycans (GAGs) that are selectively up-regulated in the tumor microenvironment (TME). We hypothesized that inhibiting CS-GAG signaling in the TME would stem GBM invasion. Rat F98 GBM cells demonstrated enhanced preferential cell invasion into oversulfated 3-dimensional composite of CSA and CS-E [4- and 4,6-sulfated CS-GAG (COMP)] matrices compared with monosulfated (4-sulfated) and unsulfated hyaluronic acid matrices in microfluidics-based choice assays, which is likely influenced by differential GAG receptor binding specificities. Both F98 and human patient-derived glioma stem cells (GSCs) demonstrated a high degree of colocalization of the GSC marker CD133 and CSPGs. The small molecule sulfated GAG antagonist bis-2-methyl-4-amino-quinolyl-6-carbamide (surfen) reduced invasion and focal adhesions in F98 cells encapsulated in COMP matrices and blocked CD133 and antichondroitin sulfate antibody (CS-56) detection of respective antigens in F98 cells and human GSCs. Surfen-treated F98 cells down-regulated CSPG-binding receptor transcripts and protein, as well as total and activated ERK and protein kinase B. Lastly, rats induced with frontal lobe tumors and treated with a single intratumoral dose of surfen demonstrated reduced tumor burden and spread compared with untreated controls. These results present a first demonstration of surfen as an inhibitor of sulfated GAG signaling to stem GBM invasion.	[Logun, Meghan T.; Wynens, Kallie E.; Mao, Leidong; Zhao, Qun; Karumbaiah, Lohitash] Univ Georgia, Regenerat Biosci Ctr, 425 River Rd, Athens, GA 30605 USA; [Logun, Meghan T.; Karumbaiah, Lohitash] Univ Georgia, Biomed & Hlth Sci Inst, Div Neurosci, Athens, GA 30602 USA; [Logun, Meghan T.; Karumbaiah, Lohitash] Univ Georgia, Coll Agr & Environm Sci, Edgar L Rhodes Ctr Anim & Dairy Sci, Athens, GA 30602 USA; [Simchick, Gregory; Zhao, Qun] Univ Georgia, Dept Phys & Astron, Athens, GA 30602 USA; [Zhao, Wujun] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Mao, Leidong] Univ Georgia, Sch Elect & Comp Engn, Coll Engn, Athens, GA 30602 USA; [Mukherjee, Subhas; Brat, Daniel J.] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Northwestern University; Feinberg School of Medicine	Karumbaiah, L (corresponding author), Univ Georgia, Regenerat Biosci Ctr, 425 River Rd, Athens, GA 30605 USA.	lohitash@uga.edu	Zhao, Qun/C-3813-2011	Zhao, Qun/0000-0003-0784-1024; Simchick, Gregory/0000-0001-9326-7203; Karumbaiah, Lohitash/0000-0001-7969-417X	U.S. National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke [1R01NS099596-01A1]; National Science Foundation (NSF) Engineering Research Center for Cell Manufacturing Technologies (CMaT) Grant [EEC-1648035]; Achievement Rewards for College Scientists (ARCS) Foundation, Inc.; NIH Office of the Director [1S10OD021719-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS099596] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021719] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke; National Science Foundation (NSF) Engineering Research Center for Cell Manufacturing Technologies (CMaT) Grant(National Science Foundation (NSF)); Achievement Rewards for College Scientists (ARCS) Foundation, Inc.; NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Dr. Jesse Schank and laboratory members [University of Georgia (UGA)] for providing access to the Applied Biosystems real-time qPCR instrument. The authors also thank Dr. Tarun Saxena (Duke University, Durham, NC, USA) for technical inputs regarding the use of cell lines and conduct of surgical procedures. This work is supported by the U.S. National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (Grant 1R01NS099596-01A1), and National Science Foundation (NSF) Engineering Research Center for Cell Manufacturing Technologies (CMaT) Grant EEC-1648035 (to L.K.). M.T.L. acknowledges funding from the Achievement Rewards for College Scientists (ARCS) Foundation, Inc.. The authors also acknowledge support by the NIH Office of the Director (Grant 1S10OD021719-01A1) for the purchase of the Imagestream X MK II for the UGA Center for Tropical and Emerging Global Diseases Cytometry Shared Resource Laboratory. The authors declare no conflicts of interest.	Abouzid K, 2008, BIOORGAN MED CHEM, V16, P7543, DOI 10.1016/j.bmc.2008.07.038; Alqasoumi SI, 2009, BIOORG MED CHEM LETT, V19, P6939, DOI 10.1016/j.bmcl.2009.10.065; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Barbero S, 2002, ANN NY ACAD SCI, V973, P60, DOI 10.1111/j.1749-6632.2002.tb04607.x; BERTOLOTTO A, 1986, J NEURO-ONCOL, V4, P43, DOI 10.1007/BF02158001; Betancur MI, 2017, ACS BIOMATER SCI ENG, V3, P420, DOI 10.1021/acsbiomaterials.6b00805; Bouchet A, 2014, TUMOR BIOL, V35, P6221, DOI 10.1007/s13277-014-1783-6; Brat DJ, 2004, CANCER RES, V64, P920, DOI 10.1158/0008-5472.CAN-03-2073; Brown DV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172791; Cai C, 2012, CARBOHYD POLYM, V87, P822, DOI 10.1016/j.carbpol.2011.08.075; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Campos B, 2011, INT J CANCER, V128, P501, DOI 10.1002/ijc.25687; Cheng Y, 2008, BIOORGAN MED CHEM, V16, P4617, DOI 10.1016/j.bmc.2008.02.036; Conover JC, 2008, CELL TISSUE RES, V331, P211, DOI 10.1007/s00441-007-0503-6; Craig SEL, 2011, ANTI-CANCER AGENT ME, V11, P133; Cuddapah VA, 2014, NAT REV NEUROSCI, V15, P455, DOI 10.1038/nrn3765; de Aguiar CBNM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-31; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Dyck S, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1128-2; Ehtesham M, 2006, ONCOGENE, V25, P2801, DOI 10.1038/sj.onc.1209302; Fisher D, 2011, J NEUROSCI, V31, P14051, DOI 10.1523/JNEUROSCI.1737-11.2011; Gaedicke S, 2014, P NATL ACAD SCI USA, V111, pE692, DOI 10.1073/pnas.1314189111; Gao P, 2016, INT J MOL MED, V38, P1190, DOI 10.3892/ijmm.2016.2725; Giese A, 1996, NEUROSURGERY, V39, P235, DOI 10.1097/00006123-199608000-00001; Goffart N, 2015, NEURO-ONCOLOGY, V17, P81, DOI 10.1093/neuonc/nou144; Gopal M, 2003, J PHOTOCH PHOTOBIO B, V72, P69, DOI 10.1016/j.jphotobiol.2003.09.003; Griffin ME, 2013, CURR OPIN CHEM BIOL, V17, P1014, DOI 10.1016/j.cbpa.2013.09.015; Gros C, 2015, J BIOL CHEM, V290, P6293, DOI 10.1074/jbc.M114.594671; Guan Y, 2018, ONCOL LETT, V15, P7595, DOI 10.3892/ol.2018.8269; He JY, 2018, J MOL MED, V96, P265, DOI 10.1007/s00109-017-1618-1; Huang ML, 2018, STEM CELLS, V36, P45, DOI 10.1002/stem.2714; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Jaime-Ramirez AC, 2017, J GENE MED, V19, DOI 10.1002/jgm.2942; Jing H, 2016, THERANOSTICS, V6, P862, DOI 10.7150/thno.12890; Kahlert UD, 2012, J NEUROPATH EXP NEUR, V71, P1086, DOI 10.1097/NEN.0b013e3182772d83; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; Kim Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204865; Kim YH, 2005, BIOCHEM PHARMACOL, V69, P1333, DOI 10.1016/j.bcp.2004.12.019; Kleihues P, 2000, CANCER, V88, P2887, DOI 10.1002/1097-0142(20000615)88:12<2887::AID-CNCR32>3.0.CO;2-F; Kobayashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054278; Laguri C, 2008, CARBOHYD RES, V343, P2018, DOI 10.1016/j.carres.2008.01.047; Lau LW, 2013, NAT REV NEUROSCI, V14, P722, DOI 10.1038/nrn3550; Lefranc F, 2005, J CLIN ONCOL, V23, P2411, DOI 10.1200/JCO.2005.03.089; Logun MT, 2016, J MATER CHEM B, V4, P6052, DOI [10.1039/c6tb01083k, 10.1039/C6TB01083K]; Mak AB, 2011, J BIOL CHEM, V286, P41046, DOI 10.1074/jbc.M111.261545; Markovic DS, 2005, J NEUROPATH EXP NEUR, V64, P754, DOI 10.1097/01.jnen.0000178445.33972.a9; Matsumoto H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12065-4; McDowell KA, 2011, CURR PHARM DESIGN, V17, P2411; Mizoguchi M, 2006, J NEUROPATH EXP NEUR, V65, P1181, DOI 10.1097/01.jnen.0000248549.14962.b2; Mizumoto S, 2013, GLYCOCONJUGATE J, V30, P619, DOI 10.1007/s10719-012-9463-5; Mizumoto S, 2012, J BIOL CHEM, V287, P18985, DOI 10.1074/jbc.M111.313437; Molina JR, 2010, NEOPLASIA, V12, P453, DOI 10.1593/neo.10126; Mooney KL, 2016, J CLIN NEUROSCI, V34, P1, DOI 10.1016/j.jocn.2016.05.012; Mulvihill MJ, 2008, BIOORGAN MED CHEM, V16, P1359, DOI 10.1016/j.bmc.2007.10.061; Munson JM, 2013, CANCER RES, V73, P1536, DOI 10.1158/0008-5472.CAN-12-2838; Nandini CD, 2004, J BIOL CHEM, V279, P50799, DOI 10.1074/jbc.M404746200; Nandini CD, 2006, ADV PHARMACOL, V53, P253, DOI 10.1016/S1054-3589(05)53012-6; Nishii H, 2010, BIOORG MED CHEM LETT, V20, P1405, DOI 10.1016/j.bmcl.2009.12.109; Pellegatta S, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat6463; Pellegatta S, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao2731; Ramirez YP, 2013, PHARMACEUTICALS, V6, P1475, DOI 10.3390/ph6121475; Rao SS, 2013, ACS APPL MATER INTER, V5, P9276, DOI 10.1021/am402097j; Reinhard J, 2016, INT J BIOCHEM CELL B, V81, P174, DOI 10.1016/j.biocel.2016.05.002; Schuksz M, 2008, P NATL ACAD SCI USA, V105, P13075, DOI 10.1073/pnas.0805862105; Serratos IN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120221; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Shteingauz A, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1085-9; Siddiqi FS, 2015, ENDOCRINOLOGY, V156, P1121, DOI 10.1210/en.2014-1650; Silver DJ, 2013, J NEUROSCI, V33, P15603, DOI 10.1523/JNEUROSCI.3004-12.2013; Sirko S, 2010, STEM CELLS, V28, P775, DOI 10.1002/stem.309; Smock RG, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.180026; Sunayama J, 2010, STEM CELLS, V28, P1930, DOI 10.1002/stem.521; Surve CR, 2014, J BIOL CHEM, V289, P17791, DOI 10.1074/jbc.M114.576827; Svendsen A, 2011, ACTA NEUROPATHOL, V122, P495, DOI 10.1007/s00401-011-0867-2; Tabernero A, 2016, NEUROSCIENCE, V323, P183, DOI 10.1016/j.neuroscience.2015.02.029; ten Dam GB, 2007, AM J PATHOL, V171, P1324, DOI 10.2353/ajpath.2007.070111; Tsidulko AY, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01104; Turetsky A, 2015, THERANOSTICS, V5, P796, DOI 10.7150/thno.11220; UMBER F., 1938, Klinische Wochenschrift, V17, P443, DOI 10.1007/BF01775866; Vecino E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125250; Velpula KK, 2012, CELL SIGNAL, V24, P2076, DOI 10.1016/j.cellsig.2012.07.002; von Thun A, 2012, J CELL SCI, V125, P1465, DOI 10.1242/jcs.092916; Wang J. -G., 2011, FRESHW FISH, V4, P6, DOI DOI 10.1371/J0URNAL.P0NE.0023062; Wei YY, 2013, P NATL ACAD SCI USA, V110, P6829, DOI 10.1073/pnas.1217002110; Wenzel NI, 2010, J MED CHEM, V53, P3214, DOI 10.1021/jm9018383; Yadav DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep38128; Yang YL, 2011, BIOMATERIALS, V32, P7932, DOI 10.1016/j.biomaterials.2011.07.018; Zhou FB, 2010, J BIOCHEM, V148, P273, DOI 10.1093/jb/mvq062; Ziegler J, 2019, AM J NUCL MED MOLEC, V9, P93; Zsila F, 2015, CHIRALITY, V27, P605, DOI 10.1002/chir.22471	91	12	12	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11973	11992		10.1096/fj.201802610RR	http://dx.doi.org/10.1096/fj.201802610RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31398290	Green Published, Bronze			2022-12-26	WOS:000507461600030
J	Tang, K; Yu, YD; Zhu, LY; Xu, PW; Chen, J; Ma, JW; Zhang, HF; Fang, HQ; Sun, WW; Zhou, L; Wei, KK; Li, F; Lv, JD; Xie, J; Liu, YY; Huang, B				Tang, Ke; Yu, Yuandong; Zhu, Liyan; Xu, Pingwei; Chen, Jie; Ma, Jingwei; Zhang, Huafeng; Fang, Haiqing; Sun, Weiwei; Zhou, Li; Wei, Keke; Li, Fei; Lv, Jiadi; Xie, Jing; Liu, Yuying; Huang, Bo			Hypoxia-reprogrammed tricarboxylic acid cycle promotes the growth of human breast tumorigenic cells	ONCOGENE			English	Article							CANCER STEM-CELLS; TUMOR-REPOPULATING CELLS; MITOCHONDRIAL ROS; PHOSPHOENOLPYRUVATE CARBOXYKINASE; METASTASIS; HETEROGENEITY; ANGIOGENESIS; MAINTENANCE; METABOLISM; ADAPTATION	Clinical applications of antiangiogenic agents profoundly affect tumor cell behaviors via the resultant hypoxia. To date, how the hypoxia regulates tumor cells remains unclear. Here, we show that hypoxia promotes the growth of human breast tumorigenic cells that repopulate tumors [tumor-repopulating cells (TRCs)] in vitro and in vivo. This stimulating effect is ascribed to hypoxia-induced reactive oxygen species (ROS) that activates Akt and NF-kappa B, dependent on the attenuated tricarboxylic acid (TCA) cycle. We find that fumarate is accumulated in the TCA cycle of hypoxic TRCs, leading to glutathione succination, NADPH/NADP(+) decrease, and an increase in ROS levels. Mechanistically, hypoxia-increased HIF-1 alpha transcriptionally downregulates the expression of mitochondrial phosphoenolpyruvate carboxykinase (PCK2), leading to TCA cycle attenuation and fumarate accumulation. These findings reveal that hypoxia-reprogrammed TCA cycle promotes human breast TRCs growth via a HIF-1 alpha-downregulated PCK2 pathway, implying a need for a combination of an antiangiogenic therapy with an antioxidant modulator.	[Tang, Ke; Yu, Yuandong; Zhu, Liyan; Xu, Pingwei; Chen, Jie; Ma, Jingwei; Zhang, Huafeng; Fang, Haiqing; Sun, Weiwei; Zhou, Li; Wei, Keke; Li, Fei; Huang, Bo] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Biochem & Mol Biol, Wuhan 430030, Hubei, Peoples R China; [Lv, Jiadi; Xie, Jing; Liu, Yuying; Huang, Bo] Chinese Acad Med Sci & Peking Union Med Coll, Dept Immunol, Inst Basic Med Sci, Beijing 100005, Peoples R China; [Lv, Jiadi; Xie, Jing; Liu, Yuying; Huang, Bo] Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Med Mol Biol, Beijing 100005, Peoples R China; [Liu, Yuying; Huang, Bo] Chinese Acad Med Sci, Clin Immunol Ctr, Beijing 100005, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Huang, B (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Biochem & Mol Biol, Wuhan 430030, Hubei, Peoples R China.; Huang, B (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Dept Immunol, Inst Basic Med Sci, Beijing 100005, Peoples R China.; Huang, B (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Med Mol Biol, Beijing 100005, Peoples R China.; Huang, B (corresponding author), Chinese Acad Med Sci, Clin Immunol Ctr, Beijing 100005, Peoples R China.	tjhuangbo@hotmail.com	Liu, Yuying/ABD-9637-2021	Liu, Yuying/0000-0003-2182-7210	National Natural Science Foundation of China [81788101, 81530080, 81601366]; CAMS Initiative for Innovative Medicine [2016-I2M-1-007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAMS Initiative for Innovative Medicine	This work was supported by National Natural Science Foundation of China (81788101, 81530080, and 81601366), CAMS Initiative for Innovative Medicine (2016-I2M-1-007).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alderson NL, 2006, ARCH BIOCHEM BIOPHYS, V450, P1, DOI 10.1016/j.abb.2006.03.005; Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Brooks MD, 2015, CELL STEM CELL, V17, P260, DOI 10.1016/j.stem.2015.08.014; Bruna A, 2016, CELL, V167, P260, DOI 10.1016/j.cell.2016.08.041; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Chua YL, 2010, J BIOL CHEM, V285, P31277, DOI 10.1074/jbc.M110.158485; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Conley SJ, 2012, P NATL ACAD SCI USA, V109, P2784, DOI 10.1073/pnas.1018866109; Dieter SM, 2011, CELL STEM CELL, V9, P357, DOI 10.1016/j.stem.2011.08.010; Garcia-Perez C, 2012, P NATL ACAD SCI USA, V109, P4497, DOI 10.1073/pnas.1118244109; Ghajar CM, 2015, NAT REV CANCER, V15, P238, DOI 10.1038/nrc3910; Gilkes DM, 2014, NAT REV CANCER, V14, P430, DOI 10.1038/nrc3726; Hitosugi T, 2011, MOL CELL, V44, P864, DOI 10.1016/j.molcel.2011.10.015; Hou HG, 2016, MED GAS RES, V6, P138, DOI 10.4103/2045-9912.191359; Koren S, 2015, MOL CELL, V60, P537, DOI 10.1016/j.molcel.2015.10.031; Lee CU, 2015, ANGEW CHEM INT EDIT, V54, P13796, DOI 10.1002/anie.201506338; Li Y, 2015, CANCER RES, V75, P1191, DOI 10.1158/0008-5472.CAN-14-2615; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Liu J, 2012, NAT MATER, V11, P734, DOI [10.1038/nmat3361, 10.1038/NMAT3361]; Liu YY, 2018, CANCER CELL, V33, P480, DOI 10.1016/j.ccell.2018.02.005; Liu YY, 2018, J CLIN INVEST, V128, P1057, DOI 10.1172/JCI96329; Lou YM, 2011, CANCER RES, V71, P3364, DOI 10.1158/0008-5472.CAN-10-4261; Luo S, 2017, ONCOGENE, V36, P3609, DOI 10.1038/onc.2016.520; Ma RH, 2018, NAT CELL BIOL, V20, P21, DOI 10.1038/s41556-017-0002-2; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Man JH, 2018, CELL STEM CELL, V22, P104, DOI 10.1016/j.stem.2017.10.005; McIntyre A, 2012, CLIN CANCER RES, V18, P3100, DOI 10.1158/1078-0432.CCR-11-1877; Medema JP, 2013, NAT CELL BIOL, V15, P338, DOI 10.1038/ncb2717; Montagner M, 2012, NATURE, V487, P380, DOI 10.1038/nature11207; Muz B, 2015, HYPOXIA, V3, P83, DOI 10.2147/HP.S93413; Olcina MM, 2016, ONCOGENE, V35, P793, DOI 10.1038/onc.2015.134; Ostergaard L, 2013, CANCER RES, V73, P5618, DOI 10.1158/0008-5472.CAN-13-0964; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Sabharwal SS, 2014, NAT REV CANCER, V14, P709, DOI 10.1038/nrc3803; Samanta D, 2016, CANCER RES, V76, P4430, DOI 10.1158/0008-5472.CAN-16-0530; Semenza GL, 2017, EMBO J, V36, P252, DOI 10.15252/embj.201695204; Shadel GS, 2015, CELL, V163, P560, DOI 10.1016/j.cell.2015.10.001; Sullivan LB, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-17; Sullivan LB, 2013, MOL CELL, V51, P236, DOI 10.1016/j.molcel.2013.05.003; Vincent EE, 2015, MOL CELL, V60, P195, DOI 10.1016/j.molcel.2015.08.013; Weyemi U, 2012, ONCOGENE, V31, P1117, DOI 10.1038/onc.2011.327; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Wong CCL, 2011, P NATL ACAD SCI USA, V108, P16369, DOI 10.1073/pnas.1113483108; Xing F, 2011, ONCOGENE, V30, P4075, DOI 10.1038/onc.2011.122; Yang CD, 2014, MOL CELL, V56, P414, DOI 10.1016/j.molcel.2014.09.025; Zheng L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7001	48	31	33	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 31	2019	38	44					6970	6984		10.1038/s41388-019-0932-1	http://dx.doi.org/10.1038/s41388-019-0932-1			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JJ1AO	31409901	hybrid			2022-12-26	WOS:000493892900002
J	Gobbi, G; Donati, B; Do Valle, IF; Reggiani, F; Torricelli, F; Remondini, D; Castellani, G; Ambrosetti, DC; Ciarrocchi, A; Sancisi, V				Gobbi, Giulia; Donati, Benedetta; Do Valle, Italo Faria; Reggiani, Francesca; Torricelli, Federica; Remondini, Daniel; Castellani, Gastone; Ambrosetti, Davide Carlo; Ciarrocchi, Alessia; Sancisi, Valentina			The Hippo pathway modulates resistance to BET proteins inhibitors in lung cancer cells	ONCOGENE			English	Article							DOSE-ESCALATION; TAZ; BRD4; YAP; SENSITIVITY; EXPRESSION; OVEREXPRESSION; TUMORIGENESIS; PROGRESSION; SUPPRESSES	Inhibitors of BET proteins (BETi) are anti-cancer drugs that have shown efficacy in pre-clinical settings and are currently in clinical trials for different types of cancer, including non-small cell lung cancer (NSCLC). Currently, no predictive biomarker is available to identify patients that may benefit from this treatment. To uncover the mechanisms of resistance to BETi, we performed a genome-scale CRISPR/Cas9 screening in lung cancer cells. We identified three Hippo pathway genes, LATS2, TAOK1, and NF2, as key determinants for sensitivity to BETi. The knockout of these genes induces resistance to BETi, by promoting TAZ nuclear localization and transcriptional activity. Conversely, TAZ expression promotes resistance to these drugs. We also showed that TAZ, YAP, and their partner TEAD are direct targets of BRD4 and that treatment with BETi downregulates their expression. Noticeably, molecular alterations in one or more of these genes are present in a large fraction of NSCLC patients and TAZ amplification or overexpression correlates with a worse outcome in lung adenocarcinoma. Our data define the central role of Hippo pathway in mediating resistance to BETi and provide a rationale for using BETi to counter-act YAP/TAZ-mediated pro-oncogenic activity.	[Gobbi, Giulia; Donati, Benedetta; Reggiani, Francesca; Torricelli, Federica; Ciarrocchi, Alessia; Sancisi, Valentina] Azienda USL Reggio Emilia IRCCS, Lab Translat Res, Reggio Emilia, Italy; [Do Valle, Italo Faria] Northeastern Univ, Dept Phys, Ctr Complex Network Res, Boston, MA 02115 USA; [Remondini, Daniel; Castellani, Gastone] Univ Bologna, Dept Phys & Astron, Bologna, Italy; [Ambrosetti, Davide Carlo] Univ Bologna, Dept Pharm & Biotechnol FaBit, Bologna, Italy	Northeastern University; University of Bologna; University of Bologna	Sancisi, V (corresponding author), Azienda USL Reggio Emilia IRCCS, Lab Translat Res, Reggio Emilia, Italy.	valentina.sancisi@ausl.re.it	dovalle, italo/AAH-2621-2020; Sancisi, Valentina/H-6701-2018; Donati, Benedetta/H-7741-2018; torricelli, federica/H-7734-2018; REGGIANI, FRANCESCA/K-1082-2018; Gobbi, Giulia/AAB-6104-2019; Donati, Benedetta/AAA-7779-2022; Ciarrocchi, Alessia/AAA-1130-2019; Remondini, Daniel/ABA-9971-2020	Sancisi, Valentina/0000-0003-4357-1228; Donati, Benedetta/0000-0002-9163-8194; torricelli, federica/0000-0003-1954-5695; REGGIANI, FRANCESCA/0000-0002-4090-8908; Gobbi, Giulia/0000-0002-4746-967X; Donati, Benedetta/0000-0002-9163-8194; Ciarrocchi, Alessia/0000-0002-5541-2075; 				Amorim S, 2016, LANCET HAEMATOL, V3, pE196, DOI 10.1016/S2352-3026(16)00021-1; Bartucci M, 2015, ONCOGENE, V34, P681, DOI 10.1038/onc.2014.5; Basu-Roy U, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7411; Berthon C, 2016, LANCET HAEMATOL, V3, pE186, DOI 10.1016/S2352-3026(15)00247-1; Boggiano JC, 2011, DEV CELL, V21, P888, DOI 10.1016/j.devcel.2011.08.028; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; Cheng HY, 2016, ONCOTARGET, V7, P28976, DOI 10.18632/oncotarget.6721; Dai XP, 2017, NAT MED, V23, DOI 10.1038/nm.4378; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Donati B, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0915-9; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Gao ZY, 2018, CANCER BIOL THER, V19, P407, DOI 10.1080/15384047.2018.1423923; Ghiso E, 2017, NEOPLASIA, V19, P1012, DOI 10.1016/j.neo.2017.10.003; Gugnoni M, 2017, ONCOGENE, V36, P667, DOI 10.1038/onc.2016.237; Gujral TS, 2017, P NATL ACAD SCI USA, V114, pE3729, DOI 10.1073/pnas.1703096114; Janouskova H, 2017, MOL CELL PROTEOMICS, V16, pS68; Kanno T, 2014, NAT STRUCT MOL BIOL, V21, P1047, DOI 10.1038/nsmb.2912; Kawano S, 2015, J BIOCHEM, V158, P413, DOI 10.1093/jb/mvv051; Klingbeil O, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.271; Lau AN, 2014, EMBO J, V33, P468, DOI 10.1002/embj.201386082; Li W, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0843-6; Lin LP, 2015, NAT GENET, V47, P250, DOI 10.1038/ng.3218; Lockwood WW, 2012, P NATL ACAD SCI USA, V109, P19408, DOI 10.1073/pnas.1216363109; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Manzotti G, 2019, CANCERS, V11, DOI 10.3390/cancers11030304; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Mohseni M, 2014, NAT CELL BIOL, V16, P108, DOI 10.1038/ncb2884; Sancisi V, 2017, NUCLEIC ACIDS RES, V45, P11249, DOI 10.1093/nar/gkx802; Sancisi V, 2015, CANCER RES, V75, P1868, DOI 10.1158/0008-5472.CAN-14-2087; Sancisi V, 2012, J CLIN ENDOCR METAB, V97, pE2006, DOI 10.1210/jc.2012-1903; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi J, 2014, CANCER CELL, V25, P210, DOI 10.1016/j.ccr.2014.01.028; Shimamura T, 2013, CLIN CANCER RES, V19, P6183, DOI 10.1158/1078-0432.CCR-12-3904; Stein C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005465; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Wang Y, 2010, CANCER SCI, V101, P1279, DOI 10.1111/j.1349-7006.2010.01511.x; Xie M, 2012, J THORAC ONCOL, V7, P799, DOI 10.1097/JTO.0b013e318248240b; Xu MZ, 2011, ONCOGENE, V30, P1229, DOI 10.1038/onc.2010.504; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025; Zaman A, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.05.02; Zanconato F, 2018, NAT MED, V24, P1599, DOI 10.1038/s41591-018-0158-8; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zhang PZ, 2017, NAT MED, V23, P1055, DOI 10.1038/nm.4379; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao Y, 2016, CELL REP, V16, P2003, DOI 10.1016/j.celrep.2016.07.032	50	36	36	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 17	2019	38	42					6801	6817		10.1038/s41388-019-0924-1	http://dx.doi.org/10.1038/s41388-019-0924-1			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JE5UU	31406246				2022-12-26	WOS:000490758200001
J	Liao, SY; Kuo, IY; Chen, YT; Liao, PC; Liu, YF; Wu, HY; Lai, WW; Wang, YC				Liao, Sheng-You; Kuo, I-Ying; Chen, Yu-Ting; Liao, Pao-Chi; Liu, Ya-Fen; Wu, Hsin-Yi; Lai, Wu-Wei; Wang, Yi-Ching			AKT-mediated phosphorylation enhances protein stability and transcription activity of ZNF322A to promote lung cancer progression	ONCOGENE			English	Article							ZINC-FINGER PROTEIN; INHIBITOR; GROWTH; RECOGNITION; DEGRADATION; ACTIVATION; EXPRESSION; EFFICACY; PATHWAY; MK-2206	ZNF322A is an oncogenic zinc-finger transcription factor. Our published results show that ZNF322A positively regulates transcription of alpha-adducin (ADD1) and cyclin D1 (CCND1) to promote tumorgenicity of lung cancer. However, the upstream regulatory mechanisms of ZNF322A protein function remain elusive. Here, we demonstrate that AKT could phosphorylate ZNF322A by in vitro kinase assay and cell-based mass spectrometry analysis. Overexpression of AKT promoted ZNF322A protein stability and transcriptional activity, whereas these effects were inhibited by knockdown of AKT or treating with AKT inhibitor. We studied AKT-mediated phosphorylation sites, viz. Thr-150, Ser-224, Thr-234, and Thr-262. ZNF322A phosphorylation at Thr-262 by AKT promoted ZNF322A protein stability thus increased ADD1 promoter activity. Interestingly, phosphorylation at Thr-150, Ser-224, and Thr-234 enhanced transcription activity without affecting protein stability of ZNF322A. Chromatin immunoprecipitation and DNA affinity precipitation assays showed that ZNF322A phosphorylation defective mutants Thr-150A, Ser-224A, and Thr-234A attenuated chromatin binding and DNA binding affinity to ADD1 and CCNDI promoters compared with wild-type ZNF322A. Furthermore, AKT-mediated Thr-150, Ser-224, Thr-234, and Thr-262 phosphorylation promoted lung cancer cell growth and metastasis in vitro and in vivo. Clinically, expression of phosphorylated ZNF322A (p-ZNF) correlated with actively phosphorylated AKT (p-AKT) in tumor specimens from 150 lung cancer patients. Multivariate Cox regression analysis indicated that combined p-AKT and p-ZNF expression profile was an independent factor to predict the clinical outcome in lung cancer patients. Our results reveal a new mechanism of AKT signaling in promoting ZNF322A protein stability and transcriptional activity in lung cancer cell, xenograft, and clinical models.	[Liao, Sheng-You; Wang, Yi-Ching] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Kuo, I-Ying; Chen, Yu-Ting; Liu, Ya-Fen; Wang, Yi-Ching] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan; [Liao, Pao-Chi] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 704, Taiwan; [Wu, Hsin-Yi] Natl Taiwan Univ, Instrumentat Ctr, Tainan 10617, Taiwan; [Lai, Wu-Wei] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Surg, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Taiwan University; National Cheng Kung University; National Cheng Kung University Hospital	Wang, YC (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan.; Wang, YC (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan.	ycw5798@mail.ncku.edu.tw	Wang, Yi-Ching/J-8702-2019; , 賴吾為/T-8615-2019; Kuo, I-Ying/AAE-4741-2020	Wang, Yi-Ching/0000-0002-7694-2067; , 賴吾為/0000-0001-9174-8310; 	Human Biobank, Research Center of Clinical Medicine, National Cheng Kung University Hospital; Taiwan Ministry of Science and Technology [MOST106-2320-B-006-071-MY3]	Human Biobank, Research Center of Clinical Medicine, National Cheng Kung University Hospital; Taiwan Ministry of Science and Technology	We are grateful for the support from the Human Biobank, Research Center of Clinical Medicine, National Cheng Kung University Hospital. We thank Mass Spectrometry Facilities of National Cheng Kung University for MS analysis. This work is supported by the Taiwan Ministry of Science and Technology Grant MOST106-2320-B-006-071-MY3.	Agarwal NK, 2016, BLOOD, V127, P605, DOI 10.1182/blood-2015-07-658781; Carpenter RL, 2015, ONCOGENE, V34, P546, DOI 10.1038/onc.2013.582; Chuang CW, 2013, J CELL PHYSIOL, V228, P341, DOI 10.1002/jcp.24136; Faber AC, 2009, P NATL ACAD SCI USA, V106, P19503, DOI 10.1073/pnas.0905056106; Fang L, 2014, MOL CELL, V55, P537, DOI 10.1016/j.molcel.2014.06.018; Filtz TM, 2014, TRENDS PHARMACOL SCI, V35, P76, DOI 10.1016/j.tips.2013.11.005; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Harper J, 2007, CANCER RES, V67, P8736, DOI 10.1158/0008-5472.CAN-07-1617; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Hong J, 2011, CANCER RES, V71, P3980, DOI 10.1158/0008-5472.CAN-10-2914; Ichihara E, 2017, CANCER RES, V77, P2990, DOI 10.1158/0008-5472.CAN-16-2300; Jacobsen K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00450-6; Jen J, 2016, ONCOGENE, V35, P2357, DOI 10.1038/onc.2015.296; Jen JY, 2019, CELL DEATH DIFFER, V26, P1283, DOI 10.1038/s41418-018-0204-6; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Lehmann W, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10498; Li YQ, 2004, BIOCHEM BIOPH RES CO, V325, P1383, DOI 10.1016/j.bbrc.2004.10.183; Liao SY, 2017, ONCOGENE, V36, P5722, DOI 10.1038/onc.2017.168; Lo FY, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-235; McCarty AS, 2003, MOL CELL, V11, P459, DOI 10.1016/S1097-2765(03)00043-1; Ono M, 2004, MOL CANCER THER, V3, P465; Persikov AV, 2015, NUCLEIC ACIDS RES, V43, P1965, DOI 10.1093/nar/gku1395; Phuchareon J, 2015, P NATL ACAD SCI USA, V112, pE3855, DOI 10.1073/pnas.1510733112; Po A, 2017, ONCOGENE, V36, P4641, DOI 10.1038/onc.2017.91; Ramos A, 2018, FASEB J, V32, P6982, DOI 10.1096/fj.201801167RR; Razin SV, 2012, BIOCHEMISTRY-MOSCOW+, V77, P217, DOI 10.1134/S0006297912030017; Riverso M, 2017, ONCOGENE, V36, P3322, DOI 10.1038/onc.2016.481; Singh AR, 2016, MOL CANCER THER, V15, P2553, DOI 10.1158/1535-7163.MCT-15-0976; Tasian SK, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00108; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Wolin EM, 2013, CANCER LETT, V335, P1, DOI 10.1016/j.canlet.2013.02.016; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263; Zheng HQ, 2014, CANCER CELL, V26, P358, DOI 10.1016/j.ccr.2014.07.022	35	14	14	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 10	2019	38	41					6723	6736		10.1038/s41388-019-0928-x	http://dx.doi.org/10.1038/s41388-019-0928-x			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JC8UZ	31399647				2022-12-26	WOS:000489552900001
J	Kuhn, J; Schweitzer, K; Ruess, L				Kuehn, Jakob; Schweitzer, Kathlin; Ruess, Liliane			Diversity and specificity of lipid patterns in basal soil food web resources	PLOS ONE			English	Article							ACID SIGNATURE ANALYSIS; FATTY-ACIDS; MICROBIAL COMMUNITIES; STABLE-ISOTOPE; COLLEMBOLA; DIETS; BIOSYNTHESIS; BIOMARKERS	Soil food webs are important drivers for key ecological functions in terrestrial systems such as carbon and nutrient cycling. However, soil food web models generally lack quantitative data, mainly due to the shortage in high-throughput methods to describe energy flows. In marine environments, multivariate optimization models (Quantitative Fatty Acid Signature Analysis) and Bayesian approaches (source-tracking algorithm) were established to predict the proportion of predator diets using lipids as tracers. A premise for the application of such models to soil systems is to acquire the fatty acid pattern of a broad range of resources and to reveal potential overlap in their signatures. We present a comprehensive comparison of lipid pattern across widespread taxa of plants (leaves and roots, n = 48), algae (n = 59), fungi (n = 60), and bacteria (n = 62) as basal food web resources. Lipid profiles from microorganisms and algae were assessed from laboratory cultures, whereas plant tissue was derived from an arable field. A lipid library was constructed and multivariate data analyses (hierarchical clustering, nMDS) was used to assess the extent of separation in lipid pattern by species or resource type. The performance of the lipid library was tested by leave-one-prey-out (LOPO) analysis, giving the distinctiveness of the resource (prey) groups. Fungi and plant leaves were correctly assigned based on their lipid pattern with more than 98%, while plant roots and bacteria achieved 88 and 85%, respectively. However, algae were only correctly classified by 60%, pointing to a bias in the herbivore food chain. Fatty acids most important for separation of algae and plant leaves were of the omega 3 type, i.e. 16:3 omega 3 and 18:3 omega 3. In plant roots 18:1 omega 9 was most important, whereas bacteria were distinguished predominantly by methyl-branched fatty acids. Overall, the lipid pattern of major soil food web resources are sufficiently differentiated to allow for qualitative (biomarker) analyses as well as quantitative modelling, yet with precaution in the case of algae.	[Kuehn, Jakob; Ruess, Liliane] Humboldt Univ, Ecol Grp, Inst Biol, Berlin, Germany; [Schweitzer, Kathlin] Humboldt Univ, Inst Agr & Hort Sci, Dept Crop & Anim Sci, Div Plant Nutr & Fertilisat, Berlin, Germany	Humboldt University of Berlin; Humboldt University of Berlin	Kuhn, J (corresponding author), Humboldt Univ, Ecol Grp, Inst Biol, Berlin, Germany.	Jakob.kuehn@hu-berlin.de			German Science Foundation [RU 780/12-1]	German Science Foundation(German Research Foundation (DFG))	The authors acknowledge the German Science Foundation (https://www.dfg.de/), granting RU 780/12-1 to LR to fund and support the work of WJakob Kuhn. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Bromaghin JF, 2016, ECOL RES, V31, P597, DOI 10.1007/s11284-016-1357-8; Bromaghin JF, 2016, METHODS ECOL EVOL, V7, P51, DOI 10.1111/2041-210X.12456; Bromaghin JF, 2015, ECOL EVOL, V5, P1249, DOI 10.1002/ece3.1429; Bromaghin JF, 2017, QFASAR QUANTITATIVE; Budge SM, 2012, CAN J FISH AQUAT SCI, V69, P1033, DOI [10.1139/F2012-039, 10.1139/f2012-039]; Buse T, 2013, PEDOBIOLOGIA, V56, P153, DOI 10.1016/j.pedobi.2013.03.005; Campanharo JC, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw245; Chitwood DJ, 1998, PHYSIOLOGY AND BIOCHEMISTRY OF FREE-LIVING AND PLANT-PARASITIC NEMATODES, P303; Chmielewski FM, 1999, AGR FOREST METEOROL, V96, P39, DOI 10.1016/S0168-1923(99)00045-3; Cosme M, 2018, TRENDS PLANT SCI, V23, P577, DOI 10.1016/j.tplants.2018.04.004; Field C, 2015, J AGR BIOL ENVIR ST, V16, P45; Happel A, 2016, CAN J FISH AQUAT SCI, V73, P1222, DOI 10.1139/cjfas-2015-0328; Haubert D, 2006, SOIL BIOL BIOCHEM, V38, P2004, DOI 10.1016/j.soilbio.2005.11.031; IUSS Working Group WRB, 2006, WORLD SOIL RESOURCES; Iverson SJ, 2004, ECOL MONOGR, V74, P211, DOI 10.1890/02-4105; Joergensen RG, 2008, SOIL BIOL BIOCHEM, V40, P2977, DOI 10.1016/j.soilbio.2008.08.017; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; Kattner G, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P257, DOI 10.1007/978-0-387-89366-2_11; Klamer M, 2004, SOIL BIOL BIOCHEM, V36, P57, DOI 10.1016/j.soilbio.2003.08.019; Kuhn J, 2018, METHODS ECOL EVOL, V9, P1265, DOI 10.1111/2041-210X.12966; Lechevalier H., 1988, MICROB LIPIDS, V1, P869; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Meynier L, 2010, J MAMMAL, V91, P1484, DOI 10.1644/09-MAMM-A-299.1; Mongrand S, 1998, PHYTOCHEMISTRY, V49, P1049, DOI 10.1016/S0031-9422(98)00243-X; Muller-Navarra DC, 2008, INT REV HYDROBIOL, V93, P489, DOI 10.1002/iroh.200711046; Murakami Y, 2000, SCIENCE, V287, P476, DOI 10.1126/science.287.5452.476; Ngosong C, 2012, J LIPIDS, V2012, DOI 10.1155/2012/236807; Oksanen J, 2018, R PACKAG, V2, P5; Oliver KL, 2008, APPL ENVIRON MICROB, V74, P5340, DOI 10.1128/AEM.02836-07; Pausch J, 2016, FUNCT ECOL, V30, P479, DOI 10.1111/1365-2435.12512; R Core Team, 2018, R LANG ENV STAT COMP; Ruess L, 2005, ECOLOGY, V86, P2075, DOI 10.1890/04-1399; Ruess L, 2004, OECOLOGIA, V139, P336, DOI 10.1007/s00442-004-1514-6; Ruess L, 2002, SOIL BIOL BIOCHEM, V34, P745, DOI 10.1016/S0038-0717(01)00231-0; Ruess L, 2007, SOIL BIOL BIOCHEM, V39, P1990, DOI 10.1016/j.soilbio.2007.03.002; Ruess L, 2010, SOIL BIOL BIOCHEM, V42, P1898, DOI 10.1016/j.soilbio.2010.07.020; Scheu S, 2002, EUR J SOIL BIOL, V38, P11, DOI 10.1016/S1164-5563(01)01117-7; Scheu S, 2013, MICROORGANISMS SOILS, P253; Shi ZY, 2017, LEGUME RES, V40, P965, DOI 10.18805/lr.v40i04.9013; Sprecher H, 1995, J LIPID RES, V36, P2471; Thiemann GW, 2008, ECOL MONOGR, V78, P591, DOI 10.1890/07-1050.1; Traugott M, 2013, ADV ECOL RES, V49, P177, DOI 10.1016/B978-0-12-420002-9.00003-2; Vance DE, 2002, BIOCH LIPIDS LIPOPRO; Weete J.D., 1980, LIPID BIOCH FUNGI OT; Williams CT, 2010, J ORNITHOL, V151, P531, DOI 10.1007/s10336-010-0513-0; Zelles L, 1997, CHEMOSPHERE, V35, P275, DOI 10.1016/S0045-6535(97)00155-0; Zelles L, 1999, BIOL FERT SOILS, V29, P111, DOI 10.1007/s003740050533	49	11	12	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0221102	10.1371/journal.pone.0221102	http://dx.doi.org/10.1371/journal.pone.0221102			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430306	Green Published, gold, Green Submitted			2022-12-26	WOS:000485026800025
J	Tornabene, E; Helms, HCC; Pedersen, SF; Brodin, B				Tornabene, Erica; Helms, Hans Christian Cederberg; Pedersen, Stine Falsig; Brodin, Birger			Effects of oxygen-glucose deprivation (OGD) on barrier properties and mRNA transcript levels of selected marker proteins in brain endothelial cells/astrocyte co-cultures	PLOS ONE			English	Article							P-GLYCOPROTEIN EXPRESSION; SHEAR-STRESS; RAT-BRAIN; GROWTH-FACTOR; CELLS; MODEL; RESISTANCE; INCREASE; STROKE; PERMEABILITY	lschemic stroke has been shown to induce breakdown of the blood-brain barrier, although these changes are not fully characterized. Oxygen-glucose deprivation (OGD) has been used to investigate the effects of ischemia in cultured brain capillary endothelial cells, however this involves a change of medium which in itself may affect the cells. The aim of the present study was to investigate the effect of OGD and simple medium exchange followed by 48 h of reperfusion on barrier properties of primary bovine endothelial cells co-cultured with rat astrocytes. Barrier properties were evaluated by transendothelial electrical resistance measurements, passive permeability of flux markers, RT-qPCR and immunocytochemistry. Both OGD and simple medium exchange caused an increase in endothelial monolayer permeability. This correlated with reduced transcript levels of a number of tight junction and tight junction-associated proteins (claudin-1, claudin-5, occludin, ZO-1, tricellulin, marveld3 and PECAM-1), as well as with altered transcript level of several transporters and receptors (GLUT-1, HB-EGF, InsR, TfR, two members of the low density lipoprotein receptor family, LDLR and LRP-1, and the efflux transporter BCRP). In contrast, effects induced specifically by OGD were transient de-localization of claudin-5 from the junction zone, increased InsR localization at the plasma membrane and transient downregulation of MRP-1 and P-gp transcript levels. In conclusion, OGD caused changes in claudin-5 and InsR localization, as well as in MRP-1 and P-gp transcript levels. Our results however also indicated that medium exchange alone caused changes in functional barrier properties and expression levels of wide range of proteins.	[Tornabene, Erica; Helms, Hans Christian Cederberg; Brodin, Birger] Univ Copenhagen, Fac Hlth & Med Sci, Dept Pharm, Copenhagen, Denmark; [Pedersen, Stine Falsig] Univ Copenhagen, Dept Biol, Fac Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Brodin, B (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Pharm, Copenhagen, Denmark.	birger.brodin@sund.ku.dk	Brodin, Birger/Y-9780-2019; Pedersen, Stine Falsig/M-8347-2014	Brodin, Birger/0000-0002-0823-1220; Helms, Hans Christian Cederberg/0000-0001-6105-1707; Pedersen, Stine Falsig/0000-0002-3044-7714	Lundbeck Foundation; Simon Foughner Hartman's Family Foundation; Novo Nordisk Foundation [NNF16OC0023194]	Lundbeck Foundation(Lundbeckfonden); Simon Foughner Hartman's Family Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	BB was supported via a Lundbeck Foundation research grant. (https://www.lundbeckfonden.com/) and a grant from Simon Foughner Hartman's Family Foundation. SFP was funded by The Novo Nordisk Foundation (NNF16OC0023194). https://novonordiskfonden.dk/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruscato TJ, 1999, J PHARMACOL EXP THER, V289, P668; Banks WA, 2012, PHARMACOL THERAPEUT, V136, P82, DOI 10.1016/j.pharmthera.2012.07.006; Brillault J, 2002, J NEUROCHEM, V83, P807, DOI 10.1046/j.1471-4159.2002.01186.x; Cen J, 2013, J PHARM PHARMACOL, V65, P665, DOI 10.1111/jphp.12033; Chatzizisis YS, 2007, J AM COLL CARDIOL, V49, P2379, DOI 10.1016/j.jacc.2007.02.059; Chen KD, 1999, J BIOL CHEM, V274, P18393, DOI 10.1074/jbc.274.26.18393; CRONE C, 1982, BRAIN RES, V241, P49, DOI 10.1016/0006-8993(82)91227-6; DAVIES PF, 1991, J VASC SURG, V13, P729; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; Dazert P, 2006, NEUROSCIENCE, V142, P1071, DOI 10.1016/j.neuroscience.2006.07.056; Estrada R, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3608137; Felix RA, 2002, J NEUROCHEM, V80, P64, DOI 10.1046/j.0022-3042.2001.00660.x; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Helms HC, 2014, METHODS MOL BIOL, V1135, P365, DOI 10.1007/978-1-4939-0320-7_30; Helms HC, 2014, AAPS J, V16, P1046, DOI 10.1208/s12248-014-9628-1; Helms HC, 2010, AAPS J, V12, P759, DOI 10.1208/s12248-010-9237-6; Hersom M, 2018, AM J PHYSIOL-ENDOC M, V315, pE531, DOI 10.1152/ajpendo.00350.2016; Hertz L., 1989, DISSECTION TISSUE CU, P105; Kawahara N, 1999, J CEREBR BLOOD F MET, V19, P307, DOI 10.1097/00004647-199903000-00009; Kilic E, 2008, BRAIN, V131, P2679, DOI 10.1093/brain/awn222; Kondo T, 2004, BIOCHEM BIOPH RES CO, V317, P315, DOI 10.1016/j.bbrc.2004.03.043; Koto T, 2007, AM J PATHOL, V170, P1389, DOI 10.2353/ajpath.2007.060693; Kuntz M, 2014, J CEREBR BLOOD F MET, V34, P95, DOI 10.1038/jcbfm.2013.169; Li N, 2003, J NUTR BIOCHEM, V14, P401, DOI 10.1016/S0955-2863(03)00071-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Neuhaus W, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00352; Patak P, 2011, EXP TRANSL STROKE ME, V3, P1; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; REESE TS, 1967, J CELL BIOL, V34, P207, DOI 10.1083/jcb.34.1.207; Robertson SJ, 2009, J NEUROCHEM, V111, P132, DOI 10.1111/j.1471-4159.2009.06306.x; Sommer CJ, 2017, ACTA NEUROPATHOL, V133, P245, DOI 10.1007/s00401-017-1667-0; Spudich A, 2006, NAT NEUROSCI, V9, P487, DOI 10.1038/nn1676; Tanaka N, 1999, BRAIN RES, V827, P130, DOI 10.1016/S0006-8993(99)01319-0; Tornabene E, 2016, J PHARM SCI-US, V105, P398, DOI 10.1016/j.xphs.2015.11.041; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Yang L, 2012, METHODS MOL BIOL, V814, P451, DOI 10.1007/978-1-61779-452-0_30; Zhang J, 2012, AM J PHYSIOL-HEART C, V302, pH983, DOI 10.1152/ajpheart.00168.2011	37	28	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0221103	10.1371/journal.pone.0221103	http://dx.doi.org/10.1371/journal.pone.0221103			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5MK	31425564	Green Submitted, Green Published, gold			2022-12-26	WOS:000485022400026
J	Campbell, ZA; Thumbi, SM; Marsh, TL; Quinlan, MB; Shirima, GM; Palmer, GH				Campbell, Zoe A.; Thumbi, Samuel M.; Marsh, Thomas L.; Quinlan, Marsha B.; Shirima, Gabriel M.; Palmer, Guy H.			Why isn't everyone using the thermotolerant vaccine? Preferences for Newcastle disease vaccines by chicken-owning households in Tanzania	PLOS ONE			English	Article							VILLAGE CHICKENS; CHALLENGES	Understanding preferences for veterinary vaccines in low and middle-income countries is important for increasing vaccination coverage against infectious diseases, especially when the consumer is responsible for choosing between similar vaccines. Over-the-counter sales of vaccines without a prescription gives decision-making power to consumers who may value vaccine traits differently from national or international experts and vaccine producers and distributers. We examine consumer preferences for La Sota and I-2 Newcastle disease vaccines in Tanzania to understand why two vaccines co-exist in the market when I-2 is considered technically superior because of its thermotolerance. Household survey and focus group results indicate consumers perceive both vaccines to be effective, use the two vaccines interchangeably when the preferred vaccine is unavailable, and base preferences more on administration style than thermotolerance. Considering the consumers' perspectives provides a way to increase vaccination coverage by targeting users with a vaccine that fits their preferences.	[Campbell, Zoe A.; Thumbi, Samuel M.; Marsh, Thomas L.; Quinlan, Marsha B.; Shirima, Gabriel M.; Palmer, Guy H.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Campbell, Zoe A.; Shirima, Gabriel M.; Palmer, Guy H.] NM AIST, Arusha, Tanzania; [Thumbi, Samuel M.] Kenya Med Res Inst KEMRI, Kisian, Kenya; [Marsh, Thomas L.] Washington State Univ, Sch Econ Sci, Pullman, WA 99164 USA; [Quinlan, Marsha B.] Washington State Univ, Dept Anthropol, Pullman, WA 99164 USA	Washington State University; Kenya Medical Research Institute; Washington State University; Washington State University	Campbell, ZA (corresponding author), Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.; Campbell, ZA (corresponding author), NM AIST, Arusha, Tanzania.	zoe.campbell@wsu.edu		Quinlan, Marsha/0000-0002-9311-9494; Campbell, Zoe/0000-0002-4759-9976	Bill & Melinda Gates Foundation, Seattle, WA through the Program for Enhancing Health and Productivity of Livestock (PEHPL) [OPP1083453]	Bill & Melinda Gates Foundation, Seattle, WA through the Program for Enhancing Health and Productivity of Livestock (PEHPL)	This research was funded by the Bill & Melinda Gates Foundation, Seattle, WA (grant #OPP1083453) through the Program for Enhancing Health and Productivity of Livestock (PEHPL). The findings and conclusions contained are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation.	Agresti A, 2007, INTRO CATEGORICAL DA; Alders R., 2001, CONTROLLING NEWCASTL; Alders RG, 2010, WORLD POULTRY SCI J, V66, P433, DOI 10.1017/S0043933910000516; ALDERS RG, 1994, PREV VET MED, V21, P125, DOI 10.1016/0167-5877(94)90001-9; Alders RG, 2000, SADC PLANN WORKSH NE, P97; [Anonymous], 2017, POUND STERLING LIVE; Bello MB, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/7278459; Bernard H. R., 2017, RES METHODS ANTHR; Bessell PR, 2017, PREV VET MED, V147, P108, DOI 10.1016/j.prevetmed.2017.08.022; Campbell Z, 2018, VACCINE; Campbell ZA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206058; Chen DX, 2009, EXPERT REV VACCINES, V8, P547, DOI [10.1586/erv.09.20, 10.1586/ERV.09.20]; de Bruyn J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188230; de Haan C, 2004, REV SCI TECH OIE, V23, P15, DOI 10.20506/rst.23.1.1465; Fisher H., 2014, ACIAR IMPACT ASSESSM; Food and Agriculture Organization of the United Nations, 2012, ENDURING FARMS CLIMA; Food and Agriculture Organization of the United Nations Agriculture Department, 2002, IMPR AN HLTH POV RED; GALVmed, 2006, PROT YOUR CHICK DEAD; Gueye EF, 2005, WORLD POULTRY SCI J, V61, P39, DOI 10.1079/WPS200440; Heffernan C., 2001, Journal of International Development, V13, P847, DOI 10.1002/jid.827; Hester Biosciences Limited, 2017, FAC MASS ACC VET VAC; Hipra, 2018, LIV VACC NEWC DIS SO; Holden S, 1999, REV SCI TECH OIE, V18, P425, DOI 10.20506/rst.18.2.1166; Kristensen DD, 2016, VACCINE, V34, P899, DOI 10.1016/j.vaccine.2016.01.001; Mariner JC, 2017, VACCINE, V35, P3773, DOI 10.1016/j.vaccine.2017.05.040; Msami H, 2007, POULTRY SECTOR COUNT; Nguyen TD, 1992, ACIAR P, P169; OIE World Organisation for Animal Health, 2016, NEWCASTLE DIS; OLABODE AO, 1992, ACIAR PROC, V39, P159; Rivoir AL, 2017, PSICOL CONOC SOC, V7, P1, DOI 10.26864/pcs.v7.n2.1; Sanchez PA, 2005, SCIENCE, V307, P357, DOI 10.1126/science.1109057; Snively-Martinez A, 2017, FAMILY POULTRY SYSTE; StataCorp, 2017, STATA STAT SOFTWARE; Tanzania Ministry of Agriculture, 2012, UN REP TANZ NAT SAMP, P3; World Bank Group, 2017, DRUG RESISTANT INFEC; World Health Organization, 1999, TEMP MON VACC COLD C	36	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220963	10.1371/journal.pone.0220963	http://dx.doi.org/10.1371/journal.pone.0220963			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415629	Green Published, gold, Green Submitted			2022-12-26	WOS:000485017200052
J	Delgado, GE; Zirlik, A; Gruber, R; Scheffold, T; Kramer, BK; Marz, W; Kleber, ME				Delgado, Graciela E.; Zirlik, Andreas; Gruber, Rudolf; Scheffold, Thomas; Kraemer, Bernhard K.; Maerz, Winfried; Kleber, Marcus E.			The association of high-normal international-normalized-ratio (INR) with mortality in patients referred for coronary angiography	PLOS ONE			English	Article							COAGULATION; VARIABILITY	Aims The international-normalized-ratio (INR) is typically used to monitor patients on warfarin or related oral anticoagulant therapy. The aim of our study was to investigate the association of the INR with mortality in coronary artery disease (CAD) patients not on oral anticoagulant therapy. Methods and results Between 1997 to 2000 the LUdwigshafen RIsk and Cardiovascular Health (LURIC) study enrolled 3316 patients of German ancestry that had been referred for coronary angiography. We excluded patients on coumarin therapy (n = 222) and patients with an INR more than 5 standard deviations (SD) away from the mean (n = 30). During a median follow-up of 9.9 years, 884 patients died, 547 patients from cardiovascular causes. After adjustment for cardiovascular risk factors the INR was associated with all-cause mortality in all patients and the CAD positive group with HRs (95% CI) of 1.14(1.07-1.21) and 1.16(1.09-1.23) per 1-SD increase, respectively. Adjustment for NT-proBNP rendered the association insignificant. Conclusion In LURIC, the INR was positively associated with mortality in patients with prevalent CAD not on oral anticoagulant therapy as well as in patients without CAD. Adjustment for NT-proBNP abolished the association suggesting clinical or subclinical heart failure strongly contributing to increased INR and higher mortality.	[Delgado, Graciela E.; Kraemer, Bernhard K.; Maerz, Winfried; Kleber, Marcus E.] Heidelberg Univ, Med Fac Mannheim, Dept Med 5, Mannheim, Germany; [Zirlik, Andreas] Univ Freiburg, Fac Med, Dept Cardiol & Angiol 1, Freiburg Univ,Univ Heart Ctr, Freiburg, Germany; [Gruber, Rudolf] Hosp Order St John God, Cent Lab, Regensburg, Germany; [Scheffold, Thomas] MediClin Med Care Ctr, Dept Cardiol, Lahr, Germany; [Maerz, Winfried] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Maerz, Winfried] Synlab Holding Deutschland GmbH, Synlab Acad, Mannheim, Germany	Ruprecht Karls University Heidelberg; Universitats Herzzentrum Freiburg; University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Medical University of Graz; SYNLAB Group	Kleber, ME (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Med 5, Mannheim, Germany.	marcus.kleber@medma.uni-heidelberg.de	Zirlik, Andreas/A-6400-2011	Zirlik, Andreas/0000-0001-6290-3297; Kleber, Marcus/0000-0003-0663-7275	7th Framework Program of the European Union (RiskyCAD) [305739]; MediClin Medical Care Centre GmbH	7th Framework Program of the European Union (RiskyCAD); MediClin Medical Care Centre GmbH	This work was supported by a grant from the 7th Framework Program of the European Union (RiskyCAD, grant agreement number 305739) to MEK and WM (https://ec.europa.eu/research/fp7/index_en.cfm). The funding institution had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Furthermore, the funder SYNLAB Holding Deutschland GmbH provided support in the form of salaries for author W.M. and the funder MediClin Medical Care Centre GmbH provided support in the form of salaries for author T.S., but they did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ardissino D, 2003, BLOOD, V102, P2731, DOI 10.1182/blood-2002-03-0954; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Gao F, 2019, EUR J GASTROEN HEPAT, V31, P824, DOI 10.1097/MEG.0000000000001339; GRIFFIN JH, 1995, NATURE, V378, P337, DOI 10.1038/378337a0; Kim HJ, 2013, CLIN MOL HEPATOL, V19, P105, DOI 10.3350/cmh.2013.19.2.105; Kinis T, 2018, PROGNOSTIC VALUE PRO, P98; Kiris T, 2018, J CLIN LAB ANAL, V32, DOI 10.1002/jcla.22164; KIRKWOOD TBL, 1983, THROMB HAEMOSTASIS, V49, P238; Kitulwatte ID, 2015, AM J FOREN MED PATH, V36, P323, DOI 10.1097/PAF.0000000000000203; Lind M, 2012, THROMB RES, V129, P32, DOI 10.1016/j.thromres.2011.07.004; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Okada A, 2016, CIRC J, V80, P913, DOI 10.1253/circj.CJ-15-1326; Quick AJ, 1935, AM J MED SCI, V190, P501, DOI 10.1097/00000441-193510000-00009; Sadat U, 2009, ATHEROSCLEROSIS, V207, P434, DOI 10.1016/j.atherosclerosis.2009.05.002; Schneider JG, 2014, INT J CARDIOL, V176, P139, DOI 10.1016/j.ijcard.2014.07.026; Tan LP, 2019, EXP THER MED, V17, P323, DOI 10.3892/etm.2018.6935; van Lammeren GW, 2012, ATHEROSCLEROSIS, V222, P355, DOI 10.1016/j.atherosclerosis.2012.03.008; Vanerio G, 2015, J STROKE CEREBROVASC, V24, P2223, DOI 10.1016/j.jstrokecerebrovasdis.2015.05.017; Wernly B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170987; Winkelmann BR, 2001, PHARMACOGENOMICS, V2, pS7	20	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0221112	10.1371/journal.pone.0221112	http://dx.doi.org/10.1371/journal.pone.0221112			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415634	gold, Green Published, Green Submitted			2022-12-26	WOS:000485017200078
J	Rehman, SU; Awan, SE; Mumtaz, FR; Raja, MAZ				Rehman, Saeed Ur; Awan, Saeed Ehsan; Mumtaz, Fazel Rehman; Raja, Muhammad Asif Zahoor			A novel application of breadth first algorithm for achieving collision free memory mapping	PLOS ONE			English	Article							INTERLEAVING LAWS; PARALLEL TURBO; LDPC DECODER; CODES	We are living in the world of handheld smart devices including smart phones, mini computers, tablets, net-books and others communication devices. The telecommunication standards used in these devices includes error correction codes which are integral part of current and future communication systems. To achieve the higher data rate applications, the turbo and Low Density Parity Check (LDPC) codes are decoded on parallel architecture which in turn raises the memory conflict issue. In order to get the good performance, the simultaneous access to the entire memory bank should be performed without any conflict. In this article we present breadth first technique applied on transportation modeling of the problem for solving the collision issue of Turbo decoders in order to get optimized architecture solution.	[Rehman, Saeed Ur; Awan, Saeed Ehsan; Raja, Muhammad Asif Zahoor] COMSATS Univ Islamabad, Dept Elect & Comp Engn, Attock, Pakistan; [Mumtaz, Fazel Rehman] Kabul Depot, Kabul, Afghanistan	COMSATS University Islamabad (CUI)	Mumtaz, FR (corresponding author), Kabul Depot, Kabul, Afghanistan.	fazel.mumtaz@kabuldepot.com	Awais, Muhammad/HCI-3725-2022; Raja, Muhammad Asif Zahoor/D-7325-2013; , Dr Saeed Ehsan Awan/B-9897-2017	Raja, Muhammad Asif Zahoor/0000-0001-9953-822X; , Dr Saeed Ehsan Awan/0000-0002-4557-9533				Amador E, 2009, DES AUT CON, P891; Angiolini Federico, 2003, P INT C COMP ARCH SY, P318, DOI DOI 10.1145/951710.951751; Bazaraa M. S., 1997, LINEAR PROGRAMMING N; Benedetto S, 1996, IEEE T INFORM THEORY, V42, P409, DOI 10.1109/18.485713; Berrou C., 2003, ENCY TELECOMMUNICATI; Briki A, 2012, P ACM GREAT LAK S VL, P153, DOI DOI 10.1145/2206781.2206819; Briki A, 2013, IEEE WORKSHOP SIG, P201, DOI 10.1109/SiPS.2013.6674505; Burr A, 2001, ELECTRON COMMUN ENG, V13, P155, DOI 10.1049/ecej:20010402; Chavet C, 2010, IEEE INT SYMP CIRC S, P3168, DOI 10.1109/ISCAS.2010.5537955; Chavet C, 2010, ARXIV10023990; Fossorier MPC, 1999, IEEE T COMMUN, V47, P673, DOI 10.1109/26.768759; Gnaedig D, 2006, TURB COD REL TOP 6 I, P1; Gong C., 2014, 6 INT C WIR COMM SIG, P1; Hartvigsen D, 2006, J COMB THEORY B, V96, P693, DOI 10.1016/j.jctb.2006.01.004; Mansour MM, 2003, IEEE T VLSI SYST, V11, P976, DOI 10.1109/TVLSI.2003.817545; Marchand C, 2009, IEEE WRK SIG PRO SYS, P220, DOI 10.1109/SIPS.2009.5336255; Pyndiah RM, 1998, IEEE T COMMUN, V46, P1003, DOI 10.1109/26.705396; Richardson TJ, 2001, IEEE T INFORM THEORY, V47, P638, DOI 10.1109/18.910579; Sani A, 2011, IEEE INT SYMP CIRC S, P1720, DOI 10.1109/ISCAS.2011.5937914; Sani A, 2011, INT CONF ACOUST SPEE, P1613; Sani AH, 2013, IEEE T SIGNAL PROCES, V61, P4127, DOI 10.1109/TSP.2013.2264057; Tarable A, 2004, IEEE T INFORM THEORY, V50, P2002, DOI 10.1109/TIT.2004.833353; Tarable A, 2004, IEEE COMMUN LETT, V8, P162, DOI 10.1109/LCOMM.2004.823364; Yang JL, 2010, IEEE T VLSI SYST, V18, P978, DOI 10.1109/TVLSI.2009.2019076	24	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0219490	10.1371/journal.pone.0219490	http://dx.doi.org/10.1371/journal.pone.0219490			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415583	Green Submitted, Green Published, gold			2022-12-26	WOS:000485017200006
J	Maxwell, S; Fox, R; McRobbie, D; Bulsara, M; Doust, J; O'Leary, P; Slavotinek, J; Stubbs, J; Moorin, R				Maxwell, Susannah; Fox, Richard; McRobbie, Donald; Bulsara, Max; Doust, Jenny; O'Leary, Peter; Slavotinek, John; Stubbs, John; Moorin, Rachael			How have advances in CT dosimetry software impacted estimates of CT radiation dose and cancer incidence? A comparison of CT dosimetry software: Implications for past and future research	PLOS ONE			English	Article							BEIR VII REPORT; ESTIMATING RISK; EXPOSURE; ADULT; PROTECTION	Objective Organ radiation dose from a CT scan, calculated by CT dosimetry software, can be combined with cancer risk data to estimate cancer incidence resulting from CT exposure. We aim to determine to what extent the use of improved anatomical representation of the adult human body "phantom" in CT dosimetry software impacts estimates of radiation dose and cancer incidence, to inform comparison of past and future research. Methods We collected 20 adult cases for each of three CT protocols (abdomen/pelvis, chest and head) from each of five public hospitals (random sample) (January-April inclusive 2010) and three private clinics (self-report). Organ equivalent and effective dose were calculated using both ImPACT (mathematical phantom) and NCICT (voxelised phantom) software. Bland Altman plots demonstrate agreement and Passing-Bablok regression reports systematic, proportional or random differences between results. We modelled the estimated lifetime attributable risk of cancer from a single exposure for each protocol, using age-sex specific risk-coefficients from the Biologic Effects of Ionizing Radiation VII report. Results For the majority of organs used in epidemiological studies of cancer incidence, the NCICT software (voxelised) provided higher dose estimates. Across the lifespan NCICT resulted in cancer estimates 2.9%-6.6% and 14.8%-16.3% higher in males and females (abdomen/pelvis) and 7.6%-19.7% and 12.9%-26.5% higher in males and females respectively (chest protocol). For the head protocol overall cancer estimates were lower for NCICT, but with greatest disparity, >30% at times. Conclusion When the results of previous studies estimating CT dose and cancer incidence are compared to more recent, or future, studies the dosimetry software must be considered. Any change in radiation dose or cancer risk may be attributable to the software and phantom used, rather than or in addition to changes in scanning practice. Studies using dosimetry software to estimate radiation dose should describe software comprehensively to facilitate comparison with past and future research.	[Maxwell, Susannah; O'Leary, Peter; Moorin, Rachael] Curtin Univ, Fac Hlth Sci, Sch Publ Hlth, Hlth Syst & Hlth Econ, Perth, WA, Australia; [Fox, Richard] Univ Western Australia, Sch Phys, Perth, WA, Australia; [McRobbie, Donald] Univ Adelaide, Sch Phys Sci, Adelaide, SA, Australia; [McRobbie, Donald] Imperial Coll, Fac Med, London, England; [Bulsara, Max] Univ Notre Dame, Inst Hlth & Rehabil Res, Fremantle, WA, Australia; [Bulsara, Max; Moorin, Rachael] Univ Western Australia, Fac Med Dent & Hlth Sci, Sch Populat Hlth, Ctr Hlth Serv Res, Crawley, WA, Australia; [Doust, Jenny] Bond Univ, Fac Hlth Sci & Med, Ctr Res Evidence Based Practice, Gold Coast, Qld, Australia; [O'Leary, Peter] Univ Western Australia, Fac Hlth & Med Sci, Obstet & Gynaecol Med Sch, Perth, WA, Australia; [O'Leary, Peter] QE2 Med Ctr, PathWest Lab Med, Nedlands, WA, Australia; [Slavotinek, John] Flinders Univ S Australia, SA Hlth, SA Med Imaging, Adelaide, SA, Australia; [Slavotinek, John] Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia; [Stubbs, John] CanSpeak Australia, Spring Hill, Qld, Australia	Curtin University; University of Western Australia; University of Adelaide; Imperial College London; University of Notre Dame Australia; University of Western Australia; Bond University; University of Western Australia; University of Western Australia; Flinders University South Australia; Flinders University South Australia	Maxwell, S (corresponding author), Curtin Univ, Fac Hlth Sci, Sch Publ Hlth, Hlth Syst & Hlth Econ, Perth, WA, Australia.	Susannah.maxwell@curtin.edu.au	Doust, Jenny/AGI-8773-2022; Moorin, Rachael/AAQ-3650-2020	Doust, Jenny/0000-0002-4024-9308; Moorin, Rachael/0000-0001-8742-7151	National Medical and Research Council [APP1144573]	National Medical and Research Council	This study was supported by a National Medical and Research Council (http.//vvww.nhmrc.gov.au/) project grant (APP1144573). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Radiation Protection and Nuclear Safety Agency (ARPANSA), 2011, NAT DIAGN REF LEV FA; Bahadori A, 2015, AM J ROENTGENOL, V205, P827, DOI 10.2214/AJR.14.14135; Berrington de Gonzalez A, 2004, LANCET, V363, P345, DOI 10.1016/S0140-6736(04)15433-0; Bilic-Zulle L, 2011, BIOCHEM MEDICA, V21, P49; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Brix G, 2011, MULTISLICE CT ABDOME, P25; Calabrese EJ, 2014, RADIAT RES, V182, P463, DOI 10.1667/RR13829.1; Clarke Roger, 2009, Annals of the ICRP, V39, P1, DOI 10.1016/j.icrp.2009.05.004; de Gonzalez AB, 2012, J RADIOL PROT, V32, P205, DOI 10.1088/0952-4746/32/3/205; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Dewitte K, 2002, CLIN CHEM, V48, P799; Ding AP, 2015, PHYS MED BIOL, V60, P5601, DOI 10.1088/0031-9155/60/14/5601; Dosimetry Working Party of the Institute of Physical Sciences in Medicine, 1992, NAT PROT PAT DOS MEA; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Gao Y, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3474-3; Gibson DA, 2014, AUST NZ J PUBL HEAL, V38, P441, DOI 10.1111/1753-6405.12278; Hall EJ, 2008, BRIT J RADIOL, V81, P362, DOI 10.1259/bjr/01948454; Health Protection Agency, 2008, EUR GUID EST POP DOS; ImPACT CT Scanner Evaluation Group, IMPACTS CT DOSIMETRY; International Commission on Radiological Protection, 2007, REC INT COMM RAD PRO; Jansen JTM, 2016, PHYS MED BIOL, V61, P5356, DOI 10.1088/0031-9155/61/14/5356; Kim KP, 2009, ARCH INTERN MED, V169, P1188, DOI 10.1001/archinternmed.2009.162; Lee C, 2015, J RADIOL PROT, V35, P891, DOI 10.1088/0952-4746/35/4/891; Lee C, 2011, MED PHYS, V38, P1196, DOI 10.1118/1.3544658; Liu HK, 2010, PHYS MED BIOL, V55, P1441, DOI 10.1088/0031-9155/55/5/012; Moorin RE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097691; Moorin RE, 2013, J RADIOL PROT, V33, P295, DOI 10.1088/0952-4746/33/2/295; National Research Council, 2006, HLTH RISKS EXP LOW L, P141; O'Connor MK, 2015, RADIAT RES, V183, P481, DOI 10.1667/RR4029.2; Regulla DF, 2005, RADIAT PROT DOSIM, V114, P11, DOI 10.1093/rpd/nch538; Ron E, 2003, HEALTH PHYS, V85, P47, DOI 10.1097/00004032-200307000-00011; Sechopoulos I, 2018, MED PHYS, V45, pe1, DOI 10.1002/mp.12702; Shrimpton PC, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150346; Shrimpton PC., 2011, PROG NUC SCI TECHNOL, V2, P165, DOI 10.15669/pnst.2.165; United Nations Scientific Committee on the Effects of Atomic Radiation, 2012, SOURC EFF RISK ION R; Wall BF, 2005, RADIAT PROT DOSIM, V114, P183, DOI 10.1093/rpd/nch505; Wu TH, 2015, J DENT RES, V94, P27, DOI 10.1177/0022034514554226; Xu XG, 2014, PHYS MED BIOL, V59, pR233, DOI 10.1088/0031-9155/59/18/R233	39	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0217816	10.1371/journal.pone.0217816	http://dx.doi.org/10.1371/journal.pone.0217816			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412037	Green Submitted, Green Published, gold			2022-12-26	WOS:000485012600009
J	Benski, AC; Viviano, M; Jinoro, J; Alec, M; Catarino, R; Herniainasolo, J; Vassilakos, P; Petignat, P				Benski, Anne-Caroline; Viviano, Manuela; Jinoro, Jeromine; Alec, Milena; Catarino, Rosa; Herniainasolo, Josea; Vassilakos, Pierre; Petignat, Patrick			HPV self-testing for primary cervical cancer screening in Madagascar: VIA/VILI triage compliance in HPV-positive women	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; VISUAL INSPECTION; ACETIC-ACID; RANDOMIZED-TRIAL; CYTOLOGY	Objective To assess triage compliance and the effect of the time from screening to triage on follow-up among HPV-positive women. Methods We recruited 1232 women in a screening campaign in Madagascar from February to October 2015. In the first period (February-May), HPV tests were performed remotely using the cobas test. In the second period (May-October), testing was performed on-site using the Xpert HPV assay. HPV-positive women were invited for triage with visual inspection with acetic acid (VIA) and Lugol's iodine (VILI). Systematic biopsy and endocervical brushing were performed on all HPV-positive women for quality control. Three groups were defined according to time from HPV testing to triage invitation for HPV-positive women-Group I: delayed (>3 months), Group II: prompt (24-48 hours), and Group III: immediate (< 24 hours). Results A total 1232 self-sampled HPV tests were performed in the study period (496 in Group I, 512 in Group II, and 224 in Group III). Participants' mean age was 43.2 +/- 9.3 years. Mean time from screening to VIA/VILI testing was 103.5 +/- 43.6 days. Overall HPV prevalence was 28.0%. HPV prevalence was 27.2% in Group I (cobas test), 29.2% in Group 2 (Xpert test), and 26,7% in Group III (Xpert test). The VIA/VILI compliance rate was 77.8% for Group I, 82.7% for Group II, and 95.0% for Group III. Of women undergoing VIA/VILI, 56.3% in Group I and 43.5% in Groups II/III had positive results. Prevalence of cervical intraepithelial neoplasia grade 2 or worse among HPV-positive women was 9.8% for Group I and 6.8% for Groups II/III. Non-adherence was higher among rural women, uneducated women, and women in Group I. Conclusion HPV-positive women with immediate VIA/VILI triage invitation had the best triage compliance. A single-day test and triage strategy is preferred for low-resource settings.	[Benski, Anne-Caroline; Viviano, Manuela; Catarino, Rosa; Petignat, Patrick] Geneva Univ Hosp, Gynecol Div, Geneva, Switzerland; [Benski, Anne-Caroline; Jinoro, Jeromine; Herniainasolo, Josea] St Damien Hlth Ctr, Ambanja, Madagascar; [Alec, Milena] Univ Geneva, Geneva, Switzerland; [Vassilakos, Pierre] Geneva Fdn Med Educ & Res, Geneva, Switzerland	University of Geneva; University of Geneva	Benski, AC (corresponding author), Geneva Univ Hosp, Gynecol Div, Geneva, Switzerland.; Benski, AC (corresponding author), St Damien Hlth Ctr, Ambanja, Madagascar.	caroline.benski@gmail.com		Petignat, Patrick/0000-0002-6835-533X; Catarino, Rosa/0000-0002-5317-7710	Action Madagascar Foundation, Fribourg, Switzerland; University Hospital of Geneva, Switzerland	Action Madagascar Foundation, Fribourg, Switzerland; University Hospital of Geneva, Switzerland	This study was supported by the Action Madagascar Foundation, Fribourg, Switzerland and the University Hospital of Geneva, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrossi S, 2015, LANCET GLOB HEALTH, V3, pE85, DOI 10.1016/S2214-109X(14)70354-7; Austad K, 2018, J GLOB ONCOL, V4, DOI 10.1200/JGO.17.00228; Bigoni J, 2015, INT J CANCER, V137, P127, DOI 10.1002/ijc.29353; Bruni L, 2019, HUM PAP REL DIS WORL; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Catarino R, 2015, WORLD J CLIN ONCOL, V6, P281, DOI 10.5306/wjco.v6.i6.281; Cremer M, 2017, J LOW GENIT TRACT DI, V21, P26, DOI 10.1097/LGT.0000000000000280; Cuzick J, 2006, INT J CANCER, V119, P1095, DOI 10.1002/ijc.21955; Des Marais AC, 2018, OBSTET GYNECOL, V132, P1412, DOI [10.1097/aog.0000000000002964, 10.1097/AOG.0000000000002964]; Doh AS, 2005, INT J GYNECOL OBSTET, V89, P167, DOI 10.1016/j.ijgo.2004.12.040; Einstein MH, 2014, J CLIN MICROBIOL, V52, P2089, DOI 10.1128/JCM.00176-14; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gage JC, 2012, INT J CANCER, V131, P2903, DOI 10.1002/ijc.27563; Goldie SJ, 2001, JAMA-J AM MED ASSOC, V285, P3107, DOI 10.1001/jama.285.24.3107; Kunckler M, 2017, CANCER MED-US, V6, P1752, DOI 10.1002/cam4.1089; Parkin DM, 2008, LANCET ONCOL, V9, P683, DOI 10.1016/S1470-2045(08)70175-X; Poli UR, 2017, J GLOB ONCOL, V4, DOI 10.1200/JGO.2016.008078; Polman NJ, 2019, LANCET ONCOL, V20, P229, DOI 10.1016/S1470-2045(18)30763-0; Qiao L, 2015, J OBSTET GYNAECOL RE, V41, P1313, DOI 10.1111/jog.12732; Rebolj M, 2010, BRIT J CANCER, V103, P310, DOI 10.1038/sj.bjc.6605771; Safaeian M, 2007, OBSTET GYN CLIN N AM, V34, P739, DOI 10.1016/j.ogc.2007.09.004; Sankaranarayanan R, 2004, INT J CANCER, V109, P461, DOI 10.1002/ijc.11726; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Tebeu PM, 2015, INT J CANCER, V136, pE743, DOI 10.1002/ijc.29250; Untiet S, 2014, INT J CANCER, V135, P1911, DOI 10.1002/ijc.28834; Wesley RS, 2003, IARC TECHNICAL PUBLI, V41; WHO, 2014, COMPR CERV CANC CONT; WHO, 2013, WHO GUID SCREEN TREA; World Health Organization, 2019, HUM PAP HPV CERV CAN; World Health Organization Africa, CERVICAL CANCER COMM; World Health Organization and Pan-American Health Organization, 2013, MON NAT CERV CANC PR; Yeh PT, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001351	32	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220632	10.1371/journal.pone.0220632	http://dx.doi.org/10.1371/journal.pone.0220632			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408474	gold, Green Submitted, Green Published			2022-12-26	WOS:000485009500016
J	Ihara, F; Tanaka, S; Fereig, RM; Nishimura, M; Nishikawa, Y				Ihara, Fumiaki; Tanaka, Sachi; Fereig, Ragab M.; Nishimura, Maki; Nishikawa, Yoshifumi			Involvement of Toll-like receptor 2 in the cerebral immune response and behavioral changes caused by latent Toxoplasma infection in mice	PLOS ONE			English	Article							GONDII INFECTION; IL-12 PRODUCTION; SCHIZOPHRENIA; ANXIETY; BRAIN; MYD88; NEUROGENESIS; MANIPULATION; DOPAMINE; NEURONS	Subacute and chronic infections with the intracellular protozoan parasite Toxoplasma gondii are associated with an increased risk of psychiatric diseases like schizophrenia. However, little is known about the mechanisms involved in T. gondii-induced neuronal disorders. Recently, we reported that Toll-like receptor 2 (TLR2) was required to initiate the innate immune response in cultured mouse brain cells. However, how TLR2 contributes to latent infection with T. gondii remains unclear. Therefore, we examined the role of TLR2 in brain pathology and behavior using wild-type (TLR2(+/+)) and TLR2-deficient (TLR2(-/-)) mice. The behavioral analyses showed that TLR2 deficiency increased the anxiety state of the uninfected and infected animals alike, and TLR2 deficiency showed no relationship with the infection. In the contextual and cued fear-conditioning tests, T. gondii infection decreased the mouse freezing reaction while TLR2 deficiency increased it, but there was no interaction between the two factors. Our histopathological analysis showed that the TLR2(+/+) and TLR2(-/-) mice had similar brain lesions at 30 days post infection (dpi) with T. gondii. Higher numbers of parasites were detected in the brains of the TLR2(-/-) mice than in those from the TLR2(+/+) mice at 30 dpi, but not at 7 and 14 dpi. No significant differences were observed in the proinflammatory gene expression levels in the TLR2(+/+) and TLR2(-/-) mice. Therefore, it appears that TLR2 signaling in the brain might contribute to the control of parasite growth, but not to brain pathology or the impaired fear memory response induced by infection with T. gondii.	[Ihara, Fumiaki; Tanaka, Sachi; Fereig, Ragab M.; Nishimura, Maki; Nishikawa, Yoshifumi] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido, Japan; [Fereig, Ragab M.] South Valley Univ, Fac Vet Med, Dept Anim Med, Qena City, Qena, Egypt; [Tanaka, Sachi] Shinshu Univ, Fac Agr, Nagano, Japan	Obihiro University of Agriculture & Veterinary Medicine; Egyptian Knowledge Bank (EKB); South Valley University Egypt; Shinshu University	Nishikawa, Y (corresponding author), Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido, Japan.	nisikawa@obihiro.ac.jp	Fereig, Ragab/AAA-2500-2022	Fereig, Ragab Makhlouf/0000-0003-1845-1312; nishikawa, yoshifumi/0000-0001-5005-6377	Funding Program for Next Generation World-Leading Researchers (NEXT Program); Council for Science and Technology Policy [2011/LS003]; Japan Society for the Promotion of Science, Japan [JP15K15118, 17K19538, 24880006, 18K14577, 15J03171]; Agency for Medical Research and Development [17fk0108120h0001]	Funding Program for Next Generation World-Leading Researchers (NEXT Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy(Council for Science and Technology Policy (CSTP)); Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Agency for Medical Research and Development	This research was supported by the Funding Program for Next Generation WorldLeading Researchers (NEXT Program) initiated by the Council for Science and Technology Policy (2011/LS003) (to Y.N.), Grant-in-Aid for Exploratory Research JP15K15118 (to Y.N.) and Challenging Research (Exploratory) 17K19538 (to Y.N.), a Grant-in-Aid for Research Activity Start-up (24880006) (to S. T.), a Grant-in-Aid for Young Scientists (18K14577) (to F.I.),and a research fellowship (15J03171) (to F. I.) from the Japan Society for the Promotion of Science, Japan. This work was also supported by a Research Program on Emerging and Re-emerging Infectious Diseases (17fk0108120h0001) (to Y.N.) from the Agency for Medical Research and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNEA A, 1994, P NATL ACAD SCI USA, V91, P11217, DOI 10.1073/pnas.91.23.11217; Barragan A, 2003, TRENDS MICROBIOL, V11, P426, DOI 10.1016/S0966-842X(03)00205-1; Berdoy M, 2000, P ROY SOC B-BIOL SCI, V267, P1591, DOI 10.1098/rspb.2000.1182; Chen M, 2002, J PARASITOL, V88, P1017, DOI 10.1645/0022-3395(2002)088[1017:IOMIHD]2.0.CO;2; Debierre-Grockiego F, 2007, J IMMUNOL, V179, P1129, DOI 10.4049/jimmunol.179.2.1129; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569; Fereig RM, 2016, PARASITOL INT, V65, P741, DOI 10.1016/j.parint.2016.09.008; Feustel SM, 2012, VIRULENCE, V3, P182, DOI 10.4161/viru.19004; Flegr J, 2003, BIOL PSYCHOL, V63, P253, DOI 10.1016/S0301-0511(03)00075-9; Flegr J, 2013, J EXP BIOL, V216, P127, DOI 10.1242/jeb.073635; Gonzalez LE, 2007, BEHAV BRAIN RES, V177, P70, DOI 10.1016/j.bbr.2006.11.012; Gould E, 1999, TRENDS COGN SCI, V3, P186, DOI 10.1016/S1364-6613(99)01310-8; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; HAY J, 1983, ANN TROP MED PARASIT, V77, P483, DOI 10.1080/00034983.1983.11811741; Henriquez SA, 2009, NEUROIMMUNOMODULAT, V16, P122, DOI 10.1159/000180267; HUTCHISON WM, 1980, ANN TROP MED PARASIT, V74, P145, DOI 10.1080/00034983.1980.11687324; Ihara F, 2016, INFECT IMMUN, V84, P2861, DOI 10.1128/IAI.00217-16; Ihara F, 2016, SCI REP-UK, V6, DOI 10.1038/srep23052; Ingram WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075246; Kempermann G, 2002, J NEUROSCI, V22, P635, DOI 10.1523/JNEUROSCI.22-03-00635.2002; Lachenmaier SM, 2011, J NEUROIMMUNOL, V232, P119, DOI 10.1016/j.jneuroim.2010.10.029; Lamberton PHL, 2008, PARASITOLOGY, V135, P1143, DOI 10.1017/S0031182008004666; Lim JE, 2012, BEHAV BRAIN RES, V227, P36, DOI 10.1016/j.bbr.2011.10.027; Mun HS, 2003, INT IMMUNOL, V15, P1081, DOI 10.1093/intimm/dxg108; Nishimura M, 2015, SCI REP-UK, V5, DOI 10.1038/srep07936; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; Park SJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08502; PIEKARSKI G, 1981, ZBL BAKT-INT J MED M, V250, P403, DOI 10.1016/S0174-3031(81)80133-3; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Scanga CA, 2002, J IMMUNOL, V168, P5997, DOI 10.4049/jimmunol.168.12.5997; Skallova A, 2006, PARASITOLOGY, V133, P525, DOI 10.1017/S0031182006000886; Takeda H, 1998, EUR J PHARMACOL, V350, P21, DOI 10.1016/S0014-2999(98)00223-4; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tanaka S, 2013, INFECT IMMUN, V81, P3609, DOI 10.1128/IAI.00439-13; Torrey EF, 2007, SCHIZOPHRENIA BULL, V33, P729, DOI 10.1093/schbul/sbl050; Torrey EF, 2012, SCHIZOPHRENIA BULL, V38, P642, DOI 10.1093/schbul/sbs043; Torrey EF, 2003, EMERG INFECT DIS, V9, P1375, DOI 10.3201/eid0911.030143; Umeda K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187703; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; Webster JP, 2007, SCHIZOPHRENIA BULL, V33, P752, DOI 10.1093/schbul/sbl073; WEBSTER JP, 1994, PARASITOLOGY, V109, P583, DOI 10.1017/S0031182000076460; Worth AR, 2013, TRENDS PARASITOL, V29, P150, DOI 10.1016/j.pt.2013.01.004	43	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220560	10.1371/journal.pone.0220560	http://dx.doi.org/10.1371/journal.pone.0220560			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404078	Green Published, gold, Green Submitted			2022-12-26	WOS:000485006800017
J	Bao, T; Su, L; Kinnaird, C; Kabeto, M; Shull, PB; Sienko, KH				Bao, Tian; Su, Lydia; Kinnaird, Catherine; Kabeto, Mohammed; Shull, Peter B.; Sienko, Kathleen H.			Vibrotactile display design: Quantifying the importance of age and various factors on reaction times	PLOS ONE			English	Article							TRUNK SWAY; FEEDBACK; CONDUCTION; TOUCH; STIMULATION; INFORMATION; PERFORMANCE; BIOFEEDBACK; ATTENTION; MODELS	Numerous factors affect reaction times to vibrotactile cues. Therefore, it is important to consider the relative magnitudes of these time delays when designing vibrotactile displays for real-time applications. The objectives of this study were to quantify reaction times to typical vibrotactile stimuli parameters through direct comparison within a single experimental setting, and to determine the relative importance of these factors on reaction times. Young (n = 10, 21.9 +/- 1.3 yrs) and older adults (n = 13, 69.4 +/- 5.0 yrs) performed simple reaction time tasks by responding to vibrotactile stimuli using a thumb trigger while frequency, location, auditory cues, number of tactors in the same location, and tactor type were varied. Participants also performed a secondary task in a subset of the trials. The factors investigated in this study affected reaction times by 20-300 ms (reaction time findings are noted in parentheses) depending on the specific stimuli condition. In general, auditory cues generated by the tactors (<20 ms), vibration frequency (<20 ms), number of tactors in the same location (<30 ms) and tactor type (<50 ms) had relatively small effects on reaction times, while stimulus location (20-120 ms) and secondary cognitive task (> 130 ms) had relatively large effects. Factors affected young and older adults' reaction times in a similar manner, but with different magnitudes. These findings can inform the development of vibrotactile displays by enabling designers to directly compare the relative effects of key factors on reaction times.	[Bao, Tian; Su, Lydia; Kinnaird, Catherine; Sienko, Kathleen H.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Kabeto, Mohammed] Univ Michigan, Internal Med, Ann Arbor, MI 48109 USA; [Shull, Peter B.] Shanghai Jiao Tong Univ, State Key Lab Mech Syst & Vibrat, Shanghai, Peoples R China	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Shanghai Jiao Tong University	Sienko, KH (corresponding author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.	sienko@umich.edu	Bao, Tian/AGX-5250-2022	Bao, Tian/0000-0002-7310-3436; Su, Lydia/0000-0001-7278-149X	National Science Foundation [CAREER RAPD-0846471, GARDE 1159635]; National Institute on Deafness and Other Communication Disorders of the National Institutes of Health [R21DC012410]; University of Michigan-Shanghai Jiao Tong University Collaboration on Nanotechnology for Energy and Biomedical Applications [14X120010006]; University of Michigan Pepper Center [NIH RCDC/KL2 P30AG024824]; NATIONAL INSTITUTE ON AGING [P30AG024824] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute on Deafness and Other Communication Disorders of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); University of Michigan-Shanghai Jiao Tong University Collaboration on Nanotechnology for Energy and Biomedical Applications; University of Michigan Pepper Center; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Science Foundation under grant: GARDE 1159635 (https://www.nsf.gov/) received by KS; National Science Foundation under grant: CAREER RAPD-0846471 (https://www.nsf.gov/) received by KS; National Institute on Deafness and Other Communication Disorders of the National Institutes of Health under award number R21DC012410 (https://www.nidcd.nih.gov/) received by KS; University of Michigan-Shanghai Jiao Tong University Collaboration on Nanotechnology for Energy and Biomedical Applications (14X120010006) received by PS and KS; and University of Michigan Pepper Center (NIH RCDC/KL2 P30AG024824) (https://www.nih.gov/) received by KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asseman F, 2007, J NEUROL, V254, P1555, DOI 10.1007/s00415-007-0587-7; Bao T, 2018, J NEUROENG REHABIL, V15, DOI 10.1186/s12984-017-0339-6; Bark K., 2011, 2011 IEEE World Haptics Conference (WHC 2011), P355, DOI 10.1109/WHC.2011.5945512; Bloomfield A, 2008, PRESENCE-TELEOP VIRT, V17, P103, DOI 10.1162/pres.17.2.103; BOLANOWSKI SJ, 1988, J ACOUST SOC AM, V84, P1680, DOI 10.1121/1.397184; Boulton AJM, 2008, DIABETES CARE, V31, P1679, DOI 10.2337/dc08-9021; Broadbent D. E., 1971, DECISION STRESS; Brown LA, 1999, J GERONTOL A-BIOL, V54, pM165, DOI 10.1093/gerona/54.4.M165; Choi S, 2013, P IEEE, V101, P2093, DOI 10.1109/JPROC.2012.2221071; Cholewiak RW, 2004, PERCEPT PSYCHOPHYS, V66, P970, DOI 10.3758/BF03194989; CRAIG JC, 1969, PERCEPT PSYCHOPHYS, V6, P97, DOI 10.3758/BF03210689; Davis JR, 2010, GAIT POSTURE, V31, P465, DOI 10.1016/j.gaitpost.2010.02.002; Diederich A, 2004, PERCEPT PSYCHOPHYS, V66, P1388, DOI 10.3758/BF03195006; DORFMAN LJ, 1979, NEUROLOGY, V29, P38, DOI 10.1212/WNL.29.1.38; Forster B, 2002, EXP BRAIN RES, V143, P480, DOI 10.1007/s00221-002-1017-9; Goebel JA, 2009, OTOL NEUROTOL, V30, P210, DOI 10.1097/MAO.0b013e318194f84d; Haggerty S, 2012, GAIT POSTURE, V35, P523, DOI 10.1016/j.gaitpost.2011.10.359; Harrar V, 2005, EXP BRAIN RES, V166, P465, DOI 10.1007/s00221-005-2386-7; Hick WE, 1952, Q J EXP PSYCHOL, V4, P11, DOI 10.1080/17470215208416600; Ho C, 2005, TRANSPORT RES F-TRAF, V8, P397, DOI 10.1016/j.trf.2005.05.002; Ho C, 2014, ACTA PSYCHOL, V151, P32, DOI 10.1016/j.actpsy.2014.05.014; Ho C, 2014, IEEE T HAPTICS, V7, P86, DOI 10.1109/TOH.2013.62; Kentala E, 2003, ANN OTO RHINOL LARYN, V112, P404, DOI 10.1177/000348940311200503; Klatzky RL, 2014, MULTISENS RES, V27, P359, DOI 10.1163/22134808-00002447; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; Kosinski R.J., 2008, LIT REV REACTION TIM; Krueger Charlene, 2004, Biol Res Nurs, V6, P151, DOI 10.1177/1099800404267682; Lee BC, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-21; Lee BC, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-10; Lee J, 2015, INT SOC POST GAIT RE; Lin CC, 2015, J NEUROPHYSIOL, V113, P2127, DOI 10.1152/jn.00083.2014; MACEFIELD G, 1989, BRAIN, V112, P1519, DOI 10.1093/brain/112.6.1519; Meng FX, 2015, ERGONOMICS, V58, P411, DOI 10.1080/00140139.2014.976278; Miller JO, 2001, J EXP PSYCHOL HUMAN, V27, P266, DOI 10.1037//0096-1523.27.2.266; Mohebbi R, 2005, DRIVER REACTION TIME, V51, P102, DOI [10.1177/0018720809333517, DOI 10.1177/0018720809333517]; Mortimer BJP, 2007, J ACOUST SOC AM, V121, P2970, DOI 10.1121/1.2715669; Myles K, 2007, TACTILE MODALITY REV, P1, DOI DOI 10.1109/HAPTIC.2004.1287224; Nanhoe-Mahabier W, 2012, PARKINSONISM RELAT D, V18, P1017, DOI 10.1016/j.parkreldis.2012.05.018; Neal R., 1982, INT J SPORT BIOMECH, V1, P221; Ng AWY, 2012, LECT NOTES ENG COMP, P1449; O'Modhrain S, 2015, IEEE T HAPTICS, V8, P248, DOI 10.1109/TOH.2015.2466231; Okamura AM, 2001, IEEE-ASME T MECH, V6, P245, DOI 10.1109/3516.951362; Palani HP, 2017, ACM T ACCESS COMPUT, V9, DOI 10.1145/3035537; Pan YS, 2013, PROCEEDINGS 27TH EUROPEAN CONFERENCE ON MODELLING AND SIMULATION ECMS 2013, P177, DOI 10.7148/2013-0177; Park D. C., 2000, COGNITIVE AGING PRIM, V11, P3; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Pashler H, 1998, ATTENTION, P155, DOI DOI 10.1016/J.TICS.2005.01.008; Peon AR, 2013, 2013 WORLD HAPTICS CONFERENCE (WHC), P657, DOI 10.1109/WHC.2013.6548486; Proctor R, 2005, PROC; Salthouse TA, 2003, J EXP PSYCHOL GEN, V132, P566, DOI 10.1037/0096-3445.132.4.566; Salzer Y, 2011, HUM FACTORS, V53, P118, DOI 10.1177/0018720811403139; Shull PB, 2014, GAIT POSTURE, V40, P11, DOI 10.1016/j.gaitpost.2014.03.189; Shull PB, 2011, J BIOMECH, V44, P1605, DOI 10.1016/j.jbiomech.2011.03.016; Shull PB, 2017, IEEE T HAPTICS, V10, P466, DOI 10.1109/TOH.2017.2689023; Sienko KH, 2008, J VESTIBUL RES-EQUIL, V18, P273; Simon JR., 1990, ADV PSYCHOL, P31, DOI [10.1016/s0166-4115(08)61218-2, DOI 10.1016/S0166-4115(08)61218-2]; Stenfelt S, 2011, ADV OTO-RHINO-LARYNG, V71, P10, DOI 10.1159/000323574; STERNBERG S, 1969, AM SCI, V57, P421; Suied C, 2008, J EXP PSYCHOL-APPL, V14, P201, DOI 10.1037/1076-898X.14.3.201; Taware G. B., 2012, Al Ameen Journal of Medical Sciences, V5, P90; Tennison JL, 2016, LECT NOTES COMPUT SC, V9775, P384, DOI 10.1007/978-3-319-42324-1_38; THORNBURY JM, 1981, J GERONTOL, V36, P34, DOI 10.1093/geronj/36.1.34; Van Erp JBF, 2004, TRANSPORT RES F-TRAF, V7, P247, DOI 10.1016/j.trf.2004.09.003; van Veen HAHC, 2001, LECT NOTES COMPUT SC, V2058, P174; VERRILLO RT, 1963, J ACOUST SOC AM, V35, P1962, DOI 10.1121/1.1918868; VONBEKESY G, 1948, J ACOUST SOC AM, V20, P749; Wall C, 2010, J VESTIBUL RES-EQUIL, V20, P61, DOI 10.3233/VES-2010-0369; Weinstein S., 1968, 1 INT S SKI SENS; Welford A.T., 1980, REACTION TIMES; WILSKA A, 1954, ACTA PHYSIOL SCAND, V31, P285, DOI 10.1111/j.1748-1716.1954.tb01139.x; Yogev G, 2009, ROLE EXECUTIVE FUNCT, P23, DOI [10.1002/mds.21720, DOI 10.1002/MDS.21720]	71	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0219737	10.1371/journal.pone.0219737	http://dx.doi.org/10.1371/journal.pone.0219737			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5FL	31398207	gold, Green Published, Green Submitted			2022-12-26	WOS:000485004000007
J	Kasper, KJ; Manoharan, I; Hallam, B; Coleman, CE; Koivu, SL; Weir, MA; Mccormick, JK; Silverman, MS				Kasper, Katherine J.; Manoharan, Iswarya; Hallam, Brian; Coleman, Charlotte E.; Koivu, Sharon L.; Weir, Matthew A.; Mccormick, John K.; Silverman, Michael S.			A controlled-release oral opioid supports S. aureus survival in injection drug preparation equipment and may increase bacteremia and endocarditis risk	PLOS ONE			English	Article							INFECTIVE ENDOCARDITIS; USERS; TRENDS	Background Injection drug use-associated endocarditis (IDUaIE) incidence in Ontario has recently been associated with hydromorphone prescribing rates. Staphylococcus aureus causes the majority of cases of IDUaIE in Ontario and across North America. Hydromorphone controlled-release (Hydromorphone-CR) requires a complex technique for injection and therefore provides multiple opportunities for contamination. Hydromorphone-CR contains several excipients, which could enhance staphylococcal survival and increase risk of contaminating the injectate. Methods Used injection drug preparation equipment (cookers/filters) was collected from persons who inject drugs (PWID), rinsed with water, and plated on Mannitol salt agar. Bacterial isolates from bacteremic PWID were used to assess the survival of S. aureus and Streptococcus pyogenes on cookers/filters with Hydromorphone-CR, hydromorphone immediate-release (Hydromorphone-IR) or oxycodone controlled-release (Oxycodone-CR). The solutions spiked with S. aureus were heated and the remaining viable bacteria enumerated. Results S. aureus was detected in 12/87 (14%, 95% CI 8-23%) cookers/filters samples used for injection of Hydromorphone-CR. Hydromorphone-CR was the only opioid associated with greater survival of methicillin-sensitive S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA) on cookers/filters when compared to sterile water vehicle control. There was a similar to 2 log reduction in the number of S. aureus that survived when cookers/filters were heated. Conclusion 14% of all cookers/filters used in the preparation of Hydromorphone-CR were contaminated with S. aureus. Hydromorphone-CR prolongs the survival of MRSA and MSSA in cookers/filters. Heating cookers/filters may be a harm-reduction strategy.	[Kasper, Katherine J.; Coleman, Charlotte E.; Mccormick, John K.; Silverman, Michael S.] Western Univ, Dept Microbiol & Immunol, London, ON, Canada; [Manoharan, Iswarya; Weir, Matthew A.; Silverman, Michael S.] Western Univ, Dept Med, London, ON, Canada; [Hallam, Brian] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada; [Koivu, Sharon L.] Western Univ, Dept Family Med, London, ON, Canada; [Weir, Matthew A.; Mccormick, John K.; Silverman, Michael S.] Lawson Hlth Res Inst, London, ON, Canada; [Silverman, Michael S.] Western Univ, Div Infect Dis, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Silverman, MS (corresponding author), Western Univ, Dept Microbiol & Immunol, London, ON, Canada.; Silverman, MS (corresponding author), Western Univ, Dept Med, London, ON, Canada.; Silverman, MS (corresponding author), Lawson Hlth Res Inst, London, ON, Canada.; Silverman, MS (corresponding author), Western Univ, Div Infect Dis, London, ON, Canada.	michael.silverman@sjhc.london.on.ca	Silverman, Michael/J-3776-2014; Weir, Matthew/G-3354-2011	Silverman, Michael/0000-0002-0389-7656; , Brian/0000-0003-1636-4215; McCormick, John/0000-0003-3742-7289	Ontario HIV Treatment Network; St Joseph's Hospital Foundation	Ontario HIV Treatment Network; St Joseph's Hospital Foundation	This study was supported in part by an unrestricted grant from the Ontario HIV Treatment Network (www.ohtn.on.ca/) and by the St Joseph's Hospital Foundation (https://www.sjhcfoundation.org/). Both grants were awarded to MSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ONTARIO NARCOTICS AT; Ball LJ, 2019, JAIDS-J ACQ IMM DEF, V81, pE127, DOI 10.1097/QAI.0000000000002063; Ball LJ, 2019, JAIDS-J ACQ IMM DEF, V81, pE99, DOI 10.1097/QAI.0000000000002062; Bassetti S, 2004, INFECTION, V32, P163, DOI 10.1007/s15010-004-3106-0; Campanella E., 2015, LONDON FREE PRESS; Dickson C, 2018, Can Commun Dis Rep, V44, P182, DOI 10.14745/ccdr.v44i78a06; Dublin S, 2018, ANN INTERN MED, V168, P444, DOI 10.7326/M18-0001; DURACK DT, 1973, BRIT J EXP PATHOL, V54, P142; Edelman EJ, 2019, JAMA INTERN MED, V179, P297, DOI 10.1001/jamainternmed.2018.6101; Gera Kanika, 2013, Curr Protoc Microbiol, V30, DOI 10.1002/9780471729259.mc09d02s30; Gibson GW, 2007, COMPARATIVE MED, V57, P563; Gordon RJ, 2005, NEW ENGL J MED, V353, P1945, DOI 10.1056/NEJMra042823; Graham PL, 2006, ANN INTERN MED, V144, P318, DOI 10.7326/0003-4819-144-5-200603070-00006; Gwizdala RA, 2011, AM J PUBLIC HEALTH, V101, P1268, DOI 10.2105/AJPH.2010.300028; Hryniewicz MM, 2017, J MED MICROBIOL, V66, P1367, DOI 10.1099/jmm.0.000585; Jackson KA, 2018, MMWR-MORBID MORTAL W, V67, P625, DOI 10.15585/mmwr.mm6722a2; Jain V, 2008, J INFECTION, V57, P132, DOI 10.1016/j.jinf.2008.05.008; Missiakas Dominique M, 2013, Curr Protoc Microbiol, VChapter 9, DOI 10.1002/9780471729259.mc09c01s28; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Murphy EL, 2001, CLIN INFECT DIS, V33, P35, DOI 10.1086/320879; Pergolizzi Joseph, 2008, Pain Pract, V8, P287, DOI 10.1111/j.1533-2500.2008.00204.x; Plein LM, 2018, BRIT J PHARMACOL, V175, P2717, DOI 10.1111/bph.13750; Pulvirenti JJ, 1996, CLIN INFECT DIS, V22, P40, DOI 10.1093/clinids/22.1.40; Purdue Pharma, PACK INS OXYCONTIN; Purdue Pharma, RESCR INF INCL PAT M; Purdue Pharma, 2015, PROD MON HYDROMORPH; Richmond R., 2017, THE LONDON FREE PRES; Rodger L, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.5220; Roy E, 2016, CAN J PSYCHIAT, V61, P136, DOI 10.1177/0706743716632503; RUDIN L, 1974, J BACTERIOL, V118, P155, DOI 10.1128/JB.118.1.155-164.1974; Schranz AJ, 2019, ANN INTERN MED, V170, P31, DOI 10.7326/M18-2124; Smith HS, 2009, PAIN MED, V10, pS30, DOI 10.1111/j.1526-4637.2009.00597.x; Thuny F, 2012, LANCET, V379, P965, DOI 10.1016/S0140-6736(11)60755-1; Tookes H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129360; Toyoda N, 2017, JAMA-J AM MED ASSOC, V317, P1652, DOI 10.1001/jama.2017.4287; Weir MA, 2019, CAN MED ASSOC J, V191, pE93, DOI 10.1503/cmaj.180694; Wiese AD, 2018, ANN INTERN MED, V168, P396, DOI 10.7326/M17-1907; Wilson LE, 2002, J INFECT DIS, V185, P1761, DOI 10.1086/340827	38	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0219777	10.1371/journal.pone.0219777	http://dx.doi.org/10.1371/journal.pone.0219777			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398210	Green Submitted, Green Published, gold			2022-12-26	WOS:000485004000008
J	Yue, MF; Tao, Y; Fang, YL; Lian, XP; Zhang, Q; Xia, YF; Wei, ZF; Dai, Y				Yue, Mengfan; Tao, Yu; Fang, Yulai; Lian, Xingpan; Zhang, Qin; Xia, Yufeng; Wei, Zhifeng; Dai, Yue			The gut microbiota modulator berberine ameliorates collagen-induced arthritis in rats by facilitating the generation of butyrate and adjusting the intestinal hypoxia and nitrate supply	FASEB JOURNAL			English	Article						rheumatoid arthritis; BUT; butyrate synthesis	RHEUMATOID-ARTHRITIS; PPAR-GAMMA; METABOLISM; INFLAMMATION; DYSBIOSIS; IMMUNITY; BACTERIA	The commensal microbiota is one of the environmental triggers of rheumatoid arthritis (RA). Recent studies have identified the characteristics of the gut microbiota in patients with RA. However, it is still unclear how the microbiota can be modulated to slow down disease progression. In the present study, berberine, a modulator of gut microbiota with substantial anti-RA effect, was chosen to explore the mechanisms by which the microbiota modulators ameliorate RA. The results showed that oral administration of berberine alleviated collagen-induced arthritis (CIA) in rats in a gut microbiota-dependent manner. Berberine down-regulated the diversity and richness of the gut bacteria, reduced the abundance of Prevotella, and elevated the abundance of butyrate-producing bacteria in CIA rats as determined by the 16S rRNA gene sequence, which might function through limiting the generation of nitrate and stabilizing the physiologic hypoxia in the intestine. Moreover, berberine treatment significantly increased the intestinal butyrate level and promoted the expression and activity of butyryl-CoA:acetate-CoA transferase (BUT). The coadministration of a BUT inhibitor largely diminished the adjustment of intestinal environment and the antiarthritic effect of berberine. In conclusion, modulators of the gut microbiota might serve as therapeutic agents for RA by inducing the butyrate generation through promoting the expression and activity of BUT.	[Yue, Mengfan; Tao, Yu; Fang, Yulai; Lian, Xingpan; Zhang, Qin; Xia, Yufeng; Wei, Zhifeng; Dai, Yue] China Pharmaceut Univ, Sch Tradit Chinese Pharm, Dept Pharmacol Chinese Mat Med, Nanjing, Peoples R China	China Pharmaceutical University	Wei, ZF; Dai, Y (corresponding author), China Pharmaceut Univ, Dept Pharmacol Chinese Mat Med, 24 Tong Jia Xiang, Nanjing 210009, Peoples R China.	zhifeng-wei@hotmail.com; yuedaicpu@126.com			National Natural Science Foundation of China [81673441]; "Double First-Class" University Project [CPU2018GY10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Double First-Class" University Project	This work was supported by the National Natural Science Foundation of China (81673441) and the "Double First-Class" University Project (CPU2018GY10). The authors declare no conflicts of interest.	Breban M, 2017, ANN RHEUM DIS, V76, P1614, DOI 10.1136/annrheumdis-2016-211064; Byndloss MX, 2017, SCIENCE, V357, P570, DOI 10.1126/science.aam9949; Chatzidionisyou A, 2016, CURR OPIN RHEUMATOL, V28, P76, DOI 10.1097/BOR.0000000000000238; Darrah E, 2018, CURR OPIN RHEUMATOL, V30, P72, DOI 10.1097/BOR.0000000000000452; de Groot PF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188475; Demoruelle MK, 2014, CURR OPIN RHEUMATOL, V26, P64, DOI 10.1097/BOR.0000000000000017; Dinan TG, 2017, J PHYSIOL-LONDON, V595, P489, DOI 10.1113/JP273106; Dubin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10391; Fei N, 2013, ISME J, V7, P880, DOI 10.1038/ismej.2012.153; Gao ZZ, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/1813086; Gilbert JA, 2016, NATURE, V535, P94, DOI 10.1038/nature18850; Grander C, 2018, GUT, V67, P892, DOI 10.1136/gutjnl-2016-313432; Guo Y, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1367-7; HOLOSHITZ J, 1986, LANCET, V2, P305; Jethwa H, 2017, RHEUMATOLOGY, V56, P1452, DOI 10.1093/rheumatology/kew374; Jia X, 2019, J DENT RES, V98, P107, DOI 10.1177/0022034518797275; Kelly CJ, 2015, CELL HOST MICROBE, V17, P662, DOI 10.1016/j.chom.2015.03.005; Kim DS, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01525; Kim JH, 2015, ARCH PHARM RES, V38, P302, DOI 10.1007/s12272-015-0559-x; Kokkola R, 2003, ARTHRITIS RHEUM, V48, P2052, DOI 10.1002/art.11161; Lee N, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.36; Li J, 2016, P NATL ACAD SCI USA, V113, pE1306, DOI 10.1073/pnas.1518189113; Li M, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0987-5; Lin HP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031286, 10.1371/journal.pone.0035240]; Lin Q, 2018, IEEE INT C MICROELEC, P3; Liu XF, 2013, CURR MICROBIOL, V67, P170, DOI 10.1007/s00284-013-0338-1; Liu YT, 2010, DRUG METAB DISPOS, V38, P1779, DOI 10.1124/dmd.110.033936; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Maeda Y, 2017, J CLIN MED, V6, DOI 10.3390/jcm6060060; Marino E, 2017, NAT IMMUNOL, V18, P951, DOI 10.1038/ni0817-951c; Mathewson ND, 2016, NAT IMMUNOL, V17, P1235, DOI 10.1038/ni1016-1235b; Mizuno M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173032; Nieuwenhuis EES, 2000, ARTHRITIS RHEUM, V43, P2583, DOI 10.1002/1529-0131(200011)43:11<2583::AID-ANR28>3.0.CO;2-U; Ozkan J, 2019, OCUL SURF, V17, P111, DOI 10.1016/j.jtos.2018.11.005; Qiu S, 2014, CHIN J NAT MEDICINES, V12, P401, DOI 10.1016/S1875-5364(14)60063-7; Rivera-Chavez F, 2016, MBIO, V7, DOI 10.1128/mBio.00960-16; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Schirmer M, 2016, CELL, V167, P1897, DOI 10.1016/j.cell.2016.11.046; SCHULMAN M, 1976, J BACTERIOL, V128, P372, DOI 10.1128/JB.128.1.372-381.1976; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Smolen JS, 2016, LANCET, V388, P1984; Song M, 2019, CLIN GASTROENTEROL H, V17, P275, DOI 10.1016/j.cgh.2018.07.012; Sun RB, 2017, MOL PHARMACOL, V91, P110, DOI 10.1124/mol.116.106617; Teng F, 2016, IMMUNITY, V44, P875, DOI 10.1016/j.immuni.2016.03.013; Villeger R, 2018, WORLD J GASTROENTERO, V24, P2327, DOI 10.3748/wjg.v24.i22.2327; Vital M, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00130-17; Vital M, 2014, MBIO, V5, DOI 10.1128/mBio.00889-14; Wang FY, 2017, TOXICOL PATHOL, V45, P150, DOI 10.1177/0192623316679898; Wang LL, 2017, J CHROMATOGR B, V1057, P70, DOI 10.1016/j.jchromb.2017.05.004; Wang XK, 2015, SCI REP-UK, V5, DOI 10.1038/srep12676; Wang Y, 2017, THERANOSTICS, V7, P2443, DOI 10.7150/thno.18290; Wang Y, 2017, METABOLISM, V70, P72, DOI 10.1016/j.metabol.2017.02.003; Weingarden A, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0070-0; Weissmann G, 2006, BULL HOSP JT DIS, V64, P12; WHITEHOUSE MW, 1986, LANCET, V2, P688; Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345; Wu Q, 2017, J IND MICROBIOL BIOT, V44, P1245, DOI 10.1007/s10295-017-1956-6; Yao J, 2015, SCI CHINA LIFE SCI, V58, P854, DOI 10.1007/s11427-013-4568-z; Yue MF, 2017, FEBS J, V284, P2786, DOI 10.1111/febs.14147	60	30	32	5	35	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12311	12323		10.1096/fj.201900425RR	http://dx.doi.org/10.1096/fj.201900425RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31425655	Green Published			2022-12-26	WOS:000507461600056
J	Chiu, JE; Thekkiniath, J; Mehta, S; Muller, C; Bracher, F; Ben Mamoun, C				Chiu, Joy E.; Thekkiniath, Jose; Mehta, Sameet; Mueller, Christoph; Bracher, Franz; Ben Mamoun, Choukri			The yeast pantothenate kinase Cab1 is a master regulator of sterol metabolism and of susceptibility to ergosterol biosynthesis inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sterol; yeast metabolism; drug action; metabolic regulation; transcription regulation; antifungal; metabolism; pantothenate kinase; pantothenic acid; regulation	ENDOPLASMIC-RETICULUM; RESISTANCE; GENE; MITOCHONDRIA; TRANSPORT; TOPHAT; FEN2	In fungi, ergosterol is an essential component of the plasma membrane. Its biosynthesis from acetyl-CoA is the primary target of the most commonly used antifungal drugs. Here, we show that the pantothenate kinase Cab1p, which catalyzes the first step in the metabolism of pantothenic acid for CoA biosynthesis in budding yeast (Saccharomyces cerevisiae), significantly regulates the levels of sterol intermediates and the activities of ergosterol biosynthesis-targeting antifungals. Using genetic and pharmacological analyses, we show that altered pantothenate utilization dramatically alters the susceptibility of yeast cells to ergosterol biosynthesis inhibitors. Genome-wide transcription and MS-based analyses revealed that this regulation is mediated by changes both in the expression of ergosterol biosynthesis genes and in the levels of sterol intermediates. Consistent with these findings, drug interaction experiments indicated that inhibition of pantothenic acid utilization synergizes with the activity of the ergosterol molecule-targeting antifungal amphotericin B and antagonizes that of the ergosterol pathway-targeting antifungal drug terbinafine. Our finding that CoA metabolism controls ergosterol biosynthesis and susceptibility to antifungals could set the stage for the development of new strategies to manage fungal infections and to modulate the potency of current drugs against drug-sensitive and -resistant fungal pathogens.	[Chiu, Joy E.; Thekkiniath, Jose; Ben Mamoun, Choukri] Yale Univ, Sch Med, Sect Infect Dis, Dept Internal Med, Winchester Bldg WWW403D,15 York St, New Haven, CT 06520 USA; [Mehta, Sameet] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Mueller, Christoph; Bracher, Franz] Ludwig Maximilians Univ Munchen, Ctr Drug Res, Dept Pharm, Butenandstr 5-13, D-81377 Munich, Germany	Yale University; Yale University; University of Munich	Ben Mamoun, C (corresponding author), Yale Univ, Sch Med, Sect Infect Dis, Dept Internal Med, Winchester Bldg WWW403D,15 York St, New Haven, CT 06520 USA.	choukri.benmamoun@yale.edu	Mehta, Sameet/A-1936-2011	Mehta, Sameet/0000-0002-3029-3217; Ben Mamoun, Choukri/0000-0001-5028-1400; Chiu, Joy/0000-0002-2345-9549; Muller, Christoph/0000-0002-1163-2527	NCATS NIH HHS [UL1 TR001863] Funding Source: Medline; NIAID NIH HHS [R01 AI138139, R01 AI097218, R01 AI123321] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI138139, R01AI097218, R01AI123321] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bhattacharya S, 2018, MBIO, V9, DOI 10.1128/mBio.01291-18; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Carrillo-Munoz A J, 2006, Rev Esp Quimioter, V19, P130; Chiu JE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14074-9; Choudhary V, 2012, P NATL ACAD SCI USA, V109, P16882, DOI 10.1073/pnas.1209086109; de Villiers M, 2017, ACS INFECT DIS, V3, P527, DOI 10.1021/acsinfecdis.7b00024; Gout I, 2018, BIOCHEM SOC T, V46, P721, DOI 10.1042/BST20170506; Hull CM, 2012, ANTIMICROB AGENTS CH, V56, P4223, DOI 10.1128/AAC.06253-11; Marcireau C, 1996, YEAST, V12, P531, DOI 10.1002/(SICI)1097-0061(199605)12:6<531::AID-YEA934>3.3.CO;2-5; Muller C, 2018, MOLECULES, V23, DOI 10.3390/molecules23051218; Muller C, 2017, NAT PROTOC, V12, P947, DOI 10.1038/nprot.2017.005; Olzhausen J, 2009, CURR GENET, V55, P163, DOI 10.1007/s00294-009-0234-1; Orhan G, 2005, J CLIN MICROBIOL, V43, P140, DOI 10.1128/JCM.43.1.140-143.2005; Pfeffer SR, 2019, J BIOL CHEM, V294, P1706, DOI 10.1074/jbc.TM118.004165; Ryder N., 1986, IN VITRO VIVO EVALUA, P88; RYDER NS, 1992, BRIT J DERMATOL, V126, P2, DOI 10.1111/j.1365-2133.1992.tb00001.x; Soni P, 2017, J CLIN DIAGN RES, V11, pDC14, DOI 10.7860/JCDR/2017/27284.10635; South PF, 2013, P NATL ACAD SCI USA, V110, pE1016, DOI 10.1073/pnas.1215768110; Stolz J, 1999, J BIOL CHEM, V274, P18747, DOI 10.1074/jbc.274.26.18747; Tian SQ, 2018, J BIOL CHEM, V293, P5636, DOI 10.1074/jbc.RA117.000596; Tian SQ, 2015, BIOSCI BIOTECH BIOCH, V79, P1608, DOI 10.1080/09168451.2015.1058702; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vanden Bossche H, 1998, MED MYCOL, V36, P119; Williams C, 2016, CURR FUNGAL INFECT R, V10, P163, DOI 10.1007/s12281-016-0268-z	26	5	5	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2019	294	40					14757	14767		10.1074/jbc.RA119.009791	http://dx.doi.org/10.1074/jbc.RA119.009791			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JP0II	31409644	Green Published, hybrid			2022-12-26	WOS:000497955000020
J	Beyes, S; Andrieux, G; Schrempp, M; Aicher, D; Wenzel, J; Anton-Garcia, P; Boerries, M; Hecht, A				Beyes, Sven; Andrieux, Geoffroy; Schrempp, Monika; Aicher, David; Wenzel, Janna; Anton-Garcia, Pablo; Boerries, Melanie; Hecht, Andreas			Genome-wide mapping of DNA-binding sites identifies stemness-related genes as directly repressed targets of SNAIL1 in colorectal cancer cells	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; EPHB3 TUMOR-SUPPRESSOR; COMPETITIVE DISPLACEMENT; SMALL-INTESTINE; EXPRESSION; MYB; TRANSCRIPTION; ASCL2; RNA; EMT	At the molecular level, epithelial-to-mesenchymal transition (EMT) necessitates extensive transcriptional reprogramming which is orchestrated by a small group of gene-regulatory factors that include the zinc-finger DNA-binding protein SNAIL1. Although SNAIL1 is a well-known master regulator of EMT, knowledge of its immediate target genes is incomplete. Here, we used ChIP-seq to identify genes directly regulated by SNAIL1 in colorectal adenocarcinoma cells. When comparing the genomic distribution of SNAIL1 to that of the intestinal stem cell (ISC) transcription factors ASCL2 and TCF7L2, we observed a significant overlap. Furthermore, SNAIL1 ChIP-seq peaks are associated with a substantial fraction of ISC signature genes. In two colorectal cancer cell lines, we verified that SNAIL1 decreases ISC marker expression. Likewise, SNAIL1 directly represses the proto-oncogene MYB, and the long noncoding RNA (lncRNA) WiNTRLINC1, a recently described regulator of ASCL2. SNAIL1 targets multiple regulatory elements at the MYB and WiNTRLINC1 loci, and displaces ASCL2 and TCF7L2 from their binding regions at a MYB downstream regulatory element. Correlation analyses and expression profiling showed antiparallel expression of SNAIL1 and MYB in colorectal and breast cancer cell lines and tumor transcriptomes, suggesting that SNAIL1 controls MYB expression in different tissues. MYB loss-of-function attenuated proliferation and impaired clonogenicity in two- and three-dimensional cell cultures. Therefore, SNAIL1-mediated downregulation of MYB and ISC markers like WiNTRLINC1 likely contributes to the decrease in proliferation known to be associated with EMT, while simultaneously abrogating stemness features of colorectal cancer cells. Apparently, the relationship between EMT and stemness varies in different tumor entities.	[Beyes, Sven; Andrieux, Geoffroy; Schrempp, Monika; Aicher, David; Wenzel, Janna; Anton-Garcia, Pablo; Boerries, Melanie; Hecht, Andreas] Univ Freiburg, Fac Med, Inst Mol Med & Cell Res, Freiburg, Germany; [Beyes, Sven; Wenzel, Janna; Anton-Garcia, Pablo; Hecht, Andreas] Univ Freiburg, Fac Biol, Freiburg, Germany; [Andrieux, Geoffroy; Boerries, Melanie] Univ Freiburg, Univ Med Ctr Freiburg, Fac Med, Inst Med Bioinformat & Syst Med, Freiburg, Germany; [Andrieux, Geoffroy; Boerries, Melanie] German Canc Consortium DKTK, Partner Site Freiburg, Freiburg, Germany; [Andrieux, Geoffroy; Boerries, Melanie] German Canc Res Ctr, Heidelberg, Germany; [Boerries, Melanie] Univ Freiburg, Univ Med Ctr, Fac Med, CCCF, Freiburg, Germany; [Hecht, Andreas] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Freiburg; University of Freiburg	Hecht, A (corresponding author), Univ Freiburg, Fac Med, Inst Mol Med & Cell Res, Freiburg, Germany.; Hecht, A (corresponding author), Univ Freiburg, Fac Biol, Freiburg, Germany.; Hecht, A (corresponding author), Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany.	andreas.hecht@mol-med.uni-freiburg.de	Boerries, Melanie/AAM-2602-2021	ANDRIEUX, GEOFFROY/0000-0002-5389-9481	Deutsche Forschungsgemeinschaft [DFG HE2004/11-1, CRC-850, GRK2344]; German Federal Ministry of Education and Research (BMBF) [FKZ 01ZX1708F]; Deutsche Forschungsgemeinschaft Research Training Group [GRK2344]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft Research Training Group(German Research Foundation (DFG))	The authors are grateful to K. Geiger and D. Herchenbach for excellent technical assistance, and to the team of the Genomics and Proteomics Core Facility, German Cancer Research Center/DKFZ, Heidelberg, Germany, for their sequencing service. This work was financially supported by the Deutsche Forschungsgemeinschaft (DFG HE2004/11-1 to AH; CRC-850 subprojects B5 to AH and Z1 to MB; GRK2344 subprojects B02 to MB and B03 to AH), and by the German Federal Ministry of Education and Research (BMBF) within the framework of the e:Med research and funding concept CoNfirm (FKZ 01ZX1708F to MB). JW and PAG were funded by the Deutsche Forschungsgemeinschaft Research Training Group GRK2344 "MeInBio-BioInMe".	Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Beck B, 2015, CELL STEM CELL, V16, P67, DOI 10.1016/j.stem.2014.12.002; Blick T, 2008, CLIN EXP METASTAS, V25, P629, DOI 10.1007/s10585-008-9170-6; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Caja L, 2018, ONCOGENE, V37, P2515, DOI 10.1038/s41388-018-0136-0; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Cheasley D, 2011, STEM CELLS, V29, P2042, DOI 10.1002/stem.761; Ciznadija D, 2009, CELL DEATH DIFFER, V16, P1530, DOI 10.1038/cdd.2009.94; Fabregat I, 2016, J CLIN MED, V5, DOI 10.3390/jcm5030037; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Giakountis A, 2016, CELL REP, V15, P2588, DOI 10.1016/j.celrep.2016.05.038; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Haraguchi M, 2008, J BIOL CHEM, V283, P23514, DOI 10.1074/jbc.M801125200; Hsu DSS, 2014, CANCER CELL, V26, P534, DOI 10.1016/j.ccell.2014.09.002; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Hugo HJ, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3580; Hwang WL, 2014, NAT CELL BIOL, V16, P268, DOI 10.1038/ncb2910; Hwang WL, 2011, GASTROENTEROLOGY, V141, P279, DOI 10.1053/j.gastro.2011.04.008; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Jagle S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007109; Jagle S, 2014, P NATL ACAD SCI USA, V111, P4886, DOI 10.1073/pnas.1314523111; Javaid S, 2013, CELL REP, V5, P1679, DOI 10.1016/j.celrep.2013.11.034; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Lambert SA, 2018, CELL, V172, P650, DOI 10.1016/j.cell.2018.01.029; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lin YW, 2010, EMBO J, V29, P1803, DOI 10.1038/emboj.2010.63; Malaterre J, 2016, ONCOGENE, V35, P2475, DOI 10.1038/onc.2015.305; Malaterre J, 2007, P NATL ACAD SCI USA, V104, P3829, DOI 10.1073/pnas.0610055104; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Maturi V, 2018, MOL ONCOL, V12, P1153, DOI 10.1002/1878-0261.12317; Meyer-Schaller N, 2019, DEV CELL, V48, P539, DOI 10.1016/j.devcel.2018.12.023; Miao RY, 2011, CANCER RES, V71, P7029, DOI 10.1158/0008-5472.CAN-11-1015; Millanes-Romero A, 2013, MOL CELL, V52, P746, DOI 10.1016/j.molcel.2013.10.015; Mokry M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015092; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Preca BT, 2015, INT J CANCER, V137, P2566, DOI 10.1002/ijc.29642; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Rembold M, 2014, GENE DEV, V28, P167, DOI 10.1101/gad.230953.113; Ronsch K, 2015, MOL ONCOL, V9, P335, DOI 10.1016/j.molonc.2014.08.016; Rosmaninho P, 2018, EMBO J, V37, DOI 10.15252/embj.201797115; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schnappauf O, 2016, BBA-GENE REGUL MECH, V1859, P1353, DOI 10.1016/j.bbagrm.2016.08.002; Schuijers J, 2015, CELL STEM CELL, V16, P158, DOI 10.1016/j.stem.2014.12.006; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Soleimani VD, 2012, MOL CELL, V47, P457, DOI 10.1016/j.molcel.2012.05.046; Srivastava SK, 2015, BRIT J CANCER, V113, P1694, DOI 10.1038/bjc.2015.400; Stanisavljevic J, 2011, J CELL SCI, V124, P4159, DOI 10.1242/jcs.078824; Stemmer V, 2008, ONCOGENE, V27, P5075, DOI 10.1038/onc.2008.140; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tran DD, 2011, MOL CANCER RES, V9, P1644, DOI 10.1158/1541-7786.MCR-11-0371; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van der Auwera, 2013, CURR PROTOC BIOINFOR, V43; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Weise A, 2010, NUCLEIC ACIDS RES, V38, P1964, DOI 10.1093/nar/gkp1197; Ye X, 2015, NATURE, V525, P256, DOI 10.1038/nature14897; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu P, 2018, NAT CELL BIOL, V1134	75	20	20	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 3	2019	38	40					6647	6661		10.1038/s41388-019-0905-4	http://dx.doi.org/10.1038/s41388-019-0905-4			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JC0EY	31391555	hybrid			2022-12-26	WOS:000488953500001
J	Barraclough, TG				Barraclough, Timothy G.			Species matter for predicting the functioning of evolving microbial communities - An eco-evolutionary model	PLOS ONE			English	Article							DIVERSITY; DYNAMICS; COMPETITION; CONSTRAINTS; STABILITY; GROWTH	Humans depend on microbial communities for numerous ecosystem services such as global nutrient cycles, plant growth and their digestive health. Yet predicting dynamics and functioning of these complex systems is hard, making interventions to enhance functioning harder still. One simplifying approach is to assume that functioning can be predicted from the set of enzymes present in a community. Alternatively, ecological and evolutionary dynamics of species, which depend on how enzymes are packaged among species, might be vital for predicting community functioning. I investigate these alternatives by extending classical chemostat models of bacterial growth to multiple species that evolve in their use of chemical resources. Ecological interactions emerge from patterns of resource use, which change as species evolve in their allocation of metabolic enzymes. Measures of community functioning derive in turn from metabolite concentrations and bacterial density. Although the model shows considerable functional redundancy, species packaging does matter by introducing constraints on whether enzyme levels can reach optimum levels for the whole system. Evolution can either promote or reduce functioning compared to purely ecological models, depending on the shape of trade-offs in resource use. The model provides baseline theory for interpreting emerging data on evolution and functioning in real bacterial communities.	[Barraclough, Timothy G.] Imperial Coll London, Dept Life Sci, Silwood Pk Campus, Ascot, England	Imperial College London	Barraclough, TG (corresponding author), Imperial Coll London, Dept Life Sci, Silwood Pk Campus, Ascot, England.	t.barraclough@imperial.ac.uk		Barraclough, Timothy/0000-0002-8084-2640	Natural Environment Research Council (NERC), UK [NE/K006215/1]; Leverhulme Trust; NERC [NE/K006215/1] Funding Source: UKRI	Natural Environment Research Council (NERC), UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Leverhulme Trust(Leverhulme Trust); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Natural Environment Research Council (NERC), UK grant NE/K006215/1 and the Leverhulme Trust Research Fellowship to TGB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen M, 2012, ISME J, V6, P1094, DOI 10.1038/ismej.2011.176; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.04.004, 10.1016/j.chom.2015.05.012]; Barraclough T. G., 2019, EVOLUTIONARY BIOL SP; Barraclough TG, 2015, ANNU REV ECOL EVOL S, V46, P25, DOI 10.1146/annurev-ecolsys-112414-054030; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Berkhout J, 2013, GENETICS, V194, P505, DOI 10.1534/genetics.113.150631; Bomar L, 2011, MBIO, V2, DOI 10.1128/mBio.00012-11; Browne HP, 2016, NATURE, V533, P543, DOI 10.1038/nature17645; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Cordero OX, 2014, NAT REV MICROBIOL, V12, P263, DOI 10.1038/nrmicro3218; Culbert CT, 2019, SPATIAL STRUCT UNPUB; Fiegna F, 2015, ISME J, V9, P1235, DOI 10.1038/ismej.2014.215; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; Foster KR, 2012, CURR BIOL, V22, P1845, DOI 10.1016/j.cub.2012.08.005; Franzosa EA, 2015, NAT REV MICROBIOL, V13, P360, DOI 10.1038/nrmicro3451; Fussmann GF, 2007, FUNCT ECOL, V21, P465, DOI 10.1111/j.1365-2435.2007.01275.x; Gravel D, 2011, NATURE, V469, P89, DOI 10.1038/nature09592; Gresham D, 2015, FEMS MICROBIOL REV, V39, P2, DOI 10.1111/1574-6976.12082; Gudelj I, 2007, J EVOLUTION BIOL, V20, P1882, DOI 10.1111/j.1420-9101.2007.01376.x; HARDER W, 1982, PHILOS T ROY SOC B, V297, P459, DOI 10.1098/rstb.1982.0055; Heinrich R., 1996, REGULATION CELLULAR; Henirich R, 1974, EUROPEAN J BIOCH, V42, P89, DOI [10.1111/j.1432-1033.1974.tb03318.x, DOI 10.1111/J.1432-1033.1974.TB03318.X]; HERBERT D, 1956, J GEN MICROBIOL, V14, P601, DOI 10.1099/00221287-14-3-601; HSU SB, 1977, SIAM J APPL MATH, V32, P366, DOI 10.1137/0132030; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Johnson LP, 2015, NUTRIENTS, V7, P4480, DOI 10.3390/nu7064480; Karlsson FH, 2011, TRENDS BIOTECHNOL, V29, P251, DOI 10.1016/j.tibtech.2011.01.009; Kettle H, 2015, ENVIRON MICROBIOL, V17, P1615, DOI 10.1111/1462-2920.12599; Kovarova-Kovar K, 1998, MICROBIOL MOL BIOL R, V62, P646; LANDE R, 1976, EVOLUTION, V30, P314, DOI 10.1111/j.1558-5646.1976.tb00911.x; Lawrence D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001330; Louca S, 2015, ELIFE, V4, DOI 10.7554/eLife.08208; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; LYNCH M, 1983, AM NAT, V122, P745, DOI 10.1086/284169; Milucka J, 2012, NATURE, V491, P541, DOI 10.1038/nature11656; Morales SE, 2011, FEMS MICROBIOL ECOL, V75, P2, DOI 10.1111/j.1574-6941.2010.00938.x; Munoz-Tamayo R, 2010, J THEOR BIOL, V266, P189, DOI 10.1016/j.jtbi.2010.05.040; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Norberg J, 2012, NAT CLIM CHANGE, V2, P747, DOI [10.1038/NCLIMATE1588, 10.1038/nclimate1588]; Pereira FC, 2017, ENVIRON MICROBIOL, V19, P1366, DOI 10.1111/1462-2920.13659; Perez-Garcia O, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00673; Pfeiffer T, 2004, AM NAT, V163, pE126, DOI 10.1086/383593; Post DM, 2009, PHILOS T R SOC B, V364, P1629, DOI 10.1098/rstb.2009.0012; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rivett DW, 2016, ISME J, V10, P2259, DOI 10.1038/ismej.2016.11; Roling WFM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00125; SALONIEMI I, 1993, AM NAT, V141, P880, DOI 10.1086/285514; Sampson TR, 2015, CELL HOST MICROBE, V17, P565, DOI 10.1016/j.chom.2015.04.011; Shoaie S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02532; STEWART FM, 1973, AM NAT, V107, P171, DOI 10.1086/282825; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Weimer PJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00296; Weisse AY, 2015, P NATL ACAD SCI USA, V112, pE1038, DOI 10.1073/pnas.1416533112; Widder S, 2016, ISME J, V10, P2557, DOI 10.1038/ismej.2016.45	56	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0218692	10.1371/journal.pone.0218692	http://dx.doi.org/10.1371/journal.pone.0218692			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5MK	31425541	gold, Green Published, Green Submitted			2022-12-26	WOS:000485022400008
J	Raj, S; Sasidharan, S; Dubey, VK; Saudagar, P				Raj, Shweta; Sasidharan, Santanu; Dubey, Vikash Kumar; Saudagar, Prakash			Identification of lead molecules against potential drug target protein MAPK4 from L. donovani: An in-silico approach using docking, molecular dynamics and binding free energy calculation	PLOS ONE			English	Article							SECONDARY STRUCTURE; LEISHMANIA; KINASE; RECOGNITION; PREDICTION; SEQUENCE; ERK; LOCALIZATION; INHIBITORS; DISCOVERY	Leishmaniasis caused by obligate intracellular parasites of genus Leishmania is one of the most neglected tropical diseases threatening 350 million people worldwide. Protein kinases have drawn much attention as potential drug targets due to their important role in various cellular processes. In Leishmania sp. mitogen-activated protein kinase 4 is essential for the parasite survival because of its involvement in various regulatory, apoptotic and developmental pathways. The current study reveals the identification of natural inhibitors of L. donovani mitogen-activated protein kinase-4 (LdMPK4). We have performed in silico docking of 110 natural inhibitors of Leishmania parasite that have been reported earlier and identified two compounds Genistein (GEN) and Chrysin (CHY). The homology model of LdMPK4 was developed, followed by binding affinity studies, and pharmacokinetic properties of the inhibitors were calculated by maintaining ATP as a standard molecule. The modelled structure was deposited in the protein model database with PMDB ID: PM0080988. Molecular dynamic simulation of the enzyme-inhibitor complex along with the free energy calculations over 50 ns showed that GEN and CHY are more stable in their binding. These two molecules, GEN and CHY, can be considered as lead molecules for targeting LdMPK4 enzyme and could emerge as potential LdMPK4 inhibitors.	[Raj, Shweta; Sasidharan, Santanu; Saudagar, Prakash] Natl Inst Technol Warangal, Dept Biotechnol, Warangal, TS, India; [Dubey, Vikash Kumar] Banaras Hindu Univ, Indian Inst Technol, Sch Biochem Engn, Varanasi, Uttar Pradesh, India	National Institute of Technology (NIT System); National Institute of Technology Warangal; Banaras Hindu University (BHU); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT BHU) - Varanasi	Saudagar, P (corresponding author), Natl Inst Technol Warangal, Dept Biotechnol, Warangal, TS, India.	ps@nitw.ac.in	Dubey, Vikash Kumar/B-3542-2008; Saudagar, Prakash/AAV-8341-2021; Saudagar, Prakash/ABE-7270-2020; Sasidharan, Santanu/M-3429-2016	Dubey, Vikash Kumar/0000-0002-4281-2504; Saudagar, Prakash/0000-0001-7211-0581; Sasidharan, Santanu/0000-0002-0204-0263; Dubey, Vikash Kumar/0000-0002-3870-2660	Science and Engineering Research Board, Government of India [YSS/2014/000147]; NIT Warangal	Science and Engineering Research Board, Government of India; NIT Warangal	This work was supported by the Science and Engineering Research Board, Government of India Grant Number: YSS/2014/000147 to PS. The authors SS and SR acknowledge research fellowships from NIT Warangal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe MK, 2002, J BIOL CHEM, V277, P16733, DOI 10.1074/jbc.M112483200; Abe MK, 1999, MOL CELL BIOL, V19, P1301; Abron JD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199631; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Castrignano T, 2006, NUCLEIC ACIDS RES, V34, pD306, DOI 10.1093/nar/gkj105; Daina A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42717; Dallakyan S, 2015, METHODS MOL BIOL, V1263, P243, DOI 10.1007/978-1-4939-2269-7_19; DELL KR, 1994, MOL BIOCHEM PARASIT, V64, P283, DOI 10.1016/0166-6851(94)00030-1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egan WJ, 2000, J MED CHEM, V43, P3867, DOI 10.1021/jm000292e; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Ellis J, 2004, MOL MICROBIOL, V53, P1487, DOI 10.1111/j.1365-2958.2004.04218.x; Erdmann M, 2006, MOL BIOL CELL, V17, P2035, DOI 10.1091/mbc.E05-10-0976; Erdmann M, 2009, LMXMPK3 MITOGEN ACTI; Ghose AK, 1999, J COMB CHEM, V1, P55, DOI 10.1021/cc9800071; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Ji GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053101; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Khoo BY, 2010, INT J MOL SCI, V11, P2188, DOI 10.3390/ijms11052188; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Lagorce D, 2017, BIOINFORMATICS, V33, P3658, DOI 10.1093/bioinformatics/btx491; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE JD, 1995, BIOCHEM BIOPH RES CO, V213, P715, DOI 10.1006/bbrc.1995.2189; Li SY, 1996, EXP PARASITOL, V82, P87, DOI 10.1006/expr.1996.0012; Libusova L, 2004, EXP CELL RES, V295, P375, DOI 10.1016/j.yexcr.2004.01.009; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Masera JJR, 2007, MED ORAL PATOL ORAL, V12, P281; Melo F, 2002, PROTEIN SCI, V11, P430, DOI 10.1002/pro.110430; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Muegge I, 2001, J MED CHEM, V44, P1841, DOI 10.1021/jm015507e; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Ohori M, 2005, BIOCHEM BIOPH RES CO, V336, P357, DOI 10.1016/j.bbrc.2005.08.082; Padmanabhan PK, 2005, BIOCHEM BIOPH RES CO, V337, P1237, DOI 10.1016/j.bbrc.2005.09.179; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RAPPE AK, 1992, J AM CHEM SOC, V114, P10024, DOI 10.1021/ja00051a040; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shukla AK, 2010, APPL BIOCHEM BIOTECH, V160, P2208, DOI 10.1007/s12010-009-8764-z; Shukla R, 2018, J BIOMOL STRUCT DYN, V36, P3541, DOI 10.1080/07391102.2017.1392897; Shukla R, 2019, J CELL BIOCHEM, V120, P2469, DOI 10.1002/jcb.27538; Shukla R, 2018, J CELL BIOCHEM, V119, P3067, DOI 10.1002/jcb.26444; Shukla R, 2018, J BIOMOL STRUCT DYN, V36, P2147, DOI 10.1080/07391102.2017.1344141; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Sinha PK, 2005, INDIAN J MED RES, V121, P407; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vannier-Santos MA, 2002, CURR PHARM DESIGN, V8, P297, DOI 10.2174/1381612023396230; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; von Freyend SJ, 2010, INT J PARASITOL, V40, P969, DOI 10.1016/j.ijpara.2010.02.004; Wang Qiong, 2005, Kinetoplastid Biol Dis, V4, P6, DOI 10.1186/1475-9292-4-6; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wiese M, 2007, INT J PARASITOL, V37, P1053, DOI 10.1016/j.ijpara.2007.04.008; Yang JY, 2013, BIOINFORMATICS, V29, P2588, DOI 10.1093/bioinformatics/btt447	58	27	28	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0221331	10.1371/journal.pone.0221331	http://dx.doi.org/10.1371/journal.pone.0221331			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5MK	31425543	Green Published, gold, Green Submitted			2022-12-26	WOS:000485022400039
J	Stone, KD; Dijkerman, HC; Bekrater-Bodmann, R; Keizer, A				Stone, Kayla D.; Dijkerman, H. Chris; Bekrater-Bodmann, Robin; Keizer, Anouk			Mental rotation of feet in individuals with Body Integrity Identity Disorder, lower-limb amputees, and normally-limbed controls	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; RUBBER HAND ILLUSION; MOTOR IMAGERY; BRAIN ACTIVITY; XENOMELIA; PREMOTOR; PARIETAL; SOMATOPARAPHRENIA; TRANSFORMATIONS; REPRESENTATIONS	Body Integrity Identity Disorder (BIID) is a non-psychotic condition wherein individuals desire amputation or paralysis of one or more healthy, fully-functioning limbs (predominantly the legs). Individuals with BIID have been suggested to have a mismatch between the perceived mental representation of the body and its actual physical structure, such that their desired identity matches that of a lower-limb amputee. Accordingly, studies have reported an altered central network involving body representation of the legs in BIID, but its relationship to behavior remains unclear. In the present study, we investigated the integrity of body representation in individuals with BIID, acquired lower-limb amputees, and normally-limbed controls using an online mental rotation task. Participants judged the laterality of left and right foot images presented from different views, orientations, and of different types. We expected BIID participants to be slower for mentally rotating images that corresponded to their affected legs than lower-limb amputees and normally-limbed participants. We found that the groups did not significantly differ in their performance. All participants were slower at judging feet presented in awkward postures than natural postures, replicating previous studies and validating our online paradigm. The results are discussed in terms of the robust nature of visual and sensorimotor lower-limb representations, whether related to the self or as prototype, in the context of disturbed lower-limb integrity.	[Stone, Kayla D.; Dijkerman, H. Chris; Keizer, Anouk] Univ Utrecht, Helmholtz Inst, Dept Expt Psychol, Utrecht, Netherlands; [Bekrater-Bodmann, Robin] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Cognit & Clin Neurosci, Mannheim, Germany	Utrecht University; Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Stone, KD (corresponding author), Univ Utrecht, Helmholtz Inst, Dept Expt Psychol, Utrecht, Netherlands.	k.d.stone@uu.nl	Stone, Kayla/AAD-3525-2020	Stone, Kayla/0000-0001-9212-2782	Netherlands Organisation for Scientific Research (NWO) [406.15.282]; Natural Sciences and Engineering Research Council of Canada (NSERC)	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by a Netherlands Organisation for Scientific Research (NWO) talent grant (406.15.282) to HCD, KDS, AK and a Natural Sciences and Engineering Research Council of Canada (NSERC) Postgraduate Scholarship to KDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama A, 2012, SPAT COGN COMPUT, V12, P96, DOI 10.1080/13875868.2011.603773; Bekrater-Bodmann R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119552; Berneiser J, 2018, NEUROIMAGE, V167, P247, DOI 10.1016/j.neuroimage.2016.06.014; Berti A, 2013, BRAIN, V136, P11, DOI 10.1093/brain/aws346; Blom RAM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163539; Blom RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034702; Boccia M, 2020, BRAIN IMAGING BEHAV, V14, P416, DOI 10.1007/s11682-019-00142-3; Bohus M, 2009, PSYCHOPATHOLOGY, V42, P32, DOI 10.1159/000173701; BONDA E, 1995, P NATL ACAD SCI USA, V92, P11180, DOI 10.1073/pnas.92.24.11180; Brugger P, 2016, LANCET PSYCHIAT, V3, P1176, DOI 10.1016/S2215-0366(16)30265-6; Coslett HB, 2010, J INT NEUROPSYCH SOC, V16, P603, DOI 10.1017/S1355617710000299; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Critchley M., 1953, PARIETAL LOBES; Curtze C, 2010, EXP BRAIN RES, V201, P527, DOI 10.1007/s00221-009-2067-z; Dalecki M, 2013, NEUROSCI LETT, V533, P55, DOI 10.1016/j.neulet.2012.11.002; de Lange FP, 2006, NEUROIMAGE, V33, P609, DOI 10.1016/j.neuroimage.2006.07.017; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Elias LJ, 1998, NEUROPSYCHOLOGIA, V36, P37, DOI 10.1016/S0028-3932(97)00107-3; Ferri F, 2012, J COGNITIVE NEUROSCI, V24, P1584, DOI 10.1162/jocn_a_00230; Fiorio M, 2007, NEUROPSYCHOLOGIA, V45, P2346, DOI 10.1016/j.neuropsychologia.2007.02.005; First MB, 2012, PSYCHOPATHOLOGY, V45, P3, DOI 10.1159/000330503; Ganis G, 2000, CEREB CORTEX, V10, P175, DOI 10.1093/cercor/10.2.175; Gentile G, 2015, NEUROIMAGE, V109, P328, DOI 10.1016/j.neuroimage.2015.01.008; Gentile G, 2013, J NEUROSCI, V33, P13350, DOI 10.1523/JNEUROSCI.1363-13.2013; Guo XL, 2017, IEEE T NEUR SYS REH, V25, P2046, DOI 10.1109/TNSRE.2017.2702117; Hanggi J, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.657; Hanggi J, 2016, NEUROIMAGE-CLIN, V11, P760, DOI 10.1016/j.nicl.2016.05.015; Hilti LM, 2013, BRAIN, V136, P318, DOI 10.1093/brain/aws316; Hoyek N, 2014, ATTEN PERCEPT PSYCHO, V76, P519, DOI 10.3758/s13414-013-0577-z; Ionta S, 2007, EXP BRAIN RES, V183, P1, DOI 10.1007/s00221-007-1020-2; Ionta S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20144; Ionta S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034382; Ionta S, 2009, EXP BRAIN RES, V195, P207, DOI 10.1007/s00221-009-1770-0; Johnson SH, 2002, J COGNITIVE NEUROSCI, V14, P841, DOI 10.1162/089892902760191072; Johnson SH, 2000, NEUROREPORT, V11, P729, DOI 10.1097/00001756-200003200-00015; Kammers MPM, 2009, J COGNITIVE NEUROSCI, V21, P1311, DOI 10.1162/jocn.2009.21095; Katschnig P, 2010, MOVEMENT DISORD, V25, P1061, DOI 10.1002/mds.23047; Kosslyn SM, 1998, PSYCHOPHYSIOLOGY, V35, P151, DOI 10.1017/S0048577298001516; Kruger M, 2014, ACTA PSYCHOL, V145, P104, DOI 10.1016/j.actpsy.2013.11.004; Lenggenhager B, 2015, NEUROPSYCHOLOGY, V29, P205, DOI 10.1037/neu0000143; Leon AC, 1997, INT J PSYCHIAT MED, V27, P93, DOI 10.2190/T8EM-C8YH-373N-1UWD; Limanowski J, 2016, J NEUROSCI, V36, P2582, DOI 10.1523/JNEUROSCI.3987-15.2016; Lu WH, 2018, J FORMOS MED ASSOC, V117, P332, DOI 10.1016/j.jfma.2017.04.020; Lyu Y, 2016, SCI REP NATURE PUBLI, V6, P2100; Macauda G, 2017, J PSYCHIATR RES, V84, P249, DOI 10.1016/j.jpsychires.2016.09.019; McGeoch PD, 2011, J NEUROL NEUROSUR PS, V82, P1314, DOI 10.1136/jnnp-2011-300224; Munzert J, 2009, BRAIN RES REV, V60, P306, DOI 10.1016/j.brainresrev.2008.12.024; Naito E, 2016, NEUROSCI RES, V104, P16, DOI 10.1016/j.neures.2015.10.013; Nico D, 2004, BRAIN, V127, P120, DOI 10.1093/brain/awh006; Nummenmaa L, 2014, P NATL ACAD SCI USA, V111, P646, DOI 10.1073/pnas.1321664111; Oddo-Sommerfeld S, 2018, NEUROPSYCHOLOGIA, V108, P135, DOI 10.1016/j.neuropsychologia.2017.11.025; PARSONS LM, 1987, COGNITIVE PSYCHOL, V19, P178, DOI 10.1016/0010-0285(87)90011-9; PARSONS LM, 1995, NATURE, V375, P54, DOI 10.1038/375054a0; Reed GM, 2019, WORLD PSYCHIATRY, V18, P3, DOI 10.1002/wps.20611; Reinersmann A, 2010, NEUROSCI LETT, V486, P240, DOI 10.1016/j.neulet.2010.09.062; Romano D, 2015, CONSCIOUS COGN, V34, P140, DOI 10.1016/j.concog.2015.04.008; Romano D, 2014, BRAIN, V137, P1213, DOI 10.1093/brain/awu009; Sedda A, 2014, NEUROPSYCH DIS TREAT, V10, P1255, DOI 10.2147/NDT.S53385; Sedda A, 2011, NEUROPSYCHOL REV, V21, P334, DOI 10.1007/s11065-011-9186-6; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shenton JT, 2004, NEUROSCI LETT, V370, P19, DOI 10.1016/j.neulet.2004.07.053; Smit M, 2019, J NEUROPSYCHOL, V13, P603, DOI 10.1111/jnp.12153; Spotts JL, 2008, THESIS; Tomasino Barbara, 2015, Front Hum Neurosci, V9, P693, DOI 10.3389/fnhum.2015.00693; Uritani D, 2018, PAIN RES MANAG, V2018, DOI 10.1155/2018/6810412; Vallar G, 2009, EXP BRAIN RES, V192, P533, DOI 10.1007/s00221-008-1562-y; van Dijk MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072212; van Stralen HE, 2018, CORTEX, V104, P140, DOI 10.1016/j.cortex.2017.05.025; van Stralen HE, 2013, PERCEPTION, V42, P991, DOI 10.1068/p7583; Vingerhoets G, 2001, NEUROIMAGE, V13, P381, DOI 10.1006/nimg.2000.0690; Wohlschlager A, 1998, J EXP PSYCHOL HUMAN, V24, P397, DOI 10.1037/0096-1523.24.2.397; Wraga M, 2003, BRAIN COGNITION, V52, P135, DOI 10.1016/S0278-2626(03)00033-2	72	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2019	14	8							e0221105	10.1371/journal.pone.0221105	http://dx.doi.org/10.1371/journal.pone.0221105			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5LL	31419248	Green Published, gold, Green Submitted			2022-12-26	WOS:000485019900029
J	Eyding, J; Reitmeir, R; Oertel, M; Fischer, U; Wiest, R; Gralla, J; Raabe, A; Zubak, I; Graggen, WZ; Beck, J				Eyding, Jens; Reitmeir, Raluca; Oertel, Markus; Fischer, Urs; Wiest, Roland; Gralla, Jan; Raabe, Andreas; Zubak, Irena; Graggen, Werner Z'; Beck, Juergen			Ultrasonic quantification of cerebral perfusion in acute anterior circulation occlusive stroke-A comparative challenge of the refill- and the bolus-kinetics approach	PLOS ONE			English	Article							CONTRAST-ENHANCED ULTRASOUND	Purpose To prospectively evaluate the potential of semi-quantitative evaluation of cerebral perfusion in acute ischemic stroke by comparing two established ultrasound approaches. Materials and methods Consecutive inclusion of patients with acute occlusion of middle cerebral artery (MCA) confirmed by either magnetic resonance imaging (MRI) or computed tomography (CT) perfusion imaging qualifying for interventional therapy. Comparison of bilateral high mechanical index (MI) bolus-kinetics (HighMiB) and unilateral low MI refill-kinetics (LowMiR) performed before specific treatment. Results In 16/31 patients HighMiB was eligible, in 8/31 patients LowMiR was eligible. In six out of these eight patients both HighMiB and LowMiR were eligible for direct comparison. In MR/CT perfusion imaging of the 16 patients eligible for HighMiB, 29/48 cortical regions of interest (ROIs) (60%) displayed hypoperfusion or ischemia, areas inadequately accessible by LowMiR. These ROIs made up 49% of the 59 ROIs displaying hypoperfusion or ischemia, altogether. Matching of parameters in normal and impaired ROIs between LowMiR and MRI/CT perfusion imaging was significantly poorer than in HighMiB. Conclusion LowMiR using refill-kinetics potentially has the advantage of real time imaging and better resolution. The diagnostic impact, however, proves inferior to HighMiB both with respect to imaging quality and semi-quantitative evaluation.	[Eyding, Jens] Univ Hosp Knappschaftskrankenhaus Bochum, Dept Neurol, Bochum, Germany; [Reitmeir, Raluca; Oertel, Markus; Raabe, Andreas; Zubak, Irena; Graggen, Werner Z'; Beck, Juergen] Univ Hosp Bern, Inselspital, Dept Neurosurg, Bern, Switzerland; [Fischer, Urs; Graggen, Werner Z'] Univ Hosp Bern, Inselspital, Dept Neurol, Bern, Switzerland; [Wiest, Roland; Gralla, Jan] Univ Hosp Bern, Inselspital, Dept Neuroradiol, Bern, Switzerland; [Eyding, Jens] Klinikum Dortmund, Dept Neurol, Dortmund, Germany; [Reitmeir, Raluca] Schulthess Klin Zurich, Dept Neurosurg, Zurich, Switzerland; [Oertel, Markus] Univ Hosp Zurich, Dept Neurosurg, Zurich, Switzerland; [Beck, Juergen] Univ Hosp Freiburg, Dept Neurosurg, Freiburg, Germany	Ruhr University Bochum; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; Klinikum Dortmund; Schulthess Clinic; University of Zurich; University Zurich Hospital; University of Freiburg	Eyding, J (corresponding author), Univ Hosp Knappschaftskrankenhaus Bochum, Dept Neurol, Bochum, Germany.; Eyding, J (corresponding author), Klinikum Dortmund, Dept Neurol, Dortmund, Germany.	eyding@web.de		Eyding, Jens/0000-0001-8154-0647; Z'Graggen, Werner/0000-0002-5684-4419; Fischer, Urs/0000-0003-0521-4051; Zubak, Irena/0000-0001-8474-6421	Swiss National Science Foundation [SNF135477]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was supported by grants of the Swiss National Science Foundation (SNF135477) held by WZ'G and JB.	Della Martina A, 2005, J NEUROIMAGING, V15, P217, DOI 10.1177/1051228405277342; Eyding J, 2006, J CEREBR BLOOD F MET, V26, P576, DOI 10.1038/sj.jcbfm.9600216; Eyding J, 2003, ULTRASOUND MED BIOL, V29, P1379, DOI 10.1016/S0301-5629(03)01035-4; Herzberg M, 2014, CRIT ULTRASOUND J, V6, DOI 10.1186/2036-7902-6-3; Kern R, 2011, J CEREBR BLOOD F MET, V31, P1716, DOI 10.1038/jcbfm.2011.14; Krogias C, 2005, ULTRASOUND MED BIOL, V31, P1007, DOI 10.1016/j.ultrasmedbio.2005.01.001; Reitmeir R, 2017, J CEREBR BLOOD F MET, V37, P1517, DOI 10.1177/0271678X16657574; Seidel G, 2006, ULTRASCHALL MED, V27, P543, DOI 10.1055/s-2006-927023; Seidel G, 2009, STROKE, V40, P119, DOI 10.1161/STROKEAHA.108.516799; Tranquart F, 2012, ULTRASCHALL MED, V33, pS31, DOI 10.1055/s-0032-1312894; Vinke EJ, 2017, ULTRASOUND MED BIOL, V43, P2751, DOI 10.1016/j.ultrasmedbio.2017.08.935; Yu YN, 2016, SCI REP-UK, V6, DOI 10.1038/srep20932	12	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220171	10.1371/journal.pone.0220171	http://dx.doi.org/10.1371/journal.pone.0220171			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415579	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000485017200011
J	Arizza, V; Vecchioni, L; Caracappa, S; Sciurba, G; Berlinghieri, F; Gentile, A; Persichetti, MF; Arculeo, M; Alduina, R				Arizza, Vincenzo; Vecchioni, Luca; Caracappa, Santo; Sciurba, Giulia; Berlinghieri, Flavia; Gentile, Antonino; Persichetti, Maria Flaminia; Arculeo, Marco; Alduina, Rosa			New insights into the gut microbiome in loggerhead sea turtles Caretta caretta stranded on the Mediterranean coast	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; DEBRIS INGESTION; EVOLUTION; DIVERSITY; DIET	Caretta caretta is the most common sea turtle species in the Mediterranean Sea. The species is threatened by anthropomorphic activity that causes thousands of deaths and hundreds of strandings along the Mediterranean coast. Stranded turtles are often cared for in rehabilitation centres until they recover or die. The objective of this study was to characterize the gut microbiome of nine sea turtles stranded along the Sicilian coast of the Mediterranean Sea using high-throughput sequencing analysis targeting V3-V4 regions of the bacterial 16S rRNA gene. Stool samples were collected from eight specimens hosted in the recovery centre after a few days of hospitalization (under 7) and from one hosted for many weeks (78 days). To better explore the role of bacterial communities in loggerhead sea turtles, we compared our data with published fecal microbiomes from specimens stranded along the Tuscan and Ligurian coast. Our results highlight that, despite the different origin, size and health conditions of the animals, Firmicutes, Bacteroidetes and Proteobacteria constitute the main components of the microbiota. This study widens our knowledge on the gut microbiome of sea turtles and could be helpful for the set up of rehabilitation therapies of stranded animals after recovery in specialized centres.	[Arizza, Vincenzo; Vecchioni, Luca; Sciurba, Giulia; Berlinghieri, Flavia; Arculeo, Marco; Alduina, Rosa] Univ Palermo, Dept Biol Chem & Pharmaceut Sci & Technol STEBICE, Palermo, Italy; [Caracappa, Santo; Gentile, Antonino; Persichetti, Maria Flaminia] Ist Zooprofilatt Sperimentale Sicilia, Palermo, Italy; [Berlinghieri, Flavia] Univ Groningen, Groningen Inst Evolutionary Life Sci, Groningen, Netherlands	University of Palermo; IZS Sicilia; University of Groningen	Alduina, R (corresponding author), Univ Palermo, Dept Biol Chem & Pharmaceut Sci & Technol STEBICE, Palermo, Italy.	valeria.alduina@unipa.it	Vecchioni, Luca/HHM-2654-2022; Gentile, Antonino/AFF-3723-2022; Alduina, Rosa/AAQ-6922-2020; Arizza, Vincenzo/I-3477-2012; Persichetti, Maria Flaminia/B-5103-2016; Gentile, Antonino/AAE-9858-2022	Gentile, Antonino/0000-0002-2408-9615; Arizza, Vincenzo/0000-0002-8772-7143; Persichetti, Maria Flaminia/0000-0002-0890-5192; Gentile, Antonino/0000-0002-2408-9615; Vecchioni, Luca/0000-0003-4325-9728; Berlinghieri, Flavia/0000-0001-7794-2918; Alduina, RValeria/0000-0003-1054-6915	Universita degli Studi di Palermo (Palermo University) -FFR; Project "Biotechnologies for Human Health and Blue Growth BYTHOS", BYTHOS-C1-1.1-9 - 2014 -2020 INTERREG V-A Italy -Malta EU Programme [CUP 676H18000180005]	Universita degli Studi di Palermo (Palermo University) -FFR; Project "Biotechnologies for Human Health and Blue Growth BYTHOS", BYTHOS-C1-1.1-9 - 2014 -2020 INTERREG V-A Italy -Malta EU Programme	This work was supported by Universita degli Studi di Palermo (Palermo University) -FFR to RA, MA, VA. This work was supported as part of the Project "Biotechnologies for Human Health and Blue Growth BYTHOS", BYTHOS-C1-1.1-9, CUP 676H18000180005, funded by 2014 -2020 INTERREG V-A Italy -Malta EU Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrhman KFA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01060; Ahasan MS, 2018, MICROBIOL RES, V207, P91, DOI 10.1016/j.micres.2017.11.010; Ahasan MS, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix139; Arndt D, 2012, NUCLEIC ACIDS RES, V40, pW88, DOI 10.1093/nar/gks497; Bacci Giovanni, 2015, J Genomics, V3, P36, DOI 10.7150/jgen.9204; Bacci G, 2015, METHODS MOL BIOL, V1231, P137, DOI 10.1007/978-1-4939-1720-4_9; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Biagi E, 2019, ENV MICROBIOL REP, V11, P361, DOI 10.1111/1758-2229.12683; Bletz MC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13699; Brooks JP, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0351-6; Campos P, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0454-z; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caracappa S, 2016, CAN J ZOOL, V94, P379, DOI 10.1139/cjz-2015-0248; Caracappa S, 2018, PEERJ, V6, DOI 10.7717/peerj.5392; Casale P, 2016, MAR POLLUT BULL, V110, P238, DOI 10.1016/j.marpolbul.2016.06.057; Colston TJ, 2016, MOL ECOL, V25, P3776, DOI 10.1111/mec.13730; Colston TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128793; Costello EK, 2010, ISME J, V4, P1375, DOI 10.1038/ismej.2010.71; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Fetzner S, 1998, APPL MICROBIOL BIOT, V50, P633, DOI 10.1007/s002530051346; Fukuoka T, 2016, SCI REP-UK, V6, DOI 10.1038/srep28015; Gajardo K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30893; Hird SM, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.2075.01403, 10.3389/fmicb.2015.01403]; Hong PY, 2011, ISME J, V5, P1461, DOI 10.1038/ismej.2011.33; Keenan SW, 2013, SCI REP-UK, V3, DOI 10.1038/srep02877; Kohl KD, 2017, MOL ECOL, V26, P1175, DOI 10.1111/mec.13921; Kohl KD, 2016, J EXP BIOL, V219, P1903, DOI 10.1242/jeb.138370; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; McLaughlin RW, 2015, MOL BIOL REP, V42, P1187, DOI 10.1007/s11033-015-3854-1; Mendoza MLZ, 2018, ACTA VET SCAND, V60, DOI 10.1186/s13028-018-0415-3; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Nodler K, 2013, MAR POLLUT BULL, V70, P112, DOI 10.1016/j.marpolbul.2013.02.018; Perez T, 2010, MUCOSAL IMMUNOL, V3, P355, DOI 10.1038/mi.2010.12; Price JT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177642; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ren TT, 2016, MOL ECOL, V25, P4793, DOI 10.1111/mec.13796; Revelles M, 2007, J MAR BIOL ASSOC UK, V87, P805, DOI 10.1017/S0025315407054707; Revelles M, 2007, MAR BIOL, V151, P1501, DOI 10.1007/s00227-006-0602-z; Savoca D, 2018, MAR POLLUT BULL, V127, P165, DOI 10.1016/j.marpolbul.2017.11.069; STEWART JS, 1990, J ZOO WILDLIFE MED, V21, P180; Takahashi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105592; Thomas F, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00093; Tomas J, 2002, MAR POLLUT BULL, V44, P211, DOI 10.1016/S0025-326X(01)00236-3; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Villeger R, 2018, WORLD J GASTROENTERO, V24, P2327, DOI 10.3748/wjg.v24.i22.2327; Waite DW, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00673; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; Yuan ML, 2015, MOL ECOL, V24, P2521, DOI 10.1111/mec.13169; Zimmerman LM, 2010, J EXP BIOL, V213, P661, DOI 10.1242/jeb.038315	53	36	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0220329	10.1371/journal.pone.0220329	http://dx.doi.org/10.1371/journal.pone.0220329			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412070	gold, Green Published, Green Submitted			2022-12-26	WOS:000485012600026
J	Jun, T; Min, IS				Jun, Tackseung; Min, In-sik			Air pollution, respiratory illness and behavioral adaptation: Evidence from South Korea	PLOS ONE			English	Article							LONG-TERM EXPOSURE; LUNG-FUNCTION GROWTH; AVOIDANCE-BEHAVIOR; TRACT DEPOSITION; CLIMATE-CHANGE; HEALTH; MORTALITY; CHILDREN; ASTHMA; FINE	Air pollution is closely associated with the development of respiratory illness. Behavioral adaptations of people to air pollution may influence its impact, yet this has not been investigated in the literature. Our hypothesis is that people experience and learn the underlying air quality to decide their adaptation, and they have a stronger incentive to behaviorally adapt to the air quality as it deteriorates. We tested our hypothesis on a sample of approximately 25,700 individuals from South Korea from 2002 to 2013 that contained information on daily doctor's visits due to respiratory disease. We matched individuals to the mean of the past seven-day concentration of the particulate matter of size between 2.5 and 10 micrometers (PM10) in their county of residence. We examined whether people living in counties with greater air pollution suffer less from respiratory disease when the concentration increases. For the analysis, we separated counties into quintiles based on their mean seven-day PM10, and regressed the binary indicator of a daily doctor's visit with a resulting diagnosis of respiratory disease on the seven-day PM10 concentration of the county of residence interacted with the quintile dummies. The key findings are that a 1-standard-deviation increase in the seven-day PM10 concentration in the two lowest quintiles is associated with an increase of 0.054 percentage points in the likelihood of a doctor's visit with a resulting diagnosis of respiratory disease, which is about 40% larger than the effect in higher quintiles, and the size of 1-standard-deviation gradually increases from 0.037 percentage points in the third quintile to 0.040 percentage points in the fifth quintile. The smaller increase in the likelihood of respiratory disease in more polluted locations can be explained by the behavioral adaptation to the environment, but the effectiveness of the adaptation seems limited among the highly polluted locations.	[Jun, Tackseung; Min, In-sik] Kyung Hee Univ, Dept Econ, Seoul, South Korea; [Jun, Tackseung] Columbia Univ, Dept Econ, Barnard Coll, New York, NY 10027 USA	Kyung Hee University; Columbia University	Jun, T (corresponding author), Kyung Hee Univ, Dept Econ, Seoul, South Korea.; Jun, T (corresponding author), Columbia Univ, Dept Econ, Barnard Coll, New York, NY 10027 USA.	tj32k@khu.ac.kr	Min, Insik/AAH-9100-2020; Jun, Tackseung/ABH-6646-2020	Jun, Tackseung/0000-0002-7701-3411				Aguilera I, 2013, ENVIRON HEALTH PERSP, V121, P387, DOI 10.1289/ehp.1205281; Atkinson RW, 2014, THORAX, V69, P660, DOI 10.1136/thoraxjnl-2013-204492; Barreca A, 2016, J POLIT ECON, V124, P105, DOI 10.1086/684582; Berhane K, 2000, AM J RESP CRIT CARE, V162, P1723, DOI 10.1164/ajrccm.162.5.2001116; Brauer M, 2002, AM J RESP CRIT CARE, V166, P1092, DOI 10.1164/rccm.200108-007OC; Brown JS, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-12; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Chen H, 2018, LANCET PLANET HEALTH, V2, pE19, DOI 10.1016/S2542-5196(17)30185-7; Chen Hong, 2008, Reviews on Environmental Health, V23, P243; Chien LC, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040829; Ciccone G, 1998, OCCUP ENVIRON MED, V55, P771, DOI 10.1136/oem.55.11.771; Clougherty JE, 2010, ENVIRON HEALTH PERSP, V118, P167, DOI 10.1289/ehp.0900994; Deschenes O, 2011, AM ECON J-APPL ECON, V3, P152, DOI 10.1257/app.3.4.152; Dong GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022470; Esposito S, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-130; Gauderman WJ, 2007, LANCET, V369, P571, DOI 10.1016/S0140-6736(07)60037-3; Gauderman WJ, 2002, AM J RESP CRIT CARE, V166, P76, DOI 10.1164/rccm.2111021; Gauderman WJ, 2014, NEW ENGL J MED, V351, P1051, DOI [10.1016/S0140-6736(07)60037-3, DOI 10.1016/S0140-6736(07)60037-3]; Gent JF, 2003, JAMA-J AM MED ASSOC, V290, P1859, DOI 10.1001/jama.290.14.1859; Guarnieri M, 2014, LANCET, V383, P1581, DOI 10.1016/S0140-6736(14)60617-6; Halonen JI, 2008, THORAX, V63, P635, DOI 10.1136/thx.2007.091371; Heutel G, 2018, NBER WORKING PAPER, P23271; Hou P, 2016, SCI REP-UK, V6, DOI 10.1038/srep23792; Janke K, 2014, J HEALTH ECON, V38, P23, DOI 10.1016/j.jhealeco.2014.07.002; Johansson C, 2007, ENVIRON MONIT ASSESS, V127, P477, DOI 10.1007/s10661-006-9296-4; Keitt SK, 2004, ENVIRON HEALTH PERSP, V112, P604, DOI 10.1289/ehp.6714; Kelly FJ, 2015, ANN NY ACAD SCI, V1340, P84, DOI 10.1111/nyas.12720; Kim KH, 2015, ENVIRON INT, V74, P136, DOI 10.1016/j.envint.2014.10.005; Lin HL, 2018, J EXPO SCI ENV EPID, V28, P392, DOI 10.1038/s41370-018-0034-0; Londahl J, 2007, INHAL TOXICOL, V19, P109, DOI 10.1080/08958370601051677; Londahl J, 2006, J AEROSOL SCI, V37, P1152, DOI 10.1016/j.jaerosci.2005.11.004; MacIntyre EA, 2014, ENVIRON HEALTH PERSP, V122, P107, DOI 10.1289/ehp.1306755; Magnus P, 1998, INT J EPIDEMIOL, V27, P995, DOI 10.1093/ije/27.6.995; Mearns BM, 2002, NAT REV CARDIOL, V9, P672; Mo Z, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19939-1; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Morgenstern V, 2007, OCCUP ENVIRON MED, V64, P8, DOI 10.1136/oem.2006.028241; Neidell M, 2009, J HUM RESOUR, V44, P450, DOI 10.1353/jhr.2009.0018; Oftedal B, 2009, ENVIRON HEALTH PERSP, V117, P839, DOI 10.1289/ehp.11491; Ostro B, 2001, EPIDEMIOLOGY, V12, P200, DOI 10.1097/00001648-200103000-00012; Ostro B, 2009, ENVIRON HEALTH PERSP, V117, P475, DOI 10.1289/ehp.11848; Peel JL, 2005, EPIDEMIOLOGY, V16, P164, DOI 10.1097/01.ede.0000152905.42113.db; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Ranzi A, 2014, OCCUP ENVIRON MED, V71, P430, DOI 10.1136/oemed-2013-101867; Rojas-Martinez R, 2007, AM J RESP CRIT CARE, V176, P377, DOI 10.1164/rccm.200510-1678OC; Semenza JC, 2008, ENVIRON RES, V107, P401, DOI 10.1016/j.envres.2008.03.005; Shah ASV, 2013, LANCET, V382, P1039, DOI 10.1016/S0140-6736(13)60898-3; Simoni M, 2015, J THORAC DIS, V7, P34, DOI 10.3978/j.issn.2072-1439.2014.12.10; Stockfelt L, 2017, ENVIRON RES, V158, P61, DOI 10.1016/j.envres.2017.05.036; WJST M, 1993, BRIT MED J, V307, P596, DOI 10.1136/bmj.307.6904.596; World Bank/IHME, 2016, COST AIR POLL STRENG; Zanobetti A, 2003, ENVIRON HEALTH PERSP, V111, P1188, DOI 10.1289/ehp.5712; Zivin JG, 2009, J ENVIRON ECON MANAG, V58, P119, DOI 10.1016/j.jeem.2009.03.001; Zora JE, 2013, SCI TOTAL ENVIRON, V448, P56, DOI 10.1016/j.scitotenv.2012.11.067	54	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0221098	10.1371/journal.pone.0221098	http://dx.doi.org/10.1371/journal.pone.0221098			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5HO	31408479	Green Published, gold, Green Submitted			2022-12-26	WOS:000485009500039
J	Tumendemberel, O; Zedrosser, A; Proctor, MF; Reynolds, HV; Adams, JR; Sullivan, JM; Jacobs, SJ; Khorloojav, T; Tserenbataa, T; Batmunkh, M; Swenson, JE; Waits, LP				Tumendemberel, Odbayar; Zedrosser, Andreas; Proctor, Michael F.; Reynolds, Harry, V; Adams, Jennifer R.; Sullivan, Jack M.; Jacobs, Sarah J.; Khorloojav, Tumennasan; Tserenbataa, Tuya; Batmunkh, Mijiddorj; Swenson, Jon E.; Waits, Lisette P.			Phylogeography, genetic diversity, and connectivity of brown bear populations in Central Asia	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; MULTIPLE SEQUENCE ALIGNMENT; URSUS-ARCTOS POPULATIONS; NATAL DISPERSAL; MICROSATELLITE ANALYSIS; GRIZZLY BEARS; POLYMORPHISM; SOFTWARE; EURASIA; REVEAL	Knowledge of genetic diversity and population structure is critical for conservation and management planning at the population level within a species' range. Many brown bear populations in Central Asia are small and geographically isolated, yet their phylogeographic relationships, genetic diversity, and contemporary connectivity are poorly understood. To address this knowledge gap, we collected brown bear samples from the Gobi Desert (n = 2360), Altai, Sayan, Khentii, and Ikh Khyangan mountains of Mongolia (n = 79), and Deosai National Park in the Himalayan Mountain Range of Pakistan (n = 5) and generated 927 base pairs of mitochondrial DNA (mtDNA) sequence data and genotypes at 13 nuclear DNA microsatellite loci. We documented high levels of mtDNA and nDNA diversity in the brown bear populations of northern Mongolia (Altai, Sayan, Buteeliin nuruu and Khentii), but substantially lower diversity in brown bear populations in the Gobi Desert and Himalayas of Pakistan. We detected 3 brown bear mtDNA phylogeographic groups among bears of the region, with clade 3a1 in Sayan, Khentii, and Buteeliin nuruu mountains, clade 3b in Altai, Sayan, Buteeliin nuruu, Khentii, and Ikh Khyangan, and clade 6 in Gobi and Pakistan. Our results also clarified the phylogenetic relationships and divergence times with other brown bear mtDNA clades around the world. The nDNA genetic structure analyses revealed distinctiveness of Gobi bears and different population subdivisions compared to mtDNA results. For example, genetic distance for nDNA microsatellite loci between the bears in Gobi and Altai (F-ST = 0.147) was less than that of the Gobi and Pakistan (F-ST = 0.308) suggesting more recent male-mediated nuclear gene flow between Gobi and Altai than between Gobi and the Pakistan bears. Our results provide valuable information for conservation and management of bears in this understudied region of Central Asia and highlight the need for special protection and additional research on Gobi brown bears.	[Tumendemberel, Odbayar; Zedrosser, Andreas] Univ South Eastern Norway, Dept Nat Sci & Environm Hlth, Bo i Telemark, Norway; [Proctor, Michael F.] Birchdale Ecol, Kaslo, BC, Canada; [Reynolds, Harry, V] Gobi Bear Fund Inc, Fairbanks, AK USA; [Adams, Jennifer R.; Waits, Lisette P.] Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA; [Sullivan, Jack M.; Jacobs, Sarah J.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Khorloojav, Tumennasan] Mongolian Acad Sci, Inst Gen & Expt Biol, Genet Lab, Ulan Bator, Mongolia; [Tserenbataa, Tuya] Sunshine Village Complex, Ulan Bator, Mongolia; [Batmunkh, Mijiddorj] Mongolian Chinese Joint Mol Biol Lab, Ulan Bator, Mongolia; [Swenson, Jon E.] Norwegian Univ Life Sci, Fac Environm Sci & Nat Resource Management, As, Norway	Idaho; University of Idaho; Idaho; University of Idaho; Mongolian Academy of Sciences; Norwegian University of Life Sciences	Tumendemberel, O (corresponding author), Univ South Eastern Norway, Dept Nat Sci & Environm Hlth, Bo i Telemark, Norway.	odbayar.tumendemberel@usn.no	Swenson, Jon/AAE-2890-2019; Jacobs, Sarah/S-9703-2017	Jacobs, Sarah/0000-0002-3125-6266; Tumendemberel, Odbayar/0000-0002-2105-3836; Proctor, Michael/0000-0002-9461-2774	Mongolian Ministry of Environment and Tourism; University of South-Eastern Norway, Gobi Bear Project; International Association for Bear Research and Management; Mongolian Ministry of Education, Culture and Science	Mongolian Ministry of Environment and Tourism; University of South-Eastern Norway, Gobi Bear Project; International Association for Bear Research and Management; Mongolian Ministry of Education, Culture and Science	The project was supported by the Mongolian Ministry of Environment and Tourism (formerly the Mongolian Ministry of Nature and Green Development), University of South-Eastern Norway, Gobi Bear Project, and International Association for Bear Research and Management. O. Tumendemberel was granted a graduate student scholarship-loan from Mongolian Ministry of Education, Culture and Science in 2016-2019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JR, 2007, CONSERV GENET, V8, P123, DOI 10.1007/s10592-006-9154-5; Allendorf FW., 2009, CONSERV GENET; Anijalg P, 2018, J BIOGEOGR, V45, P394, DOI 10.1111/jbi.13126; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Badamjav L, 2007, STATUS BEARS MONGOLI; Bannikov AG., 1954, MAMMALS MONGOLIAN PE; Barnes I, 2002, SCIENCE, V295, P2267, DOI 10.1126/science.1067814; Bellemain E, 2007, BIOL CONSERV, V134, P537, DOI 10.1016/j.biocon.2006.09.004; Boitani L, 2012, TECH ECOL CONSERVAT, P1, DOI 10.1093/acprof:oso/9780199558520.001.0001; Bold A, 1967, J I BIOL ACAD SCI MO, V2, P5; Bon C, 2008, P NATL ACAD SCI USA, V105, P17447, DOI 10.1073/pnas.0806143105; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Breen M, 2001, GENOME RES, V11, P1784, DOI 10.1101/gr.189401; Calvignac S, 2009, DIVERS DISTRIB, V15, P742, DOI 10.1111/j.1472-4642.2009.00586.x; Chestin IE, 1992, ANN ZOOLOGICI FENNIC; De Barba M, 2014, MOL ECOL RESOUR, V14, P306, DOI 10.1111/1755-0998.12188; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ENNIS S, 1994, ANIM GENET, V25, P425, DOI 10.1111/j.1365-2052.1994.tb00533.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frenzel B, 1992, ATLAS PALEOCLIMATES; Galbreath GJ, 2007, URSUS, V18, P129, DOI 10.2192/1537-6176(2007)18[129:GROCAP]2.0.CO;2; GOLDSTEIN DB, 1995, GENETICS, V139, P463; GRACHEV YA, 1982, ZOOL ZH, V61, P1242; Guskov VY, 2018, BIOL BULL+, V45, P368, DOI 10.1134/S1062359018040064; Gustafson EP, 1978, VERTEBRATE FAUNAS PL; Hailer F, 2012, SCIENCE, V336, P344, DOI 10.1126/science.1216424; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Heptner VG, 1998, MAMMALS SOVIET UNION; Hirata D, 2013, MOL BIOL EVOL, V30, P1644, DOI 10.1093/molbev/mst077; Hou WR, 2007, INT J BIOL SCI, V3, P85; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Keis M, 2013, J BIOGEOGR, V40, P915, DOI 10.1111/jbi.12043; Kindberg J, 2011, WILDLIFE BIOL, V17, P114, DOI 10.2981/10-100; Kopatz A, 2017, ECOL EVOL, V7, P10721, DOI 10.1002/ece3.3577; Kopatz A, 2012, CONSERV GENET, V13, P681, DOI 10.1007/s10592-012-0317-2; Korsten M, 2009, MOL ECOL, V18, P1963, DOI 10.1111/j.1365-294X.2009.04163.x; Kumar V, 2017, SCI REP-UK, V7, DOI 10.1038/srep46487; Lan TY, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1804; Liu SP, 2014, CELL, V157, P785, DOI 10.1016/j.cell.2014.03.054; Mace GM, 2004, PHILOS T R SOC B, V359, P711, DOI 10.1098/rstb.2003.1454; Masuda R, 1998, HEREDITAS, V128, P277, DOI 10.1111/j.1601-5223.1998.00277.x; Matsuhashi T, 2001, ZOOL SCI, V18, P1137, DOI 10.2108/zsj.18.1137; McLellan BN, 2001, CAN J ZOOL, V79, P838, DOI 10.1139/cjz-79-5-838; Meredith EP, 2009, CONSERV GENET, V10, P693, DOI 10.1007/s10592-008-9617-y; Michel S., 2017, IUCN RED LIST THREAT, V2017; Miller CR, 2006, MOL ECOL, V15, P4477, DOI 10.1111/j.1365-294X.2006.03097.x; Miller CR, 2002, GENETICS, V160, P357; Moritz C, 1998, MOL ECOL, V7, P419, DOI 10.1046/j.1365-294x.1998.00317.x; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Ognev SJG, 1931, MAMMALS E EUROPE NO, V2; Paetkau D, 1998, CONSERV BIOL, V12, P418, DOI 10.1046/j.1523-1739.1998.96457.x; Paetkau D, 1998, MOL ECOL, V7, P1283, DOI 10.1046/j.1365-294x.1998.00440.x; PAETKAU D, 1994, MOL ECOL, V3, P489, DOI 10.1111/j.1365-294X.1994.tb00127.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peyton B., 1999, BEARS STATUS SURVEY; POTTER S, 1974, GENETICS, V77, pS52; Pritchard JK, 2000, GENETICS, V155, P945; Proctor MF, 2005, P ROY SOC B-BIOL SCI, V272, P2409, DOI 10.1098/rspb.2005.3246; Puechmaille SJ, 2016, MOL ECOL RESOUR, V16, P608, DOI 10.1111/1755-0998.12512; RANDI E, 1994, HEREDITY, V73, P480, DOI 10.1038/hdy.1994.146; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Saarma U, 2007, MOL ECOL, V16, P401, DOI 10.1111/j.1365-294X.2006.03130.x; SAITOU N, 1987, JPN J GENET, V62, P547; Salomashkina VV, 2014, BIOL BULL+, V41, P38, DOI 10.1134/S1062359014010087; Schaller G, 1993, OBSERVATIONS GOBI BR, P110; Shiirevdamba T., 2013, MONGOLIAN RED BOOK U; Sokolov V, 1992, INT S ERF BIOL RESS; Sokolov VE, 1978, GEOGRAFIYA DINAMIKA, V10, P112; Sommer RS, 2005, MAMMAL REV, V35, P156, DOI 10.1111/j.1365-2907.2005.00063.x; Stoen OG, 2006, OECOLOGIA, V148, P356, DOI 10.1007/s00442-006-0384-5; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Swenson JE, 1998, J ANIM ECOL, V67, P819, DOI 10.1046/j.1365-2656.1998.00248.x; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; TABERLET P, 1994, P ROY SOC B-BIOL SCI, V255, P195, DOI 10.1098/rspb.1994.0028; Taberlet P, 1997, MOL ECOL, V6, P869, DOI 10.1111/j.1365-294X.1997.tb00141.x; Talbot SL, 1996, MOL PHYLOGENET EVOL, V5, P477, DOI 10.1006/mpev.1996.0044; Tumendemberel O, 2015, URSUS, V26, P129, DOI 10.2192/URSUS-D-15-00001.1; Waits L, 2000, MOL ECOL, V9, P421, DOI 10.1046/j.1365-294x.2000.00892.x; Waits LP, 1998, CONSERV BIOL, V12, P408, DOI 10.1046/j.1523-1739.1998.96351.x; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Wakkinen WL, 2004, URSUS, V15, P65, DOI 10.2192/1537-6176(2004)015<0065:DAPTOG>2.0.CO;2; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zedrosser A, 2007, ANIM BEHAV, V74, P369, DOI 10.1016/j.anbehav.2006.09.015; Zhirnov L, 1985, BOLISHOI GOBIISKII Z; Zwickl D. J, 2006, GENETIC ALGORITHM AP	91	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220746	10.1371/journal.pone.0220746	http://dx.doi.org/10.1371/journal.pone.0220746			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408475	Green Published, gold, Green Submitted			2022-12-26	WOS:000485009500017
J	Kobayashi, K; Kegasa, T; Hwang, SW; Sugiyama, JJ				Kobayashi, Kayoko; Kegasa, Takahiro; Hwang, Sung-Wook; Sugiyama, Junji			Anatomical features of Fagaceae wood statistically extracted by computer vision approaches: Some relationships with evolution	PLOS ONE			English	Article							IDENTIFICATION; CLASSIFICATION; QUERCUS; IMAGES; OAKS	The anatomical structure of wood is complex and contains considerable information about its specific species, physical properties, growth environment, and other factors. While conventional wood anatomy has been established by systematizing the xylem anatomical features, which enables wood identification generally up to genus level, it is difficult to describe all the information comprehensively. This study apply two computer vision approaches to optical micrographs: the scale-invariant feature transform algorithm and connected-component labelling. They extract the shape and pore size information, respectively, statistically from the whole micrographs. Both approaches enable the efficient detection of specific features of 18 species from the family Fagaceae. Although the methods ignore the positional information, which is important for the conventional wood anatomy, the simple information on the shape or size of the elements is enough to describe the species-specificity of wood. In addition, according to the dendrograms calculated from the numerical distances of the features, the closeness of some taxonomic groups is inconsistent with the types of porosity, which is one of the typical classification systems for wood anatomy, but consistent with the evolution based on molecular phylogeny; for example, ring-porous group Cerris and radial-porous group Ilex are nested in the same cluster. We analyse which part of the wood structure gave the taxon-specific information, indicating that the latewood zone of group Cerris is similar to the whole zone of group Ilex. Computer vision approaches provide statistical information that uncovers new aspects of wood anatomy that have been overlooked by conventional visual inspection.	[Kobayashi, Kayoko; Kegasa, Takahiro; Hwang, Sung-Wook; Sugiyama, Junji] Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto, Japan; [Sugiyama, Junji] Nanjing Forestry Univ, Coll Mat Sci & Engn, Nanjing, Jiangsu, Peoples R China; [Kobayashi, Kayoko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Tokyo, Japan	Kyoto University; Nanjing Forestry University; University of Tokyo	Kobayashi, K; Sugiyama, JJ (corresponding author), Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto, Japan.; Sugiyama, JJ (corresponding author), Nanjing Forestry Univ, Coll Mat Sci & Engn, Nanjing, Jiangsu, Peoples R China.; Kobayashi, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Tokyo, Japan.	aka.kobayashi@mail.ecc.u-tokyo.ac.jp; sugiyama.junji.6m@kyoto-u.ac.jp	Sugiyama, Junji/ABD-5589-2020	Sugiyama, Junji/0000-0002-5388-4925; Hwang, Sung-Wook/0000-0001-8265-8700; Kobayashi, Kayoko/0000-0003-0459-7900	RISH Cooperative Research (database); Japan Society for the Promotion of Science [25252033, 18H05485]	RISH Cooperative Research (database); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partially supported by RISH Cooperative Research (database) to KK and JS. This work was also partially supported by Grants-in-Aid for Scientific Research (Grant Numbers 25252033, 18H05485) from the Japan Society for the Promotion of Science to JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baas P, 2004, IAWA J, V25, P1, DOI 10.1163/22941932-90000349; Brunel G, 2014, ANN BOT-LONDON, V114, P829, DOI 10.1093/aob/mcu119; Camus A, 1936, MONOGRAPHIE GENRE QU, VVII; Camus A., 1936, ENCY EC SYLVICULTURE, VVIII, DOI DOI 10.1038/srep12395; Deng M, 2018, MOL PHYLOGENET EVOL, V119, P170, DOI 10.1016/j.ympev.2017.11.003; Denk T, 2010, TAXON, V59, P351, DOI 10.1002/tax.592002; Hafemann LG, 2014, INT C PATT RECOG, P1103, DOI 10.1109/ICPR.2014.199; Hwang SW, 2018, J WOOD SCI, V64, P69, DOI 10.1007/s10086-017-1680-x; IAWA Committee, 1989, IAWA B, V10, P219, DOI DOI 10.1163/22941932-90000496; Jones E., SCIPY OPEN SOURCE SC; Khalid M, 2008, INT J SIMUL SYST SCI, V9, P9; Kobayashi K, 2017, J WOOD SCI, V63, P322, DOI 10.1007/s10086-017-1625-4; Lowe D., 1999, P INT C COMP VIS, V2, P1150, DOI DOI 10.1109/ICCV.1999.790410; Martins J, 2013, MACH VISION APPL, V24, P567, DOI 10.1007/s00138-012-0417-5; Martins JG, 2015, MACH VISION APPL, V26, P279, DOI 10.1007/s00138-015-0659-0; Noshiro S, 2011, IAWA J, V32, P383, DOI 10.1163/22941932-90000066; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; R Core Team, 2021, R LANGUAGE ENV STAT; Shen Pan, 2011, Advances in Data Mining Applications and Theoretical Aspects. Proceedings 11th Industrial Conference, ICDM 2011, P147, DOI 10.1007/978-3-642-23184-1_12; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; von Arx G, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00781; von Arx G, 2014, DENDROCHRONOLOGIA, V32, P290, DOI 10.1016/j.dendro.2013.12.001; Wang B-H, 2010, WOOD RECOGNITION BAS, DOI [10.1109/ICCASM.2010.5619388, DOI 10.1109/ICCASM.2010.5619388]; Wang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076101; Wang HJ, 2013, NEUROCOMPUTING, V116, P192, DOI 10.1016/j.neucom.2012.02.045; Yadav AR, 2015, APPL SOFT COMPUT, V32, P101, DOI 10.1016/j.asoc.2015.03.039; Yadav AR, 2013, NAT CONF COMPUT VIS; Yadav AR, 2014, 2014 INTERNATIONAL CONFERENCE ON SIGNAL PROCESSING AND INTEGRATED NETWORKS (SPIN), P9, DOI 10.1109/SPIN.2014.6776912; Yan MX, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00569; Yusof R, 2013, MACH VISION APPL, V24, P1589, DOI 10.1007/s00138-013-0526-9; Yusof R, 2010, 2010 12TH INTERNATIONAL CONFERENCE ON COMPUTER MODELLING AND SIMULATION (UKSIM), P289, DOI 10.1109/UKSIM.2010.61	31	7	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220762	10.1371/journal.pone.0220762	http://dx.doi.org/10.1371/journal.pone.0220762			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404108	Green Submitted, Green Published, gold			2022-12-26	WOS:000485006800029
J	Kulawiak, DA; Lober, J; Bar, M; Engel, H				Kulawiak, Dirk Alexander; Loeber, Jakob; Baer, Markus; Engel, Harald			Active poroelastic two-phase model for the motion of physarum microplasmodia	PLOS ONE			English	Article							PROTOPLASMIC DROPLETS; CELL MOTION; PATTERNS; OSCILLATIONS; LOCOMOTION; MECHANICS; CONTRACTION; PLASMODIUM; MIGRATION; MOVEMENT	The onset of self-organized motion is studied in a poroelastic two-phase model with free boundaries for Physarum microplasmodia (MP). In the model, an active gel phase is assumed to be interpenetrated by a passive fluid phase on small length scales. A feedback loop between calcium kinetics, mechanical deformations, and induced fluid flow gives rise to pattern formation and the establishment of an axis of polarity. Altogether, we find that the calcium kinetics that breaks the conservation of the total calcium concentration in the model and a nonlinear friction between MP and substrate are both necessary ingredients to obtain an oscillatory movement with net motion of the MP. By numerical simulations in one spatial dimension, we find two different types of oscillations with net motion as well as modes with time-periodic or irregular switching of the axis of polarity. The more frequent type of net motion is characterized by mechano-chemical waves traveling from the front towards the rear. The second type is characterized by mechano-chemical waves that appear alternating from the front and the back. While both types exhibit oscillatory forward and backward movement with net motion in each cycle, the trajectory and gel flow pattern of the second type are also similar to recent experimental measurements of peristaltic MP motion. We found moving MPs in extended regions of experimentally accessible parameters, such as length, period and substrate friction strength. Simulations of the model show that the net speed increases with the length, provided that MPs are longer than a critical length of approximate to 120 mu m. Both predictions are in line with recent experimental observations.	[Kulawiak, Dirk Alexander; Loeber, Jakob; Engel, Harald] TU Berlin, Inst Theoret Phys, Berlin, Germany; [Loeber, Jakob] Max Planck Inst Phys Komplexer Syst, Dresden, Germany; [Baer, Markus] Phys Tech Bundesanstalt, Berlin, Germany	Technical University of Berlin; Max Planck Society; Physikalisch-Technische Bundesanstalt (PTB)	Engel, H (corresponding author), TU Berlin, Inst Theoret Phys, Berlin, Germany.	harald.engel@tu-berlin.de	Engel, Harald/ABD-2272-2020	Kulawiak, Dirk Alexander/0000-0002-9848-3818	German Science Foundation (DFG) [GRK 1558, SFB 910]	German Science Foundation (DFG)(German Research Foundation (DFG))	DAK was funded by the German Science Foundation (DFG) within the GRK 1558 and the collaborative research center SFB 910. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alim K, 2017, P NATL ACAD SCI USA, V114, P5136, DOI 10.1073/pnas.1618114114; Alonso S, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa8a1d; Alonso S, 2016, PHYSICA D, V318, P58, DOI 10.1016/j.physd.2015.09.017; Alt W, 1999, MATH BIOSCI, V156, P207, DOI 10.1016/S0025-5564(98)10067-6; Bauerle FK, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa8a21; Banks HT, 2011, ADV APPL MATH MECH, V3, P1, DOI 10.4208/aamm.10-m1030; Barnhart EL, 2010, BIOPHYS J, V98, P933, DOI 10.1016/j.bpj.2009.10.058; Baumgarten W, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/2/026003; Beekman M, 2015, J MOL BIOL, V427, P3734, DOI 10.1016/j.jmb.2015.07.007; Bois JS, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028103; Boisseau RP, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0446; Coussy O., 2004, POROMECHANICS; DEMBO M, 1986, BIOPHYS J, V50, P109, DOI 10.1016/S0006-3495(86)83444-0; DeSimone A, 2012, EUR PHYS J E, V35, DOI 10.1140/epje/i2012-12085-x; Dirnberger M, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa6e7b; Epstein Irving R, 2017, Chemistry, V23, P11181, DOI 10.1002/chem.201700725; Fessel A, 2015, NANO COMMUN NETW, V6, P87, DOI 10.1016/j.nancom.2015.04.001; Fessel A, 2018, J PHYS D APPL PHYS, V51, DOI 10.1088/1361-6463/aa9d2c; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Gross P, 2017, ANNU REV BIOPHYS, V46, P337, DOI 10.1146/annurev-biophys-070816-033602; Howard J, 2011, NAT REV MOL CELL BIO, V12, P392, DOI 10.1038/nrm3120; Joanny JF, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/422; Joanny JF, 2009, HFSP J, V3, P94, DOI 10.2976/1.3054712; Julicher F, 2007, PHYS REP, V449, P3, DOI 10.1016/j.physrep.2007.02.018; Julien JD, 2018, P NATL ACAD SCI USA, V115, P10612, DOI 10.1073/pnas.1805981115; Kopf MH, 2013, PHYSICA D, V259, P48, DOI 10.1016/j.physd.2013.05.009; Kopf MH, 2013, SOFT MATTER, V9, P3727, DOI 10.1039/c3sm26955h; Kolomeisky AB, 2007, ANNU REV PHYS CHEM, V58, P675, DOI 10.1146/annurev.physchem.58.032806.104532; Kulawiak DA, 2019, J PHYS D APPL PHYS, V52, DOI 10.1088/1361-6463/aae41d; Kumar KV, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.208101; Kuroda S, 2015, J EXP BIOL, V218, P3729, DOI 10.1242/jeb.124354; Kuroda S, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0205; Lai JH, 2010, J EXP BIOL, V213, P3920, DOI 10.1242/jeb.046706; Larripa K, 2006, PHYSICA A, V372, P113, DOI 10.1016/j.physa.2006.05.008; Lewis OL, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1359; Lober J, 2014, SOFT MATTER, V10, P1365, DOI 10.1039/c3sm51597d; Lu XJ, 2013, CHEM COMMUN, V49, P7690, DOI 10.1039/c3cc44480e; Matsumoto K, 2008, BIOPHYS J, V94, P2492, DOI 10.1529/biophysj.107.113050; Mayer M, 2010, NATURE, V467, P617, DOI 10.1038/nature09376; Mondesert-Deveraux S, 2018, MOL CELLULAR BIOMECH, V15, P22; Nickaeen M, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005862; Nishikawa M, 2017, ELIFE, V6, DOI [10.7554/eLife.19595.001, 10.7554/eLife.19595, 10.7554/eLife.30537]; Oettmeier C, 2016, CLOSE LOOK AMOEBOID; Oettmeier C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215622; Oettmeier C, 2018, J PHYS D APPL PHYS, V51, DOI 10.1088/1361-6463/aab147; Oettmeier C, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa8699; Radszuweit M, 2010, EUR PHYS J-SPEC TOP, V191, P159, DOI 10.1140/epjst/e2010-01348-2; Radszuweit M., 2013, ACTIVE POROELASTIC M; Radszuweit M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099220; Radszuweit M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.138102; Ren L, 2017, P NATL ACAD SCI USA, V114, P8704, DOI 10.1073/pnas.1704094114; Ren L, 2016, ANGEW CHEM INT EDIT, V55, P14299, DOI 10.1002/anie.201608367; Rieu JP, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0099; Rodiek B, 2015, EUR PHYS J-SPEC TOP, V224, P1199, DOI 10.1140/epjst/e2015-02455-2; Rodiek B, 2015, EUR BIOPHYS J BIOPHY, V44, P349, DOI 10.1007/s00249-015-1028-7; Sanchez T, 2012, NATURE, V491, P431, DOI 10.1038/nature11591; Taber LA, 2011, J MECH MATER STRUCT, V6, P569, DOI 10.2140/jomms.2011.6.569; Takagi S, 2008, PHYSICA D, V237, P420, DOI 10.1016/j.physd.2007.09.012; Tanaka Y, 2012, J R SOC INTERFACE, V9, P222, DOI 10.1098/rsif.2011.0339; Urbakh M, 2004, NATURE, V430, P525, DOI 10.1038/nature02750; Weber CA, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.248003; Werthmann B, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa8e2b; YOSHIMOTO Y, 1984, CELL STRUCT FUNCT, V9, P135, DOI 10.1247/csf.9.135; YOSHIMOTO Y, 1981, CELL MOTIL CYTOSKEL, V1, P433, DOI 10.1002/cm.970010404; Zhang S, 2017, J PHYS D	65	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0217447	10.1371/journal.pone.0217447	http://dx.doi.org/10.1371/journal.pone.0217447			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398215	Green Published, Green Submitted, gold			2022-12-26	WOS:000485004000005
J	Alkawareek, MY; Bahlool, A; Abulateefeh, SR; Alkilany, AM				Alkawareek, Mahmoud Y.; Bahlool, Ahmad; Abulateefeh, Samer R.; Alkilany, Alaaldin M.			Synergistic antibacterial activity of silver nanoparticles and hydrogen peroxide	PLOS ONE			English	Article							MECHANISMS; GENERATION; OXIDATION	The increasing challenge of antibiotic resistance requires not only the discovery of new antibiotics, but also the development of new alternative approaches. Herein, the synergistic antibacterial activity of silver nanoparticles and hydrogen peroxide combination is reported. Unlike the bacteriostatic or slightly bactericidal activity achieved by using each agent alone, using these two agents in combination, even at relatively low concentrations, resulted in complete eradication of both the Gram negative Escherichia coli and the Gram positive Staphylococcus aureus in short treatment times indicating a clear synergistic effect between them. Modifying the surface chemistry of silver nanoparticles and the accompanied change in their surface charge enabled a further enhancement of such synergistic effect implying the importance of this aspect. Mechanistically, a Fenton-like reaction between silver nanoparticles and hydrogen peroxide is discussed and hypothesized to be the basis of the observed synergy. Achieving such a significant antibacterial activity at low concentrations reduces the potential toxicity of these agents and hence enables their utilization as an alternative antibacterial approach in wider range of applications.	[Alkawareek, Mahmoud Y.; Bahlool, Ahmad; Abulateefeh, Samer R.; Alkilany, Alaaldin M.] Univ Jordan, Sch Pharm, Amman, Jordan	University of Jordan	Alkawareek, MY (corresponding author), Univ Jordan, Sch Pharm, Amman, Jordan.	m.alkawareek@ju.edu.jo	Abulateefeh, Samer/H-3874-2015; Alkawareek, Mahmoud/H-5871-2012	Abulateefeh, Samer/0000-0001-7980-7429; Bahlool, Ahmad/0000-0002-9992-7476; Alkawareek, Mahmoud/0000-0002-4852-0617	Deanship of Scientific Research, The University of Jordan [2100]	Deanship of Scientific Research, The University of Jordan	This work was supported by the Deanship of Scientific Research, The University of Jordan [grant number: 2100], URL: research.ju.edu.jo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Deanship of Scientific Research, The University of Jordan [grant number: 2100]. The authors also acknowledge the technical assistance of Miss Bayan Tbakhi and Miss Aya Barqawi.	Bastus NG, 2014, CHEM MATER, V26, P2836, DOI 10.1021/cm500316k; Bleyer L, 1925, BIOCHEM Z, V161, P91; Bush K, 2011, NAT REV MICROBIOL, V9, P894, DOI 10.1038/nrmicro2693; Czaplewski L, 2016, LANCET INFECT DIS, V16, P239, DOI 10.1016/S1473-3099(15)00466-1; Dai XM, 2016, ACS APPL MATER INTER, V8, P25798, DOI 10.1021/acsami.6b09267; Feng ZV, 2015, CHEM SCI, V6, P5186, DOI 10.1039/c5sc00792e; Fu PP, 2014, J FOOD DRUG ANAL, V22, P64, DOI 10.1016/j.jfda.2014.01.005; Gorman SP, 2011, HUGO RUSSELLS PHARM, P312; He D, 2012, LANGMUIR, V28, P10266, DOI 10.1021/la300929g; He WW, 2012, BIOMATERIALS, V33, P7547, DOI 10.1016/j.biomaterials.2012.06.076; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Iuga C, 2011, J PHYS CHEM B, V115, P12234, DOI 10.1021/jp206347u; Jung WK, 2008, APPL ENVIRON MICROB, V74, P2171, DOI 10.1128/AEM.02001-07; Kelly KL, 2003, J PHYS CHEM B, V107, P668, DOI 10.1021/jp026731y; Laura G.C., 2014, AM J ENV ENG, V4, P56, DOI DOI 10.5923/J.AJEE.20140403.03; Lemire JA, 2013, NAT REV MICROBIOL, V11, P371, DOI 10.1038/nrmicro3028; Linley E, 2012, J ANTIMICROB CHEMOTH, V67, P1589, DOI 10.1093/jac/dks129; Martin NL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131345; Naylor NR, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0336-y; Paramelle D, 2014, ANALYST, V139, P4855, DOI 10.1039/c4an00978a; Raza MA, 2016, NANOMATERIALS-BASEL, V6, DOI 10.3390/nano6040074; SIES H, 1993, EUR J BIOCHEM, V215, P213, DOI 10.1111/j.1432-1033.1993.tb18025.x; Song KC, 2009, KOREAN J CHEM ENG, V26, P153, DOI 10.1007/s11814-009-0024-y; Vatansever F, 2013, FEMS MICROBIOL REV, V37, P955, DOI 10.1111/1574-6976.12026; Watt Barbara E, 2004, Toxicol Rev, V23, P51, DOI 10.2165/00139709-200423010-00006	25	20	20	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220575	10.1371/journal.pone.0220575	http://dx.doi.org/10.1371/journal.pone.0220575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393906	Green Submitted, Green Published, gold			2022-12-26	WOS:000485002500043
J	Kanayama, T; Tomita, H; Binh, NH; Hatano, Y; Aoki, H; Okada, H; Hirata, A; Fujihara, Y; Kunisada, T; Hara, A				Kanayama, Tomohiro; Tomita, Hiroyuki; Nguyen Huy Binh; Hatano, Yuichiro; Aoki, Hitomi; Okada, Hideshi; Hirata, Akihiro; Fujihara, Yoshitaka; Kunisada, Takahiro; Hara, Akira			Characterization of a BAC transgenic mouse expressing Krt19-driven iCre recombinase in its digestive organs	PLOS ONE			English	Article							LACZ EXPRESSION; GENERATION; EFFICIENT; MICE; CYTOKERATINS; CELLS; LINES; RNA	Cytokeratin 19 (KRT19) protein is highly expressed in the epithelium of the gastrointestinal (GI) tract, hepatobiliary tissues, and pancreas of humans and mice. In the present study, we used an improved Cre (iCre) gene to enhance the efficiency of Cre expression in mammalian cells. We established a new transgenic Krt19-iCre bacterial artificial chromosome (BAC) mouse model using the BAC recombineering strategy. Site-specific iCre expression pattern was examined in embryos, adults, and elderly Krt19-iCre mice crossed with Tomato or LacZ reporter mice. Both iCre and reporter protein expressions in adult Krt19-iCre; Tomato(flox/+) (Krt19-iCre Tomato reporter) mice were observed mainly in the epithelial cells of the GI tract, hepatobiliary tissues, and pancreas. However, the expression in the intrahepatic and small pancreatic duct were lower than those in the common bile and large pancreatic duct. In the Krt19-iCre; LacZ reporter embryos, beta-galactosidase for the LacZ reporter was expressed in the glandular epithelial cells of the GI tract in 9.5-day embryos, 12-day embryos, and newborn mice. The reporter protein expression in Krt19-iCre-Tomato reporter mice was consistent with the KRT19 expression in human GI tissues. In conclusion, Krt19-iCre BAC transgenic mice can be used to investigate developmental and pathological conditions using the iCre-loxP system.	[Kanayama, Tomohiro; Tomita, Hiroyuki; Nguyen Huy Binh; Hatano, Yuichiro; Hara, Akira] Gifu Univ, Grad Sch Med, Dept Tumor Pathol, Gifu, Japan; [Nguyen Huy Binh] Hanoi Med Univ, Physiol Dept, Hanoi, Vietnam; [Aoki, Hitomi; Kunisada, Takahiro] Gifu Univ, Grad Sch Med, Dept Tissue & Organ Dev, Gifu, Japan; [Okada, Hideshi] Gifu Univ, Grad Sch Med, Dept Emergency & Disaster Med, Gifu, Japan; [Hirata, Akihiro] Gifu Univ, Life Sci Res Ctr, Div Anim Expt, Gifu, Japan; [Fujihara, Yoshitaka] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka, Japan	Gifu University; Hanoi Medical University; Gifu University; Gifu University; Gifu University; Osaka University	Tomita, H (corresponding author), Gifu Univ, Grad Sch Med, Dept Tumor Pathol, Gifu, Japan.	h_tomita@gifu-u.ac.jp	Hatano, Yuichiro/K-7454-2013; Tomita, Hiroyuki/L-5571-2019; Fujihara, Yoshitaka/G-2043-2011	Hatano, Yuichiro/0000-0002-5121-6325; Tomita, Hiroyuki/0000-0002-3291-0274; Fujihara, Yoshitaka/0000-0001-8332-3507; Okada, Hideshi/0000-0002-7775-4308	KAKENHI [24590911, 15K11289]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research is supported by KAKENHI (Grant Number: 24590911 and 15K11289) (H.T. and A.H.).	Asfaha S, 2015, CELL STEM CELL, V16, P627, DOI 10.1016/j.stem.2015.04.013; Barak V, 2004, CLIN BIOCHEM, V37, P529, DOI 10.1016/j.clinbiochem.2004.05.009; Brembeck FH, 2001, GASTROENTEROLOGY, V120, P1720, DOI 10.1053/gast.2001.24846; Bridges PJ, 2008, GENESIS, V46, P499, DOI 10.1002/dvg.20428; Cacioppo JA, 2016, GENESIS, V54, P38, DOI 10.1002/dvg.22911; Cacioppo JA, 2015, GENESIS, V53, P245, DOI 10.1002/dvg.22845; Chandler KJ, 2007, MAMM GENOME, V18, P693, DOI 10.1007/s00335-007-9056-y; Chu PG, 2002, HISTOPATHOLOGY, V40, P403, DOI 10.1046/j.1365-2559.2002.01387.x; Gebhard S, 2007, HISTOCHEM CELL BIOL, V127, P183, DOI 10.1007/s00418-006-0236-8; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Jain R, 2010, APPL IMMUNOHISTO M M, V18, P9, DOI 10.1097/PAI.0b013e3181ad36ea; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Means AL, 2005, GENESIS, V42, P23, DOI 10.1002/gene.20119; Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397; Park CJ, 2017, GENESIS, V55, DOI 10.1002/dvg.23084; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stempel AJ, 2014, MOL VIS, V20, P1366; Tamai Y, 2000, J CELL BIOL, V151, P563, DOI 10.1083/jcb.151.3.563; Testa G, 2003, NAT BIOTECHNOL, V21, P443, DOI 10.1038/nbt804; Thomason Lynn, 2007, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0117s79; Ting JT, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00111; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Zhao GF, 2017, ONCOTARGET, V8, P18303, DOI 10.18632/oncotarget.15435	27	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220818	10.1371/journal.pone.0220818	http://dx.doi.org/10.1371/journal.pone.0220818			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393940	Green Published, Green Submitted, gold			2022-12-26	WOS:000485002500065
J	Yamase, K; Tanigawa, Y; Yamamoto, Y; Tanaka, H; Komiya, T				Yamase, Kenya; Tanigawa, Yoko; Yamamoto, Yasufumi; Tanaka, Hiromitsu; Komiya, Tohru			Mouse TMCO5 is localized to the manchette microtubules involved in vesicle transfer in the elongating spermatids	PLOS ONE			English	Article							INTESTINAL GOBLET CELLS; TAIL-ANCHORED PROTEINS; INTRAMANCHETTE TRANSPORT; MEMBRANE-FUSION; MESSENGER-RNA; PANETH CELLS; GENE; GOLGI; COMPLEX; CLONING	As a result of a high-throughput in situ hybridization screening for adult mouse testes, we found that the mRNA for Tmco5 is expressed in round and elongating spermatids. Tmco5 belongs to the Tmco (Transmembrane and coiled-coil domains) gene family and has a coiled-coil domain in the N-terminal and a transmembrane domain in the C-terminal region. A monoclonal antibody raised against recombinant TMCO5 revealed that the protein is expressed exclusively in the elongating spermatids of step 9 to 12 and is localized to the manchette, a transiently emerging construction, which predominantly consists of cytoskeleton microtubules and actin filaments. This structure serves in the transport of Golgi-derived non-acrosomal vesicles. Moreover, induced expression of TMCO5 in CHO cells resulted in the co-localization of TMCO5 with beta-tubulin besides the reorganization of the Golgi apparatus. Judging from the results and considering the domain structure of TMCO5, we assume that Tmco5 may have a role in vesicle transport along the manchette.	[Yamase, Kenya; Tanigawa, Yoko; Yamamoto, Yasufumi; Komiya, Tohru] Osaka City Univ, Grad Sch Sci, Dept Biol Funct, Sumiyoshi Ku, Osaka, Japan; [Tanaka, Hiromitsu] Nagasaki Int Univ, Fac Pharmaceut Sci, Nagasaki, Japan	Osaka Metropolitan University; Nagasaki International University	Komiya, T (corresponding author), Osaka City Univ, Grad Sch Sci, Dept Biol Funct, Sumiyoshi Ku, Osaka, Japan.	tkom@sci.osaka-cu.ac.jp						Abell BM, 2007, J CELL SCI, V120, P1743, DOI 10.1242/jcs.002410; Amaral A, 2013, MOL CELL PROTEOMICS, V12, P330, DOI 10.1074/mcp.M112.020552; Aruffo A., 2002, CURR PROTOC MOL BIOL, DOI [10.1002/0471142727.mb1612s60, DOI 10.1002/0471142727.MB1612S60]; Bao JQ, 2016, REPRODUCTION, V151, pR55, DOI 10.1530/REP-15-0562; Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Berruti Giovanna, 2011, Spermatogenesis, V1, P95; Bianchi E, 2014, NATURE, V508, P483, DOI 10.1038/nature13203; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; Chen XX, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-017-0166-4; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; Costa BF, 2018, TRAFFIC, V19, P182, DOI 10.1111/tra.12550; Dacheux JL, 2005, THERIOGENOLOGY, V63, P319, DOI 10.1016/j.theriogenology.2004.09.015; Daste F, 2015, J CELL SCI, V128, P4263, DOI 10.1242/jcs.178574; Fukuda N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003858; Gervasi MG, 2018, J CELL SCI, V131, DOI 10.1242/jcs.215897; GONG S, 1990, VIROLOGY, V178, P81, DOI 10.1016/0042-6822(90)90381-Z; Haseeb A, 2018, REPROD FERT DEVELOP, V30, P1514, DOI 10.1071/RD18010; Hayasaka S, 2008, ASIAN J ANDROL, V10, P561, DOI 10.1111/j.1745-7262.2008.00392.x; Hinsch KD, 1999, ANDROLOGIA, V31, P320; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; James PS, 2004, J CELL SCI, V117, P6485, DOI 10.1242/jcs.01578; Kalbfleisch T, 2007, TRAFFIC, V8, P1687, DOI 10.1111/j.1600-0854.2007.00661.x; Kaneko T, 2019, MOL REPROD DEV, V86, P330, DOI 10.1002/mrd.23108; Kawauchi T, 2005, BIOCHEM BIOPH RES CO, V331, P50, DOI 10.1016/j.bbrc.2005.03.132; Kierszenbaum AL, 2004, ARCH HISTOL CYTOL, V67, P271, DOI 10.1679/aohc.67.271; Kierszenbaum AL, 2002, MOL REPROD DEV, V63, P1, DOI 10.1002/mrd.10179; Kiessling V, 2015, METHOD CELL BIOL, V128, P339, DOI 10.1016/bs.mcb.2015.02.005; Kleene KC, 2016, MOL REPROD DEV, V83, P190, DOI 10.1002/mrd.22616; KOMIYA T, 1994, DEV BIOL, V162, P354, DOI 10.1006/dbio.1994.1093; Komiya T, 1999, BIOCHEM BIOPH RES CO, V255, P347, DOI 10.1006/bbrc.1999.0168; Komiya T, 1999, BBA-GENE STRUCT EXPR, V1444, P434, DOI 10.1016/S0167-4781(99)00010-X; Komiya T, 1998, BIOCHEM BIOPH RES CO, V251, P759, DOI 10.1006/bbrc.1998.9513; Komiya T, 1997, ANAL BIOCHEM, V254, P23, DOI 10.1006/abio.1997.2399; Kotaja N, 2014, FERTIL STERIL, V101, P1552, DOI 10.1016/j.fertnstert.2014.04.025; Kwon JT, 2017, PLOS ONE, V12; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laiho A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061558; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Matsui T, 2004, GENOMICS, V84, P384, DOI 10.1016/j.ygeno.2004.03.010; Nickel W, 1999, P NATL ACAD SCI USA, V96, P12571, DOI 10.1073/pnas.96.22.12571; Nomikos M, 2015, ASIAN J ANDROL, V17, P444, DOI 10.4103/1008-682X.142145; O'Donnell L., 2014, SPERMATOGENESIS, V4, pe979623, DOI [10.4161/21565562.2014.979623, DOI 10.4161/21565562.2014.979623]; Russell LD, 1990, HISTOLOGICAL HISTOPA, Vxiv; Sorensen JB, 2005, TRENDS NEUROSCI, V28, P453, DOI 10.1016/j.tins.2005.06.007; Suarez Susan S, 2007, Soc Reprod Fertil Suppl, V65, P331; Swann K, 2004, REPRODUCTION, V127, P431, DOI 10.1530/rep.1.00169; Tanaka H, 2005, CELL MOL LIFE SCI, V62, P344, DOI 10.1007/s00018-004-4394-y; Tanigawa Y, 2007, GENE EXPR PATTERNS, V7, P709, DOI 10.1016/j.modgep.2007.02.003; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wei YL, 2018, GENE, V660, P28, DOI 10.1016/j.gene.2018.03.059; Wu ATH, 2007, DEV BIOL, V312, P471, DOI 10.1016/j.ydbio.2007.08.051; Zhu XD, 2013, HISTOCHEM CELL BIOL, V140, P361, DOI 10.1007/s00418-013-1119-4	53	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220917	10.1371/journal.pone.0220917	http://dx.doi.org/10.1371/journal.pone.0220917			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393949	Green Published, Green Submitted, gold			2022-12-26	WOS:000485002500083
J	Fotouhi, O; Kjellin, H; Juhlin, CC; Pan, YB; Vesterlund, M; Ghaderi, M; Yousef, A; Andersson-Sand, H; Kharaziha, P; Caramuta, S; Kjellman, M; Zedenius, J; Larsson, C; Orre, LM				Fotouhi, Omid; Kjellin, Hanna; Juhlin, C. Christofer; Pan, Yanbo; Vesterlund, Mattias; Ghaderi, Mehran; Yousef, Abdelhamid; Andersson-Sand, Hillevi; Kharaziha, Pedram; Caramuta, Stefano; Kjellman, Magnus; Zedenius, Jan; Larsson, Catharina; Orre, Lukas M.			Proteomics identifies neddylation as a potential therapy target in small intestinal neuroendocrine tumors	ONCOGENE			English	Article							NEDD8-ACTIVATING ENZYME-INHIBITOR; PEVONEDISTAT TAK-924/MLN4924; RBX1 EXPRESSION; HUMAN CANCER; PHASE-I; NEDD8; P27(KIP1); CULLIN; DEGRADATION; SUPPRESSOR	Patients with small intestinal neuroendocrine tumors (SI-NETs) frequently develop spread disease; however, the underlying molecular mechanisms of disease progression are not known and effective preventive treatment strategies are lacking. Here, protein expression profiling was performed by HiRIEF-LC-MS in 14 primary SI-NETs from patients with and without liver metastases detected at the time of surgery and initial treatment. Among differentially expressed proteins, overexpression of the ubiquitin-like protein NEDD8 was identified in samples from patients with liver metastasis. Further, NEDD8 correlation analysis indicated co-expression with RBX1, a key component in cullin-RING ubiquitin ligases (CRLs). In vitro inhibition of neddylation with the therapeutic agent pevonedistat (MLN4924) resulted in a dramatic decrease of proliferation in SI-NET cell lines. Subsequent mass spectrometry-based proteomics analysis of pevonedistat effects and effects of the proteasome inhibitor bortezomib revealed stabilization of multiple targets of CRLs including p27, an established tumor suppressor in SI-NET. Silencing of NEDD8 and RBX1 using siRNA resulted in a stabilization of p27, suggesting that the cellular levels of NEDD8 and RBX1 affect CRL activity. Inhibition of CRL activity, by either NEDD8/RBX1 silencing or pevonedistat treatment of cells resulted in induction of apoptosis that could be partially rescued by siRNA-based silencing of p27. Differential expression of both p27 and NEDD8 was confirmed in a second cohort of SI-NET using immunohistochemistry. Collectively, these findings suggest a role for CRLs and the ubiquitin proteasome system in suppression of p27 in SI-NET, and inhibition of neddylation as a putative therapeutic strategy in SI-NET.	[Fotouhi, Omid; Juhlin, C. Christofer; Pan, Yanbo; Vesterlund, Mattias; Ghaderi, Mehran; Larsson, Catharina; Orre, Lukas M.] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Kjellin, Hanna; Kjellman, Magnus; Zedenius, Jan] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Juhlin, C. Christofer] Karolinska Univ Hosp Solna, Dept Pathol & Cytol, Stockholm, Sweden; [Pan, Yanbo; Vesterlund, Mattias; Andersson-Sand, Hillevi; Orre, Lukas M.] SciLifeLab, Stockholm, Sweden; [Yousef, Abdelhamid] Univ Cambridge, Dept Pharmacol, Cambridge, England; [Kharaziha, Pedram] Linkoping Univ Hosp, Dept Clin Genet, Linkoping, Sweden; [Caramuta, Stefano] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden; [Kjellman, Magnus; Zedenius, Jan] Karolinska Univ Hosp Solna, Dept Breast Endocrine Tumours & Sarcoma, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; SciLifeLab; University of Cambridge; Linkoping University; Uppsala University; Karolinska Institutet; Karolinska University Hospital	Larsson, C; Orre, LM (corresponding author), Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.; Orre, LM (corresponding author), SciLifeLab, Stockholm, Sweden.	catharina.larsson@ki.se; lukas.orre@ki.se	Vesterlund, Mattias/AAX-8014-2021; Juhlin, Carl Christofer/C-1125-2016; Pan, Yanbo/G-9371-2016; Ghaderi, Mehran/AAB-7416-2021	Juhlin, Carl Christofer/0000-0002-5945-9081; Pan, Yanbo/0000-0001-9442-7782; Vesterlund, Mattias/0000-0001-9471-6592; Orre, Lukas/0000-0002-0384-1003	Novartis; Swedish Research Council; Swedish Cancer Society; Cancer Society in Stockholm; Gustav V Jubilee Foundation; Stockholm County Council; Karolinska Institutet	Novartis(Novartis); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Cancer Society in Stockholm; Gustav V Jubilee Foundation; Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	The study was supported by grants from Novartis, the Swedish Research Council, the Swedish Cancer Society, the Cancer Society in Stockholm, the Gustav V Jubilee Foundation, Stockholm County Council, and Karolinska Institutet. Mass spectrometry-based proteomics analysis was performed at the Clinical Proteomics Mass Spectrometry facility located at SciLifeLab in Solna, Sweden.	Bhatia S, 2016, INVEST NEW DRUG, V34, P439, DOI 10.1007/s10637-016-0348-5; Branca RMM, 2014, NAT METHODS, V11, P59, DOI [10.1038/NMETH.2732, 10.1038/nmeth.2732]; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Cunningham JL, 2011, EUR J CLIN INVEST, V41, P1353, DOI 10.1111/j.1365-2362.2011.02537.x; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Edfeldt K, 2017, NEUROENDOCRINOLOGY, V105, P170, DOI 10.1159/000452891; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Enchev RI, 2015, NAT REV MOL CELL BIO, V16, P30, DOI 10.1038/nrm3919; Fotouhi O, 2016, J CLIN ENDOCR METAB, V101, P3616, DOI 10.1210/jc.2016-2028; Francis JM, 2013, NAT GENET, V45, P1483, DOI 10.1038/ng.2821; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Galvan JA, 2013, AM J CLIN PATHOL, V140, P61, DOI 10.1309/AJCPIV40ISTBXRAX; Gao H, 2004, P NATL ACAD SCI USA, V101, P17204, DOI 10.1073/pnas.0407693101; Gao J, 2009, GLIA, V57, P989, DOI 10.1002/glia.20823; Hashemi J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-505; Karpathakis A, 2016, CLIN CANCER RES, V22, P250, DOI 10.1158/1078-0432.CCR-15-0373; Klimstra, 2010, WHO CLASSIFICATION T, P102; Kytola S, 2001, AM J PATHOL, V158, P1803, DOI 10.1016/S0002-9440(10)64136-3; Lee J, 2009, EXP MOL MED, V41, P765, DOI 10.3858/emm.2009.41.11.102; Loda M, 1997, NAT MED, V3, P231, DOI 10.1038/nm0297-231; Migita K, 2014, GASTRIC CANCER, V17, P601, DOI 10.1007/s10120-013-0318-y; Muraoka RS, 2002, MOL CELL BIOL, V22, P2204, DOI 10.1128/MCB.22.7.2204-2219.2002; Nieser M, 2017, NEUROENDOCRINOLOGY, V104, P302, DOI 10.1159/000446917; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Philipp-Staheli J, 2001, EXP CELL RES, V264, P148, DOI 10.1006/excr.2000.5143; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; Salon C, 2007, J PATHOL, V213, P303, DOI 10.1002/path.2223; Sarantopoulos J, 2016, CLIN CANCER RES, V22, P847, DOI 10.1158/1078-0432.CCR-15-1338; Shah JJ, 2016, CLIN CANCER RES, V22, P34, DOI 10.1158/1078-0432.CCR-15-1237; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Stalberg P, 2016, J INTERN MED, V280, P584, DOI 10.1111/joim.12526; Swords RT, 2018, BLOOD, V131, P1415, DOI 10.1182/blood-2017-09-805895; Tian DW, 2019, CANCER SCI, V110, P458, DOI 10.1111/cas.13865; Wang W, 2013, J SURG ONCOL, V107, P758, DOI 10.1002/jso.23317; Watson IR, 2011, CANCER CELL, V19, P168, DOI 10.1016/j.ccr.2011.01.002; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Xie P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.195; Xing R, 2016, SURG ONCOL, V25, P147, DOI 10.1016/j.suronc.2016.05.006; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Yu J, 2018, CANC MED; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhou LS, 2018, CELL SIGNAL, V44, P92, DOI 10.1016/j.cellsig.2018.01.009; Zhou Y, 2017, ONCOGENE, V36, P731, DOI 10.1038/onc.2016.242	47	5	6	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 24	2019	38	43					6881	6897		10.1038/s41388-019-0938-8	http://dx.doi.org/10.1038/s41388-019-0938-8			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JH4GX	31406256	Green Published, hybrid			2022-12-26	WOS:000492728000001
J	Nitta, RT; Bolin, S; Luo, E; Solow-Codero, DE; Samghabadi, P; Purzner, T; Aujla, PS; Nwagbo, G; Cho, YJ; Li, G				Nitta, Ryan T.; Bolin, Sara; Luo, Emily; Solow-Codero, David E.; Samghabadi, Peyman; Purzner, Teresa; Aujla, Parvir S.; Nwagbo, Ginikachi; Cho, Yoon-Jae; Li, Gordon			Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide	ONCOGENE			English	Article							UNFAVORABLE PROGNOSTIC MARKER; BRAIN-TUMORS; CK2-ALPHA; CHEMOTHERAPY; EXPRESSION; SUBGROUPS; CARCINOMA; PATHWAYS; CHILDREN; TARGET	Medulloblastoma (MB) is the most common malignant pediatric brain tumor. Since surviving patients experience severe neurocognitive disabilities, better and more effective treatments are needed to enhance their quality of life. Casein kinase 2 (CK2) is known to regulate cell growth and survival in multiple cancers; however, the role of CK2 in MB is currently being studied. In this study, we verified the importance of CK2 in MB tumorigenesis and discovered that inhibition of CK2 using the small molecule inhibitor, CX-4945, can sensitize MB cells to a well-known and tolerated chemotherapeutic, temozolomide (TMZ). To study the role of CK2 in MB we modulated CK2 expression in multiple MB cells. Exogenous expression of CK2 enhanced cell growth and tumor growth in mice, while depletion or inhibition of CK2 expression decreased MB tumorigenesis. Treatment with CX-4945 reduced MB growth and increased apoptosis. We conducted a high-throughput screen where 4000 small molecule compounds were analyzed to identify compounds that increased the anti-tumorigenic properties of CX-4945. TMZ was found to work synergistically with CX-4945 to decrease cell survival and increase apoptosis in MB cells. O-6-methylguanine-DNA methyltransferase (MGMT) activity is directly correlated to TMZ sensitivity. We found that loss of CK2 activity reduced beta-catenin expression, a known MGMT regulator, which in turn led to a decrease in MGMT expression and an increased sensitivity to TMZ. Our findings show that CK2 is important for MB maintenance and that treatment with CX-4945 can sensitize MB cells to TMZ treatment.	[Nitta, Ryan T.; Bolin, Sara; Luo, Emily; Aujla, Parvir S.; Nwagbo, Ginikachi; Li, Gordon] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Solow-Codero, David E.] Stanford Univ, Dept Chem & Syst Biol, High Throughput Biosci Ctr, Stanford, CA 94305 USA; [Samghabadi, Peyman] Stanford Univ, Dept Neuropathol, Stanford, CA 94305 USA; [Purzner, Teresa] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Purzner, Teresa] Univ Toronto, Div Neurosurg, Toronto, ON, Canada; [Cho, Yoon-Jae] Oregon Hlth & Sci Univ, Dept Pediat, Pape Family Pediat Res Inst, Knight Canc Inst, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA	Stanford University; Stanford University; Stanford University; Stanford University; University of Toronto; Oregon Health & Science University	Nitta, RT (corresponding author), Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA.	rnitta@stanford.edu		Li, Gordon/0000-0001-8372-0676; Solow-Cordero, David/0000-0002-9886-5058; Bolin, Sara/0000-0003-2835-1518	Stanford Cancer Institute Bioscience Screening Award; Swedish Childhood Cancer Foundation;  [NIH-KNS085333A]; NATIONAL CANCER INSTITUTE [P30CA124435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS085333] Funding Source: NIH RePORTER	Stanford Cancer Institute Bioscience Screening Award; Swedish Childhood Cancer Foundation(European Commission); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank Albert Wong and the Cell Sciences Imaging Facility (CSIF) at Stanford University for use of their equipment. This work was funded by generous donations of the Anatoly Machulskiy family, Keith Tsu and Carmelita Ko, Steven Sommer, and the Yatindra Singh family. This research was also funded by Stanford Cancer Institute Bioscience Screening Award and NIH-KNS085333A and SB was supported by the Swedish Childhood Cancer Foundation.	Aguilera D, 2013, CHILD NERV SYST, V29, P589, DOI 10.1007/s00381-012-2013-4; Akyuz C, 2012, CHILD NERV SYST, V28, P111, DOI 10.1007/s00381-011-1561-3; Bae JS, 2015, INT J CANCER, V136, P797, DOI 10.1002/ijc.29043; Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; BORAD MJ, 2017, J CLIN ONCOL S, V35; Cavalli FMG, 2017, CANCER CELL, V31, P737, DOI 10.1016/j.ccell.2017.05.005; Chua MMJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188854; Chua MMJ, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10010018; Dhall G, 2009, J CHILD NEUROL, V24, P1418, DOI 10.1177/0883073809341668; Faoro D, 2011, J NEURO-ONCOL, V103, P59, DOI 10.1007/s11060-010-0366-7; Gajjar A, 2006, LANCET ONCOL, V7, P813, DOI 10.1016/S1470-2045(06)70867-1; Guo B, 2000, CLIN CANCER RES, V6, P718; Kim HS, 2014, FEBS J, V281, P851, DOI 10.1111/febs.12652; Kim JS, 2007, CLIN CANCER RES, V13, P1019, DOI 10.1158/1078-0432.CCR-06-1602; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Lin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018608; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Marschke RF, 2011, ASCO M ABSTRACTS S, V29, P3087, DOI DOI 10.1200/jco.2011.29.15_suppl.3087; Michaelis M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08202; Nitta RT, 2015, ONCOGENE, V34, P3688, DOI 10.1038/onc.2014.299; Nitta RT, 2011, ONCOGENE, V30, P234, DOI 10.1038/onc.2010.414; Nitta RT, 2013, J MOL GENET MED, V8, P1; Ortega CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115609; Othman RT, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-57; Packer RJ, 2006, J CLIN ONCOL, V24, P4202, DOI 10.1200/JCO.2006.06.4980; Purzner J, 2007, J NEUROSCI, V27, P6029, DOI 10.1523/JNEUROSCI.5441-06.2007; Purzner T, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aau5147; Rabjerg M, 2017, ONCOTARGET, V8, P1613, DOI 10.18632/oncotarget.13693; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Swartling FJ, 2012, CANCER CELL, V21, P601, DOI 10.1016/j.ccr.2012.04.012; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; von Bueren AO, 2012, BRIT J CANCER, V107, P1399, DOI 10.1038/bjc.2012.403; Wickstrom M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9904; Zhang HX, 2015, ONCOTARGET, V6, P34800, DOI 10.18632/oncotarget.5470; Zheng Y, 2013, CLIN CANCER RES, V19, P6484, DOI 10.1158/1078-0432.CCR-13-0265	35	13	14	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 17	2019	38	42					6867	6879		10.1038/s41388-019-0927-y	http://dx.doi.org/10.1038/s41388-019-0927-y			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JE5UU	31406250	hybrid, Green Accepted			2022-12-26	WOS:000490758200005
J	Li, YK; Yang, DQ; Tian, N; Zhang, P; Zhu, YM; Meng, J; Feng, M; Lu, Y; Liu, Q; Tong, LF; Hu, L; Zhang, LK; Yang, JY; Wu, LF; Tong, XM				Li, Yakui; Yang, Dianqiang; Tian, Na; Zhang, Ping; Zhu, Yemin; Meng, Jian; Feng, Ming; Lu, Ying; Liu, Qi; Tong, Lingfeng; Hu, Lei; Zhang, Lukuan; Yang, James Y.; Wu, Lifang; Tong, Xuemei			The ubiquitination ligase SMURF2 reduces aerobic glycolysis and colorectal cancer cell proliferation by promoting ChREBP ubiquitination and degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell metabolism; cell proliferation; E3 ubiquitin ligase; ubiquitylation (ubiquitination); colorectal cancer; protein degradation; Carbohydrate responsive element binding protein (ChREBP); colorectal cancer; metabolism; Smad ubiquitination regulatory factor 2 (Smurf2); ubiquitin proteasome pathway	RESPONSIVE TRANSCRIPTION FACTOR; SIGNALING PATHWAY; GLUCOSE; EXPRESSION; PROTEIN; PHOSPHORYLATION; PROGRESSION; STABILITY; BINDING; GENE	The glucose-responsive transcription factor carbohydrate response element-binding protein (ChREBP) critically promotes aerobic glycolysis and cell proliferation in colorectal cancer cells. It has been reported that ubiquitination may be important in the regulation of ChREBP protein levels and activities. However, the ChREBP-specific E3 ligase and molecular mechanism of ChREBP ubiquitination remains unclear. Using database exploration and expression analysis, we found here that levels of the E3 ligase SMURF2 (Smad-ubiquitination regulatory factor 2) negatively correlate with those of ChREBP in cancer tissues and cell lines. We observed that SMURF2 interacts with ChREBP and promotes ChREBP ubiquitination and degradation via the proteasome pathway. Interestingly, ectopic SMURF2 expression not only decreased ChREBP levels but also reduced aerobic glycolysis, increased oxygen consumption, and decreased cell proliferation in colorectal cancer cells. Moreover, SMURF2 knockdown increased aerobic glycolysis, decreased oxygen consumption, and enhanced cell proliferation in these cells, mostly because of increased ChREBP accumulation. Furthermore, we identified Ser/Thr kinase AKT as an upstream suppressor of SMURF2 that protects ChREBP from ubiquitin-mediated degradation. Taken together, our results indicate that SMURF2 reduces aerobic glycolysis and cell proliferation by promoting ChREBP ubiquitination and degradation via the proteasome pathway in colorectal cancer cells. We conclude that the SMURF2-ChREBP interaction might represent a potential target for managing colorectal cancer.	[Li, Yakui; Tian, Na; Zhang, Ping; Zhu, Yemin; Meng, Jian; Feng, Ming; Lu, Ying; Liu, Qi; Tong, Lingfeng; Hu, Lei; Zhang, Lukuan; Wu, Lifang; Tong, Xuemei] Shanghai Jiao Tong Univ, Sch Med, Natl Minist Educ,Dept Biochem & Mol Cell Biol, Key Lab Cell Differentiat & Apoptosis,Shanghai Ke, 280 S Chongqing Rd, Shanghai 200025, Peoples R China; [Yang, Dianqiang] Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Signaling Network, State Key Lab Cellular Stress Biol, Xiamen 361102, Fujian, Peoples R China; [Yang, James Y.] Xiamen Univ, Minist Educ, Engn Res Ctr Mol Diagnost, Xiamen 361102, Fujian, Peoples R China; [Yang, James Y.] Xiamen Univ, State Prov Joint Engn Lab Targeted Drugs Nat Prod, Sch Life Sci, Xiamen 361102, Fujian, Peoples R China	Shanghai Jiao Tong University; Xiamen University; Xiamen University; Xiamen University	Wu, LF; Tong, XM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Natl Minist Educ,Dept Biochem & Mol Cell Biol, Key Lab Cell Differentiat & Apoptosis,Shanghai Ke, 280 S Chongqing Rd, Shanghai 200025, Peoples R China.	wulifang@shsmu.edu.cn; xuemeitong@shsmu.edu.cn	tian, na/GVR-9226-2022		National Natural Science Foundation of China [81472239, 81672322, 31601118]; National Key Research and Development Program of China [2016YFC1304800, SYjdyx18007]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning and Construction Plan of Laboratory Technical Team in Shanghai Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning and Construction Plan of Laboratory Technical Team in Shanghai Universities	This work was supported by National Natural Science Foundation of China Grants 81472239, 81672322, and 31601118; National Key Research and Development Program of China Grant 2016YFC1304800; and Grant SYjdyx18007 from the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning and Construction Plan of Laboratory Technical Team in Shanghai Universities. The authors declare that they have no conflicts of interest with the contents of this article.	Billin AN, 2006, CURR TOP MICROBIOL, V302, P255; Blank M, 2012, NAT MED, V18, P227, DOI 10.1038/nm.2596; Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Choi YH, 2014, FEBS J, V281, P3656, DOI 10.1111/febs.12887; Collier JJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE48, DOI 10.1152/ajpendo.00357.2006; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; Du JX, 2011, J BIOL CHEM, V286, P40354, DOI 10.1074/jbc.M111.258707; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Fukuchi M, 2002, CANCER RES, V62, P7162; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Guinez C, 2011, DIABETES, V60, P1399, DOI 10.2337/db10-0452; Han GW, 2006, DEV CELL, V11, P301, DOI 10.1016/j.devcel.2006.06.014; Hsu HY, 2014, ONCOTARGET, V5, P7870, DOI 10.18632/oncotarget.2317; Ido-Kitamura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047231; Itoh N, 2002, CANCER, V94, P3127, DOI 10.1002/cncr.10591; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Jin CY, 2009, CANCER RES, V69, P735, DOI 10.1158/0008-5472.CAN-08-1463; Khaleghpour K, 2004, CARCINOGENESIS, V25, P241, DOI 10.1093/carcin/bgg195; Li HX, 2004, ONCOGENE, V23, P1801, DOI 10.1038/sj.onc.1207319; Nie J, 2010, J BIOL CHEM, V285, P22816, DOI 10.1074/jbc.M110.126920; O'Callaghan BL, 2001, J BIOL CHEM, V276, P16033, DOI 10.1074/jbc.M101557200; Ohashi N, 2005, FEBS LETT, V579, P2557, DOI 10.1016/j.febslet.2005.03.069; Osmundson EC, 2008, J CELL BIOL, V183, P267, DOI 10.1083/jcb.200801049; Ramkumar C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3598; Ramkumar C, 2012, CANCER RES, V72, P2714, DOI 10.1158/0008-5472.CAN-11-3773; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sakiyama H, 2010, BIOCHEM BIOPH RES CO, V402, P784, DOI 10.1016/j.bbrc.2010.10.113; Tong XM, 2009, P NATL ACAD SCI USA, V106, P21660, DOI 10.1073/pnas.0911316106; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang HY, 2002, J BIOL CHEM, V277, P32746, DOI 10.1074/jbc.M201635200; Xavier GD, 2006, J LIPID RES, V47, P2482, DOI 10.1194/jlr.M600289-JLR200; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263; Zhang H, 2004, GENE DEV, V18, P3028, DOI 10.1101/gad.1253004	38	19	24	4	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2019	294	40					14745	14756		10.1074/jbc.RA119.007508	http://dx.doi.org/10.1074/jbc.RA119.007508			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JP0II	31409643	Green Published, hybrid			2022-12-26	WOS:000497955000019
J	Farias, IP; Willis, S; Leao, A; Verba, JT; Crossa, M; Foresti, F; Porto-Foresti, F; Sampaio, I; Hrbek, T				Farias, Izeni Pires; Willis, Stuart; Leao, Adam; Verba, Julia Tovar; Crossa, Marcelo; Foresti, Fausto; Porto-Foresti, Fabio; Sampaio, Iracilda; Hrbek, Tomas			The largest fish in the world's biggest river: Genetic connectivity and conservation of Arapaima gigas in the Amazon and Araguaia-Tocantins drainages	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; COMPUTER-PROGRAM; BASIN; MANAGEMENT; TELEOSTEI; DIVERSIFICATION; EVOLUTION; SOFTWARE; RECOMMENDATIONS; PHYLOGEOGRAPHY	Arapaima, pirarucu or paiche (Arapaima gigas) is one of the largest freshwater fish in the world, and has a long history of commercial exploitation in the Amazon region. To estimate levels of genetic variability and historical and recent connectivity in Arapaima, we examined variation in eleven microsatellite DNA markers in individuals from 22 localities in Brazil, Colombia, and Peru. The results of analysis of molecular variance, Bayesian clustering and discriminant analysis of principal components showed that Arapaima in our samples represents two major populations, one in the Amazonas and one in the Araguaia-Tocantins River basins. The Amazonas population is further structured by isolation-by-distance with the hydrologically largely unconnected Amapa locality representing the eastern-most extreme of this continuum; gene flow predominates at distances of less than 1500 km with localities separated by over 2000 km dominated by genetic drift and effectively forming different populations. We saw no evidence of multiple species of Arapaima in the Amazonas basin, and analysis of pairwise genetic divergence (FST) with Mantel tests and correlograms indicated that this largest population exhibits a large-scale pattern of isolation-by-distance, with which results from MIGRATE-N agreed. The degree and significance of genetic divergence indicates that most sampled localities represent demographically independent sub-populations, although we did identify several recent migration events between both proximal and more distant localities. The levels of genetic diversity were heterogeneous across sites, including low genetic diversity, effective population sizes, and evidence of genetic bottlenecks in several places. On average the levels of gene diversity and rarefied allelic richness were higher for localities along the Amazonas mainstem than in the tributaries, despite these being the areas of highest fishing pressure, while the lowest values were found in tributary headwaters, where landscape modification is a significant threat. We recommend that managers consider the regional and local threats to these populations and tailor strategies accordingly, strategies which should ensure the ability of young A. gigas to disperse through floodplain corridors to maintain genetic diversity among otherwise sedentary adult sub-populations.	[Farias, Izeni Pires; Leao, Adam; Verba, Julia Tovar; Hrbek, Tomas] Univ Fed Amazonas UFAM, Lab Evolucao & Genet Anim LEGAL, Manaus, Amazonas, Brazil; [Willis, Stuart] Calif Acad Sci, Dept Ichthyol, San Francisco, CA 94118 USA; [Verba, Julia Tovar] Univ Fed Rio Grande Norte UFRN, Dept Ecol, Natal, RN, Brazil; [Crossa, Marcelo] Acqua Consultoria Ambiental, Rio De Janeiro, Brazil; [Foresti, Fausto] Univ Estadual Paulista UNESP, Inst Biociencias, Lab Biol & Genet Peixes, Botucatu, SP, Brazil; [Porto-Foresti, Fabio] Univ Estadual Paulista UNESP, Fac Ciencias, Dept Ciencias Biol, Campus Bauru, Bauru, Brazil; [Sampaio, Iracilda] Univ Fed Para, Inst Estudos Costeiros, Campus Univ Braganca, Belem, Para, Brazil	Universidade Federal de Amazonas; California Academy of Sciences; Universidade Federal do Rio Grande do Norte; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Federal do Para	Farias, IP; Hrbek, T (corresponding author), Univ Fed Amazonas UFAM, Lab Evolucao & Genet Anim LEGAL, Manaus, Amazonas, Brazil.	izeni@evoamazon.net; hrbek@evoamazon.net	Farias, Izeni Pires/J-3069-2014; Hrbek, Tomas/J-6988-2012; Porto-Foresti, Fabio/AAC-4797-2020	Farias, Izeni Pires/0000-0002-1416-4351; Hrbek, Tomas/0000-0003-3239-7068; Porto-Foresti, Fabio/0000-0001-8845-3845; Tovar Verba, Julia/0000-0001-5399-6890	National Council for Scientific and Technological Development of Brazil (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [MCT/CNPq/PPG7 557090/2005-9, CNPq/CT-Amazonia 554057/2006-9, CNPq/CT-Amazonia 575603/2008-9, CNPq/MPA 42/2012]; State of Amazonas Research Support Foundation (Fundacao de Amparo a Pesquisa do Estado do Amazonas) [Tematico 899/03, Universal 062.01341/2018]; CNPq; CNPq [482662/2013-1]	National Council for Scientific and Technological Development of Brazil (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); State of Amazonas Research Support Foundation (Fundacao de Amparo a Pesquisa do Estado do Amazonas); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by the National Council for Scientific and Technological Development of Brazil (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) grants: MCT/CNPq/PPG7 557090/2005-9, CNPq/CT-Amazonia 554057/2006-9 and CNPq/CT-Amazonia 575603/2008-9 to IPF, and CNPq/MPA 42/2012 and CNPq 482662/2013-1 to TH, and the State of Amazonas Research Support Foundation (Fundacao de Amparo a Pesquisa do Estado do Amazonas) grants: Tematico 899/03 and Universal 062.01341/2018 to IPF. IPF and TH were supported by a Bolsa de Pesquisa scholarship from CNPq during the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado Manuella Villar, 2011, Int J Evol Biol, V2011, P360654, DOI 10.4061/2011/360654; Amaral CRL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074397; Arantes CC, 2010, ECOL FRESHW FISH, V19, P455, DOI 10.1111/j.1600-0633.2010.00431.x; Araripe J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054470; Araujo-Lima CARM, 1998, ECOLOGIA CONSERVACZO; Batista JS, 2006, GENET MOL RES, V5, P723; Beaumont MA, 1999, GENETICS, V153, P2013; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Behling H., 2011, GEOGR HELV, V3, P208, DOI DOI 10.5194/GH-66-208-2011; BEMERGUY RL, 1991, B MUSEU PARAENSE E G, V3, P75; Best R.C., 1984, Monographiae Biologicae, V56, P371; BEST RC, 1983, BIOTROPICA, V15, P61, DOI 10.2307/2388000; Campos-Silva JV, 2019, FRESHWATER BIOL, V64, P1255, DOI 10.1111/fwb.13301; Campos-Silva JV, 2016, SCI REP-UK, V6, DOI 10.1038/srep34745; Carvalho F, 2018, ECOL FRESHW FISH, V27, P237, DOI 10.1111/eff.12341; Castello L, 2008, ECOL FRESHW FISH, V17, P38, DOI 10.1111/j.1600-0633.2007.00255.x; Castello L, 2004, N AM J FISH MANAGE, V24, P379, DOI 10.1577/M02-024.1; Castello L, 2016, GLOBAL CHANGE BIOL, V22, P990, DOI 10.1111/gcb.13173; Castello L, 2013, CONSERV LETT, V6, P217, DOI 10.1111/conl.12008; Cremon EH, 2016, GEOMORPHOLOGY, V271, P22, DOI 10.1016/j.geomorph.2016.07.030; de Oliveira RC, 2018, HYDROBIOLOGIA, V805, P75, DOI 10.1007/s10750-017-3278-0; de Souza LS, 2012, CYBIUM, V36, P31; deQueiroz HL, 1999, ESTRATGIAS MANEJO RE, P208; deQueiroz HL, 2000, NATURAL HIST CONSERV, P222; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Farias IP, 2003, MOL ECOL NOTES, V3, P128, DOI 10.1046/j.1471-8286.2003.00375.x; Farias IP, 2008, MOL PHYLOGENET EVOL, V49, P32, DOI 10.1016/j.ympev.2008.05.033; Farias IP, 2015, NEOTROP ICHTHYOL, V13, P195, DOI 10.1590/1982-0224-20140010; Farias IP, 2010, MOL PHYLOGENET EVOL, V56, P1129, DOI 10.1016/j.ympev.2010.03.028; Fernandes MN, 2012, MICRON, V43, P961, DOI 10.1016/j.micron.2012.03.018; FONTENELE OSMAR, 1948, REV BRASIL BIOL, V8, P445; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Frankham R, 2014, BIOL CONSERV, V170, P56, DOI 10.1016/j.biocon.2013.12.036; Franklin IR, CONSERVATION BIOL EV; Frederico RG, 2012, NEOTROP ICHTHYOL, V10, P71, DOI 10.1590/S1679-62252012000100007; Santos MDF, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00263; Garcia-Dorado A, 2015, HEREDITY, V115, P185, DOI 10.1038/hdy.2015.28; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Goulding M., 1980, FISHES FOREST EXPLOR; Goulding M, 2000, FLOODS FORTUNE ECOLO; Goulding M, 2003, SMITHSONIAN ATLAS AM; Goulding M., 1979, ECOLOGIA PESCA RIO M; HAMMER O., 2001, PALEONTOLOGIA ELECT, V4, P1; Hey J, 2012, EVOLUTION, V66, P1413, DOI 10.1111/j.1558-5646.2011.01542.x; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Hrbek T., 2007, Braz. J. Biol., V67, P909, DOI 10.1590/S1519-69842007000500015; Hrbek T, 2005, ANIM CONSERV, V8, P297, DOI 10.1017/S1367943005002210; Hrbek T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083623; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jamieson IG, 2012, TRENDS ECOL EVOL, V27, P578, DOI 10.1016/j.tree.2012.07.001; Jegu M, 1999, CR ACAD SCI III-VIE, V322, P1133, DOI 10.1016/S0764-4469(99)00113-4; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kurlansky M., 1998, COD BIOGRAPHY FISH C; Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x; Lowe-McConnell R.H., 1979, Symposia of the Zoological Society of London, P219; LUNDBERG JG, 1992, BIOTROPICA, V24, P2, DOI 10.2307/2388468; Machado VN, 2017, ENVIRON BIOL FISH, V100, P1, DOI 10.1007/s10641-016-0547-0; MANTEL N, 1967, CANCER RES, V27, P209; Martinelli NMC, 1999, FISHERIES MANAG ECOL, V6, P233, DOI 10.1046/j.1365-2400.1999.00135.x; Medem F, 1983, CROCODYLIA AM, VII; Meirmans PG, 2011, MOL ECOL, V20, P3144, DOI 10.1111/j.1365-294X.2011.05164.x; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Menezes RS, 1951, SERV INFORM AGR MINI, V3, P9; Miranda-Chumacero G, 2012, BIOINVASIONS REC, V1, P129, DOI 10.3391/bir.2012.1.2.09; NEI M, 1974, GENETICS, V76, P379; Nelson JS., 2016, FISHES WORLD, DOI DOI 10.1002/9781119174844.FMATTER; Ochoa LE, 2015, ECOL EVOL, V5, P2005, DOI 10.1002/ece3.1486; Palsboll PJ, 2007, TRENDS ECOL EVOL, V22, P11, DOI 10.1016/j.tree.2006.09.003; Palstra FP, 2012, ECOL EVOL, V2, P2357, DOI 10.1002/ece3.329; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Prang G., 2001, CABOCLO SOC MIDDLE R; Pritchard JK, 2000, GENETICS, V155, P945; Purcell SW, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3296; R Core Team, 2018, R LANG ENV STAT COMP; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Rossetti DF, 2007, CATENA, V70, P253, DOI 10.1016/j.catena.2006.08.009; Rossetti DF, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2457; Rossetti DF, 2015, SEDIMENT GEOL, V330, P1, DOI 10.1016/j.sedgeo.2015.10.001; Santos MCF, 2007, J FISH BIOL, V71, P33, DOI 10.1111/j.1095-8649.2007.01514.x; Schaefer CER, 1997, HOMEM AMBIENTE ECOLO, P231; Smith NJH, 1980, BIOL CONSERV, V19, P177; Stewart DJ, 2013, COPEIA, P38, DOI 10.1643/CI-12-013; Stewart DJ, 2013, COPEIA, P470, DOI 10.1643/CI-12-017; Storz JF, 2002, MOL BIOL EVOL, V19, P1981, DOI 10.1093/oxfordjournals.molbev.a004022; Storz JF, 2002, EVOLUTION, V56, P154; STPAUL U, 1986, AQUACULTURE, V54, P205, DOI 10.1016/0044-8486(86)90329-7; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vitorino CA, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00159; von Spix J. B., 1829, SELECTA GENERA SPECI; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 1998, CONSERV BIOL, V12, P718, DOI 10.1046/j.1523-1739.1998.97524.x; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Willis SC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172349; Willis SC, 2015, CONSERV GENET, V16, P1345, DOI 10.1007/s10592-015-0744-y; Willis SC, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-96; Willis SC, 2012, MOL PHYLOGENET EVOL, V63, P798, DOI 10.1016/j.ympev.2012.02.018; Winemiller KO, 2005, CAN J FISH AQUAT SCI, V62, P872, DOI 10.1139/F05-040; WINEMILLER KO, 1992, CAN J FISH AQUAT SCI, V49, P2196, DOI 10.1139/f92-242	107	13	13	6	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2019	14	8							e0220882	10.1371/journal.pone.0220882	http://dx.doi.org/10.1371/journal.pone.0220882			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5LL	31419237	gold, Green Published, Green Submitted			2022-12-26	WOS:000485019900017
J	Gkanasos, A; Somarakis, S; Tsiaras, K; Kleftogiannis, D; Giannoulaki, M; Schismenou, E; Sofianos, S; Triantafyllou, G				Gkanasos, Athanasios; Somarakis, Stylianos; Tsiaras, Kostas; Kleftogiannis, Dimitrios; Giannoulaki, Marianna; Schismenou, Eudoxia; Sofianos, Sarantis; Triantafyllou, George			Development, application and evaluation of a 1-D full life cycle anchovy and sardine model for the North Aegean Sea (Eastern Mediterranean)	PLOS ONE			English	Article							SMALL PELAGIC FISH; POPULATION-DYNAMICS MODEL; DAILY EGG-PRODUCTION; ENGRAULIS-ENCRASICOLUS; SEASONAL-CHANGES; BODY CONDITION; GROWTH; VARIABILITY; PILCHARDUS; TEMPERATURE	A 1-D full-life-cycle, Individual-based model (IBM), two-way coupled with a hydrodynamic/biogeochemical model, is demonstrated for anchovy and sardine in the N. Aegean Sea (Eastern Mediterranean). The model is stage-specific and includes a 'Wisconsin' type bioenergetics, a diel vertical migration and a population dynamics module, with the incorporation of known differences in biological attributes between the anchovy and sardine stocks. A new energy allocation/egg production algorithm was developed, allowing for breeding pattern to move along the capital-income breeding continuum. Fish growth was calibrated against available size-at-age data by tuning food consumption (the half saturation coefficients) using a genetic algorithm. After a ten-years spin up, the model reproduced well the magnitude of population biomasses and spawning periods of the two species in the N. Aegean Sea. Surprisingly, model simulations revealed that anchovy depends primarily on stored energy for egg production (mostly capital breeder) whereas sardine depends heavily on direct food intake (income breeder). This is related to the peculiar phenology of plankton production in the area, with mesozooplankton concentration exhibiting a sharp decrease from early summer to autumn and a subsequent increase from winter to early summer. Monthly changes in somatic condition of fish collected on board the commercial purse seine fleet followed closely the simulated mesozo-oplankton concentration. Finally, model simulations showed that, when both the anchovy and sardine stocks are overexploited, the mesozooplankton concentration increases, which may open up ecological space for competing species. The importance of protecting the recruit spawners was highlighted with model simulations testing the effect of changing the timing of the existing 2.5-months closed period. Optimum timing for fishery closure is different for anchovy and sardine because of their opposite spawning and recruitment periods.	[Gkanasos, Athanasios; Sofianos, Sarantis] Univ Athens, Dept Environm Phys, Athens, Greece; [Gkanasos, Athanasios; Tsiaras, Kostas; Triantafyllou, George] HCMR, Mavro Lithari, Anavyssos, Greece; [Somarakis, Stylianos; Giannoulaki, Marianna; Schismenou, Eudoxia] Thalassocosmos Gournes, HCMR, Iraklion, Crete, Greece; [Kleftogiannis, Dimitrios] Agcy Sci Technol & Res, GIS, Singapore, Singapore	National & Kapodistrian University of Athens; Hellenic Centre for Marine Research; Hellenic Centre for Marine Research; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Triantafyllou, G (corresponding author), HCMR, Mavro Lithari, Anavyssos, Greece.	gt@hcmr.gr	Triantafyllou, George N/C-4104-2011	Triantafyllou, George/0000-0002-2353-8693; Kleftogiannis, Dimitrios/0000-0003-1086-821X; Gkanasos, Athanasios/0000-0003-4818-5262	General Secretariat for Research and Technology (GSRT); Hellenic Foundation for Research and Innovation (HFRI) through the project CLIMAFISH -'CLIMAte change	General Secretariat for Research and Technology (GSRT)(Greek Ministry of Development-GSRT); Hellenic Foundation for Research and Innovation (HFRI) through the project CLIMAFISH -'CLIMAte change	The present work was financially supported by the General Secretariat for Research and Technology (GSRT) and the Hellenic Foundation for Research and Innovation (HFRI) through the project CLIMAFISH -'CLIMAte change and FISHeries impacts on small pelagic fish: dynamic, spatially explicit models in the service of the ecosystem-based fisheries management' within the framework of the "1st Call for the support of Postdoctoral Researchers."	Alheit J, 2009, CLIMATE CHANGE AND SMALL PELAGIC FISH, P64; Alvarez P, 2012, SCI MAR, V76, P573, DOI 10.3989/scimar.03298.07H; Antonakakis K, 2011, MEDITERR MAR SCI, V12, P333, DOI 10.12681/mms.36; Bakun A, 2010, REV FISH BIOL FISHER, V20, P9, DOI 10.1007/s11160-009-9118-1; BARETTA JW, 1995, NETH J SEA RES, V33, P233, DOI 10.1016/0077-7579(95)90047-0; Bernal M, 2011, ICES J MAR SCI, V68, P519, DOI 10.1093/icesjms/fsr001; BLUMBERG AF, 1983, J GEOPHYS RES-OCEANS, V88, P4579, DOI 10.1029/JC088iC08p04579; Brosset P, 2017, PROG OCEANOGR, V151, P149, DOI 10.1016/j.pocean.2016.12.002; Brosset P, 2015, MAR ECOL PROG SER, V529, P219, DOI 10.3354/meps11275; Checkley DM, 2017, ANNU REV MAR SCI, V9, P469, DOI 10.1146/annurev-marine-122414-033819; Checkley DM, 2009, CLIMATE CHANGE AND SMALL PELAGIC FISH, P344; Costalago D, 2014, SCI MAR, V78, P41, DOI 10.3989/scimar.03898.06D; Damalas D, 2017, J FISH RES BOARD CAN, V1, P27; Daskalov GM, 2007, ICES J MAR SCI, V64, P503, DOI 10.1093/icesjms/fsl047; Ganias K, 2007, MAR BIOL, V151, P1559, DOI 10.1007/s00227-006-0601-0; Ganias K, 2014, Biology and Ecology of Sardines and Anchovies, P79; Gatti P, 2017, ECOL MODEL, V348, P93, DOI 10.1016/j.ecolmodel.2016.12.018; Giannoulaki M, 1999, MAR ECOL PROG SER, V178, P29, DOI 10.3354/meps178029; Giannoulaki M, 2014, MEDITERR MAR SCI, V15, P350, DOI 10.12681/mms.509; Giannoulaki M, 2013, FISH OCEANOGR, V22, P69, DOI 10.1111/fog.12005; Hunter J.R., 1985, NOAA Technical Report NMFS, V36, P79; Huret M, 2019, MAR ECOL PROG SER, V617, P95, DOI 10.3354/meps12574; Huse G, 1998, FISH RES, V37, P163, DOI 10.1016/S0165-7836(98)00134-9; Isari S, 2006, J PLANKTON RES, V28, P241, DOI 10.1093/plankt/fbi058; Ito SI, 2007, ECOL MODEL, V202, P174, DOI 10.1016/j.ecolmodel.2006.07.046; Ito SI, 2015, PROG OCEANOGR, V138, P331, DOI 10.1016/j.pocean.2015.05.022; KITCHELL JF, 1977, J FISH RES BOARD CAN, V34, P1922, DOI 10.1139/f77-258; Kleftogiannis D, 2015, IEEE ACM T COMPUT BI, V12, P1183, DOI 10.1109/TCBB.2014.2388227; Kooijman S. A. L. M., 2010, DYNAMIC ENERGY BUDGE; Lynam CP, 2006, CURR BIOL, V16, pR492, DOI 10.1016/j.cub.2006.06.018; Machias A, 2008, MEDITERR MAR SCI, V9, P49, DOI 10.12681/mms.143; Machias A, 1995, MAR BIOL, V123, P59; Mantzouni I, 2007, ECOL MODEL, V208, P367, DOI 10.1016/j.ecolmodel.2007.05.021; McBride RS, 2015, FISH FISH, V16, P23, DOI 10.1111/faf.12043; Megrey BA, 2007, ECOL MODEL, V202, P144, DOI 10.1016/j.ecolmodel.2006.08.020; Nikolioudakis N, 2014, MAR ECOL PROG SER, V500, P215, DOI 10.3354/meps10604; Nikolioudakis N, 2012, MAR ECOL PROG SER, V453, P173, DOI 10.3354/meps09656; Nikolioudakis N, 2011, MAR ECOL PROG SER, V437, P215, DOI 10.3354/meps09275; Oguz T, 2008, MAR ECOL PROG SER, V369, P229, DOI 10.3354/meps07540; Okunishi T, 2009, ECOL MODEL, V220, P462, DOI 10.1016/j.ecolmodel.2008.10.020; PATTERSON KR, 1992, J FISH BIOL, V40, P821, DOI 10.1111/j.1095-8649.1992.tb02629.x; Peck MA, 2013, PROG OCEANOGR, V116, P220, DOI 10.1016/j.pocean.2013.05.012; Pecquerie L, 2009, J SEA RES, V62, P93, DOI 10.1016/j.seares.2009.06.002; Pethybridge H, 2013, ECOL MODEL, V250, P370, DOI 10.1016/j.ecolmodel.2012.11.017; Petihakis G, 2002, J MARINE SYST, V36, P173, DOI 10.1016/S0924-7963(02)00186-0; Pikitch E., 2012, LENFEST OCEAN PROGRA, P108; Politikos D, 2015, PROG OCEANOGR, V138, P399, DOI 10.1016/j.pocean.2014.09.002; Politikos DV, 2011, HYDROBIOLOGIA, V670, P141, DOI 10.1007/s10750-011-0674-8; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; Rose KA, 2015, PROG OCEANOGR, V138, P348, DOI 10.1016/j.pocean.2015.01.012; Saraux C, 2019, DEEP-SEA RES PT II, V159, P52, DOI 10.1016/j.dsr2.2018.02.010; SCHEFFER M, 1995, ECOL MODEL, V80, P161, DOI 10.1016/0304-3800(94)00055-M; Schismenou E., 2012, THESIS; Schismenou E, 2016, FISH OCEANOGR, V25, P362, DOI 10.1111/fog.12158; Schismenou E, 2014, MAR ECOL PROG SER, V515, P227, DOI 10.3354/meps10958; Schismenou E, 2013, MAR ECOL PROG SER, V478, P197, DOI 10.3354/meps10178; Shiganova TA, 1998, FISH OCEANOGR, V7, P305, DOI 10.1046/j.1365-2419.1998.00080.x; Somarakis S, 2005, BELG J ZOOL, V135, P247; Somarakis S, 1999, THESIS; Somarakis S, 2007, MAR BIOL, V152, P1143, DOI 10.1007/s00227-007-0761-6; Somarakis S, 2019, MAR ECOL PROG SER, V617, P113, DOI 10.3354/meps12642; Somarakis S, 2012, FISH RES, V117, P12, DOI 10.1016/j.fishres.2010.11.027; Somarakis Stylianos, 2006, University of British Columbia Fisheries Centre Research Reports, V14, P56; Soufan O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117988; STECF, 2017, MEDITERRANEAN STOCK, DOI [10.2760/897559, DOI 10.2760/897559]; Takasuka A, 2007, CAN J FISH AQUAT SCI, V64, P768, DOI 10.1139/F07-052; Tsagarakis K, 2012, MAR ECOL PROG SER, V446, P243, DOI 10.3354/meps09456; Tsiaras KP, 2014, J SEA RES, V86, P97, DOI 10.1016/j.seares.2013.11.007; Tsiaras KP, 2012, J MARINE SYST, V96-97, P72, DOI 10.1016/j.jmarsys.2012.02.003; Tsikliras AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121188; Tsikliras Athanassios C., 2007, Rapport du Congress de la CIESM, V38, P623; Tsuruta Y., 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V108, P111; Vasilakopoulos P, 2014, CURR BIOL, V24, P1643, DOI 10.1016/j.cub.2014.05.070; Vilibic I, 2016, MEDITERR MAR SCI, V17, P1	74	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0219671	10.1371/journal.pone.0219671	http://dx.doi.org/10.1371/journal.pone.0219671			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415572	Green Published, Green Submitted, gold			2022-12-26	WOS:000485017200007
J	Hamel, R; Surasombatpattana, P; Wichit, S; Dauve, A; Donato, C; Pompon, J; Vijaykrishna, D; Liegeois, F; Vargas, RM; Luplertlop, N; Misse, D				Hamel, Rodolphe; Surasombatpattana, Pornapat; Wichit, Sineewanlaya; Dauve, Alexandra; Donato, Celeste; Pompon, Julien; Vijaykrishna, Dhanasekaran; Liegeois, Florian; Vargas, Ronald Morales; Luplertlop, Natthanej; Misse, Dorothee			Phylogenetic analysis revealed the cocirculation of four dengue virus serotypes in Southern Thailand	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; EMERGENCE; SURVEILLANCE; EVOLUTION; GENOTYPE; OUTBREAK; BANGKOK; TAIWAN; TYPE-2; EPIDEMIOLOGY	Dengue fever is caused by dengue viruses (DENV) from the Flavivirus genus and is the most prevalent arboviral disease. DENV exists in four immunogenically distinct and genetically-related serotypes (DENV-1 to 4), each subdivided in genotypes. Despite the endemicity of all four DENV serotypes in Thailand, no prior study has characterized the circulation of DENV in the southern provinces of the country. To determine the genetic diversity of DENV circulating in Southern Thailand in 2015 and 2016, we investigated 46 viruses from 182 patients' sera confirmed positive for DENV by serological and Nested RT-PCR tests. Our dataset included 2 DENV-1, 20 DENV-2, 9 DENV-3 and 15 DENV-4. Phylogenetic analysis was performed on viral envelop sequences. This revealed that part of the identified genotypes from DENV-1 and DENV-4 had been predominant in Asia (genotype I for both serotypes), while genotype II for DENV-4 and the Cosmopolitan genotype DENV-2 were also circulating. Whereas DENV-3 genotype II had been predominantly detected in South East Asia during the previous decades, we found genotype III and genotype I in Southern Thailand. All DENV genotype identified in this study were closely related to contemporary strains circulating in Southeast Asian countries, emphasizing the regional circulation of DENV. These results provide new insights into the co-circulation of all four DENV serotypes in Southern Thailand, confirming the hyperendemicity of DENV in the region. These findings also suggest a new trend of dissemination for some DENV serotypes with a possible shift in genotype distribution; as recently observed in other Asian countries.	[Hamel, Rodolphe; Pompon, Julien; Liegeois, Florian; Misse, Dorothee] Univ Montpellier, MIVEGEC UMR 224, IRD, CNRS, Montpellier, France; [Hamel, Rodolphe; Luplertlop, Natthanej] Mahidol Univ, Dept Microbiol & Immunol, Fac Trop Med, Bangkok, Thailand; [Surasombatpattana, Pornapat] Prince Songkla Univ, Pathol Dept, Hat Yai, Thailand; [Wichit, Sineewanlaya] Mahidol Univ, Fac Med Technol, Bangkok, Thailand; [Dauve, Alexandra; Vargas, Ronald Morales] Mahidol Univ, Fac Trop Med, Dept Entomol, Bangkok, Thailand; [Donato, Celeste; Vijaykrishna, Dhanasekaran] Monash Univ, Dept Microbiol, Biomed Discovery Inst, Clayton, Vic, Australia; [Pompon, Julien; Vijaykrishna, Dhanasekaran] Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Mahidol University; Prince of Songkla University; Mahidol University; Mahidol University; Monash University; National University of Singapore	Misse, D (corresponding author), Univ Montpellier, MIVEGEC UMR 224, IRD, CNRS, Montpellier, France.	dorothee.misse@ird.fr	Vijaykrishna, Dhanasekaran/AAG-2077-2020; Hamel, Rodolphe/AAG-1714-2020; Dhanasekaran, Vijaykrishna/D-1011-2010; Pompon, Julien/AAA-4463-2021; Misse, Dorothee/A-7590-2012	Vijaykrishna, Dhanasekaran/0000-0003-3293-6279; Hamel, Rodolphe/0000-0001-8603-7039; Dhanasekaran, Vijaykrishna/0000-0003-3293-6279; Pompon, Julien/0000-0003-1110-9039; Donato, Celeste/0000-0001-9262-6550; Morales Vargas, Ronald Enrique/0000-0002-8013-5372; Misse, Dorothee/0000-0002-6485-3841	French Institute for Sustainable Development (IRD, JEAI DENCHICTHAI); Thailand One Health University Network (THOHUN) through the United States Agency for International Development, Mahidol University [017/2016]; French National Research Agency under the "Investissements d'avenir" programme [ANR-16-IDEX-0006]	French Institute for Sustainable Development (IRD, JEAI DENCHICTHAI); Thailand One Health University Network (THOHUN) through the United States Agency for International Development, Mahidol University; French National Research Agency under the "Investissements d'avenir" programme(French National Research Agency (ANR))	This work was supported by grants from the French Institute for Sustainable Development (IRD, JEAI DENCHICTHAI) and Thailand One Health University Network (THOHUN) through the United States Agency for International Development (agreement no. 017/2016), Mahidol University. This work was also publicly funded through the French National Research Agency under the "Investissements d'avenir" programme with the reference ANR-16-IDEX-0006.	Anoop M, 2010, INDIAN J EXP BIOL, V48, P849; Chang SF, 2016, AM J TROP MED HYG, V94, P804, DOI 10.4269/ajtmh.15-0534; Cucunawangsih, 2017, Virology (Auckl), V8, p1178122X17695836, DOI 10.1177/1178122X17695836; Drumond BP, 2016, BRAZ J MICROBIOL, V47, P251, DOI 10.1016/j.bjm.2015.11.016; Ernst T, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003442; Flasche S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002181; Gintarong T, 2018, J VECTOR DIS, V55, P168, DOI 10.4103/0972-9062.242566; Goncalvez AP, 2002, VIROLOGY, V303, P110, DOI 10.1006/viro.2002.1686; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HAMMON WM, 1973, AM J TROP MED HYG, V22, P82, DOI 10.4269/ajtmh.1973.22.82; Hapuarachchi HC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1606-z; Health MoP, 2016, DENGUE FEVER, DOI [10.1186/s12889-016-3382-5, DOI 10.1186/S12889-016-3382-5]; Holmes EC, 2000, TRENDS MICROBIOL, V8, P74, DOI 10.1016/S0966-842X(99)01669-8; Hu TS, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2401-1; Huang JH, 2007, AM J TROP MED HYG, V77, P903, DOI 10.4269/ajtmh.2007.77.903; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Ito M, 2010, JPN J INFECT DIS, V63, P181; Klungthong C, 2004, VIROLOGY, V329, P168, DOI 10.1016/j.virol.2004.08.003; Koo C, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-275; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kurosu T, 2014, JPN J INFECT DIS, V67, P132, DOI 10.7883/yoken.67.132; Kyaw AK, 2017, EPIDEMIOL INFECT, V145, P1886, DOI 10.1017/S0950268817000735; LANCIOTTI RS, 1994, J GEN VIROL, V75, P65, DOI 10.1099/0022-1317-75-1-65; Lanciotti RS, 1997, J GEN VIROL, V78, P2279, DOI 10.1099/0022-1317-78-9-2279; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Lardo S, 2016, ASIAN PAC J TROP MED, V9, P130, DOI 10.1016/j.apjtm.2016.01.013; Lee JS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006037; Limkittikul K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003241; McElroy KL, 2011, EMERG INFECT DIS, V17, P64, DOI 10.3201/eid1701.100961; Messer WB, 2003, EMERG INFECT DIS, V9, P800; Milne I, 2004, BIOINFORMATICS, V20, P1806, DOI 10.1093/bioinformatics/bth155; Moore PR, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.103; Muller DA, 2017, J INFECT DIS, V215, pS89, DOI 10.1093/infdis/jiw649; Ng LC, 2015, AM J TROP MED HYG, V92, P1150, DOI 10.4269/ajtmh.14-0588; Nisalak A, 2016, AM J TROP MED HYG, V94, P1342, DOI 10.4269/ajtmh.15-0337; Ong SH, 2008, INFECT GENET EVOL, V8, P191, DOI 10.1016/j.meegid.2007.12.005; Ooi EE, 2009, CAD SAUDE PUBLICA, V25, pS115, DOI 10.1590/S0102-311X2009001300011; Phadungsombat J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207220; Phommanivong Viengvaly, 2016, Trop Med Health, V44, P24, DOI 10.1186/s41182-016-0020-y; Rabaa MA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001990; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Sasmono RT, 2015, INFECT GENET EVOL, V32, P165, DOI 10.1016/j.meegid.2015.03.006; Shihada S, 2017, EMERG INFECT DIS, V23, P272, DOI 10.3201/eid2302.160751; Shu PY, 2009, AM J TROP MED HYG, V80, P1039, DOI 10.4269/ajtmh.2009.80.1039; Sittisombut N, 1997, AM J TROP MED HYG, V57, P100, DOI 10.4269/ajtmh.1997.57.100; Sucipto TH, 2018, J TROP MED-US, V2018, DOI 10.1155/2018/8127093; Tan KK, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1175-4; Twiddy SS, 2003, INFECT GENET EVOL, V3, P87, DOI 10.1016/S1567-1348(02)00153-3; Twiddy SS, 2002, VIROLOGY, V298, P63, DOI 10.1006/viro.2002.1447; VinodKumar CS, 2013, J INFECT PUBLIC HEAL, V6, P302, DOI 10.1016/j.jiph.2013.01.004; Vu TTH, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000757; Warrilow D, 2012, EMERG INFECT DIS, V18, P1850, DOI 10.3201/eid1811.120014; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003; Wittke V, 2002, VIROLOGY, V301, P148, DOI 10.1006/viro.2002.1549; World Health Organization (WHO), DENG SEV DENG 2018; 2009, WOM HLTH TOD EV TOM, P17	56	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0221179	10.1371/journal.pone.0221179	http://dx.doi.org/10.1371/journal.pone.0221179			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415663	Green Published, Green Submitted, gold			2022-12-26	WOS:000485017200089
J	Heracleous, P; Yoneyama, A				Heracleous, Panikos; Yoneyama, Akio			A comprehensive study on bilingual and multilingual speech emotion recognition using a two-pass classification scheme	PLOS ONE			English	Article							CONVOLUTIONAL NEURAL-NETWORKS; LANGUAGE RECOGNITION; SPEAKER	Emotion recognition plays an important role in human-computer interaction. Previously and currently, many studies focused on speech emotion recognition using several classifiers and feature extraction methods. The majority of such studies, however, address the problem of speech emotion recognition considering emotions solely from the perspective of a single language. In contrast, the current study extends monolingual speech emotion recognition to also cover the case of emotions expressed in several languages that are simultaneously recognized by a complete system. To address this issue, a method, which provides an effective and powerful solution to bilingual speech emotion recognition, is proposed and evaluated. The proposed method is based on a two-pass classification scheme consisting of spoken language identification and speech emotion recognition. In the first pass, the language spoken is identified; in the second pass, emotion recognition is conducted using the emotion models of the language identified. Based on deep learning and the i-vector paradigm, bilingual emotion recognition experiments have been conducted using the state-of-he-art English IEMOCAP (four emotions) and German FAU Aibo (five emotions) corpora. Two classifiers along with i-vector features were used and compared, namely, fully connected deep neural networks (DNN) and convolutional neural networks (CNN). In the case of DNN, 64.0% and 61.14% unweighted average recalls (UARs) were obtained using the IEMOCAP and FAU Aibo corpora, respectively. When using CNN, 62.0% and 59.8% UARs were achieved in the case of the IEMOCAP and FAU Aibo corpora, respectively. These results are very promising, and superior to those obtained in similar studies on multilingual or even monolingual speech emotion recognition. Furthermore, an additional baseline approach for bilingual speech emotion recognition was implemented and evaluated. In the baseline approach, six common emotions were considered, and bilingual emotion models were created, trained on data from the two languages. In this case, 51.2% and 51.5% UARs for six emotions were obtained using DNN and CNN, respectively. The results using the baseline method were reasonable and promising, showing the effectiveness of using i-vectors and deep learning in bilingual speech emotion recognition. On the other hand, the proposed two-pass method based on language identification showed significantly superior performance. Furthermore, the current study was extended to also deal with multilingual speech emotion recognition using corpora collected under similar conditions. Specifically, the English IEMOCAP, the German Emo-DB, and a Japanese corpus were used to recognize four emotions based on the proposed two-pass method. The results obtained were very promising, and the differences in UAR were not statistically significant compared to the monolingual classifiers.	[Heracleous, Panikos; Yoneyama, Akio] KDDI Res Inc, Educ & Med ICT Lab, 2-1-15 Ohara, Saitama 3568502, Japan	KDDI Corporation; KDDI Research, Inc.	Heracleous, P (corresponding author), KDDI Res Inc, Educ & Med ICT Lab, 2-1-15 Ohara, Saitama 3568502, Japan.	pa-heracleous@kddi-research.jp						Abdel-Hamid O, 2014, IEEE-ACM T AUDIO SPE, V22, P1533, DOI 10.1109/TASLP.2014.2339736; Attabi Y, 2013, INT CONF ACOUST SPEE, P7527, DOI 10.1109/ICASSP.2013.6639126; Bhaykar M., 2013, COMM NCC 2013 NAT C, P1, DOI [DOI 10.1109/NCC.2013.6487998, 10.1109/NCC.2013.6487998]; Bielefeld B, 1994, 14 ANN SPEECH RES S; Burkhardt F., 2005, P INT; Busso C, 2008, LANG RESOUR EVAL, V42, P335, DOI 10.1007/s10579-008-9076-6; Cao H, 2012, P INT; Caseiro D, 1998, P ICSLP 98; Chavhan Y., 2010, INT J COMPUT APPL, V1, P6, DOI [10.5120/431-636, DOI 10.5120/431-636, DOI 10.1007/978-3-642-21402-8_35]; Chavhan Yashpalsing, 2010, INT J SMART HOME, V1, P6, DOI DOI 10.5120/431-636; Cole R. A., 1989, IEEE Pacific Rim Conference on Communications, Computers and Signal Processing. Conference Proceeding (Cat. No.89CH2691-4), P525, DOI 10.1109/PACRIM.1989.48417; Cristianini N., 2000, INTRO SUPPORT VECTOR, DOI [10.1017/CBO9780511801389, DOI 10.1017/CBO9780511801389]; Dehak N, 2011, 12TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2011 (INTERSPEECH 2011), VOLS 1-5, P864; Dehak N, 2011, IEEE T AUDIO SPEECH, V19, P788, DOI 10.1109/TASL.2010.2064307; Eyben F, 2010, P 3 INT WORKSH EMOTI; Ganapathy S, 2014, P INT; Gunawardana A., 2005, INTERSPEECH, P1117; Han K, 2014, INTERSPEECH, P223; Hansen JHL, 2018, SPEECH COMMUN, V101, P94, DOI 10.1016/j.specom.2018.05.004; Heracleous P, 2017, COMPUT LINGUIST, P180; Heracleous P, 2018, P EUSIPCO; Heracleous P, 2018, INT WIREL COMMUN, P1443; Hu H, 2007, INT CONF ACOUST SPEE, P413; Huynh X.-P., 2013, LECT NOTES ELECT ENG, V376, P441; Jiang B., 2010, PLOS ONE, V9, P1; Kim Y., 2014, P 2014 C EMP METH NA, P1746; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Le D, 2013, 2013 IEEE WORKSHOP ON AUTOMATIC SPEECH RECOGNITION AND UNDERSTANDING (ASRU), P216, DOI 10.1109/ASRU.2013.6707732; Lee C.-H., 2008, SPRINGER HDB SPEECH; Lee CC, 2011, SPEECH COMMUN, V53, P1162, DOI 10.1016/j.specom.2011.06.004; Lee J, 2015, 16TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION (INTERSPEECH 2015), VOLS 1-5, P1537; Li HZ, 2013, P IEEE, V101, P1136, DOI 10.1109/JPROC.2012.2237151; Lim W, 2016, ASIAPAC SIGN INFO PR, DOI 10.1109/APSIPA.2016.7820699; Llorens H., 2010, P 23 INT C COMPUTATI, P725; Lopez-Moreno Ignacio, 2014, 2014 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP), P5337, DOI 10.1109/ICASSP.2014.6854622; Lu XG, 2016, INTERSPEECH, P3216, DOI 10.21437/Interspeech.2016-722; Mary L, 2005, 2005 INTERNATIONAL CONFERENCE ON INTELLIGENT SENSING AND INFORMATION PROCESSING, PROCEEDINGS, P404; Metallinou A, 2010, INT CONF ACOUST SPEE, P2462, DOI 10.1109/ICASSP.2010.5494890; Montavon G., 2009, NIPS WORKSH DEEP LEA; Neiberg D, 2011, P SPEECH PROS; Nicholson J, 2000, NEURAL COMPUT APPL, V9, P290, DOI 10.1007/s005210070006; Parada-Cabaleiro E, 2018, INTERSPEECH, P3638, DOI 10.21437/Interspeech.2018-47; Polzehl T., 2010, P SPEECH PROS; Ranjan S, 2016, INT CONF ACOUST SPEE, P5830, DOI 10.1109/ICASSP.2016.7472795; Rawat W, 2017, NEURAL COMPUT, V29, P2352, DOI [10.1162/NECO_a_00990, 10.1162/neco_a_00990]; Reiter S, 2007, 2007 IEEE INTERNATIONAL CONFERENCE ON MULTIMEDIA AND EXPO, VOLS 1-5, P639; Reynolds DA, 2008, SPRINGER HDB SPEECH; Sagha H, 2016, INTERSPEECH, P2949, DOI 10.21437/Interspeech.2016-333; Sahidullah M, 2012, SPEECH COMMUN, V54, P543, DOI 10.1016/j.specom.2011.11.004; Schuller B, 2003, 2003 INTERNATIONAL CONFERENCE ON MULTIMEDIA AND EXPO, VOL I, PROCEEDINGS, P401; Schuller B, 2010, IEEE T AFFECT COMPUT, V1, P119, DOI 10.1109/T-AFFC.2010.8; Shami Mohammad, 2007, Speaker Classification II. Selected Projects. (Lecture Notes in Artificial Intelligence Vol.4441), P43; Shaw A., 2016, INT J COMPUT APPL, V145, P5; Shen P, 2016, INT CONF ACOUST SPEE, P5825, DOI 10.1109/ICASSP.2016.7472794; Sheng L., 2018, P IEEE WIR COMM NETW, P1; Siniscalchi SM, 2013, COMPUT SPEECH LANG, V27, P209, DOI 10.1016/j.csl.2012.05.001; Steidl, 2009, AUTOMATIC CLASSIFICA; Stuhlsatz A, 2011, INT CONF ACOUST SPEE, P5688; Tang H, 2009, IEEE INT CON MULTI, P294, DOI 10.1109/ICME.2009.5202493; Torres-Carrasquillo P., 2002, P ICSLP2002 INTERSPE, P16; TRAN T, 2013, SOCIAL EMOTIONS NATU, P8101; Wermter S., 2017, P IJCNLP TAIP TAIW, P423; Xu SP, 2013, PROCEEDINGS OF THE 3RD INTERNATIONAL CONFERENCE ON ELECTRIC AND ELECTRONICS, P434; Yu D, 2010, INT CONF ACOUST SPEE, P5030, DOI 10.1109/ICASSP.2010.5495072; Zazo R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146917; Zissman MA, 1996, IEEE T SPEECH AUDI P, V4, P31, DOI 10.1109/TSA.1996.481450	66	10	11	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220386	10.1371/journal.pone.0220386	http://dx.doi.org/10.1371/journal.pone.0220386			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415592	Green Published, Green Submitted, gold			2022-12-26	WOS:000485017200015
J	Hu, W; Li, L; Wu, C; Zhang, H; Zhu, HH				Hu, Wei; Li, Lin; Wu, Chao; Zhang, Hang; Zhu, Haihong			A parallel method for accelerating visualization and interactivity for vector tiles	PLOS ONE			English	Article							CELLULAR-AUTOMATA	Vector tile technology is developing rapidly and has received increasing attention in recent years. Compared to the raster tile, the vector tile has shown incomparable advantages, such as flexible map styles, suitability for high-resolution screens and ease of interaction. Recent studies on vector tiles have mostly focused on improving the efficiency on the server side and have overlooked the efficiency on the client side, which affects user experience. Parallel computing provides solutions to this issue. Parallel visualization of vector tiles is a typical example of embarrassing parallelism; thus, estimating the computing times of each tile accurately and decomposing the workload into multiple computing units evenly are key to the parallel visualization of vector tiles. This article adopts mainstream parallel computing and proposes an efficient tile-based parallel method for accelerating geographical feature visualization by building computational weight functions (CWFs) of geographical feature visualizations. The computing time of each vector tile is estimated by the CWF, and an effective workload decomposition strategy is proposed such that the efficiency of vector tile visualization is improved on the client side. Furthermore, a tile-based reconstruction scheme for geographical features is also proposed. Experiments show that the R-squared value of the estimated computing times of vector tiles is 0.914 and that the computational efficiency of the parallel visualization of vector tiles with the proposed workload decomposition strategy is 18.6% higher than that of common parallel visualization. Finally, users can obtain the entire set of features effectively and accurately based on the proposed reconstruction scheme.	[Hu, Wei; Li, Lin; Zhang, Hang; Zhu, Haihong] Wuhan Univ, Sch Resource & Environm Sci, Wuhan, Hubei, Peoples R China; [Hu, Wei] China Elect Technol Grp Corp, Res Inst 14, Syst Res Dept, Nanjing, Jiangsu, Peoples R China; [Li, Lin] Wuhan Univ, Geo Spatial Informat Sci Collaborat Innovat Ctr, Wuhan, Hubei, Peoples R China; [Wu, Chao] Nanjing Univ Posts & Telecommun, Sch Geog & Biol Informat, Nanjing, Jiangsu, Peoples R China; [Wu, Chao] Nanjing Univ Posts & Telecommun, Smart Hlth Big Data Anal & Locat Serv Engn Lab Ji, Nanjing, Jiangsu, Peoples R China	Wuhan University; China Electronics Technology Group; Wuhan University; Nanjing University of Posts & Telecommunications; Nanjing University of Posts & Telecommunications	Li, L; Zhu, HH (corresponding author), Wuhan Univ, Sch Resource & Environm Sci, Wuhan, Hubei, Peoples R China.; Li, L (corresponding author), Wuhan Univ, Geo Spatial Informat Sci Collaborat Innovat Ctr, Wuhan, Hubei, Peoples R China.	lilin@whu.edu.cn; hhzhu@whu.edu.cn			National Natural Science Foundation of China [41871298]; scientific research foundation of Nanjing University of Posts and Telecommunications [NY219036]; Open Research Fund Program of Key Laboratory of Digital Mapping and Land Information Application Engineering, NASG [ZRZYBWD201906]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); scientific research foundation of Nanjing University of Posts and Telecommunications(Nanjing University of Posts & Telecommunications); Open Research Fund Program of Key Laboratory of Digital Mapping and Land Information Application Engineering, NASG	This work was supported by the National Natural Science Foundation of China under grant 41871298, the scientific research foundation of Nanjing University of Posts and Telecommunications under grant NY219036 and Open Research Fund Program of Key Laboratory of Digital Mapping and Land Information Application Engineering, NASG under grant ZRZYBWD201906.	Andrienko GL, 1999, INT J GEOGR INF SCI, V13, P355, DOI 10.1080/136588199241247; Antoniou V, 2009, LECT NOTES COMPUT SC, V5886, P56, DOI 10.1007/978-3-642-10601-9_5; Balog D, 2017, OGC TESTBED 12 VECTO; Bandrova T, 2014, INT CONF CARTOGR GIS, P164; Cavazzi S, 2018, OGC TESTBED 13 VECTO; Dubel S, 2014, 2014 IEEE VIS INTERNATIONAL WORKSHOP ON 3DVIS (3DVIS), P11, DOI 10.1109/3DVis.2014.7160094; Dufilie Andrew, 2014, Web and Wireless Geographical Information Systems. 13th International Symposium, (W2GIS 2014). Proceedings: LNCS 8470, P19, DOI 10.1007/978-3-642-55334-9_2; Dykes JA, 1997, COMPUT GEOSCI, V23, P345, DOI 10.1016/S0098-3004(97)00009-5; Edsall R., 2008, MANUAL GEOGRAPHIC IN, P837; Graham Mark, 2013, DIALOGUES HUMAN GEOG, V3, P255, DOI [DOI 10.1177/2043820613513121, 10.1177/2043820613513121]; Guan QF, 2011, INT J GEOGR INF SCI, V25, P1241, DOI 10.1080/13658816.2011.563744; Guan QF, 2010, INT J GEOGR INF SCI, V24, P695, DOI 10.1080/13658810902984228; Guo MQ, 2015, INT J GEOGR INF SCI, V29, P1419, DOI 10.1080/13658816.2015.1032294; Huang HS, 2011, INT J GEOGR INF SCI, V25, P1561, DOI 10.1080/13658816.2010.532133; Konecny M., 2011, ANN GIS, V17, P135, DOI [https://doi.org/10.1080/19475683.2011.602027, DOI 10.1080/19475683.2011.602027]; Kraak M.J., 2013, CARTOGRAPHY VISUALIZ; Li L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176387; Li X, 2010, INT J GEOGR INF SCI, V24, P803, DOI 10.1080/13658810903107464; Li XY, 2010, COMPUT GEOSCI-UK, V36, P1060, DOI 10.1016/j.cageo.2010.03.004; Mighell KJ, 2010, PUBL ASTRON SOC PAC, V122, P1236, DOI 10.1086/656566; National administration of surveying, 2013, SPEC MAK VECT MAP SY; National administration of surveying, 2018, SPEC XML DESCR MAP S; Nordan R.P.V., 2012, NTNU INSTITUTT BYGG; Poplin A, 2015, CARTOGR GEOGR INF SC, V42, P358, DOI 10.1080/15230406.2014.991427; Robinson AC, 2012, ENVIRON PLANN B, V39, P1034, DOI 10.1068/b38026; Roth RE, 2013, J SPAT INT SCI, P59, DOI 10.5311/JOSIS.2013.6.105; Ruas A, 2014, MODERN TRENDS CARTOG, P259; Shang X., 2015, STUDY EFFICIENT VECT; Tan X, 2003, B SURVEYING MAPPING, V1, P11; Wan L, 2016, ISPRS INT J GEO-INF, V5, DOI 10.3390/ijgi5110215; Wang SW, 2013, INT J GEOGR INF SCI, V27, P2122, DOI 10.1080/13658816.2013.776049; Yang CW, 2013, INT J DIGIT EARTH, V6, P297, DOI 10.1080/17538947.2013.769783; Yang CW, 2011, INT J DIGIT EARTH, V4, P305, DOI 10.1080/17538947.2011.587547; Yang CW, 2010, COMPUT ENVIRON URBAN, V34, P264, DOI 10.1016/j.compenvurbsys.2010.04.001; [尹章才 Yin Zhangcai], 2004, [武汉大学学报. 信息科学版, Geomatics and Information Science of Wuhan University], V29, P544; Yu E.G., 2017, 2017 6 INT C AGR, P1; Yue SS, 2016, INT J GEOGR INF SCI, V30, P143, DOI 10.1080/13658816.2015.1077964; Zhang JQ, 2015, CARTOGR GEOGR INF SC, V42, P44, DOI 10.1080/15230406.2014.981586; Zhao HX, 2005, INT J GEOGR INF SCI, V19, P413, DOI 10.1080/1365881051233125120; Zhou C., 2018, IEEE T MOBILE COMPUT, P1; Zhou MY, 2016, INT J DIGIT EARTH, V9, P230, DOI 10.1080/17538947.2015.1016558	41	3	4	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0221075	10.1371/journal.pone.0221075	http://dx.doi.org/10.1371/journal.pone.0221075			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5KK	31415631	Green Submitted, gold, Green Published			2022-12-26	WOS:000485017200067
J	Morgen, CS; Angquist, L; Appleyard, M; Schnohr, P; Jensen, GB; Sorensen, TIA				Morgen, Camilla S.; Angquist, Larsa; Appleyard, Merete; Schnohr, Peter; Jensen, Gorm B.; Sorensen, Thorkild I. A.			Attitudes to and experiences with body weight control and changes in body weight in relation to all-cause mortality in the general population	PLOS ONE			English	Article							STRESS; OBESITY; STIGMA	Background and aims Increased body mass index (BMI = weight/height(2); kg/m(2)) and weight gain is associated with increased mortality, wherefore weight loss and avoided weight gain should be followed by lower mortality. This is achieved in clinical settings, but in the general population weight loss appears associated with increased mortality, possibly related to the struggles with body weight control (BWC). We investigated whether attitudes to and experiences with BWC in combination with recent changes in body weight influenced long-term mortality among normal weight and overweight individuals. Population and methods The study population included 6,740 individuals attending the 3 rd cycle in 1991-94 of the Copenhagen City Heart Study, providing information on BMI, educational level, health behaviours, well-being, weight half-a-year earlier, and answers to four BWC questions about caring for body weight, assumed benefit of weight loss, current and past slimming experiences. Participants reporting previous unintended weight loss (> 4 kg during one year) were excluded. Cox regression models estimated the associations of prior changes in BMI and responses to the BWC questions with approximately 22 years all-cause mortality with age as 'time scale'. Participants with normal weight (BMI <25.0 kg/m(2)) and overweight (BMI >= 25.0 kg/m(2)) were analysed separately, and stratified by gender and educational level, health behaviours and well-being as co-variables. Results Compared with stable weight, weight loss was associated with significantly increased mortality in the normal weight group, but not in the overweight group, and weight gain was not significantly associated with mortality in either group. Participants with normal weight who claimed that it would be good for their health to lose weight or that they were currently trying to lose weight had significantly higher mortality than those denying it. There were no other significant associations with the responses to the BWC questions in either the normal weight or the overweight group. When combining the responses to the BWC questions with the weight changes, using the weight change as either a continuous or categorical variable, there were no significant interaction in their relation to mortality in either the normal weight or the overweight group. Conclusion Attitudes to and experiences with BWC did not notably modify the association of changes in body weight with mortality in either people with normal weight or people with overweight.	[Morgen, Camilla S.; Jensen, Gorm B.; Sorensen, Thorkild I. A.] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Morgen, Camilla S.; Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Publ Hlth, Sect Epidemiol, Copenhagen, Denmark; [Angquist, Larsa; Sorensen, Thorkild I. A.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, Copenhagen, Denmark; [Appleyard, Merete; Schnohr, Peter; Jensen, Gorm B.] Bispebjerg & Frederiksberg Hosp, Copenhagen City Heart Study, Copenhagen, Denmark	University of Southern Denmark; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital	Sorensen, TIA (corresponding author), Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark.; Sorensen, TIA (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Publ Hlth, Sect Epidemiol, Copenhagen, Denmark.; Sorensen, TIA (corresponding author), Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, Copenhagen, Denmark.	tias@sund.ku.dk		Sorensen, Thorkild I.A./0000-0003-4821-430X; Angquist, Lars/0000-0002-9516-4424; Schmidt Morgen, Camilla/0000-0002-4121-2259	Danish Heart Foundation through the Copenhagen City Heart Study; University of Copenhagen's Governing Obesity Program	Danish Heart Foundation through the Copenhagen City Heart Study; University of Copenhagen's Governing Obesity Program	This study was supported by the Danish Heart Foundation through the Copenhagen City Heart Study to GBJ and by the University of Copenhagen's Governing Obesity Program to TIAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 1999, INT J OBESITY, V23, P603, DOI 10.1038/sj.ijo.0800875; Aune D, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2156; Berentzen T, 2006, NUTR REV, V64, P502, DOI [10.1301/nr.2006.nov.502507, 10.1111/j.1753-4887.2006.tb00183.x]; Block JP, 2009, AM J EPIDEMIOL, V170, P181, DOI 10.1093/aje/kwp104; Cardoso L, 2017, DIABETES OBES METAB, V19, P1223, DOI 10.1111/dom.12922; Elfhag K, 2005, OBES REV, V6, P67, DOI 10.1111/j.1467-789X.2005.00170.x; Flegal KM, 2011, AM J EPIDEMIOL, V173, P1, DOI 10.1093/aje/kwq341; Geiker NRW, 2018, OBES REV, V19, P81, DOI 10.1111/obr.12603; Graf CE, 2016, CLIN NUTR, V35, P1499, DOI 10.1016/j.clnu.2016.04.003; Harrington M, 2009, NUTR RES REV, V22, P93, DOI 10.1017/S0954422409990035; Jackson SE, 2016, OBESITY, V24, P2515, DOI 10.1002/oby.21657; Karahalios A, 2017, INT J EPIDEMIOL, V46, P526, DOI 10.1093/ije/dyw246; Kennedy AB, 2018, JAMA-J AM MED ASSOC, V319, P231, DOI 10.1001/jama.2017.21649; Kim YH, 2017, J CLIN ENDOCR METAB, V102, P4041, DOI 10.1210/jc.2017-00787; Korkeila M, 2009, OBESITY FACTS, V2, P344, DOI 10.1159/000261416; Ma CH, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4849; Mikkelsen KL, 1999, EPIDEMIOLOGY, V10, P671, DOI 10.1097/00001648-199911000-00005; Mulligan AA, 2018, EUR J EPIDEMIOL, V33, P37, DOI 10.1007/s10654-017-0343-y; Ostergaard JN, 2010, INT J OBESITY, V34, P760, DOI 10.1038/ijo.2009.274; Puhl R, 2015, CURR OBES REP, V4, P182, DOI 10.1007/s13679-015-0153-z; Razzoli M, 2016, TRENDS ENDOCRIN MET, V27, P504, DOI 10.1016/j.tem.2016.04.007; SCHNOHR P, 2001, EUR HEART J SH, V3; Song MY, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2195; Sorensen TIA, 2005, PLOS MED, V2, P510, DOI 10.1371/journal.pmed.0020171; Tomiyama AJ, 2014, APPETITE, V82, P8, DOI 10.1016/j.appet.2014.06.108; Trief PM, 2014, OBESITY, V22, P2532, DOI 10.1002/oby.20916; 1989, SCAND J SOC MED S, V41, P1	27	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220838	10.1371/journal.pone.0220838	http://dx.doi.org/10.1371/journal.pone.0220838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415614	Green Published, Green Submitted, gold			2022-12-26	WOS:000485017200038
J	Lewis, DJ; Dundas, SJ; Kling, DM; Lew, DK; Hacker, SD				Lewis, David J.; Dundas, Steven J.; Kling, David M.; Lew, Daniel K.; Hacker, Sally D.			The non-market benefits of early and partial gains in managing threatened salmon	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; ECOSYSTEM SERVICES; CHEAP TALK; OPTIMAL PROVISION	Threatened species are increasingly dependent on conservation investments for persistence and recovery. Information that resource managers could use to evaluate investments such as the public benefits arising from alternative conservation designs is typically scarce because conservation benefits arise outside of conventional markets. Moreover, existing studies that measure the public benefits of conserving threatened species often do not measure the benefits from partial gains in species abundance that fall short of official recovery, or the benefits from achieving gains in species abundance that happen earlier in time. We report on a stated preference choice experiment designed to quantify the non-market benefits for conservation investments aimed at threatened Pacific Coho salmon (Oncorhynchus kisutch) along the Oregon Coast (OC). Our results show that a program aimed at increasing numbers of returning salmon can generate sizable benefits of up to $518 million/y for an extra 100,000 returning fish, even if the species is not officially declared recovered. Moreover, while conservation investment strategies expected to achieve relatively rapid results are likely to have higher up-front costs, our results show that the public attaches substantial additional value of up to $277 million/y for achieving conservation goals quickly. Our results and approach can be used to price natural capital investments that lead to gains in returning salmon, and as inputs to evaluations of the benefits and costs from alternative conservation strategies.	[Lewis, David J.; Dundas, Steven J.; Kling, David M.] Oregon State Univ, Dept Appl Econ, Corvallis, OR 97331 USA; [Dundas, Steven J.] Oregon State Univ, Coastal Oregon Marine Expt Stn, Newport, OR USA; [Lew, Daniel K.] NOAA, Alaska Fisheries Sci Ctr, Seattle, WA USA; [Hacker, Sally D.] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA; Oregon State University	Lewis, DJ (corresponding author), Oregon State Univ, Dept Appl Econ, Corvallis, OR 97331 USA.	lewisda@oregonstate.edu	Lew, Daniel K./AAL-3013-2021; Lewis, David/AAH-4137-2022; Lewis, David/AFQ-9010-2022; Lewis, David J/I-5700-2013; Dundas, Steven/AAV-9779-2020	Lewis, David/0000-0002-2161-4189; Lewis, David/0000-0002-2161-4189; Lewis, David J/0000-0002-2161-4189; Dundas, Steven/0000-0003-3000-3395; Lew, Daniel/0000-0002-3394-138X	NOAA, National Centers for Coastal Ocean Science Competitive Research Program [NM 10AR4320091A, NA160AR4320152]	NOAA, National Centers for Coastal Ocean Science Competitive Research Program	DJL, SJD, DMK, and SDH were funded by NOAA, National Centers for Coastal Ocean Science Competitive Research Program through NOAA Cooperative Institutes Program award numbers NM 10AR4320091A and NA160AR4320152 to Oregon State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, REV ENV ECON POLICY; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bateman IJ, 2013, SCIENCE, V341, P45, DOI 10.1126/science.1234379; Bertram C, 2017, ENVIRON RESOUR ECON, V67, P321, DOI 10.1007/s10640-015-9988-8; Brown GM, 2000, J ECON LIT, V38, P875, DOI 10.1257/jel.38.4.875; Cameron TA, 2013, J ENVIRON ECON MANAG, V65, P87, DOI 10.1016/j.jeem.2012.05.008; Carlsson F, 2005, ECON LETT, V89, P147, DOI 10.1016/j.econlet.2005.03.010; Carson RT, 2019, J ENVIRON ECON MANAG, V95, P57, DOI 10.1016/j.jeem.2019.03.003; Cummings RG, 1999, AM ECON REV, V89, P649, DOI 10.1257/aer.89.3.649; Dillman D.A., 2014, TAILORED DESIGN METH; Duke JM, 2013, J ENVIRON MANAGE, V125, P126, DOI 10.1016/j.jenvman.2013.03.048; Fenichel EP, 2016, P NATL ACAD SCI USA, V113, P2382, DOI 10.1073/pnas.1513779113; Fenichel EP, 2014, J ASSOC ENVIRON RESO, V1, P1, DOI 10.1086/676034; Freeman III A. M., 2003, MEASUREMENT ENV RESO; Guerry AD, 2015, P NATL ACAD SCI USA, V112, P7348, DOI 10.1073/pnas.1503751112; Huang L, 2014, AM ECON REV, V104, P4071, DOI 10.1257/aer.104.12.4071; Huber J, 1996, J MARKETING RES, V33, P307, DOI 10.2307/3152127; Johnston RJ, 2017, J ASSOC ENVIRON RESO, V4, P319, DOI 10.1086/691697; Kellner JB, 2011, CONSERV LETT, V4, P21, DOI 10.1111/j.1755-263X.2010.00132.x; Kling DM, 2016, J ASSOC ENVIRON RESO, V3, P1023, DOI 10.1086/688498; Kolstoe S, 2017, ECOL ECON, V137, P1, DOI 10.1016/j.ecolecon.2017.02.013; Krutilla JV, 1967, AM ECON REV, V57, P777; Langpap C, 2010, AM J AGR ECON, V92, P110, DOI 10.1093/ajae/aap001; Lew DK, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00096; Lewis DJ, 2018, J ENVIRON ECON MANAG, V92, P20, DOI 10.1016/j.jeem.2018.08.014; LOOMIS JB, 1987, LAND ECON, V63, P396, DOI 10.2307/3146296; Lusk JL, 2003, AM J AGR ECON, V85, P840, DOI 10.1111/1467-8276.00492; Murphy JJ, 2005, ENVIRON RESOUR ECON, V30, P327, DOI 10.1007/s10640-004-4224-y; NMFS (National Marine Fisheries Service), 2016, REC PLAN OR COAST CO; ODFW (Oregon Department of Fish and Wildlife), 2007, OR COAST COH CONS PL; Polasky S, 2015, ANNU REV ENV RESOUR, V40, P445, DOI 10.1146/annurev-environ-101813-013253; Polasky S, 2014, P NATL ACAD SCI USA, V111, P6248, DOI 10.1073/pnas.1404484111; Polasky S, 2011, ENVIRON RESOUR ECON, V48, P219, DOI 10.1007/s10640-010-9407-0; Richardson L, 2009, ECOL ECON, V68, P1535, DOI 10.1016/j.ecolecon.2008.10.016; Ruckelshaus M, 2015, ECOL ECON, V115, P11, DOI 10.1016/j.ecolecon.2013.07.009; Street D. J., 2007, CONSTRUCTION OPTIMAL; Train KE, 2009, DISCRETE CHOICE METHODS WITH SIMULATION, 2ND EDITION, P1, DOI 10.1017/CBO9780511805271; United States Department of the Interior, 2018, END THREAT WILDL PLA; Yin XY, 2003, ANN BOT-LONDON, V91, P361, DOI 10.1093/aob/mcg029	39	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0220260	10.1371/journal.pone.0220260	http://dx.doi.org/10.1371/journal.pone.0220260			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5IT	31412046	Green Published, gold, Green Submitted			2022-12-26	WOS:000485012600023
J	Odgerel, Z; Sonti, S; Hernandez, N; Park, J; Ottman, R; Louis, ED; Clark, LN				Odgerel, Zagaa; Sonti, Shilpa; Hernandez, Nora; Park, Jemin; Ottman, Ruth; Louis, Elan D.; Clark, Lorraine N.			Whole genome sequencing and rare variant analysis in essential tremor families	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTIONS; CANDIDATE GENES; AXON GUIDANCE; IDENTIFICATION; MUTATION; LINKAGE; AGE; CONTRIBUTES; ASSOCIATION; FRAMEWORK	Essential tremor (ET) is one of the most common movement disorders. The etiology of ET remains largely unexplained. Whole genome sequencing (WGS) is likely to be of value in understanding a large proportion of ET with Mendelian and complex disease inheritance patterns. In ET families with Mendelian inheritance patterns, WGS may lead to gene identification where WES analysis failed to identify the causative single nucleotide variant (SNV) or indel due to incomplete coverage of the entire coding region of the genome, in addition to accurate detection of larger structural variants (SVs) and copy number variants (CNVs). Alternatively, in ET families with complex disease inheritance patterns with gene x gene and gene x environment interactions enrichment of functional rare coding and non-coding variants may explain the heritability of ET. We performed WGS in eight ET families (n = 40 individuals) enrolled in the Family Study of Essential Tremor. The analysis included filtering WGS data based on allele frequency in population databases, rare SNV and indel classification and association testing using the Mixed-Model Kernel Based Adaptive Cluster (MM-KBAC) test. A separate analysis of rare SV and CNVs segregating within ET families was also performed. Prioritization of candidate genes identified within families was performed using phenolyzer. WGS analysis identified candidate genes for ET in 5/8 (62.5%) of the families analyzed. WES analysis in a subset of these families in our previously published study failed to identify candidate genes. In one family, we identified a deleterious and damaging variant (c.1367G>A, p.(Arg456Gln)) in the candidate gene, CAC-NA1G, which encodes the pore forming subunit of T-type Ca(2+) channels, Ca(V)3.1, and is expressed in various motor pathways and has been previously implicated in neuronal autorhythmicity and ET. Other candidate genes identified include SLIT3 which encodes an axon guidance molecule and in three families, phenolyzer prioritized genes that are associated with hereditary neuropathies (family A, KARS, family B, KIF5A and family F, NTRK1). Functional studies of CACNA1G and SLIT3 suggest a role for these genes in ET disease pathogenesis.	[Odgerel, Zagaa; Sonti, Shilpa; Clark, Lorraine N.] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Hernandez, Nora; Park, Jemin; Louis, Elan D.] Yale Univ, Yale Sch Med, Dept Neurol, New Haven, CT USA; [Ottman, Ruth] Columbia Univ, GH Sergievsky Ctr, New York, NY USA; [Ottman, Ruth] Columbia Univ, Dept Neurol, Coll Phys & Surg, New York, NY USA; [Ottman, Ruth] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Ottman, Ruth] New York State Psychiat Inst & Hosp, Div Epidemiol, New York, NY 10032 USA; [Louis, Elan D.] Yale Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT USA; [Clark, Lorraine N.] Columbia Univ, Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA	Columbia University; Yale University; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; Yale University; Columbia University	Clark, LN (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10027 USA.; Clark, LN (corresponding author), Columbia Univ, Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA.	lc654@cumc.columbia.edu	Sonti, Shilpa/AAI-4841-2021	Sonti, Shilpa/0000-0001-8804-3010; Ottman, Ruth/0000-0001-7074-242X	National Institutes of Health [NIH R01 NS073872]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health, NIH R01 NS073872 (LNC and EDL). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alakbarzade V, 2019, NEUROL-GENET, V5, DOI 10.1212/NXG.0000000000000307; BAIN PG, 1994, BRAIN, V117, P805, DOI 10.1093/brain/117.4.805; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Belkadi A, 2015, P NATL ACAD SCI USA, V112, P5473, DOI 10.1073/pnas.1418631112; Bergareche A, 2015, HUM MOL GENET, V24, P7111, DOI 10.1093/hmg/ddv410; Bhatia KP, 2018, MOVEMENT DISORD, V33, P75, DOI 10.1002/mds.27121; Calhoun JD, 2016, EPILEPSIA, V57, pE103, DOI 10.1111/epi.13390; Carr L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172736; Choe M, 2016, MOVEMENT DISORD, V31, P393, DOI 10.1002/mds.26490; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Coutelier M, 2015, AM J HUM GENET, V97, P726, DOI 10.1016/j.ajhg.2015.09.007; Crimella C, 2012, CLIN GENET, V82, P157, DOI 10.1111/j.1399-0004.2011.01717.x; Deuschl G, 1998, MOVEMENT DISORD, V13, P2, DOI 10.1002/mds.870131303; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Filip P, 2016, CEREBELLUM, V15, P774, DOI 10.1007/s12311-015-0740-2; Findley LJ, 2000, NEUROLOGY, V54, pS8; GANETZKY B, 1978, EXP GERONTOL, V13, P189, DOI 10.1016/0531-5565(78)90012-8; Gonzalez-Alegre P, 2014, TREMOR OTHER HYPERK, V4, DOI 10.7916/D8FB51G3; Gulcher JR, 1997, NAT GENET, V17, P84, DOI 10.1038/ng0997-84; Handforth A, 2012, TREMOR OTHER HYPERK, V2; Hicks JE, 2016, MOVEMENT DISORD, V31, P1059, DOI 10.1002/mds.26582; Higgins JJ, 1997, MOVEMENT DISORD, V12, P859, DOI 10.1002/mds.870120605; Hor H, 2015, HUM MOL GENET, V24, P5677, DOI 10.1093/hmg/ddv281; Hu H, 2014, NAT BIOTECHNOL, V32, P663, DOI 10.1038/nbt.2895; Kim CH, 2015, BRAIN RES, V1622, P204, DOI 10.1016/j.brainres.2015.06.015; Kimura M., 1983, NEUTRAL THEORY MOL E; Kimura M, 2017, J HUM GENET, V62, P857, DOI 10.1038/jhg.2017.51; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Laird NM, 2006, NAT REV GENET, V7, P385, DOI 10.1038/nrg1839; LEBOURG E, 1992, GERONTOLOGY, V38, P59; Leng XR, 2017, J HUM GENET, V62, P641, DOI 10.1038/jhg.2017.21; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin L, 2009, TRENDS NEUROSCI, V32, P142, DOI 10.1016/j.tins.2008.11.006; Linford NJ, 2013, JOVE-J VIS EXP, DOI 10.3791/50068; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Liu XM, 2016, EUR J HUM GENET, V24, P1009, DOI 10.1038/ejhg.2015.228; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Lorenz D, 2004, NEUROLOGY, V62, P208, DOI 10.1212/01.WNL.0000103236.26934.41; Louis ED, 1997, NEUROEPIDEMIOLOGY, V16, P124, DOI 10.1159/000109681; Louis ED, 2007, NEUROEPIDEMIOLOGY, V29, P208, DOI 10.1159/000111584; Louis ED, 2010, MOVEMENT DISORD, V25, P534, DOI 10.1002/mds.22838; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; McLaughlin HM, 2010, AM J HUM GENET, V87, P560, DOI 10.1016/j.ajhg.2010.09.008; Meienberg J, 2016, HUM GENET, V135, P359, DOI 10.1007/s00439-015-1631-9; Meienberg J, 2015, NUCLEIC ACIDS RES, V43, pE76, DOI 10.1093/nar/gkv216; Merner ND, 2012, AM J HUM GENET, V91, P313, DOI 10.1016/j.ajhg.2012.07.002; Monteil A, 2015, J BIOL CHEM, V290, P16168, DOI 10.1074/jbc.M114.634261; Morino H, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0180-4; Park YG, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0093-2; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Peterson LG, 2014, ANN M AM SOC HUM GEN; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Saifee TA, 2013, J NEUROL NEUROSUR PS, V84, P1282, DOI 10.1136/jnnp-2012-303013; Sanchez Elena, 2015, ASN Neuro, V7, DOI 10.1177/1759091415598290; Sarnthein J, 2007, J NEUROSCI, V27, P124, DOI 10.1523/JNEUROSCI.2411-06.2007; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shatunov A, 2006, BRAIN, V129, P2318, DOI 10.1093/brain/awl120; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Sinha S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-129; SINTON CM, 1989, PFLUG ARCH EUR J PHY, V414, P31, DOI 10.1007/BF00585623; Tanner CM, 2001, NEUROLOGY, V57, P1389, DOI 10.1212/WNL.57.8.1389; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Trost B, 2018, AM J HUM GENET, V102, P142, DOI 10.1016/j.ajhg.2017.12.007; Ueda A, 2006, J NEUROSCI, V26, P6238, DOI 10.1523/JNEUROSCI.0862-06.2006; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Yang H, 2015, NAT METHODS, V12, P841, DOI [10.1038/NMETH.3484, 10.1038/nmeth.3484]	72	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220512	10.1371/journal.pone.0220512	http://dx.doi.org/10.1371/journal.pone.0220512			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404076	Green Published, Green Submitted, gold			2022-12-26	WOS:000485006800015
J	Huang, YS; Xu, DC; Kan, JM; Li, WB				Huang, Yongsheng; Xu, Daochun; Kan, Jiangming; Li, Wenbin			Study on field experiments of forest soil thermoelectric power generation devices	PLOS ONE			English	Article							WASTE HEAT; ELECTRICITY; ENERGY; PERFORMANCE; STOVE	As a new strategy to power forest wireless sensors in remote areas, an environmental microenergy collection device has been improved, and field experiments were carried out under natural conditions for the first time. The thermoelectric power generation devices used a gravity-assisted heat pipe to transmit heat from shallow soil to ground level, and a thermoelectric generator (TEG) was employed to generate electric power from the temperature difference between soil and air. Over the 6-month experimental period at two natural sites, approximately 128.74 J of energy could be harvested in a single day, and 5 209.92 J of energy could be harvested in a generation cycle. The results showed the feasibility of using this green energy to power wireless sensors in remote forests or other environments, This work is relevant to the current acute energy shortages and environmental pollution problems.	[Huang, Yongsheng; Xu, Daochun; Kan, Jiangming; Li, Wenbin] Beijing Forestry Univ, Sch Technol, Key Lab State Forestry Adm Forestry Equipment & A, Beijing, Peoples R China; [Huang, Yongsheng] Chinese Acad Sci, Inst High Energy Phys, Beijing, Peoples R China	Beijing Forestry University; Chinese Academy of Sciences; Institute of High Energy Physics, CAS	Li, WB (corresponding author), Beijing Forestry Univ, Sch Technol, Key Lab State Forestry Adm Forestry Equipment & A, Beijing, Peoples R China.	leewb@bjfu.edu.cn			National Natural Science Foundation of China [31670716]; China Postdoctoral Science Special Foundation [2016T90044]; China Postdoctoral Science Foundation [2015M570945]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Special Foundation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	Thsi work was supported by the National Natural Science Foundation of China(31670716)-No to WL; the China Postdoctoral Science Special Foundation (2016T90044)-No to DX and China Postdoctoral Science Foundation (2015M570945)-No to DX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouhacina B, 2015, APPL THERM ENG, V79, P153, DOI 10.1016/j.applthermaleng.2015.01.027; Chen J, 2016, IEEE T NUCL SCI, V63, P2738, DOI 10.1109/TNS.2016.2606090; Chiwaki N, 2018, J MICROMECH MICROENG, V28, P1; Ga LaTai, 2018, Journal of Forestry Engineering, V3, P136; Hao ZB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136639; Huang Y, J FOREST ENV, V38, P84; Jang JY, 2013, APPL THERM ENG, V51, P677, DOI 10.1016/j.applthermaleng.2012.10.024; Lawrence EE, 2002, XXI INTERNATIONAL CONFERENCE ON THERMOELECTRICS, PROCEEDINGS ICT '02, P446, DOI 10.1109/ICT.2002.1190357; Liu TJ, 2017, J ELECTRON MATER, V46, P3137, DOI 10.1007/s11664-016-5223-9; Lopez-Lapena O, 2018, IEEE T IND ELECTRON, V65, P9668, DOI 10.1109/TIE.2018.2821622; Luo X, 2018, IEEE T IND INFORM, V14, P4963, DOI 10.1109/TII.2018.2854549; Maixner MR, 2009, ENERG CONVERS MANAGE, V50, P2361, DOI 10.1016/j.enconman.2009.05.019; Najjar YSH, 2017, RENEW SUST ENERG REV, V69, P854, DOI 10.1016/j.rser.2016.07.041; Nie BC, 2018, RENEW ENERG, V128, P391, DOI 10.1016/j.renene.2018.05.081; Nuwayhid RY, 2005, ENERG CONVERS MANAGE, V46, P1631, DOI 10.1016/j.enconman.2004.07.006; Nuwayhid RY, 2003, RENEW ENERG, V28, P205, DOI 10.1016/S0960-1481(02)00024-1; Orr B, 2017, APPL THERM ENG, V126, P1185, DOI 10.1016/j.applthermaleng.2016.11.019; Qi D, 2016, APPL THERM ENG, V106, P1023, DOI 10.1016/j.applthermaleng.2016.06.048; Remeli MF, 2015, ENERG CONVERS MANAGE, V91, P110, DOI 10.1016/j.enconman.2014.12.001; Stevens JW, 2013, ENERG CONVERS MANAGE, V68, P114, DOI 10.1016/j.enconman.2012.12.029; Thielen M, 2017, ENERG CONVERS MANAGE, V131, P44, DOI 10.1016/j.enconman.2016.11.005; TYRRELL HJV, 1956, NATURE, V177, P668, DOI 10.1038/177668b0; Wang N., 2017, ACTA TECH CSAV CESKO, V6, P1; Zhang Z, 2016, ENERG CONVERS MANAGE, V127, P301, DOI 10.1016/j.enconman.2016.09.023; Zhang Z, 2015, ENERG CONVERS MANAGE, V97, P178, DOI 10.1016/j.enconman.2015.03.060; Zou SG, 2018, SCI TOTAL ENVIRON, V635, P1215, DOI 10.1016/j.scitotenv.2018.04.201	26	17	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0221019	10.1371/journal.pone.0221019	http://dx.doi.org/10.1371/journal.pone.0221019			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398217	gold, Green Submitted, Green Published			2022-12-26	WOS:000485004000041
J	Cornejo, A; Tonin, AM; Checa, B; Tunon, AR; Perez, D; Coronado, E; Gonzalez, S; Rios, T; Macchi, P; Correa-Araneda, F; Boyero, L				Cornejo, Aydee; Tonin, Alan M.; Checa, Brenda; Tunon, Ana Raquel; Perez, Diana; Coronado, Enilda; Gonzalez, Stefani; Rios, Tomas; Macchi, Pablo; Correa-Araneda, Francisco; Boyero, Luz			Effects of multiple stressors associated with agriculture on stream macroinvertebrate communities in a tropical catchment	PLOS ONE			English	Article							INVERTEBRATE COMMUNITIES; WATER-QUALITY; NUTRIENT ENRICHMENT; SAMPLING METHODS; RAIN-FOREST; PESTICIDES; RIVER; DEFORESTATION; ECOSYSTEMS; POLLUTION	Tropical forests are declining at unprecedented rates in favour of agriculture, and streams can be severely impacted due to effects of multiple stressors that have rarely been considered together in tropical studies. We studied the effects of multiple stressors associated with agricultural practices (pesticide toxicity, nutrient enrichment and habitat alteration-quantified as TUmax, soluble reactive phosphorus concentration and sedimentation, respectively) on macroinvertebrate communities in a tropical catchment in Panama (13 stream sites sampled in 20 occasions from 2015 to 2017, with 260 samples in total). We examined how macroinvertebrate abundance, taxonomic richness, community composition and biotic indices (SPEAR and BMWP/PAN, which were specifically designed to detect pesticide toxicity and nutrient enrichment, respectively) varied depending on the studied stressors, considering their single and combined effects. Our analyses revealed significant effects of the studied stressors on macroinvertebrate communities, with two particular results that merit further attention: (1) the fact that pesticide toxicity affected BMWP/PAN, but not SPEAR, possibly because the former had been adapted for local fauna; and (2) that most stressors showed antagonistic interactions (i.e., lower combined effects than expected from their individual effects). These results highlight the need for toxicity bioassays with tropical species that allow adaptations of biotic indices, and of observational and manipulative studies exploring the combined effects of multiple stressors on tropical macroinvertebrate communities and ecosystems, in order to predict and manage future anthropogenic impacts on tropical streams.	[Cornejo, Aydee] Gorgas Mem Inst Hlth Studies COZEM ICGES, Zool Collect Dr Eustorgio Mendez, Freshwater Macroinvertebrate Lab, Panama City, Panama; [Cornejo, Aydee] Univ Panama, Doctoral Program Nat Sci Emphasis Entomol, Panama City, Panama; [Tonin, Alan M.] Univ Brasilia, IB, Dept Ecol, Brasilia, DF, Brazil; [Checa, Brenda; Coronado, Enilda; Gonzalez, Stefani] Agr Dev Minist MIDA, Plant Hlth Lab, Panama City, Panama; [Tunon, Ana Raquel] Minist Environm, Environm Qual Lab, Panama City, Panama; [Perez, Diana] Aquat Resources Author Panama ARAP, Pacific Mariculture Stn, Panama City, Panama; [Rios, Tomas] Autonomous Univ Chiriqui, Museum Freshwater Fish & Invertebrates, David, Panama; [Macchi, Pablo] Natl Univ Rio Negro, CONICET, Res Inst Paleobiol & Geol, Rio Negro, Argentina; [Macchi, Pablo] Natl Univ Comahue, CONICET, Ctr Res Environm Toxicol & Agrobiotechnol Comahue, Buenos Aires, DF, Argentina; [Correa-Araneda, Francisco] Univ Autonoma Chile, Fac Arquitectura & Construcc, IEH, Unidad Cambio Climat & Medio Ambiente, Temuco, Chile; [Boyero, Luz] Univ Basque Country, UPV EHU, Fac Sci & Technol, Dept Plant Biol & Ecol, Leioa, Spain; [Boyero, Luz] Ikerbasque, Bilbao, Spain	Universidad de Panama; Universidade de Brasilia; Universidad Autonoma de Chiriqui; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; Universidad Autonoma de Chile; University of Basque Country	Cornejo, A (corresponding author), Gorgas Mem Inst Hlth Studies COZEM ICGES, Zool Collect Dr Eustorgio Mendez, Freshwater Macroinvertebrate Lab, Panama City, Panama.; Cornejo, A (corresponding author), Univ Panama, Doctoral Program Nat Sci Emphasis Entomol, Panama City, Panama.	acornejo@gorgas.gob.pa	Macchi, Pablo/AAN-2694-2020; Cornejo, Aydeé/ACU-1078-2022; Tonin, Alan M./J-4575-2014	Macchi, Pablo/0000-0002-1930-0041; Cornejo, Aydeé/0000-0001-6789-5847; Tonin, Alan M./0000-0002-8463-8823; Rios, Tomas/0000-0003-0590-6488; Correa, Francisco Javier/0000-0001-6670-6661	ARCAL project [RLA7019]; International Atomic Energy Agency (IAEA); National Secretariat of Science, Technology and Innovation (SENACYT); National Research System of Panama (SNI)	ARCAL project; International Atomic Energy Agency (IAEA)(International Atomic Energy Agency); National Secretariat of Science, Technology and Innovation (SENACYT); National Research System of Panama (SNI)	This study was part of AC's PhD thesis and TR's MSc thesis, both supported by the ARCAL RLA7019 project led by the MIDA and funded by the International Atomic Energy Agency (IAEA). AC and TR were supported by fellowships of the National Secretariat of Science, Technology and Innovation (SENACYT), and AC was supported as member of the National Research System of Panama (SNI).	ANAM, 2006, INF MON CAL AG CUENC; ANAM CATIE, 2014, PLAN MAN CUENC RIO C; [Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], NLME LINEAR NONLINEA; ARMITAGE PD, 1983, WATER RES, V17, P333, DOI 10.1016/0043-1354(83)90188-4; Barbour M.T., 1999, RAPID BIOASSESSMENT, V339; Beketov MA, 2009, ENVIRON POLLUT, V157, P1841, DOI 10.1016/j.envpol.2009.01.021; Berenzen N, 2005, ECOTOX ENVIRON SAFE, V60, P37, DOI 10.1016/j.ecoenv.2003.10.010; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Boulton AJ, 2008, AQUAT ECOL-SAN DIEGO, P257, DOI 10.1016/B978-012088449-0.50011-X; Castillo LE, 1997, ENVIRON TOXICOL CHEM, V16, P41, DOI [10.1002/etc.5620160104, 10.1897/1551-5028(1997)016&lt;0041:EAPITA&gt;2.3.CO;2]; Castillo LE, 2006, SCI TOTAL ENVIRON, V367, P418, DOI 10.1016/j.scitotenv.2006.02.052; Connolly NM, 2013, HYDROBIOLOGIA, V718, P85, DOI 10.1007/s10750-013-1605-7; Connolly NM, 2007, HYDROBIOLOGIA, V592, P423, DOI 10.1007/s10750-007-0774-7; Connolly NM, 2004, J N AM BENTHOL SOC, V23, P251, DOI 10.1899/0887-3593(2004)023&lt;0251:EOLDOO&gt;2.0.CO;2; Cornejo A, 2017, DIAGNOSTICO CONDICIO; Cote IM, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2592; De Romedi A, 2011, REV SALUD PUBLICA-CO, V15, P27; Deknock A, 2019, SCI TOTAL ENVIRON, V646, P996, DOI 10.1016/j.scitotenv.2018.07.185; ETESA, 2008, RES TECN AN REG CREC; Gessner MO, 2002, ECOL APPL, V12, P498, DOI 10.1890/1051-0761(2002)012[0498:ACFULB]2.0.CO;2; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Graeber D, 2015, SCI REP-UK, V5, DOI 10.1038/srep16328; Gutierrez-Fonseca PE, 2010, FORMULACION GUIA MET; Hanson P, 2010, REV BIOL TROP, V58, P3; Hawkes HA, 1998, WATER RES, V32, P964, DOI 10.1016/S0043-1354(97)00275-3; Heartsill-Scalley T, 2003, ECOL APPL, V13, P225, DOI 10.1890/1051-0761(2003)013[0225:RVASCI]2.0.CO;2; Hunt L, 2017, SCI TOTAL ENVIRON, V580, P699, DOI 10.1016/j.scitotenv.2016.12.016; Iwata T, 2003, ECOL APPL, V13, P461, DOI 10.1890/1051-0761(2003)013[0461:IOPRDO]2.0.CO;2; Laurance WF, 2014, TRENDS ECOL EVOL, V29, P107, DOI 10.1016/j.tree.2013.12.001; Legendre P., 2012, NUMERICAL ECOLOGY; Liess M, 2005, ENVIRON TOXICOL CHEM, V24, P954, DOI 10.1897/03-652.1; Liess M, 2008, SCI TOTAL ENVIRON, V406, P484, DOI 10.1016/j.scitotenv.2008.05.054; Lorion CM, 2009, FRESHWATER BIOL, V54, P165, DOI 10.1111/j.1365-2427.2008.02092.x; Matthaei CD, 2010, J APPL ECOL, V47, P639, DOI 10.1111/j.1365-2664.2010.01809.x; Menjivar Rosa R.A., 2010, FORMULACION GUIA MET; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Ormerod SJ, 2010, FRESHWATER BIOL, V55, P1, DOI 10.1111/j.1365-2427.2009.02395.x; Pacheco-Chaves B., 2010, FORMULACION GUIA MET; Pearson RG, 2000, FRESHWATER BIOL, V43, P31, DOI 10.1046/j.1365-2427.2000.00504.x; PETERSON DR, 1994, CHEMOSPHERE, V29, P2493, DOI 10.1016/0045-6535(94)90052-3; Phalan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051759; Rasmussen JJ, 2016, SCI TOTAL ENVIRON, V542, P12, DOI 10.1016/j.scitotenv.2015.10.062; Reemtsma T, 2013, J CHROMATOGR A, V1271, P95, DOI 10.1016/j.chroma.2012.11.023; Rice E.W., 2012, STANDARD METHODS EXA; Ruiz-Picos RA, 2017, INT J ENVIRON SCI TE, V14, P1835, DOI 10.1007/s13762-017-1299-x; Schafer RB, 2013, ENVIRON SCI TECHNOL, V47, P7996, DOI 10.1021/es4014954; Schafer RB, 2012, ENVIRON SCI TECHNOL, V46, P5134, DOI 10.1021/es2039882; Schafer RB, 2011, ENVIRON SCI TECHNOL, V45, P1665, DOI 10.1021/es103227q; Schafer RB, 2007, SCI TOTAL ENVIRON, V382, P272, DOI 10.1016/j.scitotenv.2007.04.040; Stein H, 2008, ECOL ENG, V34, P267, DOI 10.1016/j.ecoleng.2007.06.010; Suga CM, 2013, HYDROBIOLOGIA, V703, P203, DOI 10.1007/s10750-012-1360-1; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Townsend CR, 2008, J APPL ECOL, V45, P1810, DOI 10.1111/j.1365-2664.2008.01548.x; Van den Berg SJP, 2019, ENVIRON SCI TECHNOL, V53, P6025, DOI 10.1021/acs.est.9b00893; Vega MJ, 2012, HUMANITATES, V1, P94; von Schiller D, 2017, SCI TOTAL ENVIRON, V596, P465, DOI 10.1016/j.scitotenv.2017.04.081; Woodward G, 2012, SCIENCE, V336, P1438, DOI 10.1126/science.1219534; Yule CM, 2010, MAR FRESHWATER RES, V61, P204, DOI 10.1071/MF09065; ZAMORAMUNOZ C, 1995, WATER RES, V29, P285, DOI 10.1016/0043-1354(94)E0125-P; Zuur Alain F., 2009, P1	62	21	21	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220528	10.1371/journal.pone.0220528	http://dx.doi.org/10.1371/journal.pone.0220528			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393898	Green Submitted, Green Published, gold			2022-12-26	WOS:000485002500036
J	Schwartz, AJ; Converso-Baran, K; Michele, DE; Shah, YM				Schwartz, Andrew J.; Converso-Baran, Kimber; Michele, Daniel E.; Shah, Yatrik M.			A genetic mouse model of severe iron deficiency anemia reveals tissue-specific transcriptional stress responses and cardiac remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						iron metabolism; hypoxia; hypoxia-inducible factor (HIF); animal model; iron	TRANSFERRIN RECEPTOR; HYPOXIA; ERYTHROPOIESIS; CARDIOMYOPATHY; HIF-2-ALPHA; FERROPORTIN; HOMEOSTASIS; OXYGEN	Iron is a micronutrient fundamental for life. Iron homeostasis in mammals requires sustained postnatal intestinal iron absorption that maintains intracellular iron concentrations for central and systemic metabolism as well as for erythropoiesis and oxygen transport. More than 1 billion people worldwide suffer from iron deficiency anemia (IDA), a state of systemic iron insufficiency that limits the production of red blood cells and leads to tissue hypoxia and intracellular iron stress. Despite this tremendous public health concern, very few genetic models of IDA are available to study its progression. Here we developed and characterized a novel genetic mouse model of IDA. We found that tamoxifen-inducible deletion of the mammalian iron exporter ferroportin exclusively in intestinal epithelial cells leads to loss of intestinal iron absorption. Ferroportin ablation yielded a robust phenotype of progressive IDA that develops in as little as 3 months following disruption of intestinal iron absorption. We noted that, at end-stage IDA, tissue-specific transcriptional stress responses occur in which the heart shows little to no hypoxic and iron stress compared with other peripheral organs. However, morphometric and echocardiographic analysis revealed massive cardiac hypertrophy and chamber dilation, albeit with increased cardiac output at very low basal heart rates. We propose that our intestine-specific ferroportin knockout mouse model of end-stage IDA could be used in future studies to investigate IDA progression and cell-specific responses to hypoxic and iron stress.	[Schwartz, Andrew J.; Converso-Baran, Kimber; Michele, Daniel E.; Shah, Yatrik M.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Schwartz, Andrew J.; Converso-Baran, Kimber; Michele, Daniel E.; Shah, Yatrik M.] Univ Michigan, Internal Med, Ann Arbor, MI 48109 USA; [Michele, Daniel E.] Univ Michigan, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Shah, Yatrik M.] Univ Michigan, Div Gastroenterol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Shah, YM (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.; Shah, YM (corresponding author), Univ Michigan, Internal Med, Ann Arbor, MI 48109 USA.; Shah, YM (corresponding author), Univ Michigan, Div Gastroenterol, Ann Arbor, MI 48109 USA.	shahy@umich.edu			NCI, National Institutes of Health [R01CA148828]; NIDDK, National Institutes of Health [R01DK095201, F31DK116555]; NATIONAL CANCER INSTITUTE [R01CA148828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK116555, R01DK095201] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NCI, National Institutes of Health Grant R01CA148828 (to Y. M. S.) and NIDDK, National Institutes of Health Grants R01DK095201 (to Y. M. S.) and F31DK116555 (to A. J. S). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adelsperger AR, 2016, JOVE-J VIS EXP, DOI 10.3791/54436; Anderson ER, 2011, J BIOL CHEM, V286, P19533, DOI 10.1074/jbc.M111.238667; Anderson SA, 2013, CELL METAB, V17, P282, DOI 10.1016/j.cmet.2013.01.007; Bakeer N, 2016, P NATL ACAD SCI USA, V113, pE5182, DOI 10.1073/pnas.1600311113; Camaschella C, 2015, NEW ENGL J MED, V372, P1832, DOI 10.1056/NEJMra1401038; Chen AC, 2015, P NATL ACAD SCI USA, V112, P11714, DOI 10.1073/pnas.1511701112; Chung YJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125618; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Drakesmith H, 2015, CELL METAB, V22, P777, DOI 10.1016/j.cmet.2015.09.006; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Guo SL, 2013, J CLIN INVEST, V123, P1531, DOI 10.1172/JCI66969; Hayashi R, 1999, PEDIATR INT, V41, P13, DOI 10.1046/j.1442-200x.1999.01013.x; Heeney MM, 2014, HEMATOL ONCOL CLIN N, V28, P637, DOI 10.1016/j.hoc.2014.04.009; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Lakhal-Littleton S, 2016, ELIFE, V5, DOI 10.7554/eLife.19804; Loeven AM, 2018, J APPL PHYSIOL, V125, P1749, DOI 10.1152/japplphysiol.00640.2018; Ma XY, 2019, J BIOL CHEM, V294, P3974, DOI 10.1074/jbc.RA118.005549; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Muckenthaler MU, 2017, CELL, V168, P344, DOI 10.1016/j.cell.2016.12.034; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Ramakrishnan SK, 2015, P NATL ACAD SCI USA, V112, pE3738, DOI 10.1073/pnas.1504891112; Sanchez M, 2007, NAT STRUCT MOL BIOL, V14, P420, DOI 10.1038/nsmb1222; Schwartz AJ, 2019, J CLIN INVEST, V129, P336, DOI 10.1172/JCI122359; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Shah YM, 2014, GASTROENTEROLOGY, V146, P630, DOI 10.1053/j.gastro.2013.12.031; Shah YM, 2009, CELL METAB, V9, P152, DOI 10.1016/j.cmet.2008.12.012; Sutil-Vega M, 2019, ECHOCARDIOGR-J CARD, V36, P585, DOI 10.1111/echo.14271; Taylor M, 2011, GASTROENTEROLOGY, V140, P2044, DOI 10.1053/j.gastro.2011.03.007; VIELE MK, 1994, TRANSFUSION, V34, P396, DOI 10.1046/j.1537-2995.1994.34594249050.x; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Wilding LA, 2017, J AM ASSOC LAB ANIM, V56, P148; Wilkinson N, 2013, BLOOD, V122, P1658, DOI 10.1182/blood-2013-03-492454; Xu WJ, 2015, CELL REP, V13, P533, DOI 10.1016/j.celrep.2015.09.023; Xue X, 2013, GASTROENTEROLOGY, V145, P831, DOI 10.1053/j.gastro.2013.07.010; Zhou Q, 2017, ANATOL J CARDIOL, V18, P194, DOI 10.14744/AnatolJCardiol.2017.7694; Zolov SN, 2012, P NATL ACAD SCI USA, V109, P17472, DOI 10.1073/pnas.1203106109	37	11	11	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2019	294	41					14991	15002		10.1074/jbc.RA119.009578	http://dx.doi.org/10.1074/jbc.RA119.009578			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9JH	31416832	hybrid, Green Published			2022-12-26	WOS:000499253400013
J	Cui, K; Podolnikova, NP; Bailey, W; Szmuc, E; Podrez, EA; Byzova, TV; Yakubenko, VP				Cui, Kui; Podolnikova, Nataly P.; Bailey, William; Szmuc, Eric; Podrez, Eugene A.; Byzova, Tatiana, V; Yakubenko, Valentin P.			Inhibition of integrin ?(D)?(2)?mediated macrophage adhesion to end product of docosahexaenoic acid (DHA) oxidation prevents macrophage accumulation during inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						macrophage; adhesion; migration; integrin; inflammation; integrin ?(D)?(2)	ADIPOSE-TISSUE; ALPHA(D)BETA(2) CD11D/CD18; ALPHA(M)BETA(2) MAC-1; ALPHA-D; MIGRATION; BINDING; LIGAND; RECOGNITION; CD11B/CD18; LEUKOINTEGRIN	A critical step in the development of chronic inflammatory diseases is the accumulation of proinflammatory macrophages in the extracellular matrix (ECM) of peripheral tissues. The adhesion receptor integrin ?(D)?(2) promotes the development of atherosclerosis and diabetes by supporting macrophage retention in inflamed tissue. We recently found that the end product of docosahexaenoic acid (DHA) oxidation, 2-(?-carboxyethyl)pyrrole (CEP), serves as a ligand for ?(D)?(2). CEP adduct with ECM is generated during inflammation-mediated lipid peroxidation. The goal of this project was to identify a specific inhibitor for ?(D)?(2)?CEP interaction that can prevent macrophage accumulation. Using a specially designed peptide library, Biacore-detected protein?protein interaction, and adhesion of integrin-transfected HEK 293 cells, we identified a sequence (called P5 peptide) that significantly and specifically inhibited ?(D)?CEP binding. In the model of thioglycollate-induced peritoneal inflammation, the injection of cyclic P5 peptide reduced 3-fold the macrophage accumulation in WT mice but had no effect in ?(D)-deficient mice. The tracking of adoptively transferred, fluorescently labeled WT and ?(?/?)(D) monocytes in the model of peritoneal inflammation and in vitro two-dimensional and three-dimensional migration assays demonstrated that P5 peptide does not affect monocyte transendothelial migration or macrophage efflux from the peritoneal cavity but regulates macrophage migration through the ECM. Moreover, the injection of P5 peptide into WT mice on a high-fat diet prevents macrophage accumulation in adipose tissue in an ?(D)?(2)-dependent manner. Taken together, these results demonstrate the importance of ?(D)?(2)-mediated macrophage adhesion for the accumulation of infiltrating macrophages in the inflamed ECM and propose P5 peptide as a potential inhibitor of atherogenesis and diabetes.	[Cui, Kui; Bailey, William; Szmuc, Eric; Yakubenko, Valentin P.] East Tennessee State Univ, Quillen Coll Med, Dept Biomed Sci, POB 70582, Johnson City, TN 37614 USA; [Podolnikova, Nataly P.] Arizona State Univ, Sch Life Sci, Ctr Metab & Vasc Biol, Tempe, AZ 85281 USA; [Podrez, Eugene A.; Byzova, Tatiana, V] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA	East Tennessee State University; Arizona State University; Arizona State University-Tempe; Cleveland Clinic Foundation	Yakubenko, VP (corresponding author), East Tennessee State Univ, Quillen Coll Med, Dept Biomed Sci, POB 70582, Johnson City, TN 37614 USA.	yakubenko@etsu.edu		Cui, Kui/0000-0003-2615-4932	National Institutes of Health [DK102020, HL071625, HL077213, C06RR0306551]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL145536, R01HL077213, R01HL071625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK102020 (to V. P. Y.), HL071625 (to T. V. B.), HL077213 (to E. A. P.), and C06RR0306551 (to East Tennessee State University). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexandraki K, 2006, ANN NY ACAD SCI, V1084, P89, DOI 10.1196/annals.1372.039; Aziz MH, 2017, J IMMUNOL, V198, P4855, DOI 10.4049/jimmunol.1602175; Bellingan GJ, 2002, J EXP MED, V196, P1515, DOI 10.1084/jem.20011794; Bellingan GJ, 1996, J IMMUNOL, V157, P2577; Biswas S, 2016, BLOOD, V127, P2618, DOI 10.1182/blood-2015-08-664300; Bouissou A, 2017, ACS NANO, V11, P4028, DOI 10.1021/acsnano.7b00622; Cao CZ, 2005, BLOOD, V106, P3234, DOI 10.1182/blood-2005-03-1288; CHULUYAN HE, 1993, J CLIN INVEST, V92, P2768, DOI 10.1172/JCI116895; Cougoule C, 2012, EUR J CELL BIOL, V91, P938, DOI 10.1016/j.ejcb.2012.07.002; Cui K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02650; DANILENKO DM, 1995, J IMMUNOL, V155, P35; DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729; Grayson MH, 1998, J EXP MED, V188, P2187, DOI 10.1084/jem.188.11.2187; Gu XR, 2003, J BIOL CHEM, V278, P42027, DOI 10.1074/jbc.M305460200; Kim YW, 2015, CIRC RES, V117, P321, DOI 10.1161/CIRCRESAHA.117.305925; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Li R, 1998, J CELL BIOL, V143, P1523, DOI 10.1083/jcb.143.6.1523; Lishko VK, 2004, J BIOL CHEM, V279, P44897, DOI 10.1074/jbc.M408012200; Mabon PJ, 2000, EXP NEUROL, V166, P52, DOI 10.1006/exnr.2000.7488; Maridonneau-Parini I, 2014, IMMUNOL REV, V262, P216, DOI 10.1111/imr.12214; MEERSCHAERT J, 1994, J IMMUNOL, V152, P1915; Miyazaki Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112770; Noti JD, 2002, INT J MOL MED, V10, P721; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Panigrahi S, 2013, CIRC RES, V112, P103, DOI 10.1161/CIRCRESAHA.112.274241; Podolnikova NP, 2015, BIOCHEMISTRY-US, V54, P1408, DOI 10.1021/bi5013782; Salomon RG, 2017, CHEM RES TOXICOL, V30, P105, DOI 10.1021/acs.chemrestox.6b00304; Schittenhelm L, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01866; Shang XZ, 1998, EUR J IMMUNOL, V28, P1970, DOI 10.1002/(SICI)1521-4141(199806)28:06<1970::AID-IMMU1970>3.0.CO;2-H; Subramanian S, 2009, CURR OPIN LIPIDOL, V20, P39, DOI 10.1097/MOL.0b013e32831bef8b; Szpak D, 2018, J IMMUNOL, V200, P2426, DOI 10.4049/jimmunol.1700313; Thomas AP, 2011, J NUTR, V141, P1172, DOI 10.3945/jn.110.127068; Ustinov VA, 2002, J BIOL CHEM, V277, P18769, DOI 10.1074/jbc.M110242200; VanderVieren M, 1995, IMMUNITY, V3, P683, DOI 10.1016/1074-7613(95)90058-6; Wang H, 2015, CHEM RES TOXICOL, V28, P967, DOI 10.1021/acs.chemrestox.5b00001; Wang YM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15559; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Wiesner C, 2014, CELL ADHES MIGR, V8, P179, DOI 10.4161/cam.28116; Wolf D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02896-8; Wolf D, 2017, THROMB HAEMOSTASIS, V117, P325, DOI 10.1160/TH16-07-0553; Xiong JP, 2000, J BIOL CHEM, V275, P38762, DOI 10.1074/jbc.C000563200; Yakubenko VP, 2008, EXP CELL RES, V314, P2569, DOI 10.1016/j.yexcr.2008.05.016; Yakubenko VP, 2018, BLOOD, V132, P78, DOI 10.1182/blood-2017-10-810176; Yakubenko VP, 2011, CIRC RES, V108, P544, DOI 10.1161/CIRCRESAHA.110.231803; Yakubenko VP, 2006, BLOOD, V107, P1643, DOI 10.1182/blood-2005-06-2509; Yakubenko VP, 2002, J BIOL CHEM, V277, P48635, DOI 10.1074/jbc.M208877200; Yakubenko VP, 2001, J BIOL CHEM, V276, P13995, DOI 10.1074/jbc.M010174200; Zhang L, 1999, BIOCHEMISTRY-US, V38, P8064, DOI 10.1021/bi990141h; Zhu JQ, 2013, J CELL BIOL, V201, P1053, DOI 10.1083/jcb.201212037	50	6	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2019	294	39					14370	14382		10.1074/jbc.RA119.009590	http://dx.doi.org/10.1074/jbc.RA119.009590			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HH	31395659	Green Published, hybrid			2022-12-26	WOS:000499248200018
J	Brewer, LC; Hayes, SN; Caron, AR; Derby, DA; Breutzman, NS; Wicks, A; Raman, J; Smith, CM; Schaepe, KS; Sheets, RE; Jenkins, SM; Lackore, KA; Johnson, J; Jones, C; Breitkopf, CR; Cooper, LA; Patten, CA				Brewer, LaPrincess C.; Hayes, Sharonne N.; Caron, Amber R.; Derby, David A.; Breutzman, Nicholas S.; Wicks, Amy; Raman, Jeyakumar; Smith, Christina M.; Schaepe, Karen S.; Sheets, Ruth E.; Jenkins, Sarah M.; Lackore, Kandace A.; Johnson, Jacqueline; Jones, Clarence; Breitkopf, Carmen Radecki; Cooper, Lisa A.; Patten, Christi A.			Promoting cardiovascular health and wellness among African-Americans: Community participatory approach to design an innovative mobile-health intervention	PLOS ONE			English	Article							HEART-DISEASE; SCIENTIFIC STATEMENT; PHYSICAL-ACTIVITY; KNOWLEDGE; WOMEN; RISK; ASSOCIATIONS; PREVENTION; AWARENESS; EHEALTH	Background Despite improvements in mortality rates over the past several decades, cardiovascular (CV) disease remains the leading cause of death for African-Americans (AAs). Innovative approaches through mobile health (mHealth) interventions have the potential to support life-style change for CV disease prevention among AAs. We aimed to translate a behavioral theory-informed, evidence-based, face-to-face health education program into an mHealth lifestyle intervention for AAs. We describe the design and development of a culturally relevant, CV health and wellness digital application (app) and pilot testing using a community-based participatory research (CBPR) approach with AA churches. Methods This mixed methods study used a 4-phase iterative development process for intervention design with the AA community. Phase 1 included focus groups with AA community members and church partners (n = 23) to gain insight regarding potential app end user preferences. In Phase 2, the interdisciplinary research team synthesized Phase 1 input for preliminary app design and content development. Phase 3 consisted of a sequential 3-meeting series with church partners (n = 13) for iterative app prototyping (assessment, cultural tailoring, final review). Phase 4, a single group pilot study among AA church congregants (n = 50), assessed app acceptability, usability, and satisfaction. Results Phase 1 focus groups indicated general and health-related apps preferences: multifunctional, high-quality graphics/visuals, evidence-based, yet simple health information and social networking capability. Phase 2 integrated these preferences into the preliminary app prototype. Phase 3 feedback was used to refine the app prototype for pilot testing. Phase 4 pilot testing indicated high app acceptability, usability, and satisfaction. Conclusions This study illustrates integration of formative and CBPR approaches to design a culturally relevant, mHealth lifestyle intervention to address CV health disparities among AAs. Given the positive app perceptions, our study supports the use of an iterative development process by others interested in implementing an mHealth lifestyle intervention for racial/ethnic minority communities.	[Brewer, LaPrincess C.; Hayes, Sharonne N.] Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55901 USA; [Caron, Amber R.; Derby, David A.; Breutzman, Nicholas S.; Wicks, Amy; Raman, Jeyakumar; Schaepe, Karen S.] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN USA; [Smith, Christina M.; Lackore, Kandace A.; Breitkopf, Carmen Radecki] Mayo Clin, Div Hlth Care Policy & Res, Rochester, MN USA; [Sheets, Ruth E.] Mayo Clin, Dept Res Adm, Rochester, MN USA; [Jenkins, Sarah M.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Johnson, Jacqueline] Christs Church Jesus Hour, Rochester, MN USA; [Jones, Clarence] Hue MAN Partnership, Minneapolis, MN USA; [Cooper, Lisa A.] Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA; [Cooper, Lisa A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA; [Patten, Christi A.] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Mayo Clinic	Brewer, LC (corresponding author), Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55901 USA.	brewer.laprincess@mayo.edu	Urzua, Andrea Silva/AAS-7284-2020	Brewer, LaPrincess/0000-0002-6468-9324	Building Interdisciplinary Research Careers in Women's Health Scholars Program from the National Institutes of Health (NIH) Office of Research on Women's Health, Mayo Clinic Women's Health Research Center [K12 HD065987-07]; National Center for Advancing Translational Sciences (Clinical and Translational Science Awards) [KL2 TR002379]; Mayo Clinic Center for Innovation; Mayo Clinic Center for Translational Science Activities [UL1TR000135]; Mayo Clinic Department of Cardiovascular Medicine; Mayo Clinic Office of Health Disparities Research; NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD065987] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR002379] Funding Source: NIH RePORTER	Building Interdisciplinary Research Careers in Women's Health Scholars Program from the National Institutes of Health (NIH) Office of Research on Women's Health, Mayo Clinic Women's Health Research Center; National Center for Advancing Translational Sciences (Clinical and Translational Science Awards); Mayo Clinic Center for Innovation; Mayo Clinic Center for Translational Science Activities; Mayo Clinic Department of Cardiovascular Medicine; Mayo Clinic Office of Health Disparities Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Dr Brewer is supported by the Building Interdisciplinary Research Careers in Women's Health Scholars Program (award number K12 HD065987-07) from the National Institutes of Health (NIH) Office of Research on Women's Health, Mayo Clinic Women's Health Research Center, and the National Center for Advancing Translational Sciences (Clinical and Translational Science Awards Grant Number KL2 TR002379), a component of the NIH. Contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official view of the NIH. This study was further supported by the Mayo Clinic Center for Innovation, Mayo Clinic Center for Translational Science Activities (UL1TR000135), Mayo Clinic Department of Cardiovascular Medicine, and Mayo Clinic Office of Health Disparities Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe NA, 2013, J MED INTERNET RES, V15, P96, DOI 10.2196/jmir.2803; American Heart Association, 2012, FACTS BRIDG GAP CVD; American Heart Association, 2018, MY LIF CHECK LIF SIM; Bandura A., 1986, SOCIAL FDN THOUGHT A; Barrera M, 2013, J CONSULT CLIN PSYCH, V81, P196, DOI 10.1037/a0027085; Bastien JMC, 2010, INT J MED INFORM, V79, pE18, DOI 10.1016/j.ijmedinf.2008.12.004; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Bennett GG, 2014, OBES REV, V15, P146, DOI 10.1111/obr.12218; Blumer H., 1969, SYMBOLIC INTERACTION, Vx; Borrelli B, 2015, HEALTH PSYCHOL, V34, P1205, DOI 10.1037/hea0000323; Bradbury K, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/561320; Brewer LC, 2019, J HEALTH PSYCHOL, V24, P1710, DOI 10.1177/1359105317695878; Brewer LC, 2018, JMIR RES PROTOC, V7, DOI 10.2196/resprot.8842; Brewer LC, 2017, J RACIAL ETHN HEALTH, V4, P269, DOI 10.1007/s40615-016-0226-z; Brown CW, 2018, AM J HEALTH EDUC, V49, P57, DOI 10.1080/19325037.2017.1414640; Burke LE, 2015, CIRCULATION, V132, P1157, DOI 10.1161/CIR.0000000000000232; Campbell MK, 2007, ANNU REV PUBL HEALTH, V28, P213, DOI 10.1146/annurev.publhealth.28.021406.144016; Carnethon MR, 2017, CIRCULATION, V136, pE393, DOI 10.1161/CIR.0000000000000534; Center for Health Statistics, 2009, HLTH STAT REP; Centers for Disease Control and Prevention, 2015, BRFSS PREV TRENDS DA; Champion V.L., 2008, HLTH BEHAV HLTH ED, V4, P45; Charmaz K., 2006, CONSTRUCTING GROUNDE, Vxiii; Cho YM, 2018, TELEMED E-HEALTH, V24, P727, DOI 10.1089/tmj.2017.0249; DeHaven MJ, 2004, AM J PUBLIC HEALTH, V94, P1030, DOI 10.2105/AJPH.94.6.1030; Dillard AJ, 2013, HEALTH EDUC BEHAV, V40, P673, DOI 10.1177/1090198112473111; Fetters MD, 2013, HEALTH SERV RES, V48, P2134, DOI 10.1111/1475-6773.12117; Giardina EGV, 2011, J WOMENS HEALTH, V20, P893, DOI 10.1089/jwh.2010.2448; Heckman Carolyn, 2015, Internet Interv, V2, P340, DOI 10.1016/j.invent.2015.04.003; Henderson VA, 2013, PROG COMM HLTH PARTN, V7, P171, DOI 10.1353/cpr.2013.0024; Higgins JP, 2016, AM J MED, V129, P11, DOI 10.1016/j.amjmed.2015.05.038; Hilgart MM, 2012, J MED INTERNET RES, V14, P98, DOI 10.2196/jmir.1890; Homko J, 2008, J CARDIOVASC NURS, V23, P332, DOI 10.1097/01.JCN.0000317432.44586.aa; Hou SI, 2014, HEALTH PSYCHOL BEHAV, V2, P455, DOI 10.1080/21642850.2014.895368; Iribarren SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170581; Israel B.A., 2005, METHODS COMMUNITY BA, VVol. 3, P3; James DCS, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.160210; Kaushik B, 2014, CUSTOMIZABLE SCALABL; Kelli Heval Mohamed, 2017, Euro Med J Innov, V2017, P92; Kotarba JA, 2014, SYMB INTERACT, V37, P412, DOI 10.1002/symb.111; LifeGuide, 2013, BEG GUID CREAT ONL I; Lu Y, 2016, CIRCULATION, V134, P472, DOI 10.1161/CIRCULATIONAHA.115.018102; Maar Marion A, 2017, JMIR Mhealth Uhealth, V5, pe47, DOI 10.2196/mhealth.7044; Maddison R, 2015, EUR J PREV CARDIOL, V22, P701, DOI 10.1177/2047487314535076; Mendiola MF, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.4283; Michie S, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7126; Minnesota Department of Health, 2011, CHRON DIS THEIR RISK; Mobasheri MH, 2014, BREAST, V23, P683, DOI 10.1016/j.breast.2014.07.006; Mosca L, 2013, CIRCULATION, V127, P1254, DOI 10.1161/CIR.0b013e318287cf2f; National Heart Lung and Blood Institute National Institutes of Health, 2016, HEART TRUTH AFR AM W; National Heart Lung and Blood Institute National Institutes of Health, 2008, HEART HLTH HOM COOK; National Heart Lung and Blood Institute National Institutes of Health, 2008, MOV BETT HEART HLTH; National Quality Forum, 2017, DISP HEALTHC HLTH OU; Neiger B.L., 2013, AM J HEALTH EDUC, V33, P301; Odulana AA, 2014, HEALTH PROMOT PRACT, V15, P125, DOI 10.1177/1524839913480799; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Payne HE, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.3335; Person B, 1996, PUBLIC HEALTH REP, V111, P89; Ray R, 2017, J HEALTH POLIT POLIC, V42, P901, DOI 10.1215/03616878-3940477; Riley WT, 2011, TRANSL BEHAV MED, V1, P53, DOI 10.1007/s13142-011-0021-7; Ritterband LM, 2009, ANN BEHAV MED, V38, P18, DOI 10.1007/s12160-009-9133-4; Sahgal N., 2009, RELIG PORTRAIT AFRIC; Schnall R, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/mhealth.8851; Schulz AJ, 2015, HEALTH EDUC BEHAV, V42, P380, DOI 10.1177/1090198114560015; Shanedling Stanton, 2013, Minn Med, V96, P44; Skolarus LE, 2018, HEALTH PROMOT PRACT, V19, P495, DOI 10.1177/1524839917710893; Skolarus LE, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003331; Stowell DP, 2018, INVESTMENT BANKS, HEDGE FUNDS, AND PRIVATE EQUITY, 3RD EDITION, P1; vanDijk JAGM, 2014, DIGITAL SKILLS UNLOC, P21; Veinot TC, 2018, J AM MED INFORM ASSN, V25, P1080, DOI 10.1093/jamia/ocy052; Wagner J, 2005, ETHNIC DIS, V15, P679; Wallerstein N., 2015, HLTH BEHAV THEORY RE, P277; WHO Global Observatory for eHealth & World Health Organization., 2011, MHEALTH NEW HORIZONS; Yeager KA, 2013, APPL NURS RES, V26, P251, DOI 10.1016/j.apnr.2013.06.008; Yeary KHCK, 2011, PREV CHRONIC DIS, V8; Yingling LR, 2016, JMIR MHEALTH UHEALTH, V4, P38, DOI 10.2196/mhealth.4489	75	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0218724	10.1371/journal.pone.0218724	http://dx.doi.org/10.1371/journal.pone.0218724			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5OC	31430294	Green Published, Green Submitted, gold			2022-12-26	WOS:000485026800006
J	Akinleye, DD; McNutt, LA; Lazariu, V; McLaughlin, CC				Akinleye, Dean D.; McNutt, Louise-Anne; Lazariu, Victoria; McLaughlin, Colleen C.			Correlation between hospital finances and quality and safety of patient care	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; PROSPECTIVE PAYMENT SYSTEM; OF-CARE; HEALTH-CARE; RACIAL DISPARITIES; MEDICAID; PERFORMANCE; MORTALITY; OUTCOMES; PAY	Background Hospitals under financial pressure may struggle to maintain quality and patient safety and have worse patient outcomes relative to well-resourced hospitals. Poor predictive validity may explain why previous studies on the association between finances and quality/safety have been equivocal. This manuscript employs principal component analysis to produce robust measures of both financial status and quality/safety of care, to assess our a priori hypothesis: hospital financial performance is associated with the provision of quality care, as measured by quality and safety processes, patient outcomes, and patient centered care. Methods This 2014 cross-sectional study investigated hospital financial condition and hospital quality and safety at acute care hospitals. The hospital financial data from the Centers for Medicare and Medicaid Services (CMS) cost report were used to develop a composite financial performance score using principal component analysis. Hospital quality and patient safety were measured with a composite quality/safety performance score derived from principal component analysis, utilizing a range of established quality and safety indicators including: risk-standardized inpatient mortality, 30-day mortality, 30-day readmissions for select conditions, patient safety indicators from inpatient admissions, process of care chart reviews, CMS value-based purchasing total performance score and patient experience of care surveys. The correlation between the composite financial performance score and the composite quality/safety performance score was calculated using linear regression adjusting for hospital characteristics. Results Among the 108 New York State acute care facilities for which data were available, there is a clear relationship between hospital financial performance and hospital quality/safety performance score (standardized correlation coefficient 0.34, p<0.001). The composite financial performance score is also positively associated with the CMS Value Based Purchasing Total Performance Score (standardized correlation coefficient 0.277, p = 0.002); while it is negatively associated with 30 day readmission for all outcomes (standardized correlation coefficient -0.236, p = 0.013), 30-day readmission for congestive heart failure (standardized correlation coefficient -0.23, p = 0.018), 30 day readmission for pneumonia (standardized correlation coefficient -0.209, p = 0.033), and a decrease in 30-day mortality for acute myocardial infarction (standardized correlation coefficient -0.211, p = 0.027). Used alone, operating margin and total margin are poor predictors of quality and safety outcomes. Conclusions Strong financial performance is associated with improved patient reported experience of care, the strongest component distinguishing quality and safety. These findings suggest that financially stable hospitals are better able to maintain highly reliable systems and provide ongoing resources for quality improvement.	[Akinleye, Dean D.; Lazariu, Victoria] SUNY Albany, Sch Publ Hlth, Albany, NY 12144 USA; [McNutt, Louise-Anne] SUNY Albany, Inst Hlth & Environm, Albany, NY 12222 USA; [McLaughlin, Colleen C.] Albany Coll Pharm & Hlth Sci, Albany, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Albany College of Pharmacy & Health Sciences	Akinleye, DD (corresponding author), SUNY Albany, Sch Publ Hlth, Albany, NY 12144 USA.	dean.akinleye@gmail.com	McLaughlin, Colleen/AAD-8604-2020	McLaughlin, Colleen/0000-0003-4172-8172				Allison JJ, 2000, JAMA-J AM MED ASSOC, V284, P1256, DOI 10.1001/jama.284.10.1256; [Anonymous], 2005, INQUIRY, DOI [10.5034/inquiryjrnl_41.4.401, DOI 10.5034/INQUIRYJRNL_41.4.401]; Baicker K, 2011, NEW ENGL J MED, V365, P683, DOI 10.1056/NEJMp1108222; Banks DA, 1997, HEALTH ECON, V6, P133; Barnato AE, 2005, MED CARE, V43, P308, DOI 10.1097/01.mlr.0000156848.62086.06; Bazzoli GJ, 2008, HEALTH ECON, V17, P977, DOI 10.1002/hec.1311; Bazzoli GJ, 2007, MED CARE RES REV, V64, P148, DOI 10.1177/1077558706298289; BRECHER C, 1985, HEALTH SERV RES, V20, P266; Breiman L, 2017, CLASSIFICATION REGRE, DOI DOI 10.1201/9781315139470; BURSTIN HR, 1993, JAMA-J AM MED ASSOC, V270, P845, DOI 10.1001/jama.270.7.845; Casalino LP, 2007, HEALTH AFFAIR, V26, pW405, DOI 10.1377/hlthaff.26.3.w405; Cefalu MS, 2019, HEALTH SERV RES, V54, P502, DOI 10.1111/1475-6773.13056; Chien AT, 2007, MED CARE RES REV, V64, p283S, DOI 10.1177/1077558707305426; Clement JP, 2007, MED CARE, V45, P131, DOI 10.1097/01.mlr.0000244636.54588.2b; Corrigan JM., 2005, CROSS QUAL CHASM; Davies SM, 2001, REFINEMENT HCUP QUAL; Davies SM, 2001, AHRQ TECHNICAL REV R; Dong GN, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0690-x; Dranove D, 1998, HEALTH SERV RES, V33, P163; DUFFY SQ, 1993, HEALTH AFFAIR, V12, P151, DOI 10.1377/hlthaff.12.2.151; Eddy DM, 2012, HEALTH AFFAIR, V31, P2441, DOI 10.1377/hlthaff.2011.1274; Eddy DM, 2011, ANN INTERN MED, V154, P627, DOI 10.7326/0003-4819-154-9-201105030-00008; Encinosa WE, 2005, INQUIRY-J HEALTH CAR, V42, P60, DOI 10.5034/inquiryjrnl_42.1.60; Epstein AM, 2004, NEW ENGL J MED, V350, P406, DOI 10.1056/NEJMsb035374; FEDER J, 1987, NEW ENGL J MED, V317, P867, DOI 10.1056/NEJM198710013171405; Forum NQ, 2014, DRAFT REP; Freedman D.A., 2009, STAT MODELS THEORY P; Gapenski LC, 2008, HEALTHCARE FINANCE I; Gaskin DJ, 2008, HEALTH AFFAIR, V27, P518, DOI 10.1377/hlthaff.27.2.518; Glasziou PP, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5047; Goldman LE, 2007, MED CARE, V45, P579, DOI 10.1097/MLR.0b013e318041f723; Grabowski DC, 2008, REV ECON STAT, V90, P754, DOI 10.1162/rest.90.4.754; Guthrie B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6341; HADLEY J, 1989, INQUIRY-J HEALTH CAR, V26, P354; Hasnain-Wynia R, 2007, ARCH INTERN MED, V167, P1233, DOI 10.1001/archinte.167.12.1233; Health NYSDo, 2016, HOSP INP DISCH SPARC; Hibbard JH, 2005, HEALTH AFFAIR, V24, P1150, DOI 10.1377/hlthaff.24.4.1150; Hoehn RS, 2016, JAMA SURG, V151, P120, DOI 10.1001/jamasurg.2015.3209; Indicators AQ, 2002, GUID INP QUAL IND; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Jha AK, 2005, NEW ENGL J MED, V353, P265, DOI 10.1056/NEJMsa051249; Jha AK, 2010, ANN INTERN MED, V153, P299, DOI 10.7326/0003-4819-153-5-201009070-00004; Kim TH, 2008, INQUIRY-J HEALTH CAR, V45, P215, DOI 10.5034/inquiryjrnl_45.02.215; Kim TH, 2010, HEALTH CARE MANAG, V29, P52, DOI 10.1097/HCM.0b013e3181cca2c5; Krumholz HM, 2013, JAMA-J AM MED ASSOC, V309, P587, DOI 10.1001/jama.2013.333; Landon BE, 2007, JAMA-J AM MED ASSOC, V298, P1674, DOI 10.1001/jama.298.14.1674; LANGA KM, 1993, NEW ENGL J MED, V329, P1784, DOI 10.1056/NEJM199312093292407; Laschober M, 2007, HEALTH CARE FINANC R, V28, P61; Leatherman S, 2003, HEALTH AFFAIR, V22, P17, DOI 10.1377/hlthaff.22.2.17; Lieberthal RD, 2014, RISK MANAGEMENT INSU, V17, P17; Lindrooth RC, 2007, SOUTH ECON J, V73, P575, DOI 10.2307/20111912; Loubeau Patricia R, 2005, J Health Care Finance, V31, P41; Loxterkamp D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5539; Ly DP, 2011, J GEN INTERN MED, V26, P1291, DOI 10.1007/s11606-011-1815-5; Marshall MN, 2003, HEALTH AFFAIR, V22, P134, DOI 10.1377/hlthaff.22.3.134; Martsolf GR, 2014, MED CARE, V52, P982, DOI 10.1097/MLR.0000000000000248; MCCUE MJ, 1990, INQUIRY-J HEALTH CAR, V27, P242; MCCUE MJ, 1991, HOSP HEALTH SERV ADM, V36, P223; McGlynn EA, 2014, NEW ENGL J MED, V371, P2150, DOI 10.1056/NEJMp1407883; McShane M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2540; Mor V, 2011, J AM GERIATR SOC, V59, P3, DOI 10.1111/j.1532-5415.2010.03230.x; Mouch CA, 2014, SURGERY, V155, P826, DOI 10.1016/j.surg.2013.12.006; Mueller SK, 2013, MED CARE, V51, P567, DOI 10.1097/MLR.0b013e3182902151; Nguyen OK, 2016, J HOSP MED, V11, P481, DOI 10.1002/jhm.2570; Pedhazur EJ., 1997, MULTIPLE REGRESSION, V3rd ed; Platt H.D., 2002, J EC FINANCE, V26, P184, DOI [https://doi.org/10.1007/BF02755985, DOI 10.1007/BF02755985]; Popescu I, 2009, CIRC-CARDIOVASC QUAL, V2, P221, DOI 10.1161/CIRCOUTCOMES.108.813790; Roby DH, 2018, SUPPORTING TRANSFORM; Rosenthal GE, 1997, JAMA-J AM MED ASSOC, V278, P485, DOI 10.1001/jama.278.6.485; Rosko MD, 2004, HEALTH CARE MANAGE R, V29, P229, DOI 10.1097/00004010-200407000-00008; Saver BG, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001902; Shen YC, 2003, J HEALTH ECON, V22, P243, DOI 10.1016/S0167-6296(02)00124-8; SHERLOCK DB, 1986, INQUIRY-J HEALTH CAR, V23, P261; Silow-Carroll S., 2007, HOSP QUALITY IMPROVE; Smith RB, 2012, HEALTH SERV RES, V47, P1621, DOI 10.1111/j.1475-6773.2012.01385.x; Swensen SJ, 2013, J PATIENT SAF, V9, P44, DOI 10.1097/PTS.0b013e3182753e33; TRASKA MR, 1988, HOSPITALS, V62, P38; Vogel W B, 1993, Health Care Manage Rev, V18, P15; Volpp KG, 2005, CIRCULATION, V112, P2268, DOI 10.1161/CIRCULATIONAHA.105.534164; Volpp KGM, 2004, AM J MANAG CARE, V10, P505; Weissman JS, 2013, MED CARE, V51, P389, DOI 10.1097/MLR.0b013e31827fef95; Werner RM, 2008, JAMA-J AM MED ASSOC, V299, P2180, DOI 10.1001/jama.299.18.2180	82	30	30	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2019	14	8							e0219124	10.1371/journal.pone.0219124	http://dx.doi.org/10.1371/journal.pone.0219124			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5LL	31419227	Green Published, gold, Green Submitted			2022-12-26	WOS:000485019900009
J	Caldwell, JA; Niro, PJ; Farina, EK; McClung, JP; Caron, GR; Lieberman, HR				Caldwell, John A.; Niro, Philip J.; Farina, Emily K.; McClung, James P.; Caron, Gregory R.; Lieberman, Harris R.			A Z-score based method for comparing the relative sensitivity of behavioral and physiological metrics including cognitive performance, mood, and hormone levels	PLOS ONE			English	Article							QUALITY ASSESSMENT; DEHYDRATION; DECREMENTS; SYMPTOMS; EXPOSURE; CORTISOL	A method for assessing the relative sensitivity of research metrics is proposed and illustrated by comparing 18 outcome measures from a published study of the cognitive, mood, and hormonal effects of four different levels of stress induced by intense military training. Research on the human response to stress often assesses multiple disparate dependent measures. Selecting the most sensitive is difficult as formal methods to compare varied dependent measures have not been developed. The method first converts the outcome measures into standard scores (z-scores) and then compares them using analysis of variance to determine whether there are differences in how they assess the impact of graded levels of exposure to stress. The analysis detected various significant interactions in several measures and suggests self-report mood questionnaires were more sensitive to the stressors present in the study than the cognitive or hormonal measures which were used. These findings support the effectiveness of the z-score based method as a useful procedure for objectively evaluating the differential sensitivity of various metrics. This method could be useful for research on other independent variables when use of multiple assessment strategies is appropriate. It could be used for evaluating studies yielding conflicting results, such as those detecting effects on one parameter but not others. In such instances, cross-metric inconsistencies may be due to differential sensitivity of measurement strategies rather than actual differences in the effects of the independent-variable on the domains under investigation.	[Caldwell, John A.] Oak Ridge Inst Sci & Educ, Belcamp, MD USA; [Caldwell, John A.; Niro, Philip J.; Farina, Emily K.; McClung, James P.; Lieberman, Harris R.] US Army, Res Inst Environm Med, Mil Nutr Div, Natick, MA 01760 USA; [Farina, Emily K.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Caron, Gregory R.] SERE EAST, Ctr Secur Forces, Brunswick, ME USA	Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Lieberman, HR (corresponding author), US Army, Res Inst Environm Med, Mil Nutr Div, Natick, MA 01760 USA.	harris.r.lieberman.civ@mail.mil	McClung, James P/A-1989-2009		US Army Medical Research and Materiel Command (USAMRMC)	US Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This work was supported by the US Army Medical Research and Materiel Command (USAMRMC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemi TO., 2011, RES J MATH STAT, V3, P91; Armstrong LE, 2012, J NUTR, V142, P382, DOI 10.3945/jn.111.142000; Balkin TJ, 2004, J SLEEP RES, V13, P219, DOI 10.1111/j.1365-2869.2004.00407.x; Bergemann Tracy L, 2012, J Biom Biostat, VSuppl 7; Caicedo JC, 2017, NAT METHODS, V14, P849, DOI [10.1038/nmeth.4397, 10.1038/NMETH.4397]; Caldwell JA, 2004, MIL PSYCHOL, V16, P163, DOI 10.1207/s15327876mp1603_2; CALDWELL JA, 2003, AFRLHEBRTR20030086; De la Salle B, 2017, BIOCHEM MEDICA, V27, P19, DOI 10.11613/BM.2017.003; Hays W. L., 1973, STAT SOCIAL SCI, V2nd; Johnson LC, 1974, OPERATIONAL CONSEQUE; Lieberman HR, 2017, J NUTR, V147, P110, DOI 10.3945/jn.116.238246; Lieberman HR, 2016, PHYSIOL BEHAV, V165, P86, DOI 10.1016/j.physbeh.2016.06.037; Lieberman HR, 2015, PSYCHOPHARMACOLOGY, V232, P943, DOI 10.1007/s00213-014-3727-7; Lieberman HR, 2005, BIOL PSYCHIAT, V57, P422, DOI 10.1016/j.biopsych.2004.11.014; Mei ZG, 2007, B WORLD HEALTH ORGAN, V85, P441, DOI 10.2471/BLT.06.034421; Morgan CA, 2004, ARCH GEN PSYCHIAT, V61, P819, DOI 10.1001/archpsyc.61.8.819; Morgan CA, 2001, PSYCHOSOM MED, V63, P412, DOI 10.1097/00006842-200105000-00010; Nindl BC, 2015, J STRENGTH COND RES, V29, pS221, DOI 10.1519/JSC.0000000000001114; Sananes N, 2009, ULTRASOUND OBST GYN, V34, P404, DOI 10.1002/uog.6439; Saw AE, 2016, BRIT J SPORT MED, V50, P281, DOI 10.1136/bjsports-2015-094758; Taylor MK, 2009, J TRAUMA STRESS, V22, P212, DOI 10.1002/jts.20413; Verde T, 1992, Br J Sports Med, V26, P167; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060	23	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220749	10.1371/journal.pone.0220749	http://dx.doi.org/10.1371/journal.pone.0220749			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5KK	31415596	Green Published, Green Submitted, gold			2022-12-26	WOS:000485017200028
J	Riyapa, D; Rinchai, D; Muangsombut, V; Wuttinontananchai, C; Toufiq, M; Chaussabel, D; Ato, M; Blackwell, JM; Korbsrisate, S				Riyapa, Donporn; Rinchai, Darawan; Muangsombut, Veerachat; Wuttinontananchai, Chayanin; Toufiq, Mohammed; Chaussabel, Damien; Ato, Manabu; Blackwell, Jenefer M.; Korbsrisate, Sunee			Transketolase and vitamin B1 influence on ROS-dependent neutrophil extracellular traps (NETs) formation	PLOS ONE			English	Article							BURKHOLDERIA-PSEUDOMALLEI; CELL-DEATH; THIAMINE; INHIBITION; MECHANISM; ANALOG; BLOOD; BENFOTIAMINE; ANTIOXIDANT; ACTIVATION	Neutrophil extracellular traps (NETs) are a recently identified, web-like, extracellular structure composed of decondensed nuclear DNA and associated antimicrobial granules. NETs are extruded into the extracellular environment via the reactive oxygen species (ROS)-dependent cell death pathway participating in inflammation and autoimmune diseases. Transketolase (TKT) is a thiamine pyrophosphate (vitamin B1)-dependent enzyme that links the pentose phosphate pathway with the glycolytic pathway by feeding excess sugar phosphates into the main carbohydrate metabolic pathways to generate biosynthetic reducing capacity in the form of NADPH as a substrate for ROS generation. In this work, TKT was selected as a lead candidate from 24 NET-associated proteins obtained by literature screening and knowledge gap assessment. Consequently, we determined whether TKT influenced NET formation in vitro. We firstly established that the release of ROS-dependent NETs was significantly decreased after purified human PMNs were pretreated with oxythiamine, a TKT inhibitor, and in a concentration dependent manner. As a cofactor for TKT reaction, we evaluated the release of NET formation either in vitamin B1 treatment or in combined use of oxythiamine and vitamin B1, and found that those treatments also exerted a significant suppressive effect on the amount of NET-DNA and ROS production. The regulation of TKT by oxythiamine and/or vitamin B1 may therefore be associated with response to the modulation of NET formation by preventing generation of excessive NETs in inflammatory diseases.	[Riyapa, Donporn; Wuttinontananchai, Chayanin] Mahidol Univ, Fac Med Technol, Ctr Res & Innovat, Nakhon Pathom, Thailand; [Rinchai, Darawan; Toufiq, Mohammed; Chaussabel, Damien] Sidra Med, Syst Biol & Immunol Dept, Doha, Qatar; [Rinchai, Darawan] Sidra Med, Immunol Inflammat & Metab Dept, Doha, Qatar; [Muangsombut, Veerachat; Korbsrisate, Sunee] Mahidol Univ, Fac Med, Siriraj Hosp, Dept Immunol, Bangkok, Thailand; [Ato, Manabu] Natl Inst Infect Dis, Dept Immunol, Shinjuku Ku, Tokyo, Japan; [Blackwell, Jenefer M.] Univ Western Australia, Telethon Kids Inst, Nedlands, WA, Australia; [Blackwell, Jenefer M.] Univ Cambridge, Dept Pathol, Cambridge, England	Mahidol University; Sidra Medical & Research Center; Sidra Medical & Research Center; Mahidol University; National Institute of Infectious Diseases (NIID); Telethon Kids Institute; University of Western Australia; University of Cambridge	Korbsrisate, S (corresponding author), Mahidol Univ, Fac Med, Siriraj Hosp, Dept Immunol, Bangkok, Thailand.	sunee.kor@mahidol.ac.th	Toufiq, Mohammed/AAQ-8686-2020; Rinchai, Darawan/U-3246-2019; Chaussabel, Damien/AAX-1909-2020	Toufiq, Mohammed/0000-0002-6368-6746; Rinchai, Darawan/0000-0001-8851-7730; Ato, Manabu/0000-0002-3178-2645	Siriraj Grant for Research and Development, Faculty of Medicine Siriraj Hospital; Mahidol University; Thailand Research Fund	Siriraj Grant for Research and Development, Faculty of Medicine Siriraj Hospital; Mahidol University; Thailand Research Fund(Thailand Research Fund (TRF))	This work was supported by the Siriraj Grant for Research and Development, Faculty of Medicine Siriraj Hospital to S. Korbsrisate; along with Mahidol University and Research Grant for New Scholar from the Thailand Research Fund to D. Riyapa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R, 1982, CLIN EXP IMMUNOL, V47, P487; de Andrade JAA, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-11; Ardura MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005446; Azevedo EP, 2015, J BIOL CHEM, V290, P22174, DOI 10.1074/jbc.M115.640094; Babior BM, 2002, ISRAEL MED ASSOC J, V4, P1023; Banchereau R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034390; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Chanchamroen S, 2009, INFECT IMMUN, V77, P456, DOI 10.1128/IAI.00503-08; Dong YK, 2017, BIOMED PHARMACOTHER, V85, P672, DOI 10.1016/j.biopha.2016.11.078; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Handono K, 2014, ACTA MED INDONES, V46, P189; Hazell AS, 2013, NEUROCHEM INT, V62, P796, DOI 10.1016/j.neuint.2013.01.009; Higashi-Okai Kiyoka, 2006, Journal of UOEH, V28, P359; Hinze-Selch D, 2000, FORTSCHR NEUROL PSYC, V68, P113, DOI 10.1055/s-2000-11622; Horecker BL, 2002, J BIOL CHEM, V277, P47965, DOI 10.1074/jbc.X200007200; Idaghdour Y, 2012, P NATL ACAD SCI USA, V109, P16786, DOI 10.1073/pnas.1204945109; JONES PT, 1983, INT J IMMUNOPHARMACO, V5, P377, DOI 10.1016/0192-0561(83)90012-7; Keshari RS, 2013, J CELL BIOCHEM, V114, P532, DOI 10.1002/jcb.24391; Kochetov GA, 2014, BBA-PROTEINS PROTEOM, V1844, P1608, DOI 10.1016/j.bbapap.2014.06.003; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Li QS, 2009, J IMMUNOL, V183, P1975, DOI 10.4049/jimmunol.0803222; Lukienko PI, 2000, B EXP BIOL MED+, V130, P874, DOI 10.1023/A:1015318413076; Manzetti S, 2014, BIOCHEMISTRY-US, V53, P821, DOI 10.1021/bi401618y; MARTIN PR, 1995, METAB BRAIN DIS, V10, P45, DOI 10.1007/BF01991782; Mohammed BM, 2013, NUTRIENTS, V5, P3131, DOI 10.3390/nu5083131; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; Pankla R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r127; Pilsczek FH, 2010, J IMMUNOL, V185, P7413, DOI 10.4049/jimmunol.1000675; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Ranoux A, 2013, TOP CATAL, V56, P750, DOI 10.1007/s11244-013-0034-1; Rinchai Darawan, 2015, F1000Res, V4, P89, DOI 10.12688/f1000research.6241.2; Riyapa D, 2012, INFECT IMMUN, V80, P3921, DOI 10.1128/IAI.00806-12; Schenk G, 1998, INT J BIOCHEM CELL B, V30, P1297, DOI 10.1016/S1357-2725(98)00095-8; SHIN W, 1986, J AM CHEM SOC, V108, P7078, DOI 10.1021/ja00282a038; Talwar D, 2000, CLIN CHEM, V46, P704; THERON A, 1981, CLIN EXP IMMUNOL, V44, P295; Thomas AA, 2008, BIOORG MED CHEM LETT, V18, P509, DOI 10.1016/j.bmcl.2007.11.098; Thornalley PJ, 2005, CURR DIABETES REV, V1, P287, DOI 10.2174/157339905774574383; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Van Raam BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002013; Wang JR, 2013, EXP HEMATOL ONCOL, V2, DOI 10.1186/2162-3619-2-18; Wooley JA, 2008, NUTR CLIN PRACT, V23, P487, DOI 10.1177/0884533608323430; Xu P, 2009, PROTEOMICS, V9, P2037, DOI 10.1002/pmic.200800674; Yadav UCS, 2010, FREE RADICAL BIO MED, V48, P1423, DOI 10.1016/j.freeradbiomed.2010.02.031; Yadav UCS, 2009, INVEST OPHTH VIS SCI, V50, P2276, DOI 10.1167/iovs.08-2816; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Zhao YL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/572915	50	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0221016	10.1371/journal.pone.0221016	http://dx.doi.org/10.1371/journal.pone.0221016			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415630	gold, Green Submitted, Green Published			2022-12-26	WOS:000485017200060
J	Lobier, M; Castren, J; Niittymaki, P; Palokangas, E; Partanen, J; Arvas, M				Lobier, Muriel; Castren, Johanna; Niittymaki, Pia; Palokangas, Elina; Partanen, Jukka; Arvas, Mikko			The effect of donation activity dwarfs the effect of lifestyle, diet and targeted iron supplementation on blood donor iron stores	PLOS ONE			English	Article							SERUM TRANSFERRIN RECEPTOR; INTERNATIONAL FORUM; REPRODUCTIVE AGE; BODY IRON; DEFICIENCY; FERRITIN; POPULATION; HEMOGLOBIN; PREVALENCE; WOMEN	The iron status of blood donors is a subject of concern for blood establishments. The Finnish Red Cross Blood Service addresses iron loss in blood donors by proposing systematic iron supplementation for demographic at-risk donor groups. We measured blood count, ferritin and soluble transferrin receptor (sTfR) and acquired lifestyle and health information from 2200 blood donors of the FinDonor 10000 cohort. We used modern data analysis methods to estimate iron status and factors affecting it with a special focus on the effects of the blood service's iron supplementation policy. Low ferritin (< 15 mu g/L), an indicator of low iron stores, was present in 20.6% of pre-menopausal women, 10.6% of post-menopausal women and 6% of men. Anemia co-occurred with iron deficiency more frequently in pre-menopausal women (21 out of 25 cases) than in men (3/6) or post-menopausal women (1/2). In multivariable regression analyses, lifestyle, dietary, and blood donation factors explained up to 38% of the variance in ferritin levels but only similar to 10% of the variance in sTfR levels. Days since previous donation were positively associated with ferritin levels in all groups while the number of donations during the past 2 years was negatively associated with ferritin levels in pre-menopausal women and men. FRCBS-provided iron supplementation was negatively associated with ferritin levels in men only. Relative importance analyses showed that donation activity accounted for most of the explained variance in ferritin levels while iron supplementation explained less than 1%. Variation in ferritin levels was not significantly associated with variation in self-reported health. Donation activity was the most important factor affecting blood donor iron levels, far ahead of e.g. red-meat consumption or iron supplementation. Importantly, self-reported health of donors with lower iron stores was not lower than self-reported health of donors with higher iron stores.	[Lobier, Muriel; Castren, Johanna; Niittymaki, Pia; Palokangas, Elina; Partanen, Jukka; Arvas, Mikko] Finnish Red Cross Blood Serv, Res & Dev, Helsinki, Finland		Arvas, M (corresponding author), Finnish Red Cross Blood Serv, Res & Dev, Helsinki, Finland.	muriel.lobier@veripalvelu.fi	Arvas, Mikko/AAA-7438-2021; Partanen, Jukka/B-7207-2014	Arvas, Mikko/0000-0002-6902-8488; Partanen, Jukka/0000-0001-6681-4734	Finnish Funding Agency for Technology and Innovation (Tekes) [3982/31/2013]; VTR funding from the Finnish Government	Finnish Funding Agency for Technology and Innovation (Tekes)(Finnish Funding Agency for Technology & Innovation (TEKES)); VTR funding from the Finnish Government	This study was partially supported by the Finnish Funding Agency for Technology and Innovation (Tekes) to the Salwe GID (Personalized Diagnostics and Care) program (ID 3982/31/2013) and by VTR funding from the Finnish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, VIT MIN NUTR INF SYS; [Anonymous], 2003, TECHNOMETRICS; Baart AM, 2013, TRANSFUSION, V53, P1670, DOI 10.1111/j.1537-2995.2012.03956.x; Bialkowski W, 2017, AM J HEMATOL, V92, P851, DOI 10.1002/ajh.24784; Booth AO, 2014, TRANSFUSION, V54, P770, DOI 10.1111/trf.12347; Bryant BJ, 2012, TRANSFUSION, V52, P1566, DOI 10.1111/j.1537-2995.2011.03488.x; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Cable RG, 2016, TRANSFUSION, V56, P2005, DOI 10.1111/trf.13659; Cable RG, 2012, TRANSFUSION, V52, P702, DOI 10.1111/j.1537-2995.2011.03401.x; Cade JE, 2005, AM J CLIN NUTR, V82, P813, DOI 10.1093/ajcn/82.4.813; Canty A., 2017, PACKAGE BOOT BOOTSTR; Cook RL, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111216; DEBRUIN A, 1996, WHO REGIONAL PUBLICA, V58; Di Angelantonio E, 2017, LANCET, V390, P2360, DOI 10.1016/S0140-6736(17)31928-1; Dijkstra AJ, 2011, CHEM IND-LONDON, P30; Efron B., 1994, INTRO BOOTSTRAP; Fairweather-Tait SJ, 2004, P NUTR SOC, V63, P519, DOI 10.1079/PNS2004394; Fleming DJ, 1998, AM J CLIN NUTR, V67, P722, DOI 10.1093/ajcn/67.4.722; Flesland O, 2004, TRANSFUS APHER SCI, V31, P11, DOI 10.1016/j.transci.2004.01.011; Fonseca C, 2016, INTERN MED J, V46, P470, DOI 10.1111/imj.13020; Fox J., 2002, R S PLUS COMPANION A, V91; Galan P, 1998, EUR J CLIN NUTR, V52, P383, DOI 10.1038/sj.ejcn.1600561; Goldman M, 2016, VOX SANG, V111, P449, DOI 10.1111/vox.12431; Goldman M, 2017, TRANSFUSION, V57, P564, DOI 10.1111/trf.13956; Gorlin J, 2016, VOX SANG, V111, P206, DOI 10.1111/vox.12408; Gromping U, 2006, J STAT SOFTW, V17, DOI 10.18637/jss.v017.i01; HALLBERG L, 1993, BRIT J HAEMATOL, V85, P787, DOI 10.1111/j.1365-2141.1993.tb03225.x; Hastka J, 1996, CLIN CHEM, V42, P718; Houston BL, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019240; Jackson J, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020089; Jylha M, 2009, SOC SCI MED, V69, P307, DOI 10.1016/j.socscimed.2009.05.013; Kiss JE, 2018, BRIT J HAEMATOL, V181, P590, DOI 10.1111/bjh.15136; Kiss JE, 2015, JAMA-J AM MED ASSOC, V313, P575, DOI 10.1001/jama.2015.119; Kiss JE, 2013, TRANSFUSION, V53, P2766, DOI 10.1111/trf.12209; Kolbe-Busch S, 2002, CLIN CHEM LAB MED, V40, P529, DOI 10.1515/CCLM.2002.091; Lahti-Koski M, 2003, EUR J NUTR, V42, P287, DOI 10.1007/s00394-003-0425-3; Liu JM, 2003, AM J CLIN NUTR, V78, P1160, DOI 10.1093/ajcn/78.6.1160; Magnussen K, 2015, TRANSFUSION, V55, P2473, DOI 10.1111/trf.13152; Marks DC, 2014, TRANSFUSION, V54, P780, DOI 10.1111/trf.12464; Mast AE, 2016, TRANSFUSION, V56, P1588, DOI 10.1111/trf.13469; Milman N, 2017, AM J CLIN NUTR, V106, p1655S, DOI 10.3945/ajcn.117.156000; Niittymaki P, 2017, BLOOD ADV, V1, P961, DOI 10.1182/bloodadvances.2016004218; O'Meara A, 2011, TRANSFUSION, V51, P2183, DOI 10.1111/j.1537-2995.2011.03148.x; Partanen J, 2018, BIORXIV, DOI [10.1101/507665, DOI 10.1101/507665]; Pasricha SR, 2017, TRANSFUSION, V57, P1922, DOI 10.1111/trf.14173; Pasricha SR, 2014, J NUTR, V144, P906, DOI 10.3945/jn.113.189589; Pasta D.J., 2009, SAS GLOB FOR 2009 IC; Peffer K, 2013, TRANSFUSION, V53, P1468, DOI 10.1111/j.1537-2995.2012.03916.x; Pratt JJ, 2016, EUR J HAEMATOL, V96, P618, DOI 10.1111/ejh.12645; Punnonen K, 1999, TRANSFUSION MED, V9, P131; Punnonen K, 1997, BLOOD, V89, P1052, DOI 10.1182/blood.V89.3.1052; R Core Team, 2016, R FDN STAT COMP; Rigas AS, 2019, TRANSFUSION MED, V29, P23, DOI 10.1111/tme.12477; Rigas AS, 2015, TRANSFUSION, V55, P1752, DOI 10.1111/trf.13085; Rigas AS, 2014, TRANSFUSION, V54, P789, DOI 10.1111/trf.12518; Rigas AS., 2017, ISBT SCI SER, V12, P142, DOI DOI 10.1111/V0XS.12309; Rousseeuw P.J., 2005, ROBUST REGRESSION OU; Salvin HE, 2014, TRANSFUSION, V54, P2434, DOI 10.1111/trf.12647; Schotten N, 2016, BLOOD, V128, P2185, DOI 10.1182/blood-2016-04-709451; Smith GA, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009532.pub2; Spencer BR, 2013, TRANSFUSION, V53, P1645, DOI 10.1111/trf.12260; Suominen P, 1998, BLOOD, V92, P2934, DOI 10.1182/blood.V92.8.2934.420k07_2934_2939; Vehtari A, 2017, STAT COMPUT, V27, P1413, DOI 10.1007/s11222-016-9696-4; Vuk T, 2017, BLOOD TRANSFUS-ITALY, V15, P20, DOI 10.2450/2016.0101-16; World Health Organization, 2011, VITAMIN MINERAL NUTR; World Health Organization (WHO), 2015, GLOB PREV AN 2011, DOI DOI 10.1017/S1368980008002401	66	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220862	10.1371/journal.pone.0220862	http://dx.doi.org/10.1371/journal.pone.0220862			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408501	Green Published, Green Submitted, gold			2022-12-26	WOS:000485009500023
J	de Rassenfosse, G; Jaffe, A; Raiteri, E				de Rassenfosse, Gaetan; Jaffe, Adam; Raiteri, Emilio			The procurement of innovation by the US government	PLOS ONE			English	Article							SCIENCE; IMPACT	The U.S. government invests more than $50 billion per year in R&D procurement but we know little about the outcomes of these investments. We have traced all the patents arising from government funding since the year 2000. About 1.5 percent of all R&D procurement contracts have led to at least one patent for a total of about 13,000 patents. However, contracts connected to patents account for 36 per cent of overall contract value. The gestation lag from the signing date of the contract to the patent filing is on average 33 months and does not depend on the type of R&D performed. Patents that are produced faster also seem to be more valuable. We find strong decreasing returns to contract size. Conditional on generating at least one patent, a 1-percent increase in the size of an R&D contract is associated with 0.12 percent more patents.	[de Rassenfosse, Gaetan; Raiteri, Emilio] Ecole Polytech Fed Lausanne, Coll Management Technol, Chair Innovat & IP Policy, Lausanne, Switzerland; [Jaffe, Adam] MIT, Sloan Sch Management, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Jaffe, Adam] Brandeis Univ, Waltham, MA USA; [Jaffe, Adam] Motu Econ & Publ Policy Res, Wellington, New Zealand; [Jaffe, Adam] Queensland Univ Technol, Brisbane, Qld, Australia; [Raiteri, Emilio] Eindhoven Univ Technol, Sch Innovat Sci, Eindhoven, Netherlands	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Massachusetts Institute of Technology (MIT); Brandeis University; Queensland University of Technology (QUT); Eindhoven University of Technology	de Rassenfosse, G (corresponding author), Ecole Polytech Fed Lausanne, Coll Management Technol, Chair Innovat & IP Policy, Lausanne, Switzerland.	gaetan.derassenfosse@epfl.ch	Jaffe, Adam/R-8313-2019	Jaffe, Adam/0000-0003-1337-1751; de Rassenfosse, Gaetan/0000-0002-7862-0918; raiteri, emilio/0000-0002-2769-1660	Marie Sklodowska-Curie program [665667]	Marie Sklodowska-Curie program	E.R. was supported by Marie Sklodowska-Curie program for the project "Innovative Public Procurement as Innovation Policy" (Action: H2020-MSCA COFUND-2015, Grant Agreement Number: 665667). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora A., 2005, ANN EC STAT, V79, P91, DOI [10.2307/20777571, DOI 10.2307/20777571]; Azoulay P, 2015, PUBLIC R D INVESTMEN; de Rassenfosse G, 2018, EUR ECON REV, V101, P625, DOI 10.1016/j.euroecorev.2017.11.005; GEROSKI P. A., 1990, INT REV APPL EC, V4, P182, DOI DOI 10.1080/758523673; Jacob BA, 2011, J PUBLIC ECON, V95, P1168, DOI 10.1016/j.jpubeco.2011.05.005; Jaffe AB, 2017, J ASSOC INF SCI TECH, V68, P1360, DOI 10.1002/asi.23731; Lane J, 2011, SCIENCE, V331, P678, DOI 10.1126/science.1201865; Lane J, 2010, NATURE, V464, P488, DOI 10.1038/464488a; Li D, 2017, SCIENCE, V356, P78, DOI 10.1126/science.aal0010; LICHTENBERG FR, 1988, AM ECON REV, V78, P550; Link AN, 2009, ECON INNOV NEW TECH, V18, P381, DOI 10.1080/10438590802208166; Mowery D. C., 2011, ACCELERATING ENERGY, P159; Raiteri E, 2018, RES POLICY, V47, P936, DOI 10.1016/j.respol.2018.02.017; Sampat BN, 2012, RES POLICY, V41, P1729, DOI 10.1016/j.respol.2012.05.013; Toole AA, 2007, J ECON BEHAV ORGAN, V63, P716, DOI 10.1016/j.jebo.2006.05.011	15	3	3	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0218927	10.1371/journal.pone.0218927	http://dx.doi.org/10.1371/journal.pone.0218927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5GN	31404070	gold, Green Published, Green Submitted			2022-12-26	WOS:000485006800006
J	Liang, D; McHugh, KM; Brophy, PD; Shaikh, N; Manak, JR; Andrews, P; Hakker, I; Wang, ZH; Schwaderer, AL; Hains, DS				Liang, Dong; McHugh, Kirk M.; Brophy, Pat D.; Shaikh, Nader; Manak, J. Robert; Andrews, Peter; Hakker, Inessa; Wang, Zihua; Schwaderer, Andrew L.; Hains, David S.			DNA copy number variations in children with vesicoureteral reflux and urinary tract infections	PLOS ONE			English	Article							GENOME SCAN; KIDNEY; LINKAGE; GENE; ASSOCIATION; MUTATIONS; ANOMALIES; TYPE-1; FAMILY; LOCUS	Vesicoureteral reflux (VUR) is a complex, heritable disorder. Genome-wide linkage analyses of families affected by VUR have revealed multiple genomic loci linked to VUR. These loci normally harbor a number of genes whose biologically functional variant is yet to be identified. DNA copy number variations (CNVs) have not been extensively studied at high resolution in VUR patients. In this study, we performed array comparative genomic hybridization (aCGH) on a cohort of patients with a history of both VUR and urinary tract infection (UTI) with the objective of identifying genetic variations responsible for VUR and/or UTI susceptibility. UTI/VUR-associated CNVs were identified by aCGH results from the 192 Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) patients compared to 683 controls. Rare, large CNVs that are likely pathogenic and lead to VUR development were identified using stringent analysis criteria. Because UTI is a common affliction with multiple risk factors, we utilized standard analysis to identify potential disease-modifying CNVs that can contribute to UTI risk. Gene ontology analysis identified that CNVs in innate immunity and development genes were enriched in RIVUR patients. CNVs affecting innate immune genes may contribute to UTI susceptibility in VUR patients and may provide the first step in assisting clinical medicine in determining adverse outcome risk in children with VUR.	[Liang, Dong; Schwaderer, Andrew L.; Hains, David S.] Indiana Univ, Dept Pediat, Indianapolis, IN 46204 USA; [Liang, Dong; Schwaderer, Andrew L.; Hains, David S.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [McHugh, Kirk M.] Ohio State Univ, Div Anat, Columbus, OH 43210 USA; [Brophy, Pat D.] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA; [Shaikh, Nader] Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15260 USA; [Manak, J. Robert] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Manak, J. Robert] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Andrews, Peter; Hakker, Inessa; Wang, Zihua] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Schwaderer, Andrew L.; Hains, David S.] Indiana Univ Hlth, Riley Hosp Children, Indianapolis, IN 46290 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; University System of Ohio; Ohio State University; University of Rochester; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Iowa; University of Iowa; Cold Spring Harbor Laboratory; Indiana University System; James Whitcomb Riley Hospital Children	Schwaderer, AL; Hains, DS (corresponding author), Indiana Univ, Dept Pediat, Indianapolis, IN 46204 USA.; Schwaderer, AL; Hains, DS (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA.; Schwaderer, AL; Hains, DS (corresponding author), Indiana Univ Hlth, Riley Hosp Children, Indianapolis, IN 46290 USA.	schwadea@iu.edu; dhains@iu.edu	Wang, Zhiquan/HHS-6768-2022; Hains, David/AAR-1112-2020	Liang, Dong/0000-0003-2494-1537; Manak, John/0000-0002-6562-7694	National Institutes of Health (NIH) [1RC4DK090937-01];  [1R01DK106286-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK106286] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	A.L.S., P.D.B., K.M.M., N.S., J.R.M., and D.S.H. were all funded by National Institutes of Health (NIH) grant 1RC4DK090937-01. A.L.S. and D.S.H are also supported by 1R01DK106286-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A.L.S., P.D.B., K.M.M., N.S., J.R.M., and D.S.H. were all funded by National Institutes of Health (NIH) grant 1RC4DK090937-01. A.L.S. and D.S.H are also supported by 1R01DK106286-01. D.S.H. and A.L.S. initiated this project at Nationwide Children's Hospital in Columbus, OH. D. L. and D.S.H. also continued work on this project at Le Bonheur Children's Hospital in Memphis, TN.	Briggs CE, 2010, EUR J HUM GENET, V18, P245, DOI 10.1038/ejhg.2009.142; Brophy PD, 2013, HUM GENET, V132, P1339, DOI 10.1007/s00439-013-1338-8; Carpenter MA, 2013, PEDIATRICS, V132, pE34, DOI 10.1542/peds.2012-2301; Carvas F, 2010, CURR OPIN UROL, V20, P336, DOI 10.1097/MOU.0b013e328339b739; Chauvet V, 2002, AM J PATHOL, V160, P973, DOI 10.1016/S0002-9440(10)64919-X; Colonna M, 2007, NAT IMMUNOL, V8, P554, DOI 10.1038/ni0607-554; Conte ML, 2008, PEDIATR NEPHROL, V23, P587, DOI 10.1007/s00467-007-0675-z; Cordell HJ, 2010, J AM SOC NEPHROL, V21, P113, DOI 10.1681/ASN.2009060624; Darlow JM, 2014, MOL GENET GENOM MED, V2, P7, DOI 10.1002/mgg3.22; Feather SA, 2000, AM J HUM GENET, V66, P1420, DOI 10.1086/302864; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Gbadegesin RA, 2013, J AM SOC NEPHROL, V24, P1313, DOI 10.1681/ASN.2012121148; Hains DS, 2010, J UROLOGY, V183, P2077, DOI 10.1016/j.juro.2009.12.095; Handsaker RE, 2015, NAT GENET, V47, P296, DOI 10.1038/ng.3200; Hoberman A, 2014, NEW ENGL J MED, V370, P2367, DOI 10.1056/NEJMoa1401811; Hollox EJ, 2014, HUM GENET, V133, P1217, DOI 10.1007/s00439-014-1457-x; Kamath BM, 2012, AM J MED GENET A, V158A, P85, DOI 10.1002/ajmg.a.34369; Kelly H, 2007, J MED GENET, V44, P710, DOI 10.1136/jmg.2007.051086; Lee WC, 2010, AM J PHYSIOL-RENAL, V299, pF740, DOI 10.1152/ajprenal.00148.2010; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Lundstedt AC, 2007, J INFECT DIS, V195, P1227, DOI 10.1086/512620; Madsen J, 2003, EUR J IMMUNOL, V33, P2327, DOI 10.1002/eji.200323972; Malaviya R, 2004, IMMUNOL LETT, V91, P103, DOI 10.1016/j.imlet.2003.10.005; McCabe D, 2002, J BIOL CHEM, V277, P27477, DOI 10.1074/jbc.M201586200; Neirijnck Y, 2018, KIDNEY INT, V93, P1142, DOI 10.1016/j.kint.2017.11.026; Nino F, 2016, CURR GENOMICS, V17, P70, DOI 10.2174/1389202916666151014223507; Prontera P, 2006, GENET COUNSEL, V17, P407; Puri P, 2011, NAT REV UROL, V8, P539, DOI 10.1038/nrurol.2011.113; Sanna-Cherchi S, 2005, J AM SOC NEPHROL, V16, P1781, DOI 10.1681/ASN.2004121034; Sanna-Cherchi S, 2013, NEW ENGL J MED, V369, P621, DOI 10.1056/NEJMoa1214479; Schwaderer AL, 2016, J AM SOC NEPHROL, V27, P3175, DOI 10.1681/ASN.2015060700; Sencan A, 2014, J PEDIATR UROL, V10, P1008, DOI 10.1016/j.jpurol.2014.04.001; Sharma M, 2018, CELL SIGNAL, V47, P52, DOI 10.1016/j.cellsig.2018.03.004; Shen YP, 2009, CLIN CHEM, V55, P659, DOI 10.1373/clinchem.2008.112821; Shirley MD, 2012, HUM MUTAT, V33, P1075, DOI 10.1002/humu.22062; Stromberg N, 2017, EBIOMEDICINE, V26, P38, DOI 10.1016/j.ebiom.2017.11.019; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Verbitsky M, 2015, J CLIN INVEST, V125, P2171, DOI 10.1172/JCI80877; Walker KA, 2016, PEDIATR NEPHROL, V31, P885, DOI 10.1007/s00467-015-3151-1; Wang ZH, 2016, GENOME RES, V26, P844, DOI 10.1101/gr.201491.115; Weng PL, 2009, J AM SOC NEPHROL, V20, P1633, DOI 10.1681/ASN.2008111199; Williams G, 2016, PROCEEDINGS OF THE XVII EURALEX INTERNATIONAL CONGRESS, P847; Zhang YX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11720-0	43	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220617	10.1371/journal.pone.0220617	http://dx.doi.org/10.1371/journal.pone.0220617			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404082	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000485006800020
J	Ueno, K; Otani, Y; Yanagihara, N; Nakamura, T; Shimizu, K; Yamagoe, S; Miyazaki, Y				Ueno, Keigo; Otani, Yoshiko; Yanagihara, Nao; Nakamura, Takumi; Shimizu, Kiminori; Yamagoe, Satoshi; Miyazaki, Yoshitsugu			Cryptococcus gattii alters immunostimulatory potential in response to the environment	PLOS ONE			English	Article							C-TYPE LECTIN; PULMONARY INFECTION; DECTIN-1; RECOGNITION; NEOFORMANS; RECEPTOR; MATURATION; DEFENSE; GROWTH; YEAST	Cryptococcus gattii is a capsular fungal pathogen, which causes life-threatening cryptococcosis in immunocompetent individuals. This emerging pathogen is less likely to be recognized by innate immunity compared to traditional Cryptococcus neoformans strains. Previous studies indicate that C-type lectin receptors (CLRs), including dectin-1 and dectin-2, play a role in recognizing cryptococcal cells; however, it remains to be elucidated whether the receptors physically associate with C. gattii yeast cell surfaces. Based on the previous findings, we hypothesized that culture conditions influence the expression or exposure of CLR ligands on C. gattii. Therefore, in the present study, we first investigated the culture conditions that induce exposure of CLR ligands on C. gattii yeast cells via the binding assay using recombinant fusion proteins of mouse CLR and IgG Fc, Fc dectin-1 and Fc dectin-2. Common fungal culture media, such as yeast extract peptone dextrose (YPD) broth, Sabouraud broth, and potato dextrose agar, did not induce the exposure of dectin-1 ligands, including beta-1,3-glucan, on both capsular and acapsular C. gattiistrains, in contrast to Fc dectin-1 and Fc dectin-2 bound to C. gattii cells growing in the conventional synthetic dextrose (SD) medium [may also be referred to as a yeast nitrogen base with glucose medium]. The medium also induced the exposure of dectin-1 ligands on C. neoformans, whereas all tested media induced dectin-1 and dectin-2 ligands in a control fungus Candida albicans. Notably, C. gattii did not expose dectin-1 ligands in SD medium supplemented with yeast extract or neutral buffer. In addition, compared to YPD medium-induced C. gattii, SD medium-induced C. gattii more efficiently induced the phosphorylation of Syk, Akt, and Erk1/2 in murine dendritic cells (DCs). Afterwards, the cells were considerably engulfed by DCs and remarkably induced DCs to secrete the inflammatory cytokines. Overall, the findings suggest that C. gattii alters its immunostimulatory potential in response to the environment.	[Ueno, Keigo; Otani, Yoshiko; Yanagihara, Nao; Nakamura, Takumi; Yamagoe, Satoshi; Miyazaki, Yoshitsugu] Natl Inst Infect Dis, Dept Chemotherapy & Mycoses, Shinjuku Ku, Toyama, Tokyo, Japan; [Otani, Yoshiko; Yanagihara, Nao; Nakamura, Takumi; Shimizu, Kiminori] Tokyo Univ Sci, Dept Biol Sci & Technol, Fac Ind Sci & Technol, Katsushika Ku, Tokyo, Japan	National Institute of Infectious Diseases (NIID); Tokyo University of Science	Ueno, K (corresponding author), Natl Inst Infect Dis, Dept Chemotherapy & Mycoses, Shinjuku Ku, Toyama, Tokyo, Japan.	keigo-u@niid.go.jp		miyazaki, yoshitsugu/0000-0001-8942-0869; Ueno, Keigo/0000-0003-0671-0049	Ministry of Education, Culture, Sports, Science, and Technology of Japan [KAKENHI 17K10040, KAKENHI 17K18385]; Takeda Science Foundation; Tomy Digital Biology Co. Ltd; Japan Agency for Medical Research and Development, AMED [JP19fk0108045, JP19fk0108094]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Tomy Digital Biology Co. Ltd; Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	This work was supported by: Ministry of Education, Culture, Sports, Science, and Technology of Japan [KAKENHI 17K18385], Takeda Science Foundation, Tomy Digital Biology Co. Ltd [LEGEND Research Grant Program 2015] to Keigo Ueno; and by Ministry of Education, Culture, Sports, Science, and Technology of Japan [KAKENHI 17K10040], Japan Agency for Medical Research and Development, AMED [JP19fk0108045 and JP19fk0108094] to Yoshitsugu Miyazaki. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; Ariizumi K, 2000, J BIOL CHEM, V275, P11957, DOI 10.1074/jbc.275.16.11957; Ballou ER, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.238; Blanco-Menendez N, 2015, J IMMUNOL, V195, P4466, DOI 10.4049/jimmunol.1402874; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Brown GD, 2018, NAT REV IMMUNOL, V18, P374, DOI 10.1038/s41577-018-0004-8; Campuzano A, 2018, J FUNGI, V4, DOI 10.3390/jof4010033; Cheng PY, 2009, INFECT IMMUN, V77, P4284, DOI 10.1128/IAI.00628-09; Chiba S, 2014, ELIFE, V3, DOI 10.7554/eLife.04177; CROSS CE, 1995, INFECT IMMUN, V63, P2604, DOI 10.1128/IAI.63.7.2604-2611.1995; Deng ZH, 2015, NAT IMMUNOL, V16, P642, DOI 10.1038/ni.3155; Esher SK, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007126; Farkas V, 2009, FEMS YEAST RES, V9, P311, DOI 10.1111/j.1567-1364.2008.00478.x; Frank D, 2018, MBIO, V9, DOI [10.1128/mBio.00782-18, 10.1128/mbio.00782-18]; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gilbert NM, 2012, MBIO, V3, DOI 10.1128/mBio.00007-12; Giles SS, 2009, INFECT IMMUN, V77, P3491, DOI 10.1128/IAI.00334-09; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; Graham LM, 2006, J IMMUNOL METHODS, V314, P164, DOI 10.1016/j.jim.2006.05.013; Huston SM, 2016, J IMMUNOL, V196, P1259, DOI 10.4049/jimmunol.1501089; JAMES PG, 1990, CARBOHYD RES, V198, P23, DOI 10.1016/0008-6215(90)84273-W; JOHNSON BF, 1967, J BACTERIOL, V94, P192, DOI 10.1128/JB.94.1.192-195.1967; Leongson K, 2013, INFECT IMMUN, V81, P1100, DOI 10.1128/IAI.01339-12; Lim J, 2018, J IMMUNOL, V200, P3539, DOI 10.4049/jimmunol.1700790; Ma J, 2014, J IMMUNOL, V192, P1356, DOI 10.4049/jimmunol.1302835; Matsuo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059887; McGreal EP, 2006, GLYCOBIOLOGY, V16, P422, DOI 10.1093/glycob/cwj077; Mukaremera Liliane, 2018, Cell Surf, V1, P15, DOI 10.1016/j.tcsw.2017.12.001; Nakamura K, 2007, MICROBIOL IMMUNOL, V51, P1115, DOI 10.1111/j.1348-0421.2007.tb04007.x; Nakamura Y, 2015, INFECT IMMUN, V83, P671, DOI 10.1128/IAI.02835-14; Nishino K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141796; O'Meara TR, 2014, MOL CELL BIOL, V34, P673, DOI 10.1128/MCB.01359-13; O'Meara TR, 2013, MBIO, V4, DOI 10.1128/mBio.00522-12; Okubo Y, 2013, JPN J INFECT DIS, V66, P216, DOI 10.7883/yoken.66.216; Ostrop J, 2017, J IMMUNOL, V198, P1403, DOI 10.4049/jimmunol.1601665; Patin EC, 2019, SEMIN CELL DEV BIOL, V89, P24, DOI 10.1016/j.semcdb.2018.03.003; Rachini A, 2007, INFECT IMMUN, V75, P5085, DOI 10.1128/IAI.00278-07; Rapaka RR, 2007, J IMMUNOL, V178, P3702, DOI 10.4049/jimmunol.178.6.3702; Springer DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010978; Stanton BC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000860; Strijbis K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003446; Tarumoto N, 2014, J INFECT DIS, V209, P799, DOI 10.1093/infdis/jit534; Thiagarajan PS, 2013, CARDIOVASC RES, V99, P494, DOI 10.1093/cvr/cvt117; Ueno K, 2019, MED MYCOL, V57, P1046, DOI 10.1093/mmy/myy153; Ueno K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35699-4; Ueno K, 2019, MUCOSAL IMMUNOL, V12, P265, DOI 10.1038/s41385-018-0094-4; Ueno K, 2015, INFECT IMMUN, V83, P1577, DOI 10.1128/IAI.02827-14; Ueno K, 2013, MED MYCOL, V51, P385, DOI 10.3109/13693786.2012.733892; Urai M, 2016, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00101; Walsh NM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173866; Wang HF, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006568; Wright WF, 2011, LABMEDICINE, V42, P679, DOI 10.1309/LM8BW8QNV7NZBROG	52	4	4	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220989	10.1371/journal.pone.0220989	http://dx.doi.org/10.1371/journal.pone.0220989			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398236	Green Published, gold, Green Submitted			2022-12-26	WOS:000485004000036
J	Malila, Y; Thanatsang, K; Arayamethakorn, S; Uengwetwanit, T; Srimarut, Y; Petracci, M; Strasburg, GM; Rungrassamee, W; Visessanguan, W				Malila, Yuwares; Thanatsang, Krittaporn; Arayamethakorn, Sopacha; Uengwetwanit, Tanaporn; Srimarut, Yanee; Petracci, Massimiliano; Strasburg, Gale M.; Rungrassamee, Wanilada; Visessanguan, Wonnop			Absolute expressions of hypoxia-inducible factor-1 alpha (HIF1A) transcript and the associated genes in chicken skeletal muscle with white striping and wooden breast myopathies	PLOS ONE			English	Article							PECTORALIS-MAJOR MUSCLE; LIGHT-CHAIN KINASE; MEAT QUALITY; SARCOGLYCAN COMPLEX; GLUTATHIONE TRANSFERASE; COMMERCIAL CONDITIONS; MUSCULAR-DYSTROPHY; OXIDATIVE STRESS; BROILER-CHICKENS; DOWN-REGULATION	Development of white striping (WS) and wooden breast (WB) in broiler breast meat have been linked to hypoxia, but their etiologies are not fully understood. This study aimed at investigating absolute expression of hypoxia-inducible factor-1 alpha subunit (HIF1A) and genes involved in stress responses and muscle repair using a droplet digital polymerase chain reaction. Total RNA was isolated from pectoralis major collected from male 6-week-old medium (carcass weight <= 2.5 kg) and heavy (carcass weight >2.5 kg) broilers. Samples were classified as "non-defective" (n = 4), "medium-WS" (n = 6), "heavy-WS" (n = 7) and "heavy-WS+ WB" (n = 3) based on abnormality scores. The HIF1A transcript was upregulated in all of the abnormal groups. Transcript abundances of genes encoding 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 (PFKFB4), lactate dehydrogenase-A (LDHA), and phosphorylase kinase beta subunit (PHKB) were increased in heavy-WS but decreased in heavy-WS+WB. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was up-regulated in non-defective samples. The muscle-specific mu-2 isoform of glutathione Stransferases (GSTM2) was up-regulated in the abnormal samples, particularly in the heavy groups. The genes encoding myogenic differentiation (MYOD1) and myosin light chain kinase (MYLK) exhibited similar expression pattern, of which medium-WS and heavy-WS significantly increased compared to non-defective whereas expression in heavy-WS+WB was not different from either non-defective or WS-affected group. The greatest and the lowest levels of calpain-3 (CAPN3) and delta-sarcoglycan (SCGD) were observed in heavy-WS and heavy-WS+ WB, respectively. Based on micrographs, the abnormal muscles primarily comprised fibers with cross-sectional areas ranging from 2,000 to 3,000 mu m(2). Despite induced glycolysis at the transcriptional level, lower stored glycogen in the abnormal muscles corresponded with the reduced lactate and higher pH within their meats. The findings support hypoxia within the abnormal breasts, potentially associated with oversized muscle fibers. Between WS and WB, divergent glucose metabolism, cellular detoxification and myoregeneration at the transcriptional level could be anticipated.	[Malila, Yuwares; Thanatsang, Krittaporn; Arayamethakorn, Sopacha; Uengwetwanit, Tanaporn; Srimarut, Yanee; Rungrassamee, Wanilada; Visessanguan, Wonnop] Natl Ctr Genet Engn & Biotechnol BIOTEC, Khlong Luang, Pathum Thani, Thailand; [Petracci, Massimiliano] Univ Bologna, Dept Agr & Food Sci, Alma Mater Studiorum, Cesena, FC, Italy; [Strasburg, Gale M.] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA	National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); University of Bologna; Michigan State University	Malila, Y (corresponding author), Natl Ctr Genet Engn & Biotechnol BIOTEC, Khlong Luang, Pathum Thani, Thailand.	yuwares.mal@biotec.or.th	Uengwetwanit, Tanaporn/AFV-0013-2022; Malila, Yuwares/AAF-1353-2020; Rungrassamee, Wanilada/E-1718-2011; Petracci, Massimiliano/K-4169-2015	Uengwetwanit, Tanaporn/0000-0003-4710-2613; Malila, Yuwares/0000-0001-5950-5319; Rungrassamee, Wanilada/0000-0002-5802-4342; Petracci, Massimiliano/0000-0002-5671-5676; Strasburg, Gale/0000-0002-3897-4340	Cluster and Program Management (CPM), National Science and Technology Development Agency (NTSDA, Thailand) [P15-50668]; Thailand Research Fund (TRF) [TRG 5980007]	Cluster and Program Management (CPM), National Science and Technology Development Agency (NTSDA, Thailand); Thailand Research Fund (TRF)(Thailand Research Fund (TRF))	This research was financially supported by Cluster and Program Management (CPM), National Science and Technology Development Agency (NTSDA, Thailand, https://www.nstda.or.th/th/industrial-research) towards YM, YS, TU, SA, WR and WV (Grant number P15-50668) and by Thailand Research Fund (TRF, http://academics.trf.or. th/) towards YM and WV (Grant number TRG 5980007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasht B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153750; Abdellatif Y, 2007, CELL CALCIUM, V41, P429, DOI 10.1016/j.ceca.2006.08.004; Alnahhas N, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0369-2; Apidianakis Y, 2012, FASEB J, V26, P730, DOI 10.1096/fj.11-192484; Araishi K, 1999, HUM MOL GENET, V8, P1589, DOI 10.1093/hmg/8.9.1589; Bailey RA, 2015, POULTRY SCI, V94, P2870, DOI 10.3382/ps/pev304; Baldi G, 2018, ANIMAL, V12, P164, DOI 10.1017/S1751731117001069; Beckmann JS, 2008, NEUROMUSCULAR DISORD, V18, P913, DOI 10.1016/j.nmd.2008.08.005; Berri C, 2007, J ANIM SCI, V85, P2005, DOI 10.2527/jas.2006-398; Blue EK, 2002, AM J PHYSIOL-CELL PH, V282, pC451, DOI 10.1152/ajpcell.00333.2001; Boerboom G, 2018, POULTRY SCI, V97, P3977, DOI 10.3382/ps/pey266; Chesney J, 2014, ONCOTARGET, V5, P6670, DOI 10.18632/oncotarget.2213; Cirillo F, 2017, FASEB J, V31, P2146, DOI 10.1096/fj.201600878R; Clark DL, 2016, POULTRY SCI, V95, P2930, DOI 10.3382/ps/pew243; Damon M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033763; Daughtry MR, 2017, POULTRY SCI, V96, P3457, DOI 10.3382/ps/pex068; Eadmusik S, 2011, BRIT POULTRY SCI, V52, P177, DOI 10.1080/00071668.2011.554798; Ehmsen J, 2002, J CELL SCI, V115, P2801; Favier FB, 2015, CELL MOL LIFE SCI, V72, P4681, DOI 10.1007/s00018-015-2025-9; FIRTH JD, 1995, J BIOL CHEM, V270, P21021, DOI 10.1074/jbc.270.36.21021; Gan H., 2016, MUSCULOSKELET REGEN, V2, pe1193, DOI [10.14800/mr.1193, DOI 10.14800/MR.1193]; Griffin JR, 2018, AVIAN PATHOL, V47, P2, DOI 10.1080/03079457.2017.1356908; Groh S, 2009, J BIOL CHEM, V284, P19178, DOI 10.1074/jbc.C109.010728; Hack AA, 1998, J CELL BIOL, V142, P1279, DOI 10.1083/jcb.142.5.1279; Hauerslev S, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-43; Hernandez-Hernandez M, 2017, SEMIN CELL DEV BIOL, V72, P10, DOI 10.1016/j.semcdb.2017.11.010; Herring BP, 2000, AM J PHYSIOL-CELL PH, V279, pC1656, DOI 10.1152/ajpcell.2000.279.5.C1656; Higashimura Y, 2011, ARCH BIOCHEM BIOPHYS, V509, P1, DOI 10.1016/j.abb.2011.02.011; Hou XW, 2017, FASEB J, V31, P3179, DOI 10.1096/fj.201601082R; Houddane A, 2017, CELL SIGNAL, V34, P23, DOI 10.1016/j.cellsig.2017.02.019; Huenchuguala S, 2014, AUTOPHAGY, V10, P618, DOI 10.4161/auto.27720; Karalaki M, 2009, IN VIVO, V23, P779; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; KETTERER B, 1983, ENVIRON HEALTH PERSP, V49, P59, DOI 10.2307/3429581; KHAN AW, 1971, CAN INST F SCI TEC J, V4, P139, DOI 10.1016/S0008-3860(71)74218-4; Kindlein L., 2017, J VET SCI TECHNOLOGY, V8, P1000478, DOI [10.4172/2157-7579.1000478, DOI 10.4172/2157-7579.1000478]; Kravchenko-Balasha N, 2009, J BIOL CHEM, V284, P11717, DOI 10.1074/jbc.M900217200; Kuttappan VA, 2017, POULTRY SCI, V96, P3005, DOI 10.3382/ps/pex072; Kuttappan VA, 2013, POULTRY SCI, V92, P811, DOI 10.3382/ps.2012-02506; Kuttappan VA, 2013, POULTRY SCI, V92, P339, DOI 10.3382/ps.2012-02647; Kuttappan VA, 2012, POULTRY SCI, V91, P2677, DOI 10.3382/ps.2012-02259; Kuttappan VA, 2012, POULTRY SCI, V91, P1240, DOI 10.3382/ps.2011-01947; Kuttappan VA, 2017, POULTRY SCI, V96, P2992, DOI 10.3382/ps/pex069; Le Bihan-Duval E, 2008, BMC GENET, V10, DOI 10.1186/1471-2156-9-53; Lee DC, 2015, CELL, V161, P595, DOI 10.1016/j.cell.2015.03.011; Li YJ, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt408; Liu C, 2005, POULTRY SCI, V84, P376, DOI 10.1093/ps/84.3.376; Lorenzi M, 2014, J APPL POULTRY RES, V23, P754, DOI 10.3382/japr.2014-00968; Lundby C, 2009, CELL MOL LIFE SCI, V66, P3615, DOI 10.1007/s00018-009-0146-8; Macrae VE, 2006, BRIT POULTRY SCI, V47, P264, DOI 10.1080/00071660600753615; Maftouh M, 2014, BRIT J CANCER, V110, P172, DOI 10.1038/bjc.2013.681; Majmundar AJ, 2015, DEVELOPMENT, V142, P2405, DOI 10.1242/dev.123026; Malila Y, 2013, POULTRY SCI, V92, P1621, DOI 10.3382/ps.2012-02778; Malila Y, 2018, ASIAN AUSTRAL J ANIM, V31, P1807, DOI 10.5713/ajas.18.0355; Marchesi JAP, 2019, POULTRY SCI, V98, P590, DOI 10.3382/ps/pey429; Masson N, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-3; Mazzoni M, 2015, POULTRY SCI, V94, P123, DOI 10.3382/ps/peu043; Minchenko O, 2004, FEBS LETT, V576, P14, DOI 10.1016/j.febslet.2004.08.053; Minchenko O, 2003, FEBS LETT, V554, P264, DOI 10.1016/S0014-5793(03)01179-7; Minchenko OH, 2014, WORLD J GASTROENTERO, V20, P13705, DOI 10.3748/wjg.v20.i38.13705; Mudalal S, 2015, ANIMAL, V9, P728, DOI 10.1017/S175173111400295X; Mudalal S, 2014, POULTRY SCI, V93, P2108, DOI 10.3382/ps.2014-03911; MURPHY ME, 1986, BIOCHEM BIOPH RES CO, V134, P550, DOI 10.1016/S0006-291X(86)80455-7; Mutryn MF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1623-0; NUNNALLY MH, 1985, J BIOL CHEM, V260, P1020; Pampouille E, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4598-9; Papah MB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207346; Petracci M, 2015, WORLD POULTRY SCI J, V71, P363, DOI 10.1017/S0043933915000367; Petracci M, 2013, POULTRY SCI, V92, P2438, DOI 10.3382/ps.2013-03087; Petracci M, 2013, POULTRY SCI, V92, P1670, DOI 10.3382/ps.2012-03001; Petracci M, 2014, ITAL J ANIM SCI, V13, DOI 10.4081/ijas.2014.3138; Petracci M, 2012, NUTRIENTS, V4, P1, DOI 10.3390/nu4010001; Phadke MS, 2009, J PHARMACOL EXP THER, V331, P77, DOI 10.1124/jpet.109.155671; Pisani DF, 2005, J GEN PHYSIOL, V126, P173, DOI 10.1085/jgp.200509265; Qi HB, 2011, CELL PHYSIOL BIOCHEM, V27, P251, DOI 10.1159/000327951; Radaelli G, 2017, POULTRY SCI, V96, P309, DOI 10.3382/ps/pew270; Ramirez-Sanchez I, 2014, FEBS J, V281, P5567, DOI 10.1111/febs.13098; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Rodrigues SF, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.978720; Ryu YC, 2005, MEAT SCI, V71, P351, DOI 10.1016/j.meatsci.2005.04.015; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Semenza GL, 2017, EMBO J, V36, P252, DOI 10.15252/embj.201695204; Sihvo HK, 2018, J COMP PATHOL, V161, P1, DOI 10.1016/j.jcpa.2018.04.002; Sihvo HK, 2017, VET PATHOL, V54, P119, DOI 10.1177/0300985816658099; Sihvo HK, 2014, VET PATHOL, V51, P619, DOI 10.1177/0300985813497488; Soglia F, 2016, POULTRY SCI, V95, P651, DOI 10.3382/ps/pev353; Solares-Perez A, 2010, BBA-GEN SUBJECTS, V1800, P373, DOI 10.1016/j.bbagen.2009.11.011; SOSNICKI AA, 1991, FOOD STRUCT, V10, P317; Straub V, 1998, AM J PATHOL, V153, P1623, DOI 10.1016/S0002-9440(10)65751-3; Stuelsatz P, 2010, J BIOL CHEM, V285, P12670, DOI 10.1074/jbc.M109.063966; Tallentire CW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19231-2; Tarakci H, 2016, FRONT BIOSCI-LANDMRK, V21, P744, DOI 10.2741/4418; Thomas MP, 2015, CELL REP, V11, P1079, DOI 10.1016/j.celrep.2015.04.026; Tidball JG, 2011, COMPR PHYSIOL, V1, P2029, DOI 10.1002/cphy.c100092; Trocino A, 2015, POULTRY SCI, V94, P2996, DOI 10.3382/ps/pev296; Velleman SG, 2015, AVIAN DIS, V59, P410, DOI 10.1637/11097-042015-Reg.1; Wattanachant S, 2005, POULTRY SCI, V84, P328, DOI 10.1093/ps/84.2.328; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Wu Y, 2003, J MUSCLE RES CELL M, V24, P499, DOI 10.1023/B:JURE.0000009810.36038.53; Xue Q, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173824; Yang X, 2017, J BIOL CHEM, V292, P5981, DOI 10.1074/jbc.M116.756312; Zambonelli P, 2016, POULTRY SCI, V95, P2771, DOI 10.3382/ps/pew268; Zanou N, 2013, CELL MOL LIFE SCI, V70, P4117, DOI 10.1007/s00018-013-1330-4; Zhu XL, 2001, J BIOL CHEM, V276, P21785, DOI 10.1074/jbc.M101877200; Zimniak L, 1997, TOXICOL APPL PHARM, V143, P221, DOI 10.1006/taap.1996.8070; Zuidhof MJ, 2014, POULTRY SCI, V93, P2970, DOI 10.3382/ps.2014-04291	106	27	29	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220904	10.1371/journal.pone.0220904	http://dx.doi.org/10.1371/journal.pone.0220904			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393948	Green Published, gold, Green Submitted			2022-12-26	WOS:000485002500080
J	Shakibfar, S; Krause, O; Lund-Andersen, C; Strycko, F; Moll, J; Andersen, TO; Petersen, HH; Svendsen, JH; Igel, C				Shakibfar, Saeed; Krause, Oswin; Lund-Andersen, Casper; Strycko, Filip; Moll, Jonas; Andersen, Tariq Osman; Petersen, Helen Hogh; Svendsen, Jesper Hastrup; Igel, Christian			Impact of device programming on the success of the first anti-tachycardia pacing therapy: An anonymized large-scale study	PLOS ONE			English	Article							IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; RAPID VENTRICULAR-TACHYCARDIA; SHOCKS	Background Antitachycardia pacing (ATP) is an effective treatment for ventricular tachycardia (VT). We evaluated the efficacy of different ATP programs based on a large remote monitoring data set from patients with implantable cardioverter-defibrillators (ICDs). Methods A dataset from 18,679 ICD patients was used to evaluate the first delivered ATP treatment. We considered all device programs that were used for at least 50 patients, leaving us with 7 different programs and a total of 32,045 episodes. We used the two-proportions z-test (alpha = 0.01) to compare the probability of success and the probability for acceleration in each group with the corresponding values of the default setting. Results Overall, the first ATP treatment terminated in 78.4%-97.5% of episodes with slow VT and 81.5%-91.1% of episodes with fast VT. The default setting of the ATP programs with the number of sequences S = 3 was applied to treat 30.1% of the slow and 36.6% of the fast episodes. Reducing the maximum number of sequences to S = 2 decreased the success rate for slow VT (P < 0.0001, h = 0.38), while the setting S = 4 resulted in the highest success rate of 97.5% (P < 0.0001, h = 0.27). Conclusion While the default programs performed well, we found that increasing the number of sequences from 3 to 4 was a promising option to improve the overall ATP performance.	[Shakibfar, Saeed; Krause, Oswin; Strycko, Filip; Moll, Jonas; Andersen, Tariq Osman; Igel, Christian] Univ Copenhagen, Dept Comp Sci, Copenhagen, Denmark; [Lund-Andersen, Casper; Petersen, Helen Hogh; Svendsen, Jesper Hastrup] Univ Copenhagen, Rigshosp, Heart Ctr, Dept Cardiol, Copenhagen, Denmark; [Svendsen, Jesper Hastrup] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Igel, C (corresponding author), Univ Copenhagen, Dept Comp Sci, Copenhagen, Denmark.	igel@diku.dk	Svendsen, Jesper Hastrup/G-8573-2017; Lund-Andersen, Casper/AAV-9915-2021; Andersen, Tariq Osman/O-6884-2015; Shakibfar, Saeed/M-2613-2016	Svendsen, Jesper Hastrup/0000-0001-8466-8515; Lund-Andersen, Casper/0000-0003-1111-0734; Andersen, Tariq Osman/0000-0002-9342-5520; Shakibfar, Saeed/0000-0001-8399-0318; Krause, Oswin/0000-0002-0990-559X	Innovation Fund Denmark [72-2014-1]	Innovation Fund Denmark	This work was supported by the Innovation Fund Denmark under grant #72-2014-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099418; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, P567, DOI DOI 10.1234/12345678; Grimm W, 2006, PACE, V29, P759, DOI 10.1111/j.1540-8159.2006.00431.x; Mansour F, 2011, PACE, V34, P506, DOI 10.1111/j.1540-8159.2011.03037.x; Nauffal V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175205; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Shakibfar S, 2019, EUROPACE, V21, P268, DOI 10.1093/europace/euy257; Wathen M, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2007.01.020; Wathen MS, 2004, CIRCULATION, V110, P2591, DOI 10.1161/01.CIR.0000145610.64014.E4; Wilkoff BL, 2008, J AM COLL CARDIOL, V52, P541, DOI 10.1016/j.jacc.2008.05.011; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	11	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0219533	10.1371/journal.pone.0219533	http://dx.doi.org/10.1371/journal.pone.0219533			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393871	Green Published, gold			2022-12-26	WOS:000485002500012
J	Guo, YY; Li, BY; Peng, WQ; Guo, L; Tang, QQ				Guo, Ying-Ying; Li, Bai-Yu; Peng, Wan-Qiu; Guo, Liang; Tang, Qi-Qun			Taurine-mediated browning of white adipose tissue is involved in its anti-obesity effect in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						peroxisome proliferator-activated receptor ? coactivator 1-? (PGC-1?) (PPARGC1A); obesity; adipose tissue; energy metabolism; metabolic regulation; AMP-activated kinase (AMPK); adaptive thermogenesis; browning of adipose tissue; insulin resistance; taurine; UCP1	INSULIN-RESISTANCE; FAT-CELL; OBESITY; SUPPLEMENTATION; ADIPOGENESIS; PGC-1-ALPHA; POPULATIONS; METABOLISM; EXPRESSION; GLUCOSE	Taurine, a nonprotein amino acid, is widely distributed in almost all animal tissues. Ingestion of taurine helps to improve obesity and its related metabolic disorders. However, the molecular mechanism underlying the protective role of taurine against obesity is not completely understood. In this study, it was found that intraperitoneal treatment of mice with taurine alleviated high-fat diet (HFD)-induced obesity, improved insulin sensitivity, and increased energy expenditure and adaptive thermogenesis of the mice. Meanwhile, administration of the mice with taurine markedly induced the browning of inguinal white adipose tissue (iWAT) with significantly elevated expression of PGC1?, UCP1, and other thermogenic genes in iWAT. In vitro studies indicated that taurine also induced the development of brown-like adipocytes in C3H10T1/2 white adipocytes. Knockdown of PGC1? blunted the role of taurine in promoting the brown-like adipocyte phenotypes in C3H10T1/2 cells. Moreover, taurine treatment enhanced AMPK phosphorylation in vitro and in vivo, and knockdown of AMPK?1 prevented taurine-mediated induction of PGC1? in C3H10T1/2 cells. Consistently, specific knockdown of PGC1? in iWAT of the HFD-fed mice inhibited taurine-induced browning of iWAT, with the role of taurine in the enhancement of adaptive thermogenesis, the prevention of obesity, and the improvement of insulin sensitivity being partially impaired. These results reveal a functional role of taurine in facilitating the browning of white adipose tissue, which depends on the induction of PGC1?. Our studies also suggest a potential mechanism for the protective role of taurine against obesity, which involves taurine-mediated browning of white adipose tissue.	[Guo, Ying-Ying; Li, Bai-Yu; Peng, Wan-Qiu; Guo, Liang; Tang, Qi-Qun] Fudan Univ, Zhongshan Hosp, Sch Basic Med Sci, Key Lab Metab & Mol Med,Minist Educ,Dept Biochem, Shanghai 200032, Peoples R China; [Guo, Ying-Ying; Li, Bai-Yu; Peng, Wan-Qiu; Guo, Liang; Tang, Qi-Qun] Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Guo, L; Tang, QQ (corresponding author), Fudan Univ, Zhongshan Hosp, Sch Basic Med Sci, Key Lab Metab & Mol Med,Minist Educ,Dept Biochem, Shanghai 200032, Peoples R China.	liangguo@fudan.edu.cn; qqtang@shmu.edu.cn		Guo, Liang/0000-0001-7353-8336	National Key RAMP;D Program of China [2018YFA0800401]; National Natural Science Foundation of China (NSFC) [31871435, 31370027, 81730021, 31571471]	National Key RAMP;D Program of China; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by National Key R&D Program of China Grant 2018YFA0800401 (to Q.-Q. T.) and National Natural Science Foundation of China (NSFC) Grants 31871435 and 31370027 (to L. G.) and 81730021 and 31571471 (to Q.-Q. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Batista TM, 2013, MOL NUTR FOOD RES, V57, P423, DOI 10.1002/mnfr.201200345; Bhupathiraju SN, 2016, CIRC RES, V118, P1723, DOI 10.1161/CIRCRESAHA.115.306825; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Cao PJ, 2016, NUTR NEUROSCI, V19, P86, DOI 10.1179/1476830514Y.0000000153; Cheong SH, 2013, ADV EXP MED BIOL, V775, P311, DOI 10.1007/978-1-4614-6130-2_26; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Gomez R, 2018, BIOMED PHARMACOTHER, V103, P1028, DOI 10.1016/j.biopha.2018.04.131; Grundy SM, 2016, J INVEST MED, V64, P1082, DOI 10.1136/jim-2016-000155; Guo L, 2019, J BIOL CHEM, V294, P9642, DOI [10.1074/jbc.RA119.008419, 10.1074/jbc.ra119.008419]; Guo L, 2017, J CLIN INVEST, V127, P4449, DOI 10.1172/JCI96324; Guo L, 2016, MOL CELL BIOL, V36, P2553, DOI 10.1128/MCB.00227-16; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; Ide T, 2002, METABOLISM, V51, P1191, DOI 10.1053/meta.2002.34036; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kim KS, 2019, AMINO ACIDS, V51, P245, DOI 10.1007/s00726-018-2659-7; Kim KS, 2013, AMINO ACIDS, V45, P1415, DOI 10.1007/s00726-013-1612-z; Kim KS, 2012, EXP MOL MED, V44, P665, DOI 10.3858/emm.2012.44.11.075; Lambert IH, 2015, ACTA PHYSIOL, V213, P191, DOI 10.1111/apha.12365; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lin S, 2013, MOL NUTR FOOD RES, V57, P2155, DOI 10.1002/mnfr.201300150; Liu Y, 2018, J BIOL CHEM, V293, P14012, DOI 10.1074/jbc.RA118.004401; Lu P, 2016, CELL RES, V26, P1169, DOI 10.1038/cr.2016.108; Murakami S, 2017, LIFE SCI, V186, P80, DOI 10.1016/j.lfs.2017.08.008; Murakami S, 2015, MOL NUTR FOOD RES, V59, P1353, DOI 10.1002/mnfr.201500067; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Qian SW, 2013, P NATL ACAD SCI USA, V110, pE798, DOI 10.1073/pnas.1215236110; Rosa FT, 2014, EUR J NUTR, V53, P823, DOI 10.1007/s00394-013-0586-7; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Sagara M, 2015, ADV EXP MED BIOL, V803, P623, DOI 10.1007/978-3-319-15126-7_50; Smith KB, 2016, PRIMARY CARE, V43, P121, DOI 10.1016/j.pop.2015.10.001; Soukas A, 2001, J BIOL CHEM, V276, P34167, DOI 10.1074/jbc.M104421200; Suwa M, 2003, J APPL PHYSIOL, V95, P960, DOI 10.1152/japplphysiol.00349.2003; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Tsuboyama-Kasaoka N, 2006, ENDOCRINOLOGY, V147, P3276, DOI 10.1210/en.2005-1007; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang WS, 2016, NAT REV MOL CELL BIO, V17, P691, DOI 10.1038/nrm.2016.96; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yamori Y, 2001, HYPERTENS RES, V24, P453, DOI 10.1291/hypres.24.453; Yamori Y, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S21; Zhang JM, 2018, PHYSIOL RES, V67, P347, DOI 10.33549/physiolres.933650; Zhang ZG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6493; Zobel EH, 2016, CURR OBES REP, V5, P449, DOI 10.1007/s13679-016-0233-8	48	26	30	6	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2019	294	41					15014	15024		10.1074/jbc.RA119.009936	http://dx.doi.org/10.1074/jbc.RA119.009936			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9JH	31427436	Green Published, hybrid			2022-12-26	WOS:000499253400015
J	Deiana, A; Forcelloni, S; Porrello, A; Giansanti, A				Deiana, Antonio; Forcelloni, Sergio; Porrello, Alessandro; Giansanti, Andrea			Intrinsically disordered proteins and structured proteins with intrinsically disordered regions have different functional roles in the cell	PLOS ONE			English	Article							NATIVELY UNFOLDED PROTEINS; POSTTRANSLATIONAL MODIFICATIONS; UNSTRUCTURED PROTEINS; GENE ONTOLOGY; PREDICTION; ANTHOLOGY; DOMAINS; FAMILIES; DISEASES; TOOL	Many studies about classification and the functional annotation of intrinsically disordered proteins (IDPs) are based on either the occurrence of long disordered regions or the fraction of disordered residues in the sequence. Taking into account both criteria we separate the human proteome, taken as a case study, into three variants of proteins: i) ordered proteins (ORDPs), ii) structured proteins with intrinsically disordered regions (IDPRs), and iii) intrinsically disordered proteins (IDPs). The focus of this work is on the different functional roles of IDPs and IDPRs, which up until now have been generally considered as a whole. Previous studies assigned a large set of functional roles to the general category of IDPs. We show here that IDPs and IDPRs have non-overlapping functional spectra, play different roles in human diseases, and deserve to be treated as distinct categories of proteins. IDPs enrich only a few classes, functions, and processes: nucleic acid binding proteins, chromatin binding proteins, transcription factors, and developmental processes. In contrast, IDPRs are spread over several functional protein classes and GO annotations which they partly share with ORDPs. As regards to diseases, we observe that IDPs enrich only cancer-related proteins, at variance with previous results reporting that IDPs are widespread also in cardiovascular and neurodegenerative pathologies. Overall, the operational separation of IDPRs from IDPs is relevant towards correct estimates of the occurrence of intrinsically disordered proteins in genome-wide studies and in the understanding of the functional spectra associated to different flavors of protein disorder.	[Deiana, Antonio; Forcelloni, Sergio; Giansanti, Andrea] Sapienza Univ Rome, Dept Phys, Rome, Italy; [Porrello, Alessandro] Univ N Carolina, LCCC, Chapel Hill, NC 27515 USA; [Giansanti, Andrea] INFN, Rome, Italy	Sapienza University Rome; University of North Carolina; University of North Carolina Chapel Hill; Istituto Nazionale di Fisica Nucleare (INFN)	Giansanti, A (corresponding author), Sapienza Univ Rome, Dept Phys, Rome, Italy.; Giansanti, A (corresponding author), INFN, Rome, Italy.	andrea.giansanti@roma1.infn.it	GIANSANTI, ANDREA/O-2686-2014	GIANSANTI, ANDREA/0000-0002-8113-8188	Sapienza University of Rome [000008_17_RS_PICCOLI_2016_GIANSANTI-RICERCA 2016]	Sapienza University of Rome	Publication of this study was funded in part by a basic research grant to AG from the Sapienza University of Rome (000008_17_RS_PICCOLI_2016_GIANSANTI-RICERCA 2016). There were no additional sources of funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai Munehito, 2018, Biophys Rev, V10, P163, DOI 10.1007/s12551-017-0346-7; Armitage P., 1971, STAT METHODS MED RES, V1; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babu MM, 2016, BIOCHEM SOC T, V44, P1185, DOI 10.1042/BST20160172; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Bellay J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r14; Bland M, 1987, INTRO MED STAT; Borgia A, 2018, NATURE, V555, P61, DOI 10.1038/nature25762; BROOKS CL, 1988, PROTEINS THEORETICAL; Buljan M, 2013, CURR OPIN STRUC BIOL, V23, P443, DOI 10.1016/j.sbi.2013.03.006; Burgi J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158594; CARERI G, 1979, ANNU REV BIOPHYS BIO, V8, P69, DOI 10.1146/annurev.bb.08.060179.000441; Careri G., 1974, QUANTUM STATISTICAL, P15; Chen JW, 2006, J PROTEOME RES, V5, P879, DOI 10.1021/pr060048x; Cheng YG, 2006, BIOCHEMISTRY-US, V45, P10448, DOI 10.1021/bi060981d; Colak R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003030; Darling AL, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00158; Daughdrill GW, 2007, J MOL EVOL, V65, P277, DOI 10.1007/s00239-007-9011-2; Daughdrill GW, 2008, PROTEIN FOLDING HDB; DeForte S, 2016, PROTEIN SCI, V25, P676, DOI 10.1002/pro.2864; Dunker A Keith, 2013, Intrinsically Disord Proteins, V1, pe24157, DOI 10.4161/idp.24157; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Fischer E, 1894, BER DTSCH CHEM GES, V27, P2985, DOI DOI 10.1002/CBER.18940270364; FRAUENFELDER H, 1979, NATURE, V280, P558, DOI 10.1038/280558a0; Gao JJ, 2012, BIOCOMPUT-PAC SYM, P94; Garza AS, 2009, LIFE SCI, V84, P189, DOI 10.1016/j.lfs.2008.12.002; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Hegyi H, 2011, NUCLEIC ACIDS RES, V39, P1208, DOI 10.1093/nar/gkq843; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Kay LE, 1998, NAT STRUCT BIOL, V5, P513, DOI 10.1038/755; Kulkarni P, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201800061; Le Gall T, 2007, J BIOMOL STRUCT DYN, V24, P325; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Necci M, 2016, PROTEIN SCI, V25, P2164, DOI 10.1002/pro.3041; Niklas KJ, 2018, J EXP BOT, V69, P1437, DOI 10.1093/jxb/erx493; Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947; Pejaver V, 2014, PROTEIN SCI, V23, P1077, DOI 10.1002/pro.2494; Peng ZL, 2015, CELL MOL LIFE SCI, V72, P137, DOI 10.1007/s00018-014-1661-9; Piovesan D, 2018, NUCLEIC ACIDS RES, V46, pD471, DOI 10.1093/nar/gkx1071; Schlessinger A, 2011, CURR OPIN STRUC BIOL, V21, P412, DOI 10.1016/j.sbi.2011.03.014; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P., 2010, STRUCTURE FUNCTION I; Tompa P, 2009, STRUCTURE FUNCTION I; Tompa P, 2009, BIOESSAYS, V31, P328, DOI 10.1002/bies.200800151; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky Vladimir N, 2017, Intrinsically Disord Proteins, V5, pe1327757, DOI 10.1080/21690707.2017.1327757; Uversky VN, 2017, CELL MOL LIFE SCI, V74, P3065, DOI 10.1007/s00018-017-2554-5; Uversky VN, 2015, FEBS J, V282, P1182, DOI 10.1111/febs.13202; Uversky VN, 2014, CHEM REV, V114, P6844, DOI 10.1021/cr400713r; Uversky VN, 2014, FRONT BIOSCI-LANDMRK, V19, P181, DOI 10.2741/4204; Uversky VN, 2013, BIOPOLYMERS, V99, P870, DOI 10.1002/bip.22298; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/568068; Uversky VN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S7; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Uversky VN., 2017, ADV PROTEIN CHEM STR, P1876; van der Lee R, 2014, CELL REP, V8, P1832, DOI 10.1016/j.celrep.2014.07.055; Vucetic S, 2007, J PROTEOME RES, V6, P1899, DOI 10.1021/pr060393m; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Webb A. R., 2003, STAT PATTERN RECOGNI; Weber G, 1975, Adv Protein Chem, V29, P1, DOI 10.1016/S0065-3233(08)60410-6; Wright P.E., 1999, J MOL BIOL, P293; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Xie HB, 2007, J PROTEOME RES, V6, P1917, DOI 10.1021/pr060394e; Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u; Yan J, 2013, BBA-PROTEINS PROTEOM, V1834, P1671, DOI 10.1016/j.bbapap.2013.05.022; Zhang XJ, 2012, PHYS REP, V510, P1, DOI 10.1016/j.physrep.2011.09.002; Zhou JH, 2018, J MOL BIOL, V430, P2342, DOI 10.1016/j.jmb.2018.03.028	78	46	45	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0217889	10.1371/journal.pone.0217889	http://dx.doi.org/10.1371/journal.pone.0217889			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5MK	31425549	Green Published, gold, Green Submitted			2022-12-26	WOS:000485022400007
J	Aryal, M				Aryal, Mahendra			Calcium alginate entrapped Eupatorium adenophorum Sprengel stems powder for chromium(VI) biosorption in aqueous mediums	PLOS ONE			English	Article							OIL PALM BIOMASS; HEXAVALENT CHROMIUM; ACTIVATED CARBONS; HEAVY-METALS; ADSORPTION; REMOVAL; EQUILIBRIUM; KINETICS; SORPTION; CR(VI)	A novel biosorbent, Eupatorium adenophorum Sprengel-alginate beads was used for chromium(VI) biosorption from aqueous solutions. Biosorption process was optimized at pH 2.0, biomass concentration 1.0 g/L, contact time 60 min, and temperature 30 degrees C respectively. Maximum uptake capacity of Cr(VI) was calculated at 28.011 mg/g. It was found that the overall biosorption process was best described by pseudo second-order kinetics with high correlation coefficient values. Intraparticle diffusion model suggested that Cr(VI) biosorption may proceed within multiple steps. Data obtained from the batch studies confirmed well to the Langmuir, Temkin, and Hill-der Boer isotherm models. Scatchard plot analysis further supported the mono-layer biosorption of Cr(VI) ions on Eupatorium adenophorum Sprengel-alginate beads as described by Langmuir isotherm model. Numerical values of E obtained from Dubinin-Radushkevich isotherm model identified the physisorption as predominant mechanism for Cr(VI) biosorption. The negative values of Delta G degrees confirmed the spontaneous and feasibility nature, whereas positive value of Delta H degrees showed the endothermic nature of biosorption process. Positive value of Delta S degrees indicated an increase in the randomness at the solid/solution interface during the biosorption process. The endothermic nature of Cr(VI) biosorption was also described by Temkin isotherm model. The results indicated that Cr(VI) biosorption was not significantly affected by the presence of co-ions at lower concentrations. Desorption of Cr(VI) ions from metal-loaded Eupatorium adenophorum-alginate beads was observed at 92.091% with 0.5 M HNO3 solution in solid to liquid ratio of 1.0 g/L.	[Aryal, Mahendra] Tribhuvan Univ, Dept Chem, Trichandra Multiple Campus, Kathmandu, Nepal	Tribhuvan University	Aryal, M (corresponding author), Tribhuvan Univ, Dept Chem, Trichandra Multiple Campus, Kathmandu, Nepal.	mahendraaryalnp@yahoo.com	Aryal, Mahendra/AAF-5097-2020	Aryal, Mahendra/0000-0002-6267-193X				Acharya J, 2009, CHEM ENG J, V150, P25, DOI 10.1016/j.cej.2008.11.035; Ahalya N, 2006, INDIAN J CHEM TECHN, V13, P122; Ahmad T, 2011, J ENVIRON SCI HEAL C, V29, P177, DOI 10.1080/10590501.2011.601847; Ajmani A, 2019, CHEM ECOL, V35, P379, DOI 10.1080/02757540.2019.1584614; Aryal M, 2011, CHEM ENG J, V169, P100, DOI 10.1016/j.cej.2011.02.059; Aryal M, 2010, CHEM ENG J, V162, P178, DOI 10.1016/j.cej.2010.05.026; Aryal M, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-014-4173-z; Aryal M, 2014, J CHEM TECHNOL BIOT, V89, P559, DOI 10.1002/jctb.4158; BLANCHARD G, 1984, WATER RES, V18, P1501, DOI 10.1016/0043-1354(84)90124-6; Cui YB, 2019, ACS SUSTAIN CHEM ENG, V7, P1279, DOI 10.1021/acssuschemeng.8b04921; Danish M, 2012, J ANAL APPL PYROL, V97, P19, DOI 10.1016/j.jaap.2012.06.001; DUBININ MM, 1947, ZH FIZ KHIM+, V21, P1351; Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385; Gebrehawaria G, 2015, INT J ENVIRON SCI TE, V12, P1569, DOI 10.1007/s13762-014-0530-2; Gholami F., 2006, Iranian Journal of Environmental Health Science & Engineering, V3, P97; Gin KYH, 2002, WATER RES, V36, P1313, DOI 10.1016/S0043-1354(01)00332-3; Hadi M, 2010, CHEM ENG J, V160, P408, DOI 10.1016/j.cej.2010.03.016; HALSEY G, 1948, J CHEM PHYS, V16, P931, DOI 10.1063/1.1746689; Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5; Horsfall M, 2006, BIORESOURCE TECHNOL, V97, P283, DOI 10.1016/j.biortech.2005.02.016; Horsfall M, 2005, ACTA CHIM SLOV, V52, P174; Jain M, 2009, J HAZARD MATER, V162, P365, DOI 10.1016/j.jhazmat.2008.05.048; Khorramabadi G.S., 2011, CAN J CHEM ENG, V9999, P1; Lagergren S.K., 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; Levankumar L, 2009, J HAZARD MATER, V161, P709, DOI 10.1016/j.jhazmat.2008.04.031; Luan TG, 2006, PROCESS BIOCHEM, V41, P1560, DOI 10.1016/j.procbio.2006.02.020; Lytle CM, 1998, ENVIRON SCI TECHNOL, V32, P3087, DOI 10.1021/es980089x; Mahvi A. H., 2007, Iranian Journal of Environmental Health Science & Engineering, V4, P191; Namasivayam C, 2007, PROCESS SAF ENVIRON, V85, P181, DOI 10.1205/psep05002; Nameni M, 2008, INT J ENVIRON SCI TE, V5, P161, DOI 10.1007/BF03326009; Njoku VO, 2012, SEP SCI TECHNOL, V47, P753, DOI 10.1080/01496395.2011.626829; Onal S, 2007, J HAZARD MATER, V146, P417, DOI 10.1016/j.jhazmat.2007.03.005; Ozdemir G, 2005, WORLD J MICROB BIOT, V21, P163, DOI 10.1007/s11274-004-1563-3; Palmer CD, 1994, EPA540594505 OFF RES; Ranganathan K, 2000, BIORESOURCE TECHNOL, V73, P99, DOI 10.1016/S0960-8524(99)00176-5; Razmovski R, 2008, AFR J BIOTECHNOL, V7, P1693; Netzahuatl-Munoz AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137086; Rudzinski W, 2000, J PHYS CHEM B, V104, P9149, DOI 10.1021/jp000045m; Sag Y, 2000, BIOCHEM ENG J, V6, P145, DOI 10.1016/S1369-703X(00)00083-8; Samir L, 2019, SEP SCI TECHNOL, V54, P876, DOI 10.1080/01496395.2018.1521833; Sarin V, 2006, BIORESOURCE TECHNOL, V97, P15, DOI 10.1016/j.biortech.2005.02.010; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Shrestha K., 2008, J NAT HIST MUS, V23, P108; Snell FD, 1959, COLORIMETRIC METHODS, V2nd, P78; SOBKOWSK.J, 1974, J ELECTROANAL CHEM, V55, P391, DOI 10.1016/S0022-0728(74)80433-X; Temkin M.I., 1940, ACTA PHYSIOCHIM, V2, P217, DOI DOI 10.1016/J.JHAZMAT.2008.12.093; Texier AC, 1999, ENVIRON SCI TECHNOL, V33, P489, DOI 10.1021/es9807744; ul Haq A, 2019, GREEN PROCESS SYNTH, V8, P337, DOI 10.1515/gps-2019-0001; Vakili M, 2014, REV ENVIRON CONTAM T, V232, P61, DOI 10.1007/978-3-319-06746-9_3; Vinodhini V., 2009, Journal of Agricultural and Biological Science, V4, P19; Wang XS, 2009, DESALINATION, V235, P146, DOI 10.1016/j.desal.2008.02.008; Weber W.J., 1963, J SANIT ENG DIV, V89, P31, DOI [10.1061/JSEDAI.0000430, DOI 10.1061/JSEDAI.0000430]; Wolff M.A., 1999, WINNING WAR WEEDS ES, P17; Xia SP, 2019, CRIT REV ENV SCI TEC, V49, P1027, DOI 10.1080/10643389.2018.1564526; Zhou YT, 2009, COLLOID SURFACE B, V74, P244, DOI 10.1016/j.colsurfb.2009.07.026	56	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2019	14	8							e0213477	10.1371/journal.pone.0213477	http://dx.doi.org/10.1371/journal.pone.0213477			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5LL	31419220	gold, Green Published, Green Submitted			2022-12-26	WOS:000485019900001
J	Chergui, B; Rodriguez-Caro, RC; Gracia, E; Fahd, S; Santos, X				Chergui, Brahim; Rodriguez-Caro, Roberto C.; Gracia, Eva; Fahd, Soumia; Santos, Xavier			Population density of the spur-thighed tortoise Testudo graeca declines after fire in north-western Africa	PLOS ONE			English	Article							PRESCRIBED FIRE; PHENOTYPIC PLASTICITY; VERTEBRATE DIVERSITY; BOX TURTLES; HERMANNI; HABITAT; DESERT; LANDSCAPE; WILDFIRES; ABUNDANCE	Fire is a key ecological process in several biomes worldwide. Over recent decades, human activities (e.g. rural abandonment, monoculture plantations) and global warming are magnifying the risk of fire, with changes in fire intensity and frequency. Here, we offer the first study that examines the impact of fire on the spur-thighed tortoise Testudo graeca living in a native cork oak forest and pine plantation in north-western Africa. A total of 44 transects (22 burnt and 22 unburnt) were sampled at 8 sites affected by fires of natural cork oak forest and pine plantation with 8 surveys per site in 2015-2017 (264 hours of sampling effort). Tortoise densities were estimated with line-transect distance sampling. The detection probability of tortoises was higher in burnt (0.915) than unburnt (0.474) transects. The density of tortoises was negatively associated with elevation and declined with fire by c. 50% in both forest types. The negative response of T. graeca to fire should be considered in conservation planning of this species in north-western Africa in a future scenario of changes in fire regime.	[Chergui, Brahim; Fahd, Soumia] Univ Abdelmalek Essaadi, Fac Sci Tetouan, Equipe Rech Ecol, Systemat,Conservat Biodivers, BP 2121 El MHannech, Tetouan, Morocco; [Rodriguez-Caro, Roberto C.; Gracia, Eva] Univ Miguel Hernandez, Dept Biol Aplicada, Alicante, Spain; [Rodriguez-Caro, Roberto C.] Univ Alicante, Dept Ecol, Alicante, Spain; [Santos, Xavier] Univ Porto, CIBIO InBIO Ctr Invest Biodiversidade & Recursos, Vairao, Portugal	Abdelmalek Essaadi University of Tetouan; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Universidade do Porto	Chergui, B (corresponding author), Univ Abdelmalek Essaadi, Fac Sci Tetouan, Equipe Rech Ecol, Systemat,Conservat Biodivers, BP 2121 El MHannech, Tetouan, Morocco.	brahim_chergui@ymail.com	Santos, Xavier/O-4397-2019; FAHD, Soumia/GRR-1653-2022; Chergui El Hemiani, Brahim/AAT-8173-2020; Graciá, Eva/H-2270-2015; Rodríguez-Caro, Roberto/ABE-6957-2020	Santos, Xavier/0000-0002-4330-4261; Graciá, Eva/0000-0003-0790-163X; Rodríguez-Caro, Roberto/0000-0003-2321-9497; CHERGUI EL HEMIANI, Brahim/0000-0002-4989-8435	Instituto de Estudios Ceuties [2015-1]; Spanish Ministry of Economy, Industry and Competitiveness and European Regional Development Fund (MINECO/FEDER) [CGL201564144]	Instituto de Estudios Ceuties; Spanish Ministry of Economy, Industry and Competitiveness and European Regional Development Fund (MINECO/FEDER)	BC, SF, and XS received a grant coded (2015-1) from Instituto de Estudios Ceuties (https://www.ieceuties.org) to cover part of the fieldwork. The work of EG and RCRC was supported by the Spanish Ministry of Economy, Industry and Competitiveness and European Regional Development Fund (Project CGL201564144; MINECO/FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Ajbilou R, 2001, THESIS; Anadon JD, 2006, BIODIVERS CONSERV, V15, P2287, DOI 10.1007/s10531-004-8226-4; Anadon JD, 2015, ECOGRAPHY, V38, P956, DOI 10.1111/ecog.01163; Anadon JD, 2006, ECOGRAPHY, V29, P339, DOI 10.1111/j.2006.0906-7590.04486.x; Andreu AC., 2004, MANOURIA, V7, P17; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Attum O, 2011, EUR J WILDLIFE RES, V57, P251, DOI 10.1007/s10344-010-0419-4; Badiane A, 2017, AMPHIBIA-REPTILIA, V38, P67, DOI 10.1163/15685381-00003086; Benabid A., 2007, DESCRIPTION COMPOSIT; Benabid A., 1982, THESIS; Bertolero A., 2011, RES MONOGR, V5, P070; Bonnet X, 2013, J EXP BIOL, V216, P815, DOI 10.1242/jeb.078501; Bons J., 1996, ATLAS BIOGEOGRAPHIQU; Brooks Matthew L., 2002, Chelonian Conservation and Biology, V4, P330; Buckland S.T., 2001, pi; Buckland ST, 2015, METH STAT ECOL, P1, DOI 10.1007/978-3-319-19219-2; Buckland ST, 2009, J AGR BIOL ENVIR ST, V14, P432, DOI 10.1198/jabes.2009.08030; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calvo L, 2003, FOREST ECOL MANAG, V184, P209, DOI 10.1016/S0378-1127(03)00207-X; Rodriguez-Caro RC, 2013, EUR J WILDLIFE RES, V59, P911, DOI 10.1007/s10344-013-0764-1; Cheddadi R, 2016, QUATERNAIRE, V27, P15; Chergui B, 2018, ECOSYSTEMS, V21, P1, DOI [10.1007/s10021-017-0130-3, DOI 10.1007/S10021-017-0130-3]; Chergui B, 2018, ANN FOREST SCI, V75, DOI 10.1007/s13595-018-0742-6; CONGDON JD, 1993, CONSERV BIOL, V7, P826, DOI 10.1046/j.1523-1739.1993.740826.x; Couturier T, 2014, BIOL CONSERV, V170, P177, DOI 10.1016/j.biocon.2013.12.028; Couturier T, 2011, AMPHIBIA-REPTILIA, V32, P541, DOI 10.1163/156853811X601627; Cruz Felix B., 2005, Cuadernos de Herpetologia, V18, P15; Anadon JD, 2012, AMPHIBIA-REPTILIA, V33, P285, DOI 10.1163/156853812X643710; Davis RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127925; DiazPaniagua C, 1996, CAN J ZOOL, V74, P560, DOI 10.1139/z96-061; Drake KK, 2015, J WILDLIFE MANAGE, V79, P618, DOI 10.1002/jwmg.874; El Mouden EH, 2006, J ARID ENVIRON, V64, P422, DOI 10.1016/j.jaridenv.2005.06.010; Ernst CH., 1989, TURTLES WORLD; Esque TC, 2003, SOUTHWEST NAT, V48, P103, DOI 10.1894/0038-4909(2003)048<0103:EODWOD>2.0.CO;2; Fish and Wildlife Service, 1994, DES TORT MOJ POP REC; Fox J., 2019, R COMPANION APPL REG, V.; Fritz U, 2007, AMPHIBIA-REPTILIA, V28, P97, DOI 10.1163/156853807779799135; Gracia E, 2017, BIOL J LINN SOC, V121, P641, DOI 10.1093/biolinnean/blx007; GRANT BW, 1990, ECOLOGY, V71, P1765, DOI 10.2307/1937584; Greenberg CH, 2008, FOREST ECOL MANAG, V255, P2883, DOI 10.1016/j.foreco.2008.01.064; Hailey A, 2000, BIOL CONSERV, V92, P321, DOI 10.1016/S0006-3207(99)00099-3; Iverson J. B., 1992, REVISED CHECKLIST DI; Iverson LR, 2002, NAT AREA J, V22, P296; LAMBERT MRK, 1983, ZOOL J LINN SOC-LOND, V79, P149, DOI 10.1111/j.1096-3642.1983.tb01164.x; Lecq S, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou019; LEMMON PAUL E., 1957, JOUR FOREST, V55, P667; Lovich JE, 2011, CHELONIAN CONSERV BI, V10, P124, DOI 10.2744/CCB-0864.1; Mac Nally R, 2001, BIOL CONSERV, V99, P191, DOI 10.1016/S0006-3207(00)00180-4; MACDONALD LA, 1988, HERPETOLOGICA, V44, P345; Marques TA, 2007, AUK, V124, P1229, DOI 10.1642/0004-8038(2007)124[1229:IEOBDU]2.0.CO;2; Mharzi Alaoui H, 2015, REV MAROC SCI AGRON, V3, P46; Morafka David J., 2002, Chelonian Conservation and Biology, V4, P263; Moreira F, 2007, LANDSCAPE ECOL, V22, P1461, DOI 10.1007/s10980-007-9125-3; Moulherat S, 2014, J NAT CONSERV, V22, P186, DOI 10.1016/j.jnc.2013.11.004; Nimmo DG, 2012, GLOBAL ECOL BIOGEOGR, V21, P1062, DOI 10.1111/j.1466-8238.2011.00747.x; Nussear KE, 2004, THESIS; Pausas JC, 2008, INT J WILDLAND FIRE, V17, P713, DOI 10.1071/WF07151; Pausas JG, 2019, OIKOS, V128, P147, DOI 10.1111/oik.05907; Pausas JG, 2009, BIOSCIENCE, V59, P593, DOI 10.1525/bio.2009.59.7.10; Perez MB, 2002, B BIOL ASSESS, P58; Popgeorgiev Georgi, 2008, Historia Naturalis Bulgarica, V19, P115; Rodriguez-Caro RC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173485; Roe JH, 2017, J THERM BIOL, V69, P325, DOI 10.1016/j.jtherbio.2017.09.005; Russell KR, 1999, WILDLIFE SOC B, V27, P374; Santos X, 2019, BIOL J LINN SOC, V126, P55, DOI 10.1093/biolinnean/bly173; Santos X, 2013, BIOL CONSERV, V168, P90, DOI 10.1016/j.biocon.2013.09.008; Sanz-Aguilar A, 2011, BIOL CONSERV, V144, P1040, DOI 10.1016/j.biocon.2010.12.023; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Underwood EC, 2009, DIVERS DISTRIB, V15, P188, DOI 10.1111/j.1472-4642.2008.00518.x; Valdes B., 2013, BOCCONEA, V26, P13; Valentine LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034448; Venables WN., 2002, MODERN APPL STAT S 4; Vilardell- Bartino A., 2011, B SOC CATALANA HERPE, V19, P152; Vujovic A, 2015, ACTA ZOOL BULGAR, V67, P75; Whelan RJ, 2002, FLAMMABLE AUSTR FIRE; White D, 1997, CONSERV BIOL, V11, P349, DOI 10.1046/j.1523-1739.1997.95458.x; Wild KH, 2018, J ZOOL, V305, P96, DOI 10.1111/jzo.12545; York A, 1999, J INSECT CONSERV, V3, P191, DOI 10.1023/A:1009643627781; Zani PA, 2008, J EXP BIOL, V211, P3671, DOI 10.1242/jeb.019869; Zimmerman Linda C., 1994, Herpetological Monographs, V0, P45, DOI 10.2307/1467069; Znari M, 2005, J ARID ENVIRON, V62, P55, DOI 10.1016/j.jaridenv.2004.11.013	81	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2019	14	8							e0220969	10.1371/journal.pone.0220969	http://dx.doi.org/10.1371/journal.pone.0220969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5LL	31419242	gold, Green Published, Green Submitted			2022-12-26	WOS:000485019900022
J	Helou, DG; Braham, S; De Chaisemartin, L; Granger, V; Damien, MH; Pallardy, M; Kerdine-Romer, S; Chollet-Martin, S				Helou, Doumet Georges; Braham, Sarah; De Chaisemartin, Luc; Granger, Vanessa; Damien, Marie-Helene; Pallardy, Marc; Kerdine-Romer, Saadia; Chollet-Martin, Sylvie			Nrf2 downregulates zymosan-induced neutrophil activation and modulates migration	PLOS ONE			English	Article							INDUCED INFLAMMATORY RESPONSE; TRANSCRIPTION FACTOR NRF2; NADPH OXIDASE; MECHANISMS; MORTALITY; PATHWAY; CELLS; SENSITIZERS; PROTECTION; TARGETS	Polymorphonuclear neutrophils (PMNs) are the first line of defense against pathogens and their activation needs to be tightly regulated in order to limit deleterious effects. Nrf2 (Nuclear factor (erythroid-derived 2)-like 2) transcription factor regulates oxidative stress and/or represses inflammation in various cells such as dendritic cells or macrophages. However, its involvement in PMN biology is still unclear. Using Nrf2 KO mice, we thus aimed to investigate the protective role of Nrf2 in various PMN functions such as oxidative burst, netosis, migration, cytokine production and phagocytosis, mainly in response to zymosan. We found that zymosan induced Nrf2 accumulation in PMNs leading to the upregulation of some target genes including Hmox-1, Nqo1 and Cat. Nrf2 was able to decrease zymosan-induced PMN oxidative burst; sulforaphane-induced Nrf2 hyperexpression confirmed its implication. Tnf alpha, Ccl3 and Cxcl2 gene transcription was decreased in zymosan-stimulated Nrf2 KO PMNs, suggesting a role for Nrf2 in the regulation of proinflammatory cytokine production. However, Nrf2 was not involved in phagocytosis. Finally, spontaneous migration of Nrf2 KO PMNs was lower than that of WT PMNs. Moreover, in response to low concentrations of CXCL2 or CXCL12, Nrf2 KO PMN migration was decreased despite similar CXCR2 and CXCR4 expression and ATP levels in PMNs from both genotypes. Nrf2 thus seems to be required for an optimal migration. Altogether these results suggest that Nrf2 has a protective role in several PMN functions. In particular, it downregulates their activation in response to zymosan and is required for an adequate migration.	[Helou, Doumet Georges; Braham, Sarah; De Chaisemartin, Luc; Granger, Vanessa; Damien, Marie-Helene; Pallardy, Marc; Kerdine-Romer, Saadia; Chollet-Martin, Sylvie] Univ Paris Saclay, Univ Paris Sud, INSERM UMR996, Inflammat Chimiokines & Immunopathol, Chatenay Malabry, France; [De Chaisemartin, Luc; Granger, Vanessa; Chollet-Martin, Sylvie] Hop Bichat Claude Bernard, AP HP, Lab Immunol Autoimmun & Hypersensibil, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Chollet-Martin, S (corresponding author), Univ Paris Saclay, Univ Paris Sud, INSERM UMR996, Inflammat Chimiokines & Immunopathol, Chatenay Malabry, France.; Chollet-Martin, S (corresponding author), Hop Bichat Claude Bernard, AP HP, Lab Immunol Autoimmun & Hypersensibil, Paris, France.	sylvie.chollet-martin@u-psud.fr	HELOU, Georges Doumet/AAJ-9458-2021; Kerdine-Römer, Saadia/AAT-9855-2020	HELOU, Georges Doumet/0000-0002-5835-9214; Kerdine-Romer, Saadia/0000-0003-3313-952X; /0000-0001-6274-6711				Ahmed SMU, 2017, BBA-MOL BASIS DIS, V1863, P585, DOI 10.1016/j.bbadis.2016.11.005; Al-Huseini LMA, 2013, J BIOL CHEM, V288, P22281, DOI 10.1074/jbc.M113.483420; Araujo VC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076976; Barrientos L, 2014, J IMMUNOL, V193, P5689, DOI 10.4049/jimmunol.1400586; Baudhuin J, 2013, P NATL ACAD SCI USA, V110, P17957, DOI 10.1073/pnas.1221535110; Breedveld A, 2017, J LEUKOCYTE BIOL, V102, P1003, DOI 10.1189/jlb.4MR0217-048RR; Cho HY, 2014, AM J RESP CELL MOL, V50, P844, DOI 10.1165/rcmb.2014-0116PS; Cuadrado A, 2018, PHARMACOL REV, V70, P348, DOI 10.1124/pr.117.014753; de la Vega Montserrat Rojo, 2016, Current Opinion in Toxicology, V1, P62, DOI 10.1016/j.cotox.2016.10.005; Deng Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25167-4; Dias IHK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066407; Dinkova-Kostova AT, 2015, FREE RADICAL BIO MED, V88, P179, DOI 10.1016/j.freeradbiomed.2015.04.036; Dinkova-Kostova AT, 2005, CHEM RES TOXICOL, V18, P1779, DOI 10.1021/tx050217c; El Ali Z, 2017, TOXICOL APPL PHARM, V322, P41, DOI 10.1016/j.taap.2017.02.014; El Ali Z, 2013, TOXICOL SCI, V134, P39, DOI 10.1093/toxsci/kft084; Espinasse MA, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0210-0; Espinasse MA, 2016, J INNATE IMMUN, V8, P81, DOI 10.1159/000439052; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Garber K, 2012, NATURE, V489, pS4, DOI 10.1038/489S4a; Gomez JC, 2016, J IMMUNOL, V197, P2864, DOI 10.4049/jimmunol.1600043; Gomez JC, 2015, AM J RESP CELL MOL, V52, P349, DOI 10.1165/rcmb.2013-0316OC; Granger V, 2017, J LEUKOCYTE BIOL, V102, P775, DOI 10.1189/jlb.3MA0916-411R; Harada Y, 2018, J BIOL CHEM, V293, P3770, DOI 10.1074/jbc.M117.810168; Hattori H, 2010, P NATL ACAD SCI USA, V107, P3546, DOI 10.1073/pnas.0914351107; Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221; Holmstrom KM, 2013, BIOL OPEN, V2, P761, DOI 10.1242/bio.20134853; Hong CW, 2017, IMMUNE NETW, V17, P298, DOI 10.4110/in.2017.17.5.298; Iizuka T, 2005, GENES CELLS, V10, P1113, DOI 10.1111/j.1365-2443.2005.00905.x; Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Joshi N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187162; Kavian N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01896; Kobayashi E, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/529219; Kobayashi EH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11624; Koenderman L, 2014, IMMUNOL LETT, V162, P95, DOI 10.1016/j.imlet.2014.10.010; Kong XN, 2010, J IMMUNOL, V185, P569, DOI 10.4049/jimmunol.0902315; Kovac S, 2015, BBA-GEN SUBJECTS, V1850, P794, DOI 10.1016/j.bbagen.2014.11.021; Leliefeld PHC, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1250-4; Leliefeld PHC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00471; Li Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030186, 10.1371/journal.pone.0029003, 10.1371/journal.pone.0042558, 10.1371/journal.pone.0030835, 10.1371/journal.pone.0044441, 10.1371/journal.pone.0035543, 10.1371/journal.pone.0035122]; Liu XT, 2017, ANTIOXID REDOX SIGN, V26, P28, DOI 10.1089/ars.2015.6615; Makni-Maalej K, 2013, BIOCHEM PHARMACOL, V85, P92, DOI 10.1016/j.bcp.2012.10.010; McDonald B, 2017, BLOOD, V129, P1357, DOI 10.1182/blood-2016-09-741298; Mussotter F, 2016, TOXICOL APPL PHARM, V313, P170, DOI 10.1016/j.taap.2016.11.001; Odobasic D, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/2349817; Ohl K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01552; Olagnier D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002254; Pionnier N, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004605; Reber LL, 2017, J EXP MED, V214, P1249, DOI 10.1084/jem.20161238; Sadik CD, 2011, TRENDS IMMUNOL, V32, P452, DOI 10.1016/j.it.2011.06.008; Scapini P, 2016, IMMUNOL REV, V273, P48, DOI 10.1111/imr.12448; Segal AW, 2008, INT J BIOCHEM CELL B, V40, P604, DOI 10.1016/j.biocel.2007.10.003; Sima C, 2016, AM J PATHOL, V186, P1417, DOI 10.1016/j.ajpath.2016.01.013; Singel KL, 2016, CLIN SCI, V130, P479, DOI 10.1042/CS20150660; Soehnlein O, 2017, NAT REV IMMUNOL, V17, P248, DOI 10.1038/nri.2017.10; Suratt BT, 2004, BLOOD, V104, P565, DOI 10.1182/blood-2003-10-3638; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Thimmulappa RK, 2007, ANTIOXID REDOX SIGN, V9, P1963, DOI 10.1089/ars.2007.1745; Thimmulappa RK, 2006, BIOCHEM BIOPH RES CO, V351, P883, DOI 10.1016/j.bbrc.2006.10.102; Tsai JJ, 2013, NAT CELL BIOL, V15, P309, DOI 10.1038/ncb2699; Turbica I, 2015, J LEUKOCYTE BIOL, V97, P737, DOI 10.1189/jlb.3A0314-132RR; Wang G, 2016, DEV CELL, V38, P453, DOI 10.1016/j.devcel.2016.07.014; Watzlawick R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137651; Yeang HXA, 2012, J BIOL CHEM, V287, P10556, DOI 10.1074/jbc.M111.322420; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974	65	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2019	14	8							e0216465	10.1371/journal.pone.0216465	http://dx.doi.org/10.1371/journal.pone.0216465			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5LL	31419224	Green Published, gold, Green Submitted			2022-12-26	WOS:000485019900003
J	Jia, CC; Yang, T; Wang, CJ; Fan, BH; He, FG				Jia, Chaochuan; Yang, Ting; Wang, Chuanjiang; Fan, Binghui; He, Fugui			A new fast filtering algorithm for a 3D point cloud based on RGB-D information	PLOS ONE			English	Article							OUTLIER DETECTION; SEGMENTATION	A point cloud that is obtained by an RGB-D camera will inevitably be affected by outliers that do not belong to the surface of the object, which is due to the different viewing angles, light intensities, and reflective characteristics of the object surface and the limitations of the sensors. An effective and fast outlier removal method based on RGB-D information is proposed in this paper. This method aligns the color image to the depth image, and the color mapping image is converted to an HSV image. Then, the optimal segmentation threshold of the V image that is calculated by using the Otsu algorithm is applied to segment the color mapping image into a binary image, which is used to extract the valid point cloud from the original point cloud with outliers. The robustness of the proposed method to the noise types, light intensity and contrast is evaluated by using several experiments; additionally, the method is compared with other filtering methods and applied to independently developed foot scanning equipment. The experimental results show that the proposed method can remove all type of outliers quickly and effectively.	[Jia, Chaochuan; Wang, Chuanjiang; Fan, Binghui] Shandong Univ Sci & Technol, Coll Mech & Elect Engn, Qingdao, Shandong, Peoples R China; [Jia, Chaochuan; Yang, Ting; He, Fugui] West Anhui Univ, Coll Elect & Informat Engn, Luan, Anhui, Peoples R China	Shandong University of Science & Technology; West Anhui University	Fan, BH (corresponding author), Shandong Univ Sci & Technol, Coll Mech & Elect Engn, Qingdao, Shandong, Peoples R China.	fanbh58@163.com	Jia, Chaochuan/AAN-7022-2020	Jia, Chaochuan/0000-0003-3393-7900	National Young Natural Science Foundation, China [61702375]; Key Research Programs of Shandong Province [2016GSF201197]; Science and Technology Plan Programs of Colleges and Universities in Shandong Province [J16LB11]; Natural Science Foundation of Anhui Province [KJ2014A277]	National Young Natural Science Foundation, China; Key Research Programs of Shandong Province; Science and Technology Plan Programs of Colleges and Universities in Shandong Province; Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province)	This work supported by National Young Natural Science Foundation (NO. 61702375), China, Key Research Programs of Shandong Province (NO. 2016GSF201197), Science and Technology Plan Programs of Colleges and Universities in Shandong Province (NO. J16LB11) and Natural Science Foundation of Anhui Province, (NO. KJ2014A277).	Abdelgawad A, 2018, RES J APPL SCI ENG T, V15, P57; Abdul N, 2015, PATTERN RECOGN, V48, P1404; [Anonymous], [No title captured]; Berger M, 2017, COMPUT GRAPH FORUM, V36, P301, DOI 10.1111/cgf.12802; Bhaduri K., 2011, P ACM SIGKDD INT C K, P859, DOI DOI 10.1145/2020408.2020554; Boom BJ, 2017, COMPUTER ANIMATION V, V28, P25; Choy SK, 2019, SIGNAL PROCESS, V154, P30, DOI 10.1016/j.sigpro.2018.08.010; Comino M, 2018, COMPUT GRAPH FORUM, V37, P233, DOI 10.1111/cgf.13505; Das RB, 2017, IEEE INT CONF MOB CL, P1, DOI 10.1109/MobileCloud.2017.14; David JT, 2018, INT J COMPUT VISION, V126, P158; Francesco LS, 2018, J MED SYST, V42, P1; Gong XJ, 2017, 2017 IEEE INTERNATIONAL CONFERENCE ON INFORMATION AND AUTOMATION (IEEE ICIA 2017), P47, DOI 10.1109/ICInfA.2017.8078881; Guo Y, 2018, VISUAL COMPUT, V34, P1325, DOI 10.1007/s00371-017-1416-3; Hao W, 2018, INT J REMOTE SENS, V39, P6587, DOI 10.1080/01431161.2018.1463113; Hido S, 2011, KNOWL INF SYST, V26, P309, DOI 10.1007/s10115-010-0283-2; Huynh TND, 2015, IEEE 7 INT C CIS RAM, P124; Jenke P, 2006, COMPUT GRAPH FORUM, V25, P379, DOI 10.1111/j.1467-8659.2006.00957.x; Jiang RQ, 2018, IEEE T MULTIMEDIA, V20, P55, DOI 10.1109/TMM.2017.2723244; Kalogerakis E, 2009, COMPUT AIDED DESIGN, V41, P282, DOI 10.1016/j.cad.2008.12.004; Khurram K, 2018, INT J PAVEMENT ENG, V19, P565; Kriegel H.-P., 2008, P 14 ACM SIGKDD INT, P444, DOI [10.1145/1401890.1401946, DOI 10.1145/1401890.1401946]; Li Pengfei, 2016, Computer Engineering and Applications, V52, P188, DOI 10.3778/j.issn.1002-8331.1603-0354; Li QN, 2018, VISUAL COMPUT, V34, P229, DOI 10.1007/s00371-016-1330-0; Li WL, 2016, IEEE-ASME T MECH, V21, P2805, DOI 10.1109/TMECH.2016.2581808; [林洪彬 Lin Hongbin], 2017, [计算机集成制造系统, Computer Integrated Manufacturing Systems], V23, P2583; Liu B, 2013, KNOWL INF SYST, V34, P597, DOI 10.1007/s10115-012-0484-y; Liu Kun, 2017, Computer Engineering, V43, P253, DOI 10.3969/j.issn.1000-3428.2017.07.043; Ma S, 2014, 2014 11TH WORLD CONGRESS ON INTELLIGENT CONTROL AND AUTOMATION (WCICA), P3315, DOI 10.1109/WCICA.2014.7053264; Michael Z, 2018, COMPUT GRAPH FORUM, V37, P625; Moorfield B, 2015, LECT NOTES COMPUT SC, V9257, P394, DOI 10.1007/978-3-319-23117-4_34; Mortensen AK, 2018, COMPUT ELECTRON AGR, V154, P373, DOI 10.1016/j.compag.2018.09.010; Orair GH, 2010, PROC VLDB ENDOW, V3, P1469, DOI 10.14778/1920841.1921021; Rosli NAIM, 2014, AIP CONF PROC, V1605, P149, DOI 10.1063/1.4887580; Samie TM, 2017, J MANUFACTURING SCI, V139, P1; Schall O, 2008, COMPUT AIDED DESIGN, V40, P701, DOI 10.1016/j.cad.2008.01.011; Shen FL, 2019, NEUROCOMPUTING, V330, P259, DOI 10.1016/j.neucom.2018.11.027; [陶抒青 Tao Shuqing], 2018, [计算机应用研究, Application Research of Computers], V35, P619; Tomasi C, 1998, SIXTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, P839, DOI 10.1109/ICCV.1998.710815; Wang YT, 2015, COMPUT AIDED DESIGN, V62, P31, DOI 10.1016/j.cad.2014.11.004; Wu L. SH., 2016, INFRARED LASER ENG, V24, P1465, DOI DOI 10.3788/OPE.20162406.1465; Wu Q, 2018, COMPUT GRAPH FORUM, V37, P221, DOI 10.1111/cgf.13504; Yang CG, 2018, MULTIMED TOOLS APPL, V77, P25369, DOI 10.1007/s11042-018-5789-8; [杨永涛 Yang Yongtao], 2018, [计算机辅助设计与图形学学报, Journal of Computer-Aided Design & Computer Graphics], V30, P1034; Ying C, 2016, INT S COMP INT DES, P467; Yuan Hua, 2015, Journal of Computer Applications, V35, P2305, DOI 10.11772/j.issn.1001-9081.2015.08.2305; Zapicob P, 2018, PRECIS ENG, V54, P91; Zhang ZY, 2000, IEEE T PATTERN ANAL, V22, P1330, DOI 10.1109/34.888718; Zheng YL, 2018, COMPUT AIDED GEOM D, V62, P16, DOI 10.1016/j.cagd.2018.03.004	48	9	11	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2019	14	8							e0220253	10.1371/journal.pone.0220253	http://dx.doi.org/10.1371/journal.pone.0220253			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5LL	31419244	Green Submitted, Green Published, gold			2022-12-26	WOS:000485019900012
J	Premawardhana, AP; Mudiyanse, R; De Silva, ST; Jiffry, N; Nelumdeniya, U; de Silva, U; Lamabadusuriya, SP; Pushpakumara, K; Dissanayaka, R; Jansz, M; Rifaya, I; Navarathne, U; Thirukumaran, V; Arambepola, M; Bandara, WD; Vaidyanatha, U; Mendis, D; Weerasekara, K; De Silva, N; Kumara, DKS; Amarasena, SD; Hemantha, KK; Refai, MACM; Silva, I; Hameed, N; Rajiyah, F; Mettananda, S; Allen, A; Weatherall, DJ; Oliveri, NF				Premawardhana, Anuja P.; Mudiyanse, Rasnayaka; De Silva, Shamila T.; Jiffry, Nilam; Nelumdeniya, Udaya; de Silva, Udaya; Lamabadusuriya, Sanath P.; Pushpakumara, K.; Dissanayaka, Randima; Jansz, M.; Rifaya, I.; Navarathne, Upul; Thirukumaran, V.; Arambepola, Mahinda; Bandara, Wijesundara Dayanada; Vaidyanatha, U.; Mendis, Devan; Weerasekara, K.; De Silva, Nalika; Kumara, D. K. Shantha; Amarasena, Sujeewa D.; Hemantha, K. K.; Refai, M. A. C. M.; Silva, Ishari; Hameed, Nizri; Rajiyah, F.; Mettananda, Sachith; Allen, Angela; Weatherall, David J.; Oliveri, Nancy F.			A nationwide survey of hospital-based thalassemia patients and standards of care and a preliminary assessment of the national prevention program in Sri Lanka	PLOS ONE			English	Article							COMPLICATIONS; SURVIVAL; TRANSFUSION	Objectives Our aim was to describe the numbers and distribution of patients with different types of thalassemia and to assess the standards of care in all thalassemia treatment centers throughout Sri Lanka and the success of the ongoing prevention programme. Methods This cross-sectional island-wide survey was conducted by two trained medical graduates, who visited each thalassemia center to collect data from every patient, using a standardized form. Data was collected through review of patient registers and clinical records. Results We collected data on 1774 patients from 23 centers. 1219 patients (68.7%) had homozygous beta-thalassemia, 360 patients (20.3%) had hemoglobin E beta-thalassemia, and 50 patients 2%) had sickle beta-thalassemia. There were unacceptably high serum ferritin levels in almost all centers. The annual number of births of patients with beta-thalassaemia varied between 4555, with little evidence of reduction over 19 years. Conclusions Central coordination of the treatment and ultimately prevention of thalassemia is urgently needed in Sri Lanka. Development of expert centers with designated staff with sufficient resources will improve the quality of care and is preferred to managing patients in multiple small units.	[Premawardhana, Anuja P.; De Silva, Shamila T.; Rajiyah, F.] Univ Kelaniya, Dept Med, Fac Med, Colombo, Sri Lanka; [Mudiyanse, Rasnayaka] Univ Peradeniya, Dept Pediat, Fac Med, Peradeniya, Sri Lanka; [Jiffry, Nilam] Teaching Hosp, Kurunegala, Sri Lanka; [Nelumdeniya, Udaya] Prov Gen Hosp, Badulla, Sri Lanka; [de Silva, Udaya; Lamabadusuriya, Sanath P.] Teaching Hosp, Anuradhapura, Sri Lanka; [Pushpakumara, K.] Dist Gen Hosp, Polonnaruwa, Sri Lanka; [Dissanayaka, Randima] Gen Hosp, Chilaw, Sri Lanka; [Jansz, M.] Gen Hosp, Vavuniya, Sri Lanka; [Rifaya, I.] Dist Gen Hosp, Ampara, Sri Lanka; [Navarathne, Upul] Dist Gen Hosp, Monaragala, Sri Lanka; [Thirukumaran, V.] Teaching Hosp, Batticaloa, Sri Lanka; [Arambepola, Mahinda] Teaching Hosp, Kandy, Sri Lanka; [Bandara, Wijesundara Dayanada] Dist Gen Hosp, Matale, Sri Lanka; [Vaidyanatha, U.; Mendis, Devan; Weerasekara, K.; De Silva, Nalika] Lady Ridgeway Hosp, Colombo, Sri Lanka; [Kumara, D. K. Shantha] Dist Gen Hosp, Matara, Sri Lanka; [Amarasena, Sujeewa D.] Teaching Hosp Karapitiya, Galle, Sri Lanka; [Hemantha, K. K.] Dist Gen Hosp, Hambantota, Sri Lanka; [Refai, M. A. C. M.] Minist Hlth, AntiTB Campaign, Colombo, Sri Lanka; [Silva, Ishari; Hameed, Nizri] North Colombo Teaching Hosp, Hemals Adolescent & Adult Thalassemia Care Ctr, Ragama, Sri Lanka; [Mettananda, Sachith] Univ Kelaniya, Fac Med, Dept Pediat, Colombo, Sri Lanka; [Allen, Angela; Weatherall, David J.] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Oliveri, Nancy F.] Univ Toronto, Toronto, ON, Canada	University Kelaniya; University of Colombo; University of Peradeniya; University of Colombo; Colombo North Teaching Hospital; University Kelaniya; University of Colombo; University of Oxford; University of Toronto	Premawardhana, AP (corresponding author), Univ Kelaniya, Dept Med, Fac Med, Colombo, Sri Lanka.	premawa@hotmail.com	Mettananda, Sachith/H-4640-2019	Mettananda, Sachith/0000-0002-0760-0418; De Silva, Shamila/0000-0001-7241-0963	Hemoglobal; MRC [MC_UU_12009/13, MC_UU_00016/12] Funding Source: UKRI	Hemoglobal; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	NFO received the award from Hemoglobal. https://hemoglobal.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen A, 2016, HEMATOL ONCOL CLIN N, V30, P497, DOI 10.1016/j.hoc.2015.11.012; Borgna-Pignatti C, 2004, HAEMATOLOGICA, V89, P1187; Cao A, 1998, BAILLIERE CLIN HAEM, V11, P215, DOI 10.1016/S0950-3536(98)80076-0; Chern JPS, 2007, PEDIATR BLOOD CANCER, V48, P550, DOI 10.1002/pbc.21028; Cunningham MJ, 2004, BLOOD, V104, P34, DOI 10.1182/blood-2003-09-3167; de Silva S, 2000, LANCET, V355, P786, DOI 10.1016/S0140-6736(99)08246-X; Kruk ME, 2018, LANCET, V392, P2170, DOI 10.1016/S0140-6736(18)31668-4; Mettananda S, 2018, HEMATOL ONCOL CLIN N, V32, P177, DOI 10.1016/j.hoc.2017.11.003; Mudiyanse R., 2011, CURRENT SITUATION CO; Olivieri NF, 1997, BLOOD, V89, P739, DOI 10.1182/blood.V89.3.739; Pan HF, 2007, CLIN GENET, V71, P419, DOI 10.1111/j.1399-0004.2007.00791.x; Rahman M., 2004, Pakistan Journal of Medical Sciences, V20, P105; Rondelli D, 2018, J GLOB HEALTH; Siddiqi A, 2013, ETHNIC DIS, V23, P245; Statistic DoCa, 2017, BULLETIN; Statistic DoCa, 2015, BULLETIN; Taher AT, 2018, LANCET, V391, P155, DOI 10.1016/S0140-6736(17)31822-6; Vitrano A, 2017, BRIT J HAEMATOL, V176, P124, DOI 10.1111/bjh.14381; Weatherall DJ, 2010, BLOOD, V115, P4331, DOI 10.1182/blood-2010-01-251348; Williams TN, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011692; WOLMAN IJ, 1969, ANN NY ACAD SCI, V165, P407, DOI 10.1111/j.1749-6632.1969.tb27811.x; World Health Statistics, 2017, WORLD HLTH STAT 2017; Wu HP, 2017, PEDIATR BLOOD CANCER, V64, P135, DOI 10.1002/pbc.26181; Yin XL, 2011, PEDIATR BLOOD CANCER, V57, P1174, DOI 10.1002/pbc.23101	24	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2019	14	8							e0220852	10.1371/journal.pone.0220852	http://dx.doi.org/10.1371/journal.pone.0220852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5LL	31419232	Green Published, gold, Green Submitted			2022-12-26	WOS:000485019900016
J	Leader, CJ; Moharram, M; Coffey, S; Sammut, IA; Wilkins, GW; Walker, RJ				Leader, Catherine J.; Moharram, Mohammed; Coffey, Sean; Sammut, Ivan A.; Wilkins, Gerard W.; Walker, Robert J.			Myocardial global longitudinal strain: An early indicator of cardiac interstitial fibrosis modified by spironolactone, in a unique hypertensive rat model	PLOS ONE			English	Article							SPECKLE TRACKING ECHOCARDIOGRAPHY; LEFT-VENTRICULAR HYPERTROPHY; PRESERVED EJECTION FRACTION; HEART-FAILURE; MINERALOCORTICOID RECEPTOR; TRANSGENIC RATS; CARDIOVASCULAR-DISEASE; SYSTOLIC FUNCTION; ANGIOTENSIN-II; ALDOSTERONE	Objectives Is global longitudinal strain (GLS) a more accurate non-invasive measure of histological myocardial fibrosis than left ventricular ejection fraction (LVEF) in a hypertensive rodent model. Background Hypertension results in left ventricular hypertrophy and cardiac dysfunction. Speckle-tracking echocardiography has emerged as a robust technique to evaluate cardiac function in humans compared with standard echocardiography. However, its use in animal studies is less clearly defined. Methods Cyp1a1Ren2 transgenic rats were randomly assigned to three groups; normotensive, untreated hypertensive or hypertensive with daily administration of spironolactone (human equivalent dose of 50 mg/day). Cardiac function and interstitial fibrosis development were monitored for three months. Results The lower limit of normal LVEF was calculated to be 75%. After three months hypertensive animals (196 +/- 21 mmHg systolic blood pressure (SBP)) showed increased cardiac fibrosis (8.8 +/- 3.2% compared with 2.4 +/- 0.7% % in normals), reduced LVEF (from 81 +/- 2% to 67 +/- 7%) and impaired myocardial GLS (from -17 +/- 2% to -11 +/- 2) (all p<0.001). Myocardial GLS demonstrated a stronger correlation with cardiac interstitial fibrosis (r(2) = 0.58, p<0.0001) than LVEF (r(2) = 0.37, p<0.006). Spironolactone significantly blunted SBP elevation (184 +/- 15, p<0.01), slowed the progression of cardiac fibrosis (4.9 +/- 1.4%, p<0.001), reduced the decline in LVEF (72 +/- 4%, p<0.05) and the degree of impaired myocardial GLS (-13 +/- 1%, p<0.01) compared to hypertensive animals. Conclusions This study has demonstrated that, myocardial GLS is a more accurate non-invasive measure of histological myocardial fibrosis compared to standard echocardiography, in an animal model of both treated and untreated hypertension. Spironolactone blunted the progression of cardiac fibrosis and deterioration of myocardial GLS.	[Leader, Catherine J.; Moharram, Mohammed; Coffey, Sean; Wilkins, Gerard W.; Walker, Robert J.] Univ Otago, Dept Med, Dunedin, New Zealand; [Sammut, Ivan A.] Univ Otago, Dept Pharmacol, Dunedin, New Zealand	University of Otago; University of Otago	Walker, RJ (corresponding author), Univ Otago, Dept Med, Dunedin, New Zealand.	rob.walker@otago.ac.nz	Walker, Robert J/B-1498-2010; Moharram, Mohammed/AAR-1999-2021	Walker, Robert J/0000-0003-3366-0956; Sammut, Ivan/0000-0002-9217-9452; Coffey, Sean/0000-0003-2312-4666	Department of Medicine University of Otago, New Zealand; Otago Medical Research Foundation Otago, New Zealand; Healthcare Otago Charitable Trust Otago, New Zealand; New Zealand Lottery Grants Board; Maurice and Phyllis Paykel Trust New Zealand	Department of Medicine University of Otago, New Zealand; Otago Medical Research Foundation Otago, New Zealand; Healthcare Otago Charitable Trust Otago, New Zealand; New Zealand Lottery Grants Board; Maurice and Phyllis Paykel Trust New Zealand	Funding was provided by the Department of Medicine University of Otago, New Zealand (CL), a Laurenson Award from the Otago Medical Research Foundation Otago, New Zealand (IS, RW), the Healthcare Otago Charitable Trust Otago, New Zealand (RW), the New Zealand Lottery Grants Board (IS, GW, RW) and the Maurice and Phyllis Paykel Trust New Zealand (CL, RW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachner-Hinenzon N, 2010, AM J PHYSIOL-HEART C, V299, pH664, DOI 10.1152/ajpheart.00017.2010; Bader M, 2000, EXP PHYSIOL, V85, P713; Baldo MP, 2011, PHARMACOL REP, V63, P975, DOI 10.1016/S1734-1140(11)70613-2; Bauer M, 2011, CIRC RES, V108, P908, DOI 10.1161/CIRCRESAHA.110.239574; Bauersachs J, 2015, HYPERTENSION, V65, P257, DOI 10.1161/HYPERTENSIONAHA.114.04488; Bhan A, 2014, AM J PHYSIOL-HEART C, V306, pH1371, DOI 10.1152/ajpheart.00553.2013; Briet M, 2010, NAT REV NEPHROL, V6, P261, DOI 10.1038/nrneph.2010.30; BRILLA CG, 1993, J MOL CELL CARDIOL, V25, P563, DOI 10.1006/jmcc.1993.1066; BRILLA CG, 1993, AM J CARDIOL, V71, pA12, DOI 10.1016/0002-9149(93)90239-9; Catena C, 2012, AM J CARDIOVASC DIS, V2, P50; Colussi G, 2013, J HYPERTENS, V31, P3, DOI 10.1097/HJH.0b013e3283599b6a; CRAWFORD DC, 1994, CIRC RES, V74, P727, DOI 10.1161/01.RES.74.4.727; Gomes AC, 2013, HEART FAIL REV, V18, P219, DOI 10.1007/s10741-012-9305-3; Gonzalez A, 2004, MED CLIN N AM, V88, P83, DOI 10.1016/S0025-7125(03)00125-1; Howard CG, 2012, AM J PHYSIOL-RENAL, V302, pF52, DOI 10.1152/ajprenal.00187.2011; Howard CG, 2010, AM J MED SCI, V339, P543, DOI 10.1097/MAJ.0b013e3181d82a62; Ishizu T, 2014, HYPERTENSION, V63, P500, DOI 10.1161/HYPERTENSIONAHA.113.02149; Kahan T, 2005, HEART, V91, P250, DOI 10.1136/hrt.2004.042473; Kalam K, 2014, HEART, V100, P1673, DOI 10.1136/heartjnl-2014-305538; Kantachuvesiri S, 2001, J BIOL CHEM, V276, P36727, DOI 10.1074/jbc.M103296200; Koshizuka R, 2013, J AM SOC ECHOCARDIOG, V26, P316, DOI 10.1016/j.echo.2012.11.015; Krieger EM, 2018, HYPERTENSION, V71, P681, DOI 10.1161/HYPERTENSIONAHA.117.10662; Krishnasamy R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127044; Kuroda K, 2015, J MOD POWER SYST CLE, V3, P41, DOI 10.1007/s40565-015-0096-0; Lacolley P, 2001, J AM COLL CARDIOL, V37, P662, DOI 10.1016/S0735-1097(00)01129-3; Lal A, 2005, J MOL CELL CARDIOL, V39, P521, DOI 10.1016/j.yjmcc.2005.05.002; Leader C., 2018, COMPARATIVE MED, V68, P1; Markowitz M, 2012, CLIN CARDIOL, V35, P605, DOI 10.1002/clc.22025; Matyas C, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-017-0645-0; Medvedofsky D, 2018, JACC-CARDIOVASC IMAG, V11, P1569, DOI 10.1016/j.jcmg.2017.08.023; Messaoudi S, 2012, MOL CELL ENDOCRINOL, V350, P266, DOI 10.1016/j.mce.2011.06.038; Mitchell KD, 2006, J RENIN-ANGIO-ALDO S, V7, P74, DOI 10.3317/jraas.2006.013; Mulder P, 2008, EUR HEART J, V29, P2171, DOI 10.1093/eurheartj/ehn277; Nagata K, 2006, HYPERTENSION, V47, P656, DOI 10.1161/01.HYP.0000203772.78696.67; Nagata K, 2008, CURR HYPERTENS REP, V10, P216, DOI 10.1007/s11906-008-0041-y; Oktay AA, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0545-9; Peters B, 2008, J HYPERTENS, V26, P102, DOI 10.1097/HJH.0b013e3282f0ab66; Peters BS, 2010, J CELL MOL MED, V14, P1318, DOI 10.1111/j.1582-4934.2009.00778.x; Pitt B, 1996, AM J CARDIOL, V78, P902; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 2014, NEW ENGL J MED, V370, P1383, DOI 10.1056/NEJMoa1313731; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; ROBERT V, 1994, HYPERTENSION, V24, P30, DOI 10.1161/01.HYP.24.1.30; Rocha R, 1998, HYPERTENSION, V31, P451, DOI 10.1161/01.HYP.31.1.451; Shah AM, 2015, CIRCULATION, V132, P402, DOI 10.1161/CIRCULATIONAHA.115.015884; Stanton T, 2009, CIRC-CARDIOVASC IMAG, V2, P356, DOI 10.1161/CIRCIMAGING.109.862334; Stokke TM, 2017, J AM COLL CARDIOL, V70, P942, DOI 10.1016/j.jacc.2017.06.046; Sun Y, 1997, CARDIOVASC RES, V35, P138, DOI 10.1016/S0008-6363(97)00097-7; Sun Y, 2002, AM J PATHOL, V161, P1773, DOI 10.1016/S0002-9440(10)64454-9; Tanaka-Esposito C, 2014, J CARDIOVASC ELECTR, V25, P537, DOI 10.1111/jce.12379; Tesch GH, 2017, FRONT PHARMACOL, V8, P1; Valero-Munoz Maria, 2017, JACC Basic Transl Sci, V2, P770, DOI 10.1016/j.jacbts.2017.07.013; Voigt JU, 2015, EUR HEART J-CARD IMG, V16, P1, DOI 10.1093/ehjci/jeu184; WEBER KT, 1991, CIRCULATION, V83, P1849, DOI 10.1161/01.CIR.83.6.1849; WEBER KT, 1994, HYPERTENSION, V23, P869, DOI 10.1161/01.HYP.23.6.869; Whalley GA, 2018, JACC-CARDIOVASC IMAG, V11, P1580, DOI 10.1016/j.jcmg.2017.11.003; YOUNG M, 1994, J CLIN INVEST, V93, P2578, DOI 10.1172/JCI117269; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492	58	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220837	10.1371/journal.pone.0220837	http://dx.doi.org/10.1371/journal.pone.0220837			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404095	gold, Green Published, Green Submitted			2022-12-26	WOS:000485006800036
J	White, Z; Milad, N; Tehrani, AY; Chen, WWH; Donen, G; Sellers, SL; Bernatchez, P				White, Zoe; Milad, Nadia; Tehrani, Arash Y.; Chen, William Wei-Han; Donen, Graham; Sellers, Stephanie L.; Bernatchez, Pascal			Angiotensin II receptor blocker losartan exacerbates muscle damage and exhibits weak blood pressure-lowering activity in a dysferlin-null model of Limb-Girdle muscular dystrophy type 2B	PLOS ONE			English	Article							SKELETAL-MUSCLE; GROWTH-FACTOR; MIYOSHI MYOPATHY; LIPID PROFILE; DYSFUNCTION; MICE; PROGRESSION; GENE; DIFFERENTIATION; HYPERTENSION	There is no cure or beneficial management option for Limb-Girdle muscular dystrophy (MD) type 2B (LGMD2B). Losartan, a blood pressure (BP) lowering angiotensin II (AngII) receptor type 1 (ATR1) blocker (ARB) with unique anti-transforming growth factor-beta (TGF-beta) properties, can protect muscles in various types of MD such as Duchenne MD, suggesting a potential benefit for LGMD2B patients. Herein, we show in a mild, dysferlin-null mouse model of LGMD2B that losartan increased quadriceps muscle fibrosis (142%; P<0.0001). In a severe, atherogenic diet-fed model of LGMD2B recently described by our group, losartan further exacerbated dysferlin-null mouse muscle wasting in quadriceps and triceps brachii, two muscles typically affected by LGMD2B, by 40% and 51%, respectively (P<0.05). Lower TGF-beta signalling was not observed with losartan, therefore plasma levels of atherogenic lipids known to aggravate LGMD2B severity were investigated. We report that losartan increased both plasma triglycerides and cholesterol concentrations in dysferlin-null mice. Other protective properties of losartan, such as increased nitric oxide release and BP lowering, were also reduced in the absence of dysferlin expression. Our data suggest that LGMD2B patients may show some resistance to the primary BP-lowering effects of losartan along with accelerated muscle wasting and dyslipidemia. Hence, we urge caution on the use of ARBs in this population as their ATR1 pathway may be dysfunctional.	[White, Zoe; Milad, Nadia; Tehrani, Arash Y.; Chen, William Wei-Han; Donen, Graham; Sellers, Stephanie L.; Bernatchez, Pascal] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC, Canada; [White, Zoe; Milad, Nadia; Tehrani, Arash Y.; Chen, William Wei-Han; Donen, Graham; Sellers, Stephanie L.; Bernatchez, Pascal] UBC Ctr Heart Lung Innovat, Vancouver, BC, Canada; [White, Zoe; Milad, Nadia; Tehrani, Arash Y.; Chen, William Wei-Han; Donen, Graham; Sellers, Stephanie L.; Bernatchez, Pascal] St Pauls Hosp, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; St. Paul's Hospital; University of Saskatchewan	White, Z; Bernatchez, P (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC, Canada.; White, Z; Bernatchez, P (corresponding author), UBC Ctr Heart Lung Innovat, Vancouver, BC, Canada.; White, Z; Bernatchez, P (corresponding author), St Pauls Hosp, Vancouver, BC, Canada.	zoe.white@hli.ubc.ca; pascal.bematchez@ubc.ca		Sellers, Stephanie/0000-0002-3539-5730; Chen, William Wei-Han/0000-0002-9755-1428; Milad, Nadia/0000-0002-1497-8224	Jain Foundation; Canadian Institutes of Health Research; Canadian Foundation For Innovation; British Columbia Knowledge Development Fund; Heart & Stroke Foundation; MITACS Canada; Pacific Airways Centre	Jain Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation For Innovation(Canada Foundation for Innovation); British Columbia Knowledge Development Fund; Heart & Stroke Foundation(Heart & Stroke Foundation of Canada); MITACS Canada; Pacific Airways Centre	This work was supported by grants from the Jain Foundation, the Canadian Institutes of Health Research, the Canadian Foundation For Innovation, the British Columbia Knowledge Development Fund, the Heart & Stroke Foundation (PNB), MITACS Canada and the Pacific Airways Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HD, 2013, PLOS CURR US, V5; ALLEN RE, 1987, J CELL PHYSIOL, V133, P567, DOI 10.1002/jcp.1041330319; Araujo KPC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061367; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Begam M, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13727; BEJAOUI K, 1995, NEUROLOGY, V45, P768, DOI 10.1212/WNL.45.4.768; Bish LT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020856; Burks TN, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-19; Burks TN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002227; Cardenas AM, 2016, EXP NEUROL, V283, P246, DOI 10.1016/j.expneurol.2016.06.026; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Castets P, 2013, AUTOPHAGY, V9, P1435, DOI 10.4161/auto.25722; Ceco E, 2013, FEBS J, V280, P4198, DOI 10.1111/febs.12266; Chung AWY, 2007, BRIT J PHARMACOL, V150, P1075, DOI 10.1038/sj.bjp.0707181; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Collier AF, 2018, J PHARMACOL EXP THER, V364, P409, DOI 10.1124/jpet.117.244244; COULTON GR, 1988, NEUROPATH APPL NEURO, V14, P53, DOI 10.1111/j.1365-2990.1988.tb00866.x; Dabire H, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0240-6; Derosa G, 2004, CLIN THER, V26, P1228, DOI 10.1016/S0149-2918(04)80049-3; Duboc D, 2005, J AM COLL CARDIOL, V45, P855, DOI 10.1016/j.jacc.2004.09.078; Goldstein JA, 2014, HUM MOL GENET, V23, P6722, DOI 10.1093/hmg/ddu390; Grounds MD, 2014, AM J PATHOL, V184, P1668, DOI 10.1016/j.ajpath.2014.02.005; Han R., 2011, PROTOC EXCH; Han WQ, 2016, HYPERTENS RES, V39, P227, DOI 10.1038/hr.2015.144; Kalikar M, 2017, J PHARMACOL PHARMACO, V8, P106, DOI 10.4103/jpp.JPP_39_17; Kyvelou Stella-Maria G, 2006, Hellenic J Cardiol, V47, P21; Lee EM, 2015, LIFE SCI, V143, P35, DOI 10.1016/j.lfs.2015.10.023; Lerch M, 1998, J CARDIOVASC PHARM, V31, P576, DOI 10.1097/00005344-199804000-00016; Leung C, 2011, BIOCHEM BIOPH RES CO, V415, P263, DOI 10.1016/j.bbrc.2011.10.031; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Loufrani L, 2001, CIRCULATION, V103, P864, DOI 10.1161/01.CIR.103.6.864; Meinen S, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-18; Milad N, 2017, SKELET MUSCLE, V7, DOI 10.1186/s13395-017-0135-9; Miura S, 2011, J RENIN-ANGIO-ALDO S, V12, P1, DOI 10.1177/1470320310370852; Mueller AL, 2014, MUSCLE NERVE, V50, P286, DOI 10.1002/mus.24220; Onofre-Oliveira PCG, 2012, NEUROMOL MED, V14, P74, DOI 10.1007/s12017-012-8172-3; Palladino M, 2013, ARTERIOSCL THROM VAS, V33, P2867, DOI 10.1161/ATVBAHA.112.301172; PENNINGTON RJT, 1980, BRIT MED BULL, V36, P123, DOI 10.1093/oxfordjournals.bmb.a071625; Rando TA, 1998, NEUROMUSCULAR DISORD, V8, P14, DOI 10.1016/S0960-8966(97)00124-7; Rodriguez-Iturbe B, 2005, KIDNEY INT, V68, P1041, DOI 10.1111/j.1523-1755.2005.00496.x; Sellers SL, 2018, AM J PATHOL, V188, P574, DOI 10.1016/j.ajpath.2017.11.006; Sellers SL, 2018, J LIPID RES, V59, P261, DOI 10.1194/jlr.M079459; Sharma A, 2015, DIABETES, V64, P3937, DOI 10.2337/db15-0472; Spurney CF, 2011, J CARDIOVASC PHARM T, V16, P87, DOI 10.1177/1074248410381757; Srivastava A, 2016, J INVEST MED, V64, P1102, DOI 10.1136/jim-2016-000102; Srivastava NK, 2010, NMR BIOMED, V23, P13, DOI 10.1002/nbm.1419; Sun G, 2008, J NEUROL SCI, V267, P48, DOI 10.1016/j.jns.2007.09.043; Suzuki N, 2005, NEUROSCI RES, V52, P47, DOI 10.1016/j.neures.2005.01.006; Terrill JR, 2013, FEBS J, V280, P4149, DOI 10.1111/febs.12142; Tershakovec AM, 2008, DIABETES CARE, V31, P445, DOI 10.2337/dc07-0196; Tidball JG, 2007, J APPL PHYSIOL, V102, P1677, DOI 10.1152/japplphysiol.01145.2006; Walter MC, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-26; Wenzel K, 2007, J MOL MED, V85, P1203, DOI 10.1007/s00109-007-0253-7; White Z, 2017, SKELET MUSCLE, V7, DOI [10.1186/s13395-017-0120-3, 10.1186/s13395-016-0117-3]; White Z, 2016, INT J BIOCHEM CELL B, V78, P10, DOI 10.1016/j.biocel.2016.06.012; Whitehead NP, 2006, CLIN EXP PHARMACOL P, V33, P657, DOI 10.1111/j.1440-1681.2006.04394.x; Wiktorowicz T, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0057-3; ZATZ M, 1991, J NEUROL SCI, V102, P190, DOI 10.1016/0022-510X(91)90068-I	60	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220903	10.1371/journal.pone.0220903	http://dx.doi.org/10.1371/journal.pone.0220903			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404091	Green Submitted, Green Published, gold			2022-12-26	WOS:000485006800041
J	Zhang, JJ; Sha, QY; Liu, GF; Wang, XX				Zhang, Jianjun; Sha, Qiuying; Liu, Guanfu; Wang, Xuexia			A gene based approach to test genetic association based on an optimally weighted combination of multiple traits	PLOS ONE			English	Article							DETECTING ASSOCIATION; COMMON VARIANTS; RARE VARIANTS; SUSCEPTIBILITY; HERITABILITY; PHENOTYPES; DISEASE	There is increasing evidence showing that pleiotropy is a widespread phenomenon in complex diseases for which multiple correlated traits are often measured. Joint analysis of multiple traits could increase statistical power by aggregating multiple weak effects. Existing methods for multiple trait association tests usually study each of the multiple traits separately and then combine the univariate test statistics or combine p-values of the univariate tests for identifying disease associated genetic variants. However, ignoring correlation between phenotypes may cause power loss. Additionally, the genetic variants in one gene (including common and rare variants) are often viewed as a whole that affects the underlying disease since the basic functional unit of inheritance is a gene rather than a genetic variant. Thus, results from gene level association tests can be more readily integrated with downstream functional and pathogenic investigation, whereas many existing methods for multiple trait association tests only focus on testing a single common variant rather than a gene. In this article, we propose a statistical method by Testing an Optimally Weighted Combination of Multiple traits (TOW-CM) to test the association between multiple traits and multiple variants in a genomic region (a gene or pathway). We investigate the performance of the proposed method through extensive simulation studies. Our simulation studies show that the proposed method has correct type I error rates and is either the most powerful test or comparable with the most powerful tests. Additionally, we illustrate the usefulness of TOW-CM based on a COPDGene study.	[Zhang, Jianjun; Wang, Xuexia] Univ North Texas, Dept Math, Denton, TX 76203 USA; [Sha, Qiuying] Michigan Technol Univ, Dept Math Sci, Houghton, MI 49931 USA; [Liu, Guanfu] Shanghai Univ Int Business & Econ, Sch Stat & Informat, Shanghai, Peoples R China	University of North Texas System; University of North Texas Denton; Michigan Technological University; Shanghai University of International Business & Economics	Wang, XX (corresponding author), Univ North Texas, Dept Math, Denton, TX 76203 USA.	Xuexia.Wang@unt.edu			National Human Genome Research Institute of the National Institutes of Health [R15HG008209]; University of North Texas Foundation; NIH from the National Institute of General Medical Sciences [R01 GM031575]; NIH [R01 MH059490, U01HL089856, U01HL089897]; COPD Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL089856, U01HL089897] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R15HG008209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031575] Funding Source: NIH RePORTER	National Human Genome Research Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); University of North Texas Foundation; NIH from the National Institute of General Medical Sciences(General Electric); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COPD Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Human Genome Research Institute of the National Institutes of Health under Award Number R15HG008209 to QS. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. X Wang was supported by the University of North Texas Foundation which was contributed by Dr. Linda Truitt Creagh. The content is solely the responsibility of the authors and does not necessarily represent the views of the University of North Texas Foundation and Dr. Linda Truitt Creagh. The Genetic Analysis workshops are supported by NIH grant R01 GM031575 from the National Institute of General Medical Sciences. Preparation of the Genetic Analysis Workshop 17 Simulated Exome Data Set was supported in part by NIH R01 MH059490 and used sequencing data from the 1000 Genomes Project (www.1000genomes.org).This research used data generated by the COPDGene study, which was supported by NIH grants U01HL089856 and U01HL089897. The COPDGene project is also supported by the COPD Foundation through contributions made by an Industry Advisory Board comprised of Pfizer, AstraZeneca, Boehringer Ingelheim, Novartis, and Sunovion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berndt A, 2012, EMBO MOL MED, V4, P1144, DOI 10.1002/emmm.201100627; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Chu JH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-78; COLE DA, 1994, PSYCHOL BULL, V115, P465, DOI 10.1037/0033-2909.115.3.465; Han MLK, 2011, RADIOLOGY, V261, P274, DOI 10.1148/radiol.11110173; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kim J, 2015, GENET EPIDEMIOL, V39, P651, DOI 10.1002/gepi.21931; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Liang XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep34323; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Murphy TF, 2002, DRUG AGING, V19, P761, DOI 10.2165/00002512-200219100-00005; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Ott J, 1999, HUM HERED, V49, P106, DOI 10.1159/000022854; Pan W, 2014, GENETICS, V197, P1081, DOI 10.1534/genetics.114.165035; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Yang Q, 2012, J PROBAB STAT, V2012, DOI 10.1155/2012/652569; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; Sha QY, 2012, GENET EPIDEMIOL, V36, P561, DOI 10.1002/gepi.21649; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Stephens M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065245; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Teer JK, 2010, HUM MOL GENET, V19, pR145, DOI 10.1093/hmg/ddq333; Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010; Wu BL, 2016, GENET EPIDEMIOL, V40, P91, DOI 10.1002/gepi.21945; Wu BL, 2015, ANN HUM GENET, V79, P282, DOI 10.1111/ahg.12110; Yang QO, 2010, GENET EPIDEMIOL, V34, P444, DOI 10.1002/gepi.20497; Yang XL, 2017, GENET EPIDEMIOL, V41, P233, DOI 10.1002/gepi.22034; Zabaneh D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011961	31	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220914	10.1371/journal.pone.0220914	http://dx.doi.org/10.1371/journal.pone.0220914			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398229	Green Published, gold, Green Submitted			2022-12-26	WOS:000485004000026
J	Kadayakkara, DK; Balasubramanian, P; Araque, K; Davis, K; Javed, F; Niaki, P; Majumdar, S; Buller, G				Kadayakkara, Deepak Kana; Balasubramanian, Priyadarshini; Araque, Katherine; Davis, Karri; Javed, Fahad; Niaki, Pontea; Majumdar, Sachin; Buller, Gregory			Multidisciplinary strategies to treat severe hypoglycemia in hospitalized patients with diabetes mellitus reduce inpatient mortality rate: Experience from an academic community hospital	PLOS ONE			English	Article							LENGTH; IMPACT; STAY	Objective Severe hypoglycemia (blood glucose < 50 mg/dl) in hospitalized patients with diabetes mellitus is associated with poor outcomes such as increased mortality and readmission rates. We study the effects of system based interventions in managing severe hypoglycemia and its impact on outcomes. Research design and methods We performed retrospective review of pre- and post-intervention study to quantify severe hypoglycemia in patients admitted in the general internal medicine wards with primary or secondary diagnosis of diabetes mellitus based on ICD-9 and ICD-10 codes. We implemented multidisciplinary interventions including standardization of treatment, education of in-patient medical teams and physician notification and feedback immediately after severe hypoglycemia. The endpoints were the comparative analysis of incidence of severe hypoglycemia, in-patient mortality rate, 30-day mortality rate, 30-day readmission rate, recovery time from hypoglycemia, time to next glucose measurements, use of standardized treatment and physician notification rate pre- and post-intervention. Results The incidence of severe hypoglycemia per patient with diabetes was reduced from 9.6% (233/2416) to 5.6% (202/3607) (p<0.001) post-intervention. The in-patient mortality rate in patients with severe hypoglycemia reduced from 4.1% to 0% (p = 0.019), 30-day mortality rate reduced from 9.8% to 3.8% (p = 0.058) post-intervention. 30-day readmission rate was comparable between pre-intervention (31.7%) and post-intervention (29%) (p = 0.60). In comparison, the mortality and readmission rates of all diabetic patients did not reduce during the same observation periods. Recovery time reduced from 116 (83-161) to 75 (57-102) min (p<0.01), time to next glucose measurement reduced from 39.5 (34-48) to 32 (28-35) min (p<0.01), use of standardized treatment improved from 22.7% (53/233) to 72.2% (146/202) (p<0.001) and physician notification rate increased from 29.2 (68/233) to 84.7% (171/202) post-intervention. Conclusions Our study shows that multidisciplinary strategies improves the process of early detection and management of severe hypoglycemia and reduce incidence and in-patient mortality rate.	[Kadayakkara, Deepak Kana; Balasubramanian, Priyadarshini; Araque, Katherine; Davis, Karri; Javed, Fahad; Niaki, Pontea; Majumdar, Sachin; Buller, Gregory] Bridgeport Hosp Yale New Haven Hlth, Dept Med, Bridgeport, CT 06610 USA; [Kadayakkara, Deepak Kana; Majumdar, Sachin; Buller, Gregory] Yale Sch Med, Dept Med, New Haven, CT 06520 USA; [Araque, Katherine] NIDDK, Adult Endocrinol Dept, NIH, Bethesda, MD 20892 USA	Yale University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Kadayakkara, DK (corresponding author), Bridgeport Hosp Yale New Haven Hlth, Dept Med, Bridgeport, CT 06610 USA.; Kadayakkara, DK (corresponding author), Yale Sch Med, Dept Med, New Haven, CT 06520 USA.	deepak.kanakadayakkara@bpthosp.org		Araque, katherine/0000-0002-2098-2027; Kana Kadayakkara, Deepak/0000-0002-4325-7557				Araque Katherine A, 2018, BMJ Open Qual, V7, pe000120, DOI 10.1136/bmjoq-2017-000120; Bonds Denise E, 2010, BMJ, V340, pb4909, DOI 10.1136/bmj.b4909; Braithwaite Susan S, 2004, Endocr Pract, V10 Suppl 2, P89; Brodovicz KG, 2013, CURR MED RES OPIN, V29, P101, DOI 10.1185/03007995.2012.754744; Deusenberry CM, 2012, PHARMACOTHERAPY, V32, P613, DOI 10.1002/j.1875-9114.2011.01088.x; Farrokhi Farnoosh, 2012, J Diabetes Sci Technol, V6, P1022; Feinkohl I, 2014, DIABETES CARE, V37, P507, DOI 10.2337/dc13-1384; Garg R, 2013, DIABETES CARE, V36, P1107, DOI 10.2337/dc12-1296; Maynard G, 2015, ENDOCR PRACT, V21, P355, DOI 10.4158/EP14367.OR; Reno CM, 2018, AM J PHYSIOL-ENDOC M, V315, pE240, DOI 10.1152/ajpendo.00442.2017; Turchin A, 2009, DIABETES CARE, V32, P1153, DOI 10.2337/dc08-2127; Varghese P, 2007, J HOSP MED, V2, P234, DOI 10.1002/jhm.212; Varlamov Elena V, 2014, Hosp Pract (1995), V42, P163, DOI 10.3810/hp.2014.10.1153; Zapatero A, 2014, ENDOCR PRACT, V20, P870, DOI 10.4158/EP14006.OR	14	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220956	10.1371/journal.pone.0220956	http://dx.doi.org/10.1371/journal.pone.0220956			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393971	Green Published, Green Submitted, gold			2022-12-26	WOS:000485002500086
J	Li, W; Cho, MY; Lee, S; Jang, M; Park, J; Park, R				Li, Wanlu; Cho, Mee-Yon; Lee, Suji; Jang, Mirae; Park, Junsoo; Park, Rackhyun			CRISPR-Cas9 mediated CD133 knockout inhibits colon cancer invasion through reduced epithelial-mesenchymal transition	PLOS ONE			English	Article							STEM-CELLS; EXPRESSION; EMT	We previously reported that CD133, as a putative cancer stem cell marker, plays an important role in cell proliferation and invasion in colon cancer. To understand the role of CD133 expression in colon cancer, we evaluated the inhibitory effect of CD133 in colon cancer cells. In this study, we generated CD133(knockout) colon cancer cells (LoVo) using the CRISPR-Cas9 gene editing system. CD133(+) colon cancer cells (LoVo) were infected with the lentiviral vector carrying CD133 gRNA and purified cell by culturing single cell colonies. CD133(knockout) cells was validated by western blot and flow cytometry analysis. In functional study, we observed a significant reduction in cell proliferation and colony formation in CRISPR-Cas9 mediated CD133(knockout) cells in compare with control (P < 0.001). We also found the anticancer effect of stattic was dependent on CD133 expression in colon cancer cells. Although CD133(knockout) cells could not completely block the tumorigenic property, they showed remarkable inhibitory effects on the ability of cell migration and invasion (P < 0.001). In addition, we examined the epithelial mesenchymal transition (EMT)-related protein expression by western blot. The result clearly showed a loss of vimentin expression in CD133(knockout) cells. Therefore, CRISPR-Cas9 mediated CD133 knockout can be an effective treatment modality for CD133(+) colon cancer through reducing the characteristics of cancer stem cells.	[Li, Wanlu; Cho, Mee-Yon; Lee, Suji; Jang, Mirae] Yonsei Univ, Wonju Coll Med, Dept Pathol, Wonju, South Korea; [Park, Junsoo; Park, Rackhyun] Yonsei Univ, Div Biol Sci & Technol, Wonju, South Korea	Yonsei University; Yonsei University	Cho, MY (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Pathol, Wonju, South Korea.	meeyon@yonsei.ac.kr		Cho, Mee Yon/0000-0002-7955-4211	National Research Foundation of Korea (NRF) - Ministry of Education [2016R1D1A1A09918958]	National Research Foundation of Korea (NRF) - Ministry of Education	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, No. 2016R1D1A1A09918958 (https://www.nrf.re.kr/index).; This work was supported by a Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (No. 2016R1D1A1A09918958).	Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Dinicola S, 2018, J CELL PHYSIOL, V233, P4935, DOI 10.1002/jcp.26323; Feng HL, 2018, BRIT J CANCER, V118, P224, DOI 10.1038/bjc.2017.363; Gheldof A, 2013, PROG MOL BIOL TRANSL, V116, P317, DOI 10.1016/B978-0-12-394311-8.00014-5; Glumac PM, 2018, CLIN TRANSL MED, V7, DOI 10.1186/s40169-018-0198-1; Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016; Karimian A, 2019, J CELL PHYSIOL, V234, P12267, DOI 10.1002/jcp.27972; Kidd ME, 2014, AM J RESP CELL MOL, V50, P1, DOI 10.1165/rcmb.2013-0314TR; Kim EJ, 2017, KOREAN J INTERN MED, V32, P42, DOI 10.3904/kjim.2016.198; Kusoglu A, 2019, GENE, V681, P80, DOI 10.1016/j.gene.2018.09.052; Lee MR, 2015, BIOCHEM BIOPH RES CO, V463, P229, DOI 10.1016/j.bbrc.2015.05.031; Li WL, 2016, BIOCHEM BIOPH RES CO, V471, P309, DOI 10.1016/j.bbrc.2016.02.009; Li W, 2018, BIOCHEM BIOPH RES CO, V497, P354, DOI 10.1016/j.bbrc.2018.02.084; Li W, 2017, J PATHOL TRANSL MED, V51, P17, DOI 10.4132/jptm.2016.09.23; Ottaiano A, 2005, CANCER IMMUNOL IMMUN, V54, P781, DOI 10.1007/s00262-004-0636-3; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; TOMASZ M, 1995, CHEM BIOL, V2, P575, DOI 10.1016/1074-5521(95)90120-5; Turano M, 2018, INT J ONCOL, V53, P2379, DOI 10.3892/ijo.2018.4565; Wang BB, 2016, HISTOL HISTOPATHOL, V31, P299, DOI 10.14670/HH-11-676; Zhang SS, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-85; Zhou Yujuan, 2018, Oncotarget, V9, P33403, DOI 10.18632/oncotarget.23607	24	13	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220860	10.1371/journal.pone.0220860	http://dx.doi.org/10.1371/journal.pone.0220860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393941	Green Published, Green Submitted, gold			2022-12-26	WOS:000485002500073
J	Olmo, L; Reichel, MP; Nampanya, S; Khounsy, S; Wahl, LC; Clark, BA; Thomson, PC; Windsor, PA; Bush, RD				Olmo, Luisa; Reichel, Michael P.; Nampanya, Sonevilay; Khounsy, Syseng; Wahl, Lloyd C.; Clark, Bethanie A.; Thomson, Peter C.; Windsor, Peter A.; Bush, Russell D.			Risk factors for Neospora caninum, bovine viral diarrhoea virus, and Leptospira interrogans serovar Hardjo infection in smallholder cattle and buffalo in Lao PDR	PLOS ONE			English	Article							BUBALUS-BUBALIS; FOOD SECURITY; DAIRY-CATTLE; NORTHERN-TERRITORY; BEEF-CATTLE; SEROPREVALENCE; BVDV; BRUCELLOSIS; COMMUNITIES; ERADICATION	Smallholder large ruminant production in Lao People's Democratic Republic (Laos) is characterised by low reproductive efficiency. To determine if common abortifacient bovid infectious diseases are involved, a serological investigation was conducted. Sera was collected from stored and fresh cattle (n = 390) and buffalo (n = 130) samples from 2016-18 from, and then examined for associations in a retrospective risk factor study of 71 herds. The sera were assayed for antibodies to Neospora caninum, bovine viral diarrhoea virus (BVDV), Leptospira interrogans serovar Hardjo and Brucella abortus using commercially available enzyme-linked immunosorbent assay kits. These pathogens were detected in buffalo samples at 78.5% (95% CI 71.4-85.6), 0%, 2.3% (95% CI 0-4.9) and 0%, respectively, and in cattle at 4.4% (95% CI 2.4-6.4), 7.7% (95% CI 3.1-12.3), 12.8% (95% CI 9.5-16.1) and 0.26% (95% CI 0-0.8), respectively. Exposure of buffalo to N. caninum was positively associated with buffalo age, with a predicted seropositivity at birth of 52.8%, increasing to 97.2% by 12 years of age (p = 0.037). Exposure of cattle to L. interrogans serovar Hardjo was more prevalent in females compared to males, was associated with higher titres of BVDV, and was more prevalent in the wet season compared to the dry season. Exposure of cattle to BVDV was more prevalent in males compared to females, the wet and dry seasons were comparable, and was associated with rising antibody titres against N. caninum and L. interrogans serovar Hardjo. The risk factor survey identified that the probability of herds being N. caninum positive increased with farmer age, if farmers believed there were rodents on farm, and if farmers weren't aware that canids or rodents could contaminate bovid feed on their farm. The probability of a herd being positive to L. interrogans serovar Hardjo increased on farms where multiple cows shared the same bull, where farmers had lower husbandry knowledge, and on farms that used water troughs. The probability of a herd being BVDV seropositive increased with increasing herd size and increasing titres to N. caninum. The benchmarking of bovid exposure to emerging abortifacient pathogens and identification of their risk factors potentially informs disease prevention strategies, supporting efforts to establish a biosecure beef supply for enhanced smallholder livestock productivity, public health and food security in Laos and surrounding countries.	[Olmo, Luisa; Nampanya, Sonevilay; Clark, Bethanie A.; Windsor, Peter A.; Bush, Russell D.] Univ Sydney, Sydney Sch Vet Sci, Camden, NSW, Australia; [Reichel, Michael P.; Wahl, Lloyd C.] City Univ Hong Kong, Jockey Club Coll Vet Med & Life Sci, Kowloon, Tat Chee Ave, Hong Kong, Peoples R China; [Nampanya, Sonevilay; Khounsy, Syseng] Minist Agr & Forestry, Dept Livestock & Fisheries, Viangchan, Laos; [Thomson, Peter C.] Univ Sydney, Sch Life & Environm Sci, Camden, NSW, Australia	University of Sydney; City University of Hong Kong; University of Sydney	Olmo, L (corresponding author), Univ Sydney, Sydney Sch Vet Sci, Camden, NSW, Australia.	luisa.olmo@sydney.edu.au	Reichel, Michael/AAJ-5329-2020; Thomson, Peter/V-7290-2019	Reichel, Michael/0000-0002-9792-8336; Thomson, Peter/0000-0003-4428-444X	Australian Centre for International Agricultural Research (ACIAR) [AH/2012/067]	Australian Centre for International Agricultural Research (ACIAR)(Australian Ctr Intl Agr Res)	The study was funded by the Australian Centre for International Agricultural Research (ACIAR, http://aciar.gov.au/), project AH/2012/067, 'Enhancing transboundary livestock disease risk management in Lao PDR'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACIAR, 2016, ENH TRANSB LIV DIS R; Almeria Sonia, 2013, ISRN Parasitol, V2013, P947347, DOI 10.5402/2013/947347; [Anonymous], 2018, GDAM MAPS DAT; Arif S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173365; Barratt J, 2008, MOL CELL PROBE, V22, P228, DOI 10.1016/j.mcp.2008.03.001; Bartley PM, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-38; BonDurant RH, 2005, VET CLIN N AM-FOOD A, V21, P383, DOI 10.1016/j.cvfa.2005.03.002; Brown PR, 2010, CROP PROT, V29, P577, DOI 10.1016/j.cropro.2009.12.025; Brown PR, 2007, INTEGR ZOOL, V2, P165, DOI 10.1111/j.1749-4877.2007.00055.x; Butler DG, 2018, ASREML R REFERENCE M; Chase CCL, 2013, BIOLOGICALS, V41, P52, DOI 10.1016/j.biologicals.2012.09.009; Dacre I, 2019, P 3 INT C AN HLTH SU, P203; Dhandapani K, 2017, Vet Parasitol Reg Stud Reports, V7, P36, DOI 10.1016/j.vprsr.2016.12.004; Douangngeun B, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005609; Douangngeun B, 2016, AM J TROP MED HYG, V95, P558, DOI 10.4269/ajtmh.15-0913; Dubey JP, 2007, CLIN MICROBIOL REV, V20, P323, DOI 10.1128/CMR.00031-06; ELLIS WA, 1994, VET CLIN N AM-FOOD A, V10, P463, DOI 10.1016/S0749-0720(15)30532-6; Evans CA, 2016, AUST VET J, V94, P423, DOI 10.1111/avj.12517; FAO, 2011, MAPP SUPPL DEM AN SO; Ferroglio E, 2007, VET PARASITOL, V148, P346, DOI 10.1016/j.vetpar.2007.06.031; Glynn MK, 2008, JAVMA-J AM VET MED A, V233, P900, DOI 10.2460/javma.233.6.900; Graham DA, 2013, PREV VET MED, V112, P99, DOI 10.1016/j.prevetmed.2013.07.011; Grooms DL, 2004, VET CLIN N AM-FOOD A, V20, P5, DOI 10.1016/j.cvfa.2003.11.006; Kampa J, 2011, THAI J VET MED, V41, P409; Kawaguchi L, 2008, AM J TROP MED HYG, V78, P957, DOI 10.4269/ajtmh.2008.78.957; King JS, 2011, VET J, V188, P24, DOI 10.1016/j.tvjl.2010.03.002; Koiwai M, 2006, VET PARASITOL, V135, P175, DOI 10.1016/j.vetpar.2005.08.014; Lanyon SR, 2014, VET J, V199, P201, DOI 10.1016/j.tvjl.2013.07.024; Ledien J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181044; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lilenbaum W, 2014, TRANSBOUND EMERG DIS, V61, P63, DOI 10.1111/tbed.12233; Lindberg ALE, 1999, VET MICROBIOL, V64, P197, DOI 10.1016/S0378-1135(98)00270-3; Matsumoto N, 2017, TROP ANIM HEALTH PRO, V49, P87, DOI 10.1007/s11250-016-1162-y; Meays CL, 2005, RANGELAND ECOL MANAG, V58, P279, DOI 10.2111/1551-5028(2005)58[279:SOECIB]2.0.CO;2; Nampanya S, 2014, ANIM PROD SCI, V54, P899, DOI 10.1071/AN13180; Nampanya S, 2013, TRANSBOUND EMERG DIS, V60, P315, DOI 10.1111/j.1865-1682.2012.01350.x; Nampanya S, 2015, TROP ANIM HEALTH PRO, V47, P681, DOI 10.1007/s11250-015-0778-7; Nasir A, 2011, J PARASITOL, V97, P541, DOI 10.1645/GE-2687.1; Neta AVC, 2010, VET J, V184, P146, DOI 10.1016/j.tvjl.2009.04.010; Neverauskas CE, 2015, PARASITOL INT, V64, P392, DOI 10.1016/j.parint.2015.05.009; Olmo L, 2018, ACTA TROP, V177, P118, DOI 10.1016/j.actatropica.2017.10.007; Reichel MP, 2015, VET PARASITOL, V212, P75, DOI 10.1016/j.vetpar.2015.08.008; Reichel MP, 2013, INT J PARASITOL, V43, P133, DOI 10.1016/j.ijpara.2012.10.022; Reichel MP, 2002, VET PARASITOL, V107, P197, DOI 10.1016/S0304-4017(02)00086-9; Rodrigues AAR, 2005, VET PARASITOL, V129, P21, DOI 10.1016/j.vetpar.2004.12.024; Roushan MRH, 2011, T ROY SOC TROP MED H, V105, P540, DOI 10.1016/j.trstmh.2011.06.003; Sanhueza JM, 2013, PREV VET MED, V112, P90, DOI 10.1016/j.prevetmed.2013.07.009; Selim AM, 2018, VET WORLD, V11, P259, DOI 10.14202/vetworld.2018.259-267; Seng Heng, 2007, Journal of the Medical Association of Thailand, V90, P546; Smith P., 2015, MOVEMENT PATHWAYS MA; Sraboni E, 2014, WORLD DEV, V61, P11, DOI 10.1016/j.worlddev.2014.03.025; Str W.W., 2002, REV LIVESTOCK SECTOR; Suwancharoen D, 2013, EPIDEMIOL INFECT, V141, P2269, DOI 10.1017/S0950268812002981; Suzuki K, 2006, RES VET SCI, V81, P177, DOI 10.1016/j.rvsc.2005.12.002; Vongxay K, 2012, VECTOR-BORNE ZOONOT, V12, P861, DOI 10.1089/vbz.2011.0850; World Bank Group, 2020, CLIM CHANG KNOWL POR; World Meteorological Organization Standard Normals, 2018, UNDATA; Yu JH, 2007, VET PARASITOL, V143, P79, DOI 10.1016/j.vetpar.2006.07.031	58	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220335	10.1371/journal.pone.0220335	http://dx.doi.org/10.1371/journal.pone.0220335			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393897	gold, Green Published, Green Submitted			2022-12-26	WOS:000485002500027
J	Liu, HJ; Lam, HC; Baglini, CV; Nijmeh, J; Cottrill, AA; Chan, SY; Henske, EP				Liu, Heng-Jia; Lam, Hilaire C.; Baglini, Christian, V; Nijmeh, Julie; Cottrill, Alischer A.; Chan, Stephen Y.; Henske, Elizabeth P.			Rapamycin-upregulated miR-29b promotes mTORC1-hyperactive cell growth in TSC2-deficient cells by downregulating tumor suppressor retinoic acid receptor beta (RAR beta)	ONCOGENE			English	Article							TUBEROUS SCLEROSIS COMPLEX; MICRORNA-29 FAMILY; HUMAN-MELANOMA; CANCER; MIGRATION; INVASION; MULTICENTER; EXPRESSION; EVEROLIMUS; INHIBITOR	miR-29b has been identified as a rapamycin-induced microRNA (miRNA) in Tsc2-deficient, mTORC1-hyperactive cells. The biological significance of this induction of miR-29b is unknown. We have found that miR-29b acts as an oncogenic miRNA in Tsc2-deficient cells: inhibition of miR-29b suppressed cell proliferation, anchorage-independent cell growth, cell migration, invasion, and the growth of Tsc2-deficient tumors in vivo. Importantly, the combination of miR-29b inhibition with rapamycin treatment further inhibited these tumor-associated cellular processes. To gain insight into the molecular mechanisms by which miR-29b promotes tumorigenesis, we used RNA sequencing to identify the tumor suppressor retinoid receptor beta (RAR beta) as a target gene of miR-29b. We found that miR-29b directly targeted the 3'UTR of RAR beta. Forced expression of RAR beta reversed the effects of miR-29b overexpression in proliferation, migration, and invasion, indicating that it is a critical target. miR-29b expression correlated with low RAR beta expression in renal clear cell carcinomas and bladder urothelial carcinomas, tumors associated with TSC gene mutations. We further identified growth family member 4 (ING4) as a novel interacting partner of RAR beta. Overexpression of ING4 inhibited the migration and invasion of Tsc2-deficient cells while silencing of ING4 reversed the RAR beta-mediated suppression of cell migration and invasion. Taken together, our findings reveal a novel miR-29b/RAR beta/ING4 pathway that regulates tumorigenic properties of Tsc2-deficient cells, and that may serve as a potential therapeutic target for TSC, lymphangioleiomyomatosis (LAM), and other mTORC1-hyperactive tumors.	[Liu, Heng-Jia; Lam, Hilaire C.; Baglini, Christian, V; Nijmeh, Julie; Henske, Elizabeth P.] Brigham & Womens Hosp, Dept Med, Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA; [Liu, Heng-Jia; Lam, Hilaire C.; Baglini, Christian, V; Nijmeh, Julie; Henske, Elizabeth P.] Harvard Med Sch, Boston, MA 02115 USA; [Cottrill, Alischer A.; Chan, Stephen Y.] Univ Pittsburgh, Sch Med, Dept Med, Div Cardiol,Ctr Pulm Vasc Biol & Med,Pittsburgh H, Pittsburgh, PA 15213 USA; [Cottrill, Alischer A.; Chan, Stephen Y.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Henske, EP (corresponding author), Brigham & Womens Hosp, Dept Med, Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA.; Henske, EP (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	EHENSKE@BWH.HARVARD.EDU			Engles Program in TSC and LAM research, Department of Defense [W81XWH-15-1-0263 TS14003]; Tuberous Sclerosis Alliance; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL138437, R01HL122596, R01HL124021] Funding Source: NIH RePORTER	Engles Program in TSC and LAM research, Department of Defense; Tuberous Sclerosis Alliance; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Lorena Pantano of the Harvard Chan Bioinformatics Core for assistance with RNAseq analysis. This work was supported by the Engles Program in TSC and LAM research, Department of Defense grant W81XWH-15-1-0263 TS14003 (EPH) and a postdoctoral Fellowship from Tuberous Sclerosis Alliance (HJL).	Ben-Sahra I, 2017, CURR OPIN CELL BIOL, V45, P72, DOI 10.1016/j.ceb.2017.02.012; Bertolini F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199371; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Bissler JJ, 2013, LANCET, V381, P817, DOI 10.1016/S0140-6736(12)61767-X; Byron SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046823; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Cheadle JP, 2000, HUM GENET, V107, P97, DOI 10.1007/s004390000348; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Cheng JJ, 2013, CELL REP, V5, P471, DOI 10.1016/j.celrep.2013.08.050; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Cui SY, 2015, CELL PHYSIOL BIOCHEM, V36, P409, DOI 10.1159/000430108; DETHE H, 1989, EMBO J, V8, P429, DOI 10.1002/j.1460-2075.1989.tb03394.x; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Franz DN, 2013, LANCET, V381, P125, DOI 10.1016/S0140-6736(12)61134-9; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Gong JN, 2014, CELL DEATH DIFFER, V21, P100, DOI 10.1038/cdd.2013.133; Henske EP, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.35; Henske EP, 2003, GENE CHROMOSOME CANC, V38, P376, DOI 10.1002/gcc.10252; Hou Y, 2014, ONCOGENE, V33, P1997, DOI 10.1038/onc.2013.135; Jiang HS, 2014, ONCOL REP, V31, P1509, DOI 10.3892/or.2014.3036; Kinoshita T, 2013, BRIT J CANCER, V109, P2636, DOI 10.1038/bjc.2013.607; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Lam HC, 2017, ONCOTARGET, V8, P64714, DOI 10.18632/oncotarget.19947; Li J, 2008, CARCINOGENESIS, V29, P1373, DOI 10.1093/carcin/bgn086; McCormack FX, 2012, AM J RESP CRIT CARE, V186, P1210, DOI 10.1164/rccm.201205-0848OE; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Ogorek B, 2018, HUM MOL GENET, V27, P1654, DOI 10.1093/hmg/ddy073; Palacios A, 2008, J BIOL CHEM, V283, P15956, DOI 10.1074/jbc.M710020200; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Poudyal D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075034; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Ren MQ, 2005, MOL CELL BIOL, V25, P10591, DOI 10.1128/MCB.25.23.10591-10603.2005; Rosset C, 2017, GENET MOL BIOL, V40, P69, DOI [10.1590/1678-4685-GMB-2015-0321, 10.1590/1678-4685-gmb-2015-0321]; Rossi M, 2013, J CELL PHYSIOL, V228, P1506, DOI 10.1002/jcp.24306; Ru P, 2012, MOL CANCER THER, V11, P1166, DOI 10.1158/1535-7163.MCT-12-0100; Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246; Shen JC, 2007, CANCER RES, V67, P2552, DOI 10.1158/0008-5472.CAN-06-3870; Song SM, 2005, ONCOGENE, V24, P8268, DOI 10.1038/sj.onc.1208992; Sun SY, 2000, J BIOL CHEM, V275, P17149, DOI 10.1074/jbc.M000527200; Tang Y, 2014, CARCINOGENESIS, V35, P86, DOI 10.1093/carcin/bgt346; Trindade AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060014; Wang C, 2012, J CANCER RES CLIN, V138, P2127, DOI 10.1007/s00432-012-1288-x; Wang C, 2011, MOL CELL BIOCHEM, V352, P197, DOI 10.1007/s11010-011-0755-z; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Xu F, 2013, J INT MED RES, V41, P1803, DOI 10.1177/0300060513505266; Yan B, 2015, ONCOTARGETS THER, V8, P539, DOI 10.2147/OTT.S75899; Ye PY, 2015, MOL CELL, V57, P708, DOI 10.1016/j.molcel.2014.12.034; Young LR, 2013, LANCET RESP MED, V1, P445, DOI 10.1016/S2213-2600(13)70090-0; ZIMMER A, 1992, DEVELOPMENT, V116, P977	51	8	8	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 5	2019	38	49					7367	7383		10.1038/s41388-019-0957-5	http://dx.doi.org/10.1038/s41388-019-0957-5			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JT4BN	31420607	Green Accepted			2022-12-26	WOS:000500936600001
J	Yuan, YM; Ma, N; Zhang, EB; Chen, TW; Jiang, H; Yin, FF; Wang, JJ; Zhang, FK; Ni, QZ; Wang, X; Bao, Y; Wang, K; Cheng, SQ; Zhang, XL; Wang, XF; Li, JJ; Xie, D				Yuan, Yan-Mei; Ma, Ning; Zhang, Er-Bin; Chen, Tian-Wei; Jiang, Hao; Yin, Fen-Fen; Wang, Jing-Jing; Zhang, Feng-Kun; Ni, Qian-Zhi; Wang, Xiang; Bao, Ying; Wang, Kang; Cheng, Shu-Qun; Zhang, Xue-Li; Wang, Xiao-Fan; Li, Jing-Jing; Xie, Dong			BMP10 suppresses hepatocellular carcinoma progression via PTPRS-STAT3 axis	ONCOGENE			English	Article							GROWTH-FACTOR; TUMOR-SUPPRESSOR; CANCER; EXPRESSION; RECEPTOR; STAT3; CELLS; AGGRESSIVENESS; IDENTIFICATION; PROLIFERATION	Bone morphogenetic protein 10 (BMP10), one member of the BMP family, is involved in various development events. Dysregulation of BMP10 has been observed in several diseases, including hypertensive cardiac hypertrophy, Hirschsprung disease and blood vessel formation. However, its role in liver cancer remains largely unknown. In this study, we reported that BMP10 was significantly downregulated in HCC at both mRNA and protein level. Decreased BMP10 was associated with bigger tumor size, worse TNM stage, earlier recurrence and poorer survival. BMP10 negatively regulated HCC cell proliferation in vitro and in vivo. Mechanism study revealed that BMP10 suppressed tumor cell growth by inhibiting STAT3 signaling. Interestingly, we found that cytoplasmic BMP10 interacted with both receptor protein tyrosine phosphatase sigma (PTPRS) and STAT3, which facilitated dephosphorylation of STAT3 by PTPRS. Altogether, our study has revealed the clinical significance of BMP10 in HCC, and suppression of HCC cell growth by BMP10 via PTPRS-STAT3 axis, providing a potential therapeutic strategy for targeting STAT3 signaling in HCC.	[Yuan, Yan-Mei; Ma, Ning; Zhang, Er-Bin; Chen, Tian-Wei; Jiang, Hao; Yin, Fen-Fen; Wang, Jing-Jing; Zhang, Feng-Kun; Ni, Qian-Zhi; Li, Jing-Jing; Xie, Dong] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Nutr & Hlth,CAS Key Lab Nutr Metab, Shanghai 200031, Peoples R China; [Wang, Xiang] Huzhou Univ, First Peoples Hosp Affiliated, Key Lab Translat Med, Huzhou 313000, Peoples R China; [Bao, Ying] Huzhou Univ, First Peoples Hosp Affiliated, Dept Surg, Huzhou 313000, Peoples R China; [Wang, Kang; Cheng, Shu-Qun] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg 6, Shanghai 200438, Peoples R China; [Zhang, Xue-Li] Southern Med Univ, Fengxian Hosp, Dept Gen Surg, 6600 Nanfeng Rd, Shanghai 201499, Peoples R China; [Wang, Xiao-Fan] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Xie, Dong] ShanghaiTech Univ, Sch Life Sci & Technol, 393 Middle Huaxia Rd, Shanghai 201210, Peoples R China; [Xie, Dong] China Natl Ctr Food Safety Risk Assessment, NHC Key Lab Food Safety Risk Assessment, Beijing 100022, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Huzhou University; Huzhou University; Naval Medical University; Southern Medical University - China; Duke University; ShanghaiTech University	Li, JJ; Xie, D (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Nutr & Hlth,CAS Key Lab Nutr Metab, Shanghai 200031, Peoples R China.; Xie, D (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, 393 Middle Huaxia Rd, Shanghai 201210, Peoples R China.; Xie, D (corresponding author), China Natl Ctr Food Safety Risk Assessment, NHC Key Lab Food Safety Risk Assessment, Beijing 100022, Peoples R China.	tide7@163.com; dxie@sibs.ac.cn	cheng, sq/GPT-4112-2022	Xie, Dong/0000-0002-1150-8657; Wang, Xiang/0000-0002-0913-0501	National Key R&D Program of China [2018YFC1603002, 2018YFC1604404]; "Personalized Medicines-Molecular Signature-based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences [XDA12010316]; National Natural Science Foundation of China [31520103907, 81730083, 31771538]; Youth Innovation Promotion Association of Chinese Academy of Sciences; Sanofi-SIBS 2018 Young Faculty Award	National Key R&D Program of China; "Personalized Medicines-Molecular Signature-based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association of Chinese Academy of Sciences; Sanofi-SIBS 2018 Young Faculty Award	This work was supported by the National Key R&D Program of China (2018YFC1603002, 2018YFC1604404), the "Personalized Medicines-Molecular Signature-based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences (Grant no. XDA12010316), and National Natural Science Foundation of China (31520103907, 81730083) to Dong Xie; and National Natural Science Foundation of China (31771538), Youth Innovation Promotion Association of Chinese Academy of Sciences fund and Sanofi-SIBS 2018 Young Faculty Award to Jing-Jing Li.	Cai Z, 2018, CANCER RES, V78, P2536, DOI 10.1158/0008-5472.CAN-17-0028; Castonguay R, 2011, J BIOL CHEM, V286, P30034, DOI 10.1074/jbc.M111.260133; Chen YW, 2015, BLOOD, V125, P1589, DOI 10.1182/blood-2014-07-588970; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Deng YZ, 2007, J BIOL CHEM, V282, P36571, DOI 10.1074/jbc.M704141200; Felin JE, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-20; Geiger JL, 2016, ORAL ONCOL, V56, P84, DOI 10.1016/j.oraloncology.2015.11.022; Hjertner O, 2001, BLOOD, V97, P516, DOI 10.1182/blood.V97.2.516; Hou JJ, 2013, HEPATOLOGY, V57, P678, DOI 10.1002/hep.25980; Hover LD, 2016, NEURO-ONCOLOGY, V18, P928, DOI 10.1093/neuonc/nov310; Kawamura C, 2000, BLOOD, V96, P2005, DOI 10.1182/blood.V96.6.2005.h8002005a_2005_2011; Kim BR, 2015, TUMOR BIOL, V36, P9475, DOI 10.1007/s13277-015-3681-y; Langenfeld EM, 2006, ONCOGENE, V25, P685, DOI 10.1038/sj.onc.1209110; Lei HM, 2016, TUMOR BIOL, V37, P3025, DOI 10.1007/s13277-015-4116-5; Levet S, 2015, P NATL ACAD SCI USA, V112, pE3207, DOI 10.1073/pnas.1508386112; Li JJ, 2009, ONCOGENE, V28, P1759, DOI 10.1038/onc.2009.15; Min KW, 2016, ONCOGENE, V35, P377, DOI 10.1038/onc.2015.95; Mitrofan CG, 2017, J BIOL CHEM, V292, P13714, DOI 10.1074/jbc.M117.778506; Nakano N, 2007, AM J PHYSIOL-HEART C, V293, pH3396, DOI 10.1152/ajpheart.00311.2007; Neuhaus H, 1999, MECH DEVELOP, V80, P181, DOI 10.1016/S0925-4773(98)00221-4; Pestana ES, 1999, ONCOGENE, V18, P4069, DOI 10.1038/sj.onc.1202794; Shin DS, 2009, CANCER RES, V69, P193, DOI 10.1158/0008-5472.CAN-08-2575; Su FQ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3134; Sun LJ, 2014, J CELL BIOCHEM, V115, P1868, DOI 10.1002/jcb.24856; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Veeriah S, 2009, P NATL ACAD SCI USA, V106, P9435, DOI 10.1073/pnas.0900571106; Wu M, 2014, INT J CLIN EXP PATHO, V7, P529; Ye L, 2010, CANCER SCI, V101, P2137, DOI 10.1111/j.1349-7006.2010.01648.x; Ye L, 2009, J UROLOGY, V181, P2749, DOI 10.1016/j.juro.2009.01.098; Zhang N, 2013, ANTICANCER RES, V33, P1917; Zhang XD, 2007, P NATL ACAD SCI USA, V104, P4060, DOI 10.1073/pnas.0611665104	31	7	8	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 28	2019	38	48					7281	7293		10.1038/s41388-019-0943-y	http://dx.doi.org/10.1038/s41388-019-0943-y			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JR4XX	31417183				2022-12-26	WOS:000499631000001
J	Jallow, F; O'Leary, KA; Rugowski, DE; Guerrero, JF; Ponik, SM; Schuler, LA				Jallow, Fatou; O'Leary, Kathleen A.; Rugowski, Debra E.; Guerrero, Jorge F.; Ponik, Suzanne M.; Schuler, Linda A.			Dynamic interactions between the extracellular matrix and estrogen activity in progression of ER plus breast cancer	ONCOGENE			English	Article							ENDOCRINE THERAPY; TAMOXIFEN RESISTANCE; DNA-BINDING; IN-VIVO; COLLAGEN; AP-1; GROWTH; CELLS; ASSOCIATION; TUMORS	Metastatic, antiestrogen resistant estrogen receptor a positive (ER+) breast cancer is the leading cause of breast cancer deaths in USA women. While studies have demonstrated the importance of the stomal tumor microenvironment in cancer progression and therapeutic responses, effects on the responses of ER+ cancers to estrogen and antiestrogens are poorly understood, particularly in the complex in vivo environment. In this study, we used an estrogen responsive syngeneic mouse model to interrogate how a COL1A1-enriched fibrotic ECM modulates integrated hormonal responses in cancer progression. We orthotopically transplanted the ER+ TC11 cell line into wild-type (WT) or collagen-dense (Col1a1(t)(m1Jae/+),mCol1a1 syngeneic FVB/N female mice. Once tumors were established, recipients were supplemented with 17 beta-estradiol (E2), tamoxifen, or left untreated. Although the dense/stiff environment in mCol1a1 recipients did not alter the rate of E2-induced proliferation of the primary tumor, it fostered the agonist activity of tamoxifen to increase proliferation and AP-1 activity. Manipulation of estrogen activity did not alter the incidence of lung lesions in either WT or mCol1a1 hosts. However, the mCol1a1 environment enabled tamoxifen-stimulated growth of pulmonary metastases and further fueled estrogen-driven growth. Moreover, E2 remodeled peritumoral ECM architecture in WT animals, modifying alignment of collagen fibers and altering synthesis of ECM components associated with increased alignment and stiffness, and increasing FN1 and POSTN expression in the pulmonary metastatic niche. These studies demonstrate dynamic interactions between ECM properties and estrogen activity in progression of ER+ breast cancer, and support the need for therapeutics that target both ER and the tumor microenvironment.	[Jallow, Fatou; O'Leary, Kathleen A.; Rugowski, Debra E.; Schuler, Linda A.] Univ Wisconsin, Dept Comparat Biosci, 2015 Linden Dr W, Madison, WI 53706 USA; [Jallow, Fatou] Univ Wisconsin, Endocrinol Reprod Physiol Program, Madison, WI USA; [Guerrero, Jorge F.; Ponik, Suzanne M.] Univ Wisconsin, Dept Cell & Regenerat Biol, Madison, WI USA; [Ponik, Suzanne M.; Schuler, Linda A.] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Schuler, LA (corresponding author), Univ Wisconsin, Dept Comparat Biosci, 2015 Linden Dr W, Madison, WI 53706 USA.; Schuler, LA (corresponding author), Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA.	linda.schuler@wisc.edu	Ponik, Suzanne/AAF-5572-2020	Ponik, Suzanne/0000-0003-1367-4349	National Institutes of Health [R01 CA157675, R01 CA179556, T32 HD041921, R25 GM083252, P30CA014520]; UWCCC Breast Disease Oriented Team; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD041921] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA179556, R01CA206458, P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM083252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UWCCC Breast Disease Oriented Team; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health [R01 CA157675 (LAS) and R01 CA179556 (LAS, SMP), T32 HD041921 and R25 GM083252 (FJ), and P30CA014520 (University of Wisconsin Carbone Cancer Center)], and funds from the UWCCC Breast Disease Oriented Team.	ALADNANI MS, 1975, BRIT J CANCER, V31, P653, DOI 10.1038/bjc.1975.112; Anderson WF, 2011, J NATL CANCER I, V103, P1397, DOI 10.1093/jnci/djr257; Barcus CE, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0801-1; Barcus CE, 2016, ONCOTARGET, V7, P48093, DOI 10.18632/oncotarget.10137; Barcus CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116891; Barcus CE, 2013, J BIOL CHEM, V288, P12722, DOI 10.1074/jbc.M112.447631; Bertrand KA, 2018, HORM CANCER-US, V9, P117, DOI 10.1007/s12672-017-0321-6; Burstein HJ, 2014, J CLIN ONCOL, V32, P2255, DOI 10.1200/JCO.2013.54.2258; Byrne C, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djx001; Calvo E, 2012, BREAST CANCER RES TR, V134, P625, DOI 10.1007/s10549-012-2104-7; Campbell KM, 2019, CELL REP, V28, P1526, DOI 10.1016/j.celrep.2019.06.098; Cheung E, 2005, P NATL ACAD SCI USA, V102, P559, DOI 10.1073/pnas.0407113102; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Cox TR, 2014, CLIN CANCER RES, V20, P3637, DOI 10.1158/1078-0432.CCR-13-1059; Dabrosin C, 2003, INT J CANCER, V107, P535, DOI 10.1002/ijc.11398; Dumont JA, 1996, CELL GROWTH DIFFER, V7, P351; Dupont S, 2016, EXP CELL RES, V343, P42, DOI 10.1016/j.yexcr.2015.10.034; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Esbona K, 2018, AM J PATHOL, V188, P559, DOI 10.1016/j.ajpath.2017.10.025; Evans A, 2018, BREAST CANCER RES TR, V171, P383, DOI 10.1007/s10549-018-4836-5; Gerard C, 2017, J MAMMARY GLAND BIOL, V22, P1, DOI 10.1007/s10911-016-9368-1; Goddard ET, 2017, CANCER DISCOV, V7, P177, DOI 10.1158/2159-8290.CD-16-0822; Gyorfi AH, 2018, MATRIX BIOL, V68-69, P8, DOI 10.1016/j.matbio.2017.12.016; Haslam SZ, 2001, BREAST CANCER RES, V3, P365, DOI 10.1186/bcr324; Hattar R, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2220; He H, 2018, ONCOGENE, V37, P2586, DOI 10.1038/s41388-018-0165-8; Helleman J, 2008, CLIN CANCER RES, V14, P5555, DOI 10.1158/1078-0432.CCR-08-0555; Holm C, 2006, JNCI-J NATL CANCER I, V98, P671, DOI 10.1093/jnci/djj185; Houthuijzen JM, 2018, CANCER METAST REV, V37, P577, DOI 10.1007/s10555-018-9768-3; Insua-Rodriguez J, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201809003; Jakacka M, 2001, J BIOL CHEM, V276, P13615, DOI 10.1074/jbc.M008384200; Jallow F, 2018, J ENDOCR SOC, V2, P293, DOI 10.1210/js.2017-00399; Johnston SRD, 1999, CLIN CANCER RES, V5, P251; Kang JS, 2009, BIOL PHARM BULL, V32, P150, DOI 10.1248/bpb.32.150; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kaushik S, 2016, CANCER METAST REV, V35, P655, DOI 10.1007/s10555-016-9650-0; Keely PJ, 2011, J MAMMARY GLAND BIOL, V16, P205, DOI 10.1007/s10911-011-9226-0; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Kim KK, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a022293; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; LIU X, 1995, J CELL BIOL, V130, P227, DOI 10.1083/jcb.130.1.227; Liu YM, 2017, METHODS MOL BIOL, V1627, P429, DOI 10.1007/978-1-4939-7113-8_28; Lupien M, 2010, GENE DEV, V24, P2219, DOI 10.1101/gad.1944810; Malorni L, 2016, MOL CANCER RES, V14, P470, DOI 10.1158/1541-7786.MCR-15-0423; Massarweh S, 2008, CANCER RES, V68, P826, DOI 10.1158/0008-5472.CAN-07-2707; Molnar IA, 2017, VIRCHOWS ARCH, V470, P275, DOI 10.1007/s00428-017-2065-7; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Nagaraj G, 2015, BREAST CANCER RES TR, V150, P231, DOI 10.1007/s10549-015-3316-4; Nardone A, 2015, BREAST, V24, pS60, DOI 10.1016/j.breast.2015.07.015; Nelson ER, 2013, SCIENCE, V342, P1094, DOI 10.1126/science.1241908; O'Leary KA, 2015, ADV EXP MED BIOL, V846, P201, DOI 10.1007/978-3-319-12114-7_9; Ong CC, 2011, P NATL ACAD SCI USA, V108, P7177, DOI 10.1073/pnas.1103350108; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Pan HC, 2017, NEW ENGL J MED, V377, P1836, DOI 10.1056/NEJMoa1701830; Pontiggia O, 2012, BREAST CANCER RES TR, V133, P459, DOI 10.1007/s10549-011-1766-x; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Robertson C, 2016, EXP CELL RES, V343, P73, DOI 10.1016/j.yexcr.2015.11.009; Sampayo RG, 2018, J CELL BIOL, V217, P2777, DOI 10.1083/jcb.201703037; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shea MP, 2018, CANCER LETT, V433, P1, DOI 10.1016/j.canlet.2018.06.025; Shen Q, 2008, ONCOGENE, V27, P366, DOI 10.1038/sj.onc.1210643; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Smith LM, 1999, ONCOGENE, V18, P6063, DOI 10.1038/sj.onc.1202989; Socovich AM, 2019, SEMIN CELL DEV BIOL, V89, P157, DOI 10.1016/j.semcdb.2018.06.005; Svoronos N, 2017, CANCER DISCOV, V7, P72, DOI 10.1158/2159-8290.CD-16-0502; Tomko LA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31126-w; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Walker RA, 2001, BREAST CANCER RES, V3, P143, DOI 10.1186/bcr287; WEBB P, 1995, MOL ENDOCRINOL, V9, P443, DOI 10.1210/me.9.4.443; Wegner KA, 2017, J HISTOCHEM CYTOCHEM, V65, P479, DOI 10.1369/0022155417718541; Wernig G, 2017, P NATL ACAD SCI USA, V114, P4757, DOI 10.1073/pnas.1621375114; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zhou YM, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-59	78	20	20	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 24	2019	38	43					6913	6925		10.1038/s41388-019-0941-0	http://dx.doi.org/10.1038/s41388-019-0941-0			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JH4GX	31406251	Green Accepted			2022-12-26	WOS:000492728000003
J	Huang, W; Hu, H; Zhang, Q; Wu, X; Wei, FX; Yang, F; Gan, L; Wang, N; Yang, XL; Guo, AY				Huang, Wei; Hu, Hui; Zhang, Qiong; Wu, Xian; Wei, Fuxiang; Yang, Fang; Gan, Lu; Wang, Ning; Yang, Xiangliang; Guo, An-Yuan			Regulatory networks in mechanotransduction reveal key genes in promoting cancer cell stemness and proliferation	ONCOGENE			English	Article							EXPRESSION; FIBRIN; GROWTH; ACTIVATION; POPULATION; INHIBITION; CARCINOMA; PATHWAYS; NANOG; COLON	Tumor-repopulating cells (TRCs) are cancer stem cell (CSC)-like cells with highly tumorigenic and self-renewing abilities, which were selected from tumor cells in soft three-dimensional (3D) fibrin gels with unidentified mechanisms. Here we evaluated the transcriptome alteration during TRCs generation in 3D culture and revealed that a variety of molecules related with integrin/membrane and stemness were continuously altered by mechanical environment. Some key regulators such as MYC/STAT3/hsa-miR-199a-5p, were changed in the TRCs generation. They regulated membrane genes and the downstream mechanotransduction pathways such as Hippo/WNT/TGF-beta/PI3K-AKT pathways, thus further affecting the expression of downstream cancer-related genes. By integrating networks for membrane proteins, the WNT pathway and cancer-related genes, we identified key molecules in the selection of TRCs, such as ATF4, SLC3A2, CCT3, and hsa-miR-199a-5p. Silencing ATF4 or CCT3 inhibited the selection and growth of TRCs whereas reduction of SLC3A2 or hsa-miR-199a-5p promoted TRCs growth. Further studies showed that CCT3 promoted cell proliferation and stemness in vitro, while its suppression inhibited TRCs-induced tumor formation. We also contemplated CCT3 as a stemness-related gene. Our findings provide insights in the mechanism of TRCs selection through transcriptome analysis.	[Huang, Wei; Wu, Xian; Gan, Lu; Yang, Xiangliang] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Natl Engn Res Ctr Nanomed, Wuhan 430074, Hubei, Peoples R China; [Hu, Hui; Zhang, Qiong; Guo, An-Yuan] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab, Key Lab Mol Biophys,Minist Educ, Wuhan 430074, Hubei, Peoples R China; [Wei, Fuxiang; Yang, Fang; Wang, Ning] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Biomed Engn, Wuhan 430074, Hubei, Peoples R China; [Wang, Ning] Univ Illinois, Coll Engn, Dept Mech Sci & Engn, Urbana, IL 61801 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of Illinois System; University of Illinois Urbana-Champaign	Yang, XL (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Natl Engn Res Ctr Nanomed, Wuhan 430074, Hubei, Peoples R China.; Guo, AY (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab, Key Lab Mol Biophys,Minist Educ, Wuhan 430074, Hubei, Peoples R China.	yangxl@hust.edu.cn; guoay@hust.edu.cn	Zhang, Qiong/AIC-0940-2022; Zhang, Qiong/GYE-1270-2022	Zhang, Qiong/0000-0001-5001-8434; Hu, Hui/0000-0002-9208-1041; Guo, An-Yuan/0000-0002-5099-7465; Wei, Fuxiang/0000-0002-6200-6219	National Basic Research Program of China [2015CB931802]; National Natural Science Foundation of China (NSFC) [81627901, 81773653, 31822030, 31771458]; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT 13016]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072744] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the research funding from National Basic Research Program of China (2015CB931802), National Natural Science Foundation of China (NSFC) [81627901, 81773653, 31822030, and 31771458], and Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [No. IRT 13016].	Addla SK, 2008, AM J PHYSIOL-RENAL, V295, pF680, DOI 10.1152/ajprenal.90286.2008; Amini S, 2014, ANAT CELL BIOL, V47, P1, DOI 10.5115/acb.2014.47.1.1; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bu PC, 2016, CELL STEM CELL, V18, P189, DOI 10.1016/j.stem.2016.01.006; Chen JW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03877-7; Chen KD, 1999, J BIOL CHEM, V274, P18393, DOI 10.1074/jbc.274.26.18393; COSTANTINI V, 1992, CANCER METAST REV, V11, P283, DOI 10.1007/BF01307183; Cui X, 2015, WORLD J GASTROENTERO, V21, P8588, DOI 10.3748/wjg.v21.i28.8588; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Estrach S, 2014, CANCER RES, V74, P6878, DOI 10.1158/0008-5472.CAN-14-0579; Gong J, 2014, RNA BIOL, V11, P1375, DOI 10.1080/15476286.2014.996465; Guo CL, 2016, CELL BIOL INT, V40, P847, DOI 10.1002/cbin.10539; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hamzeh MT, 2015, AM J PHYSIOL-RENAL, V308, pF425, DOI 10.1152/ajprenal.00589.2014; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jung K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-328; Koshizuka K, 2017, CANCER SCI, V108, P1681, DOI 10.1111/cas.13298; Lam WA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-35; Li Y, 2015, CANCER RES, V75, P1191, DOI 10.1158/0008-5472.CAN-14-2615; Lin Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09653; Liu J, 2012, NAT MATER, V11, P734, DOI [10.1038/nmat3361, 10.1038/NMAT3361]; Lopez-Saavedra A, 2016, CELL CYCLE, V15, P2066, DOI 10.1080/15384101.2016.1198863; Luo YM, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/3598542; Malik G, 2010, CANCER RES, V70, P4327, DOI 10.1158/0008-5472.CAN-09-3312; Matsumoto T, 2017, ONCOGENESIS, V6, DOI 10.1038/s41389-017-0009-3; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mobus S, 2015, J HEPATOL, V62, P101, DOI 10.1016/j.jhep.2014.08.016; Morgan JT, 2013, EXP EYE RES, V115, P1, DOI 10.1016/j.exer.2013.06.012; Najafi M, 2019, J CELL PHYSIOL, V234, P8381, DOI 10.1002/jcp.27740; Nimmakayala RK, 2019, BBA-REV CANCER, V1871, P50, DOI 10.1016/j.bbcan.2018.10.006; Ning W, 2017, J PHYS D, V50; Palumbo JS, 2001, HAEMOSTASIS, V31, P11; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Rivera B, 2011, ANN ONCOL, V22, P903, DOI 10.1093/annonc/mdq465; Rysa J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23042-w; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Shafer B, 2011, DEV CELL, V20, P177, DOI 10.1016/j.devcel.2011.01.002; Shi L, 2010, ONCOTARGET, V1, P22, DOI 10.18632/oncotarget.105; Sironen RK, 2002, BIORHEOLOGY, V39, P111; Sun HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036808; Susswein LR, 2016, GENET MED, V18, P823, DOI 10.1038/gim.2015.166; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Tan YH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5619; Tarazona S, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv711; van Sluis GL, 2011, CANCER LETT, V306, P106, DOI 10.1016/j.canlet.2011.02.038; VILADIU P, 1975, SURG GYNECOL OBSTET, V140, P544; Vining KH, 2017, NAT REV MOL CELL BIO, V18, P728, DOI 10.1038/nrm.2017.108; Wang J, 2013, MOL NEUROBIOL, V47, P228, DOI 10.1007/s12035-012-8335-0; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang T, 2015, ONCOTARGET, V6, P30975, DOI 10.18632/oncotarget.5199; Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592; Xia HF, 2017, J HISTOCHEM CYTOCHEM, V65, P285, DOI 10.1369/0022155417694872; Zhang HM, 2015, BRIEF BIOINFORM, V16, P45, DOI 10.1093/bib/bbt085; Zhang T, 2003, BIOCHEM J, V376, P457, DOI 10.1042/BJ20030668; Zhang YY, 2016, CANCER LETT, V372, P101, DOI 10.1016/j.canlet.2015.12.029; Zhao YZ, 2015, BLOOD, V126, P2383, DOI 10.1182/blood-2015-03-633354; Zheng J, 2015, ONCOTARGET, V6, P25339, DOI 10.18632/oncotarget.4509	58	21	21	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 17	2019	38	42					6818	6834		10.1038/s41388-019-0925-0	http://dx.doi.org/10.1038/s41388-019-0925-0			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JE5UU	31406247	Green Accepted, hybrid			2022-12-26	WOS:000490758200002
J	Fukutani, Y; Tamaki, R; Inoue, R; Koshizawa, T; Sakashita, S; Ikegami, K; Ohsawa, I; Matsunami, H; Yohda, M				Fukutani, Yosuke; Tamaki, Ryohei; Inoue, Ryosuke; Koshizawa, Tomoyo; Sakashita, Shuto; Ikegami, Kentaro; Ohsawa, Ikuroh; Matsunami, Hiroaki; Yohda, Masafumi			The N-terminal region of RTP1S plays important roles in dimer formation and odorant receptor-trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						molecular chaperone; dimerization; G-protein?coupled receptor (GPCR); membrane transport; flow cytometry; odorant receptors; receptor-transporting protein	FUNCTIONAL EXPRESSION; DIMERIZATION; ACTIVATION; RETENTION; MEMBERS; FAMILY	Receptor-transporting protein 1S (RTP1S) is an accessory protein that mediates the transport of mammalian odorant receptors (ORs) into the plasma membrane. Although most ORs fail to localize to the cell surface when expressed alone in nonolfactory cells, functional expression of ORs is achieved with the coexpression of RTP1S. However, the mechanism for RTP1S-mediated OR trafficking remains unclear. In this study, we attempted to reveal the mode of action and critical residues of RTP1S in OR trafficking. Experiments using N-terminal truncation and Ala substitution mutants of RTP1S demonstrated that four N-terminal amino acids have essential roles in OR trafficking. Additionally, using recombinant proteins and split luciferase assays in mammalian cells, we provided evidence for the dimer formation of RTP1S. Furthermore, we determined that the 2nd Cys residue is required for the efficient dimerization of RTP1S. Altogether, these findings provide insights into the mechanism for plasma membrane transport of ORs by RTP1S.	[Fukutani, Yosuke; Tamaki, Ryohei; Inoue, Ryosuke; Koshizawa, Tomoyo; Sakashita, Shuto; Ikegami, Kentaro; Yohda, Masafumi] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan; [Fukutani, Yosuke; Matsunami, Hiroaki] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Ohsawa, Ikuroh] Tokyo Metropolitan Inst Gerontol, Biol Proc Aging, Tokyo 1730015, Japan; [Matsunami, Hiroaki] Duke Univ, Duke Inst Brain Sci, Dept Neurobiol, Med Ctr, Durham, NC 27705 USA; [Matsunami, Hiroaki; Yohda, Masafumi] Tokyo Univ Agr & Technol, Inst Global Innovat Res, Koganei, Tokyo 1848588, Japan	Tokyo University of Agriculture & Technology; Duke University; Tokyo Metropolitan Institute of Gerontology; Duke University; Tokyo University of Agriculture & Technology	Yohda, M (corresponding author), Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	yohda@cc.tuat.ac.jp	Fukutani, Yosuke/I-3798-2016; Yohda, Masafumi/A-5149-2013	Fukutani, Yosuke/0000-0002-3716-8590; Yohda, Masafumi/0000-0001-8307-9671	JSPS KAKENHI [JP18K14060, 16H04572]; MEXT KAKENHI Grant [18H04690]; NIH [DC016224]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC016224] Funding Source: NIH RePORTER	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by JSPS KAKENHI Grants JP18K14060 (to Y. F.) and 16H04572 (to M. Y.) and MEXT KAKENHI Grant 18H04690 (to M. Y.) and NIH DC016224 (to H. M.). H. M. receives royalties from Chemcom. The authors declare that they have no conflicts of interest with the contents of this article.	Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Asakawa M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10862-5; Behrens M, 2006, J BIOL CHEM, V281, P20650, DOI 10.1074/jbc.M513637200; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Cook BL, 2009, P NATL ACAD SCI USA, V106, P11925, DOI 10.1073/pnas.0811089106; Decaillot FM, 2008, P NATL ACAD SCI USA, V105, P16045, DOI 10.1073/pnas.0804106105; DeMaria S, 2010, J CELL BIOL, V191, P443, DOI 10.1083/jcb.201008163; Dey S, 2011, P NATL ACAD SCI USA, V108, P16651, DOI 10.1073/pnas.1018140108; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Fanelli F, 2011, BBA-BIOMEMBRANES, V1808, P1256, DOI 10.1016/j.bbamem.2010.08.006; Fukutani Y, 2015, ANAL BIOCHEM, V471, P1, DOI 10.1016/j.ab.2014.10.012; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hanchate NK, 2015, SCIENCE, V350, P1251, DOI 10.1126/science.aad2456; Hiller C, 2013, J MED CHEM, V56, P6542, DOI 10.1021/jm4004335; Jiang Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7448; Kasai RS, 2018, CELL BIOCHEM BIOPHYS, V76, P29, DOI 10.1007/s12013-017-0829-y; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Kida H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06806-w; Kniazeff J, 2011, PHARMACOL THERAPEUT, V130, P9, DOI 10.1016/j.pharmthera.2011.01.006; Li YR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001230; Lu M, 2003, TRAFFIC, V4, P416, DOI 10.1034/j.1600-0854.2003.00097.x; Lyons DB, 2013, CELL, V154, P325, DOI 10.1016/j.cell.2013.06.039; Mainland JD, 2014, NAT NEUROSCI, V17, P114, DOI 10.1038/nn.3598; McClintock TS, 1997, MOL BRAIN RES, V48, P270, DOI 10.1016/S0169-328X(97)00099-5; Mombaerts P, 2004, CURR OPIN NEUROBIOL, V14, P31, DOI 10.1016/j.conb.2004.01.014; Niimura Yoshihito, 2009, Human Genomics, V4, P107; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Serizawa SU, 2004, TRENDS GENET, V20, P648, DOI 10.1016/j.tig.2004.09.006; Sharma R, 2017, ELIFE, V6, DOI 10.7554/eLife.21895; Thevenin D, 2005, PROTEIN SCI, V14, P2177, DOI 10.1110/ps.051409205; Wu LF, 2012, J BIOL CHEM, V287, P22287, DOI 10.1074/jbc.M112.345884; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zhuang H, 2008, NAT PROTOC, V3, P1402, DOI 10.1038/nprot.2008.120; Zhuang HY, 2007, J BIOL CHEM, V282, P15284, DOI 10.1074/jbc.M700386200; Zou DJ, 2009, NAT REV NEUROSCI, V10, P611, DOI 10.1038/nrn2666	37	5	5	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2019	294	40					14661	14673		10.1074/jbc.RA118.007110	http://dx.doi.org/10.1074/jbc.RA118.007110			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JP0II	31395660	Green Published, hybrid			2022-12-26	WOS:000497955000013
J	Bamford, NC; Le Mauff, F; Subramanian, AS; Yip, P; Millan, C; Zhang, YZ; Zacharias, C; Forman, A; Nitz, M; Codee, JDC; Uson, I; Sheppard, DC; Howell, PL				Bamford, Natalie C.; Le Mauff, Francois; Subramanian, Adithya S.; Yip, Patrick; Millan, Claudia; Zhang, Yongzhen; Zacharias, Caitlin; Forman, Adam; Nitz, Mark; Codee, Jeroen D. C.; Uson, Isabel; Sheppard, Donald C.; Howell, P. Lynne			Ega3 from the fungal pathogen Aspergillus fumigatus is an endo-alpha-1,4-galactosaminidase that disrupts microbial biofilms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoside hydrolase; biofilm; protein structure; enzyme mechanism; Aspergillus; carbohydrate processing; carbohydrate biosynthesis; exopolysaccharide matrix; galactosaminogalactan (GAG); glycoside hydrolase 114 (GH114); virulence factor	ENDO ALPHA-1,4 POLYGALACTOSAMINIDASE; GLYCOSIDE HYDROLASES; ACCURATE DOCKING; ALGINATE LYASE; PROTEIN; EXOPOLYSACCHARIDE; MODEL; GLIDE; GALACTOSAMINOGALACTAN; ENDOGLUCANASE	Aspergillus fumigatus is an opportunistic fungal pathogen that causes both chronic and acute invasive infections. Galactosaminogalactan (GAG) is an integral component of the A. fumigatus biofilm matrix and a key virulence factor. GAG is a heterogeneous linear alpha-1,4-linked exopolysaccharide of galactose and GalNAc that is partially deacetylated after secretion. A cluster of five co-expressed genes has been linked to GAG biosynthesis and modification. One gene in this cluster, ega3, is annotated as encoding a putative alpha-1,4-galactosaminidase belonging to glycoside hydrolase family 114 (GH114). Herein, we show that recombinant Ega3 is an active glycoside hydrolase that disrupts GAG-dependent A. fumigatus and Pel polysaccharide-dependent Pseudomonas aeruginosa biofilms at nanomolar concentrations. Using MS and functional assays, we demonstrate that Ega3 is an endo-acting alpha-1,4-galactosaminidase whose activity depends on the conserved acidic residues, Asp-189 and Glu-247. X-ray crystallographic structural analysis of the apo Ega3 and an Ega3-galactosamine complex, at 1.76 and 2.09 angstrom resolutions, revealed a modified (beta/alpha)(8)-fold with a deep electronegative cleft, which upon ligand binding is capped to form a tunnel. Our structural analysis coupled with in silico docking studies also uncovered the molecular determinants for galactosamine specificity and substrate binding at the -2 to +1 binding subsites. The findings in this study increase the structural and mechanistic understanding of the GH114 family, which has >600 members encoded by plant and opportunistic human pathogens, as well as in industrially used bacteria and fungi.	[Bamford, Natalie C.; Subramanian, Adithya S.; Yip, Patrick; Howell, P. Lynne] Hosp Sick Children, Program Mol Med, Toronto, ON M5G 1X8, Canada; [Bamford, Natalie C.; Subramanian, Adithya S.; Howell, P. Lynne] Univ Toronto, Fac Med, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Le Mauff, Francois; Zacharias, Caitlin; Sheppard, Donald C.] McGill Univ, Fac Med, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Le Mauff, Francois; Zacharias, Caitlin; Sheppard, Donald C.] McGill Univ, Hlth Ctr, Res Inst, Infect Dis & Immun Global Hlth, Montreal, PQ H4A 3J1, Canada; [Zacharias, Caitlin; Sheppard, Donald C.] McGill Interdisciplinary Initiat Infect & Immun, Montreal, PQ H3A 1Y2, Canada; [Millan, Claudia; Uson, Isabel] CSIC, Inst Biol Mol Barcelona, Struct Biol, Carrer Baldiri Reixac 15,3 A17, E-08028 Barcelona, Spain; [Zhang, Yongzhen; Codee, Jeroen D. C.] Leiden Univ, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands; [Forman, Adam; Nitz, Mark] Univ Toronto, Fac Arts & Sci, Dept Chem, Toronto, ON M5S 3H6, Canada; [Uson, Isabel] ICREA, Passeig Lluis Co 23, E-08003 Barcelona, Spain	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; McGill University; McGill University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Leiden University; Leiden University - Excl LUMC; University of Toronto; ICREA	Howell, PL (corresponding author), Hosp Sick Children, Program Mol Med, Toronto, ON M5G 1X8, Canada.; Howell, PL (corresponding author), Univ Toronto, Fac Med, Dept Biochem, Toronto, ON M5S 1A8, Canada.; Sheppard, DC (corresponding author), McGill Univ, Fac Med, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada.; Sheppard, DC (corresponding author), McGill Univ, Hlth Ctr, Res Inst, Infect Dis & Immun Global Hlth, Montreal, PQ H4A 3J1, Canada.; Sheppard, DC (corresponding author), McGill Interdisciplinary Initiat Infect & Immun, Montreal, PQ H3A 1Y2, Canada.	donald.sheppard@mcgill.ca; howell@sickkids.ca	Le Mauff, Francois/L-3453-2019; Forman, Adam/C-7707-2019; Sheppard, Donald/B-4637-2008; Millán, Claudia/S-1634-2019	Le Mauff, Francois/0000-0003-0712-5837; Forman, Adam/0000-0001-7410-3051; Sheppard, Donald/0000-0001-8877-880X; Millán, Claudia/0000-0002-9283-2220; Bamford, Natalie/0000-0003-1959-856X	Canadian Institutes of Health Research Operating Grants [81361, FDN-154327, 43998, 123306, FDN-159902, 89708]; Cystic Fibrosis Canada; European Research Council [ERC-CoG-726072-GLYCONTROL]; Natural Sciences and Engineering Research Council of Canada (NSERC); University of Toronto, Cystic Fibrosis Canada; Hospital for Sick Children; Spanish Ministry of Science and Innovation [BIO2015-64216-P, MDM2014-0435-01]; EU-FEDER; Fonds de Recherche Quebec Sante (FRQS); Tier I Canada Research Chair;  [BES-2015-071397]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244] Funding Source: NIH RePORTER; BBSRC [BB/R012415/1] Funding Source: UKRI	Canadian Institutes of Health Research Operating Grants(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada; European Research Council(European Research Council (ERC)European Commission); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Toronto, Cystic Fibrosis Canada; Hospital for Sick Children; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EU-FEDER(European Commission); Fonds de Recherche Quebec Sante (FRQS); Tier I Canada Research Chair(Canada Research Chairs); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Canadian Institutes of Health Research Operating Grants 81361 (to P. L. H. and D. C. S.), FDN-154327 and 43998 (to P. L. H.), 123306 and FDN-159902 (to D. C. S.), and 89708 (to M. N.); Cystic Fibrosis Canada (to D. C. S. and P. L. H.); and European Research Council Grant ERC-CoG-726072-GLYCONTROL (to J. D. C. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by Vanier and CGS-M graduate scholarships from the Natural Sciences and Engineering Research Council of Canada (NSERC), Mary H. Beatty, and Dr. James A. and Connie P. Dickson Scholarships from the University of Toronto, Cystic Fibrosis Canada, and The Hospital for Sick Children.; Supported by a BES-2015-071397 scholarship.; Recipients of Grants BIO2015-64216-P and MDM2014-0435-01 from the Spanish Ministry of Science and Innovation and EU-FEDER.; Supported by a Distinguished Research Scholar Award from the Fonds de Recherche Quebec Sante (FRQS).; Recipient of a Tier I Canada Research Chair.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alhassid A, 2009, BIOCHEM J, V422, P73, DOI 10.1042/BJ20090180; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Asker D, 2018, BIOMATERIALS, V167, P168, DOI 10.1016/j.biomaterials.2018.03.016; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baker P, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501632; Baker P, 2015, J BIOL CHEM, V290, P28374, DOI 10.1074/jbc.M115.674929; Bakkevig K, 2005, J BACTERIOL, V187, P8375, DOI 10.1128/JB.187.24.8375-8384.2005; Bamford NC, 2015, J BIOL CHEM, V290, P27438, DOI 10.1074/jbc.M115.679050; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Borisova AS, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-017-1006-7; Bourne Y, 2001, CURR OPIN STRUC BIOL, V11, P593, DOI 10.1016/S0959-440X(00)00253-0; Briard B, 2016, MYCOLOGIA, V108, P572, DOI 10.3852/15-312; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cywes-Bentley C, 2013, P NATL ACAD SCI USA, V110, pE2209, DOI 10.1073/pnas.1303573110; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 2000, BIOCHEM J, V348, P201, DOI 10.1042/0264-6021:3480201; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fleming D, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01998-16; Fodje M. N., 2010, P PCAPAC 2010; Fontaine T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002372; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; GLASGOW JE, 1974, J BACTERIOL, V120, P759, DOI 10.1128/JB.120.2.759-766.1974; Gonzalez MD, 1997, MICROBIOL-UK, V143, P3023, DOI 10.1099/00221287-143-9-3023; Gravelat FN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003575; Gresnigt MS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003936; Grosse-Kunstleve RW, 2002, J APPL CRYSTALLOGR, V35, P126, DOI 10.1107/S0021889801017824; GUERRERO C, 1988, Microbiologia (Madrid), V4, P39; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jain S, 2005, INFECT IMMUN, V73, P6429, DOI 10.1128/IAI.73.10.6429-6436.2005; Jana S, 2016, J PHYS CHEM B, V120, P1236, DOI 10.1021/acs.jpcb.5b12610; Jennings LK, 2015, P NATL ACAD SCI USA, V112, P11353, DOI 10.1073/pnas.1503058112; Jorge JA, 1999, J BASIC MICROB, V39, P337; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2015, CURR OPIN STRUC BIOL, V34, P60, DOI 10.1016/j.sbi.2015.07.003; Kaur S, 2014, MED MYCOL, V52, P2, DOI 10.3109/13693786.2013.819592; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Knutsen A. P., 1990, CYSTIC FIBROSIS, V1, P103, DOI [10.1007/978-1-4612-0475-6_7, DOI 10.1007/978-1-4612-0475-6_7]; Koseoglu VK, 2015, MOL MICROBIOL, V96, P728, DOI 10.1111/mmi.12966; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Le Mauff F, 2019, J BIOL CHEM, V294, P10760, DOI 10.1074/jbc.RA119.008511; Lee MJ, 2016, MBIO, V7, DOI 10.1128/mBio.00252-16; Lee MJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005187; Lee MJ, 2014, J BIOL CHEM, V289, P1243, DOI 10.1074/jbc.M113.522516; Leung C, 2009, CARBOHYD RES, V344, P570, DOI 10.1016/j.carres.2008.12.021; Little DJ, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006998; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2018, ACTA CRYSTALLOGR D, V74, P279, DOI 10.1107/S2059798318001353; Millan C, 2018, ACTA CRYSTALLOGR D, V74, P290, DOI 10.1107/S2059798318001365; Millan C, 2015, ACTA CRYSTALLOGR D, V71, P1931, DOI 10.1107/S1399004715013127; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Muszkieta L, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00013; Nakai T, 2013, J BACTERIOL, V195, P958, DOI 10.1128/JB.01473-12; Naumoff DG, 2011, MOL BIOL+, V45, P647, DOI 10.1134/S0026893311030113; Oeffner RD, 2018, ACTA CRYSTALLOGR D, V74, P245, DOI 10.1107/S2059798318004357; Olanrewaju OS, 2019, APPL MICROBIOL BIOT, V103, P1179, DOI 10.1007/s00253-018-09577-y; Payne CM, 2012, J BIOL CHEM, V287, P36322, DOI 10.1074/jbc.M112.402149; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; REISSIG JL, 1975, CAN J BIOCHEM CELL B, V53, P1237, DOI 10.1139/o75-169; Robinet P, 2014, J IMMUNOL, V192, P5332, DOI 10.4049/jimmunol.1303180; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Sievers F, 2018, PROTEIN SCI, V27, P135, DOI 10.1002/pro.3290; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Snarr BD, 2017, P NATL ACAD SCI USA, V114, P7124, DOI 10.1073/pnas.1702798114; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stevens DA, 2003, CLIN INFECT DIS, V37, pS225, DOI 10.1086/376525; Taff HT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002848; TAKAGI H, 1985, AGR BIOL CHEM TOKYO, V49, P3159, DOI 10.1080/00021369.1985.10867250; TAMURA J, 1995, J FERMENT BIOENG, V80, P305, DOI 10.1016/0922-338X(95)94196-X; TAMURA J, 1988, AGR BIOL CHEM TOKYO, V52, P2475, DOI 10.1080/00021369.1988.10869068; TAMURA J, 1992, BIOSCI BIOTECH BIOCH, V56, P380, DOI 10.1271/bbb.56.380; Uson I, 2018, ACTA CRYSTALLOGR D, V74, P106, DOI 10.1107/S2059798317015121; Viaene T, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw119; Vuong TV, 2010, BIOTECHNOL BIOENG, V107, P195, DOI 10.1002/bit.22838; WAKARCHUK WW, 1994, PROTEIN SCI, V3, P467; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2011, METHODS, V55, P81, DOI 10.1016/j.ymeth.2011.06.010; Yasutake Y, 2006, PROTEINS, V64, P1069, DOI 10.1002/prot.21052; You X, 2018, BBA-GEN SUBJECTS, V1862, P1376, DOI 10.1016/j.bbagen.2018.03.016; Yu S, 2015, CELL RES, V25, P1352, DOI 10.1038/cr.2015.129; Zhang H, 2018, NUCLEIC ACIDS RES, V46, pW95, DOI 10.1093/nar/gky418; Zhang XZ, 2010, BIORESOURCE TECHNOL, V101, P5534, DOI 10.1016/j.biortech.2010.01.152	92	19	19	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13833	13849		10.1074/jbc.RA119.009910	http://dx.doi.org/10.1074/jbc.RA119.009910			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31416836	Green Published, hybrid			2022-12-26	WOS:000486418600030
J	Pinheiro, DS; Santos, RS; Jardim, PCBV; Silva, EG; Reis, AAS; Pedrino, GR; Ulhoa, CJ				Pinheiro, Denise S.; Santos, Rodrigo S.; Veiga Jardim, Paulo C. B.; Silva, Elisangela G.; Reis, Angela A. S.; Pedrino, Gustavo R.; Ulhoa, Cirano J.			The combination of ACE I/D and ACE2 G8790A polymorphisms revels susceptibility to hypertension: A genetic association study in Brazilian patients	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; BLOOD-PRESSURE; DELETION POLYMORPHISM; UPDATED METAANALYSIS; HAN; ANGIOTENSIN-CONVERTING-ENZYME-2; POPULATION; DISEASE; SYSTEM; RISK	Background Systemic arterial hypertension (SAH) is a multifactorial condition that already affects one third of the worldwide population. The identification of candidate genes for hypertension is a challenge for the next years. Nevertheless, the small contribution of each individual genetic factor to the disease brings the necessity of evaluate genes in an integrative manner and taking into consideration the physiological interaction of functions. Angiotensin I-converting enzymes, ACE and ACE2, are key regulators of blood pressure that have counterbalance roles by acting on vasoactive peptides from Renin-Angiotensin-Aldosterone System (RAAS). Insertion/deletion (I/D) polymorphism of ACE gene and single nucleotide polymorphism G8790A of ACE2 gene have been associated with susceptibility to SAH, but the literature is controversial. We proposed to evaluate these two polymorphisms jointly exploring the combined effects of ACE and ACE2 genotypes on SAH susceptibility, an approach that have not been done yet for ACE and ACE2 polymorphisms. Methods and findings This genetic association study included 117 hypertensive (mean age 59.7 years) patients and 123 normotensive and diabetes-free controls (mean age 57.5 years). ACE and ACE2 polymorphisms were genotyped by SYBR Green real-time PCR and RFLP-PCR, respectively. Crude and adjusted odds ratio (OR) values were calculated to estimate the susceptibility to SAH development. It was obtained homogeneity regarding distribution by sex, age range, smoking, alcohol consumption and body mass index (BMI) between case and control groups. No-association was verified for each gene individually, but the combination of ACE and ACE2 polymorphisms on female gender revealed a significative association for DD/G_ carriers who had a 3-fold increased risk to SAH development (p = 0.03), with a stronger susceptibility on DD/GG carriers (7-fold increased risk, p = 0.01). The D allele of ACE showed association with altered levels of lipid profile variables on case group (VLDL-cholesterol, p = 0.01) and DD genotype in all individuals analysis (triglycerides, p = 0.01 and VLDL-cholesterol, p = 0.01). Conclusion These findings indicate that the combination of ACE and ACE2 polymorphisms effects may play a role in SAH predisposition been the DD/G_ genotype the susceptibility profile. This result allowed us to raise the hypothesis that an increased activity of ACE (prohypertensive effects) in conjunction with reduced ACE2 activity (antihypertensive effects) could be the underlining mechanism. The association of ACE D allele with lipid alterations indicate that this can be a marker of poor prognostic on SAH evolution and contribute to CVD development. Although these preliminary findings must be confirmed by further researches with larger sample size, we could observe that the integrative analysis of ACE and ACE2 can be an informative tool in hypertension understanding that needs to be explored in new studies.	[Pinheiro, Denise S.; Silva, Elisangela G.] Fed Univ Goias UFG, Inst Biol Sci, Postgrad Program Biol Sci, Goiania, Go, Brazil; [Santos, Rodrigo S.] Fed Univ Goias UFG, Special Acad Unit Human Sci, Dept Nat Sci LEdoC, Goiania, Go, Brazil; [Veiga Jardim, Paulo C. B.] Fed Univ Goias UFG, League Hypertens, Fac Med, Goiania, Go, Brazil; [Reis, Angela A. S.; Ulhoa, Cirano J.] Fed Univ Goias UFG, Inst Biol Sci, Dept Biochem & Mol Biol, Goiania, Go, Brazil; [Pedrino, Gustavo R.] Fed Univ Goias UFG, Inst Biol Sci, Dept Physiol Sci, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal de Goias	Pedrino, GR (corresponding author), Fed Univ Goias UFG, Inst Biol Sci, Dept Physiol Sci, Goiania, Go, Brazil.	gpedrino@gmail.com	Ulhoa, CIRANO/AAV-9374-2020; Pedrino, Gustavo R/I-5614-2015; da Silva Pinheiro, Denise/Y-9276-2019; DA SILVA, ANGELA ADAMSKI/AAJ-1403-2021	Pedrino, Gustavo R/0000-0003-0488-5400; da Silva Pinheiro, Denise/0000-0001-7405-6822; DA SILVA, ANGELA ADAMSKI/0000-0002-8281-7334; Reis, AlessanRSS/0000-0001-8486-7469; da Silva Santos, Rodrigo/0000-0002-9480-4362	FAPEG (Fundacao de Amparo a Pesquisa do Estado de Goias) [CH12/13]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); MS (Ministerio da Saude); SUS (Sistema Unico de Saude)	FAPEG (Fundacao de Amparo a Pesquisa do Estado de Goias); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); MS (Ministerio da Saude); SUS (Sistema Unico de Saude)	The authors thank FAPEG (Fundacao de Amparo a Pesquisa do Estado de Goias) for financial support to this study (CH12/13 PPSUS Programa de Pesquisa para o SUS to GRP) and the associated institutions involved in the funding: CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), MS (Ministerio da Saude)and SUS (Sistema Unico de Saude). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara A, 2018, CLIN APPL THROMB-HEM, V24, P157, DOI 10.1177/1076029616679505; Barley J, 1996, J HUM HYPERTENS, V10, P31; Benjafield AV, 2004, AM J HYPERTENS, V17, P624, DOI 10.1016/j.amjhyper.2004.02.022; Bernstein KE, 2013, PHARMACOL REV, V65, P1, DOI 10.1124/pr.112.006809; Bonfim-Silva R, 2016, J GENET, V95, P63, DOI 10.1007/s12041-015-0599-5; Burrell LM, 2004, TRENDS ENDOCRIN MET, V15, P166, DOI 10.1016/j.tem.2004.03.001; Napoles OC, 2007, CLIN CHIM ACTA, V378, P112, DOI 10.1016/j.cca.2006.11.003; del Ser T, 2001, NEUROSCI LETT, V316, P21, DOI 10.1016/S0304-3940(01)02345-X; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Doris PA, 2002, HYPERTENSION GENETIC; Fan XH, 2009, ACTA PHARMACOL SIN, V30, P1237, DOI 10.1038/aps.2009.110; Huang W, 2006, J HUM HYPERTENS, V20, P968, DOI 10.1038/sj.jhh.1002090; Knowles JW, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002546; Kuba K, 2010, PHARMACOL THERAPEUT, V128, P119, DOI 10.1016/j.pharmthera.2010.06.003; Lambert DW, 2008, BIOCHEM PHARMACOL, V75, P781, DOI 10.1016/j.bcp.2007.08.012; Lambert DW, 2010, CELL MOL LIFE SCI, V67, P89, DOI 10.1007/s00018-009-0152-x; Li Y, 2012, INTERN MED J, V42, P439, DOI 10.1111/j.1445-5994.2011.02584.x; Li YY, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00364; Lin MH, 2001, CLIN BIOCHEM, V34, P661, DOI 10.1016/S0009-9120(01)00281-8; Lu N, 2012, MOL BIOL REP, V39, P6581, DOI 10.1007/s11033-012-1487-1; Matsubara M, 2002, J HYPERTENS, V20, P1121, DOI 10.1097/00004872-200206000-00023; Mills KT, 2015, J HYPERTENS, V33, pE2, DOI 10.1097/01.hjh.0000469726.59998.cc; NAKAI K, 1994, CIRCULATION, V90, P2199, DOI 10.1161/01.CIR.90.5.2199; Nawaz SJ, 2009, INTERNATIONAL CONFERENCE ON FUTURE COMPUTER AND COMMUNICATIONS, PROCEEDINGS, P36, DOI 10.1109/ICFCC.2009.136; Ned RM, 2012, AM J HYPERTENS, V25, P209, DOI 10.1038/ajh.2011.182; Niu SD, 2016, CLIN EXP HYPERTENS, V38, P63, DOI 10.3109/10641963.2015.1060985; Niu WQ, 2007, TRANSL RES, V150, P374, DOI 10.1016/j.trsl.2007.06.002; Patel S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00311; Rieder M J, 2000, Curr Hypertens Rep, V2, P44, DOI 10.1007/s11906-000-0057-4; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Rossi GP, 2017, NAT REV ENDOCRINOL, V13, P289, DOI 10.1038/nrendo.2016.196; Sakuma T, 2004, J CLIN LAB ANAL, V18, P309, DOI 10.1002/jcla.20044; Shafi S, 2013, INT J BIOMED ADV RES, V4, P849; Sharma P, 1998, J NEUROL NEUROSUR PS, V64, P227, DOI 10.1136/jnnp.64.2.227; Shih PAB, 2008, HYPERTENSION, V51, P1456, DOI 10.1161/HYPERTENSIONAHA.107.090480; Suzuki T, 1996, CORONARY ARTERY DIS, V7, P371, DOI 10.1097/00019501-199605000-00007; Tamaki S, 2002, HYPERTENS RES, V25, P843; Tchelougou D, 2015, INT J HYPERTENS, V2015, DOI 10.1155/2015/979631; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; TIRET L, 1992, AM J HUM GENET, V51, P197; Warner FJ, 2004, CELL MOL LIFE SCI, V61, P2704, DOI 10.1007/s00018-004-4240-7; Wu YH, 2017, J CLIN LAB ANAL, V31, DOI 10.1002/jcla.22033; Xu Y, 2012, J ENDOCRINOL INVEST, V35, P378, DOI 10.3275/7797; Yang M, 2015, J RENIN-ANGIO-ALDO S, V16, P1240, DOI 10.1177/1470320314549221; Yi L, 2006, J INT MED RES, V34, P272, DOI 10.1177/147323000603400306; Zhao JY, 2014, J NEUROL SCI, V345, P37, DOI 10.1016/j.jns.2014.07.023; Zhou YF, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-187; Zhu XF, 2001, AM J HUM GENET, V68, P1139, DOI 10.1086/320104	49	58	60	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0221248	10.1371/journal.pone.0221248	http://dx.doi.org/10.1371/journal.pone.0221248			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430320	Green Published, Green Submitted, gold			2022-12-26	WOS:000485026800036
J	Bilbo, TR; Reay-Jones, FPF; Reisig, DD; Greene, JK; Turnbull, MW				Bilbo, Tom R.; Reay-Jones, Francis P. F.; Reisig, Dominic D.; Greene, Jeremy K.; Turnbull, Matthew W.			Development, survival, and feeding behavior of Helicoverpa zea (Lepidoptera: Noctuidae) relative to Bt protein concentrations in corn ear tissues	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS; TRANSGENIC CORN; EARWORM LEPIDOPTERA; INSECT RESISTANCE; TOBACCO BUDWORM; FIELD CORN; COTTON; TOXIN; MAIZE; CANNIBALISM	The corn earworm, Helicoverpa zea (Boddie) (Lepidoptera: Noctuidae), preferentially oviposits and feeds on ears of corn (Zea mays L.) and can be managed using transgenic hybrids that produce insecticidal proteins from the bacterium Bacillus thuringiensis (Bt). Concentrations of Bt proteins can vary spatially and temporally in plant tissues, creating a heterogeneous environment that can increase the risk of resistance development. We planted small-plot trials of nine Bt and non-Bt corn hybrids in South Carolina in 2016 and 2017 and investigated the development, survival, feeding injury, and feeding behavior in corn ear tissues. ELISA was used to quantify the concentrations of Cry1F and Cry2Ab2 in young silk, old silk, maternal tip tissue, kernels, and husk. Cry1F and Cry2Ab2 significantly varied with silk age and both proteins were generally highest in the silk and tip tissue. Hybrids with pyramided proteins significantly reduced feeding injury to the silk, tip, and kernel ear tissues, which was less apparent with single Bt protein hybrids. The pyramided hybrid expressing Vip3A incurred no injury to either the ear tip or kernels, and only eight 1st instar larvae were collected in the silk of 520 sampled ears. Age of larvae significantly varied among ear tissues but not between hybrids. Depending on hybrid family, mean larval instar in the silk, tip, and kernels was 1st or 2nd, 3rd, and 5th, respectively. Instar-specific feeding penetrance into corn ears increased with age but did not differ between hybrids. We characterized the instar- and tissue-specific feeding behavior of H. zea larvae but did not detect differences in feeding behavior between Bt and non-Bt hybrids. Implications for resistance management strategies such as seed mixtures are discussed.	[Bilbo, Tom R.; Reay-Jones, Francis P. F.] Clemson Univ, Dept Plant & Environm Sci, Pee Dee Res & Educ Ctr, Florence, SC 29506 USA; [Reisig, Dominic D.] North Carolina State Univ, Dept Entomol & Plant Pathol, Vernon G James Res & Extens Ctr, Plymouth, NC USA; [Greene, Jeremy K.] Clemson Univ, Dept Plant & Environm Sci, Edisto Res & Educ Ctr, Blackville, SC USA; [Turnbull, Matthew W.] Clemson Univ, Dept Biol Sci, Dept Plant & Environm Sci, Clemson, SC 29634 USA	Clemson University; University of North Carolina; North Carolina State University; Clemson University; Clemson University	Reay-Jones, FPF (corresponding author), Clemson Univ, Dept Plant & Environm Sci, Pee Dee Res & Educ Ctr, Florence, SC 29506 USA.	freayjo@clemson.edu	Turnbull, Matthew/W-2865-2019	Turnbull, Matthew/0000-0002-8974-3729; Reay-Jones, Francis/0000-0002-3691-4811; Reisig, Dominic/0000-0002-9979-5813	Biotechnology Risk Assessment Grant Program [2014-33522-22265]; National Institute of Food and Agriculture (NIFA); United States Department of Agriculture (USDA); Pee Dee Research and Education Assistantship; Nettles Research Scholarship	Biotechnology Risk Assessment Grant Program; National Institute of Food and Agriculture (NIFA); United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); Pee Dee Research and Education Assistantship; Nettles Research Scholarship	This material is based on work supported by the Biotechnology Risk Assessment Grant Program competitive grant no. 2014-33522-22265 (DDR, JKG, FPFRJ), by the National Institute of Food and Agriculture (NIFA) and the United States Department of Agriculture (USDA). This study was also funded by the Pee Dee Research and Education Assistantship and the Nettles Research Scholarship (FPFRJ and TRB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk JJ, 2001, J ECON ENTOMOL, V94, P1589, DOI 10.1603/0022-0493-94.6.1589; Ali A, 1996, J ENTOMOL SCI, V31, P1; ARCHER TL, 1994, ENVIRON ENTOMOL, V23, P343, DOI 10.1093/ee/23.2.343; Barber GW, 1941, J ECON ENTOMOL, V34, P451, DOI 10.1093/jee/34.3.451; BASSETTI P, 1993, CROP SCI, V33, P279, DOI 10.2135/cropsci1993.0011183X003300020013x; Behmer ST, 2002, ECOLOGY, V83, P2489, DOI 10.1890/0012-9658(2002)083[2489:HFICHE]2.0.CO;2; Bilbo TR, 2019, J ECON ENTOMOL, V112, P1845, DOI 10.1093/jee/toz062; Bilbo TR, 2018, J ECON ENTOMOL, V111, P2233, DOI 10.1093/jee/toy203; Bird LJ, 2007, J INVERTEBR PATHOL, V94, P84, DOI 10.1016/j.jip.2006.08.005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buntin GD, 2008, FLA ENTOMOL, V91, P523; Burkness Eric C, 2010, GM Crops, V1, P337, DOI 10.4161/gmcr.1.5.14765; Caprio MA, 2016, J ECON ENTOMOL, V109, P307, DOI 10.1093/jee/tov295; Carriere Y, 2010, EVOL APPL, V3, P561, DOI 10.1111/j.1752-4571.2010.00129.x; Cattaneo MG, 2006, P NATL ACAD SCI USA, V103, P7571, DOI 10.1073/pnas.0508312103; Chilcutt CF, 2006, J ECON ENTOMOL, V99, P728, DOI 10.1603/0022-0493-99.3.728; Chilcutt CF, 2004, P NATL ACAD SCI USA, V101, P7526, DOI 10.1073/pnas.0400546101; COOPER DJ, 1984, ENTOMOL EXP APPL, V36, P253, DOI 10.1007/BF00185655; Deans CA, 2018, JOVE-J VIS EXP, DOI 10.3791/58164; Deans CA, 2017, SCI REP-UK, V7, DOI 10.1038/srep39705; Deans CA, 2015, J INSECT PHYSIOL, V81, P21, DOI 10.1016/j.jinsphys.2015.06.015; Dively GP, 2018, P NATL ACAD SCI USA, V115, P3320, DOI 10.1073/pnas.1720692115; Dively GP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0169115; Dowd PF, 2001, J ECON ENTOMOL, V94, P1067, DOI 10.1603/0022-0493-94.5.1067; DULMAGE HT, 1978, J INVERTEBR PATHOL, V32, P40, DOI 10.1016/0022-2011(78)90172-6; Dutton A., 2004, Bulletin OILB/SROP, V27, P49; FIFRA Scientific Advisor Panel, 2018, RES LEP PESTS BAC TH; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Gore J, 2005, J ECON ENTOMOL, V98, P88, DOI 10.1603/0022-0493-98.1.88; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Horner TA, 2003, J ECON ENTOMOL, V96, P914, DOI 10.1603/0022-0493-96.3.914; Horner TA, 2003, J ECON ENTOMOL, V96, P931, DOI 10.1603/0022-0493-96.3.931; Hoy CW, 1998, ANNU REV ENTOMOL, V43, P571, DOI 10.1146/annurev.ento.43.1.571; Hung TP, 2016, ENVIRON POLLUT, V208, P318, DOI 10.1016/j.envpol.2015.09.046; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; JOYNER K, 1985, ANN ENTOMOL SOC AM, V78, P24, DOI 10.1093/aesa/78.1.24; Kaur G, 2019, J INVERTEBR PATHOL, V163, P11, DOI 10.1016/j.jip.2019.02.007; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Luong TTA, 2018, AUSTRAL ENTOMOL, V57, P1, DOI 10.1111/aen.12265; Marvier M, 2007, SCIENCE, V316, P1475, DOI 10.1126/science.1139208; Neunzig H. H., 1969, NC AES TECH B, V196, P1; Nguyen HT, 2007, J PLANT DIS PROTECT, V114, P82, DOI 10.1007/BF03356208; Onstad, 2013, INSECT RESISTANCE MA; Onstad DW, 2018, ENVIRON ENTOMOL, V47, P210, DOI 10.1093/ee/nvx172; Orpet RJ, 2015, ENTOMOL EXP APPL, V156, P28, DOI 10.1111/eea.12308; Perry ED, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600850; Reisig DD, 2018, ENVIRON ENTOMOL, V47, P1357, DOI 10.1093/ee/nvy142; Reisig DD, 2018, J ECON ENTOMOL, V111, P1824, DOI 10.1093/jee/toy106; Reisig DD, 2015, ENVIRON ENTOMOL, V44, P1275, DOI 10.1093/ee/nvv076; SAS Institute, 2011, US MAN VERS 9 3; Steckel S, 2013, J ECON ENTOMOL, V106, P2048, DOI 10.1603/EC13042; Storer NP, 2001, J ECON ENTOMOL, V94, P1268, DOI 10.1603/0022-0493-94.5.1268; Svobodova Z, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0440; Szekacs A, 2010, ENVIRON TOXICOL CHEM, V29, P182, DOI 10.1002/etc.5; Tabashnik BE, 2017, NAT BIOTECHNOL, V35, P926, DOI 10.1038/nbt.3974; Tian JC, 2012, TRANSGENIC RES, V21, P1303, DOI 10.1007/s11248-012-9604-4; Tukey JW., 1953, PROBLEM MULTIPLE COM; U. S. Department of Agriculture-Economic Research Service, 2018, AD GEN ENG CROPS US; US EPA, 2018, CURR PREV REG SECT 3; US EPA, 2005, BIOP REG ACT DOC BAC; US EPA, 2001, BAC THUR SUBSP CRY 1; US EPA. Biopesticides registration action document, 2008, BAC THUR CRY 1A 105; US EPA (United States Environmental Protection Agency), 2010, BIOPESTICIDE REGISTR; WISEMAN B R, 1973, Journal of the Georgia Entomological Society, V8, P79; WISEMAN BR, 1981, FLA ENTOMOL, V64, P395, DOI 10.2307/3494500; WISEMAN BR, 1978, ENVIRON ENTOMOL, V7, P777, DOI 10.1093/ee/7.5.777; Yang F, 2019, TOXINS, V11, DOI 10.3390/toxins11020102; Yang F, 2017, PEST MANAG SCI, V73, P2379, DOI 10.1002/ps.4631; Yang F, 2015, CROP PROT, V69, P77, DOI 10.1016/j.cropro.2014.12.002; Yang FL, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0100031, 10.1371/journal.pone.0076458]; Zalucki MP, 2017, CURR OPIN INSECT SCI, V21, P19, DOI 10.1016/j.cois.2017.05.006	73	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0221343	10.1371/journal.pone.0221343	http://dx.doi.org/10.1371/journal.pone.0221343			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5MK	31425563	Green Submitted, Green Published, gold			2022-12-26	WOS:000485022400041
J	Marshall, EA; Stewart, GL; Sage, AP; Lam, WL; Brown, CJ				Marshall, Erin A.; Stewart, Greg L.; Sage, Adam P.; Lam, Wan L.; Brown, Carolyn J.			Beyond sequence homology: Cellular biology limits the potential of XIST to act as a miRNA sponge	PLOS ONE			English	Article							X-CHROMOSOME INACTIVATION; GENE; RNAS; EXPRESSION; MICRORNAS	Introduction The sponging of microRNAs by a long non-coding RNA (lncRNA) away from their coding gene targets is a conceptually-simple, yet biologically-complex method of lncRNA-mediated gene regulation. Currently, predictions of genes that participate in sponge-based regulation are largely based on sequence homology alone, which may not adequately reflect the cellular environment in which lncRNA: miRNA pairs interact. The vast number of potential interactions generated by these predictions impedes the identification of functional gene regulatory relationships, which necessitates an approach that considers biological context. XIST, the female-specific lncRNA canonically involved in silencing the X chromosome, has been suggested by many studies to act as a miRNA sponge. The sex-specificity of XIST provides the opportunity to study the biological feasibility of proposed XIST-miRNA interactions. Here we take a comprehensive approach by considering factors that affect possible regulation through XIST-miRNA sponging. Results To identify the most feasible candidates in a particular tissue (lung adenocarcinomas), we considered protein-coding genes that (1) were positively correlated with XIST expression within sexes, (2) were targeted by miRNAs shared with XIST, and (3) expressed in lung adenocarcinoma. This revealed a robust set of 124 genes potentially positively regulated by XIST through the sequestration of 804 shared miRNAs. We then used the basic sex-specific nature of XIST to compare the changes in miRNA-target gene relationships in endogenously high-XIST and low-XIST systems to discover a high-confidence set of only 13 miRNA-gene pairs. As XIST is expressed exclusively in the nucleus, we validated the nuclear presence of several of these high-confidence miRNAs using RT-qPCR, confirming the co-localization required for XIST to interact with these species. Conclusions We use a biology-driven approach to identify genes defended from miRNA-based inhibition by the lncRNA XIST. Importantly, we identify that only a small subset of miRNAs predicted by sequence homology alone have the capacity to mediate the XIST-target gene axis, as they are enriched in the nucleus and able to co-localize with XIST for sponging. Our results reinforce the necessary consideration of biological features in future studies of lncRNA: miRNA interactions.	[Marshall, Erin A.; Stewart, Greg L.; Sage, Adam P.; Lam, Wan L.; Brown, Carolyn J.] BC Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC, Canada; [Marshall, Erin A.; Stewart, Greg L.; Sage, Adam P.; Lam, Wan L.] Univ British Columbia, Interdisciplinary Oncol Program, Vancouver, BC, Canada; [Brown, Carolyn J.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada	British Columbia Cancer Agency; University of British Columbia; University of British Columbia	Marshall, EA (corresponding author), BC Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC, Canada.; Marshall, EA (corresponding author), Univ British Columbia, Interdisciplinary Oncol Program, Vancouver, BC, Canada.	emarshall@bccrc.ca	Brown, Carolyn J/A-5159-2014	Brown, Carolyn J/0000-0002-8959-0101; Lam, Wan/0000-0002-0945-0644	Canadian Institutes for Health Research (CIHR) [FDN-143345]; University of British Columbia; CIHR	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); University of British Columbia; CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes for Health Research (CIHR FDN-143345). EAM, GLS, and APS were supported by scholarships from the University of British Columbia and CIHR. EAM is a Vanier Canada Graduate Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bak RO, 2014, WIRES RNA, V5, P317, DOI 10.1002/wrna.1213; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Chow JC, 2007, P NATL ACAD SCI USA, V104, P10104, DOI 10.1073/pnas.0610946104; Detassis S, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00086; Disteche CM, 2015, J GENET, V94, P591, DOI 10.1007/s12041-015-0574-1; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Huarte M, 2015, NAT MED, V21, P1253, DOI 10.1038/nm.3981; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Lagana Alessandro, 2014, Front Bioeng Biotechnol, V2, P65, DOI 10.3389/fbioe.2014.00065; Leung AKL, 2015, TRENDS CELL BIOL, V25, P601, DOI 10.1016/j.tcb.2015.07.005; Long YC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao2110; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Luck ME, 2015, J IMMUNOL, V194, P5047, DOI 10.4049/jimmunol.1403146; Marshall EA, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.157; Minatel BC, 2018, HUM GENOMICS, V12, DOI 10.1186/s40246-018-0148-4; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Quinodoz S, 2014, TRENDS CELL BIOL, V24, P651, DOI 10.1016/j.tcb.2014.08.009; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100	22	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2019	14	8							e0221371	10.1371/journal.pone.0221371	http://dx.doi.org/10.1371/journal.pone.0221371			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5LL	31419261	Green Published, gold, Green Submitted			2022-12-26	WOS:000485019900041
J	Al-Snan, NR; Messaoudi, S; Babu, SR; Bakhiet, M				Al-Snan, Noora R.; Messaoudi, Safia; Babu, Saranya R.; Bakhiet, Moiz			Population genetic data of the 21 autosomal STRs included in GlobalFiler kit of a population sample from the Kingdom of Bahrain	PLOS ONE			English	Article								Bahrain's population consists mainly of Arabs, Baharna and Persians leading Bahrain to become ethnically diverse. The exploration of the ethnic origin and genetic structure within the Bahraini population is fundamental mainly in the field of population genetics and forensic science. The purpose of the study was to investigate and conduct genetic studies in the population of Bahrain to assist in the interpretation of DNA-based forensic evidence and in the construction of appropriate databases. 24 short-tandem repeats in the GlobalFiler PCR Amplification kit including 21 autosomal STR loci and three gender determination loci were amplified to characterize different genetic and forensic population parameters in a cohort of 543 Bahraini unrelated healthy men. Samples were collected during the year 2017. The genotyping of the 21 autosomal STRs showed all of the loci were in Hardy-Weinberg Equilibrium (HWE) after applying Bonferroni's correction. We also found out no significant deviations from LD between pairwise STR loci in Bahraini population except when plotting for D3S1358-CSF1PO, CSF1PO-SE33, D19S433-D12S391, FGA-D2S1338, FGA-SE33, FGA-D7S820 and D7S820-SE33. The SE33 locus was the most polymorphic for the studied population and THO1 locus was the less polymorphic. The Allele 8 in TPOX scored the highest allele frequency of 0.496. The SE33 locus showed the highest power of discrimination (PD) in Bahraini population, whereas TPOX showed the lowest PD value. The 21 autosomal STRs showed a value of combined match probability (CMP) equal to 4.5633(E-27), and a combined power of discrimination (CPD) of 99.99999999%. Off-ladders and tri-allelic variants were observed in various samples at D12S391, SE33 and D22S1045 loci. Additionally, pairwise genetic distances based on FST were calculated between Bahraini population and other populations extracted from the literature. Genetic distances were represented in a non-metric MDS plot and clustering of populations according to their geographic locations was detected. Phylogenetic tree was constructed to investigate the genetic relatedness between Bahraini population and the neighboring populations. Our study indicated that the twenty-one autosomal STRs are highly polymorphic in the Bahraini population and can be used as a powerful tool in forensics and population genetic analyses including paternity testing and familial DNA searching.	[Al-Snan, Noora R.; Bakhiet, Moiz] Arabian Gulf Univ, Coll Med & Med Sci, Dept Mol Med, Manama, Bahrain; [Al-Snan, Noora R.] Minist Interior, Gen Directorate Criminal Invest & Forens Sci, Directorate Forens Sci, Forens Sci Lab, Manama, Bahrain; [Messaoudi, Safia; Babu, Saranya R.] Naif Arab Univ Secur Sci, Coll Forens Sci, Forens Biol Dept, Riyadh, Saudi Arabia	Arabian Gulf University; Naif Arab University for Security Sciences	Al-Snan, NR (corresponding author), Arabian Gulf Univ, Coll Med & Med Sci, Dept Mol Med, Manama, Bahrain.; Al-Snan, NR (corresponding author), Minist Interior, Gen Directorate Criminal Invest & Forens Sci, Directorate Forens Sci, Forens Sci Lab, Manama, Bahrain.	nr.alsnan@interior.gov.bh	Al-Snan, Noora/ABP-2782-2022	Al-Snan, Noora/0000-0002-2097-4764; Messaoudi, Safia/0000-0002-5960-498X; Bakhiet, Moiz/0000-0002-5148-8849				Abdulla MAZa-A Bashir, 2009, MODERN HIST BAHRAIN; Al-Arrayed S, 2012, J BIOSOC SCI, V44, P313, DOI 10.1017/S0021932011000666; Al-enizi M, 2013, FORENSIC SCI INT-GEN, V7, pE106, DOI 10.1016/j.fsigen.2013.04.007; ALSAFIAH HM, 2017, GENETICS, V31, pE59, DOI DOI 10.1016/J.FSIGEN.2017.09.014; Alshamali F, 2005, FORENSIC SCI INT, V152, P267, DOI 10.1016/j.forsciint.2004.09.133; Balamurugan K, 2010, LEGAL MED, V12, P320, DOI 10.1016/j.legalmed.2010.07.004; Bouwmeester H, 2014, EFSA SUPPORT PUBL, V11, p621E, DOI [DOI 10.2903/SP.EFSA.2014.EN-621, 10.2903/sp.efsa.2014.EN-621]; (CIO) CIO, 2015, EST POP GROWTH AR BA; Corp. I, 2012, IBM SPSS STAT WINDOW; Council N. R., 1996, EV FOR DNA EV; De Bel-Air F., 2015, GULF LABOUR MARKETS; Fuccaro N., 2009, HIST CITY STATE PERS; Gouy A, 2017, FORENSIC SCI INT-GEN, V30, P148, DOI 10.1016/j.fsigen.2017.07.007; Hitti P.K., 1916, ORIGINS ISLAMIC STAT; Jones RJ, 2017, FORENSIC SCI INT-GEN, V28, pE41, DOI 10.1016/j.fsigen.2017.02.015; Lawson FredH., 1989, BAHRAIN MODERNIZATIO; Louer L, 2008, CITY SOC, V20, P32, DOI 10.1111/j.1548-744X.2008.00004.x; Nugent JB, 2016, RECONSTRUCTION PREHI, P28; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perez-Miranda AM, 2006, HUM HERED, V61, P67, DOI 10.1159/000092648; Ruitberg CM, 2001, NUCLEIC ACIDS RES, V29, P320, DOI 10.1093/nar/29.1.320; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Takezaki N, 2014, MOL BIOL EVOL, V31, P1622, DOI 10.1093/molbev/msu093; UNESCO, 2012, QAL BAHR ANC HARB CA	24	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220620	10.1371/journal.pone.0220620	http://dx.doi.org/10.1371/journal.pone.0220620			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415577	gold, Green Published, Green Submitted			2022-12-26	WOS:000485017200021
J	Greenblatt, R; Bacchetti, P; Boylan, R; Kober, K; Springer, G; Anastos, K; Busch, M; Cohen, M; Kassaye, S; Gustafson, D; Aouizerat, B; Kempf, MC; Konkle-Parker, D; Ofotokun, I; Wingood, G; Anastos, K; Sharma, A; Minkoff, H; Gustafson, D; Cohen, M; French, A; Kassaye, S; Fischl, M; Metsch, L; Adimora, A; Greenblatt, R; Aouizerat, B; Tien, P; Gange, S; Golub, E; Milam, J				Greenblatt, Ruth; Bacchetti, Peter; Boylan, Ross; Kober, Kord; Springer, Gayle; Anastos, Kathryn; Busch, Michael; Cohen, Mardge; Kassaye, Seble; Gustafson, Deborah; Aouizerat, Bradley; Kempf, Mirjam-Colette; Konkle-Parker, Deborah; Ofotokun, Ighovwerha; Wingood, Gina; Anastos, Kathryn; Sharma, Anjali; Minkoff, Howard; Gustafson, Deborah; Cohen, Mardge; French, Audrey; Kassaye, Seble; Fischl, Margaret; Metsch, Lisa; Adimora, Adaora; Greenblatt, Ruth; Aouizerat, Bradley; Tien, Phyllis; Gange, Stephen; Golub, Elizabeth; Milam, Joel		Women's Interagency Hiv Study	Genetic and clinical predictors of CD4 lymphocyte recovery during suppressive antiretroviral therapy: Whole exome sequencing and antiretroviral therapy response phenotypes	PLOS ONE			English	Article							GENDER-BALANCED POPULATION; SUBSETS REFERENCE RANGES; HIV-INFECTED PATIENTS; CELL COUNT RECOVERY; IMMUNOLOGICAL RECOVERY; TRANSCRIPTION FACTOR; CD4+T-CELL RECOVERY; CCL25 EXPRESSION; IMMUNE RECOVERY; HEALTHY-ADULTS	Increase of peripheral blood CD4 lymphocyte counts is a key goal of combined antiretroviral therapy (cART); most, but not all, recipients respond adequately and promptly. A small number of studies have examined specific genetic factors associated with the extent of CD4 recovery. We report a genome-wide examination of factors that predict CD4 recovery in HIV-infected women. We identified women in in a cohort study who were on cART with viral load below 400 copies, and drew racially and ethnically matched samples of those with good CD4 response over 2 years or poor response. We analyzed the exomes of those women employing next generation sequencing for genes associated with CD4 recovery after controlling for non-genetic factors identified through forward stepwise selection as important. We studied 48 women with good CD4 recovery and 42 with poor CD4 recovery during virologically-suppressive cART. Stepwise logistic regression selected only age as a statistically significant (p<0.05) non-genetic predictor of response type (each additional year of age reduced the odds of good recovery by 11% (OR = 0.89, CI = 0.84-0.96, p = 0.0009). After adjustment for age and genomic estimates of race and ethnicity, 41 genes harbored variations associated with CD4 recovery group (p <= 0.001); 5 of these have been previously reported to be associated with HIV infection, 4 genes would likely influence CD4 homeostasis, and 13 genes either had known functions or were members of product families that had functions for which interactions with HIV or effects on lymphocyte homeostasis were biologically plausible. Greater age was the strongest acquired factor that predicted poor CD4 cell recovery. Sequence variations spanning 41 genes were independently predictive of CD4 recovery. Many of these genes have functions that impact the cell cycle, apoptosis, lymphocyte migration, or have known interactions with HIV. These findings may help inform new hypotheses related to responses to HIV therapy and CD4 lymphocyte homeostasis.	[Greenblatt, Ruth; Greenblatt, Ruth] UCSF Sch Pharm, Dept Clin Pharm, San Francisco, CA 94143 USA; [Greenblatt, Ruth; Bacchetti, Peter; Boylan, Ross; Busch, Michael; Greenblatt, Ruth] UCSF Sch Med, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Greenblatt, Ruth; Greenblatt, Ruth] UCSF Sch Med, Dept Med, San Francisco, CA 94143 USA; [Kober, Kord] UCSF Sch Nursing, Dept Physiol Nursing, San Francisco, CA USA; [Springer, Gayle] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Anastos, Kathryn] Albert Einstein Coll Med, Bronx, NY USA; [Anastos, Kathryn] Montefiore Hlth Syst, Bronx, NY USA; [Busch, Michael] Blood Syst Res Inst, San Francisco, CA USA; [Cohen, Mardge] Stroger Hosp, Chicago, IL USA; [Kassaye, Seble] Georgetown Univ, Med Ctr, Dept Med, Washington, DC 20007 USA; [Gustafson, Deborah] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA; [Aouizerat, Bradley; Aouizerat, Bradley] NYU, Sch Dent, New York, NY USA; [Aouizerat, Bradley; Aouizerat, Bradley] Bluestone Ctr Clin Res, New York, NY USA; [Kempf, Mirjam-Colette; Konkle-Parker, Deborah] UAB MS WIHS, Jackson, MS USA; [Ofotokun, Ighovwerha; Wingood, Gina] Atlanta WIHS, Atlanta, GA USA; [Anastos, Kathryn; Sharma, Anjali] Bronx WIHS, Bronx, NY USA; [Minkoff, Howard; Gustafson, Deborah] Brooklyn WIHS, Brooklyn, NY USA; [Cohen, Mardge; French, Audrey] Chicago WIHS, Chicago, IL USA; [Kassaye, Seble] Metropolitan Washington WIHS, Washington, DC USA; [Fischl, Margaret; Metsch, Lisa] Miami WIHS, Miami, FL USA; [Adimora, Adaora] UNC WIHS, Chapel Hill, NC USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Yeshiva University; Albert Einstein College of Medicine; Vitalant; Vitalant Research Institute; John H Stroger Junior Hospital Cook County; Georgetown University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; New York University	Greenblatt, R (corresponding author), UCSF Sch Pharm, Dept Clin Pharm, San Francisco, CA 94143 USA.; Greenblatt, R (corresponding author), UCSF Sch Med, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.; Greenblatt, R (corresponding author), UCSF Sch Med, Dept Med, San Francisco, CA 94143 USA.	ruth.greenblatt@ucsf.edu	Kober, Kord/ABF-2657-2020; Gange, Stephen/AGY-5004-2022	Kober, Kord/0000-0001-9732-3321; Gange, Stephen/0000-0001-7842-512X	National Institute of Allergy and Infectious Diseases (NIAID) [U01-AI-034989, U01-AI-042590, U01-AI-035004, U01-AI-034993, U01-AI-034994, U01-AI-031834]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI034989, U01AI034993, U01AI035004, U01AI031834, U01AI034994, U01AI042590] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Data in this manuscript were collected by the Women's Interagency HIV Study (WIHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this publication are solely the responsibility of the authors and do not represent the official views of the National Institutes of Health (NIH). The National Institute of Allergy and Infectious Diseases (NIAID; https://www.niaid.nih.gov) provided grant support to the following co-authors: U01-AI-034989 (RMG, PB, RB, BA); U01-AI-042590 (GS); U01-AI-035004 (KA); U01-AI-034993 (MC); U01-AI-034994 (SK); and U01-AI-031834 (DG).	Abraham AG, 2013, JAIDS-J ACQ IMM DEF, V62, P405, DOI 10.1097/QAI.0b013e31828177d7; Adolescents PoAGfAa, 2015, GUIDELINES USE ANTIR; Ahuja SK, 2008, NAT MED, V14, P413, DOI 10.1038/nm1741; Al-Mawali A, 2013, CYTOM PART A, V83A, P739, DOI 10.1002/cyto.a.22322; Arya R, 2015, GENET EPIDEMIOL, V39, P678, DOI 10.1002/gepi.21938; Bacon MC, 2005, CLIN DIAGN LAB IMMUN, V12, P1013, DOI 10.1128/CDLI.12.9.1013-1019.2005; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Beaudoin M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003723; Blanco JR, 2015, JAIDS-J ACQ IMM DEF, V68, P21, DOI 10.1097/QAI.0000000000000398; Callicott JH, 2013, J CLIN INVEST, V123, P2961, DOI 10.1172/JCI67510; Carson AR, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-125; Chu TT, 2010, J HUM GENET, V55, P285, DOI 10.1038/jhg.2010.24; Dahlin A, 2015, PHARMACOGENET GENOM, V25, P82, DOI 10.1097/FPC.0000000000000110; DARMINIO MA, 2005, ARCH INTERN MED, V0165; Deng YJ, 2006, MOL IMMUNOL, V43, P1497, DOI 10.1016/j.molimm.2005.07.039; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dering Carmen, 2014, BMC Proc, V8, pS8, DOI 10.1186/1753-6561-8-S1-S8; Devadas K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147421; Ding JW, 2016, ARCH VIROL, V161, P2441, DOI 10.1007/s00705-016-2933-5; Egana-Gorrono L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155245; Finkel DG, 2003, AIDS, V17, P2009, DOI 10.1097/00002030-200309050-00032; Fujimaki T, 2015, BIOMED REP, V3, P118, DOI 10.3892/br.2014.371; Gao XR, 2016, ONCOTARGET, V7, P55757, DOI 10.18632/oncotarget.9825; Gauvin J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155868; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; Gelman BB, 2004, J NEUROIMMUNOL, V157, P111, DOI 10.1016/j.jneuroim.2004.08.044; Gooskens SL, 2015, ONCOTARGET, V6, P15828, DOI 10.18632/oncotarget.4682; Grady BJ, 2011, JAIDS-J ACQ IMM DEF, V58, P363, DOI 10.1097/QAI.0b013e31822c688b; Gutierrez F, 2008, CURR HIV RES, V6, P100, DOI 10.2174/157016208783885038; Guzman-Fulgencio M, 2013, J ANTIMICROB CHEMOTH, V68, P2349, DOI 10.1093/jac/dkt206; Haas DW, 2006, J INFECT DIS, V194, P1098, DOI 10.1086/507313; Hartling HJ, 2014, AIDS, V28, P1739, DOI 10.1097/QAD.0000000000000354; Hendrickson SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012862; Hosono K, 2010, GENOMICS, V96, P102, DOI 10.1016/j.ygeno.2010.05.003; Hunt PW, 2003, AIDS, V17, P1907, DOI 10.1097/00002030-200309050-00009; Ikram MK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001184; Imamura K, 2014, J BIOL CHEM, V289, P9865, DOI 10.1074/jbc.M113.520585; Ivanova E, 2015, NUCLEIC ACIDS RES, V43, P2874, DOI 10.1093/nar/gkv048; Ives NJ, 2001, J INFECTION, V42, P134, DOI 10.1053/jinf.2001.0810; Jahan AS, 2016, P NATL ACAD SCI USA, V113, pE705, DOI 10.1073/pnas.1521763113; Jentsch-Ullrich K, 2005, CLIN IMMUNOL, V116, P192, DOI 10.1016/j.clim.2005.03.020; Jia D, 2015, FASEB J, V29, P1371, DOI 10.1096/fj.14-258947; Kalayjian RC, 2013, AIDS, V27, P1563, DOI 10.1097/QAD.0b013e32835fabc2; Kaufmann GR, 2003, ARCH INTERN MED, V163, P2187, DOI 10.1001/archinte.163.18.2187; Kaufmann GR, 2002, AIDS, V16, P359, DOI 10.1097/00002030-200202150-00007; Keene SE, 2012, J VIROL, V86, P7934, DOI 10.1128/JVI.00856-12; Kochl R, 2016, NAT IMMUNOL, V17, P1075, DOI 10.1038/ni.3495; Le T, 2013, NEW ENGL J MED, V368, P218, DOI 10.1056/NEJMoa1110187; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079910; Limou S, 2012, CURR HIV RES, V10, P143, DOI 10.2174/157016212799937209; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Maman D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031078; Marcus JL, 2015, AIDS PATIENT CARE ST, V29, P370, DOI 10.1089/apc.2015.0040; Marenholz I, 2011, HUM MOL GENET, V20, P2443, DOI 10.1093/hmg/ddr117; Mary C, 2010, RNA, V16, P969, DOI 10.1261/rna.2040410; Mattheisen M, 2015, MOL PSYCHIATR, V20, P337, DOI 10.1038/mp.2014.43; Mavigner M, 2012, J CLIN INVEST, V122, P62, DOI 10.1172/JCI59011; Miller CL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004263; Min-Oo G, 2014, J EXP MED, V211, P1289, DOI 10.1084/jem.20132459; Morton LM, 2009, CANCER EPIDEM BIOMAR, V18, P1259, DOI 10.1158/1055-9965.EPI-08-1037; Mouaffak F, 2011, PHARMACOGENOMICS, V12, P185, DOI 10.2217/PGS.10.179; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Ng SYM, 2009, IMMUNITY, V30, P493, DOI 10.1016/j.immuni.2009.01.014; Nieters A, 2012, BLOOD, V120, P4645, DOI 10.1182/blood-2012-05-427989; Ohashi M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004822; Okulicz JF, 2015, JAMA INTERN MED, V175, P88, DOI 10.1001/jamainternmed.2014.4010; Panichareon B, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-27; Pincetic A, 2010, J VIROL, V84, P4725, DOI 10.1128/JVI.02478-09; Qin SL, 2008, J MED PRIMATOL, V37, P46, DOI 10.1111/j.1600-0684.2008.00327.x; Rajasuriar R, 2012, GENES IMMUN, V13, P83, DOI 10.1038/gene.2011.65; Rauch A, 2008, CLIN INFECT DIS, V46, P1921, DOI 10.1086/588479; Raynor J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00161; Scherzer R, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.07.048; Spadoni JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136989; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tadokoro K, 2005, NEUROGENETICS, V6, P127, DOI 10.1007/s10048-005-0003-3; Takeda E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027815; Tanaka-Nakanishi A, 2014, CANCER RES, V74, P188, DOI 10.1158/0008-5472.CAN-13-0436; Tanaskovic S, 2014, AIDS, V28, P821, DOI 10.1097/QAD.0000000000000213; Trivedi PJ, 2016, J AUTOIMMUN, V68, P98, DOI 10.1016/j.jaut.2016.01.001; Valiathan R, 2014, IMMUNOBIOLOGY, V219, P487, DOI 10.1016/j.imbio.2014.02.010; van Lelyveld SFL, 2012, AIDS, V26, P465, DOI 10.1097/QAD.0b013e32834f32f8; Vinikoor MJ, 2014, AIDS RES HUM RETROV, V30, P949, DOI [10.1089/aid.2014.0046, 10.1089/AID.2014.0046]; Wang CJ, 2015, WORLD J GASTROENTERO, V21, P8398, DOI 10.3748/wjg.v21.i27.8398; Wood E, 2004, JAIDS-J ACQ IMM DEF, V35, P261, DOI 10.1097/00126334-200403010-00006; Yahyaei S, 2016, JAIDS-J ACQ IMM DEF, V73, P11, DOI 10.1097/QAI.0000000000001070; Yang D, 2010, STRUCTURE, V18, P976, DOI 10.1016/j.str.2010.04.014; Yanik EL, 2014, AIDS, V28, P979, DOI 10.1097/QAD.0000000000000167; Yanik EL, 2013, CLIN INFECT DIS, V57, P756, DOI 10.1093/cid/cit369; Zhang XH, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0063-2	91	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0219201	10.1371/journal.pone.0219201	http://dx.doi.org/10.1371/journal.pone.0219201			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415590	Green Published, gold			2022-12-26	WOS:000485017200004
J	Hafke-Dys, H; Breborowicz, A; Kleka, P; Kocinski, J; Biniakowski, A				Hafke-Dys, Honorata; Breborowicz, Anna; Kleka, Pawel; Kocinski, Jedrzej; Biniakowski, Adam			The accuracy of lung auscultation in the practice of physicians and medical students	PLOS ONE			English	Article								Background Auscultation is one of the first examinations that a patient is subjected to in a GP's office, especially in relation to diseases of the respiratory system. However it is a highly subjective process and depends on the physician's ability to interpret the sounds as determined by his/her psychoacoustical characteristics. Here, we present a cross-sectional assessment of the skills of physicians of different specializations and medical students in the classification of respiratory sounds in children. Methods and findings 185 participants representing different medical specializations took part in the experiment. The experiment comprised 24 respiratory system auscultation sounds. The participants were tasked with listening to, and matching the sounds with provided descriptions of specific sound classes. The results revealed difficulties in both the recognition and description of respiratory sounds. The pulmonologist group was found to perform significantly better than other groups in terms of number of correct answers. We also found that performance significantly improved when similar sound classes were grouped together into wider, more general classes. Conclusions These results confirm that ambiguous identification and interpretation of sounds in auscultation is a generic issue which should not be neglected as it can potentially lead to inaccurate diagnosis and mistreatment. Our results lend further support to the already widespread acknowledgment of the need to standardize the nomenclature of auscultation sounds (according to European Respiratory Society, International Lung Sounds Association and American Thoracic Society). In particular, our findings point towards important educational challenges in both theory (nomenclature) and practice (training).	[Hafke-Dys, Honorata; Kocinski, Jedrzej] Uniwersytetu Poznanskiego, Fac Phys, Inst Acoust, Adam Mickiewicz Univ Poznan, Poznan, Poland; [Hafke-Dys, Honorata; Kocinski, Jedrzej; Biniakowski, Adam] StethoMe, Winogrady, Poland; [Breborowicz, Anna] Poznan Univ Med Sci, K Jonscher Clin Hosp Poznan, Dept Pediat Pneumonol Allergol & Clin Immunol, Szpitalna, Poland; [Kleka, Pawel] Adam Mickiewicz Univ, Inst Psychol, Wieniawskiego, Poland	Adam Mickiewicz University; Poznan University of Medical Sciences; Adam Mickiewicz University	Hafke-Dys, H (corresponding author), Uniwersytetu Poznanskiego, Fac Phys, Inst Acoust, Adam Mickiewicz Univ Poznan, Poznan, Poland.; Hafke-Dys, H (corresponding author), StethoMe, Winogrady, Poland.	h.hafke@amu.edu.pl	Hafke-Dys, Honorata/AAB-3887-2020	Hafke-Dys, Honorata/0000-0002-3417-5402; Kleka, Pawel/0000-0003-0841-0015	National Centre of Research and Development (NCRD) in Poland; European Union under Sub-Measure 1.1.1 of the Operational Programme Smart Growth (PO IR) "Industrial R&D carried out by enterprises" (Fast Track) [POIR.01.01.01-00-0528/16-00]	National Centre of Research and Development (NCRD) in Poland; European Union under Sub-Measure 1.1.1 of the Operational Programme Smart Growth (PO IR) "Industrial R&D carried out by enterprises" (Fast Track)	This work was supported by a grant from The National Centre of Research and Development (NCRD) in Poland and the European Union under Sub-Measure 1.1.1 of the Operational Programme Smart Growth (PO IR) "Industrial R&D carried out by enterprises" (Fast Track), agreement no. POIR.01.01.01-00-0528/16-00. All authors were paid for their work by StethoMe, which is the grantee. The funder provided support in the form of salaries for authors HH-D, ABr, PK, JK, ABi, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The commercial affiliation of HH-D, JK, ABi did not play a role in our study.	Aviles-Solis JC, 2017, BMJ OPEN RESPIR RES, V4, DOI 10.1136/bmjresp-2017-000250; BUNIN NJ, 1979, CHEST, V76, P690, DOI 10.1378/chest.76.6.690; CUGELL DW, 1987, AM REV RESPIR DIS, V136, P1016, DOI 10.1164/ajrccm/136.4.1016; Francis NA, 2013, EUR J GEN PRACT, V19, P77, DOI 10.3109/13814788.2012.733690; Mangione S, 1999, AM J RESP CRIT CARE, V159, P1119, DOI 10.1164/ajrccm.159.4.9806083; Melbye H, 2016, BMJ OPEN RESPIR RES, V3, DOI 10.1136/bmjresp-2016-000136; PASTERKAMP H, 1987, CHEST, V92, P346, DOI 10.1378/chest.92.2.346; Pasterkamp H, 2016, EUR RESPIR J, V47, P724, DOI 10.1183/13993003.01132-2015; Priftis KN, 2018, BASIC SCI CLIN PRACT; Rowinska-Zakrzewska E, 2004, POLISH RESPIRATORY S; Szczeklik E, 1979, POLISH DIAGNOSTYKA O; Turnbull S, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-018-0716-7; Wilkins R.L., 2004, FUNDAMENTALS LUNG HE; WILKINS RL, 1990, CHEST, V98, P886, DOI 10.1378/chest.98.4.886	14	15	17	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220606	10.1371/journal.pone.0220606	http://dx.doi.org/10.1371/journal.pone.0220606			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404066	Green Published, gold, Green Submitted			2022-12-26	WOS:000485006800018
J	Koech, WA; Rudisill, TM; Rockett, IRH				Koech, Wilson A.; Rudisill, Toni M.; Rockett, Ian R. H.			Maternal characteristics associated with injury-related infant death in West Virginia, 2010-2014	PLOS ONE			English	Article							UNITED-STATES; MORTALITY; CHILD; MALTREATMENT	Although injury-related deaths have been documented among children and adult populations, insufficient attention has been directed towards injury-related infant deaths. The objective of this retrospective study was to investigate maternal and infant characteristics associated with injury-related infant deaths in West Virginia. Birth and infant mortality data for 2010-2014 were sourced from the West Virginia Bureau for Public Health, Charleston. Relative risk was calculated using log-binomial regression utilizing generalized estimating equations. Maternal characteristics associated with injury-related infant mortality in West Virginia were race/ethnicity (X-df=2(2) = 7.48, p = .03), and smoking during pregnancy (X-df=1(2) = 13.1, p < .00). Risk of a Black Non-Hispanic infant suffering an injury-related death was 4.0 (95% CL 1.7, 9.3) times that of infants of other races/ethnicities. Risk of an infant dying from an injury-related cause, if the mother smoked during pregnancy, was 2.9 (95% CL 1.6, 5.0) times the risk of such a death if maternal smoking status during pregnancy is unknown or no smoking, controlling for race/ethnicity. This study provides important information to public health stakeholders at both the state and local levels in designing interventions for partial reduction or prevention of injury-related infant mortality in West Virginia.	[Koech, Wilson A.; Rudisill, Toni M.; Rockett, Ian R. H.] West Virginia Univ, Dept Epidemiol, Sch Publ Hlth, Morgantown, WV 26506 USA; [Rockett, Ian R. H.] Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14642 USA	West Virginia University; University of Rochester	Koech, WA (corresponding author), West Virginia Univ, Dept Epidemiol, Sch Publ Hlth, Morgantown, WV 26506 USA.	wakoech@mix.wvu.edu		Rudisill, Toni/0000-0002-2019-4274	NIGMS NIH HHS [U54 GM104942] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahrens KA, 2017, AM J PREV MED, V53, P412, DOI 10.1016/j.amepre.2017.04.018; Annest J, 2014, PROPOSED FRAMEWORK P, P1; Arbogast KB, 2012, TRAFFIC INJ PREV, V13, P172, DOI 10.1080/15389588.2011.642834; Arthur M, 2008, MED CARE, V46, P192, DOI 10.1097/MLR.0b013e31815b9d8e; Bernard Stephanie J., 2007, Morbidity and Mortality Weekly Report, V56, P1; Black D. A., 2004, LABOR MARKET PERFORM; Borse NN, 2013, J SAFETY RES, V45, P127, DOI 10.1016/j.jsr.2013.02.001; Bruckner TA, 2008, ACCIDENT ANAL PREV, V40, P1797, DOI 10.1016/j.aap.2008.07.011; Centers for Disease Control and Prevention (CDC), 2007, MMWR Morb Mortal Wkly Rep, V56, P1137; Cubbin C, 2002, ANNU REV PUBL HEALTH, V23, P349, DOI 10.1146/annurev.publhealth.23.100901.140548; Fowler K, 2017, PEDIATRICS, V140, P1; Gilchrist Julie, 2012, Morbidity and Mortality Weekly Report, V61, P270; Heerman WJ, 2016, AM J PREV MED, V51, P411, DOI 10.1016/j.amepre.2016.04.020; Jain A, 2001, Inj Prev, V7, P135; Khan SQ, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.3317; King AJ, 2015, CHILD MALTREATMENT, V20, P151, DOI 10.1177/1077559514567176; Kochanek Kenneth D, 2016, Natl Vital Stat Rep, V65, P1; Lai SH, 2000, J ADDICT DIS, V19, P11, DOI 10.1300/J069v19n04_02; Matthews T J, 2015, Natl Vital Stat Rep, V64, P1; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Northam S, 2006, JOGNN-J OBST GYN NEO, V35, P3, DOI 10.1111/J.1552-6909.2006.00016.x; Rao C., 2001, IMS LECT NOTES MONOG, V38; Rockett Ian R H, 2012, Am J Public Health, V102, pe84, DOI 10.2105/AJPH.2012.300960; SAS Institute, 2012, SAS STAT SOFTW SAS; Smith DK, 2007, CHILD MALTREATMENT, V12, P150, DOI 10.1177/1077559507300129; The United States Cancer Statistics, 2004, NAT CTR HLTH STAT ST; [West Virginia Bureau for Public Health Resources WVDoHaH], 2016, W VIRG VIT STAT 2014, P184	27	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220801	10.1371/journal.pone.0220801	http://dx.doi.org/10.1371/journal.pone.0220801			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5GN	31404105	Green Published, Green Submitted, gold			2022-12-26	WOS:000485006800032
J	Shimizu, H; Lu, Y; Vella, KR; Damilano, F; Astapova, I; Amano, I; Ritter, M; Gallop, MR; Rosenzweig, AN; Cohen, RN; Hollenberg, AN				Shimizu, Hiroaki; Lu, Yu; Vella, Kristen R.; Damilano, Federico; Astapova, Inna; Amano, Izuki; Ritter, Megan; Gallop, Molly R.; Rosenzweig, Anthony N.; Cohen, Ronald N.; Hollenberg, Anthony N.			Nuclear corepressor SMRT is a strong regulator of body weight independently of its ability to regulate thyroid hormone action	PLOS ONE			English	Article							ADIPOSE-TISSUE; INSULIN-RESISTANCE; NCOR1; TRANSCRIPTION; RECEPTORS; OBESITY; PHOSPHORYLATION; SENSITIVITY; EXPRESSION; REPRESSION	Silencing Mediator of Retinoid and Thyroid Hormone Receptors (SMRT) and the nuclear receptor co-repressor1 (NCoR1) are paralogs and regulate nuclear receptor (NR) function through the recruitment of a multiprotein complex that includes histone deacetylase activity. Previous genetic strategies which deleted SMRT in a specific tissue or which altered the interaction between SMRT and NRs have suggested that it may regulate adiposity and insulin sensitivity. However, the full role of SMRT in adult mice has been difficult to establish because its complete deletion during embryogenesis is lethal. To elucidate the specific roles of SMRT in mouse target tissues especially in the context of thyroid hormone (TH) signaling, we used a tamoxifen-inducible post-natal disruption strategy. We found that global SMRT deletion causes dramatic obesity even though mice were fed a standard chow diet and exhibited normal food intake. This weight gain was associated with a decrease in energy expenditure. Interestingly, the deletion of SMRT had no effect on TH action in any tissue but did regulate retinoic acid receptor (RAR) function in the liver. We also demonstrate that the deletion of SMRT leads to profound hepatic steatosis in the setting of obesity. This is unlike NCoR1 deletion, which results in hepatic steatosis due to the upregulation of lipogenic gene expression. Taken together, our data demonstrate that SMRT plays a unique and CoR specific role in the regulation of body weight and has no role in TH action. This raises the possibility that additional role of CoRs besides NCoR1 and SMRT may exist to regulate TH action.	[Shimizu, Hiroaki; Lu, Yu; Vella, Kristen R.; Astapova, Inna; Amano, Izuki; Ritter, Megan; Gallop, Molly R.; Hollenberg, Anthony N.] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Shimizu, Hiroaki; Lu, Yu; Vella, Kristen R.; Astapova, Inna; Amano, Izuki; Ritter, Megan; Gallop, Molly R.; Hollenberg, Anthony N.] Harvard Med Sch, Boston, MA 02115 USA; [Vella, Kristen R.; Amano, Izuki; Ritter, Megan; Hollenberg, Anthony N.] Weill Cornell Med, Div Endocrinol Diabet & Metab, New York, NY 10065 USA; [Damilano, Federico; Rosenzweig, Anthony N.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Cohen, Ronald N.] Univ Chicago, Sect Endocrinol Diabet & Metab, Chicago, IL 60637 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Cornell University; Harvard University; Massachusetts General Hospital; University of Chicago	Hollenberg, AN (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA.; Hollenberg, AN (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Hollenberg, AN (corresponding author), Weill Cornell Med, Div Endocrinol Diabet & Metab, New York, NY 10065 USA.	thollenb@med.cornell.edu	Rosenzweig, Anthony/AAD-7893-2019		National Institutes of Health [R01 DK056123]; Japan Society for the Proportion of Science, JSPS KAKENHI [18K08486]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Proportion of Science, JSPS KAKENHI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (https://www.nih.gov), grant no. R01 DK056123 to ANH and by the Japan Society for the Proportion of Science, JSPS KAKENHI, (https://www.jsps.go.jp/index.html), grant number 18K08486. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amengual J, 2010, CELL PHYSIOL BIOCHEM, V25, P657, DOI 10.1159/000315085; Astapova I, 2016, J MOL ENDOCRINOL, V56, pR73, DOI 10.1530/JME-15-0246; Astapova I, 2011, MOL ENDOCRINOL, V25, P212, DOI 10.1210/me.2010-0462; Astapova I, 2014, J CLIN INVEST, V124, P1976, DOI 10.1172/JCI73419; Astapovaa I, 2008, P NATL ACAD SCI USA, V105, P19544, DOI 10.1073/pnas.0804604105; Benhamed F, 2012, J CLIN INVEST, V122, P2176, DOI 10.1172/JCI41636; Bray GA, 2006, ENDOCRINE, V29, P109, DOI 10.1385/ENDO:29:1:109; Cohen RN, 2001, MOL ENDOCRINOL, V15, P1049, DOI 10.1210/me.15.7.1049; Cohen RN, 2000, MOL ENDOCRINOL, V14, P900, DOI 10.1210/me.14.6.900; Costa-e-Sousa RH, 2012, ENDOCRINOLOGY, V153, P5049, DOI 10.1210/en.2012-1504; Davis J, 2012, CIRC RES, V111, P761, DOI 10.1161/CIRCRESAHA.111.262717; Fang S, 2011, P NATL ACAD SCI USA, V108, P3412, DOI 10.1073/pnas.1017707108; FOLCH J, 1957, J BIOL CHEM, V226, P497; He YQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-575; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Hollenberg AN, 2012, NEW ENGL J MED, V366, P1345, DOI 10.1056/NEJMcibr1114529; Hong SH, 2018, P NATL ACAD SCI USA, V115, P10381, DOI 10.1073/pnas.1809480115; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Jepsen K, 2008, GENE DEV, V22, P740, DOI 10.1101/gad.1637108; Kiefer FW, 2012, ENDOCRINOLOGY, V153, P3089, DOI 10.1210/en.2011-2104; Kim SC, 2014, HEPATOLOGY, V59, P1750, DOI 10.1002/hep.26699; Kiss M, 2017, P NATL ACAD SCI USA, V114, P10725, DOI 10.1073/pnas.1700785114; Kumar S, 2016, DEV BIOL, V418, P204, DOI 10.1016/j.ydbio.2016.08.005; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Martinez-Iglesias OA, 2016, P NATL ACAD SCI USA, V113, pE328, DOI 10.1073/pnas.1520469113; Matsuzaka T, 2004, DIABETES, V53, P560, DOI 10.2337/diabetes.53.3.560; Mendoza A, 2017, P NATL ACAD SCI USA, V114, pE8458, DOI 10.1073/pnas.1706917114; Moore JT, 2006, CHEMMEDCHEM, V1, P504, DOI 10.1002/cmdc.200600006; Nofsinger RR, 2008, P NATL ACAD SCI USA, V105, P20021, DOI 10.1073/pnas.0811012105; Palou A, 2000, EUR J NUTR, V39, P127, DOI 10.1007/s003940070017; Sanchez-Gurmaches J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5099; Shimizu H, 2015, MOL CELL BIOL, V35, P555, DOI 10.1128/MCB.01208-14; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Stanya KJ, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-7; Sun Z, 2013, MOL CELL, V52, P769, DOI 10.1016/j.molcel.2013.10.022; Sutanto MM, 2010, J BIOL CHEM, V285, P18485, DOI 10.1074/jbc.M110.107680; Trasino SE, 2016, DIABETES OBES METAB, V18, P142, DOI 10.1111/dom.12590; Vella KR, 2014, MOL CELL BIOL, V34, P1564, DOI 10.1128/MCB.00129-14; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017; You SH, 2013, NAT STRUCT MOL BIOL, V20, P182, DOI 10.1038/nsmb.2476; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587	41	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220717	10.1371/journal.pone.0220717	http://dx.doi.org/10.1371/journal.pone.0220717			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404087	Green Published, Green Submitted, gold			2022-12-26	WOS:000485006800027
J	Boffel, C; Mussler, J				Boeffel, Christian; Muessler, Jochen			Action effect consistency and body ownership in the avatar-Simon task	PLOS ONE			English	Article							SPATIAL PERSPECTIVE-TAKING; EFFECT COMPATIBILITY; INTENTION; INTEGRATION; IMPACT; SELF; TEC	Putting oneself in the shoes of a digital alter ego becomes an increasingly relevant part of our everyday experience. In modern day psychology, these interactions can be examined within the frameworks of visual perspective taking and body ownership. Both target similar questions: What does it take, to become one with the avatar? When do we show the same behavior and make the same experiences, as if we were in its place? In this study, we want to address the role of action effect consistency for these concepts. We manipulated the participants' sense of agency over a task-irrelevant avatar in a Simon task by providing either corresponding or random action effects. These effects could be either embodied and therefore linked to the avatar (Experiment 1) or independent of it (Experiment 2). We used stimulus-response compatibility effects from the avatar's point of view as a measure for spontaneous visual perspective taking and a questionnaire to measure the perceived body ownership of the avatar. The results showed that corresponding action effects lead to increased spontaneous perspective taking of the avatar, regardless of whether the effect was linked to the avatar or not. Though the avatar compatibility effects were overall more pronounced in the embodied action effect condition. However, significant differences in perceived body ownership were only observed if the effects were linked to the avatar. The results might prove useful to further our understanding of subjective and objective measurements of interactions with avatars.	[Boeffel, Christian; Muessler, Jochen] Rhein Westfal TH Aachen, Inst Psychol, Work & Cognit Psychol, Aachen, Germany	RWTH Aachen University	Boffel, C (corresponding author), Rhein Westfal TH Aachen, Inst Psychol, Work & Cognit Psychol, Aachen, Germany.	boeffel@psych.rwth-aachen.de	Böffel, Christian/AFN-5916-2022	Böffel, Christian/0000-0003-3623-3140	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [DFG MU 1298/11]; DFG [DFG SPP 2134]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This study was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation: DFG MU 1298/11) awarded to Jochen Musseler and is associated with the DFG Priority Program "The Active Self" (DFG SPP 2134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkarim Z, 2016, ATTEN PERCEPT PSYCHO, V78, P707, DOI 10.3758/s13414-015-1016-0; Ansorge U, 2002, ACTA PSYCHOL, V109, P285, DOI 10.1016/S0001-6918(01)00062-2; Beckers T, 2002, PSYCHOL RES-PSYCH FO, V66, P166, DOI 10.1007/s00426-002-0090-9; Boffel C, 2019, ATTEN PERCEPT PSYCHO, V81, P158, DOI 10.3758/s13414-018-1573-0; Boffel C, 2018, FRONT PSYCHOL, V9, P1, DOI [10.3389/fpsyg.2018.00001, DOI 10.3389/FPSYG.2018.00001]; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Deutsche Forschungsgemeinschaft, 2009, FAQ INFORMATIONEN FU; Dolk T, 2013, J EXP PSYCHOL HUMAN, V39, P1248, DOI 10.1037/a0031031; Dutzi IB, 2009, PSYCHOL RES-PSYCH FO, V73, P425, DOI 10.1007/s00426-008-0161-7; Elsner B, 2004, PSYCHOL RES-PSYCH FO, V68, P138, DOI 10.1007/s00426-003-0151-8; Elsner B, 2001, J EXP PSYCHOL HUMAN, V27, P229, DOI 10.1037/0096-1523.27.1.229; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; HEDGE A, 1975, ACTA PSYCHOL, V39, P427, DOI 10.1016/0001-6918(75)90041-4; Herwig A, 2007, Q J EXP PSYCHOL, V60, P1540, DOI 10.1080/17470210601119134; Herwig A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00444; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; HOMMEL B, 1993, PSYCHOL RES-PSYCH FO, V55, P208, DOI 10.1007/BF00419608; HOMMEL B, 1993, PSYCHOL RES-PSYCH FO, V55, P270, DOI 10.1007/BF00419687; Hommel B, 2009, PSYCHOL RES-PSYCH FO, V73, P512, DOI 10.1007/s00426-009-0234-2; James W., 1890, PRINCIPLES PSYCHOL, V2, P283; Kessler K, 2012, SPAT COGN COMPUT, V12, P133, DOI 10.1080/13875868.2011.634533; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; Kunde W, 2004, Q J EXP PSYCHOL-A, V57, P87, DOI 10.1080/02724980343000143; Kunde W, 2003, PSYCHOL RES-PSYCH FO, V67, P153, DOI 10.1007/s00426-002-0114-5; Kunde W, 2001, J EXP PSYCHOL HUMAN, V27, P387, DOI 10.1037//0096-1523.27.2.387; Lakens Daniel, 2013, Front Psychol, V4, P863, DOI 10.3389/fpsyg.2013.00863; Ma K, 2015, CONSCIOUS COGN, V36, P277, DOI 10.1016/j.concog.2015.07.008; Ma K, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00604; May J, 2011, SOUTHERN J PHILOS, V49, P25, DOI 10.1111/j.2041-6962.2011.00055.x; Michelon P, 2006, PERCEPT PSYCHOPHYS, V68, P327, DOI 10.3758/BF03193680; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; Musseler J, 2019, Q J EXP PSYCHOL, V72, P1539, DOI 10.1177/1747021818799240; Musseler J, 2011, HUM FACTORS, V53, P383, DOI 10.1177/0018720811408599; Ottoboni G, 2005, J EXP PSYCHOL HUMAN, V31, P778, DOI 10.1037/0096-1523.31.4.778; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pfister R, 2017, ATTEN PERCEPT PSYCHO, V79, P2132, DOI 10.3758/s13414-017-1371-0; Proctor R.W., 2006, STIMULUS RESPONSE CO; Schurz M, 2015, NEUROIMAGE, V117, P386, DOI 10.1016/j.neuroimage.2015.04.031; Surtees A, 2013, COGNITION, V129, P426, DOI 10.1016/j.cognition.2013.06.008; Waltemate T, 2018, IEEE T VIS COMPUT GR, V24, P1643, DOI 10.1109/TVCG.2018.2794629	42	9	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220817	10.1371/journal.pone.0220817	http://dx.doi.org/10.1371/journal.pone.0220817			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5FL	31398233	Green Published, Green Submitted, gold			2022-12-26	WOS:000485004000023
J	Chanvatik, S; Kosiyaporn, H; Lekagul, A; Kaewkhankhaeng, W; Vongmongkol, V; Thunyahan, A; Tangcharoensathien, V				Chanvatik, Sunicha; Kosiyaporn, Hathairat; Lekagul, Angkana; Kaewkhankhaeng, Wanwisa; Vongmongkol, Vuthiphan; Thunyahan, Apichart; Tangcharoensathien, Viroj			Knowledge and use of antibiotics in Thailand: A 2017 national household survey	PLOS ONE			English	Article							PUBLICS KNOWLEDGE; SELF-MEDICATION; ATTITUDES; POPULATION; RESISTANCE; COMMUNITY; BEHAVIOR; INTERNET; BELIEFS	Background The Thailand National Strategic Plan on Antimicrobial Resistance (AMR) 2017-2021, endorsed by the Thai Cabinet in 2016, aims to increase public knowledge about antibiotics and AMR awareness by 20% by 2021. This study assesses the prevalence of antibiotics use, clinical indications and sources; knowledge and access to information related to antibiotics and AMR; and factors related to level of knowledge and access to information among Thai adult population. Methods An AMR module was developed and embedded into the 2017 Health and Welfare Survey; a cross-sectional, two-stage stratified sampling, nationally representative household survey carried out biannually by National Statistical Office. The survey applied a structured interview questionnaire. The survey was conducted in March 2017 where 27,762 Thai adults were interviewed of the AMR module. Data were analyzed using descriptive and inferential statistics. Results The one-month prevalence of antibiotic use was 7.9% for three common conditions; flu (27.0%), fever (19.2%) and sore throat (16.8%). The majority of antibiotics (70.3%) were provided by public or private healthcare facilities, and 26.7% by pharmacies. Thai adults have low levels of knowledge about antibiotics; only 2.6 gave correct answers to all six statements related to antibiotics, while 13.5% gave wrong answers to all six statements. A few factors associated with knowledge and having received information on antibiotics were assessed. People who have higher education levels, and belong to richer wealth quintiles, and receive antibiotics and AMR information have significantly higher levels of knowledge about antibiotics. In the last 12 months, only 17.8% of respondents had heard information about the proper use of antibiotics and AMR; mostly from doctors (36.1%), health workers (24.8%) and pharmacists (17.7%). Conclusions There is a large gap of public knowledge about the use of antibiotics. The main communication channel is through healthcare professionals, which indicates they are key persons in communicating information about the proper use of antibiotics to the public.	[Chanvatik, Sunicha; Kosiyaporn, Hathairat; Lekagul, Angkana; Kaewkhankhaeng, Wanwisa; Vongmongkol, Vuthiphan; Tangcharoensathien, Viroj] Minist Publ Hlth, Int Hlth Policy Program, Nonthaburi, Thailand; [Thunyahan, Apichart] Minist Informat & Commun Technol, Natl Stat Off, Bangkok, Thailand	Ministry of Public Health - Thailand	Chanvatik, S (corresponding author), Minist Publ Hlth, Int Hlth Policy Program, Nonthaburi, Thailand.	sunicha.c@gmail.com		Vongmongkol, Vuthiphan/0000-0002-7603-2557; Lekagul, Angkana/0000-0002-7335-9028; Chanvatik, Sunicha/0000-0001-8645-5097	International Health Policy Program, Ministry of Public Health, Thailand	International Health Policy Program, Ministry of Public Health, Thailand	Funded studies: The core funding was from International Health Policy Program, Ministry of Public Health, Thailand, which support staff costs and the preparation of antimicrobial resistance module in Health and Welfare Survey and data analysis. http://www.ihppthaigov.net/.	Anderson A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204878; Andre M, 2010, J ANTIMICROB CHEMOTH, V65, P1292, DOI 10.1093/jac/dkq104; [Anonymous], 2017, THAIL NAT STRAT PLAN; Auta A, 2013, TROP J PHARM RES, V12, P1087, DOI 10.4314/tjpr.v12i6.33; Bassoum O, 2018, PHARMACY-BASEL, V6, DOI 10.3390/pharmacy6040103; Bert F, 2017, EUR J PUBLIC HEALTH, V27, P506, DOI 10.1093/eurpub/ckw209; Cals JWL, 2007, BRIT J GEN PRACT, V57, P942, DOI 10.3399/096016407782605027; Chan YH, 2012, AM J INFECT CONTROL, V40, P113, DOI 10.1016/j.ajic.2011.03.017; European Commission, 2016, FLASH EUR 444 SEPT O; European Commission, 2018, SPEC EUR 478 NOV 201; European Commission, 2016, SPEC EUR 445 APR 201; European Commission, 2010, SPEC EUR 338 APR 201; Lescure D, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00370; Lim Ka Keat, 2012, South Med Rev, V5, P26; Limaye D, 2017, ANN MED HEALTH SCI R, V7, P1; Mazinska B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172146; McNulty CAM, 2007, J ANTIMICROB CHEMOTH, V59, P727, DOI 10.1093/jac/dkl558; McNulty CAM, 2010, J ANTIMICROB CHEMOTH, V65, P1526, DOI 10.1093/jac/dkq126; Mouhieddine TH, 2015, J INFECT PUBLIC HEAL, V8, P20, DOI 10.1016/j.jiph.2014.07.010; Napolitano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084177; Nepal G, 2018, CUREUS, V10, DOI 10.7759/cureus.2428; Oyindamola J., 2016, THESIS; Pavyde E, 2015, INT J ENV RES PUB HE, V12, P7002, DOI 10.3390/ijerph120607002; Raupach-Rosin H, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00776; Salm F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193336; Shehadeh M, 2012, SAUDI PHARM J, V20, P125, DOI 10.1016/j.jsps.2011.11.005; Taha AA, 2013, ZOONOSES PUBLIC HLTH, V12, P1087; Tangcharoensathien V, 2018, LANCET, V391, P1205, DOI 10.1016/S0140-6736(18)30198-3; WHO, 2017, WHO GUID ETH ISS PUB; WHO, 2015, ANT RES MULT PUBL AW; WHO, 2015, GLOB ACT PLAN ANT RE, DOI DOI 10.1128/MICROBE.10.354.1; World Health Organization, 2017, STRATEGIC FRAMEWORK; Zucco R, 2018, INT J MED INFORM, V111, P131, DOI 10.1016/j.ijmedinf.2017.12.005	33	25	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220990	10.1371/journal.pone.0220990	http://dx.doi.org/10.1371/journal.pone.0220990			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398242	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000485004000037
J	Jarvis, JD; Woods, H; Bali, A; Oronsaye, E; Persaud, N				Jarvis, Jordan D.; Woods, Hannah; Bali, Anjli; Oronsaye, Efosa; Persaud, Nav			Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists	PLOS ONE			English	Article							COUNTRIES	Background Non-communicable diseases (NCDs) are the leading cause of death worldwide. Inadequate and inequitable access to essential NCD medicines is a major concern, particularly in low and middle-income countries. National Essential Medicines Lists (EMLs) are important policy tools that indicate which medicines are prioritized as essential within a country's health system. This study sought to analyze a wide range of national essential medicines lists (EMLs) for their inclusion of priority non communicable disease (NCD) interventions recommended by the World Health Organization (WHO). Methods Three lists of WHO endorsed priority NCD interventions were included. A database with 137 national EMLs and the WHO EML was created from the WHO Repository and these EMLs were compared for listing of priority NCD interventions. Results Across 137 countries with national EMLs, the median percentage of 20 Best Buys interventions listed was 90% (IQR 80-95) and 31 Package of essential noncommunicable disease interventions (PEN) interventions listed was 94% (IQR 90-97), of 9 HEARTS interventions was 100% (IQR 89-100), and of the 43 unique interventions across the three priority lists was 88% (IQR 84-93). Less than 80% of the 43 interventions were listed by 22 (16%) countries and less than half of the interventions were listed by 2 countries: Angola (35%) and Cambodia (23%). Interventions listed on the fewest number of national EMLs were: influenza vaccine, HPV vaccine, hepatitis B vaccine, cervical cancer chemotherapy, codeine, promethazine, senna, and oxygen. Conclusion Most NCD interventions have been prioritized in national policy in most cases. The majority of priority medicines for NCDs described within key WHO NCD technical packages are listed on nearly all national EMLs across 137 countries of all income levels. Most NCD interventions have been prioritized in national policy in most cases, but in some countries and for select interventions such as the HPV vaccine, prioritization may be reviewed.	[Jarvis, Jordan D.] London Sch Hyg & Trop Med, London, England; [Jarvis, Jordan D.; Woods, Hannah; Bali, Anjli; Oronsaye, Efosa; Persaud, Nav] St Michaels Hosp, Ctr Urban Hlth Solut, Toronto, ON, Canada; [Persaud, Nav] St Michaels Hosp, Dept Family & Community Med, Toronto, ON, Canada	University of London; London School of Hygiene & Tropical Medicine; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Persaud, N (corresponding author), St Michaels Hosp, Ctr Urban Hlth Solut, Toronto, ON, Canada.; Persaud, N (corresponding author), St Michaels Hosp, Dept Family & Community Med, Toronto, ON, Canada.	nav.persaud@utoronto.ca		Jarvis, Jordan/0000-0001-9994-1748	Canadian Institutes of Health Research [381409]; Ontario SPOR (Strategy for Patient Oriented Research) Support Unit	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario SPOR (Strategy for Patient Oriented Research) Support Unit	The authors received funding from Canadian Institutes of Health Research (grant 381409 to NP) and Ontario SPOR (Strategy for Patient Oriented Research) Support Unit (http://www.cihr-irsc.gc.ca/e/45859.html). The funding sources were all governmental. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors (JJ, HW, AB, EO, NP) have not entered into any agreement with the funder that may have limited their ability to complete the research as planned. The authors (JJ, HW, AB, EO, NP) have full access and control of all primary data.	[Anonymous], 2017, BAS LIN SURV REP SOI; [Anonymous], 2017, NAT ESS MED LISTS NE; Bazargani YT, 2014, THORAX, V69, P1149, DOI 10.1136/thoraxjnl-2014-205249; Bazargani YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106072; Bazargani YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087576; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Chido-Amajuoyi OG, 2019, CALL INTRO GEN NEUTR, V7; Chivukula Meenakshi V, 2018, WHO South East Asia J Public Health, V7, P90, DOI 10.4103/2224-3151.239420; Cuomo RE, 2017, J Cancer Policy, V12, P49, DOI 10.1016/j.jcpo.2017.03.010; Ewen M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171284; Gallagher KE, 2018, VACCINE, V36, P4761, DOI 10.1016/j.vaccine.2018.02.003; Graham JE, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-27; Knaul FM, 2018, J GLOB ONCOL, V4, DOI 10.1200/JGO.17.00190; Mehrtash H, 2018, E MEDITERR HEALTH J, V24, P427, DOI 10.26719/2018.24.5.427; Neuzil KM, 2017, VACCINE, V35, P5734, DOI 10.1016/j.vaccine.2017.08.088; Parkhurst JO, 2019, CERVICAL CANC GLOBAL, V8, DOI [10.1080/17441692.2013.850524, DOI 10.1080/17441692.2013.850524]; Persaud N, 2019, B WHO; Persaud N, WHO B UNPUB; Rowlands A, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000114; Tsu VD, 2019, INVESTMENT CASE CERV, V138, P69; US Food and Drug Administration, 2009, GARD VACC SAF; WHO Collaborating Centre for Drugs Statistics Methodology, 2018, ATC DDD IND 2018; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Wigle J, 2013, VACCINE, V31, P3811, DOI 10.1016/j.vaccine.2013.06.016; Wirtz VJ, 2017, LANCET, V389, P403, DOI 10.1016/S0140-6736(16)31599-9; World Health Organization, 2019, WORLD MED SITUATION; World Health Organization, 2019, GLOB ACT PLAN PREV C; World Health Organization, 2018, GLOB HLTH OBS GHO DA; World Health Organization, 2018, HLTH FIN UN COV, P1; World Health Organization, 2018, WORLD HLTH STAT 2018; World Health Organization, 2019, AFF VACC KEY SCAL HP; World Health Organization, 2019, PACK ESS NONC PEN DI; World Health Organization, 2018, ESS MED	34	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220781	10.1371/journal.pone.0220781	http://dx.doi.org/10.1371/journal.pone.0220781			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398195	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000485004000018
J	Zhang, K; Yun, SD; Triphan, SMF; Sturm, VJ; Buschle, LR; Hahn, A; Heiland, S; Bendszus, M; Schlemmer, HP; Shah, NJ; Ziener, CH; Kurz, FT				Zhang, Ke; Yun, Seong Dae; Triphan, Simon M. F.; Sturm, Volker J.; Buschle, Lukas R.; Hahn, Artur; Heiland, Sabine; Bendszus, Martin; Schlemmer, Heinz-Peter; Shah, N. Jon; Ziener, Christian H.; Kurz, Felix T.			Vessel architecture imaging using multiband gradient-echo/spin-echo EPI	PLOS ONE			English	Article							SPIN-ECHO; CONTRAST; PERFUSION; SIZE; EXCITATION; DIFFUSION; IMPACT; GRADE	Objectives To apply the MB (multiband) excitation and blipped-CAIPI (blipped-controlled aliasing in parallel imaging) techniques in a spin and gradient-echo (SAGE) EPI sequence to improve the slice coverage for vessel architecture imaging (VAI). Materials and methods Both MB excitation and blipped-CAIPI with in-plane parallel imaging were incorporated into a gradient-echo (GE)/spin-echo (SE) EPI sequence for simultaneous tracking of the dynamic MR signal changes in both GE and SE contrasts after the injection of contrast agent. MB and singleband (SB) excitation were compared using a 20-channel head coil at 3 Tesla, and high-resolution MB VAI could be performed in 32 glioma patients. Results Whole-brain covered high resolution VAI can be achieved after applying multiband excitation with a factor of 2 and in-plane parallel imaging with a factor of 3. The quality of the images resulting from MB acceleration was comparable to those from the SB method: images were reconstructed without any loss of spatial resolution or severe distortions. In addition, MB and SB signal-to-noise ratios (SNR) were similar. A relative low g-factor induced from the MB acceleration method was achieved after using a blipped-CAIPI technique (1.35 for GE and 1.33 for SE imaging). Performing quantitative VAI, we found that, among all VAI parametric maps, microvessel type indicator (MTI), distance map (I) and vascular-induced bolus peak-time shift (VIPS) were highly correlated. Likewise, VAI parametric maps of slope, slope length and short axis were highly correlated. Conclusions Multiband accelerated SAGE successfully doubles the number of readout slices in the same measurement time when compared to conventional readout sequences. The corresponding VAI parametric maps provide insights into the complexity and heterogeneity of vascular changes in glioma.	[Zhang, Ke; Sturm, Volker J.; Buschle, Lukas R.; Schlemmer, Heinz-Peter; Ziener, Christian H.; Kurz, Felix T.] German Canc Res Ctr, Dept Radiol, Heidelberg, Germany; [Zhang, Ke; Sturm, Volker J.; Buschle, Lukas R.; Hahn, Artur; Heiland, Sabine; Bendszus, Martin; Ziener, Christian H.; Kurz, Felix T.] Heidelberg Univ Hosp, Dept Neuroradiol, Heidelberg, Germany; [Yun, Seong Dae; Shah, N. Jon] Forschungszentrum Julich, Inst Neurosci & Med 4, Med Imaging Phys, Julich, Germany; [Triphan, Simon M. F.] Heidelberg Univ Hosp, Dept Diagnost & Intervent Radiol, Heidelberg, Germany; [Hahn, Artur] Heidelberg Univ, Dept Phys & Astron, Heidelberg, Germany; [Shah, N. Jon] Rhein Westfal TH Aachen, Dept Neurol, Fac Med, JARA, Aachen, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; Research Center Julich; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; RWTH Aachen University	Kurz, FT (corresponding author), German Canc Res Ctr, Dept Radiol, Heidelberg, Germany.; Kurz, FT (corresponding author), Heidelberg Univ Hosp, Dept Neuroradiol, Heidelberg, Germany.	felix.kurz@med.uni-heidelberg.de	Hahn, Artur/AAV-2513-2020; Ziener, Christian/AAN-8411-2021; Shah, N. Jon/H-5849-2013	Hahn, Artur/0000-0002-4493-3887; Shah, N. Jon/0000-0002-8151-6169; Yun, Seong Dae/0000-0001-7398-1899; Ziener, Christian/0000-0001-8854-7358	Deutsche Forschungsgemeinschaft [DFG ZI 1295/2-1, DFG KU 3555/1-1]; medical faculty of Heidelberg University; Hoffmann-Klose foundation of Heidelberg University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); medical faculty of Heidelberg University; Hoffmann-Klose foundation of Heidelberg University	This work was supported by grants from the Deutsche Forschungsgemeinschaft (Contract Grant number: DFG ZI 1295/2-1 and DFG KU 3555/1-1). F. T. Kurz was supported by a postdoctoral fellowship from the medical faculty of Heidelberg University and the Hoffmann-Klose foundation of Heidelberg University.	Auerbach EJ, 2013, MAGN RESON MED, V69, P1261, DOI 10.1002/mrm.24719; Bonekamp D, 2017, J CEREBR BLOOD F MET, V37, P485, DOI 10.1177/0271678X16630322; Boxerman JL, 2006, AM J NEURORADIOL, V27, P859; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P555, DOI 10.1002/mrm.1910340412; Buschle LR, 2018, MAGN RESON MATER PHY, V31, P531, DOI 10.1007/s10334-018-0677-9; Chiacchiaretta P, 2013, NEUROIMAGE, V82, P35, DOI 10.1016/j.neuroimage.2013.05.069; Eichner C, 2014, MAGN RESON MED, V72, P949, DOI 10.1002/mrm.25389; Eichner C, 2014, MAGN RESON MED, V72, P770, DOI 10.1002/mrm.24960; Emblem KE, 2013, NAT MED, V19, P1178, DOI 10.1038/nm.3289; Firbank MJ, 1999, PHYS MED BIOL, V44, pN261, DOI 10.1088/0031-9155/44/12/403; Helenius J, 2002, AM J NEURORADIOL, V23, P194; Hsu YY, 2009, J MAGN RESON IMAGING, V30, P1078, DOI 10.1002/jmri.21960; Khatamian YB, 2016, BRAIN CONNECT, V6, P283, DOI 10.1089/brain.2015.0365; Kickingereder P, 2014, RADIOLOGY, V272, P843, DOI 10.1148/radiol.14132740; Kim T, 2013, MAGN RESON MED, V70, P1653, DOI 10.1002/mrm.24880; Kiselev VG, 2005, MAGNET RESON MED, V53, P553, DOI 10.1002/mrm.20383; Kurz FT, 2016, J MAGN RESON, V273, P83, DOI 10.1016/j.jmr.2016.10.012; Kurz FT, 2016, MAGN RESON IMAGING, V34, P875, DOI 10.1016/j.mri.2016.03.016; Larkman DJ, 2001, J MAGN RESON IMAGING, V13, P313, DOI 10.1002/1522-2586(200102)13:2<313::AID-JMRI1045>3.0.CO;2-W; Lu H, 2008, AM J NEURORADIOL, V29, P373, DOI 10.3174/ajnr.A0794; Rausch M, 2000, MAGN RESON IMAGING, V18, P1235, DOI 10.1016/S0730-725X(00)00219-8; Schmiedeskamp H, 2012, MAGN RESON MED, V68, P30, DOI 10.1002/mrm.23195; Schwarzbauer C, 2010, NEUROIMAGE, V49, P316, DOI 10.1016/j.neuroimage.2009.08.032; Setsompop K, 2012, MAGN RESON MED, V67, P1210, DOI 10.1002/mrm.23097; Sigfridsson A, 2015, MAGN RESON MED, V73, P1713, DOI 10.1002/mrm.25294; Stadlbauer A, 2017, RADIOLOGY, V283, P798, DOI 10.1148/radiol.2016161422; Stadlbauer A, 2017, J CEREBR BLOOD F MET, V37, P632, DOI 10.1177/0271678X16655549; Wong E., 2012, P ISMRM, P2209; Wu JJ, 2019, MAGN RESON MED, V81, P1755, DOI 10.1002/mrm.27532; Xu C, 2013, MAGN RESON MED, V69, P981, DOI 10.1002/mrm.24326; Xu C, 2011, J CEREBR BLOOD F MET, V31, P1687, DOI 10.1038/jcbfm.2011.38; Zhang K, 2019, MAGN RESON IMAGING, V57, P359, DOI 10.1016/j.mri.2018.11.018	32	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220939	10.1371/journal.pone.0220939	http://dx.doi.org/10.1371/journal.pone.0220939			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398234	Green Submitted, Green Published, gold			2022-12-26	WOS:000485004000029
J	Matsushita, K; Sang, YY; Yang, C; Ballew, SH; Grams, ME; Coresh, J; Molnar, MZ				Matsushita, Kunihiro; Sang, Yingying; Yang, Chao; Ballew, Shoshana H.; Grams, Morgan E.; Coresh, Josef; Molnar, Miklos Z.			Dyskalemia, its patterns, and prognosis among patients with incident heart failure: A nationwide study of US veterans	PLOS ONE			English	Article							SERUM POTASSIUM LEVELS; ATHEROSCLEROSIS RISK; MORTALITY; HYPERKALEMIA; ASSOCIATION; PREDICTORS; OUTCOMES; DISEASE; EVENTS; RACE	Background Although hypokalemia has been viewed as a significant concern among patients with heart failure (HF), recent advances in HF management tend to increase the risk of hyperkalemia. Objective To characterize contemporary data regarding correlates and prognostic values of dyskalemia in patients with HF. Design, setting, and participants In cross-sectional and longitudinal analyses, we studied 142,087 patients with newly diagnosed HF in US nationwide Veterans Administration database from 2005 through 2013. Exposures Demographic characteristics, laboratory variables, comorbidities, and medication use for the analysis of correlates of dyskalemia as well as potassium level in the analysis of mortality. Main Outcomes and Measures Dyskalemia and mortality. Results Hypokalemia (<3.5 mmol/L) at baseline was observed in 3.0% of the population, whereas hyperkalemia (>= 5.5 mmol/L) was seen in 0.9%. An additional 20.4% and 5.7% had mild hypokalemia (3.5-3.9 mmol/L) and mild hyperkalemia (5.0-5.4 mmol/L). Key correlates were black race, higher blood pressure, and use of potassium-wasting diuretics for hypokalemia, and lower kidney function for hyperkalemia. Baseline potassium levels showed a U-shaped association with mortality, with the lowest risk between 4.0-4.5 mmol/L. With respect to potassium levels over a year after HF diagnosis, persistent (>50% of measurements), intermittent (> 1 occurrence but <= 50%), and transient (1 occurrence) hypo- and hyperkalemia were also related to increased mortality in a graded fashion regardless of the aforementioned thresholds for dyskalemia. These dyskalemic patterns were also related to other clinical actions and demands such as emergency room visit. Conclusions Potassium levels below 4 mmol/L and above 5 mmol/L at and after HF diagnosis were associated with poor prognosis and the clinical actions. HF patients (particularly with risk factors for dyskalemia like black race and kidney dysfunction) may require special attention for both hypo- and hyperkalemia.	[Matsushita, Kunihiro; Sang, Yingying; Yang, Chao; Ballew, Shoshana H.; Grams, Morgan E.; Coresh, Josef] Johns Hopkins Univ, Baltimore, MD 21218 USA; [Molnar, Miklos Z.] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA	Johns Hopkins University; University of Tennessee System; University of Tennessee Health Science Center	Matsushita, K (corresponding author), Johns Hopkins Univ, Baltimore, MD 21218 USA.	kuni.matsushita@jhu.edu	Yang, Chao/AGR-0453-2022; Matsushita, Kunihiro/AAJ-5817-2020	Matsushita, Kunihiro/0000-0002-7179-718X	National Kidney Foundation; (Relypsa); National Institute of Diabetes and Digestive and Kidney Diseases [R01DK100446-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100446] Funding Source: NIH RePORTER	National Kidney Foundation; (Relypsa); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Kidney Foundation (funding sources include Relypsa) as well as the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK100446-01) to JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SK., 2014, CIRCULATION, V129, pAP024; Ahmed A, 2007, EUR HEART J, V28, P1334, DOI 10.1093/eurheartj/ehm091; Ahmed MI, 2010, INT J CARDIOL, V144, P383, DOI 10.1016/j.ijcard.2009.04.041; Bielecka-Dabrowa A, 2012, INT J CARDIOL, V158, P12, DOI 10.1016/j.ijcard.2011.06.121; Camplain R, 2017, PHARMACOEPIDEM DR S, V26, P421, DOI 10.1002/pds.4162; Chang AR, 2016, HYPERTENSION, V67, P1181, DOI 10.1161/HYPERTENSIONAHA.116.07363; Chen Y, 2017, AM J KIDNEY DIS, V70, P244, DOI 10.1053/j.ajkd.2017.01.044; CLELAND JGF, 1987, BRIT HEART J, V58, P572; Cooper HA, 1999, CIRCULATION, V100, P1311, DOI 10.1161/01.CIR.100.12.1311; Desai AS, 2007, J AM COLL CARDIOL, V50, P1959, DOI 10.1016/j.jacc.2007.07.067; Gerber Y, 2015, JAMA INTERN MED, V175, P996, DOI 10.1001/jamainternmed.2015.0924; Gosmanova EO, 2014, HYPERTENSION, V64, P951, DOI 10.1161/HYPERTENSIONAHA.114.03805; Heerspink HJL, 2014, EUR J PREV CARDIOL, V21, P299, DOI 10.1177/2047487313510678; Hoss S, 2016, AM J CARDIOL, V118, P1868, DOI 10.1016/j.amjcard.2016.08.078; Kovesdy CP, 2015, CIRCULATION, V132, P1538, DOI 10.1161/CIRCULATIONAHA.114.015124; Kovesdy CP, 2013, ANN INTERN MED, V159, P233, DOI 10.7326/0003-4819-159-4-201308200-00004; Krogager ML, 2015, EUR HEART J-CARD PHA, V1, P245, DOI 10.1093/ehjcvp/pvv026; Leto L, 2014, HEART FAIL REV, V19, P237, DOI 10.1007/s10741-012-9354-7; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Macdonald JE, 2004, J AM COLL CARDIOL, V43, P155, DOI 10.1016/j.jacc.2003.06.021; Nehler MR, 2014, J VASC SURG, V60, P686, DOI 10.1016/j.jvs.2014.03.290; NORDREHAUG JE, 1985, CIRCULATION, V71, P645, DOI 10.1161/01.CIR.71.4.645; Poggio R, 2010, POSTGRAD MED J, V86, P136, DOI 10.1136/pgmj.2008.072058; Quach S, 2010, CAN J CARDIOL, V26, pE306, DOI 10.1016/S0828-282X(10)70438-4; Rosamond WD, 2012, CIRC-HEART FAIL, V5, P152, DOI 10.1161/CIRCHEARTFAILURE.111.963199; Sumida K, 2017, J AM SOC NEPHROL, V28, P1248, DOI 10.1681/ASN.2016060656; Vardeny O, 2014, CIRC-HEART FAIL, V7, P573, DOI 10.1161/CIRCHEARTFAILURE.114.001104	27	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0219899	10.1371/journal.pone.0219899	http://dx.doi.org/10.1371/journal.pone.0219899			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393910	Green Submitted, gold, Green Published			2022-12-26	WOS:000485002500019
J	de Arellano, ER; Diez-Fuertes, F; Aguilar, F; Tarazona, HED; Sanchez-Lara, S; Lao, Y; Vicario, JL; Garcia, F; Gonzalez-Garcia, J; Pulido, F; Gutierrez-Rodero, FPL; Moreno, S; Iribarren, JA; Viciana, P; Vilches, C; Ramos, M; Capa, L; Alcami, J; Del Val, M				Ramirez de Arellano, Eva; Diez-Fuertes, Francisco; Aguilar, Francisco; de la Torre Tarazona, Humberto Erick; Sanchez-Lara, Susana; Lao, Yolanda; Luis Vicario, Jose; Garcia, Felipe; Gonzalez-Garcia, Juan; Pulido, Federico; Gutierrez-Rodero, Felix; Moreno, Santiago; Antonio Iribarren, Jose; Viciana, Pompeyo; Vilches, Carlos; Ramos, Manuel; Capa, Laura; Alcami, Jose; Del Val, Margarita			Novel association of five HLA alleles with HIV-1 progression in Spanish long-term non progressor patients	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CLASS-I ALLELES; GENETIC RESTRICTION; INFECTION; AIDS; POLYMORPHISM; REPLICATION; COHORT; SUSCEPTIBILITY; NONPROGRESSION	Certain host genetic variants, especially in the human leucocyte antigen (HLA) region, are associated with different progression of HIV-1-induced diseases and AIDS. Long term non progressors (LTNP) represent only the 2% of infected patients but are especially relevant because of their efficient HIV control. In this work we present a global analysis of genetic data in the large national multicenter cohort of Spanish LTNP, which is compared with seronegative individuals and HIV-positive patients. We have analyzed whether several single-nucleotide polymorphisms (SNPs) including in key genes and certain HLA-A and B alleles could be associated with a specific HIV phenotype. A total of 846 individuals, 398 HIV-1-positive patients (213 typical progressors, 55 AIDS patients, and 130 LTNPs) and 448 HIV-negative controls, were genotyped for 15 polymorphisms and HLA-A and B alleles. Significant differences in the allele frequencies among the studied populations identified 16 LTNP-associated genetic factors, 5 of which were defined for the first time as related to LTNP phenotype: the protective effect of HLA-B39, and the detrimental impact of HLA-B18, -A24, -B08 and -A29. The remaining eleven polymorphisms confirmed previous publications, including the protective alleles HLA-B57, rs2395029 (HCP5), HLA bw4 homozygosity, HLA-B52, HLA-B27, CCR2 V64I, rs9264942 (HLA-C) and HLA-A03; and the risk allele HLA bw6 homozygosity. Notably, individual Spanish HIV-negative individuals had an average of 0.12 protective HLA alleles and SNPs, compared with an average of 1.43 protective alleles per LTNP patient, strongly suggesting positive selection of LTNP. Finally, stratification of LTNP according to viral load showed a proportional relationship between the frequency of protective alleles with control of viral load. Interestingly, no differences in the frequency of protection/risk polymorphisms were found between elite controllers and LTNPs maintaining viral loads <2.000 copies/mL throughout the follow-up.	[Ramirez de Arellano, Eva; Diez-Fuertes, Francisco; Aguilar, Francisco; de la Torre Tarazona, Humberto Erick; Sanchez-Lara, Susana; Lao, Yolanda; Ramos, Manuel; Capa, Laura; Alcami, Jose; Del Val, Margarita] Inst Salud Carlos III, Natl Ctr Microbiol, Madrid, Spain; [Diez-Fuertes, Francisco; Garcia, Felipe; Gonzalez-Garcia, Juan; Alcami, Jose] Univ Barcelona, Hosp Clin, IBIDAPS, Infect Dis Unit, Barcelona, Spain; [Sanchez-Lara, Susana; Ramos, Manuel; Del Val, Margarita] UAM, CSIC, Ctr Biol Mol Severo Ochoa, Viral Immunol, Madrid, Spain; [Luis Vicario, Jose] Ctr Transfus Madrid, Dept Histocompatibilidad, Madrid, Spain; [Gonzalez-Garcia, Juan] Hosp Univ La Paz, Madrid, Spain; [Pulido, Federico] Inst Invest Hosp 12 Octubre I 12, HIV Unit, Madrid, Spain; [Gutierrez-Rodero, Felix] Hosp Gen Univ Elche, Serv Med Interna, Unidad Enfermedades Infecciosas, Alicante, Spain; [Moreno, Santiago] Hosp Ramon & Cajal, Infect Dis, Madrid, Spain; [Antonio Iribarren, Jose] Hosp Univ Donostia, San Sebastian, Spain; [Viciana, Pompeyo] Univ Seville, Virgen Rocio Univ Hosp, IBIS CSIC SAS,Lab Immunovirol, Biomed Inst Sevilla,Clin Unit Infect Dis Microbio, Seville, Spain; [Vilches, Carlos] Inst Invest Sanitaria Puerta Hierro, Inmunogenet & Histocompatibilidad, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); University of Barcelona; Hospital Clinic de Barcelona; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Hospital Universitario La Paz; Hospital Universitario 12 de Octubre; Hospital Universitario Ramon y Cajal; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Hospital Puerta de Hierro-Majadahonda	de Arellano, ER (corresponding author), Inst Salud Carlos III, Natl Ctr Microbiol, Madrid, Spain.	erarellano75@gmail.com	Del Val, Margarita/E-4769-2010; Ramos, Manuel/F-5076-2016; Díez-Fuertes, Francisco/AAA-9427-2019; Vilches, Carlos/AAG-9203-2021; , Felipe/F-4242-2014; Iribarren, José/AAK-5528-2021; Pulido, Federico/B-8417-2009; Vilches, Carlos/G-1471-2012; Alcami, Pepe/T-2242-2018; Gutierrez, Felix/Q-7880-2018	Del Val, Margarita/0000-0001-6769-4279; Ramos, Manuel/0000-0002-0404-7936; Díez-Fuertes, Francisco/0000-0003-2413-9229; , Felipe/0000-0001-7658-5832; Pulido, Federico/0000-0002-7414-8812; Vilches, Carlos/0000-0002-0300-9225; Alcami, Pepe/0000-0003-0023-7377; De La Torre Tarazona, Humberto Erick/0000-0003-0325-3735; Gutierrez, Felix/0000-0002-9485-6867; Sanchez Lara, Susana/0000-0002-7391-2081; Capa, Laura/0000-0002-0234-331X; Gonzalez-Garcia, Juan/0000-0002-3652-002X	Instituto de Salud Carlos III from the Spanish Ministry of Health, through Red Tematica de Investigacion Cooperativa en SIDA (RIS) [G03/173(2), PI050528, RD06/0006/0033, RD06/0006/0035, RD12/0017/0037, C03/173, RD12/0017/0018]; ISCIII-Subdireccion General de Evaluacion; Fondo Europeo de Desarrollo Regional (FEDER); Plan Nacional I+ D+ I from the Spanish Ministry of Science and Technology [SAF2007-60934, SAF2010-18917, SAF201348754-C2-1-R]; Instituto de Salud Carlos III [Intrasalud PI12/0056]; Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE); Fundacion Ramon Areces; Banco de Santander; Spanish Government's "Sara Borrell" postdoctoral program [CD12/00515]	Instituto de Salud Carlos III from the Spanish Ministry of Health, through Red Tematica de Investigacion Cooperativa en SIDA (RIS); ISCIII-Subdireccion General de Evaluacion; Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Plan Nacional I+ D+ I from the Spanish Ministry of Science and Technology; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE); Fundacion Ramon Areces; Banco de Santander; Spanish Government's "Sara Borrell" postdoctoral program	This work was supported by Instituto de Salud Carlos III from the Spanish Ministry of Health, through Red Tematica de Investigacion Cooperativa en SIDA (RIS) [G03/173(2), PI050528 and RD06/0006/0033 to MDV, RD06/0006/0035 and RD12/0017/0037 to the HIV BioBank, and C03/173 and RD12/0017/0018 to CoRIS], cofinanced by ISCIII-Subdireccion General de Evaluacion and Fondo Europeo de Desarrollo Regional (FEDER), and also financed by Plan Nacional I+ D+ I from the Spanish Ministry of Science and Technology [SAF2007-60934, SAF2010-18917 and SAF201348754-C2-1-R to MDV], by Instituto de Salud Carlos III [Intrasalud PI12/0056 to JA] and by Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE) [to HIV Biobank]. Institutional grants from the Fundacion Ramon Areces and Banco de Santander to the CBMSO are also acknowledged. FDF is supported by the Spanish Government's "Sara Borrell" postdoctoral program CD12/00515. The funders had no role in study design, decision to publish, analysis and preparation of the manuscript.	Balas A, 2011, TISSUE ANTIGENS, V77, P45, DOI 10.1111/j.1399-0039.2010.01578.x; Ballana E, 2012, IMMUNOBIOLOGY, V217, P889, DOI 10.1016/j.imbio.2011.12.012; Ballana E, 2010, CLIN INFECT DIS, V50, P1022, DOI 10.1086/651114; Bartha I, 2013, ELIFE, V2, DOI 10.7554/eLife.01123; Caro-Murillo AM, 2007, ENFERM INFEC MICR CL, V25, P23, DOI 10.1157/13096749; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Casado C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011079; Chaudhari DV, 2013, IMMUNOL LETT, V156, P1, DOI 10.1016/j.imlet.2013.09.002; Chikata T, 2017, J INFECT DIS, V216, P1415, DOI 10.1093/infdis/jix483; Dalmasso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003907; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; de Sorrentino AH, 2000, J INFECT DIS, V182, P1523, DOI 10.1086/315854; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Farquhar C, 2004, AIDS RES HUM RETROV, V20, P692, DOI 10.1089/0889222041524616; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Flores-Villanueva PO, 2001, P NATL ACAD SCI USA, V98, P5140, DOI 10.1073/pnas.071548198; Furutsuki T, 2004, J VIROL, V78, P8437, DOI 10.1128/JVI.78.16.8437-8445.2004; Gao XJ, 2010, AIDS, V24, P1835, DOI 10.1097/QAD.0b013e32833c3219; Gao XJ, 2005, NAT MED, V11, P1290, DOI 10.1038/nm1333; Garcia-Merino I, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-27; Ghezzi S, 2013, AIDS, V27, P2335, DOI 10.1097/01.aids.0000432474.76873.5f; Goulder PJR, 1997, AIDS, V11, P1883, DOI 10.1097/00002030-199715000-00015; Guergnon J, 2012, J INFECT DIS, V205, P718, DOI 10.1093/infdis/jir833; KASLOW RA, 1990, LANCET, V335, P927, DOI 10.1016/0140-6736(90)90995-H; Keet IPM, 1999, J INFECT DIS, V180, P299, DOI 10.1086/314862; KILPATRICK DC, 1991, DIS MARKERS, V9, P21; Le Clerc S, 2009, J INFECT DIS, V200, P1194, DOI 10.1086/605892; Leslie A, 2010, J VIROL, V84, P9879, DOI 10.1128/JVI.00320-10; Limou S, 2009, J INFECT DIS, V199, P419, DOI 10.1086/596067; Liu HL, 1999, P NATL ACAD SCI USA, V96, P4581, DOI 10.1073/pnas.96.8.4581; Machmach K, 2013, J INFECT DIS, V207, P651, DOI 10.1093/infdis/jis717; Magierowska M, 1999, BLOOD, V93, P936, DOI 10.1182/blood.V93.3.936.403k08_936_941; McLaren PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003515; McNeil AJ, 1996, QJM-INT J MED, V89, P177; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Navis M, 2007, J IMMUNOL, V179, P3133, DOI 10.4049/jimmunol.179.5.3133; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Shin HD, 2000, P NATL ACAD SCI USA, V97, P14467, DOI 10.1073/pnas.97.26.14467; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Tang JM, 2002, J VIROL, V76, P8276, DOI 10.1128/JVI.76.16.8276-8284.2002; Teixeira SLM, 2014, GENES IMMUN, V15, P256, DOI 10.1038/gene.2014.14; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; van Manen D, 2009, AIDS, V23, P19, DOI 10.1097/QAD.0b013e32831db247; Wilson CC, 1997, J VIROL, V71, P1256, DOI 10.1128/JVI.71.2.1256-1264.1997; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389; Yindom LM, 2010, J VIROL, V84, P8202, DOI 10.1128/JVI.00116-10; Zhang WL, 2013, SCI CHINA LIFE SCI, V56, P1014, DOI 10.1007/s11427-013-4555-4	51	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220459	10.1371/journal.pone.0220459	http://dx.doi.org/10.1371/journal.pone.0220459			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393887	Green Published, gold, Green Submitted			2022-12-26	WOS:000485002500034
J	Uhl, P; Awanbor, O; Schulz, RS; Bruhl, CA				Uhl, Philipp; Awanbor, Osarobo; Schulz, Robert S.; Bruehl, Carsten A.			Is Osmia bicornis an adequate regulatory surrogate? Comparing its acute contact sensitivity to Apis mellifera	PLOS ONE			English	Article							NEONICOTINOID INSECTICIDE; POLLINATING INSECTS; HONEY-BEES; PESTICIDE; EXPOSURE; MORTALITY; SEEDS	Bees provide essential ecosystem services and help maintain floral biodiversity. However, there is an ongoing decline of wild and domesticated bee species. Since agricultural pesticide use is a key driver of this process, there is a need for a protective risk assessment. To achieve a more protective registration process, two bee species, Osmia bicornis/Osmia cornuta and Bombus terrestris, were proposed by the European Food Safety Authority as additional test surrogates to the honey bee Apis mellifera. We investigated the acute toxicity (median lethal dose, LD50) of multiple commercial insecticide formulations towards the red mason bee (O. bicornis) and compared these values to honey bee regulatory endpoints. In two thirds of all cases, O. bicornis was less sensitive than the honey bee. By applying an assessment factor of 10 on the honey bee endpoint, a protective level was achieved for 87% (13 out 15) of all evaluated products. Our results show that O. bicornis is rarely an adequate additional surrogate species for lower tier risk assessment since it is less sensitive than the honey bee for the majority of investigated products. Given the currently limited database on bee species sensitivity, the honey bee seems sufficiently protective in acute scenarios as long as a reasonable assessment factor is applied. However, additional surrogate species can still be relevant for ecologically meaningful higher tier studies.	[Uhl, Philipp; Awanbor, Osarobo; Schulz, Robert S.; Bruehl, Carsten A.] Univ Koblenz Landau, Inst Environm Sci, Landau, Germany; [Schulz, Robert S.] Fed Inst Hydrol, Koblenz, Germany	University of Koblenz & Landau	Uhl, P (corresponding author), Univ Koblenz Landau, Inst Environm Sci, Landau, Germany.	uhl@uni-landau.de	Bruhl, Carsten A/F-3385-2012	Uhl, Philipp/0000-0003-4697-5949; Bruhl, Carsten A./0000-0003-1332-535X				Arena M, 2014, ECOTOXICOLOGY, V23, P324, DOI 10.1007/s10646-014-1190-1; Bonmatin JM, 2015, ENVIRON SCI POLLUT R, V22, P35, DOI 10.1007/s11356-014-3332-7; Botias C, 2015, ENVIRON SCI TECHNOL, V49, P12731, DOI 10.1021/acs.est.5b03459; Chauzat MP, 2011, ENVIRON TOXICOL CHEM, V30, P103, DOI 10.1002/etc.361; Dmochowska-Slezak K, 2015, APIDOLOGIE, V46, P432, DOI 10.1007/s13592-014-0333-y; Elias-Neto M, 2014, APIDOLOGIE, V45, P397, DOI 10.1007/s13592-013-0254-1; Fine JD, 2017, SCI REP-UK, V7, DOI 10.1038/srep40499; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Gradish AE, 2019, ENVIRON ENTOMOL, V48, P12, DOI 10.1093/ee/nvy168; Hallmann CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185809; Heard MS, 2017, SCI TOTAL ENVIRON, V578, P357, DOI 10.1016/j.scitotenv.2016.10.180; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Ollerton J, 2017, ANNU REV ECOL EVOL S, V48, P353, DOI 10.1146/annurev-ecolsys-110316-022919; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Peters B, 2016, ECOTOXICOLOGY, V25, P1679, DOI 10.1007/s10646-016-1729-4; R Core Team, 2017, LANG ENV STAT COMP; Rader R, 2015, P NATL ACAD SCI USA; Ritz C, 2005, J STAT SOFTW, V12, P1; Robinson KP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185000; Roessink I., 2016, SOLITARY BEE ACUTE C; Rundlof M, 2015, NATURE, V521, P77, DOI 10.1038/nature14420; Sanchez-Bayo F, 2019, BIOL CONSERV, V232, P8, DOI 10.1016/j.biocon.2019.01.020; Sattler C, 2007, AGR ECOSYST ENVIRON, V119, P299, DOI 10.1016/j.agee.2006.07.017; Sgolastra F, 2019, ENVIRON ENTOMOL, V48, P22, DOI 10.1093/ee/nvy105; Sgolastra F, 2017, PEST MANAG SCI, V73, P1236, DOI 10.1002/ps.4449; Slowinska M, 2016, APIDOLOGIE, V47, P227, DOI 10.1007/s13592-015-0391-9; SMIRLE MJ, 1988, CAN J ZOOL, V66, P1938, DOI 10.1139/z88-283; Sterk G, 2016, ECOTOXICOLOGY, V25, P1666, DOI 10.1007/s10646-016-1730-y; Uhl P, 2016, SCI REP-UK, V6, DOI 10.1038/srep34439; van der Sluijs JP, 2015, ENVIRON SCI POLLUT R, V22, P148, DOI 10.1007/s11356-014-3229-5; Wood T, 2017, ENV RISKS NEONICOTIN; 2013, EFSA J, V11, DOI DOI 10.2903/J.EFSA.2013.3295	33	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0201081	10.1371/journal.pone.0201081	http://dx.doi.org/10.1371/journal.pone.0201081			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393875	Green Submitted, Green Published, gold			2022-12-26	WOS:000485002500001
J	Yeh, PS; Lee, YW; Chang, WH; Wang, W; Wang, JL; Liu, SH; Chen, RM				Yeh, Poh-Shiow; Lee, Yuan-Wen; Chang, Wei-Hui; Wang, Weu; Wang, Jaw-Lin; Liu, Shing-Hwa; Chen, Ruei-Ming			Biomechanical and tomographic differences in the microarchitecture and strength of trabecular and cortical bone in the early stage of male osteoporosis	PLOS ONE			English	Article							POSTMENOPAUSAL WOMEN; SUBSEQUENT FRACTURE; BENDING STRENGTH; CANCELLOUS BONE; MALE-RATS; MEN; TESTOSTERONE; MODEL; MORTALITY; STIFFNESS	Osteoporosis is a continuous process of loss of bone tissue. Compared to women, osteoporosis in men is associated with greater morbidity and mortality. In this study, we conducted tomographic and biomechanical evaluations of trabecular and cortical bone in the early stage of male osteoporosis. Male Wistar rats were subjected to orchiectomy and sham operation. Four weeks after being castrated, decreased levels of testosterone in plasma were found and resulted in concurrent bone loss. Separately, the orchiectomy led to significant tomographic alterations in the trabecular bone number, trabecular separation, and trabecular pattern factor. Data of a mechanistic compression test further showed that the orchiectomy diminished the maximum loading force, displacement at maximum load, energy at maximum load, and ultimate stress. Interestingly, orchiectomy-triggered changes in the maximum loading force and tomographic parameters were highly correlated. In contrast, tomographic and biomechanical analyses showed that 4 weeks after rats were orchiectomized, the thickness, area, maximum loading force, bone stiffness, energy at maximum load, and ultimate stress of the cortical bone were not changed. Taken together, this study showed specific differences in the microarchitecture and strength of trabecular bone in the early stage of male osteoporosis.	[Yeh, Poh-Shiow] Chi Mei Med Ctr, Dept Neurol, Tainan, Taiwan; [Yeh, Poh-Shiow; Chang, Wei-Hui; Chen, Ruei-Ming] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Lee, Yuan-Wen] Taipei Med Univ, Coll Med, Sch Med, Dept Anesthesiol, Taipei, Taiwan; [Lee, Yuan-Wen; Chen, Ruei-Ming] Taipei Med Univ Hosp, Anesthesiol & Hlth Policy Res Ctr, Taipei, Taiwan; [Lee, Yuan-Wen; Chen, Ruei-Ming] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Wang, Weu] Taipei Med Univ Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan; [Wang, Jaw-Lin] Natl Taiwan Univ, Inst Biomed Engn, Taipei, Taiwan; [Liu, Shing-Hwa] Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei, Taiwan; [Chen, Ruei-Ming] Taipei Med Univ, Wan Fang Hosp, Cell Physiol & Mol Image Res Ctr, Taipei, Taiwan	Chi Mei Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; National Taiwan University; National Taiwan University; Taipei Medical University; Taipei Municipal WanFang Hospital	Chen, RM (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.; Chen, RM (corresponding author), Taipei Med Univ Hosp, Anesthesiol & Hlth Policy Res Ctr, Taipei, Taiwan.; Chen, RM (corresponding author), Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan.; Chen, RM (corresponding author), Taipei Med Univ, Wan Fang Hosp, Cell Physiol & Mol Image Res Ctr, Taipei, Taiwan.	rmchen@tmu.edu.tw		LIU, SHING-HWA/0000-0002-9976-1197; Chen, Ruei-Ming/0000-0002-5728-0571	Chi-Mei Medical Center, Taipei, Taiwan [102CM-TMU-14-4]; Wan Fang Hospital, Taipei, Taiwan [108-wf-eva-04]; Ministry of Science and Technology, Taipei, Taiwan [MOST107-2314-B-038-036-MY3]	Chi-Mei Medical Center, Taipei, Taiwan; Wan Fang Hospital, Taipei, Taiwan; Ministry of Science and Technology, Taipei, Taiwan	This study was supported by grants from the Chi-Mei Medical Center (102CM-TMU-14-4), Wan Fang Hospital (108-wf-eva-04), and the Ministry of Science and Technology (MOST107-2314-B-038-036-MY3), Taipei, Taiwan.	AARON JE, 1987, CLIN ORTHOP RELAT R, P260; Abdulai-Saiku S, 2017, BRAIN BEHAV IMMUN, V65, P95, DOI 10.1016/j.bbi.2017.04.005; Almeida M, 2017, PHYSIOL REV, V97, P135, DOI 10.1152/physrev.00033.2015; Bliuc D, 2009, JAMA-J AM MED ASSOC, V301, P513, DOI 10.1001/jama.2009.50; Blouin S, 2007, OSTEOPOROSIS INT, V18, P85, DOI 10.1007/s00198-006-0197-8; Cauley JA, 2018, J BONE MINER RES, V33, P1859, DOI 10.1002/jbmr.3468; Cefalu CA, 2004, CURR MED RES OPIN, V20, P341, DOI 10.1185/030079903125003062; Chin KY, 2016, NUTRIENTS, V8, DOI 10.3390/nu8120808; Eastell R, 2018, EUR J ENDOCRINOL, V178, pR19, DOI 10.1530/EJE-17-0585; Gartlehner G, 2017, JAMA-J AM MED ASSOC, V318, P2234, DOI 10.1001/jama.2017.16952; HAHN M, 1992, BONE, V13, P327, DOI 10.1016/8756-3282(92)90078-B; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Jayusman PA, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070799; Jepsen KJ, 2015, J BONE MINER RES, V30, P951, DOI 10.1002/jbmr.2539; Jiang HX, 2005, J BONE MINER RES, V20, P494, DOI 10.1359/JBMR.041133; Kanis JA, 2004, BONE, V35, P375, DOI 10.1016/j.bone.2004.03.024; KELLER TS, 1990, J ORTHOPAED RES, V8, P592, DOI 10.1002/jor.1100080416; Kovacs CS, 2017, J BONE MINER RES, V32, P676, DOI 10.1002/jbmr.3090; Lee JH, 2016, OSTEOPOROSIS INT, V27, P1691, DOI 10.1007/s00198-015-3436-z; Lee YE, 2014, J ETHNOPHARMACOL, V158, P94, DOI 10.1016/j.jep.2014.10.016; Liao MH, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.182; Lim SJ, 2018, OSTEOPOROSIS INT, V29, P2427, DOI 10.1007/s00198-018-4640-4; Mohamad NV, 2018, INT J MED SCI, V15, P300, DOI 10.7150/ijms.22732; Mohamad NV, 2016, CLIN INTERV AGING, V11, P1317, DOI 10.2147/CIA.S115472; Nayak S, 2017, J AM GERIATR SOC, V65, P490, DOI 10.1111/jgs.14668; Nazarian A, 2008, CALCIFIED TISSUE INT, V83, P368, DOI 10.1007/s00223-008-9174-x; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Rejnmark L, 2013, OSTEOPOROSIS INT, V24, P1529, DOI 10.1007/s00198-012-2230-4; Riggs BL, 2008, J BONE MINER RES, V23, P205, DOI 10.1359/JBMR.071020; Savaridas T, 2015, BONE JOINT RES, V4, P99, DOI 10.1302/2046-3758.46.2000311; Schmidt C, 2003, J BONE MINER RES, V18, P1486, DOI 10.1359/jbmr.2003.18.8.1486; Sidlauskas KM, 2014, CLIN INTERV AGING, V9, P593, DOI 10.2147/CIA.S51940; Singh R, 2006, ENDOCRINOLOGY, V147, P141, DOI 10.1210/en.2004-1649; Sinnesael M, 2013, CURR OPIN ENDOCRINOL, V20, P240, DOI 10.1097/MED.0b013e32835f7d04; Swift JM, 1985, J APPL PHYSIOL, V109, P1600; Thomann M, 2010, J BIOMED MATER RES A, V93A, P1609, DOI 10.1002/jbm.a.32639; Toben D, 2011, J BONE MINER RES, V26, P113, DOI 10.1002/jbmr.185; VAHEY JW, 1987, J BIOMECH, V20, P29, DOI 10.1016/0021-9290(87)90264-8; Vandenput L, 2002, J BONE MINER RES, V17, P2080, DOI 10.1359/jbmr.2002.17.11.2080; VANDERSCHUEREN D, 1992, ENDOCRINOLOGY, V130, P2906, DOI 10.1210/en.130.5.2906; Viswanathan M, 2018, JAMA-J AM MED ASSOC, V319, P2532, DOI 10.1001/jama.2018.6537; Vorland CJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44415-9; Wang J, 2016, BONE, V88, P39, DOI 10.1016/j.bone.2016.04.003; Watts NB, 2014, NAT REV ENDOCRINOL, V10, P412, DOI 10.1038/nrendo.2014.55; WEINSTEIN RS, 1987, BONE, V8, P137, DOI 10.1016/8756-3282(87)90012-3; WINK CS, 1980, CALCIFIED TISSUE INT, V32, P77, DOI 10.1007/BF02408524	46	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0219718	10.1371/journal.pone.0219718	http://dx.doi.org/10.1371/journal.pone.0219718			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393911	Green Submitted, Green Published, gold			2022-12-26	WOS:000485002500015
J	Hu, JM; Xia, XQ; Gorlick, R; Li, SL				Hu, Jiemiao; Xia, Xueqing; Gorlick, Richard; Li, Shulin			Induction of NKG2D ligand expression on tumor cells by CD8(+) T-cell engagement-mediated activation of nuclear factor-kappa B and p300/CBP-associated factor	ONCOGENE			English	Article							IFN-GAMMA; CARCINOMA CELLS; 4-1BB CD137; RECEPTOR; TRANSCRIPTION; MODULATION; CHEMOATTRACTANT; COSTIMULATION; CHEMOKINES; MECHANISM	The ligands for the natural killer group 2 (NKG2D) protein render tumor cells susceptible to NKG2D-dependent immune cell attack. However, cancer cells escape from immune surveillance by downregulating NKG2D ligands. We previously discovered that engagement of activated CD8(+) T cells and tumor cells induces NKG2D ligands on tumor cells, but the underlying mechanism remains to be defined. Both in vivo mouse tumor models and in vitro cell assays were performed to study the downstream signaling. Our results supported the notion that, upon engagement with the cognate receptors, CD137 ligand and CD40 initiates activation of nuclear factor-kappa B (NF-kappa B) signaling in tumor cells even in the absence of CD8(+) T cells. Like tumor and CD8(+) T cell contact-dependent NKG2D ligand induction, this CD137L/CD40-mediated signaling activation was associated with elevated levels of acetyltransferase P300/CBP-associated factor (PCAF), whereas inhibition of phosphorylated NF-kappa B abrogated PCAF induction. Although stimulation of CD137L/CD40-mediated signaling is vital, inflammatory cytokines, including interferon gamma (IFN gamma) and TNF alpha, also facilitate NKG2D ligand-induced immune surveillance via both facilitating T-cell chemotaxis and CD137L/CD40 induced NF-kappa B/PCAF activation. Collectively, our results unveil a novel mechanism of NKG2D ligand upregulation involving reverse signaling of CD40 and CD137L on tumor cells which, along with inflammatory cytokines IFN gamma and TNF alpha, stimulate downstream NF-kappa B and PCAF activation. Understanding this mechanism may help in development of induced NKG2D ligand-dependent T-cell therapy against cancers.	[Hu, Jiemiao; Xia, Xueqing; Gorlick, Richard; Li, Shulin] Univ Texas MD Anderson Canc Ctr, Div Pediat, Dept Pediat Res, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Li, SL (corresponding author), Univ Texas MD Anderson Canc Ctr, Div Pediat, Dept Pediat Res, Houston, TX 77030 USA.	Sli4@mdanderson.org	Li, Shulin/D-6478-2011		Cancer Center Support Grant [P30 CA016672]; NATIONAL CANCER INSTITUTE [R01CA120895, P30CA016672, R01CA200574] Funding Source: NIH RePORTER	Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The following Cancer Center Support Grant core resources were used: Genetically Engineered Mouse Facility and Monoclonal Antibody Core Facility with Cancer Center Support Grant P30 CA016672. The authors would like to thank Ms. Kathryn L Hale from the Department of Scientific Publications for editing the manuscript.	Altenburg A, 1999, J IMMUNOL, V162, P4140; Antonelli A, 2009, J CLIN ENDOCR METAB, V94, P1803, DOI 10.1210/jc.2008-2450; Arch RH, 1998, MOL CELL BIOL, V18, P558, DOI 10.1128/MCB.18.1.558; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Bartkowiak T, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00117; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bui JD, 2006, J IMMUNOL, V176, P905, DOI 10.4049/jimmunol.176.2.905; Cannons JL, 2000, J IMMUNOL, V165, P6193, DOI 10.4049/jimmunol.165.11.6193; Carayannopoulos LN, 2002, J IMMUNOL, V169, P4079, DOI 10.4049/jimmunol.169.8.4079; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Cooke PW, 1999, J PATHOL, V188, P38; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Gallagher NJ, 2002, J CLIN PATHOL-MOL PA, V55, P110, DOI 10.1136/mp.55.2.110; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gasser S, 2006, SEMIN CANCER BIOL, V16, P344, DOI 10.1016/j.semcancer.2006.07.004; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Han S, 2014, BRIT J CANCER, V110, P2560, DOI 10.1038/bjc.2014.162; Hauer J, 2005, P NATL ACAD SCI USA, V102, P2874, DOI 10.1073/pnas.0500187102; Held-Feindt J, 2002, INT J CANCER, V98, P352, DOI 10.1002/ijc.10207; Hu J, 2017, ENVIRON SCI POLLUT R, V24, P17090, DOI 10.1007/s11356-017-9057-7; Hu JM, 2017, CANCER IMMUNOL RES, V5, P300, DOI 10.1158/2326-6066.CIR-16-0234; Hu JB, 2017, DRUG DELIV, V24, P1856, DOI 10.1080/10717544.2017.1410258; Jung H, 2012, J EXP MED, V209, P2409, DOI 10.1084/jem.20120565; Kelly JM, 2002, NAT IMMUNOL, V3, P83, DOI 10.1038/ni746; Kim HH, 2000, MOL CELLS, V10, P247; Lanier LL, 2015, CANCER IMMUNOL RES, V3, P575, DOI 10.1158/2326-6066.CIR-15-0098; Lee DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058748; Lin D, 2012, J BIOL CHEM, V287, P4299, DOI 10.1074/jbc.M111.282152; Martinez-Forero I, 2013, J IMMUNOL, V190, P6694, DOI 10.4049/jimmunol.1203010; Mohan K, 2002, J IMMUNOL, V168, P6420, DOI 10.4049/jimmunol.168.12.6420; Molinero LL, 2004, J IMMUNOL, V173, P5583, DOI 10.4049/jimmunol.173.9.5583; Moser B, 1998, Int Rev Immunol, V16, P323, DOI 10.3109/08830189809043000; Murdoch C, 2000, BLOOD, V95, P3032; Na SY, 1998, J BIOL CHEM, V273, P10831, DOI 10.1074/jbc.273.18.10831; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Sabbagh L, 2008, J IMMUNOL, V180, P8093, DOI 10.4049/jimmunol.180.12.8093; Salih HR, 2000, J IMMUNOL, V165, P2903, DOI 10.4049/jimmunol.165.5.2903; Saoulli K, 1998, J EXP MED, V187, P1849, DOI 10.1084/jem.187.11.1849; Sauer M, 2017, ONCOGENE, V36, P933, DOI 10.1038/onc.2016.259; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Tirapu I, 2006, CANCER RES, V66, P2442, DOI 10.1158/0008-5472.CAN-05-1681; Trebing J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.555; Werbajh S, 2000, FEBS LETT, V485, P195, DOI 10.1016/S0014-5793(00)02223-7; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhu S, 2007, CLIN CANCER RES, V13, P4252, DOI 10.1158/1078-0432.CCR-06-2894	47	3	3	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 5	2019	38	49					7433	7446		10.1038/s41388-019-0960-x	http://dx.doi.org/10.1038/s41388-019-0960-x			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JT4BN	31427736	Green Accepted			2022-12-26	WOS:000500936600005
J	Chen, LY; Cruz, A; Ramsey, S; Dickson, CJ; Duca, JS; Hornak, V; Koes, DR; Kurtzman, T				Chen, Lieyang; Cruz, Anthony; Ramsey, Steven; Dickson, Callum J.; Duca, Jose S.; Hornak, Viktor; Koes, David R.; Kurtzman, Tom			Hidden bias in the DUD-E dataset leads to misleading performance of deep learning in structure-based virtual screening	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; GENETIC ALGORITHM; DRUG DISCOVERY; PROTEIN; DOCKING; SIMILARITY; STRATEGIES; PARAMETERS; ACCURACY; AMBER	Recently much effort has been invested in using convolutional neural network (CNN) models trained on 3D structural images of protein-ligand complexes to distinguish binding from non-binding ligands for virtual screening. However, the dearth of reliable protein-ligand x-ray structures and binding affinity data has required the use of constructed datasets for the training and evaluation of CNN molecular recognition models. Here, we outline various sources of bias in one such widely-used dataset, the Directory of Useful Decoys: Enhanced (DUD-E). We have constructed and performed tests to investigate whether CNN models developed using DUD-E are properly learning the underlying physics of molecular recognition, as intended, or are instead learning biases inherent in the dataset itself. We find that superior enrichment efficiency in CNN models can be attributed to the analogue and decoy bias hidden in the DUD-E dataset rather than successful generalization of the pattern of proteinligand interactions. Comparing additional deep learning models trained on PDBbind datasets, we found that their enrichment performances using DUD-E are not superior to the performance of the docking program AutoDock Vina. Together, these results suggest that biases that could be present in constructed datasets should be thoroughly evaluated before applying them to machine learning based methodology development.	[Chen, Lieyang; Cruz, Anthony; Ramsey, Steven; Kurtzman, Tom] Lehman Coll, Dept Chem, Bronx, NY 10468 USA; [Chen, Lieyang; Ramsey, Steven; Kurtzman, Tom] CUNY, Grad Ctr, PhD Program Biochem, New York, NY 10031 USA; [Cruz, Anthony; Kurtzman, Tom] CUNY, Grad Ctr, PhD Program Chem, New York, NY 10031 USA; [Dickson, Callum J.; Duca, Jose S.; Hornak, Viktor] Novartis Inst Biomed Res, Comp Aided Drug Discovery, Global Discovery Chem, Cambridge, MA USA; [Koes, David R.] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA USA	City University of New York (CUNY) System; Lehman College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; Novartis; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kurtzman, T (corresponding author), Lehman Coll, Dept Chem, Bronx, NY 10468 USA.; Kurtzman, T (corresponding author), CUNY, Grad Ctr, PhD Program Biochem, New York, NY 10031 USA.; Kurtzman, T (corresponding author), CUNY, Grad Ctr, PhD Program Chem, New York, NY 10031 USA.	simpleliquid@gmail.com	Koes, David Ryan/M-4523-2018	Koes, David Ryan/0000-0002-6892-6614; Chen, Lieyang/0000-0002-1583-8039; Duca, Jose/0000-0002-0880-5618; Kurtzman, Tom/0000-0003-0900-772X	NIH [R01-GM100946, R01-GM108340]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100946, R01GM108340] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH R01GM100946 and R01-GM108340. Deep Waters, LLC has provided support in the form of salaries for authors (T.K., A.C.) and Novartis has provided support in the form of salaries for authors (C.J.D., V.H., and J.S.D.). These funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.; This work is supported by NIH R01-GM100946 and R01-GM108340.	[Anonymous], 2017, ATOMIC CONVOLUTIONAL; Balius TE, 2017, P NATL ACAD SCI USA, V114, pE6839, DOI 10.1073/pnas.1703287114; Banks Jay L, 2004, GLIDE NEW APPROACH R; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brozell SR, EVALUATION DOCK 6 PO; Ericksen SS, 2017, J CHEM INF MODEL, V57, P1579, DOI 10.1021/acs.jcim.7b00153; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Gonczarek A, 2018, COMPUT BIOL MED, V100, P253, DOI 10.1016/j.compbiomed.2017.09.007; Graves  A., SPEECH RECOGNITION D; Hassan M, DLSCORE DEEP LEARNIN; He K., 2016, CVPR, DOI 10.1109/cvpr.2016.90; Hochuli J, 2018, J MOL GRAPH MODEL, V84, P96, DOI 10.1016/j.jmgm.2018.06.005; Imrie F, 2018, J CHEM INF MODEL; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Josejimejosejimenez J, 2018, J CHEM INF MODEL, V58, P58; Kinnings SL, 2011, J CHEM INF MODEL, V51, P408, DOI 10.1021/ci100369f; Kleanthous S, 2010, BIOORG MED CHEM LETT, V20, P618, DOI 10.1016/j.bmcl.2009.11.077; Koes DR, 2013, J CHEM INF MODEL, V53, P1893, DOI 10.1021/ci300604z; Krizhevsky A., IMAGENET CLASSIFICAT; Lavecchia A, 2013, CURR MED CHEM, V20, P2839, DOI 10.2174/09298673113209990001; LeCun Y, 1999, OBJECT RECOGNITION G, P319, DOI [10.1007/3-540-46805-6, DOI 10.1007/3-540-46805-6, 10.1007/3-540-46805-6_19, DOI 10.1007/3-540-46805-6_19]; Li Y, 2017, J CHEM INF MODEL, V57, P1007, DOI 10.1021/acs.jcim.7b00049; Lionta E, 2014, CURR TOP MED CHEM, V14, P1923, DOI 10.2174/1568026614666140929124445; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; Niu Huang, 2006, BENCHMARKING SETS MO; Olson A. J., 2009, J COMPUT CHEM, V31; Ossama A-H, 2014, IEEE ACM T AUDIO SPE, V22; Pereira JC, 2016, J CHEM INF MODEL, V56, P2495, DOI 10.1021/acs.jcim.6b00355; Ragoza M, 2017, J CHEM INF MODEL, V57, P942, DOI 10.1021/acs.jcim.6b00740; Ramsey S, SOLVATION THERMODYNA; Renxiao Wang, 2003, COMP EVALUATION 11 S; Repasky Matthew P, 2007, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0812s18; Robert Abel, 2008, ACTIVE SITE SOLVENT; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Russakovsky Olga, IMAGENET LARGE SCALE; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Sara Biancalana, 2002, CRYSTAL STRUCTURES 2; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Sieg J, NEED BIAS CONTROL EV; Smusz S, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-17; Stepniewska-Dziubinska MM, 2018, BIOINFORMATICS, V34, P3666, DOI 10.1093/bioinformatics/bty374; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Valiant G, THEORY LEARNABLE; Wallach I., 2015, ARXIV151002855; Wallach I, 2018, J CHEM INF MODEL, V58, P916, DOI 10.1021/acs.jcim.7b00403; Wang RX, 2004, J MED CHEM, V47, P2977, DOI 10.1021/jm030580l; Wojcikowski M, 2017, SCI REP-UK, V7, DOI 10.1038/srep46710; Yan YN, 2017, J CHEM INF MODEL, V57, P1793, DOI 10.1021/acs.jcim.7b00017; Young RJ, 2008, BIOORG MED CHEM LETT, V18, P28, DOI 10.1016/j.bmcl.2007.11.019; Zhang C., UNDERSTANDING DEEP L	54	75	75	8	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0220113	10.1371/journal.pone.0220113	http://dx.doi.org/10.1371/journal.pone.0220113			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430292	gold, Green Published, Green Submitted			2022-12-26	WOS:000485026800008
J	Papaspyros, V; Bonnet, F; Collignon, B; Mondada, F				Papaspyros, Vaios; Bonnet, Frank; Collignon, Bertrand; Mondada, Francesco			Bidirectional interactions facilitate the integration of a robot into a shoal of zebrafish Danio rerio	PLOS ONE			English	Article							COLLECTIVE MOTION; FISH; RESPONDS; INDIVIDUALS; BEHAVIOR; LEADERS; MODELS	Many studies on collective animal behavior seek to identify the individual rules that underlie collective patterns. However, it was not until the recent advancements of micro-electronic and embedded systems that scientists were able to create mixed groups of sensor-rich robots and animals and study collective interactions from the within a bio-hybrid group. In recent work, scientists showed that a robot-controlled lure is capable of influencing the collective decisions of zebrafish Danio rerio shoals moving in a ring and a two-room setup. Here, we study a closely related topic, that is, the collective behavior patterns that emerge when different behavioral models are reproduced through the use of a robotic lure. We design a behavioral model that alternates between obeying and disobeying the collective motion decisions in order to become socially accepted by the shoal members. Subsequently, we compare it against two extreme cases: a reactive and an imposing decision model. For this, we use spatial, directional and information theoretic metrics to measure the degree of integration of the robotic agent. We show that our model leads to similar information flow as in freely roaming shoals of zebrafish and exhibits leadership skills more often than the open-loop models. Thus, in order for the robot to achieve higher degrees of integration in the zebrafish shoal, it must, like any other shoal member, be bidirectionally involved in the decision making process. These findings provide insight on the ability to form mixed societies of animals and robots and yield promising results on the degree to which a robot can influence the collective decision making.	[Papaspyros, Vaios; Bonnet, Frank; Collignon, Bertrand; Mondada, Francesco] Ecole Polytech Fed Lausanne, Inst Bioengn, Biorobot Lab, Lausanne, Switzerland; [Collignon, Bertrand] ULB, USE, Brussels, Belgium	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Universite Libre de Bruxelles	Papaspyros, V (corresponding author), Ecole Polytech Fed Lausanne, Inst Bioengn, Biorobot Lab, Lausanne, Switzerland.	vaios.papaspyros@epfl.ch		Collignon, Bertrand/0000-0003-2463-1512; Papaspyros, Vaios/0000-0001-8257-1891	EU-ICT project ASSISIbf [601074]; Swiss National Science Foundation project "Self-Adaptive Mixed Societies of Animals and Robots" [175731]	EU-ICT project ASSISIbf; Swiss National Science Foundation project "Self-Adaptive Mixed Societies of Animals and Robots"(Swiss National Science Foundation (SNSF))	This work was supported by EU-ICT project ASSISIbf - No. 601074 and the Swiss National Science Foundation project "Self-Adaptive Mixed Societies of Animals and Robots" (Grant No. 175731). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partly supported by the EU-ICT project ASSISIbf (Grant No. 601074) and partly by the Swiss National Science Foundation project "Self-Adaptive Mixed Societies of Animals and Robots" (Grant No. 175731).	Abaid N, 2013, BEHAV PROCESS, V100, P9, DOI 10.1016/j.beproc.2013.07.010; Abaid N, 2012, BEHAV BRAIN RES, V233, P545, DOI 10.1016/j.bbr.2012.05.047; Abaid N, 2012, BEHAV BRAIN RES, V232, P406, DOI 10.1016/j.bbr.2012.03.028; Abaid N, 2010, J R SOC INTERFACE, V7, P1441, DOI 10.1098/rsif.2010.0175; AOKI I, 1982, B JPN SOC SCI FISH, V48, P1081; Bartolini T, 2016, BIOINSPIR BIOMIM, V11, DOI 10.1088/1748-3190/11/2/026003; Bertin E, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.022101; Bode NWF, 2011, J R SOC INTERFACE, V8, P301, DOI 10.1098/rsif.2010.0397; Bonnet Frank, 2017, 2017 IEEE International Conference on Robotics and Automation (ICRA), P4449, DOI 10.1109/ICRA.2017.7989515; Bonnet Frank, 2018, Swarm Intelligence, V12, P227, DOI 10.1007/s11721-017-0153-6; Bonnet F, 2014, 2014 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS IEEE-ROBIO 2014, P747, DOI 10.1109/ROBIO.2014.7090421; Bonnet F, 2012, P IEEE RAS-EMBS INT, P437, DOI 10.1109/BioRob.2012.6290826; Bradski G., 2000, DOBBS J SOFTWARE TOO; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; BUMANN D, 1993, BEHAVIOUR, V125, P189, DOI 10.1163/156853993X00236; Butail S, 2014, BEHAV BRAIN RES, V275, P269, DOI 10.1016/j.bbr.2014.09.015; Butail S, 2014, ENTROPY-SWITZ, V16, P1315, DOI 10.3390/e16031315; Butail S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076123; Camazine S., 2003, SELF ORG BIOL SYSTEM; Cazenille L, 2018, LECT NOTES ARTIF INT, V10928, P73, DOI 10.1007/978-3-319-95972-6_9; Cazenille L, 2018, BIOINSPIR BIOMIM, V13, DOI 10.1088/1748-3190/aa8f6a; Chate H, 2008, EUR PHYS J B, V64, P451, DOI 10.1140/epjb/e2008-00275-9; Collignon B, 2017, ARXIV170103611; Correll N, 2008, LECT NOTES ARTIF INT, V5040, P437; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Crosato E, 2017, ARXIV170501213; DIJKGRAAF S, 1963, BIOL REV, V38, P51, DOI 10.1111/j.1469-185X.1963.tb00654.x; Faria JJ, 2010, BEHAV ECOL SOCIOBIOL, V64, P1211, DOI 10.1007/s00265-010-0988-y; Gautrais J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002678; Gribovskiy A, 2018, ROBOT AUTON SYST, V103, P42, DOI 10.1016/j.robot.2018.02.003; Griparic K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181977; Halloy J, 2007, SCIENCE, V318, P1155, DOI 10.1126/science.1144259; Hemelrijk CK, 2008, ETHOLOGY, V114, P245, DOI 10.1111/j.1439-0310.2007.01459.x; Jiang L, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005822; Jolly L, 2016, BIOINSPIR BIOMIM, V11, DOI 10.1088/1748-3190/11/1/016007; Kim C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19083-2; Kopman V, 2013, IEEE-ASME T MECH, V18, P471, DOI 10.1109/TMECH.2012.2222431; Kopman V, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0540; Kruusmaa M, 2016, BIOINSPIR BIOMIM, V11, DOI 10.1088/1748-3190/11/5/056020; Ladu F, 2015, BEHAV BRAIN RES, V289, P48, DOI 10.1016/j.bbr.2015.04.020; Ladu F, 2015, ZEBRAFISH, V12, P205, DOI 10.1089/zeb.2014.1041; Landgraf Tim, 2013, Advances in Swarm Intelligence. 4th International Conference, ICSI 2013. Proceedings, P1, DOI 10.1007/978-3-642-38703-6_1; Landgraf T, 2016, BIOINSPIR BIOMIM, V11, DOI 10.1088/1748-3190/11/1/015001; Landgraf T, 2010, IEEE INT C INT ROBOT, P3097, DOI 10.1109/IROS.2010.5650930; Lecheval V, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0251; Lizier JT, 2014, FRONT ROBOT AI, DOI 10.3389/frobt.2014.00011; Lopez Ugo, 2012, Interface Focus, V2, P693, DOI 10.1098/rsfs.2012.0033; Lukeman R, 2010, P NATL ACAD SCI USA, V107, P12576, DOI 10.1073/pnas.1001763107; Mann RP, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0794; Marras Stefano, 2012, J R Soc Interface, V9, P1856, DOI 10.1098/rsif.2012.0084; Mwaffo V, 2017, FRONT ROBOT AI, V4, DOI 10.3389/frobt.2017.00035; Mwaffo V, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0884; Nagai KH, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.168001; Niwa HS, 1996, J THEOR BIOL, V181, P47, DOI 10.1006/jtbi.1996.0114; Perez-Escudero A, 2014, NAT METHODS, V11, P743, DOI [10.1038/NMETH.2994, 10.1038/nmeth.2994]; Phamduy P, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/3/036021; Pillot MH, 2010, BEHAV PROCESS, V83, P235, DOI 10.1016/j.beproc.2009.11.006; Polverino G, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/3/036019; Polverino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077589; Polverino G, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/4/044001; Polverino G, 2013, BEHAV BRAIN RES, V250, P133, DOI 10.1016/j.bbr.2013.05.008; Porfiri M., 2018, ANIM BEHAV COGNITION, V5, P341, DOI [10.26451/abc.05.04.03.2018, DOI 10.26451/ABC.05.04.03.2018]; Porfiri M, 2017, J THEOR BIOL, V435, P145, DOI 10.1016/j.jtbi.2017.09.005; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; Romano D, 2019, BIOL CYBERN, V113, P201, DOI 10.1007/s00422-018-0787-5; Ruberto T, 2018, ZEBRAFISH, V15, P433, DOI 10.1089/zeb.2018.1616; Ruberto T, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160505; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Shannon C. E., 1949, MATH THEORY COMMUNIC; SHI JB, 1994, 1994 IEEE COMPUTER SOCIETY CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION, PROCEEDINGS, P593, DOI 10.1109/CVPR.1994.323794; Spinello C, 2019, FRONT ROBOT AI, V6, DOI 10.3389/frobt.2019.00038; Spinello C, 2013, ALCOHOL, V47, P391, DOI 10.1016/j.alcohol.2013.04.003; Stefanec M, 2017, 2017 IEEE S SERIES C, P1, DOI DOI 10.1109/SSCI.2017.8285346; Strandburg-Peshkin A, 2013, CURR BIOL, V23, pR709, DOI 10.1016/j.cub.2013.07.059; Strombom D, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0719; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Swain DT, 2012, P IEEE, V100, P150, DOI 10.1109/JPROC.2011.2165449; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; Vaughan R, 2000, ROBOT AUTON SYST, V31, P109, DOI 10.1016/S0921-8890(99)00084-6; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Wibral M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055809; Worm M, 2018, P NATL ACAD SCI USA, V115, P6852, DOI 10.1073/pnas.1801283115; Zienkiewicz A, 2015, J MATH BIOL, V71, P1081, DOI 10.1007/s00285-014-0843-2	84	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0220559	10.1371/journal.pone.0220559	http://dx.doi.org/10.1371/journal.pone.0220559			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430290	Green Published, gold, Green Submitted			2022-12-26	WOS:000485026800010
J	Chen, HY; Xiao, XY; Chen, CW; Chou, HK; Sung, CY; Lin, FH; Chen, PQ; Wong, TH				Chen, Hsuan-Yu; Xiao, Xiu-Yun; Chen, Chih-Wei; Chou, Hao-Kai; Sung, Chen-Yu; Lin, Feng-Huei; Chen, Po-Quang; Wong, Tze-Hong			Results of using robotic-assisted navigational system in pedicle screw placement	PLOS ONE			English	Article							ACCURACY	Recent technical developments have resulted in robotic-assisted pedicle screw placement techniques. However, the use of robotic-assisted navigational techniques is still subject to controversy. This study aims to assess the accuracy and safety of a self-developed navigation system, the point spine navigation system (PSNS), for robotic-assisted pedicle screw placement surgery. Fifty-nine pedicle screws were implanted in three porcine vertebrae at the T6-T10 and L1-L5 levels, with the assistance of the PSNS. The navigation and planning system provides virtual surgical guide images, including sagittal, coronal, axial, oblique planes, and customized three-dimensional reconstructions for each vertebra to establish accurate pedicle screw trajectories and placement tracts. After pedicle screw placement, post-operative spiral computer tomographic scans were performed and screws were evaluated using the Gertzbein Robbins classification. Differences between the actual pedicle screw position and pre-operative planning paths, including the angle, shortest distance, and entry trajectory were recorded. The 59 pedicle screw placements were all within a safe zone, and there was no spinal canal perforation or any other damage under postoperative computed tomography image data. Fifty-one screws were categorized as group A, seven screws were noted as group B, and one screw was identified as group E under the Gertzbein-Robbins classification. The mean entry point deviation was 2.71 +/- 1.72 degrees, mean trajectory distance was 1.56 +/- 0.66 mm, and average shortest distance between two paths was 0.96 +/- 0.73 mm. Pedicle placement remains a challenging procedure with high reported incidences of nerve and vascular injuries. The implementation of a robotic-assisted navigational system yields an acceptable level of accuracy and safety for the pedicle screw placement surgery.	[Chen, Hsuan-Yu; Chen, Po-Quang; Wong, Tze-Hong] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Orthoped Surg, Hsinchu, Taiwan; [Chen, Hsuan-Yu; Chen, Chih-Wei; Chou, Hao-Kai; Lin, Feng-Huei] Natl Taiwan Univ, Dept Biomed Engn, Taipei, Taiwan; [Xiao, Xiu-Yun; Chen, Chih-Wei; Chou, Hao-Kai; Sung, Chen-Yu] Point Robot MedTech Inc, Hsinchu, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University	Wong, TH (corresponding author), Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Orthoped Surg, Hsinchu, Taiwan.	tzehongwong@gmail.com	Chen, Hsuan-Yu/AAT-5581-2021	Chen, Hsuan-Yu/0000-0003-4998-7566	Point Robotics MedTech Inc.	Point Robotics MedTech Inc.	This study was partially supported by Point Robotics MedTech Inc., which provided the robot system. There was no additional external funding received for this study. The funder provided support in the form of salaries for authors [X. Y. Xiao, C. W. Chen, H. K. Chou, and C. Y. Sung], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bailey SI, 1996, SPINE, V21, P2006, DOI 10.1097/00007632-199609010-00016; Costa F, 2017, J NEUROSURG-SPINE, V26, P542, DOI 10.3171/2016.11.SPINE151139a; Dede O, 2014, SPINE, V39, P286, DOI 10.1097/BRS.0000000000000127; Devito DP, 2010, SPINE, V35, P2109, DOI 10.1097/BRS.0b013e3181d323ab; Gaines RW, 2000, J BONE JOINT SURG AM, V82A, P1458, DOI 10.2106/00004623-200010000-00013; GERTZBEIN SD, 1990, SPINE, V15, P11, DOI 10.1097/00007632-199001000-00004; Kantelhardt S, 2011, EUR SPINE J, V20, P860, DOI 10.1007/s00586-011-1729-2; Kim TH, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/3284704; Kosmopoulos V, 2007, SPINE, V32, pE111, DOI 10.1097/01.brs.0000254048.79024.8b; Lieberman IH, 2012, J SPINAL DISORD TECH, V25, P241, DOI 10.1097/BSD.0b013e318218a5ef; Pechlivanis I, 2009, SPINE, V34, P392, DOI 10.1097/BRS.0b013e318191ed32; Roser F, 2013, NEUROSURGERY, V72, pA12, DOI 10.1227/NEU.0b013e318270d02c; Stuer C, 2011, ACTA NEUROCHIR SUPPL, V109, P241, DOI 10.1007/978-3-211-99651-5_38	13	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0220851	10.1371/journal.pone.0220851	http://dx.doi.org/10.1371/journal.pone.0220851			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5MK	31425528	Green Published, Green Submitted, gold			2022-12-26	WOS:000485022400016
J	Mehta, AS; Luz-Madrigal, A; Li, JL; Tsonis, PA; Singh, A				Mehta, Abijeet Singh; Luz-Madrigal, Agustin; Li, Jian-Liang; Tsonis, Panagiotis A.; Singh, Amit			Comparative transcriptomic analysis and structure prediction of novel Newt proteins	PLOS ONE			English	Article							REGENERATIVE CAPACITY; TRANSGENIC DROSOPHILA; CELL-PROLIFERATION; GENE-EXPRESSION; HIPPO PATHWAY; BOMBYX-MORI; MODEL; MECHANISMS; RNA; INTEGRASE	Notophthalmus viridescens (Red-spotted Newt) possess amazing capabilities to regenerate their organs and other tissues. Previously, using a de novo assembly of the newt transcriptome combined with proteomic validation, our group identified a novel family of five protein members expressed in adult tissues during regeneration in Notophthalmus viridescens. The presence of a putative signal peptide suggests that all these proteins are secretory in nature. Here we employed iterative threading assembly refinement (I-TASSER) server to generate three-dimensional structure of these novel Newt proteins and predicted their function. Our data suggests that these proteins could act as ion transporters, and be involved in redox reaction(s). Due to absence of transgenic approaches in N. viridescens, and conservation of genetic machinery across species, we generated transgenic Drosophila melanogaster to misexpress these genes. Expression of 2775 transcripts were compared between these five newly identified Newt genes. We found that genes involved in the developmental process, cell cycle, apoptosis, and immune response are among those that are highly enriched. To validate the RNA Seq. data, expression of six highly regulated genes were verified using real time Quantitative Polymerase Chain Reaction (RT-qPCR). These graded gene expression patterns provide insight into the function of novel protein family identified in Newt, and layout a map for future studies in the field.	[Mehta, Abijeet Singh; Luz-Madrigal, Agustin; Tsonis, Panagiotis A.; Singh, Amit] Univ Dayton, Dept Biol, Dayton, OH 45469 USA; [Li, Jian-Liang] Sanford Burnham Prebys Med Discovery Inst Lake No, Orlando, FL USA; [Singh, Amit] Univ Dayton, Premed Program, Dayton, OH 45469 USA; [Singh, Amit] Univ Dayton, Ctr Tissue Regenerat & Engn Dayton TREND, Dayton, OH 45469 USA; [Singh, Amit] Univ Dayton, Integrat Sci & Engn Ctr, Dayton, OH 45469 USA; [Singh, Amit] Indiana State Univ, Ctr Genom Advocacy TCGA, Terre Haute, IN 47809 USA	University of Dayton; Sanford Burnham Prebys Medical Discovery Institute; University of Dayton; University of Dayton; University of Dayton; Indiana State University; International Genomics Consortium	Singh, A (corresponding author), Univ Dayton, Dept Biol, Dayton, OH 45469 USA.; Singh, A (corresponding author), Univ Dayton, Premed Program, Dayton, OH 45469 USA.; Singh, A (corresponding author), Univ Dayton, Ctr Tissue Regenerat & Engn Dayton TREND, Dayton, OH 45469 USA.; Singh, A (corresponding author), Univ Dayton, Integrat Sci & Engn Ctr, Dayton, OH 45469 USA.; Singh, A (corresponding author), Indiana State Univ, Ctr Genom Advocacy TCGA, Terre Haute, IN 47809 USA.	asingh1@udayton.edu	Singh, Amit/T-5619-2019; Li, Jian-Liang/AAE-9315-2019; Mehta, Abijeet/GPP-1675-2022	Singh, Amit/0000-0002-2962-2255; Li, Jian-Liang/0000-0002-6487-081X; Mehta, Abijeet/0000-0002-5759-1716; LUZ MADRIGAL, AGUSTIN/0000-0002-7504-2753	NIH [1R15GM124654-01, RO1EY10540]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM124654] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH (1R15GM124654-01) to Dr. Amit Singh and NIH (RO1EY10540) to Dr. Panagiotis A Tsonis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnave P, 2019, SEMIN CELL DEV BIOL, V87, P160, DOI 10.1016/j.semcdb.2018.04.002; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Alvarado AS, 2006, NAT REV GENET, V7, P873, DOI 10.1038/nrg1923; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2019, REG DAT RNA SEQ; [Anonymous], 2017, DROS INFORM SERV; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cervera J, 2016, SCI REP-UK, V6, DOI 10.1038/srep35201; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Drysdale Rachel, 2008, V420, P45, DOI 10.1007/978-1-59745-583-1_3; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Eguchi G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1389; Elewa A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01964-9; Fan Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004131; Ferreira F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06614-2; Fish MP, 2007, NAT PROTOC, V2, P2325, DOI 10.1038/nprot.2007.328; Fukazawa T, 2009, DEVELOPMENT, V136, P2323, DOI 10.1242/dev.033985; Gelbart W, 2003, NUCLEIC ACIDS RES, V31, P172, DOI 10.1093/nar/gkg094; Gemberling M, 2013, TRENDS GENET, V29, P611, DOI 10.1016/j.tig.2013.07.003; Ghai K, 2010, J NEUROSCI, V30, P3101, DOI 10.1523/JNEUROSCI.4919-09.2010; Goldman D, 2014, DEVELOPMENT, V141, P2745, DOI 10.1242/dev.107839; Gonzalez-Rosa JM, 2017, REGENERATION, V4, P105, DOI 10.1002/reg2.83; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Grogg MW, 2005, NATURE, V438, P858, DOI 10.1038/nature04175; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Grusche FA, 2011, DEV BIOL, V350, P255, DOI 10.1016/j.ydbio.2010.11.020; Hales KG, 2015, GENETICS, V201, P815, DOI 10.1534/genetics.115.183392; Hariharan IK, 2017, CURR OPIN CELL BIOL, V48, P10, DOI 10.1016/j.ceb.2017.03.005; Harris RE, 2016, ELIFE, V5, DOI 10.7554/eLife.11588; Heber-Katz E, 2013, CURR TOP MICROBIOL, V367, P253, DOI 10.1007/82_2012_294; Herrera-Rincon C, 2018, CELL REP, V25, P1593, DOI 10.1016/j.celrep.2018.10.010; Howe DG, 2013, NUCLEIC ACIDS RES, V41, pD854, DOI 10.1093/nar/gks938; Hughes TT, 2012, VIROLOGY, V423, P1, DOI 10.1016/j.virol.2011.11.016; Jennings BH, 2011, MATER TODAY, V14, P190, DOI 10.1016/S1369-7021(11)70113-4; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Joven A, 2015, METHODS MOL BIOL, V1290, P47, DOI 10.1007/978-1-4939-2495-0_4; Julier Z, 2017, ACTA BIOMATER, V53, P13, DOI 10.1016/j.actbio.2017.01.056; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Kango-Singh M, 2001, J BIOSCIENCE, V26, P167, DOI 10.1007/BF02703641; Kango-Singh M, 2009, DEV DYNAM, V238, P1627, DOI 10.1002/dvdy.21996; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Li L, 2017, FISH SHELLFISH IMMUN, V64, P352, DOI 10.1016/j.fsi.2017.03.024; Liu FY, 2018, BMC SYST BIOL, V12, DOI 10.1186/s12918-018-0544-3; Looso M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r16; Madamanchi NR, 2001, ARTERIOSCL THROM VAS, V21, P321, DOI 10.1161/01.ATV.21.3.321; Mathews J, 2018, CURR OPIN BIOTECH, V52, P134, DOI 10.1016/j.copbio.2018.03.008; Mehta AS, 2019, DEV BIOL, V453, P111, DOI 10.1016/j.ydbio.2019.04.006; Mehta AS, 2019, PROTOCOLS, V1, P1, DOI [10.17504/protocols.io.5bng2me, DOI 10.17504/PROTOCOLS.IO.5BNG2ME]; Meserve JH, 2018, DEV BIOL, V444, P43, DOI 10.1016/j.ydbio.2018.10.011; Mi HY, 2019, NAT PROTOC, V14, P703, DOI 10.1038/s41596-019-0128-8; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; O'Grady PM, 2018, GENETICS, V209, P1, DOI 10.1534/genetics.117.300583; Poss KD, 2010, NAT REV GENET, V11, P710, DOI 10.1038/nrg2879; Sarkar A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31787-7; Schubiger M, 2010, DEV BIOL, V347, P315, DOI 10.1016/j.ydbio.2010.08.034; Singh A, 2007, GENESIS, V45, P169, DOI 10.1002/dvg.20280; Singh A, 2012, DEV DYNAM, V241, P1, DOI 10.1002/dvdy.23712; Singh A, 2012, DEV DYNAM, V241, P69, DOI 10.1002/dvdy.22764; Singh BN, 2012, DEV BIOL, V371, P23, DOI 10.1016/j.ydbio.2012.07.033; Smith-Bolton RK, 2009, DEV CELL, V16, P797, DOI 10.1016/j.devcel.2009.04.015; Snigdha K, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00085; Sousounis K, 2015, ELIFE, V4, DOI 10.7554/eLife.09594; Sousounis K, 2013, MOL VIS, V19, P135; Steffensmeier AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078717; Stocum DL, 2017, REGENERATION, V4, P159, DOI 10.1002/reg2.92; STREISINGER G, 1986, GENETICS, V112, P311; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tanaka E, 2009, DEVELOPMENT, V136, P349, DOI 10.1242/dev.031682; Tare M, 2013, GENESIS, V51, P68, DOI 10.1002/dvg.22355; Tare M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024361; Tsonis PA, 2004, DEV BIOL, V267, P450, DOI 10.1016/j.ydbio.2003.12.005; Um J, 2017, CLIN TRANSL MED, V6, DOI 10.1186/s40169-017-0143-8; Wells JM, 2018, NATURE, V557, P322, DOI 10.1038/s41586-018-0073-7; Wittkorn E, 2015, DEVELOPMENT, V142, P2002, DOI 10.1242/dev.117358; Wolf JH, 2014, LIVER TRANSPLANT, V20, P376, DOI 10.1002/lt.23813; XU T, 1993, DEVELOPMENT, V117, P1223; Yang Jianyi, 2015, Curr Protoc Bioinformatics, V52, DOI 10.1002/0471250953.bi0508s52; Yang JY, 2016, J MOL BIOL, V428, P693, DOI 10.1016/j.jmb.2015.09.024; Yang QP, 2016, ENVIRON ENTOMOL, V45, P1552, DOI 10.1093/ee/nvw119; Yu FX, 2013, GENE DEV, V27, P1223, DOI 10.1101/gad.219402.113; Yu FX, 2012, CELL CYCLE, V11, P4097, DOI 10.4161/cc.22322; Zhong N, 2006, BONE, V39, P5, DOI 10.1016/j.bone.2005.12.008	84	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2019	14	8							e0220416	10.1371/journal.pone.0220416	http://dx.doi.org/10.1371/journal.pone.0220416			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5LL	31419228	gold, Green Published, Green Submitted			2022-12-26	WOS:000485019900013
J	Cheng, LJ; Soon, SS; Wu, DB; Ju, H; Ng, K				Cheng, Li-Jen; Soon, Swee Sung; Wu, David Bin-Chia; Ju, Hong; Ng, Kwong			Cost-effectiveness analysis of bilateral cochlear implants for children with severe-to-profound sensorineural hearing loss in both ears in Singapore	PLOS ONE			English	Article							DEAF-CHILDREN; SPEECH RECOGNITION; PERCEPTION; BENEFITS; CONSENSUS; ADULTS; AID; AGE	A cochlear implant is a small electronic device that provides a sense of sound for the user, which can be used unilaterally or bilaterally. Although there is advocacy for the benefits of binaural hearing, the high cost of cochlear implant raises the question of whether its additional benefits over the use of an acoustic hearing aid in the contralateral ear outweigh its costs. This cost-effectiveness analysis aimed to separately assess the cost-effectiveness of simultaneous and sequential bilateral cochlear implantations compared to bimodal hearing (use of unilateral cochlear implant combined with an acoustic hearing aid in the contralateral ear) in children with severe-to-profound sensorineural hearing loss in both ears from the Singapore healthcare payer perspective. Incremental quality-adjusted life year (QALYs) gained and costs associated with bilateral cochlear implants over the lifetime horizon were estimated based on a four-state Markov model. The analysis results showed that, at the 2017 mean cost, compared to bimodal hearing, patients receiving bilateral cochlear implants experienced more QALYs but incurred higher costs, resulting in an incremental cost-effectiveness ratio (ICER) of USD$60,607 per QALY gained for simultaneous bilateral cochlear implantation, and USD$81,782 per QALY gained for sequential bilateral cochlear implantation. The cost-effectiveness of bilateral cochlear implants is most sensitive to utility gain associated with second cochlear implant, and cost of bilateral cochlear implants. ICERs increased when the utility gain from bilateral cochlear implants decreased; ICERs exceeded USD$120,000 per QALY gained when the utility gain was halved from 0.03 to 0.015 in both simultaneous and sequential bilateral cochlear implantations. The choice of incremental utility gain associated with the second cochlear implant is an area of considerable uncertainty.	[Cheng, Li-Jen; Soon, Swee Sung; Wu, David Bin-Chia; Ju, Hong; Ng, Kwong] Minist Hlth, Agcy Care Effectiveness, Singapore, Singapore	Ministry of Health-Singapore	Ng, K (corresponding author), Minist Hlth, Agcy Care Effectiveness, Singapore, Singapore.	NG_Kwong_Hoe@moh.gov.sg	Wu, David Bin-Chia/H-3267-2019					Advanced Bionics, 2015, 2015 COCHL IMPL REL; Advanced Bionics, 2018, THE NAIDA BOMODAL HE; Avan P, 2015, AUDIOL NEURO-OTOL, V20, P3, DOI 10.1159/000380741; Balkany T, 2008, OTOL NEUROTOL, V29, P107, DOI 10.1097/mao.0b013e318163d2ea; Barton GR, 2006, EAR HEARING, V27, P575, DOI 10.1097/01.aud.0000233967.11072.24; Beadle EAR, 2005, OTOL NEUROTOL, V26, P1152, DOI 10.1097/01.mao.0000180483.16619.8f; Bond M, 2009, CLIN OTOLARYNGOL, V34, P199, DOI 10.1111/j.1749-4486.2009.01916.x; BOND M, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI DOI 10.3310/HTA13440; Boons T, 2012, EAR HEARING, V33, P627, DOI 10.1097/AUD.0b013e3182503e47; Broomfield Stephen J, 2014, Cochlear Implants Int, V15, P246, DOI 10.1179/1754762813Y.0000000041; Cochlear Limited, 2016, COCHL NUCL REL REP; Cullington HE, 2011, EAR HEARING, V32, P16, DOI 10.1097/AUD.0b013e3181edfbd2; De Raeve L, 2015, AUDIOL NEURO-OTOL, V20, P261, DOI 10.1159/000381003; Department of Statistics Singapore, 2016, COMPL LIF TABL 2014; Dowell Richard C., 2011, Seminars in Hearing, V32, P53, DOI 10.1055/s-0031-1271948; Drummond MFSM, 2005, METHODS FOR THE ECON; Geers AE, 2009, J DEAF STUD DEAF EDU, V14, P371, DOI 10.1093/deafed/enn046; Gordon KA, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00719; Huber M, 2012, OTOLARYNG HEAD NECK, V147, P763, DOI 10.1177/0194599812448352; Kuppler K, 2013, INT J PEDIATR OTORHI, V77, P617, DOI 10.1016/j.ijporl.2013.01.014; Lammers MJW, 2014, LARYNGOSCOPE, V124, P1694, DOI 10.1002/lary.24582; Litovsky RY, 2006, INT J AUDIOL, V45, pS78, DOI 10.1080/14992020600782956; Litovsky RY, 2006, EAR HEARING, V27, P43, DOI 10.1097/01.aud.0000194515.28023.4b; Loizou PC, 1998, IEEE SIGNAL PROC MAG, V15, P101, DOI 10.1109/79.708543; Low WK, 2005, ANN ACAD MED SINGAP, V34, P301; Med-El, 2016, REL YOU CAN COUNT; *MIN HLTH, 2001, REP COMM STUD EARL D; Mok M, 2007, AUDIOL NEURO-OTOL, V12, P295, DOI 10.1159/000103210; Mok M, 2010, AUDIOL NEURO-OTOL, V15, P44, DOI 10.1159/000219487; National Institute on Deafness and Other Communication Disorders (NIDCD), 2016, NIDCD FACT SHEET COC; National Institute on Deafness and Other Communication Disorders (NIDCD), 2015, NIDCD FACT SHEET HEA; Offeciers E, 2005, ACTA OTO-LARYNGOL, V125, P918, DOI 10.1080/00016480510044412; Oticon, 2018, OT MED STREAM BIM GU; Perez-Martin J, 2017, LARYNGOSCOPE, V127, P2866, DOI 10.1002/lary.26765; Peters BR, 2007, OTOL NEUROTOL, V28, P649, DOI 10.1097/01.mao.0000281807.89938.60; Ramsden JD, 2012, OTOL NEUROTOL, V33, P561, DOI 10.1097/MAO.0b013e3182536ae2; Sarant JZ, 2015, J SPEECH LANG HEAR R, V58, P1017, DOI 10.1044/2015_JSLHR-H-14-0075; Schafer Erin C, 2006, Am J Audiol, V15, P114, DOI 10.1044/1059-0889(2006/015); Schafer EC, 2011, INT J AUDIOL, V50, P871, DOI 10.3109/14992027.2011.622300; Sharma A, 2005, HEARING RES, V203, P134, DOI 10.1016/j.heares.2004.12.010; Summerfield AQ, 2006, INT J AUDIOL, V45, pS99, DOI 10.1080/14992020600783079; Summerfield AQ, 2010, EAR HEARING, V31, P611, DOI 10.1097/AUD.0b013e3181de40cd; Venail F, 2010, ARCH OTOLARYNGOL, V136, P366, DOI 10.1001/archoto.2010.31; Washington State Health Care Authority, 2013, COCHL IMPL BIL VERS; WHO, 2016, CHILDH HEAR LOSS; Zeitler DM, 2008, OTOL NEUROTOL, V29, P314, DOI 10.1097/MAO.0b013e3181662cb5	46	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220439	10.1371/journal.pone.0220439	http://dx.doi.org/10.1371/journal.pone.0220439			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415595	Green Published, gold, Green Submitted			2022-12-26	WOS:000485017200016
J	Situ, AJ; Ulmer, TS				Situ, Alan J.; Ulmer, Tobias S.			Universal principles of membrane protein assembly, composition and evolution	PLOS ONE			English	Article							AMINO-ACID GAIN; TRANSMEMBRANE; TOPOLOGY; RESIDUES; BAND-3; MOTIFS; UNIREF; TREND; AE1	Structural diversity in a-helical membrane proteins (MP) arises from variations in helix-helix crossings and contacts that may bias amino acid usage. Here, we reveal systematic changes in transmembrane amino acid frequencies (f) as a function of the number of helices (n). For eukarya, breaks in f(n) trends of packing (Ala, Gly and Pro), polar, and hydrophobic residues identify different MP assembly principles for 2 <= n <= 7, 8 <= n <= 12 and n >= 13. In bacteria, the first f break already occurs after n = 6 in correlation to an earlier n peak in MP size distribution and dominance of packing over polar interactions. In contrast to the later n brackets, the integration levels of helix bundles continuously increased in the first, most populous brackets indicating the formation of single structural units (domains). The larger first bracket of eukarya relates to a balance of polar and packing interactions that enlarges helix-helix combinatorial possibilities (MP diversity). Between the evolutionary old, packing and new, polar residues f anti-correlations extend over all biological taxa, broadly ordering them according to evolutionary history and allowing f estimates for the earliest forms of life. Next to evolutionary history, the amino acid composition of MP is determined by size (n), proteome diversity, and effective amino acid cost.	[Situ, Alan J.; Ulmer, Tobias S.] Univ Southern Calif, Keck Sch Med, Dept Physiol & Neurosci, Los Angeles, CA 90033 USA; [Ulmer, Tobias S.] Univ Southern Calif, Keck Sch Med, Dept Biochem & Mol Med, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Ulmer, TS (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Physiol & Neurosci, Los Angeles, CA 90033 USA.; Ulmer, TS (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Biochem & Mol Med, Los Angeles, CA 90033 USA.	tulmer@usc.edu			American Heart Association [18TPA34170481]; National Institutes of Health [R03AG063284]; NATIONAL INSTITUTE ON AGING [R03AG063284] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work received funding from American Heart Association Grant #18TPA34170481 and National Institutes of Health Grant R03AG063284 to TSU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamian L, 2005, PROTEINS, V59, P496, DOI 10.1002/prot.20456; Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999; Baeza-Delgado C, 2013, EUR BIOPHYS J BIOPHY, V42, P199, DOI 10.1007/s00249-012-0813-9; Brooks DJ, 2002, MOL BIOL EVOL, V19, P1645, DOI 10.1093/oxfordjournals.molbev.a003988; Brooks DJ, 2002, MOL CELL PROTEOMICS, V1, P125, DOI 10.1074/mcp.M100001-MCP200; CHOTHIA C, 1977, P NATL ACAD SCI USA, V74, P4130, DOI 10.1073/pnas.74.10.4130; Dawson JP, 2002, J MOL BIOL, V316, P799, DOI 10.1006/jmbi.2001.5353; del Val C, 2012, J MEMBRANE BIOL, V245, P717, DOI 10.1007/s00232-012-9452-4; GARCIA JC, 1992, J BIOL CHEM, V267, P7770; Gleason NJ, 2013, P NATL ACAD SCI USA, V110, P1692, DOI 10.1073/pnas.1215400110; GROVES JD, 1995, J BIOL CHEM, V270, P9097, DOI 10.1074/jbc.270.16.9097; Hynes RO, 2012, J CELL BIOL, V196, P671, DOI 10.1083/jcb.201109041; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jordan IK, 2005, NATURE, V433, P633, DOI 10.1038/nature03306; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kim C, 2012, NATURE, V481, P209, DOI 10.1038/nature10697; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LANDOLTMARTICORENA C, 1993, J MOL BIOL, V229, P602, DOI 10.1006/jmbi.1993.1066; Lee SY, 2009, PLOS BIOL, V7, P676, DOI 10.1371/journal.pbio.1000047; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Mannige RV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002839; Mirdita M, 2017, NUCLEIC ACIDS RES, V45, pD170, DOI 10.1093/nar/gkw1081; Misawa K, 2008, J MOL EVOL, V67, P334, DOI 10.1007/s00239-008-9141-1; Myshkin MY, 2017, RUSS J BIOORG CHEM+, V43, P634, DOI 10.1134/S1068162017060103; Nilsson I, 2003, J BIOL CHEM, V278, P29389, DOI 10.1074/jbc.M212310200; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; Reithmeier RAF, 2016, BBA-BIOMEMBRANES, V1858, P1507, DOI 10.1016/j.bbamem.2016.03.030; ROTHMAN JE, 1977, SCIENCE, V195, P743, DOI 10.1126/science.402030; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Schmidt T, 2016, J BIOL CHEM, V291, P17536, DOI 10.1074/jbc.M116.733683; Schmidt T, 2016, SCI REP-UK, V6, DOI 10.1038/srep29809; Schulz GE, 2002, BBA-BIOMEMBRANES, V1565, P308, DOI 10.1016/S0005-2736(02)00577-1; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Situ AJ, 2018, J PHYS CHEM B, V122, P1185, DOI 10.1021/acs.jpcb.7b11227; Stansfeld PJ, 2015, STRUCTURE, V23, P1350, DOI 10.1016/j.str.2015.05.006; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Suzek BE, 2015, BIOINFORMATICS, V31, P926, DOI 10.1093/bioinformatics/btu739; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; Trifonov EN, 2004, J BIOMOL STRUCT DYN, V22, P1; Ulmschneider MB, 2001, BBA-BIOMEMBRANES, V1512, P1, DOI 10.1016/S0005-2736(01)00299-1; van Meer G, 2005, EMBO J, V24, P3159, DOI 10.1038/sj.emboj.7600798; vanKlompenburg W, 1997, EMBO J, V16, P4261, DOI 10.1093/emboj/16.14.4261; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; White SH, 2008, ANNU REV BIOPHYS, V37, P23, DOI 10.1146/annurev.biophys.37.032807.125904; WIENER MC, 1992, BIOPHYS J, V61, P434, DOI 10.1016/S0006-3495(92)81849-0; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; WONG JTF, 1975, P NATL ACAD SCI USA, V72, P1909, DOI 10.1073/pnas.72.5.1909; Yohannan S, 2004, P NATL ACAD SCI USA, V101, P959, DOI 10.1073/pnas.0306077101; ZUCKERKANDL E, 1971, J MOL BIOL, V59, P473, DOI 10.1016/0022-2836(71)90311-1	50	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0221372	10.1371/journal.pone.0221372	http://dx.doi.org/10.1371/journal.pone.0221372			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415673	Green Published, Green Submitted, gold			2022-12-26	WOS:000485017200101
J	Stavinohova, R; Hartley, C; Burmeister, LM; Ricketts, SL; Pettitt, L; Pont, RT; Hitti, RJ; Schofield, E; Oliver, JAC; Mellersh, CS				Stavinohova, Renata; Hartley, Claudia; Burmeister, Louise M.; Ricketts, Sally L.; Pettitt, Louise; Pont, Roser Tetas; Hitti, Rebekkah J.; Schofield, Ellen; Oliver, James A. C.; Mellersh, Cathryn S.			Clinical, histopathological and genetic characterisation of oculoskeletal dysplasia in the Northern Inuit Dog	PLOS ONE			English	Article							RHEGMATOGENOUS RETINAL-DETACHMENT; RECESSIVE STICKLER SYNDROME; COL11A1 GENE; SKELETAL ABNORMALITIES; LABRADOR RETRIEVERS; MARSHALL-SYNDROME; FUNCTION MUTATION; FAMILY; IX; CARTILAGE	Seven Northern Inuit Dogs (NID) were diagnosed by pedigree analysis with an autosomal recessive inherited oculoskeletal dysplasia (OSD). Short-limbed dwarfism, angular limb deformities and a variable combination of macroglobus, cataracts, lens coloboma, micro-phakia and vitreopathy were present in all seven dogs, while retinal detachment was diagnosed in five dogs. Autosomal recessive OSD caused by COL9A3 and COL9A2 mutations have previously been identified in the Labrador Retriever (dwarfism with retinal dysplasia 1-drd1) and Samoyed dog (dwarfism with retinal dysplasia 2-drd2) respectively; both of those mutations were excluded in all affected NID. Nine candidate genes were screened in whole genome sequence data; only one variant was identified that was homozygous in two affected NID but absent in controls. This variant was a nonsense single nucleotide polymorphism in COL9A3 predicted to result in a premature termination codon and a truncated protein product. This variant was genotyped in a total of 1,232 dogs. All seven affected NID were homozygous for the variant allele (T/T), while 31/116 OSD-unaffected NID were heterozygous for the variant (C/T) and 85/116 were homozygous for the wildtype allele (C/C); indicating a significant association with OSD (p = 1.41x10(-11)). A subset of 56 NID unrelated at the parent level were analysed to determine an allele frequency of 0.08, estimating carrier and affected rates to be 15% and 0.6% respectively in NID. All 1,109 non-NID were C/C, suggesting the variant is rare or absent in other breeds. Expression of retinal mRNA was similar between an OSD-affected NID and OSD-unaffected non-NID. In conclusion, a nonsense variant in COL9A3 is strongly associated with OSD in NID, and appears to be widespread in this breed.	[Stavinohova, Renata; Hartley, Claudia; Pont, Roser Tetas; Oliver, James A. C.] Anim Hlth Trust, Ctr Small Anim Studies, Unit Comparat Ophthalmol, Newmarket, Suffolk, England; [Burmeister, Louise M.; Ricketts, Sally L.; Pettitt, Louise; Hitti, Rebekkah J.; Schofield, Ellen; Oliver, James A. C.; Mellersh, Cathryn S.] Anim Hlth Trust, Kennel Club Genet Ctr, Newmarket, Suffolk, England; [Stavinohova, Renata; Oliver, James A. C.] Dick White Referrals, Stn Farm, London Rd, Six Mile Bottom, Cambs, England; [Hartley, Claudia] Univ Bristol, Vet Sch, Langford Vet Serv, Bristol, Avon, England; [Pont, Roser Tetas] Queen Mother Hosp Anim, Royal Vet Coll, Hawkshead Lane, N Mymms, Herts, England	Animal Health Trust; Animal Health Trust; University of Bristol; University of London; University of London Royal Veterinary College	Stavinohova, R (corresponding author), Anim Hlth Trust, Ctr Small Anim Studies, Unit Comparat Ophthalmol, Newmarket, Suffolk, England.; Stavinohova, R (corresponding author), Dick White Referrals, Stn Farm, London Rd, Six Mile Bottom, Cambs, England.	renatastavinohova@gmail.com	Hartley, Claudia/AFW-4217-2022; Hitti-Malin, Rebekkah J/ABB-9752-2020; Hartley, Claudia/GYJ-7203-2022	Hartley, Claudia/0000-0002-1246-6479; Hitti-Malin, Rebekkah J/0000-0002-7873-2880; Oliver, James/0000-0002-2540-2183; Stavinohova, Renata/0000-0002-8628-9102; Burmeister, Louise/0000-0002-6551-055X; Schofield, Ellen/0000-0003-0648-1418; Ricketts, Sally/0000-0002-5644-7958	Animal Health Trust; Kennel Club Charitable Trust; British Association of Veterinary Ophthalmologists	Animal Health Trust; Kennel Club Charitable Trust; British Association of Veterinary Ophthalmologists	The work was supported by the Animal Health Trust, the Kennel Club Charitable Trust and the British Association of Veterinary Ophthalmologists. Two of the funders provided support in the form of salaries for authors RS, CH, RTP, JACO and CS (Animal Health Trust) and LMB, SLR, LP, RJH, ES and CSM (Kennel Club Charitable Trust), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ` author contributions' section. Two of the authors (RS and JACO) are currently employed by a commercial company, Dick White Referrals, but this affiliation did not play a role in the study as the authors were based at the Animal Health Trust at the time of their contribution to this study. Dick White Referrals are not a funder of this study and had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; AHMAD NN, 1991, P NATL ACAD SCI USA, V88, P6624, DOI 10.1073/pnas.88.15.6624; Annunen S, 1999, AM J HUM GENET, V65, P974, DOI 10.1086/302585; Aroch I, 1996, J SMALL ANIM PRACT, V37, P333, DOI 10.1111/j.1748-5827.1996.tb02403.x; AYME S, 1984, J MED GENET, V21, P34, DOI 10.1136/jmg.21.1.34; Baker S, 2011, AM J MED GENET A, V155A, P1668, DOI 10.1002/ajmg.a.34071; Bishop MA, 2004, CAN J VET RES, V68, P315; Bishop PN, 2004, INVEST OPHTH VIS SCI, V45, P1041, DOI 10.1167/iovs.03-1017; BLAIR NP, 1985, ARCH OPHTHALMOL-CHIC, V103, P842, DOI 10.1001/archopht.1985.01050060102037; BLAIR NP, 1985, ARCH OPHTHALMOL-CHIC, V103, P848, DOI 10.1001/archopht.1985.01050060108038; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; CARRIG CB, 1977, J AM VET MED ASSOC, V170, P49; CARRIG CB, 1988, J AM VET MED ASSOC, V193, P1269; Chiwitt CLH, 2017, VET OPHTHALMOL, V20, P411, DOI 10.1111/vop.12441; Edwards AO, 2008, EYE, V22, P1233, DOI 10.1038/eye.2008.38; Faletra F, 2014, AM J MED GENET A, V164, P42, DOI 10.1002/ajmg.a.36165; Friedman JS, 2000, INVEST OPHTH VIS SCI, V41, P2059; Frischknecht M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060149; Gathwala G., 2013, INT J BASIC APPL MED, V3, P8; Gelatt K.N., 2013, VET OPHTHALMOLOGY, V5th edn.; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Goldstein O, 2010, MAMM GENOME, V21, P398, DOI 10.1007/s00335-010-9276-4; Goyal M, 2016, CASE REP PEDIAT, V2016, DOI 10.1155/2016/3198597; Griffith AJ, 1998, AM J HUM GENET, V62, P816, DOI 10.1086/301789; Hobby P, 2000, MOL VIS, V6, P72; KNIEST W, 1952, Z Kinderheilkd, V70, P633, DOI 10.1007/BF00438870; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majava M, 2007, AM J MED GENET A, V143A, P258, DOI 10.1002/ajmg.a.31586; MARSHALL D, 1958, AM J OPHTHALMOL, V45, P143, DOI 10.1016/0002-9394(58)90236-8; Martin S, 1999, EUR J HUM GENET, V7, P807, DOI 10.1038/sj.ejhg.5200377; MAUMENEE IH, 1985, AM J OPHTHALMOL, V100, P155, DOI 10.1016/S0002-9394(14)74998-0; MAYNE R, 1993, J BIOL CHEM, V268, P9381; Mayne R, 1999, BIOCHEM SOC T, V27, P832, DOI 10.1042/bst0270832; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MENDLER M, 1989, J CELL BIOL, V108, P191, DOI 10.1083/jcb.108.1.191; MEYERS VN, 1983, J AM VET MED ASSOC, V183, P975; Nikopoulos K, 2011, INVEST OPHTH VIS SCI, V52, P4774, DOI 10.1167/iovs.10-7128; Olsen BR, 1997, INT J BIOCHEM CELL B, V29, P555, DOI 10.1016/S1357-2725(96)00100-8; Pellegrini B, 2002, GENE, V282, P121, DOI 10.1016/S0378-1119(01)00842-3; Plummer C., 2013, VET OPHTHALMOL, P1050; Reardon AJ, 2000, J BIOL CHEM, V275, P2123, DOI 10.1074/jbc.275.3.2123; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Richards AJ, 1996, HUM MOL GENET, V5, P1339, DOI 10.1093/hmg/5.9.1339; Robin NH, 2017, GENEREVIEWS R; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rozen S, 2000, Methods Mol Biol, V132, P365; SCHEPENS CL, 1954, AM J OPHTHALMOL, V38, P8, DOI 10.1016/0002-9394(54)90004-5; SHAW LM, 1991, TRENDS BIOCHEM SCI, V16, P191, DOI 10.1016/0968-0004(91)90074-6; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Simon L., NO INUIT DOG DOG ZON; Sirko-Osadsa D, 1998, J PEDIATR-US, V132, P368, DOI 10.1016/S0022-3476(98)70466-4; STICKLER GB, 1965, MAYO CLIN PROC, V40, P433; TENG CC, 1957, AM J OPHTHALMOL, V44, P335, DOI 10.1016/0002-9394(57)92766-6; Van Camp G, 2006, AM J HUM GENET, V79, P449, DOI 10.1086/506478; VANDERREST M, 1988, J BIOL CHEM, V263, P1615; VANDERREST M, 1985, J BIOL CHEM, V260, P220; vanSteensel MAM, 1997, AM J MED GENET, V70, P315; Vu CD, 2003, OPHTHALMOLOGY, V110, P70, DOI 10.1016/S0161-6420(02)01446-X; WU JJ, 1992, J BIOL CHEM, V267, P23007; Yu Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4230; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992	62	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220761	10.1371/journal.pone.0220761	http://dx.doi.org/10.1371/journal.pone.0220761			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415586	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000485017200030
J	Wu, H; Yang, J; Chen, LL; Wang, QM				Wu, Hao; Yang, Jie; Chen, Leilei; Wang, Qiaomei			A new method for identifying a fault in T-connected lines based on multiscale S-transform energy entropy and an extreme learning machine	PLOS ONE			English	Article							SCHEME	Due to the characteristics of T-connection transmission lines, a new method for T-connection transmission lines fault identification based on current reverse travelling wave multiscale S-transformation energy entropy and limit learning machine is proposed. S-transform are implemented on the faulty reverse traveling waves measured by each traveling wave protection unit of the T-connection transmission line, the reverse travelling wave energy entropies under eight different frequencies are respectively calculated, and a T-connection transmission line fault characteristic vector sample set are thus formed. Establish an intelligent fault identification model of extreme learning machines, and use the sample set for training and testing to identify the specific faulty branch of the T-connection transmission line. The simulation results show that the proposed algorithm can accurately and quickly identify the branch where the fault is located on the T-connection transmission line under various operation conditions.	[Wu, Hao; Yang, Jie; Chen, Leilei; Wang, Qiaomei] Sichuan Univ Sci & Engn, Artificial Intelligence Key Lab Sichuan Prov, Zigong, Peoples R China	Sichuan University of Science & Engineering	Wu, H (corresponding author), Sichuan Univ Sci & Engn, Artificial Intelligence Key Lab Sichuan Prov, Zigong, Peoples R China.	wuhao801212@163.com			National Natural Science Foundation of China [11705122]; Project of Sichuan provincial science and Technology Department [2017JY0338, 2019YJ0477, 2018GZDZX0043]; artificial intelligence key laboratory of Sichuan province Foundation [2017RYY02]; Sichuan University of Science and Engineering talent introduction project [2017RCL53]; Enterprise informatization and Internet of things measurement and control technology key laboratory project of Sichuan provincial university [2018WZY01]; Project of Sichuan Provincial Academician (Expert) workstation of Sichuan University of Science and Engineering [2018YSGZZ04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Sichuan provincial science and Technology Department; artificial intelligence key laboratory of Sichuan province Foundation; Sichuan University of Science and Engineering talent introduction project; Enterprise informatization and Internet of things measurement and control technology key laboratory project of Sichuan provincial university; Project of Sichuan Provincial Academician (Expert) workstation of Sichuan University of Science and Engineering	This research was supported by National Natural Science Foundation of China (Grant Nos. 11705122); The Project of Sichuan provincial science and Technology Department (Grant No. 2017JY0338, 2019YJ0477, 2018GZDZX0043); The artificial intelligence key laboratory of Sichuan province Foundation (2017RYY02); Sichuan University of Science and Engineering talent introduction project (2017RCL53); Enterprise informatization and Internet of things measurement and control technology key laboratory project of Sichuan provincial university (2018WZY01); The Project of Sichuan Provincial Academician (Expert) workstation of Sichuan University of Science and Engineering (2018YSGZZ04).	An JF, 2008, POWER SYSTEM PROTECT, P93; Bai Jia, 2005, Power System Technology, V29, P69; Bhalja B, 2008, IET GENER TRANSM DIS, V2, P271, DOI 10.1049/iet-gtd:20070152; [陈明杰 Chen Mingjie], 2003, [泥沙研究, Journal of Sediment Research], V0, P41; [陈旭 Chen Xu], 2016, [电力系统自动化, Automation of Electric Power Systems], V40, P105; Dong XX, 2018, ELECT MEASUREMENT IN, V55, P7; Eissa MM, 2005, ELECTR POW SYST RES, V73, P107, DOI 10.1016/j.epsr.2004.06.009; Gao HL, 2001, RELAY; Gaur VK, 2017, INT J ELEC POWER, V93, P216, DOI 10.1016/j.ijepes.2017.05.024; Huang G, 2015, NEURAL NETWORKS, V61, P32, DOI 10.1016/j.neunet.2014.10.001; Huang GB, 2011, INT J MACH LEARN CYB, V2, P107, DOI 10.1007/s13042-011-0019-y; [黄南天 Huang Nantian], 2017, [电力系统保护与控制, Power System Protection and Control], V45, P38; Kumar A., 2017, 2017 8 INT C COMP CO; Li B, 2011, J TEST EVAL, V39, P16, DOI 10.1520/JTE101910; Li Xiaopeng, 2014, Automation of Electric Power Systems, V38, P113, DOI 10.7500/AEPS20130424005; Liao ZY, 1999, RELAY; Lin TC, 2014, IEEE T SMART GRID, V5, P38, DOI 10.1109/TSG.2013.2286292; Liu Jing, 2008, Electric Power Automation Equipment, V28, P58; Nayak PK, 2016, IEEE T POWER DELIVER, V31, P999, DOI 10.1109/TPWRD.2014.2387873; [覃星福 Qin Xingfu], 2016, [电力系统保护与控制, Power System Protection and Control], V44, P10; Shu HC, 1998, P CHINESE SOC ELECT, P41; Shu Hong-chun, 2003, Power System Technology, V27, P11; [索南加乐 SUONAN Jiale], 2009, [电力自动化设备, Electric Power Automation Equipment], V29, P4; [陶维青 Tao Weiqing], 2016, [合肥工业大学学报. 自然科学版, Journal of Hefei University of Technology. Natural Science], V39, P40; [王婷 Wang Ting], 2015, [电力系统保护与控制, Power System Protection and Control], V43, P60; [吴浩 Wu Hao], 2016, [电力系统保护与控制, Power System Protection and Control], V44, P15; [吴浩 Wu Hao], 2016, [电力系统自动化, Automation of Electric Power Systems], V40, P107; Wu Hao, 2016, High Voltage Apparatus, V52, P42, DOI 10.13296/j.1001-1609.hva.2016.01.008; [姚亮 Yao Liang], 2012, [电力系统保护与控制, Power System Protection and Control], V40, P26; Zhang Wujun, 2007, Automation of Electric Power Systems, V31, P61; Zhang Xueqing, 2013, Proceedings of the CSEE, V33, P33; [郑涛 Zheng Tao], 2017, [电网技术, Power System Technology], V41, P1660; [邹贵彬 Zou Guibin], 2014, [中国电机工程学报, Proceedings of the Chinese Society of Electrical Engineering], V34, P5677	33	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220870	10.1371/journal.pone.0220870	http://dx.doi.org/10.1371/journal.pone.0220870			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415612	Green Submitted, Green Published, gold			2022-12-26	WOS:000485017200042
J	Zhang, T; Runge, JH; Lavini, C; Stoker, J; van Gulik, T; Cieslak, KP; van Vliet, LJ; Vos, FM				Zhang, Tian; Runge, Jurgen H.; Lavini, Cristina; Stoker, Jaap; van Gulik, Thomas; Cieslak, Kasia P.; van Vliet, Lucas J.; Vos, Frans M.			A pharmacokinetic model including arrival time for two inputs and compensating for varying applied flip-angle in dynamic gadoxetic acid-enhanced MR imaging	PLOS ONE			English	Article							DCE-MRI; PERFUSION; B-1-INHOMOGENEITY; QUANTIFICATION	Purpose Pharmacokinetic models facilitate assessment of properties of the micro-vascularization based on DCE-MRI data. However, accurate pharmacokinetic modeling in the liver is challenging since it has two vascular inputs and it is subject to large deformation and displacement due to respiration. Methods We propose an improved pharmacokinetic model for the liver that (1) analytically models the arrival-time of the contrast agent for both inputs separately; (2) implicitly compensates for signal fluctuations that can be modeled by varying applied flip-angle e.g. due to B1-inhomogeneity. Orton's AIF model is used to analytically represent the vascular input functions. The inputs are independently embedded into the Sourbron model. B1-inhomogeneity-driven variations of flip-angles are accounted for to justify the voxel's displacement with respect to a pre-contrast image. Results The new model was shown to yield lower root mean square error (RMSE) after fitting the model to all but a minority of voxels compared to Sourbron's approach. Furthermore, it outperformed this existing model in the majority of voxels according to three model-selection criteria. Conclusion Our work primarily targeted to improve pharmacokinetic modeling for DCE-MRI of the liver. However, other types of pharmacokinetic models may also benefit from our approaches, since the techniques are generally applicable.	[Zhang, Tian; van Vliet, Lucas J.; Vos, Frans M.] Delft Univ Technol, Dept Imaging Phys, Delft, Netherlands; [Runge, Jurgen H.; Lavini, Cristina; Stoker, Jaap; Vos, Frans M.] Acad Med Ctr, Dept Radiol, Amsterdam, Netherlands; [van Gulik, Thomas; Cieslak, Kasia P.] Acad Med Ctr, Dept Surg, Amsterdam, Netherlands	Delft University of Technology; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Vos, FM (corresponding author), Delft Univ Technol, Dept Imaging Phys, Delft, Netherlands.; Vos, FM (corresponding author), Acad Med Ctr, Dept Radiol, Amsterdam, Netherlands.	f.m.vos@tudelft.nl	van Vliet, Lucas/E-1678-2012; Stoker, Jaap/AAH-7597-2019	van Vliet, Lucas/0000-0001-7018-726X; Stoker, Jaap/0000-0002-9822-3784				Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Aronhime S, 2014, J MAGN RESON IMAGING, V40, P90, DOI 10.1002/jmri.24341; Benjamini Y, 1966, SOURCE J R STAT SO C, V15, P216, DOI [DOI 10.2307/2346101, 10.2307/2346101]; Bozdogan H, 1987, 1 C INT FED CLASS SO, P599; Chandarana H, 2015, INVEST RADIOL, V50, P749, DOI 10.1097/RLI.0000000000000179; de Bazelaire CMJ, 2004, RADIOLOGY, V230, P652, DOI 10.1148/radiol.2303021331; Dietrich O, 2008, EUR J RADIOL, V65, P29, DOI 10.1016/j.ejrad.2007.11.005; Forsgren MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095700; Gach H, 2016, MED PHYS, V43, P3775, DOI 10.1118/1.4957651; Heinrich MP, 2012, MED IMAGE ANAL, V16, P1423, DOI 10.1016/j.media.2012.05.008; Jackson A, 2005, DYNAMIC CONTRAST ENH, DOI DOI 10.1007/B137553; Materne R, 2002, MAGNET RESON MED, V47, P135, DOI 10.1002/mrm.10045; Mukaka MM, 2012, MALAWI MED J, V24, P69; Nehrke K, 2012, MAGN RESON MED, V68, P1517, DOI 10.1002/mrm.24158; Nilsson H, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120653; Nilsson H, 2009, J MAGN RESON IMAGING, V29, P1323, DOI 10.1002/jmri.21801; Ning J, 2017, MAGN RESON MED, V78, P1488, DOI 10.1002/mrm.26520; Orton MR, 2008, PHYS MED BIOL, V53, P1225, DOI 10.1088/0031-9155/53/5/005; Park B, 2017, KOREAN J RADIOL, V18, P585, DOI 10.3348/kjr.2017.18.4.585; Parker GJM, 2006, MAGN RESON MED, V56, P993, DOI 10.1002/mrm.21066; Rohrer M, 2005, INVEST RADIOL, V40, P715, DOI 10.1097/01.rli.0000184756.66360.d3; Ryeom HK, 2004, KOREAN J RADIOL, V5, P231, DOI 10.3348/kjr.2004.5.4.231; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sengupta A, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1349-7; Simeth J, 2018, NMR BIOMED, V31, DOI 10.1002/nbm.3913; Sourbron S, 2012, RADIOLOGY, V263, P874, DOI 10.1148/radiol.12110337; Ulloa JL, 2013, NMR BIOMED, V26, P1258, DOI 10.1002/nbm.2946; van Schie JJN, 2018, J MAGN RESON IMAGING, V47, P1197, DOI 10.1002/jmri.25905; van Schie JJN, 2018, J MAGN RESON IMAGING, V47, P1190, DOI 10.1002/jmri.25906; van Schie JJN, 2015, MAGN RESON IMAGING, V33, P312, DOI 10.1016/j.mri.2014.10.008; Zhang T, 2016, PROC SPIE, V9784, DOI 10.1117/12.2216668; Zhang Y, 2008, MEDIVIS 2008: FIFTH INTERNATIONAL CONFERENCE BIOMEDICAL VISUALIZATION - INFORMATION VISUALIZATION IN MEDICAL AND BIOMEDICAL INFORMATICS, PROCEEDINGS, P71, DOI 10.1109/MediVis.2008.12	32	1	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220835	10.1371/journal.pone.0220835	http://dx.doi.org/10.1371/journal.pone.0220835			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415613	Green Published, Green Submitted, gold			2022-12-26	WOS:000485017200037
J	Adler, J; Jary, HK; Eder, SJ; Dong, SM; Brandt, E; Haraga, JK; Dombkowski, KJ				Adler, Jeremy; Jary, Hannah K.; Eder, Sally J.; Dong, Shiming; Brandt, Emily; Haraga, Jessica K.; Dombkowski, Kevin J.			Identifying perianal fistula complications in pediatric patients with Crohn's disease using administrative claims	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; QUALITY-OF-LIFE; CLINICAL CHARACTERISTICS; ENDOSCOPIC ULTRASOUND; ULCERATIVE-COLITIS; CHILDREN; ASTHMA; CARE; EPIDEMIOLOGY; MANAGEMENT	Background Although perianal fistulas occur commonly in pediatric Crohn's disease (CD), evaluations of health services have been limited since no validated claims-based methods exist for identifying cases. Objective To develop and validate accurate case definitions for perianal fistulas among pediatric patients with CD from administrative claims. Methods Retrospective cohort study in which we developed and tested candidate case definitions for perianal fistula. Patients (age 5-21 years between 2005-2012) with CD enrolled in Michigan Medicaid with healthcare at University of Michigan were identified via claims. Medical records were obtained from all identified patients, whose entire records were abstracted. Medical record evidence for perianal fistula was considered the "gold standard" against which candidate case definitions were compared. The reference case definition of perianal fistula (ICD9 565.1) and candidate case definitions were evaluated. Results Of 843 patients identified via claims, 274 (33%) met CD criteria for inclusion. The true perianal fistula rate among CD patients was 18% (n = 49). The top-performing candidate case definition identified 15% (n = 42), had sensitivity of 77.6%, specificity of 98.2%, positive predictive value (PPV) 90.5%, negative predictive value (NPV) 95.3%, and area under receiver operator characteristic curve (ROC) of 0.88. In contrast, the reference case definition identified 9% (n = 26), sensitivity 51.0%, specificity 99.6%, PPV 96.2%, NPV 90.3%, and had an area under ROC of 0.75. Conclusions We demonstrated that it is feasible to use administrative claims data to accurately identify pediatric patients with perianal fistula complications. Claims-based case definitions were found to be highly accurate through medical record review, providing a high degree of confidence for future studies where chart review is not feasible. These claims-based methods can be applied to claims data in other settings for the evaluation of health services utilization as well as to assess the comparative effectiveness of prevention and treatment strategies.	[Adler, Jeremy; Eder, Sally J.] Univ Michigan, Dept Pediat & Communicable Dis, Div Pediat Gastroenterol, Ann Arbor, MI 48109 USA; [Adler, Jeremy; Jary, Hannah K.; Eder, Sally J.; Dong, Shiming; Brandt, Emily; Haraga, Jessica K.; Dombkowski, Kevin J.] Univ Michigan, Susan B Meister Child Hlth Evaluat & Res CHEAR Ct, Ann Arbor, MI 48109 USA; [Dong, Shiming] AbbVie Inc, N Chicago, IL USA; [Haraga, Jessica K.] Case Western Reserve Univ, Sch Med, Cleveland, OH USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; AbbVie; Case Western Reserve University	Adler, J (corresponding author), Univ Michigan, Dept Pediat & Communicable Dis, Div Pediat Gastroenterol, Ann Arbor, MI 48109 USA.; Adler, J (corresponding author), Univ Michigan, Susan B Meister Child Hlth Evaluat & Res CHEAR Ct, Ann Arbor, MI 48109 USA.	jeradler@umich.edu	Adler, Jeremy/C-5738-2009	Adler, Jeremy/0000-0002-4857-6098; Peng, Hannah/0000-0003-0928-6087	Blue Cross Blue Shield Foundation of Michigan [1978.11]	Blue Cross Blue Shield Foundation of Michigan	Blue Cross Blue Shield Foundation of Michigan provided funds to conduct this study (1978.11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2017, J PEDIATR GASTR NUTR, V64, pE117, DOI 10.1097/MPG.0000000000001447; Adler J, 2013, J PEDIATR GASTR NUTR, V57, P35, DOI 10.1097/MPG.0b013e31828f1ea2; Benchimol EI, 2009, GUT, V58, P1490, DOI 10.1136/gut.2009.188383; Bernstein CN, 1999, AM J EPIDEMIOL, V149, P916, DOI 10.1093/oxfordjournals.aje.a009735; Bouguen G, 2013, CLIN GASTROENTEROL H, V11, P975, DOI 10.1016/j.cgh.2012.12.042; Bouguen G, 2010, INFLAMM BOWEL DIS, V16, P1431, DOI 10.1002/ibd.21261; Bruckner A, 2018, J PEDIATR GASTR NUTR, V66, P73, DOI 10.1097/MPG.0000000000001649; Cohen RD, 2008, INFLAMM BOWEL DIS, V14, P1707, DOI 10.1002/ibd.20530; de la Poza G, 2012, J CROHNS COLITIS, V6, P276, DOI 10.1016/j.crohns.2011.08.015; Dillman JR, 2010, PEDIATR RADIOL, V40, P97, DOI 10.1007/s00247-009-1465-5; Dombkowski KJ, 2008, ANN EPIDEMIOL, V18, P290, DOI 10.1016/j.annepidem.2007.11.012; Dombkowski KJ, 2012, J PUBLIC HEALTH MAN, V18, P196, DOI 10.1097/PHH.0b013e31821a3fa7; Dombkowski KJ, 2009, J PEDIATR-US, V155, P788, DOI 10.1016/j.jpeds.2009.06.033; Dombkowski KJ, 2009, J PUBLIC HEALTH MAN, V15, P485, DOI 10.1097/PHH.0b013e3181a8c334; Dombkowski KJ, 2005, PUBLIC HEALTH REP, V120, P515, DOI 10.1177/003335490512000506; Feagan BG, 2000, AM J GASTROENTEROL, V95, P1955; Gecse KB, 2014, GUT, V63, P1381, DOI 10.1136/gutjnl-2013-306709; Gupta N, 2010, INFLAMM BOWEL DIS, V16, P638, DOI 10.1002/ibd.21099; Hachem CY, 2008, ALIMENT PHARM THER, V28, P1078, DOI 10.1111/j.1365-2036.2008.03827.x; Herman Y, 2017, INFLAMM BOWEL DIS, V23, P1659, DOI 10.1097/MIB.0000000000001171; Iwashyna TJ, 2014, MED CARE, V52, pE39, DOI 10.1097/MLR.0b013e318268ac86; Jeshion WC, 2000, J CLIN GASTROENTEROL, V30, P294, DOI 10.1097/00004836-200004000-00018; Kappelman MD, 2013, DIGEST DIS SCI, V58, P519, DOI 10.1007/s10620-012-2371-5; Kasparek MS, 2007, DIS COLON RECTUM, V50, P2067, DOI 10.1007/s10350-007-9006-5; Keljo DJ, 2009, INFLAMM BOWEL DIS, V15, P383, DOI 10.1002/ibd.20767; Kugathasan S, 2003, J PEDIATR-US, V143, P525, DOI 10.1067/S0022-3476(03)00444-X; Lam TJ, 2014, INT J COLORECTAL DIS, V29, P923, DOI 10.1007/s00384-014-1926-7; Lane VA, 2010, J PEDIATR UROL, V6, P270, DOI 10.1016/j.jpurol.2009.08.010; Levine A, 2014, J PEDIATR GASTR NUTR, V58, P795, DOI 10.1097/MPG.0000000000000239; Levine A, 2011, INFLAMM BOWEL DIS, V17, P1314, DOI 10.1002/ibd.21493; Mahadev S, 2011, DIS COLON RECTUM, V54, P579, DOI 10.1007/DCR.0b013e3182099d9e; MARKOWITZ J, 1995, J PEDIATR GASTR NUTR, V21, P149, DOI 10.1097/00005176-199508000-00005; Norton Christine, 2013, J Crohns Colitis, V7, pe302, DOI 10.1016/j.crohns.2012.11.004; Pai D, 2011, PEDIATR RADIOL, V41, P537, DOI 10.1007/s00247-010-1892-3; Reeves S, 2014, ACAD PEDIATR, V14, pS61, DOI 10.1016/j.acap.2014.02.008; Rosen MJ, 2010, INFLAMM BOWEL DIS, V16, P461, DOI 10.1002/ibd.21067; Schwartz DA, 2002, GASTROENTEROLOGY, V122, P875, DOI 10.1053/gast.2002.32362; Schwartz DA, 2019, INFLAMM BOWEL DIS, V25, P1773, DOI 10.1093/ibd/izz056; Schwartz DA, 2017, INFLAMM BOWEL DIS, V23, P1860, DOI 10.1097/MIB.0000000000001243; Schwartz DA, 2015, INFLAMM BOWEL DIS, V21, P737, DOI 10.1097/MIB.0000000000000377; Singer AAM, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2878; Singh S, 2015, ALIMENT PHARM THER, V42, P783, DOI 10.1111/apt.13356; Smith EA, 2012, AM J ROENTGENOL, V198, pW38, DOI 10.2214/AJR.11.6803; Spradlin NM, 2008, AM J GASTROENTEROL, V103, P2527, DOI 10.1111/j.1572-0241.2008.02063.x; Steinhart AH, 2019, INFLAMM BOWEL DIS, V25, P1, DOI 10.1093/ibd/izy247; Tarrant KM, 2008, AM J GASTROENTEROL, V103, P3082, DOI 10.1111/j.1572-0241.2008.02212.x; Tozer P, 2012, INFLAMM BOWEL DIS, V18, P1825, DOI 10.1002/ibd.21940; Vernier-Massouille G, 2008, GASTROENTEROLOGY, V135, P1106, DOI 10.1053/j.gastro.2008.06.079; Zhao M, 2019, INFLAMM BOWEL DIS, V25, P1227, DOI 10.1093/ibd/izy374; Zwintscher NP, 2015, INT J COLORECTAL DIS, V30, P1275, DOI 10.1007/s00384-015-2251-5	50	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0219893	10.1371/journal.pone.0219893	http://dx.doi.org/10.1371/journal.pone.0219893			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412045	Green Submitted, Green Published, gold			2022-12-26	WOS:000485012600018
J	Goren, L; Zhang, G; Kaushik, S; Breslin, PAS; Du, YCN; Foster, DA				Goren, Limor; Zhang, George; Kaushik, Susmita; Breslin, Paul A. S.; Du, Yi-Chieh Nancy; Foster, David A.			(-)-Oleocanthal and (-)-oleocanthal-rich olive oils induce lysosomal membrane permeabilization in cancer cells	PLOS ONE			English	Article							CYSTEINE CATHEPSINS; BREAST-CANCER; MEDITERRANEAN DIET; MOUSE MODEL; OLEOCANTHAL; EXPRESSION; TRIAL; RISK	(-)-Oleocanthal (oleocanthal) is a phenolic compound found in varying concentrations in extra virgin olive oil oleocanthal has been shown to be active physiologically, benefiting several diseased states by conferring anti-inflammatory and neuroprotective benefits. Recently, we and other groups have demonstrated its specific and selective toxicity toward cancer cells; however, the mechanism leading to cancer cell death is still disputed. The current study demonstrates that oleocanthal, as well as naturally oleocanthal-rich extra virgin olive oils, induced damage to cancer cells' lysosomes leading to cellular toxicity in vitro and in vivo. Lysosomal membrane permeabilization following oleocanthal treatment in various cell lines was assayed via three complementary methods. Additionally, we found oleocanthal treatment reduced tumor burden and extended lifespan of mice engineered to develop pancreatic neuroendocrine tumors. Finally, following-up on numerous correlative studies demonstrating consumption of olive oil reduces cancer incidence and morbidity, we observed that extra virgin olive oils naturally rich in oleocanthal sharply reduced cancer cell viability and induced lysosomal membrane permeabilization while oleocanthal-poor oils did not. Our results are especially encouraging since tumor cells often have larger and more numerous lysosomes, making them especially vulnerable to lysosomotropic agents such as oleocanthal.	[Goren, Limor; Foster, David A.] CUNY, Dept Biol Sci, Hunter Coll, New York, NY 10021 USA; [Goren, Limor; Foster, David A.] CUNY, Grad Ctr, Biol Program, New York, NY 10017 USA; [Zhang, George; Du, Yi-Chieh Nancy] Weill Cornell Med, Dept Pathol & Lab Med, New York, NY USA; [Kaushik, Susmita] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA; [Breslin, Paul A. S.] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ USA; [Breslin, Paul A. S.] Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA; [Foster, David A.] CUNY, Grad Ctr, Biochem Program, New York, NY 10017 USA; [Foster, David A.] Weill Cornell Med, Dept Pharmacol, New York, NY 10065 USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; Cornell University; Yeshiva University; Albert Einstein College of Medicine; Rutgers State University New Brunswick; Monell Chemical Senses Center; City University of New York (CUNY) System; Cornell University	Foster, DA (corresponding author), CUNY, Dept Biol Sci, Hunter Coll, New York, NY 10021 USA.; Foster, DA (corresponding author), CUNY, Grad Ctr, Biol Program, New York, NY 10017 USA.; Foster, DA (corresponding author), CUNY, Grad Ctr, Biochem Program, New York, NY 10017 USA.; Foster, DA (corresponding author), Weill Cornell Med, Dept Pharmacol, New York, NY 10065 USA.	foster@genectr.hunter.cuny.edu	Kaushik, Susmita/GVS-3186-2022	Kaushik, Susmita/0000-0002-6096-5387; Breslin, Paul/0000-0001-5988-8401; Zhang, George/0000-0002-4834-6401	National Institutes of Health [R01-CA204916, R01-CA179542]; Department of Defense [W81XWH-16-1-0619]; NATIONAL CANCER INSTITUTE [R01CA204916, R01CA179542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Partial salary support was provided by National Institutes of Health grant R01-CA179542 to DAF and LG; Partial salary support was provided by National Institutes of Health grant R01-CA204916 to GZ and YND and YND was also partially supported by Department of Defense grant W81XWH-16-1-0619. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aits S, 2015, AUTOPHAGY, V11, P1408, DOI 10.1080/15548627.2015.1063871; Aits S, 2015, METHOD CELL BIOL, V126, P261, DOI 10.1016/bs.mcb.2014.10.032; Akl MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097622; Andrewes P, 2003, J AGR FOOD CHEM, V51, P1415, DOI 10.1021/jf026042j; Ayoub NM, 2017, EUR J PHARMACOL, V810, P100, DOI 10.1016/j.ejphar.2017.06.019; Batarseh YS, 2018, J NUTR BIOCHEM, V55, P113, DOI 10.1016/j.jnutbio.2017.12.006; Beauchamp GK, 2005, NATURE, V437, P45, DOI 10.1038/437045a; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Buckland G, 2013, INT J CANCER, V132, P2918, DOI 10.1002/ijc.27958; de Lorgeril M, 1998, ARCH INTERN MED, V158, P1181, DOI 10.1001/archinte.158.11.1181; DEDUVE C, 1983, EUR J BIOCHEM, V137, P391, DOI 10.1111/j.1432-1033.1983.tb07841.x; Diez-Bello R, 2019, BBA-MOL CELL RES, V1866, P474, DOI 10.1016/j.bbamcr.2018.10.010; Du YCN, 2007, PLOS BIOL, V5, P2255, DOI 10.1371/journal.pbio.0050276; Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025; Elnagar AY, 2011, PLANTA MED, V77, P1013, DOI 10.1055/s-0030-1270724; Fehrenbacher N, 2004, CANCER RES, V64, P5301, DOI 10.1158/0008-5472.CAN-04-1427; Fogli S, 2016, NUTR CANCER, V68, P873, DOI 10.1080/01635581.2016.1180407; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Gyrd-Hansen M, 2004, CELL CYCLE, V3, P1484, DOI 10.4161/cc.3.12.1287; Joyce JA, 2004, CELL CYCLE, V3, P1516, DOI 10.4161/cc.3.12.1289; Kallunki T, 2013, ONCOGENE, V32, P1995, DOI 10.1038/onc.2012.292; Karkoula E, 2012, J AGR FOOD CHEM, V60, P11696, DOI 10.1021/jf3032765; Keiler AM, 2015, PLANTA MED, V81, P1263, DOI 10.1055/s-0035-1546194; Khanal P, 2011, CARCINOGENESIS, V32, P545, DOI 10.1093/carcin/bgr001; Kwan HY, 2015, CRIT REV FOOD SCI NU, V57, P82, DOI DOI 10.1080/10408398.2013; LeGendre O, 2015, MOL CELL ONCOL, V2, DOI 10.1080/23723556.2015.1006077; Li WK, 2009, J NEUROCHEM, V110, P1339, DOI 10.1111/j.1471-4159.2009.06224.x; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Mohyeldin MM, 2016, ONCOTARGET, V7, P32247, DOI 10.18632/oncotarget.8681; MONTEDORO G, 1993, J AGR FOOD CHEM, V41, P2228, DOI 10.1021/jf00035a076; Ono K, 2003, MOL CELL BIOL, V23, P665, DOI 10.1128/MCB.23.2.665-676.2003; Pei TM, 2016, ONCOTARGET, V7, P43475, DOI 10.18632/oncotarget.9782; Perera R, 2015, NATURE, V524, P361, DOI 10.1038/nature14587; Pitt J, 2009, TOXICOL APPL PHARM, V240, P189, DOI 10.1016/j.taap.2009.07.018; Psaltopoulou T, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-127; Repnik U, 2017, J CELL SCI, V130, P3124, DOI 10.1242/jcs.204529; Scotece M, 2013, CURR MED CHEM, V20, P2467, DOI 10.2174/0929867311320190006; Serrano-Puebla A, 2018, BIOCHEM SOC T, V46, P207, DOI 10.1042/BST20170130; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; Toledo E, 2015, JAMA INTERN MED, V175, P1752, DOI 10.1001/jamainternmed.2015.4838; Wang FJ, 2018, TRAFFIC, V19, P918, DOI 10.1111/tra.12613; Wang FJ, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.170271; Wlodkowic D, 2009, METHODS MOL BIOL, V559, P19, DOI 10.1007/978-1-60327-017-5_2	43	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0216024	10.1371/journal.pone.0216024	http://dx.doi.org/10.1371/journal.pone.0216024			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412041	Green Submitted, Green Published, gold			2022-12-26	WOS:000485012600006
J	Morales, M; Oakley, L; Sartori, ALB; Mogni, VY; Atahuachi, M; Vanni, RO; Fortunato, RH; Prado, DE				Morales, Matias; Oakley, Luis; Sartori, Angela L. B.; Mogni, Virginia Y.; Atahuachi, Margoth; Vanni, Ricardo O.; Fortunato, Renee H.; Prado, Darien E.			Diversity and conservation of legumes in the Gran Chaco and biogeograpical inferences	PLOS ONE			English	Article							NEOTROPICAL DRY FORESTS; MIMOSA LEGUMINOSAE; PHYLOGENETIC-RELATIONSHIPS; SEASONAL FORESTS; SENSU-LATO; SOUTH; FABACEAE; DALBERGIEAE; MIMOSOIDEAE; ARGENTINA	The Gran Chaco is a wide ecologic-geographic region comprising northern Argentina, western Paraguay, southern Bolivia and the southwestern extreme of Brazil. This region exhibits extreme temperatures, annually regular frosts, and sedimentary soils; it has been dramatically threatened by agriculture expansion in recent decades. Therefore, increasing knowledge of plant diversity is critical for conservation purposes. We present a Legume checklist of the Gran Chaco ecoregion including conservation status of its endemic species. Leguminosae is the third most diverse plant family in the Neotropics. Assuming a rigorous spatial definition of the Gran Chaco, we recorded 98 genera, 362 species, and 404 specific and infraspecific taxa. Endemic/typical taxa were 17%, comparable to adjacent tropical plant formations, and they were found in higher percentages in Caesalpinioideae (24%) and Cercidoideae (33%) than Papilionoideae (11%) subfamily. We also analyzed the plant diversity comparing lineages and subregions. The Gran Chaco Legumes are predominantly widespread generalists, or they belong to either Chaco sensu stricto or Neotropical Seasonally Dry Tropical Forest (SDTF) lineages. Though the Humid Chaco registered the highest species richness, Dry Chaco and Sierra Chaco, the most threatrened subregions, exhibited the highest percentages of exclusive and proper Chaco-lineage species. These results suggest that diversification of Legumes has been most relevant in Dry Chaco and Sierra Chaco, probably by their more demanding and harsh environmental conditions limiting the dispersion of generalists or intrusive-invading species. This study is paramount to reach an improved delimitation of the Gran Chaco ecoregion in transitional areas with the SDTF and Cerrado formations. Conservation status is critical in genera of high economic interest, such as Arachis, Mimosa and Prosopis. At least one third of endemic taxa exhibit a critical status	[Morales, Matias; Fortunato, Renee H.] INTA, Inst Recursos Biol CIRN, CNIA, Las Cabanas & Los Reseros Sn, RA-1686 Hurlingham, Argentina; [Morales, Matias; Vanni, Ricardo O.; Fortunato, Renee H.; Prado, Darien E.] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Morales, Matias; Fortunato, Renee H.] Univ Moron, Fac Agron & Cs Agroalimentarias, Cabildo, Moron, Argentina; [Oakley, Luis; Mogni, Virginia Y.; Prado, Darien E.] Univ Nacl Rosario, Fac Ciencias Agr, CC 14,S2125ZAA, Zavalla, Santa Fe, Argentina; [Oakley, Luis] IUCN, Red List Author Coordinator Temperate South Amer, Cambridge, England; [Sartori, Angela L. B.] Univ Fed Mato Grosso do Sul, Inst Biociencias, Lab Sistemat Vegetal, Cidade Univ S-N,CP 549, Campo Grande, MS, Brazil; [Atahuachi, Margoth] Univ Mayor San Simon, Ctr Biodiversidad & Genet, Herbario Forestal Nacl M Cardenas, Cochabamba, Bolivia; [Vanni, Ricardo O.] Inst Bot Nordeste IBONE, Casilla Correo, Corrientes, Argentina; [Prado, Darien E.] UNR, CONICET, Inst Invest Ciencias Agr IICAR, Zavalla, Santa Fe, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Universidade Federal de Mato Grosso do Sul; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Morales, M (corresponding author), INTA, Inst Recursos Biol CIRN, CNIA, Las Cabanas & Los Reseros Sn, RA-1686 Hurlingham, Argentina.; Morales, M (corresponding author), Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.; Morales, M (corresponding author), Univ Moron, Fac Agron & Cs Agroalimentarias, Cabildo, Moron, Argentina.	mmorales0007@gmail.com	Morales, Matías/AAP-6723-2021; Prado, Darien/K-6360-2019	Prado, Darien/0000-0001-5112-7077; Bagnatori Sartori, Angela Lucia/0000-0002-5911-8797; Morales, Matias/0000-0001-5540-9725	Institute Nacional de Investigacion Agropecuaria (INTA, Argentina) [PNNAT1128053]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [620176/2008-3, 552352/2011-0]; Troels Myndel Foundation (Denmark); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina)	Institute Nacional de Investigacion Agropecuaria (INTA, Argentina); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Troels Myndel Foundation (Denmark); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This research was funded by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina), Institute Nacional de Investigacion Agropecuaria (INTA, Argentina), PNNAT1128053, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (process 620176/2008-3 and process 552352/2011-0) and Troels Myndel Foundation (Denmark). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamoli J., 2005, MISCELANEA, V14, P245; Alicia Zapater M., 2012, Darwiniana (San Isidro), V50, P339; Alves Fábio de Matos, 2009, Rodriguésia, V60, P531, DOI 10.1590/2175-7860200960305; Azani N, 2017, TAXON, V66, P44, DOI 10.12705/661.3; Bach HG, 2010, CANDOLLEA, V65, P291, DOI 10.15553/c2010v652a8; Bachman S, 2011, ZOOKEYS, P117, DOI 10.3897/zookeys.150.2109; Sartori ALB, 2017, PHYTOTAXA, V308, P1, DOI 10.11646/phytotaxa.308.1.1; Banda-R K, 2016, SCIENCE, V353, P1383, DOI 10.1126/science.aaf5080; BARNEBY R C, 1991, Memoirs of the New York Botanical Garden, V65, P1; Barneby R.C., 1997, MEM NEW YORK BOT GAR, V74, P1; Barneby RC, 1982, MEMOIRS NEW YORK BOT, V35, P1; Barneby Rupert C., 1996, Memoirs of the New York Botanical Garden, V74, P1; Barneby Rupert C., 1998, Memoirs of the New York Botanical Garden, V74 PART 3, P1; Baumann M, 2017, REG ENVIRON CHANGE, V17, P1179, DOI 10.1007/s10113-017-1109-5; Bertioli DJ, 2011, PLANT GENET RESOUR-C, V9, P134, DOI 10.1017/S1479262110000444; Bessega C, 2006, J BIOGEOGR, V33, P1905, DOI 10.1111/j.1365-2699.2006.01561.x; Bessega C, 2011, AUST SYST BOT, V24, P104, DOI 10.1071/SB10022; Brizuela MM., 2005, FLORA FANEROGAMICA A, V9, P3; Brown AD., 2002, ECOTROPICOS, V15, P147; BURKART A., 1937, Darwiniana, V3, P7; BURKART A, 1976, J ARNOLD ARBORETUM, V57, P450; BURKART A, 1971, Darwiniana (San Isidro), V16, P663; BURKART A, 1976, J ARNOLD ARBORETUM, V57, P219; BURKART A, 1970, Darwiniana (San Isidro), V16, P175; Burkart A., 1952, LEGUMINOSAS ARGENTIN; BURKART ARTURO, 1939, DARWINIANA [BUENOS AIRES], V3, P117; Cabrera A., 1976, REGIONES FITOGEOGRAF, VII; Cabrera AL, 1980, COLECCION MONOGRAFIA; Lozano Evangelina Carmen, 2010, Darwiniana, nueva serie, V48, P179; Cialdella AM., 2000, FLORA FANEROGAMICA A, V67, P1; da Silva MJ, 2012, TAXON, V61, P93, DOI 10.1002/tax.611007; de Miranda PLS, 2018, GLOBAL ECOL BIOGEOGR, V27, P899, DOI 10.1111/geb.12749; DeCarvalho AM, 1997, BRITTONIA, V49, P87, DOI 10.2307/2807701; Delgado-Salinas A, 2011, AM J BOT, V98, P1694, DOI 10.3732/ajb.1100069; Dinerstein E, 2017, BIOSCIENCE, V67, P534, DOI 10.1093/biosci/bix014; Drewes SI, 1995, THESIS; DWYER JOHN D., 1951, BRITTONIA, V7, P143, DOI 10.2307/2804703; Fehlenberg V, 2017, GLOBAL ENVIRON CHANG, V45, P24, DOI 10.1016/j.gloenvcha.2017.05.001; FORTUNATO R H, 1986, Darwiniana (San Isidro), V27, P527; Fortunato R.H., 1983, PARODIANA, V2, P25; Fortunato Renee H., 1996, Darwiniana (San Isidro), V34, P405; Fortunato Renee H., 1996, Candollea, V51, P215; FORTUNATO RH, 2008, CATALOGO PLANTAS VAS, V2, P2078; Franceschi E.A., 1985, COMUNIDADES VEGETALE; Gagnon E, 2016, PHYTOKEYS, P1, DOI 10.3897/phytokeys.71.9203; Giorgis Melisa A, 2011, Kurtziana, V36, P9; Gomez Sosa E. V., 2000, FL FANEROG ARGENT, V68, P3; Gomez Sosa EV, 2003, HICKENIA, V3, P161; Gomez Sosa EV, 1984, COLECCION CIENTIFICA, V8, P175; Gomez Sosa EV, 2000, FLORA FANEROGAMICA A, V69, P3; GREAR J W JR, 1970, Memoirs of the New York Botanical Garden, V20, P1; Hoc PS, 2005, FLORA FANEROGAMICA A, V93, P3; Hueck K., 1955, REV BRAS GEOGR, V17, P343; Hueck K, 1981, VEGETATIONSKARTEVON; Gasparri NI, 2009, FOREST ECOL MANAG, V258, P913, DOI 10.1016/j.foreco.2009.02.024; Krapovickas A., 1994, Bonplandia, V8, P1; Lee Y.T., 1975, SYSTEMATIC REVISION, V69, P1; Lima JR, 2015, PHYTOTAXA, V207, P1, DOI 10.11646/phytotaxa.207.1.1; Lima LCP, 2012, PHYTOTAXA, V40, P55; Luckow M., 1993, Systematic Botany Monographs, V38, DOI 10.2307/25027822; MARECHAL R, 1978, Boissiera, V28, P1; Martinez GA, 2017, AUST SYST BOT, V29, P473, DOI 10.1071/SB16046; Martínez Olga G, 2013, Darwiniana, nueva serie, V1, P279, DOI 10.14522/darwiniana.2013.12.536; Mereles F, 2005, ROJASIANA, V6, P5; Mereles F, 2004, ROJASIANA, V6, P126; Mogni V. Y., 2015, Edinburgh Journal of Botany, V72, P35, DOI 10.1017/S0960428614000298; MOHLENBROCK R. H., 1957, Ann. Mo. Bot. Gdn., V44, P299, DOI 10.2307/2394648; Morales M, 2018, AUST SYST BOT, V31, P190, DOI 10.1071/SB16033; Morales M, 2010, CANDOLLEA, V65, P169, DOI 10.15553/c2010v651a17; Morales M, 2010, AUST J BOT, V58, P12, DOI 10.1071/BT09132; Morello J, 1968, SERIE FITOGEOGRAFICA, V13; Navarro G., 2011, CLASIFICACION VEGETA; Navarro G., 2002, GEOGRAFIA ECOLOGICA; Navarro G, 2006, PHYTOCOENOLOGIA, V36, P473, DOI 10.1127/0340-269X/2006/0036-0473; Neill D. A., 2014, CATALOGO PLANTAS VAS, V127, P611; Nores MJ, 2012, TAXON, V61, P790, DOI 10.1002/tax.614006; Oakley L., 2011, ROJASIANA, V10, P55; Cardoso DBOS, 2014, BOT J LINN SOC, V175, P328, DOI 10.1111/boj.12153; Oliveira-Filho A., 2002, CERRADOS BRAZIL, P91, DOI [10.1590/1519-6984.02016, DOI 10.7312/OLIV12042-007]; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Overbeck GE, 2007, PERSPECT PLANT ECOL, V9, P101, DOI 10.1016/j.ppees.2007.07.005; PALACIOS R A, 1981, Darwiniana (San Isidro), V23, P3; Palacios RA, 2001, FLORA FANEROGAMICA A, V75, P10; Palacios Ramón A., 2005, Bol. Soc. Argent. Bot., V40, P113; Pennington RT, 2017, SCIENCE, V355, P465, DOI 10.1126/science.aal5010; Pennington RT, 2000, J BIOGEOGR, V27, P261, DOI 10.1046/j.1365-2699.2000.00397.x; Pennington TD., 1984, THE GENUS INGA; Lima LCP, 2014, PHYTOTAXA, V169, P1; Planchuelo AM, 2001, NOVON, V11, P442, DOI 10.2307/3393158; Prado D., 1995, INVESTIGACION CONSER, P19; Prado D. E., 2000, Edinburgh Journal of Botany, V57, P437, DOI 10.1017/S096042860000041X; Prado Darien E., 1993, Candollea, V48, P145; Prado Dariene E., 1993, Candollea, V48, P615; PRADO DE, 1993, ANN MO BOT GARD, V80, P902, DOI 10.2307/2399937; PRADO DE, 1992, NATURE AND DYNAMICS OF FOREST-SAVANNA BOUNDARIES, P451; Prado DE., 2015, GEOGRAFIA DEBATE, V9, P275; Prado DE, 1991, THESIS; Queiroz L. P. de, 2009, LEGUMINOSAS CAATINGA; Ragonese A. E., 1970, B SOC ARGENT BOT, V11, P133; RAMELLA L, 1989, Candollea, V44, P639; Rico Arce ML, 2007, CHECKLIST SYNOPSIS A; Rico MD, 2006, ANAL JARDIN BOT MAD, V63, P189; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Robbiati FO, 2017, BOT J LINN SOC, V183, P454, DOI 10.1093/botlinnean/bow012; RUDD VELVA E., 1955, CONTR U S NATL HERBARIUM, V32, P1; RUDD VELVA E., 1956, CONTR U S NATL HERB, V32, P173; SARMIENTO G, 1972, J ECOL, V60, P367, DOI 10.2307/2258353; Sartori Ângela L.B., 2004, Acta Bot. Bras., V18, P521, DOI 10.1590/S0102-33062004000300012; Sauer JD., 1964, BRITTONIA, V16, P663; Seigler D. S., 2009, PHYTOLOGIA, V91, P26; Seigler DS, 2005, PHYTOLOGIA, V87, P139; SEIGLER DS, 2006, PHYTOLOGIA, V88, P38, DOI DOI 10.5962/bhl.part.17845; Seleme EP, 2015, PHYTOTAXA, V212, P249, DOI 10.11646/phytotaxa.212.4.1; Simon MF, 2011, AM J BOT, V98, P1201, DOI 10.3732/ajb.1000520; Soriano A., 1991, ECOSYSTEMS WORLD A, P367; Sousa S. M., 1992, Anales del Instituto de Biologia. Serie Botanica, V63, P101; SPICHIGER R, 1991, Candollea, V46, P541; Spichiger R, 2004, J BIOGEOGR, V31, P1489, DOI 10.1111/j.1365-2699.2004.01071.x; Tavares A. S., 1992, ACTA AMAZONICA, V22, P17, DOI DOI 10.1590/1809-43921992221022; Thiers B., 2018, INDEX HERBARIORUM GL; ULIBARRI EA, 1997, FLORA FANEROGAMICA A, V32, P3; Ulibarri Emilio A., 2000, Darwiniana (San Isidro), V38, P59; Ulloa CU, 2017, SCIENCE, V358, P1614, DOI 10.1126/science.aao0398; Unzueta O., 1975, MAPA ECOLOGICO BOLIV; Valls JF, 2005, BONPLANDIA, V14, P35, DOI [10.30972/bon.141-21387, DOI 10.2307/41941266]; Vanni Ricardo, 1995, Darwiniana (San Isidro), V33, P1; Vanni RO, 2017, B SOC ARGENT BOT, V52, P549; Vanni RO, 2016, B SOC ARGENT BOT, V51, P705, DOI 10.31055/1851.2372.v51.n4.16359; Vanni Ricardo O., 2005, Darwiniana, nueva serie, V43, P216; Vanni RO, 2012, B SOC ARGENT BOT, V47, P149; Vanni Ricardo O, 2009, Darwiniana, nueva serie, V47, P232; Vanni RO., 2001, DARWINIANA, V39, P226; Volante JN, 2016, LAND USE POLICY, V55, P154, DOI 10.1016/j.landusepol.2016.03.025; Warwick M. C., 2002, Edinburgh Journal of Botany, V59, P247; Werneck FP, 2011, GLOBAL ECOL BIOGEOGR, V20, P272, DOI 10.1111/j.1466-8238.2010.00596.x; WINDLER DR, 1966, AUST J BOT, V14, P379, DOI 10.1071/BT9660379; Yahara T, 2013, TAXON, V62, P249, DOI 10.12705/622.12; Zak MR, 2004, BIOL CONSERV, V120, P589, DOI 10.1016/j.biocon.2004.03.034; Zappi Daniela C., 2015, Rodriguésia, V66, P1085, DOI 10.1590/2175-7860201566411; ZULOAGA F. O., 2017, CATALOGO PLANTAS VAS; Zuloaga Fernando O., 2015, Rodriguésia, V66, P989, DOI 10.1590/2175-7860201566405	141	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0220151	10.1371/journal.pone.0220151	http://dx.doi.org/10.1371/journal.pone.0220151			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412055	Green Published, gold, Green Submitted			2022-12-26	WOS:000485012600021
J	Badr, AM; EL-Orabi, NF; Ali, RA				Badr, Amira M.; EL-Orabi, Naglaa F.; Ali, Rehab A.			The implication of the crosstalk of Nrf2 with NOXs, and HMGB1 in ethanol-induced gastric ulcer: Potential protective effect is afforded by Raspberry Ketone	PLOS ONE			English	Article							OXIDATIVE STRESS; NADPH OXIDASE; IN-VITRO; APOPTOSIS; RATS; NECROSIS; INJURY; DAMAGE; REDOX	Ethanol consumption is one of the common causative agents implicated in gastric ulcer development. Oxidative stress plays a major role in the induction and development of gastric ulceration. NADPH oxidases (NOXs) and Nuclear factor erythroid 2-related factor 2 (Nrf2) are key players in ethanol-induced ulcers. High-mobility group box 1 (HMGB1), a ubiquitous nuclear protein, mediates various inflammation functions. However, the role of HMGB1 in ethanol-induced gastric ulcer is not yet elucidated. Raspberry Ketone (RK) is a natural phenolic compound with antioxidant and anti-inflammatory properties. In the present study, absolute ethanol (7.5 ml/kg) was used to induce gastric ulceration in rats. Raspberry Ketone (RK) (50 mg/kg) was given orally one hour before the administration of absolute ethanol. Interestingly, ethanol-induced gastric ulcer was associated with Nrf2 downregulation, which was correlated with NOX-1, 2 NOX-4, and HMGB1 upregulation, and was significantly reversed by RK pre-treatment. RK pre-treatment provided 80% gastroprotection. Gastroprotective properties of RK were mediated via antioxidant, anti-inflammatory (suppression of NF-kB and tumor necrosis factor-a), and antiapoptotic activities (reduction of Bax/Bcl2 ratio). Gastroprotective properties of RK were confirmed by histopathological examination. In conclusion, this study is the first to provide evidence to the role of HMGB1 in ethanol-induced gastric ulcer, and the crosstalk of Nrf2, NOXs and HMGB1. It also demonstrates that RK represents a promising gastroprotective activity comparable to omeprazole.	[Badr, Amira M.; EL-Orabi, Naglaa F.; Ali, Rehab A.] King Saud Univ, Coll Pharm, Dept Pharmacol & Toxicol, Riyadh, Saudi Arabia; [Badr, Amira M.] Ain Shams Univ, Coll Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt; [EL-Orabi, Naglaa F.] Suez Canal Univ, Fac Pharm, Dept Pharmacol & Toxicol, Ismailia, Egypt	King Saud University; Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Suez Canal University	Badr, AM (corresponding author), King Saud Univ, Coll Pharm, Dept Pharmacol & Toxicol, Riyadh, Saudi Arabia.; Badr, AM (corresponding author), Ain Shams Univ, Coll Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt.	AmiBadr@ksu.edu.sa	Badr, Amira/U-5840-2019; Badr, Amira/AAA-7683-2022	Badr, Amira/0000-0003-3983-868X; 	Deanship of Scientific Research at King Saud University [RG-1440-033]	Deanship of Scientific Research at King Saud University(King Saud University)	The authors extend their appreciation to the Deanship of Scientific Research at King Saud University for funding this work through the research group project number RG-1440-033. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahab SI, 2013, INT J NANOMED, V8, P2163, DOI 10.2147/IJN.S44108; Abebaw Mastewal, 2017, J Exp Pharmacol, V9, P1, DOI 10.2147/JEP.S125383; Al-Sayed E, 2015, PHYTOMEDICINE, V22, P5, DOI 10.1016/j.phymed.2014.10.002; Albaayit SFA, 2016, DRUG DES DEV THER, V10, DOI 10.2147/DDDT.S103993; Arab HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122417; Attia RT, 2019, BIOMED PHARMACOTHER, V110, P500, DOI 10.1016/j.biopha.2018.11.079; Bhattacharyya A, 2014, PHYSIOL REV, V94, P329, DOI 10.1152/physrev.00040.2012; Bhattamisra SK, 2019, J TRADIT COMPL MED, V9, P206, DOI 10.1016/j.jtcme.2018.05.001; Biglar M., 2012, African Journal of Biotechnology, V11, P6619; Brewer AC, 2011, FREE RADICAL BIO MED, V51, P205, DOI 10.1016/j.freeradbiomed.2011.04.022; Burtenshaw D, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6040090; Alfredo SIC, 2018, PHARMACOL RES, V134, P92, DOI 10.1016/j.phrs.2018.06.013; Chen H, 2014, GUT, V63, P711, DOI 10.1136/gutjnl-2012-303731; Chen NN, 2016, NEUROCHEM RES, V41, P3052, DOI 10.1007/s11064-016-2024-8; Choi YJ, 2016, GUT LIVER, V10, P348, DOI 10.5009/gnl14509; Correia C, 2015, BBA-MOL CELL RES, V1853, P1658, DOI 10.1016/j.bbamcr.2015.03.012; Drury R.A.B., 1980, CARLETON HISTOLOGICA; El-Naga RN, 2015, CHEM-BIOL INTERACT, V242, P317, DOI 10.1016/j.cbi.2015.10.018; Guzman-Gomez O, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060763; Hristova M, 2018, MOLECULES, V23, DOI 10.3390/molecules23040749; Ibrahim MY, 2016, SCI REP-UK, V6, DOI 10.1038/srep26819; Joseph SV, 2016, CRIT REV FOOD SCI, V56, P419, DOI 10.1080/10408398.2013.767221; Khan V, 2018, LIFE SCI, V194, P205, DOI 10.1016/j.lfs.2017.12.013; Kovac S, 2015, BBA-GEN SUBJECTS, V1850, P794, DOI 10.1016/j.bbagen.2014.11.021; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li N, 2004, J IMMUNOL, V173, P3467, DOI 10.4049/jimmunol.173.5.3467; Li WF, 2014, CHEM-BIOL INTERACT, V208, P18, DOI 10.1016/j.cbi.2013.11.011; Li WF, 2017, FUND CLIN PHARMACOL, V31, P174, DOI 10.1111/fcp.12255; Li WF, 2015, IMMUNOBIOLOGY, V220, P798, DOI 10.1016/j.imbio.2014.12.014; Li WF, 2013, TOXICOL APPL PHARM, V272, P21, DOI 10.1016/j.taap.2013.05.035; Lin HJ, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00341; Lin VCH, 2011, INT J MOL SCI, V12, P4819, DOI 10.3390/ijms12084819; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Magna M, 2014, MOL MED, V20, P138, DOI 10.2119/molmed.2013.00164; Mehanna ET, 2018, EUR J PHARMACOL, V832, P81, DOI 10.1016/j.ejphar.2018.05.028; Nadatani Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080130; Papaiahgari S, 2004, J BIOL CHEM, V279, P42302, DOI 10.1074/jbc.M408275200; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Park SW, 2008, J GASTROEN HEPATOL, V23, P976, DOI 10.1111/j.1440-1746.2008.05333.x; Perez S, 2017, FREE RADICAL BIO MED, V104, P75, DOI 10.1016/j.freeradbiomed.2016.12.048; Qin SX, 2006, J EXP MED, V203, P1637, DOI 10.1084/jem.20052203; Qu J, 2019, J CELL PHYSIOL, V234, P8862, DOI 10.1002/jcp.27548; Radin JN, 2011, INFECT IMMUN, V79, P2535, DOI 10.1128/IAI.01370-10; Shukla S, 2015, PESTIC BIOCHEM PHYS, V123, P74, DOI 10.1016/j.pestbp.2015.03.007; Tarafdar A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123824; Tayeby F, 2017, INT J MED SCI, V14, P1317, DOI 10.7150/ijms.20984; Wang LL, 2012, J MED FOOD, V15, P495, DOI 10.1089/jmf.2011.1717; Wu CZ, 2018, ONCOTARGETS THER, V11, P4501, DOI 10.2147/OTT.S167197; Yadav SK, 2012, FREE RADICAL BIO MED, V52, P1175, DOI 10.1016/j.freeradbiomed.2011.12.023; Yanaka A, 2018, J CLIN BIOCHEM NUTR, V63, P18, DOI 10.3164/jcbn.17-139; Yang SM, 2019, AM J CHINESE MED, V47, P613, DOI 10.1142/S0192415X19500320; Yu Y, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00093; Yu Y, 2019, INT IMMUNOPHARMACOL, V69, P11, DOI 10.1016/j.intimp.2019.01.022; Zhang T, 2017, PHARMACOL REP, V69, P1154, DOI 10.1016/j.pharep.2017.07.004; Zhang YK, 2016, J PHARM PHARMACOL, V68, P514, DOI 10.1111/jphp.12532; Zhao HR, 2015, NEUROCHEM RES, V40, P854, DOI 10.1007/s11064-015-1536-y	56	29	30	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220548	10.1371/journal.pone.0220548	http://dx.doi.org/10.1371/journal.pone.0220548			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404064	gold, Green Submitted, Green Published			2022-12-26	WOS:000485006800016
J	Meszaros, VA; Miller-Dickson, MD; Ogbunugafor, CB				Meszaros, Victor A.; Miller-Dickson, Miles D.; Ogbunugafor, C. Brandon			Lexical Landscapes as large in silico data for examining advanced properties of fitness landscapes	PLOS ONE			English	Article							HIGHER-ORDER EPISTASIS; EVOLUTION; RESISTANCE	In silico approaches have served a central role in the development of evolutionary theory for generations. This especially applies to the concept of the fitness landscape, one of the most important abstractions in evolutionary genetics, and one which has benefited from the presence of large empirical data sets only in the last decade or so. In this study, we propose a method that allows us to generate enormous data sets that walk the line between in silico and empirical: word usage frequencies as catalogued by the Google ngram corpora. These data can be codified or analogized in terms of a multidimensional empirical fitness landscape towards the examination of advanced concepts-adaptive landscape by environment interactions, clonal competition, higher-order epistasis and countless others. We argue that the greater Lexical Landscapes approach can serve as a platform that offers an astronomical number of fitness landscapes for exploration (at least) or theoretical formalism (potentially) in evolutionary biology.	[Meszaros, Victor A.; Miller-Dickson, Miles D.; Ogbunugafor, C. Brandon] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	Brown University	Ogbunugafor, CB (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	brandon_ogbunu@brown.edu		Ogbunugafor, C. Brandon/0000-0002-1581-8345	NSF RII Track-2 FEC [1736253]	NSF RII Track-2 FEC(National Science Foundation (NSF)NSF - Office of the Director (OD))	CBO was funded by NSF RII Track-2 FEC (Award Number: 1736253).	Aguilar-Rodriguez J, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0045; Baeza-Centurion P, 2019, CELL, V176, P549, DOI 10.1016/j.cell.2018.12.010; Brouillet S, 2015, MAGELLAN TOOL EXPLOR, DOI 10.1101/031583; Crawford L, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006869; de Visser JAGM, 2014, NAT REV GENET, V15, P480, DOI 10.1038/nrg3744; Eppstein MJ, 2016, DARPS; Flynn KM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003426; Gavrilets S., 2004, FITNESS LANDSCAPES O, P41; Guerrero RF, 2019, GENETICS, V212, P565, DOI 10.1534/genetics.119.302138; Iwasa Y, 2004, GENETICS, V166, P1571, DOI 10.1534/genetics.166.3.1571; Lin Y, 2012, CONTEMP SYST THINK, P169, DOI 10.1007/978-1-4614-2311-9_8; Lozovsky ER, 2009, P NATL ACAD SCI USA, V106, P12025, DOI 10.1073/pnas.0905922106; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Nichol D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004493; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Ogbunugafor CB, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0064; Ogbunugafor CB, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005046; Otwinowski J, 2018, P NATL ACAD SCI USA, V115, pE7550, DOI 10.1073/pnas.1804015115; Palmer AC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8385; Palmer AC, 2013, NAT REV GENET, V14, P243, DOI 10.1038/nrg3351; Poelwijk FJ, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004771; Provine WB., 2001, ORIGINS THEORETICAL; Sackton TB, 2016, CELL, V166, P279, DOI 10.1016/j.cell.2016.06.047; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Weinreich DM, 2018, J STAT PHYS, V172, P208, DOI 10.1007/s10955-018-1975-3; Weinreich DM, 2013, CURR OPIN GENET DEV, V23, P700, DOI 10.1016/j.gde.2013.10.007; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356	30	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220891	10.1371/journal.pone.0220891	http://dx.doi.org/10.1371/journal.pone.0220891			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404101	Green Published, gold, Green Submitted			2022-12-26	WOS:000485006800040
J	Agustin-Panadero, R; Serra-Pastor, B; Roig-Vanaclocha, A; Fons-Font, A; Sola-Ruiz, MF				Agustin-Panadero, Ruben; Serra-Pastor, Blanca; Roig-Vanaclocha, Ana; Fons-Font, Antonio; Fernanda Sola-Ruiz, Maria			Fracture resistance and the mode of failure produced in metal-free crowns cemented onto zirconia abutments in dental implants	PLOS ONE			English	Article							BITE FORCE; TITANIUM; MORPHOLOGY; FATIGUE; DESIGN	The purpose of the investigation was to analyze fracture resistance and mode of failure of zirconium oxide (zirconia) abutments placed on dental implants bearing crowns of different esthetic materials: zirconia, lithium disilicate (LDS), and nano-ceramic resin, for replacing single teeth in the anterior sector. Eighty implant-abutment-crown units were divided into four groups: Group T-MC (control): 20 metal-ceramic crowns cemented onto titanium abutments; Group Z-Z: 20 zirconia crowns on zirconia abutments; Group Z-LD: 20 lithium disilicate crowns on zirconia abutments; and Group Z-NCR: 20 nano-ceramic resin crowns on zirconia abutments. Specimens underwent a fatiguing process (dynamic loading and thermocycling), followed by static loading to evaluate mechanical fracture resistance, and the mode of failure produced. Mean fracture resistance values were: Control Group T-MC, 575.85 +/- 120.01 N; Group Z-Z 459.64 +/- 66.52 N; Group Z-LD, 531.77 +/- 34.10 N; and Group Z-NCR, 587.05 +/- 59.27 N. In Group T-MC, fracture occurred in the prosthetic fixing screw in 100% of specimens. In Group Z-Z, 80% of fractures occurred in the fixing screw, 15% in the abutment, and 5% in the abutment and crown. In Group Z-LD, 60% of fractures were produced in the fixing screw and 40% in the abutment. In Group Z-NCR, 70% of fractures were produced in the fixing screw and 30% in the abutment. All the abutments and crowns analyzed have the potential to withstand the physiological occlusal forces to which they would be subject in the anterior region. Lithium disilicate and nano-ceramic resin crowns cemented onto zirconia abutments are a good restoration alternative for single implants in the anterior sector.	[Agustin-Panadero, Ruben; Serra-Pastor, Blanca; Roig-Vanaclocha, Ana; Fons-Font, Antonio; Fernanda Sola-Ruiz, Maria] Univ Valencia, Fac Med & Dent, Dept Dent Med, Valencia, Spain	University of Valencia	Sola-Ruiz, MF (corresponding author), Univ Valencia, Fac Med & Dent, Dept Dent Med, Valencia, Spain.	m.fernanda.sola@uv.es	Agustín-Panadero, Rubén/R-9296-2018; Sola-Ruiz/L-5653-2014	Agustín-Panadero, Rubén/0000-0003-2757-6619; Sola-Ruiz/0000-0002-7946-6932				Agustin-Panadero R, 2015, MED ORAL PATOL ORAL, V20, pE94, DOI 10.4317/medoral.19958; Agustin-Panadero R, 2012, INT J PROSTHODONT, V25, P294; Att W, 2006, J PROSTHET DENT, V95, P111, DOI 10.1016/j.prosdent.2005.12.003; Att W, 2012, CLIN IMPLANT DENT R, V14, pe196, DOI 10.1111/j.1708-8208.2011.00428.x; Canullo L, 2013, J APPL ORAL SCI, V21, P20, DOI 10.1590/1678-7757201302124; Elsayed A, 2018, CLIN ORAL IMPLAN RES, V29, P20, DOI 10.1111/clr.13034; Ferrario VF, 2004, J ORAL REHABIL, V31, P18, DOI 10.1046/j.0305-182X.2003.01179.x; Foong JKW, 2013, J PROSTHET DENT, V109, P304, DOI 10.1016/S0022-3913(13)60306-6; Gehrke P, 2015, INT J ORAL MAX IMPL, V30, P546, DOI 10.11607/jomi.3942; GIBBS CH, 1981, J PROSTHET DENT, V46, P443, DOI 10.1016/0022-3913(81)90455-8; Jimenez- Melendo M, 2014, J CLIN EXP DENT, V6, P485; Joo HS, 2015, J ADV PROSTHODONT, V7, P183, DOI 10.4047/jap.2015.7.3.183; Jung RE, 2012, CLIN ORAL IMPLAN RES, V23, P2, DOI 10.1111/j.1600-0501.2012.02547.x; KILIARIDIS S, 1993, ACTA ODONTOL SCAND, V51, P323, DOI 10.3109/00016359309040583; Kim JS, 2013, J PROSTHET DENT, V109, P255, DOI 10.1016/S0022-3913(13)60054-2; Kim S, 2009, J PROSTHET DENT, V101, P226, DOI 10.1016/S0022-3913(09)60043-3; Martinez-Rus F, 2012, INT J ORAL MAX IMPL, V27, P1448; Muhlemann S, 2014, CLIN ORAL IMPLAN RES, V25, P74, DOI 10.1111/clr.12192; Prestipino V, 1993, J Esthet Dent, V5, P29, DOI 10.1111/j.1708-8240.1993.tb00741.x; Protopapadaki M, 2013, J PROSTHET DENT, V110, P389, DOI 10.1016/j.prosdent.2013.06.004; Sailer I, 2009, CLIN ORAL IMPLAN RES, V20, P4, DOI 10.1111/j.1600-0501.2009.01787.x; Sanchez-Perez A, 2010, MED ORAL PATOL ORAL, V15, pE504, DOI 10.4317/medoral.15.e504; Sghaireen MG, 2015, CLIN IMPLANT DENT R, V17, P554, DOI 10.1111/cid.12160; Spies BC, 2016, J MECH BEHAV BIOMED, V53, P1, DOI 10.1016/j.jmbbm.2015.07.005; Studart AR, 2007, DENT MATER, V23, P106, DOI 10.1016/j.dental.2005.12.008; Sung M, 2014, J PROSTHODONT, V23, P534, DOI 10.1111/jopr.12147; WALTIMO A, 1993, SCAND J DENT RES, V101, P171; WALTIMO A, 1994, SCAND J DENT RES, V102, P92	28	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220551	10.1371/journal.pone.0220551	http://dx.doi.org/10.1371/journal.pone.0220551			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393888	Green Published, gold, Green Submitted			2022-12-26	WOS:000485002500038
J	Piper, AJ; Clark, JL; Mercado-Matos, J; Matthew-Onabanjo, AN; Hsieh, CC; Akalin, A; Shaw, LM				Piper, Andrew J.; Clark, Jennifer L.; Mercado-Matos, Jose; Matthew-Onabanjo, Asia N.; Hsieh, Chung-Cheng; Akalin, Ali; Shaw, Leslie M.			Insulin Receptor Substrate-1 (IRS-1) and IRS-2 expression levels are associated with prognosis in non-small cell lung cancer (NSCLC)	PLOS ONE			English	Article							DOWN-REGULATION; EGFR; INSULIN-RECEPTOR-SUBSTRATE-1; RESISTANCE; MUTATIONS; IGF-1R; IGF1R	The insulin-like growth factor-1 (IGF-1) signaling pathway has been implicated in non-small cell lung cancer (NSCLC) outcomes and resistance to targeted therapies. However, little is known regarding the molecular mechanisms by which this pathway contributes to the biology of NSCLC. The insulin receptor substrate (IRS) proteins are cytoplasmic adaptor proteins that signal downstream of the IGF-1R and determine the functional outcomes of this signaling pathway. In this study, we assessed the expression patterns of IRS-1 and IRS-2 in NSCLC to identify associations between IRS-1 and IRS-2 expression levels and survival outcomes in the two major histological subtypes of NSCLC, adenocarcinoma (ADC) and squamous cell carcinoma (SCC). High IRS-2 expression was significantly associated with decreased overall survival in adenocarcinoma (ADC) patients, whereas low IRS-1 cytoplasmic expression showed a trend toward association with decreased overall survival in squamous cell carcinoma (SCC) patients. Tumors with low IRS-1 and high IRS-2 expression were found to be associated with poor outcomes in ADC and SCC, indicating a potential role for IRS-2 in the aggressive behavior of NSCLC. Our results suggest distinct contributions of IRS-1 and IRS-2 to the biology of ADC and SCC that impact disease progression.	[Piper, Andrew J.; Mercado-Matos, Jose; Matthew-Onabanjo, Asia N.; Hsieh, Chung-Cheng; Shaw, Leslie M.] Univ Massachusetts, Med Sch, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA; [Clark, Jennifer L.; Akalin, Ali] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Piper, Andrew J.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Beth Israel Deaconess Medical Center	Shaw, LM (corresponding author), Univ Massachusetts, Med Sch, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA.	leslie.shaw@umassmed.edu	Akalin, Ali/GMW-6237-2022; Akalin, Ali/AAH-1266-2019	Clark, Jennifer/0000-0001-9114-4285; Piper-Vallillo, Andrew J./0000-0003-0742-0350	National Institute of Health (NIH) [CA142782]; NIH F31 Predoctoral fellowship [CA180706]; NATIONAL CANCER INSTITUTE [F31CA180706] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH F31 Predoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institute of Health (NIH) grant CA142782 (LMS) and NIH F31 Predoctoral fellowship CA180706 (JMM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Chen Z, 2014, NAT REV CANCER, V14, P535, DOI 10.1038/nrc3775; Clark JL, 2011, BREAST CANCER RES TR, V130, P759, DOI 10.1007/s10549-011-1353-1; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Fukushima T, 2011, BIOCHEM BIOPH RES CO, V404, P767, DOI 10.1016/j.bbrc.2010.12.045; Gately K, 2014, CLIN LUNG CANCER, V15, P58, DOI 10.1016/j.cllc.2013.08.005; George J, 2015, NATURE, V524, P47, DOI 10.1038/nature14664; Gibson SL, 2007, CELL CYCLE, V6, P631, DOI 10.4161/cc.6.6.3987; Gorgisen G, 2019, GENET MOL BIOL, V42, P15, DOI [10.1590/1678-4685-GMB-2017-0307, 10.1590/1678-4685-gmb-2017-0307]; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Han CH, 2006, ONCOL REP, V16, P1205; Heni M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050953; Korpanty GJ, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00204; Kuo AH, 2007, ONCOGENE, V26, P859, DOI 10.1038/sj.onc.1209840; Lovly CM, 2014, NAT MED, V20, P1027, DOI 10.1038/nm.3667; Ludovini V, 2013, CANCER CHEMOTH PHARM, V71, P671, DOI 10.1007/s00280-012-2056-y; Ma ZF, 2006, MOL CELL BIOL, V26, P9338, DOI 10.1128/MCB.01032-06; Mardilovich K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-14; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Metz HE, 2016, P NATL ACAD SCI USA, V113, P8795, DOI 10.1073/pnas.1601989113; Murakami A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086459; Nagle JA, 2004, MOL CELL BIOL, V24, P9726, DOI 10.1128/MCB.24.22.9726-9735.2004; Pankratz SL, 2009, J BIOL CHEM, V284, P2031, DOI 10.1074/jbc.M804776200; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Porter HA, 2013, CANCER LETT, V338, P239, DOI 10.1016/j.canlet.2013.03.030; Rotow J, 2017, NAT REV CANCER, V17, P637, DOI 10.1038/nrc.2017.84; Schnarr B, 2000, INT J CANCER, V89, P506, DOI 10.1002/1097-0215(20001120)89:6<506::AID-IJC7>3.0.CO;2-F; Shaw CM, 2012, ANTICANCER RES, V32, P439; Shi J, 2009, CANCER RES, V69, P7180, DOI 10.1158/0008-5472.CAN-08-4470; Sisci D, 2007, J CLIN PATHOL, V60, P633, DOI 10.1136/jcp.2006.039107; Suda K, 2014, INT J CANCER, V135, P1002, DOI 10.1002/ijc.28737; Szabolcs M, 2009, AM J PATHOL, V174, P276, DOI 10.2353/ajpath.2009.080086; Yeo CD, 2015, LUNG CANCER, V87, P311, DOI 10.1016/j.lungcan.2015.01.004; Zhao J, 2017, CELL PHYSIOL BIOCHEM, V43, P697, DOI 10.1159/000480655	35	13	14	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220567	10.1371/journal.pone.0220567	http://dx.doi.org/10.1371/journal.pone.0220567			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393907	Green Published, gold, Green Submitted			2022-12-26	WOS:000485002500041
J	Peng, WX; He, RZ; Zhang, ZQ; Yang, L; Mo, YY				Peng, Wan-Xin; He, Rong-Zhang; Zhang, Ziqiang; Yang, Liu; Mo, Yin-Yuan			LINC00346 promotes pancreatic cancer progression through the CTCF-mediated Myc transcription	ONCOGENE			English	Article							LONG NONCODING RNA; C-MYC; INSIGHTS; GENE; ACTIVATION; EXPRESSION; GENOMICS; PROTEIN; ROLES; CELLS	Although multiple factors are known to contribute to pancreatic ductal adenocarcinoma (PDAC) progression, the role of long non-coding RNAs (lncRNAs) in PDAC remains largely unknown. In this study, we present data that long intergenic noncoding RNA 346 (LINC00346) functions as a promoting factor for PDAC development. We first show that LINC00346 is highly expressed in pancreatic tumor specimens as compared to normal pancreatic tissue based on interrogation of The Cancer Genome Atlas (TCGA) pancreatic adenocarcinoma dataset. Of significance, this upregulation of LINC00346 is associated with overall survival (OS) and disease-free survival (DFS), respectively. We further show that knockout (KO) of LINC00346 impairs pancreatic cancer cell proliferation, tumorigenesis, migration, and invasion ability. Importantly, these phenotypes can be restored by LINC00346 re-expression in KO cells (i.e., rescue experiment). RNA precipitation assays combined with mass spectrometry analysis indicate that LINC00346 interacts with CCCTC-binding factor (CTCF), a known transcriptional repressor of c-Myc. This interaction between LINC00346 and CTCF prevents the binding of CTCF to c-Myc promoter, relieving the CTCF-mediated repression of c-Myc. Thus, LINC00346 functions as a positive transcriptional regulator of c-Myc. Together, these results suggest that LINC00346 contributes to PDAC pathogenesis by activating c-Myc, and as such, LINC00346 may serve as a potential biomarker and therapeutic target for PDAC.	[Peng, Wan-Xin; Yang, Liu] Hangzhou Med Coll, Peoples Hosp, Key Lab Tumor Mol Diag & Individualized Med Zheji, Zhejiang Prov Peoples Hosp, Hangzhou 310014, Zhejiang, Peoples R China; [Peng, Wan-Xin; He, Rong-Zhang; Mo, Yin-Yuan] Univ Mississippi, Med Ctr, Canc Inst, Jackson, MS 39216 USA; [He, Rong-Zhang] First Peoples Hosp Chenzhou, Translat Med Inst, Natl & Local Joint Engn Lab High Through Mol Diag, Chenzhou 423000, Hunan, Peoples R China; [Zhang, Ziqiang] Tongji Univ, Tongji Hosp, Dept Pulm Med, Shanghai 200065, Peoples R China; [Mo, Yin-Yuan] Univ Mississippi, Med Ctr, Dept Pharmacol Toxicol, Jackson, MS 39216 USA	Hangzhou Medical College; Zhejiang Provincial People's Hospital; University of Mississippi; University of Mississippi Medical Center; Tongji University; University of Mississippi; University of Mississippi Medical Center	Yang, L (corresponding author), Hangzhou Med Coll, Peoples Hosp, Key Lab Tumor Mol Diag & Individualized Med Zheji, Zhejiang Prov Peoples Hosp, Hangzhou 310014, Zhejiang, Peoples R China.; Mo, YY (corresponding author), Univ Mississippi, Med Ctr, Canc Inst, Jackson, MS 39216 USA.; Mo, YY (corresponding author), Univ Mississippi, Med Ctr, Dept Pharmacol Toxicol, Jackson, MS 39216 USA.	yangliuqq2003@163.com; ymo@umc.edu	彭, 琬昕/HDN-9075-2022; Peng, Wan-Xin/AAU-1368-2020	彭, 琬昕/0000-0002-2551-8899; 	National Natural Science Foundation of China [81772575]; key project of Health Bureau of Zhejiang Province [2018274734]; NIH [R01 CA154989]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); key project of Health Bureau of Zhejiang Province; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by grants from National Natural Science Foundation of China, No. 81772575 (LY) and the key project of Health Bureau of Zhejiang Province, No. 2018274734 (LY), and NIH grant R01 CA154989 (YM).	Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen H, 2018, SIGNAL TRANSDUCT TAR, V3, DOI 10.1038/s41392-018-0008-7; Conacci-Sorrell Maralice, 2014, Cold Spring Harb Perspect Med, V4, pa014357, DOI 10.1101/cshperspect.a014357; Dang CV, 2015, CANCER CELL, V27, P160, DOI 10.1016/j.ccell.2015.01.004; Dunn KL, 2003, BIOCHEM CELL BIOL, V81, P161, DOI 10.1139/o03-052; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Gupta SC, 2014, ONCOTARGET, V5, P12070, DOI 10.18632/oncotarget.2514; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Herold M, 2012, DEVELOPMENT, V139, P1045, DOI 10.1242/dev.065268; Hessmann E, 2016, ONCOGENE, V35, P1609, DOI 10.1038/onc.2015.216; Hu WQ, 2012, EMBO REP, V13, P971, DOI 10.1038/embor.2012.145; Huang JG, 2016, NUCLEIC ACIDS RES, V44, P3059, DOI 10.1093/nar/gkv1353; Hung CL, 2014, P NATL ACAD SCI USA, V111, P18697, DOI 10.1073/pnas.1415669112; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Iaccarino I, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071497; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Khan MA, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040779; Kim J, 2018, NAT GENET, V50, P1705, DOI 10.1038/s41588-018-0252-3; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; Kung JTY, 2013, GENETICS, V193, P651, DOI 10.1534/genetics.112.146704; Li M, 2015, NAT STRUCT MOL BIOL, V22, P2, DOI 10.1038/nsmb.2946; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Lu YQ, 2018, CANCER RES, V78, P64, DOI 10.1158/0008-5472.CAN-17-0815; Maldotti M, 2016, BBA-GENE REGUL MECH, V1859, P1322, DOI 10.1016/j.bbagrm.2016.06.010; McMahon SB, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014407; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Peng WX, 2017, ONCOGENE, V36, P5661, DOI 10.1038/onc.2017.184; Peng WX, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0727-3; Sachdeva M, 2011, ONCOGENE, V30, P822, DOI 10.1038/onc.2010.463; Schmitt AM, 2016, NAT GENET, V48, P1370, DOI 10.1038/ng.3673; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; Singh R, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.168; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wu FT, 2007, MOL CANCER THER, V6, P1823, DOI 10.1158/1535-7163.MCT-06-0771; Xiang JF, 2014, CELL RES, V24, P513, DOI 10.1038/cr.2014.35; Xiao ZD, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00902-z; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang PF, 2016, EMBO REP, V17, P1204, DOI 10.15252/embr.201642067	48	34	35	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 10	2019	38	41					6770	6780		10.1038/s41388-019-0918-z	http://dx.doi.org/10.1038/s41388-019-0918-z			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JC8UZ	31391552				2022-12-26	WOS:000489552900005
J	Malone, D; Lardelli, RM; Li, MQ; David, M				Malone, Dane; Lardelli, Rea M.; Li, Manqing; David, Michael			Dephosphorylation activates the interferon-stimulated Schlafen family member 11 in the DNA damage response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transfer RNA (tRNA); cancer; cancer therapy; DNA repair; drug resistance	GENES	Human Schlafen 11 (SLFN11) is an interferon-stimulated gene (ISG) that we previously have demonstrated to ablate translation of HIV proteins based on the virus's distinct codon preference. Additionally, lack of SLFN11 expression has been linked to the resistance of cancer cells to DNA-damaging agents (DDAs). We recently resolved the underlying mechanism, finding that it involves SLFN11-mediated cleavage of select tRNAs predominantly employed in the translation of the ATR and ATM Ser/Thr kinases, thereby establishing SLFN11 as a novel tRNA endonuclease. Even though SLFN11 is thus involved in two of the most prominent diseases of our time, cancer and HIV infection, its regulation remained thus far unresolved. Using MS and bioinformatics-based approaches combined with site-directed mutagenesis, we show here that SLFN11 is phosphorylated at three different sites, which requires dephosphorylation for SLFN11 to become fully functionally active. Furthermore, we identified protein phosphatase 1 catalytic subunit gamma (PPP1CC) as the upstream enzyme whose activity is required for SLFN11 to cleave tRNAs and thereby act as a selective translational inhibitor. In summary, our work has identified both the mechanism of SLFN11 activation and PPP1CC as the enzyme responsible for its activation. Our findings open up future studies of the PPP1CC subunit(s) involved in SLFN11 activation and the putative kinase(s) that inactivates SLFN11.	[Malone, Dane; Lardelli, Rea M.; Li, Manqing; David, Michael] Univ Calif San Diego, Div Biol Sci, Sect Mol Biol, La Jolla, CA 92093 USA; [David, Michael] Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Li, MQ (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Mol Biol, La Jolla, CA 92093 USA.; David, M (corresponding author), Univ Calif San Diego, Bonner Hall 3138,9500 Gilman Dr, La Jolla, CA 92093 USA.	m5li@ucsd.edu; midavid@ucsd.edu		David, Michael/0000-0001-6510-9961; Li, Manqing/0000-0002-7593-7979	National Institutes of Health [R01-GM101982, R21-AI124199]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM128155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01-GM101982 and R21-AI124199 (to M. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdel-Mohsen M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-106; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Bustos O, 2009, GENE, V447, P1, DOI 10.1016/j.gene.2009.07.006; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Kuntziger T, 2011, CELL CYCLE, V10, P1356, DOI 10.4161/cc.10.9.15442; Li MQ, 2018, NAT STRUCT MOL BIOL, V25, P1047, DOI 10.1038/s41594-018-0142-5; Li MQ, 2012, NATURE, V491, P125, DOI 10.1038/nature11433; Mu YH, 2016, EMBO REP, V17, P94, DOI 10.15252/embr.201540964; Murai J, 2018, MOL CELL, V69, P371, DOI 10.1016/j.molcel.2018.01.012; Otero DC, 2013, J IMMUNOL, V190, P3289, DOI 10.4049/jimmunol.1203086; Schwarz DA, 1998, IMMUNITY, V9, P657, DOI 10.1016/S1074-7613(00)80663-9; Snider J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-216; Stabell AC, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006066; Tang X, 2008, MOL CELL BIOL, V28, P2559, DOI 10.1128/MCB.01711-07; Yang JY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03544-x; Zoppoli G, 2012, P NATL ACAD SCI USA, V109, P15030, DOI 10.1073/pnas.1205943109	18	14	15	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2019	294	40					14674	14685		10.1074/jbc.RA118.006588	http://dx.doi.org/10.1074/jbc.RA118.006588			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JP0II	31395656	hybrid, Green Published			2022-12-26	WOS:000497955000014
J	Radhakrishnan, A; Pascual, D; Marcos, S; Dorronsoro, C				Radhakrishnan, Aiswaryah; Pascual, Daniel; Marcos, Susana; Dorronsoro, Carlos			Vision with different presbyopia corrections simulated with a portable binocular visual simulator	PLOS ONE			English	Article							MULTIFOCAL INTRAOCULAR LENSES; ADAPTIVE OPTICS; MONOVISION; OUTCOMES; QUALITY	Presbyopes can choose today among different corrections to provide them with functional vision at far and near, and the outcomes and patient satisfaction depend on the selection. In this study, we present a binocular and portable vision simulator, based on temporal multiplexing of two synchronized tunable lenses allowing see-through and programmable visual simulations of presbyopic corrections. Seventeen binocular corrections were tested: 3 Monofocal (Far, Intermediate, Near), 4 Simultaneous Vision (bifocal, trifocal), 2 Monovision (far and near in either eye) and 8 Modified Monovision corrections (Simultaneous vision in one eye, Monofocal in the other eye). Perceived visual quality was assessed through the simulated corrections in 8 cyclopleged subjects who viewed a composite realistic visual scene with high contrast letters and a landscape at far (4 m) and a high contrast text at intermediate (66 cm) and near (33 cm) distances. Perceptual scores were obtained on a scale of 0 to 5 (low to high perceived quality). Perceptual preference was assessed by judging 36 random image pairs (6 repetitions) viewed through 9 binocular presbyopic corrections using two-interval forced choice procedures. The average score, across far and near distances, was the highest for Monovision (4.4 +/- 0.3), followed by Modified Monovision (3.4 +/- 0.1), Simultaneous Vision (3.0 +/- 0.1) and Monofocal corrections (2.9 +/- 0.2). However, the mean difference between far and near was lower for Simultaneous Vision and Monovision (0.4 +/- 0.1 PS) than Modified Monovision (1.8 +/- 0.7) or monofocal corrections (3.3 +/- 1.5). A strong significant correlation was found between the perceptual scores and the percentages of energy in focus, for each correction and distance (R = 0.64, p<0.0001). Multivariate ANOVA revealed significant influence of observation distances (p<10-9) and patients (p = 0.01) on Perceptual Score. In conclusion, we have developed a binocular portable vision simulator that can simulate rapidly and non-invasively different combinations of presbyopic corrections. This tool has applications in systematic clinical evaluation of presbyopia corrections.	[Radhakrishnan, Aiswaryah; Pascual, Daniel; Marcos, Susana; Dorronsoro, Carlos] CSIC, IO, Lab Visual Opt & Biophoton, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Optica (Daza de Valdes)	Dorronsoro, C (corresponding author), CSIC, IO, Lab Visual Opt & Biophoton, Madrid, Spain.	cdorronsoro@io.cfmac.csic.es	Pascual, Daniel/ABH-2894-2020; Dorronsoro, Carlos/AAC-8003-2019	Dorronsoro, Carlos/0000-0001-5968-1128	European Research Council under the European Union [ERC-AdG-294099]; Spanish Government [FIS2017-84753-R, FIS2014-56643-R]; 7th Framework Programme of the European Community through the Marie Curie Initial Training Network OpAL [PITN-GA-2010264605]; ISCIII [DTS16/00127]	European Research Council under the European Union(European Research Council (ERC)); Spanish Government(Spanish GovernmentEuropean Commission); 7th Framework Programme of the European Community through the Marie Curie Initial Training Network OpAL; ISCIII(Instituto de Salud Carlos III)	This work was supported by: European Research Council under the European Union's Seventh Framework Programme FP7/2007-2013, ERC Grant Agreement no ERC-AdG-294099, Spanish Government grant FIS2014-56643-R to SM; ISCIII DTS16/00127 to CD; Spanish Government grant FIS2017-84753-R to CD and SM; and by 7th Framework Programme of the European Community through the Marie Curie Initial Training Network OpAL (PITN-GA-2010264605) to AR.	Akondi V, 2017, BIOMED OPT EXPRESS, V8, P3410, DOI 10.1364/BOE.8.003410; Arnold DH, 2007, J VISION, V7, DOI 10.1167/7.7.7; Blaylock JF, 2009, J CATARACT REFR SURG, V35, P303, DOI 10.1016/j.jcrs.2008.10.042; Charman WN, 2014, OPHTHAL PHYSL OPT, V34, P397, DOI 10.1111/opo.12129; Charman WN, 2014, OPHTHAL PHYSL OPT, V34, P8, DOI 10.1111/opo.12091; Cillino S, 2008, OPHTHALMOLOGY, V115, P1508, DOI 10.1016/j.ophtha.2008.04.017; Cochener B, 2011, CLIN OPHTHALMOL, V5, P45, DOI 10.2147/OPTH.S14325; de Gracia P, 2013, INVEST OPHTH VIS SCI, V54, P415, DOI 10.1167/iovs.12-11219; Dorronsoro C, 2014, INVEST OPHTHALMOL, P55; Dorronsoro C, 2016, BIOMED OPT EXPRESS, V7, P4388, DOI 10.1364/BOE.7.004388; Dorronsoro C, 2016, OPTICA, V3, P918, DOI 10.1364/OPTICA.3.000918; Evans BJW, 2007, OPHTHAL PHYSL OPT, V27, P417, DOI 10.1111/j.1475-1313.2007.00488.x; Fernandez EJ, 2010, J OPT SOC AM A, V27, pA48, DOI 10.1364/JOSAA.27.000A48; Fernandez EJ, 2009, OPT LETT, V34, P2628, DOI 10.1364/OL.34.002628; Fisher K., 1997, INT CONTACT LENS CLI, V24, P10; Glasser A, 1998, VISION RES, V38, P209, DOI 10.1016/S0042-6989(97)00102-8; Haun AM, 2013, J VISION, V13, DOI 10.1167/13.8.12; Johannsdottir KR, 2001, OPTOMETRY VISION SCI, V78, P646, DOI 10.1097/00006324-200109000-00009; Kamiya K, 2014, AM J OPHTHALMOL, V158, P215, DOI 10.1016/j.ajo.2014.04.010; Kaymak H, 2008, J REFRACT SURG, V24, P7, DOI [10.3928/1081597X-20080101-02, DOI 10.3928/1081597X-20080101-02]; Kim MJ, 2011, J CATARACT REFR SURG, V37, P1305, DOI 10.1016/j.jcrs.2011.03.033; Koch Douglas D, 2007, Trans Am Ophthalmol Soc, V105, P36; Kohnen T, 2008, J CATARACT REFR SURG, V34, P2005, DOI 10.1016/j.jcrs.2008.10.011; Kompaniez E, 2013, J VISION, V13, DOI 10.1167/13.6.19; Lichtinger A, 2012, CURR OPIN OPHTHALMOL, V23, P40, DOI 10.1097/ICU.0b013e32834cd5be; Llorente-Guillemot A, 2012, CLIN EXP OPTOM, V95, P54, DOI 10.1111/j.1444-0938.2011.00666.x; Marcos S, 2017, VISION RES, V132, P3, DOI 10.1016/j.visres.2017.01.006; RADHAKRISHNAN A, 2015, INVEST OPHTH VIS SCI, V56; Radhakrishnan A, 2016, J CATARACT REFR SURG, V42, P1276, DOI 10.1016/j.jcrs.2016.06.034; Radhakrishnan A, 2015, CURR BIOL, V25, pR188, DOI 10.1016/j.cub.2015.01.027; Radhakrishnan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093089; Sawides L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027031; Schwarz C, 2014, BIOMED OPT EXPRESS, V5, P3355, DOI 10.1364/BOE.5.003355; Schwarz C, 2011, OPT LETT, V36, P4779, DOI 10.1364/OL.36.004779; SIMPSON MJ, 1992, APPL OPTICS, V31, P3621, DOI 10.1364/AO.31.003621; Tabernero J, 2011, INVEST OPHTH VIS SCI, V52, P5273, DOI 10.1167/iovs.10-6436; van der Mooren M, 2015, J CATARACT REFR SURG, V41, P873, DOI 10.1016/j.jcrs.2015.02.005; Vinas M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38673-w; Vinas M, 2017, VISION RES, V132, P85, DOI 10.1016/j.visres.2016.04.011; Yamauchi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068236	40	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0221144	10.1371/journal.pone.0221144	http://dx.doi.org/10.1371/journal.pone.0221144			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430328	Green Published, Green Submitted, gold			2022-12-26	WOS:000485026800028
J	Bang, MS; Kim, CM; Park, JW; Chung, JK; Kim, DM; Yun, NR				Bang, Mi-Seon; Kim, Choon-Mee; Park, Jung Wook; Chung, Jae Keun; Kim, Dong-Min; Yun, Na Ra			Prevalence of Orientia tsutsugamushi, Anaplasma phagocytophilum and Leptospira interrogans in striped field mice in Gwangju, Republic of Korea	PLOS ONE			English	Article							SCRUB TYPHUS; RICKETTSIA-TSUTSUGAMUSHI; SOUTH-KOREA; DIAGNOSIS; EHRLICHIA; TICKS; INFECTION; EPIDEMIOLOGY; VARIANTS; RODENTS	This study investigated the prevalence of Orientia tsutsugamushi, Anaplasma phagocytophilum, and Leptospira interrogans in wild rodents through molecular detection using organ samples and through serological assay using blood samples of mice collected from two distinct sites in Gwangju Metropolitan City, Republic of Korea (ROK). A total of 47 wild rodents, identified as Apodemus agrarius (A. agrarius), were captured from June to August 2016. The seroprevalence of antibodies against bacterial pathogens in A. agrarius sera was analyzed; 17.4% (8/46) were identified as O. tsutsugamushi through indirect immunofluorescence assay and 2.2% (1/46) were identified as Leptospira species through passive hemagglutination assay. Using polymerase chain reaction, the spleen, kidney and blood samples were investigated for the presence of O. tsutsugamushi, A. phagocytophilum, and L. interrogans. Out of the 47 A. agrarius, 19.1% (9/47) were positive for A. phagocytophilum and 6.4% (3/47) were positive for L. interrogans, while none were positive for O. tsutsugamushi. Four out of 46 (8.7%) blood samples, six out of 45 (13.3%) spleen samples, and one out of 47 (2.1%) kidney samples were positive for A. phagocytophilum. Three out of 47 (6.4%) kidney samples were positive for L. interrogans. The sequencing results of PCR positive samples demonstrated > 99% similarity with A. phagocytophilum and L. interrogans sequences. A. phagocytophilum was mostly detected in the spleen, whereas L. interrogans was mostly detected in the kidneys. Notably, A. phagocytophilum and L. interrogans were detected in A. agrarius living in close proximity to humans in the metropolitan suburban areas. The results of this study indicate that rodent-borne bacteria may be present in wild rodents in the metropolitan suburban areas of ROK.	[Bang, Mi-Seon; Kim, Dong-Min; Yun, Na Ra] Chosun Univ, Coll Med, Dept Internal Med, Gwangju, South Korea; [Kim, Choon-Mee] Chosun Univ, Coll Med, Premed Sci, Gwangju, South Korea; [Park, Jung Wook; Chung, Jae Keun] Hlth & Environm Res Inst Gwangju City, Div Infect Dis Invest, Gwangju, South Korea	Chosun University; Chosun University	Kim, DM (corresponding author), Chosun Univ, Coll Med, Dept Internal Med, Gwangju, South Korea.	drongkim@chosun.ac.kr		Kim, Dong-Min/0000-0001-6373-0922	Korean Health Technology Research & Development Project, Ministry of Health & Welfare, Republic of Korea [HI16C2118]	Korean Health Technology Research & Development Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the Korean Health Technology Research & Development Project, Ministry of Health & Welfare, Republic of Korea (HI16C2118) awarded to DMK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanazio DA, 2008, ACTA TROP, V105, P176, DOI 10.1016/j.actatropica.2007.10.012; Blacksell SD, 2007, CLIN INFECT DIS, V44, P391, DOI 10.1086/510585; Branger C, 2005, FEMS MICROBIOL LETT, V243, P437, DOI 10.1016/j.femsle.2005.01.007; Cao WC, 2006, AM J TROP MED HYG, V75, P664, DOI 10.4269/ajtmh.2006.75.664; Chae JS, 2008, J VET SCI, V9, P285, DOI 10.4142/jvs.2008.9.3.285; Chae JS, 2003, ANN NY ACAD SCI, V990, P118, DOI 10.1111/j.1749-6632.2003.tb07349.x; Chang WH, 1999, J KOREAN SOC MICROBI, V34, P409; CHEN SM, 1994, J CLIN MICROBIOL, V32, P589, DOI 10.1128/JCM.32.3.589-595.1994; Cho MK, 1998, EPIDEMIOL INFECT, V121, P685, DOI 10.1017/S0950268898001691; Demma LJ, 2005, AM J TROP MED HYG, V73, P400, DOI 10.4269/ajtmh.2005.73.400; Dumler JS, 2007, CLIN INFECT DIS, V45, pS45, DOI 10.1086/518146; FURUYA Y, 1993, J CLIN MICROBIOL, V31, P1637, DOI 10.1128/JCM.31.6.1637-1640.1993; Kawahara M, 2006, APPL ENVIRON MICROB, V72, P1102, DOI 10.1128/AEM.72.2.1102-1109.2006; Kelly DJ, 2009, CLIN INFECT DIS, V48, pS203, DOI 10.1086/596576; Kim DM, 2010, CLIN MICROBIOL INFEC, V16, P447, DOI 10.1111/j.1469-0691.2009.02865.x; Kim KH, 2014, EMERG INFECT DIS, V20, P1708, DOI 10.3201/eid2010.131680; 임은경, 2003, Journal of Bacteriology and Virology, V33, P177; Kurucz K, 2018, VECTOR-BORNE ZOONOT, V18, P200, DOI 10.1089/vbz.2017.2204; LaScola B, 1997, J CLIN MICROBIOL, V35, P2715, DOI 10.1128/JCM.35.11.2715-2727.1997; Lee HW, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0858-6; Lee IY, 2009, KOREAN J PARASITOL, V47, P381, DOI 10.3347/kjp.2009.47.4.381; Levett PN, 2001, CLIN DIAGN LAB IMMUN, V8, P349, DOI 10.1128/CDLI.8.2.349-351.2001; Lopucki R, 2013, CAN J ZOOL, V91, P554, DOI 10.1139/cjz-2012-0168; Luce-Fedrow A, 2015, FUTURE MICROBIOL, V10, P537, DOI [10.2217/fmb.14.141, 10.2217/FMB.14.141]; Massung RF, 2007, J CLIN MICROBIOL, V45, P2138, DOI 10.1128/JCM.00478-07; Ohashi N, 2005, EMERG INFECT DIS, V11, P1780, DOI 10.3201/eid1111.050407; Pritt BS, 2011, NEW ENGL J MED, V365, P422, DOI 10.1056/NEJMoa1010493; REE H-I, 1991, Korean Journal of Parasitology, V29, P87, DOI 10.3347/kjp.1991.29.1.87; Roh JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113193; Slack AT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-95; SUGITA Y, 1992, J MED MICROBIOL, V37, P357, DOI 10.1099/00222615-37-5-357; Toyokawa T, 2011, EXPERT REV ANTI-INFE, V9, P111, DOI [10.1586/eri.10.151, 10.1586/ERI.10.151]; TRAUB R, 1975, ANN NY ACAD SCI, V266, P91, DOI 10.1111/j.1749-6632.1975.tb35091.x; Tucunduva de Faria M, 2007, J COMP PATHOL, V137, P231, DOI 10.1016/j.jcpa.2007.08.001; You MJ, 2015, INFECT CHEMOTHER, V47, P181, DOI 10.3947/ic.2015.47.3.181	35	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2019	14	8							e0215526	10.1371/journal.pone.0215526	http://dx.doi.org/10.1371/journal.pone.0215526			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5LL	31419222	Green Published, gold, Green Submitted			2022-12-26	WOS:000485019900002
J	Kawamoto, H; Yamanaka, K; Koizumi, A; Ishii, K; Kazama, Y; Abe, T; Kawano, S				Kawamoto, Hiroki; Yamanaka, Kaori; Koizumi, Ayako; Ishii, Kotaro; Kazama, Yusuke; Abe, Tomoko; Kawano, Shigeyuki			An asexual flower of Silene latifolia and Microbotryum lychnidis-dioicae promotes sex-organ development	PLOS ONE			English	Article							ANTHER-SMUT INFECTION; Y-CHROMOSOME; DIOECIOUS PLANT; FEMALE FLOWERS; USTILAGO-VIOLACEA; WHITE CAMPION; REGIONS; GENE; SYSTEM; EXPRESSION	Silene latifolia is a dioecious flowering plant with sex chromosomes in the family Caryophyllaceae. Development of a gynoecium and stamens are suppressed in the male and female flowers of S. latifolia, respectively. Microbotryum lychnidis-dioicae promotes stamen development when it infects the female flower. If suppression of the stamen and gynoecium development is regulated by the same mechanism, suppression of gynoecium and stamen development is released simultaneously with the infection by M. lychnidis-dioicae. To assess this hypothesis, an asexual mutant without a gynoecium or stamen was infected with M. lychnidis-dioicae. A filament of the stamen in the infected asexual mutant was elongated at stages 11 and 12 of flower bud development as well as in the male, but the gynoecium did not form. Instead of the gynoecium, a filamentous structure was suppressed as in the male flower. Developmental suppression of the stamen was released by M. lychnidis-dioicae, but that of gynoecium development was not released. M. lychnidis-dioicae would have a function similar to stamen-promoting factor (SPF), since the elongation of the stamen that is not observed in the healthy asexual mutant was observed after stage 8 of flower bud development. An infection experiment also revealed that a deletion on the Y chromosome of the asexual mutant eliminated genes for maturation of tapetal cells because the tapetal cells did not mature in the asexual mutant infected with M. lychnidis-dioicae.	[Kawamoto, Hiroki; Yamanaka, Kaori; Koizumi, Ayako; Kawano, Shigeyuki] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, FSB, Kashiwa, Chiba, Japan; [Ishii, Kotaro; Kazama, Yusuke; Abe, Tomoko] RIKEN Nishina Ctr, Wako, Saitama, Japan; [Kazama, Yusuke] Fukui Prefectural Univ, Dept Biosci & Biotechnol, Eiheiji, Fukui, Japan; [Kawano, Shigeyuki] Univ Tokyo, Future Ctr Initiat, Funct Biotechnol PJ, Kashiwa, Chiba, Japan	University of Tokyo; RIKEN; Fukui Prefectural University; University of Tokyo	Kawano, S (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, FSB, Kashiwa, Chiba, Japan.; Kawano, S (corresponding author), Univ Tokyo, Future Ctr Initiat, Funct Biotechnol PJ, Kashiwa, Chiba, Japan.	kawano@edu.k.u-tokyo.ac.jp	Ishii, Kotaro/AAZ-1674-2021	Kawamoto, Hiroki/0000-0002-3182-2766; Kazama, Yusuke/0000-0001-5876-7755	Ministry of Education, Culture, Sports, Science and Technology, Japan [SK 24657046]; RIKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN	This work was supported by a Grant-in-Aid for Exploratory Research (to SK 24657046) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. In addition, this work was supported by a Grant-in-Aid for the promotion of science from RIKEN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Michael E Hood for his generous gift ofM. lychnidis-dioicae. This work was supported by a Grant-in-Aid for Exploratory Research (to SK 24657046) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. In addition, this work was supported by a Grant-in-Aid for the promotion of science from RIKEN.	ALEXANDER HM, 1990, OECOLOGIA, V84, P249, DOI 10.1007/BF00318280; ALEXANDER HM, 1988, J ECOL, V76, P91, DOI 10.2307/2260456; BAKER HG, 1947, ANN BOT-LONDON, V11, P333, DOI 10.1093/oxfordjournals.aob.a083161; Bergero R, 2008, GENETICS, V178, P2045, DOI 10.1534/genetics.107.084566; Bernasconi G, 2009, HEREDITY, V103, P5, DOI 10.1038/hdy.2009.34; Donnison IS, 1996, GENETICS, V144, P1893; Farbos I, 1999, GENETICS, V151, P1187; Fujita N, 2012, G3-GENES GENOM GENET, V2, P271, DOI 10.1534/g3.111.001420; Garber ED, 2002, ADV APPL MICROBIOL, V51, P107, DOI 10.1016/S0065-2164(02)51003-0; Giraud T, 2008, EUKARYOT CELL, V7, P765, DOI 10.1128/EC.00440-07; Granberg A, 2008, INT J PLANT SCI, V169, P293, DOI 10.1086/523964; GRANT S, 1994, PLANT J, V6, P471, DOI 10.1046/j.1365-313X.1994.6040471.x; HARDENACK S, 1994, PLANT CELL, V6, P1775, DOI 10.1105/tpc.6.12.1775; Hobza R, 2006, THEOR APPL GENET, V113, P280, DOI 10.1007/s00122-006-0293-3; Hood ME, 2002, GENETICS, V160, P457; Ishii K, 2008, GENOME, V51, P251, DOI 10.1139/G08-005; Kawamoto H, 2016, PLANT CELL PHYSL, V58; Kawamoto H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182686; Kazama Y, 2005, PLANT CELL PHYSIOL, V46, P806, DOI 10.1093/pcp/pci080; Kazama Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep18917; Kemler M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-35; Koizumi A, 2007, PLANT CELL PHYSIOL, V48, P1450, DOI 10.1093/pcp/pcm113; Koizumi A, 2009, J PLANT PHYSIOL, V166, P1832, DOI 10.1016/j.jplph.2009.04.004; Lebel-Hardenack S, 2002, GENETICS, V160, P717; Moore RC, 2003, GENETICS, V163, P321; Nakao S, 2002, GENOME, V45, P413, DOI 10.1139/G01-151; Schafer AM, 2010, BOTANY, V88, P875, DOI 10.1139/B10-061; Scotti I, 2006, EVOLUTION, V60, P1793; Uchida W, 2003, PLANTA, V218, P240, DOI 10.1007/s00425-003-1110-8; WARMKE HE, 1946, AM J BOT, V33, P648, DOI 10.2307/2437345; Zhang W, 2006, DEVELOPMENT, V133, P3085, DOI 10.1242/dev.02463	31	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2019	14	8							e0217329	10.1371/journal.pone.0217329	http://dx.doi.org/10.1371/journal.pone.0217329			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5LL	31419225	Green Published, gold, Green Submitted			2022-12-26	WOS:000485019900005
J	Omori, M; Kondo, T; Tagaya, H; Watanabe, Y; Fukasawa, H; Kawai, M; Nakazawa, K; Hashi, A; Hirata, S				Omori, Makiko; Kondo, Tetsuo; Tagaya, Hikaru; Watanabe, Yumika; Fukasawa, Hiroko; Kawai, Masataka; Nakazawa, Kumiko; Hashi, Akihiko; Hirata, Shuji			Utility of imaging modalities for predicting carcinogenesis in lobular endocervical glandular hyperplasia	PLOS ONE			English	Article							MINIMAL DEVIATION ADENOCARCINOMA; GASTRIC-TYPE ADENOCARCINOMA; CERVICAL ADENOCARCINOMA; ADENOMA MALIGNUM; UTERINE CERVIX; UNITED-STATES; LESIONS; DIAGNOSIS; IMMUNOPHENOTYPE; METAPLASIA	Objectives To investigate the use of imaging methods for predicting carcinogenesis in lobular endocervical glandular hyperplasia (LEGH). Methods We retrospectively analyzed preoperative images on transvaginal sonography and magnetic resonance imaging (MRI) in 23 cases with histologically diagnosed LEGH. Results Shape of cervical multicystic lesions on MR images could be divided into two types the flower-type with many small cysts surrounded by larger cysts, and the raspberry-type with many tiny, closely aggregated cysts. Six (46%) of 13 cases had raspberry-type lesions that were not detected on transvaginal sonography but were seen on MRI. Adenocarcinoma in situ (AIS) was identified in 4 postmenopausal women with raspberry-type lesions during the follow-up periods. In these cases, cytologic examination by targeted endocervical sampling using sonography enabled early detection of AIS. Conclusions MRI and cytologic examination by targeted endocervical sampling may be very useful for predicting carcinogenesis in LEGH.	[Omori, Makiko; Tagaya, Hikaru; Watanabe, Yumika; Fukasawa, Hiroko; Hashi, Akihiko; Hirata, Shuji] Univ Yamanashi, Dept Obstet & Gynecol, Fac Med, Yamanashi, Japan; [Kondo, Tetsuo; Kawai, Masataka; Nakazawa, Kumiko] Univ Yamanashi, Dept Pathol, Fac Med, Yamanashi, Japan	University of Yamanashi; University of Yamanashi	Omori, M (corresponding author), Univ Yamanashi, Dept Obstet & Gynecol, Fac Med, Yamanashi, Japan.	msasaki@yamanashi.ac.jp	Omori, Makiko/AAW-3775-2020	Omori, Makiko/0000-0003-4430-5490				Adegoke O, 2012, J WOMENS HEALTH, V21, P1031, DOI 10.1089/jwh.2011.3385; Ando H, 2016, J OBSTET GYNAECOL RE, V42, P1588, DOI 10.1111/jog.13083; Hata S, 2002, DIAGN CYTOPATHOL, V27, P80, DOI 10.1002/dc.10140; Ishii K, 2001, CLIN CHIM ACTA, V312, P231, DOI 10.1016/S0009-8981(01)00611-8; Ishii K, 1999, CANCER CYTOPATHOL, V87, P245, DOI 10.1002/(SICI)1097-0142(19991025)87:5<245::AID-CNCR2>3.0.CO;2-0; Kawauchi S, 2008, AM J SURG PATHOL, V32, P1807, DOI 10.1097/PAS.0b013e3181883722; Kido A, 2014, INT J GYNECOL CANCER, V24, P1474, DOI 10.1097/IGC.0000000000000229; Kojima A, 2007, AM J SURG PATHOL, V31, P664, DOI 10.1097/01.pas.0000213434.91868.b0; Kondo T, 2005, MODERN PATHOL, V18, P1199, DOI 10.1038/modpathol.3800403; Krane JF, 2001, CANCER CYTOPATHOL, V93, P8, DOI 10.1002/1097-0142(20010225)93:1<8::AID-CNCR9001>3.0.CO;2-K; Kusanagi Y, 2010, AM J PATHOL, V177, P2169, DOI 10.2353/ajpath.2010.100323; Mikami Y, 2004, MODERN PATHOL, V17, P962, DOI 10.1038/modpathol.3800148; Mikami Y, 1999, GYNECOL ONCOL, V74, P504, DOI 10.1006/gyno.1999.5462; Mikami Y, 2013, ADV ANAT PATHOL, V20, P227, DOI 10.1097/PAP.0b013e31829c2d66; Moreira MAR, 2008, DIAGN CYTOPATHOL, V36, P270, DOI 10.1002/dc.20799; Nara M, 2007, GYNECOL ONCOL, V106, P289, DOI 10.1016/j.ygyno.2007.03.044; Nucci MR, 1999, AM J SURG PATHOL, V23, P886, DOI 10.1097/00000478-199908000-00005; Ohya A, 2018, J OBSTET GYNAECOL RE, V44, P312, DOI 10.1111/jog.13528; Omori M, 2008, AM J CLIN PATHOL, V130, P585, DOI 10.1309/L8XME5JVEJ74C3F1; Omori M, 2018, AM J CLIN PATHOL, V150, P259, DOI [10.1093/AJCP/AQY055, 10.1093/ajcp/aqy055]; Omori M, 2018, DIAGN CYTOPATHOL, V46, P702, DOI 10.1002/dc.23932; Pirog EC, 2000, AM J PATHOL, V157, P1055, DOI 10.1016/S0002-9440(10)64619-6; Pirog EC, 2017, ARCH PATHOL LAB MED, V141, P1653, DOI 10.5858/arpa.2016-0356-RA; Takatsu A, 2011, INT J GYNECOL CANCER, V21, P1287, DOI 10.1097/IGC.0b013e31821f746c; Talia KL, 2018, PATHOLOGY, V50, P122, DOI 10.1016/j.pathol.2017.09.009; Tsuboyama T, 2015, ABDOM IMAGING, V40, P459, DOI 10.1007/s00261-014-0323-6; Tsuda H, 2005, PATHOL INT, V55, P412, DOI 10.1111/j.1440-1827.2005.01846.x; van der Horst J, 2017, CANCER MED-US, V6, P416, DOI 10.1002/cam4.971; Wang SS, 2004, CANCER-AM CANCER SOC, V100, P1035, DOI 10.1002/cncr.20064; Xu JY, 2005, INT J GYNECOL PATHOL, V24, P296, DOI 10.1097/01.PGP.0000157918.36354.C1	30	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0221088	10.1371/journal.pone.0221088	http://dx.doi.org/10.1371/journal.pone.0221088			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415639	Green Published, gold, Green Submitted			2022-12-26	WOS:000485017200073
J	Taber, JM; Ellis, EM; Reblin, M; Ellington, L; Ferrer, RA				Taber, Jennifer M.; Ellis, Erin M.; Reblin, Maija; Ellington, Lee; Ferrer, Rebecca A.			Knowledge of and beliefs about palliative care in a nationally-representative US sample	PLOS ONE			English	Article							DONT KNOW RESPONSES; INFORMATION-SEEKING; ADVANCE DIRECTIVES; ADVANCED CANCER; HEALTH; DECISION; PERCEPTIONS; BARRIERS; OUTCOMES; INTEGRATION	Palliative care aims to improve quality of life for people with serious illness and their families. One potential barrier to palliative care uptake is inaccurate knowledge and/or negative beliefs among the general population, which may inhibit early interest in, communication about, and integration of palliative care following subsequent illness diagnosis. We explored knowledge and beliefs about palliative care among the general public using nationally-representative data collected in 2018 as part of the cross-sectional Health Information National Trends Survey. Only individuals who had heard of palliative care (n = 1,162, M-age = 51.8, 64% female) were queried on knowledge and beliefs. We examined whether self-assessed level of awareness of palliative care (i.e., knowing a little vs. enough to explain it) was associated with the relative likelihood of having accurate/positive beliefs, inaccurate/negative beliefs, or responding "don't know" to questions about palliative care. Respondents who indicated knowing a lot about palliative care had more accurate versus inaccurate knowledge than those who knew a little on only two of six items and more positive attitudes on only one of three items. In particular, respondents with greater awareness were equally likely to report that palliative care is the same as hospice and requires stopping other treatments, and equally likely to believe that palliative care means giving up and to associate palliative care with death. Those with higher awareness were less likely than those with lower awareness to respond "don't know," but greater awareness was not necessarily associated with having accurate or positive beliefs about palliative care as opposed to inaccurate or negative beliefs. Thus, even members of the general public who perceived themselves to know a lot about palliative care were often no less likely to report inaccurate knowledge or negative beliefs (versus accurate and positive, respectively). Findings suggest a need to improve awareness and attitudes about palliative care.	[Taber, Jennifer M.] Kent State Univ, Dept Psychol Sci, Kent, OH 44242 USA; [Ellis, Erin M.; Ferrer, Rebecca A.] NCI, Behav Res Program, Bethesda, MD 20892 USA; [Reblin, Maija] H Lee Moffitt Canc Ctr & Res Inst, Dept Hlth Outcomes & Behav, Tampa, FL USA; [Ellington, Lee] Univ Utah, Coll Nursing, Salt Lake City, UT 84112 USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); H Lee Moffitt Cancer Center & Research Institute; Utah System of Higher Education; University of Utah	Taber, JM (corresponding author), Kent State Univ, Dept Psychol Sci, Kent, OH 44242 USA.	jtaber1@kent.edu	Taber, Jennifer/AAT-6045-2021	Taber, Jennifer/0000-0003-3285-4871				Ahmed N, 2004, PALLIATIVE MED, V18, P525, DOI 10.1191/0269216304pm921oa; Akiyama M, 2016, SUPPORT CARE CANCER, V24, P347, DOI 10.1007/s00520-015-2788-4; Aldridge MD, 2016, PALLIATIVE MED, V30, P224, DOI 10.1177/0269216315606645; Barnato AE, 2009, J GEN INTERN MED, V24, P695, DOI 10.1007/s11606-009-0952-6; Barwise A, 2019, ANN PALLIAT MED; Center to Advance Palliative Care, 2011, 2011 PUBL OP RES PAL; Clark D, 2007, LANCET ONCOL, V8, P430, DOI 10.1016/S1470-2045(07)70138-9; Collins A, 2017, PALLIATIVE MED, V31, P825, DOI 10.1177/0269216317696420; Cutrona SL, 2015, J CANCER EDUC, V30, P12, DOI 10.1007/s13187-014-0701-3; Dans M, 2017, J NATL COMPR CANC NE, V15, P989, DOI 10.6004/jnccn.2017.0132; Denman DC, 2018, MED DECIS MAKING, V38, P673, DOI 10.1177/0272989X18785159; Ditto PH, 2005, MOTIV EMOTION, V29, P481, DOI 10.1007/s11031-006-9017-x; Dumanovsky T, 2016, J PALLIAT MED, V19, P8, DOI 10.1089/jpm.2015.0351; El-Jawahri A, 2016, JAMA-J AM MED ASSOC, V316, P2094, DOI 10.1001/jama.2016.16786; Ellis EM, 2018, J HEALTH COMMUN, V23, P967, DOI 10.1080/10810730.2018.1554729; Ellis EM, 2018, HEALTH PSYCHOL, V37, P394, DOI 10.1037/hea0000587; Fadul N, 2007, J PALLIAT MED, V10, P1146, DOI 10.1089/jpm.2006.0259; Fadul N, 2009, CANCER-AM CANCER SOC, V115, P2013, DOI 10.1002/cncr.24206; Feeg Veronica D, 2005, Am J Hosp Palliat Care, V22, P119, DOI 10.1177/104990910502200207; Ferrell BR, 2017, J ONCOL PRACT, V13, P119, DOI 10.1200/JOP.2016.017897; Ferris FD, 2009, J CLIN ONCOL, V27, P3052, DOI 10.1200/JCO.2008.20.1558; Flemming K, 2010, J PAIN SYMPTOM MANAG, V39, P139, DOI 10.1016/j.jpainsymman.2009.05.014; Gawande A., 2014, BEING MORTAL MED WHA; Glanz K., 2008, HLTH BEHAV HLTH ED T; Goethals G. R., 1977, SOC COMP PROCESS THE; Halpern SD, 2013, HEALTH AFFAIR, V32, P408, DOI 10.1377/hlthaff.2012.0895; Hay JL, 2015, MED DECIS MAKING, V35, P436, DOI 10.1177/0272989X15572827; Hughes MT, 2014, ANNU REV PUBL HEALTH, V35, P459, DOI 10.1146/annurev-publhealth-032013-182406; Huo J, 2019, J PAIN SYMPTOM MANAG; Janssen E, 2018, BRIT J HEALTH PSYCH, V23, P407, DOI 10.1111/bjhp.12296; Kavalieratos D, 2016, JAMA-J AM MED ASSOC, V316, P2104, DOI 10.1001/jama.2016.16840; Kelley AS, 2015, NEW ENGL J MED, V373, P747, DOI 10.1056/NEJMra1404684; Klinger CA, 2014, PALLIATIVE MED, V28, P111, DOI 10.1177/0269216313493342; Koffman J, 2007, PALLIATIVE MED, V21, P145, DOI 10.1177/0269216306074639; Kozlov E, 2018, AM J HOSP PALLIAT ME, V35, P647, DOI 10.1177/1049909117725725; Loewenstein G, 2005, HEALTH PSYCHOL, V24, pS49, DOI 10.1037/0278-6133.24.4.S49; Love AW, 2014, PROG PALLIAT CARE, V22, P9, DOI 10.1179/1743291X13Y.0000000055; Lynch T, 2013, J PAIN SYMPTOM MANAG, V45, P1094, DOI 10.1016/j.jpainsymman.2012.05.011; McIlfatrick S, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-34; Meier DE, 2016, MESSAGING PALLIATIVE; Nelson DE, 2004, J HEALTH COMMUN, V9, P443, DOI 10.1080/10810730490504233; Orom H, 2018, MED DECIS MAKING, V38, P1006, DOI 10.1177/0272989X18799999; Parker SM, 2013, J HOSP PALLIAT NURS, V15, P225, DOI 10.1097/NJH.0b013e318279f4ce; Reid CM, 2008, ANN ONCOL, V19, P44, DOI 10.1093/annonc/mdm462; Rogers M, 2017, WE WORK TREND INSIGH; Schallmo MK, 2019, J CARDIOVASC NURS, V34, pE9, DOI 10.1097/JCN.0000000000000556; Schenker Y, 2014, JAMA INTERN MED, V174, P1093, DOI 10.1001/jamainternmed.2014.1887; Schenker Y, 2014, J ONCOL PRACT, V10, pE37, DOI 10.1200/JOP.2013.001130; Shalev A, 2018, AM J HOSP PALLIAT ME, V35, P431, DOI 10.1177/1049909117715215; Shen M., 2018, P IEEE INT C RFID TE P IEEE INT C RFID TE, P1; Shin DW, 2017, PSYCHO-ONCOLOGY, V26, P770, DOI 10.1002/pon.4226; Silveira MJ, 2010, NEW ENGL J MED, V362, P1211, DOI 10.1056/NEJMsa0907901; Smith S, 2014, PALLIATIVE MED, V28, P130, DOI 10.1177/0269216313493466; Sudore RL, 2010, ANN INTERN MED, V153, P256, DOI 10.7326/0003-4819-153-4-201008170-00008; Suls J, 2014, OXFORD HDB HLTH COMM, P251; Temel JS, 2017, J CLIN ONCOL, V35, P834, DOI 10.1200/JCO.2016.70.5046; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Trivedi N, 2019, J PALLIAT MED, V22, P1578, DOI 10.1089/jpm.2018.0656; Van Dussen D, 2011, AM J HOSP PALLIAT ME, V28, P418, DOI 10.1177/1049909110394339; Waters EA, 2016, ANN BEHAV MED, V50, P784, DOI 10.1007/s12160-016-9789-5; Waters EA, 2013, MED DECIS MAKING, V33, P271, DOI 10.1177/0272989X12464435; Zimmermann C, 2016, CAN MED ASSOC J, V188, pE217, DOI 10.1503/cmaj.151171	62	35	36	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0219074	10.1371/journal.pone.0219074	http://dx.doi.org/10.1371/journal.pone.0219074			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5KK	31415570	Green Submitted, Green Published, gold			2022-12-26	WOS:000485017200003
J	Tollington, S; Kareemun, Z; Augustin, A; Lallchand, K; Tatayah, V; Zimmermann, A				Tollington, Simon; Kareemun, Zainal; Augustin, Arlaine; Lallchand, Kunal; Tatayah, Vikash; Zimmermann, Alexandra			Quantifying the damage caused by fruit bats to backyard lychee trees in Mauritius and evaluating the benefits of protective netting	PLOS ONE			English	Article							FLYING FOXES; CONSERVATION; ATTITUDES; ECOLOGY; CULL	The Mauritius fruit bat (Pteropus niger) has been the subject of repeated culling campaigns, apparently in response to pressure from the fruit-growing industry concerned over damage to commercially valuable orchard crops such as lychees. More than 31,000 fruit-bearing lychee trees also exist in private backyards, making this an issue pertinent to a wide cross-section of the Mauritian general public and not just those involved in commercial fruit production. The level of damage caused by bats to fruit crops is often debated and the low number of robust damage assessment studies hampers mitigation efforts. During the fruiting season of 2016/2017, we assessed the damage among backyard lychee trees attributable to fruit bats and other causes around Vacoas-Phoenix, Central Mauritius and evaluated the impact of using protective netting as a mitigation strategy. Fruit yield from panicles that were protected from depredation by nylon netting was approximately one third greater than that from unprotected panicles. We suspect that fruit bats were responsible for approximately 42% of the total damage but illustrate the difficulties in attributing damage to a single cause in such assessments. Although we demonstrate the value of protective netting, we recognize that barriers to implementation exist and that a more holistic approach that incorporates crop protection, forest restoration strategies and addresses negative public attitudes towards bats in general is required to ensure the persistence of this endemic species.	[Tollington, Simon; Zimmermann, Alexandra] Chester Zoo, North England Zool Soc, Chester, Cheshire, England; [Tollington, Simon] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury, Kent, England; [Kareemun, Zainal; Augustin, Arlaine; Lallchand, Kunal; Tatayah, Vikash] Mauritian Wildlife Fdn, Vacoas, Mauritius; [Zimmermann, Alexandra] Univ Oxford, Recanati Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit, Tubney, Oxon, England	University of Kent; University of Oxford	Tollington, S (corresponding author), Chester Zoo, North England Zool Soc, Chester, Cheshire, England.; Tollington, S (corresponding author), Univ Kent, Durrell Inst Conservat & Ecol, Canterbury, Kent, England.	Simon.Tollington@gmail.com		Tollington, Simon/0000-0003-2450-7255				Avery M. L., 2000, WILDLIFE DAMAGE MANA, P13; Aziz Sheema Abdul, 2016, P377; Barnett S.H., 2007, RAT STUDY BEHAV; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bumrungsri S, 2009, J TROP ECOL, V25, P85, DOI 10.1017/S0266467408005531; Cheke A., 2010, LOST LAND DODO ECOLO; Crawley M. J., 2012, R BOOK, DOI DOI 10.1111/j.1365-294X.2008.03806.x; Epstein JH, 2009, J APPL ECOL, V46, P991, DOI 10.1111/j.1365-2664.2009.01699.x; Fleming TH, 2011, ACTA OECOL, V37, P521, DOI 10.1016/j.actao.2011.01.016; Florens FBV, 2017, J NAT CONSERV, V40, P85, DOI 10.1016/j.jnc.2017.10.002; Florens FBV, 2016, NATURE, V530, P33, DOI 10.1038/530033a; Florens FBV, 2015, SCIENCE, V350, P1325, DOI 10.1126/science.350.6266.1325-a; FUJITA MS, 1991, CONSERV BIOL, V5, P455, DOI 10.1111/j.1523-1739.1991.tb00352.x; Government Queensland, 2009, FLYING FOX CONTR MET; Government Queensland, 2012, FREQ QUEST PROBL LYC; Hadjisterkotis E, 2006, EUR J WILDLIFE RES, V52, P282, DOI 10.1007/s10344-006-0041-7; Harrison ME, 2011, BIOL CONSERV, V144, P2441, DOI 10.1016/j.biocon.2011.06.021; Hutson A. M, 2013, IUCN RED LIST THREAT, V2013; IUCN, 2015, IUCN SSC POS STAT CU; IUCN, 2018, IUCN SSC POS STAT CU; Jones C. G., 2012, REINTRODUCTION BIOL; Kingston T., 2018, PTEROPUS NIGER, DOI 10.2305/IUCN.UK.2018-1.RLTS.T18743A86475525.en; Kingston Tigga, 2016, P571; Kingston T, 2010, BIODIVERS CONSERV, V19, P471, DOI 10.1007/s10531-008-9458-5; Knight AJ, 2008, J ENVIRON PSYCHOL, V28, P94, DOI 10.1016/j.jenvp.2007.10.001; Krivek G, 2017, THESIS; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; Lefcheck JS, 2016, METHODS ECOL EVOL, V7, P573, DOI 10.1111/2041-210X.12512; Maas B, 2013, ECOL LETT, V16, P1480, DOI 10.1111/ele.12194; Mauritius Statistics, 2011, HOUS POP CENS; Mickleburgh SP, 2002, ORYX, V36, P18, DOI 10.1017/S0030605301000011; Mildenstein Tammy, 2016, P325; Nyhagen DF, 2005, BIOL CONSERV, V122, P491, DOI 10.1016/j.biocon.2004.08.012; O'Shea TJ, 2016, MAMMAL REV, V46, P175, DOI 10.1111/mam.12064; Oleksy R, 2015, IMPACT MAURITIUS FRU; Olival KJ, 2016, ECOHEALTH, V13, P6, DOI 10.1007/s10393-015-1075-7; Peel AJ, 2017, ACTA CHIROPTEROL, V19, P77, DOI 10.3161/15081109ACC2017.19.1.006; Prokop P., 2008, EURASIA J MATH SCI T, V4; Prokop P, 2009, ANTHROZOOS, V22, P19, DOI 10.2752/175303708X390446; Safford RJ, 1997, BIOL CONSERV, V80, P181, DOI 10.1016/S0006-3207(96)00048-1; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; State Government of Victoria, 2002, BIRD FLYING FOX DAM; Vincenot CE, 2017, SCIENCE, V355, P1368, DOI 10.1126/science.aam7582; Waples Kelly, 2002, P39; WHISHAW IQ, 1989, PSYCHOBIOLOGY, V17, P93; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	46	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220955	10.1371/journal.pone.0220955	http://dx.doi.org/10.1371/journal.pone.0220955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415626	Green Published, gold, Green Submitted			2022-12-26	WOS:000485017200051
J	Traber, KE; Dimbo, EL; Symer, EM; Korkmaz, FT; Jones, MR; Mizgerd, JP; Quinton, LJ				Traber, Katrina E.; Dimbo, Ernest L.; Symer, Elise M.; Korkmaz, Filiz T.; Jones, Matthew R.; Mizgerd, Joseph P.; Quinton, Lee J.			Roles of interleukin-11 during acute bacterial pneumonia	PLOS ONE			English	Article							RECOMBINANT HUMAN INTERLEUKIN-11; LEUKEMIA INHIBITORY FACTOR; INNATE IMMUNE-RESPONSES; NF-KAPPA-B; HOST-DEFENSE; NEUTROPHIL RECRUITMENT; IL-11; EXPRESSION; INFLAMMATION; INDUCTION	Interleukin-11 (IL-11) is an interleukin-6 (IL-6) family cytokine shown to play a protective role in acute inflammatory settings including systemic infection. In this study we addressed the role of IL-11 in acute bacterial pneumonia using a mouse model of E. coli pneumonia. Compared with other related cytokines, IL-11 protein was maintained at high levels in the lung at baseline, with only mild alterations in whole lung and BALF levels during acute infection. The primary source of IL-11 in the lung was the epithelium, but steady state production was not dependent on the inflammatory transcription factor nuclear factor kappa B in cells of either myeloid or epithelial lineage. Blockade of IL-11 with neutralizing antibodies resulted in a mild but significant decrease in neutrophil recruitment and increase in pulmonary edema during pneumonia, without detectable alterations in bacterial clearance. Exogenous IL-11 administration, however, had no effect at baseline or during infection. Overall, we conclude that maintenance of lung IL-11 concentrations may influence acute pulmonary inflammation during infection, albeit modestly.	[Traber, Katrina E.; Dimbo, Ernest L.; Symer, Elise M.; Korkmaz, Filiz T.; Jones, Matthew R.; Mizgerd, Joseph P.; Quinton, Lee J.] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Traber, Katrina E.; Jones, Matthew R.; Mizgerd, Joseph P.; Quinton, Lee J.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Mizgerd, Joseph P.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Mizgerd, Joseph P.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Quinton, Lee J.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA	Boston University; Boston University; Boston University; Boston University; Boston University	Traber, KE; Quinton, LJ (corresponding author), Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA.; Traber, KE; Quinton, LJ (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.; Quinton, LJ (corresponding author), Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA.	katraber@bu.edu; lquinton@bu.edu	Traber, Katrina/AAR-5836-2021; Mizgerd, Joseph/GRY-6369-2022	Korkmaz, Filiz/0000-0002-1158-7164; Traber, Katrina/0000-0002-8534-4480; Jones, Matthew/0000-0003-4647-2962; Quinton, Lee/0000-0003-1938-2507	National Institutes of Health [T32 HL-007035, K08 HL-130582, R01 HL-111449, R01 GM-120060, R01 HL-136725, R35 HL-135756]; National Center for Advancing Translational Sciences, National Institutes of Health, through BU-CTSI Grant [KL2 TR-001411]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001411] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R35HL135756, T32HL007035, K08HL130582, R01HL136725, R01HL111449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI115053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences, National Institutes of Health, through BU-CTSI Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants T32 HL-007035 (FTK), K08 HL-130582 (KET), R01 HL-111449 (LJQ), R01 GM-120060 (LJQ), R01 HL-136725 (MRJ), and R35 HL-135756 (JPM), and the National Center for Advancing Translational Sciences, National Institutes of Health, through BU-CTSI Grant KL2 TR-001411 (KET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chakir J, 2003, J ALLERGY CLIN IMMUN, V111, P1293, DOI 10.1067/mai.2003.1557; Einarsson O, 1996, J CLIN INVEST, V97, P915, DOI 10.1172/JCI118514; ELIAS JA, 1994, J IMMUNOL, V152, P2421; Jones MR, 2006, J INFECT DIS, V193, P360, DOI 10.1086/499312; Kapina MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021878; Kaye J A, 1998, Stem Cells, V16 Suppl 2, P207; Lee CG, 2008, AM J RESP CELL MOL, V39, P739, DOI 10.1165/rcmb.2008-0053OC; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Mei JJ, 2010, IMMUNITY, V33, P106, DOI 10.1016/j.immuni.2010.07.009; Murakami M, 2019, IMMUNITY, V50, P812, DOI 10.1016/j.immuni.2019.03.027; Murphy Sherry L, 2018, NCHS Data Brief, P1; Negahdaripour M, 2016, CYTOKINE GROWTH F R, V32, P41, DOI 10.1016/j.cytogfr.2016.06.002; Opal SM, 1999, BLOOD, V93, P3467, DOI 10.1182/blood.V93.10.3467.410k10_3467_3472; Opal SM, 1998, J INFECT DIS, V178, P1205, DOI 10.1086/515686; Opal SM, 2003, J INFECT DIS, V187, P70, DOI 10.1086/345864; Opal SM, 2000, J INFECT DIS, V181, P754, DOI 10.1086/315247; Orlova MO, 2006, INFECT IMMUN, V74, P3668, DOI 10.1128/IAI.00196-06; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Pittet LA, 2011, AM J RESP CELL MOL, V45, P573, DOI 10.1165/rcmb.2010-0210OC; Quinton LJ, 2008, AM J RESP CELL MOL, V38, P699, DOI 10.1165/rcmb.2007-0365OC; Quinton LJ, 2007, J IMMUNOL, V178, P1896, DOI 10.4049/jimmunol.178.3.1896; Quinton LJ, 2018, PHYSIOL REV, V98, P1417, DOI 10.1152/physrev.00032.2017; Quinton LJ, 2012, J IMMUNOL, V188, P6300, DOI 10.4049/jimmunol.1200256; Quinton LJ, 2011, CELL TISSUE RES, V343, P153, DOI 10.1007/s00441-010-1044-y; Quinton LJ, 2009, INFECT IMMUN, V77, P2417, DOI 10.1128/IAI.01300-08; Redlich CA, 1996, J IMMUNOL, V157, P1705; Schafer S, 2017, NATURE, V552, P110, DOI 10.1038/nature24676; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Shepelkova G, 2016, J INFECT DIS, V214, P496, DOI 10.1093/infdis/jiw176; Sheridan BC, 1999, AM J PHYSIOL-LUNG C, V277, pL861, DOI 10.1152/ajplung.1999.277.5.L861; Tang WL, 1996, J CLIN INVEST, V98, P2845, DOI 10.1172/JCI119113; Theivanthiran B, 2012, INFECT IMMUN, V80, P2558, DOI 10.1128/IAI.06230-11; Traber KE, 2017, AM J PHYSIOL-LUNG C, V313, pL548, DOI 10.1152/ajplung.00482.2016; Traber KE, 2015, AM J RESP CELL MOL, V53, P479, DOI 10.1165/rcmb.2014-0342OC; Trepicchio WL, 1997, J IMMUNOL, V159, P5661; Troeger C, 2017, LANCET INFECT DIS, V17, P1133, DOI 10.1016/S1473-3099(17)30396-1; Wasserman GA, 2017, J CLIN INVEST, V127, P3866, DOI 10.1172/JCI94639; Xu DH, 2016, CANCER LETT, V373, P156, DOI 10.1016/j.canlet.2016.01.004; Yamamoto K, 2014, AM J RESP CELL MOL, V50, P253, DOI 10.1165/rcmb.2013-0114OC; Yamamoto K, 2012, J IMMUNOL, V189, P2450, DOI 10.4049/jimmunol.1200634; Zhang Liming, 2018, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V43, P1083, DOI 10.11817/j.issn.1672-7347.2018.10.007; ZHENG T, 1994, J IMMUNOL, V153, P4742	42	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0221029	10.1371/journal.pone.0221029	http://dx.doi.org/10.1371/journal.pone.0221029			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415618	Green Published, gold, Green Submitted			2022-12-26	WOS:000485017200061
J	Lukasik, I; Woloch, A; Sytykiewicz, H; Sprawka, I; Golawska, S				Lukasik, Iwona; Woloch, Aleksandra; Sytykiewicz, Hubert; Sprawka, Iwona; Golawska, Sylwia			Changes in the content of thiol compounds and the activity of glutathione s-transferase in maize seedlings in response to a rose-grass aphid infestation	PLOS ONE			English	Article							DWARF-MOSAIC-VIRUS; OXIDATIVE STRESS; ANTIOXIDANT ENZYMES; TRITICUM-AESTIVUM; DEFENSE RESPONSES; PROTEIN OXIDATION; REACTIVE OXYGEN; RESISTANCE; PLANTS; ARABIDOPSIS	The rose-grass aphid (Methopolophium dirhodum Walk.) is a major pest of maize (Zea mays L.), but little is known about the biochemical interactions between M. dirhodum and its host plant. Thiol compounds and glutathione S-transferase (GST) play a crucial role in the defense responses of maize to biotic stress factors, including aphids. The purpose of this research was to evaluate the impact of M. dirhodum herbivory on the total thiol (TT), protein bound thiol (PT), reduced glutathione (GSH) and oxidized glutathione (GSSG) contents as well as the activity of GST in three varieties of Z mays (Ztota Kartowa, Ambrozja and Piomyk), that were classified as aphid-susceptible, aphid-relatively resistant and aphid-resistant, respectively. The earliest and strongest aphid-triggered alterations in the levels of TT, PT and GSH, and the greatest induction of GST activity, were recorded in the resistant Piomyk seedlings in relation to the relatively resistant Ambrozja and the susceptible Ztota Kartowa.	[Lukasik, Iwona; Woloch, Aleksandra; Sytykiewicz, Hubert; Sprawka, Iwona; Golawska, Sylwia] Siedlce Univ Nat Sci & Humanities, Dept Biochem & Mol Biol, Siedlce, Poland		Lukasik, I (corresponding author), Siedlce Univ Nat Sci & Humanities, Dept Biochem & Mol Biol, Siedlce, Poland.	iwona.lukasik@uph.edu.pl	Sytykiewicz, Hubert/AAC-1431-2020	Sytykiewicz, Hubert/0000-0002-6540-0561; Lukasik, Iwona/0000-0002-1585-1866; Sprawka, Iwona/0000-0001-9511-1042; Golawska, Sylwia/0000-0001-9192-6738	National Science Centre, Poland [2016/21/B/NZ9/00612]	National Science Centre, Poland(National Science Centre, Poland)	The study was performed with the financial support of the National Science Centre, Poland (grant no. 2016/21/B/NZ9/00612).	Alla MMN, 2007, ACTA PHYSIOL PLANT, V29, P247, DOI 10.1007/s11738-007-0031-8; Aly A. A., 2012, Australian Journal of Crop Science, V6, P541; Beres PK, 2015, ACTA SCI POL-HORTORU, V14, P39; Bhoomika K, 2014, J PLANT PHYSIOL, V171, P497, DOI 10.1016/j.jplph.2013.12.009; Blasi EAR, 2017, J PLANT PHYSIOL, V219, P100, DOI 10.1016/j.jplph.2017.10.005; Botha AM, 2014, BIOL OPEN, V3, P1116, DOI 10.1242/bio.201410280; Cerny M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092812; Da QG, 2017, PLANT PHYSIOL, V175, P652, DOI 10.1104/pp.16.01500; Dai H, 2017, BIOL PLANTARUM, V61, P551, DOI 10.1007/s10535-016-0669-4; Dalton DA, 2009, PLANT PHYSIOL, V150, P521, DOI 10.1104/pp.109.136630; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Dean JD, 2005, J EXP BOT, V56, P1525, DOI 10.1093/jxb/eri145; Ding N, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1179-z; Dixon DP, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews3004; de Freitas PAF, 2018, J PLANT GROWTH REGUL, V37, P911, DOI 10.1007/s00344-018-9787-x; Ferriol I, 2013, ANN APPL BIOL, V162, P71, DOI 10.1111/j.1744-7348.2012.00579.x; Fornale S, 2012, MOL PLANT, V5, P817, DOI 10.1093/mp/ssr097; Garg N, 2013, J AGRON CROP SCI, V199, P118, DOI 10.1111/j.1439-037X.2012.00533.x; Ghanta S, 2011, PLANT SIGNAL BEHAV, V6, P607, DOI [10.4161/psb.6.4.15402, 10.4161/psb.6.6.15147]; Gietler M, 2016, PLANT GROWTH REGUL, V79, P287, DOI 10.1007/s10725-015-0133-z; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Gullner G, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01836; Han Y, 2013, ANTIOXID REDOX SIGN, V18, P2106, DOI 10.1089/ars.2012.5052; Herrmann A, 2013, BIOENERG RES, V6, P372, DOI 10.1007/s12155-012-9227-x; Higashi CHV, 2013, OECOLOGIA, V172, P847, DOI 10.1007/s00442-012-2540-4; Hou M, 2019, B ENVIRON CONTAM TOX, V102, P425, DOI 10.1007/s00128-019-02553-w; Jain M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-73; Juhasz C., 2014, Acta Phytopathologica et Entomologica Hungarica, V49, P163, DOI 10.1556/APhyt.49.2014.2.3; Kang ZH, 2019, GENE, V706, P32, DOI 10.1016/j.gene.2019.04.041; Kar PK, 2013, EMIR J FOOD AGR, V25, P205, DOI 10.9755/ejfa.v25i3.10970; Kaur P, 2018, APPL SOIL ECOL, V124, P306, DOI 10.1016/j.apsoil.2017.11.017; Kerchev PI, 2012, PLANT CELL ENVIRON, V35, P430, DOI 10.1111/j.1365-3040.2011.02395.x; Khattab H., 2007, Australian Journal of Basic and Applied Sciences, V1, P56; Kiraly L, 2012, PLANT PHYSIOL BIOCH, V59, P44, DOI 10.1016/j.plaphy.2011.10.020; Kmiec K, 2006, ACTA SCI POL-HORTORU, V5, P11; Krawczyk A., 2006, P127; Kumar M, 2009, MICROBIOL-SGM, V155, P780, DOI 10.1099/mic.0.019869-0; Labudda M, 2014, ACTA SOC BOT POL, V83, P3, DOI 10.5586/asbp.2014.003; LESZCZYNSKI B, 1992, J APPL ENTOMOL, V113, P61, DOI 10.1111/j.1439-0418.1992.tb00636.x; Li ZG, 2014, BIOLOGIA, V69, P1001, DOI 10.2478/s11756-014-0396-2; Lisowicz Franciszek, 2001, Journal of Plant Protection Research, V41, P250; Liu XM, 2015, SCI REP-UK, V5, DOI 10.1038/srep08092; Lukasik I, 2017, ALLELOPATHY J, V40, P143, DOI 10.26651/2017-40-1-1073; Luo M, 2011, TOXINS, V3, P766, DOI 10.3390/toxins3070766; Makkouk KM, 2009, VIRUS RES, V141, P209, DOI 10.1016/j.virusres.2008.12.007; Mendoza-Cozatl DG, 2006, J THEOR BIOL, V238, P919, DOI 10.1016/j.jtbi.2005.07.003; Moloi MJ, 2006, J PLANT PHYSIOL, V163, P1118, DOI 10.1016/j.jplph.2005.07.014; Moran PJ, 2002, ARCH INSECT BIOCHEM, V51, P182, DOI 10.1002/arch.10064; Morkunas I, 2011, ACTA PHYSIOL PLANT, V33, P2057, DOI 10.1007/s11738-011-0751-7; Naliwajski MR, 2014, BIOL PLANTARUM, V58, P47, DOI 10.1007/s10535-013-0378-1; Noctor G, 2012, PLANT CELL ENVIRON, V35, P454, DOI 10.1111/j.1365-3040.2011.02400.x; Pienkosz Aneta, 2005, Progress in Plant Protection, V45, P989; Ramakrishna B, 2012, PLANT GROWTH REGUL, V68, P249, DOI 10.1007/s10725-012-9713-3; Rossi GB, 2013, 4 S BRAS GEN MOL PLA, P26; Satoh K, 2013, VIRUS RES, V171, P111, DOI 10.1016/j.virusres.2012.11.003; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Semencenko VV, 2013, J SCI FOOD AGR, V93, P811, DOI 10.1002/jsfa.5801; Sevilla F, 2015, J EXP BOT, V66, P2945, DOI 10.1093/jxb/erv146; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Smith CM, 2007, ENTOMOL EXP APPL, V122, P1, DOI 10.1111/j.1570-7458.2006.00503.x; Stewart LR, 2012, VIRUS RES, V165, P219, DOI 10.1016/j.virusres.2012.02.004; Stotz HU, 2000, PLANT PHYSIOL, V124, P1007, DOI 10.1104/pp.124.3.1007; Strazynski P, 2008, APHIDS OTHER HOMOPTE, V14, P123; Sytykiewicz H, 2016, BIOCHEM SYST ECOL, V69, P236, DOI 10.1016/j.bse.2016.10.009; Sytykiewicz H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030268; Sytykiewicz H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111863; Sytykiewicz H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094847; Sytykiewicz H, 2013, ACTA BIOL CRACOV BOT, V55, P51, DOI 10.2478/abcsb-2013-0023; Sytykiewicz H, 2011, INT J MOL SCI, V12, P7982, DOI 10.3390/ijms12117982; Szmigiel A., 2012, Fragmenta Agronomica, V29, P152; Mai VC, 2013, PHYTOCHEMISTRY, V93, P49, DOI 10.1016/j.phytochem.2013.02.011; Wagner U, 2002, PLANT MOL BIOL, V49, P515, DOI 10.1023/A:1015557300450; Wlodek L, 2002, POL J PHARMACOL, V54, P215; Xie Q, 2013, MOL PLANT MICROBE IN, V16, P699; Zagorchev L, 2014, BIOTECHNOL BIOTEC EQ, V28, P616, DOI 10.1080/13102818.2014.946798; Zechmann B, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00566; Zhao Y, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-018-1597-6; Zielinska L, 2012, ACTA BIOL CRACOV BOT, V54, P97, DOI 10.2478/v10182-012-0010-2	79	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0221160	10.1371/journal.pone.0221160	http://dx.doi.org/10.1371/journal.pone.0221160			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412084	Green Submitted, gold, Green Published			2022-12-26	WOS:000485012600048
J	Azevedo, A; Bailey, L; Bandeira, V; Dehnhard, M; Fonseca, C; de Sousa, L; Jewgenow, K				Azevedo, Alexandre; Bailey, Liam; Bandeira, Victor; Dehnhard, Martin; Fonseca, Carlos; de Sousa, Liliana; Jewgenow, Katarina			Age, sex and storage time influence hair cortisol levels in a wild mammal population	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; FECAL GLUCOCORTICOID METABOLITES; MONGOOSE HERPESTES-ICHNEUMON; LONG-TERM CORTISOL; EGYPTIAN MONGOOSE; ENVIRONMENTAL-STRESS; STEROID-HORMONES; EXTERNAL FACTORS; RESPONSES; ECOLOGY	The measurement of hair cortisol is increasingly used to understand the effect of natural and anthropogenic stressors on wild animals, but it is potentially confounded by individual, seasonal and sex-dependant variations in baseline cortisol secretion. This study validated an enzyme-linked immunoassay for hair cortisol measurement and characterized its baseline variation in a wild population of Egyptian mongoose. The analysis encompassed individuals of both sexes and all ages, across a range of geographic, environmental and seasonal conditions that the species experiences in Portugal allowing us to account for spatial, temporal and biological factors that contribute to hair cortisol variation. Our results showed that age, sex and storage time had an effect on hair cortisol, but season did not. Hair cortisol was higher in early stage juveniles compared to other age cohorts, in males when compared to females, and decreased with longer storage time. By identifying the factors that influence baseline hair cortisol in this wild population, we establish the basis for its application as an indicator of the effect of natural and anthropogenic stressors.	[Azevedo, Alexandre; Bailey, Liam; Dehnhard, Martin; Jewgenow, Katarina] Leibniz Inst Zoo & Wildlife Res, Dept Reprod Biol, Berlin, Germany; [Azevedo, Alexandre; de Sousa, Liliana] Inst Ciencias Biomed Abel Salazar, Porto, Portugal; [Bandeira, Victor; Fonseca, Carlos] Univ Aveiro, Dept Biol, Aveiro, Portugal; [Bandeira, Victor; Fonseca, Carlos] Univ Aveiro, CESAM, Aveiro, Portugal	Leibniz Institut fur Zoo und Wildtierforschung; Universidade do Porto; Universidade de Aveiro; Universidade de Aveiro	Azevedo, A (corresponding author), Leibniz Inst Zoo & Wildlife Res, Dept Reprod Biol, Berlin, Germany.; Azevedo, A (corresponding author), Inst Ciencias Biomed Abel Salazar, Porto, Portugal.	ax.c.azevedo@gmail.com	Bandeira, Victor/AAE-7487-2020; Azevedo, Alexandre/GRR-7158-2022; Fonseca, Carlos MMS/D-9744-2011; AZEVEDO, ALEXANDRE/HII-5648-2022; de Sousa, Liliana/K-9756-2014	Fonseca, Carlos MMS/0000-0001-6559-7133; Azevedo, Alexandre/0000-0001-5449-1157; Bailey, Liam D./0000-0002-8226-9454; Bandeira, Victor/0000-0002-2181-3372; de Sousa, Liliana/0000-0001-6656-4595	Leibniz Institute for Zoo and Wildlife Research (IZW), Berlin, Germany; FCT; European funds through the COMPETE; European funds through FEDER by project "Genetic assessment of a successful invasion: Population genetics of the Egyptian mongoose (Herpestes ichneumon) in Portugal" [PTDC/BIA-BEC/104401/2008]; CESAM, through FCT/MCTES [UID/AMB/50017/2019]; FEDER, within the PT2020 Partnership Agreement; FEDER, within the Compete 2020; CESAM [UID/AMB/50017/2019]	Leibniz Institute for Zoo and Wildlife Research (IZW), Berlin, Germany; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); European funds through the COMPETE; European funds through FEDER by project "Genetic assessment of a successful invasion: Population genetics of the Egyptian mongoose (Herpestes ichneumon) in Portugal"; CESAM, through FCT/MCTES; FEDER, within the PT2020 Partnership Agreement; FEDER, within the Compete 2020; CESAM	This research was supported by the Leibniz Institute for Zoo and Wildlife Research (IZW), Berlin, Germany. VB and CF were supported by National Funds through FCT and European funds through the COMPETE and FEDER by co-funding through the project "Genetic assessment of a successful invasion: Population genetics of the Egyptian mongoose (Herpestes ichneumon) in Portugal"[PTDC/BIA-BEC/104401/2008]; and by CESAM [UID/AMB/50017/2019], through FCT/MCTES and national funds, and co-funding by the FEDER, within the PT2020 Partnership Agreement and Compete 2020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accorsi PA, 2008, GEN COMP ENDOCR, V155, P398, DOI 10.1016/j.ygcen.2007.07.002; Ashley NT, 2011, GEN COMP ENDOCR, V172, P382, DOI 10.1016/j.ygcen.2011.03.029; Ashley Noah T., 2011, P45; Aurich J, 2015, DOMEST ANIM ENDOCRIN, V52, P11, DOI 10.1016/j.domaniend.2015.01.003; Bandeira V, 2019, CURR ZOOL, V65, P11, DOI 10.1093/cz/zoy031; Bandeira V, 2016, ZOOL ANZ, V264, P1, DOI 10.1016/j.jcz.2016.06.001; Barros T, 2016, BIOL J LINN SOC, DOI [10.1111/bij.12867, DOI 10.1111/BIJ.12867]; Barros T, 2016, MAMM BIOL, V81, P176, DOI 10.1016/j.mambio.2015.09.003; Barros T, 2016, BIOL J LINN SOC, V118, P686, DOI 10.1111/bij.12743; BATES D, 2015, J STAT SOFTW, DOI 10.18637/jss.v067.i01; Bechshoft TO, 2012, ENVIRON INT, V45, P15, DOI 10.1016/j.envint.2012.04.005; Beltran RS, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0318; BENYAACOV R, 1983, Z SAUGETIERKD, V48, P34; Brunton PJ, 2008, J NEUROENDOCRINOL, V20, P764, DOI 10.1111/j.1365-2826.2008.01735.x; Brunton PJ, 2016, J STEROID BIOCHEM, V160, P160, DOI 10.1016/j.jsbmb.2015.08.003; Creel S, 2013, FUNCT ECOL, V27, P66, DOI 10.1111/j.1365-2435.2012.02029.x; Davenport MD, 2008, BIOL PSYCHIAT, V63, P990, DOI 10.1016/j.biopsych.2007.10.025; Davenport MD, 2006, GEN COMP ENDOCR, V147, P255, DOI 10.1016/j.ygcen.2006.01.005; Dehnhard M, 2010, GEN COMP ENDOCR, V167, P287, DOI 10.1016/j.ygcen.2010.03.023; Gonzalez-de-la-Vara MD, 2011, CAN J VET RES, V75, P216; Dettenborn L, 2012, STRESS, V15, P348, DOI [10.3109/10253890.2011.619239, 10.3109/10253890.2012.654479]; Evans MR, 2006, J EVOLUTION BIOL, V19, P343, DOI 10.1111/j.1420-9101.2005.01034.x; Fanson KV, 2015, HORM BEHAV, V76, P41, DOI 10.1016/j.yhbeh.2015.05.012; Ferreira APS, 2005, VET IMMUNOL IMMUNOP, V106, P239, DOI 10.1016/j.vetimm.2005.02.024; Finkenwirth C, 2010, THERIOGENOLOGY, V73, P530, DOI 10.1016/j.theriogenology.2009.10.008; Fish EW, 2004, ANN NY ACAD SCI, V1036, P167, DOI 10.1196/annals.1330.011; Fourie NH, 2011, GEN COMP ENDOCR, V174, P150, DOI 10.1016/j.ygcen.2011.08.013; Gaubert P, 2011, J BIOGEOGR, V38, P341, DOI 10.1111/j.1365-2699.2010.02406.x; Gesquiere LR, 2005, AM J PRIMATOL, V67, P83, DOI 10.1002/ajp.20171; HALEKOH U, 2014, J STAT SOFTW; Ito N, 2004, J INVEST DERMATOL, V122, pA111; JONES RB, 1994, PHYSIOL BEHAV, V56, P379, DOI 10.1016/0031-9384(94)90210-0; Keckeis K, 2012, J COMP PHYSIOL B, V182, P985, DOI 10.1007/s00360-012-0674-7; LEFCOURT AM, 1993, J DAIRY SCI, V76, P2607, DOI 10.3168/jds.S0022-0302(93)77595-5; Levine JE, 2002, ENDOCRINOLOGY, V143, P4502, DOI 10.1210/en.2002-221041; LING JK, 1970, Q REV BIOL, V45, P16, DOI 10.1086/406361; Ludwig C, 2013, GEN COMP ENDOCR, V180, P15, DOI 10.1016/j.ygcen.2012.10.005; Macbeth BJ, 2010, CAN J ZOOL, V88, P935, DOI 10.1139/Z10-057; Manenschijn L, 2012, J CLIN ENDOCR METAB, V97, pE1836, DOI 10.1210/jc.2012-1852; Manenschijn L, 2011, STEROIDS, V76, P1032, DOI 10.1016/j.steroids.2011.04.005; Mastromonaco G. F., 2014, CONSERV PHYSL, V2; Meyer JS, 2012, ENDOCRINOLOGY, V153, P4120, DOI 10.1210/en.2012-1226; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Palme R, 2019, PHYSIOL BEHAV, V199, P229, DOI 10.1016/j.physbeh.2018.11.021; PALOMARES F, 1993, J APPL ECOL, V30, P752, DOI 10.2307/2404253; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; PALOMARES F, 1992, Z SAUGETIERKD, V57, P251; PALOMARES F, 1993, ANIM BEHAV, V45, P917, DOI 10.1006/anbe.1993.1111; Palomares F., 1991, VOCALIZATIONS EMITTE; Palomares F., 1993, INDIVIDUAL VARIATION; Perani CV, 2017, STRESS, P1; Reeder DM, 2005, J MAMMAL, V86, P225, DOI 10.1644/BHE-003.1; Rhodes ME, 1999, BRAIN RES REV, V30, P135, DOI 10.1016/S0165-0173(99)00011-9; Romeo RD, 2010, FRONT NEUROENDOCRIN, V31, P232, DOI 10.1016/j.yfrne.2010.02.004; Romero LM, 2008, AM J PHYSIOL-REG I, V294, pR614, DOI 10.1152/ajpregu.00752.2007; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Romero LM, 2002, GEN COMP ENDOCR, V128, P1; Russell E, 2012, PSYCHONEUROENDOCRINO, V37, P589, DOI 10.1016/j.psyneuen.2011.09.009; Salaberger T, 2016, GEN COMP ENDOCR, V233, P73, DOI 10.1016/j.ygcen.2016.05.005; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sharpley CF, 2009, PHYSIOL RES, V58, P757, DOI 10.33549/physiolres.931544; Sheriff MJ, 2011, OECOLOGIA, V166, P869, DOI 10.1007/s00442-011-1943-y; Slominski A, 2007, MOL CELL ENDOCRINOL, V265, P143, DOI 10.1016/j.mce.2006.12.012; Stoffel MA, 2017, METHODS ECOL EVOL, V8, P1639, DOI 10.1111/2041-210X.12797; Terwissen CV, 2013, GEN COMP ENDOCR, V194, P162, DOI 10.1016/j.ygcen.2013.09.010; Thayer ZM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23169-w; Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006; Turner AI, 2002, J ENDOCRINOL, V173, P113, DOI 10.1677/joe.0.1730113; van Lier E, 2003, ANIM REPROD SCI, V79, P81, DOI 10.1016/S0378-4320(03)00083-6; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Webb E, 2010, J ARCHAEOL SCI, V37, P807, DOI 10.1016/j.jas.2009.11.010; Wikelski M, 2006, TRENDS ECOL EVOL, V21, P38, DOI 10.1016/j.tree.2005.10.018; Wingfield JC, 2013, ANIM BEHAV, V85, P1127, DOI 10.1016/j.anbehav.2013.02.018; Wingfield JC, 2013, FUNCT ECOL, V27, P37, DOI 10.1111/1365-2435.12039	74	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0221124	10.1371/journal.pone.0221124	http://dx.doi.org/10.1371/journal.pone.0221124			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398221	Green Published, gold, Green Submitted			2022-12-26	WOS:000485004000047
J	Mitra, M; Agarwal, P; Kundu, A; Banerjee, V; Roy, S				Mitra, Mehali; Agarwal, Puja; Kundu, Anurima; Banerjee, Victor; Roy, Sujit			Investigation of the effect of UV-B light on Arabidopsis MYB4 (AtMYB4) transcription factor stability and detection of a putative MYB4-binding motif in the promoter proximal region of AtMYB4	PLOS ONE			English	Article							PROTEIN; ACID; SUNSCREENS; CRYSTALLIN; RESPONSES; FAMILY	Here, we have investigated the possible effect of UV-B light on the folding/unfolding properties and stability of Arabidopsis thaliana MYB4 (AtMYB4) transcription factor in vitro by using biophysical approaches. Urea-induced equilibrium unfolding analyses have shown relatively higher stability of the wild-type recombinant AtMYB4 protein than the N-terminal deletion forms after UV-B exposure. However, as compared to wild-type form, AtMYB4.2 protein, lacking both the two N-terminal MYB domains, showed appreciable alteration in the secondary structure following UV-B exposure. UV-B irradiated AtMYB4.2 also displayed higher propensity of aggregation in light scattering experiments, indicating importance of the N-terminal modules in regulating the stability of AtMYB4 under UV-B stress. DNA binding assays have indicated specific binding activity of AtMYB4 to a putative MYB4 binding motif located about 212 bp upstream relative to transcription start site of AtMYB4 gene promoter, while relatively weak DNA binding activity was detected for another putative MYB4 motif located at -908 bp in AtMYB4 promoter. Gel shift and fluorescence anisotropy studies have shown increased binding affinity of UV-B exposed AtMYB4 to the promoter proximal MYB4 motif. ChIP assay has revealed binding of AtMYB4 to the promoter proximal (-212 position) MYB4 motif (ACCAAAC) in vivo. Docking experiments further revealed mechanistic detail of AtMYB4 interaction with the putative binding motifs. Overall, our results have indicated that the N-terminal 62-116 amino acid residues constituting the second MYB domain plays an important role in maintaining the stability of the C-terminal region and the overall stability of the protein, while a promoter proximal MYB-motif in AtMYB4 promoter may involve in the regulation of its own expression under UV-B light.	[Mitra, Mehali; Agarwal, Puja; Kundu, Anurima; Roy, Sujit] Univ Burdwan, UGC Ctr Adv Studies, Dept Bot, Burdwan, W Bengal, India; [Banerjee, Victor] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA	University of Burdwan; University of California System; University of California San Francisco	Roy, S (corresponding author), Univ Burdwan, UGC Ctr Adv Studies, Dept Bot, Burdwan, W Bengal, India.	sujitroy2006@gmail.com	Banerjee, Victor/N-8427-2014	Banerjee, Victor/0000-0002-3906-3362	Council of Scientific and Industrial Research, Govt. of India [38(1417)/16/EMR-II]; UGC, Govt. of India [F. 30-141/2015(BSR)]; DST, Govt. of India [DST/INSPIRE Fellowship/2017/IF17001]; CSIR, GOI	Council of Scientific and Industrial Research, Govt. of India(Council of Scientific & Industrial Research (CSIR) - India); UGC, Govt. of India(University Grants Commission, India); DST, Govt. of India(Department of Science & Technology (India)); CSIR, GOI(Council of Scientific & Industrial Research (CSIR) - India)	This research has been financially supported by the research grants from Council of Scientific and Industrial Research, Govt. of India, (Ref. No. 38(1417)/16/EMR-II, dated: 17/05/2016 to SR) and a Start-Up research grant to SR from UGC, Govt. of India (No. F. 30-141/2015(BSR). MM is the recipient of Inspire Fellowship from DST, Govt. of India (DST/INSPIRE Fellowship/2017/IF17001). PA is the recipient of junior research fellowship from the above mentioned CSIR, GOI funded project.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambawat S, 2013, PHYSIOL MOL BIOL PLA, V19, P307, DOI 10.1007/s12298-013-0179-1; Banerjee V, 2014, LANGMUIR, V30, P4775, DOI 10.1021/la5007007; Banerjee V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072318; Banerjee V, 2012, COLLOID SURFACE B, V92, P142, DOI 10.1016/j.colsurfb.2011.11.036; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biswas A, 2004, J BIOL CHEM, V279, P42648, DOI 10.1074/jbc.M404444200; Bowler C, 2004, PLANT J, V39, P776, DOI 10.1111/j.1365-313X.2004.02169.x; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589; Chakraborty A, 2018, INT J BIOL MACROMOL, V119, P604, DOI 10.1016/j.ijbiomac.2018.07.151; Choudhury SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044361; Das KP, 1996, J BIOL CHEM, V271, P10449, DOI 10.1074/jbc.271.18.10449; Dastidar KG, 2006, PLANT PHYSIOL, V140, P1279, DOI 10.1104/pp.105.075150; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Fornale S, 2014, PLANT CELL PHYSIOL, V55, P507, DOI 10.1093/pcp/pct187; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; Hollosy F, 2002, MICRON, V33, P179, DOI 10.1016/S0968-4328(01)00011-7; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Kim J, 2010, PLANT PHYSIOL, V154, P611, DOI 10.1104/pp.110.162271; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lippold F, 2009, PLANT PHYSIOL, V149, P1761, DOI 10.1104/pp.108.134874; Nguyen NH, 2018, BIOCHEM BIOPH RES CO, V507, P437, DOI 10.1016/j.bbrc.2018.11.057; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pradhan L, 2015, ACTA CRYSTALLOGR D, V71, P667, DOI 10.1107/S1399004715000139; Ray S, 2014, PROTEIN J, V33, P143, DOI 10.1007/s10930-014-9546-1; Roy S, 2015, PLOS ONE, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE]; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Segarra G, 2009, PLANT BIOLOGY, V11, P90, DOI 10.1111/j.1438-8677.2008.00162.x; Sergeev YV, 2005, INVEST OPHTH VIS SCI, V46, P3263, DOI 10.1167/iovs.05-0112; Sharma KK, 1998, J BIOL CHEM, V273, P8965, DOI 10.1074/jbc.273.15.8965; Sreerama N, 1999, PROTEIN SCI, V8, P370; Stetefeld Jorg, 2016, Biophys Rev, V8, P409, DOI 10.1007/s12551-016-0218-6; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Talukdar AS, 1999, IEEE T MED IMAGING, V18, P604, DOI 10.1109/42.790460; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Weigel D, 2002, ARABIDOPSIS A LABORA; Wen W-S, 2010, MOL VIS, V16, P2777; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Xie JZ, 2010, J BIOL CHEM, V285, P4153, DOI 10.1074/jbc.M109.078881; Zhao JF, 2007, PLANT CELL, V19, P3805, DOI 10.1105/tpc.106.048900; Zhou ML, 2015, PLANT J, V84, P395, DOI 10.1111/tpj.13008	46	7	7	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220123	10.1371/journal.pone.0220123	http://dx.doi.org/10.1371/journal.pone.0220123			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393961	Green Submitted, gold, Green Published			2022-12-26	WOS:000485002500023
J	Nakamura, T; Sekimoto, S; Oyama, G; Shimo, Y; Hattori, N; Kajimoto, H				Nakamura, Takuto; Sekimoto, Satoko; Oyama, Genko; Shimo, Yasushi; Hattori, Nobutaka; Kajimoto, Hiroyuki			Pilot feasibility study of a semi-automated three-dimensional scoring system for cervical dystonia	PLOS ONE			English	Article							MICROSOFT KINECT; VALIDITY; RELIABILITY	The objective of this study is to test the feasibility of a semi-automated scoring system for the Toronto Western Spasmodic Torticollis Scale (TWSTRS) severity scale in patients with cervical dystonia. The TWSTRS requires training and experience. We previously developed a system to measure neck angle by analyzing three-dimensional position, obtained using Kinect, a marker-less three-dimensional depth sensor. The system can track patients' faces and bodies, automatically analyze neck angles, and semi-automatically calculate the TWSTRS severity scale score. We compared the TWSTRS severity scale scores calculated by the system with the video-based scores calculated by a neurologist trained in movement disorders. A correlation coefficient analysis was then conducted. Absolute accuracy was measured using intra-class correlation (ICC) (3,1), with 95% limits of agreement. To analyze the subscales, Cohen's kappa coefficient (kappa) was calculated. A p-value of <.05 was considered statistically significant. Thirty patients were enrolled. Their average age was 52.3 +/- 16.0 years, and the male to female ratio was 3:2. The average disease duration was 11.3 +/- 12.7 years. Total score measurements by the system were significantly correlated with those rated by the movement disorder-trained neurologist (r = .596, p <.05). There was a significant correlation (r =.655, p<.05) with regard to the automated part of the scale. An adequate ICC (3,1) of .562 was obtained for total severity score (p <.001, 95% confidence interval [CI]:.259-.765), while the equivalent score was.617 for the total automated part (p <.001, 95% CI.336-.798). Our three-dimensional motion capture system, which can measure head angles and semi-automatically calculate the TWSTRS severity scale score utilizing a single-depth camera, demonstrated adequate validity and reliability. This low-cost and portable system could be applied by general practitioners treating cervical dystonia to obtain objective measurements.	[Nakamura, Takuto; Shimo, Yasushi; Kajimoto, Hiroyuki] Univ Electrocommun, Dept Informat, Tokyo, Japan; [Nakamura, Takuto] Japan Soc Promot Sci, Tokyo, Japan; [Sekimoto, Satoko; Oyama, Genko; Hattori, Nobutaka] Juntendo Univ, Sch Med, Dept Neurol, Tokyo, Japan	University of Electro-Communications - Japan; Japan Society for the Promotion of Science; Juntendo University	Hattori, N (corresponding author), Juntendo Univ, Sch Med, Dept Neurol, Tokyo, Japan.	nhattori@juntendo.ac.jp	Hattori, Nobutaka/ACR-0069-2022		Novartis Pharma	Novartis Pharma	This study was supported by a grant from Novartis Pharma (Novartis Research Grants; 2015, 2016). The funders had no role in study design, data collection or analysis, decision to publish, or manuscript preparation.	Allahyari T, 2017, INT J OCCUP SAF ERGO, V23, P524, DOI 10.1080/10803548.2016.1219148; Boyce MJ, 2012, PARKINSONISM RELAT D, V18, P635, DOI 10.1016/j.parkreldis.2012.02.007; Clark RA, 2012, GAIT POSTURE, V36, P372, DOI 10.1016/j.gaitpost.2012.03.033; Comella CL, 1997, MOVEMENT DISORD, V12, P570, DOI 10.1002/mds.870120414; CONSKY E, 1990, Neurology, V40, P445; Darby J, 2016, GAIT POSTURE, V48, P83, DOI 10.1016/j.gaitpost.2016.04.030; Espay AJ, 2018, PARKINSONISM RELAT D, V52, P94, DOI 10.1016/j.parkreldis.2018.03.002; Fukuda H, 2006, MOVEMENT DISORD, V21, P1503, DOI 10.1002/mds.20986; Gregori B, 2008, CLIN NEUROPHYSIOL, V119, P273, DOI 10.1016/j.clinph.2007.10.007; Jankovic J, 2004, MOVEMENT DISORD, V19, pS109, DOI 10.1002/mds.20024; Lee SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129398; McGinley JL, 2009, GAIT POSTURE, V29, P360, DOI 10.1016/j.gaitpost.2008.09.003; Nakamura T, 2014, IEEE S 3D US INT 3DU; Timmi A, 2018, MED ENG PHYS, V59, P63, DOI 10.1016/j.medengphy.2018.04.020; Wang Q, 2015, INT C HEALTHC INF; Xu X, 2015, APPL ERGON, V49, P47, DOI 10.1016/j.apergo.2015.01.005	17	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0219758	10.1371/journal.pone.0219758	http://dx.doi.org/10.1371/journal.pone.0219758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393884	Green Submitted, Green Published, gold			2022-12-26	WOS:000485002500017
J	Sheng, YH; Wong, KY; Seim, I; Wang, R; He, YW; Wu, A; Patrick, M; Lourie, R; Schreiber, V; Giri, R; Ng, CP; Popat, A; Hooper, J; Kijanka, G; Florin, TH; Begun, J; Radford, KJ; Hasnain, S; McGuckin, MA				Sheng, Yong Hua; Wong, Kuan Yau; Seim, Inge; Wang, Ran; He, Yaowu; Wu, Andy; Patrick, Maya; Lourie, Rohan; Schreiber, Veronika; Giri, Rabina; Ng, Choa Ping; Popat, Amirali; Hooper, John; Kijanka, Gregor; Florin, Timothy H.; Begun, Jakob; Radford, Kristen J.; Hasnain, Sumaira; McGuckin, Michael A.			MUC13 promotes the development of colitis-associated colorectal tumors via beta-catenin activity	ONCOGENE			English	Article							CELL-SURFACE MUCIN; SUPPRESSOR-CELLS; DENDRITIC CELLS; MUCOSAL BARRIER; STEM-CELLS; COLON; INFLAMMATION; RESPONSES; PATHWAY; OVEREXPRESSION	Many adenocarcinomas, including colorectal cancer (CRC), overexpress the MUC13 cell surface mucin, but the functional significance and mechanisms are unknown. Here, we report the roles of MUC13 in colonic tumorigenesis and tumor progression. High-MUC13 expression is associated with poor survival in two independent patient cohorts. In a comprehensive series of in vivo experiments, we identified a critical role for MUC13 in the development of this malignancy, by promoting survival and proliferation of tumor-initiating cells and driving an immunosuppressive environment that protects tumors from checkpoint inhibitor immunotherapy. In Muc13-deficient mice, fewer tumors are generated after exposure to carcinogens and inflammation, they have markedly reduced beta-catenin signaling, have more tumor-infiltrating CD103(+) dendritic cells and CD8(+) T lymphocytes, fewer myeloid-derived suppressor cells, and are rendered sensitive to checkpoint inhibitor immunotherapy (anti-PD-L1). Mechanistically, we show that MUC13 protects beta-catenin from degradation, by interacting with GSK-3 beta, which increases beta-catenin nuclear translocation and promotes its signaling, thereby driving cancer initiation, progression, invasion, and immune suppression. Therefore, MUC13 is a potential marker of poor prognosis in colorectal cancer, and inhibiting MUC13 may be useful in the treatment of colitis-associated cancer and sensitizing tumors to immunotherapy.	[Sheng, Yong Hua; Wong, Kuan Yau; Seim, Inge; Wang, Ran; Patrick, Maya; Lourie, Rohan; Ng, Choa Ping; Popat, Amirali; Hasnain, Sumaira; McGuckin, Michael A.] Univ Queensland, Translat Res Inst, Mater Res Inst, Inflammatory Dis Biol & Therapeut Grp, Brisbane, Qld 4102, Australia; [Seim, Inge] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Translat Res Inst, Comparat & Endocrine Biol Lab, Brisbane, Qld 4012, Australia; [Seim, Inge] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Translat Res Inst, Ghrelin Res Grp, Brisbane, Qld 4102, Australia; [Seim, Inge] Nanjing Normal Univ, Coll Life Sci, Integrat Biol Lab, Nanjing 210023, Jiangsu, Peoples R China; [He, Yaowu; Hooper, John] Univ Queensland, Mater Res Inst, Canc Biol Grp, Brisbane, Qld 4101, Australia; [Wu, Andy] Univ Queensland, Translat Res Inst, Mater Res Inst, Bones & Immunol Grp, Brisbane, Qld 4102, Australia; [Lourie, Rohan; Schreiber, Veronika; Giri, Rabina; Florin, Timothy H.; Begun, Jakob] Univ Queensland, Translat Res Inst, Mater Res Inst, Inflammatory Bowel Dis Grp, Brisbane, Qld 4102, Australia; [Popat, Amirali] Univ Queensland, Sch Pharm, Brisbane, Qld 4072, Australia; [Kijanka, Gregor] Univ Queensland, Translat Res Inst, Mater Res Inst, Immune Profiling & Canc Grp, Brisbane, Qld 4102, Australia; [Radford, Kristen J.] Univ Queensland, Translat Res Inst, Mater Res Inst, Canc Immunotherapies Grp, Brisbane, Qld 4101, Australia; [McGuckin, Michael A.] Univ Melbourne, Fac Med Dent & Hlth Sci, Melbourne, Vic 3010, Australia	Mater Research; University of Queensland; Queensland University of Technology (QUT); Queensland University of Technology (QUT); Nanjing Normal University; Mater Research; University of Queensland; Mater Research; University of Queensland; Mater Research; University of Queensland; University of Queensland; Mater Research; University of Queensland; Mater Research; University of Queensland; University of Melbourne	Hasnain, S; McGuckin, MA (corresponding author), Univ Queensland, Translat Res Inst, Mater Res Inst, Inflammatory Dis Biol & Therapeut Grp, Brisbane, Qld 4102, Australia.; McGuckin, MA (corresponding author), Univ Melbourne, Fac Med Dent & Hlth Sci, Melbourne, Vic 3010, Australia.	sumaira.hasnain@mater.uq.edu.au; michael.mcguckin@unimelb.edu.au	Begun, Jakob/J-6793-2014; sheng, yong H/C-5052-2013; Radford, Kristen J/B-5550-2011; Wang, Ran/AAP-1920-2020; Hooper, John/C-1481-2016; Hasnain, Sumaira/N-3412-2014	Begun, Jakob/0000-0001-5256-7672; sheng, yong H/0000-0002-4623-9098; Radford, Kristen J/0000-0001-6512-6323; Wang, Ran/0000-0002-1741-6446; HE, Yaowu/0000-0002-7828-263X; Giri, Rabina/0000-0002-6712-6076; Hooper, John/0000-0003-1054-8486; Hasnain, Sumaira/0000-0001-8577-8628; Schreiber, Veronika/0000-0001-6088-7828; McGuckin, Michael/0000-0002-8375-2675; Wu, Andy C/0000-0002-0864-4447	NHMRC [1060698]; Mater Foundation; NHMRC; Betty McGrath/Mater Practitioner Research Fellowship; QUT Vice-Chancellor's Senior Research Fellowship; Australian Government	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Mater Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Betty McGrath/Mater Practitioner Research Fellowship; QUT Vice-Chancellor's Senior Research Fellowship; Australian Government(Australian GovernmentCGIAR)	Supported by NHMRC project grant 1060698 and funding by the Mater Foundation, MAM was supported by an NHMRC Principal Research Fellowship. RL was partly supported by a Betty McGrath/Mater Practitioner Research Fellowship. IS is supported by a QUT Vice-Chancellor's Senior Research Fellowship. The Translational Research Institute (TRI) is supported by a grant from the Australian Government.	Augustin I, 2016, STEM CELL RES, V17, P607, DOI 10.1016/j.scr.2016.10.010; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Brabletz S, 2009, J PATHOL, V217, P307, DOI 10.1002/path.2475; Chauhan SC, 2012, MOL CANCER THER, V11, P24, DOI 10.1158/1535-7163.MCT-11-0598; Chauhan SC, 2009, CANCER RES, V69, P765, DOI 10.1158/0008-5472.CAN-08-0587; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Day FL, 2013, CLIN CANCER RES, V19, P3285, DOI 10.1158/1078-0432.CCR-12-3614; De Robertis Mariangela, 2011, J Carcinog, V10, P9, DOI 10.4103/1477-3163.78279; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gavert N, 2007, J CELL BIOCHEM, V102, P820, DOI 10.1002/jcb.21505; Goldman M, 2015, NUCLEIC ACIDS RES, V43, pD812, DOI 10.1093/nar/gku1073; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Gupta BK, 2014, J GASTROENTEROL, V49, P1378, DOI 10.1007/s00535-013-0885-z; Gupta BK, 2012, J HISTOCHEM CYTOCHEM, V60, P822, DOI 10.1369/0022155412460678; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hong Y, 2015, CANCER RES, V75, P656, DOI 10.1158/0008-5472.CAN-14-2377; Jensen MA, 2017, BLOOD, V130, P453, DOI 10.1182/blood-2017-03-735654; Jonckheere N, 2014, BBA-REV CANCER, V1846, P142, DOI 10.1016/j.bbcan.2014.04.008; Katoh H, 2013, CANCER CELL, V24, P631, DOI 10.1016/j.ccr.2013.10.009; Khan S, 2017, ONCOGENE, V36, P491, DOI 10.1038/onc.2016.218; Khan S, 2014, ONCOTARGET, V5, P7599, DOI 10.18632/oncotarget.2281; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Najdi Rani, 2011, J Carcinog, V10, P5, DOI 10.4103/1477-3163.78111; Nath S, 2014, TRENDS MOL MED, V20, P332, DOI 10.1016/j.molmed.2014.02.007; Pai P, 2016, CARCINOGENESIS, V37, P223, DOI 10.1093/carcin/bgw005; Said AH, 2014, CANCERS, V6, P366, DOI 10.3390/cancers6010366; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Schneikert J, 2007, GUT, V56, P417, DOI 10.1136/gut.2006.093310; Sheng YH, 2017, ONCOGENE, V36, P700, DOI 10.1038/onc.2016.241; Sheng YH, 2013, MUCOSAL IMMUNOL, V6, P557, DOI 10.1038/mi.2012.98; Sheng YH, 2012, J GASTROEN HEPATOL, V27, P28, DOI 10.1111/j.1440-1746.2011.06909.x; Sheng YH, 2011, GUT, V60, P1661, DOI 10.1136/gut.2011.239194; Sheng YH, 2017, INT J CANCER, V140, P2351, DOI 10.1002/ijc.30651; Shimamura T, 2005, CANCER SCI, V96, P265, DOI 10.1111/j.1349-7006.2005.00043.x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Spranger S, 2017, CANCER CELL, V31, P711, DOI 10.1016/j.ccell.2017.04.003; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Tenbaum SP, 2012, NAT MED, V18, P892, DOI 10.1038/nm.2772; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Vilar E, 2010, NAT REV CLIN ONCOL, V7, P153, DOI 10.1038/nrclinonc.2009.237; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Walsh MD, 2007, HUM PATHOL, V38, P883, DOI 10.1016/j.humpath.2006.11.020; Williams SJ, 2001, J BIOL CHEM, V276, P18327, DOI 10.1074/jbc.M008850200; WITTY JP, 1994, CANCER RES, V54, P4805; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370; Zhi XF, 2014, CANCER LETT, V346, P104, DOI 10.1016/j.canlet.2013.12.021	54	14	14	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 28	2019	38	48					7294	7310		10.1038/s41388-019-0951-y	http://dx.doi.org/10.1038/s41388-019-0951-y			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JR4XX	31427737	Green Submitted			2022-12-26	WOS:000499631000002
J	Shankaraiah, RC; Callegari, E; Guerriero, P; Rimessi, A; Pinton, P; Gramantieri, L; Silini, EM; Sabbioni, S; Negrini, M				Shankaraiah, Ram C.; Callegari, Elisa; Guerriero, Paola; Rimessi, Alessandro; Pinton, Paolo; Gramantieri, Laura; Silini, Enrico M.; Sabbioni, Silvia; Negrini, Massimo			Metformin prevents liver tumourigenesis by attenuating fibrosis in a transgenic mouse model of hepatocellular carcinoma	ONCOGENE			English	Article							RISK; CANCER; PHOSPHORYLATION; EPIDEMIOLOGY; CIRRHOSIS; DISEASE; OBESITY	Metformin is a hypoglycaemic agent used to treat type 2 diabetes mellitus (DM2) patients, with a broad safety profile. Since previous epidemiological studies had shown that the incidence of hepatocellular carcinoma (HCC) decreased significantly in metformin treated DM2 patients, we hypothesised that intervention with metformin could reduce the risk of neoplastic transformation of hepatocytes. HCC is the most common primary liver malignancy and it generally originates in a background of liver fibrosis and cirrhosis. In the present study, we took advantage of a transgenic mouse (TG221) characterized by microRNA-221 overexpression, with cirrhotic liver background induced by chronic administration of carbon tetrachloride (CC14). This mouse model develops fibrosis, cirrhosis and liver tumours that become visible in 100% of mice at 5-6 months of age. Our results demonstrated that metformin intervention improves liver function, inhibits hepatic stellate cell (HSC) activation, reduces liver fibrosis, depletes lipid accumulation in hepatocytes, halts progression to decompensated cirrhosis and abrogates development HCC in CC14 challenged transgenic mouse model. The study establishes the rationale for investigating metformin in cirrhotic patients regardless of concomitant DM2 status.	[Shankaraiah, Ram C.; Callegari, Elisa; Guerriero, Paola; Rimessi, Alessandro; Pinton, Paolo; Negrini, Massimo] Univ Ferrara, Dept Morphol Surg & Expt Med, Ferrara, Italy; [Gramantieri, Laura] St Orsola Malpighi Univ Hosp, Ctr Appl Biomed Res, I-40138 Bologna, Italy; [Silini, Enrico M.] Univ Hosp Parma, Sect Anat & Pathol, Parma, Italy; [Sabbioni, Silvia] Univ Ferrara, Dept Life Sci & Biotechnol, Ferrara, Italy	University of Ferrara; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Parma; University Hospital of Parma; University of Ferrara	Negrini, M (corresponding author), Univ Ferrara, Dept Morphol Surg & Expt Med, Ferrara, Italy.	ngm@unife.it	rimessi, alessandro/O-3335-2019; Pinton, Paolo/J-8025-2012; SILINI, ENRICO MARIA/AAB-8747-2019; Callegari, Elisa/J-5763-2016; NEGRINI, Massimo/J-2377-2016; Gramantieri, Laura/K-8603-2016	rimessi, alessandro/0000-0001-7091-5765; Pinton, Paolo/0000-0001-7108-6508; SILINI, ENRICO MARIA/0000-0003-2578-3059; Callegari, Elisa/0000-0002-4969-5400; GUERRIERO, Paola/0000-0003-3724-7472; NEGRINI, Massimo/0000-0002-0007-1920; Gramantieri, Laura/0000-0002-5187-9559	Italian Association for Cancer Research [AIRG IG-15615, AIRC IG-20055]	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Italian Association for Cancer Research (AIRG IG-15615, AIRC IG-20055) to Massimo Negrini, PhD.	Akinyemiju T, 2017, JAMA ONCOL, V3, P1683, DOI 10.1001/jamaoncol.2017.3055; Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; Bo S, 2012, DIABETES OBES METAB, V14, P23, DOI 10.1111/j.1463-1326.2011.01480.x; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Callegari E, 2012, HEPATOLOGY, V56, P1025, DOI 10.1002/hep.25747; Chaube B, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.404; Chen HP, 2013, GUT, V62, P606, DOI 10.1136/gutjnl-2011-301708; Dasgupta B, 2016, TRENDS PHARMACOL SCI, V37, P192, DOI 10.1016/j.tips.2015.11.007; DePeralta DK, 2016, CANCER-AM CANCER SOC, V122, P1216, DOI 10.1002/cncr.29912; Deutsch MJ, 2014, ANAL BIOCHEM, V445, P87, DOI 10.1016/j.ab.2013.10.001; Donadon V, 2009, WORLD J GASTROENTERO, V15, P2506, DOI 10.3748/wjg.15.2506; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fukumura D, 2016, MICROCIRCULATION, V23, P191, DOI 10.1111/micc.12270; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Gardini AC, 2017, EUR J CANCER, V86, P106, DOI 10.1016/j.ejca.2017.09.003; Gardini AC, 2015, EXPERT OPIN PHARMACO, V16, P2719, DOI 10.1517/14656566.2015.1102887; Gluchowski NL, 2017, NAT REV GASTRO HEPAT, V14, P343, DOI 10.1038/nrgastro.2017.32; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hassan MM, 2010, CANCER-AM CANCER SOC, V116, P1938, DOI 10.1002/cncr.24982; Hollander MC, 2011, ONCOGENE, V30, P1812, DOI 10.1038/onc.2010.556; Incio J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141392; Ioannou GN, 2018, J HEPATOL, V68, P25, DOI 10.1016/j.jhep.2017.08.030; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8; Kasmari AJ, 2017, AM J MED, V130, DOI 10.1016/j.amjmed.2016.12.029; Kim JH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18762-4; Kim JH, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2015.115; Kluwe J, 2011, GUT, V60, P1260, DOI 10.1136/gut.2010.209551; Kodack DP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal4682; Lee JH, 2012, INT J CANCER, V131, P752, DOI 10.1002/ijc.26421; Lee MS, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-20; Linnerth-Petrik NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094595; Liu WJ, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1629-z; Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]; Memmott RM, 2010, CANCER PREV RES, V3, P1066, DOI 10.1158/1940-6207.CAPR-10-0055; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muir AJ, 2015, CLIN THER, V37, P1822, DOI 10.1016/j.clinthera.2015.05.507; Murff HJ, 2018, CANCER CAUSE CONTROL, V29, P823, DOI 10.1007/s10552-018-1058-4; Nkontchou G, 2011, J CLIN ENDOCR METAB, V96, P2601, DOI 10.1210/jc.2010-2415; Nordenstedt H, 2010, DIGEST LIVER DIS, V42, pS206, DOI 10.1016/S1590-8658(10)60507-5; Qian WK, 2018, LIFE SCI, V208, P253, DOI 10.1016/j.lfs.2018.07.046; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Scaglione S, 2015, J CLIN GASTROENTEROL, V49, P690, DOI 10.1097/MCG.0000000000000208; Schulte L, 2019, LIVER INT, V39, P714, DOI 10.1111/liv.14048; Singh S, 2013, AM J GASTROENTEROL, V108, P881, DOI 10.1038/ajg.2013.5; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tandra S, 2011, J HEPATOL, V55, P654, DOI 10.1016/j.jhep.2010.11.021; Tennant DA, 2009, CARCINOGENESIS, V30, P1269, DOI 10.1093/carcin/bgp070; Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wong FWY, 1998, TOXICOL APPL PHARM, V153, P109, DOI 10.1006/taap.1998.8547; Yang XL, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0308-4; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1	56	33	35	0	23	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 7	2019	38	45					7035	7045		10.1038/s41388-019-0942-z	http://dx.doi.org/10.1038/s41388-019-0942-z			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JL9XI	31409896	Green Submitted			2022-12-26	WOS:000495878400001
J	Somsuan, K; Peerapen, P; Boonmark, W; Plumworasawat, S; Samol, R; Sakulsak, N; Thongboonkerd, V				Somsuan, Keerakarn; Peerapen, Paleerath; Boonmark, Wanida; Plumworasawat, Sirikanya; Samol, Ratirath; Sakulsak, Natthiya; Thongboonkerd, Visith			ARID1A knockdown triggers epithelial-mesenchymal transition and carcinogenesis features of renal cells: role in renal cell carcinoma	FASEB JOURNAL			English	Article						cell cycle; chemoresistance; EMT; invasion; snaill	REMODELING GENE ARID1A; SWI/SNF COMPLEX; DOWN-REGULATION; EXPRESSION; PATHOGENESIS; EMT; ACTIVATION; MUTATIONS; MIGRATION; COMPONENT	Down-regulation/mutation of AT-rich interactive domain 1A (ARID1A), a novel tumor suppressor gene, has been reported in various cancers. Nevertheless, its role in renal cell carcinoma (RCC) remained unclear and underinvestigated. We thus evaluated carcinogenesis effects of ARID1A knockdown in nonmalignant Madin-Darby canine kidney (MDCK) renal cells using small interfering RNA (siRNA) against ARID1A (siARID1A). The siARID1A-transfected cells had decreased cell death, increased cell proliferation, and cell cycle shift (from G(0)/G(1) to G(2)/M) compared with those transfected with controlled siRNA (siControl). Additionally, the siARID1A-transfected cells exhibited epithelial-mesenchymal transition (EMT) shown by greater spindle index, increased mesenchymal markers (fibronectin/vimentin), and decreased epithelial markers (E-cadherin/zonula occludens-1). Moreover, the siARID1A-transfected cells had increases in migratory activity, nuclear size, self-aggregated multicellular spheroid size, invasion capability, chemoresistance (to docetaxel), Snail family transcriptional repressor 1 expression, and TGF-beta 1 secretion. All of these siARID1A-knockdown effects on the carcinogenic features were reproducible in malignant RCC (786-0) cells, which exhibited a higher degree of carcinogenic phenotypes compared with the nonmalignant MDCK cells. Finally, immunohistochemistry showed obvious decrease in ARID1A protein expression in human RCC tissues (n = 23) compared with adjacent normal renal tissues (n = 23). These data indicate that ARID1A down-regulation triggers EMT and carcinogenesis features of renal cells in vitro, and its role in RCC could be proven in human tissues.	[Somsuan, Keerakarn; Sakulsak, Natthiya] Naresuan Univ, Dept Anat, Fac Med Sci, Phitsanulok, Thailand; [Peerapen, Paleerath; Boonmark, Wanida; Plumworasawat, Sirikanya; Thongboonkerd, Visith] Mahidol Univ, Siriraj Hosp, Fac Med, Med Prote Unit,Off Res & Dev, 6th Floor,SiMR Bldg,2 Wanglang Rd, Bangkok 10700, Thailand; [Samol, Ratirath] Sawanpracharak Hosp, Dept Anat Pathol, Nakorn Sawan, Thailand	Naresuan University; Mahidol University	Thongboonkerd, V (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Med Prote Unit,Off Res & Dev, 6th Floor,SiMR Bldg,2 Wanglang Rd, Bangkok 10700, Thailand.	thongboonkerd@dr.com	Thongboonkerd, Visith/C-6920-2009; Sakulsak, Natthiya/AAO-9327-2021	Thongboonkerd, Visith/0000-0001-7865-0765; Somsuan, Keerakarn/0000-0002-9848-8010	Mahidol University; Thailand Research Fund [IRN60W0004, IRG5980006]; Chalermphrakiat; Faculty of Medicine, Siriraj Hospital	Mahidol University; Thailand Research Fund(Thailand Research Fund (TRF)); Chalermphrakiat; Faculty of Medicine, Siriraj Hospital	The authors are grateful to Sunisa Yoodee and Patoomporn Prasatthong (both from the Faculty of Medicine, Siriraj Hospital, Mahidol University) for technical assistance. This study was supported by a Mahidol University research grant and the Thailand Research Fund (IRN60W0004 and IRG5980006). V.T. was supported by Chalermphrakiat and Research Staff Grants from Faculty of Medicine, Siriraj Hospital. The authors declare no conflicts of interest.	Agaimy A, 2018, HUM PATHOL, V77, P139, DOI 10.1016/j.humpath.2018.04.004; Aluksanasuwan S, 2017, FASEB J, V31, P2157, DOI 10.1096/fj.201600910RR; Bianchi M, 2012, ANN ONCOL, V23, P973, DOI 10.1093/annonc/mdr362; Brodaczewska KK, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0565-8; Chen Y, 2017, ONCOTARGET, V8, P36787, DOI 10.18632/oncotarget.16375; Fong-Ngern K, 2017, METABOLISM, V74, P47, DOI 10.1016/j.metabol.2016.12.014; Foty R., 2011, J VIS EXP, V2720; Guan B, 2011, AM J SURG PATHOL, V35, P625, DOI 10.1097/PAS.0b013e318212782a; Halliday GM, 2009, INT J BIOCHEM CELL B, V41, P725, DOI 10.1016/j.biocel.2008.04.026; He F, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0164-3; Ibarrola-Villava M, 2015, ONCOTARGET, V6, P26935, DOI 10.18632/oncotarget.4775; Jia ZJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0094-4; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kadoch C, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500447; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kanlaya R, 2016, TRANSL CANCER RES, V5, pS1177, DOI 10.21037/tcr.2016.11.59; Kanlaya R, 2016, SCI REP-UK, V6, DOI 10.1038/srep30233; Kapincharanon C, 2018, CELL ADHES MIGR, V12, P247, DOI 10.1080/19336918.2017.1356554; Khoury H, 2005, MOL BIOL CELL, V16, P550, DOI 10.1091/mbc.E04-07-0567; Landolt L, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13305; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Liu RY, 2014, INT J ONCOL, V44, P1643, DOI 10.3892/ijo.2014.2310; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mamo A, 2012, ONCOGENE, V31, P2090, DOI 10.1038/onc.2011.386; Manissorn J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28808; Manley BJ, 2016, CURR OPIN UROL, V26, P383, DOI 10.1097/MOU.0000000000000307; Matsumoto T, 2018, MOL CARCINOGEN, V57, P957, DOI 10.1002/mc.22816; Miao D, 2018, SCIENCE, V359, P801, DOI 10.1126/science.aan5951; Nargund AM, 2017, CELL REP, V18, P2893, DOI 10.1016/j.celrep.2017.02.074; Ni T, 2016, NAT CELL BIOL, V18, P1221, DOI 10.1038/ncb3425; Niu N, 2017, ONCOGENE, V36, P4887, DOI 10.1038/onc.2017.72; Noman MZ, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1345415; Pal SK, 2018, EUR UROL, V73, P71, DOI 10.1016/j.eururo.2017.05.033; Pang MF, 2016, ONCOGENE, V35, P748, DOI 10.1038/onc.2015.133; Peerapen P, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201800008; Pongsakul N, 2016, FASEB J, V30, P3368, DOI 10.1096/fj.201600426R; Protzel C, 2012, EUR UROL SUPPL, V11, P52, DOI 10.1016/j.eursup.2012.05.002; Rao Q, 2014, INT J CLIN EXP PATHO, V7, P1782; Ricketts CJ, 2018, CELL REP, V23, P313, DOI [10.1016/j.celrep.2018.03.075, 10.1016/j.celrep.2018.06.032]; Sarnowska E, 2017, AM J CANCER RES, V7, P2275; Sato Y, 2010, AM J PATHOL, V177, P141, DOI 10.2353/ajpath.2010.090747; Savas S, 2018, CRIT REV ONCOL HEMAT, V123, P114, DOI 10.1016/j.critrevonc.2018.01.009; Shigetomi H, 2011, ONCOL LETT, V2, P591, DOI 10.3892/ol.2011.316; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sun HM, 2016, ANAT REC, V299, P869, DOI 10.1002/ar.23357; Sun XX, 2017, CANCER CELL, V32, P574, DOI 10.1016/j.ccell.2017.10.007; Takao C, 2017, J CANCER, V8, P1, DOI 10.7150/jca.16602; Takeshima H, 2015, CANCER LETT, V357, P328, DOI 10.1016/j.canlet.2014.11.038; Thanomkitti K, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-018-0053-6; Toret CP, 2014, J CELL BIOL, V204, P265, DOI 10.1083/jcb.201306082; Wang SJ, 2018, ONCOGENE, V37, P4164, DOI 10.1038/s41388-018-0252-x; Wang WJ, 2019, GUT, V68, P1245, DOI 10.1136/gutjnl-2017-315541; Wang XM, 2004, INT J CANCER, V112, P636, DOI 10.1002/ijc.20450; Wang YF, 2013, CURR CANCER DRUG TAR, V13, P963, DOI 10.2174/15680096113136660102; Wu RC, 2014, CANCER BIOL THER, V15, P655, DOI 10.4161/cbt.28411; Yamamoto S, 2012, VIRCHOWS ARCH, V460, P77, DOI 10.1007/s00428-011-1169-8; Yan HB, 2014, CARCINOGENESIS, V35, P867, DOI 10.1093/carcin/bgt398; Zhang JX, 2018, ONCOL LETT, V15, P4619, DOI 10.3892/ol.2018.7861; Zhang L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/903542; Zhang S, 2014, ONCOGENE, V33, P116, DOI 10.1038/onc.2013.96; Zhang XY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060781, 10.1371/journal.pone.0053931, 10.1371/journal.pone.0061922]; Zhu QC, 2013, ASIAN PAC J CANCER P, V14, P2689, DOI 10.7314/APJCP.2013.14.5.2689; Zhu Y, 2018, MOL THER, V26, P744, DOI 10.1016/j.ymthe.2017.12.023	63	18	21	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12226	12239		10.1096/fj.201802720RR	http://dx.doi.org/10.1096/fj.201802720RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31424966	Green Published			2022-12-26	WOS:000507461600049
J	Yang, L; Li, XJ; Qin, X; Wang, QY; Zhou, KM; Li, H; Zhang, X; Wang, Q; Li, WW				Yang, Lei; Li, Xuejie; Qin, Xiang; Wang, Qiying; Zhou, Kaimin; Li, Hao; Zhang, Xin; Wang, Qun; Li, Weiwei			Deleted in azoospermia-associated protein 2 regulates innate immunity by stimulating Hippo signaling in crab	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						immunology; bacteria; gene transcription; yeast two-hybrid; protein?protein interaction; DAZAP2; Hippo signaling	PATHWAY; DEGRADATION; INDUCTION; EFFECTOR; YORKIE	The Hippo-signaling pathway plays a critical role in both normal animal physiology and pathogenesis. Because pharmacological interventions targeting this pathway have diverse clinical implications, a better understanding of its regulation in various conditions and organisms is crucial. Here, we identified deleted in azoospermia-associated protein 2 (DAZAP2) in the Chinese mitten crab (Eriocheir sinensis), designated EsDAZAP2, as a Hippo-regulatory protein highly similar to proteins in various species of insects, fish, and mammals. We found that a bacterial infection significantly induces EsDAZAP2 expression, and an EsDAZAP2 knockdown both suppresses antimicrobial peptide (AMP) expression in vitro and results in increased viable bacterial counts and mortality in vivo, suggesting that EsDAZAP2 plays a critical role in innate immunity. Using yeast two-hybrid screening and co-immunoprecipitation assays, we found that EsDAZAP2 regulates the Toll pathway rather than the immune deficiency and Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathways. Our findings also demonstrate that EsDAZAP2 binds to the Hippo protein, Salvador (Sav). Moreover, by examining the regulation of Dorsal, a transcription factor that regulates AMP expression in E. sinensis, we provide experimental evidence indicating that EsDAZAP2 promotes Hippo pathway activation in innate immunity, with EsDAZAP2 and Hippo binding to different Sav domains. To the best of our knowledge, this is the first report of a DAZAP2-regulated Hippo-signaling pathway operating in animal innate immunity.	[Yang, Lei; Qin, Xiang; Wang, Qiying; Zhou, Kaimin; Li, Hao; Wang, Qun; Li, Weiwei] East China Normal Univ, Sch Life Sci, Lab Invertebrate Immunol Def & Reprod Biol, State Key Lab Estuarine & Coastal Res, Shanghai 200241, Peoples R China; [Li, Xuejie] Dalian Ocean Univ, Coll Fisheries & Life Sci, Dalian 116023, Peoples R China; [Zhang, Xin] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Lab Cellular Immun, Shanghai 201203, Peoples R China	East China Normal University; Dalian Ocean University; Shanghai University of Traditional Chinese Medicine	Wang, Q; Li, WW (corresponding author), East China Normal Univ, Sch Life Sci, Lab Invertebrate Immunol Def & Reprod Biol, State Key Lab Estuarine & Coastal Res, Shanghai 200241, Peoples R China.; Zhang, X (corresponding author), Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Lab Cellular Immun, Shanghai 201203, Peoples R China.	zhangxin68619@163.com; qwang@bio.ecnu.edu.cn; wwli@bio.ecnu.edu.cn	Wang, Qun/I-7778-2013	Wang, Qun/0000-0001-7929-7692; zhou, kaimin/0000-0001-7215-6571	National Natural Science Foundation of China [31602189, 31672639]; Training Plan for Outstanding Young Medical Talents, Shanghai Municipal Health Bureau Grant [2018YQ43]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Training Plan for Outstanding Young Medical Talents, Shanghai Municipal Health Bureau Grant	This work was supported by National Natural Science Foundation of China Grants 31602189 and 31672639 and Training Plan for Outstanding Young Medical Talents, Shanghai Municipal Health Bureau Grant 2018YQ43. The authors declare that they have no conflicts of interest with the contents of this article.	Boro M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37695; Fulford A, 2018, CURR OPIN CELL BIOL, V51, P22, DOI 10.1016/j.ceb.2017.10.006; Geng J, 2015, NAT IMMUNOL, V16, P1142, DOI 10.1038/ni.3268; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hamilton MH, 2001, J BIOL CHEM, V276, P26324, DOI 10.1074/jbc.M101205200; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hong LX, 2018, CELL MOL IMMUNOL, V15, P1003, DOI 10.1038/s41423-018-0007-1; Kim JE, 2008, MOL CELL BIOL, V28, P803, DOI 10.1128/MCB.01226-07; Kleino A, 2019, INSECT BIOCHEM MOLEC, V108, P16, DOI 10.1016/j.ibmb.2019.03.003; Li XJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00801; Little TJ, 2005, NAT IMMUNOL, V6, P651, DOI 10.1038/ni1219; Liu B, 2016, CELL, V164, P406, DOI 10.1016/j.cell.2015.12.029; Lukas J, 2009, NUCLEIC ACIDS RES, V37, P3007, DOI 10.1093/nar/gkp179; Luo SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040475; Marcinkevicius E, 2013, DEVELOPMENT, V140, P433, DOI 10.1242/dev.083949; Meyer SN, 2014, SCIENCE, V346, P1199, DOI 10.1126/science.1258236; Myllymaki H, 2014, J IMMUNOL, V192, P3455, DOI 10.4049/jimmunol.1303309; Neto-Silva RM, 2010, DEV CELL, V19, P507, DOI 10.1016/j.devcel.2010.09.009; Nielsen H, 2017, METHODS MOL BIOL, V1611, P59, DOI 10.1007/978-1-4939-7015-5_6; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pare AC, 2014, NATURE, V515, P523, DOI 10.1038/nature13953; Shi Yiwu, 2004, Genomics Proteomics & Bioinformatics, V2, P47; Staley BK, 2012, DEV DYNAM, V241, P3, DOI 10.1002/dvdy.22723; Sun JJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01151; Sun JJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006626; Tsui SL, 2000, GENOMICS, V65, P266, DOI 10.1006/geno.2000.6169; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Wang P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08680-6; Wang QD, 2015, REV AQUACULT, V7, P283, DOI 10.1111/raq.12086; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Zepp JA, 2015, J IMMUNOL, V194, P2826, DOI 10.4049/jimmunol.1402647; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhang Q, 2017, NAT CELL BIOL, V19, P362, DOI 10.1038/ncb3496; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhu YT, 2015, AQUACULTURE, V446, P140, DOI 10.1016/j.aquaculture.2015.04.032	36	16	16	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2019	294	40					14704	14716		10.1074/jbc.RA119.009559	http://dx.doi.org/10.1074/jbc.RA119.009559			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JP0II	31395655	Green Published, hybrid			2022-12-26	WOS:000497955000016
J	Reyes-Gutierrez, P; Carrasquillo-Rodriguez, JW; Imbalzano, AN				Reyes-Gutierrez, Pablo; Carrasquillo-Rodriguez, Jake W.; Imbalzano, Anthony N.			Promotion of adipogenesis by JMJD6 requires the AT hook-like domain and is independent of its catalytic function	PLOS ONE			English	Article							PROTEIN 6 JMJD6; JUMONJI DOMAIN; PHOSPHATIDYLSERINE RECEPTOR; CRYSTAL-STRUCTURE; EXPRESSION; SUMOYLATION; 2-OXOGLUTARATE; DEMETHYLATION; PROGRESSION; OXYGENASES	JMJD6 is a member of the Jumonji C domain containing enzymes that demethylate and/or hydroxylate substrate proteins. It is a multi-functional protein that has been implicated in disparate aspects of transcriptional and post-transcriptional control of gene expression, including but not limited to enhancer and promoter binding, release of paused RNA polymerase II, control of splicing, and interaction with the translation machinery. JMJD6 contributes to multiple aspects of animal development, including adipogenesis modeled in culture. We mutated proposed or characterized domains in the JMJD6 protein to better understand the requirement for JMJD6 in adipogenic differentiation. Mutation of JMJD6 amino acids that mediate binding of iron and 2-oxogluterate, which are required cofactors for enzymatic activity, had no impact on JMJD6 function, showing that catalytic activity is not required for JMJD6 contributions to adipogenic differentiation. In addition, we documented the formation of JMJD6 oligomers and showed that catalytic activity is not required for oligomerization, as has been reported previously. We also observed no effect of mutations in the sumoylation site and in the poly-serine stretch. In contrast, mutation of the AT hook-like structure, which mediates interaction with DNA and/or RNA, compromised JMJD6 function by blocking its ability to interact with chromatin at genes that express regulators of adipogenesis. The ability of JMJD6 to interact with nucleic acids may be a critical requirement for its function in adipogenic differentiation. The requirement for the AT hook-like domain and the lack of requirement for catalytic activity giving rise to the idea that co-activation of transcription by JMJD6 may be functioning as a scaffold protein that supports the interactions of other critical regulators.	[Reyes-Gutierrez, Pablo; Carrasquillo-Rodriguez, Jake W.; Imbalzano, Anthony N.] Univ Massachusetts, Med Sch, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Imbalzano, AN (corresponding author), Univ Massachusetts, Med Sch, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA.	anthony.imbalzano@umassmed.edu			NIH [R01 DK106162, R01 GM56244]; NIH Summer Research Program [R25 HL092610]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL092610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK106162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056244] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Summer Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH R01 DK106162 and NIH R01 GM56244 to ANI. JWCR was supported by NIH Summer Research Program R25 HL092610. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aprelikova O, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0205-6; Biswas A, 2018, BIOCHEM J, V475, P355, DOI 10.1042/BCJ20170664; Boeckel JN, 2011, P NATL ACAD SCI USA, V108, P3276, DOI 10.1073/pnas.1008098108; Bottger A, 2015, BIOCHEM J, V468, P191, DOI 10.1042/BJ20150278; Bose Jens, 2004, J Biol, V3, P15, DOI 10.1186/jbiol10; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Cikala M, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-26; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Clissold PM, 2001, TRENDS BIOCHEM SCI, V26, P7, DOI 10.1016/S0968-0004(00)01700-X; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; Devaiah BN, 2016, J LEUKOCYTE BIOL, V100, P679, DOI 10.1189/jlb.2RI0616-250R; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Filarsky M, 2015, RNA BIOL, V12, P864, DOI 10.1080/15476286.2015.1060394; FREYTAG SO, 1994, GENE DEV, V8, P1654, DOI 10.1101/gad.8.14.1654; Gao WW, 2015, P NATL ACAD SCI USA, V112, pE3327, DOI 10.1073/pnas.1509658112; Hahn P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013769; Hahn P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-293; Han G, 2012, J CELL BIOCHEM, V113, P1663, DOI 10.1002/jcb.24035; Heim A, 2014, NUCLEIC ACIDS RES, V42, P7833, DOI 10.1093/nar/gku488; Hong JR, 2004, DEVELOPMENT, V131, P5417, DOI 10.1242/dev.01409; Hong X, 2010, P NATL ACAD SCI USA, V107, P14568, DOI 10.1073/pnas.1008832107; Hu YJ, 2015, NUCLEIC ACIDS RES, V43, P7790, DOI 10.1093/nar/gkv645; Islam MS, 2019, J BIOL CHEM, V294, P11637, DOI 10.1074/jbc.RA119.008693; Johansson C, 2014, EPIGENOMICS-UK, V6, P89, DOI 10.2217/epi.13.79; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Konuma T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16588-8; Kunisaki Y, 2004, BLOOD, V103, P3362, DOI 10.1182/blood-2003-09-3245; Kwok J, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00032; Lawrence P, 2014, VIROLOGY, V452, P1, DOI 10.1016/j.virol.2013.12.040; Lee CR, 2016, CARCINOGENESIS, V37, P119, DOI 10.1093/carcin/bgv169; Lee JS, 2017, ADV EXP MED BIOL, V963, P283, DOI 10.1007/978-3-319-50044-7_17; Lee JE, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02403-5; Lee YF, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3200; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Li Y, 2018, TRANSCR-AUSTIN, V9, P88, DOI 10.1080/21541264.2017.1281864; Liu W, 2013, CELL, V155, P1581, DOI 10.1016/j.cell.2013.10.056; Liu XJ, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0744-2; Liu Y, 2019, ONCOGENE, V38, P980, DOI 10.1038/s41388-018-0466-y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mantri M, 2010, J MOL BIOL, V401, P211, DOI 10.1016/j.jmb.2010.05.054; Miller TE, 2017, NATURE, V547, P355, DOI 10.1038/nature23000; Miotti S, 2017, FASEB J, V31, P5356, DOI 10.1096/fj.201700377R; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Poulard C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126181; Poulard C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087982; Rahman S, 2011, MOL CELL BIOL, V31, P2641, DOI 10.1128/MCB.01341-10; REEVES R, 1990, J BIOL CHEM, V265, P8573; Richard P, 2017, ADV EXP MED BIOL, V963, P15, DOI 10.1007/978-3-319-50044-7_2; Sanchez-Corrales YE, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.156778; Schneider Juergen E., 2004, BMC Developmental Biology, V4, P1; Shao CW, 2014, NAT STRUCT MOL BIOL, V21, P997, DOI 10.1038/nsmb.2906; Taniguchi Y, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111849; Thalhammer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016210; Tibrewal N, 2007, MOL CELL BIOCHEM, V304, P119, DOI 10.1007/s11010-007-9492-8; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tsai WC, 2017, J BIOL CHEM, V292, P18886, DOI 10.1074/jbc.M117.800706; Tyagi R, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-2; Unoki M, 2013, J BIOL CHEM, V288, P6053, DOI 10.1074/jbc.M112.433284; Vangimalla SS, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7020041; Wan JH, 2019, INT J CANCER, V144, P2489, DOI 10.1002/ijc.31816; Wan JH, 2016, NUCLEIC ACIDS RES, V44, P10662, DOI 10.1093/nar/gkw808; Wang F, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001819; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Wilson VG, 2017, ADV EXP MED BIOL, V963, P359, DOI 10.1007/978-3-319-50044-7_21; Wolf A, 2013, BIOCHEM J, V453, P357, DOI 10.1042/BJ20130529; Wu TF, 2015, J BIOL CHEM, V290, P20556, DOI 10.1074/jbc.M114.607713; Yanagihara T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9820; Yi J, 2017, NUCLEIC ACIDS RES, V45, P3503, DOI 10.1093/nar/gkw1144; Yue WW, 2010, FEBS LETT, V584, P825, DOI 10.1016/j.febslet.2009.12.055; Zhang J, 2013, TUMOR BIOL, V34, P2397, DOI 10.1007/s13277-013-0789-9; Zhang XN, 2015, J BIOL CHEM, V290, P20273, DOI 10.1074/jbc.M115.646554; Zhang ZH, 2000, NAT STRUCT BIOL, V7, P127; Zhang ZW, 2017, LIFE SCI, V188, P163, DOI 10.1016/j.lfs.2017.09.002; Zhou DX, 2017, NEOPLASMA, V64, P700, DOI 10.4149/neo_2017_507	77	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0216015	10.1371/journal.pone.0216015	http://dx.doi.org/10.1371/journal.pone.0216015			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430278	gold, Green Published, Green Submitted			2022-12-26	WOS:000485026800004
J	Glennon, MJ; Langdon, SF; Rubenstein, MA; Cross, MS				Glennon, Michale J.; Langdon, Stephen F.; Rubenstein, Madeleine A.; Cross, Molly S.			Temporal changes in avian community composition in lowland conifer habitats at the southern edge of the boreal zone in the Adirondack Park, NY	PLOS ONE			English	Article							CLIMATE-CHANGE IMPACTS; SITE-OCCUPANCY; BIRDS; NORTHERN; HOMOGENIZATION; FOREST; URBANIZATION; POPULATIONS; RESPONSES; RICHNESS	Climate change represents one of the most significant threats to human and wildlife communities on the planet. Populations at range margins or transitions between biomes can be particularly instructive for observing changes in biological communities that may be driven by climate change. Avian communities in lowland boreal habitats in the Adirondack Park, located at the North American boreal-temperate ecotone, have been the focus of long-term monitoring efforts since 2007. By documenting long-term changes in community structure and composition, such datasets provide an opportunity to understand how boreal species are responding differently to climate change, and which habitat characteristics may be best able to retain boreal avian communities. We examined three specific questions in order to address how well current biological communities in Adirondack boreal wetland habitats are being maintained in a changing climate: (1) how do trends in occupancy vary across species, and what guilds or characteristics are associated with increasing or decreasing occupancy? (2) how is avian community composition changing differently across sites, and (3) what distinguishes sites which are retaining boreal birds to a higher degree than other sites? Our analysis revealed that (1) boreal species appear to exhibit the largest changes in occupancy among our study locations as compared to the larger avian community, (2) dynamics of community change are not uniform across sites and habitat structure may play an important role in driving observed changes, and (3) the particular characteristics of large open peatlands may allow them to serve as refugia for boreal species in the context of climate change.	[Glennon, Michale J.] Wildlife Conservat Soc, Saranac Lake, NY 12983 USA; [Langdon, Stephen F.] Shingle Shanty Preserve & Res Stn, Long Lake, NY USA; [Rubenstein, Madeleine A.] US Geol Survey, Natl Climate Adaptat Sci Ctr, Reston, VA USA; [Cross, Molly S.] Wildlife Conservat Soc, Bozeman, MT USA; [Glennon, Michale J.] Paul Smiths Coll Adirondack Watershed Inst, Paul Smiths, NY USA	Wildlife Conservation Society; United States Department of the Interior; United States Geological Survey; Wildlife Conservation Society	Glennon, MJ (corresponding author), Wildlife Conservat Soc, Saranac Lake, NY 12983 USA.; Glennon, MJ (corresponding author), Paul Smiths Coll Adirondack Watershed Inst, Paul Smiths, NY USA.	mglennon@paulsmiths.edu			United States Geological Survey [G14AC00434]	United States Geological Survey(United States Geological Survey)	The project described in this publication was supported by Grant No. G14AC00434 to the Wildlife Conservation Society (MG, MC) from the United States Geological Survey. Its contents are solely the responsibility of the authors and do not necessarily represent the views of the National Climate Adaptation Science Center or the USGS. This manuscript is submitted for publication with the understanding that the United States Government is authorized to reproduce and distribute reprints for governmental purposes. The sponsors played a role in the decision to publish and in the preparation of the manuscript.	ALSOP FJ, 2001, SMITHSONIAN BIRDS N; Anderson M.G., 2013, NE HABITAT GUIDES CO; Andrle R. F., 1988, ATLAS BREEDING BIRDS; [Anonymous], 2013, POP EST DAT; Beier CM, 2012, LANDSCAPE ECOL, V27, P327, DOI 10.1007/s10980-011-9698-8; Both C, 2010, P ROY SOC B-BIOL SCI, V277, P1259, DOI 10.1098/rspb.2009.1525; Bowman P, 2009, PEATLANDS HABITAT ST; Cam E, 2000, ECOL APPL, V10, P1196, DOI 10.2307/2641026; Crick HQP, 2004, IBIS, V146, P48, DOI 10.1111/j.1474-919X.2004.00327.x; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Davey CM, 2012, GLOBAL ECOL BIOGEOGR, V21, P568, DOI 10.1111/j.1466-8238.2011.00693.x; Derbyshire R, 2015, ECOLOGY, V96, P3005, DOI 10.1890/15-0191.1; Devictor V, 2007, CONSERV BIOL, V21, P741, DOI 10.1111/j.1523-1739.2007.00671.x; Dobrowski SZ, 2011, GLOBAL CHANGE BIOL, V17, P1022, DOI 10.1111/j.1365-2486.2010.02263.x; Elmhagen B, 2015, AMBIO, V44, P39, DOI 10.1007/s13280-014-0606-8; Evans P, 2017, ENVIRON REV, V25, P423, DOI 10.1139/er-2017-0009; Ferree C., 2013, MAP TERRESTRIAL HABI; Garcia-Perez B, 2014, AUK, V131, P351, DOI 10.1642/AUK-13-145.1; George TL, 2008, CAN J FOREST RES, V38, P936, DOI 10.1139/X07-238; Glennon M., 2017, ANAL BOREAL BIRD TRE; Glennon M.J., 2014, NORTHEAST NAT, V21, P51; Glennon M.J., 2013, ADIRONDACK J ENV STU, V19, P36; Glennon MJ, 2005, BIOL CONSERV, V126, P499, DOI 10.1016/j.biocon.2005.06.029; Greenberg R, 2010, CONDOR, V114, P770; Hallmann CA, 2014, NATURE, V511, P341, DOI 10.1038/nature13531; Jenkins J, 2010, CLIMATE CHANGE ADIRO; Kery M, 2010, CONSERV BIOL, V24, P1388, DOI 10.1111/j.1523-1739.2010.01479.x; La Sorte FA, 2009, P ROY SOC B-BIOL SCI, V276, P3167, DOI 10.1098/rspb.2009.0162; Laaksonen T, 2013, BIOL CONSERV, V168, P99, DOI 10.1016/j.biocon.2013.09.007; Lachance D, 2005, ECOSCIENCE, V12, P161, DOI 10.2980/i1195-6860-12-2-161.1; LARSEN KW, 1994, ECOLOGY, V75, P214, DOI 10.2307/1939395; Lloyd J, 2017, STATE MOUNTAIN BIRDS; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; Marra PP, 2005, OECOLOGIA, V142, P307, DOI 10.1007/s00442-004-1725-x; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Moore PD, 2002, ENVIRON CONSERV, V29, P3, DOI 10.1017/S0376892902000024; Morelli T.L., 2017, CLIMATE CHANGE RESPO, V4, P8, DOI [10.1186/s40665-017-0036-5, DOI 10.1186/S40665-017-0036-5]; Morelli TL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159909; Niemi G., 1998, CONSERV ECOL, V2, P17, DOI DOI 10.5751/ES-00079-020217; Niemi G. J., 2016, NRS159 US FOR SERV N; North American Bird Conservation Initiative, 2016, STAT N AM BIRDS 2016; North American Bird Conservation Initiative (NABCI), 2014, STAT BIRDS 2014 REP; Panjabi A.O., 2017, PARTNERS FLIGHT TECH, V3; Paquette SR, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0649; Parish F., 2008, ASSESSMENT PEATLANDS; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Partners in Flight, 2017, AV CONS ASS DAT; Pearce-Higgins JW, 2015, J ANIM ECOL, V84, P943, DOI 10.1111/1365-2656.12364; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Ralph CJ, MONITORING BIRD POPU; Ralston J, 2015, BIOL CONSERV, V187, P270, DOI 10.1016/j.biocon.2015.04.029; Ray C, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1379; Richmond M. E., 2008, 2 ATLAS BREEDING BIR, P258; Rittenhouse CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011938; Rodewald PG, 2015, BIRDS N AM; Rydin H, 2013, BIO HABIT, P1, DOI 10.1093/acprof:osobl/9780199602995.001.0001; Smith AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130768; Soykan CU, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1351; Stager J., 2009, ADIRONDACK J ENV STU, V15, P14; Stenseth NC, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1958; Valiela I, 2007, BIOSCIENCE, V57, P360, DOI 10.1641/B570410; Virkkala R, 2012, NAT CONSERV-BULGARIA, P1, DOI 10.3897/natureconservation.3.3635; Virkkala R, 2011, BIOL LETTERS, V7, P395, DOI 10.1098/rsbl.2010.1052; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Willson MF, 2003, CAN J ZOOL, V81, P1202, DOI [10.1139/z03-096, 10.1139/Z03-096]; Wu JX, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190557; Zuckerberg B, 2009, GLOBAL CHANGE BIOL, V15, P1866, DOI 10.1111/j.1365-2486.2009.01878.x	69	2	2	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0220927	10.1371/journal.pone.0220927	http://dx.doi.org/10.1371/journal.pone.0220927			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5MK	31425523	Green Published, Green Submitted, gold			2022-12-26	WOS:000485022400020
J	Isaacs, BR; Trutti, AC; Pelzer, E; Tittgemeyer, M; Temel, Y; Forstmann, BU; Keuken, MC				Isaacs, Bethany. R.; Trutti, Anne. C.; Pelzer, Esther; Tittgemeyer, Marc; Temel, Yasin; Forstmann, Birte. U.; Keuken, Max. C.			Cortico-basal white matter alterations occurring in Parkinson's disease	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; HUMAN SUBTHALAMIC NUCLEUS; ANTERIOR CINGULATE CORTEX; FUNCTIONAL CONNECTIVITY; INDIVIDUAL-DIFFERENCES; FREE-WATER; SUBSTANTIA-NIGRA; FRONTAL-CORTEX; RESTING-STATE; STRUCTURAL CONNECTIVITY	Magnetic resonance imaging studies typically use standard anatomical atlases for identification and analyses of (patho-)physiological effects on specific brain areas; these atlases often fail to incorporate neuroanatomical alterations that may occur with both age and disease. The present study utilizes Parkinson's disease and age-specific anatomical atlases of the subthalamic nucleus for diffusion tractography, assessing tracts that run between the subthalamic nucleus and a-priori defined cortical areas known to be affected by Parkinson's disease. The results show that the strength of white matter fiber tracts appear to remain structurally unaffected by disease. Contrary to that, Fractional Anisotropy values were shown to decrease in Parkinson's disease patients for connections between the subthalamic nucleus and the pars opercularis of the inferior frontal gyrus, anterior cingulate cortex, the dorsolateral prefrontal cortex and the pre-supplementary motor, collectively involved in preparatory motor control, decision making and task monitoring. While the biological underpinnings of fractional anisotropy alterations remain elusive, they may nonetheless be used as an index of Parkinson's disease. Moreover, we find that failing to account for structural changes occurring in the subthalamic nucleus with age and disease reduce the accuracy and influence the results of tractography, highlighting the importance of using appropriate atlases for tractography.	[Isaacs, Bethany. R.; Trutti, Anne. C.; Forstmann, Birte. U.; Keuken, Max. C.] Univ Amsterdam, Integrat Model Based Cognit Neurosci Res Unit, Amsterdam, Netherlands; [Isaacs, Bethany. R.; Temel, Yasin] Maastricht Univ, Dept Neurosurg, Med Ctr, Maastricht, Netherlands; [Trutti, Anne. C.] Leiden Univ, Cognit Psychol, Leiden, Netherlands; [Pelzer, Esther; Tittgemeyer, Marc] Max Planck Inst Metab Res, Translat Neurocircuitry, Cologne, Germany; [Pelzer, Esther; Tittgemeyer, Marc] Univ Clin, Dept Neurol, Cologne, Germany; [Isaacs, Bethany. R.] Integrat Model Based Cognit Neurosci Res Unit, REC G Room 3-03, Amsterdam, Netherlands	University of Amsterdam; Maastricht University; Leiden University; Leiden University - Excl LUMC; University of Cologne	Isaacs, BR (corresponding author), Univ Amsterdam, Integrat Model Based Cognit Neurosci Res Unit, Amsterdam, Netherlands.; Isaacs, BR (corresponding author), Maastricht Univ, Dept Neurosurg, Med Ctr, Maastricht, Netherlands.; Isaacs, BR (corresponding author), Integrat Model Based Cognit Neurosci Res Unit, REC G Room 3-03, Amsterdam, Netherlands.	broseisaacs@gmail.com	Forstmann, Birte/AAS-8515-2020	Trutti, Anne Charlotte/0000-0002-0044-4846	ERC grant from the European Research Council [Stg: 313481]; Vici grant from the Dutch Organization for Scientific Research [016.Vici.185.052]	ERC grant from the European Research Council; Vici grant from the Dutch Organization for Scientific Research	This research was supported by an ERC grant from the European Research Council (https://erc.europa.eu/, B.U. Forstmann, Stg: 313481) and a Vici grant from the Dutch Organization for Scientific Research (https://www.nwo.nl/en, B. U. Forstmann, 016.Vici.185.052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abosch A, 2010, NEUROSURGERY, V67, P1745, DOI 10.1227/NEU.0b013e3181f74105; Akaike H., 1998, SELECTED PAPERS HIRO, P309; Akram H, 2017, MOVEMENT DISORD, V32, P874, DOI 10.1002/mds.27017; Alkemade A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176130; Archer DB, 2017, HUM BRAIN MAPP, V38, P4546, DOI 10.1002/hbm.23681; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; ARTIEDA J, 1992, BRAIN, V115, P199, DOI 10.1093/brain/115.1.199; Auer F, 2018, CURR BIOL, V28, P549, DOI 10.1016/j.cub.2018.01.017; Augustine EF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133002; Baudrexel S, 2011, NEUROIMAGE, V55, P1728, DOI 10.1016/j.neuroimage.2011.01.017; Baumann CR, 2014, MOVEMENT DISORD, V29, P207, DOI 10.1002/mds.25650; Bechler ME, 2018, DEV NEUROBIOL, V78, P68, DOI 10.1002/dneu.22518; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Beisteiner R, 2011, NEUROIMAGE, V57, P1015, DOI 10.1016/j.neuroimage.2011.05.010; Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Berry DA, 1999, J STAT PLAN INFER, V82, P215, DOI 10.1016/S0378-3758(99)00044-0; Boekel W, 2017, PSYCHOPHYSIOLOGY, V54, P24, DOI 10.1111/psyp.12769; Boorman ED, 2007, CURR BIOL, V17, P1426, DOI 10.1016/j.cub.2007.07.040; Bordelon YM, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/967839; Botvinick MM, 2007, COGN AFFECT BEHAV NE, V7, P356, DOI 10.3758/CABN.7.4.356; Braak H, 2006, MOVEMENT DISORD, V21, P2042, DOI 10.1002/mds.21065; Brunenberg EJL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039061; Bryden DW, 2019, CEREB CORTEX, V29, P1020, DOI 10.1093/cercor/bhy008; Chambers CD, 2009, NEUROSCI BIOBEHAV R, V33, P631, DOI 10.1016/j.neubiorev.2008.08.016; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Cho ZH, 2008, INT J IMAG SYST TECH, V18, P2, DOI 10.1002/ima.20143; Cho ZH, 2010, J NEUROSURG, V113, P639, DOI 10.3171/2010.3.JNS091385; Chong SYC, 2012, P NATL ACAD SCI USA, V109, P1299, DOI 10.1073/pnas.1113540109; Chung JW, 2017, NEUROIMAGE-CLIN, V14, P417, DOI 10.1016/j.nicl.2017.02.012; Cochrane CJ, 2013, NEUROLOGY, V80, P857, DOI 10.1212/WNL.0b013e318284070c; Curley LB, 2018, BRAIN STRUCT FUNCT, V223, P211, DOI 10.1007/s00429-017-1480-5; Dayan E, 2017, NEUROIMAGE-CLIN, V16, P313, DOI 10.1016/j.nicl.2017.08.003; de Hollander G, 2014, HUM BRAIN MAPP, V35, P4440, DOI 10.1002/hbm.22485; den Dunnen WFA, 2005, MOVEMENT DISORD, V20, P893, DOI 10.1002/mds.20417; Despotovic I, 2015, COMP MATH MATH PHYS, V2015, DOI [10.1007/s10548-018-0638-7, DOI 10.1007/S10548-018-0638-7]; Dickie DA, 2017, FRONT NEUROINFORM, V11, DOI 10.3389/fninf.2017.00001; Dyrby TB, 2007, NEUROIMAGE, V37, P1267, DOI 10.1016/j.neuroimage.2007.06.022; Evans AC, 2012, NEUROIMAGE, V62, P911, DOI 10.1016/j.neuroimage.2012.01.024; Evans NJ, 2019, BRAIN, V142, P1170, DOI [10.1093/brain/awz096, DOI 10.1093/BRAIN/AWZ096]; Farhadi F, 2017, NEUROPSYCH DIS TREAT, V13, P329, DOI 10.2147/NDT.S124984; Feis DL, 2015, NPJ PARKINSON DIS, V1, DOI 10.1038/npjparkd.2015.18; Fields RD, 2015, NAT REV NEUROSCI, V16, P756, DOI 10.1038/nrn4023; Forsaa EB, 2010, ARCH NEUROL-CHICAGO, V67, P996, DOI 10.1001/archneurol.2010.166; Forstmann BU, 2017, TRENDS BIOTECHNOL, V35, P904, DOI 10.1016/j.tibtech.2017.06.010; Forstmann BU, 2012, NEUROIMAGE, V60, P370, DOI 10.1016/j.neuroimage.2011.12.044; Forstmann BU, 2010, P NATL ACAD SCI USA, V107, P15916, DOI 10.1073/pnas.1004932107; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Gowen E, 2007, NEUROIMAGE, V36, P396, DOI 10.1016/j.neuroimage.2007.03.005; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Herz DM, 2015, BRAIN, V138, P1658, DOI 10.1093/brain/awv096; Hilker R, 2005, ARCH NEUROL; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Horn A, 2017, ANN NEUROL, V82, P67, DOI 10.1002/ana.24974; Hoy AR, 2014, NEUROIMAGE, V103, P323, DOI 10.1016/j.neuroimage.2014.09.053; Hu YF, 2017, SOC COGN AFFECT NEUR, V12, P775, DOI 10.1093/scan/nsx008; Isaacs BR, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00060; ITO K, 2012, ISRN NEUROLOGY, V120; Jahanshahi M, 2015, NAT REV NEUROSCI, V16, P719, DOI 10.1038/nrn4038; Jeffreys H., 1998, THEORY PROBABILITY; Jenkinson M., 2012, NEUROIMAGE; Joel D, 1997, BRAIN RES REV; Johansen-Berg H, 2012, NEURON, V73, P1058, DOI 10.1016/j.neuron.2012.03.001; JOHANSENBERG H, 2010, CURR OPIN NEUROL, V4, DOI DOI 10.3389/FNSYS.2010.00146; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kamagata K, 2018, NEUROIMAGE-CLIN, V17, P518, DOI 10.1016/j.nicl.2017.11.007; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Keuken MC, 2018, BRAIN TOPOGR, V31, P513, DOI 10.1007/s10548-018-0638-7; Keuken MC, 2017, BRAIN STRUCT FUNCT, V222, P2487, DOI 10.1007/s00429-016-1352-4; Keuken MC, 2013, J NEUROSCI, V33, P4896, DOI 10.1523/JNEUROSCI.3241-12.2013; Khalsa S, 2014, NEUROIMAGE, V102, P118, DOI 10.1016/j.neuroimage.2013.12.022; Kim HJ, 2013, NEUROSCI LETT, V550, P64, DOI 10.1016/j.neulet.2013.06.050; King AV, 2012, NEUROIMAGE, V59, P1949, DOI 10.1016/j.neuroimage.2011.09.008; Kitajima M, 2008, NEURORADIOLOGY, V50, P675, DOI 10.1007/s00234-008-0388-4; Lambert C, 2012, NEUROIMAGE, V60, P83, DOI 10.1016/j.neuroimage.2011.11.082; Lenglet C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029153; Litvak V, 2011, BRAIN, V134, P359, DOI 10.1093/brain/awq332; Lorio S, 2016, NEUROIMAGE, V130, P157, DOI 10.1016/j.neuroimage.2016.01.062; Lucerna S, 2002, VIVO ATLAS DEEP BRAI, P1, DOI [10.1007/978-3-642-56381-2_1, DOI 10.1007/978-3-642-56381-2_1]; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Marceglia S, 2006, EUR J NEUROSCI, V24, P3213, DOI 10.1111/j.1460-9568.2006.05208.x; Markett S, 2017, NEUROIMAGE, V155, P473, DOI 10.1016/j.neuroimage.2017.04.005; Mazziotta JC, 1995, NEUROIMAGE; Metzler-Baddeley C, 2012, NEUROIMAGE, V59, P1394, DOI 10.1016/j.neuroimage.2011.08.043; Miller IN, 2010, MOVEMENT DISORD, V25, P2695, DOI 10.1002/mds.23388; Mitew S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02719-2; Miyachi S, 2006, NEUROSCI RES, V56, P300, DOI 10.1016/j.neures.2006.07.012; Moisan F, 2016, J NEUROL NEUROSUR PS, V87, P952, DOI 10.1136/jnnp-2015-312283; Mole JP, 2016, EUR RADIOL, V26, P3327, DOI 10.1007/s00330-015-4178-1; Molnar-Szakacs I, 2005, CEREB CORTEX, V15, P986, DOI 10.1093/cercor/bhh199; Morey RD, 2014, STAT PROBABIL LETT, V92, P121, DOI 10.1016/j.spl.2014.05.010; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; Nambu A, 1996, J NEUROSCI, V16, P2671; Nambu A., 2008, CURRENT OPINION NEUR; Neubert FX, 2015, P NATL ACAD SCI USA, V112, pE2695, DOI 10.1073/pnas.1410767112; Neubert FX, 2014, NEURON, V81, P700, DOI 10.1016/j.neuron.2013.11.012; Neubert FX, 2010, P NATL ACAD SCI USA, V107, P13240, DOI 10.1073/pnas.1000674107; Ng B, 2017, NEUROIMAGE-CLIN, V16, P575, DOI 10.1016/j.nicl.2017.09.004; Obeso JA, 2000, TRENDS NEUROSCI, V23; Ofori E, 2015, BRAIN, V138, P2322, DOI 10.1093/brain/awv136; PARENT A, 1995, BRAIN RES REV, V20, P128, DOI 10.1016/0165-0173(94)00008-D; Peerlings J, 2019, PHYS IMAG RADIAT ONC, V9, P35, DOI 10.1016/j.phro.2018.12.001; Pereira JLB, 2016, BASAL GANGLIA, V6, P83, DOI 10.1016/j.baga.2016.01.003; Perlmutter JS, 2006, ANNU REV NEUROSCI, V29, P229, DOI 10.1146/annurev.neuro.29.051605.112824; Perlmutter JS, 2009, CURR PROTOC NEUROSCI, DOI [10.1002/0471142301.ns1001s49, DOI 10.1002/0471142301.NS1001S49]; Planetta PJ, 2016, BRAIN, V139, P495, DOI 10.1093/brain/awv361; Plantinga BR, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00066; Plantinga BR, 2016, NEUROIMAGE; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Richter EO, 2004, J NEUROSURG, V100, P541, DOI 10.3171/jns.2004.100.3.0541; Roberts RE, 2013, NEUROSCIENTIST, V19, P8, DOI 10.1177/1073858411421218; Romanelli P, 2005, BRAIN RES REV, V48, P112, DOI 10.1016/j.brainresrev.2004.09.008; Rouder JN, 2017, PSYCHOL METHODS, V22, P304, DOI 10.1037/met0000057; Rowe J, 2002, BRAIN, V125, P276, DOI 10.1093/brain/awf036; Saint-Cyr JA, 2002, J NEUROSURG, V97, P1152, DOI 10.3171/jns.2002.97.5.1152; Sallet J, 2013, J NEUROSCI, V33, P12255, DOI 10.1523/JNEUROSCI.5108-12.2013; Sampaio-Baptista C, 2017, NEURON, V96, P1239, DOI 10.1016/j.neuron.2017.11.026; Santangelo G, 2007, MOVEMENT DISORD, V22, P2418, DOI 10.1002/mds.21746; Schroeder U, 2002, BRAIN, V125, P1995, DOI 10.1093/brain/awf199; Seppi K, 2010, NEUROIMAG CLIN N AM, V20, P29, DOI 10.1016/j.nic.2009.08.016; Sharott A, 2014, J NEUROSCI, V34, P6273, DOI 10.1523/JNEUROSCI.1803-13.2014; Smith KM, 2014, EXP NEUROL, V259, P44, DOI 10.1016/j.expneurol.2014.03.010; Stephan KE, 2009, NEUROIMAGE, V47, P1628, DOI 10.1016/j.neuroimage.2009.05.096; Swire M, 2018, NEURON, V98, P684, DOI 10.1016/j.neuron.2018.05.005; Temel Y, 2005, PROG NEUROBIOL, V76, P393, DOI 10.1016/j.pneurobio.2005.09.005; Theilmann RJ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00037; Tinaz S, 2017, NEUROIMAGE-CLIN, V13, P395, DOI 10.1016/j.nicl.2016.12.019; TOMER R, 1993, ANN NEUROL, V34, P579, DOI 10.1002/ana.410340412; van den Bos W, 2014, J NEUROSCI, V34, P10298, DOI 10.1523/JNEUROSCI.4105-13.2014; Walhovd KB, 2014, NEUROSCIENCE, V276, P2, DOI 10.1016/j.neuroscience.2014.06.058; Wetzels R, 2011, PERSPECT PSYCHOL SCI, V6, P291, DOI 10.1177/1745691611406923; Wichmann T, 2006, NEURON, V52, P197, DOI 10.1016/j.neuron.2006.09.022; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Wu T, 2009, NEUROSCI LETT, V460, P6, DOI 10.1016/j.neulet.2009.05.046; Wylie SA, 2010, J COGNITIVE NEUROSCI, V22, P2058, DOI 10.1162/jocn.2009.21326; Xiao YM, 2014, HUM BRAIN MAPP, V35, P4330, DOI 10.1002/hbm.22478; Ziegler E, 2014, NEUROIMAGE, V99, P498, DOI 10.1016/j.neuroimage.2014.06.033; Zwirner J, 2017, HUM BRAIN MAPP, V38, P909, DOI 10.1002/hbm.23427	139	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0214343	10.1371/journal.pone.0214343	http://dx.doi.org/10.1371/journal.pone.0214343			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5MK	31425517	Green Published, gold, Green Submitted			2022-12-26	WOS:000485022400004
J	Lv, F; Huang, JH; Wang, W; Wei, YL; Sun, YX; Wang, BL				Lv, Fang; Huang, Junheng; Wang, Wei; Wei, Yuliang; Sun, Yunxiao; Wang, Bailing			A two-route CNN model for bank account classification with heterogeneous data	PLOS ONE			English	Article								Classifying bank accounts by using transaction data is encouraging in cracking down on illegal financial activities. However, few research simultaneously use heterogenous features, which are embedded in the time series data. In this paper, a two route convolution neural network TRHD-CNN model, fed with two types of heterogeneous feature matrices, is proposed for classifying the bank accounts. TRHD-CNN adopts divide and conquer strategy to extract characteristics from two types of data source independently. The strategy is proved able in mining complementary classification characteristics. We firstly transfer the original log data into a directed and dynamic transaction network. On the basis of that, two feature generation methods are devised for extracting information from local topological structure and time series transaction respectively. A DirectedWalk method is developed in this paper to learning the network vector of vertices used for embedding the neighbor relationship of bank account. The extensive experimental results, conducted on a real bank transaction dataset that contains illegal pyramid selling accounts, show the significant advantage of TRHD-CNN over the existing methods. TRHD-CNN can provide recall scores up to 5.15% higher than competing methods. In addition, the two-route architecture of TRHD-CNN is easy to extend to multi-route scenarios and other fields.	[Lv, Fang; Huang, Junheng; Wang, Wei; Wei, Yuliang; Sun, Yunxiao; Wang, Bailing] Harbin Inst Technol Weihai, Sch Comp Sci & Technol, Weihai, Shandong, Peoples R China	Harbin Institute of Technology	Wang, BL (corresponding author), Harbin Inst Technol Weihai, Sch Comp Sci & Technol, Weihai, Shandong, Peoples R China.	wbl@hit.edu.cn		Lv, Fang/0000-0002-6778-3981	National Key Research and Development Program of China [2018YFB2004201, 2017YFB0801804]; Frontier science and technology innovation of China; Regional Innovation Center and Technology Project of China [2017QYX14]; Key Research and Development Program of Shandong Province [2017CXGC0706]; Fundamental Research Funds for the Central Universities; NSRIF [2020098]	National Key Research and Development Program of China; Frontier science and technology innovation of China; Regional Innovation Center and Technology Project of China; Key Research and Development Program of Shandong Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NSRIF	This research is supported by National Key Research and Development Program of China (grant Nos. 2018YFB2004201 and 2017YFB0801804), Frontier science and technology innovation of China (grant No.2016QY05X1002-2), Regional Innovation Center and Technology Project of China (grant No. 2017QYX14), Key Research and Development Program of Shandong Province (grant No. 2017CXGC0706), and Fundamental Research Funds for the Central Universities (grant No. HIT. NSRIF. 2020098).	Abdallah A, 2016, J NETW COMPUT APPL, V68, P90, DOI 10.1016/j.jnca.2016.04.007; Agrawal R., 1994, P 20 INT C VERY LARG, V1215, P487; BRON C, 1973, COMMUN ACM, V16, P575, DOI 10.1145/362342.362367; Cohen J., 2008, TRUSSES COHESIVE SUB; He K., 2016, CVPR, P770; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hinton G. E., 2012, COMPUT SCI, DOI DOI 10.9774/GLEAF.978-1-909493-38-4_2; Kang F, 2016, ICONIP 2016 23 INT C; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Liu X, 2008, LECT NOTES COMPUT SC, V5075, P50; Liu Yang, 2012, Proceedings of the 2012 IEEE 3rd International Conference on Software Engineering and Service Science (ICSESS), P55, DOI 10.1109/ICSESS.2012.6269404; Lv F., 2018, P722, DOI DOI 10.1109/DSC.2018.00115; Maes S., 2002, P 1 INT NAISO C NEUR, P261; Mikolov T., 2013, 1 INT C LEARN REPR I; Minegishi T., 2011, INT J INF SECUR RES, V1, P229; Ngai EWT, 2011, DECIS SUPPORT SYST, V50, P559, DOI 10.1016/j.dss.2010.08.006; Perozzi B, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P701, DOI 10.1145/2623330.2623732; Redmond Ursula, 2012, Modeling and Mining Ubiquitous Social Media. International Workshops MSM 2011 and MUSE 2011. Revised Selected Papers, P60, DOI 10.1007/978-3-642-33684-3_4; Sahin Y., 2012, WORLD C ENG, V2188, P442, DOI DOI 10.1109/INISTA.2011.5946108; Sanchez D, 2009, EXPERT SYST APPL, V36, P3630, DOI 10.1016/j.eswa.2008.02.001; Savage D., 2016, AAAI 17 WORKSHOP OPE, DOI DOI 10.1108/JMLC-07-2019-0055; Seeja K, 2014, FRAUDMINER NOVEL CRE; Simonyan K, 2014, ADV NEUR IN, V27; Wang SN, 2007, PROCEEDINGS OF 2007 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-7, P283; Wu C, 2013, ICPR 2012 P 21 INT C, P657; YL Li., 2017, BIG DATA, V3, P106; Zeiler M. D., 2012, ARXIV 12125701, V1212.5701; Zhang YY, 2016, PROC CVPR IEEE, P589, DOI 10.1109/CVPR.2016.70; Zhu TQ, 2006, 2006 IEEE AS PAC C S	29	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0220631	10.1371/journal.pone.0220631	http://dx.doi.org/10.1371/journal.pone.0220631			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5MK	31425545	Green Published, Green Submitted, gold			2022-12-26	WOS:000485022400014
J	Gorenjak, V; Vance, DR; Petrelis, AM; Stathopoulou, MG; Dade, S; El Shamieh, S; Murray, H; Masson, C; Lamont, J; Fitzgerald, P; Visvikis-Siest, S				Gorenjak, Vesna; Vance, Dwaine R.; Petrelis, Alexandros M.; Stathopoulou, Maria G.; Dade, Sebastien; El Shamieh, Said; Murray, Helena; Masson, Christine; Lamont, John; Fitzgerald, Peter; Visvikis-Siest, Sophie			Peripheral blood mononuclear cells extracts VEGF protein levels and VEGF mRNA: Associations with inflammatory molecules in a healthy population	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; GENE-ENVIRONMENT INTERACTIONS; INHIBITORY SPLICE VARIANT; CHEMOATTRACTANT PROTEIN-1; DIFFERENTIAL EXPRESSION; COLORECTAL-CANCER; A ISOFORM; IN-VIVO; ANGIOGENESIS; INTERLEUKIN-4	Background Vascular endothelial growth factor (VEGF) is a signal protein, implicated in various physiological and pathophysiological processes together with other common inflammatory biomarkers. However, their associations have not yet been fully elucidated. In the present study, we investigated associations between VEGF and four specific VEGF mRNA isoforms with levels of 11 inflammation molecules, derived from peripheral blood mononuclear cells (PBMCs) extracts. Methods Healthy participants from the STANISLAS Family Study (n = 285) were included. Levels of VEGF (four mRNA isoforms and protein levels) and inflammatory molecules (IL-1 alpha, IL-1 beta, IL-2, IL-4, IL-6, IL-8, IL-10, INF-gamma, TNF-alpha, MCP-1, EGF) were measured in PBMCs extracts. Multiple regression analyses were performed, adjusted for age and gender. Results The analyses revealed significant associations between VEGF protein levels and levels of IL-4 (beta = 0.028, P = 0.013), MCP-1 (beta = 0.015, P < 0.0001) and EGF (beta = 0.017, P < 0.0001). Furthermore, mRNA isoform VEGF(165) was associated with MCP-1 and IL-1 alpha (P = 0.002 and P = 0.008, respectively); and mRNA isoform VEGF(189) was associated with IL-4 and IL-6 (P = 0.019 and P = 0.034, respectively). Conclusions To our knowledge, the present study represents the first investigation that successfully demonstrates links between VEGF protein levels and inflammatory molecules levels derived from PBMCs extracts and identifies associations between specific VEGF mRNA isoforms and inflammatory molecules. Impact These findings provide novel insights that may assist in the development of new tissue and mRNA isoform specific measurements of VEGF levels, which may positively contribute to predicting the risk of common complex diseases and response of currently used anti-VEGF agents, and developing of novel targeted therapies for VEGF-related pathophysiology.	[Gorenjak, Vesna; Petrelis, Alexandros M.; Stathopoulou, Maria G.; Dade, Sebastien; Masson, Christine; Visvikis-Siest, Sophie] Univ Lorraine, INSERM, IGE PCV, Nancy, France; [Vance, Dwaine R.; Murray, Helena; Lamont, John; Fitzgerald, Peter] Randox Labs Ltd, Crumlin, Antrim, North Ireland; [El Shamieh, Said] Beirut Arab Univ, Fac Hlth Sci, Dept Med Lab Technol, Beirut, Lebanon; [Visvikis-Siest, Sophie] CHU Technopole Nancy Brabois, Dept Internal Med & Geriatr, Rue Morvan, Vandoeuvre Les Nancy, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Randox Laboratories; Beirut Arab University	Visvikis-Siest, S (corresponding author), Univ Lorraine, INSERM, IGE PCV, Nancy, France.; Visvikis-Siest, S (corresponding author), CHU Technopole Nancy Brabois, Dept Internal Med & Geriatr, Rue Morvan, Vandoeuvre Les Nancy, France.	sophie.visvikis-siest@inserm.fr	Visvikis-Siest, Sophie/H-2324-2014; Shamieh, Said El/J-6343-2019	Visvikis-Siest, Sophie/0000-0001-8104-8425; Shamieh, Said El/0000-0002-8522-0445; Petrelis, Alexandros/0000-0001-9156-4896; MASSON, Christine/0000-0001-5804-3722	European Union within the frames of the Operational Programme FEDER-FSE Lorraine et Massif des Vosges; Agence Nationale de la Recherche, programme d'Investissements d'avenir [ANR15RHU-0004]; GEENAGE project (Functional Genomic, Epigenomic and ENvironment interplay to IMPACT management of healthy and pathological AGEing)	European Union within the frames of the Operational Programme FEDER-FSE Lorraine et Massif des Vosges; Agence Nationale de la Recherche, programme d'Investissements d'avenir(French National Research Agency (ANR)); GEENAGE project (Functional Genomic, Epigenomic and ENvironment interplay to IMPACT management of healthy and pathological AGEing)	Financial support was provided by the European Union within the frames of the Operational Programme FEDER-FSE Lorraine et Massif des Vosges 2014-2020, by Agence Nationale de la Recherche, programme d'Investissements d'avenir, grant number ANR15RHU-0004 and GEENAGE project (Functional Genomic, Epigenomic and ENvironment interplay to IMPACT management of healthy and pathological AGEing)" within the frames of the LUE project (Lorraine University of Excellence). VG was partially funded by the "Region Lorraine". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2006, INT J CANCER, V119, P1303, DOI 10.1002/ijc.22006; Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Angelo LS, 2007, CLIN CANCER RES, V13, P2825, DOI 10.1158/1078-0432.CCR-06-2416; Azimi-Nezhad M, 2013, CYTOKINE, V61, P602, DOI 10.1016/j.cyto.2012.10.024; Aziz Hamza, 2007, Genomic Med, V1, P105, DOI 10.1007/s11568-008-9017-x; Barratt SL, 2017, AM J RESP CRIT CARE, V196, P479, DOI 10.1164/rccm.201603-0568OC; Bates DO, 2002, CANCER RES, V62, P4123; Berrahmoune H, 2007, ANN HUM GENET, V71, P54, DOI 10.1111/j.1469-1809.2006.00298.x; Boiardi L, 2003, J RHEUMATOL, V30, P2160; Borg SA, 2005, EUR J ENDOCRINOL, V152, P293, DOI 10.1530/eje.1.01843; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Bunni J, 2015, AM J CANCER RES, V5, P2083; Cai C, 2010, ANTICANCER RES, V30, P805; Canavese M, 2017, INT J CANCER, V140, P2183, DOI 10.1002/ijc.30567; Cao YH, 1997, BIOCHEM BIOPH RES CO, V235, P493, DOI 10.1006/bbrc.1997.6813; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; Choi SH, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005874; Ciardiello F, 2006, ANN ONCOL, V17, pVII109, DOI 10.1093/annonc/mdl962; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Clegg LE, 2018, INTEGR BIOL-UK, V10, P18, DOI 10.1039/c7ib00218a; Cohen T, 1996, J BIOL CHEM, V271, P736, DOI 10.1074/jbc.271.2.736; Corkum CP, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0113-0; Cressey R, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-128; De Palma M, 2012, J PATHOL, V227, P4, DOI 10.1002/path.4008; Debette S, 2011, CIRC RES, V109, P554, DOI 10.1161/CIRCRESAHA.111.243790; Dembic Z., 2015, CYTOKINES IMMUNE SYS; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; ERUSAN RR, 2012, OPEN J ENDOC METAB D, V2, P7, DOI DOI 10.4236/OJEMD.2012; Faffe DS, 2006, AM J RESP CELL MOL, V34, P213, DOI 10.1165/rcmb.2005-0147OC; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Giannopoulou EG, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0677-3; GOODWIN JS, 1980, CLIN IMMUNOL IMMUNOP, V15, P106, DOI 10.1016/0090-1229(80)90024-0; Guyot M, 2017, ONCOTARGET, V8, P9174, DOI 10.18632/oncotarget.13942; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; HART PH, 1989, P NATL ACAD SCI USA, V86, P3803, DOI 10.1073/pnas.86.10.3803; Hoekstra M, 2010, BIOCHEM BIOPH RES CO, V394, P792, DOI 10.1016/j.bbrc.2010.03.075; Hong KH, 2007, CLIN EXP IMMUNOL, V147, P573, DOI 10.1111/j.1365-2249.2006.03295.x; Hong KH, 2005, BLOOD, V105, P1405, DOI 10.1182/blood-2004-08-3178; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang S, 2000, CANCER RES, V60, P5334; Huang SP, 2004, J BIOMED SCI, V11, P517, DOI 10.1159/000077902; Iacobaeus E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019138; Jay SM, 2010, BIOMATERIALS, V31, P3054, DOI 10.1016/j.biomaterials.2010.01.014; Jeng KS, 2004, WORLD J GASTROENTERO, V10, P676, DOI 10.3748/wjg.v10.i5.676; Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788; Kieran MW, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006593; Kikuchi R, 2014, NAT MED, V20, P1464, DOI 10.1038/nm.3703; Krieglstein CF, 2001, AM J HYPERTENS, V14, p44S, DOI 10.1016/S0895-7061(01)02069-6; Lackie JM, 2012, DICT CELL MOL BIOL; Langjahr M, 2018, J NEUROL, V265, P618, DOI 10.1007/s00415-018-8748-4; Lau TP, 2014, GENET MOL RES, V13, P5555, DOI 10.4238/2014.July.25.9; Lequoy P, 2016, ACTA BIOMATER, V29, P239, DOI 10.1016/j.actbio.2015.10.026; Linde N, 2012, J PATHOL, V227, P17, DOI 10.1002/path.3989; Loeffler S, 2005, INT J CANCER, V115, P202, DOI 10.1002/ijc.20871; Manetti M, 2011, CIRC RES, V109, pE14, DOI 10.1161/CIRCRESAHA.111.242057; Marteau JB, 2005, CLIN CHEM, V51, P1250, DOI 10.1373/clinchem.2005.048546; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; Miyahira A., 2012, SANGUINE BIORESEARCH; Mor F, 2004, J IMMUNOL, V172, P4618, DOI 10.4049/jimmunol.172.7.4618; NAKAGOMI H, 1995, INT J CANCER, V63, P366, DOI 10.1002/ijc.2910630311; Nikolayeva I, 2018, J INFECT DIS; Nowak DG, 2010, J BIOL CHEM, V285, P5532, DOI 10.1074/jbc.M109.074930; Parenti A, 2004, AM J PHYSIOL-HEART C, V286, pH1978, DOI 10.1152/ajpheart.00414.2003; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Paule B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010715; Repovic P, 2003, ONCOGENE, V22, P8117, DOI 10.1038/sj.onc.1206922; Riondino S, 2017, CARDIOVASC HEMATOL A; Robinson CJ, 2001, J CELL SCI, V114, P853; Saito K, 2016, PEDIATR RES, V80, P425, DOI 10.1038/pr.2016.93; Salven P, 2002, FASEB J, V16, P1471, DOI 10.1096/fj.02-0134fje; Saryeddine L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165876; Saurwein-Teissl M, 1998, CLIN EXP IMMUNOL, V114, P271; Shah VO, 1997, J CLIN ENDOCR METAB, V82, P2294, DOI 10.1210/jc.82.7.2294; Siest G, 1998, CLIN CHEM LAB MED, V36, P35, DOI 10.1515/CCLM.1998.007; Skaria T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156002; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stevens M, 2018, GENES-BASEL, V9, DOI 10.3390/genes9020098; Tabernero J, 2007, MOL CANCER RES, V5, P203, DOI 10.1158/1541-7786.MCR-06-0404; Tang Rui-Fang, 2005, Hepatobiliary Pancreat Dis Int, V4, P460; Tortora G, 2008, NAT CLIN PRACT ONCOL, V5, P521, DOI 10.1038/ncponc1161; Turner MD, 2014, BBA-MOL CELL RES, V1843, P2563, DOI 10.1016/j.bbamcr.2014.05.014; Ueno T, 2000, CLIN CANCER RES, V6, P3282; Varey AHR, 2008, BRIT J CANCER, V98, P1366, DOI 10.1038/sj.bjc.6604308; Vempati P, 2014, CYTOKINE GROWTH F R, V25, P1, DOI 10.1016/j.cytogfr.2013.11.002; Visvikis-Siest S, 2008, CLIN CHEM LAB MED, V46, P733, DOI 10.1515/CCLM.2008.178; Wei LH, 2003, ONCOGENE, V22, P1517, DOI 10.1038/sj.onc.1206226; Winder T, 2010, GASTROENTEROLOGY, V138, P2163, DOI 10.1053/j.gastro.2010.02.005; Witsch E, 2010, PHYSIOLOGY, V25, P85, DOI 10.1152/physiol.00045.2009; Woolard J, 2009, MICROCIRCULATION, V16, P572, DOI 10.1080/10739680902997333; Zhang WW, 2017, CURR DRUG TARGETS, V18, P1125, DOI 10.2174/1389450117666160502150237	91	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2019	14	8							e0220902	10.1371/journal.pone.0220902	http://dx.doi.org/10.1371/journal.pone.0220902			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5LL	31419243	Green Published, gold, Green Submitted			2022-12-26	WOS:000485019900020
J	Simecka, JW; Fulda, KG; Pulse, M; Lee, JH; Vitucci, J; Nguyen, P; Taylor, P; Filipetto, F; Espinoza, AM; Sharma, S				Simecka, Jerry W.; Fulda, Kimberly G.; Pulse, Mark; Lee, Joon-hak; Vitucci, John; Phung Nguyen; Taylor, Patricia; Filipetto, Frank; Espinoza, Anna M.; Sharma, Sushma			Primary care clinics can be a source of exposure to virulent Clostridium (now Clostridioides) difficile: An environmental screening study of hospitals and clinics in Dallas-Fort Worth region	PLOS ONE			English	Article							BINARY TOXIN; RIBOTYPE 078; INFECTION; STRAIN; EPIDEMIOLOGY; LINEAGE; BURDEN; UPDATE; CDT	C. difficile is an endospore-forming pathogen, which is becoming a common cause of microbial health-care associated gastrointestinal disease in the United States. Both healthy and symptomatic patients can shed C. difficile spores into the environment, which can survive for long periods, being resistant to desiccation, heat, and disinfectants. In healthcare facilities, environmental contamination with C. difficile is a major concern as a potential source of exposure to this pathogen and risk of disease in susceptible patients. Although hospital-acquired infection is recognized, community-acquired infection is an increasingly recognized health problem. Primary care clinics may be a significant source of exposure to this pathogen; however, there are limited data about presence of environmental C. difficile within clinics. To address the potential for primary care clinics as a source of environmental exposure to virulent C. difficile, we measured the frequency of environmental contamination with spores in clinic examination rooms and hospital rooms in Dallas-Fort Worth (DFW) area of Texas. The ribotypes and presence of toxin genes from some environmental isolates were compared. Our results indicate primary care clinics have higher frequencies of contamination than hospitals. After notification of the presence of C. difficile spores in the clinics and an educational discussion to emphasize the importance of this infection and methods of infection prevention, environmental contamination in clinics was reduced on subsequent sampling to that found in hospitals. Thus, primary care clinics can be a source of exposure to virulent C. difficile, and recognition of this possibility can result in improved infection prevention, potentially reducing community-acquired C. difficile infections and subsequent disease.	[Simecka, Jerry W.; Pulse, Mark; Vitucci, John; Phung Nguyen] Univ North Texas, Univ North Texas Syst, Hlth Sci Ctr, Coll Pharm,Dept Pharmaceut Sci, Ft Worth, TX 76107 USA; [Simecka, Jerry W.; Pulse, Mark; Vitucci, John; Phung Nguyen] Univ North Texas, Univ North Texas Syst, Hlth Sci Ctr, Coll Pharm,UNT Preclin Serv, Ft Worth, TX 76107 USA; [Fulda, Kimberly G.; Filipetto, Frank; Espinoza, Anna M.] Univ North Texas, Texas Coll Osteopath Med, Hlth Sci Ctr, Ft Worth, TX 76107 USA; [Fulda, Kimberly G.; Filipetto, Frank; Espinoza, Anna M.] Univ North Texas, Hlth Sci Ctr, North Texas Primary Care Practice Based Res Netwo, Ft Worth, TX USA; [Lee, Joon-hak; Vitucci, John] Univ North Texas, Hlth Sci Ctr, Sch Publ Hlth, Dept Biostat & Epidemiol, Ft Worth, TX USA; [Taylor, Patricia; Sharma, Sushma] Dallas Ft Worth Hosp Council, Educ & Res Fdn, Irving, TX USA	University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton	Simecka, JW (corresponding author), Univ North Texas, Univ North Texas Syst, Hlth Sci Ctr, Coll Pharm,Dept Pharmaceut Sci, Ft Worth, TX 76107 USA.; Simecka, JW (corresponding author), Univ North Texas, Univ North Texas Syst, Hlth Sci Ctr, Coll Pharm,UNT Preclin Serv, Ft Worth, TX 76107 USA.	jerry.simecka@unthsc.edu		Fulda, Kimberly/0000-0002-5096-2983	DFWHC Foundation Hospital Engagement Network; Centers for Medicare and Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services [HHSM-500-2012-0025]; Hospital Engagement Network Contractor for Partnership for Patients Initiative	DFWHC Foundation Hospital Engagement Network; Centers for Medicare and Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services; Hospital Engagement Network Contractor for Partnership for Patients Initiative	This study was funded by DFWHC Foundation Hospital Engagement Network, under contract with the Centers for Medicare and Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services, Contract Number HHSM-500-2012-0025 Hospital Engagement Network Contractor for Partnership for Patients Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsells E, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.010407; Bidet P, 1999, FEMS MICROBIOL LETT, V175, P261, DOI 10.1016/S0378-1097(99)00204-9; Brabazon E, 2014, Ir Med J, V107, P16; Carlson PE, 2013, ANAEROBE, V24, P109, DOI 10.1016/j.anaerobe.2013.04.003; Chandrasekaran R, 2017, FEMS MICROBIOL REV, V41, P723, DOI 10.1093/femsre/fux048; Claro T, 2014, J CLIN MICROBIOL, V52, P3426, DOI 10.1128/JCM.01011-14; Cloud J, 2007, CURR OPIN GASTROEN, V23, P4; Collins J, 2018, NATURE, V553, P291, DOI 10.1038/nature25178; Cowardin CA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.108, 10.1038/nmicrobiol.2016.108]; Dubberke ER, 2007, AM J INFECT CONTROL, V35, P315, DOI 10.1016/j.ajic.2006.12.006; Dubberke ER, 2012, CLIN INFECT DIS, V55, pS88, DOI 10.1093/cid/cis335; Durham DP, 2016, EMERG INFECT DIS, V22, P608, DOI 10.3201/eid2204.150455; Eyre DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078445; Faires MC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-342; Fairley DJ, 2015, J MED MICROBIOL, V64, P1341, DOI 10.1099/jmm.0.000165; Fawley WN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118150; FEKETY R, 1981, AM J MED, V70, P906, DOI 10.1016/0002-9343(81)90553-2; Ghose C, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.62; Goorhuis Abraham, 2008, Infection Control and Hospital Epidemiology, V29, P1162, DOI 10.1086/592257; Goorhuis A, 2008, J CLIN MICROBIOL, V46, P1157, DOI 10.1128/JCM.01536-07; Goorhuis A, 2015, CLIN INFECT DIS, V61, P242, DOI 10.1093/cid/civ258; Gupta A, 2014, INFECT DRUG RESIST, V7, P63, DOI 10.2147/IDR.S46780; Hall AJ, 2012, CLIN INFECT DIS, V55, P216, DOI 10.1093/cid/cis386; Heimann SM, 2018, MED MALADIES INFECT, V48, P23, DOI 10.1016/j.medmal.2017.10.010; Hung YP, 2018, INFECT DRUG RESIST, V11, P1197, DOI 10.2147/IDR.S162874; Hunt JJ, 2013, MICROBIOL MOL BIOL R, V77, P567, DOI 10.1128/MMBR.00017-13; Janezic S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-48; Jury LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070175; Kenters N, 2017, ANTIMICROB RESIST IN, V6, DOI 10.1186/s13756-017-0210-3; Kuehne SA, 2014, J INFECT DIS, V209, P83, DOI 10.1093/infdis/jit426; Kuehne SA, 2011, GUT MICROBES, V2, P252, DOI 10.4161/gmic.2.4.16109; MALAMOULADAS H, 1983, J CLIN PATHOL, V36, P88, DOI 10.1136/jcp.36.1.88; Martin JSH, 2016, NAT REV GASTRO HEPAT, V13, P206, DOI 10.1038/nrgastro.2016.25; McGovern AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187658; Ofori E, 2018, J HOSP INFECT, V99, P436, DOI 10.1016/j.jhin.2018.01.015; Peng Z, 2017, J CLIN MICROBIOL, V55, P1998, DOI 10.1128/JCM.02250-16; Rabold D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193411; Reigadas E, 2016, EPIDEMIOL INFECT, V144, P268, DOI 10.1017/S095026881500148X; Reveles KR, 2018, AM J INFECT CONTROL, V46, P431, DOI 10.1016/j.ajic.2017.09.020; Valiente E, 2014, CLIN MICROBIOL INFEC, V20, P396, DOI 10.1111/1469-0691.12619	40	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220646	10.1371/journal.pone.0220646	http://dx.doi.org/10.1371/journal.pone.0220646			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415582	Green Published, Green Submitted, gold			2022-12-26	WOS:000485017200022
J	Milali, MP; Sikulu-Lord, MT; Kiware, SS; Dowell, FE; Corliss, GF; Povinelli, RJ				Milali, Masabho P.; Sikulu-Lord, Maggy T.; Kiware, Samson S.; Dowell, Floyd E.; Corliss, George F.; Povinelli, Richard J.			Age grading An. gambiae and An. arabiensis using near infrared spectra and artificial neural networks	PLOS ONE			English	Article							MOSQUITOS ANOPHELES-GAMBIAE; PARTIAL LEAST-SQUARES; ABSOLUTE ERROR MAE; CUTICULAR HYDROCARBONS; PRESERVATION METHODS; MALARIA; IDENTIFICATION; MODEL; S.S.; TRANSMISSION	Background Near infrared spectroscopy (NIRS) is currently complementing techniques to age-grade mosquitoes. NIRS classifies lab-reared and semi-field raised mosquitoes into < or >= 7 days old with an average accuracy of 80%, achieved by training a regression model using partial least squares (PLS) and interpreted as a binary classifier. Methods and findings We explore whether using an artificial neural network (ANN) analysis instead of PLS regression improves the current accuracy of NIRS models for age-grading malaria transmitting mosquitoes. We also explore if directly training a binary classifier instead of training a regression model and interpreting it as a binary classifier improves the accuracy. A total of 786 and 870 NIR spectra collected from laboratory reared An. gambiae and An. arabiensis, respectively, were used and pre-processed according to previously published protocols. The ANN regression model scored root mean squared error (RMSE) of 1.6 +/- 0.2 for An. gambiae and 2.8 +/- 0.2 for An. arabiensis; whereas the PLS regression model scored RMSE of 3.7 +/- 0.2 for An. gambiae, and 4.5 +/- 0.1 for An. arabiensis. When we interpreted regression models as binary classifiers, the accuracy of the ANN regression model was 93.7 +/- 1.0% for An. gambiae, and 90.2 +/- 1.7% for An. arabiensis; while PLS regression model scored the accuracy of 83.9 +/- 2.3% for An. gambiae, and 80.3 +/- 2.1% for An. arabiensis. We also find that a directly trained binary classifier yields higher age estimation accuracy than a regression model interpreted as a binary classifier. A directly trained ANN binary classifier scored an accuracy of 99.4 +/- 1.0 for An. gambiae and 99.0 +/- 0.6% for An. arabiensis; while a directly trained PLS binary classifier scored 93.6 +/- 1.2% for An. gambiae and 88.7 +/- 1.1% for An. arabiensis. We further tested the reproducibility of these results on different independent mosquito datasets. ANNs scored higher estimation accuracies than when the same age models are trained using PLS. Regardless of the model architecture, directly trained binary classifiers scored higher accuracies on classifying age of mosquitoes than regression models translated as binary classifiers. Conclusion We recommend training models to estimate age of An. arabiensis and An. gambiae using ANN model architectures (especially for datasets with at least 70 mosquitoes per age group) and direct training of binary classifier instead of training a regression model and interpreting it as a binary classifier.	[Milali, Masabho P.; Kiware, Samson S.] Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, Ifakara, Tanzania; [Milali, Masabho P.; Kiware, Samson S.] Marquette Univ, Dept Math Stat & Comp Sci, Milwaukee, WI 53233 USA; [Sikulu-Lord, Maggy T.] Univ Queensland, Queensland Alliance Agr & Food Innovat, Brisbane, Qld, Australia; [Dowell, Floyd E.] ARS, USDA, Ctr Grain & Anim Hlth Res, Manhattan, KS USA; [Corliss, George F.; Povinelli, Richard J.] Marquette Univ, Dept Elect & Comp Engn, Milwaukee, WI 53233 USA	Ifakara Health Institute; Marquette University; University of Queensland; United States Department of Agriculture (USDA); Marquette University	Milali, MP (corresponding author), Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, Ifakara, Tanzania.; Milali, MP (corresponding author), Marquette Univ, Dept Math Stat & Comp Sci, Milwaukee, WI 53233 USA.	pmasabho@ihi.or.tz		Povinelli, Richard/0000-0001-8439-0146	Grand Challenges Canada Stars for Global Health - government of Canada [043901]; Marquette University Graduate School	Grand Challenges Canada Stars for Global Health - government of Canada; Marquette University Graduate School	This study was funded by Grand Challenges Canada Stars for Global Health funded by the government of Canada grant 043901 awarded to MTSL and Marquette University Graduate School, for studentship awarded to MPM.	Aldrich BT, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.1801; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; ASTM E, 2008, STAND PRACT US TERMS; Ballabio D, 2009, CHEMOMETR INTELL LAB, V98, P115, DOI 10.1016/j.chemolab.2009.05.007; Beier JC, 1998, ANNU REV ENTOMOL, V43, P519, DOI 10.1146/annurev.ento.43.1.519; BHANDARE P, 1993, APPL SPECTROSC, V47, P1214, DOI 10.1366/0003702934067928; Caputo B, 2005, J MASS SPECTROM, V40, P1595, DOI 10.1002/jms.961; Cawley GC, 2010, J MACH LEARN RES, V11, P2079; Chai T, 2014, GEOSCI MODEL DEV, V7, P1247, DOI 10.5194/gmd-7-1247-2014; Cook PE, 2010, INSECT MOL BIOL, V19, P745, DOI 10.1111/j.1365-2583.2010.01034.x; DETINOVA T S, 1962, Monogr Ser World Health Organ, V47, P13; Dowell FE, 1999, J ECON ENTOMOL, V92, P165, DOI 10.1093/jee/92.1.165; Dowell FE, 2011, AM J TROP MED HYG, V85, P1093, DOI 10.4269/ajtmh.2011.11-0438; DYE C, 1992, ANNU REV ENTOMOL, V37, P1, DOI 10.1146/annurev.en.37.010192.000245; Hadjiiski L, 1999, CHEMOMETR INTELL LAB, V49, P91, DOI 10.1016/S0169-7439(99)00030-1; Hugo LE, 2006, AM J TROP MED HYG, V74, P462, DOI 10.4269/ajtmh.2006.74.462; Khotanzad A, 2000, IEEE T NEURAL NETWOR, V11, P464, DOI 10.1109/72.839015; Krajacich BJ, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2501-1; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; Lin MIB, 2012, EUR J APPL PHYSIOL, V112, P1603, DOI 10.1007/s00421-011-2118-6; MAGESA SM, 1991, ACTA TROP, V49, P97, DOI 10.1016/0001-706X(91)90057-Q; Mayagaya VS, 2009, AM J TROP MED HYG, V81, P622, DOI 10.4269/ajtmh.2009.09-0192; Mayagaya VS, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0661-4; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02478259; More J. J., 1978, Proceedings of the Biennial Conference on numerical analysis, P105; Mouazen AM, 2010, GEODERMA, V158, P23, DOI 10.1016/j.geoderma.2010.03.001; Ntamatungiro AJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-298; Perez-Mendoza J, 2004, J ECON ENTOMOL, V97, P1159, DOI 10.1603/0022-0493(2004)097[1159:CAOTSO]2.0.CO;2; Perez-Mendoza J, 2002, J MED ENTOMOL, V39, P499, DOI 10.1603/0022-2585-39.3.499; Reeves WK, 2010, MED VET ENTOMOL, V24, P32, DOI 10.1111/j.1365-2915.2009.00843.x; ROBERT V, 1991, B WORLD HEALTH ORGAN, V69, P735; Rosenblatt F., 1961, PRINCIPLES NEURODYNA; Sikulu M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-186; Sikulu M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-49; Sikulu MT, 2015, DATA BRIEF, V4, P461, DOI 10.1016/j.dib.2015.07.007; Sikulu MT, 2015, J PROTEOMICS, V126, P234, DOI 10.1016/j.jprot.2015.06.008; Sikulu MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090657; Sikulu-Lord MT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27998-7; Sikulu-Lord MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005040; Sikulu-Lord MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004759; Simon R, 2007, FUNDAMENTALS DATA MI, P173; Smith CJ, 2012, PHLEBOLOGY, V27, P250, DOI 10.1258/phleb.2012.012J05; STAHLE L, 1987, Journal of Chemometrics, V1, P185, DOI 10.1002/cem.1180010306; Wang MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013359; WHO, 2017, WORLD MALARIA REPORT; Willmott CJ, 2005, CLIMATE RES, V30, P79, DOI 10.3354/cr030079; Xu QS, 2004, J CHEMOMETR, V18, P112, DOI 10.1002/cem.858; Xu QS, 2001, CHEMOMETR INTELL LAB, V56, P1, DOI 10.1016/S0169-7439(00)00122-2; Zheng H, 2011, J AGR FOOD CHEM, V59, P592, DOI 10.1021/jf1032476	50	16	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0209451	10.1371/journal.pone.0209451	http://dx.doi.org/10.1371/journal.pone.0209451			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412028	Green Published, gold, Green Submitted			2022-12-26	WOS:000485012600001
J	Boutte, AM; Thangavelu, B; LaValle, CR; Nemes, J; Gilsdorf, J; Shear, DA; Kamimori, GH				Boutte, Angela M.; Thangavelu, Bharani; LaValle, Christina R.; Nemes, Jeffrey; Gilsdorf, Janice; Shear, Deborah A.; Kamimori, Gary H.			Brain-related proteins as serum biomarkers of acute, subconcussive blast overpressure exposure: A cohort study of military personnel	PLOS ONE			English	Article							AUTOMATED NEUROBEHAVIORAL ASSESSMENT; NEUROFILAMENT LIGHT; SERVICE MEMBERS; INJURY; PLASMA; DUTY; TAU; PERFORMANCE; CONCUSSION; SYMPTOMS	Repeated exposure to blast overpressure remains a major cause of adverse health for military personnel who, as a consequence, are at a higher risk for neurodegenerative disease and suicide. Acute, early tracking of blast related effects holds the promise of rapid health assessment prior to onset of chronic problems. Current techniques used to determine blast-related effects rely upon reporting of symptomology similar to that of concussion and neurocognitive assessment relevant to operational decrement. Here, we describe the results of a cross sectional study with pared observations. The concentration of multiple TBI-related proteins was tested in serum collected within one hour of blast exposure as a quantitative and minimally invasive strategy to augment assessment of blast-exposure effects that are associated with concussion-like symptomology and reaction time decrements. We determined that median simple reaction time (SRT) was slowed in accordance with serum Nf-L, tau, A beta-40, and A beta-42 elevation after overpressure exposure. In contrast, median levels of serum GFAP decreased. Individual, inter-subject analysis revealed positive correlations between changes in Nf-L and GFAP, and in A beta-40 compared to A beta-42. The change in Nf-L was negatively associated with tau, A beta-40, and A beta-42. Participants reported experiencing headaches, dizziness and taking longer to think. Dizziness was associated with reaction time decrements, GFAP or NfL suppression, as well as A beta peptide elevation. UCH-L1 elevation had a weak association with mTBI/concussion history. Multiplexed serum biomarker quantitation, coupled with reaction time assessment and symptomology determined before and after blast exposure, may serve as a platform for tracking adverse effects in the absence of a head wound or diagnosed concussion. We propose further evaluation of serum biomarkers, which are often associated with TBI, in the context of acute operational blast exposures.	[Boutte, Angela M.; Thangavelu, Bharani; Gilsdorf, Janice; Shear, Deborah A.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect Branch, Silver Spring, MD 20910 USA; [LaValle, Christina R.; Nemes, Jeffrey; Kamimori, Gary H.] Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Boutte, AM (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect Branch, Silver Spring, MD 20910 USA.	angela.m.boutte.civ@mail.mil		Boutte, Angela/0000-0003-3542-8122	Combat Casualty Care Research Program, the U.S. Army Medical Research and Materiel Command Military Operational Medicine Research Program (Research Area Directorate 3); Office of the Assistant Secretary of Defense for Health Affairs, Broad Agency Announcement Award [W81XWH-16-2-0001]	Combat Casualty Care Research Program, the U.S. Army Medical Research and Materiel Command Military Operational Medicine Research Program (Research Area Directorate 3); Office of the Assistant Secretary of Defense for Health Affairs, Broad Agency Announcement Award	This work was supported by the Combat Casualty Care Research Program, the U.S. Army Medical Research and Materiel Command Military Operational Medicine Research Program (Research Area Directorate 3), and Office of the Assistant Secretary of Defense for Health Affairs, Broad Agency Announcement Award No. W81XWH-16-2-0001. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; Bazarian JJ, 2018, LANCET NEUROL; Boutte AM, 2016, J NEUROTRAUM, V33, P147, DOI 10.1089/neu.2014.3672; Britt TW, 2000, J APPL SOC PSYCHOL, V30, P1599, DOI 10.1111/j.1559-1816.2000.tb02457.x; Bu XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13917; Cao R, 2019, JOURNAL OF NEUROTRAU; Carr W, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00049; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Chen M, 2018, J ALZHEIMERS DIS, V66, P751, DOI 10.3233/JAD-180726; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Di Battista AP, 2016, PLOS ONE, V11; Dobrowolska JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089998; Fear NT, 2012, J EPIDEMIOL COMMUN H, V66, pA35, DOI 10.1136/jech-2012-201753.091; Gaiottino J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075091; Gill J, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000186; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Hanas JS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215762; Haran FJ, 2016, APPL NEUROPSYCH-ADUL, V23, P411, DOI 10.1080/23279095.2016.1166111; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Huang YF, 2012, ARCH NEUROL-CHICAGO, V69, P1591, DOI 10.1001/archneurol.2012.18107; Kamimori GH, 2017, SHOCK WAVES, V27, P837, DOI 10.1007/s00193-017-0738-4; Kenney Kimbra, 2018, Brain Inj, V32, P1276, DOI 10.1080/02699052.2018.1483530; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kovacs GG, 2017, EUR J NEUROL, V24, P1326, DOI 10.1111/ene.13389; Lathan C, 2013, MIL MED, V178, P365, DOI 10.7205/MILMED-D-12-00438; Lejbman N, 2016, BRAIN INJURY, V30, P1436, DOI 10.1080/02699052.2016.1219054; Lewis LM, 2017, ACAD EMERG MED, V24, P710, DOI 10.1111/acem.13174; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; Mishra V, 2016, SCI REPORTS, V6; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Nakamura A, 2018, NATURE, V554, P249, DOI 10.1038/nature25456; Ono K, 2018, NEUROCHEM INT, V119, P57, DOI 10.1016/j.neuint.2017.08.010; Posti JP, 2017, J NEUROTRAUM, V34, P1427, DOI 10.1089/neu.2016.4442; Posti JP, 2016, NEUROSURGERY, V79, P456, DOI 10.1227/NEU.0000000000001226; Puig KL, 2013, EXP GERONTOL, V48, P608, DOI 10.1016/j.exger.2012.07.009; Puvenna V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096296; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Roher AE, 2009, ALZHEIMERS DEMENT, V5, P18, DOI 10.1016/j.jalz.2008.10.004; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Song HL, 2019, J NEUROTRAUM, V36, P1591, DOI 10.1089/neu.2018.6114; Song HL, 2018, BEHAV BRAIN RES, V347, P148, DOI 10.1016/j.bbr.2018.03.007; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Tate CM, 2013, J NEUROTRAUMA; Weinberger S, 2011, NATURE, V477, P390, DOI 10.1038/477390a; Wirsching A, 2018, J NEUROTRAUMA; Yang ZH, 2018, MOL NEUROBIOL, V55, P2174, DOI 10.1007/s12035-017-0424-7; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zetterberg H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028263; Zhang LY, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00088	55	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0221036	10.1371/journal.pone.0221036	http://dx.doi.org/10.1371/journal.pone.0221036			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5HO	31408492	Green Submitted, Green Published, gold			2022-12-26	WOS:000485009500034
J	Cardona-Arias, JA; Velez-Quintero, C; Calle-Gonzalez, OV; Florez-Duque, J; Zapata, JC				Cardona-Arias, Jaiberth Antonio; Velez-Quintero, Carolina; Calle-Gonzalez, Olga Victoria; Florez-Duque, Jennifer; Zapata, Juan Carlos			Seroprevalence of human T-lymphotropic virus HTLV and its associated factors in donors of a blood bank of Medellin-Colombia, 2014-2018	PLOS ONE			English	Article							CURRENT PREVALENCE; INFECTION; RISK	Background Research on HTLV in Colombia is limited; despite being an endemic country there are few studies on the magnitude of this infection. The aim of this study was to determine the seroprevalence of HTLV I/II and its associated factors in donors to a blood bank of Medellin Colombia, 2014-2018. Methods This is a cross-sectional study of 52,159 donors with a secondary information source. Seroprevalence of HTLV I/II was determined with its confidence interval and the population characteristics were described by frequency and summary measures. To explore the associated factors, Pearson's Chi square test, Mann-Whitney U test, crude odds ratios were used and they were adjusted by logistic regression in SPSS 25.0. Results 88% of the population lived in the metropolitan area, 68.5% belonged to the University. 76.2% were altruistic donors (unpaid donors who did not donate to a specific patient). 24.5% were repetitive (paid) donors. 75% of the donors were under 41 years old. The seroprevalence of HTLV I/II was 0.176% (95% CI = 0.139% -0.213%), being statistically lower in repetitive donors and men. Conclusion The seroprevalence of HTLV I/II infection in the studied blood bank is lower than that reported in other blood banks at the departmental and national levels. In Medellin, it was associated with the frequency of donation and gender, which is useful information for the hemovigilance programs of the city.	[Cardona-Arias, Jaiberth Antonio] Univ Antioquia, Fac Med, Sch Microbiol, Medellin, Colombia; [Cardona-Arias, Jaiberth Antonio] Univ Cooperat Colombia, Bogota, Colombia; [Velez-Quintero, Carolina; Calle-Gonzalez, Olga Victoria] Univ Antioquia, Sch Microbiol, Medellin, Colombia; [Florez-Duque, Jennifer] Univ Antioquia, Sch Microbiol, Blood Bank, Medellin, Colombia; [Zapata, Juan Carlos] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA	Universidad de Antioquia; Universidad Cooperativa de Colombia; Universidad de Antioquia; Universidad de Antioquia; University System of Maryland; University of Maryland Baltimore	Zapata, JC (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.	jczapata@ihv.umaryland.edu	Zapata, Juan/L-5095-2019; Cardona, Jaiberth/GZL-3892-2022	Zapata, Juan/0000-0003-1931-6147; Cardona Arias, Jaiberth/0000-0002-7101-929X	University of Antioquia; Cooperative University of Colombia; Institute of Human Virology (IHV), University of Maryland School of Medicine	University of Antioquia; Cooperative University of Colombia; Institute of Human Virology (IHV), University of Maryland School of Medicine	This research relies upon salary support for the authors. JAC-A was supported by University of Antioquia and Cooperative University of Colombia. CV-Q, OVC-G, and JF-D were supported, as students, by the University of Antioquia. JCZ salary was supported by the Institute of Human Virology (IHV), University of Maryland School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcón Villaverde Jorge, 2011, Rev. perú. med. exp. salud publica, V28, P101, DOI 10.1590/s1726-46342011000100016; Alessio Loredana, 2018, PLoS Negl Trop Dis, V12, pe0006601, DOI 10.1371/journal.pntd.0006601; Bermudez M, 2017, INFORM ANUAL RED NAC; Biglione MM, 2013, ASEI, V21, P84; Bonfante M, 2017, FACTORES ASOCIADOS S; Brun RO, 2004, MEDICINA-BUENOS AIRE, V64, P125; Carrascal E., 2004, Colombia Medica, V35, P12; Catalan-Soares BC., 2001, REV BRAS EPIDEMIOL, V4, P81, DOI [10.1590/S1415-790X2001000200003, DOI 10.1590/S1415-790X2001000200003]; Cortes A, 1999, COLUMBIA MED, V30, P19; Cortes A, 1999, COLOMB MEDICA, V30, P13; Cruz Bermúdez Harold, 2014, Salud, Barranquilla, V30, P95; Cruz Bermúdez Harold Fabián, 2013, Revista médica Risaralda, V19, P10; Davison KL, 2009, TRANSFUSION MED, V19, P24, DOI 10.1111/j.1365-3148.2008.00902.x; Daza Bolaño Nelson, 2016, Medicas UIS, V29, P55, DOI 10.18273/revmed.v29n3-2016006; Demontis MA, 2015, J MED VIROL, V87, P2130, DOI 10.1002/jmv.24264; Djuicy DD, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006832; Dodd RY, 2002, TRANSFUSION, V42, P975, DOI 10.1046/j.1537-2995.2002.00174.x; Espejo J., 2014, SEROPREVALENCIA MARC; Garcia Z, 2006, REV COSTARRIC CIENC, V27, P11; Gessain A, 2011, Bull Soc Pathol Exot, V104, P167, DOI 10.1007/s13149-011-0174-4; Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388; Gotuzzo E, 2004, INFECT ETIOLOGY CHRO, DOI [10.17226/11026, DOI 10.17226/11026]; Gotuzzo E, 2010, ACTA MED PERU, V27, P96; Gotuzzo H Eduardo, 2004, Rev. perú. med. exp. salud publica, V21, P253; Hlela C, 2009, AIDS REV, V11, P205; IARC Working group on the evaluation of carcinogenic risks to humans, 2012, IARC MONOGR EVAL CAR, V100; Instituto Nacional de Salud, 2014, INF NAC IND RED NAC, P1; Instituto Nacional de Salud Republica de Colombia, 0082 I NAC SAL; Bermudez-Forero MI, 2016, BIOMEDICA, V36, P194, DOI 10.7705/biomedica.v36i0.2943; Lubian A, 1998, REV CUBANA MED, V37, P199; Macia C, 2016, BIOMEDICA, V36, P108, DOI [10.7705/biomedica.v36i0.2942, 10.7705/biomedica.v3610.2942]; Mantilla C, 2012, MED LAB, V18, P459; Martin F, 2018, LANCET, V391, P1893, DOI 10.1016/S0140-6736(18)30974-7; Martínez-Nieto Oscar, 2007, Rev. salud pública, V9, P253, DOI 10.1590/S0124-00642007000200009; Mueller N, 1996, J ACQ IMMUN DEF SYND, V13, pS2, DOI 10.1097/00042560-199600001-00002; Munoz M, 2018, BIOMEDICA, V38, P37, DOI 10.7705/biomedica.v38i0.3417; Murphy EL, 1999, J INFECT DIS, V180, P1777, DOI 10.1086/315139; Patel P, 2014, AIDS, V28, P1509, DOI 10.1097/QAD.0000000000000298; Bedoya JAP, 2012, REV SAUDE PUBL, V46, P950, DOI 10.1590/S0034-89102012000600004; Polizzotto MN, 2008, TRANSFUSION, V48, P55, DOI 10.1111/j.1537-2995.2007.01482.x; Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968; Real Delor Raúl, 2016, Rev. Méd. La Paz, V22, P5; Satake M, 2012, J MED VIROL, V84, P327, DOI 10.1002/jmv.23181; Tagaya Y, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01425; Vasquez TP, 2003, REV CHIL INFECTOL, V20, P34; Willems L, 2017, ANTIVIR RES, V137, P41, DOI 10.1016/j.antiviral.2016.10.015	46	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0221060	10.1371/journal.pone.0221060	http://dx.doi.org/10.1371/journal.pone.0221060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404110	gold, Green Published, Green Submitted			2022-12-26	WOS:000485006800051
J	Modchalingam, S; Vachon, CM; 't Hart, BM; Henriques, DYP				Modchalingam, Shanaathanan; Vachon, Chad Michael; 't Hart, Bernard Marius; Henriques, Denise Y. P.			The effects of awareness of the perturbation during motor adaptation on hand localization	PLOS ONE			English	Article							VISUOMOTOR ADAPTATION; PROPRIOCEPTIVE RECALIBRATION; SENSORY PREDICTION; EXPLICIT STRATEGY; REACH ADAPTATION; CEREBELLUM; IMPLICIT; ERROR; CONSEQUENCES; MOVEMENT	Awareness of task demands is often used during rehabilitation and sports training by providing instructions which appears to accelerate learning and improve performance through explicit motor learning. However, the effects of awareness of perturbations on the changes in estimates of hand position resulting from motor learning are not well understood. In this study, people adapted their reaches to a visuomotor rotation while either receiving instructions on the nature of the perturbation, experiencing a large rotation, or both to generate awareness of the perturbation and increase the contribution of explicit learning. We found that instructions and/or larger rotations allowed people to activate or deactivate part of the learned strategy at will and elicited explicit changes in open-loop reaches, while a small rotation without instructions did not. However, these differences in awareness, and even manipulations of awareness and perturbation size, did not appear to affect learning-induced changes in hand-localization estimates. This was true when estimates of the adapted hand location reflected changes in proprioception, produced when the hand was displaced by a robot, and also when hand location estimates were based on efferent-based predictions of self-generated hand movements. In other words, visuomotor adaptation led to significant shifts in predicted and perceived hand location that were not modulated by either instruction or perturbation size. Our results indicate that not all outcomes of motor learning benefit from an explicit awareness of the task. Particularly, proprioceptive recalibration and the updating of predicted sensory consequences appear to be largely implicit.	[Modchalingam, Shanaathanan; Vachon, Chad Michael; 't Hart, Bernard Marius; Henriques, Denise Y. P.] York Univ, Ctr Vis Res, Toronto, ON, Canada; [Modchalingam, Shanaathanan; Henriques, Denise Y. P.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada; [Vachon, Chad Michael] York Univ, Dept Psychol, Toronto, ON, Canada	York University - Canada; York University - Canada; York University - Canada	Modchalingam, S (corresponding author), York Univ, Ctr Vis Res, Toronto, ON, Canada.; Modchalingam, S (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada.	s.modcha@gmail.com	't Hart, Bernard/AHD-9519-2022	't Hart, Bernard/0000-0002-0045-3769; Modchalingam, Shanaathanan/0000-0002-8274-6724	Natural Science and Engineering Research Council of Canada; Deutsche Forschungsgemeinschaft [HA 6861/2-1]	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Natural Science and Engineering Research Council of Canada Discovery Grant to DYPH and BM'tH was partially funded by the Deutsche Forschungsgemeinschaft: HA 6861/2-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastian AJ, 2008, CURR OPIN NEUROL, V21, P628, DOI 10.1097/WCO.0b013e328315a293; Benson BL, 2011, J NEUROPHYSIOL, V105, P2843, DOI 10.1152/jn.00002.2011; Berniker M, 2008, NAT NEUROSCI, V11, P1454, DOI 10.1038/nn.2229; Block HJ, 2012, NEUROPSYCHOLOGIA, V50, P1766, DOI 10.1016/j.neuropsychologia.2012.03.034; Bond KM, 2015, J NEUROPHYSIOL, V113, P3836, DOI 10.1152/jn.00009.2015; Butcher PA, 2017, J NEUROPHYSIOL, V118, P1622, DOI 10.1152/jn.00451.2017; Cameron BD, 2012, CONSCIOUS COGN, V21, P4, DOI 10.1016/j.concog.2010.11.006; Cressman EK, 2015, J NEUROPHYSIOL, V114, P354, DOI 10.1152/jn.00415.2014; Cressman EK, 2010, EXP BRAIN RES, V205, P533, DOI 10.1007/s00221-010-2392-2; Cressman EK, 2009, J NEUROPHYSIOL, V102, P3505, DOI 10.1152/jn.00514.2009; ERIKSEN CW, 1960, PSYCHOL REV, V67, P279, DOI 10.1037/h0041622; Haith AM, 2016, J NEUROSCI, V36, P3007, DOI 10.1523/JNEUROSCI.3245-15.2016; Hegele M, 2013, PSYCHOL AGING, V28, P333, DOI 10.1037/a0031914; Hegele M, 2010, CONSCIOUS COGN, V19, P906, DOI 10.1016/j.concog.2010.05.005; Henriques DYP, 2014, NEUROPSYCHOLOGIA, V64, P195, DOI 10.1016/j.neuropsychologia.2014.09.029; Henriques DYP, 2012, J MOTOR BEHAV, V44, P435, DOI 10.1080/00222895.2012.659232; Heuer H, 2008, PSYCHOL AGING, V23, P190, DOI 10.1037/0882-7974.23.1.190; Heuer H, 2011, EXP BRAIN RES, V211, P97, DOI 10.1007/s00221-011-2656-5; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Izawa J, 2012, J NEUROSCI, V32, P4230, DOI 10.1523/JNEUROSCI.6353-11.2012; Kong GQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13889-w; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; McDougle SD, 2016, TRENDS COGN SCI, V20, P535, DOI 10.1016/j.tics.2016.05.002; McDougle SD, 2015, J NEUROSCI, V35, P9568, DOI 10.1523/JNEUROSCI.5061-14.2015; Mckinney W., 2010, P PYTH SCI C, P51, DOI DOI 10.25080/MAJORA-92BF1922-00A; Modchalingam S, 2018, OPEN SCI FRAMEWORK, DOI [10.17605/OSF.IO/MX5U2, DOI 10.17605/OSF.IO/MX5U2]; Neville KM, 2018, EXP BRAIN RES, V236, P2047, DOI 10.1007/s00221-018-5282-7; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Ostry DJ, 2010, J NEUROSCI, V30, P5384, DOI 10.1523/JNEUROSCI.4571-09.2010; R Core Team, 2018, R LANG ENV STAT COMP; Redding GM, 2000, J MOTOR BEHAV, V32, P83, DOI 10.1080/00222890009601362; Ruttle JE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163695; Salomonczyk D, 2013, EXP BRAIN RES, V228, P313, DOI 10.1007/s00221-013-3564-7; Salomonczyk D, 2011, NEUROPSYCHOLOGIA, V49, P3053, DOI 10.1016/j.neuropsychologia.2011.07.006; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; SHANKS DR, 1994, BEHAV BRAIN SCI, V17, P367, DOI 10.1017/S0140525X00035032; Synofzik M, 2008, CURR BIOL, V18, P814, DOI 10.1016/j.cub.2008.04.071; 't Hart BM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163556; Taylor JA, 2014, J NEUROSCI, V34, P3023, DOI 10.1523/JNEUROSCI.3619-13.2014; Thomas M, 2012, EXP BRAIN RES, V221, P85, DOI 10.1007/s00221-012-3150-4; Tseng YW, 2007, J NEUROPHYSIOL, V98, P54, DOI 10.1152/jn.00266.2007; Van Rossum G., 1995, PYTHON TUTORIAL, V620; Werner S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123321; Wilke C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054925	46	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220884	10.1371/journal.pone.0220884	http://dx.doi.org/10.1371/journal.pone.0220884			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5FL	31398227	Green Published, Green Submitted, gold			2022-12-26	WOS:000485004000025
J	Arnold, RJ; Ochoa, A; Kerth, CR; Miller, RK; Murray, SC				Arnold, Robert J.; Ochoa, Alejandra; Kerth, Chris R.; Miller, Rhonda K.; Murray, Seth C.			Assessing the impact of corn variety and Texas terroir on flavor and alcohol yield in new-make bourbon whiskey	PLOS ONE			English	Article							KEY AROMA COMPOUNDS; WHEAT-VARIETIES; SPIRIT YIELD; MAIZE; BARLEY; GRAIN; VARIABILITY; SELECTION; BRANDIES; RELEASE	The whiskey industry is dominated by whiskey styles with recipes that contain corn as the primary grain. However, little research has been conducted to investigate whiskey specific distinctions arising from different corn varieties and growing environments (i. e. terroir). Further, no studies have investigated the aroma or flavor impacts of different varieties and terroirs. Here, three different commodity yellow dent hybrid corn varieties were grown on different farms in Texas, spanning from the Texas Panhandle to the Mexico-United States border. Using novel small-batch mashing techniques, a newly developed new-make (i. e. unaged whiskey, immediate by-product of distillation) bourbon sensory lexicon, a trained sensory panel, high-performance liquid chromatography, and gas chromatography-mass spectrometry/olfactometry (GC-MS/O), we report for the first time a method for evaluating sample effects on alcohol yield and flavor in new-make bourbon whiskey. We discover that variety, terroir and their interactions, previously ignored, can substantially affect valuable sensory aspects of whiskey, suggesting the importance of scientifically evaluating corn genetics and agronomy for developing better whiskey. Excitingly, our data suggest milled corn with higher levels of benzadehyde, readily measured by GC-MS/O, correlates with improved sensory aspects of distillate, which must be expensively evaluated using a trained human sensory panel.	[Arnold, Robert J.; Murray, Seth C.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Arnold, Robert J.; Ochoa, Alejandra] Firestone & Robertson Distilling Co, Ft Worth, TX 76119 USA; [Ochoa, Alejandra; Kerth, Chris R.; Miller, Rhonda K.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Arnold, RJ (corresponding author), Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA.; Arnold, RJ (corresponding author), Firestone & Robertson Distilling Co, Ft Worth, TX 76119 USA.	robsoc7@tamu.edu	Ochoa, Alejandra/GWC-2509-2022	Kerth, Chris/0000-0002-9183-7919; Murray, Seth/0000-0002-2960-8226	Firestone & Robertson Distilling Co.	Firestone & Robertson Distilling Co.	This research was directly funded by the Firestone & Robertson Distilling Co. Resources leveraged in this study were made possible by USDA-NIFA, the Texas Corn Producers Board, and Texas A& M AgriLife support. Thanks to Dennis Pietsch, Katrina Horn and the TAMU Crop Testing Program for corn samples; thanks to David Rooney for FT-NIRS support. Thank you to the Scotch Whisky Research Institute for guidance on the lab-scale whiskey production methods. Thank you to Kayley Wall for guidance with MS statistical analysis.	Adhikari K, 2011, J SENS STUD, V26, P413, DOI 10.1111/j.1745-459X.2011.00356.x; Agu RC, 2006, J I BREWING, V112, P314, DOI 10.1002/j.2050-0416.2006.tb00737.x; Agu RC, 2008, J I BREWING, V114, P39, DOI 10.1002/j.2050-0416.2008.tb00304.x; Balcerek M, 2016, MOLECULES, V21, DOI 10.3390/molecules21101320; Basso L.C., 2011, BIOFUEL PRODUCTION R; Belsito A., 2004, THESIS; Bettenhausen HM, 2018, FOOD RES INT, V113, P487, DOI 10.1016/j.foodres.2018.07.024; Boothroyd E, 2014, J I BREWING, V120, P16, DOI 10.1002/jib.103; Bringhurst TA, 2015, J I BREWING, V121, P1, DOI 10.1002/jib.192; Bringhurst TA, 2008, PRODUCTION TECHNOLOG, P51; Brosnan J.M., 1999, P 5 AV C MALT BREW D, P225; Brouwer BO, 2016, AGRON J, V108, P939, DOI 10.2134/agronj2015.0385; Brouwer BO, 2016, RENEW AGR FOOD SYST, V31, P172, DOI 10.1017/S1742170515000198; Burdock G. A, 2010, FENAROLIS HDB FLAVOR, V6th, DOI DOI 10.1201/9781439847503; BUTTERY RG, 1994, J AGR FOOD CHEM, V42, P791, DOI 10.1021/jf00039a038; Buttery RG, 1997, J AGR FOOD CHEM, V45, P837, DOI 10.1021/jf9604807; Conner J., 2001, ACS SYM SER, V782, P113, DOI DOI 10.1021/BK-2001-0782.CH010; Conner JM, 1999, J SCI FOOD AGR, V79, P1015, DOI 10.1002/(SICI)1097-0010(19990515)79:7<1015::AID-JSFA321>3.3.CO;2-I; Dawson J. C., 2018, Plant Breeding Reviews, V41, P215; DOEBLEY J, 1988, ECON BOT, V42, P120, DOI 10.1007/BF02859042; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Ferrari G, 2004, J AGR FOOD CHEM, V52, P5670, DOI 10.1021/jf049512d; Franitza L, 2016, J AGR FOOD CHEM, V64, P637, DOI 10.1021/acs.jafc.5b05426; Goodman M. M., 1988, Corn and corn improvement. Third edition., P33; Green DIG, 2015, J I BREWING, V121, P332, DOI 10.1002/jib.236; Halloran A., 2015, NEW BREAD BASKET NEW; Harrison B, 2011, J I BREWING, V117, P106, DOI 10.1002/j.2050-0416.2011.tb00450.x; Haze S., 2001, J INVESTIGATIVE DERM, V116; Hazelwood LA, 2008, APPL ENVIRON MICROB, V74, P2259, DOI 10.1128/AEM.02625-07; Herb D, 2017, J AM SOC BREW CHEM, V75, P345, DOI 10.1094/ASBCJ-2017-4860-01; Herb D, 2017, J AM SOC BREW CHEM, V75, P354, DOI 10.1094/ASBCJ-2017-4976-01; Herb DW, 2017, THESIS; Jack F, 2003, J I BREWING, V109, P114, DOI 10.1002/j.2050-0416.2003.tb00139.x; Jacques K. A., 2003, ALCOHOL TXB REFERENC; Jaradat AA, 2013, CROP SCI, V53, P956, DOI 10.2135/cropsci2012.07.0437; Kindred DR, 2008, J CEREAL SCI, V48, P46, DOI 10.1016/j.jcs.2007.07.010; Kurtz B, 2016, CROP SCI, V56, P931, DOI 10.2135/cropsci2015.07.0439; Lee KYM, 2000, J I BREWING, V106, P287, DOI 10.1002/j.2050-0416.2000.tb00068.x; Lee KYM, 2000, J I BREWING, V106, P203, DOI 10.1002/j.2050-0416.2000.tb00058.x; Li Q, 2016, MICROB ECOL, V71, P409, DOI 10.1007/s00248-015-0673-9; LONG A, 1989, RADIOCARBON, V31, P1035; Malfondet N, 2016, FLAVOUR FRAG J, V31, P361, DOI 10.1002/ffj.3325; Martin GE, 1974, J ASS OFF ANAL CHEM; Mason SC, 2012, INPROCEEDINGS 47TH C, V24, P31; Mc Donnell E, 2001, J SENS STUD, V16, P425, DOI 10.1111/j.1745-459X.2001.tb00311.x; Meng QC, 2015, CROP SCI, V55, P2234, DOI 10.2135/cropsci2014.11.0767; Nykanen L, 1963, TEKNILLISEN KEMIAN A, V20, P789; PIGGOTT JR, 1979, J I BREWING, V85, P82, DOI 10.1002/j.2050-0416.1979.tb06830.x; Poisson L, 2008, J AGR FOOD CHEM, V56, P5820, DOI 10.1021/jf800383v; Poisson L, 2008, J AGR FOOD CHEM, V56, P5813, DOI 10.1021/jf800382m; Schnell R., 2016, CORN PERFORMANCE TES; Shiferaw B, 2011, FOOD SECUR, V3, P475, DOI 10.1007/s12571-011-0153-0; Singh AK, 2011, CROP SCI, V51, P75, DOI 10.2135/cropsci2010.06.0378; Swanston JS, 2007, J SCI FOOD AGR, V87, P676, DOI 10.1002/jsfa.2767; Swanston JS, 2014, J SCI FOOD AGR, V94, P3234, DOI 10.1002/jsfa.6675; Swanston JS, 2005, J CEREAL SCI, V42, P127, DOI 10.1016/j.jcs.2005.02.001; Swanston JS, 2000, J I BREWING, V106, P53, DOI 10.1002/j.2050-0416.2000.tb00040.x; Swanston JS, 1999, MOL BREEDING, V5, P103, DOI 10.1023/A:1009606705925; Sylvester-Bradley R., 2010, 468 HGCA; Teixeira JEC, 2015, HEREDITY, V114, P229, DOI 10.1038/hdy.2014.90; Thomas Y., 2002, COFFEE FLAVOR CHEM; Troyer AF, 1999, CROP SCI, V39, P601, DOI 10.2135/cropsci1999.0011183X003900020001x; Vanbeneden N, 2007, J AGR FOOD CHEM, V55, P11002, DOI 10.1021/jf072340a; Willner B, 2013, J AGR FOOD CHEM, V61, P9583, DOI 10.1021/jf403024t; World Coffee Research, 2016, WORLD COFF RES SENS; Zoeller KM, 2008, THESIS, DOI [10.18297/etd/1652, DOI 10.18297/ETD/1652]	66	6	6	6	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220787	10.1371/journal.pone.0220787	http://dx.doi.org/10.1371/journal.pone.0220787			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393929	Green Published, Green Submitted, gold			2022-12-26	WOS:000485002500062
J	Beck, S; Borutta, B; Walter, U; Dreier, M				Beck, Simone; Borutta, Birgit; Walter, Ulla; Dreier, Maren			Systematic evaluation of written health information on PSA based screening in Germany	PLOS ONE			English	Article							PROSTATE-CANCER MORTALITY; PATIENT DECISION AID; QUALITY; MEN; COMPLICATIONS; OVERDETECTION; INSTRUMENT; KNOWLEDGE; BENEFITS; SUPPORT	Background Prostate-specific antigen (PSA) based screening for early detection of prostate cancer is common although it is associated with both benefits and potential harms (e.g., the risk of overdiagnosis). Evidence-based health information could help individuals make informed decisions about whether to undergo PSA testing or not. This evaluation aimed to determine whether the written health information materials available in Germany provide appropriate information for informed decision-making on PSA based screening. Methods A list of criteria was developed and used to systematically assess the quality of information on the benefits and harms of prostate cancer screening included in written health information materials. Fourteen information materials identified by information requests and online searches were evaluated independently by two of three reviewers. Consensus was achieved with a third reviewer. Results Of the 14 information materials evaluated, 10 (71%) list the ability to reduce the absolute risk of death from prostate cancer as a benefit of PSA testing, 9 (64%) point out the risks of follow-up diagnostics, 13 (93%) describe the risks of the available prostate cancer treatments, and all 14 specify the risk of overdiagnosis. The minority provide numerical data on benefits and risks. Partially mismatched framing was identified in four cases: two information materials report only the relative frequencies of benefits, and two report only the absolute frequencies of harms. Half of the materials encouraged participation using downplaying or frightening language. Conclusions The majority of health information materials in Germany describe the benefits and harms of PSA based screening, including overdiagnosis, but often lack adequate balance, neutrality and numbers.	[Beck, Simone; Borutta, Birgit; Walter, Ulla; Dreier, Maren] Hannover Med Sch, Inst Epidemiol Social Med & Hlth Syst Res, Hannover, Germany	Hannover Medical School	Dreier, M (corresponding author), Hannover Med Sch, Inst Epidemiol Social Med & Hlth Syst Res, Hannover, Germany.	Dreier.maren@mh-hannover.de		Dreier, Maren/0000-0003-2861-0284	German Research Foundation (DFG); Hannover Medical School (MHH)	German Research Foundation (DFG)(German Research Foundation (DFG)); Hannover Medical School (MHH)	We acknowledge support by the German Research Foundation (DFG) and the Open Access Publication Fund of Hannover Medical School (MHH).	Akl EA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006466; Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Bunge M, 2010, PATIENT EDUC COUNS, V78, P316, DOI 10.1016/j.pec.2009.10.029; Carter SM, 2016, CANCER FORUM, V40, P105; Chan Evelyn C Y, 2011, Patient Educ Couns, V84, pe44, DOI 10.1016/j.pec.2010.07.033; Charnock D, 1999, J EPIDEMIOL COMMUN H, V53, P105, DOI 10.1136/jech.53.2.105; Chou R, 2011, ANN INTERN MED, V155, P762, DOI 10.7326/0003-4819-155-11-201112060-00375; Costanza ME, 2011, PATIENT EDUC COUNS, V82, P193, DOI 10.1016/j.pec.2010.05.011; Deutsches Netzwerk Evidenzbasierte Medizin e. V, 2016, GUT PRAX GES VERS 2; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; Dreier M, 2014, BUNDESGESUNDHEITSBLA, V57, P356, DOI 10.1007/s00103-013-1906-z; Dreier M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107575; Dreier M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-843; Ecke TH, 2008, UROL ONCOL-SEMIN ORI, V26, P474, DOI 10.1016/j.urolonc.2007.12.003; Elwyn G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004705; Fenton JJ, 2017, 154 AHRQ; Fenton JJ, 2018, JAMA-J AM MED ASSOC, V319, P1914, DOI 10.1001/jama.2018.3712; Frosch DL, 2008, ARCH INTERN MED, V168, P363, DOI 10.1001/archinternmed.2007.111; General Medical Council, 2008, CONS PAT DOCT MAK DE; German Society of Urology (DGU), 2016, INT S3 GUID SCREEN D; Gigerenzer G., 2007, PSYCHOL SCI PUBL INT, V8, P53, DOI [10.1111/j.1539-6053.2008.00033.x, DOI 10.1111/J.1539-6053.2008.00033.X]; Gigerenzer G, 2009, JNCI-J NATL CANCER I, V101, P1216, DOI 10.1093/jnci/djp237; Greenland S, 2001, Biostatistics, V2, P463, DOI 10.1093/biostatistics/2.4.463; Helou A, 2014, BUNDESGESUNDHEITSBLA, V57, P288, DOI 10.1007/s00103-013-1902-3; Hofmann J, 2015, Z EVIDENZ FORTBILD Q, V109, P350, DOI 10.1016/j.zefq.2015.06.014; Ilic D, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3519; Ilic D, 2015, PSYCHO-ONCOLOGY, V24, P1303, DOI 10.1002/pon.3815; International Patient Decision Aid Standards (IPDAS) Collaboration, 2005, IPDAS 2005 CRIT JUDG; Jorgensen KJ, 2009, J MED ETHICS, V35, P268, DOI 10.1136/jme.2008.027961; Koch K, 2008, STELLUNGNAHME KRITER; Korfage IJ, 2010, EUR J CANCER, V46, P3073, DOI 10.1016/j.ejca.2010.09.011; Loeb S, 2013, EUR UROL, V64, P876, DOI 10.1016/j.eururo.2013.05.049; Luhnen J., 2017, LEITLINIE EVIDENZBAS; Lumen N, 2012, INT J UROL, V19, P100, DOI 10.1111/j.1442-2042.2011.02912.x; Marckmann G, 2014, BUNDESGESUNDHEITSBLA, V57, P327, DOI 10.1007/s00103-013-1913-0; OCEBM Levels of Evidence Working Group, 2011, OXFORD LEVELS EVIDEN; Pignone MP, 2013, JAMA INTERN MED, V173, P362, DOI 10.1001/jamainternmed.2013.2651; Robert Koch-Institut (RKI), KREBS DEUTSCHL 2013; Sanger S, 2004, CHECK IN INSTRUMENT; Schroder FH, 2014, LANCET, V384, P2027, DOI 10.1016/S0140-6736(14)60525-0; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Sheridan SL, 2004, PATIENT EDUC COUNS, V54, P345, DOI 10.1016/j.pec.2003.12.003; Sheridan SL, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-130; Stacey D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001431.pub5; Steckelberg Anke, 2005, Z Arztl Fortbild Qualitatssich, V99, P343; Strobelberger M, 2011, WIEN MED WOCHENSCHR, V161, P89, DOI 10.1007/s10354-010-0855-5; Taylor KL, 2013, JAMA INTERN MED, V173, P1704, DOI 10.1001/jamainternmed.2013.9253; van Vugt HA, 2010, EUR J CANCER, V46, P669, DOI 10.1016/j.ejca.2009.11.022; Volk RJ, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-S2-S1; Watson E, 2006, PATIENT EDUC COUNS, V63, P367, DOI 10.1016/j.pec.2006.05.005; Williams RM, 2013, PATIENT EDUC COUNS, V91, P329, DOI 10.1016/j.pec.2012.12.013; Witteman HO, 2016, MED DECIS MAKING, V36, P760, DOI 10.1177/0272989X16634085; Wu GHM, 2012, INT J CANCER, V131, P1367, DOI 10.1002/ijc.27340	53	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220745	10.1371/journal.pone.0220745	http://dx.doi.org/10.1371/journal.pone.0220745			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5EW	31393928	Green Published, gold, Green Submitted			2022-12-26	WOS:000485002500058
J	Salama, MF; Liu, ML; Clarke, CJ; Espaillat, MP; Haley, JD; Jin, T; Wang, DF; Obeid, LM; Hannun, YA				Salama, Mohamed F.; Liu, Mengling; Clarke, Christopher J.; Espaillat, Mel Pilar; Haley, John D.; Jin, Ting; Wang, Daifeng; Obeid, Lina M.; Hannun, Yusuf A.			PKC alpha is required for Akt-mTORC1 activation in non-small cell lung carcinoma (NSCLC) with EGFR mutation	ONCOGENE			English	Article							PROTEIN-KINASE-C; AKT PHOSPHORYLATION; TUMOR-FORMATION; CANCER; SUPPRESSES; RESISTANCE; EXPRESSION; SEQUESTRATION; ENZASTAURIN; MIGRATION	Mutational activation of the epidermal growth factor receptor (EGFR) is a major player in the pathogenesis of non-small cell lung cancer (NSCLC). NSCLC patients with constitutively active EGFR mutations eventually develop drug resistance against EGFR tyrosine-kinase inhibitors; therefore, better understandings of key components of mutant EGFR (mtEGFR) signaling are required. Here, we initially observed aberrantly high expression of protein kinase C alpha (PKC alpha) in lung adenocarcinomas, especially those with EGFR mutations, and proceeded to examine the role of PKC alpha in the regulation of the signaling pathways downstream of mtEGFR. The results showed that NSCLC cell lines with constitutively active EGFR mutations tend to have very or moderately high PKC alpha levels. Furthermore, PKC alpha was constitutively activated in HCC827 and H4006 cells which have an EGFR deletion mutation in exon 19. Interestingly, mtEGFR was not required for the induction of PKC alpha at protein and message levels suggesting that the increased levels of PKC alpha are due to independent selection. On the other hand, mtEGFR activity was required for robust activation of PKC alpha. Loss of functions studies revealed that the NSCLC cells rely heavily on PKC alpha for the activation of the mTORC1 signaling pathway. Unexpectedly, the results demonstrated that PKC alpha was required for activation of Akt upstream of mTOR but only in cells with the mtEGFR and with the increased expression of PKC alpha. Functionally, inhibition of PKC alpha in HCC827 led to caspase-3-dependent apoptosis and a significant decrease in cell survival in response to cellular stress induced by serum starvation. In summary, the results identified important roles of PKC alpha in regulating mTORC1 activity in lung cancer cells, whereby a primary switching occurs from PKC alpha-independent to PKC alpha-dependent signaling in the presence of EGFR mutations. The results present PKC alpha as a potential synergistic target of personalized treatment for NSCLC with constitutively active mutant forms of EGFR and constitutively active PKC alpha.	[Salama, Mohamed F.; Liu, Mengling; Clarke, Christopher J.; Espaillat, Mel Pilar; Obeid, Lina M.; Hannun, Yusuf A.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Salama, Mohamed F.; Liu, Mengling; Clarke, Christopher J.; Espaillat, Mel Pilar; Obeid, Lina M.; Hannun, Yusuf A.] Stony Brook Univ Hosp, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA; [Salama, Mohamed F.] Mansoura Univ, Dept Biochem, Fac Vet Med, Mansoura, Egypt; [Liu, Mengling] HD Biosci Inc, Dept Immunooncol, San Diego, CA 92121 USA; [Haley, John D.; Hannun, Yusuf A.] SUNY Stony Brook, Dept Biochem, Stony Brook, NY 11794 USA; [Haley, John D.; Hannun, Yusuf A.] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Jin, Ting; Wang, Daifeng] SUNY Stony Brook, Dept Biomed Informat, Stony Brook, NY 11794 USA; [Wang, Daifeng] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI 53792 USA; [Wang, Daifeng] Univ Wisconsin, Waisman Ctr, Madison, WI 53792 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital; Egyptian Knowledge Bank (EKB); Mansoura University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Hannun, YA (corresponding author), SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA.; Hannun, YA (corresponding author), Stony Brook Univ Hosp, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA.; Hannun, YA (corresponding author), SUNY Stony Brook, Dept Biochem, Stony Brook, NY 11794 USA.; Hannun, YA (corresponding author), SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA.	yusuf.hannun@stonybrookmedicine.edu	Salama, Mohamed F/C-9010-2017; Salama, Mohamed/S-3493-2019	Salama, Mohamed F/0000-0002-0002-9108; Salama, Mohamed/0000-0002-0002-9108; obeid, lina/0000-0002-0734-0847	NCI [CA97132]; NATIONAL CANCER INSTITUTE [P01CA097132] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI grant CA97132.	Abera MB, 2015, MOL PHARMACOL, V87, P832, DOI 10.1124/mol.115.097725; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Antal CE, 2015, CELL, V160, P489, DOI 10.1016/j.cell.2015.01.001; Antonicelli A, 2013, INT J MED SCI, V10, P320, DOI 10.7150/ijms.4609; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Caino MC, 2012, ONCOGENE, V31, P2593, DOI 10.1038/onc.2011.428; Cheng CY, 2009, J CELL PHYSIOL, V219, P183, DOI 10.1002/jcp.21669; Cooper WA, 2013, J THORAC DIS, V5, pS479, DOI 10.3978/j.issn.2072-1439.2013.08.03; El Osta M, 2014, FASEB J, V28, P495, DOI 10.1096/fj.13-230557; Fan Q. W., 2009, SCI SIGNAL, V2, pra4, DOI DOI 10.1126/SCISIGNAL.2000014; Feng X, 1998, J BIOL CHEM, V273, P26870, DOI 10.1074/jbc.273.41.26870; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gallay N, 2009, LEUKEMIA, V23, P1029, DOI 10.1038/leu.2008.395; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Gupta AK, 1996, CELL PROLIFERAT, V29, P655, DOI 10.1111/j.1365-2184.1996.tb00979.x; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Hill KS, 2014, ONCOGENE, V33, P2134, DOI 10.1038/onc.2013.147; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hsieh YH, 2007, CANCER RES, V67, P4320, DOI 10.1158/0008-5472.CAN-06-2486; Idkowiak-Baldys J, 2006, J BIOL CHEM, V281, P22321, DOI 10.1074/jbc.M512540200; Idkowiak-Baldys J, 2009, J BIOL CHEM, V284, P22322, DOI 10.1074/jbc.M109.026765; Jiang XH, 2004, CANCER RES, V64, P5787, DOI 10.1158/0008-5472.CAN-03-1172; Jin G, 2010, LUNG CANCER, V69, P279, DOI 10.1016/j.lungcan.2009.11.012; Kanne JP, 2014, AM J ROENTGENOL, V202, P530, DOI 10.2214/AJR.13.11540; Kim S, 2012, J SURG RES, V176, pE21, DOI 10.1016/j.jss.2011.11.1041; Kong CZ, 2005, UROLOGY, V65, P1228, DOI 10.1016/j.urology.2005.01.007; Lahn Michael, 2004, Clin Lung Cancer, V6, P184, DOI 10.3816/CLC.2004.n.032; LaPorta CAM, 1997, CARCINOGENESIS, V18, P715, DOI 10.1093/carcin/18.4.715; Liu ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080721; Mattoon DR, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-24; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; O'Neill AK, 2011, J BIOL CHEM, V286, P43559, DOI 10.1074/jbc.M111.294603; Oster H, 2006, CANCER RES, V66, P6955, DOI 10.1158/0008-5472.CAN-06-0268; Pulkoski-Gross MJ, 2018, J LIPID RES, V59, P462, DOI 10.1194/jlr.M081307; REISSMANN PT, 1993, ONCOGENE, V8, P1913; Rodrigues GA, 2000, MOL CELL BIOL, V20, P1448, DOI 10.1128/MCB.20.4.1448-1459.2000; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shames DS, 2014, J PATHOL, V232, P121, DOI 10.1002/path.4275; Singhal SS, 2005, FEBS LETT, V579, P4635, DOI 10.1016/j.febslet.2005.07.032; Smith SD, 2012, J BIOL CHEM, V287, P29336, DOI 10.1074/jbc.M112.341917; Song XL, 2015, CANCER RES, V75, P1035, DOI 10.1158/0008-5472.CAN-13-1625; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Steins M, 2014, RECENT RESULTS CANC, V201, P109, DOI 10.1007/978-3-642-54490-3_6; Tsurutani J, 2006, J CLIN ONCOL, V24, P306, DOI 10.1200/JCO.2005.02.4133; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Vansteenkiste J, 2012, ONCOLOGY-BASEL, V82, P25, DOI 10.1159/000335268; Vincent EE, 2011, BRIT J CANCER, V104, P1755, DOI 10.1038/bjc.2011.132; Wang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073985; Willey CD, 2010, INT J RADIAT ONCOL, V77, P1518, DOI 10.1016/j.ijrobp.2009.06.044	52	6	6	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 28	2019	38	48					7311	7328		10.1038/s41388-019-0950-z	http://dx.doi.org/10.1038/s41388-019-0950-z			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JR4XX	31420605	Green Accepted			2022-12-26	WOS:000499631000003
J	Wang, S; Zhang, X; Li, Z; Wang, WZ; Li, BW; Huang, XX; Sun, GL; Xu, JH; Li, Q; Xu, ZP; Xia, YW; Wang, L; Zhang, Q; Li, Q; Zhang, L; Chen, J; Wu, YJ; Cao, JC; Xu, PH; Zhang, DC; Xu, H; Xu, ZK				Wang, Sen; Zhang, Xing; Li, Zheng; Wang, Weizhi; Li, Bowen; Huang, Xiaoxu; Sun, Guangli; Xu, Jianghao; Li, Qing; Xu, Zhipeng; Xia, Yiwen; Wang, Lu; Zhang, Qiang; Li, Qiang; Zhang, Lu; Chen, Jie; Wu, Yangjun; Cao, Jiacheng; Xu, Penghui; Zhang, Diancai; Xu, Hao; Xu, Zekuan			Circular RNA profile identifies circOSBPL10 as an oncogenic factor and prognostic marker in gastric cancer	ONCOGENE			English	Article							HEPATOCELLULAR-CARCINOMA; CELL-GROWTH; CROSS-TALK; WNT2; CHINA; PROGRESSION; STATISTICS; EXPRESSION; CIRCHIPK3; MIGRATION	The prognosis after curative resection of gastric cancer (GC) remains unsatisfactory, and thus, the development of treatments involving alternative molecular and genetic targets is critical. Circular RNAs (circRNAs), which are newly discovered molecules with key roles in the non-coding RNA network, have been identified as critical regulators in various cancers. Here, we aimed to determine the circRNA expression profile and to investigate the functional and prognostic significance of circRNA in GC. Using next-generation sequencing profiling, we first characterized an abundant circRNA in GC, hsa_circ_0008549, derived from the OSBPL10 gene and named it circOSBPL10. The expression of circOSBPL10 was found to be upregulated in GC tissues by quantitative RT-PCR, and silencing of circOSBPL10 significantly inhibited GC cell growth, migration, and invasion in multiple experiments. We further confirmed that miR-136-5p is a downstream target of circOSBPL10 using RNA pull-down and luciferase reporter assays. Rescue experiments confirmed that circOSBPL10 regulates biological functions in GC cells via a circOSBPL10-miR-136-5p-WNT2 axis. In vivo experiments showed that circOSBPL10 promotes tumor growth and metastasis in mice. Furthermore, the level of circOSBPL10 was observed to be a prognostic marker of the overall survival and disease-free survival of patients with GC. Taken together, our findings reveal that circOSBPL10 may serve as a new proliferation factor and prognostic marker in GC.	[Wang, Sen; Zhang, Xing; Li, Zheng; Wang, Weizhi; Li, Bowen; Huang, Xiaoxu; Sun, Guangli; Xu, Jianghao; Li, Qing; Xu, Zhipeng; Xia, Yiwen; Wang, Lu; Zhang, Qiang; Li, Qiang; Zhang, Lu; Cao, Jiacheng; Xu, Penghui; Zhang, Diancai; Xu, Hao; Xu, Zekuan] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing 210029, Jiangsu, Peoples R China; [Chen, Jie; Wu, Yangjun] Fudan Univ, Shanghai Med Coll, Shanghai Canc Ctr, Shanghai 200032, Peoples R China; [Xu, Zekuan] Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University; Fudan University; Nanjing Medical University	Xu, ZK (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing 210029, Jiangsu, Peoples R China.; Xu, ZK (corresponding author), Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, Nanjing 210029, Jiangsu, Peoples R China.	xuzekuan@njmu.edu.cn		Wang, Sen/0000-0001-7179-626X; xu, zekuan/0000-0001-5179-4128	National Natural Science Foundation of China [81572362]; National Natural Science Foundation Project of International Cooperation (NSFC-NIH) [81361120398]; Primary Research & Development Plan of Jiangsu Province [BE2016786]; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) [JX10231801]; 333 Project of Jiangsu Province [BRA2015474]; Jiangsu Key Medical Discipline (General Surgery) [ZDXKA2016005]; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation Project of International Cooperation (NSFC-NIH); Primary Research & Development Plan of Jiangsu Province; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); 333 Project of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Jiangsu Key Medical Discipline (General Surgery); Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University	This work was partially supported by the National Natural Science Foundation of China (81572362); the National Natural Science Foundation Project of International Cooperation (NSFC-NIH, 81361120398); the Primary Research & Development Plan of Jiangsu Province (BE2016786); the Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU; the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD, JX10231801); 333 Project of Jiangsu Province (BRA2015474); Jiangsu Key Medical Discipline (General Surgery) (ZDXKA2016005); and Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University.	Abu N, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00355; Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Burd CE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001233; Chen J, 2017, CANCER LETT, V388, P208, DOI 10.1016/j.canlet.2016.12.006; Chen L, 2017, ONCOGENE, V36, P4551, DOI 10.1038/onc.2017.89; Chen PJ, 2018, ONCOL LETT, V15, P5995, DOI 10.3892/ol.2018.8081; Chen WQ, 2017, CANCER LETT, V401, P63, DOI 10.1016/j.canlet.2017.04.024; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Cheng XX, 2005, CLIN EXP METASTAS, V22, P85, DOI 10.1007/s10585-005-4578-8; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cui JA, 2011, NUCLEIC ACIDS RES, V39, P1197, DOI 10.1093/nar/gkq960; Ding H, 2017, MOL MED REP, V16, P5393, DOI 10.3892/mmr.2017.7275; Dmitriev AA, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/241301; Dong YP, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-016-0370-2; Du WW, 2017, EUR HEART J, V38, P1402, DOI 10.1093/eurheartj/ehw001; Ferreira Humberto J, 2018, Oncotarget, V9, P29208, DOI 10.18632/oncotarget.25673; Fu L, 2011, GUT, V60, P1635, DOI 10.1136/gut.2011.241638; Geng HH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151753; Han D, 2017, HEPATOLOGY, V66, P1151, DOI 10.1002/hep.29270; Hang D, 2018, CANCER MED-US, V7, P2783, DOI 10.1002/cam4.1514; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hentze MW, 2013, EMBO J, V32, P923, DOI 10.1038/emboj.2013.53; Huang L, 2006, HUM PATHOL, V37, P1557, DOI 10.1016/j.humpath.2006.05.015; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Jung YS, 2015, ONCOTARGET, V6, P37257, DOI 10.18632/oncotarget.6133; Karreth FA, 2013, CANCER DISCOV, V3, P1113, DOI 10.1158/2159-8290.CD-13-0202; Katoh M, 2003, INT J MOL MED, V12, P811; Kramer N, 2017, ONCOGENE, V36, P5460, DOI 10.1038/onc.2017.144; Kristensen H, 2016, ONCOTARGET, V7, P30760, DOI [10.18632/oncotarget.8953, 10.16632/oncotarget.8953]; Li DX, 2017, ONCOTARGET, V8, P88163, DOI 10.18632/oncotarget.21513; Li X, 2017, MOL CELL, V67, P214, DOI 10.1016/j.molcel.2017.05.023; Li YW, 2017, EMBO REP, V18, P1646, DOI 10.15252/embr.201643581; Liu J, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0630-y; Lu C, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0833-x; Meleshina AV, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0003-7; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Meng SJ, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0663-2; NIGRO JM, 1991, CELL, V64, P607, DOI 10.1016/0092-8674(91)90244-S; Oh SC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04179-8; Park JK, 2009, NEOPLASMA, V56, P119, DOI 10.4149/neo_2009_02_119; Pongor L, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0228-1; Qi JJ, 2016, GUT, V65, P1690, DOI 10.1136/gutjnl-2014-307900; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Sarkar TR, 2015, ONCOGENE, V34, P2958, DOI 10.1038/onc.2014.245; Sierra B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006220; Singh A, 2016, ONCOTARGET, V7, P17945, DOI 10.18632/oncotarget.7595; Sun GL, 2018, J GASTROENTEROL, V53, P725, DOI 10.1007/s00535-017-1408-0; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Vater I, 2015, LEUKEMIA, V29, P677, DOI 10.1038/leu.2014.264; Wang N, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0240-8; Weng WH, 2017, CLIN CANCER RES, V23, P3918, DOI 10.1158/1078-0432.CCR-16-2541; Yang YB, 2018, JNCI-J NATL CANCER I, V110, DOI 10.1093/jnci/djx166; Yao ZC, 2017, MOL ONCOL, V11, P422, DOI 10.1002/1878-0261.12045; Yuan HJ, 2017, J CELL MOL MED, V21, P3254, DOI 10.1111/jcmm.13229; Zhang F, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201703326; Zhang J, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.006642; Zheng QP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11215; Zheng RS, 2016, CANCER LETT, V370, P33, DOI 10.1016/j.canlet.2015.10.003; Zhong ZY, 2017, CANCER LETT, V403, P305, DOI 10.1016/j.canlet.2017.06.027; Zhou Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160414	61	63	64	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 31	2019	38	44					6985	7001		10.1038/s41388-019-0933-0	http://dx.doi.org/10.1038/s41388-019-0933-0			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JJ1AO	31409903				2022-12-26	WOS:000493892900003
J	Liu, Q; Li, DR; Niu, QL; Huang, DF; Chang, LY				Liu Qian; Li Daren; Niu Qingliang; Huang Danfeng; Chang Liying			Non-destructive monitoring of netted muskmelon quality based on its external phenotype using Random Forest	PLOS ONE			English	Article							PREDICTION; FRUIT	The internal phenotypes of netted muskmelon (Cucumis melo L. var. eticulates Naud.) are always associated with its external phenotypes. In this study, the parameters of external phenotypic traits were extracted from muskmelon images captured by machine vision, and the internal phenotypes of interest to us were measured. Pearson analysis showed that most external phenotypic traits were highly correlated with these internal phenotypes in muskmelon fruit. In this study, we used the random forest algorithm to predict muskmelon fruit internal phenotypes based on the significantly associated external parameters. Carotenoids, sucrose, and total soluble solid (TSS) were the three most accurately monitored internal phenotypes with prediction R-squared (R-2) values of 0.947 (root-mean-square error (RMSE) = 0.019 mg/100 g), 0.918 (RMSE = 3.233 mg/g), and 0.916 (RMSE = 1.089%), respectively. Further, a simplified model was constructed and validated based on the top 10 external phenotypic parameters associated with each internal phenotype, and these parameters were filtered with the varlmp function from the random forest package. The top 10 external phenotypic parameters correlated with each internal phenotype used in the simplified model were not identical. The results showed that the simplified models also accurately monitored the melon internal phenotypes, despite that the predicted R-2 values decreased 0.3% to 7.9% compared with the original models. This study improved the efficiency and accuracy of real-time fruit quality monitoring for greenhouse muskmelon.	[Liu Qian; Li Daren; Niu Qingliang; Huang Danfeng; Chang Liying] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai, Peoples R China	Shanghai Jiao Tong University	Chang, LY (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai, Peoples R China.	changly@sjtu.edu.cn		chang, li ying/0000-0001-5987-1765	National Natural Science Foundation of China (NSFC) [31471411]; Shanghai Municipal Agricultural Commission, China [2017 3-8-4]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Agricultural Commission, China	This study was funded by the National Natural Science Foundation of China (NSFC) (No. 31471411) and the Shanghai Municipal Agricultural Commission, China (2017 3-8-4).	Abdel-Rahman EM, 2013, RANDOM FOREST REGRES; Aquino A, 2018, COMPUT ELECTRON AGR, V144, P26, DOI 10.1016/j.compag.2017.11.026; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen DJ, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy001; Castro CAD, 2017, IND CROP PROD, V108, P806, DOI 10.1016/j.indcrop.2017.07.031; Everingham Y, 2016, AGRON SUSTAIN DEV, V36, DOI 10.1007/s13593-016-0364-z; Guo DD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08235-z; Han ZY, 2016, SPECTROSC SPECT ANAL, V36, P800, DOI 10.3964/j.issn.1000-0593(2016)03-0800-06; Heung B, 2014, GEODERMA, V214, P141, DOI 10.1016/j.geoderma.2013.09.016; Hsueh HM, 2013, GENE, V518, P179, DOI 10.1016/j.gene.2012.11.034; Leiva-Valenzuela GA, 2013, J FOOD ENG, V115, P91, DOI 10.1016/j.jfoodeng.2012.10.001; Li ZW, 2017, J INTEGR AGR, V16, P286, DOI [10.1016/S2095-3119(15)61303-X, 10.1016/s2095-3119(15)61303-x]; LINGLE SE, 1987, PLANT PHYSIOL, V84, P386, DOI 10.1104/pp.84.2.386; Medeiros H, 2017, J FIELD ROBOT, V34, P1203, DOI 10.1002/rob.21679; Nguyen GN, 2018, FUNCT PLANT BIOL, V45, P606, DOI 10.1071/FP17266; Niu XiaoLi, 2012, Scientia Agricultura Sinica, V45, P893; Nordey T, 2017, SCI HORTIC-AMSTERDAM, V216, P51, DOI 10.1016/j.scienta.2016.12.023; Perez-Sanz F, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix092; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; [陶俊 Tao Jun], 2003, [植物生理与分子生物学学报, Journal of Plant Physiology and Molecular Biology], V29, P121; Wang XF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147419; Wei YR, 2012, ACTA HORTIC, V957, P173; [吴素霞 WU Suxia], 2006, [干旱地区农业研究, Agricultural Research in the Arid Areas], V24, P137; Yang HY, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01937; [张艳 Zhang Yan], 2010, [中华烧伤杂志, Chinese Journal of Burns], V26, P366	25	1	1	5	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0221259	10.1371/journal.pone.0221259	http://dx.doi.org/10.1371/journal.pone.0221259			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5MK	31425533	Green Published, gold, Green Submitted			2022-12-26	WOS:000485022400032
J	Singh, S; Dey, SS; Bhatia, R; Kumar, R; Sharma, K; Behera, TK				Singh, Saurabh; Dey, S. S.; Bhatia, Reeta; Kumar, Raj; Sharma, Kanika; Behera, T. K.			Heterosis and combining ability in cytoplasmic male sterile and doubled haploid based Brassica oleracea progenies and prediction of heterosis using microsatellites	PLOS ONE			English	Article							EFFICIENT MICROSPORE EMBRYOGENESIS; VAR. BOTRYTIS L.; POPULATION-STRUCTURE; GENETIC DIVERSITY; INDIAN CAULIFLOWER; AFLP MARKERS; CMS LINES; DISTANCES; PERFORMANCE; ARABIDOPSIS	In Brassica oleracea, heterosis is the most efficient tool providing impetus to hybrid vegetable industry. In this context, we presented the first report on identifying superior heterotic crosses for yield and commercial traits in cauliflower involving cytoplasmic male sterile (CMS) and doubled haploid (DH) lines as parents. We studied the suitability of genomic-SSRs and EST-SSRs based genetic distance (GD) and agronomic trait based phenotypic distance (PD) for predicting heterosis in F-1 hybrids using CMS and DH based parents. 120 F1 hybrids derived from 200gura based CMS lines and 6 DH based testers were evaluated for 16 agronomic traits along with the 26 parental lines and 4 commercial standard checks. The genomic-SSRs and EST-SSRs based genetic structure analysis grouped the 26 parental lines into 4 distinct clusters. The CMS lines Ogu118-6A, Ogu33A, Ogu34-1A were good general combiner for developing early maturity hybrids. The SCA effects were significantly associated with heterosis suggesting non-additive gene effects for the heterotic response of hybrids. Less than unity value of sigma(2)A/D coupled with sigma(2)(gca)/sigma(2)(sca) indicated the predominance of non-additive gene action in the expression of studied traits. The correlation analysis of genetic distance with heterosis for commercial traits suggested that microsatellites based genetic distance estimates can be helpful in heterosis prediction to some extent.	[Singh, Saurabh; Dey, S. S.; Kumar, Raj; Behera, T. K.] Indian Agr Res Inst, ICAR, Div Vegetable Sci, New Delhi, India; [Bhatia, Reeta] Indian Agr Res Inst, ICAR, Div Floriculture & Landscaping, New Delhi, India; [Sharma, Kanika] Indian Agr Res Inst, ICAR, Reg Stn, Kulu, Himachal Prades, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Dey, SS (corresponding author), Indian Agr Res Inst, ICAR, Div Vegetable Sci, New Delhi, India.	shyam.iari@gmail.com	SINGH, SAURABH/ABB-6671-2021; BEHERA, TUSAR Kanti/AAA-8576-2022; Behera, Tusar Kanti/GLQ-9514-2022	SINGH, SAURABH/0000-0001-8038-1808; 	Indian Council of Agricultural Research	Indian Council of Agricultural Research(Indian Council of Agricultural Research (ICAR))	Financial support was provided by the NAHEP/CAAST research grant by Indian Council of Agricultural Research.	Esposito MA, 2014, SCI HORTIC-AMSTERDAM, V177, P53, DOI 10.1016/j.scienta.2014.07.033; Arashida FM, 2017, HORTIC BRAS, V35, P167, DOI [10.1590/S0102-053620170203, 10.1590/s0102-053620170203]; Bansal P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029607; Bayer PE, 2019, PLANT BIOTECHNOL J, V17, P789, DOI 10.1111/pbi.13015; BERNARDO R, 1992, THEOR APPL GENET, V83, P628, DOI 10.1007/BF00226908; Betran FJ, 2003, CROP SCI, V43, P797, DOI 10.2135/cropsci2003.0797; Bhatia R, 2017, SCI HORTIC-AMSTERDAM, V216, P83, DOI 10.1016/j.scienta.2016.12.020; Bhatia R, 2016, EUPHYTICA, V212, P439, DOI 10.1007/s10681-016-1775-2; Bhatia R, 2018, SCI HORTIC-AMSTERDAM, V233, P178, DOI 10.1016/j.scienta.2018.01.017; Bhatia R, 2015, J HORTIC SCI BIOTECH, V90, P171, DOI 10.1080/14620316.2015.11513169; Burstin J, 1997, HEREDITY, V79, P477, DOI 10.1038/hdy.1997.187; CAMUSSI A, 1985, GENETICS, V111, P945; CRESS CE, 1966, GENETICS, V53, P269; Dey SS, 2017, SCI HORTIC-AMSTERDAM, V224, P27, DOI 10.1016/j.scienta.2017.05.032; Dey SS, 2014, EUPHYTICA, V195, P169, DOI 10.1007/s10681-013-0981-4; Dey SS, 2013, SCI HORTIC-AMSTERDAM, V157, P45, DOI 10.1016/j.scienta.2013.04.008; Dey SS, 2011, EUPHYTICA, V182, P187, DOI 10.1007/s10681-011-0425-y; Dey SS, 2017, PLANT BREEDING, V136, P400, DOI 10.1111/pbr.12478; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; El-Esawi MA, 2016, CR BIOL, V339, P133, DOI 10.1016/j.crvi.2016.02.002; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans LM, 2018, HEREDITY, V121, P616, DOI 10.1038/s41437-018-0067-0; Falconer D. S., 1996, Introduction to quantitative genetics.; Fasahat P., 2016, BIOM BIOSTAT INT J, V4, P1, DOI [DOI 10.15406/BBIJ.2016.04.00085, 10.15406/bbij.2016.04.00085]; Ferrie AMR, 2011, PLANT CELL TISS ORG, V104, P375, DOI 10.1007/s11240-010-9831-4; Fujimoto R, 2018, BREEDING SCI, V68, P145, DOI 10.1270/jsbbs.17155; Gao W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076826; Garg Naveen, 2005, Crop Improvement, V32, P193; Geleta LF, 2004, PLANT BREEDING, V123, P467, DOI 10.1111/j.1439-0523.2004.01017.x; Groszmann M, 2014, PLANT PHYSIOL, V166, P265, DOI 10.1104/pp.114.243998; Groszmann M, 2013, TRENDS GENET, V29, P684, DOI 10.1016/j.tig.2013.07.004; Gupta SK, 2018, CROP J, V6, P271, DOI 10.1016/j.cj.2017.09.008; Hale AL, 2007, THEOR APPL GENET, V115, P351, DOI 10.1007/s00122-007-0569-2; Hasan Y, 2016, THEOR APPL GENET, V129, P1273, DOI 10.1007/s00122-016-2702-6; Jacquemoud-Collet JP., 2006, DARWIN SOFTWARE, DOI [10.1111/j.1365-294X.2007.03089.x, DOI 10.1111/J.1365-294X.2007.03089.X]; Jagosz B, 2011, PLANT BREEDING, V130, P574, DOI 10.1111/j.1439-0523.2011.01877.x; JOHNSON HERBERT W., 1955, AGRON JOUR, V47, P314; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kaushik P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199943; Kawamura K, 2016, PLANT GENE, V5, P1, DOI DOI 10.1016/J.PLGENE.2015.10.003; Kempthorne O, 1957, INTRO GENETIC STAT; Krishnamurthy SL, 2013, CURR SCI INDIA, V104, P738; Lariepe A, 2017, THEOR APPL GENET, V130, P403, DOI 10.1007/s00122-016-2822-z; Lauss K, 2018, PLANT PHYSIOL, V176, P1627, DOI 10.1104/pp.17.01054; Li HT, 2011, MOL BREEDING, V28, P585, DOI 10.1007/s11032-010-9509-y; Li H, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1384-4; Lin Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23326-1; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Liu X, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00354; Lv HH, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00989; Maggioni L, 2018, GENET RESOUR CROP EV, V65, P137, DOI 10.1007/s10722-017-0516-2; Makumbi D, 2011, EUPHYTICA, V180, P143, DOI 10.1007/s10681-010-0334-5; Mang XL, 2016, SCI HORTIC-AMSTERDAM, V207, P82, DOI 10.1016/j.scienta.2016.05.015; Melchinger AE, 2007, GENETICS, V177, P1827, DOI [10.1534/genetics.107.080564, 10.1534/genetics.107.084871]; Meyer RC, 2004, PLANT PHYSIOL, V134, P1813, DOI 10.1104/pp.103.033001; Moges AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151257; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Parkash C, 2017, 3 BIOTECH, V8, DOI 10.1007/s13205-017-1047-4; Pritchard JK, 2000, GENETICS, V155, P945; ROBINSON HF, 1966, INDIAN J GENET PL BR, VA 26, P171; Rosen A, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00078; Rstudio Team, 2015, RSTUDIO INT DEV R; Samec D, 2019, CRIT REV FOOD SCI, V59, P2411, DOI 10.1080/10408398.2018.1454400; SAS Institute Inc, 2013, SAS ONL DOC VERS 9 4; Saurabh Singh, 2012, SABRAO Journal of Breeding and Genetics, V44, P339; Sehgal N, 2018, 3 BIOTECH, V8, DOI 10.1007/s13205-018-1372-2; Sharma S., 2003, VEGETABLE CROP PRODU; Singh S., 2018, PHYTOCHEMICALS VEGET, P256, DOI [10.2174/9781681087399118010011, DOI 10.2174/9781681087399118010011]; Singh S, 2019, PLANT REPROD, V32, P231, DOI 10.1007/s00497-019-00371-y; Singh S, 2018, EUPHYTICA, V214, DOI 10.1007/s10681-018-2291-3; Singh S, 2018, EUPHYTICA, V214, DOI 10.1007/s10681-018-2275-3; Sotelo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107290; Su JS, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-1837-0; Su YB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138073; Taheri S, 2018, MOLECULES, V23, DOI 10.3390/molecules23020399; Tams SH, 2006, PLANT BREEDING, V125, P331, DOI 10.1111/j.1439-0523.2006.01218.x; Teklewold A, 2006, THEOR APPL GENET, V112, P752, DOI 10.1007/s00122-005-0180-3; Thakur AK, 2017, HEREDITAS, V155, DOI 10.1186/s41065-017-0041-5; Thakur P., 2015, SABRAO Journal of Breeding and Genetics, V47, P29; Tian HY, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-016-1788-x; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Verma Veerendra Kumar, 2017, Proceedings of the Indian National Science Academy Part B Biological Sciences, V87, P877, DOI 10.1007/s40011-015-0664-0; Wang WX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-523; Wegary D, 2013, EUPHYTICA, V191, P205, DOI 10.1007/s10681-012-0757-2; Wei T, 2017, R PACKAGE CORRPLOT V; Xie F, 2018, CROP PASTURE SCI, V69, P296, DOI [10.1071/CP17357, 10.1071/cp17357]; Yousef EAA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192062; Yu CY, 2005, THEOR APPL GENET, V110, P511, DOI 10.1007/s00122-004-1858-7; Zhang XZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126828; Zhao ZD, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00334; Zhao ZQ, 2014, SCI HORTIC-AMSTERDAM, V166, P105, DOI 10.1016/j.scienta.2013.12.024; Zhu SY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208551	92	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0210772	10.1371/journal.pone.0210772	http://dx.doi.org/10.1371/journal.pone.0210772			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5MK	31425498	Green Submitted, Green Published, gold			2022-12-26	WOS:000485022400001
J	Ruhl, EJ; Dixson, DL				Ruhl, Emily J.; Dixson, Danielle L.			3D printed objects do not impact the behavior of a coral-associated damselfish or survival of a settling stony coral	PLOS ONE			English	Article							REEF FISH; PORITES-ASTREOIDES; RECRUITMENT; SETTLEMENT; PREDATION; TEMPERATURE; MORTALITY; GROWTH	3D printing technology offers significant advantages in the development of objects and tools across an array of fields and has been implemented in an increasing number of ecological studies. As rates of degradation or chemical leaching of 3D printed models has not been well documented under environmental conditions, it is essential to examine if these objects will alter the behavior or impact the survivorship of the focal species prior to widespread implementation. Here, we explored the efficacy of using 3D printed models in coral reef behavioral research, an area of study where this form of additive manufacturing could offer significant advantages. Coral-associated blue-green chromis (Chromis viridis) individuals were exposed to natural and 3D printed coral habitats, and larval mustard hill coral (Porites astreoides) were offered 3D printed substrate as a settlement surface. Habitat association and behavioral analyses indicated that C. viridis did not discriminate or display modified behaviors between 3D printed and natural coral skeletons or between 3D printed materials. P. astreoides displayed significantly higher settlement when provided with 3D printed settlement surfaces than when provided with no settlement surface and settled at similar rates between 3D printed surfaces of differing materials. Additionally, growth and mortality of P. astreoides settled on different 3D printed surfaces did not significantly differ. Our results suggest that the 3D printed models used in this study are not inherently harmful to a coral reef fish or species of brooding coral, supporting further exploration of the benefits that these objects and others produced with additive manufacturing may offer as ecological research tools.	[Ruhl, Emily J.; Dixson, Danielle L.] Univ Delaware, Sch Marine Sci & Policy, Lewes, DE 19958 USA	University of Delaware	Dixson, DL (corresponding author), Univ Delaware, Sch Marine Sci & Policy, Lewes, DE 19958 USA.	dixson@udel.edu	Dixson, Danielle/B-9253-2018	Dixson, Danielle/0000-0003-1493-1482	National Institute of Health Award [NIH U01-TW007401]	National Institute of Health Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded from a National Institute of Health Award (NIH U01-TW007401) to DLD, https://www.fic.nih.gov/Programs/Pages/biodiversity.aspx.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Special thanks to A. Trembanis, C. Duval, and J. Button at the University of Delaware for help with printing, and to the Paul Lab at the Smithsonian for the collection of the coral planulae. Thank you to the Dixson Lab at the University of Delaware for their support and feedback with manuscript revisions.	Albright R, 2008, CORAL REEFS, V27, P485, DOI 10.1007/s00338-008-0392-5; Albright R, 2011, GLOBAL CHANGE BIOL, V17, P2478, DOI 10.1111/j.1365-2486.2011.02404.x; Allen G, REEF FISH IDENTIFICA, P2; Babcock R, 1996, J EXP MAR BIOL ECOL, V206, P179, DOI 10.1016/S0022-0981(96)02622-6; Behm JE, 2018, BMC ECOL, V18, DOI 10.1186/s12898-018-0190-z; Biro PA, 2010, P ROY SOC B-BIOL SCI, V277, P71, DOI 10.1098/rspb.2009.1346; Brooker RM, 2013, CORAL REEFS, V32, P613, DOI 10.1007/s00338-013-1057-6; Campbell T., 2011, COULD 3D PRINTING CH; Campos EO, 2015, FUNCT ECOL, V29, P462, DOI 10.1111/1365-2435.12378; Chivers DP, 2016, SCI REP-UK, V6, DOI 10.1038/srep32542; Coker DJ, 2009, BEHAV ECOL, V20, P1204, DOI 10.1093/beheco/arp113; DeMartini EE, 2007, B MAR SCI, V81, P139; Domingue MJ, 2015, J PEST SCI, V88, P267, DOI 10.1007/s10340-014-0598-y; Gao W, 2015, COMPUT AIDED DESIGN, V69, P65, DOI 10.1016/j.cad.2015.04.001; Green DH, 2008, MAR ECOL PROG SER, V359, P1, DOI 10.3354/meps07454; Hesterberg SG, 2017, ECOLOGY, V98, P1153, DOI [10.1002/ecy.1762/suppinfo, 10.1002/ecy.1762]; Holmes TH, 2010, BEHAV PROCESS, V83, P299, DOI 10.1016/j.beproc.2010.01.013; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Igic B, 2015, PEERJ, V3, DOI 10.7717/peerj.965; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jarrold MD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10378-y; KEOUGH MJ, 1982, OECOLOGIA, V54, P348, DOI 10.1007/BF00380003; Kuffner IB, 2006, MAR ECOL PROG SER, V323, P107, DOI 10.3354/meps323107; Leingang PM, 2019, CORAL REEFS, V38, P93, DOI 10.1007/s00338-018-01744-x; Leukers B, 2005, J MATER SCI-MATER M, V16, P1121, DOI 10.1007/s10856-005-4716-5; Lindahl U, 2001, MAR POLLUT BULL, V42, P127, DOI 10.1016/S0025-326X(00)00167-3; Manassa RP, 2013, ANIM BEHAV, V86, P717, DOI 10.1016/j.anbehav.2013.07.003; Manassa RP, 2012, ANIM COGN, V15, P559, DOI 10.1007/s10071-012-0484-z; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Noonan SHC, 2012, MAR ECOL PROG SER, V456, P127, DOI 10.3354/meps09687; Nozawa Y, 2008, J EXP MAR BIOL ECOL, V367, P127, DOI 10.1016/j.jembe.2008.09.004; Penin L, 2010, MAR ECOL PROG SER, V408, P55, DOI 10.3354/meps08554; Price NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043843; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Ross C, 2013, CORAL REEFS, V32, P71, DOI 10.1007/s00338-012-0956-2; Schelly C, 2015, J VISUAL LANG COMPUT, V28, P226, DOI 10.1016/j.jvlc.2015.01.004; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Schubert C, 2014, BRIT J OPHTHALMOL, V98, P159, DOI 10.1136/bjophthalmol-2013-304446; SHULMAN MJ, 1985, ECOLOGY, V66, P1056, DOI 10.2307/1940565; Sofia Perez-Pagan Birla, 2018, Conservation Evidence, V15, P43; Thomason JC, 2002, BIOFOULING, V18, P293, DOI 10.1080/0892701021000034409; Veron J. E., 2000, CORALS WORLD, V1	42	12	12	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2019	14	8							e0221157	10.1371/journal.pone.0221157	http://dx.doi.org/10.1371/journal.pone.0221157			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5LL	31419264	Green Published, gold, Green Submitted			2022-12-26	WOS:000485019900031
J	Morey, M; O'Gaora, P; Pandit, A; Helary, C				Morey, Mangesh; O'Gaora, Peadar; Pandit, Abhay; Helary, Christophe			Hyperglycemia acts in synergy with hypoxia to maintain the pro-inflammatory phenotype of macrophages	PLOS ONE			English	Article							NF-KAPPA-B; DIABETES-MELLITUS; MOLECULAR-BIOLOGY; EXPRESSION; CELLS; LIPOPOLYSACCHARIDE; ACTIVATION; OXYGEN; FOOT	Diabetic foot ulcers (DFUs) are characterized by a chronic inflammation state which prevents cutaneous wound healing, and DFUs eventually lead to infection and leg amputation. Macrophages located in DFUs are locked in an pro-inflammatory phenotype. In this study, the effect of hyperglycemia and hypoxia on the macrophage phenotype was analyzed. For this purpose, a microarray was performed to study the gene expression profile of macrophages cultivated in a high glucose concentration. Hyperglycemia upregulated the expression of pro-inflammatory cytokines such as TNF-alpha, IL-1, IL-6, chemokines and down-regulated the expression of two receptors involved in phagocytosis (CD 36 and Class B scavenger type I receptors). In addition, eleven anti-apoptotic factors were upregulated whereas three pro-apoptotic genes were downregulated. Subsequently, the contribution of hypoxia and hyperglycemia to chronic inflammation and their potential synergistic effect was evaluated on activated THP-1 derived macrophages. A long term post activation effect (17 hours) was only observed on the upregulation of pro-inflammatory cytokines when hypoxia was combined with a high glucose concentration. In contrast, hyperglycemia and hypoxia did not have any effect on wound healing molecules such as TGF-beta 1. Taken together, the results show that hyperglycemia acts in synergy with hypoxia to maintain a chronic inflammation state in macrophages.	[Morey, Mangesh; Pandit, Abhay; Helary, Christophe] Natl Univ Ireland Galway, Ctr Res Med Devices, CURAM, Galway, Ireland; [O'Gaora, Peadar] Univ Coll Dublin, UCD Sch Biomed & Biomol Sci, Dublin, Ireland; [Helary, Christophe] Sorbonne Univ, Coll France, Lab Chim Matiere Condensee Paris, CNRS, Pl Jussieu, Paris, France	Ollscoil na Gaillimhe-University of Galway; University College Dublin; UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; Chimie ParisTech; College de France; Centre National de la Recherche Scientifique (CNRS)	Pandit, A; Helary, C (corresponding author), Natl Univ Ireland Galway, Ctr Res Med Devices, CURAM, Galway, Ireland.; Helary, C (corresponding author), Sorbonne Univ, Coll France, Lab Chim Matiere Condensee Paris, CNRS, Pl Jussieu, Paris, France.	abhay.pandit@nuigalway.ie; christophe.helary@upmc.fr	Pandit, Abhay/B-6187-2008; Helary, Christophe/AAD-9437-2022; Helary, Christophe/AAD-3476-2022; Helary, Christophe/J-8128-2013	Pandit, Abhay/0000-0002-6292-4933; Helary, Christophe/0000-0001-9312-7278	Health Research Board, Government of Maharashtra (INDIA) [HRB RP/2008/188, 164/Edn-1]; European Regional Development Fund; Science Foundation Ireland under Ireland's European Structural and Investment Fund [13/RC/2073]	Health Research Board, Government of Maharashtra (INDIA); European Regional Development Fund(European Commission); Science Foundation Ireland under Ireland's European Structural and Investment Fund(Science Foundation Ireland)	We Thank the Health Research Board (Funding Programme: HRB RP/2008/188), Government of Maharashtra (INDIA), Postgraduate Scholarship, EBC-2012/C. No. 164/Edn-1 and European Regional Development Fund together with Science Foundation Ireland under Ireland's European Structural and Investment Fund (Grant Number 13/RC/2073) for its financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeghate J, 2017, EXPERT OPIN BIOL TH, V17, P979, DOI 10.1080/14712598.2017.1333596; Al-Mulla F, 2011, MOL BIOSYST, V7, P3006, DOI 10.1039/c0mb00317d; Andreakos E, 2004, BLOOD, V103, P2229, DOI 10.1182/blood-2003-04-1356; Armstrong DG, 1998, AM FAM PHYSICIAN, V57, P1325; Baltzis D, 2014, ADV THER, V31, P817, DOI 10.1007/s12325-014-0140-x; Baranova IN, 2012, J IMMUNOL, V188, P1371, DOI 10.4049/jimmunol.1100350; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Berlanga-Acosta J, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2923759; Berlanga-Acosta J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/256043; Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x; Clayton W., 2009, CLIN DIABETES, V27, P52, DOI [10.2337/diaclin.27.2.52, DOI 10.2337/DIACLIN.27.2.52]; D'Ignazio L, 2016, FEBS J, V283, P413, DOI 10.1111/febs.13578; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; De Plaen IG, 2006, IMMUNOLOGY, V118, P153, DOI 10.1111/j.1365-2567.2006.02344.x; Death AK, 2003, ATHEROSCLEROSIS, V168, P263, DOI 10.1016/S0021-9150(03)00140-0; Fuster JJ, 2014, EMBO J, V33, P1425, DOI 10.15252/embj.201488856; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gordon P, 2016, J LEUKOCYTE BIOL, V100, P771, DOI 10.1189/jlb.3A1215-554RR; Greenlee-Wacker MC, 2016, IMMUNOL REV, V273, P357, DOI 10.1111/imr.12453; Hanson MA, 2015, NAT REV ENDOCRINOL, V11, P261, DOI 10.1038/nrendo.2015.31; Huebener P, 2013, BBA-MOL BASIS DIS, V1832, P1005, DOI 10.1016/j.bbadis.2012.11.017; Jin X, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/732450; Khanna S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009539; Krzyszczyk P, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00419; Li MF, 2016, J INTERF CYTOK RES, V36, P48, DOI 10.1089/jir.2014.0172; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Markakis K, 2016, DIABETES-METAB RES, V32, P169, DOI 10.1002/dmrr.2740; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Maurer M, 2004, INT J BIOCHEM CELL B, V36, P1882, DOI 10.1016/j.biocel.2003.10.019; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Qing C, 2017, CHIN J TRAUMATOL, V20, P189, DOI 10.1016/j.cjtee.2017.06.001; Rahat MA, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00045; Salim T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153289; Schreml S, 2010, BRIT J DERMATOL, V163, P257, DOI 10.1111/j.1365-2133.2010.09804.x; Sindrilaru A, 2013, ADV WOUND CARE, V2, P357, DOI 10.1089/wound.2012.0407; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Strehl C, 2014, J LEUKOCYTE BIOL, V95, P233, DOI 10.1189/jlb.1212627; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Uemura S, 2001, CIRC RES, V88, P1291, DOI 10.1161/hh1201.092042; Ushach I, 2016, J LEUKOCYTE BIOL, V100, P481, DOI 10.1189/jlb.3RU0316-144R; Wetzler C, 2000, BIOCHEM BIOPH RES CO, V274, P689, DOI 10.1006/bbrc.2000.3170; Wilson HM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00357; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Zhao RL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122085	45	29	29	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220577	10.1371/journal.pone.0220577	http://dx.doi.org/10.1371/journal.pone.0220577			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415598	Green Submitted, gold, Green Published			2022-12-26	WOS:000485017200020
J	Reddy, PRK; Kumar, DS; Rao, ER; Seshiah, CV; Sateesh, K; Reddy, PK; Hyder, I				Reddy, P. Ravi Kanth; Kumar, D. Srinivasa; Rao, E. Raghava; Seshiah, Ch Venkata; Sateesh, K.; Reddy, Pradeep Kumar; Hyder, Iqbal			Assessment of eco-sustainability vis-a-vis zoo-technical attributes of soybean meal (SBM) replacement with varying levels of coated urea in Nellore sheep (Ovis aries)	PLOS ONE			English	Article							SLOW-RELEASE UREA; METABOLISM; RUMEN; RUMINANTS; CARBON; FIBER; DIETS	The contemporary environmental-stewardship programmes primarily aimed at curbing the global warming potential by adopting a multidisciplinary approach. Manipulating the feeding strategies has great potential in reducing the environmental footprints of livestock production. This study intends to assess the effect of soybean meal (SBM) replacement with varying levels of coated urea (SRU) on both zoo-technical (nutrient digestibility, heat increment, and physio-biochemical parameters) and environmental attributes. The coated urea was used to replace the SBM at 0, 25, 50, and 75 percent levels. Eight adult rams (43.02 +/- 0.76) maintained in a conventional shed were used in a replicated 4 x 4 Latin square design. Not all the physiological parameters viz. rectal temperature, pulse rate, and respiratory rate were affected (P> 0.05) f by varying levels of SRU incorporation. The SRU fed animals had higher (P< 0.05) crude protein digestibility compared to SBM fed animals; however, the replacements did not affect the nutrient digestibility coefficients of DM, OM, NFC, NDFap, ADF, and hemicellulose components. The SRU did not affect various biochemical parameters such as serum glucose, total protein, albumin, globulin, urea, creatinine, ALT, AST, Ca, P and T3, and T4 levels; however, post-prandial serum urea N (SUN) values showed a diurnal quadratic pattern (P< 0.05) with a dose-dependent relationship. Further, the SBM replacements had no effect on the calcium excretion, while the SRU incorporation decreased the faecal phosphorous content, thereby abating the eutrophication phenomenon. Although the SBM replacements did not affect in vivo water variables and faecal solid fractions, they managed to decrease the land and virtual water requirement along with global warming potential (GWP) of the entire trial. The GWP-perceptual map unveils the fact that replacement of conventional feed ingredients with NPN compounds aids in eco-friendly livestock production. Further, the conjectural analysis of the carbon footprint methodology revealed that agricultural by-products consideration could cause a huge increase in the GWP share of feed consumed, thus compelling the importance of research pertaining to feed production perspective as equal as ruminal methane amelioration.	[Reddy, P. Ravi Kanth] Sri Venkateswara Vet Univ, Coll Vet Sci, Livestock Farm Complex, Proddutur, Andhra Pradesh, India; [Kumar, D. Srinivasa] Sri Venkateswara Vet Univ, NTR Coll Vet Sci, Dept Anim Nutr, Gannavaram, Andhra Pradesh, India; [Rao, E. Raghava] Sri Venkateswara Vet Univ, Adm Bldg, Tirupati, Andhra Pradesh, India; [Seshiah, Ch Venkata] Sri Venkateswara Vet Univ, NTR Coll Vet Sci, Livestock Farm Complex, Gannavaram, Andhra Pradesh, India; [Sateesh, K.] Sri Venkateswara Vet Univ, AH Polytech Coll, Banavasi, Andhra Pradesh, India; [Reddy, Pradeep Kumar] Sri Venkateswara Vet Univ, Coll Vet Sci, Ctr Continuing Vet Educ & Commun, Tirupati, Andhra Pradesh, India; [Hyder, Iqbal] Sri Venkateswara Vet Univ, NTR Coll Vet Sci, Dept Vet Physiol, Gannavaram, Andhra Pradesh, India	Sri Venkateswara Veterinary University; Sri Venkateswara Veterinary University; Sri Venkateswara Veterinary University; Sri Venkateswara Veterinary University; Sri Venkateswara Veterinary University; Sri Venkateswara Veterinary University; Sri Venkateswara Veterinary University	Hyder, I (corresponding author), Sri Venkateswara Vet Univ, NTR Coll Vet Sci, Dept Vet Physiol, Gannavaram, Andhra Pradesh, India.	iqbvet@gmail.com	POONOORU, RAVIKANTH REDDY/AAU-5144-2020	POONOORU, RAVIKANTH REDDY/0000-0003-2451-2783				Adom F, 2012, INT J LIFE CYCLE ASS, V17, P520, DOI 10.1007/s11367-012-0386-y; Ali Y, 2018, RENEW SUST ENERG REV, V81, P1813, DOI 10.1016/j.rser.2017.05.277; Almora EGA, 2012, ANIM FEED SCI TECH, V171, P136, DOI 10.1016/j.anifeedsci.2011.10.012; [Anonymous], 2007, 200704 AOAC; [Anonymous], 1970, P 5 S EN MET; Audsley E., 2009, ESTIMATION GREENHOUS; Benedeti PDB, 2014, LIVEST SCI, V165, P51, DOI 10.1016/j.livsci.2014.04.027; Block H. C., 2004, Professional Animal Scientist, V20, P319; Capper Judith L, 2012, Animals (Basel), V2, P127, DOI 10.3390/ani2020127; Cherdthong A, 2011, LIVEST SCI, V136, P76, DOI 10.1016/j.livsci.2010.08.002; Clark JP, 2009, FOOD ENG SER, P1, DOI 10.1007/978-1-4419-0420-1_1; Constable P, 2016, TXB DIS CATTLE SHEEP; Cottle DJ, 2011, ANIM PROD SCI, V51, P491, DOI 10.1071/AN10163; Couch CE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176830; Deru M, 2007, STUFF MIT ED, DOI DOI 10.2172/884990; Du TS, 2015, J EXP BOT, V66, P2253, DOI 10.1093/jxb/erv034; Favreau A, 2010, APPL ANIM BEHAV SCI, V125, P115, DOI 10.1016/j.applanim.2010.04.007; Galo E, 2003, J DAIRY SCI, V86, P2154, DOI 10.3168/jds.S0022-0302(03)73805-3; Gardinal R, 2017, ASIAN AUSTRAL J ANIM, V30, P34, DOI 10.5713/ajas.16.0058; Hall MB, 1998, ANIM FEED SCI TECH, V70, P23, DOI 10.1016/S0377-8401(97)00068-0; Highstreet A, 2010, LIVEST SCI, V129, P179, DOI 10.1016/j.livsci.2010.01.022; Hyder I, 2017, SHEEP PRODUCTION ADA, DOI [10.1007/978-981-10-4714-5_11, DOI 10.1007/978-981-10-4714-5_11]; Hyder I, 2017, HEAT SHOCK PROTEINS, V12, P3, DOI 10.1007/978-3-319-73377-7_1; Iglesias A., 2007, AD CLIM CHANG AGR SE; IPCC, 2019, REF 2006 IPCC GUID N, V5, P1; Jayaram K., 2016, THESIS; Kertz A. F., 2010, Professional Animal Scientist, V26, P257; Khattab IM, 2013, LIVEST SCI, V155, P223, DOI 10.1016/j.livsci.2013.05.024; Kitamura SS, 2010, CIENC RURAL, V40, P1779, DOI 10.1590/S0103-84782010005000131; Kohn R., 2007, P FLORIDA RUMINANT N, P1; Licitra G, 1996, ANIM FEED SCI TECH, V57, P347, DOI 10.1016/0377-8401(95)00837-3; Lizarazo AC, 2014, SMALL RUMINANT RES, V116, P28, DOI 10.1016/j.smallrumres.2013.10.009; Pinos-Rodriguez JM, 2010, ITAL J ANIM SCI, V9, P16, DOI 10.4081/ijas.2010.e4; Millen DD, 2009, J ANIM SCI, V87, P3427, DOI 10.2527/jas.2009-1880; Mynhardt H., 2017, THESIS; National Research Council, 2001, NUTR REQ BEEF CATTL; NRC, 2007, NUTR REQ SMALL RUM, DOI [10.17226/11654, DOI 10.17226/11654]; OWENS FN, 1980, J ANIM SCI, V50, P527, DOI 10.2527/jas1980.503527x; Patra A, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-017-0145-9; Pretty J, 2014, ANN BOT-LONDON, V114, P1571, DOI 10.1093/aob/mcu205; Rahardja DP, 2011, ANIMAL, V5, P1587, DOI 10.1017/S1751731111000577; Schwalfenberg GK, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/727630; Sejian V, 2010, INT J BIOMETEOROL, V54, P653, DOI 10.1007/s00484-010-0341-1; Sharma SK, 2016, RES REV J VET SCI, V3, P1; Sinclair LA, 2012, ANIMAL, V6, P920, DOI 10.1017/S1751731111002485; SNIFFEN CJ, 1992, J ANIM SCI, V70, P3562, DOI 10.2527/1992.70113562x; STORM E, 1983, BRIT J NUTR, V50, P463, DOI 10.1079/BJN19830114; Sudarman A, 2000, ASIAN AUSTRAL J ANIM, V13, P1523, DOI 10.5713/ajas.2000.1523; Swainson N, 2018, ANIM PROD SCI, V58, P973, DOI 10.1071/AN15766; Thornton PK, 2010, 5178 WPS WORLD BANK; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Varma VS, 2018, FRONT SUSTAIN FOOD S, V2, DOI 10.3389/fsufs.2018.00033; Wallerstein I, 2012, J WORLD SYST RES, V18, P6; Wheelock JB, 2010, J DAIRY SCI, V93, P644, DOI 10.3168/jds.2009-2295; Zhang SJ, 2016, J APPL ANIM RES, V44, P1, DOI 10.1080/09712119.2014.978779; Zheng G., 2011, AIS T HUMAN COMPUTER, V3, P82	56	21	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220252	10.1371/journal.pone.0220252	http://dx.doi.org/10.1371/journal.pone.0220252			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408459	gold, Green Published, Green Submitted			2022-12-26	WOS:000485009500010
J	Wolfson, LJ; Daniels, VJ; Pillsbury, M; Kurugol, Z; Yardimci, C; Kyle, J; Dinleyici, EC				Wolfson, Lara J.; Daniels, Vincent J.; Pillsbury, Matthew; Kurugol, Zafer; Yardimci, Cuneyt; Kyle, Jeffrey; Dinleyici, Ener Cagri			Cost-effectiveness analysis of universal varicella vaccination in Turkey using a dynamic transmission model	PLOS ONE			English	Article							HERPES-ZOSTER; ECONOMIC-ANALYSIS; HEALTHY-CHILDREN; EPIDEMIOLOGY; RUBELLA; MUMPS; MEASLES; IMPACT; SEROPREVALENCE; VIRUS	Background In 2013, Turkey introduced one-dose universal varicella vaccination (UVV) at 12 months of age. Inclusion of a second dose is being considered. Methods We developed a dynamic transmission model to evaluate three vaccination strategies: single dose at 12 months (1D) or second dose at either 18 months (2D-short) or 6 years of age (2D-long). Costs and utilization were age-stratified and separated into inpatient and outpatient costs for varicella and herpes zoster (HZ). We ran the model including and excluding HZ-related costs and impact of exogenous boosting. Results Five years post-introduction of UVV (1D), the projected varicella incidence rate decreases from 1,674 cases pre-vaccine to 80 cases/100,000 person-years. By 25 years, varicella incidence equilibrates at 39, 12, and 16 cases/100,000 person-years for 1D, 2D-short, and 2D-long strategies, respectively, using a highly effective vaccine. With or without including exogenous boosting impact and/or HZ-related costs and health benefits, the 1D strategy is least costly, but 2-dose strategies are cost-effective considering a willingness-to-pay threshold equivalent to the gross domestic product. The model predicted a modest increase in HZ burden during the first 20-30 years, after which time HZ incidence equilibrates at a lower rate than pre-vaccine. Conclusions Our findings support adding a second varicella vaccine dose in Turkey, as doing so is highly cost-effective across a wide range of assumptions regarding the burden associated with varicella and HZ disease.	[Wolfson, Lara J.; Daniels, Vincent J.; Pillsbury, Matthew; Kyle, Jeffrey] Merck & Co Inc, Ctr Observat & Real World Evidence CORE, Kenilworth, NJ 07033 USA; [Kurugol, Zafer] Ege Univ, Fac Med, Dept Pediat, Izmir, Turkey; [Yardimci, Cuneyt] MSD Turkey, Med Affairs, Istanbul, Turkey; [Dinleyici, Ener Cagri] Eskisehir Osmangazi Univ, Fac Med, Dept Pediat, Eskisehir, Turkey; [Wolfson, Lara J.] Merck & Co Inc, Biostat & Res Decis Sci BARDS, Kenilworth, NJ USA; [Kyle, Jeffrey] Atlas Data Syst, Berkeley Hts, NJ USA	Merck & Company; Ege University; Eskisehir Osmangazi University; Merck & Company	Pillsbury, M (corresponding author), Merck & Co Inc, Ctr Observat & Real World Evidence CORE, Kenilworth, NJ 07033 USA.	matthew_pillsbury@merck.com	Dinleyici, Ener Cagri/AAF-8688-2019; Wolfson, Lara/AAC-1400-2019	Dinleyici, Ener Cagri/0000-0002-0339-0134; Wolfson, Lara/0000-0002-6454-3368; Daniels, Vincent/0000-0002-3226-7231; Pillsbury, Matthew/0000-0002-8128-6623	Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA	Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA	This work was funded by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. Employees of the funder participated in the study design, in the analysis and interpretation of the data, in the preparation of the manuscript, and in the decision to submit the manuscript for publication.; Medical writing and editorial assistance was provided by Elizabeth V. Hillyer, DVM. This assistance was funded by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA.	Ahn KH, 2016, J OBSTET GYNAECOL, V36, P563, DOI 10.3109/01443615.2015.1127905; Alp H, 2005, HEALTH POLICY, V72, P119, DOI 10.1016/j.healthpol.2004.03.008; [Anonymous], 2018, WHO VACC PREV DIS MO; Aypak C, 2012, J NIPPON MED SCH, V79, P453, DOI 10.1272/jnms.79.453; Baxter R, 2013, PEDIATRICS, V131, pE1389, DOI 10.1542/peds.2012-3303; Bechini A, 2018, J Prev Med Hyg, V59, pE120; Bechini A, 2015, HUM VACC IMMUNOTHER, V11, P63, DOI 10.4161/hv.34311; Benoit G, 2015, J CLIN VIROL, V72, P4, DOI 10.1016/j.jcv.2015.07.301; Briggs A, 2006, DECISION MODELLING H; Brisson M, 2000, VACCINE, V18, P2775, DOI 10.1016/S0264-410X(00)00100-6; Brisson M, 2000, EPIDEMIOL INFECT, V125, P651, DOI 10.1017/S0950268800004714; Brisson M, 2010, VACCINE, V28, P3385, DOI 10.1016/j.vaccine.2010.02.079; Cheng HY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35451-y; Choi UY, 2016, HUM VACC IMMUNOTHER, V12, P2560, DOI 10.1080/21645515.2016.1190056; Damm O, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1861-8; Devecioglu E, 2018, MIKROBIYOL BUL, V52, P324, DOI 10.5578/mb.67169; Dinleyici EC, 2015, VACCINE, V33, P3983, DOI 10.1016/j.vaccine.2015.06.029; Dinleyici EC, 2012, EUR J PEDIATR, V171, P817, DOI 10.1007/s00431-011-1650-z; Edmunds WJ, 2001, VACCINE, V19, P3076, DOI 10.1016/S0264-410X(01)00044-5; Gaillat J, 2011, CLIN INFECT DIS, V53, P405, DOI 10.1093/cid/cir436; Gurgoze MK, 2006, TURKISH J PEDIATR, V48, P185; Guzzetta G, 2016, AM J EPIDEMIOL, V183, P765, DOI 10.1093/aje/kwv240; Harger JH, 2002, OBSTET GYNECOL, V100, P260, DOI 10.1016/S0029-7844(02)02059-8; Hekimoglu CH, 2018, E MEDITERR HEALTH J, V24, P295, DOI 10.26719/2018.24.3.295; Hethcote HW, 1997, MATH BIOSCI, V145, P89, DOI 10.1016/S0025-5564(97)00014-X; Holl K, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3738-x; IRS, YEARL AV CURR EXCH R; Kanra G, 2002, VACCINE, V20, P1425, DOI 10.1016/S0264-410X(01)00459-5; Kawai K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004833; Kose S, 2013, J INFECT PUBLIC HEAL, V6, P115, DOI 10.1016/j.jiph.2012.10.003; Koturoglu G, 2011, PAEDIATR PERINAT EP, V25, P388, DOI 10.1111/j.1365-3016.2010.01180.x; Kurugol Z, 2018, TURKISH J PEDIATR, V60, P56, DOI 10.24953/turkjped.2018.01.008; Kurugol Z, 2011, INT J INFECT DIS, V15, pE475, DOI 10.1016/j.ijid.2011.03.016; Kuter B, 2004, PEDIATR INFECT DIS J, V23, P132, DOI 10.1097/01.inf.0000109287.97518.67; Lee YH, 2016, J KOREAN MED SCI, V31, P1897, DOI 10.3346/jkms.2016.31.12.1897; Leung J, 2015, PEDIATR INFECT DIS J, V34, P1105, DOI 10.1097/INF.0000000000000821; Littlewood KJ, 2015, CLIN THER, V37, P830, DOI 10.1016/j.clinthera.2015.01.006; Marin M, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3741; Marziano V, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006334; Marziano V, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2509; Mauskopf J, 2018, VALUE HEALTH, V21, P1133, DOI 10.1016/j.jval.2018.08.005; MCLEAN AR, 1993, P ROY SOC B-BIOL SCI, V253, P9, DOI 10.1098/rspb.1993.0075; Melegaro A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1094-7; Merler S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2676; Ogunjimi B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066485; Oh HS, 2017, EPIDEMIOL HEALTH, V39, DOI 10.4178/epih.e2017053; Oh SH, 2014, CLIN VACCINE IMMUNOL, V21, P762, DOI 10.1128/CVI.00645-13; Ouwens MJNM, 2015, CLIN THER, V37, P816, DOI 10.1016/j.clinthera.2014.12.017; Ozkan S, 2005, J TROP PEDIATRICS, V51, P141, DOI 10.1093/tropej/fmh102; Poletti P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060732; Prem K, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005697; Prymula R, 2014, LANCET, V383, P1313, DOI 10.1016/S0140-6736(12)61461-5; Sauboin C, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3759-z; Savas Senay |, 2004, Mikrobiyoloji Bulteni, V38, P69; Schuette MC, 1999, B MATH BIOL, V61, P1031, DOI 10.1006/bulm.1999.0126; Shinefield H, 2005, PEDIATR INFECT DIS J, V24, P665, DOI 10.1097/01.inf.0000172902.25009.a1; Spackova M, 2010, VACCINE, V28, P686, DOI 10.1016/j.vaccine.2009.10.086; Steiner I, 2007, LANCET NEUROL, V6, P1015, DOI 10.1016/S1474-4422(07)70267-3; Talbird SE, 2018, EXPERT REV VACCINES, V17, P1021, DOI 10.1080/14760584.2018.1538801; Trotta M, 2018, INFECTION, V46, P693, DOI 10.1007/s15010-018-1150-4; Valentim J, 2008, VACCINE, V26, P6281, DOI 10.1016/j.vaccine.2008.07.021; van Hoek AJ, 2012, VACCINE, V30, P1225, DOI 10.1016/j.vaccine.2011.11.026; van Hoek AJ, 2011, VACCINE, V29, P2411, DOI 10.1016/j.vaccine.2011.01.037; Weinmann S, 2013, J INFECT DIS, V208, P1859, DOI 10.1093/infdis/jit405; Weitzman D, 2013, J INFECTION, V67, P463, DOI 10.1016/j.jinf.2013.06.016; Zhu S, 2018, AM J INFECT CONTROL, V46, pE1, DOI 10.1016/j.ajic.2017.07.029	66	14	14	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220921	10.1371/journal.pone.0220921	http://dx.doi.org/10.1371/journal.pone.0220921			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408505	Green Published, Green Submitted, gold			2022-12-26	WOS:000485009500024
J	Almerekova, S; Sariev, B; Abugalieva, A; Chudinov, V; Sereda, G; Tokhetova, L; Ortaev, A; Tsygankov, V; Blake, T; Chao, S; Genievskaya, Y; Abugalieva, S; Turuspekov, Y				Almerekova, Shyryn; Sariev, Burabai; Abugalieva, Aigul; Chudinov, Vladimir; Sereda, Grigoriy; Tokhetova, Laura; Ortaev, Anarbai; Tsygankov, Vladimir; Blake, Thomas; Chao, Shiaoman; Genievskaya, Yuliya; Abugalieva, Saule; Turuspekov, Yerlan			Association mapping for agronomic traits in six-rowed spring barley from the USA harvested in Kazakhstan	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ENVIRONMENT INTERACTION; GENETIC-ANALYSIS; GRAIN-YIELD; SOFTWARE; GENOTYPE; QUALITY; LOCI; POPULATIONS; QTL	In barley, six-rowed barley is advantageous over two-rowed barley for feed due to the larger number of seeds per spike and the higher seed protein content. The growth of six-rowed barley is potentially important for breeding in agriculturally oriented countries, such as Kazakhstan. Nevertheless, until recently, very little attention was given to six-rowed barley in breeding projects in Kazakhstan, one of the largest countries in the world. In this study, phenotyping and single nucleotide polymorphism (SNP) genotyping data were generated from 275 accessions originating from six different breeding organizations in the USA as well as 9 accessions from Kazakhstan in field trials at six breeding institutions. The USA six-rowed barley was tested in comparison to local accessions over three years (2009-2011) based on analyses of key agronomic traits. It was determined that the average yield in the USA accessions in comparison to local lines showed heavier yield in all six tested sites. Principal Coordinate Analysis based on 1618 polymorphic SNP markers separated Kazakh lines from six USA barley origin groups based on PC1 (77.9%), and Montana lines from the remaining five USA groups based on PC2 (15.1%). A genome-wide association study based on eighteen field trials allowed the identification of 47 stable marker-trait associations (MTA) for ten agronomic traits, including key yield related characters such as yield per square meter, thousand grain weight, number of kernels per spike, and productive tillers. The comparison of chromosomal positions of identified MTA with positions of known genes and quantitative trait loci suggests that 25 out of those 47 MTAs are presumably novel. The analysis of 42 SNPs associated with 47 MTAs in the Ensemble genome annotation system (http://ensemblgenomes.org) suggested that 40 SNPs were in genic positions of the genome, as their sequences successfully aligned with corresponding Gen ID.	[Almerekova, Shyryn; Genievskaya, Yuliya; Abugalieva, Saule; Turuspekov, Yerlan] Inst Plant Biol & Biotechnol, Alma Ata, Kazakhstan; [Sariev, Burabai; Abugalieva, Aigul] Kazakh Res Inst Agr & Plant Ind, Almalybak, Almaty Region, Kazakhstan; [Chudinov, Vladimir] Karabalyk Breeding Stn, Nauchnyi, Kostanai Region, Kazakhstan; [Sereda, Grigoriy] Karaganda Breeding Stn, Tsentralnoe, Karaganda Regio, Kazakhstan; [Tokhetova, Laura] Kazakh Res Inst Rice, Kyzylorda, Kazakhstan; [Ortaev, Anarbai] Krasnovodopad Breeding Stn, Sarkyrama, Turkestan Regio, Kazakhstan; [Tsygankov, Vladimir] Aktobe Breeding Stn, Aktobe, Aktobe Region, Kazakhstan; [Blake, Thomas] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA; [Chao, Shiaoman] USDA ARS, Biosci Res Lab, Fargo, ND 58105 USA; [Abugalieva, Saule; Turuspekov, Yerlan] Al Farabi Kazakh Natl Univ, Dept Biodivers & Bioresources, Alma Ata, Kazakhstan	Institute of Plant Biology & Biotechnology in Kazakhstan; Kazakh Scientific Research Institute of Plant Protection & Quarantine of Zh.Zhienbaev; Montana State University System; Montana State University Bozeman; United States Department of Agriculture (USDA); Al-Farabi Kazakh National University	Turuspekov, Y (corresponding author), Inst Plant Biol & Biotechnol, Alma Ata, Kazakhstan.; Turuspekov, Y (corresponding author), Al Farabi Kazakh Natl Univ, Dept Biodivers & Bioresources, Alma Ata, Kazakhstan.	yerlant@yahoo.com	Genievskaya, Yuliya/AAF-2410-2019; Turuspekov, Yerlan/C-3458-2011; Almerekova, Shyryn/AAO-1157-2020; Tokhetova, Laura/AAC-6892-2021; Abugalieva, Saule/M-6690-2015	Genievskaya, Yuliya/0000-0001-5987-2952; Turuspekov, Yerlan/0000-0001-8590-1745; Tokhetova, Laura/0000-0003-2053-6956; Abugalieva, Saule/0000-0002-9748-507X; Almerekova, Shyryn/0000-0002-6079-264X	Ministry of Education and Sciences of the Republic of Kazakhstan [0109PK00329]	Ministry of Education and Sciences of the Republic of Kazakhstan(Government of the Republic of KazakhstanMinistry of Education and Science of the Republic of Kazakhstan)	This work was supported by the grant 0109PK00329 funded by the Ministry of Education and Sciences of the Republic of Kazakhstan (2009-2011), (http://edu.gov.kz/kz/) to TY. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLARD RW, 1988, J HERED, V79, P225, DOI 10.1093/oxfordjournals.jhered.a110503; Alqudah AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113120; Aw-Hassan A, 2003, CROP VARIETY IMPROVE, P242; Bayer MM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01792; Bellucci A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173313; Berger GL, 2013, THEOR APPL GENET, V126, P693, DOI 10.1007/s00122-012-2011-7; Blake VC, 2012, PLANT GENOME-US, V5, P81, DOI 10.3835/plantgenome2012.03.0002; Bowman JGP, 2001, CROP SCI, V41, P863, DOI 10.2135/cropsci2001.413863x; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Cockram J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045307; Costa JM, 2001, THEOR APPL GENET, V103, P415, DOI 10.1007/s001220100622; Casao MC, 2011, J EXP BOT, V62, P1939, DOI 10.1093/jxb/erq382; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Franckowiak J.D., 1997, BARLEY GENET NEWSL, V26, P9; Genievskaya Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205421; Hayes PM, 2003, DEV PL GEN, V7, P201, DOI 10.1016/S0168-7972(03)80012-9; Hu X, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01683; IBSC, 2016, HIGH RES GBS MAP MOR, DOI [10.5447/ipk/2016/29, DOI 10.5447/IPK/2016/29]; Igartua E, 2013, GENET RESOUR CROP EV, V60, P251, DOI 10.1007/s10722-012-9831-9; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Korte A, 2012, NAT GENET, V44, P1066, DOI 10.1038/ng.2376; Liller CB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140246; Mangini G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190162; Mohammadi M, 2015, THEOR APPL GENET, V128, P705, DOI 10.1007/s00122-015-2465-5; Munoz-Amatriain M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094688; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; Pauli D., 2014, PLANT GENOME, V7, P3, DOI DOI 10.3835/PLANTGEN0ME2013.11.0037; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Pswarayi A, 2008, EUPHYTICA, V163, P435, DOI 10.1007/s10681-008-9726-1; Reynolds MP, 2002, FIELD CROP RES, V75, P139, DOI 10.1016/S0378-4290(02)00023-0; RIGGS TJ, 1978, J AGR SCI, V91, P199, DOI 10.1017/S0021859600056768; Rode J, 2012, MOL BREEDING, V30, P831, DOI 10.1007/s11032-011-9667-6; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Saade S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32586; Sameri M, 2006, BREEDING SCI, V56, P243, DOI 10.1270/jsbbs.56.243; Semagn K, 2014, MOL BREEDING, V33, P1, DOI 10.1007/s11032-013-9917-x; Sharma R, 2018, J EXP BOT, V69, P3811, DOI 10.1093/jxb/ery178; TAKAHASHI R, 1951, BER OHARA I LANDWIRT, V9, P399; Turuspekov Y, 2008, CEREAL CHEM, V85, P817, DOI 10.1094/CCHEM-85-6-0817; Turuspekov Y, 2005, PLANT BREEDING, V124, P542, DOI 10.1111/j.1439-0523.2005.01161.x; Turuspekov Y, 2013, RUSS J GENET+, V49, P196, DOI 10.1134/S1022795413020129; Turuspekov Y, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-015-0686-z; Turuspekov Y, 2014, BREEDING SCI, V64, P399, DOI 10.1270/jsbbs.64.399; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang GW, 2010, THEOR APPL GENET, V120, P1559, DOI 10.1007/s00122-010-1276-y; Wang MH, 2012, THEOR APPL GENET, V124, P233, DOI 10.1007/s00122-011-1697-2; Xu X, 2018, PLANT GENOME-US, V11, DOI 10.3835/plantgenome2017.08.0073; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702	53	7	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0221064	10.1371/journal.pone.0221064	http://dx.doi.org/10.1371/journal.pone.0221064			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404111	Green Published, gold, Green Submitted			2022-12-26	WOS:000485006800052
J	Ledezma, CA; Zhou, X; Rodriguez, B; Tan, PJ; Diaz-Zuccarini, V				Ledezma, Carlos A.; Zhou, Xin; Rodriguez, Blanca; Tan, P. J.; Diaz-Zuccarini, Vanessa			A modeling and machine learning approach to ECG feature engineering for the detection of ischemia using pseudo-ECG	PLOS ONE			English	Article							ACTION-POTENTIAL DURATION; ELECTROPHYSIOLOGICAL PROPERTIES; MYOCARDIAL-INFARCTION; HEART-DISEASE; QT INTERVAL; REPOLARIZATION; VARIABILITY; REFRACTORINESS; POPULATIONS; DISPERSION	Early detection of coronary heart disease (CHD) has the potential to prevent the millions of deaths that this disease causes worldwide every year. However, there exist few automatic methods to detect CHD at an early stage. A challenge in the development of these methods is the absence of relevant datasets for their training and validation. Here, the ten Tusscher-Panfilov 2006 model and the O'Hara-Rudy model for human myocytes were used to create two populations of models that were in concordance with data obtained from healthy individuals (control populations) and included inter-subject variability. The effects of ischemia were subsequently included in the control populations to simulate the effects of mild and severe ischemic events on single cells, full ischemic cables of cells and cables of cells with various sizes of ischemic regions. Action potential and pseudo-ECG biomarkers were measured to assess how the evolution of ischemia could be quantified. Finally, two neural network classifiers were trained to identify the different degrees of ischemia using the pseudo-ECG biomarkers. The control populations showed action potential and pseudo-ECG biomarkers within the physiological ranges and the trends in the biomarkers commonly identified in ischemic patients were observed in the ischemic populations. On the one hand, inter-subject variability in the ischemic pseudo-ECGs precluded the detection and classification of early ischemic events using any single biomarker. On the other hand, the neural networks showed sensitivity and positive predictive value above 95%. Additionally, the neural networks revealed that the biomarkers that were relevant for the detection of ischemia were different from those relevant for its classification. This work showed that a computational approach could be used, when data is scarce, to validate proof-of-concept machine learning methods to detect ischemic events.	[Ledezma, Carlos A.; Tan, P. J.; Diaz-Zuccarini, Vanessa] UCL, Dept Mech Engn, London, England; [Zhou, Xin; Rodriguez, Blanca] Univ Oxford, Dept Comp Sci, Oxford, England; [Diaz-Zuccarini, Vanessa] UCL, Wellcome EPSRC Ctr Intervent & Surg Sci WEISS, Dept Med Phys & Biomed Engn, London W1W 7TS, England	University of London; University College London; University of Oxford; UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of London; University College London	Diaz-Zuccarini, V (corresponding author), UCL, Dept Mech Engn, London, England.; Diaz-Zuccarini, V (corresponding author), UCL, Wellcome EPSRC Ctr Intervent & Surg Sci WEISS, Dept Med Phys & Biomed Engn, London W1W 7TS, England.	v.diaz@ucl.ac.uk	Zhou, Xin/AAR-3098-2021	Zhou, Xin/0000-0003-2814-3399; Tan, P.J./0000-0001-8098-8837; Rodriguez, Blanca/0000-0001-6361-3339	European Union [642612, 675451]; Leverhulme Trust [RF-2015-482]; Wellcome/EPSRC Centre for Interventional and Surgical Sciences (WEISS) [203145Z/16/Z]; Wellcome Trust Senior Research Fellowship in Basic Biomedical Sciences	European Union(European Commission); Leverhulme Trust(Leverhulme Trust); Wellcome/EPSRC Centre for Interventional and Surgical Sciences (WEISS)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust Senior Research Fellowship in Basic Biomedical Sciences(Wellcome Trust)	CL and VD received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 642612 under the VPH-CaSE ITN framework (http://vphcase.eu). VD received funding from the Leverhulme Trust through the Senior Research Fellowship "Exploring the Unknowable Using Simulation: Structural Uncertainty in Multiscale Models" (Fellowship number RF-2015-482). VD is also supported by the Wellcome/EPSRC Centre for Interventional and Surgical Sciences (WEISS) (203145Z/16/Z). BR and XZ are supported by BR's Wellcome Trust Senior Research Fellowship in Basic Biomedical Sciences and the European Union's Horizon 2020 research and innovation programme under Grant Agreement No. 675451 (CompBioMed project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CL and VD received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 642612 under the VPH-CaSE ITN framework (http://vph-case.eu). VD also received funding from the Leverhulme Trust through the Senior Research Fellowship "Exploring the Unknowable Using Simulation: Structural Uncertainty in Multiscale Models" (Fellowship number RF-2015-482). BR and XZ are supported by BR's Wellcome Trust Senior Research Fellowship in Basic Biomedical Sciences and the European Union's Horizon 2020 research and innovation programme under Grant Agreement No. 675451 (CompBioMed project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya UR, 2017, INFORM SCIENCES, V415, P190, DOI 10.1016/j.ins.2017.06.027; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Britton OJ, 2017, ELECTROGENIC NA K PU; Britton OJ, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00597; CINCA J, 1981, AM J CARDIOL, V48, P1023, DOI 10.1016/0002-9149(81)90315-5; Coronel R, 2012, HEART RHYTHM, V9, P977, DOI 10.1016/j.hrthm.2012.01.021; Cybenko G., 1989, Mathematics of Control, Signals, and Systems, V2, P303, DOI 10.1007/BF02551274; Datta S, 2017, INT CONF SOFT COMP, P1; De Bacquer D, 1998, HEART, V80, P570, DOI 10.1136/hrt.80.6.570; Dutta AMS, 2013, COMPUT CARDIOL CONF, V40, P691; Dutta S, 2017, PROG BIOPHYS MOL BIO, V129, P40, DOI 10.1016/j.pbiomolbio.2017.02.007; Dutta S, 2016, PROG BIOPHYS MOL BIO, V120, P236, DOI 10.1016/j.pbiomolbio.2016.01.008; Garson G.D., 1991, AI EXPERT, V6, P46; Gemmell P, 2016, PROG BIOPHYS MOL BIO, V121, P169, DOI 10.1016/j.pbiomolbio.2016.06.003; Gima K, 2002, CIRC RES, V90, P889, DOI 10.1161/01.RES.0000016960.61087.86; GOH ATC, 1995, ARTIF INTELL ENG, V9, P143, DOI 10.1016/0954-1810(94)00011-S; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Goodfellow I., 2016, DEEP LEARNING, DOI DOI 10.4258/HIR.2016.22.4.351; Hong S. J., 2017, P COMP CARD CINC 201, P1; Lines GT, 2017, IEEE T BIO-MED ENG, V64, P1305, DOI 10.1109/TBME.2016.2600198; Loewe A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/530352; Lu WG, 2010, COMPUT CARDIOL CONF, V37, P185; Lyon A, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0821; MAEDA T, 1992, CLIN CARDIOL, V15, P525, DOI 10.1002/clc.4960150710; Martinez JP, 2017, COMPUTING, V44, P1; Mckay MD, 2000, TECHNOMETRICS, V42, P55, DOI 10.2307/1271432; Michailova A, 2005, BIOPHYS J, V88, P2234, DOI 10.1529/biophysj.104.046284; Michelucci A, 1996, PACE, V19, P1905, DOI 10.1111/j.1540-8159.1996.tb03250.x; Moller CS, 2007, HEART; MORGAN JM, 1992, J AM COLL CARDIOL, V19, P1244, DOI 10.1016/0735-1097(92)90331-G; Muszkiewicz A, 2018, AM J PHYSIOL-HEART C, V314, pH895, DOI 10.1152/ajpheart.00477.2017; Muszkiewicz A, 2016, PROG BIOPHYS MOL BIO, V120, P115, DOI 10.1016/j.pbiomolbio.2015.12.002; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Passini E, 2016, J MOL CELL CARDIOL, V96, P72, DOI 10.1016/j.yjmcc.2015.09.003; Pettersson J, 2000, AM HEART J, V139, P352, DOI 10.1016/S0002-8703(00)90246-1; Plonsey R., 2007, BIOELECTRICITY QUANT; Rautaharju PM, 2009, J AM COLL CARDIOL, V53, P982, DOI 10.1016/j.jacc.2008.12.014; Sanchez C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105897; Schiesser W., 2012, NUMERICAL METHOD LIN; Shaw RM, 1997, CIRC RES, V80, P124, DOI 10.1161/01.RES.80.1.124; Sutton PMI, 2000, HEART, V84, P365, DOI 10.1136/heart.84.4.365; Taggart P, 2001, CARDIOVASC RES, V50, P454, DOI 10.1016/S0008-6363(01)00223-1; Teijeiro T, 2017, COMPUT CARDIOL CONF, V44, DOI 10.22489/CinC.2017.166-054; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Wilhelms M, 2011, IEEE T BIO-MED ENG, V58, P2961, DOI 10.1109/TBME.2011.2159381; Wood G, 2014, MED DECIS MAKING, V34, P75, DOI 10.1177/0272989X13492016; Zabihi M, 2017, COMPUT CARDIOL CONF, V44, DOI 10.22489/CinC.2017.069-336; Zhou X, 2016, CIRC RES, V118, P266, DOI 10.1161/CIRCRESAHA.115.307836	49	15	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220294	10.1371/journal.pone.0220294	http://dx.doi.org/10.1371/journal.pone.0220294			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404081	Green Published, Green Submitted, gold			2022-12-26	WOS:000485006800011
J	Ruoff, P; Agafonov, O; Tveit, DM; Thorsen, K; Drengstig, T				Ruoff, Peter; Agafonov, Oleg; Tveit, Daniel M.; Thorsen, Kristian; Drengstig, Tormod			Homeostatic controllers compensating for growth and perturbations	PLOS ONE			English	Article							ROBUST PERFECT ADAPTATION; FEEDBACK; PRINCIPLE; KINETICS; SIGNAL	Cells and organisms have developed homeostatic mechanisms which protect them against a changing environment. How growth and homeostasis interact is still not well understood, but of increasing interest to the molecular and synthetic biology community to recognize and design control circuits which can oppose the diluting effects of cell growth. In this paper we describe the performance of selected negative feedback controllers in response to different applied growth laws and time dependent outflow perturbations of a controlled variable. The approach taken here is based on deterministic mass action kinetics assuming that cell content is instantaneously mixed. All controllers behave ideal in the sense that they for stepwise perturbations in volume and a controlled compound A are able to drive A precisely back to the controllers' theoretical set-points. The applied growth kinetics reflect experimentally observed growth laws, which range from surface to volume ratio growth to linear and exponential growth. Our results show that the kinetic implementation of integral control and the structure of the negative feedback loop are two properties which affect controller performance. Best performance is observed for controllers based on derepression kinetics and controllers with an autocatalytic implementation of integral control. Both are able to defend exponential growth and perturbations, although the autocatalytic controller shows an offset from its theoretical set-point. Controllers with activating signaling using zero-order or bimolecular (antithetic) kinetics for integral control behave very similar but less well. Their performance can be improved by implementing negative feedback structures having repression/derepression steps or by increasing controller aggressiveness. Our results provide a guide what type of feedback structures and integral control kinetics are suitable to oppose the dilution effects by different growth laws and time dependent perturbations on a deterministic level.	[Ruoff, Peter; Agafonov, Oleg] Univ Stavanger, Ctr Organelle Res, Stavanger, Norway; [Tveit, Daniel M.; Thorsen, Kristian; Drengstig, Tormod] Univ Stavanger, Dept Elect Engn & Comp Sci, Stavanger, Norway; [Agafonov, Oleg] Oslo Univ Hosp, Inst Canc Res, Oslo, Norway	Universitetet i Stavanger; Universitetet i Stavanger; University of Oslo	Ruoff, P (corresponding author), Univ Stavanger, Ctr Organelle Res, Stavanger, Norway.	peter.ruoff@uis.no			University of Stavanger	University of Stavanger	This research was financed in part by Program Area Funds from the University of Stavanger to PR and TD. There was no additional external funding received for this study. The University of Stavanger (funder) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bernard C., 1957, INTRO LIT CORRES TON; Briat C, 2016, ACS SYNTH BIOL, V5, P1108, DOI 10.1021/acssynbio.6b00014; Briat C, 2016, CELL SYST, V2, P15, DOI [10.1016/j.cels.2016.02.010, 10.1016/j.cels.2016.01.004]; Cannon WB, 1929, PHYSIOL REV, V9, P399, DOI 10.1152/physrev.1929.9.3.399; DEANGELIS DL, 1980, POSITIVE FEEDBACK NA; Drengstig T, 2012, BIOPHYS J, V103, P2000, DOI 10.1016/j.bpj.2012.09.033; Drengstig T, 2012, J PHYS CHEM B, V116, P5355, DOI 10.1021/jp3004568; El-Samad H, 2002, J THEOR BIOL, V214, P17, DOI 10.1006/jtbi.2001.2422; Ferrell JE, 2016, CELL SYST, V2, P62, DOI 10.1016/j.cels.2016.02.006; Fjeld G, 2017, J PHYS CHEM B, V121, P6097, DOI 10.1021/acs.jpcb.7b01989; Forger DB, 2017, BIOL CLOCKS RHYTHMS; FRANCIS BA, 1976, AUTOMATICA, V12, P457, DOI 10.1016/0005-1098(76)90006-6; FROMME P, 2008, PHOTOSYNTHETIC PROTE; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GILLESPIE DT, 1992, PHYSICA A, V188, P404, DOI 10.1016/0378-4371(92)90283-V; Gomez-Schiavon M, 2018, CURR OPIN MICROBIOL, V45, P47, DOI 10.1016/j.mib.2018.01.004; Goodwin B., 1963, TEMPORAL ORG CELLS; Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149; ISIDORI A, 1990, IEEE T AUTOMAT CONTR, V35, P131, DOI 10.1109/9.45168; JACOB F, 1961, COLD SPRING HARB SYM, V26, P193, DOI 10.1101/SQB.1961.026.01.024; Jacques-Silva MC, 2010, P NATL ACAD SCI USA, V107, P6465, DOI 10.1073/pnas.0908935107; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Langley L. L., 1973, HOMEOSTASIS ORIGINS; Leibiger IB, 2002, FEBS LETT, V532, P1, DOI 10.1016/S0014-5793(02)03627-X; Lim B, 2013, P NATL ACAD SCI USA, V110, P10330, DOI 10.1073/pnas.1303635110; Mrosovsky N., 1990, RHEOSTASIS PHYSL CHA; Ni XY, 2009, BIOPHYS J, V97, P1244, DOI 10.1016/j.bpj.2009.06.030; Peters A, 2007, AM J PHYSIOL-REG I, V293, pR83, DOI 10.1152/ajpregu.00907.2006; Poza-Carrion C, 2014, J BACTERIOL, V196, P595, DOI 10.1128/JB.00942-13; Qian YL, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0902; Radhakrishnan K., 1993, NASA REFERENCE PUBLI; Risvoll GB, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13408; Schmalhausen I, 1930, Wilhelm Roux Arch Entwickl Mech Org, V121, P726, DOI 10.1007/BF00583349; Selye H, 1938, AM J PHYSIOL, V123, P758, DOI 10.1152/ajplegacy.1938.123.3.758; Selye H, 1975, STRESS LIFE, DOI [10.1016/j.cels.2016.02.006, DOI 10.1016/J.CELS.2016.02.006]; Shoval O, 2010, P NATL ACAD SCI USA, V107, P15995, DOI 10.1073/pnas.1002352107; Smith JH, 1924, NEW PHYTOL, V2, P65, DOI [DOI 10.1111/J.1469-8137.1924.TB06621.X, 10.1111/j.1469-8137.1924.tb06621.x]; Sontag ED, 2003, SYST CONTROL LETT, V50, P119, DOI 10.1016/S0167-6911(03)00136-1; Thomas MK, 2000, DIABETES, V49, P2039, DOI 10.2337/diabetes.49.12.2039; Thorsen K, 2018, BIORXIV; Thorsen K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107766; UMBARGER HE, 1961, COLD SPRING HARB SYM, V26, P301, DOI 10.1101/SQB.1961.026.01.036; von Bertalanffy L., 1960, FUNDAMENTAL ASPECTS, P137, DOI 10.1016/b978-0-408-10638-2.50012-4; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; VONBERTALANFFY L, 1951, AM NAT, V85, P111, DOI 10.1086/281659; Wilkie J, 2002, CONTROL ENG INTRODUC; Wilkinso D.J., 2006, STOCHASTIC MODELLING; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649	50	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0207831	10.1371/journal.pone.0207831	http://dx.doi.org/10.1371/journal.pone.0207831			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404092	Green Published, Green Submitted, gold			2022-12-26	WOS:000485006800001
J	Wyper, GMA; Grant, I; Fletcher, E; McCartney, G; Stockton, DL				Wyper, Grant M. A.; Grant, Ian; Fletcher, Eilidh; McCartney, Gerry; Stockton, Diane L.			The impact of worldwide, national and sub-national severity distributions in Burden of Disease studies: A case study of cancers in Scotland	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; GLOBAL BURDEN	Background Increasingly Burden of Disease (BOD) measures are being used to influence policy decisions because they summarise the complete effects of morbidity and mortality in an equitable manner. An important element of producing non-fatal BOD estimates are severity distributions. The Global Burden of Disease (GBD) study use the same severity distributions across countries due to a lack of available country-specific data. In the Scottish BOD (SBOD) study we developed national severity distributions for cancer types. The main aim of this study was to consider the extent to which the use of worldwide severity distributions in BOD studies are influencing cross-country comparisons, by comparing weighted-average disability weights (DW) based on GBD severity distributions with nationally derived severity distributions in Scotland for cancer types. Methods We obtained individual records from the Scottish Cancer Registry for 21 cancer types and linked these to registered deaths. We estimated prevalent cancer cases for 2016 and assigned each case to sequelae using GBD 2016 study definitions. We compared the impact of using severity distributions based on GBD 2016, a Scotland-wide distribution, and distributions specific to deprivation strata in Scotland, on the weighted-average DW for each cancer type. Results The relative difference in point estimates of weighted-average DW based on GBD 2016 worldwide severity distributions compared with Scottish national severity distributions resulted in overestimates in the majority of cancers (17 out of 21 cancer types). The largest overestimates were for gallbladder and biliary tract cancer (70.8%), oesophageal cancer (31.6%) and pancreatic cancer (31.2%). Furthermore, the use of weighted-average DW based on Scottish national severity distributions rather than sub-national Scottish severity distributions stratified by deprivation quintile overestimated weighted-average DW in the least deprived areas (16 out of 18 cancer types), and underestimated in the most deprived areas (16 out of 18 cancer types). Conclusion Our findings illustrate a bias in point estimates of weighted-average DW created using worldwide severity distributions. This bias would have led to the misrepresentation of non-fatal estimates of the burden of individual cancers, and underestimated the scale of socioeconomic inequality in this non-fatal burden. This highlights the importance of not interpreting non-fatal estimates of burden of disease too precisely, especially for sub-national estimates and those comparing populations when relying on data inputs from other countries. It is essential to ensure that any estimates are based upon country-specific data as far as possible.	[Wyper, Grant M. A.; McCartney, Gerry; Stockton, Diane L.] NHS Hlth Scotland, Publ Hlth Sci Directorate, Glasgow, Lanark, Scotland; [Grant, Ian; Fletcher, Eilidh] NHS Natl Serv Scotland, Informat Serv Div, Edinburgh, Midlothian, Scotland	NHS National Services Scotland	Wyper, GMA (corresponding author), NHS Hlth Scotland, Publ Hlth Sci Directorate, Glasgow, Lanark, Scotland.	gwyper@nhs.net	Wyper, Grant/AAF-2382-2020	Wyper, Grant/0000-0003-2854-5822; McCartney, Gerry/0000-0001-6341-3521	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	We would like to acknowledge the GBD 2016 cancer collaborators for making detailed and transparent model definitions publically available as part of the GBD 2016 technical appendix. Additionally, we would like to thank members of the European Commission funded 'Joint Action on Health Information (InfAct)' workshop in Paris in April 2019 for productive discussions on the use of severity distributions in BOD studies.	AbouZahr C, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1299978; Burstein R, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0064-y; Devleesschauwer B, 2018, EUR J PUBLIC HEALTH, V28, P283; Global Burden of Disease Collaborative Network, 2017, GLOB BURD DIS STUD 2; Grant I, 2018, SCOTLANDS POPULATION; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; Information Services Division Scotland, COLORECTAL CANC; Information Services Division Scotland, LUNG CANC MES; Information Services Division Scotland, SCOTT CANC REG; James SL, 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32279-7, 10.1016/s0140-6736(18)32279-7]; King NB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195338; Leyland AH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-172; Marinho F, 2018, LANCET, V392, P760, DOI 10.1016/S0140-6736(18)31221-2; Mesalles-Naranjo O, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196906; Murray C.J, 1996, GLOBAL BURDEN DIS CO; National Center for Health Statistics Centers for Disease Control and Prevention, US MORT FIL 61 YEAR; National Records of Scotland, VIT EV DEATHS; O'Donovan MR, 2018, EUR J PUBLIC HEALTH, V28, P773, DOI 10.1093/eurpub/cky060; Ock M, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2904-5; Rommel A, 2018, BUNDESGESUNDHEITSBLA, V61, P1159, DOI 10.1007/s00103-018-2793-0; Roth GA, 2018, LANCET, V392, P1736, DOI [10.1016/S0140-6736(18)32203-7, 10.1016/s0140-6736(18)32203-7]; Sankaranarayanan R, 2011, CANC SURVIVAL AFRICA; Scottish Government, 2016, SCOTT IND MULT DEPR; Scottish Government, LONG TERM MON HLTH I; Spasoff RA, 1986, P WORKSH COMP LINK H; Steel N, 2018, LANCET, V392, P1647, DOI [10.1016/S0140-6736(18)32207-4, 10.1016/s0140-6736(18)32207-4]; Turan JM, 2019, BMC MED, V17, DOI 10.1186/s12916-018-1246-9; United States Department of Health & Human Services, INT CLASS DIS 9 REV; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2	29	14	14	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0221026	10.1371/journal.pone.0221026	http://dx.doi.org/10.1371/journal.pone.0221026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398232	Green Published, gold, Green Submitted			2022-12-26	WOS:000485004000043
J	Criado-Mesas, L; Ballester, M; Crespo-Piazuelo, D; Castello, A; Benitez, R; Fernandez, AI; Folch, JM				Criado-Mesas, Lourdes; Ballester, Maria; Crespo-Piazuelo, Daniel; Castello, Anna; Benitez, Rita; Isabel Fernandez, Ana; Folch, Josep M.			Analysis of porcine IGF2 gene expression in adipose tissue and its effect on fatty acid composition	PLOS ONE			English	Article							GROWTH-FACTOR-II; IGF2-INTRON3-G3072A SUBSTITUTION; IMPRINTED QTL; MEAT QUALITY; MUSCLE MASS; SKELETAL; POPULATION; METABOLISM; DEPOSITION; VARIANTS	IGF2:g.3072G>A polymorphism has been described as the causal mutation of a maternally imprinted QTL for muscle growth and fat deposition in pigs. The objective of the current work was to study the association between the IGF2:g.3072G>A polymorphism and the IGF2 gene expression and its effect on fatty acid composition in adipose tissue in different pig genetic backgrounds. A cis-eQTL region associated with the IGF2 mRNA expression in adipose tissue was identified in an eGWAS with 355 animals. The IGF2 gene was located in this genomic interval and IGF2g.3072G>A was the most significant SNP, explaining a 25% of the gene expression variance. Significant associations between IGF2:g.3072G>A polymorphism and oleic (C18:1(n-9); p-value = 4.18x10(-07)), hexadecanoic (C16:1(n-9); p-value = 4.04x10(-07)), linoleic (C18:2(n-6); p-value = 6.44x10(-09)), alpha-linoleic (C18:3(n-3); p-value = 3.30x10(-06)), arachidonic (C20:4(n-6); p-value = 9.82x10(-08)) FAs and the MUFA/PUFA ratio (p-value = 2.51x10(-9)) measured in backfat were identified. Animals carrying the A allele showed an increase in IGF2 gene expression and higher PUFA and lower MUFA content. However, in additional studies was observed that there could be other proximal genetic variants affecting FA composition in adipose tissue. Finally, no differences in the IGF2 gene expression in adipose tissue were found between heterozygous animals classified according to the IGF2:g.3072G>A allele inherited from the father (A(P)G(M) or A(M)G(P)). However, pyrosequencing analysis revealed that there is imprinting of the IGF2 gene in muscle and adipose tissues, with stronger differences among the paternally and maternally inherited alleles in muscle. Our results suggested that IGF2:g.3072G>A polymorphism plays an important role in the regulation of IGF2 gene expression and can be involved in the fatty acid composition in adipose tissue. In both cases, further studies are still needed to deepen the mechanism of regulation of IGF2 gene expression in adipose tissue and the IGF2 role in FA composition.	[Criado-Mesas, Lourdes; Crespo-Piazuelo, Daniel; Castello, Anna; Folch, Josep M.] UB, UAB, IRTA, Dept Genom Anim,Ctr Recerca Agrigenom CRAG,CSIC, Barcelona, Spain; [Ballester, Maria] IRTA, Dept Genet & Millora Anim, Caldes De Montbui, Spain; [Crespo-Piazuelo, Daniel; Castello, Anna; Folch, Josep M.] UAB, Fac Vet, Dept Ciencia Anim & Aliments, Bellaterra, Spain; [Benitez, Rita; Isabel Fernandez, Ana] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Mejora Genet Anim, Madrid, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; University of Barcelona; IRTA; Autonomous University of Barcelona; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Criado-Mesas, L (corresponding author), UB, UAB, IRTA, Dept Genom Anim,Ctr Recerca Agrigenom CRAG,CSIC, Barcelona, Spain.	lourdes.criado@cragenomica.es	Fernández, Ana Isabel/J-3265-2012; Benítez, Rita/AAL-6381-2020; Ballester, Maria/E-7201-2016; Crespo-Piazuelo, Daniel/K-2280-2015; Farré, Anna Castelló/K-9637-2015; Folch, Josep M/I-4738-2015	Fernández, Ana Isabel/0000-0002-1509-5191; Ballester, Maria/0000-0002-5413-4640; Crespo-Piazuelo, Daniel/0000-0001-7896-2507; Farré, Anna Castelló/0000-0001-8497-6251; Criado Mesas, Lourdes/0000-0002-1115-4131; BENITEZ, RITA/0000-0001-7459-2836; Folch, Josep M/0000-0003-3689-1303	Spanish Ministerio de Economia y Competitividad (MINECO); Fondo Europeo de Desarrollo Regional (FEDER) [AGL2014-56369-C2, AGL2017-82641-R]; FPI grant [AGL2014-56369-C2]; "Ramon y Cajal" contract from the Spanish Ministerio de Economia y Competitividad [RYC-2013-12573]; "Formacio i Contractacio de Personal Investigador Novell" (FI-DGR) Ph.D grant from the Generalitat de Catalunya [ECO/1788/2014]; Spanish Ministerio de Economia y Competitividad [SEV-2015-0533]	Spanish Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); FPI grant; "Ramon y Cajal" contract from the Spanish Ministerio de Economia y Competitividad; "Formacio i Contractacio de Personal Investigador Novell" (FI-DGR) Ph.D grant from the Generalitat de Catalunya; Spanish Ministerio de Economia y Competitividad(Spanish Government)	This work was supported by the Spanish Ministerio de Economia y Competitividad (MINECO) and the Fondo Europeo de Desarrollo Regional (FEDER) with project references: AGL2014-56369-C2 and AGL2017-82641-R (http://www.mineco.gob.es/portal/site/mineco/and http://ec.europa.eu/regional_policy/es/funding/erdf/). LCM was financially supported by a FPI grant from the AGL2014-56369-C2 project. MB was funded with a "Ramon y Cajal" contract (RYC-2013-12573) from the Spanish Ministerio de Economia y Competitividad. DCP was funded by a "Formacio i Contractacio de Personal Investigador Novell" (FI-DGR) Ph.D grant from the Generalitat de Catalunya (ECO/1788/2014). We acknowledge the support of the Spanish Ministerio de Economia y Competitividad for the "Severo Ochoa Programme for Centres of Excellence in R&D" 2016-2019 (SEV-2015-0533) to the Centre for Research in Agricultural Genomics and the CERCA Programme/Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfares MN, 2018, AM J PHYSIOL-ENDOC M, V315, pE1098, DOI 10.1152/ajpendo.00409.2017; Martinez JA, 2014, ADV NUTR, V5, P71, DOI 10.3945/an.113.004705; Amaya I, 2005, SOCIETY, V11, P1405; Aslan O, 2012, MOL BIOL REP, V39, P4101, DOI 10.1007/s11033-011-1192-5; Ballester M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080385; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Braunschweig MH, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-47; Braunschweig MH, 2004, GENOMICS, V84, P1021, DOI 10.1016/j.ygeno.2004.09.006; Chao W, 2008, CYTOKINE GROWTH F R, V19, P111, DOI 10.1016/j.cytogfr.2008.01.005; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Cianfarani Stefano, 2012, Front Endocrinol (Lausanne), V3, P118, DOI 10.3389/fendo.2012.00118; Estelle J, 2005, J ANIM SCI, V83, P2723; Faisal M, 2014, GENE, V533, P434, DOI 10.1016/j.gene.2013.10.006; Gardan D, 2008, DOMEST ANIM ENDOCRIN, V34, P45, DOI 10.1016/j.domaniend.2006.10.001; Hong J, 2015, MEAT SCI, V110, P46, DOI 10.1016/j.meatsci.2015.06.011; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; JANSEN GR, 1966, BIOCHEM J, V99, P323, DOI 10.1042/bj0990323; Jeon JT, 1999, NAT GENET, V21, P157, DOI 10.1038/5938; Jungerius BJ, 2004, GENET RES, V84, P95, DOI 10.1017/S0016672304007098; Laggai S, 2014, J LIPID RES, V55, P1087, DOI 10.1194/jlr.M045500; Li C, 2008, ANIM BIOTECHNOL, V19, P22, DOI 10.1080/10495390701758563; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livingstone C, 2014, CLIN ENDOCRINOL, V80, P773, DOI 10.1111/cen.12446; Lopez-Buesa P, 2013, JOINT ANAL ADDITIVE, P133, DOI [10.1111/age.12091, DOI 10.1111/AGE.12091]; Markljung E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000256; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Nezer C, 1999, NAT GENET, V21, P155, DOI 10.1038/5935; Pavelic K, 2002, MOL MED, V8, P771, DOI 10.1007/BF03402082; Perez-Enciso M, 2000, J ANIM SCI, V78, P2525; Puig-Oliveras A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31803; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramayo-Caldas Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-232; Ruan WJ, 2010, ACTA DIABETOL, V47, P5, DOI 10.1007/s00592-009-0142-3; Sambrook J., MOL CLONING LAB MANU; Smedley D, 2015, NUCLEIC ACIDS RES, V43, pW589, DOI 10.1093/nar/gkv350; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Van Wyk JJ, 1999, J CLIN ENDOCR METAB, V84, P4349, DOI 10.1210/jc.84.12.4349; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019; Wood JD, 2004, MEAT SCI, V66, P21, DOI 10.1016/S0309-1740(03)00022-6; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	41	8	8	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220708	10.1371/journal.pone.0220708	http://dx.doi.org/10.1371/journal.pone.0220708			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393967	Green Published, Green Submitted, gold			2022-12-26	WOS:000485002500055
J	Luchniak, A; Mahamdeh, M; Howard, J				Luchniak, Anna; Mahamdeh, Mohammed; Howard, Jonathon			Nicotinamide adenine dinucleotides and their precursor NMN have no direct effect on microtubule dynamics in purified brain tubulin	PLOS ONE			English	Article							WALLERIAN DEGENERATION; NAD; REVEALS; INJURY; ACTIVATION; MECHANISMS; SYNAPSES; SIRT1; AXONS; ASSAY	Microtubules are dynamic cytoskeletal polymers that provide mechanical support for cellular structures, and play important roles in cell division, migration, and intracellular transport. Their intrinsic dynamic instability, primarily controlled by polymerization-dependent GTP hydrolysis, allows for rapid rearrangements of microtubule arrays in response to signaling cues. In neurons, increases in intracellular levels of nicotinamide adenine dinucleotide (NAD(+)) can protect against microtubule loss and axonal degeneration elicited by axonal transection. The protective effects of NAD(+) on microtubule loss have been shown to be indirect in some systems, for example through the sirtuin-3 pathway. However, it is still possible that NAD(+) and related metabolites have direct effects on microtubule dynamics to promote assembly or inhibit disassembly. To address this question, we reconstituted microtubule dynamics in an in vitro assay with purified bovine brain tubulin and examined the effects of NAD(+), NADH, and NMN. We found that the compounds had only small effects on the dynamics at the plus and minus ends of the microtubules. Furthermore, these effects were not statistically significant. Consequently, our data support earlier findings that NADs and their precursors influence microtubule growth through indirect mechanisms.	[Luchniak, Anna; Mahamdeh, Mohammed; Howard, Jonathon] Yale Univ, Dept Mol Biophys & Biochem, Yale Sch Med, New Haven, CT 06520 USA; [Mahamdeh, Mohammed] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA USA	Yale University; Harvard University; Massachusetts General Hospital	Howard, J (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, Yale Sch Med, New Haven, CT 06520 USA.	jonathon.howard@yale.edu	Luchniak, Anna/AAW-6834-2020; Mahamdeh, Mohammed/AAG-6530-2019		National Institutes of Health [R01 GM110386, DP1 M110065]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH110065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	JH (R01 GM110386 and DP1 M110065) received funding from the National Institutes of Health, www.nih.gov.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy P, 2006, BIOCHEM BIOPH RES CO, V345, P1386, DOI 10.1016/j.bbrc.2006.05.042; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Babetto E, 2010, J NEUROSCI, V30, P13291, DOI 10.1523/JNEUROSCI.1189-10.2010; Brown KD, 2014, CELL METAB, V20, P1059, DOI 10.1016/j.cmet.2014.11.003; Camacho-Pereira J, 2016, CELL METAB, V23, P1127, DOI 10.1016/j.cmet.2016.05.006; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Chang JH, 2002, J BIOL CHEM, V277, P34489, DOI 10.1074/jbc.M205460200; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Chen L, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006503; Chini CCS, 2017, MOL CELL ENDOCRINOL, V455, P62, DOI 10.1016/j.mce.2016.11.003; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; D'Angelo I, 2000, STRUCTURE, V8, P993, DOI 10.1016/S0969-2126(00)00190-8; Di Stefano M, 2015, CELL DEATH DIFFER, V22, P731, DOI 10.1038/cdd.2014.164; Di Stefano M, 2017, CURR BIOL, V27, P784, DOI 10.1016/j.cub.2017.01.070; Fanara P, 2007, J BIOL CHEM, V282, P23465, DOI 10.1074/jbc.M703434200; Fang YS, 2012, CURR BIOL, V22, P590, DOI 10.1016/j.cub.2012.01.065; Gell C, 2010, METHOD CELL BIOL, V95, P221, DOI 10.1016/S0091-679X(10)95013-9; Gilley J, 2015, CELL REP, V10, P1974, DOI 10.1016/j.celrep.2015.02.060; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Gupta RS, 1996, BIOCHEM MOL BIOL INT, V38, P1211; Harkcom WT, 2014, P NATL ACAD SCI USA, V111, pE2443, DOI 10.1073/pnas.1404269111; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kapitein LC, 2015, NEURON, V87, P492, DOI 10.1016/j.neuron.2015.05.046; Kleele T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5827; Loreto A, 2015, CELL REP, V13, P2539, DOI 10.1016/j.celrep.2015.11.032; Ma N, 2016, BIOMED OPT EXPRESS, V7, P2441, DOI 10.1364/BOE.7.002441; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Mahamdeh M, 2018, J MICROSC-OXFORD, V272, P60, DOI 10.1111/jmi.12744; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Sasaki Y, 2009, J NEUROSCI, V29, P6526, DOI 10.1523/JNEUROSCI.1429-09.2009; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Wang JT, 2012, J CELL BIOL, V196, P7, DOI 10.1083/jcb.201108111; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yu QR, 2009, J PHOTOCH PHOTOBIO B, V95, P46, DOI 10.1016/j.jphotobiol.2008.12.010; Zhu XH, 2015, P NATL ACAD SCI USA, V112, P2876, DOI 10.1073/pnas.1417921112	41	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220794	10.1371/journal.pone.0220794	http://dx.doi.org/10.1371/journal.pone.0220794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393939	Green Published, gold, Green Submitted			2022-12-26	WOS:000485002500063
J	Montgomery, MK; Osborne, B; Brandon, AE; O'Reilly, L; Fiveash, CE; Brown, SHJ; Wilkins, BP; Samsudeen, A; Yu, J; Devanapalli, B; Hertzog, A; Tolun, AA; Kavanagh, T; Cooper, AA; Mitchell, TW; Biden, TJ; Smith, NJ; Cooney, GJ; Turner, N				Montgomery, Magdalene K.; Osborne, Brenna; Brandon, Amanda E.; O'Reilly, Liam; Fiveash, Corrine E.; Brown, Simon H. J.; Wilkins, Brendan P.; Samsudeen, Azrah; Yu, Josephine; Devanapalli, Beena; Hertzog, Ashley; Tolun, Adviye A.; Kavanagh, Tomas; Cooper, Antony A.; Mitchell, Todd W.; Biden, Trevor J.; Smith, Nicola J.; Cooney, Gregory J.; Turner, Nigel			Regulation of mitochondrial metabolism in murine skeletal muscle by the medium-chain fatty acid receptor Gpr84	FASEB JOURNAL			English	Article						mitochondrial function; insulin secretion; insulin resistance	PROTEIN-COUPLED-RECEPTOR; DIFFERENTIAL EXPRESSION ANALYSIS; INSULIN-SECRETION; PEPTIDE-1 SECRETION; ENERGY-EXPENDITURE; GLUCOSE-METABOLISM; GENE-EXPRESSION; WEIGHT-LOSS; MAP KINASE; PHOSPHORYLATION	Fatty acid receptors have been recognized as important players in glycaemic control. This study is the first to describe a role for the medium-chain fatty acid (MCFA) receptor G-protein-coupled receptor (Gpr) 84 in skeletal muscle mitochondrial function and insulin secretion. We are able to show that Gpr84 is highly expressed in skeletal muscle and adipose tissue. Mice with global deletion of Gpr84 [Gpr84 knockout (KO)] exhibit a mild impairment in glucose tolerance when fed a MCFA-enriched diet. Studies in mice and pancreatic islets suggest that glucose intolerance is accompanied by a defect in insulin secretion. MCFA-fed KO mice also exhibit a significant impairment in the intrinsic respiratory capacity of their skeletal muscle mitochondria, but at the same time also exhibit a substantial increase in mitochondrial content. Changes in canonical pathways of mitochondrial biogenesis and turnover are unable to explain these mitochondrial differences. Our results show that Gpr84 plays a crucial role in regulating mitochondrial function and quality control.	[Montgomery, Magdalene K.; Osborne, Brenna; Fiveash, Corrine E.; Wilkins, Brendan P.; Samsudeen, Azrah; Yu, Josephine; Turner, Nigel] Univ New South Wales UNSW Sydney, Sch Med Sci, Dept Pharmacol, Sydney, NSW, Australia; [Cooper, Antony A.; Biden, Trevor J.; Smith, Nicola J.] Univ New South Wales UNSW Sydney, St Vincents Clin Sch, Sydney, NSW, Australia; [Montgomery, Magdalene K.] Univ Melbourne, Sch Biomed Sci, Dept Physiol, Melbourne, Vic, Australia; [Brandon, Amanda E.; O'Reilly, Liam; Biden, Trevor J.; Cooney, Gregory J.] Garvan Inst Med Res, Diabet & Metab Div, Sydney, NSW, Australia; [Kavanagh, Tomas; Cooper, Antony A.] Garvan Inst Med Res, Neurosci Div, Sydney, NSW, Australia; [Brandon, Amanda E.; Cooney, Gregory J.] Univ Sydney, Fac Med & Hlth, Charles Perkins Ctr, Sydney, NSW, Australia; [Tolun, Adviye A.] Univ Sydney, Fac Med & Hlth, Discipline Genom Med, Sydney, NSW, Australia; [Tolun, Adviye A.] Univ Sydney, Fac Med & Hlth, Discipline Child & Adolescent Hlth, Sydney, NSW, Australia; [Brown, Simon H. J.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia; [Mitchell, Todd W.] Univ Wollongong, Sch Med, Wollongong, NSW, Australia; [Brown, Simon H. J.; Mitchell, Todd W.] Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Wilkins, Brendan P.; Smith, Nicola J.] Victor Chang Cardiac Res Inst, Div Mol Cardiol & Biophys, Sydney, NSW, Australia; [Devanapalli, Beena; Hertzog, Ashley; Tolun, Adviye A.] Sydney Childrens Hosp Network, New South Wales NSW Biochem Genet Lab, Westmead, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of Melbourne; Garvan Institute of Medical Research; Garvan Institute of Medical Research; University of Sydney; University of Sydney; University of Sydney; University of Wollongong; University of Wollongong; University of Wollongong; Victor Chang Cardiac Research Institute	Turner, N (corresponding author), Univ New South Wales, Sch Med Sci, Dept Pharmacol, Kensington, NSW 2052, Australia.	n.turner@unsw.edu.au	Turner, Nigel/H-7176-2013; Osborne, Brenna/F-5950-2018; Fiveash, Corrine E/I-6360-2018; Yu, Josephine/AHI-4832-2022; Biden, Trevor/AAW-2829-2021; Mitchell, Todd/G-7044-2012	Turner, Nigel/0000-0002-0119-9328; Osborne, Brenna/0000-0002-0197-3010; Yu, Josephine/0000-0002-4615-5257; Smith, Nicola J/0000-0002-7247-9562; Fiveash, Corrine/0000-0002-4700-993X; Wilkins, Brendan/0000-0003-1541-3695; Mitchell, Todd/0000-0002-1372-9963; Tolun, Adviye/0000-0003-2321-6667; Montgomery, Magdalene/0000-0003-2551-4174; Biden, Trevor/0000-0001-5211-0234; Kavanagh, Tomas/0000-0003-2184-3552	National Health and Medical Research Council of Australia; Australian Research Council; University of Wollongong; National Health and Medical Research Council (NHMRC) Career Development Fellowship; NIH National Human Genome Research Institute (NHGRI) [U01HG004085]; CSD Consortium [U01HG004080]; Children's Hospital Oakland Research Institute (CHORI) [U42RR024244]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); University of Wollongong; National Health and Medical Research Council (NHMRC) Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NIH National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); CSD Consortium; Children's Hospital Oakland Research Institute (CHORI)	The authors thank Prof. Bob Graham (Victor Chang Cardiac Research Institute) and Dr. Michael Lazarou (Monash University, Melbourne, VIC, Australia) for generous advice on aspects of this study. This work was supported by funding from the National Health and Medical Research Council of Australia, the Australian Research Council, and the University of Wollongong. M.K.M. was supported by a National Health and Medical Research Council (NHMRC) Career Development Fellowship. Gpr84tm1(KOMP)Vlcg embryonic stem cells used for this research project were generated by the Trans-U.S. National Institutes of Health (NIH) Knockout Mouse Project and obtained from the Knockout Mouse Project Repository (www.komp.org).NIH National Human Genome Research Institute (NHGRI) Grant U01HG004085 to Velocigene at Regeneron, and the CSD Consortium (U01HG004080) funded the generation of gene-targeted embryonic stem cells for 8500 genes in the Knockout Mouse Project Program and archived and distributed by the Knockout Mouse Project Repository at the University of California-Davis (Davis, CA, USA), and Children's Hospital Oakland Research Institute (CHORI; U42RR024244). Animal work was made possible thanks to kind staff in the University of New South Wales Biological Resources Centre and the Garvan Institute Biological Testing Facility. The authors declare no conflicts of interest.	Adiconis X, 2013, NAT METHODS, V10, P623, DOI 10.1038/nmeth.2483; Affaitati A, 2003, J BIOL CHEM, V278, P4286, DOI 10.1074/jbc.M209941200; BABA N, 1982, AM J CLIN NUTR, V35, P678, DOI 10.1093/ajcn/35.4.678; Baker JG, 2007, TRENDS PHARMACOL SCI, V28, P374, DOI 10.1016/j.tips.2007.06.011; Biden TJ, 2004, DIABETES, V53, pS159, DOI 10.2337/diabetes.53.2007.S159; Boden MJ, 2012, AM J PHYSIOL-ENDOC M, V303, pE798, DOI 10.1152/ajpendo.00577.2011; Bou R, 2008, ANAL BIOCHEM, V377, P1, DOI 10.1016/j.ab.2008.02.029; Bouchard C, 2007, GLIA, V55, P790, DOI 10.1002/glia.20506; Buege J A, 1978, Methods Enzymol, V52, P302; Cantley J, 2009, DIABETES, V58, P1826, DOI 10.2337/db09-0132; Cleasby ME, 2011, J ENDOCRINOL, V210, P81, DOI 10.1530/JOE-11-0039; Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024; Cotton LM, 2015, MAMM GENOME, V26, P142, DOI 10.1007/s00335-015-9555-1; Dagda RK, 2015, REV NEUROSCIENCE, V26, P359, DOI 10.1515/revneuro-2014-0085; Dickey AS, 2011, J NEUROSCI, V31, P15716, DOI 10.1523/JNEUROSCI.3159-11.2011; Dinkova-Kostova AT, 2015, FREE RADICAL BIO MED, V88, P179, DOI 10.1016/j.freeradbiomed.2015.04.036; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Du Toit E, 2018, EUR J NUTR, V57, P1737, DOI 10.1007/s00394-017-1456-5; Duarte A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100387; Elagizi A, 2018, PROG CARDIOVASC DIS, V61, P76, DOI 10.1016/j.pcad.2018.03.006; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Han JR, 2007, METABOLISM, V56, P985, DOI 10.1016/j.metabol.2007.03.005; Han JR, 2003, OBES RES, V11, P734, DOI 10.1038/oby.2003.103; Herst PM, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00296; Holt LJ, 2018, ENDOCRINOLOGY, V159, P1339, DOI 10.1210/en.2017-00851; Huang QY, 2014, DEV COMP IMMUNOL, V45, P252, DOI 10.1016/j.dci.2014.03.017; Ishikawa Y, 2003, MOL CELL NEUROSCI, V24, P451, DOI 10.1016/S1044-7431(03)00203-3; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jin KL, 2002, J NEUROCHEM, V80, P119, DOI 10.1046/j.0022-3042.2001.00678.x; Jump DB, 1999, ANNU REV NUTR, V19, P63, DOI 10.1146/annurev.nutr.19.1.63; Kebede M, 2008, DIABETES, V57, P2432, DOI 10.2337/db08-0553; Kraegen EW, 2008, CURR OPIN LIPIDOL, V19, P235, DOI 10.1097/01.mol.0000319118.44995.9a; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lauffer LM, 2009, DIABETES, V58, P1058, DOI 10.2337/db08-1237; Lee HJ, 2004, J NEUROCHEM, V88, P647, DOI 10.1111/j.1471-4159.2004.02191.x; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu Y, 2016, ACS MED CHEM LETT, V7, P579, DOI 10.1021/acsmedchemlett.6b00025; Loh JK, 2015, BBA-MOL CELL RES, V1853, P1796, DOI 10.1016/j.bbamcr.2015.04.013; Mahmud Zobaer Al, 2017, Sci Rep, V7, P17953, DOI 10.1038/s41598-017-18159-3; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Montgomery MK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14214-1; Montgomery MK, 2013, J LIPID RES, V54, P3322, DOI 10.1194/jlr.M040451; Montgomery MK, 2012, EXP GERONTOL, V47, P211, DOI 10.1016/j.exger.2011.11.014; Muller MM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00828-y; Nagasaki H, 2012, FEBS LETT, V586, P368, DOI 10.1016/j.febslet.2012.01.001; Nicol LSC, 2015, J NEUROSCI, V35, P8959, DOI 10.1523/JNEUROSCI.3558-14.2015; Oh DY, 2011, CURR OPIN CLIN NUTR, V14, P322, DOI 10.1097/MCO.0b013e3283479230; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Palikaras K, 2018, NAT CELL BIOL, V20, P1013, DOI 10.1038/s41556-018-0176-2; Papamandjaris AA, 1998, LIFE SCI, V62, P1203, DOI 10.1016/S0024-3205(97)01143-0; Pickles S, 2018, CURR BIOL, V28, pR170, DOI 10.1016/j.cub.2018.01.004; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; St-Onge MP, 2008, AM J CLIN NUTR, V87, P621, DOI 10.1093/ajcn/87.3.621; St-Onge MP, 2003, OBES RES, V11, P395, DOI 10.1038/oby.2003.53; Stoddart LA, 2008, PHARMACOL REV, V60, P405, DOI 10.1124/pr.108.00802; Stockli J, 2015, DIABETES, V64, P1914, DOI 10.2337/db13-1489; Sugden PH, 1997, CELL SIGNAL, V9, P337, DOI 10.1016/S0898-6568(96)00191-X; Suzuki M, 2013, J BIOL CHEM, V288, P10684, DOI 10.1074/jbc.M112.420042; Swanson D, 2012, ADV NUTR, V3, P1, DOI 10.3945/an.111.000893; Talukdar S, 2011, TRENDS PHARMACOL SCI, V32, P543, DOI 10.1016/j.tips.2011.04.004; Tang C, 2015, NAT MED, V21, P173, DOI 10.1038/nm.3779; Tiganis T, 2011, TRENDS PHARMACOL SCI, V32, P82, DOI 10.1016/j.tips.2010.11.006; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Trzcionka M, 2008, J EXP BIOL, V211, P1911, DOI 10.1242/jeb.016519; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Turner N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05613-7; Turner N, 2009, DIABETES, V58, P2547, DOI 10.2337/db09-0784; Venkataraman C, 2005, IMMUNOL LETT, V101, P144, DOI 10.1016/j.imlet.2005.05.010; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200; Wei L, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0970-y; Wein S, 2009, DIABETES-METAB RES, V25, P185, DOI 10.1002/dmrr.925; Wittenberger T, 2001, J MOL BIOL, V307, P799, DOI 10.1006/jmbi.2001.4520; Yousefi S, 2001, J LEUKOCYTE BIOL, V69, P1045	76	13	14	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12264	12276		10.1096/fj.201900234R	http://dx.doi.org/10.1096/fj.201900234R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31415180	Green Published			2022-12-26	WOS:000507461600052
J	Lenz, A; Lenz, G; Ku, HT; Ferreri, K; Kandeel, F				Lenz, Ayelet; Lenz, Gal; Ku, Hsun Teresa; Ferreri, Kevin; Kandeel, Fouad			Islets from human donors with higher but not lower hemoglobin A1c levels respond to gastrin treatment in vitro	PLOS ONE			English	Article							PROTON PUMP INHIBITORS; IMPROVES GLYCEMIC CONTROL; HUMAN PANCREATIC-ISLETS; EPIDERMAL-GROWTH-FACTOR; BETA-CELL PHENOTYPE; INSULIN-SECRETION; SERUM GASTRIN; COMBINATION THERAPY; GLUCOSE-TOLERANCE; DOUBLE-BLIND	Gastrin is a peptide hormone, which in combination with other factors such as TGF alpha, EGF or GLP-1, is capable of increasing beta cell mass and lowering blood glucose levels in adult diabetic mice. In humans, administration of a bolus of gastrin alone induces insulin secretion suggesting that gastrin may target islet cells. However, whether gastrin alone is sufficient to exert an effect on isolated human islets has been controversial and the mechanism remained poorly understood. Therefore, in this study we started to examine the effects of gastrin alone on cultured adult human islets. Treatment of isolated human islets with gastrin I for 48 h resulted in increased expression of insulin, glucagon and somatostatin transcripts. These increases were significantly correlated with the levels of donor hemoglobin A1c (HbA(1c)) but not BMI or age. In addition, gastrin treatment resulted in increased expression of PDX1, NKX6.1, NKX2.2, MNX1 and HHEX in islets from donors with HbA(1c) greater than 42 mmol/mol. The addition of YM022, an antagonist of the gastrin receptor cholecystokinin B receptor (CCKBR), together with gastrin eliminated these effects, verifying that the effects of gastrin are mediated through CCKBR. CCKBR is expressed in somatostatin-expressing delta cells in islets from all donors. However, in the islets from donors with higher HbA(1c) (greater than 42 mmol/mol [6.0%]), cells triple-positive for CCKBR, somatostatin and insulin were detected, suggesting a de-differentiation or trans-differentiation of endocrine cells. Our results demonstrate a direct effect of gastrin on human islets from prediabetic or diabetic individuals that is mediated through CCKBR+ cells. Further, our data imply that gastrin may be a potential treatment for diabetic patients.	[Lenz, Ayelet; Lenz, Gal; Ku, Hsun Teresa; Ferreri, Kevin; Kandeel, Fouad] City Hope Natl Med Ctr, Beckman Res Inst, Dept Translat Res & Cellular Therapeut, Diabet & Metab Res Inst, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Lenz, A (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Translat Res & Cellular Therapeut, Diabet & Metab Res Inst, Duarte, CA 91010 USA.	ayelet.lenz@gmail.com		Ku, Hsun/0000-0001-5662-9893	National Institutes of Health [R01DK099734]; Wanek Family Project for Type 1 Diabetes; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099734] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wanek Family Project for Type 1 Diabetes; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by R01DK099734 from the National Institutes of Health to H. T. K and the Wanek Family Project for Type 1 Diabetes to F.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelsson AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15652; Baggio LL, 2006, ANNU REV MED, V57, P265, DOI 10.1146/annurev.med.57.110104.115624; Barchetta I, 2015, ACTA DIABETOL, V52, P873, DOI 10.1007/s00592-015-0721-4; BARDRAM L, 1990, P NATL ACAD SCI USA, V87, P298, DOI 10.1073/pnas.87.1.298; Blum B, 2014, ELIFE, V3, DOI 10.7554/eLife.02809; Bodvarsdottir TB, 2010, DIABETOLOGIA, V53, P2220, DOI 10.1007/s00125-010-1825-6; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; CADIOT G, 1995, GASTROEN CLIN BIOL, V19, P811; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Dahan T, 2017, DIABETES, V66, P426, DOI 10.2337/db16-0641; Dalboge LS, 2014, J PHARMACOL EXP THER, V350, P353, DOI 10.1124/jpet.114.215293; Foucaud M, 2008, REGUL PEPTIDES, V145, P17, DOI 10.1016/j.regpep.2007.09.024; Fujita Y, 2018, J DIABETES INVESTIG; Gao T, 2014, CELL METAB, V19, P259, DOI 10.1016/j.cmet.2013.12.002; Gonzalez-Ortiz M, 2015, DIABETES RES CLIN PR, V108, pE11, DOI 10.1016/j.diabres.2015.01.039; Guo SL, 2013, J CLIN INVEST, V123, P3305, DOI 10.1172/JCI65390; Gutierrez GD, 2017, J CLIN INVEST, V127, P244, DOI 10.1172/JCI88017; Han N, 2015, CAN J DIABETES, V39, P24, DOI 10.1016/j.jcjd.2013.10.008; Han TS, 1998, DIABETIC MED, V15, P129, DOI 10.1002/(SICI)1096-9136(199802)15:2<129::AID-DIA535>3.3.CO;2-U; Hove KD, 2013, DIABETOLOGIA, V56, P22, DOI 10.1007/s00125-012-2714-y; Hu YM, 2006, WORLD J GASTROENTERO, V12, P4750, DOI 10.3748/wjg.v12.i29.4750; Hunter CS, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00035; Komatsu H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183780; Komatsu H, 2016, BIOCHEM BIOPH RES CO, V470, P534, DOI 10.1016/j.bbrc.2016.01.110; Lan H, 2003, DIABETES, V52, P688, DOI 10.2337/diabetes.52.3.688; LARSSON LI, 1976, NATURE, V262, P609, DOI 10.1038/262609a0; Lavine JA, 2010, ENDOCRINOLOGY, V151, P3577, DOI 10.1210/en.2010-0233; Ligumsky M, 2001, J CLIN GASTROENTEROL, V33, P32, DOI 10.1097/00004836-200107000-00008; Lupi R, 2002, DIABETES, V51, pS134, DOI 10.2337/diabetes.51.2007.S134; Morisset J, 2003, J HISTOCHEM CYTOCHEM, V51, P1501, DOI 10.1177/002215540305101110; Muraro MJ, 2016, CELL SYST, V3, P385, DOI 10.1016/j.cels.2016.09.002; Napolitano T, 2015, SEMIN CELL DEV BIOL, V44, P107, DOI 10.1016/j.semcdb.2015.08.013; NISHIDA A, 1994, J PHARMACOL EXP THER, V269, P725; Nishimura W, 2015, DIABETOLOGIA, V58, P566, DOI 10.1007/s00125-014-3464-9; Noble F, 1999, PHARMACOL REV, V51, P745; Pan FC, 2015, DEVELOPMENT, V142, P3637, DOI 10.1242/dev.126011; REHFELD JF, 1976, J CLIN INVEST, V58, P41, DOI 10.1172/JCI108457; REHFELD JF, 1973, J CLIN INVEST, V52, P1415, DOI 10.1172/JCI107315; Reubi JC, 2003, GASTROENTEROLOGY, V125, P98, DOI 10.1016/S0016-5085(03)00697-8; Rooman I, 2004, DIABETOLOGIA, V47, P259, DOI 10.1007/s00125-003-1287-1; Russ HA, 2008, DIABETES, V57, P1575, DOI 10.2337/db07-1283; Saillan-Barreau C, 1999, DIABETES, V48, P2015, DOI 10.2337/diabetes.48.10.2015; Segerstolpe A, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020; Sheen E, 2011, DIGEST DIS SCI, V56, P931, DOI 10.1007/s10620-010-1560-3; Singh PK, 2012, J CLIN ENDOCR METAB, V97, pE2105, DOI 10.1210/jc.2012-1720; Spijker HS, 2015, DIABETES, V64, P2928, DOI 10.2337/db14-1752; Suarez-Pinzon WL, 2008, CELL TRANSPLANT, V17, P631, DOI 10.3727/096368908786092775; Suarez-Pinzon WL, 2005, J CLIN ENDOCR METAB, V90, P3401, DOI 10.1210/jc.2004-0761; Taylor BL, 2013, CELL REP, V4, P1262, DOI 10.1016/j.celrep.2013.08.010; Tellez N, 2011, ENDOCRINOLOGY, V152, P2580, DOI 10.1210/en.2011-0066; Teo AKK, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-017-0014-5; WANG TC, 1993, J CLIN INVEST, V92, P1349, DOI 10.1172/JCI116708; Wang YJ, 2016, CELL METAB, V24, P616, DOI 10.1016/j.cmet.2016.09.007; Wang ZY, 2014, CELL METAB, V19, P872, DOI 10.1016/j.cmet.2014.03.010; White MG, 2013, DIABETES CARE, V36, P3818, DOI 10.2337/dc13-0705; Xiang AH, 2006, DIABETES, V55, P517, DOI 10.2337/diabetes.55.02.06.db05-1066; Yadlapati R, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0804-x; Yuan SY, 1996, DIFFERENTIATION, V61, P67, DOI 10.1046/j.1432-0436.1996.6110067.x; Zhang J, 2014, GENE DEV, V28, P829, DOI 10.1101/gad.235499.113	59	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0221456	10.1371/journal.pone.0221456	http://dx.doi.org/10.1371/journal.pone.0221456			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430329	gold, Green Published, Green Submitted			2022-12-26	WOS:000485026800058
J	Rai, SN; Srivastava, S; Pan, JM; Wu, XY; Rai, SP; Mekmaysy, CS; DeLeeuw, L; Chaires, JB; Garbett, NC				Rai, Shesh N.; Srivastava, Sudhir; Pan, Jianmin; Wu, Xiaoyong; Rai, Somesh P.; Mekmaysy, Chongkham S.; DeLeeuw, Lynn; Chaires, Jonathan B.; Garbett, Nichola C.			Multi-group diagnostic classification of high-dimensional data using differential scanning calorimetry plasma thermograms	PLOS ONE			English	Article							MELANOMA PATIENTS; BLOOD-PLASMA; DSC ANALYSIS; PROTEOME; SERUM; TOOL	The thermoanalytical technique differential scanning calorimetry (DSC) has been applied to characterize protein denaturation patterns (thermograms) in blood plasma samples and relate these to a subject's health status. The analysis and classification of thermograms is challenging because of the high-dimensionality of the dataset. There are various methods for group classification using high-dimensional data sets; however, the impact of using high-dimensional data sets for cancer classification has been poorly understood. In the present article, we proposed a statistical approach for data reduction and a parametric method (PM) for modeling of high-dimensional data sets for two- and three-group classification using DSC and demographic data. We compared the PM to the non-parametric classification method K-nearest neighbors (KNN) and the semi-parametric classification method KNN with dynamic time warping (DTW). We evaluated the performance of these methods for multiple two-group classifications: (i) normal versus cervical cancer, (ii) normal versus lung cancer, (iii) normal versus cancer (cervical + lung), (iv) lung cancer versus cervical cancer as well as for three-group classification: normal versus cervical cancer versus lung cancer. In general, performance for two-group classification was high whereas three-group classification was more challenging, with all three methods predicting normal samples more accurately than cancer samples. Moreover, specificity of the PM method was mostly higher or the same as KNN and DTW-KNN with lower sensitivity. The performance of KNN and DTW-KNN decreased with the inclusion of demographic data, whereas similar performance was observed for the PM which could be explained by the fact that the PM uses fewer parameters as compared to KNN and DTW-KNN methods and is thus less susceptible to the risk of overfitting. More importantly the accuracy of the PM can be increased by using a greater number of quantile data points and by the inclusion of additional demographic and clinical data, providing a substantial advantage over KNN and DTW-KNN methods.	[Rai, Shesh N.; Pan, Jianmin; Wu, Xiaoyong] Univ Louisville, James Graham Brown Canc Ctr, Biostat & Bioinformat Facil, Louisville, KY 40292 USA; [Rai, Shesh N.; Srivastava, Sudhir] Univ Louisville, Dept Bioinformat & Biostat, Louisville, KY 40292 USA; [Srivastava, Sudhir] ICAR Indian Agr Stat Res Inst, Ctr Agr Bioinformat, New Delhi, India; [Rai, Somesh P.] Univ Louisville, Sch Publ Hlth & Informat Sci, Louisville, KY 40292 USA; [Mekmaysy, Chongkham S.; DeLeeuw, Lynn; Chaires, Jonathan B.; Garbett, Nichola C.] Univ Louisville, Dept Med, Louisville, KY 40292 USA; [Chaires, Jonathan B.; Garbett, Nichola C.] Univ Louisville, James Graham Brown Canc Ctr, Biophys Core Facil, Louisville, KY 40292 USA	University of Louisville; University of Louisville; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Statistics Research Institute; University of Louisville; University of Louisville; University of Louisville	Rai, SN (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Biostat & Bioinformat Facil, Louisville, KY 40292 USA.; Rai, SN (corresponding author), Univ Louisville, Dept Bioinformat & Biostat, Louisville, KY 40292 USA.; Garbett, NC (corresponding author), Univ Louisville, Dept Med, Louisville, KY 40292 USA.; Garbett, NC (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Biophys Core Facil, Louisville, KY 40292 USA.	shesh.rai@louisville.edu; nichola.garbett@louisville.edu		Rai, Shesh/0000-0002-8377-353X	National Institutes of Health [P20 RR018733, P20 GM103482]; National Cancer Institute of the National Institutes of Health [R21CA187345]; Department of Defense Lung Cancer Research Program [W81XWH-15-1-0178]; Kentucky Science and Technology Corporation [COMMFUND-1517-RFP-017]; National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI129959]; Kentucky Lung Cancer Research Program Cycle 16 [GB170558]; James Graham Brown Cancer Center; Wendell Cherry Chair in Clinical Trial Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI129959] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense Lung Cancer Research Program; Kentucky Science and Technology Corporation; National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Kentucky Lung Cancer Research Program Cycle 16; James Graham Brown Cancer Center; Wendell Cherry Chair in Clinical Trial Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Collection of plasma thermogram data was supported by use of the Biophysical Core Facility at the James Graham Brown Cancer Center and by grants P20 RR018733 and P20 GM103482 from the National Institutes of Health. NCG was supported by the National Cancer Institute of the National Institutes of Health under Award Number R21CA187345, by the Department of Defense Lung Cancer Research Program under Award Number W81XWH-15-1-0178, by the Kentucky Science and Technology Corporation under Award Number COMMFUND-1517-RFP-017 and by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number R01AI129959. SNR and SS were supported by the Kentucky Lung Cancer Research Program Cycle 16 under Award Number GB170558. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to acknowledge the University of Louisville and the Indian Council of Agricultural Research for providing facilities to carry out the research. SNR was supported partially by Dr. Jason Chesney, Director James Graham Brown Cancer Center and the Wendell Cherry Chair in Clinical Trial Research. We thank the Biorepository/Clinical Trials Office of the James Graham Brown Cancer Center for invaluable assistance in providing access to patient samples and clinical data for this study. We thank Dr. Gabriela Schneider and Alagammai Kaliappan for critical reading of the manuscript.	Chagovetz AA, 2013, NEUROSURGERY, V73, P289, DOI 10.1227/01.neu.0000430296.23799.cd; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Crammer K, 2002, J MACH LEARN RES, V2, P265, DOI 10.1162/15324430260185628; Fekecs T, 2012, J THERM ANAL CALORIM, V108, P149, DOI 10.1007/s10973-011-1800-6; Fish DJ, 2010, BIOPHYS CHEM, V152, P184, DOI 10.1016/j.bpc.2010.09.007; Fox J., 2018, R COMPANION APPL REG, VThird; Garbett NC, 2008, BIOPHYS J, V94, P1377, DOI 10.1529/biophysj.107.119453; Garbett NC, 2007, SEMIN NEPHROL, V27, P621, DOI 10.1016/j.semnephrol.2007.09.004; Garbett NC, 2007, CLIN CHEM, V53, P2012, DOI 10.1373/clinchem.2007.091165; Garbett NC, 2016, BBA-GEN SUBJECTS, V1860, P981, DOI 10.1016/j.bbagen.2015.10.004; Garbett NC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084710; Garbett NC, 2013, BBA-GEN SUBJECTS, V1830, P4675, DOI 10.1016/j.bbagen.2013.05.007; Garbett NC, 2009, EXP MOL PATHOL, V86, P186, DOI 10.1016/j.yexmp.2008.12.001; Giorgino T, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i07; Hastie TJ, 1992, STAT MODELS S; Kendrick SK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186232; Kikalishvili L, 2015, J THERM ANAL CALORIM, V120, P501, DOI 10.1007/s10973-015-4426-2; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Mayoraz E, 1999, LECT NOTES COMPUT SC, V1607, P833; Michnik A, 2010, J THERM ANAL CALORIM, V102, P57, DOI 10.1007/s10973-009-0602-6; R Core Team, 2021, R LANGUAGE ENV STAT; Rai S N, 2013, OPEN ACCESS MED STAT, V3, P1, DOI [10.2147/OAMS.S40069, DOI 10.2147/OAMS.S40069]; Ripley B. D., 1996, PATTERN RECOGNITION; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Sun Y, 2006, P 23 INT C MACH LEAR, P913, DOI DOI 10.1145/1143844.1143959; Sun YJ, 2007, IEEE T PATTERN ANAL, V29, P1035, DOI 10.1109/TPAMI.2007.1093; Todinova Svetla, 2016, International Journal of Bioautomation, V20, P115; Todinova S, 2011, ANAL CHEM, V83, P7992, DOI 10.1021/ac202055m; Vega S, 2015, SCI REP-UK, V5, DOI 10.1038/srep07988; Velazquez-Campoy A, 2018, BBA-GEN SUBJECTS, V1862, P1701, DOI 10.1016/j.bbagen.2018.04.020; Venables WN., 2002, MODERN APPL STAT S, V4; Xiang D, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.e21085; Zapf I, 2011, THERMOCHIM ACTA, V524, P88, DOI 10.1016/j.tca.2011.06.019	34	6	6	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0220765	10.1371/journal.pone.0220765	http://dx.doi.org/10.1371/journal.pone.0220765			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430304	Green Published, Green Submitted, gold			2022-12-26	WOS:000485026800014
J	Sulewska, H; Ratajczak, K; Panasiewicz, K; Kalaji, HM				Sulewska, Hanna; Ratajczak, Karolina; Panasiewicz, Katarzyna; Kalaji, Hazem M.			Can pyraclostrobin and epoxiconazole protect conventional and stay-green maize varieties grown under drought stress?	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; GAS-EXCHANGE; WATER-STRESS; METABOLIC-CHANGES; PLANT-RESPONSES; SOYBEAN GROWTH; PHOTOSYNTHESIS; YIELD; AZOXYSTROBIN; SENESCENCE	Risks associated with drought are increasing and are a global problem. Therefore, there is a need for new solutions for the safe production of food, while maintaining respect for the environment. Fungicides are designed to protect maize plants against disease, but some of the active substances used in preparations can also promote plant growth, which is known as the 'physiological effect'. However, there is a paucity of information as to how some of the 'new generation' fungicides act in stimulating grain yield in plants under abiotic stress, especially drought. Therefore, the effects of these products on conventional and stay-green maize varieties need to be better understood in order to reduce losses caused by droughts and to maximize production. In this study, the effect of a pyraclostrobin + epoxiconazole fungicide preparation on maize plants was evaluated at different times after spraying; during induced drought conditions and again during the regeneration process of the plants. The preparation was applied to 'KWS 1325' (conventional) and 'Ambrosini' (stay-green) varieties at the recommended dose, three times in greenhouse conditions. Plant gas exchange, plant water use efficiency, chlorophyll fluorescence and fresh and dry plant biomass were evaluated. The pyraclostrobin + epoxiconazole preparation increased stomatal conductance and photosynthesis intensity in the 'Ambrosini' plants. When maintained under a high light intensity, the variety used increased efficiency and exchanged excessive energy in the form of thermal energy to protect the maize leaf from light-induced damage under drought stress. Plant photosynthetic efficiency (ETR and Yield parameters) during drought stress and after regeneration was significantly higher in treated plants than in the controls. Thus, the beneficial effects on the physiology of the maize varieties grown under drought stress from the fungicide application are significant for farmers and growers.	[Sulewska, Hanna; Ratajczak, Karolina; Panasiewicz, Katarzyna] Poznan Univ Life Sci, Fac Agron & Bioengn, Dept Agron, Poznan, Poland; [Kalaji, Hazem M.] Warsaw Univ Life Sci WULS SGGW, Fac Agr & Biol, Dept Plant Physiol, Warsaw, Poland	Poznan University of Life Sciences; Warsaw University of Life Sciences	Ratajczak, K (corresponding author), Poznan Univ Life Sci, Fac Agron & Bioengn, Dept Agron, Poznan, Poland.	karolina.ratajczak@up.poznan.pl	Panasiewicz, Katarzyna/U-8042-2018; Kalaji, Mohamed Hazem/E-8086-2012; Ratajczak, Karolina/U-3361-2018	Panasiewicz, Katarzyna/0000-0001-6447-9557; Kalaji, Mohamed Hazem/0000-0002-3833-4917; Ratajczak, Karolina/0000-0002-4465-9697; Sulewska, Hanna/0000-0003-4221-2135	White Hill Company	White Hill Company	The authors received no specific funding for this work. Hazem M. Kalaji is employed by White Hill Company. White Hill Company provided support in the form of salary for author MHK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abo-El-Kheir M. S. A., 2007, World Journal of Agricultural Sciences, V3, P269; Anjum SA, 2011, AFR J AGR RES, V6, P2026; Anyamba A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092538; Baker NR, 1994, PHOTOINHIBITION PHOT, P1; Bertelsen JR, 2001, PLANT PATHOL, V50, P190, DOI 10.1046/j.1365-3059.2001.00545.x; Beyel V, 2005, PHYSIOL PLANTARUM, V124, P249, DOI 10.1111/j.1399-3054.2005.00508.x; Blandino M, 2012, FIELD CROP RES, V139, P20, DOI 10.1016/j.fcr.2012.09.014; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; BOYER JS, 1970, PLANT PHYSIOL, V46, P233, DOI 10.1104/pp.46.2.233; Brodribb TJ, 2004, NEW PHYTOL, V162, P663, DOI 10.1111/j.1469-8137.2004.01060.x; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Cornic G., 1994, PHOTOINHIBITION PHOT, P297; Czeczko R, 2004, ANN UMCS E, V59; Daryanto S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156362; de Carvalho RC, 2011, ACTA PHYSIOL PLANT, V33, P359, DOI 10.1007/s11738-010-0555-1; de Souza TC, 2013, ACTA PHYSIOL PLANT, V35, P515, DOI 10.1007/s11738-012-1093-9; Ebrahimi S. T., 2011, American-Eurasian Journal of Agricultural & Environmental Sciences, V10, P257; Efeoglu B, 2009, S AFR J BOT, V75, P34, DOI 10.1016/j.sajb.2008.06.005; Ekmekci Y, 2005, Z NATURFORSCH C, V60, P435; EPHRATH JE, 1991, PHOTOSYNTHETICA, V25, P607; Fletcher R. A., 2000, Horticultural Reviews, V24, P55, DOI 10.1002/9780470650776.ch3; Flexas J, 2004, PLANT BIOLOGY, V6, P269, DOI 10.1055/s-2004-820867; Fromm J, 1998, PLANT SCI, V132, P203, DOI 10.1016/S0168-9452(98)00010-7; Grams TEE, 2007, PLANT CELL ENVIRON, V30, P79, DOI 10.1111/j.1365-3040.2006.01607.x; Grossmann K, 1997, PESTIC SCI, V50, P11, DOI 10.1002/(SICI)1096-9063(199705)50:1&lt;11::AID-PS556&gt;3.0.CO;2-8; Gruszczyk M, 2004, ANN UMCS D; Guoth A, 2009, J PLANT GROWTH REGUL, V28, P167, DOI 10.1007/s00344-009-9085-8; Henry RS, 2011, CROP PROT, V30, P1629, DOI 10.1016/j.cropro.2011.08.014; Hill CB, 2013, PLANT DIS, V97, P1212, DOI 10.1094/PDIS-12-12-1191-RE; Homayoun H., 2011, Middle East Journal of Scientific Research, V9, P418; Junqueira VB, 2017, PESTIC BIOCHEM PHYS, V137, P42, DOI 10.1016/j.pestbp.2016.09.007; Kalaji M.H., 2009, CHLOROPHYLL FLUORESC, P117; Kalaji M.H., 2008, PHOTOCHEMISTRY RES P, P447; Kanungo M, 2014, PLANT SCI TODAY, V1, P174, DOI 10.14719/pst.2014.1.3.60; Kerstiens G, 1996, J EXP BOT, V47, P1813, DOI 10.1093/jxb/47.12.1813; Khalili M., 2013, International Journal of Agronomy and Plant Production, V4, P809; Kohle H., 2003, Modern Fungicides and An- tifungal Compounds III.; Larcher W., 1995, PHYSL PLANT ECOLOGY, P321, DOI [10.1007/978-3-642-87851-0_6, DOI 10.1007/978-3-642-87851-0_6]; LAWLOR DW, 1995, ENV PLANT B, P129; Levitt J., 1980, WATER RAD SALT OTHER, VII, P2; Li P, 2006, AGR SCI CHINA, V5, P751; Liu M., 2012, AFR J AGR RES, V7, P4751; Long SP, 2003, J EXP BOT, V54, P2393, DOI 10.1093/jxb/erg262; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Malepszy S., 2012, KOSMOS, V3, P467; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Mladenova YI, 1998, AGRO FOOD IND HI TEC, V9, P18; Mohammadai H., 2012, International Journal of Agriculture and Crop Sciences (IJACS), V4, P1436; Mohsenzadeh S, 2006, ENVIRON EXP BOT, V56, P314, DOI 10.1016/j.envexpbot.2005.03.008; Nayyar H, 2006, ENVIRON EXP BOT, V58, P106, DOI 10.1016/j.envexpbot.2005.06.021; Nejad S. D., 2010, NATURE SCI, V8, P23, DOI DOI 10.7537/MARSNSJ080510.03; Nelson K. A., 2011, AGRON J, V103; NESMITH DS, 1992, FIELD CROP RES, V28, P251, DOI 10.1016/0378-4290(92)90044-A; O'Neill PM, 2006, CROP SCI, V46, P681, DOI 10.2135/cropsci2005.06-0170; Pelah D, 1997, PHYSIOL PLANTARUM, V99, P153, DOI 10.1034/j.1399-3054.1997.990121.x; Piskier T., 2006, J RES APPL AGR ENG, V51, P137; Przybysz A, 2010, ACTA SCI POL-HORTORU, V9, P53; Ritchie JT, 2003, AGRON J, V95, P4, DOI 10.2134/agronj2003.0004; Ronchi A, 1997, PLANT SCI, V130, P51, DOI 10.1016/S0168-9452(97)00190-8; Rybka K., 2014, Biuletyn Instytutu Hodowli i Aklimatyzacji Roslin, P55; Sharp RE, 2004, J EXP BOT, V55, P2343, DOI 10.1093/jxb/erh276; Soler CMT, 2007, J AGRON CROP SCI, V193, P247, DOI 10.1111/j.1439-037X.2007.00265.x; Souza RP, 2004, ENVIRON EXP BOT, V51, P45, DOI 10.1016/S0098-8472(03)00059-5; Stoyanov I, 1981, P 3 INT S PLANT GROW, P602; Swoboda C, 2009, AGRON J, V101, P352, DOI 10.2134/agronj2008.0150; VENANCIO WS, 2003, AGRARIAN SCI ENG, V9, P59; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Wise K., 2011, APSNET FEATURES, DOI [10.1094/APSnetFeature-2011-0531, DOI 10.1094/APSNETFEATURE-2011-0531]; Wu YX, 2001, PESTIC BIOCHEM PHYS, V71, P1, DOI 10.1006/pest.2001.2561; Xu ZZ, 2008, J PLANT GROWTH REGUL, V27, P83, DOI 10.1007/s00344-007-9035-2; Yang XH, 2006, PLANT SCI, V171, P389, DOI 10.1016/j.plantsci.2006.04.010; Yokota A, 2006, PHYSIOLOGY AND MOLECULAR BIOLOGY OF STRESS TOLERANCE IN PLANTS, P15, DOI 10.1007/1-4020-4225-6_2; Zaeifizade M, 2009, TURK J BOIL, V33; Zlatev Z. S., 2004, Bulgarian Journal of Plant Physiology, V30, P3	74	5	5	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0221116	10.1371/journal.pone.0221116	http://dx.doi.org/10.1371/journal.pone.0221116			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430301	gold, Green Published, Green Submitted			2022-12-26	WOS:000485026800026
J	Thomas, SM; Kainz, MJ; Amundsen, PA; Hayden, B; Taipale, SJ; Kahilainen, KK				Thomas, Stephen M.; Kainz, Martin J.; Amundsen, Per-Arne; Hayden, Brian; Taipale, Sami J.; Kahilainen, Kimmo K.			Resource polymorphism in European whitefish: Analysis of fatty acid profiles provides more detailed evidence than traditional methods alone	PLOS ONE			English	Article							COREGONUS-LAVARETUS L.; SUB-ARCTIC LAKE; NUTRITIONAL QUALITY; ADAPTIVE RADIATION; FISH; GROWTH; EUTROPHICATION; POPULATIONS; SELECTION; NICHE	Resource polymorphism-whereby ancestral generalist populations give rise to several specialised morphs along a resource gradient-is common where species colonise newly formed ecosystems. This phenomenon is particularly well documented in freshwater fish populations inhabiting postglacial lakes formed at the end of the last ice age. However, knowledge on how such differential exploitation of resources across contrasting habitats might be reflected in the biochemical compositions of diverging populations is still limited, though such patterns might be expected. Here, we aimed to assess how fatty acids (FA)-an important biochemical component of animal tissues-diverged across a polymorphic complex of European whitefish (Coregonus lavaretus) and their closely related monomorphic specialist congener vendace (Coregonus albula) inhabiting a series of six subarctic lakes in northern Fennoscandia. We also explored patterns of FA composition in whitefish's predators and invertebrate prey to assess how divergence in trophic ecology between whitefish morphs would relate to biochemical profiles of their key food web associates. Lastly, we assessed how information on trophic divergence provided by differential FA composition compared to evidence of resource polymorphism retrieved from more classical stomach content and stable isotopic (delta C-13, delta N-15) information. Examination of stomach contents provided high-resolution information on recently consumed prey, whereas stable isotopes indicated broad-scale patterns of benthic-pelagic resource use differentiation at different trophic levels. Linear discriminant analysis based on FA composition was substantially more successful in identifying whitefish morphs and their congener vendace as distinct groupings when compared to the other two methods. Three major FA (myristic acid, stearic acid, and eicosadienoic acid) proved particularly informative, both in delineating coregonid groups, and identifying patterns of pelagic-benthic feeding throughout the wider food web. Myristic acid (14:0) content and delta C-13 ratios in muscle tissue were positively correlated across fish taxa, and together provided the clearest segregation of fishes exploiting contrasting pelagic and benthic niches. In general, our findings highlight the potential of FA analysis for identifying resource polymorphism in animal populations where this phenomenon occurs, and suggest that this technique may provide greater resolution than more traditional methods typically used for this purpose.	[Thomas, Stephen M.] EAWAG Swiss Fed Inst Aquat Sci & Technol, Ctr Ecol Evolut & Biogeochem, Dept Fish Ecol & Evolut, Kastanienbaum, Switzerland; [Kainz, Martin J.] Aquat Lipid & Ecotoxicol Res Grp LIPTOX, WasserCluster Lunz Interuniv Ctr Aquat Ecosyst Re, Lunz, Austria; [Amundsen, Per-Arne] UiT Arctic Univ Norway, Fac Biosci Fisheries & Econ, Dept Arctic & Marine Biol, Tromso, Norway; [Hayden, Brian] Univ New Brunswick, Biol Dept, Canadian Rivers Inst, Fredericton, NB, Canada; [Taipale, Sami J.] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Kahilainen, Kimmo K.] Inland Norway Univ Appl Sci, Dept Forestry & Wildlife Management, Koppang, Norway	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); UiT The Arctic University of Tromso; University of New Brunswick; University of Jyvaskyla; Inland Norway University of Applied Sciences	Thomas, SM (corresponding author), EAWAG Swiss Fed Inst Aquat Sci & Technol, Ctr Ecol Evolut & Biogeochem, Dept Fish Ecol & Evolut, Kastanienbaum, Switzerland.	stephenmthomas1988@gmail.com	Taipale, Sami/AAO-3492-2020; Kainz, Martin/AAG-6268-2021	Kainz, Martin/0000-0002-2388-1504; Amundsen, Per-Arne/0000-0002-2203-8216; Taipale, Sami/0000-0001-7510-7337	Ministry of Agriculture and Forestry; European Regional Development Fund [A30205]; Academy of Finland [140903, 1268566]	Ministry of Agriculture and Forestry; European Regional Development Fund(European Commission); Academy of Finland(Academy of Finland)	All funding for this study was awarded to Kimmo K. Kahilainen. Financial support was provided by Ministry of Agriculture and Forestry (https://mmm.fi/en/frontpage), European Regional Development Fund (https://ec.europa.eu/regional_ policy/en/funding/erdf/) (#A30205) and the Academy of Finland (http://www.aka.fi/en) (#140903, #1268566).	Amundsen PA, 2003, HYDROBIOLOGIA, V497, P109, DOI 10.1023/A:1025465705717; Benkman CW, 2003, EVOLUTION, V57, P1176; Chavarie L, 2016, ECOL FRESHW FISH, V25, P109, DOI 10.1111/eff.12195; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/S0065-2881(03)46005-7; Forsstrom L, 2005, POLAR BIOL, V28, P846, DOI 10.1007/s00300-005-0008-2; Galloway AWE, 2014, FRESHWATER BIOL, V59, P1902, DOI 10.1111/fwb.12394; Goedkoop W, 2000, CAN J FISH AQUAT SCI, V57, P2267, DOI 10.1139/cjfas-57-11-2267; Grahl-Nielsen O, 2011, AQUAT BIOL, V13, P1, DOI 10.3354/ab00355; Grant P. R., 2008, WHY SPECIES MULTIPLY; Harrod C, 2010, J ANIM ECOL, V79, P1057, DOI 10.1111/j.1365-2656.2010.01702.x; Hayden B, 2019, ECOL LETT, V22, P807, DOI 10.1111/ele.13238; Hayden B, 2014, J ANIM ECOL, V83, P1501, DOI 10.1111/1365-2656.12233; Hayden B, 2014, ECOLOGY, V95, P538, DOI 10.1890/13-0264.1; Hebert CE, 2008, ECOLOGY, V89, P891, DOI 10.1890/07-1603.1; Heissenberger M, 2010, HYDROBIOLOGIA, V650, P243, DOI 10.1007/s10750-010-0266-z; HYNES HBN, 1950, J ANIM ECOL, V19, P36, DOI 10.2307/1570; Iverson SJ, 2004, ECOL MONOGR, V74, P211, DOI 10.1890/02-4105; Kahilainen K, 2006, J FISH BIOL, V68, P63, DOI 10.1111/j.0022-1112.2006.00876.x; Kahilainen K, 2005, ECOL FRESHW FISH, V14, P50, DOI 10.1111/j.1600-0633.2004.00075.x; Kahilainen K, 2003, ECOL FRESHW FISH, V12, P275, DOI 10.1046/j.1600-0633.2003.00029.x; Kahilainen K, 2003, J FISH BIOL, V63, P659, DOI 10.1046/j.1095-8649.2003.00179.x; Kahilainen KK, 2017, SCI TOTAL ENVIRON, V599, P1768, DOI 10.1016/j.scitotenv.2017.05.099; Kahilainen KK, 2011, MOL ECOL, V20, P3838, DOI 10.1111/j.1365-294X.2011.05209.x; Kahilainen KK, 2011, EVOL ECOL, V25, P573, DOI 10.1007/s10682-010-9411-4; Kahilainen KK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112085; Kakela R, 2005, MAR ECOL PROG SER, V293, P191, DOI 10.3354/meps293191; Kaya Y, 2009, INT J FOOD SCI NUTR, V60, P413, DOI 10.1080/09637480701777886; Keva O, 2019, FRESHW BIOL; Keva O, 2017, ENVIRON POLLUT, V231, P1518, DOI 10.1016/j.envpol.2017.09.012; Kuusipalo L, 2000, LIMNOL OCEANOGR, V45, P996, DOI 10.4319/lo.2000.45.4.0996; Lau DCP, 2012, FRESHWATER BIOL, V57, P24, DOI 10.1111/j.1365-2427.2011.02690.x; Layman CA, 2012, BIOL REV, V87, P545, DOI 10.1111/j.1469-185X.2011.00208.x; Logan MS, 2000, BIOL J LINN SOC, V69, P599, DOI 10.1006/bijl.1999.0383; Luzzana U, 1996, J FISH BIOL, V48, P352, DOI 10.1111/j.1095-8649.1996.tb01433.x; Mariash HL, 2014, LIMNOL OCEANOGR, V59, P733, DOI 10.4319/lo.2014.59.3.0733; Muir AM, 2014, CAN J FISH AQUAT SCI, V71, P1256, DOI 10.1139/cjfas-2013-0254; Murray DS, 2014, AQUACULTURE, V431, P85, DOI 10.1016/j.aquaculture.2014.03.039; Nielsen JM, 2018, METHODS ECOL EVOL, V9, P278, DOI 10.1111/2041-210X.12869; Nonaka E, 2015, AM NAT, V186, pE126, DOI 10.1086/683231; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Oksanen J, 2018, R PACKAG, V2, P5; Orban E, 2006, J FOOD COMPOS ANAL, V19, P737, DOI 10.1016/j.jfca.2005.12.014; Ostbye K, 2005, MOL ECOL, V14, P4371, DOI 10.1111/j.1365-294X.2005.02737.x; Paalavuo M, 1998, ERGEB LIMNOL, V50, P25; Parnell A. C., 2013, SIAR STABLE ISOTOPE; Perga ME, 2009, J FISH BIOL, V74, P2, DOI 10.1111/j.1095-8649.2008.02105.x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Praebel K, 2013, ECOL EVOL, V3, P4970, DOI 10.1002/ece3.867; R Core Team, 2013, R LANG ENV STAT COMP; Scharnweber K, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1387; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Siwertsson A, 2010, EVOL ECOL RES, V12, P929; SKULASON S, 1995, TRENDS ECOL EVOL, V10, P366, DOI 10.1016/S0169-5347(00)89135-1; Skulason S, 2019, BIOL REV, V94, P1786, DOI 10.1111/brv.12534; Strandberg U, 2018, ECOL FRESHW FISH, V27, P533, DOI 10.1111/eff.12367; SVARDSON G, 1979, Institute of Freshwater Research Drottningholm Report, P1; Taipale SJ, 2016, ENVIRON INT, V96, P156, DOI 10.1016/j.envint.2016.08.018; Taipale S, 2013, AQUAT MICROB ECOL, V71, P165, DOI 10.3354/ame01671; Taipale SJ, 2018, ECOL EVOL, V8, P2671, DOI 10.1002/ece3.3832; Thomas SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08263-9; Thomas SM, 2016, FRESHWATER BIOL, V61, P500, DOI 10.1111/fwb.12723; Thomas SM, 2015, J ANIM ECOL, V84, P861, DOI 10.1111/1365-2656.12326; Tocher DR, 2010, AQUAC RES, V41, P717, DOI 10.1111/j.1365-2109.2008.02150.x; Vasconi M, 2015, LIPIDS, V50, P283, DOI 10.1007/s11745-014-3978-4; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Vonlanthen P, 2012, NATURE, V482, P357, DOI 10.1038/nature10824	66	9	9	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0221338	10.1371/journal.pone.0221338	http://dx.doi.org/10.1371/journal.pone.0221338			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430331	Green Submitted, Green Published, gold			2022-12-26	WOS:000485026800045
J	Coelho, F; Cavicchioli, M; Specian, SS; Scarel-Caminaga, RM; Penteado, LD; de Medeiros, AI; Ribeiro, SJD; Capote, TSD				Coelho, Fernanda; Cavicchioli, Mauricio; Specian, Sybele Saska; Scarel-Caminaga, Raquel Mantuaneli; Penteado, Leticia de Aquino; de Medeiros, Alexandra Ivo; de Lima Ribeiro, Sidney Jose; de Oliveira Capote, Ticiana Sidorenko			Bacterial cellulose membrane functionalized with hydroxiapatite and anti-bone morphogenetic protein 2: A promising material for bone regeneration	PLOS ONE			English	Article							ANTI-BMP2 MONOCLONAL-ANTIBODY; IN-VITRO; BIOMIMETIC SYNTHESIS; HYDROXYAPATITE; MINERALIZATION; SCAFFOLD; NANOCOMPOSITES	Bone tissue engineering seeks to adequately restore functions related to physical and biological properties, aiming at a repair process similar to natural bone. The use of compatible biopolymers, such as bacterial cellulose (BC), as well as having interesting mechanical characteristics, presents a slow in vivo degradation rate, and the ability to be chemically modified. To promote better bioactivity towards BC, we synthesized an innovative BC membrane associated to hydroxyapatite (HA) and anti-bone morphogenetic protein antibody (anti-BMP-2) (BC-HA-anti-BMP-2). We present the physical-chemical, biological and toxicological characterization of BC-HA-anti-BMP-2. Presence of BC and HA components in the membranes was confirmed by SEM-EDS and FTIR assays. No toxic potential was found in MC3T3-E1 cells by cytotoxicity assays (XTT Assay and Clonogenic Survival), genotoxicity (Comet Assay) and mutagenicity (Cytokinesis-blocked micronucleus Test). The in vitro release kinetics of anti-BMP-2 antibodies detected gradually reducing antibody levels, reducing approximately 70% in 7 days and 90% in 14 days. BC-HA-anti-BMP-2 increased SPP1, BGLAP, VEGF, ALPL, RUNX2 and TNFRSF11B expression, genes involved in bone repair and also increased mineralization nodules and phosphatase alcalin (ALP) activity levels. In conclusion, we developed BC-HA-anti-BMP-2 as an innovative and promising biomaterial with interesting physical-chemical and biological properties which may be a good alternative to treatment with commercial BMP-2 protein.	[Coelho, Fernanda; Scarel-Caminaga, Raquel Mantuaneli; de Oliveira Capote, Ticiana Sidorenko] Sao Paulo State Univ UNESP, Dept Morphol, Sch Dent, Sao Paulo, Brazil; [Cavicchioli, Mauricio; Specian, Sybele Saska; de Lima Ribeiro, Sidney Jose] Sao Paulo State Univ UNESP, Dept Gen & Inorgan Chem, Inst Chem, Araraquara, SP, Brazil; [Penteado, Leticia de Aquino; de Medeiros, Alexandra Ivo] Sao Paulo State Univ UNESP, Dept Biol Sci, Sch Pharmaceut Sci, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista	Coelho, F (corresponding author), Sao Paulo State Univ UNESP, Dept Morphol, Sch Dent, Sao Paulo, Brazil.	Fernanda.coelho1408@gmail.com	Cavicchioli, Mauricio/A-3073-2008; Capote, Ticiana S O/G-6664-2013; Coelho, Fernanda/W-8372-2019; Medeiros, Alexandra I. AIM/J-6103-2012; Scarel-Caminaga, Raquel Mantuaneli/AAG-9095-2019; Coelho, Fernanda/A-6703-2017; Scarel-Caminaga, Raquel M./E-8888-2012; Specian, Sybele/AAB-4091-2022; Saska Specian, Sybele/B-6745-2011	Cavicchioli, Mauricio/0000-0002-6557-7391; Capote, Ticiana S O/0000-0003-0979-5826; Coelho, Fernanda/0000-0001-5794-4174; Medeiros, Alexandra I. AIM/0000-0001-6048-3647; Coelho, Fernanda/0000-0001-5794-4174; Scarel-Caminaga, Raquel M./0000-0001-5068-0268; Saska Specian, Sybele/0000-0002-0229-946X	FAPESP [2016/25926-1]; CAPES	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors thank Brazilian agencies FAPESP (2016/25926-1) and CAPES for financial support.	Akkouch A, 2011, J BIOMED MATER RES A, V96A, P693, DOI 10.1002/jbm.a.33033; Alt V, 2006, CURR MED RES OPIN, V22, pS19, DOI 10.1185/030079906X80602; Ansari S, 2015, J BIOMATER APPL, V30, P558, DOI 10.1177/0885328215594704; Calasans-Maia MD, 2015, J APPL ORAL SCI, V23, P599, DOI 10.1590/1678-775720150122; Chong MSK, 2010, TISSUE ENG PART A, V16, P23; Cromme P, 2007, MAT SCI ENG C-BIO S, V27, P1, DOI 10.1016/j.msec.2005.11.001; EASTMOND DA, 1989, ENVIRON MOL MUTAGEN, V13, P34, DOI 10.1002/em.2850130104; EINHORN TA, 1995, J BONE JOINT SURG AM, V77A, P940, DOI 10.2106/00004623-199506000-00016; Felton LA, 2007, AAPS PHARMSCITECH, V8; Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8; Freire MO, 2011, TISSUE ENG PT A, V17, P2911, DOI 10.1089/ten.tea.2010.0584; GEYER U, 1994, INT J BIOL MACROMOL, V16, P343, DOI 10.1016/0141-8130(94)90067-1; Glowacki J, 2015, J ORAL MAXIL SURG, V73, pS126, DOI 10.1016/j.joms.2015.04.009; Guex AG, 2017, ACTA BIOMATER, V62, P91, DOI 10.1016/j.actbio.2017.08.045; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; He M, 2012, CARBOHYD POLYM, V87, P2512, DOI 10.1016/j.carbpol.2011.11.029; Hing KA, 2004, PHILOS T R SOC A, V362, P2821, DOI 10.1098/rsta.2004.1466; Huang J, 2004, J MATER SCI-MATER M, V15, P441, DOI 10.1023/B:JMSM.0000021117.67205.cf; Hutchens SA, 2006, BIOMATERIALS, V27, P4661, DOI 10.1016/j.biomaterials.2006.04.032; Ionescu Mirela E, 2011, Maedica (Bucur), V6, P173; Kim JK, 2008, BIOMACROMOLECULES, V9, P149, DOI 10.1021/bm700924n; Kim TI, 2008, CURR PHARM DESIGN, V14, P2201, DOI 10.2174/138161208785740171; Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1; Kneser U, 2006, J CELL MOL MED, V10, P7, DOI 10.1111/j.1582-4934.2006.tb00287.x; KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607; Kolk A, 2012, J CRANIO MAXILL SURG, V40, P706, DOI 10.1016/j.jcms.2012.01.002; Luppen CA, 2003, J BONE MINER RES, V18, P1186, DOI 10.1359/jbmr.2003.18.7.1186; Massari K., 2015, DENT ORAL CRANIOFACI, V1, P25, DOI [10.15761/docr.1000106, DOI 10.15761/DOCR.1000106]; Moller P, 2005, BASIC CLIN PHARMACOL, V96, P9; Moshaverinia A, 2013, BIOMATERIALS, V34, P6572, DOI 10.1016/j.biomaterials.2013.05.048; Nge TT, 2007, J BIOMED MATER RES A, V81A, P124, DOI 10.1002/jbm.a.31020; Nordstrom EG, 2001, BIO-MED MATER ENG, V11, P221; Barud HGO, 2015, CARBOHYD POLYM, V128, P41, DOI 10.1016/j.carbpol.2015.04.007; Pigossi SC, 2015, J BIOMED MATER RES A, V103, P3397, DOI 10.1002/jbm.a.35472; Raquel Mantuaneli and Scarel-Caminaga., 2014, J APPL BIOL BIOTECHN, V2, P001; Rath B, 2011, BIORHEOLOGY, V48, P37, DOI 10.3233/BIR-2011-0580; Saska S, 2011, INT J BIOMATER, V2011, DOI 10.1155/2011/175362; Sepulveda P, 2002, J BIOMED MATER RES, V62, P587, DOI 10.1002/jbm.10173; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Tazi N, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-61; Vellayappan MV, 2015, INT J NANOMED, V10, P2785, DOI 10.2147/IJN.S80121; Wan YZ, 2007, MAT SCI ENG C-BIO S, V27, P855, DOI 10.1016/j.msec.2006.10.002; Wu FF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087764; Zaborowska M, 2010, ACTA BIOMATER, V6, P2540, DOI 10.1016/j.actbio.2010.01.004; Zimmermann KA, 2011, MAT SCI ENG C-MATER, V31, P43, DOI 10.1016/j.msec.2009.10.007	45	25	25	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0221286	10.1371/journal.pone.0221286	http://dx.doi.org/10.1371/journal.pone.0221286			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5MK	31425530	Green Submitted, Green Published, gold			2022-12-26	WOS:000485022400035
J	Utuama, O; Mukhtar, F; Pham, YTH; Dabo, B; Manani, P; Moser, J; Michael-Asalu, A; Tran, CTD; Le, LC; Le, TV; Vu, KT; Park, JY; Boffetta, P; Zheng, W; Shu, XO; Luu, HN				Utuama, Ovie; Mukhtar, Fahad; Yen Thi-Hai Pham; Dabo, Bashir; Manani, Priyashi; Moser, Jenna; Michael-Asalu, Abimbola; Tran, Chi T. D.; Le, Linh C.; Le, Thanh V.; Khanh Truong Vu; Park, Jong Y.; Boffetta, Paolo; Zheng, Wei; Shu, Xiao-Ou; Luu, Hung N.			Racial/ethnic, age and sex disparities in leukemia survival among adults in the United States during 1973-2014 period	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CHRONIC LYMPHOCYTIC-LEUKEMIA; RACIAL DISPARITIES; CANCER; RACE; OUTCOMES; THERAPY	There has been marked improvement in leukemia survival, particularly among children in recent time. However, the long-term trends in survival among adult leukemia patients and the associated sex and racial survival disparities are not well understood. We, therefore, evaluated the secular trends in survival improvement of leukemia patients from 1973 through 2014, using Surveillance Epidemiology and End-Result Survey Program (SEER) data. ICD-O-3 morphology codes were used to group leukemia into four types: acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), chronic myeloid leukemia (CML). Survival analysis for each leukemia type stratified by race/ethnicity, age, sex was performed to generate relative survival probability estimates for the baseline time period of 1973 through 1979. Hazard ratios (HR) and respective 95% confidence intervals (Cis) for survival within subsequent 10-year time periods by race, age and sex were calculated using Cox proportional hazard models. Of the 83,255 leukemia patients for the current analysis, the 5-year survival of patients with ALL, AML, CLL, and CML during 1973-1979 were 42.0%, 6.5%, 66.5%, and 20.9%, respectively. Compared to the baseline, there were substantial improvements of leukemia-specific survival in 2010-2014 among African-American (81.0%) and Asian (80.0%) patients with CML and among 20-49 year of age with CLL (96.0%). African-American patients, those with AML and those older than 75 years of age had the lowest survival improvements. Asians experienced some of the largest survival improvements during the study period. Others, including African American and the elderly, have not benefited as much from advances in leukemia treatment.	[Utuama, Ovie; Mukhtar, Fahad; Dabo, Bashir; Manani, Priyashi; Michael-Asalu, Abimbola] Univ S Florida, Coll Publ Hlth, Dept Epidemiol & Biostat, Tampa, FL USA; [Yen Thi-Hai Pham] Vinmec Healthcare Syst, Vinmec Times City Hosp, Dept Rehabil, Hanoi, Vietnam; [Moser, Jenna] Univ S Florida, Coll Arts & Sci, Tampa, FL USA; [Tran, Chi T. D.] Vinmec Healthcare Syst, Vietnam Colorectal Canc & Res Program, Hanoi, Vietnam; [Le, Linh C.] VinUnivers VinUni, Coll Hlth Sci, Hanoi, Vietnam; [Le, Thanh V.] 108 Hosp, Dept Hepatobiliary & Pancreat Surg, Hanoi, Vietnam; [Khanh Truong Vu] Bach Mai Hosp, Dept Gastroenterol, Hanoi, Vietnam; [Park, Jong Y.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL USA; [Boffetta, Paolo] Mt Sinai Sch Med, Icahn Sch Med, Tisch Canc Inst, New York, NY USA; [Zheng, Wei; Shu, Xiao-Ou] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Div Epidemiol,Dept Med,Vanderbilt Epidemiol Ctr, Nashville, TN 37212 USA; [Luu, Hung N.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA; [Luu, Hung N.] Univ Pittsburgh, Canc Inst, Div Canc Control & Populat Sci, Pittsburgh, PA 15260 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; Icahn School of Medicine at Mount Sinai; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Luu, HN (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA.; Luu, HN (corresponding author), Univ Pittsburgh, Canc Inst, Div Canc Control & Populat Sci, Pittsburgh, PA 15260 USA.	luuh@upmc.edu	Boffetta, Paolo/AAI-7767-2021; Le, Linh C/G-5957-2012; mukhtar, fahad/AAG-9981-2020	Boffetta, Paolo/0000-0002-3811-2791; mukhtar, fahad/0000-0002-5372-1739; Le, Linh/0000-0003-2978-936X	NIH/NCI [1P20CA210300-01]; University of Pittsburgh Medical Center start-up grant; NATIONAL CANCER INSTITUTE [P20CA210300] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Pittsburgh Medical Center start-up grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by NIH/NCI Grant #1P20CA210300-01 (PIs: Xiao-Ou Shu and Thuan V. Tran) and University of Pittsburgh Medical Center start-up grant (PI: Hung N. Luu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker KS, 2005, J CLIN ONCOL, V23, P7032, DOI 10.1200/JCO.2005.01.7269; Chen YM, 2013, LEUKEMIA LYMPHOMA, V54, P1411, DOI 10.3109/10428194.2012.745525; Clarke CA, 2004, CANCER EPIDEM BIOMAR, V13, P138, DOI 10.1158/1055-9965.EPI-03-0250; Davis AS, 2014, AM FAM PHYSICIAN, V89, P731; Dohner H, 2015, NEW ENGL J MED, V373, P1136, DOI 10.1056/NEJMra1406184; Fritz A, 2013, S AFR J CHILD EDUC, V3, P38; Gross GR, 2008, CANCER-AM CANCER SOC, V112, P900, DOI 10.1002/cncr.23228; Holmes L Jr, 2012, ISRN Oncol, V2012, P439070, DOI 10.5402/2012/439070; Hunger SP, 2015, NEW ENGL J MED, V373, P1541, DOI 10.1056/NEJMra1400972; Kahn JM, 2016, CANCER-AM CANCER SOC, V122, P2723, DOI 10.1002/cncr.30089; Kantarjian H, 2008, CANCER-AM CANCER SOC, V113, P1933, DOI 10.1002/cncr.23655; KENT JT, 1982, BIOMETRIKA, V69, P19, DOI 10.2307/2335849; Mukhtar F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199745; Murthy VH, 2004, JAMA-J AM MED ASSOC, V291, P2720, DOI 10.1001/jama.291.22.2720; Nabhan C, 2014, LEUKEMIA LYMPHOMA, V55, P2778, DOI 10.3109/10428194.2014.898758; Nabhan C, 2014, AM J HEMATOL, V89, P633, DOI 10.1002/ajh.23708; National Cancer Institute, 2018, SEER SURV EP END RES; Ostronoff F, 2015, J CLIN ONCOL, V33, P1157, DOI 10.1200/JCO.2014.58.0571; Percy C., 1990, INT CLASSIFICATION D; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Pulte D, 2013, HAEMATOLOGICA, V98, P693, DOI 10.3324/haematol.2012.063602; PULTE D, 2017, BLOOD S1, V130; Pulte D, 2008, HAEMATOLOGICA, V93, P594, DOI 10.3324/haematol.12304; Sekeres MA, 2004, BLOOD, V103, P4036, DOI 10.1182/blood-2003-09-3118; Shavers VL, 2002, JNCI-J NATL CANCER I, V94, P334; Shenoy PJ, 2011, CL LYMPH MYELOM LEUK, V11, P498, DOI 10.1016/j.clml.2011.07.002; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Ward E, 2004, CA-CANCER J CLIN, V54, P78, DOI 10.3322/canjclin.54.2.78; Yang SM, 2015, BLOOD REV, V29, P205, DOI 10.1016/j.blre.2014.12.001; Zeng CJ, 2015, JAMA ONCOL, V1, P88, DOI 10.1001/jamaoncol.2014.161	30	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0220864	10.1371/journal.pone.0220864	http://dx.doi.org/10.1371/journal.pone.0220864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5MK	31425527	gold, Green Published, Green Submitted			2022-12-26	WOS:000485022400017
J	Joelsson, LS; Elenis, E; Wanggren, K; Berglund, A; Iliadou, AN; Cesta, CE; Mumford, SL; White, R; Tyden, T; Skalkidou, A				Joelsson, Lana Salih; Elenis, Evangelia; Wanggren, Kjell; Berglund, Anna; Iliadou, Anastasia N.; Cesta, Carolyn E.; Mumford, Sunni L.; White, Richard; Tyden, Tanja; Skalkidou, Alkistis			Investigating the effect of lifestyle risk factors upon number of aspirated and mature oocytes in in vitro fertilization cycles: Interaction with antral follicle count	PLOS ONE			English	Article							LIVE BIRTH; INFERTILITY TREATMENT; ASSISTED REPRODUCTION; OVARIAN STIMULATION; SUCCESS RATE; OBESITY; IMPACT; IVF; ASSOCIATION; PREGNANCY	Introduction There is evidence demonstrating that certain lifestyle factors have a detrimental effect on fertility. Since such factors often coexist, possible synergistic effects merit further investigation. Thus we aimed to examine the cumulative impact of lifestyle factors on in vitro fertilization (IVF) early reproductive treatment outcomes and their interaction with measures of ovarian reserve. Materials and methods By following women who were starting their first fresh IVF cycle in 2 cohorts, the "Lifestyle study cohort" (hypothesis generating cohort, n = 242) and the "UppSTART study" (validation cohort, n = 432) in Sweden, we identified two significant risk factors acting independently, smoking and BMI, and then further assessed their cumulative effects. Results Women with both these risk factors had an Incidence Rate Ratio (IRR) of 0.75 [(95% CI 0.61-0.94)] regarding the number of aspirated oocytes compared to women without these risk factors. Concerning the proportion of mature oocytes in relation to the total number of aspirated oocytes, the interaction between BMI and Antral Follicle Count (AFC) was significant (p-value 0.045): the lower the value of AFC, the more harmful the effect of BMI with the outcome. Conclusions Data shows that there is an individual as well as a cumulative effect of smoking and BMI on the number of aspirated and mature oocytes in fresh IVF treatment cycles. AFC might modify associations between BMI and the proportion of mature oocytes in relation to the total number of aspirated oocytes. These results highlight the importance of lifestyle factors on IVF early reproductive outcomes and provide additional evidence for the importance of preconception guidance for the optimization of IVF cycle outcome.	[Joelsson, Lana Salih; Elenis, Evangelia; Tyden, Tanja; Skalkidou, Alkistis] Uppsala Univ, Inst Womens & Childrens, Obstet & Gynecol, Uppsala, Sweden; [Wanggren, Kjell] Karolinska Inst, Dept Clin Sci Intervent & Technol, Obstet & Gynecol, Stockholm, Sweden; [Berglund, Anna] Uppsala Univ, Natl Ctr Knowledge Mens Violence Women NCK, Uppsala, Sweden; [Iliadou, Anastasia N.; Cesta, Carolyn E.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Mumford, Sunni L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Epidemiol Branch, Div Intramural Populat Hlth Res, NIH, Bethesda, MD USA; [White, Richard] Norwegian Inst Publ Hlth, Oslo, Norway	Uppsala University; Karolinska Institutet; Uppsala University; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Norwegian Institute of Public Health (NIPH)	Joelsson, LS (corresponding author), Uppsala Univ, Inst Womens & Childrens, Obstet & Gynecol, Uppsala, Sweden.	lana.salih@kbu.uu.se	Cesta, Carolyn E/AAM-2039-2021; Skalkidou, Alkistis/C-1521-2015	Cesta, Carolyn E/0000-0001-5759-9366; Skalkidou, Alkistis/0000-0002-4935-7532; Mumford, Sunni/0000-0003-0133-3176; Elenis, Evangelia/0000-0002-2253-4682	Uppsala University Hospital; Uppsala-Orebro Regional Research Council, Sweden; Swedish Research Council and Vastmanland County Council, Sweden; Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health [259679]; Swedish Research Council [K2011-69X-21871-016]; SIMSAM [340-2013-5867]; Strategic Research Program in Epidemiology Young Scholar Awards; Karolinska Institutet; Family Planning Fund in Uppsala	Uppsala University Hospital; Uppsala-Orebro Regional Research Council, Sweden; Swedish Research Council and Vastmanland County Council, Sweden; Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Swedish Research Council(Swedish Research CouncilEuropean Commission); SIMSAM; Strategic Research Program in Epidemiology Young Scholar Awards; Karolinska Institutet(Karolinska Institutet); Family Planning Fund in Uppsala	Funding was received from the Uppsala University Hospital, the Family Planning Fund in Uppsala, the Uppsala-Orebro Regional Research Council, Sweden, the Swedish Research Council and Vastmanland County Council, Sweden. This work was also supported in part by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health. None of the authors have any conflict of interest to declare. The Uppstart study was funded by the EU-FP7 Health program (IDEAL, agreement 259679), the Swedish Research Council (K2011-69X-21871-016 and SIMSAM 340-2013-5867) and the Strategic Research Program in Epidemiology Young Scholar Awards, Karolinska Institutet.	Abadia L, 2017, HUM REPROD, V32, P1846, DOI 10.1093/humrep/dex237; Al-Saleh I, 2010, MED SCI MONITOR, V16, pCR598; Anderson K, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008189.pub2; Anderson K, 2010, AUST NZ J OBSTET GYN, V50, P8, DOI 10.1111/j.1479-828X.2009.01119.x; Balaban B, 2011, HUM REPROD, V26, pI24; Bellver J, 2013, FERTIL STERIL, P100, DOI [10.1016/j.fertnstert.2013.02.056, DOI 10.1016/J.FERTNSTERT.2013.02.056]; Bexelius C, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1298; Buck D, 2012, KINGS FUND, P1; Cardozo ER, 2016, HUM REPROD, V31, P385, DOI 10.1093/humrep/dev298; Cardozo E, 2011, TRENDS ENDOCRIN MET, V22, P103, DOI 10.1016/j.tem.2010.12.002; Cesta CE, 2018, ACTA OBSTET GYN SCAN, V97, P258, DOI 10.1111/aogs.13280; Christensen MW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163393; Dondorp W, 2010, HUM REPROD, V25, P578, DOI 10.1093/humrep/dep458; Dunson DB, 2004, OBS GYNECOL, P103; Esinler I, 2008, REPROD BIOMED ONLINE, V17, P583, DOI 10.1016/S1472-6483(10)60249-0; Evenson KR, 2014, FERTIL STERIL, V101, P1047, DOI 10.1016/j.fertnstert.2013.12.041; Ferraretti AP, 2011, HUM REPROD, V26, P1616, DOI 10.1093/humrep/der092; Firns S, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0133-x; Fuentes A, 2010, FERTIL STERIL, V93, P89, DOI 10.1016/j.fertnstert.2008.09.073; Hariton E, 2017, FERTIL STERIL, V108, P262, DOI 10.1016/j.fertnstert.2017.05.021; HEITJAN DF, 1991, J R STAT SOC C-APPL, V40, P13; Homan GF, 2007, HUM REPROD UPDATE, V13, P209, DOI 10.1093/humupd/dml056; Hornstein MD, 2016, REPROD SCI, V23, P1626, DOI 10.1177/1933719116667226; Joelsson LS, 2016, UPSALA J MED SCI, V121, P184, DOI 10.1080/03009734.2016.1176094; Klonoff-Cohen H, 2003, FERTIL STERIL, V79, P330, DOI 10.1016/S0015-0282(02)04582-X; Lintsen AME, 2005, HUM REPROD, V20, P1867, DOI 10.1093/humrep/deh898; Luke B, 2011, HUM REPROD, V26, P245, DOI 10.1093/humrep/deq306; McLernon DJ, 2016, HUM REPROD, V31, P572, DOI 10.1093/humrep/dev336; Meader N, 2016, BMC PUBLIC HEALTH, P1, DOI [10.1186/s12889-015-2639-8, DOI 10.1186/S12889-015-2639-8]; Morris SN, 2006, OBS GYNECOL, P108; PFEIFER S, 2015, AM SOC REPROD MED, V103, pE9, DOI DOI 10.1016/J.FERTNSTERT.2014.12.093; Rooney KL, 2014, CURR OPIN OBSTET GYN, V26, P181, DOI 10.1097/GCO.0000000000000069; Rossi Brooke V, 2016, Fertil Res Pract, V2, P11, DOI 10.1186/s40738-016-0026-5; Rossi BV, 2016, AM J LIFESTYLE MED, V10, P220, DOI 10.1177/1559827614558020; Rubin DB, 1987, MULTIPLE IMPUTATION, p[xxix, 258], DOI DOI 10.1002/9780470316696; Schenker N, 1996, COMPUT STAT DATA AN, V22, P425, DOI 10.1016/0167-9473(95)00057-7; Singh AK, 2013, REPROD TOXICOL, V42, P116, DOI 10.1016/j.reprotox.2013.08.005; Stephenson J, 2018, LANCET, V391, P1830, DOI [10.1016/S0140-6736(18)30311-8, 10.1016/s0140-6736(18)30311-8]; Study UppstART, 2011, MED VETENSK; Sunkara SK, 2011, HUM REPROD, V26, P1768, DOI 10.1093/humrep/der106; Thoma ME, 2013, FERTIL STERIL, V99, P1324, DOI 10.1016/j.fertnstert.2012.11.037; van Buuren S, 2011, J STAT SOFTW, V45, P1; Wenemark M., 2010, RESPONDENT S PERSPEC; Wittemer C, 2000, J ASSIST REPROD GEN, V17, P547, DOI 10.1023/A:1026477628723; Zhang D, 2010, GYNECOL ENDOCRINOL, V26, P325, DOI 10.3109/09513591003632100; Zhang JJ, 2015, GYNECOL ENDOCRINOL, V31, P409, DOI 10.3109/09513590.2015.1014785	46	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2019	14	8							e0221015	10.1371/journal.pone.0221015	http://dx.doi.org/10.1371/journal.pone.0221015			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5LL	31419245	Green Published, gold			2022-12-26	WOS:000485019900023
J	Kobayashi, H; Seike, S; Yamaguchi, M; Ueda, M; Takahashi, E; Okamoto, K; Yamanaka, H				Kobayashi, Hidetomo; Seike, Soshi; Yamaguchi, Masafumi; Ueda, Mitsunobu; Takahashi, Eizo; Okamoto, Keinosuke; Yamanaka, Hiroyasu			Aeromonas sobria serine protease decreases epithelial barrier function in T84 cells and accelerates bacterial translocation across the T84 monolayer in vitro	PLOS ONE			English	Article							BETA-CATENIN; NA+/H+ ANTIPORTERS; TIGHT JUNCTIONS; GENUS AEROMONAS; E-CADHERIN; ROLES; ASP; IDENTIFICATION; INDUCTION; ADHESION	Aeromonas sobria is a pathogen causing food-borne illness. In immunocompromised patients and the elderly, A. sobria can leave the intestinal tract, and this opportunistically leads to severe extraintestinal diseases including sepsis, peritonitis, and meningitis. To cause such extraintestinal diseases, A. sobria must pass through the intestinal epithelial barrier. The mechanism of such bacterial translocation has not been established. Herein we used intestinal (T84) cultured cells to investigate the effect of A. sobria serine protease (ASP) on junctional complexes that maintain the intercellular adhesion of the intestinal epithelium. When several A. sobria strains were inoculated into T84 monolayer grown on Transwell inserts, the strain with higher ASP production largely decreased the value of transepithelial electrical resistance exhibited by the T84 monolayer and markedly caused bacterial translocation from the apical surface into the basolateral side of T84 monolayer. Further experiments revealed that ASP acts on adherens junctions (AJs) and causes the destruction of both nectin-2 and afadin, which are protein components constituting AJs. Other studies have not revealed the bacterial pathogenic factors that cause the destruction of both nectin-2 and afadin, and our present results thus provide the first report that the bacterial extracellular protease ASP affects these molecules. We speculate that the destruction of nectin-2 and afadin by the action of ASP increases the ability of A. sobria to pass through intestinal epithelial tissue and contributes to the severity of pathological conditions.	[Kobayashi, Hidetomo; Seike, Soshi; Ueda, Mitsunobu; Yamanaka, Hiroyasu] Hiroshima Int Univ, Fac Pharmaceut Sci, Lab Mol Microbiol Sci, Hiroshima, Japan; [Yamaguchi, Masafumi] Hiroshima Int Univ, Fac Pharmaceut Sci, Lab Physiol Chem, Hiroshima, Japan; [Takahashi, Eizo; Okamoto, Keinosuke] Okayama Univ Infect Dis India, Natl Inst Cholera Enter Dis, Collaborat Res Ctr, Kolkata, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Okayama University	Yamanaka, H (corresponding author), Hiroshima Int Univ, Fac Pharmaceut Sci, Lab Mol Microbiol Sci, Hiroshima, Japan.	h-yamana@hirokoku-u.ac.jp	Yamanaka, Hiroyasu/AAG-7880-2021	Kobayashi, Hidetomo/0000-0002-5918-4268; Okamoto, Keinosuke/0000-0002-0614-5492; Seike, Soshi/0000-0001-9029-0715	JSPS KAKENHI [JP16K18926]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid from JSPS KAKENHI (Grant Numbers JP16K18926) to HK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Borrell N, 1997, J CLIN MICROBIOL, V35, P1671, DOI 10.1128/JCM.35.7.1671-1674.1997; Drolia R, 2019, TRENDS MICROBIOL, V27, P408, DOI 10.1016/j.tim.2018.12.007; Fabre-Lafay S, 2005, J BIOL CHEM, V280, P19543, DOI 10.1074/jbc.M410943200; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Fujii Y, 1998, MICROBIOL IMMUNOL, V42, P703, DOI 10.1111/j.1348-0421.1998.tb02343.x; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Herz K, 2003, J BACTERIOL, V185, P1236, DOI 10.1128/JB.185.4.1236-1244.2003; Imamura T, 2008, FEMS MICROBIOL LETT, V284, P35, DOI 10.1111/j.1574-6968.2008.01184.x; Imamura T, 2006, J IMMUNOL, V177, P8723, DOI 10.4049/jimmunol.177.12.8723; Ito K, 1999, ONCOGENE, V18, P7080, DOI 10.1038/sj.onc.1203191; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Janda JM, 1998, CLIN INFECT DIS, V27, P332, DOI 10.1086/514652; JANDA JM, 1987, J INFECT DIS, V155, P589, DOI 10.1093/infdis/155.3.589; Jang C, 2011, FASEB J, V25, P4174, DOI 10.1096/fj.11-185926; Kampfer P, 1996, MICROBIAL ECOL, V32, P101, DOI 10.1007/BF00185883; Kobayashi H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186392; Kobayashi H, 2009, J BIOL CHEM, V284, P27655, DOI 10.1074/jbc.M109.006114; Kuroda T, 2005, MICROBIOL IMMUNOL, V49, P711, DOI 10.1111/j.1348-0421.2005.tb03662.x; LEIBOWITZ MJ, 1976, P NATL ACAD SCI USA, V73, P2061, DOI 10.1073/pnas.73.6.2061; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Nakao Y., 2016, ANESTHESIA RESUSCITA, V52, P3; Nava P, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24783; NISHIBUCHI M, 1991, MICROB PATHOGENESIS, V11, P453, DOI 10.1016/0882-4010(91)90042-9; Nitta H, 2008, J IMMUNOL, V181, P3602, DOI 10.4049/jimmunol.181.5.3602; Nitta H, 2007, FEBS LETT, V581, P5935, DOI 10.1016/j.febslet.2007.11.076; Okamoto K, 2000, MICROBIOL IMMUNOL, V44, P787, DOI 10.1111/j.1348-0421.2000.tb02565.x; Ooshio T, 2010, J BIOL CHEM, V285, P5003, DOI 10.1074/jbc.M109.043760; Pemberton JM, 1997, FEMS MICROBIOL LETT, V152, P1, DOI 10.1016/S0378-1097(97)00186-9; Samanta D, 2012, P NATL ACAD SCI USA, V109, P14836, DOI 10.1073/pnas.1212912109; SCHWEIZER HP, 1995, GENE, V158, P15, DOI 10.1016/0378-1119(95)00055-B; Shimoji N., 2015, JAPANESE J MED TECHN, V64, P295, DOI [10.14932/jamt.14-93, DOI 10.14932/JAMT.14-93]; Sugawara Y, 2010, J CELL BIOL, V189, P691, DOI 10.1083/jcb.200910119; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Tanaka Y, 2002, BIOCHEM BIOPH RES CO, V299, P472, DOI 10.1016/S0006-291X(02)02681-5	36	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2019	14	8							e0221344	10.1371/journal.pone.0221344	http://dx.doi.org/10.1371/journal.pone.0221344			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5LL	31419250	Green Submitted, Green Published, gold			2022-12-26	WOS:000485019900039
J	Li, H; Yun, HM; Jiang, YR; Zeng, RS; Chen, ZC				Li, Hua; Yun, Hongmei; Jiang, Yongrong; Zeng, Ruosheng; Chen, Zhencheng			A needle-to-post air discharge ion source in tandem with FAIMS system	PLOS ONE			English	Article							MOBILITY SPECTROMETER	A needle-to-post ionization source was designed for high-field asymmetric waveform ion mobility spectrometry (FAIMS). The needle-to-post ion source includes asymmetric electrode comprised of a copper post with a diameter of 2 mm and a stainless-steel needle with 200-mu m tip radius and length of 28 mm. With the discharge voltage of -5.6 kV and N-2 gas flow, glow discharge was realized at atmospheric pressure. The mass spectra of ionized ions about acetone, ethanol and ethyl acetate were gotten by Thermo Scientific LTQ XL ion trap mass spectrometer (MS). The MS experimental results show that the main ions are protonated and dimer ions. The needle-to-post ion source was mounted on the FAIMS system and FAIMS spectra are gotten successfully. Separation of p-xylene, o-xylene and m-xylene was realized. It shows that the needle-to-post electrode could be used as the ion source in a FAIMS system.	[Li, Hua; Yun, Hongmei; Jiang, Yongrong; Zeng, Ruosheng; Chen, Zhencheng] GuiLin Univ Elect Technol, Sch Life & Environm Sci, Guilin, Guangxi, Peoples R China	Guilin University of Electronic Technology	Li, H; Jiang, YR; Chen, ZC (corresponding author), GuiLin Univ Elect Technol, Sch Life & Environm Sci, Guilin, Guangxi, Peoples R China.	lihua@guet.edu.cn; svmsung2996@sina.com; chenzhcheng@guet.edu.cn			National Natural Science Foundation of China [61864001, 61627807, 81873913]; Natural Science Foundation of Guangxi [2017GXNSFGA198005, 2017GXNSFAA198256]; Foundation of Guangxi Key Laboratory of Automatic Detecting Technology and Instruments (Guilin University of Electronic Technology) [YQ18113]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangxi(National Natural Science Foundation of Guangxi Province); Foundation of Guangxi Key Laboratory of Automatic Detecting Technology and Instruments (Guilin University of Electronic Technology)	This work was partially supported by the National Natural Science Foundation of China under Grant Numbers 61864001, 61627807 and 81873913; the Natural Science Foundation of Guangxi under Grant Numbers 2017GXNSFGA198005 and 2017GXNSFAA198256; and the Foundation of Guangxi Key Laboratory of Automatic Detecting Technology and Instruments (Guilin University of Electronic Technology) under Grant Number YQ18113.	Andriy K, 2015, ANAL CHEM, V87, P8932, DOI [10.1021/acs.analchem.5b02077, DOI 10.1021/ACS.ANALCHEM.5B02077]; Chavarria MA, 2017, REV SCI INSTRUM, V88, DOI 10.1063/1.4978960; Gary A E, 2002, ANALYST, V127, P466; Kolakowski BM, 2007, ANALYST, V132, P842, DOI 10.1039/b706039d; Kuklya A, 2017, TALANTA, V162, P159, DOI 10.1016/j.talanta.2016.10.024; Li H, 2017, J ELECTROSTAT, V86, P59, DOI 10.1016/j.elstat.2017.01.013; Li H, 2016, J VAC SCI TECHNOL A, V34, DOI 10.1116/1.4947073; Li H, 2014, SPECTROSC SPECT ANAL, V34, P1797, DOI 10.3964/j.issn.1000-0593(2014)07-1797-04; Li H, 2010, CHINESE J ANAL CHEM, V38, P1678, DOI 10.3724/SP.J.1096.2010.01678; Li H, 2010, CHINESE J CHEM PHYS, V23, P125, DOI 10.1088/1674-0068/23/02/125-132; Li H, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17010089; Liu K, 2009, ACTA PHYS-CHIM SIN, V25, P1662, DOI 10.3866/PKU.WHXB20090813; Longwitz R G, 2003, J VAC SCI TECHNOL B, V21, P111; Miller RA, 2001, SENSOR ACTUAT A-PHYS, V91, P301, DOI 10.1016/S0924-4247(01)00600-8; Purves RW, 2013, ANAL BIOANAL CHEM, V405, P35, DOI 10.1007/s00216-012-6496-3; Purves RW, 1998, REV SCI INSTRUM, V69, P4094, DOI 10.1063/1.1149255; Roger G, 2005, J AM SOC MASS SPECTR, V16, P349, DOI [10.1016/j.jasms.2004.11.013, DOI 10.1016/J.JASMS.2004.11.013]; Sabo M, 2010, INT J MASS SPECTROME; Zhao DJ, 2013, ANAL LETT, V46, P452, DOI 10.1080/00032719.2012.725190	19	0	0	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2019	14	8							e0221080	10.1371/journal.pone.0221080	http://dx.doi.org/10.1371/journal.pone.0221080			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5LL	31419259	Green Published, gold, Green Submitted			2022-12-26	WOS:000485019900027
J	Balebail, S; Raja, SK; Sane, SP				Balebail, Sujay; Raja, Sathish K.; Sane, Sanjay P.			Landing maneuvers of houseflies on vertical and inverted surfaces	PLOS ONE			English	Article							VISUAL CONTROL; NUCLEUS ROTUNDUS; FLOW-FIELD; WIDE-FIELD; FRUIT-FLY; MOTION; OPTOMOTOR; FLIGHT; COMPUTATION; DROSOPHILA	Landing maneuvers of flies are complex behaviors which can be conceptually decomposed into sequences of modular actions, including body-deceleration, leg-extension, and body rotations. These behavioral 'modules' must be coordinated to ensure well-controlled landing. The composite nature of these behaviors induces kinematic variability, making it difficult to identify the central rules that govern landing. Many previous studies have relied on tethered preparations to study landing behaviors, but tethering induces experimental artefacts by forcing some behaviors to operate in open-feedback control loop while others remain closed-loop. On the other hand, it is harder for the experimenter to control the stimuli experienced by freely-flying insects. One approach towards understanding general mechanisms of landing is to determine the common elements of their kinematics on surfaces of different orientations. We conducted a series of experiments in which the houseflies, Musca domestica, were lured to land on vertical (wall landings) or inverted (ceiling landings) substrates, while their flight was recorded with multiple highspeed cameras. We observed that, in both cases, well-controlled landings occurred when the distance at which flies initiated deceleration was proportional to flight velocity component in the direction of substrate. The ratio of substrate distance and velocity at onset of deceleration (tau) was conserved, despite substantial differences in mechanics of vertical vs. ceiling landings. When these conditions were not satisfied, their landing performance was compromised, causing their heads to collide into the substrate. Unlike body-deceleration, leg-extension in flies was independent of substrate distance or approach velocity. Thus, the robust reflexive visual initiation of deceleration is independent of substrate orientation, and combines with a more variable initiation of leg-extension which depends on surface orientation. Together, these combinations of behaviors enable flies to land in a versatile manner on substrates of various orientations.	[Balebail, Sujay; Raja, Sathish K.; Sane, Sanjay P.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Sane, SP (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India.	sane@ncbs.res.in		Sane, Sanjay P./0000-0002-8274-1181; Balebail, Sujay/0000-0002-0805-8173	Air Force Office of Scientific Research (AFOSR) [FA2386-11-1-4057, FA9550-16-1-0155]; National Centre for Biological Sciences	Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Centre for Biological Sciences(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funded by Air Force Office of Scientific Research (AFOSR) #FA2386-11-1-4057; #FA9550-16-1-0155 National Centre for Biological Sciences.	Baird E, 2013, P NATL ACAD SCI USA, V110, P18686, DOI 10.1073/pnas.1314311110; Barron AB, 2000, J INSECT PHYSIOL, V46, P439, DOI 10.1016/S0022-1910(99)00129-8; BORST A, 1989, NATURWISSENSCHAFTEN, V76, P531, DOI 10.1007/BF00374132; BORST A, 1986, BIOL CYBERN, V54, P379, DOI 10.1007/BF00355543; BORST A, 1986, BIOL CYBERN, V55, P59, DOI 10.1007/BF00363978; BORST A, 1990, BIOSCIENCE, V40, P292, DOI 10.2307/1311266; BORST A, 1988, NATURWISSENSCHAFTEN, V75, P265, DOI 10.1007/BF00378023; BORST A, 1987, BIOL CYBERN, V56, P217, DOI 10.1007/BF00365216; BORST A, 1988, J COMP PHYSIOL A, V163, P167, DOI 10.1007/BF00612426; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; COGGSHALL JC, 1972, J EXP BIOL, V57, P401; DAVID CT, 1978, PHYSIOL ENTOMOL, V3, P191, DOI 10.1111/j.1365-3032.1978.tb00148.x; De Talens A. F. P, 1970, J. exp. Biol., V52, P233; Duistermars BJ, 2007, J EXP BIOL, V210, P3218, DOI 10.1242/jeb.007807; ECKERT H, 1980, BIOL CYBERN, V37, P235, DOI 10.1007/BF00337042; EGELHAAF M, 1989, J OPT SOC AM A, V6, P116, DOI 10.1364/JOSAA.6.000116; Evangelista C, 2010, J EXP BIOL, V213, P262, DOI 10.1242/jeb.037465; Gabbiani F, 1999, J NEUROSCI, V19, P1122; Gabbiani F, 2001, J NEUROSCI, V21, P314, DOI 10.1523/JNEUROSCI.21-01-00314.2001; GOODMAN LJ, 1960, J EXP BIOL, V37, P854; HAUSEN K, 1982, BIOL CYBERN, V45, P143, DOI 10.1007/BF00335241; HYZER WG, 1962, SCIENCE, V137, P609, DOI 10.1126/science.137.3530.609; Ibbotson MR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14954-0; LEE DN, 1991, NATURWISSENSCHAFTEN, V78, P526, DOI 10.1007/BF01131406; LEE DN, 1981, NATURE, V293, P293, DOI 10.1038/293293a0; LEE DN, 1980, PHILOS T R SOC B, V290, P169, DOI 10.1098/rstb.1980.0089; LEE DN, 1976, PERCEPTION, V5, P437, DOI 10.1068/p050437; LEE DN, 1993, J EXP BIOL, V180, P85; Nakagawa H, 2010, J NEUROPHYSIOL, V104, P2487, DOI 10.1152/jn.01055.2009; Reber T, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00174; Reber T, 2016, J COMP PHYSIOL A, V202, P277, DOI 10.1007/s00359-016-1073-4; Shen C, 2018, BIOINSPIR BIOMIM, V13, DOI 10.1088/1748-3190/aa934b; SRINIVASAN MV, 1977, J COMP PHYSIOL, V115, P101, DOI 10.1007/BF00667788; Srinivasan MV, 2000, BIOL CYBERN, V83, P171, DOI 10.1007/s004220000162; Straw AD, 2008, J VISION, V8, DOI 10.1167/8.3.32; Sun HJ, 1998, NAT NEUROSCI, V1, P296, DOI 10.1038/1110; Tammero LF, 2002, J EXP BIOL, V205, P2785; van Breugel F, 2012, J EXP BIOL, V215, P1783, DOI 10.1242/jeb.066498; WAGNER H, 1986, PHILOS T ROY SOC B, V312, P527, DOI 10.1098/rstb.1986.0017; WAGNER H, 1982, NATURE, V297, P147, DOI 10.1038/297147a0; Walker JA, 1998, J EXP BIOL, V201, P981; WANG YC, 1992, NATURE, V356, P236, DOI 10.1038/356236a0; Zhao JL, 2017, J APPL PHYS, V121, DOI 10.1063/1.4977844	43	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0219861	10.1371/journal.pone.0219861	http://dx.doi.org/10.1371/journal.pone.0219861			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412069	Green Submitted, Green Published, gold			2022-12-26	WOS:000485012600017
J	Debrand, E; Chakalova, L; Miles, J; Dai, YF; Goyenechea, B; Dye, S; Osborne, CS; Horton, A; Harju-Baker, S; Pink, RC; Caley, D; Carter, DRF; Peterson, KR; Fraser, P				Debrand, Emmanuel; Chakalova, Lyubomira; Miles, Joanne; Dai, Yan-Feng; Goyenechea, Beatriz; Dye, Sandra; Osborne, Cameron S.; Horton, Alice; Harju-Baker, Susanna; Pink, Ryan C.; Caley, Daniel; Carter, David R. F.; Peterson, Kenneth R.; Fraser, Peter			An intergenic non-coding RNA promoter required for histone modifications in the human beta-globin chromatin domain	PLOS ONE			English	Article							LOCUS-CONTROL REGION; ARTIFICIAL CHROMOSOMES YACS; GENE-EXPRESSION; FETAL-HEMOGLOBIN; TRANSGENIC MICE; DEVELOPMENTAL CONTROL; HYPERSENSITIVE SITES; TRANSCRIPTION; MOUSE; DELETION	Transcriptome analyses show a surprisingly large proportion of the mammalian genome is transcribed; much more than can be accounted for by genes and introns alone. Most of this transcription is non-coding in nature and arises from intergenic regions, often overlapping known protein-coding genes in sense or antisense orientation. The functional relevance of this widespread transcription is unknown. Here we characterize a promoter responsible for initiation of an intergenic transcript located approximately 3.3 kb and 10.7 kb upstream of the adult-specific human beta-globin genes. Mutational analyses in beta-YAC transgenic mice show that alteration of intergenic promoter activity results in ablation of H3K4 di- and tri-methylation and H3 hyperacetylation extending over a 30 kb region immediately downstream of the initiation site, containing the adult delta- and beta-globin genes. This results in dramatically decreased expression of the adult genes through position effect variegation in which the vast majority of definitive erythroid cells harbor inactive adult globin genes. In contrast, expression of the neighboring epsilon- and gamma-globin genes is completely normal in embryonic erythroid cells, indicating a developmentally specific variegation of the adult domain. Our results demonstrate a role for intergenic non-coding RNA transcription in the propagation of histone modifications over chromatin domains and epigenetic control of beta-like globin gene transcription during development.	[Debrand, Emmanuel; Chakalova, Lyubomira; Miles, Joanne; Dai, Yan-Feng; Goyenechea, Beatriz; Dye, Sandra; Osborne, Cameron S.; Horton, Alice; Fraser, Peter] Babraham Inst, Lab Chromatin & Gene Express, Babraham Res Campus, Cambridge, England; [Harju-Baker, Susanna; Peterson, Kenneth R.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Pink, Ryan C.; Caley, Daniel; Carter, David R. F.] Oxford Brookes Univ, Fac Hlth & Life Sci, Dept Biol & Med Sci, Oxford, England; [Fraser, Peter] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Kansas; University of Kansas Medical Center; Oxford Brookes University; State University System of Florida; Florida State University	Fraser, P (corresponding author), Babraham Inst, Lab Chromatin & Gene Express, Babraham Res Campus, Cambridge, England.; Peterson, KR (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA.; Fraser, P (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	kpeterson@kumc.edu; pfraser@bio.fsu.edu		dai, dai yan feng/0000-0001-7147-1748	Medical Research Council, UK; Biotechnology and Biological Sciences Research Council, UK; USPHS NIH [DK053510, HL067336, HL111264]; Sparks	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); USPHS NIH(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Sparks	This work was supported in part by the Medical Research Council and the Biotechnology and Biological Sciences Research Council, UK, awarded to PF, by USPHS NIH grants DK053510, HL067336, and HL111264 awarded to KRP and by a grant from Sparks awarded to DRFC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; Bender MA, 2000, MOL CELL, V5, P387, DOI 10.1016/S1097-2765(00)80433-5; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Calzolari R, 1999, EMBO J, V18, P949, DOI 10.1093/emboj/18.4.949; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chakalova L, 2005, NAT REV GENET, V6, P669, DOI 10.1038/nrg1673; Chakalova L, 2005, BLOOD, V105, P2154, DOI 10.1182/blood-2003-11-4069; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; DICKERMAN HW, 1976, ARCH BIOCHEM BIOPHYS, V177, P1, DOI 10.1016/0003-9861(76)90408-2; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Farrell CM, 2002, MOL CELL BIOL, V22, P3820, DOI 10.1128/MCB.22.11.3820-3831.2002; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Huang P, 2017, GENE DEV, V31, P1704, DOI 10.1101/gad.303461.117; Ivaldi MS, 2018, BLOOD, V132, P1963, DOI 10.1182/blood-2018-07-862003; Jawaid K, 2010, BLOOD CELL MOL DIS, V45, P140, DOI 10.1016/j.bcmd.2010.05.006; Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305; Kim A, 2007, MOL CELL BIOL, V27, P1271, DOI 10.1128/MCB.01684-06; Koziol MJ, 2010, CURR OPIN GENET DEV, V20, P142, DOI 10.1016/j.gde.2010.03.003; Leach KM, 2001, MOL CELL BIOL, V21, P2629, DOI 10.1128/MCB.21.8.2629-2640.2001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long QM, 1998, BLOOD, V92, p333A; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Miles J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000630; Milot E, 1996, CELL, V87, P105, DOI 10.1016/S0092-8674(00)81327-6; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; O'Neill LP, 2003, METHODS, V31, P76, DOI 10.1016/S1046-2023(03)00090-2; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Peterson KR, 1998, ANN NY ACAD SCI, V850, P28, DOI 10.1111/j.1749-6632.1998.tb10459.x; PETERSON KR, 1995, P NATL ACAD SCI USA, V92, P5655, DOI 10.1073/pnas.92.12.5655; PETERSON KR, 1993, P NATL ACAD SCI USA, V90, P7593, DOI 10.1073/pnas.90.16.7593; Peterson KR, 1998, HUM MOL GENET, V7, P2079, DOI 10.1093/hmg/7.13.2079; Peterson KR, 1997, TRENDS GENET, V13, P61, DOI 10.1016/S0168-9525(97)01003-2; PETERSON KR, 1993, P NATL ACAD SCI USA, V90, P11207, DOI 10.1073/pnas.90.23.11207; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Redrup L, 2009, DEVELOPMENT, V136, P525, DOI 10.1242/dev.031328; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Routledge SJE, 2002, J MOL BIOL, V323, P601, DOI 10.1016/S0022-2836(02)01011-2; Sankaran VG, 2011, NEW ENGL J MED, V365, P807, DOI 10.1056/NEJMoa1103070; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; Schubeler D, 2000, GENE DEV, V14, P940; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Tanimoto K, 1999, NATURE, V398, P344, DOI 10.1038/18698; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Trimborn T, 1999, GENE DEV, V13, P112, DOI 10.1101/gad.13.1.112; TUAN D, 1992, P NATL ACAD SCI USA, V89, P11219, DOI 10.1073/pnas.89.23.11219; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; Xiang P, 2006, BIOCHEM BIOPH RES CO, V344, P623, DOI 10.1016/j.bbrc.2006.03.189; Xu J, 2012, DEV CELL, V23, P796, DOI 10.1016/j.devcel.2012.09.003	58	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0217532	10.1371/journal.pone.0217532	http://dx.doi.org/10.1371/journal.pone.0217532			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412036	Green Submitted, gold, Green Published			2022-12-26	WOS:000485012600008
J	Rohwer, VG; Purcell, JR				Rohwer, Vanya G.; Purcell, James R.			Geographic variation in incubation behavior of a widely distributed passerine bird	PLOS ONE			English	Article							LATITUDINAL VARIATION; AMBIENT-TEMPERATURE; SEXUAL SELECTION; LIFE-HISTORIES; PREDATION RISK; PARENTAL CARE; EXPENDITURE; EVOLUTION; SURVIVAL; SUCCESS	Incubating birds must trade-off leaving the nest to forage with staying on the nest to maintain optimal temperatures for developing embryos. This trade-off is expressed through incubation behavior, which can be heavily influenced by climate, food availability, attentiveness of their mates, and nest predation risk. Comparative studies across species have shown that incubation behavior varies across latitude, but few studies have explored how incubation behavior varies across sites within species. We might expect incubation behavior to be flexible and respond to local environmental challenges; alternatively, behavior may be relatively fixed and vary little across a species' range. We explored four incubation behaviors (male feeding rate, female off-bout duration, female off-bout frequency, and the proportion of time incubating females spent on the nest) in a widespread songbird, the yellow warbler (Setophaga petechia), breeding at a temperate and subarctic site. As temperatures warmed at both sites, males fed females less often, and as male feeding rates decreased, off-bout durations and frequencies increased causing the proportion of time on the nest to decrease. While incubation behaviors changed in similar ways between sites, off-bout durations shortened with increasing male feeding rates most strongly at the temperate site. Overall, these results show flexibility in incubation behaviors in response to different environmental cues, which likely minimize costs associated with provisioning incubating parents and maintaining warm nest temperatures, and suggests that male feeding may be especially important for breeding in cold regions.	[Rohwer, Vanya G.; Purcell, James R.] Cornell Univ, Museum Vertebrates, Ithaca, NY 14850 USA	Cornell University	Rohwer, VG (corresponding author), Cornell Univ, Museum Vertebrates, Ithaca, NY 14850 USA.	vgr7@cornell.edu			Churchill Northern Studies Centre; American Ornithologists' Union; Society of Canadian Ornithologists; Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation (CFI); Queen's University Principal's Development Fund; Senate Advisory Research Committee; Queen's University Research Initiation Grant	Churchill Northern Studies Centre; American Ornithologists' Union; Society of Canadian Ornithologists; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Queen's University Principal's Development Fund; Senate Advisory Research Committee; Queen's University Research Initiation Grant	This work was funded by the Churchill Northern Studies Centre, the American Ornithologists' Union, the Society of Canadian Ornithologists, the Natural Sciences and Engineering Research Council of Canada (NSERC), the Canada Foundation for Innovation (CFI), the Queen's University Principal's Development Fund and Senate Advisory Research Committee, and a Queen's University Research Initiation Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Paul R. Martin provided guidance and support throughout this research. We thank the Churchill Northern Studies Centre and the Queen's University Biological Station for logistical support, and Sievert Rohwer, Philina English, Juan A. Amat, and an Anonymous Reviewer provided helpful comments on earlier drafts of the manuscript. The Cornell University Museum of Vertebrates kindly allowed use of their specimens.	Alvarez E, 2014, BEHAVIOUR, V151, P1827, DOI 10.1163/1568539X-00003218; Amat JA, 2004, BEHAV ECOL SOCIOBIOL, V56, P26, DOI 10.1007/s00265-004-0758-9; Amat JA, 2004, ANIM BEHAV, V67, P293, DOI 10.1016/j.anbehav.2003.06.014; Ardia DR, 2009, J ANIM ECOL, V78, P4, DOI 10.1111/j.1365-2656.2008.01453.x; Badyaev AV, 2001, ECOLOGY, V82, P2948, DOI 10.1890/0012-9658(2001)082[2948:EOLHAE]2.0.CO;2; Bergman P, 1996, ARCTIC ALPINE RES, V28, P196, DOI 10.2307/1551760; Berntsen HH, 2016, J AVIAN BIOL, V47, P141, DOI 10.1111/jav.00688; Briskie JV, 1995, J FIELD ORNITHOL, V66, P531; Camfield AF, 2009, BEHAVIOUR, V146, P1615, DOI 10.1163/156853909X463335; Chalfoun AD, 2007, ANIM BEHAV, V73, P579, DOI 10.1016/j.anbehav.2006.09.010; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Coe BH, 2015, J AVIAN BIOL, V46, P385, DOI 10.1111/jav.00581; Conway CJ, 2000, EVOLUTION, V54, P670; Conway CJ, 2000, BEHAV ECOL, V11, P178, DOI 10.1093/beheco/11.2.178; Crossman CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019086; Deeming DC, 2015, NESTS, EGGS, AND INCUBATION: NEW IDEAS ABOUT AVIAN REPRODUCTION, P29; Deeming DC, 2015, AVIAN BIOL RES, P32; DuRant SE, 2013, BIOL REV, V88, P499, DOI 10.1111/brv.12015; Fontaine JJ, 2006, ECOL LETT, V9, P428, DOI 10.1111/j.1461-0248.2006.00892.x; Ghalambor CK, 2001, SCIENCE, V292, P494, DOI 10.1126/science.1059379; Grant G.S., 1982, ORNITHOL MONOGR, V30, P1, DOI [10.2307/40166669, DOI 10.2307/40166669]; Harrison F, 2009, J EVOLUTION BIOL, V22, P1800, DOI 10.1111/j.1420-9101.2009.01792.x; Hepp GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047777; Hille SM, 2015, BIOL REV, V90, P204, DOI 10.1111/brv.12106; Johnson LS, 2007, J ORNITHOL, V148, P9, DOI 10.1007/s10336-006-0092-2; JOHNSON SR, 1974, CAN J ZOOL, V52, P1559, DOI 10.1139/z74-202; LOWTHER PE, 1999, BIRDS N AM; LYON BE, 1987, ECOLOGY, V68, P713, DOI 10.2307/1938477; Magrath MJL, 2003, TRENDS ECOL EVOL, V18, P424, DOI 10.1016/S0169-5347(03)00124-1; Martin TE, 1999, AM NAT, V153, P131, DOI 10.1086/303153; Matysiokova B, 2018, EVOLUTION, V72, P2214, DOI 10.1111/evo.13580; Matysiokova B, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-24; Matysiokova B, 2011, ANIM BEHAV, V82, P1347, DOI 10.1016/j.anbehav.2011.09.018; Moore SD, 2012, ANIM BEHAV, V84, P1213, DOI 10.1016/j.anbehav.2012.08.027; Nord A, 2015, NESTS, EGGS, AND INCUBATION: NEW IDEAS ABOUT AVIAN REPRODUCTION, P152; Nord A, 2011, AM NAT, V178, P639, DOI 10.1086/662172; R Core Team, 2013, R LANG ENV STAT COMP; Reid JM, 2000, P ROY SOC B-BIOL SCI, V267, P37, DOI 10.1098/rspb.2000.0963; Rohwer VG, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1585; Rohwer VG, 2010, CONDOR, V112, P596, DOI 10.1525/cond.2010.090229; Sanz JJ, 2000, OECOLOGIA, V122, P149, DOI 10.1007/PL00008842; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; STUDD MV, 1985, BEHAV ECOL SOCIOBIOL, V17, P101; Summers RW, 2004, IBIS, V146, P303, DOI 10.1111/j.1474-919X.2004.00260.x; Vincze O, 2017, GLOBAL ECOL BIOGEOGR, V26, P347, DOI 10.1111/geb.12540; Vincze O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060998; WEBB DR, 1987, CONDOR, V89, P874, DOI 10.2307/1368537; Yezerinac SM, 1997, P ROY SOC B-BIOL SCI, V264, P527, DOI 10.1098/rspb.1997.0075; Yoon J, 2017, J AVIAN BIOL, V48, P220, DOI 10.1111/jav.00890; Zuur Alain F., 2009, P1	50	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0219907	10.1371/journal.pone.0219907	http://dx.doi.org/10.1371/journal.pone.0219907			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412068	Green Published, gold, Green Submitted			2022-12-26	WOS:000485012600019
J	Wang, SH; Liu, XJ; Xia, ZY; Xie, GQ; Tang, B; Wang, SG				Wang, Shaohua; Liu, Xiaojun; Xia, Zhiyong; Xie, Guoqiang; Tang, Bin; Wang, Shigui			Transcriptome analysis of the molecular mechanism underlying immunity- and reproduction trade-off in Locusta migratoria infected by Micrococcus luteus	PLOS ONE			English	Article							PATHWAY; MATURATION	Immune response and reproductive success are two vital energy-consuming processes in living organisms. However, it is still unclear which process is prioritized when both are required. Therefore, the present study was designed to examine this question arising for one of the world's most destructive agricultural pests, the migratory locust, Locusta migratoria. Transcripts from the ovaries and fat bodies of newly emerged locusts were analyzed, using RNA-seq based transcriptome and qualitative real-time PCR, at 4 h and 6 d after being infected with the gram-positive bacteria Micrococcus luteus. Changes in the main biological pathways involved in reproduction and immunization were analyzed using bioinformatics. After 4 h of infection, 348 and 133 transcripts were up- and down-regulated, respectively, whereas 5699 and 44 transcripts were up- and down-regulated, respectively, at 6 d after infection. Moreover, KEGG analysis indicated that vital pathways related with immunity and reproduction, such as Insulin resistance, FoxO signaling, Lysosome, mTOR signaling, and Toll-like receptor signaling pathways were up-regulated. Among the differentially expressed genes, 22 and 17 were related to immunity and reproduction, respectively. The expression levels of PPO1 and antimicrobial peptide defensin 3 were increased (log(2)FC = 5.93 and 6.75, respectively), whereas those of VgA and VgB were reduced (log(2)FC = -17.82 and -18.13, respectively). These results indicated that locust allocate energy and resources to maintain their own survival by increasing immune response when dealing with both immune and reproductive processes. The present study provides the first report of expression levels for genes related with reproduction and immunity in locusts, thereby providing a reference for future studies, as well as theoretical guidance for investigations of locust control.	[Wang, Shaohua; Liu, Xiaojun; Xia, Zhiyong; Xie, Guoqiang; Tang, Bin; Wang, Shigui] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou Key Lab Anim Adaptat & Evolut, Hangzhou, Zhejiang, Peoples R China	Hangzhou Normal University	Wang, SG (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou Key Lab Anim Adaptat & Evolut, Hangzhou, Zhejiang, Peoples R China.	sgwang@hznu.edu.cn	shaohua, wang/AAB-7904-2022		National Natural Science Foundation of China [31270459, 30970473]; Project of Zhejiang Qian-Jiang Talents Program [2010R10093]; Program for Excellent Young Teachers in Hangzhou Normal University [JTAS 2011-01-031]; Program for Innovate Students in Hangzhou Normal University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Zhejiang Qian-Jiang Talents Program; Program for Excellent Young Teachers in Hangzhou Normal University; Program for Innovate Students in Hangzhou Normal University	This work was supported by the National Natural Science Foundation of China (Grant Nos. 31270459 and 30970473), Project of Zhejiang Qian-Jiang Talents Program (Grant No. 2010R10093), Program for Excellent Young Teachers in Hangzhou Normal University (Grant No. JTAS 2011-01-031), and Program for Innovate Students in Hangzhou Normal University.	Becker T, 2010, NATURE, V463, P369, DOI 10.1038/nature08698; Bidla G, 2007, J CELL SCI, V120, P1209, DOI 10.1242/jcs.03420; Casadevall A, 1999, INFECT IMMUN, V67, P3703, DOI 10.1128/IAI.67.8.3703-3713.1999; CHINZEI Y, 1985, J INSECT PHYSIOL, V31, P441, DOI 10.1016/0022-1910(85)90090-3; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Flatt T, 2008, J EXP BIOL, V211, P2712, DOI 10.1242/jeb.014878; Gay NJ, 2014, NAT REV IMMUNOL, V14, P546, DOI 10.1038/nri3713; Gold KS, 2015, SEMIN IMMUNOL, V27, P357, DOI 10.1016/j.smim.2016.03.010; Guo W, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004702; Hsu HJ, 2009, P NATL ACAD SCI USA, V106, P1117, DOI 10.1073/pnas.0809144106; Kirschman LJ, 2017, J INSECT PHYSIOL, V98, P199, DOI 10.1016/j.jinsphys.2017.01.009; Luo MW, 2017, J BIOL CHEM, V292, P8823, DOI 10.1074/jbc.M117.780957; Lv MY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161585; Ma ZY, 2011, P NATL ACAD SCI USA, V108, P3882, DOI 10.1073/pnas.1015098108; Marchal E, 2011, INSECT BIOCHEM MOLEC, V41, P219, DOI 10.1016/j.ibmb.2010.12.007; Mauvezin C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8007; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Perez-Hedo M, 2013, INSECT BIOCHEM MOLEC, V43, P495, DOI 10.1016/j.ibmb.2013.03.008; Raikhel A.S., 2005, P433; Rolff J, 2002, P NATL ACAD SCI USA, V99, P9916, DOI 10.1073/pnas.152271999; Roy S, 2018, ANNU REV ENTOMOL, V63, P489, DOI 10.1146/annurev-ento-020117-043258; Schwenke RA, 2016, ANNU REV ENTOMOL, V61, P239, DOI 10.1146/annurev-ento-010715-023924; Scott CC, 2014, SEMIN CELL DEV BIOL, V31, P2, DOI 10.1016/j.semcdb.2014.03.034; Sheng ZT, 2011, J BIOL CHEM, V286, P41924, DOI 10.1074/jbc.M111.269845; Song JS, 2014, INSECT BIOCHEM MOLEC, V52, P94, DOI 10.1016/j.ibmb.2014.07.001; Stearns SC, 2000, NATURWISSENSCHAFTEN, V87, P476, DOI 10.1007/s001140050763; Swevers L., 2005, P87; Troha K, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006847; Tufail M, 2008, J INSECT PHYSIOL, V54, P1447, DOI 10.1016/j.jinsphys.2008.08.007; Uvell H, 2007, TRENDS GENET, V23, P342, DOI 10.1016/j.tig.2007.05.003; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Viljakainen L, 2015, BRIEF FUNCT GENOMICS, V14, P407, DOI 10.1093/bfgp/elv002; Wang XH, 2014, NAT COMMUN, V5, P1, DOI 10.1038/ncomms3957; Wu CX, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.140171; Wu R, 2012, P NATL ACAD SCI USA, V109, P3259, DOI 10.1073/pnas.1119155109; Xia BY, 1965, ACTA ENTOMOL SINICA, V14, P395	36	3	3	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0211605	10.1371/journal.pone.0211605	http://dx.doi.org/10.1371/journal.pone.0211605			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412031	Green Submitted, Green Published, gold			2022-12-26	WOS:000485012600004
J	dos Reis, MC; Bagatini, IL; Vidal, LD; Bonnet, MP; Marques, DD; Sarmento, H				dos Reis, Mariana Camara; Bagatini, Inessa Lacativa; Vidal, Luciana de Oliveira; Bonnet, Marie-Paule; Marques, David da Motta; Sarmento, Hugo			Spatial heterogeneity and hydrological fluctuations drive bacterioplankton community composition in an Amazon floodplain system	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; DIVERSITY; REVEALS; CARBON; BIOGEOGRAPHY; DYNAMICS; PATTERNS; RIVER	Amazonian floodplains form complex hydrological networks that play relevant roles in global biogeochemical cycles, and bacterial degradation of the organic matter in these systems is key for regional carbon budget. The Amazon undergoes extreme seasonal variations in water level, which produces changes in landscape and diversifies sources of organic inputs into floodplain systems. Although these changes should affect bacterioplankton community composition (BCC), little is known about which factors drive spatial and temporal patterns of bacterioplankton in these Amazonian floodplains. We used high-throughput sequencing (Illumina MiSeq) of the V3-V4 region of the 16S rRNA gene to investigate spatial and temporal patterns of BCC of two size fractions, and their correlation with environmental variables in an Amazon floodplain lake (Lago Grande do Curuai). We found a high degree of novelty in bacterioplankton, as more than half of operational taxonomic units (OTUs) could not be classified at genus level. Spatial habitat heterogeneity and the flood pulse were the main factors shaping free-living (FL) BCC. The gradient of organic matter from transition zone lake -Amazon River was the main driver for particle-attached (PA) BCC. The BCC reflected the complexity of the system, with more variation in space than in time, although both factors were important drivers of the BCC in this Amazon floodplain system.	[dos Reis, Mariana Camara; Sarmento, Hugo] Univ Fed Sao Carlos, Lab Microbial Proc & Biodivers, Dept Hidrobiol, Sao Carlos, SP, Brazil; [dos Reis, Mariana Camara] Univ Fed Sao Carlos, Programa Posgrad Ecol & Recursos Nat, Sao Carlos, SP, Brazil; [Bagatini, Inessa Lacativa] Univ Fed Sao Carlos, Lab Ficol, Dept Bot, Sao Carlos, SP, Brazil; [Vidal, Luciana de Oliveira] Univ Estadual Norte Fluminense, Lab Ciencias Ambientais, Ctr Biociencias & Biotecnol, Campos Dos Goytacazes, RJ, Brazil; [Bonnet, Marie-Paule] Inst Res Dev, UMR Espace DEV 228, Montpellier, France; [Bonnet, Marie-Paule] Univ Brasilia, Inst Res Dev, Int Joint Lab, LMI OCE, Brasilia, DF, Brazil; [Marques, David da Motta] Univ Fed Rio Grande do Sul, Inst Hydraul Res, Porto Alegre, RS, Brazil; [dos Reis, Mariana Camara] Sorbonne Univ, CNRS, UMR 7144, Adaptat & Divers Milieu Marin,Stn Biol Roscoff, Pl Georges Teissier, Roscoff, France	Universidade Federal de Sao Carlos; Universidade Federal de Sao Carlos; Universidade Federal de Sao Carlos; Universidade Estadual do Norte Fluminense; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universidade de Brasilia; Universidade Federal do Rio Grande do Sul; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite	dos Reis, MC (corresponding author), Univ Fed Sao Carlos, Lab Microbial Proc & Biodivers, Dept Hidrobiol, Sao Carlos, SP, Brazil.; dos Reis, MC (corresponding author), Univ Fed Sao Carlos, Programa Posgrad Ecol & Recursos Nat, Sao Carlos, SP, Brazil.; dos Reis, MC (corresponding author), Sorbonne Univ, CNRS, UMR 7144, Adaptat & Divers Milieu Marin,Stn Biol Roscoff, Pl Georges Teissier, Roscoff, France.	maricamarareis@gmail.com	Bagatini, I.L./H-9960-2017; Reis, Mariana Câmara dos/AAC-4225-2021; Vidal, Luciana O/V-4819-2019; Bonnet, Marie-Paule/J-6888-2016; Sarmento, Hugo/W-3805-2019	Bagatini, I.L./0000-0002-5549-2255; Reis, Mariana Câmara dos/0000-0003-4887-5351; Bonnet, Marie-Paule/0000-0002-3950-4041; Sarmento, Hugo/0000-0001-5220-7992; da Motta Marques, David/0000-0002-3809-8053; Vidal, Luciana/0000-0001-5065-0835	Conselho nacional de desenvolvimento cientifico e tecnologico [132749/2015-7, 490634/2013-3, 309514/2017-7]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2013/18083-0, 2014/13139-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [AUXPE-PNPD 2837/2010]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil) [490634/2013-3]; IRD (Institut de Recherche pour le Developpement); international research program Clim-FABIAM - FRB (Fondation pour la Recherche sur la Biodiversite); International Joint Laboratory, LMI OCE (IRD/Universidade de Brasilia); European Union's Horizon 2020 Research and innovation program under the Marie Sklodowska-Curie grant [691053]; INCT [16-2014]; CNPq; Capes; Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)	Conselho nacional de desenvolvimento cientifico e tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); IRD (Institut de Recherche pour le Developpement); international research program Clim-FABIAM - FRB (Fondation pour la Recherche sur la Biodiversite); International Joint Laboratory, LMI OCE (IRD/Universidade de Brasilia); European Union's Horizon 2020 Research and innovation program under the Marie Sklodowska-Curie grant; INCT; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	MCDR received a grant from Conselho nacional de desenvolvimento cientifico e tecnologico (grant process 132749/2015-7). ILB received a grant from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2013/18083-0). LOV received a grant from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (grant process AUXPE-PNPD 2837/2010). DMM received a grant from Conselho nacional de desenvolvimento cientifico e tecnologico (490634/2013-3). HS received a grant from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2014/13139-3) and Conselho nacional de desenvolvimento cientifico e tecnologico (309514/2017-7). This research was done under the auspices of CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil grant number 490634/2013-3), IRD (Institut de Recherche pour le Developpement), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2014/13139-3) and an international research program Clim-FABIAM (coordinated by MPB), which was funded by FRB (Fondation pour la Recherche sur la Biodiversite). The work also received funding from the International Joint Laboratory, LMI OCE (IRD/Universidade de Brasilia), from the European Union's Horizon 2020 Research and innovation program under the Marie Sklodowska-Curie grant (No. 691053 H2020-MSCA-RISE-2015 ODYSSEA project) and is part of the activities of the INCT no 16-2014 ODISSEIA, with funding from CNPq, Capes and Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF). The funders URLs are: http://www.cnpq.br/; http://www.fapesp.br/; http://www.capes.gov.br; https://www.ird.fr/; https://ec.europa.eu/programmes/horizon2020/; http://www.fap.df.gov.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril G, 2014, NATURE, V505, P395, DOI 10.1038/nature12797; Amaral JHF, 2018, SCI TOTAL ENVIRON, V630, P1381, DOI 10.1016/j.scitotenv.2018.02.331; Anderson M.J., 2005, PERMUTATIONAL MULTIV; APHA AWWA WEF, 2012, STANDARD METHODS EXA, P541; Bizic-Ionescu M, 2015, ENVIRON MICROBIOL, V17, P3500, DOI 10.1111/1462-2920.12466; Bonnet MP, 2008, J HYDROL, V349, P18, DOI 10.1016/j.jhydrol.2007.10.055; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Cai HY, 2013, MICROB ECOL, V66, P73, DOI 10.1007/s00248-013-0224-1; Carney RL, 2015, AQUAT MICROB ECOL, V75, P187, DOI 10.3354/ame01758; de Melo ML, 2019, FRESHWATER BIOL, V64, P108, DOI 10.1111/fwb.13198; Doherty M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00882; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Dvorak P, 2014, MOL ECOL, V23, P5538, DOI 10.1111/mec.12948; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ghai R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023785; Ghylin TW, 2014, ISME J, V8, P2503, DOI 10.1038/ismej.2014.135; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Ji Y, 2016, ENVIRON MICROBIOL, V18, P5082, DOI 10.1111/1462-2920.13491; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; LEWIS WM, 1976, SCIENCE, V192, P885, DOI 10.1126/science.192.4242.885; Liu LM, 2015, ISME J, V9, P2068, DOI 10.1038/ismej.2015.29; Lliros M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116145; Logares R, 2014, ENVIRON MICROBIOL, V16, P2659, DOI 10.1111/1462-2920.12250; Luef B, 2007, FRESHWATER BIOL, V52, P1043, DOI 10.1111/j.1365-2427.2007.01752.x; Lynch MDJ, 2015, NAT REV MICROBIOL, V13, P217, DOI 10.1038/nrmicro3400; Mackereth J., 1979, Q REV BIOL, V54, P203, DOI [DOI 10.1002/IROH.19790640404, 10.1086/411247, DOI 10.1086/411247]; Maurice Bourgoin L, 2007, J HYDROL, V335, P140, DOI 10.1016/j.jhydrol.2006.11.023; Melack JM, 2016, ECOL STUD-ANAL SYNTH, V227, P119, DOI 10.1007/978-3-662-49902-3_7; Mestre M, 2017, ISME J, V11, P999, DOI 10.1038/ismej.2016.166; Mohit V, 2014, APPL ENVIRON MICROB, V80, P2071, DOI 10.1128/AEM.02916-13; Moreira-Turcq P, 2013, GLOBAL BIOGEOCHEM CY, V27, P119, DOI 10.1002/gbc.20022; Mortillaro JM, 2016, LIMNOLOGICA, V59, P90, DOI 10.1016/j.limno.2016.03.008; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Pedros-Alio C, 2012, ANNU REV MAR SCI, V4, P449, DOI 10.1146/annurev-marine-120710-100948; Perez MAP, 2011, CHEM GEOL, V286, P158, DOI 10.1016/j.chemgeo.2011.05.004; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2021, R LANGUAGE ENV STAT; Raymond PA, 2013, NATURE, V503, P355, DOI 10.1038/nature12760; Read DS, 2015, ISME J, V9, P516, DOI 10.1038/ismej.2014.166; Reynolds C. S., 1984, ECOLOGY FRESHWATER P; Richey JE, 2002, NATURE, V416, P617, DOI 10.1038/416617a; RICHEY JE, 1990, LIMNOL OCEANOGR, V35, P352, DOI 10.4319/lo.1990.35.2.0352; Roberts D., 2007, LABDSV ORDINATION MU; Ruiz-Gonzalez C, 2015, GLOBAL ECOL BIOGEOGR, V24, P1487, DOI 10.1111/geb.12356; Ruiz-Gonzalez C, 2015, ECOL LETT, V18, P1198, DOI 10.1111/ele.12499; Salcher MM, 2014, J LIMNOL, V73, P74, DOI 10.4081/jlimnol.2014.813; Sarmento H, 2008, FRESHWATER BIOL, V53, P756, DOI 10.1111/j.1365-2427.2007.01939.x; Sarmento H, 2012, HYDROBIOLOGIA, V686, P1, DOI 10.1007/s10750-012-1011-6; Satinsky BM, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0099-0; Savio D, 2015, ENVIRON MICROBIOL, V17, P4994, DOI 10.1111/1462-2920.12886; Schmidt ML, 2016, ENVIRON MICROBIOL, V18, P1212, DOI 10.1111/1462-2920.13143; Schneegurt Mark A., 2003, Current Issues in Molecular Biology, V5, P1; Silva TSF, 2009, WETLANDS, V29, P747, DOI 10.1672/08-107.1; Sioli H., 1984, AMAZON LIMNOLOGY LAN, DOI [10.1007/978-94-009-6542-3_5, DOI 10.1007/978-94-009-6542-3_5]; Staley C, 2015, SCI TOTAL ENVIRON, V505, P435, DOI 10.1016/j.scitotenv.2014.10.012; Tessler M, 2016, MICROB ECOL, V73, P1, DOI [10.1007/s00248-016-0827-4, DOI 10.1007/S00248-016-0827-4]; Wiens JJ, 2011, ECOL LETT, V14, P643, DOI 10.1111/j.1461-0248.2011.01625.x; Woodhouse JN, 2016, ISME J, V10, P1337, DOI 10.1038/ismej.2015.218; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	63	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220695	10.1371/journal.pone.0220695	http://dx.doi.org/10.1371/journal.pone.0220695			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398199	Green Published, gold, Green Submitted			2022-12-26	WOS:000485004000013
J	Bafna, K; Narayanan, C; Chennubhotla, SC; Doucet, N; Agarwal, PK				Bafna, Khushboo; Narayanan, Chitra; Chennubhotla, S. Chakra; Doucet, Nicolas; Agarwal, Pratul K.			Nucleotide substrate binding characterization in human pancreatic-type ribonucleases	PLOS ONE			English	Article							EOSINOPHIL CATIONIC PROTEIN; CYCLOPHILIN-A INSIGHTS; UNIQUE BASIC RESIDUES; CRYSTAL-STRUCTURE; MOLECULAR-DYNAMICS; HUMAN ANGIOGENIN; LIGAND-BINDING; RNASE; NEUROTOXIN; CATALYSIS	Human genome contains a group of more than a dozen similar genes with diverse biological functions including antiviral, antibacterial and angiogenesis activities. The characterized gene products of this group show significant sequence similarity and a common structural fold associated with binding and cleavage of ribonucleic acid (RNA) substrates. Therefore, these proteins have been categorized as members of human pancreatic-type ribonucleases (hRNases). hRNases differ in cell/tissue localization and display distinct substrate binding preferences and a wide range of ribonucleolytic catalytic efficiencies. Limited information is available about structural and dynamical properties that influence this diversity among these homologous RNases. Here, we use computer simulations to characterize substrate interactions, electrostatics and dynamical properties of hRNases 1-7 associated with binding to two nucleotide substrates (ACAC and AUAU). Results indicate that even with complete conservation of active-site catalytic triad associated with ribonucleolytic activity, these enzymes show significant differences in substrate interactions. Detailed characterization suggests that in addition to binding site electrostatic and van der Waals interactions, dynamics of distal regions may also play a role in binding. Another key insight is that a small difference in temperature of 300 K (used in experimental studies) and 310 K (physiological temperature) shows significant changes in enzyme-substrate interactions.	[Bafna, Khushboo] Univ Tennessee, Genome Sci & Technol, Knoxville, TN USA; [Narayanan, Chitra; Doucet, Nicolas] Univ Quebec, INRS, Inst Armand Frappier, Laval, PQ, Canada; [Chennubhotla, S. Chakra] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA USA; [Doucet, Nicolas] Univ Laval, Quebec Network Res Prot Funct Struct & Engn, PROTEO, Quebec City, PQ, Canada; [Agarwal, Pratul K.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; University of Quebec; Institut national de la recherche scientifique (INRS); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Laval University; University of Tennessee System; University of Tennessee Knoxville	Agarwal, PK (corresponding author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA.	pratul@agarwal-lab.org	Bafna, Khushboo/AGK-9642-2022	Agarwal, Pratul/0000-0002-3848-9492; Bafna, Khushboo/0000-0002-1893-1175	National Institute of General Medical Sciences of the National Institutes of Health USA [GM105978]; Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2016-05557]; Foundation Armand-Frappier; CAS Dissertation Fellowship from University of Tennessee, Knoxville; National Science Foundation [ACI-1548562];  [MCB-180199];  [MCB-190044]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105978] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health USA; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Foundation Armand-Frappier; CAS Dissertation Fellowship from University of Tennessee, Knoxville; National Science Foundation(National Science Foundation (NSF)); ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institute of General Medical Sciences of the National Institutes of Health USA under award number GM105978, and a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (RGPIN-2016-05557 to N. D.). C. N. received a Postdoctoral Fellowship from the Foundation Armand-Frappier. N. D. holds a Fonds de Recherche Queebec -Sante (FRQS) Research Scholar Junior 2 Career Award. PKA designed the study with inputs from SCC and ND. KB performed the simulations. KB, CN and PKA analyzed the data, created the tables and figures. All authors wrote and reviewed the manuscript.; We thank Dr. Elizabeth Howell, Dr. Donald Gagne and Shantanu Shukla for discussions and feedback. This work was supported by a grant from the National Institute of General Medical Sciences of the National Institutes of Health USA under award number GM105978, and a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (RGPIN-2016-05557 to N. D.). C. N. received a Postdoctoral Fellowship from the Foundation Armand-Frappier. N. D. holds a Fonds de Recherche Quebec-Sante (FRQS) Research Scholar Junior 2 Career Award. K. B. acknowledges receipt of the CAS Dissertation Fellowship from University of Tennessee, Knoxville. This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant number ACI-1548562. XSEDE computing allocation awards to P.K.A. (MCB-180199 and MCB-190044).	ACHARYA KR, 1994, P NATL ACAD SCI USA, V91, P2915, DOI 10.1073/pnas.91.8.2915; Acharya KR, 1998, NATO ADV SCI I A-LIF, V298, P165; Agarwal PK, 2004, PROTEINS, V56, P449, DOI 10.1002/prot.20135; Agarwal PK, 2012, J PHYS CHEM LETT, V3, P1142, DOI 10.1021/jz201675m; ANDERSON DG, 1968, BIOCHEMISTRY-US, V7, P1637, DOI 10.1021/bi00845a004; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beck DAC, 2004, METHODS, V34, P112, DOI 10.1016/j.ymeth.2004.03.008; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Boix E, 1999, BIOCHEMISTRY-US, V38, P16794, DOI 10.1021/bi9919145; Boix E, 2001, METHOD ENZYMOL, V341, P287, DOI 10.1016/S0076-6879(01)41159-1; Boix E, 2013, BIOCHIMIE, V95, P1087, DOI 10.1016/j.biochi.2012.12.015; Case D.A., 2022, AMBER; Chang CS, 2002, J MOL BIOL, V317, P119, DOI 10.1006/jmbi.2002.5406; Chatani E, 2001, J BIOSCI BIOENG, V92, P98, DOI 10.1263/jbb.92.98; Cho S, 2005, GENOMICS, V85, P208, DOI 10.1016/j.ygeno.2004.10.008; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DELCARDAYRE SB, 1994, BIOCHEMISTRY-US, V33, P6031, DOI 10.1021/bi00186a001; Dey P, 2007, BIOCHEM BIOPH RES CO, V360, P809, DOI 10.1016/j.bbrc.2007.06.141; Doucet N., 2018, HUMAN RNASE 6 UNPUB; Doucet N, 2011, BIOCHEMISTRY-US, V50, P1723, DOI 10.1021/bi1018539; Doucet N, 2009, BIOCHEMISTRY-US, V48, P7160, DOI 10.1021/bi900830g; Duff MR, 2018, BIOCHEMISTRY-US, V57, P4263, DOI 10.1021/acs.biochem.8b00424; Elsasser B, 2014, J AM CHEM SOC, V136, P927, DOI 10.1021/ja406122c; Fisher BM, 1998, BIOCHEMISTRY-US, V37, P17386, DOI 10.1021/bi981369s; FLOGEL M, 1975, BIOCHEMISTRY-US, V14, P2616, DOI 10.1021/bi00683a009; FONTECILLACAMPS JC, 1994, J BIOL CHEM, V269, P21526; Gagne D, 2016, BIOCHEMISTRY-US, V55, P4184, DOI 10.1021/acs.biochem.6b00130; Gagne D, 2015, PROTEIN SCI, V24, P525, DOI 10.1002/pro.2613; Gagne D, 2013, FEBS J, V280, P5596, DOI 10.1111/febs.12371; Gaur D, 2005, MOL CELL BIOCHEM, V275, P95, DOI 10.1007/s11010-005-0997-8; Harder J, 2002, J BIOL CHEM, V277, P46779, DOI 10.1074/jbc.M207587200; HERRIES DG, 1962, BIOCHEM J, V85, P127, DOI 10.1042/bj0850127; Hofsteenge J, 1998, BIOCHEMISTRY-US, V37, P9250, DOI 10.1021/bi9803832; Huang YC, 2007, J BIOL CHEM, V282, P4626, DOI 10.1074/jbc.M607321200; Jardine AM, 2001, BIOCHEMISTRY-US, V40, P10262, DOI 10.1021/bi010888j; Kelemen BR, 2000, BIOCHEMISTRY-US, V39, P14487, DOI 10.1021/bi001862f; Klink TA, 2000, EUR J BIOCHEM, V267, P566, DOI 10.1046/j.1432-1327.2000.01037.x; Koczera P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081278; Kover KE, 2008, J MOL BIOL, V379, P953, DOI 10.1016/j.jmb.2008.04.042; Li GH, 2003, J AM CHEM SOC, V125, P15028, DOI 10.1021/ja0367851; Li L, 2017, BIOCHEMISTRY-US, V56, P5328, DOI 10.1021/acs.biochem.7b00657; Nagel ZD, 2009, NAT CHEM BIOL, V5, P543, DOI 10.1038/nchembio.204; Narayanan C, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00054; Narayanan C, 2018, STRUCTURE, V26, P426, DOI 10.1016/j.str.2018.01.015; Panov KI, 1996, FEBS LETT, V398, P57, DOI 10.1016/S0014-5793(96)01173-8; Prats-Ejarque G, 2016, BIOCHEM J, V473, P1523, DOI 10.1042/BCJ20160245; Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h; Ramanathan A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001193; Ramanathan A, 2010, J COMPUT BIOL, V17, P309, DOI 10.1089/cmb.2009.0167; Ramanathan A, 2009, J PHYS CHEM B, V113, P16669, DOI 10.1021/jp9077213; Rosenberg HF, 1996, NUCLEIC ACIDS RES, V24, P3507, DOI 10.1093/nar/24.18.3507; ROSENBERG HF, 1995, J BIOL CHEM, V270, P21539, DOI 10.1074/jbc.270.37.21539; Russo N, 1996, P NATL ACAD SCI USA, V93, P3243, DOI 10.1073/pnas.93.8.3243; Russo N, 1996, P NATL ACAD SCI USA, V93, P804, DOI 10.1073/pnas.93.2.804; Rutkoski TJ, 2008, ENG RIBONUCLEASE BAS; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shapiro R, 1998, BIOCHEMISTRY-US, V37, P6847, DOI 10.1021/bi9800146; Shukla S, 2018, BIOCHEMISTRY-US, V57, P5864, DOI 10.1021/acs.biochem.8b00783; Sikriwal D, 2012, J CELL BIOCHEM, V113, P3104, DOI 10.1002/jcb.24187; Sikriwal D, 2009, BIOL CHEM, V390, P225, DOI 10.1515/BC.2009.025; Singh A, 2011, BIOL CHEM, V392, P337, DOI 10.1515/BC.2011.037; SORRENTINO S, 1991, FEBS LETT, V288, P23, DOI 10.1016/0014-5793(91)80994-E; Sorrentino S, 2003, BIOCHEMISTRY-US, V42, P10182, DOI 10.1021/bi030040q; Sorrentino S, 2010, FEBS LETT, V584, P2194, DOI 10.1016/j.febslet.2010.04.018; Swaminathan GJ, 2002, BIOCHEMISTRY-US, V41, P3341, DOI 10.1021/bi015911f; Terzyan SS, 1999, J MOL BIOL, V285, P205, DOI 10.1006/jmbi.1998.2288; WLODAWER A, 1988, BIOCHEMISTRY-US, V27, P2705, DOI 10.1021/bi00408a010	67	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220037	10.1371/journal.pone.0220037	http://dx.doi.org/10.1371/journal.pone.0220037			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393891	Green Published, Green Submitted, gold			2022-12-26	WOS:000485002500020
J	Nilsson, OR; Kari, L; Steele-Mortimer, O				Nilsson, Olof R.; Kari, Laszlo; Steele-Mortimer, Olivia			Foodborne infection of mice with Salmonella Typhimurium	PLOS ONE			English	Article							ORAL GAVAGE; INDUCED COLITIS; NRAMP1; RESISTANCE; PATHOGEN; DISEASE; ILLNESS; DRIVES; LOCUS	The bacterial pathogen Salmonella enterica serovar Typhimurium is one of the most common causes of foodborne disease in humans and is also an important model system for bacterial pathogenesis. Oral inoculation of C57Bl/6 mice, which are genetically susceptible to Salmonella, results in systemic infection but the murine intestine is not efficiently colonized unless the intestinal microbiota is disrupted. Pretreatment of C57Bl/6 mice with streptomycin, followed by oral inoculation with Salmonella Typhimurium results in colitis resembling human intestinal Salmonellosis. The predominant method of delivery of bacteria is oral gavage, during which organisms are deposited directly into the stomach via a feeding needle. Although convenient, this method can be stressful for mice, and may lead to unwanted tracheal or systemic introduction of bacteria. Here, we developed a method for oral infection of mice by voluntary consumption of regular mouse chow inoculated with bacteria. Mice readily ate chow fragments containing up to 10(8) CFU Salmonella, allowing for a wide range of infectious doses. In mice pretreated with streptomycin, infection with inoculated chow resulted in reproducible infections with doses as low as 10(3) CFU. Mice not treated with streptomycin, as well as resistant Nramp1 reconstituted C57Bl/6J mice, were also readily infected using this method. In summary, voluntary consumption of chow inoculated with Salmonella represents a natural route of infection for foodborne salmonellosis and a viable alternative to oral gavage.	[Nilsson, Olof R.; Kari, Laszlo; Steele-Mortimer, Olivia] NIAID, Lab Bacteriol, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Steele-Mortimer, O (corresponding author), NIAID, Lab Bacteriol, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.	omortimer@niaid.nih.gov			Intramural Research Program of the NIH, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001199] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by the Intramural Research Program of the NIH, NIAID to OSM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arantes-Rodrigues R, 2012, LAB ANIMAL, V41, P129, DOI 10.1038/laban0512-129; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Balcombe JP, 2004, CONTEMP TOP LAB ANIM, V43, P42; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Bauler TJ, 2017, AM J PATHOL, V187, P187, DOI 10.1016/j.ajpath.2016.09.002; Blackwell JM, 2001, CELL MICROBIOL, V3, P773, DOI 10.1046/j.1462-5822.2001.00150.x; BOHNHOFF M, 1962, J INFECT DIS, V111, P117, DOI 10.1093/infdis/111.2.117; Bollaerts K, 2008, RISK ANAL, V28, P427, DOI 10.1111/j.1539-6924.2008.01038.x; Bou Ghanem EN, 2012, PLOS PATHOG, V8; Bou Ghanem EN, 2013, JOVE-J VIS EXP, DOI [10.3791/, DOI 10.3791/]; Brown AP, 2000, CONTEMP TOP LAB ANIM, V39, P17; Brown DE, 2013, VET PATHOL, V50, P867, DOI 10.1177/0300985813478213; Damsch S, 2011, TOXICOL PATHOL, V39, P348, DOI 10.1177/0192623310388431; Gopinath S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003408; Govoni G, 1996, INFECT IMMUN, V64, P2923, DOI 10.1128/IAI.64.8.2923-2929.1996; Havelaar AH, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001923; Hoggatt AF, 2010, J AM ASSOC LAB ANIM, V49, P329; Jacobson A, 2018, CELL HOST MICROBE, V24, P296, DOI 10.1016/j.chom.2018.07.002; Jensen TL, 2013, LAB ANIM-UK, V47, P225, DOI 10.1177/0023677213501659; Jones CP, 2016, J AM ASSOC LAB ANIM, V55, P805; Lamas A, 2018, MICROBIOL RES, V206, P60, DOI 10.1016/j.micres.2017.09.010; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; MILLER CP, 1962, J INFECT DIS, V111, P107, DOI 10.1093/infdis/111.2.107; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; Nanton MR, 2012, J IMMUNOL, V189, P5503, DOI 10.4049/jimmunol.1201413; O' Donnell H, 2015, FUTURE MICROBIOL, V10, P1615, DOI 10.2217/fmb.15.93; PLANT J, 1976, J INFECT DIS, V133, P72, DOI 10.1093/infdis/133.1.72; QUE JU, 1985, INFECT IMMUN, V48, P169, DOI 10.1128/IAI.48.1.169-174.1985; Rivera-Chavez F, 2016, CELL HOST MICROBE, V19, P443, DOI 10.1016/j.chom.2016.03.004; Roy MF, 2002, GENES IMMUN, V3, P381, DOI 10.1038/sj.gene.6363924; Santos RL, 2001, MICROBES INFECT, V3, P1335, DOI 10.1016/S1286-4579(01)01495-2; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Spiga L, 2017, CELL HOST MICROBE, V22, P291, DOI 10.1016/j.chom.2017.07.018; Stecher B, 2006, INFECT IMMUN, V74, P5047, DOI 10.1128/IAI.00072-06; Todd ECD, 2008, J FOOD PROTECT, V71, P2339, DOI 10.4315/0362-028X-71.11.2339; Tsolis RM, 2011, INFECT IMMUN, V79, P1806, DOI 10.1128/IAI.01369-10; Valdez Y, 2009, CELL MICROBIOL, V11, P351, DOI 10.1111/j.1462-5822.2008.01258.x; Vandenberg LN, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-46; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655; Walker MK, 2012, TOXICOL APPL PHARM, V260, P65, DOI 10.1016/j.taap.2012.01.025; Wessling-Resnick M, 2015, J BIOL CHEM, V290, P18984, DOI 10.1074/jbc.R115.643973	41	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0215190	10.1371/journal.pone.0215190	http://dx.doi.org/10.1371/journal.pone.0215190			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393874	Green Published, Green Submitted, gold			2022-12-26	WOS:000485002500003
J	Ko, YS; Bae, JA; Kim, KY; Kim, SJ; Sun, EG; Lee, KH; Kim, N; Kang, H; Seo, YW; Kim, H; Chung, IJ; Kim, KK				Ko, Yoo-Seung; Bae, Jeong A.; Kim, Keon Young; Kim, Sung Jin; Sun, Eun Gene; Lee, Kyung Hwa; Kim, Nacksung; Kang, Hyuno; Seo, Young-Woo; Kim, Hangun; Chung, Ik Joo; Kim, Kyung Keun			MYO1D binds with kinase domain of the EGFR family to anchor them to plasma membrane before their activation and contributes carcinogenesis	ONCOGENE			English	Article							NONMUSCLE MYOSIN-II; UNCONVENTIONAL MYOSINS; NEGATIVE REGULATION; CARGO RECOGNITION; RECEPTOR; MOTOR; RESISTANCE; KITENIN; SIGNAL; INVASIVENESS	The cell surface receptor tyrosine kinase (RTK) exists in a dynamic state, however, it remains unknown how single membrane-spanning RTK proteins are retained in the plasma membrane before their activation. This study was undertaken to investigate how RTK proteins are anchored in the plasma membrane before they bind with their respective extracellular ligands for activation through protein-protein interaction, co-localization, and functional phenotype studies. Here we show that unconventional myosin-I MYO1D functions to hold members of the EGFR family (except ErbB3) at the plasma membrane. MYO1D binds only with unphosphorylated EGFRs and anchors them to underlying actin cytoskeleton at the plasma membrane. The C-terminal end region of the MYO1D tail domain containing a beta-meander motif is critical for direct binding with kinase domain of the EGFR family, and expression of the tail domain alone suppresses the oncogenic action of full-length MYO1D. Overexpressed MYO1D increases colorectal and breast cancer cell motility and viability through upregulating EGFR level, and thereby promotes colorectal tumor progression in a syngeneic mouse model. MYO1D is upregulated in human colorectal cancer tissues from advanced stages. Collectively, molecular motor MYO1D plays a distinct role in the dynamic regulation of EGFR family levels by holding them at the plasma membrane before their activation. Overexpressed MYO1D contributes to colorectal carcinogenesis possibly as a novel oncogene and thus may serve as an additional target for suppression of RTK signaling in cancer treatment.	[Ko, Yoo-Seung; Bae, Jeong A.; Kim, Keon Young; Kim, Sung Jin; Kim, Nacksung; Kim, Kyung Keun] Chonnam Natl Univ, Dept Pharmacol, Med Sch, Gwangju 61469, South Korea; [Sun, Eun Gene; Chung, Ik Joo] Chonnam Natl Univ, Dept Hematol Oncol, Med Sch, Gwangju 61469, South Korea; [Lee, Kyung Hwa] Chonnam Natl Univ, Dept Pathol, Med Sch, Gwangju 61469, South Korea; [Kang, Hyuno; Seo, Young-Woo] Korea Basic Sci Inst, Gwangju Ctr, Gwangju 61186, South Korea; [Kim, Hangun] Sunchon Natl Univ, Coll Pharm, Sunchon 57922, North Korea	Chonnam National University; Chonnam National University; Chonnam National University; Korea Basic Science Institute (KBSI)	Kim, KK (corresponding author), Chonnam Natl Univ, Dept Pharmacol, Med Sch, Gwangju 61469, South Korea.	kimkk@chonnam.ac.kr		, Eun-Gene Sun/0000-0002-3396-6966; Kim, Keon Young/0000-0001-9703-9195	National Research Foundation of Korea - Korea government (MSIP) [NRF-2018R1A5A2024181, NRF-2017R1A2B2002040]; National Research Foundation of Korea [NRF-2017R1A6A3A11031332, NRF-2015R1C1A2A01052689]	National Research Foundation of Korea - Korea government (MSIP); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea grant (NRF-2018R1A5A2024181, NRF-2017R1A2B2002040) funded by the Korea government (MSIP). KYS (NRF-2017R1A6A3A11031332) and JAB (NRF-2015R1C1A2A01052689) were partly supported by the by the National Research Foundation of Korea grant.	ADAMS RJ, 1989, NATURE, V340, P565, DOI 10.1038/340565a0; Almeida CG, 2011, NAT CELL BIOL, V13, P779, DOI 10.1038/ncb2262; Arif E, 2011, MOL CELL BIOL, V31, P2134, DOI 10.1128/MCB.05051-11; Bae JA, 2014, CLIN CANCER RES, V20, P4115, DOI 10.1158/1078-0432.CCR-13-2863; BAHLER M, 1994, J CELL BIOL, V126, P375, DOI 10.1083/jcb.126.2.375; Barylko B, 2005, ACTA BIOCHIM POL, V52, P373; Barylko B, 2000, BBA-MOL CELL RES, V1496, P23, DOI 10.1016/S0167-4889(00)00006-9; Bergeron JJM, 2016, ANNU REV BIOCHEM, V85, P573, DOI 10.1146/annurev-biochem-060815-014659; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Casaletto JB, 2012, NAT REV CANCER, V12, P386, DOI 10.1038/nrc3277; Chandrasekar I, 2014, TRAFFIC, V15, P418, DOI 10.1111/tra.12152; Dutta Dipannita, 2012, Cell Logist, V2, P203; Fang Y, 2015, BIOSENSORS-BASEL, V5, P223, DOI 10.3390/bios5020223; Fry WHD, 2009, EXP CELL RES, V315, P697, DOI 10.1016/j.yexcr.2008.07.022; Gillespie PG, 2001, J CELL BIOL, V155, P703, DOI 10.1083/jcb.200110032; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Hegan PS, 2015, CYTOSKELETON, V72, P503, DOI 10.1002/cm.21259; Hokanson DE, 2006, MOL BIOL CELL, V17, P4856, DOI 10.1091/mbc.e06-05-0449; Huber LA, 2000, TRAFFIC, V1, P494, DOI 10.1034/j.1600-0854.2000.010607.x; Kho DH, 2009, GUT, V58, P509, DOI 10.1136/gut.2008.150938; Kim JH, 2012, J BIOL CHEM, V287, P27345, DOI 10.1074/jbc.M111.304824; Komaba S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138012; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Lee JH, 2005, CANCER RES, V65, P8993, DOI 10.1158/0008-5472.CAN-05-0590; Lee JH, 2004, CANCER RES, V64, P4235, DOI 10.1158/0008-5472.CAN-04-0275; Li JC, 2016, TRAFFIC, V17, P822, DOI 10.1111/tra.12383; Lu Q, 2014, ACCOUNTS CHEM RES, V47, P3061, DOI 10.1021/ar500216z; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maina F, 2014, CURR MED CHEM, V21, P1607, DOI 10.2174/09298673113209990222; Mazerik JN, 2014, BIOPHYS J, V106, P649, DOI 10.1016/j.bpj.2013.12.038; McConnell RE, 2010, TRENDS CELL BIOL, V20, P418, DOI 10.1016/j.tcb.2010.04.004; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; Ouderkirk JL, 2014, CYTOSKELETON, V71, P447, DOI 10.1002/cm.21187; Ouyang XM, 1999, J CELL PHYSIOL, V179, P52, DOI 10.1002/(SICI)1097-4652(199904)179:1<52::AID-JCP7>3.0.CO;2-M; Patino-Lopez G, 2010, J BIOL CHEM, V285, P8675, DOI 10.1074/jbc.M109.086959; Rosenzweig SA, 2012, BIOCHEM PHARMACOL, V83, P1041, DOI 10.1016/j.bcp.2011.12.025; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Sweeney C, 2004, BRIT J CANCER, V90, P289, DOI 10.1038/sj.bjc.6601500; Tiwari A, 2013, AM J PHYSIOL-HEART C, V304, pH687, DOI 10.1152/ajpheart.00744.2012; Valley CC, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020735; Visuttijai K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164063; Vouri M, 2017, CANCER RES, V77, P2775, DOI 10.1158/0008-5472.CAN-16-2675; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Xu AM, 2010, CANCER RES, V70, P3857, DOI 10.1158/0008-5472.CAN-10-0163; Yamazaki R, 2016, ASN NEURO, V8, DOI 10.1177/1759091416669609; Zeng FH, 2009, FASEB J, V23, P1935, DOI 10.1096/fj.08-121947; Zinchuk V, 2013, SCI REP-UK, V3, DOI 10.1038/srep01365	47	8	8	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 5	2019	38	49					7416	7432		10.1038/s41388-019-0954-8	http://dx.doi.org/10.1038/s41388-019-0954-8			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JT4BN	31420606				2022-12-26	WOS:000500936600004
J	Kaftanovskaya, EM; Ng, HH; Soula, M; Rivas, B; Myhr, C; Ho, BA; Cervantes, BA; Shupe, TD; Devarasetty, M; Hu, X; Xu, X; Patnaik, S; Wilson, KJ; Barnaeva, E; Ferrer, M; Southall, NT; Marugan, JJ; Bishop, CE; Agoulnik, IU; Agoulnik, AI				Kaftanovskaya, Elena M.; Ng, Hooi Hooi; Soula, Mariluz; Rivas, Bryan; Myhr, Courtney; Ho, Brian A.; Cervantes, Briana A.; Shupe, Thomas D.; Devarasetty, Mahesh; Hu, Xin; Xu, Xin; Patnaik, Samarjit; Wilson, Kenneth J.; Barnaeva, Elena; Ferrer, Marc; Southall, Noel T.; Marugan, Juan J.; Bishop, Colin E.; Agoulnik, Irina U.; Agoulnik, Alexander I.			Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosis	FASEB JOURNAL			English	Article						RXFP1; liver organoids; collagen; carbon tetrachloride	HEPATIC STELLATE CELLS; ACTIVATION; RXFP1	Fibrosis is an underlying cause of cirrhosis and hepatic failure resulting in end stage liver disease with limited pharmacological options. The beneficial effects of relaxin peptide treatment were demonstrated in clinically relevant animal models of liver fibrosis. However, the use of relaxin is problematic because of a short half-life. The aim of this study was to test the therapeutic effects of recently identified small molecule agonists of the human relaxin receptor, relaxin family peptide receptor 1 (RXFP1). The lead compound of this series, ML290, was selected based on its effects on the expression of fibrosis-related genes in primary human stellate cells. RNA sequencing analysis of TGF-beta 1-activated LX-2 cells showed that ML290 treatment primarily affected extracellular matrix remodeling and cytokine signaling, with expression profiles indicating an antifibrotic effect of ML290. ML290 treatment in human liver organoids with LPS-induced fibrotic phenotype resulted in a significant reduction of type I collagen. The pharmacokinetics of ML290 in mice demonstrated its high stability in vivo, as evidenced by the sustained concentrations of compound in the liver. In mice expressing human RXFP1 gene treated with carbon tetrachloride, ML290 significantly reduced collagen content, alpha-smooth muscle actin expression, and cell proliferation around portal ducts. In conclusion, ML290 demonstrated antifibrotic effects in liver fibrosis.	[Kaftanovskaya, Elena M.; Ng, Hooi Hooi; Soula, Mariluz; Rivas, Bryan; Myhr, Courtney; Ho, Brian A.; Cervantes, Briana A.; Agoulnik, Irina U.; Agoulnik, Alexander I.] Florida Int Univ, Herbert Wertheim Coll Med, Dept Human & Mol Genet, 11200 SW 8th St,AHC1 419B, Miami, FL 33199 USA; [Shupe, Thomas D.; Devarasetty, Mahesh; Bishop, Colin E.] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27101 USA; [Hu, Xin; Xu, Xin; Patnaik, Samarjit; Wilson, Kenneth J.; Barnaeva, Elena; Ferrer, Marc; Southall, Noel T.; Marugan, Juan J.] NIH, NIH Chem Genom Ctr, Natl Ctr Adv Translat Sci, Bldg 10, Bethesda, MD 20892 USA	State University System of Florida; Florida International University; Wake Forest University; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS)	Agoulnik, AI (corresponding author), Florida Int Univ, Herbert Wertheim Coll Med, Dept Human & Mol Genet, 11200 SW 8th St,AHC1 419B, Miami, FL 33199 USA.	aagoulni@fiu.edu	Agoulnik, Irina/AAD-4687-2020; Southall, Noel/H-8991-2012	Agoulnik, Irina/0000-0003-4889-0324; Ho, Brian/0000-0002-8395-6643; Southall, Noel/0000-0003-4500-880X	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [1R01DK110167]; American Heart Association [19POST34380255]; NIH National Institute of General Medical Sciences (NIGMS) [T34GM083688]; NIH/NIGMS [R25GM061347]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB014836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK110167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM083688, R25GM061347] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association(American Heart Association); NIH National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Robert G. Bennett (University of Nebraska Medical Center, Omaha, NE, USA) for valuable advice on CCl<INF>4</INF> mouse experiments, and Dr. Scott Friedman (Icahn School of Medicine at Mount Sinai, New York, NY, USA) for providing LX-2 cells. This work was supported by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant 1R01DK110167 (to A. I.A.). H.H. N. was supported by American Heart Association Postdoctoral Fellowship Grant 19POST34380255. M.S. and B.A.H. were supported by NIH National Institute of General Medical Sciences (NIGMS) T34GM083688, and B.A. C. by NIH/NIGMS R25GM061347 grant fellowships. M.F., N.T.S., J.J.M., I.U.A., and A.I.A. are the inventors in patent WO2013165606, modulators of the relaxin receptor 1. The remaining authors declare no conflicts of interest.	Agoulnik AI, 2017, BRIT J PHARMACOL, V174, P977, DOI 10.1111/bph.13656; Bennett RG, 2007, BIOCHEM PHARMACOL, V73, P1033, DOI 10.1016/j.bcp.2006.12.007; Bennett RG, 2014, LIVER INT, V34, P416, DOI 10.1111/liv.12247; Bennett RG, 2009, TRANSL RES, V154, P1, DOI 10.1016/j.trsl.2009.03.007; Bennett RG, 2009, ANN NY ACAD SCI, V1160, P348, DOI 10.1111/j.1749-6632.2008.03783.x; Chen CZ, 2013, J BIOMOL SCREEN, V18, P670, DOI 10.1177/1087057112469406; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chow BSM, 2014, KIDNEY INT, V86, P75, DOI 10.1038/ki.2013.518; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Du XJ, 2009, ANN NY ACAD SCI, V1160, P278, DOI 10.1111/j.1749-6632.2008.03780.x; Fallowfield JA, 2014, HEPATOLOGY, V59, P1492, DOI 10.1002/hep.26627; Forsythe SD, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00103; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; FRIEDMAN SL, 1989, J BIOL CHEM, V264, P10756; Halls ML, 2015, PHARMACOL REV, V67, P389, DOI 10.1124/pr.114.009472; Hewitson TD, 2010, ENDOCRINOLOGY, V151, P4938, DOI 10.1210/en.2010-0286; Hu X, 2016, BIOCHEMISTRY-US, V55, P1772, DOI 10.1021/acs.biochem.5b01195; Huang ZH, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00128; Kaftanovskaya EM, 2017, J ENDOCR SOC, V1, P712, DOI 10.1210/js.2017-00112; Kaftanovskaya EM, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.127209; Kisseleva T, 2017, HEPATOLOGY, V65, P1039, DOI 10.1002/hep.28948; Kocan M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02916-5; Lee KC, 2019, LAB INVEST, V99, P1203, DOI 10.1038/s41374-019-0240-y; McBride A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10521-9; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; Prestigiacomo V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179995; Samuel CS, 2007, CELL MOL LIFE SCI, V64, P1539, DOI 10.1007/s00018-007-6543-y; Samuel CS, 2017, BRIT J PHARMACOL, V174, P962, DOI 10.1111/bph.13529; Samuel CS, 2008, ENDOCRINOLOGY, V149, P3286, DOI 10.1210/en.2008-0250; Samuel CS, 2007, ADV EXP MED BIOL, V612, P88; Samuel CS, 2011, LAB INVEST, V91, P675, DOI 10.1038/labinvest.2010.198; Sendi H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200847; Singh S, 2015, J BIOL CHEM, V290, P950, DOI 10.1074/jbc.M114.589325; Unemori E, 2017, BRIT J PHARMACOL, V174, P921, DOI 10.1111/bph.13695; Weiskirchen R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075692; Wilson KJ, 2018, EUR J MED CHEM, V156, P79, DOI 10.1016/j.ejmech.2018.06.008; Xiao J., 2010, PROBE REPORTS NIH MO; Xiao JB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2953; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127	39	11	11	2	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12435	12446		10.1096/fj.201901046R	http://dx.doi.org/10.1096/fj.201901046R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31419161	Green Published			2022-12-26	WOS:000507461600065
J	Fernandez-Justel, D; Pelaez, R; Revuelta, JL; Buey, RM				Fernandez-Justel, David; Pelaez, Rafael; Luis Revuelta, Jose; Buey, Ruben M.			The Bateman domain of IMP dehydrogenase is a binding target for dinucleoside polyphosphates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; X-ray crystallography; small-angle X-ray scattering (SAXS); conformational change; structural biology; Bateman domain; conformational switch; dinucleoside polyphosphates; IMP dehydrogenase; molecular sensor	DIADENOSINE TETRAPHOSPHATE AP4A; SMALL-ANGLE SCATTERING; ESCHERICHIA-COLI; TRIPHOSPHATE; 5',5'''-P-1,P-4-TETRAPHOSPHATE; PROTEINS	IMP dehydrogenase (IMPDH) is an essential enzyme that catalyzes the rate-limiting step in the de novo guanine nucleotide biosynthetic pathway. Because of its involvement in the control of cell division and proliferation, IMPDH represents a therapeutic for managing several diseases, including microbial infections and cancer. IMPDH must be tightly regulated, but the molecular mechanisms responsible for its physiological regulation remain unknown. To this end, we recently reported an important role of adenine and guanine mononucleotides that bind to the regulatory Bateman domain to allosterically modulate the catalytic activity of eukaryotic IMPDHs. Here, we have used enzyme kinetics, X-ray crystallography, and small-angle X-ray scattering (SAXS) methodologies to demonstrate that adenine/guanine dinucleoside polyphosphates bind to the Bateman domain of IMPDH from the fungus Ashbya gossypii with submicromolar affinities. We found that these dinucleoside polyphosphates modulate the catalytic activity of IMPDHs in vitro by efficiently competing with the adenine/guanine mononucleotides for the allosteric sites. These results suggest that dinucleoside polyphosphates play important physiological roles in the allosteric regulation of IMPDHs by adding an additional mechanism for fine-tuning the activities of these enzymes. We propose that these findings may have important implications for the design of therapeutic strategies to inhibit IMPDHs.	[Fernandez-Justel, David; Luis Revuelta, Jose; Buey, Ruben M.] Univ Salamanca, Metab Engn Grp, Dept Microbiol & Genet, Campus Miguel Unamuno, Salamanca 37007, Spain; [Pelaez, Rafael] Univ Salamanca, Lab Quim Organ & Farmaceut, Dept Ciencias Farmaceut, Campus Miguel Unamuno, Salamanca 37007, Spain	University of Salamanca; University of Salamanca	Revuelta, JL; Buey, RM (corresponding author), Univ Salamanca, Metab Engn Grp, Dept Microbiol & Genet, Campus Miguel Unamuno, Salamanca 37007, Spain.	revuelta@usal.es; ruben.martinez@usal.es	de Clairac Arroyo, Rafael Peláez Lamamie/F-7767-2016; Martinez-Buey, Ruben/K-4296-2014	de Clairac Arroyo, Rafael Peláez Lamamie/0000-0003-1433-1612; Martinez-Buey, Ruben/0000-0003-1263-0221; Fernandez-Justel, David/0000-0001-5728-2756	Spanish Ministerio de Ciencia, Innovacion y Universidades [BFU2016-79237-P, BIO2017-88435-R]; Junta de Castilla y Leon	Spanish Ministerio de Ciencia, Innovacion y Universidades; Junta de Castilla y Leon(Junta de Castilla y Leon)	This work was supported by Spanish Ministerio de Ciencia, Innovacion y Universidades Grants BFU2016-79237-P (to R. M. B.) and BIO2017-88435-R (to J. L. R.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a predoctoral contract from the "Junta de Castilla y Leon."	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anashkin VA, 2015, J BIOL CHEM, V290, P27594, DOI 10.1074/jbc.M115.680272; Anthony SA, 2017, MOL BIOL CELL, V28, P2600, DOI 10.1091/mbc.E17-04-0263; Buey RM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02805-x; Buey RM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9923; Conant AR, 2008, VASC PHARMACOL, V48, P157, DOI 10.1016/j.vph.2008.01.005; Despotovic D, 2017, FEBS J, V284, P2194, DOI 10.1111/febs.14113; Duong-Ly KC, 2018, J CELL SCI, V131, DOI 10.1242/jcs.223289; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ereno-Orbea J, 2013, ARCH BIOCHEM BIOPHYS, V540, P70, DOI 10.1016/j.abb.2013.10.008; Fernandez-Justel D, 2019, J MOL BIOL, V431, P956, DOI 10.1016/j.jmb.2019.01.020; FINAMORE FJ, 1963, J BIOL CHEM, V238, P344; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Garrison PN, 1992, AP4A OTHER DINUCLEOS, P29; Giraldez L, 2001, J NEUROSCI RES, V64, P174, DOI 10.1002/jnr.1063; Gomez-Villafuertes R, 2004, J PHARMACOL EXP THER, V308, P1148, DOI 10.1124/jpet.103.061564; Guo W, 2011, BIOORG MED CHEM LETT, V21, P7175, DOI 10.1016/j.bmcl.2011.09.070; Jankowski V, 2009, BRIT J PHARMACOL, V157, P1142, DOI 10.1111/j.1476-5381.2009.00337.x; JOHNSTONE DB, 1991, EMBO J, V10, P3897, DOI 10.1002/j.1460-2075.1991.tb04959.x; Juanhuix J, 2014, J SYNCHROTRON RADIAT, V21, P679, DOI 10.1107/S160057751400825X; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; LIENHARD GE, 1973, J BIOL CHEM, V248, P1121; LUTHJE J, 1985, BLUT, V51, P405, DOI 10.1007/BF00320727; Marques AFP, 1998, J NEUROCHEM, V71, P1241; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nishimura A, 1997, GENES CELLS, V2, P401, DOI 10.1046/j.1365-2443.1997.1300328.x; RAPAPORT E, 1976, P NATL ACAD SCI USA, V73, P3984, DOI 10.1073/pnas.73.11.3984; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Sillero MAG, 2002, EUR J BIOCHEM, V269, P5323, DOI 10.1046/j.1432-1033.2002.03253.x; Tickle I.J., 2018, STARANISO; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Vartanian AA, 2003, BIOCHEM PHARMACOL, V65, P227, DOI 10.1016/S0006-2952(02)01481-8; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; ZAMECNIK PC, 1966, BIOCHEM BIOPH RES CO, V24, P91, DOI 10.1016/0006-291X(66)90415-3	35	9	9	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2019	294	40					14768	14775		10.1074/jbc.AC119.010055	http://dx.doi.org/10.1074/jbc.AC119.010055			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JP0II	31416831	hybrid, Green Published			2022-12-26	WOS:000497955000021
J	Campana, MB; Irudayanathan, FJ; Davis, TR; McGovern-Gooch, KR; Loftus, R; Ashkar, M; Escoffery, N; Navarro, M; Sieburg, MA; Nangia, S; Hougland, JL				Campana, Maria B.; Irudayanathan, Flaviyan Jerome; Davis, Tasha R.; McGovern-Gooch, Kayleigh R.; Loftus, Rosemary; Ashkar, Mohammad; Escoffery, Najae; Navarro, Melissa; Sieburg, Michelle A.; Nangia, Shikha; Hougland, James L.			The ghrelin O-acyltransferase structure reveals a catalytic channel for transmembrane hormone acylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane enzyme; protein structure; acyltransferase; protein acylation; membrane protein; structural biology; post-translational modification (PTM); co-evolutionary constraint; computational modeling; ghrelin O-acyltransferase (GOAT); membrane-bound O-acyltransferase (MBOAT); protein structure prediction; integral membrane protein	PROTEINS; OCTANOYLATION; PREDICTION	Integral membrane proteins represent a large and diverse portion of the proteome and are often recalcitrant to purification, impeding studies essential for understanding protein structure and function. By combining co-evolutionary constraints and computational modeling with biochemical validation through site-directed mutagenesis and enzyme activity assays, we demonstrate here a synergistic approach to structurally model purification-resistant topologically complex integral membrane proteins. We report the first structural model of a eukaryotic membrane-bound O-acyltransferase (MBOAT), ghrelin O-acyltransferase (GOAT), which modifies the metabolism-regulating hormone ghrelin. Our structure, generated in the absence of any experimental structural data, revealed an unanticipated strategy for transmembrane protein acylation with catalysis occurring in an internal channel connecting the endoplasmic reticulum lumen and cytoplasm. This finding validated the power of our approach to generate predictive structural models for other experimentally challenging integral membrane proteins. Our results illuminate novel aspects of membrane protein function and represent key steps for advancing structure-guided inhibitor design to target therapeutically important but experimentally intractable membrane proteins.	[Campana, Maria B.; Davis, Tasha R.; McGovern-Gooch, Kayleigh R.; Loftus, Rosemary; Ashkar, Mohammad; Escoffery, Najae; Navarro, Melissa; Sieburg, Michelle A.; Hougland, James L.] Syracuse Univ, Dept Chem, Syracuse, NY 13244 USA; [Irudayanathan, Flaviyan Jerome; Nangia, Shikha] Syracuse Univ, Dept Biomed & Chem Engn, Syracuse, NY 13244 USA; [Nangia, Shikha; Hougland, James L.] Syracuse Univ, Syracuse Biomat Inst, Syracuse, NY 13244 USA	Syracuse University; Syracuse University; Syracuse University	Hougland, JL (corresponding author), Syracuse Univ, Dept Chem, Syracuse, NY 13244 USA.; Nangia, S (corresponding author), Syracuse Univ, Dept Biomed & Chem Engn, Syracuse, NY 13244 USA.; Nangia, S; Hougland, JL (corresponding author), Syracuse Univ, Syracuse Biomat Inst, Syracuse, NY 13244 USA.	snangia@syr.edu; hougland@syr.edu		Sieburg, Michelle/0000-0002-2765-7235; nangia, Shikha/0000-0003-1170-8461; Irudayanathan, Flaviyan Jerome/0000-0002-0201-7151; Hougland, James/0000-0003-0444-1017	National Science Foundation [NSF ACI-1053575, CHE-1659775]	National Science Foundation(National Science Foundation (NSF))	We thank Profs. Jason Fridley and John Chisholm (Syracuse University) for assistance with statistical analysis and figure generation. We also thank Prof. Jinbo Xu (Toyota Technological Institute at Chicago), Prof. Sergey Ovchinnikov (Harvard University), and Prof. Badri Adhikari (University of Missouri, St. Louis) for advice regarding computational modeling. This material is based in part upon work supported by the National Science Foundation under Grant CHE-1659775. We also gratefully acknowledge computational resources provided by Syracuse University research computing and the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation Grant NSF ACI-1053575.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Adhikari B, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2032-6; Bill RM, 2011, NAT BIOTECHNOL, V29, P335, DOI 10.1038/nbt.1833; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Darling JE, 2015, BIOCHEMISTRY-US, V54, P1100, DOI 10.1021/bi5010359; Darling JE, 2013, ANAL BIOCHEM, V437, P68, DOI 10.1016/j.ab.2013.02.013; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Hopf TA, 2014, ELIFE, V3, DOI 10.7554/eLife.03430; Hougland JL, 2019, BIOCHEM SOC T, V47, P169, DOI 10.1042/BST20180436; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Irudayanathan FJ, 2016, J PHYS CHEM B, V120, P77, DOI 10.1021/acs.jpcb.5b09977; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Ma D, 2018, NATURE, V562, P286, DOI 10.1038/s41586-018-0568-2; Marks DS, 2012, NAT BIOTECHNOL, V30, P1072, DOI 10.1038/nbt.2419; Masumoto N, 2015, BIOCHEM SOC T, V43, P246, DOI 10.1042/BST20150018; McGovern-Gooch KR, 2016, ENDOCRINOLOGY, V157, P4330, DOI 10.1210/en.2016-1657; Muller TD, 2015, MOL METAB, V4, P437, DOI 10.1016/j.molmet.2015.03.005; Nicoludis JM, 2018, BBA-BIOMEMBRANES, V1860, P895, DOI 10.1016/j.bbamem.2017.10.004; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Ovchinnikov S, 2017, SCIENCE, V355, P294, DOI 10.1126/science.aah4043; Ovchinnikov S, 2015, ELIFE, V4, DOI 10.7554/eLife.09248; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; POST PL, 1994, J BIOL CHEM, V269, P12880; R Core Team, 2018, R LANG ENV STAT COMP; Rajagopal N, 2019, J PHYS CHEM B, V123, P983, DOI 10.1021/acs.jpcb.8b09535; Rask-Andersen M, 2011, NAT REV DRUG DISCOV, V10, P579, DOI 10.1038/nrd3478; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Resh MD, 2016, PROG LIPID RES, V63, P120, DOI 10.1016/j.plipres.2016.05.002; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Sieburg MA, 2019, METHODS MOL BIOL, V2009, P227, DOI 10.1007/978-1-4939-9532-5_18; Simkovic F, 2017, BIOINFORMATICS, V33, P2209, DOI 10.1093/bioinformatics/btx148; SMITH RH, 1986, ARCH BIOCHEM BIOPHYS, V244, P357, DOI 10.1016/0003-9861(86)90124-4; Stansfeld PJ, 2015, STRUCTURE, V23, P1350, DOI 10.1016/j.str.2015.05.006; Steinegger M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04964-5; Taylor MS, 2015, BIOORG CHEM, V62, P64, DOI 10.1016/j.bioorg.2015.07.003; Taylor MS, 2013, J BIOL CHEM, V288, P32211, DOI 10.1074/jbc.M113.510313; Tricerri MA, 2000, BIOCHEMISTRY-US, V39, P14682, DOI 10.1021/bi0014251; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang S, 2018, PROTEINS, V86, P67, DOI 10.1002/prot.25377; Wang S, 2017, CELL SYST, V5, P202, DOI 10.1016/j.cels.2017.09.001; Wellman MK, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00144; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017	51	14	14	4	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2019	294	39					14166	14174		10.1074/jbc.AC119.009749	http://dx.doi.org/10.1074/jbc.AC119.009749			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HH	31413115	hybrid, Green Published			2022-12-26	WOS:000499248200001
J	Ali, EA; Kalli, M; Wan, D; Nakamura, R; Onion, D; Alanine, DGW; Alcocer, MJC; Falcone, FH				Ali, Eman Ali; Kalli, Marina; Wan, Daniel; Nakamura, Ryosuke; Onion, David; Alanine, Daniel G. W.; Alcocer, Marcos J. C.; Falcone, Franco H.			Characterization of human Fc epsilon RI alpha chain expression and gene copy number in humanized rat basophilic leukaemia (RBL) reporter cell lines	PLOS ONE			English	Article							HIGH-AFFINITY RECEPTOR; IGE RECEPTOR; SERUM IGE; BINDING; IDENTIFICATION; SENSITIZATION; SYSTEM; MODEL	Several laboratories have created rat basophil leukemia (RBL) cell lines stably transfected with the human high affinity IgE receptor (Fc epsilon RIH). More recently, humanized RBL cell lines saw the introduction of reporter genes such as luciferase (RS-ATL8) and DsRed (RBL NFAT-DsRed). These reporters are more sensitive than their parental non-reporter humanized RBL cell lines. However, no studies so far have addressed the levels of Fc epsilon RIH surface expression on humanized RBL cell lines. This is a critical parameter, as it determines the ability of these cells to be efficiently sensitized with human IgE, hence it should affect the sensitivity of the cell assay-a critical parameter for any diagnostic application. Our purpose was to assess and compare the levels of expression of the transfected Fc epsilon RIH chain in humanized RBL cell lines. We compared surface levels of Fc epsilon RI alpha(H) by flow cytometry, using a fluorescently labelled monoclonal antibody (CRA-1/AER-37) and determined receptor numbers using calibration microspheres. Fc epsilon RI alpha(H) copy numbers were assessed by qPCR, and the sequence verified. Transfection with Fc epsilon RI gamma(H) cDNA was assessed for its ability to increase Fc epsilon RI alpha(H) expression in the NFAT-DsRed reporter. While both SX-38 and RS-ATL8 expressed about 500.000 receptors/cell, RBL 703-21 and NFAT-DsRed had approximately 10- to 30-fold lower Fc epsilon RI alpha(H) expression, respectively. This was neither related to Fc epsilon RIH gene copy numbers, nor to differences in steady state mRNA levels, as determined by qPCR and RT-qPCR, respectively. Instead, Fc epsilon RI alpha(H) surface expression appeared to correlate with the co-expression of Fc epsilon RI gamma(H). Stable transfection of NFAT-DsRed cells with pBJ1 neo-huFc epsilon RI gamma, which constitutively expresses Fc epsilon RI gamma(H), increased Fc epsilon RI alpha(H) chain expression levels. Levels of Fc epsilon RI alpha(H) surface expression vary greatly between humanized RBL reporter cell lines. This difference will affect the sensitivity of the reporter system when used for diagnostic purposes.	[Ali, Eman Ali; Kalli, Marina; Wan, Daniel; Alanine, Daniel G. W.; Falcone, Franco H.] Univ Nottingham, Sch Pharm, Div Mol Therapeut & Formulat, Nottingham, England; [Wan, Daniel; Alcocer, Marcos J. C.] Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Loughborough, Leics, England; [Nakamura, Ryosuke] Natl Inst Hlth Sci, Kawasaki, Kanagawa, Japan; [Onion, David] Univ Nottingham, Sch Life Sci, Nottingham, England; [Falcone, Franco H.] Justus Liebig Univ, BFS, Inst Parasitol, Giessen, Germany	University of Nottingham; University of Nottingham; National Institute of Health Sciences - Japan; University of Nottingham; Justus Liebig University Giessen	Falcone, FH (corresponding author), Univ Nottingham, Sch Pharm, Div Mol Therapeut & Formulat, Nottingham, England.; Falcone, FH (corresponding author), Justus Liebig Univ, BFS, Inst Parasitol, Giessen, Germany.	Franco.Falcone@vetmed.uni-giessen.de	Falcone, Franco H/F-9210-2013; Falcone, Franco/AAE-8026-2021	Falcone, Franco H/0000-0002-1732-9932; Falcone, Franco/0000-0002-1732-9932; Onion, David/0000-0002-4522-2307	Rosetrees Trust [M562]; Stoneygate Trust; Nottingham Vice Chancellor's Research Excellence Fellowship; Gordon Memorial College Trust scholarship	Rosetrees Trust(Rosetrees Trust); Stoneygate Trust; Nottingham Vice Chancellor's Research Excellence Fellowship; Gordon Memorial College Trust scholarship	Part of this work was funded through a Rosetrees Trust (M562) and Stoneygate Trust award to FHF and MJCA. EAA was funded through Nottingham Vice Chancellor's Research Excellence Fellowship and Gordon Memorial College Trust scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Part of this work was funded through a Rosetrees Trust (M562) and Stoneygate Trust award to FHF and MJCA. EAA was funded through Nottingham Vice Chancellor's Research Excellence Fellowship and Gordon Memorial College Trust scholarship. We would like to thank Dr Lodewijk Dekker for help with calibration bead experiments and Dr Anna Piccinini for her kind help with nucleofection, and Dr Sebastiaan Winkler with help with qPCR on the Agilent cycler. We also thank Xiaowei Wang for her involvement in generating the original NFAT-DsRed reporter cell line.	Albrecht B, 2000, J IMMUNOL, V165, P5686, DOI 10.4049/jimmunol.165.10.5686; Cauvi DM, 2006, J BIOL CHEM, V281, P10448, DOI 10.1074/jbc.M510751200; CONROY MC, 1977, J IMMUNOL, V118, P1317; Diemert DJ, 2012, J ALLERGY CLIN IMMUN, V130, P169, DOI 10.1016/j.jaci.2012.04.027; Falcone FH, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-015-0568-3; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; Kubota T, 2006, J IMMUNOL, V176, P7008, DOI 10.4049/jimmunol.176.11.7008; KULCZYCK.A, 1974, J EXP MED, V140, P1676, DOI 10.1084/jem.140.6.1676; KUSTER H, 1990, J BIOL CHEM, V265, P6448; LETOURNEUR F, 1995, J CELL BIOL, V129, P971, DOI 10.1083/jcb.129.4.971; LOWE J, 1995, J IMMUNOL METHODS, V184, P113, DOI 10.1016/0022-1759(95)00081-K; MALVEAUX FJ, 1978, J CLIN INVEST, V62, P176, DOI 10.1172/JCI109103; MILLER L, 1989, SCIENCE, V244, P334, DOI 10.1126/science.2523561; MURNANE JP, 1990, NUCLEIC ACIDS RES, V18, P2733, DOI 10.1093/nar/18.9.2733; Nakamura R, 2010, ALLERGY, V65, P1266, DOI 10.1111/j.1398-9995.2010.02363.x; Nakamura R, 2013, J ALLERGY CLIN IMMUN, V132, P1436, DOI 10.1016/j.jaci.2013.07.017; Passante E, 2009, INFLAMM RES, V58, P737, DOI 10.1007/s00011-009-0074-y; PAWLAK A, 1988, J BIOL CHEM, V263, P9913; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Platzer B, 2010, J BIOL CHEM, V285, P15314, DOI 10.1074/jbc.M110.104281; Sabban S, 2013, VET IMMUNOL IMMUNOP, V153, P10, DOI 10.1016/j.vetimm.2013.01.008; Sommeregger W, 2013, CYTOTECHNOLOGY, V65, P811, DOI 10.1007/s10616-013-9606-y; Takagi K, 2003, BIOL PHARM BULL, V26, P252, DOI 10.1248/bpb.26.252; Takahashi K, 2002, MOL IMMUNOL, V38, P1193, DOI 10.1016/S0161-5890(02)00062-7; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; TAUDOU G, 1993, INT ARCH ALLERGY IMM, V100, P344, DOI 10.1159/000236436; Vogel L, 2005, ALLERGY, V60, P1021, DOI 10.1111/j.1398-9995.2005.00803.x; Wan Daniel, 2014, Methods Mol Biol, V1192, P177, DOI 10.1007/978-1-4939-1173-8_13; Wan D, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003124; Wang XW, 2014, MOL BIOTECHNOL, V56, P136, DOI 10.1007/s12033-013-9689-x; Wiegand TW, 1996, J IMMUNOL, V157, P221; Ye HT, 2014, MOL IMMUNOL, V57, P111, DOI 10.1016/j.molimm.2013.08.013; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	33	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0221034	10.1371/journal.pone.0221034	http://dx.doi.org/10.1371/journal.pone.0221034			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430311	Green Published, gold, Green Submitted			2022-12-26	WOS:000485026800023
J	Denburg, AE; Ramirez, A; Pavuluri, S; Mccann, E; Shah, S; Alcasabas, T; Antillon, F; Arora, R; Fuentes-Alabi, S; Renner, L; Lam, C; Friedrich, P; Maser, B; Force, L; Galindo, CR; Atun, R				Denburg, Avram E.; Ramirez, Adriana; Pavuluri, Suresh; Mccann, Erin; Shah, Shivani; Alcasabas, Tricia; Antillon, Federico; Arora, Ramandeep; Fuentes-Alabi, Soad; Renner, Lorna; Lam, Catherine; Friedrich, Paola; Maser, Brandon; Force, Lisa; Galindo, Carlos Rodriguez; Atun, Rifat			Political priority and pathways to scale-up of childhood cancer care in five nations	PLOS ONE			English	Article							UNIVERSAL HEALTH COVERAGE; SUSTAINABLE DEVELOPMENT; PEDIATRIC ONCOLOGY; INCOME COUNTRIES; CENTRAL-AMERICA; GLOBAL HEALTH; GENERATION; CHILDREN; REGISTRIES; SURVIVAL	Background Despite increasing global attention to non-communicable diseases (NCDs) and their incorporation into universal health coverage (UHC), the factors that determine whether and how NCDs are prioritized in national health agendas and integrated into health systems remain poorly understood. Childhood cancer is a leading non-communicable cause of death in children aged 0-14 years worldwide. We investigated the political, social, and economic factors that influence health system priority-setting on childhood cancer care in a range of low- and middle-income countries (LMIC). Methods and findings Based on in-depth qualitative case studies, we analyzed the determinants of priority-setting for childhood cancer care in El Salvador, Guatemala, Ghana, India, and the Philippines using a conceptual framework that considers four principal influences on political prioritization: political contexts, actor power, ideas, and issue characteristics. Data for the analysis derived from in-depth interviews (n = 68) with key informants involved in or impacted by childhood cancer policies and programs in participating countries, supplemented by published academic literature and available policy documents. Political priority for childhood cancer varies widely across the countries studied and is most influenced by political context and actor power dynamics. Ghana has placed relatively little national priority on childhood cancer, largely due to competing priorities and a lack of cohesion among stakeholders. In both El Salvador and Guatemala, actor power has played a central role in generating national priority for childhood cancer, where well-organized and -resourced civil society organizations have disrupted legacies of fragmented governance and financing to create priority for childhood cancer care. In India, the role of a uniquely empowered private actor was instrumental in creating political priority and establishing sustained channels of financing for childhood cancer care. In the Philippines, the childhood cancer community has capitalized on a window of opportunity to expand access and reduce disparities in childhood cancer care through the political prioritization of UHC and NCDs in current health system reforms. Conclusions The importance of key health system actors in determining the relative political priority for childhood cancer in the countries studied points to actor power as a critical enabler of prioritization in other LMIC. Responsiveness to political contexts-in particular, rhetorical and policy priority placed on NCDs and UHC-will be crucial to efforts to place childhood cancer firmly on national health agendas. National governments must be convinced of the potential for foundational health system strengthening through attention to childhood cancer care, and the presence and capability of networked actors primed to amplify public sector investments and catalyze change on the ground.	[Denburg, Avram E.] Hosp Sick Children, Div Haematol Oncol, Toronto, ON, Canada; [Denburg, Avram E.; Shah, Shivani; Maser, Brandon] Hosp Sick Children, Child Hlth Evaluat Sci, Peter Gilgan Ctr Res & Learning, Toronto, ON, Canada; [Denburg, Avram E.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Ramirez, Adriana; Pavuluri, Suresh; Mccann, Erin; Atun, Rifat] Harvard Univ, Harvard Sch Publ Hlth, Boston, MA 02115 USA; [Alcasabas, Tricia] Philippine Gen Hosp, Manila, Philippines; [Antillon, Federico] Univ Franciso Marroquin, Sch Med, Guatemala City, Guatemala; [Antillon, Federico] Unidad Nacl Oncol Pediat, Guatemala City, Guatemala; [Arora, Ramandeep] Max Super Specialty Hosp, New Delhi, India; [Fuentes-Alabi, Soad] Hosp Nacl Ninos Benjamin Bloom, San Salvador, El Salvador; [Renner, Lorna] Korle Bu Teaching Hosp, Accra, Ghana; [Lam, Catherine; Friedrich, Paola; Force, Lisa; Galindo, Carlos Rodriguez] St Jude Childrens Res Hosp, Dept Global Pediat Med, 332 N Lauderdale St, Memphis, TN 38105 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Harvard University; Harvard T.H. Chan School of Public Health; University of the Philippines System; University of the Philippines Manila; St Jude Children's Research Hospital	Denburg, AE (corresponding author), Hosp Sick Children, Div Haematol Oncol, Toronto, ON, Canada.; Denburg, AE (corresponding author), Hosp Sick Children, Child Hlth Evaluat Sci, Peter Gilgan Ctr Res & Learning, Toronto, ON, Canada.; Denburg, AE (corresponding author), Univ Toronto, Inst Hlth Policy Management & Evaluat, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	avram.denburg@sickkids.ca	Atun, Rifat/AAH-5537-2021; Force, Lisa M./AAP-7874-2021	Force, Lisa M./0000-0003-3014-9204; Ramirez, Adriana/0000-0002-4975-5645; Denburg, Avram/0000-0003-0039-0742; Maser, Brandon/0000-0002-9427-0022; Alcasabas, Ana Patricia/0000-0002-3452-0245; Arora, Ramandeep/0000-0002-2613-4539; Fuentes- Alabi, Soad/0000-0003-4245-3537				Allemani C, 2018, LANCET, V391, P1023, DOI 10.1016/S0140-6736(17)33326-3; Arksey Hilary., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Atun R, 2013, LANCET, V382, P65, DOI 10.1016/S0140-6736(13)61051-X; Barr RD, 2014, PEDIATR BLOOD CANCER, V61, P345, DOI 10.1002/pbc.24802; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bonaventure A, 2017, LANCET HAEMATOL, V4, pE202, DOI 10.1016/S2352-3026(17)30052-2; Bowen GA, 2006, INT J QUAL METH, V5, P12, DOI [DOI 10.1177/160940690600500304, 10.1177/160940690600500304]; Charmaz K., 2006, CONSTRUCTING GROUNDE; Denburg A, 2017, J Cancer Policy, V12, P7, DOI 10.1016/j.jcpo.2016.12.005; Denburg A, 2017, LANCET ONCOL, V18, P709, DOI 10.1016/S1470-2045(17)30325-X; Denburg A, 2017, LANCET ONCOL, V18, P20, DOI 10.1016/S1470-2045(16)30652-0; Denburg AE, 2014, PEDIATR BLOOD CANCER, V61, P572, DOI 10.1002/pbc.24858; Department of Health, 2016, REV POL PHIL CANC PR; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688; Friedrich P, 2014, CANCER-AM CANCER SOC, V120, P112, DOI 10.1002/cncr.28339; Fuentes-Alabi S, 2018, CANCER-AM CANCER SOC, V124, P391, DOI 10.1002/cncr.31022; Ghana Ministry of Health, 2014, HLTH SECT MED DEV PL; Ghana Ministry of Health, 2011, NAT CANC PLAN 2012 2; Gilson L, 2012, HLTH POLICY SYSTEMS; Gobierno de El Salvador, 2009, PLAN QUINQ DES 2009; Gupta S, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001656; Ho B, 2015, MAPPING MED ENTITLEM; Kingdon J., 2003, AGENDAS ALTERNATIVES, V2nd; Lecciones JA., 2015, CANC CONTROL, P138; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Magrath I, 2013, LANCET ONCOL, V14, pE104, DOI 10.1016/S1470-2045(13)70008-1; Maser B, PEDIAT ONCOLOG UNPUB; Ministerio de Salud, 2011, CONSTR EQ UN COM SAL; Ministerio de Salud, 2010, PLAN ESTR 2010 2014; Ministerio de Salud de El Salvador, 2015, POL NAC AT INT PERS; Ministerio de Salud Publica y Asistencia Social, 2016, GUIA PREV AT INT CAN; Ministerio de Salud Publica y Asistencia Social, 2010, POL NAC CANC PLAN NA; Morse J. M., 2002, INT J QUAL METHODS, P13, DOI 10.1177/160940690200100202; Navarrete M, 2014, PEDIATR BLOOD CANCER, V61, P803, DOI 10.1002/pbc.24911; Ngelangel CA, 2002, JPN J CLIN ONCOL, V32, pS52, DOI 10.1093/jjco/hye126; Pan American Health Organization (PAHO), 2007, HLTH AM SALV, VII; Philippine Health Insurance Corporation, 2017, STRENGTH IMPL NO BAL; Pineros Marion, 2018, J Glob Oncol, V4, P1, DOI 10.1200/JGO.2016.008227; Pramesh CS, 2014, INDIAN J MED PAEDIAT, V35, P226, DOI 10.4103/0971-5851.142040; Quintana Y, 2013, STUD HEALTH TECHNOL, V183, P251, DOI 10.3233/978-1-61499-203-5-251; Rath GK, 2014, INDIAN J MED PAEDIAT, V35, P288, DOI 10.4103/0971-5851.144991; Ribeiro RC, 2008, LANCET ONCOL, V9, P721, DOI 10.1016/S1470-2045(08)70194-3; Ribeiro RC, 2016, J CLIN ONCOL, V34, P53, DOI 10.1200/JCO.2015.61.9148; Rodriguez-Galindo C, 2015, J CLIN ONCOL, V33, P3065, DOI 10.1200/JCO.2014.60.6376; Rossell N, 2018, J PSYCHOSOC ONCOL, V36, P319, DOI 10.1080/07347332.2018.1427174; Salaverria C, 2015, PEDIATR BLOOD CANCER, V62, P1609, DOI 10.1002/pbc.25557; Saleh K, 2013, DIR DEV, P1, DOI 10.1596/978-0-8213-9599-8; Sanofi Espoir Foundation, 2017, FIGHT CHILDH CANC MY; Sarin Rajiv, 2005, J Cancer Res Ther, V1, P240; Schmidt H, 2015, LANCET, V386, P928, DOI 10.1016/S0140-6736(15)60244-6; Shawar YR, 2017, LANCET, V389, P119, DOI 10.1016/S0140-6736(16)31574-4; Shawar YR, 2015, LANCET GLOB HEALTH, V3, pE487, DOI 10.1016/S2214-109X(15)00098-4; Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7; Shiffman J, 2010, LANCET, V375, P2045, DOI 10.1016/S0140-6736(10)60710-6; Strauss E, 1998, CLIN ORTHOP RELAT R, P2; Sullivan R, 2013, LANCET ONCOL, V14, pE125, DOI 10.1016/S1470-2045(13)70007-X; Tangcharoensathien V, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0342-3; The National Health Insurance Authority, 2018, BENEFITS; United Nations, SUST DEV GOALS; Ward ZJ, 2019, LANCET ONCOL, V20, P483, DOI 10.1016/S1470-2045(18)30909-4; Weaver MS, 2015, BRIT J CANCER, V112, P1845, DOI 10.1038/bjc.2015.158; WHO, 2018, GLOB IN CHILDH CANC; World Health Organization, 2011, PHILIPPINES HLTH SYS; Yin RK., 2009, CASE STUDY RES DESIG, DOI [10.1016/j.ymeth.2008.10.015, DOI 10.1016/J.YMETH.2008.10.015]	65	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0221292	10.1371/journal.pone.0221292	http://dx.doi.org/10.1371/journal.pone.0221292			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5MK	31425526	gold, Green Submitted, Green Published			2022-12-26	WOS:000485022400037
J	Lopatto, E; Choi, J; Colina, A; Ma, LY; Howe, A; Hinsa-Leasure, S				Lopatto, Edward; Choi, Jinlyung; Colina, Alfredo; Ma, Lanying; Howe, Adina; Hinsa-Leasure, Shannon			Characterizing the soil microbiome and quantifying antibiotic resistance gene dynamics in agricultural soil following swine CAFO manure application	PLOS ONE			English	Article							LONG-TERM FERTILIZER; TETRACYCLINE RESISTANCE; BACTERIAL COMMUNITIES; ESCHERICHIA-COLI; LAND APPLICATION; CROP PRODUCTION; ORGANIC MANURE; DIVERSITY; FATE; TRANSPORT	As agriculture industrializes, concentrated animal feeding operations (CAFOs) are becoming more common. Feces from CAFOs is often used as fertilizer on fields. However, little is known about the effects manure has on the soil microbiome, which is an important aspect of soil health and fertility. In addition, due to the subtherapeutic levels of antibiotics necessary to keep the animals healthy, CAFO manure has elevated levels of antibiotic resistant bacteria. Using 16s rRNA high-throughput sequencing and qPCR, this study sought to determine the impact of swine CAFO manure application on both the soil microbiome and abundance of select antibiotic resistance genes (ARGs) and mobile element genes (erm(B), erm(C), sul1, str(B), intl1, IncW repA) in agricultural soil over the fall and spring seasons. We found the manure community to be distinct from the soil community, with a majority of bacteria belonging to Bacteroidetes and Firmicutes. The soil samples had more diverse communities dominated by Acidobacteria, Actinobacteria, Proteobacteria, Verrucomicrobia, and unclassified bacteria. We observed significant differences in the soil microbiome between all time points, except between the spring samples. However, by tracking manure associated taxa, we found the addition of the manure microbiome to be a minor driver of the shift. Of the measured genes, manure application only significantly increased the abundance of erm(B) and erm(C) which remained elevated in the spring. These results suggest bacteria in the manure do not survive well in soil and that ARG dynamics in soil following manure application vary by resistance gene.	[Lopatto, Edward; Colina, Alfredo; Hinsa-Leasure, Shannon] Grinnell Coll, Dept Biol, Grinnell, IA 50112 USA; [Choi, Jinlyung; Ma, Lanying; Howe, Adina] Iowa State Univ, Dept Agr & Biosyst Engn, Ames, IA USA	Iowa State University	Hinsa-Leasure, S (corresponding author), Grinnell Coll, Dept Biol, Grinnell, IA 50112 USA.	hinsa@grinnell.edu		Colina, Alfredo/0000-0002-3675-3608; Lopatto, Edward/0000-0002-6625-6143	Leopold Center for Sustainable Agriculture [E2016-08]; USDA-NIFA-AFRI [2015-07849]; Grinnell College	Leopold Center for Sustainable Agriculture; USDA-NIFA-AFRI(United States Department of Agriculture (USDA)); Grinnell College	This work was funded by the Leopold Center for Sustainable Agriculture (E2016-08) SHL, USDA-NIFA-AFRI (2015-07849) SHL and AH, and Grinnell College SHL, EL, AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders URLs are: https://www.leopold. iastate. edu/leopold-center-sustainableagriculture; https://nifa.usda.gov/program/agriculture-and-food-research-initiative-afri; https://www.grinnell.edu/.	Agriculture USDA, CENS AGR 2017; Ahmed W, 2018, ENVIRON INT, V116, P308, DOI 10.1016/j.envint.2018.04.005; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Antunes P, 2005, ANTIMICROB AGENTS CH, V49, P836, DOI 10.1128/AAC.49.2.836-839.2005; Barkovskii AL, 2012, WATER AIR SOIL POLL, V223, P49, DOI 10.1007/s11270-011-0838-1; Barton MD, 2000, NUTR RES REV, V13, P279, DOI 10.1079/095442200108729106; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cederlund H, 2014, APPL SOIL ECOL, V84, P62, DOI 10.1016/j.apsoil.2014.06.003; Chattopadhyay MK, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00334; Chaudhry V, 2012, MICROB ECOL, V64, P450, DOI 10.1007/s00248-012-0025-y; Chee-Sanford JC, 2009, J ENVIRON QUAL, V38, P1086, DOI 10.2134/jeq2008.0128; Chen XF, 2015, J SOIL SEDIMENT, V15, P292, DOI 10.1007/s11368-014-0981-6; Classen AT, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00217.1; Das S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01702; Di Cesare A, 2017, ENVIRON POLLUT, V226, P473, DOI 10.1016/j.envpol.2017.04.036; Diehl DL, 2010, ENVIRON SCI TECHNOL, V44, P9128, DOI 10.1021/es102765a; Ding JL, 2016, APPL SOIL ECOL, V105, P187, DOI 10.1016/j.apsoil.2016.04.010; Dunivin TK, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy016; Fernandez-Lopez R, 2006, FEMS MICROBIOL REV, V30, P942, DOI 10.1111/j.1574-6976.2006.00042.x; Fierer N, 2017, NAT REV MICROBIOL, V15, P579, DOI 10.1038/nrmicro.2017.87; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Fitzpatrick D, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiv168; Forsberg KJ, 2012, SCIENCE, V337, P1107, DOI 10.1126/science.1220761; Gaze WH, 2011, ISME J, V5, P1253, DOI 10.1038/ismej.2011.15; Gilchrist MJ, 2007, ENVIRON HEALTH PERSP, V115, P313, DOI 10.1289/ehp.8837; Gillings MR, 2015, ISME J, V9, P1269, DOI 10.1038/ismej.2014.226; Gohl DM, 2016, NAT BIOTECHNOL, V34, P942, DOI 10.1038/nbt.3601; Hamm AC, 2016, APPL SOIL ECOL, V103, P61, DOI 10.1016/j.apsoil.2016.02.015; Hartmann M, 2015, ISME J, V9, P1177, DOI 10.1038/ismej.2014.210; He JZ, 2008, J SOIL SEDIMENT, V8, P349, DOI 10.1007/s11368-008-0025-1; Heuer H, 2011, CURR OPIN MICROBIOL, V14, P236, DOI 10.1016/j.mib.2011.04.009; Hruby CE, 2016, J ENVIRON MANAGE, V171, P60, DOI 10.1016/j.jenvman.2016.01.040; Jechalke S, 2014, FEMS MICROBIOL ECOL, V87, P78, DOI 10.1111/1574-6941.12191; Johnsen PJ, 2009, LANCET INFECT DIS, V9, P357, DOI 10.1016/S1473-3099(09)70105-7; Joy SR, 2013, ENVIRON SCI TECHNOL, V47, P12081, DOI 10.1021/es4026358; Knapp CW, 2010, ENVIRON SCI TECHNOL, V44, P580, DOI 10.1021/es901221x; Koike S, 2010, MICROB ECOL, V59, P487, DOI 10.1007/s00248-009-9610-0; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; LECLERCQ R, 1991, ANTIMICROB AGENTS CH, V35, P1267, DOI 10.1128/AAC.35.7.1267; Leclercq SO, 2016, ENVIRON MICROBIOL, V18, P3494, DOI 10.1111/1462-2920.13337; Li R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051897; Looft T, 2012, P NATL ACAD SCI USA, V109, P1691, DOI 10.1073/pnas.1120238109; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luby EM, 2016, SCI TOTAL ENVIRON, V550, P1126, DOI 10.1016/j.scitotenv.2016.01.132; Marschner P, 2003, SOIL BIOL BIOCHEM, V35, P453, DOI 10.1016/S0038-0717(02)00297-3; Marti R, 2014, APPL ENVIRON MICROB, V80, P3258, DOI 10.1128/AEM.00231-14; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; McMurry SW, 1998, J ENVIRON QUAL, V27, P86, DOI 10.2134/jeq1998.00472425002700010013x; Meng L, 2005, SOIL BIOL BIOCHEM, V37, P2037, DOI 10.1016/j.soilbio.2005.03.007; Morales VL, 2010, J HYDROL, V393, P29, DOI 10.1016/j.jhydrol.2009.12.048; Munir M, 2011, J ENVIRON QUAL, V40, P248, DOI 10.2134/jeq2010.0209; Neuwirth E., 2014, RCOLORBREWER COLORBR; Norrby SR, 2005, LANCET INFECT DIS, V5, P115, DOI 10.1016/S1473-3099(05)01283-1; Oksanen J, 2018, R PACKAG, V2, P5; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parker L, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004080; Pruden A, 2012, ENVIRON SCI TECHNOL, V46, P11541, DOI 10.1021/es302657r; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Riber L, 2014, FEMS MICROBIOL ECOL, V90, P206, DOI 10.1111/1574-6941.12403; Rieke EL, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03197; Sapkota AR, 2007, ENVIRON HEALTH PERSP, V115, P1040, DOI 10.1289/ehp.9770; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shade A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00417; Soil Survey Staff NRCS United States Department of Agriculture., WEB SOIL SURV 2017; Soman C, 2017, PLANT SOIL, V413, P145, DOI 10.1007/s11104-016-3083-y; Srinivasan V, 2007, INT J ANTIMICROB AG, V29, P254, DOI 10.1016/j.ijantimicag.2006.08.040; Stocker MD, 2015, APPL ENVIRON MICROB, V81, P4801, DOI 10.1128/AEM.00705-15; Sun RB, 2015, SOIL BIOL BIOCHEM, V88, P9, DOI 10.1016/j.soilbio.2015.05.007; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; Tang XJ, 2015, SOIL BIOL BIOCHEM, V90, P179, DOI 10.1016/j.soilbio.2015.07.027; Tian Z, 2016, WATER RES, V98, P261, DOI 10.1016/j.watres.2016.04.031; Trivedi P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00990; Udikovic-Kolic N, 2014, P NATL ACAD SCI USA, V111, P15202, DOI 10.1073/pnas.1409836111; Unc A, 2004, APPL SOIL ECOL, V25, P1, DOI 10.1016/j.apsoil.2003.08.007; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; Walsh F, 2011, J MICROBIOL METH, V86, P150, DOI 10.1016/j.mimet.2011.04.011; Wang F, 2018, ENVIRON SCI TECHNOL, V52, P13037, DOI 10.1021/acs.est.8b04330; Wang FH, 2015, J HAZARD MATER, V299, P215, DOI 10.1016/j.jhazmat.2015.05.028; Wang MZ, 2018, ECOTOX ENVIRON SAFE, V147, P817, DOI 10.1016/j.ecoenv.2017.09.055; Wang MZ, 2017, ENVIRON SCI POLLUT R, V24, P20949, DOI 10.1007/s11356-017-9623-z; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wellington EMH, 2013, LANCET INFECT DIS, V13, P155, DOI 10.1016/S1473-3099(12)70317-1; Westcott SL, 2017, MSPHERE, V2, DOI 10.1128/mSphereDirect.00073-17; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Wickham H., 2015, R PACKAGE VERSION, V0.4, P156; Wickham H, 2007, J STAT SOFTW, V21, P1; Wu N, 2010, ENVIRON SCI TECHNOL, V44, P6933, DOI 10.1021/es1007802; Xie WY, 2018, SOIL BIOL BIOCHEM, V122, P111, DOI 10.1016/j.soilbio.2018.04.009; Xiong WG, 2018, ECOTOX ENVIRON SAFE, V147, P455, DOI 10.1016/j.ecoenv.2017.08.061; Zhang YJ, 2017, ENVIRON POLLUT, V231, P1621, DOI 10.1016/j.envpol.2017.09.074; Zhang YT, 2018, BIOL FERT SOILS, V54, P269, DOI 10.1007/s00374-017-1257-2; Zhao X, 2019, SCI TOTAL ENVIRON, V654, P906, DOI 10.1016/j.scitotenv.2018.10.446; Zhao X, 2017, SCI TOTAL ENVIRON, V593, P10, DOI 10.1016/j.scitotenv.2017.03.062; Zhao Y, 2019, SCI TOTAL ENVIRON, V656, P512, DOI 10.1016/j.scitotenv.2018.11.372; Zhen Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108555; Zhong WH, 2010, PLANT SOIL, V326, P511, DOI 10.1007/s11104-009-9988-y; Zhou X, 2017, ENVIRON SCI POLLUT R, V24, P701, DOI 10.1007/s11356-016-7854-z; Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110	98	24	24	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0220770	10.1371/journal.pone.0220770	http://dx.doi.org/10.1371/journal.pone.0220770			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5MK	31425534	Green Published, gold, Green Submitted			2022-12-26	WOS:000485022400015
J	Yoshida, H; Matsushita, T; Kimura, E; Fujita, Y; Keany, R; Ikeda, T; Toshimori, M; Imanaka, T; Nakamura, M				Yoshida, Hiroyuki; Matsushita, Tokiyoshi; Kimura, Erika; Fujita, Yukie; Keany, Robert; Ikeda, Toshihiro; Toshimori, Masanao; Imanaka, Takahiro; Nakamura, Masatsugu			Systemic expression of Alu RNA in patients with geographic atrophy secondary to age-related macular degeneration	PLOS ONE			English	Article							FACTOR-H POLYMORPHISM; PROGRESSION; DISEASE	Geographic atrophy (GA) secondary to age-related macular degeneration (AMD) is characterized by irreversible loss of macular retinal tissue and retinal pigment epithelium (RPE) cells. Several studies have revealed that accumulation of Alu RNA in RPE cell causes RPE cell degeneration in AMD. In the present study, systemic Alu RNA expression levels were determined in 33 subjects with GA and 40 control subjects using a proprietary Alu RNA quantification method. It was observed that the expression level of Alu RNA was not significantly different between GA and Control groups (median = 21.3 in both GA and Control groups, P = 0.251). In addition, the systemic level of Alu RNA was not associated with subject characteristics, such as GA lesion size and SNP profiles of complement factors associated with increased risk of AMD. In conclusion, the usability of systemic Alu RNA expression level as a biomarker of GA secondary to AMD could not be established in this study.	[Yoshida, Hiroyuki; Matsushita, Tokiyoshi; Kimura, Erika; Fujita, Yukie; Ikeda, Toshihiro; Toshimori, Masanao; Imanaka, Takahiro; Nakamura, Masatsugu] Santen Pharmaceut Co Ltd, Res & Dev Div, Osaka, Japan; [Keany, Robert] Santen Inc, Res & Dev Div, Emeryville, CA USA	Santen Pharmaceutical Co Ltd	Yoshida, H (corresponding author), Santen Pharmaceut Co Ltd, Res & Dev Div, Osaka, Japan.	hiroyuki.yoshida@santen.com		Yoshida, Hioryuki/0000-0002-2578-0782; Toshimori, Masanao/0000-0003-3869-7790	Santen Pharmaceutical Co., Ltd.; Santen Inc.	Santen Pharmaceutical Co., Ltd.; Santen Inc.	This study was funded by Santen Pharmaceutical Co., Ltd. and Santen Inc. HY, TM, EK, YF, TI, MT, TI, and MN are employed by Santen Pharmaceutical Co., Ltd. RK is employed by Santen Inc. The funders provided support in the form of salary for the all the authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are mentioned in the "Author Contributions" section.	Ardeljan D, 2013, PROG RETIN EYE RES, V37, P68, DOI 10.1016/j.preteyeres.2013.07.003; Black JRM, 2016, GENET MED, V18, P283, DOI 10.1038/gim.2015.70; Boyer DS, 2017, RETINA-J RET VIT DIS, V37, P819, DOI 10.1097/IAE.0000000000001392; Campagne MV, 2014, J PATHOL, V232, P151, DOI 10.1002/path.4266; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hasler J, 2007, NUCLEIC ACIDS RES, V35, P1389, DOI 10.1093/nar/gkm044; Holz FG, 2018, JAMA OPHTHALMOL, V136, P666, DOI 10.1001/jamaophthalmol.2018.1544; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Klein R, 2008, AM J OPHTHALMOL, V146, P692, DOI 10.1016/j.ajo.2008.05.050; Lindblad AS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1168, DOI 10.1001/archophthalmol.2009.198; Rosenfeld PJ, 2018, OPHTHALMOLOGY, V125, P1556, DOI 10.1016/j.ophtha.2018.03.059; Schmitz-Valckenberg S, 2016, OPHTHALMOLOGY, V123, P361, DOI 10.1016/j.ophtha.2015.09.036; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036; Yan YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080029; Yehoshua Z, 2015, OSLI RETINA, V46, P772, DOI 10.3928/23258160-20150730-15	19	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0220887	10.1371/journal.pone.0220887	http://dx.doi.org/10.1371/journal.pone.0220887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5MK	31425537	Green Published, gold, Green Submitted			2022-12-26	WOS:000485022400018
J	Mirabello, C; Wallner, B				Mirabello, Claudio; Wallner, Bjorn			rawMSA: End-to-end Deep Learning using raw Multiple Sequence Alignments	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; DIRECT-COUPLING ANALYSIS; SOLVENT ACCESSIBILITY; CONTACT PREDICTIONS; NEURAL NETWORKS; SERVER; COEVOLUTION; POTENTIALS	In the last decades, huge efforts have been made in the bioinformatics community to develop machine learning-based methods for the prediction of structural features of proteins in the hope of answering fundamental questions about the way proteins function and their involvement in several illnesses. The recent advent of Deep Learning has renewed the interest in neural networks, with dozens of methods being developed taking advantage of these new architectures. However, most methods are still heavily based pre-processing of the input data, as well as extraction and integration of multiple hand-picked, and manually designed features. Multiple Sequence Alignments (MSA) are the most common source of information in de novo prediction methods. Deep Networks that automatically refine the MSA and extract useful features from it would be immensely powerful. In this work, we propose a new paradigm for the prediction of protein structural features called rawMSA. The core idea behind rawMSA is borrowed from the field of natural language processing to map amino acid sequences into an adaptively learned continuous space. This allows the whole MSA to be input into a Deep Network, thus rendering pre-calculated features such as sequence profiles and other features calculated from MSA obsolete. We showcased the rawMSA methodology on three different prediction problems: secondary structure, relative solvent accessibility and inter-residue contact maps. We have rigorously trained and bench-marked rawMSA on a large set of proteins and have determined that it outperforms classical methods based on position-specific scoring matrices (PSSM) when predicting secondary structure and solvent accessibility, while performing on par with methods using more pre-calculated features in the inter-residue contact map prediction category in CASP12 and CASP13. Clearly demonstrating that rawMSA represents a promising development that can pave the way for improved methods using rawMSA instead of sequence profiles to represent evolutionary information in the coming years.	[Mirabello, Claudio; Wallner, Bjorn] Linkoping Univ, IFM Bioinformat, Linkoping, Sweden	Linkoping University	Wallner, B (corresponding author), Linkoping Univ, IFM Bioinformat, Linkoping, Sweden.	bjorn.wallner@liu.se	Wallner, Bjorn/R-1030-2018	Wallner, Bjorn/0000-0002-3772-8279	Swedish Research Council [2016-05369]; Foundation Blanceflor Boncompagni Ludovisi, nee Bildt; Nvidia Corporation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Foundation Blanceflor Boncompagni Ludovisi, nee Bildt; Nvidia Corporation	BW was supported by Swedish Research Council grant, 2016-05369. CM was supported by The Foundation Blanceflor Boncompagni Ludovisi, nee Bildt (no grant number). CM and BW were supported by Nvidia Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi M., 2016, TENSORFLOW LARGE SCA; Adamczak R, 2004, PROTEINS, V56, P753, DOI 10.1002/prot.20176; Adhikari B, 2017, BIOINFORMATICS; Asgari E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141287; Basu S, 2017, J COMPUT AID MOL DES, V31, P453, DOI 10.1007/s10822-017-0020-y; Bau D, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-402; Buchan DWA, 2018, PROTEINS, V86, P78, DOI 10.1002/prot.25379; Cao RZ, 2017, BIOINFORMATICS, V33, P586, DOI 10.1093/bioinformatics/btw694; Cheng H, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003926; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Dill KA, 2007, CURR OPIN STRUC BIOL, V17, P342, DOI 10.1016/j.sbi.2007.06.001; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Ekeberg M, 2014, J COMPUT PHYS, V276, P341, DOI 10.1016/j.jcp.2014.07.024; Fang C, 2018, PROTEINS, V86, P592, DOI 10.1002/prot.25487; Fariselli P, 1999, PROTEIN ENG, V12, P15, DOI 10.1093/protein/12.1.15; Gao YJ, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2065-x; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0; Joosten Robbie P, 2011, Nucleic Acids Res, V39, pD411, DOI 10.1093/nar/gkq1105; Kukic P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-6; Lazaridis T, 2000, CURR OPIN STRUC BIOL, V10, P139, DOI 10.1016/S0959-440X(00)00063-4; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mikolov T., 2013, COMPUTING RES REPOSI, V1301, P3781; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Naftaly U, 1997, NETWORK-COMP NEURAL, V8, P283, DOI 10.1088/0954-898X/8/3/004; Pollastri G, 2005, BIOINFORMATICS, V21, P1719, DOI 10.1093/bioinformatics/bti203; Pollastri G, 2002, Bioinformatics, V18 Suppl 1, pS62; Pollastri G, 2002, PROTEINS, V47, P142, DOI 10.1002/prot.10069; Pollastri G, 2002, PROTEINS, V47, P228, DOI 10.1002/prot.10082; Punta M, 2005, BIOINFORMATICS, V21, P2960, DOI 10.1093/bioinformatics/bti454; Ray A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-224; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; ROST B, 1994, PROTEINS, V20, P216, DOI 10.1002/prot.340200303; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schaarschmidt J, 2018, PROTEINS, V86, P51, DOI 10.1002/prot.25407; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Shell MS, 2009, BIOPHYS J, V96, P917, DOI 10.1016/j.bpj.2008.11.009; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; SIPPL MJ, 1990, J MOL BIOL, V213, P859, DOI 10.1016/S0022-2836(05)80269-4; SIPPL MJ, 1995, CURR OPIN STRUC BIOL, V5, P229, DOI 10.1016/0959-440X(95)80081-6; Soding J, 2011, CURR OPIN STRUC BIOL, V21, P404, DOI 10.1016/j.sbi.2011.03.005; Steinegger M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04964-5; Tegge AN, 2009, NUCLEIC ACIDS RES, V37, pW515, DOI 10.1093/nar/gkp305; Tien MZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080635; Torrisi M., 2018, BIORXIV; Uziela K, 2017, BIOINFORMATICS, V33, P1578, DOI 10.1093/bioinformatics/btw819; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wang S, 2018, PROTEINS, V86, P67, DOI 10.1002/prot.25377; Wang S, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005324; Wang S, 2016, NUCLEIC ACIDS RES, V44, pW430, DOI 10.1093/nar/gkw306; WANG Y, 2017, ATMOSPHERE-BASEL, V8, DOI DOI 10.3390/atmos8030055; Wang YX, 2017, KNOWL-BASED SYST, V118, P115, DOI 10.1016/j.knosys.2016.11.015; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Yang YD, 2018, BRIEF BIOINFORM, V19, P482, DOI 10.1093/bib/bbw129	65	28	27	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220182	10.1371/journal.pone.0220182	http://dx.doi.org/10.1371/journal.pone.0220182			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415569	Green Published, gold, Green Submitted			2022-12-26	WOS:000485017200012
J	Parsa, VA; Salehi, E; Yavari, AR; van Bodegom, PM				Parsa, Vahid Amini; Salehi, Esmail; Yavari, Ahmad Reza; van Bodegom, Peter M.			An improved method for assessing mismatches between supply and demand in urban regulating ecosystem services: A case study in Tabriz, Iran	PLOS ONE			English	Article							AIR-POLLUTION REMOVAL; GREEN INFRASTRUCTURE; CLIMATE-CHANGE; CONCEPTUAL-FRAMEWORK; CARBON STORAGE; GLOBAL CHANGE; HUMAN HEALTH; CITIES; QUALITY; TREES	Regulating ecosystem services provided by urban forests are of great importance for the quality of life among city dwellers. To reach a maximum contribution to well-being in cities, the urban regulating ecosystem services (URES) must match with the demands in terms of space and time. If we understand the matches or mismatches between the current urban dwellers' desired quality conditions (demand) and the supply of URES by urban forests (UF) in the cities, this will facilitate integrating the concepts of ecosystem services in urban planning and management, but such an assessment has suffered from major knowledge limitations. Since it is complex and problematic to identify the direct demands for URES and the spatiotemporal patterns therein, improving the demand indicators can help to determine the actual requirements. In this paper, a methodological approach based on indicators is presented and demonstrated for two important URES: air quality improvement and global climate change mitigation provided by urban trees and shrubs. Four air quality standards and greenhouse gas reduction targets were used and compared to supplies of the URES in Tabriz, Iran. Our results show that the mean contribution of the URES supply to air quality standards and greenhouse gas reduction targets is modest. Hence, in Tabriz, there is a strong mismatch between demand and supply. Mismatches at the city scale will have to be reduced by both a reduction in pollutant emissions and an increased provisioning of URES supply through urban greenery. The presented assessment approach and the results for Tabriz make it explicit how different the demands and supplies of the two studied URES are, and we expect similar mismatches in many other cities. Therefore, our approach, relatively simple but still realistic and easy-to-apply, can raise awareness about, and the utility of, the ecosystem services concepts for urban planning and policymaking.	[Parsa, Vahid Amini; Salehi, Esmail; Yavari, Ahmad Reza] Univ Tehran, Coll Engn, Sch Environm, Tehran, Iran; [van Bodegom, Peter M.] Leiden Univ, Inst Environm Sci CML, Leiden, Netherlands	University of Tehran; Leiden University; Leiden University - Excl LUMC	Parsa, VA (corresponding author), Univ Tehran, Coll Engn, Sch Environm, Tehran, Iran.	aminiparsa@ut.ac.ir	Parsa, Vahid Amini/L-4401-2019; van Bodegom, Peter/N-8150-2015	Parsa, Vahid Amini/0000-0001-5648-5439; van Bodegom, Peter/0000-0003-0771-4500; Salehi, Esmail/0000-0002-1627-6277				Aguaron E., 2012, CARBON SEQUESTRATION, P43, DOI [10.1007/978-94-007-2366-5, DOI 10.1007/978-94-007-2366-5_3]; Andersson E, 2014, AMBIO, V43, P445, DOI 10.1007/s13280-014-0506-y; Armour T, 2012, THE BENEFITS OF LARG, DOI [10.1080/03071375.2012.743224, DOI 10.1080/03071375.2012.743224]; Ayres RU, 2005, ECOL ECON, V55, P96, DOI 10.1016/j.ecolecon.2004.07.023; Azarafza M, 2016, AD ENVIRON RES, V5, P95, DOI 10.12989/aer.2016.5.2.095; Baro F, 2015, ECOL INDIC, V55, P146, DOI 10.1016/j.ecolind.2015.03.013; Baro F, 2014, AMBIO, V43, P466, DOI 10.1007/s13280-014-0507-x; Bastian Olaf, 2017, International Journal of Biodiversity Science Ecosystem Services & Management, V13, P51, DOI 10.1080/21513732.2016.1248865; Bastian O, 2012, ECOL INDIC, V21, P7, DOI 10.1016/j.ecolind.2011.03.014; Betsill Michele, 2001, LOCAL ENV, V6, P393, DOI DOI 10.1080/13549830120091699; Bolund P, 1999, ECOL ECON, V29, P293, DOI 10.1016/S0921-8009(99)00013-0; Brandt L, 2016, ENVIRON SCI POLICY, V66, P393, DOI 10.1016/j.envsci.2016.06.005; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Bulkeley H, 2013, ROUTL CRIT INTRO URB, P1; Burkhard B., 2014, Landscape Online; Burkhard B, 2012, ECOL INDIC, V21, P17, DOI 10.1016/j.ecolind.2011.06.019; Burkhard B, 2010, ECOL COMPLEX, V7, P257, DOI 10.1016/j.ecocom.2010.07.001; Cairns MA, 1997, OECOLOGIA, V111, P1, DOI 10.1007/s004420050201; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Carreiro MM, 2008, SPRINGER SER ENV MAN, P3, DOI 10.1007/978-0-387-71425-7_1; Chen WY, 2015, CITIES, V44, P112, DOI 10.1016/j.cities.2015.01.005; Churkina G, 2010, GLOBAL CHANGE BIOL, V16, P135, DOI 10.1111/j.1365-2486.2009.02002.x; Cohen M, 2012, LANDSCAPE URBAN PLAN, V106, P277, DOI 10.1016/j.landurbplan.2012.03.007; Crossman ND, 2013, ECOSYST SERV, V4, P4, DOI 10.1016/j.ecoser.2013.02.001; Crossman Neville D., 2012, International Journal of Biodiversity Science Ecosystem Services & Management, V8, P1, DOI 10.1080/21513732.2012.695229; Daily GC, 2009, FRONT ECOL ENVIRON, V7, P21, DOI 10.1890/080025; Dale VH, 2007, MEASURES OF THE EFFE, P4, DOI [10.1016/j.ecolecon.2007.05.009, DOI 10.1016/J.ECOLECON.2007.05.009]; de Groot RS, 2010, ECOL COMPLEX, V7, P260, DOI 10.1016/j.ecocom.2009.10.006; DeFries RS, 2012, BIOSCIENCE, V62, P603, DOI 10.1525/bio.2012.62.6.11; DOI, 2015, INTENDED NATIONALLY; DOI, 2017, AIR QUALITY STANDRAD; DOI, 2016, DATABASE OF HOURLY A; Elmhagen B, 2015, ECOL SOC, V20, DOI 10.5751/ES-07145-200123; Elmqvist T, 2015, CURR OPIN ENV SUST, V14, P101, DOI 10.1016/j.cosust.2015.05.001; EPA, 2014, NATIONAL AMBIENT AIR; Escobedo F, 2010, ENVIRON SCI POLICY, V13, P362, DOI 10.1016/j.envsci.2010.03.009; Escobedo FJ, 2009, LANDSCAPE URBAN PLAN, V90, P102, DOI 10.1016/j.landurbplan.2008.10.021; Esmailnejad M., 2015, JURNAL REGIONAL PLAN, V5, P173; EU, 2017, STANDARDS AIR QUALIT; Fisher B, 2009, ECOL ECON, V68, P643, DOI 10.1016/j.ecolecon.2008.09.014; Geijzendorffer IR, 2015, ECOL INDIC, V52, P320, DOI 10.1016/j.ecolind.2014.12.016; Ghozikali MG, 2013, HEALTH PROMOT PERSPE, V3, P113, DOI 10.5681/hpp.2013.013; Goldenberg R, 2017, SCI TOTAL ENVIRON, V593, P599, DOI 10.1016/j.scitotenv.2017.03.130; Gomez-Baggethun Erik, 2013, P175; Gomez-Baggethun E, 2013, ECOL ECON, V86, P235, DOI 10.1016/j.ecolecon.2012.08.019; Gorbani R., 2012, J GEOGRAPHY PLANNING, V16, P89; Graca MS, 2017, ECOSYST SERV, V23, P82, DOI 10.1016/j.ecoser.2016.11.015; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Haines-Young R., 2010, ECOSYSTEM ECOLOGY NE, DOI DOI 10.1017/CBO9780511750458.007; Hein L, 2006, ECOL ECON, V57, P209, DOI 10.1016/j.ecolecon.2005.04.005; Hirabayashi S., 2015, I TREE ECO DRY DEPOS; i-Tree Eco International Projects, 2016, ECO GUIDE TO INTERNA; IMO, 2017, DATASET ON HOURLY PR; Jayasooriya VM, 2017, URBAN FOR URBAN GREE, V21, P34, DOI 10.1016/j.ufug.2016.11.007; Jo HK, 2001, J ENVIRON MANAGE, V61, P165, DOI 10.1006/jema.2000.0393; Keeler BL, 2012, P NATL ACAD SCI USA, V109, P18619, DOI 10.1073/pnas.1215991109; Kiss M, 2015, MORAV GEOGR REP, V23, P36, DOI 10.1515/mgr-2015-0016; Kremer P, 2016, ECOL SOC, V21, DOI 10.5751/ES-08445-210229; Kroll F, 2012, LAND USE POLICY, V29, P521, DOI 10.1016/j.landusepol.2011.07.008; Lal, 2017, CARBON SEQUESTRATION, DOI [10.1007/978-3-319-53845-7, DOI 10.1007/978-3-319-53845-7]; Lal R., 2012, CARBON SEQUESTRATION; Martinez ML, 2009, FOREST ECOL MANAG, V258, P1856, DOI 10.1016/j.foreco.2009.02.023; Martin-Lopez B, 2014, ECOL INDIC, V37, P220, DOI 10.1016/j.ecolind.2013.03.003; Masson V, 2014, URBAN CLIM, V10, P407, DOI 10.1016/j.uclim.2014.03.004; McDonald R., 2009, J CONSERVAT PLANN, V5, P1; McMichael A, 2005, MILLENIUM ECOSYSTEM, V4, P43; Mcpherson G, 2005, J FOR; Muller F, 2007, MULTIFUNCTIONAL LAND, P37, DOI [10.1007/978-3-540-36763-5_3, DOI 10.1007/978-3-540-36763-5_3]; Nedkov S, 2012, ECOL INDIC, V21, P67, DOI 10.1016/j.ecolind.2011.06.022; Niel, 2011, 19TH INT CONGR MODEL, P12; Nowak D.J., 1994, CHICAGOS URBAN FORES, P83; Nowak D.J., 2019, UNDERSTANDING I TREE; Nowak David J., 2006, Urban Forestry & Urban Greening, V5, P93, DOI [10.1016/j.ufug.2006.04.002, 10.1016/j.ufug.2006.01.007]; Nowak DJ, 2018, URBAN FOR URBAN GREE, V29, P40, DOI 10.1016/j.ufug.2017.10.019; Nowak DJ, 2014, ENVIRON POLLUT, V193, P119, DOI 10.1016/j.envpol.2014.05.028; Nowak DJ, 2013, ENVIRON POLLUT, V178, P395, DOI 10.1016/j.envpol.2013.03.050; Nowak David J., 2008, Arboriculture & Urban Forestry, V34, P386; Nowak DJ, 2002, ENVIRON POLLUT, V116, P381, DOI 10.1016/S0269-7491(01)00214-7; Nowak DJ, 2000, UFORE METHODS; Nowak DJ., 2000, THE INTERACTIONS BET, P31; Nowak DJ, 2007, URBAN COMMUNITY FORE, P25; Olivier JGJ, 2017, TRENDS IN GLOBAL CO2; Paetzold A, 2010, ECOL COMPLEX, V7, P273, DOI 10.1016/j.ecocom.2009.11.003; Palacios-Agundez I, 2015, LAND USE POLICY, V47, P145, DOI 10.1016/j.landusepol.2015.03.012; Parsa VA, 2019, URBAN ECOSYST, V22, P989, DOI 10.1007/s11252-019-00870-w; Parsa VA, 2019, SUSTAIN CITIES SOC, V48, DOI 10.1016/j.scs.2019.101548; Pataki DE, 2006, GLOBAL CHANGE BIOL, V12, P2092, DOI 10.1111/j.1365-2486.2006.01242.x; Pataki DE, 2011, FRONT ECOL ENVIRON, V9, P27, DOI 10.1890/090220; Perez L, 2009, GAC SANIT, V23, P287, DOI 10.1016/j.gaceta.2008.07.002; Pincetl S, 2010, LOCAL ENVIRON, V15, P43, DOI 10.1080/13549830903406065; Raciti SM, 2014, SCI TOTAL ENVIRON, V500, P72, DOI 10.1016/j.scitotenv.2014.08.070; Rahimi A., 2014, BIANNUAL J URBAN ECO, V5, P99; Romero Lankao P., 2011, ISSUES PAPER FOR THE; Rumble H., 2015, VALUING URBAN TREES; Scholes RJ, 2013, CURR OPIN ENV SUST, V5, P16, DOI 10.1016/j.cosust.2013.01.004; Schroder C., 2013, METHODOLOGY PROPOSAL; Schroter M, 2014, ECOL INDIC, V36, P539, DOI 10.1016/j.ecolind.2013.09.018; Schroter M, 2012, ECOL INDIC, V23, P220, DOI 10.1016/j.ecolind.2012.03.025; Selmi W, 2016, URBAN FOR URBAN GREE, V17, P192, DOI 10.1016/j.ufug.2016.04.010; Shirani-Bidabadi N, 2019, SUSTAIN CITIES SOC, V45, P686, DOI 10.1016/j.scs.2018.12.005; Solecki W, 2013, ENVIRONMENT, V55, P12, DOI 10.1080/00139157.2013.748387; Soonsawad N., 2014, AN ASSESSMENT OF ECO; Statistical Center of Iran, 2016, POPULATION AND HOUSI; Stigter CJ, 2016, CLIM CHANG MANAG, P391, DOI 10.1007/978-3-319-28591-7_21; Strohbach MW, 2012, LANDSCAPE URBAN PLAN, V104, P95, DOI 10.1016/j.landurbplan.2011.10.001; Svirejeva-Hopkins A, 2004, ECOL MODEL, V173, P295, DOI 10.1016/j.ecolmodel.2003.09.022; Syrbe RU, 2012, ECOL INDIC, V21, P80, DOI 10.1016/j.ecolind.2012.02.013; Tallis H, 2012, BIOSCIENCE, V62, P977, DOI 10.1525/bio.2012.62.11.7; Tzoulas K, 2007, LANDSCAPE URBAN PLAN, V81, P167, DOI 10.1016/j.landurbplan.2007.02.001; van Jaarsveld AS, 2005, PHILOS T R SOC B, V360, P425, DOI 10.1098/rstb.2004.1594; van Oudenhoven APE, 2018, ECOL INDIC, V95, P417, DOI 10.1016/j.ecolind.2018.06.020; van Oudenhoven APE, 2012, ECOL INDIC, V21, P110, DOI 10.1016/j.ecolind.2012.01.012; Villamagna AM, 2013, ECOL COMPLEX, V15, P114, DOI 10.1016/j.ecocom.2013.07.004; Vos PEJ, 2013, ENVIRON POLLUT, V183, P113, DOI 10.1016/j.envpol.2012.10.021; Weissert LF, 2014, URBAN CLIM, V8, P100, DOI 10.1016/j.uclim.2014.01.002; WHO, 2006, AIR QUAL GUID GLOB U, DOI DOI 10.1016/0004-6981(88)90109-6; WHO, 2017, WHO RELEASES COUNTRY; World Bank Group, 2016, IRAN ECONOMIC MONITO; Wu JG, 2008, SPRINGER SER ENV MAN, P10, DOI 10.1007/978-0-387-71425-7_2; Yang Jun, 2005, Urban Forestry & Urban Greening, V3, P65, DOI 10.1016/j.ufug.2004.09.001	120	10	11	7	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220750	10.1371/journal.pone.0220750	http://dx.doi.org/10.1371/journal.pone.0220750			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5KK	31415585	Green Published, Green Submitted, gold			2022-12-26	WOS:000485017200029
J	Ripperger, SP; Rehse, S; Wacker, S; Kalko, EKV; Schulz, S; Rodriguez-Herrera, B; Ayasse, M				Ripperger, Simon P.; Rehse, Saskia; Wacker, Stefanie; Kalko, Elisabeth K. V.; Schulz, Stefan; Rodriguez-Herrera, Bernal; Ayasse, Manfred			Nocturnal scent in a 'bird-fig': A cue to attract bats as additional dispersers?	PLOS ONE			English	Article							FRUIT-EATING BATS; ECTOPHYLLA-ALBA CHIROPTERA; TENT-MAKING BAT; FORAGING BEHAVIOR; SEED DISPERSAL; CHEMICAL ECOLOGY; AROMA VOLATILES; ECHOLOCATION; EVOLUTION; OLFACTION	The plant genus Ficus is a keystone resource in tropical ecoystems. One of the unique features of figs is the diversity of fruit traits, which in many cases match their various dispersers, the so-called fruit syndromes. The classic example of this is the strong phenotypic differences found between figs with bat and bird dispersers (color, size, presentation, and scent). The 'bird-fig' Ficus colubrinae represents an exception to this trend since it attracts the small frugivorous bat species Ectophylla alba at night, but during the day it attracts bird visitors. Here we investigate day to night changes in fruit scent as a possible mechanism by which this 'bird-fig' could attract bats despite its fruit traits, which should appeal solely to birds. Analyses of odor bouquets from the bat-and bird-dispersal phases (i.e. day and night) differed significantly in their composition of volatiles. We observed a significant increase in relative amounts of sesquiterpene and aromatic compounds at night while relative amounts of two compounds of the fatty acid pathway were significantly higher during day. This finding raises the question whether Ficus colubrinae, a phenotypically classic 'bird-fig', might be able to attract bat dispersers by an olfactory signal at night. Preliminary observations from feeding experiments which indicate that Ectophylla alba is capable of finding ripe figs by scent alone point in this direction. However, additional behavioral experiments on whether bats prefer the 'night-bouquet' over the 'day-bouquet' will be needed to unequivocally answer this question.	[Ripperger, Simon P.; Rehse, Saskia; Wacker, Stefanie; Kalko, Elisabeth K. V.; Ayasse, Manfred] Univ Ulm, Inst Evolutionary Ecol & Conservat Gen, Albert Einstein Allee, Ulm, Germany; [Ripperger, Simon P.] Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde, Invalidenstr, Berlin, Germany; [Kalko, Elisabeth K. V.] Smithsonian Trop Res Inst, Balboa, Panama; [Schulz, Stefan] Tech Univ Braunschweig, Inst Organ Chem, Braunschweig, Germany; [Rodriguez-Herrera, Bernal] Univ Costa Rica, Escuela Biol, San Pedro, Costa Rica; [Rehse, Saskia] Leibniz Inst Gewasserokol & Binnenfischerei, Muggelseedamm 310, Berlin, Germany	Ulm University; Leibniz Institut fur Evolutions und Biodiversitatsforschung; Smithsonian Institution; Smithsonian Tropical Research Institute; Braunschweig University of Technology; Universidad Costa Rica; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Ripperger, SP (corresponding author), Univ Ulm, Inst Evolutionary Ecol & Conservat Gen, Albert Einstein Allee, Ulm, Germany.; Ripperger, SP (corresponding author), Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde, Invalidenstr, Berlin, Germany.	simon.ripperger@gmail.com	Rehse, Saskia/AAD-3527-2020	Schulz, Stefan/0000-0002-4810-324X; Ripperger, Simon/0000-0003-1527-8657	Deutsche Forschungsgemeinschaft (DFG, Germany) [KA 124 8-1, AY 12/8-2]	Deutsche Forschungsgemeinschaft (DFG, Germany)(German Research Foundation (DFG))	The project was funded by the Deutsche Forschungsgemeinschaft (DFG, Germany, https://www.dfg.de/) to EKVK and MA (KA 124 8-1; AY 12/8-2). The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auguie B, 2017, GRIDEXTRA MISCELLANE; Borges RM, 2008, FUNCT ECOL, V22, P484, DOI 10.1111/j.1365-2435.2008.01383.x; Borges RM, 2011, ACTA OECOL, V37, P611, DOI 10.1016/j.actao.2011.06.003; Brodie JF, 2017, P NATL ACAD SCI USA, V114, P11998, DOI 10.1073/pnas.1710172114; BROOKE AP, 1990, J ZOOL, V221, P11, DOI 10.1111/j.1469-7998.1990.tb03771.x; Burger W, 1977, FLORA COSTARICENSIS; Burns KC, 2002, OIKOS, V96, P463, DOI 10.1034/j.1600-0706.2002.960308.x; Charles-Dominique P, 1986, FRUGIVORES SEED DISP, P119, DOI DOI 10.1007/978-94-009-4812-9_12; Fleming TH., 2013, ORNAMENTS LIFE COEVO; Galetti M, 2013, SCIENCE, V340, P1086, DOI 10.1126/science.1233774; Galindo-Gonzalez J, 2000, CONSERV BIOL, V14, P1693, DOI [10.1046/j.1523-1739.2000.99072.x, 10.1111/j.1523-1739.2000.99072.x]; GAUTIERHION A, 1985, OECOLOGIA, V65, P324, DOI 10.1007/BF00378906; Giannini NP, 2004, OIKOS, V105, P209, DOI 10.1111/j.0030-1299.2004.12690.x; GORCHOV DL, 1993, VEGETATIO, V108, P339; Grison-Pige L, 2002, PHYTOCHEMISTRY, V61, P61, DOI 10.1016/S0031-9422(02)00213-3; Herrera Carlos M., 2002, P185; Hodgkison R, 2007, J CHEM ECOL, V33, P2097, DOI 10.1007/s10886-007-9367-1; Hodgkison R, 2013, FUNCT ECOL, V27, P1075, DOI 10.1111/1365-2435.12101; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Howe HF, 1988, ECOLOGICAL RELATIONS; JANSON CH, 1983, SCIENCE, V219, P187, DOI 10.1126/science.219.4581.187; Kalko EKV, 1996, J BIOGEOGR, V23, P565, DOI 10.1111/j.1365-2699.1996.tb00018.x; Kalko EKV, 1998, FUNCT ECOL, V12, P364, DOI 10.1046/j.1365-2435.1998.00198.x; Kalko Elisabeth K.V., 2009, P491; Knudsen JT, 1999, MEM NEW YORK BOTAN G, V83, P141; Korine C, 2000, OECOLOGIA, V123, P560, DOI 10.1007/PL00008861; Korine C, 2005, BEHAV ECOL SOCIOBIOL, V59, P12, DOI 10.1007/s00265-005-0003-1; Lalel HJD, 2003, POSTHARVEST BIOL TEC, V27, P323, DOI 10.1016/S0925-5214(02)00117-5; Li GP, 2013, J HORTIC SCI BIOTECH, V88, P563, DOI 10.1080/14620316.2013.11513007; Lomascolo SB, 2008, OECOLOGIA, V156, P783, DOI 10.1007/s00442-008-1023-0; Lomascolo SB, 2010, P NATL ACAD SCI USA, V107, P14668, DOI 10.1073/pnas.1008773107; McLafferty F.W., 1989, WILEY NBS REGISTRY M, V1; Nevo O, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat4871; Nevo O, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2018.0377; Obenland D, 2012, POSTHARVEST BIOL TEC, V71, P41, DOI 10.1016/j.postharvbio.2012.03.006; Rodriguez-Herrera B, 2008, ACTA CHIROPTEROL, V10, P89, DOI 10.3161/150811008X331126; Schaefer HM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2516; Shanahan M, 2001, BIOL REV, V76, P529, DOI 10.1017/S1464793101005760; Thies W, 1998, BEHAV ECOL SOCIOBIOL, V42, P397, DOI 10.1007/s002650050454; Tschapka M, 2003, BIOL J LINN SOC, V80, P281, DOI 10.1046/j.1095-8312.2003.00235.x; Van der Pijl L, 1982, PRINCIPLES DISPERSAL, V214; Villalobos-Chaves D, 2017, J MAMMAL, V98, P1193, DOI 10.1093/jmammal/gyx044; WHEELWRIGHT NT, 1985, AM NAT, V126, P777, DOI 10.1086/284453; WHEELWRIGHT NT, 1985, ECOLOGY, V66, P808, DOI 10.2307/1940542; Willson M. F., 2000, Seeds: the ecology of regeneration in plant communities, P85, DOI 10.1079/9780851994321.0085	45	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220461	10.1371/journal.pone.0220461	http://dx.doi.org/10.1371/journal.pone.0220461			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415602	Green Submitted, Green Published, gold			2022-12-26	WOS:000485017200017
J	Zhang, G; Bogdanova, N; Gao, T; Sheikh, KA				Zhang, Gang; Bogdanova, Nataliia; Gao, Tong; Sheikh, Kazim A.			Elimination of activating Fc gamma receptors in spontaneous autoimmune peripheral polyneuropathy model protects from neuropathic disease	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC NEURITIS; REGULATORY T-CELLS; DEMYELINATION; PHAGOCYTOSIS; POLYNEURITIS	Spontaneous autoimmune peripheral polyneuropathy (SAPP) is a reproducible mouse model of chronic inflammatory peripheral neuropathy in female non-obese diabetic mice deficient in co-stimulatory molecule, B7-2 (also known as CD86). There is evidence that SAPP is an interferon-gamma, CD4+ T-cell-mediated disorder, with autoreactive T-cells and auto-antibodies directed against myelin protein zero involved in its immunopathogenesis. Precise mechanisms leading to peripheral nerve system inflammation and nerve injury including demyelination in this model are not well defined. We examined the role of activating Fc-amma receptors (Fc gamma Rs) by genetically ablating Fc gamma-common chain (Fcer1g) shared by all activating Fc gamma Rs in the pathogenesis of this model. We have generated B7-2/Fcer1g-double null animals for these studies and found that the neuropathic disease is substantially ameliorated in these animals as assessed by behavior, electrophysiology, immunocytochemistry, and morphometry. Our current studies focused on characterizing systemic and endoneurial inflammation in B7-2-null and B7-2/Fcer1g-double nulls. We found that accumulation of endoneurial inflammatory cells was significantly attenuated in B7-2/Fcer1g-double nulls compared to B7-2-single nulls. Whereas, systemically the frequency of CD4+ regulatory T cells and expression of immunosuppressive cytokine, IL-10, were significantly enhanced in B7-2/Fcer1g-double nulls. Overall, these findings suggest that elimination of activating Fc gamma Rs modulate nerve injury by altering endoneurial and systemic inflammation. These observations raise the possibility of targeting activating Fc gamma Rs as a treatment strategy in acquired inflammatory demyelinating neuropathies.	[Zhang, Gang; Bogdanova, Nataliia; Gao, Tong; Sheikh, Kazim A.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Neurol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Zhang, G (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Neurol, Houston, TX 77030 USA.	gang.zhang@uth.tmc.edu			National Institute of Neurological Disorders and Stroke (NIH/NINDS) [R01NS54962]; U.S. Department of Defense (DoD) [W81XWH-18-1-0422]; GBS/CIDP Foundation International; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054962] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); U.S. Department of Defense (DoD)(United States Department of Defense); GBS/CIDP Foundation International; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke (NIH/NINDS; grant R01NS54962); U.S. Department of Defense (DoD; Award#: W81XWH-18-1-0422); and by GBS/CIDP Foundation International. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASBURY AK, 1969, MEDICINE, V48, P173, DOI 10.1097/00005792-196905000-00001; BALLIN RHM, 1969, J NEUROL SCI, V8, P1, DOI 10.1016/0022-510X(69)90037-9; Chi L, 2007, J NEUROIMMUNOL, V192, P206, DOI 10.1016/j.jneuroim.2007.09.034; Cox D, 2001, SEMIN IMMUNOL, V13, P339, DOI 10.1006/smim.2001.0330; Dong CL, 2017, EXP NEUROL, V292, P35, DOI 10.1016/j.expneurol.2017.02.012; FEASBY TE, 1986, BRAIN, V109, P1115, DOI 10.1093/brain/109.6.1115; Gao T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23607-9; Griffin JW, 1996, J NEUROCYTOL, V25, P33, DOI 10.1007/BF02284784; Harness J, 2008, J CLIN NEUROSCI, V15, P1031, DOI 10.1016/j.jocn.2007.09.016; He L, 2015, J NEUROSCI, V35, P6770, DOI 10.1523/JNEUROSCI.4926-14.2015; Hogarth PM, 2002, CURR OPIN IMMUNOL, V14, P798, DOI 10.1016/S0952-7915(02)00409-0; Kieseier BC, 2004, MUSCLE NERVE, V30, P131, DOI 10.1002/mus.20076; Kim HJ, 2008, J IMMUNOL, V181, P8753, DOI 10.4049/jimmunol.181.12.8753; LAMPERT PW, 1969, LAB INVEST, V20, P127; Lehmann HC, 2007, J NEUROSCI, V27, P27, DOI 10.1523/JNEUROSCI.4017-06.2007; Maddur MS, 2014, IMMUNOL RES, V60, P320, DOI 10.1007/s12026-014-8580-6; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Nimmerjahn F, 2011, CURR TOP MICROBIOL, V350, P105, DOI 10.1007/82_2010_86; Nimmerjahn F, 2010, IMMUNOL REV, V236, P265, DOI 10.1111/j.1600-065X.2010.00910.x; Ortiz DF, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9418; POWELL HC, 1983, LAB INVEST, V48, P332; PRINEAS JW, 1981, ANN NEUROL, V9, P6, DOI 10.1002/ana.410090704; Quan S, 2016, CLIN EXP IMMUNOL, V184, P50, DOI 10.1111/cei.12756; Salomon B, 2001, J EXP MED, V194, P677, DOI 10.1084/jem.194.5.677; Spirig R, 2018, J IMMUNOL, V200, P2542, DOI 10.4049/jimmunol.1701171; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; Ubogu EE, 2012, J PERIPHER NERV SYST, V17, P53, DOI 10.1111/j.1529-8027.2012.00375.x; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; WAKSMAN BH, 1955, J EXP MED, V102, P213, DOI 10.1084/jem.102.2.213; Zhang G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088703; Zhang G, 2014, EXP NEUROL, V252, P57, DOI 10.1016/j.expneurol.2013.11.024	33	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220250	10.1371/journal.pone.0220250	http://dx.doi.org/10.1371/journal.pone.0220250			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415574	Green Published, gold, Green Submitted			2022-12-26	WOS:000485017200014
J	Zhang, S; Morgenstern, H; Albertus, P; Nallamothu, BK; He, K; Saran, R				Zhang, Sai; Morgenstern, Hal; Albertus, Patrick; Nallamothu, Brahmajee K.; He, Kevin; Saran, Rajiv			Emergency department visits and hospitalizations among hemodialysis patients by day of the week and dialysis schedule in the United States	PLOS ONE			English	Article							PRACTICE PATTERNS; INTRADIALYTIC HYPOTENSION; MORTALITY; OUTCOMES; ULTRAFILTRATION; TIME	Background and objective Previous reports indicated that patients on thrice-weekly hemodialysis (HD) had higher mortality rates after the 3-day interdialytic interval. However, day-of-the-week patterns of emergency department (ED) visits and hospitalizations remain under-investigated. Methods We conducted a retrospective cohort study of HD patients on thrice-weekly dialysis, using 2013 data from the United States Renal Data System (USRDS). We estimated crude incidence rates of ED visits and hospitalizations by day of the week and dialysis schedule (Monday, Wednesday, Friday or Tuesday, Thursday, Saturday). Using Poisson regression, we estimated case-mix adjusted rate ratios of all-cause ED visits and hospitalizations, and adjusted rates of cause-specific ED visits and hospitalizations. Results We identified 241,093 eligible HD patients in 2013, who had 514,773 ED visits and 301,674 hospitalizations that year. Three distinct but related patterns of outcome events were observed. Crude and adjusted incidence rates of all-cause, cardiovascular, and infection-related ED visits and hospitalizations, but not vascular-access-related events, were higher on all three HD treatment days ("dialysis-day effect"). Rates for ED visits and hospitalizations were lower on weekends than weekdays, rising appreciably from Sunday to Monday for both dialysis schedules ("post-weekend effect"); and rates were highest after the long 3-day interval between dialysis sessions for both dialysis schedules ("interdialytic-gap effect"). In contrast, rates of hospitalizations not preceded by an ED visit were nearly the same Monday through Friday and lower on weekends for both dialysis schedules. Conclusions Higher rates of ED visits and hospitalizations on the days of HD sessions and early in the week are a public-health concern that should stimulate research to explain these patterns and reduce the excessive morbidity and associated costs among patients on thrice-weekly HD, while improving quality of care and patient experience with dialysis.	[Zhang, Sai; Albertus, Patrick; He, Kevin; Saran, Rajiv] Univ Michigan, Sch Publ Hlth, Kidney Epidemiol & Cost Ctr, Ann Arbor, MI 48109 USA; [Zhang, Sai; Morgenstern, Hal; He, Kevin; Saran, Rajiv] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Morgenstern, Hal] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA; [Morgenstern, Hal] Univ Michigan, Dept Urol, Med Sch, Ann Arbor, MI 48109 USA; [Morgenstern, Hal; Nallamothu, Brahmajee K.; Saran, Rajiv] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Albertus, Patrick; Saran, Rajiv] Univ Michigan, Dept Internal Med, Med Sch, Ann Arbor, MI 48109 USA; [Albertus, Patrick] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Nallamothu, Brahmajee K.] Ann Arbor VA Ctr Clin Management & Res, Ann Arbor, MI USA; [Nallamothu, Brahmajee K.] Univ Michigan Hlth Syst, Ann Arbor, MI USA; [Nallamothu, Brahmajee K.] Univ Michigan, Dept Internal Med, Michigan Integrated Ctr Hlth Analyt & Med Predict, Ann Arbor, MI 48109 USA; [He, Kevin] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University System of Ohio; University of Cincinnati; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Saran, R (corresponding author), Univ Michigan, Sch Publ Hlth, Kidney Epidemiol & Cost Ctr, Ann Arbor, MI 48109 USA.; Saran, R (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.; Saran, R (corresponding author), Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA.; Saran, R (corresponding author), Univ Michigan, Dept Internal Med, Med Sch, Ann Arbor, MI 48109 USA.	rsaran@med.umich.edu		Saran, Rajiv/0000-0001-7317-8756	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services [HHSN276201400001C]; University of Michigan [HHSN276201400001C]	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Michigan(University of Michigan System)	Funding for this research was provided through a contract (HHSN276201400001C) between the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, and the University of Michigan. The interpretation and reporting of findings and data reported in this manuscript are the responsibility of the authors, and in no way should be seen as an official policy of or interpretation by the US government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assimon MM, 2016, AM J KIDNEY DIS, V68, P911, DOI 10.1053/j.ajkd.2016.06.020; Banshodani M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180577; Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376; Chou JA, 2017, SEMIN DIALYSIS, V30, P473, DOI 10.1111/sdi.12627; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Foley RN, 2011, NEW ENGL J MED, V365, P1099, DOI 10.1056/NEJMoa1103313; Fotheringham J, 2019, NEPHROL DIAL TRANSPL; Fotheringham J, 2015, KIDNEY INT, V88, P569, DOI 10.1038/ki.2015.141; Freemantle N, 2012, J ROY SOC MED, V105, P74, DOI 10.1258/jrsm.2012.120009; Freemantle N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4843; Kjellstrand Carl M, 2004, Hemodial Int, V8, P24, DOI 10.1111/j.1492-7535.2004.00083.x; Lopot F, 1998, NEPHROL DIAL TRANSPL, V13, P74, DOI 10.1093/ndt/13.suppl_6.74; Lovasik BP, 2016, JAMA INTERN MED, V176, P1563, DOI 10.1001/jamainternmed.2016.4975; McDonough Matthew J, 2008, Nephrol News Issues, V22, P48; Ok E, 2017, SEMIN DIALYSIS, V30, P420, DOI 10.1111/sdi.12612; Rayner HC, 2014, AM J KIDNEY DIS, V64, P86, DOI 10.1053/j.ajkd.2014.01.014; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Sakhuja A, 2013, AM J KIDNEY DIS, V62, P763, DOI 10.1053/j.ajkd.2013.03.014; Sands JJ, 2014, HEMODIAL INT, V18, P415, DOI 10.1111/hdi.12138; Saran R, 2006, KIDNEY INT, V69, P1222, DOI 10.1038/sj.ki.5000186; Saran R, 2017, AM J KIDNEY DIS, V69, DOI 10.1053/j.ajkd.2016.12.004; Scribner Belding H, 2004, Hemodial Int, V8, P188, DOI 10.1111/j.1492-7535.2004.01094.x; Tentori F, 2012, NEPHROL DIAL TRANSPL, V27, P4180, DOI 10.1093/ndt/gfs021; Varney J, 2014, INT J EVID-BASED HEA, V12, P128, DOI 10.1097/XEB.0000000000000011; Zhang H, 2012, KIDNEY INT, V81, P1108, DOI 10.1038/ki.2011.481	25	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220966	10.1371/journal.pone.0220966	http://dx.doi.org/10.1371/journal.pone.0220966			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415609	Green Published, gold, Green Submitted			2022-12-26	WOS:000485017200053
J	Brophy, LS; Greene, CM; Hare, V; Holycross, B; Lanier, A; Heady, WN; O'Connor, K; Imaki, H; Haddad, T; Dana, R				Brophy, Laura S.; Greene, Correigh M.; Hare, Van C.; Holycross, Brett; Lanier, Andy; Heady, Walter N.; O'Connor, Kevin; Imaki, Hiroo; Haddad, Tanya; Dana, Randy			Insights into estuary habitat loss in the western United States using a new method for mapping maximum extent of tidal wetlands	PLOS ONE			English	Article							ACCURACY ASSESSMENT; COASTAL WETLANDS; RIVER ESTUARY; SALMON RIVER; BLUE CARBON; MODEL; CONSERVATION; CALIFORNIA; OCEAN; OPPORTUNITIES	Effective conservation and restoration of estuarine wetlands require accurate maps of their historical and current extent, as well as estimated losses of these valued habitats. Existing coast-wide tidal wetland mapping does not explicitly map historical tidal wetlands that are now disconnected from the tides, which represent restoration opportunities; nor does it use water level models or high-resolution elevation data (e.g. lidar) to accurately identify current tidal wetlands. To better inform estuarine conservation and restoration, we generated new maps of current and historical tidal wetlands for the entire contiguous U.S. West Coast (Washington, Oregon, and California). The new maps are based on an Elevation-Based Estuary Extent Model (EBEEM) that combines lidar digital elevation models (DEMs) and water level models to establish the maximum historical extent of tidal wetlands, representing a major step forward in mapping accuracy for restoration planning and analysis of wetland loss. Building from this new base, we also developed an indirect method for mapping tidal wetland losses, and created maps of these losses for 55 estuaries on the West Coast (representing about 97% of historical West Coast vegetated tidal wetland area). Based on these new maps, we estimated that total historical estuary area for the West Coast is approximately 735,000 hectares (including vegetated and nonvegetated areas), and that about 85% of vegetated tidal wetlands have been lost from West Coast estuaries. Losses were highest for major river deltas. The new maps will help interested groups improve action plans for estuarine wetland habitat restoration and conservation, and will also provide a better baseline for understanding and predicting future changes with projected sea level rise.	[Brophy, Laura S.] Inst Appl Ecol, Corvallis, OR USA; [Greene, Correigh M.] NOAA Fisheries, Northwest Fisheries Sci Ctr, Seattle, WA 98112 USA; [Hare, Van C.; Holycross, Brett] Pacific States Marine Fisheries Commiss, Portland, OR USA; [Lanier, Andy; Haddad, Tanya; Dana, Randy] Oregon Dept Land Conservat & Dev, Salem, OR USA; [Heady, Walter N.] Nature Conservancy, Santa Cruz, CA USA; [O'Connor, Kevin] Moss Landing Marine Labs, Moss Landing, CA USA; [Imaki, Hiroo] Pacific Spatial Solut Inc, Seattle, WA USA	National Oceanic Atmospheric Admin (NOAA) - USA; Nature Conservancy; Moss Landing Marine Laboratories	Greene, CM (corresponding author), NOAA Fisheries, Northwest Fisheries Sci Ctr, Seattle, WA 98112 USA.	correigh.greene@noaa.gov		Hare, Van/0000-0003-3787-3377; Haddad, Tanya/0000-0001-5550-3359	Multistate Conservation Grant from the Association of Fish and Wildlife Agencies; US Fish and Wildlife Service [NFHP2155]; Nature Conservancy; NOAA Office for Coastal Management [NOS4192014]; Pacific Marine and Estuarine Fish Habitat Partnership (PMEP); NOAA	Multistate Conservation Grant from the Association of Fish and Wildlife Agencies; US Fish and Wildlife Service(US Fish & Wildlife Service); Nature Conservancy; NOAA Office for Coastal Management; Pacific Marine and Estuarine Fish Habitat Partnership (PMEP); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	LSB was funded as a subcontractor by a Multistate Conservation Grant to the Pacific States Marine Fisheries Commission (PSMFC) from the Association of Fish and Wildlife Agencies and the US Fish and Wildlife Service (Grant ID: NFHP2155). KO received funding as a subcontractor through a grant to PSMFC from The Nature Conservancy (managed by WH). LSB (subcontractor), AL, TH, and RD received funding to complete the original development of the methods through the NOAA Office for Coastal Management through a Project of Special Merit Grant (award NOS4192014).; Funding for this work was provided by the Pacific Marine and Estuarine Fish Habitat Partnership (PMEP), NOAA, and The Nature Conservancy. Patrick Clinton and Ted DeWitt (U.S. Environmental Protection Agency, Pacific Coastal Ecology Branch) initially introduced us to NOAA's Extreme Water Level models as potentially important datums for mapping wetland boundaries. PC Trask provided geospatial data for the 50% annual exceedance probability stage profile in the Columbia River Estuary. Evelyn Brown (Lummi Tribe), Eric Beamer (Skagit River System Cooperative), Josh Chamberlin (Northwest Fisheries Center, NWFSC), Chris Ellings (Nisqually Tribe), Jenni Schmidt (South Slough National Estuary Research Reserve, NERR), Kerstin Wasson (Elkhorn Slough NERR), Ann Kitajima (Morro Bay National Estuary Program), and Jeff Crooks and Monica Almeida (Tijuana Slough NERR) kindly shared water level and vegetation survey data in estuaries across the Pacific Coast. The PMEP Steering and Science and Data Committees and Tim Beechie (NWFSC) provided helpful reviews of this manuscript. Maddy Luthard assisted with formatting citations and the literature cited.	Adamus PR, 2006, HYDROGEOMORPHIC HG 1; Aitkin KJ, 1998, IMPORTANCE ESTUARINE; Allen T, 2011, COASTAL WETLAND MAPP; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Behrens DK, 2016, ESTUAR COAST, V39, P621, DOI 10.1007/s12237-015-0030-8; Bottom D, 1979, HABITAT CLASSIFICATI; Bridgham SD, 2006, WETLANDS, V26, P889, DOI 10.1672/0277-5212(2006)26[889:TCBONA]2.0.CO;2; Brophy L, 2017, 2017 MONITORING REPO; Brophy L, 2014, 2014 MONITORING REPO; Brophy L.S., 2017, MODELING SEA LEVEL R; Brophy L.S., 2011, NEW TOOLS TIDAL WETL; Brophy LS, 2013, 20121038 US GEOL SUR; Brophy LS, 2014, NI LESTUN TIDAL WETL; Buffington KJ, 2016, REMOTE SENS ENVIRON, V186, P616, DOI 10.1016/j.rse.2016.09.020; Cameron WM, 1963, SEA, V2, P306; Carle MV, 2011, WETLANDS, V31, P1275, DOI 10.1007/s13157-011-0242-z; Carr EW, 2018, J ENVIRON MANAGE, V206, P40, DOI 10.1016/j.jenvman.2017.10.018; CHENG RT, 1993, ESTUAR COAST SHELF S, V36, P235, DOI 10.1006/ecss.1993.1016; Collins B.D., 2003, RESTORATION PUGET SO, P79; Cortright R, 1987, OREGON ESTUARY PLAN; Cowardin L.M., 1979, CLASSIFICATION WETLA; Dahl T.E., 1990, WETLAND LOSSES US 17; Dethier M.N., 1990, MARINE ESTUARINE HAB; Deverel SJ, 1996, WATER RESOUR RES, V32, P2359, DOI 10.1029/96WR01338; Donnelly JP, 2001, P NATL ACAD SCI USA, V98, P14218, DOI 10.1073/pnas.251209298; Ehlschlaeger C.R, 1989, P INT GEOGR INF SYST; Eilers HP, 1975, THESIS; Ellings CS, 2016, RESTOR ECOL, V24, P415, DOI 10.1111/rec.12333; Engle VD, 2011, WETLANDS, V31, P179, DOI 10.1007/s13157-010-0132-9; Enwright NM, 2016, FRONT ECOL ENVIRON, V14, P307, DOI 10.1002/fee.1282; Ewald MJ, 2013, THESIS; Expert Regional Technical Group (ERTG), 2013, 201201 ERTG NOAA USA; FRENKEL RE, 1991, NORTHWEST ENVIRON J, V7, P119; GODIN G, 1984, INT HYDROGR REV, V61, P159; Gosselink J.G., 1980, Z GEOMORPHOLOGIE S, V34, P173; Gray A, 2002, RESTOR ECOL, V10, P514, DOI 10.1046/j.1526-100X.2002.01039.x; Grossinger RM, 2011, SFEI CONTRIBUTION; Grossinger Robin M., 2005, 427 SFEI; Hladik C, 2012, REMOTE SENS ENVIRON, V121, P224, DOI 10.1016/j.rse.2012.01.018; Huang L, 2011, SOLUTIONS COASTAL DI, P188, DOI [10.1061/41185%28417542918, DOI 10.1061/41185%28417542918]; Hughes BB, 2014, NURSERY FUNCTIONS US; Janousek CN, 2018, WETL ECOL MANAG, V26, P315, DOI 10.1007/s11273-017-9575-6; Janousek CN, 2014, J VEG SCI, V25, P534, DOI 10.1111/jvs.12107; Jasiewicz J, 2011, COMPUT GEOSCI, DOI [10.1016/i.cageo.2011.03.003, DOI 10.1016/I.CAGEO.2011.03.003]; Jay D. A., 2000, ESTUARINE SCI SYNTHE, P149; Jay DA, 2015, ESTUAR COAST, V38, P415, DOI 10.1007/s12237-014-9819-0; Kelleway Jeffrey J., 2017, BIOGEOSCI DISCUSS, DOI [10.5194/bg-2017-15., DOI 10.5194/BG-2017-15]; Knowles N, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR000360; Koski KV, 2009, ECOL SOC, V14; Kutcher T.E., 2008, HABITAT LAND COVER C; Lanier A, 2014, CORE CMECS GIS PROCE; Lower Columbia Estuary Partnership (LCEP), 2012, GUID LOW COL RIV EC; Marcoe K, 2017, J COAST CONSERV, V21, P505, DOI 10.1007/s11852-017-0523-7; Mattison L., 2011, TIDE GATES OREGON ES; Mattison L., 2011, ESTUARINE LEVEES INV; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Mcleod E, 2010, OCEAN COAST MANAGE, V53, P507, DOI 10.1016/j.ocecoaman.2010.06.009; Miller AK, 2014, CONDOR, V116, P113, DOI 10.1650/CONDOR-13-003-R1.1; Montane JM, 2006, PHOTOGRAMM ENG REM S, V72, P961, DOI 10.14358/PERS.72.8.961; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; National Oceanographic and Atmospheric Administration Center for Operational Oceanographic Products and Services (NOAA/CO-OPS), 2013, 067 NOAA NOS COOPS; Neubauer S.C., 2007, TIDAL FRESHWATER WET, P253; Oregon Division of State Lands, 1989, HEADS TID COAST STRE; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Peters JJ, 1975, MODEL STUDIE VERONTR, P5; Pritchard D.W., 1967, ESTUARIES NO 83, P3; Rojstaczer SA, 1991, 91193 US GEOL SURV; San Francisco Estuary Institute (SFEI), 1998, BAY AR ECOATLAS V1 5; Savenije H. H. G., 2005, SALINITY TIDES ALLUV, DOI 10.1016/B978-0-444-52107-1.X5000-X; Schoch GC, 2006, LIMNOL OCEANOGR, V51, P2564, DOI 10.4319/lo.2006.51.6.2564; Shipman H., 2008, GEOMORPHIC CLASSIFIC; Simenstad CA, 1996, ECOL APPL, V6, P38, DOI 10.2307/2269551; Simenstad CA, 2014, P 9 EUR C EC REST 20; Simenstad CA, 201101 DEP FISH WILD; SIMPSON RL, 1983, BIOSCIENCE, V33, P255, DOI 10.2307/1309038; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stedman S.M., 2008, STATUS TRENDS WETLAN; Stralberg D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027388; Temmerman S, 2013, NATURE, V504, P79, DOI 10.1038/nature12859; THORPE JE, 1994, ESTUARIES, V17, P76, DOI 10.2307/1352336; Thorslund J, 2017, ECOL ENG, V108, P489, DOI 10.1016/j.ecoleng.2017.07.012; Trask PC and Associates, 2011, USA CORPS ENG 50 ANN; Turner JF, 2010, J ATMOS OCEAN TECH, V27, P605, DOI 10.1175/2009JTECHO645.1; Turner RE, 2004, ESTUARIES, V27, P265, DOI 10.1007/BF02803383; Whipple A.A., 2012, SAN FRANCISCO ESTUAR; Wolanski E., 2007, ESTUARINE ECOHYDROLO, V1st ed.; Yang Z, 2012, ENVIRON FLUID MECH, V12, P63, DOI 10.1007/s10652-011-9214-3; Yang ZQ, 2010, OCEAN DYNAM, V60, P1621, DOI 10.1007/s10236-010-0348-5; Zhang YL, 2008, OCEAN MODEL, V21, P71, DOI 10.1016/j.ocemod.2007.11.005; Zhu MJ, 2015, ECOL EVOL, V5, P4376, DOI 10.1002/ece3.1669	91	32	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0218558	10.1371/journal.pone.0218558	http://dx.doi.org/10.1371/journal.pone.0218558			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412030	gold, Green Published, Green Submitted			2022-12-26	WOS:000485012600011
J	Dougan, TJ; Quake, SR				Dougan, Tyler J.; Quake, Stephen R.			Viral taxonomy derived from evolutionary genome relationships	PLOS ONE			English	Article							VIRUS TAXONOMY; DATABASE; SEARCH; SEQUENCE; TREE	We describe a new genome alignment-based model for understanding the diversity of viruses based on evolutionary genetic relationships. This approach uses information theory and a physical model to determine the information shared by the genes in two genomes. Pairwise comparisons of genes from the viruses are created from alignments using NCBI BLAST, and their match scores are combined to produce a metric between genomes, which is in turn used to determine a global classification using the 5,817 viruses on RefSeq. In cases where there is no measurable alignment between any genes, the method falls back to a coarser measure of genome relationship: the mutual information of 4-mer frequency. This results in a principled model which depends only on the genome sequence, which captures many interesting relationships between viral families, and which creates clusters which correlate well with both the Baltimore and ICTV classifications. The incremental computational cost of classifying a novel virus is low and therefore newly discovered viruses can be quickly identified and classified. The model goes beyond alignment-free classifications by producing a full phylogeny similar to those constructed by virologists using qualitative features, while relying only on objective genes. These results bolster the case for mathematical models in microbiology which can characterize organisms using only their genetic material and provide an independent check for phylogenies constructed by humans, considerably faster and more cheaply than less modern approaches.	[Dougan, Tyler J.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Quake, Stephen R.] Chan Zuckerberg Biohub, Stanford, CA 94305 USA; [Dougan, Tyler J.] Harvard MIT Program Hlth Sci & Technol, Boston, MA USA	Stanford University; Stanford University; Stanford University; Harvard University	Quake, SR (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.; Quake, SR (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.; Quake, SR (corresponding author), Chan Zuckerberg Biohub, Stanford, CA 94305 USA.	quake@stanford.edu						Aiewsakun P, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0422-7; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ankerst M, 1999, SIGMOD RECORD, VOL 28, NO 2 - JUNE 1999, P49; Anwar F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-414; Bolduc B, 2017, PEERJ, V5, DOI 10.7717/peerj.3243; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Clark K, 2016, NUCLEIC ACIDS RES, V44, pD67, DOI 10.1093/nar/gkv1276; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Cover TM, 2012, ELEMENTS INFORM THEO, DOI DOI 10.1002/047174882X; De Leeuw J., 2011, MULTIDIMENSIONAL SCA; Dubinkina VB, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-015-0875-7; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Fischer S, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006182; Fix E., 1951, JOSEPH; Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Hoang T, 2015, J THEOR BIOL, V372, P135, DOI 10.1016/j.jtbi.2015.02.026; Kelser EA, 2016, MICROBES INFECT, V18, P163, DOI 10.1016/j.micinf.2015.12.003; Korf I, 2003, BLAST; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Lefkowitz EJ, 2018, NUCLEIC ACIDS RES, V46, pD708, DOI 10.1093/nar/gkx932; Mahmoudabadi G, 2018, ELIFE, V7, DOI 10.7554/eLife.31955; Mazandu GK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018607; Moreira D, 2009, NAT REV MICROBIOL, V7, P306, DOI 10.1038/nrmicro2108; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Ounit R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1419-2; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Pietila MK, 2009, MOL MICROBIOL, V72, P307, DOI 10.1111/j.1365-2958.2009.06642.x; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rohwer F, 2002, J BACTERIOL, V184, P4529, DOI 10.1128/JB.184.16.4529-4535.2002; Siddell SG, 2019, ARCH VIROL, V164, P943, DOI 10.1007/s00705-018-04136-2; Simmonds P, 2017, NAT REV MICROBIOL, V15, P161, DOI 10.1038/nrmicro.2016.177; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Yu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064328	36	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0220440	10.1371/journal.pone.0220440	http://dx.doi.org/10.1371/journal.pone.0220440			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412051	Green Published, gold, Green Submitted			2022-12-26	WOS:000485012600030
J	Hyde, J; Gorham, C; Brackney, DE; Steven, B				Hyde, Josephine; Gorham, Courtney; Brackney, Doug E.; Steven, Blaire			Antibiotic resistant bacteria and commensal fungi are common and conserved in the mosquito microbiome	PLOS ONE			English	Article							AEDES-AEGYPTI; DIPTERA-CULICIDAE; VECTOR COMPETENCE; COMMUNITIES; MODE; GENE; IDENTIFICATION; INFECTION; REVEALS; FLIES	The emerging and increasing prevalence of bacterial antibiotic resistance is a significant public health challenge. To begin to tackle this problem, it will be critical to not only understand the origins of this resistance but also document environmental reservoirs of antibiotic resistance. In this study we investigated the possibility that both colony and field caught mosquitoes could harbor antibiotic resistant bacteria. Specifically, we characterized the antibiotic resistant bacterial populations from colony-reared Aedes aegypti larvae and adults and two field caught mosquito species Coquillettidia perturbans and Ochlerotatus canadensis. The cultured bacterial populations were dominated by isolates belonging to the class Gammaproteobacteria. Among the antibiotic resistant populations, we found bacteria resistant to carbenicillin, kanamycin, and tetracycline, including bacteria resistant to a cocktail of all three antibiotics in combination. The antibiotic resistant bacteria were numerically rare, at most 5% of total cell counts. Isolates were characterized by 16S rRNA gene sequencing, and clustering into Operational Taxonomic Units (OTUs; 99% sequence identity). 27 antibiotic resistant OTUs were identified, although members of an OTU did not always share the same resistance profile. This suggests the clustering was either not sensitive enough to distinguish different bacteria taxa or different antibiotic resistant sub-populations exist within an OTU. Finally, the antibiotic selection opened up a niche to culture mosquito-associated fungi, and 10 fungal OTUs (28S rRNA gene sequencing) were identified. Two fungal OTUs both classified to the class Microbotryomycetes were commonly identified in the field-caught mosquitoes. Thus, in this study we demonstrate that antibiotic resistant bacteria and certain fungi are common and conserved mosquito microbiome members. These observations highlight the potential of invertebrates to serve as vehicles for the spread of antibiotic resistance throughout the environment.	[Hyde, Josephine; Gorham, Courtney; Brackney, Doug E.; Steven, Blaire] Connecticut Agr Expt Stn, Dept Environm Sci, New Haven, CT 06504 USA; [Brackney, Doug E.] Connecticut Agr Expt Stn, Ctr Vector Biol & Zoonot Dis, New Haven, CT 06504 USA	Connecticut Agricultural Experiment Station; Connecticut Agricultural Experiment Station	Steven, B (corresponding author), Connecticut Agr Expt Stn, Dept Environm Sci, New Haven, CT 06504 USA.	blaire.steven@ct.gov	Brackney, Doug/GWU-7912-2022; Steven, Blaire/E-5295-2012	Steven, Blaire/0000-0001-5940-2432; Hyde, Josephine/0000-0002-1640-2886	Louis A. Magnarelli Postdoc program	Louis A. Magnarelli Postdoc program	This work was funded by the Louis A. Magnarelli Postdoc program administered by the CAES Board. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-23; Alivisatos AP, 2015, SCIENCE, V350, P507, DOI 10.1126/science.aac8480; Alves TD, 2018, SCI TOTAL ENVIRON, V633, P1345, DOI 10.1016/j.scitotenv.2018.03.304; Andreadis TG, 2014, VECTOR-BORNE ZOONOT, V14, P763, DOI 10.1089/vbz.2014.1669; Apprill A, 2015, AQUAT MICROB ECOL, V75, P129, DOI 10.3354/ame01753; Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742; BUTLER K, 1970, J INFECT DIS, V122, pS1, DOI 10.1093/infdis/122.Supplement_1.S1; Chandler JA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00185; Charan SS, 2013, PARASITOL RES, V112, P2627, DOI 10.1007/s00436-013-3428-x; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Chouaia B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S2; Cirimotich CM, 2011, CELL HOST MICROBE, V10, P307, DOI 10.1016/j.chom.2011.09.006; Coon KL, 2016, MOL ECOL, V25, P5806, DOI 10.1111/mec.13877; Coon KL, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1660-9; Correa MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07014-2; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Elbers ARW, 2015, REV SCI TECH OIE, V34, P123, DOI 10.20506/rst.34.1.2349; Galal FH, 2017, ERCIYES MED J, V39, P1, DOI 10.5152/etd.2017.16067; Gillespie SH, 2001, INT J ANTIMICROB AG, V17, P171, DOI 10.1016/S0924-8579(00)00340-X; HORN BW, 1981, MYCOLOGIA, V73, P724, DOI 10.2307/3759499; Hughes GL, 2014, P NATL ACAD SCI USA, V111, P12498, DOI 10.1073/pnas.1408888111; Ignasiak K, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1133-0; Kampfer P, 2011, INT J SYST EVOL MICR, V61, P2670, DOI 10.1099/ijs.0.026393-0; Kalghatgi S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006055; Kanzok SM, 2006, TRENDS PARASITOL, V22, P49, DOI 10.1016/j.pt.2005.12.008; Kim CH, 2015, J MED ENTOMOL, V52, P63, DOI 10.1093/jme/tju011; KONNO K, 1973, AM REV RESPIR DIS, V108, P101; Lindh JM, 2005, APPL ENVIRON MICROB, V71, P7217, DOI 10.1128/AEM.71.11.7217-7223.2005; Liu KL, 2012, APPL ENVIRON MICROB, V78, P1523, DOI 10.1128/AEM.06826-11; Ludvigsen J, 2018, MICROB ECOL, V76, P588, DOI 10.1007/s00248-018-1171-7; Minard G, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-146; Mingeot-Leclercq MP, 1999, ANTIMICROB AGENTS CH, V43, P727, DOI 10.1128/AAC.43.4.727; Mnyone LL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-309; Mohammed AN, 2016, PARASITOL RES, V115, P3889, DOI 10.1007/s00436-016-5154-7; Mueller RC, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiv153; MURRAY BE, 1991, J INFECT DIS, V163, P1185, DOI 10.1093/infdis/163.6.1185; Muturi EJ, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1299-6; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Onwugamba FC, 2018, TRAVEL MED INFECT DI, V22, P8, DOI 10.1016/j.tmaid.2018.02.007; Parada AE, 2016, ENVIRON MICROBIOL, V18, P1403, DOI 10.1111/1462-2920.13023; Pereira ED, 2009, NEOTROP ENTOMOL, V38, P352, DOI 10.1590/S1519-566X2009000300009; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Ramirez JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004398; Salyers AA, 1997, ANTIMICROB AGENTS CH, V41, P2321, DOI 10.1128/AAC.41.11.2321; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Scholte EJ, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.19; Singh R, 2014, MITOCHONDRION, V16, P50, DOI 10.1016/j.mito.2013.10.005; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Walsh F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065567; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Y, 2016, MOL BIOL EVOL, V33, P2544, DOI 10.1093/molbev/msw126; Zouache K, 2011, FEMS MICROBIOL ECOL, V75, P377, DOI 10.1111/j.1574-6941.2010.01012.x; Zurek L, 2014, APPL ENVIRON MICROB, V80, P3562, DOI 10.1128/AEM.00600-14	53	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0218907	10.1371/journal.pone.0218907	http://dx.doi.org/10.1371/journal.pone.0218907			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412044	gold, Green Published, Green Submitted			2022-12-26	WOS:000485012600012
J	Maurer, M; Papotto, N; Sertel-Nakajima, J; Schueler, M; De Col, R; Mohrlen, F; Messlinger, K; Frings, S; Carr, RW				Maurer, Margot; Papotto, Nunzia; Sertel-Nakajima, Julika; Schueler, Markus; De Col, Roberto; Moehrlen, Frank; Messlinger, Karl; Frings, Stephan; Carr, Richard W.			Photoactivation of olfactory sensory neurons does not affect action potential conduction in individual trigeminal sensory axons innervating the rodent nasal cavity	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; MODULATION; RECEPTORS; NERVE; ODOR; RAT; AFFERENTS; MIGRAINE; FIBERS; STIMULATION	Olfactory and trigeminal chemosensory systems reside in parallel within the mammalian nose. Psychophysical studies in people indicate that these two systems interact at a perceptual level. Trigeminal sensations of pungency mask odour perception, while olfactory stimuli can influence trigeminal signal processing tasks such as odour localization. While imaging studies indicate overlap in limbic and cortical somatosensory areas activated by nasal trigeminal and olfactory stimuli, there is also potential cross-talk at the level of the olfactory epithelium, the olfactory bulb and trigeminal brainstem. Here we explored the influence of olfactory and trigeminal signaling in the nasal cavity. A forced choice water consumption paradigm was used to ascertain whether trigeminal and olfactory stimuli could influence behaviour in mice. Mice avoided water sources surrounded by both volatile TRPV1 (cyclohexanone) and TRPA1 (allyl isothiocyanate) irritants and the aversion to cyclohexanone was mitigated when combined with a pure odorant (rose fragrance, phenylethyl alcohol, PEA). To determine whether olfactory-trigeminal interactions within the nose could potentially account for this behavioural effect we recorded from single trigeminal sensory axons innervating the nasal respiratory and olfactory epithelium using an isolated in vitro preparation. To circumvent non-specific effects of chemical stimuli, optical stimulation was used to excite olfactory sensory neurons in mice expressing channel-rhodopsin (ChR2) under the olfactory marker protein (OMP) promoter. Photoactivation of olfactory sensory neurons produced no modulation of axonal action potential conduction in individual trigeminal axons. Similarly, no evidence was found for collateral branching of trigeminal axon that might serve as a conduit for cross-talk between the olfactory and respiratory epithelium and olfactory dura mater. Using direct assessment of action potential activity in trigeminal axons we observed neither paracrine nor axon reflex mediated cross-talk between olfactory and trigeminal sensory systems in the rodent nasal cavity. Our current results suggest that olfactory sensory neurons exert minimal influence on trigeminal signals within the nasal cavity.	[Maurer, Margot; Carr, Richard W.] Heidelberg Univ, Med Fac Mannheim, Expt Pain Res, Mannheim, Germany; [Papotto, Nunzia; Moehrlen, Frank; Frings, Stephan] Heidelberg Univ, Ctr Organismal Studies, Heidelberg, Germany; [Sertel-Nakajima, Julika; De Col, Roberto; Messlinger, Karl] Friedrich Alexander Univ Erlangen Nuremberg, Inst Physiol & Pathophysiol, Erlangen, Germany; [Schueler, Markus] Friedrich Alexander Univ Erlangen Nurnberg, Dept Nephrol & Hypertens, Erlangen, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Carr, RW (corresponding author), Heidelberg Univ, Med Fac Mannheim, Expt Pain Res, Mannheim, Germany.	richard.carr@medma.uni-heidelberg.de	Carr, Richard/GSD-4859-2022; Carr, Richard/AAE-9188-2020; Schueler, Markus/AAF-6057-2021	Carr, Richard/0000-0001-8617-9133; 	Deutsche Forschungsgemeinschaft (DFG) [SFB1158]; FP7 project EUROHEADPAIN [602633]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); FP7 project EUROHEADPAIN	This work was supported by a Deutsche Forschungsgemeinschaft (DFG) grant SFB1158-Project A04 to RWC and SF, and FP7 project EUROHEADPAIN (Grant agreement no: 602633) to KM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We are grateful to Anja Bistron, Birgit Vogler and Gabi Guenther for their reliable and proficient technical assistance. We are grateful for the facilities and assistance provided by the Interdisciplinary Behavioral Core (INBC) at Heidelberg University. This work was supported by a Deutsche Forschungsgemeinschaft (DFG) grant SFB1158-Project A04 to RWC and SF and FP7 project EUROHEADPAIN (Grant agreement no: 602633) to KM.	Agarwal N, 2004, GENESIS, V38, P122, DOI 10.1002/gene.20010; Akiyama T, 2010, J NEUROPHYSIOL, V104, P2442, DOI 10.1152/jn.00563.2010; Barrios AW, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00063; Bensafi M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00883; Bove GM, 1997, J NEUROPHYSIOL, V77, P299, DOI 10.1152/jn.1997.77.1.299; Boyle JA, 2007, CHEM SENSES, V32, P343, DOI 10.1093/chemse/bjm004; Brand G, 2006, NEUROSCI BIOBEHAV R, V30, P908, DOI 10.1016/j.neubiorev.2006.01.002; Breer H, 2006, CELL MOL LIFE SCI, V63, P1465, DOI 10.1007/s00018-006-6108-5; CAIN WS, 1980, NATURE, V284, P255, DOI 10.1038/284255a0; CAIN WS, 1977, NATURE, V268, P50, DOI 10.1038/268050a0; CHAPMAN LF, 1977, J INVEST DERMATOL, V69, P88, DOI 10.1111/1523-1747.ep12497896; COMETTOMUNIZ JE, 1990, PERCEPT PSYCHOPHYS, V47, P391, DOI 10.3758/BF03210879; Croy I, 2014, NEUROIMAGE, V98, P289, DOI 10.1016/j.neuroimage.2014.05.004; Daiber P, 2013, EUR J NEUROSCI, V37, P572, DOI 10.1111/ejn.12066; Damann N, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-46; De Col R, 2008, J PHYSIOL-LONDON, V586, P1089, DOI 10.1113/jphysiol.2007.145383; De Col Roberto, 2012, J Physiol, V590, P725, DOI 10.1113/jphysiol.2011.220624; Dhaka A, 2008, J NEUROSCI, V28, P566, DOI 10.1523/JNEUROSCI.3976-07.2008; DOTY RL, 1978, PHYSIOL BEHAV, V20, P175, DOI 10.1016/0031-9384(78)90070-7; Dunston D, 2013, JOVE-J VIS EXP, DOI 10.3791/50538; FINGER TE, 1993, J COMP NEUROL, V334, P117, DOI 10.1002/cne.903340110; FINGER TE, 1990, J COMP NEUROL, V294, P293, DOI 10.1002/cne.902940212; Frasnelli J, 2004, NEUROSCI LETT, V362, P65, DOI 10.1016/j.neulet.2004.02.059; Genovese F, 2016, EUR J NEUROSCI; Genovese F, 2016, J PHYSIOL-LONDON, V594, P3501, DOI 10.1113/JP271853; GETCHELL ML, 1992, MICROSC RES TECHNIQ, V23, P111, DOI 10.1002/jemt.1070230203; Grosmaitre X, 2007, NAT NEUROSCI, V10, P348, DOI 10.1038/nn1856; Grosser K, 2000, CEPHALALGIA, V20, P621, DOI 10.1046/j.1468-2982.2000.00094.x; Harriott AM, 2014, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-014-0458-8; HUMMEL T, 1992, ELECTROEN CLIN NEURO, V84, P192, DOI 10.1016/0168-5597(92)90025-7; Hummel T, 2002, INT ARCH OCC ENV HEA, V75, P305, DOI 10.1007/s00420-002-0315-7; Jacquot L, 2004, CR BIOL, V327, P305, DOI 10.1016/j.crvi.2004.02.004; Jacquot L, 2010, RHINOLOGY, V48, P281, DOI 10.4193/Rhino09.200; Kanageswaran N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159640; Kaske S, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-49; Kass MD, 2017, SCI REP-UK, V7, DOI 10.1038/srep45851; KOBAL G, 1989, EXPERIENTIA, V45, P130, DOI 10.1007/BF01954845; Kosaras B, 2009, J COMP NEUROL, V515, P331, DOI 10.1002/cne.22049; Levy D, 2002, J NEUROPHYSIOL, V88, P3021, DOI 10.1152/jn.00029.2002; Lin WH, 2008, J NEUROPHYSIOL, V99, P1451, DOI 10.1152/jn.01195.2007; Lucero MT, 2013, SEMIN CELL DEV BIOL, V24, P58, DOI 10.1016/j.semcdb.2012.09.001; LUCIER GE, 1989, EXP NEUROL, V103, P83, DOI 10.1016/0014-4886(89)90189-1; McCulloch PF, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00085; McCulloch PF, 1999, BRAIN RES, V830, P24, DOI 10.1016/S0006-8993(99)01374-8; Mengel MKC, 1996, PAIN, V65, P181, DOI 10.1016/0304-3959(95)00158-1; Noseda R, 2013, PAIN, V154, pS44, DOI 10.1016/j.pain.2013.07.021; Patron V, 2015, SURG RADIOL ANAT, V37, P835, DOI 10.1007/s00276-015-1471-2; Pellegrino R, 2017, NEUROSCIENCE, V363, P43, DOI 10.1016/j.neuroscience.2017.07.030; REEH PW, 1986, NEUROSCI LETT, V66, P141, DOI 10.1016/0304-3940(86)90180-1; Schaefer ML, 2002, J COMP NEUROL, V444, P221, DOI 10.1002/cne.10143; Schueler M, 2014, HEADACHE, V54, P996, DOI 10.1111/head.12371; Schueler M, 2013, PAIN, V154, P1622, DOI 10.1016/j.pain.2013.04.040; Sekizawa S, 1996, RESP PHYSIOL, V103, P211, DOI 10.1016/0034-5687(95)00091-7; SEKIZAWA S, 1994, RESP PHYSIOL, V96, P37, DOI 10.1016/0034-5687(94)90104-X; Sekizawa SI, 1996, RESP PHYSIOL, V106, P223, DOI 10.1016/S0034-5687(96)00085-0; Silver WL, 2006, CHEM SENSES, V31, P807, DOI 10.1093/chemse/bjl022; Silver WL, 2009, ANN NY ACAD SCI, V1170, P202, DOI 10.1111/j.1749-6632.2009.03894.x; SILVERMAN JD, 1989, J COMP NEUROL, V280, P303, DOI 10.1002/cne.902800211; Sjostrand C, 2010, CURR PAIN HEADACHE R, V14, P244, DOI 10.1007/s11916-010-0109-7; Smear M, 2011, NATURE, V479, P397, DOI 10.1038/nature10521; Snyder RD, 1997, CEPHALALGIA, V17, P729, DOI 10.1046/j.1468-2982.1997.1707729.x; Stuck BA, 2011, NEUROSCIENCE, V176, P442, DOI 10.1016/j.neuroscience.2011.01.009; THALHAMMER JG, 1994, SOMATOSENS MOT RES, V11, P243, DOI 10.3109/08990229409051392; Touska F, 2017, MAR DRUGS, V15, DOI 10.3390/md15090269; Tremblay C, 2018, CHEM SENSES, V43, P611, DOI 10.1093/chemse/bjy049; TUCKER DON, 1963, JOUR GEN PHYSIOL, V46, P453, DOI 10.1085/jgp.46.3.453; Wang YF, 2012, CEPHALALGIA, V32, P1180, DOI 10.1177/0333102412461401; Wesson DW, 2009, J NEUROPHYSIOL, V101, P1089, DOI 10.1152/jn.90981.2008; Whiting AC, 2015, HEADACHE, V55, P71, DOI 10.1111/head.12462	69	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0211175	10.1371/journal.pone.0211175	http://dx.doi.org/10.1371/journal.pone.0211175			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412038	Green Published, Green Submitted, gold			2022-12-26	WOS:000485012600003
J	Bezdicek, M; Nykrynova, M; Plevova, K; Brhelova, E; Kocmanova, I; Sedlar, K; Racil, Z; Mayer, J; Lengerova, M				Bezdicek, Matej; Nykrynova, Marketa; Plevova, Kristina; Brhelova, Eva; Kocmanova, Iva; Sedlar, Karel; Racil, Zdenek; Mayer, Jiri; Lengerova, Martina			Application of mini-MLST and whole genome sequencing in low diversity hospital extended-spectrum beta-lactamase producing Klebsiella pneumoniae population	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; OUTBREAK; VIRULENCE; STRAINS; STATES	Studying bacterial population diversity is important to understand healthcare associated infections' epidemiology and has a significant impact on dealing with multidrug resistant bacterial outbreaks. We characterised the extended-spectrum beta-lactamase producing K. pneumoniae (ESBLp KPN) population in our hospital using mini-MLST. Then we used whole genome sequencing (WGS) to compare selected isolates belonging to the most prevalent melting types (MelTs) and the colonization/infection pair isolates collected from one patient to study the ESBLp KPN population's genetic diversity. A total of 922 ESBLp KPN isolates collected between 7/2016 and 5/2018 were divided into 38 MelTs using mini-MLST with only 6 MelTs forming 82.8% of all isolates. For WGS, 14 isolates from the most prominent MelTs collected in the monitored period and 10 isolates belonging to the same MelTs collected in our hospital in 2014 were randomly selected. Resistome, virulome and ST were MelT specific and stable over time. A maximum of 23 SNV per core genome and 58 SNV per core and accessory genome were found. To determine the SNV relatedness cut-off values, 22 isolates representing colonization/infection pair samples obtained from 11 different patients were analysed by WGS with a maximum of 22 SNV in the core genome and 40 SNV in the core and accessory genome within pairs. The mini-MLST showed its potential for real-time epidemiology in clinical practice. However, for outbreak evaluation in a low diversity bacterial population, mini-MLST should be combined with more sensitive methods like WGS. Our findings showed there were only minimal differences within the core and accessory genome in the low diversity hospital population and gene based SNV analysis does not have enough discriminatory power to differentiate isolate relatedness. Thus, intergenic regions and mobile elements should be incorporated into the analysis scheme to increase discriminatory power.	[Bezdicek, Matej; Nykrynova, Marketa; Plevova, Kristina; Brhelova, Eva; Racil, Zdenek; Mayer, Jiri; Lengerova, Martina] Univ Hosp Brno, Dept Internal Med Hematol & Oncol, Brno, Czech Republic; [Bezdicek, Matej; Brhelova, Eva; Racil, Zdenek; Mayer, Jiri; Lengerova, Martina] Masaryk Univ, Dept Internal Med Hematol & Oncol, Brno, Czech Republic; [Nykrynova, Marketa; Sedlar, Karel] Brno Univ Technol, Dept Biomed Engn, Brno, Czech Republic; [Kocmanova, Iva] Univ Hosp Brno, Dept Clin Microbiol, Brno, Czech Republic	University Hospital Brno; Masaryk University Brno; Brno University of Technology; University Hospital Brno	Lengerova, M (corresponding author), Univ Hosp Brno, Dept Internal Med Hematol & Oncol, Brno, Czech Republic.; Lengerova, M (corresponding author), Masaryk Univ, Dept Internal Med Hematol & Oncol, Brno, Czech Republic.	Lengerva.Martina@fnbrno.cz	Lengerova, Martina/E-1038-2012; Bezdicek, Matej/AEP-0793-2022; Sedlar, Karel/K-1120-2014; Nykrynova, Marketa/R-3181-2018; Brhelova, Eva/E-1081-2012	Lengerova, Martina/0000-0001-8739-9998; Bezdicek, Matej/0000-0002-5833-8325; Sedlar, Karel/0000-0002-8269-4020; Nykrynova, Marketa/0000-0002-0205-6935; Brhelova, Eva/0000-0003-3973-9278	Ministry of Health, Czech Republic [65269705]; Masaryk University Grant Agency [MUNI/A/1105/2018]; Czech Science Foundation [GACR 17-01821S]	Ministry of Health, Czech Republic(Ministry of Health, Czech RepublicCzech Republic Government); Masaryk University Grant Agency; Czech Science Foundation(Grant Agency of the Czech Republic)	This study was supported by the Ministry of Health, Czech Republic -conceptual development of research organization (FNBr, 65269705) (MB, ML, IK, ZR, JM, KP, EB), Masaryk University Grant Agency (MUNI/A/1105/2018) (MB) and Czech Science Foundation (GACR 17-01821S) (MB, ML, MN, KS, IK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033530; Beigverdi R, 2019, J GLOB ANTIMICROB RE, V18, P12, DOI 10.1016/j.jgar.2019.01.020; Brhelova E, 2016, DIAGN MICR INFEC DIS, V86, P44, DOI 10.1016/j.diagmicrobio.2016.03.010; Cheong HS, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0151-2; Dolejska M, 2012, INT J ANTIMICROB AG, V40, P510, DOI 10.1016/j.ijantimicag.2012.07.016; Falco A, 2017, INVEST CLIN, V58, P3; Fu L, 2018, MICROB PATHOGENESIS, V116, P168, DOI 10.1016/j.micpath.2018.01.030; Gilchrist CA, 2015, CLIN MICROBIOL REV, V28, P541, DOI 10.1128/CMR.00075-13; Gorrie CL, 2018, CLIN INFECT DIS, V67, P161, DOI 10.1093/cid/ciy027; Gorrie CL, 2017, CLIN INFECT DIS, V65, P208, DOI 10.1093/cid/cix270; Ito R, 2015, J CLIN MICROBIOL, V53, P879, DOI 10.1128/JCM.03067-14; Kwong JC, 2015, PATHOLOGY, V47, P199, DOI 10.1097/PAT.0000000000000235; Leopold SR, 2014, J CLIN MICROBIOL, V52, P2365, DOI 10.1128/JCM.00262-14; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lilliebridge RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019749; Little ML, 2014, J MED MICROBIOL, V63, P610, DOI 10.1099/jmm.0.063354-0; Lopez-Camacho E, 2018, J GLOB ANTIMICROB RE, V15, P48, DOI 10.1016/j.jgar.2018.06.008; Martin RM, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00261-16; McDanel J, 2017, INFECT CONT HOSP EP, V38, P1209, DOI 10.1017/ice.2017.156; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Perez-Losada M, 2018, INFECT GENET EVOL, V63, P346, DOI 10.1016/j.meegid.2017.09.022; Quainoo S, 2017, CLIN MICROBIOL REV, V30, P1015, DOI 10.1128/CMR.00016-17; Richardson LJ, 2011, CLIN MICROBIOL INFEC, V17, P1426, DOI 10.1111/j.1469-0691.2010.03433.x; Schurch AC, 2018, CLIN MICROBIOL INFEC, V24, P350, DOI 10.1016/j.cmi.2017.12.016; Shon AS, 2013, VIRULENCE, V4, P107, DOI 10.4161/viru.22718; Tong SYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029189; Weterings V, 2015, EUR J CLIN MICROBIOL, V34, P1647, DOI 10.1007/s10096-015-2401-2; Zhang T, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmicb.2016.00005, 10.3389/fmicb.2016.01830, 10.3389/fmicb.2016.00227]; Zhou HJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00371	30	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0221187	10.1371/journal.pone.0221187	http://dx.doi.org/10.1371/journal.pone.0221187			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408497	Green Published, Green Submitted, gold			2022-12-26	WOS:000485009500047
J	Akter, R; Zhyvoloup, A; Zheng, BQ; Bhatia, SR; Raleigh, DP				Akter, Rehana; Zhyvoloup, Alexander; Zheng, Bingqian; Bhatia, Surita R.; Raleigh, Daniel P.			The triphenylmethane dye brilliant blue G is only moderately effective at inhibiting amyloid formation by human amylin or at disaggregating amylin amyloid fibrils, but interferes with amyloid assays; Implications for inhibitor design	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; THIOFLAVIN-T; BETA FIBRILS; POLYPEPTIDE; IAPP; BINDING; PEPTIDE; AGGREGATION; TOXICITY	The development of inhibitors of islet amyloid formation is important as pancreatic amyloid deposition contributes to type-2 diabetes and islet transplant failure. The Alzheimer's A beta peptide and human amylin (h-amylin), the polypeptide responsible for amyloid formation in type-2 diabetes, share common physio-chemical features and some inhibitors of A beta also inhibit amyloid formation by h-amylin and vice versa. Thus, a popular and potentially useful strategy to find lead compounds for anti-amylin amyloid agents is to examine compounds that have effects on A beta amyloid formation. The triphenylmethane dye, brilliant blue G (BBG, Sodium; 3-[[4-[(E)-[4-(4-ethoxyanilino)phenyl]-[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]-2-methylcyclohexa-2,5-dien-1-ylidene] methyl]-N-ethyl-3-methylanilino] methyl] benzenesulfonate) has been shown to modulate A beta amyloid formation and inhibit A beta induced toxicity. However, the effects of BBG on h-amylin have not been examined, although other triphenylmethane derivatives inhibit h-amylin amyloid formation. The compound has only a modest impact on h-amylin amyloid formation unless it is added in significant excess. BBG also remodels preformed h-amylin amyloid fibrils if added in excess, however BBG has no significant effect on h-amylin induced toxicity towards cultured beta-cells or cultured CHO-T cells except at high concentrations. BBG is shown to interfere with standard thioflavin-T assays of h-amylin amyloid formation and disaggregation, highlighting the difficulty of interpreting such experiments in the absence of other measurements. BBG also interferes with ANS based assays of h-amylin amyloid formation. The work highlights the differences between inhibition of A beta and h-amylin amyloid formation, illustrates the limitation of using A beta inhibitors as leads for h-amylin amyloid inhibitors, and reinforces the difficulties in interpreting dye binding assays of amyloid formation.	[Akter, Rehana; Zheng, Bingqian; Bhatia, Surita R.; Raleigh, Daniel P.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Zhyvoloup, Alexander; Raleigh, Daniel P.] UCL, Inst Struct & Mol Biol, Gower St, London, England	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of London; Birkbeck University London; University College London	Raleigh, DP (corresponding author), SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA.; Raleigh, DP (corresponding author), UCL, Inst Struct & Mol Biol, Gower St, London, England.	d.raleigh@ucl.ac.uk	Bhatia, Surita R/B-4536-2008	raleigh, daniel/0000-0003-3248-7493	Wellcome Trust [107927/Z/15/Z]; National Science Foundation [CBET-1335787]; American Chemical Society PRF grant [55729-ND9]; U.S. Department of Education GAANN Fellowship [P200A160163]; U.S. National Institutes of Health; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DESC0012704]	Wellcome Trust(Wellcome TrustEuropean Commission); National Science Foundation(National Science Foundation (NSF)); American Chemical Society PRF grant(American Chemical Society); U.S. Department of Education GAANN Fellowship(US Department of Education); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by Wellcome Trust senior investigator award 107927/Z/15/Z (https://wellcome.ac.uk/) to DPR; Support for B. Z. was provided by National Science Foundation award CBET-1335787 (http://www.nsf.org/) to SB, American Chemical Society PRF grant 55729-ND9 (https://www.acs.org/) to SB, and a U.S. Department of Education GAANN Fellowship (Award P200A160163) (https://www.ed.gov/) to BZ. The LiX beamline is part of the Advanced Beamlines for Biological Investigations using Xrays (ABBIX) project funded by the U.S. National Institutes of Health. NSLS-II is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DESC0012704 (https://www.energy.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini A, 2005, ORG LETT, V7, P693, DOI 10.1021/ol047480+; Abedini A, 2018, J CLIN INVEST, V128, P682, DOI 10.1172/JCI85210; Abedini A, 2016, ELIFE, V5, DOI 10.7554/eLife.12977; Abedini A, 2013, FEBS LETT, V587, P1119, DOI 10.1016/j.febslet.2013.01.017; Akter R, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2798269; Andreetto E, 2010, ANGEW CHEM INT EDIT, V49, P3081, DOI 10.1002/anie.200904902; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Cao P, 2013, FEBS LETT, V587, P1106, DOI 10.1016/j.febslet.2013.01.046; Cao P, 2013, CURR OPIN STRUC BIOL, V23, P82, DOI 10.1016/j.sbi.2012.11.003; Chandel TI, 2019, J MOL LIQ, V278, P553, DOI 10.1016/j.molliq.2018.12.127; Chen MS, 2013, CHEM COMMUN, V49, P1799, DOI 10.1039/c2cc33432a; Chen X, 2014, NEUROSCIENCE, V279, P94, DOI 10.1016/j.neuroscience.2014.08.036; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cooper GJS, 2010, DIABETOLOGIA, V53, P1011, DOI 10.1007/s00125-010-1715-y; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; Dubey R, 2019, BIOCHEM J, V476, P889, DOI 10.1042/BCJ20180820; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Gong GH, 2019, J BIOL INORG CHEM, V24, P179, DOI 10.1007/s00775-019-01637-6; Hammouda B, 2004, MACROMOLECULES, V37, P6932, DOI 10.1021/ma049623d; Haney CM, 2017, BIOCHEMISTRY-US, V56, P683, DOI 10.1021/acs.biochem.6b01060; HOBBS JR, 1963, J PATHOL BACTERIOL, V86, P437, DOI 10.1002/path.1700860218; Irwin JA, 2013, BIOMACROMOLECULES, V14, P264, DOI 10.1021/bm3016994; Jana MK, 2016, ACS CHEM NEUROSCI, V7, P1141, DOI 10.1021/acschemneuro.6b00108; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Marek P, 2010, ORG LETT, V12, P4848, DOI 10.1021/ol101981b; Meng FL, 2011, J MOL BIOL, V406, P491, DOI 10.1016/j.jmb.2010.12.028; Meng FL, 2010, BIOCHEMISTRY-US, V49, P8127, DOI 10.1021/bi100939a; Meng FL, 2010, J MOL BIOL, V400, P555, DOI 10.1016/j.jmb.2010.05.001; Miklossy J, 2010, NEUROBIOL AGING, V31, P1503, DOI 10.1016/j.neurobiolaging.2008.08.019; Montane J, 2012, DIABETES OBES METAB, V14, P68, DOI 10.1111/j.1463-1326.2012.01657.x; Ninomiya T, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0487-z; Noor H, 2012, PROTEIN SCI, V21, P373, DOI 10.1002/pro.2023; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; Oskarsson ME, 2015, AM J PATHOL, V185, P834, DOI 10.1016/j.ajpath.2014.11.016; Potter KJ, 2010, P NATL ACAD SCI USA, V107, P4305, DOI 10.1073/pnas.0909024107; Pujols J, 2018, P NATL ACAD SCI USA, V115, P10481, DOI 10.1073/pnas.1804198115; Qiu WQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088063; Quittot N, 2018, BIOCONJUGATE CHEM, V29, P517, DOI 10.1021/acs.bioconjchem.7b00827; Sulatskaya AI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015385; Westermark GT, 2008, NEW ENGL J MED, V359, P977, DOI 10.1056/NEJMc0802893; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Wong HE, 2011, ACS CHEM NEUROSCI, V2, P645, DOI 10.1021/cn200056g; Wu C, 2009, J MOL BIOL, V394, P627, DOI 10.1016/j.jmb.2009.09.056; Wu C, 2008, J MOL BIOL, V384, P718, DOI 10.1016/j.jmb.2008.09.062; Yan LM, 2013, ANGEW CHEM INT EDIT, V52, P10378, DOI 10.1002/anie.201302840; Yang L, 2013, J SYNCHROTRON RADIAT, V20, P211, DOI 10.1107/S0909049512048984; Yang Y, 2013, NEUROSCIENCE, V250, P140, DOI 10.1016/j.neuroscience.2013.07.009	52	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0219130	10.1371/journal.pone.0219130	http://dx.doi.org/10.1371/journal.pone.0219130			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404073	Green Published, gold, Green Submitted			2022-12-26	WOS:000485006800007
J	Xiong, JS; Zhao, P; Yang, PF; Yan, QL; Jiang, LF				Xiong, Jiasheng; Zhao, Ping; Yang, Pengfei; Yan, Qingli; Jiang, Lufang			Evolutionary dynamics of the H7N9 avian influenza virus based on large-scale sequence analysis	PLOS ONE			English	Article							HEMAGGLUTININ GENE; POSITIVE SELECTION; HUMAN INFECTION; ORIGIN; SITES; H5N1; PATHOGENICITY; EPIDEMIOLOGY; SUBSTITUTION; VIRULENCE	Since 2013, epidemics caused by novel H7N9 avian influenza A viruses (AIVs) have become a considerable public health issue. This study investigated the evolution of these viruses at the population level. Compared to H7 and N9 before 2013, there were 18 and 24 substitutions in the majority of novel H7N9 AIVs, respectively. Nine of these in HA and six in NA were rare before 2013, and four of these in HA and two in NA displayed host tropism. S136(128) N and A143(135) V are located on the receptor binding sites of the HA1 subunit and might be important factors in determining the host species of novel H7N9 AIV. On an overall scale, the evolution of H7 and N9, both in terms of time distribution and host species, is under negative selection. However, both in HA and NA, several sites were under positive selection. In both the overall epidemics and the human-derived H7N9 AIVs, eight positive selection sites were identified in HA1, with some located within the known antigen epitopes or the receptor binding site(RBS) domain. This may induce variations in H7N9 AIV with positive selection. It is necessary to strengthen the surveillance of novel H7N9 AIVs, both in human and bird population to determine whether a new virus has emerged through selection pressure and to prevent future epidemics from occurring.	[Xiong, Jiasheng] Shandong Univ Weihai, Coll Marine Sci, Weihai, Peoples R China; [Zhao, Ping; Jiang, Lufang] Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai, Peoples R China; [Zhao, Ping; Jiang, Lufang] Minist Educ, Key Lab Publ Hlth Safety, Shanghai, Peoples R China; [Yang, Pengfei; Yan, Qingli] Huaian Ctr Dis Control & Prevent, Huaian, Peoples R China	Shandong University; Fudan University	Jiang, LF (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai, Peoples R China.; Jiang, LF (corresponding author), Minist Educ, Key Lab Publ Hlth Safety, Shanghai, Peoples R China.	jianglufang@fudan.edu.cn		Xiong, Jiasheng/0000-0002-3335-5364	National Natural Science Foundation of China [81872673]; National Key Research and Development Program of China [2017YFC1200203]; Original Research Support Project of Fudan University [IDF201011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Original Research Support Project of Fudan University	This research was funded by the National Natural Science Foundation of China (grant No. 81872673), the National Key Research and Development Program of China (grant No. 2017YFC1200203), the Original Research Support Project of Fudan University (grant No. IDF201011) to LJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bangaru S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04704-9; Bertoni M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09654-8; Bush RM, 1999, MOL BIOL EVOL, V16, P1457, DOI 10.1093/oxfordjournals.molbev.a026057; Fang SS, 2016, ARCH VIROL, V161, P2117, DOI 10.1007/s00705-016-2872-1; Furuse Y, 2010, VIROLOGY, V405, P314, DOI 10.1016/j.virol.2010.06.018; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; Gubareva LV, 2001, ANTIMICROB AGENTS CH, V45, P3403, DOI 10.1128/AAC.45.12.3403-3408.2001; Hu J, 2019, ARCH VIROL, V164, P807, DOI 10.1007/s00705-018-04142-4; Huang KYA, 2019, NAT MICROBIOL, V4, P306, DOI 10.1038/s41564-018-0303-7; Lan Yu, 2013, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V27, P177; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Liu Q, 2013, MICROBES INFECT, V15, P432, DOI 10.1016/j.micinf.2013.04.004; Lu J, 2018, EMERG INFECT DIS, V24, P1795, DOI 10.3201/eid2410.171063; Ma W, 2009, ZOONOSES PUBLIC HLTH, V56, P326, DOI 10.1111/j.1863-2378.2008.01217.x; Munoz ET, 2005, VACCINE, V23, P1144, DOI 10.1016/j.vaccine.2004.08.028; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Neumann G, 2006, EMERG INFECT DIS, V12, P881, DOI 10.3201/eid1206.051336; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Oshansky CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021183; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Pu ZQ, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00414; Qi X, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4752; Qin JR, 2019, VIROL J, V16, DOI 10.1186/s12985-018-1109-1; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; Schrauwen EJA, 2014, EUR J CLIN MICROBIOL, V33, P479, DOI 10.1007/s10096-013-1984-8; Schrauwen EJA, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.9; Senne DA, 1996, AVIAN DIS, V40, P425, DOI 10.2307/1592241; SKEHEL JJ, 1984, P NATL ACAD SCI-BIOL, V81, P1779, DOI 10.1073/pnas.81.6.1779; Su S, 2017, TRENDS MICROBIOL, V25, P713, DOI 10.1016/j.tim.2017.06.008; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Wang WB, 2014, J CLIN VIROL, V60, P305, DOI 10.1016/j.jcv.2014.04.006; Wang XL, 2017, LANCET INFECT DIS, V17, P822, DOI [10.1016/s1473-3099(17)30323-7, 10.1016/S1473-3099(17)30323-7]; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Webby RJ, 2017, LANCET INFECT DIS, V17, P783, DOI 10.1016/S1473-3099(17)30337-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wei KF, 2012, VIRUS GENES, V44, P450, DOI 10.1007/s11262-012-0717-x; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Wu Y, 2013, CELL RES, V23, P1347, DOI 10.1038/cr.2013.144; Xiang D, 2018, J INFECT DIS, V217, P1699, DOI 10.1093/infdis/jiy082; Xu Hui-lin, 2006, Fudan Xuebao (Yixueban), V33, P642; Yang H, 2012, J VIROL, V86, P8645, DOI 10.1128/JVI.00281-12; Zeng XY, 2018, SCI CHINA LIFE SCI, V61, P1465, DOI 10.1007/s11427-018-9420-1; Zhang Wen-tong, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P843	48	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220249	10.1371/journal.pone.0220249	http://dx.doi.org/10.1371/journal.pone.0220249			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404069	Green Published, Green Submitted, gold			2022-12-26	WOS:000485006800010
J	Semeniak, D; Faber, K; Oftering, P; Manukjan, G; Schulze, H				Semeniak, Daniela; Faber, Kristina; Oftering, Patricia; Manukjan, Georgi; Schulze, Harald			Impact of Itga2-Gp6-double collagen receptor deficient mice for bone marrow megakaryocytes and platelets	PLOS ONE			English	Article							GLYCOPROTEIN-VI; INTRACELLULAR CALCIUM; PROPLATELET FORMATION; MOUSE MEGAKARYOCYTES; INTEGRIN; GPVI; ALPHA(2)BETA(1); ADHESION; SYK; THROMBOPOIESIS	The two main collagen receptors on platelets, GPVI and integrin alpha 2 beta 1, play an important role for the recognition of exposed collagen at sites of vessel injury, which leads to platelet activation and subsequently stable thrombus formation. Both receptors are already expressed on megakaryocytes, the platelet forming cells within the bone marrow. Megakaryocytes are in permanent contact with collagen filaments in the marrow cavity and at the basal lamina of sinusoids without obvious preactivation. The role of both collagen receptors for megakaryocyte maturation and thrombopoiesis is still poorly understood. To investigate the function of both collagen receptors, we generated mice that are double deficient for Gp6 and Itga2. Flow cytometric analyses revealed that the deficiency of both receptors had no impact on platelet number and led to the expected lack in GPVI responsiveness. Integrin activation and degranulation ability was comparable to wildtype mice. By immunofluorescence microscopy, we could demonstrate that both wildtype and double-deficient megakaryocytes were overall normally distributed within the bone marrow. We found megakaryocyte count and size to be normal, the localization within the bone marrow, the degree of maturation, as well as their association to sinusoids were also unaltered. However, the contact of megakaryocytes to collagen type I filaments was decreased at sinusoids compared to wild-type mice, while the interaction to type IV collagen was unaffected. Our results imply that GPVI and alpha 2 beta 1 have no influence on the localization of megakaryocytes within the bone marrow, their association to the sinusoids or their maturation. The decreased contact of megakaryocytes to collagen type I might at least partially explain the unaltered platelet phenotype in these mice, since proplatelet formation is mediated by these receptors and their interaction to collagen. It is rather likely that other compensatory signaling pathways and receptors play a role that needs to be elucidated.	[Semeniak, Daniela; Faber, Kristina; Oftering, Patricia; Manukjan, Georgi; Schulze, Harald] Univ Hosp Wurzburg, Dept Expt Biomed, Chair 1, Wurzburg, Germany	University of Wurzburg	Schulze, H (corresponding author), Univ Hosp Wurzburg, Dept Expt Biomed, Chair 1, Wurzburg, Germany.	harald.schulze@uni-wuerzburg.de		Schulze, Harald/0000-0003-1285-6407; Oftering, Patricia/0000-0002-0967-0049	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [374031971 - TRR 240]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	The study was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - Projektnummer 374031971 - TRR 240 to HS. (https://www.dfg.de) The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbonante V, 2013, J BIOL CHEM, V288, P16738, DOI 10.1074/jbc.M112.431528; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Bender M, 2011, J THROMB HAEMOST, V9, P1423, DOI 10.1111/j.1538-7836.2011.04328.x; Briddon SJ, 1999, BLOOD, V93, P3847, DOI 10.1182/blood.V93.11.3847.411k17_3847_3855; Chen JC, 2002, AM J PATHOL, V161, P337, DOI 10.1016/S0002-9440(10)64185-5; Dutting S, 2012, TRENDS PHARMACOL SCI, V33, P583, DOI 10.1016/j.tips.2012.07.004; Eckly A, 2012, METHODS MOL BIOL, V788, P175, DOI 10.1007/978-1-61779-307-3_13; Gruner S, 2004, CIRCULATION, V110, P2946, DOI 10.1161/01.CIR.0000146341.63677.3C; Gruner S, 2003, BLOOD, V102, P4021, DOI 10.1182/blood-2003-05-1391; Gupta S, 2018, BLOOD, V131, P1106, DOI 10.1182/blood-2017-08-800136; Habart D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055094; He L, 2003, BLOOD, V102, P3652, DOI 10.1182/blood-2003-04-1323; Holtkotter O, 2002, J BIOL CHEM, V277, P10789, DOI 10.1074/jbc.M112307200; Italiano JE, 1999, J CELL BIOL, V147, P1299, DOI 10.1083/jcb.147.6.1299; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Kunicki TJ, 2012, CURR OPIN HEMATOL, V19, P371, DOI 10.1097/MOH.0b013e3283567526; Kunicki TJ, 2012, ARTERIOSCL THROM VAS, V32, P147, DOI 10.1161/ATVBAHA.111.239392; Kunicki TJ, 2010, BLOOD, V116, P2627, DOI 10.1182/blood-2010-04-262048; Malara A, 2014, STEM CELLS, V32, P926, DOI 10.1002/stem.1626; Marjoram RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114035; Mazharian A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002936; Melford SK, 1997, J BIOL CHEM, V272, P27539, DOI 10.1074/jbc.272.44.27539; Meyaard L, 2008, J LEUKOCYTE BIOL, V83, P799, DOI 10.1189/jlb.0907609; Moog S, 2001, BLOOD, V98, P1038, DOI 10.1182/blood.V98.4.1038; Munzer P, 2017, BLOOD, V130, P2774, DOI 10.1182/blood-2017-05-784413; Nagy Z, 2019, BLOOD, V133, P331, DOI 10.1182/blood-2018-09-877787; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Sabri S, 2006, BLOOD, V108, P134, DOI 10.1182/blood-2005-03-1219; Sarratt KL, 2005, BLOOD, V106, P1268, DOI 10.1182/blood-2004-11-4434; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schulze H, 2018, RES PRACT THROMB HAE, V2, P461, DOI 10.1002/rth2.12112; Semeniak D, 2016, J CELL SCI, V129, P3473, DOI 10.1242/jcs.187971; Shivdasani R, 2005, CURRENT PROTOCOLS IM; Smith CW, 2017, ARTERIOSCL THROM VAS, V37, P823, DOI 10.1161/ATVBAHA.117.309253; Spindler M, 2018, BLOOD, V132, P635, DOI 10.1182/blood-2018-01-829259; Steevels TAM, 2010, HAEMATOL-HEMATOL J, V95, P2005, DOI 10.3324/haematol.2010.026120; Stegner D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00201-7; Strassel C, 2012, EXP CELL RES, V318, P25, DOI 10.1016/j.yexcr.2011.10.003; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Tomlinson MG, 2007, J THROMB HAEMOST, V5, P2274, DOI 10.1111/j.1538-7836.2007.02746.x; Xue JN, 2011, BIOCHEM BIOPH RES CO, V405, P128, DOI 10.1016/j.bbrc.2010.12.140; Zeltz C, 2016, J CELL SCI, V129, P653, DOI 10.1242/jcs.180992	43	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0216839	10.1371/journal.pone.0216839	http://dx.doi.org/10.1371/journal.pone.0216839			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398205	gold, Green Submitted, Green Published			2022-12-26	WOS:000485004000003
J	Woo, HG; Chang, Y; Ryu, DR; Song, TJ				Woo, Ho Geol; Chang, Yoonkyung; Ryu, Dong-Ryeol; Song, Tae-Jin			Plasma Klotho concentration is associated with the presence, burden and progression of cerebral small vessel disease in patients with acute ischaemic stroke	PLOS ONE			English	Article							DIETARY GLYCEMIC LOAD; ENDOTHELIAL DYSFUNCTION; OXIDATIVE STRESS; MORTALITY; SEVERITY; MICROBLEEDS; PROTECTS; SUBTYPE; MRI	Klotho is a soluble or membrane-bound anti-aging protein, whose protective actions are important for a prudential function of many organs. Because Klotho and cerebral small vessel disease (SVD) are associated with ageing process and endothelial dysfunction, it is possible that Klotho has an association with cerebral SVD. We aimed to investigate the association of plasma Klotho concentration with the presence, burden and progression of cerebral SVD. We prospectively enrolled 262 patients with first-ever acute cerebral infarction, performed brain MRI and collected their blood samples within 24 hours of admission. An enzyme-linked immunosorbent assay was used for evaluating plasma Klotho concentration. We estimated the total SVD score of each patient after determining the presence and burden of high-grade white matter hyperintensities (HWMHs), cerebral microbleeds (CMBs), high-grade perivascular spaces (HPVSs) and asymptomatic lacunar infarctions (ALls). Univariate and multivariate analyses were conducted to investigate association of Klotho with cerebral SVD and the total SVD score. Of the 262 patients, 152 (58.0%) were men. The mean age of these patients was 64.7 years. The mean standard deviation of plasma Klotho concentration was 329.8 194.1 pg/mL. In multivariate analysis, plasma Klotho concentration was negatively associated with the presence of HWMHs [Odds ratio (OR): 0.13, p = 0.047], HPVSs (OR: 0.22, p = 0.024) and ALIs (OR: 0.53, p = 0.021) but not associated with the presence of CMBs (OR: 0.39, p = 0.404). Plasma Klotho concentration was also negatively related to the total SVD score (unstandardized coefficients beta: -0.895, standard error = 0.317, p = 0.005, R-2 = 0.239). Furthermore, plasma Klotho concentration was negatively related to the presence (OR: 0.75, 95% CI: 0.59-0.96, p = 0.025) and severity of cerebral SVD progression (OR: 0.72, 95% CI: 0.56-0.92, p = 0.009). In conclusion, plasma Klotho concentration was negatively associated with the presence, burden and progression of cerebral SVD.	[Woo, Ho Geol] Ewha Womans Univ, Coll Med, Seoul Hosp, Dept Neurol, Seoul, South Korea; [Chang, Yoonkyung; Song, Tae-Jin] Ewha Womans Univ, Coll Med, Dept Neurol, Mokdong Hosp, Seoul, South Korea; [Ryu, Dong-Ryeol] Ewha Womans Univ, Coll Med, Dept Nephrol, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Ewha Womans University	Song, TJ (corresponding author), Ewha Womans Univ, Coll Med, Dept Neurol, Mokdong Hosp, Seoul, South Korea.	knstar@ewha.ac.kr	Woo, Ho Geol/ABF-1206-2020; Woo, Ho Geol/AAX-4094-2021	Woo, Ho Geol/0000-0001-6489-0100; Chang, Yoonkyung/0000-0002-0345-2278	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education [2018R1D1A1B07040959]; Ewha Womans University	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education; Ewha Womans University	This project was supported by grant from the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (2018R1D1A1B07040959 to T-JS). This work was supported by the Ewha Womans University Research Grant of 2018 to T-JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Brombo G, 2018, GERONTOLOGY, V64, P414, DOI 10.1159/000488318; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chang Y, 2018, J CLIN NEUROL, V14, P555, DOI 10.3988/jcn.2018.14.4.555; Chang Y, 2018, AM J HYPERTENS, V31, P35, DOI 10.1093/ajh/hpx126; Chen CD, 2015, J MOL NEUROSCI, V55, P76, DOI 10.1007/s12031-014-0336-1; Cuadrado-Godia E, 2018, J STROKE, V20, P302, DOI 10.5853/jos.2017.02922; Doubal FN, 2010, STROKE, V41, P450, DOI 10.1161/STROKEAHA.109.564914; Drueke TB, 2013, KIDNEY INT, V83, P13, DOI 10.1038/ki.2012.370; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Grochowski C, 2018, FREE RADICAL RES, V52, P1, DOI 10.1080/10715762.2017.1402304; Kalaria Raj N, 2006, J Clin Neurol, V2, P1, DOI 10.3988/jcn.2006.2.1.1; Kim BJ, 2013, J STROKE, V15, P153, DOI 10.5853/jos.2013.15.3.153; Kitagawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056695; Kuriyama N, 2018, J ALZHEIMERS DIS, V61, P145, DOI 10.3233/JAD-170466; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Maekawa Y, 2009, ENDOCRINE, V35, P341, DOI 10.1007/s12020-009-9181-3; Marcais C, 2017, J CLIN ENDOCR METAB, V102, P3154, DOI 10.1210/jc.2017-00104; Nagai R, 2000, CELL MOL LIFE SCI, V57, P738, DOI 10.1007/s000180050038; Navarro-Gonzalez JF, 2014, HEART, V100, P34, DOI 10.1136/heartjnl-2013-304746; Nezu T, 2015, HYPERTENS RES, V38, P291, DOI 10.1038/hr.2015.4; Oh HJ, 2015, PERITON DIALYSIS INT, V35, P43, DOI 10.3747/pdi.2013.00150; Pan HC, 2018, ATHEROSCLEROSIS, V276, P83, DOI 10.1016/j.atherosclerosis.2018.07.006; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Poggesi A, 2016, J CEREBR BLOOD F MET, V36, P72, DOI 10.1038/jcbfm.2015.116; Rakugi H, 2007, ENDOCRINE, V31, P82, DOI 10.1007/s12020-007-0016-9; Saito Y, 2000, BIOCHEM BIOPH RES CO, V276, P767, DOI 10.1006/bbrc.2000.3470; Saito Y, 1998, BIOCHEM BIOPH RES CO, V248, P324, DOI 10.1006/bbrc.1998.8943; Semba RD, 2011, J AM GERIATR SOC, V59, P1596, DOI 10.1111/j.1532-5415.2011.03558.x; Song TJ, 2014, EUR J NEUROL, V21, P463, DOI 10.1111/ene.12332; Song TJ, 2014, NEUROLOGY, V83, P1308, DOI 10.1212/WNL.0000000000000862; Song TJ, 2018, NUTR RES, V51, P93, DOI 10.1016/j.nutres.2017.12.009; Song TJ, 2018, J CLIN NEUROL, V14, P165, DOI 10.3988/jcn.2018.14.2.165; Song TJ, 2017, J CLIN NEUROL, V13, P187, DOI 10.3988/jcn.2017.13.2.187; Song TJ, 2016, J STROKE, V18, P312, DOI 10.5853/jos.2016.00171; Song TJ, 2014, THROMB HAEMOSTASIS, V112, P1312, DOI 10.1160/TH14-02-0176; Song TJ, 2012, BIOMARKERS, V17, P738, DOI 10.3109/1354750X.2012.727027; Staals J, 2014, NEUROLOGY, V83, P1228, DOI 10.1212/WNL.0000000000000837; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Wei K, 2016, J NEPHROL, V29, P349, DOI 10.1007/s40620-016-0284-7; Witkowski JM, 2007, J IMMUNOL, V178, P771, DOI 10.4049/jimmunol.178.2.771; Yamazaki Y, 2010, BIOCHEM BIOPH RES CO, V398, P513, DOI 10.1016/j.bbrc.2010.06.110	43	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220796	10.1371/journal.pone.0220796	http://dx.doi.org/10.1371/journal.pone.0220796			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398214	Green Submitted, Green Published, gold			2022-12-26	WOS:000485004000021
J	Guo, J; Xiao, Y; Iyer, R; Lu, X; Lake, M; Ladror, U; Harlan, J; Samanta, T; Tomlinson, M; Bukofzer, G; Donawho, C; Shoemaker, A; Huang, TH				Guo, Jun; Xiao, Yu; Iyer, Ramesh; Lu, Xin; Lake, Marc; Ladror, Uri; Harlan, John; Samanta, Tanushree; Tomlinson, Medha; Bukofzer, Gail; Donawho, Cherrie; Shoemaker, Alex; Huang, Tzu-Hsuan			Empowering therapeutic antibodies with IFN-alpha for cancer immunotherapy	PLOS ONE			English	Article							INTERFERON-ALPHA	Type 1 IFNs stimulate secretion of IP-10 (CXCL10) which is a critical chemokine to recruit effector T cells to the tumor microenvironment and IP-10 knockout mice exhibit a phenotype with compromised effector T cell generation and trafficking. Type 1 IFNs also induce MHC class 1 upregulation on tumor cells which can enhance anti-tumor CD8 T cell effector response in the tumor microenvironment. Although type 1 IFNs show great promise in potentiating anti-tumor immune response, systemic delivery of type 1 IFNs is associated with toxicity thereby limiting clinical application. In this study, we fused tumor targeting antibodies with IFN-alpha and showed that the fusion proteins can be produced with high yields and purity. IFN fusions selectively induced IP-10 secretion from antigen positive tumor cells, which was critical in recruiting the effector T cells to the tumor microenvironment. Further, we found that treatment with the anti-PDL1-IFN-alpha fusion at concentrations as low as 1 pM exhibited potent activity in mediating OT1 CD8(+) T cell killing against OVA expressing tumor cells, while control IFN fusion did not exhibit any activity at the same concentration. Furthermore, the IFN-alpha fusion antibody was well tolerated in vivo and demonstrated anti-tumor efficacy in an anti-PD-L1 resistant syngeneic mouse tumor model. One of the potential mechanisms for the enhanced CD8 T cell killing by anti-PD-L1 IFN fusion was up-regulation of MHC class I/tumor antigen complex. Our data supports the hypothesis of targeting type 1 IFN to the tumor microenvironment may enhance effector T cell functions for anti-tumor immune response.	[Guo, Jun; Xiao, Yu; Samanta, Tanushree; Bukofzer, Gail; Donawho, Cherrie; Shoemaker, Alex; Huang, Tzu-Hsuan] AbbVie Inc, Oncol Discovery, N Chicago, IL 60064 USA; [Iyer, Ramesh; Lake, Marc; Ladror, Uri; Harlan, John] AbbVie Inc, Global Prot Sci, N Chicago, IL USA; [Lu, Xin] AbbVie Inc, Genom Res Ctr, N Chicago, IL USA; [Tomlinson, Medha] AbbVie Biores Ctr, Global Biol, Worcester, MA USA	AbbVie; AbbVie; AbbVie; AbbVie	Huang, TH (corresponding author), AbbVie Inc, Oncol Discovery, N Chicago, IL 60064 USA.	leon.huang@abbvie.com			AbbVie	AbbVie(AbbVie)	JG, YX, RI, XL, ML, UL, JH, TS, GB, AS, and TH are employees of AbbVie. MT & CD were AbbVie employees at the time of the study. The specific roles of these authors are articulated in the ` author contributions' section. The design, study conduct, and financial support for this research were provided by AbbVie. AbbVie participated in the interpretation of data, review, and approval of the publication.	Bazhin AV, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02129; Deng LF, 2014, IMMUNITY, V41, P843, DOI 10.1016/j.immuni.2014.10.019; Dong YN, 2017, ONCOTARGET, V8, P2171, DOI 10.18632/oncotarget.13895; Farrar JD, 2000, NAT IMMUNOL, V1, P65, DOI 10.1038/76932; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Guo J, 2018, CANCER RES, V78, DOI 10.1158/1538-7445.AM2018-2783; Huang TH, 2007, J IMMUNOL, V179, P6881, DOI 10.4049/jimmunol.179.10.6881; Jennings RN, 2014, J VIROL, V88, P14040, DOI 10.1128/JVI.02360-14; Knudson KM, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1426519; Kwok G, 2016, HUM VACC IMMUNOTHER, V12, P2777, DOI 10.1080/21645515.2016.1199310; Liang Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06890-y; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Noman MZ, 2014, J EXP MED, V211, P781, DOI 10.1084/jem.20131916; Papageorgiou A, 2007, CANCER BIOL THER, V6, P872, DOI 10.4161/cbt.6.6.4088; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Schiavoni G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00483; Sistigu A, 2014, NAT MED, V20, P1301, DOI 10.1038/nm.3708; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Woo SR, 2015, TRENDS IMMUNOL, V36, P250, DOI 10.1016/j.it.2015.02.003; Xuan CY, 2010, BLOOD, V115, P2864, DOI 10.1182/blood-2009-10-250555; Yang XM, 2014, CANCER CELL, V25, P37, DOI 10.1016/j.ccr.2013.12.004; Zhang HC, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0397-y; Zhang L, 2017, EXP HEMATOL ONCOL, V6, DOI 10.1186/s40164-017-0081-6; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118	24	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0219829	10.1371/journal.pone.0219829	http://dx.doi.org/10.1371/journal.pone.0219829			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393905	Green Submitted, gold, Green Published			2022-12-26	WOS:000485002500018
J	Ugolino, J; Dziki, KM; Kim, A; Wu, JJ; Vogel, BE; Monteiro, MJ				Ugolino, Janet; Dziki, Kristina M.; Kim, Annette; Wu, Josephine J.; Vogel, Bruce E.; Monteiro, Mervyn J.			Overexpression of human Atp13a2(Isoform-1) protein protects cells against manganese and starvation-induced toxicity	PLOS ONE			English	Article							P-TYPE ATPASE; INCLUSION-BODY FORMATION; ALPHA-SYNUCLEIN; HEREDITARY PARKINSONISM; CAENORHABDITIS-ELEGANS; LYSOSOMAL DYSFUNCTION; ATP13A2; AUTOPHAGY; IDENTIFICATION; DEFICIENCY	Mutations in ATP13A2 cause Kufor-Rakeb syndrome (KRS), a juvenile form of Parkinson's disease (PD) with dementia. However, the mechanisms by which mutations in ATP13A2 cause KRS is not understood. The mutations lead to misfolding of the translated Atp13a2 protein and its premature degradation in the endoplasmic reticulum, never reaching the lysosome where the protein is thought to function. Atp13a2 is a P-type ATPase, a class of proteins that function in ion transport. Indeed, studies of human, mouse, and yeast Atp13a2 proteins suggest a possible involvement in regulation of heavy metal toxicity. Here we report on the cytoprotective function of Atp13a2 on HeLa cells and dopamine neurons of Caenorhabditis elegans (C. elegans). HeLa cells stably overexpressing V5-tagged Atp13a2(Isoform-1) protein were more resistant to elevated manganese exposure and to starvation-induced cell death compared to cells not overexpressing the protein. Because PD is characterized by loss of dopamine neurons, we generated transgenic C. elegans expressing GFP-tagged human Atp13a2 protein in dopamine neurons. The transgenic animals exhibited higher resistance to dopamine neuron degeneration after acute exposure to manganese compared to nematodes that expressed GFP alone. The results suggest Atp13a2(Isoform-1) protein confers cytoprotection against toxic insults, including those that cause PD syndromes.	[Ugolino, Janet] Univ Maryland, Sch Med, Biochem & Mol Biol Grad Program, Baltimore, MD 21201 USA; [Ugolino, Janet; Dziki, Kristina M.; Kim, Annette; Wu, Josephine J.; Vogel, Bruce E.; Monteiro, Mervyn J.] Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; [Ugolino, Janet; Monteiro, Mervyn J.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Ugolino, Janet] Roanoke Coll, Dept Biol, Salem, VA 24153 USA; [Dziki, Kristina M.] Johns Hopkins Appl Phys Lab, Laurel, MD USA; [Kim, Annette] Virginia Commonwealth Univ, Richmond, VA USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Virginia Commonwealth University	Monteiro, MJ (corresponding author), Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA.; Monteiro, MJ (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	monteiro@som.umaryland.edu		Wu, Josephine/0000-0001-8740-7716; Monteiro, Mervyn/0000-0002-1740-5309	NIH [R01NS100008, R21NS095135]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS100008, R21NS095135] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was funded in part by grant to MJM by NIH R01NS100008 and NIH R21NS095135.	Benedetto A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001084; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Billingsley KJ, 2018, CELL TISSUE RES, V373, P9, DOI 10.1007/s00441-018-2817-y; Chesi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034178; Cho JH, 2005, FEBS LETT, V579, P778, DOI 10.1016/j.febslet.2004.12.032; Criswell SR, 2011, NEUROLOGY, V76, P1296, DOI 10.1212/WNL.0b013e3182152830; Dehay B, 2012, P NATL ACAD SCI USA, V109, P9611, DOI 10.1073/pnas.1112368109; Demirsoy S, 2017, HUM MOL GENET, V26, P1656, DOI 10.1093/hmg/ddx070; Deng H, 2018, AGEING RES REV, V42, P72, DOI 10.1016/j.arr.2017.12.007; Dobson AW, 2004, ANN NY ACAD SCI, V1012, P115, DOI 10.1196/annals.1306.009; Fleming SM, 2018, NEUROTOXICOLOGY, V64, P256, DOI 10.1016/j.neuro.2017.06.005; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Gusdon AM, 2012, NEUROBIOL DIS, V45, P962, DOI 10.1016/j.nbd.2011.12.015; Hamamichi S, 2008, P NATL ACAD SCI USA, V105, P728, DOI 10.1073/pnas.0711018105; Janicki S, 1997, J CELL BIOL, V139, P485, DOI 10.1083/jcb.139.2.485; Kett LR, 2015, J NEUROSCI, V35, P5724, DOI 10.1523/JNEUROSCI.0632-14.2015; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kong SMY, 2014, HUM MOL GENET, V23, P2816, DOI 10.1093/hmg/ddu099; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lie PPY, 2019, NEUROBIOL DIS, V122, P94, DOI 10.1016/j.nbd.2018.05.015; Matsui H, 2013, FEBS LETT, V587, P1316, DOI 10.1016/j.febslet.2013.02.046; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Monteiro MJ, 1996, EXP CELL RES, V223, P443, DOI 10.1006/excr.1996.0100; Mukhopadhyay S, 2011, P NATL ACAD SCI USA, V108, P858, DOI 10.1073/pnas.1013642108; Nass R, 2002, P NATL ACAD SCI USA, V99, P3264, DOI 10.1073/pnas.042497999; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Olanow CW, 2004, ANN NY ACAD SCI, V1012, P209, DOI 10.1196/annals.1306.018; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Park JS, 2017, CURR PROTEIN PEPT SC, V18, P725, DOI 10.2174/1389203717666160311121534; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Reddi AR, 2009, CHEM REV, V109, P4722, DOI 10.1021/cr900031u; Rothenberg C, 2010, HUM MOL GENET, V19, P3219, DOI 10.1093/hmg/ddq231; Schmidt K, 2009, BIOCHEM BIOPH RES CO, V383, P198, DOI 10.1016/j.bbrc.2009.03.151; Schultheis PJ, 2004, BIOCHEM BIOPH RES CO, V323, P731, DOI 10.1016/j.bbrc.2004.08.156; Spataro R, 2019, HUM GENOMICS, V13, DOI 10.1186/s40246-019-0203-9; Tan JQ, 2011, J BIOL CHEM, V286, P29654, DOI 10.1074/jbc.M111.233874; Tsunemi T, 2014, HUM MOL GENET, V23, P2791, DOI 10.1093/hmg/ddt572; Ugolino J, 2011, HUM MOL GENET, V20, P3565, DOI 10.1093/hmg/ddr274; Usenovic M, 2012, J NEUROSCI, V32, P4240, DOI 10.1523/JNEUROSCI.5575-11.2012; Van Baelen K, 2001, J BIOL CHEM, V276, P10683, DOI 10.1074/jbc.M010553200; Xiang MH, 2005, J BIOL CHEM, V280, P11608, DOI 10.1074/jbc.M413116200	42	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220849	10.1371/journal.pone.0220849	http://dx.doi.org/10.1371/journal.pone.0220849			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393918	Green Submitted, gold, Green Published			2022-12-26	WOS:000485002500070
J	Fukui, S; Fujita, J; Ikezaki, S; Nakatani, E; Tsujimura, M				Fukui, Sakiko; Fujita, Junko; Ikezaki, Sumie; Nakatani, Eiji; Tsujimura, Mayuko			Effect of a multidisciplinary end-of-life educational intervention on health and social care professionals: A cluster randomized controlled trial	PLOS ONE			English	Article							PALLIATIVE CARE; IDENTITY; COMMUNICATION; NURSES; VIEWS; JAPAN; COLLABORATION; SOCIALIZATION; QUESTIONNAIRE; CHALLENGES	Background The aging of populations is rapidly accelerating worldwide. Especially, Japan has maintained the highest rate of population aging worldwide. As countermeasures, the Japanese government prioritized the promotion of local comprehensive care systems and collaboration in medical care and social (long-term) care. Development of a system to connect medical and social services in the community is necessary for the increasing older people, especially for the people in the stage of end of life. Objective This study aimed to assess the effect of a multidisciplinary end-of-life educational intervention program on confidence in inter-professional collaboration and job satisfaction among health and social care professionals. Design a cluster-randomized controlled trial Setting/Participants Three professional groups (home care nurses, care managers, and heads of care workers) in an urban area participated in this trial. Intervention We implemented a multidisciplinary end-of-life educational intervention program comprising two educational workshops and an educational booklet to support multidisciplinary care for end-of-life patients during the 7-month study period. Main outcome measure Confidence in improved interactions among professionals and job satisfaction were assessed with the Face-to-Face Cooperative Confidence Questionnaire and the Minnesota Satisfaction Questionnaire at T1 (before intervention) and T2 (7 months after the intervention). Results In total, 291 professionals participated in this study (experimental group n = 156; control group n = 135). Multivariate regression analyses showed significant between-group increases on all of seven subscales in participants' face-to-face cooperative confidence over the study period; no effect was evident regarding job satisfaction. Conclusions A multidisciplinary end-of-life educational intervention program increased confidence in multidisciplinary collaboration among health and social care professionals.	[Fukui, Sakiko] Osaka Univ, Dept Nursing, Sch Allied Hlth Sci, Osaka, Japan; [Fujita, Junko] Juntendo Univ, Sch Nursing, Chiba, Japan; [Ikezaki, Sumie; Tsujimura, Mayuko] Chiba Univ, Sch Nursing, Chiba, Japan; [Nakatani, Eiji] Shizuoka Prefectural Gen Hosp, Res Support Ctr, Div Stat Anal, Shizuoka, Japan	Osaka University; Juntendo University; Chiba University; Shizuoka General Hospital	Fukui, S (corresponding author), Osaka Univ, Dept Nursing, Sch Allied Hlth Sci, Osaka, Japan.	sfukui@sahs.med.osaka-u.ac.jp	Ikezaki, Sumie/AAE-7841-2019; Nakatani, Eiji/O-2782-2013	Nakatani, Eiji/0000-0002-4876-446X; Fukui, Sakiko/0000-0003-2113-8124	Japan Society for the Promotion of Science by the Japanese government [26293481]	Japan Society for the Promotion of Science by the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science by the Japanese government (no. 26293481) (URL is https://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams K., 2006, LEARNING HLTH SOCIAL, V5, P55, DOI [DOI 10.1111/J.1473-6861.2006.00119.X, https://doi.org/10.1111/j.1473-6861.2006.00119.x]; AIKEN LH, 1997, RES SOCIOL HEALTH CA, V14, P3; [Anonymous], 2011, GLOBAL HLTH AGING; Arai H, 2015, GERIATR GERONTOL INT, V15, P673, DOI 10.1111/ggi.12450; Banner D, 2018, DEATH STUD; Baycan A.F., 1985, THESIS BOGAZICI U I; Bernacki RE, 2014, JAMA INTERN MED, V174, P1994, DOI 10.1001/jamainternmed.2014.5271; Brighton LJ, 2017, J PAIN SYMPTOM MANAG, V54, P417, DOI 10.1016/j.jpainsymman.2017.04.008; Cabinet Office, 2017, WHIT PAP AG SOC JAP, P10; Chung HO, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0653-x; Clark PG, 1997, GERONTOLOGIST, V37, P441, DOI 10.1093/geront/37.4.441; Clayton JM, 2013, PALLIATIVE MED, V27, P236, DOI 10.1177/0269216312449683; Crossley J, 2009, MED TEACH, V31, pE603, DOI 10.3109/01421590903193547; Deppoliti D, 2008, J CONTIN EDUC NURS, V39, P255, DOI 10.3928/00220124-20080601-03; Eddy Kylie, 2016, JBI Database System Rev Implement Rep, V14, P96, DOI 10.11124/JBISRIR-2016-1843; Eguchi K., 2013, OPTIM REPORT 2012 OU; Fujita J, 2015, J HLTH WELFARE STAT, V6, P1; Fukui S, 2014, JPN ACAD HOME CARE P, V16, P5; Fukui S, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0644-8; Fukui S, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-11; Hirakawa Y, 2017, NAGOYA J MED SCI, V79, P229, DOI 10.18999/nagjms.79.2.229; Howard M, 2018, CAN FAM PHYSICIAN, V64, pE190; Ikai S, 2010, THEORY CENTURY HOSP, P205; Japan national health insurance clinics and hospitals association, 2014, ANN REP 2013 SUPP PA; Karam M, 2018, INT J NURS STUD, V79, P70, DOI 10.1016/j.ijnurstu.2017.11.002; Khalili H, 2013, J INTERPROF CARE, V27, P448, DOI 10.3109/13561820.2013.804042; Kobayashi Y, 2014, J MATER RES TECHNOL, V3, P114, DOI 10.1016/j.jmrt.2013.12.003; Leutz WN, 1999, MILBANK Q, V77, P77, DOI 10.1111/1468-0009.00125; Martins H, 2012, MINNESOTA SATISFACTI; Matsui M, 2013, INT J PALLIAT NURS, V19, P606, DOI 10.12968/ijpn.2013.19.12.606; Mickan Sharon M, 2005, Aust Health Rev, V29, P211; Morikawa Mie, 2014, Int J Integr Care, V14, pe005; Murayama H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-178; Nan JKM, 2018, AM J HOSP PALLIAT CA; Nedjat-Haiem FR, 2017, AM J HOSP PALLIAT ME, V34, P308, DOI 10.1177/1049909115627773; Oishi A, 2014, PALLIATIVE MED, V28, P1081, DOI 10.1177/0269216314531999; Organization WH, 2015, SUMM WORLD REP AG HL; Plack M., 2006, J PHYS THERAPY ED, V20, P38; Sabanciogullari S, 2015, INT J NURS PRACT, V21, P847, DOI 10.1111/ijn.12330; Sarre S, 2018, INT J NURS STUD, V79, P145, DOI 10.1016/j.ijnurstu.2017.11.010; Seow H, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3496; Siebens K, 2006, INT J NURS STUD, V43, P71, DOI 10.1016/j.ijnurstu.2005.04.004; Spector P. E., 1997, JOB SATISFACTION APP, V3; Takahashi K, 1997, AMINO ACIDS, V13, P1, DOI 10.1007/BF01373044; Tsutsui T, 2007, J AM GERIATR SOC, V55, P1458, DOI 10.1111/j.1532-5415.2007.01281.x; Weiss DJ, 1967, MANUAL MINNESOTTA SA; World Health Organization, 2010, FRAM ACT INT ED COLL	47	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0219589	10.1371/journal.pone.0219589	http://dx.doi.org/10.1371/journal.pone.0219589			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5MK	31425538	Green Submitted, gold, Green Published			2022-12-26	WOS:000485022400009
J	Samarth; Lee, R; Song, JC; Macknight, RC; Jameson, PE				Samarth; Lee, Robyn; Song, Jiancheng; Macknight, Richard C.; Jameson, Paula E.			Identification of flowering-time genes in mast flowering plants using De Novo transcriptomic analysis	PLOS ONE			English	Article							GENOMIC GC CONTENT; RNA-SEQ; LOCUS-T; ARABIDOPSIS; TEMPERATURE; PHYTOCHROME; MECHANISMS; ECOLOGY; ROLES; RICE	Mast flowering is synchronised highly variable flowering by a population of perennial plants over a wide geographical area. High seeding years are seen as a threat to native and endangered species due to high predator density caused by the abundance of seed. An understanding of the molecular pathways that influence masting behaviour in plants could provide better prediction of a forthcoming masting season and enable conservation strategies to be deployed. The goal of this study was to identify candidate flowering genes that might be involved in regulating mast flowering. To achieve this, high-throughput large-scale RNA-sequencing was performed on two masting plant species, Celmisia lyallii (Asteraceae), and Chionochloa pallens (Poaceae) to develop a reference transcriptome for functional and molecular analysis. An average total of 33 million 150 base-paired reads, for both species, were assembled using the Trinity pipeline, resulting in 151,803 and 348,649 transcripts respectively for C. lyallii and C. pallens. For both species, about 56% of the unigenes were annotated with gene descriptions to known proteins followed by Gene Ontology analysis, categorising them on the basis of putative biological processes, molecular function, and cellular localization. A total of 543 transcripts from C. lyalliiand 470 transcripts from C. pallens were also mapped to unique flowering-time proteins identified in Arabidopsis thaliana, suggesting the conservation of the flowering network in these wild alpine plants growing in natural field conditions. Expression analysis of several selected homologous flowering-pathway genes showed seasonal and photoperiodic variations. These genes can further be analysed to understand why seasonal cues, such as the increasing photoperiod in spring, that triggers the annual flowering of most plants, are insufficient to always trigger flowering in masting plants and to uncover the molecular basis of how additional cues (such as temperature during the previous growing seasons) then determines flowering in mast years.	[Samarth; Song, Jiancheng; Jameson, Paula E.] Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand; [Lee, Robyn; Macknight, Richard C.] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Song, Jiancheng] Yantai Univ, Sch Life Sci, Yantai, Peoples R China	University of Canterbury; University of Otago; Yantai University	Samarth; Jameson, PE (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand.	samarth.samarth@pg.canterbury.ac.nz; paula.jameson@canterbury.ac.nz	Jameson, Paula Elizabeth/AAD-4362-2022	Jameson, Paula Elizabeth/0000-0002-6371-8234; Macknight, Richard/0000-0002-3300-7124	Marsden Fund	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	Samarth is in receipt of a PhD scholarship from the Marsden Fund U0C1401. RCM and PEJ received supporting funds from the Marsden Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126516; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bouche F, 2016, NUCLEIC ACIDS RES, V44, pD1167, DOI 10.1093/nar/gkv1054; Breza LC, 2012, ECOL EVOL, V2, P1151, DOI 10.1002/ece3.223; Burghardt LT, 2016, NEW PHYTOL, V210, P564, DOI 10.1111/nph.13799; Capovilla G, 2015, J EXP BOT, V66, P59, DOI 10.1093/jxb/eru416; Champigny MJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-578; Choi H, 2016, MOL CELLS, V39, P587, DOI 10.14348/molcells.2016.0126; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; He YH, 2012, TRENDS PLANT SCI, V17, P556, DOI 10.1016/j.tplants.2012.05.001; Huang YJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-691; Hyun Y, 2017, PLANT PHYSIOL, V173, P36, DOI 10.1104/pp.16.01523; Johansson M, 2015, J EXP BOT, V66, P719, DOI 10.1093/jxb/eru441; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kazan K, 2016, J EXP BOT, V67, P47, DOI 10.1093/jxb/erv441; KELLY D, 1994, TRENDS ECOL EVOL, V9, P465, DOI 10.1016/0169-5347(94)90310-7; Kelly D, 2013, ECOL LETT, V16, P90, DOI [1, 10.1111/ele.12020]; Khan MRG, 2014, WIRES RNA, V5, P347, DOI 10.1002/wrna.1215; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Kumar SV, 2012, NATURE, V484, P242, DOI 10.1038/nature10928; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Lee SY, 2004, PLANT J, V38, P754, DOI 10.1111/j.1365-313X.2004.02082.x; Li XS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089462; Li Y, 2017, PLANTA, V246, P91, DOI 10.1007/s00425-017-2688-6; Martin LBB, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00066; Matsubara K, 2011, PLANT J, V66, P603, DOI 10.1111/j.1365-313X.2011.04517.x; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Nam J, 2003, MOL BIOL EVOL, V20, P1435, DOI 10.1093/molbev/msg152; NILSSON SG, 1987, ECOLOGY, V68, P260, DOI 10.2307/1939256; Osugi A, 2011, PLANT PHYSIOL, V157, P1128, DOI 10.1104/pp.111.181792; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Pearse IS, 2016, NEW PHYTOL, V212, P546, DOI 10.1111/nph.14114; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pin PA, 2012, PLANT CELL ENVIRON, V35, P1742, DOI 10.1111/j.1365-3040.2012.02558.x; Proveniers MCG, 2013, TRENDS PLANT SCI, V18, P59, DOI 10.1016/j.tplants.2012.09.002; Ramirez-Gonzalez RH, 2015, PLANT BIOTECHNOL J, V13, P613, DOI 10.1111/pbi.12281; Roche J, 2016, PHYSIOL PLANTARUM, V156, P497, DOI 10.1111/ppl.12412; Samarth, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45780-1; Schauber EM, 2002, ECOLOGY, V83, P1214, DOI 10.1890/0012-9658(2002)083[1214:MBENZP]2.0.CO;2; Shrestha R, 2014, ANN BOT-LONDON, V114, P1445, DOI 10.1093/aob/mcu032; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Simsek O, 2019, TURK J AGRIC FOR, V43, P58, DOI 10.3906/tar-1806-10; Singh R, 2016, TROP PLANT BIOL, V9, P136, DOI 10.1007/s12042-016-9165-4; Smarda P, 2014, P NATL ACAD SCI USA, V111, pE4096, DOI 10.1073/pnas.1321152111; Smarda P, 2012, NEW PHYTOL, V193, P513, DOI 10.1111/j.1469-8137.2011.03942.x; Solga MJ, 2014, NAT AREA J, V34, P227, DOI 10.3375/043.034.0213; Song YH, 2015, ANNU REV PLANT BIOL, V66, P441, DOI 10.1146/annurev-arplant-043014-115555; Tan FC, 2006, PHYSIOL PLANTARUM, V128, P8, DOI 10.1111/j.1399-3054.2006.00724.x; Todd EV, 2016, MOL ECOL, V25, P1224, DOI 10.1111/mec.13526; Vorholter FJ, 2013, MOL MICROBIOL, V88, P1041, DOI 10.1111/mmi.12259; Yasui Y, 2012, PLANT CELL, V24, P3248, DOI 10.1105/tpc.112.101915; Zheng C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125031	52	4	4	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0216267	10.1371/journal.pone.0216267	http://dx.doi.org/10.1371/journal.pone.0216267			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412034	Green Submitted, gold, Green Published			2022-12-26	WOS:000485012600007
J	Tashiro, R; Niizuma, K; Khor, SS; Tokunaga, K; Fujimura, M; Sakata, H; Endo, H; Inoko, H; Ogasawara, K; Tominaga, T				Tashiro, Ryosuke; Niizuma, Kuniyasu; Khor, Seik-Soon; Tokunaga, Katsushi; Fujimura, Miki; Sakata, Hiroyuki; Endo, Hidenori; Inoko, Hidetoshi; Ogasawara, Koetsu; Tominaga, Teiji			Identification of HLA-DRB1*04:10 allele as risk allele for Japanese moyamoya disease and its association with autoimmune thyroid disease: A case-control study	PLOS ONE			English	Article							HUMAN-LEUKOCYTE ANTIGEN; CLASS-II GENES; INCREASED PREVALENCE; GRAVES-DISEASE; GENOME-WIDE; RNF213; WHITE; LOCI; MHC	Background and purpose Moyamoya disease (MMD) is a progressive cerebrovascular disease with unknown etiology. Growing evidence suggest its involvement of autoimmune and genetic mechanisms in the pathogenesis of MMD. This study aims to clarify the association between HLA allele and MMD. Methods Case-control study: the DNA of 136 MMD patients in Japan was extracted and the genotype of human leukocyte antigen (HLA) from this DNA was determined by super-high-resolution single-molecule sequence-based typing using next-generation sequencing. Next, the frequency of each HLA allele (HLA-A, HLA-B, HLA-C, HLA-DRB1, HLA-DQB1, and HLA-DPB1) was compared with those in the Japanese control database. In addition, haplotype estimation was performed using the expectation maximization algorithm. Results The frequencies of the HLA-DRB1* 04:10 allele (4.77% vs. 1.47% in the control group; P= 1.7 x 10(-3); odds ratio [OR] = 3.35) and of the HLA-DRB1* 04:10 HLA-DQB1* 04:02 haplotype (haplotype frequency 4.41% vs. 1.35% in the control group; P= 2.0 x 10(-3); OR = 3.37) significantly increased. The frequency of thyroid diseases, such as Graves' disease and Hashimoto thyroiditis, increased in HLA-DRB1*04: 10-positive MMD patients compared with that in HLA-DRB1* 04:10-negative MMD patients. Conclusions HLA-DRB1* 04:10 is a risk allele and HLA-DRB1* 04:10 HLA-DQB1* 04:02 a risk haplotype for MMD. In addition, HLA-DRB1* 04:10 is associated with thyroid disease in MMD patients.	[Tashiro, Ryosuke; Niizuma, Kuniyasu; Sakata, Hiroyuki; Endo, Hidenori; Tominaga, Teiji] Tohoku Univ, Dept Neurosurg, Grad Sch Med, Sendai, Miyagi, Japan; [Tashiro, Ryosuke; Ogasawara, Koetsu] Tohoku Univ, Dept Immunobiol, Inst Dev Aging & Canc, Sendai, Miyagi, Japan; [Niizuma, Kuniyasu] Tohoku Univ, Grad Sch Biomed Engn, Dept Neurosurg Engn & Translat Neurosci, Sendai, Miyagi, Japan; [Niizuma, Kuniyasu] Tohoku Univ, Dept Neurosurg Engn & Translat Neurosci, Grad Sch Med, Sendai, Miyagi, Japan; [Khor, Seik-Soon; Tokunaga, Katsushi] Univ Tokyo, Dept Human Genet, Grad Sch Med, Tokyo, Japan; [Fujimura, Miki] Kohnan Hosp, Dept Neurosurg, Sendai, Miyagi, Japan; [Inoko, Hidetoshi] Genod Pharma Inc, Atsugi, Kanagawa, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; University of Tokyo	Niizuma, K (corresponding author), Tohoku Univ, Dept Neurosurg, Grad Sch Med, Sendai, Miyagi, Japan.; Niizuma, K (corresponding author), Tohoku Univ, Grad Sch Biomed Engn, Dept Neurosurg Engn & Translat Neurosci, Sendai, Miyagi, Japan.; Niizuma, K (corresponding author), Tohoku Univ, Dept Neurosurg Engn & Translat Neurosci, Grad Sch Med, Sendai, Miyagi, Japan.	niizuma@nsg.med.tohoku.ac.jp	Endo, Hidenori/AAZ-3713-2020; Khor, Seik-Soon/C-4700-2015	Endo, Hidenori/0000-0003-1472-6032; Khor, Seik-Soon/0000-0002-6809-4731; Tashiro, Ryosuke/0000-0002-1099-303X; Sakata, Hiroyuki/0000-0003-0745-9538; Niizuma, Kuniyasu/0000-0001-9282-6499	Ministry of Health, Labour and Welfare (MHLW) [S17310031]; Japan Agency for Medical Research and Development (AMED) [J170001344]; Japan Society for the promotion of Science (JSPS) KAKENHI [17K10815]	Ministry of Health, Labour and Welfare (MHLW)(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Ministry of Health, Labour and Welfare (MHLW) Grant Number S17310031, Japan Agency for Medical Research and Development (AMED) Grant Number J170001344 and Japan Society for the promotion of Science (JSPS) KAKENHI Grant Number 17K10815. GenoDive Pharma Inc. provided support in the form of salaries for H. I., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahn JH, 2018, NEUROL MED-CHIR, V58, P116, DOI 10.2176/nmc.oa.2017-0198; AOYAGI M, 1995, STROKE, V26, P415, DOI 10.1161/01.STR.26.3.415; Bower RS, 2013, STROKE, V44, P1997, DOI 10.1161/STROKEAHA.111.000307; Chen JB, 2016, J NEUROSURG, V124, P1215, DOI 10.3171/2015.4.JNS142936; Delong T, 2016, SCIENCE, V351, P711, DOI 10.1126/science.aad2791; Dendrou CA, 2018, NAT REV IMMUNOL, V18, P325, DOI 10.1038/nri.2017.143; Endo H, 2010, NEUROL MED-CHIR, V50, P977, DOI 10.2176/nmc.50.977; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Fallang LE, 2009, NAT IMMUNOL, V10, P1096, DOI 10.1038/ni.1780; Fujimura M, 2018, BRAIN RES, V1679, P39, DOI 10.1016/j.brainres.2017.11.013; Graffelman J, 2017, HUM GENET, V136, P727, DOI 10.1007/s00439-017-1786-7; Han H, 2003, J KOREAN MED SCI, V18, P876, DOI 10.3346/jkms.2003.18.6.876; Harkiolaki M, 2009, IMMUNITY, V30, P348, DOI 10.1016/j.immuni.2009.01.009; Hong SH, 2009, J KOREAN NEUROSURG S, V46, P558, DOI 10.3340/jkns.2009.46.6.558; Hosomichi K, 2015, J HUM GENET, V60, P665, DOI 10.1038/jhg.2015.102; Inoue TK, 1997, CLIN NEUROL NEUROSUR, V99, pS234; Jones EY, 2006, NAT REV IMMUNOL, V6, P271, DOI 10.1038/nri1805; Kamada F, 2011, J HUM GENET, V56, P34, DOI 10.1038/jhg.2010.132; Kanoke A, 2015, BRAIN RES, V1624, P497, DOI 10.1016/j.brainres.2015.07.039; Kim JS, 2016, J STROKE, V18, P2, DOI 10.5853/jos.2015.01627; Kim SJ, 2010, STROKE, V41, P173, DOI 10.1161/STROKEAHA.109.562264; Kraemer M, 2012, ACTA NEUROCHIR, V154, P445, DOI 10.1007/s00701-011-1261-5; Kuriyama S, 2008, STROKE, V39, P42, DOI 10.1161/STROKEAHA.107.490714; LEWONTIN RC, 1964, GENETICS, V49, P49; Li H, 2011, STROKE, V42, P1138, DOI 10.1161/STROKEAHA.110.608471; Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022; Liu W, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022452, DOI 10.1371/JOURNAL.PONE.0022452]; Mallory GW, 2013, NEUROSURGERY, V73, P984, DOI 10.1227/NEU.0000000000000162; Miyatake S, 2012, NEUROLOGY, V78, P803, DOI 10.1212/WNL.0b013e318249f71f; Nakabayashi K, 2011, J HUM GENET, V56, P772, DOI 10.1038/jhg.2011.99; Nakajima F, 2001, MHC, V8, P1; Nikolich-Zugich J, 2004, NAT REV IMMUNOL, V4, P123, DOI 10.1038/nri1292; Nomura S, 1998, BLOOD, V91, P3616; Pappas DJ, 2016, HUM IMMUNOL, V77, P283, DOI 10.1016/j.humimm.2015.12.006; Research on intractable diseases of the Ministry of Health LaW Japan., 2018, SURG CEREB STROKE, V46, P1, DOI DOI 10.2335/SCS.46.1; Sasazuki T, 2016, ADV IMMUNOL, V129, P175, DOI 10.1016/bs.ai.2015.08.003; Shiina T, 2018, METHODS MOL BIOL, V1802, P115, DOI 10.1007/978-1-4939-8546-3_8; SHINDO Y, 1994, BRIT J OPHTHALMOL, V78, P223, DOI 10.1136/bjo.78.3.223; SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288, DOI 10.1001/archneur.1969.00480090076012; Tanaka M, 2014, EUR J NEUROL, V21, P867, DOI 10.1111/ene.12397; Tashiro R, 2019, NERUOL RES, DOI [10.1080/01616412.2019, DOI 10.1080/01616412.2019]; Ueda S, 2014, J CLIN ENDOCR METAB, V99, pE379, DOI 10.1210/jc.2013-2841; Ueta M, 2014, SCI REP, V4, pe5891; Yasunami M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11148-6; Zeitlin A, 2008, GENES IMMUN, V9, P358, DOI 10.1038/gene.2008.26	45	10	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0220858	10.1371/journal.pone.0220858	http://dx.doi.org/10.1371/journal.pone.0220858			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412073	Green Published, Green Submitted, gold			2022-12-26	WOS:000485012600038
J	Fronteau, C; Pare, M; Benoit, P; Tollec, S; Hamon, C; Schwiertz, V; Maillarce, C; Cransac, A; Volteau, C; Huon, JF; Burgeot, V; Tching-Sin, M; Guerin, C; Flet, L				Fronteau, Clementine; Pare, Maxime; Benoit, Philippe; Tollec, Sophie; Hamon, Catherine; Schwiertz, Verane; Maillarce, Christian; Cransac, Amelie; Volteau, Christelle; Huon, Jean-Francois; Burgeot, Veronique; Tching-Sin, Martine; Guerin, Corinne; Flet, Laurent			What do adult outpatients included in clinical trials know about the investigational drugs being assessed: A cross-sectional study in France	PLOS ONE			English	Article							INFORMED-CONSENT; MEDICATION ADHERENCE; PATIENT KNOWLEDGE; LITERACY; COMPREHENSION; PARTICIPANTS; INFORMATION	This study aimed to assess patient investigational medication knowledge and to identify factors associated with medication understanding by adult outpatients included in clinical trials. A cross-sectional prospectively designed survey was conducted on consecutive volunteers at 21 university teaching hospitals (in France) from February to December 2014. Investigational medication understanding was assessed at the time of the first dispensing using a structured interviewer-administered questionnaire based on information obtained from the literature that provided an 8-point score. Demographic and other baseline data were collected using structured interviews. Of the 236 participants, 139 (58.9%) of the respondents were male, and the median age was 54.9 years (range: 18-83 years). The mean understanding score was 6.24 and 72.5% of the patients had a score of 6 or higher. In univariate analysis, the medication understanding score was negatively correlated with age (r = -0.15, p = 0.0247) and positively correlated with the level of education (r = 0.25, p = 0.0002). In multivariate analysis, prognostic factors of a higher medication understanding score were: graduation from high school or a higher level of education; HIV infection; phase II/III/IV studies; mention of the drug on the prescription form, and the dispensing of a single investigational medication. Only a quarter of the adult outpatients included in clinical trials had a maximum possible investigational medication understanding score. Being old and having a low level of education were found to be important risk factors for inadequate medication understanding. This and other data suggest that sponsors should encourage initiatives aimed at improving investigational medication understanding in adults enrolled in clinical trials.	[Fronteau, Clementine; Pare, Maxime; Huon, Jean-Francois; Burgeot, Veronique; Tching-Sin, Martine; Flet, Laurent] Nantes Univ Hosp, Dept Pharm, Nantes, France; [Benoit, Philippe] Reims Univ Hosp, Dept Pharm, Reims, France; [Tollec, Sophie] Orleans Reg Hosp, Dept Pharm, Orleans, France; [Hamon, Catherine] Rennes Univ Hosp, Dept Pharm, Rennes, France; [Schwiertz, Verane] Hosp Civils Lyon, Dept Pharm, Lyon, France; [Maillarce, Christian] Nimes Univ Hosp, Dept Pharm, Nimes, France; [Cransac, Amelie] Dijon Univ Hosp, Dept Pharm, Dijon, France; [Cransac, Amelie] LNC UMR1231, Dijon, France; [Volteau, Christelle] Nantes Univ Hosp, Clin Res Unit, Nantes, France; [Huon, Jean-Francois] Nantes Univ, EA3826 Lab, Nantes, France; [Huon, Jean-Francois] Nantes Univ, UFR Sci Pharmaceut, Nantes, France; [Guerin, Corinne] Cochin Hosp, AP HP, Dept Pharm, Paris, France	Nantes Universite; CHU de Nantes; CHU de Reims; Universite de Reims Champagne-Ardenne; Centre Hospitalier Regional d'Orleans; CHU Rennes; Universite de Rennes; CHU Lyon; Universite de Montpellier; CHU de Nimes; CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Nantes Universite; CHU de Nantes; Nantes Universite; Nantes Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Flet, L (corresponding author), Nantes Univ Hosp, Dept Pharm, Nantes, France.	laurent.flet@chu-nantes.fr	CRANSAC, Amélie/AAH-5651-2020; FLET, Laurent/X-1192-2019; HUON, Jean-François/GYJ-3989-2022	CRANSAC, Amélie/0000-0003-1836-2619; FLET, Laurent/0000-0001-8305-7085; 	University Hospital of Nantes	University Hospital of Nantes	The authors wish to thank: (i) all of the participants who volunteered to participate in this survey; (ii) the COMQUEST team: Valerie Daniel, Francoise Renon-Caron, Marie-Claude Saux, Stephanie Tamisier, Audrey Castet-Nicolas, Christine Pivot, Isabelle Princet, Anne HuttClauss, Pierre Chauvet, Anne-Marie Caminondo, Isabelle Madelaine, Melanie Dumas, and Maxime Lebeaupin. The regulatory and ethics submissions for this work were sponsored by the University Hospital of Nantes.	Barre-Sinoussi F, 2013, NAT REV MICROBIOL, V11, P877, DOI 10.1038/nrmicro3132; Bergenmar M, 2011, CLIN TRIALS, V8, P77, DOI 10.1177/1740774510384516; Breckenridge A, 2017, NAT REV DRUG DISCOV, V16, P149, DOI 10.1038/nrd.2017.1; Burge S, 2005, FAM MED, V37, P712; Burkhart PV, 2003, J NURS SCHOLARSHIP, V35, P207; Cameron P, 2013, CURR ONCOL, V20, pE193, DOI 10.3747/co.20.1323; Davis TC, 2006, ANN INTERN MED, V145, P887, DOI 10.7326/0003-4819-145-12-200612190-00144; Davis TC, 2009, J GEN INTERN MED, V24, P57, DOI 10.1007/s11606-008-0833-4; Dollinger C, 2016, INT J QUAL HEALTH C, V28, P311, DOI 10.1093/intqhc/mzw025; Falagas ME, 2009, AM J SURG, V198, P420, DOI 10.1016/j.amjsurg.2009.02.010; Delgado PG, 2009, ATEN PRIM, V41, P661, DOI 10.1016/j.aprim.2009.03.011; MacLaughlin EJ, 2005, DRUG AGING, V22, P231, DOI 10.2165/00002512-200522030-00005; Marvanova M, 2011, J HOSP MED, V6, P488, DOI 10.1002/jhm.925; Mexas F, 2014, CLIN TRIALS, V11, P70, DOI 10.1177/1740774513509316; Mohan A, 2014, AM J MANAG CARE, V20, pE547; Ng AWY, 2017, APPL ERGON, V58, P167, DOI 10.1016/j.apergo.2016.06.005; Nishimura A, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-28; Pentz RD, 2012, CANCER-AM CANCER SOC, V118, P4571, DOI 10.1002/cncr.27397; Shrank W, 2007, ANN PHARMACOTHER, V41, P783, DOI 10.1345/aph.1H582; SPANDORFER JM, 1995, ANN EMERG MED, V25, P71, DOI 10.1016/S0196-0644(95)70358-6; Wolf MS, 2007, PATIENT EDUC COUNS, V67, P293, DOI 10.1016/j.pec.2007.03.024; Zheng F, 2017, J INT MED RES, V45, P303, DOI 10.1177/0300060516676726	22	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220383	10.1371/journal.pone.0220383	http://dx.doi.org/10.1371/journal.pone.0220383			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5HO	31408456	Green Published, gold, Green Submitted			2022-12-26	WOS:000485009500014
J	Wang, XD; Sun, YF; Li, SY; Wang, HX				Wang, Xuedong; Sun, Yanfeng; Li, Shiyu; Wang, Hanxi			Spatial distribution and ecological risk assessment of heavy metals in soil from the Raoyanghe Wetland, China	PLOS ONE			English	Article							SOURCE IDENTIFICATION; SURFACE SEDIMENTS; POLLUTION ASSESSMENT; AGRICULTURAL SOILS; MANGROVE WETLAND; HEALTH-RISK; CONTAMINATION; PROVINCE; URBAN; CITY	Wetlands are recognized as one of the most important natural environments for humans. At the same time, heavy metal pollution has an important impact on wetlands. China's Raoyanghe Wetland is one of the most important natural wild species gene banks in China. Eight heavy metal elements (As, Cd, Cr, Cu, Hg, Ni, Pb, and Zn) in surface layer and deep layer soils were analyzed using statistical-, pollution index-, and Nemerow index-based methods, the Hakanson potential ecological risk index method, and principal component and cluster analyses. The results showed that the maximum concentrations of heavy metals exceeded the background values in the core area and buffer zone of the wetland, but the heavy metal content of the soils was generally low and did not exceed 30%. With the exception of Hg, heavy metal concentrations showed strong spatial differentiation. The differences between the surface layer and deep layer soils of the core area were smaller than in the buffer zone. With the exception of Cd, a clear vertical zonation in the buffer zone soils was observed, showing greater evidence of external influences in this zone than the core. With the exception of partial surface soils, which indicated a safe level of pollution in the core area, all other soils were classified as having a 'mild' level of pollution. Thus, the wetland is moderately polluted, with both the core area and the buffer zone presenting a low level of potential ecological risk. According to the results of the present study, heavy metal contaminants in the wetland soils were found to be derived mainly from the natural sources.	[Wang, Xuedong; Sun, Yanfeng; Li, Shiyu] Liaoning Tech Univ, Coll Min, Fuxing, Peoples R China; [Wang, Xuedong] Liaoning Tech Univ, Res Stn Mech Postdoctoral Fellows, Fuxing, Peoples R China; [Wang, Hanxi] Northeast Normal Univ, State Environm Protect Key Lab Wetland Ecol & Veg, Sch Environm, Changchun, Jilin, Peoples R China	Liaoning Technical University; Liaoning Technical University; Northeast Normal University - China	Wang, HX (corresponding author), Northeast Normal Univ, State Environm Protect Key Lab Wetland Ecol & Veg, Sch Environm, Changchun, Jilin, Peoples R China.	wanghanxizs1982@126.com	wang, xuedong/AAA-3358-2019	wang, xuedong/0000-0003-0555-4814; Wang, Hanxi/0000-0003-4130-6981; LI, SHIYU/0000-0002-4272-3958	National Natural Science Fund of China [51604140]; Natural Science Fund in Liaoning Province of China [20170540423]; Open Projects of Research Center of Coal Resources Safe Mining and Clean Utilization, LNTU [LNTU17KF09]; China Postdoctoral Science Foundation [2018M631815]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund in Liaoning Province of China; Open Projects of Research Center of Coal Resources Safe Mining and Clean Utilization, LNTU; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Fund of China (Grant No. 51604140) to XW, Natural Science Fund in Liaoning Province of China (Grant No. 20170540423) to XW, Open Projects of Research Center of Coal Resources Safe Mining and Clean Utilization, LNTU (Grant No. LNTU17KF09) to XW, and a project funded by China Postdoctoral Science Foundation (Grant No. 2018M631815) to XW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah MAM, 2015, ENVIRON EARTH SCI, V73, P3603, DOI 10.1007/s12665-014-3646-2; Akcay H, 2003, WATER RES, V37, P813, DOI 10.1016/S0043-1354(02)00392-5; Alam AKMR, 2018, POLLUTION, V4, P129, DOI 10.22059/poll.2017.234867.284; Bai JH, 2016, ENVIRON POLLUT, V219, P379, DOI 10.1016/j.envpol.2016.05.016; Boruvka L, 2005, GEODERMA, V128, P289, DOI 10.1016/j.geoderma.2005.04.010; Cai C, 2015, WATER AIR SOIL POLL, V226, DOI 10.1007/s11270-015-2620-2; Cai LM, 2012, ECOTOX ENVIRON SAFE, V78, P2, DOI 10.1016/j.ecoenv.2011.07.004; Chai Y, 2015, CHEMOSPHERE, V134, P67, DOI 10.1016/j.chemosphere.2015.04.008; Chen CY, 2000, LIMNOL OCEANOGR, V45, P1525, DOI 10.4319/lo.2000.45.7.1525; Chen Quan, 2017, Chinese Journal of Plant Ecology, V41, P409, DOI 10.17521/cjpe.2016.0338; Chen TB, 2005, CHEMOSPHERE, V60, P542, DOI 10.1016/j.chemosphere.2004.12.072; Cheng QL, 2015, ENVIRON SCI POLLUT R, V22, P8586, DOI 10.1007/s11356-014-4041-y; Cui LQ, 2017, CHEM SPEC BIOAVAILAB, V29, P15, DOI 10.1080/09542299.2016.1252692; Das SS, 2019, INDIA POLLUTION, V5, P161, DOI [10.22059/poll.2018.263546.493, DOI 10.22059/POLL.2018.263546.493]; Esmaeilzadeh M, 2016, ACTA OCEANOL SIN, V35, P28, DOI 10.1007/s13131-016-0920-z; Fang HD, 2015, INT J SUST DEV WORLD, V22, P117, DOI 10.1080/13504509.2014.918908; [高静湉 Gao Jingtian], 2016, [农业环境科学学报, Journal of Agro-Environment Science], V35, P2180; Gao WH, 2016, J SOIL SEDIMENT, V16, P1093, DOI 10.1007/s11368-015-1314-0; [葛晓颖 Ge Xiaoying], 2019, [环境科学学报, Acta Scientiae Circumstantiae], V39, P1979; He JY, 2019, GEODERMA, V337, P359, DOI 10.1016/j.geoderma.2018.09.038; Hu B, 2017, J CIRCUIT SYST COMP, V26, DOI 10.1142/S0218126617501596; Hu BF, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040710; Hu J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189295; Hua L, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10093115; Huang JH, 2016, SCI TOTAL ENVIRON, V541, P969, DOI 10.1016/j.scitotenv.2015.09.139; Huang SS, 2007, CHEMOSPHERE, V67, P2148, DOI 10.1016/j.chemosphere.2006.12.043; Jamshidi-Zanjani A, 2013, ENVIRON EARTH SCI, V70, P1791, DOI 10.1007/s12665-013-2267-5; Jiang XL, 2017, ENVIRON SCI POLLUT R, V24, P436, DOI 10.1007/s11356-016-7775-x; Khosheghbal MZ, 2018, WATER SCI TECHNOL, V78, P1276, DOI 10.2166/wst.2018.396; Lee CS, 2006, SCI TOTAL ENVIRON, V356, P45, DOI 10.1016/j.scitotenv.2005.03.024; Li F, 2018, SCI TOTAL ENVIRON, V644, P649, DOI 10.1016/j.scitotenv.2018.06.366; Li F, 2017, ENVIRON GEOCHEM HLTH, V39, P923, DOI 10.1007/s10653-016-9864-7; Li F, 2013, J GEOCHEM EXPLOR, V132, P75, DOI 10.1016/j.gexplo.2013.05.007; [李吉锋 Li Jifeng], 2013, [广东农业科学, Guangdong Agricultural Sciences], V40, P164; Li LF, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8122561; Li SY, 2010, J HAZARD MATER, V181, P1051, DOI 10.1016/j.jhazmat.2010.05.120; [李卫平 Li Weiping], 2017, [生态环境学报, Ecology and Environmental Sciences], V26, P1977; Liang J, 2016, ENVIRON SCI POLLUT R, V23, P11806, DOI 10.1007/s11356-016-6372-3; Liu Li, 2018, Chinese Journal of Zoology, V53, P628, DOI 10.13859/j.cjz.201804014; [刘娜 Liu Na], 2015, [农业现代化研究, Research of Agricultural Modernization], V36, P901; LIU P, 2019, SUSTAINABILITY-BASEL, V11, DOI DOI 10.3390/su11020419; Liu Zezheng, 2018, Journal of Beijing Normal University (Natural Science), V54, P144, DOI 10.16360/j.cnki.jbnuns.2018.01.020; [罗松英 Luo Songying], 2018, [生态环境学报, Ecology and Environmental Sciences], V27, P1547; Luo Ting, 2018, Huanjing Huaxue-Environmental Chemistry, V37, P984, DOI 10.7524/j.issn.0254-6108.2017072404; [麦麦提吐尔逊·艾则孜 Mamattursun Eziz], 2018, [土壤, Soils], V50, P369; Mungai TM, 2016, ENVIRON SCI POLLUT R, V23, P18533, DOI 10.1007/s11356-016-7042-1; Leguizamo MAO, 2017, CHEMOSPHERE, V168, P1230, DOI 10.1016/j.chemosphere.2016.10.075; Peng CY, 2017, SPECTROSC SPECT ANAL, V37, P1980, DOI 10.3964/j.issn.1000-0593(2017)06-1980-07; Qiu GL, 2006, ENVIRON POLLUT, V142, P549, DOI 10.1016/j.envpol.2005.10.015; Ramachandra TV, 2018, J ENVIRON MANAGE, V206, P1204, DOI 10.1016/j.jenvman.2017.10.014; Romic M, 2003, ENVIRON GEOL, V43, P795, DOI 10.1007/s00254-002-0694-9; Sandilyan S, 2014, OCEAN COAST MANAGE, V102, P161, DOI 10.1016/j.ocecoaman.2014.09.025; Sun CJ, 2010, ANAL LETT, V43, P1989, DOI 10.1080/00032711003687070; [孙海燕 Sun Haiyan], 2015, [水土保持学报, Journal of Soil and Water Conservation], V29, P289; Varol M, 2011, J HAZARD MATER, V195, P355, DOI 10.1016/j.jhazmat.2011.08.051; Wang HX, 2019, ENERGY, V173, P263, DOI 10.1016/j.energy.2019.02.081; Wang HX, 2018, ENVIRON SCI POLLUT R, V25, P4435, DOI 10.1007/s11356-017-0751-2; Wang HX, 2015, RENEW SUST ENERG REV, V52, P1881, DOI 10.1016/j.rser.2015.08.038; Wang JunGuang, 2018, Southwest China Journal of Agricultural Sciences, V31, P611; Wang LF, 2014, J GEOCHEM EXPLOR, V140, P87, DOI 10.1016/j.gexplo.2014.02.008; [王萌 Wang Meng], 2018, [地学前缘, Earth Science Frontiers], V25, P305; Wu J.Y., 2014, ENVIRON SCI TECHNOL, V37, P268; Xiao Q, 2015, ECOTOX ENVIRON SAFE, V120, P377, DOI 10.1016/j.ecoenv.2015.06.019; Xiao R, 2017, ECOTOX ENVIRON SAFE, V141, P17, DOI 10.1016/j.ecoenv.2017.03.002; Xu JL, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5093-x; Xu Ya-yan, 2012, Huanjing Kexue, V33, P732; Ye SJ, 2019, APPL CATAL B-ENVIRON, V250, P78, DOI 10.1016/j.apcatb.2019.03.004; Ye SJ, 2019, RESOUR CONSERV RECY, V140, P278, DOI 10.1016/j.resconrec.2018.10.004; Ye SJ, 2017, CRIT REV ENV SCI TEC, V47, P1528, DOI 10.1080/10643389.2017.1386951; Ye SJ, 2017, CRIT REV BIOTECHNOL, V37, P1062, DOI 10.1080/07388551.2017.1304357; Yu L, 2016, NAT HAZARDS, V81, P1435, DOI 10.1007/s11069-015-2130-y; [袁红明 Yuan Hongming], 2018, [海洋地质前沿, Marine Geology Letters], V34, P51; Zeng YanYi, 2018, Environmental Science & Technology (China), V41, P190; Zhang GL, 2016, ECOL INDIC, V69, P331, DOI 10.1016/j.ecolind.2016.04.042; Zhang HuiJuan, 2017, Journal of Yunnan University - Natural Sciences Edition, V39, P494; Zhang Y, 2014, ENVIRON MONIT ASSESS, V186, P1219, DOI 10.1007/s10661-013-3451-5	76	16	19	6	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220409	10.1371/journal.pone.0220409	http://dx.doi.org/10.1371/journal.pone.0220409			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398209	gold, Green Published, Green Submitted			2022-12-26	WOS:000485004000010
J	D'Angeli, IM; Ghezzi, D; Leuko, S; Firrincieli, A; Parise, M; Fiorucci, A; Vigna, B; Addesso, R; Baldantoni, D; Carbone, C; Miller, AZ; Jurado, V; Saiz-Jimenez, C; De Waele, J; Cappelletti, M				D'Angeli, Ilenia M.; Ghezzi, Daniele; Leuko, Stefan; Firrincieli, Andrea; Parise, Mario; Fiorucci, Adriano; Vigna, Bartolomeo; Addesso, Rosangela; Baldantoni, Daniela; Carbone, Cristina; Miller, Ana Zelia; Jurado, Valme; Saiz-Jimenez, Cesareo; De Waele, Jo; Cappelletti, Martina			Geomicrobiology of a seawater-influenced active sulfuric acid cave	PLOS ONE			English	Article							MOONMILK DEPOSITS; BACTERIAL DIVERSITY; ACQUASANTA TERME; GENOME SEQUENCE; MICROBIAL MATS; CESAREA-TERME; MOVILE CAVE; GEN. NOV.; FAM. NOV; COMMUNITY	Fetida Cave is an active sulfuric acid cave influenced by seawater, showing abundant microbial communities that organize themselves under three main different morphologies: water filaments, vermiculations and moonmilk deposits. These biofilms/deposits have different cave distribution, pH, macro-and microelement and mineralogical composition, carbon and nitrogen content. In particular, water filaments and vermiculations had circumneutral and slightly acidic pH, respectively, both had abundant organic carbon and high microbial diversity. They were rich in macro- and microelements, deriving from mineral dissolution, and, in the case of water filaments, from seawater composition. Vermiculations had different color, partly associated with their mineralogy, and unusual minerals probably due to trapping capacities. Moonmilk was composed of gypsum, poor in organic matter, had an extremely low pH (0-1) and low microbial diversity. Based on 16S rRNA gene analysis, the microbial composition of the biofilms/deposits included autotrophic taxa associated with sulfur and nitrogen cycles and biomineralization processes. In particular, water filaments communities were characterized by bacterial taxa involved in sulfur oxidation and reduction in aquatic, aphotic, microaerophilic/anoxic environments (Campylobacterales, Thiotrichales, Arenicellales, Desulfobacterales, Desulforomonadales) and in chemolithotrophy in marine habitats (Oceanospirillales, Chromatiales). Their biodiversity was linked to the morphology of the water filaments and their collection site. Microbial communities within vermiculations were partly related to their color and showed high abundance of unclassified Betaproteobacteria and sulfur-oxidizing Hydrogenophilales (including Sulfuriferula), and Acidiferrobacterales (including Sulfurifustis), sulfur-reducing Desulfurellales, and ammonia-oxidizing Planctomycetes and Nitrospirae. The microbial community associated with gypsum moonmilk showed the strong dominance (>60%) of the archaeal genus Thermoplasma and lower abundance of chemolithotrophic Acidithiobacillus, metal-oxidizing Metallibacterium, Sulfobacillus, and Acidibacillus. This study describes the geomicrobiology of water filaments, vermiculations and gypsum moonmilk from Fetida Cave, providing insights into the microbial taxa that characterize each morphology and contribute to biogeochemical cycles and speleogenesis of this peculiar seawater-influenced sulfuric acid cave.	[D'Angeli, Ilenia M.; De Waele, Jo] Univ Bologna, Dept Biol Geol & Environm Sci, Bologna, Italy; [Ghezzi, Daniele; Cappelletti, Martina] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy; [Leuko, Stefan] DLR Inst Aerosp Med, Radiat Biol, Cologne, Germany; [Firrincieli, Andrea] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Parise, Mario] Univ Bari Aldo Moro, Dept Geol & Environm Sci, Bari, Italy; [Fiorucci, Adriano; Vigna, Bartolomeo] Polytech Univ Turin, Dept Environm Land & Infrastruct Engn, Turin, Italy; [Addesso, Rosangela; Baldantoni, Daniela] Univ Salerno, Dept Chem & Biol Adolfo Zambelli, Fisciano, SA, Italy; [Carbone, Cristina] Univ Genoa, Dept Geol Environm & Biol Sci, DISTAV, Genoa, Italy; [Miller, Ana Zelia] Univ Evora, HERCULES Lab, Evora, Portugal; [Jurado, Valme; Saiz-Jimenez, Cesareo] CSIC, IRNAS, Inst Recursos Nat & Agrobiol, Seville, Spain	University of Bologna; University of Bologna; Helmholtz Association; German Aerospace Centre (DLR); University of Washington; University of Washington Seattle; Universita degli Studi di Bari Aldo Moro; Polytechnic University of Turin; University of Salerno; University of Genoa; University of Evora; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS)	Cappelletti, M (corresponding author), Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy.	martina.cappelletti2@unibo.it	Miller, Ana Zélia/H-8140-2012; CAPPELLETTI, MARTINA/H-5414-2019; Ghezzi, Daniele/AAE-1774-2020; Cappelletti, Martina/I-4952-2012; Miller, Ana Zélia/AAD-1117-2019; Baldantoni, Daniela/ABA-4273-2020; De Waele, Jo/A-7509-2008	Miller, Ana Zélia/0000-0002-0553-8470; CAPPELLETTI, MARTINA/0000-0002-6238-8296; Ghezzi, Daniele/0000-0002-9358-1566; Cappelletti, Martina/0000-0002-6238-8296; Miller, Ana Zélia/0000-0002-0553-8470; De Waele, Jo/0000-0001-5325-5208; Firrincieli, Andrea/0000-0001-5768-3170; D'Angeli, Ilenia M./0000-0002-2471-6236; Addesso, Rosangela/0000-0002-0300-8337	University of Bologna (UNIBO); Lions Club Napoli Megaride district 108 YA; UNIBO; Europlanet 2020 [15-EPN1-029, 17-EPN3-021]; European Union [654208]; Spanish project MINECO [CGL2016-75590-P]; ERDF; UNIBO (Ricerca Fondamentale e Orientata-RFO); Rectorate of UNIBO; Medical University of Graz (Austria)	University of Bologna (UNIBO); Lions Club Napoli Megaride district 108 YA; UNIBO; Europlanet 2020; European Union(European Commission); Spanish project MINECO(Spanish Government); ERDF(European Commission); UNIBO (Ricerca Fondamentale e Orientata-RFO); Rectorate of UNIBO; Medical University of Graz (Austria)	IMDA was supported by University of Bologna (UNIBO) and by the award from Lions Club Napoli Megaride district 108 YA. DG and MC's work was supported by the UNIBO. Funding for microbial analyses was provided by Europlanet 2020 15-EPN1-029 and 17-EPN3-021 grants. Europlanet 2020 RI has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 654208. Further funding was provided by the Spanish project MINECO CGL2016-75590-P with ERDF funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Santa Cesarea Terme spa for the availability during the intense sampling campaigns, Maria Luisa Garberi, Giovanni Belvederi, and Federazione Speleologica Emilia-Romagna for the gas measurements. IMDA was supported by University of Bologna (UNIBO) and by the award from Lions Club Napoli Megaride district 108 YA. DG and MC work was supported by UNIBO (Ricerca Fondamentale e Orientata-RFO) and the Rectorate of UNIBO. Funding for microbial analyses was provided by Europlanet 2020 15-EPN1-029 and 17-EPN3-021 grants. Europlanet 2020 RI has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 654208. Further funding was provided by the Spanish project MINECO CGL2016-75590-P with ERDF funds. MC, DG and IMDA are grateful to Prof. Christine Moissl Eichinger, Dr Kaisa Koskinen and Dr Alexander Mahnert from the Medical University of Graz (Austria), for their help with sample preparation for Illumina sequencing and data analysis with QIIME2 software. The authors thank Paolo Costantini for his support with the figures drawing and adjustments. Finally, we gratefully acknowledge the valuable comments of Dr Jarrod J. Scott, Dr Satoshi Kawaichi and one additional anonymous reviewer that helped to improve the initial submission of the manuscript.	Addesso R, 2019, CATENA, V182, DOI 10.1016/j.catena.2019.104178; Amato A, 2014, J GEODYN, V82, P125, DOI 10.1016/j.jog.2014.09.007; Baker BJ, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0077-6; Banerjee S, 2013, P NATL A SCI INDIA B, V83, P277, DOI 10.1007/s40011-012-0149-3; Barton HA, 2004, GEOMICROBIOL J, V21, P11, DOI 10.1080/01490450490253428; BINI A, 1978, INT J SPELEOL, V10, P11, DOI 10.5038/1827-806X.10.1.2; Bolyen E, 2018, EERJ; Borsato A, 2010, J SEDIMENT RES, V70, P1179; Boston PJ, 2001, ASTROBIOLOGY, V1, P25, DOI 10.1089/153110701750137413; Burlet C, 2015, COMPUT GEOSCI-UK, V74, P50, DOI 10.1016/j.cageo.2014.10.009; Callahan BJ, 2017, ISME J, V11, P2639, DOI 10.1038/ismej.2017.119; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; CALO GC, 1995, J HYDROL, V165, P185; Camejo PY, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00059-17; Canganella Francesco, 2007, Reviews in Environmental Science and Bio/Technology, V6, P61, DOI 10.1007/s11157-006-9103-2; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Cappelletti M, 2016, MICROBES ENVIRON, V31, P369, DOI 10.1264/jsme2.ME16087; Chirienco M., 2004, ACTA CARSOLOGICA, V17, P257; Cirigliano A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34134-y; Clarke KR, 2015, PRIMER V7 USER MANUA; D'Angeli IM, 2018, INT J SPELEOL, V47, P271, DOI 10.5038/1827-806X.47.3.2175; D'Angeli IM, 2017, CAVE KARST SYSTEMS, P161, DOI 10.1007/978-3-319-53348-3_9; da Cunha AR, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4458-x; De Waele J, 2016, GEOMORPHOLOGY, V253, P452, DOI 10.1016/j.geomorph.2015.10.019; Delmont TO, 2018, NAT MICROBIOL, V3, P804, DOI 10.1038/s41564-018-0176-9; Engel AS, 2007, J CAVE KARST STUD, V69, P187; Engel AS, 2013, INT J SPELEOL, V42, P181, DOI 10.5038/1827-806X.42.3.2; Engel AS, 2010, ISME J, V4, P98, DOI 10.1038/ismej.2009.91; Engel AS, 2004, GEOLOGY, V32, P369, DOI 10.1130/G20288.1; Engel AS, 2003, APPL ENVIRON MICROB, V69, P5503, DOI 10.1128/AEM.69.9.5503-5511.2003; Florentino AP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00222; GALDENZI S, 1995, ENVIRON GEOL, V26, P39, DOI 10.1007/BF00776030; Galdenzi Sandro, 2003, Journal of Cave and Karst Studies, V65, P111; Galdenzi S, 2010, J CAVE KARST STUD, V72, P43, DOI 10.4311/jcks2008es0056; Ghosh S, 2017, DIVERSITY-BASEL, V9, DOI 10.3390/d9030036; Golyshina OV, 2005, ENVIRON MICROBIOL, V7, P1277, DOI 10.1111/j.1462-2920.2005.00861.x; Golyshina OV, 2017, SCI REP, V7, P997, DOI [10.1038/s41598-017-00810-8, DOI 10.1038/S41598-017-00810-8]; Hamilton TL, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00756; Han YC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00989; Hathaway JJM, 2014, GEOMICROBIOL J, V31, P205, DOI 10.1080/01490451.2013.777491; Hester ER, 2018, MSYSTEMS, V3, DOI [10.1128/msystems.00214-17, 10.1128/mSystems.00214-17]; Hill CA, 1997, CAVE MINERALS WORLD, P221; Hirano H, 2003, ENVIRON MICROBIOL, V5, P503, DOI 10.1046/j.1462-2920.2003.00444.x; Hose L, 2004, J CAVE KARST STUD, V66, P112; Hose LD, 2000, CHEM GEOL, V169, P399, DOI 10.1016/S0009-2541(00)00217-5; Hose Louise D., 1999, Journal of Caves and Karst Studies, V61, P13; Ionescu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038319; Issotta F, 2018, RES MICROBIOL, V169, P608, DOI 10.1016/j.resmic.2018.08.001; Jones DS, 2010, APPL ENVIRON MICROB, V76, P5902, DOI 10.1128/AEM.00647-10; Jones DS, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.00673-17; Jones DS, 2016, ADV ENV MICROBIOLOGY, V1, P203, DOI 10.1007/978-3-319-28071-4_5; Jones DS, 2016, ISME J, V10, P2879, DOI 10.1038/ismej.2016.74; Jones DS, 2015, APPL ENVIRON MICROB, V81, P3142, DOI 10.1128/AEM.00039-15; Jones DS, 2012, ISME J, V6, P158, DOI 10.1038/ismej.2011.75; Jones DS, 2008, J CAVE KARST STUD, V70, P78; Justice NB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1107; Kang I, 2018, MAR GENOM, V37, P176, DOI 10.1016/j.margen.2017.11.005; Keller AH, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01396; Klimchouk A, 2017, CAVE KARST SYSTEMS, P1, DOI 10.1007/978-3-319-53348-3_1; Koch H, 2019, APPL MICROBIOL BIOT, V103, P177, DOI 10.1007/s00253-018-9486-3; Kojima H, 2015, INT J SYST EVOL MICR, V65, P3709, DOI 10.1099/ijsem.0.000479; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kumaresan D, 2014, GEOMICROBIOL J, V31, P186, DOI 10.1080/01490451.2013.839764; Lavoie K.H., 2010, GEOMICROBIOL J, P1; Li YF, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02718; Liu JL, 2019, ENVIRON POLLUT, V247, P98, DOI 10.1016/j.envpol.2018.12.045; Macalady JL, 2008, ISME J, V2, P590, DOI 10.1038/ismej.2008.25; Macalady JL, 2007, ENVIRON MICROBIOL, V9, P1402, DOI 10.1111/j.1462-2920.2007.01256.x; Macalady JL, 2006, APPL ENVIRON MICROB, V72, P5596, DOI 10.1128/AEM.00715-06; Mackey E.A., 2004, J RES, DOI [10.6028/nist.sp.260-156, DOI 10.6028/NIST.SP.260-156]; Marques ELS, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7020029; Martin-Cuadrado AB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000914; Mattison RG, 1998, MICROBIAL ECOL, V35, P58, DOI 10.1007/s002489900060; Mcllroy SJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01134; Miller AZ, 2012, CHEM GEOL, V322, P181, DOI 10.1016/j.chemgeo.2012.07.005; Miller AZ, 2018, SEDIMENTOLOGY, V65, P1482, DOI 10.1111/sed.12431; Mugge RL, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00048; Northup DE, 2001, GEOMICROBIOL J, V18, P199, DOI 10.1080/01490450152467750; Onac B.-P., 1993, CAVE SCI, V20, P107; Pascual J, 2015, SYST APPL MICROBIOL, V38, P534, DOI 10.1016/j.syapm.2015.08.001; Portillo MC, 2011, MICROB ECOL, V61, P182, DOI 10.1007/s00248-010-9731-5; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Riquelme C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01342; Rohwerder T, 2003, ACTA BIOTECHNOL, V23, P101, DOI 10.1002/abio.200390000; Ruffel V, 2018, ENVIRON MICROBIOL, V20, P3717, DOI 10.1111/1462-2920.14374; Ruepp A, 2000, NATURE, V407, P508, DOI 10.1038/35035069; Sauro F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35532-y; Teramoto M, 2015, INT J SYST EVOL MICR, V65, P353, DOI 10.1099/ijs.0.064683-0; Tisato N, 2015, SCI REP-UK, V5, DOI 10.1038/srep15525; Tomczyk-Zak K, 2016, GEOMICROBIOL J, V33, P20, DOI 10.1080/01490451.2014.1003341; Trembath-Reichert E, 2016, PEERJ, V4, P1913; Umezawa K, 2016, STAND GENOMIC SCI, V11, DOI 10.1186/s40793-016-0196-0; Velaj T., 2015, PETROLEUM, V1, P269; Wei HW, 2017, BIORESOURCE TECHNOL, V243, P1149, DOI 10.1016/j.biortech.2017.07.077; Wirsen CO, 2002, APPL ENVIRON MICROB, V68, P316, DOI 10.1128/AEM.68.1.316-325.2002; Wright KE, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00063; Ye RW, 2001, CURR OPIN MICROBIOL, V4, P307, DOI 10.1016/S1369-5274(00)00208-3	97	22	22	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220706	10.1371/journal.pone.0220706	http://dx.doi.org/10.1371/journal.pone.0220706			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393920	gold, Green Published, Green Accepted			2022-12-26	WOS:000485002500053
J	Dyr, B; Boomer, T; Almasri, EA; Wardrop, JL; Rafalko, J; Chibuk, J; McCullough, RM				Dyr, Brittany; Boomer, Theresa; Almasri, Eyad A.; Wardrop, Jenna L.; Rafalko, Jill; Chibuk, Jason; McCullough, Ron M.			y A new era in aneuploidy screening: cfDNA testing in > 30,000 multifetal gestations: Experience at one clinical laboratory	PLOS ONE			English	Article							CELL-FREE DNA; MATERNAL PLASMA DNA; TWIN PREGNANCIES; DOWN-SYNDROME; FETAL DNA; POSITION STATEMENT; TRISOMIES 21; ABNORMALITIES; BLOOD; AGE	Since introducing cell-free DNA screening, Sequenom Laboratories has analyzed over 1 million clinical samples. More than 30,000 of these samples were from multifetal gestations (including twins, triplets and higher-order multiples). The clinical laboratory experience with the first 30,000 multifetal samples will be discussed. Maternal plasma samples from multifetal gestations were subjected to DNA extraction and library preparation followed by massively parallel sequencing. Sequencing data were analyzed to identify autosomal trisomies and other subchromosomal events. Fetal fraction requirements were adjusted in proportion to fetal number. Outcome data, when voluntarily received from the ordering provider, were collected from internal case notes. Feedback was received in 50 cases. The positivity rate in multifetal samples for trisomy 21 was 1.50%, 0.47% for trisomy 18, and 0.21% for trisomy 13. Average total sample fetal fraction was 12.2% at a mean gestational age of 13 weeks 6 days. Total non-reportable rate was 5.95%. Estimated performance based on ad hoc clinical feedback demonstrates that possible maximum sensitivity and specificity meet or exceed the original performance from clinical validation studies. Cell-free DNA (cfDNA) screening provides certain advantages over that of conventional screening in multifetal gestations and is available in higher-order multiples.	[Dyr, Brittany; Rafalko, Jill; Chibuk, Jason] Sequenom Inc, Dept Med Affairs, San Diego, CA 92121 USA; [Boomer, Theresa; Almasri, Eyad A.; Wardrop, Jenna L.; McCullough, Ron M.] Sequenom Inc, Dept Clin Sci, San Diego, CA USA	Sequenom; Sequenom	Dyr, B (corresponding author), Sequenom Inc, Dept Med Affairs, San Diego, CA 92121 USA.	dyrb@labcorp.com		Chibuk, Jason/0000-0003-1903-8829				American College of Obstetricians and Gynecologists Committee on Genetics, 2012, Obstet Gynecol, V120, P1532, DOI 10.1097/01.AOG.0000423819.85283.f4; [Anonymous], 2014, Obstet Gynecol, V123, P1118, DOI 10.1097/01.AOG.0000446856.51061.3e; [Anonymous], 2015, CELL FREE DNA SCREEN; Benachi A, 2015, OBSTET GYNECOL, V125, P1330, DOI 10.1097/AOG.0000000000000874; Bender W, 2018, OBSTET GYN CLIN N AM, V45, P41, DOI 10.1016/j.ogc.2017.10.004; Benn P, 2013, PRENATAL DIAG, V33, P622, DOI 10.1002/pd.4139; Bevilacqua E, 2015, ULTRASOUND OBST GYN, V45, P61, DOI 10.1002/uog.14690; Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; Canick JA, 2012, PRENATAL DIAG, V32, P730, DOI 10.1002/pd.3892; Garchet-Beaudron A, 2008, PRENATAL DIAG, V28, P1105, DOI 10.1002/pd.2145; Gil MD, 2014, FETAL DIAGN THER, V35, P204, DOI 10.1159/000356495; Gregg AR, 2016, GENET MED, V18, P1056, DOI 10.1038/gim.2016.97; Huang X, 2014, PRENATAL DIAG, V34, P335, DOI 10.1002/pd.4303; Jensen TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057381; Kim SK, 2015, PRENATAL DIAG, V35, P810, DOI 10.1002/pd.4615; Lau TK, 2013, J MATERN-FETAL NEO M, V26, P434, DOI 10.3109/14767058.2012.733768; Le Conte G, 2018, ULTRASOUND OBST GYN, V52, P318, DOI 10.1002/uog.18838; Mackie FL, 2017, BJOG-INT J OBSTET GY, V124, P32, DOI 10.1111/1471-0528.14050; Martin Joyce A, 2012, NCHS Data Brief, P1; Mazloom AR, 2013, PRENATAL DIAG, V33, P591, DOI 10.1002/pd.4127; McCullough RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109173; Meyers C, 1997, OBSTET GYNECOL, V89, P248, DOI 10.1016/S0029-7844(96)00424-3; NIEBUHR E, 1978, HUM GENET, V44, P227, DOI 10.1007/BF00394291; Norton ME, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.021; Norton ME, 2015, NEW ENGL J MED, V372, P1589, DOI 10.1056/NEJMoa1407349; Nygren AOH, 2010, CLIN CHEM, V56, P1627, DOI 10.1373/clinchem.2010.146290; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Reynolds MA, 2003, PEDIATRICS, V111, P1159; Sarno L, 2016, ULTRASOUND OBST GYN, V47, P705, DOI 10.1002/uog.15913; Sebire NJ, 1996, BRIT J OBSTET GYNAEC, V103, P999, DOI 10.1111/j.1471-0528.1996.tb09550.x; Tan YQ, 2016, PRENATAL DIAG, V36, P672, DOI 10.1002/pd.4837; WALD N, 1991, BRIT J OBSTET GYNAEC, V98, P905, DOI 10.1111/j.1471-0528.1991.tb13513.x; Wilson KL, 2013, J GENET COUNS, V22, P4, DOI 10.1007/s10897-012-9545-3; Zhang H, 2015, ULTRASOUND OBST GYN, V45, P530, DOI 10.1002/uog.14792; Zhao C, 2015, CLIN CHEM, V61, P608, DOI 10.1373/clinchem.2014.233312	36	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220979	10.1371/journal.pone.0220979	http://dx.doi.org/10.1371/journal.pone.0220979			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393959	Green Submitted, gold, Green Published			2022-12-26	WOS:000485002500088
J	El Moussawi, L; Chakkour, M; Kreydiyyeh, S				El Moussawi, Layla; Chakkour, Mohamed; Kreydiyyeh, Sawsan			The epinephrine-induced PGE2 reduces Na+/K+ ATPase activity in Caco-2 cells via PKC, NF-kappa B and NO	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NA+,K+-ATPASE ACTIVITY; K+-ATPASE; ALPHA; PHOSPHORYLATION; NA,K-ATPASE; INHIBITION; EXPRESSION; MECHANISM; COLON	We showed previously an epinephrine-induced inhibition of the Na+/K+ ATPase in Caco-2 cells mediated via PGE2. This work is an attempt to further elucidate mediators downstream of PGE2 and involved in the observed inhibitory effect. The activity of the Na+/K+ ATPase was assayed by measuring the amount of inorganic phosphate liberated in presence and absence of ouabain, a specific inhibitor of the enzyme. Changes in the protein expression of the Na+/K+ ATPase were investigated by western blot analysis which revealed a significant decrease in the abundance of the ATPase in plasma membranes. Treating the cells with epinephrine or PGE2 in presence of SC19220, a blocker of EP1 receptors abolished completely the effect of the hormone and the prostaglandin while the effect was maintained unaltered in presence of antagonists to all other receptors. Treatment with calphostin C, PTIO, ODQ or KT5823, respective inhibitors of PKC, NO, soluble guanylate cyclase and PKG, abrogated completely the effect of epinephrine and PGE2, suggesting an involvement of these mediators. A significant inhibition of the ATPase was observed when cells were treated with PMA, an activator of PKC or with 8-Br-cGMP, a cell permeable cGMP analogue. PMA did reduce the protein expression of I kappa B, as shown by western blot analysis, and its effect on the ATPase was not manifested in presence of an inhibitor of NF-kappa B while that of SNAP, a nitric oxide donor, was not affected. The results infer that NF-kappa B is downstream PKC and upstream NO. The data support a pathway in which epinephrine induces the production of PGE2 which binds to EP1 receptors and activates PKC and NF-kappa B leading to NO synthesis. The latter activates soluble guanylate cyclase resulting in cGMP production and activation of PKG which through direct or indirect phosphorylation inhibits the Na+/K+ ATPase by inducing its internalization.	[El Moussawi, Layla; Chakkour, Mohamed; Kreydiyyeh, Sawsan] Amer Univ Beirut, Fac Arts & Sci, Dept Biol, Beirut, Lebanon	American University of Beirut	Kreydiyyeh, S (corresponding author), Amer Univ Beirut, Fac Arts & Sci, Dept Biol, Beirut, Lebanon.	Sawkreyd@aub.edu.lb			SK University Research Board	SK University Research Board	This work was funded by SK University Research Board. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Alam N, 2017, J CELL COMMUN SIGNAL, V11, P309, DOI 10.1007/s12079-016-0369-z; BECKMAN JS, 1993, BIOCHEM SOC T, V21, P330, DOI 10.1042/bst0210330; Beltowski J, 2003, J PHYSIOL PHARMACOL, V54, P191; Beltowski J, 2007, CLIN EXP HYPERTENS, V29, P189, DOI 10.1080/10641960701361585; BERTORELLO AM, 1991, P NATL ACAD SCI USA, V88, P11359, DOI 10.1073/pnas.88.24.11359; Boldyrev AA, 1997, BBA-BIOENERGETICS, V1321, P243, DOI 10.1016/S0005-2728(97)00053-4; Bos CL, 2004, INT J BIOCHEM CELL B, V36, P1187, DOI 10.1016/j.biocel.2003.08.006; Chibalin AV, 1997, AM J PHYSIOL-CELL PH, V273, pC1458, DOI 10.1152/ajpcell.1997.273.5.C1458; Dey I, 2006, BRIT J PHARMACOL, V149, P611, DOI 10.1038/sj.bjp.0706923; Esmann M., 1988, METHODS ENZYMOLOGY P, P105; FESCHENKO MS, 1995, J BIOL CHEM, V270, P14072, DOI 10.1074/jbc.270.23.14072; Fotis H, 1999, EUR J BIOCHEM, V260, P904, DOI 10.1046/j.1432-1327.1999.00237.x; Fujii S, 2016, SCI REPORTS, V6; GUZMAN NJ, 1995, J CLIN INVEST, V95, P2083, DOI 10.1172/JCI117895; Hatano E, 2001, GASTROENTEROLOGY, V120, P1251, DOI 10.1053/gast.2001.23239; Hsieh YH, 2007, BIOCHEM BIOPH RES CO, V359, P643, DOI 10.1016/j.bbrc.2007.05.154; Hubbard KB, 2006, CELL SIGNAL, V18, P135, DOI 10.1016/j.cellsig.2005.08.004; Jia JH, 2013, INVEST OPHTH VIS SCI, V54, P5070, DOI 10.1167/iovs.13-11796; Kostic TS, 1999, J ENDOCRINOL, V163, P409, DOI 10.1677/joe.0.1630409; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; Li D, 1995, AM J PHYSL RENAL PHY, V269; Liang MY, 1999, KIDNEY INT, V56, P627, DOI 10.1046/j.1523-1755.1999.00583.x; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Lucas KA, 2000, PHARMACOL REV, V52, P375; Martin E, 2005, METHOD ENZYMOL, V396, P478, DOI 10.1016/S0076-6879(05)96040-0; MEISTER B, 1989, P NATL ACAD SCI USA, V86, P8068, DOI 10.1073/pnas.86.20.8068; Moussawi LE, 2018, PLOS ONE, V13; Oliveira MS, 2009, J NEUROCHEM, V109, P416, DOI 10.1111/j.1471-4159.2009.05961.x; Olivenza R, 2000, J NEUROCHEM, V74, P785, DOI 10.1046/j.1471-4159.2000.740785.x; Oussaief L, 2011, J VIROL, V85, P6502, DOI 10.1128/JVI.02560-10; Rida R, 2018, LIFE SCI, V215, P198, DOI 10.1016/j.lfs.2018.11.026; Sandle GI, 1998, GUT, V43, P294, DOI 10.1136/gut.43.2.294; Shahidullah M, 2013, J CELLULAR PHYSL, V229, P343; Shahidullah M, 2006, BRIT J PHARMACOL, V148, P871, DOI 10.1038/sj.bjp.0706795; Taussky H, 1959, MICROCHEM J, V3, P587; Wang TL, 2002, INT IMMUNOPHARMACOL, V2, P1509, DOI 10.1016/S1567-5769(02)00058-9; Wood JS, 1996, J BIOL CHEM, V271, P174, DOI 10.1074/jbc.271.1.174; Wu ZQ, 2005, MOL PHARM; Yoon Hyun-Ju, 1994, Neuroimmunomodulation, V1, P377, DOI 10.1159/000097191	39	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220987	10.1371/journal.pone.0220987	http://dx.doi.org/10.1371/journal.pone.0220987			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393950	Green Published, Green Submitted, gold			2022-12-26	WOS:000485002500091
J	Snyder, BM; Nam, SM; Khunsongkiet, P; Ausayakhun, S; Leeungurasatien, T; Leiter, MR; Sevastopolsky, A; Joye, AS; Berlinberg, EJ; Liu, YN; Ramirez, DA; Moe, CA; Ausayakhun, S; Stamper, RL; Keenan, JD				Snyder, Blake M.; Nam, Sang Min; Khunsongkiet, Preeyanuch; Ausayakhun, Sakarin; Leeungurasatien, Thidarat; Leiter, Maxwell R.; Sevastopolsky, Artem; Joye, Ashlin S.; Berlinberg, Elyse J.; Liu, Yingna; Ramirez, David A.; Moe, Caitlin A.; Ausayakhun, Somsanguan; Stamper, Robert L.; Keenan, Jeremy D.			Accuracy of computer-assisted vertical cup-to-disk ratio grading for glaucoma screening	PLOS ONE			English	Article							OPTIC NEUROPATHY EVALUATION; DIABETIC-RETINOPATHY; EVALUATION PROJECT; REPRODUCIBILITY	Purpose Glaucoma screening can be performed by assessing the vertical-cup-to-disk ratio (VCDR) of the optic nerve head from fundus photography, but VCDR grading is inherently subjective. This study investigated whether computer software could improve the accuracy and repeatability of VCDR assessment. Methods In this cross-sectional diagnostic accuracy study, 5 ophthalmologists independently assessed the VCDR from a set of 200 optic disk images, with the median grade used as the reference standard for subsequent analyses. Eight non-ophthalmologists graded each image by two different methods: by visual inspection and with assistance from a custom-made publicly available software program. Agreement with the reference standard grade was assessed for each method by calculating the intraclass correlation coefficient (ICC), and the sensitivity and specificity determined relative to a median ophthalmologist grade of >= 0.7. Results VCDR grades ranged from 0.1 to 0.9 for visual assessment and from 0.1 to 1.0 for software-assisted grading, with a median grade of 0.4 for each. Agreement between each of the 8 graders and the reference standard was higher for visual inspection (median ICC 0.65, interquartile range 0.57 to 0.82) than for software-assisted grading (median ICC 0.59, IQR 0.44 to 0.71); P = 0.02, Wilcoxon signed-rank test). Visual inspection and software assistance had similar sensitivity and specificity for detecting glaucomatous cupping. Conclusion The computer software used in this study did not improve the reproducibility or validity of VCDR grading from fundus photographs compared with simple visual inspection. More clinical experience was correlated with higher agreement with the ophthalmologist VCDR reference standard.	[Snyder, Blake M.] Univ Colorado, Sch Med, Aurora, CO USA; [Snyder, Blake M.; Leiter, Maxwell R.; Joye, Ashlin S.; Berlinberg, Elyse J.; Liu, Yingna; Ramirez, David A.; Moe, Caitlin A.; Keenan, Jeremy D.] Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA; [Nam, Sang Min; Stamper, Robert L.; Keenan, Jeremy D.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Nam, Sang Min] CHA Univ, CHA Bundang Med Ctr, Dept Ophthalmol, Seongnam, South Korea; [Khunsongkiet, Preeyanuch; Ausayakhun, Sakarin; Leeungurasatien, Thidarat; Ausayakhun, Somsanguan] Chiang Mai Univ, Fac Med, Dept Ophthalmol, Chiang Mai, Thailand; [Sevastopolsky, Artem] Youth Labs LLC, Moscow, Russia; [Sevastopolsky, Artem] Skolkovo Inst Sci & Technol, Moscow, Russia	University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Pochon Cha University; Chiang Mai University; Skolkovo Institute of Science & Technology	Keenan, JD (corresponding author), Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA.; Keenan, JD (corresponding author), Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA.	jeremy.keenan@ucsf.edu	Solodushenkova, Anastasia/H-1732-2019; Keenan, Jeremy David/AAO-5882-2020; Moe, Caitlin/GYA-1601-2022	Keenan, Jeremy David/0000-0002-7118-1457; Moe, Caitlin/0000-0002-9318-2514; Berlinberg, Elyse/0000-0001-5308-1383; Ramirez, David/0000-0003-0357-917X; Snyder, Blake/0000-0002-0049-3111	Doris Duke Charitable Foundation through Doris Duke International Clinical Research Fellows Program at the University of California San Francisco School of Medicine; Fortisure Foundation; JaMel and Tom Perkins Family Foundation; That Man May See; Research to Prevent Blindness	Doris Duke Charitable Foundation through Doris Duke International Clinical Research Fellows Program at the University of California San Francisco School of Medicine; Fortisure Foundation; JaMel and Tom Perkins Family Foundation; That Man May See; Research to Prevent Blindness(Research to Prevent Blindness (RPB))	This work was supported in part by the Doris Duke Charitable Foundation through a grant supporting the Doris Duke International Clinical Research Fellows Program at the University of California San Francisco School of Medicine. Blake M. Snyder is a Doris Duke International Clinical Research Fellow. Additional support came from the Fortisure Foundation, the JaMel and Tom Perkins Family Foundation, That Man May See, and Research to Prevent Blindness. The funders provided support in the form of salaries for authors [AS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Addis V, 2019, EYE, V33, P838, DOI 10.1038/s41433-018-0332-8; Almazroa A, 2017, INT J BIOMED IMAGING, V2017, DOI 10.1155/2017/4826385; Bartlett JW, 2008, ULTRASOUND OBST GYN, V31, P466, DOI 10.1002/uog.5256; Bhaskaranand Malavika, 2016, J Diabetes Sci Technol, V10, P254, DOI 10.1177/1932296816628546; Chan HHL, 2014, AM J OPHTHALMOL, V157, P936, DOI 10.1016/j.ajo.2014.01.024; Feuer WJ, 2002, AM J OPHTHALMOL, V133, P19, DOI 10.1016/S0002-9394(01)01338-1; Fumero F, 2011, COMP MED SY; Grisolia ABD, 2017, ARQ BRAS OFTALMOL, V80, P401, DOI 10.5935/0004-2749.20170099; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Haleem MS, 2018, J MED SYST, V42, DOI 10.1007/s10916-017-0859-4; Hu M, 2017, BIOENGINEERED, V8, P21, DOI 10.1080/21655979.2016.1227144; Kaiser-Kupfer M I, 1980, Trans Am Ophthalmol Soc, V78, P896; Kong YXG, 2011, CLIN EXP OPHTHALMOL, V39, P308, DOI 10.1111/j.1442-9071.2010.02462.x; Lamminen H, 2003, ACTA OPHTHALMOL SCAN, V81, P105, DOI 10.1034/j.1600-0420.2003.00045.x; Li ZX, 2018, OPHTHALMOLOGY, V125, P1199, DOI 10.1016/j.ophtha.2018.01.023; Lichter P R, 1976, Trans Am Ophthalmol Soc, V74, P532; Lowell J, 2004, IEEE T MED IMAGING, V23; Matimba A, 2016, J TELEMED TELECARE, V22, P311, DOI 10.1177/1357633X15604083; Morgan JE, 2005, BRIT J OPHTHALMOL, V89, P879, DOI 10.1136/bjo.2004.046169; Muttuvelu DV, 2012, ACTA OPHTHALMOL, V90, P322, DOI 10.1111/j.1755-3768.2010.01987.x; Norgaard MF, 2018, OPHTHALMIC RES, V60, P9, DOI 10.1159/000486284; O'Neill EC, 2014, JAMA OPHTHALMOL, V132, P560, DOI 10.1001/jamaophthalmol.2014.96; Parkin B, 2001, BRIT J OPHTHALMOL, V85, P1347, DOI 10.1136/bjo.85.11.1347; Sevastopolsky A., 2017, [Pattern Recognition and Image Analysis (Advances in Mathematical Theory and Applications), Pattern Recognition and Image Analysis. (Advances in Mathematical Theory and Applications)], V27, P618, DOI 10.1134/S1054661817030269; Soorya M, 2018, INT J MED INFORM, V110, P52, DOI 10.1016/j.ijmedinf.2017.11.015; Team RDC, 2008, COMP RFFS; Tham YC, 2013, CLIN EXP OPHTHALMOL, V41, P842, DOI 10.1111/ceo.12112; Zilly J, 2017, COMPUT MED IMAG GRAP, V55, P28, DOI 10.1016/j.compmedimag.2016.07.012; Zimmer-Galler IE, 2015, CURR OPIN OPHTHALMOL, V26, P167, DOI 10.1097/ICU.0000000000000142	29	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220362	10.1371/journal.pone.0220362	http://dx.doi.org/10.1371/journal.pone.0220362			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393904	gold, Green Submitted, Green Published			2022-12-26	WOS:000485002500028
J	Sparks, R; Lui, A; Bader, D; Patel, R; Murr, M; Guida, W; Fratti, R; Patel, NA				Sparks, Robert; Lui, Ashley; Bader, Deena; Patel, Rekha; Murr, Michel; Guida, Wayne; Fratti, Rutilio; Patel, Niketa A.			A specific small-molecule inhibitor of protein kinase C?I activity improves metabolic dysfunction in human adipocytes from obese individuals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						PKC; obesity; adipocyte; adipose tissue; adipose tissue metabolism; inflammation; metabolic disease; apoptosis; metabolic disorder; NP627	PKC-DELTA ACTIVATION; OXIDATIVE STRESS; PROTEOLYTIC ACTIVATION; HUMAN KERATINOCYTES; INSULIN-RESISTANCE; APOPTOSIS; CELLS; IDENTIFICATION; MACROPHAGES; SYNTHASE	The metabolic consequences and sequelae of obesity promote life-threatening morbidities. PKC?I is an important elicitor of inflammation and apoptosis in adipocytes. Here we report increased PKC?I activation via release of its catalytic domain concurrent with increased expression of proinflammatory cytokines in adipocytes from obese individuals. Using a screening strategy of dual recognition of PKC?I isozymes and a caspase-3 binding site on the PKC?I hinge domain with Schr?dinger software and molecular dynamics simulations, we identified NP627, an organic small-molecule inhibitor of PKC?I. Characterization of NP627 by surface plasmon resonance (SPR) revealed that PKC?I and NP627 interact with each other with high affinity and specificity, SPR kinetics revealed that NP627 disrupts caspase-3 binding to PKC?I, and in vitro kinase assays demonstrated that NP627 specifically inhibits PKC?I activity. The SPR results also indicated that NP627 affects macromolecular interactions between protein surfaces. Of note, release of the PKC?I catalytic fragment was sufficient to induce apoptosis and inflammation in adipocytes. NP627 treatment of adipocytes from obese individuals significantly inhibited PKC?I catalytic fragment release, decreased inflammation and apoptosis, and significantly improved mitochondrial metabolism. These results indicate that PKC?I is a robust candidate for targeted interventions to manage obesity-associated chronic inflammatory diseases. We propose that NP627 may also be used in other biological systems to better understand the impact of caspase-3?mediated activation of kinase activity.	[Bader, Deena; Patel, Niketa A.] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Lui, Ashley; Patel, Niketa A.] Univ S Florida, Dept Mol Med, Tampa, FL 33612 USA; [Patel, Rekha; Guida, Wayne] Univ S Florida, Dept Chem, Tampa, FL 33612 USA; [Sparks, Robert; Fratti, Rutilio] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Murr, Michel] Univ Cent Florida, Surg Dept, Orlando, FL 32816 USA; [Murr, Michel] AdventHlth, Bariatr & Metab Inst, Tampa, FL 33612 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; University of Illinois System; University of Illinois Urbana-Champaign; State University System of Florida; University of Central Florida; Adventist Health Services; AdventHealth	Patel, NA (corresponding author), James A Haley Vet Hosp, Tampa, FL 33612 USA.; Patel, NA (corresponding author), Univ S Florida, Dept Mol Med, Tampa, FL 33612 USA.	npatel@health.usf.edu		Bader, Deena/0000-0003-3323-1916; Sparks, Robert/0000-0002-0485-8317	U.S. Department of Veterans Affairs (VA) [I01BX003836]; National Science Foundation Molecular and Cellular Biosciences Grant [1818310]; Veterans Affairs [I01BX003836] Funding Source: NIH RePORTER	U.S. Department of Veterans Affairs (VA)(US Department of Veterans Affairs); National Science Foundation Molecular and Cellular Biosciences Grant; Veterans Affairs(US Department of Veterans Affairs)	This work was supported by U.S. Department of Veterans Affairs (VA) Grant I01BX003836 (to N. A. P.) and National Science Foundation Molecular and Cellular Biosciences Grant 1818310 (to R. A. F.). The authors declare that they have no conflicts of interest with the contents of this article. This work does not reflect the view or opinion of the James A. Haley VA Hospital or the US Government.	Alkhouri N, 2010, J BIOL CHEM, V285, P3428, DOI 10.1074/jbc.M109.074252; Anantharam V, 2002, J NEUROSCI, V22, P1738, DOI 10.1523/JNEUROSCI.22-05-01738.2002; Arkin MR, 2014, CHEM BIOL, V21, P1102, DOI 10.1016/j.chembiol.2014.09.001; Bezy O, 2011, J CLIN INVEST, V121, P2504, DOI 10.1172/JCI46045; Bowles DK, 2007, AM J PHYSIOL-CELL PH, V293, pC805, DOI 10.1152/ajpcell.00127.2007; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Bruun JM, 2005, J CLIN ENDOCR METAB, V90, P2282, DOI 10.1210/jc.2004-1696; Carter Gay, 2014, Stem Cell Investig, V1, P3, DOI 10.3978/j.issn.2306-9759.2014.01.02; Carter Gay, 2013, ISRN Obes, V2013, P161345, DOI 10.1155/2013/161345; Cerutti DS, 2009, J CHEM THEORY COMPUT, V5, P2322, DOI 10.1021/ct9001015; Denning MF, 2002, CELL DEATH DIFFER, V9, P40, DOI 10.1038/sj.cdd.4400929; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; Fiocco U, 2014, IMMUNOL RES, V58, P61, DOI 10.1007/s12026-013-8481-0; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Fukumoto S, 1997, J BIOL CHEM, V272, P13816, DOI 10.1074/jbc.272.21.13816; Gao YJ, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2065-x; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; Greene MW, 2014, J NUTR BIOCHEM, V25, P281, DOI 10.1016/j.jnutbio.2013.10.008; Greene MW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085848; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jiang K, 2008, BIOCHEMISTRY-US, V47, P787, DOI 10.1021/bi7019782; Karelis AD, 2005, J CLIN ENDOCR METAB, V90, P4145, DOI 10.1210/jc.2005-0482; Katakura Y, 2009, J BIOCHEM, V146, P87, DOI 10.1093/jb/mvp046; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; Kurokawa J, 2011, P NATL ACAD SCI USA, V108, P12072, DOI 10.1073/pnas.1101841108; Nanthapisal S, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-0781; Nguyen TT, 2010, J BIOL CHEM, V285, P22164, DOI 10.1074/jbc.M109.077578; Nishimura T, 2000, LARYNGOSCOPE, V110, P1333, DOI 10.1097/00005537-200008000-00021; Nisoli E, 2000, P NATL ACAD SCI USA, V97, P8033, DOI 10.1073/pnas.97.14.8033; Parihar SP, 2018, MUCOSAL IMMUNOL, V11, P578, DOI 10.1038/mi.2017.108; Patel NA, 2006, GENE EXPRESSION, V13, P73, DOI 10.3727/000000006783991890; Patel R, 2013, J BIOL CHEM, V288, P26834, DOI 10.1074/jbc.M113.482638; Patel Rekha S, 2016, Stem Cell Investig, V3, P2, DOI 10.3978/j.issn.2306-9759.2016.01.02; Patel RS, 2014, J BIOL CHEM, V289, P31662, DOI 10.1074/jbc.M114.592337; Peluso JJ, 2001, ENDOCRINOLOGY, V142, P4203, DOI 10.1210/en.142.10.4203; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ramnath RD, 2010, J MOL MED, V88, P1055, DOI 10.1007/s00109-010-0647-9; Ribeiro JV, 2016, SCI REP-UK, V6, DOI 10.1038/srep26536; Shanmugam M, 1998, ONCOGENE, V16, P1649, DOI 10.1038/sj.onc.1201684; Sitailo LA, 2004, J INVEST DERMATOL, V123, P434, DOI 10.1111/j.0022-202X.2004.23403.x; Sitailo LA, 2006, J BIOL CHEM, V281, P29703, DOI 10.1074/jbc.M607351200; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Soroush F, 2019, SHOCK, V51, P538, DOI 10.1097/SHK.0000000000001247; Sparks DK, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2338318; Starr ML, 2019, J BIOL CHEM, V294, P3100, DOI 10.1074/jbc.RA118.006552; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Sumandea MP, 2008, J BIOL CHEM, V283, P22680, DOI 10.1074/jbc.M802396200; Talior I, 2005, AM J PHYSIOL-ENDOC M, V288, pE405, DOI 10.1152/ajpendo.00378.2004; Talior I, 2003, AM J PHYSIOL-ENDOC M, V285, pE295, DOI 10.1152/ajpendo.00044.2003; Tang Y, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1342-y; Tsujio I, 2000, FEBS LETT, V469, P111, DOI 10.1016/S0014-5793(00)01234-5; Wallerstedt E, 2010, DIABETOLOGIA, V53, P946, DOI 10.1007/s00125-010-1668-1; Watson JE, 2014, ADV WOUND CARE, V3, P219, DOI 10.1089/wound.2013.0452; Wermuth PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027110; Wong SL, 2011, ARTERIOSCL THROM VAS, V31, P1169, DOI 10.1161/ATVBAHA.110.216044; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang YC, 2018, AGING DIS, V9, P647, DOI 10.14336/AD.2017.0924; Zhang J, 2014, BIOCHEM BIOPH RES CO, V450, P1619, DOI 10.1016/j.bbrc.2014.07.048; Zhang Y, 2012, BIOCHEM BIOPH RES CO, V417, P1, DOI 10.1016/j.bbrc.2011.11.158	60	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2019	294	41					14896	14910		10.1074/jbc.RA119.008777	http://dx.doi.org/10.1074/jbc.RA119.008777			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9JH	31413114	Green Published, hybrid			2022-12-26	WOS:000499253400006
J	Feng, DF; Qin, B; Pal, K; Sun, L; Dutta, S; Dong, HD; Liu, X; Mukhopadhyay, D; Huang, SB; Sinicrope, FA				Feng, Daofu; Qin, Bo; Pal, Krishnendu; Sun, Lei; Dutta, Shamit; Dong, Haidong; Liu, Xin; Mukhopadhyay, Debabrata; Huang, Shengbing; Sinicrope, Frank A.			BRAF(V600E)-induced, tumor intrinsic PD-L1 can regulate chemotherapy-induced apoptosis in human colon cancer cells and in tumor xenografts	ONCOGENE			English	Article							B7-H1 PD-L1; EXPRESSION; MEK; ACTIVATION; BLOCKADE; PROTEIN; RESISTANCE; RECEPTOR; MUTATION; CASCADE	Programmed death ligand 1 (PD-L1) is an immune checkpoint protein; however, emerging data suggest that tumor cell PD-L1 may regulate immune-independent and intrinsic cellular functions. We demonstrate regulation of PD-L1 by oncogenic BRAF(V600E) and investigated its ability to influence apoptotic susceptibility in colorectal cancer (CRC) cells. Endogenous or exogenous mutant vs. wild-type BRAF were shown to increase PD-L1 messenger RNA (mRNA) and protein expression that was attenuated by MEK (mitogen-activated protein kinase/extracellular signal-regulated kinase) inhibition or c-JUN and YAP knockdown. Deletion of PD-L1 reduced tumor cell growth in vitro and in vivo. Loss of PD-L1 was also shown to attenuate DNA damage and apoptosis induced by diverse anti-cancer drugs that could be reversed by restoration of wild-type PD-L1, but not mutants with deletion of its extra- or intracellular domain. The effect of PD-L1 on chemosensitivity was confirmed in MC38 murine tumor xenografts generated from PD-L1-knockout vs. parental cells. Deletion of PD-L1 suppressed BH3-only BIM and BIK proteins that could be restored by re-expression of PD-L1; re-introduction of BIM enhanced apoptosis. PD-L1 expression was significantly increased in BRAF(V600E) human colon cancers, and patients whose tumors had high vs. low PD-L1 had significantly better survival. In summary, BRAF(V600E) can transcriptionally upregulate PD-L1 expression that was shown to induce BIM and BIK to enhance chemotherapy-induced apoptosis. These data indicate an intrinsic, non-immune function of PD-L1, and suggest the potential for tumor cell PD-L1 as a predictive biomarker.	[Feng, Daofu; Qin, Bo; Sun, Lei; Huang, Shengbing; Sinicrope, Frank A.] Gastrointestinal Res Unit, Rochester, MN 55905 USA; [Pal, Krishnendu; Dutta, Shamit; Mukhopadhyay, Debabrata] Mayo Clin, Dept Biochem & Mol Biol, Jacksonville, FL 32224 USA; [Dong, Haidong; Liu, Xin] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA; [Sinicrope, Frank A.] Dept Med, Rochester, MN 55905 USA; [Sinicrope, Frank A.] Dept Oncol, Rochester, MN 55905 USA; [Sinicrope, Frank A.] Mayo Clin, Rochester, MN 55905 USA; [Sinicrope, Frank A.] Mayo Comprehens Canc Ctr, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Sinicrope, FA (corresponding author), Gastrointestinal Res Unit, Rochester, MN 55905 USA.; Sinicrope, FA (corresponding author), Dept Med, Rochester, MN 55905 USA.; Sinicrope, FA (corresponding author), Dept Oncol, Rochester, MN 55905 USA.; Sinicrope, FA (corresponding author), Mayo Clin, Rochester, MN 55905 USA.; Sinicrope, FA (corresponding author), Mayo Comprehens Canc Ctr, Rochester, MN 55905 USA.	sinicrope.frank@mayo.edu		Pal, Krishnendu/0000-0002-4006-213X	NCI R01 [CA210509-01A1]; Scientific Research Training Program for Young Talents of Tianjin Medical University General Hospital, PRC; Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China; NATIONAL CANCER INSTITUTE [R01CA210509] Funding Source: NIH RePORTER	NCI R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Scientific Research Training Program for Young Talents of Tianjin Medical University General Hospital, PRC; Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported, in part, by NCI R01 (CA210509-01A1) to F.A.S. D.F. was supported by the Scientific Research Training Program for Young Talents of Tianjin Medical University General Hospital, PRC; current address is Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China. L.S. is supported by the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. The authors' express their gratitude to Mr. Matthew A. Bockol for downloading TCGA data.	Adams JM, 2018, CELL DEATH DIFFER, V25, P27, DOI 10.1038/cdd.2017.161; Atefi M, 2014, CLIN CANCER RES, V20, P3446, DOI 10.1158/1078-0432.CCR-13-2797; Audrito V, 2017, ONCOTARGET, V8, P15894, DOI 10.18632/oncotarget.15213; Azuma T, 2008, BLOOD, V111, P3635, DOI 10.1182/blood-2007-11-123141; Bae SU, 2018, ONCOL LETT, V16, P5214, DOI 10.3892/ol.2018.9264; Baeten JM, 2016, NEW ENGL J MED, V375, P2121, DOI 10.1056/NEJMoa1506110; Bhalla S, 2011, BLOOD, V118, P1052, DOI 10.1182/blood-2011-03-340109; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Chen N, 2015, J THORAC ONCOL, V10, P910, DOI 10.1097/JTO.0000000000000500; Clark CA, 2016, CANCER RES, V76, P6964, DOI 10.1158/0008-5472.CAN-16-0258; Corcoran RB, 2018, CANCER DISCOV, V8, P428, DOI 10.1158/2159-8290.CD-17-1226; Dong HD, 1999, NAT MED, V5, P1365; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Droeser RA, 2013, EUR J CANCER, V49, P2233, DOI 10.1016/j.ejca.2013.02.015; Ghebeh H, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2605; Guzman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092444; Hamanishi J, 2016, INT J CLIN ONCOL, V21, P462, DOI 10.1007/s10147-016-0959-z; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hersey P, 2013, CLIN CANCER RES, V19, P514, DOI 10.1158/1078-0432.CCR-12-3312; Kawakami H, 2016, MOL CANCER THER, V15, P3015, DOI 10.1158/1535-7163.MCT-16-0017; Kim MH, 2018, CANCER IMMUNOL RES, V6, P255, DOI 10.1158/2326-6066.CIR-17-0320; King AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062613; Kleffel S, 2015, CELL, V162, P1242, DOI 10.1016/j.cell.2015.08.052; Kopetz S, 2015, J CLIN ONCOL, V33, P4032, DOI 10.1200/JCO.2015.63.2497; Le DT, 2017, CANCER IMMUNOL RES, V5, P942, DOI 10.1158/2326-6066.CIR-17-0375; Lee BS, 2017, BIOCHEM BIOPH RES CO, V491, P493, DOI 10.1016/j.bbrc.2017.07.007; Li YQ, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0539-x; Liu JZ, 2007, BLOOD, V110, P296, DOI 10.1182/blood-2006-10-051482; Liu J, 2018, ONCOL LETT, V15, P3321, DOI 10.3892/ol.2017.7682; Loi S, 2016, CLIN CANCER RES, V22, P1499, DOI 10.1158/1078-0432.CCR-15-1125; Luo H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.3; Merino D, 2009, J CELL BIOL, V186, P355, DOI 10.1083/jcb.200905153; Missiaglia E, 2014, ANN ONCOL, V25, P1995, DOI 10.1093/annonc/mdu275; Monje P, 2005, J BIOL CHEM, V280, P35081, DOI 10.1074/jbc.C500353200; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Orzechowski A, 2014, CANCER RES, V74, DOI 10.1158/1538-7445.AM2014-5026; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Phipps AI, 2015, CANCER EPIDEM BIOMAR, V24, P1046, DOI 10.1158/1055-9965.EPI-15-0204; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Song MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055761; Sznol M, 2013, CLIN CANCER RES, V19, P5542, DOI 10.1158/1078-0432.CCR-13-2234; Taieb J, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw272; Tang HD, 2018, J CLIN INVEST, V128, P580, DOI 10.1172/JCI96061; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; Tu XY, 2019, MOL CELL, V74, P1215, DOI 10.1016/j.molcel.2019.04.005; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; YAN F, 2016, PLOS ONE, V11, DOI DOI 10.1371/JOURNAL.PONE.0156889; Yang SM, 2018, INT J MOL MED, V42, P3477, DOI 10.3892/ijmm.2018.3890; Zaanan A, 2015, J BIOL CHEM, V290, P23838, DOI 10.1074/jbc.M115.657833; Zhang P, 2018, MOL CANCER RES, V16, P378, DOI 10.1158/1541-7786.MCR-17-0404; Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37	54	36	41	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 10	2019	38	41					6752	6766		10.1038/s41388-019-0919-y	http://dx.doi.org/10.1038/s41388-019-0919-y			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JC8UZ	31406255	Green Accepted			2022-12-26	WOS:000489552900003
J	Wang, JC; Jiang, J; Chen, H; Wang, LY; Guo, H; Yang, LK; Xiao, DB; Qing, GL; Liu, HD				Wang, Jingchao; Jiang, Jue; Chen, Hui; Wang, Liyuan; Guo, Hao; Yang, Likun; Xiao, Daibiao; Qing, Guoliang; Liu, Hudan			FDA-approved drug screen identifies proteasome as a synthetic lethal target in MYC-driven neuroblastoma	ONCOGENE			English	Article							AMINO-ACID-METABOLISM; CELL-DEATH; N-MYC; STRESS; STABILIZATION; ATF4; BAX; TRANSFORMATION; AMPLIFICATION; ACETYLATION	MYCN amplification in neuroblastoma predicts poor prognosis and resistance to therapy. Yet pharmacological strategies of direct MYC inhibition remain unsuccessful due to its "undruggable" protein structure. We herein developed a synthetic lethal screen against MYCN-amplified neuroblastomas using clinically approved therapeutic reagents. We performed a high-throughput screen, from a library of 938 FDA-approved drugs, for candidates that elicit synthetic lethal effects in MYC-driven neuroblastoma cells. The proteasome inhibitors, which are FDA approved for the first-line treatment of multiple myeloma, emerge as top hits to elicit MYC-mediated synthetic lethality. Proteasome inhibition activates the PERK-eIF2 alpha-ATF4 axis in MYC-transformed cells and induces BAX-mediated apoptosis through ATF4-dependent NOXA and TRIB3 induction. A combination screen reveals the proteasome inhibitor bortezomib (BTZ) and the histone deacetylase (HDAC) inhibitor vorinostat (SAHA) concertedly induce dramatic cell death in part through synergistic activation of BAX. This combination causes marked tumor suppression in vivo, supporting dual proteasome/HDAC inhibition as a potential therapeutic approach for MYC-driven cancers. This FDA-approved drug screen with in vivo validation thus provides a rationale for clinical evaluation of bortezomib, alone or in combination with vorinostat, in MYC-driven neuroblastoma patients.	[Wang, Jingchao; Qing, Guoliang; Liu, Hudan] Wuhan Univ, Hubei Canc Clin Study Ctr, Dept Radiat & Med Oncol, Hubei Key Lab Tumor Biol Behav,Zhongnan Hosp, Wuhan 430071, Hubei, Peoples R China; [Wang, Jingchao; Jiang, Jue; Chen, Hui; Wang, Liyuan; Guo, Hao; Xiao, Daibiao; Qing, Guoliang; Liu, Hudan] Wuhan Univ, Med Res Inst, Wuhan 430071, Hubei, Peoples R China; [Yang, Likun] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Urol, Wuhan 430022, Hubei, Peoples R China	Wuhan University; Wuhan University; Huazhong University of Science & Technology	Qing, GL; Liu, HD (corresponding author), Wuhan Univ, Hubei Canc Clin Study Ctr, Dept Radiat & Med Oncol, Hubei Key Lab Tumor Biol Behav,Zhongnan Hosp, Wuhan 430071, Hubei, Peoples R China.; Qing, GL; Liu, HD (corresponding author), Wuhan Univ, Med Res Inst, Wuhan 430071, Hubei, Peoples R China.	qingguoliang@whu.edu.cn; hudanliu@whu.edu.cn			National Key R&D Program of China [2017YFA0505600]; National Natural Science Foundation of China [81830084, 81572736, 81770177]; National Science Fund for Distinguished Young Scholars [81725013]; Hubei Provincial Natural Science Fund for Distinguished Young Scholars [2017CFA072]; Hubei Provincial Natural Science Fund for Creative Research Groups [2018CFA018]; Innovative Research Grant from Wuhan University [2042017kf0282]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Hubei Provincial Natural Science Fund for Distinguished Young Scholars; Hubei Provincial Natural Science Fund for Creative Research Groups; Innovative Research Grant from Wuhan University	We are grateful to HL and GQ lab members for technical support and critical reading of the paper. We would like to thank the Core Facility of Medical Research Institute at Wuhan University for confocal microscopy and histological analysis. This study was supported by grants from the National Key R&D Program of China (2017YFA0505600 to GQ), the National Natural Science Foundation of China (81830084 and 81572736 to GQ, 81770177 to HL), National Science Fund for Distinguished Young Scholars (81725013 to GQ), Hubei Provincial Natural Science Fund for Distinguished Young Scholars (2017CFA072 to HL), Hubei Provincial Natural Science Fund for Creative Research Groups (2018CFA018 to GQ), and Innovative Research Grant from Wuhan University (2042017kf0282 to GQ).	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; Bhatt S, 2013, J CLIN INVEST, V123, P2616, DOI 10.1172/JCI64503; Braso-Maristany F, 2016, NAT MED, V22, P1303, DOI 10.1038/nm.4198; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Carracedo A, 2006, CANCER CELL, V9, P301, DOI 10.1016/j.ccr.2006.03.005; Carroll PA, 2015, CANCER CELL, V27, P271, DOI 10.1016/j.ccell.2014.11.024; Chen H, 2018, SIGNAL TRANSDUCT TAR, V3, DOI 10.1038/s41392-018-0008-7; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Cole KA, 2011, P NATL ACAD SCI USA, V108, P3336, DOI 10.1073/pnas.1012351108; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Gan L, 2016, ONCOGENE, V35, P3037, DOI 10.1038/onc.2015.360; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hart LS, 2012, J CLIN INVEST, V122, P4621, DOI 10.1172/JCI62973; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hui KF, 2013, MOL CANCER THER, V12, P747, DOI 10.1158/1535-7163.MCT-12-0811; Kessler JD, 2012, SCIENCE, V335, P348, DOI 10.1126/science.1212728; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Lange PS, 2008, J EXP MED, V205, P1227, DOI 10.1084/jem.20071460; Liu X, 2008, ONCOGENE, V27, P1478, DOI 10.1038/sj.onc.1210769; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; O'Neil NJ, 2017, NAT REV GENET, V18, P613, DOI 10.1038/nrg.2017.47; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Porro A, 2010, J BIOL CHEM, V285, P19532, DOI 10.1074/jbc.M109.078584; Qing GL, 2012, CANCER CELL, V22, P631, DOI 10.1016/j.ccr.2012.09.021; Raedler Lisa, 2015, Am Health Drug Benefits, V8, P135; Ren P, 2015, J PATHOL, V235, P90, DOI 10.1002/path.4429; Sato A, 2012, BJU INT, V109, P1258, DOI 10.1111/j.1464-410X.2011.10533.x; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Toyoshima M, 2012, P NATL ACAD SCI USA, V109, P9545, DOI 10.1073/pnas.1121119109; Voorhees PM, 2006, ANNU REV PHARMACOL, V46, P189, DOI 10.1146/annurev.pharmtox.46.120604.141300; Wang ZJ, 2017, CLIN CANCER RES, V23, P3834, DOI 10.1158/1078-0432.CCR-16-2880; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Xiao DB, 2016, MOL CELL, V64, P493, DOI 10.1016/j.molcel.2016.09.016; Xie H, 2018, J CLIN INVEST, V128, P1300, DOI 10.1172/JCI95864; Yue M, 2017, CELL REP, V21, P3819, DOI 10.1016/j.celrep.2017.12.002	43	22	22	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 10	2019	38	41					6737	6751		10.1038/s41388-019-0912-5	http://dx.doi.org/10.1038/s41388-019-0912-5			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JC8UZ	31406244				2022-12-26	WOS:000489552900002
J	Zhong, Z; Sepramaniam, S; Chew, XH; Wood, K; Lee, MA; Madan, B; Virshup, DM				Zhong, Zheng; Sepramaniam, Sugunavathi; Chew, Xin Hui; Wood, Kris; Lee, May Ann; Madan, Babita; Virshup, David M.			PORCN inhibition synergizes with PI3K/mTOR inhibition in Wnt-addicted cancers	ONCOGENE			English	Article							ADVANCED PANCREATIC-CANCER; IN-VIVO; C-MYC; GEMCITABINE; PHOSPHORYLATION; REVEALS; PATHWAY; PROTEIN; TRIAL; DEPENDENCIES	Pancreatic cancer (pancreatic ductal adenocarcinoma, PDAC) is aggressive and lethal. Although there is an urgent need for effective therapeutics in treating pancreatic cancer, none of the targeted therapies tested in clinical trials to date significantly improve its outcome. PORCN inhibitors show efficacy in preclinical models of Wnt-addicted cancers, including RNF43-mutant pancreatic cancers and have advanced to clinical trials. In this study, we aimed to develop drug combination strategies to further enhance the therapeutic efficacy of the PORCN inhibitor ETC-159. To identify additional druggable vulnerabilities in Wnt-driven pancreatic cancers, we performed an in vivo CRISPR loss-of-function screen. CTNNB1, KRAS, and MYC were reidentified as key oncogenic drivers. Notably, glucose metabolism pathway genes were important in vivo but less so in vitro. Knockout of multiple genes regulating PI3K/mTOR signaling impacted the growth of Wnt-driven pancreatic cancer cells in vivo. Importantly, multiple PI3K/mTOR pathway inhibitors in combination with ETC-159 synergistically suppressed the growth of multiple Wnt-addicted cancer cell lines in soft agar. Furthermore, the combination of the PORCN inhibitor ETC-159 and the pan-PI3K inhibitor GDC-0941 potently suppressed the in vivo growth of RNF43-mutant pancreatic cancer xenografts. This was largely due to enhanced suppressive effects on both cell proliferation and glucose metabolism. These findings demonstrate that dual PORCN and PI3K/mTOR inhibition is a potential strategy for treating Wnt-driven pancreatic cancers.	[Zhong, Zheng; Madan, Babita; Virshup, David M.] Duke NUS Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore; [Zhong, Zheng] Natl Univ Singapore, Dept Physiol, Singapore, Singapore; [Sepramaniam, Sugunavathi; Chew, Xin Hui; Lee, May Ann] ASTAR, Biopolis, Expt Therapeut Ctr, Singapore, Singapore; [Wood, Kris] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA; [Virshup, David M.] Duke Univ, Dept Pediat, Durham, NC 27706 USA	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Experimental Drug Development Centre (EDDC); Experimental Therapeutics Centre; Duke University; Duke University	Madan, B; Virshup, DM (corresponding author), Duke NUS Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore.; Virshup, DM (corresponding author), Duke Univ, Dept Pediat, Durham, NC 27706 USA.	babita.madan@duke-nus.edu.sg; david.virshup@duke-nus.edu.sg	Virshup, David M/C-1449-2009	Virshup, David M/0000-0001-6976-850X; Zhong, Zheng/0000-0003-1614-7798; Wood, Kris/0000-0002-5887-2253	National Research Foundation Singapore; Singapore Ministry of Health's National Medical Research Council Open Fund-Independent Research Grant	National Research Foundation Singapore(National Research Foundation, Singapore); Singapore Ministry of Health's National Medical Research Council Open Fund-Independent Research Grant(Ministry of Health-SingaporeNational Medical Research Council, Singapore)	This study is supported in part by the National Research Foundation Singapore and administered by the Singapore Ministry of Health's National Medical Research Council under the STAR Award Program to DMV. BM acknowledges the support of the Singapore Ministry of Health's National Medical Research Council Open Fund-Independent Research Grant. We gratefully acknowledge the assistance from Yun Ka Wong and other members of both the Virshup lab and the Experimental Therapeutics Centre. We thank Prof. Stuart Cook and Edmund Pua for help with the MiSeq; Muhammad Idris Bin Kachi Mydin for help with bioinformatic analysis; Duke-NUS Metabolomics Facility, Dr. Jianhong Ching, and Dr. Zing Tan for help with the glucose metabolite quantification, and Profs. Shazib Pervaiz and Patrick Tan for useful suggestions on this study. Figure 1a was adapted from Servier Medical Art, licensed under a Creative Commons Attribution 3.0 Unported License (https://smart.servier.com).	Anderson GR, 2017, CELL REP, V20, P999, DOI 10.1016/j.celrep.2017.07.006; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Cancer Genome Atlas Research Network. Electronic address: andrew_aguirre@dfci.harvard.edu, 2017, Cancer Cell, V32, P185, DOI 10.1016/j.ccell.2017.07.007; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Chung V, 2017, JAMA ONCOL, V3, P516, DOI 10.1001/jamaoncol.2016.5383; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Hammel P, 2016, JAMA-J AM MED ASSOC, V315, P1844, DOI 10.1001/jama.2016.4324; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Infante JR, 2014, EUR J CANCER, V50, P2072, DOI 10.1016/j.ejca.2014.04.024; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Janku F, 2015, MOL CANCER THER, V14, pC45, DOI DOI 10.1158/1535-7163.TARG-15-C45; Javle MM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-368; Jiang XM, 2013, P NATL ACAD SCI USA, V110, P12649, DOI 10.1073/pnas.1307218110; Ko AH, 2016, CLIN CANCER RES, V22, P61, DOI 10.1158/1078-0432.CCR-15-0979; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Lin RT, 2015, NAT CELL BIOL, V17, P1484, DOI 10.1038/ncb3255; Madan B, 2016, ONCOGENE, V35, P2197, DOI 10.1038/onc.2015.280; Madan B, 2018, J CLIN INVEST, V128, P5620, DOI 10.1172/JCI122383; Madan B, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0017-8; Madan B, 2016, ONCOTARGET, V7, P12386, DOI 10.18632/oncotarget.7157; McDonald ER, 2017, CELL, V170, P577, DOI 10.1016/j.cell.2017.07.005; Miller TE, 2017, NATURE, V547, P355, DOI 10.1038/nature23000; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Muir A, 2018, SCIENCE, V360, P962, DOI 10.1126/science.aar5986; Najdi R, 2012, DIFFERENTIATION, V84, P203, DOI 10.1016/j.diff.2012.06.004; Ng M, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.2584; Papke B, 2017, SCIENCE, V355, P1158, DOI 10.1126/science.aam7622; Pate KT, 2014, EMBO J, V33, P1454, DOI 10.15252/embj.201488598; Picco G, 2017, EMBO MOL MED, V9, P293, DOI 10.15252/emmm.201606773; Possik PA, 2014, CELL REP, V9, P1375, DOI 10.1016/j.celrep.2014.10.024; Proffitt KD, 2012, J BIOL CHEM, V287, P34167, DOI 10.1074/jbc.M112.381970; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Schmid P, 2016, J CLIN ONCOL, V34, P1987, DOI 10.1200/JCO.2015.63.9179; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Van Cutsem E, 2017, J CLIN ONCOL, V33, P344; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Wall M, 2008, BLOOD, V112, P2305, DOI 10.1182/blood-2007-09-111856; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Ward PS, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006783; Whittaker SR, 2004, CANCER RES, V64, P262, DOI 10.1158/0008-5472.CAN-03-0110; Wolpin BM, 2009, J CLIN ONCOL, V27, P193, DOI 10.1200/JCO.2008.18.9514; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Zhang L, 2014, J BIOL CHEM, V289, P24863, DOI 10.1074/jbc.M114.586818	53	36	36	1	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 3	2019	38	40					6662	6677		10.1038/s41388-019-0908-1	http://dx.doi.org/10.1038/s41388-019-0908-1			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JC0EY	31391551	hybrid			2022-12-26	WOS:000488953500002
J	Maehara, M; Rah, JH; Roshita, A; Suryantan, J; Rachmadewi, A; Izwardy, D				Maehara, Masumi; Rah, Jee Hyun; Roshita, Airin; Suryantan, Julia; Rachmadewi, Asrinisa; Izwardy, Doddy			Patterns and risk factors of double burden of malnutrition among adolescent girls and boys in Indonesia	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; PHYSICAL-ACTIVITY; OBESITY; OVERWEIGHT; PREVALENCE; TRENDS; UNDERNUTRITION; DETERMINANTS; CHILDHOOD; CHILDREN	Objectives As an emerging middle-income country, Indonesia is grappling with the double burden of malnutrition across all age groups, including adolescents. Slow gains in reducing undernutrition are compounded by rapidly increasing overnutrition. This study aims to determine the patterns and determinants of this double burden, particularly stunting, thinness and overweight, among adolescent girls and boys aged 12-18 years in Indonesia. Methods A cross-sectional survey was conducted among 2,160 girls and boys in the districts of Klaten and Lombok Barat in 2017. Data were collected on adolescents' nutritional status, socio-demographic characteristics, morbidity, dietary intake and physical activity and other relevant factors. Multivariable logistic regression models using generalized estimation equation were employed to determine risk factors for stunting, thinness and overweight. Results About a quarter of adolescent girls (25%) and boys (21%) were stunted. Approximately 5% of girls and 11% of boys were thin, whereas 11% girls and boys each were overweight. Living in a higher wealth household (OR = 0.67; 95% CI: 0.49-0.91), compared to a lower wealth household, and living in a district with higher socioeconomic status (OR = 0.63; 95% CI: 0.51-0.79) were associated with lower odds of being stunted. Adolescent education was also protective against stunting (OR = 0.52; 95% CI: 0.33-0.88). Older adolescents aged 15-18 years were more likely to be stunted (OR = 1.88; 95% CI: 1.42-2.46). Being a girl was associated with reduced odds of being thin (OR = 0.42; 95% CI: 0.30-0.58). Higher household wealth (OR = 1.93; 95% CI: 1.27-2.97) predicted being overweight, while maternal primary or some secondary education, compared to no or incomplete primary education, was protective against adolescent overweight (OR = 0.60; 95% CI: 0.40-0.90). Conclusion Indonesian adolescent girls and boys face both extreme spectrums of malnutrition. Addressing the dual burden of malnutrition requires a multi-pronged approach, and urgent shift is warranted in nutrition policy and programmes targeting adolescents to effectively address the associated underlying determinants.	[Maehara, Masumi; Rah, Jee Hyun; Roshita, Airin] United Nations Childrens Fund, Child Survival & Dev Cluster, Nutr Unit, Jakarta, Indonesia; [Suryantan, Julia; Rachmadewi, Asrinisa] Savica Publ Hlth & Commun Consultancy, Jakarta, Indonesia; [Izwardy, Doddy] Minist Hlth, Directorate Community Nutr, Jakarta, Indonesia	Ministry of Health - Indonesia	Maehara, M (corresponding author), United Nations Childrens Fund, Child Survival & Dev Cluster, Nutr Unit, Jakarta, Indonesia.	mmaehara@unicef.org			Government of Canada; Canadian UNICEF Committee; 25th Team for the project "Addressing MNCH gaps to create scalable investments for the future"	Government of Canada(CGIAR); Canadian UNICEF Committee; 25th Team for the project "Addressing MNCH gaps to create scalable investments for the future"	The study was funded by The Government of Canada, Canadian UNICEF Committee and the 25th Team for the project "Addressing MNCH gaps to create scalable investments for the future" to UNICEF and implemented by UNICEF Indonesia and the Ministry of Health Republic Indonesia. The funders had no role in study design, data collection and analysis, decision to public or preparation of the manuscript.	Abdullah A, 2015, CURR OBES REP, V4, P337, DOI 10.1007/s13679-015-0170-y; Aryeetey Richmond, 2017, BMC Obes, V4, P38, DOI 10.1186/s40608-017-0174-0; Badan Pusat Statistik, 2018, PERC POOR PEOPL 2007; Badan Pusat Statistik, 2018, POV SEV IND PROV 200; Bassett R, 2008, APPETITE, V50, P325, DOI 10.1016/j.appet.2007.08.009; BRANCA F, 2015, BMJ-BRIT MED J, V351, DOI DOI 10.1136/BMJ.H4173; Brown JE., 2016, NUTR LIFE CYCLE, P266; Candler T, 2017, J ADOLESCENT HEALTH, V60; Chowdhury S, 2000, ANN HUM BIOL, V27, P249, DOI 10.1080/030144600282136; Christian P, 2018, ANN NUTR METAB, V72, P316, DOI 10.1159/000488865; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Demographic and Health Surveys Program, DHS PROGR WEALTH IND; deOnis M, 2007, B WHO; FHI 360/LINKAGES, 2016, MINIMUM DIETARY DIVE; Ford ND, 2017, ANNU REV PUBL HEALTH, V38, P145, DOI 10.1146/annurev-publhealth-031816-044604; Haddad L, 2015, HEALTH POLICY PLANN, V30, P1193, DOI 10.1093/heapol/czu110; Indonesia Central Bureau of Statistics, 2017, IND STAT IND STAT; Jaacks LM, 2015, PEDIATR OBES, V10, P428, DOI 10.1111/ijpo.12000; Janssen I, 2005, OBES REV, V6, P123, DOI 10.1111/j.1467-789X.2005.00176.x; KELDER SH, 1994, AM J PUBLIC HEALTH, V84, P1121, DOI 10.2105/AJPH.84.7.1121; Laxmaiah A, 2007, OBESITY, V15, P1384, DOI 10.1038/oby.2007.165; Lopez-Arana S, 2013, OBES REV, V14, P806, DOI 10.1111/obr.12051; Matthiessen J, 2014, ACTA PAEDIATR, V103, P1083, DOI 10.1111/apa.12722; Mboi N, 2018, LANCET, V392, P581, DOI 10.1016/S0140-6736(18)30595-6; Miller J, 2009, INVESTASI UNTUK KESE; Mistry SK, 2015, PUBLIC HEALTH, V129, P200, DOI 10.1016/j.puhe.2014.12.004; National Institute of Research and Development M of H, 2013, BAS HLTH RES SURV; Osteria TS., PHILIPP J NUTR, V36, P150; Peltzer K, 2011, INT J ENV RES PUB HE, V8, P3859, DOI 10.3390/ijerph8103859; Pengpid S, 2016, SE ASIAN J TROP MED, V47, P250; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Rah JH, 2009, PUBLIC HEALTH NUTR, V12, P2400, DOI 10.1017/S1368980009005345; Roemling C, 2012, APPETITE, V58, P1005, DOI 10.1016/j.appet.2012.02.053; Rogol AD, 2000, AM J CLIN NUTR, V72, p521S, DOI 10.1093/ajcn/72.2.521S; Shrimpton R., 2013, DOUBLE BURDEN MALNUT; SPEAR BA, 2002, J AM DIET ASSOC, V102, pS2; Story M, 2002, J AM DIET ASSOC, V102, pS40, DOI 10.1016/S0002-8223(02)90421-9; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Telama R, 2005, AM J PREV MED, V28, P267, DOI 10.1016/j.amepre.2004.12.003; Ullmann SH, 2011, INT J PEDIATR OBES, V6, pE373, DOI 10.3109/17477166.2010.498520; UNICEF Reality Check Approach, 2016, REAL CHECK APPR AD T; Viner RM, 2012, LANCET, V379, P1641, DOI 10.1016/S0140-6736(12)60149-4; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Yi XQ, 2012, EUR J PEDIATR, V171, P389, DOI 10.1007/s00431-011-1566-7	44	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0221273	10.1371/journal.pone.0221273	http://dx.doi.org/10.1371/journal.pone.0221273			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5OC	31430324	gold, Green Published, Green Submitted			2022-12-26	WOS:000485026800039
J	Martemyanov, V; Bykov, R; Demenkova, M; Gninenko, Y; Romancev, S; Bolonin, I; Mazunin, I; Belousova, I; Akhanaev, Y; Pavlushin, S; Krasnoperova, P; Ilinsky, Y				Martemyanov, Vyacheslav; Bykov, Roman; Demenkova, Marya; Gninenko, Yuri; Romancev, Sergei; Bolonin, Ivan; Mazunin, Ilia; Belousova, Irina; Akhanaev, Yuri; Pavlushin, Sergey; Krasnoperova, Polina; Ilinsky, Yury			Genetic evidence of broad spreading of Lymantria dispar in the West Siberian Plain	PLOS ONE			English	Article							ASIAN GYPSY-MOTH; POPULATION-DYNAMICS; FOREST LEPIDOPTERA; DISPERSAL; OUTBREAKS; SYNCHRONY; LINNAEUS; GROWTH	Gypsy moth Lymantria dispar L. 1758 (Lepidoptera: Erebidae) is one of the most dangerous forest pests of the Holarctic region. Outbreaks of gypsy moth populations lead to significant defoliation of local forests. Within the vast territory of the West Siberian Plain, we noted the outbreak front movement in the north-east direction with a speed 100-200 km per year. The reason for the outbreak's movement is still unclear because L. dispar females are characterised by limited flight ability, which is not enough to support that movement per se. Herein, we analysed the mtDNA divergence pattern among L. dispar populations collected from the vast territory of the West Siberian Plain to determine the boundaries of populations and reveal the effect of the outbreak's front movement on mtDNA patterns of populations. The 590-bp region of the cytochrome oxidase subunit I gene of the mitochondrial genome was sequenced for 220 specimens that were collected from 18 localities along a transect line (similar to 1400 km). Our results clearly show that the gypsy moth populations of the vast Siberian territory are not subdivided. This result can be explained by extensive genetic exchange among local populations. Taking into account that the flight ability of L. dispar females is rather limited, we suggest that spreading occurs through ballooning of early instar larvae. This hypothesis was confirmed by the coincidence of the outbreaks' movement direction with that of the dominant winds, complemented by the observation of ballooned larvae far from a forest edge.	[Martemyanov, Vyacheslav; Belousova, Irina; Akhanaev, Yuri; Pavlushin, Sergey] RAS, Inst Systemat & Ecol Anim SB, Novosibirsk, Russia; [Martemyanov, Vyacheslav] Natl Res Tomsk State Univ, Biol Inst, Tomsk, Russia; [Bykov, Roman; Demenkova, Marya; Ilinsky, Yury] RAS, Inst Cytol & Genet SB, Novosibirsk, Russia; [Gninenko, Yuri] All Russian Res Inst Silviculture & Mechanizat Fo, Pushchino, Moscow Region, Russia; [Romancev, Sergei; Bolonin, Ivan] FSI Russian Ctr Forest Hlth, Novosibirsk, Russia; [Mazunin, Ilia; Ilinsky, Yury] Baltic Fed Univ, Kaliningrad, Russia; [Mazunin, Ilia] Skolkovo Inst Sci & Technol, Ctr Life Sci, Skolkovo, Russia; [Krasnoperova, Polina] Siberian Fed Univ, Krasnoyarsk, Russia; [Ilinsky, Yury] All Russian Plant Quarantine Ctr, Bykovo, Moscow Oblast, Russia	Russian Academy of Sciences; Tomsk State University; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; All-Russian Research Institute for Silviculture & Mechanization of Forestry; Immanuel Kant Baltic Federal University; Skolkovo Institute of Science & Technology; Siberian Federal University	Martemyanov, V (corresponding author), RAS, Inst Systemat & Ecol Anim SB, Novosibirsk, Russia.; Martemyanov, V (corresponding author), Natl Res Tomsk State Univ, Biol Inst, Tomsk, Russia.; Ilinsky, Y (corresponding author), RAS, Inst Cytol & Genet SB, Novosibirsk, Russia.; Ilinsky, Y (corresponding author), Baltic Fed Univ, Kaliningrad, Russia.; Ilinsky, Y (corresponding author), All Russian Plant Quarantine Ctr, Bykovo, Moscow Oblast, Russia.	martemyanov79@yahoo.com; paulee@bionet.nsc.ru	Pavlushin, Sergey/AAH-5329-2019; Krasnoperova, Polina/GRF-1225-2022; Bykov, Roman/AAD-2410-2022; Solodushenkova, Anastasia/H-1732-2019; Martemyanov, Vyacheslav/Q-7466-2016; Belousova, Irina A/L-3280-2017; Ilinsky, Yury Y/A-1326-2017	Pavlushin, Sergey/0000-0002-4210-0662; Krasnoperova, Polina/0000-0002-2499-2230; Bykov, Roman/0000-0001-7405-1773; Akhanaev, Yuriy/0000-0003-3180-5998; Ilinsky, Yury/0000-0002-2691-3241; Martemyanov, Vyacheslav/0000-0002-7061-3772	Russian Foundation for basic research [15-29-02676]; Russian Science Foundation [17-46-07002]; State Budgeted Project [0324-2019-0041]; Federal Fundamental Scientific Research Programme for 2013-2020 [-16-116121410123-1]	Russian Foundation for basic research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF)); State Budgeted Project; Federal Fundamental Scientific Research Programme for 2013-2020	The study was funded by the Russian Foundation for basic research (grant #15-29-02676 for VM) and by the Russian Science Foundation (partial sequencing of DNA samples) (grant #17-46-07002 for VM), as well as partially by State Budgeted Project No 0324-2019-0041 (grant for YI) and The Federal Fundamental Scientific Research Programme for 2013-2020 (-16-116121410123-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allstadt AJ, 2013, OECOLOGIA, V172, P141, DOI 10.1007/s00442-012-2474-x; [Anonymous], 2007, RUK PLAN ORG VED LES; [Anonymous], 1987, DIGITAL SPECTRAL ANA; Bakhvalov SA, 2010, FACTORS ECOLOGICAL M, P296; BANDELT HJ, 1995, GENETICS, V141, P743; Baranchikov Y. N., 1989, P LYM COMP FEAT NEW, P319; Bell JR, 2005, B ENTOMOL RES, V95, P69, DOI 10.1079/BER2004350; Bogdanowicz SM, 2000, MOL PHYLOGENET EVOL, V15, P487, DOI 10.1006/mpev.1999.0744; Box G. E. P., 1970, Time series analysis, forecasting and control; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; deWaard JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014280; Djoumad A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14530-6; Doane C. C., 1981, GYPSY MOTH RES INTEG; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EDLAND T, 1971, Norsk Entomologisk Tidsskrift, V18, P103; Elton CS, 1924, BR J EXP BIOL, V2, P119; Ferreri M, 2011, AFR J BIOTECHNOL, V10, P12799; Franklin MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096679; Fu YX, 1997, GENETICS, V147, P915; GIESE RL, 1979, ENTOMOL NEWS, V90, P1; Gninenko YuI, 2003, LESNOY VESTNIK MGUL, V2, P166; Hajek AE, 2009, USE MICROBES CONTROL; Hamming R. W., 1989, DIGITAL FILTERS; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Ilinsky Y. Y., 2017, Evraziatskii Entomologicheskii Zhurnal, V16, P1; Inoue MN, 2019, FOREST ECOL MANAG, V434, P154, DOI 10.1016/j.foreco.2018.12.022; Iwaizumi R, 2010, APPL ENTOMOL ZOOL, V45, P121, DOI 10.1303/aez.2010.121; Johnson DM, 2005, J ANIM ECOL, V74, P882, DOI 10.1111/j.1365-2656.2005.00980.x; Kendall MG, 1976, ADV THEORY STAT DESI; Kravcov VM, 1999, GEOGRAPHY NOVOSIBIRS; Leggett HC, 2011, ECOL ENTOMOL, V36, P318, DOI 10.1111/j.1365-2311.2011.01275.x; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liebhold A, 2000, POPUL ECOL, V42, P257, DOI 10.1007/PL00012004; Liebhold AM, 2008, AGR FOREST ENTOMOL, V10, P69, DOI 10.1111/j.1461-9563.2007.00359.x; Liebhold AM, 2006, POPUL ECOL, V48, P253, DOI 10.1007/s10144-006-0014-4; Martemyanov VV, 2016, ECOL EVOL, V6, P7298, DOI 10.1002/ece3.2460; Martemyanov VV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130988; Myers JH, 1998, ECOLOGY, V79, P1111, DOI 10.1890/0012-9658(1998)079[1111:SIOOFL]2.0.CO;2; Myers JH, 2013, ANNU REV ECOL EVOL S, V44, P565, DOI 10.1146/annurev-ecolsys-110512-135858; Nei M., 2000, MOL EVOLUTION PHYLOG; Picq S, 2018, EVOL APPL, V11, P325, DOI 10.1111/eva.12559; Pogue M., 2007, REV SELECTED SPECIES; QIAN TR, 2000, PLANTS QUARANTINE, V14, P317; Rozkhov AS, 1982, GYPSYS MOTH CENTRAL, P4; Schoonhoven L. M., 2005, Insect-plant biology; Soukhovolsky VG, 2015, ZH OBSHCH BIOL, V76, P179; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tenow O, 2013, J ANIM ECOL, V82, P84, DOI 10.1111/j.1365-2656.2012.02023.x; Tropin IV, 1965, CONTROL CALCULATION; Weseloh RM, 1997, CAN ENTOMOL, V129, P355, DOI 10.4039/Ent129355-2; Wu YK, 2015, MOL ECOL, V24, P1275, DOI 10.1111/mec.13103; Yang F, 2017, APPL ENTOMOL ZOOL, V52, P265, DOI 10.1007/s13355-016-0475-7	55	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0220954	10.1371/journal.pone.0220954	http://dx.doi.org/10.1371/journal.pone.0220954			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430316	gold, Green Published, Green Submitted			2022-12-26	WOS:000485026800019
J	Sokol, JT; Schechet, SA; Rosen, DT; Ferenchak, K; Dawood, S; Skondra, D				Sokol, Jared T.; Schechet, Sidney A.; Rosen, Darin T.; Ferenchak, Kevin; Dawood, Sherif; Skondra, Dimitra			Outcomes of vitrectomy for diabetic tractional retinal detachment in Chicago's county health system	PLOS ONE			English	Article							PARS-PLANA VITRECTOMY; TRANSCONJUNCTIVAL SUTURELESS VITRECTOMY; 23-GAUGE VITRECTOMY; PROGNOSTIC-FACTORS; VISUAL OUTCOMES; RETINOPATHY; MANAGEMENT; SURGERY; COMPLICATIONS	Purpose To examine outcomes of 23-gauge (23G) pars plana vitrectomy (PPV) for complex diabetic tractional retinal detachment (TRD) in Chicago's Cook County Health and Hospitals System (CCHHS). Materials and methods This is a retrospective noncomparative study of diabetic TRD cases that underwent PPV at CCHHS. Primary retinal reattachment rate, visual function, and postoperative complications were analyzed. Results Sixty nine consecutive cases were included. Primary reattachment and final attachment were achieved in 68/69 eyes (98.6%). Secondary retinal detachment was noted in 1 eye (1.4%). Vitreous hemorrhage requiring repeat PPV developed in 5 eyes (7.2%) and reoperation due to other complications was required in 4/69 eyes (5.8%). Perfluoropropane (C3F8) gas tamponade was used in 91.3% of eyes and silicone oil in 8.7% of eyes. Mean LogMAR visual acuity significantly improved from 1.84 +/- 0.61 to 0.93 +/- 0.66, (P<0.0001). Vision was stabilized or improved in 66 eyes (95.7%). Visual acuity of 20/200 or better was achieved in 49/69 eyes (71.0%) and 20/50 or better in 16/69 eyes (23.2%). Conclusions Even in patients with severe and advanced diabetic TRD pathology and unique demographics as seen in CCHHS, modern vitrectomy techniques can provide excellent anatomical and visual outcomes.	[Sokol, Jared T.; Schechet, Sidney A.; Rosen, Darin T.; Skondra, Dimitra] Univ Chicago, Dept Ophthalmol & Visual Sci, Chicago, IL 60637 USA; [Ferenchak, Kevin; Dawood, Sherif; Skondra, Dimitra] Chicago Cook Cty Hosp & Hlth Syst CCHHS, Dept Ophthalmol, Chicago, IL 60612 USA	University of Chicago	Skondra, D (corresponding author), Univ Chicago, Dept Ophthalmol & Visual Sci, Chicago, IL 60637 USA.; Skondra, D (corresponding author), Chicago Cook Cty Hosp & Hlth Syst CCHHS, Dept Ophthalmol, Chicago, IL 60612 USA.	dskondra@bsd.uchicago.edu		Schechet, Sidney/0000-0001-8996-3855				Altan T, 2008, RETINA-J RET VIT DIS, V28, P1201, DOI 10.1097/IAE.0b013e3181853d3c; Arevalo J Fernando, 2008, Ophthalmology, V115, pe21, DOI 10.1016/j.ophtha.2008.02.008; Berrocal MH, 2018, RETINA-J RET VIT DIS, V38, pS2, DOI 10.1097/IAE.0000000000001884; CANNY CLB, 1985, CAN J OPHTHALMOL, V20, P11; Choovuthayakorn J, 2019, J OPHTHALMOL, V2019, DOI 10.1155/2019/9481902; Dikopf MS, 2015, EYE, V29, P1213, DOI 10.1038/eye.2015.126; Eckardt C, 2005, RETINA-J RET VIT DIS, V25, P208, DOI 10.1097/00006982-200502000-00015; El-Batarny AM, 2008, MIDDLE EAST AFR J OP, V15, P99, DOI 10.4103/0974-9233.51983; Emanuele N, 2005, DIABETES CARE, V28, P1954, DOI 10.2337/diacare.28.8.1954; Farouk MM, 2011, GRAEF ARCH CLIN EXP, V249, P369, DOI 10.1007/s00417-010-1506-7; Fine HF, 2007, OPHTHALMOLOGY, V114, P1197, DOI 10.1016/j.ophtha.2007.02.020; Flaxel CJ, 2007, RETINA-J RET VIT DIS, V27, P1274, DOI 10.1097/IAE.0b013e31805d0bfb; FLYNN HW, 1992, OPHTHALMOLOGY, V99, P1351; Fong DS, 1999, AM J OPHTHALMOL, V127, P137, DOI 10.1016/S0002-9394(98)00309-2; Fortun JA, 2011, ARCH OPHTHALMOL-CHIC, V129, P352, DOI 10.1001/archophthalmol.2011.15; Gupta B, 2012, EYE, V26, P576, DOI 10.1038/eye.2011.348; Khan M Ali, 2019, Retin Cases Brief Rep, V13, P244, DOI 10.1097/ICB.0000000000000571; Khan MA, 2018, OPHTHALMOLOGY, V125, P423, DOI 10.1016/j.ophtha.2017.09.013; Kumar A, 2014, EUR J OPHTHALMOL, V24, P107, DOI 10.5301/ejo.5000305; Kwon JW, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006263; La Heij EC, 2004, GRAEF ARCH CLIN EXP, V242, P210, DOI 10.1007/s00417-003-0815-5; Lange C, 2009, GRAEF ARCH CLIN EXP, V247, P137, DOI 10.1007/s00417-008-0926-0; LEWIS H, 1987, AM J OPHTHALMOL, V104, P607, DOI 10.1016/0002-9394(87)90173-5; Machemer R, 1971, Trans Am Acad Ophthalmol Otolaryngol, V75, P813; Mason JO, 2005, AM J OPHTHALMOL, V140, P231, DOI 10.1016/j.ajo.2005.02.052; Meier P, 1997, GRAEF ARCH CLIN EXP, V235, P569, DOI 10.1007/BF00947086; Meleth Annal D, 2014, Int Ophthalmol Clin, V54, P127, DOI 10.1097/IIO.0000000000000021; Michels R G, 1981, Retina, V1, P1; Mikhail M, 2017, GRAEF ARCH CLIN EXP, V255, P255, DOI 10.1007/s00417-016-3442-7; NOVAK MA, 1984, OPHTHALMOLOGY, V91, P1485; Oliveira LB, 2007, RETINA-J RET VIT DIS, V27, P1054, DOI 10.1097/IAE.0b013e318113235e; Oshima Y, 2009, OPHTHALMOLOGY, V116, P927, DOI 10.1016/j.ophtha.2008.11.005; Ostri C, 2014, ACTA OPHTHALMOL, V92, P571, DOI 10.1111/aos.12325; Ozone D, 2011, OPHTHALMOLOGICA, V226, P76, DOI 10.1159/000328407; Rahimy E, 2015, RETINA-J RET VIT DIS, V35, P303, DOI 10.1097/IAE.0000000000000310; RICE TA, 1983, AM J OPHTHALMOL, V95, P22, DOI 10.1016/0002-9394(83)90330-6; RICE TA, 1983, AM J OPHTHALMOL, V95, P1; Ryan S.J., 2012, RETINA-J RET VIT DIS; SCHACHAT AP, 1983, OPHTHALMOLOGY, V90, P522; Schoenberger SD, 2011, OPHTHAL SURG LAS IM, V42, P474, DOI 10.3928/15428877-20110901-02; SEBESTYEN JG, 1982, ANN OPHTHALMOL, V14, P853; Shroff CM, 2018, RETINA-J RET VIT DIS, V38, pS134, DOI 10.1097/IAE.0000000000002093; Silva PS, 2014, RETINA-J RET VIT DIS, V34, P1960, DOI 10.1097/IAE.0000000000000171; Smiddy WE, 1999, SURV OPHTHALMOL, V43, P491, DOI 10.1016/S0039-6257(99)00036-3; Steinmetz RL, 2002, OPHTHALMOLOGY, V109, P2303, DOI 10.1016/S0161-6420(02)01291-5; Sternfeld Amir, 2015, Clin Ophthalmol, V9, P1989, DOI 10.2147/OPTH.S90577; Storey PP, 2018, RETINA-J RET VIT DIS, V38, P1913, DOI 10.1097/IAE.0000000000001793; Tao Y, 2010, RETINA-J RET VIT DIS, V30, P447, DOI 10.1097/IAE.0b013e3181d374a5; THOMPSON JT, 1987, ARCH OPHTHALMOL-CHIC, V105, P497; TOLENTINO FI, 1980, OPHTHALMOLOGY, V87, P1078; Tsang CW, 2008, RETINA-J RET VIT DIS, V28, P1075, DOI 10.1097/IAE.0b013e31817b98ba; Velez-Montoya R, 2011, CLIN OPHTHALMOL, V5, P1709, DOI 10.2147/OPTH.S26838; Wang ZY, 2016, ACTA OPHTHALMOL, V94, P365, DOI 10.1111/aos.12951; WILLIAMS DF, 1989, OPHTHALMOLOGY, V96, P752; Wimpissinger B, 2008, BRIT J OPHTHALMOL, V92, P1483, DOI 10.1136/bjo.2008.140509; Wu Wen-Chuan, 1999, Kaohsiung Journal of Medical Sciences, V15, P461; Yorston D, 2008, BRIT J OPHTHALMOL, V92, P365, DOI 10.1136/bjo.2007.124495	57	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0220726	10.1371/journal.pone.0220726	http://dx.doi.org/10.1371/journal.pone.0220726			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430299	Green Published, Green Submitted, gold			2022-12-26	WOS:000485026800013
J	Zheng, Y; Liu, HM; Zhuo, Y; Li, ZY; Liang, CZ; Wang, LX				Zheng, Ying; Liu, Huamin; Zhuo, Yi; Li, Zhiyong; Liang, Cunzhu; Wang, Lixin			Dynamic changes and driving factors of wetlands in Inner Mongolia Plateau, China	PLOS ONE			English	Article							CLIMATE-CHANGE; LONG-TERM; ECOSYSTEM; LAKE; RECLAMATION; MARSHES; TRENDS; PLAIN	Wetlands are one of the most critical resources in Inner Mongolia Plateau. However, the region has experienced severe wetland loss in the context of global change. To quantify the dynamic change and the related driving forces, we extracted wetland information using multi-temporal Landsat images between 1993 and 2013 using ArcGIS platform and man machine interactive interpretation. Dynamically changing characteristics for the past 20 years were analyzed, including wetland types and spatial distribution patterns of the wetlands in Inner Mongolia. We also performed correlation analysis and generalized linear models to quantify the contribution of natural and human factors to the changes in natural wetland area. Our results indicated that the total area of wetlands was 42421.2 km(2) in 1993, and decreased to 38912.4 km(2) in 2013, a decline ratio of 8.3%. Meanwhile, all types of wetlands showed a trend of transformation into non-wetlands. Anthropogenic factors led to the loss of natural wetlands in Inner Mongolia. In grasslands, mining coal was the dominant driver for natural wetland loss, while in arable lands, agricultural encroachment and irrigation were the primary driving forces. These findings can provide meaningful information for improving sustainable wetlands management strategies according to local conditions in different sub-regions.	[Zheng, Ying; Liu, Huamin; Zhuo, Yi; Li, Zhiyong; Liang, Cunzhu; Wang, Lixin] Inner Mongolia Univ, Sch Ecol & Environm, Hohhot, Peoples R China; [Liang, Cunzhu; Wang, Lixin] Inner Mongolia Univ, SUCCESS Ctr, Hohhot, Peoples R China; [Wang, Lixin] Inner Mongolia Univ, Inner Mongolia Key Lab Environm Pollut Control &, Hohhot, Peoples R China	Inner Mongolia University; Inner Mongolia University; Inner Mongolia University	Wang, LX (corresponding author), Inner Mongolia Univ, Sch Ecol & Environm, Hohhot, Peoples R China.; Wang, LX (corresponding author), Inner Mongolia Univ, SUCCESS Ctr, Hohhot, Peoples R China.; Wang, LX (corresponding author), Inner Mongolia Univ, Inner Mongolia Key Lab Environm Pollut Control &, Hohhot, Peoples R China.	Lx_wimu@163.com			National Natural Science Funds, P. R. China [31560146, 41562020, 41571090]; Science and Technology Major Project of Inner Mongolia [ZDZX2018054]; Science and Technology Project of Inner Mongolia [201802100]	National Natural Science Funds, P. R. China(National Natural Science Foundation of China (NSFC)); Science and Technology Major Project of Inner Mongolia; Science and Technology Project of Inner Mongolia	This research was supported by, the National Natural Science Funds, P. R. China (No. 31560146, 41562020 and 41571090 to LW), Science and Technology Major Project of Inner Mongolia (No. ZDZX2018054 to LW) and Science and Technology Project of Inner Mongolia (No. 201802100 to LW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao Y., 1998, CHINA PROGR GEOGRAPH, V17, P49; Beuel S, 2016, ECOL INDIC, V67, P684, DOI 10.1016/j.ecolind.2016.03.034; Brinson MM, 2002, ENVIRON CONSERV, V29, P115, DOI 10.1017/S0376892902000085; Chen H, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10030356; Chu Xiao-jing, 2015, Yingyong Shengtai Xuebao, V26, P2978; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Council NR, 1995, WETL CHAR BOUND; Davidson NC, 2014, MAR FRESHWATER RES, V65, P934, DOI 10.1071/MF14173; [丁玉龙 Ding Yulong], 2013, [中国矿业大学学报. 自然科学版, Journal of China University of Mining & Technology], V42, P970; Fallah M, 2017, WETL ECOL MANAG, V25, P597, DOI 10.1007/s11273-017-9538-y; [范立民 Fan Limin], 2016, [煤炭学报, Journal of China Coal Society], V41, P2672; Farrer EC, 2009, ECOL APPL, V19, P398, DOI 10.1890/08-0485.1; Fluet-Chouinard E, 2015, REMOTE SENS ENVIRON, V158, P348, DOI 10.1016/j.rse.2014.10.015; Gao X, 2012, METEOROLOGY INNER MO, P19; Gunderson LH, 2016, J ENVIRON MANAGE, V183, P353, DOI 10.1016/j.jenvman.2016.05.024; Hu SJ, 2017, SCI TOTAL ENVIRON, V586, P319, DOI 10.1016/j.scitotenv.2017.02.001; Husar RB, 2001, J GEOPHYS RES-ATMOS, V106, P18317, DOI 10.1029/2000JD900788; Inner Mongolia Autonomous Regional Bureau of Statistics, 2014, INN MONG STAT YB 199; Junk WJ, 2013, AQUAT SCI, V75, P113, DOI 10.1007/s00027-012-0253-8; Khaznadar M, 2009, J ARID ENVIRON, V73, P369, DOI 10.1016/j.jaridenv.2008.09.026; [雷少刚 Lei Shaogang], 2014, [生态学报, Acta Ecologica Sinica], V34, P2837; Li N, 2015, RESOUR CONSERV RECY, V94, P129, DOI 10.1016/j.resconrec.2014.11.010; [梁康 LIANG Kang], 2011, [资源科学, Resources Science], V33, P1089; Lu Z., 2011, CHINAS W DEV STRATEG; [吕新 Lyu Xin], 2014, [煤田地质与勘探, Coal Geology & Exploration], V42, P54; Ma C, 2017, GEOGRAPHICAL RES, V9, P1755; [马雄德 Ma Xiongde], 2015, [煤炭学报, Journal of China Coal Society], V40, P1126; Mao DH, 2018, SCI TOTAL ENVIRON, V634, P550, DOI 10.1016/j.scitotenv.2018.04.009; MEA, 2005, EC HUM WELL BEING WE; Meng WQ, 2017, OCEAN COAST MANAGE, V146, P50, DOI 10.1016/j.ocecoaman.2017.06.003; Mwita E, 2013, INT J APPL EARTH OBS, V21, P173, DOI 10.1016/j.jag.2012.08.010; Niu ZG, 2012, CHINESE SCI BULL, V57, P2813, DOI 10.1007/s11434-012-5093-3; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Qi W., 2002, SHANXI WATER CONSERV, P28; Rebelo LM, 2009, J ENVIRON MANAGE, V90, P2144, DOI 10.1016/j.jenvman.2007.06.027; Rokni K, 2014, REMOTE SENS-BASEL, V6, P4173, DOI 10.3390/rs6054173; Savickis J, 2016, J HYDROL, V535, P204, DOI 10.1016/j.jhydrol.2016.01.082; Seto KC, 2007, GLOBAL ENVIRON CHANG, V17, P486, DOI 10.1016/j.gloenvcha.2007.03.001; Sica YV, 2016, SCI TOTAL ENVIRON, V568, P967, DOI 10.1016/j.scitotenv.2016.04.200; Smith SM, 2015, WETLANDS, V35, P127, DOI 10.1007/s13157-014-0601-7; Song KS, 2012, J ENVIRON MANAGE, V111, P120, DOI 10.1016/j.jenvman.2012.06.038; [苏布达 Subuda], 2011, [中国草地学报, Chinese Journal of Grassland], V33, P73; Sugimoto N, 2003, GEOPHYS RES LETT, V30; Tao SL, 2015, P NATL ACAD SCI USA, V112, P2281, DOI 10.1073/pnas.1411748112; Tian B, 2016, ESTUAR COAST SHELF S, V170, P83, DOI 10.1016/j.ecss.2016.01.006; Tian R, 2014, GEOMAT NAT HAZ RISK, V7, P1; Tong LG, 2014, ENERGIES, V7, P2515, DOI 10.3390/en7042515; van Asselen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081292; Wang HB, 2015, NAT HAZARDS, V79, P1753, DOI 10.1007/s11069-015-1924-2; Wang HY, 2011, INN MONG WATER RESOU, V4, P111; [王力 WANG Li], 2008, [煤炭学报, Journal of China Coal Society], V33, P1408; [王强民 Wang Qiangmin], 2017, [水资源与水工程学报, Journal of Water Resources and Water Engineering], V28, P77; Wang XM, 2004, J ARID ENVIRON, V58, P559, DOI 10.1016/j.jaridenv.2003.11.009; Wang ZM, 2012, AMBIO, V41, P782, DOI 10.1007/s13280-012-0280-7; Woodworth MD, 2015, CITIES, V43, P115, DOI 10.1016/j.cities.2014.11.017; Xu Feng-jiao, 2014, Shengtaixue Zazhi, V33, P1606; Yan FQ, 2017, ECOL ENG, V104, P184, DOI 10.1016/j.ecoleng.2017.04.032; Yan XL, 2017, WETLANDS, V37, P885, DOI 10.1007/s13157-017-0922-4; Yao Dulin, 2012, Hupo Kexue, V24, P965; [张兵 Zhang Bing], 2013, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V27, P190; [张二勇 Zhang Eryong], 2012, [中国地质, Geology of China], V39, P811; [张俊 Zhang Jun], 2013, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V27, P141; Zhang Q, 2011, EL CONTR ENG ICECE 2; Zhang Y, 2011, ENVIRON MONIT ASSESS, V180, P189, DOI 10.1007/s10661-010-1781-0; Zhao X.Y., 2010, GLOB ENV RES, V14, P63; Zhou Y., 2000, RESOURCE ENV KNOWLED	66	7	7	11	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0221177	10.1371/journal.pone.0221177	http://dx.doi.org/10.1371/journal.pone.0221177			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5MK	31425547	Green Published, Green Submitted, gold			2022-12-26	WOS:000485022400028
J	Alfaro, A; Leon, A; Guajardo-Correa, E; Reuquen, P; Torres, F; Mery, M; Segura, R; Zapata, PA; Orihuela, PA				Alfaro, Aline; Leon, Andrea; Guajardo-Correa, Emanuel; Reuquen, Patricia; Torres, Francisco; Mery, Mario; Segura, Rodrigo; Zapata, Paula A.; Orihuela, Pedro A.			MgO nanoparticles coated with polyethylene glycol as carrier for 2-Methoxyestradiol anticancer drug	PLOS ONE			English	Article							PROSTATE-CANCER; PACLITAXEL; BREAST	Novel Magnesium Oxide (MgO) nanoparticles (NPs) modified with the polymer polyethylene glycol (PEG) were synthesized as carrier for the anticancer drug 2-Methoxyestradiol (2ME) to improve its clinical application. The functionalized NPs were characterized by Infrared spectroscopy with Fourier transform to elucidate the vibration modes of this conjugate, indicating the formation of the MgO-PEG-2ME nanocomposite. The studies of absorption and liberation determined that MgO-PEG-2ME NPs incorporated 98.51% of 2ME while liberation of 2ME was constant during 7 days at pH 2, 5 and 7.35. Finally, the MgO-PEG-2ME NPs decreased the viability of the prostate cancer cell line LNCap suggesting that this nanocomposite is suitable as a drug delivery system for anticancer prostate therapy.	[Alfaro, Aline; Guajardo-Correa, Emanuel; Reuquen, Patricia; Orihuela, Pedro A.] Univ Santiago Chile, Lab Inmunol Reprod, Fac Quim & Biol, Santiago, Chile; [Alfaro, Aline; Leon, Andrea; Guajardo-Correa, Emanuel; Reuquen, Patricia; Orihuela, Pedro A.] Ctr Desarrollo Nanociencia & Nanotecnol CEDENNA, Santiago, Chile; [Leon, Andrea] Max Planck Inst Chem Phys Solids, D-01068 Dresden, Germany; [Torres, Francisco] Univ Atacama, Fac Ciencias Nat, Dept Fis, Copayapu 485, Copiapo, Chile; [Mery, Mario] Univ Tecn Federico Santa Maria, Ctr Cient Tecnol Valparaiso CCTVal, Valparaiso, Chile; [Segura, Rodrigo] Univ Valparaiso, Inst Quim & Bioquim, Fac Ciencias, Valparaiso, Chile; [Zapata, Paula A.] Univ Santiago Chile, Grp Polimeros, Fac Quim Biol, Santiago, Chile	Universidad de Santiago de Chile; Max Planck Society; Universidad de Atacama; Universidad Tecnica Federico Santa Maria; Universidad de Valparaiso; Universidad de Santiago de Chile	Orihuela, PA (corresponding author), Univ Santiago Chile, Lab Inmunol Reprod, Fac Quim & Biol, Santiago, Chile.; Orihuela, PA (corresponding author), Ctr Desarrollo Nanociencia & Nanotecnol CEDENNA, Santiago, Chile.	pedro.orihuela@usach.cl	Segura, Rodrigo A./P-2005-2016	Segura, Rodrigo A./0000-0003-0928-0021; Guajardo-Correa, Emanuel/0000-0002-6091-6745	Basal Program for Centers of Excellence [DICYT 021743OD-DAS]; CONICYT [FB0807 CEDENNA]; DGIIP-USM; Proyecto Basal [FB0821 - CONICYT]; FONDECYT Regular; CONICYT Becas Chile Postdoctorado Grant [N 1170226];  [74190099]	Basal Program for Centers of Excellence; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); DGIIP-USM; Proyecto Basal(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); FONDECYT Regular(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT Becas Chile Postdoctorado Grant; 	This work received financial support from grants DICYT 021743OD-DAS and Basal Program for Centers of Excellence, Grant FB0807 CEDENNA, CONICYT and the DGIIP-USM. Proyecto Basal FB0821 - CONICYT. P. A. Zapata acknowledges the financial support of FONDECYT Regular N 1170226. A. Leon acknowledges the financial support of CONICYT Becas Chile Postdoctorado Grant No. 74190099.	Akram MW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23105-y; Behzadi E, 2019, INT J NANOMED, V14, P257, DOI 10.2147/IJN.S186428; Bunker A, 2012, PHYSCS PROC, V34, P24, DOI 10.1016/j.phpro.2012.05.004; Chang AJ, 2014, NAT REV CLIN ONCOL, V11, P308, DOI 10.1038/nrclinonc.2014.68; Di DR, 2012, NANOMED-NANOTECHNOL, V8, P1233, DOI 10.1016/j.nano.2012.02.010; Haume Kaspar, 2016, Cancer Nanotechnol, V7, P8, DOI 10.1186/s12645-016-0021-x; Ireson CR, 2004, BRIT J CANCER, V90, P932, DOI 10.1038/sj.bjc.6601591; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Jokerst JV, 2011, NANOMEDICINE-UK, V6, P715, DOI [10.2217/NNM.11.19, 10.2217/nnm.11.19]; Kumar R, 2015, J NANOSCI NANOTECHNO, V15, P1543, DOI 10.1166/jnn.2015.8915; Leon A, 2017, APPL SCI-BASEL, V7, DOI 10.3390/app7010049; Li YC, 2012, J PHYS CHEM B, V116, P7334, DOI 10.1021/jp300301z; Lowes LE, 2015, PROSTATE CANCER P D, V18, P358, DOI 10.1038/pcan.2015.36; Mahmoud A, 2016, INT J TOXICOL, V35, P429, DOI 10.1177/1091581816648624; Mano SS, 2012, INT J MOL SCI, V13, P3703, DOI 10.3390/ijms13033703; Mastuli MS, 2012, APCBEE PROC, V3, P93, DOI 10.1016/j.apcbee.2012.06.052; Mueck AO, 2010, STEROIDS, V75, P625, DOI 10.1016/j.steroids.2010.02.016; Naghibi S, 2014, CERAM INT, V40, P5481, DOI 10.1016/j.ceramint.2013.10.136; Ranathunge TA, 2019, NANOMATERIALS-BASEL, V9, DOI 10.3390/nano9020208; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Shi JJ, 2017, NAT REV CANCER, V17, P20, DOI 10.1038/nrc.2016.108; Somanathan T, 2016, J NANOSCI NANOTECHNO, V16, P9421, DOI 10.1166/jnn.2016.12164; Tang ZX, 2014, BRAZ J CHEM ENG, V31, P591, DOI 10.1590/0104-6632.20140313s00002813; Venkatasubbu GD, 2013, ADV POWDER TECHNOL, V24, P947, DOI 10.1016/j.apt.2013.01.008; Verenich S, 2010, MOL PHARMACEUT, V7, P2030, DOI 10.1021/mp100190f; Vilos C, 2013, BIOMATERIALS, V34, P4098, DOI 10.1016/j.biomaterials.2013.02.034; Wang Y, 2011, BIOMATERIALS, V32, P3322, DOI 10.1016/j.biomaterials.2010.12.060; Welch HG, 2015, NEW ENGL J MED, V373, P1685, DOI 10.1056/NEJMp1510443; Wu Y, 2014, J CONTROL RELEASE, V190, P485; Yameen B, 2014, J CONTROL RELEASE, V190, P485, DOI 10.1016/j.jconrel.2014.06.038	30	23	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0214900	10.1371/journal.pone.0214900	http://dx.doi.org/10.1371/journal.pone.0214900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415561	Green Submitted, Green Published, gold			2022-12-26	WOS:000485017200001
J	de Bresser, I; Remers, TEP; Wieland, MWM; Prawiranegara, R; Siregar, AYM; Baltussen, R				de Bresser, Inge; Remers, Toine E. P.; Wieland, Monse W. M.; Prawiranegara, Rozar; Siregar, Adiatma Y. M.; Baltussen, Rob			Prioritizing HIV/AIDS prevention strategies in Bandung, Indonesia: A cost analysis of three different HIV/AIDS interventions	PLOS ONE			English	Article							HIV PREVENTION	Background Indonesia has one of the fastest growing HIV epidemics in Asia, which mainly concentrates within risk groups. Several strategies are available to combat this epidemic, like outreach to Men who have Sex with Men (MSM) and transgender, Harm Reduction Community Meetings (HRCMs) for Injecting Drug Users (IDUs), and Information, Education and Communication (IEC) programs at Maternal & Child Health Posts (MCHPs). Reliable cost data are currently not present, hampering HIV/AIDS priority setting. The aim of this study thus is to assess the societal costs of outreach programs to MSM and transgender, HRCMs for IDUs and IEC at MCHPs in Bandung, Indonesia in 2016. Methods The societal costs were collected in Bandung from April until May 2017. Health care costs were collected by interviewing stakeholders, using a micro-costing approach. Non-health care costs were determined by conducting surveys within the target groups of the interventions. Results The societal costs of the outreach program were US$347,199.03 in 2016 and US$73.72 per reached individual. Moreover, the cost of HRCM for IDUs were US$48,618.31 in 2016 and US$365.55 per community meeting. For the IEC program at MCHPs, US$337.13 was paid in 2016 and the cost per visitor were US$0.51. Conclusion This study provides valuable insights in the costs of outreach to MSM and transgender, HRCMs for IDUs and IEC at MCHPs. Policy makers can use these results in setting priorities within Indonesia. Data on effectiveness of interventions is necessary to make conclusive statements regarding cost-effectiveness and priority of interventions.	[de Bresser, Inge; Remers, Toine E. P.; Wieland, Monse W. M.; Prawiranegara, Rozar; Baltussen, Rob] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, Nijmegen, Netherlands; [de Bresser, Inge; Remers, Toine E. P.; Wieland, Monse W. M.; Siregar, Adiatma Y. M.] Padjadjaran State Univ, Dept Econ, Badung, Indonesia	Radboud University Nijmegen; Universitas Padjadjaran	de Bresser, I; Remers, TEP; Wieland, MWM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, Nijmegen, Netherlands.; de Bresser, I; Remers, TEP; Wieland, MWM (corresponding author), Padjadjaran State Univ, Dept Econ, Badung, Indonesia.	ingedebresser@gmail.com; toineremers@hotmail.com; monse_wieland@hotmail.com	Remers, Toine E.P./AAA-5706-2019; Siregar, Adiatma Y.M/AAB-9617-2021	Remers, Toine E.P./0000-0002-4436-9542; Siregar, Adiatma Y.M/0000-0003-0747-1596; de Bresser, Inge/0000-0002-5939-3326				Afriandi I, 2010, HEALTH POLICY, V95, P69, DOI 10.1016/j.healthpol.2009.11.003; Baltussen Rob, 2006, Cost Eff Resour Alloc, V4, P14, DOI 10.1186/1478-7547-4-14; Creese A, 1994, COST ANAL PRIMARY HL; Dandona L, EC ANAL HIV PREVENTI; deBresser I, 2017, COST ANAL HIV AIDS I; Drummond MF, 2015, METHODS EC EVALUATIO, V4th; Hsu J, 2013, HEALTH POLICY PLANN, V28, P20, DOI 10.1093/heapol/czs021; *JOINT UN PROGR HI, 2008, 2008 REP GLOB AIDS E; Joint United Nations Programme on HIV/AIDS, 2014, RED HIV REL STIGM DI; Ministry of Health Indonesia, 2010, NAT HIV AIDS STRAT A; Ministry of Health Republic Indonesia, 2015, IND HLTH PROF 2014; Ministry of Health Republic of Indonesia, 2011, INT BIOL BEH SURV; Needle RH, 2005, INT J DRUG POLICY, V16, pS45, DOI 10.1016/j.drugpo.2005.02.009; Remers TEP, 2017, COST ANAL HIV OUTREA; Siregar AYM, 2016, ACTA MED INDONES, V48, P207; Siregar AYM, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1098-3; Siregar AYM, 2011, TROP MED INT HEALTH, V16, P193, DOI 10.1111/j.1365-3156.2010.02675.x; Tromp N, 2015, PRIORITY SETTING HIV; Tromp N, 2013, ACTA MED INDONES, V45, P17; Tromp N, 2015, HEALTH POLICY PLANN, V30, P345, DOI 10.1093/heapol/czu020; UNAIDS, 2021, YOUNG PEOPL HIV; Verstraaten EJM, 2017, ACTA MED INDONES, V49, P236; Wammes JJG, 2012, INT J DRUG POLICY, V23, P358, DOI 10.1016/j.drugpo.2012.06.009; Wieland MWM, 2017, COST ANAL HARM REDUC	24	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0221078	10.1371/journal.pone.0221078	http://dx.doi.org/10.1371/journal.pone.0221078			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5KK	31415647	Green Submitted, Green Published, gold			2022-12-26	WOS:000485017200069
J	Phillips, S; Quigley, BL; Aziz, A; Bergen, W; Booth, R; Pyne, M; Timms, P				Phillips, Samuel; Quigley, Bonnie L.; Aziz, Ammar; Bergen, Wendy; Booth, Rosemary; Pyne, Michael; Timms, Peter			Antibiotic treatment of Chlamydia-induced cystitis in the koala is linked to expression of key inflammatory genes in reactive oxygen pathways	PLOS ONE			English	Article							TRACT DISEASE; INFECTION; POPULATIONS; PREVALENCE; KEGG	Chlamydial-induced cystitis in the koala (Phascolarctos cinereus) is currently treated by antibiotics. However, while reducing the chlamydial load, this treatment can also lead to gastrointestinal complications and death. Development of alternative treatments, such as a therapeutic chlamydial vaccine, are hindered by the lack of detailed understanding of the innate immune response to chlamydial clearance and disease regression during antibiotic treatment. Through clinical, microbiological and transcriptomic approaches, disease regression, bacterial clearance and innate immune responses were mapped in koalas with signs of chlamydial-induced cystitis while receiving anti-chlamydial antibiotics. Significant reduction in the signs of cystitis were observed during and post antibiotic treatment. This was observed as a thinning of the bladder wall and complete reversal of urinary incontinence. Transcriptomic analysis before treatment, at the end of treatment and prior to release identified significant down-regulation of specific genes involved in 21 biological pathways. Of these, the chemokine receptor signalling and NOD-like receptor signalling pathways where identified as important markers of inflammation. Specific genes within these pathways (NCF1 and NOX2) were significantly down-regulated, suggesting a decrease in reactive oxygen species production. Through the monitoring of specific clinical and transcriptomic markers, these findings allow detailed profiling of the clinical response to therapeutic vaccination in koalas with current signs of disease. This also adds to our understanding of innate immune responses to chlamydial infections and indicates that chlamydial-induced cystitis in the koala is linked to the regulation of reactive oxygen pathways.	[Phillips, Samuel; Quigley, Bonnie L.; Timms, Peter] Univ Sunshine Coast, Genecol Res Ctr, Fac Sci Hlth Educ & Engn, Sunshine Coast, Qld, Australia; [Aziz, Ammar] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT, Australia; [Bergen, Wendy; Booth, Rosemary] Australia Zoo Wildlife Hosp, Steve Irwin Way, Beerwah, Qld, Australia; [Pyne, Michael] Currumbin Wildlife Hosp, Currumbin, Qld, Australia	University of the Sunshine Coast; Charles Darwin University; Menzies School of Health Research	Phillips, S (corresponding author), Univ Sunshine Coast, Genecol Res Ctr, Fac Sci Hlth Educ & Engn, Sunshine Coast, Qld, Australia.	Samuel.phillips@research.usc.edu.au		Phillips, Samuel/0000-0002-2549-8111; Timms, Peter/0000-0002-1682-0025	Australian Research Council Linkage Scheme; Gold Coast City Council; Queensland Department of Environment and Heritage	Australian Research Council Linkage Scheme(Australian Research Council); Gold Coast City Council; Queensland Department of Environment and Heritage	This project was supported financially by the Australian Research Council Linkage Scheme, the Gold Coast City Council and the Queensland Department of Environment and Heritage awarded to PT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Sater AA, 2010, J BIOL CHEM, V285, P41637, DOI 10.1074/jbc.M110.137885; Andrade WA, 2018, CURR ISSUES MOL BIOL, V25, P99, DOI 10.21775/cimb.025.099; Baskin LS, 1997, J UROLOGY, V157, P2388, DOI 10.1016/S0022-5347(01)64786-4; Bao Philip, 2009, J Surg Res, V153, P347, DOI 10.1016/j.jss.2008.04.023; Bodley K., 2008, MED AUSTR MAMMALS; BROWN AS, 1987, AUST VET J, V64, P346, DOI 10.1111/j.1751-0813.1987.tb06064.x; CANFIELD PJ, 1989, AUST VET J, V66, P103, DOI 10.1111/j.1751-0813.1989.tb09758.x; Chao WC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189453; Flanagan C., 2015, KOALA REHABILITION M; Fossum M, 2016, J TISSUE SCI ENG, V7; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hayes BW, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.UTI-0024-2016; He XB, 2010, J IMMUNOL, V184, P5743, DOI 10.4049/jimmunol.0903937; He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002; Jelocnik M, 2017, PEERJ, V5, DOI 10.7717/peerj.3799; Johnson RN, 2018, NAT GENET, V50, P1102, DOI 10.1038/s41588-018-0153-5; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Lawrence A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31466; Marsh J, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-77; Mathews KG, 1995, J ZOO WILDLIFE MED, V26, P440; Miyano K, 2007, BIOCHIMIE, V89, P1133, DOI 10.1016/j.biochi.2007.05.003; Nagamatsu K, 2015, P NATL ACAD SCI USA, V112, pE871, DOI 10.1073/pnas.1500374112; Nowak WN, 2017, ARTERIOSCL THROM VAS, V37, pE41, DOI 10.1161/ATVBAHA.117.309228; Nyari S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210245; Nyari S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190114; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; OSAWA R, 1990, AUST VET J, V67, P305, DOI 10.1111/j.1751-0813.1990.tb07805.x; Pal S, 2009, INFECT IMMUN, V77, P5602, DOI 10.1128/IAI.00766-09; Patterson JLS, 2015, J WILDLIFE DIS, V51, P309, DOI 10.7589/2014-07-176; Phillips S, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00070; Phillips S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206471; Polkinghorne A, 2013, VET MICROBIOL, V165, P214, DOI 10.1016/j.vetmic.2013.02.026; R Development Core Team, 2018, R LANG ENV SA COMP R; RANK RG, 1981, SEX TRANSM DIS, V8, P203, DOI 10.1097/00007435-198107000-00006; Reish RG, 2008, PLAST RECONSTR SURG, V122, P1068, DOI 10.1097/PRS.0b013e318185d38f; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schiwon M, 2014, CELL, V156, P456, DOI 10.1016/j.cell.2014.01.006; Shimada K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021477; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Song JM, 2007, PLOS PATHOG, V3, P541, DOI 10.1371/journal.ppat.0030060; Stevens Sue, 2011, Community Eye Health, V24, P45; Wang Y, 2010, INFECT IMMUN, V78, P1670, DOI 10.1128/IAI.01339-09; Waugh C., 2016, PLOS ONE, V11; Wedrowicz F, 2016, CONSERV GENET RESOUR, V8, P511, DOI 10.1007/s12686-016-0574-3	44	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0221109	10.1371/journal.pone.0221109	http://dx.doi.org/10.1371/journal.pone.0221109			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415633	Green Published, Green Submitted, gold			2022-12-26	WOS:000485017200076
J	Salerni, F; Repetto, R; Harris, A; Pinsky, P; Prud'homme, C; Szopos, M; Guidoboni, G				Salerni, Fabrizia; Repetto, Rodolfo; Harris, Alon; Pinsky, Peter; Prud'homme, Christophe; Szopos, Marcela; Guidoboni, Giovanna			Biofluid modeling of the coupled eye-brain system and insights into simulated microgravity conditions	PLOS ONE			English	Article							CEREBROSPINAL-FLUID PRESSURE; BLOOD-FLOW AUTOREGULATION; OCULAR PERFUSION-PRESSURE; CEREBRAL VENOUS OUTFLOW; CENTRAL RETINAL ARTERY; OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; INTRACRANIAL-PRESSURE; MATHEMATICAL-MODEL; GLYMPHATIC SYSTEM	This work aims at investigating the interactions between the flow of fluids in the eyes and the brain and their potential implications in structural and functional changes in the eyes of astronauts, a condition also known as spaceflight associated neuro-ocular syndrome (SANS). To this end, we propose a reduced (0-dimensional) mathematical model of fluid flow in the eyes and brain, which is embedded into a simplified whole-body circulation model. In particular, the model accounts for: (i) the flows of blood and aqueous humor in the eyes; (ii) the flows of blood, cerebrospinal fluid and interstitial fluid in the brain; and (iii) their interactions. The model is used to simulate variations in intraocular pressure, intracranial pressure and blood flow due to microgravity conditions, which are thought to be critical factors in SANS. Specifically, the model predicts that both intracranial and intraocular pressures increase in microgravity, even though their respective trends may be different. In such conditions, ocular blood flow is predicted to decrease in the choroid and ciliary body circulations, whereas retinal circulation is found to be less susceptible to microgravity-induced alterations, owing to a purely mechanical component in perfusion control associated with the venous segments. These findings indicate that the particular anatomical architecture of venous drainage in the retina may be one of the reasons why most of the SANS alterations are not observed in the retina but, rather, in other vascular beds, particularly the choroid. Thus, clinical assessment of ocular venous function may be considered as a determinant SANS factor, for which astronauts could be screened on earth and in-flight.	[Salerni, Fabrizia] Univ Parma, Dept Math Phys & Comp Sci, Parma, Italy; [Repetto, Rodolfo] Univ Genoa, Dept Civil Chem & Environm Engn, Genoa, Italy; [Harris, Alon] Indiana Univ Sch Med, Eugene & Marilyn Glick Eye Inst, Indianapolis, IN 46202 USA; [Harris, Alon] Indiana Univ Sch Med, Dept Ophthalmol, Indianapolis, IN 46202 USA; [Pinsky, Peter] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Prud'homme, Christophe] Univ Strasbourg, Inst Adv Math Res UMR 7501, CNRS, Strasbourg, France; [Szopos, Marcela] Univ Paris 05, Lab MAP5, Sorbonne Paris Cite, UMR CNRS 8145, Paris, France; [Guidoboni, Giovanna] Univ Missouri, Dept Math, Dept Elect Engn & Comp Sci, Columbia, MO 65211 USA	University of Parma; University of Genoa; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Stanford University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Paris Cite; University of Missouri System; University of Missouri Columbia	Guidoboni, G (corresponding author), Univ Missouri, Dept Math, Dept Elect Engn & Comp Sci, Columbia, MO 65211 USA.	guidobonig@missouri.edu	Repetto, Rodolfo/AAQ-4616-2020	Prud'homme, Christophe/0000-0003-2287-2961; Salerni, Fabrizia/0000-0001-6727-4055; Szopos, Marcela/0000-0002-7300-3267	NSF [DMS-1853222/1853303]; Chair Gutenberg funds of the Cercle Gutenberg (France); Labex IRMIA (University of Strasbourg, France); IdEx Unistra (University of Strasbourg, France)	NSF(National Science Foundation (NSF)); Chair Gutenberg funds of the Cercle Gutenberg (France); Labex IRMIA (University of Strasbourg, France); IdEx Unistra (University of Strasbourg, France)	This work has been partially supported by the award NSF DMS-1853222/1853303, the Chair Gutenberg funds of the Cercle Gutenberg (France) and the Labex IRMIA and the IdEx Unistra (University of Strasbourg, France).	Alperin N, 2005, ACT NEUR S, V95, P177; Apelblat A, 1974, Biorheology, V11, P1; Arciero J, 2013, INVEST OPHTH VIS SCI, V54, P5584, DOI 10.1167/iovs.12-11543; Arciero JC, 2008, AM J PHYSIOL-HEART C, V295, pH1562, DOI 10.1152/ajpheart.00261.2008; Bhan A, 2002, INVEST OPHTH VIS SCI, V43, P1389; BILL A, 1990, EYE, V4, P319, DOI 10.1038/eye.1990.43; BILL A, 1963, ARCH OPHTHALMOL-CHIC, V69, P780; BLOMQVIST CG, 1980, ACTA ASTRONAUT, V7, P543, DOI 10.1016/0094-5765(80)90043-0; BRUBAKER RF, 1975, INVEST OPHTH VISUAL, V14, P286; Buishas J, 2014, CROAT MED J, V55, P481, DOI 10.3325/cmj.2014.55.481; Burgoyne CF, 2011, EXP EYE RES, V93, P120, DOI 10.1016/j.exer.2010.09.005; Caprioli J, 2010, AM J OPHTHALMOL, V149, P704, DOI 10.1016/j.ajo.2010.01.018; Carichino L., 2014, INTEGRATED MULTIDISC, P59; Carlson BE, 2008, AM J PHYSIOL-HEART C, V295, pH1572, DOI 10.1152/ajpheart.00262.2008; Cirovic S, 2003, AVIAT SPACE ENVIR MD, V74, P125; Conroy Deirdre A, 2005, J Circadian Rhythms, V3, P3, DOI 10.1186/1740-3391-3-3; Costa VP, 2014, ACTA OPHTHALMOL, V92, pe252, DOI 10.1111/aos.12298; De Simone R, 2019, NEUROL SCI, V40, pS59, DOI 10.1007/s10072-019-03775-w; DIELEMANS I, 1995, OPHTHALMOLOGY, V102, P54; Dorner GT, 2002, CURR EYE RES, V25, P341, DOI 10.1076/ceyr.25.6.341.14231; Dumskyj MJ, 1996, MICROVASC RES, V51, P378, DOI 10.1006/mvre.1996.0034; Eklund A, 2016, ANN NEUROL, V80, P269, DOI 10.1002/ana.24713; Evans DW, 1999, BRIT J OPHTHALMOL, V83, P809, DOI 10.1136/bjo.83.7.809; Feke GT, 2008, OPHTHALMOLOGY, V115, P246, DOI 10.1016/j.ophtha.2007.04.055; Feke GT, 2011, J OCUL PHARMACOL TH, V27, P347, DOI 10.1089/jop.2011.0014; FRIEDLAND AB, 1978, B MATH BIOL, V40, P823; Fritzson P., 2005, 46 C SIM MOD SCAND S; Gisolf J, 2004, J PHYSIOL-LONDON, V560, P317, DOI 10.1113/jphysiol.2004.070409; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Gross JC, 2017, EXPERT REV OPHTHALMO, V12, P443, DOI 10.1080/17469899.2017.1383896; Grunwald JE, 1998, ARCH OPHTHALMOL-CHIC, V116, P150; Grunwald JE, 1996, BRIT J OPHTHALMOL, V80, P327, DOI 10.1136/bjo.80.4.327; Guidoboni G, 2019, J MODELING OPHTHALMO; GUIDOBONI G, 2018, INVEST OPHTH VIS SCI, V59; Guidoboni G, 2014, INVEST OPHTH VIS SCI, V55, P4105, DOI 10.1167/iovs.13-13611; Guidoboni G, 2014, MATH BIOSCI ENG, V11, P523, DOI 10.3934/mbe.2014.11.523; Harris A, 2007, J GLAUCOMA, V16, P159, DOI 10.1097/01.ijg.0000212290.08540.93; Harris Alon, 2013, J Glaucoma, V22 Suppl 5, pS46, DOI 10.1097/IJG.0b013e3182934b6b; Kiel JW, 2011, PROG RETIN EYE RES, V30, P1, DOI 10.1016/j.preteyeres.2010.08.001; Kiel J.W., 1998, PATHOPHYSIOLOGY EYE, P79; KIEL JW, 1992, INVEST OPHTH VIS SCI, V33, P2399; Kurtcuoglu V, 2011, BIOL MED PHYS BIOMED, P169, DOI 10.1007/978-1-4419-9997-9_8; Lakin WD, 2003, J MATH BIOL, V46, P347, DOI 10.1007/s00285-002-0177-3; Lakin WD, 2008, MATH BIOSCI INTERACT, P211, DOI 10.1007/978-3-7643-8591-0_11; Laurie SS, 2019, OPHTHALMOLOGY, V126, P467, DOI 10.1016/j.ophtha.2018.09.042; Lawley JS, 2017, J PHYSIOL-LONDON, V595, P2115, DOI 10.1113/JP273557; Leske MC, 2007, OPHTHAL EPIDEMIOL, V14, P166, DOI 10.1080/09286580701501931; LINNER E, 1952, ACTA PHYSIOL SCAND, V26, P57, DOI 10.1111/j.1748-1716.1952.tb00891.x; LINNER E, 1951, ACTA PHYSIOL SCAND, V22, P83, DOI 10.1111/j.1748-1716.1951.tb00755.x; Linninger AA, 2016, ANNU REV FLUID MECH, V48, P219, DOI 10.1146/annurev-fluid-122414-034321; Linninger AA, 2009, J MATH BIOL, V59, P729, DOI 10.1007/s00285-009-0250-2; Longo A, 2004, INVEST OPHTH VIS SCI, V45, P546, DOI 10.1167/iovs.03-0757; Louveau A, 2017, J CLIN INVEST, V127, P3210, DOI 10.1172/JCI90603; LUCE JM, 1982, J APPL PHYSIOL, V53, P1496, DOI 10.1152/jappl.1982.53.6.1496; Lyubimov GA, 2007, FLUID DYNAM+, V42, P684, DOI 10.1134/S001546280705002X; Mader TH, 2017, J NEURO-OPHTHALMOL, V37, P133, DOI 10.1097/WNO.0000000000000467; Mader TH, 2011, OPHTHALMOLOGY, V118, P2058, DOI 10.1016/j.ophtha.2011.06.021; Mitchell P, 2005, AM J OPHTHALMOL, V140, P131, DOI 10.1016/j.ajo.2004.12.088; Morgan WH, 1998, INVEST OPHTH VIS SCI, V39, P1419; Murthy G, 1992, Physiologist, V35, pS184; Nateras OS, 2014, CURR EYE RES, V39, P1059, DOI 10.3109/02713683.2014.892997; National Aeronautics and Space Administration, 2017, RISK SPAC ASS NEUR S; Nelson ES, 2017, J APPL PHYSIOL, V123, P352, DOI 10.1152/japplphysiol.00102.2017; Nelson Emily S., 2014, Life-Basel, V4, P621, DOI 10.3390/life4040621; PARAZYNSKI SE, 1991, J APPL PHYSIOL, V71, P2469, DOI 10.1152/jappl.1991.71.6.2469; Pedley TJ., 1980, FLUID MECH LARGE BLO; Plog BA, 2018, ANNU REV PATHOL-MECH, V13, P379, DOI 10.1146/annurev-pathol-051217-111018; Pointer JS, 1997, OPHTHAL PHYSL OPT, V17, P456, DOI 10.1111/j.1475-1313.1997.tb00083.x; Prada D, 2016, SURV OPHTHALMOL, V61, P164, DOI 10.1016/j.survophthal.2015.10.004; Ravalico G, 1996, INVEST OPHTH VIS SCI, V37, P2645; Reiner A, 2018, PROG RETIN EYE RES, V64, P96, DOI 10.1016/j.preteyeres.2017.12.001; Ren RJ, 2011, ACTA OPHTHALMOL, V89, pE142, DOI 10.1111/j.1755-3768.2010.02015.x; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; RODRIGUEZ G, 1988, J CEREBR BLOOD F MET, V8, P783, DOI 10.1038/jcbfm.1988.133; Salerni F, 2018, J MODELING OPHTHALMO, V2, P64; Salerni F., 2016, THESIS; Schmidl D, 2015, CURR EYE RES, V40, P201, DOI 10.3109/02713683.2014.906625; Seedhouse E., 2015, MICROGRAVITY VISION; Siaudvytyte L, 2015, ACTA OPHTHALMOL, V93, P9, DOI 10.1111/aos.12502; Sit AJ, 2011, EXP EYE RES, V93, P291, DOI 10.1016/j.exer.2011.05.003; STRAUSS AL, 1987, MED INSTRUM, V21, P255; Szopos M, 2016, J MODEL OPHTHALMOL, V2, P29, DOI [10.35119/maio.v1i2.24, DOI 10.35119/MAIO.V1I2.24]; Taibbi G, 2016, INVEST OPHTH VIS SCI, V57, P495, DOI 10.1167/iovs.15-18530; Taibbi G, 2014, AVIAT SPACE ENVIR MD, V85, P983, DOI 10.3357/ASEM.4055.2014; Takahashi T, 2009, J BIORHEOL, V23, P77; Tarumi T, 2018, J NEUROCHEM, V144, P595, DOI 10.1111/jnc.14234; Vera J, 2015, NASA HUM RES PROGR I; Weinreb RN, 2009, OCULAR BLOOD FLOW GL; Werne A, 2008, SURV OPHTHALMOL, V53, P559, DOI 10.1016/j.survophthal.2008.08.021; Wiederhielm C., 1967, ANALYSIS SMALL VESSE, P313; WIEDERHIELM CA, 1979, MICROVASC RES, V18, P48, DOI 10.1016/0026-2862(79)90017-7; Xu L, 2007, AM J OPHTHALMOL, V144, P461, DOI 10.1016/j.ajo.2007.05.013	92	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0216012	10.1371/journal.pone.0216012	http://dx.doi.org/10.1371/journal.pone.0216012			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412033	Green Published, gold, Green Submitted			2022-12-26	WOS:000485012600005
J	Scherz, MD; Glaw, F; Hutter, CR; Bletz, MC; Rakotoarison, A; Kohler, J; Vences, M				Scherz, Mark D.; Glaw, Frank; Hutter, Carl R.; Bletz, Molly C.; Rakotoarison, Andolalao; Koehler, Joern; Vences, Miguel			Species complexes and the importance of Data Deficient classification in Red List assessments: The case of Hylobatrachus frogs	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; CRYPTIC DIVERSITY; MADAGASCAR; TAXONOMY; AMPHIBIA; ANURA; UNDERESTIMATION; MANTELLIDAE; MALAGASY	Taxonomy is the cornerstone of extinction risk assessments. Currently, the IUCN Red List treats species complexes either under a single overarching species name resulting in an unhelpfully broad circumscription and underestimated threat assessment that does not apply to any one species lineage or omits them altogether resulting in the omission of species that should be assessed. We argue that taxonomic uncertainty alone, as in species complexes, should be grounds for assessment as Data Deficient (DD). Yet, use of the DD category is currently discouraged, resulting in assessments based on poor data quality and dismissal of the importance of taxonomic confidence in conservation. This policy may be leading to volatile and unwarranted assessments of hundreds of species across the world, and needs to be revised. To illustrate this point, we here present a partial taxonomic revision of torrent frogs from eastern Madagascar in the Mantidactylus subgenus Hylobatrachus. Two named species, Mantidactylus (Hylobatrachus) lugubris and M. (H.) cowanii, and several undescribed candidate species are recognised, but the application of the available names has been somewhat ambiguous. In a recent re-assessment of its conservation status, M. (H.) lugubris was assessed including all complex members except M. (H.) cowanii within its distribution, giving it a status of Least Concern and distribution over most of eastern Madagascar. After describing two of the unnamed lineages as Mantidactylus (Hylobatrachus) atsimo sp. nov. (from southeastern Madagascar) and Mantidactylus (Hylobatrachus) petakorona sp. nov. (from the Marojejy Massif in northeastern Madagascar), we show that Mantidactylus (Hylobatrachus) lugubris is restricted to the central east of Madagascar, highlighting the inaccuracy of its current Red List assessment. We propose to re-assess its status under a more restrictive definition that omits well-defined candidate species, thus representing the actual species to which its assessment refers, to the best of current knowledge. We recommend that for species complexes in general, (1) nominal lineages that can be confidently restricted should be assessed under the strict definition, (2) non-nominal species-level lineages and ambiguous names should be prioritised for taxonomic research, and (3) ambiguous names should be assessed as DD to highlight the deficiency in data on their taxonomic status, which is an impediment to their conservation. This would reduce ambiguity and underestimation of threats involved in assessing species complexes, and place the appropriate emphasis on the importance of taxonomy in anchoring conservation.	[Scherz, Mark D.; Glaw, Frank] Zool Staatssammlung Munchen ZSM SNSB, Munich, Germany; [Scherz, Mark D.; Vences, Miguel] Braunschweig Univ Technol, Zool Inst, Braunschweig, Germany; [Hutter, Carl R.] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Hutter, Carl R.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Bletz, Molly C.] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA; [Rakotoarison, Andolalao] Univ Antananarivo, Zool & Biodivers Anim, Antananarivo, Madagascar; [Koehler, Joern] Hess Landesmuseum Darmstadt, Darmstadt, Germany	Braunschweig University of Technology; University of Kansas; University of Kansas; University of Massachusetts System; University of Massachusetts Boston; University Antananarivo	Scherz, MD (corresponding author), Zool Staatssammlung Munchen ZSM SNSB, Munich, Germany.; Scherz, MD (corresponding author), Braunschweig Univ Technol, Zool Inst, Braunschweig, Germany.	mark.scherz@gmail.com	Scherz, Mark D./C-9870-2019; Hutter, Carl R/A-7380-2015; Bletz, Molly/Q-2817-2018	Scherz, Mark D./0000-0002-4613-7761; Bletz, Molly/0000-0003-4120-9356; Kohler, Jorn/0000-0002-5250-2542; Rakotoarison, Andolalao/0000-0003-2620-440X; Vences, Miguel/0000-0003-0747-0817; Hutter, Carl/0000-0001-6381-6339	Deutscher Akademischer Austauschdienst; Deutsche Forschungsgemeinschaft [VE247/13-1, 15-1]	Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	AR was supported by a fellowship of the Deutscher Akademischer Austauschdienst https://www.daad.de/en/. Recent expeditions of MV and MDS were supported by grants of the Deutsche Forschungsgemeinschaft http://www.dfg.de/ (VE247/13-1 and 15-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altig R, 2006, P BIOL SOC WASH, V119, P418, DOI 10.2988/0006-324X(2006)119[418:DABNOT]2.0.CO;2; Andreone F, 2007, TROP ZOOL, V20, P19; Andreone F, 2005, CONSERV BIOL, V19, P1790, DOI 10.1111/j.1523-1739.2005.00249.x; Avise J.C., 1990, Oxford Surveys in Evolutionary Biology, V7, P45; Blommers-Schlosser R.M.A., 1979, Beaufortia, V29, P1; Blommers-Schlosser RMA, 1991, AMPHIBIENS PARTIE FA, P75; Blommers-Schlosser RMA, 1993, AMPHIBIENS PARTIE FA, P75; Boulenger GA, 1882, CATALOGUE BATRACHIA; Bruford Michael W., 1992, P225; Cocca W, 2018, SALAMANDRA, V54, P178; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dubois A, 2003, CR BIOL, V326, pS9, DOI 10.1016/S1631-0691(03)00022-2; Ely CV, 2017, J NAT CONSERV, V36, P10, DOI 10.1016/j.jnc.2017.01.003; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Fouquet A, 2007, MOL PHYLOGENET EVOL, V43, P567, DOI 10.1016/j.ympev.2006.12.006; Gehara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103958; Glaw F, 2006, ORG DIVERS EVOL, V6, P236, DOI 10.1016/j.ode.2005.12.001; Glaw Frank, 2007, P1; Gonzalez-del-Pliego P, 2019, CURR BIOL, V29, P1557, DOI 10.1016/j.cub.2019.04.005; Group ISAS, 2016, IUCN RED LIST THREAT, V2016, DOI [10.2305/IUCN.UK.2016-1.RLTS.T57973A84181290.en, DOI 10.2305/IUCN.UK.2016-1.RLTS.T57973A84181290.EN]; Guibe J., 1978, BONN ZOOL MONOGR, V11, P1; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Howard SD, 2014, DIVERS DISTRIB, V20, P837, DOI 10.1111/ddi.12218; Hutter CR, 2018, MOL PHYLOGENET EVOL, V127, P568, DOI 10.1016/j.ympev.2018.05.027; IUCN SSC Amphibian Specialist Group, 2017, IUCN RED LIST THREAT, V2017, DOI [10.2305/IUCN.UK.2017-2.RLTS, DOI 10.2305/IUCN.UK.2017-2.RLTS]; IUCN SSC Amphibian Specialist Group, 2016, IUCN RED LIST THREAT, V2016, DOI [10.2305/IUCN.UK.2016-3.RLTS, DOI 10.2305/IUCN.UK.2016-3.RLTS]; IUCN SSC Amphibian Specialist Group, 2016, IUCN RED LIST THREAT, V2016, DOI [10.2305/IUCN.UK.2016-1.RLTS, DOI 10.2305/IUCN.UK.2016-1.RLTS]; IUCN Standards and Petitions Subcommittee, 2017, GUID US IUCN RED LIS; Jetz W, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0016; Kohler J, 2017, ZOOTAXA, V4251, P1, DOI 10.11646/zootaxa.4251.1.1; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lehtinen RM, 2007, MOL PHYLOGENET EVOL, V44, P1121, DOI 10.1016/j.ympev.2007.05.020; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; McLeod DS, 2010, MOL PHYLOGENET EVOL, V56, P991, DOI 10.1016/j.ympev.2010.04.004; Nagy Zoltan T, 2012, PLoS One, V7, pe34506, DOI 10.1371/journal.pone.0034506; Nori J, 2018, J BIOGEOGR, V45, P2588, DOI 10.1111/jbi.13435; Nori J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125055; Palumbi S.R, 1991, SIMPLE FOOLS GUIDE P; Penny SG, 2017, CONTRIB ZOOL, V86, P273, DOI 10.1163/18759866-08604002; Perl RGB, 2014, AMPHIBIA-REPTILIA, V35, P197, DOI 10.1163/15685381-00002942; Rakotoarison A, 2017, VERTEBR ZOOL, V67, P271; Rosa GM, 2012, BIODIVERS CONSERV, V21, P1531, DOI 10.1007/s10531-012-0262-x; Ruane S, 2017, MOL ECOL RESOUR, V17, P1003, DOI 10.1111/1755-0998.12655; Salzburger W, 2011, MOL ECOL, V20, P1952, DOI 10.1111/j.1365-294X.2011.05066.x; Scherz MD, 2016, MOL PHYLOGENET EVOL, V100, P372, DOI 10.1016/j.ympev.2016.04.019; Vences M, 2005, PHILOS T R SOC B, V360, P1859, DOI 10.1098/rstb.2005.1717; Vences M, 2003, J ZOOL SYST EVOL RES, V41, P205, DOI 10.1046/j.1439-0469.2003.00205.x; Vences M, 2006, CALLS FROGS MADAGASC; Vences Miguel, 2005, Front Zool, V2, P5, DOI 10.1186/1742-9994-2-5; Vences M, 2018, ZOOTAXA, V4486, P575, DOI 10.11646/zootaxa.4486.4.10; Vences M, 2017, SALAMANDRA, V53, P77; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Wollenberg KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-217	53	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0219437	10.1371/journal.pone.0219437	http://dx.doi.org/10.1371/journal.pone.0219437			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412043	Green Published, gold, Green Submitted			2022-12-26	WOS:000485012600014
J	Sindhu, MS; Rashid, T; Kashif, A				Sindhu, M. Sarwar; Rashid, Tabasam; Kashif, Agha			Modeling of linear programming and extended TOPSIS in decision making problem under the framework of picture fuzzy sets	PLOS ONE			English	Article							AGGREGATION OPERATORS; DISTANCE MEASURE; RANKING	Picture fuzzy sets (PFSs) are comparatively a new extension of fuzzy sets which describe the human opinions that has more answers like acceptance, rejection, neutral and desist, which cannot be correctly presented in fuzzy sets (FSs) and intuitionistic fuzzy sets (IFSs). The PFSs are categorized by three objects, the degree of belonging, the degree of neutral belonging and the degree of non-belonging such that the total of these three degrees must not be more than one. So far, there is no such work presented in the literature which deals with unknown weights of criteria based on PFSs. In the present work, we have developed a linear programming (LP) model to find the exact weights from the given constraints of weights for the criteria and construct a modified distance based on similarity measure between picture fuzzy sets. Then we have utilized this similarity measure to achieve the best option in the multiple criteria decision making (MCDM) problem. Lastly, two practical examples for the selection of alternatives are presented to compare the obtained results with the existing similarity measures.	[Sindhu, M. Sarwar; Rashid, Tabasam; Kashif, Agha] Univ Management & Technol, Dept Math, Lahore 54770, Pakistan	University of Management & Technology (UMT)	Sindhu, MS (corresponding author), Univ Management & Technol, Dept Math, Lahore 54770, Pakistan.	15001229001@umt.edu.pk	Kashif, Agha/AAH-1553-2019; Sindhu, Sarwar/AGZ-8041-2022	Kashif, Agha/0000-0002-1097-3450; rashid, tabasam/0000-0002-8691-1088				Aliyev RR, 2017, PROCEDIA COMPUT SCI, V120, P47, DOI 10.1016/j.procs.2017.11.209; [Anonymous], 1981, MULTIPLE ATTRIBUTES; Ashraf S., 2018, J NEW THEORY, V24, P59; ATANASSOV KT, 1986, FUZZY SET SYST, V20, P87, DOI 10.1016/S0165-0114(86)80034-3; Cuong B.C., 2014, J COMPUTER SCI CYBER, V30, P409, DOI DOI 10.15625/1813-9663/30/4/5032; Cuong BC, P 3 WORLD C INF COMM; Di AD, 2018, FUNCT MATER LETT, V11, DOI 10.1142/S1793604718500066; Figuera J., 2005, MULTIPLE CRITERIA DE; Garg H, 2017, ARAB J SCI ENG, V42, P5275, DOI 10.1007/s13369-017-2625-9; Ishizaka A, 2018, EUR J OPER RES, V264, P462, DOI 10.1016/j.ejor.2017.05.041; Jana C, 2019, APPL SOFT COMPUT, V74, P99, DOI 10.1016/j.asoc.2018.10.021; Kacprzak D, 2019, EXPERT SYST APPL, V116, P243, DOI 10.1016/j.eswa.2018.09.023; Kuo T, 2017, EUR J OPER RES, V260, P152, DOI 10.1016/j.ejor.2016.11.052; Son LH, 2017, APPL INTELL, V46, P652, DOI 10.1007/s10489-016-0856-1; Son LH, 2016, APPL SOFT COMPUT, V46, P284, DOI 10.1016/j.asoc.2016.05.009; Peng SM, 2017, J INTELL FUZZY SYST, V33, P3451, DOI 10.3233/JIFS-16298; Thong PH, 2016, ENG APPL ARTIF INTEL, V56, P121, DOI 10.1016/j.engappai.2016.08.009; Thong PH, 2016, KNOWL-BASED SYST, V109, P48, DOI 10.1016/j.knosys.2016.06.023; Sindhu MS, 2019, DISCRETE DYN NAT SOC, V2019, DOI 10.1155/2019/1527612; Singh P, 2015, J INTELL FUZZY SYST, V28, P591, DOI 10.3233/IFS-141338; Su B, 2015, ENERG ECON, V50, P177; Tian C, 2019, MATHEMATICS-BASEL, V7, DOI 10.3390/math7010039; Tian ZP, 2018, INFORMATICA-LITHUAN, V29, P773, DOI 10.15388/Informatica.2018.192; Vanderbei R. J., 2014, LINEAR PROGRAMMING, P345; Wang C, 2018, INFORM SCI, V429, P421; Wang CY, 2017, INFORM SCIENCES, V397, P155, DOI 10.1016/j.ins.2017.02.045; Wang L, 2018, PICTURE FUZZY MULTI; Wang L, 2018, J CLEAN PROD, V191, P105, DOI 10.1016/j.jclepro.2018.04.169; Wang R, 2018, SYM, V10; Wang WQ, 2005, PATTERN RECOGN LETT, V26, P2063, DOI 10.1016/j.patrec.2005.03.018; Wang XK, 2019, EXPERT SYST, V36, DOI 10.1111/exsy.12352; Wei GW, 2019, INT J INTELL SYST, V34, P50, DOI 10.1002/int.22042; Wei GW, 2019, J AMB INTEL HUM COMP, V10, P863, DOI 10.1007/s12652-018-0738-y; Wei GW, 2017, J INTELL FUZZY SYST, V33, P713, DOI 10.3233/JIFS-161798; Wei GW, 2016, J BUS ECON MANAG, V17, P491, DOI 10.3846/16111699.2016.1197147; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; Zhou SH, 2016, CHAOS SOLITON FRACT, V89, P47, DOI 10.1016/j.chaos.2015.09.018	37	19	20	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220957	10.1371/journal.pone.0220957	http://dx.doi.org/10.1371/journal.pone.0220957			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408506	gold, Green Published, Green Submitted			2022-12-26	WOS:000485009500029
J	Eslami, B; Rosa, M; Barros, H; Torres-Gonzalez, F; Stankunas, M; Ioannidi-Kapolou, E; Lindert, J; Soares, JJF; Lamura, G; Melchiorre, MG				Eslami, Bahareh; Di Rosa, Mirko; Barros, Henrique; Torres-Gonzalez, Francisco; Stankunas, Mindaugas; Ioannidi-Kapolou, Elisabeth; Lindert, Jutta; Soares, Joaquim J. F.; Lamura, Giovanni; Melchiorre, Maria Gabriella			Lifetime abuse and somatic symptoms among older women and men in Europe	PLOS ONE			English	Article							ELDER ABUSE; CARE PROGRAMS; CHRONIC PAIN; PREVALENCE; ASSOCIATION; DEPRESSION; COMMUNITY; STRESS; TRAUMA; ADULTS	Background Research suggests that survivors of interpersonal violence have an increasing experience of bodily symptoms. This study aims to scrutinise the association between lifetime abuse and somatic symptoms among older women and men, considering demographics/socioeconomic, social support and health variables. Methods A sample of 4,467 community-dwelling persons aged 60-84 years (57.3% women) living in seven European countries (Germany, Greece, Italy, Lithuania, Portugal, Spain, Sweden) was recruited for this cross-sectional study. Lifetime abuse (psychological, physical, sexual, financial and injury) was assessed on the basis of the UK study of elder abuse and the Conflict Tactics Scale-2, while somatic symptoms were assessed by the Giessen Complaint List short version. Results Women reported somatic symptoms more frequently than men. Multiple regression analyses revealed that lifetime exposure to psychological abuse was associated with higher levels of somatic symptoms among both women and men, while experiencing lifetime sexual abuse was associated with somatic symptoms only among older women, after adjusting for other demographic and socio-economic variables. Country of residence, older age, and low socio-economic status were other independent factors contributing to a higher level of somatic symptoms. Conclusions The positive association between the experience of abuse during lifetime and the reporting of higher levels of somatic symptoms, in particular among older women, seems to suggest that such complaints in later life might also be related to the experience of mistreatment and not only to ageing and related diseases. Violence prevention throughout lifetime could help to prevent somatic symptoms in later life.	[Eslami, Bahareh] Univ Gavle, Dept Occupat & Publ Hlth Sci, Gavle, Sweden; [Eslami, Bahareh; Soares, Joaquim J. F.] Mid Sweden Univ, Dept Hlth Sci, Div Publ Hlth Sci, Sundsvall, Sweden; [Di Rosa, Mirko] IRCCS INRCA, Natl Inst Hlth & Sci Aging, Lab Geriatr Pharmacoepidemiol, Ancona, Italy; [Barros, Henrique] Univ Porto, Inst Saude Publ, EPIUnit, Porto, Portugal; [Torres-Gonzalez, Francisco] Univ Granada, Dept Psychiat, Fac Med, Granada, Spain; [Stankunas, Mindaugas] Lithuanian Univ Hlth Sci, Dept Hlth Management, Kaunas, Lithuania; [Stankunas, Mindaugas] Griffith Univ, Sch Med, Hlth Serv Management Dept, Gold Coast, Qld, Australia; [Ioannidi-Kapolou, Elisabeth] Natl Sch Publ Hlth, Dept Sociol, Athens, Greece; [Lindert, Jutta] Univ Emden, Dept Publ Hlth, Emden, Germany; [Lindert, Jutta] Brandeis Univ, Womens Studies Res Ctr, Waltham, MA USA; [Lamura, Giovanni; Melchiorre, Maria Gabriella] IRCCS INRCA, Natl Inst Hlth & Sci Aging, Ctr Socioecon Res Ageing, Ancona, Italy	University of Gavle; Mid-Sweden University; IRCCS INRCA; Universidade do Porto; University of Granada; Lithuanian University of Health Sciences; Griffith University; National & Kapodistrian University of Athens; Brandeis University; IRCCS INRCA	Rosa, M (corresponding author), IRCCS INRCA, Natl Inst Hlth & Sci Aging, Lab Geriatr Pharmacoepidemiol, Ancona, Italy.	m.dirosa@inrca.it	Barros, Henrique/Q-8609-2019; Barros, Henrique/A-5488-2008; Di Rosa, Mirko/J-5974-2016	Barros, Henrique/0000-0003-4699-6571; Di Rosa, Mirko/0000-0002-1862-4159; Fernandes Soares, Joaquim Jorge/0000-0001-5221-9504	CHAFEA, Consumers, Health, Agriculture and Food Executive Agency [2007123]; IRCCS INRCA, by Ricerca Corrente from Italian Ministry of Health	CHAFEA, Consumers, Health, Agriculture and Food Executive Agency; IRCCS INRCA, by Ricerca Corrente from Italian Ministry of Health	This research was funded by grant support from the European Commission, through the Executive Agency for Health and Consumers (EAHC, currently CHAFEA, Consumers, Health, Agriculture and Food Executive Agency, http://ec.europa.eu/chafea/index_en.htm Public Health Programme 2008-2010), Grant Agreement n. 2007123, which made possible the realisation of the ABUEL Project, "Elder Abuse: A multinational prevalence survey." This study was partially supported, only for authors from IRCCS INRCA, by Ricerca Corrente funding from Italian Ministry of Health to IRCCS INRCA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afari N, 2014, PSYCHOSOM MED, V76, P2, DOI 10.1097/PSY.0000000000000010; Alemayehu B, 2004, HEALTH SERV RES, V39, P627, DOI 10.1111/j.1475-6773.2004.00248.x; Bohn D, 2013, J TRAUMA DISSOCIATIO, V14, P342, DOI 10.1080/15299732.2012.736930; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; Cooper C, 2008, AGE AGEING, V37, P151, DOI 10.1093/ageing/afm194; Creed FH, 2012, J PSYCHOSOM RES, V72, P311, DOI 10.1016/j.jpsychores.2012.01.009; Davidov E, 2014, ANNU REV SOCIOL, V40, P55, DOI 10.1146/annurev-soc-071913-043137; de Bruin SR, 2012, HEALTH POLICY, V107, P108, DOI [10.1016/j.healthpo1.2012.06.006, 10.1016/j.healthpol.2012.06.006]; Eberhard-Gran M, 2007, J GEN INTERN MED, V22, P1668, DOI 10.1007/s11606-007-0389-8; Eslami B, 2017, EUR J PUBLIC HEALTH, V27, P686, DOI 10.1093/eurpub/ckx047; Eslami B, 2016, INT J PUBLIC HEALTH, V61, P891, DOI 10.1007/s00038-016-0816-x; Fisher BS, 2006, GERONTOLOGIST, V46, P200, DOI 10.1093/geront/46.2.200; Giraldo-Rodriguez L, 2015, J AM GERIATR SOC, V63, P1594, DOI 10.1111/jgs.13552; Hanel G, 2009, J PSYCHOSOM RES, V67, P189, DOI 10.1016/j.jpsychores.2009.04.013; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Hobfoll SE, 2001, APPL PSYCHOL-INT REV, V50, P337, DOI 10.1111/1464-0597.00062; Hofelmann DA, 2018, EUR J PUBLIC HEALTH, V28, P603, DOI 10.1093/eurpub/ckx224; Johnston MC, 2019, EUR J PUBLIC HEALTH, V29, P182, DOI 10.1093/eurpub/cky098; Lindert J, 2012, EUR J PUBLIC HEALTH, V22, P662, DOI 10.1093/eurpub/ckr079; Logan JG, 2008, J CLIN NURS, V17, P201, DOI 10.1111/j.1365-2702.2008.02347.x; McCall-Hosenfeld JS, 2014, J PSYCHOSOM RES, V77, P196, DOI 10.1016/j.jpsychores.2014.07.011; Melchiorre MG, 2018, HEALTH POLICY, V122, P53, DOI 10.1016/j.healthpol.2017.08.006; Melchiorre MG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146425; Melchiorre MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054856; Mladovsky P., 2009, HLTH EUROPEAN UNION; O'Keeffe M, 2007, NURSING OLDER PEOPLE, DOI DOI 10.7748/NOP2007.10.19.8.24.C6268; Penninx Brenda W J H, 2010, Ned Tijdschr Geneeskd, V154, pA1784; Pillemer K, 2016, GERONTOLOGIST, V56, pS194, DOI 10.1093/geront/gnw004; Rijken M., 2013, Eurohealth, V19, P29; Rodrigues R., 2012, FACTS FIGURES HLTH A; Scheer, 1995, GIESSENER BESCHWERDE; Soares JJF, 2014, J ADULT PROT, V16, P213, DOI 10.1108/JAP-08-2013-0034; Stickley A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191651; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Tomenson B, 2013, BRIT J PSYCHIAT, V203, P373, DOI 10.1192/bjp.bp.112.114405; Tredal I, 2013, DRUG-EDUC PREV POLIC, V20, P96, DOI 10.3109/09687637.2012.751087; Winnersjo Rocio, 2012, J Inj Violence Res, V4, P87, DOI 10.5249/jivr.v4i2.122; Wuest J, 2008, J PAIN, V9, P1049, DOI 10.1016/j.jpain.2008.06.009; Yan E, 2012, INT PSYCHOGERIATR, V24, P1437, DOI 10.1017/S1041610212000294; Yi QQZ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206640; Yon YJ, 2017, LANCET GLOB HEALTH, V5, pE147, DOI 10.1016/S2214-109X(17)30006-2; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	43	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220741	10.1371/journal.pone.0220741	http://dx.doi.org/10.1371/journal.pone.0220741			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5EW	31393925	Green Published, gold			2022-12-26	WOS:000485002500057
J	Palekar, R; Rodriguez, A; Avila, C; Barrera, G; Barrera, M; Brenes, H; Bruno, A; El Omeiri, N; Fasce, R; de Almeida, WF; Franco, D; Huaringa, M; Lara, J; Loayza, R; Lopez-Martinez, I; de Paiva, TM; Medina, J; Ojeda, J; Ropero, AM; Sotomayor, V; Vazquez, C; Von Horoch, M				Palekar, Rakhee; Rodriguez, Angel; Avila, Cinthia; Barrera, Gisela; Barrera, Miriam; Brenes, Hebleen; Bruno, Alfedo; El Omeiri, Nathalie; Fasce, Rodrigo; Ferreira de Almeida, Walquiria; Franco, Danilo; Huaringa, Maribel; Lara, Jenny; Loayza, Roxana; Lopez-Martinez, Irma; Maria de Paiva, Terezinha; Medina, Jose; Ojeda, Jenny; Maria Ropero, Alba; Sotomayor, Viviana; Vazquez, Cynthia; Von Horoch, Marta			Patterns of influenza B circulation in Latin America and the Caribbean, 2010-2017	PLOS ONE			English	Article							AUSTRALIA	Objective There are limited published data about the circulation of influenza B/Victoria and B/Yamagata in Latin America and the Caribbean (LAC) and most countries have a vaccine policy that includes the use of the trivalent influenza vaccine. We analyzed influenza surveillance data to inform decision-making in LAC about prevention strategies, such as the use of the quadrivalent influenza vaccine. Methods There are a total of 28 reference laboratories and National Influenza Centers in LAC that conduct influenza virologic surveillance according to global standards, and on a weekly basis upload their surveillance data to the open-access World Health Organization (WHO) platform FluNet. These data include the number of specimens tested for influenza and the number of specimens positive for influenza by type, subtype and lineage, all by the epidemiologic week of specimen collection. We invited these laboratories to provide additional epidemiologic data about the hospitalized influenza B cases. We conducted descriptive analyses of patterns of influenza circulation and characteristics of hospitalized cases. We compared the predominant B lineage each season to the lineage in the vaccine applied, to determine vaccine mismatch. A Chi-square and Wilcoxan statistic were used to assess the statistical significance of differences in proportions and medians at the P<0.05 level. Findings During 2010-2017, the annual number of influenza B cases in LAC was similar to 4500 to 7000 cases. Since 2011, among the LAC-laboratories reporting influenza B lineage using molecular methods, both B/Victoria and B/Yamagata were detected annually. Among the hospitalized influenza B cases, there were statistically significant differences observed between B/Victoria and B/Yamagata cases when comparing age and the proportion with underlying co-morbid conditions and with history of oseltamivir treatment (P<0.001). The proportion deceased among B/Victoria and B/Yamagata hospitalized cases did not differ significantly. When comparing the predominant influenza B lineage detected, as part of surveillance activities during 63 seasons among 19 countries, to the lineage of the influenza B virus included in the trivalent influenza vaccine used during that season, there was a vaccine mismatch noted during 32% of the seasons analyzed. Conclusions Influenza B is important in LAC with both B/Victoria and B/Yamagata circulating annually in all sub regions. During approximately one-third of the seasons, an influenza B vaccine mismatch was identified. Further analyses are needed to better characterize the medical and economic burden of each influenza B lineage, to examine the potential cross-protection of one vaccine lineage against the other circulating virus lineage, and to determine the potential impact and cost-effectiveness of using the quadrivalent vaccine rather than the trivalent influenza vaccine.	[Palekar, Rakhee; Rodriguez, Angel; El Omeiri, Nathalie; Maria Ropero, Alba] WHO, PAHO, Washington, DC USA; [Avila, Cinthia; Loayza, Roxana] Ctr Nacl Enfermedades Trop CENETROP, Santa Cruz, CA, Bolivia; [Barrera, Gisela; Lopez-Martinez, Irma] Inst Diagnost & Referencia Epidemiol InDRE, Mexico City, DF, Mexico; [Barrera, Miriam] LNS, Guatemala City, Guatemala; [Brenes, Hebleen; Lara, Jenny] Inst Costarricense Invest & Ensenanza Nutr & Salu, San Jose, Costa Rica; [Bruno, Alfedo] Univ Agraria Ecuador, Inst Nacl Invest Salud Publ INSPI, Guayaquil, Ecuador; [Fasce, Rodrigo] Inst Salud Publ Chile, Santiago, Chile; [Ferreira de Almeida, Walquiria] Minist Salud, Brasilia, DF, Brazil; [Franco, Danilo] Inst Conmemorat Gorgas Estudios Salud, Panama City, Panama; [Huaringa, Maribel; Medina, Jose] INS, Lima, Peru; [Maria de Paiva, Terezinha] Adolfo Lutz Inst, Sao Paulo, Brazil; [Ojeda, Jenny] Minist Salud Publ, Quito, Ecuador; [Sotomayor, Viviana] Minist Salud, Santiago, Chile; [Vazquez, Cynthia] LCSP, Asuncion, Paraguay; [Von Horoch, Marta] Minist Salud Publ & Bienestar Social, Asuncion, Paraguay	Pan American Health Organization; World Health Organization; Instituto Conmemorativo Gorgas de Estudios de la Salud; Instituto Adolfo Lutz; Ministerio de Salud Publica y Bienstar Social	Palekar, R (corresponding author), WHO, PAHO, Washington, DC USA.	rpalekar@gmail.com	BRUNO, ALFREDO/AAW-8354-2020	BRUNO, ALFREDO/0000-0002-9678-4203; HUARINGA, MARIBEL/0000-0001-9247-4040				Ambrose CS, 2012, HUM VACC IMMUNOTHER, V8, P81, DOI 10.4161/hv.8.1.17623; [Anonymous], 2014, INFL VIR INF HUM; Caini S, 2017, EUROSURVEILLANCE, V22, P7, DOI [10.2807/1560-7917.ES.2017.22.35.30606, 10.2807/1560-7917.es.2017.22.35.30606]; Caini S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174592; Caini S, 2015, INFLUENZA OTHER RESP, V9, P3, DOI 10.1111/irv.12319; El Omeiri N, 2018, VACCINE, V36, P3555, DOI 10.1016/j.vaccine.2017.06.036; Fielding JE, 2016, VACCINE, V34, P4905, DOI 10.1016/j.vaccine.2016.08.067; Glezen WP, 2013, AM J PUBLIC HEALTH, V103, pE43, DOI 10.2105/AJPH.2012.301137; Hannoun C, 2013, EXPERT REV VACCINES, V12, P1085, DOI 10.1586/14760584.2013.824709; Hay AJ, 2001, PHILOS T R SOC B, V356, P1861, DOI 10.1098/rstb.2001.0999; Hirve S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153003; Moa AM, 2017, INFLUENZA OTHER RESP, V11, P102, DOI 10.1111/irv.12432; PAHO/ WHO, 2016, COUNTR REP PAHO WEBS; Pan American Health Organization, EXP PROGR IMM VACC P; Pan American Health Organization, IMM AM 2017 SUMM; Skowronski DM, 2014, J INFECT DIS, V210, P126, DOI 10.1093/infdis/jiu048; WHO, WHO GUID PHARM MAN P; WHO, 2011, MAN LAB DIAGN VIR SU; World Health Organization, GLOB EP SURV STAND I; World Health Organization, FLUNET VIR SURV DAT; World Health Organization, GLOB INFL SURV RESP	21	13	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0219595	10.1371/journal.pone.0219595	http://dx.doi.org/10.1371/journal.pone.0219595			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393886	gold, Green Published, Green Submitted			2022-12-26	WOS:000485002500014
J	Rujimongkon, K; Mungthin, M; Tummatorn, J; Ampawong, S; Adisakwattana, P; Boonyuen, U; Reamtong, O				Rujimongkon, Kitiya; Mungthin, Mathirut; Tummatorn, Jumreang; Ampawong, Sumate; Adisakwattana, Poom; Boonyuen, Usa; Reamtong, Onrapak			Proteomic analysis of Plasmodium falciparum response to isocryptolepine derivative	PLOS ONE			English	Article							TOPOISOMERASE-II; MALARIA PARASITES; PROTEIN; INHIBITION; CRYPTOLEPINE; CYCLE; MEFLOQUINE; ALKALOIDS; ANALOGS; TARGETS	Drug-resistant strains of malaria parasites have emerged for most of antimalarial medications. A new chemotherapeutic compound is needed for malarial therapy. Antimalarial activity against both drug-sensitive and drug-resistant P. falciparum has been reported for an isocryptolepine derivative, 8-bromo-2-fluoro-5-methyl-5H-indolo[3,2-c]quinoline (ICL-M), which also showed less toxicity to human cells. ICL-M has indoloquinoline as a core structure and its mode of action remains unclear. Here, we explored the mechanisms of ICL-M in P. falciparum by assessing the stage-specific activity, time-dependent effect, a proteomic analysis and morphology. Since human topo II activity inhibition has been reported as a function of isocryptolepine derivatives, malarial topo II activity inhibition of ICL-M was also examined in this study. The ICL-M exhibited antimalarial activity against both the ring and trophozoite stages of P. falciparum. Our proteomics analysis revealed that a total of 112 P. falciparum proteins were differentially expressed after ICL-M exposure; among these, 58 and 54 proteins were upregulated and downregulated, respectively. Proteins localized in the food vacuole, nucleus, and cytoplasm showed quantitative alterations after ICL-M treatment. A bioinformatic analysis revealed that pathways associated with ribosomes, proteasomes, metabolic pathways, amino acid biosynthesis, oxidative phosphorylation, and carbon metabolism were significantly different in P. falciparum treated with ICL-M. Moreover, a loss of ribosomes was clearly observed by transmission electron microscopy in the ICL-M-treated P. falciparum. This finding is in agreement with the proteomics data, which revealed downregulated levels of ribosomal proteins following ICL-M treatment. Our results provide important information about the mechanisms by which ICL-M affects the malaria parasite, which may facilitate the drug development of isocryptolepine derivatives.	[Rujimongkon, Kitiya; Boonyuen, Usa; Reamtong, Onrapak] Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand; [Mungthin, Mathirut] Phramongkutklao Coll Med, Dept Pharmacol, Bangkok, Thailand; [Tummatorn, Jumreang] Chulabhorn Grad Inst, Minist Educ, Ctr Excellence Environm Hlth & Toxicol, Program Chem Biol, Bangkok, Thailand; [Tummatorn, Jumreang] Chulabhorn Res Inst, Lab Med Chem, Bangkok, Thailand; [Ampawong, Sumate] Mahidol Univ, Fac Trop Med, Dept Trop Pathol, Bangkok, Thailand; [Adisakwattana, Poom] Mahidol Univ, Fac Trop Med, Dept Helminthol, Bangkok, Thailand	Mahidol University; Phramongkutklao College of Medicine; Chulabhorn Graduate Institute; Chulabhorn Research Institute; Mahidol University; Mahidol University	Reamtong, O (corresponding author), Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand.	onrapak.rea@mahidol.ac.th	Boonyuen, Usa/AAX-7128-2020	Boonyuen, Usa/0000-0003-0640-6215; Adisakwattana, Poom/0000-0002-0313-9900; Tummatorn, Jumreang/0000-0002-1662-151X; AMPAWONG, Sumate/0000-0002-5378-2996	FTM2013 of Faculty of Tropical Medicine, Mahidol university; Thailand Toray Science Foundation	FTM2013 of Faculty of Tropical Medicine, Mahidol university; Thailand Toray Science Foundation	This study was supported by FTM2013 of Faculty of Tropical Medicine, Mahidol university and Thailand Toray Science Foundation.	Aly NSM, 2007, PARASITOL RES, V100, P1119, DOI 10.1007/s00436-007-0460-8; Ampawong S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33372-4; Aroonkit P, 2015, EUR J MED CHEM, V94, P56, DOI 10.1016/j.ejmech.2015.02.047; BELL A, 1994, BIOCHEM PHARMACOL, V48, P495, DOI 10.1016/0006-2952(94)90279-8; Bertin GI, 2016, SCI REP-UK, V6, DOI 10.1038/srep26773; Bhaumik P, 2011, BIOCHEMISTRY-US, V50, P8862, DOI 10.1021/bi201118z; Bonjean K, 1998, BIOCHEMISTRY-US, V37, P5136, DOI 10.1021/bi972927q; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briolant S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-141; Chen BJ, 2014, CANCER LETT, V354, P378, DOI 10.1016/j.canlet.2014.08.045; Cromm PM, 2017, ACS CENTRAL SCI, V3, P830, DOI 10.1021/acscentsci.7b00252; Dassonneville L, 1999, BIOCHEMISTRY-US, V38, P7719, DOI 10.1021/bi990094t; de Almeida-Bizzo JH, 2014, EXP PARASITOL, V147, P60, DOI 10.1016/j.exppara.2014.08.015; Devi SB, 2019, MED HYPOTHESES, V125, P119, DOI 10.1016/j.mehy.2019.01.006; EPPING RJ, 1988, MOL BIOCHEM PARASIT, V28, P1, DOI 10.1016/0166-6851(88)90173-9; FRANCIS SE, 1994, EMBO J, V13, P306, DOI 10.1002/j.1460-2075.1994.tb06263.x; Ghosh P, 2014, RSC ADV, V4, P22442, DOI 10.1039/c4ra03650f; Grellier P, 1996, PHYTOTHER RES, V10, P317, DOI 10.1002/(SICI)1099-1573(199606)10:4&lt;317::AID-PTR858&gt;3.0.CO;2-0; Guo XY, 2011, J CELL MOL MED, V15, P296, DOI 10.1111/j.1582-4934.2009.00969.x; IBRAHIM ES, 1988, EUR J MED CHEM, V23, P183, DOI 10.1016/0223-5234(88)90192-4; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Ismail HM, 2016, P NATL ACAD SCI USA, V113, P2080, DOI 10.1073/pnas.1600459113; Jenner L, 2013, P NATL ACAD SCI USA, V110, P3812, DOI 10.1073/pnas.1216691110; Kassa FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026495; Kumar S, 2007, LIFE SCI, V80, P813, DOI 10.1016/j.lfs.2006.11.008; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Lasonder E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000195; Lavrado J, 2011, J MED CHEM, V54, P734, DOI 10.1021/jm101383f; Le Manach C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-424; Makanga M, 2005, PROTEOMICS, V5, P1849, DOI 10.1002/pmic.200401076; MARQUEZ VE, 1972, J MED CHEM, V15, P36, DOI 10.1021/jm00271a010; Morita M, 2012, J PROTEOME RES, V11, P5704, DOI 10.1021/pr3005315; Moura PA, 2009, ANTIMICROB AGENTS CH, V53, P4968, DOI 10.1128/AAC.00882-09; Mudeppa DG, 2015, J BIOL CHEM, V290, P20313, DOI 10.1074/jbc.M115.639039; Mukherjee A, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.02309-17, 10.1128/aac.02309-17]; Ng CL, 2017, TRENDS PARASITOL, V33, P731, DOI 10.1016/j.pt.2017.05.009; Nirmalan N, 2004, MOL MICROBIOL, V52, P1187, DOI 10.1111/j.1365-2958.2004.04049.x; Pal HC, 2016, MOLECULES, V21, DOI 10.3390/molecules21121758; Pelchovich G, 2014, FEBS J, V281, P3701, DOI 10.1111/febs.12892; Prieto JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004098; Ray S, 2012, J PROTEOMICS, V75, P3063, DOI 10.1016/j.jprot.2011.10.018; Reamtong O, 2015, INT J MASS SPECTROM, V391, P82, DOI 10.1016/j.ijms.2015.09.009; Reiter K, 2013, J BIOL CHEM, V288, P27724, DOI 10.1074/jbc.M113.498410; RIOU JF, 1991, MOL PHARMACOL, V40, P699; Sachanonta N, 2011, ULTRASTRUCT PATHOL, V35, P214, DOI 10.3109/01913123.2011.601405; Segura C, 2014, BIOMEDICA, V34, P237, DOI [10.7705/biomedica.v34i2.1700, 10.1590/S0120-41572014000200010]; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; Skinner TS, 1996, INT J PARASITOL, V26, P519, DOI 10.1016/0020-7519(96)89380-5; Sun J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129626; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Uchuskin MG, 2012, ORG BIOMOL CHEM, V10, P7262, DOI 10.1039/c2ob25836f; Vaid A, 2010, BLOOD, V115, P2500, DOI 10.1182/blood-2009-08-238972; Van Miert S, 2005, J NAT PROD, V68, P674, DOI 10.1021/np0496284; Voss TS, 2002, J BIOL CHEM, V277, P17493, DOI 10.1074/jbc.M200100200; Wang N, 2014, BIOORGAN MED CHEM, V22, P2629, DOI 10.1016/j.bmc.2014.03.030; Whittell LR, 2011, BIOORGAN MED CHEM, V19, P7519, DOI 10.1016/j.bmc.2011.10.037; WHO, 2018, WORLD MAL REP 2018; Willcox ML, 2004, BMJ-BRIT MED J, V329, P1156, DOI 10.1136/bmj.329.7475.1156; Wong W, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.31; Yang KS, 2013, ANGEW CHEM INT EDIT, V52, P10593, DOI 10.1002/anie.201304096	61	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220871	10.1371/journal.pone.0220871	http://dx.doi.org/10.1371/journal.pone.0220871			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393938	Green Published, Green Submitted, gold			2022-12-26	WOS:000485002500075
J	McAuley, JR; Bailey, KM; Ekambaram, P; Klei, LR; Kang, H; Hu, D; Freeman, TJ; Concel, VJ; Hubel, NE; Lee, JY; Klei, HB; Cheng, J; Sekar, P; Bridwell, RE; Covic, L; Lucas, PC; McAllister-Lucas, LM				McAuley, J. Randall; Bailey, Kelly M.; Ekambaram, Prasanna; Klei, Linda R.; Kang, Heejae; Hu, Dong; Freeman, Tanner J.; Concel, Vincent J.; Hubel, Nathaniel E.; Lee, Jia-Ying (Lloyd); Klei, Hanna B.; Cheng, Jing; Sekar, Preethiya; Bridwell, Rachel E.; Covic, Lidija; Lucas, Peter C.; McAllister-Lucas, Linda M.			MALT1 is a critical mediator of PAR1-driven NF-kappa B activation and metastasis in multiple tumor types	ONCOGENE			English	Article							BREAST-CANCER; PARACASPASE MALT1; IN-VITRO; THROMBIN; RECEPTOR; PROTEASE; PAR1; OSTEOSARCOMA; TUMORIGENESIS; INFLAMMATION	Protease-activated receptor 1 (PAR1), a thrombin-responsive G protein-coupled receptor (GPCR), is implicated in promoting metastasis in multiple tumor types, including both sarcomas and carcinomas, but the molecular mechanisms responsible remain largely unknown. We previously discovered that PAR1 stimulation in endothelial cells leads to activation of NF-kappa B, mediated by a protein complex comprised of CARMA3, Bc110, and the MALT1 effector protein (CBM complex). Given the strong association between NF-kappa B and metastasis, we hypothesized that this CBM complex could play a critical role in the PAR1-driven metastatic progression of specific solid tumors. In support of our hypothesis, we demonstrate that PAR1 stimulation results in NF-kappa B activation in both osteosarcoma and breast cancer, which is suppressed by siRNA-mediated MALT1 knockdown, suggesting that an intact CBM complex is required for the response in both tumor cell types. We identify several metastasis-associated genes that are upregulated in a MALT1-dependent manner after PAR1 stimulation in cancer cells, including those encoding the matrix remodeling protein, MMP9, and the cytokines, IL-1 beta and IL-8. Further, exogenous expression of PAR1 in MCF7 breast cancer cells confers highly invasive and metastatic behavior which can be blocked by CRISPR/Cas9-mediated MALT1 knockout. Importantly, we find that PAR1 stimulation induces MALT1 protease activity in both osteosarcoma and breast cancer cells, an activity that is mechanistically linked to NF-kappa B activation and potentially other responses associated with aggressive phenotype. Several small molecule MALT1 protease inhibitors have recently been described that could therefore represent promising new therapeutics for the prevention and/or treatment of PAR1-driven tumor metastasis.	[McAuley, J. Randall; Klei, Linda R.; Kang, Heejae; Hu, Dong; Freeman, Tanner J.; Hubel, Nathaniel E.; Lee, Jia-Ying (Lloyd); Lucas, Peter C.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Bailey, Kelly M.; Ekambaram, Prasanna; Concel, Vincent J.; Hubel, Nathaniel E.; Klei, Hanna B.; Cheng, Jing; Sekar, Preethiya; Bridwell, Rachel E.; Lucas, Peter C.; McAllister-Lucas, Linda M.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Covic, Lidija] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tufts Medical Center	McAllister-Lucas, LM (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA.	linda.mcallister@chp.edu	Cheng, Jing/AGR-7527-2022; Nuñez, Gabriel/A-7160-2014	Bailey, Kelly/0000-0003-3925-3243; Lucas, Peter/0000-0003-4880-7172; Lee, Jia-Ying/0000-0001-9012-766X	NIH [5F30CA196095]; Hyundai Scholar's Hope Grant [91499PA]; University of Pittsburgh Medical Scientist Training Program (MSTP) [T32GM008208]; NIH career development award [K12HD052892]; Alex's Lemonade Stand Foundation Young Investigator Award; John G. Rangos Senior Research Scholar Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD052892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008208] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hyundai Scholar's Hope Grant; University of Pittsburgh Medical Scientist Training Program (MSTP); NIH career development award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alex's Lemonade Stand Foundation Young Investigator Award; John G. Rangos Senior Research Scholar Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors wish to thank Celia Paris for her support and Katrina O'Halloran, Emily Elliott, Yijen Wu, Amir Borhani, and Nathan Salamacha for their technical assistance. In addition, we thank Dr Ed Prochownik for use of his laboratory equipment. This work was supported by NIH Grant 5F30CA196095 to JRM and a Hyundai Scholar's Hope Grant #91499PA to LMM-L. JRM also received support from The University of Pittsburgh Medical Scientist Training Program (MSTP) T32GM008208. KMB received support from an NIH career development award, K12HD052892, an Alex's Lemonade Stand Foundation Young Investigator Award, and the John G. Rangos Senior Research Scholar Fund.	Afonina IS, 2015, FEBS J, V282, P3286, DOI 10.1111/febs.13325; Bacci G, 2005, ACTA ONCOL, V44, P748, DOI 10.1080/02841860500327503; Bagati A, 2015, JOVE-J VIS EXP, DOI 10.3791/51480; Bardet M, 2018, IMMUNOL CELL BIOL, V96, P81, DOI 10.1111/imcb.1018; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Bohers E, 2015, LEUKEMIA LYMPHOMA, V56, P1213, DOI 10.3109/10428194.2014.941836; Bohers E, 2014, GENE CHROMOSOME CANC, V53, P144, DOI 10.1002/gcc.22126; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Borensztajn K, 2009, BRIT J HAEMATOL, V145, P548, DOI 10.1111/j.1365-2141.2009.07643.x; Chay CH, 2002, UROLOGY, V60, P760, DOI 10.1016/S0090-4295(02)01969-6; Chen HT, 2010, J CELL PHYSIOL, V223, P737, DOI 10.1002/jcp.22083; Cisowski J, 2011, AM J PATHOL, V179, P513, DOI 10.1016/j.ajpath.2011.03.025; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Coughlin SR, 1999, P NATL ACAD SCI USA, V96, P11023, DOI 10.1073/pnas.96.20.11023; Dai BY, 2017, BLOOD, V129, P333, DOI 10.1182/blood-2016-05-718775; Delekta PC, 2010, J BIOL CHEM, V285, P41432, DOI 10.1074/jbc.M110.158949; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Ekambaram P, 2018, CANCER RES, V78, P1225, DOI 10.1158/0008-5472.CAN-17-1089; Foley CJ, 2012, J BIOL CHEM, V287, P24330, DOI 10.1074/jbc.M112.356303; Fontan L, 2018, J CLIN INVEST, V128, P4397, DOI 10.1172/JCI99436; Fontan L, 2012, CANCER CELL, V22, P812, DOI 10.1016/j.ccr.2012.11.003; Hailfinger S, 2011, P NATL ACAD SCI USA, V108, P14596, DOI 10.1073/pnas.1105020108; Han N, 2011, ONCOL LETT, V2, P599, DOI 10.3892/ol.2011.291; Hernandez NA, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-47; Hernandez-Rodriguez NA, 2002, INT J BIOL MARKER, V17, P189, DOI 10.1177/172460080201700308; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Ichikawa J, 2012, CANCER-AM CANCER SOC, V118, P2494, DOI 10.1002/cncr.26518; Jaworski M, 2016, CELL MOL LIFE SCI, V73, P459, DOI 10.1007/s00018-015-2059-z; Justus CR, 2014, JOVE-J VIS EXP, DOI 10.3791/51046; Kelly AD, 2013, GENOME MED, V5, DOI 10.1186/gm406; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Liao D, 2015, CLIN CANCER RES, V21, P5349, DOI 10.1158/1078-0432.CCR-15-0198; Lim SM, 2015, J MED CHEM, V58, P8491, DOI 10.1021/acs.jmedchem.5b01415; Lin C, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3081-3; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Ludeman MJ, 2004, J BIOL CHEM, V279, P18592, DOI 10.1074/jbc.M310836200; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Mahanivong C, 2008, ONCOGENE, V27, P1273, DOI 10.1038/sj.onc.1210746; Massague J, 2016, NATURE, V529, P298, DOI 10.1038/nature17038; McAllister-Lucas LM, 2007, P NATL ACAD SCI USA, V104, P139, DOI 10.1073/pnas.0601947103; McAllister-Lucas LM, 2010, J BIOL CHEM, V285, P25880, DOI 10.1074/jbc.C110.109421; McAuley JR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01887; Meloni L, 2018, MOLECULES, V23, DOI 10.3390/molecules23123144; Nagel D, 2012, CANCER CELL, V22, P825, DOI 10.1016/j.ccr.2012.11.002; Pagani O, 2010, JNCI-J NATL CANCER I, V102, P456, DOI 10.1093/jnci/djq029; Pires BRB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169622; Queiroz KCS, 2014, INT J CANCER, V135, P2294, DOI 10.1002/ijc.28726; Radjabi AR, 2008, J BIOL CHEM, V283, P2822, DOI 10.1074/jbc.M704855200; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; Rehman AO, 2009, INT J ORAL SCI, V1, P105, DOI 10.4248/IJOS.09059; Sano T, 1999, INT J ONCOL, V15, P1197; Shi XL, 2004, MOL CANCER RES, V2, P395; Smith SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106966; Staal J, 2011, EMBO J, V30, P1742, DOI 10.1038/emboj.2011.85; Steeg PS, 2016, NAT REV CANCER, V16, P201, DOI 10.1038/nrc.2016.25; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Tang QL, 2012, JNCI-J NATL CANCER I, V104, P749, DOI 10.1093/jnci/djs210; Taniguchi K, 2018, NAT REV IMMUNOL, V18, P309, DOI 10.1038/nri.2017.142; Tantivejkul K, 2005, J CELL BIOCHEM, V96, P641, DOI 10.1002/jcb.20533; Toruner M, 2006, J BIOL CHEM, V281, P8686, DOI 10.1074/jbc.M512178200; Villares GJ, 2011, ONCOTARGET, V2, P8; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Xia YF, 2014, CANCER IMMUNOL RES, V2, P823, DOI 10.1158/2326-6066.CIR-14-0112; Yang E, 2016, ONCOGENE, V35, P1529, DOI 10.1038/onc.2015.217; Yuan Ta-Chun, 2004, Clin Prostate Cancer, V3, P189, DOI 10.3816/CGC.2004.n.030; Zhang SL, 2017, PROTEIN CELL, V8, P856, DOI 10.1007/s13238-017-0441-3; Zigler M, 2011, CANCER RES, V71, P6561, DOI 10.1158/0008-5472.CAN-11-1432	71	15	15	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 5	2019	38	49					7384	7398		10.1038/s41388-019-0958-4	http://dx.doi.org/10.1038/s41388-019-0958-4			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JT4BN	31420608				2022-12-26	WOS:000500936600002
J	Golec, E; Rosberg, R; Zhang, EM; Renstrom, E; Blom, AM; King, B				Golec, Ewelina; Rosberg, Rebecca; Zhang, Enming; Renstrom, Erik; Blom, Anna M.; King, Ben C.			A cryptic non-GPI-anchored cytosolic isoform of CD59 controls insulin exocytosis in pancreatic beta-cells by interaction with SNARE proteins	FASEB JOURNAL			English	Article						insulin secretion; glycosylphosphatidylinositol; VAMP2; CD59 isoforms; diabetes	ENDOPLASMIC-RETICULUM; COMPLEMENT; DEGRADATION; INHIBITOR; LYSIS	CD59 is a glycosylphosphatidylinositol (GPI)-anchored cell surface inhibitor of the complement membrane attack complex (MAC). We showed previously that CD59 is highly expressed in pancreatic islets but is down-regulated in rodent models of diabetes. CD59 knockdown but not enzymatic removal of cell surface CD59 led to a loss of glucose-stimulated insulin secretion (GSIS), suggesting that an intracellular pool of CD59 is required. In this current paper, we now report that non-GPI-anchored CD59 is present in the cytoplasm, colocalizes with exocytotic protein vesicle-associated membrane protein 2, and completely rescues GSIS in cells lacking endogenous CD59 expression. The involvement of cytosolic non-GPI-anchored CD59 in GSIS is supported in phosphatidylinositol glycan class A knockout GPI anchor-deficient beta-cells, in which GSIS is still CD59 dependent. Furthermore, site-directed mutagenesis demonstrated different structural requirements of CD59 for its 2 functions, MAC inhibition and GSIS. Our results suggest that CD59 is retrotranslocated from the endoplasmic reticulum to the cytosol, a process mediated by recognition of trimmed N-linked oligosaccharides, supported by the partial glycosylation of non-GPI-anchored cytosolic CD59 as well as the failure of N-linked glycosylation site mutant CD59 to reach the cytosol or rescue GSIS. This study thus proposes the previously undescribed existence of non-GPI-anchored cytosolic CD59, which is required for insulin secretion.	[Golec, Ewelina; Rosberg, Rebecca; Blom, Anna M.; King, Ben C.] Lund Univ, Dept Translat Med, Sect Med Prot Chem, Malmo, Sweden; [Zhang, Enming; Renstrom, Erik] Lund Univ, Diabet Ctr, Dept Clin Sci Malmo, Malmo, Sweden	Lund University; Lund University	Blom, AM (corresponding author), Lund Univ, Lab Med, Dept Translat Med, Sect Med Prot Chem, Wallenberg Lab Floor 4,MAS Entrance 46, S-21428 Malmo, Sweden.	anna.blom@med.lu.se	Blom, Anna/B-9607-2009; Blom, Anna/AFS-7369-2022	Blom, Anna/0000-0002-1348-1734; King, Benjamin/0000-0001-6776-8741; Rosberg, Rebecca/0000-0003-2512-1207; Zhang, Enming/0000-0002-0401-4608	Knut and Alice Wallenberg Foundation; Diabetesfonden; Greta and Johan Kock's Foundation; Royal Physiographical Society in Lund; Lars Hiertas Memorial Fund; Albert Pahlsson Fund; Crafoord Foundation; Tore Nilssons Foundation	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Diabetesfonden; Greta and Johan Kock's Foundation; Royal Physiographical Society in Lund(Royal Society of London); Lars Hiertas Memorial Fund; Albert Pahlsson Fund; Crafoord Foundation; Tore Nilssons Foundation	This work was funded by the Knut and Alice Wallenberg Foundation (to A.B. and E.R.); Diabetesfonden (to A.B.); and the Greta and Johan Kock's Foundation, the Royal Physiographical Society in Lund, the Lars Hiertas Memorial Fund, the Albert Pahlsson Fund, the Crafoord Foundation, and the Tore Nilssons Foundation (all to B.C.K.). Funders played no role in study design or execution. The authors declare no conflicts of interest.	Afshar N, 2005, MOL CELL BIOL, V25, P8844, DOI 10.1128/MCB.25.20.8844-8853.2005; Arborea G, 2017, MOL IMMUNOL, V89, P2, DOI 10.1016/j.molimm.2017.05.012; Bodian DL, 1997, J EXP MED, V185, P507, DOI 10.1084/jem.185.3.507; BROWN D, 1994, BRAZ J MED BIOL RES, V27, P309; Butikofer P, 2001, FASEB J, V15, P545, DOI 10.1096/fj.00-0415hyp; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Chen R, 2002, J CELL BIOCHEM, V84, P68, DOI 10.1002/jcb.1267; Ghosh P, 2014, J CLIN ENDOCR METAB, V99, pE999, DOI 10.1210/jc.2013-4232; Hajishengallis G, 2017, NAT IMMUNOL, V18, P1288, DOI 10.1038/ni.3858; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; HOLGUIN MH, 1990, BLOOD, V75, P284; Karbian N, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000280; King BC, 2019, CELL METAB, V29, P202, DOI 10.1016/j.cmet.2018.09.009; KODUKULA K, 1991, J BIOL CHEM, V266, P4464; Krus U, 2014, CELL METAB, V19, P883, DOI 10.1016/j.cmet.2014.03.001; MERI S, 1990, IMMUNOLOGY, V71, P1; Morito D, 2015, MOL CELL, V59, P335, DOI 10.1016/j.molcel.2015.06.010; Nevo Y, 2013, BLOOD, V121, P129, DOI 10.1182/blood-2012-07-441857; PARKER CJ, 1985, J CLIN INVEST, V75, P2074, DOI 10.1172/JCI111927; Rushmere NK, 1997, IMMUNOLOGY, V90, P640, DOI 10.1046/j.1365-2567.1997.00200.x; Spooner RA, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-26; Takahashi N, 2010, CELL METAB, V12, P19, DOI 10.1016/j.cmet.2010.05.013; Tokunaga F, 2000, J BIOL CHEM, V275, P40757, DOI 10.1074/jbc.M001073200; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	25	7	7	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12425	12434		10.1096/fj.201901007R	http://dx.doi.org/10.1096/fj.201901007R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31412214	Green Published			2022-12-26	WOS:000507461600064
J	Fujikawa, A; Sugawara, H; Tanga, N; Ishii, K; Kuboyama, K; Uchiyama, S; Suzuki, R; Noda, M				Fujikawa, Akihiro; Sugawara, Hajime; Tanga, Naomi; Ishii, Kentaro; Kuboyama, Kazuya; Uchiyama, Susumu; Suzuki, Ryoko; Noda, Masaharu			A head-to-toe dimerization has physiological relevance for ligand-induced inactivation of protein tyrosine receptor type Z	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; chondroitin sulfate; dimerization; mass spectrometry (MS); oligodendrocyte; phosphotyrosine; pleiotrophin; X-ray crystallography; knock-in mouse; receptor-type protein-tyrosine phosphatase	ZETA RPTP-BETA; ZETA/RPTP-BETA; PHOSPHATASE-ALPHA; REDOX REGULATION; STRUCTURAL BASIS; PLEIOTROPHIN; YEAST; DEPHOSPHORYLATION; INHIBITION; ACTIVATION	Protein-tyrosine phosphatase (PTPase) receptor type Z (PTPRZ) has two receptor isoforms, PTPRZ-A and -B, containing tandem intracellular PTP-D1 and -D2 domains, with only D1 being active. Pleiotrophin (PTN) binding to the extracellular PTPRZ region leads to inactivation of its PTPase activity, thereby facilitating oligodendrocyte precursor cell (OPC) differentiation and myelination in the central nervous system. However, the mechanisms responsible for PTN-induced PTPRZ inactivation remain unclear. We herein report that the crystal structure of the intracellular region of PTPRZ (PTPRZ-ICR) shows a ?head-to-toe?-type dimer conformation, with D2 masking the catalytic site of D1. MS analyses revealed that PTPRZ-ICR proteins remain in monomer-dimer equilibrium in aqueous solution and that a substrate-derived inhibitory peptide or competitive inhibitor (SCB4380) specifically bind to the monomer form in a 1:1 ratio. A D2 deletion (?D2) or dimer interface mutation (DDKK) disrupted dimer formation, but SCB4380 binding was maintained. Similar to WT PTPRZ-B, monomer-biased PTPRZ-B-?D2 and PTPRZ-B-DDKK variants efficiently dephosphorylated p190RhoGAP at Tyr-1105 when co-expressed in BHK-21 cells. The catalytic activities of these variants were not suppressed by PTN treatment, but were inhibited by the cell-permeable PTPase inhibitor NAZ2329. Of note, the PTN treatment did not enhance OPC differentiation in primary cultured glial cells from ?D2 or PTPase-inactive PTPRZ-B (CS) mutant knock-in mice. Our results thus indicate that PTN-induced PTPRZ inactivation results from dimer formation of the intracellular tandem PTP domains in a head-to-toe configuration, which is physiologically relevant to the control of OPC differentiation in vivo.	[Fujikawa, Akihiro; Tanga, Naomi; Kuboyama, Kazuya; Suzuki, Ryoko; Noda, Masaharu] NIBB, Div Mol Neurobiol, 5-1 Higashiyama,Myodaiji Cho, Okazaki, Aichi 4448787, Japan; [Sugawara, Hajime] Asubio Pharma Co Ltd, Chuo Ku, 6-4-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan; [Tanga, Naomi; Noda, Masaharu] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, 5-1 Higashiyama,Myodaiji Cho, Okazaki, Aichi 4448787, Japan; [Ishii, Kentaro; Uchiyama, Susumu] Natl Inst Nat Sci, Exploratory Res Ctr Life & Living Syst ExCELLS, 5-1 Higashiyama,Myodaiji Cho, Okazaki, Aichi 4448787, Japan; [Uchiyama, Susumu] Osaka Univ, Grad Sch Engn, Dept Biotechnol, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan; [Noda, Masaharu] Tokyo Inst Technol, Inst Innovat Res, Midori Ku, 4529 Nagatsuta Cho, Yokohama, Kanagawa 2268503, Japan; [Sugawara, Hajime] Daiichi Sankyo Co Ltd, Shinagawa R&D Ctr, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan; [Kuboyama, Kazuya] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Dept Neuropharmacol, 1314-1 Shido, Sanuki, Kagawa 7692193, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Asubio Pharma Co., Ltd.; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; The Exploratory Research Center on Life & Living Systems (ExCELLS); Osaka University; Tokyo Institute of Technology; Daiichi Sankyo Company Limited; Tokushima Bunri University	Noda, M (corresponding author), Tokyo Inst Technol, Inst Innovat Res, Midori Ku, S2 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268503, Japan.	noda.m.ae@m.titech.ac.jp	UCHIYAMA, Susumu/F-9590-2017	UCHIYAMA, Susumu/0000-0002-5181-179X; Kuboyama, Kazuya/0000-0002-9878-1209; Ishii, Kentaro/0000-0003-1722-2673	Joint Research by Exploratory Research Center on Life and Living Systems (ExCELLS)	Joint Research by Exploratory Research Center on Life and Living Systems (ExCELLS)	We thank Yoshiko Isoshima and Norie Nakanishi for technical assistance, and Akiko Kodama for secretarial assistance. Immunofluorescence photomicrograph images were acquired at the Spectrography and Bioimaging Facility, NIBB Core Research Facilities. Native MS experiments were supported by the Joint Research by Exploratory Research Center on Life and Living Systems (ExCELLS).	Adamsky K, 2003, J CELL SCI, V116, P1279, DOI 10.1242/jcs.00302; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; Blanchetot C, 2002, EMBO J, V21, P493, DOI 10.1093/emboj/21.4.493; BURKE TR, 1994, BIOCHEM BIOPH RES CO, V204, P129, DOI 10.1006/bbrc.1994.2435; Chow JPH, 2008, J BIOL CHEM, V283, P30879, DOI 10.1074/jbc.M802976200; Chow JPH, 2008, NEUROSCI LETT, V442, P208, DOI 10.1016/j.neulet.2008.07.028; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fujikawa A, 2017, J BIOCHEM, V162, P381, DOI 10.1093/jb/mvx042; Fujikawa A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05931-8; Fujikawa A, 2016, SCI REP-UK, V6, DOI 10.1038/srep20473; Fujikawa A, 2011, J BIOL CHEM, V286, P37137, DOI 10.1074/jbc.M111.270140; Fukada M, 2005, METHODS, V35, P54, DOI 10.1016/j.ymeth.2004.07.008; Fukada M, 2006, FEBS LETT, V580, P4051, DOI 10.1016/j.febslet.2006.06.041; Groen A, 2008, FEBS J, V275, P2597, DOI 10.1111/j.1742-4658.2008.06407.x; Ishii K, 2018, BBA-GEN SUBJECTS, V1862, P275, DOI 10.1016/j.bbagen.2017.09.019; Jiang GL, 1999, NATURE, V401, P606, DOI 10.1038/44170; Kawachi H, 2001, P NATL ACAD SCI USA, V98, P6593, DOI 10.1073/pnas.041608698; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuboyama K, 2016, J BIOL CHEM, V291, P18117, DOI 10.1074/jbc.M116.742536; Kuboyama K, 2015, J NEUROSCI, V35, P12162, DOI 10.1523/JNEUROSCI.2127-15.2015; Kuboyama K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048797; Maeda N, 1999, J BIOL CHEM, V274, P12474, DOI 10.1074/jbc.274.18.12474; Maeda N, 1996, J BIOL CHEM, V271, P21446, DOI 10.1074/jbc.271.35.21446; Murasugi A, 2003, BIOSCI BIOTECH BIOCH, V67, P2288, DOI 10.1271/bbb.67.2288; Nam HJ, 2005, J EXP MED, V201, P441, DOI 10.1084/jem.20041890; Nam HJ, 1999, CELL, V97, P449, DOI 10.1016/S0092-8674(00)80755-2; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Nishiwaki T, 1998, J BIOCHEM-TOKYO, V123, P458; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Shintani T, 1998, NEUROSCI LETT, V247, P135, DOI 10.1016/S0304-3940(98)00295-X; Shintani T, 1997, BIOCHEM BIOPH RES CO, V230, P419, DOI 10.1006/bbrc.1996.5973; Tamura H, 2006, NEUROSCI LETT, V399, P33, DOI 10.1016/j.neulet.2006.01.045; Tanga N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217880; Tanga N, 2019, GLIA, V67, P967, DOI 10.1002/glia.23583; Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681	42	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2019	294	41					14953	14965		10.1074/jbc.RA119.007878	http://dx.doi.org/10.1074/jbc.RA119.007878			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9JH	31416834	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000499253400010
J	Zhao, DY; Poge, M; Morizumi, T; Gulati, S; Van Eps, N; Zhang, JY; Miszta, P; Filipek, S; Mahamid, J; Plitzko, JM; Baumeister, W; Ernst, OP; Palczewski, K				Zhao, Dorothy Yanling; Poege, Matthias; Morizumi, Takefumi; Gulati, Sahil; Van Eps, Ned; Zhang, Jianye; Miszta, Przemyslaw; Filipek, Slawomir; Mahamid, Julia; Plitzko, Juergen M.; Baumeister, Wolfgang; Ernst, Oliver P.; Palczewski, Krzysztof			Cryo-EM structure of the native rhodopsin dimer in nanodiscs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); receptor; rhodopsin; retinoid-binding protein; retina; cryo-electron microscopy (cryo-EM); rod outer segment; transmembrane helix 1 (TM1); helix 8 (H8); cell signaling; double electron-electron resonance (DEER); rhodopsin dimerization; transducin	PROTEIN-COUPLED RECEPTOR; CRYSTAL-STRUCTURE; OPIOID RECEPTOR; C5A RECEPTOR; DIMERIZATION; OLIGOMERIZATION; CELLS; OPSIN; ORGANIZATION; ARRESTIN	Imaging of rod photoreceptor outer-segment disc membranes by atomic force microscopy and cryo-electron tomography has revealed that the visual pigment rhodopsin, a prototypical class A G protein?coupled receptor (GPCR), can organize as rows of dimers. GPCR dimerization and oligomerization offer possibilities for allosteric regulation of GPCR activity, but the detailed structures and mechanism remain elusive. In this investigation, we made use of the high rhodopsin density in the native disc membranes and of a bifunctional cross-linker that preserves the native rhodopsin arrangement by covalently tethering rhodopsins via Lys residue side chains. We purified cross-linked rhodopsin dimers and reconstituted them into nanodiscs for cryo-EM analysis. We present cryo-EM structures of the cross-linked rhodopsin dimer as well as a rhodopsin dimer reconstituted into nanodiscs from purified monomers. We demonstrate the presence of a preferential 2-fold symmetrical dimerization interface mediated by transmembrane helix 1 and the cytoplasmic helix 8 of rhodopsin. We confirmed this dimer interface by double electron?electron resonance measurements of spin-labeled rhodopsin. We propose that this interface and the arrangement of two protomers is a prerequisite for the formation of the observed rows of dimers. We anticipate that the approach outlined here could be extended to other GPCRs or membrane receptors to better understand specific receptor dimerization mechanisms.	[Zhao, Dorothy Yanling; Morizumi, Takefumi; Van Eps, Ned; Ernst, Oliver P.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Poege, Matthias; Plitzko, Juergen M.; Baumeister, Wolfgang] Max Planck Inst Biochem, Dept Mol Struct Biol, D-82152 Martinsried, Germany; [Gulati, Sahil; Zhang, Jianye; Palczewski, Krzysztof] Univ Calif Irvine, Gavin Herbert Eye Inst, Irvine, CA 92697 USA; [Gulati, Sahil; Zhang, Jianye; Palczewski, Krzysztof] Univ Calif Irvine, Dept Ophthalmol, Irvine, CA 92697 USA; [Gulati, Sahil; Zhang, Jianye; Palczewski, Krzysztof] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Miszta, Przemyslaw; Filipek, Slawomir] Univ Warsaw, Fac Chem, Biol & Chem Res Ctr, PL-02093 Warsaw, Poland; [Mahamid, Julia] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Ernst, Oliver P.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Ernst, Oliver P.] Univ Toronto, Anne & Max Tanenbaum Chair Neurosci, Toronto, ON, Canada; [Palczewski, Krzysztof] Univ Calif Irvine, Leopold Chair Ophthalmol, Irvine, CA USA	University of Toronto; Max Planck Society; University of California System; University of California Irvine; University of California System; University of California Irvine; Case Western Reserve University; University of Warsaw; European Molecular Biology Laboratory (EMBL); University of Toronto; University of Toronto; University of California System; University of California Irvine	Ernst, OP (corresponding author), Univ Toronto, Depts Biochem, Toronto, ON M5S 1A8, Canada.; Ernst, OP (corresponding author), Univ Toronto, Depts Mol Genet, Toronto, ON M5S 1A8, Canada.; Palczewski, K (corresponding author), Univ Calif Irvine, Gavin Herbert Eye Inst, Irvine, CA 92657 USA.; Palczewski, K (corresponding author), Univ Calif Irvine, Dept Ophthalmol, Irvine, CA 92657 USA.	oliver.ernst@utoronto.ca; kpalczew@uci.edu	Morizumi, Takefumi/AAA-2063-2021; Plitzko, Juergen M/H-9576-2014; Filipek, Slawomir/A-2985-2008	Morizumi, Takefumi/0000-0002-2785-209X; Plitzko, Juergen M/0000-0002-6402-8315; Filipek, Slawomir/0000-0003-3147-3858; Poge, Matthias/0000-0003-2331-4638; Gulati, Sahil/0000-0002-8255-479X	Allergan; NATIONAL EYE INSTITUTE [R24EY027283] Funding Source: NIH RePORTER	Allergan(AbbVieAllergan); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Dr. Beata Jastrzebska (Case Western Reserve University) for involvement in designing the cross-linking experiments and Dr. Maryam Khoshouei (Novartis Corp.) for helpful discussions. The authors wish to acknowledge Allergan for their generous support of research at the Center for Translational Vision Research (CTVR) at Gavin Herbert Eye Institute, University of CA, Irvine.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Banerjee S, 2008, J MOL BIOL, V377, P1067, DOI 10.1016/j.jmb.2008.01.066; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Berthouze M, 2007, BIOCHEM BIOPH RES CO, V356, P642, DOI 10.1016/j.bbrc.2007.03.030; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; Caro LN, 2015, METHOD ENZYMOL, V556, P307, DOI 10.1016/bs.mie.2015.01.005; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Comar WD, 2014, J AM CHEM SOC, V136, P8342, DOI 10.1021/ja501948w; Danev R, 2017, ELIFE, V6, DOI 10.7554/eLife.23006; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dijkman PM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03727-6; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Ferre S, 2014, PHARMACOL REV, V66, P413, DOI 10.1124/pr.113.008052; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Govardovskii VI, 2009, MOL VIS, V15, P1717; Gunkel M, 2015, STRUCTURE, V23, P628, DOI 10.1016/j.str.2015.01.015; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Harding PJ, 2009, BIOPHYS J, V96, P964, DOI 10.1016/j.bpj.2008.09.054; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Herrick-Davis K, 2005, J BIOL CHEM, V280, P40144, DOI 10.1074/jbc.M507396200; Huang JY, 2013, NAT STRUCT MOL BIOL, V20, P419, DOI 10.1038/nsmb.2504; Jastrzebska B, 2006, J BIOL CHEM, V281, P11917, DOI 10.1074/jbc.M600422200; Jastrzebska B, 2015, J BIOL CHEM, V290, P25728, DOI 10.1074/jbc.M115.662684; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kang YY, 2018, NATURE, V558, P553, DOI 10.1038/s41586-018-0215-y; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Khoshouei M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10534; Klco JM, 2003, J BIOL CHEM, V278, P35345, DOI 10.1074/jbc.M305606200; Knepp AM, 2012, BIOCHEMISTRY-US, V51, P1819, DOI 10.1021/bi3001598; Koehl A, 2019, NATURE, V567, pE10, DOI 10.1038/s41586-019-0983-z; Kota P, 2006, P NATL ACAD SCI USA, V103, P3054, DOI 10.1073/pnas.0510982103; Lee SP, 2004, J BIOL CHEM, V279, P35671, DOI 10.1074/jbc.M401923200; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Liang Y, 2004, J BIOL CHEM, V279, P48189, DOI 10.1074/jbc.M408362200; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Mansoor SE, 2006, P NATL ACAD SCI USA, V103, P3060, DOI 10.1073/pnas.0511010103; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mishra AK, 2016, BIOCHEM J, V473, P3819, DOI 10.1042/BCJ20160422; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Pellissier LP, 2011, J BIOL CHEM, V286, P9985, DOI 10.1074/jbc.M110.201939; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pin JP, 2016, NATURE, V540, P60, DOI 10.1038/nature20566; Pin JP, 2004, BIOCHEM PHARMACOL, V68, P1565, DOI 10.1016/j.bcp.2004.06.035; Redka DS, 2014, J BIOL CHEM, V289, P24347, DOI 10.1074/jbc.M114.559294; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Rivero-Muller A, 2010, P NATL ACAD SCI USA, V107, P2319, DOI 10.1073/pnas.0906695106; Robertson N, 2018, NATURE, V553, P111, DOI 10.1038/nature25025; Rohrer DK, 1998, PHYSIOL REV, V78, P35, DOI 10.1152/physrev.1998.78.1.35; Ruprecht JJ, 2004, EMBO J, V23, P3609, DOI 10.1038/sj.emboj.7600374; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Salon JA, 2011, PHARMACOL REV, V63, P901, DOI 10.1124/pr.110.003350; Smith NJ, 2010, PHARMACOL REV, V62, P701, DOI 10.1124/pr.110.002667; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Suda K, 2004, MOL MEMBR BIOL, V21, P435, DOI 10.1080/09687860400020291; Tsukamoto H, 2010, J MOL BIOL, V399, P501, DOI 10.1016/j.jmb.2010.04.029; Van Eps N, 2018, P NATL ACAD SCI USA, V115, P2383, DOI 10.1073/pnas.1721896115; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Wen XH, 2009, BIOPHYS J, V96, P939, DOI 10.1016/j.bpj.2008.10.016; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang T, 2016, P NATL ACAD SCI USA, V113, P9093, DOI 10.1073/pnas.1609018113; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	80	39	39	4	33	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2019	294	39					14215	14230		10.1074/jbc.RA119.010089	http://dx.doi.org/10.1074/jbc.RA119.010089			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HH	31399513	hybrid, Green Published			2022-12-26	WOS:000499248200006
J	Hol, JA; Lopez-Yurda, MI; Van Tinteren, H; Van Grotel, M; Godzinski, J; Vujanic, G; Oldenburger, F; De Camargo, B; Ramirez-Villar, GL; Bergeron, C; Pritchard-Jones, K; Graf, N; Van den Heuvel-Eibrink, MM				Hol, J. A.; Lopez-Yurda, M. I.; Van Tinteren, H.; Van Grotel, M.; Godzinski, J.; Vujanic, G.; Oldenburger, F.; De Camargo, B.; Ramirez-Villar, G. L.; Bergeron, C.; Pritchard-Jones, K.; Graf, N.; Van den Heuvel-Eibrink, M. M.			Prognostic significance of age in 5631 patients with Wilms tumour prospectively registered in International Society of Paediatric Oncology (SIOP) 93-01 and 2001	PLOS ONE			English	Article							RENAL TUMORS; STAGE-I; INTERMEDIATE-RISK; SURVIVAL; CHILDREN; TRIAL; GAIN; 1Q; NEPHRECTOMY; ASSOCIATION	Background To enhance risk stratification for Wilms tumour (WT) in a pre-operative chemotherapy setting, we explored the prognostic significance and optimal age cutoffs in patients treated according to International Society of Paediatric Oncology Renal Tumour Study Group (SIOP-RTSG) protocols. Methods Patients(6 months-18 years) with unilateral WT were selected from prospective STOP 93-01 and 2001 studies(1993-2016). Martingale residual analysis was used to explore optimal age cutoffs. Outcome according to age was analyzed by uni- and multivariable analysis, adjusted for sex, biopsy(yes/no), stage, histology and tumour volume at surgery. Results 5631 patients were included; median age was 3.4 years(IQR: 2-5.1). Estimated 5-year event-free survival (EFS) and overall survival (OS) were 85%(95%CI 83.5-85.5) and 93% (95%CI 92.0-93.4). Martingale residual plots detected no optimal age cutoffs. Multivariable analysis showed lower EFS with increasing age(linear trend P<0.001). Using previously described age categories, EFS was lower for patients aged 2-4(HR 1.34, P = 0.02), 4-10 (HR 1.83, P<0.0001) and 10-18 years(HR 1.74, P = 0.01) as compared to patients aged 6 months-2 years. OS was lower for patients 4-10 years(HR 1.67, P = 0.01) and 10-18 years (HR 1.87, P = 0.04), but not for 2-4 years(HR 1.29, P = 0.23). Higher stage, histological risk group and tumour volume were independent adverse prognostic factors. Conclusion Although optimal age cutoffs could not be identified, we demonstrated the prognostic significance of age as well as previously described cutoffs for EFS (2 and 4 years) and OS (4 years) in children with WT treated with pre-operative chemotherapy. These findings encourage the consideration of age in the design of future SIOP-RTSG protocols.	[Hol, J. A.; Van Grotel, M.; Van den Heuvel-Eibrink, M. M.] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands; [Lopez-Yurda, M. I.; Van Tinteren, H.] Netherlands Canc Inst, Dept Biometr, Amsterdam, Netherlands; [Godzinski, J.] Marciniak Hosp, Dept Paediat Surg, Wroclaw, Poland; [Godzinski, J.] Med Univ, Dept Paediat Traumatol & Emergency Med, Wroclaw, Poland; [Vujanic, G.] Sidra Med, Dept Pathol, Doha, Qatar; [Oldenburger, F.] Acad Med Ctr, Dept Radiotherapy, Amsterdam, Netherlands; [De Camargo, B.] Inst Nacl Canc INCA, Paediat Haematol Oncol Program, Rio De Janeiro, Brazil; [Ramirez-Villar, G. L.] Hosp Univ Virgen Rocio, Dept Paediat Oncol, Seville, Spain; [Bergeron, C.] Ctr Leon Berard, Inst Hematol & Oncol Pediat, Dept Paediat Oncol, Lyon, France; [Pritchard-Jones, K.] UCL, UCL Great Ormond St Inst Child Hlth, London, England; [Graf, N.] Saarland Univ, Dept Paediat Oncol & Haematol, Homburg, Germany	Netherlands Cancer Institute; Wroclaw Medical University; Sidra Medical & Research Center; University of Amsterdam; Academic Medical Center Amsterdam; National Cancer Institute (Inca); Virgen del Rocio University Hospital; UNICANCER; Centre Leon Berard; University of London; University College London; Universitatsklinikum des Saarlandes	Hol, JA (corresponding author), Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands.	j.hol@prinsesmaximacentrum.nl	Vujanic, Gordan M./AFS-3176-2022; Graf, Norbert/H-1328-2011; Vujanic, Gordan M./AAW-4712-2020; Pritchard-Jones, Kathryn/F-4286-2014	Vujanic, Gordan M./0000-0003-0726-6939; Graf, Norbert/0000-0002-2248-323X; Vujanic, Gordan M./0000-0003-0726-6939; Hol, Janna/0000-0002-3156-5229; Ramirez-Villar, Gema Lucia/0000-0001-9986-5861; Lopez-Yurda, Marta/0000-0003-3678-3222; Godzinski, Jan/0000-0001-9687-7146; van Tinteren, Harm/0000-0002-4626-8702; Pritchard-Jones, Kathryn/0000-0002-2384-9475	Princess Maxima Center for Pediatric Oncology, Foundation KiKa (Children Cancerfree) [278]; Great Ormond Street Hospital Children's Charity [W1090]; Cancer Research UK [C1188/A8687]; UK National Cancer Research Network and Children's Cancer and Leukaemia Group; Societe Francaise des Cancers de l'Enfant; Association Leon Berard Enfant Cancereux; Gesellschaft fur Padiatrische Onkologie und Hamatologie and Deutsche Krebshilfe, Grupo Cooperativo Brasileiro para o Tratamento do Tumour de Wilms'; Sociedade Brasileira de Oncologia Pediatrica; Spanish Society of Paediatric Haematology; Spanish Association Against Cancer; National Institute of Health Research (NIHR) Biomedical Research Centre at Great Ormond Street Hospital	Princess Maxima Center for Pediatric Oncology, Foundation KiKa (Children Cancerfree); Great Ormond Street Hospital Children's Charity; Cancer Research UK(Cancer Research UK); UK National Cancer Research Network and Children's Cancer and Leukaemia Group; Societe Francaise des Cancers de l'Enfant; Association Leon Berard Enfant Cancereux; Gesellschaft fur Padiatrische Onkologie und Hamatologie and Deutsche Krebshilfe, Grupo Cooperativo Brasileiro para o Tratamento do Tumour de Wilms'; Sociedade Brasileira de Oncologia Pediatrica; Spanish Society of Paediatric Haematology; Spanish Association Against Cancer; National Institute of Health Research (NIHR) Biomedical Research Centre at Great Ormond Street Hospital(National Institute for Health Research (NIHR))	This work was supported by the Princess Maxima Center for Pediatric Oncology, Foundation KiKa (Children Cancerfree) (278), Great Ormond Street Hospital Children's Charity (W1090), Cancer Research UK (C1188/A8687), the UK National Cancer Research Network and Children's Cancer and Leukaemia Group, Societe Francaise des Cancers de l'Enfant and Association Leon Berard Enfant Cancereux and Enfant et Sante , Gesellschaft fur Padiatrische Onkologie und Hamatologie and Deutsche Krebshilfe, Grupo Cooperativo Brasileiro para o Tratamento do Tumour de Wilms' and Sociedade Brasileira de Oncologia Pediatrica, the Spanish Society of Paediatric Haematology and Oncology and the Spanish Association Against Cancer. KPJ is supported in part by the National Institute of Health Research (NIHR) Biomedical Research Centre at Great Ormond Street Hospital.	Boccon-Gibod LA, 1998, PEDIATR DEVEL PATHOL, V1, P243, DOI 10.1007/s100249900033; BRESLOW N, 1991, CANCER-AM CANCER SOC, V68, P2345, DOI 10.1002/1097-0142(19911201)68:11<2345::AID-CNCR2820681103>3.0.CO;2-T; Chagtai T, 2016, J CLIN ONCOL, V34, P3195, DOI 10.1200/JCO.2015.66.0001; DANGIO GJ, 1976, CANCER-AM CANCER SOC, V38, P633, DOI 10.1002/1097-0142(197608)38:2<633::AID-CNCR2820380203>3.0.CO;2-S; de Kraker J, 2004, LANCET, V364, P1229, DOI 10.1016/S0140-6736(04)17139-0; Fernandez CV, 2017, ANN SURG, V265, P835, DOI 10.1097/SLA.0000000000001716; Frazier AL, 2010, PEDIATR BLOOD CANCER, V54, P879, DOI 10.1002/pbc.22396; Graf N, 2012, EUR J CANCER, V48, P3240, DOI 10.1016/j.ejca.2012.06.007; Gratias EJ, 2016, J CLIN ONCOL, V34, P3189, DOI 10.1200/JCO.2015.66.1140; Green DM, 2001, J CLIN ONCOL, V19, P3719, DOI 10.1200/JCO.2001.19.17.3719; GREEN DM, 1993, J CLIN ONCOL, V11, P91, DOI 10.1200/JCO.1993.11.1.91; Grundy PE, 2005, J CLIN ONCOL, V23, P7312, DOI 10.1200/JCO.2005.01.2799; Hing S, 2001, AM J PATHOL, V158, P393, DOI 10.1016/S0002-9440(10)63982-X; Pastore G, 2006, EUR J CANCER, V42, P2103, DOI 10.1016/j.ejca.2006.05.010; Perlman EJ, 2011, J CLIN ONCOL, V29, P698, DOI 10.1200/JCO.2010.31.5192; Perotti D, 2012, GENE CHROMOSOME CANC, V51, P644, DOI 10.1002/gcc.21951; Popov SD, 2011, PEDIATR DEVEL PATHOL, V14, P189, DOI 10.2350/10-06-0855-OA.1; Pritchard-Jones K, 2003, J CLIN ONCOL, V21, P3269, DOI 10.1200/JCO.2003.01.062; Pritchard-Jones K, 2015, LANCET, V386, P1156, DOI 10.1016/S0140-6736(14)62395-3; Segers H, 2013, GENE CHROMOSOME CANC, V52, P1065, DOI 10.1002/gcc.22101; Shamberger RC, 2010, ANN SURG, V251, P555, DOI 10.1097/SLA.0b013e3181c0e5d7; Spreafico F, 2017, J UROLOGY, V198, P1138, DOI 10.1016/j.juro.2017.06.081; Spreafico F, 2017, NAT REV UROL, V14, P3, DOI 10.1038/nrurol.2016.247; Spreafico F, 2013, J UROLOGY, V189, P260, DOI 10.1016/j.juro.2012.09.009; THERNEAU TM, 1990, BIOMETRIKA, V77, P147, DOI 10.1093/biomet/77.1.147; van den Heuvel-Eibrink MM, 2015, EUR J CANCER, V51, P498, DOI 10.1016/j.ejca.2014.12.011; Van den Heuvel-Eibrink MM, 2008, PEDIATR BLOOD CANCER, V50, P1130, DOI 10.1002/pbc.21389; van den Heuvel-Eibrink MM, 2017, NAT REV UROL, V14, P743, DOI 10.1038/nrurol.2017.163; Vujanic GM, 2002, MED PEDIATR ONCOL, V38, P79, DOI 10.1002/mpo.1276; Vujanic GM, 2018, NAT REV UROL, V15, P693, DOI 10.1038/s41585-018-0100-3; Weirich A, 2004, ANN ONCOL, V15, P808, DOI 10.1093/annonc/mdh171	31	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0221373	10.1371/journal.pone.0221373	http://dx.doi.org/10.1371/journal.pone.0221373			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5MK	31425556	Green Published, gold, Green Submitted			2022-12-26	WOS:000485022400042
J	Yamazaki, R; Nishiyama, O; Saeki, S; Sano, H; Iwanaga, T; Tohda, Y				Yamazaki, Ryo; Nishiyama, Osamu; Saeki, Sho; Sano, Hiroyuki; Iwanaga, Takashi; Tohda, Yuji			The utility of the Japanese Association for Acute Medicine DIC scoring system for predicting survival in acute exacerbation of fibrosing idiopathic interstitial pneumonia	PLOS ONE			English	Article							DISSEMINATED INTRAVASCULAR COAGULATION; HUMAN SOLUBLE THROMBOMODULIN; CRITICALLY-ILL PATIENTS; PULMONARY-FIBROSIS; PROSPECTIVE VALIDATION; INTERNATIONAL SOCIETY; DIAGNOSTIC-CRITERIA; CLINICAL-COURSE; ORGAN FAILURE; SEPSIS	Background Although evidence of a disseminated intravascular coagulation (DIC)-like reaction has been identified in the lung parenchyma of patients with acute exacerbation of idiopathic pulmonary fibrosis (IPF), an association between DIC and IPF outcome has not been elucidated. Therefore, we retrospectively investigated the association between the Japanese Association for Acute Medicine (JAAM)-DIC score and mortality in patients with acute exacerbation of fibrosing idiopathic interstitial pneumonia (AE-fIIP). Methods Between January 2008 and December 2016, consecutive patients with chronic fIIP who were admitted for the first time for AE-fIIP were recruited into the study. Associations between clinical data and JAAM-DIC score at the time of admission and mortality were examined. Results During the study period, a total of 91 patients with fIIP (73.0 +/- 8.4 y.o.) were hospitalized for AE-fIIP for the first time. The 30-day and hospital mortality were 8.7% and 17.5%, respectively. A multivariate analysis showed that the JAAM-DIC score on admission was an independent predictor of 30-day mortality (odds ratio [OR] 2.57, 95% confidential interval [CI] 1.50-4.40, P = 0.0006). The APACHE II score (OR 1.29, 95% CI 1.01-1.63, P = 0.03) and the JAAM-DIC score (OR 3.47, 95% CI 1.73-6.94, P = 0.0004) were independent predictors of hospital mortality. Conclusions The JAAM-DIC scoring system can predict survival in patients with AE-fIIP. The role of DIC in the pathogenesis of AE-fIIP merits further investigation.	[Yamazaki, Ryo; Nishiyama, Osamu; Saeki, Sho; Sano, Hiroyuki; Iwanaga, Takashi; Tohda, Yuji] Kindai Univ, Dept Resp Med & Allergol, Fac Med, Osaka, Japan	Kindai University (Kinki University)	Nishiyama, O (corresponding author), Kindai Univ, Dept Resp Med & Allergol, Fac Med, Osaka, Japan.	nishiyama_o@yahoo.co.jp		Nishiyama, Osamu/0000-0002-9163-9605				Abe M, 2015, DRUG DES DEV THER, V9, P5755, DOI 10.2147/DDDT.S90739; Bakhtiari K, 2004, CRIT CARE MED, V32, P2416, DOI 10.1097/01.CCM.0000147769.07699.E3; Bargagli E, 2014, INFLAMMATION, V37, P10, DOI 10.1007/s10753-013-9706-z; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Collard HR, 2016, AM J RESP CRIT CARE, V194, P265, DOI 10.1164/rccm.201604-0801CI; Collard HR, 2010, AM J PHYSIOL-LUNG C, V299, pL3, DOI 10.1152/ajplung.90637.2008; Cottin V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0166462; Ebina M, 2011, PULM MED, V2011, DOI 10.1155/2011/916486; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Gando S, 2006, CRIT CARE MED, V34, P625, DOI 10.1097/01.CCM.0000202209.42491.38; Gando S, 2008, CRIT CARE MED, V36, P145, DOI 10.1097/01.CCM.0000295317.97245.2D; Gando S, 2010, CRIT CARE MED, V38, pS35, DOI 10.1097/CCM.0b013e3181c9e31d; Hanamoto S, 1992, Nihon Kyobu Shikkan Gakkai Zasshi, V30, P2051; Hayakawa S, 2016, MULTIDISCIP RESP MED, V11, DOI 10.1186/s40248-016-0074-z; Isshiki T, 2015, RESPIRATION, V89, P201, DOI 10.1159/000369828; Kataoka K, 2015, CHEST, V148, P436, DOI 10.1378/chest.14-2746; Kobayashi N, 1983, Bibl Haematol, P265; Kondoh Y, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0050-2017; KOTANI I, 1995, THROMB RES, V77, P493, DOI 10.1016/0049-3848(95)00025-9; Kubota M, 2014, RESPIR INVESTIG, V52, P242, DOI 10.1016/j.resinv.2014.03.003; Levi M, 1999, NEW ENGL J MED, V341, P586, DOI 10.1056/NEJM199908193410807; Lin SM, 2008, CRIT CARE MED, V36, P683, DOI 10.1097/CCM.0B013E31816537D8; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Martin FA, 2013, AM J PHYSIOL-HEART C, V304, pH1585, DOI 10.1152/ajpheart.00096.2013; Martinez FJ, 2005, ANN INTERN MED, V142, P963, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00005; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mohri M, 1999, THROMB HAEMOSTASIS, V82, P1687; Navaratnam V, 2014, THORAX, V69, P207, DOI 10.1136/thoraxjnl-2013-203740; Park IN, 2007, CHEST, V132, P214, DOI 10.1378/chest.07-0323; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Serafim R, 2018, CHEST, V153, P646, DOI 10.1016/j.chest.2017.12.015; Song JW, 2011, EUR RESPIR J, V37, P356, DOI 10.1183/09031936.00159709; TAKANO S, 1990, BLOOD, V76, P2024; Takei R, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0412-8; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068; Toh CH, 2013, HEMATOL-AM SOC HEMAT, P286, DOI 10.1182/asheducation-2013.1.286; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Tsushima K, 2014, PULM PHARMACOL THER, V29, P233, DOI 10.1016/j.pupt.2014.04.008; Vincent JL, 2010, CRIT CARE, V14, DOI 10.1186/cc8204; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Yamakawa K, 2013, INTENS CARE MED, V39, P644, DOI 10.1007/s00134-013-2822-2; Yoshimura J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0810-3	42	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0212810	10.1371/journal.pone.0212810	http://dx.doi.org/10.1371/journal.pone.0212810			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5MK	31425562	Green Published, Green Submitted, gold			2022-12-26	WOS:000485022400003
J	Gonzalez, C; Gallagher, AJ; Caballero, S				Gonzalez, Cindy; Gallagher, Austin J.; Caballero, Susana			Conservation genetics of the bonnethead shark Sphyrna tiburo in Bocas del Toro, Panama: Preliminary evidence of a unique stock	PLOS ONE			English	Article							SCALLOPED HAMMERHEAD SHARK; NORTH-ATLANTIC OCEAN; GULF-OF-MEXICO; POPULATION-GENETICS; CORAL-REEFS; FISHERIES MANAGEMENT; MICROSATELLITE LOCI; CRYPTIC SPECIATION; BLACKTIP SHARK; MITOCHONDRIAL	The bonnethead shark, Sphyrna tiburo, is a small elasmobranch distributed in the Eastern Pacific from southern California to Ecuador, and along the Western Atlantic, with preferences for continental margins of North, Central and South America, the Gulf of Mexico, and the Caribbean. Recent studies have suggested that it could be under a process of cryptic speciation, with the possibility to find different species in similar geographic locations. Here we assessed the population structure and genetic diversity of this highly philopatric and non-dispersive species in the Bocas del Toro Archipelago, Panama. Fragments of the mitochondrial genes cytochrome oxidase I and control region, were used to test the genetic structure of adult and juvenile S. tiburo in this area, and were compared with other locations of the Western Atlantic and Belize. We found significant genetic differentiation between Caribbean bonnethead sharks from Bocas del Toro and Belize, when compared to bonnetheads from other locations of the Western Atlantic. These results also suggest that Bocas del Toro could constitute a different genetic population unit for this species, whereby bonnethead sharks in this area could belong to a unique stock. The information obtained in this study could improve our understanding of the population dynamics of the bonnethead shark throughout its distribution range, and may be used as a baseline for future conservation initiatives for coastal sharks in Central America, a poorly studied an often overlooked region for shark conservation and research.	[Gonzalez, Cindy; Caballero, Susana] Univ Andes, Dept Ciencias Biol, LEMVA, Bogota, Colombia; [Gallagher, Austin J.] Beneath Waves Inc, Herndon, VA USA; [Gallagher, Austin J.] Smithsonian Trop Res Inst, Panama City, Panama; [Gallagher, Austin J.] Univ Miami, Rosentiel Sch Marine & Atmospher Sci, Miami, FL USA	Universidad de los Andes (Colombia); Smithsonian Institution; Smithsonian Tropical Research Institute; University of Miami	Gonzalez, C (corresponding author), Univ Andes, Dept Ciencias Biol, LEMVA, Bogota, Colombia.	ct.gonzalez@uniandes.edu.co		GONZALEZ, CINDY/0000-0001-7156-3642				[Anonymous], FAO FISHERIES SYNOPS; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; BODEN WE, 2013, CIRCULATION S, V128, P46079; Bonfil R, 1997, FISH RES, V29, P101, DOI 10.1016/S0165-7836(96)00536-X; Caballero S, 2012, MOL ECOL RESOUR, V12, P233, DOI 10.1111/j.1755-0998.2011.03089.x; Cardenosa D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110193; Chapman Demian D., 2010, Endangered Species Research, V9, P221, DOI 10.3354/esr00241; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Compagno, 2002, FAO SPECIES CATALOGU, V2, P269; Cortes E., 2016, UICN SPHYRNA TIBURO, P8235; Cortes E, 2005, NOAA FISH, P1; Driggers WB, 2014, J EXP MAR BIOL ECOL, V459, P61, DOI 10.1016/j.jembe.2014.05.006; Dudgeon CL, 2012, J FISH BIOL, V80, P1789, DOI 10.1111/j.1095-8649.2012.03265.x; Escatel-Luna E, 2015, J HERED, V106, P355, DOI 10.1093/jhered/esv030; Excoffier L, 2006, NAT REV GENET, V7, P745, DOI 10.1038/nrg1904; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAO, 2006, REP 9 SESS SCI ADV C; Feldheim KA, 2014, MOL ECOL, V23, P110, DOI 10.1111/mec.12583; Fields AT, 2016, J FISH BIOL, V89, P2219, DOI 10.1111/jfb.13025; Frazier BS, 2014, J FISH BIOL, V85, P688, DOI 10.1111/jfb.12450; Gallagher AJ, 2018, REV FISH BIOL FISHER, V28, P777, DOI 10.1007/s11160-018-9530-5; Gallagher AJ, 2014, BIOSCIENCE, V64, P619, DOI 10.1093/biosci/biu071; Guzman HM, 1998, REV BIOL TROP, V46, P601; Guzman HM, 1998, REV BIOL TROP, V46, P889; HARPER S, 2014, US NMFS MAR FISH REV, V76, P51, DOI DOI 10.7755/MFR.76.1_2.3; Hayes CG, 2009, N AM J FISH MANAGE, V29, P1406, DOI 10.1577/M08-026.1; Hazin F, 2001, ENVIRON BIOL FISH, V61, P151, DOI 10.1023/A:1011040716421; Heupel MR, 2007, MAR ECOL PROG SER, V337, P287, DOI 10.3354/meps337287; Jawad LA, 2013, J FISH BIOL, V83, P1487, DOI 10.1111/jfb.12250; Keeney DB, 2003, MOL ECOL NOTES, V3, P501, DOI 10.1046/j.1471-8286.2003.00492.x; Keeney DB, 2005, MOL ECOL, V14, P1911, DOI 10.1111/j.1365-294X.2005.02549.x; Lim DD, 2010, MOL PHYLOGENET EVOL, V55, P572, DOI 10.1016/j.ympev.2010.01.037; Lombardi-Carlson LA, 2003, MAR FRESHWATER RES, V54, P875, DOI 10.1071/MF03023; Maddison D., 2000, MACCLADE ANAL PHYLOG, P1; MORITZ C, 1994, MOL ECOL, V3, P401, DOI 10.1111/j.1365-294X.1994.tb00080.x; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Nance HA, 2009, MOL ECOL RESOUR, V9, P955, DOI 10.1111/j.1755-0998.2008.02510.x; Naylor GJP, 2012, B AM MUS NAT HIST, P1; Palumbi SR, 2003, ECOL APPL, V13, pS146; PARSONS GR, 1993, ENVIRON BIOL FISH, V38, P25, DOI 10.1007/BF00842901; Pinhal D, 2012, MAR BIOL, V159, P829, DOI 10.1007/s00227-011-1858-5; Portnoy DS, 2015, MOL ECOL, V24, P5877, DOI 10.1111/mec.13441; Portnoy DS, 2010, MOL ECOL, V19, P1994, DOI 10.1111/j.1365-294X.2010.04626.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Quattro JM, 2006, MAR BIOL, V148, P1143, DOI 10.1007/s00227-005-0151-x; Quintanilla S, 2015, J HERED, V106, P448, DOI 10.1093/jhered/esv050; Seemann J, 2014, ENVIRON MONIT ASSESS, V186, P1747, DOI 10.1007/s10661-013-3490-y; Struck TH, 2018, TRENDS ECOL EVOL, V33, P153, DOI 10.1016/j.tree.2017.11.007; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Wong EHK, 2009, MOL ECOL RESOUR, V9, P243, DOI 10.1111/j.1755-0998.2009.02653.x	50	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220737	10.1371/journal.pone.0220737	http://dx.doi.org/10.1371/journal.pone.0220737			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415593	Green Submitted, Green Published, gold			2022-12-26	WOS:000485017200027
J	Gorski, SA; Lawrence, MG; Hinkelman, A; Spano, MM; Steinke, JW; Borish, L; Teague, WG; Braciale, TJ				Gorski, Stacey A.; Lawrence, Monica G.; Hinkelman, Amy; Spano, MarthaJoy M.; Steinke, John W.; Borish, Larry; Teague, W. Gerald; Braciale, Thomas J.			Expression of IL-5 receptor alpha by murine and human lung neutrophils	PLOS ONE			English	Article							AIRWAY EPITHELIAL-CELLS; INFLUENZA-VIRUS; SEVERE ASTHMA; INTERLEUKIN-5; EOSINOPHIL; DIFFERENTIATION; INFLAMMATION; PHENOTYPE; REPRESENT; MIGRATION	The role of eosinophilia in atopic diseases, including asthma, is well established, as is the well-known role of IL-5 as a major eosinophilopoeitin and chemoattractant. Following influenza A virus infection of mice, type 2 innate lymphoid cells are recruited to the respiratory tract and produce large quantities of IL-5, which contributes to the recruitment of eosinophils into the infected lungs during the recovery phase of infection. We demonstrate here that while IL-5 is required for optimal recovery from influenza A virus infection in BALB/c and C57BL/6 mice, the protective effect of IL-5 is independent of eosinophils, suggesting an alternative cellular target. We describe the unexpected finding of IL-5 receptor alpha (CD125) expression on neutrophils infiltrating the inflamed mouse lungs, as well as on neutrophils at other anatomic sites. We extend this finding of neutrophil CD125 expression to humans, specifically to neutrophils found in the bronchoalveolar lavage fluid from the inflamed lungs of children with treatment-refractory asthma. We further demonstrate that the IL-5 receptor on neutrophils is capable of signal transduction. Our data provide further evidence that neutrophils can play a role bridging atopic type 2 and innate anti-microbial immunity.	[Gorski, Stacey A.; Hinkelman, Amy; Spano, MarthaJoy M.; Borish, Larry; Braciale, Thomas J.] Univ Virginia, Carter Ctr Immunol Res, Charlottesville, VA 22903 USA; [Lawrence, Monica G.; Steinke, John W.; Borish, Larry] Univ Virginia, Dept Med, Div Asthma Allergy & Immunol, Charlottesville, VA USA; [Teague, W. Gerald] Univ Virginia, Dept Pediat, Div Pediat Resp Med Allergy & Immunol, Charlottesville, VA USA; [Braciale, Thomas J.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Gorski, Stacey A.] Sanofi Pasteur, Charlottesville, VA USA; [Hinkelman, Amy] Campbell Univ, Dept Microbiol & Immunol, Buies Creek, NC 27506 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; Sanofi-Aventis; Campbell University	Braciale, TJ (corresponding author), Univ Virginia, Carter Ctr Immunol Res, Charlottesville, VA 22903 USA.; Braciale, TJ (corresponding author), Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA.	tjb2r@virginia.edu		Steinke, John/0000-0003-4571-8473	USPHS/NIH [U01 AI-123337, UG1 HL-139126, R01 AI-15608, R01 HL-33391, R01 AI-136297]; American Lung Association/AAAAI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UG1HL139126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015608, U01AI123337, R01AI136297] Funding Source: NIH RePORTER	USPHS/NIH(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); American Lung Association/AAAAI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by USPHS/NIH grants U01 AI-123337 (LB), UG1 HL-139126 (WGT), R01 AI-15608 (TJB), R01 HL-33391 (TJB), R01 AI-136297 (TJB) and the American Lung Association/AAAAI (ML). Sanofi Pasteur currently provides support in the form of salary for author SAG, but SAG was not an employee of this commercial entity during the time period in which this work was completed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelilah SG, 2001, J IMMUNOL, V166, P2768, DOI 10.4049/jimmunol.166.4.2768; ALAM R, 1995, INT ARCH ALLERGY IMM, V107, P226, DOI 10.1159/000236985; Andersson CK, 2017, J ALLERGY CLIN IMMUN, V139, P1819, DOI 10.1016/j.jaci.2016.09.022; Barretto KT, 2016, J ALLERGY CLIN IMMUN, V137, pAB410, DOI 10.1016/j.jaci.2015.12.1269; Camp JV, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00550; Cheung DS, 2010, J IMMUNOL, V185, P4983, DOI 10.4049/jimmunol.1002456; Chung KF, 2015, LANCET, V386, P1086, DOI 10.1016/S0140-6736(15)00157-9; COLLINS PD, 1995, J EXP MED, V182, P1169, DOI 10.1084/jem.182.4.1169; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; Dewachi O, 2006, VET IMMUNOL IMMUNOP, V109, P31, DOI 10.1016/j.vetimm.2005.06.017; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; Gorski SA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003615; Hauk PJ, 2008, PEDIATR PULM, V43, P916, DOI 10.1002/ppul.20880; Horikawa K, 2001, J IMMUNOL, V167, P5018, DOI 10.4049/jimmunol.167.9.5018; Kagami S, 2000, BLOOD, V95, P1370, DOI 10.1182/blood.V95.4.1370.004k29_1370_1377; Kawaguchi M, 2000, INT ARCH ALLERGY IMM, V122, P44, DOI 10.1159/000053632; KITAMURA T, 1991, CELL, V66, P1165, DOI 10.1016/0092-8674(91)90039-2; Lawrence CW, 2004, J IMMUNOL, V173, P1209, DOI 10.4049/jimmunol.173.2.1209; Lee JJ, 2010, CLIN EXP ALLERGY, V40, P563, DOI 10.1111/j.1365-2222.2010.03484.x; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; Linch SN, 2012, AM J RESP CRIT CARE, V186, P246, DOI 10.1164/rccm.201201-0134OC; Matsukura S, 1998, AM J RESP CELL MOL, V18, P255, DOI 10.1165/ajrcmb.18.2.2822; McKenzie Andrew N J, 2014, Ann Am Thorac Soc, V11 Suppl 5, pS263, DOI 10.1513/AnnalsATS.201403-097AW; Mesnil C, 2016, J CLIN INVEST, V126, P3279, DOI 10.1172/JCI85664; Moore WC, 2014, J ALLERGY CLIN IMMUN, V133, P1557, DOI 10.1016/j.jaci.2013.10.011; Mori Y, 2009, J EXP MED, V206, P183, DOI 10.1084/jem.20081756; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; PALACIOS R, 1987, EMBO J, V6, P3687, DOI 10.1002/j.1460-2075.1987.tb02702.x; Pavord ID, 2017, NEW ENGL J MED, V377, P1613, DOI 10.1056/NEJMoa1708208; Romeo MJ, 2014, J ALLERGY CLIN IMMUN, V133, P952, DOI 10.1016/j.jaci.2013.08.006; Samarasinghe AE, 2017, J IMMUNOL, V198, P3214, DOI 10.4049/jimmunol.1600787; Samarasinghe AE, 2014, IMMUNOL CELL BIOL, V92, P449, DOI 10.1038/icb.2013.113; SHER A, 1990, P NATL ACAD SCI USA, V87, P61, DOI 10.1073/pnas.87.1.61; Smith SG, 2015, J ALLERGY CLIN IMMUN, V135, P1594, DOI 10.1016/j.jaci.2014.12.1918; Suttmann H, 2003, INFECT IMMUN, V71, P4647, DOI 10.1128/IAI.71.8.4647-4656.2003; Teague WG, 2019, J ALLER CL IMM-PRACT, V7, P1803, DOI 10.1016/j.jaip.2018.12.027; Terai M, 2011, MICROBIOL IMMUNOL, V55, P341, DOI 10.1111/j.1348-0421.2011.00320.x; Wenzel SE, 1997, AM J RESP CRIT CARE, V156, P737, DOI 10.1164/ajrccm.156.3.9610046; Wright AKA, 2017, J ALLERGY CLIN IMMUN, V140, P1430, DOI 10.1016/j.jaci.2017.04.025; Xu J, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002365; YAMAGUCHI Y, 1988, J EXP MED, V167, P1737, DOI 10.1084/jem.167.5.1737	41	25	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0221113	10.1371/journal.pone.0221113	http://dx.doi.org/10.1371/journal.pone.0221113			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415658	Green Published, Green Submitted, gold			2022-12-26	WOS:000485017200079
J	Lyons, TJ; Tuckett, QM; Hill, JE				Lyons, Timothy J.; Tuckett, Quenton M.; Hill, Jeffrey E.			Characterizing the US trade in lionfishes	PLOS ONE			English	Article							PTEROIS-VOLITANS; COLONIZATION PRESSURE; PROPAGULE PRESSURE; FISH INTRODUCTIONS; AQUARIUM TRADE; MILES BENNETT; INVASION; INVASIVENESS; POPULATION; PATHWAYS	Invasive lionfishes Pterois volitans and Pterois miles have spread throughout the tropical western Atlantic Ocean, Gulf of Mexico, and Greater Caribbean. Beyond these two invaders, additional species within the subfamily Pteroinae are regularly imported into the United States. We evaluated the trade of lionfishes as a surrogate measure for propagule pressure, an important component of invasion success. Proactive evaluation of marine ornamental fishes in trade is vital, particularly for those sharing characteristics with known invaders. We utilized one year of import records from the U.S. Fish and Wildlife Service's Law Enforcement Management Information System database and two domestic databases to capture the trade of all lionfishes in the US, the invasive complex in its invaded range in Florida, and two Hawaiian endemic lionfishes. Retail surveys were completed to assess lionfish availability across 10 coastal states. Compared to species diversity within the subfamily, the number of traded species was low and just two species were traded at moderate to high volume, including P. volitans and Dendrochirus zebra. At the retail level, fewer species are available to consumers. The trade in lionfishes is consolidated because most lionfishes originate from two Indo-Pacific countries and arrive through the port of Los Angeles. The volume and diversity of traded lionfishes presents some risk of introduction for lionfishes which are not established, and secondary introductions of the invasive P. volitans. In combination with rapid risk screening, this research can be applied to a proactive risk management framework to identify risky species prior to introduction and establishment.	[Lyons, Timothy J.; Tuckett, Quenton M.; Hill, Jeffrey E.] Univ Florida, IFAS, SFRC Program Fisheries & Aquat Sci, Trop Aquaculture Lab, Ruskin, FL 33570 USA	State University System of Florida; University of Florida	Lyons, TJ (corresponding author), Univ Florida, IFAS, SFRC Program Fisheries & Aquat Sci, Trop Aquaculture Lab, Ruskin, FL 33570 USA.	tjlyons123@gmail.com	tuckett, quenton/ABB-9090-2020	Lyons, Timothy/0000-0003-3202-0543	Florida Fish and Wildlife Conservation Commission [FWC TA-3015]; Marine Aquarium Societies of North America's Dr. Junda Lin Memorial Fund	Florida Fish and Wildlife Conservation Commission; Marine Aquarium Societies of North America's Dr. Junda Lin Memorial Fund	Initials of the authors who received each award: J.E.H.; Q.M.T. Grant numbers awarded to each author: FWC TA-3015. The full name of each funder: Florida Fish and Wildlife Conservation Commission. URL of each funder website: http://myfwc.com/. The authors thank the Marine Aquarium Societies of North America's Dr. Junda Lin Memorial Fund for Publishing Open Access Marine Aquarium Research for offsetting the open access publishing costs of this article awarded to TJL (more info at tiny.cc/MASNAPubFund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the United States Fish and Wildlife Service, the Florida Fish and Wildlife Conservation Commission Fish and Wildlife Research Institute, and the Hawaiian Division of Aquatic Resources for data contributions. The authors especially thank John E. Randall for his photograph contributions and Kali Spurgin for facilitating data acquisition. Additional support was provided by the University of Florida/IFAS Tropical Aquaculture Laboratory, Craig Watson, director. The authors thank the Marine Aquarium Societies of North America's Dr. Junda Lin Memorial Fund for Publishing Open Access Marine Aquarium Research for offsetting the open access publishing costs of this article awarded to TJL (more info at tiny.cc/MASNAPubFund).	Albins MA, 2008, MAR ECOL PROG SER, V367, P233, DOI 10.3354/meps07620; Albins MA, 2015, MAR ECOL PROG SER, V522, P231, DOI 10.3354/meps11159; Albins MA, 2013, BIOL INVASIONS, V15, P29, DOI 10.1007/s10530-012-0266-1; Anderson LWJ, 2005, BIOL INVASIONS, V7, P1003, DOI 10.1007/s10530-004-3123-z; [Anonymous], 2015, HAW REV STAT, V12; ANSTF (Aquatic Nuisance Species Task Force), 2015, NAT INV LIONT PREV M; Azzurro E, 2017, BIOINVASIONS REC, V6, P95, DOI 10.3391/bir.2017.6.2.01; Bariche M, 2013, MEDITERR MAR SCI, V14, P292, DOI 10.12681/mms.428; Bomford M, 2010, BIOL INVASIONS, V12, P2559, DOI 10.1007/s10530-009-9665-3; Briski E, 2012, P ROY SOC B-BIOL SCI, V279, P2990, DOI 10.1098/rspb.2011.2671; Cohen FPA, 2013, REV FISH SCI, V21, P98, DOI 10.1080/10641262.2012.760522; Colautti Robert I., 2003, P227; Copp GH, 2005, J APPL ICHTHYOL, V21, P263, DOI 10.1111/j.1439-0426.2005.00673.x; Copp GH, 2016, MANAG BIOL INVASION, V7, P343, DOI 10.3391/mbi.2016.7.4.04; Crocetta F, 2015, MEDITERR MAR SCI, V16, P682, DOI 10.12681/mms.1477; Dabruzzi TF, 2017, AQUAT BIOL, V26, P1, DOI 10.3354/ab00668; Eschmeyer W.N., 1986, P463; Gertzen E, 2008, CAN J FISH AQUAT SCI, V65, P1265, DOI 10.1139/F08-056; Hayes KR, 2008, BIOL INVASIONS, V10, P483, DOI 10.1007/s10530-007-9146-5; Holmberg RJ, 2015, MAR POLICY, V53, P7, DOI 10.1016/j.marpol.2014.10.024; HOOKER EA, 2012, REEF FISHES E INDIES, V1; Johnston MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073023; Kuiter R.H., 2001, ZOONETICS, V2001, P1; Kulbicki M, 2012, MAR ECOL PROG SER, V446, P189, DOI 10.3354/meps09442; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Lawson LL, 2013, RISK ANAL, V33, P1414, DOI 10.1111/j.1539-6924.2012.01896.x; Lesser MP, 2011, BIOL INVASIONS, V13, P1855, DOI 10.1007/s10530-011-0005-z; Lieske E, 1998, CORAL REEF FISHES; Lockwood JL, 2009, DIVERS DISTRIB, V15, P904, DOI 10.1111/j.1472-4642.2009.00594.x; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; Lyons TJ, 2017, COPEIA, V105, P630, DOI 10.1643/CP-17-612; McKinney ML, 2002, DIVERS DISTRIB, V8, P311, DOI 10.1046/j.1472-4642.2002.00153.x; Myers RF, 1991, MICRONESIAN REEF FIS; Olivotto I, 2011, J WORLD AQUACULT SOC, V42, P135, DOI 10.1111/j.1749-7345.2011.00453.x; Orr Richard, 2003, P415; Pejchar L, 2009, TRENDS ECOL EVOL, V24, P497, DOI 10.1016/j.tree.2009.03.016; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Randall JE., 1985, GUIDE HAWAIIAN REEF; Rhyne AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035808; Robertson DR, 2018, PEERJ, V6, DOI 10.7717/peerj.4328; Schofield PJ, 2010, AQUAT INVASIONS, V5, pS117, DOI 10.3391/ai.2010.5.S1.024; Schofield PJ, 2009, 92 NOS NCCOS NAT OC; Semmens BX, 2004, MAR ECOL PROG SER, V266, P239, DOI 10.3354/meps266239; Shaffer M., 1987, P69, DOI 10.1017/CBO9780511623400.006; Simberloff D, 2003, CONSERV BIOL, V17, P83, DOI 10.1046/j.1523-1739.2003.02028.x; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Sommer C, 1996, FAO SPECIES IDENTIFI; Strecker AL, 2011, FISHERIES, V36, P74, DOI 10.1577/03632415.2011.10389070; Stringham OC, 2018, J APPL ECOL, V55, P2632, DOI 10.1111/1365-2664.13237; Tlusty MF, 2013, ZOO BIOL, V32, P1, DOI 10.1002/zoo.21019; Vaz MCM, 2017, SCI REP, V7, P1, DOI [10.1038/s41598-016-0028-x, DOI 10.1038/S41598-016-0028-X]; Wabnitz Colette, 2003, P1; Whitfield PE, 2007, BIOL INVASIONS, V9, P53, DOI 10.1007/s10530-006-9005-9; Wilcox CL, 2018, J HERED, V109, P162, DOI 10.1093/jhered/esx056; Williams SL, 2015, MANAG BIOL INVASION, V6, P13, DOI 10.3391/mbi.2015.6.1.02; Williamson M., 1996, BIOL INVASIONS; Zajicek P, 2009, REV FISH SCI, V17, P156, DOI 10.1080/10641260802536577	57	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0221272	10.1371/journal.pone.0221272	http://dx.doi.org/10.1371/journal.pone.0221272			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5KK	31415642	Green Published, gold, Green Submitted			2022-12-26	WOS:000485017200097
J	Mohnen, SM; van Oosten, MJM; Los, J; Leegte, MJH; Jager, KJ; Hemmelder, MH; Logtenberg, SJJ; Stel, VS; Hakkaart-van Roijen, L; de Wit, GA				Mohnen, Sigrid M.; van Oosten, Manon J. M.; Los, Jeanine; Leegte, Martijn J. H.; Jager, Kitty J.; Hemmelder, Marc H.; Logtenberg, Susan J. J.; Stel, Vianda S.; Hakkaart-van Roijen, Leona; de Wit, G. Ardine			Healthcare costs of patients on different renal replacement modalities - Analysis of Dutch health insurance claims data	PLOS ONE			English	Article							ECONOMIC-EVALUATION; HEMODIALYSIS; DIALYSIS; DISEASE	Background The aim of this study is to present average annual healthcare costs for Dutch renal replacement therapy (RRT) patients for 7 treatment modalities. Methods Health insurance claims data from 2012-2014 were used. All patients with a 2014 claim for dialysis or kidney transplantation were selected. The RRT related and RRT unrelated average annual healthcare costs were analysed for 5 dialysis modalities (in-centre haemodialysis (CHD), home haemodialysis (HHD), continuous ambulatory peritoneal dialysis (CAPD), automated peritoneal dialysis (APD) and multiple dialysis modalities in a year (Mix group)) and 2 transplant modalities (kidney from living and deceased donor, respectively). Results The total average annual healthcare costs in 2014 ranged from (sic)77,566 (SD = (sic)27,237) for CAPD patients to (sic)105,833 (SD = (sic)30,239) for patients in the Mix group. For all dialysis modalities, the vast majority (72-84%) of costs was RRT related. Patients on haemodialysis >= 4x/week had significantly higher average annual costs compared to those dialyzing 3x/week (Delta(sic)19,122). Costs for kidney transplant recipients were (sic)85,127 (SD = (sic)39,679) in the year of transplantation and rapidly declined in the first and second year after successful transplantation (resp. (sic)29,612 (SD = (sic)34,099) and (sic)15,018 (SD = (sic)16,186)). Transplantation with a deceased donor kidney resulted in higher costs ((sic)99,450, SD = (sic)36,036)) in the year of transplantation compared to a living donor kidney transplantation ((sic)73,376, SD = (sic)38,666). Conclusions CAPD patients have the lowest costs compared to other dialysis modalities. Costs in the year of transplantation are 25% lower for patients with kidneys from living vs. deceased donor. After successful transplantation, annual costs decline substantially to a level that is approximately 14-19% of annual dialysis costs.	[Mohnen, Sigrid M.; de Wit, G. Ardine] Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands; [van Oosten, Manon J. M.; Jager, Kitty J.; Stel, Vianda S.] Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Amsterdam UMC, Dept Med Informat, Amsterdam, Netherlands; [Los, Jeanine; Hakkaart-van Roijen, Leona] Erasmus Univ, iMTA, ESHPM, Rotterdam, Netherlands; [Leegte, Martijn J. H.; Hemmelder, Marc H.] Nefrovisie Fdn, Dutch Renal Registry Renine, Utrecht, Netherlands; [Logtenberg, Susan J. J.] Diakonessenhuis Utrecht, Dept Internal Med, Utrecht, Netherlands; [de Wit, G. Ardine] Univ Med Ctr Utrecht, Juliusctr Hlth Sci & Primary Care, Utrecht, Netherlands	Netherlands National Institute for Public Health & the Environment; University of Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Diakonessenhuis; Utrecht University; Utrecht University Medical Center	Mohnen, SM (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands.	sigrid.mohnen@rivm.nl	Hemmelder, Marc/AFQ-0383-2022	Mohnen, Sigrid Mechthild/0000-0002-1537-8706; Stel, Vianda S/0000-0002-0007-1947; Jager, Kitty/0000-0003-0444-8569; de Wit, G. Ardine/0000-0002-1375-7657; Hakkaart-van Roijen, Leona/0000-0003-0635-7388	Dutch Kidney Foundation; Institute of Medical Technology Assessment of Erasmus University Rotterdam	Dutch Kidney Foundation; Institute of Medical Technology Assessment of Erasmus University Rotterdam	This work is financed by a grant from the Dutch Kidney Foundation to National Institute of Public Health and the Environment and the Institute of Medical Technology Assessment of Erasmus University Rotterdam.	Agar JW, 2005, NEPHROLOGY, V10, P557, DOI 10.1111/j.1440-1797.2005.00471.x; Boo A., 2011, TIJDSCHRIFT GEZONDHE, V89, P358; Chertow GM, 2010, NEW ENGL J MED, V363, P2287, DOI 10.1056/NEJMoa1001593; Couillerot-Peyrondet A-L, 2016, EUR J HEALTH ECON, P1; de Wit GA, 1998, HEALTH POLICY, V44, P215, DOI 10.1016/S0168-8510(98)00017-7; ERA-EDTA Registry, 2017, ERA EDTA REG ANN REP; Hakkaart-van Roijen L., 2015, COSTING MANUAL METHO; Hoekstra T., 2018, RENINE ANN REPORT 20; Icks A, 2010, NEPHROL DIAL TRANSPL, V25, P1647, DOI 10.1093/ndt/gfp672; Jaar BG, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-3; Kitazawa T, 2017, TRANSPL P, V49, P4, DOI 10.1016/j.transproceed.2016.10.007; Klarenbach SW, 2014, NAT REV NEPHROL, V10, P644, DOI 10.1038/nrneph.2014.145; Kroeker A, 2003, AM J KIDNEY DIS, V42, pS49, DOI 10.1016/S0272-6386(03)00538-9; Lamb KE, 2011, AM J TRANSPLANT, V11, P450, DOI 10.1111/j.1600-6143.2010.03283.x; Lee H, 2002, AM J KIDNEY DIS, V40, P611, DOI 10.1053/ajkd.2002.34924; Legendre C, 2014, TRANSPL INT, V27, P19, DOI 10.1111/tri.12217; Li B, 2015, NDT; Mazairac AHA, 2013, NEPHROL DIAL TRANSPL, V28, P1865, DOI 10.1093/ndt/gft045; McFarlane PA, 2004, SEMIN DIALYSIS, V17, P118, DOI 10.1111/j.0894-0959.2004.17208.x; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; NZa, 2016, SCAN HLTH INS MARK 2; Oostenbrink JB, 2005, TRANSPLANT INT, V18, P437, DOI 10.1111/j.1432-2277.2004.00063.x; Pippias M, 2015, NDT; RIVM, DIS ORD COSTS; van Oosten MJM, 2020, NEPHROL DIAL TRANSPL, V35, P2138, DOI 10.1093/ndt/gfz146; Vanholder R, 2017, NAT REV NEPHROL, V13, P393, DOI 10.1038/nrneph.2017.63; Vanholder R, 2016, NEPHROL DIAL TRANSPL, V31, P1251, DOI 10.1093/ndt/gfv233; Vanholder R, 2012, J AM SOC NEPHROL, V23, P1291, DOI 10.1681/ASN.2011111094; Villa G, 2011, NEPHROL DIAL TRANSPL, V26, P3709, DOI 10.1093/ndt/gfr088	29	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220800	10.1371/journal.pone.0220800	http://dx.doi.org/10.1371/journal.pone.0220800			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415578	Green Published, gold, Green Submitted			2022-12-26	WOS:000485017200033
J	Van der Pol, CW; van Roovert-Reijrink, IAM; Gussekloo, SWS; Kranenbarg, S; Leon-Kloosterziel, KM; van Eijk-Priester, MH; Zeman, M; Kemp, B; van den Brand, H				Van der Pol, Carla W.; van Roovert-Reijrink, Inge A. M.; Gussekloo, Sander W. S.; Kranenbarg, Sander; Leon-Kloosterziel, Karen M.; van Eijk-Priester, Margaretha H.; Zeman, Michal; Kemp, Bas; van den Brand, Henry			Effects of lighting schedule during incubation of broiler chicken embryos on leg bone development at hatch and related physiological characteristics	PLOS ONE			English	Article							ENDOCHONDRAL OSSIFICATION; MELATONIN PRODUCTION; HORMONE-SECRETION; GROWTH; TEMPERATURE; DIFFERENTIATION; CHONDROCYTES; OSTEONECTIN; PHOSPHATASE; INDICATOR	Providing a broiler chicken embryo with a lighting schedule during incubation may stimulate leg bone development. Bone development may be stimulated through melatonin, a hormone released in darkness that stimulates bone development, or increased activity in embryos exposed to a light-dark rhythm. Aim was to investigate lighting conditions during incubation and leg bone development in broiler embryos, and to reveal the involved mechanisms. Embryos were incubated under continuous cool white 500 lux LED light (24L), continuous darkness (24D), or 16h of light, followed by 8h of darkness (16L:8D) from the start of incubation until hatching. Embryonic bone development largely takes place through cartilage formation (of which collagen is an important component) and ossification. Expression of genes involved in cartilage formation (col1 alpha 2, col2 alpha 1, and col10 alpha 1) and ossification (spp1, sparc, bglap, and alpl) in the tibia on embryonic day (ED) 13, ED17, and at hatching were measured through qPCR. Femur and tibia dimensions were determined at hatch. Plasma growth hormone and corticosterone and pineal melatonin concentrations were determined every 4h between ED18.75 and ED19.5. Embryonic heart rate was measured twice daily from ED12 till ED19 as a reflection of activity. No difference between lighting treatments on gene expression was found. 24D resulted in higher femur length and higher femur and tibia weight, width, and depth at hatch than 16L:8D. 24D furthermore resulted in higher femur length and width and tibia depth than 24L. Embryonic heart rate was higher for 24D and 16L:8D in both its light and dark period than for 24L, suggesting that 24L embryos may have been less active. Melatonin and growth hormone showed different release patterns between treatments, but the biological significance was hard to interpret. To conclude, 24D resulted in larger leg bones at hatch than light during incubation, but the underlying pathways were not clear from present data.	[Van der Pol, Carla W.; van Roovert-Reijrink, Inge A. M.; van Eijk-Priester, Margaretha H.] HatchTech BV, Res Dept, Veenendaal, Netherlands; [Van der Pol, Carla W.; van Eijk-Priester, Margaretha H.; Kemp, Bas; van den Brand, Henry] Wageningen Univ & Res, Adaptat Physiol Grp, Wageningen, Netherlands; [Gussekloo, Sander W. S.; Kranenbarg, Sander; Leon-Kloosterziel, Karen M.] Wageningen Univ & Res, Expt Zool Grp, Wageningen, Netherlands; [Zeman, Michal] Comenius Univ, Dept Anim Physiol & Ethol, Fac Nat Sci, Bratislava, Slovakia; [Zeman, Michal] Slovak Acad Sci, Inst Anim Biochem & Genet, Bratislava, Slovakia	Wageningen University & Research; Wageningen University & Research; Comenius University Bratislava; Slovak Academy of Sciences	Van der Pol, CW (corresponding author), HatchTech BV, Res Dept, Veenendaal, Netherlands.; Van der Pol, CW (corresponding author), Wageningen Univ & Res, Adaptat Physiol Grp, Wageningen, Netherlands.	cvdpol@hatchtech.nl	Gussekloo, Sander W.S./D-4886-2012; Gussekloo, Sander/AGI-4222-2022; Zeman, M/L-2392-2019; van der Pol, Carla/GQP-0559-2022	Gussekloo, Sander W.S./0000-0002-9691-4661; Gussekloo, Sander/0000-0002-9691-4661; Zeman, M/0000-0002-2712-6805; van der Pol, Carla/0000-0001-7388-9734				Archer GS, 2017, POULTRY SCI, V96, P2670, DOI 10.3382/ps/pex040; Archer GS, 2014, APPL ANIM BEHAV SCI, V152, P44, DOI 10.1016/j.applanim.2013.12.010; Augat P, 2006, AGE AGEING, V35, P27, DOI 10.1093/ageing/afl081; Bai XJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216392; BEKOFF A, 1981, TRENDS NEUROSCI, V4, P181, DOI 10.1016/0166-2236(81)90059-X; Bertram JEA, 1997, GROWTH DEVELOP AGING, V61, P51; Bradshaw RH, 2002, AVIAN POULT BIOL REV, V13, P45, DOI 10.3184/147020602783698421; DiPietro JA, 2001, AM J OBSTET GYNECOL, V185, P1421, DOI 10.1067/mob.2001.119108; Dishon L, 2018, POULTRY SCI, V97, P1998, DOI 10.3382/ps/pey078; Drozdova A, 2019, ANIMAL, V13, P1635, DOI 10.1017/S1751731118003695; Farquharson C, 2000, POULTRY SCI, V79, P994, DOI 10.1093/ps/79.7.994; GERSTENFELD LC, 1987, DEV BIOL, V122, P49, DOI 10.1016/0012-1606(87)90331-9; Hasan KMM, 2012, AGE, V34, P1421, DOI 10.1007/s11357-011-9319-0; HAUSCHKA PV, 1982, BIOCHEMISTRY-US, V21, P2538, DOI 10.1021/bi00539a038; Heetkamp MJW, 2015, INDIRECT CALORIMETRY: TECHNIQUES, COMPUTATIONS AND APPLICATIONS, P35, DOI 10.3920/978-90-8686-261-0_2; Huth JC, 2015, POULTRY SCI, V94, P3052, DOI 10.3382/ps/pev298; JACKSON H, 1978, J COMP PHYSIOL PSYCH, V92, P682, DOI 10.1037/h0077496; JUNDT G, 1987, CELL TISSUE RES, V248, P409; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Kurtul I, 2009, KAFKAS UNIV VET FAK, V15, P869; Lai LP, 2005, J CELL BIOCHEM, V96, P1163, DOI 10.1002/jcb.20635; Lourens A, 2011, POULTRY SCI, V90, P516, DOI 10.3382/ps.2010-00928; MACHIDA M, 1995, J BONE JOINT SURG BR, V77B, P134, DOI 10.1302/0301-620X.77B1.7822371; MCKEE MD, 1992, ANAT REC, V234, P479, DOI 10.1002/ar.1092340404; MILGROM C, 1989, J BIOMECH, V22, P1243, DOI 10.1016/0021-9290(89)90226-1; MONSONEGO E, 1995, MOL CELL ENDOCRINOL, V114, P35, DOI 10.1016/0303-7207(95)03639-O; Moriya K, 2000, J EXP BIOL, V203, P895; MURRAY PDF, 1969, J EMBRYOL EXP MORPH, V22, P349; Noiva RM, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0234-3; Onyango EM, 2003, POULTRY SCI, V82, P1787, DOI 10.1093/ps/82.11.1787; Ostrowska Z, 2002, NEUROENDOCRINOL LETT, V23, P417; Oviedo-Rondon EO, 2008, BRIT POULTRY SCI, V49, P666, DOI 10.1080/00071660802433149; Ozkan S, 2012, POULTRY SCI, V91, P2912, DOI 10.3382/ps.2012-02426; PACIFICI M, 1990, CALCIFIED TISSUE INT, V47, P51, DOI 10.1007/BF02555866; PECHAK DG, 1986, BONE, V7, P441, DOI 10.1016/8756-3282(86)90004-9; PECHAK DG, 1986, BONE, V7, P459, DOI 10.1016/8756-3282(86)90005-0; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pollard AS, 2016, PHYSIOL BIOCHEM ZOOL, V89, P331, DOI 10.1086/687228; Rath NC, 2000, POULTRY SCI, V79, P1024, DOI 10.1093/ps/79.7.1024; Roach HI, 1997, J BONE MINER RES, V12, P795, DOI 10.1359/jbmr.1997.12.5.795; Robson H, 2002, PEDIATR RES, V52, DOI 10.1203/01.PDR.0000023494.70201.1C; Shen G, 2005, Orthod Craniofac Res, V8, P11, DOI 10.1111/j.1601-6343.2004.00308.x; VAANANEN HK, 1980, HISTOCHEMISTRY, V65, P143, DOI 10.1007/BF00493162; van der Eerden BCJ, 2003, ENDOCR REV, V24, P782, DOI 10.1210/er.2002-0033; van der Pol CW, 2014, POULTRY SCI, V93, P2878, DOI 10.3382/ps.2014-04210; van der Pol CW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210886; van der Pol CW, 2017, RES VET SCI, V114, P416, DOI 10.1016/j.rvsc.2017.07.013; Yalcin S, 2007, POULTRY SCI, V86, P1772, DOI 10.1093/ps/86.8.1772; Yu Y, 2016, PEERJ, V4, DOI 10.7717/peerj.1825; Zawilska JB, 2007, POULTRY SCI, V86, P1397, DOI 10.1093/ps/86.7.1397; Zeman M, 2004, AVIAN POULT BIOL REV, V15, P197, DOI 10.3184/147020604783638155; Zeman M, 1999, J PINEAL RES, V26, P28, DOI 10.1111/j.1600-079X.1999.tb00563.x; Zeman M, 1999, DOMEST ANIM ENDOCRIN, V17, P199, DOI 10.1016/S0739-7240(99)00037-5; Zhang L, 2016, ASIAN AUSTRAL J ANIM, V29, P1562, DOI 10.5713/ajas.15.0976; Zhang L, 2014, ITAL J ANIM SCI, V13, DOI 10.4081/ijas.2014.3266	56	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0221083	10.1371/journal.pone.0221083	http://dx.doi.org/10.1371/journal.pone.0221083			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415653	gold, Green Submitted, Green Published			2022-12-26	WOS:000485017200072
J	Wood, CR; Squire, MS; Finley, NL; Page, RC; Actis, LA				Wood, Cecily R.; Squire, Mariah S.; Finley, Natosha L.; Page, Richard C.; Actis, Luis A.			Structural and functional analysis of the Acinetobacter baumannii BlsA photoreceptor and regulatory protein	PLOS ONE			English	Article							BLUF DOMAIN; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURES; LIGHT SIGNAL; APPA; ELECTROSTATICS; FLAVOPROTEIN; ORGANIZATION; INSIGHTS; TLL0078	The Acinetobacter baumannii BlsA photoreceptor has an N-terminal (NT) BLUF domain and a C-terminal (CT) amino acid sequence with no significant homology to characterized bacterial proteins. In this study, we tested the biological role of specific residues located in these BlsA regions. Site-directed mutagenesis, surface motility assays at 24 degrees C and protein overexpression showed that residues Y7, Q51 and W92 are essential for not only light-regulated motility, but also BlsA's solubility when overexpressed in a heterologous host. In contrast, residues A29 and F32, the latter representing a difference when compared with other BLUF-containing photoreceptors, do not play a major role in BlsA's biological functions. Analysis of the CT region showed that the deletion of the last five BlsA residues has no significant effect on the protein's light-sensing and motility regulatory functions, but the deletion of the last 14 residues as well as K144E and K145E substitutions significantly alter light-regulated motility responses. In contrast to the NT mutants, these CT derivatives were overexpressed and purified to homogeneity to demonstrate that although these mutations do not significantly affect flavin binding and photocycling, they do affect BlsA's photodynamic properties. Notably, these mutations map within a potential fifth a-helical component that could play a role in predicted interactions between regulatory partners and BlsA, which could function as a monomer according to gel filtration data. All these observations indicate that although BlsA shares common structural and functional properties with unrelated photoreceptors, it also exhibits unique features that make it a distinct BLUF photoreceptor.	[Wood, Cecily R.; Squire, Mariah S.; Finley, Natosha L.; Actis, Luis A.] Miami Univ, Dept Microbiol, Oxford, OH 45056 USA; [Page, Richard C.] Miami Univ, Dept Chem & Biochem, Oxford, OH 45056 USA	University System of Ohio; Miami University; University System of Ohio; Miami University	Actis, LA (corresponding author), Miami Univ, Dept Microbiol, Oxford, OH 45056 USA.	actisla@MiamiOH.edu			NIH - National Institute of General Medical Sciences (NIGMS) [R35GM128595, R15GM117478-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM128595] Funding Source: NIH RePORTER	NIH - National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by RCP (PD/PI) R35GM128595, NIH -National Institute of General Medical Sciences (NIGMS). This information should be listed as shown: LAA (PD/PI), NF (Co-I); R15GM117478-01, NIH -National Institute of General Medical Sciences (NIGMS) (https://www.nigms.nih.gov), RCP (PD/PI) R35GM128595, NIH -National Institute of General Medical Sciences (NIGMS) (https://www.nigms.nih.gov), Miami University (http://miamioh.edu).	Abatedaga I, 2017, PHOTOCHEM PHOTOBIOL, V93, P805, DOI 10.1111/php.12760; ACTIS LA, 1985, J BACTERIOL, V161, P736, DOI 10.1128/JB.161.2.736-742.1985; ACTIS LA, 1993, J CLIN MICROBIOL, V31, P2812, DOI 10.1128/JCM.31.10.2812-2815.1993; Anderson S, 2005, BIOCHEMISTRY-US, V44, P7998, DOI 10.1021/bi0502691; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BARCAK GJ, 1991, METHOD ENZYMOL, V204, P321; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bramucci E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S2; Brust R, 2014, J PHYS CHEM LETT, V5, P220, DOI 10.1021/jz4023738; Brust RJ., 2013, MOL MOVIE MAGIC REAL; Conrad KS, 2014, NAT CHEM BIOL, V10, P801, DOI [10.1038/NCHEMBIO.1633, 10.1038/nchembio.1633]; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dorsey CW, 2006, PLASMID, V56, P112, DOI 10.1016/j.plasmid.2006.01.004; Dorsey CW, 2003, J CLIN MICROBIOL, V41, P4188, DOI 10.1128/JCM.41.9.4188-4193.2003; Dorsey CW, 2003, MICROBIOL-SGM, V149, P1227, DOI 10.1099/mic.0.26204-0; Dorsey CW, 2002, APPL ENVIRON MICROB, V68, P6353, DOI 10.1128/AEM.68.12.6353-6360.2002; Dragnea V, 2009, BIOCHEMISTRY-US, V48, P9969, DOI 10.1021/bi9009067; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Endimiani A, 2011, J ANTIMICROB CHEMOTH, V66, P2248, DOI 10.1093/jac/dkr289; Eveillard M, 2013, INT J INFECT DIS, V17, pE802, DOI 10.1016/j.ijid.2013.03.021; Fudim R, 2015, FEBS J, V282, P3161, DOI 10.1111/febs.13297; Fukushima Y, 2005, BIOCHEMISTRY-US, V44, P5149, DOI 10.1021/bi048044y; Gomelsky M, 1998, J BIOL CHEM, V273, P35319, DOI 10.1074/jbc.273.52.35319; Gomelsky M, 2002, TRENDS BIOCHEM SCI, V27, P497, DOI 10.1016/S0968-0004(02)02181-3; Harlow E., 1988, ANTIBODIES LAB MANUA; Heine T, 2017, BBA-PROTEINS PROTEOM, V1865, P1770, DOI 10.1016/j.bbapap.2017.09.004; Huys G, 2007, RES MICROBIOL, V158, P228, DOI 10.1016/j.resmic.2006.12.011; Jung A, 2005, P NATL ACAD SCI USA, V102, P12350, DOI 10.1073/pnas.0500722102; Jung A, 2006, J MOL BIOL, V362, P717, DOI 10.1016/j.jmb.2006.07.024; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; Kempf M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039495; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kita A, 2005, J MOL BIOL, V349, P1, DOI 10.1016/j.jmb.2005.03.067; Losi A, 2008, PHOTOCH PHOTOBIO SCI, V7, P1168, DOI 10.1039/b802472c; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Masuda S, 2005, PLANT CELL PHYSIOL, V46, P1894, DOI 10.1093/pcp/pci208; Masuda S, 2004, BIOCHEMISTRY-US, V43, P5304, DOI 10.1021/bi049836v; Masuda S, 2008, PLANT CELL PHYSIOL, V49, P1600, DOI 10.1093/pcp/pcn132; Masuda S, 2007, J MOL BIOL, V368, P1223, DOI 10.1016/j.jmb.2007.02.087; Masuda S, 2013, PLANT CELL PHYSIOL, V54, P171, DOI 10.1093/pcp/pcs173; Muller GL, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00011-17; Mussi MA, 2010, J BACTERIOL, V192, P6336, DOI 10.1128/JB.00917-10; Okamura H, 2002, J POLYM RES-TAIWAN, V9, P17, DOI 10.1023/A:1020623213658; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Rafei R, 2015, APPL ENVIRON MICROB, V81, P2359, DOI 10.1128/AEM.03824-14; Sambrook J., 2001, MOL CLONING LAB MANU; Tanwar M, 2016, FEBS LETT, V590, P2146, DOI 10.1002/1873-3468.12227; Tuttobene MR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26127-8; Vangnai AS, 2007, FEMS MICROBIOL LETT, V268, P209, DOI 10.1111/j.1574-6968.2006.00579.x; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wood CR, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00442-18; Wu Q, 2008, BIOCHEMISTRY-US, V47, P10271, DOI 10.1021/bi8011687; Yuan H, 2006, BIOCHEMISTRY-US, V45, P12687, DOI 10.1021/bi061435n; Yuan H, 2011, BIOCHEMISTRY-US, V50, P6365, DOI 10.1021/bi200701d; Zordan S, 2011, EMERG INFECT DIS, V17, P1751, DOI 10.3201/eid1709.101931	56	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220918	10.1371/journal.pone.0220918	http://dx.doi.org/10.1371/journal.pone.0220918			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415622	Green Submitted, gold, Green Published			2022-12-26	WOS:000485017200045
J	Yu, H; Tang, DL; Geva, T; Yang, C; Wu, ZY; Rathod, RH; Huang, XY; Billiar, KL; del Nido, PJ				Yu, Han; Tang, Dalin; Geva, Tal; Yang, Chun; Wu, Zheyang; Rathod, Rahul H.; Huang, Xueying; Billiar, Kristen L.; del Nido, Pedro J.			Ventricle stress/strain comparisons between Tetralogy of Fallot patients and healthy using models with different zero-load diastole and systole morphologies	PLOS ONE			English	Article							PULMONARY VALVE-REPLACEMENT; REPAIRED TETRALOGY; ADULTS LATE; MECHANICS	Patient-specific in vivo ventricle mechanical wall stress and strain conditions are important for cardiovascular investigations and should be calculated from correct zero-load ventricle morphologies. Cardiac magnetic resonance (CMR) data were obtained from 6 healthy volunteers and 12 Tetralogy of Fallot (TOF) patients with consent obtained. 3D patient-specific CMR-based ventricle models with different zero-load diastole and systole geometries due to myocardium contraction and relaxation were constructed to qualify right ventricle (RV) diastole and systole stress and strain values at begin-filling, end-filling, begin-ejection, and end ejection, respectively. Our new models (called 2G models) can provide end-diastole and end-systole stress/strain values which models with one zero-load geometries (called 1G models) could not provide. 2G mean end-ejection stress value from the 18 participants was 321.4% higher than that from 1G models (p = 0.0002). 2G mean strain values was 230% higher than that of 1G models (p = 0.0002). TOF group (TG) end-ejection mean stress value was 105.4% higher than that of healthy group (HG) (17.54 +/- 7.42kPa vs. 8.54 +/- 0.92kPa, p = 0.0245). Worse outcome group (WG, n = 6) post pulmonary valve replacement (PVR) begin-ejection mean stress was 57.4% higher than that of better outcome group (BG, 86.94 +/- 26.29 vs. 52.93 +/- 22.86 kPa; p = 0.041). Among 7 selected parameters, End-filling stress was the best predictor to differentiate BG patients from WG patients with prediction accuracy = 0.8208 and area under receiver operating characteristic curve (AUC) value at 0.8135 (EE stress). Large scale studies are needed to further validate our findings.	[Yu, Han; Tang, Dalin] Southeast Univ, Sch Biol Sci & Med Engn, Nanjing, Jiangsu, Peoples R China; [Tang, Dalin; Yang, Chun; Wu, Zheyang] Worcester Polytech Inst, Math Sci Dept, Worcester, MA 01609 USA; [Geva, Tal; Rathod, Rahul H.] Harvard Med Sch, Dept Pediat, Boston Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Huang, Xueying] Xiamen Univ, Sch Math Sci, Xiamen, Fujian, Peoples R China; [Billiar, Kristen L.] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA; [del Nido, Pedro J.] Harvard Med Sch, Dept Surg, Boston Childrens Hosp, Dept Cardiac Surg, Boston, MA 02115 USA	Southeast University - China; Worcester Polytechnic Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Xiamen University; Worcester Polytechnic Institute; Harvard University; Boston Children's Hospital; Harvard Medical School	Tang, DL (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, Nanjing, Jiangsu, Peoples R China.; Tang, DL (corresponding author), Worcester Polytech Inst, Math Sci Dept, Worcester, MA 01609 USA.	dtang@wpi.edu		Tang, Dalin/0000-0002-6965-6417; Rathod, Rahul/0000-0002-7149-5421; Wu, Zheyang/0000-0003-0641-0791	National Sciences Foundation of China [11672001, 81571691]; Postgraduate Research & Practice Innovation Program of Jiangsu Province [KYCX19_0110]	National Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Postgraduate Research & Practice Innovation Program of Jiangsu Province	This research was supported during this study in part by National Sciences Foundation of China grants 11672001, 81571691(DT; Dalin Tang) and by the Postgraduate Research & Practice Innovation Program of Jiangsu Province (grant number KYCX19_0110 awarded to Dalin Tang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axel L., 2000, ANNU REV BIOMED ENG, V4, P321; Billiar KL, 2000, J BIOMECH ENG-T ASME, V122, P23, DOI 10.1115/1.429624; BOVENDEERD PHM, 1992, J BIOMECH, V25, P1129, DOI 10.1016/0021-9290(92)90069-D; Costa KD, 1999, AM J PHYSIOL-HEART C, V276, pH595, DOI 10.1152/ajpheart.1999.276.2.H595; del Nido Pedro J, 2006, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, P29; Fan LL, 2015, PROCEDIA ENGINEER, V126, P446, DOI 10.1016/j.proeng.2015.11.267; Fan LL, 2016, BIOMED ENG ONLINE, V15, DOI 10.1186/s12938-016-0151-8; Fan R, 2014, CMES-COMP MODEL ENG, V99, P491; Gan Y, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/1475-925X-14-S1-S9; Geva T, 2004, J AM COLL CARDIOL, V43, P1068, DOI 10.1016/j.jacc.2003.10.045; Geva T, 2010, CIRCULATION, V122, pS201, DOI 10.1161/CIRCULATIONAHA.110.951178; Holmes JW, 2018, J CARDIOVASC TRANSL, V11, P71, DOI 10.1007/s12265-018-9787-z; Holzapfel GA, 2009, PHILOS T R SOC A, V367, P3445, DOI 10.1098/rsta.2009.0091; Humphrey JD., 2002, CARDIOVASCULAR SOLID; Hunter PJ, 2003, ANNU REV BIOMED ENG, V5, P147, DOI 10.1146/annurev.bioeng.5.040202.121537; Lee C, 2014, J THORAC CARDIOV SUR, V148, P2589, DOI 10.1016/j.jtcvs.2014.07.051; Leonardi B, 2013, EUR HEART J-CARD IMG, V14, P381, DOI 10.1093/ehjci/jes239; Mansi T, 2011, IEEE T MED IMAGING, V30, P1605, DOI 10.1109/TMI.2011.2135375; MCCULLOCH A, 1992, CRIT REV BIOMED ENG, V20, P427; Ohayon J, 2007, AM J PHYSIOL-HEART C, V293, pH1987, DOI 10.1152/ajpheart.00018.2007; Saber NR, 2001, ANN BIOMED ENG, V29, P275, DOI 10.1114/1.1359452; SanchezQuintana D, 1996, HEART, V76, P280, DOI 10.1136/hrt.76.3.280; Speelman L, 2009, J BIOMECH, V42, P1713, DOI 10.1016/j.jbiomech.2009.04.020; Tang D., 2015, J THORACIC CARDIOVAS, V151, P687; Tang Dalin, 2017, Molecular & Cellular Biomechanics, V14, P137, DOI 10.3970/mcb.2017.014.137; Tang DL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162986; Tang DL, 2014, J THORAC CARDIOV SUR, V147, P537, DOI 10.1016/j.jtcvs.2013.08.054; Tang DL, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2913339; Therrien J, 2000, J AM COLL CARDIOL, V36, P1670, DOI 10.1016/S0735-1097(00)00930-X; Toussaint N, 2008, PROCEEDINGS OF THE E; Vliegen HW, 2002, CIRCULATION, V106, P1703, DOI 10.1161/01.CIR.0000030995.59403.F8; WAIEN SA, 1992, J AM COLL CARDIOL, V20, P295, DOI 10.1016/0735-1097(92)90093-3; Zhang HH, 2010, IEEE T MED IMAGING, V29, P350, DOI 10.1109/TMI.2009.2030799; Zhou Zhedian, 2018, Molecular & Cellular Biomechanics, V15, P99, DOI 10.3970/mcb.2018.00558	34	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0220328	10.1371/journal.pone.0220328	http://dx.doi.org/10.1371/journal.pone.0220328			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412062	Green Published, gold, Green Submitted			2022-12-26	WOS:000485012600025
J	Jung, Y; Chun, H; Moon, JI				Jung, Younhea; Chun, Heejeong; Moon, Jung Il			Corneal deflection amplitude and visual field progression in primary open-angle glaucoma	PLOS ONE			English	Article							FIBER LAYER LOSS; BIOMECHANICAL PROPERTIES; PROSTAGLANDIN ANALOGS; INTRAOCULAR-PRESSURE; MATRIX METALLOPROTEINASES; HYSTERESIS; THICKNESS; EYES; DEFORMATION; LATANOPROST	Purpose To investigate the relationship between corneal deflection amplitude and visual field progression rate in patients with primary open-angle glaucoma (POAG). Methods This study included 113 eyes of 65 patients with POAG followed for an average of 4.81 +/- 1.24 years. Evaluation of visual field progression rate was performed using mean deviation of standard automated perimetry. Corneal deflection amplitude was measured using Corvis ST (Oculus Optikgerate GmbH, Wetzlar, Germany). Linear mixed models were performed to determine the relationship between corneal deflection amplitude, intraocular pressure (IOP), and visual field progression rate. Results Mean age was 56.36 +/- 14.58 years. Baseline average mean deviation was -8.20 +/- 9.12 dB and mean treated IOP was 14.38 +/- 3.08 mmHg. Average deflection amplitude was 0.90 +/- 0.13 mm. In both univariate and multivariate analysis, IOP (P = 0.028 and P < 0.001, respectively) and deflection amplitude (P = 0.034 and P < 0.001, respectively) significantly affected visual field progression rate. Eyes with high IOP and greater deflection amplitude showed faster progression rate. Conclusions Corneal deflection amplitude was significantly related with glaucoma progression. Eyes with greater corneal deflection amplitude showed faster visual field progression rate in patients with POAG.	[Jung, Younhea; Chun, Heejeong; Moon, Jung Il] Catholic Univ Korea, Yeouido St Marys Hosp, Coll Med, Dept Ophthalmol, Seoul, South Korea	Catholic University of Korea	Moon, JI (corresponding author), Catholic Univ Korea, Yeouido St Marys Hosp, Coll Med, Dept Ophthalmol, Seoul, South Korea.	jimoon@catholic.ac.kr			Institute of Clinical Medicine Research in the Yeouido St. Mary's hospital, Catholic University of Korea	Institute of Clinical Medicine Research in the Yeouido St. Mary's hospital, Catholic University of Korea	This research was supported by grant of the Institute of Clinical Medicine Research in the Yeouido St. Mary's hospital, Catholic University of Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alward WLM, 2001, OPHTHALMOLOGY, V108, P247; Aoki S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21424-8; Bolivar G, 2015, ACTA OPHTHALMOL, V93, pE495, DOI 10.1111/aos.12689; Congdon NG, 2006, AM J OPHTHALMOL, V141, P868, DOI 10.1016/j.ajo.2005.12.007; De Moraes CGV, 2012, J GLAUCOMA, V21, P209, DOI 10.1097/IJG.0b013e3182071b92; Girard MJA, 2011, INVEST OPHTH VIS SCI, V52, P5656, DOI 10.1167/iovs.10-6927; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Heijl A, 2009, OPHTHALMOLOGY, V116, P2271, DOI 10.1016/j.ophtha.2009.06.042; Herber R, 2018, OPHTHALMOLOGE, V115, P635, DOI 10.1007/s00347-018-0716-y; Hirasawa K, 2018, AM J OPHTHALMOL, V195, P26, DOI 10.1016/j.ajo.2018.07.025; Honda N, 2010, ARCH OPHTHALMOL-CHIC, V128, P466, DOI 10.1001/archophthalmol.2010.40; Hong Y, 2016, INT J OPHTHALMOL-CHI, V9, P973, DOI 10.18240/ijo.2016.07.06; Huseynova T, 2014, AM J OPHTHALMOL, V157, P885, DOI 10.1016/j.ajo.2013.12.024; Jung Y, 2017, ACTA OPHTHALMOL, V95, pE556, DOI 10.1111/aos.13466; Jung Y, 2016, OPHTHALMOLOGY, V123, P959, DOI 10.1016/j.ophtha.2015.12.043; Kotecha A, 2006, INVEST OPHTH VIS SCI, V47, P5337, DOI 10.1167/iovs.06-0557; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Matsuura M, 2017, SCI REP-UK, V7, DOI 10.1038/srep40798; Meda R, 2017, BRIT J OPHTHALMOL, V101, P120, DOI 10.1136/bjophthalmol-2016-308432; Medeiros FA, 2013, OPHTHALMOLOGY, V120, P1533, DOI 10.1016/j.ophtha.2013.01.032; Medeiros FA, 2009, OPHTHALMOLOGY, V116, P1125, DOI 10.1016/j.ophtha.2008.12.062; Oh DJ, 2006, INVEST OPHTH VIS SCI, V47, P3887, DOI 10.1167/iovs.06-0036; Roy AS, 2015, J MECH BEHAV BIOMED, V48, P173, DOI 10.1016/j.jmbbm.2015.04.010; Sigal IA, 2011, INVEST OPHTH VIS SCI, V52, P1896, DOI 10.1167/iovs.10-5500; Steinhart MR, 2012, MOL VIS, V18, P1093; Tejwani S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097591; Tsikripis P, 2013, DRUG DES DEV THER, V7, P1149, DOI 10.2147/DDDT.S50622; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Vellara HR, 2015, INVEST OPHTH VIS SCI, V56, P6941, DOI 10.1167/iovs.15-17396; Vinciguerra R, 2016, J REFRACT SURG, V32, P803, DOI 10.3928/1081597X-20160629-01; Wu N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155527; Zhang CW, 2016, AM J OPHTHALMOL, V166, P29, DOI 10.1016/j.ajo.2016.02.034	32	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220655	10.1371/journal.pone.0220655	http://dx.doi.org/10.1371/journal.pone.0220655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404083	Green Published, Green Submitted, gold			2022-12-26	WOS:000485006800023
J	Kermanizadeh, A; Brown, DM; Stone, V				Kermanizadeh, Ali; Brown, David M.; Stone, Vicki			The variances in cytokine production profiles from non- or activated THP-1, Kupffer cell and human blood derived primary macrophages following exposure to either alcohol or a panel of engineered nanomaterials	PLOS ONE			English	Article							IN-VITRO; NANOPARTICLES; INFLAMMATION; LIVER	The portfolio of cytokines is key to the function of macrophages as sentries of the innate immune system as well as being critical for the transition from innate to adaptive immunity. Cytokine bias is critical in the fate of macrophages into a continuum of inflammatory to anti-inflammatory macrophages. Due to advances in the field of toxicology, increasingly advanced multi-cellular in vitro safety assessment models are being developed in order to allow for a better predication of potential adverse effects in humans with many of these models include a macrophage population. The selection of the correct macrophage cells in these advanced in vitro models is critical for a physiologically relevant and realistic immune response. In this study we investigated cytokine response profile (IL1-beta, IL6, IL10 and TNF-alpha) of activated and non-activated THP-1 (immortalized monocyte-like cell line), primary human Kupffer cells (liver resident macrophages) and human primary peripheral blood mononuclear cells following exposure of a panel of nanomaterials or ethanol. The data demonstrated that the THP-1 cell line are not great cytokine producers. The PBMC appear to be a good in vitro surrogate for circulating/pro-inflammatory macrophages but are not a suitable replacement for Kupffer cells. The findings from this study highlight the necessity for the selection of appropriate macrophages populations to meet the specific physiological requirements of in vitro experiment.	[Kermanizadeh, Ali; Brown, David M.; Stone, Vicki] Heriot Watt Univ, Sch Engn & Phys Sci, Nano Safety Res Grp, Edinburgh, Midlothian, Scotland	Heriot Watt University	Kermanizadeh, A (corresponding author), Heriot Watt Univ, Sch Engn & Phys Sci, Nano Safety Res Grp, Edinburgh, Midlothian, Scotland.	Ali.Kermanizadeh@hw.ac.uk	Kermanizadeh, Ali/AAD-6281-2019	Kermanizadeh, Ali/0000-0002-2989-9078	H2020 [760813]	H2020	This work has been financially supported by H2020 funded project PATROLS [Grant code 760813]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2018, J IMMUNOL, V200, P3599, DOI 10.4049/jimmunol.1701552; Al-Rashed Fatema, 2019, Cell Physiol Biochem, V52, P397, DOI 10.33594/000000028; Balkwill F, 2006, CANCER METAST REV, V25, P409, DOI 10.1007/s10555-006-9005-3; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Brock M, 2011, J BIOL CHEM, V286, P40142, DOI 10.1074/jbc.M111.251793; Brown DM, 2010, J BIOMED NANOTECHNOL, V6, P224, DOI 10.1166/jbn.2010.1117; Cao ZW, 2016, INT J NANOMED, V11, P3331, DOI 10.2147/IJN.S106912; Cruz T, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1105-z; Dabrowski MP, 2001, MEDIAT INFLAMM, V10, P101; Duque GA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00491; Franken L, 2016, CELL MICROBIOL, V18, P475, DOI 10.1111/cmi.12580; Gonnord P, 2018, SCI SIGNAL, V11, P544; Gosens I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126934; Hamilton RF, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-57; Jacobsen NR, 2015, FOOD CHEM TOXICOL, V85, P84, DOI 10.1016/j.fct.2015.08.008; Jessop F, 2015, NANOTOXICOLOGY, V9, P365, DOI 10.3109/17435390.2014.933904; Kermanizadeh A, 2019, NATURE SCI REPORTS, DOI [10.1038/s41598-019-39903-x, DOI 10.1038/S41598-019-39903-X]; Kermanizadeh A, 2017, TOXICOL SCI, V158, P176, DOI 10.1093/toxsci/kfx080; Kermanizadeh A, 2017, BASIC CLIN PHARMACOL, V120, P380, DOI 10.1111/bcpt.12692; Kermanizadeh A, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0056-2; Kermanizadeh A, 2014, NANOTOXICOLOGY, V8, P149, DOI 10.3109/17435390.2013.866284; Kermanizadeh A, 2013, NANOTOXICOLOGY, V7, P301, DOI 10.3109/17435390.2011.653416; Kochumon S, 2018, CELL PHYSIOL BIOCHEM, V46, P953, DOI 10.1159/000488824; Krenkel O, 2017, NAT REV IMMUNOL, V17, P306, DOI 10.1038/nri.2017.11; MacParland SA, 2017, ACS NANO, V11, P2428, DOI 10.1021/acsnano.6b06245; Mocellin S, 2003, TRENDS IMMUNOL, V24, P36, DOI 10.1016/S1471-4906(02)00009-1; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Petkov DI, 2019, J LEUKOCYTE BIOL, V106, P1241, DOI 10.1002/JLB.1A0119-017R; Schiwon M, 2014, CELL, V156, P456, DOI 10.1016/j.cell.2014.01.006; Septiadi D, 2018, ADV MATER, V30, DOI 10.1002/adma.201806181; Sumner DR, 2014, CLIN ORTHOP RELAT R, V472, P3728, DOI 10.1007/s11999-014-3580-3; Tachibana S, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-6; Vranic S, 2017, ARCH TOXICOL, V91, P353, DOI 10.1007/s00204-016-1673-3; Wong CP, 2015, MOL NUTR FOOD RES, V59, P991, DOI 10.1002/mnfr.201400761	36	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220974	10.1371/journal.pone.0220974	http://dx.doi.org/10.1371/journal.pone.0220974			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393970	Green Published, gold, Green Submitted			2022-12-26	WOS:000485002500087
J	Martin-Torrijos, L; Kokko, H; Makkonen, J; Jussila, J; Dieguez-Uribeondo, J				Martin-Torrijos, Laura; Kokko, Harri; Makkonen, Jenny; Jussila, Japo; Dieguez-Uribeondo, Javier			Mapping 15 years of crayfish plague in the Iberian Peninsula: The impact of two invasive species on the endangered native crayfish	PLOS ONE			English	Article							PATHOGEN APHANOMYCES-ASTACI; PACIFASTACUS-LENIUSCULUS; FUNGUS; POPULATIONS; DISEASE	Crayfish plague, caused by the pathogen Aphanomyces astaci, is one of the main factors responsible for the decimation of the native European crayfish species Austropotamobius pallipes. In Spain, two North American freshwater crayfish species, Procambarus clarkii and Pacifastacus leniusculus, were intentionally introduced during the 1970s for aquaculture and fishery purposes. Since then, incidences of crayfish plague have been continually reported. In this work, we evaluated more than 50 diagnosed cases of crayfish plague that have occurred in the Iberian Peninsula since 2004 by performing a microscopic examination of infected specimens and by molecularly identifying and haplotyping the pathogen. Our results showed that (i) the pathogen A. astaci has been active 45 years since the first introductions of the invasive North American crayfish species in the Iberian Peninsula, and (ii) P. clarkii and P. leniusculus are chronic reservoirs of the crayfish plague pathogen. Moreover, our data confirmed a correspondence between pathogen origin and spread and the specific haplotypes carried by the North American invasive crayfish located in the vicinity of each outbreak. We generated a crayfish plague incidence map of the Iberian Peninsula that shows (i) a northern area, mainly inhabited by alien P. leniusculus, where crayfish plague cases are associated with the b-haplotype specific to P. leniusculus, and (ii) southern, central and eastern areas that are basically inhabited by alien P. clarkii, where crayfish plague cases are associated with the d1- and d2-haplotypes specific to P. clarkii. The results presented here are evidence of the long standing and negative impact of the two invasive crayfish species on the native species, indicating the need for more extensive control measures.	[Martin-Torrijos, Laura; Dieguez-Uribeondo, Javier] CSIC, RJB, Dept Mycol, Madrid, Spain; [Kokko, Harri; Makkonen, Jenny; Jussila, Japo] Univ Eastern Finland, Dept Environm & Biol Sci, Kuopio, Finland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; University of Eastern Finland	Dieguez-Uribeondo, J (corresponding author), CSIC, RJB, Dept Mycol, Madrid, Spain.	dieguez@rjb.csic.es	MARTIN-TORRIJOS, LAURA/AAH-8654-2019; dieguez-uribeondo, javier/I-2178-2015; Diéguez-Uribeondo, Javier/ABF-1130-2021	MARTIN-TORRIJOS, LAURA/0000-0002-2850-2737; dieguez-uribeondo, javier/0000-0002-4488-0658; Diéguez-Uribeondo, Javier/0000-0002-4488-0658	Spanish Ministry of Economy and Competitiveness [CGL2016-80526-R]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This research was partially supported by a grant from the Spanish Ministry of Economy and Competitiveness (CGL2016-80526-R) to JDU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was partially supported by a grant from the Spanish Ministry of Economy and Competitiveness (CGL2016-80526-R). We also like to thank the assistance in providing us with crayfish plague samples and information to Jokin Larumbe (Gobierno de Navarra); Fernando Alonso and Javier Valenciano (Junta de Comunidades de Castilla-La Mancha), Sara Lapesa (Gobierno de Aragon), Joan Motserrat (Parque Natural La Garrotxa, Catalunya), Lluis Benejam (CEBCAT-La Balca S. L.) Antonio Pradillo (CCEDCV-EL PALMAR, Generatlitat Valenciana), Juan Maria Herrero (Juanta de Castilla y Leon), Jon Zulaika (Diputacion de Gipuzkoa, Pais Vasco), Borja Nebot (Junta de Andalucia) and Javier Galindo (Agencia Medio Ambiente y Agua Andalucia). We also thank Jeffry Lintsen, from the University of Eastern Finland, Nina Keller from the University of Koblenz-Landau and Emilio Cano and Marta Higuera from the RJB-CSIC for their technical assistance.	Alderman DJ, 1997, SCI TECHNICAL REV, V15, P15; Alonso F, 2000, B FR PECHE PISCIC, P31, DOI 10.1051/kmae:2000003; Alonso F., 2012, BASES ECOLOGICAS PRE; [Anonymous], 2014, PREVENTION MANAGEMEN; [Anonymous], 2013, ENV NEW EU ACTION PR; Aydin H, 2014, KNOWL MANAG AQUAT EC, p03P1, DOI 10.1051/kmae/2014004; Cerenius L., 1988, P131; Clement M., 2002, P 16 INT PARALLEL DI, P7; Cornalia E., 1960, ATTI SOC ITAL SCI NA, V2, P334; Crowl TA, 2008, FRONT ECOL ENVIRON, V6, P238, DOI 10.1890/070151; Dieguez-Uribeondo J, 2006, B FR PECHE PISCIC, P1303, DOI 10.1051/kmae:2006036; Dieguez-Uribeondo J, 1997, B FR PECHE PISCIC, P753, DOI 10.1051/kmae/1997051; DIEGUEZURIBEONDO J, 1995, MYCOL RES, V99, P574, DOI 10.1016/S0953-7562(09)80716-8; Edsman L, 2015, DIS AQUAT ORGAN, V112, P219, DOI 10.3354/dao02811; Grandjean F, 2014, VET MICROBIOL, V170, P317, DOI 10.1016/j.vetmic.2014.02.020; Gutierrez-Yurrita PJ, 1999, CRUSTACEAN ISS, V11, P161; Habsburgo Lorena A.S., 1986, Freshwater Crayfish, V6, P131; Habsburgo Lorena A. S., 1979, Freshwater crayfish 4, P175; HUANG TS, 1994, AQUACULTURE, V126, P1, DOI 10.1016/0044-8486(94)90243-7; Jussila Japo, 2016, Freshwater Crayfish, V22, P53; Jussila Japo, 2014, Freshwater Crayfish, V20, P73; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kozubikova E, 2011, J INVERTEBR PATHOL, V108, P214, DOI 10.1016/j.jip.2011.08.002; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Lowe S., 100 WORLDS WORST INV; Maguire I, 2016, DIS AQUAT ORGAN, V118, P45, DOI 10.3354/dao02955; Makkonen J, 2018, PARASITOLOGY, V145, P1210, DOI 10.1017/S0031182018000227; Makkonen J, 2016, SCI REP-UK, V6, DOI 10.1038/srep36089; Martin-Torrijos L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195353; Moorhouse TP, 2015, WIRES WATER, V2, P1, DOI 10.1002/wat2.1059; Oidtmann B, 2004, VET MICROBIOL, V100, P269, DOI 10.1016/j.vetmic.2004.01.019; Oidtmann B, 2006, DIS AQUAT ORGAN, V72, P53, DOI 10.3354/dao072053; Peiro DF, 2016, HYDROBIOLOGIA, V781, P181, DOI 10.1007/s10750-016-2841-4; Rezinciuc S, 2014, FUNGAL BIOL-UK, V118, P612, DOI 10.1016/j.funbio.2013.10.007; Ricciardi A, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P211; Richman NI, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0060; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sandstrom A, 2014, BIOL INVASIONS, V16, P1961, DOI 10.1007/s10530-014-0641-1; Silvestro D., 2011, ORG DIVERS EVOL, V12, P335, DOI [10.1007/sI3127-011-0056-0, DOI 10.1007/S13127-011-0056-0]; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Unestam T., 1969, RESISTANCE CRAYFISH	41	22	22	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0219223	10.1371/journal.pone.0219223	http://dx.doi.org/10.1371/journal.pone.0219223			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393870	gold, Green Submitted, Green Published			2022-12-26	WOS:000485002500007
J	Cook, LM; Frieling, JS; Nerlakanti, N; McGuire, JJ; Stewart, PA; Burger, KL; Cleveland, JL; Lynch, CC				Cook, Leah M.; Frieling, Jeremy S.; Nerlakanti, Niveditha; McGuire, Jeremy J.; Stewart, Paul A.; Burger, Karen L.; Cleveland, John L.; Lynch, Conor C.			Betaglycan drives the mesenchymal stromal cell osteogenic program and prostate cancer-induced osteogenesis	ONCOGENE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; STEM-CELLS; BONE METASTASES; RECEPTOR; WNT5A; EXPRESSION; DIFFERENTIATION; INHIBITION; MIGRATION	Bone metastatic prostate cancer provokes extensive osteogenesis by driving the recruitment and osteoblastic differentiation of mesenchymal stromal cells (MSCs). The resulting lesions greatly contribute to patient morbidity and mortality, underscoring the need for defining how prostate metastases subvert the MSC-osteoblast differentiation program. To gain insights into this process we profiled the effects of co-culture of primary MSCs with validated bone metastatic prostate cancer cell line models. These analyses revealed a cast of shared differentially induced genes in MSC, including betaglycan, a co-receptor for TGF beta. Betaglycan has not been studied in the context of bone metastatic disease previously. Here we report that loss of betaglycan in MSC is sufficient to augment TGF beta signaling, proliferation and migration, and completely blocks the MSC-osteoblast differentiation program. Further, betaglycan was revealed as necessary for prostate cancer-induced osteogenesis in vivo. Mechanistically, gene expression analysis revealed betaglycan controls the expression of a large repertoire of genes in MSCs, and that betaglycan loss provokes >60-fold increase in the expression of Wnt5a that plays important roles in stemness. In accord with the increased Wnt5a levels, there was a marked induction of canonical Wnt signaling in betaglycan ablated MSCs, and the addition of recombinant Wnt5a to MSCs was sufficient to impair osteogenic differentiation. Finally, the addition of Wnt5a neutralizing antibody was sufficient to induce the expression of osteogenic genes in betaglycan-ablated MSCs. Collectively, these findings suggest a betaglycan-Wnt5a circuit represents an attractive vulnerability to ameliorate prostate cancer-induced osteogenesis.	[Cook, Leah M.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA; [Frieling, Jeremy S.; Nerlakanti, Niveditha; McGuire, Jeremy J.; Burger, Karen L.; Cleveland, John L.; Lynch, Conor C.] H Lee Moffitt Canc Ctr & Res Inst, Tumor Biol Dept, Tampa, FL 33612 USA; [Nerlakanti, Niveditha; McGuire, Jeremy J.] Univ S Florida, Canc Biol PhD Program, Tampa, FL USA; [Stewart, Paul A.] H Lee Moffitt Canc Ctr & Res Inst, Biostat & Bioinformat Shared Resource, Tampa, FL USA	University of Nebraska System; University of Nebraska Medical Center; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute	Lynch, CC (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Tumor Biol Dept, Tampa, FL 33612 USA.	conor.lynch@moffitt.org	Cook, Leah/AAV-9640-2021; Nerlakanti, Niveditha/X-5741-2019	Cook, Leah/0000-0002-9996-7419; Nerlakanti, Niveditha/0000-0001-8808-2220; Frieling, Jeremy/0000-0002-2181-1836; Stewart, Paul/0000-0003-0882-308X; Burger, Karen/0000-0002-3805-9580	American Cancer Society [PF-13-175-01-CSM]; Biostatistics and Bioinformatics Shared Resource at the H. Lee Moffitt Cancer Center & Research Institute, an NCI designated Comprehensive Cancer Center [P30-CA076292]; Miles for Moffitt; Department of Defense PCRP program [W81XWH1810523]; Cortner-Couch Endowed Chair for Cancer Research from the University of South Florida; Molecular Genomics Core; Analytic Microscopy Core; Small Animal Imaging Laboratory Core; NATIONAL CANCER INSTITUTE [P30CA076292, P50CA097186] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Biostatistics and Bioinformatics Shared Resource at the H. Lee Moffitt Cancer Center & Research Institute, an NCI designated Comprehensive Cancer Center; Miles for Moffitt; Department of Defense PCRP program(United States Department of Defense); Cortner-Couch Endowed Chair for Cancer Research from the University of South Florida; Molecular Genomics Core; Analytic Microscopy Core; Small Animal Imaging Laboratory Core; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Colm Morrissey, University of Washington for providing human bone metastatic prostate cancer specimens (P50-CA097186 16A1). LMC was supported by a fellowship from the American Cancer Society (PF-13-175-01-CSM). This work has been supported in part by the Molecular Genomics Core, the Analytic Microscopy Core, the Small Animal Imaging Laboratory Core and the Biostatistics and Bioinformatics Shared Resource at the H. Lee Moffitt Cancer Center & Research Institute, an NCI designated Comprehensive Cancer Center (P30-CA076292). Funding also provided by Miles for Moffitt (CCL), the Department of Defense PCRP program (W81XWH1810523; CCL), and by the Cortner-Couch Endowed Chair for Cancer Research from the University of South Florida (JLC).	Araujo A, 2014, CANCER RES, V74, P2391, DOI 10.1158/0008-5472.CAN-13-2652; Balooch G, 2005, P NATL ACAD SCI USA, V102, P18813, DOI 10.1073/pnas.0507417102; Bauer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080526; Belotti D, 2016, MATRIX BIOL, V55, P106, DOI 10.1016/j.matbio.2016.03.003; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Bilandzic M, 2011, MOL CELL ENDOCRINOL, V339, P180, DOI 10.1016/j.mce.2011.04.014; Biswas S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027090; Bragado P, 2013, NAT CELL BIOL, V15, P1351, DOI 10.1038/ncb2861; Canesin G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184418; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Cook LM, 2016, SCI REP-UK, V6, DOI 10.1038/srep29384; Cook LM, 2014, CANCER METAST REV, V33, P511, DOI 10.1007/s10555-014-9494-4; Crane JL, 2014, J CLIN INVEST, V124, P466, DOI 10.1172/JCI70050; Dai JL, 2014, CLIN CANCER RES, V20, P617, DOI 10.1158/1078-0432.CCR-13-0839; Dong M, 2007, J CLIN INVEST, V117, P206, DOI 10.1172/JCI29293; Edwards JR, 2010, J BONE MINER RES, V25, P2419, DOI 10.1002/jbmr.139; Eickelberg O, 2002, J BIOL CHEM, V277, P823, DOI 10.1074/jbc.M105110200; Erlebacher A, 1996, J CELL BIOL, V132, P195, DOI 10.1083/jcb.132.1.195; Fournier PGJ, 2010, BONE, V47, pS268, DOI 10.1016/j.bone.2010.01.332; Fournier PGJ, 2015, CANCER CELL, V27, P809, DOI 10.1016/j.ccell.2015.04.009; Frieling JS, 2015, CANCER CONTROL, V22, P109, DOI 10.1177/107327481502200114; Gebken J, 1999, J ENDOCRINOL, V161, P503, DOI 10.1677/joe.0.1610503; Guise TA, 2003, CLIN ORTHOP RELAT R, pS32, DOI 10.1097/01.blo.0000093055.96273.69; Hasegawa D, 2018, J CELL PHYSIOL, V233, P1752, DOI 10.1002/jcp.26086; Hill CR, 2015, DEV DYNAM, V244, P122, DOI 10.1002/dvdy.24225; Hodgkinson CP, 2013, STEM CELLS, V31, P1669, DOI 10.1002/stem.1416; Huang S, 2015, J ORTHOP TRANSL, V3, P26, DOI 10.1016/j.jot.2014.07.005; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Jenkins LM, 2016, J BIOL CHEM, V291, P25716, DOI 10.1074/jbc.M116.748624; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Katoh M, 2017, INT J ONCOL, V51, P1357, DOI 10.3892/ijo.2017.4129; Korpal M, 2010, EUR J CANCER, V46, P1232, DOI 10.1016/j.ejca.2010.02.040; Korpal M, 2009, NAT MED, V15, P960, DOI 10.1038/nm.1943; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Kumawat K, 2013, FASEB J, V27, P1631, DOI 10.1096/fj.12-217539; Lee GT, 2018, BRIT J CANCER, V118, P670, DOI 10.1038/bjc.2017.451; Logothetis C, 2018, CANCER METAST REV, V37, P189, DOI 10.1007/s10555-017-9719-4; Lopez-Casillas F, 2003, J BIOL CHEM, V278, P382, DOI 10.1074/jbc.M208520200; Luo K, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022137; Miyamoto DT, 2015, SCIENCE, V349, P1351, DOI 10.1126/science.aab0917; Mohammad KS, 2011, CANCER RES, V71, P175, DOI 10.1158/0008-5472.CAN-10-2651; Mythreye K, 2009, P NATL ACAD SCI USA, V106, P8221, DOI 10.1073/pnas.0812879106; Nishida J, 2018, ONCOGENE, V37, P2197, DOI 10.1038/s41388-017-0084-0; OHTSUKI M, 1992, MOL CELL BIOL, V12, P261, DOI 10.1128/MCB.12.1.261; Olivares-Navarrete R, 2011, ACTA BIOMATER, V7, P2740, DOI 10.1016/j.actbio.2011.02.030; Ren D, 2019, J EXP MED, V216, P428, DOI 10.1084/jem.20180661; Ren GW, 2015, J MOL MED, V93, P1203, DOI 10.1007/s00109-015-1329-4; Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250; Sakaki-Yumoto M, 2013, BBA-GEN SUBJECTS, V1830, P2280, DOI 10.1016/j.bbagen.2012.08.008; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Serra R, 2011, J MAMMARY GLAND BIOL, V16, P157, DOI 10.1007/s10911-011-9205-5; Shinojima N, 2013, CANCER RES, V73, P2333, DOI 10.1158/0008-5472.CAN-12-3086; Stenvers KL, 2003, MOL CELL BIOL, V23, P4371, DOI 10.1128/MCB.23.12.4371-4385.2003; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Thiele Stefanie, 2018, Oncotarget, V9, P27293, DOI 10.18632/oncotarget.25551; Thiele S, 2016, J BONE MINER RES, V31, P1488, DOI 10.1002/jbmr.2899; Thiele S, 2015, J BONE MINER RES, V30, P488, DOI 10.1002/jbmr.2362; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Todorovic N, 2011, BIOMARK MED, V5, P855, DOI [10.2217/BMM.11.59, 10.2217/bmm.11.59]; Turley RS, 2007, CANCER RES, V67, P1090, DOI 10.1158/0008-5472.CAN-06-3117; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; WU HC, 1994, INT J CANCER, V57, P406, DOI 10.1002/ijc.2910570319; Zhang SJ, 2016, EUR REV MED PHARMACO, V20, P899	65	12	12	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 31	2019	38	44					6959	6969		10.1038/s41388-019-0913-4	http://dx.doi.org/10.1038/s41388-019-0913-4			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JJ1AO	31409900	Green Accepted			2022-12-26	WOS:000493892900001
J	Li, MY; Peng, WH; Wu, CH; Chang, YM; Lin, YL; Chang, GD; Wu, HC; Chen, GC				Li, Meng-Yen; Peng, Wen-Hsin; Wu, Chien-Hsun; Chang, Ya-Min; Lin, Yu-Ling; Chang, Geen-Dong; Wu, Han-Chung; Chen, Guang-Chao			PTPN3 suppresses lung cancer cell invasiveness by counteracting Src-mediated DAAM1 activation and actin polymerization	ONCOGENE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; FAMILY KINASES; MIGRATION; INVASION; ADHESION; METASTASIS; GROWTH; MORPHOGENESIS; PROLIFERATION; EXPRESSION	Cancer cell migration plays a crucial role during the metastatic process. Reversible tyrosine phosphorylation by protein tyrosine kinases (PTKs) and protein tyrosine phosphatases (PTPs) have been implicated in the regulation of cancer cell migration and invasion. However, the underlying mechanisms have not been fully elucidated. Here, we show that depletion of the FERM and PDZ domain-containing protein tyrosine phosphatase PTPN3 enhances lung cancer cell migration/invasion and metastasis by promoting actin filament assembly and focal adhesion dynamics. We further identified Src and DAAM1 (dishevelled associated activator of morphogenesis 1) as interactors of PTPN3. DAAM1 is a formin-like protein involved in the regulation of actin cytoskeletal remodeling. PTPN3 inhibits Src activity and Src-mediated phosphorylation of Tyr652 on DAAM1. The tyrosine phosphorylation of DAAM1 is essential for DAAM1 homodimer formation and actin polymerization. Ectopic expression of a DAAM1 phosphodeficient mutant inhibited F-actin assembly and suppressed lung cancer cell migration and invasion. Our findings reveal a novel mechanism by which reversible tyrosine phosphorylation of DAAM1 by Src and PTPN3 regulates actin dynamics and lung cancer invasiveness.	[Li, Meng-Yen; Peng, Wen-Hsin; Lin, Yu-Ling; Chen, Guang-Chao] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Chang, Ya-Min; Chang, Geen-Dong; Chen, Guang-Chao] Natl Taiwan Univ, Coll Life Sci, Inst Biochem Sci, Taipei 106, Taiwan; [Wu, Chien-Hsun; Wu, Han-Chung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan	Academia Sinica - Taiwan; National Taiwan University; Academia Sinica - Taiwan	Chen, GC (corresponding author), Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan.; Chen, GC (corresponding author), Natl Taiwan Univ, Coll Life Sci, Inst Biochem Sci, Taipei 106, Taiwan.	gcchen@gate.sinica.edu.tw	Wu, Han-Chung/B-1209-2011	Wu, Han-Chung/0000-0002-5185-1169; Chen, Guang-Chao/0000-0002-4980-4718	Ministry of Science and Technology of Taiwan [NSC102-2311-B-001-027-MY3]; Academia Sinica	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	We thank Ruey-Hwa Chen, Raymond Habas, Jean-Cheng Kuo, Jai Prakash Singh, and Tzu-Ching Meng for helpful discussion and reagents. We thank Chin-Chun Hung for confocal and cell imaging assistance; Suh-Yuen Liang for the bioinformatic support; Min-Feng Hsu for structural assistance; the National RNAi Core Facility for shRNAs; Academia Sinica Common Mass Spectrometry Facilities for mass spectrometric assistance; IBC Histopathology Core Facility for tissue processing and histology. We are grateful to Cindy Lee for English editing. This work was supported by the Ministry of Science and Technology of Taiwan (NSC102-2311-B-001-027-MY3) and Academia Sinica.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Aspenstrom P, 2006, EXP CELL RES, V312, P2180, DOI 10.1016/j.yexcr.2006.03.013; Bollu LR, 2017, CLIN CANCER RES, V23, P2136, DOI 10.1158/1078-0432.CCR-16-0934; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chen DY, 2012, J CELL SCI, V125, P4841, DOI 10.1242/jcs.108597; Devreotes P, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a005959; Disanza A, 2005, CELL MOL LIFE SCI, V62, P955, DOI 10.1007/s00018-004-4472-6; Dong L, 2018, MOL CELL BIOCHEM, V438, P183, DOI 10.1007/s11010-017-3125-7; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Gao Q, 2014, GASTROENTEROLOGY, V146, P1397, DOI 10.1053/j.gastro.2014.01.062; Gardberg M, 2016, J PATHOL CLIN RES, V2, P41, DOI 10.1002/cjp2.34; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Glondu-Lassis M, 2010, CANCER RES, V70, P5116, DOI 10.1158/0008-5472.CAN-09-4368; Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011; Hou SW, 2010, CANCER RES, V70, P2901, DOI 10.1158/0008-5472.CAN-09-3229; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jung Y, 2012, GENE CHROMOSOME CANC, V51, P590, DOI 10.1002/gcc.21945; Kan-o M, 2012, BIOL OPEN, V1, P889, DOI 10.1242/bio.20121370; Kedrin D, 2007, J MAMMARY GLAND BIOL, V12, P143, DOI 10.1007/s10911-007-9046-4; Kim D, 2016, ONCOTARGET, V7, P17829, DOI 10.18632/oncotarget.7429; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Labbe DP, 2012, PROG MOL BIOL TRANSL, V106, P253, DOI 10.1016/B978-0-12-396456-4.00009-2; Li DQ, 2011, DEVELOPMENT, V138, P303, DOI 10.1242/dev.055566; Li MY, 2015, ONCOGENE, V34, P3791, DOI 10.1038/onc.2014.312; Li SQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep36873; Lin G, 2011, GENE DEV, V25, P1412, DOI 10.1101/gad.2018911; Liu GY, 2018, ONCOL REP, V39, P465, DOI 10.3892/or.2017.6124; Lizarraga F, 2009, CANCER RES, V69, P2792, DOI 10.1158/0008-5472.CAN-08-3709; Lu CL, 2015, ONCOTARGET, V6, P24912, DOI 10.18632/oncotarget.4701; Lu J, 2007, J MOL BIOL, V369, P1258, DOI 10.1016/j.jmb.2007.04.002; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Mendoza MC, 2013, SEMIN CELL DEV BIOL, V24, P272, DOI 10.1016/j.semcdb.2013.01.007; Nelson KS, 2012, NAT CELL BIOL, V14, P518, DOI 10.1038/ncb2467; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Patel A, 2016, LIFE SCI, V157, P52, DOI 10.1016/j.lfs.2016.05.036; Prokop Andreas, 2011, Commun Integr Biol, V4, P538, DOI 10.4161/cib.4.5.16511; Randall TS, 2014, EUR J CELL BIOL, V93, P205, DOI 10.1016/j.ejcb.2013.11.004; Reig G, 2014, DEVELOPMENT, V141, P1999, DOI 10.1242/dev.101451; Reynolds AB, 2014, ONCOGENE, V33, P4537, DOI 10.1038/onc.2013.416; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; SEN B, 2011, J SIGNAL TRANSDUCT, DOI DOI 10.1063/1.3603036; Shojima K, 2015, SCI REP-UK, V5, DOI 10.1038/srep08042; Stehbens SJ, 2014, METHOD CELL BIOL, V123, P335, DOI 10.1016/B978-0-12-420138-5.00018-5; Svitkina Tatyana, 2018, Cold Spring Harb Perspect Biol, V10, DOI 10.1101/cshperspect.a018267; Tepass U, 2009, CURR OPIN GENET DEV, V19, P357, DOI 10.1016/j.gde.2009.05.006; van Vliet C, 2005, NAT IMMUNOL, V6, P253, DOI 10.1038/ni1169; Wang SE, 2005, MOL CELL BIOL, V25, P4703, DOI 10.1128/MCB.25.11.4703-4715.2005; Wang XW, 2018, CELL BIOL INT, V42, P598, DOI 10.1002/cbin.10936; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Xiong HP, 2018, CELL SIGNAL, V44, P33, DOI 10.1016/j.cellsig.2018.01.013; Yamashita M, 2007, GENES CELLS, V12, P1255, DOI 10.1111/j.1365-2443.2007.01132.x; Yan T, 2018, J BIOL CHEM, V293, P10172, DOI 10.1074/jbc.RA117.000327; Yin M, 2017, ONCOTARGET, V8, P88232, DOI 10.18632/oncotarget.21088; Young KG, 2010, BBA-MOL CELL RES, V1803, P183, DOI 10.1016/j.bbamcr.2008.09.017; Zeng YF, 2015, EXP MOL PATHOL, V98, P260, DOI 10.1016/j.yexmp.2015.03.008; Zheng YH, 2013, CHIN J CANCER, V32, P75, DOI [10.5732/cjc.012.10084, 10.5732/cjc.012.1008]; Zhou F, 2009, HUM MOL GENET, V18, P2472, DOI 10.1093/hmg/ddp185; Zhu XL, 2008, INT J COLORECTAL DIS, V23, P1041, DOI 10.1007/s00384-008-0520-2; Zhu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037823	63	17	17	2	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 31	2019	38	44					7002	7016		10.1038/s41388-019-0948-6	http://dx.doi.org/10.1038/s41388-019-0948-6			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JJ1AO	31406243				2022-12-26	WOS:000493892900004
J	Chen, CH; Di, YQ; Shen, QY; Wang, JX; Zhao, XF				Chen, Cai-Hua; Di, Yu-Qin; Shen, Qin-Yong; Wang, Jin-Xing; Zhao, Xiao-Fan			The steroid hormone 20-hydroxyecdysone induces phosphorylation and aggregation of stromal interacting molecule 1 for store-operated calcium entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						steroid hormone; calcium intracellular release; stromal interaction molecule 1 (STIM1); G protein?coupled receptor (GPCR); protein phosphorylation; 20-hydroxyecdysone; apoptosis; insect; metamorphosis; store-operated calcium entry	DOUBLE-STRANDED-RNA; CYSTEINE PROTEINASE; STIM1; RECEPTOR; GENE; OLIGOMERIZATION; TRANSCRIPTION; ACTIVATION; EXPRESSION; APOPTOSIS	Oligomerization of stromal interacting molecule 1 (STIM1) promotes store-operated calcium entry (SOCE); however, the mechanism of STIM1 aggregation is unclear. Here, using the lepidopteran insect and agricultural pest cotton bollworm (Helicoverpa armigera) as a model and immunoblotting, RT-qPCR, RNA interference (RNAi), and ChIP assays, we found that the steroid hormone 20-hydroxyecdysone (20E) up-regulates STIM1 expression via G protein?coupled receptors (GPCRs) and the 20E nuclear receptor (EcRB1). We also identified an ecdysone-response element (EcRE) in the 5?-upstream region of the STIM1 gene and also noted that STIM1 is located in the larval midgut during metamorphosis. STIM1 knockdown in larvae delayed pupation time, prevented midgut remodeling, and decreased 20E-induced gene transcription. STIM1 knockdown in a H. armigera epidermal cell line, HaEpi, repressed 20E-induced calcium ion influx and apoptosis. Moreover, 20E-induced STIM1 clustering to puncta and translocation toward the cell membrane. Inhibitors of GPCRs, phospholipase C (PLC), and inositol trisphosphate receptor (IP3R) repressed 20E-induced STIM1 phosphorylation, and we found that two GPCRs are involved in 20E-induced STIM1 phosphorylation. 20E-induced STIM1 phosphorylation on Ser-485 through protein kinase C (PKC), and we observed that Ser-485 phosphorylation is critical for STIM1 clustering, interaction with calcium release-activated calcium channel modulator 1 (Orai1), calcium ion influx, and 20E-induced apoptosis. These results suggest that 20E up-regulates STIM1 phosphorylation for aggregation via GPCRs, followed by interaction with Orai1 to induce SOCE, thereby promoting apoptosis in the midgut during insect metamorphosis.	[Chen, Cai-Hua; Di, Yu-Qin; Shen, Qin-Yong; Wang, Jin-Xing; Zhao, Xiao-Fan] Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Qingdao 266237, Shandong, Peoples R China; [Chen, Cai-Hua] Northwest A&F Univ, Coll Plant Protect, Dept Entomol, Yangling 712100, Shaanxi, Peoples R China	Shandong University; Northwest A&F University - China	Zhao, XF (corresponding author), Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Qingdao 266237, Shandong, Peoples R China.	xfzhao@sdu.edu.cn	Wang, Jin-Xing/AAU-1514-2021; Zhao, Xiao-Fan/AGW-9886-2022	Chen, Cai-Hua/0000-0002-2900-9530; Wang, Jin-Xing/0000-0003-0283-3930	National Natural Science Foundation of China [31730083, 31572328]; Shandong Provincial Key Laboratory of Animal Cell and Development Biology [SDKLACDB-2019024]; Northwest A F University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Key Laboratory of Animal Cell and Development Biology; Northwest A F University	This work was supported by National Natural Science Foundation of China Grants 31730083 and 31572328, Shandong Provincial Key Laboratory of Animal Cell and Development Biology Grant SDKLACDB-2019024, and startup funds from Northwest A & F University. The authors declare that they have no conflicts of interest with the contents of this article. The nucleotide sequence(s) reported in this paper has been submitted to the DDBJ/GenBankTM/EBI Data Bank with accession number(s) MK910371.	Balasuriya D, 2014, FEBS LETT, V588, P2874, DOI 10.1016/j.febslet.2014.06.054; Berry PA, 2011, PROSTATE, V71, P1646, DOI 10.1002/pros.21384; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brini M, 2011, BIOFACTORS, V37, P131, DOI 10.1002/biof.163; Cai MJ, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-9; Chen CH, 2017, P NATL ACAD SCI USA, V114, pE7121, DOI 10.1073/pnas.1704999114; Chmura SJ, 2000, CLIN CANCER RES, V6, P737; Chung WC, 2005, J PHARMACOL EXP THER, V313, P191, DOI 10.1124/jpet.104.078311; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; De Smet P, 1999, CELL CALCIUM, V26, P9; Eid JP, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-104; Eylenstein A, 2012, J BIOL CHEM, V287, P2719, DOI 10.1074/jbc.M111.275925; Eylenstein A, 2011, FASEB J, V25, P2012, DOI 10.1096/fj.10-178210; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gudlur A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06816-8; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Hou L, 2011, AMINO ACIDS, V40, P953, DOI 10.1007/s00726-010-0720-2; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Jing YP, 2016, J BIOL CHEM, V291, P12771, DOI 10.1074/jbc.M115.706028; Jing YP, 2015, J BIOL CHEM, V290, P8469, DOI 10.1074/jbc.M114.622696; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Lan Q, 1999, MOL CELL BIOL, V19, P4897; Li YB, 2017, CELL CALCIUM, V68, P24, DOI 10.1016/j.ceca.2017.10.004; Li YB, 2016, INSECT BIOCHEM MOLEC, V79, P73, DOI 10.1016/j.ibmb.2016.10.004; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Liu CY, 2013, APOPTOSIS, V18, P171, DOI 10.1007/s10495-012-0784-4; Liu PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019776; Liu W, 2014, J BIOL CHEM, V289, P13026, DOI 10.1074/jbc.M113.547018; Liu W, 2014, ENDOCRINOLOGY, V155, P1738, DOI 10.1210/en.2013-2020; Liu W, 2013, BBA-GEN SUBJECTS, V1830, P5184, DOI 10.1016/j.bbagen.2013.06.037; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Manaboon M, 2009, J INSECT PHYSIOL, V55, P122, DOI 10.1016/j.jinsphys.2008.10.013; Manji SSM, 2000, BBA-PROTEIN STRUCT M, V1481, P147, DOI 10.1016/S0167-4838(00)00105-9; Melien O, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-5; Muramatsu Y, 2007, EUR J PHARMACOL, V563, P40, DOI 10.1016/j.ejphar.2007.01.060; Nogueira FCS, 2012, PROTEOMICS, V12, P2704, DOI 10.1002/pmic.201200039; PALLI SR, 1992, DEV BIOL, V150, P306, DOI 10.1016/0012-1606(92)90244-B; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Pozo-Guisado E, 2013, J CELL SCI, V126, P3170, DOI 10.1242/jcs.125054; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Shao HL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003127; Sheridan JT, 2013, J BIOL CHEM, V288, P33509, DOI 10.1074/jbc.M113.486662; Smyth JT, 2009, NAT CELL BIOL, V11, P1465, DOI 10.1038/ncb1995; Soboloff J, 2011, NAT CHEM BIOL, V7, P488, DOI 10.1038/nchembio.619; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; THOMPSON EB, 1995, CURR BIOL, V5, P730, DOI 10.1016/S0960-9822(95)00146-1; Thummel CS, 2002, GENE DEV, V16, P3113, DOI 10.1101/gad.1042102; Wang D, 2016, CELL CALCIUM, V60, P1, DOI 10.1016/j.ceca.2016.05.003; Wang D, 2015, SCI REP-UK, V5, DOI 10.1038/srep08675; Wang JL, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-76; Yang DL, 2017, BIOCHEM BIOPH RES CO, V487, P517, DOI 10.1016/j.bbrc.2017.04.047; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; YULE DI, 1992, J BIOL CHEM, V267, P13830; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zhao XF, 1998, INSECT BIOCHEM MOLEC, V28, P259, DOI 10.1016/S0965-1748(98)00015-0; Zhou YB, 2013, NAT STRUCT MOL BIOL, V20, P973, DOI 10.1038/nsmb.2625	64	6	6	4	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2019	294	41					14922	14936		10.1074/jbc.RA119.008484	http://dx.doi.org/10.1074/jbc.RA119.008484			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9JH	31413111	Green Published, hybrid			2022-12-26	WOS:000499253400008
J	Bhoopathi, P; Pradhan, AK; Bacolod, MD; Emdad, L; Sarkar, D; Das, SK; Fisher, PB				Bhoopathi, Praveen; Pradhan, Anjan K.; Bacolod, Manny D.; Emdad, Luni; Sarkar, Devanand; Das, Swadesh K.; Fisher, Paul B.			Regulation of neuroblastoma migration, invasion, and in vivo metastasis by genetic and pharmacological manipulation of MDA-9/Syntenin	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ALPHA-6-BETA-4 INTEGRIN; TUMOR INVASION; CANCER; EXPRESSION; PROLIFERATION; GLYCOPROTEIN; INHIBITION; GTPASES; TARGET	Despite multi-modality treatments, prognosis for advanced stage neuroblastoma (NB) remains challenging with residual long-term disabilities in survivors. Advanced stage NB is metastatic, which is a principal cause of cancer-related deaths. We presently document a primary role of MDA-9 in NB progression and define the molecular mechanisms by which MDA-9 promotes transformed phenotypes. NB cell lines and clinical samples display elevated MDA-9 expression and bioinformatic analysis supports an association between elevated MDA-9 and bone metastasis and poor prognosis. Genetic (shmda-9, mda9 siRNA) or pharmacological (small molecule inhibitor of protein-protein interactions; PDZ1i) blockade of MDA-9 decreases NB migration, invasion, and metastasis. Blocking mda-9 expression or disrupting MDA-9 partner protein interactions downregulates integrin alpha 6 and beta 4, diminishing Src activity and suppressing Rho-Rac-Cdc42 activity. These signaling changes inhibit cofilin and matrix metalloproteinases reducing in vitro and in vivo NB cell migration. Overexpression of integrin a6 and beta 4 rescues the invasion phenotype and increases Src activity, supporting integrins as essential regulators of MDA-9-mediated NB migration and invasion. We identify MDA-9 as a key contributor to NB pathogenesis and show that genetic or pharmacological inhibition suppresses NB pathogenesis by an integrin-mediated Src-disruption pathway.	[Bhoopathi, Praveen; Pradhan, Anjan K.; Emdad, Luni; Sarkar, Devanand; Das, Swadesh K.; Fisher, Paul B.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Sch Med, Richmond, VA 23284 USA; [Bhoopathi, Praveen; Pradhan, Anjan K.; Emdad, Luni; Sarkar, Devanand; Das, Swadesh K.; Fisher, Paul B.] Virginia Commonwealth Univ, Sch Med, VCU Inst Mol Med, Richmond, VA 23284 USA; [Bacolod, Manny D.] Weill Cornell Med Coll, New York, NY USA; [Emdad, Luni; Sarkar, Devanand; Das, Swadesh K.; Fisher, Paul B.] Virginia Commonwealth Univ, VCU Massey Canc Ctr, Sch Med, Richmond, VA 23284 USA	Virginia Commonwealth University; Virginia Commonwealth University; Cornell University; Virginia Commonwealth University	Fisher, PB (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, Sch Med, Richmond, VA 23284 USA.; Fisher, PB (corresponding author), Virginia Commonwealth Univ, Sch Med, VCU Inst Mol Med, Richmond, VA 23284 USA.; Fisher, PB (corresponding author), Virginia Commonwealth Univ, VCU Massey Canc Ctr, Sch Med, Richmond, VA 23284 USA.	paul.fisher@vcuhealth.org	Pradhan, Anjan K/O-2555-2014	Bacolod, Manny/0000-0002-2085-4877	National Foundation for Cancer Research (NFCR); NCI Cancer Center Support Grant [P30 CA016059]; VCU Institute of Molecular Medicine (VIMM); Genetics Enhancement Fund; InVaMet Therapeutics, Inc. (IVMT); NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER	National Foundation for Cancer Research (NFCR); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); VCU Institute of Molecular Medicine (VIMM); Genetics Enhancement Fund; InVaMet Therapeutics, Inc. (IVMT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The present study was supported in part by the National Foundation for Cancer Research (NFCR) (to PBF), NCI Cancer Center Support Grant to VCU Massey Cancer Center (MCC) P30 CA016059 (to PBF and DS), the VCU Institute of Molecular Medicine (VIMM) (PBF) and the Genetics Enhancement Fund (PBF, SKD, and LE). Support was also provided by a Sponsored Research Agreement from InVaMet Therapeutics, Inc. (IVMT) (SKD). PBF holds the Thelma Newmeyer Corman Chair in Cancer Research at the MCC.	Bacolod MD, 2015, ADV CANCER RES, V127, P49, DOI 10.1016/bs.acr.2015.04.006; Bhoopathi P, 2016, CANCER RES, V76, P3572, DOI 10.1158/0008-5472.CAN-15-2959; Bhoopathi P, 2011, CELL SIGNAL, V23, P1978, DOI 10.1016/j.cellsig.2011.07.008; Bolos V, 2010, ONCOTARGETS THER, V3, P83; Boukerche H, 2005, CANCER RES, V65, P10901, DOI 10.1158/0008-5472.CAN-05-1614; Boukerche H, 2008, P NATL ACAD SCI USA, V105, P15914, DOI 10.1073/pnas.0808171105; Chaturvedi NK, 2016, ONCOTARGET, V7, P15215, DOI 10.18632/oncotarget.7714; Colburn ZT, 2018, J CELL SCI, V131, DOI 10.1242/jcs.214593; Das SK, 2019, MOL CANCER THER, V18, P1997, DOI 10.1158/1535-7163.MCT-18-1019; Das SK, 2019, ADV CANCER RES, V144, P137, DOI 10.1016/bs.acr.2019.03.011; Das SK, 2019, ACS CHEM NEUROSCI, V10, P1121, DOI 10.1021/acschemneuro.9b00016; Das SK, 2018, CANCER RES, V78, P2852, DOI 10.1158/0008-5472.CAN-17-2992; Das SK, 2016, ONCOTARGET, V7, P46848, DOI 10.18632/oncotarget.10040; Das SK, 2013, CANCER RES, V73, P844, DOI 10.1158/0008-5472.CAN-12-1681; Das SK, 2012, CANCER RES, V72, P6217, DOI 10.1158/0008-5472.CAN-12-0402; Das SK, 2012, FRONT BIOSCI-LANDMRK, V17, P1, DOI 10.2741/3911; Dasgupta S, 2013, CLIN CANCER RES, V19, P4621, DOI 10.1158/1078-0432.CCR-13-0585; Dominguez-Gimenez P, 2007, J CELL SCI, V120, P1061, DOI 10.1242/jcs.03404; Guan XM, 2015, ACTA PHARM SIN B, V5, P402, DOI 10.1016/j.apsb.2015.07.005; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Kaminska K, 2015, J CELL MOL MED, V19, P283, DOI 10.1111/jcmm.12408; Kegelman TP, 2017, P NATL ACAD SCI USA, V114, P370, DOI 10.1073/pnas.1616100114; Kegelman TP, 2015, EXPERT OPIN THER TAR, V19, P97, DOI 10.1517/14728222.2014.959495; Kegelman TP, 2014, NEURO-ONCOLOGY, V16, P50, DOI 10.1093/neuonc/not157; Kramer M, 2016, J NEUROSCI, V36, P10425, DOI 10.1523/JNEUROSCI.0183-16.2016; Lee SH, 2010, MOL CELLS, V29, P311, DOI 10.1007/s10059-010-0053-8; Lin JJ, 1996, MOL CELL DIFFER, V4, P317; Lin JJ, 1998, GENE, V207, P105, DOI 10.1016/S0378-1119(97)00562-3; Melzer C, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8534371; Menezes ME, 2016, ONCOTARGET, V7, P80175, DOI 10.18632/oncotarget.13373; Mercurio AM, 2001, CURR OPIN CELL BIOL, V13, P541, DOI 10.1016/S0955-0674(00)00249-0; Meyer A, 2004, NEOPLASIA, V6, P332, DOI 10.1593/neo.03445; Miao H, 2002, J CELL SCI, V115, P2199; Morandi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029922; Nakajima S, 2004, CLIN CANCER RES, V10, P4125, DOI 10.1158/1078-0432.CCR-0578-03; O'Connor KL, 2012, AM J PHYSIOL-CELL PH, V302, pC605, DOI 10.1152/ajpcell.00095.2011; Rastogi P, 2015, INDIAN J HEMATOL BLO, V31, P57, DOI 10.1007/s12288-014-0405-1; Russell AJ, 2003, J CELL SCI, V116, P3543, DOI 10.1242/jcs.00663; Sarkar D, 2008, CANCER RES, V68, P3087, DOI 10.1158/0008-5472.CAN-07-6210; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066; Seong BKA, 2017, CANCER RES, V77, P696, DOI 10.1158/0008-5472.CAN-16-1502; Shohet J, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1863; Son H, 2010, TOX RESEARCH, V26, P245, DOI 10.5487/TR.2010.26.4.245; Stivarou T, 2015, CANCERS, V7, P238, DOI 10.3390/cancers7010238; Su ZZ, 2002, ONCOGENE, V21, P3592, DOI 10.1038/sj.onc.1205445; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221; Talukdar S, 2018, AUTOPHAGY, V14, P1845, DOI 10.1080/15548627.2018.1502564; Talukdar S, 2018, P NATL ACAD SCI USA, V115, P5768, DOI 10.1073/pnas.1721650115; Talukdar S, 2016, ONCOTARGET, V7, P54102, DOI 10.18632/oncotarget.10851; Webb AH, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3418-y; Welch DR, 2016, ADV CANCER RES, V132, P1	51	17	17	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 10	2019	38	41					6781	6793		10.1038/s41388-019-0920-5	http://dx.doi.org/10.1038/s41388-019-0920-5			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JC8UZ	31406249	Green Accepted			2022-12-26	WOS:000489552900006
J	Skrott, Z; Majera, D; Gursky, J; Buchtova, T; Hajduch, M; Mistrik, M; Bartek, J				Skrott, Zdenek; Majera, Dusana; Gursky, Jan; Buchtova, Tereza; Hajduch, Marian; Mistrik, Martin; Bartek, Jiri			Disulfiram's anti-cancer activity reflects targeting NPL4, not inhibition of aldehyde dehydrogenase	ONCOGENE			English	Article							CANCER STEM-CELLS; INITIATING CELLS; MITOCHONDRIAL; DRUG; ACETALDEHYDE; METASTASIS; METABOLISM; RESISTANCE; REVERSES; ADDUCTS	Aldehyde dehydrogenase (ALDH) is a proposed biomarker and possible target to eradicate cancer stem cells. ALDH inhibition as a treatment approach is supported by anti-cancer effects of the alcohol-abuse drug disulfiram (DSF, Antabuse). Given that metabolic products of DSF, rather than DSF itself inhibit ALDH in vivo, and that DSF's anti-cancer activity is potentiated by copper led us to investigate the relevance of ALDH as the suggested molecular cancer-relevant target of DSF. Here we show that DSF does not directly inhibit ALDH activity in diverse human cell types, while DSF's in vivo metabolite, S-methyl-N, N-diethylthiocarbamate-sulfoxide inhibits ALDH activity yet does not impair cancer cell viability. Our data indicate that the anti-cancer activity of DSF does not involve ALDH inhibition, and rather reflects the impact of DSF's copper-containing metabolite (CuET), that forms spontaneously in vivo and in cell culture media, and kills cells through aggregation of NPL4, a subunit of the p97/VCP segregase. We also show that the CuET-mediated, rather than any ALDH-inhibitory activity of DSF underlies the preferential cytotoxicity of DSF towards BRCA1-and BRCA2-deficient cells. These findings provide evidence clarifying the confusing literature about the anti-cancer mechanism of DSF, a drug currently tested in clinical trials for repositioning in oncology.	[Skrott, Zdenek; Majera, Dusana; Gursky, Jan; Buchtova, Tereza; Hajduch, Marian; Mistrik, Martin; Bartek, Jiri] Palacky Univ, Fac Med & Dent, Inst Mol & Translat Med, Olomouc, Czech Republic; [Bartek, Jiri] Danish Canc Soc Res Ctr, Copenhagen, Denmark; [Bartek, Jiri] Karolinska Inst, Dept Med Biochem & Biophys, Div Genome Biol, Sci Life Lab, Stockholm, Sweden	Palacky University Olomouc; Danish Cancer Society; Karolinska Institutet	Mistrik, M; Bartek, J (corresponding author), Palacky Univ, Fac Med & Dent, Inst Mol & Translat Med, Olomouc, Czech Republic.; Bartek, J (corresponding author), Danish Canc Soc Res Ctr, Copenhagen, Denmark.; Bartek, J (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Genome Biol, Sci Life Lab, Stockholm, Sweden.	martin.mistrik@upol.cz; jb@cancer.dk	MAJERA, Dusana/U-1079-2019; Buchtová, Tereza/GSI-5771-2022; Hajduch, Marian/J-4015-2014	Hajduch, Marian/0000-0002-4834-908X; Mistrik, Martin/0000-0002-2321-0348; Buchtova, Tereza/0000-0001-5233-1504; Skrott, Zdenek/0000-0001-6004-3609	Grant agency of Czech Rep. GACR [17-25976 S]; MEYS CR [LM2015062, DRO-61989592]; Internal grant of University of Palacky [IGA_LF_2019_026]; Cancer Research Czech Republic, Ministry of School, Education, Youth and Sports of the Czech Republic [LM2015064, CZ.02.1.01/0.0/0.0/16_019/0000868]; Novo Nordisk Foundation [16854]; Danish National Research Foundation [DNRF125]; Danish Cancer Society [R204-A12617]; Swedish Research Council [VR-MH 2014-46602-117891-30]; Swedish Cancer Society [170176]	Grant agency of Czech Rep. GACR; MEYS CR; Internal grant of University of Palacky; Cancer Research Czech Republic, Ministry of School, Education, Youth and Sports of the Czech Republic; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Cancer Society(Danish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society)	We thank Dr. M. Tarsounas (Oxford, UK) for the human H1299 cell lines with regulatable expression of shBRCA1 and shBRCA2. The study was supported by grants from: Grant agency of Czech Rep. GACR 17-25976 S, MEYS CR (LM2015062 Czech-BioImaging and DRO-61989592), Internal grant of University of Palacky IGA_LF_2019_026, Cancer Research Czech Republic, Ministry of School, Education, Youth and Sports of the Czech Republic (EATRIS-CZ No. LM2015064 and ENOCH No. CZ.02.1.01/0.0/0.0/16_019/0000868), the Novo Nordisk Foundation (no. 16854), the Danish National Research Foundation (project CARD: no. DNRF125), the Danish Cancer Society (R204-A12617) the Swedish Research Council (VR-MH 2014-46602-117891-30), and the Swedish Cancer Society (no. 170176).	Allensworth JL, 2015, MOL ONCOL, V9, P1155, DOI 10.1016/j.molonc.2015.02.007; Batlle E, 2017, NAT MED, V23, P1124, DOI 10.1038/nm.4409; Bista R, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0493-5; Brooks PJ, 2005, ALCOHOL, V35, P187, DOI 10.1016/j.alcohol.2005.03.009; Bryan N, 2011, BIOSCIENCE REP, V31, P199, DOI 10.1042/BSR20100064; Chang JS, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0327-y; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Chen D, 2006, CANCER RES, V66, P10425, DOI 10.1158/0008-5472.CAN-06-2126; Chen W, 2018, ACS APPL MATER INTER, V10, P41118, DOI 10.1021/acsami.8b14940; Choi SA, 2015, NEURO-ONCOLOGY, V17, P810, DOI 10.1093/neuonc/nou305; Duan JJ, 2016, INT J CANCER, V139, P965, DOI 10.1002/ijc.30091; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; HART BW, 1993, BIOCHEM PHARMACOL, V46, P2285, DOI 10.1016/0006-2952(93)90619-8; Huddle BC, 2018, J MED CHEM, V61, P8754, DOI 10.1021/acs.jmedchem.8b00930; Jin N, 2018, J CELL BIOCHEM, V119, P6882, DOI 10.1002/jcb.26885; Koppaka V, 2012, PHARMACOL REV, V64, P520, DOI 10.1124/pr.111.005538; Lai CL, 2014, ALCOHOL CLIN EXP RES, V38, P44, DOI 10.1111/acer.12215; Lam JP, 1997, BIOCHEMISTRY-US, V36, P13748, DOI 10.1021/bi970948e; Lipsky JJ, 2001, CHEM-BIOL INTERACT, V130, P93, DOI 10.1016/S0009-2797(00)00225-8; Liu P, 2013, BRIT J CANCER, V109, P1876, DOI 10.1038/bjc.2013.534; Liu P, 2012, BRIT J CANCER, V107, P1488, DOI 10.1038/bjc.2012.442; Liu P, 2014, ONCOTARGET, V5, P7471, DOI 10.18632/oncotarget.2166; Liu XW, 2016, ONCOTARGET, V7, P58516, DOI 10.18632/oncotarget.11305; MacDonagh L, 2017, ONCOTARGET, V8, P72544, DOI 10.18632/oncotarget.19881; Majera D, 2019, PROSTATE, V79, P352, DOI 10.1002/pros.23741; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI 10.1517/17425255.4.6.697 ; Marques DS, 2010, LEUKEMIA RES, V34, P757, DOI 10.1016/j.leukres.2009.11.004; MAYS DC, 1995, BIOCHEM PHARMACOL, V49, P693, DOI 10.1016/0006-2952(94)00504-F; Peng XY, 2019, BIOMACROMOLECULES, V20, P2372, DOI 10.1021/acs.biomac.9b00367; Pors K, 2014, DRUG DISCOV TODAY, V19, P1953, DOI 10.1016/j.drudis.2014.09.009; Raha D, 2014, CANCER RES, V74, P3579, DOI 10.1158/0008-5472.CAN-13-3456; Shen ML, 2001, BIOCHEM PHARMACOL, V61, P537, DOI 10.1016/S0006-2952(00)00586-4; Skrott Z, 2017, NATURE, V552, P194, DOI 10.1038/nature25016; Suh JJ, 2006, J CLIN PSYCHOPHARM, V26, P290, DOI 10.1097/01.jcp.0000222512.25649.08; Tacconi EMC, 2017, EMBO MOL MED, V9, P1398, DOI 10.15252/emmm.201607446; Tirino V, 2013, FASEB J, V27, P13, DOI 10.1096/fj.12-218222; van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806; Wang NN, 2018, EXP CELL RES, V362, P72, DOI 10.1016/j.yexcr.2017.11.004; Wu L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-35619-6; Yip NC, 2011, BRIT J CANCER, V104, P1564, DOI 10.1038/bjc.2011.126; YOURICK JJ, 1991, BIOCHEM PHARMACOL, V42, P1361, DOI 10.1016/0006-2952(91)90446-C; Zhou L, 2019, CELL BIOL TOXICOL, V35, P161, DOI 10.1007/s10565-018-9444-y	43	41	41	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 3	2019	38	40					6711	6722		10.1038/s41388-019-0915-2	http://dx.doi.org/10.1038/s41388-019-0915-2			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JC0EY	31391554				2022-12-26	WOS:000488953500005
J	Elsner, DJ; Siess, KM; Gossenreiter, T; Hartl, M; Leonard, TA				Elsner, Daniel J.; Siess, Katharina M.; Gossenreiter, Thomas; Hartl, Markus; Leonard, Thomas A.			A ubiquitin-like domain controls protein kinase D dimerization and activation by trans-autophosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein kinase D (PKD); autophosphorylation; signal transduction; diacylglycerol; dimerization; crystal structure; ubiquitin-like domain; second messenger; structural biology	G(Q)-COUPLED RECEPTORS; LOOP SER(744); PKD; DIACYLGLYCEROL; MECHANISM; CHK2; PHOSPHORYLATION; RECRUITMENT; SCATTERING; MUTATIONS	Protein kinase D (PKD) is an essential Ser/Thr kinase in animals and controls a variety of diverse cellular functions, including vesicle trafficking and mitogenesis. PKD is activated by recruitment to membranes containing the lipid second messenger diacylglycerol (DAG) and subsequent phosphorylation of its activation loop. Here, we report the crystal structure of the PKD N terminus at 2.2 ? resolution containing a previously unannotated ubiquitin-like domain (ULD), which serves as a dimerization domain. A single point mutation in the dimerization interface of the ULD not only abrogated dimerization in cells but also prevented PKD activation loop phosphorylation upon DAG production. We further show that the kinase domain of PKD dimerizes in a concentration-dependent manner and autophosphorylates on a single residue in its activation loop. We also provide evidence that PKD is expressed at concentrations 2 orders of magnitude below the ULD dissociation constant in mammalian cells. We therefore propose a new model for PKD activation in which the production of DAG leads to the local accumulation of PKD at the membrane, which drives ULD-mediated dimerization and subsequent trans-autophosphorylation of the kinase domain.	[Elsner, Daniel J.; Siess, Katharina M.; Leonard, Thomas A.] Max Perutz Labs, Dept Struct & Computat Biol, Campus Vienna Bioctr 5, A-1030 Vienna, Austria; [Gossenreiter, Thomas; Hartl, Markus] Max Perutz Labs, Mass Spectrometry Facil, Dr Bohr Gasse 3, A-1030 Vienna, Austria; [Hartl, Markus] Univ Vienna, Vienna Bioctr, Dept Biochem & Cell Biol, Max Perutz Labs, Dr Bohr Gasse 9, A-1030 Vienna, Austria; [Elsner, Daniel J.; Siess, Katharina M.; Leonard, Thomas A.] Med Univ Vienna, Dept Med Biochem, A-1090 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna	Leonard, TA (corresponding author), Max Perutz Labs, Dept Struct & Computat Biol, Campus Vienna Bioctr 5, A-1030 Vienna, Austria.; Leonard, TA (corresponding author), Med Univ Vienna, Dept Med Biochem, A-1090 Vienna, Austria.	thomas.leonard@meduniwien.ac.at	Hartl, Markus/F-2866-2010; Leonard, Thomas/A-5143-2013	Hartl, Markus/0000-0002-4970-7336; Leonard, Thomas/0000-0001-6853-666X; Gossenreiter, Thomas/0000-0002-2935-4078	Max Perutz Labs junior group leader start-up package; Austrian Science Fund (FWF) [P28135, P30584]	Max Perutz Labs junior group leader start-up package; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by a Max Perutz Labs junior group leader start-up package (to T. A. L.) and by Austrian Science Fund (FWF) Grants P28135 and P30584 (to T. A. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahn JY, 2002, J BIOL CHEM, V277, P19389, DOI 10.1074/jbc.M200822200; Aicart-Ramos C, 2016, J BIOL CHEM, V291, P23516, DOI 10.1074/jbc.M116.735399; Bard F, 2006, ANNU REV CELL DEV BI, V22, P439, DOI 10.1146/annurev.cellbio.21.012704.133126; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Bossard C, 2007, J CELL BIOL, V179, P1123, DOI 10.1083/jcb.200703166; Cai Z, 2009, MOL CELL, V35, P818, DOI 10.1016/j.molcel.2009.09.007; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Durand N, 2015, CELL MOL LIFE SCI, V72, P4369, DOI 10.1007/s00018-015-2011-2; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; Gehart H, 2012, DEV CELL, V23, P756, DOI 10.1016/j.devcel.2012.07.019; Goginashvili A, 2015, SCIENCE, V347, P878, DOI 10.1126/science.aaa2628; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Iglesias T, 1999, FEBS LETT, V454, P53, DOI 10.1016/S0014-5793(99)00772-3; Iglesias T, 1998, J BIOL CHEM, V273, P410, DOI 10.1074/jbc.273.1.410; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Jacamo R, 2008, J BIOL CHEM, V283, P12877, DOI 10.1074/jbc.M800442200; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; LUI I, 2016, J MOL BIOL, V428, P121, DOI DOI 10.1016/j.jmb.2015.11.001; Maeda Y, 2001, EMBO J, V20, P5982, DOI 10.1093/emboj/20.21.5982; Matthews SA, 2000, EMBO J, V19, P2935, DOI 10.1093/emboj/19.12.2935; Matthews SA, 1997, J BIOL CHEM, V272, P20245, DOI 10.1074/jbc.272.32.20245; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Oancea E, 2003, DEV CELL, V4, P561, DOI 10.1016/S1534-5807(03)00087-X; Oliver AW, 2007, TRENDS BIOCHEM SCI, V32, P351, DOI 10.1016/j.tibs.2007.06.004; Oliver AW, 2006, EMBO J, V25, P3179, DOI 10.1038/sj.emboj.7601209; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Rybin VO, 2012, J BIOL CHEM, V287, P22609, DOI 10.1074/jbc.M112.379719; Rybin VO, 2009, J BIOL CHEM, V284, P2332, DOI 10.1074/jbc.M806381200; Sinnett-Smith J, 2009, J BIOL CHEM, V284, P13434, DOI 10.1074/jbc.M806554200; Spitaler M, 2006, IMMUNITY, V24, P535, DOI 10.1016/j.immuni.2006.02.013; Sumara G, 2009, CELL, V136, P235, DOI 10.1016/j.cell.2008.11.018; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Theile CS, 2013, NAT PROTOC, V8, P1800, DOI 10.1038/nprot.2013.102; Van Lint J, 1998, J BIOL CHEM, V273, P7038, DOI 10.1074/jbc.273.12.7038; VANLINT J, 1995, J BIOL CHEM, V270, P1455, DOI 10.1074/jbc.270.3.1455; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; Wang P, 2014, P NATL ACAD SCI USA, V111, P7683, DOI 10.1073/pnas.1310972111; Weinreb I, 2014, NAT GENET, V46, P1166, DOI 10.1038/ng.3096; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X; Zhang ZR, 2017, J EXP MED, V214, P2671, DOI 10.1084/jem.20162040; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x	48	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2019	294	39					14422	14441		10.1074/jbc.RA119.008713	http://dx.doi.org/10.1074/jbc.RA119.008713			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HH	31406020	Green Published, hybrid			2022-12-26	WOS:000499248200022
J	Kim, TJ; Makowski, AC; Knesebeck, OV				Kim, Tae Jun; Makowski, Anna Christin; Knesebeck, Olaf von dem			Obesity stigma in Germany and the United States - Results of population surveys	PLOS ONE			English	Article							WEIGHT STIGMA; OVERWEIGHT; BIAS; DISCRIMINATION; ASSOCIATIONS; ADULTS; IMPACT	Introduction Over the past decades, obesity stigma has become a substantial public health issue as studies have highlighted its negative consequences for mental and physical health. However, comparative studies are scarce. In this cross-national study, we focus on the following research questions: (1) Are there differences in the magnitude of public obesity stigma between Germany and the United States (US), and (2) are there differences in the associations of sociodemographic as well as experience (i.e. former obesity experience) and contact-related (i.e. contact to a person with obesity) factors with public obesity stigma between these two countries? Material and methods National telephone surveys in Germany and the United States were conducted (total sample = 2,802) by using vignettes for the description of a person with obesity. Fat Phobia Scale, negative reactions, and desire for social distance were assessed as components of public obesity stigma. All three stigma components were examined with multilevel linear regression analyses. Results Overall, results show that public obesity stigma is significantly more pronounced in the US than in Germany. Relationships between obesity stigma and sociodemographic as well as experience and contact-related factors remain rather inconclusive, though, in general, stronger associations are shown in the US. Conclusions Contrary to the normalization hypothesis, findings indicate that a comparatively high prevalence of obesity like in the US is associated with a higher level of obesity stigma.	[Kim, Tae Jun; Makowski, Anna Christin; Knesebeck, Olaf von dem] Univ Med Ctr Hamburg Eppendorf, Dept Med Sociol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Kim, TJ (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Sociol, Hamburg, Germany.	t.kim@uke.de		von dem Knesebeck, Olaf/0000-0001-6310-5879	Volkswagen Foundation	Volkswagen Foundation(Volkswagen)	This study is part of the joint research project 'Nutrition, Health and Modern Society: Germany and the USA' and is funded by the Volkswagen Foundation to OK. The funder had no role in the design or outcomes of the study. Website: https://www.volkswagenstiftung.de/.	Allport G. W., 1954, NATURE PREJUDICE; Angermeyer MC, 2010, EPIDEMIOL PSICHIAT S, V19, P26, DOI 10.1017/S1121189X00001573; Bacon JG, 2001, INT J OBESITY, V25, P252, DOI 10.1038/sj.ijo.0801537; Bogardus ES, 1925, J APPL SOCIOL, V9, P299; Boswell Rebecca G, 2015, Adv Eat Disord, V3, P259; Burke MA, 2018, JAMA-J AM MED ASSOC, V319, P221, DOI 10.1001/jama.2017.18947; Durso LE, 2012, INT J EAT DISORDER, V45, P423, DOI 10.1002/eat.20933; Federal Statistical Office, 2016, STAT JB 2016 DEUTSCH; Finkelstein EA, 2005, ANNU REV PUBL HEALTH, V26, P1500; Jackson SE, 2016, OBES EAT DISORD, V2, P1, DOI [10.4172/2471-8203.100006, DOI 10.4172/2471-8203.100006]; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Latner JD, 2005, OBES RES, V13, P1226, DOI 10.1038/oby.2005.145; Lee YS, 2009, ANN ACAD MED SINGAP, V38, P45; Lieberman DL, 2012, OBESITY, V20, P1803, DOI 10.1038/oby.2011.247; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Marini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083543; Nutter S, 2016, J OBES, V2016, DOI 10.1155/2016/3753650; Organisation for Economic Co-operation and Development, 1999, CLASS ED PROGR MAN I; Papadopoulos S, 2015, OBESITY, V23, P1743, DOI 10.1002/oby.21187; Pearl RL, 2012, HEALTH PSYCHOL, V31, P821, DOI 10.1037/a0027189; Perusse L, 2000, AM J CLIN NUTR, V72, p1285S, DOI 10.1093/ajcn/72.5.1285s; Puhl R, 2001, OBES RES, V9, P788, DOI 10.1038/oby.2001.108; Puhl Rebecca, 2003, Eat Behav, V4, P53, DOI 10.1016/S1471-0153(02)00096-X; Puhl R, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0552-6; Puhl RM, 2006, OBESITY, V14, P1802, DOI 10.1038/oby.2006.208; Puhl RM, 2010, AM J PUBLIC HEALTH, V100, P1019, DOI 10.2105/AJPH.2009.159491; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Roehling MV, 1999, PERS PSYCHOL, V52, P969, DOI 10.1111/j.1744-6570.1999.tb00186.x; Sikorski C, 2015, OBESITY, V23, P266, DOI 10.1002/oby.20952; Sikorski C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046924; Sikorski C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039325; Statistisches Bundesamt, 2016, BILD BEV; Stein J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114641; Tiggemann Marika, 2004, Body Image, V1, P29, DOI 10.1016/S1740-1445(03)00002-0; Tomiyama AJ, 2014, HEALTH PSYCHOL, V33, P862, DOI 10.1037/hea0000107; United States Census Bureau, 2016, AG SEX AM COMM SURV; United States Census Bureau, 2016, ED ATT POP 18 YEARS; United States Census Bureau, 2015, POP EST AM COMM SURV; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; Washington RL, 2011, PREV CHRONIC DIS, V8; Wu YK, 2018, J ADV NURS, V74, P1030, DOI 10.1111/jan.13511	41	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0221214	10.1371/journal.pone.0221214	http://dx.doi.org/10.1371/journal.pone.0221214			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5OC	31430315	gold, Green Submitted, Green Published			2022-12-26	WOS:000485026800034
J	Lartey, ST; Magnussen, CG; Si, L; Boateng, GO; de Graaff, B; Biritwum, RB; Minicuci, N; Kowal, P; Blizzard, L; Palmer, AJ				Lartey, Stella T.; Magnussen, Costan G.; Si, Lei; Boateng, Godfred O.; de Graaff, Barbara; Biritwum, Richard Berko; Minicuci, Nadia; Kowal, Paul; Blizzard, Leigh; Palmer, Andrew J.			Rapidly increasing prevalence of overweight and obesity in older Ghanaian adults from 2007-2015: Evidence from WHO-SAGE Waves 1&2	PLOS ONE			English	Article							BODY-MASS INDEX; CARDIOMETABOLIC RISK; WAIST CIRCUMFERENCE; WEIGHT MANAGEMENT; HEALTH; AFRICA; INCOME; WOMEN; TIME	Background Studies on changes in the prevalence and determinants of obesity in older adults living in sub-Saharan Africa are scarce. We examined recent changes in obesity prevalence and associated factors for older adults in Ghana between 2007/08 and 2014/15. Methods Data on adults aged 50 years and older in Ghana were drawn from the WHO SAGE 2007/08 (Wave 1; n = 4158) and 2014/15 (Wave 2; n = 1663). The weighted prevalence of obesity, overweight, normal weight and underweight, and of high central adiposity were compared in 2007/08 and 2014/15. Multinomial and binomial logistic regressions were used to examine whether the determinants of weight status based on objectively measured body mass index and waist circumference changed between the two time periods. Results The prevalence of overweight (2007/08 = 19.6%, 95% CI: 18.0-21.4%; 2014/15 = 24.5%, 95% CI: 21.7-27.5%) and obesity (2007/08 = 10.2%, 95% CI: 8.9-11.7%; 2014/15 = 15.0%, 95% CI: 12.6-17.7%) was higher in 2014/15 than 2007/08 and more than half of the population had high central adiposity (2007/08 = 57.7%, 95% CI: 55.4-60.1%; 2014/15 = 66.9%, 95% CI: 63.7-70.0%) in both study periods. While the prevalence of overweight increased in both sexes, obesity prevalence was 16% lower in males and 55% higher in females comparing 2007/08 to 2014/15. Female sex, urban residence, and high household wealth were associated with higher odds of overweight/obesity and high central adiposity. Those aged 70+ years had lower odds of obesity in both study waves. In 2014/15, females who did not meet the recommended physical activity were more likely to be obese. Conclusion Over the 7-year period between the surveys, the prevalence of underweight decreased and overweight increased in both sexes, while obesity decreased in males but increased in females. The difference in obesity prevalence may point to differential impacts of past initiatives to reduce overweight and obesity, potential high-risk groups in Ghana, and the need to increase surveillance.	[Lartey, Stella T.; Magnussen, Costan G.; Si, Lei; de Graaff, Barbara; Blizzard, Leigh; Palmer, Andrew J.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Magnussen, Costan G.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Si, Lei] Univ New South Wales, George Inst Global Hlth, Kensington, NSW, Australia; [Boateng, Godfred O.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Biritwum, Richard Berko] Univ Ghana, Dept Community Hlth, Accra, Ghana; [Minicuci, Nadia] CNR, Neurosci Inst, Padua, Italy; [Kowal, Paul] WHO, Geneva, Switzerland; [Kowal, Paul] Univ Newcastle, Res Ctr Generat Hlth & Ageing, Newcastle, NSW, Australia; [Palmer, Andrew J.] Univ Melbourne, Sch Populat & Global Hlth, Ctr Hlth Policy, Melbourne, Vic, Australia	University of Tasmania; Menzies Institute for Medical Research; University of Turku; George Institute for Global Health; University of New South Wales Sydney; University of Sydney; Harvard University; Harvard T.H. Chan School of Public Health; University of Ghana; Consiglio Nazionale delle Ricerche (CNR); World Health Organization; University of Newcastle; University of Melbourne	Palmer, AJ (corresponding author), Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia.; Palmer, AJ (corresponding author), Univ Melbourne, Sch Populat & Global Hlth, Ctr Hlth Policy, Melbourne, Vic, Australia.	Andrew.Palmer@utas.edu.au	Magnussen, Costan/AAA-8260-2020; Boateng, Godfred Odei/AAB-8341-2020; Lartey, Stella T/ABA-8491-2020; MINICUCI, NADIA/D-5237-2016; Si, Lei/AAM-3218-2020; Magnussen, Costan/J-7177-2014; Palmer, Andrew/J-7289-2014	Boateng, Godfred Odei/0000-0001-5898-6966; MINICUCI, NADIA/0000-0002-0970-6531; Si, Lei/0000-0002-3044-170X; Magnussen, Costan/0000-0002-6238-5730; Kowal, Paul/0000-0002-6314-8753; Palmer, Andrew/0000-0002-9703-7891; Lartey, Stella Twumwaa/0000-0001-9519-7886				Abubakari AR, 2008, OBES REV, V9, P297, DOI 10.1111/j.1467-789X.2007.00462.x; Adeboye B, 2012, CARDIOVASC J AFR, V23, P512, DOI 10.5830/CVJA-2012-040; Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; Agyemang C, 2015, METABOLIC SYNDROME, P1; Australian National Preventive Health Agency, 2014, OB PREV TRENDS AUSTR; Baldwin W, 2015, BURDEN NONCOMMUNICAB; Biritwum R, 2013, STUDY GLOBAL AGEING; Boatemaa S, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5336-6; Boateng GO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186947; Brody J., 2002, NUTR BYTES, V8, P1; CAPLAN LS, 1995, PREV MED, V24, P553, DOI 10.1006/pmed.1995.1088; Case A, 2009, ECON HUM BIOL, V7, P271, DOI 10.1016/j.ehb.2009.07.002; Chen TA, 2016, PEDIATR OBES, V11, P88, DOI 10.1111/ijpo.12025; Cois Annibale, 2015, BMC Obes, V2, P42, DOI 10.1186/s40608-015-0072-2; Coreil J., 2001, SOCIAL BEHAV FDNS PU, V1st ed.; Courtemanche C, 2018, J HEALTH ECON, V57, P31, DOI 10.1016/j.jhealeco.2017.10.006; Dare S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123579; Dosu GS., 2014, ELDERLY CARE GHANA; Ekoru K, 2018, INT J OBESITY, V42, P487, DOI 10.1038/ijo.2017.240; Felix HC, 2013, AM J HEALTH PROMOT, V27, P191, DOI 10.4278/ajhp.110617-LIT-259; Finkelstein EA, 2010, OBESITY, V18, P333, DOI 10.1038/oby.2009.253; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Fryar CD, 2016, PREVALENCE OVERWEIGH; Ghana Statistical Service (GSS) Ghana Health Service (GHS) ICF International, 2015, DEM HLTH SURV 2014; Goettler A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014632; Hosseinpoor AR, 2012, BMC PUBLIC HEALTH, V12, DOI [10.1186/1471-2458-12-198, 10.1186/1471-2458-12-912]; Howe LD, 2009, J EPIDEMIOL COMMUN H, V63, P871, DOI 10.1136/jech.2009.088021; Keating CL, 2013, OBESITY, V21, P652, DOI 10.1002/oby.20290; Kent S, 2017, LANCET PUBLIC HEALTH, V2, pE214, DOI 10.1016/S2468-2667(17)30062-2; Klein S, 2007, OBESITY, V15, P1061, DOI 10.1038/oby.2007.632; Klimentidis YC, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00089; Kortt MA, 2005, QUAL LIFE RES, V14, P2177, DOI 10.1007/s11136-005-8027-6; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Lartey ST, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208491; Lehnert T, 2013, BEST PRACT RES CL EN, V27, P105, DOI 10.1016/j.beem.2013.01.002; Low S, 2009, ANN ACAD MED SINGAP, V38, P57; Lowe A., 2017, CREATING OPPORTUNITI; Lung T, 2019, INT J OBESITY, V43, P782, DOI 10.1038/s41366-018-0210-2; Mendez M. A., 2004, eJADE - Electronic Journal of Agricultural and Development Economics, V1, P220; Mendis S, 2014, GLOBAL STATUS REPORT; Ministry of Health, 2012, STRAT MAN PREV CONTR; Neuman M, 2011, AM J CLIN NUTR, V94, P1348, DOI 10.3945/ajcn.111.018127; Ofori-Asenso R, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3901-4; Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008; Philipson TJ, 2003, PERSPECT BIOL MED, V46, pS87; Pickering RP, 2011, J CLIN PSYCHIAT, V72, P1494, DOI 10.4088/JCP.10m06077gry; Rutstein S.O., 2014, MAKING DEMOGRAPHIC H; Sartorius B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130218; Scott A, 2013, HEALTH PROMOT INT, V28, P4, DOI 10.1093/heapro/das038; Singh GP, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064893, 10.1371/journal.pone.0065174]; Slagter SN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140599; Subramanian SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018962; Sweeney S, 2018, SOC SCI MED, V215, P7, DOI 10.1016/j.socscimed.2018.08.041; Teixeira PJ, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0323-6; Tenkorang EY, 2016, HEALTH EDUC BEHAV, V43, p25S, DOI 10.1177/1090198115602675; The World Bank Group, 2015, RIS CIT GHAN TIM ACT; Tremmel M, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040435; UK Data Service, 2015, AN CHANG TIM REP CRO; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WHO, 2003, WHO TECH REP SER, V916, P1; WHO,, 2014, GLOBAL PHYS ACTIVITY; Wiklund P, 2016, J SPORT HEALTH SCI, V5, P151, DOI 10.1016/j.jshs.2016.04.001; World Health Organization, GLOB PHYS ACT QUEST; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454; World Health Organization, 2006, WHO SAGE SURV MAN; World Health Organization-WHO, 2014, GHAN COUNTR ASS REP; Yankson Paul W.K., 2012, MOBILE CITY ACCRA UR	68	20	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0215045	10.1371/journal.pone.0215045	http://dx.doi.org/10.1371/journal.pone.0215045			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5MK	31425568	gold, Green Accepted, Green Published			2022-12-26	WOS:000485022400005
J	Ma, ZB; Zhang, J; Xu, XR; Qu, YL; Dong, H; Dang, J; Huo, ZH; Xu, GX				Ma, Zhanbing; Zhang, Jing; Xu, Xiangrong; Qu, Yuliang; Dong, Hui; Dang, Jie; Huo, Zhenghao; Xu, Guangxian			LncRNA expression profile during autophagy and Malat1 function in macrophages	PLOS ONE			English	Article							LONG NONCODING RNA; INJURY; PROLIFERATION; REGULATORS; MECHANISM; MIR-30A; CELLS; DNA	Long noncoding RNAs (lncRNAs) are a class of functional non-coding transcripts that are longer than 200 nt and regulate gene expression via diverse mechanisms in eukaryotes. In fact, they have emerged as critical epigenetic and transcriptional regulators of autophagy in mammals in response to various stressors. Autophagy not only plays a crucial role in maintaining cellular homeostasis, but it is also essential to immunity, targets intracellular pathogens for degradation, modulates inflammation, and participates in adaptive immune responses. However, the expression profile of lncRNA and its role in regulating autophagy in macrophages have been poorly defined. Here, we used transcriptomic and bioinformatics to analysis LncRNA expression profile during autophagy and functional studies to evaluate the function of the metastasis-associated lung adenocarcinoma transcript-1 (Malat1) lncRNA in macrophages. A total of 1112 putative lncRNAs (240 novel lncRNAs) were identified, including 831 large intergenic, 129 intronic, and 152 anti-sense lncRNA, of which 59 differentially expressed transcripts exhibited a greater than 1.5-fold change under different conditions. The interaction of Malat1 lncRNA with microRNA (mir)-23-3p and lysosomal-associated membrane protein 1 (Lamp1) was found, Malat1 releases inhibition of Lamp1 expression in macrophages through competitive adsorption of mir-23-3p. The results of this study provide a better understanding of IncRNA function in macrophages and a basis for further investigation into the roles and mechanisms of ncRNA in immunology, particularly the functions of Malat1 and mir-23-3p in the pathogenesis of macrophages.	[Ma, Zhanbing; Xu, Guangxian] Ningxia Med Univ, Gen Hosp, Ningxia Key Lab Clin & Pathogen Microbiol, Yinchuan, Peoples R China; [Ma, Zhanbing; Zhang, Jing; Dang, Jie; Huo, Zhenghao] Ningxia Med Univ, Coll Basic Med, Dept Med Genet & Cell Biol, Yinchuan, Peoples R China; [Ma, Zhanbing; Zhang, Jing; Dong, Hui; Dang, Jie; Huo, Zhenghao] Ningxia Med Univ, Minist Educ, Key Lab Fertil Preservat & Maintenance, Yinchuan, Peoples R China; [Xu, Xiangrong; Qu, Yuliang; Xu, Guangxian] Ningxia Med Univ, Coll Clin Med, Dept Med Lab, Yinchuan, Peoples R China	Ningxia Medical University; Ningxia Medical University; Ningxia Medical University; Ningxia Medical University	Xu, GX (corresponding author), Ningxia Med Univ, Gen Hosp, Ningxia Key Lab Clin & Pathogen Microbiol, Yinchuan, Peoples R China.; Huo, ZH (corresponding author), Ningxia Med Univ, Coll Basic Med, Dept Med Genet & Cell Biol, Yinchuan, Peoples R China.; Huo, ZH (corresponding author), Ningxia Med Univ, Minist Educ, Key Lab Fertil Preservat & Maintenance, Yinchuan, Peoples R China.; Xu, GX (corresponding author), Ningxia Med Univ, Coll Clin Med, Dept Med Lab, Yinchuan, Peoples R China.	huozhh@163.com; xuguangxian@nxmu.edu.cn		Zhanbing, Ma/0000-0002-8392-3008	National Natural Science Foundation of China [81860355]; Ningxia Scientific and technological innovation leader training project [KJT2015020]; First-class Discipline construction of clinical medicine of Ningxia Medical University [NXYLXUK2017A05]; Natural Science Foundation of Ningxia Province of China [2018AAC03088]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ningxia Scientific and technological innovation leader training project; First-class Discipline construction of clinical medicine of Ningxia Medical University; Natural Science Foundation of Ningxia Province of China	This work was supported by grants from the National Natural Science Foundation of China (81860355), 2015 Ningxia Scientific and technological innovation leader training project (KJT2015020), First-class Discipline construction of clinical medicine of Ningxia Medical University (NXYLXUK2017A05) and Natural Science Foundation of Ningxia Province of China (2018AAC03088).	Adelman K, 2017, NATURE, V543, P183, DOI 10.1038/543183a; Alessandrini F, 2017, SEMIN ONCOL, V44, P239, DOI 10.1053/j.seminoncol.2017.10.013; An Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.123; [Anonymous], 2018, NAT CELL BIOL, V20, P223, DOI 10.1038/s41556-018-0061-z; Aredia F, 2017, FUTURE MED CHEM, V9, P25, DOI 10.4155/fmc-2016-0173; Atianand MK, 2017, ANNU REV IMMUNOL, V35, P177, DOI 10.1146/annurev-immunol-041015-055459; Backofen R, 2018, METHODS MOL BIOL, V1704, P363, DOI 10.1007/978-1-4939-7463-4_14; Bernardes D.J.B., 2018, NAT COMMUN, V9, P94, DOI DOI 10.1038/s41467-017-01921-6; Bustin SA, 2017, CLIN CHEM, V63, P1537, DOI 10.1373/clinchem.2016.268953; Chekanova JA, 2015, CURR OPIN PLANT BIOL, V27, P207, DOI 10.1016/j.pbi.2015.08.003; Chen Z, 2015, JPN J INFECT DIS, V68, P420, DOI 10.7883/yoken.JJID.2014.466; Cohen-Dvashi H, 2016, J VIROL, V90, P10329, DOI 10.1128/JVI.01624-16; Cohen-Dvashi H, 2015, J VIROL, V89, P7584, DOI 10.1128/JVI.00651-15; Cui HC, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124522; Du Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10982; Duval M, 2017, SEMIN CELL DEV BIOL, V65, P11, DOI 10.1016/j.semcdb.2016.06.016; Dykes IM, 2017, GENOM PROTEOM BIOINF, V15, P177, DOI 10.1016/j.gpb.2016.12.005; Eissmann M, 2012, RNA BIOL, V9, P1076, DOI 10.4161/rna.21089; Elkon R, 2017, NAT BIOTECHNOL, V35, P732, DOI 10.1038/nbt.3863; Fang SS, 2018, NUCLEIC ACIDS RES, V46, pD308, DOI 10.1093/nar/gkx1107; Frankel LB, 2017, AUTOPHAGY, V13, P3, DOI 10.1080/15548627.2016.1222992; Fu ZQ, 2017, BIOCHEM BIOPH RES CO, V492, P480, DOI 10.1016/j.bbrc.2017.08.070; Gaiti F, 2015, MOL BIOL EVOL, V32, P2367, DOI 10.1093/molbev/msv117; Gao XX, 2018, BMC GENET, V19, DOI 10.1186/s12863-018-0608-9; Golicz AA, 2018, PLANT PHYSIOL, V176, P2133, DOI 10.1104/pp.17.01657; Guo D, 2017, CELL PHYSIOL BIOCHEM, V43, P182, DOI 10.1159/000480337; Hu XM, 2018, ARCH VIROL, V163, P639, DOI 10.1007/s00705-017-3659-8; Hu YR, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0743-3; Huang J, 2018, J CELL BIOCHEM, V119, P3853, DOI 10.1002/jcb.26464; Ilott NE, 2013, METHODS, V63, P50, DOI 10.1016/j.ymeth.2013.03.019; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kotzin JJ, 2017, SCIENCE, V358, P993, DOI 10.1126/science.aar2300; Kuballa P, 2012, ANNU REV IMMUNOL, V30, P611, DOI 10.1146/annurev-immunol-020711-074948; Kugelberg E, 2014, NAT REV IMMUNOL, V14, P779; Li JW, 2015, BRIEF BIOINFORM, V16, P806, DOI 10.1093/bib/bbu048; Li L, 2016, MOL CANCER THER, V15, P2232, DOI 10.1158/1535-7163.MCT-16-0008; Li S, 2019, J CELL BIOCHEM, V120, P4092, DOI 10.1002/jcb.27694; Li ZJ, 2017, NEUROSCIENCE, V354, P1, DOI 10.1016/j.neuroscience.2017.04.017; Lu ZP, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0356; Luo HT, 2017, BRIEF BIOINFORM, V18, P789, DOI 10.1093/bib/bbw046; Ma XY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1881-x; Mao AP, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1270-5; Mondal T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8743; Murphy MB, 2016, J LEUKOCYTE BIOL, V99, P839, DOI 10.1189/jlb.2RU1215-575R; Noack F, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00085; Pawar K, 2016, SCI REP-UK, V6, DOI 10.1038/srep19416; Redis RS, 2017, CELL METAB, V25, P220, DOI 10.1016/j.cmet.2016.12.012; Schmitt AM, 2016, NAT GENET, V48, P1370, DOI 10.1038/ng.3673; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun QY, 2018, TRENDS GENET, V34, P142, DOI 10.1016/j.tig.2017.11.005; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Thomson DW, 2016, NAT REV GENET, V17, P272, DOI 10.1038/nrg.2016.20; Uchida Shizuka, 2017, High Throughput, V6, DOI 10.3390/ht6030012; Yan WW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11904-8; Yang LX, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.464; Yang XF, 2016, SCI REP-UK, V6, DOI 10.1038/srep38963; Yu XH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14016; Zhang J, 2017, AUTOPHAGY, V13, P1004, DOI 10.1080/15548627.2017.1312041; Zhang L, 2017, HEPATOLOGY, V65, P604, DOI 10.1002/hep.28882; Zhao ZS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7212; Zhou HJ, 2018, AM J PHYSIOL-CELL PH, V315, pC52, DOI 10.1152/ajpcell.00278.2017; Zur Bruegge J, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00095	65	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2019	14	8							e0221104	10.1371/journal.pone.0221104	http://dx.doi.org/10.1371/journal.pone.0221104			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5MK	31425535	Green Published, gold, Green Submitted			2022-12-26	WOS:000485022400027
J	Peixoto, LAW; Ohara, WM				Wanderley Peixoto, Luiz Antonio; Ohara, Willian M.			A new species of Eigenmannia Jordan & Evermann (Gymnotiformes: Sternopygidae) from rio Tapajos, Brazil, with discussion on its species group and the myology within Eigenmanniinae	PLOS ONE			English	Article							ELECTROSENSORY NERVOUS-SYSTEM; ELECTRIC KNIFEFISHES; FISHES OSTEICHTHYES; COMPARATIVE ANATOMY; GENUS; TELEOSTEI; BASIN; REDESCRIPTION; MORPHOLOGY; EVOLUTION	A new species of Eigenmannia is described from the rio Mutum, tributary of upper rio Juruena, rio Tapajos basin, Comodoro, Mato Grosso, Brazil. The new species is distinguished from all congeners by coloration pattern, position of the mouth, number of scales rows above lateral line, number of premaxillary and dentary teeth, number of precaudal vertebrae, orbital diameter, mouth width, relative depth of posterodorsal expansion on infra orbitals 1+2 and relative size of coronomeckelian bone. Comments on potentially useful characters in phylogenetic studies derived from musculature, discussion on Eigenmannia species-group and the first dichotomous key for Eigenmannia are provided.	[Wanderley Peixoto, Luiz Antonio; Ohara, Willian M.] Univ Sao Paulo, Museu Zool, Secao Peixes, Sao Paulo, SP, Brazil; [Ohara, Willian M.] Univ Fed Rondonia, Dept Engn Pesca, Presidente Medici, Rondonia, Brazil	Universidade de Sao Paulo; Universidade Federal de Rondonia	Peixoto, LAW (corresponding author), Univ Sao Paulo, Museu Zool, Secao Peixes, Sao Paulo, SP, Brazil.	luizwp@yahoo.com.br			FAPESP [2018/05084-1, 2013/22473-8]; Diversity and Evolution of Gymnotiformes Project (FAPESP/Smithsonian) [2016/19075-9]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Diversity and Evolution of Gymnotiformes Project (FAPESP/Smithsonian)	Authors were financially supported by FAPESP (LAWP process #2018/05084-1; WMO process #2013/22473-8). This contribution was also supported by the Diversity and Evolution of Gymnotiformes Project (FAPESP/Smithsonian proc. 2016/19075-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera O., 1986, Acta Biologica Venezuelica, V12, P13; Aguilera S. Orangel, 1993, Acta Biologica Venezuelica, V14, P21; Albert JS, 2007, J VERTEBR PALEONTOL, V27, P17, DOI 10.1671/0272-4634(2007)27[17:PROFNE]2.0.CO;2; Albert James S., 1998, P419; Albert JS, 1998, EVOLUTION, V52, P1760, DOI 10.1111/j.1558-5646.1998.tb02255.x; Albert JS, 2001, MISC PUBL MUS ZOOL U; Albert JS., 2005, SYSTEM BIODIVERS, V4, P375, DOI DOI 10.1017/S1477200004001574; Alves-Gomes J. A., 1997, HOMEM AMBIENTE ECOLO, P509; Alves-Gomes Jose A., 1998, P447; ALVESGOMES JA, 1995, MOL BIOL EVOL, V12, P298; Campos-da-Paz R, 1999, COPEIA, P1041; Campos-Da-Paz R, 2017, ZOOTAXA, V4216, P73, DOI 10.11646/zootaxa.4216.1.5; CARR CE, 1982, J COMP NEUROL, V211, P139, DOI 10.1002/cne.902110204; Carvalho TP, 2011, NEOTROP ICHTHYOL, V9, P457, DOI 10.1590/S1679-62252011000300001; CHARDON M, 1973, ANN SOC NAT ZOOL  15, V12, P1; Crampton W.G.R., 2006, COMMUNICATION FISHES, P647; Crampton W.G.R., 2007, FISH LIFE SPECIAL EN, P283; Crampton WGR, 1996, J FISH BIOL, V48, P298, DOI 10.1006/jfbi.1996.0029; Datovo A, 2014, ZOOL J LINN SOC-LOND, V171, P554, DOI 10.1111/zoj12142; Datovo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060846; Datovo A, 2010, NEOTROP ICHTHYOL, V8, P193, DOI 10.1590/S1679-62252010000200001; de la Hoz E., 1984, Bulletin de la Societe Royale des Sciences de Liege, V53, P9; de Santana CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068719; Dutra GM, 2018, ZOOTAXA, V4422, P132, DOI 10.11646/zootaxa.4422.1.8; Dutra GM, 2017, COPEIA, V105, P85, DOI 10.1643/CI-16-439; Dutra GM, 2015, ZOOL J LINN SOC-LOND, V174, P114, DOI 10.1111/zoj.12221; Dutra GM, 2014, COPEIA, P345, DOI 10.1643/CI-13-066; Eigenmann C. H., 1894, ANN NY ACAD SCI, V7, P625; Ellis MM, 1913, MEM CARNEGIE MUS, V6, P109, DOI DOI 10.5962/BHL.TITLE.12969; FINK SV, 1981, ZOOL J LINN SOC-LOND, V72, P297, DOI 10.1111/j.1096-3642.1981.tb01575.x; Freihofer WC, 1978, OCCAS PAP CALIF ACAD, V128, P1; Giora Júlia, 2005, Neotrop. ichthyol., V3, P291, DOI 10.1590/S1679-62252005000200007; Hilton EL, 2007, P ACAD NAT SCI PHILA, V156, P1, DOI 10.1635/0097-3157(2007)156[1:ROOTBG]2.0.CO;2; HOPKINS CD, 1991, COPEIA, P151; Jordan D.S., 1896, B US NAT MUS, V47, P1, DOI [10.5962/bhl.title.39714, DOI 10.5962/BHL.TITLE.46755]; LANNOO MJ, 1990, J COMP NEUROL, V294, P37, DOI 10.1002/cne.902940105; LANNOO MJ, 1989, J COMP NEUROL, V280, P331, DOI 10.1002/cne.902800302; Lima Michele Soares de, 2019, BIOTA NEOTROP, V19, DOI [10.1590/1676-0611-BN-2018-0708, DOI 10.1590/1676-0611-BN-2016-0224, DOI 10.1590/1676-0611-BN-2022-1399]; Lopez R. B., 1966, Comun Mus argent Cienc nat Benardino Rivadavia (Zool), V4, P7; Lundberg JG, 1996, COPEIA, P657; LUNDBERG JG, 1986, P ACAD NAT SCI PHILA, V138, P53; MAGO-LECCIA F, 1978, Environmental Biology of Fishes, V3, P379, DOI 10.1007/BF00000530; Mago-Leccia F, 1994, BIBLIOTECA ACAD CIEN, V29, P1; Mago-Leccia F, 1978, ACT CIEN VENEZ, V29, P1; OHARA WM, 2016, BIOTA NEOTROP, V16, DOI DOI 10.1590/1676-0611-BN-2016-0224; Peixoto LAW, 2017, NEOTROP ICHTHYOL, V15, DOI 10.1590/1982-0224-20150199; Peixoto LAW, 2016, ZOOTAXA, V4126, P262, DOI 10.11646/zootaxa.4126.2.6; Reinhardt J.T., 1852, VIDENSKABELIGE MEDDE, V1852, P135; Sabaj M.H., 2016, STANDARD SYMBOLIC CO; Soares M.G.M., 1979, Acta Amazonica, V9, P325; Tagliacollo VA, 2016, MOL PHYLOGENET EVOL, V95, P20, DOI 10.1016/j.ympev.2015.11.007; TAYLOR W R, 1985, Cybium, V9, P107; Triques M.L., 1996, REV FRANCAISE AQUARI, V23, P1; Triques Mauro L., 2005, Lundiana, V6, P121; Triques Mauro Luis, 1993, Comunicacoes do Museu de Ciencias da PUCRS Serie Zoologia, V6, P85; Vari RP, 2012, ZOOL J LINN SOC-LOND, V165, P670, DOI 10.1111/j.1096-3642.2012.00827.x; VISCHER HA, 1989, J COMP NEUROL, V290, P16, DOI 10.1002/cne.902900103; Waltz B.T., 2017, FIELD GUIDE FISHES A, P341, DOI DOI 10.1590/1982-0224-20150199; Waltz BT, 2018, ZOOTAXA, V4399, P399, DOI 10.11646/zootaxa.4399.3.9; Peixoto LAW, 2015, ZOOL J LINN SOC-LOND, V175, P384, DOI 10.1111/zoj.12274; WINTERBOTTOM R, 1974, P ACAD NAT SCI PHILA, V125, P225	61	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2019	14	8							e0220287	10.1371/journal.pone.0220287	http://dx.doi.org/10.1371/journal.pone.0220287			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5IT	31412067	Green Published, gold, Green Submitted			2022-12-26	WOS:000485012600024
J	Raben, D; Sullivan, AK; Mocroft, A; Kutsyna, G; Hadziosmanovic, V; Vassilenko, A; Chkhartisvili, N; Mitsura, V; Pedersen, C; Anderson, J; Begovac, J; Dragsted, UB; Bertisch, B; Grzeszczuk, A; Minton, J; Necsoi, VC; Kitchen, M; Ajana, F; Sokhan, A; Comi, L; Farazmand, P; Pesut, D; De Wit, S; Gate, JM; Gazzard, B; Monforte, AD; Rockstroh, JK; Yazdanpanah, Y; Champenois, K; Jakobsen, ML; Lundgren, JD; Clumeck, N; Gatell, J; Gazzard, B; Lundgren, J; Monforte, AD; Rockstroh, J; Mocroft, A; Yazdanpanah, Y; Zangerle, R; Kitchen, M; Vassilenko, A; Necsoi, C; Genotte, AF; Pedersen, C; Redder, L; Caby, F; Bouvet, E; Khuong, MA; Caldato, S; Morlat, P; Coban, D; Arvieux, C; Cabie, A; Chkhartishvili, N; Gerdes, S; Sambatakou, H; Sthoeger, ZM; Elbirt, D; Comi, L; Bini, T; Celesia, BM; Gussio, M; Brinkman, K; Grzeszczuk, A; Rosca, EC; Pesut, D; Sanchez, MAG; Estrada, VP; Gonzalez, EO; Ocampo, A; Masia, M; Agusti, C; Sonnerborg, A; Vernazza, P; Sullivan, A; Rayment, M; Rae, C; Foxton, M; Morris, S; Palfreeman, A; Calderwood, J; Ong, ELC; Mummery, D; Kuznetsova, A; Sullivan, A; Champenois, K; Raben, D; Jakobsen, ML; Hansen, EW				Raben, Dorthe; Sullivan, Ann Kathleen; Mocroft, Amanda; Kutsyna, Galyna; Hadziosmanovic, Vesna; Vassilenko, Anna; Chkhartisvili, Nikoloz; Mitsura, Viktar; Pedersen, Court; Anderson, Jane; Begovac, Josip; Dragsted, Ulrik Bak; Bertisch, Barbara; Grzeszczuk, Anna; Minton, Jane; Necsoi, Valentina Coca; Kitchen, Maria; Ajana, Faiza; Sokhan, Anton; Comi, Laura; Farazmand, Paymaneh; Pesut, Dragica; De Wit, Stephane; Maria Gate, Jose; Gazzard, Brian; Monforte, Antonella d'Arminio; Rockstroh, Juergen Kurt; Yazdanpanah, Yazdan; Champenois, Karen; Jakobsen, Marie Louise; Lundgren, Jens Dilling; Clumeck, N.; Gatell, J.; Gazzard, B.; Lundgren, J.; Monforte, A. d'Arminio; Rockstroh, J.; Mocroft, A.; Yazdanpanah, Y.; Zangerle, R.; Kitchen, M.; Vassilenko, A.; Necsoi, C.; Genotte, A. F.; Pedersen, C.; Redder, L.; Caby, F.; Bouvet, E.; Khuong, M. A.; Caldato, S.; Morlat, P.; Coban, D.; Arvieux, C.; Cabie, A.; Chkhartishvili, N.; Gerdes, S.; Sambatakou, H.; Sthoeger, Z. M.; Elbirt, D.; Comi, L.; Bini, T.; Celesia, B. M.; Gussio, M.; Brinkman, K.; Grzeszczuk, A.; Rosca, E. C.; Pesut, D.; Goenaga Sanchez, M. A.; Estrada, V. P.; Ortega Gonzalez, E.; Ocampo, A.; Masia, M.; Agusti, C.; Sonnerborg, A.; Vernazza, P.; Sullivan, A.; Rayment, M.; Rae, C.; Foxton, Matt; Morris, S.; Palfreeman, A.; Calderwood, J.; Ong, E. L. C.; Mummery, D.; Kuznetsova, A.; Sullivan, Ann; Champenois, K.; Raben, D.; Jakobsen, M. L.; Hansen, E. Wiuff		HIDES Study Grp	Improving the evidence for indicator condition guided HIV testing in Europe: Results from the HIDES II Study-2012-2015	PLOS ONE			English	Article							CARE	Background It is cost-effective to perform an HIV test in people with specific indicator conditions (IC) with an undiagnosed HIV prevalence of at least 0.1%. Our aim was to determine the HIV prevalence for 14 different conditions across 20 European countries. Methods Individuals aged 18-65 years presenting for care with one of 14 ICs between January 2012 and June 2014 were included and routinely offered an HIV test. Logistic regression assessed factors associated with testing HIV positive. Patients presenting with infectious mononucleosis-like syndrome (IMS) were recruited up until September 2015. Results Of 10,877 patients presenting with an IC and included in the analysis, 303 tested positive (2.8%; 95% CI 2.5-3.1%). People presenting with an IC in Southern and Eastern Europe were more likely to test HIV positive as were people presenting with IMS, lymphadenopathy and leukocytopenia/thrombocytopenia. One third of people diagnosed with HIV after presenting with IMS reported a negative HIV test in the preceding 12 months. Of patients newly diagnosed with HIV where data was available, 92.6% were promptly linked to care; of these 10.4% were reported lost to follow up or dead 12 months after diagnosis. Conclusion The study showed that 10 conditions had HIV prevalences > 0.1%. These 10 ICs should be adopted into HIV testing and IC specialty guidelines. As IMS presentation can mimic acute HIV sero-conversion and has the highest positivity rate, this IC in particular affords opportunities for earlier diagnosis and public health benefit.	[Raben, Dorthe; Jakobsen, Marie Louise; Lundgren, Jens Dilling] Rigshosp, Ctr Hlth & Infect Dis Res, Copenhagen, Denmark; [Sullivan, Ann Kathleen; Gazzard, Brian; Sullivan, Ann] NHS Fdn Trust, Chelsea & Westminster Hosp, London, England; [Mocroft, Amanda] UCL, London, England; [Kutsyna, Galyna] Luhansk AIDS Ctr, Lugansk, Ukraine; [Hadziosmanovic, Vesna] Univ Sarajevo, Infect Dis Clin, Clin Ctr, Sarajevo, Bosnia & Herceg; [Vassilenko, Anna] Belarusian State Med Univ, Minsk, BELARUS; [Chkhartisvili, Nikoloz] AIDS & Clin Immunol Res Ctr, Tiblisi, Georgia; [Mitsura, Viktar] Gomel State Med Univ, Gomel, BELARUS; [Pedersen, Court] Odense Univ Hosp, Odense, Denmark; [Anderson, Jane] Homerton Univ Hosp, London, England; [Begovac, Josip] Univ Hosp Infect Dis, Zagreb, Croatia; [Dragsted, Ulrik Bak] Zealand Univ Hosp, Roskilde, Region Zealand, Denmark; [Bertisch, Barbara; Vernazza, P.] Kantonsspital, St Gallen, Switzerland; [Grzeszczuk, Anna] Med Univ Bialystok, Bialystok, Poland; [Minton, Jane; Palfreeman, A.; Calderwood, J.] St James Univ Hosp, Leeds, W Yorkshire, England; [Necsoi, Valentina Coca; De Wit, Stephane] Univ Libre Bruxelles, St Pierre Univ Hosp, Brussels, Belgium; [Kitchen, Maria] Univ Hosp Innsbruck, Innsbruck, Austria; [Ajana, Faiza] Ctr Hosp Tourcoing, Tourcoing, France; [Sokhan, Anton] Kharkiv Natl Med Univ, Kharkov, Ukraine; [Comi, Laura] ASST Papa Giovanni XXIII, Osped Bergamo, Bergamo, Italy; [Farazmand, Paymaneh] Huddersfield Royal Infirm, Huddersfield, W Yorkshire, England; [Pesut, Dragica; Clumeck, N.] Univ Belgrade, Clin Ctr Serbia, Sch Med, Belgrade, Serbia; [Maria Gate, Jose; Gatell, J.] Univ Barcelona, Hosp Clin Barcelona IDIBAPS, Barcelona, Spain; [Monforte, Antonella d'Arminio; Rockstroh, Juergen Kurt; Gazzard, B.; Comi, L.; Bini, T.] San Paolo Hosp, Unit Infect Dis, Milan, Italy; [Rockstroh, Juergen Kurt; Monforte, A. d'Arminio] Univ Bonn, HIV Outpatient Clin, Bonn, Germany; [Yazdanpanah, Yazdan; Rockstroh, J.] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Yazdanpanah, Yazdan; Champenois, Karen; Mocroft, A.] Hop Bichat Claude Bernard, Paris, France; [Clumeck, N.; Necsoi, C.; Genotte, A. F.] St Pierre Univ Hosp, Brussels, Belgium; [Gatell, J.] Hosp Clin Barcelona, Barcelona, Spain; [Gazzard, B.; Sullivan, A.; Rae, C.] Chelsea & Westminster Hosp, London, England; [Monforte, A. d'Arminio] Univ Milan, San Paolo Hosp, Unit Infect Dis, Milan, Italy; [Rockstroh, J.] Univ Bonn, Dept Med, Bonn, Germany; [Mocroft, A.] UCL, Med Sch, London, England; [Yazdanpanah, Y.; Bouvet, E.] Hop Bichat Claude Bernard, Paris, France; [Zangerle, R.; Kitchen, M.] Univ Hosp Innsbruck, Dept Dermatol & Venereol, Innsbruck, Austria; [Vassilenko, A.] Minsk Municipal Infect Dis Hosp, Minsk, BELARUS; [Pedersen, C.; Redder, L.] Odense Univ Hosp, UB Dragsted, Roskilde Hosp, Odense, Denmark; [Caby, F.] Hop La Pitie Salpetriere, Paris, France; [Khuong, M. A.] Hop Delafontaine, St Denis, Reunion, France; [Khuong, M. A.] Ctr Hosp Rene Dubois, Pontoise, France; [Caldato, S.; Morlat, P.] Hop St Andre, Bordeaux, France; [Coban, D.] CHU Clermont Ferrand, Clermont Ferrand, France; [Arvieux, C.] Hop Pontchaillou, Rennes, France; [Cabie, A.] CHU Ft de France, Fort De France, Martinique, France; [Chkhartishvili, N.] Infect Dis AIDS & Clin Immunol Res Ctr, Tbilisi, Georgia; [Yazdanpanah, Yazdan; Rockstroh, J.] Univ Bonn, Dept Med, Immunol Ambulanz, Bonn, Germany; [Gerdes, S.] Univ Hautklin Kiel, Kiel, Germany; [Sambatakou, H.] Hippokrateion Hosp, Athens, Greece; [Sthoeger, Z. M.; Elbirt, D.] Ben Ari Inst Clin Immunol, Rehovot, Israel; [Celesia, B. M.; Gussio, M.] Univ Catania, Unit Infect Dis, Catania, Italy; [Brinkman, K.] Onze Lieve Vrouw Hosp, Internal Med, Amsterdam, Netherlands; [Brinkman, K.; Grzeszczuk, A.] Med Univ Bialystok, Dept Infect Dis & Hepatol, Bialystok, Poland; [Rosca, E. C.] Univ Med & Farm Timisoara, Clin Emergency Cty Hosp, Timisoara, Romania; [Pesut, D.] Univ Belgrade, Sch Med, Clin Ctr Serbia, Teaching Hosp Pulmonol, Belgrade, Serbia; [Goenaga Sanchez, M. A.] Hosp Donostia, San Sebastian, Spain; [Estrada, V. P.] Hosp Univ San Carlos, Madrid, Spain; [Ortega Gonzalez, E.] Consorcio Hosp Gen Univ Valencia, Valencia, Spain; [Ocampo, A.] Complexo Xeral Cies Vigo, Vigo, Spain; [Masia, M.] Hosp Univ Elche, Elche, Spain; [Agusti, C.] CEEISCAT, Badalona, Spain; [Sonnerborg, A.] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Sullivan, A.; Rayment, M.; Rae, C.; Foxton, Matt] Chelsea & Westminster Hosp NHS Fdn Trust, London, England; [Morris, S.] Western Gen Hosp, Edinburgh, Midlothian, Scotland; [Ong, E. L. C.] Newcastle Upon Tyne Hosp, Newcastle, England; [Mummery, D.] North End Med Ctr, London, England; [Kuznetsova, A.] Kharkov Reg Clin Infect Dis, Kharkov, Ukraine; [Champenois, K.] Inserm UMR1137, IAME, Paris, France; [Raben, D.; Jakobsen, M. L.; Hansen, E. Wiuff] Rigshosp, CHIP, Copenhagen, Denmark; [Lundgren, J.] Rigshosp, Copenhagen, Denmark; [Lundgren, J.] Univ Copenhagen, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Imperial College London; Oxford University Hospitals NHS Foundation Trust; University of London; University College London; University of Sarajevo; Belarusian State Medical University; Gomel State Medical University; University of Southern Denmark; Odense University Hospital; University of London; Queen Mary University London; Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen; Medical University of Bialystok; Saint James's University Hospital; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Medical University of Innsbruck; Kharkiv National Medical University; ASST Papa Giovanni XXIII; Clinical Centre of Serbia; University of Belgrade; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; San Paolo-Polo Universitaria Hospital; University of Bonn; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of Barcelona; Hospital Clinic de Barcelona; Imperial College London; San Paolo-Polo Universitaria Hospital; University of Milan; University of Bonn; University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Medical University of Innsbruck; University of Southern Denmark; Odense University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre Hospitalier Rene Dubos, Pontoise; CHU Bordeaux; CHU Clermont Ferrand; CHU Rennes; CHU Martinique; University of Bonn; University of Kiel; Schleswig Holstein University Hospital; Hippokration General Hospital; University of Catania; Onze Lieve Vrouwe Gasthuis Hospital; Medical University of Bialystok; Victor Babes University of Medicine & Pharmacy, Timisoara; Clinical Centre of Serbia; University of Belgrade; University Hospital Donostia; Karolinska Institutet; Karolinska University Hospital; Imperial College London; University of Edinburgh; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Jakobsen, ML (corresponding author), Rigshosp, Ctr Hlth & Infect Dis Res, Copenhagen, Denmark.	marie.louise.jakobsen@regionh.dk	Redder, Louise/ABI-1987-2020; Kitchen, Maria/AAN-4964-2020; Arvieux, Catherine/AAQ-3128-2021; Lundgren, Jens/AAE-6876-2019; Rosca, Elena Cecilia/C-5543-2012; Begovac, Josip/AAI-5672-2021; Mitsura, Viktar/G-2457-2017; Gerdes, Sascha/J-4308-2017; Rosca, Elena Cecilia/AAE-6234-2021; Vassilenko, Anna/AAB-4152-2021; Malagon-Rojas, Jeadran N/AAS-4687-2021; Gatell, Jose M/ABC-3607-2020; Sokhan, Anton/Q-2373-2016	Redder, Louise/0000-0003-3965-2025; Kitchen, Maria/0000-0003-1391-0532; Rosca, Elena Cecilia/0000-0003-2412-1942; Begovac, Josip/0000-0003-2641-4327; Mitsura, Viktar/0000-0002-0449-5026; Gerdes, Sascha/0000-0002-6667-7757; Rosca, Elena Cecilia/0000-0003-2412-1942; Malagon-Rojas, Jeadran N/0000-0001-5801-936X; Sokhan, Anton/0000-0003-1860-3099; , IIS Galicia Sur/0000-0003-3812-7413; Anna, Vassilenko/0000-0003-1907-2322	HIV in Europe initiative from Gilead Sciences; ViiV Healthcare; Merck; Tibotec; Pfizer; Schering-Plough; Abbott; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; European Commission under the 2nd Health Programme; Danish National Research Foundation [DNRF126]	HIV in Europe initiative from Gilead Sciences; ViiV Healthcare; Merck(Merck & Company); Tibotec; Pfizer(Pfizer); Schering-Plough(Merck & CompanySchering Plough Corporation); Abbott(Abbott Laboratories); Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); GlaxoSmithKline(GlaxoSmithKline); European Commission under the 2nd Health Programme; Danish National Research Foundation(Danmarks Grundforskningsfond)	The HIDES study was funded by the HIV in Europe initiative which has received unrestricted funding from Gilead Sciences, ViiV Healthcare, Merck, Tibotec, Pfizer, Schering-Plough, Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, and the European Commission under the 2nd Health Programme. The study is also supported by a grant [grant number DNRF126] from the Danish National Research Foundation. The operational procedures within the initiative include the following to maintain the autonomy of the initiative. The Steering Committee is the governing body and sponsors do not have representation on the Steering Committee. Furthermore, data, records, reports, Intellectual Property Rights and Know How generated as result of the initiative shall be deemed vested in and the property of the Steering Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankiersztejn-Bartczak M, 2015, HIV MED, V16, P88, DOI 10.1111/hiv.12175; [Anonymous], 2012, HIV INDICATOR CONDIT; Bert F, 2018, HEALTH POLICY, V122, P533, DOI 10.1016/j.healthpol.2018.03.007; Croxford S, 2018, EUROSURVEILLANCE; Gazzard B, 2008, HIV MED, V9, P34, DOI 10.1111/j.1468-1293.2008.00592.x; Helleberg M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072257; Lord E, 2017, HIV MED, V18, P300, DOI 10.1111/hiv.12430; Menacho I, 2013, HIV MED, V14, P33, DOI 10.1111/hiv.12064; Mocroft A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001510; Raben D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140845; Rayment M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039530; Rothman RE, 2012, ACAD EMERG MED, V19, P497, DOI 10.1111/j.1553-2712.2012.01351.x; Sullivan AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052845; Yazdanpanah Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013132	14	13	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220108	10.1371/journal.pone.0220108	http://dx.doi.org/10.1371/journal.pone.0220108			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408476	Green Published, gold, Green Submitted			2022-12-26	WOS:000485009500007
J	Li, XY; Pape, T; Zhang, D				Li, Xin-yu; Pape, Thomas; Zhang, Dong			Gasterophilus flavipes (Oestridae: Gasterophilinae): A horse stomach bot fly brought back from oblivion with morphological and molecular evidence	PLOS ONE			English	Article							SPECIES COMPOSITION; DIPTERA; MYIASIS; IDENTIFICATION; SARCOPHAGIDAE; BIODIVERSITY; PHYLOGENY; NASALIS; LARVAE	Species of Gasterophilus Leach are obligate parasites in domestic and wild equids and responsible for cosmopolitan gasterophilosis. Although with only eight species known so far, they have received considerable attention because of their significant veterinary and economic importance. Surprisingly, we found that G. flavipes (Olivier) is a valid species based on morphological characters from male, female and the egg, after spending half a century as a synonym of G. haemorrhoidalis (Linnaeus). In the present study, G. flavipes, G. haemorrhoidalis and G. inermis (Brauer), which are the three closely related species possessing a remarkable mixture of shared morphological characters, are diagnosed and comparatively redescribed; the key to separate adults and eggs are provided, together with a series of high-resolution photographs from all the body parts. COI barcodes do not allow for a separation of G. flavipes, G. haemorrhoidalis and G. inermis, but showed a closer relationship between G. flavipes and G. haemorrhoidalis than the other two combinations, which is consistent with the morphological evidence. Geographically, G. flavipes seems to be common and widespread in the warmer parts of the Palaearctic region. Thus, the epidemiology of gasterophilosis where G. flavipes is known or supposed to occur calls for a more careful veterinarian re-assessment. A decline in the populations of Gasterophilus spp. has been noticed in Europe, but all seven Palaearctic species of Gasterophilus appear to maintain stable populations in Xinjiang (China), which may be explained by a higher biodiversity of equids and less use of anti-parasitic treatments in Xinjiang than in Europe. Our study shows that morphological characters still provide the solid backbone in classification of Gasterophilus at species-level, and updated diagnoses and a key is provided to distinguish G. flavipes, G. haemorrhoidalis and G. inermis, and to facilitate studies of epidemiology, phylogeny and host-parasite co-evolution.	[Li, Xin-yu; Zhang, Dong] Beijing Forestry Univ, Sch Nat Conservat, Key Lab Noninvas Res Technol Endangered Species, Beijing, Peoples R China; [Li, Xin-yu; Pape, Thomas] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen, Denmark	Beijing Forestry University; University of Copenhagen	Zhang, D (corresponding author), Beijing Forestry Univ, Sch Nat Conservat, Key Lab Noninvas Res Technol Endangered Species, Beijing, Peoples R China.	ernest8445@163.com	Pape, Thomas/E-7520-2011; Zhang, Dong/J-2296-2014	Pape, Thomas/0000-0001-6609-0609; Zhang, Dong/0000-0001-6427-7867; LI, XINYU/0000-0001-5136-0303	National Natural Science Foundation of China [31872964, 31572305]; Fundamental Research Funds for the Central Universities [JC2015-04]; Program for New Century Excellent Talents in University [NCET-12-0783]; Beijing Higher Education Young Elite Teacher Project [YETP0771]; State Scholarship Fund of China Scholarship Council [201806510006, 201306515009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Beijing Higher Education Young Elite Teacher Project; State Scholarship Fund of China Scholarship Council(China Scholarship Council)	This study is supported by the National Natural Science Foundation of China (Nos. 31872964 and 31572305), Fundamental Research Funds for the Central Universities (No. JC2015-04), Program for New Century Excellent Talents in University (No. NCET-12-0783), Beijing Higher Education Young Elite Teacher Project (No. YETP0771), the State Scholarship Fund of China Scholarship Council (No. 201306515009) awarded to DZ, and also the State Scholarship Fund of China Scholarship Council awarded to XYL (No. 201806510006) to pursue her study in University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashtari B, 2013, B ENV PHARM LIFE SCI, V2, P169; Bezdekova B, 2007, ACTA VET HUNG, V55, P241, DOI 10.1556/AVet.55.2007.2.10; Brauer F, 1858, VERHANDLUNGEN KAIS Z, V8, P464; BRAUER F, 1863, MONOGRAPHIE OESTRIDE; Buenaventura E, 2018, ACTA TROP, V182, P291, DOI 10.1016/j.actatropica.2018.01.020; Colwell D. D., 2006, The oestrid flies: biology, host-parasite relationships, impact and management, DOI 10.1079/9780851996844.0000; Colwell DD, 2009, TRENDS PARASITOL, V25, P500, DOI 10.1016/j.pt.2009.07.011; Cumming Jeffrey M., 2009, P9; de Jong Yde, 2014, Biodivers Data J, pe4034, DOI 10.3897/BDJ.2.e4034; Felix S. R., 2007, Parasitologia Latinoamericana, V62, P122; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Getachew AM, 2012, TROP ANIM HEALTH PRO, V44, P757, DOI 10.1007/s11250-011-9961-7; Grunin K.J., 1969, Fliegen Palaearkt Reg, VNo. 279,1969, P1; Grunin KJ, 1955, FAUNA URSS INSECTA D, P1; Guimaraes JH, 1999, MYIASIS CAUSED OBLIG, P167; Guimaraes JH, 1967, FAMILY GASTEROPHILID, P1; HALL M, 1995, ADV PARASIT, V35, P257, DOI 10.1016/S0065-308X(08)60073-1; Huang Heqing, 2017, Scientia Silvae Sinicae, V53, P142; Huang HQ, 2016, PARASITE, V23, DOI 10.1051/parasite/2016036; James MT, 1974, FLIES CAUSE MYIASIS; Jordaens K, 2013, INT J LEGAL MED, V127, P491, DOI 10.1007/s00414-012-0767-6; Kaboret Y, 1986, REV ELEV MED VET PAY, V39; Kamiya T, 2014, ECOGRAPHY, V37, P689, DOI 10.1111/j.1600-0587.2013.00571.x; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kutty SN, 2010, SYST ENTOMOL, V35, P614, DOI 10.1111/j.1365-3113.2010.00536.x; Lafferty KD, 2012, PHILOS T R SOC B, V367, P2814, DOI 10.1098/rstb.2012.0110; Li XY, 2018, VET PARASITOL, V262, P56, DOI 10.1016/j.vetpar.2018.09.011; Lindner E, 1999, ICZN INT CODE ZOOLOG; Liu SH, 2016, VET PARASITOL, V217, P36, DOI 10.1016/j.vetpar.2015.12.028; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meiklejohn KA, 2011, INT J LEGAL MED, V125, P27, DOI 10.1007/s00414-009-0395-y; Nei M., 2000, MOL EVOLUTION PHYLOG; Nelson LA, 2007, MED VET ENTOMOL, V21, P44, DOI 10.1111/j.1365-2915.2007.00664.x; Olivier GA., 1811, ENCY METHODIQUE HIST; Otranto D, 2005, VET PARASITOL, V133, P111, DOI 10.1016/j.vetpar.2005.05.015; Papavero N., 1977, Series Ent., V14, P1; Pape T, 2001, SYST ENTOMOL, V26, P133, DOI 10.1046/j.1365-3113.2001.00143.x; Paramonov SJ, 1940, FLIES OF THE GENUS G; PATTON W. S., 1937, Annals of Tropical Medicine and Parasitology, V31, P351; Pawlas-Opiela M, 2010, VET PARASITOL, V169, P219, DOI 10.1016/j.vetpar.2009.12.030; PEARSE BHG, 1989, AUST VET J, V66, P380, DOI 10.1111/j.1751-0813.1989.tb09745.x; Pilo C, 2015, PARASITOL RES, V114, P1693, DOI 10.1007/s00436-015-4352-z; PONT AC, 1980, CATALOGUE DIPTERA AF, P883; Pont AC, 1973, CATALOG DIPTERA ORIE, P700; Sequeira JL, 2001, VET PARASITOL, V102, P261, DOI 10.1016/S0304-4017(01)00536-2; Soos A., 1986, P237; Tavassoli Mosa, 2012, Scientia Parasitologica, V13, P83; Wood DM, 2006, OESTRID FLIES: BIOLOGY, HOST-PARASITE RELATIONSHIPS, IMPACT AND MANAGEMENT, P78, DOI 10.1079/9780851996844.0078; Wood D.M., 1987, Agriculture Canada Monograph, P1147; Xue WQ, 1996, FLIES CHINA, V2, P2207; Zhang D, 2016, INT J BIOL SCI, V12, P489, DOI 10.7150/ijbs.12148; Zumpt F., 1953, Journal of the Entomological Society of Southern Africa, V16, P59; Zumpt F., 1965, MYIASIS MAN ANIMALS	55	4	5	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220820	10.1371/journal.pone.0220820	http://dx.doi.org/10.1371/journal.pone.0220820			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404100	Green Published, gold			2022-12-26	WOS:000485006800035
J	Ahsan, MN; Bockerman, P				Ahsan, Md Nazmul; Boeckerman, Petri			Alternative measures of body composition and wage premium: New evidence from Indonesia	PLOS ONE			English	Article							OBESITY; WEIGHT; HEIGHT; HEALTH; BMI; EARNINGS; MASS; MEN	This paper examines the relationship between body composition and earnings in a developing country setting. We use body mass index, waist circumference and hip circumference. Exploiting the panel structure of our longitudinal survey, we find that along with BMI, waist circumference is related to higher earnings in Indonesia.	[Ahsan, Md Nazmul] St Louis Univ, Dept Econ, St Louis, MO 63103 USA; [Boeckerman, Petri] Univ Jyvaskyla, Jyvaskyla, Finland; [Boeckerman, Petri] Labour Inst Econ Res, Helsinki, Finland; [Boeckerman, Petri] IZA Inst Labor Econ, Bonn, Germany	Saint Louis University; University of Jyvaskyla; IZA Institute Labor Economics	Ahsan, MN (corresponding author), St Louis Univ, Dept Econ, St Louis, MO 63103 USA.	nazmul.ahsan@slu.edu	Böckerman, Petri/M-4969-2013	Böckerman, Petri/0000-0002-5372-2985				Ahsan MN, 2018, SOUTH ECON J, V85, P121, DOI 10.1002/soej.12298; Atella V, 2008, ECON HUM BIOL, V6, P305, DOI 10.1016/j.ehb.2008.06.007; Bozoyan C, 2011, ECON HUM BIOL, V9, P356, DOI 10.1016/j.ehb.2011.07.001; Burkhauser RV, 2008, J HEALTH ECON, V27, P519, DOI 10.1016/j.jhealeco.2007.05.005; Cawley J, 2015, J HEALTH ECON, V43, P244, DOI 10.1016/j.jhealeco.2015.03.001; Dinda S, 2006, ECON HUM BIOL, V4, P342, DOI 10.1016/j.ehb.2005.10.003; Frankenfield DC, 2001, NUTRITION, V17, P26, DOI 10.1016/S0899-9007(00)00471-8; Huang W, 2013, AM ECON J-APPL ECON, V5, P86, DOI 10.1257/app.5.2.86; Johansson E, 2009, ECON HUM BIOL, V7, P36, DOI 10.1016/j.ehb.2009.01.008; Johar M, 2012, HEALTH ECON, V21, P597, DOI 10.1002/hec.1736; Kedir AM, 2013, ECON ISS, V18, P1; Lakdawalla D, 2009, ECON HUM BIOL, V7, P283, DOI 10.1016/j.ehb.2009.08.001; Machado JAF, 2019, J ECONOMETRICS, DOI [10.1016/J.JECONOM.2018.09.003, DOI 10.1016/J.JECONOM.2018.09.003]; Maluccio JA, 1998, 54 IFPRI FCND; Sabia JJ, 2012, ECON HUM BIOL, V10, P14, DOI 10.1016/j.ehb.2011.09.004; Schaner S, 2016, 2737842 SSRN; Strauss J, 1998, J ECON LIT, V36, P766; Strauss J, 5 WAVE INDONESIA FAM; Thomas D, 1997, J ECONOMETRICS, V77, P159, DOI 10.1016/S0304-4076(96)01811-8; Wada R, 2010, ECON HUM BIOL, V8, P242, DOI 10.1016/j.ehb.2010.02.001; Wooldridge J, 2017, 24003 NAT BUR EC RES	21	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0219438	10.1371/journal.pone.0219438	http://dx.doi.org/10.1371/journal.pone.0219438			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5FL	31398206	Green Submitted, Green Published, gold			2022-12-26	WOS:000485004000006
J	Kansiime, S; Mwesigire, D; Mugerwa, H				Kansiime, Sheila; Mwesigire, Doris; Mugerwa, Henry			Prevalence of non-communicable diseases among HIV positive patients on antiretroviral therapy at joint clinical research centre, Lubowa, Uganda	PLOS ONE			English	Article								Introduction Antiretroviral therapy (ART) has changed the course of HIV/AIDs by enabling patients to live longer, raising concern of the co-existence of HIV with other chronic illnesses, notably non-communicable diseases (NCDs). NCDs are on the rise in developing countries and evidence shows higher occurrence among people living with HIV (PLHIV). In Uganda, the burden of NCDs among PLHIV remains largely unquantified. Objective To determine the prevalence of hypertension, osteoporosis, diabetes mellitus, renal impairment, asthma, cardiomyopathy and multi-morbidity among HIV positive patients, receiving Anti-Retroviral Therapy at Joint Clinical Research Centre, Lubowa, Uganda. Methods This was a cross-sectional study conducted among 387 systematically sampled patients, receiving ART at the Joint Clinical Research Centre, Lubowa, between March and April 2017. The study used data extracted from routine care patient files to identify individuals with non-communicable diseases. Prevalence of the NCDs was estimated and reported with 95% confidence intervals. Prevalence was also reported at various levels of socio-demographic, behavioural and clinical factors. Results The overall prevalence of having at least one NCD was 20.7% (95% CI: 16.7-24.5). The prevalence of hypertension was 12.4% (95% CI: 9.1-15.7), osteoporosis 6.5% (95% CI: 4.0-8.9), diabetes mellitus 4.7% (95% CI: 2.6-6.8), renal impairment 1.6% (95% CI: 0.3-2.8), asthma 1.6% (95% CI: 0.3-2.8), and cardiomyopathy 1.3% (95% CI: 0.2-2.4). Prevalence of multi-morbidity was 4.7% (95% CI: 2.6-6.8). Prevalence was significantly higher among older participants, widowed participants and individuals with an opportunistic infection. Conclusion Non-communicable diseases are common among people living with HIV. There is need to encourage early diagnosis and treatment of non-communicable diseases in PLHIV in Uganda.	[Kansiime, Sheila; Mwesigire, Doris] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Kansiime, Sheila] MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda; [Mugerwa, Henry] Joint Clin Res Ctr, Luboowa, Uganda	Makerere University	Kansiime, S (corresponding author), Makerere Univ, Coll Hlth Sci, Kampala, Uganda.; Kansiime, S (corresponding author), MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda.	Kansiimesheila@yahoo.com		Kansiime, Sheila/0000-0003-3700-1501	NIMH NIH HHS [R25 MH064712, R25 MH123256] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alvarez E, 2016, CURR OPIN HIV AIDS, V11, P268, DOI 10.1097/COH.0000000000000269; Cailhol J, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-40; CDC, 2013, BACKGR BRIEF PREV BE; Dimala CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148100; Edwards J. K. B., 2015, T ROYAL SOC TROPICAL; Haregu T. N., 2012, EPIDEMIOLOGY COMORBI, V2; Hernandez-Romieu, 2016, IS DIABETES PREVALEN; Isa SE, 2016, CLIN INFECT DIS, V63, P830, DOI 10.1093/cid/ciw381; Kavishe B, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0357-9; Kotwani P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1151; Kwarisiima D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156309; Magafu MGMD, 2013, PAN AFR MED J, V16, DOI 10.11604/pamj.2013.16.84.2831; Magodoro Itai M, 2016, BMC Res Notes, V9, P379, DOI 10.1186/s13104-016-2187-z; Musoke D., 2006, UGANDAS HIV RESPONSE; Narayan K, 2014, HIV NONCOMMUNICABLE, DOI [10.1097/QAI.0000000000000267, DOI 10.1097/QAI.0000000000000267]; Onyia, 2014, PREVALENCE COMORBIDI; Struik GM, 2011, INT J STD AIDS, V22, P457, DOI 10.1258/ijsa.2011.010521; Uganda M. o. H., 2014, HIV AIDS UG COUNTR P; UNODC, 2016, HIV AIDS E AFR; Wandera B., 2014, LOW BONE MINERAL DEN; World_Health_Organization, 2018, 2018 NCVRW RES GUID	21	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0221022	10.1371/journal.pone.0221022	http://dx.doi.org/10.1371/journal.pone.0221022			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398244	Green Submitted, Green Published, gold			2022-12-26	WOS:000485004000042
J	Rangarajan, N; Gordy, CL; Askew, L; Bevill, SM; Elston, TC; Errede, B; Hurst, JH; Kelley, JB; Sheetz, JB; Suzuki, SK; Valentin, NH; Young, E; Dohlman, HG				Rangarajan, Nambirajan; Gordy, Claire L.; Askew, Lauren; Bevill, Samantha M.; Elston, Timothy C.; Errede, Beverly; Hurst, Jillian H.; Kelley, Joshua B.; Sheetz, Joshua B.; Suzuki, Sara Kimiko; Valentin, Natalie H.; Young, Everett; Dohlman, Henrik G.			Systematic analysis of F-box proteins reveals a new branch of the yeast mating pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein; mitogen-activated protein kinase (MAPK); yeast; ubiquitin; protein sorting; F-box; fungal mating; pheromone signaling	CONTROLS AUTOPHAGIC SEQUESTRATION; GUANINE-NUCLEOTIDE EXCHANGE; PHEROMONE RESPONSE PATHWAY; HETEROTRIMERIC G-PROTEIN; MAP KINASE; STE5 SCAFFOLD; SIGNALING SPECIFICITY; TRANSCRIPTION FACTOR; ALPHA-SUBUNIT; A-FACTOR	The mating pathway in yeast Saccharomyces cerevisiae has long been used to reveal new mechanisms of signal transduction. The pathway comprises a pheromone receptor, a heterotrimeric G protein, and intracellular effectors of morphogenesis and transcription. Polarized cell growth, in the direction of a potential mating partner, is accomplished by the G-protein beta gamma subunits and the small G-protein Cdc42. Transcription induction, needed for cell-cell fusion, is mediated by G beta gamma and the mitogen-activated protein kinase (MAPK) scaffold protein Ste5. A potential third pathway is initiated by the G-protein alpha subunit Gpa1. Gpa1 signaling was shown previously to involve the F-box adaptor protein Dia2 and an endosomal effector protein, the phosphatidylinositol 3-kinase Vps34. Vps34 is also required for proper vacuolar sorting and autophagy. Here, using a panel of reporter assays, we demonstrate that mating pheromone stimulates vacuolar targeting of a cytoplasmic reporter protein and that this process depends on Vps34. Through a systematic analysis of F-box deletion mutants, we show that Dia2 is required to sustain pheromone-induced vacuolar targeting. We also found that other F-box proteins selectively regulate morphogenesis (Ydr306, renamed Pfu1) and transcription (Ucc1). These findings point to the existence of a new and distinct branch of the pheromone-signaling pathway, one that likely leads to vacuolar engulfment of cytoplasmic proteins and recycling of cellular contents in preparation for mating.	[Rangarajan, Nambirajan; Gordy, Claire L.; Askew, Lauren; Bevill, Samantha M.; Elston, Timothy C.; Hurst, Jillian H.; Kelley, Joshua B.; Sheetz, Joshua B.; Suzuki, Sara Kimiko; Valentin, Natalie H.; Young, Everett; Dohlman, Henrik G.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Errede, Beverly] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Suzuki, Sara Kimiko] Univ N Carolina, Curriculum Bioinformat & Computat Biol, Chapel Hill, NC 27599 USA; [Gordy, Claire L.] North Carolina State Univ, Dept Biol Sci, Raleigh, NC 27607 USA; [Askew, Lauren] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Errede, Beverly] Duke Univ, Sch Med, Dept Pediat, Duke Childrens Hlth & Discovery Inst, Durham, NC 27705 USA; [Kelley, Joshua B.] Univ Maine, Dept Mol & Biomed Sci, Orono, ME 04469 USA; [Sheetz, Joshua B.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Young, Everett] Orlando Hlth, Dept Orthopaed Surg, Orlando, FL 32806 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University; Emory University; Duke University; University of Maine System; University of Maine Orono; Yale University	Dohlman, HG (corresponding author), Univ N Carolina, 4016 Genet Med Bldg,120 Mason Farm Rd, Chapel Hill, NC 27599 USA.	clgordy@ncsu.edu; lauren.casey.askew@emory.edu; jillhurst@gmail.com; Joshua.b.kelley@maine.edu; joshua.sheetz@yale.edu; egyoung11@gmail.com; hdohlman@med.unc.edu	Rangarajan, Nambirajan/AAU-1349-2020; Sheetz, Joshua/Z-1774-2019	Rangarajan, Nambirajan/0000-0002-8332-2448; Gordy, Claire/0000-0002-7379-4417; McGirr, Kimiko/0000-0003-2225-7416; Sheetz, Joshua/0000-0003-2052-1252; Dohlman, Henrik/0000-0003-2443-0729; Hurst, Jillian/0000-0001-5079-9920; Kelley, Joshua/0000-0002-5700-1173	National Institutes of Health Cancer Center Core Support Grant [P30 CA016086]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000678, R01GM114136, R35GM118105] Funding Source: NIH RePORTER	National Institutes of Health Cancer Center Core Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The University of North Carolina Flow Cytometry Core Facility is supported in part by National Institutes of Health P30 CA016086 Cancer Center Core Support Grant to the University of North Carolina Lineberger Comprehensive Cancer Center.	Abeliovich H, 2000, J CELL BIOL, V151, P1025, DOI 10.1083/jcb.151.5.1025; Andersson J, 2004, EMBO J, V23, P2564, DOI 10.1038/sj.emboj.7600250; Apanovitch DM, 1998, J BIOL CHEM, V273, P28597, DOI 10.1074/jbc.273.44.28597; Apanovitch DM, 1998, BIOCHEMISTRY-US, V37, P4815, DOI 10.1021/bi9729965; Aranguiz-Urroz P, 2011, BBA-MOL BASIS DIS, V1812, P23, DOI 10.1016/j.bbadis.2010.07.003; Backer JM, 2016, BIOCHEM J, V473, P2251, DOI 10.1042/BCJ20160170; Bao MZ, 2004, CELL, V119, P991, DOI 10.1016/j.cell.2004.11.052; Bardwell L, 1998, GENE DEV, V12, P2887, DOI 10.1101/gad.12.18.2887; BARRAL Y, 1995, GENE DEV, V9, P399, DOI 10.1101/gad.9.4.399; Baskaran S, 2014, ELIFE, V3, DOI 10.7554/eLife.05115; Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Boularan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086680; Breitkreutz A, 2001, CURR BIOL, V11, P1266, DOI 10.1016/S0960-9822(01)00370-0; Butty AC, 1998, SCIENCE, V282, P1511, DOI 10.1126/science.282.5393.1511; CHAN RK, 1982, MOL CELL BIOL, V2, P21, DOI 10.1128/MCB.2.1.21; CHAN RK, 1982, MOL CELL BIOL, V2, P11, DOI 10.1128/MCB.2.1.11; CHOI KY, 1994, CELL, V78, P499; Conlon P, 2016, P NATL ACAD SCI USA, V113, pE5896, DOI 10.1073/pnas.1610081113; Cook JG, 1997, NATURE, V390, P85, DOI 10.1038/36355; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; DIETZEL C, 1987, CELL, V50, P1001, DOI 10.1016/0092-8674(87)90166-8; Dikic I, 2017, ANNU REV BIOCHEM, V86, P193, DOI 10.1146/annurev-biochem-061516-044908; Dixit G, 2014, MOL CELL, V55, P85, DOI 10.1016/j.molcel.2014.05.019; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; DORER R, 1995, J CELL BIOL, V131, P845, DOI 10.1083/jcb.131.4.845; Dyer JM, 2013, CURR BIOL, V23, P32, DOI 10.1016/j.cub.2012.11.014; English JG, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005774; Erdman S, 2001, GENETICS, V159, P919; Erdman S, 1998, J CELL BIOL, V140, P461, DOI 10.1083/jcb.140.3.461; Errede B, 2015, MOL BIOL CELL, V26, P3343, DOI 10.1091/mbc.E15-03-0176; Farley FW, 1999, GENETICS, V151, P1425; Feng YY, 1998, CURR BIOL, V8, P267, DOI 10.1016/S0960-9822(98)70108-3; Flatauer LJ, 2005, MOL CELL BIOL, V25, P1793, DOI 10.1128/MCB.25.5.1793-1803.2005; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Ghidoni R, 1996, EUR J BIOCHEM, V237, P454, DOI 10.1111/j.1432-1033.1996.0454k.x; Guo M, 2003, MOL CELL, V12, P517, DOI 10.1016/S1097-2765(03)00307-1; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hao N, 2003, J BIOL CHEM, V278, P46506, DOI 10.1074/jbc.M308432200; Hao N, 2008, MOL CELL, V30, P649, DOI 10.1016/j.molcel.2008.04.016; HARDING TM, 1995, J CELL BIOL, V131, P591, DOI 10.1083/jcb.131.3.591; Hegemann B, 2015, DEV CELL, V35, P458, DOI 10.1016/j.devcel.2015.10.013; HERMAN PK, 1991, EMBO J, V10, P4049, DOI 10.1002/j.1460-2075.1991.tb04981.x; Hoffman GA, 2002, METHOD ENZYMOL, V344, P617; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Inouye C, 1997, SCIENCE, V278, P103, DOI 10.1126/science.278.5335.103; Isom DG, 2013, MOL CELL, V51, P531, DOI 10.1016/j.molcel.2013.07.012; Kametaka S, 1998, J BIOL CHEM, V273, P22284, DOI 10.1074/jbc.273.35.22284; Kang C, 2007, GENE DEV, V21, P2161, DOI 10.1101/gad.1573107; Kang CH, 2009, GENE DEV, V23, P12, DOI 10.1101/gad.1723409; Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200; Kanki T, 2010, MOL MICROBIOL, V75, P795, DOI 10.1111/j.1365-2958.2009.07035.x; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Kaufmann A, 2014, CELL, V156, P469, DOI 10.1016/j.cell.2013.12.022; Kawamata T, 2005, BIOCHEM BIOPH RES CO, V338, P1884, DOI 10.1016/j.bbrc.2005.10.163; Kelley JB, 2015, CURR BIOL, V25, P275, DOI 10.1016/j.cub.2014.11.047; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kus BM, 2004, PROTEINS, V54, P455, DOI 10.1002/prot.10620; Kusari AB, 2004, J CELL BIOL, V164, P267, DOI 10.1083/jcb.200310021; Lee YK, 2016, BMB REP, V49, P424, DOI 10.5483/BMBRep.2016.49.8.081; Lipinski MM, 2010, DEV CELL, V18, P1041, DOI 10.1016/j.devcel.2010.05.005; Liu CC, 2016, MOL CELL, V61, P84, DOI 10.1016/j.molcel.2015.11.001; Lizaso A, 2013, AUTOPHAGY, V9, P1228, DOI 10.4161/auto.24893; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lynch-Day MA, 2010, FEBS LETT, V584, P1359, DOI 10.1016/j.febslet.2010.02.013; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Maleri S, 2004, MOL CELL BIOL, V24, P9221, DOI 10.1128/MCB.24.20.9221-9238.2004; McClure AW, 2015, DEV CELL, V35, P471, DOI 10.1016/j.devcel.2015.10.024; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; MIYAJIMA I, 1987, CELL, V50, P1011, DOI 10.1016/0092-8674(87)90167-X; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Moore TI, 2013, MOL BIOL CELL, V24, P521, DOI 10.1091/mbc.E12-10-0739; Moskow JJ, 2000, MOL CELL BIOL, V20, P7559, DOI 10.1128/MCB.20.20.7559-7571.2000; Nagiec MJ, 2015, MOL BIOL CELL, V26, P3359, DOI 10.1091/mbc.E15-01-0037; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Nern A, 1999, J CELL BIOL, V144, P1187, DOI 10.1083/jcb.144.6.1187; Noda T, 2008, METHOD ENZYMOL, V451, P33, DOI 10.1016/S0076-6879(08)03203-5; Oehlen LJWM, 1998, J BIOL CHEM, V273, P8556, DOI 10.1074/jbc.273.15.8556; OgierDenis E, 1996, J BIOL CHEM, V271, P28593, DOI 10.1074/jbc.271.45.28593; OGIERDENIS E, 1995, J BIOL CHEM, V270, P13, DOI 10.1074/jbc.270.1.13; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Palecek SP, 2000, GENETICS, V156, P1005; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Petiot A, 1999, BIOCHEM J, V337, P289, DOI 10.1042/0264-6021:3370289; Polson HEJ, 2010, AUTOPHAGY, V6, P506, DOI 10.4161/auto.6.4.11863; PRINTEN JA, 1994, GENETICS, V138, P609; Pryciak PM, 1998, GENE DEV, V12, P2684, DOI 10.1101/gad.12.17.2684; Reggiori F, 2013, GENETICS, V194, P341, DOI 10.1534/genetics.112.149013; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Rosado CJ, 2008, AUTOPHAGY, V4, P205, DOI 10.4161/auto.5331; Rostislavleva K, 2015, SCIENCE, V350, P140, DOI 10.1126/science.aac7365; Rubinsztein DC, 2012, CURR BIOL, V22, pR29, DOI 10.1016/j.cub.2011.11.034; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Schweltzer K, 2005, YEAST, V22, P553, DOI 10.1002/yea.1234; SEGALL JE, 1993, P NATL ACAD SCI USA, V90, P8332, DOI 10.1073/pnas.90.18.8332; Sette C, 2000, MOL BIOL CELL, V11, P4033, DOI 10.1091/mbc.11.11.4033; Shimada Y, 2000, NAT CELL BIOL, V2, P117, DOI 10.1038/35000073; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; SIMON MN, 1995, NATURE, V376, P702, DOI 10.1038/376702a0; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; STACK JH, 1995, J CELL BIOL, V129, P321, DOI 10.1083/jcb.129.2.321; STACK JH, 1993, EMBO J, V12, P2195, DOI 10.1002/j.1460-2075.1993.tb05867.x; Stasyk OV, 2006, AUTOPHAGY, V2, P30, DOI 10.4161/auto.2226; Stewart A, 2015, PROG MOL BIOL TRANSL, V133, P1, DOI 10.1016/bs.pmbts.2015.03.002; Stromhaug PE, 2001, J BIOL CHEM, V276, P42422, DOI 10.1074/jbc.M104087200; Sugawara K, 2004, GENES CELLS, V9, P611, DOI 10.1111/j.1356-9597.2004.00750.x; Tanaka K, 2010, METHODS, V51, P206, DOI 10.1016/j.ymeth.2010.01.017; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Umekawa M, 2012, J BIOL CHEM, V287, P16300, DOI 10.1074/jbc.M112.344952; VALTZ N, 1995, J CELL BIOL, V131, P863, DOI 10.1083/jcb.131.4.863; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081296; Wang YM, 2005, J BIOL CHEM, V280, P13084, DOI 10.1074/jbc.M410461200; Wang YQ, 2003, J BIOL CHEM, V278, P22284, DOI 10.1074/jbc.M301272200; Wang YQ, 2002, J BIOL CHEM, V277, P15766, DOI 10.1074/jbc.M111733200; Wauson EM, 2012, MOL CELL, V47, P851, DOI 10.1016/j.molcel.2012.08.001; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Wenk MR, 2003, NAT BIOTECHNOL, V21, P813, DOI 10.1038/nbt837; WHITEWAY MS, 1995, SCIENCE, V269, P1572, DOI 10.1126/science.7667635; Windmiller DA, 2003, J BIOL CHEM, V278, P11874, DOI 10.1074/jbc.M211787200; Xiao J, 2015, GENE DEV, V29, P184, DOI 10.1101/gad.252528.114; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Yen WL, 2007, AUTOPHAGY, V3, P254, DOI 10.4161/auto.3823; You YJ, 2006, CELL METAB, V3, P237, DOI 10.1016/j.cmet.2006.02.012; Yuan HX, 2013, AUTOPHAGY, V9, P1983, DOI 10.4161/auto.26058; Zeitlinger J, 2003, CELL, V113, P395, DOI 10.1016/S0092-8674(03)00301-5; Zhang T, 2015, ELIFE, V4, DOI 10.7554/eLife.06734; ZHAO ZS, 1995, MOL CELL BIOL, V15, P5246; Zheng N, 2017, ANNU REV BIOCHEM, V86, P129, DOI 10.1146/annurev-biochem-060815-014922; ZHENG Y, 1994, J BIOL CHEM, V269, P2369	143	5	5	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2019	294	40					14717	14731		10.1074/jbc.RA119.010063	http://dx.doi.org/10.1074/jbc.RA119.010063			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JP0II	31399514	hybrid, Green Published			2022-12-26	WOS:000497955000017
J	Ahmed-Yahia, S; Decousser, JW; Flouzat-Lachaniette, CH; Dervin, G; Roubineau, F; Audureau, E; Hourdille, A; Royer, G; Eymard, F; Chevalier, X				Ahmed-Yahia, Salim; Decousser, Jean-Winoc; Flouzat-Lachaniette, Charles Henri; Dervin, Guillaume; Roubineau, Francois; Audureau, Etienne; Hourdille, Alexia; Royer, Guilhem; Eymard, Florent; Chevalier, Xavier			Is the discopathy associated with Modic changes an infectious process? Results from a prospective monocenter study	PLOS ONE			English	Article							LOW-BACK-PAIN; PROPIONIBACTERIUM-ACNES; ANTIBIOTIC-TREATMENT; BONE EDEMA; BACTERIA; DISC; PCR; DIAGNOSIS; SCIATICA; DISEASE	Background The local infectious origin and the putative role of Cutibacterium acnes (CA) of a particular subtype of discopathy (Modic 1) are still debated. Purpose To establish the association of CA in intervertebral disc (IVD) and Modic 1 discopathy in patients with low back pain. Methods The prevalence of bacteria in IVD samples obtained by anterior approach in patient with chronic low back pain harboring Modic type 1, 2 or no Modic changes was compared to that measured in IVD samples obtained by posterior approach for sciatica. From 45 patients included in the study, 77 discs samples were obtained: 58 by anterior approach (32 Modic 1/2 changes, 26 without Modic change) and 19 by posterior approach. Conventional microbial cultures, universal 16S rRNA molecular detection and a CA specific PCR were performed. Results 12 /77 (15.6%) disc samples were culture positive. Among the 10 CA positive cultures, 5 out of 58 (8.6%) were identified from specimens obtained by anterior approach and 5/19 (26.3%) from posterior approach (p = 0.046). Moreover, the percentage of CA culture positive sample was statistically no different between the patient with or without Modic changes. The CA prevalence was lower through molecular, culture-free approaches: the universal 16S rRNA PCR was positive for 6 specimens, including one CA positive sample and the CA specific PCR was positive for one specimen obtained by posterior approach. Conclusions In spine surgery the prevalence of CA in culture was significantly higher in IVD samples collected through a posterior approach compared to an anterior approach, suggesting a contamination process. This study did not support the CA related local infectious origin of Modic 1 discopathy.	[Ahmed-Yahia, Salim; Dervin, Guillaume; Hourdille, Alexia; Eymard, Florent; Chevalier, Xavier] Univ Hosp Henri Mondor, AP HP, Rheumatol Dept, Creteil, France; [Decousser, Jean-Winoc; Royer, Guilhem] Univ Hosp Henri Mondor, AP HP, Dept Bacteriol & Infect Control, Creteil, France; [Decousser, Jean-Winoc] UPEC, EA Dynamyc 7380, EnvA, Fac Med Creteil, Creteil, France; [Flouzat-Lachaniette, Charles Henri; Roubineau, Francois] Univ Hosp Henri Mondor, AP HP, Orthopaed Dept, Creteil, France; [Audureau, Etienne] Univ Hosp Henri Mondor, AP HP, Publ Hlth Dept, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Ecole Nationale Veterinaire d'Alfort (ENVA); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Decousser, JW (corresponding author), Univ Hosp Henri Mondor, AP HP, Dept Bacteriol & Infect Control, Creteil, France.; Decousser, JW (corresponding author), UPEC, EA Dynamyc 7380, EnvA, Fac Med Creteil, Creteil, France.	jean-winoc.decousser@aphp.fr	, DECOUSSER/AFM-9917-2022; Royer, Guilhem/ABE-9991-2021; Audureau, Etienne/AHE-2826-2022	Royer, Guilhem/0000-0001-9092-8336; Audureau, Etienne/0000-0002-6166-149X; DECOUSSER, Jean-Winoc/0000-0001-7105-6202				Achermann Y, 2014, CLIN MICROBIOL REV, V27, P419, DOI 10.1128/CMR.00092-13; Agarwal VJ, 2010, SPINE J, V10, pS45; Albert HB, 2008, BRIT J SPORT MED, V42, P969, DOI 10.1136/bjsm.2008.050369; Albert HB, 2007, EUR SPINE J, V16, P977, DOI 10.1007/s00586-007-0336-8; Albert HB, 2013, EUR SPINE J, V22, P690, DOI 10.1007/s00586-013-2674-z; Albert HB, 2013, EUR SPINE J, V22, P697, DOI 10.1007/s00586-013-2675-y; Ben-Galim P, 2006, SPINE, V31, P2507, DOI 10.1097/01.brs.0000238657.13263.b2; Boisson M, 2018, RMD OPEN, V4, DOI 10.1136/rmdopen-2018-000660; Bossard DA, 2016, J CLIN MICROBIOL, V54, P3043, DOI 10.1128/JCM.01435-16; Campbell WN, 2000, ANN THORAC SURG, V69, P548, DOI 10.1016/S0003-4975(99)01354-5; Capoor MN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161676; Eishi Y, 2002, J CLIN MICROBIOL, V40, P198, DOI 10.1128/JCM.40.1.198-204.2002; Jensen TS, 2008, EUR SPINE J, V17, P1407, DOI 10.1007/s00586-008-0770-2; Johnson ZI, 2015, EUR CELLS MATER, V30, P104, DOI 10.22203/eCM.v030a08; Kjaer P, 2006, EUR SPINE J, V15, P1312, DOI 10.1007/s00586-006-0185-x; Kuhn C, 2011, J CLIN MICROBIOL, V49, P2919, DOI 10.1128/JCM.00830-11; Kunishima S, 2001, TRANSFUSION, V41, P1126, DOI 10.1046/j.1537-2995.2001.41091126.x; McLorinan GC, 2005, CLIN ORTHOP RELAT R, P67, DOI 10.1097/01.blo.0000175716.76247.81; MODIC MT, 1988, RADIOLOGY, V168, P177, DOI 10.1148/radiology.168.1.3289089; MODIC MT, 1988, RADIOLOGY, V166, P193, DOI 10.1148/radiology.166.1.3336678; MODIC MT, 1986, RADIOL CLIN N AM, V24, P229; Nguyen C, 2012, OSTEOPOROSIS INT, V23, pS857, DOI 10.1007/s00198-012-2164-x; Nguyen C., 2017, BMC MUSCULOSKEL DIS, V18, P1; O'Dowd J, 2013, EUR SPINE J, V22, P1694, DOI 10.1007/s00586-013-2893-3; Rigal J, 2016, EUR SPINE J, V25, P1000, DOI 10.1007/s00586-016-4396-5; Sfanos KS, 2008, PROSTATE, V68, P1492, DOI 10.1002/pros.20820; Stirling A, 2001, LANCET, V357, P2024, DOI 10.1016/S0140-6736(00)05109-6; Street TL, 2017, J CLIN MICROBIOL, V55, P2334, DOI 10.1128/JCM.00462-17; Teboul-Core S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196536; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wedderkopp N, 2009, ACTA RADIOL, V50, P65, DOI 10.1080/02841850802524485; Wellinghausen N, 2009, J CLIN MICROBIOL, V47, P2759, DOI 10.1128/JCM.00567-09	32	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0221030	10.1371/journal.pone.0221030	http://dx.doi.org/10.1371/journal.pone.0221030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415619	Green Published, gold, Green Submitted			2022-12-26	WOS:000485017200062
J	Howe, PDL; Vargas-Saenz, A; McNeill, IM				Howe, Piers D. L.; Vargas-Saenz, Adriana; McNeill, Ilona M.			Commitments increase preparedness for floods	PLOS ONE			English	Article							FATALITIES	The current study investigated whether we could encourage Australian residents to become better prepared for floods by inviting them to make a specific commitment to do so. We sampled 374 residents of the state of Victoria (56% male, 81% metropolitan) and 400 residents of the state of New South Wales (45% male, 59% metropolitan) who lived in locations that were potentially at risk of floods. They residents were sampled so that their distributions of ages, genders and living locations were as representative as possible of the population of those two states. These residents completed two surveys that ascertained their preparedness for floods at two points in time, separate by a two-week period. At the end of the first survey all residents received information about how they could better prepare for floods. In addition, approximately half the residents were randomly selected to be invited to commit to becoming better prepared for floods. We found that 74% of residents who were invited to commit to becoming better prepared for floods, were willing to make this commitment. We found that the group that was invited to commit to become better prepared for floods increased their preparedness for floods over the two-week period that separated the two surveys more than the group that was not invited to make this commitment, F(1, 772) = 4.53, p = .034, eta(2) = .006. We conclude that when emergency services inform residents of flood-prone areas how to better prepare for floods, they should also attempt to elicit from the residents a commitment to become better prepared for floods.	[Howe, Piers D. L.; Vargas-Saenz, Adriana; McNeill, Ilona M.] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia	University of Melbourne	Howe, PDL (corresponding author), Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia.	pdhowe@unimelb.edu.au	; McNeill, Ilona/C-8821-2018	Howe, Piers/0000-0001-6171-1381; McNeill, Ilona/0000-0001-9766-1099; Vargas Saenz, Adriana/0000-0002-0578-0953	Natural Disaster Resilience Grants Scheme, Emergency Management Victoria (Australia) [NDRGS16/17-0008]	Natural Disaster Resilience Grants Scheme, Emergency Management Victoria (Australia)	PH received grant NDRGS16/17-0008 from the Natural Disaster Resilience Grants Scheme, Emergency Management Victoria (Australia); https://www.emv.vic.gov.au/ndrgs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I, 1985, ACTION CONTROL, P11; Bureau of Transport Economics E.c.o.n.d.i.A, 2001, 103 BUR TRANSP EC; Cioffi D, 1996, PERS SOC PSYCHOL B, V22, P133, DOI 10.1177/0146167296222003; Coates L, 1999, AUST GEOGR, V30, P391, DOI 10.1080/00049189993657; Goldstein N. J., 2007, YES 50 SCIENTIFICALL; Haynes K, 2017, ENVIRON SCI POLICY, V76, P165, DOI 10.1016/j.envsci.2017.07.003; Martin SJ, 2012, J ROY SOC MED, V105, P101, DOI 10.1258/jrsm.2011.110250; McNeill IM, COMMUNITY CULTURE FL; Milkman KL, 2011, P NATL ACAD SCI USA, V108, P10415, DOI 10.1073/pnas.1103170108	10	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0219993	10.1371/journal.pone.0219993	http://dx.doi.org/10.1371/journal.pone.0219993			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5KK	31415571	Green Published, Green Submitted, gold			2022-12-26	WOS:000485017200009
J	Sun, J; Have, CT; Hollensted, M; Grarup, N; Linneberg, A; Pedersen, O; Nielsen, JS; Rungby, J; Christensen, C; Brandslund, I; Kristiansen, K; Jun, W; Hansen, T; Gjesing, AP				Sun, Jihua; Have, Christian Theil; Hollensted, Mette; Grarup, Niels; Linneberg, Allan; Pedersen, Oluf; Nielsen, Jens Steen; Rungby, Jorgen; Christensen, Cramer; Brandslund, Ivan; Kristiansen, Karsten; Jun, Wang; Hansen, Torben; Gjesing, Anette P.			Sequencing reveals protective and pathogenic effects on development of diabetes of rare GLIS3 variants	PLOS ONE			English	Article							PLASMA-GLUCOSE; ASSOCIATION; TYPE-1; LOCI; HOMEOSTASIS; POPULATION; RESISTANCE; MELLITUS; MODEL	Background Based on the association of common GLIS3 variants with various forms of diabetes and the biological role of GLIS3 in beta-cells, we sequenced GLIS3 in non-diabetic and diabetic Danes to investigate the effect of rare missense variants on glucose metabolism. Methods We sequenced 53 patients with maturity-onset diabetes of the young (MODY), 5,726 non-diabetic participants, 2,930 patients with newly diagnosed type 2 diabetes and 206 patients with glutamic acid decarboxylase antibody (GADA) -positive diabetes. Results In total we identified 86 rare (minor allele frequency < 0.1%) missense variants. None was considered causal for the presence of MODY. Among patients with type 2 diabetes, we observed a higher prevalence of rare GLIS3 missense variants (2.5%) compared to non-diabetic individuals (1.8%) (odds ratio of 1.37 (interquartile range: 1.01-1.88, p = 0.04)). A significantly increased HbA1c was found among patients with type 2 diabetes and with GADA-positive diabetes carrying rare GLIS3 variants compared to non-carriers of rare GLIS3 variants with diabetes (p = 0.02 and p = 0.004, respectively). One variant (p.I28V) was found to have a minor allele frequency of only 0.03% among patients with type 2 diabetes compared to 0.2% among non-diabetic individuals suggesting a protective function (odds ratio of 0.20 (interquartile range: 0.005-1.4, p = 0.1)), an effect which was supported by publically available data. This variant was also associated with a lower level of fasting plasma glucose among non-diabetic individuals (p = 0.046). Conclusion Rare missense variants in GLIS3 associates nominally with increased level of HbA1c and increased risk of developing type 2 diabetes. In contrast, the rare p.I28V variant associate with reduced level of fasting plasma glucose and may be protective against type 2 diabetes.	[Sun, Jihua] Univ Copenhagen, Biol Dept, Copenhagen, Denmark; [Sun, Jihua] BGI Europe, Copenhagen, Denmark; [Have, Christian Theil; Hollensted, Mette; Grarup, Niels; Pedersen, Oluf; Hansen, Torben; Gjesing, Anette P.] Univ Copenhagen, Novo Nordisk Fdn, Fac Hlth & Med Sci, Ctr Basic Metab Res, Copenhagen, Denmark; [Linneberg, Allan] Bispebjerg & Frederiksberg Hosp, Ctr Clin Res & Prevent, Copenhagen, Denmark; [Linneberg, Allan] Rigshosp, Dept Clin Expt Res, Glostrup, Denmark; [Linneberg, Allan] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Nielsen, Jens Steen] Odense Univ Hosp, Steno Diabet Ctr Odense, DD2, Odense, Denmark; [Rungby, Jorgen] Univ Copenhagen, Bispebjerg Hosp, Denmark Lab Genom, Copenhagen, Denmark; [Christensen, Cramer] Hosp Lillebaelt, SLB, Dept Internal Med & Endocrinol, Vejle, Denmark; [Brandslund, Ivan] Hosp Lillebaelt, Dept Clin Biochem, Vejle, Denmark; [Brandslund, Ivan] Univ Southern Denmark, Inst Reg Hlth Res, Odense, Denmark; [Kristiansen, Karsten] Univ Copenhagen, Dept Biol, Lab Genom & Mol Biomed, Copenhagen, Denmark; [Kristiansen, Karsten] BGI Res, Shenzhen, Peoples R China; [Jun, Wang] ICarbonX, Shenzhen, Peoples R China	University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; Rigshospitalet; University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Copenhagen; Bispebjerg Hospital; University of Southern Denmark; University of Copenhagen; Beijing Genomics Institute (BGI)	Gjesing, AP (corresponding author), Univ Copenhagen, Novo Nordisk Fdn, Fac Hlth & Med Sci, Ctr Basic Metab Res, Copenhagen, Denmark.	anette.gjesing@sund.ku.dk	Pedersen, Oluf/AAG-8015-2020; Kristiansen, Karsten/J-5148-2014; Dina, Christian R/D-3535-2015; Gjesing, Anette/ACC-7521-2022; Rungby, Jørgen/AAQ-4332-2021; Pedersen, Oluf/Z-1731-2019; Grarup, Niels/K-2807-2015; Nielsen, Jens Steen/N-5218-2018	Kristiansen, Karsten/0000-0002-6024-0917; Dina, Christian R/0000-0002-7722-7348; Gjesing, Anette/0000-0003-4580-1576; Pedersen, Oluf/0000-0002-3321-3972; Grarup, Niels/0000-0001-5526-1070; Nielsen, Jens Steen/0000-0003-3179-1186; Hansen, Torben/0000-0001-8748-3831; Hollensted, Mette/0000-0001-5572-3183; Brandslund, Ivan/0000-0002-4203-5442; Linneberg, Allan/0000-0002-0994-0184	European Union [667191]; Danish Diabetes Academy; Danish Medical Research Council; European Foundation for the Study of Diabetes (EFSD); Novo Nordisk Foundation [NNF15CC0018486]; Danish Diabetes Association; Danish Agency for Science [09-067009, 09-075724]	European Union(European Commission); Danish Diabetes Academy; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Foundation for the Study of Diabetes (EFSD); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Diabetes Association; Danish Agency for Science	This project received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 667191 (authors awarded: APG, NG and TH). In addition, the study was supported from the Danish Diabetes Academy, the Danish Medical Research Council, the European Foundation for the Study of Diabetes (EFSD), the Novo Nordisk Foundation (Immunometabolism, NNF15CC0018486) and the Danish Diabetes Association. The DD2 cohort was funded by the Danish Agency for Science (grant no. 09-067009 and 09-075724) (authors awarded: JSN and JR). The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent research center at the University of Copenhagen, partially funded by an unrestricted donation from the Novo Nordisk Foundation (www.metabol.ku.dk).The BGI provided support in the form of salaries for author [JS and KK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The iCarbonX provided support in the form of salaries for author [WJ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ` author contributions' section.	Amin S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03901-w; Awata T, 2013, BIOCHEM BIOPH RES CO, V437, P521, DOI 10.1016/j.bbrc.2013.06.102; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Calderari S, 2018, GENOMICS, V110, P98, DOI 10.1016/j.ygeno.2017.09.001; Ding M, 2018, DIABETOLOGIA, V61, P1758, DOI 10.1007/s00125-018-4637-8; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Gao R, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-13; Glumer C, 2003, DIABETES CARE, V26, P2335, DOI 10.2337/diacare.26.8.2335; Goodarzi MO, 2013, DIABETOLOGIA, V56, P1282, DOI 10.1007/s00125-013-2880-6; Jetten AM, 2018, CELL MOL LIFE SCI, V75, P3473, DOI 10.1007/s00018-018-2841-9; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kang HS, 2009, MOL CELL BIOL, V29, P6366, DOI 10.1128/MCB.01259-09; Kim YS, 2003, NUCLEIC ACIDS RES, V31, P5513, DOI 10.1093/nar/gkg776; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lau C, 2011, DIABETES METAB, V37, P546, DOI 10.1016/j.diabet.2011.06.001; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Mahajan A, 2018, NAT GENET, V50, P1505, DOI 10.1038/s41588-018-0241-6; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nicolino M, 2010, DIABETES, V59, P733, DOI 10.2337/db09-1284; Nogueira TC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003532; Organization WH, 1999, WHO DIAGN CLASS DI 1; Osbak KK, 2009, HUM MUTAT, V30, P1512, DOI 10.1002/humu.21110; Portal TDK, 2019, TYP 2 DIAB KNOWL POR; Rathmann Wolfgang, 2010, Diabetes Care, V33, pe29, DOI 10.2337/dc09-1780; Senee V, 2006, NAT GENET, V38, P682, DOI 10.1038/ng1802; Sorensen Henrik Toft, 2012, Clin Epidemiol, V4, P1, DOI 10.2147/CLEP.S31104; Thomsen Reimar Wernich, 2012, Clin Epidemiol, V4, P43, DOI 10.2147/CLEP.S30083; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Watanabe N, 2009, FEBS LETT, V583, P2108, DOI 10.1016/j.febslet.2009.05.039; Wen XJ, 2017, J MOL ENDOCRINOL, V58, pR73, DOI 10.1530/JME-16-0232; ZeRuth GT, 2013, MOL ENDOCRINOL, V27, P1692, DOI 10.1210/me.2013-1117; Zhan XW, 2016, BIOINFORMATICS, V32, P1423, DOI 10.1093/bioinformatics/btw079	33	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220805	10.1371/journal.pone.0220805	http://dx.doi.org/10.1371/journal.pone.0220805			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415576	Green Published, Green Submitted, gold			2022-12-26	WOS:000485017200034
J	Wong, YL; Hysi, P; Cheung, G; Tedja, M; Hoang, QV; Tompson, SWJ; Whisenhunt, KN; Verhoeven, V; Zhao, WT; Hess, M; Wong, CW; Kifley, A; Hosoda, Y; Haarman, AEG; Hopf, S; Laspas, P; Sensaki, S; Sim, X; Miyake, M; Tsujikawa, A; Lamoureux, E; Ohno-Matsui, K; Nickels, S; Mitchell, P; Wong, TY; Wang, JJ; Hammond, CJ; Barathi, VA; Cheng, CY; Yamashiro, K; Young, TL; Klaver, CCW; Saw, SM				Wong, Yee-Ling; Hysi, Pirro; Cheung, Gemmy; Tedja, Milly; Hoang, Quan V.; Tompson, Stuart W. J.; Whisenhunt, Kristina N.; Verhoeven, Virginie; Zhao, Wanting; Hess, Moritz; Wong, Chee-Wai; Kifley, Annette; Hosoda, Yoshikatsu; Haarman, Annechien E. G.; Hopf, Susanne; Laspas, Panagiotis; Sensaki, Sonoko; Sim, Xueling; Miyake, Masahiro; Tsujikawa, Akitaka; Lamoureux, Ecosse; Ohno-Matsui, Kyoko; Nickels, Stefan; Mitchell, Paul; Wong, Tien-Yin; Wang, Jie Jin; Hammond, Christopher J.; Barathi, Veluchamy A.; Cheng, Ching-Yu; Yamashiro, Kenji; Young, Terri L.; Klaver, Caroline C. W.; Saw, Seang-Mei		Consortium Refractive	Genetic variants linked to myopic macular degeneration in persons with high myopia: CREAM Consortium	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ENDOTHELIAL GROWTH-FACTOR; REFRACTIVE ERROR; SUSCEPTIBILITY LOCUS; PATHOLOGICAL MYOPIA; COMMON VARIANTS; CA2+ CHANNELS; EYE DISEASES; AXIAL LENGTH; METAANALYSIS	Purpose To evaluate the roles of known myopia-associated genetic variants for development of myopic macular degeneration (MMD) in individuals with high myopia (HM), using case-control studies from the Consortium of Refractive Error and Myopia (CREAM). Methods A candidate gene approach tested 50 myopia-associated loci for association with HM and MMD, using meta-analyses of case-control studies comprising subjects of European and Asian ancestry aged 30 to 80 years from 10 studies. Fifty loci with the strongest associations with myopia were chosen from a previous published GWAS study. Highly myopic (spherical equivalent [SE] <= -5.0 diopters [D]) cases with MMD (N = 348), and two sets of controls were enrolled: (1) the first set included 16,275 emmetropes (SE <= -0.5 D); and (2) second set included 898 highly myopic subjects (SE <= -5.0 D) without MMD. MMD was classified based on the International photographic classification for pathologic myopia (META-PM). Results In the first analysis, comprising highly myopic cases with MMD (N = 348) versus emmetropic controls without MMD (N = 16,275), two SNPs were significantly associated with high myopia in adults with HM and MMD: (1) rs10824518 (P = 6.20E-07) in KCNMA1, which is highly expressed in human retinal and scleral tissues; and (2) rs524952 (P = 2.32E-16) near GJD2. In the second analysis, comprising highly myopic cases with MMD (N = 348) versus highly myopic controls without MMD (N = 898), none of the SNPs studied reached Bonferroni- corrected significance. Conclusions Bonferroni-Of the 50 myopia-associated loci, we did not find any variant specifically associated with MMD, but the KCNMA1 and GJD2 loci were significantly associated with HM in highly myopic subjects with MMD, compared to emmetropes.	[Wong, Yee-Ling; Cheung, Gemmy; Hoang, Quan V.; Zhao, Wanting; Wong, Chee-Wai; Sensaki, Sonoko; Lamoureux, Ecosse; Wong, Tien-Yin; Barathi, Veluchamy A.; Cheng, Ching-Yu; Saw, Seang-Mei] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Wong, Yee-Ling; Sim, Xueling; Wong, Tien-Yin; Saw, Seang-Mei] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Wong, Yee-Ling] Essilor Inc Corp, R&D Vis Sci AMERA, Singapore, Singapore; [Hysi, Pirro; Hammond, Christopher J.] Kings Coll London, Sect Acad Ophthalmol, Sch Life Course Sci, London, England; [Cheung, Gemmy; Hoang, Quan V.; Wong, Chee-Wai; Lamoureux, Ecosse; Wong, Tien-Yin; Wang, Jie Jin; Barathi, Veluchamy A.; Cheng, Ching-Yu; Saw, Seang-Mei] Duke NUS Med Sch, Singapore, Singapore; [Cheung, Gemmy; Tsujikawa, Akitaka; Wong, Tien-Yin; Cheng, Ching-Yu; Saw, Seang-Mei] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore; [Cheung, Gemmy; Wong, Tien-Yin; Barathi, Veluchamy A.; Cheng, Ching-Yu; Saw, Seang-Mei] Natl Univ Hlth Syst, Singapore, Singapore; [Tedja, Milly; Verhoeven, Virginie; Haarman, Annechien E. G.; Klaver, Caroline C. W.] Erasmus MC, Dept Ophthalmol, Rotterdam, Netherlands; [Tedja, Milly; Verhoeven, Virginie; Haarman, Annechien E. G.; Klaver, Caroline C. W.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Hoang, Quan V.] Columbia Univ, Med Ctr, Dept Ophthalmol, New York, NY USA; [Tompson, Stuart W. J.; Whisenhunt, Kristina N.; Young, Terri L.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI USA; [Verhoeven, Virginie] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Hess, Moritz] Johannes Gutenberg Univ Mainz, Univ Med Ctr Johannes Gutenberg, Inst Med Biostat Epidemiol & Informat, Mainz, Germany; [Hess, Moritz] Univ Freiburg, Fac Med, Inst Med Biometry & Stat, Freiburg, Germany; [Hess, Moritz] Univ Freiburg, Med Ctr, Freiburg, Germany; [Kifley, Annette; Mitchell, Paul] Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Westmead Inst Med Res, Sydney, NSW, Australia; [Hosoda, Yoshikatsu; Miyake, Masahiro; Tsujikawa, Akitaka; Yamashiro, Kenji] Univ Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan; [Hopf, Susanne; Laspas, Panagiotis; Nickels, Stefan] Johannes Gutenberg Univ Mainz, Dept Ophthalmol, Univ Med Ctr, Mainz, Germany; [Ohno-Matsui, Kyoko] Tokyo Med & Dent Univ, Dept Ophthalmol & Visual Sci, Tokyo, Japan; [Yamashiro, Kenji] Otsu Red Cross Hosp, Dept Ophthalmol, Otsu, Shiga, Japan; [Klaver, Caroline C. W.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, Nijmegen, Netherlands	National University of Singapore; Singapore National Eye Center; National University of Singapore; Essilor International; University of London; King's College London; National University of Singapore; National University of Singapore; National University of Singapore; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Columbia University; University of Wisconsin System; University of Wisconsin Madison; Erasmus University Rotterdam; Erasmus MC; Johannes Gutenberg University of Mainz; University of Freiburg; University of Freiburg; University of Sydney; Westmead Institute for Medical Research; Johannes Gutenberg University of Mainz; Tokyo Medical & Dental University (TMDU); Radboud University Nijmegen	Saw, SM (corresponding author), Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore.; Saw, SM (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.; Saw, SM (corresponding author), Duke NUS Med Sch, Singapore, Singapore.; Saw, SM (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore.; Saw, SM (corresponding author), Natl Univ Hlth Syst, Singapore, Singapore.	ephssm@nus.edu.sg	wang, jie/GRS-0942-2022; Wang, Jie Jin/P-1499-2014; Wong, Tien Yin/AAC-9724-2020; Sim, Xueling/AAZ-6652-2020; Cheng, Ching-Yu/Y-2229-2019	Wang, Jie Jin/0000-0001-9491-4898; Wong, Tien Yin/0000-0002-8448-1264; Sim, Xueling/0000-0002-1233-7642; Cheng, Ching-Yu/0000-0003-0655-885X; Hysi, Pirro/0000-0001-5752-2510; Cheung, Chui Ming Gemmy/0000-0003-3358-3516; Tsujikawa, Akitaka/0000-0003-0779-7799; Tompson, Stuart/0000-0001-9788-6730	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200327] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Bloomfield SA, 2009, NAT REV NEUROSCI, V10, P495, DOI 10.1038/nrn2636; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; Broustas CG, 2004, J BIOL CHEM, V279, P26780, DOI 10.1074/jbc.M400159200; Chen C, 2015, INT SURG, V100, P1, DOI 10.9738/0020-8868-100.1.1; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; Fan Q, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11008; Fan Q, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002753; Feldkaemper M, 2013, EXP EYE RES, V114, P106, DOI 10.1016/j.exer.2013.02.007; Fernandez-Medarde A, 2009, J NEUROCHEM, V110, P641, DOI 10.1111/j.1471-4159.2009.06162.x; Foong AWP, 2007, OPHTHAL EPIDEMIOL, V14, P25, DOI 10.1080/09286580600878844; Gao Y, 2012, OPHTHAL PHYSL OPT, V32, P68, DOI 10.1111/j.1475-1313.2011.00885.x; Grimes WN, 2009, NAT NEUROSCI, V12, P585, DOI 10.1038/nn.2302; Guldenagel M, 2001, J NEUROSCI, V21, P6036, DOI 10.1523/JNEUROSCI.21-16-06036.2001; Hayashi H, 2011, INVEST OPHTH VIS SCI, V52, P4853, DOI 10.1167/iovs.11-7311; Hohn R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120476; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Hofman A, 2015, EUR J EPIDEMIOL, V30, P661, DOI 10.1007/s10654-015-0082-x; Hofman A, 2013, EUR J EPIDEMIOL, V28, P889, DOI 10.1007/s10654-013-9866-z; Hofman A, 2011, EUR J EPIDEMIOL, V26, P657, DOI 10.1007/s10654-011-9610-5; Hofman A, 2009, EUR J EPIDEMIOL, V24, P553, DOI 10.1007/s10654-009-9386-z; Holden BA, 2016, OPHTHALMOLOGY, V123, P1036, DOI 10.1016/j.ophtha.2016.01.006; Hosoda Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03649-3; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hysi PG, 2014, INVEST OPHTH VIS SCI, V55, P3344, DOI 10.1167/iovs.14-14149; Hysi PG, 2010, NAT GENET, V42, P902, DOI 10.1038/ng.664; Iwase A, 2006, OPHTHALMOLOGY, V113, P1354, DOI 10.1016/j.ophtha.2006.04.022; Jiao XD, 2012, MOL VIS, V18, P2633; Khor CC, 2013, HUM MOL GENET, V22, P5288, DOI 10.1093/hmg/ddt385; Kiefer AK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003299; Kihara AH, 2009, J COMP NEUROL, V512, P651, DOI 10.1002/cne.21920; Knaus HG, 1996, J NEUROSCI, V16, P955; Lavanya R, 2009, OPHTHAL EPIDEMIOL, V16, P325, DOI 10.3109/09286580903144738; Li YT, 2016, OPHTHALMOLOGICA, V235, P57, DOI 10.1159/000439446; Li YJ, 2011, OPHTHALMOLOGY, V118, P368, DOI 10.1016/j.ophtha.2010.06.016; Li ZQ, 2011, HUM MOL GENET, V20, P2861, DOI 10.1093/hmg/ddr169; Lin B, 2005, J NEUROSCI, V25, P6696, DOI 10.1523/JNEUROSCI.1894-05.2005; Lu BY, 2011, INVEST OPHTH VIS SCI, V52, P8258, DOI 10.1167/iovs.11-7914; Meng WH, 2012, INVEST OPHTH VIS SCI, V53, P7983, DOI 10.1167/iovs.12-10409; Misonou H, 2006, J COMP NEUROL, V496, P289, DOI 10.1002/cne.20931; Miyake M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7689; Nakanishi H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000660; Ohno-Matsui K, 2017, RETINA-J RET VIT DIS, V37, P1043, DOI 10.1097/IAE.0000000000001348; Ohno-Matsui K, 2016, PROG RETIN EYE RES, V52, P156, DOI 10.1016/j.preteyeres.2015.12.001; Ohno-Matsui K, 2015, AM J OPHTHALMOL, V159, P877, DOI 10.1016/j.ajo.2015.01.022; Oishi M, 2013, INVEST OPHTH VIS SCI, V54, P7492, DOI 10.1167/iovs.13-12825; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; Qiang Y, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-51; Rosenthal R, 2007, MOL VIS, V13, P443; Rozen S, 2000, Methods Mol Biol, V132, P365; Sangwan SK, 2017, ESSENT OPHTHALMOL, P403, DOI 10.1007/978-4-431-56511-6_28; Schache M, 2013, OPHTHALMOLOGY, V120, P292, DOI 10.1016/j.ophtha.2012.08.006; Seeliger MW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1540; Seko Y, 1999, INVEST OPHTH VIS SCI, V40, P3287; Shi Y, 2013, HUM MOL GENET, V22, P2325, DOI 10.1093/hmg/ddt066; Sohl G, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-27; Solouki AM, 2010, NAT GENET, V42, P897, DOI 10.1038/ng.663; Stambolian D, 2013, HUM MOL GENET, V22, P2754, DOI 10.1093/hmg/ddt116; Sun XL, 2003, J NEUROSCI, V23, P3639; Tedja MS, 2018, NAT GENET, V50, P834, DOI 10.1038/s41588-018-0127-7; Tideman JWL, 2016, GENET EPIDEMIOL, V40, P756, DOI 10.1002/gepi.21999; TURNER SC, 2006, TRIGGLE VOLTAGE GATE, P310; Verhoeven VJM, 2013, NAT GENET, V45, P314, DOI 10.1038/ng.2554; Verhoeven VJM, 2012, HUM GENET, V131, P1467, DOI 10.1007/s00439-012-1176-0; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wimmers S, 2007, PROG RETIN EYE RES, V26, P263, DOI 10.1016/j.preteyeres.2006.12.002; Wimmers S, 2008, MOL VIS, V14, P2340; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; WOLFMAN A, 1990, SCIENCE, V248, P67, DOI 10.1126/science.2181667; Wong TY, 2014, AM J OPHTHALMOL, V157, P9, DOI 10.1016/j.ajo.2013.08.010; Wong YL, 2016, ASIA-PAC J OPHTHALMO, V5, P394, DOI 10.1097/APO.0000000000000234; Xu L, 2006, AM J OPHTHALMOL, V141, P591, DOI 10.1016/j.ajo.2005.10.018; Yoshikawa M, 2014, INVEST OPHTH VIS SCI, V55, P7343, DOI 10.1167/iovs.14-15105; Yu ZQ, 2012, OPHTHALMOLOGICA, V228, P123, DOI 10.1159/000338188	74	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2019	14	8							e0220143	10.1371/journal.pone.0220143	http://dx.doi.org/10.1371/journal.pone.0220143			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5KK	31415580	Green Published, Green Submitted, gold			2022-12-26	WOS:000485017200010
J	Koerner, C; Miller, M; Brielmeier, M				Koerner, Carolin; Miller, Manuel; Brielmeier, Markus			Detection of Murine Astrovirus and Myocoptes musculinus in individually ventilated caging systems: Investigations to expose suitable detection methods for routine hygienic monitoring	PLOS ONE			English	Article							EXHAUST-AIR; INFECTION; ERADICATION; DIAGNOSIS; PREVALENCE; DISEASE; BIOLOGY; MOUSE; MICE; AGE	Murine Astrovirus is one of the most prevalent viral agents in laboratory rodent facilities worldwide, but its influence on biomedical research results is poorly examined. Due to possible influence on research results and high seroprevalence rates in mice, it appears useful to include this virus into routine health monitoring programs. In order to establish exhaust air particle PCR as a reliable detection method for Murine Astrovirus infections in mice kept in individually ventilated cages (IVC) and compare the method to sentinel mice monitoring regarding reproducibility and detection limit, we conducted a study with defined Murine Astrovirus cage prevalence. In parallel, the efficacy of both detection strategies (soiled-bedding sentinel (SBS) and exhaust air dust (EAD) analysis) was tested for Myocoptes musculinus. The fur mite was used as a reference organism during the whole study period to ensure the validity of this method. Because some publications already demonstrated successful detection of several pathogens, including murine fur mite species, via EAP-PCR. Detection of Murine Astrovirus infections at low prevalence is possible with both methods tested. Detection by exhaust air particles (EAP) is faster, more sensitive and more reliable compared to soiled bedding sentinels (SBS). Exhaust air particle PCR also detected the reference organism Myocoptes musculinus, which was not detected at all by sentinel mice, not even by high sensitivity fur swab qPCR. In conclusion, Murine Astrovirus can be detected by both exhaust air particle PCR and soiled bedding sentinels. We recommend exhaust air particle PCR as the better detection technique for Murine Astrovirus, because it is more reliable. Environmental samples are the method of choice for detection of Myocoptes musculinus because relying on soiled bedding sentinels harbors a big risk of missing existing infestations.	[Koerner, Carolin; Miller, Manuel; Brielmeier, Markus] Helmholtz Zentrum Munchen, Res Unit Comparat Med, German Res Ctr Environm Hlth, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Brielmeier, M (corresponding author), Helmholtz Zentrum Munchen, Res Unit Comparat Med, German Res Ctr Environm Hlth, Neuherberg, Germany.	brielmeier@helmholtz-muenchen.de	Körner, Carolin/AAT-7799-2020					Arbona RJR, 2010, J AM ASSOC LAB ANIM, V49, P564; Arbona RJR, 2010, J AM ASSOC LAB ANIM, V49, P633; Arbona RJR, 2010, J AM ASSOC LAB ANIM, V49, P583; Bauer BA, 2016, J AM ASSOC LAB ANIM, V55, P782; Brown JR, 2015, CLIN INFECT DIS, V60, P881, DOI 10.1093/cid/ciu940; Compton S J, 2017, JOURNAL OF THE AMERI; Compton SR, 2004, COMPARATIVE MED, V54, P382; Cordey S, 2016, EMERG INFECT DIS, V22, P846, DOI [10.3201/eid2205.150807, 10.3201/eid2205.151807]; Cortez V, 2017, ANNU REV VIROL, V4, P327, DOI 10.1146/annurev-virology-101416-041742; De Benedictis P, 2011, INFECT GENET EVOL, V11, P1529, DOI 10.1016/j.meegid.2011.07.024; Donato C, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050102; Farkas T, 2012, VIRUS GENES, V45, P518, DOI 10.1007/s11262-012-0803-0; Fox J., 2006, MOUSE BIOMEDICAL RES; Fremond ML, 2015, J PEDIAT INF DIS SOC, V4, pE53, DOI 10.1093/jpids/piv040; Gerwin PM, 2017, J AM ASSOC LAB ANIM, V56, P752; Glass RI, 1996, ARCH VIROL, P287; Grove KA, 2012, J AM ASSOC LAB ANIM, V51, P789; Hedrich HJ, 2012, LABORATORY MOUSE, P1; Jensen ES, 2013, J AM ASSOC LAB ANIM, V52, P28; Johnson C, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010022; KJELDSBERG E, 1985, ARCH VIROL, V84, P135, DOI 10.1007/BF01310560; Kriston S, 1996, EPIDEMIOL INFECT, V117, P159, DOI 10.1017/S0950268800001266; Li LL, 2013, EMERG INFECT DIS, V19, P1385, DOI 10.3201/eid1909.130682; Lindstrom KE, 2011, J AM ASSOC LAB ANIM, V50, P54; Liu N, 2014, VET MICROBIOL, V170, P39, DOI 10.1016/j.vetmic.2014.01.026; Mahler M, 2014, LAB ANIM-UK, V48, P178, DOI 10.1177/0023677213516312; Manuel CA, 2016, J AM ASSOC LAB ANIM, V55, P58; Martella V, 2011, EMERG INFECT DIS, V17, P2287, DOI 10.3201/eid1712.110967; Miller M, 2016, J VET SCI TECHNOL, V7, P1, DOI [10.4172/2157-7579.1000343, DOI 10.4172/2157-7579.1000343]; Miller M, 2018, LAB ANIM-UK, V52, P233, DOI 10.1177/0023677217739329; Miller M, 2016, J AM ASSOC LAB ANIM, V55, P775; Mitchell DK, 1999, PEDIATR INFECT DIS J, V18, P249, DOI 10.1097/00006454-199903000-00008; Moats CR, 2015, COMPARATIVE MED, V66, P197; Naccache SN, 2015, CLIN INFECT DIS, V60, P919, DOI 10.1093/cid/ciu912; Ng TFF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066937; Quan PL, 2010, EMERG INFECT DIS, V16, P918, DOI 10.3201/eid1606.091536; Rice KA, 2013, J AM ASSOC LAB ANIM, V52, P773; Russell WMS., 1959, MED J AUSTRALIA; Sajewicz-Krukowska J, 2016, ARCH VIROL, V161, P2581, DOI 10.1007/s00705-016-2940-6; Sato M, 2016, J CLIN VIROL, V78, P66, DOI 10.1016/j.jcv.2016.03.010; Schmidt K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187174; Walter JE, 2003, CURR OPIN INFECT DIS, V16, P247, DOI 10.1097/00001432-200306000-00011; Wasimuddin, 2018, ISME J, V12, P2883, DOI 10.1038/s41396-018-0239-1; Weiss EE, 2012, J AM ASSOC LAB ANIM, V51, P574; WOOD DJ, 1988, J MED VIROL, V24, P435, DOI 10.1002/jmv.1890240410; Wunderli W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027483; Yokoyama CC, 2012, J VIROL, V86, P12262, DOI 10.1128/JVI.02018-12; Zorn J, 2017, LAB ANIM-UK, V51, P301, DOI 10.1177/0023677216661586	48	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0221118	10.1371/journal.pone.0221118	http://dx.doi.org/10.1371/journal.pone.0221118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408494	Green Published, gold, Green Submitted			2022-12-26	WOS:000485009500042
J	Leicht, K; Jokela, J; Seppala, O				Leicht, Katja; Jokela, Jukka; Seppala, Otto			Inbreeding does not alter the response to an experimental heat wave in a freshwater snail	PLOS ONE			English	Article							CLIMATE-CHANGE; IMMUNE DEFENSE; LYMNAEA-STAGNALIS; ANTIMICROBIAL PEPTIDES; HABITAT FRAGMENTATION; EXTREME TEMPERATURES; MASS MORTALITY; DEPRESSION; DROSOPHILA; STRESS	Global climate change affects natural populations of many species by increasing the average temperature and the frequency of extreme weather events (e.g. summer heat waves). The ability of organisms to cope with these environmental changes can, however, depend on their genetic properties. For instance, genetic load owing to inbreeding could alter organisms' responses to climate change-mediated environmental changes but such effects are often overlooked. We investigated the effects of an experimental heat wave (25 degrees C versus 15 degrees C) on life history (reproduction, size) and constitutive immune defence traits (phenoloxidase-like and antibacterial activity of haemolymph) in relation to inbreeding by manipulating the mating type (outcrossing, self-fertilization) in two populations of a hermaphroditic freshwater snail, Lymnaea stagnalis. High temperature increased reproduction and size of snails but impaired their immune function. In one of the two study populations, inbreeding reduced reproductive output of snails indicating inbreeding depression. Furthermore, this effect did not depend on the temperature snails were exposed to. Our results suggest that L. stagnalis snails can be negatively affected by inbreeding but it may not alter their responses to heat waves.	[Leicht, Katja; Jokela, Jukka; Seppala, Otto] Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, Dubendorf, Switzerland; [Leicht, Katja] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Jokela, Jukka; Seppala, Otto] Swiss Fed Inst Technol, Inst Integrat Biol IBZ, Zurich, Switzerland; [Seppala, Otto] Univ Innsbruck, Res Dept Limnol, Mondsee, Austria	Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Jyvaskyla; ETH Zurich; University of Innsbruck	Seppala, O (corresponding author), Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, Dubendorf, Switzerland.; Seppala, O (corresponding author), Swiss Fed Inst Technol, Inst Integrat Biol IBZ, Zurich, Switzerland.; Seppala, O (corresponding author), Univ Innsbruck, Res Dept Limnol, Mondsee, Austria.	otto.seppaelae@env.ethz.ch		Seppala, Otto/0000-0001-7902-3069	Biological Interactions Doctoral Program (BIOINT); Emil Aaltonen Foundation; Swiss National Science Foundation [31003A 140876, 31003A 169531]	Biological Interactions Doctoral Program (BIOINT); Emil Aaltonen Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was supported by the Biological Interactions Doctoral Program (BIOINT) to KL, and the Emil Aaltonen Foundation and Swiss National Science Foundation (grants 31003A 140876 and 31003A 169531) to OS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, NAT CLIM CHANGE, DOI [10.1038/nclimate1627, DOI 10.1038/NCLIMATE1627]; Armbruster P, 2005, HEREDITY, V95, P235, DOI 10.1038/sj.hdy.6800721; Bijlsma R, 1999, J EVOLUTION BIOL, V12, P1125, DOI 10.1046/j.1420-9101.1999.00113.x; Boldt R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064489; Busch JW, 2005, HEREDITY, V94, P159, DOI 10.1038/sj.hdy.6800584; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; Christidis N, 2015, NAT CLIM CHANGE, V5, P46, DOI [10.1038/nclimate2468, 10.1038/NCLIMATE2468]; Crnokrak P, 1999, HEREDITY, V83, P260, DOI 10.1038/sj.hdy.6885530; DAHLGAARD J, 1995, HEREDITY, V74, P157, DOI 10.1038/hdy.1995.23; David JR, 2005, J EVOLUTION BIOL, V18, P838, DOI 10.1111/j.1420-9101.2005.00914.x; Doums C, 1996, EVOLUTION, V50, P1908, DOI [10.2307/2410749, 10.1111/j.1558-5646.1996.tb03578.x]; Enders LS, 2012, P ROY SOC B-BIOL SCI, V279, P3756, DOI 10.1098/rspb.2012.1018; Faltynkova A, 2007, PARASITE, V14, P39, DOI 10.1051/parasite/2007141039; Fox CW, 2011, EVOLUTION, V65, P246, DOI 10.1111/j.1558-5646.2010.01108.x; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Hance T, 2007, ANNU REV ENTOMOL, V52, P107, DOI 10.1146/annurev.ento.52.110405.091333; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hou QQ, 2014, BIOL INVASIONS, V16, P2049, DOI 10.1007/s10530-014-0647-8; Hughes RN, 2009, BIOL J LINN SOC, V98, P519, DOI 10.1111/j.1095-8312.2009.01312.x; Imler Jean-Luc, 2005, V86, P1, DOI 10.1159/000086648; Joubert D, 2010, CLIM RES, V43, P57, DOI 10.3354/cr00883; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kirtman B, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P953; Kopp KC, 2012, EVOL ECOL, V26, P483, DOI 10.1007/s10682-011-9504-8; KREBS RA, 1994, J EVOLUTION BIOL, V7, P39, DOI 10.1046/j.1420-9101.1994.7010039.x; Langeloh L, 2017, EVOLUTION, V71, P227, DOI 10.1111/evo.13148; Le Clec'h W, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1319-6; Leicht K, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0988-x; Leicht K, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-192; Leicht K, 2013, ECOL EVOL, V3, P4861, DOI 10.1002/ece3.874; Leimu R, 2010, ANN NY ACAD SCI, V1195, P84, DOI 10.1111/j.1749-6632.2010.05450.x; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; MILLER PS, 1994, ZOO BIOL, V13, P195, DOI 10.1002/zoo.1430130302; Mitta G, 2000, FEBS LETT, V486, P185, DOI 10.1016/S0014-5793(00)02192-X; Moret Y, 2006, P R SOC B, V273, P1399, DOI 10.1098/rspb.2006.3465; Nakadera Y, 2017, J MOLLUS STUD, V83, P56, DOI 10.1093/mollus/eyw043; Nakadera Y, 2014, J MOLLUS STUD, V80, P1, DOI 10.1093/mollus/eyt049; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PECHENIK JA, 1995, PARASITOLOGY, V111, P373, DOI 10.1017/S0031182000081920; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Puurtinen M, 2007, J EVOLUTION BIOL, V20, P901, DOI 10.1111/j.1420-9101.2007.01312.x; Puurtinen M, 2004, EVOLUTION, V58, P2747, DOI 10.1111/j.0014-3820.2004.tb01626.x; RICH SS, 1979, EVOLUTION, V33, P579, DOI [10.2307/2407781, 10.1111/j.1558-5646.1979.tb04711.x]; Rigby MC, 2000, P ROY SOC B-BIOL SCI, V267, P171, DOI 10.1098/rspb.2000.0983; Roth O, 2010, MAR BIOL, V157, P1605, DOI 10.1007/s00227-010-1433-5; Sadd BM, 2007, CURR BIOL, V17, pR1046, DOI 10.1016/j.cub.2007.11.007; Salo T, 2018, OIKOS, V127, P1437, DOI 10.1111/oik.05310; Salo T, 2017, FRESHWATER BIOL, V62, P1831, DOI 10.1111/fwb.12999; Schiegg K, 2002, P ROY SOC B-BIOL SCI, V269, P1153, DOI 10.1098/rspb.2002.1966; Seppala O, 2011, BIOL LETTERS, V7, P119, DOI 10.1098/rsbl.2010.0459; Seppala O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161584; Seppala O, 2013, J EXP BIOL, V216, P2902, DOI 10.1242/jeb.084947; Sminia T., 1981, INVERTEBRATE BLOOD C, P191; VAUGHN CM, 1953, AM MIDL NAT, V49, P214, DOI 10.2307/2422289; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wegner KM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-124; White JD, 2015, CAN J FISH AQUAT SCI, V72, P1221, DOI 10.1139/cjfas-2015-0064	60	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220669	10.1371/journal.pone.0220669	http://dx.doi.org/10.1371/journal.pone.0220669			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393914	Green Published, gold, Green Submitted			2022-12-26	WOS:000485002500050
J	Salinas, J; Lin, HH; Aparico, HJ; Huan, TX; Liu, CY; Rong, J; Beiser, A; Himali, JJ; Freedman, JE; Larson, MG; Rosand, J; Soreq, H; Levy, D; Seshadri, S				Salinas, Joel; Lin, Honghuang; Aparico, Hugo J.; Huan, Tianxiao; Liu, Chunyu; Rong, Jian; Beiser, Alexa; Himali, Jayandra J.; Freedman, Jane E.; Larson, Martin G.; Rosand, Jonathan; Soreq, Hermona; Levy, Daniel; Seshadri, Sudha			Whole blood microRNA expression associated with stroke: Results from the Framingham Heart Study	PLOS ONE			English	Article							CIRCULATING MICRORNAS; ATRIAL-FIBRILLATION; CARDIOVASCULAR-DISEASE; POTENTIAL BIOMARKERS; HEPATIC STEATOSIS; ISCHEMIC-STROKE; SEVERITY; THERAPY; UPDATE; BRAIN	Emerging evidence suggests microRNAs (miRNAs) may play an important role in explaining variation in stroke risk and recovery in humans, yet there are still few longitudinal studies examining the association between whole blood miRNAs and stroke. Accounting for multiple testing and adjusting for potentially confounding technical and clinical variables, here we show that whole blood miR-574-3p expression was significantly lower in participants with chronic stroke compared to non-cases. To explore the functional relevance of our findings, we analyzed miRNA-mRNA whole blood co-expression, pathway enrichment, and brain tissue gene expression. Results suggest miR-574-3p is involved in neurometabolic and chronic neuronal injury response pathways, including brain gene expression of DBNDD2 and ELOVL1. These results suggest miR-574-3p plays a role in regulating chronic brain and systemic cellular response to stroke and thus may implicate miR-574-3p as a partial mediator of long-term stroke outcomes.	[Salinas, Joel; Lin, Honghuang; Aparico, Hugo J.; Huan, Tianxiao; Liu, Chunyu; Rong, Jian; Beiser, Alexa; Himali, Jayandra J.; Larson, Martin G.; Levy, Daniel; Seshadri, Sudha] Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA; [Salinas, Joel; Rosand, Jonathan] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Henry & Allison McCance Ctr Brain Hlth, Boston, MA 02115 USA; [Lin, Honghuang] Boston Univ, Sch Med, Dept Med, Sect Computat Biomed, Boston, MA 02118 USA; [Aparico, Hugo J.; Rong, Jian; Beiser, Alexa; Himali, Jayandra J.; Seshadri, Sudha] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Beiser, Alexa; Himali, Jayandra J.; Larson, Martin G.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Freedman, Jane E.] Univ Massachusetts, Med Sch, Dept Med, Worcester, MA 01605 USA; [Larson, Martin G.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Rosand, Jonathan] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Soreq, Hermona] Hebrew Univ Jerusalem, Life Sci Inst, Dept Biol Chem, Jerusalem, Israel; [Soreq, Hermona] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel; [Levy, Daniel] NHLBI, Populat Sci Branch, Div Intramural Res, Bldg 10, Bethesda, MD 20892 USA; [Seshadri, Sudha] Univ Texas Hlth Sci Ctr San Antonio, Glenn Biggs Inst Alzheimers & Neurodegenerat Dis, San Antonio, TX 78229 USA	Framingham Heart Study; Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston University; Boston University; Boston University; University of Massachusetts System; University of Massachusetts Worcester; Boston University; Harvard University; Massachusetts General Hospital; Hebrew University of Jerusalem; Hebrew University of Jerusalem; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Texas System; University of Texas Health San Antonio	Salinas, J (corresponding author), Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA.; Salinas, J (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Henry & Allison McCance Ctr Brain Hlth, Boston, MA 02115 USA.	joelsalinas@mail.harvard.edu	Levy, Daniel/ABB-2752-2021; Salinas, Joel/AGH-5046-2022; Huan, Tianxiao/AAF-3577-2021; Levy, Daniel/ABF-6873-2021; Aparicio, Hugo/M-2051-2014	Salinas, Joel/0000-0002-3735-0018; Levy, Daniel/0000-0003-1843-8724; /0000-0003-1391-9481; Soreq, Hermona/0000-0002-0955-526X; Aparicio, Hugo/0000-0001-8584-1455; Huan, Tianxiao/0000-0001-5840-9413; Seshadri, Sudha/0000-0001-6135-2622	Robert Katzman Research Training Fellowship in Alzheimer's and Dementia Research - American Academy of Neurology; American Brain Foundation; Alzheimer's Association;  [P30AG10161];  [R01AG15819];  [R01AG17917];  [R01AG30146];  [R01AG36836];  [U01AG32984];  [U01AG46152];  [N01-HC 25195];  [HHSN268201500001I];  [75N92019D00031];  [NS017950];  [UH2NS100605];  [AG049505];  [AG052409];  [AG054076];  [AG049607];  [AG059421];  [T32NS048005];  [AG057760]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [UH2NS100605, R01NS017950, T32NS048005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG052409, RF1AG059421, U01AG032984, U01AG046152, R01AG015819, P30AG010161, R01AG030146, R01AG017917] Funding Source: NIH RePORTER	Robert Katzman Research Training Fellowship in Alzheimer's and Dementia Research - American Academy of Neurology; American Brain Foundation; Alzheimer's Association(Alzheimer's Association); ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by P30AG10161, R01AG15819, R01AG17917, R01AG30146, R01AG36836, U01AG32984, and U01AG46152 to the Rush Alzheimer's Disease Center; N01-HC 25195, HHSN268201500001I, and 75N92019D00031 to the FHS; NS017950, UH2NS100605, AG049505, AG052409, AG054076, AG049607, and AG059421 to SS; T32NS048005, AG057760, and the Robert Katzman Research Training Fellowship in Alzheimer's and Dementia Research Cosponsored by the American Academy of Neurology, the American Brain Foundation, and the Alzheimer's Association to JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P628; Bryant RJ, 2012, BRIT J CANCER, V106, P768, DOI 10.1038/bjc.2011.595; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Carandang R, 2006, JAMA-J AM MED ASSOC, V296, P2939, DOI 10.1001/jama.296.24.2939; Dufouil C, 2017, CIRCULATION, V135, P1145, DOI 10.1161/CIRCULATIONAHA.115.021275; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Farazi TA, 2013, ADV EXP MED BIOL, V774, P1, DOI 10.1007/978-94-007-5590-1_1; Freedman JE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11106; Freedman Jane E, 2012, F1000Res, V1, P50, DOI 10.12688/f1000research.1-50.v1; Hanin G, 2014, HUM MOL GENET, V23, P4569, DOI 10.1093/hmg/ddu170; Huan TX, 2015, ARTERIOSCL THROM VAS, V35, P1011, DOI 10.1161/ATVBAHA.114.305176; Huan TX, 2013, ARTERIOSCL THROM VAS, V33, P1427, DOI 10.1161/ATVBAHA.112.300112; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI 10.1016/S2214-109X(13)70089-5; Lai ZM, 2018, BIOMED PHARMACOTHER, V97, P162, DOI 10.1016/j.biopha.2017.10.062; Li PF, 2015, CELL MOL NEUROBIOL, V35, P433, DOI 10.1007/s10571-014-0139-5; Li WY, 2014, J HUM HYPERTENS, V28, P288, DOI 10.1038/jhh.2013.94; Li William A, 2017, Neurol Res, P1, DOI 10.1080/01616412.2017.1327505; Lin HJ, 1996, STROKE, V27, P1760, DOI 10.1161/01.STR.27.10.1760; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Lucas T, 2005, STEM CELLS DEV, V14, P556, DOI 10.1089/scd.2005.14.556; McKimmie RL, 2008, AM J GASTROENTEROL, V103, P3029, DOI 10.1111/j.1572-0241.2008.02188.x; McManus DD, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3533-9; McManus DD, 2015, HEART RHYTHM, V12, P3, DOI 10.1016/j.hrthm.2014.09.050; McManus DD, 2014, HEART RHYTHM, V11, P663, DOI 10.1016/j.hrthm.2014.01.018; Mellinger JL, 2015, J HEPATOL, V63, P470, DOI 10.1016/j.jhep.2015.02.045; Mick E, 2017, STROKE, V48, P828, DOI 10.1161/STROKEAHA.116.015140; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Rao P, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00039; Rink C, 2011, PHYSIOL GENOMICS, V43, P521, DOI 10.1152/physiolgenomics.00158.2010; Schackmann MJA, 2015, BBA-MOL CELL BIOL L, V1851, P231, DOI 10.1016/j.bbalip.2014.12.005; Sepramaniam S, 2014, INT J MOL SCI, V15, P1418, DOI 10.3390/ijms15011418; Shah V, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00272; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Soreq H, 2015, TRENDS NEUROSCI, V38, P448, DOI 10.1016/j.tins.2015.05.007; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Sudlow CLM, 1997, STROKE, V28, P491, DOI 10.1161/01.STR.28.3.491; Summerer I, 2015, BRIT J CANCER, V113, P76, DOI 10.1038/bjc.2015.111; Volny O, 2015, ADV EXP MED BIOL, V888, P155, DOI 10.1007/978-3-319-22671-2_9; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang WH, 2014, J STROKE CEREBROVASC, V23, P2607, DOI 10.1016/j.jstrokecerebrovasdis.2014.06.002; WOLF PA, 1970, NEUROLOGY, V20, P373; Yang DG, 2012, CHINESE MED J-PEKING, V125, P3479, DOI 10.3760/cma.j.issn.0366-6999.2012.19.021; Yin HS, 2006, BIOCHEMISTRY-US, V45, P5297, DOI 10.1021/bi052354e; Zhou J, 2015, J ALZHEIMERS DIS, V43, P479, DOI 10.3233/JAD-140666; Zou FG, 2008, HUM MOL GENET, V17, P929, DOI 10.1093/hmg/ddm365	51	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0219261	10.1371/journal.pone.0219261	http://dx.doi.org/10.1371/journal.pone.0219261			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393881	Green Published, gold, Green Submitted			2022-12-26	WOS:000485002500008
J	Vossius, C; Selbaek, G; Benth, JS; Wimo, A; Engedal, K; Kirkevold, O; Rokstad, AMM				Vossius, C.; Selbaek, G.; Benth, J. Saltyte; Wimo, A.; Engedal, K.; Kirkevold, O.; Rokstad, A. M. M.			Cost analysis of day care centres in Norway	PLOS ONE			English	Article							DEMENTIA; PEOPLE; SCALE	Background Day care services aim to offer meaningful activities and a safe environment for the attendees and a respite for family caregivers while being cost effective. This study compares the use of formal and informal care in users and non-users of day care centres designed for persons with dementia. Method Users of day care designed for dementia (DC group) and non-users (NDC group) were followed over a period of 24 months or until nursing home admission (NHA) respectively death. Demographic and clinical characteristics were collected at baseline and after 12 and 24 months. The use of care was recorded by Resource Utilization in Dementia (RUD). Results A total of 257 persons with dementia participated in the study, 181 in the DC group and 76 in the NDC group. Users of day care centres cause higher costs due to the expenses for day care, while neither the use of home nursing, secondary care, informal care nor the time until NHA did show any differences between users and non-users. The overall costs were higher in the DC group at baseline and after 12 months, but this difference was no longer present at the end of the two-year study period. Conclusion Our results indicate no potential cost-saving effect of day care designed for people with dementia, as the use of day care did neither result in a reduced use of care nor in a delay of NHA. Future research should balance the non-monetary benefits of day care against its costs for a full cost-effectiveness analysis, most favourable in a RCT-design.	[Vossius, C.] Stavanger Univ Hosp, Ctr Age Related Med, Stavanger, Norway; [Vossius, C.; Benth, J. Saltyte; Kirkevold, O.] Innlandet Hosp Trust, Res Ctr Agerelated Funct Decline & Dis, Brumunddal, Norway; [Selbaek, G.; Engedal, K.; Kirkevold, O.; Rokstad, A. M. M.] Vestfold Hosp Trust, Norwegian Natl Advisory Unit Ageing & Hlth, Tonsberg, Norway; [Selbaek, G.; Benth, J. Saltyte] Univ Oslo, Inst Clin Med, Oslo, Norway; [Selbaek, G.; Engedal, K.] Oslo Univ Hosp, Dept Geriatr Med, Oslo, Norway; [Benth, J. Saltyte] Akershus Univ Hosp, Hlth Serv Res Unit, Nordbyhagen, Norway; [Wimo, A.] Karolinska Inst, Dept Neurobiol Care Sci & Soc NVS, Div Neurogeriatr, Stockholm, Sweden; [Wimo, A.] Uppsala Univ, Ctr Res & Dev, Cty Council Gavleborg, Gavle, Sweden; [Kirkevold, O.] Norwegian Univ Sci & Technol NTNU, Dept Hlth Sci Gjovik, Gjovik, Norway; [Rokstad, A. M. M.] Molde Univ Coll, Fac Hlth Sci & Social Care, Molde, Norway	Stavanger University Hospital; Innlandet Hospital Trust; University of Oslo; University of Oslo; University of Oslo; Karolinska Institutet; Uppsala University; Norwegian University of Science & Technology (NTNU); Molde University College	Vossius, C (corresponding author), Stavanger Univ Hosp, Ctr Age Related Med, Stavanger, Norway.; Vossius, C (corresponding author), Innlandet Hosp Trust, Res Ctr Agerelated Funct Decline & Dis, Brumunddal, Norway.	c.vossius@hotmail.com	Wimo, Anders/ABA-2678-2021	Selbaek, Geir/0000-0001-6511-8219; Rokstad, Anne Marie Mork/0000-0002-3713-1229	Norwegian Research Council as part of the Health, Care and Welfare Services Research (HELSEVEL) programme [222083]	Norwegian Research Council as part of the Health, Care and Welfare Services Research (HELSEVEL) programme	The study was funded by unrestricted grants from the Norwegian Research Council as part of the Health, Care and Welfare Services Research (HELSEVEL) programme, project number 222083.; We would like to thank the municipalities of Harstad and Songdalen, Innlandet Hospital Trust and SESAM-Centre for Age-Related Medicine and our colleagues at the Norwegian National Advisory Unit on Ageing and Health for assisting with the recruitment of participants and data collection.	Abramson CM, 2009, INT J AGING HUM DEV, V68, P65, DOI 10.2190/AG.68.1.d; Arksey H, 2004, REV RESPITE SERVICES; Costa N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/852368; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Dahm KT, 2014, EFFECT DAY CARE CTR; ENGEDAL K, 1989, Scandinavian Journal of Primary Health Care, V7, P161, DOI 10.3109/02813438909087234; Fields NL, 2014, J APPL GERONTOL, V33, P130, DOI 10.1177/0733464812443308; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gaugler J E, 2001, J Aging Soc Policy, V12, P23, DOI 10.1300/J031v12n02_03; Greene J G, 1982, Age Ageing, V11, P121, DOI 10.1093/ageing/11.2.121; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; JOHANNESSON M, 1991, HEALTH POLICY, V18, P141, DOI 10.1016/0168-8510(91)90095-F; Landmark, 2011, EFFEKTEN TILRETTELAG; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lyketsos CG, 1999, J AM GERIATR SOC, V47, P487, DOI 10.1111/j.1532-5415.1999.tb07245.x; Mavall L., 2007, DEMENTIA, V6, P27, DOI DOI 10.1177/1471301207075627; Norwegian Ministry of Health and Care Services, 2008, DEM PLAN 2015 MAK MO; Norwegian Ministry of Health and Care Services, 2015, DEM PLAN 2020 MOR DE; O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P1091, DOI 10.1001/archneur.65.8.1091; O'Shea E., 2000, 60 NAT COUNC AG OLD; Rokstad AM, 2014, J CLIN TRIALS, V4, P2167; Rokstad AMM, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3686-5; SBU. Dementia, 2008, 172E13 SBU; Statistics Norway, EARN; Statistics Norway, CONS PRIC IND; Tretteteig S, 2016, AGING MENT HEALTH, V20, P450, DOI 10.1080/13607863.2015.1023765; Vossius C, 2015, RESSURSBRUK SYKDOMSF, P1; WIMO A, 1994, HEALTH ECON, V3, P395, DOI 10.1002/hec.4730030607; Wimo A WB, 2003, BRAIN AGING, V3, P48; Wimo Anders, 1993, Scandinavian Journal of Primary Health Care, V11, P117, DOI 10.3109/02813439308994913; World Health Organization, 1992, ICD 10 CLASSIFICATIO	31	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0219568	10.1371/journal.pone.0219568	http://dx.doi.org/10.1371/journal.pone.0219568			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5EW	31393890	Green Published, Green Submitted, gold			2022-12-26	WOS:000485002500013
